>EGALAKHO_00001 hypothetical protein
MALTAAVNIKTDVNCKGDATGSATASATGGTGIYSYSWNTSPAQTSATANNLIAGTYIVT
VTDEKGCTDTESVTITEPELILSATKSQINVSCGGASSGSATVVVSGGTTPYTYSWNTTP
AQTSATANNLIAGSYSVIITDAKGCTITESFEIIDGDSVLPVINPLPITSTINCPALPVF
AQATATDENGTIASLTYEDTVTPGNCTGSYTITRTWTAKDACENISLPVSQTIIVQDITA
PTWTTQISSLNQTIECSNTEALASAQALFPIADDTCDSDVSDIVKISSKFVASEGCSNAG
TYTNTWTVKDDCGNSSETFTQVITIQDTTAPVFTGNLPQNITVSCDAVPQPATVEASDNC
NGDLPIVFSEVKSDVQNECGTNYTLTRTWTTSDCGGNQASYIQIIKVEDTTPPTGTAPSD
VANLQNIADIPTGSASDITNAADNCSANVNITVSDTNNGASGCDGNAYILTRTYTLTDCA
GNKTVLVQTFTVDNKVSVSGVASNVTCLGKSDGSILVTSSPGSTVIITNANNEVVGSTNL
PAGTYTLTATSSVNNENQTCTATATVIITEPNYTIKVSGQVINVETNTPIANVPITLIPQ
GTTPGPILFRLTGADGMYSFSGMVAGSYLVQVQDANLNSAYELYPVDSSLFFTTLEECKF
QVHNFEYGKSKLPVLGDYVWYDTNGNGIQDEWYDANNDGIVTKNIPDAEGAIDYSLWEWI
DFNGDGSYAGPQNVGELNAGGFGNALSSNVIIDGPNGYHDEVIVGIQGYWRNRPESANPY
GQYNVKLVRDTNLDAVAAALGVTGLVKVIPSLNDKKIASKINKTQLHTVCQTTTDAGYIV
NITPEDLVHLDLDFGVNCKEYKDIVANDDTAGPIAGVNHTTTNVLNVLPNDTIEGVVVTA
SDVIITTVTPNEFLQLNPDGSVDVLPNAPVGTLTMVYQICEADQTSNCDTATVTVTIEAP
VMTVSATPICVNDVPYVDYVVTPGNFTPVNGVTIAWADSNNNVITTMNNLPLSGRVLWPG
AVVDQAGNGVDWPGWLFQNNQWIQGADGFETLRPTATLTISVNPSQTIVVNYPPADPYCI
ARPTFAIVANDDTAGPISGNTGGTNVVNVYTNDTLNGNALNPADVTLTTVTPDPTGTLTL
NPDGSVNVAPNTPTGTYVLTYQICENADFGNCDTAIVTVIVINTPPAPPVVNALADTYSV
NCNGYGNVGNVLSNDTIDLSPALIGLLNFTLLPSTNGNAGITVDGSGNVNVATTTPPGTY
NYDYQICLKNYPQVCTTRTITITVVPNVTNLASEACADDSTPIDLLSLLPANTPANGTWV
DTNGSNALQGSILNPFGLALGNYVFEYKIADQSCPRTILLSMEINDDCKVLACGNVVVHN
AFSPNGDGINDVFTIDSIDEITCYPENTVEIYNRWGILVFETSNYNNTTNAFDGTSRGRT
TVNKSDGLPTGTYFYIINYKSLDGNNVMQSNKKDGYLYLSK
>EGALAKHO_00002 hypothetical protein
MRTKLFSFVIMFVTIAGFAQQDAQFTQYMYNTININPAYAGSRGALSVFGLYRTQWVGLD
GAPETSSFSVNTPINNSNVGIGASLVNDKIGPTNENNISVDLSYTVQTSANFKLSFGIKG
TANIFNLDVSKLNPEDAGDPQFQDLDNKFSPNVGAGVYWHSDKAYIGLSVPNFIETNRYD
DNDVAIYKDKINYYLMAGYVFDLDKYQYVKFKPAVLTKMVEGAPLQVDISANFMFVDKFV
VGVAYRWSASLSAMVGFQITDGLYLGYGYDRETTNLNNYNSGSHEIFLRYEFFKNNGKMT
TPRFF
>EGALAKHO_00003 Outer membrane porin F
MKNCTLLCLTIATVFSFDGYAQQSKINAADKKYDSYAYIDAIKTYEKVANKGYKSEDMFK
KLGNAYYFNSDFEGAAKWYGELFAMNTAVEPEYYYRYAQSLKSTGQIEKANKLLSEFNAK
NKTDNRAKLYEEDMNYLDQIKANSGRYTIENAAINSKYSDYGTFVHNNKIYFASARDTGN
FSQRKHKWTGEYFTNLYIADVDSAKVKKFKTTLNTKFHEATPVFTKDGKTVYFTRNNYAD
GKKGKDEEKATLIKIYKATLENDKWTNITPLPFASDNYSTAHPALSPDEKTLYFASDMPG
TLGQSDIYKVSINNGVFGTPENLGKSINTEGKETFPFVTDENEIYFASDGHPGLGGLDVF
AGKIENDGTIGDIQNLGSDINSPKDDFAYIIDPATRKGYFSSNKDGGQGSDDIYKFLETK
RLRCIQELDGTITDAETGAILPGAKVSLYEDLVVKNTTIADANGLYNFPVDCGKTYNVRA
EKEEYETKEVSITIGKVTGKTSLPIGLTKNTCRVTVGDDLGKCFGIKMIYFDLDKSNIRT
EAAIDLEKILVVLNENPSMKLDIRSHTDSRATFKYNEALSDRRAKSTIQWLIKNGVKADR
LTGKGYGETQLVNKCADDVPCTEAEHQENRRSEFIITAL
>EGALAKHO_00004 hypothetical protein
MKKKIMHTMLFIAIFIAMNSCSADTAEGTDSSSSTETLITNYTYNDSELETMKLINEYRL
SIGLNALEPINHISFKCEEHNKYMIANNVVDHNDFVSRSDNMIKVLGAKKVGENVAYNYK
TSEAVLKAWLESPGHKENIEGNFTHFGLSVTTDLATGKKYYTNIFIRI
>EGALAKHO_00005 Pyridoxine/pyridoxamine 5'-phosphate oxidase
MNDLSNYRKSYEKSELLETTIPEDPINLFNRWFHEVEDFGGSGEVNAMTVSTIGLDGFPK
SRVVLLKKFSEEGFIFYTNYNSEKGKAISANPHVCLSFFWQEMERQVIIKGIAQRTSENI
SDGYFDSRPDGSKLGAIVSNQSEVIPSRTFLEENLKKLEAEFEGKSIPRPENWGGFLVTP
LEVEFWQGRPNRLHDRIRYQSQSDYSWKIERLSS
>EGALAKHO_00006 Ribonuclease Z
MKLTILGCYAATPRTLTNPTSQVLEIKNRLFLIDCGEGTQVQLRKNKIKFSKINHIFISH
LHGDHLYGLIGTISTFSLLGRTTDLHVYGPKGIKELILLQLKLTESWTTYSLFFHELESK
ESEVIFEDQKVIVKTIPLKHRVYTNGFLFQEKPGDRKLNIEAVQQYNIHTAYYQKIKGGG
DVTLDDGTVIENKKLSFDSIPSMSYAFCSDTVYNEAIIPIIENVDVLYHESTFLESEAPL
ALKTLHSTAKEAARIALKANAKQLVLGHYSTRYDGIERFKEEAETIFSNVLLGDDGVSFE
F
>EGALAKHO_00007 hypothetical protein
MKVDQKGHTVTIKDTQGDFNSFLEKVTQQFKTFEKQNIIIDLSADANLAESDLKLFLPLS
KQQKKSKKSFVIVVSDLDFNSISDKLVVVPSLLEAHDIIEMEEIERDLGF
>EGALAKHO_00008 Aspartate carbamoyltransferase
MKELSVNHLLGIKYINENDINLIFETADHFKEVINRPIKKVPSLRDITIANIFFENSTRT
KLSFELAQKRLSADVISFSAAQSSVKKGETLIDTVNNILSMKVDMVVMRHSNPGAAYFLS
KNVKASIVNAGDGAHEHPTQALLDSYSIREKLGDVAGKKVVIVGDILHSRVALSNIYALQ
MQGAEVKVCGPKTLIPRYIESLGVTVEPNLRKALEWCDVANMLRVQNERMDVNFFPSTRE
YAQQYGVDKPLLDSLGKEIIIMHPGPINRGVEITSEVADSNHSVILNQVENGVAIRMAVI
YLLASKIQ
>EGALAKHO_00009 hypothetical protein
MTENESFIYESIFNQVRMGFLSLDEIQENILEEIEDNEFEDEISEEWAFVKIKEEYQKLL
SESKKWNSPTDTERLIKAFDELGDENIIALHNAGYTTTDGEYEVVEVERELQENEVESDG
YCFYHEQDLARAIDIENPGLYIAFQKVDNADDAVTIEIGKRVAEVLINNDFKIKWDGSAK
TKIEIPGFRWQKIFDEDARDLQDYSEVVDKMIQ
>EGALAKHO_00010 Bifunctional protein PyrR
MSQKVLLNSKEVTIILHRLACQLIEKHLDFSDTILVGIQPRGVFLAERLKQILEDEYKVP
EISLGYLDITFFRDDFRRTDKPLEANKTQINFIVEDKKVIFIDDVLFTGRSIRSALTAIQ
SFGRPSEIELLVLIDRRFSRNLPIQPDYRGRQVDAINDEKVKVSWKENEGEDVVYLVTN
>EGALAKHO_00011 Trans-aconitate 2-methyltransferase
MDKYKETFETWNKIANLYQDKFMNLDLYDETYDFFCNVLKDNQINIFEIGCGPGNITKYL
LSKKTNIKITGIDIAPKMVKLAKSNNPSASFKVMDTRKLDEVNEKFDAIMCGFCLPYLSE
TDCSKLLYDADKILTKDGVLYLSFIEGSPSKSGFISGSTGDRTYFYYHSLEDIKDQLLKN
NFEILKSFEVKYPKADDFEIHTVIIANKIG
>EGALAKHO_00012 hypothetical protein
MRKIIVITMITIDGVMQAPGGPEEDTSGGFEYGGWVAPFGDEEYGNVMQEQMKPADILLG
RKTFDIFEDYWPKHAEGWPGINEVTKYVLSSTRNNSDWENTEFLSTIEDIKKLKNAEGGD
IKVWGSATLVQLLLQHDLVDELALLVYPIILGNGKKLFNDSSTPAGFTLIESTVTPSGVI
AVSYKRAGEVKTGTIGE
>EGALAKHO_00013 hypothetical protein
MANTYSQLYIHIIFAVKGRQSLISENWKEEVYKYITGITTNKGQKLIAINGMPDHIHILI
GLKPDKSISDLVRDIKSNSSKFINDKKWITGKFEWQIGFGAFSHSHSQLTNAIKYIQRQE
EHHKVKTFKEEYIEFLKLFNIEFKDEYLFSEI
>EGALAKHO_00014 hypothetical protein
MQKNITRLLMVFVILFSFTSCEVIGDIFKAGMGFGIFIVIFIVAIIIFIFAKLFGKK
>EGALAKHO_00015 putative ABC transporter ATP-binding protein YbiT
MLTVNNLSVQFGKRILFDEVNTTFTHGNIYGVIGANGAGKSTFLKIISGDIDPTSGHIHL
EPGKRMSVLNQNHNMFDEHTVLETVLMGNKVLYAVKKEMDELYLDYNDKNADRIGELQVQ
FEEMNGWNADSDAASMLSNLGINEEHHYTLMGDLEGKIKVRVLLAQALFGNPDLLIMDEP
TNDLDFETIAWLENFLANYENTVIVVSHDRHFLDSVCTHISDIDFGKINHYSGNYTFWYE
SSQLAAKQRAQQNKKAEEKKQELEEFIRRFSANVAKSKQATSRKKMISKLNISDIKPSSR
RYPAIIFDQDREAGDQILNVENLEASVEGDLLFKGVHLNMAKGDKIVLFSKDSRATTAFY
EILNGNQKADAGTFDWGITTNQAYLPAENHSFFENDLTLVDWLRQYAKTEEERDEVFIRG
FLGKMIFSGEEALKTSRVLSGGEKVRCMLSRMMMERANILMLDEPTNHLDLESITAFNNS
LKNFKGSVIFTTHDHEFAQTVGNRVVELTPNGAIDRYMTFDEYLDDEKIQELRKKMYNL
>EGALAKHO_00016 Thiol-disulfide oxidoreductase ResA
MKKSIKFLLAFLISIVSFSQTKFGNAEVDPIQIQKNFSEWSAYQSKNIMLSRDFVALDLL
SKEISKETFVNELTNGNFIPIRLKSDDSIYYYKLFKIDPNSDSSIKATINQIGFDALKNY
KMEGTAFPKFSFKDLNGNEVSNETMKGKIIVIKCWYIHCAPCIREFPQVNKLVEEYKDRK
DILFISLAEDSPEQLKGFLARKPLSYAVIPDMKIYMNETLDLNAFPTHFILNKEGLIAKV
LPNFESLEVALAKESALQSN
>EGALAKHO_00017 Prolipoprotein diacylglyceryl transferase
MTFPFQFEIFGKTFYWHFIFETLAFFIGIRTYYFLKKRTQDPISDINRLIIMIGAMIGAL
IGSRFIALLENPSAITHQTFLTLYQNKTVAGGFLGGLFGVELIKKIIGVKIASGDLYVIP
IIVALFIGRIGCFSMGIAEPTYGNETTFFTGMNLGDGLQRHPVALYEMLFMILLFVLFQS
IKNKDLINGDRFKLFMVLYFLFRFLVEFLKPYQPLFLNLSSIQWSSILIFIYYWKFLCRI
FAFKYKDNLITSP
>EGALAKHO_00018 Antilisterial bacteriocin subtilosin biosynthesis protein AlbA
MKTRDYIFYDYTKSLCPHCLALVDTKIVFQDEKVWMLKHCKTHGESKSMIADDVNYYKQL
RNYNKQSEMPLKFNTKVHYGCPYDCGLCTDHEQHSCLTIIEVTDRCNLACPTCYASSAPN
YGRHRTLEEIEKMFDTVVANEGEPDVVQISGGEPTVHPEFFKILDIAKSKPIKHLMVNTN
GIRIAKDIKFVETLATYMPDFEIYLQFDSFKPEVLEKLRGEDLTEVRRKAIEHLNQFNIS
TTLVITLQKGENDDEIGKIIEYALQQKCVRGVTFQPTQVAGRNDNYDDISGRITLTEVRR
KIYEQAPLFTPQDLIPVPCNPDALCMAYALKIDGEVFPMTHLINPEDLLNNSKNTIVFEH
DEKLKKHMLNLFSTGISVDCAEDEFSELMCCLPRVQSDTLNYNNLFRILIMNFMDAHDFD
VRAVKKSCVHIVSDKMKIIPFETMNLFYRDNKIDQIREKLNV
>EGALAKHO_00019 hypothetical protein
MEFLLFLVFILVAMFLIGLFGLIFNQENKKFFLTLMLISIVLFVIGFGTCAVILSSLSNK
L
>EGALAKHO_00020 hypothetical protein
MGEILVLLGGFTALISVIAFVVGIGRLIFISDDKKISLKIILFAVIAFIIGFGTCAANFT
LGNMH
>EGALAKHO_00021 Chitinase ChiA
MKHYYRLLFLLLFPLLALAQPAHGKKVVGYYAQWSIYARDFNIPKIDGSKLTHLNYSFYG
TTYDPAHPENTKLLCLDSYADFEHMEGGIPWDAPVKGNFYDLMKLKEKYPHLKILISVGG
WTKGQDLSPIAASPVARAALATDMANFIIKYPFIDGFDIDWEYPLSGGTDGTEVINGAPI
PAQKYSPDDNKNLVYLLKAMRQAMPNKLISIAAGNNVRKVAQQYLGPSNRAQYGMTEDIS
TYCDYITYFGYDFGGNWYDKTCYNAPLYSSGNTNDPLYGATQSESLDELTNQYLNVVGFP
ANKLIMGLPFYGKKFDHVANNGTNPNLPGLFVSAPRDIVSGCTNPQNPTGTWDGPAACEK
SGSIEICDLVGNPVTNSHAYLDPTTMQVTSTAAAAGWVRYFDNTTKVPYLYNATLKQFIS
YEDKQSMDLKVQYIKSRNLAGGMVWELSQDTRGSIPNALLTQVDTSFGSVVPGTVSISGS
IKNGSALVPNVTVDLRNASNVILQTVVSTGGNFTFSNLTSGQNYILTASKATYTFTPVTL
TNVTTNQTAVVINGTQPLYTVSGTVLNGTTGVSGVTVTATSGSTVLTAVSNASGVYSVAG
LTAGLNFTVTAAKTGFSYTPTSTVYNAIDANKTLNFAQGAPVVYYTVSGTVLNGTTPVSG
VTVTATSTTGTFTATTNSSGVYSIANLPAGGNYTVAAALAGQTYTPASTVYTNLTANKTL
NFAQDVIVVPSGKISGTVKNGTTPVAGAKVEIVLPWTDSTHNWKSVIAITDAQGKYSFDN
SVVAGYTTVTSLKLNSWENGEVAYFPNNLANFAVPANPTVYNFNTSSTAKSALAAVVNLI
TGTVKNGTTPVAGAKVEIVLPWTDNTHNWKSVLATTDSSGNYSFDNSVVAGYTQILSLKL
NAWENGDVTYYPNNLANFAVPTTPTVYNFNRQAVVATKPVVTITAPTASAIAINQGSSIN
FIASVGLSAADATTISSVVFSLDGQSLSATNSSGTYTAIWTPAANQFSLNHTLTVTATAS
NGTTDAKTYSFTLSCSGANCPNAAPVITWNSPSNTTVNQSSFQVVPISVTAVDSDGSVSG
VTITINGGTFNMAAGTNNTYTYNFTPSAYQDYPVVIKATDNKAAVTTLNNTIKIAPVSTN
RFIALPSKVLLGYAHSWENTGAPFLYFSQIVGSKFNVVDYSFVETVNRDGYTPVLTTNDT
RYLTNGVFNKQLLKNDIKSLRDSGVPVIVSIGGQNGHVVLDNVTQKNIFVNGLKAIIDEY
QFDGVDIDFEGGSMNFNAGGLRDISYAGISAYPRLKNVVDAFKELKAYYGPGFLLTAAPE
TQYVQGGYSTYTDTFGSFLPIIQNLRNELDLLAVQLYNTGGENGLDGQYYGSAKKANMVT
ALTDMVIKGYNIGTTGMHFDGLPASKVLIALPACPSAAGSGYLTPAEGISAMHYLRTGTT
FTGRTYTMQPGGPYPSLRGLMTWSVNWDASSCGNSSELSKAYATYFASQLTAKTLAVDKI
ELQSSTMTYFKNDVLLVTNEAEDITQVDVFNTAGQFLTRQRNVQNSKEILLQNPSFTTKQ
LFIVVVTDKAGNRKSFKVMNFLN
>EGALAKHO_00022 Beta-hexosaminidase
MKYLLVLLLAGLTSSAQIQKEQLNLMPWPQSVVLNDGNFTLTKNFKVNITGNPNPRIFGG
VTRFLRRLDGRAGIFFEQGFITKLNEVPTAELQINCTKSGKIGLYEDESYHLDIKQNKIT
INATSDLGALHGLETLLQMLQNNNTSFYFPNAQISDFPRFTWRGLMIDAARHFQPVDVIK
RNIDGLAAMKMNVFHWHLVDDQGWRIEMKKHPKLIELVSDGMYYTQEEIKNIVKYADERG
ILIVPEIDVPGHGSAILTAYPEIGSKVITLTGGTSEKNIQGTAIATYGVERNAGIFSPTL
DPSNPKTYQLLSELFDEVCPLFPGAYFHIGGDENEGKDWDANPKIQEFKKKHDLKTNHEL
QTYFTMQLVPMLKKHGKQLMGWEEILTKNMSKEAIIHSWRGANEGAAPGQSLIDAVTKGY
KTVLSNGYYIDLMYPIESHYLNDPMPKGTTLTAEEKARILGGEATMWTELATPTTIDSRV
WPRTAAIAERLWSAEDVKDVANMRKRLETVSFRLEELGLTHIRNKDVILRNVANNQNINS
LNEFSNVCEPLKGYTRNKGGTEYQMYSPLTLFADACTPDSKDSLAFDEAVNQYLANKTPE
NKAKVAAFFTKWIAVNKGLNELSKNAPLVQPVLPLAQKLNDASQEMLLVLDNKSTLKADD
LKSLIEQCNSKDYADVELGVYTSLKKLL
>EGALAKHO_00023 Glucosamine-6-phosphate deaminase 1
MKSALEIKPDISYKSAGKFEETRFEKIHNEIFKSSAEASVIVAQEIAQLIRSKQEKNKSC
VLGLATGSSPIKVYEELVRMHKEEGLSFSNVITFNLDEYYPMTKENNQSYHYFMHQHLFN
HIDIKPENVNIPDGTVAIDELNQYCIDYEMNIKSAGGLDFQLLGIGRTGHVGFNEPGSHI
NSGTRIITLDHITRVDASSDFNGIDNVPKRAITMGVSTILRSKRIVLMAWGQNKADIIKR
TIQGDISSEVPATFLQNHPNATFVLDQSAASELTRFKTPWLVGECIWTQELKSKAIVWLC
QKTKQSILKLTDRDYNNNGMSDLLAQEGSAYDLNINMFNVLQHTITGWPGGKPNTDDSHR
PERANPAKKRVILFSPHPDDDVISMGGTFSKLIKQGHDVHVVYQTSGNIAVTDDEALKFA
EVAKDFIGEAGSGINFKSVIEFLNNKSENQIDSLEVRKLKGLIRRRESYAATRYIGLKDE
NTHFLDLPFYETGQVKKNPLGAEDIFIVKDIIAKIKPHQVFAAGDLADPHGTHEVCLNAI
FAAMKELKPEKYMDDCWLWLYRGAWHEWDIHEIDMAVPLSPSEVLLKRHAILYHQSQKDR
VMFQGNDSREFWVRAEDRNKNTAILYDELGLAEYEAIEAFKRFDY
>EGALAKHO_00024 hypothetical protein
MKLNTIKRTAICISLLAAVGCTGDFEEINTNPNGITPELFEQDFNHIKGGFAPIFNNIQV
LTPEWVYQLQQGLNSDIWSGYMATPTGFEGGINNTTYALVDNWNGFIWDYAYSNVMFNAY
DIAQKSKGKYDQFYALSLILKVEGMHRLTDTFGPIIYSKFGTTAATIEYDSQQEVYNQMF
AELDLAVAELTKRVDAGEASSFATTDMSAYGGDYKSWVKFANTLRLRLAMRVVKIDPALA
KTQAEKAVAHKFGVFITNADLFKVVSPVYTNPINTLSGAWLDIRMSADMESILGGYNDPR
MATYFDTSTQFPGQYKGVRTGIEIAAKSDHQDFSGIGAVVRSKEIVLMTTAEAYFLRAEG
ALRGWNMNGTAQDLYEAGIRASFEQRGASGAAAYIADNAKVAKAYVDPNFPVNNSPAVNN
VTVAWDAAATNEVKLQKIITQKWIAGFPEGQEAWSDYRRTGYPKLFPVLKNYSGGKITTE
FGARRINYVNSEKAGNSGGVASGVAKLGGPDNGGTRVWWDVNKANF
>EGALAKHO_00025 TonB-dependent receptor SusC
MKKIFLIFMIVFTAQVSLAQVKSVKGVITDSDGMPLPGASVAVQGGQKGSTTDFDGLYSI
EAQKGQTLVFSYVGLETQSIIVGDAATINVKMNTASTNALNEVVVTSLGIKKTRKSLTYA
AQELKGEELTRVRDANLINTIAGKIAGVAVTKSSSGTGGSTKVVIRGNSSVTNNQPLYVI
DGIPLYNGSSSQPNDSFGSTSTGNRDGGDVVSLINPDDYEGMTVLKGAAASVLYGSQGAN
GVILLSSKKAKAGKPALTVSSVTTFESAAYLPKFQSDYIAAPGADESWGAAGKSKDHVKD
FFNVGNTQITSVGYSTAAENSSTAFTYSNTSGTGIMPGNSIKKNNFGVRQTAKFFDDKLL
FAANANYTTQDIVNKPVNGFYFNPLTGVYLMPRGNDFEYYKNNYEVFDPSRNLMAQNWMT
NRDIMQNPYWGINRNKSVDKNNFFNGALSLTYKANNWLSIAGRYSYNRAESAFDKKIYAT
TQGTISHINGRYYVEDALSTQRYADLIATINTKFSEDFTFTANIGTSVTNTLGNQKTILD
SGIGGGLKYANWFTLQNFNNNSGNYQTIDSRKEVQSIFAATTFGYKEMLFLDVAARNDWS
STLANTSSPSYFYPSVGLTAIISEMTTLPEWINFGKVRATYAEVGNDVAPFVTTPTYYYT
PGVTDPKPKVAPKTGTSLKPELKSEYEFGTEWRMFNNRFAFELSYYNSETRNQYLQVVAP
KGNSQGVDFYGINAGSIENKGFEAVVTAGIIRGDKFSWDSSINFSQNKNKVKEIPTELGG
RVNLTEAGVNNYRYALIEGRPFGVIEGINFKKDAQGRILLNDDGTIQKTGFEEVGNSNPD
FMLGFSNTFKFGSFFANVLLDGRFGGEVMSMTQAQNDSFGVSKSTGDARNAGGVSINAVR
ASDGTPVSTMDAQLYYTQVGGRAGITGEYVYSATNVSVRELSIGYNFSAKKLPFIQSASV
SLIARNLFFIYKDAPFDPNIALSTGEGLQGVDIYGLPSTRSIGLNLNVTF
>EGALAKHO_00026 Sensor histidine kinase YehU
MFKVAEYYRETTIASKPLLIKLNDIQKLNFDIKLQNHIWFWGTYFTLNFLRWGAYFNDYP
YSFKSNLVEFSLHIPLVYFNLFVLVPRYVLKQKYITYTFSLLVSLFAIYLLKTALTYYII
SENIWPEANREYHPFEINHIVAVCIGELYVLAMASSVYLTLTWLRERERNRSLRENQFKI
KLKYLENQIQPHFFFNTLNNLYALSLESSDKVPDVIIKLSNLMEYVLYDVKGTKFVPLIK
EIDYIQNYIEIEKLRFENVEVTINLESNIEDIVVPPLIFISLVENAFKHGGLNNRNLKIK
INCKVIDNKLLDFEILNNFVISQNLNSKGGIGLANTKKRLKLIYKNNFSLKQVTKLNYYI
IRLQIPTHNED
>EGALAKHO_00027 Transcriptional regulatory protein YpdB
MKIKCVLIDDEPLAIKVLQNYFTNFTDFEVIATFNNSLEALDFINSTTVDAVFLDINMPM
MTGFELISLIENKTKVIITTAFREFAAESYDLDVLDYLVKPIPLPRFIKCINKITTEYNL
KNNIKVETTKGDSHIFIKVDKKMMKINIEEILFVEGMKEYIKVVTPDKTYITHKSLTSLS
EELPADRFLRIHKSYVIALNKVKSIEGNRVQIQSYTIPIGRNYSKDVKTKILE
>EGALAKHO_00028 L-fucose-proton symporter
MSSENVQTKWGQFISLIIVFFFWGFVGSANDILIPVFKKVFTLSQVQSQLVAWAFYVSYF
VGSIIFFLISLKVDVLQKFGYKKTLSAGLVLSAIGSFLFIPAATMESFPFFLTALFTVGL
GFSIQQIVANPLAIKMGSPATGAHRLTLAGGINSFGTTIGAILLGIALFGMGDDKKTSLS
LEDIKLPFIILGLAFIAVAIFMNFSKIEDPAKEEEEVVKVAHEKFNILDYPQLYLGMLGI
FIYVGTEVTIISNLPALLKTAEFGNVLEDAIAPFIALYWGSLMIGRWNGGVNVFNTSNLL
NTALKFIVPAIGFGVIIGANIFAGHDVSSFYIYPIWILLFIAVSFVGGKNAGKTLMLFGI
SGLLMMLIGLVCPDPSIAKFFFISGGLFLSIMWPSIFDLAIAGLGKNTGKASSFLIMMIL
GGGVIPLVQGSICDIDLTSPEGIFGITWTHFSYIVPLIGFAYLGFYGFYCPKILKRQGIN
HVEGGGGGH
>EGALAKHO_00029 hypothetical protein
MKKVLVMFLFLVAGLQVNAQARILKSVNEAGDVATFELDCTVKFQTLAKGLRYNITRHEF
KGPEMKNSYRLLLVMDGFYSKTLNKEMTISAILSDGTVIEARKIIEDDGFFDGACTLKIK
DPKALLEANIDKIIVHADKEVVYTLSEQNKAIFKKNLSNIMTEK
>EGALAKHO_00030 Transaldolase
MKFFIDTANLAQIKEAQALGVLDGVTTNPSLMAKEGITGKNNILKHYVDICNLVEGDVSA
EVNALDYDGMIKEGEELAELHDQIVVKLPMTKEGVMAAKYFSDKGIKTNVTLVFSAGQAL
LAAKAGATYVSPFIGRLDDVSTDGLNLIEEIRLIYDNYGYETQILAASVRHTMHIVNCAK
IGADVMTGPLSAIYGLLKHPLTDIGLAQFVADFEKGNK
>EGALAKHO_00031 Phytochrome-like protein cph1
MLEENFKQDILNIQSISIVPTLLNVICQTTGMGFAAVARVTEDRWITCSVQDNVSFGLKP
GDELEIKTTICDEIRQNRKVVVIDNVSEDNEFRYHHTPAMYGLQSYISVPIIRKDGSFFG
TLCAIDPKPNELKTFKTREMFNLFSELISFHITSIEEANENKIILKEKNNLLEKTVVEKQ
EVEKIKTNIEQTLIEKNISLKKMNSELEAFNYISSHDLQEPLRKIQLFTDIIERDEIQNL
SDKGLNAFYKIRSSAFRMQNLINDLLIYSKTKFDERKFEVKDLTIIVNEVIEDLSEEIKN
KKVNFEIKNLGTLSIIQFQFRQLLYNLISNSLKFSDPDKNLTISITGKIINGSELVSDNL
SATARYYNITVSDNGIGFDQTYSERIFGLFQALHTKPLKSTGIGLTIVKRIVENHNGFIK
AEGVLNEGAKFEIFIPIE
>EGALAKHO_00032 Cyclopentanol dehydrogenase
MNKVVLITGGSSGIGKSIGEFLHKKGFVVYGTSRNPEKVVNSIFPLLTLDVRNTESIKSA
VAKIIEVSGRLDVVINNAGVGITGPLEEIPMEEIKNNFETNFFGPIEVMKAVLPQMREQK
SGLIINITSIAGYMGLPYRSVYSASKGALELVTEALRMEVKSFGIEITNVAPGDFATNIA
SGRYHAPVIQGSAYEKVYGDTLATMNEHVDAGSNPNEMAEAIYKIMQQKNPKVHYKVGVF
MQKFSIVLKRALPDKVYEKMLMNHYKL
>EGALAKHO_00033 hypothetical protein
MKKYNFLTVILLGITLIGCGDKNKGENSFFTIDDSAFPAHFLPQEAISIAVLNPNAKEID
SIAYFVNDKKVGSTKGAEKFKFELKDQKLGYQYLKATVYFGGDSSDATKRIELVSNVEPK
LLNYKIVNKYPHDTKSFTEGLEFYNDTLYENTGQKGASYLRKYDYKTGKIFKQIDMDSKY
FGEGITFINGKLFQLTWQEKTGFIYDAKTLKLEKTFTYDKDIEGWGMTNDGKYIYQTDKT
EKIWKMDPATQKMVDYINVYSGESKIKAINELEWINGKIYTNVWQKDAIAVVNPTSGAVE
GILNMSGLKKFVKNTDADVLNGIAYNPKTKTIFVTGKYWDTLFEITVSE
>EGALAKHO_00034 Imidazolonepropionase
MITLIKNIKELLQVRETSLSKVSGAEMAILPTIKNAFLILKDNLIEDFGAMENLSEIKAD
TIIDATGRIILPSWCDSHTHIVYAGNREQEFVDRINGFTYEEIANRGGGILNSAKKLNET
SEEEIYEQSKVRLEEVMHLGTGAVEIKSGYGLTVEGELKMLRVIKKLAENYPIAIKATFL
GAHAFPVHYKENKQGYIDEIITKMLPEIAQNKLADYIDVFCETGYFSVEETEKIMEAGIQ
FGLKPKIHVNQFNSIGGIQSGIKFKALSVDHLEIMNPEDIDALKDTQTMPVALPSCSYFL
SIPYTPAREMIKAGLPLALATDFNPGSTPSGNMNFVVATACIKMKMTPEEAINAATINGA
YAMGLSETHGSITKGKKANLILTKPISSYYQIPYAFGSNLIESVFLEGKILN
>EGALAKHO_00035 hypothetical protein
MENPKNNNSSLKAIIAVLAVLLIGSLVYIFKLSSDTEVVKTELTSTMTEKESVMKDLQEL
KATYDAAIAENTSMSDELIQERDKVVALMDDLNKSKGDVSKYRSQVQAMQGKMKTLVAEN
DELKKQNGVLTVQRDSTIVVLGESKKYNEVLVGQNEELAKTVEKGSKLSVLNTKTIAYKV
KSSGKQIETDKASRADVLKVSFTIAENSIAKSGDKTYYVQVIDSKNNVLGDKKTETFGDN
TLTYSFKTTVKYENKTVQVSEDLIGKDFEKGTYFINVFDNDELVSKTSFSLR
>EGALAKHO_00036 Formimidoylglutamase
MEKLIPFTVNDLAKVTNHRSGEIKFGEKMIVIPKAADKLAFLKESEAKYVLLGIPEDIGV
RANYGRPGAASAWQSAIKSIANIQHNRFCKGSQIIILGQINVEEEMRDVENLDFNDIDDR
SKLSQLVEKIDKEVSHIIFNIVKAGKTPIIIGGGHNNAYGNIKGSALAKGKPINAINFDA
HSDFRILEGRHSGNGFSYAYEEGFLKKYFIFGLHENYTSKSVLDIIKKLEDRVRYNTYDS
VNIRKEKEFNKEMIMALEFIKNDSFGIEIDLDAIPNIASSAMTISGFSVEELRQFVSFFG
QHKNATYLHICEGAPDLADSPNNNLIGKLIGYLITDFIKANNEKI
>EGALAKHO_00037 ATP-dependent RNA helicase RhlE
MLFEDLSLSKSIQKAVFEEGYLNPTPIQEQSIPIVLSGRDLIGCAQTGTGKTAAFAIPII
HQLHRIVGSSKKAKQIRALIVTPTRELAVQIGQSFDTYAKYTNLTQLTIFGGVSQNPQVD
TLKNGVDILVATPGRLLDLQKQGFLDLDHLHTLVLDEADQMLDMGFINDVKKIVKLTPKN
RQTLLFSATMPIAIRELAEMFLQDPAKVEVSPVSSTAETVEQRVYFVEKTEKRNLLYHLI
KNEELSNVLVFSRTKHGADNVVKALRKKDIPAEAIHGDKSQNARQRVLDAFKNKEVGVLV
ATDIAARGIDIDQLPYVINFDLPNIPETYVHRIGRTGRAGNGGIAISFCGKDEEPYWKDI
QKLIKVDVKTITDHPYPWHSGSPEATAEKPKNSNRSGGAHKSRKSNASKQNKKRWY
>EGALAKHO_00038 Aerobic respiration control sensor protein ArcB
MPLNRFCFLIFVFLHIFCFELQAQTKIASLTKVKDITQQACDYLDDTNYEKSLEKSGIAL
QYAFDIKNDTLISRNYNIIGINFHELGEVDKAVFFYKKALFYAKRSNIVGLRMMITSNLG
NLYFFEKKMYSNGIAYYKESLKFGNQEKYLKEVAITNLNIVWSYFQIGNYSEGLPYLRYI
NQHQNDLKGKSNDIALNFLNGMYWANKNDNVTANKYFLKAISYSNSQDEKADLLYAYLEY
SKFLNKIGKFDAAYKNLLAYSKIRDELTDKEKLKRASVAGFNRELDEYKRQIDKIENEKV
EQYHNLKKSRIIVILFIIISLILLLLIITLIKNIRLKKKANVELLQAKEIAEEASLLKTQ
FISTISHELRTPLYGVVGITNMLLEEHKELSQSQHLSSLKFSARYLLSLVNDILQINKIE
ENKVVLENLTFNISDEITMIKNSLSFLSQKNNNKIKISIDPCIPEYLIGDKLRLAQIMMN
LVSNALKFTKDGEVEIIVKLTKVEEKFNFLEFNIKDNGVGIAVVDQGKIFEKFVQVGRKD
EDYQGTGLGLSIVKRLLGLFGSTINLESDIGAGTSFSFIIPFEHDPQKTKSIINEIEVDL
TSNEVYKILIVEDNLINQLVTKKIIEKNNYVCKVVDDGFGALEILKKEDFDLILMDINMP
LMNGFETTKRIRLQDVKTPIVALTAFDKDEITDEAISSGINDIIIKPFEPVKLFKIISYL
IKEAKNVG
>EGALAKHO_00039 hypothetical protein
MLENFLKFAETEKLTKAQQKTIKGGETPEEEEARKGKVAAKIF
>EGALAKHO_00040 C4-dicarboxylate transport protein
MQQQVTETKKKSFLSGLTGQIIIAMVLGATLGIILHNYISPEAAQSFSNKIKMLATIFIR
LVQMIISPLVFTTLVVGIAKLGDIKTVGRIGGKALGWFFTASFISLLIGLFYVNVLQPGV
GLKLHHIDMAAASEVTGKTKILSVENFVEHIVPKSLFEAMATNEILQIVIFSIFFGLAAA
SLGSTVKPVINALDKASHIVLRMVNYVMNFAPIGVFGAIAGVFAIRDAEELVLTYFKFFG
SFLIGISTLWVILIAIGYIFLKGRMTELLKRIVGPLAIAFGTTSSEAVFPKLTEELEAFG
VKDKVVSFMLPLGYSFNLDGSMMYMTFASIFIAQFYGVHLSLGTQMAMLLVLMLTSKGIA
GVPRASLVVVAATCGMFDIPVEGIALILPIDHFCDMFRSATNVLGNALATSVVGQWENNK
ENALNNNMEEN
>EGALAKHO_00041 Chorismate synthase
MAGNSYGTLYKVTTFGESHGEALGGIIDGCPSGIELDLEAIELEMSRRKPGQSAIVTQRK
EPDAVQFLSGIFEGKTTGTPIGFIIPNTNQKSDDYSHIKDNYRPSHADYVYDQKYGFRDY
RGGGRSSARETASRVVAGAIAKQMLPQIKINAYVSSVGPIHLDTPYQELDFSKIESNPVR
CPDEKSAVVMEEYIRDIRKQGDTVGGVVSCVIQNVPVGLGEPVFDKLHAELGKAMLSINA
VKGFEYGSGFSGSEMKGSEHNDLYNPDGTTKTNLSGGIQGGISNGMDIYFRVAFKPVATI
MQTQDSLDNKGNITPMTGKGRHDPCVVPRAVPIVEAMAAIVLADFYLINKTY
>EGALAKHO_00042 UDP-2,3-diacylglucosamine hydrolase
MKKRNVELVILSDVHLGTYGSHAKELNNYLSSIKPKTLVLNGDIIDAWQFRKSYFPKAHL
RVIQRIIGMASKGTKVYYITGNHDEILRKFSDMNMGNFALLDKLVLDLDDKKAWIFHGDV
FDASVQHSKWIAKLGGLGYDYLILSNRFANWCLAKLGREPYSFSKKIKASVKKAVKFISD
FETTATDLAIEKKYDYVICGHIHEPKIVTKENKHGSTLYLNSGDWVENLTALEYHKKRWK
LFSYAESNLTGEDENLFEMEDIVASQLITSFIAKK
>EGALAKHO_00043 hypothetical protein
MKKVILSAIMLLGLAFTAQAQDIAKNALGLRLGDNNGFGGEVSYQRGLNDKNRLEFDLGW
RNSSDVDAIKGVALYQWVWNIDGGFNWYAGVGGGIAAWDHDYYNNNVKYNDSGTYVFAAG
DIGIEYGFKEVPILLSLDARPEIGSGYYDDDNFGFDVGLGIKFKF
>EGALAKHO_00044 hypothetical protein
MKKVISVVAVFVLISCGVKKTSDSKALYEVLTTQSDGGGNIKFYEILTEPNEIKMLENDP
LLADKMKQDDISNSNYVILNMGEKNTGGYSIGVEKVEETDKNIIITVKENSPAPDAMTMQ
VITYPYTVVKIHSKKEIIIK
>EGALAKHO_00045 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKIAIVCYPTFGGSGVVATELGLELARRGHEIHFITYSQPVRLALLNPNVHYHEVNVPEY
PLFHYQPYELALSSKLVDMVKLYKIEVLHVHYAIPHAYAGYMAKQMLKNEGINLPMITTL
HGTDITLVGNHPFYKPAVTFSINKSDYVTSVSQSLKDDTLKLFKIKNKIRVIPNFIELDK
MRKDPQQPCHRYVMAKENERIITHISNFRKVKRIPDIIKIFYNIQKVMPAKLMMVGDGPE
KEKAEVLCMELGIYDKVIFFGNSNEIDKILCLTDLFLLPSETESFGLAALEAMACGVPVI
SSNSGGLPEVNFDGISGYLSNVGDVEEMAANAIKILEDDAILKQFKENALEVAKKFDIKN
ILPKYEALYQRAIDDYKHEKHSS
>EGALAKHO_00046 hypothetical protein
MYIPFENLPGESRVWIYQSNRKFSEEEFSEIETDLKAFIEEWAAHGTSLEASYLLKYNRF
IILAVNQDVQAATGCSIDSSVEFIQSLEKKYNVDLLDKMNVTFKNGEHIAHKTLIDFKKM
VKDKSVSENTIVFNNLVNNIEEFNESWEVPAADSWHSRFF
>EGALAKHO_00047 Lactate utilization protein A
MSESLVVPTMAEMLAEGKQPEVLFWVGCAGSFDDRAKKITKAFVRILNRTNVSFAVLGTE
ESCTGDPAKRAGNEFLFQMQAMMNIEVLNAYEAKKIVTACPHCFNTLKNEYPELGGQYDV
IHHTEFLKSLIDDGRLTVEGGQFKGKKITFHDPCYLGRANKVYEAPRDLIQKLDVELVEM
KRSKANGLCCGAGGAQMFKDAEPGNKEVNVLRTEDALEVQPDIIAAGCPFCNTMLTDGIK
HKEKEGQVKVMDIAELIANAQDL
>EGALAKHO_00048 hypothetical protein
MSYLDNILFAILLIAGFGFFASSIKKIIRNINLGVDVDRKDNPKARWANMALIALGQSKM
VKRPVAGALHIIVYVGFIIINIELLEIIIDGLFGTHRIFAPYLGVVYDVLIASFEILAIL
VIFAVTVFWIRRNVIRLKRFINPDLNGFPKSDANYILYFETVLMLLFLLMDAADLHLQNV
PGGFSHFHKAGSFPISQFIAPIFNGMSNELVGILFEAFWWLHIAGILVFMNYLYFSKHLH
ILLAFPNTYFANLKPEGQFDNLESVTKEVKLMMDPNADPFAAAPVDENAAPSKFGASDVQ
DLNWVQLLNAYTCTECGRCTSSCPANQTGKKLSPRKIMMDTRDRLQEVGKNIDANKGVFV
PDNKTLLNDYITPEELWACTSCNACVEECPVNISPLSIIMDMRRYLVMEQSAAPMSLNAM
MTNIENNGAPWQYSQQDRLNWKNEN
>EGALAKHO_00049 hypothetical protein
MKLTREIKTAILVIASILLFIWGYSFLKGKDLFTNYKTLYVEYDNVEDLAQSAPVTLNGL
AIGKVTKITINETTGKLLVELQLKTDFPISKTSTAALYSPSLIGGKQIKIIPNLADKELA
VEGQTLAPAIELGLTESLGGKIEPIQQKLNLMLANINTLVAGLNNVLDTKGQADLKKSLA
ELSQTMEQFHKASGSINSILDTNKAQINGAVTNFNKMSSNFNKISDSLNKADLGKTVRNL
NQTLAKLDGIMSNLNSGKGTAGKLLNDDALYNNLAKTSKELELLLQDVRLYPTRYVNVSL
FGKKNKPYVAPTEDANTTDKK
>EGALAKHO_00050 N-acetylmuramoyl-L-alanine amidase AmiB
MNIFNKTRLIFSFFLTIISFSSYSQANVFKVTLDAGHGDHDFGAVYSGRIEKNIALAIVL
KVGKILEDSPNVNVIYTRKSDVFIDLVERANIANRANSNIFVSIHCNANKNTAADGTETY
VMGLSKVASNLEAAKKENSVITLEKDYKRKYEGYDPNSPESMIGMTLMQEEYLDNSIALA
SKIEDNFDRLGKKLRQGGVKQAPFMVLHKAYMPRVLVETGFVSNPVEGTILNSEEGQNDI
AKAIAEAILSYKREYFGSGAPEIMDAKPAKDTAKPKTVVTPAANKNAPKGTVFKVQLIAS
IKKTSLEPKNFKGLKNVTMLYENNIYKYFYQETSDYEAAQKYLQEAKSKGYGASFLVATK
DGEKISIQDATK
>EGALAKHO_00051 LPS-assembly protein LptD
MQLIIFAKKLYVSLTCQKTSHTFTKIAFKPLHTNLFNIVLLSFFLTLGCGKLYSQEIKSK
KNSLPAVKQTDKPVTTVGDTIKLDTVRPKKTFLDGKVKYRAKDYAKIDQKNKRITLYNEA
ELYYKDVELKSGIIVLDYEKDEVYAGRIKDSAGVLTQYPNFKQGSSEVQPDSIRFNFKTK
KALIFNSRTEQGEFKIKAAVTKKENDSVYFLKGARFTTSSDVDNPEYYFQTNKVKFIPGK
KVITGLTNMVIADVPTPLALPFAYFPMSEEKSVSGIIIPSYNDSNTRGFSLQNGGYYFAL
SDNYDLTVLGDYYTNGSYAMRFESSYATRYKYRGNVNVRFENLINSERGYPDYSKQNIYN
IQWSHSKDTKSNPNSSFSASVNMGSSKYFKQSINQANVGSNLNNTLSSSISYNKTFNTIP
GARIALTATHQQNTQTEEIQMTLPSLQGSIDRVYPFVGKDGVKKGFIKNINLQYNVTGQN
KFVTTDSLFFKPQMFRDAQIGLQQSIPISTNFKIFKYFSAGASSNYQETWVTKTINKNYD
SSKNEVVTQTVNGFDAYRTYNFSSNLGTTIYGTFNFGDDKRIQSIRHVMRPSITYAYTPS
FEKYYDNYYVDASGRISTSYSRFDGSVYGAPSKENSNIVGFALSNTFEAKVRDRDSTKTE
PKKIMLLNNLNFSTSYNFNADGKDILGWQPVLVSGGTQLFDNKMNVNFGATLDPYAIDNS
GKRMDVYNIDNGGSLFRMTSANLTLNYSFSNKGVKEENKQSERNGGRKDDLFGTNTDLSD
SRNSQFAKEKDEGEDVITEFFNSKIPWDMTMAYSLTYSNINRESKITGNSVMVSINMDIT
PKWKGGVSTGYDFVQKGVTFTQFRFERDLLSWRMAFNWTPLGPNQNWNFFIGIKSGVLSD
IKWNKRSASNR
>EGALAKHO_00052 2-iminobutanoate/2-iminopropanoate deaminase
MKKIIFTEKAPAPIGPYNQAVLSGNTLYASGQIAINPASGELVTENINDETKQVMENIAA
ILEAANMTFENVVKATIFIMDMNNFGAINTIYGSYFNEKTAPARETVQVACLPKNVNVEI
SIIAVQ
>EGALAKHO_00053 Methylglyoxal synthase
MLLINSSGFMEIAIIAHDGKKADLINFLIKNSEILHHEKIKLIGTGTTGGKAEAAGFKTQ
RMLSGPLGGDAQIAGRVAEGITQMVFFFKDPLSSHPHEADINMLIRVCDVHNVPLATNEA
TAQLLLDAIALQL
>EGALAKHO_00054 hypothetical protein
MKLIVDSGSTKADWIAIDDNGKVLFTTQTLGLNPEILDGPEIVERLNDRFDILQNKKNAS
HLFFYGAGCGTDRMKLALSQIFQEYFSNAIVEVHEDTYAAVYATTPKGEAAIVSILGTGS
NCSFFDGKVLHQKVQSLGYIAMDDCSGNVFGKELIRKYYFNKMPKELAVEFEKEYDLDPD
FIKNKLYKEPNPNAYLATFAKFLIKHKDTDFCRKIIFKGMKSFVKNYIKQYDNCKEVPVH
FVGSIAFYLKDELQETFDKYELQLGNVLRRPIDGLIAYHVANQ
>EGALAKHO_00055 Glyceraldehyde-3-phosphate dehydrogenase A
MSKVKLGINGFGRIGRIVFRETFNRDNVEVVAINDLLDVDHLAYLLKYDSVHGRFNGTVE
VKEGKLYVNGRNIRITAERNPADLKWNEVDVDVVAECTGIFTTIETANEHIKGGAKKVII
SAPSADAPMFVMGVNHETAKATDLVVSNASCTTNCLAPLAKVIHDNFGIVEALMTTVHAT
TSTQMTADGPSRKDWRGGRAASINIIPSSTGAAKAVGKVIPELNGKLTGMAFRVPTADVS
TVDLTVKVAKETSYEEIMAVLKNASETTMKGILGYTEDAVVSQDFISDKRTSIIDATAGI
GLNSTFFKLVSWYDNEYGYSSKLIDLSVHIAGLK
>EGALAKHO_00056 ATP-dependent 6-phosphofructokinase 1
MPKTIKKVGVLTSGGDSPGMNAAIRSVVRTCAYHNIECIGIYRGYQGMIEGDFKEMGPRS
VNNIVNKGGTILKSARSVEFRTPEGRKKAHENLLKAGVDALVVIGGDGSFTGGLIFNAEY
GFPVMGIPGTIDNDIFGTTHTLGYDTALNTVVDCIDKIRDTASSHNRLFFVEVMGRDAGH
IALNAGIGAGAEEILIPEEDLGLDRLLDSLQKSKASGKSSSIVVIAEGDKIGKNVFELKD
YVEANLPEYDVRVSVLGHMQRGGSPSCFDRVLASRLGVKAVESLIEGKSNYMVGLREDKV
ALTPLEQAIKGKSEIDRELLRVSDIMST
>EGALAKHO_00057 hypothetical protein
MALAITLSLPIVQTKIAQYVTNSLNEDFKTDIHVDKVAINIFGGVKLKKVLIYDHHKKVL
IYSDIISTDILSIKRLLDGDLFFGDLRLTGLIFNLKTYKNENENNINKFIRLFDSDKPSK
TNKHFLLTAKNAYISKGIFSVVDENKKTPKFLSFTKLNAYISDFKLYGPDVNTTIHRFSF
LDHRGLYVSNFAGKLSYTKKQIRVENLAIKTKRSSIYGQAILNYKVGDFLAFTDKVKFDV
TIDSSSIATNDIRYFYDGLGKNQHFKLKTKLNGPLNNLNLRGLRLTDTNGSRIVGNINFK
NLLGTKEQKFAMDGKFDRLVSSYDNMVALLPIVLGKRLPKQLKRIGKFTIVGKAKVSTTA
LEANFTMVTDIGGGKVDLHLNNMDFIDKASYSGNIVLENFNVGALLDRKDLGRTTLNLDV
DGVGFTEKYLNTIIKGDIAKLDYNKYTYNNIVVNGNFKLPYYKGQISVNDPNLSLTFDGL
VDLSTRENKYDFHVNVENSDLRKLKFISDSISHFSGDAVVQVSGNSIENLHGNIYIKDAI
YQNPKATYEFDEVTINSSFDADRLRTITINSTDIVDGKIVGKFQFAQLGKLAMNSVGSLY
TNYKPYKVKKGQFLRFNFHVYDKVVEMLYPEINVDSSTVVRGKIDADLNEFKFRFKSQKI
TAAKNTFDNVRVNIDNKNPLYNAFIELDSIKTPYYKIRDFNLINVTSKDTLFVRSEFKGG
DKGQDYFNIDLFHTIDKNKNNIVGIKKSEMKFKDYLWYLNEDEGSDNQIIFDKNFKNFTI
DNIVLSHEDQKIDLNGVLKGSDYKDLVLNFEDVDINKITPLNSKFVFNGNLNGNVNFKQN
KDVYQPTASIVIDHLNLNNTELGTLDFDISGDENLRRFTINSSIHNGFSESFNASGNFAI
ENKETILDLKLKLEGFNLATLGTVGKDVLSNVRGSVSGNAAVVGNIKKPEINGRLYVEKA
GMTIPYLNVDYELSDRTVIDLTDEKFLFRNNQLTDTKYGTKGLLNGSIEHHNFGDWKLDL
NISSKRLVALDTKDSDDAAYFGTAFINGTASITGPTESLFIKVAAKSEKGTEVKIPINNV
QSVGESSWIHFVTPKEKYNLANGIVEKTKNYGGLELEFDFDITPDAEVEVILDRNSGHGM
KGKGYGSLLFKINTLGKFNMWGDFQAYEGTYNFKYGGLIDKKFAVKKGGSIIWEGNPMKA
QLNLEAVYRTSANPAVLLENSSFNKKVPVEVVIGLRGDLASPEPNFDIQFPSVSSVLKSE
IQYKLDDKDVRQTQALYLLSTGSFMSPDGFNQSDLSGTFAETAASLLGGIIKSDNDKFNI
DLNFISADKRIGQEADGQFVANISSQINEKISINGKVGVPVGGVNESAIVGDIEILYRVN
EDGSMNLRLFNKENDINYIGQGIGYTQGVGISYEVDFDTFSELVNKLFKSHKLERSLKNS
SDDLQDSNLNPDYINFSSKKDDDKNKKKGDKKEEEKQPQPQNNNQGLIPDNDDF
>EGALAKHO_00058 tRNA N6-adenosine threonylcarbamoyltransferase
MQNSEVFILAIESSCDDTAAAVLHNDKVLSNVVANQLIHNQYGGVVPELASRAHQQNIVP
VIDAALRKANVQKEQLTAIAFTQGPGLMGSLLVGSSFSKSLSLALQIPLIAVNHMHAHIL
AHFIDEDGFDKPEFPFLALTISGGHTQIVKVNGFFDMEIIGETTDDAVGEAFDKSAKILG
LPYPGGPLIDKYAKEGNPKAFAFTKPKVPGLDFSFSGLKTAILYFIQKKKLENPNFIEEN
LNDICASIQYTIIEILMDKLKLAVKETGIKQIAIGGGVSANSGIRTRLKESESKYGWKTF
VPKFEYTTDNAAMIGIVGYQKYLSNRFETQAVVSKARIQF
>EGALAKHO_00059 Ribosomal RNA small subunit methyltransferase E
MQLFYNPDIDETTETFSFDKEESRHIIKVLRKKDSDILHVTNGLGLLFETEITLASDNKC
IVDVLSIKKSPEPKFRLHLAVAPTKMNDRFEWFLEKATEIGIQEITPVFCDRSERKVINL
ERFEKIILSAMKQSNETYLPKLNEAISFKEFIKQKNEGLQLIAHCEETDKKSLKDVLKPN
ENVTILIGPEGDFSDKEIALAIENNYQAVMLGNTRLRTETAAVVACHSVVFFNETPN
>EGALAKHO_00060 hypothetical protein
MKKIFFLFLFVSVSSFSQEIALLKYSGGGDWYANPTSLPNLIRFCNSNINTRIKAKPSTV
EPSNPDLLSYPFVHMTGHGNVVFSDSDVTNLRNYLTAGGFLHIDDNYGMDQYIRKEIKKI
FPNNNLVEIPANHPIFQKPFPFPNGLPKIHEHDGTRPQAFGIFVENKLVLLYTYECDLGD
GWEDPEVHNDPADVRDKALKMGANIINYIFTN
>EGALAKHO_00061 23S rRNA (adenosine(1067)-2'-O)-methyltransferase
MQLTHEENQFERKTFPITLVCDHIYFQQNIGSLFRISEAFGVENIIFLGKDIPLTPRKIN
KTSRSTHLHVPHTIIEQTSDLVTYLLQNDFEIIALEIASNSKPLKEVKIPENQKIALLIG
SEIDGISDELLKISHQIVHINMFGNNSSMNVVQAASIALYEFTS
>EGALAKHO_00062 hypothetical protein
MKKVFITAFTALVLFSCQNDQTEPAGSDASAATERRCASQEVLEAQLKADPMLAIRMNEI
EAFTTNRVLTNRLVNGKIEIPVVVNVLYKTTAQNISNAQIQSQIDVLNKDFNALNSDYNS
VPALFAGVKANVGITFVLDQVIRKSTTKTSWGTNDAMKKTAQGGLAPTSPTTKLNLWSCA
IGGGILGYAQFPGGSSSTDGVVIDSRYFGLSGAANAPFNLGRTATHEVGHWMNLRHIWGD
ATCGSDLVADTPTHNTANYGVPTYPHYSTCSGTPVEMTMNYMDYTDDNGMYMFSLGQKSR
MAAIFVSGGPRAAFGQ
>EGALAKHO_00063 hypothetical protein
MITSKIISNGILRALATILVVAAILYFLYEIQTVIVYLCISLILCLIANPLVQFLKNKLK
FSNSLAATTTIIIFILLMVGFILLFVPLIISQANNLSLLDTNHLQKQFFETERSIESYFN
IQHVDLNKVLKESKITTAFGFGYFTSFINSIMSFMADMGMGLVSVFFITFFLIKDQEDFK
AGARRILPDTNEDKILNSITKINHLLTRYFIGLLLQLTVVFILYLIVLMVFGNKNALVIA
FLCAILNIIPYIGPIIGTILAALLTMISLIGSDFQSEILPTTIYVVIGFLLVQAIDNNIS
QPIISSKSVNSHPLEIFLVTLISGITFGIVGMVIAIPVFTMLKVILKEFFPDNKIVSVLT
EKI
>EGALAKHO_00064 hypothetical protein
MNSSLLSKNIQQFIAKNTGASITKLALQKNPFPEVDWILILNQIEAKTKAKDKLPTWFST
ENIIYPSKISVEQTSSEKTAAYKASLISGESLIDLTGGFGVDDYYFSKNFKVVTHCEINE
DLSAIVKHNLTQLDVKNCFCYAGDSANTLNEAKSDFKWDWIYIDPSRRNDAKGKVFMLKD
CLPNVPDLLDFYFEKTNSILIKTAPLLDLSAGLSELKFVKNIHIIGLENEVKELLFEIHN
HYLGEITIKTANILKDKIETFEFVLGNESDFPSYELPEKYLYEPNSAIMKSGGFDEVSSI
FKINKLHKNSHLYTSKELIDFPGRTFEIEKVISYNKNEMKTELLNQQANITTRNFPDTVE
NIRKKWKIKNGGNLYCFFTTDKNDNKIVLICRKII
>EGALAKHO_00065 hypothetical protein
MKQLITLTFFLLTLTAFAQKPCEYSANVTDSIGTYKVTNEYLISEKNFGGTFNYVFFSLA
QTDGLPTLNLQLIQKSKDFIKANCFDKNSKVFLQLQNGKIVTLMHIDQENCGTLIRDDKG
FDNRVNTGIFMFLKDNYEELKKSPVNIMRIKYLTDTEDYIVKGELKSEMNNKTYKPDTYF
MENIRCVE
>EGALAKHO_00066 D-alanyl-D-alanine dipeptidase
MPKSINSLFLLIVLFLGLVSNAQNEVYTNEPKQAIADTVFVNLKDFSQDFIYDMKYATDD
NFLKAKVYDCAECFLRFKTVQALIAANNDFKKKGFKIKLYDCYRPLSIQKKMWEIVSNPE
YVADPKKGSIHNRGGAVDISLVDKNGKEVDMGTPFDFFGIQASHNYTKLSSEVKSNRKFL
KKVMIKNGFNSFDSEWWHYNLKTGLKDKVSNQKWNCE
>EGALAKHO_00067 hypothetical protein
MNKETRIYLFIVALSSLTLISCKKETIKNIPSTDSTSIKIDALKSDSTIINPSDTLNNLV
DKSVIGTHLLTESTLSPRLKKLLGTDYDQMVKYWNTETPFIKEGDILHASGCKQHDCNTY
SYDLYIDTKNNKINVYKFSQSKLTFFAEDDYRIVLKDSLLQDLNTKKLNANIPKEK
>EGALAKHO_00068 NADPH-dependent stearoyl-CoA 9-desaturase
MEKLNRPVYVKPGTDDFFKKIRKEVNETVLKKTSLYRFNVIKSLGLVVLFFLFYSCILLF
GNSTPLLFLFYILCGITMIVLFINAFHDAAHGALFKKSKHNEWFMYVLELFGGNHWLWTR
RHINLHHAYPNVPDWDVDIKQSDIIRIFPNSPLFNYHKYQHIYMWLIYPLYSLNWIYIRD
FKDFFGKRDNYVKKVIEKIPTIEIYKMFAAKIINLFYVLFVPMLVLNQHWYIVLGSWFAM
HMCGSAIGVVALVSTHVDEDAHFPVTDEEGNLSATWAMHQMIVTKDFSTDSKLANFLYGG
FTHHVAHHLFPNVGHTYYPYITPIIKRYAEEYSLPYTSYPFYHAVRSHFRMLKQKGVHEN
ILMTGEI
>EGALAKHO_00069 hypothetical protein
MVKFCKRSACFIITLFLSFTAYSKPIIYVNQIGFDIKSPKIAVIGVEQGLDAKTTFNLVD
IKSGKIIYTSKIGKSQNVEEWKPGQLFYKADFSSFQKAGDYKITIIVDGVTYSSPNFAID
ENILAKRTISSIVHYYNKQRANTPEELNADKNMLLFGSTKKVDVRGGWCDASGDVSKYLS
HLAYANFVSPQQTPMVTWSLINTSETITKQLTEWKIKDSLDSEALWGADYLMRCLSDEDY
FYMIVFSYFDKDPAARRIVGLKANSVTTNEYQSAFREGGGMAIAALARISQWKKNGEFTS
NQYLDGAKRAYAHLLLNNTKYDDDGKENIIDDYCALMAATELWISTDNNFYRDEARKWAH
KLENRMTENGWFRSDDGNRPFWHAADAGLPVVALVRYLKKETDSKEQTAAQSVIKKALDY
NLTVTNNVQNPFGYARQSFLYNGKVKDGFFIPHDNETGWWWQGENARLASLATAGIEGSR
IVYTKKNDKEKKAFDLYASQQISWILGCNPYSVCFMYQFGQNNVPYMHSNYGHGSEKGGI
SNGITGKEGNGDGSGIDFKMDVEGNDEWRWTEQWIPHSAWFLQAITAMVEK
>EGALAKHO_00070 hypothetical protein
MIASQFFQSECMAQTSKKSKFKALVLYENGGHHLPFTTAAKPWLNKLAIDSSFTIDYIEN
TKTINDELLKQYQVFIQLDYPPYTWSEESMKAFQKYITKGKGGWIGLHHATLLGEFDGYP
MWQWFSDFMGGIKFADYIPTFVNAQVNTEDKSHPVMKGIPSRFPIAKEEWYIYDKSPRQN
VKVLASVDEATYDPVSKIKMGDHPVVWTNEHYAARNVYIFMGHSPELFNNEVYTTLLRNS
IFWAASKK
>EGALAKHO_00071 hypothetical protein
MQRIKKYSLKSKALALLSLILVLFFSSCEDVVQLDLETGQTKLVIDAEIIWQKGTIGNEQ
IIKVSKTAPYYNNTTPKVSGAQVKIENSNGDVFTFNETEPGSYVCTNFVPVIDMDYTLYV
TAEGQSFTAVEKLTAVTPIDRVEQETVKDAVGDEFIEVVFYYKDPADQINYYLTDFKSNY
LLFPEYNLSRDEFFNGNEMDTRFTDDDKIKPGITYDITHRGISKNFYNYMNLILEIYGGS
PFSIPPGNIRGNIVNTSDSNNFAFGYFRLCEADKVSYLVK
>EGALAKHO_00072 TonB-dependent receptor SusC
MKHIISACFFLFSWSIFSQSITVTVDKTVTLKELFKQIENQTDYKFAFTDQIDTSRKYFT
KKKTYNSVEIKQFVNELNSSTPIQFSIVGNNIFVKQKAVNTAKKKNKLTGQVLDESRQPV
IGANVFIKELSTGATTDASGKFSLELDNGNYTVLITYVGFKSKEKQITVSEDIRIDFNIE
ADSQQLDQVVITSSKAVDVRNTQMSVNKLTMEEIKRIPSAMGEPDPLKSILTLPGVTNAG
ELSSGFNVRGGAADQNLLLLDGAPVYGDSHMFGFFSVFNADAISGLDLYKGGIPSKFGGR
VSSVLDITQQIGDFEEYKVNGGIGLISSRLLVQGPIQKDKGSFLLAGRTSYAHLFLKLND
NSNSAKFYDINAKLNYRLGDNNSISFSGYFGNDVFDIDNRFESTFGNTMGILSWKHKFSD
QLNTNLSLYYSDYKFTLGLPTEFFDWNNKIENYGLKYAWNHSVSEKLKLNYGIDAQYYNF
NPGTVKPTSSESQFNYKQLDKKYALESSLYLDFEHQITEKLNLRYGLRYSMFYRLGGEDI
STYENGQAVVYNPLYNIYEEGTPTGSISYKSGETISKFNNFEPRAALSYAFNNNTSVKAS
YNRMAQYIHMLSNTQFPLPMTIWTPSGPFTKPQILDQYALGYFKNFNDDVYSLEGEMFYK
KIQNRIDYIDGADILANNNIEQVILNGKARSYGMELSFRKNTGNFTGWISYTLSRAEQKT
PGRTAQEPGIANGDWYLSGYDKMHNLNIVGSYQYNPKWSFNANFTLQSGQPVTYANGYYE
FGGINIPNFSLRNENRLPLFHHLDLAATYTPKPDKKKGWQSYWVFSLYNVYNRKNAASMT
FATNDDTGANETRRLSIFGIVPGISYNFKF
>EGALAKHO_00073 hypothetical protein
MDKKNIEEELKKAWDETPISHSDDMKEASWDDFHSKAFPPKKQKFKIWRYAAAAVLILMG
IGSGIYFNRSPLQNNVQLSSNVIEIENMTLKVKTVFLPDSSKVELNPNSKISYINNFQSN
RKIEIEGEAYFKVKKDKKHPFQVFCNETTTTVLGTSFTVTGQDKSGVIVELYEGSVQMNV
KDQTQKWILKPGDKFTYGNKIASVIEFNRFMDFDNEKLTVVSDYIEANYGYKMIIPQEYT
NQRITVRINKKEDLKTIVQLLSEMYNLNFEINDELKQITFR
>EGALAKHO_00074 hypothetical protein
MNIEAYKTDVKTREEAKFIVALLQFVISDCIMNFDLDDSNHILRIETNREIKEMVYGVFN
KQGFYCQKL
>EGALAKHO_00075 ECF RNA polymerase sigma-E factor
MDNKKFILSLKKGNEASFKEAYLQYYDKLINIAKRFNFTVLTPQDFVQETFLRLYNKREL
LNEDVLFDKQLFTICKNIIINHVNRENKIIQLDPSQVEMEEETVETGIFEERSEKLHSFI
NQLPEQQQKIFTLHKLENLSYKEIAAMTDLSEKTIANHIYLASKFIRKKIENH
>EGALAKHO_00076 Phospholipase A1
MHFKYLFLCLIFYSIQSNSQILEEKKNFRAADSLLKEPSFSVHKDNYFLTGVPLDEPIDR
NSADVKYQISFKLRLKSKPLWGGFFPYLMYTQKAFWDIYASSKPFAEINFNPGVAVVRPF
YLKGGRLTYGTISLEHESNGRDSIYSRTWNMLAFSLKSQISPRWIVGLRGWIPIVDKEDN
PELTKYVGYGEASATYQIQPGRWSADILFRKGSGLINYGSLQTQLNWRPYKNENYYLTLQ
WFIGYTESLIDYQEHNNMIRIGFTIKPENMGIF
>EGALAKHO_00077 hypothetical protein
MENLINQENLEDIRELLENKIKDIPGELILAGALGSILLSSYLNKTGHLQAASLIGSLAV
PIAGIGLAKYKDLLKSGIESFEKPEQEAS
>EGALAKHO_00078 Cold shock-like protein CspJ
MQEGTVKFFNEEKGFGFITPKNGGSEIFVHVSGLSENIRENDEVRYEVAEGKKGPNAVNV
VVL
>EGALAKHO_00079 Narbonolide/10-deoxymethynolide synthase PikA2, modules 3 and 4
MKAFVINKYSKKGSLKLTEVPVPEVKDNDVLVDVYAAGVNLLDSKIKTGEFKLILPYKLP
LILGHDVAGVVIKVGKKVKKFKIGHEIFARPADHRIGTFAEFIAIDESNVALKPKNLSME
EAASIPLVALTAWQVLVERAQLKKGQKVFIQAGSGGVGTIAIQLAKHLGATVATTASAKS
FDLLTELGADLIIDYKNSDFENRLSDYDVVLNSQDQKTLEKSLRILKSGGKLISISGPPT
LDFAKEINAPWFVKIILSLLSSGIRKRAKNRNVDYSFLFMRADGQQLSEITSLIEANIIK
PTVDRIFSFQETNEALSYVESGRAKGKVVIKVK
>EGALAKHO_00080 Fatty acyl-CoA reductase
MNIKGKTILITGGGSGIGLESAKQFLAEGARVIITGRNQDKLEAAKKLLPSVIIIKSDVE
NPEDSKELFEKVVSLGGIDILCNNAGVGSPALNLGMANEQILKNAVYEMNINYFGVIRLN
TLFIDMLKSRKEGAIINTTSILSIVPALEEPTYSATKAALSFYTRTLRKNLEILGSAVKV
FELLPPVVETEMTAQRKDKKMTPEELVKALITGIKKNRYTIRVGDTKLLYVVNRFFPRLA
FNLVNPKKMYAGLKQ
>EGALAKHO_00081 HTH-type transcriptional regulator AcrR
MLTKAEKTKQFILETAVPIFNEKGIAGANIDDVLEATKLTKGCLYGHFDGKDDLSEQVID
LALKMVSDKIRAEVYKGKTIKAKIFAFLDFYKNPIETFISGGCPIFNTAVQVDDNYPFIK
EKVAKVIKIGQQELTALLQEGINNGEFSKTLDSVVFAFKLVASVEGGIVMCRVMDTAKPM
QGLIKSLKMELEQYVA
>EGALAKHO_00086 putative acetyl-CoA acyltransferase
MNKRVVIVSAVRTPIGSFMGGLSTVPAPKLGAAAIKGALQKINLDPKLVDEVFMGNVVQA
GVGQAPARQAALFAGLSEEVAATTVNKVCASGMKAVMFAAQAIACGDAEIVVAGGMENMS
LIPHYVQMRNGTKFGPATMLDGMQKDGLTDAYDNNAMGVCADLCASEYNISREEQDNFAI
QSYERSAKAWDAGKFDNEIVPVEVPQRRGEPIIVSKDEEYTNVKLDKIPSLAAVFTKDGT
VTAANASTINDGAAALVLMSEEKAIALGLKPLAYIKGYADAAQEPKWFTTSPAKALPKAL
NKAGITIGDIDYFEFNEAFAVVGLANSKILDLDNDKVNVNGGAVSLGHPLGCSGARIIVT
LLNVLEQNDAKTGAAAICNGGGGASAIVIERA
>EGALAKHO_00087 Gamma-D-glutamyl-L-lysine endopeptidase
MFGICNLAIVPVRSEPSDRSEIVTQLLFGEHIEILERQNQWARIKIQFDDYEGWVDSKQY
QVISEANYNQLSKEAIILNADLIDYISAPDNLLLPIPLGASLSFLNNSEINTSNFDFEGT
KTSGIKPKSALINTAFMYLNAPYLWGGKTPFGIDCSGFTQMVYKLNGYKIHRDASQQALD
GEPLSFIEESEAGDLAFFDNDEGNIIHVGIIMDNNYIIHASGKVRIDRLDHLGIYNPELN
KHTHKLRVIKKII
>EGALAKHO_00088 hypothetical protein
MKKAVQQTKPFDTKRSIQNASGKVISIRKSTLYSGGKEYSWSNKLERVGVIRSGIPYDAI
EEISRRLNNPVKSVLAIVGIPQTTYNKKKSEHLLLDSRDSELVILINELIDYGLEVFNNE
EEKFQRWLKKPNLSIGGNMPENMLDTITGINEVKFSLNRLEFGNLA
>EGALAKHO_00089 hypothetical protein
MIVFRIEREKYLITTLSGIGASMTEGYRWNSLNTKIVYTADSRALATLEVSVHLDLSEDL
PSDRFYVEIEIPDDITIQEVKLADLPEDWNSKPPILTTQIIGDDFVYYNDSAILKVPSSI
VPQEFNYLINPNHPDASKIKVISSTKMAFDSRLKQ
>EGALAKHO_00090 HTH-type transcriptional activator RhaS
MKKENLYEPFTVSFETLDEYPDVGDRHNFFELVYILGGTGSQCINKNIFEYDAGHMFLLT
PEDCHNFTIETETKFFFLRFNDIYLKNSSLQNENIQRLEYILQNANHQPGCILKNDADKC
LVKVMIEAICREHQDKDVYNQELIQQLVNTLIIIVARNIAKYLPEQVNVGTEGKAMDILQ
YIQNNIYYPEKIKAESLSEYFGISNTYLGRYFKKHASETMQQYISNYKTKLIEHRLQFSD
KRINEIAYEFGFTDESHFNKFFKKQRGNSPSEFRKTIRISA
>EGALAKHO_00091 General stress protein 69
MEYRKLGNTELELSTITYGAFAIGGNMWGGNEKADSIASIQASIDHGVTTIDTAPFYGFG
LSEEMIGEAIKSHDRSKVQLLTKFGLVWDGSNNGKGDFFFEADDNGKKIPVYKYASKANV
IKEVEESLKRLQTDYIDLLQIHWPDSTTPIHETMEALETLLQQGKIRAAGVSNYSASQIQ
EAQKTIQLASNQVPFSMLNRKIETDLIPLTLAENIGIIAYSPMERGLLTGKYFTDSKLKD
NDHRNGYFGQFDLQKVKTLVEELSSLANAKHISISQLVLRWTTLQKGITIVLAGARNAEQ
AISNAKAMDFDLSVSELDFINQAISKVK
>EGALAKHO_00092 Modulator of drug activity B
MKKIFIINGSQNFAHSGGKFNQTVTDWTIEYLTNSKQFEIKTTDIKQAFDLDKEVEKFVW
ADVVVYHTPVWWFQLPNLFKKYIDDVFTAGHNKGIYRSDGRTRTNPDINYGTGGQLHGRK
YMLTTSWNAPATAFTLPGEFFEETSVDDGAMFGFHKMNKFVGMEKLDSFHFHDVEKGATG
ENIDIFKENYTKHLEKTFNF
>EGALAKHO_00093 Putative monooxygenase YcnE
MISITAIIKSKQENIEQVKNMIHHLVTETKKEAACIRYDLHTTENVFIIWEEWQDQPGLD
FHNNQPYLQDFITKSESLVSSPIQVFKTTQSL
>EGALAKHO_00094 hypothetical protein
MSKYHLAEINIAKMKGVTINDPIMKEFVDNLDVVNKLAEDSEGFVWRLKDESSNATNLNP
YDDEQIIVNVSVWENIETLEHYMYKTFHSEFLKRRKEWFLKFGKAATAMWWIPKGHIPTL
EEAIEKLDYLQQNGPSQLVFDLRNKFPAPKQIA
>EGALAKHO_00095 2-methyl-6-phytyl-1,4-hydroquinone methyltransferase
MKKSTIEEIRERFDNDVERFSNLETGQVATIDATISLELITEASKRIVPNAVHVLDIGCG
AGNYTLKMLSKLPNLNSTLVDLSLPMLDRAFERVSAATNGKVEVKQGDIREVELPENHFD
IILAGAVLHHLRDDQDWETTFTKIFKLLKPGGCFMISDLITQDTNLLNEYTWQRYGDYLE
GIGGAEYRQKVLDYVEKEDTPRSMNYQLDLMKKVGFTSVEILHKNMCFGAFGGIK
>EGALAKHO_00096 HTH-type transcriptional regulator CatM
MELRHFKYFLAVAEELNFTKASEKLFISQPPLSRQIMELEEELQAKLFIRNNKKVELTEA
GKYFEKEVKALFQNLERISVKTKKIAENVSGEFRIAYISSIYSSVISDLIKQLKEQFPYV
NFKLFEISTTKQISALEQGKIDLGIIRSPIKSPKIKAQLWFQDGFSVVYNKSLIQIKSEE
EIPNLKDETFVFFNKDYAPHYHEVLLELCAFYGFEPQVVHESNNINSIVQLVKNGLGVSI
VPSNIAKNNSDKEIGFIELKKVNLFTDVSLITSKEDDSEITKSAVEFLLNFSKK
>EGALAKHO_00097 hypothetical protein
MAEQSSIICPNCGTPIDVNDVLKHQLEDSIRKEFQQKANAQSRELELKNEQFEKAKADFE
AKKKQENELFAERLEREKKTAEKEITEKLKTKLEEENKDRLTLMEKELSEKSEKLRELNK
MTGEIAKLQREKLEMKEAIEAEAQKQLNATLVLERDKIRKQEEEKNELKIKEYQKQSDDQ
KKLIEEMKRKQEQGSMQLQGEVMELAIEEWLANNFPLDSIDEIKKGANGADCLQIVNTRE
LQNCGSIYYESKRTKAFQPSWIEKFKNDIRTKRANIGVLVTEVMPAGMDRMGMRDGIWIC
TYEEFKGLSAVLRQSLIQVSQAVQAQENKGDKMSMLYDFLTSNEFRLQIEGIVEGFTQMQ
GDLDAEKRAMQRIWKQREKQIEKVVHNTLGMYGSIRGIAGNAVQTVRALELDFIEEDNDD
PKELLE
>EGALAKHO_00098 hypothetical protein
MKNIFVFLVLSSLIVSCKSTSTGSKETASATNSQEADMTIYFKATGNEPFWGITLGKEQT
IFTSLIPGKEKIIFSSVEPIKAMDANVKMYKLSNEQATATVTIQQVDCQDSMSGAISPYK
VSIEIKNNSELESKKVEGCGKYITDYRLHDIWVLEELNGYKVFIADYQRELPRIEIHAQE
NTFMGFGGCNSISGTLFYEKDVLRFTKVISTLMACAPGNKESEFTKALQSTTTYSIGDNR
LTLSNPSGKLLVFRKVD
>EGALAKHO_00099 Nitrite reductase [NAD(P)H]
MIRVIVVGNGMVGYKFCEKFIAKSGQEKYQITVFGEEPRRAYDRVHLSEYFGGKTADDLS
MSTSEWYAENNIILNTSELITDINREEKTIHTHLEKTHTYDYLVLATGSSAFVPPIDGVE
KEGVFVYRTIEDLDAIMGYAKKIKQKGATEAAVLGGGLLGLEAAKAVRDLGLNPHVVEFA
PRLMPRQLDKGASDMLQSKIEELNIGIHLNKATQHIDGAACITGMMFANEELLKVDMLVI
SAGIKPRDELARVSGLEVGLRGGVVVNNQMQTSDPSIYAIGEVALYNQNIYGLVAPGYEM
ADVAAEQILNGSKTMRETIDMSTQLKLIGVEVASFGDPFIENDDVTAIIYENKLSGVYKR
INVTKDSKTLLGGILVGDSSDYNSLFQIYSNAMALPKNPEDLILGSRDGSEGSSLGSVMD
LPDTAVICSCENVTKGAICCKILDESCSTLSDVVKATKATSGCGGCKPMVSDLVKATQKS
LGKEVKEVICEHFSYNRQELFDLVKINKYENFYEVIDHHGKGDGCEVCKPVVASIFSSIY
NDTANKHVTTQDTNDRFLANIQRNGTYSVVPRVAGGEITAEKLIVIGEVAKQFDLYTKIT
GAQRVDLFGAHLNDLPKIWKILIDNGFESGHAYGKSLRAVKSCVGNAWCRYGMDDSAGFA
IELENRYKGIRSPHKLKGGVSACIRECAEARGKDFGLIAVEGGWNLYIAGNGGANPKHAV
LLAEKIDKETVIKYMDRFLMYYIRTAGPLIRTSTWLEKLDGGLEYLKEVIIEDSLGLCET
LEAEMQTLVNTFECEWKQVLEKPRLLKRFNHFVNSEEKDDNVVFVPLRDQKAPKAWT
>EGALAKHO_00100 Assimilatory nitrite reductase [NAD(P)H] small subunit
MEEILSQYETVHPNDATIWFKAGKVEDFPTNRGGCIKYKNKQIAIFNFTRRNEWYACQNA
CPHKMEMVLARGMTGSTDDIPKIACPMHKKTFSLVDGSNLNGDDDLKIATYPIKVVEDEV
FVGFVD
>EGALAKHO_00101 hypothetical protein
MTTPFQKASEWIDAENAQDPNIEIDQNNEYPKELLYSNRMYERLMQFEPEASEEVQIASK
AQHICRWKVARESYPMDRVGYLRWREELKKFHAKLTAEILEKAGYNQDFIDRVSFLIEKK
LLKKDAETQLLEDVICLVFLEYYLDPFVHKHDEEKLKNIIKKTWDKMSDKGHQEALKINY
SEENLNLIKASLGL
>EGALAKHO_00102 Signal transduction histidine-protein kinase/phosphatase DegS
MKKSNQETADKITFKNLRRLYFFALWTIAITIIISQVLVQYNLKQQLSDSKIINISGKQR
MLSQKIVKEVLILHYVSDTTSQKQISHLKNVLSLWKNNQNSLENGSDSLAFPKEKSETLD
KLYLEIKPSFNNIVETTDLFLLNLEQKSNLATNQKMVETILKNEGLFLSKMNQIVSQYDL
EAHEKVTEQRRIEYWIFAFTLLVLLLEFFFIFKPTNKKIERLIAKLLSSEKKALKLAYDT
EIISEIKENSVKELKSLNYAMENTLLYCRIAPDGSIIHIGEKFAKLLNYTKFSSNKKFSE
VLTTDEKEQLNIDRIIFEKQRSGWQGEINIINKEAQNIWLDLSMVPVTIKKDELELLIVC
FNITERKKAQREVERLNIENSTEKINQQKVISSKIVENQENEQNRIAKEIHDGIGQMLTG
LKFSLESINLDDKEKSAQKIEYLKKLSLDIIKGVRTATFNLMPPELSDHGIVSSLAKLTQ
ELSKLTGKEILFYNKTDFSQRLDSLIEINIYRLTQEAINNAIKYAESSHIIVQLSHSNTL
LSIIVDDNGKGFDVAAVDKKRNSESGMGMLFMQERIQYINGRVFFKSIPGEGTRITFNIP
I
>EGALAKHO_00103 Transcriptional regulatory protein DegU
MSATIRVVLADDHVFVRDGIKSLLENEANIEVVGEAIDGADALEVVADSKPDLLIVDIRM
PNLTGIEVVEKLRSENNEVKIIMLSMHESEEYVLKSIKAGADGYLLKGSSKEEFLKALHT
VAAGGKYFSGDISSILIGQLTNASASLEPKQNFGEEMMITKREKEILTLLLSGKGNKEIA
EALDISKRTAEVHRFNLMKKLKVKNLMELSNKATEYSLL
>EGALAKHO_00104 Nitrate transporter
MKTTNSLSQSHKILFLNTLAFTVCFACWTLNGVLVTFLVDNGIFHWSVVQVGWLLGIPIL
TGSIMRLPIGILTDKFGGKYVFSLLLLLCSIPLFLLPLADSFITFALLSFLFGMVGTSFA
VGIGYTSIWYPKEWQGRALGIFGMGNAGAAITTFLAPSLLNHFSIEDPQNGWKILPVIYG
IALVVIGVAFLIFAKNKKIENNTKSVSQMLQSLKCARVWRFGAYYFLVFGCFVAYSQWLL
PNFMNVYQTSLVMGGLFATLFSLPSGVIRAFGGYLSDKFGARKVMYWVLSSSVVLSALLM
VPKMEITTTGPGVLATKKGTITQVSNDKIKVGDTDFAVAQKNETDAENAIFPTKTSWQQV
VVQQNQTVKKKELLAKGITVIKFDANMWVFLVLVILIGISWGIGKAAVYKHIPEYFPTEV
GVVGGMVGMIGGLGGFFGPIIFGYLLTATGIWSSSWIFILVFSAICLIWMHYTITKIMNE
KQPILSRVIDRN
>EGALAKHO_00105 hypothetical protein
MKKSGIILLALMGMITAGVQAQELEANLQIRPRFEYRNGYRTLLPEGQEGTSQISQRTRL
NFNYKQDQLSTKLTLQNIRTWGDVPTTTLADKNSIALFEAWAQYDINEKWSARAGRQVLA
YNNQRIMAEMDWAQQGQSHDALVVSFHPENHQLDLGAAYNSTSENIIQTPYTVANYKAMQ
YAWFHSTYENFGASLLFLNTGYEYENIQKKLLVDYKQTFGTYLTYKTKKIDTNLGLYGQT
GKSADKQVTAWYAGGSFGYTVTDSFKACLGYEFLSGKDTNDKSTVIKSFSPIFGNNHAYN
GYMDYFYVGNYQNTMGLEDAYLKLNYASNKWQFALIPHVFNTPNKIVTPLRNEELKHYLG
TEIDFTTGYNFKKDITLTGGYSQMFGSKTLEFLKAGDAGHTNNWAWMMVSVNPRLFSWKK
>EGALAKHO_00106 hypothetical protein
MLTFFVTHTGIGQKFNDTLISKNSEINFAKTQKRGIIKNNIVYYVENDLQTISAYKGSKL
KWQTNVISICGKPKNGNPEIRYVGYNTDKLLIVMGKHNFAEIDINNGITKLVG
>EGALAKHO_00107 hypothetical protein
MTCIITLYNISNLESMKHELLSIEEDAPFKYCKLSRQVYAEILTEVVKTNSQGFVMGLNS
RWGTGKTTFVKMWQQYLKNDDFQTIYFNAWENDFEDNALTALIAELKPIVKSESQISFDK
VLEKGLIISKHILPILIKSLIEKYIDSKSLKDNLSDITEQAKDIFKGEIDEYLHRKENII
EFKESLKKFVADTTKDKPLVFMIDELDRCRPNYAVSLLEQIKHFFSVPNIVFILSIDKTQ
FEYAIQGVYGNDKIDSEEYLRRFIDIEYSLPNPDPKIFSEYLYDYYNLSEFFEKKNSEMI
DNEKSEFMTICNYLFSNPKVTLRQQEKIFAHATAVFKTCRAQRQFLPILFMTLVYLKVLH
VEFYNKIKLKLLTIENIQRELISIFPSSERNMMQSSIGAYIVFFYNNFLKPHNPDLLYEF
EDNGEVKLLIPPIYNEKHFLDVLKWLSQDYNRQFETIDKLIARIDLIDRN
>EGALAKHO_00108 hypothetical protein
MKLITWNCNMAFRKKAAFILPYNPDIAVISECENPEKLKFPIESKLPTDILWYGTNPHKG
VGVFSYADYRFQLLDCHNPSFKNILPIAVTGGKVDFTLFAVWANNPSDKDGAYVTQVWKA
INYYKDLIRETKTILIGDFNSNTIWDKPRREGNHTTVVNKLEAKKIYSTYHKYFNQIQGK
EEHPTLYLYRHENKPYHLDYCFASNDFIEVLDHVEVGTYHEWTMHSDHKPLIINFNL
>EGALAKHO_00109 hypothetical protein
MNDTWTERWNDRYSNEEFAYGEEPNNFFKEQIEKLNTGTILFPAEGEGRNAVYAAKLGWE
VAAFDISEEGKNKALKLAEANNVTIDYKVGELETLNYQPEQFDAIALIYAHFPADIKSYL
HRTLETYLRKDGIIIFEAFSKKHLEYLAINDKVGGPKDIESLFSIEEIKADFPNYEIIQL
EETEIELNEGSFHNGKGSVIRFVGKKK
>EGALAKHO_00110 Bicarbonate transport ATP-binding protein CmpD
MSYLEIKNLEISFPTPKGKYIAVRDINLSIQKGEIISIIGHSGCGKSTIMNAIGGMLTPT
GGSVELANQKIKGPGPDRGIVFQNYSLLPWLTVEQNIFQAVDSVMNCSKKEKHEIVIENL
KMVNLFEHKDKLPGQLSGGMKQRVAIARAFAINPGVLLLDEPFGALDALTKGSMQLEVLK
LWNLDNREKTIIMITHDIEEALFLSDRIVVLNNGPASTIREIVEVHLPRPRNKIEIVKMP
EYIALRDKLLHLLTDKFSIEDMGMKYKN
>EGALAKHO_00111 Bicarbonate transport system permease protein CmpB
MSNKDTLTLNDIADQTEVLMENTAIDTVRNEKLKLILNAIAIKLKSTAFAGIGIALFIGF
WSLLSFYTKDALPGPLATFTVLKEMLSDPFYDYGPNDKGIGLQLFNSIKTVLLGFLLGSL
VAIPIGILMGASTICKQIMYPIVQLLKPVSPLAWFPIGLVVFKDTGMATIFIVFITSLWS
TLINTSFGIASIPQDHKNVAKAFGFSKMRYLTKILIPFSLPHIITGLRLSISVAWLVIVA
GEMLSGGAGIGFFVWDSWNALSLEKVISAIIIIGIVGLIFDKFFTFIENKVSYKA
>EGALAKHO_00112 Nitrate transport protein NrtA
MKKIQTNTSEVFKRIVLTLMLVLALSFSEVSAQNDPVKLGFIPLTDCSPIVMAKELGLFK
KYGVEVVVTKESSWANVRDKILTGELDGAHCLYSMPFSVYTGVGGKAGSEMKIAMMLNVN
GQAITLSNDFCGKVGFKQMNKIAPVVAAKLKAEKEVTFAMTFPGGTHDLWLRNWMAIAGV
NQKTSKIITIPPPQMVANMKVGNMDGYCVGEPWGGVAVKQGIGFTQVASQDIWKDHPEKA
LVVNKEFSEKRRTDLVKVMKAVLEACIWLDNPANRKKAAAIIGKAPYVNAPADVIENRLM
GNYDLGCNQGTEVYAKDYMLFYKGGLVNYPRKSYAIWAMAQYVRFGYLKEAPNYKAIADK
LILQDLYEEVAKSMKVKVPNDDMKPFSLTMDKTVFDPSNPAAYLKVVKK
>EGALAKHO_00113 hypothetical protein
MSKLTNPILKNHKINFSSKLSKSILLGFALTIFGSYEAQAQFTLTGQLRDRVEMRAGQGT
LQQEGDKAAIFTSQRTRLNAGYSGYRFKIFTALQDVRVWGQDASSINRTTTEANNGILLH
EAWAEIFLNDTVSTIQNLSIKAGRQEISYDDQKVLGSLDWLQQGRRHDAIVFKFANKGWI
ADVGAAFNQNKENNVGTVYNGTNPAYGAGTNGIGTMYKSFQYAYVGKKFFFGDLSFLFFK
DDFNKYTLVTAGTPAVTTKVNGTGVWSRNTTGVYFNTNVTRKLNLMGSYYYQGGKNKDGR
SLNANLFSITSTLQVGRKLFIGPGVDFLSGDDGTKAVTADSKDNRFDPLYGTPHKFWGSM
DYFYAANGFGKQGLLDYFFKIKYNAKDNLSFALDIHGFESANTLSNGAGGKLNSYLGTEL
DLLVKYNLTKIINIEAGYSFMKATNSMASAAVKNVANADLTPQFAYVMLNIKPNFLAKK
>EGALAKHO_00114 Fumarate and nitrate reduction regulatory protein
MKDEQAICYSCANENCFIKKHLHLEQMKQYVQKKHSFVCKKSQQFIIEGAPIQGLYFICK
GKVKTVKTGINGREQIVRLTKNGDTIGFRGFGTSKRYLIGAYALEDTVLCNFSNETMMEI
LQNVPEFTYALMLFYADELNKSENNIRKIAHMNVRERVIDLLLYIHRKFGQMNGLIDIEL
SRKEIADFAGTTEEQVIRVLSSLKKESLIKTVGKRIGILAIPKLQSEIMEHKYF
>EGALAKHO_00115 Nitrate reductase
MQNTKIKTTCSYCGVGCGIIVTNDAKNGVMVTGDKDHPVNKGMLCSKGMNLHYVVNDTSD
RILYPEMRGSKSYPLERVSWDTALDRAAAVFTSIIKKHGPDSVGFYISGQCLTEEYYLVN
KLVKGFLKTNNIDTNSRLCMSSAVVGYKKTFGEDSVPIAYDDIELADTFLITGANPAWCH
PILFRRIEKHKENNPKIKIIVIDPRRTDTAAFADLHLQILPGTDIILYHALAKRIIEKGY
VDHDFVKNHAENFKQYKDLVLGTSLEKASKLCGISVNDIKLAADIIGKAKGFISLWAMGL
NQSAVGVDKNTALLNLSLLTGQIGKPGSGPFSLTGQPNAMGGREVGGMATLLAAHKDIAN
PEHRKEVADFWGVDEISDKPGLTATEMFEALESGKMKAVWIICTNPMVSLPDSRRIEKAL
QKAKFVVVQDISHNADTSKYADLLLPAAGWLEKEGTMTNSERRISYLPKGINAPGEALPD
IEILIRFAKKMNFNGFNFNSAEEVYKEHCALTKNTNIDISFLNYHRLRTEGTFQWPVPDY
GHPGTPRLFTDKKFYTPSKKAIFNLPTAIENTSEQPSPQFPFILTTGRVRDQWHTMTKTG
KVSRLMTHTPSPVLEINPIDAYKNDIKNGDIVIVSSKNGEVRVKAKVTDSIREKVVFLPM
HWGKQLDNDLNRTNNLTNTVVDPVSKEPDFKYTTVNITKYVKPFQKIAIVGAGAAAFRFI
QNYREFNSTDEIIVFSNEINPFYNRVLLPEYMTGEFTWEQLLKVKDGEALSKLKITMKAG
VAIDKVNASAKTIVDSLGETHTFDSLILATGSRPFIPENAQLHLPGRFTVRRKEDADRLK
AYLDNTNLPAEEQHVVIIGGGLLGLELAAALKHKKVKITIIQRASRLMERQLDLISSKLL
AEEVQLRDIQIYFDNEVSTVFETENPNELEIALKSGRIITANTIVYTIGTIPNIEIARET
GLACGRGVKVNQYLQSSNPDIYAIGEIAEFDNKLFGITSAAEEQADILANYLAGDISSYY
KGSVLMNILKLEDINLCSIGDIEIPENDDSYEEIVFADLKQRYYKKCIVKNDLLVGAILM
GDKNEFAEFKTMIESKIELSDKRNSLLRGSSNAKPVLGKLVCSCSQVGAGNIEETIKGGV
NNFTDLCKNTGAGLGCGSCKTEVKEILAKCKV
>EGALAKHO_00116 hypothetical protein
MELTRLIVKGGVISPGELREVVNMAMDHGLDSISFGSRQDIIFPKGLNLSSKEKIGKHHF
VFPNEKSGNNIVSSYVSTDIFRNTNWLTGNKFLYILEQFKEQPKLKVNINDPKQQLVPLF
TGHLNFIASEHEDYWYLYIRLPKWERMEVYPVLIYSWDIATFYYEIEKIVSEESYGIDMI
FSLVSEALDTNNRTIDKPLNVPFYPFPYYEGMNRMGIDQYWLGLYWRNNLYDLDFLKEMC
DLCFDCKIGKICITPWKSFIVKGIPKDRKLEWEKFLGKKGINVRHSLLELNWHLPVAMEW
ALNLKTFLVRTLDQFDISTYGLTFGISEYNRDGHYFTSIVVEKNELPAALESIKIRDTYN
VLFAKNFDPNTREYIVHSQDIDKLELPTILIELSRKYFEELGNSIPESTENTQKKEKQQL
DIYQCQECLSLYNSEYGDESQGIPKGILFTDLAESYCCSLCEAPKSNFKILEVVEN
>EGALAKHO_00117 hypothetical protein
MIKRTTRTPAVKKTETPATEPTKDTTETTVEAKPAAQTPAPKATTPKAPVKRAPRTATKT
PAATVKATAQTPVKPASKSTPKAVVKRVTTAAPKTGEVTPEIIEIKTIDKPQDNQAILNI
EEIALEIVKNKSKDKKIKSKLKEKKEKAKKREKAIKAVIKKLEKAKKAKLKAETKKKEKA
KKEKEKKAKAKAKKAEKEKAKKGKSKDKKKKK
>EGALAKHO_00118 GTP 3',8-cyclase
MTPSKTILTDDFGRKHNYLRISLLEKCNLRCTYCMPADGIALSPKASLMTADEIFSMAQI
FVENGVDKIRLTGGEPLLRKDFPEIISKLSTLKTSLSITTNGILIDRHIEALKEANIKKI
NLSLDTLVSSKFHTITLRNQFEKVIDNLHLLLNNDFHVKVNVVLMKGFNENEITDFVQLT
QFLPISVRFIEFMPFAGNEWDRSKMVSQNEILSEVNNVFPSEEIQKLEDEKNFTARTYKI
KGFQGDFGIISSITNPFCDGCNRIRLTANGKIKNCLFSNSETDLLTAFRNGESISDLISE
SIKNKKKVRAGMVTVSEMDDPALHFDNRSMIAIGG
>EGALAKHO_00119 Cyclic pyranopterin monophosphate synthase 2
MVDITHKINTLRAATATAIVKVSKQETIDAVVNNLVPKGNVLEMAKTAGLFAVKNTHLSI
PDCHPIPIEFTSVEYKIEGLTIQIIFNVKTVYKTGVEVEAMHGASIVALTMYDMLKPIDK
EIEISTIKLVNKEGGKSSFKNKFPNVIKAAVFVCSDSIFAGDKEDRSGKIIVEKLDSYGV
ETSHYEIIPDEIDIIQERTKAFAEEHQLVIFTGGTGLSPRDVTPEALSPLLESRIPGIEE
AIRNYGQQRMPYAMLSRTVAGTLGKSLVLALPGSTNGARESMDAVFPHVMHVFHILKGKN
HDTL
>EGALAKHO_00120 Molybdopterin synthase catalytic subunit
MSKNVFVEGPISPEFIAESIAKHQSKHTIGAHNIFLGQVRADVIHDNTVVAIDYSAYTDM
ANEALYAIREKAFAKFDLTCMHIYHSLGVVKAGEICLFVFVSATRRKQVYEATEAIVNWI
KTDVPIFGKEMFENDTFTWKQNTNG
>EGALAKHO_00121 putative adenylyltransferase/sulfurtransferase MoeZ
MLPEIGENGQHKLSIAKVLIIGAGGLGAAVLPYLAAAGVSEIGIVDDDVIEVSNLQRQVI
YKTSAVGNYKVEEAKAMVLELNPLVKVNAIAEKLSGKNAIALFEQYDIVVDATDNLSIKY
LINDACVVTNKPMVYGSIFRFQGQVSVFNYKNGPTYRCLYPDENNKSINCEDAGVIGISV
GIIGMLQANEVIKMILEIGEVLRGKILVYNILNNEQQKYDFEKNTITKPDKKSFEEKYKV
TENQIEEIAAAAILDEIENDEVLFLDVRNEDELPKLNFKNGIQIPLIKLESEIENLNPNQ
TIYVYCQSGIRSKIAVELLQKKNYRYVKSIVGGALDLSQIVKEKIAD
>EGALAKHO_00122 hypothetical protein
MIEVKYFGAVAEKTKCEFEKIPFSEVSLQQLLQDLEIKYQFDSLSFSVAVNQKIVPKATN
FALKTSDVVALLPPFAGG
>EGALAKHO_00123 Uroporphyrinogen-III C-methyltransferase
MRNSKTPKLTIVGAGPGDVELITLKAIKALESADVVLYDALVNEELLQYATNAEIVFVGK
RLGCHAYTQDQINELIVSMANRHGHVVRLKGGDPFIFGRGSEEIDYVERFGLETAIVPGI
SSALGVPASVGISLTQRQVAESFWVITGTTSNHELSKDVYLASKSAATVVILMGMHKLEE
IISIYKENRTDDLPIAIIQNGTKNTERKVVGTISSITKLVSEKKISSPAIIVIGEVVKNT
SKLTSYFQEHFDDEFIFQNLNLE
>EGALAKHO_00124 putative molybdenum cofactor guanylyltransferase
MKTLTVFILCGGKSSRMQSEKGLVLFQGKPFIEHIIQAILPITDQIKLITATKEYDYLPY
QKIPDIILDKGPLGGIYTALTNSETEFNLILSCDIPLISTELLSELISKHNNEAEVTVFA
SESRLHPLIGIYSKKVLPVIKSAIDNDELKMMDLLARIPHQILNIDESENFHLTNINSVD
ELNDLNINLS
>EGALAKHO_00125 hypothetical protein
MNLLSSENILLFSFALIVIAFLYSSVGHGGASGYLALMTIFAFPISVMKPSALLLNLFVS
SISFFFYYRMNYFKPKLFYPFAIASIPAAFIGGFITLDNTVYKIILGVVLVFAALRLFGI
FNFKEKEAVKINLPLALAIGFVIGLLSGMLGIGGGIILSPILLFLGWASIKESAAISSLF
IFVNSFAGIMGFFLGGKTVPTESFYLVPIAVVGGVLGGYYGSGYFSNKTLKIVLGTVILM
ASIKLIFP
>EGALAKHO_00126 Molybdopterin molybdenumtransferase
MIQVEQALSIIAENSTKMPVQKIDVHKALGYVLAETVYSPIDMPPFRQSAMDGYAFIHSE
KHQYDVVSSSQAGDHANIKLKENEAIRIFTGAFVPDDADTVIMQEHVMANENSILITRMP
TQFTNVREKGEQIKKEEVVFAANTLITPAAIGFLACLGITEITVYKKPKVAILVTGNELV
KPGKKLPKGKIYESNSIMLEAALQTIGIKKTKVYKVKDNLKATKKALKGILDKYDIVLIS
GGISVGDYDFVKEALLANGVEELFYKINQKPGKPMFFGSKMDTLVFALPGNPASSLTNFY
VYVYPAIKNRMGFSDIHLPKLVRKLDSAFTNTTGKTLFLKALYDETNVTILDGQASSMLN
TFAIANSLLIVQDDVEGLKKGQLVTLLPIN
>EGALAKHO_00127 hypothetical protein
MSTFRRSQNRANPNKLNNILSTLIFILILNVSIQIWLLYASLNNALDNNKEILLPAFIAS
AILFLIGFSWLYYLPKGNFKKK
>EGALAKHO_00128 Cytochrome bc1 complex Rieske iron-sulfur subunit
MSKEDNLNKNWKKDFPIQKQESTQVSRRDFAKFLTFVSGGLMIGSGFVAAKAYLLPKEGV
QGKHFICNKEEVPVGGTRGFVIEGSTIPYILVHLESGDFRAYEQKCTHLSCSVFYKPGTG
IIHCPCHEGSFDAMTGDVIAGPPPRALPQLEVFFKEDKVYVKAFIEEKES
>EGALAKHO_00129 Formate dehydrogenase, nitrate-inducible, iron-sulfur subunit
MNLTNFNRNEEFFVDLQRCIGCKACEMACAECETNGQESLISVNYVERSSTIQTTVQVCM
HCEDPVCANVCPADAISQDEFGVVHTASTERCIGCSNCVMACPFGVPKKMEEYDLMMKCT
MCYDRTSVGKKPMCATVCPSGALFYGTRAEIEEMRPNSTPVNSFIFGKETVNTKVNIMMP
KGSNELRIY
>EGALAKHO_00130 Assimilatory nitrate reductase catalytic subunit
MAKSPVSTEKIIEAFGPHLNYAPKDGYEGRDEPDELVKTHCCFCGMQCGIQLSVKDNKVV
GFEPWMEFPFNEGRLCPKGVQRYLQNNHPDRLLHPIQRVEGKGFEKVSWDEAMDKTVSEI
KRIQEKYGKHAFSMLSGVSLTNEKSYLVGKFARVALKTRNLDYNGRLCMVSAGAGNKKAF
GLDRASNNYSDLEYAEVIIVAGANISETFPTLTHWIWKARDRGAKLIVIDPRMIPLARTA
DIHLDVKPGTDSALYGAMLKHLVDNDMLDHDFIDNYTSGFQETIDAVKDYTLEWAEEITG
IDKDKIQAAAELWGKAKTSFLLHARGIEHHSKGVDNVLGCINLVLATGRIGRPYCGYGTI
TGQGNGQGGREHGHKCDQLPGNRDIENPEHRKYISEVWGIDEKDMPGKGLTAYEIIEAIH
RDEIKGLISICFNPLVSLPNNNYVRSALEKLEFYVCIDFFLNETARHADIVLAGSLQEEE
EGTTTSAEGRVIRIRQAVTPPGDARTDTSILLEIAQRLGEKDKFTYANSEAIFNELRVAS
KGGTADYFGITYQKVEDNMGVFWPCPSLDHPGTPRLWEDKKFKTPDGKAHFNAAPYREPG
EITNDEYPITLTTGRVVSQYLSGTQTRRIGKLVDQFPEPMLEIHPELALKYNIKQRELVR
VATRRGEGIFPANIVETIRKDTVFIPYHWPGAKSANQLTTGILDPISKIPEFKVCACLLD
PLGKIAPSSKESEAYASV
>EGALAKHO_00131 hypothetical protein
MKNSTFNTKALLVATLVSLLTIVFVFYGSRELQNFDAALVTYLFGTIFAFFGIVYRYTVW
LQRPPTWMYFKRSLQFLFTGKILSHLWFLGKESVGNIVVQKFIYPRSKYRWFAHFCIALG
CLSAFAITIPLTFGWIHFTLAPNSISIYEAHFFGFKMMDFKIGSILAFLIFHALNWSSWL
VIIGSVYYLRRRLTNPGLIATQSFEGDLLPLILLIAISVTGLCLTYSYQFMKGFAYDFLA
VIHAVTVIMFLIWIPFGKFFHIIQRPAQIGAHIYKKEGIKKGMAVCPHTGEEFATQLHID
DLKIVTKQLGFNFTHEDGTSHLDLSPEGKRSRLAQAHLKARLESGSLFG
>EGALAKHO_00132 Nitrate/nitrite transporter NarK
MKTWLDKWEPEDETYWNTAGSKIAWRTLTITTLTLILSFASWFMMSVIAVKLPGLGFNFS
KDQLFWLTAIPGLAAGFLRIIHTFILPIFGTRHVVSFATAIKLIPVIGIGFAVMNINTPF
WVFAVLAFTTGFGGGDFSSYMPSTSFFFPKRLKGTALGIQAGIGNFGVSVAQFVTPLIIS
VGIYGTAQVFTSIDQKESVTVFQNSTIEKQKEVFGLLNAEVQTKILSNVKKTVIDSVLTS
IKSDDKTVVFISLPIKAKAKAIANANPKLAEKILNDINPQNTAVKNKEIYLQSAAFWFVP
FLLILSIVSWFYLRSIPMKASIKEQLDIFSNKHTWYCTITYLMTFGTFAGLSAAFPLMIK
FLYGDFPNAPDPLVYAFYGPLIGSASRIAFGFVADKIGGAILTTITGLGILAGAIILVTQ
GLVAPTSMDQFPLFVIVILAMFFFTGIGNAGTFRQYPIIFGENQRQAAGVIGWTAAIAAF
GPFIFSKLIGNNISANGTVNQFFIGVAFFAVIATGINWWFYNRKNCEKPS
>EGALAKHO_00133 Nitrate transporter
MSGLSQSHRILFLNTLAFTVCFACWTLNGVLVTYLIDKGIFNFTVVQTGWLLGIPILSGS
IFRLPIGILTDKYGGKIVFTVLLLLCSVPLFLLPLANSFWSFAVLSFFFGLVGTSFAVGI
GYTSVWYPKEWQGRALGIFGMGNAGAAITTFIAPTLLNYLSENDPINGWKMLPVIYAVSL
LIIGLLFIVAAKNKTNQGASKSIKKLLSPLKNIRVWRFGVYYFLVFGFFVAYSQWLLPNF
MNVYHTSLVMGGMFATMFSLPSGVIRAFGGYLSDKFGARKVMYWVLGSSIVISFLLMFPK
MEVFTAGPGVMASTNGIVTEVSATEIIVNGKVHKISEKQIGNKNEASIFPVKKSWQEVVV
KQNQEVKKKELLAQGITQIKFEANLWVYVVLVILIGISWGIGKAAVYKHIPEYFPNEVGV
VGGMVGLIGGLGGFMGPIIFGYLLNSTGLWTSSWIFIFAVSVFCLLWMHRTIIKAIRIKS
PDFTRDIEDK
>EGALAKHO_00134 TonB-dependent receptor SusC
MKKNLKIYAILFLLLLTAGVNAQNTTPLIQSKLDGTIVDDVTNQPIIGASVVIKGTTHGV
QTDAEGKFYFQTGQKLPYTLIISYIGYKKTEVIVDKNPVTIGIKEERQELDELVVVGYGS
QKRKDITGSVASVPKANLSQVTSSADNLLRGAIPGVVVTQSSGRPGASSSVRIRGGNSIT
AGNEPLYVLDGILIYNDNNNSTAGVANAGATVNVLSTINPADIESIEVLKDASATAIYGS
RGANGVVIITTKKGTKGQDNISYQGYFGFQNVSKKLHVMNASQWASLRNDVQASIGQAPS
FSAAQIEAFKTSGSYDWQDAIFRTAAPVQNHQLSLSGGDDKSRYAISAGYFQQEGVVIAS
DFKRISLRANYERNYSQNFKFGVNANYSNSVSNGIGTNGGAAAGRQPNPLVVALYQPPVV
PIKNADGSYNLTNNPYATAVNGIVPNPINDLENTTNETKINRILASLFGEYKITKKLTAK
VAVSGDVLDTKQNYYAPSTTTSGAGTKGLGSVGDRLVSSILNENTLNYNTTFGENHKFSA
LAGYTLQYTEGEVVNAGANTFVNDANTYNALQDGVPVKPYTDAFESVLKSWLARVNYSYK
GKYNFTLSGRADGSSRFGSESLWGYFPSAGFSWNITDEEFANNIKGVTEAKLRITAGTTG
NQEIGNYLSLAQMGSVNYSFGGTLYTGLAPTRLANPDLKWEKTNQYNVGLDLSLLDRKIN
FVFDVYYKKTNDLLISVPIPLTSGYASVLQNIGGVENKGLEIGLITENIKTENFSWNSNF
VFSTNKNKVVAIGNGVDQFFPVVPNGSLLQQQPVTVKVGLPLGTFWGYRTAGIFQTQEEV
NTQPKINSLANTKVGDRKYVDTNGDGVITALDKGNLGTSQPKFVGSFSNTISYHDFDLNF
SFQGAYGGKIFNALNQQLEISTLGTNANVTLDDRWTPTNPSNEIPRATSSPLGIVSERYV
EDASFLRLKLITLGYTLPKSISTKLKTKSIKFYVSAENLITWTKYTGYDPEVSSYEQNNL
YPGIDFGSYPNSKTFISGLNITF
>EGALAKHO_00135 SusD-like protein
MKKIFITFILSAGLFISCTDLEVTPTSFVTEDNYFKTQDDAVASVNAAYASLSLDPGEQS
LFGRNLYFLTDMGSDYAAAGVSATNPQVRALSSLTHDATNDRVQVAWRQIYAGINRANVS
IDNIPKVAGTEAVKTRLVNEAKFLRGLLYFQAVRLWGGVPIVLHEPTSIELESLKSKRAS
VEEVYTQIISDLKAAESLPSTYPANDAGRATSGAAKAILAKVYLTRKDWPNAIAKSREVI
NGGYGYALFESFGDIFAKAKKNGKEHIFSVQFEANQAGNGSSGNNFQATSFTGFTATEPA
DIISDVALFYDIYAPGDTRRDVSYAKQLPNPATGALYTFPKPIFKKYLDLTNLATPGNVA
INVPIVRYADILLSLAEAINEQGAPTAEAYELINQVRRRAFGKPITTPDATVDLVGLTQT
TFRAALQEERKKEFVQEGQRWFDLVRWGTLVTEVKKVTAKNSVSERNNLYPIPQSERNID
PVGLPQNPGY
>EGALAKHO_00136 Arylsulfatase
MIKKLLLIALLVVAQFQLFAQRRQPNIIVILADDLGFSDIGAFGSEIKTPNLDKLAKNGL
ILKQFYNAGRCCPSRASLLTGLYPHQAGVGDMVQDKGFPAYQGYLNEHCITIGQALKQAG
YNTIVSGKWHVGLVPSAWAVNRGFDDSFTLQNNGSSYFNSEPLYNDGRKVTFLKGDKEII
RTDTSTYLTQEITNFALNSLEKQRNQQHPFFLYVAYNAPHWPIQALPEDIAKYKGKYLEG
WDKLRASRFKKLKEQGIIDKNWDLSNRFEKVPDWEKLSAEEKEKWDTRMAIYAAMIDRMD
AGIGEILQKVKSLGEEDNTLILFLSDNGGSADDVKNWNYVTQKNGTPGSVASIDSYESPW
GNVSNTPFQLFKKNTHEGGIASPFIAYYPKHIKAGKVSNRVSHLIDIFPTFLEYAGFQYP
NSYQGKNLTPLEGISLKKEFEGQQSEAHEALFWEHEGSKAVRKGQWKAVAESNQPWELYN
LATDRTETKNLARAEPKLLQTLIELHQQWSAKVGVEDWNKIK
>EGALAKHO_00137 Arylsulfatase
MKKSKNSISIKSSQKGLLITAILLAQFGLAQTKPEEFKGVIGKTLADSKEYWPEPVTAPK
GAPNVVWIVLDDVGYGASSAFGGLIETPVLESLANNGLRYTNFHTTAICAPTRSALLTGS
NSHKVHVGGFSHTIMSAGFPGWDGRLPSKNGTVAEILRDKGYNTFGVGKYGVTPDEEATD
AGPFDHWPTGKGFEHFFGFLGSATDQYKPDLIEDQAHITPDGRHLSEQITDKAISYIQKQ
QKAAPGKPFFLYYSPAAVHAPHQVATKWSDQYKGKFDDGWDAYREKTIANQKKLGVIPAN
AVLPERNPLIADWKKLTPDQKKVYSRFMEVYAGYLTYTDYEIGRVINYLKESNQLENTVV
FVLIGDNGASKEGTLQGAVNRQTYVNGETDETVFQNNLKRIGEIGTPETYGNYPLGWAQA
TNVPFKDWKQDANSEGGTHNPLIVYYPKGIKTPGIRTQYSHVIDILPTTLDILGVKAPES
IREIKQDTIQGYSFFNSLNDAKAISNHKIQHYYIFGARAIYNDGWKAAAAHHPNSIEAKE
ALNDPKKAGLLNADFDKDVWELYNVNEDFNERKDLAKKYPEKLAELKKLFDEQAKKNNLY
PLIDWQDVYLRKIHKTPATEGKSAQELLTKANK
>EGALAKHO_00138 Arylsulfatase
MKKLKINSKIKSPQKGLLITAILLAQFSFAQEKQEEFKGVIGKTLADSKEYWPEPVKAPK
GAPNVVWILLDDVGFGASSAFGGLIQTPTFDQLANNGLRYTNFHTTAICAPTRAALLTGR
NSGRVHVSGFSHTILSAGFPGWDGRIPSDKGTIAEILRANGYNTFAVGKYGVTPDEEASD
AGPFDRWPTGKGFDHFYGFLGSQTDQYNPDLVEDQVHVTPDGRHLNELITDKAISYIKAQ
QKAAPGKPFFLYYAPGAAHAPHQVATKWSDPYKGKFDKGWDAYREEVIANQKKLGVIPSN
AVLPERNPLITDWKKLTPEQKKVYARFMEVYAGFLTYTDYEIGRVVNYLKESNQLDNTVI
FVAIGDNGASKEGTTEGTINQSLFSQGTSDDENLKKNLANIDEIGTAKGLNTNYPLGWAQ
ATNVPFKNWKQDAQSEGGTHNPLIVFYPNGIKEKGGIRNQYSHVTDLLPTTLDIAGIKAP
EYIKNVKQDIIQGSSFYASLDNAKAESLHKVQYYYIFGNRAIYKDGWKAGAAHLPDSFAV
KKSLGKNEKPVESNFDADVWELYNLNEDFNERNNLAAKYPEKLAELKKLFDEQAKENNVY
PLIDWQDVYNRRIHNSGADKGKTLQDLIKQASKPGSAGSSN
>EGALAKHO_00139 Arylsulfatase
MKKIKYILIPALLMTQFGFAQIKPDPNYKGVIGKTLANSKEYWPDPVKAPEGAPNVVWIL
LDDVGYGATSAFGGLINTPTFEKLANEGLRYTNFHTTAICAPTRASLLTGRNAHAVHVGG
FSHTAMSAGFPGWDGRIPSSAGTIAEILRENGYNTFAVGKYGVTPDEDATDAGPFDRWPT
GKGFDHFYGFLGSETDQYNPDLVEDQAWLNGNTRLNNSGKDKSKNEFTADLGGKHLSELI
TDKAITYIDRQKSAAPNKPFFLYYAPGATHSPHQVAKEWSDKYKGKFDEGWDVYRDKVIA
NQKKLGLIPANAKLPTRDSYVKAWNTLTPDQKKLYSRFMEIYAGYLEYTDYEVGRIVEHL
KGINQLDNTVFYIVLGDNGASKEGTANGTIDQPLFSKLFGAPKDDLQENLSKIDILGTPD
AIEGNYPYGWALAANTPFKNLKQDAHSEGGTRNPLIVYYPKGIKTPGIRNQYGHVNDILP
TTLETIGIKAPATIKGIPQDSIQGTSLVYSYKDAKAASKHTIQYYYIFGSRSIYKDGWKA
AAAHHPDFIDIVDNGALAKSTGPSTYDNDVWELYNLNEDFNERVNLAEKNPEKLKELLAA
FDDQAKKNNVYPFIDWQDALKQRIHKTKK
>EGALAKHO_00140 hypothetical protein
MAATKPLIKKGLFALVLVVIAVSFYYLTIWATPYYVQNKFAEKSVGFVNTPRFGEQPNPE
NSRVIPLPNPDFLYSTIIYDLKDNVLKISGIVPDSTYWSISAYQENTTNYFVENEEKVKA
KFEYYLAPEGSTSEALKNIPKEKIIYSPTTKGLILFRYLVSKAYPVKTLAELQHGVKVEK
LGK
>EGALAKHO_00141 hypothetical protein
MALNQKIKKIALGLGLVLLAIVLGSGIGIYNIASGKSSSQRVIGNWQTVDKDKDLNTADL
LTIAQISVYGTYALTKKEVIYLSTNTDSEGNAIDPKSDYVISGKNLDAKYWSITAYDQDG
FLIKNPINTYSYNLETVKYEAYSTSYKINLAASEKKENWLPINNVKKATLVIRLYLPSDA
LRNNLTVETLPTIQKVK
>EGALAKHO_00142 hypothetical protein
MRKADYEVIGKKIIVGAIVFLVPLVILAGGLALINQFLK
>EGALAKHO_00143 hypothetical protein
MALDQTRLKRDLGISLFIYSLPVLAILLYFKLNNGHVSESHLTLPTYLEFLQPAFTNIRS
WGLIAFSIVLGIVEFAAGLYDEHWTGRERKVDIICFLAPKLLLPPVITFFSLTALPYLLP
NLANTLSWVPFWGGFFLIAIADDLTQYWYHRLHHQVPFLWRFHRTHHSAPYMGMAMASRQ
NFLYTVFFSQIYLTATLTYLGLGIPALFVLVIKSIITLGAHSSIAWDKPFYKYRALHPIA
WVLERLISTPATHHAHHADTSGDGVGHFKGNFGNMFFIWDVIFGTGLITRKFPQSYGTKT
YKSEEWYAQFLWPIFKSKIEGSPLADGVLALPTSQKENTVVTNQNVYEPVQS
>EGALAKHO_00144 hypothetical protein
MAIVQKEKLTRDLSISLLLYTLPVLAIYLYFKLSNGVVSESHLTLPSFLEFTKPAFENIR
TWGLIVFMLALGIIEFTAGLYDDEWTGEERKIDIICFLVPKLILPPVIAFFSLTILPNLI
PNLENSLSWVPFWGGFFLIAVADDLTQYWYHRLHHQVPFLWRFHRTHHSAPYMGVAMLNR
QNFIYTVFFSQIYLTATLTFLGLGLPALFVLVIKSIIVLGAHSSVAWDKPFYKYKVLHPI
AWVLERLISTPATHHAHHADTSGDGVGHFKGNFGNMFFIWDIIFGTGLITRKFPESYGMK
SYKQEEWYAQFLWPIFKSKKEGSALADGVLSIPLKPKPENVTPSPVYEQAQS
>EGALAKHO_00145 Putative alkyl/aryl-sulfatase YjcS
MKKIKLSALLISITLAANAQASKQASTFTQKSNEAVYSKLNFEDTADFVDAKRGFIATLT
DGKVLSKSGNVAVDVNTFNFIKGKSPATVNPALWRQAQLNNINGLFKITTGVYQVRGIDA
ANISFIETKNGYVVVDALTISEASAAAYELIKKHVANKPILAVIVTHSHGDHYGGIEGLI
SAEDIKSGKVKFITPKGFYEEAVSENVLLGNVMRRRAGYQFGLGLERNDKSQVDIGLGKP
FLGGGSSSLLEPNLEIEKTGQTINIDGLDLVFQLTPNSEAPAELTLFTPAQKVFFSAEIA
SHTYHNVLTPRGAKTRDAKAWSGYLDEAIDLFGDKTEFVVPSHTWPVYGHDKGITFLEKQ
RDLYKYVHDQTVHLANKGLNKDEIAEEIKLPAELAKEWYNRDFYGTVKHNAKATYQFYLG
WWDGNPAEYDKLPQVEAAKKYVEWFGGEETAVKKATESFEKGEYRWVAEVLKHVIFANPN
NVAAKNLQADAFEQIAYQSESGIWRDLYLSGVKELREGVIVPKNPVNRAAGFLATLTPEA
IFDYLSVTVDGTKAGGKDIKLRFIFPELNKNILVYLKNGVLHQSEARPNEKTEFTLTIPK
AKFVELLTKPETARDILTSDGVSFDGDPFKFRELASVFEPANPYWNIVTP
>EGALAKHO_00146 Thioredoxin
MKTKIFKNSFTIVFFLLTISGFSQDKSSSSIVLLDAFYAKIKSQKSPQIIDARGTDEFAL
NHIEGAVNFNLKSEDYEKQVAALNSSQPVFIYSIAAYRSGLLSTELIKKGFSEVYILDGG
IASWIGGGKPFYTNLKSKLTLPEYKKIIADNNYVLVDIGSKYCATCKTVKPILENLRTQY
GEKLKIVQIELEESPQVIADLKTVKVFPTLILYQNGKIVFKKDGLGDLKNDVDVALAIK
>EGALAKHO_00147 Arylsulfatase
MALTKTKKIVFSILTILLIIAIFLFWPINTDGTLIKPNEKLVAGKAAFLAEKIPSDSSFK
KPNIIILLADDLGKYDISLYGGTATPTPQIDSLAASGVTFTDAYVSASICSPSRAGLITG
RYQERFGHEFQPGDRYPKNNLEYYGFKYLINTNNWRLNPKIEYPNEASIATQGLPQSEIT
FADLAKREGYSTAIIGKWHLGHNKGFFPLDRGFDYHYGFYQAFSLYTPEDDNPDIINHHH
KDFTDKTIWGNGRVGIGQIRRDTTIIHNKAYLTETFADEAEAFIDKNKKKPFLLYVPFNA
PHTPFQVRKKYYDRFPNVKDENKRVYFAMISALDDAIGRIRAKVKKEGLEDNTLIFFASD
NGGADYTFATTNAPLKGGKFSHFEGGINVPFALSWKGKIKPHTVYKTPVSTLDIFSTIAA
AIHSDLPKDRVYDGVDLVSTVNENKEAHKTLYWRSGDAKAIRSGDWKLIISGKTHQEWLY
NLANDKSETTDLAQKNPAKVKELHAVLQNWEKGLVKPLWPNLTHYEFDFGTQKYFVDL
>EGALAKHO_00148 TonB-dependent receptor SusC
MQKSHKSLCILTLLNQNKVMKKKLYILSFLTIFMISLGINAQETTPLIQSKLEGTIVDQI
TNEPVIGASVNIKGTTHGVQTDLDGKFYFQTGQKLPYTLIVSFLGYKTKELVVNESPVHI
TLSADVQELTDVLIVGYGTQKKKDYTGSLSSIPTELKSLPTLSVDRLLQGGISGAQVTQS
SGQPGAGTSVRIRGGTSIIAGNEPLYVIDGFPVYNGDGAVDSGVTSGASINPLSSLNPAE
IESIDVLKDASATAIYGSRGANGVILITTKRGKKGQMSVTYDAYYGVQNVINTIPMLNAE
QWGYLKNDALKDSGKAPLYTQEQLDNLGVGTNWQDEAFTSAPISSQTISVTSGSDKTRLL
VSGNYFKQDGVLINSGFNRYSGRLNVDHDFTPKFKFGLSLSGSITNADVAPDGVVQNILG
MVPVVPVRDANGAFTANSSYGAAVANPIATMTLQINETNTTRFLFNGFGEYKIIEGLTAR
VSLGTDIINNKQNRYIPSTLYESPAGGSASKGSLSSVGWLNENTLSYKKKIGEKHAFDIL
TGYTQQKTTSEVFRAGSSNFASDEFTYNNLASGTVITTPMSSASESSLQSFLTRINYGFD
DRYLFTFTVRADGSSRFGSSNKWGTFPSAAFAWNISNENFLKNVEQISSLKLRLSAGLTG
NQEISPYQSIARLSYYPYVFANTLVPGFAPSSFENPDLGWETTTQYNIGTDVSLFNNRIN
LTADVYYKKTEDLLLEVPIPYTSGLESAFQNLGSVENKGIEIGLKTLNFVGDFEWTTNFI
YSANRNKVLSLGEGTDFFIPVNPATTTTPSGIVKVGEPLGSFYMYKFDGLFQEGDDFSNS
PLANTKAGSQKFKDLNNDGKITQADDRTVVGNSEPLFLASLTNTFRYKNFDLIIFINSSY
GNKIFNRSAADYELGTGFTGAYATLLDRWTPTNTNTRIHRAVEDPSATLSDRYVEDGSYI
RFKNISLGYTLPKKIASYLTLSSARVYIAGQNLITFTDYSGYDPEVNRNGQAALNSGVDV
GVYPGTKTILGGVSVTF
>EGALAKHO_00149 SusD-like protein
MKKIYILLTAISLGLAACTGLSEDPESFISPGQFYKTSNDAVAAVNSIYFHLNQNDIVGQ
PIYNSLYNTGMDFMTDDLSAGPGSPNPDVRSLSALAHSSTLLRGKESWQQHYSGINKANV
AIERIPEVTMDEKLKSRLLGEARFLRALYYFDLVRQFGGVPLLLTDQTQLPIEQLQVPRN
TATEIYAQIITDLKESVNNFKAGSTGEVGRATEGAAKSLLSKVYLTKRDWANAVTTAEEV
INGSYGYVLLSDYSQVFLPAYKNSKEHIFSVQFNSAANITNAVTGRDIATGVPGIKGSYG
DQLTFYTKGTDKFFSIYKLYTAKDKRRNVSFVTKYKSPTNGKWYGTLNDIKIPGDSVPYL
NKYWDPNFASTGKSEANANIIRFAEVLLIHAEAENELNGPTAKAYASLNRVRKRAGLDDL
TPDLTKDQFREALYLDRRLELVGEYQRFFDLIRQTGSEATGVGPEGRGTLLKNLQAVGKT
NVAARHYLFPIPQFEIERNKKLTQNPGWE
>EGALAKHO_00150 Arylsulfatase
MNIKKILIATVALLGVSTSIIAQHEPIQPFQGKIGKTLDESTQWWPEKVKAKKDAPNVLW
ILLDDVGFGASSAFGGLAETPNFEALANDGLRYTNFHTTGICSPTRAALLTGRNHHKVAM
GHHAELGIGEPGYLGEIPLEAGTVAEIFRENGYNTFALGKWHGIQPAQQSLTGPFNRWPT
GRGFEQFYGFIGGATDQWHPQLVDGINDVNIEPNTKHLNELLADKAISYIANQKSTDPEK
PFFLYYATGATHAPHHVAKEWSDKYKGKFDKGWDWYRQEVFNRQTAQGLLQKGTVLPPRQ
AGVQEWNSLSADEKKVFARFMENYAGYLSYTDHEIGRVIDFLKRSDLLDNTIIFLVIGDN
GGSKEGTYTGSLGISSGERSLTGDVPFLLENLDKIGTENTNPNYPLGWSQACNTPFRYWK
SDANSEGATHNPLIVSWPKGIKEKGGIRTQYSHVSDILPTTVELTGVTVPEVINGYPQWP
IQGTSFAFSLNDEKAPTRHHVQYYELHGGRSIYKDGWKASVYHPRNFSGETGTDPNFNPR
PFSQDKWELYNLNEDWNEINDLAAKYPDKLKELQDLFDSEAKNNNVYPLHSYQEGLAKPV
IKPKTVILEGTSQKIQVNIGKGAVTITANIETSAKTDEGVIFANGGLLGGSSLYIKGGKL
HYLLNNGVDQKILTASKPIQAGKSTIKIEYPDSKSIVLYLNGEKVAEQTNIIRGKYINSI
SGEGLSVGRDLNSPVTKTYPAPFNFKGKVSRIVIEQSVQ
>EGALAKHO_00151 hypothetical protein
MKSKYSIIAALLLYGVTTFGQNKSEADFFNGKQLFSTVQKYVSLGEHRTGTPTDLATSDW
LGKELASYGYDVKYLEFPIRQFFPEKVSLSSGKETIKAFPLWWVNESINRTVTGTLVEAD
KVKAYTKSNIALIHLPLKQQKGNPKKYIDSIINMGVKGIVAITDNQSGEIEAYNTNKDQQ
PWKVPIILIAPKDSAKALAFVKTGAAVTLAINGTFKEVKGRNVYGTIGNGEQYIVISTPI
SGWFTCGGERGSGIAIWLSLAKWAASLKSKYTFVFTANSGHEHAFKGAHEYLERNAPPVE
KTHLWIHFGAGAATLEFKNTASGLVKQTNADPKRRFFFNDPVKNSFNTAFTGINAVKVLA
NENPGGELIYVAQKGYKRFAGVSYAHPFFHVKTDDANTTSPEILEETAKAFRDFIKEDTK
Q
>EGALAKHO_00152 D-galactonate dehydratase
MKIGTSNSSRRSFLKIAGLGAVLPLVPSVMSASPDFHPESTFGNKLLVTDIKVYNVKVNQ
RGSWYFIELITDKGLSGFGEASHAFGGLSGEGDKALHKELSYFFELVKGQSPFNIEQFRQ
LAWKRSLQSKISGTAFSGIEQALWDLKGKALGVPVYELLGGKLRDTVKVYANINRANNDK
ENSGHRSVANFQRNAEEAMKNGFKAVKLAPFDEMAPLTSSPSKLKADIDYAVNCIQTIRQ
TIGNDIELLIDVHSHLNRDLAIETAKRLEPYNLYWFEEPVNPEKFVQETKEIKDNIKQNL
AGGEAIFGVQGFAPLLQANALSIIMPDVKHCGGVQELKNIAAIANALGEVRVAPHNPSGP
VATAASAHLCANIPNFAILEFAYGEVPWRAELLSPPEQFVNGNIVVNDNPGFGFTLNKKL
IDALL
>EGALAKHO_00153 Arylsulfatase
MNKIIFKTGISMLFASSLLMNTYGQQSGQLTSDKEFKGKIGRTVAESQEYHPEKKKAPAG
APNVVVFLIDDAGYGTASAFGGLMETPVLDSLANNGLRYTNFHSTGVCSPTRAALLTGRN
HHSVHMGTLNYSSSGFPGYDAIMPADKATIAEVLHENNYNTFAVGKYHVAPLNEITANGP
FDRWAVGRGFDHFYGFQLGHTDQYHPNLYEDAKVIDIEPNNKHLTTLLADKAISYIANQK
SIEPEKPFFLYFATGAIHSPHQVDKKWSDLYKGKFDKGWDWYREEVFARQKRLGVIPANA
ILPDRDPTVKAWDSLTPEQKKVYARFMEVYAGFLTHADYEFGRIVNYLKEIGQSDNTVIL
VSIGDNGSSHSPTNGTLNGYISSLDEDKQVAELYKNIDKIGTEHSFEDAPSGWTQATNTP
FRLWKADPNSEGGTHQPLIVYYPNGGFKKGEIHTQYGHVIDIAPTIYELTGAKVPEVIKG
YKQQPIEGTSLVYSFKNAEAPNRHTVQYYELFGKRAIVKEGWKASVFHKSGTDFSKDVWE
LYNLNDDFNERIDLAAKYPEKVKELQALFDAEAIKYNVYPLSDNALGHSAGGRERSPYGL
KNKVVLYPGIDQLLTYSGPQFQNDPFTITADIELKSKTEQGVLFASGSEFDGLSLFIKDG
KFIVAHNTGSIIKHLESNIPVPVGKSKLRFEFNYIEPAKGNKDRNLPAGTESIYINDQKV
AERPIVASEGRIAIYKDGIDVGADRNSPVSDKYKVPFNFTGKLNNVTIEYK
>EGALAKHO_00154 hypothetical protein
MSTQPKKNTIHEDWTVVILGFIIIGISLFIFLPEVPIFKWSNGTDLISDVFDFENLKILG
IQFLYLISIGAFGAFLIGKSVKYFLLVFPIVYILTVLALIIAGNTEVKALNLEAVIFSLI
IGLAIGNFLKLPEWFKSALSTEVFVKIGLVLLGTSVIFSDILKAGSLGLIQALVVVLSVW
YFAFWLCRKLKVDDELTMMISSAVSICGVSAAIATSGAIKGDSKKLSYVISIVLVTAIPM
MIFMPIIAKCFNFPEEVTGAWLGGSIDTSGAVVASGTLVGETALKISTIVKFSQNVLLGL
AAFAISVYWTYTHNNSAEAKESKPTLSVIWERFPKFVIGFILASIVFSFFLTSEVRDGLK
DSLKNLQGIWFALAFTSIGLETNFKDLLQNNSRKPLYAFLIAQLFNVIVTLIIAFLLFGK
>EGALAKHO_00155 Arylsulfatase
MNYKVKSILFSFLLSGFVGSIESNAQNATSKPNIILIMVDDMGYSDLGNYGSEIKTPNLD
KLASEGLRLREFYNNSICAPTRGSLLTGQYQHKAGMGFFDVNLGLPAYQGYLNKESLTLG
EVFRSGGYSTLLSGKWHVGSEDQAQWPNQRGFDKFYGILKGASNYFDTKGLPFGKTPYPV
KLLRNNEELHPKDDSYYFTDEIGNNAVTFLDEQNKENKPFFLYLAFTAPHWPLQAKPVDI
AKYRGKFDEGWDILREKRIEKLKANGILPANQTVAPRDPEVPEWSKLTYDEKQFWKAKME
VYAAMVDNMDQNVGKVLEKLKALKKDKNTLIIFISDNGAQGGFNTYNPLGRGLVRNDGPV
GTSGSFDYQEQNWAYLSNTPLQQYKNNMHEGGFSSPFIAWFPSKIKAGRIDKGTGHIIDL
APTFYELAGIEYPKTYNGVNSNPLVGKSLLPVLFDNVSEVNRGAPLFWERAGNRAVRDGK
WKLVSTYPSYEWELYNIETDRGETTNVAQQNPGIVNKLSASYFEWADRTGVVEYSKFKLK
PEVMPGGAILKK
>EGALAKHO_00156 Major membrane protein I
MAESKQQQTALGDVAARQLAIATRTVPQIGTISPRWLTHLLHWTPVESGVFRLNKVKDGS
HIEVDCSARDERILPNTFVDYIENPREYNLAAVQTIVEVHTRVSDLYSKPYNQITEQLRL
AIETIKERQESELINNKDYGLLSNVAPSQIIKTRTGAPTPDDLDELLTKVWKEPGFFLLH
PLAIAAFGRECTRRGVPPPTTSLFGSQFLTWRGIPLIPSDKLPIKNGKSKIILLRTGESR
QGVIGLIQPGLQGEQSPGLSVRFMGINERAIASYLVSLYCSLAVLVDDAIAVLEDVEIGK
YHEYKY
>EGALAKHO_00157 Cysteine desulfurase
MSINTNENGLPNIDDLQNLANELFQTLPNEFPKEISLSPDKAEHPRATKIAETLLHAGGT
NILAPFPTQIPLNVQPSPTSFSGFGVSPSIANQSSSASALYPNAGAGFDPQYGIPSSGIP
EDNSVNINNPHTGFQDINLKNGGTPQINEESFFSSLLLNNQYLPFQSENSSFEAELKVAL
EMVDTQFRKRVDFPSSGSETPNSYYFLDQNPFAFDQKNANAIVGNTFGLKEFGGLTGNNF
NAELIRKDFPILRETVNGKPLVWFDNAATTQKPQAVIDRVAYFYEHENSNIHRAAHELAA
RASDAYEAAREKVKTFLNARSVNEIVFVRGATEGINLVAQSWGDHNLVAGDEIIVSNLEH
HANIVPWKRLADKKGLKLRVIPVDDDGQILLDEYAKLLNSKTRLVAFTQVSNALGTVTPA
KKIVEMAHAAGAKVLIDGAQSVSHMKVDVQDLNPDWLVFSGHKLFGPTGIGALYGKEELL
NEMQPYQSGGNMIQDVTFEEIKYHKAPNRFEAGTGNIADAIGLGAAIDYVTKIGIDTIGQ
YEHYLLEYATRLLKEIPGVRLIGTAKDKASVLSFNLQGYTNDQVGQALNKEGVAVRTGHH
CAQPILRRMGVETTVRPSLAFYNTTQDVDTFIKTLWELKKVRF
>EGALAKHO_00158 hypothetical protein
MSYANNDITRFLDAQNKLYLTALSEIKKGKKETHWMWFIFPQIKGLGKSTIANYYALNGL
TEAEEFLNHPILAKHLIEISQLLLNYKTRSIEAILGELDARKLRSSMTLFSQAENAHPVF
QEVLDTFFSGYSDPFTLSMPASSRQIAMAS
>EGALAKHO_00159 Ornithine aminotransferase
MIHTENTLSSKSEILIDKENKYGAHNYHPLPVVLERGEGVYVWDVDGKKYYDFLSAYSAV
NQGHCHPKIVKAMVDQAQKLTLTSRAFYNDKLGDYEEYVTKYFGFDKVLPMNTGAEAVET
ALKVCRKWAYEVKGIPENQAQVIVCENNFHGRTTTIISFSNDETARKNFGPFTDGFIKIE
YDNLEALEKVLESSKNIAGFLVEPIQGEAGVYVPSEGYLAKAKALCEKHNVLFIADEVQT
GIARTGKLLAVHHENVQPDILILGKAISGGVYPVSAVLCNNEIMNVIKPGQHGSTFGGNP
VAAAVAIAALEVIKEEKLAENAEHLGIILRKGLNEIAERNNLITLVRGKGLLNAIVINCG
EDSDLAWEICLRFRDNGLLAKPTHGNKIRLAPPLVMTETQIQECLEIIEKSLNDFRD
>EGALAKHO_00160 Regulatory protein AsnC
METLDEFDINIIKELEKDGRMAFSAIAANLKISNTMVHQRINRMIEQGVIGGIKPIIQEK
KIGYDWASFTGITLNKDSDSDRIIEALKDIPEITECYYVTGSFTLYIKIIAKNHEHMRRI
LYEKIDSIPGIAKTDSIIELGCAFKRNITL
>EGALAKHO_00161 Glutaryl-7-aminocephalosporanic-acid acylase
MFYSFKILKLTFLFCCISFQISAQKINSKEVDRLKKLAQQVTIIRDNWGIPHIYGKTDAD
AVFGLLYAQCEDDFKRIELNYIEKLGRLSEIKGQSVLYNDLEIKILIDVDEAKADYKKAP
SWLKILLNSYADAINFYLYKHPEVKPALLTHFEPWFPLLWTDGSIGAISTADLSIGELKT
FYSGNNDKVAYVEKEKNVQTGSNGFAFAPSKTADGNAILYINPHTTFYFRPEVQVTSEEG
LNVYGAVTWGQFFIYQGFNENCGWMHTSSNVDVADMYAEKIINKNGKLFYEFDKKLLPVI
EKEITINYSENGKLIPKKFKTYSTNNGPIMAKRDGKWISLKSNNRSMTSLIQSWVRTKSK
NFDDYKKAMDLKANTSNNTVYADSKGNIAYWHGNFIPLRDKKLNWSKVIDGSISSTQWKG
LHEVNETVHLYNPVNGWLQNCNSTPYTVAGENSPKRENYLPYMAPDGENFRGINAVRIFS
KSDKYTLDKVIADGYDSKLSIFEILIPSLTKAFEKNIKPDYPDYIELAEAVTILKNWDYY
AKENSVATTLAVEWAYKLDPIILKAYVNEGELDQVENTKKFAATAGVDQLIPQLQTVLKE
LKLKWGTWQVAWGEINRFQRSNGAIDLKYDDLKPSLPIGFGPGSFGSLPSFKSSYQNGSK
KRYGSNGNSFICAVEFGPKIKAKSLLAGGNSGDENSKHFTDQAEMYRKGQFKDVLFYKED
VIKNADKTYHPGE
>EGALAKHO_00162 hypothetical protein
MKNSIALVFATIIFSGNMNAQLKPVKYAEGSQTLNGLSIKAAKKSSNNPGILLLPAWLGI
DNASKGIAEDLSKLGYHVFIADIYGEGNYPKNTSEAGKQAGFYKTNYEAYQKRINAALQE
LIKSGANADNIVAIGYCFGGTGVLEAARGHLNVKGVASFHGGLGKDAARPATPITAKVLI
CHGADDPYESKEEITAFQQEMRDSKADWQMIYYSDSVHSFTNPEAGNDNSKGAAYNPVAA
KRSFEHLKLFLDEVLKK
>EGALAKHO_00163 hypothetical protein
MSHSPIRKDKTCLNCRHVVEQNFCPNCGQENTDSRKTFHHLFIHFFEDLTHYENAFWKTI
KNLLFKPSTLTKEYLSGKRLSYLAPVRLYIFISFITFLLIAMFPNKVTENLSKNENEISS
NFEKSSKDKTEKLHDKNYLESKTMKQVNKNYFQLKTMKEIDSIQKYGKESEKLNAFSYWI
YEKAIHVTEHNTKAEIIEKFIESFLHNIPKILFIIMPFFAFFLWIFHNKKKWYYFDHGIF
TLHYFSFLLLIFLILFIISKIIGLFGEDSPLNVVGNIINFVGILWMSYYFYPAHHRFYGE
TRIVSFVKSFILFFINFFFILFLLVFYMLYIFINLH
>EGALAKHO_00164 Bacterial leucyl aminopeptidase
MKKIVILLLIASAFSCKNAQSVASKDNSDPTKYMNVITAKDLKKMLYVVASDEMEGRETG
SKGQKKAGLYMIEQYKKNKVSFPKGATDYYQHIPAAFLNAKRNENLPDSENIWAYIEGSE
KPDEVLVISAHYDHVGIKNGDIYNGADDDGSGTVAVMEIAKAFAKAKKDGHGPKRSILFL
HVTGEEHGLHGSRYYSQNPLFPIANTISDINIDMIGRRDVEHAKTNNYVYVIGADRLSSD
LHNAVVAQNNKYTKLDLDFKFNDPKDPNHFYERSDHYNFAKFGIPAVFFFNGVHEDYHGK
GDEPQKIEYDALTKRTQLAFVVAWDLANRENRPVVDKK
>EGALAKHO_00165 Transcription termination factor Rho
MFDISALKEMKLSELQEIAKLAKTIKFNGVKKETLISQILAHQETTEKPPVNVAPEAEIG
DDKPKRARIVPTKKAAPNKNVPVLEFDKVEETTEKIEETPEKVITPKISKPNAKIQPAPK
VQETAESAPVEKKGPKIVKFNKSAYEKKVALQKEKEGNSEQPTEVEAETEAVAQAPVAEK
VEGIAPVKKINPNQNKNQNPNQNPNQNPNQNGNGNGNVNGNNGNQNPNHNKNKKNNFRDS
DFEFDGIIESEGVLEMMPDGYGFLRSSDYNYLASPDDIYLSTSQIRLFGLKTGDTVKGVV
RPPKEGEKFFPLVRVLKINGHDPQVVRDRVSFEHLTPVFPSEKFKLAEKGSSISTRIIDL
FSPIGKGQRGMIVAQPKTGKTMLLKDIANAIAANHPEVYLIVLLIDERPEEVTDMQRSVR
GEVIASTFDREPQEHVKIANIVLEKAKRLVECGHDVVILLDSITRLARAYNTVQPASGKV
LSGGVDANALQKPKRFFGAARNVENGGSLSIIATALTETGSKMDEVIFEEFKGTGNMELQ
LDRKIANKRIFPAIDLTSSSTRRDDLLLDEKTLQRMWIMRKYLSDMNPVESMDFVNDRFK
KTRNNEEFLISMND
>EGALAKHO_00166 hypothetical protein
MIQRIQTVYLLLTFVVTGVLMFFIPLWTLNTGKAFYFMQDQFYTILLGLSTMLTIVSIIS
FKKRQNQFVMNRLNIILNLILLGLFVYRSLNLSGETANAVSEKGIGMFLPIVAIVLLVLA
NKAIKKDEDLVKSVDRLR
>EGALAKHO_00167 Oxygen regulatory protein NreC
MTNKIKIHLADDHQVLIDGLTNLLQTVPNFEVVGNSLDGTHVYDNVTENNADILILDISM
PQKDGIEVLQEFNKKESLCKVIILSSYDDLKIIKEVMKFGAKGYLTKKCAGKNIIEAIET
VYKGQEYFSDAVREKIFTTFAHNNPKLNKNIYIENPILNPREIEIVTLISLEYSGKEISK
KLFISTNTVETHRKNIMRKLQTKNTIGLVKYALKNNLINP
>EGALAKHO_00168 Signal transduction histidine-protein kinase/phosphatase DegS
MFFIRLLTLLFFFLSFNENLIFSQHKEILKEEIQMPEKSNKISVVELHKYEQLRNRKVVT
LFIVLVVILFFLFYFFYQNNKLKQKIKRKDVKQKILLDVINSGIDTQELERKKIASFLHD
NINSLLSSAGLHLNVFTNQNNIESEEIQKTKAILADVHDLLRDMSHDLVPALLVRFGLIY
ALEDLCERNSNSNIVFEFSSKIPTEKRYIEKFEMRIYFIVSELFNNIIKHSEAKKTTISL
LEKNSQLIIRIHDNGKGFTTKKIKDPEGFGLNRIRARIKKFKGSFTINSKPNEGTTIKIK
IPLPH
>EGALAKHO_00169 hypothetical protein
MKIKIKIPTRFENLLGYKSDLRKQTGFFFKLRTLATQNLSFFKKNLCTFAPQNLCTSKKM
TKILLLSDTHSHIDDTILKYVAQADEVWHAGDIGDLHVTDTIKKLKPLRCVYGNIDGAEA
RLEFPLHNRFLCENVSVWITHIGGYPGKYNPAIREEMASNPPKLFICGHSHILKVMFDKK
NNLLHMNPGACGKSGFHQMRTMLRFVIDDDKIKDLEIIEIGKK
>EGALAKHO_00170 hypothetical protein
MNEITSYWWIILILFSIIFYKFILRVFFGMVMVPEDKIGLVTKKFVLFGTDRSLPDGRII
ATKGEAGYQAKTLAPGLYWGMWIWQYSIDMSGFTVIPEGKIGLVLSKDGQEIPTGRILAR
KVDSDNFQDATFFLDNGGQKGRQTAFITTGSYRINTFLFEIVIADQIKIYENMIGIVTAL
DGEPIPQGQIAGKFVEGHNNFQDFDKFLDTGGNRGLQPQVMLAGSYYINTWGIQIEQNPM
TDVPIGYVGVVISYIGEDGQDVTGDTFKHGNIVSKGQRGVWMEPFGPGKYALNKYTTKLE
PVPTTNLVLNWANARSESHDLDKNLSTITVRSKDGFPFNLDVAQIIHVPAAEAPKVIARF
GSMNNLVSQVLEPTIGNYFRNSAQDSDVISFLSTRKERQESAKNHIKLVLDEYNVNAVDT
LIGDIVPPDSLMKTLTDRKLAEEEQKTYQTQRMAQEQRQGMEKETAIADMQKEIVRASQS
VEIAQRTADATVKKAEGDATSLKLNVNAEAEATKMRANAEAEATKARAGAQAEATKLNAS
AEAERISKTGLAEAEKIMAIGKSTAESYQLQVSAMGGDNFTRYKVTEEIGKGNIKVIPDV
LISGNGGSDGSISGLLGLKLMEMMDTKDSKDGKNSKN
>EGALAKHO_00171 tRNA pseudouridine synthase A
MRYFIQFAYNGTHYHGWQFQPNAASVQETLNKALSVLLNAPINVMGAGRTDTGVHAQEMY
GHFDFETTLDVPNLVHKLNSYLPKDIAIFDIILVHDDAHCRFDATKRTYEYHINTVKNPF
LEELSWYFNQKLDVALMNEAAKILLNHTDFQCFSKVNTDVNTFDCTIFEAYWKQENNKLV
FTISANRFLRNMVRSIVGTLVNIGLHKISLEDFENIIASKSREKAGFSVPAHGLYLTEIK
YDYL
>EGALAKHO_00172 Putative multidrug export ATP-binding/permease protein
MKAKAFDTGLFKRILTYTKPYKWRYYGVILFAVSLSIFAALRPYLLKQTVDGYIKTHDKY
GLLMYIILMGIVLICEVFSQFFFVYWANWLGQDIVKDIRTKLFKHILSFRMKYFDLVPVG
QLVTRSVSDIESIARIFSQGLFMIISDLMKMLVVLLFMFYMNWKLTWIVVVAMPILVFIT
RIFQRKMQVAFEEVRTQIANMNSFVQERVTGMKIVQLFNREKIEAENFKEINNKHRVAWI
KTILYNSIFFPIADIISSITLGLVVVYGGFKILNGDHFTTFGDLFSYTMFIGMLFNPLRQ
IADKFNEMQLGMIAANRVFDIIDTQDHIQDTGTLEAPIFNGSIEFKDVRFSYIPEEEVIK
GIDLSVNAGQTIAIVGSTGAGKSTIINLLNRFYEINSGTIFIDGHNIENYTLASLRKQIA
VVLQDVFLFADTIYNNITLHNPEITREQVLNAAKKIGVHDFIMSLPDNYDFDVKERGVML
SSGQRQLIAFLRSYVSNPSILILDEATSSIDTYSEELIQRATETITKGRTSIIIAHRLAT
IVNADKIVVMDKGLIVEQGTHQELLNKIDGYYKNLYDSQFSVAN
>EGALAKHO_00173 hypothetical protein
MPQNRFYPNEQFKEIEINASLQLRYAISNRGRLISFTDEIENGRLLKGGLSDGYPTFRFK
VKKDDKIVNKYLFLYKLVAQYFLPKDSEEQTYVLHLDYNRSNDDISNLRWATKAEMMAHS
RKSPRVIQAKKNLIEHNLKADGRKLTTTKVMLIKKILARPEQKTRLKMIAKQFGVSEMQI
RRIASGENWGHVKV
>EGALAKHO_00174 Dihydrolipoyl dehydrogenase
MKYDVIVLGSGPGGYVTAIRASQLGFKVAVVEKENLGGVCLNWGCIPTKALLKSAQVFDY
LKHASDYGLKVSEFDKDFPAVVQRSRGVAEGMSKGVQFLMKKNKIDVIEGFGKLKPGKKL
DVTDKDNKVTEYSADHIIIATGARSRELPNLPQDGVKVIGYRQAMTLPTQPKSMIIVGSG
AIGVEFAHFYNSMGTDVTIVEFMPNVVPVEDEDISKQFERSLKKAGIKIMTNSSVERIDT
TGSGVKAFVKTAKGEEVLEAEILLSAVGIKTNIENIGLEEVGIAVDRDKILVNAYNATNI
PGYYAIGDVTPGQALAHVASAEGINCVEKIAGLHVDPIDYGNVPGCTYATPEIASVGLTE
KQAKEKGYELKIGKFPFSASGKAKAAGTPDGFVKVIFDAKYGEWLGCHMIGAGVTDMIAE
AVVARKLETTGHEILKSIHPHPTMSEAVMEAVADAYGEVIHL
>EGALAKHO_00175 hypothetical protein
MVTIPKRIFNNKALILQRPKKQIFMKKLVFFLAISLFLSHNLFAQTKTESKNIFAKSYNY
VNDFEKIFTPNQITDLNATLKSFEKKHLYKIVVVTTSSIKPYSDFPEYTTELDKYLATDL
KAEPTILIVVSKELRQIQIQSIDLIRYKLSDEQTKEIISNFAVPEFKKGDYYKGIEAAVT
QIIDKLKMV
>EGALAKHO_00176 Arginase
MKEIYIVEFPSNLGLKEPHQGKEPGVKKLPDWLWKHNLHKFIPHKDIIRLDPPRYSNIKD
LETQILNANSLVEYAREQAYLINNILTQNKFPFVLGGDCSILLGSAIALKQKGNYGLFYL
DGHTDFMNISLSETGGVGGMAASIVTGNGHEKLTNILNLSPYIKEENLWCVGNREYDEEY
ENEIRNADATYISLDMLRKQGLENCANSFLSQITAKNLDGFWLHIDVDVLNDLIMPCVDS
RTADGLTYEEFNELTSYLFQSEKLSGLEITILDPDLDTSGQYTREFITNITATFNSFKK
>EGALAKHO_00177 Carbonic anhydrase 2
MKTKIAILAFIIFSVISCKKHQTVEEKTLTTLEQLTTGNERFLNGRSAHPRQNKKTVLAN
QDGQKPFAVVITCSDSRVSPEIVFDQGIGDLFVIRNAGNLISDIDMGSIEYAVEHLDTKL
IVVLGHTECGAIKAYINDKDGSYKKHFNHIDNIVETISQEKEEIDADKVTPKATNYLGAI
NANIEHSVKLIQDNPIVKEHQVKIVSMRYDVHTGKVVQL
>EGALAKHO_00178 hypothetical protein
MNPAVQDYNNLQSDSDKEICNQLAIIINKNLPDAENKIWHAHPVWFLDGNPIVGYSKLKN
NVRLLFWSGQSFDEEKLSNEGSFKAAEFRYTLSEQIIKEDLERWLKKAREIQWDYKNIVK
RKGVLERLK
>EGALAKHO_00179 hypothetical protein
MENFTITTQLTTKEFAKVMIIGLYKKPGLILATILGLYYIITFILDGFKIVNFYEEVPYF
EIALGVFLLLSPIIITFIAVRQFNSNISFKNGIKYTFDNNGIIAEGSTFKGEFSWNHIVK
IKEISDFLLLYHGKNTGNYIDKRKLTVDQIEFIKSKLKR
>EGALAKHO_00180 hypothetical protein
MIKKILLSALFLIGITAFSQEVPFKIPDYKAIEKEIKDKNSSYYYPKLMERLVKNDTLLT
TEDYQHLYLGYVFQPKYNAFWRSPDELKLREFYSKESLDTKDYDEIIKLANHSLSDFPFD
LKQLNFLSYVYHLKGDDEAAKMASLKFHSILNAIFSTGDGKQCETGFHVILVEHEYLMLN
VFEIEPNSQALVGNCDYLSFEKGKYKVDGIYFNIEKMLENESKAFK
>EGALAKHO_00181 hypothetical protein
MNLRLSNRKTKQSIFNLDSKTIIAQKELRKLKKPNRNKPKNEFNRITH
>EGALAKHO_00182 hypothetical protein
MNLTELPIDLKKLIENENVDFSIKAKRNTPLGKSLSGLFFGVVWCAFISIFVIAFFGPLL
KNGEVHFKSNDIPVTASWDDLSELLVPGLIIGLFVIVGVVIILYSVYSLFQKGGYFIGTQ
TRMIQYRNGKFNITDWEQFTGNVKVNAKNNFGDLEYELRTGKMQSRKNQSDKFVPDIIYI
SGIENVYEIEKKCKIRIKENDPTPAVLAN
>EGALAKHO_00183 hypothetical protein
MKILTKKDIDKPIGGLFFMIINTSIWAFIAEYYLENKDLRLVGVFIGLIISSFLYFYFKF
TKIQKSLPENIIEKTTEEKKNDKWFGIIFALEGLGIFLAKNVLLNINHDELFISIFVLIV
GLHFFPLGKIFKRTFDIYMGIWTCLFAIVGIYLITQKITTVNFANVIVSLGAAISTICYG
TKMIIEVRKLLSNT
>EGALAKHO_00184 Glutathione-regulated potassium-efflux system ancillary protein KefF
MNILIVYSHPSKKSYTFQVLQHLKSQILKQNWNLEISDLYANNFQSDMSEQEYEREGFAK
TELPISNDVLDEHAKIEKADCIIFLYPVWWSDCPAKLKGWFDRVYSVGYAYGQNETSKKM
KTIPYGLVICSAGHPNEFLKEINMAQSMETIMLEDRLGKRFENKEMLILGGTLELEKVME
YHMKQIDEIVQKIKSYFA
>EGALAKHO_00185 hypothetical protein
MILKKIKAHHLFLIVSILILLIGMDRSTDPNSGLDINIHSTYLVISNYDCTLILFTTYFL
MGILYWLFEKLPQKRLIKSLTIIHSTILIGSFVFYWLLIIYSKLFLSNSTFPLFDNGSQL
INVTLIIEFLSIAFLAIPIFIINLLIGLLKRADNKI
>EGALAKHO_00186 hypothetical protein
MTIQEIIDRQMSAFNNRDIANMMSLYTDDTKIYTFSDHELVINGKKECEEMFVKLFEQSP
DLNANFIKTIYFTNKAIVHEYVYGRNGIKEKKEQVVIFEIQDQKISRMDIMRD
>EGALAKHO_00187 hypothetical protein
MMSAQDFTTTLIVDQSPEEVFNAVTNVRGWWSEQIDGNTAKLNDEFDYHYEDVHRCKVKL
TEVLPNEKIVWLVEKNYFKFTEDETEWTGTKPTFEISEKDGKTALRFTHVGLVPDYECFD
ICRDSWTNYIQNSLKKLITTGKGQPNGKDKPQTENEKRLSAK
>EGALAKHO_00188 NAD(P)H azoreductase
MKIIITGSLGNISKPLATALVQKGHDITVITSDAEKQTAIEALGAKAAIGSVEDVAFLTQ
TFTGADAVYCMIPRANYFDPNLDLDAFTREIGNNYAEAISKSGLKRVVFLSSIGAHLKEN
SGIIQRYNEIEAVLNQLQDVSITFMRPTSFYYNLLAYIPMIKNAGIIAANYGADQMIPWV
SPNDIAEAIAEELTSPLDGKKVRYVASEELTGDETASILGEAIGIPDLKWKLVRDQETLE
GLVSIGMQPKIAQGLVEMYAGLYNGSLGEDYYRNRPAVMGKVKLTNYAKEFAAIYNQN
>EGALAKHO_00189 Arabinose operon regulatory protein
MANQQPLRIKTISEFHQFRDLPKPEHPLVSVYNFEDLKYLNEDEPKSLMLDFYSIALKRN
SNAKMKYGQQEYDFNEGVLMFISPGQVFSIEGNAELQHTGWSLLIHPDFLWNTSLAKKIK
QYEYFGYAVHEALHLSEKEENMLIGIIKNIRQEYQSNIDKFSQDVIIAQIELFLTYAERF
YNRQFITRKINNHQILERLEKLLEDYFTDDSLVKKGLPTVHYIAENLNVSPNYLSGLLKL
HTGQSTQQHIHNKLIEKAKEKLSTTDLSVSEIAFELGFEHQQSFSKLFKTKTNVSPLEFR
QSFN
>EGALAKHO_00190 hypothetical protein
MEKSAKIKPAKMCYEHIGGKLGQLLAETFADKGWIAKNNPSDKHFYITESGQKEFEKLGL
DLSQIKSENL
>EGALAKHO_00191 hypothetical protein
MTKKYIAQEFLKLAANGHSHEAFRLYVGENFKHHNAYFKGDANTLMIAMEESSRKNPNKT
FKIHHALRDGDLVAVHSCVKQNSADLGSAVVHIFRFEADKIVELWDLGQPIPKETINENG
MF
>EGALAKHO_00192 Penicillin-binding protein 4*
MNTITRFSFLLSIVFLLANCNSFAQKKENYAAKIDSLIKVADPKFNGVILIAQNGKTKYE
KAQGFANFDTKKPLTINSQFEIMSNSKLIAAVLILLEVEQGKINLQDPIKKYLPELSQTW
ADSVTVHQLLNHTHGIVAIDKPLEFKPGTNFHYGNMSYSLLGQIVEHTSNKSYSEVVNAL
FKKLKMQHTFAYNQDKIQNLTTGYINNKNTYEAVKKSLIKPENLGADGIISTVHDLAIWN
NNLHKGKILKPESYQSIIKPSVLSQHNFFGKEKEGYGYSIRTIEKDTVKYLGHTGLGDGF
SSVNLYFPESDVSLIVIENQMNDDSNLFYASERKIKDILLKSDLVHPKK
>EGALAKHO_00193 hypothetical protein
MAKNKTTETETSVIDFINTFVDDEAKRNDAFELVKIMQNVTGFEPKMWGPSIIGFGSYHY
KYASGHEGDAPLAGFSPRKAAISLYVYLSPENREDLLSKLGKHKPSKGCIYVKKLADIDI
EILKKMVSLSVENLNKLYPSK
>EGALAKHO_00194 hypothetical protein
MILTLTILVLAVIFYFLYHPRFGKRPAGERLALIQNSPQYKNGKFENETFTPELAEGYGY
YDVLKDFFFKKVDRKVPTDLIPSIKTNLKELDINQDVLVWFGHSSYYIQLEGKRFLIDPV
FSGNASPIYGTTKAFKGTDIYTYDDIPVIDYLLITHDHYDHLDYKTIMELKPKIKKVITA
LGVGSHFEFWGFATENIIEKDWHEKIELDQNLTIHTAPSRHFSGRSIKRCNTLWTSFILE
SKDFKMYLGGDSGYDSHYATIGNKYGPFDIALIDNGQYNPAWKYIHNLPEDGIKAMKDLK
AKRVFPVHNSKFPLALHPWDEPLIKVTELNRLSENPIPLITPKIGELVELKNENQVFQQW
WKGVR
>EGALAKHO_00195 6-phosphogluconolactonase
MKLKINLVVIAFLVTLNLFSQNTYVFLGSYNKDKNAESIQIYQLDTVKGKLTKVTFAKNV
INPSYLTISPNGKYVYACTETKTQNDGNVSSFEFNPENKTLTFLNKQKSGGENPVYVSVH
KSGKWLVNANYTEGSVSVHPLLENGKIDSLAQNFQYTDGSVHKERQTRSHVHSAVFSPQN
DYLFLPDLGADKIRCYRFDETLKQPLVETKNSFTKTDLEAGPRHFTFHPNQKFGYCIEEM
AGAISVYQYENGTLSKIQRINTHPDKIKEGFESSDIHISPDGKFLYATNRGKENNIAIFS
IDENGLLKNIGYQSTLGKHPRIFALDESGKFLVASNVNTGNVVVFKRNTKTGLLKKTGNE
IKMENVSCVQVKRI
>EGALAKHO_00196 hypothetical protein
MITTNFNLQPNFLENEITKLIPLQEKHFEELFEAASDPLIWEQNPSKDRYTREGFKTYFD
IIINKKGGFLILDKQTNEVMGTTSFYDYNPEKSSVGIGYTFITRKYWGGPYNKSNKKLLI
DYAFQHVNSVLFHIGSENFRSQKAVSKLGAEKINNVMFTINGVDVPYFEYELVEKNYEL
>EGALAKHO_00197 LOG family protein YvdD
MKRITVFCGSSFGTEAIYTEQATLLGETFAKENIELVYGGANVGLMGAVADGVLNNGGKA
IGVLPNFLRSREIAHLGLTELIVVESMHERKTKMNDLCDGVIALPGGFGTLEELFEMLTW
AQLGLHKKPIAILNIDGFYDSLIQLTETMVEKGLLKEANQKMLLVSDNIPDLLHQMRNYT
PPTVGKWIDKDKV
>EGALAKHO_00198 hypothetical protein
MKTENNKFAKAEMLIRKPVSEVFQAFIDPEITSKFWFTKGSGKLEQDKKTEWTWEMYGFS
LTVTTHVLQENKKIVVEWGNPEESTLVEWIFTPLDENETFVSITNSGFKGDSDRIIDQVR
NSTEGFTLVLAGAKAYLEHHILLNLVLDRFPKGLA
>EGALAKHO_00199 hypothetical protein
MDTKKPSSIDEYIGAFPNDIQEILEKVRMTIQKAAPEATEKISYSMPAFEQNGIVVYFAA
FKNHIGLYALPSGHEAFQEELSKYKSGKGSVQFPLNQPIPFDLITKIVKFRVKENLDKAK
KK
>EGALAKHO_00200 hypothetical protein
MNLEEHYNRLYEKSSKAILSGNYTIDNIINDATDSRFGITILIRPSDEIKAKIQLFLDDL
REVDSQQYYYPDSDIHITVMSIISCYEGFTLDKIRIEEYTEIIQKSLLDVDKISINFKGV
TASPSAIMIQGFPTDESLNNLRDKLRENFKKSTLQQSIDSRYTIATAHSTVMRFQDKPEN
PRKLVEVVEKFRDFDFGEFTVDKLELVYNDWYQRKNNTINLADLYL
>EGALAKHO_00201 O-acetyltransferase OatA
MQKKLYGLDHLRAFAICFVFLYHYQIPIFGHPEWLTGIAKFGWTGVDLFFVLSGFLISSQ
LFFNIKNGIKISFKDFFLKRFFRILPLFWFVTAVYFLFPPFREREALPPLWKLLTFTQNF
GLNIQDFGTFSHGWSLCVEEHFYLFLPLVLLFLQSTNLFNKSYWILVALFIFGFMIRLYS
WEILYFPNSGKENAWLFWYKFIYYPTYNRLDGLLIGVSIAAIYQFLPNFWDKISRFGNEF
LIVSLFLLTAAYFLCYEERSFYASILGFPLVGLGYGFMVLGAICPTSFLYKWNSKTTTFI
ATLSYGVYLIHKGIIHLTQQFLLTFNIDINSSITLIICILTCLIVAYILNKIIEKPFMQL
RTKIQQIK
>EGALAKHO_00202 Bleomycin resistance protein
MQHKVQSIRPFIGAKDFEISRSFYRDLGFEEVILDPKFSVFKTGEIAFYLQDYYAKEWID
NTMIFLEVDDVDLYYQELLALNLTEKYGVKLTPTRHLDWGSECFLNDPSGVLWHFGKFK
>EGALAKHO_00203 hypothetical protein
MTVHLEKIIEKYSFPKRDLNSCVEVNDVELYSKLKLPEDYVFYLENYHGIDQFIGVEFIN
LWSLEEIIASNKNYNIVEGLQQTIGIGSNGSGEFIGIKFDQDGNVKIILSPFIDLNSKYN
IEIGTSFTDFLVRLDKGVDWFS
>EGALAKHO_00204 Na(+)/H(+)-K(+) antiporter GerN
MIEFFRNLLEEFELPLSNPVLIFSLILFIILLSPILLKKINIPGIIGLIISGVIIGPHGL
NILAKNSAVDLFSTIGLLYIMFIAGLELDMNEFKANKNKSLLFGFFTFIFPLSIGFPVCF
YLLKYDFNASFLTASMFATHTLVAYPIVSKLGIAKNQAVAITVGGTILTDTAVLIILAVI
MGSSQGSLNQAFWLKLTASLIIFSAIMFLVIPRIAKWFFKKLESEKHAHYIFVLSVVFFA
AFLAQVAGVEPIIGAFVAGLALNPLIPQSSALMNRIEFIGNSLFIPFFLISVGMLVDISV
ILSGPTALIVAGTLSVVAIFGKWIAAFFTQIVFKYTKTERQLIFGLSSAHAAATLAVILV
GYKAKILDENILNGTIILILITCIVASFATEKAAKKIAICEEEVSHEDAHSDQILDEHIL
IPLAKTSATSSLLDFALLIKDKKSANPVTLLTIVPNNDQAEKNILRYRKAVDKFVIQGSA
SEVKINTIARIDHNPASGIARTSKEIMSDIVIVGWPRKTGFLDKIFGENVDSIINNVDKS
LFICRFEKNFIEEKRLVFICPPFSERGAGFQLLIQKISRLSQELSIPIVIYAEYKTHQTI
QQIANNLKLNAKLGFKSILDWDDFEAISDEIKPTDLIVFNLSRKGSVSYQSIFDKLPQKF
ERSFSENNLILVYAQDDRKVTSMDAYEDFTATPLTKGLEAIEQIGRGLGNILKKS
>EGALAKHO_00205 L-serine dehydratase 1
MEECISVFDMLKIGVGPSSSHTLGPWRAAERFLEELKNESILEQVTRVKVDLYGSLSLTG
KGHATDLAVMLGLSGQDPEYIPVDNIAGIIKTIETKNEIILGNQITIPFYFLQDIVFNKD
FLPFHANALKFTAYKADDFEYESTFYSIGGGFVVKEERTNAKIKEEIKCAFPFPIQNAVE
LLNYTVSENKLISEIVYENEKSMRPEEEIHSELMRIWNTMLECMYIGCHTGGILPGGLHV
RRRAFDMHQNLIGLANYDNPQSWLEEIRKTEVKFRQILKWVSCFALAVNEVNASLGRVVT
APTNGSAGVIPAVLMYYLVIENHNAGEKEIKQFLMVAGEIGSIFKKGSTISAAMGGCQAE
IGVSSSMAAAALCELMGGSPAQVLMAAEIAMEHHLGLTCDPIGGLVQIPCIERNTMGAIK
AINAAELALETDSKNAKVPLDKVINTMWQTAKDMNSKYKETSEGGLAIAVNMADC
>EGALAKHO_00206 3-methyl-2-oxobutanoate hydroxymethyltransferase
MSVAKKDYKRITTKSLIEMKSNGEKISMLTAYDYTMAKIVDTAGVDVILVGDSASNVMAG
HETTLPITLDQMIYHASSVVRAVERALVVVDLPFGSYQSDPKEALRSAIRIMKESGGHAV
KLEGGKEIKESIKKILNAGIPVMGHLGLTPQSIYKFGTYSVRAKEDEEAEKLIEDAKMLE
KIGCFGVVLEKIPADLAKKVAESISIPVIGIGAGGAVDGQVLVIHDMLGMNNEFSPRFLR
RYLNLYEQMTTAIGQYAADVKSSDFPNEKEQY
>EGALAKHO_00207 hypothetical protein
MHRFKDLEIWKSSRKFCSEIYTITSAFPESEKFGLINQLRRASVSVPSNIAEGCSRSSNK
DFSRFLEIAIGSIFEIETQLLISFDLGYINQMKLDELCFNLDRIVKMTSKFRSTLV
>EGALAKHO_00208 Ribosomal large subunit pseudouridine synthase C
MKILSNKNNLQILHEDNHIIVVNKRVGDIVQGDKTGDKPLSDVVKEYIKDKYNKPGDVFL
GVIHRLDRPTTGIVVFARTSKALTRMNEMFSNRETQKTYWAVVKNKPQETTAKLVHFLKR
NEKNNTSKAHLKEVPDSKIASLDYTVFKELQNYVALEINLHTGRHHQIRAQLAAIGSPIK
GDLKYGFDRSNPDGGIHLHARKLVFVHPVSKENITIIAPTPDETIWNAL
>EGALAKHO_00209 Aldehyde dehydrogenase
MDYKNDIGYRKETLKKLLYNIQKSEDLIVKALYDDFKKPEFEAVLTETNYVISDLKDTIK
NIYKWSGRKRVFPSILNFPSTDYIYKEPYGNVLVIAPWNYPFQLALCPLIAAVAAGNRVV
LKPSELTPNTSSIIAKIIAKTFHINHVEVQEGGVEVSTKLLSQRWDYIFFTGSVAVGKVV
AKAAAENLTPITLELGGKNPCIIDETANLKLAAKRIVWGKFINAGQTCIAPDYILIQKNM
KVNFISFLMEEIIKAYGKKLDKSPDFARIINTKNFLRLDSMIEREKVIFGGETDANKLFI
SPTLIEEPALDSPVMKEEIFGPILPILTYETEAEIHNVISKYEKPLAFYIFSENHSFAKK
LIAEYSFGGGCINDTVVHFSNKRLPFGGVGHSGIGAYHGKLSFDIFSHHKAIVKKGNWLD
FPMRYAPYKDKLASIKRLLDWM
>EGALAKHO_00210 hypothetical protein
MKSTLDQIEDIKNHGYSLDFSTVFNHAFENYKKIALYFGLIILVFSVIFFFALFSVLFAY
YGVESMSKDFFENFDAQKQTSVQTLISLLATSVVSGLVAPFSAGFLKMADCADKDEEFNV
STIFTYYKTHHFSQIFTIGFIIAIISSAISTAIGAYFNEMGIISMSFLLNLIISYLTYLA
IPLVIFGNLKALDALKSCLIIISKKPLLIFALVLVGFIGSFIGFFGCCIAIIFTLAFSTS
MTYATYCGIFNMEEEEDSIDSIGQSDLE
>EGALAKHO_00211 Autoinducer 2 sensor kinase/phosphatase LuxQ
MVANYSFYNLLISGIANLGNTLKSVMTNWYVFSPEIIFYNNPKLIILGLALFGFLSILVY
QFFRIKAKIGNFIEKKRETDIASNEYQLYILFFGIAVILIEIINEIFKIRPKSLLLINVC
IGIFVLIIYFLTDKIKILRDRIQEIFIVSFFIYISYVARNIICLSNDVVPIITFLISFFF
SYNILKPIKIYWTFVALTFIFLIITVAFNLIPIKSSVLLINFCILIFIINQVKYAVLLNN
RDNFRFANEIVHKGNSLTIATNENGELLFCSETITSILGYQPEEVKGMEFWRLTEDQEFD
KENYQKNYIDNKLYIRKLKNKSGEFKYIQWKDKKFSQDLIISIGQDVTEQIIVQDQYKNL
IQTATDIIFEVNTDGYFTFINEFGFSILGYAEHEVLFQHYTNFIHEDYIRSAAEFYENLE
KNGNNYPTIEIPILKKDGTELWISQKVIVRKNDLGEIIGFAGISRDITEMRNIENEKKRR
LEKIEAYNNSTKKLSTTDFREYNNLQTVIDYIIKEAAIISKANRVSFWKFADDVIVCKNL
FSVDNQNLSDKNILDKESYPIYFETLKNKAIINAPDVFDKLETSEFQEIYFRKNKIKSML
DVPIFSNGQLAGVVCFESTGEKRDWDNEDINYARTISDVISLAISSQMRLKAEKKLEHKS
ELLSALALCTEKFLLSKSLQKMFQETYDIIGNASKVDHIFYYEKDLETNTISQQYKWSRE
GIEHQITELQVFTEDDLKEIVSHSQNRKVLNMRTSDLEETFFKNLLMTNKIKSILILPLF
TNNIFSGFIGFDDCTKERKWTDDEIYIFQTLANNISSALDRNRNIAKIKESEDAIKAKEL
AEAANKSKSDFLANMSHEIRTPLNGIIGFTHLLMKTNLEEIQEKYMTTINQSAHSLLEII
NDILDFSKIEAGKLELFIDLYDVQKILGQIFDLIIYESNQKNLELELNLDPAVPKYIWTD
IVRLKQILINLLSNAIKFTNEGSIKLNVTVLDKKSDENYIIRFSVIDTGIGILEKNQKKI
FKAFSQEDSSTTRKFGGTGLGLTISNQLLALMESRLQLKSKINEGSNFYFDLNLKTSHKS
INEKFKKISNNTDPEYALSYNSNQKKISILIVEDNKVNMLLLKTIVKNLNLNAIIFECEN
GYEAVKQIENINPDLVFMDIQMPIMNGYEATKAIRITEIGQGIPIIAVTAGAEKEERNKC
LSAGMNDYISKPIIRGTVEEAIRKWLK
>EGALAKHO_00212 hypothetical protein
MKWLGRRQSDNVEDRRGVSGGKVALGGGVIGIIILLLNVFGGETGQTVGSALEQLQGGQQ
QTEAAAPLSKEDEEMGNFVRVILADNEDIWSKIFEEHGMTYKNPKLVLFRGSVQTACGGA
SSASGPFYCPGDQKVYMDLGFFEELKTKFGAKGGDFAIAYVISHEIGHHVQTLLGTSEKM
RQAQEGKSETEANKLSVALELQADFYAGVWTHYNQKNLDTDDIDEALSAANAVGDDAIQS
KMSNQVVPDSFTHGTSEQRMYWFKKGFKTGDIEQGTTFEEIR
>EGALAKHO_00214 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MKLDILAFGAHPDDVELGCAGTILKEVSLGKKVGIVDLTRGELGTRGTAETRDEEAKAAA
KILGVLVRENLALRDGFFVNDEKHQLEVIKMIRKYKPQIVLCNAIDDRHIDHGKGSKLVS
DACFLSGLMKIETVVDGEKQEAWRPKVVYHYIQWKNIEPDFVVDITGFEDKKVEAIAAYK
TQFYDPNSNEPATPITSKNFFESLNYRAKDLGRLVGKDFAEGFTVERCLAVNSLEDLI
>EGALAKHO_00215 Isochorismate synthase EntC
MNDFFSTIRKHQEQKLPFVIYSKPNSSSIFALLQQNETLYKVTDYSEKGFVFASFDEKQL
IIIPEEESKIISAEQTFVGFSFNEIDDLSVDAEAKSQYEDLVSKGIEAINNDEFKKVVLS
RSETTDLIDFDFIVTFKRLIHLYPSSFSYCFFHPEIGFWMGATPEQLLKANGNVFETTAL
AGTQKATLETEISWQQKEKDEQQYVTDFIVKRLREVASSVVVTEPYSIKAGSIWHIKTDI
SGVLNDNSTLEEVIDTLHPTPAVCGLPKKKAKAFIIENENYDRTFYTGFLGELNCSFAHN
AHSSDLFVNLRSMQIVDKTAILYMGCGITKESIPEKEWEESVNKSMTMKRVLNIKKNSSC
>EGALAKHO_00216 Putative esterase
MNYTKEQILERCNQFSKNTLMETLKIEYIDAGEDFLTAKMPVNPSVHQPMGLLHGGASVA
LAESVGSAASFFFIDAKEQEVRGIEISANHLKSIREGWVFGTARIIHKGRSIHLWEIKIT
DEAGNLISLCKLTNMVLDKKKD
>EGALAKHO_00217 hypothetical protein
MNLTLFCYFYKKRIQMRHYFALFILGLLLAFSSCRTDFDTVASTGDLKFSKDTVYLDTVF
KNIGSSTYQLKVFNKSKNDISIPIIQLKKGLNSRYRMTVDGMTGNNGKIFNNVTLLAKDS
LYIFVETTADITDANPADFLYTDEIQFDSGANLQQVALVTLIQDAVFLYPKQNPDGSKEK
IKIDGKDVDGFYLDENDAVNGNELIFTKQKPYVIYGYAGVPENKTVTFEAGSRVYFHANS
GLFVDKKASLQINGAKSTTEKLENEVIFEGDRLESLYDDIPGQWNSVILADGSTNHLINH
LTLKNAVVGLSFKNQDATTVSIKSTQIYNCVEYGILAQNARITGENIVINYAGLASLSCV
YGGNYSFTHCTFNNNWQSSSHFAVNISNTLAGSTPEANPLTQATFNNCIIYGSNTNEFNL
NKSTAVPFVYQLNNCLLKFNSSTTNPDYQFKTDAVHYNQIILNENPKFYNVSQNKFNINN
TSAAFAKGNQAYIIPLDIIGATRTSPPDLGAYQSAVFPK
>EGALAKHO_00218 hypothetical protein
MKSSFLSIIFLLTFSYAFAQNTTTIKCDSIYKNKGITIKLINFDDEKDGYENEKNSILII
NQKINGKNSTLIKDSIFSKVQEIEFKDFNNDKIKDILVQNISDVRSNWTYNLYLYNSKTN
NFKKVNGFEEIKNPSYHSKYKIIESHVNSGKNWVAFYKIKNFKVYDYNIEIIDDGSLKAE
KEYRKAIKKITEKK
>EGALAKHO_00219 Extracellular ribonuclease
MKKHYSFFLLLVITASFAQIPSGYYNTATGTGYTLKTQLYNIIKGHTDNGYAGLYTTYQT
SDVDNFYENDGTVLDMYSENPSGTDPYNYSTGTTQRCGSYSVEGDCYNREHIIPQSVFNE
QSPMVADAHFITPTDGKVNGIRSNYPHGTVASATYTSQNGSKLGSSSVSGYSGTVFEPVN
AFKGDIARMYFYFATRYENTVAGYSYAMFDGSSNKVFTTAFLNVLLAWNAQDPVSAREIA
RNNAVYARQNNRNPYIDHPEYVNQIWGGTPPSGDTQAPTTPTSLASTSKTATSITVAWTG
STDNVGVTGYDVYANSVLKTTVSGLSATITGLTASTSYSIYVKAKDAAGNASASSNTIAV
TTNSSGTGTATDLLFSEYIEGSSNNKALEIANNTGSSVSLSAYTIKKQTNGAGSWSTGLA
LSGTLTTGSKFVVVNSSISSACFSTSAANISTTATELTFNGNDAVGLFKNGVLIDIIGTF
SGGTANFAADVTLRRKSTVTSPSTTFNLSSQWDSYTTDTCNNLASKMAQPEEKEIVELSD
EITLYPNPSDGNFYVGFSALDEIYSIEIISFAGQKVFEKQNTSDPAISVSHLARGIYLIK
ITKDSKTIIKNIVIK
>EGALAKHO_00220 Phosphoribosylformylglycinamidine synthase
MIHFFENQSKTVFAVQTQNEISAQDISKLNWLFANSNKIEKSALSDFFVGPRATMITPWS
TNAVEITQNMGIPGIIRIEEFHPATEDFTDFDPMLFQKFTQLDQEIFTINVQPEPILEID
DIATYNKVEGLALSQEEVDYLDNLAVKLGRKLTDSEIFAFSQANSEHCRHKIFNGTFVID
GEEKETSLFKLIKKTSQENPNDIVSAYKDNVAFVKGPKVQQFAPKTADKPDYYEIKEFDS
VLSLKAETHNFPTTVEPFNGAATGSGGEIRDRLAGGQGSLPLAGTAVYMTSYSRLNDDRK
WENALEERKWLYQTPMDILIKASNGASDFGNKFGQPLITGSVLTFEHSENDRKIGYDKVI
MQAGGIGYGKLDQAIKKKPQEGDKIVILGGENYRIGMGGAAVSSADTGAFGSGIELNAIQ
RSNPEMQKRAANAIRGLVESDHNPIVSIHDHGAGGHLNCLSELVEETGGLIDLDKLPVGD
PTLSAKEIIGNESQERMGLVIGQKDIDQLQRIADRERSPMYQVGDVTGDHRFTFESKSNG
SKPMDYALEDFFGSSPKTVMNDKTIDRKYAAVSYDNANFESYLKDVLRLEAVASKDWLTN
KVDRCVGGKVAKQQCAGPLQLPLNNVGVMALDYLGKEGIATSIGHAPIAALIDPVAGSRN
AIAESLSNIVWAPIKDGLKGISLSANWMWACKNEGEDARLYAAVEGCSEFAIELGINIPT
GKDSLSMKQKYPNDEVIAPGTVIISAGGNCTDIRKVVEPVLQKDGDSIYYINLSQDDFKL
GGSSFAQIRNTIGNETSTIKDASFFKNAFNTIQELIGESQILAGHDIGSGGLITTLLELC
FADVNLGAKIDFSAFAEKDLLKILFAENIGIVFQAKEDAAVEAKLKANNIEFFKLGKATT
TETLDLGLWTLDIPTYRDIWFETSYLLDQKQSKNGTAKARFENYKNQALNYTFPAHFTGK
APVIDASKPRPKAAIIREKGSNSEREMANAMYLAGFDVKDVHMTDLISGRETLEDIQFIG
AVGGFSNSDVLGSAKGWAGAFLYNEKAKTALENFFKREDTLSVGICNGCQLFMELEVINP
EHEVHGKMLHNDSNKHESIFTSVTVQENNSVMLSTLAGTTLGVWVSHGEGKFNLPMGEEN
YNIVSKYAYEGYPANPNGSHYDVAMMCDKTGRHLVTMPHIERSTFQWNWAHYPKDRNDEF
TPWHEAFINARKWIEKN
>EGALAKHO_00221 hypothetical protein
METALYLAMGWCGTKYPGWWRRFWKNPPPPPDPEPWWTVALIGIGLVAGLAGGTLFSNAI
HENQFFSGQGAVASGLFAFGASNIVTGITSAFKN
>EGALAKHO_00222 hypothetical protein
MKKWIQQLSLFTLLFSISQFSFGQKTPSIKGNVSDGKLPVEFVDVILKNVSDSTKVASYA
VTDVAGNFDLENVLSGEYLLQLKLIGFKTRTQKVKITDTPVSIGTVVLENDANLLNDVVV
KSQKKQIQKTDEGFIFNAVSNISQSGGTATDMLKSIPTVAVDAEGGITLRGKSPMILING
KNSAITNMDQIAASSIESIEVISNPTAKYDANAESGIINIKLKKNNQNGLNGAVVLGGGF
GAKGRVNSSVLLNQKTGKWNFGLAYDNRFAGRTKEIHGDRTNYFIDDEHYIKQYRNDERT
EGLQNLKFNIDFSPNEKNNFSFEALGNMESQDNDETLYTQVNTSTNQFFSNNRRHSLELE
RSKVAELAFNYDRKFSDERKSLNASITSSFNHDKENTDIDTYNYDEYNQQIGDALLQRTH
NYEHENITNAIVNYALPISAKTIFETGYKGTFRFFNSEYQSADMINGDYVINPIASNTFD
YNEQINAFYGMLNSFSGSAENPKWKYNLGLRAENVSNTGATQTNSDRFTNDYIKFFPSAS
AQLNLASDEFVKIGYSKRINRPDLDDLNPFVDITDALNPHSGNPYLKPEIIHIAEMSFNK
DWTDYSFSTNAFYRNATNTMRQYAELQDNGVVLLMPKNIGSTITYGLETIFSLKPIGFYD
ANISITAFQQNINASNLGEDIVRNAFSWYGKIINNFVPWKSGKLQIIGNYNSALATPQGK
RIPVYNVDMGFQQKLGKGNARLGLVVTDMFNTLESGYKNNTALFSSNRTSKSDTRALMVT
FAYTFKSDFKEKLLENQFSTE
>EGALAKHO_00223 hypothetical protein
MKFIKLLLFSFFLISLNTYAQVEVNKITHNGRDRYITTTIGYPVPGIYIPMGQKEPSTVL
NPDGTGVIQADDLSKSKMNWGIECTEEGVPIFKEGFNSASYTFWYRPNDSNEWIYSQFSI
HFTKKKMFLMGERVKDYVDYNVQ
>EGALAKHO_00224 Long-chain-fatty-acid--CoA ligase FadD15
MVSITRLFDFPYYQQETYNLPVALATKKNGVWEKTSSEEYIAKANAVSRALLRMGVQKDD
KIALITSNNRTEWNVMDIGILQTGAQNVPIYPTISEEDYEYILNHSGSIYCFVSDDEVLQ
KVRLIQANVPTLKEVYSFNEIAGCKHWTDLLALGEDNSNQNEVEARKDSIQTDDLATIIY
TSGTTGRPKGVMLSHKNIVSNVLDSAPRIPFDPGKSTALSFLPICHIFERMILYIYQYYG
VSVYFGESIDKISDNLKEVRPTVITAVPRLLEKVYDKIYAKGAELTGIKKKLFFWAIDLG
LKYEPYGANGFWYEFQLKIARKLIFSKWKEGLGGNLDLMVSGSAALQPRLTRVFAAAEIP
VMEGYGLSETSPVIAVNDQRNKGFKIGTVGKVIRNVEVKIAADGEILCKGPNVMLGYFKD
PEKTAEALQDGYFHTGDIGEIDSEGFLKITDRKKEMFKTSGGKYIAPQLIENAMKQSRFI
EQIMVIGDGEKMPAAFIQPNFEFVKEWAKLHKITLGSTNAEISANPEVIKRIDEEVEGIN
EKFGHWEKVKRIELTPDVWSIDGGQLTPTLKLKRKIIKEIYKDLYAKIYGHE
>EGALAKHO_00225 hypothetical protein
MSTILKEYKKAIKIQYEIEKKGKYFDYLESPSRGKLRDFCWLIFENNPTQDDLNVFRNLF
SLDFDHTKKNKFKEQKDKFRPIETFFKGETDPVNIDAINMAAIMVDFQPRPFKKFYEQSR
IEEGKQIENSEKKVINIFKWRKRYKSIERNLRQMIALF
>EGALAKHO_00226 hypothetical protein
MILKYNNTYKMNFNTNINKAKSLDARSGEWITMSVHQYKQ
>EGALAKHO_00227 hypothetical protein
MKKSLKYIDGNSDKFWQIEVTGLDYTVTYGKNGTSGTSQTKSFSTNEECLKVAEKTVAEK
IKKGYSENGEVSIISKTDTVKNSSNSNQIIEEYDAILKSKNVALLLPFLKEKSKGNIEVL
KNQIKKNKRHWMTYIDLTKEPGYNKITRNNWDWGTRGDDKIKNIITLSATALFDKSSILA
FDEVLQVLEKVNEPYVLEILHWAKPNWIETYILDRFRKSEWLNFDYKALRSLEEQELISF
NPELAALCLSRFNSWSGKVNAREFVAYLVNDKIAYERDIPQLYNYETGIQNSTFRETENA
SYRECNTWSITFLQLLSENKLDKKSFIENAILIQTKEWNNNLKLFFRKILAELNLTPGEL
IPFQENIFTYFHNSNPTITNYGSELIKKIYDHPKFKTKSYLEWLEALMMRSECKAAIKSN
LIVLEKLSKINPKLNKLTALLIADIYVVSDLSLQERATKIILKLGNKKDAPLREKLSNYA
SYMQGSIKSSLSDFLSEDILAANESSLELYEFNPKKSKVLIDEVKIPRDWNEILFLFGRF
ISSEDVIDSETLLNVYITQRDLFPTDYSDQLQPYLKQLDKNHFTSILKIYIKNLLVNKIN
DKNFFYVLDDKKLVSLKTLRSVKPLIQKVLQKNKDNSTLPLLSFPTHKPHWVAPKILLER
IISYQATGETIDLVDLSIAINRMPRENIEEAIPLLSKLDADMEQLMSFCLGVKKDINIQS
SSIITKLFQKATGASQNIEKVGLWATASRTFYPNETFTEFEKTYLKDLPFLVAPFSPKLE
FKEKSNEWTDSYTKKIMRTTWTEILFELPDDTSIPSHFLYSLDIHKKKEQYTWMSHFKLE
SIENAYYWNSLMPQNNDPLGYLLLEKCCSTADGTNAELKGFLTVVNQPDFKFSDITLLIF
TCCFFQEKKDTRLLASEVLINLVENQKIEINLFAEKVALLISNRYGVLLRLVESIIALKD
ISSLHNSALFLLLDGILKNVELKEKLPANFKKLIENYLDVLSKTNQKPAPETKVFLEKLK
ENNSLKVLVKQILN
>EGALAKHO_00228 hypothetical protein
MTDLQYNYKGISTYSKTKGINNLVLAHQTEIEEVNNIPCFFWGSLTDPYVTAKCWSTIAK
VVRSSFGPIPPSLRDPIVSAGSERLRFEGFSSCNGVYVRLDMKPEAIDGEFIANGTTNVD
FNDPMLNALNAIQKNEKVTLAVGQQDVQVITSKAKVTEKKVTLPMRWIKGLTSVQLYLAD
MDIKFELNKIQTIQLFQSLPKGAVKGDFFITKRAGKFMFSTLATADSVRIGGVQRLRLLE
GILAIVDKIYIYESSDKQTCAIVAEFGKMQLLMAFSPDSYRGFSGEGNVLETMTENLPIE
WVYGLNSLLKSNETFDPTMLSIENDIDFGTMDNLTSNLSSMGLLGYDLSEKAHFYRRLPF
KTERILSLNPRLKNAKKLIDNEDIEIVERKANYIEAKVKGSGVIHRVIIDNSTQRCTCDW
FTAYQGKRGICKHILAVKMTIS
>EGALAKHO_00229 hypothetical protein
METINRDFEILTDYILTFYYYKYLNVDLIEDWAIELINSGYESEAIYNLACFYKPIDSDE
VQPYLEAVFSELNLTAKNKVESQKSHIRYFLNKVVKQEDIRSNLKRMLHFYCDFEIDKDI
ADFSVLQYLWYDLAAGQVNWYYKDISLNNIEQQVVEMAEKWMREN
>EGALAKHO_00230 hypothetical protein
MKSRNSNNKSRVKNNIIKDEPAYCEQNPDLPKAIICDLDGTLALMNGRNPFDASRCDNDL
IHHPVANLLKNYKFLGYKILLVSGRENVYKEPTLRFLEKHEITFDELLMRRAKDYRKDSI
IKTEIYNDSIKGKYFIEFVLDDRNQVVDTWRKDLKLPCFQVYYGDF
>EGALAKHO_00231 hypothetical protein
MNLKDKYTELLTNIGFGENEIQQNWLDLEKAYFKKSRHYHNLTHIQDMIACYETYFDQLQ
FPNEVLYSIFYHDYIYVSSKKDNELKSAEYALKILPKEKTLNSELVFDAICATQLHQHNK
IEDINWLIDFDLKILARDWDDYKIYFEQIRKEYRIYPDFLYNPGRAKALKHFLENEFIFQ
TEEFRKLYEEKARENIEKEISILESKK
>EGALAKHO_00232 hypothetical protein
MAIKNFATLRLCAIQIFSFSITYNYFEFLGVFRRGESDFRLYLLFRSTSQKDIASIPHAS
CSIMAFLLLQYYLPLQYLSPRGTACLYKPAGKHIYRNNKTYLQNPIGVTCFVILSKNRIS
LRCSFDSKIKY
>EGALAKHO_00233 hypothetical protein
MSQNKNALIRYKTIDKCLQNKYRQWTLEDLIECCSEALFEYEGRENPISKRTIQMDIQLM
RSEKLGYNAPIVVYDKKYYKYEDDAFSITDIPLTETDMNVLTETVSMLKQFKDFSLFSDV
SDILQRLEDKIYAEKSHTKPVIYLDKNENLKGLHFLDEIYQAIIKKVTLVITYKSFKSKE
ETKFHFHPFILKEFNNRWFLVGKKKASQPITNLALDRIIAIDYDFNLPYIEEDFDADSFY
KNVIGVTVNTGLKPRCIELWIDAVNAPYVVTKPLHSSQRLIKENEDGSIIVHLFISPNYE
MERILLGFGDGIEILRPENLRNRMKKILQKALSKYELNNNTAL
>EGALAKHO_00234 Organic hydroperoxide resistance transcriptional regulator
MKDKTIDYILRATWQAVSRMYNEEAAKYDATMATGFALLSMDKEEGTPSTALGPRMGMEA
TSLTRTLKSMEDKGLIVRKKNPSDGRGVLIYLTEFGKEKRDLSKNTVLKFNETVRKHVSD
EKLKHFIEVSEIINELIHDKNIFTQTENKEKE
>EGALAKHO_00235 putative 3-hydroxyacyl-CoA dehydrogenase
MKRTIKKVAVIGSGIMGSGIACHFANIGVEVLLLDIVPRELTEAEAKKGLTLESKAVRNR
VVNEHLANSLKSKPSPIYSQKFASRITTGNTTDDMAKIANVDWIIEVVVERLDIKKLVFE
QIEKFRTPGTLVTSNTSGIPIHFMSEGRSEDFQKHFCGTHFFNPARYLKLFEIIPGPKTS
NEVLDFLNEYGSKFLGKTSVVAKDTPAFIGNRIGIYGIQSLFHLVKEMGLTIEEVDKLTG
PVIGRPKSATFRTVDVVGLDTLVHVANGIYENCPTDEQHELFKLPDFVNKMMENKWLGSK
TGQGFYKKVDKDILSLDLDTLEYRAAKKANFATLELTKTIDKPINRFKVLVKGKDKAGEF
YRKSFSGMFAYVSNRIPEISDELYKIDDAMKAGFGWENGPFEIWDAIGVANGIEIMKAEG
LEPAAWVTEMLASGSESFYSVKEGATYFYNIPTKSQVKVPGQDSFIILNNIRESKKVWSN
SGAIIQDLGDGILNLEFQSKMNTIGGDVLQAINKAIDLSEKEYQGLVIGNQAANFSVGAN
IGMIFMMAVEQEYDELNMAIKMFQDTMMRVRYSSIPVVVAPHGMTFGGGCEMSLHADKVV
AAAETYMGLVEFGVGVLPGGGGSKEMALRASDLFRKNDVELNVLQEYFLTIAMAKVSTSG
YEAFDTGLLQHGKDVIVVNKDRQIAEAKKHALLMAEAGYTQPIRRTDVKVLGKQALGMFL
VGTDQMEAGKYISEHDKKIANKLAYVMAGGDLSEATLVSEQYLLDIEREAFLSLCTERKT
LERIQYMLTKGKPLRN
>EGALAKHO_00236 hypothetical protein
MHQFEKLKIWQKAMDIAVHVYEISSLLPNDEKFNLIHQIKKCAVSIPSNIAEGSGRNSEK
EFMHFLGIANGSTFELITQLILAKRLKLVSEDLIQPTINQLVEVSNMNFSFQRTLKDKIN
KTIGKS
>EGALAKHO_00237 3-ketoacyl-CoA thiolase
MKTAYIVKAYRTAVGKAPKGVFRFKRPDELAAETIQFMMDELPDFDKKRIDDVMVGNAMP
EAEQGLNVGRLISLMGLKVEDVPGVTVNRYCASGLETIGMATAKIQSGMADCIIAGGAES
MSFIPMGGYKPTPDYKVAAAGHEDYYWGMGLTAEAVANQYKISREDQDEFAYNSHMKALK
AQAEGKFDKQIVPITVEQTFINENGKKETKSYVVKQDEGPRAGTSVAALAGLRPVFAADG
SVTAGNSSQMSDGAAFVLIMSEDMVKELNLEPIARLVNFASSGVEPRIMGIGPVKAIPKA
LKQAGLELKDIDLVELNEAFASQSLAVIRELGLNPDIVNVNGGAIALGHPLGCTGAKLSV
QLFDEMKRRGSKYGIVSMCVGTGQGSAGIYEVL
>EGALAKHO_00238 putative acyl-CoA dehydrogenase
MADTIEKNVTRGGQFLVKETKCEDVFTPEDFSEEQLMMRDSVKEFVDKELWAHKDRFEKK
DYAYTEASMRKAGELGLLGVAVPEEYGGLGMGFVSTMLVCDYISGATGSFSTAFGAHTGI
GTMPITLYGSEEQKKKYVPKLASGEWFGAYCLTEPGAGSDANSGKTKAVLSEDGTHYKIT
GQKMWISNAGFCSVFIVFARIGDDKNITGFIVENDPSNGISMNEEEHKLGIRASSTRQVF
FNDTKVPVENMLSERGNGFKIAMNALNVGRIKLAAACLDAQRRVTSNAVKYANERIQFNT
AISSFGAIRSKLAEMATNAYAGESASYRAAKDIEDRIAAREAEGTSHQEAELKGVEEYAI
ECSILKVAVSEDVQSCADEGIQIFGGMGFSEDTPMESAWRDARIARIYEGTNEINRMLSV
GMLIKKAMKGHVDLLGPAMKVSEELMGIPSFDTPDFSELFAEEKGIIANLKKVFLMVAGS
AVQKYGPDLDSHQQLLMAASDILIEVYMAESTILRTEKLAKNQGEAKVQEQIAMAKLYLY
KAVDIVNSRGKEGIISFAEGDEQRMMLMGLKRFTKYTNNPNVVALRETITSKLVAENEYC
F
>EGALAKHO_00239 hypothetical protein
MRVNYSAYKIILLQITALKIFENPINKSQ
>EGALAKHO_00240 Chitinase A1
MKRINLIILLLLCNFTANIFAQKNKKMDIIAYYTGDDKLINEYEVNKLNQIIFSFCHLKD
GKLSVDSPKDSTTIKYLVAAKANNPQLKIILSLGGWGGCEPCSAAFSTPEGRLKFAKSVK
EVSTYFKVDGLDLDWEYPAIEGLPGHLYQAVDKPNFTELIKILRSTLGKKYELSFAAGGF
QKYLDESIDWKAVAPLVNRINIMSYDLVNGYSKVTGHHTPLYSTNPNEESTDRAVTYLLK
QGIPSEKLIIGGAFYTRTWKNVENINNGLYQPGEHIQGVSFKDFGSFYTEANGWKYFWDD
KAKAPYWYNEKEKTFATGDDLASIKAKTEYVKAKKLGGIMFWELPLDATRNGMVNAIYEV
KMAK
>EGALAKHO_00241 hypothetical protein
MFEINLKLKTMKKLSLILVMAIASFSSYAQSSYKEDVELVQSIYGKSKSDLVKQYMNLSD
TQNVAFTKVYDKYESERKALGQTKLQLINYYAENYSTLTEEKADELAKGTLKNNQDYEKL
YSKTYDQAKKAVGAINAAKFIQLEVYLQTVIRNEIQDTIPFIGELDKTKVQM
>EGALAKHO_00242 hypothetical protein
MPKNTFYVLIYKHQLLIVFLLGMFSGFSQDLEPRVYANVPKKLNVAAIGYAFMDGNVLTE
PSLPVSDFTIQSHNLAATYVRTFGLANKLARVQVALPYTFMDGSANVSGENITGSRTGFG
DMKIRFGINLLGSPALDKSEFRKFEQKTILGVSLVTSIPTGKYYDDKRVNIGTNRWGFKP
EIGISQRFSHFYAEVYGGVWFYTDNNDFLGKRMEQKPTGSLQAHASYYFKNGMWLGFNTT
WFFGGQTIIDGVGEASEMDNWRVGGTFSTPIAKGQSLRFQYHVGAYTNNGLNYYALTAAY
QYSFF
>EGALAKHO_00243 hypothetical protein
MKSKLLILLVLSCFFSFQLFAQEKTKKELKAERELQKQKEIEALIDSKNFVFEAQKASPQ
GGRLLNLDYNTYFLKFNEEKTTCDLPFFGRAFNVAYGGDGGIKFEGVPENIKIEKKKKSY
NVKATVKGKDDVYTLYFNVFFDGGTSLSISSNNRASISYDGEIEAPKTDEIKK
>EGALAKHO_00244 hypothetical protein
MMKNVCILIFLSTILISCKCKKVDSVSKLEGNWELNYISGPRIAFDGLYPTKKPTINFDL
KENHISGNSSCNSFNGKLVVDGNKIDFTQPMAMTKMMCQDGQGEQVFMSTLQKITSYDVT
DDGKTLNLISGDIALMRFTKK
>EGALAKHO_00245 Superoxide dismutase-like protein YojM
MKKIIVSFVVITALIIGCKTNTKSNDAKTITVNLEPKSNSTVSGTATFTEKNGKVTFVAK
VAGLQPGVHAIHIHEKSDCTAADGSSAGGHWNPTFKKHGKWGVGEYHKGDIGNFTADAKG
NGTITLTTDEWCVGCGDATKDVLGKGLIVHQGTDDFTTQPTGNAGGRVACAGIIK
>EGALAKHO_00246 hypothetical protein
MINPSAPGWIDKFFSEQKFSEAIPFETNESFYDKVRATGFVYGHIISIDSQFPIPIKGWF
KTEISKIALLNTLYGVFCLEKRNSEPNNFITEVLKFYKEMNPEGFSLFKILLPKDTPSLS
LESIIDQRVQTNDSIISKNFSHLVTNALLFIDVLAFRQYLEHGSIPEKYLKRIEETVLGI
VGLALKTKTIKSQHDDLLIKLFEASIRYSKFSKVTVDTLETLQLDYFANKLEHYYLIDMA
GMALWSDGVVENEEAYFLYSLGSMMRVPDDFVTHSIDTTNSFITTHKKKIPYFNYSNPVK
HFYDQMTHTVVKLIIRNKNRLVKEIVQSKELMVLLAYSTTRDLDAKEKKKVKKQLLDICK
TIPSLTIFLLPGGSLLLPILIKFIPTMLPSAFNENLDENE
>EGALAKHO_00247 Carbonic anhydrase 2
MRKFYEQLLENNKEWVEKSLALDPNYFADLAKGQTPPLLWIGCSDSRVPANEIIGAKPGE
VFVHRNIANMVVHSDMNMLSVLDYAVNVLKVKHVIVCGHYGCGGVKAAMGNMSVGIIDNW
IRHIKDEYRLHDKYLNSIEDETERFNAFVEINAKEQVYNLAKTSIVQGAWKNGQDLMLHG
WVYGLNSGFVTDLNVNIASNDELDDVYQLSNL
>EGALAKHO_00248 C4-dicarboxylic acid transporter DauA
MSKKINLFANLKSDFASGLVVFLVALPLCLGIAMASGAPLFSGIIAGVIGGIVVGFLSQS
HISVSGPAAGLTAIVLTAITDLGAFDVFLMSVFIAGLIQLALGFLKAGSISNYFPTNVIE
GMLAGIGIIIILKQLPHAFGYDADFEGDQAFIQNDGSNSFSFLFDVINHIQIGAIVISLI
SLAILIAWDRVSFLKKLKLVPGALIAVIAGVVLNEIFTSTGSSLAIAKDHLVSLPVPKSF
DEFKSILVTPNFAAVTNPQVWVVGVTIAIVASIETLLCIEAADRMDVQKRYTNTNVELRA
QGIGNIVSSLLGGLPMTSVVVRSSANNNAGAKSKMSAIIHGVLLLVSVLSVPALLNKIPL
ATLATVLILVGYKLAKPATFFHFWEKGKYQFVPFIATLVFVVATDLLKGVALGIIISIIF
VLRGNLKRAYSFKKEEYEDGDVIHIDLAQEVSFLNKAAIKLTLNEIPENSKVIINAHDTE
YIAHDVLDLIREFKETRAIDENIKVKLKGFKKAYELENTPEKDNHVTIEHYYDVAKRALV
KKETLK
>EGALAKHO_00249 hypothetical protein
MKLVARILLFIFIAFLATPTIVTLMKKSNDTSMFFSFSEEEHSHKELKAAVYPTILQHEV
VMPVYIEKKTIVSENIVKLDNISPSIFAPPPNLV
>EGALAKHO_00250 DNA protection during starvation protein
MKTNILGLPVKESELLVKELNVLLSNFQVYYQNLRGIHWNIRGKRFFDLHVKFEELYTDA
QLKIDMIAERVLTIGGTPLHTFEDYIKNNKLAVGKNISNDEKAVQLIVHSLSDLLKIERE
ILNQSDEINDEGTNSMMSDFIAEQEKTIWMMNAWLEEEL
>EGALAKHO_00251 Hydrogen peroxide-inducible genes activator
MTITQLQYVLAVAEHKNFTLAAEKCFVTQPTLSMQIQKIEEELNILIFDRSKKPIQLTDI
GQKIVNQAKNIVNEADRIKDIVEQQKGFIGGEFRLGIIPTIMPTLLPMFLNNFIKKYPKV
KLLIEELNTDEIIVKLKNGHLDAAIAATPLEDEKIKEIVLYFEPFVAYIPEHHANFQKEE
IEVADLNINEILLLQDGHCFRDGILNLCKNGTDVEQNNFQIQSGSFETLIKLADEGLGTT
LLPYLHTMDLKDSDKLKLRNFKEPKPAREVSLIYPKSELKMQIIDALRSTIAGVVKGAIV
FQNVQIISPLQKK
>EGALAKHO_00252 hypothetical protein
MSKMMFDYTKSILERVSFDPILFCKEVEKAIKTLLPYEMEQLKEWLLNFIIEKPELKQSL
LLIKV
>EGALAKHO_00253 tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC
MEREIIKTLDGSTTIHLKEWDECYHSKHGAIQEAKHVFIKNGLSLFENNPVSILEIGFGT
GLNAFITFLEAIEKNQKIDYVGVEAYPVKAEEVLAMNYVEELGALKFHNIFEKMHKCEWD
NKVEICDTFTLTKRKQFFDEIDDFEIFDLIYFDAFGYRVQPELWSTEIFQKMYNSLKPNG
VLVTYAARGVVKRSMIAVGFTVEKLAGPPGKREMFRAFKKG
>EGALAKHO_00254 Branched-chain-amino-acid aminotransferase 2
MSTTQTSKIEIRKATSSKISAVDFENLSFGAVFTDHLFECDFKNGEWQTPVIKPYAPILM
DPSSKVFHYGQAIFEGMKAYKDENNDVWLFRPDENYKRFNNSAVRMAMPEVPEAIFMDGL
NELLKIDQEWIQRGNGSSMYIRPFMIATGPGVIANPSDEYKFMILLSPAKSYYGGEVKVI
IAEHYSRAANGGIGAAKAAGNYAAQFYPTNLANKDGFQQVIWTDDATHTKLEEAGTMNVF
FRINDTLMTAPTSERILDGITRKSLIAMAEKEGLNVDVRPVLVSELVEAAKNGSLKEIFG
AGTAAVISVIKGFSYQDVYYEMTPIENSYASLLKEKLTSLQNKLSEDTFGWTVKVQ
>EGALAKHO_00255 hypothetical protein
MKKQLDAVKEFHTAFKIGHSETPIADVGETKKYLRYNLMKEENEEYLDAVQNNDLVEIAD
ALGDMMYILCGTIIEHGLQDKIEAVFDEIQRSNMSKLGEDGQPIYREDGKVLKGPNYFKP
DFSKLLEK
>EGALAKHO_00256 hypothetical protein
MKILKYLFLLSLLSLVALTVFVATQKGIFSVERSKVINSPRATVYNYVNDFRNYEDFESW
SVEDPTIRMTFPNKTSGNGASFYWEGAEGTGNAITLKTKEGENIQQKINFDGTEADVNWI
FKDTLAGKTKVTWKAKGTMSFLFKIYTALNGGSDNIIGTISEKSLANIDKNLDYETKTYA
IKVNGVVKKIETAYIKQTFTSEIQKVNKNARIVIPKLIQFSETNGLSTNGKPFIIYHTYD
TTSGLAKISICLPINKEISTSAGSDITAGKLNGFEAVKTTLKGDYTHTNEAIAKTTAFIN
NEKITPDLSWSHLEILTISKLDTKSPSKLMTEIYFPTKPKVIPVVKVPVYQPQTETQTAK
PATPAPAAPKPTEEEDSEF
>EGALAKHO_00257 ECF RNA polymerase sigma-E factor
MTNEKEFIAQLLDPKTQNVAFQKLLSDYQKPLYAHIRNIVLNHDDADDVLQNTFVKVFQY
LKSFKGESKLFSWMYRIATNEALTFLNQKAKLNGITSEALQNKTIDNLKADTYFDGDEIQ
IKLQKAIVTLPEKQQLVFKMKYFEELKYEEIAEILGTSVGALKASYHHAVKKIELYVTSN
>EGALAKHO_00258 hypothetical protein
MKAFKLENEPKIKTGFKTPDHYFDDLSAKVLQQINEKQVKVIPLYKRKKVLSLLAAAAIV
IGLMIPVVNNYNATSKELDEATLETYLSYQSNLNQYDLAKELDTKDIEKLGKSVALEQET
LEDILSSNPNIENLISE
>EGALAKHO_00259 hypothetical protein
MKFKNILPLFMFLITFSFYAQNDKKVDEKREKIKAYKVSFLTTELELTSAEAEKFWPIYN
AFDDKQYELRHDKMKMYLSKLDDDKLNSMSEKEAATLLCQIESTDKELYLLREKYISNLK
KILSHKKILKLKKSEDDFNRKLLKQYKEKAGK
>EGALAKHO_00260 Ycf48-like protein
MKKVLLFCCAFVLFMSFKTLNDSDKKIVFNGFTSMQVDTLFQDKISIRAISIDKNKIWYG
GDNSRFGYYDLDKKEKFEEHIYRDTLKLEFRSIAQNSKNIFLLSVGNPALLYQVSKKDNK
VKLVYKEINPKIFYDSMQFWNDKEGIAIGDPTEDTFSIIVTRDGGESWTKLLSDKLPTNA
QGEAAFAASNTNIVVNGDETWLVSGGKKARVFYSADKGKTWKVVETPIVQGKTMTGIFTA
DFYDSKHGFIAGGDYELPNKKSGNKAFTTDGGKTWQLIGQDMGFGYASCIQYVPGGNGKE
IVCVGSEGIQYSQNGGENWTQLSTDSKLFTIRFINRNTAIAAGHNKVVRLRFK
>EGALAKHO_00261 hypothetical protein
MKAKVLFLVLLAVGFSSCSVQSQTTVYAKNSDISDNLDLRAVASIFGESANLQDFERRLN
DPKYQISNLDLNGDDQVDYLRVIESVEARTHVVIIQAVLDRDVYQDIATIDVERDNYNQV
NVQVVGNSYLYGANYIYEPVYSVAPVIYTSFWITNYRPYISTWNWGYYPSYYYAWRPYPI
YRYRNNINVCINVNNHYNYVNTRRSYRAPALYESRRTYGYEKMRPNNSFAQRHSNVNNRY
ELDQRRVVSRETSRNSNAYNTNRSNTDRVSGNNNRNTSRDNSQNRTISDRSYNSNPVSPR
DNQNRVSTPSRVENTQRTPEQRRDYSENNNSRGNSENRMNTNRTAATPRAEAPGNLDNNM
NNSRGNSENRMNTNRTVATPRAEAPRNSDNNMNNSRGNSENRMSTNRTASSPRAEAPRNY
SENRASTARPQAPQSAQRAESPRVSQESRGGQSQRENNSGGSRNGGRRI
>EGALAKHO_00262 Low affinity potassium transport system protein kup
MSAAHKNLHSKLSIGGLLITLGIIYGDIGTSPLYVMKAILGEYAINADIVLGGISCVFWT
LTLQTTIKYVLITLSADNHGEGGIFALYALVKKTKIQWLIVPAIIGGSALLADGIITPPI
SISSAVEGIRAFYPTMETETIVYIVIAILFILFTIQQFGTKLVGKFFAPMMLIWFAMLGT
LGAIQVLNHPEVIKAINPYYAYHLLSIHPDGFFVLGFVFLCTTGAEALYSDMGHCGRKNI
RISWIFVKTTLVLNYFGQAAYLIHHEGSTLQQLGGENGNPFYLIMPHWFLPFGIVVATLA
AVIASQALISGSFTLINEAMRLNFWPKVKIKYPTEVKGQLYIPSINWLLFFGCVGIVLHF
QKSGNMEHAYGLAIILCMIMTTILLNYYLIMKRVKLYFMVPLITIYLLIEFSFLFANITK
FAEGGYVTLIIAIMLISIMTIWYLAKKINKSYTKIIKIDDYKKVLMELSEDLSIPKYATH
LVYMTNANRVDELEEKVIYSILQKRPKRADIYWFVHVNILTEPYKTQYKVTEIAKDDIYR
IDFNLGFREPTKINLMFREVIRDMVKRGEVDITSRYESLNKNNIIGDFKFVLSEKFLSND
NDLRWHENIIMNSYFFIKKLSLSEERAFGLDSSSVKIEKFPMVLHAPENIGLTRIIK
>EGALAKHO_00263 Ribosomal RNA small subunit methyltransferase B
MRLHRNLVYTTIDSLNAIFNEGEYADKVVARALKKDKRWGSSDRKFVAETIYEIVRWKRL
YAEIAEVKEPFDRDNLWRMFAVWAVLRGYPIPDWRQLEGTPERKIKGRFDELSKTRALKE
SIPDWMDELGVKELGEAVWSKEITAQNQPAKVILRTNTLKGTKESLRNTLMDLNIETEYL
KDQPEALVLKERANVFLTDAFKQGLFEVQDANSQLVAGFLDVRPGMRVVDTCAGAGGKTL
HIASLMENKGQLIAMDLYESKLKQLKLRAKRNGAFNIEYRIIDTTKVIKKLHEKADRVLI
DAPCSGLGVLKRNPDAKWKLQPEFIDNIRKVQFEVLESYSKIVKPGGKLVYATCSVLPSE
NQEQVEKFLKTEIGKQFTFIKDRKILASESGFDGFYMALLERKA
>EGALAKHO_00264 2-succinylbenzoate--CoA ligase
MLDLTHKNVHNHFRINGYHLSATDLCRVAYDYIKEGDANEQAIGEFLLDWFDDKEYIEMR
TSGTTGLPKVVKLEKQAMIQSALATGDFFELEPRNKALLCLPVKFVAGKMMLVRSLILGL
DLDIVTPSTTPLALNNTKYDFVAMVPLQVQNSIEALVNVKKLIIGGAKLDSALEAKLLPL
KTEIYETYGMTETITHIAAKKLGESVFTVLPNVKIAQDNRGCLVITVPSISDEPIVTNDL
VEIIRENQFIFLGRIDNVINSGGVKLIPEQIEAKLIEKINSRFFVTGIPDPVLGEKLILV
IEGEKQDFEAGFFDVLDKFERPKEIVFVPKFKENENGKLLRKPSLL
>EGALAKHO_00265 hypothetical protein
MFLEQGIKPQNKFWLYLVGSVLIIIASFIGQIPFSIAVLYSSFENKKAFPTDNAEVMKIF
DPNLTLFLVMISFAFAFAGVYYVIKYLHNQTLLSVTTSRKKVDWSRILFSFVVWSVFSAL
SFWVIYLRSPENFVWNFKLVPFLILVLVGIILIPIQTSTEEYVFRGYLMQGFANLARNKW
FPLLMTSIIFGSMHILNPEVSKMGYIIMVYYIGTGLFLGVITLMDEGMELALGFHAANNL
VGAMLVTSDWTVFQTYSIFKDMSEPSAGLDVILPIFVVYPILLFIFGKKYKWSNWKEKLT
GKITTLEISN
>EGALAKHO_00266 Arsenate reductase
MIQIYHNPRCGKSRTCLAFMDQANQEYEIIPYLTDTPTFADLKVLLGKLDLEPLQLVRTK
EKIWIENYKGKTMSKDEIIQSMVDNPILIERPIVIKDGKAIIGRDLDLVASFLD
>EGALAKHO_00267 Colicin I receptor
MKPKITMKKIKFAVLLVLFFTSFYNYAQQTPPGKNKVKVTGKVFEKVSKQPLEYATISIM
APNDTKVIAGGITNPKGEFEVAVAPGTYDIKVEFISFKSTEIKGKVISGDTSLGVVNLSE
DAAQLNEVVVRAEKSTVEIKLDKKVYNVGQDMMVKGGTVSDVLDNVPSVSVDTEGNVSLR
GSDNIRILIDGRPSNAINVAEALRQLPADAIDKVEVITNPSARYDAEGGSGLINIILKKG
KNQGINGTFIASTGLPETYGLSANLNYKTEKLNYFTTLGYNYRTNEGGGETNTSYFNADG
TPKGFLDEDRDTKRTNDGFNGRAGIEWTVAKNTFWTNAINYQKNSGNTTDLINYNNYDAA
HAFTGSSFRLNNGDTGSENVEYTSNLIKNFNDKGHKLTADLSISRNTDDSNSIITASPNF
NTTLNDQVQKQIQVQADYVLPLGKGSQFEAGYKGSFGDLNNEYFVTDNAGVNDPNLSNTL
EYKENINALYTSYGFKVNKFSYLFGLRWEDTNIQVNLLDTNDFNTKKYNNLFPSAFISYE
ISDQSNFTASYSKRLTRPRGRFMNPAVNYSSNVNIFQGNPDLDPSLTDKYDIGYIKRWEK
VTFTTSAYFEDTKDVFSFVRTPNGEEVNGIPVILSRPINLGKEQKFGFEFTFNYNPYKWW
RLNSNFNLYNVKTTGSNTYTDVNGNDVVQNLDNQANTWFARISSKITLPYKIDWQLNGTY
NGEQKTAQGKNLGQFAMNTALSKDVMKDKGTIAFNISDIFNSRIMRSYTYLQNDTTLESQ
TSYGEMQFRKRQFNLSFTYRFNKPKNDREKNAQPRNEGEGGGDFPG
>EGALAKHO_00268 hypothetical protein
MSLHSKIPENMFEFSQYLGFLLFLTILTIGFWLMFFLVGFVSYWVTGASWEMFKEKRAKK
RQEEQSI
>EGALAKHO_00269 Fumarate hydratase class II
MKYRIEKDTMGEVQVPADKYWGAQTERSRNNFKIGPSASMPSEIIEGFAYLKKAAAYANC
NLGVLTIEKRDAIAAVCDEILAGQLKDEFPLVIWQTGSGTQSNMNVNEVIANRAQVLKGF
NIGEGEPFIKANDDVNKSQSSNDTFPTAMHIAAYKVIVETTIPGVEKLHATLAAKAAEFA
AVVKIGRTHLMDATPLTLGQEISGYAAQLSFGLKALKNTLAHLSEIALGGTAVGTGLNTP
KGYDKKVAEYIAEFTNHPFVTAENKFEALAAHDAIVETHGALKQLAVSLNKIANDVRMLA
SGPRSGIGEIHIPENEPGSSIMPGKVNPTQCEALTMVCAQVIGNDMAIAIGGMQGHYELN
VFKPVMAANFLQSARLLGDACVSFDEHCAQGIEPNYKRIKELVDNSLMLVTALNTKIGYY
KAAEIAQTAHKNGTTLKDEAVRLGYVTPEDFDAWVKPEEMV
>EGALAKHO_00270 Alanine dehydrogenase 2
MKFGIIKERKSPPDRRVVFAPSELTKLKQLYHEATVEVESSDIRIFTDVQYKSMGINVTE
DVSDCDVLFGVKEVPVENLIPNKAYFFFSHTIKKQPYNRKLLQAILEKNIDLYDHETIVD
AENRRLIGFGKYAGMVGVYNGIRAFGIKFELFKLPKAETLAGKEALITQLKRITLPPLKF
VVTGTGKVGSGVKEILDAIKVKEVTVENYLTKNYTQSVYVQLDVLEYNKRIDGQVLDFND
FTSHPEAYVSDFEKFTKVSDIYYAGHFYDNAAPMILTQEMLNASDCKLRVVADISCDVNG
PIACTLRSSTIEEPIYGYFPLENKEVDVFHPAAIVVMAVDNLPCEIPKDASEGFGEQFME
HVIPAFFNGDKDGILQRAKITEKGKLTPRFAYLQEYVNG
>EGALAKHO_00271 Penicillin-binding protein 4*
MNFLKRTNIPQILFLILVLSSCGKDKKTSIDTASTVEDTMPKMKPHAPEKRLTQAYINSV
KGRINHFYNKNWPNNSMNGSFLVARNGEIIFERYNGYANKNEGTKITAETPVQIASVSKV
LTATTVLKLVNAGKLDLDQKVNTILKTFPYEDCTVRMLLSHRSGMRNYAYFTDHDKSVWD
RHNQLTNKDILNILATKDIGLEAKTGTRFGYCNTNYAMLALIIEKITGLTYKEAMSEIIF
KPLGMTHTYVFDDDKEKKTIVPSYKGNGAEIGFDYLDNVYGDKNVFSTVRDLLKFDRARN
SPDFLKPALLKEVFTGYSNERKGTKNYGLGIRMINWETGQNFYFHNGWWHGNTSSYITLQ
KENVTILALSNKMTRNTYAVRKLAPIFGDYPFNFKDEE
>EGALAKHO_00273 Sulfoacetaldehyde dehydrogenase
MENTTKIIFPFDQSFVKELPLINKNDIDKILNTAQDLFNDQSNWIPAYKRIDILEKAAAI
MNDRSEELIHLAISEGGKPYKDSKAEILRAIKGVKLAAEHIAQIKGEQIPMGLTEASLNR
IAFTSKEPIGVVVAVSAFNHPLNLAVHQIATAVAAGCPVVFKPSSNTPLSGLALAAILKE
AGLPEGWLQVVLCDNETAELLVIDSRVHFFSFIGSAKVGWSLKNKLAPGTRCALEHGGAA
PVIVESDADFSEMIPDLVKGGFYHAGQVCVSVQKIYVNQEVCDRFLEQFSEATNKLIVGN
PFDKTTDVGSLITPKEVNRVEEWVNEAIEEGAKLITGGKRISDTCFEPTILFNPSENSKV
STNEIFGPVVCIYPFADREEAIQKANALDVHFQAAVFTKNIDIALDAARKLNATAVMVND
NTAFRVDWMPFGGRDASGLGMGGISYTINEMTREKLTVFKSKFL
>EGALAKHO_00274 (4S)-4-hydroxy-5-phosphonooxypentane-2,3-dione isomerase
MENQNPVHVFATWKVKEGQIENVLQLLKTVHKESIKEDGNLFYKIHQSNSDLNMIVLFEG
YRNENAVAEHRNSKHFQDLVLGEIVPLLENREIVLTMPLEY
>EGALAKHO_00275 Putative cysteine protease YraA
MKRLMILTLAIAFSSNAQTKKESTSVKQETNLKKESTMKKKILIIVSNANAIGPNNRRTG
TFLPEVAHPYAEFDRANYQIDFASLTGDTPYLDALNLANDPDNLAFLTGKGWETMQKAVK
LSTVEVSKYDAVFVPGGLAPMVDMPENELLKKVIKETYERNGVVGAVCHGPVSLLNVKLS
NGSYLVNGKNITSFTDEEERGYAIADVPFLLETALTKQGAKFHAAAVWSAHSIADGNLVT
GQNPASAKGVAEKMIVILESPKK
>EGALAKHO_00276 hypothetical protein
MEKLRKHIEEIIPISDEEFEAIKPFFTIRRVLKNQYLVQQGDDAKYEYIIMSGIFRVFYL
DEEGKEHIVQFATENWWMSDYMAYFNQKQANMYVVCMEAGEVLCLTLEGREKLSAILHKM
EHFFRIKLTKGYIALQQRIISLLSSNPQQRYKEFADLYPSLMQKIPKKYIAEYLGVSRET
LSRLYSSNK
>EGALAKHO_00277 Chemotaxis response regulator protein-glutamate methylesterase
MDQELPKPTFKKILVIDDNPTDRYIAKRMAEKYHFAEEIILQESALEALNYIKSLEKTPD
LLPQFIFLDINMPGMNGYEFLDEYTKLSEAIRINCIILMITTSIHPDDFKRAENNPSVFR
FLNKPLDREKFRLIEDEFLLKN
>EGALAKHO_00278 Sensor protein kinase WalK
MKQELDDLEQSMHIQDFLFVIKRKSDHLINYFLISFFIVGLLLSFFYDTWEIGIGVGSLL
LIGYYSTKIALPKSNLYQYVLSVVLGIFMAQFIYQMHGMFEMHFMAFIASAILITYQNWK
LQIPLMLVVGIHHGLFGYFQYLDFNKIYFSQLDYMSLQTFIIHMILAGCIFSICGLWAYQ
FKKYSEAHIDLIFNKRETENQELKRANYELDRFVYSTSHDLRAPLNSMLGLIEIAKEDTN
EELMLNYFKMLKGSAKKLDGFICDILDYSRNSRMEVNNELIDFNKLLKDVTENLKFIGDN
NRMVEFIIEIAGETSFYSDKNRLITILSNLISNGIRYQNPQIPNPFVTIKIETSATETNI
LIQDNGIGIDKEVHSKIFDMFYRVSQESVGSGLGLYIVKEAVNKLNGEINIQSQIGIGTT
FLIKIPNQ
>EGALAKHO_00279 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MTFITTELSLFFEGYLFLIILYAVLIMSSYLILAHLSTRELREYLKKNSFVDYDVLLTSE
FAPSLSLIAPAYNEGFTIQENVKSLLSLNYNNYQVIVVNDGSKDNSMELLIKTYDLILTE
LDIHPKIETKKIKGIYTSRNAAFKKLIVVDKENGGKADALNVGLNIAQNQYVVCIDVDCI
LDKDALLKLAKPFLESYGKRIIATGGVVRIANQCVIKNGRLVEVNIPDVMLPRIQVLEYL
RAFLLGRMAWSRLDGLLLISGAFGAFDKEIALLAGGYSTKTVGEDMELVVRMRRYMLENK
IPYGVSYIPDPLCWTEAPEDFKIFKKQRSRWMRGTIETLGLHKKMFLNPKYKLLGMVSVP
YWTLFEFLAPGIEFIGLVLTIIFVILGLLNWHFFILLVLFVYFFAVMFSVIALYSEERTY
HKYPKQTDFLKLLIAAFIEPLYFHPLTVYAALIGYKEKIMGTKGWGEMTRKGFTKK
>EGALAKHO_00280 hypothetical protein
MTKLWELYKSGTWIEPFLILSIVVFIVTSFILYLLIIGSRSRNIRRSRVIEKYNAVIENL
MFSVVFNDMPFSEVKKDENFNKLFNNSFFREVMIDSIMNLHKNYEGSYAQKLEEFYRESG
LIKDSFKKLKNLKWEVKCKGITELSEINCTEAFDKIIKASKGRNKILKITAVNAAIKLGG
IKSIVYLTRYSYPIDDWTQINIINAFKKHDIGDTTGVELLLESQNTTVIALGLKLIKELK
LTQKIPYLAKLIANTPNTIIKYEAQNVLQILTV
>EGALAKHO_00281 hypothetical protein
MKFLYYTFFLFFITPVVLAQEINIDEVMTQAKREVEKGNYDAALSLIEPLSSKFPDNEEI
KIYTGRIYSWKKDYNASIKILAPMADRTNPSPDALLAIINTYYWSEQFDKCINYCDRYLT
IEPNSLDVLRIKVTCLEKLNRDEEALAIIEKVSITDNSTQAFRGVRTLIGRKAKNAVSAS
YLNISTSNPGQSPLHYGYVEYSHKFTKSALVGRANVGHVNGDTQMLFEADYYQTFAKKNY
LYVNGGFSTGETVFPVAKAGVEYYFVPHKKFDYALGVRYMHFETEDVTLLTGQIAFHTGA
NTIAYRPYYDTANELFSHVLSFQNTNEEKERIIRLELQYGNVPYLYLYNSLTQPLKSYRA
GIQYQHRFGDSFFIRPVFLYEYEEYLPDEYRNRFNVQVILTKRF
>EGALAKHO_00282 Transcriptional regulatory protein SrrA
MRIILSEDNDILRKSLSYFLESKGFSVDQFSDGKEALDAIETNNYDLILTDINMPGISGM
EITQYVRESLGSDVPIIIFTSSGVEQTELDSFDIGANEFIAKPVSPAVLLVRINKLLKTR
VQ
>EGALAKHO_00283 Autoinducer 2 sensor kinase/phosphatase LuxQ
MKLLYFYILLNRMDNTEELIPHNEFLRLAALKRYNILDTLPEHAFDDATKLVSYICGVPI
AHISFIDASRQWFKSEIGIGVSEVPREISFCRYTIMDSQMVEIPDTHLNERFRDDPNVTG
GFKVRFYAGVPLTTPDGYNIGTLCAIDHVCKELNENQRNALSIVAKHVINQLELRTKNIE
LDAQKKIAERAVFAKDSFLANMSHEIRTPLNAIIGFTDLLAQTKLDTVQQDYINSVQIAG
ENLLLIVNDILDLSKIESGNLVIEAHPFNLKKTLKHIYKFLKVKVPKGIEFNLFLDADMP
DHVIGDQGRLNQILVNLTGNALKFTEEGEVTVSVKLVNETDDDYSLRFSVKDTGIGIPED
KLETIFERFKQAEESTTRRFGGTGLGLNIVKQLVELHGAEIQVKSKQNRGSEFFFVLNYK
KVKHIETAPQSISDEKLGKLKILLCEDNLLNQKLVRSVIQNFGFELDIAENGEEGIAFLS
KNNYDLVLMDLQMPVKDGYQTTEYIRNEMNLSIPIIAMTAHSLVGEQERCFDVGMDAYVP
KPFKQATLLKAIKAVMNKDVNTVKKRRLDLSYLDEMACGDPNFKKEMITLFVEKIPAEFA
QLEEAFNSDNHDTVKKLAHNMKSSLDMFMLKDLSNSLSVIEEEASLEQFTSEAANQINLL
NCGVKEVVKILNEL
>EGALAKHO_00284 hypothetical protein
MTSDFFETNNYFVDKKDSFQEHYNVYNDKRERIGRIKQKLTILQKVLRVTLNKTWLPFCV
EIRSANGGLEASILKKGIFSKAEIIVQDASGKKIGIISNKSKNFKPKFKILNNANQVIAE
IGDVWKKSNFIIIDSLENQIGSIDKKWTGAMKNVVRSKNSYNVSINVKYSNIEEKVAILS
SAIVINMFLN
>EGALAKHO_00285 hypothetical protein
MKAKRISTNCLFLPQLRVGLIVFIMLILPYRSLCQELQKTVPDGTEGDVLRAADSSKAEK
LPWNMFDTSFTTIKLGAGFLYEYAGYTQDATAKRQMDSIGSPLKYDFDVRDFRVLIGGQL
KTKRTITWKAGFMYDGDAKEWYVRESGVMIATPEIWGSIFIGRTKEGFSLSKVMNGYSGE
SLERHMNIDAIPILGDGIKWLGYLPKPGIVWNMGIFTDWLSKDQGFSTYSWQFITRAAWL
PIHSEEKQTTLHIGGNFRIGQPEDNMIRLKSRPESNTAPIFIDTGTFSSNQGTFIGWEIY
YNKGPWLFGTEYNWEMFNSKEKNDPVFHGGEVMMSYIFTGASRPYTTTSGIYTFIPVKKS
VFQGGWGEIEAALRYSTNELNGGLIEGGRFWRITPTFNWYLSGNFRFEFAYGYGILDRYS
LKGATQFFQSRIQILL
>EGALAKHO_00286 L-asparaginase
MKLNTILFKKILLILLILVSNAIIAQAKPKVLILATGGTIAGSAATGVQSGYTSGQVTID
AMVNAVPDAMKLADIKGEQIANVGSQDMSFEIMLKVANRINELAGSKDVDGFVITHGTDT
MEETAYFLNLVVKTEKPVVLVGSMRPSTAISADGPLNLYNGIAVAADPKAKGHGVLLVMN
DWIHSAQSLTKVSTTAVQTFMSPIRGLIGTTSYGVNDFYHYPDQRFGKDSQFDVKGVTTF
PRVDIIYADADMKPDLIDASIEKGAKGIVIAGVGNGNMNKASLDACARASKKGIIVVRST
RVATGIVGRNVECNDDELGLIASYGLNPQKSRILLTIALLKPRKLDELQKIFLEY
>EGALAKHO_00287 Aspartate ammonia-lyase
MCKKIHYVILFGLYISFLSAQTRTEKDLLGEKQIPNNAYYGVQTARALENFQISGMTTQF
YPDYVKAFAMVKLAAARANAEDGRLKKDRLAAIEKACQAVIDGKYHDQFLVDLYQGGAGT
SANMNVNEVLANIGLEMSGHKKGEYQYLEPHDDLNMGQSTNDVYPTAIKVALLLHNDKLI
KEADLLAKAFHKKGDEFKDILKMGRTEGQDAVPMTMGQEFHAFGNQLDAEIATLRKVEVF
LCEQNMGATAIGTGITASPGYAEKVATHLAKITGKPIVMSKDLIAATSSQQGFVLYSSAL
KSMAVAMSKISSDLIFLASGPRAGIFEINLPALQPGSSIMPGKVNPVMPELMNEVCFKVI
GNDLTVTLAAHSGLLQLNAFEPVEAIAMMESQGLFFKTFPLFRKNCIEGITANKSVQDHY
MERSVGIVTALNPVLGYEKTTELAKEALETNKGILEIIREKKLLTEDQIKKLLDPASLTG
QK
>EGALAKHO_00288 hypothetical protein
MKKKFLQMATIRYFAIIICFLMANLMQAQEDEANKSMEIYGFIMTDIGYNFNQIQPDWYD
AVRPTKLPSYENEYGPDGSYYASVRQTRFGIKNYFDTGIGELKTTFEFELYGTGVDAGQT
TFRLRHAYAELGKFGAGQTWSPFMDIDVFPNTLEYWGPTGMVFFRNIQIRYMPIQGDTRL
TIALERPGASADQGIYENRIELQGVKGRFPLPDLSAEYHHGFNWGYLELAGIVRKIEWKD
QNNDQFDLSGDAVGWGLNLSTNVKLGKSTVFKGQVVYGEGIQNYMNDAPVDIGIENNPGN
AVKPVKGVALPLVGVVAFLDHSWNEKFTTSIGYSMIDIDNSDGQTPDAFKKGQYVVGNVL
YSPAKNCLVGAEFQWGDRENFSDGWSTSISKVQFSFKYNFSQAFYRKN
>EGALAKHO_00289 hypothetical protein
MSIPEKLYSEKLSNYQESIKVLYLVDDDFKSMCDDYCCSKINIEKYQKKLQEDFHLKVEY
ENLAKELEQEIVEYIAKNME
>EGALAKHO_00290 hypothetical protein
MENVKKNTHEEIFTELESVLTFTSLKSSPILSKFLRYIVEETLNENQHFIKEYSIAINVL
NRSANFNSNDDAVVRIHAGRLRRILNEYYLTIGQNNSLIIDIPKGCYVPRFIRKEINRDE
TNKPIVSLRNDTNPIIAIFPFKSITTDQNLDLFSLMLCEELSAQLSLFDDISVVGNFSSE
MISKINLNIMEAAKSIGADFIITGNILCIDRTLQIRVNLLNSKTGEFAMTKSFDHIDIKD
IHHIQNEITHSIVSEIGGYYGIIFKEIIKTSPSRITDNLSIWKGIYGYYKYQCDCTFENY
WSAFRNLDEAAKLHPNHATTWAMLGEFHLYGVAFAIDNDENTIEEAHRCVMKSLKINPHC
QHAWHTLTAINLFKKEPEACLSSAEQCIKINPNASGRVCGVGCMLVFAGYFDKGYSIMQN
AIEKNPYSPWWINIGFCCYYLSKKEYKNAFLWAEKMDSEETFIDPLLKCATLSLINEDVK
AKKYLSKLLALMPDSPNKIRQLLSGLILSEDLVTEIVEAIERIGLVQNN
>EGALAKHO_00291 Carboxymethylenebutenolidase
MQKLTKEDIAQEVFDLYDDYAHNKIERRQFIEKLSIFAVGTLTLPSLLSFMMPNYEDSIL
IKPGDPRIKSDYITYESPKGGGSIKGLLSQSVETKKKLPGIIVVHENRGLNPYIEDVGRR
AAVEGFITLAPDALSPLGGYPGNDDTGRELQKKRTREEMLEDFIAAYEYLKAHKDCNGNV
GVVGFCFGGWISNMMAVKIPTLSAAVPYYGGQPTKEEAEKITTPLLLHYAGLDTRVNEGW
PAFEEVLKKNKVENTAYFYPGVNHGFHNNTTPRYDEAAATLSWTRTIDFFKLKLKKK
>EGALAKHO_00292 hypothetical protein
MELIAKATIQIQKPIEEVFEGIVNPEKMIKYFISESNGRMETGKELIWKFPEFEDEVPLK
DIHIEINRSISYVWDPETVVKIELEAQADKSTVVKVTEDGKAYSEKNLKWAIGNTEGWAN
FLACMKAYLEYGIQLRKGAFDFMRKN
>EGALAKHO_00293 hypothetical protein
MNCIRTFLLVFASFTFLLFSPTIYAQTTETPTAENAVKYPQFQFRGLFQGRFLAAMTDNV
DVLGVQHTTGEVTQTSFDIKRMRVGLTTKISPETEVVILVNLADFKSDPKGKVLENAYAK
YTFNKYAALVGGQFRAPFGIEDQVSVDIIKSFDFSNQYYEFGKNGWTSFQIGAAVLGSVD
IGKIPVNYAFTIVNGNGKNQEKDKDNGKQYFTRWVLGLSKKNNINLGFNGGIGRVSTQEV
FAIGADITSNFKIADKFHLELQAEYKQGTNHNLYFSLPADNRTASVADYQMRGLYFLPNL
RYSIAYKRLSSIEVSCRYETFDYSYKIDSNVRQTYTPMVSLEFGKAYTGRIELGFTLDNY
EKDIPDTSTYSSNLFLMQLQCRL
>EGALAKHO_00294 Putative malate transporter YflS
MKEVKILQTIITFAVGILIWFIPAPEGVKIEAWHLFAIFVATIFGIILKAAPMGTMCMIA
IALTAFTQVLAPGEAGKSITLALQGFGDKVIWLIGISFFIARGFIKTGLGNRIAFLFIKV
FGKSSLGLAYGLGLADVVLAPAVPSNTARGGGIIYPIMKSMSMSFGSMPDQPETHRKLGA
FLTLNSYNMNLIASSMFLTGTASNPMCQKFALNLGIKISWMSWAIAAIVPGIVSFFVIPF
VLYKIYPPELKSTGDAPQIASQKLKEMGPISRNEWLMLLTFFILLFLWITGDLFSIDATT
TAFIGLVVLLLTSVLTWEDVKAEKGAWDTIVWFSVLVMMASSLNELGFIGWFSNLVKAEI
GGLSWQMAFPIIILVYFFSHYLFASATAHVAAMYAALLGVGISIGVPGLLLAFMLGFVGS
LYGTLTHYGHGPAPVFFGSGYVDLKSWWVKGLVTGLVMLLIYMVIGGLWMKVIGYF
>EGALAKHO_00295 hypothetical protein
MLQAFITGLLATSSLIIGGILAIRYSLSNRAIGVIMGFGAGTLISAISYELIFEAVKLGR
GTMYPAFGFFAGASIFYFSDKLIANFGARNRLKLNESKSSSLIIPMVLAIILDGVPESII
IGLGIFEGMSGNLTMLVAVFISNLPEAIAGSSGMKSGGWSNKKIILLWTGISLLCALATL
AGYSVFSSASQEWLSFIQAFAGGAILMMLANSMIPEAYEHGGKLAGVFTVFGFFLSVCLV
VFENFH
>EGALAKHO_00296 Flavohemoprotein
MNSNQKELIKATIPILRASGEDLTHYFYARMFREHPELRNMFNMGNQANGRQKSALANAV
LAYAENIEDPSVLIGVLKGIGTKHRSLNIQPEQYKIVGTQLIASIAEVVGEAATPEILEA
WTVAYYQLAKIMIDLEKDLYEENAAKAGSWNGWRKFVIKKIVEESTEIKSFYLYPEDGKE
ITDFHAGQFISVQVFVPELDLLQPRQYSLSTAFNPEYYRISVKRESGIAPNPSGMVSNTL
HSKLEGDAISISAPAGLFHLEKDSKNPLVLISGGVGLTPMLSMLETNLNAIQNKKTVWIH
GCRNESVHAFKEQISILKEKAEWLETFTFYDSAPNDEAFSNEIIEGRVDLHKCKEAILLE
EAKFYICGPEMFIKTQYEALLNLNINQENIFYEEFGPQLINLN
>EGALAKHO_00297 Response regulator rcp1
MNKQHYNLLLADDDEDDCAFFKEALDELSLPVSLAVVNDGVQLMDYLAANSSNNLPDLLF
LDLNMPRKNGHECLKEIKEIDDLNSLPVIIFSTSLDTEIVDLMYKKGATYYIRKPGEFSK
LKKVIENAVNVVSENKLKQPVREHFVLQP
>EGALAKHO_00298 Phytochrome-like protein cph1
MNRTNEEHYFLAGGGEMGELIRGKDWSKTSLGDPSTWPQSLCTMVAVMLENPFGMYIAWG
DDYTQLYNDGYRPILGSTKHPEALGISTRQTFSEIWDIIGPMFDGVMDGKPIGFPDFMLP
LNRNGFVEECYFDFSYSPIRKEDGTVGGVLVTVIETTEKKRATDALKESNSRFLNNIMQA
PVAMCVFRGKEHIVEIANEKMIQLWGTTAEKVLNKPIFEGLPEAKDQGLENLINSVYNTG
EKFIANERPVQLPRNGKVETFYLNFVYDALKESDGTISGVVAIAIDVTTQVLSRERVHEG
EQKVRQLVENAPFPIAVYVGKEMIVELANDSIIKIWGKGNDVIGRSFKDVVPELENQLVF
EQIKTVFETGQSFHTKNTPLDLTVDGKLGTYYFNYSLTPLYDVNGNVYGVMNTGVDLTDL
NVAKKKIEESDKRFRNTVKQAPVGITILRGSNYMVEMANEAYLRLVDREENTFVGKPLFD
SLPEVEETVSSLLNGVLTTGIPFHGYEVPIPIKRYGKLGVSYFDFLYSPLKEEDGTISGI
IVTVTEVSEKVEVRKAIEQNEERLKIILEASELGTWELNVKTREPIYSHRYLEVVGGYKE
NLKLTHDQLLKHLHPDDMHIRNKAFKEALVSGYLNYEARTIWIDGSIHWVEGKGKLFYDE
ENNPEKLIGTIRDITDEKNHQHELEESEKRFRSLTESIPQLIWETDEKGNALFASGKWFE
YTGIHPDGEAEWRAMIHPDDFDENGRIWSHSLATGEAYRCDVRVRRKDGNYRWHAVIGEP
VFDIDGKILKWVGAFTDIHTEKAFTHELEQQVAARTKELNLMNESLQKSEERYHLMVEEV
QDYAILYLDHQGTVENWNLGAEKIKGYKAEEVIGQNFSKFYTEEDRKSNLAQKLLNIAIE
KGKATQEGWRVRKDGTHFWASVVITAVHNKKGQVIGFSKVTHDLSEKKKADDKLKLNALE
LEQKNIELEKMNQELQSFAYISSHDLQEPLRKIQTFASLILEKEFENLSDGGKDKFQRMQ
SAAQRMQTLINDLLSYSRTNIQERVFEKTDLSKIIDEVKDDLKEEIEQKNATIENCENCE
ANIIPFQFRQLLYNLVSNSLKFSNPETPIVIKIQSEIVKGSLLNNKKLDEETHYCHIKIS
DNGIGFEQQYSAKIFEVFQRLHGKLEYNGTGIGLAIVKKIVDNHNGIITATGEKNKGATF
DIYLPVQ
>EGALAKHO_00299 hypothetical protein
MKRIVIIIALCLCSGIYAQIKLPRLISDGMVLQRDIPLKIWGWASPDEKIEINFNQKKFK
TTAAKDGNWMVELPSQKAGGPYEMTLTASNTIVLKNILIGDVWLCSGQSNMELPMERVKD
KYKDVIAKIDNSNIRQFLVPDQYEFAKENVDLSSGEWLSANPGNILKFSAVAYFFADEIY
QKYKIPIGLINSALGGSPAECWISAEAVKKFPEYDTEYQKFKDGTLGTQIEESDKKISST
WYSTINSEDEGLKNKWSNPELEDTDWKNMNIPGYWADNELGNVNGVVWFRKEFTVSNLKE
ANAKLILGRIVDADSVYVNGHFVGTTSYMYPPRIYPFDAKFLKEGKNEIAIRVINNSGRG
GFVEDKPYELILGNEVIDLKGSWKYKLGVKMLPLPSPTFIRWKPVGLYNAMIAPLKNYGI
KGVLWYQGESSTKKPQEYSALMKTLITNWRTEWKQGSFPFLYVQLTNFMAPKTEPGESSW
AALRQQQKNTLTVPNTGMAVTIDLGEWNDIHPLNKYDVGKRLSLLARKMVYGEKNLVASG
PLFKSMVQKGNKLVLSFTDIGTGLISKENKPLKAFEIAGKDGKFVWANAVIEGDKIIISN
ETILNPTKVRYAWADNPDQANLYNKENLPSSPFESSL
>EGALAKHO_00300 hypothetical protein
MVTAMITLFLGACSNVLEEEPRSIYTPEYFKTEKGVVGGLTSMYAHLRYIYGQGYYYNTT
ETGTDEATYAQSADANFKDMDLSGVGSITPSSSRTDALWQPAFININTASGIIENAQAIG
TISNAMISEARFFRAFDYFQLVQTFGGVPLDLGAGELKFNTSPSRFSVRNTVPQVYTKAI
FPDLVIAANELPDVGRVKGGVTKTAARLFLAKAYLTYAWWLKNPNNIPTYPEATRVDPDG
HDAAWYFQKAYDVAATAIDSHGTFALQPTYYDVNLGSNDRNSEILLYADHTEKSEFFNAS
SLTYSNGAAPENFAVWMMTPNYTNIRSSGVSSVQREAEQHLGRPYIRMCPTIGAIANTFA
DKTNDSRYDGTFTTVYRGNWNKAGVTSPTLNNANGLPVAPGGAILSFLNSENPSIAYNAS
NGGVGAGVLAGRSDFVIAPSGISRIIYPGLWKLGVYRTDGAGGLGQPNAASTRPYNIAKL
SELYLIAAEAVVMGATPQGGKSARELVNVLRARAGKWRFDNNGNVVKTADNSAALTAATP
ATIDINYILAERSREYYGEGYRWFDLIRTQKWTELSSSYQICGTAYGDHTPATVARDIKP
YHYLRPIPQSQFDAMIMTPAEKAAYQNPGY
>EGALAKHO_00301 TonB-dependent receptor SusC
MTNFFTIKSKSKLLKCLGFLFLMFLFSLSASAQTTVTGIVSDATGPIPGANVTIKGTKTS
VATGFDGNYTLSNVPSNGVLVFSFLGLTTKEVPVGGKNKINVVLEENSNALQEVVVIGYG
TQRKESVTGSVGSIKGDVVREVPSANITQALQGRLAGVQMTQTSSKPGAEMQIRIRGTRS
LSADNNPLVVLDGIPFAGSIGDISPDNIKSIDILKDASATAIYGSRGANGVILITTNKGQ
KGQKATFTYNTYSGLKNIFAKFPMMNGPEFVALRKIATLPGSTAPLYSNGADEADNVNTD
WQDLMFGSGVVTNHDIGVSNGTENGNYNFGASYYKEEAVLPGQDYSRLTLRGAVDQSIGK
YFKFGFTTNNNYSVTNGGNLSLYNTLSTTSIANPYNADGSLKRTVKMPLDENWVYTRETV
NNLGDKWIDQTKAYSSYNNLYAELKIPGIEGLKYHIDLGGNFRSTSGGQYTGEGVFSINP
TTVSTAQIINTLNTNWAIQNLLSYDRTFGKHQVNAVAMYSSEQTSYNKSQVNAKDIPSDS
FQFYNLGRAAGEISINPDNQDYFKSGLISYMARAMYSYDNRYMLTATVRSDASSRLAEGH
KWHTYPAVSAGWNVKNESFMQNVSWLDQLKLRAGYGETSNQAVAPYSTLGLLASRPYNFG
DTNTTGYYVSKLPNPELGWEYSTTMNYGIDFSLFKNRLTGTAEYYVTDTKNILLDVNLPP
TAGVGSYTANVGETQNKGYELTLNGTIFDNANGWSWDVGVNYYSNKNKLVALSSGQTRDE
NNWWFVGHPIDVIFDYEKTGLWQQGDANLTKYEPGGNVGMIKVKYTGDFNADGTPTRQIG
PADRQIIDVNPNFQGGFNTHVAYKNLDLSVVGAFQDGGVLISTLYSSSGYLNMLSGRRGN
VKVDYWTPENTDAKYPRPGGITSNDNPKYGSTLGYFDASYVKIRTITLGYNITEKFIKDL
GVDRFRLYATVQNPFVIYSPYHKETGMDPETNSYGNENAATTDFYKRRLLTLGTNTPSTR
TFLIGLNLTF
>EGALAKHO_00302 Transaldolase
MKFFIDTANLEDIKEAQALGVLDGVTTNPSLMAKEGITGKDNILKRYLDICNIVDGDVSA
EVISTDFDGMIREGEELAALHEQIVVKLPMIADGIKACKYFSDKGIRTNVTLVFSPGQAL
LAAKAGATYVSPFLGRLDDISTDGMHLIAEIREIYDNYAFNTQILSASIRHTMHVVNCAK
VGSDVMTGPLSSIKGLLKHPLTDIGLNQFIEDAKKMQL
>EGALAKHO_00303 Xylose isomerase
MIVLGNKEYYKGIGQIKFEGKESDNPLAFKYYNPDQVVAGKTMREHFRFAIAYWHTFCGQ
GSDPFGPGTQHFPWDQPTDAIAAAKEKADAAFEFITKMGFDYYCFHDYDLVNEGATFAES
ESRLATITEYLKEKQAASGVKLLWGTANCFSNPRYMNGAATNPDFNVLARAGGQIKLALD
ATIALGGENYVFWGGREGYMTLLNTDMGRELDHMGQFLAQARDYARAQGFKGNFFIEPKP
MEPMKHQYDFDSATAIGFLHKYGLEKDFKMNIEVNHATLAQHTFQHEMEVAAKAGMLGSL
DANRGDYQNGWDTDQFPNNIQEVTEAMLVFLKAGGLQGGGVNFDAKIRRNSTDMEDVFLA
HIGGADTFARALLTADKIITSSPYDKLRTDRYSSFDSGNGKAFEEGKLSLTDLYKIAQEN
GELNLQSGKQELFENIINQYI
>EGALAKHO_00304 Xylulose kinase
MYYIGYDIGSSSVKVALVEAATGKKIIVLHEPQNEMEIVSLHADWAEQDPEIWWQHICVA
TKRAIREANIEASKIQGVGISYQMHGLVIVDEACNPLRNAIIWCDSRAVAIGDKAFEEIG
AEKCFSHLLNSPGNFTASKLKWVKENEPEIYSKVYKYMLPGDYIAYKLTGDVTTTKNGLS
EGMLWDYKENKVANWLLDYYGIDQSLTPTIVENFTNQGVLNEKGAKEAGLPVGIPVVYRA
GDQPNNALALNVLNPGEVAATGGTSGVFYAVSEMSAGNKSTRVNNFVHVNYEVAKPRIGK
LLNINGAGIQYRWLRNNMGDETYESMNRKASKIDIGSDGVVVIPFGNGAERMFNNKNIGT
HFLNLNLNIHSSSHLFRASLEGIAFSFVYGMECLKDDNATIGVIRAGNDNLFRSEIFSNT
VATLIGHEIEIYNTTGAVGAARAVGLIDGDFEKFGSSITTNDHVMTFLPLQNKEPYVQAY
QKWKQELELILTYKK
>EGALAKHO_00305 Mannosyl-D-glycerate transport/metabolism system repressor MngR
MLNEEQEKFVFVINHDSDIPKYQQLVNGINNAIAENILQKGDLLPSVNAICKENQLSRDT
VFKAYSILKDQNVIDSVPNKGYYVSGETRKVLLVLDTFKAYKEVLYHSFVNNLPDNVITD
VQFHHYNIDVFKTIINNSVGKYYKYVVMNFDHKEVSPTLSTISNDKLLLIDWNIHSKKEN
NYIFQDFGKAFYNSLKEAADLFKKYKNIQFIYPDYTNHPKETLESFKKFCADFHFKYDII
TDSKKFNIEKGIAYISVSDRILGHFLEQCKEKDLEPGTDVGFLSYNETPMKKFIYKGISV
VSTDFKEMGTKAAAFITTDESVQKYIATSLIIRESL
>EGALAKHO_00306 Xylosidase/arabinosidase
MPEDSIENIDFAALDKRAISNPLVNHMYTADPSAHVFNGKIYIYPSHDIDAGIPFNDNGD
HFGMEDYHVISMENVNAAAVDNGLALHVNDVPWAERQMWAPDAACKNGKYYLYFPAKRAN
GIFQIGVAISDSPTGPFTPEPEAIKGSYTIDPAVFEDNDGKYYMYFGGIWGGQLQKYRDN
KYDGQNEEPSSHEPALGPIVALLSDDMKEFAEEPKEIKILDEYGAVLLAGDNDRRFFEAS
WVHKYNGKYYFSYSTGDTHFICYAIGDNPYGPFTYKGRILNPVIGWTSHHSICEIENEWY
LFYHDSSLSKGVTHLRSIKVTKIEYNADGSIVTIDPYDKKEK
>EGALAKHO_00307 Inner membrane symporter YicJ
MNFNTQKLSIKEKIGYSLGDLAANLVFQTLITYLAYFYTDIYGLSPKDSSIIMLVVGLIA
AFVFNPIIGVLADRTSTKWGKFRPWILWTAVPLGVIALLAFTTPNFAYHGKVIYAVVTYT
FLLLFYASNNLPYSALSGVITGDMGERNSLSSYRFVAVMFAQFFVQVFMLGIIKSAGNGD
KAIGIEKVMTALAIFGTIMLLITFFTTKERIVPKPEQKSSIKEDLSDLVKNKPWLIMLAL
TTLVFITLAMKGSAYVYYFENYVDKQQLAIFIQPILDGLAGIGLNQFGNDPIAAGFGLFN
AGGIIFMIVGITLSKRLADKYGKRNVFASFLFVSTLFILAFYVFPSKSINLIFFSQILHG
FFYGITIPILWAMIADVADYSEWLNNRRATAIIFSAMMVGLKAGLSIGGALTTSLLGYFD
YVPNSLTQTAVAINGIKLLVSIFPAIPFLIGVGLLFFYKINKKMEIQIEADLKERRV
>EGALAKHO_00308 Endo-1,4-beta-xylanase A
MKLIKPCLLAITTLLLVNCTAQKKATSLKEAYKKDFYIGTALSASQIETKDAKQDALIRK
EYNAITAENIMKSMFVHPEKDKYNFALTDKFVAYGEKNKMFIHGHTLIWHSQLAPWMEKI
KDSTEMKAFMKDHITTIVSKYKGRIGSWDVVNEALNENGTLRKSVFLNTLGEQYLTDAFK
LAAAADPKVDLYYNDYNNEAPAKREGTINLIKKVRAGGGKVDGVGIQAHWRLESPSLQEI
EESILAYSAIGLKVAFTELDITVLPNPWDLQGADVNQNFEGSAKMNPYPEKLPDSIQEKL
AQRYADIFKLFLKHKDKISRVTFWGVYDGQSWLNDWPIKGRTNYPLLFDTQLQPKKAYYT
IMQLKNQKNTSIDKGFKD
>EGALAKHO_00309 hypothetical protein
MRLLKSPLLSIILMLFLFGISTKSHAINGDKYIVNKASAENFPLASKGKIASILVSATDF
PGVLKVAGHLENDLFKVTNIHPKQINSISEATDYVVIIGTIGKSEIIDQLVRDGKINASQ
LNGKWEKFTTQIVDNPSKGIKKALVIAGSDKRGTIYGMYDLSNQIGISPWYFWADVPVKK
QSELHVLPGIHSNGEPKVKYRGIFINDEAPALSGWAFDTYGGFNAKFYDKVFELILRMKG
NYLWPSMWGRMFYVDDPQNAVLADEYGIVMGTSHHEPLTRAHAEWANLGKGKWDFSTNSE
NLISFWKDGMKRMGNTETIVTVGMRGDGDEPMTQGTAIDLLENIVKTQREIIKETTKKPI
EETPQMWALYKEVQDYYDKGMRVPDDITLLLCDDNWGNIRKLPELNAKPRKGGYGIYYHF
DYVGGPRNYKWINTNQIERTWEQMDLAYQYGVNKIWIVNVGDIKPMEFPTEFFLDLAWNP
EKWNAENLDQYYIQWAKENFDDQNTSEIAEILKLYTKYNSRRKPELLNEKTYSITNYNEA
ETVLADYKKLVEKANSINEKIKPEYKDAFYQLVLFPVLASANLSELYVATAKNQLYASQG
RASANAYAKQVKELFQKDSLLTNYYHTKLANGKWNYMMAQTHIGYTSWQEPKNNVIPETK
IIEVPNKSEAGIAIEDSENWWPNSKAEIVLPTYNSSENKSYFIDIFNRGNIPFDFKITSK
ENWIKFSKSKGKINSEERISISIDWKKAPKGDAKSQFTISANRQNFIVLVNTKNIDLKDV
KGFVENNGFVSIEAQNYSRTINSEVKWTLIPNMGKTESGVTLKPSNVQPIAISEKSPRLE
YDINLLQKGIIKVHAYFSPTINFSIREGLKYGIAIDDEKPQIINFNEKDSDKTWNRAVAD
NIKILTTSHTIENAGNHTLKFYGIDPALVLQKIVIETESGKILESYLGPPESFQKK
>EGALAKHO_00310 Mannonate dehydratase
MIKMQQTMRWFGPQDNVTLRDIKQAGATGIVTALHQIPVGEVWSIEDIKERQQIIREAGL
EWSVVESLPVHEEIKRATGAYLQYIENYKISLKNLADCGIKIITYNFMPILDWVRTNHNF
INEDGSKALLYNQLAFTYFDVFLLKRPNAKNDYSEEEKANALEFGNKLSENEKALLFKNV
LLGLPGSKISFTAEQILSLLDNYAEIDNNKLRENLIYFLSEVAPVAEELGSKLAIHPDDP
PFSVLGLPRIVSTEKDIKAIFEAVPLNANGLCYCTGSLGADPKNNLEQIIDDCGDRIHFL
HLRNTFRESENIFRESAHLEGDTKMEVLIEKLILLMNKTKVRLPMRPDHGFLHDVDEKTE
TYPGYSLVGRLKGLAELRGLEMGIAYKLNL
>EGALAKHO_00311 NADP-dependent 7-alpha-hydroxysteroid dehydrogenase
MSTKTAIVTGGNSGLGFATAKKLCDNGIKTYIIGRSKEKTEDACKEIGANAIPVIYDLNN
LAGIPEMIENIIKENPIDILVNNAGINLKKEFLDVTDEDFLSVIHTNLLSVFAVSKAVVK
NMKENGTGSIINISSMASQYGIPKVIAYSASKGAIESMTRAMAVELAPFGVRVNCIAPGF
IKTKMSSTALDNDPERKNKVLGRTPMGFLGEPSDIADAVYYFALSESKYTTGTVLPVDGG
NSIGF
>EGALAKHO_00312 Extracellular xylan exo-alpha-(1->2)-glucuronosidase
MAQKDYKLWLQYEKKTNAQVVSKYLSEVQGIVFLGNSETLKIASKELEAGLSEMFGNKIA
IKSKIEGDRNIIIGSKEVLSSEIQKEIGNFDQINEEGFIIRSISVKGKNQIVITGKKDIG
VLYGVYSFLRLIQTDKSIKNLNIVDSPKTNIRILNHWDNLDRTVERGYAGFSLWNWQKLP
DFIDQRYIDYARANASIGINGTVLTNVNANALILTPQYLEKVEALANVFRPYGIKVYLTA
RFSAPIEIGGLKTADPKDTDVANWWKNKAKEIYKRIPDFGGFLVKANSEGQPGPQNYGRD
HVDGANMLADAVAPFGGVIMWRAFVYSEHDANDRAKQAYAEFVPYDGKFKDNVIVQVKNG
AIDFQPREPFHPMFGAMPKTPLMMEFQITQEYLGFSTHLVFLPKLFQEVLESDTYQKGKG
TTVAKVIDGSVTKTKLTGIAGVSNIGNDLNWAGHPFAQANWYGFGRLAWNPELDSEVIAD
EWLRCTFSNDENFIKPVKEMMMDSREAVVNYMTPLGLHHIMDTGHHYGPGPWVSNLSRPE
WNPVYYHKADKNGIGFDRSKTGTNATAQYAPEVAKIFDNLETCPEKDLLWFHHVSWDYKL
KNGQTLWNGLALKYQEGVNQVAAMQNVWNKTEKFVDSERFKEVQMLLEIQYKEAKWWRDA
CLLYFQQYSGKELPVGVEKPTQSLNYFQSLKFPFAPGN
>EGALAKHO_00313 HTH-type transcriptional regulator DegA
MEESKDVTIYDIAERMNLATSTISRALKDHHTISDKTIKKVKKVAEEMGFRPNILAAGLR
GNSTKIIGVLVSRINRPFISSLISGIEEIAQKAGYSVMITQSHDSYEDEVNLSKALYDSR
VCGIICSLAMDTRDTSHFQKFIDKNIPLVFVDRVPKDFNTYRVMIDNYSAGYKATKHLIE
QGCTRIAHITGSQYRNTYSERKRGYVDALLEANLTVDEGLIIETTLTYEEGETAATTLFD
LPNPPDGIFVVNDTAAVGAIQIAKKRGLKIPEDIAIIGFNDDPIASIIDPGLTTISHPAV
KMGQTSAKKILNHLKSPKKNADTPKKDRITEVTFLNTEVLVRASSKRIE
>EGALAKHO_00314 Xylan 1,4-beta-xylosidase
MDKKQCHMKKSIALYHIILFSFLSLYSNAQDKKEKFPFENTTLSFEARVNDLVSRLTLEE
KVSQMLNSSPAISRLNIPAYDWWNETLHGVARTPFKTTVYPQAIAMAATFDKNSLFTMAD
YSALEGRAIYNKAVELGRTNERYLGLTYWTPNINIFRDPRWGRGQETYGEDPFLTATLGD
FFVKGLQGDDPKYLKAAACAKHYAVHSGPEPLRHTFDVDVTPYELWDTYLPAFKKLVTES
KVAGVMCAYNAFRTQPCCASDILMTDILRKQWKFDGYVTSDCWAIDDFFKNHKTHPDAAS
ASADAVFHGTDIDCGTDAYKALVQAVKTGKIPESQIDISVKRLYMIRFRLGMFDPVEMVK
YAQTPASVLESPAHQEHALKMARQSMVLLRNENNTLPLSKKIKKIAVLGPNADNSISILG
NYNGTPSKLTTVLQGIKDKLGANTEVIYEKAINFTNDTLLVYSDVKNQYTFEGKQGFKAE
YFNNENLSGQPEITQTETELNHFWQEGEAVGKNIKANNFSARYTTNFTATEDGSITFELT
ADDGYRFLVNGKEELNAWKKNRWGGQTFQLKTTKGTAYNLVVEYWQGEGKGNVSLNAGNF
KKTDFAALVNRLKDVDAFVFAGGISPQLEGEEMKVNFPGFKGGDRTSILLPAVQTDLMKA
LNKTGKPVVFVMMTGSAIAIPWEAQNVPAIVNAWYGGQAAGTAVADILFGDYNPAGRLPI
TFYKGDSDLPQFVDYKMDNRTYRYFKGTPLYGFGFGLSYTSFKYDQLKMPSKISKGKSVS
VSVRITNTGKMAGEEVAQLYLINQNKTIKAPLKTLKGFERINLKSGESKTLTFTLSPEDL
SHITDEGISQEYNGEIKIAIGGHQPDEANTSTSSILTKNILIQ
>EGALAKHO_00315 hypothetical protein
MINVSFFEILGMFIIPFFSILIPILAGQYYGLFVKNKTGKINDSPVGSVVGAALGLLAFM
LAFTFQIVDNRYNNRKELLLDEVTTIRTAYLQSGLIPEPYRSSSRKLLIEYTDLRAALFK
DLSVKNVENLKTKSQTILDSLWSYSEALAAQDRSSEAYSLYTGSINELIDVYNKRVTFTF
EYRIPVTILWVLFIITLFTMLILGYQFGISGKKNHILAVFISIIFASVMFLILALDRPET
GIMKLNQAPVLTLHKQLHSKD
>EGALAKHO_00316 hypothetical protein
MKNFTLTIFLISCFSVSSFGFSKDKTLSENKKTTFFIPGPSFDNYAVPIIDDASLLAFFK
KYSQLKEYQNDVSSLYKDRSYKSIWYEGNDINEFGHLMYQKLNSTYEQGVQVRIPYKEKI
DEVFNEESNKKISESDTELLLSSMYILYAKHVFQGMDAAEQNKIEWYLPKKKLSYETLLD
SIVSNPNLLDENNHVLFSQYYKLQNVLKKYREIEKNNTWKTITMPNPYKDLRPDDTGVTI
QDVRTRLFVLGDLAKDSKSNFYDQELMDGVMKYKLRHVLTPNYIINKEHINQMNEPVSDR
IKTLMLNMERCRWIPPTLENQEEYVMVNIPSFRLYFVRNGNYDVVSKVFIGTPLTKTVIF
SGQIDRIVFSPYWYVPASIIKNELQLKMAEDKNYLAEHNMEWNGGNVRQKPGPENALGLV
KFMFPNPNDIYMHDSPSKTLFGFEKRIFSHGCINVEKAKELAVAMMKDYPDWTIDKINAA
MSGEKETPFKLTKKIPIYIGYFTAWVSKEGDIGFFPDVYERDVKLNSLLFPLDTGYKTAN
N
>EGALAKHO_00317 1,4-beta-D-glucan glucohydrolase
MNKVEKSFLHKDQFGQNFLWGVSTAAFQIEGAHDADGKGSSIWDVFTSQKGKVKNGHHAL
TACDFYNSYQNDIDLISHLNIPNFRFSISWPRIMPTGTHPVNQAGIDYYNKIIDSLLEQG
IEPWVTLYHWDLPHALEVNGGWTNRDSVSWFSEYVEICAKHFGDRVKNWMVINEPSVFTG
AGYFLGIHAPGKKGITNYLKAMHHVTLATAAGGKILREKVAAANIGTTFSCTHIEPFSQN
IKDIEAAKRVDTLLNRTFIEPILGMGYPQNDLAVLKKLNNYIKEDDGNNLAFDFDFIGLQ
CYTREVVKASLLTPYIGAELISAEKRNVIATDMGWEVYPPALYHILKRFNEYEGIRKIII
TENGAAFPDTVTNGKVYDIKRTHFIQDHLEQILKAKEDGLSVDGYFVWSLTDNFEWAEGY
NARFGLIHVDFETQKRTIKHSGLWFRDFLS
>EGALAKHO_00318 hypothetical protein
MEINWFIISAIVIGVALLVYFLIKQNKKDRKKIEEELNYSQESEEAEINNDLNL
>EGALAKHO_00319 hypothetical protein
MNFENWEYDVITTVFICVLLPLFLYFAYWFFISGVIGLHRMEESTRWKYCIGEVKNAEIK
YMSFSDDYRFTLKKTYKYVVDGLEYESNQTYASDYLFEKEYKSLDQFPKIDGIFLKSNQF
IQIEKEKEIQIGRKVTVYYDKNNPKKSCLINKINNQIYLPIFMGLFFGLVLTIFALKLIG
NLTE
>EGALAKHO_00320 hypothetical protein
MKKTILFEFLYFLLSLIIGLFGIAFLSRITYSKTTFVIPVFGNNIQMTAGLMLSFFWLGS
LFILTLVRQFKQKINNLFHNLILLIAGLALTYFFLNFIDIAQNMKNVFEKELPAEKITSL
NYEIALFSFLQILVTITMIKAIINSTQKLKKHCA
>EGALAKHO_00321 hypothetical protein
MKKIIQLFLALIIISSCNHRKYENLNSLPFNELVAESDQIVIKLYDSTVEKQITSTESNL
KKIFNVSEEKIEDFKSIFENAKKTGYCCCPISNYSISLLDDNEEFGLFYVDTTEFKGKVR
IYDCSYQYSYILEEQKWRKFLSDTKK
>EGALAKHO_00322 hypothetical protein
MHMKNDILLILGLLFLTLNCNSQIKYNEKLKKELQNILFTDQIYREFTDSNTTKDRKEEI
AKLTNTTVEILYKDIFKIIEQTDKENFEKVKIIVENYGYPGESLVGVPENTAVFYVIQHN
PDKISEYYPIIEKAGKNNELPFSLVAMMLDRKLTGEHKEQIYGTQLAMKQIINDKTGQKE
NFIYVLPIEDSINVNKRRMEAGFDTTVEDNAKRFGIEYKSYTYGELDAMK
>EGALAKHO_00323 hypothetical protein
MNKQEQDFISLLVIVFSFAYTFFYMLNGKGNSPLSFRYNQLFEWKSLKYHLLFATILAIL
GFVRIDSLTLETYYFTPILFITSTLICNLIVKAIFNRNILMEVPSRLGDTFSKNAKSLDK
FFTFIISLISLTVPIILKAPKFKEINNRHLTEIKILPITATTTDLGIGLNGKLVLYLGRF
GKSEE
>EGALAKHO_00324 hypothetical protein
MKKLLALLIVLCIFGCEKYVVSFEQPTNMKLDNLKLEVLLDKKKVQDINLKATNAMPSYE
TVALSTSGEGKHLLQVKVKDTIFSYDIKYPEEKYILLTAHLKENGKIHIGILKQQYKFRL
H
>EGALAKHO_00325 Molecular chaperone Hsp31 and glyoxalase 3
MKKIIYFIAVVFLPTCLLAQTEEEAAVKKCIQNYLDGTSYNKPDCIEKAFYSEANLFLSH
KDKELWIVPISEYTTWFKKDNQGQFNGRIGSIISVDLYNNIAQAKAEILLPDKKMEFIDL
FLLKKIQGEWKIISKSASSMKSNKSGQQILFIVSNAHYYGKSTIATGNSFAEIVNAYHTF
KIAGYNVDFVSPDGGSIPLAYINTSDTLQKQYLFDPDFMYAIKNTKKPEEINSKNYKAVY
YVGGGSAMYDVPENKEIQTIALKVYEENKGIISSVCHGTAGIVNLKTCDGKYLVAGKKIS
GYPDSFEKQDGAYFKHFPFLIQKTIEARGGTFKFSKGDVSHVETDGRIVTGQNFQSSSDV
ALKIIEILNGGKINNEL
>EGALAKHO_00326 hypothetical protein
MHHTLEEYKKGIKIKYEIEKEAEHFDFLYNPSRGKLRDLCWLIFENNPTKEDLNVFRNLF
CLDFDHTKKNKFKEQKDKFRPIETFFKGETDPSNIDAINLAAIMVDFQPRPFKKFNEKCR
IEEAKQIEIAHKANAVVEIEKEVIGVECLVKNEHEESKEHPEKGNLLFDFAARFSKKIGQ
KIYPRKIITIGIGAVALMSSAILYFVQKKD
>EGALAKHO_00327 hypothetical protein
MKKLLLLSVFALLFTIFSCTPDEIETHPKKKTEKVIDPLKSTQADEGQGPGDGDPKGPPP
PPN
>EGALAKHO_00328 Sensor histidine kinase ComP
MLRSPFFYFIIPLFLFSCQEKKTVNINTESIRQQALSLRNKGILNYEKQNFNLAFYEFNK
SKIIYETLKDSANIGYILVQMSKIQQVNGDYYGSKETVTEALPYVKKDREYLGVINNRLG
IADKELSLYNDAIIYYKKAANQLTDPVEKLVPLSNIAPIYIQQKKYNKAIILLESILSKK
ILDDKARARINDNLGYAYFKDGMEEKGFSLMKTALLTKNKIKDAYGSIESYLHLADYYTK
KDIQKSDENAFAAYNIATKLNSVDERLEALQIIISNNHTNQNSKYVQQYFTLNDSLIKVR
NNFKNKFAKIKYDAKKEKDENVKLRLEKAENLLSLQKEKYLRIVFAIAFIFLVILIAILI
RYYKNKNKAIAFKTSYNTEIRIAKKIHDELANDVYHVIAFAESQALSKESTKENLLEKLD
DIYGRVRGISKENNKIETGNDFTKSIKEMLLAFNTSDRNIIATNLEDINWELIDDTKKIT
ISRVLQELMVNMKKHSKASLVLIKFENDHKSILIRYTDNGVGCEKTKMTKNGLQNMESRI
QAVKGTIDFDTEPEKGFKVKISMPK
>EGALAKHO_00329 hypothetical protein
MKFDIIFKESVTRKQLTLIYNLHWKKVLRQNTLNLFMSIGSLILGIYDVDNNGNFGFILI
IISFYGFFLFIKTLVKYFINKRKYSKNVNHLIEYYKQNRDNATIIEFNNDFVACKNFESD
VKFQWEEFSGFRIIDNNIVLERTNFPLQPIILGKDDIGEKQYIKLIDFIETKIQRTSH
>EGALAKHO_00330 hypothetical protein
MFGFFKKNNDKNKQNPKKPIEKDSMQLYKQARMTSDPKIAVKLYSDAIDVEKQKESPNRE
LISEIYQWRGELYLELQVAILSSSDFLHSLDFNPKNAISHNNLAIWLTMPQFAKPDLDRA
MEHFNKAIELAPERLDFQMSRAVIRIKNGDRETGKTELEDLHSKGYENAKIAMERFL
>EGALAKHO_00331 hypothetical protein
MKGHIIVIISLILFSCSIKEVKNKNTILNQENLKNKKMKNYVYLKDMYADSYFPKFLVDK
VKTILIELCIDIEKASPKNLDELYQLTHTATIKINDLQNEFFEHNSEIETGARESIGADF
DFIAKAYGFNADGEELIAPREW
>EGALAKHO_00332 hypothetical protein
MTTAQKEILDKLRTYLEKNPSQRFGQALFNLGINQFLENEEFQLRDIYSNADSEILNRIE
NRIKWFDLQKKVKIGVAKVDGIGGMTVNERLYASDLSELFYEARENNKEQAEFILKALKV
DEESIAQILK
>EGALAKHO_00333 hypothetical protein
MEGIRITKDNIKNWPKFEALLNDGKIKFDSTGRLRYLHGAPIGDLIQTRTDKKGQPIFRE
NAEEWFDPESQKAKEFIWE
>EGALAKHO_00334 hypothetical protein
MEMKTLFIIGGILVVAFILKSCISNNNSKNESRPKNAEIPTEKIQNDKIVLFENVKSEDL
KNAIQKFCNNYNQEGLRALPLLTILSENKFVVTFPYDTDFVTYCYFVNYMYYPNDIFHKP
IIKAWTSTKQNDDWMTNEIVNKKVMLFIPIDDKDYDNVYLTTSDNIGYKMGFAMGEEKQK
LNIPRQTYVEPINLEELKGKEEIQYK
>EGALAKHO_00335 Solvent efflux pump outer membrane protein SrpC
MSKFKLYQYSVAVGLCLAVAGCKAPAAETATTSTPVPEAFGIAKAQDTTNTSTLKWNEFF
KDQNLVDLIDVALKNNQELNMTLQEIEIAKNDVRVRKGLLLPTVGVRAGAGVEKVGRYTS
QGAGDATTEIKPGIETPDPLGDFTIAAYANWEVDIWKKLRNSKKAAVSRYLASVEGKNFV
VTNLIAEIADSYYELLALDSQLDIVKQTIKLQSNALEIVKIQKQAARATELGVKKFEAEV
LTSKSLEFDILQQIKENENKINFLLGRYPQEIKRTNTNFLTLLPASVSAGMPSQLLMNRP
DVKQAELELVAAKLDVKVARAEFYPSLDISAAFGVQAFKPSYLFTFPESILYSLAGDLAA
PLINRNAIKAEFSSANARQLQALYNYDKTILNAYLEVSNQLSKIDNLQKSYDLKSQQVDA
LNTSIDVSNDLFKSARVDYFEVLMTQRDALESKLELIDTKKEQLNAAVHVYRDLGGGWK
>EGALAKHO_00336 Efflux pump membrane transporter BepE
MFNKFIQRPVLSIVISLIIVFLGVLSVMNLPITQFPSISPPMVNVTADYPGSNGELMIKS
VVIPLERALNGVPGMKYMTSDAGNDGEASIQVVFNLGTDPNQAAINVQNRVASVTNKLPP
LVVREGVKITREVPSMLMYVNLYSTDKNTDMKFLYNYADINVLSELKRVNGVGSGDILGT
REYAMRIWLKPDRMLAYKISADEVMEALSSQSLEASPGKTGESSGKRSQAFEYVLKYSGR
FTTKEQYENIVVKSNSNGELLRLKDIAKVEFGSSMYDIYSNLNGRPSAAIVLKQSFGSNA
NQVIEDVKAKLEKIKTKFPKGMDYEISYDVSKFLDASIEKVIHTLIEAFILVGLVVFLFL
GDWRSTVIPAIAVPVSLVGTFVFMTFFDISLNLITLFALVLAIGVVVDDAIVVIEAVHAK
MEEEHLSPLKATKKAMHEIAGAIVAITFLMAAVFIPVAFMSGPVGVFYRQFSITMATAII
LSGIVALTLTPALCAMMLKNNHGTPKKKTPINRFIDGFNNKFNLAQGKYQNLLGQIVNRR
AVTIIALLGFCAGTWLISSTVPSGFIPNEDQGMFYAIIQTPPGSSLERTNNISEKLQKIA
ETIDGVKSVSSLAGYEILTEGTGSNSGTCLINLKDWNDRKESVQEIMTELEEKSKDIPGA
NIEFFQPPAVPGYGAAGGFELRLLDKTGAGDFKKVEAVNKEFVEELNKRPELSNVFSFFS
ASFPQYMMRVDNDLAQQKGVSIENAMNSLSTLVGSNYEISFIKYGINYKVIVQAAPEYRA
QPDDILKLYVKNDRDEMVPYSAFMKLEKVYGLSEITRHNMYTSTEISGGPAPGYSSGTAI
KVIQEVAAKKLPRGFDIDWAGISADEVAQGNQAIWVFLICLGFVYLVLAAQYESFILPLS
VILSLPAGIFGAFLLLKITGLENNIYAQVAMVMLIGLLGKNAVLIVEFAIQRHAAGKTVL
EAAMEGAKARFRPILMTSFAFIAGLLPLAFATGPGKIGNRTIGTAAAGGMLIGTICGVFV
IPGLYYIFGRIAEKHKLVKNEEENPLTEEIDNNHV
>EGALAKHO_00337 Solvent efflux pump periplasmic linker SrpA
MKRIIVLTGMLALLCLTSCTSKKEEKEEVEKFTVTNPVKIDTSFTKEYVSQIKSVRNIEL
RAQEKGFLQNIYVDEGQFVKKGQLLFKIMPNMYEAELLKAQAEQKSAEIELQNAKLLADK
NIVSKNEQAVAQSKLQSAKAEVALAKLHLSFTEIRAPFDGTIDRIPLKLGSLIDEGELLT
SLSDNSQMFAYFNVSEPEYLQYQTDVKDRAETKVNLLLADGELFKYKGNVEVIESEFNNE
TGNIAFRARFQNSEKLLRNGETGKVQMLVPLKNAIVIPQKATYEIQDKKYVFVVDKNNKV
TSREITITGEIPDLYVIKTGLAETDKILLEGVQKVKENDKIKYDYQAPQTVINHLRVKAE
>EGALAKHO_00338 hypothetical protein
MRKLIVFLVFMNFLLLGGGQYLNAETHQTSHHYLEKRHRVKFTNQDQGSSIIEDADVDLD
EEFLGNDNLKDGLSNKFFATTYSILDSWYLTFSRQIVVNSFNRFEIFGSSCGQSNPIYIT
QRVLRI
>EGALAKHO_00339 hypothetical protein
MKIEAIKASETWEIRHKVMWPDQPFEFVQLNEDNFGLHFGVFDQDKLVSIVSCFIVDDEM
QFRKLATLKEFQGKGIASELLEFILKLAKDKGLRKVWCNARTSKKSFYEKFGMIAVGKTF
FKSGQEFIIMEILLT
>EGALAKHO_00340 hypothetical protein
MKKFILAALLCISVNGFAQLIQIGPQVSYNITSPSTDDFSSKSAGNGMGVGGFVRLNLLL
FYAQGELGYSESKFSVSQTGIGETEYKLSGTDAALIAGFKIVPLGKLGNVRLFVGYDWKN
YSDISANNSLNYIALERNNSSFLGGVGVDLWKFTIDYRYLAGVTDLDPSGRSLKTNVSNF
SVGFKFL
>EGALAKHO_00341 hypothetical protein
MKKPLIFLVLLFSFKMIAQSDPKVAFQKTRYELAVSCYKKADFVKALDLFSIASKIKPEN
ELGKESIKKVDTLKTMLRKSIMDKVIGTWKMNGDKPLWSVNSSSTNANAVEEFVEINQNQ
IIFYEVDSKTKVKKQIKSEDLKYYNKDEADSLFSAIILSDGTIWNCSLNEDADILHVINI
AKQTENGVEKIKADNLERFYSKVN
>EGALAKHO_00342 hypothetical protein
MAGEKDLQILLKSMKPEHNLGDYVFCKVEKVENLNLDEVEMFFKEREAITLILKKQIAEK
LNFEHSMTMSWITLSVHSSLEAVGLTAAFSKALSDNGISCNVVAGFYHDHIFVGKNDTEK
AMQILNSF
>EGALAKHO_00343 hypothetical protein
MRKELLQLVVVAFIFLAQNSFAQELYMPRNIKEAYAKGTRSMDGKPGKNYWQNHGKYTME
ISVDPKTKIVTGTESIVYENNSNDTLRNLPIRFVNNLHKPSSPRGGSVSDDFLSNGLTIT
SLKIEGEAYKEDARSWGTVGSIKMKKPLLPHSKITINIDWNYPLSKESGREGQIDETTFF
VAYSYPRVTVFDDYNKWDKLPHTDRQEFYNDFNDYTYAVKAPKNYIVYATGDLLNPDEVL
QPEFSARLKKSYTADEVMHIATEQEMKSGVVTKQNDWNVWKFEAKHISDVCFGLSDHYLW
DASSVLVDKKTNRRASVQAAYDVKGTDFVASVKNNQYALDYFSNKWPGVPYPFSKMTAFQ
GFADMEYPMMCNDSQMGDPVFAQLVQDHEVAHTYFPFYMGINETRYAFMDEGWATTFEYL
IGIEEHGKEAADKFYKSFRVQQYIGDASTEEDQPIISMSSQLSGAGYGNNSYGKASLSYI
ALKDMLGDDLFKKSLHAYMENWNGKHPIPWDYFNSINTASAKNLNWFFNNWFFTNNYIDI
SVKNVTKDVVSIENVGGFAIPFDINVIYSDDSKETLHQTPAIWESNQKIATVVLKSKKQI
KSIVLDGGIFMDATPTNNTFISK
>EGALAKHO_00344 NADP-dependent glyceraldehyde-3-phosphate dehydrogenase
MSLIPEEYQITNLINQDTYLVNGELKKWTGQTTPVFSTISSTEKYTPTLLGSIPFMAEKE
AAEVVEAANVAYNKGQGLWPTMKVVDRIKCMENFVRQMKETREEVVKLLMWEIGKNLGDS
QKEFDRTVEYIQDTIASYKELNGRSSHFEKVQGVNAMIRRGPLGVVLCLGPYNYPLNETF
SLLIPALIMGNTVIFKPAKHGVLCISPLLEAFRSSFPKGVINIVYGRGREVASPIMKSGK
IDVLALIGNSKSAIALQDQHPNKNRLRLILGLEAKNPAIILPDADLDLAIQECITGTLSF
NGQRCTALKVLYVHASIADEFNKRFSEKVDALKFGNPWEAGASLTPLPETDKPAYIQGLI
DDATSKGAKILNEKGGKHTDNYIFPAVLYPVNSEMRVYHEEQFGPVVPIISFNDIQEPLD
DMAESNYGQQVSLFGKDIKTLAPLIDALVNLVCRVNLNSSCQRGPDAFPFTGRKDSAVGT
LSIPDALRSFSIRTFVASKDIAYNNEILQELLNSKESNFINTDYIL
>EGALAKHO_00345 putative adenylyltransferase/sulfurtransferase MoeZ
MNLSQEDWVNQLAADENAVILDVRTEDEFNDGYIENAVNIDINKGQGFIYEIEELDKNKN
YYVYCRSGARSAKACQVMNELGINNAYNLLGGILDWEGDTVNP
>EGALAKHO_00346 Global nitrogen regulator
MQNTLKDIFPNFSSELLSTIEENGSAQDFKAGTILMRTGQYIKNTVLITKGKIKIYREGE
DGGEFLMYYLQPGQACAISMICTAKSEKSQIMAKVVEDVSVMMIPLQMMDKWMMEHRSWY
EFVIETYRSRFEEVLEVVDNIAFRSMDERLEFYLKRHSDACGCSEVKLSHQEIATELNTS
REVVSRLLKKMEQRGLVKLNRNQIELLMKS
>EGALAKHO_00347 hypothetical protein
MEYLGYFASIIIGISLGLIGGGGSILTIPILVYLFKVNPEQATSYSLFIVGLTAMFGSYS
HYKMGNLKLKSALYFAIPSVISILIIREVIFPQIASTLFSIASYSVSKDFLIMIIFSVLM
ITAAISMIRKNQPEIKGAETNYIQLSFIGFIVGIITGFLGAGGGFLIIPALLFFAKLPMK
QAVGTSLLIISINSSIGFAGDLYIGTPINYPFLLGVSAMALLGMILGSQLSKKIDGTKLK
PIFGWFVLVMGFYIITKEVLF
>EGALAKHO_00348 hypothetical protein
MKNVTIAIFFFFFGWLNCKACDCDTPKAILEFYSSKYVFKGIITSKTFSKDSATYTIKFK
VLESYKKGKIPKELSFTFSYKEDLEWDACYSKVYKNQKWLIFAYENDGKLGFSKMCSNSH
SIKGEINSSLQKILDNGNNFKLEDYIYGNDWDIKSEFNFPKPITNIDSIFENGKIKDYQN
TFAAFTVVINKKGKLVSIFSFLDWDYSYGEFKYDPIFNVLKSFTIKSKRPLNEFEIDAID
LLKSVQDWEIKRNNTTKVAVDYTAHVNVEFDTKTKKWSYDLR
>EGALAKHO_00349 hypothetical protein
MMKRIIFITIQFIFINCYSQSNESSVLKNKTKLEKYVRANGKTFAKFELKKIQDFAPETD
AQDSICRRIGDSLKINEYYYKGDFDNNGLVDFLLIGDDYNCDESRSIRCNFKSLVMMSFP
KDSLKIYNINLGDGCFIPEIAKKNNQTVLQVYNRRRGVLSVKGNNVEQHTLIYKYDGFID
YNERPVKHSIEKIEFSTSGCYGTCPVFSLVIDKERNSTFFAERFNFGTEEENMKKMSSFF
NNNREGTFKTIIKEENYNQILALLEYMNFVNFQNENILYEEDSGSSILKITYDNGKEKII
EDYGVVGSYSLKKLHELLFELRMNQKWN
>EGALAKHO_00350 Cytochrome bd-I ubiquinol oxidase subunit 2
MEFFWYIVLMGILAVYIVLDGYDFGAGIIHLFFANTEKDKKAITNAIGPFWDANEVWIIA
AGGVLFFAFPTLYASSFSGFYLPLIMILWLLIFRAIGLEMRGQVHHPMWEAIWDKAFGIA
SLLLALFFGIALGNIVRGVNLGMVQNGVSTQEAHFFFLPLWNPTFSPKANELGIIDWFTL
FLGIVSVVALTIHGANWIIFKTNSSLNTQLKNIVFKLNIVLLILVFISLGIWHFIEPEPF
HNFVENPILWFFPIMTFVGILGLFKVRSFKKDGQAFIFSTLFLVGGFASTAVSIFPNVLP
STNNVNPSLTIYNTAAGEYGLNAGLSWFFIALFLVIVYFIIQYRVFNGKMDDVGYGEH
>EGALAKHO_00351 Cytochrome bd-I ubiquinol oxidase subunit 1
MLFYDRMQFAFTITFHYLFPQLTMGLSLIIVYFKWKYLKTQNEQYNHATHFWMKIFALNF
AMGVVTGIPMEFQFGTNWAKFSELTGGIIGQTLAMEGMFSFFLESSFLGIFLFGEKILGH
KWHFVTGVLIMIGSWASGFLIIATHSWMQNPVGYEILENGKFVLNNFQALFLNPWLWPSY
LHNQAASLVTSSFVVAGIGAFYILSQKNVSFGRLFLKTGVIFGLISSLIVAVPTGDLLAK
NVVKYQPVTFAGMEGIFHTEEKGSEIVLIGQPDVKDKKLDNKIAVPNILSFLTYGNWNQE
IKGLDQFEEDQHPTNISGLYYAYHIMVGLGTVFIGLMVLSLFQLIRGKLFETKWILWSLM
FMMPFPYIANTTGWYTAELGRQPWLVYNLMRTAAGASPTVSSGNTLFTLLGFIGLYLLLG
MLFLLLIGKIINKGPHHVELSTEKI
>EGALAKHO_00352 5'-deoxynucleotidase YfbR
MNTTDLLDQIAFIKEIDKVKYIQRKTKLFNSDRCENDAEHSWHLALMAIVLAEHSNEPID
VLKVVKMVLIHDIVEIDAGDVFLYDTQINHSNTDEERLAANRIFGLLPKKQGEDMIAIWE
EFEAGETNEAKFAKSMDRLEPLLQNTSNDGGTWKEFGVPYKKVYEKKSVIKEGSTTLWNY
AEGLINESVAKGILKK
>EGALAKHO_00353 Hydroxyacylglutathione hydrolase GloC
MKIEQIYTGCLAQGAYYITSNGEAAIIDPLREIQPYLDRLDRDAVKLKYIFETHFHADFV
SGHIDLSKETGAPIVYGPNAACEFDCISAKDGQEFKIGKITIKALHTPGHTMESTTYLLI
DENGKDHSIFSGDTLFIGDVGRPDLAQKAAGMTQDQLAGILFHSLRDKIMTLADDVIVYP
AHGAGSACGKNMSKETVSTIGNQKATNYALRADMTEAEFIEEVTDGLLPPPAYFSMNVAM
NKGGYESFESVLHNGMKAIAVKDFEAVAEETGALILDTRKSGDFYKGFIPQSINIGINGD
FAPWVGTLIANVKQPIILVTENGLEEETVTRLSRVGFDSIIGHLEGGFEAWQKTGFEVDT
VNRISADQFASEFKIEEDKVIDVRKETEYEAEHIEDAYSKPLAYINDWVKDINPKEHFYL
HCAGGYRSMIAASILQARGFRNFTEIDGGFGAIAKTAIPKSDFVCQSKVLKA
>EGALAKHO_00354 hypothetical protein
MSIIEIIKEPWPWYVAGPLIGLTVPILLIIGNKSFGISSSLRHICAACIPANISFFKYDW
KKESWNLFFVFGIFLGGIIAAYFLANPNPVEITPQLSEQLASYGIKDHSGLLPKELFSWE
SLFTLRGFIMIVVGGFLVGFGTRYAGGCTSGHAIMGISNLQWPSLVATICFMVGGFIMAN
LILPYILAL
>EGALAKHO_00355 hypothetical protein
MNNLENKNTDTEGINESQIKDSGLSNLKYLLVGIFFGIVFVKAEIISWFRIQEMFQLQSF
FMYGVIGSAVVVGVISIQIIKRFNIKTLHGEKIEIQPKVFSKGQIYGGLMFGFGWAITGA
CPGPLFAQIGTGVTVIVVTLLSAIAGTWFYGLIKDKLPH
>EGALAKHO_00356 hypothetical protein
MIITALQLRKATLSEVPQIWEIIQDAIEQRRLEGSKQWQDGYPNELSITNDINNGFGYVL
TENETILCYAAIFFDIEPAYEEIEGNWLTNGDYVVVHRVAVSKLAKGKGIATKLFQKIED
LAVQQNVYSIKVDTNFDNVPMLKILDKLNYTYCGEVYFRGGARRAYEKQLK
>EGALAKHO_00357 HTH-type transcriptional regulator MhqR
MYIQLLKVYTFVYTNYTLTTMTIEEVIKSTVKMDNAKKVILNIMYTQNVIQDHFNELIKP
YDLSGEQYNVLRILRGQKGNPANMCVIQERMLAKTSNTTRLVDKLLLKDFVTRNVCPGNR
RKIEVSITQKGLDVLKELDPKVDEHERLFANNISQEELELLNKLLEKYRTQQN
>EGALAKHO_00358 Putative NAD(P)H nitroreductase YfkO
MSTLLENLNWRYATKKFDATKKISASDLNTLKEAVRLSASSYGLQPYKVVIVENPEIREK
LKAAAYGQTQITDASQLFIFANDLDLGAVSVDNYIKNISETRGVPVEALGGFSDMMKGTI
ANLSDDAKNIWSAKQTYIALGTLLSAASELKIDATPMEGFNAAQFNEILGFDKLGLNASV
IATVGYRHGEDDAQHYKKVRKSHEELFITI
>EGALAKHO_00359 Protein YceI
MKNFKTIAIALFVAVASISVNAQTKKIDAKASTIKWVGKKVTGEHSGTVNFKDGAVVFKG
KKLVGGSFTVDMTSLTSTDLTGEYQGKLNGHLKSADFFGTDKFPTAKLVFKTIGAKSTDV
YTVTADLTIKGITAPVTFDITVAGNTATTAFKVDRTKYDIKYNSGNFFENLGDKTINDDF
ELTVALKF
>EGALAKHO_00360 Mechanosensitive channel MscK
MSNFAFLLPNSPKKYKSIGFQLFLIACTFLSSLSGISQNTTSKLDSIVKELGIKDKASLI
LLKGQAEREKKMREEKYINYQNVQKQNRLFNLIELEIQNAKFLLTKGFNYKDVTGEIHQL
KDWEEFAIKGIVGRKFRVLTDRNLSSTSILLDELLNRSTDRLKKISLENQQLSRTQEKID
SLVSQKSLYYIPSDSVSREIYRLQSERTSKDITLISERLKNAVDSIQTLEIMGDQLKYKI
ESDIIENNRLRKLELDQLFTKKVPVFERPFIHIDPFTTSIRTNYLVMYFYCINNKNSILT
MLLLIVGTAIYFRLQKGKFIDLGFKKEMLLDINILNSPISAAFLVVLNLYQFVLPMPPLI
FSIIIWTLSTISLTIMMLHTIRTFVWKVLISIFVLNLLAFFDIIILIHFVGESYLILAIN
ILGIGIGIYSFINRAQFQRKIYLWYIVIGAILQIFSFYYLVNGHYNLGKFLMTKAVYSVV
VIFSLYHTLIAIKEINLVSKILKTIDEDSTKKKIKGIPHNFSFSFYLLLFVSCFILMIRN
TYIFQSIVDPFRNSLSETRNIGNISFTFENIITFILIILLSGFISKVVSFLASDNQVIKN
KDNAKNIGSWMFLSRITIVTVGVLVAFASTGIPLDRITLIISALGVGIGFGMQSLVNNLI
SGLIIAFEKPVNLNDIIEVGTQSGKMKSIGIRSSVVTTYDGADVVIPNGELLNQNLTNWT
LGSNQRRSQIRFGVAYGTDLELTKKVLLEILEKNKNILMKPAPSIWFTKFGDNSIDLVVM
YWIKHFDFDYDVKSELIVAIDKTLKENKIVIPFSQQDIHIINKNRDPED
>EGALAKHO_00361 hypothetical protein
METKIQIAILTLLSSFFLQAQQQPKGIIGNTNWMNNWTNFKPASAEYNEATNIIAGNIDK
DTRLTKRNTYQLVGVVYVTNNATLTIEPGTVIRGDDKTCGTLVITNGAKIMAEGIETDPI
VFTSNKEIAERKPGDWGGIIILGKAPINTLGGLHTLPFDLEPMLNHYGGQDVEDNSGILK
YVRVEYAGRKLSSLKELNGISLAGVGRKTVLSNIQVSYSNDDSFESYGGDLIMTNLISYR
TTDDDFDFTQGVQCNISNSIAIRHPFSSDVSGSRCFEVDSYDKIGNTDMSKKLTKIDASN
ITLVNLEENNQGLVRESVYVRENTFFNLSNSIISGFTPFVLLEGNIGDGDVNLSKITFKN
LVINNCNGGITSESGSGNPAIQRFYGNPAFFLDYTKLKNSELFTMPNIKGNPDFRMNVNN
TLAIGN
>EGALAKHO_00362 Anthranilate synthase component 1
MKPFILNTHYKQILADTITPVSIYFKIRDKFPNSLLLESSDYHGNDNSFSYVCCNPIATI
KIENEIISKTFPDGTTEQIAIDASTNIPQVIQEFSSQFKSEKNDFKFINNGLFGYISYDA
VRYFEKVSIAKKDSATLIPDVFYAVYQNIIAINHFKNEAYIFCHSVDGRNNISEIEQLLQ
SRNIASYKFAKEGEGFSNLTDEEFKHNVALAKKHCFRGDVFQLVLSRRFTQGFKGDEFNV
YRALRSINPSPYLFFFDYGDFKIFGSSPEAQIIVKNRKAEIHPIAGTFKRTGNDEHDAVL
AKQLSEDKKENSEHVMLVDLARNDLSRNGHDVNVEKYREVQFFSHVIHLVSKVTGHLHEK
ATTMQVVADTFPAGTLSGAPKHRAMQLIEDYEKTNRNFYGGAIGFMDFEGNFNHAIMIRT
FLSKNHQLHCQAGAGIVASSDEESEMQEVYNKLRALNTALEMAEKI
>EGALAKHO_00363 hypothetical protein
MKKAISILFLIIGVTACNSEKKENPIEGTWRLISAETTEKDSTFSTFNPKTKMIKIINNT
HFAFFNHDLNNGKDSTAAVFFGGGGKYTLKDSVYTENLEYFNNRQWENGKFEFVVKIKND
TLTQKGIEKVEKLGINRIITEKYVREK
>EGALAKHO_00364 Aminodeoxychorismate/anthranilate synthase component 2
MKKILVIDNYDSFTYNLVHYLEDLNCEVTVYRNDEFDIDEIATFDKILLSPGPGIPDEAG
LLKEVIQKYGPTKSILGVCLGQQAIGEVFGGTLSNLDKVYHGVATNVKTVVSDEILFEGL
GNEFEVGRYHSWVVDANLPDVLEATSIDENGQIMSLRHKTYDVRGVQFHPESVLTPKGKL
ILENWIKS
>EGALAKHO_00365 Anthranilate phosphoribosyltransferase
MKYILNKLINHEVLSKEEAKDVLINISSGNYNPSQISAFLTVFMMRSITIDELSGFREAL
LELCVRVDLSAYNTIDLCGTGGDGKDTFNISTLASFISAGAGIKVAKHGNYGVSSISGSS
NVMEKMGIKFSNDPSFLEKCIDKAGICVLHAPLFHPAMKNVGPIRKELAVKTFFNMLGPM
VNPSFPQNQLVGVFNLELARMYAYLYQNTDINFTILHSLDGYDEISLTGPTKTITSHMEG
MLNPSDFGVRLLSQTEIEGGKTIEESAEMFTNIISGKGTEAQNNVVLANAAMAIATVTKC
SPLEGFELAKESLFSGRGLKALQTLQELSK
>EGALAKHO_00366 Indole-3-glycerol phosphate synthase
MNILDKIIFDKQREVVLKKSIIPVSQLENSVFFGRETISLSQKLRTSSTGIIAEHKRRSP
SKLVINQSFTVEEVVKGYENAGACGISVLTDGKYFGGSLDDLILARASVNIPLLRKEFIV
DKYQILEAKAFGADLILLIAAVLTREEIKSLSEFAKKLDLEVLLEVHNQEELEKSIMPSL
DMIGVNNRNLKTFEVSLDFSKQLASQIPNDFVKVSESGISSIEAISELRPYGYSGFLIGE
NFMKTDNAGQAAIDFISQL
>EGALAKHO_00367 N-(5'-phosphoribosyl)anthranilate isomerase
MKLKICGMKYPENILEVGALLPDYMGFIFWEKSARYFDGEIPELIETVKKVGVFVNQNQE
EILEKVQKYNLQAVQLHGNETVEFLSELKKQLPKKIEIIKAFSVENDFDFEVLKPFESVC
NYFLFDTKGKLPGGNGTTFDWTILKKYKSEKPFFLSGGIGINELKAIEEISKSNLPIYAI
DVNSKFEIEPGLKNKNLFSNFKRKFDVANF
>EGALAKHO_00368 Tryptophan synthase beta chain
MNFNVNEKGYYGEFGGAYIPEMLYPNVEELRQNYLKITSEPDFKAEFDQLLKDYVGRPSP
LYFAKRLSEKYNTKVYLKREDLNHTGAHKVNNTIGQILVAKKLGKKRIIAETGAGQHGVA
TATVCALMGMECIVYMGEIDIARQAPNVARMKMLGAEVRPALSGSRTLKDATNEAIRDWI
NNPVDTHYIIGSAIGPHPYPDMVTRFQSVISEEIKWQLKEKEGRENPDYVVACIGGGSNA
AGTYYHFLHEPEVGIIAVEAAGKGVDSGHSAATSKLGKVGVIHGCKTLLMQTPDGQITEP
YSISAGLDYPGVGPMHAHLAQTGRGEFFSVTDDDAMNAGLQLTKLEGIIPAIESAHAFAV
LDQKKFKPTDIVVISLSGRGDKDLDNYIEYFKL
>EGALAKHO_00369 hypothetical protein
MEKLFSYGTLRSKQIQMQLFNKVLTGTKDQLLNHKLKSLQIEEEFGMADYVVAVPTEDAA
DPIHGIVYNISPSDLAKVDIFESNAYKRVEVTLKSGIVAWIYIEN
>EGALAKHO_00370 hypothetical protein
MILAAAQTKPTRGNIEANLLDHYRLIELAVQNGAQLIAFPEMSITGYERENAQKLAFKKD
DSRLDHLKQLASKNNVIIVAGAPIQIEDEMLIGEFVIAPDNSISIYTKQFLHEGEDEFFQ
SSFDYNPMITIEEQKISFAICADIDNPLHPENARKRATDIYIASIFFSPNGIRNAYRDLQ
SYAEKHKMNVLMSNFSGESWGSPSAGQSAFWNNKGELVGKMNDSDSGLLLVENKNDNWTS
KVAKI
>EGALAKHO_00371 Tryptophan synthase alpha chain
MMNRITQKLQEDKKILSIYFSAGYPNLNDTVQIIQDLEKNGIDLIEIGLPFSDPLADGPT
IQASSTTALHNGMTTQILFDQLKNIRESVKIPLIIMGYFNPMLQYGVEAFCKKCAEIGID
GLIIPDLPVDVYADEYKAIFEKYGLINVFLITPQTSDERIRFIDSVSNGFIYMVSSASVT
GSQSGFGNIQESYFERIGNMNLKNPQIVGFGISNKETFNQATKYAKGAIIGSAFIKHLSE
SGSGKIEEFVGEIR
>EGALAKHO_00372 HTH-type transcriptional repressor NicS
MSNIELNDKKIQILEVAEKLFSEKGFEGTSIRDISKHAKINIAMVSYYFGSKERLLEALI
LYKTSDLKLQLENLLQENLEPIEKVNKLIEIYINRISCNKGIFRVLHFEINSEKREKSMI
AFTELKKGNLKAVESIIAQGQSKGVFRKDVIIPLLTPTIIGTFFHFHMNKSFFVELLNLK
TEEMYNNYIKTSLTKHIQQTIKALLVYEN
>EGALAKHO_00373 hypothetical protein
MKINPLLLFGIFFIGISSIEAQEKTSLTLDEAVKLAWEKSNEVTLANTKVNSKKYELQEV
KNNQYPDIKVSGQYQRLTKASIDLHNNSSDQASAEPMPSPDQALLGMATLSLPIFSGFKI
QNSIKAYDNLYEAESAYAAKTKEDVALRVITYYTALYKAQKTLDLLNENQKQAKQRVTDF
TELEKNGIIPRNDLLKSQLLVSKTQLSIDEANNNINNINFYLTTLLKLDPSVKLTVNEGD
FFNLKTSNAPSSDVVALENRKDLEAIRLQQKASEANIKIAKAGYYPSLALLGGYTALDLK
DFITVKYAMNFGLGLSYDISGLYKNSAHVKVAESQALETKSSEAILTDRIKNEVQKSIED
YDLAINQSVVYDEALQQASENYRLVKDKFDNGLSDTNDLVEADVEHLNAKINTALSKATI
IQKYYELLSVSGQLSQSFNLSKI
>EGALAKHO_00374 Multidrug export protein EmrA
MEKKKTNTKFIIILTVLVLLGGTYGISKYLHGQAHEETDDAQIEKKMNPIIPRVSGYISK
VYVKDNDFVKKGDTLFTIDKRDYQLKIDEANAALLGAEGQYEAAKADIGSANASISVSDA
QMRSASGSIESAKIRLRQITNDYNRYNNLYKTHTITKQQYEQALTAKDEAENQVRVLEQQ
QRASSYQKSVIESKSKASDKQTEVAAANIKRAKTMLDVAHLNLTYTVVTAAIDGQVSKVD
IQPGQLVQPGQSLFYIINNNEAWVVANFKETQLNKMIVGQKVSLKVDAYPNYEFKGIVTS
FSPATGSRFSLLPPDNATGNFVKTIQRLPVKISLDPTNDPEKVKLLRPGMNVDVDVHLK
>EGALAKHO_00375 Multidrug export protein EmrB
MATAVQADDDLVEYGYRRVIITITAVLCALLEIVDTTIVNVALTDMRGSLGATLTDVAWV
ITAYAIANVIVIPMTSWLSQQFGRRNYFVASIIIFTVCSFLCGNASNIWELVAFRFVQGM
GGGALLVTAQTIITESYPVAKRGMAQAIYGMGVIVGPTLGPPLGGYLVDNYSWPYIFYIN
IPLGIIATILALTFVRSPKYGEKLKANQVDWWGIILLSAFIGSLQFVLEHGQQDDWFNDS
TIVALSVVTVLGLVLFIWRELTYKFPIVNLSVLKDGNLRIGTVMCFILGFGLYGSTLIIP
IYTQSILGWTATDAGLLLIPGSITTAFMMPFVGNMIQKGVPQAYMVGVGFLVFFFFTFMM
QTRMTPDTGVEHMYWPLILRGIGLGLLFVPITTLSLSTLKGKHIGEGAAFTGMMRQLGGS
FGIAIITTFITRFSQEHRVNLINNLDPAKFDVQQRIQGMQRAFMSKGYSADVALKKAYQA
IDYSIMKQSTVMSYIDIFMYLGIMFLCCIPIILFIKRGKNKINPADAMH
>EGALAKHO_00376 hypothetical protein
MKIVISPAKSLNFEKELPTTQHTEPSFLKEARQVHKILKTKKPKDLAELMSISEKLSDLN
WERNQKWKTPFSPENARPAVYTFDGDVYTGLDAYTIPLEKLEAVQDKLRILSGLYGVLKP
LDLMQAYRLEMGTKMPVGEYKNLHEFWKPIVTKSLNKELKKGELFVNLASNEYFSAVDVK
ALKVPVITPDFKDYKDGKLKMISFFAKKARGMMVRYIIDTNAETIDDLKGFNYEGYQFDA
NLSKGNHLVFTR
>EGALAKHO_00377 Multifunctional CCA protein
MAIQTNYKTALQHKIFGIISQASQELNVDSYVIGGFVRDLLLNRGSKKDIDVVAVGSGIE
LALKVSELLPKKPKVQVFKTYGTAMLRFEDTDIEFVGARKESYNFDSRNPIVENGTLEDD
QNRRDFTINALALSLNEKTFGDLSDPFDGLADLENKTIKTPLDPDITYSDDPLRMLRAIR
FANQLGFEIEKNSLDAITKNAERIKIISGERIVDELNKILSTDKPSIGFLLLYQTGLLDI
ILPELTALNQVEEIEGHTHKNNFYHTLEVVDNICPNTDDVWLRWSALLHDIGKAPTKRFT
KKQGWTFHGHEFLGGKMAKKIFERLHMPLNHKMKFVQKMVIMSSRPIVLAQDIVTDSAVR
RLVFDAGEDVEDLMTLCEADITTKNPAKFKKYHKNFDIVRKKIVEVEERDHVRNFQPPIS
GEEIMEIFDLKPSREIGVLKEAVKEAILEGDIPNEYQAAYDFIIKKAEKMGLSKV
>EGALAKHO_00378 hypothetical protein
MTTSEIKLYLIKKIIETTDIDLLLKIKSLLEENNYAVSQENSSIVNTSVIEYKSSKTRNI
RIFSEAEQKRINIALEQYENGEWISNEEAQIELEKWLTEQEK
>EGALAKHO_00379 Heme A synthase
MKKHFPTIAKTALVLVYLVIVAGALVRMTGSGMGCPDWPKCFGYYIPPTDLKELTWEPNR
AFEKGQVIIKDESLLVAKDNFTTETSFDASHWEKYTKHDYALFNPLHTWIEYINRLCGAL
AGMACFFMAIASFRFWKQNKKITLLSWLVVFMMGFQAWLGAKVVYSVLNPIKITVHMVMA
LVIVAVILYIIQLARPKLVTVKYNSTFRNVLLFSLLLTLIQVAIGTQVRQFVDEQVKNGL
TASILWLQNPSVIFYVHRSFSILVLLVNLYLYIKNTKFGLGFSKINWVIAIIGVEILTGM
AMAYLDFPIGSQAIHLVLASILFGIQFYMILEAKKPNPANS
>EGALAKHO_00380 Sensory transduction protein LytR
MTTLIIEDEKPAARLLQRKLEKLEIAVETMLHSVEESVNWFTNNEHPDLIFLDIQLSDGL
SFEIFEKIDIKSAIIFTTAYDEYALKAFKLNSIDYLLKPIDEDDLEVAVAKFKSRMPKSN
SENQNLQLDFEQIRRMLSNPFEKNYKKRFTVKIGQHLKVITTDEIECFFSENKGTYIHTF
DNRNYLIDSTLEILEQELDMKNFFRVSRKFIVPLQAIKEIQVYTNSRLKVILPTYKEDEV
IVSREKVQDFKSWLG
>EGALAKHO_00381 hypothetical protein
MGRLRRRMFEEYREEFTNDESFNIAYRKVKRIKGFYSHLRVYVIVNLIIIVSNLNHDFSG
FGFNVDGLFEWNTYSTAIYWGIALVIHAFTVFGRDIFFSDDWEEKKIQEYMKKESTNNNK
WE
>EGALAKHO_00382 hypothetical protein
MGVIMEVNFNEEDKYYLAKKKVENIKGFYSNLTSYIGVNIVLIFINLYTTPHHLWFYWPL
IWWGVGVLFHGLKVFEVFPVLGRSWEERKIKEYMDKEKENQKKWQ
>EGALAKHO_00383 hypothetical protein
METNCSYNQGKFKFEAIFSKKIIKLRSFYIHAFIYAIGLILYVLKEFYGISLDFFPIRYL
NSVVMIIWTSVFLVSAIDLFASFKIFDEKWEERKVKNLLDKKTKTQKWE
>EGALAKHO_00384 hypothetical protein
MEPDYNEERRYHQAQKKVKEIKDFYQHLTVFILVTIMLIVINLMTSPEYLWFIWCILGWG
IGVIVHGLKAFGVSPFFNKEWEERKIREFIDKEKESKKQTWK
>EGALAKHO_00385 hypothetical protein
METNYAEAERYYQAQKRVKEIKDFYSHLTVYLLCNPIVIAVNLLTSPGYLYFWYSLLGWG
FAIVMHGLAAFRVSPIFNKEWEERKIREILEKEKKTQTWG
>EGALAKHO_00386 Sensor histidine kinase YpdA
MKDHRNTFSNLKSGTIACFRISMVFTIIFSAFLGADLTFTNVLITFLLSCLYSFGLGFGN
GYINVLLDRKWDWLEQTNLRVYYGILVTVLYTVPAVLGINYIIFVIIQNMPLASFFSERM
ILVHLFYIILSLGVSIFMQARSFMVKWKQASKFEITQQKIIAGTANAKFESLKNQIDPHF
LFNSLNVLSSLIEENPDNAQRFTTSLSKIYRYVLEQKDKELVSVDDELSFAKTYMNLLKM
RFENSLFYELPTTVINPDAKVVPLSLQLLLENTVKHNVVSEQKPLHIRIFVDGDYLAIQN
DFQKKEVLQDRQGVGLTNIVNRYGIITNRKVLIEQNEETFTVKIPILTKQITVMETSADY
SDENKAYFRAKKRVEELKGFYGNIISYCCVIPFLVFINLRYSPGFQWFWFSALGWGFGVV
MHAFKVFGYSSDWEERKIREILEKENNKQTWK
>EGALAKHO_00387 hypothetical protein
MTKIITITTLFICSLLSAQTQFEQGMGKAFGLWKEGKTTEASAMFERIAAAEKTSYLPNY
YVSLINTTAAFSEKDITKIDLLLTKAQDVLDVEMIKDQNNAELYAMQALIYTAWVVADPM
TNGMKYSSKVMEAYAKGKAIDPNNPRIVFGEADYQIGGAKWSGVDTKPLCAQVDKAIELF
ATFKPETPFSPKWGLERALETQKNCKK
>EGALAKHO_00388 TonB-dependent receptor SusC
MKTKIFFTITFLFFTAFIFAQNTISGKVVDQKGKPVPGANIYIDGTYDGATSSATGEFSF
ETAAAGNQFIVVSFLMYDTFKQEIDVTNFKGQTIKLRDNVNALDAVVITAGNLEAGDKAR
VSVLKPLDILTTAGSAGNIVAALQTLPGTQTVGEDGRLFVRGGEASETQTFVDGLRVAQP
YGATTNNLPTRNRFSPMLFSGIAFSTGGYSAEYGEALSSVLLLNTQDEPDQNKTDIALMT
VGLGVGNTQKWKKSSFSINTNYINLAPYQAVVPQNVDWNNPYQSLGGEAVYRYHFERGIF
KLYAAFDSEKFDLNQKNVNFVNPIRTDLNNNNFYLNSSYKGDFGTGWQITSGISYGYNSN
KVKYDINDVDSNENAMELKLKLRKNISNYFKLSVGGDYFITKYNENFNDNVSIKVANGYD
SNIAAFYTEGDILFSKKLAAKVGFRLSNNSLLDETNIAPRASLAYKVSKNGQFSFAYGDF
SQTPVVDYIKFSKYHQFESEKAQHYILNYQFSKPGQTFRAEVYYKDYSNLVQYDTRDIAY
NSVFNNNGSGYAKGLDLFWRDSKLYKNLEYWISYSYIDSERQYKNFPTMATPSFIANHSL
SIVTKYFITDWKSQVGFTNSYSSGRPYNDPNQTQFMNGKTKSYNSLSFNWAYLLTTQKIL
YFSVSNVLGSQNVFGYDYAKLPDANGVYNRQAVTPTADRFFFVGFFWTISQNKNENQLKN
L
>EGALAKHO_00389 hypothetical protein
MSESRRVSNLYQSIYNGNPWLEVTLADTLSNVTAEQAYKKANPNLNTIWEIVNHLIQWRR
NILRRVQGEIVTTPSHNYFVPVLDSSEAAWEQSLQSLAKSQELWTTFFNDFNDADFDKID
PNNNHNFYEDIHGIIQHDVYHLGQIVILKKLV
>EGALAKHO_00390 Maltose O-acetyltransferase
MISGEYYIAGDPVLVKERRKAKNLLHRLNVTEYRLTKKAKEILAELIPNTGKSFYIEPPF
HCDYGYNIVCGDNVYFNVNCVVLDCAPVTIGSNVFFAPNVQIYTATHPLDAELRKTLENA
LPISIGDDCWIGGNSVICPGVTIGKGCVIGAGSVVTKDIPDNSLAVGNPAKIIRKLNQEP
ESK
>EGALAKHO_00391 hypothetical protein
MLTLNKVHHIAILCSDYQKSKTFYTEVLGLTIIREIYREERQSYKLDLALNGTYVVELFS
FPNPPKRPSRPEAVGLRHLAFEVINLEETVAFLDSKNIESEPIRIDDTTEKRFTFIADPD
ALPIEFYER
>EGALAKHO_00392 H(+)/Cl(-) exchange transporter ClcA
MNKTAQIKKNHQFIKFRKLVIVSILIGFLSAFLGISLKKITEYYEEIFFHEVSVNPIFYI
IFPVFGLSVIYFLRQYLFKKKENKGIKEVFESTKSTSKNLPSYKIPSHFINGLLTVIFGG
STGIEVSTVVATATIGSVAQQKENVFRQYKTELICAGVAAGVTALFSSPIAGILFALEVI
SRKVTRAFIISNVIAVSIAFGLLTILKEEPLFAVTITTWHLKAIPYFILLGILAGMNSVY
LTKCVLFFKSQFGKIDTHYYKIILGSTVLSISLFIFPQLYGEGYHAIKGIFANSSELPLT
ITLAFTFVGILLLKPIVTSITLASGGDGGVFAPSLFIGAFLGLLLASILNSFFHVNVIPV
NFMIIGMAAVLSASIHAPFTAIFLVCGLTNDYTLFLPILVVCLISKYTAKMIYPFTVYTY
STSLTK
>EGALAKHO_00393 hypothetical protein
MPVQKIKRGYRKTRYILYKETLVDYKEHFWSFLGSFVGIGILAYIQSIHFSGNDAVYLIG
SFGASSVLVYGIIQSPFSQPRNLIGGHVISAFIGVTVHKLAPDVIWIAAPLAVSFAIICM
QITKTLHPPGGATALIAVIGSDKIKALGYMYVFSPVLVGCLILFLTALVFNNMTSSRTYP
SHSTYHKHYHKIRKRLGRK
>EGALAKHO_00394 hypothetical protein
MVYKFRVILDAEEDIFRDIAILEDDTLEDLHNAIFNAFGFDGTEVASFYTCDETWNQEDE
IPLFDTGDVPGEQRTMGDYPLSSILDKENTKIIYVYDFISMWTFLVELAAIDEQSAGAVY
PETLFSHGEMPDEATEKSFEADMHDDIYGEFEDDLDEEDLDMFEGDDSFEDYGFEENWN
>EGALAKHO_00395 hypothetical protein
MSNFRSLLIWQKSMALTTKIYFSTNNFPKEEIFGLTSQIRRSSISIPSNIAEGFGRESDK
ELLRFLNISVGSLFEMQTQLEIAKNISYLKEYDFNNLYEDSREVERMLVSFIKKIKDRS
>EGALAKHO_00396 hypothetical protein
MINLFNTHIETLAIHRVGNKSRNEAIFLSEQPFNLNDEIVPLIKEYFFKPFREKEENYYQ
FAHEVDLDYNDMFKYATEIFTNPGNLQEISKKITTHLFEQSNHPHIKNGEVYVTYLTNLS
IDNNVVDAIGIFKSELQADFLQFEEKDSNLEMILQQGINLSKLDKGCLIFNYKKEEGYKI
LTVDSNRYDARYWLEHFLSVDAFEDENFITKKYLKFCQNFAKDVVLPAEDKKEEVMFMNR
SVNYFAKNDQFEEQNFLNEVLDNPDLIPEFKNYKVDKGEKYSIEDVTSFPIANAAVSDAR
KSIKNVINLDTHIQIKMDFINPESAEKFVEKGWDEEKQMYYYLVYFNKEEKS
>EGALAKHO_00397 hypothetical protein
MRIVFGQRNFKIREFSSHELGFTNEQHNNFNIEIRQNYFHIYWIPFFGTGKIWAIKKDGQ
LYELPAHYIYEIKKRQKIRSPWYTYTLPILICMGFLIYFLSDQIKERNYEKQRIQYFNES
VQVLDNYIDNPAVNEFFTLQDTKEDTEESKMYLKVEKVYADRIVFTLIPGFFLHSTQSEL
EECYNDNKANLDTISISKAALKNAVNKDYDASQTYTYKGINLLKSNKLYILTAVEKKFQP
QISIVQTYNDYKVIQIELINTSSAFKIVAIKNVTNSIPWNMKLPFEVAAGTKLKPTKFVL
ENTEKDNFSFYNNKDYSVLIKILDSFNIEHTFTINGSGSSNSIM
>EGALAKHO_00398 hypothetical protein
MNIKDLKWYFVALIILVLPFFLLPETKYNSMGWSIGVVTSLLVAIFVFLGLTKTDSISEL
FYFDSENPNLNGTSIGIPIVIFIFGSIFINVNFSSRLEAKIKKEGIIAKATIDSGFSKTT
QSSRSSYTDHTLALTLTTDDNVEHKLIAENVSAEAYDKVGVGLDVEIIYLPENPQIFRVI
IDDEAIKKFKHIANRDIEFKDLEKLIALKEPAKLEKELNKLSSGWQPHQSENPGFGFINP
LKKEAIFINTTIGALMYVHDKQDFTTRFEIPKERILKELKDSASISYELDKYIIEKHTES
KGGEGTRFSMIENVIMRTK
>EGALAKHO_00399 HTH-type transcriptional repressor ComR
MARTKEFSEDQALDKAIEIFWHKGYNGTSAQDLVTHLGLSRSSLYDTFGDKQKLFTKALQ
KYHEDNYVKVKEILETATNIRETLTVIFKLAVVESLEDRITKGCFMVNSAVELAMHDEEI
AKIVSDNREIMGEVFYNAIKKGQDLGQISTKQDARLLSRFIFNTYSGIRVLARAGEKDKQ
VYDDILKAMFSLF
>EGALAKHO_00400 Diacetyl reductase [(S)-acetoin forming]
MKNLENKVAIVTGGNSGIGYATAAELAAKGAKVIVTGRNKEALAKAEQELNVTGIVADQS
DLKSIDSLVEEVKAKFGKVDILFLNAGIAAFAPVDSASEDHYDSIMNVNVKGVYFTVQKV
LPILNDGGSIIFNTSVNAQLGMPGSSVYGASKAAVLSLNRIFAAELAGRKIRVNAVSPGP
IETPLYGKVGLEKEEVEGLGAALGNKILLKRFGQASEVAKTIAFLASDDASFITGTEIVV
DGGLTVNTVL
>EGALAKHO_00401 hypothetical protein
MDIHLFNESPFKTIISFHKLIESFEEIALSNVDYRSNYAKAILKQIESIPELKTGIEDYS
IIKNNEALIKNILADLFPTALTQNEIKAVTIPFQNISFNYTERFKKILRNAGDEFYMEIR
DFDDHQFYINNCCLILSSYYKQHIDFNRPFFYDIPDEEGIEKHYRILYNADFMEITPTEN
AIQLTQDDIDNLIDNYDDLELWKSKFPKGSWVLKGFGIVSLFDATTESSISNLKSNLLKP
DTKSVATDEIVANIFRSIFKIHDLKVGFIIYNPEEEKFVKPAKLDSQLESFLLSNDQEVD
CKNAFFGCSFDNLLNKKEPFVISNVKKFIEESPNKKMGEHLLKQGIQSCIFAPVIKDDHL
LGVLELVSSNSRALNSVNAQKLELVLPYLTDTIDRYNTDMQHQIEAIIQREYTTIHPSVY
WKFRKESQNYFQNNNPSKDYIFKEIVFKNVYPLYGQIDIKGSSEHRNETVKRDLKSQLNI
LLEIFDNQKPNTNLVLLEQRKFELESLRNELDFPLKADTEQHIQRYIEEEIHPILKNTKS
SAKNEKLEELYFENLDEKTGLFYQERKKFDNAMSIINKKMASVLDRKQLEAQQIYPHYYE
RFKTDGVEHNLYIGASIAPTKPFDIMYLHNLRLWQLQTLCEMELEHHQLKESLPYELDVT
SLILVFSAPLSIRFRMDEKRFDVDGTYNARYEVVKKRIDKANIKGTKDRITEKEKITIVY
SQNNEETEYLKYIKYLQHKKILEPAIEQFEVEDLQGVSGLRAIRVKVINNTASPAKKITY
QDLLDELN
>EGALAKHO_00402 hypothetical protein
MNLIEQSEDFVSNLLKDKLSNLYSYHNLNHTLTVVNAVKELCKKEDVGGEEKEALLVAAW
FHDTGYVEGFENHEKTSVKIAAAFLKEKGQSEEFITKVSNLILTTVKEYVPKTHLEKIIK
DADYAHLMGPEYEITCELLRMELKNAFDVSYSNAEWAKENLNFLLNKHRFYTDFALKKWQ
PLKEKNLILVQKKIEKQEKKEANKMEEENKKKDKIEKPDRGVDTLFRVTLGNHTRLSGIA
DSKANILLSVNAIIISIALSSIIPKLDSPKNAHLVIPTFIMLISSVTTIIFAILSTRPKV
TTGVFTREDIEAKKINLLFFGNFYKMPLAEYDWAMNEMMKDRDYLYSTMIKDLYYLGLVL
QRKYNLLRIAYNIFMVGLIVTVIAFVIAFKSI
>EGALAKHO_00403 hypothetical protein
MKLFLYNHFITKIKTYSFVITLLLLLNSCATHKAQYGKNVSAYETENATDTIKIAHTIFL
VGDAGNADEEQAQQTLELLHQKLKKANKKSTLVFLGDNIYPKGFPAEKNDSEKALAETKL
TNQLKLTKGFKGKTIVIPGNHDWYNGIKGLENQADFVTKYLNDKKAFLPRKSCPIEDVKI
DSTCTLVTIDSEWFLEDWDNHPTINDNCDIKTREDFFAELENILNKNQEKTVVLAIHHPL
LSNGSHGGQYSWEKQLFPLEKKIPLPVIGSFINLLRKTSGVSPQDLQNKQYTIYAKRIKT
LLQGQKNVIVVSGHDHNLQYVNKENITQIISGAGSKSEAARAISPTDFSYGGNGYATLTL
FKSGDAKVAFFGNENNHEKMLFEREIIKAKEINWAADVPNKFPPTVTTSIYSSKMTDKGI
FHKFLFGQHYRKYYSMPIEARTATLDTLMGGLKPIREGGGHQSVSLRMSDPKGREYIMRA
MKKSATVFLQSVAFKDQYVVNDFEQTYAEDFLLDFYTTTHPYTPYAIASMSDQLGLLHTN
PVLYYIPKQVGLKEFNSNFGDQLYMVEERPADNHLDGKNFGKPTDIISTDDMMANLHKDE
KYSVDQKEWIKVRLFDMLIGDWDRHSDQWRWAEHKIGDKVVYTPIPRDRDQAFPKYDGTL
LSILMNVPAIRHMRTFKNKIDNVKWLNREPYPLDLAFLKTTEEKDWIEQAKYIQEHLSDS
DIDKAFKNLPKEVQDETIEDIKQKLKNRKKDLQKYASEYSDVLDKTVMIAGTDKKDKFVL
NHNSRKSIEIQVYRMKKEGDELVYTKTVTDDKTKNLWIYGLDDADVFQVTGEQKSDIKIR
LIGGQNNDTYNIENGRKVIVYDFKSKENTYNLDSKTKTQLTDDYDVNLYNYEKPKYNVVS
GLPNIGYNPDDGVKVGINVNYTVNNFKQNPYTQRHIFNAFYYFATGGLEFNYAAHFPGLL
GKWIIDVESLYTTPNFAMNYFGYGNETVNNDDELGLDYNRVRIRKFNVSTAIRHVGRYGS
EFSVQPIFQRMTVEETENRYINIPNIVNPAVFESQNYGGLKVKYLFKNADFAAKPTLGMA
FMAAATWTANLNETKQNFPTLESLLGFTYKLDKNGKWVLATLLKGKAILNNNYEFYQGAT
LGGDTDLRGYRNERFLGNSYFSQSSDLRFSIGKIQRTVAPLTYGILGGFDYGRIWLDGED
SKKWHQDYGGGLWLNAINVITARISYFQSPDEKGRVIFGAAYSF
>EGALAKHO_00404 hypothetical protein
MKKFLLLVASVFLLACQQQSDSDFKTLYSLPKKLKEVSGITYFPDSKLIYTLEDSGNKNA
IYSINQEGKLDKTITITNAKNVDWEDITKDKNGNIYIGDFGNNDNERKDLCIYKVNKNQL
NKDKASAEYKISFSYPEQTEFPPKKKEMFYDVEGFFEYQNYFYLFTKNRSKGFDGTAFIY
KIANKPGIQKAIKIGEFKTCNNYNHCVLTSATISPDGKKVVLLSHDKIVLFKGYKGDLFH
KGTQTEIKLNHFSQKEAIVFKDNNTLLIADEKTNKVGGNVYEFKLK
>EGALAKHO_00405 hypothetical protein
MSEPLMVLKKPSYPLTPSLLNYLERYERISKVSVFYDDLLRFAGSINVYDKNETDTLWIR
VYYSEFERNEIDLNLKKIYSLLHSDGNSEIIQFLNIDAIDYCTFGNSKPFRIKVRNILND
NYVHFYIKKADASRIYGLELEDILSPDKINFLVFKDTLIEEHIIGIPGDVFMDTLLDSCT
ETEKSQIAKEFVKFNERCMIRLLGDMRAYNYVIVPIHDFDQVVYKIRPIDFDQQCYEGNF
KVYRPQFFKENYPMIKLIKDKLEDRSIIQYKDEERAILAKRIHSAENRIKKLLNIMCHDT
ISTEEHLNQLKMELYRYTNDMKFKNAKSMGHIMFAAFEFITRNFKNTNLI
>EGALAKHO_00406 putative ABC transporter ATP-binding protein YxlF
METILTIENLSKRYGRIQALKNVSFEIQKGRVYGILGPNGSGKSTTLGIVLSVVNRTSGD
YRWFNGQMQTHEALKKVGAIIERPNFYPYMTAEENLKLVCKIKSINYAKINEKLDLVGLT
ERKDSKFSTFSLGMKQRLAIASALLNDPEILILDEPTNGLDPQGIHQIRDIIKKIASQGT
TILLASHLLDEVEKVCSHVIVLRKGEILYSGSVDEMSANEGFFEVQADDNLLLKTTLQEH
PSIDRIAEEDGKILVYLKSELSASELNQFLFSKNIALSHLVKRKNSLEAQFLELTKNATI
QKN
>EGALAKHO_00407 hypothetical protein
MNRLISIELQKIWKNKASRILTLTYFILLSFIALIASIKFDIGPFKFQAAEMGIFNFPFI
WHFNTYVAAWLKFFLAIVIVSMMANEYSYGTLKQNLIDGLSKKEFILSKFLTVVLFALCS
TVFVFVMSLILGLSFSSYDEYDVIFMNLDYLLAFFVKLTGFFSFCLFLGILVKRSAFALG
FLLVWSILEGIAKGLLVFKIFPDSTTGQTVMNFFPLEAMSNLIIEPFTRLSVIRSIGTQI
GVENTKDYGVHYLSILIVLVWTFLFVYFSYKLLKNRDL
>EGALAKHO_00408 hypothetical protein
MNYMKFFLIPLFICSLSVKVNAQNITVDDTKTAAELVKDVLINSSCINTETINASGNPGN
NGQSFAYFNSGSSGFPFSGGVVLSTSPSKNAAGPFNASTSVGSQNGSWKGDPDLNKALNY
DTSTQATVLEFDFVALTNSISFNYIFASNEYQTYFPCKFSDGFAFLIKEAGSSDNYKNLA
LLPNTTIPVSSTTVHTKINSVVINGDTYNGCDALNESYFNGYNTGNSPINYAGQTIVMNA
QIEVIPNKTYHLKLVIGDDTTRQFNSAVFIEAGSFTSKINFGKDRTTANSNPACMGENII
LNTQLDNNRYTFKWFKKNTANNFDQIQSQFGSTYEVKEAGDYKVEAVLNGTSCMSTGEIK
IEYAPEILSTNTLLLQCDDNTDGMSTFNLNKVDNIVKNNVSEITNKGYYESLVNAQSKTN
PILTPEKYTNKSPNQIVFARIENKYGCFKIAEVTLKISNTTISDQNPVAICDEDENQDGL
YQFDLGLQVTPQIVTGLPSGLAVNYFLNTNDALTEANPLPNIFKNTISFSQIIYARAVNG
SDCYDIVPITLVVNTFSPPNFEDETVHLCKGSEITLAVATGFNSYLWNNGSTENSIPVNI
AGDYYVKVTNTNGCQRTKKYKIILSEPATITNAIVKDFSANENSVLLEYTGAGNYEFSLD
GIFFQDQPLFTNVNPGIYNAVARDNNGCGLSNPYKVIVLDYPRFFTPNGDSYNDLWSIKN
MDQLPDYTISIFDRYGKLLKQMNQNSIGWTGLFNGQELPSDDYWFNLIFSDGRTVKGHFS
LKR
>EGALAKHO_00409 hypothetical protein
MNLVKISLLLFLFSNVFYGQNDCTDAIVVCGNSGFEGLEVNGYGKIQEFYSCSQSENNSV
WLKFSIKTGGNLGFIIKPDNTALFEDFDFFVFGPNATCNSLGSTIRCSTTNPLQAHLISN
QTGTNGSEEDVSEGPAEDGNGYVKWLNVKAGESYFLVVTRPIGKSSFSLKWTGDATFYTP
PTLNIPNINALNLEKADKEGTANQSLSFDLTKNNSTIIGGQADVEISYHTSSTEAIINSN
PITNPSQFKNIENPQIIYARISNTVSHCYNWTSFTIKVSDKINFPKTDYETCDDNDANLK
DGKTKINLNAITAYIFDNQNIDKLTINYFLTENDAKTNSNPILGSFINSIPFAQSIFAKA
STEGSSATIQEIKILVNTPPEIIKSTLVQCEIEANPDGLCVFNLNESNPIFTNNNPNITT
TYHITKDDALNNINQLSATYTNVSNPQLLYARNSNNKTGCSTINLLTLKVNAISETIYYL
NPVCDDDGNEDGFHLFDLTQAQIPYTATQNIKYYKNENDGLLEQNPIEDPTSYVNDIPYN
QFVYARIEEGNDCFGISKIKLEVNKLPNLKPNTTTNICESNPEYFATLDAGIIDYSTKDN
FSFVWTKDGVELPGKNFLKLDVNEAGTYEVVIKNNFNCIKTRTIEVVASDIAKITSIDII
DLLTGNSNKITINVIGKGDYEFSLNNPNGPFQESNTFENVASGIHDVYINDKKNCGLISK
TVAVIGAPKYFTPNYDGYHDYWNIDGLDSDTAKNAIIYIYDRYGKLLKQIQPTDLGWDGT
FADNPLPADDYWYTLKLEDNREAKGHFSLKR
>EGALAKHO_00410 GTP-binding protein TypA/BipA
MESIRNIAIIAHVDHGKTTLVDKIMYHCQLFRDNENTGDLILDNNDLERERGITITSKNV
SVQYKGTKINIIDTPGHADFGGEVERVLNMADGVCLLVDAFEGPMPQTRFVLQKAIDLGL
KPCVVINKVDKENCTPEEVHEKVFDLMFELGAEEWQLDFPTVYGSAKNNWMSDHWENVTD
NVEALLDMVVENVPAPKVSEGTPQMLITSLDFSAFTGRIAIGRLERGVLKEGMPISLVKR
DGTVSKSRIKELHTFEGLGRKKVQEVIAGDICAIIGVEGFEIGDTIADFENPEGLKTIDI
DEPTMSMLFTINDSPFFGKEGKFVTSRHIRERLTKELEKNLAMKLGETDSADKFMVFGRG
VLHLSVLIETMRREGYELQIGQPQVIIKEIDGKKCEPIEELTIDLPESLSGRAVEFVTMR
KGEMLSMETKGERMIVKFNIPSRGIIGLRNQLLTATAGEAIMAHRFIGYEPYKGEIAGRN
KGSLISMEKGKAIPYSIDKLQDRGKFFVEPNAEIYEGQVIGENSRGDDMCVNVTKEKKQS
NVRSSGNDEKARIIPPIIFSLEEALEYIQKDEYVEVTPKSIRLRKIYLTETERKRFKI
>EGALAKHO_00411 Cell-division control histidine kinase PdhS
MKSKTLQITLIYIIISLFMAIICHKLLTNYFSSTENYNLFLIKDIFFILATGLVFKYILS
KNEIKNKSVFEKLKQTNEEIKESNEKYDIVAKATSDTIWDWKIQEDSISWNRGIEGIFGY
NQEEVGKTSKWWFDKIHPEDSIRMSIKLYSFIEQKTEKWQDQYRFRCADGTYKYVLDRGF
LLKDEKGRAIRMIGAIQDITKQKEEEQRLKLLETVITQSKDSILITEANSAVRKIPKIVY
VNPAFSQMSGYQSNEIIGKSPNIFKGPKSDSDELKKLLRAIKNEEECLIETISYTKQKEE
YWVRFSMIPIFNNEGVISHWISIQRDITDEKKLETEKEHLIRELTQNNKDLKQFSYITSH
NLRAPLSNLIGLLNLIEDIPFDNPELEEILTGFTKSTHLLNETINDLVKVIIIKDNPSMQ
KEEVSLKEVFENVFSQLSFQIELHKPIIKLKFDRVPLLNTNKAYIESILLNLLTNSIKYK
SENRKLKISIMAEQIDHKAILTFKDNGIGIDLERNRDKVFGLYQRFHNYPDSKGLGLYLV
KSQVETMGGTISIDSEVNKGTTFTITFKN
>EGALAKHO_00412 putative response regulatory protein
MLEQILCIDDDPITLMLCKKVISKSEFSNEIITAQNGEEALLHFNTLKYTNNKNKVNKKP
ELIFLDLNMPVMGGWEFLDHFTSGDYAEFNTANVIVLSSTIDPEDLAKAKKYPIIIDFLS
KPITQPMLEYLKKKIDL
>EGALAKHO_00413 30S ribosomal protein S20
MANHKSALKRIRSNEKRRVLNRYQHKTTRNAIKALRLATEKSDAASKLSTVISMIDKLAK
KNIIHDNKASNLKSKLTKHVAKL
>EGALAKHO_00417 Proline--tRNA ligase
MSKNLTTRSEDYSKWYNELVVKADLAENSGVRGCMVIKPYGYAIWEKMQAELDRMFKETG
HQNAYFPLFVPKSMFEAEEKNAEGFAKECAIVTHYRLKNDPDKPGKLMVDPNAKLEEELI
VRPTSEAIIWSTYKGWVQSYRDLPLLINQWANVVRWEMRTRLFLRTAEFLWQEGHTAHAT
KAEALEESEKMMNVYADFAENFMAIPVVKGIKTETERFAGADETYCIEALMQDGKALQAG
TSHFLGQNFAKAFDVKFANAEGKQEHVWGTSWGVSTRLMGALVMTHSDDQGLVLPPNLAP
IQVVIVPIYKTDEQLAEITTAVNDLTVKLRKLKISVKYDDRTTQKPGFKFAEWELKGVPV
RIAVGPKDLENGTFEVARRDTLTKETVSGEGIVTYINDLLEQIQADLFNKALDYRNTHIT
EVNSFEEFKEVLDGKAGFVSAHWDGTAATEEKIKDLTKATIRCIPLDSKEEAGTCVFTGN
PSAKRVLFAKAY
>EGALAKHO_00418 hypothetical protein
MKTSTSLRQNSSHFYLIGLLSFLVASCGSYQNSSYQDNDGVYGGSTRTYVQSTNANSQYK
DYFKSLQDTDDQPTEIFTDVDNYGNYTQNDSTQTSSVAYPGWGSATSDVSVNVYSDPTWS
FGIGFGWGYPYYGYGYGYGWGYPYYGWGYPGYYPGWGYPGYYPGYGYGYNNYNYSYGRRG
SAAYYGSRGYATRGSSYANRNYAGRGNYTTNRNSYTNRNSNYSDFRRSSNVNGRSYSSPT
FTNRRSTAQGQNNYNYSNRASSSTNRSYNNTNSNSSRSYTPSSSSRSMNSGGGSMRSSGG
GGGGGRSYGGGGGGGRR
>EGALAKHO_00419 hypothetical protein
MKKILFLFITGLTFSVSHSQEVSDAVRYAQDNLTGTARFRAMGGAFGAVGGDLSALTVNP
AGSAIFTNNQVGITFSNQIIKNNSNYFGTQTSDKENSFILNQAGGVFVFNDRNPNNNWKK
IAIGATYENTNNFNNEVFSAGTNPTNSIDQYFVTYANGIPLNVIADIPYKDLFYDEQQAY
FGYKGYVINPVSNTSDNTQYTSNVPAGGNYYHENEVYTSGYNSKLSFNIATSYKDKIYFG
ANLNVHVTDYRRSSSFYEDNNNPLEPTETISNLRFNNNLYTYGNGFSFQLGAIGKVTEAF
RLGIAYESNTWYELYDEVAQSLSTTRQADGGESIYESINPNVVNVYERYTLQTPAKWTFS
GAYVFGKSGLISVDYAIKDYSNTKYKPTSDPGFNGLNNDINNQLTSNGELRIGAEYKINR
LSLRGGYRFEGSPYKNGSTIGDLNSYSGGLGYSFGATKLDLAYSYLERKSNQGFFATGFT
DGANISSKLNNVSLTLLFEL
>EGALAKHO_00420 Ribosomal protein S12 methylthiotransferase RimO
MRTKSLKKNKINVITLGCSKNVYDSEVLMGQLRANGKEVQHEAPAAEEGNIIVINTCGFI
DNAKAESVNMILEYADKKDKGLVDKVFVTGCLSERYRPDLEKEIPNVDQYFGTTELPQLL
KALGADYKHELLGERLTTTPKNYAYLKIAEGCDRPCSFCAIPLMRGKHVSQSIEKLVKET
EGLAKNGVKELILIAQDLTYYGLDIYKKRNLAELLEALVKVEGIEWIRLHYAFPTGFPMD
VLEVMKREPKICNYIDIPLQHISDSILKSMRRGTTQAKTTQLLKDFRAAVPGMAIRTTLI
VGYPGETQEDFEILKDFVQEMKFDRMGCFAYSHEENTHAYLLEDDVPDDVKQARANEIME
LQSQISWDLNQEKVGQVYKCIIDRKEGAHFVGRTEFDSPDVDNEVLIDASKHYVKTGEFV
NIRIIEATEFDLYGEPA
>EGALAKHO_00421 hypothetical protein
MKPTHTLFILIFTLICFNSVSAQYGNGYNNGYGGGGYGRGGGMGMDRSMMAGPQANTSKP
KEIPAEETAAKIVEQMKPAVNLDELQAIAITNVIADSMREQGVLLKNENSSQDVKIEQMT
ALRESLTKKITAFLNPDQVEKYTAFMANFKEIKKTKTKKKKDSDTKETKEVKEETEATKI
HE
>EGALAKHO_00422 N-acetylmuramoyl-L-alanine amidase AmiD
MAKRHFYYLILAIIITSCSTNPYKTTEKAYDQQLKTLENQITSKEAKPIPAVSPVVIDTS
YASQLGIVKDTLSKTGSTALLNGINTEWIGTVNFNLRKPSFIILHHTAQDSVQQTIKTFT
LTKTQVSAHYVISENGKVVQMLNDYLRAWHAGASTWGKNTDLNSSSIGIELDNNGFKPFT
EAQISSLVALLTKLKKDYNIPTQNILGHSDIAPGRKQDPSALFPWKTLAEKGFGIWPDEV
LEEAPFDFKIEQALRIIGYNTKNLSAAIQAFKLHYIQTDTTPVLDRKTIDTIYSIYKKQL
Q
>EGALAKHO_00423 hypothetical protein
MKKVLHILTVMLTSSFAFAQDEAPASPATTWGGSADAYYKYDFSKQMNGLTSFTNSQNSF
ELGMASIQAGHTFGKASVFVDLGFGKRAGEFSYNETTDKDINAKFLIKQLYFTYQVTDEF
KFVAGSFGTHIGYEVVDAIGNKNYSMSYAFSYGPFFNTGVKAQYTSGKFTAMFGVTNPTD
FKSAMDAGSTQKTFIGQLGYIGETGSAYLNFTSGSANPAFDENKTQFDLVASKTLSDSFA
LGFNATYAKTTNDFDSTLDGDWFSLVGYLNYSFNPSLLLAYRMEYFDAKDAAPSLGTLTG
SNVFANTVSLNYKVGKLTIIPELRYDAASEDIFLDSDANPTGGSFFGLIATTYSF
>EGALAKHO_00424 hypothetical protein
MHLKNKTPYKNQGYNQINKTKQHNTYILAQAKKNHFTNKKFLQKLVSKNSHISFKHSICF
LNQKQKVLQLK
>EGALAKHO_00425 Endoglucanase 5A
MKSKAIFFTIILLFIFDASKAQFVKHHGRLHVQGTQLTDQNNNPIMLRGMSFGWHSMWPR
FYNEKAVQWLKKDFKCNIVRAAMGIELGKMSYIKEQEFSKERIEAVVNGAIKSDIYVIID
WHSHNINLKEATDFFNEISKKYAKYPNIIYEIFNEPDQESWQEVKAYAEEVIKVIRKNDP
DNIILVGSPHWDQDVNLPAADPIKGYDNIMYTMHFYAATHGKELRDRTDDAMKNGLPIFI
SECAGMEASGDGPLNMKAWQEYIDWMEDRKLSWVTWSVSDKEETCSILKKSAKSEGNWKE
EDLKESGVKVREFLRKYNKQE
>EGALAKHO_00426 Alpha-galactosidase A
MKKIILAIVLSISSFGFSQGNTHTQKAGKFEGLAMTPPMGWNSWNTFETNIDEKLVKETA
DIMVSSGMAAAGYNYIVLDDGWMTKERDANGDLVPDPIKFPNGMKAVIDYVHTKGLKFGL
YNCAGTQTCAGYPGTRGYEYQDARFYAKLGIDFLKYDWCNTQGITAKEAYTTMSNALKTA
GKSIVFSLCEWGDNQPWEWGKPVGNLWRISGDIYPCFDCEYKHEEGNWSSWGFMKIIEMR
KDIRKYSGPDHWNDFDMMEVGDGMTNTEDKSHFAMWCMMASPLIAGNDFRKMSKETLAIL
TNKELIAVNQDKLGIQGFKYSAEDGLEIWVKPLSDGNWAISFLNRSDVAKKINFDWKKHI
IKDADFGYEADFNKTVFKLQDLWKNKEAGNTKKNFISDIASHDVITLRLIP
>EGALAKHO_00427 IPT/TIG domain-containing protein
MKNIKIVSLTACMTWVLSLMLFSSCSNDDSASAYTGGPVIESVMPSGYNQDGSLKPLTPT
TLVDPKNYYVIHGKGLLGTTKVYFNDFDTYFRPTFVTDTDIIVLVDEKTPYANASNQLKV
VTSKGTAVFNLTVAPPIPTFNWFNSINAAEGDVVTINGDYFLNPIVKVGTQNATVISSTL
TEVKFKMPANTLDKYISVANISGATVSNVAVGSALYDDVLQGDAGHWMWNGTDVFDTNYK
TDKTQGDSSIRFVFGGWGGADMKFNSRDVSKYKAFRVKVRSISANTDAKITFVFGGWAYQ
IQKSIASTWTTIEIPFSDIGNPTTFDQLTLQESGNFGGNTILMDDMGFVLK
>EGALAKHO_00428 SusD-like protein
MKNIIKRSGAVAMTLVMLMSASCSQDFLDVPAEGTPTIGNYYDSDVKLDNASNGLYGLVW
FNMNKSAFYGITDVISGNMYADIYNDFGKFTDLSFTNTQSFISDAWRSCYGAVANSNAYI
SNLPQSVGPNVSKEALNNALGESHFIRAFSYFFLVRLFGNVPIIENNADYSQNFVIPSNP
TEDVYKFIENDLKFAIANLRTKNRGSDYAANAHVSSGSAKALLAKVYLYEKKYDLARQMA
QEVINSGEFKLLGGDELPTKSFADLWLQKNNNNEESIFSWQWNGAGTYFDGNFSNTLFAP
ENRLVETTYSGQIAPSQDLIKNVYENGDKRRIETFMLPGDYYPNLTYAQTLAVDSPKLLG
YTFDIQYEAQKSGAGLKKYVIGKENLPITGPFNPPFNGESSMNSYMMRYADLLLIHAEAI
LGSQSGSTSDPNALKSFNAVRKRAGVSQKASISFDDIFKERRAELACEGDYYFDLGRLPF
AKAKAILEAQNRGNREVEKHISITATNLLLPYPSDDLIKNPKLTEVAPYTFK
>EGALAKHO_00429 TonB-dependent receptor SusC
MTNFIHWNANHKAIPLILFLLLSNFISAQVKISGTVADEKGLSIPGANITVVGLKTTVST
DFDGKYTIDVPANATLVFSFIGFDTQKIAVEGKKTINVVLKSNVEDLKDVVVIGYGTQKR
KDVNSAISSISSKDIENLKVASFDQMMQGKAAGVVVNSNSGEPGSNVSVRIRGVSSLTGT
NEPLYVIDGVPISGDARNSSTSGRNAQGNSNFSNNGNITQSPLALINPSDIESIDILKDA
SATAIYGSRGANGVVIVTTKSGKKGTGKLTFENSYSISNLPKKLPSMNLQQYAAHQNALS
DVYDPLSKRPEFAHPELLGNGTDWQDAIYETGIMKSNQLSFSGGKDGISYYISGGVLNQD
GIVIESGFKRYNVRSNIDARVNKFIKVGVNISGALTDEKLTLNGQFNGVVATSLLATPDV
AVRELSGAFAGPPSGGNTSFVNPVATSLLGSNTLVRKNYSGNFYTQIDIVKGLEYRFEAG
GYMYDNLGERFDPMYSLGNAVKSFANLYYSPSSGNSWNLKNMLTYRKSIGKHNFTVLAVQ
ESNRAHWEGYTITGEGYKDNNDKSLAASDLPKAVTSGVYSGTQTLASYLGRVVYDFGDRY
SVSAAVRTDGSSKFFVGNKWGVFSSASGSWKLSNESFMEDTKKYVDGIKLRFGWGQTGNN
QIGNNLYDSNLHLVNSSMGTSYLPSNTPNKDLKWETQDQTNLGLDFNMFKAKLTASIDVY
KKVSKNFLYQVPLPNYLSGGGDYEGGVNPPYFNLGNMENKGIEVTLGYTENFTENFSWNS
SLNITKYVNKVTDMAGLNIVRTMGTLAYNTVTVSRTMEGLPIGSFLGYEALGIYRTDEDL
TNYGHTTTGGTKVVLKNGTNSLKPDFQKGDVIYKDINNDGIIDQNDLKAIGNPNPKFTYG
FTNNFKYKNVDLSIFLQGTAGNKLMNLTRLSGTLNSGTGTNYLTEAADFYSASNLDGALP
RPSTYDNINNAVSSRIIEDGSYLRIQNVTLGYSLPSDMISKLSLTRLRIYASGQNLYTFT
KYKGYDPEVGAYNQDALLSGVDNGRYPVPRQITFGFNVEF
>EGALAKHO_00430 HTH-type transcriptional activator Btr
MSSAKNFYREIAPLSTGDSFLVFDRVKDSFDFPVHYHPEFEINFILNGKGVKRVVGDNIE
EIDNVELVLIGPNLYHGWELNKCTSKKIHEITIQFHNDLFHESLLSRRIMNPIRDMFNRS
IHGILFSKKVADELTPRLVRLSKLDGMDYFLEITSLLYDLANSRNQRLLSTYTVDYDTFE
DYDKMKVVYEYVQKHFAEKITLEDVANVASMSIISFNRFIKKRTGKTFVNYINDIRIGYA
ARWLVEKDMSVSEVAFKSGFNNIANFNRSFKAIKNCTPSQYREDFSGLKRIL
>EGALAKHO_00431 Mannan endo-1,4-beta-mannosidase
MKKNIQILIITVLLGTSCSSKTIISNTNLSLSDKKATPETVSLYKKLNQLVHKGYLFGHQ
DDLAYGVNWKYEKDRSDIKDVVGDYPAVYGWDLAGLEKDSPNNIDGIPFTKMKQFIEEGH
ARGGIITMSWHFDNPATGKSAWDNTPNAVKTVLPGGENHQKFTIWLDKAANYLLSLKDKK
GKNIPVLFRPYHELTGGWFWWGKGNCTPEEFKSLWKFTIEYLQKKGVHNLIYIYNTSSFN
SKEDFLANYPGDNYADILSFDSYQNNDDKEGKKFIEEVQNQLKIVNEIGNEKHKLIAVAE
AGYEAIPDPKWWTGTLNKAIGDYKISYVLLWRNHGWQEKEQKMHYYAPFSGQVSEKDFVD
FYNLDKTLFEKDINKN
>EGALAKHO_00432 Inner membrane symporter YicJ
MHDKISLKEKVGYGLGDAASSMFWKIFSMYLLFFYTDVFGLAPAVVGTMFLITRIWDSCF
DPIVGIIADRTKSKWGKFRPYLLWVAIPFAVIGVLTFYTPDFDEKGKIIYAYVTYSLMMM
IYSLINVPYASLLGVMSSDRKERTTLSSYRMVFAFGGSLLALWLIEPLVNYFGGSLNSKS
GWLTTIAVFGVITTAFFWGCFFFTKERVKPIAGEQSNLKEDLRDLLKNKPWWILLGAGIG
ALVFNSIRDGAAVYYFKYYVSSSINFDFTLFGTDFHMTPTSIYLVLGQTANIIGVIIATP
IANKIGKKKTFFGAMALAAILSIIFYFFGKEDVFLIMTFQVLISICAGCVFPLIWSMYAD
SADYSEWKQGRRATGLVFSASSMSQKFGWTIGGAGAGWLLGYYGFQANVEQTAVAQNGIQ
LMLSILPAIAAILSVAFILFYPLSEEKLQIIEQDLNDKRDQTN
>EGALAKHO_00433 4-O-beta-D-mannosyl-D-glucose phosphorylase
MTTIASSTTFQDRKAVLEKEHKTLTEQKNAPQDSAGNGIYERYKNPVVTAAHVPLNWRFD
LNEKTNPFLQERIGMNAAFNAGAMKWNGKYLLAVRVEGIDRKSFFAIAESPNGVDNFKFW
DKPCVIPQTAEPDTNVYDMRLINHEDGWVYGIFCTERKDPKAPKGDTSSAVANAGIVRSK
DLVNWERLPDLISNTGQQRNVVLHPEFVNGKYALYTRPQDGFIDVGAGGGIGLGYVDDMT
NPIVKDEKIIFGKQYHTIYELKNGLGPAPIKTDKGWLHLAHGVRNTAAGLRYTLYMFMTD
LNDITKVTHVPAGHFMGPEGIERVGDVSNVLFSNGWIEDTDGTVYVYYASSDTRMHVAVS
SVAKLVDYVTNTPADTFISAGSVETIINQIEKNNAI
>EGALAKHO_00434 Cellobiose 2-epimerase
MSKLKELKSELTTELNSILKYWSKHTLDNHNGGFIGQIDFNDHLIATSEKGSVLNARILW
SFSASYQITKNEEHKKLATRAFEFLSKYFYDSEFGGLFWSINADKTPKDTKNQIYALAFA
IYGLSEYYIISKDEKALEIAINLYLQIERHSYDSINGGYLEAFTRDWKPIADLRLSEKDA
NEKKTMNTHLHIVEAYANLFKVWKDKKLQNSITELLETIEKHFINTETGHLRLFFNEDWI
EKPDVISYGHDIEAAWLLLQCAEISEDENLIANYKKHAIHMAEVTQEGLDADGGLWYELD
PKNNELIAEKHWWVQAEALIGFYNAYQLTGDERYLNIVLRNWNFTKQYILDKENGEWFWG
VYRDYSLIEKDKAGFWKCPYHNSRACLELIQRIKD
>EGALAKHO_00435 Mannan endo-1,4-beta-mannosidase
MKKNLLNILFISLSMLAISGCSSNDESDPEVVVDPPVIVDTDPLTTSNAATYLVDANATK
ETVALFYNLKKMAKTKIAIGQQDAFNSFYQDAGGDSDIKKNTGYDPAILGSDFMFITDKS
NNNQVDNWFYQQEQKIVSDAKSAYAKGIINTFCWHLREPNKEETFNTSEMTSEQKTTAFK
SILPGGANHEWYKKKLDKVASVVSNLKGTNGELIPIIFRPFHEFDGSWFWWGASFCTPDE
YKTAYQFTVDYLKNTKGVHNILYAFSPDNSYLTQADYLSRYPGDKYVDILGMDNYGDFDN
QGSTGASRANSKLKTISDLAKTKVKIAAMTETGYQVTSTKSPITGWFSNYLYSALTSNNI
EVSYVLFWNNTKDGYWVPNGTVSNAADFKTFSSQTKSALVNSLPKMYEMPK
>EGALAKHO_00436 hypothetical protein
MKNTFLKTLGLALIFSSMACQSQERITVKGTQFYKGDKPYAYIGTNYWYGSLLASKKIGD
RKRLLRELDLMQKNGIDNLRVLVGGDGGKYDFTVRPALQYEQGKYDEDLLDGLDFLMNEM
RKRKMYAVLYLTNNWEWSGGMSQYLEWNGKGPVPVPGIAPNTWPQFMTYTEQFHSCEPCM
QALENHVKFIMGRTNAYSHKKYTDDNTIMAWQVGNEPRTFTPENETKFTVWLNNIVNLMD
SLDKNHLISTGSEGLNSSNDDIGIFERTHQNPNIDYLTMHIWPKNWNWFKADDAEKTLPT
TLENAGKYIDKHVAVANHLKRPIIIEEFGLGRENESLLPAASVVNRDIFYNYIFGRVSES
VKNNGPLQAANFWGFGGEGKAINESGKWSPGDPLTTDPPQEPQGLNSVFSSDKSTLAIVK
KYNAQLKKK
>EGALAKHO_00437 Retaining alpha-galactosidase
MNLYDLYGLKNIPIMKNLFVFFFLLMLNLSFSQKKQDFVLTSPNGKIEIKILVNDKISWS
ILHEKDLILAPSEMSMTLDKNVVLGKNPVVLNSKKESLDASFDSPFYKKKSVQNKYNHLT
INFKNDFSIEYRAFDDGVAYRFLTKKKKDITIKDEEVVLNFDQDYNTLMPYVRDLRNPKD
PYISSFESHYETKKVSEFAKDTLAFLPFLIDYKNHKKAVFLEANVEDYPGLFVTNNSSKS
GFESRFSKYPLKETNGGFNYLNKLITERADYLVKTKGTRNFPWRIIVISENDAQLANNDM
VQKLSEPSKIKDISWIKPGKVAWDWWNDWNIYNVDFKAGINTQTYKYYIDFASKNKVEYV
VLDEGWSVETDIMKHNPNVDLEALIAYAKERNVGIILWSSWMALHENIDGIFYNYSKLGI
KGFKVDFIDRDDAKMLNSVYTIAEKASKYKLLLDFHGMYKPTGIQRTYPNILNFEGVKGL
ENNKWTPNDNVPLYDCTIPFIRMMAGPMDYTPGAMRNATKSEFKPSHSNPMSQGTRCHQL
ALYTIFEAPLQMMADSPTAYMKEQESTDFIAMIPTTFDETVALDSEVAKFVTITRRKANT
WYLGAITNWDSREITIDFSFLEKGKKFQAEIFSDGLNADKSAVDYKREIITVDSTTKLKY
RLASGGGLAMIIK
>EGALAKHO_00438 L-glyceraldehyde 3-phosphate reductase
MKYNRCGKSGLLLPEISLGLWHNFGSVDNFDNAESIAVEAFDKGITHFDLANNYGPVPGS
AETNFGKILWHNFQGNLRDEIIISTKAGYTMWDGPYGDWGSRKYLLSSLDQSLKRMKVDY
VDIFYSHRPDPETPIEETMMALDYAVRSGKALYVGISNYSAEQTRVAVDVLKQLGTPCLI
HQAKYSMLERWVENGLLYVLEEKGVGCIAFSPLAQGLLTDKYLNGIPENSRAHNPNGHLK
ENEVTAERIEKLVQLNEIAKNRNQSLAQLALAWLQKDKRITSVLIGASSVKQLCNNIDCL
QNTEFTTDELNAIEKILS
>EGALAKHO_00439 Beta-glucosidase BoGH3B
MKNKKLLIIGVFALFTGNMNAQKKPYLDKTKTIEERIDLLLPLMTLEEKVGQMNQYNGFW
DVTGPAPKGGTAELKYEHLRKGWVGSMLTVRGVKEVRAVQKIAVEETRLGIPLIIGFDVI
HGYKTLGPIPLAEAASWDLEAIKKSAAIAADEASASGINWTFGPNVDVANDARWGRVMEG
SGEDPYLGSKIGYARVKGFQGETIADLAKVNTIAACAKHFAAYGYVEAGLEYNIVDISNS
KLYNSVLPPFEATVEAGVRTFMNSFNTLNGVPATGNAFLQRDILKGKWKFDGFVISDYAS
IREMIAHGYAKDEADATAKAVNAGSDMDMESYLYVAKLTGLVKEGKVKEALVDDAVRRIL
RVKFELGLFDDPYRYCDEKREKATIGNKANNDGVLDMAKKSIVLLKNACPPGRNENLLPL
KKSGQKIALIGALANDKNSPLGSWRIAADDNSAVSVLEGMQQYKDNQLTFEKGVDLLSQK
ATFLTETVFNTTDKSGFDAAKTAAKNADVVVMVLGEYGFQSGEGRSRTDLNLPGLQQELL
EEIYKVNPNVVLVLNNGRPLSIPWAAENVPAIVEAWHLGTQTGNAVAQVLYGDYNPSGKL
PMSFPRNVGQVPIYYNKYSTGRPIDSDKNVFWSHYMDVEKTPQFPFGFGLSYTKFDYKNL
KVNKTSYAKGEKVQVTVEVTNSGNYDGKEVVQLYIHDEFASIIRPIKELKGFELVNLKKG
ETKTVTFTLTDKELGFYDNEGNYLVEEGTFKIMVGGSSDKGLESGFEIKG
>EGALAKHO_00440 hypothetical protein
MKNNIFKFVFFLMISSTMMANVSLPNIFGDNMVLQRNSEVKIWGWANPKEEIKLVSSWNN
KEYKVIANNQAQWELHIKTPEAGGPYTISIKGYNEVILKNILIGEVWVCAGQSNMEMSAS
WGIDNGEEEMKNATNPNIRFFTVPKLTATTPQNNLLGNWTESTPETMKNFSAIGYFFAKR
LREDLKNVPIGLISSNWGGTPAEIWMPEEVVQNDAVLLENAKKLNEQEYGPRQPGRAYNA
MIYPLVGFKIAGTLWYQGESNVGSLVYDKTLSALISSWRKAWQDEFSFYFVQIAPYKTGS
NNFSNVTVRNSQRKILNEVPKTGMVLTSDISDTIDIHPKNKKSVGVRLANLALADTYPEA
SGLNSNLVNGPLFKDIKIEKNKAIVSFNYADGLHFKNKSSNQFELAGADKVFYPAEASIK
NNEVILTSKKVPNPAKVRFAWGNTIQADLFNKANLPASCFITE
>EGALAKHO_00441 Acetylxylan esterase / glucomannan deacetylase
MFIKKIPFLILFLLISTVSISQNKKTFLYEGRIEKLQNDNVILIGTASSVSFNFSGNECS
IKLQSVDSYEHHNYVALVLDGKYIGKIKIEKGDVQSFPIKVTSNKKEHRLEIYKNTEAHS
GGILFAGTTAKLTSISSKKKKKIEFIGDSITCAAASDSVDCDKGEYMDHHNGYYAYGPVL
SREIDVDYLVSSVSGIGMYRNWNDENKDEAIMPDVYQNLYLTKDNSKPKYDFAFQPNIIS
IAIGTNDFSGGDGKKERLPFNPEKYVSNYINFIKMLYEHNPKAQIVITNSPMVGGERGIV
FEDCLNKVKAAFTKDKTHKEIKIFKFKPMTPKGCLGHPDVADQKVMADQYAPFLKKLLNE
K
>EGALAKHO_00442 Gamma-DL-glutamyl hydrolase
MKSSFYISIISTVVLCSCFTSKEETKTETFQIRKTATNIERDSIISYAKQYLGTPYVYAG
SDPKTGFDCSGFISYVYHHFDVDLPRSSGSYKNLGKALNPEDFKVGDILVFYGYKDHTVI
GHLGIICEANGMQSKFIHASSGKVNSVTITSLDTEHYTNRFYKCIDVLSK
>EGALAKHO_00443 hypothetical protein
MKIFYSPVVVIVLFLVFSCNSKSEKKEEDLKKTSEKVVPELKLHIDSVAVSKFYEAYPKL
VKFQSEILALYKKKNSTQLWLDNKGVVEFGNTLFNKYKGLEAEGLKANFPYNEKINPIFE
SAVDNKLSKVDTDLMISNLYFYYVQKVSGVDEKTTKSLEWLLPRKKVNYQVFSDSIHEKA
TISDDKKSKMFSQYYKLRDALHQYREIEKKGGWKNIEVGEDFKNFKIGDSVDAIGKIRER
LYITGDLKENDKSNVCDTTLIKAIKNYELHHGLTPKNIITTEHIAELNIPVSDRIKTIIA
NMERCRWIDPQLEKGKEYIEVNIPEFRLYLIRDHEIVFVSPVVVGKAMTKTVIFSGMMNN
IVFSPYWNVPTSIINKEIKPGMAKNKNYLAQKNLEWNNGAVRQVPGKNNSLGLVKFLFPN
SNNIYLHDTPAKSLFERENRAFSHGCVRVGKPRELAIELLKQDPTWTPARIDKAMHAGKE
NWVSLKKKVPVYIGYFTAWVDRKGELNFYKDVYKRDESLIKLLTEE
>EGALAKHO_00444 hypothetical protein
MKIIKISMLALALGLMSFSAIVPAKVIASKIEATASTIAWKIETIDVGQIPQGTPKAIVY
EFKNTGKTAVVITNVQGSCGCTATDYTKEPILPGKTAKVTATYNAANKGAFTKTVTVTTS
AETTPKILTLKGTVI
>EGALAKHO_00445 Sensor histidine kinase WalK
MKINKLNSIILLGLIAIISILVAQLLWTKEAFTLEQKKLSQKANIALLEVARKLYDGKDH
EPSCQNPVRKISNDYYIVNIENAFEPDILEFYLRSEFKKMHITTDFEYAVYNCQSDEMVY
GKYISLSEKEKDKKAVSFPKHKDLVYYFAVRFPNETTYLFSSMRFWFILSIALILILLIY
VYSIFTLLQQKKYSELQRDFINNMTHEFKTPLSSILIASKYLIEQAPIKEDKKLHTYTDI
IINQSNKLNNHIEQILNISKADYSPLELKKESLLIIPILEETIENIQMKYPEATIKIDSN
SVEYYIETDVFHFSNLVYNLLDNAVKYCSEKPDITIRISLENQILKIAFIDNGIGISPKN
ISLIFDKFYRAQNEKSNEVNGFGLGLYYVKEICNIQNWKIKAENNLEKGITITLSIPYKK
>EGALAKHO_00446 Response regulator ArlR
MKQFRILYTEDDETLAFLTKDNLEQNNYEVIHCPDGKLGLETFKKENFDICIFDIMMPKM
DGFELATEIRKANTDIPIIFLSAKTLKEDRIKGLRLGADDYLVKPFSIEELLLKIEIFLK
RSQKNIPVEKAVYEIGKYQFDTKNFILFNESEKIGLTQREAELLKLFLDNKNSVLKREQI
LTSLWGTDDYFMGRSLDVFISRLRKILANENGISIENLHGIGFRFSIV
>EGALAKHO_00447 hypothetical protein
MKLHHLRNATLVIETEQHVILVDPMLGKRKTIPPFTIFRYNPHRNPLVSLPKNSREILSK
VTHCLITHLHPDHIDKAGEVFLRRKSIPVICSVQIEKELTKRGLNITQTLNYWEPQPFLD
GKITGIPAIHGYGFIAKFMGNVMGFFIELANEKSIYVSSDTIFTEHVQKVLVEFKPDIST
VACGTARLDIGQPLLMRMNDILKFTALAPGKVFANHLEALNHCPTTREQLKNALLENDLL
SKTAVPADGTFVEY
>EGALAKHO_00448 hypothetical protein
MDNFLRKINLIKDITIQLPISKTEFIQKFRNNVDESDLSYVPFEVFQSSKNEYKGYIGNN
IFELKKRKKIFDTNYSFAKVIGELTQENNELTIDVEIFGFRKRMLIFAVFILLFYLIFFV
GAISNSSDFPFFMFPFLLIHMSIMLIIPYFVIKRSVNRMAYDLERDFHYWVTKN
>EGALAKHO_00449 hypothetical protein
MKTKLFIITPPFTQLNTPYPATAYIKGFLNTKNIESAQADLGIDVILELFSKKGLKDLFQ
VSGFRFASPVRLSVSGEVVGNEISDNSKRIFALQDEYIKTIDAVIQFLQGKNPTLALQIC
QEDFLPEASRFAQLEELDWAFGTMGTQDKAKHLATLYLEDISDYIVECVDENFGFSRYAE
RLGRSANSFDELYEALQQKPTYIDSILISLLKAKIEAINPTLFLISVPFPGNLYSAFRCA
QWVKQNHPEIKISMGGGFPNTELRSLSDKRVFDFFDFITLDDGEVPIEELIFNLENPNSD
SYKRTFLLENGEVVYKNNSLKHDYKQAQVGTPDYSDLPLDKYISVIEIVNPMHRMWSDGR
WNKLTMAHGCYWGKCTFCDISLDYIKVYEPVAANLLCDRMEEMMLQTGQNGFHFVDEAAP
PALMRALALEILRRKLAVTWWTNIRFEKSFSKDLCLLLKASGCIAVSGGLEVASDRLLKL
IDKGVTVEQVAKVTRNFTEAGIMVHAYLMYGYPTQTIQETIDSLEMVRQLFEAGILQSGF
WHQFAMTAHSPVGLYPEKFGVTKATEAIGTFANNDIDYTDSTGINHDKFSFGLKKSLFNF
MHGICFDYELQDWFDFKIPKTKIDPDFIFNALEEGNDFNTKPNAKVVWLGGKPSVEHFTK
SKKGNSWEMMNFTFHDKKESFNLQTNKNEGEWLVEILSKIAISNAKHYTFQEVKTDFETE
LDDFELFWYSKPVNTLREFGLLVL
>EGALAKHO_00450 hypothetical protein
MKHKLLLLFFIISIQLFSQNKNQTIGFKENKGQIVDQKGKPNTDVKYLLNSNGLNVQLKK
NGFSYDVYEVKKTAIVRSVTSKTLPYQIPEKDKETKPEYNLEYIFHRIDIDFVNCHSKVE
LITEEKSSDFDNYYNVPNKPEGITNVYQYKQITYKNIYPNIDVVFSIPNDPQKVVEYNFV
IHPKGKISDIQLKFDGAETDLVDNKIQMNVRFGKMEETLPASWVEDGSSKKEIAVGYRKI
KKNVYGFDSSDDVFDKTLIIDPVPIRLWGTYYAGNNSEFSTDICNDINNNVYFSGYTWST
TNIATSGSYIEYYMAHFYGNGFVAKFDTNGVRLWGIYYAAVPTAIKIDTNENLYFTGSVD
AGSDTDNSMIATPGSHQAESKGYYTNAYLVKLNSSGTRQWSTFYGGDYLNIGYDIALDAQ
NNVYLVGMTMSSTNIASTNAHQLTHADDYYGDDGFIAKFTPQGVRVWGTYYGGERDERIL
SANISDDGFLYVTGRTSSTVGISTTNNLVGVVSGMISKFNLDGQQIWGRYFNGSTFSLID
KSTIKGQFLYFIGTTNDHNNLNSTNTFNESFIDLPMNFGTSSYIAKFDVSTQNLVWGTYF
GEIIQDIAVNSKNKIIIEGCTSLQSGIATPGTYSTTPQYGDAYMIKLDENGQREWGTYYG
GNANEGINGAADVNNKISLDRLNNIYLVGNTQSTLGISTPGAHQENYSLNSVGGLYNVYL
AKFQDCLSNPTVTSNSPVCIGKTLELKASGGTNYLWTGPNGFTSTDQNPTIINAKTVNSG
EYSCLITGTGGCDDTKKINVVIGDIEKPIPDLATLPTITGDCKTTIITIPTATDVCAGAI
TGSTTNPLSYNLPGTYIIIWNYDDGNGNISHQNQTITITSEPIATANTPQTFCILQNATF
NDVSITGQNIKWYTAQTAGTILPNVTILQNGTTYYASQTINGCESERIPVSINIQNTLSP
TGNTNQPFCSAQNPTIASLQVTGDLIKWYDAASNGNLLLTTTSLINGKTYYASETVNGCE
SPRFGVTVSIVNTPSAPTGNANQPFCKSQKATLDNIAITTGQNIKWYDTNFSAAALPNTT
LLEDNKTYYASQTVGCEGDRTPILVRVYNTALPTGSTSKQFCIDENATLASIGISGTNIK
WYDASSNGNILPQTTLLQTGLYYATQTLNNCESERLAVTIKIQDTQIPIADSPQKFCIQK
KASINNIDITGQNIKWFESLSSTINISENTFLENGKTYYASQTINTCESDRIPVTVNILE
ATSRDCINLVDELPYQKFFTPNNDGYNDTWTIDFAYLAPNTGIRIFDRYGKFIKELNFNG
AWDGTYIGRNEPAADYWFTVTRLNGTEFRGHFSLKR
>EGALAKHO_00451 hypothetical protein
MKHKLLLIFLFFSLFFHCKVECQDFQWVRQVGNQQTDEAEAIEVDNDGNSYFIGVAQSYT
YDLDPTPSGTQIIDNTGGQGSPYRDIYLIKLKNNGDFAWGKTFGNVKSGQYAYEIKIGPN
GDIYVFLQTTESTGSNQAESFTTIVKITPDGNELSRIKIKNPGSFYTDSFAIDNQNNILV
SGWFVNSQTVNFSNQSVKFESQNSIASFIFKLDNSGNFIWKKIFDYPELANVSIQTRPDG
NIIAVLSTSFQGYPMSSILNINTSNTDIVWEKKLSQQAISSFHLDRKGNIVIAGTNGVYE
GIVDVDPSSNVRNTSSQKFLLWLDYNGNFLDLKEYFLQQYKEDFQMTKIASDEQNNIYLV
GYFNGKVDADPSSNEFFLENPLGRIQYGSGYAIKFDYNRAFVTAYSLLSNYRTFVNDIKV
RNKSIYLLGDFNGECDFDPGVGIQTFDSLHDGAVLSSDGFVVKLSPCDPTKPYGDENQSF
CNSHSSTIADLVPNFTGIKWYDSASNGNILSSATYLENGKTYYASQTLNNCEVERLAVTV
SIKTKPSVPQELNNRTFCKYENATLNDLHFSGENLKWYDSNTSTTPLINTTLLQDNTTYF
VSQTSGCESDRAAIIVKIFDTAAPVGEKEQTFCIDQNTTIAAIKIRGENLLWYDALNGGN
HLAETTILQNSTYYVSQTLNDCESKRIPVEVKLKKSESPVVDANQQFCSQEKASLKDIKI
TGQNIKWFETSTSNSNLPESSLLRNGTYYVSQTINQCESNRIPVTIQIMESTTADCSTLD
DELPYPKFFTPNNDGYNDTWTIDFTYLAPNTGIRIFDRYGKLLKELHNNDAWNGTYIGRN
EPASDYWFTVTRLNGTEFRGHFSLKR
>EGALAKHO_00452 Esterase EstD
MKKTILIIITILASSFAIGQEITGQWNGLLKVPGAQLRIVANISKTETGYVSTMDSPDQK
AKGIPVASTTFENSILKLEIPVIKGSYEGTLNKDNIIVGKLTQNGQSFDVNLSKESISEQ
VYARPQEPKKPYPYYTEDVKFVNKTANITLAGTLSLPKKEGNFPAVILITGSSAQNRDEE
VLGHKPFLVLSDYLTKKGIAVLRLDDRGVGESTGNFSTSTTVDFVSDIQAGLDYLKTRNE
INKKKIGLIGHSEGGLIAPMVAGNSKDISFIVLLAGPGLRGDKLLLLQNELIKRQMGMPE
IEVQKEKEIFKGAYDLIITSTVNDEKLKSNISSYLKTKYNDPSKDADVELLTSQVTNTWW
YNFIKLDPVPFLEKVKCPVLALNGSKDLQVPAEVNLESIKKTLVESGNKKVTTKVLPNLN
HLFQECQTGLPTEYKTIEQTFSPIALEEISNWLLVQIK
>EGALAKHO_00453 Immunity protein SdpI
MNLELKKELPIIGIVLTPFVYLAIIWNSLPEKVPVHWNYKGEIDRWGDKFSLIIILFLLP
VLIYVLMTFIPRIDPKHRISLMGGKFYQLKFILVLFMSLIALLILYTTKERSINNPNLVF
ALMGFFFVILGNYFKVIQPNYFIGIRTPWTLENSEVWKTTHLFAGKLWVAGGFILVLGGL
LLSKAFANAFVFIIIIMALVPVLYSFIKFKEIQKRD
>EGALAKHO_00454 Transcriptional repressor SdpR
MNDIFKALNDATRREILELLKEKDLSAGEIADAFNISKPSISHHLDILKRADLITSEKNG
QFIIYSINTTIMEDVLQWILTFKK
>EGALAKHO_00455 Inner membrane metabolite transport protein YhjE
MKNNPNQENSLRHVLFGSLIGTTIEFFDFYIYANAAVLVFPQLFFPGASSTNSTLESLAT
FSIAFLARPLGSAVFGHYGDKIGRKVTLVVALLTMGLSTIAIGFLPGYASIGIAAPILLM
LCRFGQGVGLGGEWGGAVLLAIENAPPNKRAWYGMFPQLGAPIGLLLSGGTFLILTDSMT
SEAFMDYGWRIPFIASSLLVIVGFYIRLKISETPAFENSKEEQKEVRIPFLTLLESYKNQ
LIFGTLSAVTTFLVFYLMTVFTLSWATSDLGFTKRDALLIQLLSVLFFAFFIPVSALVAD
KIGRRKILIITTAAIAVFGFFFSYFLNSGNPVLVTAFVCMGMSLMGFTYGPLGTFLSELF
PTTVRYSGASLTFNLAGILGAAFAPMIAIWLASTYGLSYVGFYLTAAALISLISFLVISK
KVHQF
>EGALAKHO_00456 Putative cysteine ligase BshC
MPTDCISYQTSGYFSKLIQDYLDQKPELNSFYNHFPTLENFEKQIAEKQANFDNANRIPL
VQTLKKQYQNIEISDATKQNIELLAYPNTFTITTGHQLNLFSGPLYFLYKIISTINLTKE
LKSKYPTHNFVPIYWMATEDHDFEEINYFNFKGKKFRWNKESTGPVGRLSTEGLAEFFEI
YSLELGSSTNASVLKKLFEEAYLKHENLADATRFLADKLFANYGLVILDADDTDLKRAFI
PFVKEELQQQNSFKAVQETISKFGDYTVQVNPREINLFYIEDDLRERIIFEHDKYYVNNT
KISFSKEELFKVLESNPEKFSPNVIMRPLYQEIILPNLCYIGGGGEIAYWLELKSFFDAV
NITFPMVLVRNSVLLNTEKQAKKADKLELSWADLFTKPANLVNAITHKLSAFPIDLTPQK
ETLEKQFEYLYQLAQQTDKSFTGAVKAQEVKQKKGLENLEKRLLKAQKRKLDNELQRVID
LQFELFPNQSLQERQTNFSEFYLEKGEQLIPLLIQKLKPLETNFNIITI
>EGALAKHO_00457 hypothetical protein
MTRERLISLDVFRGLTILLMTIVNNPGDWGNVFSPLLHSQWHGCTPTDLVFPFFIFIMGV
AVPLAMPTKNWDETTFNKILVRSLRMFCLGIFFNFFAKIQLFGLDGIPLLIGRLVITIAV
GYALMGSFSSKIKNILAFSILVIYLFLAYSGIEAYHDVRLPGVLQRIAIVYFVVSLLYLK
TTQKTQIITGVTLLLGYWAIMTLIPVPEIGAANLEKGTNLASWVDSVLLKGHMYHETVTW
DPEGILSTIPSIVNGIIGLLIGQLLLREIGKTEKAQKMALIGVALIIGGLIWNLLFPINK
SLWTSSYVLYTTGLATTFLAILYYIIDIADYKKGFKLFLIWGVNPMIVFFASEIIPQALV
MIEFQNPHNPAEKINLLNYLYSFGIAPFFSNPMTASLAGALVYVAIWTFILWIFYKKKLI
FKV
>EGALAKHO_00458 Nucleoside diphosphate kinase
MATNRTFTMIKPDAVANGHIGNILAMITNGGFKIVSLKLTQLTVADAQAFYAVHAARPFY
GELVEFMSRGPIVAAILEKDNAVEDFRTLIGATNPAEAAEGTIRKAYATSIGENAVHGSD
SDENAAIEGAFHFAGREQF
>EGALAKHO_00459 hypothetical protein
MAKRLNSQSTIGDVLNQIIQVNKLQPGMDQIDVKEAWGNLMGNGVKTYTKNVVLKGSTLY
VELGSAVLREELSHGKSKIVKMINEELGREVVKDVVLR
>EGALAKHO_00460 hypothetical protein
MKNTFMILVLSLLFVSCKQEIKPADIAKLNGYWEIEKVVFDEGEVKDYGMNENFDYFQIK
GTKGTRTKVMAQLDGTFLTTNTFENVSVRFTDKGTFLDYKTDYAKWSEELISVSDKEFVV
KNEQQKEYHYKKAAPLNILNDGKETK
>EGALAKHO_00461 hypothetical protein
MKYYFFILLFSLISCVKKDNENSVEKRQNQKVIVIQPLGNFELEQSNKVLSEIRIINPNV
VLRKNIPFPEKAYYKPRNRYRADSIIKNLKNNIGKDSVIVGLSNCDISTTKNGIRDWGVM
GLGYRPGKACVVSDFRLPPKNKNQQFYKLVLHELGHTAGLPHCKVKTCLMRDAKGANHLD
EENDFCLNCKNFLLKKGWKLI
>EGALAKHO_00462 hypothetical protein
MSFSSLKNITPVTFYFASVVSFVLANLLKDKSLSFYYILLVLGLGLFFAGMLKRIRTKK
>EGALAKHO_00463 Signal recognition particle receptor FtsY
MSFFKKLFSTDKKETLDKSLEKSKTTFFSKLSKAVAGKSKVDDDVLDNLEEILVASDVGV
NTTLKIISRIEKRVAEGKYLGTEELNQILRDEIGALLSETNRGEATEFEIPKDKKPYVLM
VVGVNGVGKTTTIGKLAYQFKKAGYKVVLGAADTFRAAAIDQLQVWADRVDVPIVRQNMG
SDPASVAFDTLQSAVAQNADIVIIDTAGRLHNKINLMNELTKVKRVMQKVVADAPHDVLL
VLDGSTGQNAFEQAKQFTAATEVTSLAVTKLDGTAKGGVVIGISDQFQIPVKYIGVGEGI
EDLQVFNKYEFVDSFFK
>EGALAKHO_00464 hypothetical protein
MAKKTVASLQTSSKRLSKAIKMVKSPKTGAYTFVESIMTPEEVDEFLKKK
>EGALAKHO_00465 50S ribosomal protein L33
MAKKGNRIQVILECTEHKTSGVPGTSRYITTKNKKNTPDRLEIKKFNPILKRVTVHKEIK
>EGALAKHO_00466 50S ribosomal protein L28
MSRVCDLTGKRAMVGNNVSHAMNKTKRKFSVNLVKKRFYLPEEDRWITLRVAASTIKTIN
KNGISAVLKKAQSEGFIK
>EGALAKHO_00467 Nicotinamide-nucleotide amidohydrolase PncC
MKATIITIGDEILIGQIVDTNSGFIAKSLDRIGVDIHEMISISDDKKHILDTFAQLQNKV
DVVIITGGLGPTKDDVTKKTFCEYFDDELVVNPEVLAHVTQLIEGFYKRPISQLNKDQAL
VPSTCTVLHNQVGTAPGMWMKKENTVFISLPGVPYEMKYLVEEEIIPKIVREYKRPYIIH
KTILTYGQGESMVAERIENWEDNLPDFIKLAYLPNPGRVRLRLTGRGTNKEELEAAIEEK
VKSLDAIIHDIIVGYEENETIETVIGKILTKQNKTISTAESFTGGKIASLLAAVPGASNY
FKGSVVSYATEAKVNVLGVSQDLVDQYSVVSAEVASAMALNVKEILKTDYAIATTGNAGP
SKGDSDAEIGAVFIALATPTDIIVEEFNFGQPREKVIDRATIKSLEILQKEILKNVQ
>EGALAKHO_00468 hypothetical protein
MALKYNLSKVYALSDNDPEFVNEILKLFVTEVPEDLKQIKEGIKKKDHKYAYAYAHKIKP
TLDLIGLNVAFEEILQVEAWTKAEGKKKEIIETFKSIKIQVKEAIKEIKKDFDV
>EGALAKHO_00469 Ureidoglycolate lyase
MKIICIGRNYTNHIEELKNERPTEPVIFMKPDSAVLLKQHPFVIPEFSEEIHHEIEIIVK
INKVGKYIEPKFAHKYYDEISVGIDFTARDLQDKLKAKGLPWEKAKAFDGSAVIGDFLPK
TDFVSMENLSFELTNNSQTVQKGNTALMLWKIDELIAYVSQYFTLKIGDIIFTGTPAGVA
SVKPNDVLEGFLEEKKLFRIQVK
>EGALAKHO_00470 putative ATP-dependent helicase DinG 
MELKLNKPICFFDLETTGIDIGKDRIVEISIFKVFPNGNKESKTWLVNPTIPIPPQTTAV
HGITDEKVANEPTFNELAPQVHNMIKDSDLGGFNSDRFDIPLLAEELLRAGVDFDMKNKV
SVDVQTIFHKMEERTLSAALKFYCGKSLENAHSAEADTMATYEILKAQLDRYPDLENDMK
ALSEFTTRKRIADFAGMIAFDADNEEIFTFGKHKGAKVDKVLETEPGYFSWIQNADFPLY
TKKVLTAIKLRKLNTK
>EGALAKHO_00471 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MARFELKLPKMGESVAEATITNWLKEVGDKIEADEAVLEIATDKVDSEVPSEVSGVLVEQ
LFGKDDLVQVGQTIAIIETEGDAPAVKAVEEQAFAAEVTDPETSGENTIEVVKDTFSTPQ
DFTTSDKFFSPLVKNIAKEEGISVAELESIQGSGKDGRVTKEDILKYIEDRKSGIITPKS
AQVATATVTPVTQKAEPVVQKSQQAVPVSVNGGDEIIEMDRMRKLISGYMVASVQTSAHV
QSFIEVDVTNIVKWREKVKTAFEKREGEKLTFTPIMMEAVAKALKDFPGMNISVDGDYII
KKKNINLGMAAALPNGNLIVPVIKNADQLNLVGMAKAVNDLGNRAKAGKLKPDDTQGGTY
TVTNVGTFGSVFGTPIINQPQVGILALGAIRKVPAVIETPEGDFIGIRQKMFLSHSYDHR
VVDGALGGSFVKRVAEYLEAFDIDRDF
>EGALAKHO_00472 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MQLSVIILNYNVRYFLEQCVLSVQEALCALDAEIIVIDNNSTDDSCWMMQERFPSVKLIQ
NKENFGFPKGNNLGVSQAKGKYVCILNPDTVVAEDTFTKILAFAEEQKNLGIIGCKLIDG
TGEFLPESKRGIPTPWVAFTKIFGLYKAFPNWKLFNQYYAQHIDKNETGKVEILVGAFMF
MQRDLYLELGGFDEDCFMYADDIDLSYRALQKQKSNYYFHETTVIHYKGESTVKDEKYMN
RFQSAMNFFYQKHFKKSWFFTFFIKIGIVVFSFIKMFQGKAKAKSIPERYIFYSSNEILS
EKLPLILKNKVLFFDFKKEKMVNSCLILRAGKTEIILDNQYISFKKCIKIIETLKDKNIT
FKIFPKNSNFIIGSDSRNDRGQIIKI
>EGALAKHO_00473 hypothetical protein
MNSLKIKFIWFVFFISPFCYSQNDSTTVESKDILDVIRKIFKKDDSISKQRKLAFSLLPV
PIGANNSNGLVISFLTTFYLGEDHETTNMSQVSFSPYFSFNKQYVFPIQSYIYTKDNKWN
FIGDYRYLIYPQLTYGLGDHNTKEEMSTLDYQQWRFYQFITRKIVGNYRLGIGFLYDNYQ
NISEESYIDEETDYVKYMNGDFSDETSFGFALQGLYDSRKNIVNPEQGLYVEADLRINTS
GVDGNNWQSLYFDARKYHSFSKTKHRVWASRAFYWSTFGGKPHYLDLPSIGWDRDGKTGR
GFTKNRYRSNALIYLETEYRTDITRNGFFGAVFFGNISSVSQLDTYKFDKWHPAVGTGIR
IKWNKKNNSNLALDYGISKNDWSLRLGLTENF
>EGALAKHO_00474 hypothetical protein
MKITLYFFLFIGILFSNFGFSQNNSDVSKININGVWEDINPGVQNAVVIISEQNGKVIFS
HYLEWKGQKFVESGTGTRKGNEVIYTVDVTLPIEGWATKGTHTLVLSEDGNTLEGTFIDN
KKREGPISFKRIR
>EGALAKHO_00475 hypothetical protein
MRIKENLYNKRIVSIDALRGITIFVMIFVNELASVKNVPQWMKHMPADADAMTFVDLVFP
SFLFIVGMSIPFAFNARLLKGDSARTIWTHTLKRALALIIIGVFMVNAEYGYDASKMLIA
PAFWGLLAYAMPIPIWNKYPKDFPIWLKNILQYGGMLVLIALYFLYVQDTGEIGMTPKWW
GILGLIGWAYLFSVVYYWLVSGRLWAMITFLVFCIAANAMNLIEGSVIQQSSPLSFIAGH
LTHASVVTAGVIISLLFFDRKIAPKINWPVIGFTVFFFGVGYFLRPYFRISKIKGTPSWT
MFSASICTVLFYFLYWLMEIKKQTKWSDFFMPAAANPLLIYILPGVIYYFNLTFKIEIIP
EYFREGVLGIIWSLIFSTIMLFVMKICNKYKIQLHL
>EGALAKHO_00476 Tyrosine-protein phosphatase YwqE
MLSFLKSKPYLKDLLAGNYVDIHSHLLPGIDDGAKTIADTSKLATSFQEIGVCQFITTPH
ISHYIWNNSPEAIIAKHEETKLLLEADNIKMPFQAAAEYFMDDWFETHFQNEKLLTLKDN
YVLVEMSYMNAPVQLYKILFDLQVAGYIPVLAHPERYLFYHKNFNEYNKLKKAGCMFQLN
LLAVVGYYGGEITKIAEELLKKGMYDFVGTDVHHNNHIASFSQKVKIDHVNVAALKTIIA
NNQFFKF
>EGALAKHO_00477 Tyrosine-protein kinase ptk
MQKQDFYNDVIDDEIEDVNLREQLDKYLVHWRWFLVSTVIGLVLAFLYLRYTTPSFEATT
TILVKDEKKGGMLSELSAFADLGMGGSMKNNVDNEIEILKSRTLVESTIKELDLNIGLYV
KGKVVDRDVYADTPIHVYFYNRNSFFDNVNVVLNCELLNSNTFRLDNETESDSKGAFVLS
AKKEFNYGEKIATRVGTLVVTKTLFYGKNHTGRFKSIRILINPLDGITEGFKQGLKVEPV
SKTSSVVNISISNHVAEKAENFLDTMIEIYNENAAEDKNYISENTSKFIASRLALIAQEL
DGVEQDVESFKKANKLTDIESEAKLFIEGSSEYDKKGVEAEIQLNVVSSMLDFMKKSTNS
DLLPTNIVSDNGDASGLISSYNQLVLDRNRILKSATTENPSVIKLDAQISSLKANVAASL
RRMQANLQIQNRDIKSQEGILNSKIGKIPVQERQFRVIARQQKVKEELYLYLLQKREETA
ISLAATEPNARVIDAAKAEKEPVSPKKKIIYLAGMLLGLLVPFGIIYADDLLDTKIKSKL
DLEGKTQIPFIGDVPTSDDTAELIKSESRTSSAEAIRIVRTNLEFMLNKVPDGLAKTVFV
TSTFPSEGKTFISVNLAATFALSGRRVLLIGADIRNPKFGEYINVPSLGLTNYLSSTGKD
VQDYIIKHEGYENFFILPSGVIPPNPAELLMGKKVDQLFAELKKEFDYIIVDTAPVSLVT
DTILIAKNADTFVYVMRANVLEKRMLNIANTFYKEKKLPNMCIVLNDTDSTKGYGYGYGY
GVREDKKPWYKRLLSK
>EGALAKHO_00478 hypothetical protein
MKFKKSCIKFASFLQVLFLCLSCGSKQDVVYYQNIDSLTVPKNNNSYEIKIQPDDLLMII
VSADDPEVAIPFNLRTYSAPTNNRLDIAQGQQTVQLYLVDQSGNIEFPVLGKLKLGGLTR
TEALQLLQNKINVYIKNPIVNLRIMNFKVSLQGEVNLPGTYPIASERVTLIEALSMAKDL
TIYGKRDNILVIREINGVKSYNRVDITKSDFINSSFYYLAQNDVVYVEPNKTRINSSAVG
PNTSVIISAISILVSLSVLIFK
>EGALAKHO_00479 UDP-glucose:undecaprenyl-phosphate glucose-1-phosphate transferase
MKILRELSQYHFSRYFKLLFVIWDVVLLNVSIVLSALVRFGTLDKLFLKEVQTVSLLCNL
VWIGLLLFRDSYRIVRIEPIESIIYRTIKKVLIHAAIIAIFVVFLKYSDISRLRLVYFYS
FFFALLMISRYLSMKLLKYIRAKGYNFRSFIIIGANDAGERIRKTLAKDLTFGYRFLGFF
DEKLDPFAFISSPLVGGFDDIEEFIINEEVDEMYVALHINNIEIINKLTRICEHNMVRIK
FIPDFQLYTKSNKVELSFYENTPVLMFRPEPLEFTVNRLLKKAFDVVFSSLVILLIFPWL
FPIIMLLIKLESPGPILFKQERSGRDNRSFTCWKFRSMRLNGAADKKQAKKGDSRVTKFG
TFMRKTSIDELPQFFNVFFGDMSVVGPRPHMVNHTKQYSELINNYLVRQYAKPGITGWAQ
VNGYRGETRELIDMENRVEYDIWYIENWSLLLDIKIIIKTVLNVFRGEENAY
>EGALAKHO_00480 hypothetical protein
MKIAITGTRGIPNHYGGFEQCAEYLASGLVKMGFEVIVYNSHNHPYQEKVWNGVQIVHCY
DPEHTLGTAGQFIYDLNCILDVRKQNCDIVLQLGYTSSSVWGWLMPKKAIVTTNMDGLEW
KRTKYSEKVKKFLKYAESLGVKYSDHLISDSIGIQNYLKETYKADSIYIAYGATLFGRSN
IEFLNNYNLEPHNYDMLIARLEPENSIEIILDGVAKASLSRPFLVVGNHETEYGNYLKNK
FSFSSQIEFIGGIYNIEILNNLRYYSNIYFHGHTVGGTNPSLLEAMASNSLICANDNDFN
RYILGNDAIYFKEADDVVDHLLKTKYHDDSFQSMLIENRRKIENIYDWEIIVDQYAKHFA
DIAKRNSN
>EGALAKHO_00481 hypothetical protein
MSELYKIFKKIEGKKVLTQFVKNNLFFFVSFQVLLLGLNRKALEIIKIASQFKIYNRLKR
RYKFLKIKIDSNSIDSLPKISSNIVWFCWLQGIENSPSLVRHCYESLVNNLPDKNIIIIT
TDNFNEYITFPDFIIDKWKKGIITNTHFSDLLRLELLINHGGTWIDSTVYCTGSNVPNCF
FESELFMYQMLKPGLDGHSIAISSWFITSVTNNKLLIATRTLLYDYWANNNKMIDYFLLH
FFFCIVCEWYPEEWKKVPKYCNSIPHVLQLELFSDYNMNRFSDIKNMSAFHKLSNKLDDC
LKQKKNTFYDVLFQRQNSL
>EGALAKHO_00482 hypothetical protein
MSITNTDKLHKVDLEILKEVVNICDENDLKYYMIGGTMLGAIRHKGFIPWDDDIDLGLPR
EDYEKFLSIAPTLLSKRLRVVNYKTDPDYPYYITRIQDTDTKVIEIRYRHENKFTYASID
IFPLDGTPNNSLIRKLYYLRVLMHRAMMSLHYKKGIDSERKRNMVERLFLNLVTKLPTDK
MFNAFNQKNNIDKILKKHKMHESNYTGNIMGAYRTREIVPTKLYGKDSFYQFEDVSLRGF
EFYDEYLTQLYGDYMKLPPIDNRKTHFEIIEI
>EGALAKHO_00483 hypothetical protein
MVVGLHANFLKDVNSILNFLLVNGIFRIAVPTFFIINGFYFNDVIKENRILIWLKKTIIL
FLIWMLLYCYFWFPPSDSNMKLYFKIILFLIGYNHLWYLSALVGSGVLLFLLRKLTTTKI
LISAIFLFLIGVSLQYIGNYDLFSGRLINKIFHFGPIYRNCLFFGFPFFSIGYIINKTNF
YKKICQKHLMAFLAASVIVLIFESLVNYINMPKAYPFEMYISLFIVCPLLFLNSFAYSLQ
SKFSGKTLSLYATSIYLIHPMFNIMFFNLTSLSYVVTFLSSLFSILAGYFMIKIYNKYGW
IL
>EGALAKHO_00484 hypothetical protein
MQNKAESGLDVSIIIVCMNNLNVLIPCLDSIKKYTKKITYKIYVVAYLFSEENLKILKAQ
YPEVIIIESNEIRGFSENNNLALRLVESKYCLVLNDDTFLKSSVIDKLFLEIEKLPNDVA
VISPNIKYPDGRDQFCGVAEHNLKTFVFGLLRINYNNIVKSPYINKGGIFQTYNLMGAAF
LIKTNIFRDFGFFDEVYFFCPEDVALSTDLNKKGFKCYVDADNIIYHIQGGTWSKMQSAT
MPAHMKGSLIFHANNSNVRYFFIGLLIMIIRFLYGIGWLLKSINGNDKAKTMYKANFNVC
KTVLSNAKPKEIFIDCYAKIKSK
>EGALAKHO_00485 hypothetical protein
MIFILIYFPLIIYMFYDFQKAFLLFVLLKIFLNKYINVINIPGVPLFTLELFTNICFILY
FFFLLNKKSKYAREDFPLKTAYIWCISSIIISTIFSVVGFSSAFTRALQDIINNYIYIYI
LWYILRSKSDVFFLINGFVVIFIILGLYGFFEKTTGINPLIDYEISLNPSLKDVNLRYDL
DGRLGLGRVQSAISHPIGFGIYLAIILSFYFFIQNKVANAWRQNIILKLLFCLLSISCLF
FTNSRSPLIYLFISVLPMFIFEGKRRFQMILFGLFGLLLTWNIIEPYMQNILSLIDSKAS
NNVGGSDSAMRYDQFASAIRIFFKSPFIGNGIKSMDDFLDSDMGLLGGESVWIWLMIERG
FLGIISHIILIISIAKMGYGKVKYFVWFSTLAWLVTTTITSTPGIDISFFITIILLLNRI
QILTVKTNKSAK
>EGALAKHO_00486 hypothetical protein
MKKKVVIVDPYASGVFHQVFNASVLIMASISFDTVHYIGQSSACDKMKDFILEVDTKKQY
KNIVYQVINNDFKFNSSGWGHTAKLVYCAWVTLYNYIKMTKGSTLIVNQNIPTLLHLLNF
LSKFKKNKIVIFCHSELEIVCNPKIKLAKSQIFMVWLFRNFFKKNKISKYIRFVLLADYM
KAFFCDNIASYNVDAIFTIDHPYIKAPIVEDNNLSILYKDKIKIGITGLLSQGRGLNETI
KLLDKINLNIPEIKIFAISRVLSEVNLEKLGLTYLNNSDELLPVNEYSNYVKQMDYILIM
YSLDSYKLTASGAILEAVWWQKPIIALKNDYLVYLFEKYGDMGILCESIEELIYTITNIN
KVFFNNYELYCVNLVNARIRLLPENLQKIVVAKKIFD
>EGALAKHO_00487 GalNAc-alpha-(1->4)-GalNAc-alpha-(1->3)-diNAcBac-PP-undecaprenol alpha-1,4-N-acetyl-D-galactosaminyltransferase
MNILFCLRYFPVYGGGETVTITLANEFVNRNHNVHIVYCYENIKENLPFIDPNIKTFKVD
NLIDLFTMKDVINLRNIIVDNNIDIIINQWASPNICFEANRGTNTKIITCRHTNVIRETA
IKGYGLKSIVKRVFYSQFQKYMFNKQIKEHDEICEKSDKYVFLSSSFVNEYKNISSYGFK
SNNLIAIANPLTYRENVSSKILDDKKNEILFVGRFEEYPKRITRLLNIWEIINNTNKFER
WKLILVGEGPDFELIKQISKKKNLRNISFEGFQSPMKYYKRASIFTMTSAIEGFPMALVE
AQQNGAVPIAMNSYSSLHDIITSNENGVIVEDGNIQQYSEKLMELMSNRDKREQLAIKAL
DSCKKFSIDNIANQWENLFRSMEAK
>EGALAKHO_00488 hypothetical protein
MIQENNKRIAKNALFLYFRMLLTMLISLFTVRLVLNALGVVDYGIYNVVGGIVTMLSFLS
GTMASASERFFSFELGKNDLIQLKKTFSLTVTIYVIIAIIFLLIAETIGLWFLNSKLVIP
TERIDAANWVFQFSVLSFLVTIIATPYNASIIAHEDMKLYAYVSLIEVLMKLIIVYLLIL
FTYDKLKLYAVLIFVTTLIIKFTYLIISHCKYTECRYKFFWDKALFKTLLSYSSWNLFGT
VSSILNSQGINIILNIFFGPVVNAARGISVQIQSAVSGFIMNFQIAINPQIVKSFAKKDL
KYMHSLIFASSRYSFFLMLLIALPVVLEIESILTWWLKIIPEHTINFVRLIMCTALVETL
ANPLAIGIEATGKVKWFQIIVGGLLMLSVPVSYVILKFGAKPEVVFIVHLIVVISAQIIR
LLFIGALIKISFKQYFSEVIKKIFPVTIISLLLPIFFFYTLSQNFISFIVISFISIVSVC
VSVFFLGINSKEKEFVISKKNDLLKKIKKT
>EGALAKHO_00489 Glucose 1-dehydrogenase 2
MKTALITGGTKGIGRSVAERLLKEGWNVIVTYLSDEKAAMTMSKSLSVLFPTSSIIVLKV
DCGNLISIAEITTYLSNNNICLDAVFFNAGATDRTAFGDITPENWQRVFDININFPTFLL
QQIVTNLNNEASIVFTGSLMGIQPHSVSLSYGVTKAAVHALVKNLVKVFAPRKIRVNSVA
PGFVNTEWQRSKPEEQKANINMKIALSRFCEPDELTDAYWFLINNHYVNGEILVIDGGYS
ML
>EGALAKHO_00490 Glycerol-3-phosphate cytidylyltransferase
MSHKKKIIYTSGTFDMFHSNHLKMIKYAKGLGETLIVGVSTDELVCSYKKAPIIPFEERL
AIVDALKYPDVVIPQRSLDHSILVKNLNIDAFVVGDDWVGKYDYLRNLGVEVFYFPYGDG
VSSSKLKEEIFIKYKELKDNSDKHGNPDIK
>EGALAKHO_00491 hypothetical protein
MSKKLLLIMSCFIFLLSCSAQEDFNNFTSKPVSVDNPDSIAKPGNVNNDSIVNYPIVDVP
VIPVKRRIVAHRGAWKNKKLPQNSIASLREAISLGCKGSEFDILLTADDSIVVCHDANYN
NLFIQNAKYSDLITLKLSNGEKLPTLREYILAGKQNNTNTQLFCELKNNGLDGRAKKVFV
TKTLELVNKLNAEQLMVYISFDYDLLGRIHTLNSTAKLQYLNGDLPPDQLKIDNVASLDY
NNSVYEIHPEWIDNAKKNNLELSVWTVNEANRIIFYLNNNFDAITTDEPELALSFQNKLK
>EGALAKHO_00492 hypothetical protein
MIKALFFFVIAFSYSLHAQISGCTDPLSKNYNSQATINDGSCIYESFKAKTLLSTKLSDS
IKETSGLISFDNLLWTHNDDHDKTIYGLDTLGKIQKKIILDKAINHDWEEISQDSSYLYI
GDFGNNASGNRTDLQILKIEKKSFLQENPIIETIAFKYADQTDLSPQKPNNTNFDCEAFI
ISKDSIYLFTKQWKSSKTTIYALPNQSGNHIAQLKQTLDTKGLVTGATYLESKKLIALCG
YSKLGKPFLYLLYDFKNNDFLSGNKRRIDLQLSFHQIEGITTTDGLHYYLTNELLIRKPI
INVPAQIHYFNLSPILNSYLHK
>EGALAKHO_00493 Energy-dependent translational throttle protein EttA
MNYLSVENISKSFGERTLFDNISFGINKDQKIAFIAKNGSGKTTIMSIINGLDEPDTGQV
VLRKGIRMAFLSQDNNLQEELTIEESIFASDNETLKVIEAYEKALENPDDEEAYQKAFDG
MDQHNAWDFETQYKQILFKLKLEDFKLKVKNLSGGQKKRLSLAIILINRPDLLILDEPTN
HLDLEMIEWLESYFAKENITLFMVTHDRFFLERVCNEIIELDNGKLYQYKGNYSYYLEKK
EERITSENASVDKAKNLFVKELEWMRRQPKARTTKSKSRQDDFYLIKEKAQSRRQENKVE
LEINMERMGSKIIELHKISKKFKDHVILDNFSFDFQRGARIGIIGKNGTGKSTFLNLLTG
TIPLDSGRVVKGDTIKIGYYTQSGINPKPNQRVIDIIKEYGEFIPLAKGRMISASQLLER
FLFDAKKQYDFVEKLSGGELKRLYLCTVLIQNPNFLILDEPTNDLDIVTLNVLESFLLDY
PGCLLVVSHDRYFMDKIVDHLFIFRGKGEIENFPGNYSDFRAYEDSADVAQKEENKAEKK
DWKQNNPTGNLTFNEQKEYQKLEREIKDLEIDKTKIEQLFSDGKVADADIEKKANELQNI
INKIDQKEERWFELSAKIEG
>EGALAKHO_00494 hypothetical protein
MDFKELLAYKKSFELAMEIFDLSKTFPKEEKYSLTDQIRRSSRSVSANIAESYRKRRYVN
HFISKLTDSDAENSETFVWLEFCLQCKYINKETFEILNKKSI
>EGALAKHO_00495 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MKYILTSLFALTLFISCNSNDDPKKTDYTVENEKEIVDYIAKNKLDAKRTDSGLYYVVNE
PGDGAQPTASSNVTVAYKGYYSNGSIFDQSKAAGISFGLNQVIKGWTEGIPYFKVGGSGI
LLVPSHLGYGPFDYNSIPGGSVLIFDVKLISVN
>EGALAKHO_00496 hypothetical protein
MENLHNPDGTKREILTGMFSDRDSIERAYDTLSDRGYTKDEINLIMSDETRKKHYSDKDD
HSELGTKAAEGAGTGSAIGGTIGAIAGVVAALGTSLVIPGLGLIVAGPLAAGLAGAGAGG
IAGGVIGALVGSGIPEDRAKIYEDGIKDGHVVLGVHPRNNEDAEYFKQQWEANNGVNIYR
>EGALAKHO_00497 hypothetical protein
MMLKEEIEDNSIISSEEINRCIAILAQLNTNTDQIFDIPKEQRIALIKEAGMFSRPDRGE
FSRRIKDGLQAAKRKKEKKDKTARKETGIRHAREASIFVAPKLLANTDLVQKEQLELETP
RNCYVCKTEFTKMHHFYDSMCTDCGDFNYAKRFQTADVKGKIAVITGSRLKIGYHITLML
LRGGATVIATTRFPVDSALRFAKEDDFMDWGHRLKIHGLDLRHIPSVEIFCNFIEQKYDR
LDILINNAAQTVRRPAGFYSHLMENEELPISELPQKAQELLLDHINCLDELKMLTSAASS
NENMPVTWHGPEPGIGLRASAQLSQIPYSFDNALVANEVFPEGELDADLQQVDLRKTNSW
RLRLGQIETTEMIEVQLVNSVAPFVLCNRLSEVMKKDNTGQKHIINVSAMEGKFHRFFKE
DRHPHTNMAKAALNMLTHTSSGTLAKHGIFMNAVDTGWVTDEDPAELAKKKQELEDFQPP
LDIVDGAARVMDPLFDGINTGKHWCGKFLKDYNPIPW
>EGALAKHO_00498 hypothetical protein
MLFEIKSYLKFLWNSKNEHGVHSPFVFNLLTKCFYDKKTKPEYEILKNYRKSLLQNENFI
EVTDFGAGSRVFKSNRRQISKIASTAGISPKRAELLFRVTNYFQPATILEIGTSLGLATS
ALALGSRSLGTKAKVITLEGCPQTATIAENQLNQFDCKNVENIISEFESFLISENLQSTI
YNLIYFDGNHSKKATLTYFDLLLPTIDNDSVWIFDDIHWSSEMEEAWEIIKNHPKVTVTI
DTFQWGFVFFRYEQPKEHFVIRA
>EGALAKHO_00499 hypothetical protein
MKNIQLLSGIALIALSFTSCKDEKQEKAQKTIDAYVTYVDSVKNVKADDLKADWKNVDAE
YDRRAENAQLALADIKDNAAETERINASKTKYEEFKNEMTTVLAPPAPSPKQQLRNALFG
EGKIGDDMSFSWVNAQNIHSVYQQFVHTVEDHKDSYSREDWDEIKILYEALDSRKNTVEK
EGLTSEDNRKIAGLKMKFAPMYTVNRMGAKSEENKEAKK
>EGALAKHO_00500 putative ABC transporter ATP-binding protein YknY
MANPLIKITNIKRDFVLGNEIVYVLKGIDLQINKGEYVALMGPSGSGKSTLMNLLGCLDT
PTSGNYVLNGKDVSQMKDDELAGIRNKEIGFVFQTFNLLPRTTALDNVALPMIYAGYSKS
DRNERAKEVLAQVNLADRMDHQPNQLSGGQRQRVAIARALVNKPSIILADEPTGNLDSKT
SVEIMKLFGDIHAQGNTVILVTHEEDIAAYAHRVIRLRDGLIESDTTK
>EGALAKHO_00501 Cob(I)yrinic acid a,c-diamide adenosyltransferase
MKVYTKTGDKGTTALFGGTRVPKDHIRIDSYGTVDELNSYIGLIRDQEMDTHYKTILIEI
QDRLFTVGAILATPQEKEVLKNGELRLKNLGIIDTDIELLENEIDQMEESLPPMTHFVLP
GGHQTVSYCHIARCVCRRAERLAVHLSHNEHVPEIAIMYLNRLSDYLFVLARKLSSDLKA
EEVKWIPRK
>EGALAKHO_00502 hypothetical protein
MYWTLELASYLSDAPWPANKDELIDYAIRAGAPLEVVENLQSIEDEGEIYESMEEIWPDY
PTDEDYLWNEDEY
>EGALAKHO_00503 Protein translocase subunit SecA
MSFINSIIKVFVGDKSQKDVKALQPYLNKIKTFETSLMSLSHDELRARTVYFKERIKEAR
ADKDAKIASLKAEVENIEDIDKREDLYDAIDALEKEAYEISEKTLLEILPEAFSVVKETA
RRFKDNSFIEVTATPKDREFSATKTYVTIEGEKATWANKWNAAGKEITWDMIHYDVQLIG
GMVLHEGKVAEMQTGEGKTLVATLPLYLNALTGNGVHLVTVNDYLAKRDSTWKAPLFEFH
GLTVDCIDNHQPSTEQRKKAYDADITYGTNNEFGFDYLRDNMAHSPGDLVQRKHNYAIVD
EVDSVLIDDARTPLIISGPVPQGDRHEFNELKPKIENLVSQQRQLANGFLAEAKKLIKEG
NTKEGGFLLLRAYRSLPKNKALIKFLSEEGIKQLLQKTENQYMQDNNREMHKVDEALYFV
IEEKNNQVELTDNGIQYLSGDTDADFFVLPDIGTEIAAIEKQKLDKDAEAEAKERLFQDF
GVKSERIHTLTQLLKAYALFEKDVEYVIMDNKIMIVDEQTGRIMDGRRYSDGLHQAIEAK
ENVKIEAATQTFATVTLQNYFRMYSKLGGMTGTAVTEAGELWQIYKLDVVEIPTNRAISR
QDKEDYIYKTTREKFNAVIEDVTQLSNAGRPVLIGTTSVEISELLSRMLKMRGVTHNVLN
AKMHKQEAQIVEEAGKAGVVTIATNMAGRGTDIKLSPEVKAAGGLAIVGTERHDSRRVDR
QLRGRAGRQGDPGSSQFYVSLEDNLMRLFGSERVAKVMDRMGLQEGEVIQHSMMTKSIER
AQKKVEENNFGVRKRLLEYDDVMNSQREVVYKRRRHALFGERLKLDIANMLYDTCELIVS
QTKPTNDFKNFEFDLIRYFSITSPISEADFQKLTDIEITGKIYKETLAFYTEKTERSARE
AFPIIKGVYEEPNNHFERIVVPFTDGIKTLNVVTDLKKAYDSEGAQLIADFEKNITLSIV
DEAWKKHLRKMDELKQSVQLAVHEQKDPLLIYKLEAFNLFRGMLDTVNKDVISFLFKGDL
PAQNVPEIHEAREVRQKENFKLSKDEIPNSEDINREAGETQQRQVTETIVRDMPKINRND
TVTVQEVATGKTEEMKFKKAEILIASGAWVLVK
>EGALAKHO_00504 hypothetical protein
MLLLPSFGSFFVYTSFKLNQEEISKTICVQRKMVFNSCNGRCELQKSLKKYADNEKRMQN
NLKEKAEVVYIQNLSTANFKLVTPIESKVKLFASFDKKPISVSNSTFHPPSYFI
>EGALAKHO_00505 Colicin I receptor
MKKIYFTLLIIGQCVLAQNEVKQDTTKSQELENIFVTANRTATLRKETPVAISKITAKTI
NETKATAVYEIINKTPGVLMVNLGNEQHMMSIRQPMTTNAYYLYLEDGLPIRPMGIFNHN
ALLEINQYNLQSIEVVKGPVSSLYGPEAVGGTINLISVKPPVDPEFKFGVQADNYGYRRF
QAAGGATIGKVGFHIAGISSLQENGWMTYSDYNKDNLNARIDYNISPSTRLISNTMYGKY
YSDMSGTVNEEAFNNRTYKSTSDFTYRKSDALRTRLTLEHDWNSNSSSYITAYLRDNKLG
QNPSYGIKWSPTVNPTKATGEVNSNNFKSYGAIGQHTQKFDFLNTKLVAGALYDYSPVTY
WAYVIDLKANLNPGEAGKQTVDSYEIIAEHPDSKLADYTADIFNTAGYAQVSFNPIEKLV
ITVGGRYDNMKVNYDNALDNSTGSKVYDKMTFKAGANYNPFEFAGFYGNYSQGFAPPGIT
SIFRTKPGTGGTTGVPADFYYNLEPATFNNYEVGGWLSFLQNKLNFDYALYYMEGKNELL
NIKLADNSTDYRSAGETRHKGIEFGATYRPSKQINFRLGGTYAQHTYIDFKLSDKPSDPV
QNLNGKEMPSAPKWSGNSELSYYPNWLPNLRTSVEWQLVGSYYQDQINTVKYDGYNIFNA
RIGYQWKRIEIYGNVLNLTDKLYAYNVTRANTTNAQPTYTAAAPRTFVFGIQYNFSLKK
>EGALAKHO_00506 hypothetical protein
MSKEIKEKKSKKKDSKLVKKIKQHMYKWHRTIGLITIIPVIFWTLSGLMHPFMAHFFKPE
IAHDKLEQQIIDKSQLHFSIQEVLQKNEISQFKNFRIVTFNNATYYQVKTILGQLLYFDT
SNAKKLEDGDQKYAEWLSRYFLEDQKSAVKKSEVVTEFTSQYKYVNRYLPVYKLSFDRPD
TMEVYVETSSSKLATYNPTSRQWFIWFFDTFHNWSFVDAISNNSIRIITMIFLLSIIGFS
ALSGILIYGLLWKQFKKTDNLQPKKGLRKYHRQIGIWISLFTLTFAFSGAYHATTKWAPY
TLSQMVYEPTFETKEIPLASNALNLDWSRFQNASIITLNDTTYFRCQLLEKEKFKKPKAD
SNSKWNKKEDQKSEVVYINATTNKVVPNIDLKYAEFLAYYFTDGAPKAACCEMVESSDEP
EASLENAKLLESKVLTDFESREYGFVNKRLPVVKLAYDTPEKTTYFIETATSRLAAKIKS
SDMVEGYSFAILHKFLFMDWAGKNIRDLTMVLAALTILIVSILGFILFLRK
>EGALAKHO_00507 tRNA (guanosine(18)-2'-O)-methyltransferase
MIDLDYLAFLENILTDNRKERFLNVLENRTKHFTIAVEDVFQMHNTSAVMRSCEVFGIQE
LNVIEQRYGKKIDKEIAMGAQKWVDINQFDSITTCVSTLKNHGYQIIATTPHENDCLLED
FDITKPSALFFGTERDGLSEEILQKADGFLKIPMVGFTESLNISVSAAIIIQNLTNRLRN
SDIKWQLSEEEILEKRLAWARSSIKDIKRIEARYYEENPR
>EGALAKHO_00508 hypothetical protein
MESELKVKIKRSFLDNYHRPLHLHPEFIQFDDKDLTNNGFTTFKSSEIKDFRCGVNWFHY
YFVFGREYEFHIRNFNDQVLKIKFNSYFGIKKREHHKLYTSIIDSLWNLYFNNQVNDFLR
EFENGESFYIGDVVVNPEGIIIKVSKLTKLEKVQISWEDLRFRLYRTYFSVYSKSNPIEI
NRGYSYKEDWNTFVLYNVIKIILSNKKIDND
>EGALAKHO_00509 Spermidine/spermine N(1)-acetyltransferase
MQTPAIKKIGLSEIEELQKIGKQTFSETFSDVNSEENMNEYLEDKFSVQKLTSELTNPNS
EFYFAYTDDKILGYLKVNFAESQTELKDKNGLEIERIYVLKEFHGHKIGQILYDKAVKIA
RNYDLNYIWLGVWEENHRALNFYKKNGFVEFDKHIFRLGDDEQTDLLMKLTLK
>EGALAKHO_00510 NAD-dependent protein deacylase
MKKKLVVLTGAGISAESGIKTFRDSDGLWEGHDVMEVATPEGWRKNQELVLDFYNKRRQQ
LKEVEPNLGHKILAELEQDFDVHIITQNVDDLHERAGSTKVLHLHGELLKVRSVQNRNHI
LDWSEDLYTGDFDENGHQLRPHIVWFGEDVPALEEAIEITETADYFAVIGTSLQVYPAAG
LISYTYSITPVFYIDPKPIAIPNIQNKVEVITKIASEGVAELRERLNTDFTNFH
>EGALAKHO_00511 Adenylosuccinate lyase
MTTLNELNAISPIDGRYRSKTLSLAPFFSEEALIKYRVLVEIEYFIALCEVPLPQLSGVN
SNLFDSLRDIYKNFSTEDALWIKETEKVTNHDVKAVEYFIKDAFEKLGLSQYKEFIHFGL
TSQDINNTAIPLSTKEAFEQVYMPSLISLISKLKELSVEWKDIPMLARTHGQPASPTRLG
KEILVFVERLEEQMRLLFNIPFAAKFGGATGNYNAHHVAYPQIDWKQFGNKFVETDLGLH
HSFPTTQIEHYDHFAAFFDALKRINNIIIDLDRDIWTYVSMEYFKQKIKAGEIGSSAMPH
KVNPIDFENSEGNLGIANAIFEHLAAKLPVSRLQRDLTDSTVLRNIGVPIGHTIIAFEAT
LKGLNKLLLNESKFAEDLDRNWAVVAEAIQTILRREAYPNPYEALKGLTRTNEAIDKKAI
HNFIATLEVSDAIKEELMQITPANFTGI
>EGALAKHO_00512 Inner membrane protein YbaL
MISLYAAAETTHHLRPLISDLGLILITAGIAVLLFKKMKQPLVLGYLIAGFLAGNHFDFF
PSITEMKSVEVWAEIGVIILLFSLGLEFSFKKLMKVGGTASITAITQIITMVIIGYLVGQ
WMGWGSMDSIFLGVILSISSTTIILKTFDELGVKAQKFAGIVIGSLIVQDIVAILMMVLL
STIAVSQQFSGSELMMSVLKLIFFLTVWFLGGIFFIPTLLKKTKHLLTDEMLLIISLALC
LMMVSFAANVGFSPALGAFIMGSIIAETTQAEHIEHLIKPVKDLFGAIFFVSVGMLIDPK
MLYTHALPVAILTLVTIVGQSVSSTIGALLAGQPLKQSVQTGMSLSQIGEFSFIIATLGM
TLNVTSSFLYPVVVAVSAITTFTTPFMVKYAVPFSNFLERKLPRKWVKNINRYSVNAQAI
KSVSIWQKVLNAYIIQIILHTVIITAVILLSAKFVAPLVADTRFGNTLAALITLVIIAPF
LWALSLRRIADDEVELLWEERKYRGALLMMILIRMGLGLFFIGFLLNIFFSPLVAFVALI
IAIAVYQIFPKKLNEQYHKIESHFLKNLNDRENKKIDRRYANLMPWDGHMSFFDIGKESN
LAGKTLEELRIREQMGINIAYIKRGDVMISIPTKNERLFPGDEVCVIGTDAQVTEFTKYL
NQNEVDAPASVEESQIVLRQLEVSQEEFIDKSIGQFRGKTGGMVVGIERNGKRILNPESN
IILGKNDIIWVVGDKKRMSELMKRA
>EGALAKHO_00513 Selenocysteine-containing peroxiredoxin PrxU
MSTLRLGDIAPDFHAETTEGPINFHEWLGDSWGVLFSHPSDFTPVCTTELGTVANYLPEF
TKRNTKVIALSVDGLESHKEWIKDINETQNTTVNFPIIADEDKKIATLYDMLHPNASDKF
TVRSVFVIGADKKIKLTLTYPASTGRNFDELLRVIDSLQLTANYSVATPANWKDGEDVVI
TPAVPDSDIPAKFPKGHTPIKPYLRMTPQPNK
>EGALAKHO_00514 hypothetical protein
MNNFIQIFFFLFLGLLLQNVKRFPTHIYKSINKIVIYICLPAITLYHIPKIKWNNDLLFP
IGAGWISFFLAFVFFHFLGRRLGWSNKLIGCLVLTAGLSNSSFLGYPIVEALFGKKGLET
AILVDQPGTFVVVSTLGVFVAAFYSKGSPDAWSILKKVILFPPFITFVVACSLNVFNYDL
DLNLQSVLLKVGSLVTPLALFSVGLQLNFDRRSQHWRFLRLGLFFRLIVTPFIIMVLYVF
IFNQHSEAIKITIIEIAMAPMITGAILASTYGLKPKLSSMMIGFGIPISFITLAIWYFIV
GFI
>EGALAKHO_00515 Putative HTH-type transcriptional regulator YwnA
MLSGKFAITIHILTLLTKYPNDYLSSEYIAGSINLNPVLVRKEIANLKAHHIVESKEGKN
GGTKLALDPTNLTLKEIFEMTFETINLGYAKNQPNPDCPVGKKINQNLAALYADMNQKVS
LQLEGISLEDFSNQF
>EGALAKHO_00516 hypothetical protein
MKIALIGATGFVGSAILNELASRNHEITAIARTPKETANVNWVSTDIFNSDALAEVLKGN
DLIISAYNAGWTNPNIYDDFIAGSKSVQEAVKKSGVKRFIVIGGGGSLFVAPGLQAVDTP
DFPKEYYVAATAARDYLNIIKEEKELDWAFFSPAFEMHQGITTGRTGKYRLGLENPVFNE
EQRSILSVEDLAVVIADEAETPKHHQVRFTAAY
>EGALAKHO_00517 GTPase ArgK
MSSPNKQSSSLQEKDGISPPEIINVSAISQIQKNRRKQPSSEELIAGILNGNRTALSRAI
TLAESTNPEHADKANEVINGCLPYANKSIRIGITGVPGVGKSTFIEAFGTFLTQLGKKVA
VLAVDPSSSLSHGSILGDKTRMEELVKDENAFIRPSASGDTLGGVARKTRESIILCEAAG
YDTIIIETVGVGQSETAVHSMVDFFLLLKISGAGDELQGIKRGIMEMADAIVINKADGDN
IKKANQAKLEFNRALHLFPPKKSNWQPKVTTCSAITKEGVSEIWDTISDYVQMTNETGFF
QEKRKEQNNFWMMETINEQLKLNFYNQPEIISQLEQNKKAVQNDEISPFAAAQSLLKLYF
NKGSK
>EGALAKHO_00518 Lipoteichoic acid synthase 1
MKKLSFLKPILNFIAIGLLITTLSRIFLFFIFKDRVVETPNFWYIFPIGLRMDLILLCYL
SFLPAVLITFLPNKWLKLTNKFLVIYSFLFLFLILFVELASPDFVKQYDTRPNKIFLDYL
IYPKEVVGMLLKSYLTSIIVTFLILGVVIYFAFKKGKKYFYTSLADYKFKLMVFPLVAFL
LFFGARSSLVSKRPINASNAVFSTDQLTNTLGLNSFYTVAFAAYSIKNEGNTKMYGKMDE
AEAIARVKKYMIAGPNDFTDAEIPFLHVQQPDSVNKKPYNLVIFLQESLGAEYVGILGGK
PLTPEFDKLSKEGLLFTNLYCTGTRSVRGIEAVVTGFLPSPSESVVKLGNSQQGFFTLAD
ALKQKGYDTSFIYGGMANFDNMASFFNGNGFQDIVDQEDFDADGKKYAFKGTWGYSDEDL
VTKANNYFKAKGNKPFFSLMFSTSNHEPFEYPAGRIKPFDKKPATVNNAMKYADFSIGKF
FEMAKKEAYFKNTIFIVIADHNTRTYGKNLVPINKFHIPALIMGPGVKKGTVYSNLASQI
DIPPTLLGYLGIPFETPMVGRNLNKLDAKTQGRSIMQFNDINAFRVENQVVIMQPNLKPL
QFEIKNDTTLIPVKLNEELAKDALAHVITAGNLYKENKYKLRGTK
>EGALAKHO_00519 hypothetical protein
MELPKFLLGDNTDFPDDIFIIHLDYPRFIINLKDDEVEFLEEAEDLDEAELNAEMEGLIE
KANDFYDREINRYEE
>EGALAKHO_00520 Multidrug resistance protein NorM
MNLAQYTKEFSYNLKLAYPVILGMVGHTLIGIVDNIMVGKLGSTELAAVSLGNSMIFIAM
SLGIGFSTAITPIVAEGDAEKNDTKVRSAFHHGLFLCTILGLMLFGVIVLAKPIMELLHQ
PADVIALAKPYLDWVAFSLIPLIIYQGYKQFADGMSMTKYSMYAMIMANVLHVGINYMLI
YGIWIFPKMGIIGAALGTVISRIFLVMFMHIMLSRRNDLKRFFKDFSFQEIKKETINKII
SIGFPSAMQMLFEVVLFTASIWLCGNIGKTSQAANQIALSLASMTFMFAMGLSVTSMIRV
SNQRGLQDFKKLVVVARSIFLLAIILETIFAILFVAFHNYLPYLFLNMENGGQLMDNNEV
ISIASKLLLIAAIFQISDGIQVVVLGALRGLQDVKVPMYITFVAYWVIGFPISYYLAEYT
PWKASGVWIGLLAGLTSAAIFLYIRFHYLTKKLINNSVSNS
>EGALAKHO_00521 hypothetical protein
MISKNLKFICLATIAFLSANTTFAQDTATAKPEGEIKNYDQGFRLGFGLNGGLPTDNAYD
WSLGGDVRLQYDLTKRASLTLTTGFTNLFMGKDDNGVDQKDLGFIPAKAGFKAFIWEDQF
YVLGEVGAGFAVTNGYNDTTFLWAPGIGYANKYIDISVRYEDYNKFKTNQVALRLAYGFD
L
>EGALAKHO_00522 hypothetical protein
MKSIDPNDFKVVKKIKLSKVPTLLDIDADEETKEKKLDKVQGKLSDLQDVMYSHNKYGVL
ICLQGMDTSGKDSLIREVFKEFNPRGVVVHSFKTPNSSELEHDYLWRHYIALPEKGKFAI
FNRTHYENVLVTRVHPEYILGENLPGINSVDDITPQFWENRIEQINNFEKHISQNGTIVM
KFYLHLSKEEQRQRLLRRLEEEKHHWKFSPGDLKEREHWKEYQKYYEEAINKTSTDYAPW
YVIPADDKEMARYIVAKIIWEEMQKHTDIKEPELDDKIKANIEMYKKELGA
>EGALAKHO_00523 hypothetical protein
MEKFTLEILFQIIGIGSASGLFFNNNSLYIIGDNSGFLYEYNMQNQQLSHHPLIDNPSQN
IPKNIKPDFESITHHNDTLYVFGSGSTEKRNKMIAFDLKSKTILQKNDLVDLYALMQSFG
EIKPEDFNLEGAIFDGENWYLFNRGNGISNKNTIFTIHAKSLGEEFALVATNYKLPKIKG
VRSSFTDAILVEDKIYFLSTAEDTKSTYDDGDILGSFIGRIDLKTMKIDFTQKITSTNKF
EGLTFYQKSNDKIEFLLCEDNDTELLETKIFKLTLPVK
>EGALAKHO_00524 hypothetical protein
MKKIILSLIIVFILLTGGYLFYDFKINKTKKEYYKTLAPKDLDPKAFITLFTERYSKGSL
NIVTMNGEFPKDWVKSSDVGYLISIMDSKEKCCGYMNIFSSFISSEDAEVGGFAIIFLNS
YISKTKINLGLNSNPKVDSASIKKIETWYQKNR
>EGALAKHO_00525 ECF RNA polymerase sigma factor SigE
MQRDAQRQVYEHMAPKLYRVCKRYLKKEEEIEEAMADAFYTIFTKLDQLKEILAFEAWAR
KITVNHCLATIKKNTNFNMYLDDVKLLSQPFTEEINSLEEEDLLNLLNHIPDGCKTVFNL
FVIEGFGHKEIAAMLNISEGTSKSQLNAAKTKLKELVNKLYYQKAK
>EGALAKHO_00526 hypothetical protein
MDNQDKIFDKFKEAAHNSEQKDFPGMDKVWARVEEKLDKKEDKKAISLWKKIAIAASLLL
LISLGTQFFKSDQNTTIPASEVVVKETEKEVIQNSEIEKDGVAVEDSKLIPKAEAVKILE
KQIKEQQTVVANNDQITVTEAVGAGTVISAPAYEEANAPISESVHSGYVNDDERSVEKDK
VADFGYSKKAEREAFAAKAAGQQAERAKKTTPLVILNGKAMSNSNDAKRDEMMQAELPNL
QPENVESLVVLDEPLYIIDGVYYSENDLFGDNPTSPYAPLNKQEIKTITILQDTEAVAKY
GEKGKKGVVIITTKKGKPADKK
>EGALAKHO_00527 TonB-dependent receptor SusC
MKNVKIISLSIAMLVCFITHAQEKISSDTISKETKSNQREIMITPVKVSSNFVQPSSTST
CRVTICAPSRSLTNEPIYILDGTQINSKQFAKINPNDIESIKIIKDAAAMALYGSKAKNG
VILIITKKKFNQNNNDE
>EGALAKHO_00528 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MTDLKNKNALITGAGKGIGKAIALALAKEGVNVILVSRTQTDIDQLADEASNLGVKSLAL
AADVSDMNSINSAVEKALSKFKTIDILINSAGIASFGKFMELEPAAWEKIIQVNLMGTYY
TTRAVIPNMIERQTGDIINISSTAGLAGNALTSAYSASKFAVLGLTDSLMQEMRKHNIRV
SALTPSTVATDMAKDLNLTDGNPEKVMQSEDIAELLIAQLKLNRRVFIKNSSIWSTNP
>EGALAKHO_00529 hypothetical protein
MMEQYLRQLIAIEFTDKKEIFTGFLIDYSDDWILLRNNPVDYILDGFVILKNKNIEAIHR
DQDLAFTEKVIRLKGLKTNAEDIIPIRDLSTIVNFLTNKYGIFQISKKSAKSAYLGKLLE
LNDEELTIDFLDTRGQFGGELSFNPEKIRVIEFDTDYINSLKLVIPEDQKK
>EGALAKHO_00530 Threonylcarbamoyladenosine tRNA methylthiotransferase MtaB
MENRKKVAFYTLGCKLNFSETSTIARNFNDEGFDRVDFEEVADIYVINTCSVTENADKQF
KQVVKKAMKLNEKAFVAAVGCYAQLKPEELAAVDGVDLVLGATEKFKITDYIHDLSKNDM
GEVHSCEIAEADFYVGSYSIGDRTRAFLKVQDGCDYKCTYCTIPLARGISRSDALENVLQ
NAKEISAQNIKEIVLTGVNIGDYGKGEFGNKKHEHTFLDLVQALDKVDGIERLRISSIEP
NLLKNETIEFVSKSRTFVPHFHIPLQSGSNDILKLMKRRYLREVYTERVNKIREVMPHAC
IGVDVIVGFPGETDEHFLETYHFLNEMDISYLHVFTYSERDNTEAADMPGVVPANVRAKR
SKMLRGLSVKKRRAFYESQLGTNRTVLFESENKEGYIHGFTENYVKVKTPWNPELINTLQ
DINLTKIDEDGSVRLEFLNKLAEV
>EGALAKHO_00531 hypothetical protein
MKAFLPTICLMFLTIFSSQAQTNATAAANPFPSISTLTNWASLNSQSQFDIAIRAVGFKF
EVKEPGAESTSYTYIRKVTVNEVNYTDRIVYRITNNNSASIISLVTASTDLVSLYTPQLA
TFKNNNCKTEMSKDKNTTCSCYESVNFAIDLCDERVKLTMGDGNKYFVSVAKK
>EGALAKHO_00532 Putative ribosomal N-acetyltransferase YdaF
MKKSIETERLLLRELQMSDVDGMFELDSNPNVHLFIGKKPVKSIEESIGYIENIQQQYKD
FGTGRWAVILKGTNEFLGWSGIKFITNEINNHKDFYEIGYRFIEKHWGKGYATEAGKAFV
DYAFNELKADALYAYADAGNENSRKILEKIGLKYVNSFEYEGESEVWYELKNPHL
>EGALAKHO_00533 Sugar phosphatase YidA
MQYKMLVLDMDDTLLTDDHKISELNKKVLLEAQAKGVYVVLASGRPTSAMTAYAKELELD
LNDSYIISFNGAIISTVKDDLVLFEQKLTVEQIHDLYDYSVKMKTHIITYLDNEIISETD
SEYIEIEKEITGLAHIKVPSFKEAVTKPTVKCILLAEPSYLKEVEADLKAVMPHLSIAMS
KPFFLEAAQYGIDKAASIKILAEKLNIHQSEIIAVGNAGNDLTMIEYAGLGVWVDNVTPE
LRDRANVIVASNNDNGVAEVVQRYILKNFVYEEVN
>EGALAKHO_00534 hypothetical protein
MGLMKVFSGSEVLAIALQERLEEAGVETVKKDNIQSARLGGFGQTDLAVEVFIQETDFAK
ANPVIEEFRMSI
>EGALAKHO_00535 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MEIIKTLKFLTIILLAFFVVIYLVVVSYVYFNQVGMVFQSASLPKEYKFDYQSKFEELNI
KSFDGANLNGLLFKADKSKGLVFYLHGNAGTLEAWGKIAKTYTNLGYDIFILDYRSFGKS
EGEIENEKQLNKDIAVVYKTLNKRYPENKIIIDGYSIGSGLAAILASENKPKALILQSPY
YSFTELSTGRVPFFPDFMKKFQLETYEYLSKIKAPIYIFHGKDDQLIPYENSVRLSKIIK
PNGHFYLLNDQGHIGMNENNDFQNQLKTILE
>EGALAKHO_00536 ATP-dependent RNA helicase DeaD
MAYSLKPKALKNMKLKKINEKLQDALIENGLTEANVLQMETFSTIKSGADCMIVSPKGTG
KSTTIVINVIQQLVGHTEESPRALIIVEDKEKVLAMEALFEKYGKYTNLEVYGVHDKGDM
DYDKNYISTGVDVLIGTPNKLSDMFTTAGYNVNRLKMLILDDADPILRLRNETKIMRISN
SIAKTQRIIFAEILTERIEILADKFLLEPYFFDMDEEGEEELDEEEDGIEEEE
>EGALAKHO_00537 Transcriptional regulatory protein ZraR
MSKILIIEDEAAIRRVLVKILSEENDTYQVDEAEDGAVGLDKIKNNDYDLVLCDIKMPKM
DGVEVLEEVKKIKPEIPMVMISGHGDMETAIHTMRLGAFDYISKPPDLNRLLNTVRNALD
KKQLVVENKILKKKVSKNYEMVGESDAISHIKLMIDKVAQTEARVLITGPNGTGKELVAH
QLHEKSERANFPLIEVNCAAIPSELIESELFGHVKGAFTSAVKDRAGKFEAADKGTIFLD
EIGDMSLSAQAKVLRALQESMITRVGAEKDIKVDVRVVAATNKDLKIEIAEGRFREDLYH
RLAVILIKVPPLNERRDDIPALIRHFAEKIASEQGNVVKVFSQPAIKLLQEYDWTGNIRE
LRNVVERLIILGGTEISETDVKMFASK
>EGALAKHO_00538 hypothetical protein
MSIISLIIKREFIAKVRNKSFVVMTFLSPLLFVAIAVFIGYLSSMKADTKRIAIHDETGL
FADDFVKQNKKDAEYKYLNLSEIDTKSLKDSIAKEDFSGLIVIPKTNNLKDLESKIEFIS
NNSPSIAFIENTQDVIAGKITKLNLEKAKLDTLAIQKAQAEVNIHLAKASGEESLKGLNE
IKIGIGGAFGYLIMMFIIIYGNMVMRSVIEEKTNRIIEIIISSVKPFQLMIGKIVGTSLA
GLLQFFIWAIIGLGLMFAASAFFGVNVGPTAKIPPELMNAAQHELSGSAQMYISELWNLP
IASILIGFVIYFVGGYFLYSSFYAAIGAAVDNQTDSQQFLLPIIMPLILSVYIGFFTVVN
DPHGTVAVVFSMIPLTSPIVMLMRIPFGVPWWQIAISVSLLFATFFLVVWFAAKIYRVGI
LMYGKKPTWKELYRWLKY
>EGALAKHO_00539 ABC transporter ATP-binding protein NatA
MSNLLEVHKVVKQYGDYVALNEVSLNVPKGSIYGLLGPNGAGKTSLIRIINQITLPDSGE
IILDGEKLQPKHVQTIGYLPEERGLYTSMKVGEQCLYLAQMKGLSKAEAKVQLEYWFDRL
GIQGWWNKKIQELSKGMAQKIQFVVCVLHKPKLLIFDEPFSGFDPVNANIIKDEILALKE
QGATIIFSTHRMESVEELCDHIALIHKSNKLIEGKLSDVKRQFKTNSFEVGILTSNVEGL
MYDITQKFTVSPANFKSLNDDLKLNIQIGDATPNELLHILTQRGQVTHFVEKIPSVNDIF
IQTVTESKN
>EGALAKHO_00540 Chaperone protein DnaJ
MKKDFYEILGISKNADAAEIKKAYRKSALKYHPDKNPGDKEAEENFKLAAEAYEVLSDPS
KKAKYDQYGHQAFDGSGGFGGGGHGGMNMDDIFSQFGDIFGGGFGGFGGGGGGPRRAKGS
NLRIKVKLTLEEIANGVEKKVKVKRKVQAKGVTYKTCSTCNGQGQVMRVTNTILGRMQSA
STCPTCGGSGQILDKRPSEADAQGMVQEDETVSIKIPAGVVDGMQLKVSNKGNDAPGNSV
PGDLIVAIEELEHEFLKREGENIHFDLYISFPEAVLGVSKDIEAINGKVRIKLEEGIQSG
KILRLKGKGIPSINGYGSGDLLVHVNVWTPKTLNKEQKQFFENALNDEHFVPSPEKSEKS
FFEKVKDMFS
>EGALAKHO_00541 Protein GrpE
MTTENTEFDQELDDVTLENNANGEQLIVEELSVEEQLAQDLAKEKDKFLRLFAEFENYKK
RTSKERMDLFKTANQEVLLAMLPVLDDFDRATVEINKSDDENLKKGVELIHEKLKSTLLA
KGLEQVEIRAGDAFNADFAEAITQIPAPSDKLKGKIVDVIEKGYKLGDKIIRFPKVVIGN
>EGALAKHO_00543 Histidine--tRNA ligase
MASKPSIPQGTRDFSPAEVSKRQYIIQTIKNNFEKFGFQPIETPSFENSDTLMGKYGEEG
DRLIFKILNSGNFFFNKNKIELPESIESLQVNSAETIDLNQRIELNKFTGKISEKALRYD
LTVPFARYVVQHQNEIEFPFKRYQIQPVWRADRPQRGRYREFYQCDADVVGSKSLWQEVE
LVQLYDTVFTSLGLAGVTIKINNRKILSGIAEVIGASDKLIDFTVALDKLDKIGEDGVKK
EMIEKGIAEEALVKVQPLFSFTGTFSDKINQLSDLLASSEEGMKGVQELKFICDNVATLG
LSTATLDLDVTLARGLNYYTGAIFEVAAPKTVSMGSIGGGGRYDDLTGIFGLKNMSGVGI
SFGLDRIYLVLEELQLFPETVAATSKALFINYGDAEALYASQAIQKLRKENIKVELYPDN
VKVGKQFQYADKRLIPFAVIAGDQEIASNSYSLKNLVTGEQVSVDFEGLKNALLS
>EGALAKHO_00544 Macrolide export ATP-binding/permease protein MacB
MMLKLFKENIRIAFGSIKTQLLRTILTVLIIAIGITALVGILTVVTALENTVSTNFASMG
ANTFNINQYENNVKNRGGNKREIINPIISYPEAVAFKNKYKYPFTETSLSFTATSTAEVK
YLDQKTDPEIKVLGVDEHFIGNSGLEISSGRSFNQFDIENNTYSCIVGSDFEKGLLKDVN
PIDKIISIRGARFKVIGVLKEKGSTFGNSQDLRVLIPIQVARSLFTAPNINYTMSVMVSK
KELLDEAVDNATSTMRRVRKLSPVRDNNFGIGRSDDLINRILGITKYLGWASWIISIITI
LGSSIALMNIMIVSVTERTREIGVRKALGATKITISVQFFIETLLIGQIGGMVGIVLGIL
IGFAFAAAMSFAFVIPWMAIFAAFATSFMVAIVSGLYPAIKASQLDPIEALRYE
>EGALAKHO_00545 Release factor glutamine methyltransferase
MKIKQYRTQFIKELSPFYDAYEAESFFYLILEDKHKLRQIDLALNHELNFLESDFVVWNS
LLGQLKKEVPIQYLLGKASFYGLDFEVNENVLIPRPETEELVEWIINENSITDKTKKLKI
LDIGTGSGCIAISLAKNLPNADVYALDVSKKALDTAKRNSVNNNVEVTFMLKNVLELEAL
KSNYDIIVSNPPYVRNLEKVEIKKNVLNYEPHLALFVEDNDALIFYRKIAEIGKKNLLEN
GQLYFEINQYLGKETRDLLDQMNFKNIELKKDIYDNDRMISCKVSKTL
>EGALAKHO_00546 putative N-acetyltransferase
MKNWVIRRIKKEDNQAVAKLIRSVFDEMEIPKVGTAYADPYLDLMFEEYNKPQSVYFVVE
NEGKIVGCCGIAPLENGDPLICELQKMYFLPETRGLGIGSEMMKKCLEQAKVFGFEKCYI
ETMPFMHAAQKLYKKSGFEYLDSPMGCTGHSSCPVWMLKDL
>EGALAKHO_00547 Riboflavin biosynthesis protein RibD
MNTHEKYIKRCIELAKNGFGTTYPNPMVGSVIVYNDQIIGEGWHKKAGEPHAEVNAVRSV
KDKSLLKKATIYVSLEPCSHFGKTPPCCDLIIANEIPNVVVGTVDPNEKVAGNGIKKLIE
AGINVTVGILENECYELNRRFFTFHNKNRPYIILKWAESQDGFLAPEKQIDQERKPVWIT
NTYSRQLVHKWRSEEQAILVGTQTVIDDNPKLNVRDWSGNNPARVVLDQNNRISKESFIF
DDSVKTILFTKSEINFSAENTTFEVIDFNQNIIPQILAVLHQNQIQSIIIEGGLKTLQAF
IDQNIWDEARIFIGKTTFSQGTKAPIIKKKTTTKTHIQNDELIYVRNHD
>EGALAKHO_00548 D-ribitol-5-phosphate phosphatase
MIDTIIFDFGDIFINLDKQATISGLQKLGMTEWNSELDRLNLLFETGDISHDDFLAGFQK
QLPKASIEEILEAWNAVLADFPLYRLEFLQMLSKKYRLFLLSNTDSIHIETFETKSGISF
YSDFYQCFEKVYFSFEIGKRKPNPEAYQYIINKHELSPKRTLFIDDKKENTDAAAALGLH
VWNLQVGQEDVVNLFEKKIL
>EGALAKHO_00549 IMPACT family member YigZ
MEYNDTYQTIAFESEEVLFKEKGSKFFGYAFPIISEEEVKPIIENLKKQHPHAVHYCYAY
QLGTAPKISYRANDDGEPSNTAGAPIYGQIQSFGLTNVLVVVVRIFGGVKLGVGGLIAAY
KTTAQITLEVCEIVEKTIDVQFLISFDYKNMNKVMRVIKEKKLEITSQEMEIDENSGLPI
GKIMTKTRKKNAESVFDIFDLMFEIDIKII
>EGALAKHO_00550 Acyl-CoA thioester hydrolase YbgC
MKNHQTQVRVRYSETDQMGVVYHGNYVPYFEIGRVEWLRDKGISYKSMEESGIGLPIVSM
QINYKKSARYDELLTIHTTFKSQSSVKIEFDCAIYNEANELLTTAVFILVFISLKSGRPT
APPDYILELFKTLV
>EGALAKHO_00551 Chromosomal replication initiator protein DnaA
MTKTAQSVWENCLSFIKDNIQDQAYKTWFEPIKSVELTDNALYIQVPSKFFYEWLEEHYV
KLLKVALTKELGKNAKLLYKIKMENTYGNKQPFTEQLPSANRVPMKPQEVDAPFKNLNPE
LKNPFVIPGIRNLKIESQLNANYSFDNFLEGDSNRLARSAGMAVANKPGGTSFNPLLIFG
GVGLGKTHLAHAIGVEVKDKYPEKTVLYISAEIFTQQYIDSVKKNNRNDFIHFYQLIDVL
IIDDVQFLSGKSGTQDVFFHIFNYLHQNGKQVILTSDKAPVDMQDIEQRLLSRFKWGLSA
ELHQPDYETRISILKNILYRDGVEMPDDIIEYVARNIKSNVRELEGAIISLIAQSSFNKK
EVTIELAKSVVEKFVKNVKREISIDYIQKIVSDYFQLDIETLQSKTRKRHVVQARQLAMF
FAKKFTKASLANIGSQIGDRDHATVLHACKTVDNLVSTDKQFKKFVEDINKKLTL
>EGALAKHO_00552 Low molecular weight protein-tyrosine-phosphatase YfkJ
MPVKILMVCLGNICRSPLAEGILASKLPKDKFTVDSAGTGSWHVGHAPDKRSIAVAQKNG
LCIDAQKGRQFKTSDFDEFDYIYVMDNSNYRDVIHLAKTPEHKEKVHLILNELFPGENVD
VPDPYFGAVNGFDNVYQMLDEVADIISKKLIEKHS
>EGALAKHO_00553 Ribosomal RNA small subunit methyltransferase I
MKLPGKLYLIPTTMGESDPMDVLPQTVKRSIDFIDHYIVENEKTARKSIKAVSPEKKQSD
LILFTLNKRTEPSEHLDFIKPLLEGKNVGLMSEAGCPGVADPGAVIVKLAHEKGIQVVPL
VGPSSILLAMMASGMNGQSFTFNGYLPIDKDEKKSALKHFEKLSQDKNQSQIFIETPYRN
NKLVEDLLQILNPSTHLCIATDITLPTEFIKTMRVSDWKKLKVDLHNRPTIFIIHKM
>EGALAKHO_00554 Methionine aminotransferase
MSKLPNVTTSIFTVMSKMASEYNAINLSQGFPNFPVDERLTDILAKLSKENVHQYTPMAG
YPPLMHQIAKLIQSSYNRTINPDVELLVTAGATQGIFTTILALVKTGDEVVILDPSYDSY
ESPVLLCNAKPVRVALNDDYTPNWETIEKACSSKTKMIIINNPHNPTGKILTENDFLELE
KLLSKYPEILVLSDEVYEYITFEEKHISAHTKDFLLNRCIMVSSFGKSFHITGWKIGYTV
APEYLMKEIKKVHQFLVFSVNSISQFAINEYLNVVDVNLLGKFYQEKRDYFQKLLQNSRF
ELKPCEGTYFQVASYANISNDDDVTFCKKLIIDHGVAAIPISTFYSDHKDQKLIRFCFAK
DNFTLESAAKKLCDI
>EGALAKHO_00555 putative 2,4-dienoyl-CoA reductase
MSYTDKMLRDDALKGKVIVVTGGGSGLGKAMTKYFLELGAQVAITSRDLDKLKATAAELE
TETGGKCLPLQCDVRHYEEVENMLQAVLKEFEKVDVLLNNAAGNFISPTERLSANAFDTV
IDIVLKGSKNCTLAFGKHWIDTKQTSATILNIVTTYAWTGSAYVVPSATAKAGVLAMTRS
LAVEWAKYGIRSNAIAPGPFPTKGAWDRLLPGDLAEKFDMAKKVPLKRVGDHQELANLAA
YLVSDFSAYVNGDVITIDGGEWLKGAGQFNLLEAIPEELWDQLEMMIKAKKNK
>EGALAKHO_00556 Uridine kinase
MLIIGLAGGTGSGKTTVVHQIMTELPDTEVGVISQDSYYKETTNLSFDERALINFDHPRS
IDFELLVKHLKALKAGETIDQPVYSFIQHNRTDDTVSTHPRKVMIVEGILILTNPELREL
FDIKIFVHADSDERLVRRLKRDISERGRDIDEVLNRYQNTLKPMHEQFIEPSKAFADIII
PNDKYNTVAIDVVRAVINQRIS
>EGALAKHO_00557 Cell division protein FtsL
MKIKNPYKGKSWFKFLGNKYVWVLLFFVIWMLFLDNYSYFDHRFLDGQINELQDNKKYYQ
EEIKKDQEQIKQLKNPEQIEKYAREKYFMKKDSEDIYIIQFEGDTIQEKE
>EGALAKHO_00558 Methylmalonyl-CoA mutase small subunit
MATTLFDDFNPISSKQWKQKIQFELDGAEYNQTVIWNSPEDIQVKPFYHRDEFSKAATVK
TEASNFKICQNIFVYDIEKSIQRAINTIERGAESLLFTIENETIDIQKLLETLPLENRIV
YFNLNFISIDFVKKLDTISLQKKAVFYCNIDPIGHFAREGNWFPTSDKNNFETIENIAKA
TTNLSLLSIDLGLYQNAGANITQQIAYSLAHANEYLNRLSNISKPFVFQVSVGTNYFFEI
AKLRALRMLFKLIADEYNPDIECHLLVTPTKRNKTIYDYNVNMLRTTTECMSAILGGADA
VANLPYDALYHKDNEFGDRIARNQLLVLKHESYFDKVDNPADGSYYIESLTTQLAEKSLK
LFKDIEDDGGFLKLLNDGTIKKKIQESAAKEQELFDSKKEVLLGTNKYPNKEDKMKHDLE
LFPFVKIKPRKTLITPIIEKRLAEKLEQERLELE
>EGALAKHO_00559 Methylmalonyl-CoA mutase large subunit
MIRKDLKHINLDSQKLKVESQKSDILADNFFTAEGIELKKTYSEKDLENLEFLDFGAGFA
PNLRGPYATMYVRRPWTIRQYAGFSTAEESNAFYRRNLAAGQKGLSIAFDLPTHRGYDSD
HERVVGDVGKAGVAIDSVEDMKVLFDQIPLDEMSVSMTMNGAVLPIMAFYIIAAEEQGVA
IGKLSGTIQNDILKEFMVRNTYIYPPTPSMKIIADIFEFTSKKMPKFNSISISGYHMQEA
GATADIELAYTLADGLEYIRTGLSTGMTIDEFAPRLSFFWAIGMNHFMEIAKMRAGRMIW
AKLIQQFNPKSDKSLALRTHCQTSGWSLTEQDPFNNVARTCIEATAAAFGGTQSLHTNAL
DEAIALPTDFSARIARNTQIFLQEETKITKTVDPWAGSYYVESLTNELLESTWKLIEEVE
ELGGMTKAIEAGIPKLRIEEAAARKQARIDSGQDIIVGVNQFRLEKEDPLHILDVDNQMV
RKQQIERLEEIKAKRNTEKVNESLEKLIHCAKTGQGNLLEIATEAARERATLGEISDALE
SVFGRYKAQIKSFSGVYSAAIKNDENFEKAKQLADAFAKQEGRRPRIMIAKMGQDGHDRG
AKVVATGYADVGFDVDIGPLFQTPAEAAKQAVENDVHILGVSSLAAGHKTLVPQVIEELK
KHGREDIMVIVGGVIPAQDYQYLFDAGAVAVFGPGTKISEAAIKILGILID
>EGALAKHO_00560 hypothetical protein
MIKKWYFYASLVVIITFLTLGFKPFNLETKPWFLIEKTDGSEYLFPSLDKDDYPESNKLN
VPYTGNHLIGFKEAVAFKESQGKYRLVNSLGYMGKYQFGPQALRSIGVRSGKAFLKDPAL
QEKAFVALLSKNKWILRNEIERYEGKIINGVAITESGILAAAHLGGAGSVKNFFKNKGNR
FFRDAYGTSLRSYMKAFGGYDLSYIEADSNATIND
>EGALAKHO_00561 Endolytic murein transglycosylase
MSLKKIITITAVAVISGLMIYGFILISRIFSANTKFEEKELYVYIPTGANYTDVKKILEP
YIKNFENFEMVANKRSYPENVKSGRFLLKKDMNNIDLVRAMRSNVPVKLAFNNQERLENF
AGRVGSEIEADSLSLMKAIKDSTFMAANGFNEDNVFAMFIPNTYEVYWNTSAEKFRDKMI
KEYHNFWTDKRIAEAKEQGLTPVQATILASIVHKESVKKDERPRIAGVYLNRLRLAMPLQ
ADPTVIYALKLRDNNFDQVIKRVFYNDLVMKSPYNTYVNIGLPPGPIAMPDITALEAVLN
PEKNDFIYFCASVERFGYHEFASTLAEHNVNAKKYSDWIASQGVTR
>EGALAKHO_00562 Spermidine N(1)-acetyltransferase
MITLKGENIYLRALEPNDLEFVYAMENDQSIWEVSNTYTPYSRFLVRQYLENAYQDIYEA
KQLRLAICQDEDFPAIGLIDLFEFDPKNNKAGVGIVIQKNENKRQNIGSEALELLIKYAF
YNLNLHQLYANISVENVASIALFTKFGFEKIGIKKDWILLNNHYQDEAMFQLINKQI
>EGALAKHO_00563 Diaminopimelate epimerase
MQIEFYKYQGTGNDFVMIDNRTNFFPKEDIQLIEQLCDRRFGIGADGLILLENDSDTDFR
MVYYNSDGNESSMCGNGGRCLVAFANQLGVINNQAIFMATDGLHHASVGNDAIVSLQMID
VDEIQKKDSYTFLNTGSPHHVQIVEDLKNYNVKDNGASIRYGELYGEKGSNVNFVKKIDD
DTFSVRTYERGVEDETLACGTGVTAVAIAMNAIGETDKTSINLNVEGGKLNVSFDKLGDH
FTNVFLTGPAKFVFKGTIEI
>EGALAKHO_00564 Periplasmic pH-dependent serine endoprotease DegQ
MKRFSSLFLVSLLSGATTLGAYKLLFDGNNSFFGRENSVVTLAPNSFGRNVALSAETVDF
TAAADKTIHTVVHVKNVSRRTVSNPMMEFFYGYGGQQQQEQVGTGSGVIISEDGYIVTNN
HVIKDASEIEITLNNKKSYTAKLIGTDSKMDIALLKINADEKLPYTAFANSDNVKIGEWV
LAVGNPYNLTSTVTAGIVSAKARNLDTSGIQSFIQTDAAVNPGNSGGALVNTRGELIGIN
TMISSMTGSYVGYSFAVPSNIARKIIEDIMEFGNVQRGILGVEGGELNSTASKELGVTQT
QGFYISKVSKNSGAEKAGLSKGDIIVKLDDQNIATYADLSGYINTKRPNDVVKVTYMKDG
QSKTVPVTLSKNEFFSTEFKGIELENIDDADKKKFRIDYGVKIKNITNDNLMQYQNELQG
NIILSIDNVKATNVETVSKLLSKKDEGQSVRIEMINRNGEIFRIII
>EGALAKHO_00565 Glyceraldehyde-3-phosphate dehydrogenase-like protein
MSKKSLYQKEVSLQVDRRRAGVELIKVISDLWYDKSIEMVLFKNQLLDKNVSDIINLHQY
AGEFVGKPISIFDSVEIAKVILSLDFPPAKLDLGKLTYEYLLEEEKYPDARYFVMEKLKK
AKSTKEIQPKDVVLYGFGRIGRLLARELMSKTGKGNQLRLRAIVTRDKNDASILEKRASL
LRYDSIHGDFQGSVTADPKNNALIINGTTVHIINANTPEEIDYTQYGINDALVIDNTGAF
TTEETLKRHLTSNGVSKVLLTAPGKGVPNIVHGVNHNEYNPDEINIFSAASCTTNAITPI
LKAVEDTLGVAKGHLETIHAYTNDQNLVDNMHKKYRRGRAAALNMVITETGAGTAVAKAI
PSLEGKLTSNAIRVPVPNGSLVVLNLEVKKATSIAAINKIMKKYALEGELVEQIKYSLNN
ELVSSDIVGTSAPSIYDSNATIVSKDGKNIVLYIWYDNEYGYSHQVIRLAKYIAKVRRFT
YY
>EGALAKHO_00566 Leucine-responsive regulatory protein
MALDEIDKKILRLLQENAHYTLKDIANKINLSLTPVHDRVKRLEKEGVIEKYVSILNKKK
LGNNLTVYCQVTLTKQTYDTSEGFNQSILNLQEVVECNYVSGNFDYMLKIIIPDMETYHH
FHQKKLSILPEVSLINTVFVISEVKSTTVLPI
>EGALAKHO_00567 Alanine dehydrogenase
MIIGVPKEIKNNENRVALTPAGVSEMKKHGHTVYVQATAGLGSGFSDDEYATAGAVVLGT
IEEVYAIAEMIIKVKEPIASEYPLIKKDQLLFTYFHFASSEPLTHAMLEKGAVCLAYETV
EKADRSLPLLVPMSEVAGRMAIQQGAKYLEKPLKGRGILLGGVPGVPPAKVLVLGGGIVG
TQAAKMAAGLGAQVTIMDLSLPRLRQLDDIMPANVNTEMSNHYNITRAIKDADLIVGAVL
IPGAKAPHLITRDMLKLMRPGTVVVDVAVDQGGCIETCTPTTHENPTFIIDDIVHYCVAN
MPGAVPYTSTLALTNATLPYAVQLANKGWEKACNENEELKKGLNIANGKILYKGVAEAWN
LPYNEELVLANA
>EGALAKHO_00568 Alkaline phosphatase PafA
MSFNLGSVSHFKCESVFLCKYYNLSMKKSIVLLTLFVISNLSAQQRPKLVVGIVVDQMKM
EYLYRFSDDFSPNGFKKLMNNGYTFQNMHYNYMPTYTAPGHASIYTGTTPATHGIVGNEW
FSRTLGKEMYCTDDAGVKTVGDGTVEEGAMSPKNLQSTTITDEVRMATNFEGKVIGMSLK
DRGAILPAGHFANWAFWYSKTGSFISSTFYGEKLPEWVNQFNNEKNYMPYINKGWDLYKP
ASTYNESLPDNNPYEGKLYGSAAPIFPYDLKTMYEKNDAGILRATPYGNDLLAEFAKRAI
EKEELGKDNITDFLTVSFSSTDYVGHLLGPRSMELQDTYLRLDQTIADFLAYLDKTVGKG
NYLLFLTADHAGAENVIYLKDRKYNVDNYPSKDFKKNLQDFSVKTFGVDLLLNYSNFNIF
FNKQIIKEKGLELAKVKQAFKDYMISLPQIKKVYTEEEILANSGNDYYLNFVAKGYDVTQ
DGDMVIINKPGDMEYSVTGTSHGTPYSYDTHVPAIFYGWHIKKGESYDKKAITEIAPTIA
QKIKVSFPNGTEAKVLQEVLDEKIEKIEKK
>EGALAKHO_00570 hypothetical protein
MNLKIELISLTSESKAIWGKMSVAQMLAHCNVAYEMAYEDIHPKTNPFIRIILKLLVMNS
VVSEKPYPKNNQTASQFIIKAERNFDIERDRLIAYLNKKHELGQSNFEGKESLSFGKLSA
VNGIICSQNIWIIT
>EGALAKHO_00571 hypothetical protein
MKGFVICFFLFLGLSSNAQKQDVQKTVEYFFEGFH
>EGALAKHO_00572 hypothetical protein
MKFHEKILSYTIQIDGTMAHVWAPYEFYLNDKLSHSDVNTFTLFKEKDASKIIYLIDTRR
N
>EGALAKHO_00573 Ultraviolet N-glycosylase/AP lyase
MNLFGETSDWEVKLQPILEKYKGKKHPLEYQNTYQLMIMVILSAQDSDANINKIAPSLFE
KFPTLKSLSLTDSKALMSYISKVRNYPTKTQWILEIAKTLKEDKNIPLNMKELTSLKGIG
RKSANVILRETHQPAEGIIADLHVIRVAPRIGIIKESKDGNKVEKELMQVLPKSIWAEIG
MAISFHGRETCRPKPKCEECMLADICLYYATNVA
>EGALAKHO_00574 2-hydroxy-6-oxononadienedioate/2-hydroxy-6-oxononatrienedioate hydrolase
MAKKETNPIESLKIPQLIILSAKLCAFISTKLATTYAAKLFTTPIKHKVPKRELEMDFKS
VKKAINVPTIGKNIITYQYGTSEHKILLVHGWSGRGTQLFKIADALLKIGYSTISFDAPA
HGKSEGTTTIMSEFIHSILEIEKKIGPFEIAIGHSLGGMSVLNAIKDGLKVDKAVIIGSG
DIVQDILDEFTSKLGLKSEMSIQLRDHFEQKYEVEMDDFSAYKAARKIEIPVLVIHDNDD
PEVPVKAGIHIHKNLEKGLLFLTDGLGHRKILGNQNVINKIITFIKSS
>EGALAKHO_00575 Glycogen synthase
MEIFHISAECYPMAKVGGLADVVGALPKYQTNDGHQVRVVVPYYDTKFKNENDFECVHWG
NVKLGNFDFPFSVLKETTNKLGYELYLIEIKELFDRPNVYGYEDDIERFISFQIATLDWI
SARETVPNVINCHDHHTGLIPFLLKYGYKYESLQSVRTVITIHNGLYQGWFGFDKLHYLP
EFDLIHVGFLEWNNSINSLAVGVKCAHAVTTVSPSYLNEINIAANGLEDLFKSVRSKSIG
ILNGIDFEVWDPSKDQMIAENYSIATFEIGKQKNKERLCEQFELDPTKPLFSFIGRLFEE
KGGDLLPQASALALSENFENINILILGSGNTVIEEQLIQLRTDYNGNYNVFIGYNEELAH
LIYAGSDYILMPSRVEPCGLNQMYALRYGTVPIVRRTGGLRDTVIDFGGNGNGICHDQAS
VGDICYSINRAVKLYGDKINFNEIVKKGMATDHSWERVCQEYIEIYNLIIEKNEI
>EGALAKHO_00576 Glucose-1-phosphate adenylyltransferase
MKFKKKNVVAIILGGGQGSRLFPLTETRSKPAVPIGGKYRLVDIPISNCINSDIFKIFVL
TQFNSASLNAHIKNTFNFSIFSQSFVDILAAEQTPDNPTWFQGTADAVRQCMSHFLKHEF
DHALILSGDQLYQMDFNEMLEAHIAANAEISIATLPVNAKDAPEFGILKTDHENNIHAFI
EKPDASLLPEWESEVSEHMQEKGKKYLASMGIYIFNRQLLEDLMADPHTKDFGKEIIPQA
VGKHKILSYQYEGYWTDIGNIESFFEANIGLTADIPEFNLFDNDNKIFTRPRLLPPSKFR
NSIINQSLISEGCIINAQEIKRSVIGIRSRIGAGTVLENCYVMGNDFYQDLDELNHEANN
NKIHVGIGENCFIKNALVDKNVRIGNNVHISGGKHLDNFTNELYSIKDGIVVIKKGAILS
DNFRIE
>EGALAKHO_00577 1,4-alpha-glucan branching enzyme GlgB
MSKVITHSLFTDFDIDLFKAGKHFKLYEKLGAHLVEVNGVKGVYFAVWAPTAQSVSVAGD
FNYWTGNEHQLQVRWDSSGIWEGFVPEITKGALYKYKIQSNINGIVTEKADPFALYCEKP
PHTASVVWDLDYKWKDENWMQSRQNHNGLDKPYSVYEVHLGSWKRGEHNRFLTYLELADD
LVSYVKETGFTHVEFMPIMEYPYDPSWGYQLTGYFAPTSRFGKPQDFMVLVDKLHQAGIG
VILDWVPSHFPDDAHGLGFFDGSHLYEHPDRRKGYHPDWKSLVFNYGRNEVRAFLISNAV
FWLHHYHADGLRVDAVASMLYLDYSREEGEWEPNIYGGRENLDTISFLKEFNEVIYTNFD
GVQTIAEESTSFPMVSRPTFTGGLGFGMKWMMGWMHDTLKYFQKETVYRKYHQNDLTFSM
TYAFTENFMLPFSHDEVVYGKKSIANKMPGDEWQKFANLRLLYGYMFTHPGTKLLFMGSE
FGQSDEWNFEKSLDWHLLQYDYHTGVKRIITDLNQLYKSQPALYEKQFTGEGFEWINYSD
QQNAVLSYIRKGNNAKENLIIVGNFTQVVRENYRIGISQKGKLIEIFNTDATIYGGSGIA
NSGSLKIESSPYDGRDYSVELTLPPLSVTVYSFG
>EGALAKHO_00578 Oligosaccharide 4-alpha-D-glucosyltransferase
MITNTSLEYKGDLYPSKIVSYEHEGDSIFFHTDNKVILKVTILRDSLIRFRFTTKGYFSN
DFSYAIDKTQLHGYNFLELTEEETYFLIRTSKVKCKIQKADLRLSIYDLSDLLILEDELG
FHWEESYEYGGNIVKMSKSSKDGECFYGLGDKATQMNLKGKRLENFATDQYAFQKEQDPL
YKVVPFYIGLQNKQSYGIFFDNTFRTFFDFCQERRNVASFWAEGGEMNYYFIYGPQMQDV
VTTYTDLTGKPELPPLWVLGYHQCKWSYYPESKVKEITSKFRELKIPCDAIYLDIDYMEG
FRCFTWNKEYFPDPKKMVAELAEDGFKTVVIIDPGIKIDKDYWVYQEALEKDYFCKRADG
PYMKGKVWPGECNFPDYTNPVVREWWAGLFKELISDIGVKGVWNDMNEPAVMEVPNKTFP
MDVRHVYDGNPCSHRKAHNIYGTQMARATYHGVKRFAYPKRPFVITRSAYSGAQRYTSSW
TGDNVATWEHLWIANIQVQRMCISGMGFTGSDIGGFAEQPTGELYARWIQLGVFHPFCRT
HSSGDHGNQEPWAFDEEVIDITRKFVSLRYQLLPYLYTMFWQYIEEGVPMLKPLVYYDQE
DIQTHYRNDEFIFGNQILVCPILEPNAVGRRMYIPRGEWYNYWTNEFAIGGREIWVDTKF
DEIPVFVKAGAIIPKYPVQQYVGELEFDELTLDLYFKIGKEQSFVYEDAQDGYDYKKGRY
SYLSFRTIGKEKELIIQLHKEGKYDTPYSKYKINLIGLPFKVTEIEIDNEKVEFDKIVFE
SSHVLLVDKGFNELHIIGE
>EGALAKHO_00579 Beta-barrel assembly-enhancing protease
MKKYLPIGIFAALLVCACATNPITGKQNLNFVSNSELFPTSFQQYNAFIAENKVITGTAD
AKRVDLVGSKIKAAAEKYLAYLGQTQYLKDYRWEYKLVDNKEVNAWCLPGGKIVVYSGIL
PVTQNESGLATVMGHEVSHALANHGAQRMSAAQLQQIGGVALDAATSNKSESTRQIFSQA
YGVGSEVGVMLPFSRSNESEADKIGLTLMAIAGYNPDDAIAFWSRMSASAGGAGTPEFMS
THPSDATRIANLKALVPEAKAIALKVGVVR
>EGALAKHO_00580 hypothetical protein
MKNLQKGDKKLLNAWAFYDWANSVYTLTIASAVFPIFYEALFSKDNHYIDVFGMHLKNSA
LISFTTAFAFLVVSFISPLLSGIADYVGNKKSFMKFFCYLGALSCMGLYWFDLDNIYIGL
AFYFLGLIGYWGSLVFYNSYLPDIAFEEQQDKISAKGYSLGYIGSVILLIINLAMIMKPK
LFGITGTDGEAAMKAMRYSFIMVGVWWVLFSQYTYYYLPKGSKENGQKLTNDVIFNGFNE
LKKVWALLQENIPLKRYLGGFFVSSMAVQTVMLVATYFGAQEIQWSSKEEGTIGLIICIL
IIQLVAVVGAVLTSRASAKFGNIPSLIVINIIWAVFCALAFFITLPIHFYVMATVAGFVM
GGIQALSRSTYSKLLPETEDTASFFSFYDVAEKIGIVIGMCVYGIIDQITGSPRAAIVIL
GVFFVTAIFLLRRVHKKETVN
>EGALAKHO_00581 Beta-lactamase
MNKITFLLLLSFSISIFSQQKQNNFSEKKILAAITQTANTLLKDSKGHSVSIAVVQNGKS
YIRHFGLIDKENQANDNTLFEIASVTKVFTGTLMATAVLEKKIKLDDDIRVYLNEAFPNL
EYKGNPIRIKDLLTHRTGILTPFPDTKEIRQKYSPDSFLVHKNRLDKSYTKTDFFNALKK
VKVDTLPGTTFKYGALGPELCAHILENVYKKDYEDQLHEVIFDKLKMNSTKIKLNKYDIV
ANGYNEHELLMIPLSSNLWGASKMLKSTISDLTKFIKFELDRNNKMVLESHRKIASNPDM
GYFWEIQTDNNGNVSYSKDGGSNGTQNILKIYPESNFGFIILMNQSDKNSGTYLESAVNN
LLNNLKSTSITNK
>EGALAKHO_00582 hypothetical protein
MKKIIQLAVCGAFLIGLTAKAQEKINGNGKVVTETRTTSEYDAIKISGFFDVDLVAGKEG
KITIKGEQNILSSIIVEVEDNALKIHVKKGINLRPSTGQKVELTVPFDKISELSLSGSGD
ITTKSPIKNDKFSAKLSGSGDIDLDVVTNSFDFALSGSGDIKLKGNSDTLVIKLSGSGDI
EAANLKSKNANITVSGSGDVKVNCNESLTARVSGSGDIKYTGNPEKRDVKVSGSGSISKA
>EGALAKHO_00583 hypothetical protein
MKKHYKVLILFILIPFLGFSNDDTFISKQKSIKKTYIVNSNAGIDIDNKYGNISVSTWDE
DKVDFDISIKVTGPNENWVNERLNNIDIDITALKSMVTAVTNLGSSSLKSKGSNNSFEIN
YVIKIPKNGTVKLMNKYGNITILTLEGASDITCKYGKVTAGKLNNTNNRFQIEYCQNSTI
DYIKNGNVEARYSGLKINDSGNLNLDTNYTDLVISDGQNIKYDCNYGTLKFQKISSFSGS
GNYLTISIAEISNNVNVDATYSKINISNITSKANNVNINTDYTDISLGYDTNYAFDFDIN
TKYGNVKSDNTLDVSVTESKNTSKRISGFNKKKGQNKVIINSNYGNVTLIKKQ
>EGALAKHO_00584 hypothetical protein
MKKENDNLDELFNKFENQWDVQEMSSDHQLDFLNKLNKKQPNRKNHWFVTAIAASIVLML
GISLFYKNEKPKEFKFASKETQRTDSIFSILIDNELVKLKEKSSPENEQIINDALKQMKV
FDADYQKIITELQKNGENKQIIYAMISNLQTRISFLQTVLKRIEENENLKNTTDEKTL
>EGALAKHO_00585 ECF RNA polymerase sigma factor SigW
MSITNQNIEELIALCRNNNQKAQFEIYNRYSKAMYNVAYRIVKDEHFAQDVMQEGFLKAF
TKINDYKQEVAFGAWLKKIIVNYSIDFYRKNNAFQVEDLSKTLYKIEENDSFFSENIDLN
SLKVRQVLDTILGLKDNYRMVLTLFYIEGYDQEEICEILNISYANCRTTLSRAKESLRKK
LEEI
>EGALAKHO_00586 hypothetical protein
MKSVIKIRFNRLYLIKSYESRSMKNIFCFLLLFCLTSCTKDDDGTKHNLPSESTEGKNTF
GCKIDGVTFLPRSLGGFSAGYKFPILSANYFKLDEKYYDFEPGYHLRIIAINEITNKDIV
IKLIRSDQPLMEGKTYPINIEGDGLFNARYSAPTTEPAKDIKAYIYTDHIYKTSEEYSGE
IKITKIDEVNLIISGNFWFDCINKADNTTAKISDGRFDIKYVPYVE
>EGALAKHO_00587 Lon protease 2
MSNHKILTIDNLSLQEFDSEAELIPLLTPEDEEEMNNEELPLSLPILPLRNTVLFPGVVI
PISAGRDKSIKLINDANAGGKIIGVVSQINEEDEDPSKDDIHKIGTVARILRVLKMPDGN
VTVILQGKKRFEIDEVVSEEPYITATIKEVSEDRPDENDTEFTAILDSVKELAIQIIKES
PNIPSEATFAIKNIESQSFLINFVSSNMNLSVKEKQGLLSINGLKERALETLRYMNVELQ
KLELKNDIQSKVRFDLDQQQREYFLHQQMKTIQEELGGVSQEEEMDEMGQKAKTKKWDEK
TQKHFEKELSKMRRMNPQSPDFGIQRNYLELFLELPWGEYSKDKFDLKFAQKVLDKDHFG
LEEVKKRMIEHLAVLKLRNDMKSPIICLTGPPGVGKTSIGRSVAEALGREYVRISLGGLR
DEAEIRGHRKTYIGAMPGRIIQSLKKAGTSNPVFILDEIDKLSSGNSGDPSSALLEVLDP
EQNNAFYDNFLEMGFDLSKVMFIATSNNMATIQPALRDRMEVIKMSGYTIEEKVEIAKRH
LFPKQLEAHGLTSKDLTIGKKQLEKIVEGYTRESGVRNLETKIAQVIRNAAKAVAMEEEY
NKKVTDEDIVTVLGVPRLERDKYENNDVAGVVTGLAWTSVGGDILFIESLISEGKGSLSI
TGNLGTVMKESATIALEYIKANAKKLGLSVELFQKYNIHLHVPEGATPKDGPSAGIAMLT
SLVSLLTQKKVKKSLAMTGEITLRGKVLPVGGIKEKILAAKRAGIKEIILCHENKSDIDE
IKAEYLEGLAFHYVKEMSEVLALALTDQNVKNAKTLK
>EGALAKHO_00588 hypothetical protein
MLKRFVLLFFILICSISYGQIGGRYTYQFLNLTSSPRQAALGGENITIYDEDVNQAMANP
AALNEDMDNHLAMNYGSYYGEASYGTASYAYTYDRHVQTFYAGVSYVNYGTFDGYDENGQ
STSDFSGSEAALSLGYAYNIPFTDVHIGANAKLITSTLETYNSVGGAIDVGIMYQIEKNN
VNLALVFRNIGTQFTTYSGIQENLPFEIIAGVSQELEHVPLRWHISLENLQQWNISFSNP
VRGETNIDGTTSEEKVSFVNNALRHAVIGVELFPGRAVNLRLGYNFRRAEELRIDEQRNF
SGISLGFGLKMNRLKFNYSYSRYTLAANTSLFGLILNFQ
>EGALAKHO_00589 hypothetical protein
MKLFYLILFVTAGFFNTSKLNFKDESLSEVEVERINFHVNTVREMVYAGPQYNTKIAFLV
DMRIKSGKNRFFVYDLVSNKIIDQGLVAHGSGSETPVGGELKFSNEPNSNCTALGRYSIE
KCYKGIFGKAYRLNGLDETNNNALKRAIVLHHYSAVPLDEQDHYISRSHGCPMVNEEFFK
RIEKIIDNSKSKIILDIYY
>EGALAKHO_00590 hypothetical protein
MKKILIVFLMILFVFIGYKIIYKDKYSSDATTAINVKYINEVKKLIESNKKYNKRIAFFI
DMKIPSGKNRFFVYDLKTNRIIDKGLVAHGSGSETNVKGKLKFSNVPNSLSTSLGKYYIG
NSYYGKFGKAYKLYGLDKTNSNAFHRDIVFHYYFDVPYQEQKGYICNSFGCPMVNKKYFD
RTATIIDDSESDIVMSIYY
>EGALAKHO_00591 Cytidylate kinase
MKKITIAIDGFSSTGKSTLAKQLAKELEYVYVDTGAMYRAVALFAMQNSFIGADSFNKES
LIEALPKIQLEFKYNADLGFAEMYLNGENVEKQIRTIEVSSYVSKVAEVSQVRSKLVEQQ
QEMGKNKAIVMDGRDIGTVVFPDAELKIFMTASAETRAQRRFDELQQKGDDVSYEDVLKN
VVERDYIDTHREDSPLIIADDAIEIDNSYLTREEQFEAVLELINDVVKTA
>EGALAKHO_00592 Xanthosine permease
MGIKNRLIVMSFLQFFVWGAWLITIGNYWFGTKNWEGTQFGLVFGTMGIASLFMPTLTGI
IADRWVNAEKLYGFLHIAYAVVLFGIAQVTTPDTFIAVMLIAMCCYMPTIALSNSISYTS
LKLNDKNIVKDFPPIRVWGTIGFIVAMWITNLSGSKATEYQFYIAGIGAVILGIYAFTLP
KCEPQRLTKENASLTETLGLEAFKLFGNYKMALFFVFSMFLGGALQLTNAYGDVFLDEFK
HFPKYADSFVIKYSTIIMSISQVSETLFILAIPFFLRRFGIKQVMLISMLAWVLRFGLFA
FGDPVGGLWMIILSCIVYGMAFDFFNISGSLFVESNTDSKIRSSAQGLFMMMTNGVGAVL
GSLTSGWAIDRFFTKSFHNTIELSGFLQTETTNPKMLEFVKSQGNSISPEGIFSNPILMK
DWHTIWLSFAAYALVIAIAFAVLFKHKHDPKEIENLSH
>EGALAKHO_00593 hypothetical protein
MKQEHNLSQSFFTIIALTLLSIYTLMVFLFIFEFSDNYKFIKHKNEFKKIKVKIDSTKTS
STRSGKSSASSTSTTFYFKKGHLLSATETEGIILNKKSYEQEINEYMFNHQDSLNIWYLD
NQTAKFAYEDQKKLDISEEVKNNNKLKIYFIIYILLLSLFLKFRNKF
>EGALAKHO_00594 30S ribosomal protein S1
MSEQLKSQEEFLANFNWHNFQEGIDAVDEKNLQEFEELVSKTFIATDQEEVVEGVVVRIT
DRDVIVDINAKSEGVISLNEFRYNPNLKVGDKVEVLIDIREDKTGQLVLSHRKARTIKSW
DRVISANETGEIVNGFVKCRTKGGMIVDVFGIEAFLPGSQIDVKPIRDYDVYVNKMMEFK
VVKINHEFKNVVVSHKALIEADIEVQKKEIIGQLQKGQVLEGVVKNITSYGVFIDLGGVD
GLIHITDLSWSRINHPSEVLELDQKLNVVILDFDDEKTRIQLGLKQLNAHPWDALDANLT
IGDKVKGKVVVIADYGAFIEVAEGVEGLIHVSEMSWSTHLRSAQDFVKVGDVVEAVILTL
DRDDRKMSLGIKQLTQDPWTDITSKYPVGSKHTGIVRNFTNFGIFVELEEGIDGLIYISD
LSWTKKIKHPSEFVNVGEKLDVVVLELDVEGRKLSLGHKQTTANPWDQYEDSFAVGTIHN
GEISEIVDKGATVEFGDDIVAFIPTRHLEKEDGKKLKKGDTADFKVIEFNKEFKRVVASH
TAIFREEEEKNVKAATENTSSNSSNTNAPAATLGDNNDVLAALKAKMEKTEKK
>EGALAKHO_00595 hypothetical protein
MENLSKKVRSKKLSTRVDLTAMVSVSFLLIIFFMVRIELAKPKLMEYGRPDCDDCYPDLG
CYNPDPNRIMTILLDENDKIITYMGLLYAPIQQPKQVQYGKNGIQKELLVTNKKVHEYSA
AIGRPQIGVTVIIKPSKKSNYGNLVAILDEMKITGIKSYSILDEFTPEESKLLAQK
>EGALAKHO_00596 hypothetical protein
MSNLNEKKVRSKKLSTRVDLTAIVSISFLLIVFFMVTIELAKPKVIDLSLPDNDVTCGGW
HGCGENRIITILLGENNKLISYMGILESPISPAKEMKYGKEGIRKELLKRNKSEIEYSNS
FGRPKRGAIVIIKPSKKCNFKNLVDILDEMAIARIETYAIVNEFTPEESKLLASK
>EGALAKHO_00597 Ferrous-iron efflux pump FieF
MENKTQSDHGSNHIIQSLLVNVAIAVSKGFAAFMTGSGTMLAETIHSTADCANQLLLLLG
VKQAKKDADDEHPFGYGKSVYFWSFMVAMLLFSIGGMFSIYEGVHKYNNPEPVHNIGWAI
GIIIFSIGMEGYALISNIIELRKRKKTIPFFRYLHVTKDSDLIIIFGENAAAVLGLFIAL
IALLLSHYTSDSRYDAIGSLAIGIVLIAVAIFLATEVKSLLIGESADPIILDAVKRIADE
NVNITEVINCRTVQQGPAEVLVCIKIKLVPDLTTQKISIIINGFEKELRFHHPEVKYLYI
EPDFQEWKSI
>EGALAKHO_00598 Immunogenic protein MPB70
MKSRKFLASAVLALTFGFTSFAQKTVMVGGAAMYPNKNIVENAVNSKDHTTLVAAVKAAG
LVETLQSKGPFTVFAPTNAAFDKLPAGTVETLLKPENIKTLQTILTYHVVAGKMNSSDIA
KAIKMGKGKATLKTVSGGTLTAWMDGKDLYISDESGNKSKVTIADVNQSNGVIHVVDTVL
LPKM
>EGALAKHO_00599 Threonine/homoserine exporter RhtA
MKNKEFNIPPVPAVLLAIISVQCGAAIAKTLFPAIGAAGTASIRIGISALILLLVYRPNL
KAITPEQWKIVVPYGLSLGAMNLIFYLAIERIPIGLAVTLEFIGPLLVAIIGSKRVIDYC
WVLLAAAGIILIAPWSNERIDSLGVLFALIAGALWAAYIVLGGKISKIMNDGQAVSTGML
FAALLVLPFGFLENGLVNLTPKLFGMGVALALLSSAIPFTLEMKALGQLPPRTFSILMSL
EPAAASVCAFIFLQENLSFYEILAVVCVVVASAGSTLTAKK
>EGALAKHO_00600 hypothetical protein
MFKILAKINKVLLPSFTKQGLDISKAKKWQMAIIGYRAYVTKRALE
>EGALAKHO_00601 hypothetical protein
MEALFIFIAKSSGLLILFYFAYFFLLRKETFFNSNRWFLLAGLITSLILPFLVYTKIVWV
DPTPMPVVNYSSGYIPHNIINTIPEESFEINWNYVALAIYGIGFLVLIIKFAADFYSLNS
VLKGKKVQQDADFKFIDIDENIAPFSYFDYIVYNSSLYSALELESILEHEKVHSDQNHTV
DVIISRIFCVLFWFNPIIWLYKKAVLQNLEFIADSEAAKKISDKKAYQYTLLKITTHETC
VAITNHFYQSLIKKRIVMLNKNQSKKTNYWKYCTIIPALALFVFLFQIKTIAQEKKSTHE
VIKTTSDDVYKIEKTTTDQELKVIAEKIKQNHDFDVAISNVKRNSNKQLTAIKMNIKKGT
QEVQTIQIDGDEAIKSFGLVVSTEDNGVKKIGVVTDGEPNKSMMLQDRIADVNEANSPDE
MDDVAPPAPPAPPARVGSIAPPAPPAVPAFPGGAMPKLPTIDMSKMPKAPAAPANPRDKV
AMAKFEKDMAEFEKKMEAFEPDLAAYEKEVNTIMSKHEAIYGKDMEKYEVAMEKYTKYME
DIYGKDMKEYEKNMKQYEKDMKQHEKELKKLEKDYKKS
>EGALAKHO_00602 Penicillinase repressor
MVKLTNKEEEIMHILWKLKKAFVKEIQAEITDDQPHYNTLSTIVRNLEEKGYVSHSAFGN
THQYYPIVSIEDYRKGFMNTAIDNYFNSSYKTMVSFFAKEEKISAAELREILAMIETPKE
GK
>EGALAKHO_00603 hypothetical protein
MEALFIYIAKSAGLITLFYCAYYILLRKETFFNSNRWFLLTGLITSAVLPLAVYTKVVWV
NSTSVSDVNYSSLYSTPVEKDGIEMNWNLVLLVIYGLGVLALLIKFAFDFYSLNSVLKGK
QIKQQADFKFVDINENIAPFSYFEYIVYNSSMFTASELESIIEHEKVHSDQNHTIDVLIS
RAFSILFWFNPIMWFYKKAIIQNLEFIADKEAAQKISDKKAYQYTLLKITTHESCLSITN
HFYQSLIKKRIVMLNKNQSKKRNSWKLYVVIPALVAFAVLFQVEVIAKEKKETVKEITEN
SSVDVYKISKTTTDQELKEMAEKMKLNHNVDAKVSDIERNSNNELTAIRFDLKRGSEQSQ
SYRVKGSTAIKNCEIVIETEKDGSKKIGLKTDNENGNVTAINKERKVEVNKIENSNINSN
VKTTDNINTNISTSTNTNTNVNTNVNTDVNTDVNTNVKVGFSKDLKSPAKMANSVSTTTK
GNNNLKQLIIINGEIVYDVDIHELDPENIKEMNVYKSSEAIKKYGDQGKDGAIEIDTK
>EGALAKHO_00604 Penicillinase repressor
MQKLTNKEEEIMHILWKLKKAFVKEVQAEITEDQPHYNTLSTIVRNLEEKGFVAHNAFGN
THQYYPIITLEAYSKKYMKTAIDNYFNSSYKNMVSFFAKEEKISAAELREILAMIEEPKE
GKK
>EGALAKHO_00605 Multidrug resistance protein MdtG
MLKTAANHYINNFRGFSREIWILTLVTFINRAGTMVLPFLSKYLKEDLHFSYNQVGWIMV
SFGLGSMLGSWLGGKLSDKIGFYKIMIFSLFTSGVSLFFVQYITTFWGLCIAMFILMVIA
DMFRPAMFVSLGAYAKPENRTRALTLVRLAVNLGFAAGPALGGLIIMGIGYSGLFWVDGA
SCIVSISIFALLVKEKKKVVHEDQIESGSDKKSVFHDRIFWVFLFVSFVTAMIFFQLFTT
LPLYHNEKFGLSEFQTGLLMTLNGLLIFALEMPTVGFMERKGFPKIKIIILGSFVMASSF
FLLLINIWAGILVISMICISIGEILTFPFSNAFALSRAPRGQEGRYMALYTMSFSLAHII
SSKVGFEIITRLGYQINWLFMASIGVVATLCCFWIKKALVLEKK
>EGALAKHO_00606 hypothetical protein
MKKIAFFTLLLLFNLGFSQKKFDKKETEKFQTTINSEYADPKTSPLMEEDLKVFKTLDFY
PINAKYFVTAKFVKAKNEKVFEMKTTGTRTPKYVKYGTLYFTIEGKKMQLNVYRSIDLSK
TEEYKDHLFLPFSDLTCGKESYIGGRYIDLKVPKGNTIAIDFNQAYNPYCAYNHKYSCPL
VPLENDLNIEIKAGVKTFH
>EGALAKHO_00607 D-aminoacyl-tRNA deacylase
MEFFNFHTHQFTNQPGILELVNQYPNEFNASIPFYSIGIHPWYIVADRIEADLKIIEEKL
QTENCLALGECGLDKRIEIPLEQQIIVFEKQLALAEKYKKPVVIHCVAAFQEVIEIKKRM
KISVPVIIHGFSKNLQLAKQLIEAGFYISFGKYLLRNPDLKTVFQNVPNDRFLLETDTIE
ENIQQVYELASEYKNLTIKELKGIISSNFEDIFRKNKE
>EGALAKHO_00608 tRNA threonylcarbamoyladenosine dehydratase
MAEWTERAELLFTKEGLGNLKSANVLVVGLGGVGSFAAEFLARAGVGNMTIVDGDVVDIT
NINRQLPALHSTVGQPKITIVGDRLMDINPELKLTRVQEFLSPERAFEIVSPEFDYVLDC
IDSITPKLNLIIAAKRKRVKIISSMGAGGKMLASKVKVADISKTINCYFSKAIRKRLKAV
KINKLKVVFSSEIQDEKSLKLTDGKNFKKSFYGTNSYMPGLFGLHAAETVIRHLLKKE
>EGALAKHO_00609 Phosphorylated carbohydrates phosphatase
MIKTVIFDMDGVIVDTEPVHRYAYYKQFSELNIEVTEEMYTSFTGFSTRNTFQSLKGFFP
TIEHEVEDLIQRKRNIFNDAFDTKQDLYLLEGVEDLIKDLHATGIQLILASSASKVTIER
VFTRFNLHQYFSHIVSGEDFPQSKPNPAIFLHAASLSIAPKENCIIIEDSTNGVKAAKAA
GIYCVGYNSHHSKLQDLSDANLIINHFNELNAQKISQLGS
>EGALAKHO_00610 hypothetical protein
MKKLLIALAIIIAPFATEAQIKTPQASPKAYIKQTVGLTDVEVTYSRPGARGRAVFGNLV
PFGKLWRTGANENTIINFSDDVIIDGKTLKKGKYAIYTIPKIESWEIIFYLSTDNWGLPE
NWNDAYVSLRTTVKENALSTPVETFTIGINGLDPNFAYLEMAWENSHVALKFEVPTAKTA
TASIEKTLAGPSSNDYFSAAQYLFQSNGNIETARTYVDKALDMSTEKPYFILRLKSLIQA
KQGDKKGAIETAKASLAAAETANNQDYVKMNKDSIAEWSR
>EGALAKHO_00611 Transcriptional regulator AcuR
MSPKERILEKTFSLFHQHGYNATGINKIIEEAKVAKASFYQHFKSKEDLCVAFLNERHSY
WFKQLEQFTSKEKEPKTKVLTSFDFLIFMNEKENFRGCSFLNILSEIPSDNTKILNVLQS
HKQDLRVYFQDIIVDKLLSDHIYLLFESCIIESQLFKSNQLIEQSKKIIQTLIS
>EGALAKHO_00612 hypothetical protein
MEQKLPLPPFTLETAKEKIQLAEDAWNSQDPERVSNAYTVDSEWRNREQFVNGREEIVRF
LTQKWKRETNYKLKKEYWAHTENRIAVHFEYEYQDLNGNWFRAYGNENWEFDSNGLMQKR
FASINDLPIKEEDRKLK
>EGALAKHO_00613 hypothetical protein
MKDLKKYSNKTKAAFILLVVMLIILLSNFNTLQNSKKVNENINAIYNDRLMVSHYIFQYA
KELHFIKSEAEKLDVSDNIKKDEIIHTLKIVHNIDDLYAKTVLTNKEKEHFDAFLASCKE
INNQVENKNWNKIAYSSGEALKTLESLSQIQIKEGKAKLASANKMYNDNNSLGQLQIALL
IILGGITFYLLIVKKIKRNIKIPEPPSLN
>EGALAKHO_00614 hypothetical protein
MLLILAPYILVPFIITFLFRQFNLESKKLTYYITGLLMFFYPILFFWIKDLIDPPTSGFR
CGNPQMAFIFLNIIFFLPISLLFQLAFNKSYL
>EGALAKHO_00615 hypothetical protein
MKKKHPILKTIKRIWFFIAISFTIWMVYSYQSKGVSKSFLKSDTTISVRDNENYFLFEPK
QKFDKVFIFYPGAMVDPKAYVPLCRKISENGIKVYLIKMPWRLASKGYEIPKKLHLFDDK
TKTYILAGHSQGGKMAAQFVKENPGLVDKLILIGTTHPRDISLANSTIQILKIYGSDDGV
ADEYTIFKNKSKLPKTAKFVKIEGANHAQFGYYGFQFGDNSARISREKQQSETLRYILNF
IN
>EGALAKHO_00616 Sodium/glucose cotransporter
MQLFDWIVLIVTLLFIVGYGSWKTKGSKNVEDFILGNNETPWYTVGLSVMATQASAITFL
STPGQAYHDGMGFVQFYFGLPIAMIVICVTFIPLYHKNKVYTAYEFLEKRFDVKTRSLAA
ILFLVQRGLGTGLTIYAPAIILSALLGWNLTVMNIIIGLLVIIYTFSGGTKAVNVTQKQQ
MFVIMSGMFITFFLILHYLPNDMTFTSAMHIAGANDKMNIVDFSFNPEEKYTFWSGITGG
FFLALAYFGTDQSQVGRYLSGKSVRESQMGLIMNGLLKVPMQFFILLTGVMVFVFFQFNP
VPLNFNPNNKIVIEKSAYKEEYHALEKKLITLSEDKKVINLLYIDQLNQDYDNPILRKEL
VALSNKEKDLRDRAKEIILKADSNSETNDKDYVFFHFILHYLPKGLIGLLLAVILSAAMS
STASGLNALASTTAIDIYKRNLKTEKSEKHYLNATKFFTLFWGVIAILFACVGTLFENLI
QLVNIIGSIFYGTVLGIFLVGFYLRRVQAKPMFYSAIISQITIFIIYYFMIAIYPSGQEK
LGYLWLNFIGAILTIVLALLMQVLFFKGRPDVEEVVLE
>EGALAKHO_00617 hypothetical protein
MEAKKEKKWKKSYTYVLVANAIYILIFFLIMQLYS
>EGALAKHO_00618 Mycothiol S-conjugate amidase
MRKIQLQILFFFITGISISYAQQPQKPSSVEIYNQIKKLNFLGSVLYVAAHPDDENTRLI
SYMANEMNARTGYLSLTRGDGGQNLIGPQLRELLGVIRTQELIEARKIDGGEQFFSRAND
FGFSKNPDETLQIWDKDKVLADVVWTIRKFQPDVIINRFDHRSPGTTHGHHTSSAMLSVE
SFKLTNDAKIYPEQLKYVKPWQVKRQFFNPSWWFYGSQEKFDAANKSKFTKLETGVYYTG
IGKSNQEIAALSRSRHQSQGFGSTGARGEETEYLELINGETPTERDNLFDGIDTSWNRVK
NGKPIGELISKIISKYDFSNPSASISDLVKVYNMIEALDDDHWKPLKSTAIKNIIASCAG
LYLEAVATEQEATPGSTIKLNLEMINRSPVEMQLKSVTSLPDNKTTVQNSVLKNNNDQKS
ILQIQLPDNLEYTQPYWLKEKASVGMYTVSNQENIGIPDIIREVKVVFNIKINNVEIPFE
RTVVYKYNDGVKGEMYNFLDIVPEVTTSISERVLIFKDTKSKMIPVKVRAGKDGITGNLQ
LDLPKSWVVSPKQIPFSLSKKGNEQTFYFEVTPPVNQEETVAKAIATVDNKRFDKDETII
DYSHITKQMVLKPAESKCIRIDLKNSGDAIAYIMGAGDEVPESLAQMGYKVTILKPEEIT
PERLDSFSTVITGVRAYNTVNALANKQKILFDFVKSGKNMIVQYNTFGKMVTDQIAPYPL
KVSNDRVTEENAKITFLAPNHPVLNTPNKITEKDFQGWTQEQGLYYPDQYDPAFTPIISS
HDKGESAKDGALLIAPYGKGYYIYTGLSFFRELPEGVAGAYRLLSNIISLKQPIEAPKQE
LKK
>EGALAKHO_00619 hypothetical protein
MKKSVYLFSFLAMSLFTFCDNNDDTTTGDNQSKVNNVEINNDVTSLNKRLDYTNSGVITI
TNNSTSKLLKSSESANDLALVQIAEVNPPIDKSGNTLQANHVAVNGNYAYVAYTMRGGAY
SGAIDVIDISDPYKPKLITSALIANTDITSLTYSNGNLIIAGATDIDKDATLTSPSIVIN
MQLSSGLLTDKYTINKLEGQVTTDVAANSASYFGVTGDNGSLFKINSSSKTISGKVTVED
LRSVAVNGDKIITLSGTKGVNIYNESTLALQKSFTTSKDVSEAKRTMDFDGTKLLVSEGH
NGLGVYDINSGSKLQTIGISVPGEDNVTNAVSVNDGYAFIADGALGLSVYKSGSQLGFVG
YVGITGSSNYVKSSGDYIYVASGKGGLKIIKMEKPNPSFSNCSQYGTYNQGQNLILNSNE
IKSYSGSTAITSVIVNSGGVLTHCGAITVQNTLILNSGGTFNMRGTLAQGKYQQQNPTEL
IINSNATLQIEGSVVIWGDLRLNSGAKINFIGNDSSITIYGKVTKNSGVTITGNYKDTEN
KLK
>EGALAKHO_00620 hypothetical protein
MKTIKIAIAGLFLLVANATQAQVSINVNIGTPPAWGPAGYAETEYYYLPDIEAYYDVRAS
QFIYFGGGRWVRATYLPRQYRNYDLYGGYKVVLNDYHGRTPYTYFDRHRVTYYKGYHGAP
QRPYRPRPVYGYNDRHDNHRDYKHYDKHDHHDKHDHHDKHDGHGPGRR
>EGALAKHO_00621 hypothetical protein
MSLKKKIVVLILLCFCLQGSYAQIDKKTTNQGKKDSTEIYNKIRNYSKKNKFTQTLHKLL
FRSKKPRKKEDLIIPHDSADYNGKIIRKINIITLDPFGHSLTDTTQVPKNWGERTGNRLH
LKTKRIAITNLLLFKRNSAYDSYKVAESERLIRAQKYVTAVRVTHEVVGDSVDVTIRVLD
SWSTIPKFSISSNQVSVGFKEKDFFGSGQQLEYRFTNRFDDGRNGNDVTYTVPNIKNTYI
GTTLHYNIDLDNNYSKTINIERLFYSPLTKWAGGIYVGQNFRKDTLQAPDMTYEYQPFKY
NFQDFWAGHATKLFETENGGITNLIVSARFLNVNFSESPTDLYDPTNFYSDEKLILSGIG
FNTRKFIKDIYIFRNGQTEDVPIGRIYGITLGYQYKNTMWRPYIGGQFSFGNYYRWGFFS
TNFEAGTFFHQSKTYETAFAIESNYFTKLYSIGKWKLRQFVNPRIVIGVNREDIVGDQLN
INEQNGLAGFDSAIYGTNKMILSLQTQTYSPHALWGFRMNPFFNYSIAVLGSPNNAMGRN
KAYSKFTLGLVISNDYLVFSSFQLSLSYYPTIPNDGDNVFKTNTFETTDYGLQSFELGKP
RIVDYK
>EGALAKHO_00622 hypothetical protein
MIRSIKLPFYAKLSLILVSLICFATIFCLGKDIITPVLMAFLFAVLLLPLFTLLNVRFKF
PRHLAAIICVLLFAAFIIGILVFISYQVKDIANDFDAIKKNTNYFITEVHKFVKENFHIS
IGEQKKYLDTVTKDSVKNGGAVTVGSAILSITDLLLDCTIIPIYTFLFLLYKDHFILFLA
KLIDKEDHSALKDILSQIRLSINNYIVSLLLEMIVVSVLTGLGLWIVGVKYFILLGLITG
ILNLIPYIGIAIAGVITLLASLTGTPEMSVIVSILIVNVIVQLIDNNILVPLIINSKVEI
NAFVSIMGIIVGGAAAGISGMFLAIPLLAILKIIFERIESLEAWGYLMGNHMPRKFTWRV
RKTKIESKVNE
>EGALAKHO_00623 hypothetical protein
MFSFKEYSQEILTTTILLLSLVALRVIIARLIRRYAHSSQLLEHRTNLVIKYIHILMNIL
VTISLIVIWGVDTKDIFITVSSIATVIGVAMFAQWSILSNITSGMILFFSFPFRIGDTIK
IHDKDFPIEAEIEDISAFHVNLKTKEGERIIFPNNLLLQKGISIMPSKYEDKEFFD
>EGALAKHO_00624 Septum formation protein Maf
MLKEKLKKYTIILASGSPRRQQFFKDLDLDFEIRIKDIEEIYPPQLQAAEITDFLAELKA
SAFEGELKPNEILVTSDTIVWHQNKALGKPKSAEEAFDMIKSMSNTTHEVITSVCFKTST
ASTLLNDITKVTFNDLSDEAILYYIENYKPYDKAGAYGIQEWFGFMAVAKVEGSYTNVMG
LPTAKVYEYLSTLV
>EGALAKHO_00625 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MQLLFRYSFLKQQNIPLALADWQYGLLVLSTVLLAAAGYVINNIFDVASDTINKPNDVVI
GKGISETRAYNIYFGLNITGVAIGFYLSNVIMRPGFATIFILIASLLYFYSTTLKQIMLL
GNFVVALLLALSVIIIGVFDIFPATNVDNQAQMASLFSILIDYALFAFMINFIREIIKDI
EDVNGDYNQGMNTLPIAIGISRAAKIALGFAIIPFILSLLYINKYFMENDLLIVTLYAFA
FVLAPLLYFIVKIFGAKSQKDFHHLSTVLKLILLFGILSILVITLNINYNA
>EGALAKHO_00626 hypothetical protein
MLVNTFWKILLKIIGLWILFLSLTLIPQYIAALSFTEDKLNIFNWTMLFLALITYTIIIR
LFIFKTEWIIEKLRLEESFQEERIDFNIQTPIVLNISIIIIGALIMIDAVPSFCSKLYAF
FQQDLLFKDYPDSSWLILYFIKIIIGYLLLTNGKSFAKFIEHRTKE
>EGALAKHO_00627 3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC
MNDITTFVFDVDGVLTDSSVFVTNEGEILRTMNIRDGYAMKAAVESGYNLCVISGGSNEG
VRVRLRNLGITDIHLGTPDKVKTFKEYLDTNNIKPEQVLYMGDDIPDFHVMKLVGLPTCP
QDASPEIKNISRYISHVKGGRGAARDVIEQVMKVQGKWMEYFNGKHD
>EGALAKHO_00628 Pyrroline-5-carboxylate reductase
MIRITLIGSGNVAQHLIKAFSKSETVEIAQVFSRKKETLASLIEYDKIVNNFEELKEADL
YIIAVSDNAISEVSKQLPFNNQLVVHTSGTASIETLDNKNRKGVFYPLQTFSKNKDIDFS
IIPICLEAENTFDFRVLETVAKSISNAVFPINSEQRKALHVAAVFVNNFTNHLYQIGKEI
CDENQVSFEILKPLIQETAEKIKSLDPIDAQTGPAKRNDSSTIEAHLGYLNNENQKEIYN
ILTQSIQHNGKKL
>EGALAKHO_00629 Polygalacturonase
MKTRPLNLLCIALTLLLSNWSNTAVAQNSKPYDSYENIEFKMAKIQEPKIPNNTVNIKDF
GATNGGYVLNTKAFADAIDAVSKKGGGKIIIPPGIWLTGPIILKSNIELHAETGALIKFS
TDKSLYPIIETSFEGLNTWRCISPIYGKNLENIAFTGNGVWDGSGEVWRQVKKSKLTESQ
WKKFVASGGVLNDKKESWYPSETFMKASVGADQNVRLDLKTKEEFEAIHDFLRPVMVSIQ
NSKRVLFDGPVFQNSPAWNIHPLMVEDLIVRNVTVRNPWYSQNGDGLDVESCKNVLVENS
SFDVGDDAICIKSGKDKDGRERGVPCENIIVKNNIVYHGHGGVTVGSEMSGGVKNLHVSN
CTFMGTDVGLRFKSNRGRGGIVENIFISDIFMTDIPSQAISFNLYYGGKSIEETLAEGDT
KIKTQVVAVNEETPQFKNISIKNITIKGAQQAVFLQGLPEMNLQNIELSNLIITADKGFS
IIDANGIKITNAKLDIKSPTVFEIYNGKNMTLKDVEFNSTSPKAVTIDGAASEKIELVSS
KKTEYAKKTTISEAVSKGAVKL
>EGALAKHO_00630 Cytochrome c biogenesis protein CcsA
MDKKIFSFLFSTRLMAVLFLTFAIAMGVGTFIESKYNTDTARILIYNTWWFEAIMVFFMI
NFFGNIKRYQLLKKEKWATFLLHIAFIFILLGAFITRYISYEGMMPIREGAAENQIYSDK
TFLTVFADGEYKGEMKRRVFEKNLLFSPVTNNDFTLSGKFDETPFEVTYVNYIMGAKETV
KPDPKGTLYIKLVEAGAGGREEHYLKEGEVQNIHNVLFALNKHTDGAINITTTGEKYTIQ
TPFEGEFMRMADKLKGTVTKDNVQPLMMRSLYSIGDIRIVFPDPAVRGVIDYESNNDFKA
KSHHDALIVKVKADGEEKQVRLLGSKGSVGEPQTVKIGKVEYSLFYGSKAYVLPFKVKLN
DFIATKYPGTEKSYSSFESKVTVQDSAETFDARIYMNHVLDYKGYRFFQSSFDPDEKGTV
LSVNHDFWGTSITYLGYFMLFFGLMAIMFTKGSRFADLKRKLEKVKEKKEKLITILVLMI
GLSGFAQAPHVHTPGHDHNHAADPNDHANHVTAAPNKKQLDSLLSIYKAPEEHAAKFGRL
IIQDAGGRMKPINTFSSELLRKVSQSDTYNGMNSDQVFLSMTQYAQVWIQVPIIYLNTKD
DSIRKIIGIEKGMKLAPFVKFFDENGNYKLAPYLDAAYKAGNPNSFEKDFIEADKKVNLM
ESALSGSILKIFPIPNDPNNKWISYLEIEHAGLKGMDATYVKQILPLYFSALNNGSISKN
FNTADQLVESINGFQKKFGSKVRPSEQKIDLEIAYNKYNILPKMFYWYSLAGIFMLIFTL
FSIFFDKKWLRITVNGFHILIGIIFAFHTVALIGRWYISGHAPWSNAYEAIVYVAWSTMF
FGLAFDRKSKLTVASAAFVTAMIFMASNANWIDPEIANLQPVLNSYWLMIHVAVIVASYG
PTALGMILGFVSLILIFFTNEKNKAKMELNIKEITYINEMSITIGLIMLTIGNFLGGQWA
NESWGRYWGWDPKETWALISIMVYAFVIHARFVPSLRGKWFFNLMTMYAFVSILFTYYGV
NFHLVGLHSYASGEAHSLSWVYYSLGTITLIGIVTYPKYRKYYKTKKVKK
>EGALAKHO_00631 Arsenical-resistance protein Acr3
MTLNHCTPVAARKKLGFLDRFLTFWIFMAMAIGISIGYFIPSSGKVIYSFSNGTTNIPFA
IGLILMMYPPLAKVKYEQIGNVFKNLRILGASLFLNWIVGPILMFALALLFLNEYPDYMM
GLILIGLARCIAMVVVWNDLANGNREYAAGLIALNSIFQVLLYSLYAYLFITVLPPYFGY
TGFDIAISIRQIAESVGIYLGIPFALGIISRYVLIKLKGEAWFQNKFIPLISPITLIALL
FTIVLMFSLKGELIVQIPMDVIRIAIPLVIYFVVMFVISFFTGKYFGADYSKSTAIAFTA
TGNNFELAIAVAIGVFGINSGQAFTGVIGPLVEVPALIALVNVAFWFRKKYFS
>EGALAKHO_00632 Protein ArsC
MPNSNTLFPELNKIVSLFDFRQITTGRKETLQPLIDFIQSKANDNLEIRLNFICTHNSRR
SHLSQVWAQTAAYYFGVKNVFCYSGGTEATALFSKVAETLKKSGFHIEILSEGNNPIYAI
KFAATQSPVIGFSKTYDAVFNPESGFAAIMTCSQADDGCPFIAGAEKRIPITFEDPKAFD
NSPQQTEKYEERSLQIATEMFYVFSEIKK
>EGALAKHO_00633 hypothetical protein
MKLSEIKKLLTTVETVNFQLPNGSFVPEHFHVTEVGLITKNFIDCGGIVRKETVVNFQLW
DANDFEHRLKPQKLIHIIELSEKVLGIEDFEIEVEYQDTTIGKYDLDFNGKDFELINKNT
ACLAQEQCGIPSEKSKFQLTQLNADTANSCTPGAGCC
>EGALAKHO_00634 HTH-type transcriptional repressor SmtB
MGASKSDHFTDQQNELAILTKALGHPARIAIIEYLLKVNTCICGDIVNELPLSQPTVSQH
LKELKNAGLIKGNIDGNAICYCINEAGFEKIKGFFQTITLHIEKNKKECC
>EGALAKHO_00635 hypothetical protein
MEIICKNCNQVFKGHYCNNCGQPAETHKINGHFLWHDIQHGLLHFDAGIPYSLKQLFTRP
GNSIREFIEGKRVKHFKPLSLVALLGAFYGFLYHYYHIDLFPNSDKSGVNLHDFGEWMAS
HFAWTTIATIPIYTIGTFIVFRKQGYNFFEFFVLNTFKASQRLFVQILTFPILLYLNSTH
HVEKFSTITYFIGIILTFWTNIQFFNKMSKTRAFFLSILSHIIFLTCFIIIVALALVLTG
RMPN
>EGALAKHO_00636 hypothetical protein
MNGTLLLRITVAIILLTHSVFGMFNNGINDFGNLYLNQIGFAPFGVFLAWSIKLSHVVAA
ILLILNKYVKLAGFVTIFVLIMGIVLVHFQEGWFVVGGGRNGVEYNFLLIIVLLAIMFPN
GFKKNKTV
>EGALAKHO_00637 hypothetical protein
MEAQEYIESGILELYVYGLLTETENLEIAELAKKNPEVDQEIIAIEKAIVALSSSFSPFH
SVANFEKIKARLELKHGKVVEMKPASKWSQYVGWAAAVLLLLGFGYQTFELTKTKDAIAT
VGNEKTKIEREFAYLDQQHKETEKNLTIVRDIKNTGVTLGGQAVSPTSFAKVYWNKDTKT
TYIDAAGLPKPPKGMVYQVWALKLTPVLTPTSIGLLSDFEGNSNKIFAVDRTSEAEAFGI
TLEPAGGSLTPTMTQLYTLGKV
>EGALAKHO_00638 ECF RNA polymerase sigma factor SigK
MSQEELLVLIYKKDERAFTHLYDMYSKSLFSVINVLIRNREEAEDVLQEVFVKIWKNIDS
YNESKGRFYTWILNIARNTSIDKLRSKDFNNSQKNLSSDNFVNLLDDSNKLINRIDTIGI
QEFVKKLKPKCIEIIDLLFFKGYTQQEASEELAMPLGTIKTQNRNCINDLRNYLKI
>EGALAKHO_00639 hypothetical protein
MKNLNKLKILIVGLTTVLALSSFNNSDLKKANIRLNNSPLNVNVK
>EGALAKHO_00640 Glutathione peroxidase  BsaA
MNKIAFLVCSAVFLMASQLQAQTSINKSKTEKVMGKQTIYQFKVEDLSGNTFDFASLKGK
KVMIVNTASKCGLTPQYKDLEAVYKEYKDKGFVIVGFPANNFASQEPGTNEEIQTFCQQN
YGVTFPMMDKVSVKGDDMCEVYKFLTQKSKNGLQDSEVEWNFQKYLINEKGELVKVIKPK
TLVTEPEVINWIKS
>EGALAKHO_00641 L-methionine sulfoximine/L-methionine sulfone acetyltransferase
MSLTLRPATVNDLEKILDIVNFSILHTTANYNYDIQTLEVQTKWFEDKTAKNLPIVVADL
DGEVVGFGSYGQFREKIGYQYTVEHSVYVVDNVIGKGIGSKLLTELIRLAKEQGYHVMIG
AIDADNAGSIAFHEKFGFVVTGTIREVGYKFDHWLDLVFMQLILA
>EGALAKHO_00642 Thiol:disulfide interchange protein DsbD
MRFIYLFLLCISIQTVKSQNQFVPDDTPYKKALETAKNEGKPLFIMLYADWCPHCNQMKK
EVFSDPNVMAFLKENYVCIWKNIEKEEGIALKNKYNTKSLPTFLFLDSNETLLYALKGEM
KTTEFMTEAKYALNSKMQLPYLEKEFLSDPSNSIKFFAYLNTLKKGKDRTDLSVPTDIYL
KTQSDEQLVSETNWIIIANGITDINSREFQYVLKHQKEFAAVASQNRVDRKIENIVTELL
RPLVDNLDTINYYKQREVAKSIRLQKTDLLVFKFDLTLAERTEKWQFYKKTTLADTQKLV
WNDASFLKDIGQTYLKHIKDTESLKKSIFWVKHSLELNDSYDGNLLVARLYNKIKDKKLA
LQYANDAKVICTEMTWNTNEVDTLLAELNTK
>EGALAKHO_00643 2-succinyl-5-enolpyruvyl-6-hydroxy-3-cyclohexene-1-carboxylate synthase
MIYPKIPLAQSIIEICLAKGITNIIISPGSRNAPLTIGFAQNPNFTCYSIADERCAAFFA
LGIAQQIKKPTAIVCTSGSALLNYYPAVAEAFYSQIPLLVISADRPQSKIDIGDGQTIRQ
ENVFQNHSVYNANLTEEASEENDLKINKAIETAILQKGPVHINAPFEEPLYETVSALSVQ
PIITHSEENIGTKAIENVADFVSIWNSSKRKLVMVGVNEANAIDQEIIDNLAQDPSVVVL
TETTSNLHHPDFINSIDTLITPFDDVDFKELNPDILITFGGMIVSKRIKGFLRKHKPKEH
WHIDTLRAYDTFNALTHHFVMQPNDFFKDLLSKTEHTKSKYAEKIGTIYKFRKIRRNQYL
EKIPFSDFKVFEKVIESLPKNSQLQISNSSAIRYAQLIHIDPSIEVFCNRGTSGIDGSTS
TAIGASVGSGKPNVFITGDISFLYDSNALWNSYVPKNFKIILVNNGGGGIFRILPGHEEK
PVFNTYFETSHHLTAEHLAKMYQFEYLKAFDIESLETGIENFYSQNDKPVILEVFTPTIQ
NDAILKQYFKELN
>EGALAKHO_00644 hypothetical protein
MSAREELIAKYAADLKEKCGVTPNMDLLTKVTIGCGPSIYNADSSTVAGSQKSELETVKN
NFLIKKLGLTNSPALDEGIDTVLEKYGKSNKNKYRAVVYYLLTLYFKKENIYN
>EGALAKHO_00645 Conserved virulence factor B
MIEIGKYNTLTILRDTKVGLFLGNPEKDPEGIHDILLPNKYVPNEFEIGEELIVFVYLDH
EQRPIATTLEPYILLNEFALLRVNYTNQVGAFMDWGMEKDILVPFKEQARPMEKGKRYLV
YLYMDEKTNRLVASSKLNQFLSNDQLTVEKGEEVDLIVSHITELGINVIINERHKGLLYK
DEVYDDAIRTGDRMIGFIKNIRPDNKIDVALQVQGYQSIEPNAEKILDELRANRGFLRLN
DASHPEDIKTVLKMSKKTFKKAIGALYKDKLIEIKEDGIYLVKEN
>EGALAKHO_00646 1,4-dihydroxy-2-naphthoyl-CoA synthase
MDWITAREFEDITYKKCNGVARIAFNRPNVRNAFRPKTTSELYQAFYDAQEDTSIGVVLL
SAEGPSTKDGVYSFCSGGDQNARGHQGYVGEDGQHRLNILEVQRLIRFMPKVVIAVVPGW
AVGGGHSLHVVCDMTLASKEHAIFKQTDADVTSFDGGYGSAYLAKMVGQKKAREIFFLGR
NYSAQEAMDMGMVNAVIPHDELEATAYEWAQEILQKSPTSIKMLKFAMNLTDDGMVGQQV
FAGEATRLAYMTEEAKEGRNAFLEKRKPNFGENKWLP
>EGALAKHO_00647 1,4-dihydroxy-2-naphthoate octaprenyltransferase
MKHWIEAARLRTLPLSVSGIIVGSIYALSNPTATINTPTEVFSWKIFGFALLTTLGLQVL
SNFANDYGDGVKGTDNADRVGPQRAIQSGVITPQAMKKAIIITASLTLLSAIILIYFAFG
ESNFGYSIFFLLLGIAAIVSAIRYTVGNSAYGYRGFGDLFVFIFFGLVSTLGVNFLYSKE
VDPLLILPAISIGLLSVGVLNLNNMRDEESDKKSGKNTIVVQMGGAKAKIYHFALIITAM
ILVVVFAILSDYRFDQYLFLLAYIPLTKHLITVSKNQDPKLLDPELKKVALSTFFLSILL
TVCMISLISDVFVNLFMGGR
>EGALAKHO_00648 Hydroxyacylglutathione hydrolase
MKITFYGHASLGIEVGGKHIIVDPFITGNPQAASIDINTLKADYILLTHAHGDHVLDVEA
IANRTNAVIVSNAEITSYYAKLGHNAHPMNHGGSWKFDFGKVKYVNAIHSSSFPDGSYGG
NPGGFVIEGEHKNIYIAGDTALTMDMKLIPMRTKLDLAILPIGNNFTMDVEDAIIASDFV
ECDKILGYHFDTFGYIEINHEESIRKFFDKGKDLMLLGIGESIEL
>EGALAKHO_00649 hypothetical protein
MNFKKIALFFLITVSYNTFAQKDGYWDKERATTKEVILSARDRITLKTEDLPVGTTEIVY
RITLLDENEKMANSLVSVLKSIPDPTGISQGSAGAVFLMSKISGDDTCTYALFTSNEDAK
KYVEDGKTDKSCYAQLEEISKDAKRLSLDKSSCLGQNISTIYFGFHSENLLLSQKIVLEV
VPWVDTKLNRGWNQDNKNEIISLCKTSTMAQKMANSDDFCVCILDKIIKQYRYTEFQKLL
PIEKNKVYKDFGNACYKDADISKNVYDDLRVQAATLIKLQKYNEAIQKLTTIINDGKATA
IDYGSIGYCYILTKQYAKAIKFLKEGEKLDDTELLVKLNLAHVYLVSDDYSEAKVIYKKY
QTQNVTDSLSWKDKTKKDFEIFQKAGLPSKDFEKVLKLYN
>EGALAKHO_00650 L-amino acid-D/L-Glu epimerase
MKANYHKYMLEFKRPSGTSRGVMTEKETWFIVLEENGKKGIGECGILRGLSADDRDDYEE
KLNWVCQNIHLGETALWEALLEFPSIQFGIEMAFLSLKSENPYLLFPSDFTSNSESIVIN
GLVWMGEAYFMKEQIEEKLEQGFDCIKLKIGAIDFQKELELLQFIRSHFSEEQIEIRVDA
NGAFSLNEALDKLNQLKVFQLHSIEQPIKKGNVSAMAELCKTTPFPIALDEELIGVFSFE
EKEKLLQKIQPQYIILKPSFVGGFKGTQEWIDLANKYNIGWWITSALESNIGLNAIAQWT
FTLKSKMPQGLGTGALYTNNFDCPLEVSQGQLWYNTTKSWNSDLLEKV
>EGALAKHO_00651 50S ribosomal protein L21
MHSVFIYLLNLIGIYLHSFSRTIIILFNQKLTIMDISCILIPLLAGLIFGILGYYLGKKA
SFKSEHSLASSLQSDLDACKKHTKSLTTRISSLEADLAEKKAKPSKKKSITLQTTPTFLF
DTGQAKNIFGKKVKENDLKIVEGIGPKIEALFNAAGITTWHDLSNASTEKLQAILDAGGE
NYAMHNPSTWAKQALMAYEGKWQELKDWQAGLRGGKE
>EGALAKHO_00652 Inorganic triphosphatase
MIEIERKFLVKSNDFKEQAFAQNQIAQGYLSSLPERTVRVRIKGKKGFLTIKGIGHQGGM
SRFEWENEIPVDEAQELLKLCEKGKIEKTRFEIKSGKHVFEVDEFYGENEGLIMAEIELE
SETESFEKPDWLGEEVTNDERYYNAYLSKKPFRTWEK
>EGALAKHO_00653 Ferredoxin--NADP reductase
MTEYDLIIVGGGPIGLACAIEAQKKNLRYLIIEKGAIVNSIFNYPLYMTFFSTAERLEIG
DIPFNCLAPKPGRQEALEYYRNIHRYFNFSIHLFEKVISVQKQENSIFKIVSDKNSYEAK
NVVIATGFYDIPIKMNVKGEELSKVRHYYKEAHEYAFRNVLIVGANNSSVDAALECWRKG
ANVTMVIRKNEINNRVKYWVKPDIENRIAEGSITAYFESNITEIRENEVDIETSTGKVTI
ENDFVLALTGYKPDLTFLEKMGIQLSEDELKIPVYNPETMETNVEGLFLAGVVCGGMQTH
KWFIENSRVHANMIVDYITSK
>EGALAKHO_00654 hypothetical protein
MVEKIIISMKNLKINNRFTAELPADPDETNEIRQVKNTLFSYVNPTKPSNPTLIHASQDV
AEMVGITADEIQSEEFLNAFSGKEILPETRPYAMCYAGHQFGNWAGQLGDGRAINLTEVE
HNNTFFTLQLKGAGKTPYSRTADGLAVLRSSIREYLCAEAMYYLGVPTTRSLSLILSGDQ
VLRDVLYNGNPAYEKGAIVCRVAPSFIRFGSFEMLTARNELKNLKEFVEYTIKHYFPEIK
GEPKEQYLQFFKTVADTTRKMIVDWQRVGFVHGVMNTDNMSIHGLTIDYGPYGWLENYDP
NWTPNTTDSQNRRYRFGNQPQVAQWNLYQLANALYPLINEAEPLEKILESFINDFQTDYK
EMFLSKLGLFTSTEADGKLIEGLEAVLQLSETDMTIFFRNLSKVAKTDSAENAIEKIQDS
FYLPQEISGNILDSWKKWFTVYLQRLNQEELSDKDRSEKMNQINPKYVLRNYMAQLAIDD
ADKGDYALINELYVLLQKPYDEQPESEKWFEKRPDWARSKVGCSMLSCSS
>EGALAKHO_00655 Peptide methionine sulfoxide reductase MsrA
MENLSVATFGGGCFWCIEAVIQRLNGVESLKSGYSGGFIKNPPYREVCTGRTGHAEVIQV
TFNPDIISYHDLIFIFMTSHDPTTLNRQGADVGTQYRSIILYHDAEQKAIAEKVFEEVKS
FYDDPIVTELTAFEVFYDAEEDHQNYYNNNQDARYCQIVIDPKVQKLKKMYADRLVN
>EGALAKHO_00656 Cysteine desulfurase SufS
MNSKNNTITLETYFQDFRKNIVGINQEFTSPYGKKQIIYTDWTASGRLYRPIEEKLFNDF
GPFVANTHTETTVSGTAMTKAYHHARNIIKRHANANLDDVLITDGTGMTGVINKFQRILG
LKIPENLKDFINVPAEKKPVVFISHMEHHSNQTSWLETIADVEIIPSCEKGLFSLENLAL
LLEKYNSRTIKIASITSCSNVTGLKTPFHEAAKLMHQHNGVCFVDFACSGPYVEIDMHPS
DPEAYLDAVFFSPHKFLGGPGTSGVLIFNKKLYNNMIPDCPGGGTVSWTNPWGEHKYIDN
IEDREDGGTPGFLQVIKTALAIELKEEMGIDNILQREHEIVDYVFEALEPIENIKILAGQ
HKNRLGVVSFFIENLHFNLGVKLLNDKFGIQTRGGCSCAGTYGHFLLHVDQETSNKLVNE
ITIGDLIKKPGWIRMSIHPTTTDEEIAYVCDSIKDLAKNHETWALDYAYNNKTNEFVHKN
ATSFEDELVAGWFKS
>EGALAKHO_00657 putative amino acid permease YhdG
MKEVVHKKLNQLQATAICGNDISSSCLYVSALTILYAGQYAWISLLIVAVVLFLFRRIYG
EVVGAIPLNGGAYNVLLNTSTKRLASLAATLTVLSYMATAVISASEGMHYLHGIFEGLNV
TIATVIVLILFTGLAILGIGESAFVAVIIFLTHLATLSLLVLASLWFLMQNGLETFHINW
QTPIASGNIKTALFLGFSAAMLGISGFESSANFVEEQEHGIFPKTLRNMWAIVSFFNPVI
AILLISVIPLTEVGENKESLLAHLGQTTGGSWLAWLISIDAVLVLCGAVLTSFVGVSGLL
NRMTLDRILPNFFLKQNKRGSHYRIVISFLVLCISVLFATSGHLESLAGVYTFSFLAVMA
LFGIGNLLLKFKRRKLPRPERARGIAVVIAVSFIIAAFIGNMKLNINAFYTFLQYMIPSL
IFIGIMLNRVMLIKLLIEALEYFYQPLRRMVIVSNRYLQKMSVEINSQEFVFFTKGDDIA
ILNKVLQYVENNETTKKLKIVHIKSDGANNEALKKDLEVLDRAYDDIDIEFLEIKGVFGP
EIIDELSEKWKIPKNFMFIGSPGNKFSYRVSDLGGVRLIM
>EGALAKHO_00658 hypothetical protein
MTANENLITKFYTAFANADAKTMSECYHPKVHFIDPAFGLLKEEQVSQMWEMLILKSKGN
IKIEFSDIKADEFTGSARWVATYNFSKTNRKVINKISAEFVFQDGLIIKHTDNFDVWKWS
KQAFGVTGYLLGWTGFFQRKIKEQALLSLKKFQKSK
>EGALAKHO_00659 hypothetical protein
MKFKTPFLILLLLSTFVNAQETMSVKGSKGYPATQNYTFICEKYAFSGETNVQIAKTEKG
GILKLSIVTANAEARISGGVYVDLANGDVIPCVDKNVKETAEGKTTSYYYFTPAEMIKLK
KSDIQGIRFIIAGNSKSFGNQTGYFTAVNKTDYFSTIYDKSKKTFDTATAISAL
>EGALAKHO_00660 hypothetical protein
MKKAVLIICLLLLIGCKSKTVTRDTEDLKIKQVPAAEVNANQQKKAYDLGKRVLETCNTS
KFKPFNETEVTKSVMENTTEDRLTKTCQRFRQYYGSFIDLKLDGVYRTKQEVIYRYHALY
SKKVANKELRVFVNEDNLVSAIKSMDWDEKFDSKIEGQ
>EGALAKHO_00661 hypothetical protein
MKTLISILKAIPPTKIIDASIDFSNYIPLDLSITNKELMESKPENASEFESFISNYLKNN
NAEVAFGGYIEGRTLYKRSTIFKNDSVPERNIHIGLDLWTKVNTPVLAPLDGKVHSFKNN
VGLGDYGPTIILEHEVENEKFYTLYGHLSLESIKDLIVGKKFKKGEQIATLGNAAVNGDY
APHVHFQIIQDIEDYWGDYPGVCNSNDLNFYIENCPDPNLLLKIT
>EGALAKHO_00662 Polyamine aminopropyltransferase
MIQKFFSYLIPIKIFKKKSARSKTIEVTWANGELVLDSENTNYSYGSLQRILRYGLRNIG
YKAIFDMEHILLLGVAGGSVVKTLVDEIEYKGKITGVEIDSEMIQIANDYFNLNQIKQLE
IIIDDAFEFVLKTKDKYNLIIIDIFEDTKMPNFLFERFFSERVCSLLKDQGFVLFNTMIL
DEAHNVRNRKYIAEINPELFSSKMLPRIEDHNELIIIEKVA
>EGALAKHO_00663 1-acyl-sn-glycerol-3-phosphate acyltransferase
MGWNIRGIENAEVKKCVMMVMPHTSNHDFYLGIFTRGISGLEMNWVGKKELFKFPFGYYF
RSVGGEPLDRSGGLNKVDSIAAIFKRKEVFRLAVAPEGTRKKVSEIKSGFYYIALKANVP
IIPVAFDWGKKEVNLGKPFYPTGDYEADLQILKKHYESVLGKIPQDAFKL
>EGALAKHO_00664 hypothetical protein
MVNIDDFVKRLEIILDYYGLNASSFADKIGVQRSSMSHLLSGRNKPSLDFVMKILDVFPD
VDLYWILNGKGSFPKAEDQNVNSNIEIVSEIEKPLAPILPSENFTAGDLFSNVNFKEELK
TETRNSVEVKNSNFISEESEIEKIVFFYKNGTFKVYVP
>EGALAKHO_00665 hypothetical protein
MNLEALFNLHKEQSIEGRYLTLDHIQPLLDKLNTNDQVQLIGKSVLDKPIYSYQIGTGET
RIYLWSQMHGNESTTTKALFDFINVLNSGSDLANKLLEKFTFYTIPILNPDGAALYTREN
ANKIDLNRDSQNLTQPESNVLREVFETFKPHYCFNLHDQRTIFGAGNTGKPATVSFLAPS
YNEEREINENRLKAINLIAGINDTLQKYIPGQVGRFDDSFNINCIGDTFQFLGVPTILFE
AGHFPNDYEREITRKFIFFSLISSFELLCENDLVDNRINDYLNISQNKVVFYDFMYKNIK
INYDGIEIITNFVAQYKEELIENKIHFNAYIAEVGELENYFGHYEYDAQGAIYSHNHNSF
PKVNEKADFYLNKNVKFVNGLIKS
>EGALAKHO_00666 Regulatory protein AsnC
MSKFRLDEVDHQILDMLIDNTRVPFTDIAKKLLISAGTVHVRVKKMEDAGIIMGSSLALD
YDKLGYSFIAYVGVFLNNTSQTKFVLERINQIPFVTVASVTTGKFNIFCKIRAKDTKHAK
EVIFMIDDIEGVYRTETMISLEESINDKKRLMHTIFKNM
>EGALAKHO_00667 Phosphoenolpyruvate carboxylase
MYTLPKIERFNQDVLSKYHIYNSVFITLPFDSIDNTGVLLPLFTETCETGFRKQETPKEI
FDFFSNKYLNNASEKEKIDLMFRFIQYIERQIVLFDAIEDAAFPAVNNMEGRGSLRDIKE
KTDAKEKNEELIEFLENFNVRTVLTAHPTQFYPGPVLGIINDLTDAIRLNDLLKIKQLLA
QLGKTPFIQNEKPNPYDEAVSLIWYLENVFYATSGEIVHYLQKNILHGSAIKNQLIKLGF
WPGGDRDGNPFVTTEITLKVAERLRTSILKCYYVEMRNLKRKLTFSGVDTLVSELEHKLY
RSVFYSKGEIYITLEELLAQLNKIRTIIIEKHQALYLDELEAFLVKINLFGFHFATLDIR
QNSKIHDAVFKDVVNHYLNSDSKIFPENYFELSESEKLVVLSKVKGDLNPADFNDEITRS
TLESVQAIKTIQERNGEFGANRYIISNNESALNVMETFAMIRLNNWENPTVDIIPLFESV
DDLQNAHEIMEQLYTNPEYSKHLQARGNKQTIMLGFSDGTKDGGYLMANWSIYQAKISLT
EISRKYGIHAIFFDGRGGPPARGGGKTHKFYASLGPKIENNEIQITVQGQTISSNFGTLD
SCRYNIENLLSAGVTNQVFSKEDNELSADETQILTQLADLGYDKYLSFKNHPKFIPYLEK
MSTLKYYSKTNIGSRPSKRSKSESLDFADLRAIPFVGSWSQLKQNVPGFFGVGSALKYFE
ESGQWDKVSDLYHNSLFFKTLLENSMMSLAKSFLPLTAYMRNDPEFGEFWQIIYNEFSET
KRLLLKIAGHKTLMENYPDGIASIQVRERIVLPLLTIQQYALLRINELNNDKSGNEELIK
VYEKIVTRSLFGNTNASRNSA
>EGALAKHO_00668 hypothetical protein
MKLPETEYSGPFANYIQEAGEINLIEELEISLHDFIKFVQNIPLDKFDYRYAEGKWTIKD
IIQHLIDCERIFAYRALRFSRNDKTALPGFEENDYVDNTNANGRSIQDLLTELSAVRHST
LLFYKSLSEEQLKRIGTASTHQLSARALGYVIIGHQKHHQNVFQERYL
>EGALAKHO_00669 ATP-dependent DNA helicase RecQ
MNTELLHSKLKENFGFEKFRPNQETIINTILAGQDTLAIMPTGGGKSICFQLPALVLPGI
TIVISPLIALMKDQVDSLKTNGINACYINSSQSSEEQQFYIDNLKSNNFKLVYIAPESLS
YLDVIFNELTISLIAIDEAHCISSWGHDFRPAYTNLGYLKNRFPSTPILALTATADKATR
TDITKQLNLKNPKTFVASFDRKNLSLEVRPALDRVKQIIDFVENKPNESGIIYCLSRKTT
EELAQKLQKSGVSAKAYHAGLDNKLRAKTQDEFINDDCQVVCATIAFGMGIDKSNVRWVI
HYNLPKNIEGYYQEIGRAGRDGLPAETVLFESYADVIQLQKFASEGLNSDVQLAKLERMK
QYADALSCRRKILLSYFGELVKENCGNCDICNNPPKFFDGTILAQKALSAISRLQESEPL
AVIVDFLRGSKNAYIYEKSYQNLKTYGIGADISWYDWNQYLIQLINLGYCEIAFHQHNKI
LLTAFAKKVLFEGEKVKLTTVVKKVIDKNEIKETKPKAAKNSLFEILRKLRYEIAKNEDV
PAYVIFSDAALRQMETLRPMSDEEFLAVEGVGKAKLEKYGSEFIDAITYYEKVKKENAKV
KKEGNTYKTTLALFNEGNSIEEIAGKRNLGQTTIISHLAKLYADGADIDLSPFVTDNEVK
QLHKAQIELEYPTALKPYYDHFEEKLSYDKIRFGLAIVERNK
>EGALAKHO_00670 hypothetical protein
MKRVIVDYAKLTNEILNLLVEKFPDGYDDSDVIRFRNAKNELVEAVEVRTEDTIYLVKIS
TKLADRIENYDEDDDIDLDVDTIEPVKGLDLDDDADDEEDEKEDKPDVDGGDDDDEDRDP
DDIADEDDDEDDED
>EGALAKHO_00671 Deoxyhypusine synthase-like protein
MKGPISQFIEKHYLHFNSAALVDAAKAYEQQLANGAKMMVSMAGAMSTAEIGKIFAEIIR
QDKVQIISCTGANLEEDVMNLVAHSHYERVPNYRDLTPEDEWALLERGLNRVTDTCIPEH
EAFRRLQKHIYKIWKDADDKGERYFPHEFMYKMLLSGVLEEYYEIDLKDSWMYAAAEKNL
PIIVPGWEDSTMGNIFASYVIKGDLKASTMKSGIEYMTFLADWYPKNSANGIGFFQIGGG
IAGDFPICVVPMLYQDMEMHDIPFWSYFCQISDSTTSYGSYSGAVPNEKITWGKLDIKTP
KFIIESDATIVAPLIFAYLLDL
>EGALAKHO_00672 Biosynthetic arginine decarboxylase
MNTKYSDLINQTYYFPQEEFKLNKDNLQFHNIDLMKLVEQYGTPLKFTYLPQISENINKA
KAWFRKSMEKNKYEAKYYYCYCTKSSHFEYIMNEAFKNNIHVETSSAFDINIVENLLENG
KINKSTYVICNGFKRDEYITNIARLINNGHKNTIPIIDNYEELDLLQAEIKGKFKIGIRI
AAEEEPKFEFYTSRLGIGYKNIVSFYKKQIQENDKLELKMLHFFINTGINDTAYYWNELV
KCIKVYIALKKECPTLDGLNIGGGFPIKNSLAFEYDYQYMIDEIINQIKIACDEAEVDVP
NIFTEFGSFTVGESGGAIYQILYQKQQNDREKWNMIDSSFITTLPDTWAINKRFIMLAVN
RWNDTYERVLLGGLTCDSDDYYNSEQNMNAIYLPKYNKEKPLYIGFFNTGAYQETIGGYG
GLHHCLIPQPKHILIDRDENGIIGTEVFSEQQTSDDVLKILGYTKKV
>EGALAKHO_00673 3-dehydroquinate synthase
MQSIQANNYLVHFNQNAYEALNTHLKENKYSNLFIIVDNQTNEYCLPKFLPLLETDLNIE
IIEFEAGEANKNIETCIQIWNVLTELGADRKSLIINVGGGVVTDLGGFVASTFKRGINFI
NIPTTLLSMVDASVGGKTGVDLGNLKNQIGVINVPQMVLIDTNYLETLSQAEMRSGLAEM
LKHGLIYDATYWKQFLDLQSIDYADFDALIYRSVEIKNDIVIQDPTEKNIRKALNFGHTL
GHAIESYFLESETKTTLLHGEAIAIGMILESYISLHKGLISAEEYTEIKTALKNIYDDVQ
IEENDIDPILELLIHDKKNEYGLIQFALIEGIGKIKINQSVENKLILDAFQDYKS
>EGALAKHO_00674 Proline dehydrogenase 2
MEKIFDNTQVAFSLKSDTELDRAYFLFKMIDSEPLVRIGTAVTNFAIKAHLPVEGLIRAT
VFDHFCGGINEDDCITVVDKMFTKGVSSVLDYSVEGKEEEAQFDAALEMTLKTIEFAKER
LAIPFAVFKPTGLGRFELYEKLGEKQTLNPTEQAEWDRVVARFDKVCSEAHKKDVALLID
GEESWMQDAADDLVTDMMRKYNKEKAIVFNTLQMYRWDRLDYLKKLHEIAKGEGFFIGMK
LVRGAYMEKENKRAEEKNYVSPICVSKEATDVNYDEAVHYMLDHLETMSIFAGTHNELSS
YKLMEMMQQRGIAKNDNRIWFGQLYGMSDNISYNLAENGYNVAKYLPFGPVKDVMPYLIR
RAEENTSVAGQTSRELSMIKAERKRRKGKK
>EGALAKHO_00675 hypothetical protein
MPHLRIILILLFIVLNTISVLAQDKPFNVVNISKDGSQYIKFGMNLQVWGRYSELNAGSK
IGTNEVKDTYDIVIRRLRLQAMGMLTENIFFHLQFGQNNINFTQNNGPSVMDALGEYHFN
KSFHIGGGLTAWGAGTTRYSANSSSSQLPLDTPMYQQFINTSSTFGNRNLSIYAKGDLGK
FNYRAAITNPYRNSTNNLGLNSTVSTETPRAQYSGILTYSFFDKESLEDAYHKGTYLGTK
KVFNLALGYLTQAKAMWHLTPDARIAYDDMKVLGFDVFYDSPLSEKGNALTAYASYNNCD
YGKNYIQSVSTPNPAVGDGSLINGSGAGFIGVGTGNIYYAQLGYLFAKSDNQEKKGRFQP
YVATQIAALEALDEPMTMYELGANYYTTGTLGPKISLNYQNRAVYDKTLVGQYKQSDRLG
MVVLQCQVSF
>EGALAKHO_00676 Putative multidrug export ATP-binding/permease protein
MARFQENDLPKAKLDSNSLQKAIRIFKYGKGHKWKFFLGLIFLLLTSATALAFPKLMGML
VDCVTNKDLSRANEIAVGLMVILTLQAIFSFFRISLFVNFTENSLSNIRFALYENLVKLP
MGFYSQKRVGELNSRISADISQLQDTFTTTIAEFLRQFILIVGGFVILGNISPKLTLMML
AIVPIVAVAAVIFGRFIRKYGKKTQDKVAESQVIVEETLQGISNVKAFANEWYEIQRYKN
KIKEIVKIAIKGGQYRGYFASFIILCLFGCVVAVVWYGITLTIKGEVEGVGDLISFVLYT
TFIGASFGGIAEMYAQIQKAVGATERVFELLEETPEAINANPKTTPIEKIKGTVSFKNVA
FSYPSRKEVEVLKDVNFNAEFGQKIAIVGPSGAGKSTISSLLLRFYDITSGEILVDGKNI
YDYDLENLRGNMSIVPQDVILFGGTIRENIAYGKPDATDEEIMLAAKQANALNFVEGFPE
KFETLVGERGVKLSGGQRQRIAIARALLKNPSILILDEATSSLDSESEKLVQEALEVLME
GRTSIIIAHRLSTIRNADKILVLDNGKITEEGTHQELINLENGIYKNLSNLQFSNS
>EGALAKHO_00678 hypothetical protein
MEFIVYILFSESKNKFYIGFTSNLEERLVRHNQKSKGFTGNVNDWKVVYAEN
>EGALAKHO_00679 hypothetical protein
MEFIIYILFSESKNKFYIGFTSNLEERLVRHNQKSKGFTGNVNDLKVVYAENYETNELAH
KRELQIKSWKSRIKIQELISKKD
>EGALAKHO_00680 hypothetical protein
MSTATTVPNEDSGSSKKLLYIDNIKVLLTILVVLHHTFIAYSSSKGWYYNEPSSFLGARA
IMTMFVSINQSFFMGCFFLLAAYFTDASYSRKGVSKFIKDRLTRLGIPLVFYSFILTPFM
CYLVYYFAKKHHITYFEYLNGYDSWIDVGVTWFVAALLLFTLIYVIAKMIFKVSWNKTMV
VPNSKTILSFAFALGIISFLVRIIFPVGWVLEPIGFQLGHFPQYIALFIIGLLAAKNNWF
DELSEKTGRQLKRSAYLCLLFFPVFFIISFKLNTPSSWFCGGLHWQALLYAIWEQWIGIS
IVTALLIKGKTNWNTSSKLLTKASRSSFAVYIFHPLVIIVFTLAIRNWAIDPVIKLLVVA
PLIILGSFVLGSLILLIPGVKKII
>EGALAKHO_00681 hypothetical protein
MRFYINTEHLRKEIEFPQRYRSQNIIKSSVVVFFVILLFLLLFRPFGVYDPELRMHYLFI
CFFHAFVPALILFVYFGVLNYFRKTKNQKWNLLKEYFQIGVLLFLMGMASFLMRDLLYNN
PNNWSWNYFFEEIRNCLVAGIFFYFLLRLSSFYFESKKGSPFVLQFIPLAAEPEKTILKS
NLFISTQVKQDDFSLDIHQLLFVKADGNYIELTKSNGREITTEVKRISLTQFESQITDFP
HFFRCHRTYLVNMFKIEKVSGNSQGYLLSFDETNLKIPVSRKQIDSFNNYYEELRSKYTA
>EGALAKHO_00682 hypothetical protein
MHKLSNMKLSLIFTILLIVFSNFIFGQNNFSDNPLDAVFETKDSKNFWEAFDKMDKSKEN
PFIAYMQKGSPGVKGFTENRILNADSLFSAVKKRKADYELSRNVLDGLPSKEKRVRAIYS
ALKYWYPKAKFPPIYFVYGRFNSGGTSSPEGIIIGTEKLQNLDGISGLIAHELIHYQQKI
EGKDALLKWCLLEGGADFIGELISGESINKLEYKYGEQNQDKLYQEFLTRLKNPDYQDWL
YGTSKKDDRPNDLGYWIGYKITEAYFNKQKDKQKAIEEILNIKDPMQFLKQSGFLDAYIE
KYQKSKKESFDDFFK
>EGALAKHO_00683 Thiol-disulfide oxidoreductase ResA
MKKLFLFTLILIFQSFSFYGQDKVVKKPEYVIIINNEIVSKETVEKYGADGYVKSMDKGV
SEEKRNELAKKFGDKIGDKEFIIVVGIYTQQEKNERDKKINSQPVESKSLVKADEKEYLL
NINDKAKDFTLKLIDGKEIKLSDLKGKVVLVNFWATWCAPCLMEFYDIPSKIIEPFKNED
FVFLAISSGETQEKVLNKVTKLRKDGIDFNYGVDTNRTIWNDYATASIPKNFLIDQNGVI
RFVATGNAPGNLDNIATEIRKLLAK
>EGALAKHO_00684 HTH-type transcriptional activator RhaS
MIYKGTSHQFLLLTEINTENKDLVFGAKDTELTLLWNTGSEMNISVDKVKYRLAQNEIIF
LTEFHQIDYLEVESAKMLRFNQNFFCIINNDNEVGSKGLLFYGAMGIPVVSISETHLQSL
ETTWDILLSEMDAKDNLQIDMLQSMLKRVLILCARSLMSTTNYVRLENNQADIIREFNYL
VEGHFAKHHDVAFYASKLNKSPKTLSNLFAVFSERPPLSIIHDRIMIHARKQIAYTQLSI
KEIAYDLGYEDLQSFSRFFKNKEGISPVQFREKVN
>EGALAKHO_00685 Haloalkane dehalogenase
MKTIYQTRKINGVEIFYREAGDKSKPTLVLLHGYPSSSHMYRNLIKDLSDHYHLIAPDYP
GYGRSEQPLISEFEYTFDNYAKIVHTLLEELEINKFSLYVMDYGAPVGFRIASENPTKID
SLIVQNGCAYEEGLEEFWNPIRAYWKNIDDKEAEKTLSTFHAPELLKWQYTHGIPDPSVV
SPDNWEIDLRHLERPQNNDIQLALFYDYKNNVTLYPKWQEYFRTYNPEMLIVYGKNDYIF
PESGAKAFKKDIKNLEYHLFDAGHFALESKGNEIAAIIGDFLSRKVTK
>EGALAKHO_00686 hypothetical protein
MGINKYTTLIINKVVSFYYEIIKSCKLKNQLAGFTINDYLVTLRERKSPIIAAISFPLLS
NAKCPASNK
>EGALAKHO_00687 Glyceraldehyde-3-phosphate dehydrogenase
MKKIAINGFGRIGRSSLKIILDTPDLEVVGINDLMTIENAVYLLKYDSIYGKYNKKVSFE
GDFIVIDDHKIKYTAIKDPAELPWKELQVDVVIESTGFFTNKADAEKHLTAGSKFVVISG
PTKDTPTVVHGVNTEDGKVAIFSCASCTTNNISPIIEILGRRIGIKKAILNTTHAYTASQ
TLVDAPSKREPRMGRTAGINLAPAATGAAIATTKALPQYLGKFDGVAVRVPVPVGSISDI
TFVTEKPTTVEEINSILIEESKTARYHKVVAVTDEPLVSTDIIKSPFAATVDLEMTRVVD
GDLVKVMAWYDNEWGFTNQMIRQIQEL
>EGALAKHO_00688 hypothetical protein
MGIYQPNDQTDSGIIKFSTTKLEKSRTSIMNYAQLAFTDNIKKIQEEAGSRNSYDRMEKM
SVVDGLTDNEIRFIGDRDSFYMASFGENE
>EGALAKHO_00689 hypothetical protein
MVSYPQRARLKLYAKAKIVDLKDNEELYDSLKPEDYKFRPERMMIFEIQAYDWNCPQHIT
PRYTTEEIEEALLPQKKYINELENKVKELELKLSGK
>EGALAKHO_00690 N-acetyl-alpha-D-glucosaminyl L-malate deacetylase 1
MNIDILAFGAHPDDVECAVAGIVLSATANHEKVVICDLTKGELGSFGDEHSRKNESEIAS
KMLNLFAREQLDLEDGNIENSHENRLKVIRIIRKYRPKIILANAIRDRHPDHHKAAELVS
EASFLAGLKKIETFDDEGKSQEKWRPEAVYHYIQDLFMEPSVVVDISAYFDQKMEVIKAY
NSQFVTANDNKANGIMNLLQQIESTNQIFGRAINVKYAEGLTSERYVGTRNLLDLL
>EGALAKHO_00691 putative oxidoreductase UxuB
MKIVLITGANRSIGLEITKQLSKKGLFVYLGARDLEKGNAVVQELNKEGFKNIKAIEIDV
TKPVSIEAAKKTIENEQGKLDILINNAGISGEFPQSASTASITAIQNVFDTNFFGVISVT
QAFLELLKKSEAPRISNITSGLGSLTLHSDPSWKYYDFKATSYVTSKAALNAFTITLAHE
LKDLPFKVNAIDPGYTATDFNHHNGPGTVESAATFIIKHTVTDNDAPTGKFYSNDIEDES
GISPW
>EGALAKHO_00692 hypothetical protein
MKEFIEYILQFGNLNQQQLDLISKKATERVLHKDEYFSEAGKIAQEVGFILEGIIRVCYY
NNKGEEITKYFIDENNLVVDLESFDNDICSNAYVQAITDCKMLVFSKKDWKDLLDIIIPW
EAIVNKIISRALRQKIERRSPLVSEDATTRYLMFLKIYPNVVNRIPLSYIASYLGITQSS
LSRIRKNIR
>EGALAKHO_00693 hypothetical protein
MATVTFPTTPDCEIVSSRIVNFSQELVFEAWTDPNHLKNWWGPKGFTNTFEEFDLRPGGR
WKFVMHAPEQGNFQNECEFVKVEKPSEIAWIRISKPLFNIVATFEKIADSETKIVFRMVF
ETAQECAKLRPYVVDKNEENFDRLEDELAKMIV
>EGALAKHO_00694 hypothetical protein
MKLITTFFILFLSLNVSAQELPSPYNSGYEFPIGAKFTIKLNTDDPKNITYSIIKFEPFT
EIINTFENEDLFEKTGEEGTIDFYFCIGTHGESEKEKNKNMQVLLIFKNRTKFSLKYISE
IQRNEEDEFKETSNMGAYPGAVGNEMWPYMITMIRLRDFEISNK
>EGALAKHO_00695 hypothetical protein
MNIEKAISSDHQILTEITKKSKAYWGYSDEQIEKWSQFLTVTPVYIDANGVYKLTVENKL
AGYYSFLYENEKTVKLDNLFVLPEYIGKGFGKILMKHFLLEIAKTSINKIILNSEPNAEQ
FYAKLGFVKTGQIETSIKDRFMPIMELELKN
>EGALAKHO_00696 hypothetical protein
MKTKIIMAVLLLGFVISAKAQKKIKTTELPKPAQEFLKKHFSYTSVEIAKKDAEHGEKGY
EVKLKDGTEVEFWKDGSYREVDGDDKPIPTEFIPVSVKDYVSKNYPNEKITHIDYGHKDL
DVDLTNNIDLEFTKEGKILKDKKE
>EGALAKHO_00697 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MKSETIIQEQFYTSNTISNKGELPLNSNIFNIKNQYSHKDFKKNVNPLSFIVLIGTFALM
LAGSFLVYRLQSDFDQFHIDRINSAWGLPFLILTAALFFFQTGSFLYNLFLYFKYKPIES
VSYESLPTCTVIVPAYNEGKLVWDTLLSLADSDFPQQKLQLLAIDDGSKDDTWYWMQQAK
LKLGDRLEIYQQPENKGKRHALYRGFELGTGEIFVTVDSDSIVKKDTLRNLVSPFVVDEK
CGAVAGNVHVLNNKKALLPKMLNVSFVMSFEFMRSAESMLGSVLCTPGAAAAYRRDAVFN
CLPEWIDQTFMGQPSDIGEDRAMTNMILKQGLHVLFQRNAIVLTNVPEEYVGLYKMFIRW
GRSNVRENLMMAQYVFKDFRKESKFGARLLFLNQSLKIVMAYPFLLFMLFFIAIHPILFF
SSTLLSILIVSSFSVLFYAKRYSLSEAFWAYSYSIFYTFSLFWITPYAIATANKRGWLTR
GLSEAK
>EGALAKHO_00698 hypothetical protein
MLQIVEKNKNHIADLRRIFLEVRQKTFYWLDTQNYNLTDFDHQTEAEFVLVALFDNKVVG
FISLWLRGNFIHHFYIDDEYQQHKIGTQLLEEAIQIMKTPITLKCLEKNTRAVEFYKNKG
FVVTEKGISDHGDYLLFTLHEKE
>EGALAKHO_00699 hypothetical protein
MKNSKLFILGIALSTLLMISCHNKRNKLVNSWKITAVETNHVALTDSAKHVILTSGNLTF
TEDGHVTGFLLQPITNGTYALTNGGKSLVIKDETGTPFPSESTITDDELILKLKEVKITL
KKI
>EGALAKHO_00700 hypothetical protein
MMKFPKIDFPQLKSKLQVKSPWDRIIIMLLSLLITIPVFIILHQNLIDLKWAFNLDRVFI
FIIVFAAIFFFLMLLRTIIILCIALYLLVLFYGSVIGNYGFNEISEDYNSMIYTMSDNPY
PQDIIAAKLLPFPNKSKIINAIEYQNPKVRNFAIMSTTKHFKNVKGYSDYRTIIQCFAVF
KEINSRWNYVNDPKEGDYIATASESLAYFSGDCDDHSILMAAAVRSIGGTPRLIHTKGHI
YPEILIGSLIDLEKVNYLIKNVLFVKESYGKRIHYHIDDRGQVWMNLDYTATYPGGPFLY
EEILGALTLN
>EGALAKHO_00701 hypothetical protein
MKTVKIVGVPEHFNLPWQLCIENGEFEAENIDLQWKNIPEGTGKMCQMLRDGEADIAVIL
TEGIVKDIVAGNPSKIVQIYVQSPLIWGIHVASNSDFHSIKDLKDKKVAISRLGSGSQLM
AYVNAHEQGWETDDLQFEIINTIDGAVEALTNETADYFMWERFMTKPLVDQGIFRRVGDC
PTPWPSFVITVRDEFLKKNPKIVEKILEIINKTTHDFAQIPDIDKTLADLFNQKIEDIQE
WLKLTQWSQKHLSEKAFDKIQNQLFDLGIIDKKSTFVETVKAL
>EGALAKHO_00702 hypothetical protein
MADTHKKILFKYYSDFLGETVSETMWAEIINLEKGFFRLDNIPFFGASIATADLFYAQYD
EDEKNYIYLETIEHSGNSIVQILILEKDFDKEVIREKLKAINCLSESLNDTFLAVEVARD
IDYSIVKNILKEYEAQEIIEFSEPYISEKHRADLLKN
>EGALAKHO_00703 hypothetical protein
MFLRVARHTNDLERIEKFYVDILGFERLGGFQNHNNYDGVFIGKSGLDWHFEFTQSDSKA
KHTFDEEDVIVLYPKTISDYNELENKLVRNNISTIAAINPFWNENGKMFQDPDGYRIVIS
PLKAIIDEIN
>EGALAKHO_00704 hypothetical protein
MKDSILKFDQLLNENSEFFPTIDAAILEERKPGKWSKKEVLGHLIDSAIHNLVRFTEINY
AEKPYRHRPYNQIDLVNLNQYQTKDINELNQLWLSLNKQIIRIMKSVDEEALDYKIILND
DSVIDLRFLMTDYVEHLEHHINQIRS
>EGALAKHO_00705 Purine nucleoside phosphorylase DeoD-type
MIKQSELILNPDGSVYHLNLRPEHIANDIIFVGDQNRVEKITQFFDTIEFSTQKREFKTQ
TGTYKGKRISVMSTGIGPDNIDIVLNELDALVNIDLATRQPKEKLTSLNIIRIGTSGSLH
ADIPVDSFVMSKFGLGLDNMLRSYLIDDVSQDALEDAFIMHTNWDIRKGRPYAIPCSETL
EKIIESDKMFKGITATAGGFYGPQGRVLRLNIQDEQLNNKMDNFNFDDQRITNLEMETAA
IYGLSALLGHNALSLNAIIANRASGTFSDDPYKAVDALIAYTLNKLAQK
>EGALAKHO_00706 hypothetical protein
MDLQDQLKNLFPDHVESNEPEEIQEQEHVLYVQKEPMICKFEKRKGKATTIIEGYEGSDE
DFKILAKEIKTKLSVGGTFKDDSIIIQGDYRDKIMTILKEKGFKTKRVGG
>EGALAKHO_00707 hypothetical protein
MQNIPSVDLRDFLSDDPKRKQKFVNEIGSAFENIGFVALKGHFLDDQLVDELYSEIRKFF
ALPVETKHNYEIPGIGGQRGYVSFGKEHAKGRKEGDLKEFWHFGQYVDKDSKYASEYPEN
VEVKELPHFNAVGKEAYQMLEKTGVYVLRALALHLGLDEFYFDQYAKEGNSILRPIHYPP
ITSEPENAIRAAAHGDINLITLLMGAQGKGLQVQNHDGEWIDAIAADDELVINVGDMLSR
HTNNKLKSTIHQVVNPPRELWGTSRFSVPFFMHPVSDMRLDCLENCIDAENPKKFEDITA
GDYLYERLVDLGLIKK
>EGALAKHO_00708 2-oxoisovalerate dehydrogenase subunit beta
MIFYRQDLTDAQLLDLYKKLLKPRLIEEKMLILIRQGKVSKWFSGIGQEAIAVGVTAVLD
ETEYVLPMHRNLGVFTSRNIPLHRLFSQWQGKASGFTKGRDRSFHFGTQEYKIIGMISHL
GPQLGIADGIALADKLQNNKKITAVFTGEGATSEGDFHEALNIAAVWKLPVMFIIENNGY
GLSTPTNEQYLCTNLADKGIGYGIESHIIDGNNILEVYNKLSELKEQMQNDPHPVLLEFK
TFRMRGHEEASGTKYVPQELMDEWAAKDPVTNYRDYLTKINVLTAEFDEQLHAEIKQEID
ENLAIANAEPEIIPTYSGELDDVYKPFQYEEVSPSSEVKNIRFIDAIRNGLEQSMQTHKN
LIIMGQDIAEYGGAFKITDGFVEFFGKDRVRNTPICESAVVSTGMGLSINGYKAIVEMQF
ADFVSTGFNPIVNLLAKSHYRWGEKADVVVRMPCGGGTQAGPFHSQTNEAWFTKTPGLKV
VYPAFPYDAKGLLNTSINDPNPVLFFEHKQLYRSVYQDVPTDYYTIPLGKAAVLKEGNKV
TIIAFGAPVHWALDTLAKNPEIDADLIDLRTLQPLDTETIFASVKKTGKVIIYQEDTMFG
GIASDISALIMEECFEYLDAPVKRVASLDSPIPFTKALEDQFLSKNRFEEILFDLLKY
>EGALAKHO_00709 hypothetical protein
MKKLFFSIFTISLLFSCNKTTKTTDKALDQKFNKYKEGFVTDLWKINPGWASGVGYHKLD
SVLVIPDANEAKIQLDFANAQLDSLKQYDIESLSDNNKTDFQMIKNQIEASIFSIKELKS
SEWNPSEYNVCGAFAEILNGNYDSLEVRLRTFNVKMKNIPAYYEAAKKNIKNPTIEHTDL
AIAQNIGGSTVFEADLNDALAKSKLSAAEKKEIQDKAKLSIKAIKDYAEWLQNLPNKTPR
SFRLGADLYAKKFNFDIQSSYTADEIYKIAVDHKNDLHDKMFVLADKLWKKYKGNAPKPA
DKLDLIKEVIDKISLQHTTPEKFQSEIEKQIPELAAYVKAKDLLYIDPSKPLVVRKEPAY
MAGVAGASISAAGPYDKNANTYYNVGSMSGWTAENAESYLREYNDYILQILNIHEAIPGH
YTQLVYSNQSPSIIKSILGNGAMVEGWAVYAEKMMLESGYKNSDEMWLMYYKWNLRTTCN
TILDISVHTKDMSKEEAMILLTREAFQQQAEAEGKWKRVTLSQVQLCSYFTGYTEIYNLR
EELKKQEGDKFNLKKFHEKFLSYGSAPVKYIKELMLSNE
>EGALAKHO_00710 Phenolphthiocerol synthesis polyketide synthase type I Pks15/1
MKAAVVYKKGESPKYVEFAEPIPQNENQILLSVKAVAITNLDKGKASGKHYSSDNHSENG
FVVSSDAVGLLENGTRIYARGITGTMAEKTIIDKNIFVPLPEGITDTIAAAMSNAVAGSA
MALKFRAGIKPGETVLINGGAGFTGQMAIQIAKHYGAKRIIVTARNEKTFLNLLELGADE
VISLKQDEETIINQLKKIHQNTPIDIVLDYLWGHTAQLILSALKGNGSFTHKTRYVNVGS
IAGNSIKLSAGILRSVDLQLSGSGLGSWSKGEVKLLFSEILPEMFLLAAQNKIKVNIEEV
NLKDIEQMWNAEVSDGKRLVVKI
>EGALAKHO_00711 hypothetical protein
MFNQFRNKFPLHDSKWIEYTSYFNRLEVPAKTILLEEGEISKRLFIIEKGCIRVWFNNNG
KDLTTQFFFENQSVASIESFMKKIPSPVVIETIEASVIWWISKNDLDKILEEIKEIPELR
DRFINMLFERTFDYMKHFVSFIKDSPTQRYLNLIEERPQVLQRVPQHYIASYLGVSTVHL
SRIKSQLLHKK
>EGALAKHO_00712 hypothetical protein
MADRDTFLREFRGETLGTVSAQSSADELFQNQTIRPILKLQNDLFIAVFINYVNKNKADF
YSYTVEKKLQVIENSIQKDIKFRNSLKGIVMALFTIEEYETYIQNSSSLNKRMMNLLIDR
LKSQVQLFELESNSN
>EGALAKHO_00713 hypothetical protein
MRFHTRKWVKPEDLNPNGTLFGGKLLAWIDEELALYTIIQLENTRVVTKYMSEINFKSSA
RQGDIVEIGIDVVKFGNTSLVLKCAVRNMMTREIIITIDQTTMVNLDEDGKPKAHGKTQI
EFVKDRL
>EGALAKHO_00714 hypothetical protein
MIFKNFVTVSLLSVFLYSCNSKEEKDKYNRVFYRAINNKDTAILDININDKRFYGRYEIL
YHKIGKDSGDVRGDMRGDTLRGDYHFISNGGSWKRIPIALLKKDNKLILGKGVIGTYFNL
PLFLPEVPIEYSNSEFVFQKIEK
>EGALAKHO_00715 Miniconductance mechanosensitive channel YbdG
MHKPLDKIFNFLYPLFRDWGMSRNFASYISLIFNIVIMVALAYAIYYVAKFVLVTLTAVF
AQKTKTKFDDYLIHNKTTKYTAYLIPFFFIYKAVPIILDRYEYWETLFGKIVGIYIVLIS
LWIIRTIFNALRDYLKQKPEYSDKPIDSFVQVIMIVLWIFGVAMIISTLFGIKKGELLTI
LGTLSAIIILIFRDTILGFVSSVQVSINDMVRIGDWITMDKFGADGDVIEINLTTVKVRN
FDNTFTTIPTYSLSSDSFQNWRGMQKSDGRRIKRHILIKSSSIRFLSNEDLNQMKKVQLI
SSYIVTRQAEIEKYNAIHGIDKTLSLNGRNMTNLGLFRKYIMQYLVDHPGLNKNMHIMCR
QLQSTAHGVPLEIYAFSSDKRWANYEYIMADIFDHIMASVEYFDLEIFELPSKIGRLD
>EGALAKHO_00716 hypothetical protein
MLKIFKVTAILEGISYLVLFANMLFIKTNNPELYHTLLRPLGMTHGVLFIGYIILAFLLR
KSQNWDVKTFGIILIASLIPFGTFYIEKKYLENNA
>EGALAKHO_00717 hypothetical protein
MSKRDLKKYLAELNKEQLEEQIIELYEKFVPVKTFYDFVFNPKEDKLLQESKTKISHEYF
PIKKPNAKWRPKAKMRRSVAQKMIKHFIVLGVDSFIVADLMLYNIEIAQTFSSGNFVKQE
LFYKSMFNSFEQAVNFIISNGILSEFKARILEIQQQTIQQKWKNKYDFEAILDKIDL
>EGALAKHO_00718 Putative DNA repair helicase RadD
MSQNTLEIEREEKKELYAYQKGDIDAIFERLDNAPAQHHLLYQLPTGGGKTVIFSEIVRR
YLANNDKKVVVLTHRIELCKQTSKMLKGFGVSNKIINSKVKELPDQNDYSCFVAMVETLK
NRINDEKLHLDNIGLVIIDEAHYNSFRKLLNSFKNAFILGVTATPLSSNIKLPMHQSYDE
LIVGDTISSLIDKGFLARATTYSYDVGLTSLKVGINGDYTVKSSDDLYTNTIMQEKLLHA
YTERSLGKKTLIFNNGIHTSLYVYETFREAGYDIRHLDNTSSSEERKDILAWFKKTPDAI
LTSVGILTTGFDEPTVETIILNRATKSLTLYYQMIGRGSRKLPGKDEFTVIDLGNNAARF
GLWSEPVNWQHIFKSPEFYLENLRDDTEIELYFKYTMPPELRAKFSKTADVTFDVDEEHK
LIIKQNLRSKVVLDKSLEQHASMCVDNTETLQEAKSLGKELDDDIECRIKRYAKCLSQCS
KNYREWLVEDYKKNMTLLIGKKYREKIMNEPD
>EGALAKHO_00719 ATP-dependent RNA helicase DeaD
MSKQFSALGVSAPILKALSELNIVEPTEIQQKTIPLLLSESHDVVGLAKTGTGKTAAFGL
PLLQLINTEIATVQAVILVPTRELGQQIFRNLEDFGKHIPNISIASTCGGIPIKPQIERL
TQPTQIVVATPGRLIDLIQRKAIDLKQTEYLVLDEADEMVSILKESLDEIVAELPKKHRT
LLFSATLPGTIKQLIQNYLNKNVVQVSANMETVGNQGIDHEYIVVDPIEKLDVLMHFLNS
KEGERGIIFCKTKAAVNKLAKNLAINRFSSGALHGSLSQGIRDRIMEQFREGHINILVAT
DLAARGIDVKEISYVVNYHLPDTYETYVHRSGRTARAGAKGLSLTVLQEEEVIEIPEFEK
ELGIKFTKFQKPSVISLEENNTLLWAKQIFKTKPNHDISADLKTKVKTVFHHLTKDELIE
KLMANYVLQNKVEITEKPVKKFKK
>EGALAKHO_00720 NADH dehydrogenase
MNIVIIGGGFAGINLAKELVDHPQIQVTLVDKNNYNFFPPLIYQVATAFLEPSSISYPFR
KFFAGKKNLQFRLGELLSVVPEENKIILSNGELTYDHLVFATGAETSYFGMENVMKNAIP
MKTLNDAIEMRNALLKNLEKAAICKDIRKRRKLLTIVVAGGGPTGVEVSGMFAEMRKNIL
LKEYPELETSASNVYLVDGGDALLSPMSEASQKDTLEALTKLGVVVKLHTRVTDYVDDTV
FFENGETIKTKNLIWAAGVSAKLFDGIPKESYGRGRRMATDQFNKVNGFQNIYAIGDTAI
LAGDAKFPDGHPQVAQVAIQQGLNLAKNFKALVQNKPLKPFAYKDKGSMAIIGKNQAVVD
LPSPKWHFKGFFAWIIWLFIHLISLITYRNRLNTFWNWMVAYFARDQSLRMIIRPDKKQQ
IE
>EGALAKHO_00721 Bicyclomycin resistance protein
MTAKKYIQLILILGSLTALGPFSIDMYLPGFSGIAKDLHTTVAKVSMSLSSYFIGISAGQ
LLYGPLLDRFGRKKPLFVGLMVYILASLGCIYVNNIDTFIFLRFIQAIGSCAATVASVAM
VRDLFPVKDIPKVFSLLMLVLGLSPMLAPTIGGYVTEDFGWHIVFLILMFMGIAILIASQ
VGLPNSYKPDTSISLKPKPIISNFMKVLKEPQFYTYAFTGSIAFSGLFTYVAASPIVFMD
IYHVDAKTYGWIFAFMSVSFIGSSQLNSLLLKRFSSEQMILAALISQSVISIVFLLLSVN
NLLGLYETIAMLFLFLGCLGISNPNTAGLTMAPFAKNAGSASALMGAIQLGLGALASFAV
GVFVKDSVAPMVLIMTVTTLIALVVLNIGKRFIKEKVEVSNDDDVLAGH
>EGALAKHO_00722 hypothetical protein
MKKFTLLLALIFTTISFAQTITSKQEDANVEQYALLTKVNQYYPDITLSKTVTNFYADGK
IIDSQQEFKLKGTKFSSYKIGIEPDNKKVLFEYVSDENGKVYGDVSLFKGNVIRTTFTDK
TGEVEVSLNGKAVYQTKI
>EGALAKHO_00723 hypothetical protein
MPKFLKMKKIILLLLLISLSSYAQTNQFTGTWSNENCKDCSKKYIFKITIAQSNNKIVGT
AEIISDNSELNSGVMDITGYVYVLGEKAQIKIKSQNGQSTNAVLFANQNVLQFTKRGGSD
LVPEETILAKLYE
>EGALAKHO_00724 Inosine-5'-monophosphate dehydrogenase
MNTIAEHIADFLKEYPPFDNLTFQELSDIATNIRVINLEKHTVLFQNNDVLHDSFYVVAS
GVINLTTIADAEETIINKCHEGDIFGLRPFFAKNNYMMTAKAREESIIYAIPIAVFRPFV
ANNSDVLNFLLESFAVNSRHTKDSVNSNGKVISDTSFYVDQQSEMQYIQSLTYNNSPLTT
EANHVVKDVAILMTEAMVDNIIVCEKNKPIGIVTAADLSSKIATGRYPITETIDKIMSSP
VVTVIENVSLAEAQLLMLKHNVTHLCVTKDGTNKSAVKGIISEHDLIVAQASNPGVLIKE
IKRSQLPKDLKQIRDRLSDLIQNSIQKNIPISHISNIASEINLAIIKRAVELSILDLGSP
PARFAWLSIGSQGRKEQLLLTDQDSTLIFEDVTPDKYRETKDYFLRLAKRTTAILEKVGY
EYCPNGHMGSNMLWCKSLTDWTKQYNSWMNTPGENSNDLSSIFFDYEIVFGEPKIEEVIE
NVIFKNAVNNTLFFDFLGNDALKRNSPLSFFKKFIVEEEGPHKTKFDIKTRALMPLIDGA
RLLILNANIKGIKNTYLRFKQLAITDSKNAEIYLSCAEAFLTLSKFRTVEGLKNDDSGQY
INLREMSKTDKEKLKNALTPMKDLEELIKSKFQLTQFS
>EGALAKHO_00725 DNA polymerase III PolC-type
MLDWLKNINKEYPDFWKDYLTKFETKPNRFVVLSTETSGLNPNKDVILSLGAFSVIDDSI
VIKDNFESVLLQYKFLQDNGLSNEFIIESKMIKMPEPDALEAFINFLGNAILVGHHINFD
IEMLNSALERLDCGRIKNEALDVDVMYRKLMDVNDKQFSLDDLCEIYKIPKSDRNSSAED
AYRIALLFLKLKSRLGIK
>EGALAKHO_00726 hypothetical protein
MKKLLFIVPLLFFVSAIFAQNQDPSSRRIVGSWYSNTNRTIKWIFTQDGKVYNYNNDIMK
VMYKYTISHNCQNYSDDTTEFITLRDKDGDEFCFKINVINENKNGILSLINLSNMQPLIF
VNDLNLKIAQ
>EGALAKHO_00727 Acetyl-coenzyme A synthetase
MSYYKIENLEQYFKHYNKSIREPRKFWGKIAEENFTWYQQWEKVVDFNMADAEVKWFTEA
KVNITKNCIDRHLSKRGEKTAIIFEPNDPSEEALHITYNELYERVSKMANVLREQGVRKG
DRVCIYLPMIPELAVAVLACARIGAIHSVIFAGFSASAVSARINDCECKMVITSDGGYRG
NKTIDLKGIVDEALDSCPSVSKVLVVKRTQTEIKMKEGRDQWLQPLLDAALDNSVAEIMD
AEDPLFILYTSGSTGKPKGMVHTTAGYMVYTAYTFKNVFSHEENDIFWCTADIGWITGHS
YILYGPLLNGGTTVIFEGVPSYPDFSRFWDIIEKHKITQFYTAPTAIRSLAKESLDYIQK
YPLKSLKVIGSVGEPINEEAWHWFNDHVGDKRCPVVDTWWQTETGGIMISPIAFVTPTKP
TYATLPLPGIQPVLMDEKRNEIEGNQVVGSLCIKFPWPGIARTIWGDHDRYKETYFSAFP
GKYFTGDGALRDEVGYYRITGRVDDVVIVSGHNLGTAPIEDAINEHQAVAESAIVGFPHE
IKGNALYGYVILKETGEVRNKENLTKEINQYIADHIGPIAKLDKIQFVSGLPKTRSGKIM
RRILRKIAEGDFSNFGDTSTLLNPEVVEEIMKERIS
>EGALAKHO_00728 Ketol-acid reductoisomerase (NADP(+))
MANYFNTLPLRLQLEQLGVCEFMEQSEFADGIAALAGKKVVIVGCGAQGLNQGLNMRDSG
LDISYALRADAIAEKRASYKNATENGFKVGTYEELIPTADLVCNLTPDKQHTAVVTAIMP
LMKQGSTLAYSHGFNIVEEGMQIRKDITVIMCAPKCPGSEVREEYKRGFGVPTLIAVHPE
NDPNGAGLDQAKAYAVATGGHKAGVLKSSFVAEVKSDLMGEQTILCGLLQTGSILCFDKM
VEKGIEPAYASKLIQYGWETITEALKHGGITNMMDRLSNPAKIEAYEIAEELKDIMRPLF
QKHQDDIISGEFSRTMMIDWANDDKNLLTWRAATGETNFEKTPPTDAPIAEQEYFDNGVL
MIAMVKAGVELAFETMTEAGIIEESAYYESLHELPLIANTIARKKLFEMNRVISDTAEYG
CYLFDHACKPLLTEYMKTVETNIIGKPFSTSNGVDNAILIAVNKEIRQHPIEEVGAWLRE
SMTAMKKIG
>EGALAKHO_00729 Putative acetolactate synthase small subunit
MEDKTFTISVYSENNVGLLNRISGIFLKRHINILSLNVSESEIENVSRFIIVVNTTEKWV
QNIVGQIEKQIEVIKAFYHTDEETIFLENALFKIQSSLLFDEKQIQNIIKESQSTIVTVS
RDFFVISKSGRRSEIEELYAKFKPYGIMQFVRSGRISVSKEKMEISSLLETFN
>EGALAKHO_00730 Acetolactate synthase large subunit
MKISGAEAVIRCLLAEGVDLVYGYPGGAIMPVYDELYKFQDQLHHVLVRHEQGATHAAQG
YARATGKVGVAIATSGPGATNLVTGIADAQIDSTPMVCITGQVGRHLLGSDAFQETDIIG
ISTPVTKWNFQITEASQIPEIIAKAFYIARSGRPGPVLIDITKNAQFDEFDFNYEKCTSI
RSYVPVPKLKLDKVAEAAALINSAKKPFIVFGQGIILGQAEEQLKAFIEKSGIPAGWTIL
GLSALPTDHPLNVGMLGMHGNYGPNMLTNECDVLIALGMRFDDRVTGKLATYAKQAKVIH
FEIDPAEVDKNVKTEVAVLGDVKEALTALLPLIEKNSHASWHNEFKEFAAIEYASVIKEE
LNPTNGKGISMGETMEMINKHSKGDAIIVSDVGQHQMFACRYAKFNSTKSNITSGGLGTM
GFALPAAIGAKMGRPDREVVAIIGDGGFQMTIQELGTIFQTQVPVKIVILNNEFLGMVRQ
WQELFFDNRYASTKMINPNFVAIAEGYHIKSKKVTQREDLDAAVAEMMASKDSYFLEVMV
EKENNVFPMIPTGACVSEIRLS
>EGALAKHO_00731 Dihydroxy-acid dehydratase
MELNKYSKTITQDQTQPAAQAMLYGIGLTEEDLKKAQVGIVSMGYDGNTCNMHLNDLAKD
VKKGVWDANLVGLIFNTIGVSDGISNGTEGMRFSLVSRDVIADSIETVVGAQWYDGVIAI
PGCDKNMPGALIAMGRLNRPSMMVYGGSIHSGKWKGESLNIVSAFEALGKKVKNEITPED
FKGVIQNACPGAGACGGMYTANTMSSAIEALGMSLPYSSSNPALSQEKRDECLAAGEAIK
ILLEKDIKPRDIMTRKAFENAITIVAVLGGSTNAVMHLIAMAHAVDIKITLDDFQAINDR
TPVLADMKPSGKYMMEDIHEAGGIPSVMKYLLKVGLIHGDCLTVTGKTVAENLASTPDLQ
DGQQVIHEIQKALKPTGNIQVLYGNLASEGAVAKISGKEGEYFEGPAVVFEGEFEVIPGL
EAGKIKPGNVVVIRYCGPKGGPGMPEMLKPTSAIIGAGLGSTCALITDGRFSGGSHGFVV
GHITPEAYDGGGIALVKDGDLIAIDAVKNTIDLKISDEEFAARKAAWVQPPLKVTKGVLL
KYARSVSSASTGCVTDN
>EGALAKHO_00732 3-isopropylmalate dehydrogenase
MNLKIAVLPGDGIGPEVILQAKKALYAIGEVYNHEFVFEEALMGAIAIDKTGNPLPEQTL
NLCLNTDAVLFGAIGDPKYDNNPNAKVRPEQGLLKLRKELGLFANIRPIKPYKSLVESSP
LKREIIEGADFTIFRELTGGAYFGAKTLNEEGTHASDLCEYSEEEITRIAHLAFKSAQNR
RKKLTMVDKANVLETSRLWRKVVQKVGESYPDVALDFLFVDNAAMQIILNPKQFDVILTE
NLFGDILSDEASVITGSIGLLASASLGEKNALFEPIHGSYPQAKGKNIANPIASILSAAM
LLEHFGLFKEASVIYQAVEKAIEFKVVTVDLKADSKFGTNEVGEFVSNFIFSKDDLLYFN
NDNVSIGQSTIV
>EGALAKHO_00733 2-isopropylmalate synthase
MNREKVQIFDTTLRDGEQVPGCKLDTKQKLVIAERLDKMGVDVIEAGFPVSSPGDFLSVS
EICKIVENATVCGLTRAVKNDIDVAAAALKHAKRPRIHTGIGTSESHILHKLNTTREDII
ARAKYAVSHAKSYVEDVEFYAEDAGRTDNAFLAQVCEEVIKSGATVLNIPDTTGYCLPEE
YGAKIKYLRENVKGIENVILSCHCHNDLGMATANSIAGAINGARQIECTINGIGERAGNT
ALEEVVMIFKQHPYLNLDTNINTRELNEMSRLVSESMGMIVQPNKAIVGANAFAHSSGIH
QDGVIKNRATYEIMDPLDVGVNESSIILTARSGRAALAYRAKKVGYELTKVQLDIVYIEF
LKFADIKKEVVDADIHQIIEASKIQGELIRS
>EGALAKHO_00734 hypothetical protein
MANHQKDFLFVLIKSLSKSEKRQFKIFASRLETSSNTKFIELFNILDKSETYDEKLILKS
GIIKKVQLSNLKSYLYKQILVSIRLNIPSQNIRYQLREQIDFAVILYNKGLYKQSLKILD
KTKILALENDEKYMAYEIVEFEKLIESQYITRSIQGRADELVIQAKELNYRNTISSKLSN
LSLQLYGIMLKTGYVKSDEEYKYIDDYFNRHISKLDESKFGFREKYWFYNANLWRSFLVQ
DFLASYKYAYKWVTLFYDNPNMIFLNPVFFLKGNHYFLESLYMLRYQSNFKKYLTLLEET
IADPKFPVNDNIASLSFLYVYNNKLNLHILEGTFAESEYLIPEILEKIKIHSEHLDEHHE
MLFFYKIASIYFGNEKYNECIFYLDKIINNKNLTMREDLMCFARLLSLIAHYELGKDYYL
ENHLKSTYKFLLKMNDLHEVQKEIIKFLKNLNNFYPADIKKEFIKMRARFIELEKNTYEK
RAFLYLDIISWLESKIENRKIADIIKEKAKLSSR
>EGALAKHO_00735 Aminopeptidase N
MKKYFSGVFVAFLVGFNANAQGLLNKSETVFTHQDTLRGSITKERAWWDLKYYHLDVKVN
PAEKTITGSNTVKYTVLAENNKMQIDLQEPMQIYKVTQDGKELKFERDGNAFFIQLTAKQ
KVGETKEIVISFGGKPKEAVRAPWDGGFSWKKDQNGKDFIATSCQGLGASVWWPCKDHMY
DEVENMLISVNVPGDLTEVSNGRLKSVKKEKDGTKTFNWYVSNPINNYGVNINIGDYVNF
SEKFKGEKGDLDCNYYVLRDNLAKAKEQFKDAPKMLKAFENWFGPYPFYEDSYKLVEVPY
LGMEHQSSVTYGNQYKNGYLGKDLSGTGWGLKFDFIIIHESGHEWFANNITYKDIADMWI
HESFTNYSESLFVEYYYGKEAAAEYVIGCRKNIHNDTPIIGHYDVNNEGSGDMYPKGANM
LHTIRQVINDDAKWKSILRGLNSTFYHQTVTSKQIEDYINTQSGINFNRVFAQYLTTTQI
PVFEYMFKNGTLGYHWTNCVAKFDLPVKVKINGVETWLKPTTEWQSVKTTNENRTLEVDK
NFYVTSSNIVE
>EGALAKHO_00736 Aminopeptidase N
MIKKYFGGVFTAFLIGFSANAQGLLNKSEMVFTHQDTLRGSITKERSWWDLKYYHLDIKV
NPIDRTIKGSNTVRYTVLSEYNKMQIDLQEPMQIYKVMQDGKELQFERNGNAFFIELTAA
QKVGETKEIVISFGGVPKEAVRPPWDGGITWKKDNNGKNFIASSCQGLGASIWWPNKDHM
YDEVENMLISVNVPGDLTDVSNGRLKSVKKEKDGTKTFNWYVSNPINNYGVNINIGDYVN
FSEKFKGEKGDLDCSYYVLRDNLAKAKEQFKDAPRMLKAFENWFGPYPFYEDSYKLVEAP
YLGMEHQSSVTYGNDYKNGYKGHDMSGTGWGLKYDYIIIHESGHEWFANNITYKDIADMW
IHESFTTYSEALFIEYYYGKDAINEYIRGIRKLIANKKPIIGHYDVNNEGSGDMYPKGAN
MIHTIRQVINDDAKWKSILRGLNSTFYHQTVTTKQIEDYINTQSGIDFSTVFNQYLRTAQ
VPTLEYYFKDQKLVYHWINCVDKFDLPVKVTLNGVETWLKPTTDWKAEDSKTDKPTFEVS
KNFYVTEFNITN
>EGALAKHO_00737 hypothetical protein
MKFIKITSILFLMCSITSYSQDVLVHKINEKITIDGELSEWKTPFIGPLVIHNSGKKAIQ
NTMISLSWNDDNLYIAYNSVDSKIIGSNQKKDSPIFNTDDLVEFFIDADEDGQNYVEIGV
NAFSSHYDMLLKCISPTCGGWKTSMTFDIEGLETASKITPEGFTTEIKIPFSSLEKIQNG
NFLKPEIGTKWKGNAFRIDYGNTTEYLALQPYKSLKFGFHQPQEFAVFEFVE
>EGALAKHO_00738 Phosphoribosyl-AMP cyclohydrolase
MNIDIKSSHGLIPAIIQDSETKNVLMLGYMNEESLQKTIETQKVTFFSRSKQRLWTKGEE
SGNFLELVDIKNDCDGDTLLIQAKPVGPTCHTGADTCWQEENKENYGFISNLEKTIATRR
ENADSEKSYVASLFEKGINKIAQKVGEEAVEVVIEAKDDNDDLFLSESADLLFHYLILLQ
AKGFQLNDVVDVLKKRQK
>EGALAKHO_00739 Imidazole glycerol phosphate synthase subunit HisF
MLAKRIIPCLDIKNGRTVKGVNFVDLRDAGDPVELAEIYSAEGADELVFLDISATEERRK
TLVNMVRSVAEKINIPFTVGGGISSVEDVEILLNNGADKVSINSSAVKNPQLINDLAQKF
GSQCVVVAIDAKQIDGQWIVHLVGGKVPTELNLFDWAIEVAERGAGEILFTSMDNDGTKN
GFANEALAKLSELINIPIIASGGAGNIQHFVDSFKVGKADAALAASVFHFKEIEIKALKE
ELRNNDIEVRL
>EGALAKHO_00740 1-(5-phosphoribosyl)-5-[(5-phosphoribosylamino)methylideneamino] imidazole-4-carboxamide isomerase
MRIIPAIDIIDGKCVRLSKGDYDTKIIYNENPLEVAKSFEAHGIEYLHLVDLDGAKSSKI
VNYKILEQIATQTSLQIDFGGGLKSDEDLKIAFESGASQITGGSIAVKNRAIFEKWISEY
GSEKIILGADAKDEKVAISGWLEDSDEDLVPFIQQYQTKGIQYVICTDIAKDGMLEGPSF
DLYGKILKEANGIKLIASGGISTFDELPKLAHLGCEGTIIGKAIYEGRISLKQLENFIIR
>EGALAKHO_00741 Imidazole glycerol phosphate synthase subunit HisH
MKIVIINYGAGNIQSIMFAIERLGFKAVLSNDPEEIRSADKVIFPGVGEASSAMKKLKES
GLDSLIPNLKQPVLGICLGMQLMCKSSEEGYTKGLGIFDVDVIKFTSKVKVPQMGWNQIY
DLKSDLFKGIAENEFMYLVHSFYAPDCVESIATTNYELEYASALQKDNFYGTQFHPEKSG
AVGEKILENFLKLNYNF
>EGALAKHO_00742 Histidine biosynthesis bifunctional protein HisB
MKKVLFIDRDGTIVLEPENLQLDSLEKLEFYPKAFQYLAKIASELDYELAMVTNQDGLGT
DSFPEDTFWPTQNFILKAFENEGVLFDEIFVDRSFPEDNAPTRKPRTGMLTKYLNNPEYD
LANSFVLGDRLTDVELAKNLGAKAIFINDNDGIGSNEISSKREELDETIILQTMSWKEIY
EFLKLEARSASITRKTHETDIFINVNLDGTGKSKIDTGIAFFDHMLDQISRHGQMDLEIL
VKGDLEVDEHHTIEDTAIALGEVFAKALGNKLGIERYGFCLPMDDCLAQVAIDFGGRNWL
VWETEFKREMVGKMPTEMFYHFFKSFSDGAKANINIKAEGINEHHKIEAIFKAFAKAIKV
AVKRDTEKMILPSTKGML
>EGALAKHO_00743 Histidinol-phosphate aminotransferase
MKFDINTITRENVKILKPYSSARDEFEDFDTAEMIFLDANENPFQNGVNRYPDPQQSSVK
AILAKNNSVKASQILLGNGSDEVLDLLFRAFCEPKIDNIISLPPTYGMYSVLANINAVEN
REVLLSTDFQPQVEKILEAVDDNTKIIFLCSPNNPTGNSFSDESVVKLLQNFKGLVVIDE
AYIDFSGKESWLIEIDEYPNLVITQTLSKAYGLAGIRLGICYASEAVISVLNKIKPPYNV
NELTQQRAISRLKDSDKIKQEIASIIEQREELLKVLLEVSFVEKVYPTEANFVLVKVDDA
NKRYDELIAKGIVIRNRTTQPLCENCLRFTIGIPEENAVLIKELRLLK
>EGALAKHO_00744 Histidinol dehydrogenase
MNKIDNPKPETWSEILKRPTKTIDDIEVTVKEIFKEVQKKGDEAVAKYTSIFDGITLDNY
EVTPEEIEEAINSISDELKSSIQLAKENILKFHTAQKTDRISVETIEGVNCWQEKRPIQK
IGLYIPGGTAPLFSTVLMLAVPAEIAGCKEIVLCSPPDKTGKINPAILYTANLCGVTKIL
KVGGIQAIAGMTFGTQSIPKVYKIFGPGNQFVTVAKQLATQFGVAIDMPAGPSELLIVAD
DTAVPAFVASDLLSQAEHGTDSQVILVSTSRRLIDAVEEEIQTQIEALPRKEIAKKAIEN
SKLIYVENDQIALDLINEYGPEHFIICSEFDDFYCNGIVNAGSVFIGNYTPESAGDYASG
TNHTLPTNGYAKNYSGVNLDSFMKSMTFQKISKTGIQNIGRAIEVMAEAEGLQAHKNAVT
LRLKSIE
>EGALAKHO_00745 ATP phosphoribosyltransferase
MSTLKIAIQKSGRLNEDSIQILKDCGISINNGNDQLKAEASNFPLEVLYLRNSDIPQYLI
DGVVDLAIVGDNLLVEKGKHIEVIQKLGFSKCKVSVAVPKTFEYNSIQDLAGLRIATSYP
NTVNEYFSSFGLTVDIHQISGSVEIAPNIGLADAIVDIVSSGSTLFKNNLREVEVILKSE
AVLAVSPKVSPEIQKHIDTLKFRIQSVLRARNSKYILMNVPNDKIDEIGKILPVLRSLTV
LPLAQEGWSSVHSVIDKDTFWDVIDKLKEAGAEGILVCPIEKMVL
>EGALAKHO_00746 hypothetical protein
MIYMHTINTSPESNNENDDDVIGLKSLFGLFYNSLIRLQIY
>EGALAKHO_00747 Signal transduction histidine-protein kinase ArlS
MAQLSFKNRIALNYIITTGLLILVVFSVIYSIVKHTVYSHIDENIKVEIQNHLAEIKVVG
KKVILIDEEEWSEREHNSVDVNPVFVEFLDLNKKIIEKAPNLKTETLEFKDSVEDYELFD
TKMGDHAIRQIQVPLHIKKKQIGYVIVAMSLADSKMILNNLFDIMCLSFLAILLLLFFIA
RFFAGRSIKPINAIINTSKIITKDNLKTRIPLPKTRDELYTLSKTINNLLNRIEDAIERE
KQFTSDASHELRTPLTVIKGTLEVLIRKRRDNKEYEEKINYCINEVDHLNMLVDQLLLMA
RFENQKQNINAESVYLNALILDVLTLNSEKIKTKKVDVKFDAEQDYYIQSDNFLVITILR
NIISNAIKYSNPNGEVSIMLSKQNEKIICKISDKGIGIAKADLESILNPFFRSNSTDHPE
IKGTGLGLSIVKRTTELLGIKFKIESEIEVGTNVTLSFNENMKTL
>EGALAKHO_00748 Transcriptional activator protein CzcR
MHILIVEDELGIVQFLQQGLQEEGYEVTTANDGSKGFELVQNQQFDLILLDWMLPKINGL
DLCKAIRIKDQKTPIIFLTAKDTVQETIEGLKAGANDYIKKPFSFEELVERIKIHFRNRK
GSEVLTLGTIKIDLSKHIVLKNDEEIALTQREFELLTYLIEHKGKVCTRNQILKDVWEIH
FEYDTGVIDVFMNAIRKKLNLKIEEDYIKTIRGIGYIANDL
>EGALAKHO_00749 Lipoteichoic acid synthase 1
MTFYKKLAPFYNLALFYFIISFLLRIVLFFHPITQSSFTILQSLKIFSLGLISDFFVFVI
ASVFLWLYLIFVSNSKYNKPSGFIILGIFVALFLYLASGKSIFDEYGGALPRIILIFIGI
KTVLFAALLFLPKWRDKIRFWLFAFVVFLYVLLILQNGLSEYFFWNEFGVKYNFIAVNYL
IYTTEVIGNIMQSYPVIPLFSALFLITGIVTYFILRNSKNFIKEIPNLNQKLKLSGIYII
LFLISLIAIPTLAKTENSKNVFVNELQANGLYKFYLAFQNNKLDYFKFYKTLPNKEAFAL
LKQQFPAISGENTTRTISGDSLENHRNVVLITIESYSADFMKAYGNYQNITPFLDSLSQK
SLQFTNLYAAGNRTVRGLEAVTLCLPPTAGESVVKREDNKNKFSTGSIFNQKGYNVKFMY
GGDAFFDNMQDFYSGNGYQIVDKSSFSPEEITFSNVWGVCDEDMYNKAIKVMNAEAKENK
PFFNHIMTVSNHRPFTYPNNKIDIPGDIKSRDGGVKYTDYSLKKFFEMASKQPWFQNTVF
VIVADHCASSAGKTQLPLDKYRIPAFIYDPTGKPAKCNKLMSQIDLMPTLFGLLHFDYQS
KFFGQDVLKSDYKPRAFIATYQDLGLIKDNVLTILSPKQTVKQFELKLNSKPGIAPEFQI
YYDEIPMQTERTDLVNETISFYQTASEMLKEKKYQK
>EGALAKHO_00750 hypothetical protein
MPPQTNLQMKNFKMKPRLIAFFALGIGFLTLSWGIVGHERINKAAVMALPQPLQIFFYNH
IDFITQEASVPDIRKYALNYKDENPRHYFDMENFGSVDSLPKTMEEAKKKYDAKFLNDNG
ILPWYIEDMMVKLTKAFKDKNRGEILFLAADLGHYIGDAHMPLHTSANHDGQLSDQKGIH
SLWESRLPELFAKNYKLNVPQAHYYEDVHKATWDMINDTHSLAKPLLDIDKKLRTATPEN
EVFKMDADGKVLKSKYNTALFSDEYAKKLNKELNGMVENQMKKAIEATASFWYTAWVNAG
KPDLSDLDSSALTQRNNQALKDDLKLYQTGDLFGMKNQND
>EGALAKHO_00751 hypothetical protein
MYNNYQLPILKTKQHSETHLFEVNLYLQQAVFVLIIALCLFSLISPPIALLLGVLTVNVF
GNPFVAFNHKAITFLLQFSVVGLGFGMNATSAIAAGKEGFLLTVFSIFSTLIFGTLLGKW
LKTEKKTSHLISCGTAICGGSAIAAISPVIKSNENQTSIALGVIFILNSIALFVFPLIGH
QLDLSQKDFGLWCAIAIHDTSSVVGAANKYGAEALQVATTVKLARALWIIPISLGTAVIF
KNQSRSVGTKIKFPYFIGLFVLAMLLNTYLPATAIVAPHIVGIAKIGLTITLFLIGATLN
INTLKSVGVKPLLQGVFLWIFIAGLGLASILYFH
>EGALAKHO_00752 HTH-type transcriptional regulator CysL
MDFRLKVFYTVALRLNFTKAATELYISQPAVSKHIQELEETYKTKLFERNGSKIALTPAG
EILLKHTKNIFEIYREIDFDMSSFINERQGLLRLGASTTISQYIISPVLARFHQKQKDIK
VNLLNGNTEQIENALINKEIEIGIVEGQSKNQSIKYIPFLKDELVLVCNTNNSFVKQNKI
SLEDLKAMKFITRERGSGTLEVIEYALKQVDFKLSYLQIEMQLGSTESIKSYLLNSDCFA
FMSIHAVSNELKNNELIVLDVENLSIERFFYIITLVGKSDSLSELFIQNLSSYYNLKL
>EGALAKHO_00753 hypothetical protein
MTTNTILLLLLSLVIAGCLSYFQYYFKAKNKSNVIVFLAFLRFLAIFGLLVLLINPIVSK
NSLEITKTPLAIAIDNSSSIVALKSDKKVAELYQKLISNPALQEKFDIQSYQFDADFKSS
DKFDFKGKQTNLDEVAKNLKSINKNLIFPTVIITDGNQTTGNDYVYRFDPVNKVYPLVVG
DTTTFFDLKINQLNVNKYAFHKNKFPVEVFLQYAGDKAATADFTISQGNSVIAKEKVAFS
PSKKTATVNLLLPAEKVGLQIFKASISSNAKEKNSYNNIKNFAVEVIDQKSTIAIVSSIN
HPDIASLKRSIEVNAQRKVILVKPNDINQLQDVSVLVLYQPTTAFKAIFDNNKLAGRNTF
IITGNNTDFNFLNQQQNNLIFKMSGQKEDYLSEFQSQFNLFAIEDFGFENFPPLQNLFGT
ISTNGNVSVLLSSKIRNVATNSPLLAFAENQGKRTAFLLGENSWKWRLQSHIDNQSFEKY
DVFIDKIIQYLASSTSKKSLVVTHESFYNSGEAIAINAQYFNKNYEFDEKARLTITVTNA
ETKQSKNYDLLKGNNSFSVNLDGLTAGKYNFSVKELNSNTSYSGHFEILDFDIEKQFVNP
DVLKLKQLALQTNGKAFFENQADDLINTLLENKEYKSIEKNISTKTPLIDWVWLLILIAV
LLTTEWFVRKYNGLL
>EGALAKHO_00754 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKLLEGKVAIITGASRGIGKGIAEVFAKHGANVAFTYSSSVASAEALETELNALGVKAKG
YQSNAADFNEAQTFVDAVLADFGTVDILINNAGITKDNLLMRMSEADFDQVIDVNLKSVF
NMTKAIQKTFLKQRAGSIINISSVVGVSGNAGQTNYAASKAGAIGFTKSVALELGSRNIR
CNAIAPGFIETEMTAKLPEDVVKGWRDGIPLKRGGTTEDVANACLFLASDMSAYVTGQVL
NVCGGMLT
>EGALAKHO_00755 hypothetical protein
MRKNATPIKIVFFLWALILIAITEFYPEYRRNYLWFSLIVIIPVVIIDLIKKKKDDKLND
TKEFQSSIYRMLFVGGILLAFFLITKQNHI
>EGALAKHO_00756 hypothetical protein
MKIKHIYKYLFAALLVLQLSSCTNNTDAEPKFDQTPTERLNAQKAELNNLLLSSEFGWKA
VYFTDNTVLGGYTHLFKFAADGTVQMASDFDSDTNTYKSEYEVQLGSTVSVVFTTKNRIH
LLSESDNYPIPALRAKGYLGDFQFLYYGQENGEIIFKTNRTAKELRFVKATAADWADLPK
NLIMEQNVIGGEDRPLFRLLETNDGTAKHQFDFSFSDVTRFAEANSIEAGYTISYDMGIG
YTPTGIVVSPAVEVGGQKLTNFTYNSTDGSFTATGTNGVTAVIKYTDKPLVLTDDYKITL
PGQPVVWFGFFIDDYTVEAQTNSPLFYSELEKINASLPAGQSIASVEIYTNHAIGTFIYY
TFVGRSPLQHHVTIQEDAVGKKIILKHKSWNGNTTAATPAFLASFDKYLMDPNGIYVKKE
NFRLVYSNTVYTFTSSSSPFRMTTWKLN
>EGALAKHO_00757 hypothetical protein
MKLLKYNKIAVLAIVSIALISCASDDQPGESQLNYTQPIKTSLDNWITTTYLNPYNINVQ
YKWNQNTVDNSRYLFPPTIDKVQPALEIVQTIWLKSYSTIGGADFVKKIAPREIVLVGGV
NLNSVGTRTLGLAEGGQRVTLFETDYIDKSDRANVSEFIHTIQHEYIHILNQNKPFDEKA
WKALTPGGYTADWYNYDIPESNELGFITSYARSNINEDFAETASMILIYSKAEYAAFLAG
IQSPEAYNALKAKEAIVVKYFKEAFNMDFYALRDEAEKNTTAVINN
>EGALAKHO_00758 hypothetical protein
MKNLKITLSLLILICITSCDDFLSEKPDNRTEIDTPAKISELLVEAYPQMSYFEIAETMS
DNVFDSGLTETLPKNEQNYNWLIQTETTDIDTQAYYWDACYKAIAHANKALEAIDELGNS
PSLNPQKGEALIARAYSHFMLVSLWSKRYNPATAASDLGVPYVTKPETELLTKYKRNTVA
EVFDFIEKDIEEGLKYVTNNYKEPRFHFNINAAKAFASRFYLVKGNWDKVIELSNDLGSK
PVGKLRDYAAYESIGVEDQQLKYGASNIETNLLIVSANTIVSRVYYLNRFNLSGTRQTEI
FGGTTNLFGKPYYYNLYSSNSSITLFVPKFYEYFKYSNVTAGIGDPYVAEVLLSNDEFFL
NRIEAHVMKGETALANEELEYFLATRTPTYNSTTDKVTQAKIVAKFPVIADEYTPFYTMT
PVQTSYIKAIAETRRRDFIHEGLRWFDIKRFNIVVKHETANKPVNTLVKDDNRRALQIPL
HASSTGVELNPR
>EGALAKHO_00759 TonB-dependent receptor SusC
MKKPVVKQRLLHRIMKITLFQFVLALVFSSVTMANSVNGQRKLDTKVTITVENLSLDNAL
SKIEKSAHVKFSYNSRLPQLNQKVSIEANQETLSSILNRILVPFNITYSEVSNQIILQKN
IAADPFSSTGNHDSLFEILTVGPIIKGKVTDATGSPLPGATIMAKGTKVAVLTDFDGNFS
IEMPANSTTLVISYVGMETKEIGIDNTTPTIILNEIGQNLKEVVVTTGYEKTSKRTFTGA
ISKISGTELKVDGVVDVSRMIEGKAAGVTVQNVTGTFGTAPKITVRGSSSIFGDTKPLWV
IDGVVQEDIINMSFADLASGNSSTLLSSSVAGLNANDIQSIEILKDASATSIYGSRSLNG
VVVVTTKQGRRDSPLKITYGLEQTVRTVPNYGQYDILNSQESMSIFKEMEAKGYLDLPST
VNGRYGGAYNILGRAINTYNPETGGYLVNNDPVSRNNFLKKYELANTDWFEVLFRPSITQ
NHSLSFSGGGKNNTFYASLGYYTDPGWTIADDVKQISSNIKGTFYVNDKLNITLSTLASI
RDQGAPGSYESEKDVVFGKVTRDFDINPFNYVLNTSRTLRPYDEKGNLEYYRNNWAKMNI
VNELANNYMEIEVKDIRFQLDLDYKINPHLTYNLTGSARYANTSREHKILEGSNVVGAYK
AGTPEGEDGVNTLVRNDNIFLYQDPNDLNAPKVSVLPNGGFLRKFTNDMTSYNLRNSVNY
RNIFNDVHELEALFGTEMRVVDRSSDNFTAAGLQYDRGLTAFTDPRLIEKIINGGDSYYG
FNEEKERTVGFFGKVGYTYDRRYTASVTGRYDGSNRQGNSDSSRWLPTYTFSGKWNVAEE
KFMKNVESVNTLALRASYGLTATAGPATNSLAIYKSAVTDRFILDDRETGIRIDELQNSD
LTWEKQFETNIGVDLGMFNNRVQFTTDVYRRKAFDLVDYVITSGIGGQRIRQGNNADMET
KGLEVAFTTKNFDNRDFKWSTTLNFSVYNQEITRLENTPTAFDLIDANGGNTVGHPRNSL
YSYQFTGLNNQGLPTFILQDGAENNITEANFQDNLNVTKYLKYEGSIEPNKSIGLANTFT
YKNWSLYVFFVGSGGNKVRLNPIYDSTYDDLTVFTKDFTNRWINPGDENFTNVPVIADKR
LNANYDGARNLAKAYNTYNYSDVRIADGDFVRLKNISLSWEFPSDFKRKIGVSTFTLKGS
AVNPWLIYSDKRLNGQDPEFRNSGGVALPVTSQYTFTLNLSL
>EGALAKHO_00760 hypothetical protein
MQKRNTYTQIEDFLSDESFQSWILFKIDESGWEEWTLESRQRAKLVEDARLLLLAMKVPE
SNLSSSDIHNALQTVWNKIEEKENQISFIENSKTNIFRKYLYTGIAASLFFCLMSVWFYK
NHFHTDNVVTYKELIDENSEGLVEQTNNSSKPQIITLSDGSSVLLQPNSKLSYPKIFTGN
ERKVYLSGEGFFEISKNPKKPFYVYANEIVTKVVGTSFRVRAYSDQPDVEVLVRTGKVKV
KSNDLVATTDQQEVVLLPNQALRFLRSDLKFNKITNITQDETLVRNVGNIEQLSFEFTDI
PVSQIFETIEQAYLVDIDYPKNKLKDCHLTTSLSDQPLTEKLKIVCKSIGTNTNFEMNGN
QIVITSDGCN
>EGALAKHO_00761 hypothetical protein
MKTTTLPFSTFDDITLWNNLREGDEKSFSILFERYYADLVRYGNSLSPYEEKVQDCVQDV
FTDIWVYRSALQSSVVVKAYLLSSVRKRIARLFERDHIFRKTTSTDSIAFLLEFSVEHEL
IDDDYLTKEKVLHLNKLLNDLPVRQKEALYLRYHQGLSVEQIAEMLDVNYQSASNLLHRG
LLSLRKEWKGVFSLFLILSSNSF
>EGALAKHO_00762 Internalin-J
MIKNYLLLLALCIFSSTNAQTITIPDANFKAKLLEANETNYIANYLGGKSAKIDTNGNGE
IEISEALKITELSLDNAKIISLEGIKNFVNLKYLSFYNNMVSTFDLNGMNIINLDCSSNQ
ITDIDVTGLANLITLGCVDNQLTTLDLSKQNVDKFLNLNCSGNKLTILKIDQFKNLQSLS
CSDNQLTNLNITAYSTLQSLDYSNNKMPNYDLKKFLNLEDLRCTNTETTNLDLTGSTKLR
QIICDNNNLTNLDVSHLPILERIFCSNNKLTSLDLKNLEDKLEYLEVDNNKLSVIDLESF
TKLVYVHASNNDIKTLNLSNASGLQELFVTQNSFLESLFIKNGSLEPLMIFSDNPNLKYI
CADDNQLVQIEDILQIFDSKDCTVNSYCTFSPGGNNFVIHGNVRNDSNNNGCDASDVPVS
NLKFQISDNVKSINFISSEVGNYSIKVPVGSYTISPSFENPEYFAVSPTSLNVVFPTQPS
PFSQDFCIRPNGVHNDLEVTLLPLEAARPGFDAKYKIVIKNKGNKTQWGTVRLNFNDAVL
DFVSSVPKISNQITDNLSWNFTNLKPFETKEIDVVLNVNSTQETPSVNASDILSYIVDVS
FPDTDEKVNDNIFSLNQTVVGSYDPNDKICLEGNVIKPELIGEFVHYMIRFENTGTYAAE
NIVIKDVIDLSKLDISTLVPTKASHSFITKISDGNKVEFIFEKINLPFNDVNNDGYIAFK
IKTLPTLAVGDSFVNEANIYFDYNFPILTNKATSTFKVLETPDFAFSNYFNVYPNPVNEV
MNIVNKSEIEIKSLSVYDILGQLVIAVPNAQKVVNIDVSKLQTGNYILKIKSDKGIFNQK
FVKK
>EGALAKHO_00763 hypothetical protein
MSKELKKFKVSNSFTFTIEDSLEQVCNAPEGSAGIFVVYAVEGDAKELIMVASTGTVQND
GTLKSKNGGLYDKIVNGHQFAKTGRKYSWPAQMKLENIDALEVVWYETFNADVKAIPTAV
EGQVLQNFLDDNAKLPRWNVAF
>EGALAKHO_00764 Succinate--CoA ligase [ADP-forming] subunit alpha
MSVLVNKDSKIIVQGFTGSEGTFHASQMIEYGTNVVGGVTPGKGGTSHLDRPVFNTVKDA
VDQAGADTSIIFVPPAFAADAIMEAADAGIKVIIAITEGIPVADMIKANNYVKERNSRLI
GPNCPGIITPGEAKVGIMPGFVFKKGTVGIVSKSGTLTYEAADQVVKQGLGITTAIGIGG
DPIIGTTTKEAVELLMNDPETEIIIMIGEIGGQLEADAAKWVRADGNRKPVVGFIAGETA
PAGRTMGHAGAIVGGSDDTAAAKKQIMRDNGIHVVDSPAEIGKKVKEVLG
>EGALAKHO_00765 hypothetical protein
MSIKEFVQKFYKSDALIDSEILKTYLHPEIIVEWNSSKGLIQMDYDSMVSMANELSRAYV
RSKVRISHIIAEDDLVSIRYSHFVKTIENPREEMLLAHFSTIWQIKDDKLYRGYQMSQFS
>EGALAKHO_00766 UDP-3-O-acylglucosamine N-acyltransferase
MKFPKSHSLQEIANLLNCEFIGDQNFPVLGMNEIHVVEPGDIVFVDHPKYYDKALQSAAT
IVLINKKVDCPEGKALLISDDPFRDFNTLTKHFRPFQGTSLAISLSATIGEGTVIQPNCF
IGNNVSIGKNCLIHPNVTIYDNTVIGDNVMIHAGTILGADAFYYKKRPDGFDQLISGGRV
VIEDNVGIGALCTIDKGVTGDTTIKEGTKIDNQVHVGHDTVIGKRCLIASQTGIAGCVII
EDEVTIWGQVGTTSGITIGAKAVIMGQTGVTKSVEGGKSYFGTPIEESREKLKQLANIKK
IPEILNKLK
>EGALAKHO_00767 Elongation factor P
MASTSDIRNGLCIKFNHDIYKIVEFLHVKPGKGPAFVRTKLRSLTTGRVLDNTFSAGHKI
DDVRVETHNYQFLYAEGDEFHFMNTESFEQISLNKNILDAPGLLKEGTSVMVQVNTETDL
PLSVDMPSSVILEVTYAEPGVKGNTATNATKSATVETGASVNVPLFINEGDKIKIDTASG
SYMERVKE
>EGALAKHO_00768 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MNQPLAYVHPGAKIAKNVVIEPFTTIHNNVIIGDGTWIGSNVTIMEGARIGKNCNIFPGA
VISAVPQDLKFGGEDSLAIIGDNCTIRECVTINRGTVASGQTILGNNCLVMAYAHIAHDC
EIGNNAIIVNGVALAGHVVVGNHAVIGGLAAIHQFIHIGDHAMISGGSLVRKDVPPYTKA
AKEPLSYVGINSVGLRRRGFSTEKIREIQEIYRILYQKNYNTTQALSIIEAEMEATPERD
EILDFIRNSSRGIMKGYSGNY
>EGALAKHO_00769 UDP-3-O-acyl-N-acetylglucosamine deacetylase
MVKQKTIKNEISLTGVGLHTGKEVTMTFKPAPINNGFTFVRVDLQGQPVIEADANYVVNT
QRGTNLEKLGVKIQTPEHVLAALVGCDLDNVIIELDASELPIMDGSSKYFVEAIEKAGIE
EQDAKRNVYVVKEVISFTDETTGSEILVMPSDDYQVTAMVDFGTKVLGTQNATLKSIADF
KDEIANSRTFSFLHELESLLENGLIKGGDLNNAIVYVDKEISDSTMENLKKAFGKDKISV
KPNGVLDNLTLHYPNEAARHKLLDVIGDLSLIGVRIQGKIIANKPGHYVNTQFAKKLAKI
IKIEQRNHVPVYDLNLEPLMDIHKIMAVLPHRPPFLLIDRIIEMSDSHVVGMKNVTMNEN
FFVGHFPEAPVMPGVLIVEAMAQTGGILVLSTVPDPENYLTYFMKIDNVKFKHKVLPGDT
LIFKCELISPIRRGICHMQANAYANGKLVTEAELMAQIARKQ
>EGALAKHO_00770 UDP-3-O-acylglucosamine N-acyltransferase
MKFTAEQIAGILEGEVVGNPNAEVSRLSKIEEGEEGSLTFLANPKYINYIYTTRASVTIV
NDSFIPEQEITTTLIKVEDAYASFSKLLEFYNQVKLNKNGIEAQSFISEGTKYGENLYLG
SFSYVGQNVVLGNNVKIYPNSFIGDNVVIGDNVYIFAGAKIYSETIIGNNCTIHSGTIIG
ADGFGFVPNEEGVYSKVPQIGNVIIEDNVDIGANTTIDRATLGSTIIRNGVKLDNQIQIA
HNVEIGKNTVIAAQSGVAGSTKIGENCMIGGQVGIAGHLVIGNNVRLQAQSGVARNIKDD
EVLQGSPSLGYGDFNKSYVHFKNLPKIVAEVEELKKQIINPKNGNNG
>EGALAKHO_00771 hypothetical protein
MTHINKLKIFNDPIYGFISIPNELIYDLIQHPYFQRLRRISQMGLSYLVYPGANHTRFHH
ALGCMHLMQKAVETLRFKGVAISNEEECALLIAILLHDIGHGPFSHAMEKSIVEDVNHEA
ISLLFMNQLNEEFDGKLSLAIQVFKGEYHRKFMLQLISSQLDMDRMDYLKRDSFYTGVAE
GNVNSERLIQMMNVVDGVLVIEEKGIYSVEKFLLSRRLMYWQAYLHKTSLVAELILMKVL
KRAKELTLKGVSLPCSEPLLFFMQNKVSLEDFDAEKLDLFSQLDDFDIISALKAWQKQDD
FILSTLSKMIINRDLLKIKLSAEKIPMEESQSMKEEFAEEHHISQAEAGYFIFRGKIKNQ
AYSKEAEPIRILKKDKTIEDVVEASDQLNLKSLSKLVTKYYICFPKQLI
>EGALAKHO_00772 Transcriptional regulatory protein SrrA
MDKIKILWVDDEIDLLKPHILFLEKKNYAVTTCNNGLDAIALFEEDNFDIVFLDENMPGM
SGLETLSEMKEKKSAIPMIMITKSEEEYIMEEAIGSKIADYLIKPVNPNQILLSLKKNLD
HSRLISEKTTLDYQKEFRKISMELAMVNSFEDWVELYKKLIFWELELENINDQGMIEILE
SQKVEANSQFGKYIERNYEDWFAPKADKPIQSHNLFKELVVPELKKKDKPILFVVIDNLR
YDQWKSFETVVSNYYKLEKEVPYFSILPTATQYARNAIFSGLLPIEMEKQFPQYWKNDVE
DGGKNLFEAEFLSAQLKRLGLNLKEDYFKITNYAGGKKLAENFKALKGNDLVTVVYNFVD
MLSHAKTEMEVVKELASDDKAYRSLTLSWFKNSPLLEIIQQAQLLGFKLILTTDHGTINV
KNPSKVVGDKNTSLNLRYKTGRSLTYEQKDVYVVKEPKDIGLPAINMSSSFIFAKNDFFL
AYVNNYNHYVSYYRNTYQHGGISLEEMIIPFLVFNPK
>EGALAKHO_00773 tRNA threonylcarbamoyladenosine biosynthesis protein TsaE
MNIVFSLDQIQEVAEQIIASNPKKIILFNGEMGVGKTTLIKQLCKSLGVEGATSSPTFSL
VNEYYTSNNQIVYHFDFYRLNKETEALDMGVDDYLYSGNWCFIEWSEKIASLIPEEHSTV
TIELKADEKRSLELK
>EGALAKHO_00774 hypothetical protein
MTNEQRRKYKKWAIIGISSMTLISAIGYFTFKETNKLEEPASNNNPDEEWSTGWVSLEDC
QYWGARTFTISEYDDIPINFKRGIVKIFKDNKYYNLDGDDNQYFFTKIKDRAKKVIAYGN
FTDNKSDKNIELAFLLEKQDFESSIIFVISERGDVLFKKEYRNELPTITSFKKKALIYLD
EMKLSPSPTDGILLNFKSYQKVIIYNKESKKFEEYYQYDNKDLNRKDEFEEENESEEPVE
TSTDSIK
>EGALAKHO_00775 Mycothiol acetyltransferase
MNSVEIIPYSLDRKEYIKTLNIEWLQKYFRVEEKDELVLSNPQEEIIDKGGMIFYAKYNN
EILGTVSLMKIDEETFELSKMAVSDKAQGLGIGNKLLVHSIAVAEENKIKKLLLYSNRIL
LPALHLYEKFGFVEVPLGDVSYERADIKMEKTIS
>EGALAKHO_00776 Alanine dehydrogenase
MSITLTPFTKQQLLPQEEKLEVGRFKRELFIGIPKETSYQERRICLTPDAVNSLTYEGHR
VMIESGAGESSSYSDKEYSDAGAEVTNDTKKVFGCPMLLKVEPPTLAEIKMINPETIIIS
AIQLKTKKKEYFEALAQKKITALAFEYIKDEDGSYPAVKSLSEIAGTASILIAAELMITD
EFGKGLLFGNITGVPPTEVVILGAGTVGEFAAKTAIGLGANVKVFDNSITKLRRLQNNLN
QRIFTSTVQQKALLKALRRCDVAIGAMRGKERCPIVVTETMVEHMKKGAVIVDVSIDTGG
CFETSEVTTHEKPTFIKSNVLHYCVPNIPSRYSKTASLSISNILTPYLLQIADDGGLESS
IRCNKGLKNGVYLYHGILTNKAIGDWFDLPDNDINLLVF
>EGALAKHO_00777 hypothetical protein
MKFVHRFAYYLIGLIMGCFFVALVFSGKDTRCNYFPNARVLNNLRTKPFQYSDKAIQTLN
EKWVDTADIKNTLTYGDVDFDQSNVDFKKGKLYIIEGKTVKNQEIILKVVNYEKKAVLEE
IIKKPAEK
>EGALAKHO_00778 Uracil-DNA glycosylase
MKINLSQEWQDILVDEIAKPYFIELLFSLEEDCKQHICYPPLDLIFSAFNHCSFKDVKVV
VIGQDPYHGAGEANGLSFSVNDNVKIPPSLRNIFREINSDLDSVFMPTSGNLEKWADQGV
LLLNASLTVRKDSPNSHKHLKWNLFTDAVIQAISDKKENVVFLLWGSFAQKKGLKIDRSK
HYVLESGHPSPMSANQGKWFGNKHFSKTNAFLISKGIKEIEW
>EGALAKHO_00779 Endonuclease MutS2
MISITEKTLQDLQFPTVLETISAGCNTDIGKEKALQITPFKDKETLMQALMQTSEYVSSF
QNNNAIPNHGFDAITHEIKFLAIEDSFLEVGSFRKIATLSSTSNFLLNFLKKFDDYYPNL
NARASRVEYTKDIVTLIDAIVDKYGEIKDNASPALLSIRQNMNIVRGKVNQSFGVALSHN
NSLGYLDDIKESFVQNRRVLAVLAMYRRKVKGSILGSSKTGSIAYIEPEATLQYSRELAN
LEYEEKEEITRILKQLSNQIRPYLPLLIEYQEFLSDIDVVAGKAKYANRINGILPTITEE
RRLFFREAYHPILYLNNKQKNEITHPQTIELKQDNRIIVISGPNAGGKTISLKTVGLLQL
MLQSGMLIPVHERSETFLFDRILTDIGDNQSIENHLSTYSYRLKNMNYFLKKCNKKTMFL
IDEFGTGSDPELGGALAEIFLEEFYHREAFGIITTHYSNLKILANELPFATNANMMFDEK
SLEPMYKLALGQAGSSFTFEVALKNGIPFGLINRAKKKIEVGKVRFDKTIATLQKERSKL
EKTSINLKEEETRAREESKKMENINVKIKQKLESYQELYDSNQKTIYIGQKIEDISEKYF
NNKNKKELIGEFLKIIEIENSKRKKATPKEAKAIIEKKKEVIAEVSVQVEEIRKEKKEKK
LKPVIEKPKPILKVGDRVRMLDGRSVGSIDSIEKNKATVNYGIFTSKVSLDELEFVEAGK
K
>EGALAKHO_00780 hypothetical protein
MALQSDLGKEICNYIGVDQNKIDSIILYHPGVAYYYKSSAAIEIAENLGGIYSLISIFKI
FPEKLRNYVYDYFARNRYKWYGKKESCMIPTPELKTKFL
>EGALAKHO_00781 Energy-dependent translational throttle protein EttA
MSDDKKVIFSMQKLSKTYQGADKPVLKNIYLSFFYGAKIGILGLNGSGKSSLLKIIAGVD
KNYQGDVVFQPGYTVGYLEQEPILDDSKTVIEIVREGAAETMAVLEEYNQINDLFGLEEN
YSDPDKMDKLMDRQAALQDKIDALGAWEIDTKLEIAMDALRTPEGDTPIKNLSGGERRRV
ALCRLLLQQPDVLLLDEPTNHLDAESVLWLEQHLAQYAGTVIAVTHDRYFLDNVAGWILE
LDRGEGIPWKGNYSSWLDQKSSRMAQEEKVASKRRKTLERELDWVRQGAKGRQTKQKARL
QNYDKLLNEDQKQLDENLEIYIPNGPRLGTNVIEAKNVAKAFGDKLLYDNLNFTLPQAGI
VGIIGPNGAGKSTIFKMIMGEQATDSGEFSVGETVKIAYVDQSHSNIDPNKSIWENFADG
QELIMMGGKQVNSRAYLSRFNFGGGEQNKKVSMLSGGERNRLHLAMTLKEEGNVLLLDEP
TNDLDVNTLRALEEGLENFAGCAVIISHDRWFLDRICTHILAFEGDSEVYYFEGGFSEYE
ENKKKRLGGDLTPKRLKYRKLIR
>EGALAKHO_00782 hypothetical protein
MGMNKNTVLGWATFIMILMGLLLIGLGAFRYSEVSGWGFVAVGVGFFANAWVFNALKGRV
>EGALAKHO_00783 hypothetical protein
MDEVVKIVNDIKAGNIKPIYFLMGEEPYYIDKLSEYIEQNVLSEEEKGFNQTVLYGRDVS
VEDIISTAKRYPMMSDRQVVIVKEAQDLSRTIDKIESYVNNPMETTVLVFCYKYKTLDKR
KKVTKLLAQNGIVYESKKLYENQVGDWIKRILAGKKYTIDPKANAMLVEFLGTDLSKINN
ELEKLQIILPQGTMITPQHIEENIGFSKDYNVFELRKAIGERNQLKAYKIAENFAHNPKE
YPLVMTTGLVFGFFVQLLKYHGLKDKNPKNVASAIGVNPYFLKEYDLALKNYPMRKVSQI
VGALRDVDVKSKGVGANALPQSDLLKEMLYKIFN
>EGALAKHO_00784 hypothetical protein
MLKLNFPSYTFRFKNSENKVSIFDEIRKKFIILTPEEWVRQHVVHYLMNEKKYPKSLINV
EKVLTINGLRKRYDVVVFNSDGSIHILVECKAPEVKISQTTFDQIARYNMTMQARFLNVT
NGLNHYYCQMDFENEKYEFLQGLPDYKEIY
>EGALAKHO_00785 hypothetical protein
MDKIAVVILNWNGKKLLEQFLPSVIQFSAEATIYVADNASTDDSINFVKQNFPSIRIIQN
SGNHGFAKGYNDALKEVNAEIYALVNSDIEVTENWLKPIIETFDNEKQTAIIQPKILDFK
NKEYFEYAGAAGGFIDKYGFPYCRGRIFDTIEKDNGQYDDNIELFWASGACFFIRKEVYD
ELKGFDESFFAHQEEIDLCWRAANEGHIIKYNSKSVVYHVGGATLQQGNPKKTFLNFRNS
LLMLVKNLPKKGLFFRIFFRMVLDGIAGIRFLTQGKFSHTFAILKAHFSFYCLSLMYLRK
RKDFQIQQYYTVKSIVYLYYIKKLTVFKEIFNSNQNIKN
>EGALAKHO_00786 Motility protein B
MRKIVIALSVLMALTSCVSKKQYAALEAKNKETQDLLNSCTVKLNSCLEEKAGLAATAES
YKAHNQDLINSSKDLTVLTTKGAENLEKSLESLKEKDLKISRLQDALTKKDSVTLALVTS
LKGAVGINDPDIEINVEKGVVFISIADKLLFKSGSYEVSDKAKSVLAKVAKVVNDKPDFE
CMVEGHTDDVPYKSNGVILDNWDLSVKRSTSIVRVLTNDLGVNPAKLIAAGRSSYVPLVA
NDSAENKARNRRTRIVVMPKIDQFYDMIEKEMKKQAK
>EGALAKHO_00787 hypothetical protein
MLISTVFNNEFMKNVIFLYFLIFSINCFSQKITGKVFNKDNIALSAANIYLDGTTISTLS
DENGNFTLDYDPKANNILVISFVGYENEYVTGFDFKKDLIIHLSPSKNELKEVVVNRKDM
FTRAQKLKIFKAYFIGKTVNSEKVIIQNEDDIYFKYDKQNFILKAFSDKPLNIINPSLGY
KIIYDLQNFEVTFSSLSISALDVVKDFYAGLSHFEEIDNSTNIATRREEAYKGSQINFFR
NLANGTWSKDQFMLFQDDKKVFSSNCFKIFNEEYFTRVEVVKQSKAVENKNSVASFDLLF
NNKEKSSVIFETNTFNIYKYGNNSNIENIVFTGIIADERIAEMLPLNYGLN
>EGALAKHO_00788 Threonylcarbamoyl-AMP synthase
MAEFIKIYPDKPSEAAIAKVVKVLQNGGLVIYPTDTVYGLGCDITNSRALEKIAKIKGVK
LEKANFSFICHDLSNLSDYVRQIDTSTFKILKRALPGPYTFILPGNNNLPKEFKKKTTVG
IRVPDNNIILEIVRQLGNPVVSTSIRDEDDVIEYTTDPELIFEKWQNLVDMVIDGGYGDN
VGSTIIDLSEHEPVIIREGKGDIDIL
>EGALAKHO_00789 hypothetical protein
MQEKRLLRKLNFIEIYQFFGGVIGLLIMTYLVCTTNAHEYAGPFYIFIILSFLFFGFCIY
SAWLLNNKNYLIGLNLVIISLILQLVAFEFYGVYFTSVNGIAINFTLDLTNDTKVGFDFQ
PSQFIFAFRENEDIFRFKLNLFACGMLFYTIKIIREVKTSLYSII
>EGALAKHO_00790 ATP-dependent DNA helicase PcrA
MQKYIDQLNEAQREPVLKKDGPMIIIAGAGSGKTRVLTIRIAYLMAQGVDAFNILSLTFT
NKAAREMKHRISDIVGATEAKNLWMGTFHSIFARILRSESDHLGYPSNFTIYDSQDSARL
ISSIIKEMQLDRDIYKPKQILGRISSYKNSLITVKAYFNNPELVEADAMAKRPRLGEIYQ
QYVERCFKAGAMDFDDLLLKTNELLTRFPEVLAKYQNRFRYILVDEYQDTNHSQYLIVRA
LSDKFQNICVVGDDAQSIYAFRGANINNILNFQKDYEGVVMFRLEQNYRSTRNIVEAANT
VMEHNKTKLDKVVWTANDFGAKIKVHRSLTDAEEGRFVASTIFEQKMQNQLHNGAFAILY
RTNAQSRAMEDALRKRDIPYRIYGGLSFYQRKEIKDVLCYLRLIINPKDEEALIRVINYP
ARGIGDTTVEKLTIAANHYKRSIWEVMVNIDKIDLKLNTGTKNKLNDFVTMIQSFQVINE
NQDAFYITDHVAKKTGLVQELKKDATPEGMAKIQNIEELLNGIKDFTEGQREIDGARGAL
SEFMEDVALATDLDKDTSDEDRVALMTIHLAKGLEFPHVFVVGMEEDLFPSAMSMSTRSE
LEEERRLFYVALTRAEHQAYLTYAQSRYRWGKLTDSEPSRFIEEIDPQYLEYLTPAESNY
RYKSQIDSDIFGDVDKSKLRLAKPIGGTPPKHITDNEPKPDLNIRKLKPVAANNPNSSAP
NLFDSKLTIGNVVMHERFGKGEVVNLEGFGADKKAEIKFEVGGIKKLLLRFAKLDIIG
>EGALAKHO_00791 hypothetical protein
MKIVLTENAQKTYFDITNKYSKNKAALFSKNTISVLHMIEQNNQIGSRYKKTSYRKFLMS
NQVYLFYKIEYQIIYIVLFWDNKRNPANLDIILSS
>EGALAKHO_00792 hypothetical protein
MIEIVENYENYINNLPELISKSYYKAEFFMQKLGLKHATYYRKLKSKNFTHQEVKLITAL
LFPEEILIQQLEKSEEDIKAGRTIDFSDFKEKLRTKYNI
>EGALAKHO_00793 hypothetical protein
MESYIIILLCLAAFAAGFIDAIVGGGGLIQTPMGLILLPNLPVSTVIGTLKLPAFTGTAF
AAFQYLKKVVIQWKLLLIMMCLAIPSAFLGSTILTMVSNDFMKPLLLIVLSLLFIYTYAK
KNFGQHVAKDHSATAQIIYAVVISVIVGFYDGFIGPGTGSFFVVAFIALLGFDFLHASAN
AKMVNLATNFGSICLFMIKGKIIWTIAIPMAVSNGLGGWLGAKLAINKGNGFIRIFFLVV
VIGTLIRFSYDVFFK
>EGALAKHO_00794 hypothetical protein
MDYTRIIELASYTLPAIVTGFVAYSFFELHIKNNDKKRNFLLNREYQKQSLPIRLQAYER
MTLYLERINLTKLLIRIAPISNEKHDYENFLIDQIEQEFEHNLTQQIYMSDECWTIITTA
KNSTIQIIRKAAMSDRVDSADKLREKILNDLLEKQSPSNAALGYIKNEVSELW
>EGALAKHO_00795 hypothetical protein
MRALVISGGGSKGAFAGGVAQYLIEEKNHEYDLFLGTSTGSLLIPHLALGHIKKIHSVYT
NVTMGSIFNICPFVVKNKDGVDIVTINHFNVLRQFFKGKRTFGESKGLKRYIRNNFSLSD
FNKLKKLNNDVVITVTNFTKNESEYKSVKDCTYEEFCDWSWISSNYVPFMSLVEKDNCEY
GDGGFSSLVPIREAINRGATEIDVIILETEVNMDKTVIGKNPFSLMIDLFRIALDQVEKH
DIAIGKLMANNKNVKLNLYYTPTKLTDNALIFNKEVMKEWWEQGYEYAQNKSEVMSDNR
>EGALAKHO_00796 Aminopeptidase N
MKYILLLFTTFIFAQQTKFVDFKTVSGQLSFNAKEKLVSGSVDYQFEILKPIDTIKIDAK
NMEFTKVQIDNKEVYSINTSKQLQIIGNFQKGKSHLTFEYLVKPKQALYFVSIENLDFQI
WTQGQGRYTSNWFPSFDDVNEKVIFNLGINYEAGYQVVSNGILKDKTSSGNSNHWQYEME
KPMSSYLLMLAIGKYDKNELKAKSGIPLEYYLEHKDENRFEPTYRYSKRIFDFLEKEIGV
KYPWEIYRQIPVRDFLYAGMENTTSTLFATRYVIDSIGFEDRNYTNVDAHELAHHWFGDL
ITAESSTHHWLQEGFATYYAALAEREIYGDDYFYSKLYDTAQQIKFASRTDTVAVLNGKA
SSLTFYEKGAWALFVLHESIGDKAFKKAIKSYLKKYAYQTVNTQNFFDEIKKVSNFDLDK
FQKNWLESTVFDTATANALLSKNKAIQVRLEVDKLKKTPLAEKEVFFKKRLESDVYYSVK
QAIVDQLENEKYEAKKAMLLAALKTNNIQVRQDVATTLNKIPEDFRTEYETLLDDKSYQT
QEIALYWLWKNFPNHRTEYLEKSKKWIGFNDYNLRTMWLSLALSTPNYVENPETLIAELI
SFSSTKYEATTRQNALEKLIAFKIINDQVLSNLVGATTHHMWQFSKFGRDTIRFLLKNSE
MRASFERILPNLTPDEQFQLNRLLKEIDK
>EGALAKHO_00797 hypothetical protein
MTLYQDKYKIHSKRLKDWDYSSEAIYFITIVTKKRECIFGSIENEKMILNANGQIVENEL
LKSIKIRKNWFFHNWIVMPNHVHLLIEIQKQNEISTTMDTVDANNPHTHIVEAHSSASTP
SMSTKIVSNIAETHRCAPLRDNRDENMNQDQSEFKLLRKPNSISSFVALFKSVTTTQINN
ICVDKNESVSKKIWQSNYHDHIVRNYQRFETIYNYIKNNPRSWDTDSINSNF
>EGALAKHO_00798 hypothetical protein
MPTPKKALFNWSSGKDSAITLYKILQNPEYKIECLLTSVNQQFQRISMHGVRVELLEAQA
KSIGLPLEILQVPEMPTMEVYENVMTKTLTELKSQGISYSVFGDIFLEDLRKYREDQLAK
IGFEGVFPIWKIPTKELIQEFISLGFKTIVVCVNERYLDKSFVGRIIDQDFINDLPDNVD
VCGENGEFHTFAFDGPIFLEPINFEIGEIVYRKYEKPKNEDSSGTACDSSSSDAFDYGFW
YCDLIPKKLN
>EGALAKHO_00799 hypothetical protein
MTTHLALLRGINVSGHNMMKMEALKTMLENIGFTNVRTYLQSGNVFVDTEEESASKVGFM
IKQEIFKVFGHEVPTIVITKEDLELCFKNSPYLKEKDIDTKKLYVAFVATELKKENINDL
KISQFKPDEASIDGNRIFIKYAVGAGKTRLEGKYIEKKLNVIVTMRNWNTITNLLTMYVE
N
>EGALAKHO_00800 hypothetical protein
MNNKLLFLLTFLFLFTIESKVSAQVQNVTITSKRNDDKSVDLYYEKKNPGTYTVRIELSN
VNNCDITSYEKTITGFSGNFVKLRPVDKSRGISYSMRYSTVMGEVNPKVDSLFHYILPFK
SEKKIKVFEAGNVGEKYLGQEKALNWKSYVVRTENPDTICSMRKGIVVLIKNEYDSNATK
DVQYTSMRNYVVVEHADGTYASYKGFKKNGIFVQLGETVYPQTELGIVALYDKNSYRVDF
NVYYLSDNNFPSEKQSLNNYKSKYKFITPIFVTKEGDNTLESKKEYTAAANELVITHEFS
RSEKKKYSKEHALIK
>EGALAKHO_00801 ATP-dependent DNA helicase RecG
MSNNLLETPIEYLKGVGPSRGQLLRKELGIHKYRDLVNFFPNRYIDRTRYYKINELQNTG
AEVQIIGKIINIKTVEFAKNKKRLVATFVDDTGQIDLNWFQGHKWIRESLKLNEVCVIFG
KCSLYGSQFSMAHPEIELWSEHERSLRSAMQPVYPSTETLANRGISNRTINKLMEQLFIE
TQALFTETFPPYLIEELKLIPKRAALFNIHFPKSTDTLAKAQFRLKFEELFFIQLQLITK
NLIRKHKIKGHPFTKVGELFNEFYQNHLPFELTNAQKRVIKEIRSDMGSNAQMNRLLQGD
VGSGKTIVAFMSMLLAIDNGFQACLMAPTEILANQHFIGLSELAKTLDLNIKILTGSTKT
AARKIIHEELENGSLHILIGTHALLEDKVQFKNLGLAVIDEQHRFGVEQRSKLWKKNDIP
PHVLVMTATPIPRTLAMSLYGDLDISVIDELPPGRKPIQTVHRFDSNRLKVWKFLRDEIA
LGRQIYIVYPLIQESEKMDYKDLIDGYESISRDFPLPQYSISILHGKMKPADKDAEMKRF
SEGKTNIMVATTVIEVGVNVPNASVMIIESAERFGLSQLHQLRGRVGRGAEQSYCILMTS
HKLSADSKTRMETMVQTNDGFEIAEVDLKLRGPGDLMGTQQSGVLNLQIADIVRDRDILG
LARNYAMKILKEDGPLQKPEHAVLKAVFIELTKKKNIWNYIS
>EGALAKHO_00802 hypothetical protein
MIKYCPFIFLFFIFSSIHGQSGCYNSDFSTGDFTGWRASYGPRSQPDLNKEFSPEHHKIM
MTGDDLYDPYAAACEGPLEMIPPGEMYSARLGNDKGGSEAEQLIYDIDVSEDNNLFIYKY
AVVLQDGGHEKSVQPNFSVRILNQQGAVIDPLCGVYNVSAAEPYQNGIQCRDVYWTQWNT
VGINLANYVGQKVSIEFTTRDCGFQEHFGYAYISAKCSKLKINVGVCVGGNNFALTAPLG
FVSYVWSYQGQVIGTPTQSITLPLADYPPGAIFECVLTSFNNGNKCESTIQAILSSPTII
TPDFAISIPCKVDYNNFSPITFLDKTTVLNGVINKWEWNFGDGKTSLQQNPSHIFENSGD
YTISLKTYSETGCSDFISKPIHIENNPIVKPAVPETQTFCSYPIPTIANLDTNGLTLKWF
DSLLSTNALSETTVITNRDLYCAILKDGCLGPRTKVTTMVNSVTPPTGDTTQFFCLRDNP
VIADLAVKESSVLWFSTQDGVTPISTSTPLKNNTIYYASKRDEAKGCSSSRLAITAILKE
SPAALAPDFTQEFCSNQDFTLRNLKLYSPTVKYYSNLNTTTTLAHTTALENETTYYAGYV
DPDTKCESDVRTAISVKIVPCDITIFNLITIDNNTQNDHLEIENIEYFPDNAIQIYNRFG
QLVYKMNGYGLDNNYFYGKANAGEVFLKDEKLPTGSYFYIINYKKKDLTDGTKKGFLYIH
NNG
>EGALAKHO_00803 hypothetical protein
MAQKKAFYTYIIMGKIFKKITFLTAIILFSVHNIQAQNDAKLSIFNYNPLLYNPAFAGSA
DGLSIVGIYSSQWVGFDGAPKTQYLSADTKSLGNIGYGISLYHDVIGPKKEYNIEGNFAY
YIKLDRKYNLVLGVKSGINSYSINRNNLDVYQPGEDISNFDQESKTSPIFGIGANFYTNK
FFIGLSSPNLIQDRYSNSSGSGLSQRRNYYYTNFGYQFELERDVTLTPALLARITAGAPI
SVLTSLNLNLRNKYLASVNFDYNSSVGLFAGIQIIDDLKIGYAYDIATTKFSNYNNGSHT
FFLSYTLLNENSEKCTCHLY
>EGALAKHO_00804 Aerotaxis receptor
MDTRITRPTPSEREVDWNKNKVLLSKTDTKGTILYANEDFIDVSGYDEFELIGQPHNIIR
HPDMPKVIFKFLWDSIKSSNNIHVIIKNMSKTGRYYWVITDFKIIADSDGEIVGYFGTRK
SVPDDIIIKFIEPLYKKLLHIEEASGMLASEEYLIGFLEERKKTYMQYIDHLVATGKDDK
NKVSKGLFNGLFEKKETSKKK
>EGALAKHO_00805 hypothetical protein
MKAKASLNEQDYLRNFMSTMTQKSDTIINYVLAIYFLLGIALAFKYDTWEIGAGVGTLNL
LAYYSAKFFLKNSKFYQYVLAFVLAIFMAQYIYQMHGLFEMHFTVFIASTILIIYQNWKL
QIPLTFLVVGHHIALAYMQNFVYNDPKGIQLYFSQVNFDMETLIIHIVLAAVVFFMNGYW
AYYFKTHSQNHISKISDEYELENMKLASAKYSSLTATKEYNDFVHRTTLDLKLPVSSVLK
LIDVSKGHTDNDQLLSYLDMMRESAKKIDDMVNDIHVKSINSRPGH
>EGALAKHO_00806 hypothetical protein
MKKKLLLGLWFTLLLTAICYLFWQNEFKYSLPTPIPQNYHAIAMGSKVDLKCCITDQRPV
FIHFFNPDCPCSRFNIPHVSGLIKKYGDRINFKIVVLNKEKTFTIEEIQNKFNAKIPVYF
DEEIAKNCGVFSTPQAVLIDASQNLYYRGNYNKTRYCTDANSNYAQQAIDSLLSHTNAPS
FDALALRAYGCSLPKCTK
>EGALAKHO_00807 Multidrug resistance protein MdtA
MKVKNLIYALLIIVLGGFIAYRVVSNKSKNDESKKSGDKDRPTTVTGIVVKTSTFDNNLS
LSGSIEANEQVEIHSEVSGIVEGIYFTEGTYVNKGQVLFKVNDIELRAQLRQAQTKEGLA
AENERRAKLLLQKEAISQEEFDVANADYASMKAQTQLIKAQIAKTSVKAPFSGKIGLRSI
SPGTYITPTVLVAKLVNTGKLKITFSIPEKYASQVKSGSTIDFSVSGSDKVYSAKIYAIE
PEVEVATRTLQIRAIADNIDGKLFPGTFADVKLPLSIIKDAIVVPSESIVPVQDGKKVYI
ANMGKAKEVMVDATTRTDASILILSGLKAGDTLITSGVMSLKNEAPIKVQVKK
>EGALAKHO_00808 Efflux pump membrane transporter BepE
MSLSTTSIRRPVLTIVLNLLIILFGFIGYTFLGVREFPSIDPAQVSIRTNYTGANSDIIE
SQITEPLEKAVNAIDGIRNITSSSNQGSSSITIEFNLDKNLEEAANDVRDKVSQAVRSLP
QDIDAPPVVSKADADSESIISMTVQSDSRSSLELSDYAENVISQRLETIPGVSGVQIWGQ
KRYAMRLWIDPVKLNAYKCTVSDVRDALNAQNVELPSGKLTGNNTELTVKTIGNLSKPEE
FNNIIIRTDGDKIVRLSDVGGAELGPENIETSLTSSGLPMIGLAIVPMPGANYLDISNEF
YKKYDALKKDLPKDIKLNIALDNTLFVKKSVLEVAETLGISIILVIIIIYLFFRDWAIAF
RPLIDIPVSLIATFFIMWLFGFSINVLTLLAIVLATGLVVDDGIVVTENIFKKVEEGMSP
IEAAIKGSNEIFYAVISISVTLAAVFLPVIFLEGFVGRLFREFGVVIGAAVLISAFVSLT
LTPMLNAYLMKGGEQKKSKFYVKTEPFFEKLNSGYADALNRFMAKKWISFPILIACFGLI
YLFFTILPKETAPYDDRSSVTMRMTTPEGSSYEYTNRFMQEMSKLVDDSIPEKKVSLVIT
AGGSGGSATNSGFIRLSLKAPDERTKSQKDIADQLTKWTKKYPSAKTSVLQQPTISVNRR
GGLPIQYIIQAPTFEKLREKIPVFMDEVGKSDVFSTTDVNLKFNKPEINVSIDREKAESL
GISIIDIAQTLQLSLSGQRFGYFIKNGKQYQVIGQFDQKDRSKPLDLTSMFVKNKSGELI
QMDNVVKVEEQSNPPQLYHNNRYMSATVSAGLAPGKSISDGIEEMDRIKAKVLDETFTTD
LSGESRDFVESSSNTSFAFGLALLLIFLILAAQFESFIDPFIIILTVPMAVAGALFSLWL
FNQTWNIFSQIGTVMLIGLVTKNGILIVEFANQLREQGKPKLEAILEASEARLRPILMTS
LAIALGALPIAMSLGAASTSRIGMGVVIVGGTIFSLALTLFVIPAIYLMWSKARKHYPEF
DHIEEYEKESK
>EGALAKHO_00809 hypothetical protein
MNTKILFRSLIFFFFCITNINAQEVLTIEDAMRIALENNFEIKIAKNNTKISETNVTIGN
AGMLPVATASITDNNSIQNSSQTRQDGTSTSLDNAKNNNLNYGVSLGWTVFDGMKMFARL
DQLKELQKLGDAQLKQTILFKIAQVNSSYYDLVQQQQQLSALDTTIVISQQRLKLAQNRF
SIGKASKLEVLNAQVDLNSDQVALLRQKESYANAKILLNQYLARDPKIDFRVTDLVTVDN
TLVLADLMELAQKQNPGLEAQIINKRIAELQLKQVKADRYPVVNLTSGYNFAESQSSLGF
TSQASSRGLNYGFNATLNVFDGFNQHRNEKVAKLEIENSQIAIEQQNMILNTQLSTAFQT
YLTNLELIGLEEDNEAIARQNLEITLDKFKIGTITTLDFRTAQLNYVNAKVRYSNAQYVA
KLSEIALKELAGNMNF
>EGALAKHO_00810 hypothetical protein
MISYNTKDWLTFIFHFHKSDTVRKLFPLMIAIGIYSGIVGYLEVVYLGIDTNHYIKNIPL
MHGILGFVISLLLVFRTNTAYDRWWEARKLWGGLVNNSRNFAIKLSAILKDENDRKFFRK
FIPGYASILYKHLNNSETAKQLFEDVDLELDHHKHKPNQVKRMMYHKINDLYDAKKITGD
QLIILNNELVAFTDICGACERIKNTPIPYSYSAFIKKFIFFYTMTLPFGYSLSLGYYVVP
VVVFIFYVLASLELIAEEIEDPFGDDENDLPIKKISENIKKHVEELI
>EGALAKHO_00811 Phenylalanine--tRNA ligase beta subunit
MKISYNWLKQFIKTDWTSEQTSELLTDLGLEVEVVEKYQSIKGGLEGVVVGHVLTCEKHP
DADRLKVTTVNIGLEAPVQIVCGAANVAAGQKVPVATIGTVLYDKEGAEFTIKKGKIRGQ
ESHGMICAEDELGLGTSHDGIMILDDALEPGTPASVVFKIANDEVFEIGLTPNRADAMSH
YGTARDLRAGMLQRGVNVELITPSVSNFRVDMRTLKIDVNVEDSHLAPRYCGVTISGITV
QESPAWLQDRLKAIGLTPKNNIVDVTNYVLHELGQPLHAFDATKINGKIIVKTLPEGTKF
TTLDDVERTLHSEDLMICDEKGPLCIAGVFGGKKSGVTDSTTSIFLESAYFDAVSIRKTA
KRHGLNTDASFRFERGIDPTITEYALKRAAILILEVAGGKLTSDVVEVYPKKVEDFSVLL
NFSHVYKIIGQEIPKDTIKKILVSLDIKVNSVSDSGLGLTIPAYRVDVQREIDVIEEILR
VYGYNNIDFSNKFSATVANSPRTEDYKVQNVIASQLNSQGFHEMMANSLTTASYAKLSAS
LKEEHNVTMLNPLSSDLATMRQSLLFSGLEAISYNINRKNSDLKLFEFGKTYHKYLNGYE
EHKHLSLLISGNRNKESWTNPQKTTDFFLMKGYVKGILARLGIDKISNAPVQSDIFSEGT
AICYNNDTLVEMGVIKKSILKHFGIKQDVYYADFNWDLILKIITGKIKYSEIPKYPEVRR
DLALLIDQNTTYESIFNLAKQTEKALLKDINLFDVYEGKNLPEGKKSYALSFTIQDNTKT
LTDSQIDKIMSKLQQTFETELGASLR
>EGALAKHO_00812 hypothetical protein
MENLVSNTTTINQNPPVTASSDLLRNSVGLNAVNNTPDVLQIQNYLKELGYPVNISGNIA
NSQTDNTIISILNFQSNNNIQVTGIINPNDATYIALKQLPRTITPLTESEDESLHQPFLT
NSYFFRRNAGNANTLNVIFEGDSWLDYPVPRILDLYDTITDRNQRLNLNCLHLAKFGETT
SQMLADKAHFEQYITSYRIDRIYFSGGGNDVFPQLGVILNSGVTTFTPNFFTDTAKLNEL
RTLSGDTLFQKCIQYKRYLNTQSFDTALFNSTNLNRIFNTILRNYLGFGTIINAHSTPNT
IFYMHTYDYPLFKLGVRPSVGGVNLPLGPWIKPVFDRLGIADDILRCYIIIRLLDRFYAL
LCQIKNHFNYYGFRFQSRIIDYRGLLNSSEYWRDEIHPNSVGARRLSTRVNF
>EGALAKHO_00813 Serine protease AprX
MDPRLKIILYGNQDEELSLLMRLEKEKEYPEHCKIISEFGTIVSIRTQRRYLCRIYNSKK
VKSLKAPSVVPANMAEEQAFSSEILEKKNDVLNENSSNVVFGIIDFGFDFTHPDFIKEDK
TRFEKIWIQSDRYEENKFGYGRIITKAQINESLLEEFPFKKIGYHPGKSDLFGNGTHGTH
VLGIACGNGAVAQKSFAPDVSILAVDMGVNLVNGCNLSLGDSVKLVEGIDFLLTEAGDRP
IVINMSLGGHGDAHTGQTLVEQAIDYILSTRKGTAIVQSTGNYHQANVHTYGDIKINQKI
KIPWMFKKYDRTPNEMEIWYHGDDILSVNVYDDNQNILLSSTPFKDELIIKDGDEVGICL
HRYNEPNTNKNQINILVNGKLNSKFWTIELVGRKVINGRYHCYIERDDGGQSIFLPKIAN
KTHTTNSICNSKYSIVVGAYNQNDDNKTILSFSSSGPTADGRMKPEVVAPGFKIKSSCSS
SSKENKASNKLTSKSGSSMAAPYIASLVMKILEKEPQLDIVSIRKKLFKACDPASFEEND
FEIFRAGHGYINPNKII
>EGALAKHO_00814 hypothetical protein
MKTVVKEEGINLEKIEKTTDQILKKINGLRSNLFNKTLKFSKKAEEEKMFLFKNLIPKRI
LVIENTIELLNKILIHPNFSKLEKEDLDFISGLEKMGFKDSHYAREINDYITKEASEGAF
MAVMEENIYFTLLNSELNSIEAKLLSIL
>EGALAKHO_00815 hypothetical protein
MNPFNLLINYVIANSRASFYNVPGNQEITNTALLTGIVSENPLMSYLIIDNKAKIEGEKF
NSTTSEVTTTTNGPGLPVHTETVVNPPTNQTKPTEGATVEGEEIVTLETIRAEIVKTNTA
LATITAEVGILKTKITTIEENKDLSKSLTEIKQTLSGISKENQTPDTVVASKTSAAQKSP
SKPDTK
>EGALAKHO_00816 hypothetical protein
MSYFESYLDEDLLNEDYFNEDLLGEDLLESYDESYDEAAKRRRPSTRSIRPNVSSAVKQR
SNFGKALSGRANDYATKSELKKSLDSISSQVNELKKTSLATNKAIVALDQKHTEFAKFDA
RKGDNQTKVLKNMQMMSMMGSLLNQPKLDVTKLKVIKSTEVGKPDTIVQDGTAIVVDQTM
SLLLPMMTTMGDSASGKSDNSNMMLPLVLIMSQQGQNNTGNSNNTMLPIVMMMMMNK
>EGALAKHO_00817 hypothetical protein
MDAYLEYLKEHNPEMAKYFELMQPMMQKKEPEEENEVPKIDPDLEERIKKLKKINHKLFT
IIEGLKFQLEFELNQNDDLAKAIGACTECFGENSDCPECFGTGKPGNTIPDFILFNKYIQ
PAIQKYNKHYFNKN
>EGALAKHO_00818 hypothetical protein
MSLYHEVFQGESFSEDNYFEAVRYVLGPEYSNLNEDELEDVLLSRVDQMSESEAEGFWSS
LGNVASSIGSGVLRGVSAVAPIVGTAVGTYFGAPQIGGAVGGLVSNLAGAGSAALDNSRQ
PQRRAAPQQQQRRPQQRRQAPSPVRQAWGNTTRYLADAGRAALPAIQQYVQDNPVQLRPQ
AAQDIGRVQGLYNQLGGVINNPQFQAGQAQQSLGTASPNSPIESHSFAELIESVNYLTEN
ILYEYYNGGLIPTEDYFIDQYGQFVGTNTPNRINRLENSIASL
>EGALAKHO_00819 hypothetical protein
MEKEPGRPSQLITRKFAKELHANFMKYRASIIAKYIKKEDANAVWFSVEELENYIHYIKS
KGEKTGYDVNGIRIYFGVYPEEKKYEEKAGLMTVFLQATGKKIKTITKNEIQTFAIAREE
SNADISSIEPMNYGSIGRPPSLIY
>EGALAKHO_00820 hypothetical protein
MFEFLRFYTFYLALFSGIIGLISMHKLPSNRAKFLVILIWFSVVIEKVGYYFTEWTGLLN
YYVFNFYMLVTFSAYILLLRSLLSKTSHRITAILFLMLFIVSFFLNILYFKEDVNHSFTY
SFAIGVILIMILACLYLIEIFNSDKILNFKRSVYFWYILGILVFHVPFLPFMLALNWFLI
KHDESIFSLVVFILNVLAHSCYIIGFLWSEKKYNY
>EGALAKHO_00821 Oxygen sensor histidine kinase NreB
MERKEIQLLVISLGIVFLTLLVILLVIFFYFLKKKNNYLVEKMESELYFQSELVKTRIEI
KDQTLSEISKELHDNIGQIVSVGIMQLNMYLDSGKPVQANELNDLKGILAKSLDEIRILS
RIINKDNLLQSNFIEAIQQDLERIKKLKNIQYHYNLTGEIPKISQEHDLFIYRIFQEALH
NSLKHSHSDLFEVNINTTNTVFRLEIKDFGIGYEVTQINSGLGLSNMKLRAKLIGALLIM
ESNSSGTTVTLQYPLTKTNET
>EGALAKHO_00822 Transcriptional regulatory protein DegU
MKLNTKNKIIIVDDHQLFSQSLQLLINSFKDFEVINRFENGKVFLSYLQDHEDTDVDLIL
LDVNMPILDGVSTMKWIKENRPDLKVIALSVNDDEEIIIKMITNGAKGYLLKDTSPEIFK
EAMISVIEKGFYFTEHVSGMLVKKANDDSKKINLKEKEIVFIKHACTEKTYKEIASEMCL
SPKTIDGYRECLFDKLEIKTRIGLVLYAIKNKIVLV
>EGALAKHO_00823 Adenine phosphoribosyltransferase
MKIENYIRDIQDFPKEGILFKDITPLLNDPIARTECLRILLESLKGQKIDKVVGAESRGF
FFGMLLAQELQAGFIPVRKPKKLPYEVISASYELEYGSDSLEMHTDAIQKGDRVLIHDDV
LATGGTAKAVCELVEKLGGEIVQCNFLMELSFLNGREKIKSHPIFAALTY
>EGALAKHO_00825 hypothetical protein
MKKFKIVPLSKEFVSQIRKTNIDNFGNEVYEQLATGKGPCRISLTPFNVGQDIRLVFAYS
PFSENNAFNQSGPIFIHKNEVEQYSNIYNFPTELKADKENFPLSLIGYNKEQKMIFTKLV
GDNDIDLLIAEIFETKSDIEYLHARNSEACCFICKIERV
>EGALAKHO_00826 hypothetical protein
MKIKMISLIVLVTANSALFAQHNFSVEVSGVEPGKGSVFFGLYDKEKGFLDNESQIATGK
VKATENKVVYTFKNLPDGDYAIAVYQDLNNNGKCDRNIIGYPTEGFGFSKNYKPKLSAPN
FDEVKIAINQYAKTSIALIVK
>EGALAKHO_00827 N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 4-epimerase
MENKISRKKILLTGASGTVGFETLQHLVQHTDYEITVFDLKTQNSVKKLAPFRSRVEILY
GDISNREEVLKVALNKDVAIHLAAVIPPLADIDPGMAYSVNVRGTENLIYALEKNSPDCY
LIFSSSISVYGDRMKNPQISITDILQPSPGDHYGETKVLCESLIGKSKLSWSIFRLAAIM
GNHKISKLMFHMPLDTPMEICTPKDTGRAFAKAIENQKKLDKQIFNLGGGEDCVITYGSF
LDKMFAEFGLGKADFPQKAFAEKNFHCGILKDGEDLDNILRFRQQNLDDYFEMVRQKIHP
LQKKGTFIFKSIIKKWLLSQSEPYEAFKKGNVKKMNHFFNQLEKEKLEKVLL
>EGALAKHO_00828 hypothetical protein
MDLRKDRRVQYTKKILREALFNLLDERELSEITITELCKTADVNRNTFYRHYNIPMDILL
EIEDDVFEKLSTVLRKSTNMDDVILLSCQLLESDKQMSKIVFTKADGSGILSRILRSVRN
NFPIENQIELTAEVMPYAEMAYQFGEKGSIAVIKNWVENDFSIPAENIAQMISYLVNKLN
KL
>EGALAKHO_00829 Thiol-disulfide oxidoreductase ResA
MKKETYIIILFFFINLIQAQKNSPDYFTLKGVLKNNYKGYLYVSYADKKDSCLLENNKFS
FKGHIPGNMTNVFFWLKGKTCIMKKEFFLENKNVKINLAFYEEIQNKDTTVFFHTTSIVG
TKTALIQDDYERFVAGNLFGKDRHQKLYRKLNTIAVQNPKNYYVGNLIEEMCWDSTLDKN
QLRKIYSKLDKKNQRRGNIYIIEKKLYPKNDIKVNDMVYDFELPDENNTVFKTVSLKGKW
YLIDFWATYCSICIDTFPKLQKIHDLYKDRNFEILAVSVDKDLKKWENFLKMNDLKWKNL
IEKRGIDNSEAVKKYISFTPSNFLINPEGKIVASNISPEDLEKFLKKNLK
>EGALAKHO_00830 hypothetical protein
MKALIIGATGSTGKFLLNELIQDDDYSSVTIFVRHPTGRSHPKLTEHVIDFSNVGQYQKY
ITGDVLFSCLGTTLKDAGSKDKQWEIDFNIPALFATIARKNRVNSIVLVSSAGASAKSMI
FYSKMKGELETAITELDFGQYIIFRPGPLLRTGTDRPGEKIMVNTLGLLNSVGLLKKYKP
LPTEVLAMKMAKAPWKLPQGTSVLELAEIARF
>EGALAKHO_00831 hypothetical protein
MENLIHQENLEDIRILIESKIADVPGELILVGAIGSLLLSTYLNKTGHTQAGSIIGKLSV
PIIGIGLAKYKNVLQSGIENYQAAVQEVA
>EGALAKHO_00832 Cyclic di-GMP phosphodiesterase response regulator RpfG
MGYKTIFHIDDDDDDIEFFATAVNQLSSEVSYTSFTDAREAFQKLLAGEITPDVIFLDLN
MPVINGREFLSKLKTMESLQDIPVIILSTSADIYMIQQLKNEGAIDFLTKPPGIKELMNL
LRPYLI
>EGALAKHO_00833 Phytochrome-like protein cph1
MNIENEQELYLLVMSAPVGICVLDAPTLTAEIVNDSFIAVAGKTREAIVGNFYWDTFAEV
RQFYESALENVIREGKSYSADEAEMVLVRHGKEETVYVTFVYAPLKNNAGDVKKVAIWVL
ENTLQVNSRLKVEESEKFARTVFYNSPVAKLVYIGTDMVLREANEKMLDILGRDASIIGL
PILESMPEIKQTKLFEEYQQVLKTGEIYTKTAQRIELIKNGSTRSGYYDYIYKPLQDIAG
HVYGVIFTLIDVTDQVMVRNKLEEAELSMRGAVELAQLGTWSIDVATNGLTYSDRLIEWF
GYDPAAQDYNEVIPILSEADQQRVANAVAWGLNPESGGLYDEIYTVIHPTTGKKRILHAQ
GKTVFDPEGRPVRMNGTAQDITFQVEVQMELEDQVQQRTEEIAAVVEELSATNEELEEAN
VQLIHTNEELAQFAYIASHDLQEPLRKIGTFTSLLEAKIEDHLDEKSRAYIEKIKDASTR
MSTLIRDVLAYSALPKKDDAFVIVDLEAIAKQALEDYDVRMEQTGATVTWNKLPEIKGIP
LQMSQLFFNLIGNALKFVKRNVEPKIQIHCSIAPPEDLKSLHLKDSASYYKITFSDNGIG
MLPENTDKIFSIFQRLHRKNEFAGTGIGLAMCKKIVQNHNGEINAEGSSEKGAVFNVYLP
IDK
>EGALAKHO_00834 hypothetical protein
MKTIIKSTLLTILLVTAMSCKKNEPATQDSDITGSDSTETTIDTVGPNSDTTTVSGAGTT
GATGEGSTGSGSAGTVQKGTAAVKTDSTSTKKGK
>EGALAKHO_00835 hypothetical protein
MHTISPWAATVHADLENSTVIWEKEFKNYTFQAFNTGDSIWIVAVWPDRGKMAFRAAFGM
NSYFEVTNLLDDGALLVINLETRLGKYEVCVTFPESEAVMLHYTTSFKAYMPLLIPFWPR
DIIAVTQHGNVENTNGVIHMSQMGSRSGILLASMTKPKTGSIFYFQNLGSLSAYCEATQT
TLDDTVGGTWPEIGFQLPVTKDKPLPSDKAYIISDAYVVFSDKIIDNEIQETQQFLNNLA
EVYKLLPHPEVIYHNWPEITQNCLNDLQKNKGCWTQTKGNSYLNAYLCDYDTPAEVMVQL
AVLMPLNELKDWYGETHPMYSELLEGIECFFDPKVKTMNRWLPELTDKLDKSEEQKQEMV
MDSWYLHHPLMNLARLALKGEKKAEELVLKSIEFAIKVAHHFDYEWPVFYKMDTLEVIKK
ETEPGKGGEKDVPGSYAHLMLLLFRLTKDNRYLHEAEKSVKKLVGCGFNILYQANNTAFA
AGALLELHKITNKKEYLDLSYACLACLFKNMQIWDCQYGFGKNYPNYFSVFPLNNAPYTA
AYEEMEVYAGLSEYLIQSNTVDVLPSLKILIPEFLKYAISRFPYYYPSKLPEDMISKEVK
TGEIGKELWIPVEDLYNGWEKSGQVGQEVYGAGVGFGVLTRQYHKVKEEEFLLFSDYPIT
SMKKSKKALTFTILGTNIFECNLKVIFPKKATLQIEVFADKNSITASEKNAELISYKIAG
GSRVKMTW
>EGALAKHO_00836 Putative DNA repair helicase RadD
MAIKIQPKASFYAYQEKDIEAIFEKIGDTATTRLLYQLPTGGGKTVVFSEITRRYIAQYG
KTVVILTHRKELCKQTSTVLKSHGVQNCTINSTSGNFKKGCDCYVAMVETLRNRIKSKKI
KPHDVGLVIIDEAHHNSFRKLMGSFKNAFIIGVTATPFSSDISKPMNRHYETLVTGESIE
TLINDGFLAKPKSFVFEVELNTLKKGIHGDYTVSSSNELYSSAAMQDLLLKAYQENAIGK
KTLIFNNGIATSQKVFETFTQARIPIKHLDNKTTDEQRKEILKWFKKTKDAVLTSVSILT
TGFDEPTIQHIILNRATTSITLYHQMIGRGSRRLPSKKTFGITDLGNNIQRFGEWQIPVD
WQFVFKKPEEFAKQLQYHAVGNSAVQSHSISAELRARFPHTLEMSFDIEAAYNEAIESEK
KPKIVIQESIRQQAKMCMDNADTLSEAVALAEALQPEIEWRVKQYVKCLENASKSYKDWL
IEDYQNRLKLLIVKLFSRVKSPLAEIL
>EGALAKHO_00837 hypothetical protein
MIYIIRCSADIKIITNANYKIMFKEGQNVQQDFGNQVMKIIGFEPELIENVITQWEDEEG
TIVTGKFMESQLHPAEE
>EGALAKHO_00838 putative zinc-binding alcohol dehydrogenase
MKAAVIHGPGSVKYDTVEDPKINAQDDIILKVTSTAICGSDLHIYSGAMPTSPMVLGHEF
MGIVEETGSAVTNLKRGDRVVVPFPIACGNCFFCNHDVPGNCEHSNPEHYGPEGGILTEK
GGALFGYTDLYGGYDGGQAQYVRVPYANYGPRIVPENLTDEQVLFLTDIFPTGYTGVDWG
EVKGGETVAIFGSGPVGIMAAKSAWLRGAAQVIVVDTLQYRLDKARVSTGSTTILWEDPK
DVVEHIRSLTNGRGADVCIDAVGFEPERSITDKIKATINFEKGSIKVLEACMSAVRRSGI
VSVLGVYPVNYDNFPLGQFFDKGIILKGGQAPAHKHIDKLLEYVVQGKVQLDDIITHRLP
LSEISHAYEIFNKKEDGCVKVVLDPWK
>EGALAKHO_00839 hypothetical protein
MNSLIILQILISSVIATSVMTLFSYTVSEAARETYKEPVLLGYIFSSLNIKVSSPLKLFL
GWFMHYLIGIAFVVAYHVVWYYQLMDISWKASILLGIISGIIGIVSWVILFKIVPTKPNI
DFKGYYAQLFVAHIIFAIVAYVIYNLFI
>EGALAKHO_00840 hypothetical protein
MAKNATSQNLIDAINDHLEVTKGQVARLEEVFASVGEKASAKKCDAMEGLIKEGEGILEE
TEPGAVRDAGIIAASQKIEHYEIATYGTLASFAKTLGEDEAVSLLVQTLNEEKEADVTLT
EAAYNTINFDATEGDEK
>EGALAKHO_00841 hypothetical protein
MKDSNTKTAVKKTSTAKSSSTSKSTASKTANSKTKSSSNGDVKPKARKSFS
>EGALAKHO_00842 hypothetical protein
MWNQAGNFCFKYHVIDHKGLAPEIAVLGRLSIPCMAYNSLQEQNYSLEIRVLFQHELSKK
THVSYYVGIKWLAENNADVGLLYLISKNLQLVFMAGTSLIMLLQKSLLKLDSLNNSILIF
K
>EGALAKHO_00843 Phytochrome-like protein cph1
MKEIIKINLDNEMDLILAHKRCMKIAEMCGMPSSFQTRFSTAVSEIARCSIAKGKNSLLV
LCINTIKPTQKQIEAIITDSVDLKSCSPEAFNYASKISGDIEYSFKGNLSTTRIIQPVAS
PGLLSETKIKSLIDYFKFEPPLSPYDEIRKKNIELIAISEKLTESENRYRKLANTIPILI
CEVNERNKVLLYNESLLHYLKVPPPTFEKKNLINFIHLDDINVILDGWEKAKLTRSSFSG
EVRIKDSALFVWHLVTMIPNKSEDGSFNSWLVYFININAQKMIVEALKDNSELKMIQREL
ESANSKLLFKNKELEQFAYVASHDLQEPLRKIMIMLSRAGEQLSDEQKKQFYFDRMTLSA
TRLSELITDVLNYSRIDNSKQIFEEVDLNEITSEILGDLSMIIDEKNAVITIEPLPRVLG
LHTQLRQLFYNLVNNALKFNTAVPLVTISAEIVPDDNNELALSGNYHIISISDNGIGIEN
QYSNRIFNMFQRLHERDQYGGNGIGLALCRRIIENHNGFINFTSTPGKGTIFWIYLPKNN
D
>EGALAKHO_00844 Serine/threonine-protein kinase RsbT
MDNTFSSYKIDDRSLIAFIKREIHNLALHIGFTPHRAAETDIIVAELTSNLIKYANGGEL
LYRANLEGDLKIIEIYCLDKGVGFENLAKIMHDGYSSSNTLGHGLGSIKRLSNDFQIYSM
KNWGCVQHIKIAEKSDILLPCLQSGLNYAAIAVNYPGEKFCGDGYHIKSSKKGFQIFLGD
GLGHGENANEAVQLAIKAFKQSIETEPSEILRDIHAKVKKSRGLVGTIAAVDYKSELWNI
CGIGNISTRVYDGLDNKTYTPYNGIIGHNIPRTLNNTIVPYKKHQIIVMHSDGLRTRWNL
NEMTSIVKQHSGIIASAILKENIRGTDDASILVGKIM
>EGALAKHO_00845 Serine/threonine-protein kinase RsbT
MTTITNSKEEALIIREQDVVPLRNRVKEYGVKIGMSILNQTKLITATSELVRNLLKYGGG
GKVIIESVSNGRDNGVRVTFIDKGPGIADITLAMKDGYSTGKSLGLGLPGTKRLVNEFDI
KTELGNGTTVTITKWKNG
>EGALAKHO_00846 RsbT antagonist protein RsbS
MERIPILKMGDFLLVTIQVDLYDQLAENLESDLINTISKHSSKGVLIDISAVSIIDSFMG
RILGNIAVMSKIMDAQTVVVGMQPAVAITLVELGLSLNGVISALNVERGMDLLRSKMHTS
DNEEQDYDDDNE
>EGALAKHO_00847 RsbT co-antagonist protein RsbRA
MQNNFLSGLKEHENSLLTIWSQLLIESGSDDGAVEEEESKEFASLFLSALASLNGKFQDS
PEFEKVEDLIVGISSSRGKRGFSPRENAQYLTTFKQASSKILSKLITDSEQLYQANLQLN
EILDNMTIMTFEAYMRGREDVISRQVDEISEISTPVITVWDGIVALPIIGTLDSSRTQIV
MENLLQQIVDTGSSIAILDISGVPAVDSLVAQHLIKTVSATRLMGAECIISGIRPEIAQT
VVHLGIDLTGIITKATLASALKTAFDMLQLTVVKRKLV
>EGALAKHO_00848 Cold shock-like protein CspJ
MQEGTVKFYNEEKGFGFITPKNGGSEIFVHATGLTESIRENDQVRYEVADGKKGPNAVNV
VVI
>EGALAKHO_00849 hypothetical protein
MENLNIQTHKIKKCPYQVMAYGENNCDVDYRTSYKGDWGHWDEPTEDSLPTKNTEDTEIV
MN
>EGALAKHO_00850 hypothetical protein
MVLFVSLSSFSTYNATDKKEALSELEYVRLTDHVSDIKSVLGNDGRYNTKIAFLVDMKIK
SGKNRFFVYDLQNNKILDQGLVAHGSGSETGIRGELKFSNTPNSNCTSLGRYSVEKSYNG
IFGKAYRLNGLDESNNNALKRAVVLHQYSAVPYEEQDYYISNSHGCPMVNEMFFKRLEKI
IDSSNSKIMLYVYY
>EGALAKHO_00851 hypothetical protein
MNRLILIGNGFDLAHGLKTSYCHFITDYISKAINNFYKNNLHDDILLKIEFKFTGHRNNP
KDVVIIQPEEALKHLNLLQENSYFAVEFKSGFLRDSINKINTLNWVDLENDYFERLVECK
LPRSGFNIVKVNKINNEFDFLKKELESYLLRIQLDKNVCCSPELAKEFYGEIKSSEIITC
QISPRKVPHKILFLSFNYTNTVEKYLPFLLGQQEVNINYIHGKLDVNENPIIFGFGDEYN
KSYLEFEELKSNELLTHIKSFGYFNASNYHNLMKFLEDDQFQVYTFGHSLGLSDRTMLKE
IFENENCKSIKIFYHKDRKDFINKTYDISKHFTNKGLMRKKIAPFTKSSAMPQPNNN
>EGALAKHO_00852 hypothetical protein
MTDHLLSLLDNYKSKIRNPFIGTIISVWLIRNWKVVYAVFTFDNDRTMECKINYISSYFS
KISFWGELVNCFLIAFLTLLITFILLFISRSMTDFYFKVAEPYIVTIIDKKAIFTVEQKE
KLEKRIATLVEKLDKQSDSLSKAEVINERLQNKNNENQDSFNEQLTSLSTKANQTFEINS
KLSAEVKKVKHIVEMYNDMFNKLATVDKNTLLDLRHNGNIKLDITNEKKQDLSRLIENGL
VKANLANKRYELTDSGILFMNIYQINVDNPGISN
>EGALAKHO_00853 hypothetical protein
MKKLLLFSFLMLCLNLNAQIVRSEDTVKPDKEICIGVGNYCSTWFKDLVYFTFPDNSFTE
IKVQWYYTLKKSELDEIYSEIDRVFALSEFPKGTSFEFTNFEGKKITIIFHKSGYKGVSF
VNHVNVAPTIGNPKGIVTQLTDKLNRRQVDKLFGKEK
>EGALAKHO_00854 hypothetical protein
MMHEILEIKELNTDDIKFLKRELKKTYLFLFFLSLFGIVLPIYIIYLIINKPDNTDKGFA
FLMVLIIFSFWTYITIKVMIKTGEEKHGLLLQKKVEGNVKVVEKEIVTNQGYDSDTLTYE
IAIYSQIEGKYKNISIEKKEYDKIEIGDFIRITFFTDNPAIKTLIFNEQHLKYKSFTSTR
ISVK
>EGALAKHO_00855 hypothetical protein
MKSNIIMIVIILALSFACSKKEEAKVHSTSENSGTFFKKKLSNQKLMDSLENRTLFNGDT
LAYNELKGIFYIGEQRVTGLLYYSLIMSNKYNYKRASFDVYDILTHDKKVLDDKTKKMAN
DYLKISR
>EGALAKHO_00856 hypothetical protein
MNKLSFKYFKKALIVITLLVNIISGNLLAQSKNPSPLHFPTPKNIDNMLFYIQRDPNINT
AIYAINYQENGKIDKSNPIKAYWIRYAEKGEKKDLNYLQRKFAYGIETKTVNNEEFEFQF
VSYKKLALTLKKIDSDQKYHVFVNVNQKKIQVEKIFVRIEGGSFWLPNVKYVEVTGIDVS
SNKVITERMLLK
>EGALAKHO_00857 hypothetical protein
MFRKKSILTFLQAQVAAFLGGITDYGLMILLTEVFKLHFTFSILISGTVGAVINFSINRF
WVFKNQSGYSSHINNQLFRFALVVLGSISLKSFGTLLLQKSFQIDYRIGRLITDSFVSYG
FNYPLIKYWVFRANEKQNVIESN
>EGALAKHO_00858 hypothetical protein
MGKETQVEDYSEIAKRTFSDRKRTNILKKAEQLTIVFLLPKVPKFISPNILTLIGTLGSG
LVFLAFVLGTYFANWYLLLGIIGLAINWLGDSLDGRLAYYRNIPRRWYGFALDIIADWIG
IVLIGFGYYIYAENGTQIVAFAFVALYGWSIIISQLRYKITNEYSIDSGFVGPTELRFII
AFILITEVLFLGSITYLAGLITIILLIINIIDSVKLLKLGDLKDKNHN
>EGALAKHO_00859 hypothetical protein
MVSSYKTFTLTEQLTNEQIAFFNEHGFIHFKKFINPETVSSIIDASKQVEQKWIDNDLQK
VNGVPIKYGKDLDGSPIVQRFAFINQHHQTLSGLLLDPRFNSLLPLAGEGSRLGTEEKDG
MVFNHYINGPESKFTKMGWHTDGLRDIFYGGKLNPMLNVGIHLSTLQPENGGLKIIPGTH
KQSVYQMLFRKKYFLDNKPDPQEVSITPEAGDLTIHDGRLWHRVAESTIRGEASRRRVIY
VPIIAGKYAPKDENSPTVFYQRFAGIVK
>EGALAKHO_00860 hypothetical protein
MSLILLKIECTPTLCECVAVVAVANPLDKISNTIISIIKYIYYGIFL
>EGALAKHO_00861 Putative ketoacyl reductase
MSEKTKPYAIITGASKGIGKAIAYELAKQGHPLLLVARSEAELKALSDELKVKYGINAPI
LSIDLSISGAALKVTDWIKTNNYPVGFLVNNAGYGVWGDFSQSPLSDQLGMMQLNMNVVV
ELSHLLIPILLQEKQAYILNISSTAAYQAVPTLAVYSATKAFVLSFTRALRFELAQTSIS
VTCFSPGPVDTGFAARAGVNPLNKMAEKFNMQPDEVAKMAVKAMFNKKSEVIPGFTNIIS
VYANRILPKAFIEKTAAGIYKI
>EGALAKHO_00862 hypothetical protein
MSKKAIALYFETTNLITSEMAQEIASHFESKIILKNQMHLTEGTICDEYLFLEKGFMRAF
AFDIEGNEVTTNFYSPGDVVFEVASFFNRTKSKENINAVTDSVGWYITYEQLNNLFHSLP
EFREFGRSILVKGFSELKTRMLSMISETAEERYVHLLKSNPEIFQQASLKTIASFLGITD
TSLSRIRKEISKK
>EGALAKHO_00863 hypothetical protein
MDTLPLYISLVFGITLLTAIVLFYKASYSSKIVLAVLFLWIIAQSLISYFGFYKLENTIP
PRFALLLFPPLTMIVILFITKKGKAFIDGLNIKILTLLHVIRIPVELVLLWLFMHKAVPE
LMTFEGRNFDILSGISAPIVYYFTFVKKKIKYKFLLIWNFICLALVLNIAVNAVLSLPTK
FQQFAFDQPNVALLQFPFTLLPAVLVPIVVFSHLVSIRQLLHYKIRGEE
>EGALAKHO_00864 Glyoxal reductase
MNAQNPKNEINRRRFLQSSVAAGIYLSMFGMPKLFGNVLTEKTAVNIPDVKLNNGLKMPI
LGFGTYGLSGEVCQQSVAAALSSGYRLIDTAKVYGNEEAVGRGIKQSGIDRKQLFVTSKL
WVDDAGYENAKKGFEETLRKLGLQYLDLYLIHRPRGDVKGSWKAMEELYKAGKIKAIGIS
NFDAAQVADLLSYAEVKPVVNQIETHAYFQQSNDYDLLKQHNIQMEAWAPFAEGRNGLFT
NEVLVQIAKKYDKTVAQVNLRWHYQRGIVAIPRSSQKAHIVENLNIFDFKLDSADIKAIE
KLDLNRTQFPEWS
>EGALAKHO_00865 hypothetical protein
MKALKILAITLLIAACDSNIDFTGPAPEPPSPDQGKDLIISEIATFINTDAAAGGVRNHY
VELYNGTGGTVDLSKYAIGYQAALDENTLTDWSFASSANYLLLTGSLEKGKCYVIASPQA
NANAVKRDIDWGTTSSANADASKPLQLSGNSGIALLKKDTAGTYIVNGVSYTIIDAFGSP
NVARVTSGGSSSSRNNFMWTIAGETKDTRNRTIWRKGTVKDPNPDWATGKGTSASNSEWT
ISGDRAWDYSNLGLRSN
>EGALAKHO_00866 hypothetical protein
MKLKYSLFIFCTLAIAFQSLRAQVSEVGKSDSNVRYVPGDGTYIMLSKKDKFVFNINATL
QPGFQIKSEDAEDVTTNSEKLSLNLVRLGFNFSAYDDQLTMAILSDFTGTSGILEGWIGI
ASKNKKYKLIFGERQTNTNNRLAMADERYASVMAPSISGKSDDGSIYGGLMQNFVSTTRE
GGLFFETNFSISNMRLYPSVSITTGEGQGFFDPVANSGFKYGGRIDFMPLGDFIKNNAFI
SEDIYHEPKPKLAIGVADSYNVKTSNSIGAGNGTVSGIYDENGEVAYANYNKFVLDFIFK
YNGFSFVGEYMDGSIHGKDLFTDAAATVRFTPENASSKYSMGSAVNLQSSYVTHDGWAFE
GRYSYVKPEFDVATSIIQTQHWYTAAFNKYMMNNALKFGINATYIDQNGNGPNKTTWINN
LAVQISF
>EGALAKHO_00867 hypothetical protein
MFTICFVSLMQGQTGDIYQKYFPDPAIDMPLPITKGNPVFNYFTKYQDVLSFIQELAAKY
PDIISVSSIGTTQKGKNQSMVLLTRKSKIADEDKLRVTFIGGIHGNEPLSTDGMLYLMYM
VTHDASNTAMLDNVILQVIPMVNADGRTAETRVSNNSTDLNRDLTILNAKESTNLKIAIN
KFDPHVVIDFHEFSPARMDFKELNDCFTSAYDILFLYTGNLNVDPAIRDVIKNVFVEPTK
SFLTDRGRRVTDYCTTFMKDNEVWLNIGGIASRSSATNYALQNRISMLMEIRGLSEKEKS
GKRRIETAALTGLSYLKIAHDNETEIKAAVKTANKNAAEATRVSVITSKPEIIKRDYVFV
DKCKVSDTTIVFNANYNIKQSPDITRPKPGAFLIFPASEKVKKVLEVSGVSVKVIKQPFQ
LNDVGQYSVNQEGQINIKEGAVSVPEDALVIDSQQPMSNVIADLIEPDGANSLYVNNIIR
KKSKENLIPLYRISREQLSQLSTK
>EGALAKHO_00868 hypothetical protein
MDSEQTTQNQDASETMRLKKGYSLGDGLTLESASTYLNFTQSLQLLAGVSSTDGFDSYSS
EFNMRRARFNFRGTLFNEKVYVRVRVNLVGNYQSTTTGARSYNGALQDALIEYRPSPNQR
INFGVRASYDDSREARIEGESLGFIERSAISTAFDPIFDYGIRYYGVYRLGGNVFKPYVS
ITTGDGTAALQKNYGGFRYGIRLDYLPFGTFSKGGEYFMDDLAHERVPKLIIGPTFSYND
GTSSAKGTNGGRYIYGDAAQNELLPDLIKTGIDYMFKYRGWYSLGEYVYTHAKVPSGIAG
EFSTSGKFTPYTGQTPEQIENTVLSRLNVGSGFNIQAGYCFNSFALAGRYSYLENDPNSA
SFADMNRYYTCVGTFYFSGHNLKLQTEVGYQEYKNILKTPDVKGNIYGQIMFTIQL
>EGALAKHO_00869 Isoaspartyl dipeptidase
MFKLIKNSVLYAPKSLGRKDILICGEKIALIRDTISLNLPEVEIIDANGKIVTPGFIDQH
VHIIGAGGKHGFNSLTPEISLSELISCGTTTVVGLLGTDGATKSLNALYAKTKALDNEGI
TAYMFTGYFGLPPITMMGSVLDDMLFIDKVLGCKVAISDERSSFPTAKELLSILKDVYVG
GLTSGKKGIMHVHLGALKTNMQLLIDLVEQYGFPIRNISPTHVGRTAPLFEEAIRFAKLG
GMIDITTGGTKFDEPYKQVLYALGKGVPMENMTFSSDGNAGIGVNDKDGNLTGFEKAPID
LNLKQVQKLVKEANIPIGQAIQLVTSGPARNLSLKDKGSVFVGGDADLCLFDSNFNLTDV
IARGKVMMKEKEIIVRGSFEKID
>EGALAKHO_00870 hypothetical protein
MSNPFSDNSQIATVSTFSELVHTEFKGEMNALCWYRNLDGDFNDIVAQLSLKENITEVSP
EDLIVLQLSEKGNIAREIILNDLQLLTDFGASPSLNLLKCYERDDEFDFISTDVYSFHVD
RSPIATDTFLCTYHGAPSDIVSNSQAEQKILIPEIRAKLNELYDGPSEEFEEFLKENYFD
LHYQVHEDAKPINLGLGNLWRLAVDHPKQQVLPCIHRAPIEKEGEYRLLLIC
>EGALAKHO_00871 hypothetical protein
MWPWQERLLCMIETYRNHVLKTKFSLVSECFLNNIRFLNKEFFCVFLKMPQMATIT
>EGALAKHO_00872 23S rRNA (guanosine-2'-O-)-methyltransferase RlmB
MEASFNKFHFKISSGYLAIKKLIYVYTVCTFAVMNDNFINEYFGIGIQNGKTPENLGVLW
RSAQNLGATFIFTIGNRYAKQACDTHDAVKAIPYFHYDTFEAFFENLPKGARLVGVELDD
KASDLETFEHPRRCVYLLGAEDHGLSKKVMDKCHHLVKFKSEKSLNVAVAGTIIMYDRNL
SKPRS
>EGALAKHO_00873 hypothetical protein
MRKISILLVLLLISYKTLAQNAKVMDSIQTDTVRNIRFNYKQLIIPGILIGYGFWGIESG
QIKSFNFQIRDEITENIDTKVTIDDFTRYVPAVSVYALNAFGVKGKNNVRDRSVILATST
ILTVVTVFGLKSITNVERPDGTSNDSFPSGHTAIAFAGAEFLYQEYKDKSIWYGVAGYAI
AAGTGVFRMYNNRHWLTDVAAGAGIGILCTKAAYWMNPYLTRKLFGNKESKSTSFLAPSY
DGKSFAINYIKTF
>EGALAKHO_00874 hypothetical protein
MYSNKLTFLSLSIFLLCTFNLFSQVTLPKILGHNMVLQQLKNVSIWGTASPGEKVSVDFA
GQNKTTFADNSGKWSLKLKPMKASFTPREMTIKGTNTIVLKNILVGEVWLCSGQSNMEYA
MRKYSKFETAIKGQKPPEDDLNKANNPNIRIFLDRRKYMDPSPEHAGWDSAMGKPLVDFS
AVGYYFAKDLYSKLHVPIGMISAAVPGSRIEPWIEASKMEVSPKMKNGKTLEKLSTDGGD
PGKFYDTMIQPLIPFTLKGFLWYQGESNCFLSENIRYAYKFKTLIESWRNDWKDKKMPFY
FVQIAPYAYSTAKDDRVHTTENLPEFWEAQQLALHLKNTSTIAITDLVDSIADLHPGYKW
EVGRRLSLVAANKAYGQKNVVYSGPVYKKMTAVNHTIEITFSNTGSGLASRDGKNLSWFS
IAGSDGKFSPAKAEIKDNKIILSASEVPDPVSARFGWNEAAQSNFINKEGFPAVPFRTDN
PWDKLFQ
>EGALAKHO_00875 hypothetical protein
MPVIEQSEYNFPSIIHRNRHISTIYAALFKKFEVPEYTREKLELNDGDFINIDFILNDPK
KAVILCHGLEGDSRRTYNNSCADYFQHKEFSVFAWNNRTCGGEMNRLPRLYHHGAVDDLD
GVVQFVLQKGFEEVYLIGYSMGGVQLLNYFGWTKIDKRVKAGVSISVPTHIATSAEVLKQ
GFNRVYLKNFTIDIKRKLKYKAEQFPDFINSDQIDNISSFDEVDHYFTAPLHGFASRDDY
YQRVSPEFSLKNITTPVLIINSLDDPFLGDRCYPRAIAKDSAYVYLETPKYGGHCAFPLR
NSTYSYAEKRAYEFFKSYK
>EGALAKHO_00876 Peptide methionine sulfoxide reductase MsrA 3
MENLKKAYIAGGCFWGMEDLFRVRPGVKDTEVGYIGGQNDNPTYENHPGHAEGIEITYDS
NETSYKELLDYFFRMHDPTTVDRQGNDRGSSYRSAIFIQNEEEKQIAHEVINIVDQSAKW
SGTIVTTLEPFTTFWPAEENHQDYLIKHPNGYTCHFERFGTFL
>EGALAKHO_00877 hypothetical protein
MKTVFKLQIVMAILLTGFLFSCKDNKDGYIDEIDTAKTPFDTASADTTNINNSQNNNDTN
STGATKSEGVTGAGSISAPGKPTSPSTNTKSTGTGPGPSAKDGSAYDISSQSKNDTTKLG
AKALKKEKGSKE
>EGALAKHO_00878 hypothetical protein
MKNYLILLLSIFFLSCQQKENKQTAIDVPDTTLTNKSKEENKQIKEENKQIGDTIFMNFR
DEKGLFIAEGSLDSIHSKVYVKYKNENLGELKAKIIPADGKGNIRFNQIIFPDKSSDGPF
GMDLEIPLKQKGSHTLVIGHSLMADSPYFGKFKVQLEKK
>EGALAKHO_00879 hypothetical protein
MLKKILYTTLFAFALTSCSDTLDDINKNPNATETPLAPYLLTGTLKQGADLYWGSTNNFD
SSLLFVQHWAKIQYTEPDRYDVSNTSFTTLWNTGYATLITDLNTIINFPEAQANSNYKGI
ALTLRSWTFLLLTDAYGSIPYKEAGLKVTPAYNTQKEVYTGLLEDLKQAQSLLNTANGAV
TGDLSYKGDILKWKKLVNSLRLRIALRISDREPALAKQAAIEATSDAAGVFTSNNDTFKF
TYTSSPQQNPASAWFETRDDYRISKTMVDKLNQLSDPRLPVYAQLPSDASVGKYVGGANG
LSNSDANSQGFAKTSKPGTYFLTSASPAVIVSYSEVLFNLSEAVARGYISGDAEQLYKNA
ITASFNQFGITDATVISNYLNQATVKYDTTNYAKSIGTQKWIAFYGQGLDAFTEWRRLDY
PVLTAGPATVLDGKLPSRFFYPGTEQSLNGASYQAAISVQGKDLLTTKLWFDVK
>EGALAKHO_00880 TonB-dependent receptor SusC
MVKLKEIVHLYKKSENGVNPFRAHLFLNQNKVMKKKLNRYIWLCILLISIGINAQETKPL
IQSKLEGTVVDAVTKEPIIGASINIKGTTHGVVTDFDGKFFFQTGQKLPYTLIVSYLGYK
KAEVVATTNSVVIELTQEQNALSEVVVTALGITKEKKSLGYTTQGLKGKELSDTKETNFL
NSLSGKLAGVRITNSQGDMGSSRIVIRGETSIAGNNQPLFVVDGVPVDNSQLGSVGGATR
DFKNAIADLNPQDIENITVLKGPNAAALYGSRAAHGVVLITTKSGKNQKGLGISVNSGIT
ISQVTTLPAFQNSFGQGSNGLFSYVDGKGGGVNDGVDESWGPKLDGRLIPQFYSNGQAVP
FVAHPDNVKDFFNTGVTYDNSVSIARSDEKSDFRLGVNNQKQLGTVPNSEVNKTNFTINT
NYQISKNVKVGVNANYIVTNAPALPGGPSGNRAAGVMLQFLWFGRQVDVNELNNDWNRNW
NNSYYSNPYWNAYYNTTSQQRNRLIGDIHLDAKIIDGLNFRFRTGVDYYNDRRKYEIKYG
TNGTPFGSYAEDAYTVNEQNTEGIFTYTKKLNDDFSLDALTGFNIRNHSDANNYQKAPRL
AVPDLYTLTNSRDPLTSSNYLSRLRVYSAYASAQLGYKNYAFLNVTARNDWSSTLPSSNR
SYFYPSVSGSLVLSDALNLKSNTLDFLKLRGGWSEVGNDADPYQLSTVYNFQTAFDGNPI
QTSSQKKLNENLKPETTRSTEIGLESSFWKNRLHFDFAYYNTNSFDQILEIKTTASSGYN
SQLINAGKINNHGIEIQLDGNPIQNENFKWNVAVNYSKNISKVEILDYDKQIQNYTIGTS
GGVDVLVSVGQAYGALYGTAYQRDANGDIVVGANGLPKADPQKKVLGHYTPDYLAGVTNT
LTYKNIELSFLVDASVGGELFSGTNRTGNYTGVLAQTLPGRDAANGGLNYYLAGSTKTLL
PAGATAPGGAAVYDDGMIFKGVYADGTPNTSVLSAQEYYKASYNISEAYLYSSTFVKMRE
IKLAYNLNKSFARRLGLDGASITAVGRNLFFIYKDAPNIDPETAFNTGNAQGLESLALPT
TRNFSLNVNLRF
>EGALAKHO_00881 hypothetical protein
MKKILKLASLLFVTALVFNSCEKEQDLNEPQSVKKEVTESSSQGAVQSTNKPAAAAAVAA
GGGAGAKTITLQTNTLSCPGGSCTSYGVWSEGVYTVWFQMKFNSGFYWSRGGKCGYGILI
GDQNTGGDPGWDGNGGSARFMWYCPNGSNSAKGSGAYLQPYVYYRDQPGQFGNDFGKKYY
IQEGVTYNCQISVKLNTGSNTNGYVKYYVNGTEILNQTIRWVTNDAKRNVNAVSLHTFRG
GSQEYWKAPVTSSIYYASAAWDAQ
>EGALAKHO_00882 Thiol-disulfide oxidoreductase ResA
MIKPKRINKRIETAIITLMILFCLPLLAQHKFSIAGTIPSQYKGTDIILSSENSSFAPIS
TKEKNGKFYFSGEIKQGFECVYLDVKKDNKHLGGSFLFIGAQDMKIQIVKLNEKDPLNDF
HFSNVPFIEEQKEYNRLTKPSADSAKVAFDIYYDARQKHLKASEQDSLWTIVSDLREKLI
IQRIKCIESFPDAYISLYLFNKEVVYGFHPISSYRLNATYNKLSYNLKETDLGKSVGEYI
KKKLTLVVGHILPNFSFSTDKGQNFELLSSFKNKKLVLLCFWSNGCAPCIKKIPTLKIIN
EKYNAKGLQLISVSTDRRSDIWLNSLNKYQMPWLQTCDLLAYIQGERLQNLLDVVSFPQY
FLMDDTGKLVYQNEQLNDDEGLSILQKLLESQLP
>EGALAKHO_00883 Starch-binding protein SusD
MKKYIHNKISRLLPIIALAALSSSCSKDFLESDPLSFYEPEATFSTEAGLQATLALCDKQ
LRNNYIHYGYSGVNVPISTEYLFSDMAQYGKTDTGSNIADYAATVVPTGDFRRDPGGESL
YLGFLWTEAYTGIKNANTVLSYIGNVTTLSEDVKNKYIGQAYFHRAYRYLNLVYEFGDIP
LITKILEVPKQSYYSTKKEAIIEMITADMEKAVQFVPEQSKIGYVGMVSKGACRQLLIKC
YLASGRFADAEAQANILINQSGYSLVQNTLGIFDPGGNPTAWPITRNVIWDLHRPENKVI
TANTEAILVAPNGGAQSFLAFSSMRIFGPNWNDANLITPDGKTAAPRFPLTDKTNYNAKY
DYQRALGRGIGTISGSYYSQHPMWVVNGVEDKVDLRHNSTVGNWVNMEDLKYAPGAGGSA
AWAGQNFRMKDAAGKLLAQDSIRDWFDFPHYKIFYHDVVAEANPAANDFQGATAGASAHM
YIYRLAETYLLRAEARFYQGNASGAAQDVNIVRARAKASQMYTTVTIGDICAERGRELYM
EEWRNVELKRISHCLALSGKPDEWGHTYSKETWDKQSGTDAAGGSYWYQRIVHYTLYNKY
PSGIALKPGVKFYTMDKRNNYWPIPYRLAIEPNIKGQLSQNFGYDGYNAGVKVWDKWQDA
VDDESKI
>EGALAKHO_00884 TonB-dependent receptor SusC
MTNFIRMKKNPGSVSGFNLKKKMMIFCVLFSLSQIHGYAISSKGTKVSQNVNQQKSIKGQ
VNDENGVPMPGVTVLEKGSKNGTSTDFDGKFTLKLENENAVLVVSYLGYLTAEVAVKGQT
SVTVKMQKATASLDEVVVVGYGKMKKKDLTGAIVQVTPDKLANQNPQTVQDVLRGTPGVR
VGYDPSAKGGGSIQVRGQTSVYTGGSHNSPLIILDGMQFYGELSEINPDDIAQLDILKDA
SAASVYGAKAAAGVILISTKKGKTGKPIVSFTTNTTISNKSAYRGVYSPEGYLKYREDWE
TAQTYGVNTTTKQYEAWIAGTVAPGKPGYFSNPNDLGKWGITEAQWLAYQPATQTVGKSS
KEVWGNRLGLNFDPSLMANFLADKTHDWSDSSFRTGINHDNNLSISGAGDKVNYYMSFGY
LTSEGAIVGNDYKSARSNMKVDAKITDWLDFGANINFQDRSDGDVTPSLGTASGDNNMMR
TSPFGTFIDANGNYERQPMGKNVSGQNYNYYYERQFIEKETGYTTLNAIFNTKVTLPLGI
TYSFNISPRYQFYHDRYFRSTQNPNWPAATTGANRNNATRFEYNLNNTLAWDYTIAEKHH
IVATFVQEAEERRYWSDGMDAYNIQPSDALGFHLVNTATMANSAIRSYDSHETADGLMGR
LFYSYDNRYMLTATVRRDGYSAFGASNPYAVFPSFGVAWNFKNESWFNWDAMSTGKLRLS
WGRNGNRSLADPYISLANLVNTGTMGYLDASGKALELKYLALDRMANPNLEWEKTTSTNI
GLDLGFLHDRITATLDLYKAATHDMIMSQSLPGFTGFSSIATNLGEVENQGFELSVNTLN
MKKPNFEWRTTFGISYNENKIISLYGNMVDIKDASGNVIGKKEGDDSANGWFIGRPISQI
WDYKVTGIWQKDEWKEAQRYGQRPGDPKVQNSNTTDDIDAVDADGVAYKKAVYNEKDKQF
LGNSNPPVQWSLRNDFKIYKNWDLAISMYSYNGGKSLNSNYMNTFNDSSLYKFNFNPYVN
PYWTLDSPTNDWARLDAKGPAGTPVAPGKLYDRSFIRLDNISLAYTLPRDLLDRVHIKNI
KIYASVQNVATWSASKEWKYFGDPETGGLATRQFNLGFNFQL
>EGALAKHO_00885 hypothetical protein
MTDKSQLRSSIFRHLDGLAVAPVAIALKKKEVLEFILNKKEVQLKELVTVFKANEGYLNV
GLRVLASQGFLDYNVDNKTQEIKISVNEKTEIAFSLFYLYEDVVDLLHFSIQFHTRIFDD
VPFEKLNVIFEKYKKGYGIEQAEDALTNIVQDQVLKHIEGYLIAPTIVRLAMNGMFHKYF
METSFKPEEFHKSPENFKKILDFLVHLGWFLEKNGNYQFTEVGLFFAKRSSAYGVTVSYL
PTFAKIEELIFGDPAVLRMIADGENEIHVDREMNVWGSGGAHDTYFKVVDEIIIKLFNLP
IEEQPKGILDMGCGNGAFLQHIFEVIERQTLRGKILDEYPLFLVGADYNQAALKVTRANL
TKADIWAKVIWGDIGRPDILSDDLKENYNIDLKDLLNVRTFLDHNRIWKDPEYIDQNRIS
KSTGAFAYRGKRISNNLVEDNLLEHLQKWSPYVRKFGLLLIELHTIDPKLAASNLGKTPA
TAYDATHGFSDQYIVEIDVFNSVAAEAGLFPDKSIFKRFPEADIATVSINLLKGKEKQIS
SL
>EGALAKHO_00886 hypothetical protein
MENNTIIEIILLLSIILGYSVYLYILRRRIITYKRLGQGILVSDFSGSMSIALNKKQEEK
LRQSVFKAEQMMNQTKEQMTYSIVLPSDIKLVETESCLLIKGFIESIEKICYEFSNMDQL
PEGFCVQLGDWKFFILEEKPQSSREDKIIVMPASHWLFVSRKLRESINGQEMHPCTYIYE
PSTFKKILQYGIGVEATDYII
>EGALAKHO_00887 Oxygen regulatory protein NreC
MLPEIQNLYDVWQKNRTVQTTSAHQISFDNLRNSIISTGPFSFYIIDFFDMSLSHISPSL
CEMHGFNPDTLTFNDVLGAIHPDDIDFVVKAEAFLTKFFYENVGREKLLNYKISYSHRCR
LENGEYVLFNHQALMLTMDDNGGYGKSLNIHTRIDHLSSFNTYKISLIGLNGEPSYMNLS
LEEDNKEFAEFSKREIDIIKLIGEGLSTIEIAEKLFISPLTVKKHRNNILTKSNSKNTAE
LIKNCILQGVI
>EGALAKHO_00888 hypothetical protein
MNTNNQNPKGNNQKIGADRSDTRKHQYKDHDDVLTNDENYDVDTHKFKGKEPELDDKLNN
EEKK
>EGALAKHO_00889 FAD-dependent urate hydroxylase
MEKKETSWEICPECQGRGKKSQRLSKKVRLQYQTELDQFEKSKSEGTAPVRPKAHLYLCL
KCSGSGLLRSCTPPVVTKENYPHVAIIGGGIGGVALAVACLHRGIPFTLFERDINFEARS
QGYGLTLQQASKAIEGLGVFSLDEGVISTRHLVHTTEGKVIGEWGTRKWIQSEIKTSPKR
TNIHIARQSLRLALLDQLGGHDKVQWGHQLINFKQSEDEGIDLSFQVNGEIKNFKTDLLV
GADGIRSSVRKLLIGEDSTPLRYLGCIVILGICPLSALEGLDSSLLDSATVFQTANGNER
IYIMPYTSDSVMWQLSFPMPEEEAKALSALGTLALKEEACRRTQWHAPIPQILAATLETQ
ISGYPVYDRELLKSELLEKSGQVTLIGDAAHPMSPFKGQGANQALLDALSLARGIAKGCK
SLSHWKKTGIRESVLTEFESEMLERSAIKVEDSAKAAEFLHSEIVLHEGDEPRGRCIKKK
DK
>EGALAKHO_00890 hypothetical protein
MKILPSNSTLLIIDVQERLLPKIHQNEDVIKNVLWAVDLAQTIGIPNLLTEHCPHKIGPT
PTELRDKFKEKDILTKVYFSAVREGNLLDKIQKERKQIIIAGTEAHICVQQTVLDLLEKD
YQVFILDSAVGTRFPNDKERALERMSKNGAEIITPDMLAFEWLEKAETPLFKEVLNKFIK
>EGALAKHO_00891 Non-heme chloroperoxidase
MSTITVKDGTEIYYKDWGTGQPIFFHHGWPLSADDWDAQMLYFLEQGFRVIAHDRRGHGR
SSQTYKGNEMDTYAADVAELTAFLDLKDAIHIGHSTGGGEAIRYAAKYGKGRVAKVILIS
AVTPYMILNDNNPDGVPLAVFDDIRFNTANNRQQFYQDLTFPFYGYNREGADVKKGIQDN
WWRQGMAGGIKAHYDCIKAFSETDFTEDLKSVDFPVLILHGEDDQIVPYVPTALRAAKLV
KNGKLITYPGLCHGMPTTDAATINADILAFIKS
>EGALAKHO_00892 hypothetical protein
MTKSKSIILIHGNFVNDVSWAKWKSHYEQKGYTVYTPANPGHDGNPGALRKQVHPALTKT
GFIDVVDNISKLIDSLPEKPLVIGHSMAGMAAMKLLELNKVAAAVSIDGAPPKNVFPPLQ
TLKSVIGAFGFFSGKKYFMGSREWYDKCFFNTLPENERANAFETYAVPESFKVNRELVLN
SFSNIDFGASHEPILFIGGGSDNIFSPALTTTLANKYKDKKSRVDLKIFQGKSHFICGEN
GWEIVADYILDWYEKL
>EGALAKHO_00893 hypothetical protein
MFPLKKYLSIVLFLFLLSCQNGMDEQDTNAQGTITNTSPLATYMQRVAMVTTVQDNIIDR
SSYCTIKLPYIVTVNSTQIAVNTTADYQKVLDNINASTTDDDVVKITFPVTMVYYNYIEK
NIPNEADFNSLIDYWNLYPDLLYKINGLNINYPITINSYNSANQMASSVSIISDQAFFNF
IKNLSSSQYISLQYPISIVDYNNQTKSITSNLDFENAIKYAIDYCPENNIVALDFVAAIT
KGSWIIPYYFDDSEKTSFYSGYSFVFKSDKSVVATKGAISETGTWESTVQNNVKELKLNF
STELLGKLNTNWKLFEFNNSQIRLRDVSNSTNYLYFEKK
>EGALAKHO_00894 putative RNA polymerase sigma factor FecI
MPNKNQSNTCDEIIFSTFFKGHIKALRNFLFYKFGNMDQAEDVAQEAFVKLWQNCTSVPL
EKAKSYIYTIANNSSLNEIAHQKVVLRYEKNFTGLDKTNESPEYILEEKQFQSKLLKAIE
NLNEKQRIAFLMHRIDGKKYSEIAVELDISVKAVEKRIHLALLSLRKEIDL
>EGALAKHO_00895 hypothetical protein
MKKNRLLAKWLNNDLSPDELAEFEASADFEKYQKIKNYTDHLAVDDLDENAMLSNILSQK
KVDRKVVPLYKNWIFRAAAIFIIALGIFALRFFAPQTETANFGEKTTFSLPDNSEVVLNS
GSEINYKKWNWDNNRHLELKGEAYFRVAKGRRFEVNTNLGKVTVLGTQFNVKARKDRFDV
VCYEGRVKVNYANTQILLTHGQSVTFEKGKQTKMRIRTLKPEWTENQICFYNENIRSLFD
EVERQYNITIELNTKDTTSLFTGKLPTKNLDIALQIISTTYHLEAKKVSKNKIIFDEK
>EGALAKHO_00896 hypothetical protein
MLLPKQFHFLFLTFFLVLNLFAQDKGKIMPFKKIIIEIEQQHKVIFNYTEDNIAGLQLTP
PKHSLSLDQKLQYLATETNLSFENIGNKFINIYKKNNESQVICGYIFSNTDKKPIENANI
YLINKTQITSDSNGYFEFKKEDAAILSISHIGFISKRVTVDNPESKNCIQIFLEPQITEL
HEIKTNAILASGISKNKDGSFEIKPKKFGILPGLIEPDALQTMQQIPGVNSIDESVSSIN
VRGGTHDQNLFLWNGIRMYQTGHFFGLISVFNPNLAHTISIYKNGSSAFYGESVSSVVAI
SSTPETAEKNAFSAGINMINADIYGKYNLSKKSYIEISARKSITDFVETPTYKEYFNKIF
QNTTITDFSQKQNVDYQSDKKFGFYDATLKYAQKIGTKDQLVLDLITIKDNLEVFQSATV
YDINRSENNILRQQNYGGNLLWKRNWNNFNTTKINIYNSSYKLLADQKTTNANQIVIQEN
TVNNNGINVENYHIINSKFSFNDGYQFNEIGVTNLEQVTNPDFYRKVKDVLRTHALILEG
KYNDTISRIYFKAGTRINYIEKFKKYIVEPRIQFSYGINKNLSLELLGELKSQNLQQIID
LQKDYFGIEKRRWIISNDTTIPIQRSKQLSLNLFYKKNNWLLDIENFYKKVNGITTSSQG
FQNQLEFIRTTGNYEVWGSEMLIQKKMNHFLTWLSYTYNHNNYHFATYEYPVFPNNFEVM
HTVAWAGIYEKNNFKIALGTKWSSGRPKTSLNSSQIGLLNPELDYNKPNNTNLNIFSQVN
LSSTYKWETTSGIQYKLGISILNILNRKNEISQYYRISSLTNSIEEIETFALQRTPNVSF
RVSL
>EGALAKHO_00897 hypothetical protein
MKLKQLKFALVALVATTFFLSCSSDNGNDTSTPPPTEVKNDGVMLSTSATLGSYLTDKNG
RSLYFFATDANGQSSCTGGCEALWPAFFVDNLTADKVGAGLTFSDFATITTTSGKQLTYK
GWPLYYYAPVSAGDGYGGAGVNKPETAGQTTGEGIDGTWFIAKPDYSIMIARSQLKGHDG
KNYKSDYTVGDGVTTYFTDAKGVTLYTFKNDTFKKNNFTAADFSNNSVWPIYETDKIVVP
SILDKSKFSVITVFGKSQLVYNGWPLYYFGQDANVRGANKGISFPAPGVWPVPVKDIALA
I
>EGALAKHO_00898 hypothetical protein
MNKTRIKILIFLLVISFGPYYIYQNILYKDARNISNEKSILTITAQNLEKEYAENPPEAN
AKYLNKTIEVEGIVSEVTDSSLVIDRKVFCKMDEKVKRTFLNKHINVKGRCIGFDDLFSI
VKFDQCSTQQH
>EGALAKHO_00899 hypothetical protein
MQYSTTLNMKKKIFLIVSFLICLCSNAQDDLLSTLDSTQVVDKSVTATFKALQIITLQST
KLAAKKEFYIVISHRFGSVKGGISEFFGFDDATTKIGGIYGVTNWLSVSASHHTLLKINE
ASAKFRLMKQSEDFPVDIVGYSTIDFNSGLKEDDYPKIEFSDRLSYINQVLISRKFSDKI
SLELAPSFIHKNLYNPEIENDNQFTLGAGGRLKLTKRLSLNLEYAQNFNKPAFYNNPLSV
GLDIETGGHVFQLLFTNSQSMTESGYLTSASGDWGNGDFFFGFNLYRVF
>EGALAKHO_00900 hypothetical protein
MKKYIYLSGIILSLYSCESTTYEELQEPALIVGEVTYTANVKAIIDANCIACHSSGSGNR
PLQTYTQVKDAVLNTDLLDRIQRQNGTPGQMPQSGRMPQDKINTILQWNTDGLLEN
>EGALAKHO_00901 hypothetical protein
MKKIIALLFLFAGIVSVSAQKYITKTGSLKFQASVESFEEVAAENKNTSAVLESSTGEIA
VLTLMKGFRFKIALMEEHFNENYVESDKFPKATFKGKIEDFDASTLSATAKIFKISGDLT
LHGKTKKISTNVKVLKSGDKITVTGNFEAKPEDFDIEIPKLVSKKVADKINISFNLILTK
>EGALAKHO_00902 hypothetical protein
MEKHIESVTSLPLENNPITYPQIKKADLLPNPESRLDTAEMKETPLSDPSIPYRDLTSVA
SKKESIARLIDKLDVENSIRYQKTIEDTYCNVYSYDYCYFSGVYLPTVWWTKDSIEKIIQ
GQDVEAVFEETVDRIYSSAITDWFSEWGPNFGWKKMFTADEIQNEVNEKGGIGIICAKRR
EKGLSGHIVPVVPETDLHKAYRENGIVLYPLQSQAGKLNYNYFSEVRKDWWNDELYSSFV
FYYHD
>EGALAKHO_00903 hypothetical protein
MKDNQTKKYYWGIGLENETYMQFEESLIVSGEFIQEKIGFEKYSIDYRKCYKPESLAPVL
KKAFGLNENYKVSRMMNSHSLEKLDINYQHKTLSPIKPLVDTETGEVSAQPIENPEYLGK
SIMELFLEDQPYNIQSMITQRNKTMGSVHFDGDSIEFVTKYFENRTIADSCKELKATKKL
FLDKINESSVLNGKLGFPDYNNGLNMFMTNQENLVLFNNGTYHFHITLPSLTEDSRIVDY
TEFEKTHANAIYLLQWFEPFFIATLGSPDIMGVISDKYSLDKKFTLGSMRNAMSRYIGVG
TYNKAMPKGKILTYNVDNFRKLLKFEKEENIWWRDQIETEMEYEMLSEVGLDFNQEKMYQ
SGFEFRSFDEFPAEYLNDVLFSIILICEHSLNLPDVQWGHDSKAWNNLVFKTLKMGYATE
INEEEKNEVLNLLQLLNSSDENYNTLKSEFEAITMLDEFFFKILAVLHDKYKDNNICLDA
MYGQKTTSPPKWNNFNKYQTEKHLQQIGIFSDN
>EGALAKHO_00904 hypothetical protein
MKTIFKLKLLLFLVLIGLAFSCKTSSVSGNTTPSESDAIKAGDSTALNTGIKGTTRSNEG
NGNESDDVPAKKK
>EGALAKHO_00905 Gamma-glutamylputrescine oxidoreductase
MDESNYHLKSSSITSGDNVSFWIDSTQIISFNKPDQNIETEVLIIGGGIAGLTTAYKLLK
AGKKVVLVEDGFIGSGETGRTTAHLTCALDDRYYFLEKIFGENTAKLAAESHSEAINEIE
KIVTELNIDCSFKRVNGYLFLHPSDKEENLDKEFRATQKAGLQTSVIKGIPALANSENQR
CLVFGNQAQFHILHYLKGLAQAIIDLGGIIYTEAHAENITKKGAKVNEFTFSAEDIVVAT
NSPVNDVLIMHTKQHAYRTYVIAGKIPKGQLPYSLWWDTGDQDSKWVSQPYHYVRLENYD
DQYDLLIAGGEDHKTGQSEEEGISELARYDRLEAWTRNYFPMLEDDLTYRWSGQVMEPVD
SLGFMGKNPGDDNIYIITGDSGNGMTHATIGAMIICDSIMGIKNKWADLYNPSRITLKIA
IDFAKEVCNMASQYVDWITASDLKNTADLAAGDGGIISSGLNKIAVYRDYDNSLKAFSAV
CPHLGCIVHWNPDEKSFDCPCHGSRFATDGSVTNGPAQTDLHKIHVK
>EGALAKHO_00906 hypothetical protein
MKAIILLATLKNKGRSNTETLVEFFVEYLTEQNIDYEIIKLIDYQIVPGTFTHMDTKDDW
PEIYQKILDSKILLFATPIWWNNHSSELQRCIERLDEVYDIILSGKDSPLDNKIGGVIVT
GDSDGVEHITANIANFFCSIGVTVPPYTSLGVIWDGHAKDAKKTKPQLLQYYKRMYAKDA
RAMAESLKKASK
>EGALAKHO_00907 hypothetical protein
MKIPKEIINGFYIFLGIALFFLLMEILNLSHLFYLRLLNVLFIFYGVNRTLKMNLAEGKN
TFLPNAISAMVTSFTGVILSIIALLIYSYARGGDAYVKSLSEAFMFGGDPSVPTYVLCLL
FEGSASCVIVTLLLMLLWNNKYKAD
>EGALAKHO_00908 hypothetical protein
MNTSNHRNSRSDNEAINSETMENKDPAINQHQNDYSNLDQYNTESSERHHIDDNDDINPS
FQENSNRTIDAEKDLRDKNDPDRRTLDEYSANKAEPDEDNEEDN
>EGALAKHO_00909 hypothetical protein
MKKTLFLIFIIGISLQGYAQDELNRKQQSIQPKNSENKEAIPPTETPPTEEPPALSKEPI
VLKINPEELFNNNILYKREANVEGVFYRRNEYLGGFVTKSFTSTIRYRDAAFVDGDKIKV
YLNDKVIEPEVLLDGSYKGFKINLVKGINKIDFEALNEGSASPNTAEFQVYDDKGTVIES
SQWNVGKGYKAVIILYKE
>EGALAKHO_00910 hypothetical protein
MKKFSIIIVFLFCTSSWAQSTVTDSSKVAKPPTKNIDFNVMPYINYNRTLDFMFGAIPMM
MYKINPKDTISPKSLSGMMAIYTTNKSYFISLFNKFHFKEDKWRAQFFFLTGDHNSQFYL
DDLEAPAFYDYGTKTTIVSFTVQRKIVKAFYGGIGYTYSHYDTTYQDDIQPSSVSHTNGL
QLIALYDTRDAVYYPTKGEKIRARWINYPTWFGNDVSANKILSEYNKYFPMRKGVDVLAA
RFSGKFGLGDISFEQQVTIGGEDIRGYSEGKYRGDGLMALQSEYRYNFNKKMGLVAFAGV
ATIYGSDTADFNWNLYPGAGVGYRYRAFKNEKFNVGLDGAVGKGDWGIYFRIGEAF
>EGALAKHO_00911 hypothetical protein
MENSNVNKRKELFDTILQLFFIFLVVGFCLTLLMPFFMPILWAAILAVAFYPLFNFLQRI
LKGRKTLAAVIITITIIAVMLMPVIYALKAATSNFLELKTEFEAGTLKVSPPGPSIKEWP
VIGKPLYEFLLAASTDLEQSVVKYQDQIKEFSTKIMGSILSSGMAFLQFILSVIIAGVLL
VSPGATTMVHKFLKKIAGNEADEIMTISTSTIYQVVKGILGVAIIQTIIQAFGLFLADIP
YAGILTLICLVFSILQIGPIIINIGVIVYLFSTGDSGYAIGWTIFFVISGLSDNVLKPLL
LGKGALVPMLVIFLGVIGGFIMSGFIGLFVGPIVFSIGYKLFIAWLDDHPHAEPKPLIID
PEVIE
>EGALAKHO_00912 hypothetical protein
MELKNDRFLYRLWTREKGLSVMFLLLCIMQFIVIPLFGSYSRFMIFINIFWMLFIMAGII
SLAKDKKQALVVSIIPFLFLMVQWIDFFQTNIIVVFADLFLSVALMLLLIGLVLIKVLEP
GPVTQYRIIGSIVVYMLLVNLWCTVYLFVFKHIEGSFQIAASPFESSSEQANFMYFSYIT
MTSTGYGEIVPIHPFARSLVQIEVLTGVLYPVILIGRLVSDANFSLKK
>EGALAKHO_00913 hypothetical protein
MIAGKKGSVFTLIGLYILTIPFFNGLNVTTYDNSQILGHFGASTTVFTYSVYIPIFSMLA
FMPLGLKLGKQIKVRTLILSASFLSLLFNTASLFAPTIEWFTLCRALMAIVSVIGIFASM
VPILLKYNPVFNMALLYGILQFIQKGSQHLYQYIGAHFTSLHNWTFSVYFLNVNFLVCIL
LAWYFYKADVAPMKAVFQFDWRGWIIMMLFLMVILFLCAEGQTRNWFDDPKIGLATALLF
VLLGIYLLHTRFTENPIIDPDVYRYKNVVIGAFLMFYIGVINGTGSIVTGYMTNILGFDS
VLGAQTHLALLLGLCISIPLSTYLLYKRIYLATIWIIGFACYGLYHVILFLRFYPGIDSS
DFFLPLIFKGLGMGFLFPVSLLYISEGVPPKLSTSRMMSGIIAQAVFASLLGGAILGTFI
SNMNIQHKTGLSQQLTMTNKQAENQLASSKRNFLFMGLSDAEAQKKAEKSLSNQTAQTAM
LLAYKDIYLVMSAICFLPIFIILLFKLWRRPIGKVEAEPIPI
>EGALAKHO_00914 Multidrug export protein EmrA
MSEENAPNEEIQKKDKRRNTVLTVLSFVFLIAGALWILSLFFDFSNYETTNNAQVEAYIN
SVAARATGHIKEIRFEANQYVHKGDTLIILDDSEYIIKVKQAEADLAIAEGNLHSLVQTI
TTSASNQASGQEKLAGDLASLEKAQKDYQRFKNMYADSAVTRNQYDQVISKLKSEEAYVK
ASQKGLEASGSVTKQSNINLEAARATVARKKADLDAAKLQLSYTDIIAPSDGYVGERNLS
IGELINANQTIATIVLNQKLWVSANFKETQIEKIKQGQQVTITIDALDGKEFKGKVLGFS
PATGAKFSMVEPDNSTGNFVKITQRIPVKIEFEAAAKDLEEVKPGMNVTVEVKK
>EGALAKHO_00915 hypothetical protein
MNYWQLKDFRLVLFFALVCCVNVNFAQDSLGIAKKIKLDEAILLGIQNNKQLKIANTNLA
IANENVDQAKIAKMPRVGLSAGYTYIGDPKLYEGFYESNITVDYFNHMGFANIVSAVPIY
SGGSINNRIEQQKLLSQMQESVVKMTEADVKNAITEQYFTLEKLYRQIEVTKQNIINTDL
RISQLKSRVNNGQNLKSDLLRTELQQSNFKVSVFRSTNTIELISNYLDILIGFPTNTILK
PEVAESMIPTENINLQQSLTEAFQNREELKRAEIGIQLSESSLSLTKSGFLPNINANLIL
NTEYPAQWPSYVNILNYWAAGLSLSWDVSSFYTLKHRISGDKLEIDKSNIALAVTKDQIG
TEVKNAYVRYVESKENIKTFKKDVELSMSNYKIVKSRYDNDFALISEIVDAELQLNNSRI
ELVNANLDLIIQYYSLQYAMGKL
>EGALAKHO_00916 hypothetical protein
MKNRFLISILLFLTSYLQAQNYLGSGVEMGIFGPFSFEVSTAWATARTATPGYYSWTIAS
GNYTGADDRHHINGYVKKYGPEPFVFPVGSGTDLRTLEISAPSDPGDVYAVAWIIGNPTT
TQDPTNGNATHAVTAVSGTISAVSTIGQWDWQAVRGTGDGLIITVSIPQLFGAEFTDASK
LRLVGWNGSAWENLGTAGASGTAENSILSGIMKTGIQAIGIGALSTISADVDSDGDGLYD
SAEGLINDTDQDGIPDYLDADDDGDGILTIDENPDPNGNGIPDDAKDTDGNGIPDYLQPS
TGTSDDDLVVYNAVSPDDSNGLNDTFKIKNIENYPDNTVTIYDRWGNKVYETTHYNQNGN
VFTGEASGDTRYRNGVRLGQDTYFYTIEYRKDSNDPFRKKSGYLYLKRG
>EGALAKHO_00917 hypothetical protein
MKKTTKPVLWSVFVLLVFQITSAQIKIGNNPTVINSSAILEIESANKGFLLPRLQLTDSA
LPAPLLQHVAGMLVYNIANTNGLTSGFYYNDGTKWISISQSTATGLLSADNGLTNVSGVA
KLGGSLTQPTVLTTTTINTLAIQGLGMGNTAQGDFVLIDKSTGVLKTIPYSFIEEALNKK
IDSNTAIVAGTNTKITYDEKGLIIKGENAVIQDIPGLQTELDKKSTIDSPVFTGTPKTTP
VTATSSADAIANKGYVDGAIIDAKTSEVSQTITDGQTTTAPSENAVYDALTQKADKTYVD
TQDALKADKTYVDSQDLLKADKTYVDTQDALKADKTYVDSQDALKADKTYVDSQDLLKAD
KTYVDSQDLLKADKTYVDTQDALKADKTYVDTQDALKADKTYVDSQDALKADKTYVDTQN
ALKADKTYVDTQDALKADKTYVDTQDALKADKTYVDTQDALKADKTYVDSQDALKAEKTY
VDSQDILKADKTYVDTQDALKADITYVDSQDATKADRTFVIIQDALKADKTYVDSQDALK
ADKTYVDSQDLLKADKTYVDSQDALKADKTYVDSQDATKADRTFVIIQDALKADKTYVDS
QDALKADKTYVDSQDALKADKTYVDAQNAQKANITYVDAKVEDQIIDGEVTKAPSQNSVY
DALSTKIESNPVITGGSNTKITYDAKGLVTKGEIALITDIQGLQMELNRKAPTDSPLFTG
TPKTIPINITSSANSIVNKSYVDDLVSQSQSEVISQTITDGQTFTAPSENAVYDALALKA
PTESPTFTGLVRTVTPTATSDGKTITTKEYVDAKVGQVATDLISQTILLGDTTTAPSEDA
VRKELDLKAPINAPVFTGIAQVPDITTNSITDPLAITNKGYVDAQITTAGNIYTKDGTLA
DNRKVTLNGKNLDFVGSTINNPTRLSPDGNMTVGGNLNLNNKVTGSNVPVSALQFTNDVQ
GIGYASASIAAQTGGDQSKGQLSFKVKTATGVDTEAVRITDNGNVLIGANTDVTTAVLNV
QSTTKGVLMPRQTETQRTTIVAPAQGLQVYQTDNSGNSPEGQYLNTSTGWRRMLLEGEIK
QDYFEAINTSGVTISGTATVPVAVHITGVDTPTNAKNIQISDPATSTTARFDGVVIDIVP
AGAPCKVYLRHISVHNDTSALTQNAFIFLNTGGSFTNDPSSLPFGVDVGKVLNISPTDGA
ILYTVYTVTDFFRNQYERINGTTDETVFTGRIVSSLEPLDDTYLANKKYVDETVASLQQY
QGVWNAATNSPVLAGVGVAQKGWTYDVTVASGVAVNYPNMCTSVNILKGDVIKFDGSCWI
VLEKQYPSATTIQEGMVKLDDVISASTSLVPTSSLLKSVSDVNQSHIANTNNPHSVTKAQ
VGLANADNTSDANKPVSGPQQAALNLKVDKANGASQITDNNSYANIGTLAGATQDAINAG
INTRLGGQTQLNGTGLVRMAGTTVSYDNTTYAPLASPVFTGDALAVTPAFGDNDTSIATT
SFVNRSAIDLWSKTGNNIIDTDFIGTINNKDLVFKAFNIERMRLNQSLGQVEIGTGSSPT
SLRINTTTELSKNVPLKIITNETNPFIMSFEAFGTGSGTHYFDISSNVYDNTNFVYIPAN
ISMLSEGGILSIGKDDFTGLSERLEVNGNVRATGFKIPSGTSGQFLMADGSTSSGPVSNE
WSLNGNAITTSNFIGSTNNFDIVFKTNNRERWRMGSNTGRFYIGDLIDPNSAGSLYIVTE
GGTTNSIPLTITTSDLDNPLSMLFRTNISGSSKYFDISTYTGSSTASTPANLSLMAEGGI
LNLGFFDFTGLAEKLEVNGKVRATGFKTLSGTASQYLMADGSTSTGPVSNDWSLAGNAGT
VPGTSFIGTTDNKDLVFKANNIERMRMNNATGRLSVGNNTNSGSLLITAHTSDPMSPFSI
VTSGANPLVMTINDIGVAPNNFFSVDAFRVGSPNVPSNLSYLSSGGLFFIGYNDYSGLTE
KVEVNGSVRATGFKIPGGTSGQFLMADGSTSAGTALNQWSLNGNSISTTDFIGTINQADI
IFKGNNKERWRMGTDTGTLYVGDIVDPNSSGTLMVITNAVGDDSTPFIIKTADAASPLVM
SIQTITKLGERFFKMSTKGETSAPPVNLSLMPDGGVLNIGSDVFSGLTEKVEVNGRVRAT
GFKIPGGTGSQYLMADGTVSTATSGWSLTGNAGTNPLVNALGTTDLTDFIIKTNNAPRIL
VPAEGGLFVNRDELFGFQFYVSGVAGGTTDWAAASDRRLKTNIKPVEDGLSKVMQMKPVT
YDKKVSLESNDYNTSEIGFIAQDLKLLFPKGVVYEGKDKDKLLSVYYSALIPVLTDAIQE
QQKIIETEKARNDQQQKEIDDLKILVRQLLDKK
>EGALAKHO_00918 hypothetical protein
MFVNNSFSFGALVKFSGGYLLWIVVWSFLVLFSYEFLHLKWISIPWVSIGIIGTAVSFYI
GFKNNQSYDRIWEARKVWGTILNISRMWGVTTRGYIKNNLSDEKFSEEEINAITKKLIYR
NIAYVYAFRDQLLIPTSWEHITLGTHIAKRSRRSIEKVVEDTLEDGFTKEMLEKHLSRED
YEDLKKFRNISTHIIDQQSQDLMQLRQDGLINDFYHAQLQTLLNNLYDEQGKAERIKNFP
LPRLYAYASNLFVWIFIVLLPFGLIAEFDQIGPYNVWLFIPVVSIVSWIFLLMELVGDYS
ENPFGGLPNDIPMLSICRTIEIDLKQMMGEEDIPKTIHAQNGILL
>EGALAKHO_00919 Transcriptional regulatory protein CseB
MKYRHILVIDDDPEDIEIFSEAVNSFKEDITITASTDAFLALENLKKTEKLPDIIFLDLQ
MPRLTGKDFLEKIKEESNLQNIPVVVLSGQSDLIIKDTYHKIGASNYICKPNSYKELVDQ
LHHMLH
>EGALAKHO_00920 putative sensor histidine kinase pdtaS
MKQSFCFYLLVFISFQTFSQVPSSTANYDLAKKRLLIQFCTSFLYATNQGKISEDSATVL
AVKIYKLPLLLNYDEGFYDASDKAFLDGSALLEKGNLTAFNRILTRAKGTTKIKLLLQVG
NFYLFKPGTKPENLQNALYNINEALKISNELKIQKWQHQSMMLLGKYYAQAHNLDESKKC
FAKVVNECRKQNDPKALAEALANQAQFLPFFDPQKEIILNEVIKLYSTLGLQEKMIENHL
RLITIHYFSGNIKLALKEFYQSLYYQRKAGFKHIHFTEATISYIELLQNNSKSALYYALK
CIKTMETLNDYNFADDFYLRLGNVYLVLGHFEEAKATYEKSIEEGQKRSNNGGWYKSFVS
LVAAMSSKGKNKEAIDYINSITAKYPPPNLFDKMILANTKAVCYNELNNFVLAEKNFKEM
DNCAQQILAPETVIDILNLYSNMTAFYAYRYKVKEAKFYADKVSSIAQLYKQNFSSEKLE
LSLSKIDSLDGNYLSALKHHQDYKKLSDNLVNFSKNKEIEELKIQYETQNKEKEIKLLSN
QSELQKSELRKSQLLNYLAIGSSVLFLITIALLYNRYRLKQRNHAKLEQKEREIHKKNIN
LKHLLDEKEWLLKEIHHRVKNNLQTVISLLNSQSAYLDNDMALSAIKNSQHRIHSMSLIH
QKLYNSENISTINMPNYIKELVEYLKESFNTGQRIRFEIKVAPLELDVAQAVPLGLILNE
SITNSIKYAFPDDRTGMINVTLEKVNDSYYLLTISDNGIGYDTNVSCERKNSFGMSLIKG
LSDDLEGKLSIENQNGTIIKIEFLAEFLIDKNR
>EGALAKHO_00921 Soluble epoxide hydrolase
MKTIIKNSAMLIAALLVGTTSPAQNKSVKAANPPANFKHATVNVNNVDIHYVIGGKGEPL
VLIHGFGQNWYMWNRLLPELSKHFTVIAPDLRGVGESGKPESGYDKKTMATDIHELVKKL
GYKNVNVAGHDIGLMVAYAYAAQYPTEVKKLALMDALLPGIEPVWSQVSASAWWFGFFSW
PSSGDIVAGKEKEFLTGFWPVVANKKDSFTKEETAEFIRAYSVKGATTGSFKWFGAFQQD
GKDNVEFMKTKLTMPVLTMGGQYFAAAFLKDHTKLVANDVRETNIPNSGHWIVQENTEAV
QKGLLDFFLETK
>EGALAKHO_00922 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKNENRTWFITGTSQGIGLVLVKQLLAQGFNVVATARNVESLKEAVGFTTAQFLPLQVNL
IDEESVKEAVKTAISKFGAIDYLVNNAGYGLIGGIEESSDAEVRANFDVNVFGLLNVTRA
ILPHMRAAKFGHVINLSSVFGLLAGAGWGIYCSTKFAVEAISEALSQEVKSFGINVTIIE
PGYVRTNFLNSSSLIAPTSPIEAYTDIREGVRKHQQDLPGNQLGDPEKVAALIIKLSQNP
EPPLRMLTGSDAYQFANYKIDALKTEIENNKELTFSTDFSA
>EGALAKHO_00923 Peptidoglycan deacetylase
MKDRRTFLKQASLVGLAGLLPTNTLLASDLEPNTLANKEDSITKWADGSRLVVSLSMQFE
AGGQPVNAESPFPQNMQKGFTDLPGETWYQYGYKEGIPRMLDNWDKFGVKVTSHMVGSAV
LKNPDLAKEIVERGHEAAAHGMDWTTQYSMPYETEKQFIKDGADAIKKVTGFQPVGYNAN
WLRRGTNTLEILQELGFKYHIDDLSRDESFLLKVKGKDFAVVPYTIRCNDIVLIEGKNFS
ADQFVRQVILEFDQLYKESEKKRRQMSISFHDRIGGTPQMVAATTEILSYIQKHKGVSFK
RKDEIAQMAYEDKNIIRE
>EGALAKHO_00924 hypothetical protein
MKKIFLILAILLLNFSVQAQVYTDEEIQTKQTAEKFFGYIGAKDPEKIASMVSENVDWYI
FESKYMPWTGHRSKRAEISELFKTLFSYFVDGSEKLDAQSFLVRGNEVAVFGFVERTVKK
NGKHFKMPLAIHLTIENNLISKFSLYEETLIIEKVLK
>EGALAKHO_00925 hypothetical protein
MKTQKIISAFAVALLLLISINAHAQFPMPDHVPIWDANKVTLKLHKISENVYSVAPETAE
TETSKGIAQATSAGFIVGDKGVLLIETMLCKRLYDQLYKLIRSVTDKPIIYAINTSDHGD
HCFGNYLLPKETIVIQNEFCKDNLSKNYDNIKGFMIMLFGKGRGIEESVYRPADITISIN
ETMKIDMGKGNIVEVINVGTAQSPADLFVYLKGPKGNVLWAGNPFIAESPTIPWLFDGYF
LEPVNNLNKIYNMIGDNDIVVPGHGRVTNKAGIKYTIDYVEALKTNVENAVKKGLTLEET
KKAVTMKEYDKGYELFNWLHFNFNIPNAYKDIKENGSKK
>EGALAKHO_00926 N-substituted formamide deformylase
MKRIFVLLLFFFGLLVQAQEKADLIIFNGKIATMQKSGEFVQAIASKSGIILATGTSKEI
LGNYKIATTQIIDAKGKTVVPGLNDSHMHVIREGLNYNSELRWDGVKTLKRAMEMLKEQA
ARTPPGVWIKVIGGWNEYGFEEKRQPTIEEINAAVPDKPVFITYLYGKAFLNKKGIEVLG
YTKDTHYEGSVLEQDKNGNLTGLMFAKETPKAIYTTLGLTTKLSPEERINSSLQFNRELN
RFGLTSVIDAAGGSQNFPTDYGTSMELAKTGKLNLRISYYLFAQQKGKELQDYEKWVATT
LINKNDNLLVANGYTEEGAGENIVASAADFENFLEPRIVLSDDMEKDLEPIIRLLVKNRW
PFRLHATYGESIDRMLNVFEKVNKEIPFNGLRWFFDHAETITPQELERVKALNGGIAVQF
RMYFQGELYEKMYGAPKTQLPPIKEMLKMGIPVGMGTDATRISTYNPWMAMHWLLTGKTL
GGMQFWPKDQILDKFTALQLYTSGSAWFSGEENEKGKLIKGMYADMTILSDDYFAIPADK
VRNIESDLTIVNGKVVYGSRDFKALDPGIATVIPEWSPIKYFGGYTK
>EGALAKHO_00927 Soluble epoxide hydrolase
MKSISNQNARSKNTRAFLGLLVISFFMLVSCNKKAEPIAVDDAKVTTDSATVKPADPPAN
FKHATAFVNGVNIHYVIGGKGDPLVLVHGFGQNWYMWNRLLPELSKHFTVIAPDLRGVGE
SDKPESGYDKKTMATDIHELVKKLGYTNINLAGHDIGLMVAYAYAAQYGSEVKKLALMDA
LLPGIEPVWSQVSASAWWFGFFAWPASGDIVKGKEKEFLVNFWPMVGHVKDPFTPEETAE
FVRAYAVKDGAKSTFKWFGAFPQDGKDNLVFAKTKLKMPLLAMGGEYFAAAFLKEHSKLV
AENVSESKIAGSGHWLVQENTAQVQKDLLAFFLAK
>EGALAKHO_00928 hypothetical protein
MQTENPKTILFITGAFVSNESWNDWRDFYESKGYKTIAPPWPHKNDTAEKLRQRHPDPEI
ASIRLQQLINYFEEIAASFSEKPIIIGHSLGGLIAQILNQKGSAAAVVAIHSVPPQGIMS
FKFSFLKAGWGPLGFFTSAKKTFLMSFPQWQYAFTNGLSFELQKKGYEELAIPESKLVVR
DTITAVAKVDFSKPHRPILFIAGEADHTIPYQLNQENFKKYTDKNSVTDYKLFSGRNHFV
LGQPGWQEIAIYISEWLEKNIEHRI
>EGALAKHO_00929 hypothetical protein
MSYSFKKMAFKTNLFRINKNNANVKINISKTILFGKENQS
>EGALAKHO_00930 Phosphocholine transferase AnkX
MKKKLFISIALLAALFSNAQQKNTLLEASFWKTTPNVETVKAEIAKGNSPSQANPNAFDV
VVLAINNDAPNETIKFLLDQSGNPVTKSTHDNRIYLHWAAYKGNVEMVEYLIKKGSDINL
EDSHGATPADFAASSGQLNPALYEAFFKAGLDPKKKYNDGANLLLLAIAYDKNLTAADYF
TTKGLSLKDVDNNGNTAFNYAARVGNIELLKKIAAKGVKYNDNALFFAAQGNRRETTSLE
AYKYLVEELKLKPTAVNKSGENVLHLLATKPNQKEIINYFLAKGADANKVNKDGNTPLMI
AAGARENGALELLLPAAKDINLKNLKGESALTIAVKSGTPENVGLLLNKGADVNVSDKGG
NNLGVYLIQSYRPESSKGQDPFEAKIKLLQDKGLNLAAAQKDGSTLYHLAVVKNDLTLVK
KLAPLNIDVNAKNKDSMTALHKAAMISKNDEILKYLISIGAKKDIKTEFDESAYALAKEN
ESLTNQNISIEFLK
>EGALAKHO_00931 hypothetical protein
MKSIFKVALTAALICFVSFQSVAQSKYKCMLQMNNYMGEGAYIVVSLINSKGEYEKTLYV
MGDDKKWYKSLKEWNKFQTQKHEDISAISGASVTGGDRSITTFEIDDSKLNKGYKLRFES
AVEDQKYHVTDAEIPLTTAGLADKTDGKGYIKYVRLNKI
>EGALAKHO_00932 Bifunctional cytochrome P450/NADPH--P450 reductase 1
MTLSFWRSSHLALALVSSLFLILASVTGIILAVDAVQEKTLPYKIENFDKITLGETLPVL
KKNYSEMTELTVDYNQFVTLQAIDQDGNDINAYVDVKTGKKIGTPVKKTEFIQWITSFHR
SLFLHEAGRFFVGVISFLLFLIAISGFVLVLKRQKGIRNFFSKVIKEYFAQYYHVVLGRL
ALIPILVIALTGTYLSLERFNFFMDKKEQKDKTETVFPAKKGTAVNIFKTTLLADVKKIE
FPFTDDPEEYYIIELKDREIEVNQVTGEVISEKKSPMTAQFADLSLDLHTGRINAIWALV
LALAAANILFFIYSGFAMTLKRRSSRIKNKFKANESKYILLAGSENGSSLRFANAIQKQL
NAAGEKAFLTELNSYTVFPKAEHIIIFSSTHGLGDAPSNGKKFISLLKKHNQQQKINFSV
VGFGSTAYPDFCGFAREIDGLLEEQNWAERFLDLQTVNDKSAVEFVEWIKLWSAKSGIPL
STTPSLYNHAPKGLQKLMVLDKTAISEEEHTFIITLRANMRAKFTSGDLLAIYPANDTRE
RLYSIGNHSGNIQLVVKLHPNGLGSGFLNELKPGNVIKARIINNHAFHLPKKASKVAFIS
NGTGIAPFLGMIEQNKKKTEIHLYAGFRMETETVTGYKTFASQMMQKQHLQSFHLALSRE
ENHYYVMDLIKRDADFFIDLLANSGVIMICGSLAMQKDVEATLEALLVEKNKQLSDYKNK
GQVLTDCY
>EGALAKHO_00933 FAD:protein FMN transferase
MPIKYKSLFNSFLFLLVLVCSFNAEAQTLRKRTTMLMGGRFDISIVANDSLTAEKSIDEI
IAEITRIENLISDWKPTSQVSEVNQNAGIRPVKVDKEVFELTQRALHFSEITNGAFDISF
AAMDRIWKFDGSMTEMPSAEAIKKSVEKVGYKNIILDSIQSTIFLKLKGMKIGFGALGEG
YATNKCKDLMLAKGIKAGIVNATGDMTVWGKQPNGKDWNIGMTNPFNTDKLFAVVPLHEG
AVTTSGSYEKYVVLDGKRYSHIINPSTGYPSTGLCSVSVFGPNAETANGFSTSIMVLGKE
AGIKLINQYPEYRWIMITDKGKIIKSKNFNKTKFHLKN
>EGALAKHO_00934 Regulatory protein PchR
MTTDILEVNDFIVLIEQSYATKTVVEKCEIDGDSIGFAFYGSGNVELEIKHNNQTKYLTN
TTGLAICFFGNQKVEFAHKIEPDKPLQSISIFAKLKYINSLPKAEKEIFENHLSDLMHPK
EHFVKGPAFYMTLDMQQAVQKIFNTSYTGTTRLLFLKSQVNELLAHFFALLTTEKKGDLS
EYDKNKLFHAKEIVTTHYSKPPSITELSKMVGLNSNKLKKNFKELFGIPVFKYIQEERLH
KAYELLRDSEKTVQESAWEVGYESLSSFSNAFYTKFGTRPNDVKQQFFSNKS
>EGALAKHO_00935 NAD(P)H azoreductase
MKTTKILVLGANGKTGRRVLERLENNTDVEVRAGSRSAAIPFDWEKPETWQAALKDIDTV
YISYQPDLAIPSATTAIQLFSGLATQMGVQKMVLLSGRGEKEAQVCEEIVKTNAKKWTIV
RASWFNQNFSESFFLEPILAGYVALPRAEALEPFTDADDIADVIVTSLLNEKHNGQTYEL
TGPRLLTFKEVIAEIAKASGREIIFQDLALEEYIQILREYQVPEDHIWLVNYLFEQVLDG
RNSSITNDIEKVLGRKAKDFSAYALETAKTGVWNQTVSQN
>EGALAKHO_00936 hypothetical protein
MLFWRGMLSGLFVWICVSLSFYVLGSIPVIKDYFFAQAFIVMICISFYAFLAAQFYYKKG
YQTNGMIVGILLSGIALLLDIFITVPLI
>EGALAKHO_00937 hypothetical protein
MAVPKELYNAKFAEYIESLKILYLVDDKFKMICDDYCTSRLKADKFKKKFEKYFQHKLEC
ENLSKELEDEILIYLIRKG
>EGALAKHO_00938 hypothetical protein
MNISNHKSNVEDSSRTSAKKTGIKSTSARSNEKSHIETRKSVQMNK
>EGALAKHO_00939 hypothetical protein
MPKEINEDFGLDDRNFHPEEQLIHSVSKKKRNKRLKQDIEPELDKDLDATMDAELKNYSD
EDFDKKDKSDS
>EGALAKHO_00940 Trans-aconitate 2-methyltransferase
MPLQPENKLNRILSELVDEEPFRSYLKGYNRDSPVLSIDDYAQIFFDGGLQDLQLQQKVY
PIIANDHETLYNFISGSALIPYIERLEGDYEELFIKIFKERIAIHFPKLPAIYSFKRLLL
YGKKE
>EGALAKHO_00941 putative trans-aconitate 2-methyltransferase
MPWNPEIYNKFKNIRYQPFYDLIDFIQPMEEMKAIDLGCGTGEQTAILANKFPGANFLGV
DSSEEMLEKSKSLETDNLHFRKATNEETINSGKKWDLIF
>EGALAKHO_00942 Inner membrane transport protein YdhC
MRNLQVNRKGFSTILALALIPLSGFATDIYLPSLPAIAKDLNVSAGAIQLSLVFFMFSLG
VSQIFIGSILDSFGRFKISIASLAVFSVTSFIIAFVPNIYVIYAMRIIQGIAIAFIVVSK
RAYFVDLYSGDKLKSYISLFSIIWACAPIMAPFLGGYLQSLFGWRSNFYFLGGLSLLFLI
LELLYSGESLKYFHPFKLKSIAETYSGMLKTADFTLGIIVLGICFGLVVIYNLVSPFIIE
RVFGYSAITTGYSSLLSGLSVMTGGIVAKSLIHKPLVKKVTIAVSVQFTLVLLMIFTSQF
VSNIYTVIGFTMGLNVCGGFIFNIIYGYCLSRFSKNAGIASGLTGGATYMVSSVFSYGFV
NLYAVKSQLLLGMANLSLILIISLIFIAFNRYRALHIATE
>EGALAKHO_00943 HTH-type transcriptional regulator TtgR
MSKAERTRQFIIETSAPLINKKGMAGTSLSDIMEATKLAKGGIYGNFENKEEICMESFLY
LRSQLASKLDVGVSKGKSAKEKLFNLLDVYSNDKNMVEGCPILNFGTEADDTNPVMKEQV
KKAILSAQKRFFNIVEDGIKNKELSSEINPGHFSVKAFAIIEGAILYRKIFGNNDQMNIV
IESIKYEFEKYVL
>EGALAKHO_00944 Putative monooxygenase
MWYNTKATELLGIQYPILQGPFGGNLSSVELTAAVSNAGGLGGYGAYTMSPQEIFEVDKQ
IKAATDKPYNINLWVSDHDIAEGGLTDEQFNKAKELYKPYFDEVGIPLPEKPASFQSRFE
NQLQVILDVRPKVFSFMFGALSSDVLEQCRKLGIVTVGAATTVDEAVFLENSGVDMIIAS
GFEAGGHRPSFLASAESSVTGTFVLLQLIREKVKIPVIAAGGIANGKGVAAALTLGADAA
QIGTAFLVVDESNALPIHKEMLFSDAAKYTTLSRAYTGRLGRGITSRIAKEVIGKEADIL
PFPLQTTLMSPLRKAAIDQQKWNMILFWGGQIAPILKHTKANDLMRSLIKETTAYFDNLK
A
>EGALAKHO_00945 hypothetical protein
MKLQKLKLSVSKIILLIAFMFYNVQSMKAQNNSTMENHNLDTEAITAAIENFYFKGIYEG
DEMLLGSIFEPGTLVYGDVKGQPYFKTVDMYLDGVKNRQSPKDSGTPYKGEILNIKVVNS
IAIAEINLKMYEFNYRDFLSFHKVNGKWLIVNKMLTDVSE
>EGALAKHO_00946 General stress protein 18
MKNIIKSVFIALFAISSFASVAQENKKTKVLFVLTSHNKLGDTGELTGSWIEEFATPYFY
FLDKGIEVVIATPNGGQAPIDPKSNDPSFQTPATKRFYADQKAQNALASTLKITSVKQKD
FKAVFYPGGHGPMWDLATDKNSIQLIQDFYNNSKPIAFVCHAPAALVNVKDKDGKYLIAG
KKVTGFTNTEEAAVGLTKVVPFLLEDKLKERGGKYSQGSDWGSYVVEDGLLLTGQNPQSS
EEVATKLLSKIK
>EGALAKHO_00947 Dihydroanticapsin 7-dehydrogenase
MKKQTIIVTGAASGIGKGIAKYFLDRGDNVVINSFTESSLEKAYNEFGAGDNLAMFAGDV
SNKQTGEQLVKIALEKFGSVDVLVNNAGIFDSKPFLEVDEAYLDKFLTTNLKGTYFTTQA
AVPQMLEQKSGVVINIGTPLVNHGLGGWPASAPVASKGAIHALTVQLAAEFGKRNIRFNT
VAPGVIRTPMHGDKADQSAGLHLLNRVGEIDDVAEMVYTVAKSNFITGAIINVDGGKAAG
HNLN
>EGALAKHO_00948 putative tautomerase
MPYVKIELTREGVTREQKQKLISGITNLIVEVLNKDPHLTHVAIQEIELDNWGYAGEQVS
VLREKGITADKK
>EGALAKHO_00949 Protein YceI
METTNFKIVSSNSNVEWTGRKVTGAHNGTIGIKDGLFTLVGGKIKEGYVIINTSSIKILD
ITDPATNQQFAGHLASDDFFSIEKFPTASFDILNVKELSNHTYYLEGNLTIKDISQIVGF
EVTAEHNKNTMILSGKLVIDRTQFNIKFRSGNFFKDLGDTLIYNDFELDFNITAEAIFTE
QSKN
>EGALAKHO_00950 hypothetical protein
MEAKELLQQHIAKTVSLTDEDFSYIFSHFKPQSFKKGQVIISEGDKVDCEYFVITGCLKA
FFINDEIKMYILQFAMPTWWASDYAALYNNTPATISVDCITDAEVLCLSNSDREKLCNEF
HQVEHFFRRRTNKGYIASQKRLLSFMNNNVKKRYEELLSLYPQLYNLVPKHLIAAYLGVS
RETLSRLHSSKKEM
>EGALAKHO_00951 Putative 3-methyladenine DNA glycosylase
MKLQSSYYLNQDVLFLAKDLLGKVLFTQKEGQITAGIIVETEAYFGEIDKASHAYGGRRT
NRTEIMYSEGGVSYVYLCYGIHHLFNVVTSVKGEPHAVLIRAIEPIIGTEIMELRRNMSS
SKSAISSGPGSAAKALGIDNSFNHKDLGGEEIWLEDHGIKYPDDQIVASPRVGVAYAEED
AFLPWRFFVKGNKYVSKPNKI
>EGALAKHO_00952 hypothetical protein
MNAKTTKIIYWTGVILTSLWFGASGFFELTTNPIVWGITQQLGYPEHFIYLLGVLKVSGV
IVLLIPNKLLRLKEWDLRVFFSTSPSPSFQKWLF
>EGALAKHO_00953 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MNKVWFITGSSRGLGRNLTEAVLESGDKVVATARDINQLNDLKDRFKDQIFPLALDVTNY
EQVYSAVKTAAEHFGRIDVLVNNAGFGIIGAAEAYTDEQVRSQLETNLYAPIEITRAVLP
YMRKQGSGRILQISSIGGRVGNPGLTMYQAAKFGLSGFTEALAKEVAPLGILVTSVEPGG
FRTDWAGASMSYAAEIEGYEMVKQRTDFFKGGKFVAVGDPEKAAKVMVDLASHPNPPVHL
VLGSEAIGILKNADQSRTEEMEKWIDVSLSTDHDDAGSFFDTAQGKWYTNNGKKQ
>EGALAKHO_00954 Exoenzyme S synthesis regulatory protein ExsA
MNDSKINQKTSPIAYSCYYTQNREGEQFAAEHVLSFQISGILTLNNGNQEYVFKPGDFRF
IRRNQLIKFNKQPDPNTAFQSISIYLNQEALRDFSIKHNQKTSLIKSPETETVFQLKEVP
LLKSLMNSLIPYINEDQLITEELQALKVNEAINILLQCKPELKDILFDFNEPGKIDLEAF
MKKNFHFNVQLDRFAYLTGRSLATFKRDFQRIFDISPSRWLLQKRLQQAYYLIKEKGKTP
SEVYLEVGFEDLSHFSFAFKKQYGLSPSKIL
>EGALAKHO_00955 Sensory transduction protein LytR
MTIIIIEDEVKTAKALGQLILSIRPDTQILAYIQSIDGAVSYLSENDQPDLIFMDIQLAD
GLCFEIFKNVEVLSPVIFCTAFDDYAIEAFKSNGIDYVLKPFSRESIAQAITKAAELKNF
FQRNKKMIPDFDYLLTRTGENKGKSSFLVFKNNKYQTVLTENIALFCIKNETPTIITFDK
TEYQITQSLDEIHKLLSPIQFFRINRQYLINFSAIREAEHYFSRKLILKLTIPTEEKLLV
GKEKATAFLSWLENR
>EGALAKHO_00956 Sensor histidine kinase YehU
MEKVKRFQVSQRIIWGSSIALAILASIPKLFDAMSTFRDLVINSSITLLFSIFIWYYNIY
SLPKFSAQRTNRGLFNWKLLLSVILGILVMVILVIAHQELFQVSKMDAPIMFELRGILIN
LIVYMFLHLLFQNYQTQQIGTELERTHAVNLGAQYELLKQQVNPHFLFNSLNTLKSMVDI
QDPQSSDFILKLSDFYRFTLESRKLDLISIREELEILDSYVYLLKARFEDGFVLINEVDQ
KQYDSAVPPFTLQLLIENCIKHNVVSLDKPLRIKLYSENDFLVIENPIQLKRGVLSTGVG
LDNINQRFMHLIHKEIEIDKTETIFKVKIPMIYDYHNN
>EGALAKHO_00957 hypothetical protein
MKKIKLIPAFFITMMLLIGITVLGQTTEKKAVKGFALLELYTSEGCSSCPPADELMGKIQ
NEYKDQNLYVLAYHVDYWDKQGWKDIFSKAEYTKRQYDYAKFMEKDPIYTPQLIINGKID
YIASQETAVRNGIKNALAKPEVAELSIQANQLDGKLNLNYNTAKVSKNSRLFVAVVQKSA
KSNVKRGENAHRILSHYQIVRSLSNFSLSGNLKGIVSIAIPKDFNSKDYEVIGFIQDMNS
GNILVVDRAIFASSSL
>EGALAKHO_00958 Organic hydroperoxide resistance protein OhrB
METKILYTGKTHTTGGREGASQSSDDQLNIKLSSPGSSRPGTNPEQLFAAGWSACFIGAM
GIAASKLNIKLPVDTAVDAEVDLAVTEGAYSLQARLNISLPGLDAETAGKLADEAHQTCP
YSKATRGNIKVEINIL
>EGALAKHO_00959 Epoxide hydrolase B
MKTISKITKVFLIAVLFFAITIVNAQSENQKTNAFAVSSSLGTLKQINAGLLSVGYTEAG
PSKGTPVIILHGWPYDIHSYNEVVPILVAKGYRVITPYLRGSGTTTFLSKDTFRNGQQAA
LATDIIALMDALKIDKAVIGGFDWGARTAVVMAALWPERLQGLVSVSGYLVVNLEANLKP
LPPKAELGWWYQYYFATERGKLGYTQNTYEFNKQIWQIASPLWKFDKATYDQTAQSFDNP
DHVAIVIHNYRWRQSLEAGESKYDSLEKRLAARPAIKVPTITIGSDFDGAFADGKVYRDK
FTGKYEHRVLKGIGHNVPQEDPKAFAQAIIDVANGKL
>EGALAKHO_00960 hypothetical protein
MEPKKNKTWVIIAIIILGIIAFLIPNQIAAQTGIKRTNLQQHDLSVAGRETVQARIDFDA
HSAFGKHIHPGEEIIYVLEGSLEYQINDDKPVTLKAGEVLFIPAGVVHSARNNSNAKASE
LATYIVEKGKPILVLKK
>EGALAKHO_00961 Soluble epoxide hydrolase
MKTIQKNKRGFLNAIATGAFILIAATSFGQKTQTKKAKDSEAIRPYHISVNQEAITDLKN
RVNATRWPQQETVTDQSQGVKLAQIQKLIKYWGTDYDWHKAEAKLNALPQFVTNIDGLDI
QFIHIKSKHKNALPLIITHGWPGSVFELLKVVGPLTDPTTYGGKTEDAFDLVIPSMPGYG
FSEKPKGTGWGPEKIGTAWDVLMKRLGYKHYVSQGGDWGSVIADAMARQAPEGLLGIHVN
MPATVPADVAKALKDGDPAPAGLSVKEKAAFASLNKLYTKGGGYAGMMVTRPQTLGYGLT
DSPVGLASFFLDKFNEWTYSGGDAEKSLTKDEMLDDISLYWLTNTANSSANLYWENNTNN
FNVVEQRTTEIKIPVAVTVFPGEIYQAPKNWTEKAYKNLIYFNEVNKGGHFASWEEPQLF
AEEMRAAFKSVRK
>EGALAKHO_00962 Acetoacetyl-CoA reductase
MDNLKNKVAVITGGNSGIGYATAKQLKEQGATVIITGRRKEAIEKAASELGVHAIVADQS
RVSDIENLASKVKEDFGQVDILFINAGITTKGTIEEATEELFDSVMNINFKGAYFTLSRF
ISILKDGASVVFLSSNTASMSYAGTSIYSSSKAGLNSIVKIAALELAPRKIRVNSISPGP
TETEIMKKIGLDEDGVKSLMNAIVDAIPLKQMGTSEDVAKMVSHLSSEASKFITGADFIM
DGGMVLA
>EGALAKHO_00963 putative HTH-type transcriptional regulator YybR
MARNQKEEFQALQDTLYVLGGKWKLPIINSICNGNTRFKEIQQSIPGITSRMLSKELKDM
ELNNLVKRTEDRDAKVPILYESTEYCQSFGPIIAEMINWGISHRNHIKNRQKTI
>EGALAKHO_00964 hypothetical protein
MMKVFLLMNVILLSCSVGLAQTSKALKPQQIPGKIECELYDQGGEGIAYHDTDAVNNGSG
KLNPVNGNPLNEFRINEGVDISYSKADDIDNNPFNKVPRSIGDLYVGWTVPTEWINYTVE
VKKSGTYKIGLLYTANGDGEIAIDVNGKDATGKMKITSTHDDKDPIDWRQWHHWNSSESI
GTIKLKKGKQVLRLHIVSNGNMNFDYLTFTAQ
>EGALAKHO_00965 HTH-type transcriptional regulator TtgR
MSKAERTKQFIIEKTAPIFNTKGYSGTSMSDITEATGLTKGSIYGNFENKDEVALAAFKY
NIKKLQDAFGSEIEKQKTFKNKLLVYPRLYSHYYDLRVTKGGCPILNTASEADDTHPVLR
KSVERVILFWKEKIMYFIEQGILEGEFKAKSIDIERTALTIIALIEGAVMIAKVTGNVKD
LSTVMLSVTQIIEELE
>EGALAKHO_00966 hypothetical protein
MTRLQVLQNHIDREFTASPSPFMLWMRPIVLAAEDGSVTFQYLVREEMSNPVKSLHGGVI
AAIADDCIGATMFSLNEENFYTTINLNVDYFAPARVGDTIIARTSIIKKGRQFVNAQCEI
WNEAQTRLIATAYSNLFKTNLVKQELSI
>EGALAKHO_00967 Multidrug export protein EmrB
MTDLQRKLLIFTVILAAIMELIDISIVNVALSHMSGNLGATLEDTSWVITAYAIANVIII
PITSFLSANLGRRNYYIGSIILFTFCSFMCGHSSNIWMLVFFRFLQGIGGGALLSISQVV
VFELFPKDKQSTAGALFGAGIFIGPTIGPTLGGYITENYDWPWIFLINIPIGILVAISCY
FLLKEPPIKPEISKVDWTGIALLAIGVGALQTVLERGQVEDWFETRYIVVLTAIATITLL
AFIYWELKIDKPVVNLRVLKSKSLSIAAILTFVTGFGMFISIYISPVVAQRLLSFSPYQT
GLLLLPGALFALVALKICGTLLQKGVSPVLIIATGFLLFIYFNWRMSEISLDTSAFEVAT
ALIFRALGLALLTVPLTMLAVSSLDDKDVGQGAALNNMMRQLGGSFGVSIINTYIAHRYA
AHRNVLISNVTPDNAKAMDRINAYIIYFQHRGFAYNEARAKALKLMENIVTKQSSLLSYR
DAFFLVGLFFALTLPLLLLVMNKSKKPKTNIILSDH
>EGALAKHO_00968 HTH-type transcriptional repressor ComR
MAKGEETRQFIIDKAAPIFNTKGIAATSMSDIMEATKLSKGSMYVHFENKEVLACAAVDH
NMKVLGDKLMAKISQSKTAKEELFTYIDFFSNAVNPPLTGGCPLLNFGTEADDTNPVVKE
KINQGIKYNQQLLENSIKKGIVNGEFNPNWNAADFATVIFAMMEGGHLISRMSGSNDKMQ
IIVKTLKKTIEENSL
>EGALAKHO_00969 hypothetical protein
MSFVRLQSLCFYVFNFLFISIVTLLPIDLSTLAPQNLRIFKKVTERSFFKQKKLEAVFLY
RFFEGFYYDLHLIVAA
>EGALAKHO_00970 Putative oxidoreductase SadH
MKTILISGASKGFGRAWAEAFLAKGYKVAATARNIDTLADLKAQYGDAILPLKLDVNNRA
ESLAVVEKVHQHFGAIDILINNAGYALNGAVEEASEQEARAQFETNFFGTLWLTQAVLPI
MRKQQSGHIIQVSSILGITTLPNLGLYNASKFAVEGLTETLAQEVKQFGINVTLVEPNGY
FTDIWGNGFNSESIDAYDGLKKAIAEGHDPDTFGQTSATVPAIIKLVEAENPPLRLFLGK
VALPFAKQAYEQKLATWEEWNEVSVAAHG
>EGALAKHO_00971 hypothetical protein
MPLSSTFHFLFSIFYILYSIFYILYSCLLLVDSFFYFPFSIFYFLVSCFLHLASFFYFPF
SILYFLYSCLLSLASCLFLLFSIFYSLCSIFYVLASCLLPLASKNLPKQPPLHLPSQILH
NPHLKFLTNLNILTLFPIINQSKPLLPLNYSNFIQTSVKSLIKTNH
>EGALAKHO_00972 Circadian clock protein kinase KaiC
MQKKTKSHSFIFPKTPTGVDGLDEITDGGFPKGRPTLICGGAGCGKTLLSMQFLIKGITD
YNEPGVFMSFEEPSDDLTLNVKSLGFDLEKLKADKKLVVDHVRVERSEIEEAGEYDLDGL
FIRLGYAIDSVKATRVVLDTIESLFAGLDNQAILRAELRRLFHWLKAKGVTAIITGERGE
ATLTRQGLEEYVSDCVIVLDHRVIEQVSTRRLRIVKYRGSTHGTNEYPFLIDEEGISVLP
ITSLKLDNEVSSDVVSTGVPGLNDMFHGGGFFRGSNILVSGTAGTAKTTVACYFANEQCE
KGEKTIYFAFEESPQQLVRNMRSIGIDLQKHIKKGTLQIHSSRPSLNGLELHLLTLRKLI
KEFEPTTIIIDPISNLITVGSEHEVRSMLVRLIDMLKAHNITALFTSLNKQTDNFRPDLA
EESVSSLVDTWITVRDMEGIGERNRGIFIIKARGMGHSNQVREFVITSKGIELLDVELGP
NGILTGTARQTQKFKKTISDIKLQNEISRKDREIERKRRVLEANIEALRNEFESAQEELS
SLKATEELQASFSKKK
>EGALAKHO_00973 Circadian clock protein KaiB
MKKEVVAEWQLLLYIAGQTPKSIKALENIKKYAEEHLAGKYSIEIIDLLKNPQLAEGDQI
LAVPTLVRKFPEPIRKIIGDLSNEERVLVGLNIKPLNT
>EGALAKHO_00974 Circadian clock protein KaiB
MDNSADGASTTKHKFMLFVSGMSVKSGHAIENLRKICDKHLRENYELEIIDISRDTEQAV
IHQIVAIPTLIKIQPAPRRIILGDLSDKEKVLRVLNLSE
>EGALAKHO_00975 Phytochrome-like protein cph1
MIVNDKNIDSLLAEIESLKQQLYESNSIIDAIKEGDVDALVVNTNGTPQLYSLETADYTY
RLLIEKFRQGALSIAKNGLILYCNDYFAKLVNTPSEKIIGNYLQEFFDNPSQFATLIEGL
KLGLGTHEILFKSDGGSPTTFPAYISLTDLEPSVDAIGIVVIDLTEKKKHEEALIQHQAE
LEGKINELNRINSSLEEFIHVISHDLKEPLRKIVMHNGKIDGTYLTEIDAKSMNIIKFSV
LRLNSLVDDLVQYSSHTKQEERGEVNLAAVITEVIEDLEVIITDKNAKIKTGNLPVIKAS
RVQMRQLFANLISNAIKYSKTNIPPVIQILEADATDVEVPQQNTKFVKIQIKDNGIGMES
SHLLKIFTIFQRLHARNEYSGNGIGLAICKRIMENHSGNITVESTLNEGTTFNLYFPIV
>EGALAKHO_00976 Transcriptional regulatory protein DesR
MPQKNLHIIIAEDDEDDADVISEIFNNNPSFAKVSLVANGEELLHFLKNAANENPDVILT
DINMPILNGIEALQEILNHNDLKNIPCFVYSTSINPSYKQKCDVLGVKGYLIKPYSYEAF
AEIPKTILSSIEE
>EGALAKHO_00977 RNA polymerase-associated protein RapA
MIIDNENQKLKVHEWITKYNEEGTLDIVTGYFTIGALAYLSKCTNDKIENYRFVLGDIVN
FDKKIKALDLLNESIGIETSFKLNSLAKKAVKFLKLDKVVTKTLEPNFCHAKLYLKTALN
DDRNHYFISGSSNLTEAGIGQKTTSNVELNIAETGNNNQYKELVDWFNDLWNRPQAHSKK
TLIDENGKLSKKDFKEYLIEEISKLFEIYTPEQIYYKILFELFHKEQDNAEVEKQLIKLE
DTIVYNKLYDFQKGGVNSLIRMLNKYNGAILADAVGLGKTWSALAVMKSFQHKADVLLLC
PKKLEQNWKQYIKKHNSIFEEDKLDFDVKFHTDLRNGGFNDNFLQYLLNDKSKLLVIDES
HNLRNDKSSRYKYLIEEILQQSKGDIKILLLSATPINNSFKDIRNQFKLLTKGENTGFKE
SLDVNNIESTFREIQTIFNKWSEEPSAKLSEFHSNIKDSAFFRLTDHLLVARTRKNVKAN
FDNSLSFPTHKKPINVFKTPLKFGDVENFAELMDNLDLNLSAYLPATYTLSKEEREVIAL
EKKQRKRLRENIDVLKDNQQREHFLVKMMMILMLKRLESSWYSFMITVERIYNHHENALD
KINKYQEFKTDLTINGNEEIYQEFIDEDETGILDTFLFGKKNPISLSAIDDAGNLEEFKN
EIKKDKKSLKYIFDNVLEFKKKLSPEKEFKSIDPKLEELLKIIIEKQQTKNKKIVIFSAY
KDTVQYLFNQLKTRGFNNYAMVAGDENKIWNETHSSKKHENILERFAPFTKLFKEKNWND
FKPSSKGLSEQECFQEWEKYIQGNEPKTYYQLQNQIDILITTDVLSEGQNLQDADMVINY
DIHWNPVRVIQRVGRIDRIGSPNNEIQSINFWPAKDIDDYINLKSRVEKRMAIMKITGSE
VINEFTDDFNDLAEAEKLEDQQNANMLRQMETTMEDLDGEQTLGFDDFSFDNYRQLLQNM
LNQKKKEFENMPNGVFSGIKIENNPEMQPGIISLLGYPAHKKYNPENKYLSHELIYIDLQ
GNQISNNQKIILEQLNNNYTLTRAIDPKIESGDNVEIEKLSNALKTWINNQARAEIELED
GSKKEVISKAGLDLINKLKNNPKQTLEKLKTEGTISEKYDFENFDLITWLIIS
>EGALAKHO_00978 Type IIS restriction enzyme Eco57I
MNLLQDFKTKPFIEAVKSFFNNLNVPVNEIATVPANAFDIIGDNSLNELISEVYVYGMVD
DAIFEQNKTFNSLDEVKSLKADYDGILLFGITLHSRDNNLLPTRSQLSEITRAFSRVFKF
TPLTIIFKYDHYIAFANTERIQFKQEWRDGEKIGKVIMLRDIDCINLHSGHERILKNLTI
NRTGKNAVTNFEDLYKYWQEVLSVSILNKAFYNELSNWYFWAIREVRFPNEPNQIELALN
DEAYAEALKEHKGKNVIRLLTRILFIWFIKEKGLIPEDIFDEKEITANFIDGFTPQKPEG
IFANGKHSSKYYRAILQNLFFATLNQQQGQREFRKENTHQNVTQLMRYKSYLKNPDNFIQ
LMEETVPFMNGGLFECLDKPHPTARGNQGGERIIYVDGFSDREDNELVVPDFLFFDANEE
VDLSTDYGSAKFRKSKTRGLITILKSYKFTITENTPIDEEVALDPELLGKVFENLLASYN
PETKTTARKQTGSFYTPREIVNYMVEESLIAYLKNQLLHEDAGILEFGKSQIDMFGNETK
IKQLSLEQKIDENPFKNDIESLDVMLHDLVSYSNNNPFDQQPEVQKKIIKALDNCKILDP
ACGSGAYPMGILQKMVHILHKIDPNNTEWKQRQIDRVNSAIDNLEQNDNTEANEKIIKEL
NAQIEDIEASFANNELDYGRKLYLIENCIYGVDLQPIATQISKLRFFISLVVDQKVNKTK
KDFGIRPLPNLETKFVAANTLVGLQKPKKGEFSGSLFDKKEVKKLEDQLKKVRHSLFSIK
TSKRKKELREKDKQLREEISTLLAADYGNETAKSLANWDPYDQNTSSSFFDNEWMFDLTD
GFDIVIGNPPYILIQNIPNTSKNLIEIYNSYEVAQYKTDLYHLFIQKAIDITKDDGIISY
ITPNTFIKNKYNNKLRKYIYDNCNINAVILFYSQVFESVSVDNLVFVLSKSLTKIKSKIY
EVKTTIKDISNPQRLYDQSKIIAPNYTFNLDIDDSKELILNLILNKSVELKNYAKAYFGI
QTHNRAIYVSKLKESKDWGPVIDGGNVFPYLIKEPTEYIKFLPEAIKSGGNEHIYNQDRI
VVRQIGKYPEGAICNAGVYTLNTIYNIYKINNTVNLKFLLGIINSQLVKFYWLNTNYDNK
ETFPKIKKAPLEEIPIKLNQKIEGNISLIVSFLSDELTDRNILFKEIINALVFELYFEEH
MREKDIEIALYIENDIKTVIGDKNFEKLEDNVKRNMIEELAEQWTSSNNEVRNRIKLFAV
RSPEILKPILESK
>EGALAKHO_00979 hypothetical protein
MKKTIETIKIKNFKAFQEEQVFDIKGKNVLIYGTNGSGKSSLFWALYTFLQSSIKSDNEV
KKYFETFDELNSLTHQSLKNVFMPDNSESYVDITFQDENMVRTSYKISDSIVNTNKNTDT
SIQELNLASDFINYKLLHNFYNTSHKQEINLWPVFERDIFPFLTVGTQNWLEDIIKAVTR
DVPRTPKGNVVSQNRKANYENELTALNGKIEVLLQEIQVNANKFLKEEFFENNEVIEVDL
KFTKKFNFNKVRQELWKEDMAYKRREELQIKLSIKLKEGNTWKTIHRPHSFLNEAFLTRV
AIAIRIGATQTRLESLFKILVLDDMLISLDMSNRMDVMRLILNVDNKAELKFFDNFQKII
LTHDKGFFNLIQRHTNDNEWVYYKFIKDESKNEAPKINNDLTHLQKAEKYFEDAELDNCG
NELRKVAEQVLTQYLDPNMKKLKSDFESLGTMLNKAITDINNNRFNKFKSNFISELELDK
LKKIKENYLADGTLTDEEKIALTNTKTRIFDLLIELNSVSHKKETLLLNTKEILDRIMNA
ASHAGDNPLYTAELKDAIIKIKELKDHLNN
>EGALAKHO_00980 Actin cross-linking toxin VgrG1
MEIAIPIFTNRSNPNSTIMSKFSEQVHIAISSFSQNVIYYDLQLSQKMAEHHYFSFMWQY
TAKAVIEPADQAAALSKHIGAEVIFTFKVNGIQLMSKGIINGVESVDLHGSPAGILVSGI
SHTIVIDDMKKSRIFLEKNLQDIALEIFSEESSGEFYQREAILPTFTKPFKYKPQYNETS
FEFLKRLATRYGQWFYFDGMRMQFGQTKTSKVKLINGSSLHHFKIQAQLVSHKTSFGGYD
SNNASNIKNASEKSTSGSQDRFAKSVGFNQGSIARQGLSNGAYTNNAQNKDEIDEMVKLQ
TTGRDANSIFYSGTSYLPIGVGQVFTILNKTVEHELIAIEITHHSEVNGNYSCEFKAIPA
DVAAPHYTDVTSFATAESQSALVKDNNDPEGMGRIKVDFYWPGWGNTSEWMRVVQPYAGA
DKGLYFRPEIGEEVRVAFEGNNVDCPYVSGTYYNGQAKPEFFDSGNMIKGWKLRFGQLFK
FIEKVGIWLSDPSGNEIHLDEEGKNIKATTPETFTIRAKNIVFEATESITYTAGTNISET
AGINKTLSVGAILSTNVTGDNFLHVEGEYNANIVGDYKSHTNKDRTVSSANGIETFTEGE
HKSHAKGEVHHNSNENTKHN
>EGALAKHO_00981 hypothetical protein
MAYRLTVGGKIIETTGGNTNIYAGKNIVTNANKSITISSEVGHFYGEPEDAPKKQLIESK
FKLESTYLHNHLLSVAKEMVPKFNADDTSIVYKFYKAIIDGKIINPDIEISANMISGKAF
YDLDKKKIIVWEVSLLGIGKSTDKKIKLLQDLTQSYSTYLNNSLKEISCEDQFEAYDYDM
FRFDAIGTETVVIGKLESPTYTGDLEISFPNSAVSTTENYKWKSEKDPRAHGPNAGNGDV
FYDGPDDPPGINPNIGFKFSYSLKGGFTASVYVGISKNLNTGDFGVMGSLNTALTYYAKG
AVGTSSMSPTLVTLSATPSITLGYKTGNALQMNLFNNASGTGVWNPYEYAFTLGTTGILS
SGKVSPEFNPETGEFDKNPYNSHDVSRSSDNIQGKRSHEDYTRNQIVGGAAIKVGNFMIA
SFNDIYKPPLFFGMNSDQYWSAGINMQAIMPHDIKLAYAVDMYYGKSNNKNPLNLDKMID
NQNYDYQQLFDVLLNRGQETFSITDSYGKLTTNTKQGYGTFWPTNAMHDSISFPEKPREP
KEPEKSQYSTPEKYDIAKTKFKNDLKKYKTDQLNYNISIQLKAKPTFHHLYVIYDVNNKA
SLDRLKKYLYAGQSEEGKLLKEFYLIEENKKINK
>EGALAKHO_00982 hypothetical protein
MIKRLITLIIVISVIACSSYKDNKEKEKKNHKAYVNYLISRNIDTIKANDLDYYDDFFEF
KEHHKRQVLLLNPYLKTNKVYVYQEGPQKNTFCIFSDDGSEYLTRIYKADSSVLTKSDNG
VIMLKKTVKLEFLGNFELTDTIIKISRNIRELSGKEWNECDVGVIQKDTIRLIENYDTKK
YSYKKRWLKKTYKTNYKLVYQSSLKATRYESDKTHNAYYLIEGSFNLNEN
>EGALAKHO_00983 Actin cross-linking toxin VgrG1
MVSHKTSFVGYDANNASNIKNASEKSTRGSQDRFAKSVGFNQGSIARQGLSNGAYTNNAQ
NKDEIDEMVKLQTAGRDANSIFYNGTSYLPIGLGQVFTIQNKTVEHELIAIEITHHSEVN
GNYSCEFKAIPADVAAPHYTDVTSFATAESQSAVVKDNNDPEGMGRIKVDFYWPGWGNTS
EWIRVVQPYAGADKGLYFRPEIGEEVRVAFEGNNVDCPYVSGTYYNGQAKPEFFDANNSI
KGWKLRFGQLFKFIEKVGIWLSDPSGNEIHLDEEGKNINATTPETFTIRAKNIVFEATES
ITYTAGMNIIQEAGNNINVSAGGNITEHGDEKIEFIEEKITINSAEHIEMAEKINMNATQ
GNMTLKASKSILANSGENSNFN
>EGALAKHO_00984 hypothetical protein
MKVNKRHVIIAGKIEKTAQNMKVVATYGNIELNSTHKIIKNGNIS
>EGALAKHO_00985 hypothetical protein
MGTSVSLGNYEPEKIPEPWEEYQYRDLSRAYYTQSLNMKIETDSDGLLHCITALTSLELN
KCYTDSEKQVTIDKSPRNCYLSALTIYMNNKGEIIKGERVLTQFKLIYNPSSSTHILDSS
FKIRKQKESCIEAKDLHNHVIANKIITFRNGKVLLLKKFHEYVVQASLCNRRTDVNYTNL
KVTENRDELNKTLSLLGITAASVGFAPGKASVLADTTMKILGLALSVEPRFSLAEYTYPI
KGPVYLDEKTKIENYKRDNNNGYITAQKLTFPPPHEEKRDLLKELEDYGLKVTAK
>EGALAKHO_00986 hypothetical protein
MKIITTFILAFVFISCNKKEQINHYLVNPITQQELVSNGFYRYSSIYLPENQGKINSDSA
SVIKFDMYSNVKPIKNDENQLCPTQLWHFYHEDSIIKKRNKNYLKNKLNDRIITYFFRND
TLLYKDIIVNSIDKSRKEIADFTSLDKVIRYYESLKISIKPQIKNKETGEVYSNRFIIDN
YKTRFYTEDNFYEMFVDYKGDNYHAILDHLYGGTYCQ
>EGALAKHO_00987 D-methionine-binding lipoprotein MetQ
MNTKLNFFKTAGIIALSLVLSNCGENKKNDPHHIKVGVASGPELKVAEAAKKVAKEKYGL
EVELVSFNDYVIPNEALSQGDIDANAFQHKPYLDEQSKQRGYKLAIIGKTFVYPIAAYSK
KIKSLSELKNESTIIIPNDPTNGGRSLLLLEKNGLLKLRAGVGLLPKVTDIISNPKNLKI
LELEAPQLPRSLDDQNVSIAIINNTFASQAGLVPARDALFVEDKDSPYVNLVVSREDNKN
EEKVKQFLQAFQSAEVEQAAVREFKGGAVKGW
>EGALAKHO_00988 D-methionine transport system permease protein MetI
MSESIIELLLKGTWETIVMTFLSGFFGFLLGLPTGILLFLTRKNQILEQPVLNRVLSVLV
NIFRSIPFIILIVWMIPFTRAIVGTSIGVSAALVPLSIGAAPFIARLVENSLLGLPSGLI
EAARALGATPFQIVYKVLLPEALPSLINAASITLITLVGYSAMGGAVGAGGLGQVGYQYG
YIGYDAVTMNSVLALLVILVFLIQFAGDTLSKRFDHR
>EGALAKHO_00989 Methionine import ATP-binding protein MetN
MIELKNVSKTFHQKDRIVSALSDVSLKVPPGKIFGVIGTSGAGKSTLIRCVNLLERPTSG
EIIVDGKSLIQLSNAQLAIERRQIGMIFQHFNLLSSRTVFENVAFPLELAGTSKATIKER
VLELLQLVGLSEKANDYPASLSGGQKQRVAIARTLANNPKVLLCDEATSALDPATTRSIL
NLLKDINRRLNITILLITHQMEVVKSICDEVAVISHGKLIEQGSVGEIFADPKHELTREF
IASSLHLDIPAVYQERLQKEDGENLNPLLRLEMTGKSVNEPVISEVSRLFDTNFKIISAQ
MDQAGEVNFGIMLIELSGKRENYKAAIEYFISKHIKTEIIGYV
>EGALAKHO_00990 Peroxiredoxin OsmC
MKFTRRANANWKGTGMEGKGTISTQSTTLNEAQLSFKTRFEQGVGTNPEELIAAAHSGCF
TMQLSFLLSEAGFVPEDLDTVAKVTFEDGTITLIQLELTGKVPGISAEDFQLAAQKAKEI
CPISKLLNTEITLSVKLN
>EGALAKHO_00991 Pyrethroid hydrolase
MKTLSIKEQLKSYFLFAALILSLAFTTVNVNAQTKTTAPQIKNVVLVHGAFADGSGWQGL
YQILTKKGYNVTIVQNPLSSLADDVAATNLALDRQDGPTILVGHSWGGTVITEAGNHPKV
AALVYVAALQPDNGENSIQWLQTAPPAPENGVLPPDDKGIAYYDKAKFHAGFAGDLSKEQ
ADFMYASQGAFHAQGFGTPITKAAWRDKPSYGIVATEDKSINPDIERAMYKRSNTKITEI
KGSHVVFISQPAKVANVIIEASKK
>EGALAKHO_00992 Hydrogen peroxide-inducible genes activator
MTIQQLKYIVALDEERHFARAAEVCMVTQPGLTIQLKNLEEEIGIKIFDRNKVPLTPTLL
GTEIINRAKKILREADEIRDFVVNEKNLLEGEIKVGIISTLSPYLIPLFIKAMKEATPKV
HFIIRESNTGQLMKDVETGTIDVAIMATPTGNPNLIEHPIFKEPFVAYLNESHPMAKEAF
YEMQPGDKTELLLLHHEFCYNAQLLDICGLKSSDKIKEQFTYDISSIETLKNLVRAHLGF
AIIPQLSILNDAPSGLFKPFTEPIPVREISLVVSDSFSKKLILEKMNEAIWNSLPDSLKK
DFAYRKIRWNDSPYFVKAVSKFM
>EGALAKHO_00993 Transcriptional repressor SdpR
MATPALDVFQVIGDPSRRKMLSLLCEDRLTINSLADHFDMSRPAVSKHVKILYNAGFISI
EDSGRERYCSLKKDGFDELKTWISFFDAFWGSKLKKLDSLMGEDKLSN
>EGALAKHO_00994 hypothetical protein
MERSIKHQYFFAHSPEKVWQYLTNSDLMELWLMKNNFKPIVGTDFQFRINPIPDLDFDGT
FYCTVLEIEPYKKLSYSWKSGPGDEKITLESVVIWKLEPTEKGTHVYLEHNGFDKDENLD
FFNGLNHGWLEKFEKINNLLNA
>EGALAKHO_00995 hypothetical protein
MEKLELQRLKKSLQYLESKQRELKKQEYNDTRSIESIIKYLKKDIIQQFNLTYYNPLIKQ
EIKNTDVFIIHVKHIIESNFSNSI
>EGALAKHO_00996 hypothetical protein
MFDFLKTRFFLLVVMATQFGFSQEKIPHLQKKGNKTQLMVNEKPFLVLGGELGNSSATSV
ESMEPIWPKLKDMNLNTVLTPIYWELIEKEEGKFDFSLIDDLILRARKEDLKLVFLWFGS
WKNSMSSHAPAWVKLNQKKYPRVKDDKNKSHEILTPFSENNLKADINAFQKLMAHLKDFD
QKEQTVIMIQVENEIGMLPTARDYCPQSNEAFNKEVPAELLQYMQKNKQNLVPEFLEIWK
KNGFKTKGNWEEVFGKGLQTDEIFMAWYFSKFTNTVAKAGKDSYAIPMFVNAALNAAEKK
PGEYPSAGPLPHLMDVWKAAGNSIDFLSPDFYNPLFKHWNDLFTRQGDPLFIPEHKFDKT
APFKGLYAIGHYEAIGFSPFSIESVDDAKKEPLGKIYDLVRQLTPVIEANKGLHKIDGVL
LDKENPSQVIQLSDYEFTFKHDYTLNWSDGAKEETWPMTSAIIIELAPNEFYIAGSGIVV
TFKSLKDKTANVGILKVDQGTFENKIWKTFRHFNGDQTHQGRHVRIAVDDFEIQKVQLYT
YE
>EGALAKHO_00997 Exoglucanase/xylanase
MKYKYIIPIIASSLLILSSCDDNLMDWEKDPEHGAVTGAELPLELVEKISRYEPLKNYTN
FVLGNGIGTDLYMSDPAYRKLVNENFDEVTPGYAMKHGAMVNSKGEINFTAMDAFVAATK
SAGLKVFGHTLVWHSNQNASYLNSIIAPTVIPGSSGTNVLDVAGLKAGTFANWSRNNPGK
GISIVANAGLTSTSQAIQLASSATSAAAYSLQLTSPNTSIVAGHNYEISFYIKSDVAGKG
RLSFNASLTNQYPYKDWYNTGGSWVEAFATSAQWQQVKIKLAPGDFKAGSTNFQFNIDLG
YLPNVTYLIDVNTIAVVDLDAAPTVVNLVSNGTLNTDINGWSKFNGADNALSFAGAANAY
EGSGAMKVVNATSDAANQWKTQIHADFTSVMTSGKDYTISYMIRSEAAGSVRCSTTGTTA
HYQGDQTTSPTWKLVEWKFTGNGTETGLNFDLGGAAGTYYIDNVVVTSGATTGGATPPVN
IDKTDAEKTTIIGNAMQDWISKMMTHYKTGVFSWDVVNEPMREDGTLRNGTEGDTATDYF
SWAKYLGKDYAVTAFKLARQYGNTTDKLFINDYNLESRLDKCDGLIEYVKYIESKGGTVD
GIGTQMHISLSTDKDKIVQMFQKLAASGKLIKISELDIRLGTSTPTVAQQASQAEMYQYV
IDMYKKYIPAAQQYGVTIWGLSDSVKEHENWLPNESPNLWDANYVRKHAYKGTADGLAGK
DVSKDFSGELVK
>EGALAKHO_00998 IPT/TIG domain-containing protein
MKQYILDKKYWAPIAFLGMMFFALMFTSCDNTDSSSKSIVISKVFLEDVNSTVQDREVSF
ARLGQTIRIEGSGFKGLKKVYINGYSTYFNVVFVSDNSMIISISGDTPTIEADAAERNTI
RFVNDNTETVFPFQIRSSRPVITDISNTMPNPGELITVHGDGLTEISKVVFPGNVTVTTG
ITSDPDGEFFTIKMPAGVSDLGGSILVEGSNGGAYSPAYFNFKKGILLNFDGQGSQGYWS
VDTNPSMISPPDLESTLTGTGTISQGNYVPHRPARIASFAPGKNRLTEVWTAGNGVDNWR
AQLTPYIPASTPLDQVAFQFDVYVPDAWKDSGFLKICTINNFNGGEWAGAVYNYVPWIVD
GKSVAFQTTGWTTVTIPLNKFYAWSKEAFTFETVLAYREAATYQNFGIFFENSDIKLKDV
TGTASEVEFPSKATSVKVYTDNWRIVSLNTPTYNDFPN
>EGALAKHO_00999 SusD-like protein
MKTKKIFYTALIIALPFVWTSCSDILEVEPNDVITKENFYKSESDFQAATGPLYNKVWFD
FNDKFYYGLGDGRADNLYAPYSDYVYPFTDLSETGLTGPLVSAWASLYNVVQQSNNVIIG
ISDSQVNENIKNKYIAEARFMRGTAYWYLASLWGDVIISTDPKDLVKNPVVNKNPMKDVY
EFAMRDLEYAAKYLPETAGQSGRLTRYSAYGMLSRVYLSFSGVSDNPNSGTRKQEYLDLA
KKAAQKVINSGVYSLMPNYADLFMIDNNNNSESMFALQWVPNGDYGVTNTQQAYFALGSD
ITGDDTGWGSWTRASYNVLQEYESKDVRRKATWMADNDFYPEISKANGGYTVDHTNDFVT
VKKGVVGSTKDNSKISRMNSSLNTYMLRLGEVYLNYAEAALGNNANTTDALALDGINKLR
VRAGLDPKTSLTYADIIHERRVELCMEGQYWYDLVRRSYYKQQEVVNYITAQNRGTIVPI
LYDNATNAVSIDATKSNSTRSIGVIDATIFALPYPESELIQNPLLRESPVPYEFKEEKIK
DLF
>EGALAKHO_01000 TonB-dependent receptor SusC
MTNFLITKSKSKYFKNLGFMILLFVFSASVNAQTTVSGTVSDNTGPIPGVNIIVKGTNIS
AATNFDGTYSIKTAPNAVLVFSFIGYRTQEVPVSNKSQINVTLEEDVSSLKEVVVVGYGT
VKRGDLTGAVSTVSSAAISQSVATTIDQVLQGRAAGVQIQSNSGTPGGSSSVRIRGISSI
TGSNEPIYVIDGVIIDGNSGSLNSNPLAGINPSDIVSMDILKDASATAIYGSRAANGVIM
VTTKTGKKGDLTLNFDSYVGWQQMPKELQVLNLREYGTLKNTRSDLGIVQRDNYFVRPDL
LGEGTNWQDELFQTALIQNYNLSASGGSDSTTYALGMSYFDQDGTIIGSSFDRMTLRGVI
DSQVKKWLKVGVNMNVNKYNQVTTVNDDSVILTALKQTPNVSARNADGTFDGPDTAEFVQ
TNPLGIALLKDNHATNYGIRGNAYAEISFTKDLKFKTQYSLDYGFGNNYTFNPSYTFGAL
VNDVREGSRTKSTSENWIWNNLLTYNKTFAKHNINAILGQELQEQNWENLYGYRSGYLTN
GATDLNAGDPTTARNSNASSTKSLSSYFGRVAYSFGDKYFLTGTIRRDGSSQFAEDNKWD
WFPSAGLAWKISNEGFLKDNQTVNNLKLRAGWGVTGNSSVPNNAYTSVYGTSATNWGSGQ
IATNTANPDLKWEKTNQTNIGLDLGLFDNRVEITADVYYKKTDDLLLRLSLPAYVGTTGQ
GSTAPPYANIGSLENKGIEFTINTINMQSEDFLWKSNFNISMNKFKVLKLNSESGVYDQT
LQQGSDVTVVTRTAVGQTLGQFYGYKVIGRFEKATDFYYKDATGTVKPTALPEGMQIGEN
GVWIGDYMFEDVNKDGVINEKDAGYIGDPNPDFTFGFTNSFSFKGFDVSIMFTGSYGNDV
LNYQRRWLENPRENTNLLKSALGYAQLDLIDPTGPNDYRNVQIVGGDPYMPRIGASSASS
ASNYRLSNRFVEDGSYVRLKNISFGYNLPKSLYSKYGISNIKVYSNMQNVLTFTKYKGYD
PEVGAINQNQLLNGIDNGRYPSPVTTTLGLNVNF
>EGALAKHO_01001 HTH-type transcriptional repressor CytR
MEENKHVTIYDIAEKLNLATSTISRALKDHHSISDKTIKKVKKAAKEMGFVPNTLAAGLR
GNKTKTIGVLIPTVTQPFLSSLISGIEITAQKADYSVIIMQSHDSYHEEVNMAKSLYSNR
VSGVICSLAMETRDTSHFQQFSNNNIPLVFVDRVPKDYNTFRVVIDNYAAGYKATKHLIE
QGCLRIAHLTAGSEFGNLYNERKRGYVEALRDHNLPIDEDLIIDLKAVTYEEGVKASNKL
FDLKPIPDGLFASGDIIAVSAVQTAKKRGIKVPEDIAIIGFNNDPISQIIDPNLSTITHP
AEKMGKAAADIIIKNLKSAKNEDVQEIAFLNTEVLVRESSSRK
>EGALAKHO_01002 Sodium, potassium, lithium and rubidium/H(+) antiporter
MENITVIIMLLFGVAFLSLISKKYNFPIPIVLVLCGVVISIIPGLPVITLNPEVVFIIFL
PPLLYYAAWYTSWYEFKKTIRPITLAAVGLVLFTTVSVAIAAHSLINDMSWPLAFLLGAI
VSPPDAVSATSITKGLSLHPRLIALLEGESLLNDASGLVAYKYALAAILAGNFVLWEAGL
NFFIMSTLGIAIGLVVGFVMSIVHKKFVCDDIIEATLTLLTPFASYLIAEHFECSGVLAV
VTTGLYLSARSGSIFTHESRIMSVTIWSILTNILNGLIFILIGLQLRHIIIGISNYSGSS
LFIWGASISAVVILVRFLWVIPSTLLQKYLSSKNKHKEEFDYRNMIIFGWSGMRGVVSMA
AALALPLMMNEKEEFPLRNLIIYLVFCVILSTLVIQGLTLPWLIKKLKLQPYSIIAEEYE
IRNVIVSETIAHIEDNFSLLNDDLLHNIKSKYEVKFNRLQKTELPANFFGKGNIMGGQIF
NEFTKLQIDLLNIERAKLEVMHKQGSVNEEIFRKIEKELDLEETRLWMEMYEE
>EGALAKHO_01003 Miniconductance mechanosensitive channel MscM
MFQKRNSLCLLALLLALFYAPISYSQNDAPKKETRSKLFEEATTDSEYLMAIEKANEMME
SAYNDADFDSASHHLFGEIKRTQSKLDLILESLKGANPNVRNQQMYQTVLQEIQQQLDEQ
NTAINLRNENLEKIKGRFIELRKDKNLMALLKDTIRRKQFKKEFANLRKKYLSTDSLMTK
NQGILNKKKRITVQRKIAVSNALLVVEGKLEKSGISMLHKEYPFLWSINDSVPKKTVAQN
IGVKIVIEEKVAAYYLSYRTGGLITLLLFMGLVAWYVSRNLKYLKTNGHTENLSLFNFKY
LNRGFLIPVAVIGLNIAVVSNLFAPALFLELLQLLLLGILTILFKNKWSKVAMKNWLFLL
GLFFTLCFLDLFIEVGFFQRCAFIAINVLGIRYGLVQIKTLKEQLYIQGFFKWASIIFIG
FNGLSILYNLFGRVSLSNMLSLTAFISLTQIVALSVLLKIILEIIILQIYTTRVKRGIEK
IFDHESLSNTLKKPFVLVIGYMWLVVIASNLNIWQSLRTSLGGLLSRPNNIGSITFTLGN
IVLFFIIIWIAHLLQKYVAYFFGEIDDENEENVNKRQHSKLLITRLIVLIGGYLLAVAAS
GMPLDKLSILLGALGVGVGLGLQNVVNNFVSGIILIFDKPIQIGDVIEISSESGRVKSMG
LRTTKINAPNGAEIIIPNGNLLSQNITNWTYTDNFKLVEVSIDITGDTTPDDINATIMEA
LESLSLVNTSKTPQIFYNAISEGKYKVLVKFWCSIYRTEESISSARQVLFSSFKAKGLNF
SS
>EGALAKHO_01004 hypothetical protein
MKKLVFALVLFMSVFFAQAQVSINVNIGTPPSWGPEGNDNSRYYYLPDIDTYYDVAESQY
IYDNNGRWIRDRRLPAQYRNYDLYGGYKVVLNDYKGNTPYTYHNKHRESYPKGYHGKPQK
NRGSKPEKNKSDHGQKNGNSKNSKGNSNNDKKHSHDDHH
>EGALAKHO_01005 Outer membrane protein OprM
MTHSSNKYILLVLTAVLLSACSVTKKYERPETISTDKLYRDQASADSTTIANMPWQSVFK
DEKLKALIQKGLDQNLNLKNAIENIVQANASLVQSKLAYYPTLNLDANATRNKQSKAGLN
FPAGININTLTTTYKLGLSTSWEADIWGKLSSSKRAALATYLGTDAARQAVQTQLIADIA
NNYFLLLAYDKQLVITEETLESRIKNVQTIKDLKEGAIVTGAAVVQSEANQHAAEVLIPD
LKRNIREIENAIHILLGEAPGPIDRGVLGTQVIPENLAIGLPSQLLQNRPDVRQAEFNLR
TAFEMTNMAKTYFYPSLTLTASGGFSNLQLTDFFTNSVFYSLIGGLTQPLFNQGINKMRL
TTAQSQQVQAYNNFQQSLLVAGQEVSNALYAYQMAADKEDSREKQIAALEKAVDYTQQLL
EYSSATNYTDVLTSQQNLLAAQLSGVNDNLQKLQAVVDLYRALGGGWK
>EGALAKHO_01006 Efflux pump membrane transporter BepE
MFKIFIQRPVLSTVISVIIVILGVLGLVELPISQYPDIAPPTVNVSASYTGANADVVLKS
IVIPLEEQINGVENMTYMTSSATNDGNASIKIFFKVGTNPDLAAVNVQNRVSRATSLLPV
EVTQAGVTVTKSQSSNLLIFSLYSEDKAYDQTFLQNYAKINLVPQIQRVVGVGDVTVFGA
KDYSMRIWLRPDIMQQYKLIPSDISAALAEQNIEAAPGKFGENGDQAFQYVIKYKGRLTS
QKEFGEIIVKSVGNGQMLRLKDVAKVELGSLSYSSTIKTNGVESAAMAISQTPGSNARDV
INNSKKLIEDAAKNFPKGVKYTILVDVNENLDASIEKVIHTLIEAFILVFIVVFIFLQDF
RSTLIPAIAVPVAIVGTFFFLSLFGFTINLLTLFAMVLAIGIVVDDAIVVVEAVHAKLDH
GYKSSKKATIDAMDEISGAIISITLVMAAVFIPVTFINGSTGVFYKQFGITLAVAIILSA
INALTLSPALCALLLKPHADDHKHKSFLQRFYTSFNVAFDNVTNRYKRSVSFLSVKKWIV
LAAILIASAGLFYMMKTTPSAFVPAEDQGTVFANISLPPSASMERSDVIAKRVDSIAKTI
PGVKNTLRIVGQNFTAGAGSAYSMVIVKLVPWDQRDLSVNDVIGQLFAKTSGIREANIFF
ISPPTIQGFGQSGGFEFQLQDKGGHTTAEFYKVNTDFLEKLSKRPEIQYATTPFNPGFPQ
YMMEINLAKAKDAGVAVNSILSTMQGYYGGLYASNFNKFGKQYRVMIQASPEFRANTQGL
NKIFVRNSAGTMAPITEFIKMTRVFGPESISRFNLFTSISITGAPNPGFSSGDAIKAIQE
VAAENLPAGYGYEFSGLTREELASGSETIFIFILCLVFVYFLLSAQYESYILPFAVLFSI
PFGLAGAYLFSIIFKLNSNIYLQISLIMLIGLLAKNGILIVEFALDRRRKGMPIVQSAIE
GAVARLRPILMTSFAFILGLVPLMFASGAGAVGNKSIGTGAVGGMLIGTILGVFVIPILF
IVFQTLQEKVSGPAKDGYDDEDDDEEVQLIEAHKE
>EGALAKHO_01007 Efflux pump periplasmic linker BepF
MNKQSFLSILAASVIIASCGNKNDNSAQAGGAPQIKEYKTLTLEPKTATLYTDFPATIQG
QQNIEIRPRVEGYIDKIFVDEGAVVKTGQPLFKISAPEYEQEVRTASASIKSAQASVSAA
KLAVNKVKPLVDKGIISKYDLESAQYNYESAMATLAQANAALVNAKTNLGYTTVTSPVNG
VVGSIPFRLGSLVSSNTADPLTTVSSIGNVYAYFALNEKKLLDFTQSTASPGTTLAQKIK
NMPEVSLLLSDGTTYPEKGRVETVNGLINTETGSVTFRARFGNPKSIIRSGSSTTVRIPN
EVVEKILIPQSATFELQDKIFAVTVGKDGKTKNVNITVLENTAGNYYVVTSGLKTGDQIV
LEGVASLKDGSEIKPQNQNPETVYADLK
>EGALAKHO_01008 Sensor histidine kinase YpdA
MTFNFFKPYMFPVIHILTWILLGYIQLFYIPLTWNINLPDIFWFWQSLVLFLLIVVFYYN
ALIIVPKTIIKDKVTPFLLWALWIVFAMQLVSYLYNYNTDLHNKLAALLGFKKYRNDYFD
NYVFSLTLLVLGISTSFAMLQHWQKAAQHKQKLEQDKTMAELAMLKAQINPHFFFNSLNS
IYSLTYTDIEDSRNALHTLSRMMRYLLYSTEERTTLLKEADFMKDFIALMKLRANSKLTI
TTDIPEKIQDYPIVPMLLLPLVENAFKHGVHATDKSEIHISLSQNKSDLTFEVENTYFEK
SSTTNEGGIGLTNTKRRLHLIYPNKHSLKAGIGENGKYNVKLQITLD
>EGALAKHO_01009 Transcriptional regulatory protein YehT
MITLKCIAVDDEPLALKLVETFIEQTPFLELISSCDNAVEAMGIIREKQPDVVFLDINMP
NLTGMELARLLQEQPGPLPKIVFTTAYNHYAIEGYRVNAVDYLLKPFSYEEFLRAANKVL
QLAEETSNENPQASAEDDFIFLKVEYQWVKVNLKEILYIESLKDYVKVHLENSDKALMSL
ISLKALEEKLPSSKFMRMNRSFIVSLEKISAISKNSIFINKIEITVGEQYKETFKVIVDK
WIK
>EGALAKHO_01010 hypothetical protein
MEKRSNKYYLTLSLKEYANGEIKPAKELGIEFGNHDEIFDIIERIKAKNLFDNESEAIQF
ALGLKLFGEIKLKHRKNPLFDELNEVFPVFMKKLKSL
>EGALAKHO_01011 Thiol-disulfide oxidoreductase ResA
MKKIILLVMLAFSAFLSQAQNATLKAGDTAPDFKLKNVDGKEVSFNSFPKAKGYIVVFTC
NTCPYAVGYEQRIIDLDNKFRPQGYPVIAINPNDPEASTADTFDKMQELAKNKKYPFPYL
FDAGQKITDQYGAKRTPHLFIVSKTAKGNVVEYVGAIDNDPEGNNAQKTKYAEDVIAALK
SNQKPAITQTKEIGCTVKRKAKA
>EGALAKHO_01012 Thiol:disulfide interchange protein TlpA
MMKIQKFSILAFLFVAFSFSASSQNVKLLSIDQLNERVKNGKDSTYVVNFWATWCAPCIK
ELPHFEKLQADYKSDKVKVLLVSVDFKSKLNSAVVPFVKRKNLKNEVFLLNESSPQEYID
RIDPSWSGSIPATLFIKGDKRKFVESEFTYEQLLTEYKKL
>EGALAKHO_01013 hypothetical protein
MTVLTFTLIMILGAFLAGFIGSLSGLGGGIIIIPLLTVILGVDIHYAIGAALVSVIATSS
GSAAAYVREGITNMRLGIFLEIATTIGAVCGALLSTIAPTSFIAVLFGMTLIFSAINSLR
KKEEHIVLESSPLAKKLRLQGTYPSHDGEVISYGTKNVIGGFSMMGIAGMMSGLLGIGSG
AFKVIAMDNIMKIPFKVSTTTSNFMMGVTAMASSVIYIQKGYIEPGICMPVVIGVLFGAM
AGAKVLVKTNPKKLRIFFACLIFILAVNMIYNGLNGKI
>EGALAKHO_01014 hypothetical protein
MEKSNSMQQEKFGEKDFQNIVGNLLRYGVWISLAVAFIGGIVYLMGHSSDIENYSVFHEN
DRNIFEVISDIYNGAIQGKGESLIFCGIILLFLTPVFRVLLSLFSFLLEKDYLYVVITTI
VILIILISVSFGFSH
>EGALAKHO_01015 Alkanal monooxygenase alpha chain
MEIGIDSFASAMYGSNNLSSVDAMEQLLQRIELADQVGLDVFGIGEHHKKEFLDSATVVI
LSAAAARTKNIRLASAVSVLSAADPVRVYQSFATLDLISKGRAEIVVGRGSSIEAYPLFG
FNLNDYDALFKEKLELFLQIRDNEFVTWSGKFRPAINNLPIYPRTLQEKLPVWLGVGGTP
ESFVRAGSLGLPLMVAIIGGQTHRFRPLIDLYRQAGKAAGYKPEELKVGIHSPGFVGSTT
EKAIDEYYPGYAELWTKLGLERGWPPVTKAKFDGLIDDDGVLIVGSPERVVEKLLRHSES
LGGVDRFTFQMDNAGLSHKQLMNAIELIGTKVIPLIKKP
>EGALAKHO_01016 Ferrichrome-iron receptor
MNINITKKVFFFMLLLTSLNMMSQELGKVTGKVSLSGNIPAENISVTLTGTKYSAVTNSN
GQYEIKSVKPGSYVINIRAVGIHSIEDNILVKANQTTTKNFSLSESQEDLDEVVITKNKY
KQDKPSLSLRLQTPVLEIPQNIQIVSGQTLKDQQITSMSDGVIRNVSGAVRLEHWGDLYT
NITMRGSQIQAFRNGFNVVSSFWGPLTEDMSFVDHIEFVKGPAGFMLSSGDPSGLYNVVT
KKPTGITKGEVSVLGGSYDFYRVSIDLDGKLDKKGKLLYRFNGAAQNKGSHRDYEHNNRY
VIAPVISYQFDDKTKITAEYNFQYANMTEVGSYYVFGPESGGYGTLPVGFTMTQPGLPDT
NIQDHSGYLMFEHKFDDNWKLTAQTSYFKYIQQGYSSWPSVVGPGPVDTDFDGVPEGTLA
AGEIIRNVGIWDAESNMYLGQIFLNGKFNTGAVSHKILGGVDLGSKDYAADWGQSHDLDT
VDSPFNVNSPNYGPPSNGFPAFDHTTPLSIRAKNAGGLMSSEYAAGYIQDEIGFFENKLR
LTLAGRYTWISQASWGGAPISDSHITPRVGISYSVTESLAVYGLYDQAFTPQSGIIKSGE
SVKPLTGNNVEFGIKKDWFDGSWSTTLAAYSILKKNELTSDPANTPGEQYSVVLGEKRAQ
GIEFDLRGKLFDGLNLIANYAFTESIVNKVDPAVSAATGIMVGDIVPGYAKHVANAWLNY
TVQNGKIKGFGVSLGGTFQDGRQTDTWSEGLQKLPSYFKLDGGLSYETGKVKVTANVFNI
LDKYLYSGSYYEWLSAYYWQTEAPRNFRVGVTYKF
>EGALAKHO_01017 3-ketoacyl-CoA thiolase
MNNSNTIRKVAIVGYNRIPFARANTNYANVGNQEMMTAALNGLIDKYNLKGQLLGEVVGG
AVIKHVYDSNLIRECVMKTALDPATPACDLQQACDTGIESAIYVANKIALGQIESGIAGG
VDSISDMPIAVSEKLRKILLNARQAKSLGEKIKTFLKLRPADLTPLVPRNEESQTGLSMG
GHTEITAKHYKIAREDQDNLALKSHLNMAKAYDEGFFDDMITPFNGLDKDNNLRKDSSIE
KLASLKPAFDKVNGTLTAGNSTPLTDGASCLLLASEEWAKERGLPILAYITFAEVAAIEY
VKNQQNLLLAPLFAASRMLEKAGLNLQDFDYYEIHEAFAAQVLATLKIWESPELSAQIGL
KKPLGAIDREKLNVKGSSLAAAHPFAATGGRIIGVMAKLLNEKGSGRGFISICAASGQGI
TMIIEK
>EGALAKHO_01018 FMN-dependent NADH-azoreductase 1
MSKRILNIVTSIKGDASFSNKLSNAILEKLKVEHNEIQVQTLDLSKTPLPYLSELDISAF
YTPAELHTEAQKETLKYSDHAVKELFDADIIVIGVPLYNFGIPAVLKGWIDQVARAGKTF
SYDENGPKGLLTDKKVFLSIASGAIFSEGPYKSYDFSESYLRTVLGFLGITDITTFRVEG
TAIPDFAENALPKALASVEEFAF
>EGALAKHO_01019 putative HTH-type transcriptional regulator YtcD
MKRSGEIKKEKCGEPEECLAALLPVRDALEVLSGRWKLPILIALSNRPKRFKEISKDVNG
ITDKMLSKELKDLEINKLVTRTVYDTFPPTVEYARTAHSHTLYNVIGALNEWGTLHRKEI
IGK
>EGALAKHO_01020 Fumarate reductase flavoprotein subunit
MIDSKIPEGPLAEKWSHYKAKAKLVNPANRKKLNIIVVGTGLAGASCAASLAEQGYNIKS
FCFQDSARRAHSVAAQGGVNAAKNYKNDGDSTFRMFYDTIKGGDFRSREANVYRLAECSA
HLIDHAVAQGVPFAREYAGYLNNRSFGGVQVSRTFYARGQTGQQLLLGAYQALLRQVSLG
KVDLNTRHEMLELVVIDGKAKGIIARNLETGAIERHAADAVVLASGGYGKVYYLSTLAMG
CNSSAIWRAHKKGAFMAGVSWIQFHPTSLPQHGENQSKLTLMSESLRNDGRIWVPKTAAD
DRNPNTIPEEERDYYLERKYPSFGNLAPRDISSRAAKEQIDAGHGVGPMKNAIYLDFSDA
IRAQGKDKIEAKYSNLFAMYEKITGINAYKEPMLISPSAHFTMGGLWVDYELMTTIPGLF
ALGEANFADHGANRLGANSLLQACVDGYFIAPYTIPNYLSGELNAPKIDTSHLAFEEAEK
TVQSQLNRFLSSKGTLSTDYFHKKIGRLLYEKCGLSRSKEKLEEALEEIKILKSSFEKDL
LITGDDKLNSELEKAGRIADYIELAELMCHDALQREESCGAHFREEYQTADGEAVRNDAD
FCYVSAWEWKGKEQLPQLHKEPLVFESVELAVRSYK
>EGALAKHO_01021 Fumarate reductase iron-sulfur subunit
MKLYLKIWRQFDTSSKGEMVDYEIDNVSEHMSFLEMLDLLNESLIHKRERVIEFDHDCRE
GICGQCGVMIDGRAHGPLKNTTTCQLHMRSFKDGDTIYIEPFRAKAFPVLRDLKIDRSAF
DKIITAGGFIGASTGQAPEANSIPISYETAEASFDAAACIGCGACVATCKNASAALFTGA
KITHLALLPQGKIEASKRVLTMVQQMDAEGFGNCSDTRACEIECPQGISILSIAKMNAEY
TKALIFRK
>EGALAKHO_01022 hypothetical protein
MKHLLALILFSTSIVAYSQKESIVKEELKLTELSKKQIIDSLTQELEEFYIRPNAIADIK
KKLNENYKKGIYKDILNSNDFANKITTDLVDFSKDLHFRVVYDPEWTENQKNKEDKAVQQ
KIKAQELTDARKKNFGFQQTRILEGNIGYLEFDYFEDPAIASETAAAAMHFFENTDALII
DLRKNNGGVMEMGQFISSYFYSGAELPLYKYYTYEKNRKKIEREMWLLPSVPGKRLADID
IYILTSAITFSAAEWMSYSLQNLKRVTIVGEKTAGGAHPIDRKVLPNGFSVNIPFGEVRD
PITNGDFEGKGVTPDVSCKSEEAVNASHLLALQKLSLKNKDSLNNLDWYIPIVKNRQKPF
VADVTTLKAYQGKYGKSELLYENDNLYYKWNNIASFLLVPIENELFSIDGIDSFRIKIVS
EKNEITAIKRIYQDGQERLYKKD
>EGALAKHO_01023 Transcriptional regulator HosA
MKEKSPTGTVLYSIEQAIKEYRKICQKNIQKVVSDITVDQCLVLIILNDNAGIPQIEIAK
LIFKDNASITRIIELMVQKDYLTREVDASDKRKSKLLLTEKGQKTILLLTPVFKLNRKTA
LEGLSLDEIVLLDKLLHKIISNCKTS
>EGALAKHO_01024 4-hydroxy-tetrahydrodipicolinate reductase
MKIGLIGFGKTGKSVASILLENKKFCLEWVLRQSTVLEHRSVPEFFGIQSDEPGLIYSSS
KTSMEELLDKHPVDVIIDFSSNEGIYRYGELAAKRNIKIISAISHYKDKELQLLKKLSLK
TTVFWSPNITLGVNYLLFAAKFLKKIAPWVDIEVNEEHFKKKEGTSGTAIKIAEALDVEK
ENINSVRAGGIVGKHEVIFGFPYQTVRLIHESISREAFGSGVVFVAENLKDKQKGLYNFE
DILSPYFAV
>EGALAKHO_01025 hypothetical protein
MAYNNNELMRFLDAQNKLYLSALSEIKKGKKESPWMWFIFPQIKGMASCDTSKFYEIKNA
DEAIAFLEHPILGKHLIEITEELIKNEEKTATDIFGNPDDEKLQSCLTLFASIQNSEPIF
QEALHKYFDGSSDFHTLQLLYSNL
>EGALAKHO_01026 Penicillin-binding protein 4*
MLKLLISFTALFSFSVSMAQLQPETAQQSSTQIDQYLKEVLGKYNIPGISIAVIKNDKII
HRNNYGKANIEYNIPLSDKSIFRIYSLTKTIIVTGAFQLIEQNKLSLEDPISKYLHDLPV
SWNSVQVKHLVTHSSGLPDIVNYEQLPENEAREKVFADAIQFEKGAKFEYNQTNFWLLQK
IIEMISKQNIETFIKENQFSKIDGKDVFFSTDSRDIISNRVTQYSNFATGKMQIELPNNG
NYLNSCNGLNITMDALIQWDSKLNTNKLINEKSKKMMWEIFPYTKSDYKFTFGWDQNIVN
GHTSYGFSGGRRAAYRNFPKDNLSIIFLANGIGSDVDIVNIVNRIAYFVDNDIVDYNFLA
LETLQKTVKENILNLKDTFVSLKRDTKYSNVKWEEHLNGIGYTLLYQDKNVADALTVFNL
NAREYPKSSNAFDSLAEAYEVNKDKENALLNYTKAMELNTDPTYLARVNKKIKELKELSK
>EGALAKHO_01027 Arylsulfatase
MKSIQIFILFLLMTGSITSAQNKNTKPNIIIINMDDMGYGDTEPYGMTGVATPHFNQIAQ
EGMRFTNFNAGQAICTASRAALLTGCYPNRIGMSGVLLPGAKHALNPSEETIASLLKKAG
YKTANYGKWHLGNVLPYWPTNYGFDEFFGIPYSHDVWPIDYDGYSIVTDPKDMRSGFPPL
PLISNTTIIDTIKNIKEASKLTTIFTEKAIDFIKKNKKEPFFLYLTHPLPHAPLAVSDKF
KGKSDLGLFGDVIMELDWSIGEIMKTLDHEGLSKNTVLIITSDNGPWLVFGDNAGSSGGF
REGKSTTWEGGTRVPFLIRWPGKIKAGMVNSSLMTNMDLLPTIAAITGASLPKNQIDGMN
FLPLLTGKEDKGPRDTFYYYFGVGSNNLEAIRYKHWKLVFPHKGTTYNKELQGKDGLRGK
GASAEFPMALYDLAHDPGELRNVQALYPEVVTQIQKIAETAREDLGDDLNNKVGKNVRKP
ALY
>EGALAKHO_01028 hypothetical protein
MPFVRVSLPKKLSLETKNTISESIHQSLIEEFRIPKDDYFHVIEELENHQIKYPENYLGI
SHSEEIVYVQIIAGQGRTLEQKKKLYQQIATRISSSTPILINNVIIVLLENNGLENWSFG
NGEIQEPKHLKK
>EGALAKHO_01029 Zinc-transporting ATPase
MEHTEEKIVKKKKNQSGCCSAHEEHNHTENDGHDHDHDHEHAAEGGIFQMFLPAIISFVL
LLIGIGFDNYFPQGWFSGYVRIGWYIVAYLPVGLPVLKEAYESITKGDVFSEFFLMCLAT
IGAFAIGEFPEGVAVMLFYTIGENFQGLAVSRAKSNIKSLLDQRPDEVNIIENNVTTKVK
ASDVKIGAIIQLKAGEKLGLDGELLSDTASFNTAALTGESKPATKVKGETVLAGMINGNT
IAQVKVTTDYKDSKLSRILEMVQNATTKKAPAELFIRKFAKIYTPIVVYLAIAICLLPML
FVDNYVFSDWLYRALVFLVISCPCALVISIPLGYFGGIGAASKNGILFKGSNFLDSISTI
QNVVMDKTGTMTEGVFKVQEVIIYHDVDKGEILKMINALESQSTHPVATAIHNYVGEIDS
TIELKNVEEISGHGLKAEINGKELHVGNFKLMDKFGINYDLDPNEVVYTTIAIAYNKKFA
GYLTIADEIKEDAQEAVTKLKALGVKVTMLSGDKTNVVQFVARKLGITNAFGDLLPEDKV
NKLNEIKAKNQTVAFVGDGVNDAPVIALSTVGIAMGGLGSDATIETADIVIQDDKPSKIP
MAINIGKQTKKIVWQNITLAFVVKAFVLILGAGGLATMWEAVFADVGVALLAILNAVRIQ
KMKF
>EGALAKHO_01030 Nickel and cobalt resistance protein CnrB
MKNILENLTTKFAKKRKHKVHKVIKLGALCGIFVLFVVNLSCNEKKTEETHEEEKSSTEV
ALTASQYKTIGIKTGFVENRNLNKVIKANGYTTVPPQNSAEVSTLIGGTVKDIYVLEGTF
VNKGKVLATIQNLEVIEMQEEFHSATANIEYLQLEYNRQKTLSDENVNPRKTFQEVKAKL
AAERARAQAAKNKLEALHVSTKGSTSLVPIVAPINGYVGKISIAKGAYAQTGVSLFEVVD
NSQMHLDLNVYEKDLGSISVGQVIDFVLTNQSNKSIKGKIFGINKSFSNESKTVAVHAKI
ESADAKGLIPGMYVSANINITNATVPALPKDAVVRNADKYFVFVEEAEHQEKQTGKEENH
EKEIHFKAIEVIPGTTDLGFTEVKFVDEIAPNAKIVTEGAFYLLSAMKGGGEHEH
>EGALAKHO_01031 hypothetical protein
MRTLHKINLKPLANFAKKTLRTLRLSAFLLASTLTSAQAKISLEKAIELAKSNNIDLKIA
DKEIEKQTVLKKTAFQAEPLQVQYQGGQFNSADFDHNVSIQQYFPIGNITKANRQLQEEL
VKLAEKRKALSSYEIEKAVTLAYYQYLYGVSIQRLNSELNDVYTKFLKNAELRFQTGESG
NIEVISAKAKVKEIETQKAQLEYDLAIYQKQLQFFVQTDENIIPDEKTALQYVIVKQEGD
SKAEGLLTDYYQQQISVYQKETNTYKAMRTPKLGLGYFAQSINTDWLYQGFTAGLQIPLF
GGVNSAKAKASEISISQSQLALDKSKLSLNLQQQELQNNFAKQQKALDYYQHEGLQYADQ
IISTAQKSYANGDMSYWSYISFLNQAIDIKKQYAEATHTYNQSAIELQFPSIKNY
>EGALAKHO_01032 Cobalt-zinc-cadmium resistance protein CzcA
MLDKIIQFSIKNKFFILLFTLVLIAWGSYSLKNLPLDALPDVTNNQVQIITTAPTLASQE
VEQLITYPLEQAVKTVPDIIELRSISRFGLSVVTVVFEDDVDIYWAREQIFQRLKQAEEN
IPTYAGSPELAPITTGLGEIYQYDVYAKKGYENKYDAIKLRTIQDWIIIPQLQGIKGVAD
ISTWGGKLKQYEIAVNPNTLNSLGVTITEIFDALEKNNQNTGGAYIEKDQYAYFIRGVGM
AKGVKDLGNVVVKNRNGSPVLVRDVAEVREGVALRYGASTKDGKGEIVSGLVLMLKGENS
SAVVNRIHERMIQINKSLPEGVVAEAFIDRGKLVDNAIGTVTKNLLEGALIVIFVLILFL
GNLRAGLIVASVIPLAMLFAVILMKAFGVSGNLMSLGAIDFGIIVDGAVIIVEATMHHLQ
KLKRKKDLTQSEMDIEVYNSASKIRNSAAFGEIIILIVYLPILALIGTEGKMFKPMAMTV
GFAVIGAFVLSLTYVPMMSALFLSKNTEHKANFSDRMMVWLENVYRPFLEKALQFKKIVL
GISLGLFASALLIFNSMGGEFIPTIEEGDLAINVSIMTGSSLTQMVETTTKLEKILKDKF
PEIKTIVAKIGSGEIPTDPMPIESGDLIIVLKDKKEWKGEYHNWEDLANAMKEEMEIIPG
INIEISQPIQMRFNELMTGSRSDIAIKIFGDDLEILDAKATELISKIRNIEGIGDLKADK
VTGLPQITIKYDYNKIALYGLNISDINQIIRSSFAGESAGKIYEESKRFDVVVRMNQDNR
ADITDVSNLFIPLPNGQQVPLSQVASVDYEQGPVQVTREDGKRRITVGLNVRGRDIKSVV
EEIQERLVRDFDLPSGYYVTYGGQFENLIKATNRLMVALPIALGLILILLYLTFNSFKQA
ALIFTAIPLSAIGGVFALFMRGMPFSISAGIGFIALFGIAVLNGIVLISYFNQLKAEGIL
DPLQRVLIGTKTRLRPVLMTAAVASLGFLPMALSTSGGAEVQKPLATVVIGGLVSATLLT
LIVLPILYLMLERFNRKVK
>EGALAKHO_01033 hypothetical protein
MKWIAILLSIYLMALSNMPCADMEVNSAMHKTAQFSSEANHSHDKDNDLCSPFCACNCCG
AQVLSYQISENIEFPLDFAMISKALPNYNSVFASNFYGSIWQPPQIA
>EGALAKHO_01034 hypothetical protein
MKCNTLISASLLFFSMQIFGQVYTDKIVGKKNEQLKDSLKTEKYPYALPIWGEKVAQKGY
KLPYSAGVSVNYFWQESEIVISNLEVGFNHGPLYNLDEIIRFDKSTVEAGALTIRPDIWL
LPFLNIYGIFGKANTSTKINAGVYVPDADNNWSEIANFSTKANFDATTVGIGMTPTIGIG
GGWLALDMNMAWTDISSLDKPAFSYIFGPRLGKTFQLPKPETNVAVWVGAFRVHINGDTN
GDLPLSDFIDLSNAQAKVDSGLAKVSENQTKVDNWWDGLSTAEQKNPVNVAKHNTANRAL
DRAGTFLSTLDGALSTAGDSSVQYSLQKRPKDMWNFIIGSQYQFSKHVMFRAEVGFLGSR
TQALGSLQYRFGL
>EGALAKHO_01035 hypothetical protein
MKKGLLLLIAFFCITSAKSQVLISLLFGDKLNSPFLEFGLDGGVNFSTISNMETSGTEVG
FNLGFYFDIRSKKNPAWMINTGVIVKSPMGAHGMPVYSLGDANLDNTFAGGRVDREIRYF
NVPILIKYQFKNNIYLKAGPQFGLLAKAFDKFRKEYDGDEVVYKHNIRDQIHVIDAGIAV
GTGYHMNVGNGLNMTVQYYYGLVTVMKGDGPKQYNRVVYITAGLPIGRGKAARKKAEKEA
ELNRVILPEEEAPKPGN
>EGALAKHO_01036 Chemotaxis response regulator protein-glutamate methylesterase
MEESKIISDCKVVIIGGSAGSLNALMQILPELTPLKGFSIVIVLHRKSTDDQTLEELIAL
KSSIEVKPVEDKVPLLPGFVYVAPSNYHLLFEKDNFLALDTSEKINYSRPSIDVSFESAA
EIYGSSLVGILLSGSNTDGTEGLKAIKAAGGTIVVQNPLVADMPFMPNNAVLYADPHFIL
RNHEILRLIVSINSPTN
>EGALAKHO_01037 Chemotaxis protein methyltransferase
MIEDIELETLINDVYEYYGFDFGSYSRASLKRRVNRIYHLDGFAHFHEFLSRVRYDPEYY
KRMVDEITVNVTEMFRDPAFYRVLRNEILPLLGTKPFIRLWHAGCSTGEEVYSMAIMLKE
AGLLHKSLIYATDINASVLETAKKGIFPLRMMKEYSENYRDAGGQEDFSNYYIANYGIAK
FNEELAEKMVYSQHNLVSDTSFNEFDMILCRNVLIYFDNDLQKRVINLFDESLAVLGFLA
LGTKETIKYSISPTKYKQFEKEKIWRKVK
>EGALAKHO_01038 Polar-differentiation response regulator DivK
MNKKRLLIIDDDPRNIFALENTLRAKSFDCLSCLSAEEALKILASEEIIDAVLIDMMMPE
MDGYEAIPLIKAIPSRRLTFVVSVTAQAMVGDKEKCLEAGADAYISKPVDVDKLLQVLKE
I
>EGALAKHO_01039 Signal transduction histidine-protein kinase BarA
MKNNFKRNLLISSLVSLLVLMISSTASYFSIKSLLDSNFWVNHTQEVIYNLNEGSAIVTE
AQTNMRGYLITGDEQFVERYNDAEVRSNDYFEKVKELTVDNPTQQKQLIELKVLRDSFFK
YLNNQIVKKRLGKDTVVFDLNAGRTMMNDLRAKIKSVESIEQGLLKERGENSERYGTYSL
VLIVVAFIIAFVISIVFLFRILKDYNERLILQNELVKKDQETAERIQAISMIASNISSGN
YDIRVTDTQSDALGSVGESLNNMGVSLKSSFELLSQKEWMQTGVASLNNVMLGDKTLQKL
SKDVIEFLCNYTNSSAGVLYVLEGDELHFSGGYSYIPGKNREHIQKGEGLIGQAIISKEL
LELKVLSPDDIQINYALGQIKPTHIIAFPLLDTRIEGAIELASIYGFSDLQIEFLKTIAN
NIGIALKSTQNRRRVMELLEETKSQSEELQAQHTELEAINAELEAQTEKLQASEEELRVQ
QEELEQTNEELSERSVLLEEKNNEIQKKSEALELTTRYKSEFLANMSHELRTPLNSILLL
SRLLSENNNKSMVPEEIEFAKVIQSSGNSLLGLIDEILDLSKIEAGKMDLEFLDVSTKEI
TDGLWNMFSHIAKEKNIKFEIIAKEAPIVIKTDKMRLEQILKNLISNAIKFTDKGSVSLE
IKVNTDDDKIICFIVKDTGIGIPLGKQPLIFEAFQQADGSTKRKYGGTGLGLSISRELAK
LLRGEIILHSKENEGSTFTLCLPVFGSAVNKINVEKIPPTDFTEVENEEKAPEKNKYLSA
VIPDEIEDDRDSVKEGDKVILIVEDDINFAKSLLAFTRNKGYKGIVSVRGDYALNFALLY
KPVGVLLDIELPIKSGWEVLEELKNHSNTKHIPVHIMSSHKLKQESLLKGAVDFLDKPVA
FDKIPDVFLRIEHIINKEAQKVLIIEDNPKHAKALAFFLETYNINAEIKSEVSDGLQALN
NTEIDCVILDMGIPDKQAYSILEGVKKNPGLENLPVIVFTGKSLSIKEEVKIKKYADSII
VKTAHSYQRMLDEVSLFLHLVEDKKDPKDKKDSHKKLNLLNNILFEKKVLIVDDDVRNIY
SLTKALEVFKMNVITAFDGKEAIKILGEHPDTDIVLLDMMMPNMDGYETAEKIRSMPKFL
NLPLIAVTAKAMTGDREKCIKAGASDYITKPVDIDQLLSLLRVWLYDKM
>EGALAKHO_01040 Phytochrome-like protein cph1
MVLIVDDIRANIIALKKTLELHDIDVDTAESGEEALKKILKTNYCLIIMDVQMPGLDGFE
VVKILSGNKRTKDIPVIFLSALNIEKKYIFKGYETGAVEYITKPVDSDLLILKVKTFIKI
YEQQNELKGMKDLLSKEIKIRKEAQDNLEIKIAERTRELVLKNEELELRNHELQQFSWVV
SHDLNEPIRKIQIFIKIIKELYLTADEKAIDYVDRTIKSAERMQTLITDLLAYSRLSSQV
KPETTDLNEVLQEVLSDFDYMIERKNATIKTTELPTIDSIPSQLRQVFQNLIGNALKFSG
NTDHPVIEITSELITEKSFDSPASPEGKFCRIMVKDNGIGFDEIYLDRIFIIFQSLNDRQ
KYEGTGIGLAIAKKIIEKHNGLITAKSQEGEGASFIIILPLKYE
>EGALAKHO_01041 General stress protein 39
MKKKKTFPEQKQNLPGNEHLMHPEPEIIRENYVGSGKLLGKVAFITGGDSGIGRSVAVHF
AREGANIAIVYLKEDKDALETKTLIEKEGQECLLISGDLKDEKFCKDAVKKCHTHFKKIN
IVVNNAATQFPQNELEKITASQLHKTFETNIYPYFYITKAALPFLKEGDTIVNTSSVTAY
RGSDHLADYASTKGAIVSFTRSLSTMLAKKKIRVNGVAPGPIWTPLIVASFDKLADFGKD
NPMERAGQPSEVAPAYVFLACEDSSYISGQFIHINGGELVGG
>EGALAKHO_01042 Sugar transporter SemiSWEET
MNYIDIIGLFAGTCVTISVIPQILKVWKTKKVKAISLKTFGILTFGIAVWIVYGILKKDL
PIIITNSVSFCLNLLMVYFIIYYEKES
>EGALAKHO_01043 hypothetical protein
MKKLYLNTGGFNTIFNDLKDSFDGKLVVNNNEYTLNIKSKWARGTIKAVRFEKEMSYVNF
DLVFNHDVTLSIESLQTAPVFFAYCEKGTLTHSFGANGMQKKIKENQTAVLNNTSVINSV
LFFESHKPIQFSLVGIPTVVSATEENIEMVSQLKKRFTTDSGQYLYIGSKNDKIAEKLQE
LNKIPQKGIVRNLLQKSILSSILEMEIAQHSYNYMNTFEPILHLATRQINEIKRISNINI
AEVFTAASRNYLPRIFKEKYHLSFKPYNQKLAS
>EGALAKHO_01044 hypothetical protein
MKKEQKHETDYIRKYQEEGYTANFLFENGCLLDSETKYAYKPEEIFIVAHHRYEGMSDPD
DMSILYIIETGDQKKGTHLIGYGPTADLEEAEFFKDIPEENYSVNADVQKLT
>EGALAKHO_01045 Phytochrome-like protein cph1
MTKVNQDFLAKGGEMGVLTRAKDWSKTAVGPVESWPQSLRTTLGILLNSKFPMFLFWGPE
HICFYNDAYRPSLGMEGKHPFILGEKGADFWPEIWDFIKPLIDQVLTEGESTWHEDQLLP
IYRNGKMEDVYWTFSYSPVTNDSGKIDGVLVICNETTDKVKMLNKLEESNTRYLNNILQT
PSAMCVFRGPEYVVEIANALMLELWGKKSSEVQNKPIFEALPEVKGQGLETVLENVYTTG
EKFEAHERLVKLPRGGEIEDIYVNFVYEALKETDGTISGIVAVANDVTAQVDARKKLEDV
EQRARLAAEIAEIVTWDLDVTTQELIYSENLPALFGHKKNKKLNRPDILHQIHPDDLSIL
EKAYKVALKTSIYKYEARIIKPDNSIAWIKAHGKIFFDDNVEPIQMIGTIIDITDEKTSQ
DILMKSEEKFRLLADSMPQFIWTGDEMGNLNYFNKSVYTFSGLSEEETDKEGWLQIVHPD
DRELNINKWMESIQTGNDFLLEHRFRRYDGEYRWQLSRAIAQKDEEGNIQMWVGTSTDIH
DQKNFTDKLAKEVYERTAQLELKNKDLINMNIELQSFAYISSHDLQEPLRKIQTFASRLD
DLDDGSISAKAKTYLNRIEVSAKRMQTLIQDLLAYSRTNSADRVFVKTNLDEIAEEIQSD
FSERIEETNAVIDFDPLGEATVIPFQFRQLLHNLIGNSLKFSKKGEVPYIEVRANRIKGK
EIEIPVTYPEKMYYHLKISDNGIGFDDEYKERIFEVFQRLNTESEFSGTGIGLAIVKKII
ENHKGIITAHSEKGKGATFEIYLPEL
>EGALAKHO_01046 Response regulator rcp1
MTNLTIFYTDDDEDDLSIFADAIESLPEKIQLKTYNGGDKLLTAIYNPPPTPHVVFLDLN
MPGKNGFDVLTELRSSDKKDIPVIIFSTSNEPGIIEKCRLLGANLFITKPVLMKDIVKSI
EHALQVNWKEFVPDTKNFVYKS
>EGALAKHO_01047 hypothetical protein
MGDHKDLTNEFAVDKIKDLAENIKTCMFCTYNEYRLQSRPMSVQKIDDLGQLWFLSDRNS
SQNADITLNPQVELFFSEPHDKFLTLHGTASISYDREKIKELYDPIVKVWMPGGVDDPNL
SVIKVVPEDGYYWNNKNGKMVAIAKMAAALVTGKTMDDGIEGNLTLE
>EGALAKHO_01048 hypothetical protein
MKNEIQIGCSSFNNRFWKGIFYPENLPTSKWFDFYCQHFSTYEFNGSFYKFPTVRVFENW
YNKAPENFTFSVKAHKEITHIKKFINCEDLIADFYQICKLGFKEKLGAILFQFPPSYKYS
DENLQLIINNLNPEFKNVIEFRHESWWIPEVWNAFLANKITFCSVSYPNLPKTIFTNFPL
VYMRFHGIPKLFYSGYDTVELLQIKAEINSKPGFVYFNNTASEAGILNALEFKRIN
>EGALAKHO_01049 Formamidopyrimidine-DNA glycosylase
MPEGPSIVILREEVQQFTGKKILEVSGNSSIDIERLKDKTIQEFKTWGKHFLICFEGFTV
KIHMLMFGTYRVNERKETQPRLSLVFSDGEINFYTCSIKILEGDINDIYDWSEDVMNDDW
DPKKAKKSLEKIPNEMICDAILDQNIFSGVGNIIKNEVLYRCHIHPESLVGKIPFDNLNE
IISECSIYSFEFLYWKKKFELKKHWEAYTKKVCLRCNLPMIRKHTGHRNRRSFFCTNCQQ
LHT
>EGALAKHO_01050 hypothetical protein
MKTATNKKETTTKSKATAKTTSKTGVTKPKSDAASGLTELFEDGLKDIYWAEKALTKALP
KMAKNATSPELIDALNNHLTETEGQISRLEQVFELIGQKATAKKCDAMAGLIEEGNGILE
ETEIGVVRDAGIIAACQKIEHYEIATYGTLRQFAETLGMEEAASLLEQTLEEEKGADKAL
TIVAVNAVNFEAAEAD
>EGALAKHO_01051 hypothetical protein
MNTTEQKNSTTSNRDPRNQNLKAADKNSVMNEELYDIDDMKETDDDNATIGERGYTVRNG
HNPDGVNPDEMIYDRKDIEELDDDFHSKKDLVHTSDDLYDDAVDEDLDPAVDELDNPSDV
REREDGDFNEVDDLEDIDPDDEDDDNEFKEEEIEEEDSEEDYPANDPRKF
>EGALAKHO_01052 hypothetical protein
MGTQSGAYQDVYIKRDDEMVSLKKDVTDFCEKYIKPVHPENWDWSVRDFENPKNDPTVEE
ARAIGNVVYNDLKNKRTDVDLSTMNNVEAIAAYLNPNSKHEQFNMEEFAFALKVELEHGK
IKDVNVTNNHPFLTAMIALAHMTESLTYYKRLKVMEAEGEIYEIMRKIESSETGKEEWYK
ELGKAEQELNEARAGLAERLEKMDDIPALEKIGD
>EGALAKHO_01053 hypothetical protein
MLRWTVIFIILAIVAGIFGFGGIAAGAAGIAKVLFFIFIVLFILSLISGRRSI
>EGALAKHO_01054 hypothetical protein
MNATAIAKAEKLVNQLIKTPHLVLEKLDLVYISHQELTIERCKCEEGFIYKKNGRCIKQK
SELKRINSLVLPPAWQNVQISNLPNGHLQAVGLDDRNRKQYRYHPKWNLIRNQTKFYKIA
EFGSKLPAIRKQVDEDLERKEWGREKVVALVIRLMEETHIRIGNEKYAKDNKSYGLSTLR
KRHINIDKNSLRFEFVGKKGIQHTITTKNKKLIKLVSRCEEIPGWEVFKYYDRNGEKKVL
DSHMVNEYLHNISGEYFSAKDFRTWAASIIFFETLMEIGTTSDEKEIKKNILEAFDITAE
ALGNTRNVCKNYYVHPLLVSTYEDGSIQHYFDRAKKSRSNQKYFSRTEIAFSELIQNYQL
NLL
>EGALAKHO_01055 hypothetical protein
MYATTKSDYRGLLKEGYNKTESGQVSTKKNPDLKGEKTKPYEEWTKEELYQEAIKADIPG
RSYMSKKNLINSLKKI
>EGALAKHO_01056 hypothetical protein
MNGSTAIKNSSLIFSLVFFAFLIYVSIGLFSIFSITITDKGIEKKALISGKKEFIPFTSI
IGLAREKVRMRTKSGALTDGYTVTILKLQNGKKIVISPDDFDNYKELILEIKNHLE
>EGALAKHO_01057 hypothetical protein
MKVKKESSSSQILWGFLSICGAVLLYYELSKLEASGGTMTVNVIIAVLYNLFGKNVAVGF
FAALGFFITISGILDFKNDKKVKAIEEEENKSEFISFSDEKFEIIRKLSDEEIDYFETLN
LKIIESQIYQQYWTDFLDYENEEDENWLNISKYFWKADEPFYNTSLPKDFKHYQHLKFTF
VDDNIKENLKIEKLYGIVEKFHVEEENRVISISELLERGLIAYCKIVDLAYESINDIKHY
QSDFFFAITNPKITSLNNELYIGKNKISIDLAYAVGGIELVRTLPTKETNKKYETKKLLN
QAEMLSSTPQNSEYAVKKTSSIETTMVANHVFTTTTKKIDYSNYVPDVENKQLYFETIIL
LMNFIQHNDKSIDITKNKFYILALENSNSLKDFTGDELENRIFENAKKCFVEFTDAQLGY
LVRNSVNVLKGKFAIDSDISNLYYKLFGVFEFRTITHEVYFYSLLE
>EGALAKHO_01058 hypothetical protein
MRVLKIIGGLALLIFSAILTLATIMSFLNSLPQIRRELAESISGGIGYLFGSMLVVIALI
ALIYFSVKKALKLLQPKQLREDTIDDIG
>EGALAKHO_01059 hypothetical protein
MNSHTNNQIKTLVRNLFFSSLIFCFSVIVSNLSAQQLTFNPNKSGNGLIFGSLTFPKEKA
RFNGYFLQINFISTDPKVARKNFKEAKFFPAQIIKMRHKGDLDNGLTYLFAIERPAGDYE
ISGIRLFSNSGFAVLQRNDNIGGLSIPFKVNKGEILYVGNIQFNEYAADNETVFNYQNNF
EKDLSGIKKAEPYIYWDAAKKDDSIKISNSK
>EGALAKHO_01060 hypothetical protein
MKKILLATKVILGAGLIILFLNSCKNEPKQEDPKEVAEDANEAKFDSIDSKEDDSEFLVD
QAEVNLAEIEIGKLAQTKGVNPEVKKFGQMLVDDHTKAASEVSALAKAKNFTLPTSLTED
GQEEYKKLNEKSGTDFDKKFADMMIDGHEKAIKKLEKASKDAKDPDVRTWASNNIAGLTA
HLEHAKMLKQNLDKK
>EGALAKHO_01061 Aldehyde reductase YahK
METKNVKAFGTEAAEAPLKTLDIKRRAVQAHDVEIEILYCGICHSDLHSARNEWHGTVYP
IVPGHEIVGRVVKVGEHVKNFTVGQLAGVGCMVDSCRECEHCKNDLEQFCDEGNILTFNS
PDKHLGGQTFGGYSQSIVVDENYVLHISDKLDLAGVAPLLCAGITTYSPLRHWKVGPGQK
VGIVGIGGLGHMGIKLAKAMGAHVVVFTTSLSKTEDAKRLGADEVVLSTNPDQMAKHAKT
LHFILDCVSAEHNIDSYLNLLKVDGNLVLVGAPMDPLPVTSFSLILGRRSFAGSAIGGIK
ETQEMLDFCAEHNITADIEVIGVNEVNDAYERLLKGDIKYRFVIDMASLK
>EGALAKHO_01062 hypothetical protein
MSTNYTTVIEEGKVPNTYMTGEVSYKKQTSNIHPENTMIKEVTFEPCARSNWHINSSLHM
LIAKEGVGYYQEKGSAVRLIHKDEVITILPGIEHWYGATPFRKFSYLAIITEIDKGHGEW
LDSVTDKEYHSFGS
>EGALAKHO_01063 hypothetical protein
MKTSENQLNEIFPKGDLASADYFTGKAWVKMLVPNDPVLNTAVGNVVFEPGARNNWHTHP
GGQILIVTHGTGYYQEVGKPIQLLQVGDVVNIPPELKHWHGASPDSEFTHIAISTNTQTG
IVDWLEPVTDAQYNSFK
>EGALAKHO_01064 HTH-type transcriptional activator RhaS
MKEQLDFQASEVGLNDLKLKGFKVYEINGDVSKIPTYNRRDFYKICINTSKSLIHYADRG
IEVDGTILFFGNPHIPYSWDTLSPSYEGFACVFTEDFLKVNDRSASLHESPLFKIGGTPI
FSLLPEQKLFIDSLFQKMIEEQETDYVFKDDLIRNYINLILHESMKMQPSENFFKHKNAS
SRITSLFLELLERQFPVETKDQPLILKTPQDYAQSLAVHVNHLNRSVKEVTGKPTTAHIT
ERIIGEAKALLQHTDWSIADIGYSLGFEYPSYFNNYFKRLTGTIPKSLRM
>EGALAKHO_01065 hypothetical protein
MKDLQPVIDYVSRYVDLTDDEKTHLASFLKITKVKKRQFIVQPGFVCQHKSYVVKGAFRG
YLVDNEGKEHTLSFAIEDWWISDYSSLIYQEPATLFVEALEDSVLIQIAYEDEQRFLQEI
PKLEKFERIITQRSLAFQQKRLLSNFTKTAEERYDEFMYKYSAIAKRVPQYALASYLGFS
TEYLSKIRNRKSSKS
>EGALAKHO_01066 hypothetical protein
MKNTILITALSILFVACDSEKKSGTTSASFQSKYTITDTGLYPEGIDYDSKNEKFLFSSL
YKGAVYVMDSKGESKVFATSSKLVLPTGIYTDELRNRLIVANADLGISQKSTPTSAGSIA
TVSIFNLTTGELIKEIDLKNFTPNAGSCLNDITVDTKGNIYVTDSFSPNIYKIDENYNAS
LFLTNTLFQPAPNQFGLNGIVFHPDGYLLVVKTDDSKLFKISLSNPAVITAVTGTTFSAP
DGIELDKNNNLVVVENGLALGKTYTFSSTNNWASASKISETNIGKEEFPTTAALASDGNV
YVVNSKLGKLLAGDKTQSSYIIQRIN
>EGALAKHO_01067 Beta-galactosidase BoGH2A
MKTTFPKEILFCFIFLISFCTSAQNKSERELTLIDKDWRFSFGHLYDTQKDFGHAEGYFS
YLTKTGFGDGPAASGFDDRAWRILDLPHDWAVEQLFSEKASYSHGFKTAGKGFPEKSIGW
YRKKISIPETDKGKIISLQFNGVFRNSKVFFNGYFLGTEESGYNGFEYDVTSYVNYGGEN
TIVVRVDASMEEGWFYEGAGIYRHVYLKKTNPIHVIENGTYVTSEVKDNNAEITAEVTIE
NKGNNKSSVEITETIFEGSGKQIASVSENVQVPDFYQTANFISKLNVKNPLLWDIENPNL
YRLETQIKQNGKVIDRYETPFGIRTIQFDAEKGFFLNGKSVKLKGTNNHQDHAGIGTALP
DELQYYRIKKLKEMGSNAYRCSHHPPTPELLKACDELGMLVIDETRLMGINNYHLNDLKR
MIERDRNHPSIFCWSVGNEEWNIEGNTVGERITNVMQGFAKSIDSTRPVTVGISSGFKSG
ISSVVEIMGYNYLGNGDIDAHRNEFKNQPGMGTEEGSTFATRGIYFTDDAKHYQSAYDKK
PRPTFYSIEEGWKFYAGRPYLAGVFFWTGFDYRGEPTPYGWPSVTSYFGMMDVCGFPKDN
VFYLKSWWGNEPVLHILPHWNWSGMEGKEIDVWAYSNCDEVELFLNKKSLGKKKMEQNGH
LEWKVKYEPGTLEAIGFKNGKKILTEVQKTTGNSEKIKLSVDKENLLNSNIVVVTAEFID
KKGLHVPIANDEITFSIKGGKILGVGNGNPTSLDRDKFIDDINLFAINNFKEKKLISAEL
PDKIEGYADNEWNDAFKDRDYKKQAPAYVYKGDFELKNNLDSNIVTFFYKKIGKETVVFV
NGNKVEPSKDDSQKYILNKAILKEGKNTIYIATTPLEKIKDWDVMNTDPGIIQIVTPAEQ
WKRKLFNGYAQIIIQKDEGEKEVSLTASSKGLKSGVLIVVR
>EGALAKHO_01068 hypothetical protein
MSVIKDESTLLSTIKRIDDKIDKLNDQKIIAFFDHLGLPERPDIPKDFLKWETILIVVPN
RHISHELKYFKYSISRLSFVTNPYAKQIHIYDFKEWNAITRNKTQFQVRELLKTSFGGVR
DITEGMN
>EGALAKHO_01069 HTH-type transcriptional activator Btr
MKWITRERPKIDRIACPWLIKKFVDQDAEFIYVPFDEVLAKAEVLNAIPFDIPNVEYTHY
NEECTFDYIVKKHEIKDPAILIIAKIVRGADTDQHEIAKESAGLWAISAGLSHNITNDAE
LLTSGMVIYDALYSWATHLYKQNHLQNSPFESLLHEVYNKFLAEKKSNQKTPSWVKDLKE
IIQDQIDTQFAFDLKKISSDLELNPSYLSREFSKYFEDLNFGEYVRKLRIEKAINLIQNS
AYTLTEIAYMTGFSDQSHFTRIFKLHTGKNPSSYRKNTLKSKPDTKGK
>EGALAKHO_01070 hypothetical protein
MITFRHIAIIASFFTTISIFSQTTYPKITGYFGILHPIVTISSEQTNLNFRDYYAVGFPT
GINIWKSSKIGFSFEIVPNIKVQGASDKVTNILFHPGVLVALGKGYTFAGRAAFESSGRY
GFTPVINKTVLKSDNCSYFVAVPLPVRFGNDHPATFTLGFQFGIAF
>EGALAKHO_01071 putative chromate transport protein
MTDSKYSLKELTLYFLKLGTVGFGGPVALVGYMHKDLVENRQWISEEEYKQGLALAQLAP
GPLAAQLGIYIGFVHYRLLGATLIGFAFVLPSFLMVVLLGIIYKLYGGLSWIQAVFYGVG
AAVIGLIMVSSYKLTVKSIGKFNLESLKLNWLLWLFFLIALGVTFITQQEPVLLFIAAGF
LYMLIKAPPKWWNSRVASSILLLQVSFWNYESTTLLKIAIFFAQAGTFVFGSGLAIVPFL
HSGVVTENHWLTEQQFLDSVAVAMITPGPVVITVGFIGYLVDGFLGALVAALATFLPCYL
FTVAMAPSFHKIAKNKSVKSFVDGITAAVIGALVGSVFVIASRTIIDIPTAFIAIATIAT
LLYVKNIAESYIIIIAAVVGLIIKFI
>EGALAKHO_01072 hypothetical protein
MESKLSLLDFRERLKNNTEIGSPKAALGQVRIFPISGAIKPFYGFFDDKSFRLTVNSPKS
STPFIVKGNYKDVNNKVRVDYSVESNNKFQVIWARYSPIILILAINIFFLFFARGLRRAS
TIVNLFLLFMAFYSRWNEEKKRKKLEQKFIQIFRIIE
>EGALAKHO_01073 Thiol-disulfide oxidoreductase ResA
MKKTLLILAFLCCIINSNAQVVGLEVGDIAPEIDLPDTKGTNVALTSLRGDLVLIDFWAS
WCGPCIKEQPELIKLYNTYPGKLSIYSVSMDTKKPLWLGAIAKQKLPWIQVSDLKYWKSP
AAVDYMLQSVPLNFLIDKNGIILAKNIHGNALNEMVKSILAPQQN
>EGALAKHO_01074 hypothetical protein
MLEWLKEPEIHFPDQLQHAGFEHGVCVGQIQAKAGLTQSTVSEYLSILQRAGFIEAKRVG
QWTYYKRNEGAFEALSKLIQTNL
>EGALAKHO_01075 NADH oxidase
MSTNNLFSPFNLKTLNLKNRIVMAPMTRSFSPNGIPTDDVASYYQKRAEGEVGLILSEGT
VINRPSSSNDANVPHFHGDAALKGWKKVIDEVHAAGGQMGPQIWHMGIMDNHHSGWVPPV
PFEGPSGLNRPDFRNGVAMTEKDIEDTILAFGQAAADAKRLGFDTIEIHGAHGYLIDQFF
RAETNLRTDIYGGKTLPERNRFAIEVVKEVRKQVGDDFAVIMRFSQFKPSDYNYKLAKNP
QELEAWLTPLVDAGVDILHCSQRRFWEPEFEDSDLNFAGWAKKVTGAPTITVGSVGLSGD
FFGAFAGESSEPTSLEELNRRFDRGDFDLVAVGRPLLSDPNWVAKIKAGKMDELKGFNKE
ALGQLVLE
>EGALAKHO_01076 O-acetyltransferase OatA
MSSTSIDIQPKKHYQILDGLRGVAAILVVAFHIFEAHNGGSRFNQIINHGYLAVDFFFLL
SGFVVAYAYDDRWGKMTQWEFYKRRLIRLQPMVIMGMIIGAIFYYFQASDILFPMIAGME
VWKVILTMVIGFTLLPIPPSLEIRGWGEMHPLDGPAWSLFFEYIANILYAVLFRKFSNKV
MTVFVLIFAGLLINYTVFGPKGDVIGGWSLNLEQMNVGFTRLLYPFFAGVLLCRLGKLIH
IKGAFWICSLMISAVLIIPRIGDENSLWMNGLYESFCIILVFPLIVAIGAGGEIKSAFSA
KICKLLGDISYPIYITHYPLIYWYTAWVVDNKVEIKDGYVIGIGVLISSIVIAYLCLKLY
DEPVRNWLQKKVQGSKVQRFKGTK
>EGALAKHO_01077 hypothetical protein
MMKNILLAVITLFVAHNLSAQSLNKMQWFNEPEKWEIKNNALIMNVTASSDYWRISHYGF
TVDDAPFYYATYGGEFEAKVKITGNYIARFDQMGLMIRIDEKNYIKTGVEFVDGKFNIST
VVTHDKSDWSVTTLDKAPPFVWIKVVRRLDAVEVFFSYDDKNYILTRNAPLQDNTPVMVG
LMAASPDGKGFEAKFENFSVKHLPDQRRLEWLKNHQE
>EGALAKHO_01078 Beta-glucosidase BoGH3A
MFKNVKTLLVILMLSSFGINAQNKVPVYLDDQKPINERVEDALSKMTTAEKIAIIHAQSK
FSSPGVKRLGIPENWMTDGPHGIRTEVKWDEWDQAGWTNDSCIAFPALTALAATWNKDLA
SLYGKSIGEEARYRNKNVLLGPGVNIYRSPLNGRNFEYMGEDPFLTSKMVVPYIKGVQSN
GVAACVKHFALNNQETNRNTVNVIVDDRALYEIYLPAFKAAVQEGDAWAIMGSYNKYKGQ
QCCHNEFLLNDILRGEWGFKGVVVSDWGGVHDTKQAIHNGLDMEFGSWTNGLSWGTSNAY
DNYYLAKPYSEMIRKGEIGTKELDEKVRRVLRLSFLTTMNKNRPFGSFGTEEHAQAGLKI
AEEGIVLLQNNNNILPINLSKTKKIAVIGENAIKMMTVGGGSSSLKARYEITPLEGLKKR
IGNQAEIVYARGYVGDPTSNYNGVIAKVSLEEKRSPAELTAEALKVAKDADIVLFIGGLN
KSPNQDDEGHDRKGLELSYGQDKLISELAKVNKNIVYVNISGNAVAMPWVKEVPGIVQGW
FLGTEAGNALAAVLVGDVNPSGKLTFTFPVKLSDNGAHALGDFPGGDEVTYKESIFVGYR
WADKQKVKPLFSFGHGLSYTTFEYGKATADKKQMTAGDQITFSVKVKNTGSREGSEVVQL
YISDLKSSLVRPIKELKGFEKVSLKAGEEKTVTFTVDKTALSFFDDKKHDWVAEPGAFEA
LIGASSTAIKSKVSFSLQ
>EGALAKHO_01079 hypothetical protein
MLFFLLVLLGNPVHASDSTDTILDKLNDALRNKQHYVQLKEERILNFKKIKSDDLTKEQE
YNYNKTLYTEYQKFNSDSAIFYVKKNLKIAEELQNKDLSNLAKIQLVTLYSSSGKYRESE
ALIKSIDKKTLSKALLPNYYVAYREFFEHYAANSYSVQYMQQIQKYRDSLLMVLDPGTLN
YKINKIQQGMYLKMGMAQKQLKALLETIKEDNPQYAMITYLLGSIYERSHQLELRKKYYA
LSATADIKNANKDNASLQELALVFYEIGDVDMAYKLTQSAIEDALYCNVQFRTLLMSEVY
SIINTVYLEREAKRKTELQLYLLCISLLSAFLIVAIIYVYKQMKKVSRIRGELYDTSQKL
AELNKDITETNNQLQERNAQLSESNHIKEEYIAHFFSLCSTYINKLENYRIILNKKATAK
QFDEIYKMLKSTTLVDNELEELYKNFDIIFLNLYPTFVKDFNELLIKEEQIVLKQGELLN
TELRIFALIRLGITDSVKIAAFLRYSLSTIYNYRTRARNKAAVSRNDFEEMVMKIGLISL
KM
>EGALAKHO_01080 hypothetical protein
MPHFVIDCSENVIRLNSAEEIMQEVFNAALSTDLFVASEIKVRINPFSYYNNGNTLDDFI
HVFGYIMEGRNTDQKAKLSKAIVTSLNNILAEVPVISINIKDFEKASYFNKTMI
>EGALAKHO_01081 Caffeyl-CoA reductase-Etf complex subunit CarC
MKNTKLQAFIPLFYLVWSDDLLTQKEFATIQQFINDLVWLSPEEKEQLLSKVDISNPPSR
NELAQWKLDIEKSIQDKSSIKSIFDIAEALSEKDLDISTVKPEFTKLENDLGILGEEVIQ
NFKTKADSFTANSQTTSNFDIQKITELLDGKEAAIIKKVKSVISRPEFAYETSTDINVYR
QTVYNWCKILAEENLGSMAYPKEYGGGGNVEDYFAIMETLSYHDLSLVIKFGVQFGLWGM
SVQSLGTEKHYAKYLKDIGSLKIPGCFAMTETHHGSNVKGLETTATYNHNDQTFTIHTPN
KNAQKEYIGNAAVHGQMATVFAKLIIDNHDYGVNAFVVPLRDTNGNTLDGITIGDCGHKM
GLNGVDNGTISFDNVVIPKENMLDRFASVNEKGEFESPIPSDNRRFFTMLGTLVGGRIGI
PRSALAAAKSGLTIAIRYSDQRRQFGPEGGSEVPILNYRMHQRRLIPPLAKTYAVHFALQ
YLTNRFLNRTEDEMQEIEALAAGMKSYSTWSTRDILQECREACGGKGYLSENRIDALKND
TEIYTTFEGDNTVLMQLVAKNRLSEFRKSFGEMGSLGIINYVYENAKVAITEKNPIATRR
TDDEHLLDDQFHLQAFIHREKTILASAAQRIKKLVDNGLEPYDAFNVVQHQMIDVAQAYL
ERVVLEQFQAAIKTVQDEKSKEILTKLNQLYALSQLEKNKGWYLEDGYMEAVKTKAIRKM
VNQLCWDIRPDAVALVNAFDIPESCLAAPIAVN
>EGALAKHO_01082 hypothetical protein
MKTTKYYIAAITCFAIWGFFSLVLKPIHDYPSLDILFYRVFSCSILMLLIVFAFKRKKLV
ETVLIFKALSASEKRKAILLNIGGSVFLMLNWFTFIYVMNHISVKATSLAYLVCPILTTL
LAYFLLKEKLSKTQWISVGLSVSGCLLLSYTAIMDMFFSIIIGFTYACYLVSQRINKGFD
RFIILTFHITLAALFLLPFYPAYSGPVPTEFKFYFCIETIAVLFTIFPLFLNLYALSGIN
SSTVGMLLNINPMIAFCLASFVYHEVISPLQIAAYSIIFIAVIIFNSHHIFALKQKYTLS
SKDSI
>EGALAKHO_01083 2-aminoadipate transaminase
MRNSNYLYLQFADRIEKQIKSGVLNVGDKLPSIREVCAETGYSMSTVSKAYYEVESRSLI
ESRPQSGYYVSNTSARIIAEPSPSSPDLKCLNIDREDLIDQVYGNMTDKNITMLSLGFPS
NELLPIAKLNKGIIQATRQLPNSGTSYEQVQGNLNLRKEIARWSFTWGGSLTEHDIITTP
GCTSAISHCLMTLTKPGDTIITESPAYFGILQLAKSLGLYIMELPTNITTGIELEALKKA
LATKKIKLCLLMSNFSNPSGSMMPVEHKIEVVKLMEFYNVPLIEDDIHGDLYFGSSRPTN
CKTYDESGIVLCCSSVSKTLAPGYRVGWVSPGKFKKQILRNKIYHTLSSPTITHEVVGDF
LKNGRYENHLRKIRQILNHNCNNYINTVLESFPTGTKVSQPQGGFFLWIELDKNVDTAAF
YHLAMKHNISIAPGRIFSFQDQFSNCMRLSFGLPWTNELRESIKTLGRLLHY
>EGALAKHO_01084 hypothetical protein
MLLKKRIPMKYVLGKIKVELALVLTYTILFEVFHHYFINVSVDVPIAIPTMIGTIISLLL
AFKSNQAYDRWWEARIVWGAIVNESRTLVRQMLTFYKDPDFSVEANEFKENFTKRQIAWC
YSLGQALRNKDAIKPIKDLISEEEVNFVKNHQNVPNAILLLHGRDLRIARKDRRLNPYQQ
VEIDNTITRLCDAMGKCERIKNTIFPTTYSMYIRMTLCLFILLLPFGLVNLLSWFAIPLI
TIIGGMFFLIEKMAIHLQDPFENRPTDTPVTAISNTIEKNLMQMLNEYQSEFDIIKEFDL
KPETKKATADAYFVL
>EGALAKHO_01085 hypothetical protein
MKNFLIPTTLEEDTISAVKSAVNQAKNTNCEIILMMVSDTPDTFSSAQFLREMRVSLTAS
QELVLETCRYIIEHTANCKIKIHNQYGLSAPIFKGIIEAFDVKLIVLTQSYKQETKRIHQ
YAMQLAGNQKCPILHLGNEQFKEDFNKALYIENGNANMHVKDVQQYLSANFSFEIVSQTS
KFDDNYEEFAPYLSEAISKYDIDLLVETRKGEKIKFTKNKKTNSNDRLGLPVLSLYEELT
>EGALAKHO_01086 Signal transduction histidine-protein kinase ArlS
MDIRKKITFTYVALSTFSTLLLCVLVFVLFRENNRYHFLKRLEDRAKIVASIHFQKDPEK
IKYYSNLKKNGLEELIEEEEYVLKINSANSFDYNTKLNLPNEFYSNILETGRDYFEVNSK
YYLGQVFTENNQKYIVIVGARDRRGKTTSIYIIKILLFGGIGFVILAFFLGRFLAKRVIN
PVARITKEVNRISASNLHNRLPEVKNSDEISDLTHTFNDMLDRLETSFEIQANFINNASH
ELKTPITTIIAESEIMLLKERAVPEYIQSLENIYSQASRLGNLTESLLKLTQTGYDGKKQ
VLDIARIDELLMDVKSDLDKIYPDNRVSIKLNFAPKESNLLLIPCNRPLLELAINNIITN
GVKYSDNNEVFVTLSANKDWIKISINDIGIGIPPEDIPHLYEPFFRGKIAAKYIGYGLGL
PLASKIIRMHDGEIQVQSEQNKGTIVTIIFKKDNTKKVNIRNSNVES
>EGALAKHO_01087 Transcriptional activator protein CzcR
MKLLIVEDEPNLLSILRKGFAENNNDVSVALDGKTALEMIQNYTFDVVILDVMLPDINGI
EICRRLRADKNFVPVLLLTALGTSENIVTGLNAGADDYVVKPFKFGELDARVNALNRRAN
QETEKVDSIIISDLEINSKSKTVKRNGESIVLTAKEFKLLYYLAKNTGRIVSRDQILDNV
WDINFDMNTNVVDVYINYLRKKIDKPYTTKLIHTMKGLGYVIQP
>EGALAKHO_01088 hypothetical protein
MVKFLKNNCFQKKYKILVLLFFIHFASIAQNDSINPNICPPKTILEIFKKKDSIYVVKPI
KNSFFLVIPAIGSQPATGFFFGAVAQYTFKGKEKADKYSIANVGITYTTKKQWLVNVKNN
ILLKNNKIFLSGDYRLYIFSQPNYGLGTNIIPPARDKAPGFSIDSIAQAMDYNYFKFHQA
ASFEVKKNFYVGGGINIDWYSSIVDKELDLANGKTTYHYEYSQKYGFDNLEYFLTGVSLN
LVHDSRDNQVNATRGWFANINYRFNPVLFKNQDNSNVLYAEYRHFIPVSKKNDRYILALW
TYGQFVTSGKVPYLNLPAIGWDQRSRSGEGYTQGLFRGTNLVYLASEFRFPITCNQMFSG
VVFTNFVTTSNPETNTKLFHSVQPAAGLGLRILIDKATRTNLIVDQAWGNSSKGFYLNAG
ETF
>EGALAKHO_01089 hypothetical protein
MKKESEYFLDKEYDAIVYGRDEANFKDFECCVFNNCNFSACTFLAVTFIDCVFNDCIFNE
AKINYVAFRTATFNRCEIKEVNFAMCDKLIFEIHFYDCVLDFSKFYTLKIKGTTFTNCSL
IAVDFMATDLTSVLFDNCDLYRSEFDKAIANKADFKTSYNYSIDPSKTKLKKAVFALKEV
KGLLFKHDVIVRN
>EGALAKHO_01090 hypothetical protein
MSFFGLSPIYITKINSIFLQYPDIEEVIIFGSRAKGNFRDNSDIDLAIKGKVISLSILHQ
IENKLEELYIPNFIDLIVFDNIENSDLINHINRVGKQFYKKGSFNL
>EGALAKHO_01091 hypothetical protein
MEDIRWEQRFSNFNKAVLKLEESVNYIKLNYLNDEDELNDENLENVVEELIKEGLIQRFE
YTHELAWNVMKDYAFFQGNSTIGGSRDATREAFKLQIIENADIWMDMIQSRNKTSHTYNE
EIANEIFGKIIKDYFQLFLNFQKTMEEKRSSEQTNLTL
>EGALAKHO_01092 hypothetical protein
MITISEAKISDIKLIQNIVHITWPITYGEILSKQQLDYMLGLFYSTEALTEQYDKKEQLF
YMIYEEETNLGFIGIEHNYNGEALTKIHKIYLLPETQGKGIGKKVIDEIGKLASDNNSTA
LILNVNRFNSALGFYKRIGFEVVEEIDIEIGNGYLMEDYVMEKRL
>EGALAKHO_01093 GMP reductase
MRIETDLKLGFKDVMIRPKRSTLKSRSEVSLERNFKFLHSTTIWTGIPIMAANMDTVGTF
EMAKVLSKEKLFTAIHKHYSPQEWNDFLKDQPEDFYNYIAISTGTGKEDFAKIGQVITAN
PLLKFICIDVANGYSEHFVQFLKQTRKQYPDKVIIAGNVVTGEMVEELLLAGADIVKVGI
GPGSVCTTRVKTGVGYPQLSAIIECADAAHGLGGHIISDGGCSTPGDVAKAFGAGSDFVM
LGGMLAGHTESGGELIEVNGEKFKQFYGMSSTTAMDKHVGGVAEYRASEGKTVQVPFKGK
VINTVLDILGGLRSACTYVGASRLKELTKRTTFIRVSEQENQVFTK
>EGALAKHO_01094 hypothetical protein
MGVLRLQLPTDPRWVNIVEKNIEEILTDHAWCEQKAATNAITIITNNSEHQDLVKDLLAL
AKEEIDHFEQVHNIIIKRGLKLGRERKDDYVNELYLYMKKSGDGSRVSGLVERLLFSAMI
EARSCERFKVLSENIQDEELAVFYRELMESEAGHYVTFITYARKYGVGIDVEKRWREWLA
YEESIISNYGKGETIHG
>EGALAKHO_01095 Serine hydroxymethyltransferase
MQRDEQIFDLILEEQDRQIHGLELIASENFVSDEVMEAAGSVLTNKYAEGYPGKRYYGGC
EVVDVIEQIAIDRAKELFGAEYANVQPHSGSQANTAVYHACLNPGDTILGFDLSHGGHLT
HGSPVNFSGRLYRPVFYGVDAETGRLDYDKIQEIATKEQPKLIIAGASAYSRDMDFARFR
EIADSVGAILFADISHPAGLIAKGLMNDPIPHCHIVSTTTHKTLRGPRGGLILMGKDFEN
PQGLKTPKGEIRMMSSLLDLAVFPGNQGGPLMHIIAAKAVAFGEALKDEFFTYAMQLQKN
ANAMADAFVKRGYKIISGGTDNHMMLIDLRNKNISGKEAENALVKAEITVNKNMVPFDDK
SPFVTSGIRVGTAAITTRGLVEEDMETIVALIDKVLADHTNEAVIEEVANEVNEMMSERP
IFVY
>EGALAKHO_01096 hypothetical protein
MPITANDTKRKSWLEVPENSDFPIQNIPFGVFLTKENVVTVGTRIGDYAIDLGALQQLNY
FEGIDLTDDMFMQDTLNDFISDGKKTWRLVRNRIADIFDAANPQLRDSTKDRDIVIFKID
DVEMQLPVLIGDYTDFYSSKEHATNVGKMFRDPENALLPNWLHIPVGYHGRSSTIVPSGI
PVHRPMGQTLPAGEKYPVFGPSRLVDFELETAFITTDVNVMGENIPTYEAEDYIFGMVLL
NDWSARDIQKWEYVPLGPFLAKNFATSISPWIVTMDALEPFRTKGPKQDPSPLPYLQTKG
KKAFDIHLEVSIQPEDHEETIVSQSNFKYLYWNMAQQLAHHTSNGCRVNSGDMMGSGTIS
GPTPDSFGSMLELTWGGKNPIKLKDGSERKFIEDNDTVIIRGFCESNEVRIGFGEVSSQL
LPPFVRA
>EGALAKHO_01097 Putative agmatine deiminase
MSTNNRRFPAEWEKQQGIVLCFPHNGNDWPGKYEAVQWAFVEFIKKVATFETVFLVVADE
KGKEKVNEMLERARVNLANVSFIIHKTNRSWMRDSGPIIVKNGSKREALNFNFNGWAKYK
NYQLDKFVPGKIADFIDVPLTQVMYKGKPVIVEGGAIDVNGKGTLLTSEECLMHPTIQVR
NKNFSKEDYEAVFKEYLGVTNVIWLGDGIEGDDTHGHIDDLCRFVNEDTIVTIVETDKND
SNYKPLQDNLKRLQNAKLEDGKSPTIVALPMPKRVDFEDLRLPASYANFLILNKCVLVPT
FNDSNDRVALNILSECFPDREVIGISCIDFIWGFGTLHCLSQQIPA
>EGALAKHO_01098 hypothetical protein
MKKLTISLLTALVIMTSCNNDDNSNNEPEVVVNENPATFKEIGSITIGGEAAAEISTYDE
KTKRLFTVNNSGTNQIDVIDISDPTKPVKIGKIDLTPYEGASNSVDVYDGKLAVALESTI
NKQGNGKVVIFNTSDYSLIKQVTVGALPDMITFSPDGKYIMTANEGEPNTDYTQDPNGTI
SIIETSNYTVTTLDFASFSSQAETLKKDGFRVSKVAKSFAQDIEPEYITISDDSKTAWVT
LQENNGVAKVDLASKTITAIYPLGFKDYNTAENAIDVSDKDDKVAFNPWKLKGMFMPDAI
SHFSANNVPYFVTANEGDTREYTAYTDFKRMKDMKLDATVFPDAATLKLEPNLGRLNLVA
DMGDTDGDGDLDEMVSFGARSFSI
>EGALAKHO_01099 hypothetical protein
MNGNTGKIVYDSKNDADKKTQELGTYDDKRSDDKGSEPEAVKVVKMGNQNILFVGLERSD
AFMTYDVTNPTSPQYLQTVKTGDAPEGVLFIPASKSPTKRSLLVVSSEGDGTVKIYQPDL
K
>EGALAKHO_01100 Outer membrane porin F
MKKKLASLSFLILSFAASAQTMTTTSAAPAVDQPAYNKWSIELNGGVNKPTRAMTPGYQT
ATLNPFHADLGVRYMFSPTFGAKLDFGYDQFTERDDTAPFESKSIRASIQGVINVGRALN
FETWTKTIGVLVHGGVGVSQLTSDDGFNGEDYMGHGILGLTGQLRLSNRVALTGDLTGIV
NGKQDWNFDGMGKAGTGAFDGVLLNASVGLTFYLGKNEKHADWYAEENERLAKLEGRVDL
IETGLLDTDKDGVADLYDLEPNSITGVAVNTKGQSIDTNQNGVPDELESYLDKTYAKKGS
GSDSVTNNTVEELINGGYVNVYFDFNSAKPTNASLSGVDFLVKYLKNNPGKSADIIGYAD
EIGSSSYNTELSRKRAEAVKRVATNAGIDASRLNVVANGEDTSVNKNSKEARQIVRRVTF
QVK
>EGALAKHO_01101 N-carbamoyl-D-amino acid hydrolase
MPKRKYKIAVIQLNLNDVAENNLKKCISWVKDAANKGAEVILLPELYSSHYFCQSEDVDN
FALAEPLYSTSFIAFSELAKELGVVIIVPFFEKRMAGIYHNSAYIIDTDGTEAGLYRKMH
IPDDPHFYEKFYFTPGDLGFQAIQTKKGTVGTLICWDQWYPEAARITALKGAEVLFYPTA
IGWHPKEKEQYGENQYGAWMNVMKGHAVANGVFVAAANRIGLEQYIDGTDGIQFWGASFI
AGPQGEILAQASHDQEEILIAEVDLDLQENVRQNWPFFRDRRIDAFGDITKRAID
>EGALAKHO_01102 hypothetical protein
MKKFKLQSIALTLFLATILTSCSSDDTPHTPEFVYKTSYVTEVNGPLTGKVNQELSYEVS
FYVDNSCGEFNKMTDIELDKLPGYQVEAKYATSCTPTTPVAPQIRRTIYKVKSALKGTFY
LRFTKSETEYITTTVVID
>EGALAKHO_01103 Inner membrane protein YedI
MASGFFVLLDDIAAIMDDVAVMSKVAAKKTAGILGDDLAVNAEKASGFASSRELPVLWAI
SKGSLLNKIIILPIAFLLSAFFPIAIIVVLVLGGLFLAYEGAEKIYEFIFPHSHEESEGI
TEESFTEEEILAMEKGKIKSAIVTDFILSVEIVIIALGTVIGKPISQQIIVVSIIAVIAT
IGVYGIVALIVRMDEAGFKLIQISKKDKSVLKFIGNILVKALPLVIKALTVIGTIALLLV
AGGIFVHYIPFFHHLSPKINLPAIVKEFVVGLALGLVVLAIVNLVKKIIKKK
>EGALAKHO_01104 hypothetical protein
MNNIFRGLIAGYGAKKLGGGCFGTILVFVIIWVLLGQCN
>EGALAKHO_01105 hypothetical protein
MIHGFKFFSKKNTSSTTGVFLKISFKVMLLGVSGF
>EGALAKHO_01106 Chaperone protein ClpB 1
MNINKFTTKSQEAIQLSQQLAQRYGQQQIENEHIFKAIFEVDENVAPFILKKLNVNVPLF
LQILDSTIQSFPKVSGGDVMLSRDANKALNEAEIIAQKMNDEYVSIEHLILAIFDSKSKV
AQILKDQGVTGKALKATIEELRKGERVTSASAEETYNALNKYAKNLNELAREGKLDPVIG
RDEEIRRVLQILTRRTKNNPMLVGEPGVGKTAIAEGLAHRIVDGDVPENLKDKIVFSLDM
GALIAGAKYKGEFEERLKSVVKEVTAAEGDIVLFIDEIHTLVGAGGGEGAMDAANILKPA
LARGELRAIGATTLDEYQKYFEKDKALERRFQKVLVDEPDTESAISILRGIKEKYETHHK
VQIKDEAIIAAVELSQRYITNRFLPDKAIDLMDEAASKLRMEINSKPEELDVLDRKIMQL
EIEIEAIKREKEESKLKILGMDLANLKEERNEIYTKWKSEKDVVDGIQSVKQEIEDFKYE
AERAERDGDYGKVAEIRYGKIKEAQERLDVLLKQLQEYQSGNSLIKEEVTREDIAEVVAK
WTGIPVMKMLQTEREKLLHLEEELHRRVVGQEEAIEAVSDAVRRSRAGLQDMKKPVGTFL
FLGTTGVGKTELAKALAEYLFDDENAMTRIDMSEYQERHSVSRLVGAPPGYVGYDEGGQL
TEAVRRKPYSVILLDEIEKAHPDTFNILLQVLDEGRLTDNKGRLADFKNTIIIMTSNMGS
QIIQEKFENLKGGVEAATEAAKVEVLGLLKQTVRPEFINRIDEIVMFTPLTVDNISRIVS
LQLKSVSKMLALQGITMDATPEGIKYLSDKGYDPEFGARPVKRVIQREVLNQLSKEILAG
NITTDSIILIDAFDGKLVFRNQTHPVA
>EGALAKHO_01107 hypothetical protein
MSFLNSIFGNSDNSESQKSNVNWIPLTNLAQLNDIENMSNVKPIVIFKHSTRCSISRFAL
KQFEREYDLDETVDAFFLDLIEHRDVSNKIANKFGVYHESPQLILIKKGKAVYDVSHSDI
SAEALKNKV
>EGALAKHO_01108 hypothetical protein
MIAHDKQFLNDLALLEEANSLQNAGFISKEQKDLIKKELPDFKDHKNILVRLGFFVLGSF
LYGSICGAISIIGMVGDELYFKICCYIFAGVGFAGAEFLANQKYYGHGLDDAFILGAILN
IGFAIGITTDGYELIIAIFMAITAFIMYRRYLHLPSLLVFCLASSAVLFYGLFEFGEIGK
TILPFAAMISAAGFYFFTKKSIQNLTESYYYKGLLLSNSFCLILFYLSCNYLVVRELSVM
LLANEVLPGKDIPFAYFFYAFTLIVPLVYLVQALKAKDRIMLWISFLAIAFSIYTIRFYY
SVLPIEVALTLGGVVLFAIAYFSIKKLKEKENGLTFKPDRINNSNALLNAEALIVASTFG
MKPEVKTESPMEFGGGGYSGGGSEGSF
>EGALAKHO_01109 hypothetical protein
MNKFDDQATKSLLDKNLITENQYHEITTYRNLNVFSLNAELKLFLYLSVLLFTSGIGILI
YKNIDSIGHIALLSILLIVIAACFYYCFKNSKGFQKTETVFESPILEYLVLAANILTCIF
IGYLQFQYKPFGTHYDLATLIPTIVSFFCAYYFDNKSVLTIAITGLAAYIGLSVTPQDLL
HNDFYSNPNLSYSAIILGGLLILYTIYSSRINLKTHFNIIYLTFALHLISIASISNMVDD
YSYDGIWMLFGLVLAASSYYFYKVSHETKAMSLYVFMIVYAYIGLNIFVFRFFEFIDFSD
IWMLFVFILPAYFIGSIVLFIKLIKNFHKEITE
>EGALAKHO_01110 Pectate trisaccharide-lyase
MKKLFLLAFVLGLTNLSAQNYLMTAPEGFGAAATGGGNATPVTVSTYADLTAKLKLTTPQ
VILVSGTISCSYTSILVNDKTIIGLPGARLVNTDQTATGSGILSLKPGSNNIIIRNLIFE
GPGAYDVDGHDNLTSEATNTWVDHCEFQDGMDGNFDNKGAADNITISWCKFTYLKAPKAG
GSGGADDHRFTNLVGSGKSDAPADGHYSITFKNCYWADGCRERMPRARNAELHILNCYYN
TSVTSSLAIGLGGGDKNSTCYVEGTDFAKIGTAFKNYISTDGGTVGISFLNCLKASADYG
DAVTKPTYNYTTLPVSDVAGYIANTTCGAGATLQVSTAGAISTSCTNLGVAENTNNLDLK
YYPTVIDSLLNIQFSNKENGKAIISIFSANGSKVYSNTKNITADEKLELNMGDLAKGNYI
CKIQIDNRIKTFKFIKN
>EGALAKHO_01111 Argininosuccinate lyase
MKLWEKGIPTDKQIEHFTVGNDRELDLVLAKYDALGSIAHAKMLGQIGLLTSEETTSLVD
ALNDIIADIVVGNFEIEDSFEDVHSKIEYLLTVKLGDAGKKIHTARSRNDQVLVDVHLYL
KDELKAIKEQVKTLFDLLMESAEKHQNVLLPGYTHLQIAMPSSFGMWFSAYAESLIDDIT
MLNAASKVVDQNPLGSAAGYGSSFPINRTFTTQELGFETLKFNAVAAQMSRGKAEKTVAF
AMSSVAATLSKFAMDVCLYMSQNFDFISLPAHLTTGSSIMPHKKNPDVFELIRGKCNKIQ
ALPYEITLITNNLPSGYHRDLQLLKEGLFPALQNLKACLDIAIFSVKDITVKDNILKDKK
YDYLFTVDTLNEMVVAGMPFRDAYKAVAEQLEAGTYQSPKETKHTHEGSINNLCLDAIKD
KMKAAF
>EGALAKHO_01112 Acetylornithine deacetylase
MKNIATLTQEAISLLKSLIETPSFSSEEDQTALLIENWFNQNEIPFKRENNNVWAFNKYF
DENKPTLLLNSHHDTVKPNQAYTNDPFRAIEKDGKLFGLGSNDAGGCLVSLLATFVHFYE
NQNLSHNLVIVASAEEESSGKNGLNSVLKHLPELDCAIVGEPTLMQLAVAEKGLLVLDVK
VKGTASHAAHQNDDNSLYKSIPVMEWFKNYKFDKISDVLGPVKMTVTQISAGKQHNVVPS
ECDLVVDIRVTDRYSNTEILEVVKANVNAEVTPRSMHLNASSIPIAHGLVQAGIALGRTT
YGSPTLSDQSVLSCQSLKLGPGETLRSHSADEFIFVNEIEEGVELYIKILSDFFKL
>EGALAKHO_01113 Acetylglutamate kinase
MKKVTVIKIGGNIIDNPTELEQFLTDFSKIEGHKILVHGGGKSATKMAQSIGLVPQMIDG
RRITDAPMLDVVVMIYAGQINKDIVAQLQAKDNNAMGFSGADGNLIQSVKRNHPTIDYGF
VGDVKQVNTKLLATLLEAGIVPVFSAITHDKNGQLLNTNADTIASELSIALSEVFDVTLT
YCFEKQGVLQNSEDDSSVITEINEVLYNKLKEEKVIHSGMIPKLDNCFNSLSRGVQKIKI
GHHKMLQNPDVLHTTITL
>EGALAKHO_01114 N-acetylornithine carbamoyltransferase
MNYISIQDINSLSKWVKSALKIKQNPLKNQSLGKNKTLGMLFFNPSLRTRLSTQKAALNL
GMNVMVMNFTNEGWTLEFEDGAVMNSGASEHIKEAAEVVSQYCDIIAIRAFAGLADKEKD
YAETVISGFLKHATVPIVNMESAVRHPLQSLADAITMEEYKTKHKPKVVLSWAPHPKALP
QAVANSFVEMMQMQKDMDFVITHPEGYELSPEITKDCKIEYDQNKAFENADFVYVKNWSN
FNDYGKVTNIDPSWTVTAEKMALTNNGKFMHCLPVRRNVIVSDEVIDSENSIVIQQANNR
TYSAQLVLQKILKKL
>EGALAKHO_01115 hypothetical protein
MKLLHQDLTDVIIKTFYEVYNELGYGFLERVYQNSLYLELKSKGLKVEAQKKIEVYYKGI
EVGQYYADLIVEDLIILELKAADCIVKEFENQILNYLKGTNCEVGLLLNFGVKPEFKRKI
FENNRKIRIEKSV
>EGALAKHO_01116 Glutamate 5-kinase
MGKKRILLKIGSNTLTKETNHISRGKIEDIGMQIAALNKDYEFVIVSSGAIAAAKQFVKL
ESKGKEIALKQALASIGQPHLMRIFHENFSDLGLLTSQCLLSYSDFEKQQSKVNIVNTIN
VLVENNYIPIINENDTVATDEIRFGDNDKLAALTAVLLNVDILIIATNTNGIYTKDSIHD
ESPETIKLVNDLKVLEKEIGESKSSHGTGGMQSKIEAAGIAKAANIETWIVNGLNDNFIL
KALKEEIPFTKIV
>EGALAKHO_01117 Gamma-glutamyl phosphate reductase
MNPLSIEKRNLVLRSMAKLVEQERNQIILTNQEDLLAYDGSDLAMEERLKVDDKKVDEMI
LSLNQLASQEDPVGVERFHFVHDNGIKVINKTAAFGTILIIYESRPDVTIEAGGIAFKSG
NKILLKGGKESLRSNLKIVALWHQALEENGVSKDWVEYLNYNRTETQAFLEKPTQKVDLI
VPRGGEKLIEFVKQHATCPVIVSGRGNNFVYVHENADTDLALKVILNAKTSKISACNALD
KVLIDSRLPNFEGFAAILIEALIESKVEIIVDKSLENFENTETLQNEDIWYEEFLDYKIV
IGTIDSEQHAIEKINKYCGGHSAAIITKDEKKAKQFMESIDAAAVYHNASTRFTDGGQFG
LGGELAISTDKLHQRGPIGLQHLVTNKWYVYGEGQIR
>EGALAKHO_01118 hypothetical protein
MNISKNFKSNRIFRIWMYTVSHSTLILRSEKQYSDVVYDFNYDDPDTTIDLIFSVVDFIS
IPDWFDNVEIEKHDDKFIFNNNQNWFVKAVFCNVGKYSGEDEDDIWHRNLEYNEVINIK
>EGALAKHO_01119 Acetylornithine aminotransferase
MNLFNVYPLYDITPVKAVDCTITDINGVEYLDLYSGHGVISIGHTQPDYVAKLKDQLDHL
GFYSNAIQNPLQVELAQKLGKLSGLEDYELFLCSSGAEANENALKLASFHNGKSRVIAFD
NSFHGRTSAAVAVTDNKKIVAPINAQQVVTFLPLNQIDLVEAELAKGDVTAVIIEGIQGV
GGLDQGTTEFFQALEKACKKYDVVLILDEVQSGYGRSGKFFAFQHHGINADIISVAKGMG
NGFPVGAILISPKFEASFGLLGTTFGGSHLSCAAGIAVLDVIEKLDLQKNVNEVYKYFSE
QIKQVPGIKQVKGKGLMLGVEFDFDVSALRKKLIIEKHIFTGSANNKNLLRILPPLTVKK
SDIDTFIVALKESLEELKN
>EGALAKHO_01120 N-acetyl-gamma-glutamyl-phosphate reductase
MINVGIIGGSGYTAGELIRILMYHPNVNIDFVYSTTNAGKPLSVAHHDLMGDIEMNFTDT
INPDVNVVFLCLGHGKSISFLKENQFASHTKIIDLGNDFRLNKDAHFEGKDFIYGLPELN
KSDIKKANYIANPGCFATAIQLALLPLAKNNLLNNDVHINATTGSTGAGVGLSETSHFSW
RNNNMSHYKAFEHQHLGEIGESLVQLQDDFESELLFIPNRGDFPRGIFATLYTISDDSLE
QLVAKYEDFYKNEPFVTVTTTNINMKQVVQTNKCIISLLKKGNRVLVTSIIDNLTKGASG
QAIQNMNLMFGLEETTGLHLKPSGF
>EGALAKHO_01121 Argininosuccinate synthase
MKKVVLAYSGGLDTSYCLKYLKNEKGYEVHTVLVDTGGFDAEELSAIEKRAYELGSAQHA
NLTIVDKYYDKAIKYLIFGNVLKNNTYPLSVSAERVFQAIEAIKYAKKVGASAIAHGSTG
AGNDQIRFDLIFQTIAPEIEIITPIRDLKLSRQEEVDYLAQNGVHYSWEKAQYSINKGLW
GTSVGGKETLTSSQPLPSDAYPSQLQKEGEEKVRLHFEQGELVGLNGIMDKPSNNIVALE
KLANAFAIGRDIHVGDTIIGIKGRVGFEAAAPLIIIKAHHLLEKHTLGKWQQYWKEQLGN
WYGMLFHEGQFLDPVMRNIETFLQDTQKTVNGIVTVSLKPYHFSLDGIESDNDLMNTGFG
QYGEMNNAWTSDDAKGFIKILGNAQNIFSSVNHLDHD
>EGALAKHO_01122 hypothetical protein
MKISIVVTQEEHFKFAQEICDTIESSALLRGTGIAKRTPEYIQKKMANGDAMIALADGKF
AGFCYIESWQHGKFVAHSGLIVHPDYRSLGLAKKIKSKVFDYSLKRYPDAKIFGITTGLA
VMKINSDLGYKPVPFSELTTDPSFWSGCKTCTNYEILKSKENKMCLCTGMLYDPKEKQKD
PPRHPFNEAVLNRLKKIKQALFLNKLLSFIFLP
>EGALAKHO_01123 hypothetical protein
MKKQSSKAFLTMALLVGISSVWAQQTPSSAAVNPVNNYNYHDAFAPHFYTKNGTSTRSAS
GQPGFEYWQNRADYQITAKLDAVKNEIIGTDEITYTNNSPDKLSFVWLNLDQNLFKEDSR
GNAVVPLTGSRNGAQGQVFEGGNKIKSVKVISGGKTKIEADAKFIVTDTRMQIFLPQELA
SKGGSVKIKIEFSFIAPFEGSDRMGVLETKNGKIFTIAQWYPRMCVYDDVRGWNTAPYLG
ASEFYLEYGNFDVKLTVPANHYVVGSGELLNGAEVLPAEQLKRYKEASQSDKTVMIRTAE
EVAATANTNATAQKTWHYQIKNARDFSWASSPAFILDGAKINLPSGKKSLALSAYPVESA
GKDAYGRSTEYVKSSIENYSKRWFEYPYPAATNVAGNEGGMEYPGIVFCGWKSKGDDLWG
VTDHEFGHIWFPMIVGSNERLFAWMDEGFNTFINSVSSFDFNNGEYKQKPTDLHEDVEYY
TSPKLETIMSSPDNMKEANIGVLCYSKPSAGLTILREQVLGEERFDKALRTYVERWAYKH
PTPDDFFRTIENVAGEDLSWFWRSWFVNNWRFDQGINSIKYVKNDPAKGVIITVENFDKM
PMPIVLDVKTKSGKVTRVKLPVEIWQRNNDWSFKHNSTEEIESITLDPDHAFPDYNESNN
VWTAGKGVVEKDIILDGYLGNYVTTKSPLTIELTEKNSVLNAELPNYPKFSLSPVANEKD
TFESKRAGLKFKFNEAKTGFDMTVTGNGQVIPFTKK
>EGALAKHO_01124 hypothetical protein
MDITISNSTLTASIKEHGAELFSLKNNQNKEYIWEGNPDFWGKHSPVLFPIVGTLKNNTY
TVNGKKYQLPRHGFARDMNFQLVNKTENNAVFSLESNSETLKKYPFEFELQLIYTVDNSS
LIIEYRVINKTKDKIPFSIGAHPAIALPENFENYSLKFEKKEPLKYNLLENDLISNKTDT
LETTENLVPLNYKLFENDALVFKTLESNSLTILENSRPYINVKFEDFPSLGIWTKDKAPF
ICIEPWLGYSDTADNSGNLFEKEGILILEAYQIFNSKFSIEIL
>EGALAKHO_01125 Putative ribosomal N-acetyltransferase YdaF
MLQFNFSPFPIIETERLLLRRITNDDVNEVFELRSNPETMKYIPRPLVKNTEDALEHIAM
IEDKINTNVGINWGITLKNDPKLLGIIGYYRMQPENYRAEIGYMLLPEFHGKGIISEAVN
RLIKYGFNDLKLHSIEAVIDPENFASEKVLQKCGFIKEAHFKESEFYEGRFLDKVIYSLL
DK
>EGALAKHO_01126 hypothetical protein
MKKILILLVLFFSVHSQSQTYLKFNGATALFAIPNIGVETSIGDKTTFSVDVMASFWESV
NGHNPMKFVTLTPEVRYHFKEKYDGFYIGGHFGGDVYEIQKWNYWDSNRYEHGFGYRLGV
TVGYNIKLNDKFLLDIFAGGGWHQGFYHGYYNDGTPGRYDKAENWNKSGEWLPYRGGVMI
SYKLN
>EGALAKHO_01127 DNA-binding protein
MQNQSKDPLHGITLQSIIEKLVAYYGFDMLSELIPIKCFTSNPSIKSSLTFLRKTDWARK
KVEDLYIKSLSKF
>EGALAKHO_01128 hypothetical protein
MKKILSLVGLVFIGLTAKAQDVNHGLKGAWFATSQFGYQQTKTADVKNTTLSVLPIVGTF
VTPSVAVGAAVGYINIKSDGYDNVDPNIKTLAKTDLIVIEPLARKYWNVAGSLYFFGQLA
LPVITGKEKESELKVNQIGLSLSGGFDYFVTKNFSVEFSYDLANFTSTTLDPQVGEKTTV
TNFGLAHVANVESSYNGALGGSNPNLLSPLSFGFKFIF
>EGALAKHO_01129 SsrA-binding protein
MLKTVNILNKRARFDYEIIDTYTAGVVLTGTEIKSIRLGKANITESFCEFSNLELFAINT
YIEEYSFGNQFNHKSRSERKLLLNKKELKSLHKSVQAKGLTIVPLKLFTNEKGLAKLQIG
LCKGKKNYDKRESLKEQDTKRDLDRIKKAYN
>EGALAKHO_01130 hypothetical protein
MKKYLVLLIAVLALSGCGSNTSIVNSWKDPDVTVAQEQFKKVLVVALVKDEASRRITENR
IAASNQIFRTSYQFLNETTKQFTQEQKLKILQDENFDGVVTMRLVSTEKETNYVPGTYTG
MYYGGFDGMYTGMYGYGFGNWYGMYSPSFYDPGYYQETTSYMVETNIFSLKQNKLIWTGT
TKSEYVTDLGQTVDAIMQAVVGEMKKDGSLPK
>EGALAKHO_01131 Adenosine monophosphate-protein transferase and cysteine protease IbpA
MKTLLKNAREQKGLKTREVAQLLGIDQALISKFETGTRKPTKEQISKISQLLEIDFETLM
IAWLKEKILYEIGDDEFALKALKVAEDEIKYNKAISNLKISTSLEKILKEIDILKDKLDT
YRKFDSYKIKQALELEYTFESNRIEGNTMTLRETDMVINEGLTISGKSMREHLEAINHQE
AIGFIKDLMQKNNALNERDLLSIHNLILRGIIPEDAGRYRKVQVMIQGSSHMPPQPLLVA
QEMEEYFIWYEINKNKLHPIILAAEMHERLVTIHPFIDGNGRTSRLIMNLILMQKGYLIA
NIKGDYENRMQYYQSLEKAQTKKDKEDFLLFIAQIEKESLERYISILTQ
>EGALAKHO_01132 Protein-L-isoaspartate O-methyltransferase
MKDTAKHQGLRNQLVSTLEQKGITDKAVLDAIKKIPRHLFLNSSFEDYAYQDKAFPIGAG
QTISQPYTVAFQSQLLEVKKDHKILEIGTGSGYQTAVLFMLGAKVYSIERQNELFKATSN
LFPKLNIRPKHLSFGDGYKGLPNHAPFDSIIVTAGAPFIPQPLMAQLKIGGRLVIPLGED
VQIMTLLIRKNETQFEKHEFGEFRFVPLLEDKN
>EGALAKHO_01133 scyllo-inositol 2-dehydrogenase (NAD(+))
MLKVGVLGAGHLGKIHLRLLQQSDKYELVGFYDENQENAERISKEFGYKNFNTIAKLIHA
VDVIDIVTPTLSHYKCAKVAIKSGKHIFIEKPIANTVEEAEEIIALAKEYNVKGQVGHVE
RFNPAFIATKNMIENPMFIETHRLAEFNPRGTDVPVVLDLMIHDIDAILSVVHSKVKDIH
ASGVSVISDTPDIANARIEFENGCVANLTASRISMKNMRKTRFFQRDAYISVDFLEKKCE
VVRMKDAPEVPGDFDMILQNAEGVKKQIYFTNPDVEQNNAILDELESFANAINTDTTPVV
TLEQATDALRVAYQIIDCFDK
>EGALAKHO_01134 putative 3-hydroxybutyryl-CoA dehydrogenase
MKTIAVIGAGTMGNGIAHTFAQSGFTVKLIDVSEKSLDKGMTTIAANLDRMLSKGTITQE
DVAKTITNIITYTDIKDGVVGVDLVVEAATENVELKLNIFKQLNEACSHNTILATNTSSI
SITQIGAVVAHPERVIGMHFMNPVPIMKLVEIIRGYNTSDEVTKIIMDLSVKLGKTPVEV
NDYPGFVANRILMPMLNEAIETLYNKVAGVYEIDTVIKLGMGHPMGPLQLADFIGLDVCL
AILNVMYEGFKNPKYAPCPLLVNMVRAGKLGVKSGEGFYDYSESKKAEKISKQFILS
>EGALAKHO_01135 hypothetical protein
MSIQSNLNSIKASLPEHVTLVAVSKTKPVSDLMQAYEAGQRIFGENKIQEMTDKWEEMPK
DIQWHMIGHVQSNKVKFMAPFVSLIHGVDSLKLLQEINKQALKNNRVIDCLLQIYIAEEE
SKFGLDENELNELLSSSEFKEMKNIRILGLMGMATFTDDQNQIKKEFTHLKSIFDSIQTI
EDENLQLNTISMGMSGDYQLAIECGSTMVRIGSSIFGGR
>EGALAKHO_01136 hypothetical protein
MEKIFNFEDRLVRFAGECIFFTRQLEKIFENEYYKNQLIRSSGGASLNFGEAQGTITDKD
FIFKVSLVVKELKESRNSLKILDYIKEGDNDKRNKLLIEVEQLIAISSKMIINKK
>EGALAKHO_01137 putative ATP-dependent helicase DinG 
MYAILDIETTGGQFNEEGITEIAIYKFDGHEVVDQFISLVNPEIPIQPFVVKLTGINNAM
LRSAPKFFEVAKRIIEITSDCIIVAHNASFDYRILRTEFRRLGYDFEARTLCTVELAKKL
IPEQPSYSLGKLVRALGIPMADRHRASGDAMATTKLFKMLLEKDLEKTIVKDFIKLEVEK
GIAPKLLDLVGQMPTKTGVYYIHNEGGNLIYIGKSQNIRKRVNQHFTGITTKSKKIQAEV
FTITYDETGSELIALLKESEEVKINRPRHNRSQKKTVFPFALYAEKDSNGYFNIKLQKAD
GRKKEITSFASLQEGKNMLFKFTTNYHLCQKLTGLYQTKKECFQYKIKECDGACIGEVSP
ETYNLRVQQFITEHSFENKSMILIDRGRNVNERSAVLIENGVYKGYAFYDLNYQITNIEI
LKNILIPMQNNRDVKNIIQNYMRKSKSLKILHF
>EGALAKHO_01138 Cyclic nucleotide-gated potassium channel
MTQMKSKYEIFREKIKVILYGTDTVLGRLFDLVLLGLILLSVLLVMMETVQGINQKYHSQ
LIICEWIITVFFTIEYILRIISIQKPVKYIFSFYGIIDLLAVLPMYLSIFFPGASILSVI
RALRFFRLFKILHIPQISHQSVQLREAIEASKEKILVFIYFVLISTVIIGSVMYVIEGKE
SGFTSIPVSIYWTIVTLTTVGYGDISPITPLGQFVASFVMILGYGIIAVPTGIVTAEFAK
NSLKNNTVSGKKSCKNCNSQVHFDNAKYCYECGTELPNV
>EGALAKHO_01139 tRNA dimethylallyltransferase
MKYLITIVGPTAIGKTALSIALAQHFNCEIISCDSRQFFKEMTIGTAVPNQEELNSAKHH
FIQNKSIFENYTVGDYEKEALLKLEELFQKNDFTILIGGSGLYVDAILKGFDEFPEINPQ
VRSEVNSNYEKLGINYLQEQLQNLDPDYFQKITLENPQTLQNPQRMMRFVEVCIGTQKPY
SSFLNQKRNNRNFTPILIGLEADRKVIYDRINQRVDIMMTAGLLDEAKALYPNKALNALQ
TVGYRELFSYFDGEFSLPFAIEEIKKNTRRFSKRQLTWFKRNENTKWFDYATDRKEIINY
IENLIK
>EGALAKHO_01140 hypothetical protein
MPISPNFTSVLSKDWEINFTQCTPNGFLKYTDLCNILQLTAAAHSEVGGISFFDMQEFHQ
AWVLSRMRVEISALPKWQDVVTVKTWINSLENSRSVRALEMYVNGKKIVGCETYWAVFNT
QLRRPEALALPYEHFELFPENRATSEGFSKININHDKEVVFEKTVYLSDLDIVNHVNNVK
YLEWCIDHVDPKRILKQEVKSFEMNFMKELSLKDNVVIHESEDDNNTTATFSITKNEKTC
FALELHWK
>EGALAKHO_01141 Transcriptional regulatory protein OmpR
MENNNKRILLVEDDLNFGAVLKDYLMLNDFEVTLAKNGMEGFEKFKKDVYDLCILDVMMP
YKDGYTLAKEIREKNSEVPIIFLTAKSMKEDVLKGYKAGADDYLNKPFDSEVLLMKIKAI
IQRKSADTKAEQVQFEFNIGKFHLNSKLRFLTFENDEPIKLSPKENELLKMLILHENDLM
PRELALTKIWRDDNYFTSRSMDVYIAKLRKYLKADEDVEILNIHGEGFRLVVKSKVTE
>EGALAKHO_01142 Sensor protein kinase WalK
MNKLFFRILVLLMSLSLIGIILVQVFWFNSSFKNNDEQFKYHVTQVIGNVADKLEQQEEY
SFYDKYNRIKDSTGKIPKKEDLLEVLYVQRNTKTNKTIVYSNTLTSEDYDISGSLFNKKF
SSERFKNFSSKRVTEVYNNNNGIDNNALGQSIIPDLKIEKSGSLDILNKVQQQIQYKDIA
SLTPIEGRITKDKLSKLLKKELEEYGVKTKFEFGVLNSGLPTKVKSDGFHFDKDASYHIP
IYTDNEGNSKYELYITFPYKKKFLLSELLSITILSIVFTLIIIIAYTSALNQLLRQKHIS
EIKTDFINNMTHEFKTPIATINLALDAIKNPKIIEDKEKVFRYLQMIRDENKRMHAQVEN
VLRISKLEKRELDITKEPTAIHDIIDDAIEHVNLILEDRHGTVVKHFNASRTTCLVNEVH
FTNVLVNILENAIKYSPDVPEIEIFTENIKDMILIKVKDNGLGMSKIAQKRVFEKFYREH
TGDLHNVKGHGLGLAYVKRIVEDHNGQVYVESEKGKGSTFIIKIPLIN
>EGALAKHO_01143 Dephospho-CoA kinase
MTKVIGLTGGIGSGKTTIANYFAEMGVPVYIADDGARAVMQLDNVIKEVKNTFGESVFEN
GILSRAKLAEIVFNDKEKLAKLNAIVHPAVKKDFEVWLLQHTNYEYIIYEAAILFESGRY
KECDYIITVTAPEEIRIDRVLKRDNTTPAQVLSRMQMQWKDEDRISRSNFVINNVNLKIA
KEEVVKILKILDIKQNQS
>EGALAKHO_01144 Putative glycosyltransferase EpsH
MIFSLIIPVYNRPDEVDELLESLSKSDYNEPFEIVLVEDGSSIPCKDVVMTYQGKLNISY
YFKENSGPGDSRNFGMQKARGDYFIIFDSDCIIPPNYLTEVRKALNEEYVDCFGGPDKAL
DSFSDIQKAINFAMTSFLTTGGIRGGSEKINKFQPRSFNMGISKKAFEASKGFGNIHPGE
DPDLSIRLWNLGFETRLFSEAYVYHKRRIDWEKFSIQVNKFGIARPILNSWYPEHNKITF
FFPTLFILGLLLAFLLLIFNIDILLQLYFVYFVIIFLTASVQNKSIKIGYLSVIAVWKQF
YGYGTGFLESFIKIIILKKKPQEAFPRMFFKI
>EGALAKHO_01145 Enoyl-[acyl-carrier-protein] reductase [NADH]
MIIEPRMRGFICLTAHPKGAEQNVKNQIEYIKSKGSIAGAKKVLVIGASTGFGLASRITS
AFGSDAATIGVFFEKPPVEGKTASPGWYNSAAFEAEAHKAGLYAKSINGDAFSNEIKRQT
LDLIKADLGQVDLVIYSLASPVRTNPNTGVLHRSTLKPIGQTFTNKTVDFHTGNVTEVSI
APANEEDIENTVAVMGGEDWAMWMDALKDENLLAEGATTVAYSYIGPSLTEAVYRKGTIG
RAKDHLEATAFSITDSLKSIGGQAYVSVNKALVTQASSAIPVIPLYISLLYKIMKEEGIH
EGCIEQIQRLFQDRLYTGSPVPVDEKGRIRIDDWEMRDDVQEKVAKLWEEATTETLPAIG
DLAGYRNDFLNLFGFEFAGVDYKAEANEVVNIESIK
>EGALAKHO_01146 DNA repair protein RecN
MITSLSIKNYALIEKLSIDFSKGFSIITGETGAGKSIILGALGLVLGKRADLTSLKNKEE
KCIIEAQFEISKYNLKEFFEANDLDYEDDTIIRREILPSGKSRAFINDSPVNLQELQDLS
LFLIDIHSQQQTQELSDETVQFKIIDAIAGNFDVIASYQKLLKGYKSDKSKLNALLKKQS
DSGKEQEYNTFLLNELIAAKLKSGEQEELEAEFEKLNNVEVIKESIDKSLVIANEEQFGV
FHNLNEIKASLQKIAPFSTEYQSLFERVTSVAIEFDDVSRELQNVSEKLLNDPEKLEITN
QKLQLIYNLQKKHQVISVDELLQIQANLENAVIELGNIEEEITSLTNSIAQKVEELDSFS
AEIHHNRANAIPVLSNKLISILETLGMPNVRFNMELLPSETYFQNGKDELQFLFSANKGT
DFGLLKKVASGGEMSRIMLAVKAILAQYSKLPTLIFDEIDTGVSGEIAIRMGEIMKEMSK
NMQIFAITHLPQIAAKGDSHFKVFKSTVGDDTQSELKLLSQDERVIEIAQMLSGAVVSDS
ALNHAKALLN
>EGALAKHO_01147 hypothetical protein
MKKIVTLLVFLIFGFTQAQQLNCTVTINTERLPNPNQQVFKTLQTSLSEFVNKTDWTGSV
LKQNERINCSMYITLSSNSSDQFSGTIQVQSSRLIFNSTYSSPIFNFNDKDFSFRYTEYE
PLLFNPTTFESNLVSVVSFYSYLILGMDADSFQMGAGNQYLETAQNIANVAQQGGYKGWS
QADGIQNRYYLITDMISPMYSDLRQVTFLYHNGLDKMSDDLKGAKERIKSSLLLIGKFNS
VKPNAFLTRVFFDAKSDEIVSIFSGGPSIPVTDLTDVLNKVSPLNSTKWSQIKY
>EGALAKHO_01148 Coenzyme A biosynthesis bifunctional protein CoaBC
MSVLNGKKILLGVSGGIAAYKTASLVRLFIKAGAHVQVIMTPASKDFVTPLTLSTLSKNP
VHSTFFNQDNEDAVWNNHVELGLWADLMLIAPATANTLSKMATGNCDNLLIATYLSAKCP
VYFAPAMDLDMYKHPSTLSSFGALKQFGNVMIPAENGELASGLSGEGRMAEPENIIAFLE
ADLESKLPLKGKKILITAGPTYEAIDPVRFIGNHSSGKMGFDIANEAAKLGAQVILIAGP
THFKAKSSLVEVINVVSAQEMYDACHLHYNQVDVAIAAAAVADYKPKVVALQKIKKAADE
FSIELEKTKDILASLGAIKKNQFLIGFALETQNEIENAKLKIQKKNLDLIVLNSLQDEGA
GFKKETNKVTFIDKDFKIEPMELKSKESVAVDILNKVILYFAKS
>EGALAKHO_01149 hypothetical protein
MDLKKTNAPVNTITYNKTVIEEPTGNVYEAITIMAKRANQINSEIKKELTEKLEEFATYN
DSLEEVFENKEQIEVSKFYEKLPKPHALAVQEWLDGKTYHRGSNK
>EGALAKHO_01150 Outer membrane protein assembly factor BamD
MKKIVSLLIVVVLFCSCSDYQKALKNEDVAAKFEMATKMYDAGRYSKAIRLFEQLAPSYR
GKPQAEKLFYMFSQSYYKTQQYYLAGYQFESFVSGYPRSEKVQEAAFLGAYSYSKLSPIY
SLDQADTVKALEKLQAFIDNYPNSEYIAQANEAVKILNGKLETKAYENAKGYNTISDYKS
ALVAFDNFIADFPGTPLKEDALFYKYDSAYQLAINSIPSKMEERLNVAKVAYNNLLKYKS
DTKYKKQADEMYARVETDLQKFTK
>EGALAKHO_01151 4-hydroxy-tetrahydrodipicolinate synthase
MQSLIGTGVALVTPFKKDFSVDIEALQRIVNFSIDGGVEYLVVMGTTAENATLTQAEKEL
VIKTVIDTNKGRLPLVLGVGGNNTMQIVEELKTGDFSAFEAILSVSPYYNKPTQEGIYQH
FKAVAEASPIPVILYNVPGRTSSNMLPSTVIRLANDFNNVVAIKEAAGDMAQALQLLKNA
PKDFLVISGDDMIALPIVLAGGAGVISVIGQGFPKEFSEMIRLGLNRKVNEAFKTQYFLS
DCIDMIFEQGNPAGIKQVFEALGIADNTVRLPLVAVDDSLAERLNKFVQNSIKLE
>EGALAKHO_01152 hypothetical protein
MFLNYIKEFFVKKSLKNHLHIVKNEVFTSNVQTIGLLIDESTFRHSKELVKELILQGIAS
ENITIVVYRGKLKKEKTYSRPTFGVKHINWMGEFTEEFLNVFTETEFDLLISYYQIEKPI
LMMTTSKSKAKFKVGFSSVDKRLNRWMIDTEIENYKLFVTELFKYLRSIK
>EGALAKHO_01153 Mannosylglucosyl-3-phosphoglycerate phosphatase
MVKLKKYNGFLKLFVIFLTLFFIFSCSQKNYNLTKIEGKQLPITEKGNETAEIENFIKPY
RDHINKDLDSVLAYCPETLDKSTGKWQTTIGNLMADVCLERGNLVFKAREKKDIDICLLN
HGGIRAILPKGNVTTRTAYEIMPFENSLIVVALSGNQILDIASYIIKEKKPQPLSGMTFT
ISKDNKAKNILIQGKPIDINKTYYVVTNDYLANGGDNMSFFSKATAQFDLNYKIRNVLID
YFKEVDTIPVKTDVRITVE
>EGALAKHO_01154 Trifunctional nucleotide phosphoesterase protein YfkN
MKRREFIEKTAASTALLSLGLSLSSFETNDIKHLTILHTNDVHSHIDPFPADDPRNANKG
GVSRRAALIEAIRKENPNVLLLDAGDIFQGTPYFNYYGGELEFKLMSMMKYDASTIGNHD
FDNGLDGLYSQMPHATFEFINSNYDFKNTVMNGLVKPYKIFNKNGIKVGVFGVGIELDGL
VDKKNYLETVYNNPVEIAQDMTQLLKKEQKCDLVVCLSHLGYNYRDDESKICDLKLAELT
QDIDLIIGGHTHTFLDKPTIVKNKAGENVLVNQVGCYGINLGRIDFYFDKDKAHTNQGKS
IIV
>EGALAKHO_01155 hypothetical protein
MKANKPSLILYFLALLLTIICDWAEQDFLAIYAKAIVLPAIFFYFFISNESKVGKTEAFV
FLFCFVGQVFDLMGVEVSEIGGVLSFLIVYLLLLKIFIADREKVKLSKKDILPVSIVIIF
IVYLLVSVLSLQSDNMKKYNALYTFYGIVLSIMSYFCFVRYITKGTHIALIMSLMAVCYI
FSDIFYIFNEYFSHSVVLVLIRDVTQILAYYFMVEYFLERSKAQRKVLYND
>EGALAKHO_01156 DNA ligase
MSIQETIQTLREELNQHNYNYYVLDNATISDYDFDIKLKELQDLENKHPEFFDEHSPTQR
VGGTVTKNFKTIAHQYRMYSLDNSYSKEDLLDWENRIQRVLGNVKLEYTCELKYDGASIS
ITYQNGKLLQALTRGDGFQGDEVTNNIKTIKSIPLQLKGNYPDKFDIRGEIILPLKGFEK
MNQELIEIGETPYSNPRNTASGSLKLQDSAEVAKRPLECLLYSVTSSNLPFSSQIEGLES
ARNWGFKVPNEAKLVNSMNEVFDFIDYWDIHRHKLPYETDGVVIKVNSIQHQQELGYTAK
SPRWAIAYKFKSEQVSTKLKSISYQVGRTGAITPVANLEPVQLAGTIVKRASLHNADQIE
KLDIRINDTVFVEKGGEIIPKIIAVDLEQRPENSVKTEYITHCPECHTELVRTEGEANHY
CPNFYGCPPQIIGRIQHYISRKAMDIEGLGGETVALLFNNGLVHNYADLYELKVEDVLPL
ERMAQKSAENLVNGVKKSKEIPFESVLFALGIRFVGETVAKKLAKHYKNIDSLSKASLME
LILVDEIGERIARSVIEFFENEENQRIIERLKSYGVQFEIVEKINPNATEKFIGKTFVVS
GVFAQFSRDELKKTIEDNGGKVGSSISAKTDFVVAGDNMGPAKLEKANKLNIPILSEEDF
ITKLNESE
>EGALAKHO_01157 Outer membrane porin F
MKKLYILSLVLSFTFSFAQTNLKKADALFRNYSYVDASKAYEEILQNIKSPSAQTLKNAA
DSYYFISDARNALKWYKKLYEVQGNNLTDIYYLRYIQSLKGVMDYDEADKMTKEYLTKKG
DQNEINKYVAQKKQMDSLSKTKSLYTVKNLDINTSKSDFGATFFQDRIVFTSARDTTKFS
EKLYTWNNQPFLNLYVAERNPADGSLFNETVFLPNVMTKYHEATASFDPKGKTIYYSTNI
VKKNKLVIDETKTNNFQIVKGDIVNNKLENPQKVFFDSDDYSVGHPSLSEDGQWLFFASD
MPGGIGETDLYYVKIAADGTMSSPVNLGPKINTIGNDLFPFFRNGKLYFSSDGHYGFGDL
DVYESKLLTDGTFSDPVNLGAPINSNKDDFSFVIDSAENYGYVSSNRAEGKGDDDIYSFI
KGKPVCNQSISGVATDRKTKLPLSDVIVMAYNSYSEVLGETKTNYEGKYAIEVPCSKVVK
MIAAKPNYSSDERTVETTKENGGEIKDVNFELSNYDDLVVKKKGVEKVDVKPIYFDYDKY
DITPLAIEELTKVVFIMKKFPNIRIKIESHTDSRGKDSYNLKLSDNRAKSTRDYIISQDI
DSSRIESAIGYGESRLINKCKNGVKCTEDEHLLNRRSDFIIIQK
>EGALAKHO_01158 hypothetical protein
MKLYIKSLETYFIIICSFITFCASAQQDPEYTQYMYNTMAVNPAYAGSTGTLEATLLHRS
QWIGISGAPETQSFSIHAPLRNEKIGLGLSVVNDKIGPSNELYLDGNFSYSIPLGYEKRL
AFGLKAGMRMLNVDWSKGRYYDPNDVLLNQNIDNQAKLAVGAGIYYYTDKWYVGLSIPSF
IQSNYYDDVQESIDYDRLHYYLMGGYVFDLNPNLKFKPAFLVKAVTGAPITADISANFMI
AEKFVIGGSYRTDDSISILAGFQISKSFYIGYAFDYTVSDLNKYNDGSHEIILRYQFNKG
ESKIKSPRFF
>EGALAKHO_01159 hypothetical protein
MVNTPTFATIDVSPAVAANIVWYDALTGGNFIPSTTALTTGTYYAAIKDPITNCESAVRL
AVAISVTDPGTPTTTENTQDFCLVNAPTVANIQVNETNVVWYNTQTGGTVIPAATALVNG
IYYGAILDPVTNCESATRLQVTISISNPLTPTTTATTQNFCLVNAPTIANIQVNEPNVVW
YSTVTGGTALASTTVLTSGVYYGAIKDPVTGCESSVRLQVTINVTDPGTPTTADNTQDFC
LVNAPTIANIQVNEANLIWYSTATGGTSISATTALASGIYYGAILDPLTNCESATRLQVT
INLINPATPTTTNASQSFCITNAPTVASIQVNEANVVWYSTLTGGTLLASTAALTNGIYY
GAIKDPVTGCESSVRLQVAVSINNPAATPTTSAATQNFCSLNSPTVANIQVNEANVVWYS
TATGGTAIPATTALATGTYYGAISSTVGCENPIRLAVVVNVNTPGVITTPRTTQTFCLSK
LPTLASILVNETNVVWYSSATGGTPLAVNTQITAGTYYASALNNTTNGCESATRLGVTIN
FENDALVPITTSDDTPCVFQGVTYSIANGKSNYVWSVTNGTIVSGGGTADGSVTISWSDI
GPGQVKVTYINNCDETTTKTLNVTVATCSDLTITNTVSNPTPNFGEQITFTVTVNNVGQG
NFINTVVSDLLPSGYDLVSTNTTAGTYDPATSLWTIPTLNAGQSVTLTIVAEVLSGGDYL
SVATVEISTPLDVNAANNTASVSVDPICLTVYNEFTPNNDGANDFFRIDCIESYPNNELK
VYNRYGSLVYSKQHYENDWNGTANVSGVINRGDMLPTGTYFYVIDIGDGTVKKGWLSIMR
>EGALAKHO_01160 hypothetical protein
MQNKQRHGCLTAWLIYLMISYSIVSLGLFYKIDTIARKFQYIKSENLLLIVASIEILNVL
FLFMLLKWFKLGFWGLLSTSTLLFIIQIMNSNNILTPIITAIVMLIIYGLLKLKKRNVSG
WDNLE
>EGALAKHO_01161 Tyrosine recombinase XerD
MTWKAKMITHKKEKRIAVYFEKNAELIARIKKLTGSRWSQTLGVWHLPDTVENRERFQLV
PLSHSLPSAEGIEQIKKYIQWLSSKRYSPNTIKTYSEALKSFLIFYREKHITEISNEDVI
IYNNEFILKNNLSDSYQNQIVNAIKLYFTTIRETKIEIDKIHRPKRSKLLPNVLSKEEVK
LILNAHNNIKHRMMLSLIYSCGLRCGELLALRPVHIDSKRNIVLLKNSKGKKDRITPLSP
KILEMLREYYILFKPTIYLFEGANPGEPYSEKSLQSVLKQALKKVGITKPVSLHWLRHSF
ATHLLESGTDLRYIQELLGHQSSRTTEIYTHVSTKSIQQIKSPFDNL
>EGALAKHO_01162 Thiamine pyrophosphokinase
MSSHHIVRDDQEPALIIANGAACNPELLGQLLEWSPLVVVLDSAIERVIELDIKVDVLLG
DFDRGFDPEIYKTSQYPIEIVHTPDQDKTDLEKAFDYLIERKIPAVNVVWATGKRADHTI
TNLTNIVRYRNLLKIVILDDHSKIFLLPNKFEKWYTAKTPISLIPIGVVNGINSTNLEYP
LQNDTLTMGYRTGSSNSVAQDGLVIITHQNGDLLLMECID
>EGALAKHO_01163 hypothetical protein
MLTETLKSLFNRDLNKLKVEIESYENESQMWVIDKNISNSAGNLCLHLIGNINTFIGTEL
GKTGYVRNRPLEFSLKDVPRSEIISKINETIVVVNNTLDSLTEADLKAIYPQIVFEKEMT
TEYFLIHLATHLAYHLGQINYHRRLI
>EGALAKHO_01164 hypothetical protein
MEARIETLTEKKLIGKHLDMSFIENKTFQLWNSFMPRRKEIKNATDSNLYSLEVFPVGYF
DNFDSGNTFQKWAAVEVSDFDDIPSEMEILLIPTGLYAIFLHKGAATEAYHTYHTIFTEW
LPNSEYIVDDRPHFAVMDERYKKDDPNSEEEIWIPIKHRP
>EGALAKHO_01165 hypothetical protein
MKKVTLLIVFFISILFTSCEEVVDVDLETAPPKLVIEAALNWQKGKTGNQQIIRLTTTTG
YFENVIPTVSGAIIYVKNTKNEKFNFNEIPKTGRYACTNFKPEINETYTLTVISNGQTYT
ATEIMQSLAPITRIEQNNEGGFTGKDIEIKAFYNDPGDADNFYLYKYVYSNKIKSSYYVD
DDEFYNGNEFFSLSDDDELEVGNEIEITHYGISKQYYNYMNILVSIAGSNVGGPFQSPPA
TVKGNIINTTNKENYPLGYFSLSEIDIKKYTIK
>EGALAKHO_01166 hypothetical protein
MITKKICIFFIIILTTLTSFSQEKFTLSGTITDFKNNETLIGVNIYIPALKIGTTTNEYG
FYSLTVPAGEQQIEITYVGFQTIQKTVNLNQNVKMNFGLNEGGEELQEVVITDNKGKVNI
KSPEMSTNKLSIATIKKMPVVLGEVDVLKSILLLPGVTNAGEGASGFNVRGGGADQNLIL
LDEATIFNSSHVFGFFSVFNPDAIKDLKLYKGGIPARYGGRASSVLDIYQKDGSSKDFHM
NGGIGLISSRILAEGPIVKDRGSFLVGGRASYAHLFLKLSEDQKDNSAYFYDLNTKLSYK
LNDNNNLYLSGYFGRDVFSLNKSFTNIYGNSTLNLRWNHLFSEKLFSNLSLIYSDYYYGL
DLDFVGFKWDSGIRNYNIKYDFKHYISDKFKLNYGLNGIYYEFNPGTIKPSEPDSGINSD
QLDKKYAFEPSVYIDAENRLSKKITISYGLRYSLFYRLGESTVNLYENNNAVVFNSDLQI
YEKGTPSGTEYYGKNKVIKSYNNLEPRFSASYQLNDDQAIKASYNRMAQYLQLVSNTSSP
TPLDVWMPSDTYIKPQIADQVALGYFRNINNGTYSIEAETYYKKIQNRLDYIDGADLIAN
NAIEQVILNGHMRAYGLELMFKKNEGRFNGWISYTLSKSEQQTPGRTSEETGINNGQWYN
SAYDKTHNLAITSAYNLNEKWSFGANFALQSGQPVTYPNGQYEYLGITVPSYGLRNENRL
PAYHHLDVSATLTPRKNKDRNWKGEWVFSIYNLYNRKNAASINFRQNVDTGENEAVKTSI
FGIVPAVSYNFKF
>EGALAKHO_01167 Isocitrate dehydrogenase [NADP]
MTQNSKIFYTLTDEAPLLATYSLLPIVQAFTATAGIAIETRDISLAGRILSNFPEVLTDA
QKTGDALAELGQLATQPEANIIKLPNVSASVPQLKAAISELQSHGYKIPDFPEEPQNDAE
KEIKAKYSKVLGSAVNPVLREGNSDRRAPRAVKNFAKANPHSMGAWSADSKTKVASMPNG
DFYGSEKSLTVAEPNDVKIEFVAKDGTTTVLKASTPLKAGEIIDSSVLSVNKLKSFAAEA
IADAIKEGLLLSVHLKATMMKVSDPIIFGAIVEVYFADLFKKYEALFNELNIDTRNGLGD
IYAKIAGRPEQAEVEADITKAIENGPALAMVNSDKGITNLHVPSDVIVDASMPAMIRTSG
QMYNKEGKQQDTIAIIPDRSYAGLYTATIDFCKKHGAFDPKTMGSVPNVGLMAQKAEEYG
SHDKTFQIKGDGVVRVVDTNGNVLMEQNVETNDIFRMCQAKDAPIQDWVKLAVNRARLSD
TPAVFWLDENRAHDRELIIKVQKYLKDYNTVNLDIRILNPIAATEFTLDRIIKGLDTISV
TGNVLRDYLTDLFPILELGTSAKMLSIVPLMNGGGLFETGAGGSAPKHVEQFTEEGYLRW
DSLGEFLALGASLEHLGQTLDNSKAIILSETLDQANDKFLANDKSPARKVGQIDNRGSHF
YLAFYWAQALAAQNKDAELKAIFTPIAAEFEANEAKIDAELIGAQGKPQTLGGYYQPTPA
LVSKAMRPSETFNAIIAKIK
>EGALAKHO_01168 50S ribosomal protein L19
MADLMKFVQNELVAKKDFPVFGAGDTITVFYEIKEGEKTRTQFFKGVVIQRRGSGNTETF
TIRKMSGAIGVERIFPVNLPALQKIEINKKGAVRRARIFYFRELTGKKAKIKDKRR
>EGALAKHO_01169 tRNA (guanine-N(1)-)-methyltransferase
MRIDIITILPELLKSPFEASIMKRAIDKGLVEVHFHNLRDYTTNKQKSVDDYPFGGGAGM
VMTVQPIDDCITHLKSQREYDEIIYMSPDGETLNQKMANTMSMYENIIILCGHYKGVDQR
VRDHFITKEISIGDYVLSGGELGALVLSDALIRLIPGVLSDETSALTDSFQDNLLSGPIY
TRPADYKGWKVPEVLTSGHFAKIDKWREDMAFEHTKNRRPDLLE
>EGALAKHO_01170 hypothetical protein
MKNFILLIALVLLSACSSSKNTGDKWVGKTKQSLIKTWGTPIRIFDNTTDGEILVYADQI
YNESNRGDSRAAGSSYWNYTYMYVDKNGKVSSFRNEKQNYPPQALDSDKLSTMKLLTAK
>EGALAKHO_01171 hypothetical protein
MRKLFLLMVTVCTLISCTNQNQSKVVDTSENEKIVKQYFEHFNSHNWKKMAEMYTETADF
KDPSLGKGIVKQTRKQTQDKYAELNKIFPDLHDKVIQIYPSGENHIVVEFISTGTAPDNS
KLELPICTVFTIENGLVTKDFTYFDNFQADTTKK
>EGALAKHO_01172 hypothetical protein
MANTYTQIHIHFVFAVKFRKAVIANDWKAELYKYITGIIKNNNHKLLAINGVSDHVHILI
GIRPAQSISDLMKNIKQDSSKWINASKFSKSHFEWQEGYGAFSYSKSQLNAVVTYIQKQE
LHHKKKTFKEEYIDFLEKFEVDYDERFIFKELI
>EGALAKHO_01173 Chromate reductase
MPKQFKIFAITGSTRKNSSNYKILKHISENIKTGFEVEIFEDLDELPHFNPDLDTDNPPP
TIISFRNKITEADGVIICTPEYVFSLPGSLKNALEWCVSTTIFSKKKVGLITASASGEMA
HDQLILIMKTLEARFENKNLLLIQGVRGKINEEGKIINDETLSILNKFITNFENQFLTEM
>EGALAKHO_01174 Inosose dehydratase
MVTRRNFIINTSLAATAVLASPSFAFTMNKKEIGLQLYTLRDELPKSVQSVLEKVAKAGY
TTVETYGYSIKDQFWGLTPIELKKILDANNLKAVSGHYNLGSFLYDGNLEEVKAAIEAAK
ILQNEYLTVPWVDEPFRNDFHKIAARLNEAGKMCADAGLKLAYHNHDFEFKKQDGITGYD
ILLKETDKNLVSFELDLYWVVRSGNDPLQLFKENPGRFKMWHVKDMDKINPALNTEIGSG
SIDFKSFFAEVKQSGMVHFFVEQENNYVPNAFESIKTSCDFISKKII
>EGALAKHO_01175 hypothetical protein
MKKLLLLFLVVLCSCQSDKKEKLSTKPQSNPEENLPLQPYFAAIQINDVKLEEPVFGEWL
YSHKEKGQSFKQFIKTAHVVPSQEENIIYLKPIGKFNSVQLRQIELVRQYLQIFFQLETK
VLENVSNDIIPDNARRIGDVGQEQFLAGYILTNVLKEEKTDKGIALMAITEKDLYPKPEW
NYVFGLASYRDKIAVSSIYRMQQEADFNLCLDRLLKICSHEIGHMFGLHHCINANCVMNG
TNSMPETDRHFIRLCSLCQRKLNSGFKYDNKKRLVALEKYFKENNLAEGIELMKKDLEVF
DK
>EGALAKHO_01176 hypothetical protein
MQSFGASKEFIKGDDIEWEVVGEGIKRKILAYDDRVMLVNVHFEKGGIGTLHEHYHTQVT
YVSSGKFDVTISGVTETLKEGDSFYIPPHAIHGVVCLEEGMLTDVFSPIREDFMKK
>EGALAKHO_01177 putative transporter
MNLSKTNVLFMAACTGLIVANLYYCQPLIVLIANEFKIPEASAGTITYLTQAGYAIGLFF
MVPLGDKLERKKQILITTFASVIALILAATAKSFFLLQVASLLIGITSIVPQLILPLAAS
LSSVEQRGKVIGTIMSGLLVGILLSRTLSGFIGQVLGWRSMFYIAAGICLLIFFVIQKKF
PVNKPQFQGTYGQLIQSLFTLIKTQPILREATIINVFSFAQFGAFWTTMVLLLSGKPFDF
NSATIGLFGIVGASGALAAPLVGRLGDKGGSRVAVGYGCLLILLSFIIFYFSIESVIGIA
IGIVFIDVGIQGVHISNQTRVYSLLPEARNRLNTVFMSFSFLGTAAGSAYGLFLWKLGGW
HAVAIGCVGLSVLALTVYGLTYKSSRRVGTKK
>EGALAKHO_01178 putative peptidyl-prolyl cis-trans isomerase
MENGIYAKFNTSKGSILVKLTHDLTPGTVGNFVALAEGNMENKVKPQGQKFYDGLTFHRV
IPDFMIQGGCPKGTGTGDPGYKFDDEFHPSLKHDRPGVLAMANSGPASNGSQFYITHVPT
SWLDGKHTVFGHVVEGQDVVDAVAQGDNLDAVEIIRVGEEAEKFNAIEAFVGLKGARLKR
DAALKAESEAKMEQLAAGFDKTESGLRYKMIQKGDGKKAEAGKTVSVHYEGSLESGKVFD
SSYPRKKPIEFRLGQGQVIEGWDEGIALLQVGDKARFVIPSDLAYGASGAGGVIPPNATL
IFDVELMDVK
>EGALAKHO_01179 hypothetical protein
MKVKILTLAAITLLAVSCGTKKTASTPATPAVTETAKAVELTPELAAGKSMYENNCAKCH
KLYEPKKFTQEEWAPILVRMQKKAHLDDTQMASVTNYIHSQL
>EGALAKHO_01180 hypothetical protein
MIFQTPHHYEGVFLCHFKIKKLFNKDLLNSLIINIFSDSLTIENVYN
>EGALAKHO_01181 Transcription inhibitor protein Gfh1
MKPTPIFCKTDYQLLRELILKSKNETNAKEVGQLAQELDRAIISKEVTLDSSIIRIGSHV
TIEDVKANKQMKIQIVLPSLANVTERKISILAPLSVAIIGFKENDQVDWELPAGIKTLKI
IAVDNSTSDNS
>EGALAKHO_01182 Thiol-disulfide oxidoreductase ResA
MARTPSNMIPLGTIAPDFHLKDTNSNNEFSFEDVKGSKGTLVIFMCNHCPFVLHVLPEII
MIANDYRVQGLGVVAISSNDIEKYPEDSPELMSEFAFKNKIDFPYLFDKTQEVAKAYEAA
CTPDFYLYDNQNRLFYRGQLDDSRPGNGIPLSGSDLRSAIDALIYNRSLNEQQKPSIGCS
IKWK
>EGALAKHO_01183 Non-heme chloroperoxidase
MENTILNSDHSIKDFDFDIHEQNTDKYIRTAKNVQLYVKDYGKGKPVILIHGWPLSNEMW
EYQMEFLVQNNYRVIAYDRRGFGKSSQPWDGYDYDTLADDLSEIIEQLQLENATLVGFSM
GGGEVVRYFSRHGGKGVTKAALISSIIPFLAKTDDNPEGRPKEKGEATATAIREDRIGFL
ENFGKIFFGVTIINKPLSTPLLEYFTKLCSAASPRATLKCAESLNITDFRDELHTIKVPT
LIIHGDEDKNVPIEVSSKKTAEAITDNTFIIYEGAPHGLFYTAKDRLNQDLLNFLNS
>EGALAKHO_01184 putative chaperone CsaA
MDLTWSEFERTEMRVGTIIDVNDFPEARKPAYQLTIDFGTEIGIRKSSAQITVHYKKEDL
VNRQIIAVVNFPKKQIGKFMSECLVLGAIGKEGDVILLAPDFKIENGLRIG
>EGALAKHO_01185 hypothetical protein
METNLLILPGLGNSGEKHWQTFWHKKFENSIRLVQDNWDEPIREEWLARLNEEIAKLNQP
TILVAHSLAVSLVLHWAEANTNKNIVGALLVAPADVDSPQHTPECTRNFSPIPTLKLPFP
SVVVASENDPYASFERKQFLAEKWGSDFVNVGQKGHINSDSDLKYWEEGQLILHQLIEKI
S
>EGALAKHO_01186 Acetyl esterase
MKKIFFLLSILFIGISSFGQKAEYETKTNIQYYNAATNKSDTYINERCVLDIYYPKNTKG
FATIVWFHGGGLTGGNKEIPEALKNKGFAIIGVNYRLSPKVKAEKAIEDAAAAIAWAFNN
MANYGGDTSQIFISGHSAGAYLALMNGLDKKWLQKEGIDANKIAGLIPLSAQCITHFEIR
RENGIPDTTPTIDAYAPLFYVRADAPPILLITGDRELEMLGRYEENAYMARMMKLVGHKQ
TKLYELDGYGHGMTEPAFPLVINEVNRIIKEKQTKK
>EGALAKHO_01187 hypothetical protein
MRENDMLEKEEIFSKVLRAGRRTYFFDVRATKADDYYITITESKKFTEEDGSFHFKKHKI
YLYKEDFGAFAEILEEMTSYVLNHKGEEVISERHQKDFKKEYGSDKPEGQRSSFTDIDFD
DI
>EGALAKHO_01188 putative multidrug resistance ABC transporter ATP-binding/permease protein YheI
MKELSYLNKYFIKYKYSFSLGILITIIAQIFSLFTPKLISKSLNAIEKFDKLPETQQASQ
VIIDSYRQDLIHNVLLIIATTIVAGFLTFLMRQTLIVMSRHIEFDLKNEVFRQYENLSQN
FYKQNRTGDLMNRISEDVSKVRMYVGPAVMYTINTFIRFAIVIIYMYNVSPLLTLYTILP
LPILSYCIFKLSSEINKRSTTFQQYLSKVSSFSQEIFSGIRVIKAYSLENQHQNNMVALA
DESKKKSLDLAKVQSLFGPLMIALIGISNLVVIYFGGVMYINGTIANIGTIAEFILYVNM
LTWPVASLGWVSSMVQEAEASQKRLNEFLKIEPEIKNNNENSSDIQGSIAFENVNYTYED
TNIEALKNVTFTVKKGETLAILGKTGSGKSTILSLISRLYDVTDGRITIDQNEISTLNLN
DLRNNIGIVPQDAFLFSDTIKNNIKFGNQNATDEEVMDAAKSAVVHDNIIAFNKQYDTVL
GERGITLSGGQKQRVSIARAIIKNPAILLFDDCLSAVDTETEETILNNLFEICKDKTTII
VSHRVSSAKNADKIIILEDGKIIQQGSHNQLINQEGYYASLYLKQLSEKELL
>EGALAKHO_01189 Leucine dehydrogenase
MDATFATGKELQKMDPVFGQLSFDDHEQIVFCNDKDTGLKAIIGIHNSVMGPALGGTRMW
NYNTEWEALNDVLRLSRGMTYKSAITGLNIGGGKAVIIGDAKTQKTPELMRKFGEFVHSL
SGRYITAEDVGMETKDMDTVRDVTPYVTGISEERGGSGNPSPVTAYGVYLGMKAAAKSQF
GSDVLDGKKVLVQGIGHVGEALVEYLTKEGAIVTIADINEEKLYEVAQKYNAAIYTGEDL
YSADVDIYAPCAMGATINDNTVNKIKAKVIAGAANNQLADENVHGARLQERGILYAPDFL
INAGGIINVYAELANYGKAEIMTKTENIYNTTLEIIDYAVKNGITTHKAALTIAQNRIDL
RKIENAAKK
>EGALAKHO_01190 N utilization substance protein B 
MVNRRHIRVKVMQSIYAMHQSGSDNMEKEEKFLFYSIDNIQDLYLIMLSSLIEICKKESV
FLHLSSKKHLATAAERNPNEKFIKNKIFQLLAESNSLSIALENRKINNWSLNDDYILLLL
NDIKASEVYAKYMSNSTNTFEEDRQFIIDLFADVIVPNEKLYEYLEDDKLTWVDDIPVVN
THIVKQLKAIKTEDPDDFRVPKLYKDVEDKDFAKDLFRRTVLNESILAKEYDDKTPNWDS
ERIAEIDTIILKMAICEFLKFPSIPVKVTLNEYLEIAKEYSTPKSSIFINGILDNLVKEL
TANKKMVKVGRGLM
>EGALAKHO_01191 hypothetical protein
MQDLMKFAPYLLMFVVLYFFMIRPQQKRAKNEKEFESGLKVGDKIITKSGFHGKIVELAE
TSAIIETMSGKLKIERSAISMEMSAALKKA
>EGALAKHO_01192 hypothetical protein
MINIGDLNFNKKIPNSNLSLTFVKVKTLTKVFLCANKCHCAERSNHTKYFTDRNPKVCHS
EERGIPTRNSTIKITNLCRATCGDSSFLGMTYFAAMHHEIASYLAKTHTMLNHKPKKIPN
SIIGIWDLNLLEFKKP
>EGALAKHO_01193 hypothetical protein
MEPNSHKKHFWDKVNQWEEELLFLKSIIDKTELEESIKWGGPIYVYNKKNVIGIGGFKNY
FAIWFLNGVFLKDEKKRLINAQEDKTKSMRQWRFTSKGDVNEKEVLEYILEAIENEKQGK
IIKPSKKEAIVSELLQKEMDQNPALAEAFQKFSPYKQYEFLEYIETAKQEKTKLTRIEKV
IPMILGNVGLNDKYR
>EGALAKHO_01194 Peptidase T
MQHIIDRFISYVTIDTESDPNSQTTPSTEKQWNLANKLVEELKTIGLEDVTIDDKAYIMA
TLPSNVDHEVPTIGFVSHFDTSPDFSGANVKPQIIENYDGKDIILNAEKNIILSPNYFKD
LLQYKGQTIITTDGTTLLGADDKAGITEIVSAMEYLVQHPEIKHGKIRIGFTPDEEIGRG
AHHFDVAKFGAQWAYTMDGSQIGELEYENFNAAGAKITFKGKSVHPGYAKGKMINSMLIA
NDFINELPKGETPQETKGYEGFFHVHHLTGSIEETVLELIIRDHNKIKFEKRKDLIEKIA
KKINKKYAKQFGEDIVTAVVKDQYYNMKEKVLPVKHIVDIAEKAMRELDIKPIIKPIRGG
TDGSQLSFMGLPCPNIFAGGHNFHGKYEYVPAESIQKATDVIVKIAELTAIPGIFDVAEK
SKRKR
>EGALAKHO_01195 Serine/threonine-protein kinase pkn1
MKNKTYWIFAILTISIISIAYGYTKLVVPKQKLAAMDCAETPNSDSASLFKPTIENKNKP
SGKAPKGMVWIPGGEFSMGSNVEDESLCSIKGVTKDAAPIHRVYVDGYYMDQTEVTNDQF
EAFVKATGYVTLAEKAPTHEEYPDAPIENLVAGSAVFTPTPAKVDLNNYMQWWTYEKGAD
WRHPEGAGSSIKGRGNYPVVQVSYDDAAAYAKWAGKRLPTEAEWEFAARGGKTGELYAWG
NTLKPKGKFQANIYQGHFPIEKGDTGEDGYIGIAPTKQFEPNGYGLYDIGGNVWEWTNDW
YTADYYSVISDNGQVVKNPQGPETSYDPGEPNLPKKVQRGGSFLCTDQYCTRYMVGTRGK
GDYKSPANHIGFRCVQ
>EGALAKHO_01196 hypothetical protein
MYKASLLIRISKNILLSLILSLSLNGWSQQIKDTTKLINVRYGDKGIELRTKDNKFLFQL
QSRFQFRFSTPNDQDPLTYDDYSQDKETTFKINRARLKVGGHAFEPWLKYYWEYELSQSN
LLDFRIMIEKWEWLSFKVGQWKVEYTRERFISSGEQQTVDRSLINRPFTADRQMGVEVYG
HLKGSGIADFNYWAAALTGTGRGNTSNDDNNLMYFGRAQWNFLGRFLDFEGSDLEFHEKP
TPIIAFSALTNRSPYTRFSQSGGGSLEGYENGLPGQYRVNQWNLESAFMYRGFSWQSEWH
TKEIIDKLNNNETTTMKGYYVQAGYFFHNAFDWWPKHLEMAGRHAAYRPDNSIRQNLQDE
TTIAFNWFFKGHKNKLTSEVSYFSFQDKTLPLEQGWRFRIQWDISL
>EGALAKHO_01197 Dihydroorotate dehydrogenase (quinone)
MYKLIIRPLLFCFDPEEVHYFTFSFVKFISKIPGVSSIIKSIYEVKDSRLEREVFGIKFK
NPVGLAAGFDKDAKLYKELSDFGFGFIEIGTVTPVGQEGNPKKRLFRLKEDQAIINRMGF
NNGGVLEAVERLKKNSGVLIGGNIGKNKITPNENAVDDYIICFDALFDHVDYFVVNVSSP
NTPNLRALQDKEPLTALLQTLQNRNVEKQKISTQKIKPILLKIAPDLTDEQLLDIIDIVK
TTQIAGVIATNTTISREGLQSQNQSEIGGLSGKPLTKRSTEVIRFLSEKSNKAFPIIGVG
GIHSADDAIEKLNAGASLVQLYTGFIYEGPALIKAINKKVLKGL
>EGALAKHO_01198 hypothetical protein
MILFIKLLLAHLLGDFIWQPNSWVTDKEAKKHKSIYLYLHILLHGVLAAILVWEISFIPY
AVLIAVTHGIIDLTKLNFQKPKTKRSWFIGDQIAHVLILIGIVLLYENKGIINFWQDNEF
WILLTGILFVTKPASIIIKTIISIWSPENENTHADNSLANAGNYIGILERLFVFCFILTG
HFEAIGFLLAAKSIFRFGDLKEAKDRKLTEYVLIGTLISFGIAIVTGLIVQALILQSL
>EGALAKHO_01199 hypothetical protein
MTSVITGDIIDSRQQKSKDWVEGLKKILTPFGETPGQWEVYRGDEFQIEIKNPEEALLSA
ILIKAHLRSIKLDARMSIGFGDKTHNAEKISESNGSAFIHSGELFETLKKQKVTLAMRTG
DNNIDEKMNLMIQLALTFMDSWLAQSAEFVATAIENPTLSQEEIGQILGINQAAVSRRQK
RAQFDLVMQLDRYFRTQIKQLTAL
>EGALAKHO_01200 Hydroxymethylglutaryl-CoA lyase YngG
MNKEIKIIECPRDAMQGIKTFIPTEKKVSYIQSLLRVGFDTIDFGSFVSPKAIPQMQDTA
EVLAQLDLSQTTSKLLAIIANTQGAISASEHEAIQYLGFPFSISENFQMRNTHKTIAQSL
VTLEEIFEIAAKKNKEVVTYLSMGFGNPYGDPWNVEIVGEWTEKLSNMGAKILSLSDTVG
SSTPEVITYLFSNLIPKYPQIEFGAHLHTTPNSWFEKIDAASKAGCARFDGAIQGFGGCP
MATDKLTGNMPTEKLVSYFTANKKITGLNSLSFESAYNEASKLFGKYH
>EGALAKHO_01201 hypothetical protein
MKANILNKIPKVLVFAFLFFSCSSDLDFDQAKDLKLEPAFVANLAYFNVPATQLVNDGSP
QVISDVQGFDAFKDPFFRDNLIKAEFDFEVENTIVRAFKIEMLLLDANDQTLETDSYSVP
AYLGGSNIIKYPTEVFENARLDLLKKTVKLKFIIRMESGPPLDKNSVGNLKFRSSANIYM
VIE
>EGALAKHO_01202 hypothetical protein
MRKAYLILILFLQFVCFSQNRQLLYNFTAIPQSSLVNPGADVSYKYYFGIPVLSGISANV
GSNSFSAYDLFANNGVDFNDKVRNIVNNSSNKDKAQVNEQLELFSGGFRVGGEDSQSYVS
FGAYQEFDFLMYVPKDPAILALYGNKDYVGKSFNLADITVRAEVLSVLHVGFHKKLSEKF
VLGGRVKLYSSGANATSTRNSGFIYTTQNAGTPNLYTQIISSNLELRTSGIAKFTKDEYE
GNIAEDIAHNTFFNGSLGLGIDAGFTYYFRENLQFTASIIDLGFVNQSKDIETITNKGNY
RYEGVNPVFNATNVPKDVFDDFEKAIPRDTLYNKYTTWRPTKLYSSVQYSFGESRSDEEC
NCKGSTKRRYLNAIGGQLFAMTMPNEPFIAFTAFYKRSIFEKLDFKATYTLDSYSSKNIG
LGLSGTIGKVNIYALVDNVLEYKDVSKANSVAFQFGINFIVPE
>EGALAKHO_01203 Inosine-5'-monophosphate dehydrogenase
MIAHNSKIIGEGLTYDDVLLVPNYSNVLPREVSIKSKFSRNITLNVPIVSAAMDTVTESA
MAIAMAQEGGIGVLHKNMTIEQQAAKVRKVKRAESGMIIDPVTLPMTSTIADAKNAMKEF
GIGGIPIVDENKILKGIVTNRDLRFEKNGARPIAEVMTSTNLVTVAEGTSLEQAEVVLQG
HKIEKLPVVNAKNELVGLITFRDITKLTQKPIANKDVYGRLRVAAAIGVTGDAVERAAAL
VAAGVDAIIIDTAHGHTEGVVNTLKEVKSKFPQIDVIVGNIATPEAAKYLVANGADGVKV
GIGPGSICTTRIVAGVGFPQFSAVLEVAAAIKGTGVPVIADGGIRYTGDIPKAIAAGADC
VMLGSLLAGTKESPGETIIFEGRKFKSYRGMGSVEAMQTGSKDRYFQDVEDDVKKLVPEG
IVGRVPYKGELNESMLQFIGGLRAGMGYCGSKDIPTLQETGRFVRITSSGITESHPHNVT
ITKEAPNYSR
>EGALAKHO_01204 hypothetical protein
MKHTLLLFLILFPFFNYGQSNQTLDFKAGYSPETSYNQTTSNSSEYEILYSGSEKLIETL
KQNGVSNPTKIKNIFDLETLSKTGKIDKNGDFPITIEYLKSIDANGKTIIPNGTLLYGKT
SLSTMPQMDSIVSNGMEESFKNIIFQTVKSTFSQLVMPRKKLKIGESFIQESPLTLPIAG
INIEMLITTTYNLKSMNSKNAFFDITQTYTMKMSDTRFETTGSGIGKGDLIYDIPNHFII
GNTLGMDFNLNLKSNDFTLQLKSKSDFKQTSEISK
>EGALAKHO_01205 hypothetical protein
MTSQVSNKRTCKKGHHYFKTSDCPTCPICEREHKPQSGLLFVVSAPARRALENKGIETAQ
DLSKYSKKEIMLLHGIGPSSIPKLLSELKKQNLSFKED
>EGALAKHO_01206 6-hydroxynicotinate 3-monooxygenase
MHTSIIKNKKIAIIGGGPVGLTTARILQINGADVTVYERDFNAQARTSGGTLDIHADSGQ
LAIEKADLMEEFYKYARPTGEKMADMFGNITSDEMPDETNAYSRPEIDRNDLRKIMLENL
QENTVVWNSHLSKIKKSENQYHLEFKNGTSTTADFVIVANGGRSNARKFVTDKEPHLSGT
YIIQGEISNPDRDYPEFKPKYGDGNMMAMGEQKMFYTHTLRDGSIHFGVSFKADENWVLN
HGIDFEDNTSVIAFLNKTFENWGTDYKKFFAAATDFSGLPLRLFSLEESWKEHSNITLVG
DAAHLMPPFAGEGVNMGLMDAYQLTENLTNGEFKTIQDAISDYEQKMFAYALEAQRMTKK
MEDLLHSDITAEDILNSRYEG
>EGALAKHO_01207 putative HTH-type transcriptional regulator
MRTRDTNKEEIVKQKALEMLVSQGVEGFGMNRLARECGVSVATLYIYYSDKEDLIRKIGI
EIGQNYFSKMLEGFSPEMSFVDGLRQQWKNRSNYATTFILETTCFELLKHSTYGDGILAE
ITSEFKNEMTKFITKAIEKKELVPVTFEVFWSIAYGSLYSLLELHREGKSMSGKTFAFTK
EINDEAFNLVIKALTP
>EGALAKHO_01208 hypothetical protein
MKKLYYTSNILLLVVLVVLGSCAKSKTTRRTEAQVHKTIEYKKPESSIAFKFVKTKQWLG
SIKGDSSKLDIAYAINRTDKANFAKMDSVVIPTDFSGDLVYYLPFPIHVDVLEEVSKVLI
FSYPTQTFAAYENGELVYTGPTNMGRKKDPTPTGLFFTNWKAEKTTSTFNDEWDLKWNFN
IENKLGVGFHQYELPGYPASHSCLRLLEKDAKYLYKWADEWILKDSENVKVKGTPVIVFG
SYNFDGPKPWLDLVNDSKALNISESEIESQVQPYLQQILDNQKLREGDHTPSS
>EGALAKHO_01209 hypothetical protein
MRPGIIFISLLLYVQSWSQNNNQIEDLQIKYFNLAKDFLKDSNLNGAMNSFYNANRFNPK
TQIGALSFKKADSIKIILRKNLNNELVGNWKMIDVVPSWVMREDSIVGQMIKINTSEIQF
FELIRNAKNWKLAKTEKILYSDEFSESSSYADLIYSNNEIWQYWIDEKTGYLNLTNTGEK
TDTGRTDISCGTLRRTYFKLQ
>EGALAKHO_01210 GDP-mannose pyrophosphatase NudK
MKNPEIKVTETKLLSDNWYILNKVTFSYQKENEKVQTHVREVYDRGNGAGILLYNSTKKT
VILTKQFRLPTFLNGNKTGMMIEVCAGLLDEDNPEECIIRETEEETGYRIKKVNKVTQTY
MSPGAVTEILYLFTGEYDESMKVSEGGGLASEQENIQVLEYTFDEAYAMIESGEIVDAKT
IILLQHAKIKGLI
>EGALAKHO_01211 Adenylosuccinate synthetase
MTVDLLLGLQWGDEGKGKIVDVLTSNYDIIARFQGGPNAGHTLEFDGIKHVLRTIPSGIF
HKNSINIIGNGVVIDPVVFQKEIEGLEKFNLDIKSKLIISRKAHLILPTHRLLDAASEAS
KGKAKIGSTLKGIGPTYMDKTGRNGLRVGDVELEDFKERYRALADKHEAMIAFYDVAIQY
NLAELEKEFFEAIEELKKLDFIDSEEYMYQAQKAGKSILCEGAQGSLLDVDFGTYPFVTS
SNTTAAGACTGLGIAPNKIKEVYGIFKAYVTRVGSGPFPTELFDEVGATMARVGNEFGSV
TGRQRRCGWLDLVALKYAVQVNGVTQLMMMKGDVLSGFETLKVCTEYNYKGQIISHFPYN
IEPENVTPIYKEFKGWQADLTGLTTYEQLPIELKEYIEFIEAEVGVPIKIVSVGPDRKQT
ITK
>EGALAKHO_01212 Ferric uptake regulation protein
MTLISTDNTKNQEIVKNVFTMYLEQKGHRKTPERYAILQEIYDSEEHFDIENLYIKMKNK
NYRVSRATLYNTIELLLDCALVRKHQFGQNQAYYEKSYFDKQHDHIIMTDSGEVIEFCDP
RIQTIKKTIEEIFDIEITNHSLYFYGNKKQKQ
>EGALAKHO_01213 hypothetical protein
MKSDSLEIPKIQFDENGALLIVASETSSKDDFDFFQGKSFIKNKKLKQRFANCTEWIEFP
STQEMYKILNGIGNIDNFLATFDGEPFEGMTVRLFNPKTKLWSIYWADSTSGTLDKPVMG
SFENKVGHFFSEDIFEKKNVLQVFRWDARDENNPVWSQAMSDDKGKTWEWNWYMYMSKTK
>EGALAKHO_01214 GTP pyrophosphokinase
MIEIDIEKENKAIAQEYKELLRISYQTLTPADKKLIRKAFDVAVDAHKEQRRKSGEAYIF
HPIAVAKIVASEIGLGATSIAAALLHDVVEDTPITVEDIERLFNPKVAQLVEGLTKISLV
QKDLNASMQAENFRKMILTLNDDVRVILIKLADRLHNMQTMDSMVEYKQTKIASETLYIY
APLAHRLGLYNIKTKLEDLGLKYTEPNVYNDIVSKIRETKEEQDAYIKDISDVLKNSLDK
EEIDYIIKGRPKSIYSIRRKMRAQNVSFDEVYDKFALRIVYKADPHDEKFVAWKIYSIVT
DHYRPSPSRLRDWISSPKSTGYEALHITVMGPKGRWVEVQVRSERMDEIAEKGYAAHYKY
KNGATEESGLDVWLNLLREALENQETNAVDFVEDFKMNLYSKEIFVFTPKGEIKSLPKGA
TSLDFAFSIHSEIGIKTRGTRVNGRLVPLNHELKSGDQVEVITSANQKPTINWLEYVTTS
RAKNKIKNVLNENTKKIAEEGKELLTRKLKHLKITISEQVINELVNFFKLKTSLDLFYRV
GIGAIENQQLKDYAAQKSNSIINFFKNKIKRNKDTADEDIHKPVISSNYDMLVFGTEHDK
LDYKLSQCCNPIPGDDVFGFVTINEGIKVHKKDCPNAIGMQSNYAYRIMSAKWIDSSQEE
FKAIINITGMDVLGLTNQLTRVISNNMSVNIQSISLSTDAGIFHGQIAVIVKNNTILKKM
INAIKKIDGVDKVTREYRT
>EGALAKHO_01215 D-aminopeptidase
MSYKLSLVLFLFGFTVSAQITNPEVDELVNRTIKAFDVPGIAVAIVKDGKVVLAKGYGVK
SITTQEKVDANTLFGIASNSKAFTTASLAMLVDEKKIKWDDKVIQYLPDFKMYDDYVTKE
FTIRDLLTHRSGLGLGAGDLMIWPDGSDFKAADIVHNLRYLKPVSSFRTKYDYDNLMYII
AGEIVHVVSGQTWADFVETRIMKPLEMDKSVASVKRLKDTSNVITPHVPIDGKLKTIKRY
ENNLFDGAAGIYSSVNDLSKWAILQINNGKYGDNKQLFSEKEHDEMWQLQTIIPTKTKPP
YNTHFSGYGLGWFLSDVKGYKQVSHTGGLEGNVTQTTLIPEIGLGIIVLTNQQSGAAFSA
ITNTIKDSYLGVKSDDYVTVYSNRMKANEASADKVTDEVWATVAKNKKDKIKTDFSKITG
TYKDNWFGEITITEKKGKLYFASKRSSQLVGEVFFYKDGNYVVKWNNAFFHADAHLLFKY
DESRNVINLKMLPISELTDFSYDFQDLDFSKE
>EGALAKHO_01216 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MKQITSIQNPFIKSLVLLQEKAKARKQTGTFLIEGLREISIALKGGYELETVLFLPELVT
ESQINKLVNTPVQLIEINKEVYQKLAYRDTTEGILAVAKTKSMQLSDLKLSDNPLILVAE
APEKPGNIGALLRTADAANLDAVLIANPKSDLYNPNIVRSSVGCLFTNQIATGTTAEIIA
FLKEKKIDFYCATLQNSTSYHTQNFTTPTALVVGTEATGLTQEWRDAATQNIIIPMQGEI
DSMNVSVAAAILIFEAKRQRGFN
>EGALAKHO_01217 hypothetical protein
MKKILLMFFLSALFIPKIMAQADTTEAYYDKIDKSLKYETGKITLTEGEGILNVPKGFKF
LNGEQTQHVVGDLWGNPKDESILGALVPDGKGVTHSNSWMFVISYQGDGFVKDDDANDID
YDDLLKTMQEDTKTTSEERKKAGFEEVQLVGWASKPYYDTNLKVLHWAKELKFGQNPSNT
LNYDLRVLGRKGMYNISAVANMSELGEVKASIPGILKSVEFNEGHKYLDFDADTDTVAAW
TIGGLVAGKVLAKVGFFAIIAKFGKVIFLAIAAAFAACKKFLFGKKDQVVSKPQEETALL
EEPTSTEE
>EGALAKHO_01218 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MKKVILILFILLSWKSLAQKTENIIIITTDGFRWQEVFKGMDPAIANDKKFNQGDSTYIY
KKYSSSDFKESRKKLMPFLWSEIASKGQIYGNRDLGNKVDVSNPYWFSYPGYSEIMTGNV
DVAVNSNGYKANPNVNILEFLNKQPKLKGKTAAFGAWDAFDRILNEERSGFPVISAFDKV
GGNKTTASQKLLNEMRDNSFKPFHSDECLDVFTHYQALDELKNNKPKVLYIAYGETDEWA
HEGHYKSYLDAANQVDKWIKEIWEFVQNDPQYKNKTTLLITVDHGRGDKTKAQWTDHGAD
VVGASEIWFAVIGPEIAAKGEIKNNSQLYQKQFAQTIAKIMGYNFTTTHPVANEIPDLLR
K
>EGALAKHO_01219 hypothetical protein
MKFIKSLYLNNFFFYILLGIIVMFVCAFIFPNLYNGVWFIVLVLSTFLVLDILLLYLAKT
GIEASRKTPEKLSNGDLNPIQIIIKNGYTFPVSVKIIDEIPFQFQVRDFKIIKTIPASTQ
KELGYDLRPTERGEYYFGNLNVYVSSPLKLISRRFTFDKDQLVPTYPSFIQLKKYDLLAF
SNNLYQYGIKKIRRIGHTMEFEQIKEYVQGDDLRTINWKATAKKNSLMVNQFQDEKSQSV
YMAIDKGRVMQMPFDGLSLLDYAINSTLVLSNVILKKQDKAGIFAFSKKVENRVFAERRS
SQMQKILETLYNIKTDFFESDYSRLYVDIKKNINQRSLIILYTNFETMDGLNRQLPYLKG
IAKSHLLVVVFFSNTELNAIINKKTDSVQEIYDKVIAEKFMFEKRLIANELKKYGIHSVL
TQPENLTLDAINKYLEIKARGIL
>EGALAKHO_01220 ATPase RavA
MDDINNPETEITNENVNFETRINLAPLLEHVNAIKTELETVIVGQHKMIDQLLVAILSNG
HVLLEGVPGVAKTITAKLLSKTLNIGFSRIQFTPDLMPSDILGTSIFNLKNSEFEFKKGP
IFSNLILIDEINRAPAKTQAALFEVMEERQITIDGSAFQLETPFLVIATQNPIEQEGTYR
LPEAQLDRFLFKITIDYPKLDEEILIIQREHLLQDHGKLEAIKTVLSAEEIKGYQGLVKQ
IRVEQNLLEYIARIVVNTRENAFLYLGASPRASIAILNAAKGFAAIRGRDFVTPEDVKEA
AIPVLQHRVIVTPEREMEGITSSEIIKQILETVEIPR
>EGALAKHO_01221 hypothetical protein
MNKSIKIYIAILVFVLALILISDRNQTKPIDWRPTFSVHDKIPYGLYILNKEIKPILKNQ
KIERIANVTPYEFLDSKYDADTLVENYKIEGTFLSISDLENIDEQSVKELFYFVSRGNNA
FLSMRTFPEALMDSLKIDTKFEFHEPKNNLIWMANKNVSSKKYVFQQAVEDYFSKIDTAN
TTVLGYQSNEKKEKHINFIKVPYKSGNFYLHTQPAAFTNFHLLKKDHFQYAENVLSYISK
GDVFWYTKLQNDKSISHSPLRYIHSQPALKWAWYLSLLGILIFIIFNAKRKQRIVPILKP
LPNLTVDFTKTIGNLYYQEGDHENLIDKKIVYFLEKIRNEYLIDTTKLDDVFIQKLHHKT
GKNLTDIQELVFLINEHRNSYHGSLEEDLIRINNAIEKILH
>EGALAKHO_01222 hypothetical protein
MKRIFLILSFFFCFSISHAQDTLAEAEPPKVAAVKYTEKDIHIDSDTIEAKTFSKNFKKK
YTDPEFIYEPKAPERGIWDNIKEWLANFFRRIFSFTDAKTSITFTIIFLRVLAVLVIIAV
IYLIVKALINKEGQWIFGKNANKRAVQYSDIEKNIHLLDFEKLIKESIQNGEKRPAIRYY
YLWLLKVMAQNNYIEWDIEKTNSDYLYELKSPVYREDFTYLSYLYNYIWYGEFEIDETTF
TKAENRFKKSIKTFSNE
>EGALAKHO_01223 hypothetical protein
MREVAFIKQNKEKWLEFELAIFGKAKKNPDELANLYIQMMNDLAYAQTYYPKSKTVVYLN
HLASQIYQKIYKTKRTEKNRIAEFFKTEVPLLVYEYKRYLAYAFVFFFAFVAIGAISARY
DPDFARLIMGDEYVNMTLENIKKGNPMAVYGSSANWGTFIGITVNNIQVGAACYFYGIFG
GLGTFYYLLQNCIMLGSFQYFFFEHGVFWKSVRGIWIHGSMEIFAIVIESAAGFIFGASI
LFPKTFSRLNSFKIGFKNSFKIYISTLPFTFAAGFLEGFITRYSIDMPIWLSVLIIVSTL
SLISFYYLIYPFIVNKKVQQFSATKLT
>EGALAKHO_01224 hypothetical protein
MSELSITTTQNVKINFIAASVGVRLGSYFIDLIIKISYLLVVALILFYFFHFERVFDGFD
VWSRRAAIFIISFPILMYSITLESIFEGQTFGKKLLHIKVVKIDGYQAGFGDYFIRWFFR
LIDISILGGLVALISIVTSKKAQRLGDMAAGTAVITLKNKINISHTILEEIGTSYVPTYP
LVIKLSDNDMRIIKETFQKAVKKNDHEIIYKLVAKIESVAGIKNQSGDNSDFIRVVLKDY
NYYTQNM
>EGALAKHO_01225 hypothetical protein
MKIKKIIALLLMLFVSAFGFAQGGKKLDKIIKRDYTIIECTIAKMSDQSVEYSLPGETIQ
ISLDVSQIARIDFASGRSQTFDVSAGSTYIPSAPGPISVAEMKPNTIAVLPVPYVNSDNM
QSSEDMSKFAQNDMYNKLLDKSANIFPLTVQDLRTTNSLLHQAGIDHHNIDETPIADLEK
ILGVDNIIAAKISYTMSTSSTASTYGSGSTTWSNNDKKVKSNDYSTTTANTQMYYYYNVY
FDMYKNTTKIYSQTRKPFLNLKDSWIDSITYLLKRSPIYTKK
>EGALAKHO_01226 hypothetical protein
MFHLLDIIGTMAFAMSGALTAMHKKLDPFGVFIIAFVTAVGGGTLRDVLIGRTPVGWMKD
LQYVYVIILGFFLAILFRKKFEKLRTSLFLFDTIGLGVFTLIGLEKGISKGLHPVICIAL
GTMTACFGGVIRDILCTEIPTIFRREIYATICIFGGIVFFALRSLNLDNDILYLLTSIVI
ITVRLLAVKFKWYLPAFSHK
>EGALAKHO_01227 hypothetical protein
MANFSLQNLYFQFKMNKYSIKKYDQNDYSIWNDFIALAKNATFLFHRDFMEYHKDRFEDF
SLLVFENEKLKAVLPANIKGKSVYSHQGLTYGGLVFSSKLKGEKVESILDEILSFFKENL
IEAFHYKPIPSFYFSKGNQEIDFFLHQRGALSERKEMNLAVNLQLPLHVSKSKMKHFRRI
ENLDLDIIEEKDFEPFWDSILEPRLLEKFNAKPVHTKEEIVLLKQKFPENIRQYSVYQND
EIIAGITIFETENVVKSQYGATSEKGEQVRALDFLFINLLHKYKRKGKKFFDMGIVNDEN
EKGYHSGLLQQKEELGCAVYNQDFYKIDIK
>EGALAKHO_01228 dTDP-3-amino-3,6-dideoxy-alpha-D-galactopyranose transaminase
MIPFLDLKKINEPYETAFQEKLKLVLENGWYILGKELETFEKAFAEYNQTNYCIGVGNGF
DALVLIFKGYIQLGKLKKGDEVIVPANTYIASILAILQADLIPVLVEPKLETYNINPDLI
QEKITSKTNAILVVHLYGQLAEMEKINEIAIQNNLIVVEDSAQSHGAVANSKKEVPNSKL
AVNLKSAQAYSFYPGKNLGCLGDGGAINTNDSELAKVLFSLRNYGSEQKYYNEYIGVNSR
LDELQAAFLNLKLPNLDADNNKRRVIAKRYLSEIKNDKIILPFWDLSKNHVFHLFVIRTE
NREDLQEYLRQNNIQTVIHYPIPPHKQKAFSPETSGWNNLSFPITEKIHNEVLSLPISPV
LTDAEVDFIIEILNHY
>EGALAKHO_01229 Lipid III flippase
MSDSKSSYQQILKTTSLFGGVQFFNILISIVRTKLVAVFIGPAGMGIIALLNSTLSVISS
ISGFGIETSAVKNISEDYKNDDLKTVSKTIQIVKKIVFFTGIFGMLLTILFSKALSIITF
GDSDQTYSFIFIAITVLFKQLSSGQLAVLQGLRQMKLLAKANLYGNLFGLLFSIPLYYFL
GIDAIIPAIIVASLSALIFSFYYSNKIKTEKEKLSNSALLLEGKAIVKLGFMLTISSVLT
LLSTYLVQIYIGKNGGLEQVGFYNAGFTLLNSYVGIIFTVMSTDYFPKLSSINSDNDKVR
ESVMQQAFISIIIITPIIVLFLTFISLIIPIIYTANFNAIIPMVCFGILGMLFRAVSWAM
GFILIAKGDSKMFIKTAIGFNILSLIMNIAGYYFYGLEGLGLSFCLYFLFHFIGLKIITK
NRYDFYFNPDFYKAYFVCFVICIITFLIRYIDIPVLKYGLMFLMILISFAFSFYQLNKKM
NVSEIFTSFVQRKKDKNDSEQL
>EGALAKHO_01230 Polysialic acid O-acetyltransferase
MIQNSYRKYRSFYHKLRFYCKVNWIKTLYFNFKKFPFETAKKLPVFFYGGVKFTSIKGEI
QIDGKIQKGMIGFGQPYELNSAHKGIAEVFILGKLTFKGKFQFGKDCFVFVGENASCELG
NMASMASGGKIICTEKIVLGDYARFGSEAQIIDTNFHDLIDTQTGEKLQKSAPIFIGNYN
FGSNRVSIMKGTQTPNFCTIASNSLCTKDYKSLGENILIGGIPAKLIRSNISRDWEGEKQ
QLDDFLTV
>EGALAKHO_01231 Chondroitin synthase
MQDKSLVTIICLCYNQEKYVVESLFSAINQDYPFIEMIIVDDFSTDNSKEVIQKWLVDYP
EIQFIANETNLGSTKSFNKALKLAKGKYIIDLACDDILLPNCVSSQLQAFEESSFKNLGV
VYGNAELINEKGDFYFYYFPVDSHKKTIEKRATGDIYLSVISGGNSICSVSSMVKKSVFD
ALNGYDENLAYEDLDLWIRASRVYDFDYIDAILIKKRISTTSFGTHFFIKNDARSKKINY
STYLIVQKAIALNKSKIEHKAILKRVHFEMILAFKTSDYKLFFKYLVLEIKQRFRIIFA
>EGALAKHO_01232 N-acetylgalactosamine-N,N'-diacetylbacillosaminyl-diphospho-undecaprenol 4-alpha-N-acetylgalactosaminyltransferase
MIMSHKKKKIALIGYRLSGGGSDKVMANLSVFFERQGFEVDIIIVLDEVSFPYSGKLVNL
GLLKNKSNGFFNKAKRLWALRNYLIDNKFDFIIDFRFRTKVLQELILARYIYNTQTIFTV
HSFLIDHYMPNNSWLTRLMYNHCLANVAITAEMKTLIENKHQLQNVVTIHNPVYLEEILE
KQKENIKIGFDFIVAVGQYENEIKQFDKLISSYAKSNLPQKQIHLIIVGDGNGIKLRKIA
VENDIEEFVHLVGYQTNPFQFMVKAKFLVLCSKNEGLPNVILESLACKTPVVSFDCDFGP
RDMISNLENGVLVENQNWEKLTEAMNLLVSDEILYQHCKENALESIQPFLLEKIGQEWLH
LLKAN
>EGALAKHO_01233 TDP-4-oxo-6-deoxy-alpha-D-glucose-3,4-oxoisomerase
MATFTQSQLNMTTIQDIALIKIPVVEDLSGNLAFIQNDILPFEFKRVYYLFDVPSSAFRG
GHSHIEQHEVLIALSGSFEVTVNDGTEKKSYLLNKPNIGLHLPKGIWRELENFSSGAVCL
VLASDVFEESDYIRDYDLFLKSKK
>EGALAKHO_01234 Poly(glycerol-phosphate) alpha-glucosyltransferase
MRLLYIVPKIKTAGGVARVLAIKANYFVEHFGCEVHFLSQNEEDIQPFYSFDSEIVFHNM
ILKGNIFMFFNSFQKQINQKIKEIKPDVILVADNGLKAFVFPFIVKTKVPIVFECHGSKF
IEEEIQKANFISKSLQKIKYRLKDFGVQKFTKIVALSEENLKEWNVENGIIIPNPCWIKS
KKSADLTQKKVIAIARNSYEKGLDRLLLIWKTIGEKYPDWTLDIYTDDVDSLEQEALKLE
IESGINYLHFVKNIQEKYLKASICVMTSRTEGFPMVLLEALASGLPCIAYDCPTGPRAII
TNAENGFLIPDNNIEMYVEKLSFLIENEEVRLKFGLDAKETSEQYSVKKIMEQWRDFLES
L
>EGALAKHO_01235 hypothetical protein
MLSILIPVYNYPVLPLVNELVKQCNASGITFEILCQDDASNSQENSRNQEVNLLPNCSFF
INETNLGRGKNINSLAQKAVYDWLLILDCDTFPADATFIQNYVDVTSDSSKKITFGGIIY
EDKKPEKEQLLRWIYGQKRETSAILTSNLLIQKEVFLQYTFDDSITKYGYEDLSFFSLLK
KNNFEISRIENPTFHLNLETSEVFLNKTKTALENLVFIYNSKKISSEDSKIIKAFELLKK
VKLTKFSTFLFKKNQIKIEQNLLSKNPSLLLFDLYKLGYFCSLKM
>EGALAKHO_01236 Cell division ATP-binding protein FtsE
MSQTVLSLKEVTIYQEGRKILSHINLDVQHGEFIYIIGKTGSGKSSFLKTLYADLPLTEG
EGHIVEFDLATLKESDIPYLRRKIGIVFQDFKLLPDRSIKDNMLFVLKATGWTEKEAMEH
KIDEVLDKVGMKDFVNKMPHQLSGGEQQRVAIARALLNDPEFILADEPTGNLDPQTSSEV
LEVLKNINALGKTVIMATHDYALLMKFPSKTLKCEDERIFEVVQRSV
>EGALAKHO_01237 Lipopolysaccharide assembly protein B
MRKLFWFFILQIILISTTVSAQKSAIYTYDLKDFDKAVALYNDKQYASAQHIFEYVKNHA
TTEEVQSDCAYYIANCAIRTNQANADALMEKFVNDYPTSTKQNQAYIEVGQFFFEQGNYP
KALFWFDKVDESYMSKADSDKFNFQKGYSYFTAKKKKEATTYLNKVVNSPEFGSQAKYYL
GFMAYEGDDYKEATKYFDEVSGEEKYKEKLSYYQADMNFKLGNFQKAIDLGQKAMAKSNE
IEKSELNKIIGESYFNLKQYGNAIPFLEQYAGKKGKWNNTDFYQLGYAYYEQKEYEKAIS
QFNKIIEGKDFVAQNAYYHLGLSYLNTGKKQEALNAFKNASEMEFNAQIQEDAALNYAKL
SYEIGNAYQTVPGILLDFLKKYPNNSSKAEVEKLLVDSYISSKNYKEALVLLEKNRSAEN
KAAYQKVLFYRGLELYNESNYAEAGRMFKSAVSEQKTPEFTARATFWKAETEYLSDDFQN
ALLTYKQFAGQAAAKSTEEYKNINYNIGYTYFKLKDYDQAATSFQAQIDNAPSDKVRLND
SYLRLGDCRFVTSKYSAANEAYAKAIAAKGVDADYAQFQKAISYGFMSKNDKKVEELNNF
LQMYKKSEYRDDALYELGNTYVAEKKNDQAIKTYDQLISEYKNGSFTSKSILKQGLIYYN
SDRDEQALVKFKKVAAEFPKTPEALEAVSTARLIYVDSGKVDEYATWVRTLDFVSVTDAE
LDNDTYDAAFKQYSQNNSKQAITGFTGYVNKFPSGLHAGEANFYLAQLLYAEGSEVKSVS
GYQYVIDQPRSEFTEQSLNKLAQIYLKAKDCDKALPILKRLDDEADSAQNKSFAQANLMK
CYYDKKDYDNSVIYADKVLVNTKADANVKADAQIIVARAAMQTGDEDKAKAAYAKLSTTS
KGELAAEALYYDAYFKTKEGKFDASNVSVQKLAKNYSGYKYYGAKSLVLMAKNFYGLKDS
YQATYILDNVINNFTDFPDVVEEAKKELSAIKLEESKTNSSITK
>EGALAKHO_01238 Trans-2,3-dihydro-3-hydroxyanthranilate isomerase
MSLPFYIVDVFTDKKYAGNQLAVFLDAGSLSSEEMQKIAREINFAESTFITKLDAENNKA
EIKIFTPEHEMQFAGHPIIGTSWVLMNKVFENSPENIKLNVPIGPIAIHKTEELIWLKAA
QPKFWDIFSKEDITVFSNLKVSDFENQFPIQEVSTGSAFVMVGLSSKRALENLVLDKDKT
DQWLKRNCKTTHRGLYFYYLEDSKLFSRMLCVENNQLVEDAATGSASTCLQAFLLKYHKP
EFELINYQGDYIGRPSQIYFKGKLTDNQFDIQIGGKAQFVAKGEWEA
>EGALAKHO_01239 hypothetical protein
MKIKCQNKIIILLLLFVVQLSFSQKKNESIGTETVNVVKPYSPTISDAFKVKETPSLDDS
GNQPKETIKYSILSVPVASTFTPSKGNAAVVDKSKKERLFSNYATLGVGNYGTLNAELFV
TQDLGNNDYVAGMLRHHSSQGGIKDVNLNDEFYDTALNVGYGVNNRDMSWAVDLGYQNQV
YNWYGLPTDFGMTLPPETQEDLIRGINPNHSYNTISLGGNIEFNEGIFSKIDTRFTHFSD
SFSSSENRFYVKPTFKVDVMDQSINTNVIIDHVSGSFENNYERTNLEPVKYSLTNFGIEP
SFVVHENDWTLELGAGLYYGLDSENSGNKFYIYPKVNASYKLVGDLMIFYTGVNGSLNQN
SYADFVTQNPFLSPTLNMRPTSNQYNVFAGLKGKLANNINYNLTGSYVNEKDKALFKSND
YTENFDNQNYAFGNSFGVVYDDVRTLRFYAELKADFSKSVSFGINGTFNSYKQDGLEAWN
LPSMKISSNLDVTITDQWYAGLNVFFVGERKDMQTQQTDFAMPIPGVPVTLKSYFDANAH
LGYKYSERLTFFLKLNNIGNQAYERWLNYPVQGFQVLVGGNYKFDF
>EGALAKHO_01240 hypothetical protein
MNFKQKIHSYYLQMVQDRIDVFRDMISALTEDSKNDAKGSAGDKHETALSMMHIEQEKLT
NKLKEAITQKAILDKIDASKTTENIISGSLVKANGIHLYLSVALPKITIDGINVIALSPQ
SPLGSHLMGNKVGFQFEINKTHYTIESVE
>EGALAKHO_01241 Asparagine synthetase B [glutamine-hydrolyzing]
MCGIVCAFDLKQKAETLRPQVLEMSKIIRHRGPDWSGIYSNDKAILSHERLAIVDPASGK
QPLFTEDKKLVLAANGEIYNHRELRKQFEGKYNFQTESDCEVILALYKEKGPHFVDEMNG
IFGFAIYDVEKDEYFIARDHMGIIPLYIGWDQHGTFYVASELKALEGYCTKIQLFPPGHY
MTSKDGEFVQWYKRDWTEYDAVKDNETSIPAIKEALEAAVHRQLMSDVPYGVLLSGGLDS
SITSAVAKKFAQKRIESDDTTDAWYPQLHSFSVGLDGSPDLAAAQIVAKHIGTIHHEIKF
TIQEGLDAVRDVIYNLETYDVTTVRASTPMWLMARVIKSMGIKMVLSGEGADELFGGYLY
FHKAPNAREFHEENVRKLGKLHMYDCLRANKSLAAWGIEGRVPFLDKEFMDVAMRINPQD
KMINKEHPMEKWVVRKAFEDMLPESVAWRQKEQFSDGVGYSWIDTLKEVVAKEVSDEQLA
NARFKFPLQTPTSKEEYYYRSIFAEHFPSDAAALCVPQEASVACSTKIALEWDEAFKNMN
DPSGRAVASVHDDAYEKA
>EGALAKHO_01242 Asparagine synthetase B [glutamine-hydrolyzing]
MSGLLAVIGKGKDPKLVKELSKRMSHRGPDENDLRIMENGSIICHESLSIVDLQTGKQPI
QGTSKAWMVHDGEIYNYQELKDTVLKEHTFRTKSDSEVIVHLYEEFGYNFCNKLDGDFAF
VVIDGDDYIAGRDPIGVKPLYYGLDERGRIYFSSEMKSIADQCKSFSTFPPGHYYTAKTG
FVKYYRPEYEDHLKAVESLDLDLIRETLVEATRKRLMSEAPLGVLLSGGLDSSLISSITA
RIYAENGKKLNSFSIGLGGDSPDNIAARKVAEFLGTEHHEIHFSVEEAVEMIEKVIYHIE
TYDIISVRAGVPMYLLSKAITEKGIKVILSGEGADEIFGGHLYFRNAPSAEEFQDETIER
VQKLFTADLLRADKTTMATGVEVRIPFLDTDFLDVAIRIKTEEKQPKTYGGVEKYILRKA
FETPENPYLPTEVLWRQKEQFSDGVGYNWVDGLIEYCAEQVSDEQLAGAAAEFPYNSPTT
KEAYFYRSIFHKYYPQVSAAQTVRKWIPKWQDNQDPSGRANSAHVKADTKISKSGVVV
>EGALAKHO_01243 putative zinc protease
MRNLLLSGILYCSFVSLSSVYAQKPEAPKYITNVEGVKEYSLNNGLKILLIPDASQSNMV
VNIVYNVGSRNEGYGEKGMAHLLEHMLFKSTKNLGDIKKMLSDKGGNANGTTWFDRTNYY
EIFPSNDENLKWSLEMEADRMINATILQTDLDKEFSVVRNEFEIGENNPDGVLQERILST
AYLWHNYGNSTIGSKEDIERVKANRLKVFYEKYYQPDNATLIIAGKYDEQKALQYVGQYF
GAIPKPKRVLDKTYTIEPPQDGEKFVELKRAGDSKNVGALYHTVPYADKDFAAIDALGEI
LTADPSGYLYKSLVEAQKASSIYTWQPNVRDASFMYFGVAVPNDKDIKATQEIVRTELDK
IATTQYTDQDVSRAKAKIIKQIEGIKNNTISYTINLTEIIGAGDYRLGYLYRDAVEKLTK
EDIQRVAEKYFRSNNRTIGIFIPSKEEQRVKSVEYTDEQVVALTKDYKGKALEKEAAAFE
ASIKNLKQNLVEGKLSNGAKYGLIKKEIKGGKVQANFKFPVSNEKDLAGKTDTGGILAQL
LKTGTKTRTKEQIQDRLDQLKSSINFNYSRQVLSINISTYKESFKEVMEILNDLLVNSTF
PENELTKTITEYNTYLESNLNDPQTVAFTELTRQTTKYDKTSIFYTPTIQEQIDAFKKIK
QTEIVDFYKNILGGNNGVGSVVGDLDAKSTVQILENTFGKWNSKSKYELAKPTYFETKVL
DKDYITPDKENAVALGRIGFKMTRSSADYPAFVIANEILGSGGFLSARIPMRLREKEGIS
YGAGSFIDVPITSDVASWSYYAFLNPTKKNAVETATKEEIAKALKDGFTAEELKSNLVSW
KNERKTRLGSDDTLMNLVNTYLQYGVPLEDYDDLENKAKALKVEEVNAVLKKYLSLDKMT
SVYAGDFNKK
>EGALAKHO_01244 DNA gyrase subunit B
MSEEIKKNNYSADSIQALEGMEHVRMRPSMYIGDVGVRGLHHLVYEVVDNSIDEAMGGHC
DTIGVAINEDGSVTVEDNGRGIPVDLHKKEGVSALEVVMTKIGAGGKFDKDSYKVSGGLH
GVGVSVVNALSVHMKSTVFRDGKIYEQEYERGKSLYPVKQIGETDKRGTRQTFYPDNTIF
TQTTEFSYDTLSARMRELSFLNKGITITFTDKREVDEKGEFKVEVFHSDEGLKEYIRYLD
GNREPIISHVISMDNEKGEIPVEVALIYNTSYTENIFSYVNNINTHEGGTHLQGFRSGLT
RTLKKYADASGMLDKLKFEIAGDDFREGLTAIISVKVAEPQFEGQTKTKLGNREVVSPVS
QAVGEMLENYLEENPNDARIIIQKVILAAQARHAAKKAREMVQRKTVMGGGGLPGKLSDC
SEQDPARCEVYLVEGDSAGGTAKQGRDRNFQAILPLRGKILNVEKAMHHKVFENEEIRNI
FTALGVTIGTAEDSKALNLEKLRYHKVIIMCDADVDGSHISTLILTFFFRFMKELIEEGH
VYIAAPPLYLVKKGNKKEYAWNDVQRDQANERMGGSAAIQRYKGLGEMNAEQLWETTMDP
SFRTLRQVTIDSLAEADRVFSMLMGDEVPPRREFIEKNAVYANIDA
>EGALAKHO_01245 Malate dehydrogenase
MKVTIVGAGNVGATCADVISYRGIASEVVLLDIKEGFAEGKALDIMQCATNTGFNTKVSG
VTNDYSKTAGSDVVVITSGIPRKPGMTREELIGINAGIVKTVAENVLKHSPNTILVVVSN
PMDTMTYLALKSTGLPKNRIIGMGGALDSSRFRTYLSLALDKPANDISAMVIGGHGDTTM
IPLTRLASYNGIPVTEFLSEAALQKVAADTMVGGATLTGLLGTSAWYAPGASVAYLVDSI
LNDQKKMIACSVFVEGEYGQNDICIGVPCIIGKNGVEEILDIQLNDQEKALFAKSADAVR
GMNDALKSILV
>EGALAKHO_01246 hypothetical protein
MQNKGLIKFFAILFALVSIYQLSFTFVANSVKSEAKAFAGDNPDKELKYLDSIGKVEVLN
LGFTNFTYNEVKNKQLNKGLDLEGGINVILQISVKDVLKGLSNNSKNPVFNKSLADATAN
LEGNKTYLNKFFEAFEANSNGTTKLASPDIFANRSLQGEGGIDFQMTDAQAQKVIKRKVD
ESIESAYKVLRERIDKFGVTQPNIQKLGETGRILVELPGAKDVDRIKKLLGGKAQLEFWE
TYKVEEIGNFLVATNEALKKTEVKKTETKAVVKDSLNALLTDAKDSVDVKKGNNPLFDKM
LGQGGGPVLAYFAPKDTATINAYFKRPEITVLLTADQHNAKFVWSKPTTLKDAKGKEVEA
VELYALKGNRDNVPAMSGGVVTDAKDTFDQLGKPAVSMQMNSQGAKVWEELTGRAFSQKG
YIAIVLDNIVYSAPGVTSGPIAGGRSEITGSFDVAETKDLANVLNAGKLPASADIIQSTV
VGPSLGQAAIDAGTISSVIGFLLVCLWMVFYYGKAGWYANLALLLNLLFLFGIMASFGFV
LTLPGIAGIVLTLGTAVDANIIIFERAKEELREGKSLSEAVVASYGWHGAMRSIIDANVT
HVLTGAILFIFGTGPIKGFALTLLIGIVTSLFTSIFIARIFIDRNIAGKADLTFSTNITK
NWFTNFHFDFIKIKKFTYIFSSIVVVVSLVSIFFVNGLDEGVDFVGGRTFQVKFEKPVDA
TVVSDELSAAFGTPVEAKILGDDDQLKITTKYKIKEDGVAVDEEVNKKLYDALAKYFPNV
TYDKFTNTYDGKKIGVLQSSKVGASISEDIKTNSYWAVLGAMGVIFLYLMISFRKWQYSL
GAIAAVAHDVIFVLGIYSLCYKFMPFHMEMDQHFIAAILTVIGYSMNDTVIVFDRIREFI
LGNRKGSFEDIVNASINTTLSRTLNTSLMMIIVLLTMFIFGGESIRGFIFAMLVGIVVGT
YSSLFIATPVLVDTISKDDKHTIEDKHNKA
>EGALAKHO_01247 Prolipoprotein diacylglyceryl transferase
MTHALNLVWNPSEGINLGFFMIRYYSLMFVIAFGLGWYLMKKIFERENESIDKLDSLFVW
TVLATLAGARLGHVFFYDWEYFRNHLLEIFLPFRFEPKFEFTGYQGLASHGAAIAIIVAM
YFYSKMVLKRPLLWILDRVVIPVASGAIFVRLGNFFNSEIIGHETTSAFGIRFLHDKFSK
AEAVNATQIADPKEAYNAIAHDPKFAELLAQVPAKHPTQLYEAFCYIFVFAILFFLYWKT
NARLKSGLLFGLFLVLLFVVRFIVEFVKESQGGIEQELGYFSTGQWLSIPFIIIGLFFII
RAQRNPLAAS
>EGALAKHO_01248 Putative membrane protein insertion efficiency factor
MKVITPFVLLVRFYQTAISPFTPASCRFEPTCSSYMIEALQKHGLRYGGYLGIKRILSCH
PWGRTGYDPVPEKKCSHKH
>EGALAKHO_01249 Cysteine--tRNA ligase
MPLYTTQPLKIYNSLSGEKENFNPIHEGNVGMYVCGPTVYSNVHLGNVRTFMSFDVIFRY
FLHLDYKVRYVRNITDVGHIVDDVDEGEDKIAKKARLEQLEPMEVVQRYTVDFHDILKSF
NFLPPSIEPTATGHIIEQIEIIKKIIDTGIGYEANGSVYFDVVKYNETNNYGVLSGRNIE
DMLANTRDLDGQSDKRNPQDFALWKKAEPEHIMRWPSPWSDGFPGWHLECTAMSTKYLGN
HFDIHGGGMDLKFPHHECEIAQNEACTGQSPVNYWMHANMLTLNGKKMAKSTGNNILPGE
ILSGDNNILSKAFSASVTRFFMLQAHYRSILDFSDDAIVAAEKGYKRLMEAVESLPAIAP
GATSSIDIASWKQLCYDAMNDDFNTPILIAQLFEAVRYINLLKEGKETISTEDLKTFTTA
INAFVFDVLGLSDEKAADGNNDKLEGVVNMLIGMRNQARADKNFALSDQIRDQLIALGIQ
LKDGKDGTTFSV
>EGALAKHO_01250 GTP cyclohydrolase 1
MINNEDFLDEIGDNHFSSNAKNPVRQDAFDLTDDEKIEKIKKDVENILQTLGMDLTDDSI
KGTPNRVAKMFVKEIFGGLNPAKQPKASTFDNNYKYGEMLVEKNITVYSTCEHHLLPIIG
RAHVAYISSGRVIGLSKMNRIVEYYAKRPQVQERLTMQIVQELQKALGTEDVACVIDAKH
LCVNSRGIKDIESSTVTSEFGGKFKDPQTKREFLDYIKLDTQF
>EGALAKHO_01251 hypothetical protein
MKKLIIIAFLFLISTSFTIHNNSLHTKSTLKINYSSNVQKEDIEYYRQEIKRAFSLLKKQ
KKDIDLELNKNEKVQILSIAFPEMLRYDSYSDYLETSSNQILYVKEGKKASDFSTGYFQM
KPSFLEDLENYVANNESLKQYNWILIQKKNEIEVRKERINRLGNFQWQLRYLKVFWYVAE
YKYQSLDFKTKEDKIRFFATAYNYGFTKPEKEITKYQVAKKILTGRDLYQKICLFRFFN
>EGALAKHO_01252 Aspartate aminotransferase
MPTISHKGRNMPESPIRKLAPYADIAKQKGHKVYHLNIGQPDIKTPEVAIEAVKNIDLSI
IEYSPSAGYESYRKKLAKFYQRQNVNVNSEDIIVTTGGSEALLFALATITDPGDEIIIPE
PFYANYHAFASSTSATVVPLVSTIETAFALPGIEEVEKLITPKTKAILICNPGNPTGYLY
SEAEIKQLAGLIKKHDLYLIADEVYREFLYDGDDVHFSVMNLEDVQQNVIMVDSVSKRYS
MCGARIGCLVTKNKDVLATVMKFAQARLSPPTIEQIACEAAIDTPQSYFDEVIAEYKSRR
DTLITELNKIEGVIVTKPKGAFYCIAQLPIENSEDFAQWLLESYDLNGETVMVAPAAGFY
STPGMGLNQVRIAYVLNKQDLIKAVNVLKEALLVYNKR
>EGALAKHO_01253 hypothetical protein
MLFFGLLIPFSLLAQEDFSIEDHQSKVVIPFKLINNLVFIPIKVNGVELNFLLDSGVEET
ILFSMEEKKEVSFNNVQKIKLRGLGSEAEIEGLKSTNNTLETHGLKSHNHLLYIILDQSF
NLSSHIGIPVNGIIGYQFFKNNLVEVNYQKRKIIIHSNNKKIQKRIEKTFKTIPITIERS
KPYIMANAIVDSVNISSKLLIDIGNSDAFWVFENNKIKLPKKNFPDFLGKGFSGDVEGHR
GKIKKFSIGEFDFKNPIVAFPDSTSIRNVKMVPGRIGSVGGEVLKRFTVILDYEDQKMYL
KKNSKFSEPFTYNKSGITLQHNGLQWVQETVHLETVQVVSAVNEMEANDNKNDNFRYKFS
LKPVYEIVNIRKFSAAEKCGLKAGDIIVSINQTTPYKYSLQQINMLLKSEEDIWITLEVE
RDSLILKFRFKLEDEL
>EGALAKHO_01254 hypothetical protein
MTEKYTNFLRIILFFVFFSCLPTTTYAQCAGEDGQVTICNVSDPVNQTVDLFSYLTGFPV
TGGEWTDDNSSGGLDAATGILNAQLIRRSGTYSYTYTVEGFGLCPDNKATVIVTIGGYSG
VASPNVSVCSAVETFNLFSAFNGVYLGPHSNGQWHNDTTNQNVGPSLAVKNLRGTFQFTY
TMPAIGTCPAMSSTVMITVFRAPEPGTGSRLLLCADDGLSSYTNYDLFNLVSGQDAGGVW
RDNNNTGELTTVGDHFIDIQKIYNKFGTGDFRFTYTVASPNPICSDESVSVRIRIEKKLD
FTGAIVRVDSDICETDIPTATYSVTISKGPAVIPNGSYYVYFSVSGPDGGSERIMANFTN
GVLIFPIKSEYFQRVGNFSVNITNIIAENSEGACRNIINNLSDVLSVYPIPDLTGAKIAP
ITTCQNTGNLVTITDAVKIIDGDYDIIYNISGANNASSQIARVTFAGGIGTFQMPAILNS
QSGTGEIKITNITHVISGCTNSADLKGDIRINPLPNVPNLRIQINDVCFGSPVTASVSGL
GSLTDVTLSYVLTGSNVATVQTVTLISTNGSASFVVPAGLLLNTGSTTATVTNLTNNTTT
CGITITGVSDPFSLNPIPVAPTAGNQSFCKSEGATVANLFPNGAQYKWYNSATLMTPLAN
TYLLKEENYYVTETSLNCTSSATIITVKLKDTPAPELNSDGQNFCGLDAPTIASLSNNTN
VPSSVVWYDAPKNGSLLAPTTALIDKGKYYGFDFSTTENCLSYDYTEVIVSLTDCPVVPP
DFFIPDGFSPNGDGVNDVFVITNIDFLFPDYEIEIFNRYGNGMYRGGKDKPGWDGVNYET
QGLNHGTAPNGVYFYVIHFNKGNTPPKQGRLYLNR
>EGALAKHO_01255 hypothetical protein
MKKIILFISFLFYITTSSAQQDPEYTHYMYNMSVINPAYATGTPLMMNFGGLYRTQWVGA
VGAPKTFTFFGHTALSDKIEVGLSLVSDDIGDGAKKESNAYADFAYVLNLGGKNKLSFGL
KAGFSALQSNFNGFLLQSGNAATDAAFAEDINVTKPNIGVGAYYFRDNFYVGLSAPNLLK
SKQIEEKSGLNAYGSEEIHTYLTAGYVFQVNDMWKIKPASMAKFVKGAPVAVDITANVLY
NEKFELGAAYRINDSFSALANINVTPSLRIGYAYDYTLSNLGQFNSGTHEIMLLFDLDLL
GKGYDKSPRFF
>EGALAKHO_01256 Photosystem I P700 chlorophyll a apoprotein A2
MKKLLVIIFVFSIQFINAQDKDLARAKRFFDKTFYSEAIILYEKLAEEKPSQEVIKNLAD
SYYYTNDLIKAQRYYRLLFQNYGKDLDREYYFRYAQTLKASNTYADANEVLKQYYALSTT
SKDSVYFKNELHELENVSAIGNRFDIKNLAINTPNSEFGAVKYKGNLVFAGVKLKPGLFD
KKFKWDNETYLNLVSVPLTEINAPQVNITYFADELKTGMHEANAVFTKDGKTMYFTRNYS
KNGTKKKNDEKISNLQIFKAELVEGKWSNITALPFNSPNYSVEHPALSADEKVLYFASDM
PGTLGSFDIYSVNVNKGAFDKPKNLGPIINTDKREQFPFVSNDNKLYFSSDGHLGYGSLD
VFVSDISGNEYAEPVNIGLPLNSNLDDFSFNIDSDTKEGYFASNREGGKGSDDIYQFKEI
KDLIVEDCKQFIAGTITDVDTHLVLENATVMLQDSGKKVLNTITTSADGKFSFTVACESS
YTIVAFKEKYTNESRILEIGKTRNATNDGSLALKSLDAIKLEEQKNAEDRRKEEIRQEKE
KKDKEALALIALNEATKKAKADEIAAGEAKKKEKEKQIMTQEKDVVKDKDRLIIKTDPIY
FDYNMWYIRKESKVVLGRVVALMNKYPGMVIEIGSHTDSRGNAKFNEELSQKRASSTREF
IIQSGINANRVTAKGYGESVPIIKCKTDDACSEEDHELNRRSEFVIKKL
>EGALAKHO_01257 hypothetical protein
MKKLIAFCLLSACIGFQSCKNDEKQKEIEAAKAEGEKVVGSQCYKAIYEKDTIDLKVNTL
KNGKVSGDMVMKVANAPERTGEVAGEFKGDTLFVDYTFVDTKHKDTKFKNPMALLKRDNQ
LILGNGTMQTTMGVTYLVKDKPIDFTNVKYKFATVECSDKAK
>EGALAKHO_01258 hypothetical protein
MKNVASFIAIVLFSAMGYAQNGPKIEFAAQDNTIDYGKISKSDNAVRSFEFTNTGDAPLL
ILGAESTVSSIIVTKPAAAIQPGKKGKIDVKYNMAAGPIRKTITVETNAVNYPDGRVALK
IKGEVL
>EGALAKHO_01259 Valine--tRNA ligase
MTIPAQFDAKTIENKWYDYWMKNNYFHSEPDHRTPYTIVIPPPNVTGVLHMGHMLNNTIQ
DVLIRRARLKGFNACWVPGTDHASIATEAKVVAKLKAEGINKNDLTREEFLAHAWEWTDK
YGGVILDQLKKLGASCDWERTKFTMDPDMSASVIKSFVDLYNKGLIYRGYRMVNWDPEAK
TTLSDEEVIYEEQQGKLFFLKYKIEGSEDFLTIATTRPETIFGDTAICINPNDERFTHLK
GKKAIVPICGRVIPIIEDEYVDVEFGTGCLKVTPAHDMNDKTLGEKHNLEIVDIFNEDAT
LNSFGLHYQGKDRFVVRTEIAKELEEIGALAKTEIHLNKVGTSERTKAVIEPRLSDQWFL
KMEDLVKPAIKSVLETGEIKLHPKRFENTYAHWLNNIRDWNISRQLWWGQQIPAYYYGDG
KEDFVVAENIEDALVLAKEKTNNQQLTTDNLKQDVDALDTWFSSWLWPMSVFGGIMDPES
ADYKYYYPTNDLVTGPDILFFWVARMIIAGYEYAGEKPFTNVYLTGLVRDKQRRKMSKSL
GNSPDPLDLIEKFGADGVRVGLLLSASAGNDIMFDEELCNQGKAFSNKIWNAFKLIKGWE
VSETIPQPESSKVAIEWFEAKLQQTLVDIEDNFEKYRISDSLMAIYKLVWDDFCSWFLEM
IKPAYQQPIDKATFDKAIEMLESNLKLLHPFMPFLTEEIWHLIADRTPEEALIVSTWPEL
KPFNASLISDFESTIEVISGIRTIRKDKNIPFKDAIELKAINSENISTYFDTIVTKLGNI
SAFEYVSAKVDGALSFRVKSNEYFIPISGGNIDVEAEIAKLAAELVYTQGFLKSVQAKLS
NEKFVAGAPEKVLANEKQKEADALAKIATIEQSIAGLK
>EGALAKHO_01260 Serine/threonine exchanger SteT
MSDSKQNQLKKTLGLSFNIAVLIGGTIGVGILRTPGTIAGMLDNYWLIIASWLFGGIYVL
IGANSYAELATMLPKAGGSYNYIKRAFGDYAGFLSGWFDYITNAIPPAFYCIVISEYLII
LFPGLANYATVMAISLLIAFVLLHLSGVKNGSAIQQITSFLKVICFVCLVVACFMYSGVQ
LAPIPKDNTAFQIGLIFSFFKSLQLIIGTYNGWNSVCFFAEENDDPSKNIPKSLYSGVLL
VIAIYVLVNIAFFHVLSLENVAKSNLAAADVANIIFGKNGAIIVTVISIFSLISILNAFM
MIPPRILYGLSRDGFFTQKGTNVNKGGTPITALLVSSVFSLSLICIGSFEVLFSFAAFTS
IIVWGLAYCSLIKLRNSEPDLPRPYRSVWYPWTTILAIIASLALLIGFIFSDPKSFGIIV
AITIISYPLFLILKRKK
>EGALAKHO_01261 putative TonB-dependent receptor BfrD
MRYNLLLVLSFLSFASYSQEYANAQDNQSVNDTVKNKKGEILNEVLITPNKPKKPIEAAR
SGIKVMDLPQSVQVIGSEVIEQQQAIRLSEVVKNLNGVYVGSARGGAQESFFSRGYDMSA
NNMFKNGFRYNAGSIPEVSSLEKVEFLKGGSALLYGNVAPGGIMNLVTKTPKFTPGGEVS
MQMGSYSYYKPSIDFYGPLNKSIAYRFTGSYENSESFRDFVKNERIYINPSFLFHLSDKT
QITLQGDYLSADWTPDFGTGIYGKTILDLPRNEFFGALWSTANTKSSSASLLFNHDFNKN
WKLNFNSSYQSYRRTQTSTAQLSTIDADGNWKRGLTKSDGAEQIFGDQLSLQGTFNTGSI
KHQIFTGVDYENSLAPSYTYGFYATPTSTVAITTEATAINLYTYDYSTQSRDIPYPTRAT
QLATTNTQRFGAYAQDLISVTKHVKVLAGLRWSWQDSNVDTSKEVVTKGVITTSLDKAQT
VEGPKTVNKAFSPKAGLVVQPTKDLSLFASYSNSFTPNTGTTADLKPLDPSIIDQYEVGV
KKDFFRGLLTTNVTLYQISNNNLAQTAPYLADGVTQNTNTAIKELVGATKGKGVEIDITA
NPLEGLSIMAGYSFNETKVSKSSGTNGSLVVGDVLARTPKNTANLSFFYKVPEGLLKGVT
FGAIGNYVGDRTGGWNDDYLWTPVVPATNPPTYVVTIRDRDIPLEGYVTVDASLGYEWKK
FSILCRLSNITNELNYTVHENYSVNPIAPRQIMTSLRYKF
>EGALAKHO_01262 hypothetical protein
MKSNTLKKITFFLFMLVASPQLFAHALWIETKATGTKGKAQEISVYFGEFSDNDITKADK
WFSDLKDFSLVLISPSKKEIKLTAKALDNKYQSFFTPDEDGVYTIVMHHKVKDVYGTMVL
DYNSSATVTVGNAAKGNEALANTNIISLFSKDVITAKQNTKVNVNALYEGKIAKEQKMKV
IAPNGWEKELWSNENGEVSFTPIWPGNYMVEFAYTEKASGEHNGKKYDEIWKMATYLITV
K
>EGALAKHO_01263 Inner membrane protein YbjJ
MIIPFLKKIHGSPKGFRLANTVFFFLSGFGYSSWVSRIPHIQAELHLSEAQFGAVLFAFP
IGLMLTMPFTGMLLNKYSSRYIMLLGAIMFNIALSLPGLVAFVWQLVIVLLIFGASRNIF
NLSINAQSLEVQKLYPKSIITRFHAVWSIAVFSGAGLGYVMVTQHIAPSYHLLGVSVFMM
ALTFCFYPMSIHNQPVPVKKKFFSMPEKNLVKFALICFVSMACENTMYDWSGIYFKNILH
ASPKLTSAAFVFFATAVTLGRLFGDYGVMKFGTKRILFYSGILITAGFGICFLLPYAYPT
IFGYILIGVGVSCVVPLVFAIAGRSSKLSSGSALTSISTVGYLGFLLVPPMVGFISEYLS
MKWAFLIMALLGILMIFMVNKIGENE
>EGALAKHO_01264 hypothetical protein
MKHLFVFFFLVVINPLQAQNLKVEDLKVLVNKNIPEWTTSFKNFNWNDFLKVDSIADFEK
VQKQSFKDLKKFQNIYNPIISYSENKDKFIDIYSYQLNLEKKNGKYYSIIDVGQAIYLCD
IRNNYWERIAYNEYSKNFDDVIWVNENEFLLVGSERNENNKNSPILYIGNLKNQSFEIVI
NTNEKCIQKESFYKSRKLKNIQIENQN
>EGALAKHO_01265 hypothetical protein
MKKKSLIIINFLLLACGQSQIKTPENAMNKFEAFKKKEKFVEDNTIFYPGIGDEKLKPIL
TEKINLAADDFKKVAQSQNVTDEDYQEAIKIGLQRFSQIYLDIDTENRERICAYFEELMD
IVGLESSDGQLNDFMYDFDFTEK
>EGALAKHO_01266 hypothetical protein
MFQKTTLLLVLLAVVSCKKAETVEKDKIKLADWLIGTWENKSEDGVLTESWQKVNDSTFT
ATSYFIKNNDTLHAEKITLAQKGEMLLYSAAVNGQNNDKAIDFGSTTESTNKLVFENPSH
DYPQKITYSKGANNTLTAEISGNLQGKMTTEKFVMSKK
>EGALAKHO_01267 hypothetical protein
MYADLYNSKLICLNLQNLREIKNIKIASTYSLRLGLGKAFFSYFSSTI
>EGALAKHO_01268 DNA topoisomerase 3
MKVCIAEKPSVAREIASVLGANTKHDGYYEGNGYAVTYTFGHLCTLKEPNDYKPHWKSWD
LNNLPMLPEKFETKVVENSGIQKQFKIVKSLFDKAEVVINCGDAGQEGELIQRWVMNEAN
YKGEVQRLWISSLTTEAIKEGFDNLKPSANYDNLFYAGFSRAIGDWLLGMNATRLYTVKH
GGYKQVLSIGRVQTPTLAMVVDRFKEIENFKPQPYWELQTLYRETLFSYEEGRFLNKEDG
QLLANKVKESDFEIVSVDKKNGNEFAPKLFDLTGLQVYCNTKFGFSADETLKIAQSLYEQ
KVVTYPRVDTTFLPSDIYPKVPGILQKLSNYSTLTQPILEKKIKKSPKVFNDKKVTDHHA
IIPTGIEINLPYNQQQVYDIIVKRFIAVFYDDCLVANTTVIGKAADVLFKTTGKEILKKG
FRVVFEDPNAKEKEADILPSFVVGERGPHEPSFLEKETKPPNQFTEATLLRAMETAGKQV
DDEDLRELMKENGIGRPSTRANIIETLFKRQYIVRNKKQVLPTPTGIQLIETIQNELIKS
AELTGSWEKQLKDIEKGTYTAGAFIKNMKRMVEALVTEVRSETRHANISHVGNVQKEAVK
VEQKKAAGILAETCPKCKEGNLIKGKSAYGCSEYKSGCDFVLPYIFADKKITESQYMRLL
QKGSTVNIKGFKTEAGAVEGLIRFEENYKLKLEAKKTAPKAKTEATSDALACPKCKKGTV
LKGNTAYGCSDYKLGCDFKVTFDEVRAKLKDQKPSKELVYAILTENF
>EGALAKHO_01269 hypothetical protein
MKRENFLKVCFSSLALMSTPFAMVAKASLHFREKNGFKVDSGKDRKNKSLPLFDGDIFDC
KVSTADSDGDIYVFESKRVKEGGPSHHYHFDQDEWWYVLQGQFLIKVGDITYEAKTGDSV
FGPRMVPHSFSKVGEGEAKLLMFFQPAGKMEEFFNKMSAGAAKNMSEAEKDKFREEHGFK
TVGPPIDKLKW
>EGALAKHO_01270 hypothetical protein
MKLIITTLLLIFNLTLFAQSNQFAGEYQRKLEDTQTKYVIEYKLTLNQDGTFVFHSYSNV
GSVNPPEVSKSGKGKWTAKGNLITFSTNKQEDFDAKYTLDFNKSTARFVTKNPRDKTDQI
VKTRLTFLESGIFWMERLDVFKI
>EGALAKHO_01271 hypothetical protein
MTFDSTDLQFVLSEKKKQMDKFNFNNKRFAVTQNSDNGQVNTETIFNYKQEDNLVTADYF
GGTIKYGKIIAELKDDQLNMLYQCLTIDNELKAGKALAKITLTENGKIKLSLDWEWLTDG
NDKGRSEYIEIE
>EGALAKHO_01272 hypothetical protein
MNIKNLKPAILFLFLLLSGASYSQDYLLPNEVNLYSFETKSGKKMILAKDKNDKYMIYRF
GTKSKIEFEYPEKTKESWKKFTYSFYLRGGGKVNEGMDLNYVAFTNKNFKYVIYYSYFAV
GEKVNIGVKIIDLKTKKTVDIKGDYKTLKGNLVKFRDNNLINVDDNGELYD
>EGALAKHO_01273 hypothetical protein
MENKDCEQFIKHIGTPREYSDSLYLVYIELYKADAELAKIIAEHCKIVSELEFGYICEAN
IQSIPEIARSLSLKNHAIYQIIRLVKLS
>EGALAKHO_01274 hypothetical protein
MKKFYFFLFFGLLFNIGFSQESICEKFKIGKFLYTSEGLPDITVTRTKTTQTETIKESPE
VIQGTIVWKSDCSYEFIFTKGPIPELIGRTMSVEIFNINGNVAKGKALFEGKYVNFGLEK
LD
>EGALAKHO_01275 hypothetical protein
MKKVYFIAICFLLSSKFYSQDTKIDYKTDTVQGRHFGDFIKPIDSDGTIFKENENKESVY
FKKCQYLKISDERNKCFSETFYEVLRKNISFHNEHLKGKEIDLVVKFTISKSGKIVDISF
PKSNDSSGEFEKEIIRVLGKLPKIIPAKVNNQFVDSTYKFPIKFTNK
>EGALAKHO_01276 hypothetical protein
MIKKITFLLFIAFTLSTNAQTTTDFSIVKTHTGDVKIPGNWEQLNTENESGQTYLKNSEG
VIIAIAQNPKKAYSFFKSNKSGFENVKLFYVWDSDYMKESKFKTDKIKENPEAEYIIWKY
NDGKLENVFLFGSAKDNFLNLLVCTTIWDEDKKVLFLENLYQLNK
>EGALAKHO_01277 hypothetical protein
MIKKITFLHLSLLFLFCCSNTLFAQTQLEMNQIAIDNFKKADNELNQVYKKLVKKLDEKE
KNLLITAQKNWIKFRDSKCEFEKQQYDGGSIQPSIYYTCLAECTEDRIKDLKRNLEDHNR
>EGALAKHO_01278 hypothetical protein
MENKLIRCYKLSKWNVITICFYVLLSFFLWSYCSVNKINKREILFYYGFGTQFFIYFFQY
RALRNFNYFLMWIVIAIIQFCVYLAIKDSPELAFVNYHAALGLRSTIITLLLFQFLRFLS
LKIQDKELVAPARNSRTDLLDERRITIVDIICFIIFVVLTIFFLVTG
>EGALAKHO_01279 hypothetical protein
MTPSIITLISKYELNSNETDNFLKRIYDNCNSELNSTKSYIASSYGIASTTPYKDYPQNL
RIQMLGELNRIIQSISQYSNFEIPQLTDKSGVMKFSMTNVNFEIDDSNGLIFNLLFKTEL
MTLIGNINNTLILALGDKLKLLENNVDINVFCLEYGNNIWISTYRK
>EGALAKHO_01280 hypothetical protein
MSELIEMTKIYIIESPSFLDMIDNRKEGEALSRILSLANIKNDVYSVSDIETLKIAFNRI
TDDINSIKKDLGGVYIHFSMHGSNEGIALSDKTFLHWEYLFSLIKDFNNKIEYIALPSGL
LISPTYLSFSVCDGYSARLIKSFDEDNYSTYTALIGPTQPVSWSDSLLAYSIFYHNIIIK
KLDVNMALENMNKTVGLNEVFKVDLGTGLNH
>EGALAKHO_01281 hypothetical protein
MKLEQYKKEAHEFQGLASTLVRQLAFGGIALIWIFKIDKPIEHLLPNECYWPLLLFVLAL
SFDFLQYFVPSIIWIIFFRYHEKKNSGNVDVELKAKEIYSIPGYCFYLGKVILIFFGYIF
IIKFLLCKL
>EGALAKHO_01282 hypothetical protein
MAKKNENDKKNSTTGKSESKQEHKKSYSNLGQEKKRDTDDTGPRDKK
>EGALAKHO_01283 hypothetical protein
MDMTVKYGNMMIGQNNTYFKSSWIDLIDIMIFIIFPYK
>EGALAKHO_01284 Peptide chain release factor 1
MLDRLQIVKQRFDEISDLIIQPDVISDQKRYVQLNQEYKNLKALAEKRDEYVLLMANIDE
ANEIIADGSDADMTEMAKMQLDEAKERLPELEEEIKFMLIPKDPEDAKNVMVEIRAGTGG
DEASIFAGDLFRMYTKYCENQGWRTSVVDMNEGTSGGFKEVIFEVSGEDVYGTLKFEAGV
HRVQRVPQTETQGRVHTSAATVMVLPEAEEFDVQIDMNDVRVDFFCSSGPGGQSVNTTKS
AVRLTHIPTGLVAQCQDQKSQHKNKDKALNVLRSRLYEQELAKKEAEDATKRTSQVSSGD
RSAKIRTYNYAQGRVTDHRVGLTLYDLGNIMNGDIQKIVAELQLVNNMEKLKEASEVF
>EGALAKHO_01285 hypothetical protein
MKKTLLLLCFLGSFFCARAQSYFGFRDDNYAGIQSALFNPSVIVDSKYKADVTIFSASST
AQNDLYGVSFTDALGSNFDFDTEASKNIKNNNRGNLNVDIMGPSLMLTLSPKHSIAVFTR
LRSVTNMVNINGQLVDEVNKNIDVSNSFLITGGNPNGVSNSWAEIGASYGTILLDNDYHF
IKGGLTVKYLMAGVNGYISGNNLKVAFNKNNANPELSTYTSTGTLQTSASYDYENGADPK
FDGAPAGVGLDLGFTYEYRTNCHTCIGNRYKYKAAISVTDIGKLNYKNAIENTYNLTGTV
TQDDIDSADDIFEFFDANYTKTATRKGIKANLPTALHTNFDWNVNNKFYLNLSGDFSLVD
AKRINATAIANSVTFTPRYETRQFSFYLPLTYMDYSGTQIGMGFRAGPLFVGSGSIVSNF
FSNNSKACNLYVGLKLPIYQTYD
>EGALAKHO_01286 hypothetical protein
METVYTVDALNQRITQLEAQQDAEWIAIKDEIDEIKENLKPLNLIRNTVSEINETVGFKS
DIAQSAISIGIGFLAKKLVIGKSDGIFKNIFGSLVQLAVTTLVAKPQHEHETSPEESSQH
ESSVE
>EGALAKHO_01287 hypothetical protein
METNATTNENLNMYEKAENYTKTSLELIKLKTVAAAADVLSSLTSKIAVGAVVAFFTLFL
NIGISLWIGKELGEYFYGFFIVALFYLLVAVILLKTQHKLIKTPIGNMIVSSILKETKN
>EGALAKHO_01288 hypothetical protein
MKTSSTLLGILGAAAAGAFLGVLFAPDKGSNTRKKISDKSKDYGDNLKGKFDGILSTITS
NGKDIIDEGKAKFNQVKEDFNQVKDEAKTVKTNY
>EGALAKHO_01289 hypothetical protein
MSNLLYTIAVILVILWALGFFYYSAGGLIHILLVIAIIAIIFRLIKGRDI
>EGALAKHO_01290 hypothetical protein
MKMQSNFLCALTLFMTASFGMLHAQDDNVTTEFGVKGGFNMSNLYQSEADDNNVIYGFNA
GVYATLPISDFIAIQPEILYTTKGAELDYNNAFLQGNAKFKLNYIEVPLLVRVNITKNFN
VHAGGYASYLVSSKVTGDGDINFDDTVDTDDLNKFDAGLSAGVGVDFNPISVGLRYNYGL
TTVGKERTVAGTTYTFPDAKNSNLTLYLSYKLN
>EGALAKHO_01291 hypothetical protein
MPPLKTIFKVLFLLIFIVCFSSCGEKSKRENSKKEIFNKSKNEEIETSFFIEMGNAMNSI
ISKSQVAQQKSSESKIVEVSKKIANHQNQLLQQVTEMANKKLIIITDINASHKDELLELN
NANGSSFNKAYLSSMTTALDQQIKLFEQISKRTNDQLILKLVLQYLPEQYQLLRETEQLK
SEFN
>EGALAKHO_01292 Phytochrome-like protein cph1
MKWIPNFNSSNSLRVIFVIAVFILLFLSSIAYKHNQDLNESSKLVMHTYEINIQLERLMS
AIKDAETGQRGYIITRNNRFLSPYLYSRDKVNASFVTLKKLTVDNAVQQKNLENLFKLII
QRFVSFENCLKYSDPKTYDKRKLDNHMFGGRILMENIRFQVDKMNDIEKKYLEKRLKIYD
QEISLSPVFSISLFLTALIFILLAYRQISRDFQRLKVFNKQLLISGGLMAESEIIGKFST
WQWELDSHKITYSDNQYRLLGVTPNSFVPVIETFLDFVHPDDRAAVSESMDKIMEKKNLP
FIYYKIVRPNNEIRYFKSTGKLLTDQQGGKILLGINFDITDEHLLNIELQERNRELEKSN
KELASFNHVASHDLQEPLRKIQTFISRVSEADKAVMSESGKDYISKIAVSAKRMRVLIDD
LLLFSRTNTTKKEFIKSNLNELLQNAESELAEVINEKKAIITASKLPKLNVIPYQIEQLF
INLIGNSLKYNQPGVAPEISIETEKVSSADYPELLEQSVKKFHKITFTDNGMGFDPQFKE
TIFILFQRLHSKTDYPGTGIGLAICKKIVENHKGHILADSTPNVGSVFTVFLPE
>EGALAKHO_01293 Response regulator rcp1
MQKNALYILLADDDEDDRLFFKDAFEEIKIQTKVQFVHDGMQLMDHLLDPETKLPDILFL
DLNMPKKTGKECLIEIKKTDRLKNIIIAIYSTSSSEEDIEDTFVQGANIYIKKPSDFNTL
KKIINEVVTVNWHYHTSGLNRDNFLLRLK
>EGALAKHO_01294 hypothetical protein
MKLFIKFDINTICSLYLKQNLEEQNINFKTLGFGEIEIEDNLDVEALDALKENLAPHGFE
VVENQKSVLVQKIKDAIIELVFLEDSNNYKSSVFLAEKLNHSYGYLSNVFSEVTYSSIEN
FIILQKIERAKQLIIINEMSLTEIAFLLNYSSVAHLSTQFKNTTGITPSAFQRIIKKRRE
NLK
>EGALAKHO_01295 hypothetical protein
MNTTQIKGNWNELKGKLKQQYADLTDDDLLYEEGKEDELYGKVQQKLGKTKEEVQQIISD
L
>EGALAKHO_01296 Metalloregulation DNA-binding stress protein
MSPNIGISPKNLKKSTSILATILSNEMTLYVKTRKFHWNISGNSFMELHKLFEDQYRILE
ANIDEVAERISQLGEKTIGTMKEFIENSTLKESPKEYASQKNMLEELLENHEQLVTEFRD
YIPVFENENNDIGSADFITGLLQEHEKMAWILRRYQV
>EGALAKHO_01297 Orotidine 5'-phosphate decarboxylase
MAENHSQTNNIICNFAALVKYNMTTQQLHEQILQKKSFLCVGLDPDLTKIPPHLLETEDP
IFEFNKAIIDATHDLAVGYKPNTAFFEAYGIKGWMSLQKTINYINENFPEQFTIADAKRG
DIGNTSSMYAKAFFEDLNFDSVTVAPYMGKDSVEPFLAFENKHTIMLALTSNEGAFDFQT
LTTNGKELYKQVLETSKTWKNSENLMYVVGATKAEYFADIRKIVPDSFLLVPGIGAQGGS
LSEVCKYGMNDKVGLLVNSARAIIYASKGTDFAEKAREEALKVQKEMEEILNSRFQV
>EGALAKHO_01298 Vitamin B12-binding protein
MKQLKDQLGTLHSFETAPKRIISLVPSQTELLFDLGLEEKIIGITKFCVHPYHLKSTKKI
VGGTKKIHFEKIKLLQPDIIICNKEENTLEIVEQLSTICPVWVTNIVSVQDNFQMISDFG
QLFNCRTEAQKWNDKLAFALNDFKKYIQDIPSKKAAYFIWKNPYMVAGKDTYINELLKLN
HFQNIYEEKGRYPEIELKKMRLEGDPDLVFLSSEPYPFKEEDAFEIGRFTHHAKTIFVDG
EMFSWHGSRLLKAFPYFKLLHERLKN
>EGALAKHO_01299 Formyltetrahydrofolate deformylase
MQKITILIHCKDQKGIIAAVTTFIAKVEGNITYIDQHVDVEQNVFFMRLECELTNSHITV
ESFKEDFDKSIASDFNMSWDLYNQEQKPKMALFVSKYDHCLFDILGRYSADELNVEIPVI
ISNHNDLRSIAERFDIPFHCVPFSKDNKEEGEAKQIELLKRYQINFIVLARYMQIVTPKL
ISLYENKIINIHHSFLPAFPGAKPYHSAFKRGVKIIGATSHYVTEELDEGPIIEQDIARV
SHIHSVDDFIMKGRDLERIVLARAIKLHAERKTMVYSNKTVVFS
>EGALAKHO_01300 hypothetical protein
MKKILLLALTFSLTSCAEMQQTLNQLPQIASQYPGIGGVDIAGGLKEALNKGITQQVSKL
TAVDGFYKNQAVKILLPAELQQVDATLRKVGLSSLADEGIKMLNRAAEDAVKEATPIFVS
AVKNMTFTDAKNILLGNDSAATSYLQGSTTTALYGKFNPVIKSSFEKVGADVVWTKIITK
YNTIPLVKKVNPDLTDYTTTQALSGVFKMIAVEEKEIRNNINARTTPLLKSVFAMQDGK
>EGALAKHO_01301 hypothetical protein
MEDSNELIVDKRSWWNRNWKWFVPTGCLSLIVLFALLLVGVFFEVTSIIKDSDAYKESMT
RVEHNKIIMEKLGSPIETDGMVSGTVSSTNDIRNCDVQIPLKGPKGKATLFVVGEKRGTW
KYSEMSVYIEKTGEKIDLLAK
>EGALAKHO_01302 hypothetical protein
MKTENIEGLTLFEINLLIQQGGRFVTFPNLGNNLKTPTIYFIRPGEKTFKYALKHFFKNL
SNSWHTLPTRPFYLSKSLFYLAIGGKDYTHSLLADMNTINPINNPNLDCLPYV
>EGALAKHO_01303 hypothetical protein
MKTLYPIAIILVTSFFISSFNNLDENDLNKKETLAHNYLSAKNDDVVDSEVLSDFFKRYT
ELKKYQNDVISLYKNRSYGTIWFENGKMTQYGQLLYAKLNNASDEGVGIPYKNEIDQIFD
KTATEKPSKTDSDMLLSAAYIIYANHAFEGVDIETVKKSEWLLPKKKIARDTVSSAVATA
KPTAETNKIVKFDQYNKLQDVLKKYKKIEQDNTWTPITVETPYKDIRPDAKSVTVAQIRN
RLFVMGDLQNDSKSDFYDRELMDGVMKYKVRNGLKPNYIISEANIKDMNEPIEEKIKKIS
LNMERCKEIYPTLLTDTEYIMVNIPSFELVYVKNGKIELVSKVFVGAPLTKTTIFNGNID
KVVFSPYWTVPQSIVDNELKMKIAADPNYLAEHNMEMVNGQVRQKPGPDNSLGLVKFIFP
NPDDIYMHDTPAKTLFDFEQRTFSHGCINVSKAKELAVAMLKDYPEWTADRIDKAMDGTA
ETTFKLPTKVPIYITYFTTLVKESGEVSFFQDVYDRDGDLNKVLLSEQTVTSNP
>EGALAKHO_01304 Fused isobutyryl-CoA mutase
MEQQIPYIPKNKVRIVTAASLFDGHDAAINIMRRIIQSTGVEVIHLGHDRSVEEVVNTAI
QEDANAIAMTSYQGGHNEYFKYMYDLLHEKGAGHIKIFGGGGGVILPSEISELHEYGITR
IYSPDDGRSLGLQGMINDLVQRADYPIGDKLNGEIDHIENKTPTAIARLISAAENFPEIA
KPIFDQIHQNNTDSKIPVLGITGTGGAGKSSLVDELVRRFLIDFPEKTIGLISVDPSKRK
TGGALLGDRIRMNAINNPRVYMRSLATRQSNLALSKYVAEAIQVLKAAKYDLIILETSGI
GQSDTEIMDHSDVSLYVMTPEFGAATQLEKIDMLDFADLVALNKFDKRGALDAIRDVKKQ
YQRNHNLWDKNPDEMPVFGTIASQFNDPGMNTLYKAIMDKIVEKTSSDLKSTFEITREMS
EKIFVIPPHRTRYLSEIAENNRSYDEIALSQQKVAQKLYGIFKTIESVSGKIPQINKAGI
DDATVLPSGIQEHDENRIFLNLLLNQFDKVKMDLDPYNWEIILNWDEKVNKYKNPVYTFK
VRDKEIKIATHTESLSHLQIPKIALPKYEAWGDILRWSLQENVPGEFPFASGLYPFKREG
EDPSRMFAGEGGPERTNKRFHYVSAGLPAKRLSTAFDSVTLYGNDPDLRPDIYGKIGNAG
VSICCLDDAKKLYSGFDLVHALTSVSMTINGPAPMLLGFFMNAAIDQQCEYYIKENDLEK
EVEATINKIYKEKGTERPKYQGDLPEGNNGLGLMLLGVTGDQVLPLEVYNEIKVKTLSQV
RGTVQADILKEDQAQNTCIFSTEFALRLMGDVQEYFITKNVRNFYSVSISGYHIAEAGAN
PITQLAFTLSNGFTYVEYYLSRGMSINDFGPNLSFFFSNGVDPEYSVIGRVARKIWAKAM
KNKYGANERAQMLKYHIQTSGRSLHAQEIDFNDIRTTLQALYAIYDNCNSLHTNAYDEAI
TTPTEESVRRAMAIQLIINKELGLAKNENPIQGSFIIEELTDLVEAAVLQEFDRITERGG
VLGAMETMYQRSKIQEESLYYETLKHNGDFPIVGVNTFLSSKGSPTVIPAEVIRATEEEK
QYQITMLDNLHQFHEAKVNEHLNKLQEAAIKNENLFDHLMEATKVCSLGQITSALFEVGG
QYRRNM
>EGALAKHO_01305 hypothetical protein
MRKKQAILLLLTIFCLQVSAQNENYITDPTNKKYVNVDVIKTYEKVAAKGYKSIDLFQKL
GNSSYAVCNLDKAATWYGELFAMTYDLEPMYYYRYAESLRFISQNEKADALIERLKRKAK
VLPKKNKTT
>EGALAKHO_01306 hypothetical protein
MTKFTQMGLVAALFLTTIFTYAIDGKGDYILNIITGNGKVVSFTLNTVETSVFSIYDESN
NLVYTGNSAADKLEISKTISLEGFPAGTYVLEVKENGKVAKHEIKVVAKKAKKVALDESV
NESPAFRR
>EGALAKHO_01307 hypothetical protein
MKKILKLSLVCAVLFTGVSTYAIDGNEDFNLHVLKTNGKLITFALNQVKKASLSIYDKDG
NLIYSENASGKDGILRTFSLEEFPEGTYYLEVEDNVKKVKHEITITDEATVLSKKAVSSV
YKAGFYNKNTSVATR
>EGALAKHO_01308 hypothetical protein
MKKILKLSLVCAVLFTGMSTYAIDGNDDFNLHVLKGNGNGKVVTFALNQVKKASLTIYDK
DGSVLYFENATGKDGILRTFSFEEFPAGTYILEVEDNTKKVKHEITITDDSSVLSAKAIS
SVYKADSAKNTSVAVR
>EGALAKHO_01309 HTH-type transcriptional activator Btr
MKTIAPALEVISNSYGSSFTYTKHAEKTNSKAHLWHYHPEIELVYINGGAGKRQIGSHVS
YYTNGSLMLIGANLPHCGFTNELTGNINETVIHIKPEFLGSDFFGAPEMRRVQNVLTQSK
GGIAFGGKTKKQIGDKIEKMEKQLPFERLLTLLSILDELEASEEYTVLNADGFSLELNTQ
DNDRMKMIFNYVKDHFQESIALDEVSSLVSMTTPSFCRYFKKVSNKTFTEFVNEYRLVHA
SKLLAEKPISINEVCYESGFNNFSHFSKSFKQYTGVSASQYRHEHKIIIS
>EGALAKHO_01310 Diacylglycerol acyltransferase/mycolyltransferase Ag85B
MKNFKIFVFTAFLCVSAMSYAAKVDTLQIASTAMSKTYKAAVVVPNSYAKSKTAYPVMYL
LHGAYGHFSDWLKNTPNKKLVQGLSDQYNIIIVMPEGETFSFYLDSPVNKESQFETFITQ
EVIQKVDKTYRTISNRNGRVITGLSMGGHGALYLSAKHPDLFCAAGSMSGAVDMSTMLNR
ESSAQVVKLMQPVFGDKSDSSEMYAKYAVMNMLDKIKENKLALIIDCGVDDFLIEPNREL
HRRLVYNKVEHDYTERPGAHTWDYWENSLPYHVLFFNKILLKNQLVAKK
>EGALAKHO_01311 hypothetical protein
MKKILTLFAVIGLVAFSSCEGPEGPPGEPGLNPQAFEIRNVNLSRIADNHYELTSTFNSE
VGGDLYDDESVLIYRMTGTINSNTPVWQLIPRTLYLDNGNELDYDYDFSKVDFVIYADGT
YNLGSTPNLIQNQTFRIVIIPSDLLASVNKNNYLEVMKAAKLNESQIQKINF
>EGALAKHO_01312 Inner membrane protein alx
MVWILFLLAVVLILALDLGVFNKTPHIISTKEASKWTLIWVTLSFAFSGVIYWLYTTDYI
ANPDQLKPAVASMKFITGYLIELSLSVDNIFVIAIIFASFKIPQKYQHRVLFWGILGAIV
FRGLMIFFGVMLINKFTWTTYLFGLFLLFTAIKMLFSGDDEDFQPKDSFVYKTLGKIIPI
TAEMDGENFFISTKTAKRAATPLFVALIVIEVMDVLFAVDSVPAILAITSDPFLVFSSNI
FAILGLRSMYFFLANMLAKFSYLEYSLVAILAFVGLKMLLHDFFIVPEWASLGFIALSLL
VGVLVSLKFGEEKELSDLDPE
>EGALAKHO_01313 Glutamine synthetase 2
MAKIKLEYIWLDGYEPTQNLRSKTKVEEHENFKGTLEELGNWSFDGSSTKQAEGGSSDCL
LVPVAIYPDPTRINGYLVMTEVMYADGTPHSSNGRATIDDDGDFWFGFEQEYFIMDTKTL
LPLGFPVGGYPAPQGMYYCSVGGKNTHGRKLVEEHADLCIAAGINFEGINQEVACGQWEF
QLFAKGAKKAGDEIWVARYLLDRLTEKYGYYIEYHPKPLGDTDWNGSGMHANFSNEVLRT
CGDQATYERICEAFRPVTAEHIAVYGAYNDQRLTGKHETASIHDFSYGVSDRGCSIRIPL
MTVQKGWKGWLEDRRPASNGDPYKIAARIIKTVKSAL
>EGALAKHO_01314 Glutamine synthetase
MSTLRFQALKEASTRKPVHFEEIDRKSNIFGSNVFNEKAMKQYLTSDALKGVRDAIQHGT
KIDRKLADYIAMGMKEWALAKGVTHYTHWFQPLTGTTAEKHDAFFDISYDGSDPVEKFGG
AQLVQQEPDASSFPNGGIRNTFEARGYTAWDPTSPAFIYGTTLCIPTVFIAYTGEALDNK
IPLLRALSAMDEAATEVCRYFDKNVKKVTATLGWEQEYFLIDKALANSRPDLMMTGRTLL
GHTSAKGQQLDDHYFGSIPTRALTYMRDLEQECMLLGIPVKTRHNEVAPNQFELAPIFEE
TNLAVDHNSLLMDVMQRVAERHDFKVLFHEKPFKGVNGSGKHNNWSLATDTGVNLLSPSK
TPMSNLQFLTFFINTIKAVNDYETLLRASIATASNDHRLGANEAPPAIISVFIGAQLTKV
LSELESVTTGKLSPEEKTDLKLNVVGKIPDVLLDNTDRNRTSPFAFTGNKFEFRAVGSNA
NCSNAMTTLNAIVAKQLKDFKIEVDNLIDSKDMKKDDAIFNVLREYIKQSKKILFEGDGY
SEAWEKEAAKRGLSNFKTTPEAIKAKVSKQALDLFEELGILNHVEAEARYEIELEEYTKK
IQIEGRVLGDIARNHVIPTAIRYQNTLIENVKGLKEIFGKEFETIAKEQIVLIKEISGHI
EGINSKVLAMTNERKKANQLTDAQKMAEVYCNNVKPYFEDIRNHCDKLELLVDDESWTLT
KYRELLFTK
>EGALAKHO_01315 hypothetical protein
MKKVILSISAMLFAGVAFAQNVSDVDQTGALNGALVVQIGSNDSDVDQIGIANVAIVGQL
GVDNESTVYQLGAGNTATVAQVGWGNGSTIAQGIWIGNSATTTQLGVDNQSDVLQIGNFN
SATTTQVGWGNGSTTVQYGDANYASTNQLGFFNDASTVQAGVLNFAFTDQDGLFNNASTT
QAGWLNISSIEQDGIANFASTTQLGILNLSTVSQTGFLNGSVVIQAN
>EGALAKHO_01316 hypothetical protein
MKAVTVIFFLFTGILFSQTIDGNINDYVMALNATNNQNQNTNQYIISHNIIKIAQIGNYN
QANLIIISNNADVTAQQTGNNNYMNVYKKADEINQSYIQSGNNNYISDVSLYSRGAEQMK
VNQEGNNLTVFSTGSNSISRDMIINQSGNSGTIYVFNR
>EGALAKHO_01317 hypothetical protein
MKKYLNIIVATFFILFSENGFSQTEYNKEVKAKIEVKEIENMLFITGTVENLKSEFKNIS
YKLSVFKKNKSNSNKSTNAQDGRVTLEPIQKVELSKTQVNYTKQDEVIVMLLIYNESNAI
IGKDRIVFNEVTESDAGKSVPVDGIEMVGIVANDTKTKLGNDFYDMFYAQYSKLKVHTIK
IVTVQEELTFGRTTKITIVVDSDVIEEFISRPDEDFLKYMAESAASKLFKYFKDQEKQNK
MITQY
>EGALAKHO_01318 hypothetical protein
MKTIALLVCLFGFTTVSIAQNLAYKASNPNFGGETFNYPWLLSSAQAQNDYKEESNTGYK
QQTDLERFKSNLNNQLLNKLSNSLFDNQFGTSTGGTGTGTGTGTGTGSGTGTGNLNPGTY
VFGTLSVDIYHSNLGLVVDVLDTDTGEQTQVILPGQ
>EGALAKHO_01319 Curli production assembly/transport component CsgG
MNKSPLFLFVLICLFSGCGAYFNQPVGVQKAVYGETTPATAKLVEMPKPKEQVVVGVYKF
KDQTGQYKPTELGSTFSTAVTQGATSILIKALQDSKWFVPIERENLGNLLNERNIIRSTR
QEYAAKTEPNEAVLTPLLFAGVLLEGGIISYDTNIITGGFGARYFGAGGSTQYRQDRVTV
YLRLVSTSNGKILNTVYVSKTILSQSVDASLFRYVNLNRLLEVETGFTRNEPIQMAVTEA
IEKAVEGLIVDGIKDKLWEVNAPQQQIDDFVAEYDKEKNEADLAQLYNRSLSENRRARFG
IEASGGTAIMQGDYPNPEPMPMIRGALKFFFSPTFNLSASSNAFQVANKNKMDLGYLSLD
LNLECTILPRDVFSPFVFAGTGFEFDHHRENFHTKVQAGAGVEYLVSPHVGIKLYGEFNA
AFSDNVDHLEAGIRDDYYYRIGLGMTYYFPKEVKYKKK
>EGALAKHO_01320 hypothetical protein
MKIGLKILACFILLISCSEEQLDESGTGTLKGRVVDVRTYTGIENARVSSNPTTSTVYTD
KDGYFKIENVPSGKYAFQAQKDGFIARFVPATMEKGIEIEVIFELEVSTATNKPPEIPVL
TAPADNAVGQALSLNLTWTAKDPEGDPLTYTVTVKNGTTDEIKTYPDIKTTSLAISGLSF
STKYYWQVTVDDGINKPINSVANSFRTLAFPNPRYMYVKKVKNNNVIFTADEAGNELQLS
SAEVNSYRPRKNLSINRIAYISTDGSLNQIFTMNPDGTDVKKITNFIPIAGFNMDNVSYS
WSTNGKQIIYPNFDKLYRIDSDGSGLIQLFKTPNGKFISECEWSRDGSQIILKVNDVSGY
NVEIYAINMSGNVLYQVLSGVTGGASGIDISIDNKRVVYTRDVSGFENATYRRLDSRIFI
YTVATNTSAELASGKENGFNDLDVKFSPNEAKVIFVNTSNDGLSANSIQTVSITDDTSRT
TLFENASMPDWK
>EGALAKHO_01321 Phosphoribosylformylglycinamidine cyclo-ligase
MNQTSESIKELKKGIIFAPHQHKLIFMSSDSSKRYAQRGVSASKEDVHNAIKNIDKGLFP
QAFCKIVPDYLTQDSDHCLIMHADGAGTKSSLAYMYWKETGDISVWKGIAQDALIMNIDD
LLCVGATNNILLSSTIGRNKNLIPAEVISAIINGTEELINELKSFGVTIHSTGGETADVG
DVVRTIIVDSTVTARMKRSDVVDNANIKAGDVIVGLASFGQATYEKGYNGGMGSNGLTSA
RHDVFGKYLAKKYPESYDALVPEELIYSGQVSLTDEVENSPINAGQLVLSPTRTYAPIIK
KILDTYTPNEIHGMVHCSGGAQTKILHFVQNLHIIKDNLFPVPPLFKLIQEQSKTDWKEM
YQVFNCGHRMEIYVPENIAQDIIAISKSFNVDAQIVGRVEAADAKKLTISSEYGTFEY
>EGALAKHO_01322 hypothetical protein
MYELLFWRYLDEIYLNHHEVYEALLEKEEVDGLETLPVEVIFNRIASVFSEWEKVDENSW
QNTKGKGAFQVISTPQSIKIDCYGTEGKTMNKLVALMEEFKCPLYDPQVPERYDEMSE
>EGALAKHO_01323 hypothetical protein
MNQEYNFSFSDNIILEDDLVLLRPLQESDVDNLLEISITEPETWKYSLVGADGKENLINY
IQSAIKARDEKREFSFIVFDKKSQKYAGSTRFYDIQLAYKTLQLGYTWYGSAFRGTGLNK
HCKFLLLQFAFENLGMERVEFRADNNNERSIAAMKSIGCKVEGVLRSHMPTANSEARRDS
IVLSILKDEWFAEVKENLKGKL
>EGALAKHO_01324 hypothetical protein
MTIPLEDIEKILFEQTVNTGEFVQFIGNVEFINDGDFENINWLNTPGPIYTSYTDNLGIG
QIEAMNNIGGDEDYHEVIFKQPSSRQELKEILTAAAVDPYSSYYFDGNKNWTSKLIIDWW
LKSNERITYILDCYQYELNLPDILDRPLYGPREPIPENYKNWLDFYQSGMKEYLEWYISK
ISTPLVTLTELDFDWTRKDELDNLLKLKKQL
>EGALAKHO_01325 hypothetical protein
MKKITLLLFLLNSLFSFSQKVESFKLTKKEITERELDGVSDLPIYKAFEYSDKGGVNELL
LCENQKTISKKDTLNTKIQAICTINDHGGFLEKWRINDLLEITEPQETNIWFWTKYCSTK
DLDGDGYIEPIIIYGTRNENDEISRVKIITIYKNKKYVIRAVECVFDDCRSFKKDANWSL
LPQKIKVYVDNLVERIREEQDLILKNG
>EGALAKHO_01326 hypothetical protein
MNILQKHGFLLAIAVLMLLFTNNITGQKKENEKRNLIQFVDPMIGTAKMGHTYPGATVPF
GSVQLSPETDTIAYGLNGKYNGEVYKYCAGYQYEDKTIVGFSHTHFSGTGHSDLGDFLIM
PTTGKLQLNPGVASKPQSGYRSAFSHTTEKAEPAYYSVLLEDHNIKAELTATTRVGMHQY
TFPRSDEAHIILDLTSGIYNYDKKNVWTFVRVENDTLITGYRQTNGWARTRTVYFAMSFS
KPIKSYGQAAQEKSVYRGFWGRFDQTKNFPEMAGQNLKLFFDFNTDEGEKIKIKMALSPV
SSAGALENMKKEVRGWDFEKVKKQSQEVWNNELNKIQIDAIQKEDYVNFYTAMYHAFLGP
TEYMDLDGNYKGLDMNVHKAENFKNYTSYSLWDTYRALHPFFNIVQPARNSDMVSSMLAH
SDQSVHKMLPIWSHYANENWCMIGYHSVSVVADAIVKGNTNFDPEKALQACVNTAKVPYY
DGLEYYMKMGYVPEDKNGSSVSKTLEYAYDDWAIAQAAKKLGKTEIYNEFIVRSKNYKNV
YDAKTGFMRPKLNDGTFKKEFDPLDTHGQGFIEGNSWNYSLYVPQDPAEMIKMMGGNDKF
NVRLDSLFNMHLPDKYFENTEDITREGIIGNYVHGNEPSHHVVYLYNWTNSPWKAQDKIR
MILKKMYRNGADGLGGNDDFGQMSAWYIFSSLGFYPVAPGSDEYALGSPLVENAVFNLEN
GKKFEVETVNQSDKNVFVSKVLLNGKELSTPFVKHGDVMNGGKITFYMSSKPNKKNYQK
>EGALAKHO_01327 hypothetical protein
MELNKIITILEENNYKYIVKDKVIVVTLEFSQHVIIDLSNSNKTIISDQLVNWNFLTGCF
KMSLKNAILYNFILLLFFGFFCQYAALINQDFTSLFLTFIAWILLFASFYLIKLENFKLQ
LLLLLK
>EGALAKHO_01328 hypothetical protein
MKKLLLSFLLLISVSIAYISCTNEKTSEEQSSKTKPSIALKDYGIYHNEALALYYKNQKG
VENKKSDVIIDEMTAELKAKYPNEFQNVKIDDIKLAFKDIEPKNFDIVSFWNSQKEALFV
TNKISRKLGSFVDEILKTNLKYPQYTAKIEAFKANNSLTSDEQNQILLFESVLKSSNEYW
TSRTSLTSKSANPGSKVIVADSLGALMFAYSGPGAIIAGGISSLFVNEALPPFQVADDEI
PVEENPDTPRAITIE
>EGALAKHO_01329 hypothetical protein
MKINLKSGIDKLLFGMKQNDVTAVFGKPDKNYKDEDDNVIFVYNTHKIRLTFYQEEDLKL
GYLVASSSDLEVFGFKIIGRKIADIKKDLATKGITKYTQETFDTFENYFNEDNWFILQTE
FDEVVKFEIGAIINDKDEFDWKFPVKK
>EGALAKHO_01330 hypothetical protein
MKKIIYTLALAVTLWSCKTGSTSGAAKSNTVDVNINLVDVKDDKVLVTVTPPAIKTDEII
YSIPKTVPGTYSTDNYGKYSDDFKAFDAKGNALTVKRIDDNSWSIANAKTLKKITYLVGD
TFDTEKGTGFGNDDVFSPAGTNINAGINFMVNTHGFVGYFKDKLDVPYNVTITHPETLWG
ATSMTDEDASKTSDVFKTSRYAVLVENPIMYSKPDYTTFNVNGMDILIAVYSPTGKFTAE
SITPEMKTMMTAQKNFLGKVNATKKYTVLLYLSSMAKDDAHGFGALEHPTATTVVLPESM
PKEKLVESMKDVVSHEFFHIVTPLTVHSKEIQYFDYNAPQMSEHLWMYEGVTEYFANLFQ
INQGLINETEFYTRIAEKIEQAKSLNDTMSFTVMSKNVLEQPYKDQYLNVYQKGALIGMC
IDIIIREKSNGERGILDLMHKLSNEYGIEKPFNDNELFAKITELTYPEVGEFLTKYVAGT
TPIPYDFYLAKVGVTKSSEKKAGPIFLKGQTPYIKIDKQTKEISVRPDIEPNDFFKNLNL
KGGDIILSINEKPYSLTNIYDLIGESENWKENDPITLKVKRGGKEETIKGTVKLPYEETE
TFKATDASKEKLKNAWLKG
>EGALAKHO_01331 hypothetical protein
MKKSNRKELNWEQTEKLVSLALEERNPFEIIKKEFGLAEKEVLEIMKKKMPLEKFEMWKK
KAIANKPKPKPVKIDDFDEDLDGKYYIKNKLD
>EGALAKHO_01332 hypothetical protein
MNDIIAYFSTIPSSHRSLILVGGITIFWLIENTFPLFQMQYRKWHHAGINFFLTFTTIIV
NFVLAFILIKTASWTTENHFGILEWLPEIPIWLYTIIGLLLLDLIGAYLAHFVQHKVKIL
WRFHLIHHTDTWIDTTTANRHHPGESIIRFLFTTTGVLIVGSPMWMVFLYQSLSVVASQF
NHANISLPNKLDVFLSYFIVSPNMHKVHHHYVLPYTDSNYGNIFSVWDRLFGTFTTLPKE
ELIYGVDTHMLPEEHNKLKNLLQIPFQKSRSIKNS
>EGALAKHO_01333 Aquaporin Z
MKKLFAEFFGTYWLVFGGCGSAIFAAGIPELGIGFAGVALAFGLTVLTMAYAVGHISGGH
FNPAVSFGLWAGGRFPAKDLIPYILAQCVGAIAAAGTLYTIASGKAGFAIDNTKAGAFAS
NGFGAFSPDGYSLSSAFIAEFVLTLFFLLIILGATDKFANGRFAGIAIGLGLTLIHLISI
PITNTSVNPARSLSQAVFVGGEPLSQVWLFWVAPILGAIVAGFIYKSLLQNHDAA
>EGALAKHO_01334 hypothetical protein
MNLPWHLYLMAFLYIIAGINHFRSPGMYLRIIPPIFKNPKLINTLSGAAEIVLGILLLFP
FSKRFAAWGIIALLIAIFPANLFMFQDKKASFGLPKWILFVRLPLQIVLIYWAYQYTF
>EGALAKHO_01335 hypothetical protein
MSQNNVLKGVFLVALGATTYGMLATFVKMAYSQGYTTAEVTTSQFVLGIIGILLINAFQK
IKHKDKVVKATPKNIFSLMLAGTSLGMTSLFYYLAVKYIPVSIGIVLLMQTVWMGVLLEM
ILEKKLPSKQKVIAVFIVLIGTVLATNIINNDIKLDWRGIVWGIMAAASFTTTMFTANRV
ATEISSAQRSLYMLLGGAVIVFSFAFVTQVTPFNLEIFMKWGIVLSLFGTIIPPMLMNAG
FPLTGIGLGSIVSALELPVSVMMAYVLLNEKVIFSQWVGIVLIILAIIIMNVNFKRKN
>EGALAKHO_01336 putative peptidyl-prolyl cis-trans isomerase
MKFKFLFLFCLAIVNIQAQTTKKTVAKPKTVPTKAVAQADPNDGIFATISTTKGDIVVSL
EYIKAPVTVANFISLAEGKNPNVKVEKLKGKPFYDGLKFHRVINDFMIQGGDPDGNGSGG
PGYSFKDEFREELKFDKGGILAMANSGPATNGSQFFITHKETPWLNGKHTIFGHVVSGMD
NVNKIVQDDIMTKITITRKGATAKKFDAVKVLADDVKKEEAKKLEGQKVIKDKVAYFAAT
KAKATTTASGLKYVVTQKGTGVKGADGSTIYFHYAGYFEDGNLFDSSMSSVAKAYGKYDA
SRDAQGGYKAFPFTVGKKDGMIPGFIEALDMMTEGEKAIFFIPSNLAYGDKGAGGVIPPN
ATLIFEIETYKTQPAK
>EGALAKHO_01337 putative peptidyl-prolyl cis-trans isomerase
MKKSILLLLLAVTSFYSCKDEHSNLPDGLYADIETNKGHIIVELDYKKAPITVANFVTLA
EGKNEFVTKEYLKGKPFYDGLKFHRVIEDFMIQTGDPEGTGSGDTGYKFKDEITDLKFDK
GGVLAMANNGPGTNSSQFFITHVETPWLDGKHTIFGHVVEKGQEVVNQVKQDDKIVTVTI
IRNGEAAKKFDAVKIFHDYFSEIAKEQSKYAGVQKEKVESLAALKAKATKTSTGLEYVIT
EKGTGKKPAIGTQVYIHYSGFLENGTLFDSSVEEVAKTFGKFDPARAEAKGYQPIPFTAG
SKSGLIPGFIEGIEQLSFGDKAVIFIPSHLAYGATGAGGVIPPNANIVFEIQLLEKPQ
>EGALAKHO_01338 putative FKBP-type peptidyl-prolyl cis-trans isomerase FkpA
MNYIKLSIYTLLFAVLLVSCKQHEDARRPLSRTSGSFMKKSVDRNKKLIADEENVIKKII
KSNPKVKYYATRKGYWLSYEERNLNETQTPRKGDIAYFNLEIKDIKGNVIYSEADLGPQT
YRVDKQEIMMGLRDGIKLMRKNETATFLFPSHIAYGYHGDNKKIGPNQSLICTVTLRNFV
PDPSVPQTAPPAAQATAGQTVNQPAAGQTVKPATAKPAAAKPAVQTKKDTINP
>EGALAKHO_01339 Bifunctional oligoribonuclease and PAP phosphatase NrnA
MKIQDIQAIQLLLATPKKIAIIPHRGPDGDAMGSTLALYHFLLKNNHQPTVIAPNDFPDF
LAWLPGSETVKIFEKDTENCTKILEEAELIFTLDFNAFHRTGEMEHTLVKLTAPFIMIDH
HQKPDNYAAYTYSDTSYGSTCEMIYNFISFLNKKEDLDKTIATCIYTGILTDSGSFRFPG
TTGNTHRIIAELIDLGVENTQIPVLLFDNSSYSRLQLLGRALQNMKVFEDHKTSYTSLTQ
DELDSFNYVKGDTEGIVNYGLSIKGIVFTAIFIENKDEKIIKISFRSQGGFDVNQFARDH
FNGGGHSNAAGGRSDVSMEETLKKFEDLVTKLKI
>EGALAKHO_01340 Chloride/fluoride channel protein
MISQKLKEISLTTFKWILICFLIGILSGSASAFFLVSLEWVTQFRIHHDWIVWLLPFGGL
IIGLSYYYWGESVVKGNNLLLEEYENPKKVIPFKMAPLVLLGTLITHLFGGSAGREGTAV
QMGGAIADQFTKLFNLDNSERKILIILGISAGFASVFGTPLAGAIFALEVLYFSKINFKS
IILSFLVAYAAYFTVEFWQVKHTHYSIPYIPEINVHNIVYTAIVGVLSGFAALLFSRSTH
LWSSLFSKNIKYPPLRPFVGGIILAIAIAGFGFTKFAGLGVPIIVESFSNVSPWYDFLLK
ILFTGFTLGAGFKGGEVTPLFFVGATLGSALSVIIPMPIALLAGIGFVAVFSGATHTPIA
CTIMGMELFGIQPGIFIAIACTIAYFSSGSVGIYKSQIVKGAKYKLYQRLNSNF
>EGALAKHO_01341 Putative aminoacrylate peracid reductase RutC
MKRENILTGSPWEDKMGYCRAVRIGNIIEVSGTVAIVDGEKVKADDAYAQTYNILERVEK
VLEDLNVGMKDVIRTRIFTTDISTFEDVARAHSAFFKDVKPTTGFYEISKLVAPEYLVEI
EFTAVVQ
>EGALAKHO_01342 Chaperone modulatory protein CbpM
MNSKNLIQIKQFCVYHEIENTFITELHNYGLVEFIIQEEDEYLQPEQLPSIEKMIRMHYD
LKINLEGIDAIYHLLNKIEALQQNLTATQNKLRLFEQYQIE
>EGALAKHO_01343 Curved DNA-binding protein
MDYIDYYKILDVTKSATEAEIKKAYRKLARKYHPDLNPNDKEAEKKFKEINEANEVLSNP
ENRKKYDKYGKDWKQADEFEKAGYDPNQQQYSRQQPQGGAQDFSGFGGDFSGSDFSDFFN
SMYGGGRSSRSQSKYRGQDFNAELQLDLASAYTTHKQSLTVNGKNIRITIPAGVENGQII
KIPGHGGPGANGGPNGDLFITFNIENNSDFKREGNNLYSNVDLDLYTAVLGGEVFVNTFD
GKVKVKVPAETQTGTKVKLKGKGFPIYKKENQFGDLYITYNVKTPTKLSQKEKELFEELA
KIRNHE
>EGALAKHO_01344 hypothetical protein
MKHILLFILFFTAVTVSAQTEFGTKFKSIPAPKFSAKPKKIPQPETLDPSAPAAEVPSIK
APNVYDNNTITSKSKFQIGEEKSKFTMSTETDFANPGDRYVAKMEKDLDRALKDAGLKEG
RGTLVKKNISLGDFKTKSNYFIVRFRDFGAIDGDLVKVSSNDQVIKEQLFLDANFKDVKI
NLVTGFNKLDFEALNIGSLGGNTAEIQVYDDKGQLVTNDYWDNLAAGFKASIIVTKE
>EGALAKHO_01345 Pyruvate dehydrogenase [ubiquinone]
MSKIVAEQLVEMLVEAGVKRVYAVTGDSLNYFNDAIRRNGKIKWIHVRHEEVGAYAAAAE
AELDGFAVCAGSCGPGHVHLINGLYDAHKSHVPLLAIASTINTGEMGMDFFQETNTIKLF
DDCSCYNQMIMTAEQAPRIIQTAIQHALGKKGVAVIGLPGDVSELKAVESNISTQYFHCN
PVIRPSDMELQQLAKAINESKKITVYCGIGAEKAHDQVVQLSQHIKAPVGYSFRGKMSIQ
PNNPNEIGMTGLLGQPSAYHSMHESELLLLLGTDFPYDKFMPGNNKIIQIDTSTERLGRR
ANLFMGLCGDVADTIEALLPLLETKTDDSFLQTQLKLYASVKENMNTYIYDNGGEDTIQP
EYVAHIIDKLANQDAIFTLDTGMTCVWGARFIKGTGERKMLGSFNHGSMANAMPMAIGAA
LAHPEKQVIAMCGDGGLSMLLGDLATINQYNIPVKIIVFNNRALGMVKLEMEVNGLPDNE
TNMVNPDFGLIAQAMGFQGVNVHKPEEVEGAIENAFRHNGPVLLNIFTNPNALAMPPKVD
WEQVTGMAKSMTKLMLGGKMEEVLDTIKSNYKHLKEGL
>EGALAKHO_01346 GMP synthase [glutamine-hydrolyzing]
MQHNVLILDFGSQYTQLIARRVRELNIFCEIFPYNHFPSDLSPYKAVILGGSPFSVRAED
APHPDLSQIRGKLPMLAVCYGAQYLAHFSGGEVAASNTREYGRANLSYIKENEVFFNDVS
ENSQVWMSHSDSIKALPTNAVKLASTHDVEYAAYKIEGETTYAIQYHPEVFHSTDGSKML
KNFLVDIAEVPQNFTPNAFVEEMVGELKEKLGNDKVVLGLSGGVDSTVAAVLLHQAIGKN
LYCIFVNNGLLRKNEFQNVLDQYKGMGLNVKGVDAGDRFLGELAGISDPETKRKTIGRVF
IEVFDDESHLIEDVKWLAQGTIYPDVIESVSVKGPSATIKSHHNVGGLPDYMKLKIVEPL
RMLFKDEVRRVGATLGIDPELLGRHPFPGPGLSIRILGDITPEKVQILQDVDAVFIDGLK
SWGLYDKVWQAGAILLPVNSVGVMGDERTYEKVVALRAVESTDGMTADWVHLPYDFLMKV
SNDIINKVKGVNRVVYDISSKPPATIEWE
>EGALAKHO_01347 hypothetical protein
MRELLTISLVFILSFNKIIAQDSIIEHKIQKGETAYFIAQKYKVSVDEIYKLNPESQSGI
QDNQVLKIPVHSSNQNQKQQITHIVAAKETLYGISKQYKVTVDAIQNANAEILAGGLQIG
QELVIPQNAGNLPKTEIATSSKVSHQVVAKESLFSIARQYNVSVQDLEILNKELLQNGLQ
IGQTITIPNKRKTLDGRVRVINQETIFHVVEAKETKFSIAKKYGISIDQLESQNPEIVNG
LVVGNKLAINTKEITPTNESEELMLALAEKQVVVEKTKAKTVEIDDLKDRLVVQKEMNQK
IIKINDLKVNLNDMNGSKENSVEKLRLVLEANKNVQDILMAKLDSLVNTMNNDLVELKRM
DVLNVDESKRLEKQSYESIGQTNELSTQLKKELAENRKAYAGLMNKVEKIAVEENQEYKK
KIRESEKNTATTSLQQRLSLEEIKRYKIEQEQGDAQNQLLIAKIDSLDTQKKIEVKRHIS
KANYYSMEARQFDDKLALIKLKKYQDDAIKNQSKSNSEEASKEISLEEMKRELKENPLKN
DKIIKVEVFDNLKEVSNGYYLVLGIFTDAPQRDKFIMKLIDSGDFNASFFFNINSLSYYV
YSDRYQNMEEVLYKCKKKEEDELYKDIIIAKAEIDLR
>EGALAKHO_01348 Muramidase-2
MKYYSTLLSLFFLITCSAFSQEKVVKYTVSGGETVNQIAVKFKITPYDIYTLNPDARNGI
KPNTVLLIPSAGNKTPVKTETVAKSTGNNKDIIHEVQPKETFYSIEKKYGISDEVLKAAN
PFLEKDGVQIGQKLIIPFNKSSKQSQLTPAKKQSSSQEKYVYHDVAPKETKFGIAKQYGM
TVEELEKRNPEIISNLPIGYRLTIKGTAPKTETSAPTVAKPAETKKPAETPRKVTTYMEY
QVKPKETFYSLGRTFHITQEELTELNPSLSEGVKEGMVLKVPSGYLAPTPIIPQVQPAEK
AVEKPLNNAGGGGISVLEKVKSETVSADPEVVELTKKRGQTDRKKMVLLLPFNLAKMQND
TTSTANRIKNDKFLNMTLDFYSGAMMAIDSAKTLKLPIDVSIYDSGETKIASNVSGLIAQ
NKLQDASAVIGPFYQTNAETTANSLRLYNVPVISPLSKDSANPIDNLYQSIPTNDVVRNA
IFDYMRAKNGNIVAVVDKKKESVVSYIKQNQKGVVFASLSETGGLDVANLKSLLLPNRMN
YVVMETGNTAMIKTTIKALLDAQKSCQVQLVILEPNSTLDTDEISFENLIKLKLMYPSVT
RESDEAGVLIFEKEYRLKNKVNPTTYATRGFDVTFDTMMRLVQGKTYQETADLMTTEQVD
NKFQYYKKEDGGHANKGVYILYYDSDLTLKVAN
>EGALAKHO_01349 hypothetical protein
MTSKVTYLGDLRTQSIHVQSGSEIISDAPLDNNGKGEAFSPTDTVANALASCMMTIMGIK
ARDLNVDFIGSTAEVTKIMNAEPRRIGAIEIVFDMQGVESEKNRTILERAAMTCPVFLSL
SSEIEKRITFNWK
>EGALAKHO_01350 Glycosyl hydrolase family 109 protein 1
MKSTILKYILIFCLFFGWTMASAQMIKTKTPSRPKGQQDVLRLATAPIPTVRIAFIGLGM
RGPGAVERMTHIPGVEIVALCDMLEKNTQSANEILTKAGLPKAQEFFGDENAWKKVTALP
NVDLVYVATDWLHHAQIGVQAMKDGKHVAIEVPGALTMKEIWELIDTSEKTRKHCMQLEN
CVYDFFELTTLNMAQQGLFGEILHAEGSYIHGLQPFWGEYWNNWRMDYNIKHRGDVYATH
GMGPACQALNIHRGDKMNFLVSMDTKAVGNPAYIKEKSGQEIKDFRNGDHTMTMIRTENG
KTIQIQHDVTSPRPYSRMYQLSGTKGFANKYPLEGYALDGKELGDDVKPNHEKLSAHSFV
PEEVKKALMEKYKHPIVKNIEEQAKKVGGHGGMDFVMDYRLIHCLQKGLPLDMDVYDLAE
WSCLGPLTEISLDKGSGPVEIPDFTRGGWNKLQKLEFSE
>EGALAKHO_01351 hypothetical protein
MIHQMKNLFYIFLAFLIVSFSYADTTNLPYENSIESPKTEISLPLAGNAFSSKHVDGSTT
ITDKGIENWTDSSEYFTAYFRVSKAGTFQITIEESVEVFGKSELEFSINNESKKIKFITS
KKAVIVGSWKINKEGYVAIKIKGISKTGDRFPSINRLTISSENYDGKISYVPNNEGNFYH
WGRRGPSVHLNYLVPENINAEWYYNEVTVPKNEDKIGSYFMANGFGEGYFGIQVNSETER
RILFSVWSPFNTDDPNSIPDSHKIKMLKKGENVHTGEFGSEGSGGQSYMQYNWKAGTTYK
FLLRGIPEGNNSTTYTAYFYAPELQKWLLIASFSRPQTSNYLKRFHSFLENFIPEQGDLS
RRVLFNNQWICDEKGNWSEINSARFTTDNTGAKEYRMDFAGGLEKDSFYLKDGGFFNNYT
TPKTLFTRPLANKKPEIDFSKLP
>EGALAKHO_01352 Aminopeptidase N
MKKAFIKYTIFSLIAIMGQKMEAQNTDQKTDELTAYRVTALKVHDLVHTKLDVSFDYGKR
HLNGKAWITLKPHFYETDQLTLDAKGMEFKEIAIIDGKKTIPLKYTQDSEQVFITLNRKY
KSTEKYLVYIDYIAKPNDLKTKGGESMTDSKGLYFINPDGKEDKPVQIWTQGETEASSAW
FPTIDKPNQKTTSEIAMTVDSKYTTLSNGKLTSQKDNKNGTRTDIWKMDQPNAPYLFMMA
VGDFKVYKDTYKGKEVSYYLEPKYAPYAKQIFWKTPDMMNFYSKMLGVEYPWPKYSQIVC
KDYFGGAMENTSATVHGEYVQKTERELLDDNQESTIAHELFHQWFGDLVTAESWSNLTMN
ESFATFGEVLWHGHDAGQDGEDRSRYEKLQNYLRSQKNGNSEILARFHYKNKDDLFDNIS
YSKGSIILYAIKNQMGDEAFFKSLNLYLTANAYKSGETHQLRLAMEEVTGKDWNPYFNQW
YYQGGNPILNIEYGYTNGKATIAVKQVQESTVQTFSLPLKVDYYVNGTKIRKEILIEQRE
QNFSFDIPSQPTFVDLDPDKILVGEVRDNKKIADYLYQYKNVATYYNRIEAIKFATKDKS
HEAQLILLAGLKDQQDDLQVLSIKAIDLGDNQIKDEAIKTLLDIAKNDKKTICRATALIK
LASTGDVSYKALMEESIKNQSYNVISGGIIGLTKYAPAEGEKALSSLDDDTKKHVTALIK
RLSK
>EGALAKHO_01353 Beta-barrel assembly-enhancing protease
MKLKPFLSILLFGSLFVTAQNKPTFKDYKKVFTTYPFSDPDPIPKPDTKVYPYFRFDGFT
DKPVQKEWKVIEIENDYIKLMILPEIGGKVWSAVEKSTGKDFVYNNHVIKFRDIAMRGPW
TSGGVEGNYGIIGHTPNCATPVDYKIITREDGSISCVIGVLDLLTRTSWKLDINLPKDKA
YFTTNSFWFNSTEFEQPYYTWMNTGIKASQSLQFIYPGQSYIGHNGEHNAWPIDKANGKD
LSFYKNNNFGGYKSYHVFGKYNDFFGGYYHDEDFGMGRYGNHDDKPGKKIWIWGLSQQGM
IWEKLLTDTDGQYVEVQSGRLFNQASDNSNLTPFKQRSFAPYQTDAWTEYWFPVKQTKGF
VKANNYGAVNVKSENGWLKIYLSPLQKLNEKLEVFDNGKKVYSKNIALNTLQLFKDSIQV
AVDPNKLKLVLGDNKLVWNSAPEDGNLARPLEVPKDFDNNSVYGLYLQGKNYISFKDYIK
AEEFLTACLKKDSNYAPALSDLAGLQIRKLEYKEAIATASKALAIDTYNPAANYYYGIAN
LHLGNTTDAKDGFDIAAASVEYRSPAYTALSKIYFAENDQAKAIEYAEKSLLNNQNNLEG
LQLLAVIYRLQNKSEKAHSILDKINEVDPLNHFVGFEKFLWNNSNASKSDFTSLIQNEMP
EQTYLELGIWYQHLGRTDEAVKVFTVAAPSAEIIYWKSFLENKAVDLSKIQPGISFPFRG
ETAEILESLVKTNEQWQLKYHLALIEWNRNNISKAKELFLQCGTKPNDPAFYAAKASLFK
DDSQLVVTSLQQAIKLDAQSWRYPKLLAEHYIIQKQNDKALAIIEPFYKRHTENYVIGML
YGKTLLLNKKYAEADAFLTKLKILPFEGATSGRQLYHEAKLMQALAQMKNKQYKKALQFI
GEAKLWPENLGVGKPYDENIDERLENWLDYLCYTSLGDTETANKSLQKIVAFNPKIDNTV
MNFLPANQLVSAWAIEKTSSPKQAEEWLKHQAALYPTNKIVQWSLEMYTKKQSAILTEDE
KDGEVRIIEKL
>EGALAKHO_01354 hypothetical protein
MKLNLKNRPLLSKVLIMCLCIFSIPLAAQQIKYTDGNDSWNPNLLGNHRVVVEFTGKDNV
AKTTIEWRRRDENPELKRIIVQDANGKEILNTKTENINRENGTIFFEPVSGKGTYYVYYM
PYIDEGDANYPKGVYAKPENKTDAAWLSKIKTNLKDNCSVKEIQSVNAFNSFYPMEVIAT
AAETKDIIAKNSGNSFLVFPEDRIYSIRMKNDLPQRWIQKGVQNSFADTAMKGEYLAFQL
GVYALENLSNVKVQFSDLKNESGAVIAAKNINCINTDGVRYDASPFTATVSVSKGKVQTM
WCGVDVPETASAGTYTGKATVIADGKSKEITLQIKVTNEVTKNGGIDSPEKMTRLKWLNS
TLAQENTVIAPYTPLEIKGSEISLLGRKLILGTDGFPAQIQTFFTPEMTVIGTKANDILS
APIAFHFVDGAGKESLQWKNTGVKFTKKEAGTVAWESVSTSKSLQMDVNASIEFDGFVHY
SVKITALEDASFNDINIHLPMQASSAKYMMGLGQKGGNRPETFDWKWDVAHKNQDGAWIG
NVNSGLQFSLRDEKYSRPLNTNFYLQKPLLLPTSWGNENKGGISITPNQKSVLVNAYSGA
RTVKKGDILYYNFNLLITPFHALNTDFQWNTKFYHKYSPIDTIAKTGATVINIHHANAIN
PYINYPFVEFKKMKSYIDEAHEKGLKVKIYNTIREVSNKAYETFALRSLGHEIYSPGKGG
GFSWLQEHVGDDYIAAWFVPEIKDAAIVNSGMNRWHNYYVEGMNWLTQNVGIDGIYLDDV
AFDRITMKRVKRVLTKDGHPGIIDLHSANQYNKSDGFNNSANLYMEHFPYINKLWFGEYF
DYEKNQPDFFLTEVSGIPFGLMGEMLQDGGNPWRGMVYGMTNRMPWSHNADPRAIWKLWD
TFGITGSEMIGYWSENCPVKTNNDKVLATVYKKNGSTLISIASWADTDVKVKLSIDWKKL
GIDPSKATITAPEVVNFQPAQTFTTKDELPVSPGKGWLLIIK
>EGALAKHO_01355 Thiosulfate dehydrogenase
MKKIILIGIFSALPIVVFNSCNTSNSQTLAEKTSEDEAYITIDTSKIPDDQFGESVRYGR
ELMMKTAYYIGPNGVKGKYLGNKMNCTNCHQDAGTKPHAFNLMSSHDNYPQYRGRENKVL
TLAERVNNCIMRPHSGKPLPLDSDEMVAFLSYFKWISKFVPKDGDFKGAKNLEIEFPDVA
ASPERGKALFVENCARCHGNNGEGVYNADKSGYTYPPLWGEYGYQPGSSMHRVIKQAQWL
KSNMPYDKVTIGKPYLTDQQALDIAAFVNNDEIHKRPNPKTFDYPNKMGKPIDYSHSPFQ
DNFTEEQHKYGPYKPIIAYWKKNGWKAVY
>EGALAKHO_01356 hypothetical protein
MIKKIIVKGSFILALLALASCSKNQGNCITNINIGTHSNNELKIQIDVTTNDNVQVYAEY
WSDKKGIKSKISSPISKTGLKHSLVLCNITPETNYSFQLVTIQGENTHTSKLYNFKSRSL
PEWLQKRFKANCPKPELLPQNFKKGFMLLAKRETPGVAYIVDYKGNLRWYHTVEGTGFKV
THFTKDQTILSILGTNDEPTSYGSEILEINLQGDTLTHIKKGQGDFKQTIHHEILKKSAN
EIVTITVDQKIMDLTSIGGKKNDTINGDGILIMDKKGKQLWKWSVFDDLDPLKDKALLKT
KKDWTHANSLNYDKDGNFLISFYNNGQIWKVDSKTGKVIWKLGKDGTMKMDADTNFSQAH
AAHINADGSLMFFDNGVDKKQSSVFALKVDEKGKTVKLDFHINLPKDIYNDRMGSAYMID
KDAILVCCSKRHITVLTNKKGVLLWALESEIPPYRTQFIPEENMKPFLLN
>EGALAKHO_01357 SusD-like protein
MKKYTLLLLLLTAGAQFSCNQDLDPTVYSSLTNTNGYQTKSDAMAAVNSIYGRLKGPSVT
DNFSYWATRHFALTDIATDLGHCQFGGDPGQLSLGTWNSTNGLLKEDWLAMYKLIANANS
AIFNIAPMAGITAAEKAQFIAEAKFLRASAYMDLTDSWGPVVLITEANLGNPGYLDQTPP
SSVEEIDAFLVKELTEAAEVLPVNYKNNAIYSTNDVGRATKGAALTLMAKLYLRSHDWQK
VVALTQQVINLNEYNLYPTYLGLFKESNKWCSENIFSSLSDANTNGTELLNHFGPVDHPV
VQNRWQYYTVNWDFYNTFGNEDERKQCFFPEYEGIDGLLHKQPPTLGAEPPAGVFYMQDV
STRKYADDETTTYYDGHSVNILRYADVLLSRAEALNEISGPTTEAIDLINKVKGRSHAKL
LVLADYNQNTLRDAILQERGWEFFYEGKRRADLIRMNKYDVLVNAYHLRVGEAALIKMPQ
NKYYTYPQSQVDLNPKLSNADRQ
>EGALAKHO_01358 TonB-dependent receptor SusC
MKLLTQKKPRDFRINNLSGKEIKLTVLSLLVFTFQASAVSTITTSHKNNTVLFFEKTVKG
TITDQNGLPLPGVNVTVKGSTKGVQTDVDGSFAITVPDNATKLIVTYIGMEDQEVTISNT
PLKIVMKEVGQKLDEVVVGYGKAKKKDLTGSVSSIGKDNLNLGGTVSNVGQALQGRASGV
QVQQNSYAPGTSPSIVIRGGNSINNSNAPLYVVDGFITSTGASISPNDIENIQVLKDASS
TAIYGARGANGVILITTKKGKLGKMQVEAEISDGFQNIIKEPSLLNGQQYADIQNAIAKE
NGRPPVFPSSFPIANTNWFDAATRQGEVLNRTLTFSGSDKTSKFFLSGNYIKQTGAIENT
DFERYSVRMGGEKRFNEKLNMGTNFYGASSEGNNSDFGDNILSPMFSVQTAPPTIPIYNA
DGSYYKYQGKDNALALLLEPTDHTINRLVNGNMFLDYEIIKGLTYHFGAGAEWQENIQGK
YTPSTLVAGAALKGSGSEENKTYFRWSTEQYLTYKFNINEHAITAMIGTSNQKDTYERVK
AAGTGFSNDLLTYYNLQGAAINLKPETEKTETKLTSYFGRLNYAYNDKYLASFTLRRDGS
SRFGPNNRYGIFPSGAVAWKISNEQFMQNSNTFSELKLRASYGITGTDGIGDYAYMNRLT
SWGVSLAPDSFVPGTEPANLANPNLKWEQTAQTDIGLDMGFFNDRLSATIDVYEKRTTDA
LLNVPVGGWWGFTTQRVNSGVIKNQGIELGISSTNYRNDKFTWTTSLNVAYNKQEIVSLS
DNVKIISTNTSNPSGTVSGQEFTRLEPGKEMGVLFGYKYAGVIKTGETYAAQPLSVAGDP
KYEDVNGDGKITADDRTYLGNSIPHYIAGFNNDFKYGNFDMNIFFQGAFDYSVYNMTAMV
GESSTSTDALNRWVAGTNENTNIPRDGYYKSTYGSYVNSKFVEEASYLRLKNLSIGYSIP
ESVLKQAKFIDSIRLYAIGQNLLTITDYSGNDPEINGHSGNNLGGGIDFNSFPASRTFIL
GIKVAIH
>EGALAKHO_01359 hypothetical protein
MKEYQVILIDKNQKNGTGIPDLFSWEKANCLTDFSSPWKNDPISKIEFRAVYDLENFYFN
FRVFDADIYIDQKDDSFDSIGNSDRVELFFRANDLLNPYYCLEMDTLARIMDFKAKPNKD
FDFDWNWPKNDLEVKSSKNENFFVVEGRISIQSLKDLNLIQNNTIEAGVFRAKFSLVENL
QYDATWISWVNPNKQEPNFHIASSFGKFILMK
>EGALAKHO_01360 Catabolite control protein A
MDKKYTIKDIAKMAGVSKGTVDRVLHKRGKVSPTALEKINEVLNVINYEPNLIARNLKNT
KVYRICVLLPDPEIDPYWLPCVNGIQDAITEFKAYSVIIETYYFNPESTKSFLSTNEKII
GKSPDAVLIAPLFHKETIEIIKQYDELEIMVNTFNNQVESSSIKTFVGQDLYKSGRVAAS
LMNLILSEGQIAIIHIDESLKNAVHMQEKEKGFRNYFDEKKLSDFSLTTLKLKYSNIDTK
FPAFVEENPNLRGIFITTSKAYQIASVLSSIKNRKIALIGYDLIEKNVNFLNQGLVHFLI
HQNQKRQAYLGVSTLVDHFLFRKEIPETILLPIDIINVENASFYVS
>EGALAKHO_01361 Galactokinase
MRKITSLAPGRTCLFGDHQDYLGLPVIACAINRDIKLTAEENQTNTFVLNMIDINEIRVI
DIHATFEKLEPRDYFASSLRVLRRHGCIPNVGYNITITGDIPINSGTSSSSALLMAWIQF
LITAFGVDDDVTPEFIAKMGYASEVLEHGEPGGMMDHFSIGVGNIVYINTKDPFSYEVIG
TNLKGLITGVSGVPKETIGLIGELKGNALMAIDIVKQNFPNFDLNTSEIGDIDRYRNCLP
DRLIPFFEAALKNYHYTKEALKEFEKPVLNLKKIGELMNQHHEVLRDLLKITVPRIDSMI
NAALRAGAYGAKIVGSGGGGSIVVIAEPAKENLVIDAILKAGALEAYSVSVDPGVRIIEN
IEF
>EGALAKHO_01362 Glucose-1-phosphate adenylyltransferase
MHNNLVILAGGASSRMKKEAVLDNLSPEEIAQANERSKGLIGVGASGRPLLDYLLLNAKK
AQYKNIYIIIGEQGELFKEFYGNQDTNNNFHGLNISFAVQYIPEGRVKPFGTADALFQAV
EQFPELNTQEYSVCNSDNLYSAKALLALRETQSPNAFISYDRDALEFPSERISRFAIAKL
DQNNQLLDILEKPTAEDLEHYKDVDGKIRVSMNAFKFNGNTLYTHLKNCPVNPERDEKEL
PTVLLNSVKANPNTTIGIPFSEHVPDLTAKEDIADVKEYLKKHYPALDWNV
>EGALAKHO_01363 L-fucose-proton symporter
MSNIESIIQVEKRSAILPMVILTALFFILGFVTWLNGPLIPFFELACELSSSQAYFVTFA
FYIAYFVMAVPSSWVIEKVGYKNGISLGLLIIAFGAFMFYPAAESRTFLLFLIALFVMGT
GLAILQTASNPYVVVIGPRESAAARISVLGIANKLAGFVAPIILTALVLSNMQEFTADKI
ALLDSVSKSNALNSLALQLQRPYLYMGLIIMVLALLVKLSPLPEIDLDEEGNISNLSIFK
QIKNAFRRPQLVLGVITLMLYLAAEVLAGDSIGGFGKQLGVYGDEGNFYLKLTSFTMSAM
VVGYILGITMIPKYLSQVTALKGSGILGIILVLAIVIISPKLMIQLPGIPNLPIVILLVA
LLGLANALCWPAIWPMALEDLGGYTKIGSAILIMGIIGGAIFPLLYGLITETINTSNIAA
GTQEVSRSGNQLAYLMLLPSYIMILFYAVKGHKYRKW
>EGALAKHO_01364 Glucosamine-6-phosphate deaminase 1
MLKSKIDKATGFEKRFENINTVVFENSSDASKAVAQEIAALIQSKQKENQPCILGLATGS
SPKGLYAELVRLHKEEGLSFKNVISFNLDEYYPMEPNSINSYVRFMKELLFDHVDILPEN
AHVPDGLLTKEQIADYCHEYEARIEALGGIDLQILGIGGNGHIGFNESGSLQNSKTRLVA
LDHITRVAASKDFFGLSNTPRTAITLGVKKIMEAKQVILMAWGEGKANIVKKSVEDEVTN
RVPASFLQEHNNAVFVLDKEASSKLTRINKPWLVEKVIWTDKLIRKAVLGLALQLKKPIL
MLTDADYIENGMSDLLADSGPAYDINIKIFNKLQNTITGWPGGKPNADDSNRPERAEPAK
KRVLIFSPHPDDDIISMGGTFMRLQEQGHEVHVAYQTSGNIAVADDEALRFARFVIDYNE
KFGIKSAEADDIYEKAATFLTNKKNSEIDIPEVRYIKGLIRKGEARATSHFVGLSDDQIH
FMELPFYETGTIEKKPLGKEDIQLTMDLIEKIKPHQIYAAGDLADPHGTHKVCLDAIFEA
VKALKPKSFMDDCWLWLYRGAWQEWGIDEVEMAVPMSPDQVLAKRHGIFKHQSQKDGVVF
QGTDAREFWQRAEDRNAETAALYQQLGLATYAAMEAFVRWHY
>EGALAKHO_01365 hypothetical protein
MEQDKKLLIKLAHTKMPFGKYEGRFLIDLPEYYVVWYHNKGFPNGELGQQLALVYELKLN
GLEELIRNIKKQYPKPVK
>EGALAKHO_01366 CTP synthase
MPSFLHNYNTNNNRMNQTKYIFVTGGVTSSLGKGIIAASLAKLLQGRGYRTTIQKFDPYI
NVDPGTLNPYEHGECYVTDDGAETDLDLGHYERFLNVPTSQANNVTTGRVYLSVIEKERR
GEFLGKTVQVVPHITNEIKDRMQLLGKSGDYDIVITEIGGTVGDIESLPYIESVRQLVWE
LGENNGIVIHLTLVPYLAAAGELKTKPTQHSVKTLMESGIKADILVCRTEHELSDELRNK
LALFCNVKREAVIQSIDASTIYEVPNLMLEEGLDVVALKKLDLPKKAAPDLKNWNTFLRR
LKNPKHTINIGLIGKYVEMQDCYKSILEAFIHAGAANETKVNVISIHSEHINIDNVEEKL
GPLDGVLVAPGFGERGIEGKIEAVRFARENNIPFFGICLGMQMSVIEYSRNILGYAEANS
TEMNDKTKHPVVNLMEEQKTITDKGGTMRLGAWKCDIKPNSLAHKIYGQKTISERHRHRY
EYNNKYKDELQKAGLIASGVNPDTGLVEIIELENHPFFIGVQYHPEYKSTVANPHPIFVN
FVAAAVNAHKK
>EGALAKHO_01367 Membrane protein insertase YidC 2
MEEKKFDLNSIIGFVLIFGILIWIMYQNQPSDKEIAAEKAKKELVAKQEAQAKADKTKTA
VLPVAATTPGDTVQLANLQKTLGGFAYSATLPSAKEGFTTIENEKMILKIANKGGYIVEA
KLKEFKRLEKNSGQLVELIKDNNSNLNIQLQTTDNRTLNSKDLYFEPTLTKNGSDQILTM
RLKAGANEFLEYKYILKANDYLVGFDVRSQGLNKVLNSAKPLDLQWDLKSYRNEKSVSIE
KRYAQLEYEYGDEKYSSVSLGVGKEDTPEKVSYIAFKQHFFTAILSTDKAFEKSKLQSDD
LVKDEKLDTTYIKQFRATVPLAFTNGEVDYKMSWYFGPSDYKVLKSYDKNFEKIIPLGWG
IFGWINKWIFIPLFGFLSSTIGLSLGIAIIIFTIIIKLAMSPITYKSFLSQAKMKVLRPE
ITELGEKFKKDPMKKQQETMKLYNKAGVNPMAGCIPALIQLPFMYASFQFFPSAFELRQK
GFLWADDLSSFDAVVKLPFNIPVYGDHISLFPILAAIAIFFYMKMTSGDQQMAAPQQEGM
PDMAKMMKIMIYISPLMMLVFFNNYGAGLSLYNFISNLITIGIMFVIKNYIVDTDKIHAQ
IQENKLKEPKKQSKFQQRLQEVMEQQEAAKGQNKKK
>EGALAKHO_01368 hypothetical protein
MIYKRIIIGLLFLNAFLVSAQDVNKLDANGKKDGVWKGTYELSKRARYEGTFNHGKETGI
FKFFDDTKKGDVVATRDFTSNDGSSFTIFYDQNKNKVSEGKEVGKAREGEWKYYHKASKV
VMTLENYKNGKLDGVRSVFYPDSKIAEEMTYKNGLKEGTYKKYGQNALLLEQSTYKNNEY
NGEAIFYDSDGVMASKGKFLNGKKVGMWQFYLKGKLTKEVNMSDPKSNYKADSKPKME
>EGALAKHO_01369 hypothetical protein
MDLNELIGRFLLLFFSILILYFFSNRKDNETINPLMVIVGLCTFSLCYLFTKIEIGVGIG
FGLFAIFSILRFRTQSFTVNAIIFLFATITLSILDIMYPFEKIEVLLFFQIIIIGFYIFA
SILVNKKASKYLNVIDVKIPLEGNFSLDNQRIRKSIQQKLNVEDFDFKINLINTVSNEID
LQVFY
>EGALAKHO_01370 hypothetical protein
MRKFVYTFIFLFTITALSAQSYSASLLNYDAYKAFKGKPLSDKFSNIESVKIVYDLRTKK
MYYFNSTLISHHYDFVTSYLGYDKEVEIFNRDNYSETEKNRDYLLGNLNHIKGTDKWIFE
LAASDRMSIPLIENFYNLVLKSSFIGPDLKFYLNNPEKMEWFQQNKFKIPCVKSDYIFND
ITYQEVVSGINVGILKQYKIKDLETIKPKTDEIIILDGTPDILPDVRGIIVNELQTPLSH
LVLLGKNRKIPIMAYTTVFKDNNIKRLISKKVELKIEIDTFYIKETTKKINERATSKKKQ
LTVDNSITDLVDLNSIPKKGVNSIGSKAQNLAYLIAISKDITKDIPFKTPENAHAIPFYF
YTEHVQKKSISPLISELLAYPHKDSTVWINHQLKKIRDAIKKEPINPELIAKLNQTFKNA
AFKNFRFRSSTNAEDLDDFNGAGLYDSKTGIIGDSIKSFEKAIKQVWASVWNEGSYNERE
LFGIDQQSIAMGVLVHRSFPDELANGVIITQNIFRKNFPGITVNIQKGENSVVKPEKGEI
CEQFTAYYLTPEKTTDEDFNVDYTSNSNLNNNEPLLNRKEMIRLNLISQKIETQMNRYWK
KNRLNPVDIEFKIVGENRDLYIKQVRPFNE
>EGALAKHO_01371 tRNA-specific 2-thiouridylase MnmA
MAYLCTLVKYKRFRMKRVVVGLSGGVDSSVAAYLLQQQGYEVIGLFMKNWHDDSVTISNE
CPWLEDSNDALLVAEKLGIPFQTVDLSEEYKEKIVDYMFNEYEKGRTPNPDVLCNREIKF
DVFMKIALSLGADYVATGHYCQKNEIEVDGKPVYQLIAGADNNKDQSYFLCQLSQEQLAK
ALFPIGALTKPEVREIAAEMDLVTAEKKDSQGLCFIGKVRLPEFLQQKLQPKEGKIVQID
KNDPIYNIERPAGLSLEEELKLEAQKRAYLPTMGKVVGKHQGAHYFTIGQRKGLNVGGTT
DPLFIIATDVETNTIYTGLTSNHPGLFKKALFIEKSEVHWIRTDLTLKVGETMEVMARIR
YRQPLQKATLRQFEDGMYVHFDEPQSAITEGQFVAWYFDNELVGSGVIS
>EGALAKHO_01372 Subtilisin NAT
MKYCFTFLLLFVFSAMFSQEDAWVYFKDKPSSQLFLDKPLDMLAQRSLDRRTNQNIPLNS
TDVPVEKSYINQIKATSGITVMAKSKWLNALHIRGTQANISALKSFSFVDKVVFANKTLN
TTSKKVSEHKQVQTKDKLKTTIDYAYGNSANQIQMLNGQLLHKQNYTGSGKIIAVLDAGF
PGVNTAQPFQNLQTKNQILGGYDFVNRNTNFYTGDDHGTLVLSTMGGYKENALVGTAPDA
SYYLFITENDATENPVEESLWVEAAEKADSLGVDIITTSLGYFEYDNANYSHTYSDMNGN
TNFISRGAEIAFSKGIIVVASAGNEGTTSEPHIGGPADAISVITVGSVTSSKVRSGFSSI
GPSFDNRIKPDVMAQGTATVVSDASGIIGISNGTSFSCPVMAGMIACLWQAFPAKTNKEI
RQMLLEISDRYANPNNNYGYGIPNFGSTLGVENFQVSSDFSVFPNPAKSFVSFTFSNENY
EALVSIYSVLGQKLIEKQITNQNPILSVEALNSGLYFYTFDAEGLHKTGKIIKQ
>EGALAKHO_01373 Nitronate monooxygenase
MNKITQLFNIKYPIIQGGMIWNSGYKLASAVSNSGGLGLIGAGSMYPEVLREHIQKCKKA
TDKPFGVNIPMLYPNLEEIINIVVEEGVKIVFTSAGNPKTWTSFLKEKGITVVHVVSSSV
FALKAQEAGVDAIVAEGFEAGGHNGRDETTTLTLIPMVKEKIQIPLIAAGGIATGRGMLA
TMILGADGVQVGSRFAASIESSSHNNFKETIVNSKEGDTHLTLKELAPVRLIKNKFYNDV
QELYKKCPSKEDLIQLLGRARSKKGMFEGDLEEGELEIGQIAGLIHEILPVEQIIRQMMT
EFEAACQEKAKFEF
>EGALAKHO_01374 hypothetical protein
MNSIRTYIILLFLAFGLQQVQSQSYQFKTSGFSVLEKNERGKWGEWSNLDLVNLSVILDT
NKHRIVVYSQEIQLFSILDYIEREENDTDIVYSFMCKDNDGRECKLSIITRKKQDYRKQL
YINYDDHIILYNIFSV
>EGALAKHO_01375 hypothetical protein
MEHEEVKKDFREINEFSEFEAPKIYSTKAIWGFSVIFSPIFGGFLLMQNLKDTNRKHEAN
LVLFSAFGLTLLTFAIVTYSNIQIPNLAFLCNMIGGGVLSYYFQKKYFPNEDKFEKKKIW
KALIISIVITIPFIVAMIYSMQ
>EGALAKHO_01376 hypothetical protein
MYSREESQKIKREFWVAFAEKYPRKWVLYDTKIKDFSFKFYVDNKKAQVLIDIEQRSDEK
RNAYFEKLEALKGILEDEFIKDLVFEKNYTLESSKTISRIWTEIQGVGFSNRNNWDTIFD
FFFEKMNALEMFYLEYDEFIKDIS
>EGALAKHO_01377 putative Nudix hydrolase NudL
MDFQDFLQYVPNLIPVELPANLSHLKMAPKGRLEELRNIDLKTKNPRVAGVMMLFYPKNG
ITHLVLIVRNAYNGVHSSQIAFPGGKYEISDVNFEETALRETEEEVGICTDKMEIIKKFT
PVYIPPSNFLVHPFLGIAKEELSFFPDIREVADIIELPLSVFLDDEIIIETTLSTSYANN
IQVPAFNIQNHIVWGATAMILSELRDVLKITFQENS
>EGALAKHO_01378 hypothetical protein
MGLFKRNPFGHILFIKKWLIRILGAMTHRRYRGFNELQIEGSEIIKTLPDNNVLFISNHQ
TYFADVVAMFHVFNASLSGRQDTIKNIGYLWQPKMNIYYVAAKETMQAGLLPRILSYVGA
ITVERTWRAKGVDVTEKREVNPNDTENIRIALEDGWVITFPQGTTKSFKPVRKGTAHIIK
QHKPIVIPIVIDGFRRSFDKKGLRMKKKGILQSFIIKEPLDIDYENDTIEEIVEKVEYAI
EQHPSFLKVIPAEVIKAEEELNEMRRWSYKESENEN
>EGALAKHO_01379 hypothetical protein
MKELDLLKKDWQKNSDSFEQISEKEIYKMIHKKSSSIVKWILIISILEISFWTFSNLFLN
TDDVLKKINHPEIVTALEVLTYFNYAVAAFFVIIFYKNYKTISTTVSTKLLMSAILRTRK
TVQYYVWYNLGMIVITAILSFFIAFVYNPDMAFIREKLAANGKAMFVTIGLSMLVACAFF
GLFWCFYRLLYGTLLRRLYANYRELKKIDF
>EGALAKHO_01380 ECF RNA polymerase sigma-E factor
MSENLEQSFVAQLKANQNIIHKICRLYTAGEDAHKDLFQEITIQLWKAYPKFRGDSKFST
WTYRVALNTAITLYRKTKRTISTVEYESHQHFVKDVDYNYEEEEQIKLMYKAVYQLNDIE
KALVFMYLEDKDYQEIAETLGISEVNARVKMNRIKGKLKKILNP
>EGALAKHO_01381 hypothetical protein
MYLYLRIKIYTVKSKYILPLFLLIQIIFLKILPFFPDFVEGAYSNNLYVRISHFLRTLLG
KIPFSVGDYIYALLLLSVISWFWRIRKTWKTDWKDHLLKILGKISVFYFFFHLLWAFNYY
REPLFEKMEIKREYTDAELLAFTKKLIQKTNEIQFQLTKNNSSKIIFPYSQKEAFQINLN
GYNNLAKEHPYFKYEILSVKKSLFSLPLTYMGFGGYLNPFTNEAQVNDLLPMYNFPATTC
HEMAHQMGFASESECNFIGVLASVKNENLYFQYSGYSFALRYCLGIWQVKNERIFEQLKK
QTHVGILKNYQESQDFWKQYDTFIDEGFHVFYDNFLKSNNQKDGIDSYSKFVDLMVNYYK
TKKL
>EGALAKHO_01382 Cytosol non-specific dipeptidase
MSQEIRNLEPKALWNKFADLNAVPRPSKKEERVIEFMKNFGNSLGLETFEDEIRNVIIRK
PATPGMENRKAIVMQGHLDMVHQKNADTVFDFDTQGIDMYVDGDWVRARGTTLGADNGLG
VATIMAILESKDIPHPAIEALFTIDEETGMTGALNLKGGILQGQILLNLDTEEDDEIDIG
CAGGIDVTATRTYHEEEVPEGSVGHIITLKGLNGGHSGMDIHKGLGNANKIMNRLLFDAF
ENFGLQVAEINGGSLRNAIPRESVAKVIISEMFDEAYIFDMQEIINDIKAEYKTTEPNLS
IEIVKCDLPEKVMDLGVQEGIIRAIYAAHNGVYRMSADMADLVETSNNIARVIVKDGEIL
VGCLTRSSVETSKFDLANSLRSAFELVGCEVELSGSYPGWTPNVNSEILDTLVGIYEKQN
NEKPKVVACHAGLECGILGTNYPDMDMISFGPTIHGAHSPDERASISSAQKYWKFVLEIL
SNIPVK
>EGALAKHO_01383 hypothetical protein
MSKSQDAKKTAKKEPLKTAKEKKEEKREKKNSPKRD
>EGALAKHO_01384 hypothetical protein
MTDLTQKILNFIDLHKGEENKKSVIENITGSVSFRGSNIWILACAIIIASVGLNVNSTAV
IIGAMLISPLMGPIVGAGFGLGMYDFELLKKSIKNLIIATLVSLVTSTIYFYVSPFKEAQ
SELLARTSPNIYDILIAFFGGLVGVIAVTRVEKGNPIPGVAIATALMPPLCTAGYGLALG
NYIYFLGAMYLYTINCVFICIATFLIVKYLKYPIAKQLDQKHQKRVQYGISILILFLITP
SVYFAYQLYNQKSYNSRVEVFLEDEFQNKDYPIIYKKIRYNSDPKKIEVAFLTKKFNDNE
IANLNKKLINYDLPNTKLIIRQDTVNLRKDIMNQINNNQSVVDQKDILINTLRNQLSQYN
FNTNQINNEAKILFPAVTSLKIGNYTIENETNKLKVIPVILFQSKKGLDEATQIKMKLWL
KQRLAKDSIEVYQQN
>EGALAKHO_01385 hypothetical protein
MKYFAVFFFILVSTISFAQETESTTPQRVSGYIYNDNSKQPLPNVNIINTNKVRGAMSDA
KGYFEIDVQPNDTLHFSLLGFQSLRIRVTNDWIKNKVTRIQLTEKAIALEEVVIAPFNLT
GYLEVDSKLIPTKENYRYSISGLTQGYEAGEYSPNAFGKVLGSIFNPADMLYNFFGKNGK
ELKKLKDMKKDDTIRNLLESKYDRETLAVLLGISKDEIPEILQRCNYSESFIQSANDLQI
LDAISGCYEQYKVLKRN
>EGALAKHO_01386 ATP-dependent RNA helicase CshA
MNKFEQLGLNESLLKAILDLGFENPSEVQEKAIPLLLEKDTDMVALAQTGTGKTAAFGFP
LIQKIDADNRNTQALVLSPTRELCLQITNELKNYSKYEKGINVVAVYGGASITEQARDIK
RGAQIIVATPGRMQDMINRGLVNIKNIDYCILDEADEMLNMGFYEDIVSILSDTPDQKST
WLFSATMPQEVARIAKQFMSDPVEITVGAKNSGSATVSHEFYLVNARDRYEALKRLADAN
PDIFSVVFCRTKRDTQAVAEKLIEDGYSAAALHGDLSQAQRDGVMKSFRGRQIQMLVATD
VAARGIDVDNITHVVNYQLPDEIETYNHRSGRTGRAGKLGTSIVIVTKSELRKISSIERI
IKQKFEEKSIPSGIEICEIQLLHLANKIKDTEVDHEIDNYLPAINNVLEGLSKEELIKKM
VSVEFNRFIAYYKKNRDISSQAGERRERSDSEPREFNNNGAVRYFVNIGSRDNFDWMTLK
DYLKETLDLGRDDVFKVDVKEGFSFFNTDPEHTEKVMEVLNNVQLEGRRINVEISKNDGG
GRRDHNGRSGGGRSSGPRREGSGGGSFGPRREGSGGGGFRSDRNSAPREGGFRSDRNSAA
PKREGGFRSATPRTEGGSDRAPRRSESFGDSPRPRRPRRD
>EGALAKHO_01387 Non-canonical purine NTP pyrophosphatase
MKLVFASNNLNKIKEIQSILNGSIQLLSLEEIGCFEEIPETADTIEGNAILKANYVTEKY
GYDCFADDTGLEVASLNGEPGVYSARYAGEQKNANDNMDKLLDALKDKKDRSAQFKTVIA
LNLNGEQHLFTGLAKGEITFNKTGNYGFGYDPIFQPENYKETFAELSSEIKNKISHRAKA
TQQLIDFLNSTK
>EGALAKHO_01388 Putative multidrug export ATP-binding/permease protein
MEISALYKKITPFVKPYRKMVIATLLLTFLGSFAAQVNALILKYTVDTISNLMVAHEPLS
KGFHLLGIISIVLLSKELIYSVVQFGQKFYGEKLRIFITRDISQTIVEKILSYRMEFYTS
NENESGKLQTRIDLGISSLTRLVQNFFIDILPLFANAFVALILMFYANVYVGLVSLCIIP
IYFYVSQLQASKLSGFRRRMRNYRETKNNGIISLIESITVIKSFVREPMEADRHQKIQFE
MTENQLATRKTSFIFESIKGFIEQIGVVIIIILTAYFVLNNTMTIGAIMFHIMLFNNVSS
PIRQLHRIYDEVNDALIYSEGFFDILESDQEKETSGSYIPEKIVGLIEVKNVDFFYPNGT
KALSDINFTIKPNETSALVGLSGAGKSTIINLLDKFYLPSSGKIYLDGVDLNDYDTDFLR
KNIGLVLQKNHIFKGTIAENILYGNPDATQSEIVDAAKQAYIHEQIMELPKGYDSDAHLL
SGGQQQRIAIARLFLKNPPIIFLDEPTASLDAIATEQIKKSLDAIKKDRTVIIISHSISQ
IIDASHIIVLEKGKCIEQGTHDELYDNKSVYYGIFTAMANSLNIEKITQTLD
>EGALAKHO_01389 hypothetical protein
MKKYRFHYYIIFIGIICLGILSRKISFIPLCTGDLLYAIMIYVLIRIVLINNKAIQIAII
SLSICYGIEFLQLYQGEWMIELRKTLFGRYVLGQGFLWTDILAYTFGISIAFLIEKLALK
RLSNQVSV
>EGALAKHO_01390 Unsaturated chondroitin disaccharide hydrolase
MITRFTPFILSLFLLTGSAYSQKSDSFKVKKQLEYCAEQASKTLKVTPADGTSPRMVPNG
SKEWKFVGYKDWTSGFWPGELWYLYEATGDKIWEKEADKFSRFLTPLSVSKAGDHDLGFQ
VFNSFGNGYRLTKNKEYKDIILKTADTLATLFNPKVGTIQSWPHNKMGGHNTIIDNMMNL
ELLFWASKNGGNKKLYDIAVKHAETTMANHFRPDYSAYHVLIYDYETGKKIKGRTAQGYS
DDSMWARGQAWAIYGFTMVYRETKDPKFLDFAHKVTRVYLDRLTTEDLVPYWDFNAPGIP
NEPRDASAAAIVSSALIELSSYTKDKKLKNEYLTKSKKMIVSLSDHYQSHDVNSAFLLHS
TGHKPAGSEIDCSINYADYYYLEALLRLQKLK
>EGALAKHO_01391 hypothetical protein
MKKITQILFAVVVALTVISCKNTKQKLQEYVVSYNKAAPNFKSENVTLTTARGYINDNKI
ELRFETDLEQNDSNKTKASTEFPTLLKEMVNKDESFKELVKEGVQFDVYFLANDNTVLEK
RIIDKEEMSSLLK
>EGALAKHO_01392 hypothetical protein
MKKITQIAFAIFFVLLLISCKNTKQKIQEHVSNYNTSSSIKGGNVVSTSAKAFLNDNKIE
IRIETNLEGTDANKLAYKDTFPDLLKEMVKNDQISPELIEEGVKFDVYFLSYNNIILAQQ
LVDKEELAVLENGSSAGKETAKL
>EGALAKHO_01393 Glutamate synthase [NADPH] large chain
MRKKFFIYGFLLFIIVVTIYFYTKRGFLLVIILPILLVVGVYNIIQKKHAILRNFPVLGY
FRYLFEMIAPEIQQYFIERSTDGKPFSRNQRSLVYQRAKNIDSNSPFGTQLNLNQNSYEG
IKHSIFPAKVNEELPRVLVGGKDCRQPYLASLFNVSAMSFGSLSENAVRAINIGAKKGNF
YQNTGEGGLTEYHLAGGGDITWQIGTGYFGCRAADGNFSPEKFSEKANLPNVKMIEIKLS
QGAKPGHGGVLPAAKNTVQIAKIRGVEPHTTILSPPGHHAFSDSKGLVHFIKQLRELSNG
KPIGFKLCIGNTAEFESICHEMIAEDIYPDFITVDGAEGGTGAAPLEFADGVGMPFEPAL
IFVNKTLVGLNIRDKIRIIGSGKIISGYSILHAIALGADMCNSARGFMFSLGCIQALRCH
NNECPTGVATQNKMLMKGLVVTDKSERVYHFHKNTLHAANELLAAAGKKSFADVDINIFM
RGDEFANLSDSYFPDNLTNVTKH
>EGALAKHO_01394 hypothetical protein
MPLSNSKDLKLAVLIDADNVPYSNVKGMMEEIAKFGTPTTKRIYADWTKPNSNGWKGVLL
EHAITPIQQYSYTVGKNSSDSALIIDAMDLLYSGKLDGFCIVSSDSDFTRLAIRLRESGM
KVIGIGEKKTPNSFIVACDRFIYIEVLDGAIQKKKPKTAVAADAKKPVEKPAEKALHKID
KQTIDLIEATIEDIEDDDGWAFLGDVGNLIVKKKPEFDPRNYGFSKLTPMLKSLTDILEI
DERESDKKGIKHVYVRLRFN
>EGALAKHO_01395 HTH-type transcriptional regulator IscR
MFSKACEYGIRASIFIATKSSEGIRVGIKDVAKEIDSPEPFTAKIMQILTKSGIIISAKG
VGGGFEVSNEAVKSVKLIQIVDAIDGNTIYKGCGIGLKECSETHPCPVHNEFKKIRELLL
AMLTNTTLEQLASGVNSGDFYLKILNKRE
>EGALAKHO_01396 Azurin
MIMLMGALAITSCGKKETPATEESQTKETPSDEGQKPAVSNVLVIEGNDQMQFNTNELRA
EAGKPITLTLKHVGKIPKEAMGHNLVILQEGTDEAAFAAKAINAKDTDYIPASEKASIVA
HTKLLGGGEEDTIEFTVDKKGTYNFLCTFPGHVAMMKGVLIVE
>EGALAKHO_01397 Iron-sulfur cluster repair protein YtfE
MENLKDKTIGAFVAQDFRTAAVFSKYKIDFCCKGNRTITEVCEKQEIDADTLLQNVFDVL
QLENNGAIDFNSWPLDLLVDYIEKTHHRYVEEKTGIILQFLNKLCSVHGVNHPELFKITE
LFTAGAGELSQHMKKEELMLFPFIKRMVKTKESNGILSQPSFGTVSNPIAMMMQEHDNEG
DRFREIANLTHNYTAPADGCTTYKVAFAMLNEFEQDLHKHIHLENNILFPKAVILEEEFA
>EGALAKHO_01398 hypothetical protein
MNVLAKMNSQRSWIICCFLNFIIASMMGLLMRFYYLFRITNINYIYLLHAHSHVAMLGWA
YMMIYVLIVRFFIPKETSDKPIYNQLFWITEFTVIGMMISFPIQGYALFSILFSTLHILL
SYVFCWLVFKDCSKNKNAAEKLLITSVLFMVFSTFGVWCLGPTVKIIGKQSDFYQIAIQF
FLHFQFNGWFLFAVLGLFTKQFKNEIEVKQFKIFLILQILATFFTVAFPISWFVENQILN
WINTFGVLLQLVSFIYFYKMLKPQINYFKSTIDSVTKWPYSFALTSLFLKITIQLVVLFP
NLGEVSHHIRNLVIGFIHLTTLGIITGFLLGILLQNNFLPQKAFLLKIGVKYFFFGYLIT
ELLLFLQGIFYYLEKGKLFGYYETIFGASIFIVAGLLLILISALKTKTRFD
>EGALAKHO_01399 SCO1 protein 
MKKIIIAVFILLFSLQSCKEKSKEANSTAPKNKEISDLSIYNLPSAWTTQDGKNIELKTL
NGNVLVMVMIYTSCKAACPRLVADMRNIEAKLDHKTKKNVKLILVSIDPVTDTPKKLKSF
AIANKMNQDPWLFLRSTEDNTREFAAILAVNYKQISPMKFSHSNIISVFNPKGELIYQQE
GLGVNNDQTVNKINEEAAKI
>EGALAKHO_01400 Serine/threonine-protein kinase pkn1
MQKKIFIIFLFLVLIEFVRAQESKMVPIQEGSFVPLYGATSKNPVIVKSFFLDVFPVTNS
EYLKFLKKNPELSKSKIKRLFADKSYLDYWTTDFDFGNANPKAPATNVSWFAAKKYCECQ
GKRLPTIDEWEYVAMADEKKIDARTKAEFNKYILAWYEKSKTYENPIGQTFKNYWGVYDM
HGLVWEWTSDFNSIFLSGESRKDKSADSNLFCGSSSVNATDLMDYAAFMRYAFRGSLKAQ
YSTRNLGFRCASTTKP
>EGALAKHO_01401 Copper-containing nitrite reductase
MKKKSKIATRLKVFFYAICATMILSSCKKNEQSQDYTKIVAEGEMQAELTAPPMVPKPVG
KRGAMKLKVNMEIKEQEGTMADGVKYTYWTFGGSVPGSFIRTRVGDEVEFHLKNHPDNKL
PHNIDLHAVTGPGGGATSSLVAPGHEKVFSFKVINPGLYVYHCATAPVGMHIANGMYGLI
LVEPEGGLPPVDKEYYVMQGDFYTQGEYGAKGLQAFDMNKAIKETPDYVVFNGKVGSMTN
GNELTAKVGETVRLFVGNGGPNLVSSFHVIGEIFDHVHVEGGALVNQNVQTTLIPAGGSA
IVDFKVETPGNFIIVDHSIFRAFNKGALGILKVEGEENKSIYSGTIQEGIYLPEGGTIQK
MPENATTKTASPKRSLTEKITVGKQIFGTTCFACHQSEGQGIPNSFPPLAKSDYLNADSK
RAIKTILHGLTGEITVNGKKFNSVMPAQNLSDDEIANVLTYMYSSWGNNKTEITPEMVKA
LR
>EGALAKHO_01402 Putative pyridoxal phosphate-dependent acyltransferase
MVKDLFERIQNNKGPLGKWASQAEGYFVFPKLEGELGPRMQFGGKEILNWSINDYLGLAN
HPEVRQADIDAATQFGAAYPMGARMMSGHTKYHEQLENELAEFVMKPAAYLLNFGYQGMV
SIIDALVTKNDIIVYDVDSHACIIDGVRLHMGKRFTYKHNDLESMEKNLQRATKMATETG
GGILFITEGVFGMRGQQGKLKEIVALKEKYNFRLLVDDAHGFGTLGKTGAGAGEEQGVQD
GIDVYFSTFAKSMANIGAFVAADQDIIDYLKYNLRSQMFAKALPMIQTIGSLKRLELLRS
HPELKDKLWENVNALQNGLRERNFNIGDTNTCVTPVYLEGSVPEAMVMVNDLRENYGIFL
SIVIYPVIPKGIILLRMIPTTSHTIADIDETLVAFEAIREKLVNGTYKEIAGRTTVDLDA
>EGALAKHO_01403 hypothetical protein
MKKLLAATIIILGVFISCKKETTLPPPQIEPNPPKEAEIVEPAGDQCYTSRLNGNIVALS
FNVNSHQEVNGKLSYNITGKDKNEGTIIGNMKGDTLIADYTFMSEGVSSVREVVFLQKDG
SLIEGYGDVVDANNKVTFKDKKKLKFDAKNTLTKSDCPQ
>EGALAKHO_01404 hypothetical protein
MITIKEAKTKKELTEYIKFPFSLYKDNPYWVPPIIADELESFDKTKNPAFDHAEAYFYMA
YKNNEIVGRITAIINWSEVNNQHKRKVRFGWFDVIDDIEVTKALLEKVYELGRKHNLEHA
EGPMGFSNLDKVGVLTEGYDQIGTMITWYNHAYYVTHLEQLGFQVEKQYIESIFPFSNVK
PEFFLKAQALIKKRYELRALNFTKTKDIMPHVDKMFDLFNETYANLASFVAISDVQKAYF
KKKYISFINPEYIKFVVDKDDNLVAFSIVMPSFTEALQKIKGKLFPFGFLQLLKAKKHSK
DVVFYLIGVHPDYQNKGVTAIIFDEYYKTFSEKGIRNCIRTPELLENNAIHLLWKNFDPK
IHCQRKTYRKDL
>EGALAKHO_01405 hypothetical protein
MLKIKNLFITTLFLSPQIFFAQYTDVINSNRPGETMSAYGVGKSVIQAEIGVYGIKEKHD
LLDYDASGFGTDLTIRYGAFLEKLEFVLDLQYQMENFDTPYTSYKKNNFRQTVLGAKYLI
YDPFKSDKKTANIYSYKANHTFDWHQLIPAVSIFAGANFVGADNPYSFSPQSSISPKVML
ITQNLFGGGKWVFVTNFIADYITTDYPSYGYVLTLTHGFNEKWSGFIENQGYKSDFYSDA
ILRGGAAYLLNSNMQIDASISTNFKNTPSVLYGGVGFSWRYDGWYKEKQELVSKKAKKDK
NKDAEENIDYQEKERKRKAKYE
>EGALAKHO_01406 hypothetical protein
MWIIAFYYIFKFLARIFLPVLVKKAVEKAGENFQRQQQYGQDNSWQKTRTNNDEIIINTA
NAKNPRETKKVGDYVDYEEID
>EGALAKHO_01407 hypothetical protein
MKIVNKFYPHALVILGFILVSLIYFYPVLQGKQIFQSDIAQYTGMAKEQNDFRAAEHAEP
YWTNSAFGGMPTYQLGANYPNDFVGKLDDVLRFLPRPSDYLFLYFLGFYGLLLVLKADPL
KAFIGAIAFGFSTYLIIILGVGHNAKAHAIAYMPLVIAGFILVFQKKYIWGGLLTMFAVA
LEVNANHFQMTYYLLIFLLILSGYFAFQFIKEKDFKGLLKAIGVLAVAGIFAIGANAGNL
LATSEYAKYSIRDKSELTFNPDGSKNETTASMTTDYITEYSYGIAESLNLIAPRIFGGSS
HENVGTDSRMYSFMIEQGVPSDQAQDFVSGMPTYWGDQPIVSAPAYIGVVVFFLAVLALF
IDERKIKYVFLAGALFTLMLSWGKNFSLLTNFFIEYVPMYDKFRAVSSIQVILELCIPVL
AVMGLQSFFKAKDEPKLQQKALIQAGVFGVGVLLILVVAKGMFHFTGMSDNAYLQSYGPA
FVDALKEDRMSLYSADLLRSGFFIVITFGILWLFIKNKLAQNTTLIIVGILMIFDLFFVD
KRYVSAKDFVSPVQIAAPFQETPIDAKILEDKSIYRVFDVQGQLQGRSSYFHKTIGGYSA
VRPRRMQQLMDYQIQKGNIEVLNMLNVKYVIQTDKEGNEVPVANPEANGNAWFVGSITLV
NKPDDVMKALNNLDTKKVAVFNVHDYEGKFQSARLKKQWDTTGTIKVLEYKPNYIKYQSE
NGKDGLAVFSEMYYKNGWNAYVDGKLTDHFPVDYVLRAMEVPGGKHTIEFKFEPQVVKTG
GTITLASSIGMLLLLIGGIYFEKFFRKDSQRNHGDAQK
>EGALAKHO_01408 hypothetical protein
MEPKKLLIITYYFPPAGGPGVQRWLKFVKYLPEFNVQPIVYVPENPTYPIMDEGLVSEIS
GKVIVLKNKIWEPYQLASIFSKKKTKKISSGIFPQKKKQTFLDKTFLWVRGNLFIPDARV
FWVKPSVVYLEKYIRENNIDTIVTSGPPHSLHLIGLELKEKLNVKWFADFRDPWTTIGYH
KALRLSAYAAKKHKSLEHKVLNSADTIIVTSKTTKTEFQAITNKPISVITNGYDIENVEK
QTLDSKFTLAHIGSFLSDRNPKFLWVCLVELLEEIPDFKLHLEIKLIGAVSQEVLDSIQE
FDLNPYLNLLGYVSHHEAIAHQKKSQVLLLIEINSEDTKSIIPGKLFEYMVSNRPIIAIG
PQGSDFADIIKETNTGVFFDYSEKAKLKSVILDFYNQFLEGKLQANGVGLQQYSRKSLTK
QLAQLINN
>EGALAKHO_01409 hypothetical protein
MGIVLNQSFKNTIITYIGFAIGAINTLYLYPVYLGATYYALTNYILSAANVIMPLFAIGM
QNTLVKFYSQYKTEDEREQFLSFTALFPILMCIPLGIIGIFFFDDITAFVTKKNPVVKEF
MFLIPFIGICMAYFEIFYAWARVHMHSVFGNFIKEVGLRLFSTFALVGLYFKWMTLIQFV
YVTAGIYFVAFIVTMFYAFYVKRPKFQINIPQNVKDVMEYTFFIILSGSVANLLLDGDKL
MLNQYMKIENIAYYSVATYIALVISVPSRAMHQIVYPITAKLMHENKHDELNNLYKKTSI
NLQMVGGFVMLCIFVNISQLYELVPKEYSGGIAVVFMIGLSKYFDLILGNNNAIIFNTKY
YRMVLYLGLLLVFLTIILNMIFIPIFGIFGSAFATLLSITLYSLAKLLFVVKKLHLYPFT
KETIYSILLTFALFLVFYFWEFPFYQLISIALKSILVTILYVYLNYKFNISPDINKVIDG
LFKKIGIKI
>EGALAKHO_01410 Small-conductance mechanosensitive channel
MKKKLLCFLLLFVVLFSSIVSAQKDTLKTTQTSFSQPKLKGYPIVPFKDTLFYVYNKVGS
FSAENRANAITEKIRKLYHDSFFESDSIVVVPSDISQDITYKGDFIVMSVLDIDAKVENE
TPAFIAKRNLTLIKNAVVYQNANYSQLPKRLGYTVLLILIIGLVLYFVGKIFNWIKFRIL
KKSDKYFKGVNYNNINILSPHKQQFVLMRLFGFIKIITLIFIVYLSLPVLFSIFPATEAY
TTTLLRWILTPAKLAIMGFVDFLPSLITIIVIVVIFRYSIKIIKFFFDEIKKENIKIDGF
YNDWAMPTFNIIRLLMYAFMLVIIFPYLPGSDSPIFKGVSVFVGVLFSLGSSNAIANMVA
GLVITYMRPFKIGDFIKIGDVSGEVIEKTALVTRIRTPKFEDITIPNATVLSSTSTNFSA
NTKQATNGLLIHTTVTIGYDVPWKDIHKALIDAALKTDMTEKTPEPFVLQTSLDDFYVSY
QINVYTKEPTKQPRIYSSLHQNIQDSFNAAGIEIMSPHYSALRDGNTTTIPENYLKPDYE
APSFNFRKKD
>EGALAKHO_01411 hypothetical protein
MKKNQLSQEQSLQVFSNMISNKVHKGFKLEERNDKMLFAVLSKGGKVVNHGLNFTIFCLT
LGLWSFAWLYLTLQASKERKILVAIDEDGFPFEERCLVA
>EGALAKHO_01412 UvrABC system protein A
MQIDLSKLDPKHNIIIKGAQVHNLKNVDVAIPRNKLVVITGLSGSGKSSLAFDTLYAEGQ
RRYVESLSSYARQFLGRLDKPKVEYIKGIAPAIAIEQKVNTTNARSTVGTSTEIYDYVKL
LFARIGRTYSPISGLEVKKNTVTDVVSDVKTFELDSKWLLLSPIHLEEGRQLEDKLKVLL
QQGFARILVDNEMIRLDEFTPTEIHKLDNKDILLIIDRIVVKEEEEFYNRLADAVQTAFF
EGKGICYLQELNSDKRFTYSNNFELDGITFLEPNVHLFSFNNPYGACPVCEGYGNIIGID
ADLVVPNTSLSVFESAIYPWRGDSMSWYKDELVKHAYKFDFPIHKPYFQLTDNQKDLIWK
GNQYFQGLNDFFRELEEKNYKIQNRVMLSRYRGKTKCHACRGKRLREEASYVKIGGKTVS
DLVDLPIKHLVTFFKNLELNKYEQQIAKRLMVEINNRLSFLTEVGLDYLTLNRNSSTLSG
GESQRINLATSLGSSLVGSMYILDEPSIGLHPKDSERLIKVLLSLRDLGNTVIVVEHDED
IMKAADMIIDIGPEAGTFGGNLVAQGTYDEILKSESLTAKYLNGDLEISVPKKRRKFKNH
IDIIGARENNLKNIDVTFPLDVLTVVTGVSGSGKSTLIKKILFPAMQKKLENAAEKAGQF
TEIKGSFSQIKHIEYVDQNPIGRSSRSNPVTYIKAYDDIRDLYAKEKLSKIRGYQAKHFS
FNVDGGRCETCKGEGSINVEMVFMADVSLPCETCGGKRFKKEILEINFDEKNINDILTMT
IDDAIAFFEKNKQSKITQKLQPLQDVGLGYVQLGQSSSTLSGGEAQRIKLASFLVKGATK
DKALFVFDEPTTGLHFHDIKKLLASFDALIEKGHSIIVIEHNLDLIKCADWIIDLGPEGG
ENGGHLLAVGTPEDIVKVKESVTGVYLKDKL
>EGALAKHO_01413 hypothetical protein
MKTKLSTLLFLMSFFLFSQEFPPIVKYSSSVYGAGNQSWMISQDDQNYLYFANNDGLLEF
NGTTWQLYPAPNETIIRSVKVIGTKIYTGCYMNFGYWTRQTNGKLKYTSLSDTIKNKILD
DEQFWNILKYDQWILFQSLNRIYIYDTNTGKFKIISPKNGVIKSFAPKNAIYFQTIKEGL
FEIESGKAKLVSDHPILKKFTIVNIFTTDDGLLIQTQLDGIYKLVGNTLTRFTTDVDTEL
KSSFVYSSQFLQDGSFALGTVSNGIFILSNNGKLKYHISQRKGLSNNTALSLFEDKDQNL
WVGLDNGINCININSPVHSFTDDSGVLGTVYASATFNGMLYVGTNQGLFCKSNQSNAEFK
FINGTKGQVWSLFVYDNTLFCGHDSGTFIITNDSARSIFSASGTWKFEPVPNNKNQLLQG
NYYGISVLEKVNNQWVFKNKIEGFDYSSRYFELTNNFDVYVSHEYKGIFRLKLDKTLSKA
RGFYTYRSPQKGKNASLTKFNNQIYYAYKGGIFKLNPNTKLFEKDNLLSSIFEKDEYTSG
KLIVDNSNKIWLFSKNYIHYFSASKLSNQLKQNVIPIPSSLTNSMLGFENITQISKSTYL
IGTTDGYYTLNIDDLSFKNYAVFLTDITINKQNETLKNVEIQNEGSFHSNENNITLNYTV
PEYNKYINSEYQYLLEGFQNDWSEWSTKATVNFKNLSPGQYTFKVRARYANTILQNTATY
TFIVLKPWYLTNLAWFIYFLLFLIMAYFINKAYINYYHKQKEKLIEENNLLLEIKELENE
RQLMKVRNEQLSQDVDSKNRELAVSTMSLNSKNELLAFIKEDLKKTTQDDNKNIKSVIST
INKNITEEDSWNVFKEAFDSADKDFLKRIKQLHPLLTPNDLRLCAYLRLNLSSKEIAPLF
NISVRSVEIKRYRLRKKMDLQHEIGLVEYILAV
>EGALAKHO_01414 TonB-dependent receptor SusC
MKSKLLLTVLLLFTSFAFSQNFDVSGTVLDGSGLSLPGVNVKVKSSSQSTTTDFDGSFKL
LGVPKGTIIVFSYIGFKTQEVAVSGAKLTIKMSDDARSLDEVVVIGYGTQKKREVTGAVS
VVDSKTLDMLKPVKVEQALQGTVSGVNVTTQSGAPGAKLDIRIRGIATNGENGPQAIIDG
YVGDLSLLNPNDIETITVLKDAQAAIYGTIGANGIILITTKMGKKNSKTKVSINSYSGFQ
EASRKLPMLDATEYALLLNESYANGGRALPYPNVSGLGKGTDWQKEVLGTGVPILNTDLT
ISGGSEKITYAISGSHLDQEGIVGQDKSGFLRNTARIALGADLSDKFKIKTNVIYTYFNR
KTINENGLGSVLFNALNVPATLTPYDANGNFTLVPSTTGLGTEIINPLAQIANTYNDYNY
KKLNGNFGFDYKIFKGFVLSSSIGFNTSNSEGKTFGKQISYGGKVFDVQRSSVTQTATND
NDYSFDIYGTYTAKIAENHNITATLGNTIFKTWGNSANATGFDVPNNSWEYADLSLTRGL
PTALNTGGYVYDQRRLSYFGRAQYDYKGKYLFSAMIRRDSSTKFGPGNKVGYFPSFTAGW
VVSDEGFFGESKTINFLKFRASYGTLGNDQIPNNGYLSLLTGEATYVFDGNLTSGKATGQ
IPNPDLKWEEAKKFDVGLDLRLFNDKVSVVADYFIDTRDDLLIPNIPVSGIVGIGAPGAS
APTLNAGSVRNSGFEFAIDYKEKFSDSFSMSVGYNVTLIKNEVLEVNNGTGIIEQGGFGV
GQPAASRMEAGKPIGYFYGYKTDGLFQNQAEVDAHPSQLALGANAAPGDIRYVDLNGDGV
IDTKDKTNIGDPIPEATMGFNLQLNYKNLDFALYSFASVGNDMVRNYERVLSDANRLDYV
LDRWTGEGTSTTVPRVTTGATANNVLSDYFVEDASYFRIQNIQLGYTLSPKVSQKAGITK
LRLYTGVNNLYTFTKYKGFDPGSSSGPTNQDGVSQSPIGAGIDYGFYPVPRTYLLGVNIN
F
>EGALAKHO_01415 SusD-like protein
MKKYLITTIITLTLFSTISISCSDEFVSPKPEYSIDSENYFNSKEDYNDALVATYDLLQS
SYANVLLGEIASDNTLAGGESPTDVIGWQQIDDMIHTPVNSNLRDIWNWMFAGVQRANYI
LEFKDKTDFEGKTQLIAETRFLRAYYQFELVKWFGGIPMKGDARFKVGDEKTVPRSSAEE
VYASIEADLIFAAANLSPTASQKGRVTKGAAQALLGKAYLYQNKFAQAATALDAVITSGK
YTLETDYNAMFELDGENGPESVFEVQYTDVEGAGFTCLQCSEGNVAVGFSGIRNYSGPLF
SSGFSFNVPTKESADAFEVGDKRKDVAILDIAAWAAANASFDGGKGVSYGKGNEDTGYFN
RKYLPRKRSATAAGDLNLTNPNNYKAIRYADVLLMAAEAYNRGGINDAKAKDYLNQVRRR
AFGDTNHDISVSGAALTDFILAERRVELFGEGHRFFDLVRTGKAVGKIPGFTASKNELFP
LPIEEIQFANGNWKQNPGY
>EGALAKHO_01416 hypothetical protein
MKKLHLIISLFVLTIFIGCSSDESSNIDLDGVSAPDNIAALTTVTQDNSGKVTFIPKGEG
VTQFKINYGDGSPESAYFGSGGTTTHTYKEGIYQSKIIAMGISGKTTEVIQPVVVSFRAP
ENLKVVITNDISVSKKVTLKATADFALFYDVYFGEAGKPEPISANNGESVSYVYKEAGTY
TIRVVSKSAAIKTTEYTEQFAAKLVLNPTTSATTPPNRPAGNVISIYSSKYTNVAGTNFY
PNWGQSGGYTEFDLNGDKMLNYTNLNYEGIALADNVTVDVSGMDYIHMDVWTADLPKLDV
FLISINKANGERPVTKDLTANQWTSIDIPISAFTSQTGFTVADIFQLKLVGTPAGKNVFI
DNIYFYKNGEALSVAAPTPTKPASDVISMFSDAYSNVPIATWRTDWSAATLEETAVAGNA
VKKYSDLNFVGIEPTATIDASAMTHFHVDVWSADFTEFRIKLVDFGANGVYNGGGDDKEH
EIKVTAPAKGTWVSLDIPLSDFTGLTTRAHIAQLIYSGNPSGAHTIYIDNVYFHK
>EGALAKHO_01417 Beta-glucanase
MKKYNKYFVLLFVLLLVISCQKDDYAFGDLSAPTNLEVKAEIVGKTTAAPNGDGSGMIKL
TATADNAISYKYVFPDGTSENAPSGVFTKRFTKTGLNKYTVTVIASGKGGIATNTTIDVE
VLSNFSDDEAVQFLTAGTSKKWYWSASEPGHLGVGQNDGDATKNYFANYYMAGPFEKAGS
PSSSCLYENVLTFSLEGEQLKYELNNGGSTFFNAAFASVAGGSGPDDSCLSYNASGKKSV
SLSPSESVVMSNPNHATQTRGTTMNFSDGGFMGYYIGQSSYEILSITANRMVVRAVMGGN
PALAWYHIFTTTKPTQAPPADFTKLVWSDEFNTDGAPDAAKWNYDLGKGDNGWGNNEKQN
YTNSATNVIVQGGSLKITAKKEASGGADYSSARLKTDAKFAFTYGKIEIKAKLPTGAGTW
PAIWMLGQNYATKPWPACGEIDIMEHVGNNQNVILSTLHYPGHSGGSGNTGSKTIPNVST
EFHVYKAVWSAASVTTFVDDVQIHSVPNDGSLPFNSDFFLILNVAMGGNLGGNIDAAFTQ
SSMEIDYVRVYQ
>EGALAKHO_01418 Beta-glucanase
MKRVIVLLLISSFCFAQEVKRKLVWEENFNDTALNEKDWNFEVGDGCPNLCGFGNNERQI
YTRTNHEFKDGNLVIEAKKEGNKYTSTKITTKGKKEFLYGRIEARAKLPIGHGLWPAFWM
LGANIDEVHWPKTGEIDILEYIGRDPGMVYTTLHTQDSHGNTINTKRTAFPNIEEGYHVY
AIEWTKDKMDFFVDKTLVYTFNPPIKNDDTWPFNKPFYIIVNLAIGGNFGGPEVDDKVLP
QKYYVDYVRVYQ
>EGALAKHO_01419 RNA polymerase sigma factor CarQ
MADLHIPDALLVKNYIEGNETALSILIKRHESKIYGFIYSKIADRDISNDIFQDTFIKVI
KTLKSNSYNEEGKFLPWVMRISHNLIVDHFRKTKKMPMYRETEEFSIFSVMSDDSLTIEG
KMIVDQVEVDLKRLIEELPEDQKEVLVMRMYQDMSFKEISELTDVSINTALGRMRYALMN
LRKIIDKHQIILTN
>EGALAKHO_01420 hypothetical protein
MAKIYSKKELASKNLKPKKEVVSFLLNYSQALTVVKVKDKSFEIIAN
>EGALAKHO_01421 hypothetical protein
MKKNLHILSIFLLINIGAFAQQDQVKEAQSLYDKGKSQEALAILNKTEYLILNAPDETKS
DYYFLKGNVLKDLAEKNIDAANSFTLASQAYQDVFLYENESGKFKFTVKANAALKEMKSV
LVNGAMTDFKTGKFKESAEKSYKVYLFDKKDTLNLYNAASSSINAKDFDSAVKYYEILKK
INFSGKAVLYLATNKKTKEEDAFVSPKAREYAIQQGLYEKPRTESVPSKKIDVNSNLAYS
YLEKKDYAKAEVVYNYVLELDPNNVDAYINMAYLKMQVKKDLSDEIATLGTSAADMQKYD
KLNAKKDDIARSAIPYLKKALTLEPKNTDATKSLLGIYRSLDMTNEYNALKGGM
>EGALAKHO_01422 Endonuclease III
MNKEARVQFVINTLKELYPTIPIPLDHKDPYTLLIAVLLSAQCTDVRVNQITPLLFAKAD
NPYDMVKMYVEEIKEIIRPCGLSPMKSKGIHGLSQILIDKYDGKVPQSFEALEELPAVGH
KTASVVMSQAFGVPAFPVDTHIHRLMYRWNLSNGKNVVQTEKDAKRLFPKEIWNDLHLQI
IWYGREYSPARGWSLEKDIITKTIGKKSVIEEAAKK
>EGALAKHO_01423 Putative peroxiredoxin bcp
MITLQKGDKAPNFSGVDQDGKTHKLADYAGKKLVVFFYPKASTPGCTAEACDLRDNFERF
KANNYELLGVSADSQKAQSKFKDKYEFPFPLLADEDKSVINAFGVWGPKKFMGREYDGIN
RTTFVIDEKGIIDEVIEKVKTKEHASQILK
>EGALAKHO_01424 hypothetical protein
MGTEIKLKGDKVIEQIPSIKDKALRINLNENIYGTFAEIGAGQETVRHFFRSGGSSGTIA
KAMSAYDKDFSDAVYGIEGDGRYVTENRLKKMLTFEGELIEERLSREKHPNKLFFSYANT
VATIDFAKQFKGHGWVGIRYQIEPDEAYNEIILHIRFKETDARLQQETLGILGVNLIYGA
FYKYNDPKRLLRYLYDHLDKDQLEIDTINFSGPRFADVDNRLMSLQLVKNGMTDAVMFNP
DGKNVLPAAVLYKKNLLAFRGSFRPVTNVNLDMYQKSLTMFLEENKVEKDNTLVVFEITL
SNLRSDGEIDERDFMDRAELLCSLGQTVMISNFQEYYKVVEYFSNYTKARMGLAMGVNNL
VDIFDEKYYRHLSGGILEAFGKLFYRDMKVFLYPMLGENGEVITSDNLKVHPRMKELYKF
FKFNGKVVDIKDYNPDILNVFSREVLKMISQGKTGWEPMLPSGVAEIIKEHHLFGYHPQK
ELEQNTQE
>EGALAKHO_01425 Ribonuclease Z
MKVYFLGTGTSQGIPIIGVDHPVCKSTDLKDKRLRVSIWITWEEHSYVIDCGPDFRQQML
SCGCRKLDAILFTHEHADHTAGLDDIRPFNFRQGEIPVYGHERVITNLKRRFEYVFETVN
KYPGAPSVKTIEVVNDKPFAVGDKIAIPVNVMHGDLQVFGYRIDDFAYLTDVKTIEEVEI
EKLKNLKVLVVNALRVEPHDTHFNLKEALDFINLVKPEKAYLTHISHVLGFHEEVQKQLP
ENVFLAYDNLEITI
>EGALAKHO_01426 hypothetical protein
MLYLFILAILMNIFTYMFYSREVKFGEERYDKMTKKLRDSITLVSTKLTDADYFSLEHNE
NAQNYFDNSASGGKAILFEKLIPVVTEKLLDLNANPNGNPYTGQDKIGPNKFIINKVKIL
NHRWIIADYSNGEIWGEVLLKYFVNDDESINFEVNQSLLYQK
>EGALAKHO_01427 hypothetical protein
MKKLLLFSIFIALSFSCAKKVSEEKKVSKETTKTVKEETNPPVVVGGDLDSHGCKASAGY
TWSILKKECIRIFENSTKLSHAEDGKNYTTVAYVIFDGDKAELFLDTQKESIILERKSEG
DSWVKDDLQLIPWKGYVLKKGEKILYTGE
>EGALAKHO_01428 Streptothricin hydrolase
MSITKLDNPALILIDIQKGFNDVSYWGGDRNNVNAEQKCGELLEIWRAKKLPIFHIQHCS
SNPNSILNETNPGNAFQDVVKPLEDETIIKKNVNSAFIGTNLKALLDDAKITNLVIVGLT
TDHCVSTTTRMAGNFGYSTYLVADATATFNKKGINGEDFSAETIHQTALASLNEEFAQVV
TSDFIKEIV
>EGALAKHO_01429 Carboxylesterase 2
MNLSLEYKIQEPKVILDKNPVLILLHGYGSNEADLFSFATELPDNYYIISARAPYDLQYG
AYAWYAINFDADQNKFSDNEQAKTSRDLIAKFIDELVASYPIDANDVTLIGFSQGSILSY
SVALSYPEKVQRVVAMSGYFNDEIIKEGYEKNDFKNLKIFASHGTVDQVIPVDWARKTPA
VLENLNIPITYKEYPVGHGVAPQNFFDFKNWLAL
>EGALAKHO_01430 hypothetical protein
MNNSVEEGKSIAITSYILIIGVLIAMSMNSENKNSFASFHIRQALGLSLAFISFGAIISN
FDSFMITFPMWICISILWTYGIFSAIQGQTRPIPLVGNLFQKWFKSIG
>EGALAKHO_01431 Dihydroorotase
MKIIIRSAKIIDSKSPFHNQTVDLLIADGLIEKIGTSILDIDDTTEVKFDNLHLSQGWFD
SSVSFGEPGYEDRETIANGLNVAAKSGFTGVALQPNSFPVIDNQSQVNFVKNKANGFATE
LFPIGALTKGSEGKDMAELFDMKKSGAIAFGDYNKSLDNANLLKIALQYVQDFDGLVIAY
SQDANIKGNGVANEGIVSTKLGLKGIPNLAEELQVARNLFLLEYAGGKLHIPTISTAKSV
ELIKEAKAKGLQVTCSVSVHHLVLTDEKLEGFDTRFKVTPPLRTEADRKALINAVLDGTI
DMITSDHNPIDIEFKKMEFDTAKNGTIGLESAFGALLTVLPLETVIEKLTLGKAVFGIEN
NSIAEGSKANFTFFTPEGKSTFTKENILSKSKNSAFLGTEIKGSVYGILNQNKLVTTK
>EGALAKHO_01432 hypothetical protein
MHFKHPEILYFLFLLIVPILVHLFQLRRFKTSYFTNVKFLKELAVQTRKSSKIKKRLLLA
TRLLLLTCVIIAFAQPFFEAKDSKNASNEMYIILDNSFSMQAKGKKGELLKRAVQELLEN
TPENAQFSLLTNTENYFNTDIKSSKSALQNLNYSATPFELSSIMAKIKAHKSAHKKDIVI
ITDAVGLAEKDIKNIDSEEIPYFIIPEAEQKNNVAIDSVFINQTLENFYEIGINLSAYGD
DFKPISTALYNQNKLIAKTIINFDKKKKEIHFTIPKEAFHGYVSIEDNGLTYDNKLYFSI
SKAKKTNVISIGEPEKSNFLSRIYTSAEFNYHNYSISSLDYNSLEEQNTIILNELVEVPQ
ALQTTLKAFVSKGGNLVVIPSEKTSVSNLNSFLGNFGKVQFQNLEAKSKLITKINFDHPL
FSGVFENKITNFQYPKTNSSFALLSPYPAVLSYEDQSVFVTAIQNPVSGITVFSAPINSE
NSNFQQSPLIVPLFYKMGQNNQKTGVNALIIGNNQPYFVDVLLTKDAILEVKGNEDSFIP
IQQILNNKVKLTFNDFPETAGNYTVFDKKESIENLSFNYKRSESDLSQVNTNIVSDFKTA
DTISTIFNTLQTERTDSQIWKWFVIFALLFLALEMAIIKFVK
>EGALAKHO_01433 6-phosphogluconolactonase
MKGLYMLLFSAVAFTTQAQNKFNLLIGTYTNTCQSKGIYVYEFDAASGEFKFKNSSENVI
SPSYLSVSSDNKFIYAVNENGDQSAVSAFGYNAKSGKVTFLNTNKALGADPCHLINDDKN
VIVANYSGGSIVVFKKQTNGSITTVQQIIQHEGKGPNVARQEKAHVHMVVFSPDKKFVFS
NDLGLDKVFIYKYNPNSKNEMLTLKETVDVKPGSGPRHLTFSKDGKFVYLIQELDATLTT
FSYDKSGSLKKIAETSILAKDFKGGTSAAAIKISPDGKFLYVTDRLDANDISVYKILKNG
AIELVEQQSTLGKGPRDFAIDPSGNYLLVGHQYTNDIIIFKRDKTTGKLKDTGKKIELCS
PVGLVFTKI
>EGALAKHO_01434 ATP-dependent RNA helicase RhlE
MSTFEKFNLPKSVQKAIDELGFVTPTPIQEKSFSVIMSGRDMMGIAQTGTGKTFAYLLPL
LKLYKFTPTNTPKIVILVPTRELVVQVVDEIEKLTKYMSVSTLGIFGGVNINTQKKAVYE
GVDILVGTPGRMMDLALDAVVRFDETQKLVIDEFDEMLNLGFRTQLTALLAMMKTKRQNI
LFSATMTDEVDAVLNDFFDFPEEVTLAASGTPLENITQVTYNVPNFNTKVNLLKHLLETN
ESMERVLVFVNNKKISDMLHTRIEEDFEGQFGVIHSNKSQNYRLSTMAEFQEGNLRGLIT
TDIMARGLDISNISHVINFELPEFPELYMHRIGRTGRADATGTAISFITPREEEFKVEVE
VLMNQELEIADFPEEVEISLKLIEPEKDKQPIKFLMKKQTLKGDGAFHEKDKKNKKVNLG
GPSKTKKKTHGSVNRNMLKTRDKKRKDKDK
>EGALAKHO_01435 Transcriptional regulatory protein WalR
MDSNEKKILIIDNDEMTIEILKFILKKEGYIISIANDGVSALERIPTILPDLVITTIIIP
LKSGMQIISEIKQNFKDIRVIALSSLGEEENTVEEAFKLGVDDFIAKPFNPNELLLRIKR
LL
>EGALAKHO_01436 hypothetical protein
MAQSEISISNKNSIISKSEDSQSAALLLKKYLDKAFAKPFDNISENKKEEDLSEIILEIS
DQEKLKANEFIIKSDSKSIYLIAANPKYLRYAVYTLLEIWEFRKFTATETYIPKVENFTF
LKDTKKIYQPSFDYRALFYPDCYDEAFREWHKLDWQVDDFGLWGHSFSVLVPPKEYYKSN
PKLFALYQGKRNGESLCMTNDTVVDLVGKKMMQIIADKPNAQFYSVSQNDDVVYCECTEC
KKLNEKYGGPQGSFYYFLNKIAKQFPKTKITTLAYLHTFKPPVNLKIEPNIYTIFCPIEL
NRGKAISAESAPSFIKTLENWSKTSPHLFLWDYTVQFSNYQSPFPNFEPFQSNYKFFKKN
KVKGIFAQGYADVPGDFSELRQYLLAKLLWDTDIDIKAITADFLRGFYGKAAPFVGNYLA
LLTENQNISNTYLDIYSGPVQARNSFLTPEAMDQYDKLLEKALAAVENDKTINLRIEKLR
LALEYVYFEQSKFYGKNQHGMFVVNSKGEKEVKKGLTERVLKFTKSCNEFGIYELSEGGL
SPDNYYKEWLEICKNTTTHLGEDLKVNFITQPSGDFKGKGSAGLVDGNKGYKDFNINWIG
WYGTEPSFEIETKKLNFNTLKLNFLEDQRHWIFAPKKILVYGYENQKWKLLEEKTCDKLT
ENDQITTKSWEIINQKFSSFIKIKILIKSQTELPGWRKRKNKKPMLMMDEIELYKK
>EGALAKHO_01437 hypothetical protein
MKSNKLISITTSLFCLLLFCYQNINAQKKVDTDSLLTVIIKNMKTNNPDYKLNIQRALLG
KKLAPDYLDFHLVLGRSYDLIKVKDSARYYYNYVIEKNPTYEDAFLYLINLDIEEKKYEE
GLITTEKAIELFPDSKPFYIRRIGIYSLQNDTYNEEKYLKSIKAKFPNDPDIGQRLYLLY
SKTNFERVGVYYNETTINRAGVGPWYLASADYMMQRIWGSISAKLNYAKRSSSNLVMSSG
FQAEAESYLFAKKNNYHYIDVAYSQDNAFPELRLGYSYYHNFNKGWEADLGARYILMQDN
TNLKALNIGLGKYFGSFWVNLRSFIQEDGTSINITSRYYYKTKFDYLTLGAGYGTSLDDR
TRAAQYEVRMSSSSYRVSGGFSKMIKGHYIFGLLITANRQEYVTNEFQTELDFAFILQYK
F
>EGALAKHO_01438 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MTYEFVSYLVRIYDIFVASFSLGYIIFYIFLAILSYLAIIKHLKEQKYLEEEVLLRSNHI
WGVSVVAPAFNEGVNIVYNVKSLLSLTYPKFEIIIVNDGSTDDTLEKLITEFDLVKIDFY
YQEKIVTQPVKGHYRSKNPVYSKLLVVDKVNGKSKADASNAGINTSQYPLFLCTDVDCIL
KSDTILKLAKPFMENETRVIATGAGIRISNSCEIKEGFLFKVHYPTEWYPCFQELEYVRS
FIFGRMAWSQINGLLLVSGGLGMFDKDIVIKAGGYWHKSLGEDMELVTRMRKYMHDTNEK
FLIKYIPESLCWTEVPSTKEVFLRQRIRWARGLVQTLYLHRKMFLNPKYGRTAFLVLPFF
FSFEFLVPIIELLGIITLIVSIIFDMIDYQYLLLISSLVYLFYLSITIISILIDEILYKS
YANYKELITLVGMAIIEPIVYHPVNVYASLKGYWYFFAQKEQKWGVMVRKGYEKPVKK
>EGALAKHO_01439 hypothetical protein
MEYVIHTIKHYYVIPFFSILALALVVFLLLNRIYYQYNLPYRYHFTLESQRFLTEITLAN
HDKNTIKQKIAEFKSEIPIHKTWCKEILVEDLIKIKNNLKGKTAKNILIIYKALDLNHYS
ASLIRDFRKHKKYEGIRHFQALGYKPGLSLLQKYLFHPNKVIRSNVNVAYLALSKGDWKA
VGKVPIKRSIIATIKVMDVLHKEKIPQPIHLDLWIESKDPMVLKLAVMAMVFYNYRNKSE
EIIKLLYHENKALKIDVITAVQHLFLEKAEDDLLFLFHNEPLVIQLEMLKALGVIGSEKT
ITFLKIEIPKQEIKDIKLKMVDSLNNLDPVGLDLLGNKDIDTQKMINHTRKLAL
>EGALAKHO_01440 hypothetical protein
MNKAELKEFLDEKVIQYNNQDFIESDPVQIPHLFTQKEDIEIAGFLSATIAWGNRKMIIK
NSHQMMELMGNTPYDFVMSHSDEDISRLESFVHRTFNGKDFGGFIKGLQHIYKNHNGLEA
VFAKNQEANNLQKSIHEFKKIFFEIDHLPRTQKHISDPLNNSAAKRINMYLRWMVRQDTK
GVDLGIWKTISPALLSCPLDVHSGNVARKLGILSRKQNDGKALAELDFKLREMDSNDPVK
YDFALFGLGVFEGF
>EGALAKHO_01441 hypothetical protein
MILILISWIYILFTIINLGFGLDKILGLKNNNFVITAVLGLFSATIITSIWAIFGRINIE
FHVLLLFLNSSLLFKFRKPIIEIYKSFILEIKELKIPSKLFLILITFLIIAQCASIPYVI
DNESYYIQTIKWLNEYGFVKGLVNLHLFYGQMSGWHIAQSAFNFSFLYQNFNDLSGFCLL
LGNIFSIQKLNEFYKNGNKNFLVTGLLPVFNIFFFQFISAPSPDIPVYIFSFILFFYFLE
NFKKITIEAFYLIVILVLFLLYIKNTTLTFAAIPLILLALHYNFLSKKLLKPVILATIML
LLFIAKNMIICGSPIYPSKIANSFSTSYAIPNSISVFYYDQIKYYGFFVDMNQYNSMSVF
DLFIKWISMPKLNGLFNKLSILLILIVPFFIFKFQNKKALWTLYFIMALQLFLLFITSPQ
YRFFMNFILFFSLFCLVSIIQNKKMINSLLMLSLLPTVVVLFLPINLNQFSNHKFMLEIS
NFSIKNIISPYQNTKNSTAFETIQLGNLKYNSPIKNDFFWANGNGNLPCVNKEQLDYFKK
YFHIIPQMRTNDLKDGFYAKKVLENE
>EGALAKHO_01442 Lipoprotein-releasing system ATP-binding protein LolD
MIHAKNIHKFYDQLEVLKGVDLHIKKGEIVSIVGASGAGKTTLLQILGTLDKPSKSETET
SLTINGENILGLNDKTLSKFRNLNLGFIFQFHQLLPEFTALENVCIPAYIAGKKPSETEA
EAKKLLTFLGLSHRINHKPNELSGGEQQRVAVARALINKPDVIFADEPSGNLDTHSAENL
HQLFFQLRDEFGQTFVIVTHNEELANMADRKLVMSDGQILS
>EGALAKHO_01443 hypothetical protein
MQDLEVINEEDKMRKLILGLLLDGIGMISFSIPLIGEFSDVIWAPIAAFIMTRMYKGRVG
KVASILTFVEEIIPFTDIIPSFTLTWIYTYYFQKSNKEI
>EGALAKHO_01444 hypothetical protein
MDKLKKRWGITSNVQAIIILVVFAITGSASAWLSKPFCVWLGITKEDFGGWFTLIRLLII
FPIYQVLLVAIGTVFGQFRFFWNFEKKMLKNMGLGFLFKN
>EGALAKHO_01445 hypothetical protein
MKKTIYILIIIFTVIACSTASKNNAVATTSPKPNPKVNDTIRIANDSLEYEVIIIDNGFS
TWLVSRAYPRNYHSLSYLEQKNYLYVTEWNNRVLQPQRYNPDLYEMSINYRPDIHYGYEV
NYLIYNYMIYFQNTYKQKLWGYVPSR
>EGALAKHO_01446 hypothetical protein
MFEQLTQLVQQYGGDAVVNNTAVPNEHNEAVIGETSNSIFAGLQKIVSEGGAEQLAGLFN
GTSSIDSSNPVVQQLTQQVSGNLGEKFGLSNETSSGVAASMIPQILSSLVSKAKDPNDSS
FNISDIISSISGNSGQASSIMDTISKYGTQFGLDQNADGKLDVADVMVVAKTKGGIAGFI
GKIFGSK
>EGALAKHO_01447 Hydroxypyruvate reductase
MKVLANDGISKSGILALEKGGFEVITTKVAQEQVANFVNENNVDVVLVRSATKVRKDIID
ACPGLKIIGRGGVGMDNIDVDYAKSKGIHVINTPASSSESVAELVFGHLFSGVRFLHDSN
RNMPLEGDSNFDGLKKAYANGTELRGKTLGIVGIGRIGQATAKMALGLGMKVIAADSFIP
KVDIKVEFFDGQSITTTIESQSLESLFKEADFITLHVPAQDGYIIGEKELAIMKDGVGIV
NCARGGVIDEVALVKALDSGKVAFAGLDVFESEPKPEMAILMHTKISLTPHIGAATGEAQ
DRIGTELASQIISLLS
>EGALAKHO_01448 Phosphoserine aminotransferase
MKKHNYSAGPSILPQEVFEKASKAVLNFNDSGLSILEISHRSKDFVAVMDEARSLALELL
GLQGKGYQALFLQGGASTAFLMAPYNLMKENGKAAYLDSGTWATAAIKEAKNFGETVVVA
SSKDENYNHIPKGYAIPSDADYFHCTSNNTIFGTQMKEFPATNVPVVCDMSSDIFSRELD
FSKFDLIYAGAQKNMGPAGTTLVVVKEEILEKSGRTIPSMLDYAKHIKAESMYNTPPVFA
VYVSLLTLQWIKEKGGIAAVEKLNNAKADLLYTEIDRNPLFKGAAAVEDRSNMNVTFLLN
NADHTATFDALWKEAGISGLPGHRSVGGYRASIYNAMPIESVQVLVDVMKALETKV
>EGALAKHO_01449 hypothetical protein
MTLETKKSVFVELGKFLKQFSENDTAKESNVLHNDLFFDDFEKLIQLSQSHNGWYTPEQV
YFAIKSWADALTEENLDKWLSTYQNEFSQNTEDEKSVALILAGNIPLVGFHDFLSVLITG
NKALIKTSSNDQHLLPFLAKYLIAVDQNLKDKITFVEGKLENFDAVIATGSNNTARYFEY
YFKDKPSIIRKNRNSAAVLNGNESKEELEALGEDIFRYFGLGCRNVSKIFVPKGYSFDAF
FEAIFKNQDVIHYEKYANNYDYNKAVFLMSNFKLLDNGFLTIKEDSSYASPISSVFYEFY
ETIEDLQARLKADSEQIQCIVSNDLIENSIPFGQTQNPQLWDYADNVDTITFLLTTK
>EGALAKHO_01450 Ferredoxin
MAIIITDECINCGACEPECPNTAIYEGADDWRYKDGTSLKGKVILPDGTEVDADDAQTPI
SDEVYYIVPGKCTECKGFHDEPQCAAVCPVDCCVPDDNHVEDEETLLNRQAFLHG
>EGALAKHO_01451 hypothetical protein
MRGLLLLLFVVFVNTSIFSQNVEYSIVVKDIETQLPIENAIVLIMKTKQTLISNQDGKVT
FVLNGGSNIQVSETNYEKVTLRWGPLKPDMFVVYLKNNNNNLDEIVVSKEKPEKNLQKIV
SNSREKLATSYRLKVYVREFFMLDNKYSYYNDGLVNFQFEGNQKKATTTLLVEQNRSYGL
LENDVSADLMGYNLNNIMENYSNLKYFDPLLDSKTKKEYEFTTKGHPNNKEYYIMSVTPL
DKSKKALDTFEIIYDPIKKLIVEFSIIIAPGNLAQIEEQTKVGSKNVTRSQVKVTYRIDG
ENYYLLSSNEEIAYDLILKDQAKKNIQVRNNFITTNFNRQNFTYKESDVFKEKTLFNKQN
KILTKYWDISGFTATDEEKTIIDSLEFKL
>EGALAKHO_01452 TonB-dependent receptor SusC
MKKIVLLLLLLNTAFLFAQKEVKGTVKDKTGTALPGVNIVEKGTNNGVSTDYEGGFTIKV
KEGATLIFSYVGYTTVEKSASSSNLAITLDESGGQVLNDVVVVGSRNTKRTVVNSAVPID
VINVKDVTTQSGKLEINELLQYVAPSFNANKQSGSDGADHVDPASLRGMGPDQTLVLING
KRRHQSSLINLFGTRGRGNTGTDLNAIPAASIKRIEILRDGAAAQYGSDAIAGVINIVTN
DNVNELTGSITYGVFNTNAKGDFLPGTPNTKGFRLDQDGYGNSYGKDQSFDGGSIKVAAN
YGTTIGTKGGFVNVTGEFLNKNKTLRPSYDFRKGFGDAEIQGVNLFANLAIPISDKTEFY
AFGGSNFRNTDAYAFTRNDGERVVEEIYPGGYTPRITSKINDNSIAAGIRTETSGGWKFD
LSNTLGQNKFQYDIKGTLNASLEENSPTEFDAGGHSLLQNTTNFDVSKNYPDVMSGFNIA
FGTEFRVEQFKIFAGEEGSYTTYDTNGQPITDPTTQSAPIDPISGEPRPGSSQGFPGYSP
ANVVDESRTNFSLYTDAELDITEGFMVSGAVRFENYSDFGSTVNGKLASRLKLSDHINMR
GSISTGFRAPSLAQVYYNLRFTNFNASGATEVLLAPNNSPVTRAFGIDKLNEEKAVNASL
GFTGTFGDFTATVDGYYIKVKDRIVLTGYFDASSLNLGVSEAQFFANGVDTSTHGLDLVF
SWKKTYDFGNIGATLVGNINDMKIDEVKNGDLDADTFFGKREKAFLLASAPDSKFGLNLT
YSKNKFDGGLAFTRFSKVVLVDYADEDDVYNPRLVTDLTLGYRISKNLKLSIGSNNLFNV
YPTKQDEQGNTEAGGYWDAVQMGFSGAYYYARLGFNF
>EGALAKHO_01453 Ribosome-binding ATPase YchF
MKAGIVGLPNVGKSTLFNCLSNAKAQSANFPFCTIEPNIGVVNVPDPRINKLEELVKPER
VQMATVDIVDIAGLVKGASKGEGLGNQFLGNIRECNAIIHVLRCFDNDNIVHVDGNVNPI
RDKETIDIELQLKDLETVEKRLEKVNRAAKTGNKEAQTEKALLDRIREALLQAKSARTIT
PQGNDEEVLMESFQLITAKPVLYVCNVDENSAVNGNKYVDQVRELVKDEDAEVIILSVGA
EADITELESYEERQVFLEDMGLTEPGASVLIRAAYKLLKQQTYFTAGVKEVRAWTINIGA
TAPQAAGVIHTDFEKGFIRAEVISYEDYVQYGSEAKAKEAGKFKVEGKEYIVKDGDVMHF
RFNV
>EGALAKHO_01454 hypothetical protein
MLKKSFKFLGWTILGIITFLVLYLIAMYLISKITVNSDIAKVDEKEAIPIYILSNGVHTD
IVVPVANEIKDWRNKIQFSQTQSKDSLATLVAFGWGDKGFYLHTPEWSDLKASTALKAIF
GVSSSAMHTSFYKSLAENENCKRILISKENYKKLVVFISDSFNNPTNPEWIEGYSYGKKD
AFYEAKGSYSLFYTCNTWANSALKAANQKASLWTVYDKGIFCHYQ
>EGALAKHO_01455 hypothetical protein
MKKIFIILVLIVLVVSCKKVRIRPCPDCFIFYFENPQPENDTELDHFPVRFRGLYIDKDS
SFLRIKEDRMIYKYFGTYKIHKIEFDSIKEEFMIIGNEATNKTTHEKSVIHIKGDSIEFK
ETFLDTFFRLSYYNKLKRIDGQLVLSKKDSIFWTIEIMSLNNKTLKIKEIYLPGDLKKLD
SITEVKGEKLDSMSYLIKPTRSEFKKILRIKKMGTDSEYKRISK
>EGALAKHO_01456 hypothetical protein
MRIKNIFAKSWFLLKNTFLEFNDDNAIKLSAALAYYTIFALPPLLIIIITICGFFFGEEA
VTGELYGQINGLVGNGAASQIQEAIKNVELSGDNMFATVFGIVMLLIGASGVFAEIQSSI
NFIWGLRAKPDKGIKKFIQNRLMSFSMIASVGFLMLVSLLISTTLDLLSSRLKVYFPEST
VYLFYVVNIVIVLASITTLFAIIFRTLPDGKIRWKDAFIGSGVTAVLFMIGKFAIGFYLG
SSTVASVYGAAGSVIIILVWVYYSAIILYFGAEFTKVYAKSYGGKIYPNEYSVEIAKEIY
EIDEPKKEPIEETLQKEKP
>EGALAKHO_01457 Chromate reductase
MKIIAFGGSNSTQSINKHLATYAAGLFENAEVEVLDLNDFAIPLFSVDLEKEVGQHDLAK
AFLAKLGSADILVVSLAENNNNYSAAFKNVFDWSSRIMKEVFQQKPMLLMATSPGSRGGA
SVLEIGRNALPRYGADIKATFSLPAFNANFDLEQNKILNAELDKELRDLIKECF
>EGALAKHO_01458 hypothetical protein
MKIKKIFFLFLFLSVFFLHSSHAQKYSAVDKIVLKYPKNFDTTEELAQRIEKDFNSDYDK
ARAIYSWMAFNMKYDFNAFLNPPRTQSFSYRNEAEKQRKIQDINNKMLQKAFNSKKAVCE
GFTLLYQHLTALVGIKSEIIRGDSKVRLADIGRKNTTSNHAWNTVLIDGKWRLVDVTWGQ
GYYDSSKGRMVKDFEPAYFDTEPDYFFAKHFPDSGSYLGHKLSKEDFLNGPLIYNKAIAG
DNKIITPESGILQVKNGDKITFQIKNISKVSQFYYLNKKNQAVRVVNAKERKGGLEFQIT
FDNTIGDYITFFLDTNSIASFKVTSK
>EGALAKHO_01459 Nicotinate phosphoribosyltransferase 2
METTFLKSILDNDFYKFTMQHAVIRLFPKAKVRYGFINRGKHIFPAGFSDLLRKSVDAMA
DLRLTKDEKHYLSHHCPYLDPTYLDFLQGYSYDPSEVHISQEGSEIKVTIEGFWYRTILW
EVPLMALISELFYKANHLIRLNDQAIKELTKNKIDNYNKLGVSILEFGTRRRHSYDVHIL
VNETLSAYGSQSFMGTSNVHFAMVNNKRPLGTHAHEWFMFHAAQYGFKMANLMSLEHWTQ
VYGGDLGIALTDTYTTEIFFNQFDKKYSKLFDGVRHDSGDPIAFAQKVINHYTKMGIDPK
SKVIVFSDSLNFDKVKTIVDFCKDKIKMSFGIGTNFTNDVGLPSMNMVIKLTDTKPDNTH
WQGVVKLSDEKNKNTGTPEMIALAKEVLGIKS
>EGALAKHO_01460 DNA gyrase subunit B
MLEQNQYNEDNIRSLDWKEHIRMRPGMYIGKLGDGSSPDDGIYILLKEVLDNCIDEFVMG
SGKTIEVTIKDKTVSVRDYGRGIPLGKVVDVVSKMNTGGKYDSKAFQKSVGLNGVGTKAV
NALSNYFRVESVRDDKQKAAEFSGGNLVLEEDVIETTKRKGTKVTFTPDETIFKNYKFRM
EYVIKMVKNYCYLNNGLTIIFNGEKYISENGLRDLLEETISEEDLEYPIIHLKDHDIEIA
LTHSKTQYSEEYHSFVNGQNTTQGGTHLAAYREALVKTIREFYNKNFEASDVRKSIVSAI
SIKVMEPVFESQTKTKLGSTDMGSDDGTPAVSVRTFVNDFVKNKLDNYLHKNPQTAEALL
RKILQAERERKELSGIRKLATDRAKKANLHNKKLRDCRAHLPDTKNPRNLESTLFITEGD
SASGSITKSRDVNTQAVFSLRGKPLNSYGMTKKIVYENEEFNLLQAALDIEDGLEKLRYN
NIVIATDADVDGMHIRLLLITFFLQFFPELIKEGHLYILQTPLFRVRNKKETIYCYSEEE
RRDAIEKLKPKPEITRFKGLGEISPDEFKNFIGETIRLDPIMMDKNTSIEQLLSFYMGKN
TPDRQEFIIKNLKVELDAVEEI
>EGALAKHO_01461 hypothetical protein
MINKISFKNYKGFKEKQTLELKPITVLFGKNNSGKSAILKLPTLIAGSLGGNFSLPFQQE
NEGVKIANEYKDIVYGRTFKEVEFEVFQKNNVSDVEDFLRTEIFIDDNEPIIESWNCNNK
FDLLRNEGSNYFDSKTNKSYEVHFEGINLKSIDSIGERDIQLPIFKINTDFIGAIRQEAL
QNYSYSSIIPEKSGTDGNNLYQFLIEDYQTTNKFFFTQISEWIKEKFEGWELKIEVDGYK
KEIPALIKLQKKKLDINISQTGMGISQVLPLIIRAYKPCKEETLIIVEEPESHLHPYAHA
QVAQLFFESLELDKNKKYLIETHSQNFILRMRRLIAEGKLDPKEFSLYYVEFDEDKNESI
LQPIEVDEFGRVDTWPDNIFGETLEESIGIRTAQLEK
>EGALAKHO_01462 hypothetical protein
MWFELKNDLFSTANLENLRKLINDLCYKHKYNFFVDISTIEDQDIFDKIYPENTQIIIDY
YDLYITKSPKNIITISNIEGDFNIDEAIIFIEEKFDLILENDKYDGYFVDCLLREFNNKS
KKIKRFKENNWFRYHNAGGADNIINTLEQKIGHFGNNKFLKCFVLVDSDLEYPSNENQKR
KRLSEFCYENRIPFHILEKREMENYMPINVFESINSTNFFIRTYLDKLNCMQKDFIDIQK
GFGRNRVKIKEEKIEVFNLFSDLLDDDFKKLETGIESEFENYKRDYPKLFDKATQEGLIK
RTKKQDDPDELRNLLIKIDKLL
>EGALAKHO_01463 hypothetical protein
MKSELKIETRVRSLKNYIDEFENGVFQIPTFQRDFLWSSDDIKQLFDSIKNSYPIGSIQF
WQPLENANDWIGERPIGPYTILRQETQNPIFILDGYQRLSSLFGCLVNPEKFNKEKLKFD
EELWKEKFNIFYDLEDQEFITLRKGGKNKTYQIPVYLLLSASDFRKYAREIIEKIEDKNK
IDIYLDRADQLADIFNNYQIASVDIKYATIGEAVEIFWRVNAKGLEISKDWIVNALTNKN
GFRLQTELDLLIENLELYNFNKIKRDLLFNCIQSSFGKLYYDTNIETLIKDPIFNFIKTA
EKTISSIPKAVKFMFENLHIVHHKLLPSNWQFIFIVEFFNIIPVPTDDEIKELEEWFWFT
AYSNYFTIYNPSKRSKAFIQFRSYLLMIENELIYNDEPLLGFSSPKYRYSHFGSVRFTTN
VLFQLKPFKISAENCLGFETIKLYKEKPESLENMVYLPIFIKDNIFTLNNKKHKDLSFLL
NSEYRGQFSELFITDDMRDAYSDLDDDEVLKLRYKLIVEKERYFVKEVLGIDYIK
>EGALAKHO_01464 DNA gyrase subunit A
MKDEEDDNIIPNDEENNSEENPLDENQEGDEIIDVDARHFEGQHFYENQEEEGDDVITKV
TGMYKDWFLDYASYVILERAVPAIEDGFKPVQRRIMHSLKELDDGRYNKVANVVGHTMQY
HPHGDASIGDAMVQIGQKDLLIDCQGNWGNILTGDGAAASRYIEARLSKFALEVLYSPKI
TDWGVSYDGRRAEPNNLPVKFPLLLAQGAEGIAVGLSTKVLPHNFNELIDASIKILKGKP
FTLYPDFMTQGIADVSNYNDGLRGGRVRVRAKIAQLDKNTLVITQIPFSTNTTTLIDSIL
KANDKGKIKIKKIEDNTAADVEILIHLFPGVSPDKTIDALFAFTACETSVAPLGCVIEDN
KPLFIGVSEMLKISTHRTVDLLKQELEIQLEELKNKWHFSTLEKIFIREEMYIEFKLYSD
RESLYKYLYDRFEPFKKSFVREINDDDLQRLTQIPMIRITRFDSDKADDFISKLEEEMKE
VEHNLANLTDFAIAYFTKLKEKYGKGRERQTELRVFDNVEATKVVLRNTKLYVNREEGFV
GTSLKKDEYLTDCSDIDDVIVFLRDGKMIITKVDAKTFVGKDIIHVAIFDKSDKRTIYNM
IYRDGKSGPSYIKRFNVTGVTRDKAYDLTNETAGSQVVYFSHNPNGEAEVITILLRQVGT
IKKLKFDIDFAKLAIKGRASKGNLVTKYPIKKIELKEKGISTLLPRKVWFDDTVKRLNVD
ARGELLGEFKPSDKILIINQTGKLKVIIPELSTHFDEDMIVLEKWNPKKPISAIYYDGEK
ERYFLKRFLVESEGKEESFITDHPNSQLEIVSTDYRPLAQLVFAKVKGVQKEDLHIDVED
FIAVKGFKALGNQLTADKLKQVNLLEPLPYEEPVEEVPETPEFSDDDSVETELDDDGQIG
LVLE
>EGALAKHO_01465 DNA polymerase III PolC-type
MSLLNFWKKEENLFDKNSTIEETRFVVLDTETTGFDYENDRILCIGALVLQNGVIAVQNS
FEVYIEQDHYDKSTAQIHGILKAFVLKRPSELEALQQFLDFLGDSIIIAHHTVFDVTMIN
KALERNGLPELKNHRLDTAFLYKKTLIKSHLFERKDHYTLDDLADKFDISKQDRHTALGD
AYITAIAFLKIVKKLREKKEVNLNSLFK
>EGALAKHO_01466 Inosine-5'-monophosphate dehydrogenase
MKNTISHRVADFLKDFPPFSFLHKMDLEKLSEQISIIYKDKDAVIFAENEKTHDSFYVVH
KGAVALKKSTKNTVLDMCDEGDIFGLRPLLAQENYIMEAVAHEESILYAIPIAVFKPYAL
ENRTVGNFLIESYASNTRNPYSDIHKDKLYGDDDDHNTMHSHTNSFDLTPIKYSKKIVTC
SPSTTVRDVAKIMNKKKVGAILIVDEMLPIGILTDKDLRNKIVTGEYSIMTTAETIMTKP
VITYPKKMTVTEAQMAMMKSNISHLCLTKDGTVNTKAVGILSKHDVMVALGNNPAVLIKA
LKRAKKIKEIKPIRNRIMQLLQGYLDQNIPMTLISKIITELNEACTTRVIEMCIEKMSSP
PPVKFAWLALGSQGRSEQMLHTDQDNAIVYENVSEVFRDETRIYFLKFAGLVNKGLFEIG
YDYCPAEMMASNPKWSMSLDEWKSQVHHWITNPGKNEVLLSFIFFDYSVTYGDTEIASQL
SDSIFENVKANPIFYVHLVSGALQSPSPTGFFRQFLVEQDGANKDNFDIKRRALMPLTDA
ARVLILSHSVKGISNTAERFEKLAELEPTNSELYLSCSYSFKALLKFRTKQGLLHHDSGQ
FIALESLSKMEKIKLKRTFKTIKELQELISVRFNVSNVV
>EGALAKHO_01467 hypothetical protein
MKKIIFLLPLITLFSCYDAEHNCKDFKNGKFKFEFEVKGVKKTTFFERKDNIEIETFDGK
TDTSTVRWVSDCEYILQKKHPKNMAEEKAISMKILTTSKDSYTFEFGMVGSEEKQRGKVF
KVE
>EGALAKHO_01468 hypothetical protein
MRHTLLTDIGGFLYWIIFKFCKTDLKEEQSKNNWSRNIFIFIVALIIMFFLSVQLKK
>EGALAKHO_01469 hypothetical protein
MEATQSYLESVKKQFLYYKMLGEKAMDQLEPEQLFVSINEDTNSIATIIKHISGNMLSRW
TDFLISDGEKEWRNRDAEFENDLQSKEEVLEAWNKGWHCFLDALNSLNSEQLSDIIYIRN
EGHTVIEAINRQLAHYPYHVGQIVFYAKQLKNSDWESLSIPKNKSGNYNAEKFAKEKEIK
NFTDDELKRLK
>EGALAKHO_01470 Pentapeptide repeat protein MfpA
MEGIIHIQKTFEKVIYIDKKINNREFEDCVFKNCDFSNSNFAYNTFLDCEFIDCNLSMTS
LAGTNLKNVTFKNCKLLGIAFNECDDFLFQVYFEETALDYAIFSNKKMPKTKFINCSVRE
VTFIGTNLTNSVFDNCDLDGAIFNETQLAAVDFRTAYNYKIDPEFNPMRKAQFSNQGIVG
LLDKYDIKIV
>EGALAKHO_01471 hypothetical protein
MGKKIIWSKDALDQLEDIHFYIFFESKSITIADKVVNTIFESTEILKTQPEIYKLDKQKT
NNDGSFRVYSVYDYSISYQINNDSIYILRVRHNARKSKKHSWKV
>EGALAKHO_01472 hypothetical protein
MDIQAEINWIHQEIDKVKDPSFVEKLKHLLQSINNSTVDSDASYNLDIENALENIKKGNF
YTEDEAKEIAKKWGRK
>EGALAKHO_01473 hypothetical protein
MATNKELLGKGIKYLSGSLPLLFIGPSLIYNAFMNQHTNWHYLVLGIGIVACLSAMFLIF
YGLKIIMKGLFND
>EGALAKHO_01474 N-acetylmuramic acid 6-phosphate etherase
MTLLLKFQDCKKNSNFDTSNNSKKMTFTKTTEQASKYEHLENMSVHELLTNINQEDKTVP
DSVEKVIPQIEALVQQVVAKLKLGGRIFYIGAGTSGRLGVVDASECPPTFGVPFDLVNGI
IAGGDTAIRRAVENAEDNAEQAWLDLKAYHISEIDIVIGIAASGTTPYVIGGLETCNQNN
IVTGCITCNAGSPLALTAQFPIEVVVGPEFITGSSRMKAGTAQKLVLNMISTAAMIQLGK
VKGNKMVDMQLSNIKLVDRGVKMIMGEIPVSYDDASELLKKYGSVRNAVDNYIK
>EGALAKHO_01475 HTH-type transcriptional activator RhaS
MDKLSLLQGIGKISVFVSLLLAFFLLTVKTENKLANRLFAWFFIFSAVDLSGFFIDAVTR
TGLNWEIFKSTACLFEMPLFYLFVLAVCYSDFRLQWKHLIHLLPFIVVNLVFIPRIYLNL
DTDKDAFLSTFNQLPEIYFVQILIEFQYAFYIISVFLILKKYREIYLENYANSSTATYKW
LFQITCVFLTAHSIVALKNLLRYSGFREVFLWANVLVGSIALFITCWFIMKALNHPELFR
GVNSKLKLTKDILPEVEDKSSSSNVQNDVINSQISSLKQYMAEKEPFLDPSLTIQELANQ
IEIPVRDLSVLINHKMDQHFFDFVNEYRIQKAMNILKDESKNQLTVLEILYEVGFNSKSS
FNTSFKKYTNLTPTAYRNAS
>EGALAKHO_01476 hypothetical protein
MKTSNLLIFLLLPFFCLAQASFKLKGKIASETASLEWADISILNSEGKIIDGTTTKQDGT
FEINLKKGSYKIGASLLGFEEYEKEISIERDTDLGTIILKENATNLVEVVVQSKKKTIEQ
KTDRLVYNLENNVTNVGGDALSAINTAPGVVVKNNTITILGKGTSRVMIDGRMIELAGEE
LNNFLKSISANDIKNIEIISNPPAKYEAEGTGGLINIIMKKGVRDSWKNTATASYDQNKY
GIFTLRDNFFYNKKKFRFSASVNAKTGYLNATDDLKMYFPDGLSHMSSITKLKTENLSGK
IALDYDFSERTTVGFQFMNDRNNPDFKSDITINNYNTQNQLDNITLNKSNTDRGSGNQTY
NAHLITKLDGLNRKLSFDVDYFNYDSKFDRSFIANNYTPEMIFVDVNQAGKNISTQDIDN
WSFKADMEHPFQAINLSYGAKMSFTNSISDVLYYNTISGNPELDPNQSNRFIYTENNQAI
YVNADKKLNEKWNFQMGLRLENTQTNGFSETMNQTTENNYLKLFPTVYASYKKNENNSFS
LNYGKRINRPRFDLLNPFRIYINSNSYSEGNPFLKPSFSDNFEFAHSYKEILRTSVFVNS
VTNGYGVLFSANPETNTQIVTRENYFKNLSYGVGESYSATFADWWQSENSLYFLGAKTEF
IKDLNATPSNSLQIDFSTNNTFVLGKTTKLQIDFSYTTPFKSGLYEVGYASSFDIGFKQD
LFNKTMQIAFLANDIFNTAYLKDFTSVVNGVKQVYSQTESNRFVRLSVVYNFGNKKINVK
ERAFGNQDEKKRTGN
>EGALAKHO_01477 hypothetical protein
MNYLLPLFSVLLGYAVALFLKPSNKTNLKLLLAFSGSFLLSLTVMHLLPEVYESHNHNIG
LFIMVGILFQIILEFFSKGAEHGHVHGHAQMSQIPWLLFISLCIHAFLEGFPVSHHHGLA
LGIAIHHLPIAVILTTFFINANLNKKAIFAFMLTFAIMTPLGTIASEYLPILNAYYTEIT
AVVIGILFHISSTIIFESSEGHKFNVAKVSMIVLGILLAFVL
>EGALAKHO_01478 Glycine/sarcosine N-methyltransferase
MSEAPNSSTPNQERNTENWFTSWFDTPYYHILYKDRNYREAQIFMDNLTHYLNLPEKAKV
LDLACGKGRHSIYLNQLGFDVLGADLSENSIAEASKNSNETLHFKVHDMREPFEEKFDAI
FNLFTSFGYFENDDDNLTTLKAIKESLSEYGFAVIDFMNVAQVIETLVPEEVKTVDGIDF
KIKRYLEDGHIFKEIDFEDQGHQYHFTEKVKALTLKDFEELMAEAGIFLLDIFGDYKLKK
FHKTESERLIMIFK
>EGALAKHO_01479 Ribosomal RNA large subunit methyltransferase L
MEENFRMIAKCFFGFEEILEKELRDLGAQDVEKGVRMVSFKGDKGFMYKANLSLRTALKV
LKPIYSFRANNEQALYKGISGVNWSKLLNANQTFVIDATVHSTYFNHSEFVSQKCKDAIV
DQFRERTGQRPSIDKAFPDLRINVHIDKDQVSVALDTSGNSLHQRGYRTATNIAPINEVL
AAGILLLSGWEGQSHFLDPMCGSGTFLAEAAMIACNIPANINRKEFAFEKWKDWDNDLFD
QIVNSLMKKTKEFHYTIKGFDKAPSAVNKAKDNIKNANLEDYVTISEDNFFDTEKAVEGK
LHMVFNPPYDERLDIHMEEFYKNIGDTLKKSYPGTNAWFITANLEALKFVGLKPSRKIKL
FNASLEARLVKYEMYEGSKRTKFQV
>EGALAKHO_01480 hypothetical protein
MTKLQVRGFLYQLGCFAILFIAGRFVIANYTQLTGIWIPMTSFIVATLIAPKFQAVKTKD
GEKLFMKWIFIKGIREIG
>EGALAKHO_01481 Aspartate racemase
MRKIGLIGGISWVSTADYYKLINEGINEKMGGLNFSECLIYSFNYSDIKKNNEANDWDST
FEMLFKGCQFLKSGGAEAIVLCANTMHLIADRLEEAIDLPLIHIATATAAEIQKQEIKKV
GLLGTKFTMELDFFTDKLNAKGIEAIIPESQEDKDFIHTTIFEELGRGLVTAETKKRYLE
IANQLIEKGAEGIILGCTEIPLVIKPGDLSVPIFDTTLIHSNAAIEFQLS
>EGALAKHO_01482 hypothetical protein
MKHMLKYFFSICLLFSVFWGYTQETSTTTATKETVPVKPKTEAAKPDIQEVKPDSIKTDR
YGLRVGVDLYKLTRGLYDKDYKGIEIVGDFRLTKKYYLAAELGFEDKTTEDDRLNSTATG
TYIKGGFDYNLYQNWLDMENLITIGLRGGFSTFSQDLNSYKIYNPNPYWGEKPSIISDKK
YNGLTAGWFEVAMGLKAKVFNNVFVGFGVQLKMLLVNTKPDGFDNLYIPGFNRTYDGSFG
IGFNYTVSYFIPIYKKKTVIPTIKKDQTKK
>EGALAKHO_01483 hypothetical protein
MKKIISLLLIFTFGLSSCEKDDICDPDTPTTPRLVIKFYDINNPTVPKAVTGLKVIGEGK
SETNEAIIFNENAIGEAKYLTNGNTISIPLKTDANSTSYTLILDSQNPNAAAINKDVIKF
NYTHQDLYVSRACGFKTNFLLDAQDDTTTPPKVPFVQADVDLRGLWMQRVRVIEYNIENE
NETHVEVFF
>EGALAKHO_01484 23S rRNA (uracil-C(5))-methyltransferase RlmCD
MGRKNTDKVVFHQIQVLDAGAKGVSVAKAPDGKVIFIPNVVPGDVVDVQTFKKRKAYYEG
KAVKFHELSEHRIEPICEHFGVCGGCKWQNMKYSQQLYYKQNEVKNHLQRIGKVELPEFE
TILGSEKQFFYRNKMEFSFSNSRWLTEKEIGSTEDLGNRNALGFHIPKMWDKILDIQKCH
LQEDPSNAIRNEIRDFANEHNLAFFNPREQSGLLRTFMIRTASTGEIMVLIQFFENDKKN
RELILDHLYEKFPQITSLQYVVNSKQNDTIYDQDIKLYKGRDYILEEMEGLKFSINAKSF
YQTNSDQAYELYKITRDFAGLTGTETVYDLYTGTGTIAQFVSKKAKKVIGVESVPEAILD
AKANAERNNITNCEFFVGDMKVVFNESFIAQHGKPDVIITDPPRDGMHAAVIDQILKIAP
KKVVYVSCNSATQARDLALMDEKYKVTRVRPVDMFPQTHHVENVVLLELR
>EGALAKHO_01485 Adaptive-response sensory-kinase SasA
MNLYHNLSQISFLKKSYAFKFLFVAFIGIHIPLIGILFFVLFYSHNISPASILIFALIMT
LLATAVTLLILNQLIKPISKASKSLDDYRNNRKLSVLPTEYTDEAGLLMCNIQESIYEAE
SFINEKQDLIYMLSHDLKNFAGNPQGLAKLILSENPSESIRHLADLICESTNLQFRYIEN
FIKLLNEQDQVVKFNQEPREILFPNILPFINEQVEQRLIDKNIKLSLSLETESAILKIDE
GLLIQVIVNLISNAVKFSYFDSEIKVRIYNEDSRLLITVVDRGIGFNKNQIEELFKKFTK
MSRLGTANESSTGIGLYLCKKIIERNKGTLTASSEGKNRGAEFKIEFDL
>EGALAKHO_01486 hypothetical protein
MLKKSKFKEWFDRYKYAELASTSAALTASLFSKIYSGLTTAYIITFSEYLAFYSVIFISS
YKKLALQNKALNRVTTFKEILLLLKNLVLEFGYPAFLDFLVIRPFCMYWIPILFGNYFFG
IIFGKISADLCFYFFTIVNYEIIKKRKN
>EGALAKHO_01487 hypothetical protein
MYQNIISLSLVNTKSCTDSREWDFTAIGSKSCGGPTDYIAFSKKIDKTEFLGKVKAYPDA
QAAFNVKWNIFSTCNILLPPTAVECFDGKPRLSYITLFEN
>EGALAKHO_01488 hypothetical protein
MKKLSFIVFAFAFCSLFASCSANSDELSMEEESQKLDARYNEIIGLSLMNSQPCTNPDEW
EFVLISTGNCGGFKGYIPYSKKINKTDFLAKVQKYIHDRGAFYSKWGLVASCAPTDPPTG
VECVDGKPTLIF
>EGALAKHO_01489 General stress protein 69
MNYRKLGKTNFNISEISLGTWQVGGKWGSAFDNKTADELLNTAIDNGVNFIDTADVYENG
LSETAVGRVIRSRSERIYVATKCGRQINPHVNEGYQPKVLQKFVEDSLKRMNLETLDLIQ
LHCPPTEVYYRPEIFEMFDRLKDQGKILNLGVSVEKVEEALKAIEYSNVTTVQIIFNLFR
QRPSQLFFSEARKKDIGIIARVPLASGLLTGKFDAKTTFEPQDHRNFNRNGDAFDKGETF
SGIDYNLGLKAVEKLKALFPEATNLAPIALQWILNFDEISCIIPGASNANHVLSNLSVYD
LPKLTLEKISAMNAIYEEYIKPSVHHLW
>EGALAKHO_01490 Cysteine synthase B
MGPQKLLNLIGNTPLMETVNLVKNKNVKLLLKLEGNNPGGSVKDRAAYNMIASALERGDI
KKGDKLIEATSGNTGIALAMIAQLFQIEIELVLPEDSTKERTQTMRAYGATVILTPASEG
IIGSRDYADKKVAEGGYLMLNQFANDDNWKAHYKTTGPEIWNDTEGTVTHFVSAMGTTGT
IIGTSTYLKEKNQAIQIVGAQPSDGSQIPGIRKWPQEYLPKIFDASKVDTVIDVSEEEAR
AMTKRLALEEGVFAGMSSGGSVAVALKIAEQLESGVIVAIICDRGDRYLSSDLFD
>EGALAKHO_01491 Serine acetyltransferase
MPRNLIIQNIKALKSHSNINYGIKTKTEDFTEKLFYTLFDSNAPLDQSIDELEVRFKEIA
VLACKKPENLCESIWDRFLEKLPGVLEKLNQDAEYILENDPASNSIDEVYLGYPGFYAIA
IYRLSHELYLLDLLLFSRLMSEYAHRITGTDIHAGAKIASPFFIDHATGIVIGETTVIEK
HVKIYQGVTLGALSVSKEMKNAKRHPTVEKNVCIYANATILGGETIIGKNSIVGGNAWIT
KSIPEDSIVLNTTTTEVKIKEKK
>EGALAKHO_01492 hypothetical protein
MKNNSTFKSAISNLEFPESEKIYRKSIHDPVLGLITKDYPSFCDTDCIGVQELNVYRQKY
ISNYLSAEMGALSDLEKNVITSLKEDKSIVSIVEDEEETRSFGQKIADQVADFGGSWTFI
ISFLAFIVVWIASNVYILVNKGFDPYPFILLNLILSCIAALQAPVIMMSQNRQEEKDRNR
AKKDYMINLKSELEIRMIHDKIDHLIMHQQQELIEIQKVQIEMMNDILNQVKK
>EGALAKHO_01493 hypothetical protein
MILAISVALYEQVSEEKNIYIMVIAIAVFMYGMMQLSAKTPSKNQDKEEKDAD
>EGALAKHO_01494 Endonuclease MutS2
MLTKGDKVSVLDEAINGIVVSVKNNEVLIETEDGFMMTFFVNELLKIHDSSNLMNSIKRI
DLDTISKEKEEPKARSFVKEKKDKREISAPEFDLHIEKLVPNKRAMSNYDILTLQTETAK
RHIEFAIRNRIPKIVFIHGVGEGILKAELDFLLGRYDGVDFQDANYQKYGLGATEVYFRQ
NNK
>EGALAKHO_01495 hypothetical protein
MKKYVSLLLFALLLNGCDDGDLTVDTIDFDEVTSTSCDTTNTLIYKLKTQEALLLQMLPK
SIINEDKDTIVYNIDDTNYRVLYRAYNGTVAKENICGTIPPKTPSVTEEWIGIAGKIQIA
TAAVYKTPAPTDGHTEIIGYNHNIIFKNITFSKPSGPQVEVEYPFGDFKTDVTPIVVNFT
NPDVAKQCTITNKVFNDNGITSLAIENFDTATLFVNEPTPVGQPRKGLINQNNKNNLFYK
VYATLLPTKTEDYICAATPPSSPIVRDTWVGVDGVQNVSGIIEVTTTTAVNTFYHKVVLR
NVTLKKGNNTFKLATEFSLGTVTITP
>EGALAKHO_01496 Cysteine desulfurase IscS
MIFKNSQLIFHNFASMKKVYLDNASTTAMRAEVIQEMTKVMAEDFGNPSSTHSFGRNGKT
ILELSRKSIAKHLNCSAQEIIFTSGGTEADNWILRSAVEDLKVERIITSKIEHHAVLYTV
LALQSDYNIQVDYVKINTDGTIDLTHLSNLLSEEKKTLVSLMHVNNETGTILDLDRVSVI
CKQYNTLFHSDTVQSVGKTEIDLQKTSVDFIVASAHKFHGPKGIGFAFVRKNSGLQPLLF
GGEQEKGLRAGTEAVHQIAGMAKALSISYDNLGREREYISDLKTYLIEQLEIHFPEFRIN
GKKDDFYNIINIILPFSSDKTSMLLFSLDMKGIAVSRGSACQSGSIKPSHVLKEMLSETD
LKLPNLRISFSHYNTKEDIDWLIESSKNL
>EGALAKHO_01497 Threonylcarbamoyl-AMP synthase
MNEEIIKAYEVIKEGGIILYPTDTVWGIGCDATNPEAVAKIYKLKQRAETQSMIVLMNGE
KMMYNVFKNIPEVAWQILDLSEKPTTLILDEPRNVAPNIIAADNSLGIRIVKEPFCFKLL
ERMKKPLVSTSANISGQPTPIAFKDINPEIVKGVDYVVNLYHDKVAGKPSTIIKLTKDSQ
VKVIRK
>EGALAKHO_01498 hypothetical protein
MLKNSVKVVIPVYKDHFGELEEKSFLQCCKVLKDYEIVIVHPEGLNHSYISTKGDNITTK
SFPKHYFNNIDGYNELMLSPVFYESFLDSEYILIYQLDAFVFKDDLKKWCEKGYDYIGAP
WLATSTTSLGMKLFDGIARIFRSKNRKDREQTFFKVGNGGFSLRKVASHYTITNNKKEFI
SESLNAKEKKLYAIEDVFWSMKAPEFAPDFKIPNYKEAVYFAIDRKPKIGMKLTNNELPF
GCHSINKPKVVHFWNPIISQY
>EGALAKHO_01499 hypothetical protein
MIKIFVVTHKENPLLSNEVLVPIQVGTNETIAKDILRDNTLDNIATKNGNYCELTAAYWI
WKNVKDADYVGICHYRRYLNFYNDWYNLKPSAQKKIKTEDFKNTKLYNSSSDKLEKKIAS
ILSEYDVILCRPYTFKDTTLTKNYCDDHRIEDWNLTKKIILEKYPEYEDSIVNYLDEGTT
FHIGNMLITSKEKFDAYYSWLFSILFELESKIEIPEDAYQARIFGFISERLINLYMYHNK
FKIKGIPSFKIIDL
>EGALAKHO_01500 UDP-galactopyranose mutase
MKKQYDYLIIGSGLYGSVFAHEAKKAGKKCLVIDKREHSGGNVYCENIEGINVHKYGAHI
FHTNDKGLWDYVNQFVEFNNYINSPLALTKDKLYNLPFNMNTFYQLWGTKTPEEAKAKIA
EQVAIYGVENPKNLEEQALTLVGKDIYDNFIKEYTEKQWGRKATELPAFIIKRLPVRFTF
DNNYFNDTYQGIPIGGYNKLIDGLLKGIDVEINSDYFSDREKFNDIADKIVYTGKIDEYF
DYKLGVLEYRSLRFENEILDTDNFQGNAVVNYNDATYDFTRIIEHKHFEFGKQNKTVITK
EYPQEWNPSNEAFYPINDDKNQKLFEDYKKLSLKEENVIFGGRLSEYKYYDMHQVIAMAL
TQSKKELKND
>EGALAKHO_01501 hypothetical protein
MIGKIQVGYLVSYDYELLKNALPTTYKDADTVFLAIDKNRKTWNGGSFEIDKSFFEWLEN
FDVDKKVVLYEDDFYVPTLTTMQCEIRERKMLSEKMGIGNWLIQIDCDEYFIDFKKFVSD
LRKYDSYLKDPLKKTVQVAVFWIILYKYTPEGILYVDKPTKAIFATNNPEYRVGRRVKGQ
VIYTNNIVLHESLSRTEEELRFKFENWGHNKETNKDFLNKWIAINENNYKEYKNLYYIEP
KRWKRLDYFPTKDIKTIRNIVEKSGSLNISKVKLVYKNFEQWFKYLLK
>EGALAKHO_01502 hypothetical protein
MIKIKKLKKSIILNTSFITNHKELIDDIENFDSKGTLFGNGDRNKIKLFEIDDKTVNIKS
FKVPHLINKIAYKYFRKSKARRSYEYANALLKVGIGTPSPIAFLESFSLLGLEKSYYASE
HLTCDLTYRELVEIPNFPDHDNILRQFTRFTFDLHEKGVEFLDHSPGNTLIKKVTENQYE
FFLVDLNRMNFHDNMSFEQRMNNFSRLTPQKGMIAVMSNEYSKFYTDKTEDEIFEKMWQA
TSDFQEEFARKKRLKKKLKFWKKS
>EGALAKHO_01503 SPBc2 prophage-derived glycosyltransferase SunS
MILPEKQLLTALVITYNEQQNIKIVLDYLAFADEIIVVDSFSSDQTFEIASDYKNVQVVQ
RTFDNFASQRNYALSLASNSWILFIDADERLTPELQQEICTVIQQKNSASAYYMRRNFMF
QDKKLRFSGWQTDKIIRLFRKENASYNIQKIVHEKLIVNGKIGKLKNRLIHYSYSNYEDY
KQKMIFYGQLKAKEELLKNTNPNFFHFYIRPAYQFLNQYLVRFGFLDGKKGIIICYLNAL
SVSVRFQELKKMRTKS
>EGALAKHO_01504 Lipopolysaccharide core heptosyltransferase RfaQ
MIGDVLISSIICNNLRTAYPDAQIDYLVYASTTPVLEGNSSIDNIILFEEKHRKSKKELL
NLGLQIRKEKYDLVIDAYSKLESWILVLLSSAKRKISYKKPGRTFLYTDNVPFEPFPKTN
LGLAIERRLSLLEPLNLKVKIDPIPKLFVSEKENQEATALFEKHNVRKDRKTVMISLLGS
ETLKTYPLEFMSKVVDYVADTAAVNILFNYFPKQIEEAKTVFNTCKPSTQEKVYFDLLGG
DLRSFIGLVNQCDLIIGNDGGAINMAKALKKPSFIIFSPWIEKKIWATFEDGIHHLSVHL
KDYRPELFEGKTEKILKKEALSLYQEFQPEFFKDKIELFLNQNLSASVK
>EGALAKHO_01505 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase
MSFIILNHNDKKIFIKFKTKSYICNIIKRFYFSAFPQIRYLCQKLKLMNSLQTIIEQAWE
NRALLQETTTTDAIREVIELVDAGKLRCAEPVGDKWQVNEWVKKAVVMYFPIQKMETWES
GIFEYHDKMLLKRGYAEKGIRVVPNAVARYGAYISSGVILMPSYVNIGAYVDEGTMVDTW
ATVGSCAQIGKNVHLSGGVGIGGVLEPLQAAPVIIEDGAFIGSRCIVVEGVHVGKEAVLG
ANVCLTASTKIIDVTGDEPVEMKGFVPARSVVIPGSYTKKFAAGEFQVPCALIIGTRKPS
TDLKTSLNNALREYDVAV
>EGALAKHO_01506 Putative pre-16S rRNA nuclease
MARILSIDYGQKRTGIAVTDEMQIIASGLTTIPTNTLIDFLKDYFAKEKVETVLIGEPKQ
MNGQPSESASIIKGFVTHFSNIFPDMKVVRVDERFTSKMAFQTMIDSGLSKKQRQNKGLI
DEISATIMLQDYLSAKRF
>EGALAKHO_01507 Malate:quinone oxidoreductase
MPDETIRSNSEVVLIGAGIMSATLGVILKELQPDIKIEIYERLDVAAAESSDAWNNAGTG
HSAFCELNYTPEKADGSIDPKKAISIAESFEVSRQFWSYLVQQNKVPSPDNFIKSVPHMS
FVWGDKNVKYLKKRFDALQSNPIFSQMEFSTDFEQLKKWMPLVMEGRETGDKLAATHMEI
GTDVNFGALTRSMFNYLEKLDGVTLHFNHEVTKLKQRDDKTWRIKITDLNTGQKRKAYTK
FVFIGAGGGSLPLLEKANVPEGNGYGGFPVSGQWLKCTNPEVIAKHQAKVYGKASVGAPP
MSVPHIDTRVIDGEKALLFGPFAGFSTRFLKNGSYLDLPLSIKANNLIPMLSAGFHNIPL
TKYLIEQVRQKPKDRMAALREYLPSARSKDWKLEKAGQRVQVIKKDEKEGGVLEFGTEVI
NTHDGTLAVLLGASPGASTAVSIMVDLIGRCFTSQLKTPEWEAKMKNMIPSYGQTLNDKP
ELLAELRKHTSEVLKLKNN
>EGALAKHO_01508 Inner membrane protein YccS
MFDRISKFTNSTSFLNASKVTIASVVPVLILNFLGHFEIGFTIALGAFYTYPSDIPSSLG
HKIKGLIVASLIVSGVNLLVNLAYPYPFLFYPFLGFLLFLCSMISVYGQRATLVSFSALL
SISLSFGHLHTGWEAFEYSGFIFIGGILYLIVSLVFHFIQPYKYVELQIAEGIKLTAKYL
KLRGDLWNPEANRQTIIEKQLAVQVELNLIHEDLRKMLIGNQNTSGTTAQNRKMLLVFIT
LVEIQELALYTSFDHSKLHEKFAKHPEVLRTYQNVAYKLASTLKKLSKNVHHIAVYVDKN
DLKNELDALEFAIFDYEKKLGKEEASEGVLMLTNMLKYAKNQVGKIKIIQRAFSLAMQSF
KLKDKDKELEKFLTPQYYPLRTLIENLSFSSSIFRHSIRLTITILIGFLIGKILPFQNVY
WILLTIVVIMRPGYGLTKERSYNRIFGTILGGLFAFGIVSVVQNHVALSIFSIVCMLLGI
SFTQINYKISATFVTMYVVFIYGILTPDVVEVIQFRILDSLAGAILAFLANQFLWPAWEF
INTPIHIENAVRANRNYLKEIADFYNKKGEIPTSYRLARKNAFVEIGNLMTSFQRMMQEP
KSKQKTLPLVNKLVVLNHSILSALASLSTYIQSHQTTSASESFNYIIKTILSNLDQSISI
LKNETIIKDTFFDKEDVTLQFEELKRKNFSRLATDEDLDKETRQAKMQEAQMVIEQLIWM
SNLAEKILKITKELKATNPD
>EGALAKHO_01509 Peptide deformylase
MILPIVGYGDPVLRKVGEAITPDYPNLKETIANMYETMYNAYGVGLAAPQVGMAIRLFVI
DTTPFSDDEDLPSDEQKDLKGFKKTFINAKIVKEEGEEWSFNEGCLSIPDVREDVYRKPT
VTIEYCEEDFVMKTEVFDGLIARVIQHEYDHIEGILFTDKISSLKKRLIQKKLKNITEGK
TFQEYRMKFAAAKKGR
>EGALAKHO_01510 hypothetical protein
MNLDKILAISGKPGLYVLKVQTRTGFVAESLTDGKKITVNLKSNVSLLSEISIYTYEGEK
PLTEVMQKIAVKENKGQAISHKEDNAKLAAYFKEILPEYDEERVYPSDIKKVLNWYNTLQ
AKGLVTDLAPAPVETTEEAPIVEEKPKKAPAAKKAKAKKEE
>EGALAKHO_01511 Nucleoside triphosphate pyrophosphohydrolase
MSKELQLKAFERLLIIMDELREQCPWDKKQTLQTLRHLTIEETYELGDAILDNDLNEVKK
ELGDLLLHIVFYAKIGSETNDFDIADVCNEICDKLIHRHPHIYSDTVVKDEEEVKQNWEK
LKLKEGKKSVLEGVPRSLPALVKASRIQDKVKGVGFDWEEPHQVWDKVQEELEELQEEVK
AGDQDKIESEFGDVLFSMINYARFLNVNPEDALERTNKKFIKRFQYLESKASELGKPLMD
MTLAEMDVFWNEAKKL
>EGALAKHO_01512 CRP-like cAMP-activated global transcriptional regulator
MNKCDQCIVRQLTSLQALNKEEVIKLANSKTTYKIKKGEAIFEEGEVTNGVFCVKDGVGK
LSKLSANGKDQIVKLVKSGELLGQRSMISNEPANLTAKAVADMEVCFIPKSEIIGFFNTN
NQFSMKLMQTVCEDLKESENDKIALVQKTVKQRLAETLLYLHDFFGENEDKTLKVQLTRE
ELAGMIGTATESCIRLLSDFNKLGLIELIGKKILLKDVKALKKIAD
>EGALAKHO_01513 putative copper-transporting ATPase PacS
MSEQGCFHCGLTIAKNEEINFDGKKFCCNGCKTVYEIFSLHDLTCYYDFEKSPGATPQDI
QGKYDFLENEAILSKVLEFEEGNTSIVSLNIPHIHCSSCIWILENLNRIQKGISISQVNF
LEKRVRITFNSDVVSLKTIAYLLSSIGYEPYISLENYEAGKNNVDRSLTYKLGVAFFCFG
NIMLLSFPEYFEIKEFWLDNYKPFFRILIFLLALPSFLYSASGYYISAYKSIKSRMLNID
IPIALGIIVMFVRSTFDIVMNYGSGFFDSLTGLVFFMLLGKMFQIKTYSFLSFERDFKSY
FPIAVTKINMDTSEESVAIYDVIKGDRLLIRNQELIPVDGILISEKAEIDYSFVTGEAVP
INKKSGDKVFAGGKQIGKMIEMEVLHSVSQSYLTQLWSNEIFQKNVEQKHKTITDKISRY
FTPILLLIAFAGFGYWIFINANTAFNVFTAVLIVACPCALALTAPFTFGNILRIMGKQKM
YLKNALVIEQLAKVDTIVFDKTGTITTNKKSNIVYEGNPISDANYVFIKNVLRASNHPLS
RMLYDFLPDSKRSKVDNFEEITGKGIFATIENKSIQIGSAAFVGISDSQTSEPEKTALHV
KINNEYYGQFNFQNQYRDGLATLFLTLSKNYQLKVLSGDNDGERSNLEAILPKGTELIFS
QKPEQKLEFIKNLQEKGQNVMMVGDGLNDAGALAQSNVGISISENVNVFSPACDAILDAS
EFSRLDYFLKLSQKSILIIKMSFVLSLLYNAIGLSFAITGNLLPLVAAIIMPLSTITIVS
FVTIMSNYLSNSNLKRL
>EGALAKHO_01514 hypothetical protein
MSVIYLLISVSIFVAIGFFIAFIIAVKSGQYDDDYTPSVRMLFDDETKITPQNNNSPTEE
KQV
>EGALAKHO_01515 Cbb3-type cytochrome c oxidase subunit CcoN1
MEMEQFYYDNKIVKKFIYATILFGVVGMLVGLTLAVMYLFPNMTDGISWLSYGRLRPLHT
NAVIFAFVGNAFFAGLYYSLQRLLKARMFSDFLSNLHFWGWQLIIVAAAITLPLGYTSSK
EYAELEWPIDIAIALIWVVMGINMIGTMLRRRERHLYVAIWFYLATFVTVAVLHIFNNIE
LPVSALKSYSVYAGVQDALVQWWYGHNAVAFFLTTPFLGLMYYFIPKIANRPIYSYRLSI
IHFWSLIFIYIWAGPHHLLYSALPNWAQNLGVVFSIMLIAPSWGGMINGLLTLRGAWDKV
REEPVLKFFVVAITGYGMATFEGPMLSLKNVNAIAHYTDWIIAHVHVGALAWNGFMSFGI
IYWLIPRMTKSTLFSKKLANFHFWIGTLGIILYALPMYVAGFQQASMWKQFNPDGTLTYG
NFLETVTAIMPLYWMRAIGGTLYLVGMLTLVYNIIMTVKAGETIEDELAQAPALQRISSN
RLNGEKFHTWLERKPIQLTILATIAILIGGVIQIVPTIMVKSNIPTISSVKPYSPLELEG
RDLYIREGCVGCHSQSVRPFRSEVERYGPQSKAGEFVYDHPFLWGSKRTGPDLLRVGGKY
NDNWHFNHFWNPQSTSAGSIMPGYKWLFDNEAMDVSLTQKKMQAMVSLGVPYTADEIANA
QKTLRTQALSIEKSLENDPDFVKSYQDSKNKAAAKGEKFVPMNEREIVALIAYIQRLGTD
IKVKETAKK
>EGALAKHO_01516 hypothetical protein
MFEQIKHNMENISGIEIYPILSLLIFFFFFVGLGFWVFSYQKDKIKEMSEIPLNEGLGVT
SKDK
>EGALAKHO_01517 Cbb3-type cytochrome c oxidase subunit CcoP
MKKFFPAYVRVPLFFFIGFALMEYCIDSGDKPAFIKYPMVSVFLFVFLFILIAIEITLNA
VNRVMYQLLTPEEKAKLDYEDSLSLQESTWFKDLMHKLTKTEPIEKEGDLLMHHDYDGIK
ELDNNLPPWWVYLFYITIIFGVIYLARFEIFGADNQEMELKKEMAQAKIDVEEYLKTAPD
LMDEKTVVLLTDKESLEAGKEIFTTNCAACHRADAGGQIGPNLTDDHWILGGGIKNIFHT
ITNGGRDGKGMVSWKTNGMKPKEIQKVASYILSLQGSKPKDPKDPEGEIWTDEAAPKKDA
AISNPKDSTEVKK
>EGALAKHO_01518 Putative electron transport protein YccM
MSNLPDEAFRDTIGTIDEGGNRKFIFPKKPSGKFYNYRKIVSYVLLAILIANPFIKVNGN
QFMMFNVLERRFNIFGFPFWPQDFYLFVISMLVGVVFVILFTVVFGRIFCGWICPQTIFL
EMVFRRIEYWIDGDRGAQSRLARQEWNAEKIRKRLIKWTIFFLISFGIANVFLAYLVGSD
ALLLMIEEGPVKQSSNFIALLIFTSVFYFVFVWFREQVCIIACPYGRLQGVLLDNKSINV
AYDFVRGEKEEGRAKFNKKEDRAITGKGDCIDCHQCVHVCPMGIDIRNGTQLECTNCTAC
IDECDTIMETVGLPKGLIRYASEDEIAKKEPFKFTARMKGYTAVLFILLSVFVGMLFLRT
NVEAIILRLPGQLFQHKGDKISNVYTYKIVNKTMKDYNDIHFELIDQEGEITNVGKEHFK
IQKEGISQGTLFIEINEVLLESDKTKVKIGVYNGKELLETTTTNFLGPRSFN
>EGALAKHO_01519 hypothetical protein
MKINWGTGIVIAFALFMSFILYFVFEVQSNSKYDNDLVVEEYYKHDSHFQEEMARIQNAH
DLQQKPSIVYSEEGVKVAFPANFESDKIKGNILLYRPSNKKFDFNTQIALTNSAMLIPKD
KLVKGRWDVNMEWQYNGTKYLTKEVIYVN
>EGALAKHO_01520 hypothetical protein
MLYSALILGLISSLHCIGMCGPIAMMLPVDHQNEAKKVTQIVTYHLGRLTAYATIGLIFG
LLGRGFFLAGLQQNMSIFIGIAMIIIVLIPEKVFSRYNFSKPVYKVISKIKTSLGNQFKN
RSYKSLFTIGLLNGFLPCGMVYVALFGAIAMQSAGFGVLYMLLFGLGTMPLMTTVVYLHS
LIKLPFRNKIQKAIPYVAVIIGVLFILRGLGLGIPYVSPSNMSLFVHGTPNCH
>EGALAKHO_01521 Oxygen-independent coproporphyrinogen III oxidase
MKISLIQKYNVPGPRYTSYPTVPYWNEAGFSEQKWTESFQKAFSESNSQNGISLYIHLPF
CESMCTFCGCNKRITKNHSVEETYIKALIKEWSLYCKLLPEKPFIKEIHLGGGTPTFFSK
NNLEHLINGIFTFANKADKYEFSFEGHPNNTTYEQLQKLYDLGFRRVSFGVQDYAEKVQK
AINRIQPFHNVAKVTFWAKEIGYTSIGHDIIFGLPYQTIEDVVDTVEKTNSLKPDRLAFY
SYAHVPWIKGNGQRGFNEENLPKDAEKRKLYEIGKQLLSKNGYHEIGMDHFALESDSLYK
ASTNKGLHRNFMGYSASKTQLMIGLGVSSISDSWYSFAQNTKNLEDYYQLLEWDKLPIVK
GHILTDEDLIIRKHILNLTCEFETSWNDKTLYFEELPSILKDLEEIEKDQLIVIEENKIK
VTEAGKAFVRNICMAFDLHLKRKSPETNLFSMTV
>EGALAKHO_01522 hypothetical protein
METSVTIIGIVIAIIVAIPIYFSARTSAANKSKILNIKKKFNPSHPEDFDLTESQSNKTL
TIDQKHRRFILMNFNPNQQESTFVDLKSVSSCKLILTTDGNSDTILKIDFEFQERETSKK
ITIPFYDFDDDRIKQISAYQDHMFAKKWLKIIQDSI
>EGALAKHO_01523 hypothetical protein
MNWIRKTVIFVSLLILAFFASQESNASMQKIENQKTDTNFSKDYTDSLAFIQPQASYQFA
ANIKTNHPGIIKWFDSLLVVIPQHQVAKSASNFANQFSTQSKKVLLMLYPFHFFW
>EGALAKHO_01524 hypothetical protein
MENVKSLNKWANSHTYLPVDLVRIVLGVFLFMKGVSFVTNAQYLHDLISPIDQYGGGMFL
LHYIAPAHMIGGIMIVFGLLTRWAIAAQLPILFGAILVNFMGRMHSESLILAIVILLLCI
FFLFYGGGKHSADYYFKMQQ
>EGALAKHO_01525 putative propionyl-CoA carboxylase beta chain 5
MDLNFNKNEDHNKLLLSELKQKFAKVKLGGGEKRIQKLHAEGKMTARERIDYLLDENSKS
IEIGGFVGEGMYAEHGGCPSGGVVIKIGYIRGKQCIVVANDATVKAGAWFPITGKKNLRA
QEIAMENRLPIIYLVDSAGVYLPLQDEIFPDKEHFGRIFRNNAQMSSMGITQIAAVMGSC
VAGGAYLPIMSDEALIVDKTGSIFLAGSYLVKAAIGETIDNETLGGATTHCEISGVTDYK
AKDDKDALDKIKNIVDKIGDFDKAGYSRIKAEKPALEPKDIYGILPKARNEQYDMMEIIN
RLVDNSEFEAYKDGYGQTIITGYARIDGWAVGIIANQRKVVKTKKGEMQFGGVIYSDSAD
KATRFIANCNQKKIPLVFVQDVTGFMVGSKSEHGGIIKDGAKMVNAVSNSVVPKFTVIVG
NSYGAGNYAMCGKAYDPRLIFAWPSAELAVMGGTQAAKVLAQIEASSLKAKGEIIDEAKE
TELFNKIKARYDEQTSPYYAASRLWTDAIIDPLDTRTWISMGIEAANHAPIQKAFNLGVI
QV
>EGALAKHO_01526 UDP-3-O-acylglucosamine N-acyltransferase
MRSYSIQEINEVINGVIYGTTSQSITATEQLEKATTSEISFIGNKKYEKYWSASNASIAV
VNEDISIEPGENRAFIKVKNADLAMSQILALFAPPTPIFHSNIHKTATVDETAIIGEGAR
IGAGCYIGPKVEIGANATIYPNVTILDECTIGKNTIIWSGTVVRERCHIGSDCIIHPNAT
IGADGFGFRPCKEKGLVKIPQIGNVIIGNGVEIGANTCVDRGKFSSTILGDGCKIDNLVQ
IGHNSNLGKFCIMAGNSGLAGSVTLGNGVIIGGSASIKDHTTIGDGAIVGAGSGVTGDVP
AGKTMLGYPAVEARDALKQWAILKRMVCDSKK
>EGALAKHO_01527 Peptide methionine sulfoxide reductase MsrB
MIKWADVIHFTNKGNPTPEKRVEKTEEEWKQILTPEEYQVTRLKGTERSFSSELCSLFDP
GIYECKCCGTLLFDASEKFESGTGWPSFTQPIKENAIAYHADKSYGMIRVEVVCNTCDAH
LGHVFPDGPEPSGLRYCINAVSLSKIKD
>EGALAKHO_01528 Peptide chain release factor RF2
MAHDFYKEGELSAEELDEHYKTTQDHIENIEFKNMLSDEGDSLSAVVQITAGAGGTESCD
WAGMLMRMYMMWGESYGYKIKELNFQEGEVAGIKTVTLEFEGDYSFGYLKGENGVHRLVR
ISPFDSNAKRHTSFVSVYVYPLVDDSIEIDINPADIEITTSRSSGAGGQNVNKVETKVQL
VHKPTGIQIQCSETRSQQDNRQRAMQMLRSQLYEIELKKQQAQRADIEAGKMKIEWGSQI
RNYVMQPYKLVKDVRTGYETSDVDGVMNGNIDPFLKAFLMMMGQREEE
>EGALAKHO_01529 L-allo-threonine aldolase
MEINLISDTITKPTHEMLQYMFNAQVGDDVYKQDPTVIELEARVAEFFGMEAGLFFPSGT
MANQTAIKLHTQPGEQLIADKYAHVYHYEGGGVSFNSGVSCCLLDGDRGMINATQVAAAI
NDPEFYHSPLTSLVCVENTTNKGGGACYELEDLREIKKVCDANNLKFHLDGARIWNALVA
KRQNPKEFGAIFDTISVCLSKGLGAPIGSILLGSKDDIRRALRIRKMLGGGMRQVGYLAA
AGLYALAHNIERLAEDHRRAKEIAAVLSTKPWISAIEPVETNILIFSLAEGYSDQLLIEK
LKQKNILISALGHNKLRIVTHLDYKEVMHTYVIETLQKF
>EGALAKHO_01530 hypothetical protein
MKLTYKILAISFASLFLFSCSNDSSNPKDESIKDDFSYLSVDSWGQINKIGNNSGKITSY
ANFTGLLTNVINLNTVAISPDKIFLVEHYPAPNDNLFIFDRITQKTTSKTLVYPNEIVVR
NALYHL
>EGALAKHO_01531 Nucleoid-associated protein
MDLMGMMGKLKETQQKIEDTKKRLDTVLIDEQSADGLLKVTLTANRKVTSISIDDSLLED
KEQLEDYLIVTLNKAIEKATNVNERELDAVAKMDMPMIPGMDNLFK
>EGALAKHO_01532 Dipeptidyl aminopeptidase BI
MQNDITAPQAKVIPKNLKKHKETRIDNYFWLNDRENSEVIDYLNQENAYYQNMTSHTKEL
QESLYEEMKGRIKEDDSSVPYFYNGYYYITRFETGQDYPIFSRKKGSLSAEEEIMFNCNE
MAKGHAYFKLGGLSISPDNKFASFGLDLVGRRIYTIQIKNLETNEILNDKIENATGGSVW
ANDNKTIFYVRQDEVTLRSDKVFRHKINSDSVADVLVFDETDDTFNVSISKEKSRKYIVI
GSGSTLTTEYRILNSDNPDGEFEVFQKRVRGLEYSISHYEDSFYILTNKDKATNFKLMKT
PENKTGKKNWVDLIPHREDVLLEDIEIFRNYLVVEERSNGLNHIRIMPWNDEPDYYLPFG
SETYNAYTTTNIDFDTDVLRYSYQSLATPSSVIDFNMTTKIKEILKEQQVLGGKFDKENY
IEERVWATARDGVKVPISMIYRKGLEKNGKNPLLLYAYGSYGITMDTYFSSTRLSLLDRG
FVYAIAHIRGGEDLGRQWYEDGKLLKKKNTFTDFIDCSKFVINEKFTSAEHLYAEGGSAG
GLLMGVIVNEAPQLYNGVIAQVPFVDVITTMLDDSIPLTTGEYDEWGNPNNKKYYDYMLS
YSPYDNVKEQNYPNMYVSTGLHDSQVQYWEPAKWVAKLRNMKTNDNLLFLDTNMDAGHGG
ASGRFEALKDLAKEFSFLLDLEKIKS
>EGALAKHO_01533 Putative cystathionine beta-synthase
MLNLQPIGGYFKMPLINYFFMKEEINAYNNVLELIGNTPLIKLNKITEELEGNFYAKVEA
FNPGHSSKDRIALYIIEEAEKKGILSPGDTIIETTSGNTGFSLAMVSIIKGYNCILAVSS
KSSKDKIDMLRSLGAKVYVCPAHVSADDERSYYNVAKRLHEETKGSVYINQYFNQLNIDA
HYNTTGPEIWEQTKGQITHLVACSGTGGTISGTAKFLKEQNPNIRILGVDAFGSVLKKYH
ETREFDNKEIYPYRIEGLGKNLIPSATDFDIIDKFMKVTDEESAHSAREITRKEGLFVGY
TSGAVMQAIKQYAEEGEFTKDSNIIAIFPDHGSRYMSKVFSDDWMNEQGFFDSINEEEVQ
KIEFVK
>EGALAKHO_01534 hypothetical protein
MKKVLLTLMFVSFLTVNAQNPIQEFNFNGTLINAKNTTSFMGTNNFVADRNGVANSAQRL
VNKGMEAIIVDLPQNNNARTITIWVKMNDIAKANYIWGYGTAYNTQYCGLLQQGTASTNS
DLSLAGWGASNDVIVSTPLVKNTWYHYSITYDGADSKIYRDGQLLKSVNGISRSTKGNIF
RLGEINTTVGINADIDDLKIYNVAMTAEQILAEYNNSKPVTIIAPDPIVAAKSNSKTSGK
VKTTAKAGPSNVIIATNDINAVSKSVEVFSQGQKIVGDNLMSISDLPEGTYLLKITNKPS
NTITAK
>EGALAKHO_01535 hypothetical protein
MKTSKYTKAAVIIMVILFVVISVLSCSTHTHTTGSGKVPPGQAKKMSGSKSAKAYAPGQQ
KKR
>EGALAKHO_01536 hypothetical protein
MKKLLLTLMFVSFLNSNAQNPVQEFNFNGSLNNTDNTISLLGTPNFVNDRMGVTKGAQRL
TNKVLQGVVGDLPQDNKPRSISVWVKFNTIASANYILGYGTTVNAQYFGLVQQPISSGNS
DASLIGWGDTNNVVAPVSLQKEVWYQYSITYDGTSSKIYRNGELLKSVDGIQRSTKGYIL
RLGQLNTAVGINADIDDLKIYNVAMTGEQVMESYNSSKPASTTTQGQAHTASNTLKNIPA
GNPSQTSLTTKTTTGSKTVEVFSQGRQIMGTNASNIGDLPEGTYLIKVTNGSPKK
>EGALAKHO_01537 hypothetical protein
MKKYIKSQDLPKILDDETITILAKMANEIPQSNEWLLIFDLLSFEDIRKVMDRRIEIQHL
ETEQHKSQMTEEENLEDEEKKQALLKKLKENPHFFYGNMSQPDTPEEFNSKFGVWPDGTS
GKSYNPKK
>EGALAKHO_01538 hypothetical protein
MHHYSDFAELVDPINMTYKKIDFNRLPQKLTSEIISTLVEMAMEFPNKNDDWEKISNILL
ERNQLNLILDIVEKHKEEEREKKWNSLSIDFQNDELTKRKESLTDKKFSGNMGEEETILN
KNRKPKLP
>EGALAKHO_01539 putative transcriptional regulatory protein
MGRAFEFRKGRKMKRWSAMAKTFTRIGKDIVMAVKEGGPNPDANSRLRAVIQNAKAANMP
KDNVERAIKNASNKDTANYKEILFEGYAPHGIAILIETASDNNNRTVANIRSYFNKCNGT
MGTQGSVEFMFDHTCNFRIAKGNLDPEELELELIDFGAEEVFEDEDGILIYAPFGSFGAL
QKELENRGLEILSSGFERIPQITKELTEAQIADVEKLIEKIEEDDDVMNVYHTMKEE
>EGALAKHO_01540 Tail-specific protease
MANFMCISSKTNRLNVRYFRKNITFNQKNKRKFKVNVDSRFMKKILLFFLMTTSVLFSQN
SATSCEILSKINRLIQAEHIRPKPVDDSLSIFVFDNLINELDPSRNIFFKTEYDELSKKY
RVSLDDMIMEGNCSFIDDISAKYKNGLLRTKTVLEKIQAGTIDYTKKDTIRFYKKSFPFY
LKKEDLEKVWLKKLRYQILDDIAETSENLDSIKTNFKSIELASRSTILANEICRFNTLLE
TDTKLEERLYNFFCTYFDPHTAYFSDDSKSSFVASLSKEHLSLGMTVNLNEKNEIIIDEV
DPNGPAFKTGQIKKGDQIVSISNHKDTLQVSCSSLESISTMILSESNKSITLTLKRNSGK
SFDVYIEKQVMKDEENSVFSFIVGKESKIGYIKIPSFYADLDGNSRKGCADDVAREVIKL
DRDNIKGLVIDLIDNGGGSMEEAIKLAGMFVDYGPLSIVVDNKQGKSVINDPYRGMIYRG
PIVVLVNSNTASASEFFSSILQDYNRALILGSNTLGKATMQTILSLDEEKNTDYLKITIN
KFYRVTGKSHQYIGVTPDVILPEFYEGVYQKESDFPTAIKNDSIEPFLKYKPFVKRALID
KLAQSSKARLADNFYFNDVKRINLKIDQLVNTPKAEIPMTIDAVFNQKKIVNSLWKEINT
FNDENNPLDVYNSSVNQFLLGVYPTEKTINQYQIENLKTNPYLNEAVNIITEFNASK
>EGALAKHO_01541 Aminomethyltransferase
MKNTALTHIHESLGAKMLPFAGYNMPITYEGVNAEHETVRNSIGVFDVSHMGEFLLTGPN
ALALIQKVTSNDASTLTIGRAQYSCLPNNDGGIVDDLIVYKMKDEEYLLVVNASNIEKDW
NWISSHNDLGVEMKNLSDDYSLLAIQGPKAVEAMQPLSSIDLSAIAYYHFEVADFAGFND
VIISATGYTGSGGFEIYCKNADAEAIWNKVFEAGAAFGIKPIGLAARDTLRLEMGFCLYG
NDINDTTSPLEAGLGWITKFNKDFTNSESLKKQKEEGVSKKLVAFEMQERAVPRHDYEIV
DASGAVIGIVTSGTMSPSMNKGIGLGYVTVNNSAVDSDIFIRIRKNDVAAKVVKLPFYKK
>EGALAKHO_01542 Bifunctional NAD(P)H-hydrate repair enzyme Nnr
MKTPFLITKEEILKFYKPVNPLTHKGLQGHAVIIAGSYGKIGAAVLASKSCLKSGCGLVT
TFTPKCGYQILQISIPEVMVVTDENTNSITNIQLQILPQAIGIGPGIGQELATQKALFEF
LRTNKIPLVLDADALNILAENQSWLELVPENTILTPHPKELERLIGKWNSESEKFQKTIA
FSEKYKVIIVMKGAPTYIINKQEIYENTTGNAALATAGSGDTLTGIITSFLAQGYEPKHA
AKLGVFIHGLTADIALPETGYQSFIASDIIANLGKAFLELDN
>EGALAKHO_01543 hypothetical protein
MKNNFDLRTVNVTRYITPLREGGSLPALAEADDDFKYVLKFKGAGHGVKALIAELVGGQI
AKALKLQLPELVFANLDEAFGRSEGDEEIQDLLQGSQGLNLALHFLSGSITFDPVVTTVE
AKLASQIVWLDAYITNVDRTFRNTNMLIWHKELWLIDHGACLYFHHSWNNWEQHAKSPFA
LIKDHVLLPQASLLKEVDAEFKVLLTNEKLEEIVNTIPEEWLVWEDTDETPEALRNVYLQ
FLQTRLNNSEIFVNQAQNAR
>EGALAKHO_01544 hypothetical protein
MQDSHLYEYAVIRVVPRVEREEFLNIGIILFCKKAKFIKVLSHIDDDRVEALSNDFDIEQ
LHCNITALKKIASGDKDGGPIGTMEIPERFRWLTAIRSSAIQTSRPHSGLCQDLEKTIQR
LFEELVL
>EGALAKHO_01545 hypothetical protein
MNIRLLSKNDIKASIWSGGLTYEYLIYPETASYADRDFTFRISSATIEQEPSAFTKFKGY
HRYLVMLDNDLQIEVNKERKVYEKYEIMEFNSDDEVTSYTKGIDFNWMVSDKISHHKLKI
INSSQNCNAQILILFSLDTTVIRINEKPYDLKPYDLLVIENPKKENIMLHFSHECLFGIL
DF
>EGALAKHO_01546 Amino-acid acetyltransferase
MITKATLQDIPALNILINSAYRGETSKKGWTTEANILEGKRTNEEELTETILNPKNTILK
YTENDKIIGSVLLVEKEHQLYLGMLTVSPELQNSGIGKKLLAEAENHAKNLGLSSIIMTV
ISVREELIAWYKRHGYVDTGEREAFPESEIHITISDVPLEFIYLEKLL
>EGALAKHO_01547 hypothetical protein
MKDINPNKRIIELIIIGGLFMFILYRSYHVDNIFAVFFYLILGVLEIILLSKVISENFRE
FKKSKRVKSLIPTFTAFFIICVTISLYVYYENLERSKTYIHAVGNGLIIDLKENGKYIIK
SGSWGGRIHHYGNYKIEDCIIVLDKNKFGKINISGELKQGKIYIDKEKLSENVLFQTKKN
KILENTDYFYIDN
>EGALAKHO_01548 hypothetical protein
MKRRDFVKTTLLFVTSVQLFPNNKLLESTSILRSNFKYIYTNSKLKNQFFLFLKNVFNLY
PEEEFHKLIYDDTISN
>EGALAKHO_01549 hypothetical protein
MNFRKHTETFIGFSIAFAIITLILFIIKTTELKSELAIDTGIFADYGSIVGGILSAFFGL
LSVLLVIQTLNEQERQNELQNIESRFFELLKIHRDNVSEFQQKGKTARSVVIDIYDEFNE
LYDFVEVWYTFEKSELHNQKEWKKKCAQIAYLILFFGVDNNSTNQLLKEIQKIVSNQKFY
EIEFYPMALSLLIKKHITTKQENKLKEKGKRLYLDHDGQQSRLGHYYRHLYQTIKFINDQ
PKRLLSYSEKYNYIKTLRAQLSTHEQAILFYNSLTYLGQAWELGIKDENQKLITKYNLIK
NLPEGFTGKIDPKVFFEDVFFEYDTEKTKTRKELEKIYS
>EGALAKHO_01550 hypothetical protein
MNLIELKSKVEHIISEIKNNGIYPKENNLIDYKLKLNLTISKSNIEQFLMNFAKDIISFS
NADGGIILIGISEDSTGNYNDSGLDKSNIELLTNIDLNDVTQQFVKITNVGVSLDLQMFQ
IATRKFFYIIIEKNNNILVPKDNFPEYKILNGAIYYRASGKNEHANISTANFNRFIQMKA
NEKSKEFMEIWSKLLPEMVDINPREVLILNPMQNKVYGFNSKDNVLSGSDIEIDKTHNGV
FNIILNAITAGEIGKITTNEGKPLYKIVGEFQNNRDHIILNNLVKAVQNKAKYKITSAQV
KTLMCYLKWVDCVDFKVDNPKEDSINQSFKDFLWIETMDSLSKKSKVYFSSEAIPELIKM
IDNDEIHLEVFNKSLTIKEVLKKNKPENLHIA
>EGALAKHO_01551 Threonine synthase
MKYYSLNHNAPEVSFKEAVIQGLASDKGLYFPQIITPLNPAFFNVIENLSHNDIAFDVIQ
QFVGDDIPEENLREIIKDTLSFDFPVVEVEHGIYSLELWHGPTMAFKDVGARFMSRCLAY
FNKDKKDSKNTVLVATSGDTGGAVASGFLGVDGVDVVILYPSGKVSDIQEKQLTTLGKNI
KALEVDGVFDDCQDMVKKAFLDETLAHKNLTSANSINIARWLPQMFYFFFAYKALKSQNK
PLIFSCPSGNFGNICAGIMAKKLGLPIEHFVASTNVNDTVPRFLENGKYDPKPSKATISN
AMDVGNPSNFIRIQELYNNDLKAFEKDFSSYSYTDEETLAALKQIYNTDGYIAEPHGAVG
YLGLKKELQKHDNAIGVFLETAHPIKFLDVVEPALSITLPIPEQIESVLNEDKVSVKIKT
YEELKAFLG
>EGALAKHO_01552 Homoserine kinase
MTKTSEPLSLCHSEPINMEEIKLFCPATIANLSCGFDVLGLCLDNAGDEMIVRKVDQKGV
RITKIVGADLPLETEKNVSGVAALAMLETLDELDFGFEIEIYKNIKAGSGIGSSAASSAG
AVFGINELLGRPYSRKDLVQFAMQGEKLASGNAHADNVAPALLGGFTLVRSYAPLDIIRI
DSPEELYATVVHPQIELKTSDARSVLKQTVSLKSAIMQWGNVGGLIAGLYTKDYDLIGRS
LHDEIVEPLRSVLIPGFDLIKQTALENGALGSGISGSGPSIFALSRGKQTADQIAKAMSE
VYEKMNLPYEIHVSKINPDGVRIL
>EGALAKHO_01553 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKVLKFGGTSVANAQNIKLVLEIINQKSKQDQLVVVVSALSKVTDLLQLAAAKAAANDES
FREIVAEIEKKHLDTLKELIPVSEQSSLLSHVKRIVNHLETLLDGCFLLGELSPRTADTI
LSFGELLSSYIIAQAYQQIDKNVVYKDSREIIKTNAEFGKAAVNFDISNQLIQDYFAENK
AQINILPGFIALTLDGITTTLGRGGSDYTAAIIAGALDASQLEIWTDVNGMFTANPKIVK
QARPIAAISYQEAMELSHFGAKVLYPPTIQPVLRKNIPILIKNTFEPEAEGTLISDQVSS
NDTVVKGISHIDNISLVTLEGPGMIGVAGSSRRLFEVLSQEKINVIFITQASSEHSICIG
ILNSDAESAENAINRAFEVEILQNKIDPAIVEKDLCIIALVGENMKNHQGLSGRMFSTLG
KNNVNIRAIAQGASERNISTVINERDVKKALNTLHENFFEENTKQLNLFVMGVGNVGEKF
IEQIHNQRKFLKDNLKINVRVIALSNSRKMLFDEDGISLKDWKSTLDKGEHAIPTEFIAR
AKELNLRNSIFVDITANASVSEMYEKFLKESIAVVTCNKIACSSAYDNYKKLKSLSRQYN
APFLFETNVGAGLPIIDTVKNLIASGDKVHKIQAVLSGSLNFIFNNFDKNNSFHDVVKEA
GVQGFTEPDPKIDLSGVDVARKILILIRESGYEMDIDAIANESFLPAECLDTTNNEAFFA
SLINHAPHFEKIYEEALAKDSRLKYVAQFENGKASVGLQFIAKDHPFYNLEGKDNIVLFY
TDRYVDQPLLIKGAGAGAAVTASGIFADVIRIGNN
>EGALAKHO_01554 Histidine ammonia-lyase
MREIHYISTETLNLEDLQEIIVHQKMLELSEEAKVNIQKCRDYLDKKMASHSEPIYGINT
GFGSLCNVKISNENLSKLQENLVKSHACGTGEEVPAEIVKLMLLLKIQSLSYGHSGIQLQ
TVSRLVDFYNNDILPIIYTQGSLGASGDLAPLAHLSLPLLGEGEVLFEGKKVASAEILKH
FNWEPIVLQSKEGLALLNGTQFMSAYGAHILLKAYKYSYLADLIGTISLEGFDGRSEPFN
ELIHFIRPHKGQIVTAQRINEFLEGSEIIEQEKKHVQDPYSFRCMPQVHGASKDAIDYVR
KVFKTEINSVTDNPNIFIEADQIISGGNFHGQPLALALDFMAIALAELGSISERRTYQLI
SGLRNLPAFLVDNPGLNSGFMIPQYTAASIASQNKQLATPSSIDSIVSSNGQEDHVSMGA
NGATKALRVMDNLERILAIELMNASQAIAYREPLKSSDFIEMFLSSYREVVPLVKEDRIL
HYDIEKTVAFLDSFQIENDLLTLA
>EGALAKHO_01555 hypothetical protein
MSINSIFQFLVPKDKKFFPLFEEASSNLIELASNLHEAVNLPLKEREVLFQKIDELEQRG
EDITRQTNLELSRNFITPFDREDIHTLITSIDNVADYLHGAASRMRLYQVDKITKSIRKM
TEINLEACQNIDSAVKELSNLKNMNIIKDACARINKLENKSDNVYNKAVFEIFENETDAK
NIIKYKEVLSVLESATDKCKSVANILESISVKHS
>EGALAKHO_01556 Low-affinity inorganic phosphate transporter 1
MTLLIIIIVLALIFDYINGFHDAANAIATVVATKVLTPFQAVLWAAFFNFLAYWVFGFGV
ADTVAKTAHTMEINLVVILAGVIAAICWNLLTWWLGIPSSSSHTLIGGFAGAAVAHAIAV
HGFSGYAGEDGTTHYWYEIVSWYKAGKDGGMPSGVLIIIAFIVLAPLLGAFASYLISIWL
LNASRKVIGPKIFTVALMIATVWIVSNLMVPYADIEKPRFESHFWSVAFDPHNIKWFLVA
FIILTVSAFCLIFSSLNLHQADAALKKMQLLSSAAFSLGHGGNDSQKVMGIIAAAVAVYI
NTNPGVHMASWLDVVLPNDDMGIKGVMPGWIPLACYSAIAAGTLSGGWKIVKTMGSKITK
VTSFEGVAAETAGALTLYFTEHLKIPVSTTHTITGSIIGVGLTKRVSAVRWGVTVSLIWA
WILTIPISAILAGLVYFILSVFM
>EGALAKHO_01557 hypothetical protein
MEAIFEKPIILNGGKDDVVLVYSKYIIGNIKKEITDLIIEGIDNDLLNPARFECLVKIKE
VFAYKFEPGSDSHITFFIKNITGTSYRTIDFKDVETTKQAEVFLTEQFLKLGFKRNEKHL
TPTKAAISPLILTSIIAAAGSVLTWFSYQFQKYEVQTKTDNWCFNLFMKLCRGIGYVPFL
ILTTTLLVLSLFWLFKRILKPPYQVSAIK
>EGALAKHO_01558 hypothetical protein
MLNPYLDIILRSLAVYFFMTIALRIFGKKELSQLNTADIILILLISNSVQNAMVGPDTSL
WGGLVAALALFVINYIIKKLTHKYKGLNDLLLDKPEILIHDGILDFKTLGKLDISHEELK
EAAREHGIEHLTDVKLAMLEIDGTISIISEDKKNLKQTHYKRKHNHKNFRK
>EGALAKHO_01559 Ribosomal protein S6--L-glutamate ligase
MLQNKVILGSEEWCSFPDLGIPTIKARVDSGAKTSAMHAINIAPFIKNDANWVKFDINPI
QNNIKTIIHCEAPLVDKRIVKSSSGFREHRYVIQTNLKIGDVKWPIEMTLTNRDSMGFRM
LLGREAMSGRVLVDPEEKYLLGQPTTEALKELYQNSEKATSGLRIGLLASNPELYSNKRI
MEAGEMRGHEMHFLNIKECYMKLDAKTPEIHYRGGKILNQFDAIIPRIRPSITFYGCALT
RQFEALKVFVLNSATAITQSRDKLYSLQLLLNSGIDIPTTGFANSPLDTDNLIKMVGGSP
LIVKLLEGTQGKGVVLAETKKAAESVINAFKSLNANILVQEFIKEANGKDIRCFVIDGKV
VAAIQREAMPGEFRANIHLGGTASVIKVTAEEKKIAIKAAKAMDLKVAGVDIIRSSKGPL
LLEVNSSPGLEGIEGATNKDIAGEMIKAIEKNFKIIS
>EGALAKHO_01560 Negative regulator of genetic competence ClpC/MecB
MDDNFSPRVKDVITYSKEEALRLGHDFIGTEHLMLGILRDGNGKAIHILNNLAVDLDHLR
RKVEILSPANQSVEVNAEKKNLHLTRQAERALKTTFLEAKVFQSSSISTAHLLLCILRNE
NDPTTKLLNKLKIDYDIAKEQYLNMTPNEEEFLENLPRNESYNDDSGQDDSLKESSFNNP
ANKSNKKSKTPVLDNFGRDLTEMAEEGKLDPVVGREKEIERVSQILSRRKKNNPLLIGEP
GVGKSAIAEGLALRIIQKKVSRILFHKRVVTLDLASLVAGTKYRGQFEERMKAVMNELEK
NDDIILFIDEIHTIVGAGGATGSLDASNMFKPALARGEIQCIGATTLDEYRQYIEKDGAL
ERRFQKVIVEPTSVEETIAILNNVKDKYEDHHNVTYTQEAIEACVKLTNRYMSERFLPDK
AIDALDEAGSRVHITNIDVPKQILDLERQLEEVRENKNMVVKKQKYEEAAKLRDDEKRIE
KDLAVAQEQWEEDSKNNRIEVTEDNVADVVSMMTGIPVNRIAQTESNKLAKLPELIQNKV
IGQNEAVLKIARSIQRNRAGLKDPNKPIGSFIFLGQTGVGKTQLAKVLAKELFDSEDALV
RIDMSEYMEKFAISRLVGAPPGYVGYEEGGQLTEKVRRKPYCVVLLDEIEKAHPDVFNMM
LQVLDDGYLTDSLGRKIDFKNTIIIMTSNVGARQLKDFGQGVGFGTAAKVAQADENSKSI
IENALKKTFAPEFLNRIDDVIVFNALEKADIDLIIEIELKKLYVRIAELGYKLSLTDKAK
AFIAEKGFDRQFGARPLKRAIQKYVEDLLAEEIITSKIHSGDEIMMDLKDDSQELSVEIH
KAEEPTNQ
>EGALAKHO_01561 DNA gyrase subunit A
MSEGEKLIPINIEDEMKSAYIDYSMSVIVSRALPDVRDGLKPVHRRVLYGMYDLGVTSRS
AHKKSARIVGEVLGKYHPHGDTSVYDAMVRMAQEWSMRYLLVDGQGNFGSVDGDSPAAMR
YTEARMRKISEDIMADIEKETVDFQLNFDDTLYEPKVMPTRVPTLLVNGATGIAVGMATN
MPPHNLTEVINGTLAYLDNNDIEIDELMTHIKAPDFPTGGVIYGYEGVREAFKTGRGRIV
MRAKVGFEEVDGRECIIVTEIPYQVNKAEMIKRTADLVNDKKIEGIANIRDESDRNGMRI
VYILKRDATPNVVLNTLYKFTSLQSSFSVNNIALVKGRPQMLNLKDMIHYFIEHRHDVVV
RRTQFELRKAEERAHILEGLIIASDNIDEVIAIIRGSKNTEEAREKLIERFNLSDIQARA
IVEMRLRQLTGLEQDKLRAEFEELMKLIEHLKALLADVNLRTNLIKEELEEIREKYGDER
RSIIEYSGGDVSIEDLIADENVVITISHAGYIKRTNLTEYKTQNRGGVGQKSAGTRDQDF
LEHMFVATNHQYMMFFTQKGKCFWMRVYEIPEGSKTAKGRAIQNLVNIESDDKVKAFICT
QDLKDKDYINSHNLVMVTKQGQVKKTSLEKYSKPRVNGVAAITIKEGDELMGAQLTNGDS
QIILAVKSGKLVRFEETKTRPMGRTASGVRGITLKDDTDEVIGMVTVAKEDVNDSQILVV
TENGYGKRTKLVDEDGEDVYRITNRGGKGVKTLNITEKTGKLISINAVTDADDLMIINKS
GLTIRMAIEDLRVMGRATQGVRLINLKGKDSIAAVTKVMKDDVAEVIVDEDGNVIESVIE
RVKPDLEVLEDDGTVDDDDDDTDEEVEEEDDSEEEESEE
>EGALAKHO_01562 Beta-barrel assembly-enhancing protease
MKSKYVILASALLISVATFAQKDQIKNAEKALKGGDAQGAITILKDAENLVVNAKDVDQA
QYYFVQGNAYLDLANKKVEESKNLLLAAESFKKLIDIEKTSGKVKYSTQAAASITDIKGK
LINAAIADTQANKHSDGAKKLYEAYLLDKKDTINLYYAASTAVNAQDFDTALPMYDELKK
LNYSGKGTSYTAVNKASGSEDGFNTAKERDLAVKLGTHEKPKTEAIPSKRGEIYKNLALI
LVQKGKIEEAKKAIADARKTNPDDSSLILTEANLYLETKDYDTYKRLVGEALQKDPNNAD
LIFNLGVISANANNKADAEKYYLKAIEINPNYTNAYLNLAALKLEAEKPIIDEMNKLGTS
DKDTKRYNVLKAQREDVFKGVIPYLKKAHELDPKNEDVSKTLLGVYKALEMSAEAKALKA
TMN
>EGALAKHO_01563 Peroxiredoxin OsmC
MKFTRKANANWQGTGMEGKGTISTQSTTLDNAQLSFKTRFADGVGTNPEELIAAAHSGCF
TMQLSFLLNEGGFTADDLSTEATVTFEDGTITLIHLDLKGKVPSISAEEFEKTAAKAKEI
CPISKLLNTTITLTATLV
>EGALAKHO_01564 hypothetical protein
MLEEKNDNLQEADGKSGIEISDSIQNDAIETLSSETTPENEISTENEIENSAEVEETNHQ
TALDAITNSNAEESEDETLKERHDIPMQDYDTFSLDALVDELKKLVNTDKAMSVKDHIEE
IKKSFLLQYNHLIEEKKEEFNASKQDPNEEFEYHSPLKSKFDEYYNIFREKRNAHFKHLQ
TNLKSNLENRLAIVEELKELINPQENIKDTLKHFNDLRERWKNAGAIPKDKYNHVWNNYH
FHVENFYDYLHLDREARDLDFKYNLDQKQKIIARVEELVNETDISKAFRELQDLHRIWKE
DIGPVSKEHRDAIWNKFSELTKKIHDKRELLFESQRANEQQNLEVKKGIIATIEVLATEK
VGSHSQWLVQIQKVEALRNEFFAAGKVPSDVNEETWAAFKTAVRNFNSFKNSFYKDIKKD
QNDNLNKKMALVAKAKELQESTDFGATTPIMKQIQEEWKQIGHVPKKYSDKIWKEFKDAC
NHYFNKLKEHKSEENGDEVAAFDNKKAYLDILRAYQLTGDHKTDLDAIKLHIETWKGFGK
VPFSRRHIEGKFNKILDALFEKLSLSKKDTEMMRFSNRIDSLSESNDTRKLDNEKIFLMR
KIEEVQNEIFQLENNIQFFTNTKNAKKENSIVLEVRKNIAIHKESLEVWKDKLKQLRNLG
QE
>EGALAKHO_01565 hypothetical protein
MYKVFILNIAKDSKGVSKYKINPLFITDFTIKFLFYRIILYISDKVLILYLKYMQIV
>EGALAKHO_01566 hypothetical protein
MKKIYSLYILVFLGITASHAQGTEVEEKIPFTEPRFRYYLQTLLFYNEYLDTDNGSFNTT
QVRGLLPIGSKAWNLRFDLPLVSANTNEQNKTGLGDVGMGISYIPFMKNNQGIALRTRVY
ANSATDPAFGSGKWVVMPAFFYGRYFNSKKNLWISSLEYQQSFAGSSQRNDISTAVFETV
LFHFFGKNWIAGDVALRYNSTLKGYQNNAYLEYGRRITPTNLVYIHPSVAFGGDKTYNYG
IEGGVLILF
>EGALAKHO_01567 Shikimate dehydrogenase (NADP(+))
MIDILRRRFGLLGRNISYSFSKGYFTEKFSDEVFAGNSYENFDISEINHFTGLLKNNPDL
KGLNVTIPYKEQVIPYLDKLSTKAKLIGAVNTIKFTKSGKLKGYNTDYYGFKKSLKPLLE
PHHKKALILGTGGASKGVAFALDELNIPYTFVSREAKENIIDYDLINATTFDNFQIIINC
TPVGTSPNIEACPDLPYEFFTDKHIAYDLIYNPAETQFMKNAKKYGAITKNGYDMLIFQA
EKAWKIWNK
>EGALAKHO_01568 Lipopolysaccharide assembly protein B
MQLSNEEEDYNLSLSKFESMLKTNKVLFFDSEEFEEIILHYLDIGKANLAKKALKLALDQ
HPKSTGLKLVQVEMLVYDDKLEIAEKLLNELYAIEPNNEEIYIQKANICSKRDQHEKAVE
LLKIALQYTDDYADVYNLIGMEYLFMDNLEMAKDSFIKCLEEDLEDQSALYNVVYCFEFL
DQNQEAIVYLNDYINKNPYSEIAWHQLGRLHYGVKEYENAIRAFDYATLIDDEFLGAFME
KAKAYERLKKYHEAIESYNRTIELDDATSYALLRIGKCYEKLGNAIKALQYYNQTVHEDP
LLDKGWIAITDFYVRQKNFQKALFFVNKALAIDNQNRLYWKRYATINKQMNFFEEAEFGY
RKAVEFGDYALDTWLYWVDILQFLGEFESAIQTLLQASEYFPEENEVEYRLAGLYFMIQD
NTKAKFHLSNGLRLNFDNYILIEDLFPVVWTKKMVKNYIEKHRKQ
>EGALAKHO_01569 Acetylornithine aminotransferase
MNPDFIKYQAQTSPYPLGMEVSHAIGSYIYDTNDKKYLDFVAGVSACTLGHQHPRVNQAI
KDQLDKYSHVMVYGEYSQSPAVQYCKLLASLLPESLNKTYLVNSGTEAIEGALKLAKRTT
GRSQLISCHNAYHGNTMGSMSVMGFEERKQAFRPLLPDVDFITFNNEEDLQKITTRTAAI
LLETIQGGAGFIQPENNFLQKVRKRCDEVGAMMIVDEIQPGFGRTGKLFGFQNYNVVPDI
VVMGKGMGGGMPVGAFTASAEKMDLLTENPKLGHITTFGGHPVIASACLATLQELTETNL
MQEALEKEKLFRSLLVHPLIKEVRGKGLMLAAMTETAEITNQVILNCQDKGLILFWLLFE
GCAIRITPPLTISEEEIKEGCAIILSVMDDIIKNEQRA
>EGALAKHO_01570 hypothetical protein
MKIFPASNYSFKLIGEQTESLDRLKRRTHISENLSSKITDKSFLGIINNNTFRIISSEIG
KGAFCVLSGQITNTNGTVNVEINKAFQILLCILLCLPIVGLVVQLFTQEINLFLVFITVT
IGQILMIRFIFIELAFRRLSKRSLSRLVDVLDIDSLEKIQ
>EGALAKHO_01571 LPS-assembly protein LptD
MKKSLFFISYCLFLLSVQSIFAQAPKKIIIENADYSDVDQVAAPDALLLTGNVKINHDGV
VLTCNKAYFFQKENYLKAFGNVQLVQGDTLFLNSKYAEYNGNLKKAFATGNAVMTSPDAT
LQTDTINFDRNVQEVFYNTKGTIVNKDNTLVSKSGKYYVTEKKFQFLTEVTLTNPKYVVK
SNHLDYYSNSGHTYLLGPSTITSKANYIYTEKGFYDTKKNLAHFLRKSYIKYDDRLIEGD
SLYYNRNIEFASATRNVKITDSINRGIVKGHYAEIYKLKDSMFVTKRAVAVNFVENDSVY
IHGKKLMVTGKEGERILRAYNNVRFFKVDMSGKCDSIHSNSKTALTKLIGNPILWNGDNQ
ITGDVMHLIGDNTTKKLDSLKVLNNTFLVSRDTLGTGFNQVKGLNLFGKFRDGKLHDVDV
IKNTEVVYYMRNDANELIGINKNVSSKINLILENNAVETITFYNKVDGDIYPEADLPENA
RKLRGLVWRGDERIKSKDDIFTAEENEENDKLVQEGKDQEAKDKDVPMKVRKETLNYDKK
KPAVKTSPPKTDTTKTAVKTKK
>EGALAKHO_01572 Intracellular maltogenic amylase
MVFSKKWFKFKHQKNQIINKSMVNKHFIVAGMAVTVLFSACKTKDLKMNTSKEEIPTEKK
VVVYQVFTRLFGNKNTTNKPWGTIEENGVGKFNDFTDTALHEIKDLGVTYIWYTGVPHHA
LVRDYTAYGIANDDPEVVKGRAGSPYAVKDYYNVNPDLAVNPANRLQEFEALITRTHKAD
LKLIIDIVPNHIARKYEGKNNPEGIRDFGADDDVNVEYKRDNNFYYIPKEHFQIPDGDVP
LNGEKNPMVDGFFDENPAKWTGNGSRKVKPDQNDWYETVKVNYGIRPDGSKDFPELPAGF
DKKSYQEHFAFWQDKDVPDSWKKFKSIALYWTAKGVDGFRYDMAEMVPYEFWSYMNSAIK
MKNPNAFLLAEVYNPNEYRNYIRLGKMDYLYDKVETYDKLKDIIKGKSSPDGLSDIQKGM
SDIEHHMLHFLDNHDEQRLASPEFAGTPERGKPLMVVSTTISTSPTMVYFGQEVGEAGNE
NAGFGTHSRTSIFDYVGVPNHQRWMNEGKFDGGQLSDSEKNLRDFYKRLLNFTINSSALM
GSFQEIQSVNRENNQGYDDSIYSYVRWSGKQKLIVVVNFSSEKTSEFELKVPSDLISKWN
LKDGEYQLTDQIYKKSSVQLKVNNGEGIAKVKIGPSESFIYELK
>EGALAKHO_01573 Superoxide dismutase [Mn]
MKKNFTRFGILTSFFVLFSCNDSNKLTEVVEVPLPTKEEKITIGTPDDVKADPGSFELTK
LTFAYDGLAPDIRSLTLETHYSKHYLTYTNNFNKEIVSTEFENMPIEDILKKMDLSNAKL
RQNAGGYYNHTMYFNLLTPKEQTPKDTLAGSINKEFGSFNNLTNQFKAMATKQFGSGWVW
LVVDRYGKLQVTLTGDQDNPLMKNALIPGTPIMGIDLWEHAYYLDYQNRKGTYIDAFYRH
VNWEKVNENYKEALKKVKKV
>EGALAKHO_01574 hypothetical protein
MTEKDLDTRFSEAVEIALKMTQASLPQDVQLRLYAYYKQATFGTAVYNQSENFDLRDAFK
TNAWMQISHISIDEAKENYIEIINSLTSK
>EGALAKHO_01575 Phosphatidylserine decarboxylase proenzyme
MFHKEGGPSILLGTVFAVAVLLIADKFIDISWLRILVQVAGIAVLIIILQFFRNPKRIAI
RNSDHILAPVDGKVVVIEEVYEGEFFKDKRLQVSIFMSPINVHVTRYAMDGIIKFSKYHP
GKFLVAWHPKASEENERTTVVIENETFGQILYRQIAGALARRIVNYAQEGMQVVQGTDAG
FIKFGSRVDLFLPLGTQINVELNQKAIGGKTIIATKA
>EGALAKHO_01576 Phosphatidate cytidylyltransferase
MNETLKRTISGAVYIALLLTAILFSTESFIILFGLFLIITIYEFCNLVNLNKVFSILFGI
LLYGTILLISHYNKETTSFLNTTFNSNLILNTNIQQLDLVLLAVTLVISIKCILFLFYDN
IQSVSTSSKYLYLLGYIVLPFIFIVKISFGTNDYNPKIILGLFILIWTNDTFAYLVGKSM
GKHKLFERVSPKKTIEGFLGGVVFAAFAGFLISKLYIQPKPEFSSRSILIWMIIALIVSI
FGTIGDLIESKFKRIAGVKDSGSIMPGHGGILDRLDSVIFVAPIIFLFYQILYYVS
>EGALAKHO_01577 hypothetical protein
MNFFKKIFGSSDAASDEEHESEYGGGNPIPNSHLSIDEQFIFNFKKNGGKFLYCENKQEV
AEQFENILEENDWFENEVLCYEPGLFHLLEENKLIYVSPKAPKFLLASCENLIADEGSIL
FSSKQIRQDKPNELPANIVIIATTSQILPMKSDGLSAIKRKYERDYPTNITTIKYFEKAK
EEDFTQYGSVAKNLYLLLLEDL
>EGALAKHO_01578 ATP-dependent zinc metalloprotease FtsH
MAKDNNPNPSKFKISPWLIYTAILLVFLFISFATGGSNLSEPAQLTSSKFNVLLEKGQIE
KVIVYNKAEAEVYLTAAALKDAANKKVAKDIFDRANKGPHYTLEIGNDQIFQTKLEKAVG
EGKLKDFNFLQKNNWSDILISLLPIIIIIGVWIFIMRKMSGGAGGGGGQIFNIGKSKAKL
FDEKTDIKTTFKDVAGLEGAKEEIQEIVEFLKNPEKYTNLGGKIPKGALLVGPPGTGKTL
LAKAVAGEAQVPFFSLSGSDFVEMFVGVGASRVRDLFKQAKEKSPAIIFIDEIDAVGRAR
GKSNMSGGNDERENTLNQLLTEMDGFGTNSNVIVLAATNRADVLDKALMRAGRFDRQIFV
DLPDIRERAEIFKVHLAPIKKIEGLDLDFLAKQTPGFSGADIANVCNEAALIAARNNKTA
VDRQDFLDAVDRIIGGLEKKNKIITPEEKRAIAIHEAGHATVSWMLEHAAPLIKVTIVPR
GQSLGAAWYLPEERQIVRTDQMLDEMCATMGGRAAEKVTFDRISTGALSDLEKVTRQARA
MVTIYGLNEKIGNVTYYDSSGQSEYNFSKPYSDETAKVIDKEISELIEGQYQRAIQILEE
NKDKLNQLADILIEKEVIFKDDLETIFGKRTFDKNLEEVVS
>EGALAKHO_01579 Ribosomal silencing factor RsfS
MAKKTINNDVLLANIIKGIEEVKGNDIDILDLREIDTAVCDYFVICNGSSNTQVNAIVNS
IQKTVSKDLKDKPWHVEGTDNAEWVLMDYVHIVVHVFQKHIREYYNIESLWGDAKITTIE
NKY
>EGALAKHO_01580 Bifunctional ligase/repressor BirA
MKLIKLDAIDSTNDFLKALSSKDELDNFTVVTAENQTKGKGQMGAKWESESGKNLIMSAL
VKDFLYDNEQVFNLSLIVSLSVIEALKSLNIPDLSIKWPNDIMSYNKKIGGILIENTIKS
DGRIVSVVGLGLNVNQTNFDELPNASSLAVISGHTFNKELLPALIIEKVQQKIESWESNS
AIFWKEYFNTLFRKGIPMPFKNLSIEALGQNFMGIIQGVSPVGKIQILLEDDSVSEFDIK
EVQMLY
>EGALAKHO_01581 hypothetical protein
METTIKILIYIHAFFGGIGLMSGIGSVLVKKGSALHKRMGKLFSIGMITNCLISLPICWL
PGHQNIFLFLIGLFTIYLVISGNRTSSFKYKSEADFMDKLISGSMLFFSVIMVSIGLYCQ
LNSIENGILFTFFGGFGLYMTVKDFIFFKNASEFRKKWLSKHIGKMVGALIASITAFIVA
GMGIGNLISWMLPSVLGTIYIIYWNRKIAPKKESLVKV
>EGALAKHO_01582 hypothetical protein
MNLESPKVTVQKSAQDLFEQLTDVKNFEKLMPDNIAKFEVIGEDAFIFGLKGMPEIKLKM
KEKTAPSKIVLGAASDKLPFTLTSNIESISDSESAVQLFFEGEFNAMMAMMIKGPISKFI
ETLANNMTKL
>EGALAKHO_01583 Orotate phosphoribosyltransferase
MIFNKDTAEKTAELLLQINAIKLNPENPFTWASGWKSPIYCDNRLILSFPIIRNYVRDEF
AKNIEKQFGKPDVIAGVATGAIGIGILVAESLGLPFVYVRPEAKKHGRQNQVEGFLQKGQ
NVVVVEDLISTGNSSLMAVEALRNEGANIKGMAAIFTYGFGVAEENFKSANIDLYTLSNY
ENLLELAVQKQYITEEQQSTLQEWNAIPSTWGQD
>EGALAKHO_01584 Diadenosine hexaphosphate hydrolase
MYKVFVNDKPLFLTNEISKETNFQLFLLESIDIEQLIVKIFQNKIQKAYLYHPDEREIMK
TLKAKIPVSKAGGGFVYNKNGEVLFIFRNGKWDLPKGGIEKGEEIENTAMREVEEETGVG
KLRITNKLQKTYHVFKRNGKYKLKITHWFEMFSDFEGTPQGQIEEGIEKVAWLNPEQIKE
ALKNSYENIKLLFEEESKISVEE
>EGALAKHO_01585 hypothetical protein
MSFQGYLKTIKKKTGNGPAEFRTLAEQKSFTQDGKLKPDVKAGHIVTWLKEDFDLGQGHA
MAIYALLKGIKDENSQ
>EGALAKHO_01586 hypothetical protein
MLSGYPLRRGGLFLSLTRTHFQKLVSVFRLIFILHLFTNKEDKNPNKASRIKNRLLKGLS
STADNGKILVRIIKENAIQ
>EGALAKHO_01587 hypothetical protein
MKTLKLVVILILLSSCKKDEETKLLYIQLNNYNDHLKTTIKAQDQYLFNQATENNYF
>EGALAKHO_01588 hypothetical protein
MKLFTIVISLFTISIFAQNTKKYDTFFEKGNGNQSASYEETIKYFKLLANDFQTIQIKEM
GLTDSGEPLHMVTFNPDKEFDFDKIQKTKAVLFINNGIHAGEPDGIDATMQFYRDLAIGK
MKAPKNTVLVCIPVYNIGGALNRNSTTRANQDGPEVYGSRGNARNYDLNRDLMKSDTRNT
KSFVEIFQKINADVFIDNHVSNGSDYQYKLTYIMTQHNKLGTVLGDYMNDIMMPALVKDL
QQKKIETTPYVDSFKDTPDKGFGQFVDSPRYTTGYTSLFNTIGFVVETHMLKKYGERVKM
TYEYMKSTIDFTDANYQKIKELRVKNLEQYQPRKPYTLKWELDSTKATTFSFLGYEAGYK
KSDATTGDRLYYDRTKPYKKDVRYIKEFKSLKDVVIPSAYIIPRGYWNIIELLKNNNISY
TQLKNDTIIEVESYRIADFKTSSNAYEGHYLHYNTKITPKSVKMTFAKGDYLVSTKQKGV
KYLVEAFEPEGVDSFFNWNFFDPILQQKEHYSEYIFEDTAAKLLKDNPALKAELETKKQN
DREFAKNPEAQLNWIYKNSVHYEKAHMLYPVYRIL
>EGALAKHO_01589 ATP-dependent RNA helicase DbpA
MQEVAQDAILNDNNVLLLSPTGSGKTLAFLLPVLELLQPEILSVQCLILVPSRELGLQIE
QVWKKMGTQYKVNICYGGHSIDTEIKNLSNPPAVLIGTPGRIADHIDRDTFRTDKIQTLI
LDEFDKSLQLGFHEQMSYIIGKLTKLNKRVLVSATSDIEIPRYTRVVNPTVLDFIPEEEE
KANLSMKMVVSPAKDKLESLFNLICSLKSQSAIIFCNHRDAAERISDTLNEKGIYATYYH
GGMDQDERERALIQFRNGSMSYLITTDLAARGLDIPEMKHVIHYHLPLKEDEFTHRNGRT
ARMQASGTAYIIIHESEKKLDYIDYGMEVLKVENTTTLPKPPEYQTIYISGGKKTKLNKI
DIVGFFSQKGKLEKGDLGLIEVKDFISFAAVRYNKVKDLLKNIKDEKMKGKKFKIEVARK
VVKKEEER
>EGALAKHO_01590 hypothetical protein
MKRIITIAVLLLSVASFAQIKVLETVPVEKLGKVNNNYIQKIGDEYTVYYTSIQNDDEEG
SSLRKFTFKNVNNDYASLYSIIMNGFGASPLYDIKLELPNNYIWLHYTGSVIPEKATVQF
MVSSKEASSATSSVSEPFVKDQINKLFQK
>EGALAKHO_01591 hypothetical protein
MSIERELNKRSGSKCELCGAEENLKVYQVLPTKKGGLDESILACTTCIDQIENPDNVDLN
HWRCLNDSMWNENVAVQVVAWRMLSRMRSAGWPQELLDMMYLDEDTLAWAQATGEGEDDE
NKLVHRDSNGVILEHGDSVVLIKDLKVKGSSMVAKQGTAVRNIRLDHENAEYIEGKVDGQ
QIVIITQYVKKI
>EGALAKHO_01592 Acyl transferase
MTDNKICLISKIILLSLMLLPVQRLMAQKSYDFGKEIQNADQYNFEEINFIDSEDNTKLS
GTLIFPKTEYSKIVVIVPGSGNDTRNSHYILAEELLKNGIAVYRFDDRGVGKSGGEVNFS
VDQIIKDLYYALDNIQKNDSLSKKEIGVLGHSLGGIATIDAYQEGLKIDFLILMSTPIEK
FHKFNQPQYSSKTNPEIKVSTKTIFQNLQIPMLFIGGTNDSFFHYEKTAALVNVLNNKNI
EVKTLSGLNHFLKADTDAWKKTKEFDTLYQIDKKAVNDIVNWITNLK
>EGALAKHO_01593 Phosphopantetheine adenylyltransferase
MRKAIFPGSFDPITLGHEDIIKRGISLFDEIVIAIGVNAEKKYMFSLEERKQFIEETFKD
EPKISVITYEGLTIDLAHKEKAHFILRGLRNPADFEFEKAIAHTNRRLSKIETVFLLTAA
RTSYISSSIVRDVLRNGGEYEMLVPDAVRVKK
>EGALAKHO_01594 hypothetical protein
MKEIFEWNRLFYNDLPANFALEVVFRSTVMFIILLLTLKLAGKRGVKQLSIFETVIIIAL
GSAAGDPMFYEDVGIVPAAIVFLVIIILYRSVTWLTGKSKNFEEFIEGKTECLINDGKFS
IATFKKESLAQDEFFSELRIKSIEHLGQIKHAFIETSGEVSVFFYEDKDVKYGLPILPGL
FNDKSKNILNEGVHACTFCGHTEEQKKGTAKCKVCHKDEWVPAIKTLRIT
>EGALAKHO_01595 D-alanine--D-alanine ligase
MKNIAIIMGGYSSEYKISLISGNVVHQYLDKTKYNGFRIHIFKEKWVYVDENNAEFAIDK
NDFSVTVNDQKITFDCVFNAIHGTPGEDGLMQAYFELLGIPQSSCDYYQSALTFNKRDLL
SVLKPYGIKTAISYYLNKGDVIDTAEIVKKVGLPCFVKPNKAGSSFGISKVKSEAELPIA
IEVAYKEDNEIIIESFLDGTEVSVGVINYKGEIKVLPITEIVSDNDFFDYEAKYEGKSQE
ITPARISDELTQKVGETAKRAYEVLKMKGFSRSEFIIVDNEPYMLEMNTIPGLTTESLIP
QQAKAAGISLEDLFTNAIELALS
>EGALAKHO_01596 hypothetical protein
MSLRQYLTSRVFFVQILIAFAIIAVLGYLFMHWLTFTTDHGHEIAVPNLSKLTEEQVEEK
LDELDLDYVLLDSVDYRSEFPKYSVVEQDPLPGTKVKVGRKIYIKINASGFSSVKIPDLI
EKTYREAVPTLKALGLEAGTITYIPNLGKDMVLEMRYKGRNVKAGDRVLKASKIDLVLGD
GKASYVDDSQATDSLAVPETETPKDEQ
>EGALAKHO_01597 Ribosomal large subunit pseudouridine synthase D
MNNNIENLDLEDELFEHFRFEVPKGQAFLRIDKYLMNLIQNATRNKIQNAATEGNIFVND
IPVKSNYKVKPFDVVTVMLSHPPFENHILPEDLPLNIVYEDDALLLINKEPGMVVHPGHG
NYTGTLVNALAHHFDNLPMNSSERPGLVHRIDKDTSGLLVVAKTEAAMTHLAKQFEAKTS
EREYIALVWGNVTEEEGTIEGNLARHLKDRMQMAVFADPEIGKPAITHYKVLERFGYVTL
ISCRLETGRTHQIRAHMKHIGHPLFNDERYGGHLILKGTTFTKYKQFIENCFKALPRQAL
HAKTLGFVHPNTGEMMRFDTELPQDFQDCIEKWRNYGKTHSIEDEEN
>EGALAKHO_01598 hypothetical protein
MRIKLIALFAITQIVISCSTTISTANKEYKITKISKFKSDWDFNAKEWLLQKDTLIGIGG
PMHWGVIESKKQLPKNYEIDFKVNMTKESLFEVMLNIDKEKYIRTYLYQIDQNIVIGQGV
YSKNSDEYGKRGGPTLFKKPMKLENNKWYSVKIRVANNQLYFSVNNETFLECSIEKSKLS
QQGKLGFLTNGEAKIIDLIIKSLK
>EGALAKHO_01599 putative ABC transporter ATP-binding protein YlmA
MQHWDILLSNLVNKKAFINILLSGEAKGELAVFNNQKGILFSDIAIEKFIEKEYQYDSVE
ASPESHRQLRTFSSGERKKEFLKYCINQKPDFIIFDNPFDHLDQASRVILAESLKDLANI
IAIIQIVNRVVDVLPFVPNKAQINDNSFELHPISKTENHFKTLNTAAIPKAIDPNSFHES
VLIKMENVSVSYDERKILDNISWTIKQGEFWQLIGPNGSGKSTILSLITGDNPKGFGQDL
YLFGRKKGTGESVWDIKKQIGIFTTSMTDLFQKGHTLEEMILSGFFDSIGLYIEPTTHQK
QIVSQWLEVIEMTHLRKKRFIDLSIGQQRVGLIVRAVLKHPPLLILDEPVEGLDDENVDM
VIQLINTIKQETNVSILYVSHRIESGLAPTSVFELLPHPTGSIGKIKNHSELN
>EGALAKHO_01600 3-mercaptopyruvate sulfurtransferase
MSNKRSPIINPEEVVQLKDLTEIVLIDARAGINAEENYQNKHLKGARYVDLNRDLATVEK
NPANGGRHPLPSLEKFSEVLSKLGISPNSHVIIYDDKNGSNAASRFWWMLRAIGHEKVQV
LNGGLQEAIKSGFPTSSEIEHFDTTEYKVSGWKLATADIEEVEKARNSNQNIVIDVRDKN
RFDGLTEPLDLIAGHIPGAINVPFSENLNEDGFYKSAEDLAKKYAEILGNTKPEDVIVHC
GSGVTACHTLLAMDYAGIEIPKLYVGSWSEWSRNDREMFTQETKTAK
>EGALAKHO_01601 hypothetical protein
MSKNYILIVLFSISFLGFSQSKKANSKFKVIAFYTAKNDQAHISFVHEANKWFPKVAEEN
HFQYDSTSNWDNLNAKFLAQYKVVLFLDTRPETPSQREAFQKYMENGGGFIGFHFSAFAL
NDSSYPQNWDWYHNTFLGSGEYGSNTWRPTSAVLRVENQDPITKGVPKTFSSQPNEWYRW
GNDLTKNPDIKILLAIDESSFPLGTGPKAHEIWHSGYYPVVWTNKKYKMLYVNMGHNDID
YEHGTNKTLSNTFENENQNKLILNAIKLFGNSKK
>EGALAKHO_01602 hypothetical protein
MFTIEQIKEAHAKVKSGADFPNYIQDLIILGVKGYDTFVNDGHTEYYGVNNYTVASDDKY
ALIPISTTVNKERFIEFLVAHQDGQSDYMTFCNQSGQCGIAKWRVDIIEMTCTYFDLAQN
EILIEKIPG
>EGALAKHO_01603 4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase
MKMKIIKKLILLIFPIFCFSQEGNIKPLDINLTNYEYPFPVKFIALSNQRQSLKMYYMDI
IPEKYNNKNIVLLHGKNFNGAYWESTIKALTKEGFRVIVPDQIGFGKSSKPENFQYTFQQ
LAENTKKLLDHLGIEKTTILGHSMGGMLATRFALMYPETTEKLVLENPIGLEDWKLVVPY
KPVDWWYESELKQNYQAIKKYQMENYYDGKWNANFQKWAELGAGWTSAPDYDRVAWNSAL
LYDMIFTQPVVYEFKNIKSPTLLIIGTRDKTALGKNLVSEEVRKTMGNYAELGKKTQKVI
PNSKLVEVPNTGHLPHIESFDQFIKPLIVFLKQ
>EGALAKHO_01604 hypothetical protein
MLLAKLGIMKKTILLLLLTVPTFAQEINTFDFAVINSTLISANIDLDKGRSVVAANEDQY
SAYFQYAFNMCDDDIIFGAGIDKSEIDRTYIGYIGKICGKFRATIGLGYLESRSGYDGTF
TGFSISWHFSENTYIGGNLENLHSTSVDYETDESFDYYKKLVPKVFGSYEMIRNVIVFGQ
LSSRVNDIALKYQVRRFSAGGFYSGHGVEGIFGTVNLGRFAISCSTTFDKVNFGLKFQ
>EGALAKHO_01605 Small-conductance mechanosensitive channel
MIDYLKDFRIGIFIAIIAITTIILGAITDKVLRYFLYRKQANKDYDATGFKFLKHLIITV
IYILGFAFALIQIPEFKIIGHSVLAGAGMISLVAGLASQQALSNIVSGIFLVIFKPFRIN
DKITINNFVGTVEDINLRQVVLKDAENNRIIIPNAVISNQIIVNTNMHDTKCCKIIEIGI
GYDSDVEKALEIMKDEIAKHPLFIDSRTAETKKQKAPLVVARVVALADSSVTLKAWAWAK
NSTDGFVMYCDLLQSIKKRFDDANIDIPYPQRVITLKKDKTSTEESTK
>EGALAKHO_01606 hypothetical protein
MASFIKEISFRWSDLDPNFHVRHSAYYDFGAQHRIEILEELGLTLRVMQTQGFGPVLFRE
ECVFRKELKLSDKIFIHTKTSKMKADASRWSIIHEFRREDDTLCATITVDGAWMDTKLRK
LASPTPEIAIEALSIFPKSDDFVGL
>EGALAKHO_01607 hypothetical protein
MNQELESKFDEFEKPAIIRRKLLPWWIKTFCWIFMILGVCALASLIGNAFTDNVSLSLYG
FSCNTAYSGVGIFIIAVMALKGFASYSLWFEKPNAIIIAKIDAIVGIVICIASMFIIPFA
SGDGHIAFRLEILLLIPYYIKINKIEYEWDNLESL
>EGALAKHO_01608 hypothetical protein
MEESQLLPNLFRTEYRKIVSVLCYLFGIENIEIAEDITSDTFLAATETWSIKGIPENPTA
WLYTVAKNKTKNYLKRDAVFEQKLSVEIKHTANKSEEIEIDLSNKNINDSQLAMIFTVCN
PVNSAEAQIALALNLLCGFGIQEISDGFLTNKEVIYKRINRAKEKLKESNIRIEQPTISE
INDRLETVLTTLYLLFSEGYYSTSQNTILRKDLCAEAMRLTFLLIENPTTNLPAANALLS
LMCFHSSRFDARTNENGETILYQDQDESLWNQELIEKGQYYLVQALTGNKLSKYHLEASI
AYWHTQKEDTAEKWQNILQLYNHLLILEYSPIAALNRTFALAKTNGKKEAILEAEKLNLT
QNPFYYSLLGNLYTDINNQKAIENFEKALQITSSPSDKATIIKNINSIKSY
>EGALAKHO_01609 hypothetical protein
MNEFVLIFRRDFSTKETQPSPQELQNSLKLWQDWLGGIAAQDKLAKPLQRWDGEGKIVTK
NKNVINGPYVEIKESIGGLIMIKAADYDEAVAIANGCPILDLGGNVEIRMAVTGTH
>EGALAKHO_01610 hypothetical protein
MENRINIHEKGQNALKTLYPIGGYLKKSPVELALLELVFFRVSQINQCAYCLDMHYKDAR
DKGETEQRLYGLTAWRETSYYTNRERAAFAWAEALTKCEVTDSVYNETAKEFSEQELIDL
TLAITNINTWNRINLAFPNEPGTYKVGQFG
>EGALAKHO_01611 Sodium, potassium, lithium and rubidium/H(+) antiporter
MENYTIIIFILAIVIGLSAFADKSKIPYPILLVIVGIGIGFIPTMAEIEINPEIIFLIFL
PPLLYDASFNISPKHFRTNLSTISTLAIPLVFLTTFWIAVVSHYLIPGMTWPLSFVLGAI
LSATDAVAAVNVTKGLGIPEKTITILEGESLINDASALVAYRFAVATAMGSAFIIWKATF
QFVLLLAGGFLVGFVMAKILAFILTKVRKNINVTVSFMLLMPFVTYLVAEHLHVSGVIAV
VCLGLSISRFSNKIFPESLKNNSKSLWDVIIFILNGLIFILIGLNFRYILKNIDDNMILP
YIGYAAIITIVALLTRMIRIFFQKINLQKSFLKNDTKKRKVSEHALLDSKNSLVIAWSGM
RGIVSLAIALGLPKHLPDGTPFPERNAILFISVAVVLLTIVGQGLSLPWIVKKLNLKEEE
K
>EGALAKHO_01612 Chaperone protein DnaK
MGKIIGIDLGTTNSCVSVMEGNEAVVIPNAEGKRTTPSIIAFVEGGEIKVGDPAKRQAVT
NPTKTIASIKRFMGHSFAEITEEAKRVPYSVVKGDNNTPRVDIDGRLYTAQELSAMTLQK
MKKTAEDYLGQTVTEAVITVPAYFNDAQRQATKEAGEIAGLKVMRIINEPTAAALAYGLD
KKGTDQKIAVYDLGGGTFDISVLELGDGVFEVLSTDGDTHLGGDDFDHTIIDWLADEFKA
EEGIDLRLDPMSLQRIKEAAEKAKIELSSSAETEINLPYVTATASGPKHLVKKLTRAQFE
KLTDSLVKRSMAPVAKALKNAGLSVSDIDEVILVGGSTRIPRIVEEVEKFFGKKASKGVN
PDEVVAIGAAIQGGVLSGDVKDVLLLDVTPLSLGIETMGGVMTILIEANTTIPTKKSQVF
STASDSQPSVELHVLQGARAMAVDNKTIGRFHLDGIPPAPRGVPQIEVAFDIDANGIIKV
TATDKGTGKSHDIRIEASSGLTSEEIERMKQDAEANAESDKIARERAEKINEADSTIFQT
ETQLKELGDKIADDHKTAIEFALTELRFAHQSQDLEAIQKGLDNVNAAWKTATEAMYAQG
DQGQQAAPQQEQSQGDNVEDVEFEEVK
>EGALAKHO_01613 Hexuronate transporter
MHTKNEVIGKYRWTICGLLFFATTVNYLDRQVLSLLAPSLSEEFNWNNTDYANITAVFQF
IYAISMLFAGRIIDKIGTKTGYILAITIWSLGAIMHAYAIPIGTTVNSILVWVGIAAVPV
SILGFMISRSFLAIGEAGNFPAAIKAVAEYFPKKERSLATGIFNSGSNVGAILAPLTVPW
IAVNWGWETAFIIIGAIGFLWMFFWYILYEKPEKQKRLSAAELNYILEGEVKEKEAGVSE
PKEKISWIKLLKYKQTWAFVSGKFLTDGIWWFFLFWLPKYLEAQFGLVKTDIAFPLSVLY
TMTMVGSIYGGYFPMYYINKGYNAYEGRMKAMLIIALFPLVVLLAQPLGHISYWIPVVLI
GVGASAHQAWSANIFTTVSDMFPKKAIGSIIGIGGMAGGIGGVLVSKIGGALFDYYEAQG
HIQTGYTIMFVLCAVAYLVAWTVMKILVPKYSEIKDL
>EGALAKHO_01614 Uronate isomerase
MQKSFITDNFLLHNDFAKKLYHDFAKTQPIYDYHSHLSPKDIAEDRQFENITQLWIEGDH
YKWRAMRANGIDEKYITGDASDFEKFQKYAETLPNTLRNPLYHWTHLELQRYFGVTELLN
AESAKRIYDACNELLKKPEYSVRNLLHKMNVKMVGTTDDPTDDLQYHKQLLDEGFTISVL
PTFRPDKATEIEKGEAFVLWIKKLERVVVFRIKSFDDLVKALQIRHDFFHLRGCKISDHG
HASFYNASATKEEVNLIFEKAMQSASLTSLEIEKYKSALLFEIAVINHKKSWVQQFHVGA
IRNNNSKMMNLIGPDQGFDSIGDLTMAQSMSGFFDKLNSNDALTKTIVYNLNPRDNEMFA
SMAANFNDGLVPGKMQYGAAWWFLDQKDGMQKQLDVLSNFGLLSRFVGMLTDSRSFLSFP
RHEYFRRILCNVLGEEMEKAELPNDMNLIGDLVQKICGENAVQYFDFHQK
>EGALAKHO_01615 Mannonate dehydratase
MKQTLRWFGPNDPVSLSDIAQAGATGVVTALHHIPNGQVWEVEEIQKRIDIVKYKDGNSA
NGLTGLNWTVVESIPVHEDIKKQSGNYLQYIENYKQSIKNLAECGIHCVCYNFMPVLDWS
RTDLSYEMPDGSKALRFDMTEFAAFELFILKRPDAEKSYSAEQIKAATAYFEKAPAEDKK
KLQQNILAGLPGAEEAYSVEDFLITLAAYDGIDSNKLKEHLFFFLKEIIPVAESNHVLMA
IHPDDPPYPILGLPRVVSTENDLIELMRAYDSKSNGFTMCTGSYGVRADNDLAGIVRRHG
DKMNFIHLRSTQRDEQGNFYEANHLEGDVDMYEVVKEILIVEKRNGTKLPMRPDHGHQML
DDLKKKTNPGYSGIGRLRGLAELRGLELGIKRSL
>EGALAKHO_01616 putative oxidoreductase UxuB
MLNLEGKIALITGGAGVLGSNMAEVLAKQGVTTGIVGLTLEEAQTAVDRIESNGGKAFAV
KGNVLNQEDLEAIRDFIKEKYGRLDILINAAGGNMPGATIGPDQAIYDLKLGDLQKVMDL
NVIGTMVPSKVFSELFAAQKSGIIINISSASAERPLTRVVGYSASKAAIDNFTKWMSVEL
ASKYGEGIRVNAIAPGFFIGEQNRALLLTPEGDLTPRGIKIIEHTPMGRFGVPEDLDGVL
LFLCSDLSKFVTGTVIKVDGGFGATSI
>EGALAKHO_01617 KHG/KDPG aldolase
MSKIDQIITTITNQGTLPLYFNKDETVSIEILRALYRAGIKAIEYTHRGAEATENFKKMI
AVRNAEMFDLLIGIGTIKNETQTEAYLELGADFFISPGFVPEVAALLKSKEILYIPGCMT
PTEIIAAENKGIQFIKLFPGNKIEPDFLSSIKDIFPDLIFMPTGGVDTTRENIQAWFDAG
VSAVGMGSKLISKKLMDEKDYQTIENQTKNVLNIIKTINK
>EGALAKHO_01618 2-dehydro-3-deoxygluconokinase
MSNKIVCFGEILLRLSPPNHLKIFKSKTFEAHYGGAEANVGASLALMGCDVNIVTALPQN
ELGTSAESEMLSYGMRANIIRQGERIGIYYFEQGASERPGRVIYDRNSSSFSLLKKGMID
WKTIFKDAKWFHWSGITPALSQDLAAVCEEALIIASEMGLTISADLNYRPTLWNYGKKAN
ELMPNLIQYCDVLLGGIDDSENCLAIKTTEDESFEVVYKKWQKQHPKLKTIVSTLRYNAN
ASSNTIGAVLWSDSKLYQSREYKISHIIDRIGAGDAFMAGLIYGLINWPEDPQKTVDYAL
AGSCLKHSIAGDVNTASAHDIIALMNGSTGGRVIR
>EGALAKHO_01619 hypothetical protein
MKTILNLHRISMKKILFLTSVAFLFNASVLWSATRNVVTGYGADNTGATYATVQIQNAIN
ACQPGDILFFPDGTYLMDSGLTLKSNDLTVIISPGALIKANTIYVWRENGSDLFFGENLQ
NIEITGGGIIDGGGLVYERSTRPYNKPGRGIELIGCTNVNIHHLTVRNIPNFAINIERCN
LVVADNLLIRGRPFDNFRGSADGLDIQSCYDVTITNCDIEVGDDALCLKVKPEAPLHKVR
IKNCILASSCNALKLGTDTKNDAYDIIAENIIINKHSNPAASGEDPISTGDCISAITIQS
NDNTNVHDITVRNVTINSCYNPIYLELQNRGNNNPFLGKLSNILIENVNCKKSTIQPVVF
NYDCDYPTKMEDVTLNNITVYNYSSNAGVNQTCMSGNYPEVKNNGIAAAYGIWARGIDGL
DINSCDFINTGNSTRPRTYFENTTADVHETNGCTRIPIDPFSKVNNGAYRNIPITVAATG
ASVTFGPQPTNGTWSWTGPNGFNSSSREITISNVQDSKYGTYTATYTNTCGAVSTMDFEI
TNKNIYEAENALINEGTINDGATGRYVDLNAGGFLKWGNVNMTTAGTYTLAFNVAVYSAG
TRKMGLYVNGVKKGIITSSSLAFAEVSLNSTLNQGNNVVELRDTEGTTELNVDYLVVKTT
SGGIAAKGAKTAAVTTEPLAEEGFYVYPNPTNGILNIDFHGEKYTSIQVYDSTGNTIFSK
KIDAENALQIDLSSVLKTGIYVVSLKSDSKVTNKKLMVN
>EGALAKHO_01620 Alcohol dehydrogenase cytochrome c subunit
MKKNDTIPVLILVLVIVASVVAMIKSKDTVYILNTELELPQGFVAIKLIDSLGKVRHITV
TDNDRIYARLAKPINGKGTLLLEQQNGKATVKFGFGNYGGTGVHLYRGYLYTSSNSEIFR
YKLDKNGQVIDTTARETIVTGLLDNGTHETKSIMMDNKGNMYIPIGCPLNSCQQEDRKKG
SMGIPDCPLLKISGGVWQFKSNVLNQTIEDGVRYATGLRNVVAVDWNTQTNQLFVMQHGR
DQLDYLFPDLYTIKQNAEIPAECMYALKKGDNAGWPFIYYDYLKKKKIQMPEYGGDGKKE
GSSKYLDPIAAYPAHLAPNDILFYTGNQFPKRYKNGAFIAFHGSWNRRPEPQMGYFVVFQ
PFKNGKPYGNWEVFADGFSGSAENTASGKAIRRPCGLAQGPDGSLYISDDKKGAIYKITY
DENRITQNLESSKSKTIIKDDDKILDETNKINAAGAQIYSRNCAVCHMDDGTGVTNLNAP
LKKSSNVVGEKSRLIKTLLNGLKGGKLDGEMYSNAMPSHSFLTDKEIADVLTYVRNSFGN
KADAVSNEEVSAVRKIK
>EGALAKHO_01621 L-glyceraldehyde 3-phosphate reductase
MTYQPSSERYQNMEYRRCGNSGIKLPAFSLGLWHNFGNVNNFENSRELIKTAFDNGITHF
DLANNYGPPPGSAEENFGKILKQDFKCHRDEMIISSKAGYTMWDGPYGDWGSKKYLASSL
DQSLKRMKLDYVDIFYHHRPDPETPLEETMAALDLIVRQGKALYVGISNYNAEQALQAVK
LLKHLGTPCLIHQPKYSMFVREPENGLLDVLGKQGVGCIPFSPLAQGLLSDKYLNGIPKD
SRVATSGQFLKESHITPEILEKISLLNNISRQRGQKLAHMALSWLLRDERVTSVLIGSSK
PEQIIDSIEALKNTSFTNEELQTINTILK
>EGALAKHO_01622 Exo-poly-alpha-D-galacturonosidase
MKKKLSISFFSLIAFICTNITIAQTNSFDHLKLASDLEVMAKKLEKSLAADHSNLPVYNV
VKDFGAINDGKQLTTKQLQAAIDECSKKGPARLFFPEGMYLTGTLILKSGVHIELDKGAR
ILGSTDPKDYIVVQPAYKNNTDLQVDKSLFYAEKVDGISITGKGIIDFQGTSATYLGTGN
NDKRRPYGIRIISSKNIYMSGVMLLNSPQWLQHYLDCENLMVENMNVFNHAHQNNDGIDI
DGCRNVYVRNSRFDSDDDAICLKSNGTSLCENVLIENCTAASHCNSLKLGTETTGGFKNI
IYRNCKVVQSVTGLHKVNGTETTRTAITLIITDGGKMENVWFDNIEATDCVTPIFVTLGN
RSRKHTASAPTPPIGSIKNIRISNMKAFGAGPMASSVTGLDNANKVNNVVLENIAIELTH
PGETADRNIDMTALLAAKKRGYPSPDTFGNMTSYGFNFKYVNGLKIENLKFDLKCKDPRE
AIVIEDCENVDKAKK
>EGALAKHO_01623 hypothetical protein
MTKKIILLGLFLFVFCPIMAQKTAISAKDIEKTIRSTELERKSLSDTATINLYQGNGVFG
SSYGPLGLHIDPSKNASFTKYGKTEYFNMHHYVRAKYGADYLIPLAKFYWQKEPEKVTKY
SQNQSYYDGTISTYFEETQNKVTVLTWFDAVNTNLAGIKINVEGKSSDIIFKPSDILDVH
YDQKLTQISKITNEKEQWKIELSCLNAKIIVYLKTNAAVELQDNNLVLKLKSGENNILLS
VKEPISISAEKSLNQNSEWWHSKWQNMGIIIVPDLNAQKLWVRSMAQFLSSFNDQKLGLP
PPMGFTGNHWSFGYPQDVSFVHSILLSTGNIEMAKSWVENFADRIPGMKAYTKRLLNVDG
IMAPWTFPYGDFEGYHDPAVPNKFYYEIHNSGYMARMAYETSVFVNDKNWTEKNAKPLIA
ELAKFYKSISKKEADNLWHIIIQPSTGQDEKGGVNQDDYLCALFSAEYCFQKAIELNLDE
DGTYAKILKEGLAFPALKSQRGIYFTNRGRGESDFGSQKHPVQLNPLAFLPIEKTVSETS
KTAYELRYDITMGAKKPYFYGWTLGEFLLAGSRMGDVAGWQKDWDNLRKADYVDAEWIQV
YETSGVYKDAYYNITNGLITQSLLNNIVTDWYGKLEIAKCNPWKEKVYLQNIYSKLGVIL
SGDVEGKSASLELKAWKDCKFDLNGENITLKKNETIKKKIALK
>EGALAKHO_01624 Unsaturated rhamnogalacturonyl hydrolase YteR
MRQILIFTVAASLSMISFAHAQADLKHWPKGTSPEEIGQRVAQRFIETPHTNFGKPTPPK
NITYSEVCVWYGALTFAKESGNKKLAGQLKDRFDILIKKEANLIPVPDHVDRTVFGAIPL
ELYQQTKQEVYLAIGKNYADTQWNTPDSLKLKPELQEYLKKGLSWQTRLWIDDMYMITLV
QSQATRATNDLLYIDRAANEMVVYLNSLQRENGLFYHAPDVPFFWGRGNGWMAAGCAELL
RTLPKNHPKRAKIMEGYKKMMATLLQYQDETGMWRQLVDDSQSWPETSCTGMFTFAMITG
VKNGWLDKNTYEPAARKGWLALLTYLDANGDIREVCQGTNKKNDRQYYLDRERLTGDMHG
QAPLLWCATALLRN
>EGALAKHO_01625 Exo-poly-alpha-D-galacturonosidase
MRKQATLNFTITEKSFFLAFVVFLLSGFCVILNAQSKETNNVFNVRSYGAIGDGKNLDSP
AINKTIDAAVKVGGGTVWVPAGTYLSGSIHLQSNINLHIDAGATILGAPQEMNAYDETEP
SNVGPYQDGAHTYFHNSLIWGENLTNVFITGHGFINGGGIIRDDEILNKMNGHDNWQNPN
PVFKPMRLGNKAIALKSCKNITISDITIVHGGHFAILATGCDMMTVDNVTMDTNRDGIDI
DCCRNVVVSNCRVNSPGDDGICLKSTYALGEFRTTENVSITNCQVSGFQEGTLLDGTMKP
RPKASGRIKLGTESSGGFRNITISNCTIRSCRGLALESVDGAMLENITISNLVMTDLYHY
AIYIATGNRNRSPGIKTNSRMKNVLISNVIATVSDKMSGIQIMGLPEEPIDGLRLENIRL
ITKGGGTSEDAAIKPKELGDGYPEPYKIGTLPSYGIFVRHVKNLELANITTSFETTDNRP
AAMFSDIQGIDIDNLKLQTVDGVKKIILTDDVKGVNIRNTTLTK
>EGALAKHO_01626 hypothetical protein
MKKNLIILFSILFYSIGTNAKTPVAADRWLEIDLYWFEHKDMQKSANEFWERYEPLMQGI
DGWKGVIINVGWITDYLYEWQGDINQEIKLPKNMKTWGSIKDQGQLAGTTPERMDLWKER
FEKADKPQSINYEKWTYADLKKLVAILKKTAQNKYNLKDIKVGTFITGGQSSYDGDKSSF
SLRHANSYRNGKPNMVAKLAAESHKYGAFPEEIPEGTPLTEFFGKQWGSLSKALNLDVII
LRDGFLGTGLYSRRKGPYGETAPKDPKLVAEWSKATADLVKQTKISNPKALVIGYSNAAS
AIGGWRANCFDLETIAKEGYLDGWIDQSWAGSWNEVGQRPVMNYVPEVRFWSSPLLGYSY
MLGYMLSHSAMLADTKVHHYFLTETFDAWETWDIIHNARERLRWGVWAYSHAALKTPSGL
KMPNGSYISWGNRGKMLLPAEDVKFLAQTTNEAFTDAAATKEVFGPTLVYNRNAMEWQSN
NKPDENIKEWIDEQAGTLMKWSAPIMSVTRLEYLPNVQSDLFIFQTPSHLNSSEKENLIK
VLKSGKPSMVIGSPVGGLDKDIASILGVSSSDTIINSTKYIGTINYKTEGIYNSIPNTFP
IFQPFTQNKFTSDLETIYSVSFSPALGWNQKDGKNLIYWDAPEFFNNLPAGTDNYKGSLD
QIMGSPTPYVLTARLMNETMKKSGFAYVDEIKQEQPVQLSMWKLNDGSFRIMAGNLEEGI
NHTANHTVQTTLNLPFINNKAVEVSELWNRANTIIGNKKLEINLTQAQTKLFKIEKP
>EGALAKHO_01627 Glucosidase YgjK
MKKFYSFFLILSFIGQITAQKAVIELGTESWGKGIKKLYIPNKFVAENNFIKNTPQNFTA
LPTFIQIKDKLPIPIWKANNNAIACYWKAWEIAFSNLHTVSLENGFVSPYIDAAFNGNIF
MWDTTFMTLFGRYGSRAFNFQGSLDNFYNKQKPDGFICRQIYGSNGEDCFERYDPSSTGP
NILPWSEWEYYTNFNDKVRLAKVFPALLAYYNWFNLNRSWKDGTYYSTGWGCGMDNQPRL
QSEYSVKWSNGQMSWIDTTLQEIFAARFLIKMAVELDRENDVKNLQEEVQNLTQFVNEKM
WNEKLNFYTDVFKDGSPSNVQSIGSYWALLAGVVPENRVNQFISPLSDPKKFNRPHRVPT
LSADSPDYNADGGYWRGSVWAPTSYMVLRGLTQMHQDSLAHEIATNHFDNVLIVYNQTGT
FFENYSPEKIQGNDRKNFVGWTGLTPIAVLFEYIFGIRADVPHNKIVWDVTLTDEFGVKQ
YPFGTDGTIDFYCKSRKDAKTMPQITVKSNKDFTLTLLWAGGKKDILIKGKKYKTE
>EGALAKHO_01628 hypothetical protein
MFGEGTYQNWVNFFPKIREDLIFVMDDSWDIPLSETSKDGPSFGLTELNQERFPSYTGTP
AERLTKLVDAVKAKGWKGLGGWICAQEAPIAGNVNSEEYWTQRLKDANKANFTYWKVDWG
KQSRNLEWRKTMTKLGRTYAPNLVIEHAFNGYAIEVSDTYRTYDVENVTAQPLTIQRIAN
LLHYQPQGDAKSIINCEDEPYIAAGLGCAIGVMRYPFPDKLPNNTNDYAFPPIGRNMKYR
MDEITRGVRWHRIAEPFGVGSENYSIDKNVLKDYWVLAERETWNKKHKPGDTLRENAPAR
VSRGLPLAKVLNPSADQPFVLSSMYPNGAVAVVTIGRGLNREYITKRVKVEQEIENIDNA
IGIFGDYEALTFLLPTKIKASDYEVLGQDLAGDTASVITKDVVFKDNKIIISGDLIRKIG
LSSASKNDISDPGLVLKFNKKIK
>EGALAKHO_01629 SusD-like protein
MKSNNFLIVTALSILITSFSSCSNDFLDENPQSFIAPTNFYKTEADANAALVAVYNGLRA
IYSQDITFVGDTAGEQTWPGVSNSNVDRANIDAFQFEPSNTILLGNWNNNYVVINRANAV
IDRVPAIEMPAATKDIIVAEARFLRAFSYFNLVRTFGGVPLRLAETTPLHLERSTADAVY
AVIIDDLKQAEAKLPAVQPTANVGRATKGAASTMLAYVYLTKKDWTNAAAKSQEVINNAG
AYGYGLYATPADVWKIANENKLEHIFSIQFQSGPEGFGSAYAQFYLSRTANVIQASGISG
FGQNLVEDKFWKSFAAADTRRDASILSRFVDPKTQKVYQYPSTDLTELSIFKYFDTAPYA
RSNNNNNYPILRYADVLLMKAEALNELNGPSAESYGAINAIRKRAGAGMTDLAGLTKEQF
RAAVLQERSWEFCFESKRYFDLIRTEQLIPIMTAAGKNPQAKNLLFPIPQKEIDTNNKIN
PEDQNPGY
>EGALAKHO_01630 TonB-dependent receptor SusC
MKKPPKSNGLFPWNLLFDLKMKLSLLFFVTVSFVMQANTSYSQKTKITLDRESVTVKEVI
DEIETTTEFKFLFNTKAVDLNRKVSLSVKKVPINVILDILFKGTDTSYEIDDRKILLTKT
KANKIATVDSPAVIDFVPKQIKGVVTDSNGQPLPSANVVEKGTKNGVTTDFDGKFALTIS
DENATLVVSYIGFDTQEFQVKGQATIKITLKENAAGLNEVVVVGYGTQKKHDVTGSISSI
SKNSIKDLVLTSTEQALRGQAAGVQMTQSSSAPGGNASVRIRGGNSISAGNEPLYVIDGF
PIYNDTSASSTGVLGNGQPSNVLASINPSDIESMEILKDASATAIYGSRGANGVIIITTK
RGKTGQSNVTFETYYGFQQLSKKIDLLNAHDYAISVNADNIRRGRQPYVANPDSYGEGTD
WQDEAFRVAATQNYQLNFTGGDDKTKYSVSGNYFTQDGILLGSDFTRGSVRVNLDRNLSS
KFKLGLSFSSSLTENNQAKTDSDLDANNQGAVSAILYAPPTQTPYNADGSYSRFRNADGN
FYVNPIASLLEIKNLNKTNRTFGNIFLDYKITNDLVFKITLGGDQINVKEDYYNPAFIQD
TGITAKARIGVNQSFSWLNENTLTYTKTFGGKHNLTALGGFSRQKLTRETVTAGSERYVN
DILEDNNLGAGATANTPGSNVSDWELESYIGRINYGYNDRYLVTLTGRADGSSRFGESNK
FAFFPSGSVAWRASEEEFLKSSKVISNLKLRASYGETGNQEIPQYRSLAALGTANYPIGG
IIGSGIASTRFANPDLRWETTAQFDAGIDVSFFSNRINIVADYYDKRTKDLLLDVQIPGS
SGFTSSLQNVGSVKNSGLEFAINTVNFDGEFKWKTSFNITFNKNEVLDLGGEYERVVGGG
SASKQITNTGILRVGEPVGAFYGYVTDGLFQTQAEVDAGKAAGQPTTSVIGDRRYKDTNG
DGKFNESDRTILGYAQPDFFWGLTNTFTYKNFDLNVLINGVQGNDIVNLNVNAQTDVNAP
ESLNRWTPTNTNTDIQRHTQDTRLTNKQVEDGSYVRIQNISFGYNMPQVVFKNTFVQSIR
LYVSLQNWWTFTDYKGYNPDVSSFGQDNLSLGVDRGGYPAAKTFLMGLNVKL
>EGALAKHO_01631 hypothetical protein
MDFKDIEIIIVKYFSQSANMQDLDVLNKWIEDPENELIFQEYVKTHFAITLAMNDPDVKS
IRKALLKEIRKEKKKAKNNRLRSFMKYAAIAILFLGIGAFLQKNVFNENITKEVIVPKKD
EITLKLGNGNIKVIAADGTSKVYDANGKVVGQQNGKELIYTNDPNATKLVYNTLTIPNGK
RFNITLSDGTMVYLNAGSSMTYPVQFIKNQNRKIFLTGEAYFDVTHDKKHPFIVNANKLD
VQVYGTKFNVSNYQEDDATDVVLVEGSVSMTEAGLVGKNKNEFFLTPGYKGTFVKQNRSI
SNEKVNTSLYTSWMNGNLVFRQETFANIIKKLERHYNVIIINNNKSLGNETFNATIETDS
ESIVQVFNYFKKVYQIDYSIVENKIIIN
>EGALAKHO_01632 ECF RNA polymerase sigma factor SigW
MDFDDNVVLMESLKNGDEKAYKFLLNKFHRKLNAYALTLVNDHSMAQDIVQNVFLKTWKN
RNKLNPEFSIQSFLYKSVYNEFINTYQQNKAMMLLQQKYVDSLQQVVETTDESSIERMLA
IINKEIQNLPPKCQKVFILSKKEGLTNIEIAEHLEISIKTVEAQISKAFKILKEKLKDNY
NMMLFLLFHSPQKE
>EGALAKHO_01633 hypothetical protein
MKKHNCLLLLQFLLVCFFNQTTIAQSIIIKGAIPIYVSPDEPAPVRRAAEDLQRDLYTVL
GQPSAFVTKLPQKGPVIVIATGDHYKKDNRLIKGWEAHQIYTNKERIILNGADMRGTIYA
IYSFSELILGVKPLWFWASEPPVHNNQITMAANYKKVFNSPDIKYRAWLPNDTDFLTPWQ
KLSDSNYQALFEAMLRLKLNTLEGVITGKESFIPPYSPGKDATTGQQRGLITTGHHLNIF
GSTYAFWEDYWKEVRHLPAPELTIANRQALKEFWGYHIDLAKRNNLEVVWLVGFRGNHDI
PFWEFFPDAPKDDKSRAKVIEEMVQMQIDLLKEKTGDPHPPMRLTLYNEMSNLTAAGLFH
IPDEPSLIINFVAARRDHFPALDVRNYTFSGKPVGYYLNFQFTSTGSHLAQAEGPRKMEQ
NYRIVDSLSGHKLLFSVVNAGNIREHLVELSANADMMWNFKSFNPTSFLSTFSNNYYGSQ
YGIEISQLYQDFFNSYWQQKKGDLPGFERQYLFQDLRYARAIEMLLNDLEKGKYSTNPLD
NHPLDDPSKGSVGYFRVIPADNDAENQLEAMAKGTASSIAKLEKITIKSDQIYNKLESGK
VFFDDNLRGQAYLMLHLNRSLNYLVQAYESKENKEKKREFIKQTLNEIHLTKERLNTSNH
APFNDWYTNDAKFGMNLLEKRLSDLYNELSK
>EGALAKHO_01634 putative hydrolase
MENINKPIEGVTTGILKVSGAELYYETKGEGPLLLMIPGANGDHFIFTPIREILSKTFTV
ATYDRRGFSGSKLIGEQDYSHRIDTDANDAANLIKHLTNKPAFVFSSSSGALVGLQLMCL
HSDLIKALIPHEPTAIKYLPDTEKWKSTIQEIHDIYTKEGEGPAKEKFVNDLIPGTQDGE
LMKGGKEPETSNTKYWFEYEIRQYPSTDYDTNKLEENKDKILFCVGRDSVNTMPAWPVTN
LAKQFGTAVLYVPGGHLGYALHPAEFAKELLEGLQKRGKL
>EGALAKHO_01635 hypothetical protein
MKIITIEEHFTSPKITAKMQRFQSNNLDAGKAKNMEEIIKHFLPTNDDIEDVGIRRLQFM
DESGVDMQVISYGGGSPQGIADPNLALELCKEANDELAAFIKQNPTRFAGFTTLPLADPI
AAAKELERAIKVLGFKGALIAGTFQGKFCDDPLFFPIFEKAAELNVPVYMHPGIVEKSVA
DHYFRNENWSKLVNGVFPAAGFGWHMDSGIHVIRMILSGIFDKLPNLKLISGHWGEFVPA
FLERLDETLYPEITNLKRPISEYYKEHVYITPSGIFSEVQLQFAIAQMGADHIIYSADYP
YLMKKNTGDFLKNASISDQDKEKIGHLNVEKLLNL
>EGALAKHO_01636 hypothetical protein
MKMLLKKPQENTIQNIVDKFSIKELIEFERFCRDNAQWEEMKKCFAENSTVTISWYKGSG
HGFVDASSKMATYAPHKIYDTLIWLNNDKAVSITMAKIQMRMEIQGHLLELSSDVKLLYK
TQKANGLWSIISMDGIYEKDALVPVSPADGIVIPKEEIAKFRPSYANMSYCLSKNGHPVD
VNLPGIDKPEMVDKLYQESEDWLNS
>EGALAKHO_01637 hypothetical protein
MTDIFKDFITELAEINEQDMNRIMSCISVYKVKRNTIILSQGEVCDKFYFLEKGCMRTYY
ITEEGQEKTRLISFDNTPVTVLTSFINLKPSVEYIDTLEDSELLSMSQADFFRLLDEIPS
WALFYRKILELAFAFQNNRIEDLVTLSAKERYEKLLKERPHYIQRLSNKIVASYLGISQE
TLSRLKSK
>EGALAKHO_01638 Cocaine esterase
MNNIAEKMIFKPAFEYIDNGIEHGVLSPFETKETILNKGEQIAPGFKPLGCDIRFLKDVP
VKMRDGITIYTDVYLPVTEEKVPTLIAWSPYGKSAGTAPRYVGLFNMLGMGNAWGSGLTK
FEAPDPAYWVQHGYAVCNPDARGIAHSEGDITMIGSQEAEDAYDLIEWLAAQDWSNKKTA
LSGTSYLAFSQWFIAAGQPPHLTCINPVEGLQDAYRDLAYIGGIPDPNFLHRLQVNHVSA
TGAKREDMVAELEAYPLANCDLWEDKVADVSKITVPAYIVASYSNTLHTMGTFRSWRSIG
SKEKWLRIHDTQEWPDYYANESTEELRKFFDYYLLGKQNGWEKTPTVQYSILDFHGGNRT
GLTSETFPPKESELQRYYLNGKTRTLQLTADENETPLRYFPEAMPARVSFQTVFDKDTTF
IGYPKVKLFMEAENADDMDIFVWVQKIDKLGNVLSEFVVPNRNAALQDFTQDGASALRYK
GASGRLRASHRHLDPKRSTDEIPAYSFDRIEKLSPKEIVELDIVLSPLGLIYYAGETLRV
MISSKDEIGSVMPGTPGCTPNNKGIHVLHTGGKYASYLQMPLMK
>EGALAKHO_01639 HTH-type transcriptional regulator ChbR
MKATVNFPNTELKTILKQRGFKVSWNKVKKGGPSAFGRRHFYLILLSIGNSKIQYNDKVF
ELDGVYLFFANSRIPYATEILSEKHTGYSCVFTEEFIKPLERLDNLQQSPLFQLNSNPAF
KLNPEQQAKLSGIFDTMIARDSSDYLYKDDLMRTYIELIVHEALQMRPAEHYIQSSNASL
RIVTRFMDILERQFPIENLNEPLKLKSAQDYAGLLSIHVNYLNRAVKEITGKSTTAIIAE
RIAAEATTLLRHTDWSVSEIAYILGFEYPNYFSNFFKKMTGNIPKSYRDH
>EGALAKHO_01640 Cobalt/magnesium transport protein CorA
MRKIKYKKGRKLQHITLEYTGTQKEHKTEMQLFVYDDNDVIEYEKFTVESLNSCIDYSKN
NWLNVHGLNDIGLIKTIGTHFKLDDFLLADILNTSKRTKLEEQQNILFFNIKSLLPSEYS
DNISVEQISFILKDGILISFQEKRSDFFTHIRERLRTHAGIVRTKKVDYLLYLLLDAVME
NFYITIEDEEDKIEELINLTKKGADPIILEKIENHRDNFNFLKRSIIPLRDSLYYLKTIK
DDDTYNGIQKETFSFFIRLHQKSLELLEQIDSDMSSLESASNFYFSEQSRKMNEIMKTLT
IISAIFIPLTFIVGVYGMNFEYMPELREKNGYFIVMGGMFLLVIALIIYFKRRRWF
>EGALAKHO_01641 Phosphate acetyltransferase
MSKAVYIATSDHNSGKSIITLGLMSILIGKTAKVGYFRPIIEDFVDGEQDNHIETVLSYF
NLDIKFEEAYAITKSKLIKKKNKGKIGEVLDLIIEKYKKLEERFDFVLVEGTSFTGEGTS
IELDLNVLIAKNLGIPTMIIGSGVGKTLEELVDSLYLVYDSFKVKEVEVLSVFANKVQPE
NIELVTKGLQKSLPANVLINTIPLISSLNNPTMQEIVNQLDAKVLFGSAYLNNEIGHYSV
GAMQLHNYLVHLNDNALVITPGDRSDIILGALQANESANYPTISGIILTGNIIPEDSILK
LIEGLSAIVPIIAVDGGTYNITNKIGSIRSEIYANNTHKIETSITTFEKYVAIEALSQRV
ITFVPEGMTPKMFQYNMVKRAKQHRKHIVLPEGNDDRIITAASRLLDMDVVDISIIGDKK
QIENKVAELGITFDFSKIKIINPAESEFYEDYANTYYELRKAKNVSITMARDLMEDVSYF
GTMMVYKGHADGMVSGAAHTTQHTILPALQFIKTKPNSSVVSSVFFMCLEDRVSVFGDCA
INPNPTAEQLAEIAISSADSSSAFGIEPKIAMLSYSSGTSGKGDEVEKVRTATEIVKQKR
PDLKIEGPIQYDAAVDRAVGKSKMPDSEVAGQASVLIFPDLNTGNNTYKAVQRETGALAI
GPMLQGLNKPVNDLSRGCTVDDIINTVVITAIQAQGL
>EGALAKHO_01642 Acetate kinase
MKILIINSGSSSIKYQLMIMPTNEVICSGMIDRIGLDTSNITFKTSTNSLQEIIPIPTHK
IGLQKVAEMLLDSDKGVIKSTSEITAVGHRVVHGGSYFSDTTIITDEVKEKIKELSELAP
LHNPAHLVGINVAEEIFSEAKQVAVFDTAFHQTIPVEAYKYAIPNYLLTENKVRVYGFHG
TSHKYVSEKAIEYLEKNSKIITIHLGNGCSMAAIKDGKCIDTTMGFSPSNGLIMGTRSGD
IDQSVVFYMIKNLGYSPDQVNSILLKQSGMLGLTGYSDLRDIEAAAEEGSKECQLALFMN
AYRIKKFIGAYTAALNGLDAIVFTAGIGENSSYMRKLVCSDMDYFGIEIDDEKNQIRSKA
IREINKTDSGAKVLVVPTDEEYEIANQVYHLLHN
>EGALAKHO_01643 hypothetical protein
MKSILLKSLFFFFIASQIQAQELLPFVENYNKSNYQGDNQIWNVVQGKDNAMYFANNHYL
LRYDGVKWEKYTLPNKTIIRSILIEGDRIYSGSYKEFGYWYRKEGKMHYVSITKNLRLFD
EKDNEEIWKIFRFNGSLYFQSFNDVFIYNGKHIQKIRFPFLISYCFVVDKNLYVASVAKG
TFKMNGPRIVNPKGWDVLKNCVVHAIEKYQNKTYIFTQKKGIFTVEKEGLKPWNNPLNEI
LKESTINVGRFTKNNKLIVGTGNRGVFVYDFNSDTFKNIDRKNVLMNNSILSIGFDKEND
LWLGLDNGIAHVEINSPISIFYDNSGILGSVYSVATTKKGYLIATNHGVFEFDSGKFKMM
PNTQGQAWNITEINNKYIIGHNDGTFAYDNGSLSKINNISGGWNLSKSSISDSYFQSTYS
GVIVYDNLSDLTQKKVINDLSKPIKYVAQNKKNEIWAADNYRGLYRVLYDDNFKTRKVEN
ITQQSKIKNDFGVKIFEFRSEILFLINNSWYTYNSITNKLEENELFNQNFKNVSDIISID
EDHFMVLQDGILYHIKATGNKFLWNIIQAKYYKGKLINDNLRIFKHANHYLLNLDDGFIS
LQLKYENKQNSAVRIESFNDENLVPNDSKIKYNTELQINVISGIYGASKPNLFYKLDNDK
EFIPVSNGLIVLNNLSSGSHSVKVYKHDGANYDTVAGFDFSVAKPWYFSFWMILLYLLII
GAVLFFYYKWNKLRYMQKLRLQAEELKHQREILEMELKAENELNMQEYQKHILELELQTK
SSEVAGKSLSIAKQSEMIENIQNILDSEKDFNKLKSEIKKAIKINEVNKHEWEIFETNLN
QIHNEFIINLSKKYPHLTPKDIKLCVYLKMNLSSKEIAPMMNISFRGVELHRYRLRKKLN
LSQEENLSKFLLSL
>EGALAKHO_01644 TonB-dependent receptor SusC
MKNFIFSFLALLLLPAYMSGQAIKGKVVDGNGMGVPGAVISAPQSRTSADADFDGNFTIN
AKAGELLKVSMLGFDAVSVPATATPMTITLKEAEDTALKEVVVIGYGTRKKIDNTSAVSS
IKSEEITKMKVLNASQAIQGKAAGVQVSTSDAPGSTPSVVIRGAGTALGGRNPLYVVDGM
PTENINNINTNDITSYEILKDASSLAIYGTRGANGVIMITTKAGKGKLTVDVESFAGVRT
PLKKVKMANSDEYVRYSNAAFSNAFPQGRFSANQPYNTDWLDEITRTGSYTQNNIAISGS
SENVKYFFSVGNYEEKGILNGSDYGRTTIRNNNEFKLSEKVRISQNFSVSTIKNTPMPLS
AFTNAYRQSPLVPVRYTDGKYGVPFVSNGVVAETGASFNNVGNPVAQLDYTNEQQESVIL
QGGLKLDWDIIKSLKFTSQFNGEYFTYNQYNYVDNLALWLSADPTRTESGYDTKSLNTNT
LTRGRDEYFNWNLSNYLTYNKVFAEIHDVEVTAGIEANVQGTREKLTIDRKNVNPNSNYW
SLKDINVASAVTGYKDEALNQRRLASYFARFQYKLLDRYLVTGTVRRDGSSQFAEDKRWG
TFPSVGLGWIVSKESFLSNVEPINLLKIRGSWGRLGNQNVPLNTQVFTSGLDYPDLGSGN
TINSQVDPNLSWEIVEELSGGFDFEVLNSRLKGSFDLYDKNTTNTILNVKPYSTSGITLA
TPAHVGEVSNKGYEIALRWDDKINDNLSYWVGGNFSHNKNELTSLKNVQLNPIIGGSLGN
GQNTKILDNTSIGQPLGSFYMYEYAGVDPANGQMLYYKADGSKVAQAGLDELKDKKYVGS
LLPTSNYGVTLGLNYKNLDFSVDGYGTGGAKVYNGKKAQRFGGENVEASMTRDFWTPTNT
TASNPAPSNETPYASTFYLESADFFRINNITLGYKLPLKDNQFISFCRIYVNAINPFISQ
KFSGFSPDVTSDGKLVEGTQGVELDAYPALRSFVIGANLKF
>EGALAKHO_01645 SusD-like protein
MKRLYISIFVLTGLFLSGCSDDFLDVNPTESIPADVELVNNDAGAKSFVSAIYNQFLGWE
MSSFGWNAVSSIISDDADKGSDPGDAGGDKDIIDALTYNASTASFQSTWNANYAGINRCN
QALDIFPKLDKVTPALKVRLEGEAKFFRAFMYFTLVKGYGGVPIVDHVPLPVSEDDRIMQ
LTRKTPAEVYAFIEKDLNDAITNLPDKSTYGAEDKTRVSKGSAYALLAKVNLYQKKWQNV
IDNCDKVTGYSLVADYAAQYKKEGEFGPESIFEIDGIGGTSSPGFGIGNYSVSQAPRGAG
GWGWGFNTPTEGLANAYEAGDVRRAATIIFAGSVLYDGREIPSTVANPRYNYKAYSSSFY
NQEFTDTNLRYLRYAEVLLMKAEALNELGQTPAAIPLVNMIRKRAGLGDTPFTSQADIRK
AIWKERRLEFAFEHDRWFDLVRTGQAAAAMAADGKTFVVGKHELWPIPTSFLREAGALSQ
QNPGGY
>EGALAKHO_01646 hypothetical protein
MIRISVLLIAFTFFGCGSNTDKSKETVVENTSEAQLTDEQLLDAVQKQTFKYFWDYAEPN
SGLGRERYHPDGVYPENDSNIVTTGGSGFGLMTIVSGMSRGYITKDQGVERLNKIADFLG
KADRFHGAWSHWIDGNTGKVKPFGTKDNGGDLVETSFLVAGMITVREYLKDGSEKEKAVA
QKYDALWKGVEWNWYTNNKNVLYWHWSPTYDWQMNFALQGYNECLITYVMAASSPTHAID
AKVYHEGWARSGGIVSSNTKYNIPLILKHNGAEEFGGPLFWAHYSYVGLDPNQLSDKYAN
YWDLNVNQTKINYEYCIQNPKKGYSADYWGLTASYSRNPDGSIGYNAHMPSNDQGVMSPT
AAISSIVYTPKESMAVIRNLYDNHKNETWGNAGFYDALSLQNNNWVAKRYLAIDQGPEVV
MIENYRSGLLWKLFMNAPEVKQGLVKLGFSSGKYGF
>EGALAKHO_01647 hypothetical protein
MKYKITLLILLFSVLGFAQSETVGAIKTVVVVKHELGYVLHKPANTKEKKPLIVFISGDG
EKGTDIEKVKINGPLKYLKTHQLDAYVLAPQCKEDENWDIESINELILKVQRENKIDADR
IYVTGLSSGGWAAWNLALSYPEKFAAIVPISGFVDLIELESACKIANIPTRIFHGLLDDV
VKVDYAITIYKELKKCNAKDVQLTIFDDAGHDSWTRVYDNPEIYDWMFKQNKTNTNK
>EGALAKHO_01648 Beta-glucosidase BoGH3B
MKNKLVLLFLGCAVLGYAQKKNTKNTVTIKPKSEFVAELLSKMTLDEKLGQLNLPTSGDI
TTGQANSSDVAKKIAEGKVGGLFNIKSVQKIKEVQKIAVEKSRLKIPLIFGMDVIHGYET
TFPIPLGLSCTWDMNLIERSAQIAAQEASADGINWTFSPMVDISRDPRWGRISEGSGEDP
YLGSQIAKAMVNGYQQHDLSKNNSIMACVKHFALYGAPEAGRDYNTVDMSHIKMFNDYFP
PYKAAVDAGVGSVMASFNEVDGIPATGNKWLMTDVLRKQWGFKGFVVTDFTGINEMIEHG
MGDLQAVSALSLNAGVEMDMVGEGFLTTLKKSLDEKKVTIEQIDNAVKLILEAKYDLGLF
HDPYKYCDEKRAKTEIFTTASRKEARQIAAQSLVLLKNQNQVLPLKKSGTIALIGPLANA
KENMPGTWSVATKMENAISLLAGIKEVAGSSTKVLYAKGSNLDYNETFETNATMFGKTLH
RDGRSKEDLLAEALKVANQSDVIVVALGESAEMSGESSSRTNLEIPQAQKDLLNALLKTG
KPVVLVLFDGRPLVLKEENETVPAILNAWFAGTEAGYAIADVLFGDVNPSGKLTTTFPRS
VGQVPIYYAHKNTGRPLANTEGKFEKFRSNYLDERNEPLFPFGFGLSYTNFDYSNLKISS
DKMNESGKLKVTVDVTNTGNYDGKETVQLYIKDLVGSVTRPVRELKNFQKITLKKGEKQT
VTFDITVEDLKFYNSDLQFVAEPGQFDIFVGGNSAADKKVSFELTK
>EGALAKHO_01649 hypothetical protein
MKITTPFRKLLLLAMIIIFHSCGVEKNAIVAHRGAWKKNNLPENSIASLRHAIELQLPGS
EFDVWRTADDSLVINHDAHYNKLLIEETSYADLIKFKLSNGEKLPTLYEYITEGKRNNKH
TLLVCEIKPSEISKERGKKTALKTVEAIKKLQADKITCYISFDYEILKQIREIDQKTVLQ
YLEGNKSPKEVKLDKISGVDYHYSVFKKHPEWIKEAKENNIMLNAWTVNEAPDMDWIIEH
KFNYITTNEPELLKERLKAKK
>EGALAKHO_01650 Xylosidase/arabinosidase
MKKAYQFTLLILLFLMIFNSNVFAQKTNIPGKTEWFDPNKPATTYCNPINIGYNYTTQNH
NGIPESRRSSADPVIITFKGEYYLFATNQAGFFWSKDMSDWKFVYGSFQRNPGDDDQCAP
AAWVVNDTLFYVGSTWKRDHPIWKTADPKSGQWLRHVDKAMLPTWDPAIFQDDDKKVYMY
YGSSGKLPLVGVEVDYNTWLPKGNQSDYEKLYKATEVEDIQRPYGQIKEVAILDPSSHGW
ERFGPNNDMEPAPWGNFIEGAWMTKHNGKYYMQYGAPATEFKGYANGVHVGDNPLGPFTY
QKHNPMSYKPGGFVIGAGHGNTFADNYGNYWNTGTCKISIKDRFERRIDMFPAGFDKDDV
MYSITAYGDFPIALPTSQRNQEKGASSGWMLLSYKKPVTVSSSEECMEVETHRVDNGGKK
VYEKFCYGAENLTDENIQTYWSAKTDAPSEWLQLDLGRSMEIKALQINYADHKATQYNKA
MDIYYQYKIFMSDDAQNWTLVVDKSQNAKDIPHDYVELSKSIKARYIKMVNIHNASGLFA
VSDFRVFGNGLAAKPKAVSSFKVARNAKDSRNAMISWKKQPDAVGYNIYYGISPDKLYNS
IMVYDEASYDFRGLDKGTKYYFTIEAFNENGIGAQNKLIEVK
>EGALAKHO_01651 Bacterial leucyl aminopeptidase
MKKTILLTVLVINGLTSFAQSNDEKNIKLFYKKALTEAKCYTWLEYLSNDIGSRLSGSPS
AETAVQYTKSQLETLGLDKVYLQDVMVPHWVRGEKETAYILDNKVKTVVPICALGGSIAT
PKTGITAEVIEVQGINELKALGDKVKGKIVFFNRPMNPENIGTFEAYSVAGDQRRSGAQE
AAKLGAIGTIVRSLNLLLDDFPHAGAQSYGDLPKEQYIPAAAISTNGAELLSKLLKNNPT
LKFYFKQSCETLPDVLSHNVIGELTGTVTPENIMVVGGHLDSWDLADGSHDDGAGVVQSM
EVVRILKNLNYKPKNTIRVVLFMNEENGGKGGAKYEEVSKQKNENHIFALESDSGGFTPR
GFSIEADDANLKKIQGFAPLFEPYYIHSFTKGHAGSDIEHLTSKTIVKAGLQPDSQRYFD
YHHAANDKFDAINKRELELGAATMTSLIYLIDQGGIVLPTAN
>EGALAKHO_01652 hypothetical protein
MKKSKYLFPVITFLLSFACALFVAMKVFPNNPFSGTKTENSVSNKVQDGDLIFQTSESKQ
CEAVRIATNSKFSHCGIIFFVNGGEFVLEAVQPVRITPLEEWIAHGKEHKYVVKRLKNAE
TILTEETLEKMKTYGKQLLGKEYDAYFEWTDTRIYCSELIWKIYKNGAGIELSKLKQLKD
FNLIDERVQKIIKERYGNDVPLDEQVVAPSDLVESDLLKTVIDTY
>EGALAKHO_01653 hypothetical protein
MKTNILFFFLVCFSLNTFAQEEIAVERYTAHNKGKFFVSWGGNRDSYTESDVNFRGKDYN
FTVADMKAHDKPKGYHIDYVNPANMTIPQTNFRMGYFFNDHYSVSIGWDHMKYVMTQNQI
ANVTGNINLPADQAGSYYNGVYNNTPVDMSQNGAIEGGYDKGVAQGNPPAFLMYEHTDGL
NYINTEVSRHDDISKWFGLPNTDKVQINLTEGLGAGVLYPKTNTTLLGMERHDDFHISGY
GLSAKAGINFTFFKYFYLQGELKGGYINMQDIRTTVSNEDKASQDFFFFQRIIAVGGIFR
I
>EGALAKHO_01654 2-dehydro-3-deoxyphosphooctonate aldolase
MNIQHIPQIKHTDSGNFFLLAGPCAIEGEEMALRIAEKLVGITDKLQIPYVFKGSFKKAN
RSRIDSFSGIGDEKALKILRKVSETFHVPTVTDIHTNEDAEMAAQYVDVLQIPAFLVRQT
DLVVAAANTGKVVNLKKGQFMSPESMKHAVQKVLDCHNENVMVTDRGTMFGYQDMIVDFR
GIPTMQQYASTVLDVTHSLQQPNQTAGVTGGRPDMIETVAKAGIAVGVDGIFIETHFDPA
NAKSDGANMLHLDYFEGLMTKLVAIRKTVNSF
>EGALAKHO_01655 N-hydroxyarylamine O-acetyltransferase
MEQSKNNYKIEAGSFNLQQYLDRIKFSGKIELNIEGITKLMRSQLFNVPFENIDVQAGKV
ISLNGDDIVEQIVTKNRGGYCYQINGLFSLALQEIGIPHYYVAARPLVNPGQNAKTHLGI
IATIENEEYLIDLGFGGNSIRKPLKLSKIETEIQHDFDTFTLVKTEENEFLLQILIGQEW
SNLYSFDLSPQRWIDFKPANYYNYSHPDSVFTQKLIVVLQNPLGKKILSKNSLKVMTNGV
SEIFSFEDSQLNNILETEFNLRLEES
>EGALAKHO_01656 hypothetical protein
MRGTFYMDFENIYMIVENKKVYLDFNFYQKLKDNKGNNLLDGEKL
>EGALAKHO_01657 hypothetical protein
MIKTKTAFIIFILLSIIVFPYYVAIIIINSDFFYSLIPGWNTTIIPGQIIPNLIKFIILS
VVTFYYWKLSKLTKEIAYKKFLIHFCLTVPGVLFGKINLYDILNFHSVDPDHFINQIYIV
VYTHIFMTILFFAGQILFWIFYVRLQKLYINS
>EGALAKHO_01658 hypothetical protein
MIRKIVLSIFIILLALFGWIGFGLYLMEIDDHYGDLQEVYFDSKSGDIIVNKQTQKFGII
TKNWKRADVITKENDTLDLYELIYTNEAENKYEVFRSENELKIDELNFRKIIELKRKNLI
RTIIKN
>EGALAKHO_01659 hypothetical protein
MKKIAFFIILLITATSCVSTKSTLKNVDDNAPDLILKKDNTFTITLFSKDKKYGYDPDYP
VNIFYQNTRNETLNETRFLNALAGPNGEKITYKRLETCCPFPTKRSDMGAGFLNVYELTW
QGQKKPIKLYLNVYEKGILMVPMGLSLKKE
>EGALAKHO_01660 hypothetical protein
MRNATIFKAYVAFSLLYLLILLLGHENLDLFLKPVLIPILGFGVYLYRKFPTKNALLLAL
LFSWIGDVILLFADFAEIYFILGLVSFLTAHIIYCVLFNNQIKIKTKTNKIVFGIGSVII
SFYLIGMLSVLLPSLGDLKIPVIVYASVISIMLLFAFNGFLVWKNPGNKYIFVGAIVFVI
SDSILAINKFYAPIERSSFYIMLTYLVAQYLIVVGILKLNPKKVE
>EGALAKHO_01661 hypothetical protein
MEEYGKILIIATPIFLVLIIIEKIYGIYKKEDTAPLIDSVSSISSGITNSVKDVLGLSLT
FISYEWLVSNIAIYHLKANILSYFIAFFVIDFYGYWSHRWAHQINFLWNKHAIHHSSEEF
NLACALRQPIASLANLFTFLLIPAALLGVPASVIAITLPLHLFLQFWYHTKHIKNIGFLE
NILVTPSHHRVHHAINPEYLDKNHSQIFIFWDKLFGTFQAELDDVPPVFGITRPAHTWNP
IKINFQHLTLLIRDAWHSENWKDKLIIWFKPTGWRPENFEEKYPVNKIEDVYNFEKYGTQ
NSKKLIYWSVAQVLITLLFVTYLFDNIAKIGLPNIFIYGFFILITIYSYSELMDKSKYAI
YWEGLRFMVAIAIISYYGDWFGLNQSLPAINYIIIGYLSISFIASAYFITKDFKTIPNQL
INS
>EGALAKHO_01662 ATP-dependent Clp protease adapter protein ClpS
MSTKEKVRERVREKEAVDFNNEIIVYNDDVNTFDHVIDTLMRVCSHTAEQAEQCSLIVHY
NGKCTVKTGPMDKLKPQCTQLLEAGLSAEIV
>EGALAKHO_01663 Ribosomal protein L11 methyltransferase
MSNIYLGYHFTIEPKEPGSEILIAELGEKAFETFTETDNGISAYVKKDLWDENILDDIYI
LQSEEFKIEYTIEEIDQVNWNEEWEKNFEAIDVDGKCHVRAPFHPKTDAEFDIVIEPKMS
FGTGHHETTHMMIQHLLEMDVKGLKTLDMGCGTAILAILAEMKGAEPIDAIDIDNWCYLN
SIENAERNNCKHITVYEGDAALLAGKKYDLIIANINRNILLNDMQSYVDCLNPKGTILFS
GFYEADIPFIDASCTEKGLTYVKKFQRNNWVSLKYVN
>EGALAKHO_01664 Triosephosphate isomerase
MRKKIVAGNWKMHKNAAQTEELLNELITKIPAQTTAQVIVAPTFVNLQAAVAKVKNTTIG
VAAQNVHQAEGGAFTGEISADMLTSIGVNTVILGHSERRAIFHETDALIANKVDTALKHD
LTVIFCFGEELKDRQSANHFNIVENQLRDGLFQIAKESWANVVLAYEPVWAIGTGETASP
EQAQEMHEFIREVVRKAFGADIAEEVSILYGGSVKPDNAKEIFGKPDVDGGLIGGAALKA
EDFLAIVTAI
>EGALAKHO_01665 Thiol:disulfide interchange protein TlpA
MKQIALVVIALITFSCSQAQKTSFSKEALSEKLLTVDGGQTSFKNILKKYKGKTLVIEVW
ASWCGDCVKAMPKVKELQANNPDVSYLFLSADKTAEKWKIGIEKHELKGDHFMMNDGMKG
VFGKAIDLDWIPRYIIIDKTGKIVLYRAIETDFDKINETLKSLKQA
>EGALAKHO_01666 hypothetical protein
MKQPPKFLLTFLLTILSSFSGFCQATINKDQAYIFFLHNAFIEQNDLSVAHPEYGKAEYN
EIIASFRKDNFIVYSEIRKKNTNAYEYAEKIAKQIKKLLKKGIPPNKITVIGTSKGGYIA
QYVSTFLANPDMNFVFIGCFRGVDIQEIPDINWCGNILTIYEESDVLGVDATKRKETSKL
KINHFKQIELHTNLKHGFLYKALDLWIAPSKKWANGNYELN
>EGALAKHO_01667 hypothetical protein
MKNIITQFSRIFVGVLFIISGLIKLNDPVGFSYKLAEYFSEPVFNMPFLEPFALGLAIFL
VILEVVLGVMLLVGYRVKTTILALLLLIVFFTFLTFYSAYFDVVKDCGCFGDALHLTPWQ
SFTKDVVLLFFILILFFNQKLIKPLFSTPQTNFAVYVSVVLCAFMAVWVLNHNPIKDFRP
YKVGTNIEKGMEIPEGAPKSVVEMTFIYKVNGVDKEFREKDLANIPAGATFVDRKDKVIT
EGYVPPIHDFTMTKDDSDYKAELLKEPKLLLFVTYDLTLSDPSGMKKLEALNKEAQAKGY
KVVAMTASGADEISKAKKEYGLNVDFYFCDATALKTIERANPSVVVLHNGTVVQKVHYND
IGDLKL
>EGALAKHO_01668 hypothetical protein
MKNTSLEYDNVITVCRTLFINKMTDYGSAWRILRLPSLTDQIFIKAQRIRSLQENEIRKV
DEDEKGEFIGIINYSIMALIQLELGVAEQPDLDVEKATELYDAKIKLTKELMEAKNHDYG
EAWRDMRVSSLTDLILQKILRVKQIEDNKGKTLVSEGIDANYQDMINYAVFALILNPLK
>EGALAKHO_01669 Dihydropteroate synthase
MLINCKGQLIDLSIPKVMGILNVTPNSFFDGGKYKNEEEIISQVNKMLSEGATFIDIGAY
SSKPSAEFVTQAEEIERIVPVIELLLKHFPEALLSIDTFRSEVAKASIESGAAIINDIAA
GELDNKMFDVIAKYNVPYIMMHMRGNPQTMQTLTQYGDIVKEMLFYFSEKVKKARSLGIN
DLILDPGFGFAKTTNQNYEVLQKMELFNLLELPVLAGVSRKSMIYKTLNNTAQEALNGTT
VLNTIALTKGAKILRVHDVKEAVECVTLFEKMNYNKI
>EGALAKHO_01670 hypothetical protein
MKYFTLIIAFLLFSCEEKKDVLLPKANVSIVKDVQDHSPIYIFFKTEGKDTIAEVNRKNS
IISTNWIFNIDKRLPLKLVIPEVMKLQEKKRGDSAHKNEKAENYYSYADSIGKNLAFLPF
TKVYYKNKKPMDQPGFVFEFRKGNDLVLLNNHFAVKKADILKELYKIDFAINPKIVFIFD
KNMSYEEYIQNKILVHDLDTFNDEIPSEFIF
>EGALAKHO_01671 Ribosomal RNA large subunit methyltransferase H
MNIKLIAIGKTDNKSLQTLIDDYTKRLSFYIKFDLEIIPDIKNVKNLSESQQKEKEGELI
LSKLSPTDQLILLDENGKNFSSVGFSEELQKKMNSGIKTLVFVIGGPYGFSDTVYSKAQG
KISLSLMTFSHQMVRLFFIEQLYRGFTILRNEPYHHQ
>EGALAKHO_01672 hypothetical protein
MILEAVFLFIKPYLANQFEVDFANASQYISSIDGYLGHRLEKCLEVDNKYLLLVDWNTLE
NHTIGFRTSEAYLEWKKILHHYYEPFPIVEHFETVFENKK
>EGALAKHO_01673 Aminodeoxyfutalosine deaminase
MTRIITLFCFFIAQIGFSQTAGDYLEKIRNNEALLTAFFQQMPKGGDLHHHFSGSIYAEP
LLERAIAEDFYLNLETMAVLKIKPEKGNWESFSSLKEKGKLDYYEQQIMQTWSAKDYNGS
VPSDDLFFDSFLKFEPTIQGHFAEGMLELKKRATTENVNYIETQLSIIPCDMNVSDLTDF
NTKLRQASTQKDEKAVLKLLDELYKAIQQKDAKKYASDFNTNFIAKLHKDLKIDDDKFTM
RYQNFVLRFMDPVDLFKNLTIAFISANDSKLIAGVNIVSPEHGENSMKDYWLHMVMFKYC
HSKFPDVKYTLHAGELTLGLVQPEDLTWHINDAIHIAGANRIGHGVDIAYEANSYDLLKY
MAKNNIPIEINLASNEFILKVKDGRHPFTLYKEFNVPIVISTDDAGILRTNMTEQYVLLA
KRYPDVSYATIKQYVYNSINYSFIQDASVKKQLLKDLDVRFKTFEDKFSKN
>EGALAKHO_01674 hypothetical protein
MEINQINDIRKGYFEAIEDGKEAGKMTYTWAGDSKFIIDHTEVNEGFNGKGVGKKLVMKA
VEYARNNNLKIIPLCPFAKSVFDKTEEIRDVLFS
>EGALAKHO_01675 hypothetical protein
MDTISAKIDTRLYRTEITSASDNVLISDEPQELGGKNLGLNPTELLAASLASCTVITLRM
YINRKQWNVSEINVKIDFERDSERSVSVFTRKIEVIGEVDETQRQRLETIANSCPIHKTL
THSIEIKTTLI
>EGALAKHO_01676 Quercetin 2,3-dioxygenase
MSNISLIIEERAANIGNFMVGRLLPFREKRAVGPFVFIDHMGPAHLSDHENMDVPPHPHI
GLSTLTFLFEGSIMHRDSLGTELEIKPGAVNWMTAGKGIVHSERTPEYLRHSDKMLHGLQ
IWVALPKELEQMDPNFAHVEADDIPKWEEDGVSYKLIAGEAFGKKSPVPVYSPLYFIEIK
STEAKKINIGKDLFGESGLYILEGSIKSGEHVYDPKQILITNDSTLCEFEITENSTVYIF
GGQPFPEEHFIFWNFVSSDKELLEKAKKDWTEQTFPKVPGETEFVPLPEPRIK
>EGALAKHO_01677 hypothetical protein
MGLIKDIYSVSFYGNFGQAVAEVHPDFNKQKFIETIYEGDFAQKEWKERMKHTTVVLHQF
MPENFAEAVALIDKIIKNLKKNSFTDGNLAFIFFADYIEKYGLEDFKTSAKAFVSITQFI
SCEFAVRPFILKYKEKMIDEMTKWSLHENHHVRRLASEGSRPRLPWAMAIPFLKKDPTSI
LPILENLKNDPSEYVRRSVANNLNDIVKDNPEIVLEIAQKWSGISKETDAIIKHGCRTLL
KQGHPEILTHYGLESTNIELSNFEIKTPKVKIGEYLQFQFHLNNKNDEAKTIRLEYAVHY
KKSKGHLVKKVFKISEKIYQPHQLTKVERNQSFKLITTRVFHNGMHQLSIIINGTESEAL
EFELIK
>EGALAKHO_01678 putative nicotinate-nucleotide pyrophosphorylase [carboxylating]
MISEAQFQTELQLLISNAIREDVGPGDYSSLACIPDTAHGQAKLLVKDQGIIAGVGLAKM
IFEYVDPKLKIKTFIEDGTHVEYGDIVFEVSGSSQSILKSERVVLNTMQRMSAIATKTSQ
LMQLLEGTGAKILDTRKTTPNFRVAEKWAVKIGGGENHRYALYDMIMLKDNHIDFAGGIT
LAIKKTKDYLKANNLDLKIIVEARNLDEIREILLSDGVHRILIDNFNYEDTKKAVALIGK
KCQTESSGNINEKTIREYGLCGVNYISSGALTHSIYNMDLSLKAF
>EGALAKHO_01679 hypothetical protein
MSQEIEDRIEKVPVVRSVARLFKRIKFPWLEGFSLYDLLEMYVLGILEGAFSYHASAVSF
SFFMALFPFALFILNLIPFIPIEGFQDDFLQFVQQGVPPNTYDAISKIISDILNNSHSGL
LSSGFLLSIFLMANGINGILSGFESSKHVFDKRGFFSQYLVALAISLIMTIILFVTVATI
VVFEVFIQKTIIQDVLSDRIPLIILGRYLFVILMILITSSILLRYGTKQYNKVPFISIGS
VFTTILIVISSFFFGIWVIKFSKYNELYGSIGTLLILMFYIWINCMILLLGFELNASIRK
LKQKKNK
>EGALAKHO_01680 hypothetical protein
MKNWMLAIGVFFLTISTIQAQSVIGKWKTIDDETGEAKSVVEIYEKSGKVYGKVVEILRA
DHKKDLCAKCEGAEKNKPILGMVIINGLKKDGSEYNGGSILDPTNGKKYKCYIELDSADK
LKLRGYVGISIMGRTQYWTRVK
>EGALAKHO_01681 Metallo-beta-lactamase type 2
MRKLASIFLFLAILSNSFGQSKNSPLQISHLTGDFYVYRTFHDYNGTMISANALYLVTDK
GVVLFDAPWDKTQFQPLLDTIKARHQKDVIMCFATHSHDDRAGGLDFYRQKGIKTYSGKL
TDNILKNNNEKRAEFIVPNDTIFTVGNHTFEVFYPGKGHAPDNIVVWFYKEKVLYGACFI
KSADAKDLGYLADSDVKEWKKSIAKVKTKFKNPIYVIPGHEDWTNTESLNHTLKLVDEYL
AQKPSSKK
>EGALAKHO_01682 Primosomal protein N'
MFFVEVVLPLSLAKTFTYSISEAESHFIKKGMRVAVPFGKSKIYTALIIDTHQNAPTLYD
AKEIHQILDEKPIATEIQIKHWLWVANYYMCGIGDVYRGAFPTGLLLESETMISRKPEVL
VNDSELSDDEFLIYEALQHQNSLKVQEIASILNKKNILPVLQKLMEKDIIVLEEEIKESY
KPKLVRYVKLHSKYESDNGLSELLEVLKSANKQKEVVLAYFQVSASEKKPITVKKLTEVS
NSTSTIVKTLIEKEIFEEYYLQHDRVSFDGKASEKQLQLSGAQETAFNEIKKNLAEKEVC
LLHGVTSSGKTEIYIKLIEEYLETGKQVLYLLPEIALTTQLVSRLRNHFGDKVAVFHSKY
SNNERVEVWKQTLENSDKAQIVIGARSALFLPFNDLGLLIVDEEHEQTFKQTDPAPRYHA
RDSAIVLANFHNAKVLLGSATPSIETYFNTQIEKFGLVTVTERYNNVRMPEVVLVDLKDK
HFRKRMTGHFSDLLIEEIAEALSLDEQVILFQNRRGYSPIIECMTCGHVPHCQQCDVSLT
FHKNKNQLRCHYCGYSIAKPTHCHSCSSIDLTTKGFGTEQIEQELLSLFPKAKTGRMDQD
TTRGKFGFEKIIDTFKNREIDILVGTQMLAKGLDFDNVSLVGIMNADNMLHHPDFRAFER
SFQMMTQVAGRAGRSEKQGKVVIQTYNPNHNTIQQVTTHNYIGMYKEQLYDRQIYKYPPY
FRIIKLTLKHKDFEKLKEGSMWLYQVLSQNLQMPVLGPEEPAISRIRNEYIRTILIKIPQ
NLHLGNTKKTIQKMLNSFEAVAQYRAIKVIANVDFY
>EGALAKHO_01683 Transcriptional regulatory protein NatR
MKLNCVVVDDSSIQRTIIAKLVNNHPGLHLIGDFSNAIEAKSCISLNNIDLIFLDIEMPV
INGFDFLDGLKSKPQIIFITSKAEYALKAFDYDATDYLQKPIAVDRFNASVKRAIDMHLL
RKEVKEEEGEHIFIKSNLKKLKIFTSKIKWIEAFGDYVRVVTEDDSNLVLSTMKSFENDL
SKDKFIRVHKSYIINIDKVERFNSKFAEIGITKIPLSRNKKEDLVKALSTSS
>EGALAKHO_01684 30S ribosomal protein S6
MNHYETVFILNPVLSEVQVKETVTKFEEFLTSRGAEMVSKEDWGLKKMAYEIQNKKSGFY
HLFEFKVAGEVLIAFETEFRRDERVMRFLTVSLDKHAISWAERRRAKLKSTKA
>EGALAKHO_01685 30S ribosomal protein S18
MSTIEQSAKGKKDGDIRYLTPLNIETNKTKKYCRFKKSGIKYIDYKDADFLLKFVNEQGK
ILPRRLTGTSLKYQRKVSVAVKRARHLALMPYVADLLK
>EGALAKHO_01686 50S ribosomal protein L9
MELILKQDVQNLGFKDDVVSVKAGYGRNFLIPQGFAQLATPSAKKVLAENLKQRAHKEAK
VVADAKALAETLKALEIKLTAKAGGEKLFGSITNIDIAEALEKSGNAIDRKFITSGIVKR
TGKYSASIRLHRDVIVDLPYEIIAEK
>EGALAKHO_01687 hypothetical protein
MKYARLTKEQFDELHAEFASFLATQAIDKAEWDSLKINKPEVAEQELDVFSDLIWEGVLS
RAEFLEHFSKNHIFLFQCFETHVQSIVLKSLVPETDFLTKEGLQWLSDNMFTEKIEMKVG
KKVFTEDRNFSIFELIQQGAFLSDGQLFKQINTIIES
>EGALAKHO_01688 hypothetical protein
MKLTITLLIKFALGLQIILALFFILENRNKLIQKANFNLNLNLFQKSQYYVSFLFANPSW
CVDEKVLS
>EGALAKHO_01689 hypothetical protein
MFKVVNKPTKAPNLISNLSNAAEVGKLTLNLFPDNTCKFNKLLFT
>EGALAKHO_01690 hypothetical protein
MAFAKFTVPQPTKGAAITVKGVTVGKLTITCFRLFISFSQVEALATEI
>EGALAKHO_01691 hypothetical protein
MVNPVSKLTSKSTEGFEITILKVSLTIDGVLNCTVKSAAASAPTPLYIVAKVETSLSAIF
CASLTPTVAVNAPTGSPKSVAP
>EGALAKHO_01692 hypothetical protein
MSLNKSDDVYEQAIGMEHSFSNISGSKQIVYIKDALECTFELQVVMPESVVLNPFVTVNY
GCSFNSAKITIDANTDLLDVDYALDNGNYQKDNLFTNLSAGSHTVTARHTNGCTQSTKSF
IIKHFEPLDCP
>EGALAKHO_01693 hypothetical protein
MTYGELNEVVAKATGGSGEYQYSFENQSFSKDYKFIIYKSGNYKVTVTDKNGCSTNVTQY
FAYIDVCIPNYFTPNGDGVNDEWGPDCTVNYRNLTYTIIDRYGREIANYHYGQKWDGKYN
GKELTSGDYWYVVKLNDPKDHREFVGHFTLYR
>EGALAKHO_01694 hypothetical protein
MKKIILLILLTAVNSSYSQELNLPVFTQYLADNPFVVSPTYAGIGDNLRIRANGLTQWVG
IKDAPENQAIYADMRILDRSGIGISLYNDKNGNTRQTGAKISFAHHLTLDYYSKQYLSFG
ISYNINTFKIDIDKFNFETGTFGGVDPGVTDNRKIANNNFDIGILYRNKEFYASLNIGNL
LNKDIDKFYHEEPVLLRNYQLYTGYVFKENAQNRVEYEPSIFYQYFASDKRSSTDLNFKY
RQFNRYDDYFWIGVSYRFLNDQILEPNALGPMAGFKKSNFYFGYSYQASLSQISTYNSGT
HVITIGLDFFQGISNCPCTQSPVHY
>EGALAKHO_01695 hypothetical protein
MVIVTLQRDKCIGCNYCVEMDPVHFQMSNKDGKSVLINSVNAKGFYTLKSPHHSIVESCE
LAAKACPVKIITIKET
>EGALAKHO_01696 putative protease YhbU
MTFYKKIELMAPAGSFDSLQAALDNGADSIYFGVEQLNMRARSTVNFTVDDLQEIANRCE
AKKVRSYLTLNTIIYDHDLSVVKTLLNKAKQANITAVIASDQAVIAMARSISMEVHISTQ
LNVTNIETIKFYSLFADTMVLSRELSLRQVKKITDQMEKEQIKGPNGNLVEIEIFGHGAL
CMAVSGKCYLSLHSHNSSANRGACKQNCRKKYTVIDKETGFEIELDNEYMMSPKDLCTLD
FLDQVIDSGIQVLKIEGRGRAPEYVATVIKTYREAIDAYYDKTFSKEKVEVWMESLNTVY
NRGFWSGYYLGQKLGEWSDIPGSAATQKKVYVGKGTHYFPKAEVGQFKIEAYDIKIGDKI
LVTGPSTGAQEMIIDEMFVGDSVAEKATKGDDCTFKLPFRIRMSDKLYKIVEM
>EGALAKHO_01697 putative adenylyltransferase/sulfurtransferase MoeZ
MQLYNTLSAEERAIMIDDAGKQRLTLSFYAYAKIQDPKKFRDDLFLAWNKLDALGRIYVA
TEGINAQMSIPEENLEAFRATLEVYDFMKGIRLNEAVEHDDHSFLKLTIKVRDKIVADGL
NDETFDVTNIGVHLKAKEFNEILDDPNTIVVDFRNHYESEVGHFKGAITPDVETFRESLP
IINEQLQNHKEDKKLVMYCTGGIRCEKASAYFKHQGFKNVYQLEGGIINYAKQIEAEGLE
SKFIGKNFVFDNRLGERITDDIISQCHQCGKPCDNHTNCENDGCHLLFIQCDECKSAMEN
CCSTECLEIIHMPLVDQVRLRTGKQVGNKVFRKGKSENLKFKHSGELADTALASTEKPAD
IRQKIKLKKVLLGKAEHYYVKAQVAQFTIENQELRLGDKILISGPTTGNQELVLEKMIVD
GAAVTTAKIGDIVTFEVPFRIRLSDKIYKILG
>EGALAKHO_01698 hypothetical protein
MSKKNKIKSKNLNSASSDLKALSKKELLHKAKKFSEQYCVGDDKNFTLKDKPTSYFGNES
KSVIKETLQIGVKALSTMQDILYAQDKWSVLLIFQAMDAAGKDGAIKHVMSGINPQGCQV
SSFKGPSSEELDHDYLWRCQKHLPERGRIGIFNRSYYEEVLVVRVHEQILKSQKIPEKLI
TENIWENRFEDIRNFERYLNRNGTVVIKFFLNVSKDEQKRRFIERVDNPDKNWKFSATDA
KERGYWNDYMHAYEELIKNTSTKKSPWYVIPADNKSYARIAIASAIIHALDEMDLEYPKV
SEEKIAELNAVKQALLDEKE
>EGALAKHO_01699 Multidrug resistance protein MdtE
MNRIYSPTIFLLFLLLSCKKETPPAPKPLEIQIVKVLQQDVNLESEFTGETFGQSDIQIN
PRVDGVIESLNFKEGSVVHKGQLLYTIDPLPFQTKVSEAEGQLAESQARLAKTKSDYEMM
EPLAKMNAISQRELIGARSAYNASVAGIKAASANLKNSKIELSYSKIVAPISGLIGISKV
RVGDYVRPGALSVLNTISDLGDVRVRFTMSEQEYLRIFKELAKKDSNLKGAGKSVSILLS
DGSLYPQKGQISFADRQIDPSTGAVTFEAAFANPDQLIRPGQYVKVQVVTDVRKNVLIIP
QRSVIEMQGISQVYVLGKNNKVEMKAVQIGPAFKDSYIVLDGLTANDKVALGGTSLLKSG
SVITPQIKEWTPGQAVN
>EGALAKHO_01700 Efflux pump membrane transporter BepE
MGEFFVRRPIVAMVISIIIVILGLLALQKTPISQYPDINPPVVKITTSFTGANALNVEQA
VATPIEQKVNGVEQMLYIKSTNTSDGACTIEVTFDVGTNLDNANMLTQNRQAQSAPFMPP
SVKQQGVVVKKSLSFPMMLFTLTSTNPKYDSKFLNNYANINIVDQLARIKGVGEVSLFGG
SDYSMRIWLKADVMSKLGVTVDDVKNALNAQNMISPGGKFGAEPTPPGTDFTYGVTLQDR
LVTEKQFGQIVVKSKSDGAQVLLNDISRIELGTENYSSNARRNGSASAAITVFQMPGSNA
LEVATLAKEAMKKMSEKFPKDVVYQESLDTTLAITAGVEDIVHTLFEAVILVILVVFIFL
QNWRATLIPLITVPVSLIGTIAVFPLLGFSINTLSLLGLVLAIGIVVDDAIVVVEAVMHH
IEHGKSPKDATIQAMREVSGPVIAIALILIAVFVPVAMTPGITGRFYQQFAITIAVSVAF
SAFSALSLSPALCAMLLKPTKPVEEQTGWLAKFFAGFNRIFEKVTGGYIKGATFFAKKSL
RIVALLGVILLAVVLLGKKIPPGFIPEEDQGYVLINIALPPASSLQRTDEISKKVDSFLK
QEESILSYTTINGFSMLTNSYQPNNAFIFISLKPWEERAETAKQLVDRLNMKLSTQITTA
TAFAFGPPAIQGLGASAGFSLMLQDRGGNTPQYLAQQTQAFIAAAQKRPEIKRIYTTFNA
GTPQIKLDIDNEKAMKLGVPVSKVTEVLGAFLGGTYVNDFNRFGRQYKVYLQGEAVDRLK
PENLNKIYVRNNNGDMLPVSTLVTATKVAGPDFTNRLNLFRSAEIGGSPNDGFSSAQALD
ALEEVAKETLPADMSYDYINLSYQEKHSPGGGTVFLMALVFVFLILAAQYESWKLPFSVL
LGAPFAVFGAFLGLFLARLGSDAYVNNVFAQIGLVLLIGLVAKNAILIVEFAKEEYEKGR
PLYESAMIAAKLRFRPILMTAFAFILGVVPLLTATGAGSQARIVMGMAVFSGMLIATVLG
VLIVPGLFVMIENIGKKKDEVVATEISTDSKTTDHDE
>EGALAKHO_01701 Outer membrane protein OprM
MMNKVKILIVILTLAVLPTACLVGPKYQKPEDPQTSNFRYGPGYADTLASVVNVKWFDLF
NDDVLKGLINKGLENNYDLRIAMARIEQTRAELGYSKADLLPAIGYNGTINSNDKAFIPS
SASASLSWELDFWGKIRHENRAVQDELIASEEGRKVILSNLVSDIATAYFELRNFDNQLI
ITNQTLETRRKAFDIINARFLAGYVSEVDKVQIEQQVAIAEAVIPSIQRQITMRENTISI
LTGQAPGPIERGKTVTELEVVNNIPVSIPSILLRNRPDVRQAEMYYMASNERIGVAQAMR
FPSFNIAAIAGFASSKVSTLFDGSSYVQNASGSIAGPIFNFGKNKRRVEIYRQIAEESRL
SYQKTCIIALSEVEQSLQNVKTYKEEWAARDRQVIAARKNLELSQARYYNGYVSYLEVLE
VQRSLFDAELSLSDLTQSQLASMIQLYRALGGGWSL
>EGALAKHO_01702 hypothetical protein
MYPEEMVKPMQAELTAAGFQDLHSADAVDNAIKAEGTTLVVVNSVCGCAARNARPGAKMS
LEGAKKPDHLITVFAGVDKEAVDAARQHMFPFPPSSPSMALFKNGELVHMLERHHIEGRP
AELIAENLQDAFNEFC
>EGALAKHO_01703 hypothetical protein
MRMNSSQIKHFNYIFTGTGLSTLMTVYKMVLSGKFADKSILLLDESQKKSNDRTWCFWTE
KETMWNSIISKKWDSASFANEDFRRDLELKPYQYNQIRGIDFYDFVFETISKQENITFLN
EKVTDINELETHVFVGTEENRYTCDYLFNSIYTKAFVQSQTKYPVLQQHFVGWFVKTEDE
VFNPEQATFMDFSVEQRGNTRFMYVLPISKTEALVEYTLFSENLLPKEEYEKEIQLYLQK
LGADKFQIIEKEQGSIPMTCYPFWKKNTKKVLNIGTAGGWTKASTGFTFRNSDKKSSELV
EFLQKENFKMTSFHKKGRFWFYDLLLLDILYRHNELGSPIFSSLFKKGNPALVFKFLDEE
TSLMEDFQVIMKCPKMPFIKSLFRVVFR
>EGALAKHO_01704 hypothetical protein
MKKLFLLIIFFGITSTGFCQLQSRSFKAIDSLQQIQKRKIIVFIHTDWCQYCQKMKSTTF
KNQEIIKSLNSDFYFIDFNAEEKKDISFNNQTFKYQPTGNNVGVHELALQLGTMNNQIVY
PVLCVLNEKNEIMVQYNSYLSPKDFKLLLEKLKE
>EGALAKHO_01705 Colicin I receptor
MKNSTVILILFTLQFSYAQETSTISGFVTGEGNKIQAANVHLLGTKQKTVTDSLGYYSFE
NVTRGKYTIRVTSTGFKPMTIEILVVEAQNTNQDFELEDNENQLNEVVVSGTLKAVKRLE
SAVPVEVYSPVFFKKNPTPSIYEALQNINGVRPQLNCGVCNTGDIHINGLEGPYTLVLID
GMPIVSSLSTVYGLSGIPNSLVERIEIVKGPASSLYGSEAVGGLINIITKNPTNAPVFAA
DVFTTTYLETNVDLGMKFSPTKKSMTLLGINYFNYNEVVDKDKDNFTDVTLSERISVFNK
WSFLRNENRLFTIAARGMYEDRWGGDVRWEKKYRGGDEIYGESIYTKRGELIGSYQLPFE
EKLMLSFSGNVHYQDSRYGTTSYIANQKIGFLQLTWDKKLGSNDLLAGIANRYSYYDDNT
TATKEAESTWLPGIFVQDEITLSPKSQVLLGMRYDYNSIHGSIYTPRVAYRWKKNENTIF
RLNAGTGFRVVNLFTEDHAALTGSRDVVIQNDLKPEQSVNANLNYIQKINFGNGTFIGIE
TTAFYTRFSNKIISDYETDPNKIIYDNINGYAISQGISTNVDVNFPSGLKMILGATVLDN
KNVENGVSEKPFLTENFTATWSVSYKIESLNLLLDYTGNVYSPMNLPLLSELDPRSPKSP
WYSIQNIQFTYSGWKNFELYGGIKNLLNFTPMQKNPFLISRANDPFDKNVQYDSAGKVLV
TPDNPYGLTFDTTYVYGQNQSIRGFFGLRYTLR
>EGALAKHO_01706 Thioredoxin reductase
MEQKHFEVIIVGGSYSGLSAAMSLGRSLRQVLVIDSGLPCNRQTPHSHNFITQDGEVPAV
ISAKAKLQVAFYKTVQFFNGLAVQATKTKEGFEIKTDSGETFTSKKVLFTTGVKDLLPKI
EGLAECWGISVLHCPYCHGYEVKTEKTAIIANGEMAFEYAKLISNWTKDLRLLTNGKSTL
TLEQTKILQKHQIEIIEEEIESLEHENGNIKQIIFKSQSKATVKAIYFRPPFEQHCSLPE
SLGCELTEQGLIKVDMMQKTTIPGVYASGDCVIQARSVAMAVSSGSFAGASINKELIDER
FN
>EGALAKHO_01707 hypothetical protein
MKKTTTPFYDILGISSATICLVHCLVFPLLTVLPLGLSHNPFIDLLFAIIGLFAIIKIIK
KSALLITSILIVSMALIWISVLSEIILDIHLDLIFIGGIGMIIGHLLNYKTHKSKNH
>EGALAKHO_01708 hypothetical protein
MKKTRNTTAKTAVLEIFGKSKTALSHTEIYKQIETLCDRVTVYRILDRLVNDDIVHKIVD
LDGTIKYAKCHHHAQRVHIHNHAHFSCEKCLEITCLENVKPSYIIPHNYKVNDINFTLSG
ICPNCSNSNI
>EGALAKHO_01709 Divalent metal cation transporter MntH
MTKSLEEVNQSVATEHKKTGFRKILAFLGPAYLVSVGYMDPGNWATDIAGGSQFGYTLVW
VLLMSNLMALLLQSLSARLGIVTQRDLAQASRETYSKFINYILYFLAEIAIAACDLAEVL
GMAIGINLLFDIPLMEGVLITVLDTFLLLFLINKGIRKMEAFIIALVAIIGFSFIFEMIF
AEPEVSKIMAGLIPSIPNSAALYIAIGIIGATVMPHNLYLHSSLVQTRKFDRSPAGIKQA
LKYNFIDSTIALNLAFFVNAAILILAAATFHKNGMFEVAEIQDAHKFLEPLLGTKWAPAL
FAIALIAAGQSSTVTGTLAGQIVMEGYLHLRIQPWVRRIITRLIAIVPALIVIYIYGESV
TGKLLILSQVILSLQLGFAIIPLIHFVSDKSKMNGFHISKLTQVVSWIIASIIVSLNAKL
VYDEITSWLESASNPMILWFTVIPLAFGFLALLLYIIAKPFIVKAQAKFVNHSPHNLKLQ
FSPKESQSYKNIAISVDFSKADESALNRAFELGGLDTKYTLIHIVETVGALMYGGHVDDH
ETTIDEKLLLEYQEMLSQKGFNIKTELGFGKPNKVIPKIINEGNFDILVMGTHGHTGLKD
ILFGTTVDKLRHKISIPLLIVK
>EGALAKHO_01710 Iron-dependent repressor IdeR
MTFSEENYLKSIYHLTASLETEVSTNAIAEMMETKASSVTDMLKKLADKDLVNYKKYQGV
SLTENGKLAAKMIVRKHRLWEVFLVEKLNFSWDEVHDIAEQLEHIKSEQLINRLDDFLGN
PTEDPHGDPIPDANGRIIKIEKYLLSELKENQVGICVGVKDTSSEFLKYLDKQEIALGSK
IEFLSKESFDLSVKIKVDGRELSISNKIASNLFVKLI
>EGALAKHO_01711 hypothetical protein
MYEPIFALFCERVKESIQAGTFAKLTLAKTIGDTEIKNIYFRLVLNEDNTYSISLTSRYK
TEEIESIHTLDEALMVLGTYIKNPFLTALLFTTDNDVTFKVNKKNAGSIIEQEPTFKNAS
PVMLEMIEKGIV
>EGALAKHO_01712 Short-chain-enoyl-CoA hydratase
MNYENLLISIEEKIATVTINRPTKLNALNKATISDLNKAIKLLGKNDEVGVIILTGSGEK
AFVAGADISEFANYTVVEGAQLAAEGQESLFDYIENLKKPVIAAVNGFALGGGLELAMAC
HFRVASDNAKMGLPEVTLGLIPGYGGTQRLPQLVGKGRAMEMIMTAAMISAEEAKQYGLV
NHVVPQAELLEFTNGIAQKIIKNAPFAIGKAIKAINANFKDGKDGFETEIKSFGKCFGTQ
DFKEGTTAFLEKRKAEFTGK
>EGALAKHO_01713 Sensor protein ZraS
MLNNFKMSMLSLRVRIFLSMIVLIVVASFLLASISIIQFKNEAKEYHQERLERKENAVKE
HINYVLSTTTYPLKTSNLDLIFKDKIHELAQIHKIEINIYSLDGKLLKSSKESFAVDKVA
PPVPDYILKLVKSSIEKRFVDIKTIDGVKNRSSYSLIKDEKFKPLGILNLPYLEDDGYYD
NELNTFLIRLSQVYSFMLIVAFALAYFLSTYITKSLKTISDRLEETNLDQKNEKIVLEAN
SKEVNFLIKAYNGMVDKLETSAIKLAQSEREEAWREMAKQVAHEIKNPLTPMRLTVQSYQ
RKFDPTDPDAKQKLNDYSETLIQQIDTMTAVASAFSNFASMPAQQNETLNVVEVVELALD
IFNEDYIVFESEEEEIISKMDRTQLIRVITNLVKNATQAIPESQFHKSILVTVKRIDNTV
EIAVKDNGIGIQKQDTGRIFEPKFTTKTSGMGLGLGIIKNIIENYKGTITFESTYGKGTT
FIVSLPITNS
>EGALAKHO_01714 hypothetical protein
MEYYNYLKSLHLIFVITWFAGLFYIVRLFVYQIEANEKPSPEKEILQAQYKIMAYRLWYI
ITWPSAILASIFAFWMLFFTDLGNAWLKMPWMHVKLCFVFLLYLYHLKCHQIFKQLQNDE
VKYSNNFMRLWNEGATIILFAVVFLVVLKSAINWIFGVIGIVLFSFLIMLGFRFYKRIRE
RK
>EGALAKHO_01715 Ferrochelatase
MKGVLLVNLGSPESPTTKDVKPYLDEFLMDKYVIDVPYLLRAFLVRGIILRKRPEESAHA
YAKIWWEEGSPLVVLSERMQKKVQPLVNVPVSLAMRYGSMTIEKGLQELHDKGVTEVMLF
PLYPQYAMASTLTILVKAEEIRKKKFPHMTFTDVPAFYNKPDYIKNLADSIQKHLVGFDY
DHLLFSYHGIPERHIRKTDVTKSHCKIDGSCCNTPSPAHDFCYRHQCYETTRQVIKLLGI
PADKYSLTFQSRLAGDKWLEPYTDVEIDNMPAKGIKKLAVVTPAFVSDCLETLEEIAMRA
KEDFEAKGGEEFLAIPCLNDDDEWCQTVSNWINDWAK
>EGALAKHO_01716 Regulatory protein PchR
MSSQEIIKIEDDFTLIRFQNDSLEPFFGQHEVGSGLIQFHFGIKGNAKFLFNQGSYALDL
KEEKSLLLYNPQKELPLNLELAPNSWVISVIVSIKKFHALFSAEADYITFLSPDNKDKKY
YNEGNISPSMAIVLSQLFHYNLHPSIKNLYYKGKGYELLSLYFNRTEDPNAEQCPFLIDE
DNVLKIRKAKEIIIANMAEPPGLQELADEIGLNLKKLKMGFKQIYGDTVYGFLFDYKMDF
ARKLLDSGSYNVNEVGLKIGYSTGSHFIAAFKKKFATTPKKYLMSINTNV
>EGALAKHO_01717 Glutamyl-tRNA reductase
MIRNKKTCSDTNSTLSVTFITTIIIILLHFYESEFMENNNAPKHLYFYSVGLSYKKADAE
VRGQFSLDAVAKTRLLEQAKTEGIESLIVTSTCNRTEIYGFAEHPFQLIKLICDNSNGSV
DAFQKVGFVYKNQEAINHLFRVGTGLDSQILGDFEIISQIKTSFTHSKSMGLANTFMERL
VNAVIQASKKIKNETEISSGATSVSFASVQYIMKNVEDIGNKNILLFGTGKIGRNTCENL
VKHTKNEHITLINRTKDKAEKLAGKLNLIVKDYSELHLELQKADVVVVATGAQNPTVDKA
ILNLKKPLLILDLSIPKNVHENVEELEGVTLIHMDYLSQLTDETLENRKLHIPAAEAIIE
EIKEEFVVWMKGRKFAPTINALKEKLNAIKDSELNFQSKKITDFNEAQAEIISNRIIQKI
TTHFANHLKDDDTMVDESIEWIEKVFKIKAS
>EGALAKHO_01718 Porphobilinogen deaminase
MAEKIIRIGTRDSELALWQAHTVEKKLNDLGYKTEIVAVKSTGDIILDKPLYELGITGIF
TKTLDIAMINGDCDIAVHSMKDVPTALPQGIVQAAVLERANVLDILVHKGNPDFEKPSTI
ATGSLRRQALWFNKYPNHTVVDLRGNVNTRMQKLQDNNWDGAVFAAAGLERINIKPENYI
NLDWMIPAPAQGAMLVVAMENDNYTLDALSQLNHIETEICTYIERQFLRTLEGGCTAPIG
ALVTYNEDEDTLHFQGVLLSVDGKQKLEIDKTVDISEWKKLGFFAAQEILNNGGTELMQS
IKESLKK
>EGALAKHO_01719 hypothetical protein
MAKSIQILSTKKLSGEQKQALNDANLDVIDTDFIQTQNKSFELKDLNENLIFTSQNAVHS
ILSHPKAEELKTKNVFCVGLKTKILLSESGFNVVAYTGYASDLAEIITLIYRSESFTFFS
GNLRRETLPKALKDAEVKLNEIQVYDTSLTPQKIKTAVDAILFFSPSGVESYLKDNTIKK
ETCFCIGETTADALHKITKNIIIADQPTVEDVIEDVIVEYSNKL
>EGALAKHO_01720 Uroporphyrinogen decarboxylase
MLKNDLFLKALKGETVQRPPVWMMRQAGRYLPEFRALRDKYDFFTRCETPELAAEITVQP
IRRIAPDAAILFSDILVVPRAMGIHVELKDNLGPIIPDPIRTMEQVNQVYVPDVNETLGY
VFDAVKLTKEMLNDEVPLIGFAGSPWTIFCYAVEGKGSKSFDTAKGFCFSNPIAAHTLLQ
KITDTTILYLKEKVKSGVNAVQIFDSWGGMLSPVDYQEFSWKYINQIVDALAEVTPVIVF
GKGCWFALGEMGKSKASALGVDWTCSARNARYLSGGNITLQGNFDPSRLFSPIPTIKKMV
HEMIDEFGKDKYIVNLGHGILPNIPVDHAKAFIDAVKEYGN
>EGALAKHO_01721 hypothetical protein
MTQKNIVSNIEEISPNFIGFNILVLFFFIIWWYNVISSIIFHNYYLSGEKQMFEIFMYGI
GSLALPLLYTFYILAHIDYNKIKKQSLYFKLIGLAWLPTLILLIIFLYIQLTVDNRVYFE
SN
>EGALAKHO_01722 hypothetical protein
MLNKGLRDDEAIRIDNVLKTLRSLDFVPQPLTNDQKFDIENQLKEFGLNIESLIDYQNEE
LITLLVRRHLDFNQLEQFADFLMEFSKVENYNFEIKALALYQYIQRESNIFSFGINAKIA
AAKNK
>EGALAKHO_01723 Putative ribosomal N-acetyltransferase YdaF
MSSTDWKIDRIENVTAEEFFTLVNKNKNHIHKTFPVTLANSDSLEKAKAFLGVSKDKEKN
NEGFYFYARDIKTNALIGYLCVKTIDYRISKCELGYFTDEDFQGKGITSKMVSHALDFNF
NELKLNKVFICTSEINFASQRVALKHNFKQEGILRDEFRNGDGELQNTVYFGLLKSEYNT
SKKY
>EGALAKHO_01724 hypothetical protein
MTKETAIKLFEQKQIRSSWNDEEEKWFFSIVDFMAVLTDSQNPQVYWRVLKKRLLLEGNQ
TVTNCNGLKMQAADGKMRLTDVADTEQLFRLIQSVPSKKAEPFKLWLAQVGRERIDEIED
PELGFDRLMETYLKKGYSKEWVNQRLKSIEVRKELTDEWDKRGVKKGQEYAILTDEITKA
WSGLSVKEYKNHKNLKKENLRDNMSNLELVLNMLAEATTKEISKEKKPQTFQENKKIANQ
GGTIAGNTRKEIEEKTGKKVVNKLNAIDYLEDNKELE
>EGALAKHO_01725 Oxygen-dependent coproporphyrinogen-III oxidase
MKDKFYAYIQNLQDQICAGLEAVDGTAKFREDLWKRPEGGGGRTRVIENGAVFEKGGVNI
SAVHGKLPEAMQKMFGVGEADFFACGLSLVLHPKNPMTPTVHANWRYFEMYDEHGKVIEQ
WFGGGQDLTPYYLFEEDAIHFHQTCKTACDKHSRSVGTEFYPKYKKQCDTYFWNAHRNEA
RGIGGLFFDYCKANEQMSMEDWFNFVSEVGNSFLEAYVPIVEKRKNLAYTAENRNWQEIR
RGRYVEFNLVHDKGTLFGLRTNGRIESILMSLPPHVQWVYDHHAEAGSEEEKLVNVLENP
REWIS
>EGALAKHO_01726 Fructose-bisphosphate aldolase class 1
MEREMNIAQLDRMHSGQGFIAALDQSGGSTPKALAQYGVQETSFTNDEEMYTLVHEMRTR
IIKSPAFKSEYILGAILFENTMDRKIDGQWTADYLWEKKNIVPFLKVDKGLADLANGVQL
MKPISNLDDLLDRAVEKNVFGTKMRSVIKEANAEGIREVVAQQFKVGLQIFEKGLVPIIE
PEVDIYSADKEKSEEILKEEIQKQLNLLDKEVKVMLKLSIPTVNDFYKELMSDPHVVRVV
ALSGGYLEEEANAKLTQNHGLIASFSRALSEGLSAGQSDAEFNQKLDKTIKAIYTASIT
>EGALAKHO_01727 Delta-aminolevulinic acid dehydratase
MFPLQRGRRLRVNESIRSLVRETTLSPTDFMFPMFIAEGENYKVEIPSMPGIFRRSIDLT
VEEVKEIFALGIRAVNIYVKVDESLKDNTGKEAWNPNGLMQNAIKAIKAACPEMVVMPDV
ALDPYSIYGHDGIIENGDVANDATNDALVKMAVSHAQAGADFVAPSDMMDGRILRLRQGL
DAAGFHNVGIMSYSAKYASAFYGPFRDALDSAPREADVVVPKDKKTYQMDYANRIEAIRE
TLMDVEEGADMVMVKPGIAYLDIVREVKNAVNVPVTVFHVSGEYAMIKAAAERGWLDNDK
IMMEQLMCIKRAGASLISTYFAKEAAILLKK
>EGALAKHO_01728 Cytochrome c-552
MKKVLFLSTVLAFASCKKEQEPFGKSTESTKESYSEGESAEAKTPEALGQSIFEGKGNCI
SCHQVDQKIIGPSIQEIGKTYKDKKGDIVTFLKGNADPIVDPSQFSVMKTNFPVTQAMSD
EELKAIEAYIYSHLK
>EGALAKHO_01729 hypothetical protein
MDIQKFSVIGISTRTTNENGQSEQDIPALWNKFMTEGIAEKIPNKIDNALYCIYTEYEKD
HTKPYTTILGCLVSSLDFVPEGMIGKTIEKATYEKFVAKGNLHEGIVFNEWMQIWNSDLD
RSFTADFEIYGEKAQNPENAEVDIFIAIK
>EGALAKHO_01730 Neutral endopeptidase
MKKQLSKPLFCAFSVMFSFTAINAQNASSKEPGINVSYMDTKVSPSQNFFQYVNGTWLNK
TEIPNDRTTWGSFNELIKKTDKDAMAILKEASKNPKYKSNTDQGKAVNLFNTVLDTVGRN
KRGIEPLKPYLKKIDAIKNVADLQKYLVEMEPQGGNDFFGIYIGADEKNSSKNAVSLNVS
RLGLSDKDYYTSEDKDSKEKRAKYELHVARMMQFIGESPEKAKQSATEILALETSLSAPR
LNRVESRDSRLQYNPMTVAELQKITPAIKWDAYFTGLGLAKLDTVIVVEPRYMKALQTVF
TENKVAEWKEYLKWTLLNRSTLQLTTEIETANFDFYSKTLRGAIKQLPREENALQVVNRS
IGEALGKLYVEKVFPAEAKTKAVDMIHNVILAYQNRINNLTWMSAETKTKAIEKLNKITI
KVGYPDKWKDYSALEIKSVAEGGSYFENSHNLSKWNFNKGLEKLSKPVDKTVWGMSPQTV
NAYYNPSYNEIVFPAAILQPPFYNYQADEAVNYGGIGAVIGHEISHGFDDSGARYNADGN
LVDWWTADDLKQFTTLGTELADQYSALEPLPGIHVDGKFTLGENIGDLGGINAAYDGLQL
YLKAHGNPGLIDGFTPEQRFFISWATVWRTKTRDEAIKSQVKTDPHSPGMYRAYVPIQNV
DAFYDAFGIKSGDKMYISPDKRVKIW
>EGALAKHO_01731 putative inner membrane transporter YedA
MKAKIQNAFSGKIEAIGFPILALWWVSFFWGTTWLASKEAVRHMPGLQVATIRQFLGGLL
YVGYFLIKKEPWPRGKQWKTIIILSILNFALSNGLSTWGVKYISSGLGAIISALFPIWII
IINFFNGIKIARVALFGILISFGGICIVFMDYLSDFLRPDFQFGILLMVASTITWAFGIL
ETKKKASSFNPYFSLGLQMLISSVFLFGITEAAGTNIPLSEISLNSWWAIVYLIIIGSVL
TFIAFIYTLQHLPTEISSIYVYINPIVAMVLGSFIFGETLTQAIAIGAAVTLVGLYLVNK
SIRKTKN
>EGALAKHO_01732 SCO1 protein 
MKSLLYKYRKFFIVLIVFSVVTISLFYSALKPQKTLPIYNPADVNPELVDSTIQYKSKYH
TIADFSFVNQNGDTITQKNYEGKIYVADFFFTTCGSICPKMTTNLEDVQKAVLNNPKVML
LSHTVFPEVDSIPVLKAYAIKHHVVDSKWNLVTGDKKEIYTMARKSYLAVKLGRPDQLYD
MVHTENFVLVDQKRRVRGFYDGTNKEEIKRLIDDINFLSNE
>EGALAKHO_01733 hypothetical protein
MQNTIHTLKKGEKAIIKDFDIDLIPLKLLEMGCLPGSLVELLQIAPFGDPLYLDINGSHV
AIRIETAREIEVELIKTNL
>EGALAKHO_01734 Fe(2+) transporter FeoB
MSIQNINVALIGNPNTGKTSVFNQLTGLNQQVGNYPGITVEKKIGFCKLPHNIKANILDL
PGTYSLNASSMDESVVIELLLNKNDKLYPDVAVVVTDVENLKRNLLIYTQIKDLEIPTIL
VINMSDRMESKGITLNIPYLEEKLKTKIALVSSRKGHGIEELKELIVSYKTIPHEPCLNA
SVIDAEYFAKLQHAFPNQLLYKLWLVITQDVNFLNLERNEIRSTFTKSHSELKRLQQKET
IKRYQFINDVLKEGLQVDESMAKDIRAKLDRVLTHKFWGYVIFLAILFVIFQSIFSWSTI
PMDFIDSTFASLSSWAASELPSGILTDLLSQGIIPGIGGILIFIPQIAFLFLFISILEES
GYMSRVVFLMDKIMRKFGLSGKSVVPLISGTACAIPAIMATRNIENWKERLITILVTPFT
TCSARLPVYTIIISLVIPDQRVLGILNLQGLSLMLLYLLGFGTAILSAYILNKILKFNSK
TYFVVEMPSYKMPLLKNVGINVVEKTKAFVVGAGKIILAISVILWFLASFGPGRDFNEAE
TIVKERFANTTLNEVQFENEVASQKLENSYIGIMGKAIEPAISPLGYDWKIGIAIISSFA
AREVFVGTLATIYSVGDSDNEATIKSKMQKEVNPQTGEKIFNFASGISLLLFYAFAMQCA
STLAITKKETNSWKWPAMQLFLMSGLAYFVALLAYQLLK
>EGALAKHO_01735 hypothetical protein
MNNSELINKTIAFVKEKLSDAEGGHDWFHIERVYKNALLIAKDTDCDLVVVQLGALLHDI
ADSKFHNGDETIGPKTARLFLESENVSEDTIQHVVSIIENISYKGGNFEKNFSSVELDIV
QDADRLDAIGAIGVARAFNYGGFKNRALYDPEIAPVTNMSKEEYKKNNAPTINHFYEKLL
LLKDKMNTETGKQIAAERHKFMETFLAQFYAEWEGVK
>EGALAKHO_01736 Putative acyl-[acyl-carrier-protein] desaturase DesA1
MSIKNIRLEVMQFLEKNVDSFVEQYLIPVEKIWQPSDFLPNSEGDNFFEEVRELREIAKE
LPYDFWVTLVGDTITEEALPTYESWLMDVEGINQIENGGNGWSKWIRQWTGEENRHGDLL
NKYLYLSGRVNMREIEMTTQHLINDGFDIGTGSDPYKNFVYTSFQELATYVSHNRVAQMA
KKFGDNKLSKMCKMIAGDEMRHHHAYSEFVTRIFAVDPSEMMLAFQYMMKQKIVMPAHFL
RESGQKISSAFEQFSDSAQRIGVYTANDYVDIMQKLIDKWEIDKVSNLTDEAEKARDYLM
KLPARMARISERLVIPQESHIFKWVEPARL
>EGALAKHO_01737 hypothetical protein
MQKIISYPISVIYYLCFGLCLVVFHPIQWICLNVFGYQAHKISVDYLNFFLLRCTNLVGT
RYTIENRETIPTGVPLIFVSNHQSMYDIVAMIWYFRRFHCKFVSKKELGSGIPSVSFNLR
HGGSVLIDRKDPKQAIPVIKGLSEYIEKNKRSAVIFPEGTRSKTGKPKEFAQSGLKILCK
YAPSAYVVPVSINNSWKMVKYGAFPVGLGNHLTFTVHNAMAVKDYDFAELMKLTEKAVVE
GVNEYK
>EGALAKHO_01738 Ribonuclease P protein component
MNFTYPKNERLKSKTIIGLLFSEGKSVSKYPLRLVYRQAEADSEEKIKMGVSVSKKYFKR
AVDRNYFKRVLRETYRLNKHLLFDNLEQPYSLMFFYQTKDKLSYEEINTKTIQLFEKFLQ
QINKTTDSETKTEI
>EGALAKHO_01739 hypothetical protein
MRYIFCFFFFGLFFSNCAKNSEEIVNSEVSAITMVKLPAKSESISETDINIPQKIVKNAS
VRFETDDLEKTFNQLQIAIKENKGSVQNDFQDKNYNKISRNITVRIPSQNFDSFLEAISK
GVSYFDEKNISSQNVTEEYIDLNSRLNTKRKLEARYLEILQKANKISEILEIEKQISTIR
EEIEAKEGRLKYLESRVSESTVTIDFYKTIAQKEGVKISYGSKIWNAVKSGFFSLSDFLL
SIVSVWPFIILFVVLVYFIRKRFKRKKA
>EGALAKHO_01740 putative CtpA-like serine protease
MYPYLKKKFVIPAVAAGFLFIGTSFKDDFFEIAKQIEIFTTLFKAVNTNYVDETNPGDLM
DKAIKSMLGSLDPYTVYFNEQDVVNFKINNTGEYTGIGALISRKKDRLIVREPYKNYPAD
KAGLKAGDEIIQIGDVLIADFKDDASQLLKGTKNTKIQIKYLRQGKTFTTELILNEVDIK
SVPFYGKIDDKTGYIVLAHFSRKAAAEVKEALEKLKTDGATQIVLDLRGNPGGLLNEAID
ICNLFVPKNEVIVTTKSRIEKHNNTYKTTKEPVDTQIPLAILVNGRSASASEIVSGALQD
LDRAVILGSRSFGKGLVQRSVDLTYGTQLKVTISRYYTPSGRCIQALDYAHKDKNGVAQK
TDAKNFNAFKTRKGRTVYDGGGVLPDIELEETKTSPITTALLKNDGIFDYATTYYYKNPN
LGDKIPVLTDADYASFKQYLKANKISFDTETEVALKNTLAAAKTEKIDETIAPEYQQLLA
ALEKSETTLLDKNQKEIRGLIQEELIKRYQYQEGLYQFYIKNNSEIKKAVSVLNNQNEYK
TILKM
>EGALAKHO_01741 Outer membrane protein P6
MKICLALFLFTIYNLSAQQKPIETIYFEFDKYDLTPNQTEVVTNFIKSIDTTKVESIQIY
GYCDDRGNDDYNFRLSNNRANTIQNLIVSTGFNQSKIVILEGKGRVVVKPDTVENLHETR
SKNRRVDLIVVKRNSFGKGIYTSFKDNLKVGDKIYLDNILFDIGSSKLTAASKKELDKIA
VKLQTDKKIQFEIRGHVCCTPEIYSDGIDKDTKERRLSWNRAKTVFNYLSTKKVSKNRMT
YQGCGNKYPLGRGDDFDRRVEFLITKI
>EGALAKHO_01742 Acetyltransferase
MELKWKIKPFEALTVHELYDLLKVRSEIFVVEQNCVYLDIDGKDKKGLHLIGEYDGKVVA
YSRLFDAGISFDNASIGRVVVDANYRDKKWGHDLMREAIAGIKSNFGKDKITIGAQLYLK
KFYESHGFVQSSEMYLEDDIEHIEMIRGE
>EGALAKHO_01743 hypothetical protein
MNKTHFLLVLIPFLLISCLKTEKQPEPVSGKTNTISVIIDDQLWYGEVGDSIRNKFASPV
WGLTQEEPLFTINQYPAKLLEGFVTDSRSIIVVKKAATDKFEIIRSKALPHNTFRIYGKS
VDDIICSLEMNGSQIVKLIRDAEIEKIQQDNSKALLNPAVLKNKFHIDLQIPIGYEYMLH
KKNFIWLKKEIISGNTSLLIYQVPIKQLTKTSDIVGNIVKMRDSIGLYIKGREPNTQMIT
GEAYAPYFSTISLDEKKTFETKGTWELKNDFMTGPFINYAIVDEANKRILVIEGFCYSPS
NQERDLMLELEAIIKSVKIDKR
>EGALAKHO_01744 Membrane-bound lytic murein transglycosylase D
MIIKKISLAVTALFSITMFAQETASTSLDIKPEIKLSYLDSVKSSFKKDVVATKVDSLWM
NECVNLDIYNDLSKDIQTVNTDQDINAELPTELLKQRLQAMNEKSPFNIEYNEGLENIIK
SFLKNRKKSFSRLMALSEYYFPIFEETFAKQNIPLEIKYLAIVESALNPKAVSKMGATGL
WQFMYGTGKQYALKIDSYIDERSDPLKATAAASDYFSKMYTIFGDWELVLASYNSGPGNV
TKAIRRSGGQTKYWDIRNNLPKETQGYVPAFYATMYLFEYHKEHGINPERAVVKNFETDT
VNVKSEMTFKQIADLLDMPQSQIQLLNPSYKLNVVPFYQGENHFIRLPKDKIATFVSNED
KIYAYVRHEAQNKTMPSRLALKVTPKAKAQLEKIIDTDVKLYKIQKGDNLGSIADKYDVS
ISDLKKWNNLKSNSVALGRTLKIKSDVDPLKVSKDVKVIPAIEKKSEEAIVAVDDKEKAA
GQTQEYVVVAGDNLGSIAKKFGTTIADLKELNNLTSNNIGLGKSLVISKEIPAIEETASV
TTAIASNASVDSFKKKTASAKSLGEDYYVKKGDSLYSISKKYPGVTISDIKKWNGIKDGD
IKPGMKLKING
>EGALAKHO_01745 Phosphoglycerate kinase
MKTLNDFDFKNKKAIIRVDFNVPLDENFNVTDATRIEAAKPTIDTILAQGGSVILMSHLG
RPKGAEEKYSLKHILKTASEILGVEVKFATDCIGEPAKTAAAALQPGEVLLLENLRFHAE
EEAGDVAFAKELASLGDIYVNDAFGTAHRAHASTTIIAQFFPTEKCFGTLLAKEIESLNK
VLKNSEKPVTAVLGGSKVSSKITVIENILDKVDHMIIGGGMTFTFVKALGGKIGDSICED
DKQELALEILRLAKEKGVQIHIPVDVVAADDFSNTANTQVVDVKEIPDGWQGLDAGPKSL
ENFKKVILESKTILWNGPLGVFEMETFSKGTIALGDYIAEATQNGAFSLVGGGDSVAAVK
QFGFEDKMSYVSTGGGAMLEMLEGKILPGIAAILD
>EGALAKHO_01746 hypothetical protein
MQESLLDISLYTDNKIMPLMMLSKKIITMKKLILSLVLMAVTTGYSQELNLPVFTQYLAD
NPFVLSPAYAGIGDNLRIRANGLTQWVGIKDAPENQSVYADFRVLDRSGVGISIYNDKNG
YTRQTGAKVSFAHHIILDYYSKQYLSFGLSYNFNSFKIDIDQFATDPYEHPVIDPTVTDN
RYNANNNFDISALYRNKNFYLSFNANNVLKKNTNKYRGVEPNLLSNYQVYTGMVFKDGEN
SRIEYEPSIFYQYFASDKRSSTDFNFKYRRYNRYEDYYWIGVSYRMLNDQFPKPLSVGPM
AGFMKSKFYFGYSYQIMFNDLGNYNTGTHVVTIGFDFLQSISNCPCTQGPVHD
>EGALAKHO_01747 hypothetical protein
MHKKLNTMKKPTILKIALLLLLFLQADIVFSQKTYKGFVREYNKQLKGDIITIGNSILNR
GTKNNKGVYTVNPNTPYDVFDTNVTNGSFDMYYVNVDPTPNSTTTFSSSSATLTVPNNIA
PADPCYRVAYAALYWSGILRSPDDRTKITNVKIKVPNTTISDYQDVKGTLIYDIDKNVDG
IPDASGNKTQAYACWAEVTSLLSETNPNGLYTVANVVATEGVKNTNGSTGLAAGWSLFII
YEDNSLPTKSISSFNGFAGIGSNATVPLTTNISGFTTPALGDVNARVAFAALEGDYGYSG
DYLKINNTSITTTPASVRPTNNFFNSTITTTTGPFLARNPASKNTLGFDAGVLDILPSSG
IIKNKATSADIMLGTNLDVYIVYFMAFSVDVIAPNIKLIKTVQDADNKDAANANVTLGQE
LRYTLDFKNEGNDSATQFTITDQLPVNTNFNFPKDIFKLPTGMVVSDPPKPATDDVTYNS
TTRTITFKVPRSFVDKSDPWEQIRFKVHVVDDCASLTDACSNVIKNSAMSSYRGNPDKGG
GGDGTLFGDKSYAVANSCTAIPQSTNFLVGLDACKNRQAEICLSEMEISASGGYGSYKWS
LSPTYSPVLGTEQKLKITAPGKYYVYDTAKPGSDCKDFAEIIEVKDGGGVKTNPIITYAD
NKLADGTIKGCDIDGKPLPKIFLCGANDSRLFNLNLPLADIVWEYRQCNNPTDPAELCAD
ESESASCPWLSAGANGSIFTVKNDGNYRVTITSGGCVNRYYFKVYKSDIAINETHKNILC
TTPGNITVDKLTGYEFSLTHVLIPANTSTTTDWGDNNIFSITTAGNYIVNYRLKNVNPTC
IYKTAQIIIAKDDFTAQVENPTENPFCYGDSGRMVVSATSGFTAYYYTLYEDGVKVQELG
PLPDRSHPFENLAPGKTYLVEVFTKNADQTIQCTASAGRTIPNVAAELKLTSSVIKPLTV
CEGGLYKITATGGNGGYSFFVDGSTTAYATDENGNTDPNSIIVSIPTAKEYTILVRDSKT
CTTTLKFTVAASPKPVFTITPSVIKCYGEKGQIDINVTNPNGYTLEYSLDGTNFNSNTAI
LNLKPGTYNVIVRYTLSGVVCTDPAQAITILPPAGALTASGGVAELAGCRLSGLGGRLRF
TNVTGGTLPYKYSFDGGGSWQDDPFKDVLQGTYILIVKDNAGCTYKLPYDVVLDPKPADP
KIELAGVVYNCNGTGQTTATVINPANGNYSYEYYLDGVANTPITNNVFNNILSGSHEIKV
VYKLEDASTYSNLLKEDFGHGDPTTSPGIAAAYCFNDQRVTAPFVCGTRSVEDNQYSVAS
FFWRGDTAWYPFKDHTSNGTVADGRYLLVNIGGAAGLDGVLYSKPIADVIPNQPVKVDLA
VANLLNAGQGGGAPIVKFQLVNPAGVVVAEANTGKIAEDPNDPNRTKWIEIPTISLNPGP
NTNLTFVVRSGSTVYGGNDLLIDDISVYQLPKSCLAEQKIPFSVGTDKAFTVLEPAIQDV
ACSGGSTGTITITAQNFDTTNGFFYSIDNGANWSTSTTSPVIISGLTAKTYTVIVQSDAV
GTCSKSFTKTIGSPTPVIATAQVTIQPTCTKNATITAGASGGTGTSYKYELRAGDGITVI
MPIQDSNVFTGPLVVSGSYTVVATDVKGCSSAASAVISITNPTAPTAKLATSSDLCFDSV
NKATITVTATGTGTLSYSLDGAPGVGTNTFTNVSAGTHNVVVTDSNNCTATVSDIVVFPE
ITGKAKVTKTLDCNTAGATIKVDITTGTGPFTYKVKEGSNSYGSSNPVTGNTFDYTAPGA
GSYTFEISDANSPTACKAEITATVNSITKPTVDATPVQVACNGGLTGEVTLTGHGGSLSY
TYSFNNSLFTTTTKYTGLKAGIPYSYQVKDSNGCTSDVGSITLTQLPAVDGTISATIIKC
NATGTTPGVVTIEGKGGTGTYTYSFNGNTNYTGTNTFPTSVAATVTAYVKDSNGCEAGPF
SISVGALQTITAINLVDKGYDCSTTPQGGHVTITAVKAGSLANVSYQIIAGPTGYNNASN
TTGDFQPLAPGLYTFQATDSQTGCSKTIVYDVKGTSDIVAGGSVVTTIKCNAGTGTIQFT
VAGAKTSGYDYIIRNAANSIIQQATNIPASTTTITVATALVAGDYTITVTDRLTKCPSPY
TVTLTQPANPLDVTATAPNVNCNNYTVFITAAGKDGTPNYTYAVVEHNATAPTVFAADPK
LSVNTANGTKLSWDVYVKDANSCTDFVTIDIIKDQAPSVTATLDNQCTGSGNKFRITAHG
TGGTGTLEYGINGVNGAFSTNNVFDVAASATPYTVWVRDANLCPSSATPITVYSQLTATK
VVKELDCSATKDATITITANGGKTPYKYEVSSDSGTTYNTMLTNVFTTSTAGTFLIKVTD
ANNCSFVESTTILSIADPTVTVVTQANVKCNGGSDGSVKLIGHGGSGGYNYSSNATSGFS
TVDTFSGLAAGDHTFYVKDSKGCTGSIIVTITEPTKLVATASAPAFTCNTTNVKQSTTVT
IAVPTTGTGPYEYSFNGGAYNTTVRTLVVSDNGTDQTINFSVRDKNLCVFSDSVILLKLN
PPAITSVQPSVVTCLATTSTAVVNVTTGTGVGALKYETIAPSPIIRGKQTSNSFANLTPG
DYIFKVTDASGCFDTESITIKAVTNITVNGITNNDVKCKGTSTGNGTYTVSNIATVGDYA
FLLTAGNLGSGTLTKLNNTLSLNNVPVGSYTVKVTDNATGCFNSATIVIAEPANVVDVTA
LATKINCNNDVSTITAAGAGGTVTYKYAVVEHNVTAPTTFAAGEILTVDTAGGTKMEWDV
YVQDANGCTDFVSVLIDTDPTPTVTATLDNQCTASGSNFRITATGLNGVAPLKYGINGVN
GAFGALNTFDVAARATPYIVWVKDANGCTAQAAAIMVYPQLTALAKVTKTLDCSSSPKAQ
ITVDINGGKSTYTYKVDSGTGYGTSFPVTGNQFIYTDAATAGVYKFEITDSNNPACKIEA
SATVIAISNPTVVAVNQVNITCFGANNGSVKLKGSGGSGTGYTYSNNATTGFSTVDTFTG
LTPGLHTFYVKDGKECPASVDVNILEPSALTTTASALPFSCNTTTNAKQSTTVKIVPPTT
GTAPYEYSFNGTSYDATIKTLTVNDNGSDQVITFYVRDKNLCVYSNTVTIAKLNPPTILS
VVPTPVTCTDLKSTVTVTKTTGTGVGNIEYSITAPAAYATTNTDGIFANLDPNITYTFKV
ADENGCFDTETLKVNAVIPILVTPSKLSDVKCKGDATGIARYTISQFSATTNYDVTVTTV
PAGLTSILTQVGDVITLSGLKTGAYKLSVVDKTTNCPAEATVTISEPVDALSATFVAVNA
NCKIGTSKVTVTTLGGTLPYKYSFVHDGAAMGVLTPVASANLDPTVTDWDVYVIDANGCQ
VILDVAIAKDDAPTVTATAAGQCLGNGTYTITAVGLGKAPLTYSITNATTGFGTLNTFEV
TASGTYNVWVKDANGCVAQTAVPVTVLDALTISAKLDKNITCVLGSEDAKITLTVTGGSG
SYAYSYTSTPATATGTFAGNVFTTNDAADFIFTVTDTSTLPVADRCKATTTAPIHITTPV
PPHFTFTEGPKINCNGDESGSLNIVIDPALGQAPFVINVHNDDIPKDYFTQTSGLPAGNY
TITLTDAKGCTFKEIYEIEDPEPIVVDYDTTPMQCVGAGVSKGEIIIKSVTGGTANYDYY
VTGINGYSKEVHGIPGTTVVFEVVDFGLYQIRVVDKNGCSNIISDVLIAAPVDELGVVIN
TTATCAPGGGSATITIKTAFAGNGPYHFNIYTGKTPAQIWMADNVDGWQGETSPKESIYN
GLTPGVTYTFIIYDEDTKCYYYQVAPTPVPTNSKLKVVGEVINNVTCTGSKDGSFTFAIQ
NNYPVVPPTPASTVNVSFQVYEALTNLPVSIVPPLAITTATITDGTTSANINVGPLPVGS
YYILVKETSGPNVGCSVVSTNFNIKESAIKVSLTASATSIADCTNLGTISAQAKDGTGPY
KYIVLPSPSTKPADDDAAWSSVNTYTKAGSVAGIVYDVYAKDAYNCIVNVPVTVFKYKDP
KIDPIDPICYDGKPFKITIKGFVDPAIVGGATYSVDGSTYDASPEFTFNAAGIYHLFIKD
GKGCTATIDYEVKPVLKLDAALTKDLDCSVTDANSSKAIITLTASGGYATTYGYEYSTDG
GNNWITMTPTPQLGGLPTLPDNVLQTNVTGDYIFRATDGGNTTTCQVTKEFTLDPIPAIV
FDIVETNITCPGGSDGTITVDVTAGVGPFEYQLEKGGAIITAFNSSNEFKGLANGTDYVV
TVRDAKLCFDTKTAIITIPAPLVATAVLTKGLTCNTDNSPINAEITVTVTSGGTTPYQYS
FDGGTNFSNDNKYTTSIAAPVTVIVKDGNGCETTLPVVPVPALNPPSAMNISGTPIYCLP
TTSQQSTVTINTVTGGVFDATHPLQYEILSPIVVAKQTSKVFANLDPSTEPYVFQVTDMN
GCTFRDSFKVDPVVSITVSSQLDKNVSCIGFNDGSVKFTVANHGAHTYTAILTTGSGTLT
KAGDIVTATGLIAGTYVLEVTDDITKCTSSASMVVSEPTALNLVANLSLFVNGNCTDDAF
VSVTASGGTAPYQYSFVPSGSPAGTYADANEVYLDPTTPNWDVWVKDAHNCVIAAPLAIS
VVKDPSPTVAMPAPICFEGVPVNIDLSIGQTFGTGLGPVTYKINNATQSSATYAITAPGF
YDISIIDKNGCESNVVSYEVKPQLELDAKVTRDLSCIVGSEDAQFELTASNGHGSYAYSY
TLDGGPSVPMTLNTLTNGASGTYVFKVTDAENCEATYTIVLDPITPIAFTVAETAVSCKG
DSTGKISVSVTSGNGPYEYQLEDGATIITPYQPLPQFTGLLAKNTYVVRVRDAKMCDTTM
PAIITQPVDDLTADSDITTKLVCTPGNLPSLAVVTITPAGGTTPYQYSYDGGVNYSGDNT
YETTTGITFDVYVKDNNGCIFKFVDGVDVPALTPPTGFGFDLVQAFTCAQKATVDVVSVL
GGKLPLQYETLSPSPVIVGKQNSASFTNLTPGFYVFQVTDDNGCTHQESFTVPNVINITV
AGSLVKNASCKGLSDGSIKFTVENKAGGYSATLSPNLGNLTTTGDVVTVTNLPVGSYTLN
VTDAITQCVNSATVEVEEPETLEIKLLSNKAANCYDGAIVTVEAKGGKGLYKFAFVAKGV
TPAASDYTTADTAILDPATPSWDVYVQDENLICSAMINVDVTKDDAPTIDVNANVYCYTG
GPVPITITGTTDKDIVDPPMYSIGNGYYASPNFTLNAPGSYEFFIKDGNGCVVKATYVLR
QELLIDAVLTQDLNCTTNDATITLSASQGAGAGTYSFEYDFNNSGTFTAVPALPYHPTAP
GTYTFRVKDGQCSTVSVPVIVTPITTPKFTTAVADVLCQGDSNGSITVTAANGVAPYEYS
INGGAFGSVNIFTGLAAGPYTIAVRDAKKCPATAAIVNVKQPTVLTATHAVTPFGCDPSN
TAKDALITLTAHDGTQPYSYSFDNGVTFGASPTHTINTASTVNYIIVDINGCRATGTATV
PVYNPPTHFDLTATPIYCSNLAGTATVTVSNISGGEPGYKYDIIEPAASATSNTVGSFAD
LLPATYVIKVTDANGCSTVNSIEVKKASEISVEGQLLSDVLCNGGTTGSIAFTISNYITP
SNYVFALSPNNGTFTQTGDVVTYKGLTAANYTFTVTDKTSGCTDNVANFLVSQPTAPLSF
TMTATNISCNNKNATITVNATGGTKDYSYAAVVSGQTPTAYSTSNKLEVDTNNGTAWDVY
VKDFNGCTTLVQTQNILTDALPSAITANVTSQCPSATGTYEIVVAATGKAPLEYSIGSGF
QSSPSFQVNSSGSYDVTVKDANGCTVTVTAAVTISNALDLQLDIQALPSCDAPDGRIVAK
ATGGSGNYRYSSGAYVPVTGATATFNNVSAGSHTVTVTDLTTGCTDIVTVDLKDATQITG
LALDKADVTCNGGSNGRIIVNLAPNAPGVNDNPIYKYTLTGTAIGNVPVSVGPQDSNVFD
NLLPGDYTVRVTSGRGCTAQADTRIIQPTPIVVNAPTITPFGCTTGTNTTNFASITVNSV
TGGTNPYVLYVFSKNGTVVQSSDSNVYNETDLKGGSYSVKVFDSKGCEGSSTAPITIAPF
ITMNDVDVNVVAPITCLVNETIQVSVATTGGTPTALVYTLTGVTGTVYNQTNPTGLFSGL
AIGNYQISVFNPTTGCTITDFHYVFDPNSFAINAIPVNGEICYGAADGSVDLLFVDNQPN
PNDAGAFTYTITGPVPSSGTSATAGPVRISGLTAGQYSVTAKLTNSPECTVTTVFNIKQP
TEAITIIKSQSPITCAAGNSDGTISVAASGGWDSNYEYELVGPVNKAYSTENMFTGLTAG
TYTINVKDGRGCIAFTTATLVNPTPIVVNAIPSATMLSCYGDKSAVITVAPPTGGQGSNY
MYTLKTLSDNPISVAGPQADPVFTGLGAGTYTVTVTDGFSCEATSGQIVISEPTIVEGSL
IQSRIETCKTQAQLTLSAKGGTGPYTYSTDGVTVLGTFTTPITFNVAPGEYKYYVADVNG
CVGFVTNGVTVDPIIPLGVGLDVSSAIVRCQGDATAILIAQANGGLGNYVYTLLSGTTGT
NIVRPAQNNGTFLDLPVGFYRVSVQSGADCNVVSAAFEITEPKAPFEAEFTQTNVSCFGE
SDGKMVVTATGGTGSYKYSINPDSDKFDTKNVFENLAVGDYTVIAMDENGCNEIHTFTIT
QPELLKAKEVPNSMIPEICAGDKDGAFSVEISGGTPVYSVSLDNEDGPFTQGAVGQTIFD
FKNLSGGAHNVYFKDAAGCSNLVTIVMPESVTLNPTNVVSYDCVNNTNANMVTIDPGYDD
HSQIDYRLDGTGPIQESNIFTNLTPGNHTVTVRHTNGCSADTSFEILAVAKLDITVTEEQ
GVWNTLTASAVGGGGNYEYSIDGVTFSSETKFIIYKTGTYRITVRDKNGCTDFEDHYIEY
VDVCIPNYFTPAGQNNTWAPGCTNIYTNLIFSIFDRYGREIAKYHYGQSWDGRYNGEELP
SGDYWYVLKLNDEKDAREFVGHFTLYR
>EGALAKHO_01748 hypothetical protein
MKKILLFITLFYGFSNLLYSQDTQSENGVVSFSLPIRNSLKFNRYLINPAFSFVRESNPY
VSFYNKRQYVQFDDAPNTYLFNYSGRFRENEAFAFGLFQQNYGVFTVFGGIANFAHNIVL
QEDSNLTFGLNVGAYQSGLNKGKIVTNDPNLPIDNIQSNTLLTVNPGINYGTAFLDFGLS
VNNLVLYNFGSGMVKDDPERAIELHAMYTGYIDSYGFFDRSKFSGIVKTEIKQDKTVLSG
LAMIAIPQGVWAQAGYNTLYGVSAGLGVNISPSIAIEYNYERGMGNFSNLGGSHEFVIAY
KFKNKNYYYGDDDEGSLIDPAKPKPVMAKKTTTAPVTRVDGATKAKLAADAKAKADAEAQ
QARLAAAEKTKADAEAARVKLLADNKAKADAAEAQKLKLAADAKAKADAEATARKTAVAA
SKPAPQKTAAQLAADKSKADAEALKVKLAADAKAKADAESAAKAKVASAPATPQKTQAQL
TAEKAKADAEAAAKAKLAADTKAQADAEALKIKLAADAKVKADAAEAKRKADAKAKAEAA
DLQSILAADAKAKADSDAYQARLAAEAKAKLAADAKTKANIDAANKAKLAADAKAKAAED
AALKEKLAADAKAKADAEARQALIAAEAKAKADAEALKIKLAADAKAKADAEALQAKLAA
DAKTKADAEALQAKLVADAKAKADAEALQAKLAADTKAKADAEAQQAKLAADAKAKADAE
ALQAKLVADAKAKADAEALQAKLAADTKAKVDAEAQQAKLAADAKAKADAEALQAKLVAD
AKAKADAEAQQAKLAADAKAKADAEALQAKLVADAKAKADAEAQQAKLAADAKAKADAEA
LQAKLAADAKAKADAEAQQAKLAADAKAKADMEALQAKLFADAKVKADAEATAKLKAEDE
AKQLQLAEEARLAKLAADTKAKADAEALQAKLAADAKAKADAEALQAKLAADAKAKADAE
ALKVKLAADAKAKADAEALQAKQAADAKVKADEEARLAKLAADAKTKADAEALKAKLAAD
AKAKADAEALQAKLAADSKAKADAEALQAKLAADAKAKADAEALKAKLAADAKAKADAEA
LQAKQAADAKAKADEDAVRAKLEAEERAKADAEARQAKLAADAKAKADAEALQARLAEEA
ELKAKLAADAAAAAAASAPKDDSAKEIEALSKAIEAAIVSQKELYAQFTTTVAKKQKDLD
DLREENDLSEKGIYREPKPFKSVAAENSQLEAFKVQLADANRTSKDELAKLNNLYNERLR
KVPNKNDALNKAYLEKINQLKAAQLQMEQDSAALLANLERIKAETEIEKKRRIKRAAYEN
DQGRYAQDIAALKRIKETTKPSSTPLTASDFDFGEDQSNMQIIKNIKNSENGYYMIIAVH
SSVEKRDEFLTKAVAAGRTDINFFYNIATSKYYIYYEKFEGLSEATKALEAKGNKPYNGK
MAIVKVEN
>EGALAKHO_01749 hypothetical protein
MIQKTTLSLIRFFLFFSIILCTKTNSYAQTIVPQQLAYPRICAGLIVDGKPFNEYNATFS
YVDFPAGTTFEVELSDETGSFTNPVATTKISAVDNPALQQQTIKFAVPTTLKGSDIYSMR
IKSSTATPVVSLKYKNSQGVTSFPIYYRTYVESFFINDKLATATFCTGGSLSLSLYNPTP
NDKPSSPANYPNLKYKWFKDDVAIAGQSGTTLLVNTPGVYYAQIDYGGCNDENFSSNRVS
VTSSASGSSVTIESSLGNPFCATGTGTVLTATAGNKYQWKKVGSTDVLSTSRTLTTNESG
VYMVDVDFGGCISTGTIDLKSNSFNASLNVPEENSIDAGTTLQVAVTTDASTPKYEWYLN
NSIIDGANTNTLEADKRGTYKVIISQSGGCVSTKELVFKVAFSTDPPTDITKIANVISLS
SYPYDVWDIPSEYKNENTSVKIISSNGDLVLDVVNYQGDWPPSGSIDIKNVNPVYYYVIQ
SDTGEKKGSITVLK
>EGALAKHO_01750 hypothetical protein
MAPTIKKYFIYTIFLVSPIALSLHAQSTKANNTVAFDANCQTASIAILDQNNDIADKRIS
KLDDNSNQLIAGLSIPKDSLSIATETNSQTTTNCQENSSITASYSVLAKGIIENYKYDFS
ETFIDILFFEDIDLARTRTI
>EGALAKHO_01751 hypothetical protein
MKKITQIICVLLTVTSMSAQQEKGIMGYTNWLNNWTEFKPNKVEYGEANQILAGNISVNT
KLLKRNIYVLQGNVYVTNNAVLTIEPGTLIIGDFETKGTLVVTKGAQLVADGLETDPIVF
TSNRSQKKAGDWGGIVMLGDAPINKFGNVGSYNLDLDPTLTTYGGDNAAGNSGVLRYVRI
EFAGKKVKGADTFNGLTLAAVGNKTILENVMVSYSGGDSFAFFGGDVNATKMVSYKSIND
DYKFTQGVQCRLYNSLAVRSSYLSSNKDGSRCMEVKSFEKKNETDFTKKQTLVVATNITM
LNDSENIKADIQAGLVKEAIYVAETASLEMKRSVISGFNPAVLLDSKTEINDANLKKIKI
EEMYLNLCNGNIFTEYNTNNEDLESWYGNPVFFNVMSQSDNKETFIDIFNPKKPDFRLQL
GKITASSGNK
>EGALAKHO_01752 hypothetical protein
MKGKIIFLSALFFLTTGAISAQAKNAPRSIISTTALIRKYHDQKELSGMQKGELLELYIE
RIKVLVKTLPYIALVTKPGVTMADLGIPDDSEHKKVLDNQALGTTTFLDTTVEFQRKMMP
YSDKGNLIAAILFYESTLKSLHEFNDLNEM
>EGALAKHO_01753 DNA polymerase III subunit gamma/tau
MQFSQILGQDYIKSHLIKSAASGRIPHAQLFIGPEGSGTLSTAIAYAQYILCNNTGDENE
NGNDSCNLKFQNISHPDLHFIYPTVTTEDVKTKPKSLDFIQDWRTFIQEMPYGGLFDWYK
MLGVQNKQGEIRVEDAQEVLKSLSLKAYEGGYKIMIIWMADKMNIAASNKLLKLLEEPSD
KTIFILISENEEDIIQTIRSRCQVIHFNGLPEKVIAEALISQENIDSNLAKKIAHQAQGN
FNKAVSLLKEDDSEYPFEQWFVNWVRAAFRAKGNAAAIQDLITWSEEIAGLGRESQKKFI
QFCIEMFRQALLLNYEAPTLVYIEPKVEKFKLENFAPFVNGNNIHEIFKELSDALYHIER
NGNAKIILTDLSIKLTRLIHKK
>EGALAKHO_01754 hypothetical protein
MNNVASILLLAFLALTFLQSGYEKIFYWKDNVEWLKGHFAKTPLKNQVPLALAHLLVLEL
ISGILCVVGAIQLLTNSGREFGFYGAIFSCISLLMMLFGQRLAKDYDGARTIVIYFIPAV
MAVYWLN
>EGALAKHO_01755 putative acyl-CoA thioester hydrolase
MQSVAKNKFYIKKMNPKHPSESLTILTDLVLPSETNPLNNLFGGELLARMDRAASIAARR
HSRRIVVTASVNHVAFNRAIPLGAVVTIEAKVSRSFKSSMEVFIDVWVEDRESGSRTKAN
EAIYTFVAVDDSGRPVEVPAIIPETELEIQRFDAALRRKQLSLLLAGKIKPSEATELKAL
FI
>EGALAKHO_01756 Protein RecA
MKEKEKKEMSSEKDAKLKALQLTLDKLDKTYGKGTVMKMGDKAIVEVETISSGSLGVDLA
LGVNGYPKGRIIEIYGPESSGKTTLTLHAIAEAQKAGGIAAFIDAEHAFDRNYAEKLGVD
IENLIISQPDNGEQALEIAENLIRSGAIDIVVIDSVAALTPKSEIEGEMGDSKMGLHARL
MSQALRKLTGTISKTNCTVFFINQLREKIGVMFGNPETTTGGNALKFYASVRIDIRRSSQ
IKDGENVIGNRTKVKIVKNKVAPPFKTAEFDIMYGEGVSKTGEILDLAVEFEIVKKAGSW
FSYGDTKLGQGRDAVKALIKDNPELADELEAKIKAHIKELANA
>EGALAKHO_01757 1-acyl-sn-glycerol-3-phosphate acyltransferase
MSFSQTQISVILFACNKVSNLPFSVKIFVLSVVKKAFYLPREAILLSKIHFCFLTFEAMK
GIKIIFWVLWRIWFYVVMAIPILIMLPFLLISIISESGYPYFFKMARIWAKFILFGMGFY
YLVERQQKLEKGKSYMIVANHTSMTDIMLTLAVVRNPFVFVGKKELVKIPLFGFFYKRTC
ILVDRNSSRSKNEVFKRAQNRLNQGLSICIFPEGGVPDDESILLDEFKDGAFRLAIDHQI
PIVPIVYADNKERFSYTFLSGSPGKMRVKIFPFIETKGLTGESRKELRDKVRQVIYGGLV
DFQKVKNKE
>EGALAKHO_01758 hypothetical protein
MTENEISTIIIGLAIEVHRALGPGLLENAYQECLFYKITQRGLLVEKEKAMPLIFENVKL
DCGYRVDLLVENKFIIEIKSVESLTVQHLAQTLTYLRLGNFKLGLLINFNEILLKNGVRR
VINDK
>EGALAKHO_01759 Tryptophan--tRNA ligase
MAKILTGVQSTGTPHLGNLLGAIIPAIELSNNPANESYLFIADLHSITQIKDGKTLRENT
YSTAAAWLACGLNPDKVTFYRQSDVTQTAELTWYLSCFFPFQRLTLAHSFKDKSDRLDDV
NAGLFTYPMLMAADILLYDAEFVPVGKDQLQHLEITRDVASRFNHQMGETFVIPEAKIQE
DSMLIPGTNGGKMSKSANNIINIFLDDKTLRKQVMSIETDSTPLEEPKNPDTCNAFAIYS
LLATEEQIAEMRANYLGGNYGYGHAKQALFELITEKFKTEREKYNYYINNLEEVDALLKK
GAEKASVVANGVLAKVREVLGFGKQII
>EGALAKHO_01760 hypothetical protein
MRVLAIIVFILLSNIMNSQNSNNVYSSVIEIIKNSSEFNSFLAGYSSKEKDFAVSEITYP
ICPFYSEFEEFLVPCKSDKWSEIWPKEQIENLDLLGNKKNKKVIVGITNTENLYLVSELS
IKSKNKSLIYLFQLKDDKPILIKVKITTLNK
>EGALAKHO_01761 DNA processing protein DprA
MSDQELFYLLALLKVDGIGDIMAKKLLTHFGNPEAIFKVKSNQIAGIDGVGSVLLRNLKD
KTVFEKANKELEFIKSNAINVSFFQDESYPDRLKHCIDSPVLIFTSGSINLKNKKLISIV
GTRQITSYGMEFCKKFIEDLAPLDPVIVSGFAYGVDIVAHQLAMDNNLQTIGVLAHGLNQ
IYPKTHKKYIARMEENGGFITEFWSSSNPDKEKFVRRNRIVAGMTEATIVIESADKGGSL
ITANLANDYNRDVFAVPGRVTDKYSQGCNDLIKTQKANVLTSAADLVYVLNWDIENKSKP
VQKQLFVELELEEQKIYDFLIKNGKELLDVIALRCDFPIYKISGMLLNMELKGVIRPLPG
KLFEAI
>EGALAKHO_01762 hypothetical protein
MYNFVTMKIETYIAQLLYRYQCVTVPGFGAFLTEIHSAQLNSSTNSFSPPRKTIAFNSLL
KNNDGLLANHIALTEKTSYGFAVSAIAFEVLSWQKTLEESGVLNIKNIGDIRLNADNNMV
FTPSDQTNYLTSSFGLSPFVAPMVKREIFEKKLQEIEESKVYQLHDSEEESRSSSSFLKY
AAIFVLGLGITGSIGYPIYQNQITTKTLVVENAVQKKVENKIQEATFFIENPLPAVTLSV
DSAKVETAEIKVMPYHIMAGAYRSEQNARKAYNQLIKDGYEARMLGENKHGLFPVLYGSY
TTMAEAQKAQKEIQKGENPDAWILVENL
>EGALAKHO_01763 hypothetical protein
MCYKLKLFFAFLLALSSQYFYAQQITTTSKAQIALEKKAEKSSEDYHKKLNDEQAKLKQN
QDKVKKEQKTVEKHQKDLKNSEKDLQNSKNKIAKLESENQKINSKLSSLSTEESQKQQVK
LKKNELEIQKLKLKQINQQKALEKAQAQI
>EGALAKHO_01764 hypothetical protein
MKRKNLFLILLFFYANFLSAQTVKPEYQKCIKSFIDNVKIDNKEAVAEMVFYPLKREYPI
PDVIDKADFINRYSEIFDTTLKNEITKSDPGKNWSDMGWRGIMLNKGNVWMDFDGRLTSV
NYQSQAEIDLKKKLNDAQKKELDSSIAFFQKPICVLETEKFRIRIDNLGNENYRYVSWPI
DKAMSEKPDLIIYRGNFVVEGSGGNHQYEFKKENYTYECAFIVAGEKNPPAAKLTIYQGG
KVILSQNAKIIAK
>EGALAKHO_01765 hypothetical protein
MRKIIYIIAIVFWIQNISGQDLKPEYQKFVKSFIANVKSNNKNGVAAFISFPLGREYPIP
VVKNKADFIKRYDQIFDATLKKEIINSNPAKDWSEMGWRGIMLGQGDIWMDTTGKIITVN
YQSQTEKDLKNKLISSEKGKLHSSIATFKAPVYVLETSKFRIRIDDLGNDNYRYASWSIK
NPMSQKPDLIITNGKWISDGSGGNSHYDFKKDAYLYECYIIVIGTDDSPPAYLSISQNGK
EILNQNAKIVIK
>EGALAKHO_01766 ATP-dependent RecD-like DNA helicase
MQNVSEAAAYTLQFINQTQKSIFLTGKAGTGKTTLLREIIATTHKNTVVVAPTGIAALNA
GGVTIHSMFQLPFSAFLPTYEESSQFTETVKFENKESLRRHFKMNNVKRNVIRNMELLII
DEVSMLRADLLDAIDFMMQTVRRNTRAFGGVQVLFIGDLLQLPPVIRDEEWRTLRNYYKG
KFFFHSHVIQQNPPLYIELSKIYRQSDDKFISVLNNLRNNKITPQDIQILNEYVKPDFDL
KNNPGYITLTTHNAKADSMNEQAIGDLAGNEYAYQPFVVGDFPEKIFPVEENLKLKIGAQ
VMFVKNDLSFEKRYFNGKMGVIKSLSPEEIFVHFPEENKTIEVEKYEWKNIRYKVNELTK
EIEEEVLGTFAHYPLKLAWAITVHKSQGLTFEKAALDVSQVFVPGQAYVALSRLTSLNGL
ILLSPLQMNGISNDQDVMDYALNKATEEVLKNSLHFETKNFIHNYLINSFNWTDLAQEWR
NHRFSYNENAVNSEKAKHSVWAHKRLETIDSLVDPSQKFVQQLNKIFSKETVDLVFVQER
VVAAYDYFFKPMDKLVTDLLQKMAEIQKFKKVKEFYEELALLDDLQTKAVLRLMKAKLLI
EIVVAGETICKEKLTSTTIKNYKTDKVNKIRLEFNMSNTDIFKLDEPAVRYTARKLDKNE
QKAVKKTTVEETHDLWLEKNSIQDIARIRKLNVQTIELHLVKLIQAKKVDISDVLPYDKI
LALREAFQFYQEESLNGLKEKHGDEFTWDELKMFKASIN
>EGALAKHO_01767 hypothetical protein
MKKALVIIALSILVVSCNKATEVKEVKTAYVDTSVLMKEYTEAKDLEAKYKAQAEEKGRQ
LQAEITRFKQDAASFQSQAQANGQAWAQQRGAELQKREQQLGYAQQALSQQLQQESGVEM
DSLISGVKKYIKEYGKKNGYSYIYGTGDAASILYAEDKYDITKDIIKALNDKYKAEPKTE
APAKEEAKK
>EGALAKHO_01768 Demethylmenaquinone methyltransferase
MDVLNKKHFLTVKDHSVSKEIFELYHDEILDMLITSPQPALENLGRYYESEDYISHTDNK
RSLFEKAYHFVKNIALKNKLNLINLEQSQKGRILDIGAGTGDFLLTAKNDGWETVGVEPS
ERAKNIAIQKGISFVNEIDALENNSFDVITMWHVLEHVPNLELQIQELKRLLKPTGTLIV
AVPNFKSYDAKYYNEFWAAYDVPIHFWHFSKKAIQSLFEKVDMKLEKVLPMKFDSFYVSL
LSEKYKTGKMNYISAFFVGLKSNLKASSTNEYSSHIYVLKNKQNAI
>EGALAKHO_01769 tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG
MFLEEYDVIVVGAGHAGSEAAAAAANLGSKTLLVTMSLQNIAQMSCNPAMGGIAKGQIVR
EIDALGGYSGIVSDRTAIQFKMLNKSKGPAMWSPRVQSDRMRFAEEWRMMLEGTPNLDFY
QEMVKGLIIENGKIKGIRTSLGVEIRSKSVVLTNGTFLNGLIHIGEKQFGGGRAGESAAT
GITEDLVKAGFESGRMKTGTPPRVDGRSLDYSKMNEEKGDAKPDKFSYSDLTTPLTHQRS
CHMTYTSLDVHDILREGFDRSPMFNGRIKSLGPRYCPSIEDKINRFADKERHQLFVEPEG
WNTCEVYVNGFSTSLPEDIQFKALSSVAGFEKVKFFRPGYAIEYDYFPPTQLKHTLETKL
VEGLYFAGQINGTTGYEEAASQGLMAGINAHLKVHEKAPLILKRDEAYIGVLIDDLITKG
TEEPYRMFTSRAEYRTLLRQDNADFRLTPMSHEIGLASEARLRRMEKKLNESEKMVAFFK
ETSVSVAETNPILEAKETAPITQGDKMFKVFSRPQIDLEDMMKFEKVKEYIEANDVDQEI
LEQAEIQVKYSGYIEKERNNADKLTRLEEVKIPENFDYDKIKSMSIEAKQKLSRIRPVTI
SQASRISGVSPSDISVLLIYMGR
>EGALAKHO_01770 Endoribonuclease YbeY
MINFNYETEFTLDNEQAFSDWLSAVIVSENKNEGEINYIFCDDEYLHKINVEYLDHDTLT
DIISFDYTVGNELNGDIFVSVERVEDNAKDFNVSFEEELKRVLAHGILHYCGYKDKSDKD
AKLMRSKEDEKTAMFHVEQ
>EGALAKHO_01771 hypothetical protein
MKTTSAIYQKLEAFIKKYYTNELIKGGLLFIGFGLLYFLFTLFIEYFLWLKPVGRTVLFW
MFIGVEVFLLFRFILFPIFKLFKLQKGIDYNQASKIIGNHFTEVSDKLTNFLQLSSSENS
AESSELMLASIEQKANSLQPIPFGNAINFKTNKKYLPLALIPILLFAVFFISGNSNIISQ
SLNRVVHFNATFLPPASFKFVVLNSNLQTEQNKDFVIKMESVGKVVPENVMIHIGDESYF
MESSQPGKFEFKIEKPVDNVQFSFEGNSVSSDEYELKVITVPSIANFEMVLNFPSYLKKK
SETIQGTGNAIVPEGTLVTWKMNTQSTQEIVWKDENAVFKFNKAENEFKLAKNISQNTEY
QILTSNNKVKNYEKLDYQLSVIRDQHPTITVSSAPDSLKLDKNYVLGRLGDDYGLSKLQI
VYYERNKPNTAKRGTIPVKQAVFDQFVFNFPSNLAVEEGVSYEYYFEVFDNDAPHHFKST
KSSVFSDRVSTTDEVQDMELQQQNQNINSLEKSLKNQNKQFSEMDKIQNTGKEKDNLEFK
DQQKINDFIKRQKQQDELMKQFAEKMNQNLDKFKDEKKDKTAEDLQKRLDNAEKDLEKNQ
KLLEELKNLNDKLNSEDLFDKMEKFKQISKNQSRNLEQLVELTKRFYVEKKADQVAEKLN
KLADQQEKLSNKESENTKDKQDEINKSFDKIQEDLKDLKEENKTLKAPLDIPSDASKEKD
VDSDLQKASEELAKKNTSSAKPKQKSAAQKMKSMAQQMQSSMEGGDQEQLEEDVAMLRQV
LDNLLAYSLSQEDVMKQFKSMKLGSSAYTKNIKVQQNLKQQFKHVDDSLFALSLRNPKVA
EDVTKEIGNVQYNVDKAIESLTDVQVPKGVSHQQYAVSSANKLADFLSDLLNNMQMSMSK
PGSGKPKPGDGQGMQLPDIIQKQKGLADKMKQGMKEGNKPGEGKEGQGQNGEGKQGQGKD
GQGKDGKGNQSGGKGNENKEGNDGEGDAEAIMEIYKEQVKLREALQKELAKQGLDSQGKP
VIDQMKQSEKQLLNKGFKNENLQRILNIQQELLKLNNAVQQQGQDTKRQSETNKAEFSNR
SNALPSSLLEYLNSVEILNRQSLPLRSNFNQKVQEYFNTK
>EGALAKHO_01772 Glutamate--tRNA ligase
MSKQVRVRFAPSPTGPLHIGGVRTALFNYLFAKKNNGVFYLRIEDTDQTRFVPGAEAYIM
EALEWLGIAPEETVGKNEKFGPYRQSDRKDLYQSYADQLIDSGWAYYAFDTPEALDAHRK
QHEAEGKTFIYNHHNREKLDTSLVISAEEVAKRIANGEHYVIRFKTPVDETLHLKDIIRG
DVKFETNLLDDKVLFKSDGMPTYHLANIVDDHLMETSHVIRGEEWLPSMPLHVLLYRAFG
WDAPEFAHLPLILKPVGNGKLSKRDGDKLGFPVFPLEWKTEEGVSSGYREKGFFPEAVIN
FLALLGWNDGTDKELFSLEELVASFDLNRVHKSGAKFDPEKNKWFNHQYLIKQNDADLAK
DFTPILVEKGIDVSKYDVTRIVSLIKERAHFVSEFWDLTDFFFQAPTSYDEKASKNWKEE
TPALMQELISTLEYIDGFDSANIEAIVKDWLTKNEIGMGKVMQPFRLSLVGALKGPHLFD
IVEIIGKEETISRIQKAISTL
>EGALAKHO_01773 Modulator of FtsH protease HflK
MGTAFIILIVLGLFILMSSFFTVKQQSSVVIERFGKFLSVRNSGLQLKIPIVDRIAGRVN
LKIQQLDVIIETKTKDNVFIKMKVSVQFKVIQEKVYDAFYKLEYPHDQITAYVFDVVRAE
VPKLKLDDVFERKDDIAIAVKRELNEAMTTYGYDIINTLVTDIDPDIQVKNAMNRINAAD
REKTAAEFEAESSRIRIVAKAKAEAESKRLQGQGIADQRREIARGLVESVEVLNNVGINS
QEASALIVVTQHYDTLQAIGADANSNLILLPNSPQAGSDMLNNMVASFTASNQVGEMMKK
NNKKIVKPKPIEPQSGYEDDIQPETK
>EGALAKHO_01774 hypothetical protein
MEPKKYASYAEIERDLEILKLEKEINYQKLVLSFQRTKENITPQNIVSGFFSSYKDYLSD
NYPKILQSFLPHIIGWLFNKKRGN
>EGALAKHO_01775 hypothetical protein
MLFYTTTMAFEELKENTENIQDQAKVYLDSHLAYYKLWGFKVAMKSTTLIFKFTLILLCF
SMVLLFGSFAAAYAFGALFESTALGFLAVGGIYLLFTILLFFIKDKFVEGPILEKFSEIF
FND
>EGALAKHO_01776 hypothetical protein
MSNKSNAIAAVIAGAAIGAAIGILFAPDKGSKTRAKLKEGLDDAKHNLKDSFEASSEVLR
EKFKGATQNLDGTFDELLSNVSHKTEEVITFLESKLADLKAQNAKLQK
>EGALAKHO_01777 hypothetical protein
MKNVFFTLAILFANIAISQTHQISKHNGEELDVNFIKHENDLIHYSFNGSSEEHKITKYA
VSKITNKQTNQTQKISDRVVVDSKSDYKMVTVLPQEKTIGLKQAANFSGISTKTKGEPPI
ANQNQTALRIKTHSASKGYPFVSIVENDGKYEAVAYMY
>EGALAKHO_01778 Glutamine--tRNA ligase
MASEEKSLNFIEQIIEEDLKSGLSQTKLHFRFPPEPNGYLHIGHASSIALNFGLGIDYQS
PVNLRFDDTNPEKEEQEFVDAIKKDVEWLGYTWAEERYASDYFQQLYDWAVLLIKKDKAY
VDSQSSEDMAIQKGTPSTVGTDSPYRNRSVEENLDLFERMKNGEFEAGTHILRAKIDMKS
TNMLMRDPIMYRILHRHHHRTGDDWKIYPMYDWAHGQSDYLEEISHSFCTLEFLPHRELY
DWFLDQIIDENQIRPKQREFARRNLSHTVVSKRKLQQLVKEKHVNGWDDPRMSTISGLRR
RGYTAASLRNFANTIGIAKRDNLINVSVLEFCIREDLNKIAPRVMAVLDPVKLVITNYPE
GKEEWLEAENNQEDENAGFRKVPFSRELYIEREDFLEEAPAKFFRLTLGKEVRLKNAYII
KGESVVKDSAGNITEIHVTYDTDSLSGSGTEASQRKVSGTLHWVSIQHAVEAEVRMYDRL
FTDEAPDSYKEKNFLDFVNPNSLEIIKGFVEPSLATAQNEDKFQFQRLGYFTVDKDSTAS
KLVFNKTVGLKDAWEEKGKKEENSINNSLKDISKYFKVETKPERIAIESAIGESIKNVST
FSLLQNSLKKNINNNKASLLFAQFILKYSHLKSADFEEEDIKKLYTMSLRSESTYVRSKA
LLNLRDLENESFKTQFEDEILKLYSNPPKNASEREIEILSEMVKK
>EGALAKHO_01779 Dihydroneopterin aldolase
MGVIKLKNIRTFSYHGCLIEEGKIGSDYTVDLKIKTNLQKSAQTDHLLDTVDYVHLNKIV
TEEMAIRSHLLEHVAKRINIRVLEEIEMIEKTTVWVSKINPPIGGDVESVTIKMTEIRK
>EGALAKHO_01781 hypothetical protein
MINDILAGLPWGLFLSFMVGPVFFILLETSITKGFRAAIVFDFGVVLGDIFFIAIAYLGS
YRLIQSLKDKPALFIFGGIIMLAYGIISFVRLKNEEKIDDEEIDRDIIKRNYGSLFIKGF
LLNVINIGVLGFWLAVIISVGPKLEMQNSRMITFFTAVIVTYLLVDCIKILLAKQLKSKM
TPNNILKIKKIISIVLMVFGFALMIQGWFPKEKEMVRNAFEKIEK
>EGALAKHO_01782 hypothetical protein
MKKLLIGVAILFVQMSFAQITKEVGDFDEVKVFDKLHVKLVASSDNKVVIKGARESEVEV
INKKGILKIRMTISKPLAGDELDITLYYKHIELIDVNEGALVTSTEPVKATSFKVSAQEG
GKINVDLDVDKLKVSSVSGGEITLTGKASNQDASLGAGGFLLASKLVTSQTTVSVSAGGK
ADVNATTLVDAKVSAGGSIYIYGKPRQINQKTVFGGKIEEVK
>EGALAKHO_01783 Ribonuclease R
MSKKIRKPIKNEKDFSSKIVKILSQSPNKAFNYKQIGAKLELDDTKSRNQIIKDLKILAA
SKKIIETEPGKYLVKAESQDYYEGTIDMTSRKTAYFVCPDFTEDVFIPTNNLNRALDKDK
VKVYVYNRRKGKRPEGEVIEVIERNKTEFVGVIDIQANFAFVSTANPKMYTDIFIPKDKI
GEAENGDVVLVTIEDWPKRADSPFGSVIKVLGKPGEHNTEIHAILAEYGLPSDFPVEVEV
FAQKIDTSIQESEIAKRRDMRDTLTFTIDPKDAKDFDDALSFKKLENGNYEIGIHIADVS
YYLEEGTILDDEAYQRATSVYLVDRVVPMLPEVLSNFACSLRPNEEKYTFSAIFEVSPTS
QVINQWFGRTVIYSDQRFAYEEAQYIIETKDNTIPVDISITGESYVVSDEIVEATLKLDE
LAKILRKKRMANGAISFDKVEVKFNLNTEGEPEGVYFKVSKDANHLIEEFMLLANRKVAE
YIGKQKKTFIYRIHDEPNEDKLIAMQTVIAKFGYKIDFRNKGDISKSLNALMEEVNGKKE
QNLIDTLAIRSMSKAKYSTENIGHYGLAFDYYSHFTSPIRRYPDVMVHRLLQFYLDGGAS
VNEEIYETKCLHCSNMESLATNAERDSIKYMQVKYMQDHQDEEFLGVISGVTEWGIYVEI
VSNKCEGMVRIREIKDDYYTFDEKQYALVGATSNSILQLGDEIYVKVKNADLVKKQLDFH
FLRRAE
>EGALAKHO_01784 hypothetical protein
MESFKTIAIFNYQHETVVLKHLLEQEEIPYFFENEMTLSVAPMYSAALGGIKLKVHPNDF
EEVQQILDNLNSPLKIV
>EGALAKHO_01785 Ribose-5-phosphate isomerase B
MKISIGNDHAGPDYKKAIVAMLKAKGYEVTNYGTDSEDSVDYPDYGHPVANDVSEGKADF
GIVICGTGNGIAMTVNKHPKVRAGLCWTKEIAALVRLHNDANIISIPARFTSVPQAVEMV
ETFLTTAFEGGRHQNRVNKIACS
>EGALAKHO_01786 hypothetical protein
MKVLIVSFLFINIVVFFLAGYDKHQARKNKRRIPENTLFFLEAIGGTIGLLLAMLFFRHK
TSKPSFIIKLSIIIFIQILIAVLLLIYKNDIFTIAHFLTS
>EGALAKHO_01787 hypothetical protein
MSPVQLFEEKKVRSHYDAEKEIWYFSVIDVIQILTGSTIPKRYWTDLKKKLKAEGSEAYD
KIVQLKMLADDGKNRMTDTADTETLLRLIQSIPSPKAEPFKQWLAKVGYERIQELADPSQ
SLDRARDNWQNLGRSEKWIQQRMTGQETRNKLTDYWKESGVEKKDEFVLMTNIIHQEWTG
LTVKKHKDVKGLKSQNLRDHMSEAELIFTALAELSTRQIAESDEAKGLLENAKASKKGGA
IAKNARIALEDKTGKSVVTGENFLAPDKKKLE
>EGALAKHO_01788 30S ribosomal protein S1
MTNIQFIAKTVQTAPINIQKTVQLLEEDCTIPFISRYRKDTTGNLDEVQIEQIAKLQKEY
ETIVKRKEAVLKSIEEQKALTPELKQKIEQSFDLQEIEDFYLPYKKKKKTKADVAREFGL
EPLAKIIISESNVDVDFISTQYINENVINEEAAMQGARDIVAEWINENIFVRKQLRRLFQ
RKATIGTKVVKKKAEEEGAQKFSQYFDWEEPLTKAPSHRLLAMLRAENEGFVKMKVDVDL
DEAYDVIDEIIIKKQNSTTAHLQLAIEDSYKRLLNPAIGNETLQEAKAKADANSIQVFAN
NLGQLLLAPPLGEKRILAIDPGFRSGCKVVCLDEKGDLLYNETIYPHAPQNEEAMAIKKI
RSMVNAYHIDAISIGNGTASRETEFFIKKIAFDKPLQVFIVSEAGASVYSASKIAREEFP
NYDVTVRGSVSIGRRLSDPLAELVKIDPKAIGVGQYQHDVDQTKLKEELDNTVIRCVNSV
GININTASKHLLSYVSGIGEKLAENIVQYRSENGPFEDRKQLKKVPRLGDKAYQQGAAFI
RISNAKNPLDNSAVHPEAYPVVEKMAKDLKLSVNDLIANKEKTALIKAENYITPEIGLLT
LKDIIKELEKPGLDPRKSAKVFEFDANVKSIKDLRTGMILPGIVNNITNFGCFVDIGIKE
SGLVHISQLKAGFVSDVNEVVKLHQHVDVKVTEVDEDRKRIQLTMVL
>EGALAKHO_01789 hypothetical protein
MKKTLLLLFFLLKSFLSFSQNPTDIKKTFGSFPGFDNYVYATVVQPDGKILVGGVFSKYK
GAPESCLVRLNPDGSKDATFNIGAGIGAVYSIVLQNDGKILVGGSFTKFQGKTQNRLIRL
NPDGSKDLTFDIGTGFDSFNDVVYSIALQTNGKILVGGNFLTFQGVSQKYFIQLNADGSK
DTTFNLGTGPSNIVYTLALQNDGKILVGGNFAQYQGASQNRLVRLNPDGTKDLSFSVGLG
FDYTAKEILIQPDGKILVAGWFTSYQGEDASNLVRINTDGSIDTTFNIKAGFNDTSVESI
ALQPDGKILAGGTFLYFQGFSQNHFVRLNADGSKDASLDVGTSFGYGNGNNIFSIAVQTD
GKILVGGDMYAFQDIQTNHFIRLNANGSKDNSFDSGQGFDYPVCSIVTQPDGKLLISGQF
SKYQETSQNCLVRLNPDQSRDNSFKIGTGFFNYWGGEPIIQAIALQTDGKIIAGGCFTAY
KDVSQKGLVRLNTDGSKDASFNIGSGFDGSVGTDKVHAIVIQPDGKIIVGSDFWQYNQVR
NDKIIRLNIDGSVDKTFITGGGFDYVVEAIVLQDDGKIIVGGQFTKYQGVAQNYLIRLNP
DGSKDDSFNIGTGFNYPVRSLSLQKDGKLLVGGEFTSYQNKVEKYFIRLNADGSKDALFN
TGTGFNSYVNSIVVQNDDKIIVGGQFTMYKGYIQNRLARLNTDGSSDNPFNAGVAPGFND
SSFINTVKLLPDGQIILGGDFTTYHNDNKSAYIIGLEGNYIATPLIAKITPTNITCSAIS
GDASVSVNGGKSPYTYLWSNGATTTKITGLSPGDYSCKVTDADLTTVTESFKIAAIADTE
KPTITAPINVAVNISSGCTSGAVVLGNPITADNCSVVSVTNDAPAVFPLGNTTVIWTAKD
TSNNTATATQIVTVNDVTLPTIKAPASIIVNTNTNCTATAVVLGNPITADNCTVISLTNN
APSVFPIGNTTVTWTVKDASNNTATATQLVTVKDMTAPTITAPLPVTVSTNLKCTAVGVV
LGNAVTADNCSSVTVSNNAPSAFPLGKTTVTWTAKDSNNNTTTATQIVTVNDATLPTIKA
PAAITVNANTNCTATNVVLGNPVTADNCSVASVTNNAPLAFTVGETTVTWTVKDGSNNTA
IATQIVTVKGIDATIANNAGILTAVETGATYKWLECNNGTFTPILNENKVSFTPKKTGNY
AIEITKNGCSVTSTCYEVKTLGTNDFNFENSLKLYPNPTKDFVTIQINTLDNALLKIFNV
NGQFILSKELKTVSNTINISHLASGVYLFEVSNDNGKFTKKVIKN
>EGALAKHO_01790 Sec-independent protein translocase protein TatA
MGRLGLTEILVIVGIVILLFGGKKIPELMKGLGSGIKEFKNAAKDDQPAAAKKEEEEVK
>EGALAKHO_01791 hypothetical protein
MAKKKHNFRRKLFTKNRLVILNEDTFEETFSLKLNLMNVFVVLSLGSIFLILITTFIIAF
TPLREFIPGYSSSKLKRDATKLAIKSDSLETALKKNEAYIHGIQKVLRGELDYAKFNKDS
ILAEVDEPSEVNMKASEEELKLREEVTKIEKESGEKRRSKNKSDKK
>EGALAKHO_01792 hypothetical protein
MSIKSVAAKLFASKIYYKTQAWANKPVETQQQVFKGLINSAKETQFGVDHHFDKIKTVHD
FKKRVPIRDYEDLKPYIDKVRMGEKNILWKGKPIYFAKTSGTTSGAKYIPLTKESMPFHI
EASRNAILHYIYETGNADFVDGKMIFLQGSPILVEKYGIKFGRLSGIGAHFVPKYLQKNR
MPSWETNCIEDWETKIDAIVEETIEQDMTIISGIPSWVQMYFERLQEKSGGKKIGDLFKN
FNLFIYGGVNYEPYRAKFENMIGRKVDSIELFPASEGFFAYQDSQKTKGMLLLLNSGIFY
EFIKADEFFEPNAKSYTIGEVEVGVNYALIVSTNAGLWRYNIGDTVQFTSLFPHRVIVSG
RIKHYISAFGEHVIANEVENAMKEATAGTKIVINEFTVAPQINPSSGLPYHEWFVEFETE
PENMEAFAEAIDDSMRKQNIYYDDLITGNVLRKVVVTKVSKNGFQEYMKSQGKLGGQNKT
PRLSNDRKIADNLK
>EGALAKHO_01793 hypothetical protein
MSQGKFQNKYRTSSIRAQWWDYGWNGAYFITICTQDRQHYFGEIQKDKMVLSEVGIIADI
LWHQIPIHHKNVELGDFVVMPNHIHGILIIDKQSDNIDIDNVETGRVDTGHVDTGHALSL
PSPPPLPSLPKPGSQRFQNIGKNTISSIVGSYKSAVTKHANRLGYPHQWQKLFYDNIIRN
NNDYQRISDYIVSNPENWAKDKFKREDK
>EGALAKHO_01794 hypothetical protein
MKETKHISRSRAQESSAAIERMYITMRHLFNRGFYKPMGVSGDGLRESLLALRPEIYGNI
GEEKVELNGLLYVIERLPIGIEQCRFINLTSDEGYSKSHFQAIVPPKRRRNCYRIDEEQM
NVEITRGRSDIYDILTHLTFIFIESHKIKNRVLLDDGGEVSRDWLKLEQAVTQTKKLALI
EKEKAISHVANILGRTFEEVLDIYDAFGSENAPDRFLHVIYWLGKLAIEEVIENNKRTIT
FSPVLRERLGHHIHGEIWATNIKEVLKANDLLKRPIHVISANMHSVMNSIFATPLLKTKF
KDKSDFFIYEELSKSGAKELRSQVEELALKNGMISLPDTSGTNIDVQIFDTAKIDWAKTT
FTYANIDEEKPVIIVMDYAFGEQAYETIDELLKPYKKETLLNVQSVSIMGKAGILEGGKG
DIMIPTAHINEGTADNYFFENELTGAMFEGNDIAVFEGAMVTVLGTSLQNRDLLKFFHES
TWGVIGLEMEGSYYQKAIQSASKIRKSVPHDIKVRYAYYASDNPLETGSTLASGGLGTTG
VKPTYLITIKILEQIFNVK
>EGALAKHO_01795 hypothetical protein
MSTKVPQNSDQEIDIFQLSRSINGFFDRVNSSIFRAIQFFIRNWIIVLILVVLGAALGYY
LDSNKKSYNNQIVVTPNFESVDYLYAKVDLIQSKIAAGDVDFLKNTVGISNPQAIRRIEI
KPIADVYKFIEDKEQNLELIKLMAEVGEVKKVLEDNVTSKNYTYHTISFVSSGTVNEKEV
VEPLLKYLNNSAYFNSIQKIGYKNLEREIAQNDTIIAQIDHVLDGLSNTAKNSSKNEKLV
YYSENLQLNDIIKTKQKLVTEQGKNRFRLISFDKTIKEINSTLNINESKTVNGHFKIWLP
LFFIFIFVLISLFKRFYHRQLAISKANQL
>EGALAKHO_01796 hypothetical protein
MRTNSIFERFSKNRFLRQSFSTLSLRVFGALLLFGFTVFLTKTYSPKLVGQYDFVRSFLL
SIGSMCLLGFDQSIIYFKGKLASQNALDELKSIYIKMVLMLFGTSLLVLLLIAIISKETI
NNYFSDQAVYSILLKGTLTLFFSGLSILNTEVFRALDKLYVAELFRNIIKYIPLIIGSVI
LFYWHKEEYLVDVFLLGFVFLAVLSSVFVFIFFRKKMISITAEKFSHKEIFLKSYPIAIS
AMALFLLMCFDIMFLKKYRNDETVAFYSVGVKIMTIISIIIVSINITVSAKIAEFFASHK
TAELIEVSRNSARLIFGITLPIIILISYYSKHILSIFGHQYVAAQQAFLILIIGQGICSA
FGTASVYLNMTGRQHIFQLILMIAVVINFVLNRFLIPIYGMTGGAIAFVSSSFFWNLVSA
IVIYRKDKIKVFLH
>EGALAKHO_01797 putative glycosyltransferase EpsJ
MNIQKETLLFSIIIPVYNVEDYLPQCLDSILCQSFSNFELILVNDGSTDSSLEICQQYKQ
KFSQIILIDKENGGLSDARNTGLKTAKGEYIIFTDSDDYWQGKKVLEDLNHLIKEANPDI
ILHEESRFFAENDVTCKYNQRFIKNKNGKFEDAILNLVYFDLYAASAWDKVIKRSILIEN
QLFFPLGRKSEDIEWCGKLMHYLKTFSIYSKSFYVYRQARQGSITTTVSAKHIEDVYEMV
KEGLEAQETTLEALNKAIENYWACNYVVILKDFYVLSPKTQKQIWDDLISWKYLLKKGRN
IKVDKVMKFYKFLSFKTLIFFLNGYRLKRGLNKKRRASK
>EGALAKHO_01798 hypothetical protein
MKLLIKKSTAAFLLIASANLVVAFLAFFVLPPKFFYDTAIIIYDKYNEIGYFGSYPLTIL
FYKIIGFRYLPFPIIALIQFPILMYILYKIGIPDNFEKVNVKNLLVYLGIFMVAIFISMP
SKEFITYLFIALIVFVCKNERFSFRKTIFFAILLLIVFGALYRPYFALIPIVGGGMYLVS
FINFKNKTITTIFYGLLIAVFLSLSYGVLQGKYFSEISREVVNSTRLVSGDANSIITSPV
KTDTWYGETISVFYGFFTVNLPLNGLKHILSPQIIVFVIWQLLLFYILLVRFSKCLKERK
KYRYELLIMFILFSFFILQGVFEPDLGSAIRHKIGIFPLIYFALYYEHFRKELQ
>EGALAKHO_01799 hypothetical protein
MILIAFIASPILLELLLFWNNDSFAKGLKAIEKSTSLLIFPLFIIGNYQRLNFLKIAQTY
AIATTIIMLFFFLRFLIIYPELMDKYLNGIDLWEMGYQFADSIGIHAPALNMHLAFVSVC
ALYFVFESFRNHEKAALKIGRLIHFLFSFFFVLFVNTRMALINVLIGFLIVFFFEIRSKF
NTKKIVLTAVTVLVLLGGITFFFVQKNPYMKEKYSSVTFAYMDKVGKLDEIDHPEIKVFN
SLVTRVSIWKSAWELSVKNLPFGVGASDGKPELNKYYKATNQHFLAKYEFPTHNQFLDFL
LKFGILGPIVVFLYIFTIGYLGYDLKNAMILSFFLIFFTSNLTDDFLLRFDGIAFSGLWF
SIFGSYWLQQKVTLDKAPEVA
>EGALAKHO_01800 N,N'-diacetylbacillosaminyl-diphospho-undecaprenol alpha-1,3-N-acetylgalactosaminyltransferase
MKVVHIIEALGGGVYTYFRDLSTFFGDDEVNKNIETTIIYSGNRKEIDAQKIKSEFSDSV
NLVQVNMVRELSPIQDLKSAFQLAKEIKKINPDVIHLHSSKAGVLGRIAYFFLFKKKKLF
YTPHGYSFLRTDISKTVKNIYWGIEKNFQRFFGGTIVACGDTELEIAKGIGNAKLVRNGI
DIANVQEHFAPHQNEKLTIGIMARITAARNPEMFNQIALKFPDFNFVWIGDGELRPLITA
PNIRITGWILDRKTVLKELNNIDIYMQISLWEGLPIAVLEAMALQKPVIATNIIGNKDAV
LHNETGFLFTDINELESFFKILKDPQTRDSFGKNALARCRNLFDKNQNFKQLLALYQE
>EGALAKHO_01801 UDP-glucose 4-epimerase
MKRILITGAAGFLGSHLCDRFIKEGYFVIGMDNLITGDLKNIEHLFKLENFEFYHHDITK
FVHIPGDLDYILHFASPASPIDYLKIPIQTLKVGSLGTHNLLGLARVKKARILIASTSEV
YGDPLVHPQTEEYYGNVNTIGPRGVYDEAKRFQESITMAYHTFHGVETRIVRIFNTYGPR
MRLNDGRVIPAFIGQALRGEDLTIFGDGLQTRSFCYVDDQVEGIFRLLHSDYVYPVNIGN
PDEITIKDFAEEIIKLTGTNQKVVYHPLPINDPLQRQPDTTKAKELLGWEAKVSRSEGMK
ITYDYFRSLSPEELSKEEHKDFSSYIK
>EGALAKHO_01802 Putative teichuronic acid biosynthesis glycosyltransferase TuaG
MSELVSIITPTYNAEKFIAETLKSVQNQTYQNWEMILVDDASTDETVKIISDFVEKDSRI
KLFKLEKNSGNGFARNIALEKAVGKYIAYLDADDLWFPNKLEKQIKFLKQNNLNFTFSFY
DCIDEEGNSLKRRVEAPLNLTYDELFFCNYVGNLTAIYDADYFGKIVIEATQKRQDWRLW
LTILKQIQVTKPVPESLAFYRIRKDSISSSKFKLIKHNFGVYREFHGFNFVFSVLLMVRF
LFTQLIIKPRYIKKI
>EGALAKHO_01803 hypothetical protein
MDDQSLLSEETISNKIYFIRNQKVMLDRDLAILYEVENRVLNQAVKRNLSRFPEDFMFQL
TENEYNSLRSQIVILKKGRGEHQKYLPFAFTEHGILMLSSVLKSDKAIQTNIQIMRIFTK
VRQMLLDTTEIKVDILQIQKKLQNHDKNIELVFSYLDELTEKKENESERVKIGYKK
>EGALAKHO_01804 Phenylacetate-coenzyme A ligase
MISLFDISLQLNGFSIKKAKAELDQIVNLSEEDYAVFLQNKKEETVAFHLQNNTFYQELV
GNKGIPKWEDLPILNKQNLQKPLAERLSKGYTLKNVYLNKTSGSSGTPFVFVKDKYSHAL
TWASNIMRFGWFNIDFNHSYQARFYGIPMDFVGYQKERFKDFLSRRFRFPVFDLSDVVLE
KFLQKFKTKKFDYLNGYTSSIVLFAKYLEQKNIILKEICPTLKACFVTSEMLFESDKKLL
ERQFAIPIINEYGASELDLIAFENPEGEWQVNAETLFVEILDENNKVLPYGEEGRIVITS
LFNRANPFIRYEIGDIGILDEKSTPQKPILKKLIGRTNDVAILPSGKKSPGLTFYYVTKS
IIEDDGNVKEFIIKQTKLDTFEIEYVSEKELNSEQIQKIEEAISLYLEPNLNFTFTRKKV
LERTNRGKLKQFKSYL
>EGALAKHO_01805 putative HTH-type transcriptional regulator YbaQ
MEKLKNIHPGEILLEEFLIPLNITPYRLSKDLKIPQTRISEITKGNRRITADTALRLSQY
FGNSAKFWLGLQDDFDIEEEESNKGQELRSIKRFDLKEAV
>EGALAKHO_01806 Toxin HigB-1
MIISFGSKETEKIWNGIVVKKPSIEIQQIGRRKLRMLHNSLNLIDLRIPPSNRLEKLTGN
LKDFYSIRINNQWRIIFRWEDGNASAVEIVDYH
>EGALAKHO_01807 Phosphoribosylamine--glycine ligase
MTILLLGSGGREHAFAWKMIQSPLCEKLFVAPGNAGTAGIATNVDMSPTDFDAIKAFVLK
ENVKMVVVGPEDPLVKGIYDYFKNDESLNHIPVIGPSKLGAQLEGSKEFAKEFLMKHNIP
TAAYDSFTAETVENGCAFLETLQPPYVLKADGLAAGKGVLIIQDLEEAKTELRNMLVHEK
FGAASSKVVIEEFLDGIELSCFVLTDGKSYKILPTAKDYKRIGEGDTGLNTGGMGAVSPV
PYVDAVLMEKIETRIVKPTIEGFQKDGIEYKGFVFIGLINVKNEPIVIEYNVRMGDPETE
VVVPRLKSDLVALFQSVADQKLDTFELEVDPRSATTIMVVSGGYPEDFEKGKVITGLENI
TDSIVFHAGTKLDNENVVSNGGRVLTVTSYGDDFQQAIKKSYQNIDKLNFDKMYFRKDIG
FDLL
>EGALAKHO_01808 hypothetical protein
MTTFFEGIQYLFVNILFAPLDFLRRLELVSWFAASTINWIFMIICACAIGYWIKQLRIFD
DAGTENQDTTAHSFLK
>EGALAKHO_01809 hypothetical protein
MITSVFRKSTPLNYSLVVILILVFFFLFQIQEPSWMSSYFLAFQKVSLLCFIFASFFLIN
FIVKKNGLSKDNGYAIFFYLLFILFFPTIFNNSNVIYANFFLLLALRRLISLQSLKSSKE
KIFDASFWILVASLFQFWCVLFLILVFISIVFHVSRDYRNWVLPFVALLAVAIIFLLVSL
IFHFNAIEFFEKRAVIDLRVDYFKNNYENGALSIYVAVALFFVVSMLTTLSNRPQIVHTS
YKKVVACFFIAAFVFILSPNKSNDLLIFSITPLTIMAASHVEYVQQKLNNEIVFYVLICC
SLFTFFSQL
>EGALAKHO_01810 Uracil phosphoribosyltransferase
MKIHYISENNSVLNHFLGQIRNVNVQNDSMRFRRNIERIGEIMAYELSKNLSYKEVEIQT
PLGIKKTTEIESDLVLCSILRAGLPLHNGFLNYFDQAENSFVSACRYHPNNDHEFEIRVE
YQALSDLNDKTVLLLDPMLATGQSIVAVHEKLVQNAVPNEIHIVVVIAAPEGVAHLEKNL
PDNCHLWVAALDEKLNEKNYIVPGLGDAGDLAYGSKL
>EGALAKHO_01811 hypothetical protein
MFSKLAYSVFEQSIKDYHQFDNVDQPINNPYPKDKFEHLLYLKNWIDTVQWHFEDIIRDP
QIDPVAALTLKRRIDASNQERTDMVEYIDSYFLQKYSNVQAKDGAKINSESPAWAFDRLS
ILALKIYHMQEEANRAEASQEHRDKCQEKLNILLEQRSDLSTAIEDLLTDIENGNKFMKV
YKQMKMYNDDDLNPVLYQNKK
>EGALAKHO_01812 ADP-heptose--LPS heptosyltransferase 2
MRLSAMGDVAMTVPVLRAFVKQYPDVKLTVISRPFFKPFFDGIPNLDFFAFDEKERHKGF
AGLLRLYKDVKKFKIDAFADLHNVLRSKIVSLLFALSGKKRATVNKGREGKKELTRAENK
IFKQLPTMFERHTKVFEELGFPLDLSNPEFPEKANLSADILEIIGNQNQKLIGIAPFAQY
DSKVYPVDLMTEVISSLAQNPNYKILLFGGGKKEIEVLDSLSKSFENVINMAGKIKFQQE
LQLISNLHVMLSMDSGNAHIAAMLGVKVITLWGATHPFAGFLPFNQSLEDALTSDRNQYP
KLPTSVYGNKIIEGYEDAMRSISPKDVIAKIEEQFSNKF
>EGALAKHO_01813 hypothetical protein
MAMHHYLRLSFILLFVITSFVCLYFIIKKRRNRKGPKLLSQEKYTSSMSEKMTEIPVSND
SIFNIWPYISELKAVKILSNKVKESDLIHKVYRNSTDDFEHILLATEKENRFVKVVVDRN
KKKPMGYLFLEL
>EGALAKHO_01814 1,2-phenylacetyl-CoA epoxidase, subunit E
MPSFLKLIIKEVKRETKDAVSVLFNVPEELKPDYKFIAGQYINLKLTLDNQEIRRAYSIC
SAPESGELRIAVKAVKNGLFSQFANTKLKAGDVLEVGHPEGKFTFEPDAERQKNYAAFVA
GSGITPVLSIIKSVLKSEPKSSFVLVYGNRTPEETIFHEELHDLQLKYVGRFFVHYVYSQ
AKAENALFGRIEKSAVNFVLNNKHKELQFDKFYLCGPEEMINTVSGILKEKNVKDSAIKF
ELFTTSSQEHEIKTSLEGHTKITVLVDDDEVSFEMSQKQTILDAALKQGIDAPYSCQGGI
CSSCLARVTSGTAEMTKNSILTDKEIASGLILTCQAHPTSESIYVDYDDV
>EGALAKHO_01815 hypothetical protein
MIKKFIYLEWKAFTRSASFGANLAMKILLGFLMIYFSLLFIGAGVGAFYLLKEMNLEPFI
TVNKFLIYYFLLDLIVRLLMQAIPVLNIKPLLVLPFKKPTIVHFSLGKTALSFFNWVHAL
FFVPFSIVLVLEGYDTIGILFWLLAIFSLVYINNFLNIILTNIDKLFVVFVGIAIGLGAA
QYYKLFDITFYTTPFFLGLYAKKELFLIPVLVLIGLYQFTFKYFKNNLFLDAGLSKKEDI
ATTENFVWLNQFGTLGTFLKNDIKLIRRNKRSKTTLIMSFFFLFYGLIFFGNTHQPAVMH
IFAGIFVSGGFLFVFGQFVPSWDSSYYQLMMTQNIPYRGYITSKWWLIVIATFISTVLAS
FYLLYGWEVYLTIVVGAIYNIGVNSHLVLLGGAFTKTPIDLSNASGAFGDKKAFNASAML
LTLPKLLLPLGLYGLGLYLGDKTLGLLLVAGAGVLGFVFRNTVFSIIEKRYKVEKYSTIS
AYKQKN
>EGALAKHO_01816 Glycine betaine/carnitine/choline transport ATP-binding protein OpuCA
MIQVSQLSKKYNGTTVLNINNLEIPKGQSFGLVGNNGAGKTTFFSLLLDLIQPSTGHITS
NNIQVNTNENWKSFTGSFLDESFLIGYLTPEEYFYFIGDLRHQNKADIDALLAQHEEFFN
GEILNNKKYLRDLSKGNQKKVGIIATLIGNPEVVILDEPFANLDPTTVSRLKKIIKDLAE
NPNVTVLVSSHDLQHTVEVCDRIVALNKGEIVKDIQTSKETLQELESFFAV
>EGALAKHO_01817 hypothetical protein
MSRNSHALSTKYNILYNGGIGLEKGLKSIYANDQDNFWKMLPIEKMQVDENYSGDEKAKN
PDFELAETKATKAIQKHSMNIGGREKNSQIDEAYLMLGKARYYDQRFIPALEAFNYILYK
YPNSSNIYTAKIWREKTNMRLGNDAIVIKNINLLLKNTDLNKQTFSDANALLAEAFLHLE
QKDSAVAKLRIAEDFSRVNEDKARYRFILGQMYQEIGKRDSAIYFYNAVIDMNRKADRKY
MMHAYAKKAQMFDYENGDQDMFIETYNRLVDDRENRPYYDILFYEMGVFFDNYKEQENAL
EFYNRSLARKSKDPYLVASTYRNIGNMYFKNTDYTMAAKYYDSTLVKLDPKSREFAFIEK
NRKNLDNVIKYEAIAKRNDSIIMVYGLPEAERKSYFDNYITELKKKDDAKRIAEEIEKEK
LANVERNSKAGNLPTAVNPQAPVPTDLPSGGAFNPPGVNDQASTFYFYNPTTVAYGKVQF
RKMWGNRSLAGNWRLASSKTIVNPALKDSLSIRQDSLNALQDSVVVEKYTTAFYEKQLPT
SPIVMDSIGKERNFAYYQLGLIYKEKFKEYNLASDKLEQLLKNKPEEKLVLPSMYNLYKI
YQITNPAKAEKVKSDIIGNYPTSRYAQLLNNTNTNDLASPDKEYKKWYKLYEEEQFDVVL
DNIDNLINQYAGDEIVSKYELLKANTLGKVNGLAAYKKGLETVADNYPNSEEGKNAREIL
EKQIPSLEKLDFTAVDGKNWKILYLVANNDSQTIKKIEEAIKVFLLVENYERLTTSLDKY
NKTQSFVVIHGVKSEAYARDVSGVLRDDKKYKIAHPSIIISSDNYKVIQIKKNLETYLAP
KNP
>EGALAKHO_01818 hypothetical protein
MFEKAKKSGTELLGKTNRIVEGTSIIGDIVSKADFRLDGELIGNFTSQGKLVIGPSGIVK
GEIICHNADIEGEFQGKLKVLEVLNIKATAHIHGEIAVGKLSIEPGAEFTATCTMLTNSK
EVTLKDGKGAEQKSKE
>EGALAKHO_01819 hypothetical protein
MEKEPNKNQRNKWIALINIPIQMGVIIFLFSYLGTWLDENHPSPKIYYNKILVMVGVFLA
LYNVFRQVNEINKTK
>EGALAKHO_01820 hypothetical protein
MPFKDKTILHLFFFALASYIVHKAVFIFFEIPNQNFHYSIESLYLIFFSFAAVFFMILLK
FKISHFDNIGMLFMGGTFIQMFFFYFVLRPILIDKLPNMRIEKINFFITFILFLLFETLL
TIRLLNEKR
>EGALAKHO_01821 ATP synthase subunit a
MVISNKPLRLILVALVACLPVISFANSEKDAAHTQTEVAHEAAAEGHNAEPTDVKSKIKG
FIGHHVLDSHDFTLTQDDETGKYYGFPLPVIIWDNGLQIFSSSKFNHGHTVAESNGNFYA
INHHDGKIYKTDAAGTITEDEKTGHPTNVRPLDFSITKTVVSILAAALLMFWLFTSLAKS
YTKNGGIASGAGRIFEPLVVFIRDEVAIPNIGEKHYKKYMSYLLTIFFFVLFLNIFGLTP
LGINATGNLTITFALALITFLITNLSANKNYWGHIFWMPGVPKPMRIILAPIELLGVFIK
PFSLMIRLYANIFAGHIVLMSIIGLMFIFKSWIGSSLSFGLSFALSILEILVAFLQAYIF
TMLSALYFGSAVEEHHHDEAHH
>EGALAKHO_01822 ATP synthase subunit c
MNGLNYIGAGLIVIGAALGIGRIGGSAMDAIARQPEASGKIQTAMLIAAALIEGIGFAAL
FAA
>EGALAKHO_01823 ATP synthase subunit b
MDKLINQFEFGLFFWQVLIFVGLILLLKKFAWKPILDAVNDREQGIKDALLSAENARKEM
ENLQADNLRILNEARAERDAMLKEAREMKEKMIADSKNEAQAQGQKMIEQAKAAIESEKN
AAMAELKSQVSTLSLSIAEKLLKEELSNKESQTKLVEKMLGDVKLN
>EGALAKHO_01824 ATP synthase subunit delta
MASTRAAIRYAKAILDLANSKGVAEAVNNDMKLIASTIESNLELSTFIQNPTTKVEVKES
ALLEVFANVNGVTKGLFHLLFENKRFEILNAIAVEYSRVFDESNGIEVAKVTTAIPMDAA
LEAKVLAKVSTLSDKKITIENIVDPSIIGGFILRIGDQQYNASVANRLQVLKRELSN
>EGALAKHO_01825 ATP synthase subunit alpha
MAEIKPAEISAILRKQVEGFESGATLEEVGTVLQVGDGIARIYGLSNVQYGELVEFENGL
EAIVLNLEEDNVGVVLLGPSTGIKEGSTAKRTQRIASLKVGEQMVGRVVNTLGFPIDGKG
PIGGDLYEMPLERKAPGVIFRQPVTEPLQTGVKAVDAMIPVGRGQRELVIGDRQTGKSTV
CIDTILNQKEFYDAGKPVFCIYVAIGQKASTVAGIAKMLEEKGAMAYTVIVAANASDPAP
MQVYAPFAGAAIGEYFRDSGRPALIVYDDLSKQAVAYREVSLLLRRPPGREAYPGDVFYL
HSRLLERACKVIADDGIAKNMNDLPDSIKSIVKGGGSLTALPIIETQAGDVSAYIPTNVI
SITDGQIFLDGDLFNSGVRPAINVGISVSRVGGNAQIKSMKKVSGTLKLDQAQFRELEAF
AKFGSDLDSVTLNVIEKGKRNVEILKQGLNDPYTVENQVAIIYAGSKNLLKSVPVNKVKE
FEADFLAYLNSKHKDTLNALKAGKLDDNITDVIEKAAKEISAKYI
>EGALAKHO_01826 ATP synthase gamma chain
MANLKEIRNRITSVSSTMQITSAMKMVSAAKLKKAQDAITAMRPYAEKLTELLQNLSATL
DGEVGGDYTTQREVKKVLLVAITSNRGLCGAFNSNVIKEIKNRAAFYAGKQVDVFPIGKK
GNDVLSKTFKVHGHHNAIFDHLTFENVAGIADNLTQKFLSGEYDRIELIYNQFKNAATQI
VQTEQFLPLAPIKTDVPVSAADYIFEPSKEEIVLTLIPKSLKTQLYKGIRDSFASEHGAR
MTAMHKATDNATELRNQLKLTYNKARQASITNEILEIVGGAEALNG
>EGALAKHO_01827 hypothetical protein
MVSIFFTMELQIQELTTIEEMLAQIDTMRFLYPKLSIEKYRSFLLEMVPHNYIQIGVFED
DVCLGITGCWSSTKLWTGKYLEIDNFVVNPEHRSKGIGKLLTDYIEQKAIDLDCSSIVLD
AFTGNFAAHRFYYNQGYGPKGFHFVKILDENKLTQ
>EGALAKHO_01828 hypothetical protein
MGLYKNLFKQTAIYGLATVLPRMLSFLLVRLYTGILPTAEYGEVSIVLSWMVFFNVVLSY
GMETAFFRFYSAEEDKKNVIATSTISIFWSSIIFLFVALIFRNTLASLAEVDSQYVTYSV
WILVLDALVLVPFSKLRANQRPMVYAAIKIGNVVINLLLNIFFLMYLPKLAASNPNSVWD
NLYVENFQIAYIFIANLLASLATFVVLSPNYLSLGRKFDPVLWKKMMKYGLPILVAGLAF
AVNEHFDKILLGYLLPENLAKSEVGAYSACYKLGLFMVLFATAFRLGIEPFFFSHAKNEN
APQTYAVITKYFVILGSLILLGVIVFADILKILLLNDKSYWEAMKVVPLIILANFFLGIY
NNLSVWYKLTDKTKIGAYISIVGAIVTLVLNYFLIPTYSYYGSAIATISAYGSMMLISYV
LGNKYYPIPYDMNKIGAYLGISIIFSAISFYGFRENYFVGIPLLLGFMYFVYHNEKATIK
GIMNRK
>EGALAKHO_01829 Deoxyuridine 5'-triphosphate nucleotidohydrolase
MKIQIINKSQHDLPNYETIASAGMDLRANLTESITLKPLERTIVKTGLFIELPIGYEAQV
RPRSGLAAKKGVTVLNSPGTVDADYRGEIGVILVNLSNEEFVVENGERIAQLIIAKHERA
EWIEVEELSETSRGEGGFGSTGVK
>EGALAKHO_01830 Bifunctional protein GlmU
MKIIVPMAGRGSRLRPHTLTVPKPLIPVAGKSIVHRLVEDIAKILKQPIEEVAFILGDEA
FFGDDVVSSLEDLAKGLGAKASIYRQDLPLGTGHAIMCAKESLSGPAVIAYADTLIRADF
ELDPAADAVIWVKQVDQPEAFGVVKLNPNNEIIELVEKPKEFVSDLAVIGIYYFKEVGDL
KKELQGVLDNNIQNGGEYQINDGIKAMMANGKVFKTGSVDEWMDCGNKDVTVETNSRMLG
FLHNDGEHLVDYDVTLENSTIIPPCYIGENVVLKNATVGPNVSLGKGCHVTDSTIKNSLV
QTFSQIKNANLDNAMIGNHVSYDGKFTSISIGDYSVLE
>EGALAKHO_01831 Beta-barrel assembly-enhancing protease
MKKRVFVILFFVLLGNLTSVSAQTEPEDIAMATDEYQDSFYESLKQKGIENYDKAIVSLE
KCIKLKPNDAVAYFELGKNYLFLKQYSSAQSSFEKATQLDPKNKWYWLGIYDVSFETKNY
PLAIETIQKIIPFDEEYKDDLISLYMLTNQYDKALATINEMNDKFGKSEDRERYKLQILS
QGKYQNSEIENLIAQIKQNPKEESNYVNLIFLYSKSEETDKALDVAKQLAKEIPNSEWAQ
VSLFKGYLDANKADQAIKSMNIILSSSKIDSKIKHRTLNEFLIYVNKNPQYAPDLEKAIA
YFDNDSNVDVAKEVGKFYHSKGQFENAIKYYEKDLKANSNTDRETNLLLLEAYTQAKQFD
PMTKRAMNMIEVYPSQPQFYYYAGLGNNKLQQFKNAKTVLEMGLDYVVDDKTLEANFNIQ
LGEAYNGLGDAKKKEEYFLKANELLKQKK
>EGALAKHO_01832 hypothetical protein
MKKYIALVLLSVFVVSCKSKAVAVQNTDKTVEAPKEDKKAIAKHYDNKLDFKTLNIKASA
KYEDEKQSQNVTAEIKIEKDKQILVSVRFLGITMAKALITPTTVSYYEKIKGTYYEGDFT
SLSKWLGTELDYSKVQNLLVGEALDDLRKGKYTQTIVENLFKLEDEKEAKIKKTFYLDSE
KYLIQKEEISQPTENRMLAIKYSDSKTFNQGILPTKIEINAVQPKGKTDINLEYNNITFN
EELSFPYSVPSGYKKVIIN
>EGALAKHO_01833 hypothetical protein
MPKFLLSLIFICATTFTWAQDSQQEKLEQRKAQIQQEIRDNEKMLQSVKKKEKSAVNVFL
IQANKIKLKEKLINTTAKQEKLISNDMYINQVQVNKLKKELKILKEDYSKMILKSYKSRS
EQSRAMFILSSESFLQAYKRAQYLKQYTNFRKNQGLEIQSKTAQLVDFNAKLDGQRQVKK
KIIAENQKEKISLEVEKKEQQKLVNAIKKDKNKIIADTRNKQAEAKRIDRQIDRLIREAI
AEANRKAAAERAKDNPGSTASTAPVSSSKIALTPEGKILAADFKANRGKLPWPVEKGFIS
LGYGDQPHPLYPSVTTHNSGVEITTDQGATARAVFEGVVSAVMITTPVTRAVMIQHGDYF
TVYQNLSSVSVEKGDKVNTKQSIGKVRTSGDTGKTVIKFLILQNVTNMNPEGWLQNR
>EGALAKHO_01834 Protein-glutamine gamma-glutamyltransferase
MAVFKIVHLTKYQYNYPIKESINEIRLFPHHFENQEVLQYQLLITHNPDVDISEDYYGNR
VGNFNVLDAHNEMTIESRMLVRVNHSLKIPEIDPTSVEDIQAEKEKSIILLRLCYLDDIQ
KQNEIGAILKKINIENKSIIEIAQQCNAYVYDNFTYTKGITNIETTVDEILTLKKGVCQD
FAHILLQLLRTAGIPSRYVSGYICPNESGLRGEGATHAWVEIYTPKQGWLGLDPTNNIWT
MDNHVRLSVGRNFSDCTPIKGTFKGLARQTLSVCVSIGYEDGRQFEEINDVKLQEVSSRV
QEQLDYMDHLQQQQQ
>EGALAKHO_01835 hypothetical protein
MGVNMLSRVADGMFWLNRYMERTDGMLLTLNTSYILSFDKEINDSQGYKPLLQYYTNLSK
DKIHAIQYDTTYVLKYIICDNQNDNSVKNLVVKARENARGSQDKITKELWEHINSMYHYM
NSPDLPRKLETSDALKIITKLNKDLLLYNGILQVTMPRGLGWCFSSIGKHIERCLQTISM
TQAYFAPINYNLEGEEDLMYWRRLLLSLSGYELYLKSYSNISHNRKVAHQVIFNMDFAHS
VIYTLDFINTYLNCLFKDNDLSEARTLMNQFGRLKSYIAYTDYQHLTNQELEEVLQNTKN
QLIQFSTDFSKLFFSYT
>EGALAKHO_01836 hypothetical protein
MAKLAPSLNHSGWDEMFSKDGVRESYSQVFKTLQSLSHKNLTNKQQQASDLFMNQGITFT
VYSDDANGIERIFPFDIIPRIITQKDWLEVESGIKQRLMALNLFLEDIYNDQNIIKEGII
PAGLIASCPHYIQEVQGIKVPHNIHVHIAGIDLIRGAKGEFYVLEDNLRCPSGVSYMLEN
REITKRIFPDMLSSNHVSMVGNYPMIFHSILVSLSPRNVSNPNVVLMTPGVYNSAYYEHT
YLARQMGIPLVEGRDLVVNNNRVYMKTTSGLQQVDVIYRRLDDEYLDPLVFKPDSALGVP
GLISAYRQGNVALVNAVGNGVADDKAIYAYVPDMIKYYLNEEPILKNVPTYRMENLDERE
HVFANMETMVIKETNQSGGYGMIMGNKATQEEMDEAKIAITKTPRNFIAQPIIQLSTVPC
LIDGQLKLRHVDLRPYALCGPKGIQIVPGGLTRVALTEGSLVVNSSQGGGSKDTWIIK
>EGALAKHO_01837 Inosine-5'-monophosphate dehydrogenase
MKKREPISHIMTKTVVTSNENDDLKKVVEKLKKNTIRHIPIVKGKEVVGIISRTDINRLT
FGALFEGQEGADEAILDMLTVSQVMTSKPKTVSSDTIIRDLAEIFAKEDFHALPVVDNGE
LKGIVTTTDVVKYFLEQYE
>EGALAKHO_01838 hypothetical protein
MTFISIEISEEQSHLLGFHQKKNQNGSKKG
>EGALAKHO_01839 Ribosome-binding factor A
METNRQKKIGGVIQKDLVDILQGEVRKNGINNLVISVSKVSVTSDLSVATVYLSIFPQEK
AKETLEGIKSNTTLIKHDLSQRVRLQLRRVPNLVFFIDDSLDYIEKIDNALSNRENPIEN
RDLLEKRRKS
>EGALAKHO_01840 Lipoprotein-releasing system transmembrane protein LolE
MGIIVGTMALFVVLSVFSGLKVFSLSFTNEIDPDLKITSTLGKSFLITPDQESKIKKIEG
VASYTKIIEERVLFLFKDKQQVTYLKGVDSLYPVVNDIRKKLFNGQWVKPDTYQVVVGYG
IARDFSMGVLDFENPLQIFAPKPGKGAFENPEEAFNKTDVLPVGIYSISEDLDSKYVFAD
LSLAQELLMYKPNQISGVEFKLKENANEDAIRSQLESIFKNKITIKNRAQLNESLYKMLN
TENIAVYLIFTLVIIVALFNLVGALIMMILDKKGNLKTLFNLGTEIKSLRKIFMLQGTLL
SVFGGIIGLALGIIMVVLQQKYNLIMLTPTLAYPVVFTLENVLIVMTTIVSLGFLASLIA
SSRVSKKLLD
>EGALAKHO_01841 putative FMN/FAD exporter YeeO
MTETTIHKSLFSKIFTTLKQAIKGDESFDYTSGSIKKAVILLAIPMVLEMMMESVFALVD
LYFVGHLEHSSFAIQTVGLTESVLTIIYSLAIGMSMAATAVVARRIGEKDPVAAAKAGMQ
AIIIAFAVNSVMSILCVMYAKDILILMGASVEAAEHGFRFTQIMIGSSLCIMLLFLINGI
FRGAGNAAIAMKSLWLANICNIILCPILINGLGPIPAFGLVGAALATTLGRSIGVLYQVY
HLFFGNGALKIYIFYFIPDFTQIKALVKIAAPGILQFVIASCSWIFLAQLVATTGGDHGS
AGYQTALRIMMFFILPAWGLSNAAATLVGQNLGAKQIERAEKSVFTTAKYNVIFMATIMV
ITLVFGKYIISFFTNDEMVRVVAVEALQIMSVGFVFYGIGMVLINTFNGAGDTWTPTGIN
FFGFWLFQIPLAYVLAKHFHMGPTGVFIAIPVAETAITLAGIVLYKRGRWKRIQV
>EGALAKHO_01842 Sporulation-specific N-acetylmuramoyl-L-alanine amidase
MKTKIKVLVILSAAVFGLFAFKSLDTKKIIVIDAAHGGDDTGATSLNGLQEKTIVETIAK
KIRAQNKNENLEIVLLREGDHFMELSERVSMINNLNPNLVISLHVNASENYSKNGVEAYI
SSSTKFHEQSKAKAEIMIDKVAGDYFSKGEVKEASYYILKNSNCPAMTLEVGYLSNVNDR
TYLVSEKGQNEIAAKILEAVK
>EGALAKHO_01843 putative tRNA-dihydrouridine synthase
MVKIGNIELPEFPLLLAPMEDVSDPPFRRLCKTHGADMMYSEFISSEGLIRDAIKSRMKL
DIFDYERPVGIQIFGGDEEAMALSSKIVSTVKPDLVDINFGCPVKKVVCKGAGAGVLKDV
DLMVRLTKAVIRSTDLPVTVKTRLGWDDSSINIDEVAERLQDIGVQALTIHARTRAQMYK
GHSDWSHIARVKNNPRITMPIFGNGDIDSPEKALKYKNEYGIDGIMIGRAAIGYPWIFNE
IKHYFKTGEHLPAPTVIDRVEAARNHLIWSMEWKGERLGIVEMRRHYTNYFKGIHSFKEY
KQRLVTTDAPEDLFAVMKEIEQVYAGYEFA
>EGALAKHO_01844 Phenylacetate-coenzyme A ligase
MNMIPSIEKDSLAEIKIFQEQKLTELLKYISENSPFYKRLFAGRNIDISTIKTLEDLQYL
PVTTKEDLQQYNDDFLCVPQHKIIDYASTSGTLGDPVTFGLTDSDLDRLAYNEAISFACA
GIAEGDVVQLMTTIDRKFMAGLAYFLGLRKLKVGVIRVGAGIPELQWDSILKYKPSYLIT
VPSFLLKLIEYAEIHGIDYNNSSIKGAICIGESLRNEDFSMNTLSKKIAEKWNIKLFSTY
ASTEMSTAFTECEHGIGGHHHPELIIVEVLDENNMPVKNGEVGELTFTTLGIEAMPLLRF
KTGDIVQLHNEPCACGRNTLRVGPVIGRKKQMIKYKGTTLYPPAMNDVLSGFDNIENHII
EISTNDLGTDEILIKIAVKNQTPEFLQEIKDHFRAKLRVTPKIEFASKETLNPLVFNPMS
RKPIRFFDYRS
>EGALAKHO_01845 hypothetical protein
MKNRITYLLFIGFLGILISCGTSKSKNHQPDISSYNATNPAVIKFSDSVFISGKNSLLKN
KQGLWELYVEGDPLEIGLNTGALSDSLLHRQQQIFFSKINDFVPSKYEQTILHLFLKWYN
RKLYSNVPAEYQTEIFGLSQYTSHDFDNIAHPYQRSLYLHAAHDIGHALQDLALVGCSSF
AAWGEKSEDGNLILGRNFDFYVNDAFAENKIIAFIKPKEGYNFMMVTWPGMIGAVSGMNQ
QGLTVTINASKSKIPMSAKTPISILAREILQHAQNIEEAITIAKKRKVFVSESIMVGSAA
DNKAVLIEVSPEKIGVYDVPNSNQLLCSNHFQSDALKNNEGNLSQIANSHSKYRFDRMEE
LFKENPKINPKIAAEILRNKKGLKNIPLGYGNEKALNQLLAHHGIIFKPKEKLVWVSASP
YQMGEFVCYNLDSIFSRKSNLALSFEDENLNIAKDSFIETIEFKNYQKFKIEDHKMDLYL
KNKETVSFEFIQNYQSLNPDYWVVYYKAGLYFYQKKYFQLAQSNFEKALTKEITTVPEKE
TIEKYLKKLRRK
>EGALAKHO_01846 Phytoene desaturase (lycopene-forming)
MKERYDVVIVGSGLGGLVSAIILAKEGYSVCVLEKNNQYGGNLQTFVRDKTIFDTGIHYI
GGLGEGQNLHQYFKYLGIIDKLNLKQLDENAFDIISFEDDKIEYPHAQGYENFVHQLEQY
FPEEKENIENYCEKLKSICDSFPLYNLEWEGKYDSEILTLNAKETIDDFTQNEKLKAVLA
GSNFLYAGIPDKSPFYVHALIVNSYIQSSWRCINGGSQITKQLLKQLKKHGGEFYKHKEV
TRFEVENHKVNSVEMKDGTQVSGSIFISNIEPKTTLKMAGEENFRKPFYNRIQSLDGVLS
AFSLYIVFKPETFKYINHNYYHFKNSNEVWTAHEYDEDSWPKTYMASMNASKKDEIWADG
MTFMTYMKFDDVLPWANSFNTTVEKNDRGESYEEFKARKAAKFLAEIEIKFPGIKDCIQS
IHTSTPLSYRDYIGGDNGNMYGYVKDSNNPMKTLIPSKTKLDNLYLTGQSINMHGVLGVT
IGAVVTCSEIVGKEYLITKINQATE
>EGALAKHO_01847 hypothetical protein
MHQYFYAIHMFVNRRKSLSVVLALLMLLVFGFFASQIKFEEDITKLIPTNDKADVTAKVL
KQLNFADKITVIFKLEKNGSDEDLKEMATAFSDSVSKSCKPYITGIQGKIDEENIQETID
FVYGNLPLFLDNKDYEAIQNKLQKDSIATTVQGNYKSIIAPSGFITKDFILQDPLGISFI
ALKKLQQLNVGDDFTLDNGFVMTKDKTKLLLFITSNLPSSETEKNTIFAAKLKSIQENLN
QKFKGKTSISYFGSALIAVANANQIKSDIVLTTTIAMITLMLILILFYRKVLIPLIIFLP
TVFGALFAVAFLYFVKEQISAISLGIGSILLGITIDYSIHILTHYKHNSDVKTLYKDITM
PVIMSSSTTAVAFLCLLFVKSDALNDLGIFAAVIVMASAFFSLLIVPHLYKPKEDNFEHK
KNVIDKLAHFSFHNNKILIGFCILITIVCCFTYNNVGFNNDLSQLNFVPKEIKAAEKELE
ESTSLTSKTIYVASYGKSMEEVLQNNSQLFSDLSKEKQNNKILNFSSVGGIMLSQKEQQQ
KIDKWNSFWDANKKQLLKSELIAEGLKFGFKPTTYSTFYDHLDFDFKPISAQEYLKIQAL
QLKEFVTEKNGFYTISTLVKVTPEQRDAFVKSASAKNNLIAIDRQQMNETFFSTLKTDFN
SLVNYSFVAVILILFFFFRRIELVIVSCIPIALTGIVTAGIMGIFGIQMNIFSMIVCTLI
FGHGVDFSIFMTSALQKEYTTGKNEIAIYRTSIILAVITTILGIGAMIFAQHPALRSISS
VSLIGVFAALIITFIFYPILFKLFLSNRPKNGNAPFELRSFLHGVISFFYYGLGGIVMSL
FSLIIMPILPIKAETKMKGFRYVISKFMKSVLYSNPFIHKKVINKYGETFEKPAIIIANH
SSFVDILAMGSLSPKIIFLVNDWVYNSPIFGATVRKAGFYPVSEGIEGGVEHLRKKVKEG
YSLMIFPEGTRSESNQIKRFHKGAFYLAEEFNLDILPVAIHGASEAIPKGDFVIHRSNLT
VSILERITPENLSFGKNYGERTKLISTFFKAEFRKIRQQLEGQDYFKPMLLHSYDYKEIE
IIHSVKSDIKNHLETYFHLNKYLSAKAKILHLANNYGQLDVLLTLQEPQRKIQSYIFDEE
KRDVAKTNYLAKKRKIAYIENLESISANQYDAVLISSEIYQEEIEKIIAVTSIVILVDCS
HLKNTLINFGFEPVLDKNGLIVFKKN
>EGALAKHO_01848 Polyprenol monophosphomannose synthase
MSLTLPHQDLLNSTSFCVIVPTYNNHKTLRKVLDSVLDFTPNVIIVNDGSTDETFEILQQ
YSQLTQIHHPKNLGKGRALRNGFRKAIEMKFEYAITIDSDGQHFASDIPSFIEEIQNEPN
SLLIGSRNMTQENVPKKSSFGNKFSNFWFKFETGIKLDDTQSGFRLYPLNLIPKKFYTNK
FEFEIEVIVRSAWKGIVVKNIPIQVLYDPAERVSHFRPFRDFTRISILNTVLVTNALLYI
KARDFLRRAKRKGFKKFFLEDILESKDSNFKKSAAIALGVFIGISPFWGFQTILLFTFAA
LFKLNKVIAYLSSNVSFPPFIPFVIYGSLKMGSYFVSTDAPLILDSSITLDDIQKNATQY
IVGSLILASVSALFFGLLSYLLLTAFTKTRVE
>EGALAKHO_01849 hypothetical protein
MKLLLTLLLWVNFTGTPELAAIRKMYTSVSKSENNAKEFSAKLADVSTNDDKTLVAYKAA
AILLESKFEKKLHDKIERFKEGAKLLESTIKSEPNNIEIRLIRLSIQENVPGITGYKKNI
KEDKKYLTDHYAEQNNALKEYLKEFILQSKSFSEKEKQFAK
>EGALAKHO_01850 hypothetical protein
MVLKDFYKVLSEEKTGDSKYTITILVNEKHEIFKGHFPGNPIMPGVCMIQIIKELTEKIT
QSTLMIQTLANVKFMALINPENNPELRLELDVTITEDNLVKVKNTTYFTETVALKLSNVY
KKL
>EGALAKHO_01851 hypothetical protein
MKYTNLLFIVAVFFAVQITQGQVTFKPGLRGGLSFSTISETHSAYKTDFYIGVLGEINIS
EKYALQPEITYSRQGSNNVGYYFNDNTQTEIVKFRDLQLGYLSFTLLNKLTFGPGIQIQF
GPAVDVLVNDNLDKVETYNDLALISGIAYRLSSGVTIEARLKKGVLDVFDSSYYNDRNDY
YLFGSYNTNVNFQLGLSYAFGGKK
>EGALAKHO_01852 hypothetical protein
MRKLTFIAFILFIGLTSLQAQISVSPGIRGGLNLSTLTNIDNNSMKSDFYVGGLVAIKFN
KYFTLQPELTYSRQGAEGREYFAGPNNYQDTKYELNYVTLGAVAKFNFGGQGFHVLAGPS
LDIKTDDNFGQFGYDPIGTDLAFVGGIGYSLPNGLTFEARFKQGLIDIYGYDGIDYDDYY
YDQVILNQVLQFGISYTFKVK
>EGALAKHO_01853 hypothetical protein
MQKSTIQFFLINCFLAIVLVSCGSVTKNYTPKKLDKTSYTVPYFAEPKMDYVYKTNITVY
GHEMSGIFIAKKINDTTHRVVFTTEFGNKLFDFEISDTTFKVNSIVSELDKKILINTLKE
DFRLLLKKEYLIQEQFENESDNIYKSADGNRDNYLFISKKEHKLEKVVRSSKTKEKITIT
FTLENDIFAKKVVILHQNIKLRIELNYLKSE
>EGALAKHO_01854 Outer-membrane lipoprotein carrier protein
MKTKIAILILFISCNLFAQEQKMTDAEIATFKQDVNVVSKKIKTLSTDFVQYKHMDFLSK
DIETSGKMIFKEPNLLQWQYKKPYNYSIVFKNGKILINDEGKKSAVDIGNSKIFGRINKL
IVGSVSGNMFDDKEFAISYFKLKGQNIAKFIPKDATLKKYIKQIELTFDKEEATVVQVKL
LESSEDYTRIVLKNKVINAKIDDSVFSN
>EGALAKHO_01855 Peptidoglycan-N-acetylglucosamine deacetylase
MITHRKTTIFFISLLLLLFILKADKGIDELWFLIVPFPFIAISIYGSFRISSNYHVKAFC
NNPSETEKKIALTFDDGPSVFTLEVLDLLKKYNAKATFFCIGKNIEAHPEILQRIIEEGH
LVGNHSYSHSKFFDFYTYPAIIEELQKTDKLLEKFTSKKINFFRPPYGVTTPSIRRALKF
TKHKVIGWNIRSLDGGTKNQELILNRIKKRVSPGGIVLLHDTGSHSVSVLEQFLQFLQQN
KYEVISVEELLNLKAYGMGRG
>EGALAKHO_01856 3-oxoacyl-[acyl-carrier-protein] synthase 2
MIKKTYINGVGCISTQKTFDTVFLEEAVINTNETVLSIVPPVYKDYISPAAARRMAKGVK
NGIVASALAMKDANVENVDAIITGTGLGCIEDSEKFLKNILDNNEEFLTPTSFIQSTHNT
VGAQIALSLQCKGYNFTYVNGAVSFESALLDAKMQIEENEANSILVGGVDENGEYTLSLF
KLAGRIKKEDDLPSNILYTNSTGVVYGEGASFFVLENERKDSTYAEILDVEIRNTLEENE
IESELITFLKTNNLEISDIDAIVLGFGGNIESDVYYKNLAENAFAKTPQLYYKHLSGEYD
TASAFALWVASKIIKTQEIPEILKVNLVTKPAYNILLLYNQVNGKNHSFTLLSK
>EGALAKHO_01857 3-oxoacyl-[acyl-carrier-protein] synthase 2
MKGIAITGMGIISSIGNSVEENYISLIENKIGISKIQNIPTVHADVIKVGEIKKTNEELV
AELQLSENNNFSRTAMIGTLAAKQAVENAGITSINEFRTGLISATSVGGMDMTEKHYYDY
FENPDLVKYIACHDGGDVAEKIASELGLKGMVTTISTACSSAANAIMLGARLIKTGKLDR
VIVGGTDALAKFTINGFKTLMILSDDYNKPFDNTRKGLNLGEAAAFLVLESDEMVQKYNK
KVLARVSGYGNANDAFHQTASSENGDGAYLAMKKAFEVSGLQPSEIDYINVHGTATPNND
LSEGRALLRIYEDGKVPDFSSTKPFTGHTLAAAAAIEAVYSVLAIQNSVVYPNLNFEVPM
EEFELQPQTSLKMKNIEHVLSNSFGFGGNCSTLIFSKS
>EGALAKHO_01858 Acyl carrier protein
MEALKEELKNKIITTLNLEDIAIEDIADNDPLFGDGLGLDSIDALELIVILDKDYGIKLV
DPKEGKSIFQSIETMAAYISANRTK
>EGALAKHO_01859 hypothetical protein
MPIKNKTYIQSYITIQNNEIVLNGTSVFKIEPTNFADFSKQAYRNFDIQYPKFFKMDALS
KLAFLGAELLLSPITSSEAENNIALVLANKSSSLDTDVKYQESISDKENYYPSPAVFVYT
LPNICLGEISIRHQLKSENSFFIFDVFNTEFMSNYSNILLNSDKADVVLCGWVEFFNDDY
KAFLCTISKEENTKYTNDTINTLYNNSSWKH
>EGALAKHO_01860 hypothetical protein
MENKETKFLIYDNPDGKVRVDVFVQDETVWLTQKAMSELFGTTPQNITLHLKNIFESEEL
QENSTCKEILQVQIEGNRQVSRNQKFYNLDAIISVGYRVNSTKATQFRIWATQTLKEYII
KGFVLDDERLKQGQTVFGKDYFKELLRRVRSIRASERRIYQQVSDIFAECSIDYDKNSEV
TKNFYAMVQNKFHFAITGNTAAEIIHKSADKEKDNMGLSTWKNAPDGRILKSDVIVAKNY
LQEKEISQLERTVTGYFDYIEGLIERENTFTMDQLATSVNKFLSFNEYKILDGKGKISKI
QADKKAIKEYDEFNKTQKIISDFDKEIKQIGKKK
>EGALAKHO_01861 3-oxoacyl-[acyl-carrier-protein] synthase 2
MTREVYINETNCITPLGFDVASNIEAILRGDSGIQLHQDVSLMPNPFYASVIADEKINSA
FEKISTDTKYSRLEKMMILALEPIIKNSGVELNSKTAFILSTTKGNVTALQENSEASFQN
AHLDVLAQNVADFFGFETTPIVISNACVSGILAISVAKRMIQSEFYDAIFVVAGDEVSEF
VLSGFNAFQAMSDLPCKPYSKNRTGVSLGEATAAVLVSAESRNAKIKVIGDSSINDANHI
SGPSRTGEGLFRSIQNAMKEAKINSSQIDYISAHGTATPFNDEMEAIALNRLNLQNVPVN
SLKGFYGHTLGASGLLETVIAIESANQNVLFESKGFDEIGVSEKINVIVRNEEASIGIFL
KTASGFGGCNTAVVFEKIK
>EGALAKHO_01862 hypothetical protein
MKKIILFALILLSFSKIHASEYYGLLVGYDKTGKRIMKGTCRAYPLNMFIYILNRKKDIV
KYYPKEKMDYITFKTLDQSANDDFYFENKTLNSKADFKDPELLRKYLSNLYYVIRTKKKE
LLNDKIFEDEDEIENFAAPILTLIGILETMCENNCTKVTWVAKLY
>EGALAKHO_01863 Putative esterase
MTKRKEQYNEATSLTVSHEIRIRFNETDPLGIVWHGHYITYFEDGREAFGRKHGLTYLDI
GNTGYTTPIVKSKCEHKLSLRYGDVVTIETTVVDTPAAKIIYRFRIIDAQGEVACTGETV
QVFLDKEGNLMLTNPPFYEKWKRKVGLLK
>EGALAKHO_01864 Inner membrane transport permease YbhR
MLYKIWMSIVKEFLLLKRDLGGLIILFIMPLILVITVTIIQDSTFKTVSDNKIQILLVDN
DKGSVSKTVFDNLQKNNAFDIITQIDNQPITEEVARENVYKGKFKLAIVIPKDLSVDLQA
KVDQNVQNIVSKMGFTDSVAEPKTSKVLQQKEVKLYFDPAVQMSFKTSVMNAIDKMISQI
ETKSIYTTFQNQLGEENAQFEQKSFITFKEIIPRINNKEVLPNSVQHNVPAWTLFAIFFI
VIPLSINIVKEKSQGTFVRLLTNPVSNLIVIIGKTITYLMICMIQFYMMVAVAIFLFPHI
GLPPLNVEGHLFLMSVVALFSGFAAIGFGILLGTVASTQEQSAPFGATSVIILAAVGGVW
VPVFAMPKIMQIIAKSSPMNWGLEAFYDVLLRNGSFVEIIPKISLLFLFFIITTSIALFY
DKKKRTV
>EGALAKHO_01865 ABC transporter ATP-binding protein NatA
MNSIIKIESLSKKYKDAEMFSLNDVSLDINEGQIFGLLGPNGAGKTTLISMLCGLIKPTS
GHFTINDLDYSHHSSKIKKIIGVVPQEYALYPTLTARENLHYFGSMYGLKGSDLKDKVIE
TLDLLGLLKFADKRIETFSGGMKRRVNLIAGILHNPKVLFLDEPTVGVDVQSKNAILDYL
KVLNQNGTTIIYTSHHLAEAEDFCDTIAILDQGRIYAQGTPSTLIASVEEARNLEEVFIS
LTGKDFRDAI
>EGALAKHO_01866 hypothetical protein
MQVTFTHHQSAHCENGVASNLLKNSGLNISEPMVFGIGSGLLFVYLPFIKVNHAPAISYR
TLPGQIFNKVASRLNLKIKRQKFSSVSNATQALDENLKNNIPTGLQVGVYNLSYFPDEYR
FHFNAHNLVVYGKTETDYLISDPVMETVTTLTHDELEKVRFAKGAFAPRGQMYYPIQVPG
EVDFKSAIIKGIKDTCRTMLAPMPIVGVRGIKFVSRRIRKWPAKHGVRKANHYLAQMVRM
QEEIGTGGGGFRFIYAAFLQEASVILGNEELKNLSKEMTQIGDSWRDFAVEASRIYKNRS
AKEDAYNAIADELLDIANREEIFFKKLKKAIS
>EGALAKHO_01867 hypothetical protein
MEKENVPQHDGNLSKKNLKELVYATDENGNYTTALSTGWEPKAIALSNAIDDIKERAEEA
KLKVQIGELSPICYYMELNKMDLTILAGYVDMWKWRVKRHFKPTVFAELNDKTLQKYADA
FDISIAELKNFKTD
>EGALAKHO_01868 hypothetical protein
MIVGIDIQNYLPHRAPMLMVDLILDIDANFVETTFLIKEDNIFVDKNIFTEAGLIENTAQ
TCSSIVGKKYFFDEDGTENENVNVIGFISALKNVKIHALPQVGNSITTKATLVSKFVGDN
YTLCTMSCQSFLEEQLLLECEINLFIQKTISAAT
>EGALAKHO_01869 hypothetical protein
METTILLEKEAVGDLLPQKFPFVMVDRLFSYSETSLVAGLKIENDNIFLEENTFLEAGLI
EHMAQSVALHTGYQFFLKNEMAPTGYIGSIKDIEIKKLPQINDTIQSTITILQEFGGITL
VDIVTFLNNEEIATGQMKTVLAK
>EGALAKHO_01870 3-oxoacyl-[acyl-carrier-protein] synthase 3
MFDVYITKAAKYLPNEAVSNDEMENYLGLINDTASKARRIILRNNKITSRYYAVDKEGKS
THSNAELTRNAVVQLFDENFTDQDVEVLSCGTSSPDVLAPSHAAMVHGLLKNRSVELNSS
MGICCSGMNSLKYGFLSIRSGNSKNAICTGSEKVSTWLSSPKYNHEIINLKNLEAQPIIA
FKKDFLRWMLSDGAGAFLLENKPSGDISLKIEWMESYSYAFELEACMYAGGDKLENGEIK
PWSDFRPDEWLNESVFAVKQDVKLLDEFILPKGVESMSDAMAKHNVTAEEIDYFLPHVSS
HFFVEGLKNGLNEKGIAITDEKWFMNLLRVGNVGSASIYIAVEELMNSGTLKKGDRILLS
VPESGRFSFAYAYLTVC
>EGALAKHO_01871 hypothetical protein
MKNVLVIFYSQSGQLESIARNIAKPFLNSDNIKVTFHEIQLEKPFPFPWNKTTFFDAFPE
SFLQIPTALKPVSEEILNTKYDLVLLNYQVWYLSPSIPMNSFLKSSEAKTILNNTPVITI
NGSRNMWIMAQEKIKVLLRDVNAKLVGNVALVDRVGNLISVITIVNWMFSGVKKKYLGFF
PLPGVSDKDIQESDKFGEVMLSQLNQNNLDNLQPKLAEIGAVKISPYLVTVDKTANKIFN
KWSNIIHKNQKNRKTLLKIFYVYLFLAIWLISPIVYILHLITYPFKFKKIKKETQYYQGV
>EGALAKHO_01872 Lipid A biosynthesis lauroyltransferase
MSQWDGKSKGTVLGYRIFVFLIQKAGVKSAYVLLYLVASYYFLFLKKSNRAIFYYFKERL
YYSNFQAKKMVFKSYYTFGQTIIDKISISAGMRNKFTYEFDGIEILKKLLAEKKGGVLIS
AHVGNFEIAEHFLGDIDLEFQINLVTTDLEHSAIKNYLESVTQKPTVKFIIIKDDLSHIF
EINAALANNELVCFTGDRYFEGTKSLSTEILGKEANFPAGPFLIASRLKVPVVFVYVMKE
PNLHYHLYAREATVKHRDEKGLLKEYVKSVESILQKYPLQWFNYFDFWNDLKS
>EGALAKHO_01873 Acyl carrier protein
MNKEEIITRINGFLVDEFEVDNDEIEPDANLKDTLGLDSLDYVDLVVSIESNFGVKLVEA
DFVGIATFQNFYDLIETKIKAKTA
>EGALAKHO_01874 3-oxoacyl-[acyl-carrier-protein] synthase 1
MNKRVVITGMGIYSCIGTSLDEVKESLYNGKSGIQFDSDRKEFGFQSALTGVVPKADLKN
LLTRRQRMSIGEETEYAYMATIEALKNANIDDAFFDAREVGIMYGNDSVSKAIIDATDIV
REKKDTALIGSGAIFKSMNSTVTMNLSTIFKLRGINLTVSAACASGSHSIGLAYFLIKSG
FQDIIITGGAQEINKYAMSSFDGLGVFSKRENEPEQASRPFDSDRDGLIPSGGGATLILE
SYDSAIARGANIIAEVVGYGFSSNGGHISTPNVEGPSIAMQRALDDAKLKATDIEYINAH
ATSTPVGDGNEAKAIFEVFGEKNPYVSSTKSMTGHECWMAGASEVIYSILMMQHDFIAPN
INLDNPDEDASKLNLVKTTLNKKFDIFLSNSFGFGGTNSALVVKKFKLNNE
>EGALAKHO_01875 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKCVLVTGGSRGIGSAICKKLAVDANYHILINYHSNKTAAEATLQEIQKLGATGEILGFD
VSNFEEVQSVLTKWQEANPEALVEAIVNNAGITKDGLFMWMTPEDWNGVLNTSVNGFFNV
TQFFIQKMLRNKYGRIVNMVSVSGVKGTAGQTNYSAAKGAIVAATKALAQEVAKRNITVN
AVAPGFIRTDMTSQLDEKELLKLIPVNRFGEAEEVADLVSFLISKKSSYITGEIININGG
IYS
>EGALAKHO_01876 Histidine ammonia-lyase
MNTINEYLSLAEFESIIFGNNKVAISDVVLNRVNESFNFLKEFSGNKIIYGVNTGFGPMA
QYRIKESDQIQLQYNLIRSHSSGTGKPLSPVCAKAAILARLNTLSLGNSGVHPSVIHLMA
ELINRDITPLIFEHGGVGASGDLVQLSHLALVLIGEGEVFYKGERRPTPEVFEIEGLKPI
QVEIREGLALINGTSVMTGIGVVNVHYANKLLDWSLKCSCAINELVQAYDDHFSAELNQT
KRHKGQQEVAERMRKNLSDSTLIRKREDHLYSGENTEEIFKEKVQEYYSLRCVPQILGPV
LETINNVASILEDEFNSANDNPIIDVKNKHVYHGGNFHGDYISLEMDKLKIVITKLTMLA
ERQLNYLLNSKINEILPPFVNLGTLGFNFGMQGVQFTATSTTAESQMLSNPMYVHSIPNN
NDNQDIVSMGTNAAVITSKVIENAFEVLSIEMITIVQSIDYLNQKNKISSVTKKWYDDVR
NIIPEFKEDQVMYPFVQQVKDYLINS
>EGALAKHO_01877 Ferredoxin--NADP reductase
MTKEFVDVLVIGAGPSGCVSASYLHKNNIKIKVVEKAKFPRLVVGESLIPRVMDHFAEAE
LFECLDAMNFEKKLGARFIRGEEICVFDFSQKFGEGWDWTWQVPRADFDNTMAQEIVRKG
IDLEFESEVLEVSFEGKNSKTIVKDKDGNLKEIHAKFIIDSSGYGRVLPRLLDLDTPSKL
DPHSSIFTHVKDINRPEGEEGTQISFDILETEVWLWVIPFSNGNTSLGVVGPTDFINSLS
ENKDNAEALRNAIQKSDYYIQRFKGTEFLFEPVKLENYSRAVKRMYGDGFALTGNSSEFL
DPVFSSGVAFATESGMLAAKLYIKESQGIEVDWETEFTAYMKKGIAVFTTYVKEWYTGNL
QTLFFHQPENPDVKEKICSVLAGYVWNEENPFVKKHDHVIKNMAYLLNMQKEEMNKE
>EGALAKHO_01878 Sodium/glucose cotransporter
MNQNLAFADYAVFIIYFIVVSVYGYTVYRKRKQDEQDAKAYFLAEGNLTWWAIGASLIAS
NISAEQFIGMSGEGFFLGIAVAAYEWLAAVALIIVAVWFIPVYLKNKIYTMPQFLKTRYN
ESTALIMAVFWLFLYVFVNLTSILYLGAVAINGLAGGQYLHVIMIGLAVFALFISLGGMK
VVAYTDVIQVAVLIIGGLVTSYIALTTVGQYFGVGENAIAGFKVLMREAPEHFKMIIPKP
TATSSQLEIDKYLTFPGLMSYLAGIWIINLNYWGCNQYITQRALGADLQTARTGILFAGL
LKLLMPLIVMLPGIAAYVLYQNGHLPQLVGGKDGAYSAVLTFLPTGLKGLSVAALTAAIV
ASLAGKVNSISTIYTLDIHKKYIQKEAGEKQQVNIGRIAVFAAMLLAVLFTWNDLLGIGG
VGGFTYIQKYTGFISPGVFAMFFLGMFWKRTTGTAAIVGVILGFVLSVLFNEYAPMLFGN
ETLLYTAYPNGKGAFEIPFHICMGLSFFFTMLAMIGISFAGPKVNPKAFEIDAEMFKVKP
QTTVLIVITLLVIVALYVKFW
>EGALAKHO_01879 Galactose-1-phosphate uridylyltransferase
MKNFDINEDPHRRFNPLLNEWVLVSPHRAKRPWQGQNETIATEALPKYDSTCYLCPGNVR
ANGVNNPKYDSSFVFENDFAAMKQEEIIFEEDIKHTFFKAKPEQGISRVVCFSPRHDLTL
PEMDLDGIENIIRTWQKEYTDLGSIKYINHVQIFENKGSVMGCSNPHPHGQIWAQSSLPT
QVEKTHHSLKTYFDKNKRTLLEDYLQAELRSGSRIVIENDDFVALVPFWAIWPYETMILS
KRAISKITDFTEDEVSSYAKILKQLTIKYDNLFSTSFPYSSGIHQAPTDGLEHPEWHFHM
HFYPPLLRSATVKKFMVGYEMLGESQRDITPEKSAEILRQQSDVHYKSKETVGEKVGVK
>EGALAKHO_01880 Galactokinase
MNDILIQNTTAFFEKSFGSVPQKIVLSPGRINIIGEHIDYNDGYVLPAAIDKVICFAFEK
NNTKKSKIIAIDLNEEFEIDLTASVQLSDVVWTNYIRGVIKQLQDYGFSFEGFNCVFSSN
IPVGSGLSSSAALECGTLFGIKELFGLKIEKVDIALMGQKAEHWVGINCGIMDQFSSVHG
LENKVIKLDCNTLEFEYHDADFKDYSVILFDSNVKHSLFTSEYNTRRLECEEGLSIIKKH
FSEVKSFRDCSEAQLLSIQDQFTTVVFKRVHFVVKEINRVIKACEALDKGNIELLGQLLF
ETHYGLSQEYEVSCAELDMLVDTAKADEAIIGARVMGGGFGGCTINLVKKGNENEVKRKF
SKLYLDTFGIELKFYDVKISNGTTLL
>EGALAKHO_01881 Beta-galactosidase
MKLIFKSIFFLFLLTFSFGKIQAQSRTKVNFGADWEFKREETPASEWEKVTIPHTARLEN
LVVIKQFQGNSWYQKKFKTEASKDQKTFLYFEGVMQEADVWINDKKVTNHKGGYLPFTVD
VTPYLNSNNENTIKLKVNNEDNPDFLPGKPIKDLDFNYYGGIYRNVYLVTTSKLYITDAV
NANKVASGGLYVNFKNINKTEASGTVQVHLKNDFESDQNAALKFILTDNKGKKTEFKSEN
FTVKPNSDFTLTQNISVKNPKLWSIHNPNLYQLEVQIVSDKKVIDSHSEKIGIRKSELKA
DGYYLNDEKIYITGTNEHQEYPYLGYAISDEAQYRDAVKIKNAGFDFVRMSHYPHAEAFL
NACDELGILVMNSLTGWQFFGGDAFQKSAYQDIRDMARRDRNHPSIVFWEASLNETNMSD
AFMAEATKTLKEELPFEHNYSASWIDNENYDLFIPARQHAKAPDYWTKYNKGNRKIFIAE
YGDWEYYAQNAGFNQTEFANLKEEERTSRQLRSAGEKRLLQQAYNFQEASNSNRKGTTTI
GEANWAMFDYNRGYSPDLESSGISDIFRIPKFAYYFYQSQRDANVILDKKLFSGPMVNIA
NFWTPESPLNITVYSNCDEVALYLNDVLVSKEKPLINSNSDKLQHAPFIFKVPTFKPGTL
RAEGFINGKKVASNSVKTPETASKIELSYDLSSIKINPEFPDMVFVYAKITDTNGTIIPT
ATNEVTFALSEGNAAIIGQNPVKAEAGIATIILKTENLKKKITIKATSEKLKDNTITITK
>EGALAKHO_01882 Arabinogalactan endo-beta-1,4-galactanase
MDLLKKAGVTPEWVQVGNEIPGGMLWPEGSTDNFPQLAQLLNKGYEATKAINPKIKVVVH
LDEGNKSEKFRWFFDKATENKVKYDVIGLSYYPYWIKTDYQSTILDLENNLKDMASRYNK
EVMVVEVGGDYTLVQNTKEMLEATIKAVKSVPNNKGLGVIYWEPQGEKSWSGYQLSAWLS
DGKPSPALDAFK
>EGALAKHO_01883 Arabinogalactan endo-beta-1,4-galactanase
MKKQLNIITLLLVIAAAFTSCKSQKASNSKDSFAKGADVGWLPQMEATGYKFYDTDGSQK
DCLQLLKDRGINTIRLRVWVNPNDNKASGHCSPEETVVMAVRAKKMGMRIMTIFTTAIPG
QIQPNKTNPQPGQNILLPNF
>EGALAKHO_01884 Arabinogalactan endo-beta-1,4-galactanase
MKKYIKFLGLLLTAVVQFSCSNGDSSDAPVFPPLPEDFIRAADISFLPEIEASGTKFYNN
SKAEDMLTTLKNAGCNTVRIRLWKNPSDGHSGMAEVKTLATRAKQAGLKVWLTVHYSDTW
ADPAAQTIPAEWKNLNFADLKTAIETYTSLIITEINPDIIQIGNEINSGFVWPQGHLINN
EQQCIALLSAASATIRSKAPTTKIMIHYAGVNASDTDWFFNKVKTVTYDYIGLSYYPVWH
GKDLSVVKTTIDALGKKYSKKVVIAETAYPFTLGYNDWTNNIVGLDTQLVSGYPATPEGQ
KSFVLAIKNTVKSSTYGQGFAYWGGEWISFKGKEATNGSTFENQALYNFENQALPVMQAF
SKE
>EGALAKHO_01885 Aldose 1-epimerase
MQTPGMFLFLNFTFGKNCMEIKHISHFQDKSSYKLFGLMTDNEEIHSFELTNKNGMKVQL
INYGATVTSLKIPASNGKLVDVVLGFDTLESYLSSYNLPSAPYFGTTIGRYAGRISKGAF
TLNDEKFQLIGNNNGNTLHGGNFGFGRRVWNVADITGGENPSITFGLLSEDSDENFPGEL
HVYLTYTLTEKNELKLEYKATTTKDTVINLTHHSYFNLDGHDTSVLDQQMYIDADKMLET
DAEGIPTGKFTALSNHNFDFRTAKNCPSSIDNSFVIESQDKVAAQLFSKKNNLQMNVYTD
QPSVHIYVGGNCFNILEGKENTKYHATSGICFETQNFPDAPNKEHFPNSVLKKGEEYKQK
TVYKFESI
>EGALAKHO_01886 putative HTH-type transcriptional regulator YydK
MNIISIQSNLGLPKYKQIILSIEKAIEEGKLVKGDRLPSVNKVCLAFSLSRDTVLLGYDE
LKKRGIIYAIPGKGYYVKSTEIAIKQKIFLLFDELNIFKEDIYNSFLKNIGKNVQVDIFF
HHFNAQVFQKLINDSNGNYTKYIIMPTNLNDIVNLIKTLPVNDVIILDQTNPDLRLYPAI
YQNHEKDIFEGLVKGKTRLSKYQKLILIFPGFREPLGMKLGFEAFCAEYHFESEIITEFT
NREITLGDLYIIPNDRDLVAVIENARNQNLKLGSDFGIISYNETPLKKVVANGISTISTH
FEMMGKILAEMVIKGNNVQIENKSSLIMRNSL
>EGALAKHO_01887 Transketolase
MNNNINQLAANNIRALAISMVEKANSGHPGGAMGGADFMYILYSEYLKYDPSDMHWIFRD
RFFMDAGHLSALMYSQYYLLGNFKKTDLQSFRQWGSVTLGHPEVDVKRGIENTSGPLGQG
HTMGVGAAIAAKFLSARFENLFDHKIYAYITDGGVQEEISQGAGRIAGHLGLNNFIMFYD
SNDVQLSSMTDEVTTENTAMKYESWGWKVVTIDGHDHDQIRKALTEAHNEKEKPTLIIGR
TIMGKGAVTAEGKPYEGQPELHGKPIGATKADFEKTLLNLGANPEDSFAIYDEVETYYKT
ILNKKTAESAERKAKILTWEGQNPEAAQKIKQFFNGDLPALDFSSITQKANAATRDASAA
VLGYLAENVENMIVSSADLSNSDKTDGFLKKSSILKKNDFSGAFLQAGVAELTMAAIANG
IALHGGVIPVVATFFVFSDYMKPAIRLAAIQELPVKYIWTHDSFRVGEDGPTHQPIEQEA
QIRLLEKVKNHSGDQSLLALRPADAIETSVAWQMALENKKTPTGLILSRQEIKDIPATGK
SRFQDALNSKKGGYLVKSSEDPAITLIGNGSEVATLIEAAEELEHIIKIKINVASIISEG
LFRSQPKMYQESVIPHNQLVFGLTAGLPVNLENLAGSRGKVFGLDHFGYSAPASVLDEKF
GFTSKNACEEIMKYLEQNNYNISK
>EGALAKHO_01888 hypothetical protein
MLNSYSSADKVLLAVDCIIFGFDHEGLKILLIKRDFEPEKGKWSLIGGFLKRDEVLDNAA
IRILHTYTGLHDIYMEQLYAYSEIDRDPVERTISVSYYALINIENHNTELIQNYHAQWFS
ITDMPNLIFDHNEMVDYAIKRLRYRTSIKPIGFELLPEKFTMRQLLELYEAILSKELDKR
NFISKINSLEILNKLDEKDMASSRKGSYLYTFNKEKYEEKLLNDFVLNL
>EGALAKHO_01889 Intracellular exo-alpha-L-arabinofuranosidase 2
MKKAFLISLAILCIQTIQAQKDLTIITIKNDAAAPVINKNIYGHFAEHLGRCIYGGFFVG
DTSKIPNTDGVRNDIIAALKDLKIPNLRWPGGCFADTYHWKDGIGPKEQRPTIVNQWWGG
VTEDNSFGTHDFLNLCEVLGAEPYLSGNVGSGTVQEFADWIQYANFGGKSPMSDLRRKNG
RTEPWKVKFWGIGNEAWGCGGNMTAEYYAGEYRKFATFMADWNNSGGINRIASGANSSDY
NWTEVLMKNIPLNMLGGIGVHHYSVIDWNKKGDAVNFSEEQYFKTMKQALKMEELVTKHA
AVMDKYDPEKKVAMVVDEWGGWYDVEKNTNPGFLYQQNTIRDAVLAGATLNIFNNHADRV
RMANLAQCVNVLQAVILTDKTKMILTPTYYVMKMYSVHQDAKLLPIGFNSPTYSFNGETL
PAVSASASKDKNGVVHISLVNIDAKNSNKIEMDIKDLGVKNFTGLILSSTKLQDYNSFDT
PTKIVPTVFKGFENKKGKLEITLPPFSVLVLEGK
>EGALAKHO_01890 Extracellular exo-alpha-L-arabinofuranosidase
MKSNLITKITLCGLLLNGFYASAQKNNLQVDAAKTITKIEPTMYGVFFEDINFAADGGLY
AEMIKNRSFEFELPMMGWSEPNSDRHKLNEQSGIAKIVQYSNKGTNHNYCRVSINDATGY
ELINEGFRGMGIKKDLKYNLTLKASKESGNVSKIKIQFIDKDKKVLGETSITPTSKDWAN
YTAQLTATATEAKAKIRITFEGSAVIDLDAISLFPEDTWKGRKNGMRADLVQLLYDLKPG
FLRFPGGCIVEGKTLALRYQWKKSIGNVEDRETMINRWNTEFAHKLAPDYFQSFGLGFYE
YFQLSEDIGASPLPILSCGMACQFNTGELVPMDQIDPYVQDALDLIEFANGDQTTAWGKV
RADMGHPKPFNLKFIGVGNEQWGPDYIERFKVFQKAIKAKYPNITIVSGTGPFPDGDYFD
YGMKELKKLNAEIVDEHYYKDPAWFRKNVTRYDNYDRKGPKIFAGEYAAQSVAAASPLNK
NNWECAFSEAAFMTGMERNAEVVHLTSYAPLLAHVEGWQWTPDMIWFNNLQSYGTPNYYV
QKLFSNNKGTDLINITKDGKAVTGQNDLFASAVKDVNSKEVILKIVNTAATAQNVSIDVK
GAKLDTKGTAIILKGDGLNDENSFEAPTKISPKESEFKLKGGQIQYDFPAYSVTVLKIKM
K
>EGALAKHO_01891 Ribulokinase
MKNYVIGLDYGTDSVRAVLIDTENGQELASNVSHYKRWKNKQYCDASINQFRQHPLDHIE
GLEITIQTVIKESKVDPSQVRGICIDTTGSSPVPVTKEGIPLALTKGFEENPNAMMVLWK
DHTSINEANEINELAVSWGGENVTKYVGGIYSSEWFWAKILHIAREDEAVRNAAHTWMEH
CDLMTYLLIEDKDLKTFKRSRCAAGHKAMWHADWNGLPPVEFLEKLHPYLAQLRGNLYDE
TYTSDLVAGNLSKEWADRLGLSTDTVIAVGTFDAHSGAVGAKIGENTLVRVMGTSTCDIL
VGSYDEVGTKTVRGICGQVDGSVIPGFIGLEAGQSAFGDLLAWYKELLMWPTEHLLTSST
VLNDAQKEQLREEFSDKLIVELTKEAEKIPVSESLPIALDWINGRRTPDANQELKSAISN
LSLGTKAPHIFKALVNAICFGAKKIVDRFEEEGVKIDSVIGIGGVARKSPFIMQTLANVL
NKPIKIAASDQTPALGAAIYAAVAAGIYPNVIEASQKIGSDFDGEYFPQLDKVAAYNKLL
IAYDQLSAFEDPTIKTSQHEFSL
>EGALAKHO_01892 L-ribulose-5-phosphate 4-epimerase
MSSLYKDLKQECYEANMQLNALNLVVYTFGNVSAVDRKNGVFAIKPSGVPYEDLKPEDIV
IVDFDNNVIEGTMRPSSDTKTHAYLYKNWPNIGGVAHTHATYSVAWAQSQQDIPIFGTTH
ADHLTADIPCAPPMADSLIEGNYEHNTGIQILDCFKEKNLSYEEVEMILIGNHGPFAWGK
NAAKAVYNSKVLEVVAEMAYLTLQINPNAPRLKDSLIKKHYNRKHGKDSYYGQ
>EGALAKHO_01893 L-arabinose isomerase
MIDISQKEVWFVVGSQELYGEETLRKVAEHSQIIAKGLDGASNIPVKVVYKDVVKSPSQI
LDVCLAANSAKNCIGIIAWMHTFSPAKMWIGGLSILKKPLCHLHTQYNAEIPWGTIDMDF
MNLNQSAHGDREFGFIMSRMRKKRKVVVGHWEDERVQKKLGIWTRVALGWDELQNLKVAR
IGDNMREVAVTEGDKVEAQIRFGMSVNGFDSSDVTKYIEKVTDKELNDLLAVYEASYTLT
DALKEGGAQRSSLAEAAKIELGLRAFLEEGGFGAFTDTFENLGVWKQLPGIATQRLMADG
YGFGGEGDWKTAAMVRALKVMNVGLEGGTSFMEDYTYHFTPQKSYVLGSHMLEICPSIAD
GKPSCEVHPLGIGGKEDPARLVFNSPAGDAINVSLVDMGTRFRLIVNEVTAIKPMAELPK
LPVARVLWDCKPNLDIAATAWILAGGAHHTVYSQSLTTEYMEDFADIAGIELLVIDEKTT
VRDFKDKINANEAYYHLFQNGL
>EGALAKHO_01894 Aldose 1-epimerase
MNVLKRCLFGISLLSLAAVSVQCKNDKKMDDTTVSSDEKATVTIEKSSYGTTAKGEKVDS
YKLKNQNGMEVDIITFGGRITDLKVPNKEGVSENVVIGFDNLAQYEKENPFFGALIGRYG
NRIAKGKFTLDEKEYQLAINNAPNALHGGPQGYFNVVWKADEAKSGDFATLKLSYLSKDM
EEGYPGNLKVFVTYTLTNDNELEVLYEATTDKKTVINLTQHSYFNLSGDFTKTILDHELT
LNADKLVPVDATLIPTGKLDDVANTPFDFRQPKLIGKDIEVKNEQLERGKGYDHCWVLNN
PEKGKTIIAKVYHAASGRVLEMTTDEPGIQFYSGNFLDGTLPNPKGGTYAHRTGLCLETE
HYPDAPNQKNFPTTVLNPGENYKTKTTFKFSVKK
>EGALAKHO_01895 hypothetical protein
MKHLFKAEVKWTSDQKPVDSTKRFYSKSHKIVIEGKPVLNVSAAKAFKGDPELYNPEDLL
LSSLVSCHMMSYLYVCSQNGIEVLEYSDNAEATLEVNPDGSGRFVEVRLKPKVKILNSDK
IELAIELHKKANQLCFIANSCNFPILHEASCAT
>EGALAKHO_01897 Ribose-phosphate pyrophosphokinase
MHLVKTTHTQLTTPEAFIHVLFYPKRLSRIVQSATEQKQQIIMSHLEPEAKIFACSQSVY
LAEKIAEQYGIPLGKVTMSTYSDGEFQPSYEESIRGLRVFIVCSTFPSADNLMELLLMID
AAKRASARHITAVMPYFGWARQDRKDKPRVPIGAKLVANLLTAAGATRIMTMDLHADQIQ
GFFEKPVDHLFASTIFLPYVQSLNLENLTIASPDMGGSKRAYAYSKFLESDVVICYKQRK
AANVIDTMELIGEVKGRNVILVDDMIDTGGTLAKAADLMIEKGALSVRAICTHAILSGGA
YEKIENSKLSELIVTDSIPLKKESNKIRVVSCAPLFAEVMHMVHHNNSISGKFIM
>EGALAKHO_01898 50S ribosomal protein L25
MKSITIKGSERESVGKVSTKALRNAGAVPCVLYGGNQAVHFSADAAAFKNLVYTPNAHTV
VIELGKGKSFNAILQDIQVHPVSDKILHIDFFQLFDDKEITMEVPVKIVGTSKGVLAGGV
LRLNTRKLKVKALPKNLPDFVEADITPLEMGNKLYVTKVGSPEYKVMHPENTVVAQVRIS
RAAMKAAQEAAKAAKAPAKGKKK
>EGALAKHO_01899 Peptidyl-tRNA hydrolase
MIKWITKLFSSTQKEENIDNTKPEVHEHPKNNIKNVSKKYLIVGLGNIGAEYVNTRHNIG
FKVLDFFAKKESLSFETVKLGALAEYKFKGRTFFLLKPNTYMNLSGKAVKYWMDKENIPL
ENILVITDDLNLSFGTIRIKPKGSDGGHNGLKNINLVLNTQQYTRFRFGISDQFKKGQQV
DYVLGDWDEEEKAKLPERLEISSEIIKTFGTAGLENTMTTFNGK
>EGALAKHO_01900 Superoxide dismutase [Mn]
MAFELPQLPYAYDALEPHIDARTMEIHHSKHHNAYTTNLNAAIAGTDLEGKTIENILINL
DKSNAAVRNNGGGFYNHNLFWTVMTPNGGGLPTGDLLAAIESSFGTFEEFKAKFAKAGAT
QFGSGWAWLTVQKGGKLEVVGTPNQDNPLMPEVAGNGGTPILGMDVWEHAYYLNYQNRRP
DYIEAFFNVINWTEVARRYALDK
>EGALAKHO_01901 Amidophosphoribosyltransferase
MSDALKHECGIALVRLLKPLEYYKEKYGTAFYGIQKMYLMMEKQHNRGQDGAGFASIKLD
VEPGQRYISRVRSNHAQPIQDVFKQINDRINEELTARPEIADDVAKLKSEIPYIGELFLG
HVRYGTFGKNSIESVHPFLRQSNWMHRNLILAGNFNMTNVKELFENLVELGQHPKEMADT
VTVMEKIGHFLDKEVMQLYQDCKTEGYSKREASPVIADRLDIAKILARSAKNLDGGYAMA
GLLGHGDAFVFRDPAGIRPAYYYQDDEVVVVASERPVIQTVFNVPFESVQEIDPGNALII
KKSGKVSMQQILEPTVKKACSFERIYFSRGSDAEIYQERKNLGKLILPAVLESIDSDTDN
TVFSYIPNTAETSFYGLVEAAQDFLNQRKNNYILENRNTLTAETLQELLAVKIRTEKVAI
KDAKLRTFITEDSSRDDLVAHVYDVTYGVIKPTDNLVIIDDSIVRGTTLKMSIIKMMDRL
KPKRIVIVSSAPQIRYPDCYGIDMAKLEGLVAFRAALALLKERNLYHIVDEVYAKCKAQE
NYLDTDVVNYVTAIYDQFTPEEISDKIAEMLSSPEINAEVKIIFQKVEDLHIACPKNLGD
WYFTGDYPTPGGNRVVNRAFMNFYEGKDARAY
>EGALAKHO_01902 putative sugar kinase YdjH
MNKLLIVGTVAFDAIETPFGKTDKILGGAATYIGLSASFFNLQSAIVSVVGDDFPQEHLD
LLTSKNIDISGIEIVKGGKTFFWSGLYHNDLNSRDTLVTELNVLADFQPKVPQNYKDADV
VMLGNLHPLVQSSVLDQMEKKPKLVVLDTMNFWMDCALPELLDVIKRVDVITINDEEARQ
LSGEYSLVKAANRIQEMGPKYVVIKKGEHGALLFHNREVFFAPALPLEDVFDPTGAGDTF
AGGFSGFIAQSENISFGNMKNAIIYGSNLASFCVEKFGTERMETLSKAEVAIRLQQFKSL
TQFDIEI
>EGALAKHO_01903 hypothetical protein
MKKILALLILLCLLISCERKEYNFSKEMIEKLAIHDEGKSEVVTINKYSFIDLYIRTNED
EIFITNGESLYQSYRLYHQNKYKKFKDFLKIVLSKDYVLDASKQKIILLQNFKLNSKVYK
EYNQVGFDEFLKKYSELSVRKNELQLNRSNLNRDEYLTVKYLLYLNRYDVSRDDMHAKDY
IKKREDSFK
>EGALAKHO_01904 Esterase EstD
MTIFKHILRAKKTYTYSLLILLFFFTSYASANPPNFTTKEIKFVSEGISLAGTIFTPNNV
QAAVVIVHGSGQEKRMMDFATTLANNGIAVLTYDKRGVGESAGVYAGPEVGTNNVDFSNL
NLLSLDASNAVNTLSKYLSNDQIRIGLIGGSQAGWIIPLTAEKNKKVKFMTIFSGALITV
KEQLRFQFYTNGDKNFWDTHSEEDTRKHVFHDPDKYEFIDTNPNDILSKLSIPGIWIFGG
KDIQVPVKLSIEYLDILKSKGKNYDYKLFPNLGHNTAFSNSEEPMKDAINWIKNIK
>EGALAKHO_01905 hypothetical protein
MKESDKNIENLIDKIMAEDTLETPSFDFTSKIMAQVLVAEKSKVKSYQPLISKTTWIIIG
FGLLGLAVYASLFSGTEYNLGIDKSYTEKFSTVFSGIHISKNILYAVLIVSFMILIQVGV
LKNYFDKKYQL
>EGALAKHO_01906 ECF RNA polymerase sigma factor SigW
MSAISDQHYIDKILQGETNSFAVLVDRYKDMIFTLALKMVKNREEAEEVAQDTFIKIYSS
LNKFKGDSKFSTWIYKIAYNTCLDRLKKNKKEDLNISIDEFSAHLIKTMDNALSALEDKE
RKQTIQNCLNLLPSDENFLLTLFYFEDQSLEEIGKIMNINANNVKVKLFRSRQKLAVILK
KQLEPEIVACYEIGKIPKQKQNEDYR
>EGALAKHO_01907 hypothetical protein
MGPQVLIPVSLFLMIFGIVYLFFSTRNRERMALIEKGVDASIFLKGAGKGGSAWKVFVVN
LAFLLIGSGVGIFIALLITTYTSLNDEAVFPSIIFIMAGIGLLAGFRTAKDLDKE
>EGALAKHO_01908 Ribonuclease HI
MTHEVHIYTDGAAKGNPGNGGYGVVMELVGTPHKKEFYEGFRLTTNNRMELLAVIVGLEK
LKNPNMKVLVISDSKYVVDSVEKKWVLGWEKKKFAGRKNADLWKRFLIVYRKHQVDFKWI
KGHNNHPQNERCDQLAVMASMQPKLSIDEYYETIGSKME
>EGALAKHO_01909 Phosphoribosylglycinamide formyltransferase
MKKIIVFASGSGTNAENIIKYFAKTKIANVVSVFTNNASAKVIERAKNHQIPVEIFSKNE
LLERNVLQKIQEIDPDLIVLAGFLLKFPENIIEKYPNKIINIHPALLPNYGGKGMYGMHI
HRAIINNKEKETGISIHYVNENYDEGGIIFQKNVALTEDDTPETVAEKIHELEQKYFPEI
IQAVLEDSEKENSN
>EGALAKHO_01910 Acyl carrier protein AcpP
MSDIASRVKAIIVDKLGVDENEVVTEASFTNDLGADSLDTVELIMEFEKEFDIQIPDDQA
ENIATVGQAISYIEEAKK
>EGALAKHO_01911 3-oxoacyl-[acyl-carrier-protein] synthase 2
MALRRVVVTGLGALTPIGNNIQDYWNALVNGVSGAAPITYYDTEKHKTKFACEVKNFNIE
DYMDRKESRRLDKFAQYAIAASDEAIKDAGLTNDNIDKTRVGVIWGAGIGGLETFQEEVI
YYAKGDGTPKFNPFFIPKMIADIAPAHISMRNGYMGPNYTTVSACASSANALIDAFNYIR
LGMCDIIVSGGSEAAITIAGMGGFNSMHALSTRNESPETASRPFDATRDGFVLGEGAGAL
VLEDYEHAKARGAKIYCEIGGGGMSSDAYHLTAPHPEGIGVIAVMKNTLRDAGMNPEDVD
HINTHGTSTPLGDVAELKAISAVFGDHAKNININSTKSMTGHLLGAAGAIEAIASILAMQ
HSLVPPTINHTVVDEKIDPALNLTLNKPQKREVNVAMSNTFGFGGHNACVLFKKLVD
>EGALAKHO_01912 Ribonuclease 3
MNIIKKIFSKSRSLEDGIFFDTIQKILGFPPANVDFYKKAFTHRSSNKLDESGNPINYER
LEFLGDAMLSAVIAAHLFNKAPNGDEGYLTKMRSKIVSREHLNELGKDLNLVRFVESKVP
IQHFGENIHGNIFESLVGAIYLDRGYAFCEKFIQKRVVTPYVDIARLEGKVISYKSLVIE
WCQKEKRVFHYDIFEDNGIDGQRLFGVKLSIDDKVIARARATSKKKAEEKASQRAYFAFQ
EKIDKK
>EGALAKHO_01913 hypothetical protein
MAIHRLDLDEFDEIDYYLMAIHTSLEDYRLAYFINKNLPINLSKSKNEIHAQTKEGEANF
SRFYYYDSEKAISWNLIQNKNEIISVSTNDFQNLFSNETSEVSTTIHLLPEFKKVDFFLK
IDNSDEAVDFSEIQQQLNSIESIAAIYAVDTNKIKSKNNLIF
>EGALAKHO_01914 Pyruvate kinase
MLTNKKTKIVATLGPACSTREIIKDMIEAGVNVFRINFSHADYEGVKDKINIIRGLNEEF
GYTTAILGDLQGPKLRVGVMEEGTVVHDGDLITFTTAEDIIGTAQKAFMKYQNFPNDVNV
GERILLDDGKLIFEIVSTDKKTEVVAKVIQGGELKSKKGVNLPNTKISLPALTEKDIADA
IFAIEQKVDWIALSFVKTPRDLQDLQELIAKHSDVKIPIVAKIEMPEALENIDKIIAYCD
GLMVARGDLGVELPAHEVPLVQKDLIRRAKTARIPVIVATQMMETMITSLTPTRAEVNDV
ANSVMDGADAVMLSGETATGNYPVQVIQKMTQICEAVEDSPLIQVPQNTPQIKTKRFVTK
TVCHQAALLANEIKAKAICTLTNSGYTAFQISAWRPSSHILVFTSNKRILTQLNLLWGVK
SYFYDKDESTDDTVTDVNEIAKQKGYVVKGDYLINLAAMPIKDKGMVNTMRVSEIE
>EGALAKHO_01915 Arylsulfatase
MLMALACFTCMQINAQNAKKPNVLILWGDDIGTTNISAYSDGVMGYTTPNIDRLANEGLR
FLHYYGEQSCTAGRAALLTGQHGLRTGLTKVGFPGAPMGMSQLDPSIGGIMKNLGYVTGQ
FGKNHVGDRNESLPTVNGFDEFFGNLYHLNAEEEPELADYPKDPEYLKRFGPRGVLKCTA
TNSDDATTDPRFGRVGKQRIEDTGPLTKKRMETIDDETSAAAIDFIKRQNAAGKPFFCWF
NATRMHLRTHVRAEHRGRYTHGDSEYIDGMIEHDETIGSILKALDELGIADNTIVVYSTD
NGPHMNTWPDGAMTPYRSEKNTNWEGAFRVPCIVRWPGVIKPGQVTNELMSHNDWMPTLA
SIAGEPDLVNKLLKGYSANGKNYKVHLDGFDQSNFLRGKSPKSARDKFFYTDDDGLLVGL
REGDYKYVFAEQRLGGTLGVWAEPFTKLRLQKIFNLYQDPFERADITSNTFWDWQLNHVQ
LMYGAIQDVVVFAETFKEYPPRSIPPSFSAYTIMEEAMKDIKAQKYIEKNVLPKLKEEEA
ADSKKKK
>EGALAKHO_01916 hypothetical protein
MYKKIYVLPLFLLFLVSCKKAENTTTDANTKDSTTTVATSGDPLPSWNDGALKKEIIDYV
TKVTKEGSPDFIPVENRIATFDNDGTLWAEKPYVQELFAFYRVKKMIEKNPALAQKQPFK
AVVEKDKTFFEKGGDKALIELVAATHTGMTEDEFEASTKEFFAGAQYPGKNVPLKQIRYQ
PQLELLNYLRANGFKTFIVTGGTVELVRAISADFYGIPKDQVVGTSFKYSFDDATNSIKR
EPALDLLDDKAGKPVGIQLHIGQRPVFACGNEGGAGDLAMLRYSSGSKYPSFQMIVNHND
SIREYNYQEKDNLSLNTAAKYKYHVISMKDDWKTIFPSK
>EGALAKHO_01917 hypothetical protein
MKLPRYSISIQSLFIAVVFLLNFTAFAQEEKAGTSAQELADKMANPVASLISVPLQNNLT
YGIGPYNGSKYQINIQPVVPFKLSENLNLITRYILPVVDQQDVTGENTHEFGLSDATVTA
FFAPKTKGIILGVGPAFLVPTATEKFLGTEKFGIGPSVLVMHQGKGLSIGFLANQIWSVA
GSSDRADFNQFYTQIFLTHSYKSGASLGITSEITQNWQGNTTLITVSPNVGAITKLGGQT
MQFAVMPLIPIVGHSDIRPDWGLRAVVAFIFPQ
>EGALAKHO_01918 hypothetical protein
MKSKILALVTVCFLVSCTKSTKTNETTVVADTTGTAKFKPENFEEQLVYNRAIEAVIWGM
PAVNAELLHESLLKAKGDYNQIVYWSGLISSKNQTLTPNPDVIYINPLYDTRQGPVVLEI
PAVEGVSSLTGSVDDGWQTAIEDIGPAGVDKGKGGKYLILPPNYKDIPPIGYIPLQSSTY
TGFAILRSNLTDGSPSDIKRAVEYGKKVKIYPLSEADNPPATTFVDLINVDFSNTIPYSV
HFFEVLNQFVQREPWLTRDLLMIDQLKSIGIEKGKIFQTDARRQEILSAAIKDAHNWIDK
KYENIFTPPFYDDTNWALPASPDVVKAIMSNYLAPNLYPVDERAISYSMAYFSAKKLGTG
QFYLMSIKDDNDQSFDGSKLYKLHLPAKVPVKLYWSVTAYDRETHALILGMKYSSRASTS
PGLQKNADGSVDIYFGATAPAGKESNWVPTDPKRKFELLARFYGPEKGFFDKTWKMGDVE
EVK
>EGALAKHO_01919 hypothetical protein
MTEKFTDTDDNLFNPAASKAARFDKGVAIRKLVPRSIHAEWNPSENREDPIEILIKTSSG
RMENLVPLRYSRMMESPFTFFRGAAAIMAADLENTPNTAIDLQLCGDCHLMNFGGFATPE
RKLVFDINDFDETFPGPWEWDVKRLATSFVIAGRWKKFSSKNCKEFAWHVADSYKRNMLD
YSQLSALQIWYADIDLAELIEKGDDEELKEFQQKRLKKASEFTAHEKEFAKMTYIEGNRA
RIKDDPPLIFHPIGEQWQRLEKEATTIHKRYMETLSDEKKVLLSRYALHDFAIKVVGVGS
VGTLCGISLLMSATGEPIFLQFKEARQSVLEDHVKAKGKYSHQGERIVRGQKLMQSASDM
FLGWTNDSEDKFFYIRQLRDAKVKPVLEIMKPKNMASYAKACGWALARSHARTGDPSILS
GYLGKGNEFANAIAKFSISYANQNDADYDKMLDAIKEGRLPISEEV
>EGALAKHO_01920 hypothetical protein
MNIKRKNLRIIPFFFFLGLFYSCSPTVKVTNDYDHAANFSEFKTFTVYDLRAQEGQVNQL
NVDRVAKAIRAEMTAKGFTESSSNPDLKVNAVSILKNKTQVTADTNFYGYGGMYRPYGYW
GGGAMMGGGSTTFNTYDYVDGSLIVDIVSTKTGKLVWQGIGNAQIDSKPDNPEEFINGAI
KKILEGFPPGLAKK
>EGALAKHO_01921 hypothetical protein
MLDIVLSLFFFIATIVGFATSFMVLFSKKNYSKSFFLGLFLFSLAVVSVYNFYLSANTFK
PFPDLFMITKSFIFLVAPSAFLYVRSVLFSDKIFRKYDWLHFLPFIFYFSLTLIVWVDSY
VDLPIINYLSVKIKSPFSMLSLTIWLMYAFCQTMMILNYDLKKFNVNQFNRIKVLSWIRL
YNLMILFLFSTLFVHYFLVNQVDSIDFSCYILISSVLVFTVGWLYFKPQIFYDPNEIEEV
NDSNEVNENFDFDKEDARLVIIKTNETKNNLPLVKELTSEKKKQYLAKLENIFATKELFL
KKDLVIRDIAEETGISVHHLSNLINSEFNLHFQDYVNLKRIEYFKEKINDPDWKDLSLEG
MAWGSGFKSRTTCFRAFIKHTGKSPSEYFKVIRINPEKTTTFYLKQSSN
>EGALAKHO_01922 hypothetical protein
MMKTKFKQKQTIKSLLTLLLLFVSFIGQAQLKGGHILGAMGLQSGTQTPANTLSVYVPGY
FYTASSLKDANGDKAIVDPNITMTITGAGVSWVSDFKILGANYGASALLAFASNTIQGNS
IDATNCMKLTDTYIVPIQLGWHNKRADFVASYQIYLPTGSYTAGAPDNSGLGMFMNEFSA
GTTLYFNDKKTFHFATLASYEINGKKKDTNIKTGDILSIEGGLGKTFYMMNAEKTAPKGI
LNAGLIYYLQYKVTNDKIPVPIIGIVEGEKDHVGGIGAEVNYFHIGCSTSAGFRWIGEVN
AINRFQGNTFFLTLAHVFSLKKE
>EGALAKHO_01923 hypothetical protein
MKNIKLFQKIVLTNVFFLLSFNMMMGQKQHVSLRDSLDHAVDLSDYIIYAHGFIVIPTII
TEPALGGIGGAVAPIFLKKHAPVIDENGKKRFINPDITGGLGMYTGNNSWMAGAFRSSTL
IKPKILYRVFAAYGDLNLSFYENMPNGNDKEFKLNFRSTMFYTQWLKQFRNAKWSAGPQY
IFLNSDITLPDLNLNLPPSFVKPKDLNSLVSQLGGALQFDGRDNIFTPDKGIRIQSDFFW
SDKAIGSDYNSWRVNLSAIGYYPLSSKLIGGLRIEGEQAFGSPPFYLLPSINLRGVPTAR
YQGRTSLVTEAEFRWDLYRRWSLMAYGGLASAFDDWDQAYAKPVVYNYGTGFRYLLARKF
KLRMGVDVAKGPEQWAYYIVFGSNWMR
>EGALAKHO_01924 hypothetical protein
MEVQTLTTKQKIFNFPLIKIILALIVCLALINFGQAIAAKLLLMTPLDKNYRNLIKGIIV
SALALTSYILFFTYYEKRQITEFALKGIAKNLIVGTLIGMVLQSLTILVIYLNGTYTVLS
VNPVSFIIIPLTLAFTAAIIEEILVRGILFRIMEEKLGSYIALAISAIIFGALHLANPGA
TLVSALCVAIEAGLLLGAAFMYSRNLWFPIAIHFAWNFMQSGIYGAITSGTTKVDSLLVA
KIEGSTWITGGEFGPEGSIQAILFCSIASAILLILCHKENKIVLPYWKK
>EGALAKHO_01925 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MVFWFLFLIRNKLKMFELQKEKYLGNTKNIFNNTQGLAVVETEYQSKVYEGWHSHNNAHI
TLFLRGGTTEKRKNFSEVVGPGSLLFYHSDELHMNHETLFPSKNINIEIEEGLLKELQIS
EAIIEKSVQNSTLTKFLILKIFKECLVADAFSSDTITMLFSQLANGNSHLERFEKSPFWV
KSLNELLNDCWNENPNLQDLGQVLNLNPITISKHFPKYFGCTLGEYMRRIKINRSLSLIE
SSNSNLTEISFQCGFADQSHFIRTFKNQTGFLPKQFQKL
>EGALAKHO_01926 Aminopeptidase C
MKSVFVASAFLVGVSSCFAQDVLVNSLKLNASDKSKENFKFTEQINLGTTSVKSQGSSGT
CWSYASNSFLESEMIRLGKQPVELSQIYSARNVYVEKGINYVRMHGAVSLGDGGALHDVI
NMYKKYGTVPREVYTGLNYGTDKNKFGEMAALIEGVLAAVVKNPNGELTPNWQKAYAAVI
DTYLGKVPDNFTYKGKNYTPQSFAKEVVGINPDEYIEMSSFTTAPYYQKTVLAVPDNWSF
DQVYNVKVNDMTDVIDNALKKGYTVAWATDVSEKSFSWKNGVAYVPTKKFDDMTAEEKAD
MFNGPKPEPEITPEMRQAAFDNYTTTDDHGMHIIGLAKDQTGREYYIVKNSWGETNDYKG
FLFVTKNFVKYKTTALMVNKGGIPTEIAKKLGV
>EGALAKHO_01927 hypothetical protein
MKTYAAYFTLIACVFSFSCFAQRGTSNTPATASIANTHSPSDNKSDNDLVLDYYHVEETI
NMTFGRRVTKYEVSKLDMVNTYDLGPNNTRTVTPVYRKAKVKPTEIAMLSKTIKDTVPPS
IKPVKLAVIAPSQKTKYLTVNRTKTYMQVIDKGYASADMLKKVADQHYFDGEMTEAAKFY
AQLLDIAPSTEPTYYYRYAQSLKEIGQTEKANEMMVLFDSKNMTNKIAKE
>EGALAKHO_01928 hypothetical protein
MNIDELEIYQTKIYYGLKTIGEEIATFYLDGVSLIKDVNYLSKSYLIGHIAREIDGGLRD
ILAPKENKTKFQLDDVPQKIRNHVNSILLALDSEKDMPLAKEYIDVATNFVMYAHRRGAY
KNPREPEEIIQLWHRYEKILYKLFGDYINQLKHLDRILKFDVPSEYILETLPNFFNDESK
KVHFYETLKNTNWFKPMYEKDFFNANTIENGKHWQQLTYLVYISEEIKEKKIDRENSKYI
VDLIYKITNAANYNEYRNDIRLWYFLFKILSNLPKIYLGSDFLAIFPRFFNSTDSTLTGK
GAFEFIESYFLEEKISEEGKLIVEEILKYAFELTNDKASRYLNRHEEESIYPNFESYLLK
DLSESVDFCQKISSICTNSLLYHICDKLEIYLIDNYHEGIFRNSIFFENDRTFSDETIDV
IYTDFLKKTISHISTIDLKRHREITETLLSIRYKHFYVRKLCFYTISLNWKNTRDLFFDL
IKNNDEKHCFSNWENNEDLYFLLDKISTSLTIAECKYLEKIIDCGSQDKYFYADKAEDFK
LYWLSALKNSYQFKHKFEQLSLKHNRSYESLKPKNRESIIWGSTSPISEDDFIKLNPSDL
VNVIRNFDPHRGFKTPDSDGLANFLEDYFSKNPNYFTENFTLYLNVPFIYISKITYGLSS
YLEKNDNINWVNILEFISQYIRQSNFKENKLKLQNGNFGYDKYSFVIASCRLLSQGCAKG
DIYEKSLEPVVESIFKNYITYVEVKEDNNKTEKLGSIMHLINSNNGRILQSYFQYILGRY
RDLCDNKDKSSKWTVIEKRYFTKLSNSNCKEFFMLLAYLKSNFLFIDYEWTIKKIRSIPS
KEIGIIKAFFGVHISISDPTELDYIIFKNTYIEAINNQWNFDESGISNSLERHIGVFYLF
SYDDFQNNSIIETFLKSKRVEKIGKLIHFYSFYVKPYVDTLELSQQRKIKDRIFILWERC
YETLTQIRDNNSKNEISGLVNFLQFIDEIDQLNFNLIHKTALIAAKHWEIETILKQINRL
KDKAKSQENAYYIIQLLNDTIFLDIYYFRVDKNDLFEIIEYLFELNIDFIKIQVNKICNS
LAKKGLHFSTPLYEKYNSEF
>EGALAKHO_01931 Putative zinc metalloprotease
MDIVIKLSQFLLSLSLLIILHELGHFIPAKLFKTRVEKFYLFFDVKYSLLKKKIGETEYG
IGWLPLGGYVKISGMIDESMDKEQMALPPQPWEFRSKPAWQRLIIMLGGVTVNFILAFII
YIGMAYAYGDTYIANADLKDGVWIQSDAMQKAGIKTGDKIISIDGHPVEKLDSDFLVNLV
ISKKVVISRNGVQQEINMPIDFADQRKDEKVSPASMRIPFYVDAVEKTSLNKNLKSGDVL
VSLNNQEAKYYDQVKPIVDQNKGKTIPAVIIRDKKEQQINVTVSKEGKLGVAVGQLDDKL
LAQLAYYKITEKKYSFAESIPAGLERGKDRLLGYGRQLKMIFNPETKAYKQVGGFAAIYK
IFPATWSWEVFWNITAILSIMLGVMNLLPIPALDGGHVMFLLYEIISGKKPSDKFLENAQ
MAGFVLLIALLLFANGNDIYKAIVK
>EGALAKHO_01932 NADPH dehydrogenase
MASLLFSPLTIKKITLKNRIVISPMCQYSAVDGFANDWHLVHLGSRASGGVGLIIQEATA
VSPEARISPADLGIWKDEHIQKLKTINQFIVSQNSIPGIQLAHAGRKASVSAPWEGNKKL
DFAQGGWQTVSSSAIPYHDDEPFLPEALDKDGIQKVISDFKSATKRAIEAGYQVLEIHGA
HGYLLHQFLSPLTNNRTDAYGGSFENRIRFTLEIVEAVQSEWPSDLPLFVRISATDWAEG
GWNPEESVKLSEILKEKGVDLIDVSSGGLVSHQQIPLHPNYQVPFAEKIKKEANILTGAV
GLITHAVQAEDILKNNQADLVLFARESLRNPNLPLDFAKDLNDDIQWPKQYERAKIK
>EGALAKHO_01933 scyllo-inositol 2-dehydrogenase (NADP(+))
MQKIRTALLSYGMSGKVFHAPFLDIHPGFELLGSWERSKNLIQEDYPYVKSYPTIDDLLA
DDVDLVVVNTPVGTHFEYAKKVLLAGKHAVVEKAFTTTVAEAEELASIAKEKGLKLAVFQ
NRRWDSDFKNIQKVIKEGVLGDLVEAEFHFDRYNPVLSPKAHKETVNDGAGILKDLGPHL
IDQAVCLFGSPKSVFGDIRYTRENSLVDDWIDLLLIYDNFRVRLKASFFVREANPAFTIH
GKKGSFLKPRGDVQEDELKIGKKPNLESWGTESEALQGLLHTEINGEVIREKIPTLQGNY
FSFFDGVYDSIVNNKPEPVTAEDGVKVMQIIEAAIASSAQQRAINL
>EGALAKHO_01934 Inner membrane protein YbjJ
MINFNPLSLFQTKGKIKKVYREAKASYLNRIRFAVGMFYFGMGLSFATWASRIPDIKSAL
HLTEGDLGSILFALPMGQLVIMPFSGKMVTKFGSHRILVFSLIMYVLCLANLGLATTAFQ
LSVGLFLFGLFGNLANIAVNTQGVYTEVLFKKTIMSSFHGMWSFAGFTGALVGLGMLALN
LSPLHHFLIVGGIVILMVVFNFKFLVKAKEKIKHKASEGKKLFVKPDSALIWLGVIGFCS
MASEGVMFDWSGVYFKDIVKAPGPLVILGYTSFMIMMAGGRFLGDGLINKFGRERVMQIS
GVMISAGLFTAVFLPYIIPCTIAFMAVGLGVATIVPTVYSMAGKNPTVPPGEALTIVSSV
SFLGFLMGPPVIGHIAQNFGLQFSFAFIGIFGVLIAFMVSKIRTTA
>EGALAKHO_01935 hypothetical protein
MEKKYLLFFILLPLNFVFAQEETTFFGFVIDAKTQNPIENVVASIQNSALTQLTSAEGRF
ELHSQIKGEQLLLIHSQGYKDLLLKLESNFGFKVNLGILQLEDNFSDETPAALITLLDSD
LTDDNSSSEMTSGLLQSSKDAFMQASAFNWGQARFRVRGLDSENGTMMLNGMVMNKLYDG
RPQWNNWGGLNNVLRNQEFSVGTAPSTYTFGGILGTQQIFTRASMYRKGGQLTFSGSNTS
YNWRAIGTYASGMNASGWAYAISAGKRWSDEGFFEGTNFKAESFFISVEKKLNAKQSLNF
TGFYTPNSRGKNSANTAEVTQLTNERYNSYWGYQNGEKRNARVKNVEEPLLMLNHYFQID
EKTNLNSSVMYQFGKVGNSNIDYQKADSPDPTYYRKLSNYFSSLYAKDQGEFSGAFTPNY
ENAEKNKISFLENSQIDWSAIYQANQKQLSNSDSTISDYGPAQSHYVLYEDRTDDKTFAA
SSNLNSQLTTNIYFDGGVTFRNLKSHNFQYLLDLLGGEYFEDIDPFYKGNQSQSDLQNPN
RKVKGGDIYGYNYNFLASTIDAFTQFRLSYKKTDFYLAQSYSVSNYQREGLYQNGIYPTT
SLGKSQKINFENFGFKGGFTYKISGRQSLFFNGEHLTRAPSLRNTFSNSRLNNAVVNGLE
SENISSAEANYVYHSPKLKTRLTAYYTLIKNGTKTSFFYAEGIFDNGAGYDATDAFVSQT
LTHLDKKNVGAELSFEYQISSTLKSTLSAAYGNYTFNSNPDVLITNDANAVKEDKQTSFD
FGKAYIKNYKQAGMPQQACSFGLEYRDPKFWWIGANINYLSQSYIDISPIARTSQFYMNP
ANGFPFPEATKERGDELLKQEKFNPITLLNFSGGKSWRVHGKYIGLFSSVNNAMNSVYKT
GGFEQARNANFRALNQDVSSGTPSFGPKYYYGYGRTYFVNVTIGL
>EGALAKHO_01936 hypothetical protein
MKKIFLKSIFALSLLLICGCNNDVETPKLECTQPDLTVNKTVGKVHELSETTAKQYVYDD
VIEAYVVSSDEDGNFFKTISFQTLAKEGIPATGFSVPVDASNTYIDYRVGNKVYVKLKNQ
FTDLSYGGLRIGSLNVSNAGDPTIGRISQNDYKNVLNASCTMIDENLLVKKISIEEALDD
TKLNTLIELTDVEFTEGALGRHYFEETNNVGGSTNWNLRDKTGNQIIFRTSSYASFSDHL
VPEGSGTVRGILTKFGSDYQMMIRSEQDVVMNGKRNTPFFAEDFQTVKNNVNFALPGWSN
IVEKATKLWKSIVYGGNGYAEFNTTSTTAAENIAWLVSPKINTTGYKSAVLSFRSAQHDL
KIDSPLNALEVYVSTNFDGSSVTKAKWTKLEAKFPSLSTPARTFISSGAIDLSAYSGNIH
IAFKYIGSGKDKTLNGAFMVDDIKIFGEK
>EGALAKHO_01937 hypothetical protein
MKTYFIAILMMVLPCLVHSQNDTAPVRLKQINIVKTNYQNSTDGEIVNKTVVFKDGKIQT
ITTSDVVQHFFYNKTGLLDMTVKDKVGSDWKEVVNYTYNADNNIIKFVKKYQEGPDYITK
VVTFFYEGARIKVTTKKSTNHQNLVDDIEYIVENGIIVRRTSRDKNKQIVGKIEYVYTND
NVVRHKGLVGDKISKTYTFDDKKSVDQLIVQSLFGDNYKVIVPMISYHEDEFSFEAISYN
NEVNFSPSSAALVAVSRKYKYNKLNFPIFCSQIEENGIVKTEKTFIYE
>EGALAKHO_01938 GTPase HflX
MLEKEVINFERTAIVGIVTQNQSEEKLNEYLDELEFLTYTAGGEVIKRFSQKMERPNPKT
FMGTGKIEEINLFVKENDISTLIFDDELSPSQQKNISKIIDCKILDRTNLILDIFAQRAE
SSYARTQVELAQCIYLLPRLSGLWTHLERQKGGIGMRGPGETEIETDRRIVRDRISLLKE
KIKTIDKQMGVQRSNRGAMVRVALVGYTNVGKSTLMNAVGKSDVFVENKLFATLDTTVRK
VVIKNLPFLLSDTVGFIRKLPTQLVDSFKSTLDEVREADLLLHIVDISHPDFEDHIASVN
QTLQDIKAHEKPVIMVFNKIDAYKHLTIDEDDLMTEKTPRHYTLEEWKSTWMHRLGEENA
LFISATNKENFEEFRERVYEAVRQIHITRFPYNKFLYPDYKDAIEKDDEE
>EGALAKHO_01939 hypothetical protein
MTKIHIAAFFLMIAVAVNAQKTDTETKKFKIPVPKSDYFNAIKKYNIIVQGISKWDRSRE
FLPNETFQKDITIDKYKNDKQIDSINPDLKIIVGLNPSKYLFNASGQPSVTGDLSFLILG
KNNEIITMASVNRNIPLDRVKGRNQETEMANALCLQAYDLLDGYLITKNEVELTFNYGIF
EKCEAFPELVDFNTKTQELLGKLEALTFDDAYLDQMQNFYKGYLGKPYGKIKDKEITKIV
NLNLSLIEIFKVNFAKANEYLAIAKDNAGMLAMWPDNAKKNLQILGFVNQTNFPHKIETI
TARTAYCITLKGTAYYKKKIFVGTFEFTRFKPASSGSSGMVSLDSYSPAIAIYEGTDKAG
YVWPNGNQFNVKTEDGKEIYFKKYQGEQIMVQKNADGTFKPYESESDDVYTSPDDEKLEL
KKA
>EGALAKHO_01940 hypothetical protein
MKKITLLCFSLFSVASFAQKVDLDRFYFNVSYQDLPKTIVPLEQRTYATNIITDGPISVQ
FPSAKVLNNQLNIYGWKKVNDNASVTVDLNLADFYEEGTTVETRKVEEKDKDGKVLRSYP
MYTLVTTYRGKGYAVVTAPVVAKAPVAAAPVEAAPKPANRFLKSTNQEAPASDAGATSNT
MKYNFSDQYTYRSAENANQSYLERENAKNRSVNLQNRLREYVENAIKSANTQLNYNFGFT
PISFQEQLWIMDSKEEEGAIQKEAIEAVKVQFAGMKADQPIDKLTADLQPLIEYFESLKT
KYTEDNKGSKKIRYSAYYNLGKIYLYLDQPEKTIKEGEGLIANDYDKGDGKDLISSAKKL
IDKFNAAQIRTRHNPSL
>EGALAKHO_01941 hypothetical protein
MRKLALLLFVLVNFTFVQAQNTEKELIQNTEKAVKKINDTIEGEGWKKKGTVSLLLNQSS
FNNWIAGGEDSFSGTLGINYDFNYKKDDITWDNKILAYYGLLQTKNSDFSKKTDDRLEFN
SIVGKKAFGQWYYSYFLNFRTQFSTGYIYGQDANGKEIRTERTKFMSPGYLTTGPGIYWT
KDANLKINFAPLTSKFTFVDNAYTTGIDQATGLPYVDGSYFGIDEGKSMRYELGFYASVY
YKLAIMTNVTAENTLNLYSNYLEDPQNVDIDYSLNIVMKVNKFLSANLSFQAIYDDNAYQ
GLQTREVFGLGLNFGF
>EGALAKHO_01942 hypothetical protein
MEEIINKVANSALEVFDLEDYYPKGMRVQIDISQWLLEGFLLKEKDFREHLKNHDWSQYQ
DQYVAVNCSTDAIVPAWALILVSVHLAPYAKKVVNGTIEDLDGSLYEEILKNIDYSAYQG
KPVIVKGCSKKPVPMRAYILATTYLQPFARSIMYGEACSAVPLYKETKK
>EGALAKHO_01943 hypothetical protein
MTYMVEKTKKMEQEIDTNELGESIVKVLKGIYDPEIPVDIYELGLIYDVMVNTDYEVKIL
MTLTSPNCPVAESLPREVEEKVKTIENIKDVDVEITFDPPWSKDLMSEEAKLELGML
>EGALAKHO_01944 hypothetical protein
MITKKYLKDLIYQVNGAAIEVHKNIGAGLLENIYHQCMIKELSLRGINFQSELVIPVEYK
GLELESDLRCDLFIENCLVVELKSVDQIIPVHIAKLMSYMKLLNCPIGLMINFNVTNIYH
EGQKTYVNELYRWLED
>EGALAKHO_01945 Cysteine desulfuration protein SufE
MTIKEIQNEIIDEFSMFDDWMQRYEYIIELGKSLPLINEEYKTEENLIKGCQSKVWLHGE
ENDDKIVFTADSDAILTKGIIAILIRAFSNQKAEDIINADTQFIDEIGLKEHLSATRANG
LVSMIKNIKMYALAFNAKNK
>EGALAKHO_01946 hypothetical protein
MKIVSLLLMVICIATGCSSQKKTDMAGTQIEYTAMSRGLYKRIVVQDQKVAITNGRDTEA
IVSQIDNAKWNKIVSEFEKINLDSLSALKAPTEKRFYDGAAIGNLKIIQNPKTYETAGFD
NGFPPKEIEKLVNLLTDFVKE
>EGALAKHO_01947 Cysteine desulfurase SufS
MLDIQKIRAEFPILSQKVNGKPLVYFDNGATSQKPQIVIDAEVKYYQEINANIHRGVHTL
SQLATDAYEISRGKVQQHINAKFAHEVLFTSGTTHGINLVTNGFASILKPGDEVIVSSLE
HHSNIVPWQMLCEKTGATLKVIPMNEDGELIMEAFDALLSEKTKVVTVNHISNALGIINP
IKYIIDKAHAVGAAVLIDGAQAVPHLKPNVRELDCDFYAFSGHKMCGPTGTGILYGKEEW
LNKLPPYQGGGEMIKEVTFEKTTYADLPHKFEAGTPNIAGGIVLGTAIDYLNNIGFENIQ
QYENELLDHATKRLLEIEGLKIYGTGKNKASVVSFNIDGIHPYDVGSIIDKLGIAVRTGH
HCAQPIMNFFCIPGTIRASFSFYNTKEEIDTMVEAVKKAKTMLS
>EGALAKHO_01948 hypothetical protein
MKKFLKVLVLVLVLAFLYFGFTTYPKLDLISGFSAKSVASGHFMDNRSLDLIQKTDNDIK
MIDLAKNSIDDAGKFATATVYGLKERKAIYREGLGATLINEDFDISKPYLLPKRTKLVNN
LPFPYGNNEPKDTTFSNVDYEKLKSAVDNSFDKNGGKAKRTRAVVVLYKDKLIAEKYDTG
FNKDSKILGWSMTKSITSSAFGVLAKQGKIDIYKPVPIAEWQKDDRKIITINDLLHMNSG
LEWEENYTKICDATKMLFQAEDMGKVQMDKPAQFKPNTHWYYSSGTTNLLSRILRSQFKT
QQEYLDFWYSAVIDKIGMNSMIVEQDMSGTFVGSSYGWATPRDWSKFGLLYLRKGNWNGE
QILDESWVKYTATPTNTSEGKYGAQFWLNAGGKFPDVPRDMFYCSGYQGQMVAIIPSLDM
VIVRMGVKEEEPGFDFNGFLKGIIDSVKK
>EGALAKHO_01949 FeS cluster assembly protein SufD
MDLKEKLVSSFMAFEERVDVHSDLHDIRTNALKNFENKGFPTKKEEAWKYTSLNAILKND
FTVFPKEENAIEFNQVKKYFLHEIDTYKLVFIDGVFSSHLSSTTHDGIDVCLMSSALTKP
KYKMIIDTYFNKVASKDESLTSLNTAFASEGAFINIPKKKVADKPIEIMYFSTGNESALL
VQPRNLIIVGENSHVQIIERHQSLNENPVLTNSVTEIFAQKRAIVDHYKIQNDNLEANLI
DNTYVSQQQESHVYVHTFSFGGNLTRNNLNFYHFGERLTSTLNGITIIGEKQHVDHYTLV
NHATPNCESFQDYKGIFSDRSTGVFNGKVLVEKEAQKTNAFQKSNNILLSDKATINAKPQ
LEIFADDVKCSHGCTVGQLDETAMFYMQSRGIPKKEAKALLMYAFSNAVIESIKIPELKQ
RITKIIAMKLGVNLGFDL
>EGALAKHO_01950 hypothetical protein
MSKFKSFEEINSWQKSRVFNKKIYLVTENPNFKKDFDFVRQIRRASLSISSNIAEGFERN
TDKEFVYFLYVAKASAGEVRSQLYLAFDLEYIIKEEFEMLLNSVTEISKLLSGFIKYLSP
KS
>EGALAKHO_01951 putative ATP-dependent transporter SufC
MLSIKNLHAGIGDKEILKGINIEVKAGEVHAIMGPNGSGKSTLSAVIAGNENYEVTGGQV
FLDGEDLADLAPEERAHKGVFLSFQYPVEIPGVSVTNFMKTAINETRKANGQEEMPANEM
LKVIREKSELLEIDRKFLSRSLNEGFSGGEKKRNEIFQMAMLEPKLAILDETDSGLDIDA
LRIVANGVNKLKSEKNAIIVITHYQRLLDYIVPDFVHVLYNGRIVKSGGKELAYELEEKG
YDWIKAEN
>EGALAKHO_01952 Putative NAD(P)H-dependent FMN-containing oxidoreductase YwqN
MENKKVIILGSARKNGNTTKIVDKIAKESGIDVIDLSDYNISHYDYESKNREDDFLPLIR
RILEEYDTLIFATPIYWYNMSGIMKVFFDRFSDLIRIEKETGRKLRGKKIGVISNSHDNE
IEESFYIPFKKTADYLGMEYLGHAHFNANILNQTTKIELTFI
>EGALAKHO_01953 Toxin YoeB
MEIVFSRKAENDLEFWSKSGNKKILKKISELLRAIQENPFEGIGKPEQLKYNLSGVWSRR
IDQEHRLVYEIIDENTIEILNIISLKGHYE
>EGALAKHO_01954 hypothetical protein
MDITLKNVKKKDFPVFQSLAKSLGFEIIEENEKPYNPEFVKEILQAREELRQGKGIKMTI
EDIDKLWK
>EGALAKHO_01955 FeS cluster assembly protein SufB
MSKYTEDDLKIELETKEYEYGFYTDIESETFPIGLNEDIVRAISLKKEEPEWMTEWRIEA
FRAWKEMIEPEWANVHYVKPDFQAISYYSAPKQVDPTKTLDDVDPELLEMYKKLGISVDE
QKMMNNVAMDIVVDSVSVATTFKKTLGEKGIIFCPISEAIKEHPELVRKYLGSVVPQKDN
FYAALNSAVFSDGSFCYIPKGVRCPMELSTYFRINQAGTGQFERTLVIADAGSYVSYLEG
CTAPSRDENQLHAAVVELIALDDAEIKYSTVQNWFPGNKEGKGGVYNFVTKRGLCETNAK
ISWTQVETGSAVTWKYPSCVLKGDNSVGEFYSIAVTNNYQQADTGTKMIHLGKNTKSTII
SKGISAGKSQNSYRGLVQISPRAENARNFSQCDSLLMGNNCGAHTFPYIESKNPSAKIEH
EATTSKIGEDQVFYCNQRGIPTEKAIALIVNGFSKDVLNKLPMEFAVEAQKLLEISLEGS
VG
>EGALAKHO_01956 Iron-sulfur cluster insertion protein ErpA
MIKVSDTAKKKIIDLMSDDGFDAAHDYVRVGVKSGGCSGLSYDLKFDKTKGEDDKIFVDN
DITIAVEKKSFLYLAGTILEFSGGLNGKGFVFNNPNASRTCGCGESFSL
>EGALAKHO_01957 hypothetical protein
MKKHYKNGWVKTLFAVLFVFGLGATFYIFSKESDINNLSKDIADKKQNTLKLSESELAQK
GILDSLNILKLAYDVAILEKTSLSQQLEIEKNSVENLMEIIKASENPSTQQITLYRKQLS
DLKVSLNSNIQEVKKLKSQNKNLLTEIENQNVVMYQQMAANDTLVSKQKKLETTIKDASK
LTMNNFKVVALREKKSGKELETDKAKSAQKFKVSFSINGNSIAKTGKKIFYIQVLDQKNK
VLGEDKLIEFGNDKALVYSFIVTVDFQGKPASVYGILNSDVDHFPKGTYFVNFFDKQEIF
GSTSITLE
>EGALAKHO_01958 putative quorum-quenching lactonase YtnP
MKLYPIESGNFKLDGGAMFGVVPKTIWNKTNPADANNLIDIAARCLLIEDDNRLILIDTG
MGDKQSEKFFGYYSLWGSHSIDKSLAKYGFHRDDITDVFMTHLHFDHCGGSVQWNADKTG
YEPAFKNAKYWTNENHWDWATKPNPREKASFLSENILPMQESGQLNFIKRPEADFGFSEE
MNFGIFYVDGHTEKQMIPHIQYNNKTIVFCADLLATAGHIPLPYVMGYDTRPLLTMPEKA
KLLNAAADKNYYLFLEHDAHNQIITVEHTEKGVRLKDVFTCEEML
>EGALAKHO_01959 hypothetical protein
MNKIILLFFILFFFRMSGQIADTLVMKNNDIKIKELKIPHEQWTDTIVLKNNDIIIGEIK
SMNKGVLQIETDYSKSDFKLEWKEVKFISSSRTHIINLTSGVLVNGILSKSKTPNKCEIK
NIETQTITEVSLRDIVYIKPVDDSFWDRLDASFDVGIKLTKAENLQQLTININLGYTAKR
WFATGMYKQIQSIQDDSDPIRRIDTDLSYVHLLPKDFFIPLAVTTLSNTEQDIQLRVLSK
AGYGKYILRDNKKYWGVATGLSFNHERYFNSSEAFKSLEIYLGTDFNLYDMGDFSIQSKV
NVFPSITENKRVRTDFNLDTKYDLPLDFFIKLSFVYNYDNKPKNGAVKDDYVFQTTFGWK
LD
>EGALAKHO_01960 hypothetical protein
MKNFIYLSIISLVFTACGSGGGDDPEPIPGPEPVPVNTAPTVPALASPADNKLCLDNTVV
FQWNQSSDTEKDAVLYQIQVAKDNGFTQIVSTLDATSNLTNTATLDKNTAYYWRVKATDA
KGLASAYSVTYKFYTAGVAVVNHLPFAPALTQPVINSVLTGTSATLGWTASDVDTSDILS
YDVYFGTANPPTVKISDNIAALSATIAVEPTKQYFWRVVVKDNKGGETIGQVWKFKTN
>EGALAKHO_01961 Internalin-J
MKTKLLLLLLLANFSIYSQTNLVPNGGFELWTGTGSTFTNWTTTNFVTNSFDVAQGTQSA
KLGYQSASPKITTLVPMKAGVTYTVKYKYKYVSANYSGDHPISLNISQTGAAATLSSSTF
ATNNLWTEKVTTFTADKDLSYNLSLSTFSFDSAAFEVLIDAIQVYVQGSEQYTKIPNLNF
EKKLIALGLDSGATDGQVPTININTIISLNVSNSSISDLSGIEDFTALTTLDCSQTGLIS
LDISKNPNLLRLNCATNSGLKNFDVSKNPNLIFLDCSNLGLLTLNLASNTALQYLESTNN
YLTTLDLSANTNLVELQVRSNKLTNLDLAKNTALKQVSCTSNLITSLNLSNNTGLKVLDA
SSNKLTSIDLSKNKLLTDLTIYGNELTSLDLSSNNALVMMNCSGNKISSLNLKNGNNSNF
LLSHSIGYININGNPMGGAYTSSFASNPLSCIQVDNTAYSNANWSAIKDKDANYTSLNCS
LSTLIPDSKFEDELMALGIDTDGKNGAVLNSSINTVSTLNVSAKGITSLAGIEGFTGLTN
LNVSGNALKRLNLSKNTTLTTLNTSNNPALTCIEVPDLTLASKWVVTKDATTGFSLDCNV
YTLIPDPKFEDYLISINIDKDGKNGKVLTENINKITILNIYNLGISDLTGIQDFTSLLQL
QGYGNAIETIDVSKNSALTSLDLSNNKLSKIDLSKNTALISIDLSNNLISEIDLTNNLNL
KTLRIGTNNLSKIDVSANTKLTYILANTNKLTSFDISKNPDVYQVWCQGNQIRNLDFSKN
SKLVQVLADNNKLVNLNFKNGANTLIDVSSGNNGGLRFTGNPDLKCIQVDNVAYSDTNWA
AKKDASATFSSVACPVVIPYTLIPDANFEAKLIALGIDKDGIAGKVETMSIVTLTSLNVS
NSGISDLTGIQDFNALTSLDASNNKLATIDVSKNISLKTLNVSKNQLTSLNVTTNTSLNN
LNLAYNVITSFNVTKNTELGSLSCNSNAIETLDVSKNTKLTLLSASFNKLQYLDVSKNTL
LKELDCASNDLYNLNLKNGNNANMQRMIFGNFTQNPHLVCIAVDDAAFAETNWIAKDATA
TYSSQACPLNEQQTLIPDLSFERILIAKGLDKDGENGKVRTANISTLTSLTLNDSTNKVS
DLTGIQDFKALSSLTANNNTIKTIDLSKNTALITLDLSNNLLTDVDLSNNTLLWVLNLEN
NQLTTLDVAKNTELSSLDIERNQLTAVEVSKNLKLNRLEVGNNKLKNINLSQNAKLDYLS
IYSNLLTSLDVSNNPLLNVLQCSQNQINTLDLSKNNKLSQLNVSYNKLYNLNLKNGANSL
LNTSYSSLRDNKYLTCIEVDNVTFSNEKWSTIKDATSNFSSELCTNGEPFTLIPDVNFEN
KLIALGIDKDGPNGKVATFSIDTVTSLNVSKSNIADLTGIQNFAALTTLDATDNKLTKID
VSKNRLLANLNVSKNQLTALDVSTNYSLVSLNCSANAITTVGDLSSITLLSNLNCSNNAI
KTLDVSRLTQLNNLNCSTNALTVLNTSKNLKLTILSASINQLENLDISKNIVLKEIDCAA
NNLYNLNLKNGNNVNMERVFFGNFTQNPNLLCIQVDDAAFSDKNWIAKDATATYSSEACS
VNGKYTLIPDVNFEKLLIARNIDKDGENGKVFTSSISNITNLNLSDNTLKVSDLTGIQDF
TALETLDCSNAGLKTLNLSKNLKLKTLYASDNALTTLDISPNVALTNLYASNNQLTTLNV
SKNATLTNLDLHNNKLTNLDVSANVSLTNLSVYTNQLTNLDVSTNVALTNLSANNNQLTT
LNVSKNILLTNLNVSANQFTTIDFSTLSALKVLDLSKNKLTAVDISKNPALLAFYVQENN
LTSLDLRNGKNTLLTNYNISFKTNPKLTCILVDDVTFANANFSANKDAIATYNTECTGEL
TLPANNFAIETKGESCLGENNGEISIVAKTAFDYTATINDKPYTFANNSLKVAALTPGVY
KIKITIPNMIFEQNFNITIAKGATITGKSTITSKKVDVEITEGTAPFTVSIDGTEQFQTN
DSNFSIALTEGGLLEVATSKACEGIYSKKIKTADILGTILSAYPNPTTGIFEIEIPTDKN
EVTIELYNFGGQLVSGKKYVIENGTAKLNLENQPSGIYAAKIYLENPEYIKIIKK
>EGALAKHO_01962 Cell wall-associated protease
MNHIKSNCLSAFALLVLAGCGATVQAQESAQKSPIVAPLAIVKKAPVTENELKRWSHLDL
VKDSIPGMSVDKAYAELLQGKTGKKVIVGIVDSGVDIEHEDLKGMIWTNPKEIPGNGIDD
DKNGFIDDIHGWNFLGNAVHENLELTRVVKKGDNGSAEYKNALAQYNEKYEKAQKDKEQV
DFLLEVHNTIKKELNKTTYKIEDLSTITSTDPKVAQSKNIMTQIFTNAGPTFDPEAELEE
YRKQVYDELNYNLNKDFDGRKIVGDNPEDIKNNHYGNNVVFGPDKEEALHGTHVAGIIAQ
VRGNGLGGDGITNNVEILTVRAVPDGDEYDKDIALAIRYAVDNGAKVINGSFGKSFSPHK
QWVYDAIKYAQKKDVLIVHAAGNDGYNIDETKNINYPNDSEDNIKEFSNNLITIGAINKE
YGKNVVAGFSNFGKINVDVFAPGEEIYATVPNNKYKYLQGTSMASPNAAGVAALIRSYYP
KLKASQVKQILMDSGVALPAEVVLGENPNRDQEPVAVSSAESSKTAKMVNAYNALLMAEK
MSKK
>EGALAKHO_01963 hypothetical protein
MHKIILFSFLSFGLNSAFAQNAPYWQQRVDYKMEVSMDVKNYQYKGKQELVYTNNSPDTL
RKVFYHLYPNAFQPGSEMDARLHSIKDPDGRMVNKVKGADGKEIKQSRIETLKPNEIGFL
KITNFKQDGVTAQTRTSSTILEVTLAKPILPNSKTTFTLDFDGQVPVQIRRSGRNNTEGV
ELSMSQWYPKLAEFDFEGWHADPYIAREFHGVWGDFDVKITIDKDYTIGGSGYLQDKNTI
GHGYEDAGVTVVYPKKAKTLTWHFIAPNVHDFTWAADKAYTHDIVKGPNDVDLHFFYKND
PKTTGNWKQMEPLMVKVMDYYNHKVGAYPYKQYSFIQGGDGGMEYAMCTLMLGSGTLEGI
LGTATHELGHSWFQHILASNESKHPWMDEGFTTYIEDSALNELKGDKKEVNPFKGAYNAY
YSLVNSGKEQPQTTHGDRYDENRPYSISSYVKGCIFLSQLSYVIGQENLDATLKRYFNDF
KFKHPTPNDIKRSAERVSGAELDWYLVDWAETANTIDYGISAVADNAGKTTVSLERIGRM
PMPIDLTVEYTDGTSESFYIPLRMMNFIKPNPNPNVKRTVLDDWAWAQSNYSFTIDKNKT
AIKKITIDPSGLMADVKPANNVFEVK
>EGALAKHO_01964 hypothetical protein
MTNSYHPVEQSKRTAIVDILRGWAILGVAIGNYSDFLYIGIEHKINNSLISDILYYFNRY
FFAAKSWTLLTLLFGYGFAILINNVAAKGKNPVKFFAWRMILLFILAFINSSFWLGDILK
DYAFLGLVMLFFYKSSAKTLSIICAVIVLTIPFVMAFVNGYTVEHPEIATNPEYLKLYHS
GNWLDFFKFNLLASFYEQIIIPGYAITAHLVMFACMLFGFLLQKLDFFNRLNELKKLLKK
TLWISLATAIFIGVGFNLMIFYKLAPLKIFHPLYWLVLSTMIFIATGICLLYINGKLKTI
FSYFSAGGKMTLTNYIVQNILAAFIFSGIGLGIADTMPYWFYFTLAVFVFILQLFISKWW
LSKYNYGPIEWLWRSASYWKLFPFKKTQPQTVTEIKTV
>EGALAKHO_01965 putative epimerase/dehydratase
MNPKILIIGACGQIGTELTQKLRKLYGTENVIASDIRKLNTDVVNSGPFEVVNALDFNQI
EHLVEVHKITDIYLMAALLSATAEKNPAFAWDLNMNSLFHVLNLAKAKKVKKIFWPSSIA
VFGPTTPKENTPQYTVMEPSTVYGISKQAGERWCEYYHNIYGVDVRSIRYPGLISWSTPP
GGGTTDYAVDIFYKAIADKKYECFLSSETKMPMMYMDDAIDATINIMKAPAEKIKIHSSY
NLAAMSFTPTEIAAEIKKYIPEFEITYNPDFRQKIADSWPASIDDAEARKDWDWKHTFDL
ETMTKDMLEHLS
>EGALAKHO_01966 hypothetical protein
MKYKISLFLLLIFVLNSCQNENEKRLAENLKVAKKNEKIFNNINKAWVFIDEPINEASEK
NVSSWNEWRDFLKELGEKPRKTIGAFQKKSTAISKKAMALNNNIPAEFNQPQIKSRISIL
ITKVKMLDLFIHLSAIPDEKVTFLIGEINKELVSLERQMDKIVEKAKIPKEEGEADFLRM
LDTTRAIPNSGPVPPIQNSPKVE
>EGALAKHO_01967 Transcription-repair-coupling factor
MSKNALYTTYDNLPKTEQIATQLLEQNQVKMHLSGLLGSAVSFIIRAVFKKNELPFLIIL
DNKEEAAYYLNDLEQMIGEQDVLFYPASFRRPYQVDETDNANVLLRAEVLNRINSRKKPA
VIVTYPEALFEKVVTRQQLDKNTLKVALNDKISIDFINEVLFEYEFKRVDFITEPGEFSV
RGGIVDVFSFSNDHPYRIEFFGNEVDSIRSFDVETQLSVETHKKITIIPNVENKIFQENR
ESFLDYIAEKTVLFIQNTDGLFSQLDKQFARAEEAFEKLSGEIKHATPEQLFLNQSSFIK
RALDFSIVELASKPIFKTTKKVEFHFQPQPSFNKQFDLLLNNLSDNHFNGYKNYLFCSND
AQAKRFHDIFESLDEANSENIRKQYHTIVLPLYQGFIDEENQITAYTDHQIFERYHKFNI
KNGYSKKQNITLKELTALSVGDYVTHIDHGIGKFGGLQKIQVEGKTQEAIKLVYADNDIV
YVSIHSLHKISKYNGKDGTPPKIYKLGSNAWKILKQKTKARVKHIAFNLIQLYAKRRLEK
GFQFAPDSYLQNELESSFIYEDTPDQTKSTQEVKADMESDRPMDRLVCGDVGFGKTEVAI
RAAFKAVDNSKQVAILVPTTILAYQHYRTFTERLKDMPVSVGYLNRFRTAKQKAQTLKDL
AEGKLDIVIGTHQLVNKNVVFKDLGLLIVDEEQKFGVNVKDKLKTIAANVDTLTLTATPI
PRTLQFSLMAARDLSVITTPPPNRYPIETNVVGFNEEIIRDAISYEIQRNGQVFFINNRI
ENIKEVAGMIQRLVPNARVGIGHGQMEGAKLEELMLGFMNGDFDVLVATTIIESGLDVPN
ANTIFINNANNFGLSDLHQMRGRVGRSNKKAFCYFICPPYSSMTEDARKRIQALEQFSEL
GSGFNIAMKDLEIRGAGDLLGGEQSGFINEIGFDTYQKIMNEAIEELKENEFKDLYPEEN
DIETKEYVKDLQIDTDFELLFSDEYINNVTERLSLYNELGSVKNEEELVIFQNKLIDRFG
PMPPRANALMNSIRIKWIATNIGIEKLVMKKGKMIGYFVSDQQSDYYQSSKFRKVLQFVQ
KYSSLCQMKEKQTPNGLRLLLTFDNVKSTKRALELMEMLGE
>EGALAKHO_01968 hypothetical protein
MLKQYNYTFNSDSGYYSFFTKRQIEYRIAFYEDFMLASCVSDHLKLGNIYQITIDKISAQ
PAPFDVLVSQTIKNIITAFFESVQDALIYICDDNDKKAFQRFSTFDRWYNKSSMTSYITK
LNNIIEFNSDNETIKLYTSLMFHKKNANIKNIEEAFNNISNTLNGEKP
>EGALAKHO_01969 hypothetical protein
MKTTSVNKDVIKEAIIKMREDKIAVRSFLQGKTSAETLTLKGIKLVKTI
>EGALAKHO_01970 Alpha-amylase 2
MKIKITTRLFHFTKTILCFLLLFASSVYAQDPAQYGTPYTGVPDPRDANIYQVHIRPHSA
SGTLAAVTSDLDRIKSLGINVLYLMPIYPYGTDSRSSNSPYCIKDYKSVGSEYGTLTDMR
NLVDAAHAKGMAVMLDIAVNGTSWDHPWTVSHPEYYQRTGTTINQLANFSDIAALDLNNT
ALRAAMKDAMRYWIFAANIDGYRCDFANNPPIDFWTEIISNLRGITSHNLLMLAEGDRLQ
NFQAGFDMNFGDKWFYDALKNVAGGGPVSTRFQTTNDMEYTYATGNQQEVRWTANHDSEN
NSDTAPFTVFKSNAGVVANFLVSGYMKGVPFLTSGQEVAFNQVIPWPYTSVKINWSNTAA
TPEFAKILNFRNSSAAIRRGTMTPYASDDICAFTKTLGTEKVIVMTNLRNASKTFVIPAA
LAGTYKDAYTGATVTLVSGATQSFNAFQYIVLTNTNVANVAVTAVSVSPTTATVGLGSTQ
QLTATLAPANATNQNVTWTSSNTAVATVNATGLVTAVATGTTTITVKTVDGNKTATSAIT
VAAIPVASVSVTPTTASLYAGNTQQLTATVLPANATNKNVTYSSSNTAIATVNSSGLVTA
VSAGTANITTTTQDGNKTAVAAITVNPNSNFTVYFYKPSNWGTGIKIYYWSALPAGVLAD
ATWPGVNMTDAGNGWYSYTFTNVTSTNLIFNDGTSQSADLSRNKTGWYMNNTWYDSNPGT
VVAVTGVTLSPTTATLLVGATQQLTPTVAPATATNKTASYSSSNTAIATVNATGLITAIA
AGISTITVTTQDGAKTATCAVTVNATNVAVTSVSLSPATASLAVGGTQQLTPTILPANAT
NKNVTYSSSNTAVATVNASGLITAVANGTATITVTTVDGSKTSTCAVTVSTATGNYYTIK
NRWTGAYLSDAGANVGYGTTVSGNSYKWQKIAIDATYFVLKNVATGELINIEGQTGSVQC
NITDTTFWSAQWSSDYIDGTWTRLRNRWQSGNIIHVENQTGSAQYGNSQDGWYSAQWQLE
PTTVGTGKSALKIDDVSTTEAVIGIYPNPATDNEFHVLMPELQAGDMASITVSDMNGRTV
LTDRLSTSGQINHHLASGIYIVNINSNEFNVTKKLIVK
>EGALAKHO_01971 Glucan 1,4-alpha-glucosidase SusB
MNFQSKKALLRVSSVGKTICLCLFLCVNSVWIQAQEITSPDKNLSLKFELKEGGIPSYQL
SYKQKAVIKPSSLGLELQNLPSFLDGFTVTNTAQSSVDENWNPVLGEEKTIRNHYNELVV
TLAQAKNNNRYIRIRFRLFNDGLGFRYEFPKQNDLSYFVIKEERSEFNLAGNHKIFWIPG
DYDTNEYAYTTSKISEIPSLMKKATIEINSQWPIKELAVQTPSMMKSDDGLYINIHEAGL
INYPAMYLEVDAVNNKMRSHLAPDAVGAKGYMQTDAQSPWRTIVVSDKATEILASKLILN
LNEPTSYKDVSWIKPVKFIGIWWEYFVAGRSTWAFGKENNVKLTDDFTKLTPNGKHGATT
ERAKEYIDFASKNGFDAILIEGWNIGWEDWINNWKEEVFDYVTAYPDFDVKAVHAYAASK
GVKIIMHHETSGSATNYERRLDRAFQFMNDNGYDAVKTGYVGKIIPRGEHHDGQWMVNHY
INVAKRAADYKIMIDSHEAVRPTGLNRTFPNWIAQESARGTEFESMGGLAPDHTTILPFT
RLMGGPMDFTPGIFQTDLSYYGTGSTQRVNTTLVKQLAYYVTMYSPLQMAADIPGNYERF
PDAFQFIKDVAVDWDNSYILEAEPGDYITIARKAKGKDAWFVGGITDENARTANITFDYL
PAGKKFIATIYADAKEANWDKNPQKYTVTKVVVTSKTILKQYLAPGGGVAISIKEGNTTE
LKGLKKL
>EGALAKHO_01972 Alpha-amylase 2
MKSNTNILFALLLTLAFISCSSSDDSPKTDPKPDPGTGTDYQQYGTPFDKVPTKEDAIIY
QVNIRAFSSEGTLKGVEKRLDSIKKLGVNVVYLMPIYPVGQVKKSGKLGSPYSVKDYKAV
NADFGTLEDLRSLVNESHKRNMAVILDWVANHTSWDNKWITEHSDWYQKDASGNIIIPPG
TNYNDVAQLNFNNTQMKTAMIDAMSYWVYNANIDGFRCDYADFVPTAFWTQAISTVRKIK
NQNFLMMAEGSRADNFSAGFDYNFGFGFYDSLKKVVANGQPASDLQTQNTKEYGANSTSG
RIVRYTSNHDVNLSDGTPLELFGGKKGSIAAFVVAFSMNSVPMIYNGQEVGYNKRIDYFD
RTPIDWSTADYAMLKEYKNLIAFRNTSDALRKGKLTGYSNTDVSAYIMQTDTEKVLVVVN
LRNNAVTYGAATGIANSTWKNALTGESVEITNQIKLEAYQYLILKK
>EGALAKHO_01973 hypothetical protein
MKKYINKLVALLTIVMFATSCDSDAPLTVLQSVSFPAPITSSVSTIVLTEANADKEAITI
SWPAVVFPVEAPVLYTVQFDLTVNTKGKNAWLNAKAFEAGNDVLSKSFTVRDLNKIATDL
GLKADVAGAISARVVAVMDRSIYSNAIDLTVTTYEKVVVFGEIYMPGAYQGEWDVNTASV
LTAIEKGVYQGYATVLPGYGTIFKVNTARNWEEFYGAGAGEGNLERMNDKNLEFPGVGSY
QVKVNLNTLKWSATPYAWGIVGPASATAEQTASDPNYGWNHSVPMSYDHKTKSWKVTANL
LPGAVKIRLNDNWAVNYGPADPATNIIDKDNGGAYTITEAGSYEVTFTIVETDPASNGYP
ATATCTIVKK
>EGALAKHO_01974 SusD-like protein
MKIKNILIAGSVCFFALVGCTNVDETVYDKYQPDEFYGTPKGADIALASVYAQIGGNWNG
VGYAGADLGWYDLNSMCADEQVIPHRNTGDWGTDFARTYKHDWLPTDTMINNTWNWLYLS
VFNANLAVNQLELAGADTSKIAEAKVLRAFFYYLLIDDFGDVPFYTDNNITVDKIPQASR
QVVFDFIVSELKANVDLLPTGKGGEFYGRFNKWAGYTLLAKVYLNAGVLTGTPKWAECLA
ACNVVDGGGFSLHSGAEDLGNPLKSKYYELFGDVLPQDETILSIYTTVDVVSRNIFTVRS
LYGANCRALFGYDGWNGTIIPKEFYLKYEDGDVRKNQFLVGQQAGGANYTLDVTSLDDPG
AGAQEGVRDIKFYPVVPRGGGGASNDFPIYRYADLVLMMAECNVRLGNPGAAKPFVDAIR
TRAGISGLTGNPTLENIYDERGRELNWEGHRREDMIRFDKFLLPNQFRGTSPEFRKIFPI
PTSALNANPGLKQNPGY
>EGALAKHO_01975 TonB-dependent receptor SusC
MKKKSKNTGFLYRVFQNDLKLKLTTLLILVAMFNIRGNTYAQKTKVTLELNNSTIEKVIE
TIEQKTDFRFIYKLNDIDLDRTISINVKDQSIYVVLDRLFKGTPTEFKIRDTQIILKKPE
LKTQIIEFQKQTVSGIITDENGLPLPGASVLEEGTRNGMVTDFDGKYKITVESNSSVIIV
TFVGYKEKKVIANQSVINIQLLPNATDLQEIVVVGYGTTSRRDVTGAVSSIAAKDMNQGA
IVNPLQLISGKAAGVNINQIGSEPGSGPSVRIRGVSSLIGGSDPLVVVDGIQGNLDLLTS
IPPTEIESIDILKDASATAIYGSRGAAGVILVTTKSNKNGKSTIEYVGSTSIDFIPKKLN
MLNASEWSAAAAANGVPASSNHGADTDWYGVLTQTGFTQTHTLSFGGGTNKFNYRASLTA
ILQDGVVINSNNKKYIARVQATQKGLDDKLKLTFNLNNGVETSTRSIADLGRSGQVSNLI
SQAYLMRPTDPVFDTDGKTYFTDPGLFQYINPYAVAEKTINDSQWDNLFGSLKADLDLAD
GLQAGWFGSWRKTNKTTGFYLPSSSTDPGAVRQDGFGNITNERQNEKLMDISLTYKKTFG
VHSINALALYEWQNQTYEGSFLQARGFISDVTSYNALQYGDMSKVLYNDIRSYKNDRTLA
SFVARANYTLLDRYLVTASMRRDGSSVFGANNKWGNFPSASVAWQITKESFMSNQTLINE
LKLRAGYGVTGNQQGLNPQGSLSLVDGAGSTYFGGSQITNFAISQNPNADLKWETKKQTN
LGLDFALLDNRLRGTFDVYTATTDNLLFNYTVPQPPYPKSDIKANVGSIRNEGLEVSLGY
DVIRNENTTLTLAGNVSLMRNEVLNLSGSINGIPLNTDYVAWGGGTPNMYLIKGQPIGTF
NILQHEGVNASGVETVVDQNGDGTFDQGARSPDRVMEGSALPTYTFAFNPTLHYKNFDAS
LLLRGSGGNKVYNLVNQRSSYLENIGKSNVLDSALDKGIRTSVYGSDIWLEDASFIRLEN
VTAGYNFVFKDRFFESIRLSLTGNNLFLITDYTGIDPEINLNGSNADNAYFGGDRGIYPR
TRSVAFGVIVKFK
>EGALAKHO_01976 hypothetical protein
MNSNSEIKTLLQKFVLNQCTIEETNEVIAYYKKNKLTEDFPTVEDIQMLLAETPKMDQQT
ADNIFLNILETSKQNETTIEMFPQKSHFRKYISIAASVLVLLGVGFAYKQGTFTKQEQPK
FDVKSNEIVLQLEDGSTQVITENTSAQVKDEKGNVVGNQNGDKLTYGNESDVEKITYNTI
RIPYGKKFRLQLSDGTLVHLNAGTTLKYPMKFIQGENRQVFLDGEAYFEVAKDKKHPFIV
NADELNVRVLGTHFNVSNYPEDDITDVVLVEGSVGMYRTNEEFNADVNTILKPGYKGSFN
KENAKISTKAVITDIYTSWINGGLTFRNMSFKNIITKLERRYNVTIVNKNEKLANEKFNA
SFKDESIDKVMSYFNDIHGINYTIKNNQILIK
>EGALAKHO_01977 ECF RNA polymerase sigma factor RpoE
MLETKNYSEQLLVSELKNGNEKAFRQLFDHYYQDIYGYSISLLKSKEAAEENVQDVFMKV
WLHRENLNPDQSFKAYIFTIARNQAFNTLNKAANDLVLKEAVFYESQKSHDYGDYSIREA
DCKKLRKQAMKQLPPKRKQIFKMSRKKGMSYEEISQELGISINTVRNQMSKALESMRVFF
HVHDEII
>EGALAKHO_01978 hypothetical protein
MKTVSSIVENYIKTKPFLLNALSLGIINLTSLSRNIMTELESEFGKEVKQGAVVMSLKRL
TEELDFKLNHKINKVIKNIGEITVRSELTDYTFAASETVLNKQADLISDINALSDIFYTS
SRGVNETNIVVSSSVNHLVEKHFMREKLIQKLDNLASITVKLPKENIVVPGIYYFIFQRL
AWEGIIINEVISTSNEFTILVGEDQVDVAFKVIKDLKN
>EGALAKHO_01979 hypothetical protein
MAEHNELGKKGEELAVNFLQENGYEIIERNWTFQKAEIDIIAQKDNFLAIVEVKTRSSLD
FGDPQDFVKPKKIQLLIKAVNAYINDREMDFDDEIEVRFDIIAIHKNGESFAIEHLTDAF
YHF
>EGALAKHO_01980 putative murein peptide carboxypeptidase
MLFYYNTIMIHHIYNNIKKHFTHCRFVFLIFAFQSFTCQSQQNMITPPYLQKGDTIALLA
TARKNIDDNLKPTIDLLHSWGLEAVIGSTIGLDVNQLAGTDEQRAADFQKQLDNPNIKAI
WCVRGGYGTVRMVDLLDFTKFKKHPKWVIGFSDVTVLHNHLNTMGYKSIHGTMPVSVARN
TPEAISSLKASLFGEPLSYNVAPDPMNRFGKATGELVGGNLSILYSLLGSQSAIDCKDKI
LFIEDLDEYLYHIDRMMMNLKRNGCIENLKGIVIGAMTSMKDNEVPWGKNALEIIDDVTK
KYNIPVIFNFPAGHIRDNRALIMGSTVNIDVNASGSTVVFQK
>EGALAKHO_01981 hypothetical protein
MYIFQLRFYFVFLLSVANFQAQSKKYIIHTVAFYNFENLFDTNNDINTNDDEWTPTGAQH
WTEEKYHKKLKNLSRVISEIGTPENPNAPTIIGGSEVENRGVLEDLIKEPKLLPFDYGII
HFDSPDKRGIDVALLYQKKYFKPTSFSNIPLLIYKNKIVVKEEKKEETDDELEDKTEITK
DNNRVFTRDQLLITGFLEGEEISIIVNHWPSRSGGEKASSQFREAAGRLNRKIIDSLQRI
NPNAKVFTMGDLNDGPFNKSVKIALGAKAKKKEVPEFGVFNPFEEMANKGMGTIAFRDSW
DIFDQIMMTESVLKPDYSAFTFWKAGIFNRPFLVQTSGQYKGYPLRHSQTEVGFSDHFPV
YIYLIKEKK
>EGALAKHO_01982 3-hydroxyanthranilate 3,4-dioxygenase
MSIAKPFNLTKWIDENRHLLKPPVGNKNLYVDSGDYIVMIVAGPNARKDYHYNETEELFY
QLEGSIKVVIQEDGERKEMELIAGDMYLHPAKIPHSPVRSAGSIGLVIERKRAGKGYTDG
LLWHCDNCNHKLYEVYFELHNIEKDFLPHFEHFYNSEDLRTCDNCGTVMESDPRFTVKK
>EGALAKHO_01983 hypothetical protein
MIQEIIAYRNIVNNIEDLMNKSPFKKGYIIEKVGIPSPTFYRKLKSRTFTPDEVLSIAKI
LSPEEYFRLELLADIEQAKQEYVEGNFITHEEMLLELKRKKII
>EGALAKHO_01984 hypothetical protein
MNIVWSKRANYTFYTTRNYLKQYRSNEVAQKFVNEVLRTIDLISKNPHIGKFRYDLECNE
ILISKYTSLYYIINTDFIHLIRFHDNRQEPLTIFNL
>EGALAKHO_01985 hypothetical protein
MSIFNRLLLCFLLITGSAFSQKTEKPSFQIVPLGIKGGIDEKNLSAYLLAPINTNDYISL
DAGTINAGIEKAIENKVFKVSTSEVLRKYIKGYFISHAHLDHVSGLIINSPADSSKTVYA
TNKCMEMMENHYFNDQTWANFGDIGPGKPLKKYHFQTLNLGEETPITNTKMTVKAFSLSH
VNPFESTAFLIKNGDSYALYLGDTGPDAVENSTDLKDLWTAIAPLIKAKQLKGIFIEVSF
PNEQPDQFLFGHLTPNYLMKELHVLEELAGKGTLKGFKIIVTHLKPPTKNILTLKEQIKS
QNDLGLQIIYPEQGKKFEL
>EGALAKHO_01986 NAD/NADP-dependent betaine aldehyde dehydrogenase
MTTIASQFGMNEALDKLGIKLINDGTSTGIQNFSSGEILDSFSPVDGKLIASVKMSTQED
YEKVMRSATEAFKTFRMIPAPQRGEIVRQFGEKLRQNKEALGKLVSYEMGKSLQEGYGEV
QEMIDICDFAVGLSRQLHGLTMHSERPGHRMYEQYHSLGVVGIISAFNFPVAVWSWNTAL
AWISGDVCVWKPSEKTPLCGIACQNIIAQVIKENNLPEGISCLINGDYKIGELMTKDTRI
PLISATGSTRMGKIVAQAVAGRLGKSLLELGGNNAIIVTPDADIKMTVIGAVFGAVGTAG
QRCTSTRRLIIHESIYDKVKDALVAAYKQLRIGNPLDENNHVGPLIDTHAVEMYAIALNK
VVVEGGKILVEGGVLSGEGYESGCYVKPAIAEAENSFAIVQHETFAPVLYLIKYSGEVDN
AIEIQNGVGQGLSSAIMTNNLREAERFLSVVGSDCGIANVNIGTSGAEIGGAFGGEKETG
GGRESGSDAWKIYMRRQTNTINYTTSLPLAQGIKFDL
>EGALAKHO_01987 Pectate trisaccharide-lyase
MLFFASVQIWAQQINEASGWLESAFVKWQPVSGAQTYNVYYTGQGVTDKKIDDQLIRSYG
SYFRADIPGLQSGTYTVKVKPVISGVEGTGTTTGSLTVSAQDRNGFAFSGGRVPGGYKAD
GTPKDNVVILYITQNTKNTISMNITGASSNPCVGLQNILYAIKKGQDTRPFIIRLIGNIT
DMTVMEGGDVVIENSNNASSYLTIEGVGTDAVANGWGVRLKSASNIEVSNLGFMNCNSTA
GDNVGMQQDNDHIWVHNCDLFYGNAGSDADQIKGDGALDNKTSTYITLSYNHFWDNGKAS
LLGLSEGTTSGLYITYHHNWFDHSDSRHPRVRYYSAHIYNNYFDGVSKYGSGSTLGSSLF
VEGNYFRNSKHPMLTSLQGSDIWDEANQVNNAGTMGTFSGEAGGSIKAFNNTFDASNGTN
NMRFVAYNDPNPLYNISGKISSTTDFDAYVATTRGETVSSAVKSKSGANVYNNFDTDAAL
YVKNLVIDQPATAKTKTTQYAGRVSGGDLKWTFDNSVDDTSSLVITALKSALTNYTGALV
AVQGEGNPPTSSQTLTSTGNNNQTVTSGTAIASIVFTWGDDATDATVTGLPASGISFVKN
ATAKTITITGTPTTTLSYSIATTGTGTPATASGTITVNPAGTQTLTSTSNNNQTVSSGTA
IASIVFTWGGTATDATVTGLPASGISFVKNTSAKTITITGTPTATLSYSISTTGTGTVAT
GSGTITVTTGTPSGDQNHNFTTSGKTSSFYTITGNMNSTPGSVTYAGLTLTARLKIESST
SITYTTTSASTLTLVFDSNFTGTIKVNNVSYTASAGIVTASIPAGSNTITKGSVANLFYI
GTHYTGGTGRMTQPTEVVAEPEVAKIILYPNPVADVLYLTKSTQQIAQILIYNMSGTLVS
SAGKGADSIDLSGLIAGTYLVKIYTNDGSFNQTILKK
>EGALAKHO_01988 hypothetical protein
MNFNSKNPFLSDKRFSSNAVSKAEEVHEAKIIDYNQEMTLSGTINKTAILFLILTGAAMV
TWWMAFNGMNPVLPAFGGAIIGLILVVISSFKPQLSPYLAPGYALFEGLFIGGISAIFEI
KYPGIVINAVSATLVTFLVCLGLYKFKIVQVTEQFKSVVIASTLAIATYYLFSWLASLIF
NFTPVHYGNGMMSIGISVFVIIIAALNLFLDFDQIEKGVQQRMPKFMEWFGAMGLMITLV
WLYVEFLRLLSKLSSKD
>EGALAKHO_01989 NADH-quinone oxidoreductase subunit N
MNTLIAITGLGIFCLLFEILNLRKAIVPITILGLLGVLALNFSEFGSTESYYNNMITVSK
FSTAFSSLFIILTIFLVALSHNFYENHPTKISDFVAIKVFLLAGGVAMVSFGNLAMFFLG
IEILSIALYVLAASERLNLKSNEAGMKYFLMGSFASGIILFGICLIYGAMGSFDVVEISE
SSLSAELPIWFPIGMVLMTIGMLFKVAAVPFHFWAPDVYEGSPALTTALMSTLAKVVAIA
TLYKLISALNLIPSLENQELLGTFETIIVVISIASMTVGNIMALRQVNVKRMLAFSGISH
AGFMLMTLLTIATSAGVLLYYTAAYALAGIAAFSVILYVCKNQDNEDITNFHGLGKTNPL
LAAILTGSLLSMAGIPIFSGFFAKLFLFNQTIEAGYIALVIVAVINSIISVGYYFKLILA
MYSKEPNQERTGKPFLIYAVAIVSIALNIILGLFPSLVLDLLN
>EGALAKHO_01990 NADH-quinone oxidoreductase subunit M
MNVSLILIILLIGAFVTYFVGDKLASKVALFFSLAALGCSVVLLNHFCAGENISVINAWI
TQPKISFALNADGLAIAMLLLTVALTPIIIFSSFGNEYKNSKAFYALILFMAFAMTGTFL
AADGLLYYIFWELALIPIYFIALIWGNGDAEERRKAVVKFFIYTLAGSLFMLVAFIYLYQ
KAGSFLIEDLYKLNLSADEQLWIFLAFFLAYAIKIPIIPFHTWQANVYQKAPTVGTMLLS
GIMLKMGLYSVIRWQLPIAPLAAKEYMNVFIALGIAGVIYGSIVALRQKDLKKLLAYSSL
AHVGLIAAGTYTLTVDGLRGAVLQMIAHGFVVVGLFYAAEIIYRRFQTRNISELGGIRTQ
SPKFTSMFLILVLASVALPGTFNFVGEFTVLYSLSQINICFAVLGGTTIILGAYYMLKMF
QGVMLGETNSKIFADVTLNEGISLVVIIAVLIFFGFYPKPITDLITPSLETILSVINKN
>EGALAKHO_01991 NADH-quinone oxidoreductase subunit L
MEMDTNLALVLVLSPFLGFLINVFFGKSLGKTVSGIIGTVAVAISFVVTLILFNQITSTG
KAIQVTLFDWIQISNLHINLGFLLDQLSVLWLLFVTGIGSLIHLYSISYMHDDENMHKFF
AYLNLFVFFMITLVIGSNLLVLFIGWEGVGLCSYLLIGFWYKNQDYNDAAKKAFIMNRIG
DLGLLIGMFILGSMFSTLDYATLKTAIAGATNLNIPLLSLAALCLFIGACGKSAQIPLYT
WLPDAMAGPTPVSALIHAATMVTAGIFMVTRLNFVFDLAPDVQTVIAIVGAVTSLVAATI
GLVQTDIKKVLAYSTVSQLGLMFLALGFGAYEVAVFHVITHAFFKACLFLGSGSVIHGLH
GEQDMRKMGGLRKAMPVTFWTMLISSLAISGVPFFSGFFSKDEILMTAFHHSIPLYVIGS
IASIMTAFYMFRLMFLTFFKDFRGTEEQKHHLHESDGLITFPLMILALLATFGGLISLPG
NSWLNEYMAPLFTKVSGEEHHLGTTEYTLMGVAVLGGLIGILIAYIKYFKQDNVPESDEN
ITGLTKVLYNKYYVDEIYDAIFVRSINGLSRFFRDYVETSLSAVVFGLGKVTNELAFQGK
KLQNGSIGLYLFAFVLGLCAIISYIFLAQ
>EGALAKHO_01992 NADH-quinone oxidoreductase subunit 11
MGNILNQIGIENYIFLSVVLFCIGVFGVLYRRNAIIVFMSIEIMLNAVNLLFVAFSTYHQ
DAQGQVFVFFSMAVAAAEVAVGLAILVSIFRNLGSISIDNLKNLKG
>EGALAKHO_01993 NADH-quinone oxidoreductase subunit J
MIHIPDFAHATTVQIIFCFLAFITVITAFLTIFSRNPIHSAIYLVICFFSIAGHYLLLNS
QFLAIVHIIVYSGAIMILFLFTIMLMNLNERHQVHRPRITRLGAIVSFCLIVIVLITIFI
NSKPIVGEYDSTGEDFQSIKVLGKILLNEYMVPFEFASILLLVAMIGTVLLSKKEKLNK
>EGALAKHO_01994 NADH-quinone oxidoreductase subunit 9
MSIETISLSGRKKMVSNKEMTFWERLYLVAIVKGLLITLKHLFRKKVTIHYPEQVREMSP
VYRGQHQLKRDEQGRENCTACGLCALSCPAEAITMKAAERKPDEKHLYREEKYAEIYEIN
MLRCIFCGLCEEACPKDAIYLTTSKVLVPSSYEREDFIFGKDRLVMPLDVAIKNAQLNNA
N
>EGALAKHO_01995 NADH-quinone oxidoreductase subunit H
MMVDGTFIIEKSVVIVVVFAITMIMAMYSTWAERKVAAFLQDRVGPNRAGWGGLLQPLAD
GMKLFSKEEFEPNTPNKFLFVVGPAIAMSTALMTSAVIPWGDRLHVFGRDVLLQATDVNI
ALLYVFGVISVGVYGIMIGGWASNNKFSLMGAVRAASQMVSYEVAMGLSMIALLMMTGTL
SLKEISEQQAGMNWNVFYQPLSFLIFLICAFAETNRTPFDLAECESELIGGYHTEYSSMK
MGFYLFAEYANMFISATIISVLFFGGYNYPGMQWMVENVGVNIANILGIAVLFAKICFWI
FFYMWVRWTIPRFRYDQLMNLGWKILIPLSIVNIIITGVVILRHDIAAYLGF
>EGALAKHO_01996 NADH-quinone oxidoreductase chain 3
MKVTIDGQSIDVEPGTTILQAARMIGGDLVPPAMCYYSKLKGSGGKCRCCLVEVSKGSEA
DPRPMPKLMASCVTGCMDGMEVNSKSSDRVTEARKSVTEFLLINHPLDCPVCDQAGECDL
QNLSFEHGNPKSRFIEEKRTFEPEDIGPNIQLHMNRCILCQRCVQVADQLTDNRVHGVLD
RGDHANISTGISKAIDNEFSGNMIDVCPVGALTDKTFRFKSRVWFNKPYNAHRECTTPGC
CGKTTVWMFGGEIQRVTGRKDEYHEVEEFICNSCRFDHKNVNDWVIEGPREFEKDSVINQ
NNYTQKLEKVEIDTEKTILMGRDIDRKKISMAEIPLNTNNKIS
>EGALAKHO_01997 hypothetical protein
MNKIIFSVIFCLVSVTFYGQNYKGYYITNENDTIKCSFDIPVILFDSEKFDPQTVRNKIK
IVTDTGEKFSFKPNQIKSFFIKETKKGDYNFVSIANQNYFYHEIIKGKLSYLKVYLNNSG
GVLGYYASVRYFILKDGDLTELNSMNLKKGLSKQIKDYPELDLKWMDSNNYYKVNQIEEV
IELYNKHFNS
>EGALAKHO_01998 NADH-quinone oxidoreductase subunit 1
MSQKILLDKINVPGIKTYEVYRQNGGYASVEKALRTLTPDEVVEEVKKSGLRGRGGAGFP
AGMKWSFIDKKSGKPRHLVCNADESEPGTFKDRYLMEFIPHLLIEGMITSSFALGANLSY
IYIRGEYMWVFKILERAIAEAKAAGWLGKNILGTGYDLELYVHCGAGAYICGEETALIES
LEGKRGNPRIKPPFPAVSGLWANPTVVNNVETIATVPWIINNSGDDYAKIGVGRSTGTKL
ISASGHIKNPGVYEIELGLSVDEFMNSDEYLGGMSSSRPLKAFVPGGSSVPILPAELIFK
TANGEDRLMTYESLSDGGFATGSMLGSGGFIVYNDTACVVRNTWNFARFYHHESCGQCTP
CREGTGWLEKILWRIENGQGREEDIELLWSIQSKIEGNTICPLGDAASWPVAAAIRHFRD
EFEYHVRFPEKIKHRDHFVAEPFSQVKHLVGGKVIV
>EGALAKHO_01999 NADH-quinone oxidoreductase subunit 2
MERKHYKQEINMTEALMTRINELISHYPEDKRKSALLPVLHEVQDAHDNWLSTELQDKVA
EILHIKPIEVYEVVTFYTMYNQKPIGKYMFEFCQTSCCCLNGAENLMDYTSEKLGIKMGE
TTPDGMFTIAGVECLGACGYAPMMQLGDFYKEKLTEEKIDQLIADCRDDKIILHDK
>EGALAKHO_02000 NADH-quinone oxidoreductase subunit 4
MSELLLPPEHRYAKIINEKLNDDGSELSVLNLGPTHPATHGIFQNILLMDGERILEAEPT
IGYIHRAFEKIAENRPFYQITPLTDRMNYCSSPINNMGWWMTLEKLLGVEVPKRAQYLRV
IVMELARITDHLICNSILGVDTGAYTGFLYVFQFREKVYEIYEEICGARLTTNMGRIGGF
ERDWSPEAFRKLDVFLRDFPVAWQEFENLFERNRIFLDRTVNVGAISAEQAMAYGFTGPN
LRAAGVDYDVRVAQPYSSYEDFDFIVPVGKSGDTYDRFCVRNAEVRESLSIIRQALDKMP
AGNEYHAEVPDYYLPPKEDVYTSMESLIYHFKIVMGEVPVPVAEIYHPVEGGNGELGFYL
VTDGSRTPYRLHFRRPCFIYYQAYPEMIKGALLSDAIVILSSLNVIAGELDA
>EGALAKHO_02001 NADH-quinone oxidoreductase subunit C
MALENTLIQDKLTETFDASVFNFQQERDIFSIETTADKITALILFLKNDSDLRFHFLTDL
CGIHYPDNETDRQFAIVYHMHNWYENKRIRIKVYLSGEKPEIKSISNIFLSSNWMERETY
DFFGINFIGHPQLKRILNMDEMISFPMRKEFPLEDSGRTDKDDRFFGRTTTNC
>EGALAKHO_02002 NADH-quinone oxidoreductase subunit B
MSDSNVNMVAPPEGVVGEGFFATKLNDVVGLARANSLWPLPFATSCCGIEFMATMASHYD
LARFGSERVSFSPRQADMLMVMGTISKKMGPILRQVYEQMAEPRWVIAVGACASSGGIFD
TYSVLQGIDKVIPVDVYVPGCPPRPEQIVDGVMKLQELVRSESVRRRSSPEYQELLASYN
IS
>EGALAKHO_02003 NAD(P)H-quinone oxidoreductase subunit 3
MQSDQYSYIPILMQFILAVGFVVGTIIISGKLGPKRTSEVKDKNFECGIESVGNARIPFS
VKYFLVAILFVLFDVEVIFLYPWAVNFKELGMEGMLKMIVFMALLLVGFFYIIKKKALDW
E
>EGALAKHO_02004 Cold shock protein CspV
MRTGTVKFFNESKGYGFITDEETGKDIFVHASGINAEELREGDRVSYEEEEGRKGKVAAK
VAVI
>EGALAKHO_02005 Aspartate--tRNA ligase
MYRSHNCGELNASNINTEVTLAGWVQKSRDKGFMNWVDLRDRYGITQLIFDESRTDKTVF
ELAKTLGREFVIQVKGTVIEREAKNKNIPTGEIEILVSELNILNAALTPPFTIEDETDGG
EDIRMKYRYLDIRRNPVKNSLLFRHKVAMEVRKYLSDLDFCEVETPYLIKSTPEGARDFV
VPSRMNEGQFYALPQSPQTFKQLLMVGGMDKYFQIVKCFRDEDLRADRQPEFTQIDCEMA
FVEQEDILNVFEGLTRHLLKEIKGIEIDKFPRITYDYAMKTYGNDKPDIRFGMEFGELNE
FAQHKDFPVFNAAELVVGIAVPGAGNYTRKEIDGLIDWVKRPQVGASGMVYSKCNEDGTF
KSSVDKFYDQDDLGQWAKITGAKPGDMIFVLSGPANKTRAQLSALRMELATRLGLRKPEE
FAPLWVVDFPLLELDEESGRYHAMHHPFTSPKPEDMQLLETEPGKVRANAYDMVLNGNEI
GGGSIRIHDKATQQLMFKYLGFTEEEAKAQFGFLMDAFQFGAPPHGGLAFGLDRLVAILG
GQETIRDFIAFPKNNSGRDVMIDAPATIDDTQLKELHIKVDIQ
>EGALAKHO_02006 Thiol:disulfide interchange protein TlpA
MNKIFVTGLLLFGALNIFGQTKEQVKFSAKIANRNSDSLVIRGGGEFRKVIKIDKNGAFE
STFEAPKGFYNFSDGVESSSLFLLPNSEVNLTMDAKQFDETIVYKGKGVNESNFLAKYLL
DTEKFQEEAFKKEKPEFTKLLDEKTKADKETLNKGDFDPVFKAAISGSFDQFSQYAMEQY
ERTAQMKKLDGNASPEFDYENHKGGKTKLSDFKGKYVYIDLWATWCGPCRQEIPYLQKIE
EKYHGKNIEFVSISIDNAKDNEKWKNFVTAKNLGGVQLFADKDWGSDFVVKYGVTGIPRF
ILIDPKGNIVSSDAARPSSPELQVQLDSILN
>EGALAKHO_02007 hypothetical protein
MKKCVILVAILFSGILVAQEVKPELEAVGNKVKATYYYENGKVQQEGFFKDGKLDGVWVS
YDEKGNKVAVGEYTDGLKTGKWVFFNENNLCEVAYENSKVSSVKNLQKNALANRN
>EGALAKHO_02008 hypothetical protein
MGFKKQIRFLHKWLGLISGLIVFIISITGCIFCFHDEIKDITRKEWRFVEPQNKSFLMPS
ILQQKAKEILPKNTASMVSYYGRNRSAIVYTYSETENLYLYFNPYTGKYLKTENPKTDFF
IIVEYIHLYLLLPDYIGKHIIGGATIIFILLLISGIIQWWPKRKHDIKRSFTVKWSAKWR
RVNYDWHNTSGFYISLIALILALTGLTFTYEWVGDGIYKTFNFGGDKAVETKAPIIDTTK
FKTNSIIAVDRAFIETEKLQPKSEMFYVTFPHQKGDIINTGAYPHTLRYDHQSNYYFHPL
DGKLLQSDPYNKKTLGLQVVEMNYGIHTGQILDLTGKIIAFIVSLIASALPVTGFVIWYG
RRKKSCKKLKA
>EGALAKHO_02009 hypothetical protein
MSNRNYNIYFHTHTVSGIVISVVLFVIFFAGSFSFFRDEIINWERSESTALTKEIQLDYN
TALQKLDKQYVLHGRNITISKPSTERRVAIYMEGTKDTLAPAKQKEGSFFYLDTKSFKTY
TYEESYSLGEFLYRLHFLAQIPYPVGYYLSGFIALFFLFAIITGVLLHWNKIVSNFYIFR
PKEKLKTLWTDAHTALGMIGLPFQFVYAVTGAFFMIKLLIVAPAVMALYKGDQDKLYKEL
EYTDPDYKFENKKLANPFNIDQLVAKTKSNWSDFEITRVFIQNYGDANMHVLVEGEIPNH
KKFTGIGKVIYRIADGKEIARKNPITQTNYLDVVKNVLYRIHYGDYGGYALKIVSFILGI
ITCFVIISGVMIWLVARQKNNMPEKKRRFNAAVVRIYLAICLSMYPITALAFIVTKIFYP
LTQENLYTFYFVGWLILTLFFILKKNDAFTNKFCLISGSILGFLIPITNGIVSGNWFWTS
FMQNKIQVFVIDVFWIVLASISLYVAYHLKPQKETVVEK
>EGALAKHO_02010 hypothetical protein
MPANPKYLTQSKWQRFAKITAAILGGYFVSVTFHLALASWFNRANILMTMAFTGFILWVA
LMVIAFLAKSGWKIWGIYILLTLIFSLFIYLGQTYNPMTQ
>EGALAKHO_02011 hypothetical protein
MITIASLIVFLAFYTLYYTSKRATLSYDLGFEKWMKNNPKQTKITGLLLLLLAYSVWLFT
QSLCCGTLMFFIQLMAIGSLIIILKPLKKVNSIALLLLFIIIALLEFYYY
>EGALAKHO_02012 Ferripyoverdine receptor
MKYKFTIYFLSFFVFLLASTSTWAQEKATIKGQISLANNQAADNVSIVLKGTKIGTNTDD
NGNYEIKNVKPGSYVLRVSAVGYSSKEKSLTLNGGDEVIENFTITSNSEQLDEIVVSGGS
KKNPLARKETQQVSRLPLKNLENPQVYTTITSELLKEQVVTNIDDALKNAPGLSPLWAST
GRGGDGAGYFSLRGFAVQPTMINGLPGLTNGSIDPANIDKIEVIKGPSGTLFGSSLISYG
GLINLTTKKPYDHFGGIVDYTAGSYGLNRVTVDVNTPLDEEHKINVRVNSAYHTENSFQD
AGFKKSFFFAPSLSYQVNDKLSFFINTEFMNNKATNPTMLFLDRGAPLRVHNIDELGYDN
KRSYTSNELAIETPSFNLQGQMNYKFSDQWSSQTVVSRGSSKSEGYYSYIYEGTQSAPAA
ISEGIVLARYMNYQNSTTLTTDIQQNFIGDFVIGNMRNRIVAGLDYFNRGAIDNGSGYVG
NGLIYIGNLDLKTVNENLYGITDPAKYITNGDSGKLTKAGSDALLATAPMNNNKTKQEVY
SAYVSDVINFTPGLSAMASLRVDRFMTEGDVSTNADDYNQTSFSPKFGVVYQPILDKVSI
FANYMDGFANTAPVNDVLPDGTSQPRTFSPEHANQFEVGTKLNIFQDKLYATLSYYDIKV
TDQVYTVYTATTQTSYQNGGQRNKGFEAEFVANPITGLNIVAGYSYNDALLTAGDPDFVG
HRPESAGPQNTANLWASYKFSEGDLQGFGLGFGGNYADKNKIMNRTLTGQFTLPSYTVLN
SSIFYGTEKYVLTLKLDNIANIDTYDGWSTIHPKNMRSVSANFSYKF
>EGALAKHO_02013 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MILEMKVPSPGESIKEVEIATWLVKDGDYVEKDQAIAEVDSDKATLELPAEMSGIITLKA
EEGDTVAVGAVVCLIDTDAAKPAGDAPAAPAADAPKAEAPKAEAPKAEAPKAAPAPAATP
AATSYAAGTPSPAARKILDEKNIAPATVSGTGKGGRITKDDAVNAVPSMGTPTGGSRGSE
RTKLSMLRRKVAERLVSAKNETAMLTTFNEVNMTPINQIRNEYKDAFKAKHGGLGLGFMS
FFTKAVTRALQLYPDVNSMMDGDYKIAYDFADISIAVSGPKGLMVPVVRNAELLTFRGIE
AEIKRLALRARDGQITVDDMTGGTFTITNGGVFGSMLSTPIINPPQSGILGMHNIIERPI
AVNGKVEIHPMMYVALSYDHRIIDGRESVGFLVAVKEALENPVELLMNGDAKRALEL
>EGALAKHO_02014 2-oxoglutarate dehydrogenase E1 component
MDRFSFLNAAHTEFFAQLYDQYLVNPDSVEPSWRSFFQGFDFGMTTYNDENPVQQIVEYV
TSDNTDYSKVSEKLQKEFNVLKLIDGYRTRGHLFTKTNPVRDRRTSSPTLDIENFGLTTA
DLSTVFDAAKTIGVGPSTLQDIVTRLKSIYCQHIGIEYMYIRNPGVVKWIQDKLAVNVNQ
PNFSTEEKKTILNKLNEAVSFENFLHTKYVGQKRFSLEGGESIIPALDALIEQAAEKGVE
QFVMGMAHRGRLNVLANIFGKSTQDIFGEFDGKDYDQEYFDGDVKYHLGLTADKKTRSGK
SININLAPNPSHLETVGAVIEGITRAKQDKYYADDFSKVLPIAVHGDAAIAGQGILYEII
QMAQLDGYKTGGTIHIVINNQVGFTTNYLDARSSTYCTDVAKVTLSPVLHVNADDAEAVV
HAVSFALDYRMQFGRDVFIDLLGYRKYGHNEGDEPRFTQPVLYKIIAKHKNPRDIYAEKL
LSDGVIDASYVNALEKEYKSDLEQNLEASRKKDLTIITPFMKNEWDGFVQVTDTQMLQKV
DTTFDKKGLDSIINTISTLPEDKKFINKITKIVTDRKTGYDNNTLDWGTAEALAYGSLLT
EGFDVRISGQDVERGTFSHRHAVVKVEDSEEEVILLDAIENKKGKFGVFNSLLSEYGVLG
FDYGYALANPNALTIWEAQFGDFSNGAQIMIDQYISCGEDKWNNQNGIVLLLPHGYEGQG
AEHSSARMERYLQLCARQNMYVADCTTPANFFHLLRRQMKTNFRKPLVVFSPKSLLRDPR
CVSSVEDLATGSFQETIDDNTVDKKAVKTLVFVTGKFYYDIVAERENNGRNDVAVVRIEQ
LFPLPVEQLKAIIAQYPNADDYVWAQEEPKNMGAYSFMLMNFDLVKWRLASLKAYAAPAS
GSYTRAKRRHADAIRMVFDKNLFR
>EGALAKHO_02015 hypothetical protein
MAKVQQSHLFKSFFYVLLRKNLLKIDLTMKKNQISIVFKSFFVIMTVFFSSYVSAQQNYT
INNSNDFWDKVQFGGGLGLGFGSGYTDISVMPSAIYNVNEIVSLGVGLQFGYLYQKDYYE
SFVYGASFLTYVNPIPQIQLSAELEQVRVNADYKETYYNPAYSDDFWNTALYLGAGYRTG
NVTIGARYDVLYNPNKSLYGSGFMPFVRAYF
>EGALAKHO_02016 hypothetical protein
MFVAPINTESLLAEAQAETLYLKLIEQINKDFNLANEGIDFPLSISPEELKIQLHEKIYR
MIQYKFAEYLNLLYIIDVSEIEIKKLDGSDLVILAEQVSFLVLKREWQKVWFRNYYK
>EGALAKHO_02017 (2E,6E)-farnesyl diphosphate synthase
MHDISQYQEFFINYLENQSIDKEPKNLYEPITYILGLGGKRMRPVLTLMAAEVFDADYKA
ALPAAMAVEVFHNFSLVHDDIMDDAPLRRGQVTVHEKWNINTGILSGDAMLILAYQYFEQ
YDPTIFRDLAKLFSKTALEVCEGQQWDVDFEERNNVTIPEYLKMIEYKTAVLVAAAMKMG
AIVAKTSEKEADLIYDFGLNLGLAFQLQDDYLDAFGDPETFGKQVGGDIIENKKTYLYLK
AIEFSSEEKATELQQLFELQLEDNAEKIETAKAIFNKSGASKATQEAIEMYTFKAFETLD
KMDINTEKKDILRTFGENLMGRKV
>EGALAKHO_02018 Protein YceI
MRTTWTVDSSQSDVLIKMRHSIIAYLGGTTNKFDGYVNIEDNEIEDASVEFSLDINNKND
SFQHVDSHMQLNDLFNVNEHPIISFKSTSFQKINDNINFFKGDLTIKDVTRVVELDAEFI
GINSYNGQKKVAFEIKGDIKRQDFGLDYNAFNFNGGLALGKDIKLIANLEFSI
>EGALAKHO_02019 hypothetical protein
MKEKIISKASELFLRLGFKSVTMDDIAGEMCISKKTIYKYFCNKEVLIEESTSMVHKQVH
EVIDTIVAKNYNAIHENFEIREMFREMFKNATDTSPLYQLKKHYPEIYQNVMTHEIDQCN
HYFKDNILKGISENLYRADLNIDIYVKFYYTLIFHINATTVSEREAQKIELEALEYHTRA
MATEKGIIELEKQLKKFST
>EGALAKHO_02020 Outer membrane protein TolC
MKRIILIFLCSIGLTANAQVKTLTLKEALTYALQNKADAKKSKLQVENSEYQIQEIRSRA
LPQISGNASLTYNPILQTSVIDGGSFGQPGTSIQATFGQKWTSGAGLSLSQALFDQSVFT
GLRAAKSTREFYQINDQLTEEQVIERVANNYYGVYVQRERLILLDSNYVNTTKVRDIVQG
QFDNGLAKKIDLDRIIVKMSNIDTERQQIKNQITLQENALKFYMGMPIEAQIEIPKEEFE
VVPAALTEVPNVENRTEYLLLKKQEELLVYNKKATEALYYPTLNLVAGYNYLGQGPEMPL
FGKPRDGVYWSDYSAIGLNLHVPIFTGFGTRAKVRQADVEIRSLQEDIKDTKLSLDLDYR
NAMAQIENNLITINNQRENMRLAKEILSDTKNNYLQGLASLTDLLDAENESLEAQNNFTR
AVLNYKIAEITLIKSKGELKTLIK
>EGALAKHO_02021 Multidrug resistance protein MexA
MKKTIITIVIIIAALGVIGYVLNNNKKENKAKTDIVAEKNAAVSVKISPVKTEEVSLDFV
ANGNFQPIQQLTFSAEKSGKVISVLAKEGDYVKVGQTLLTVRGDVINVNAQQAQAVYANA
KSDYARYENAFKTGGVTKQQLDQAKLALTNAQSSLTQANINVGDTRVKAPINGFINKKYI
EPGSILTGMPATALFDIVNVSKLKLVVTVNENQVASLKVGNTINVTASVYPDKNFSGKIT
FIAAKADESLNFPVEIEIANNINNDLKAGMYGTANFASNQQKQHLMVVPRNAFVGSVSSN
EIFVAENGIAKLKKVTAGRILGDQVEIINGLSDGEKVITTGQINLQDGNKVEIIK
>EGALAKHO_02022 Multidrug resistance protein MdtC
MKLAEISIKRPSLVIVLFTILTLGGLFSYSQLGYELIPKFEQNVITISTIYPGASPSEVE
NTVTKKIEDAIASLENVKKIDSKSYESLSIVSITLTSNAKVDFSLNDAQRKINAIISDLP
DDAETPSLTKFSLSDLPIMTLGANGKMDEAEFYDLIDKKIAPILSRVQGVAQVNIIGGEE
REIQVNLDALKMQGYGLSIPQVQQNILSSNLDFPTGNIQTRNQKILIRLAGKYKSVEELR
NLVVSSQNGIQVRLSDIADVQDTQKVAEKISRVDQKSAIVLQIVKQSDANAVAVSEQLLK
TIAILEKDYEKNHLKLEVAKDSTIFTLEAADSVVHDLLIAVILVAFVMLFFLHSIRNSLI
VMVSIPASLIATFIGIYLMGYTLNLMSLLGLSLVVGILVDDAIVVLENIYRHMEMGKSRI
RASYDGTAEIGGTVTSITLVIVVVFLPIAMSSGLVSNIITQFCVTVIISTLLSLLASFTI
IPWLSSRFGKLEHIEGKNLFGRVILGFESYLTRFTNWVSELLTWCLDHYVKTILVVLVLF
FGSTIGLMGGGFIGGEFFASSDSGEFLVQIEMPKDASLEQTNFMTQKAEAYLKAQEYVHS
QITTVGQTSEGFGASQATAYKAEIDVKMIEQKDRTDDANVYAAKIKRKLEKVLVGAKVKT
VPVGILGTAEDATLGLIVTGPSTEAAMAFAKKAEAELRTIPGTTEIKLTVEDGNPEINVK
VDRDKMAALGLTLQTVGLTMQTAFSGNTDGKYRAGEYEYDINIRYNAFDRKSITDVSNLI
FINAAGQQIKLSQFATITEGSGPSQLERRDKSASVTVKGQNVGVPSGTIVTQWQAKLDKL
QKPAGVNYIWGGDQENQSEGFGTLGIALLAAIILVYLVMVSLYDSFVHPFVVLFAIPLSF
IGAMLALALTNNSLNIFTILGIIMLIGLVCKNAIMLVDYTNQRRAAGESIRTALIQANHA
RLRPILMTTIAMVFGMFPIALASGAGAEWKNGLAWVIIGGLISSLFLTLIVVPVIYNIME
KIIAKVSKGEKIDYEAEMVADYEHTELSEDGFNPKHTH
>EGALAKHO_02023 hypothetical protein
MKKTLLCFLFLFTTVFYAQVSDIVHCPGDNNFDLAKQKPLLIGNLNPDETIVSFHLSLAD
ATTNANTIANPSNYNASTGSTTIYVRIDNNGTITTNSFNIKVVAALNIIATNTSILCAGE
KASLTVTASGGGGQYYYSLNSGSFTSNNVFNNLTAGVYTIQVLDAVAGCTTTISHIINAP
GIFNATTMVSGQMATITAIGGIAPYQYSLEGINYQFSSFFPNLTPGNHVFMVKDSNGCIV
AVPATILPALTTTAFITKEIDCSVNSNASITVDAAGGQSPYTYSFNGGPFQAGNNFSNLT
AGTYTITAKDAVNTISDPTAITIVPPVAVNATAISTNPTNCSIGTITAMATGGKAPYVYS
FDGGMTFISSNVFSTPYPGIYVIIVKDSKGCLSSSFTTIIQPATPLVLTASNTSISCNGG
NDASLTINVNGGKAPYQYAINTGVYTSSNIFTSLNAGTYTLKVRDAAGCVNTLLYTITEP
SAVNANMIIDGNTISILDANGGTGSYQYAIDNGNFQVNNVFTNVNPGIHQVRVKDSNNCE
PGSFWAEIAIPITAAISITKPIECTSNAEITVTATGGFSPYIYSIDGGATFQASNLFTNL
IAGTYSVTVKDNDDKLYTKSITISPLIPIYADFLIDKQTLTINGQAGTAPYQYSVGGSPF
QTNNIFTNLSPGVHQVYITDSKGCQSLAFQVTIENVNQLTASVAITKEIDCISNAVIAVN
ASGGTAPYSYSINGGANFQVSNVFSNILMGTYSIVVKDANNALVTSNNITILPLSLPLIS
VTKINPSCYQAGNGIITVQAHGGKAPYLYSIGGSYASSNVFTGLVAGTYNVTVKDANGCL
STNSLTIEEPLPITATTSIANSTTINDNNGKITVTATGGVYSYTYALTNFNGIIIRAFQS
SNIFDGLQAGLYGVQVKDANGCIASKTNISIINKINNLSATVITQITCNNPFATLTVTAV
GGTIPYQYSADNGITYSALNVFNFTSGSYTLKVRDADNNTATLTATITDQIAPSFYYNTY
KGICSTSDQDRGGITIAASGGQPPYTYSFNGGPFVVHEDLYEGLEPGTYTFSIKDANGCT
SATQNFTIEEPDPIISKVIIDNQTITVKALGQGRSYEYSLDGINFQSNNVFANLKKGTYT
VYIRDYRGCTATHSDIIIYEPTSLTANFEITPLTCDSTTGKLNIIALGGIAPYQYSIDNG
NTYTSSNLFTGLFPGSYAIIVKDAQNTTASSIAVIKPIELLAVTAVVTKGIDCLSNASIT
VNAIGGNGPYTYSIGNGYTTSNIFNNLTSQTYTISAKDAFGCIATTSTTILQPTILSLSN
IGTNSKTLGSSDGSITITASGGTAPYQYLLKYENGSQIVGPQSSSVFTGLVVGKYTIEVT
DAAGCKVSKSGILISSDTIFGTLMITPLTCTTLGIITINAAGGKYPHQYSFDNGITYGSS
NIASNLQAGTYTIKVKDAGGDILTLSTSLSAVNPVVATTAITYPIHCNGSNDAVIQITAT
GGKAPYFYSINGSPYQSNNTFSNLYAGNHIITVKDSNECSSVTALAIAQPAVLVSSIEIA
NQTVTVNSTGGTGPYQYAISPNLNVFSTSNTFPNLTPGTYRVITSDVKGCFVIMDAIVDP
IAPTINGQDKLTVEFKAGQTLADLTPEGQDIKWYSTPNTLEGKTSKTKETPLPLSTVLVH
GTTYYASQTINGIESKERLAVTAKLNGALSTPDFVLSNFTCYPNPVQHSLTINNTAVIDE
VEIFSVNGKSILAKKINSEHSEIDLSSVSSGVYLLKVKSEGKTKTVKIVKK
>EGALAKHO_02024 hypothetical protein
MENLHELLKKKSYKKIKFKVTKTQHLLIKAKINGVSGDFILDTGASNTCIGFESIELFNV
TAKKSKTKASGAGGTGMRTQISIQNQLQIGSWKSANFSIVIFDLSHVNEALEAYKTKAVH
GIIGADVLLEGKAIIDYYNHYVYLRL
>EGALAKHO_02025 hypothetical protein
MNSWRKILNMTKLYCYIFIFFTLILFGQKPLSQEDKIYTAIDVFVAHPSAKALQNLTKTE
TDFWKNPQPKTKDELLAIVVLNCNKAYYENQFGQTEKAVSSYEKAWQIYQKKKLSNYDII
EFCLKPLGNLYTVLGDYDNAENTIKQYFFIVNTTKNYPDAAKQKFAAILNLSNVYQSSGK
TSLAIELLENTLKTEKLSNVQKGILFNNLGNSYLLSSGGNLLMPGIIQKAEKAFESSIKY
LQNEKDQLETLSNSYRNLATFNREGRNHEIANLYLEKAEKLFLQTSNQQPRKLAKLYYEK
ALLLFDEKKYEESSKQVAVVFKTLIPNYNSKNILPDQNQLYAETVLLDALDLQGEILKIN
EPQKALKAFDLSFYIEDLLMNSLIYENSKILMQLQSRNRTEKCIMIYDELFKKEGETQYL
EKAFQLAEQTKSGILRSYRSTIKSASTEEKELLQQLQNLNNAIVKEQQKAGLANILKINQ
LIKKQSELILSLKKIKSKSQDYIPEKCDLKSLLKKLENDKAIMVYYFMGAKKLYSFVLQH
SRVTLDEVRIGHGKIINILFFIDYFNNSSSITNDIAGYNRSGKVAYDLLKLPSNVIYKNL
IIVPDGILNFLPFEALITKESNTTNFAKMHYLLNDFNIAYNNSANMYLNSKPISKSEKTV
LGIFPIFEKTAFELSYSKKELESIRNNFKGKYLKNSAANFYNFKNNAPNYSILHLSTHAS
SGDIETPASIKFYDQEILYSELYNLNINPDLVVLSACETGIGKLYKAEGAMSVARGFQFA
GAQNLLFSLWKVNDYTTSVFMTDFYKNVKNDVPYFEANADAKIAFLNDKSIPNAKKSPYY
WSSFVYYGSISQEEKPSNYIYYIISLLIVIGLFLIFNHYQKWKIFTSFSKKRATKK
>EGALAKHO_02026 hypothetical protein
MKPQLSIFFILFTILSIGQTKVKDTITRRANIGFIQNGNAVTFKPETPPLIPIAGAPKPS
YSYLWELGDGHYSKEAEPKHVYKNKGTYTTRLAVTNNYDNGKPPATRPKKVAVNDITDTN
YKDIASIEDQNGFAIIKNCDPIPEQEMVVVVGYQNLENYVASGKLYLFYNEKQFKNNNFE
LVDFRTYANEREVKQNTVASVDDLDDSKNYLASAENTIKLKKYRNTTAEEDLDASLLEAN
KLYHNVNVLEFDDTNPGETHNVFYTFKTTPEMIKDTSATVTMRGIFVPNRSYKNHKIKNL
EMEIVTSHDPNKMGSNGSFMNYRLVRFKRVNFKTRFQNNGEGPARMIRLETDIPDMFDKK
TFQIEDMYPKCPICPKDEEPTVSCLDTIIKQKQIFFTFKNIYLPGSEQKNIHEKDSTKGF
VKYSMKFAEDFHKVKTRSRTAIIFDKNEPIITNYATTRFLPGISIGAKAGYNLYPDLEKS
TSYFVGATISPFKSYRFYWQAEWLNALNKYDSEVNIQNVINTTANGVRQLVRTTTETENK
NVNWEVPLLIRYNINNYIGIGAGIQANINVSEEQNQNIKVETFEGDKESFLISTTTTSNT
VKNSFADFKTGLLFDLTAGFARIGPSFGARYVINFEQNFNYFQFYGIWKF
>EGALAKHO_02027 hypothetical protein
MNTKFKTISLLFLLVITLVSCDTNSDGDDIIISPPTSAAFKGITEKGIKRNTQNFTITAG
AGVVSFTSAKGVKVNINGNCLTKNGNPVTGTVDIEYIELFDKGNMLVTNKPTMGITADGK
KNLLISGGEVFIKATQGGVELQNSCTMNMMIPTALTDGLDNAMTLWTGVIDEKGELAWRD
ANKPNADGTGGKGGVQGEGNNYYVTFGNFGWTNVDRFYSDPRPKTTILADAPDGYDNNNS
AIYLSYDGEGQNALAKLDTYTAAGLFSEHYGQIPIGLACHVIFVTEDNGNWRYAIKAVTV
AANDVYTFTLAETTVGTEAQLVAAINAIQ
>EGALAKHO_02028 hypothetical protein
METYQFTNKKNLDQFYELISAKKRNGFVIIEHNEKLPYVVLSKEKKAIKHSFHLFLTCLT
FGLWSIVWLYLIVTLSRKKNILVAVDEDGNLFEDKCLSA
>EGALAKHO_02029 hypothetical protein
MGNNKIHPDQMYIEGLAANDSAIIQSIYKKFVPKVVFFVMNNSGDKEQAQDVVQEVMILL
FNQAKTNTLKLTCPFDAYFFLLCKRKWLNEFKKTSNKGVTIHEDIVSMNESALDLIGQTE
EFDEKQQLFDTMFQKLGDKCQELLKLSFSIKSMEEVAEKLNVTYGYVRKKKSLCVGQLTQ
WIQEAKNFNSLKNN
>EGALAKHO_02030 hypothetical protein
MNEERYILFDQYLQSEMTAAEKTDFEKQLADDPEFASEFETFKAVELQLQNKFGFEAERE
AFKENLSQIAEKHFNKEKPKVVLMRPWYLAAAASVIILFGLFFFDYNQNPSFNDYNHPGQ
AHFTERSTTDMHLLQAEKAFNSRKFKEAILFFEMALKDNKTPEVQYYYGVSLLETSEYQK
AEAVFNELITSSPIYKDKSLWNLAIMKLKQKDYKGCKQILQTISQDYEDYDEVQELLDAL
D
>EGALAKHO_02031 hypothetical protein
MKKIALFFLLVLSQITFGQAKITETEKLAATCKVWGFLKYYHPKVASGELNWDNQLLEKL
PKIEKAQTKEEFSLILENWIDDLGTIKEIAPIATPKGVEYFDKNFDLSWINSNKLFSKKL
SKKLKFIENNRFQTEEEIGPGYNPLKNGNYFDLKFDNQNSRILWFCMYWNLVEYFFPYKY
LMDQKWDRTLGQTLPLVLNSQSEDEFLKAMRKTSTNLDDSHVEFVIYKNGIFNEDRKFFP
ADCKIIDNKMVVTEIFADSLAEADNIKVGDVITKVNDKTITELIVEYRDLCTASNEPALL
DKIVKKILNGYSANVNVEFLKEGKYSTKAMTWYDYHDSHRNEFKKGAKKKKEKFKILDNN
VGYVNMGVLKIANVPNMIETLKSTKAIVFDLRNYPNGTFREISNFLNAHEEKFAIYTYPD
FSYPGRFKWQNDGTKSGSENKDNYKGKVIVLLNEESLSQSEWTAMCFQTAGNTTIIGSET
AGADGNVTELDFKEFHTRYSGVGVYYPDKRQTQRIGIVPDIKVKPTIKGIQEGKDEVLDR
ALLFIETGK
>EGALAKHO_02032 putative metal-dependent hydrolase YcfH
MNSTPIITDTHTHLYSEEFDQDRDEMVQRAINAGVKRFFIPAIDAAATQSMYDLEQNYPD
YVFLMMGLHPTYVKDNYEEELNHVETELAKRKFYAVGEIGIDLYWDKTHLKEQQIAFRRQ
IQLAKQYKLPIVIHCREAFDEIFEILEEEKSDDLFGIFHCFTGTHEQALQAISYNMKLGI
GGVVTFKNGKIDQFLNQIDLKHIVLETDSPYLAPIPYRGKRNESSYLVNVLAKLSYIYSI
SEEEIAEITTQNSKDVFGI
>EGALAKHO_02033 hypothetical protein
MQRFDAIRPFYDSEINEALRDVVNHPMMKTMMNFTFPEVQDEVWKEQLKKTHSIRDFQCN
FIYNTIQKVLEKSSEGLTTSGFEKLEKNTSYLFISNHRDILLDTTLLNVCLFEHGLVMTA
SAIGDNLVKKAFLSTLAKLNRNFLVLRGLTPREMLQSSKLLSEYMGQLLLRENRSVWIAQ
REGRTKDGNDETNPGVLKMIGMGSDEANLMDYFKKLKIVPVSISYEYDPTDVLKMPQLMA
EAKNEVYIKEKNEDFMTILSGIMGTKKRIHISVGDVLDTEIDQIVAENDNANKQVQALAQ
VIDDSILKSYRLWPTNFIAYDILNQTDKFSHLYRESEKSLFERRLEMRIGSDNPVTRNGF
LCMYANPVVNKLKYQDVI
>EGALAKHO_02034 L-asparaginase 1
MSSKAKILLVYTGGTIGMSKDFETGALKAFNFGKLLQKIPEIKQLDCEIETVSFEHPIDS
SNMNPEMWTKIATIIEQNYVAYDGFVVLHGSDTMSYSASALSFMLENLTKPVVFTGSQLP
IGDLRTDAKENLITAIQIASLQENGKPVITEVCLYFEYKLYRGNRTSKVNAEHFKAFTAP
NYPELVESGVHLKLNRHLFLPIKQDAKLIVHKNLDNHVAIIKMFPGMSEVVLSSILAIKD
LKGIVLETYGSGNAPTEDWFLNLIEKAIQSGLHIVNVTQCSGGSVNMGQYETSTALKSLG
VISGKDITTEAAITKLMYLLGHNIQQNEFKNVFETALRGEISL
>EGALAKHO_02035 hypothetical protein
MFKALKSKNFKLFFYGQSVSVIGTWLQKTAVSWMVYSVTGSVFLLGLATFLSMIPSLFLA
PIAGSIIGRYDRHKSMILLQSLAMFQAGALALLIYLKIYNINFILALSLFQGIINSFDMT
CRQTMMIDIVNDKEDLANAVALNSTLNNFARIAGPALAGIILHQYGEDICFIGNFLSYIP
VLISLFMMKITPHIKATDKLKMWDDFVEGLDYVKKETEMTKMLLMLMVSSLFVISFNTLM
PVFAKDIFSGNAQTFSWFESAAGIGSIVSAIYLANLKKSDNMNKIMIAASLLLGFSIIIL
AYSNSLTVALICMSLSGIGMMAQTSSINIYVQTQSTVNMRSRSISYYLMAYQGMIPVGSL
IIGYVSHIIGTRNTVAIQGIICIISVIVYVYYKRHTSEEELETCPVPYRNSKN
>EGALAKHO_02036 HTH-type transcriptional regulator CynR
MEIYQLEYFIKTAAVLHFTKAAELCFVTQSGLSQQIKKLEEELGMPLFVRIGKKVQLTEA
GSVFLIHAKQVIENVQSGKQAIDDLNQLIGGELRIGVTYIFGLLVLPIVDLFAKTYPHLK
IVVEYGTTEPLEQKLLNNELDLVLVISSNEIELPFQKVPLFTSKLVLAVSKTHPLAVLDK
ISFKKIEDLPLILPVKGFNSREFLDELFLKNNMKPTVSIELNAVHALLRLVGDSDYWATI
VTEKALKGWDNIKSINITGVATQRDSFMLTIEGAYQKKAVKLFMEEFRKSM
>EGALAKHO_02038 hypothetical protein
MNFFKTTNEDIDAIFNIYNEATAYQKTVNNKSWRGFEKALIEKEIKENRHFIIKEGNEVA
CTFVLTFDDLIIWKEASADPAIYLHRIATNPKFRGQSYVKKIIEWAKIYAKENGKQYIRL
DTHSGNERINKYYTSCGFDYKGISTIEWTNELPEHYKEGSFSLFEIKL
>EGALAKHO_02039 (R)-stereoselective amidase
MKNLKIATAQFENKSGNKKYNLSVIERLSQKASNEGCNIISFHECSITGYTFARHLSKEQ
MLDLAEVIPSGESILKLIEIAKKHDIIILGGLFEKDENDNLFKAYVCVDKNGLVAKYRKL
HPFINPYLTAGDEYCVFEIQGWKCGILICYDNNIIENVRATKLLGADIIFMPHVTMCTPS
TRPGAGFVAPQLWENREADPTSLRLEFDGMKGRDWLMKWLPARAYDNAIYAVFSNPIGMD
DDQLKNGCSMIIDPFGDILAECRTFDDSFVTAIINAQKLTQAGGNRYIKARRPELYRDII
GQNHQSEQNVVWLNSNEKS
>EGALAKHO_02040 HTH-type transcriptional activator RhaS
MQVLPSRELSPYIKHYLFLDNAATDIQKLRLFSDGNTGVVFSFKSKIISGIHNYEIKNYL
PTSFLYGQLNGFKDIYSNAEISLIIVVFQPNGIYRMLGIPAHEFLDSIISIDAVFGKNGL
FLQEKLAEHNNHQTKTDLLNHFFSTQFSKKLQSNQSIINSSLDFIISNKGNFSVKELVHY
IGYTERHLERKFKESIGLNPKKFGNIVKLHHFLKLLKHKSEDLNLTTICYDAGFSDQSHL
IKEFRKHTGITPTEYLYNTGKLANNLIQTPPLFTL
>EGALAKHO_02041 hypothetical protein
MKPQHFKQIVIVILSIFLLSCSAEETSSEMAVTPTPVIPPTTQIPTTPISGSTNYLALGD
SYTIGQSVCETCRYPEQLKTSLKALYPESSFSLKVIATTGWTTTNLISAIKTQNPDSNYD
LVTLLIGVNNQYQGRDFSIYEKEFPELVTKAITLAKGDKKNVIVLSIPDYAYTPFGKMTM
NQETISNEINKYNTFAENYCTMNNVTFVSITDITRQGLNNPGLVTTDGLHPSELAYKMFV
ERMLPKVKMALQN
>EGALAKHO_02042 hypothetical protein
MNIETINNSIQPQKEQLLQHSLYNKIQSIDDLHIFLESHVYAVWDFMSLLKALQAKLTCT
TTPWFATKNPETRYLINEIVLAEETDLTIDGRRQSHYEMYLEAMEDCGADTSGINTFLAE
VHSLHNIFVAIKQSTLHPNIKAFLDFTFRVIEEGKPHEIAAAFTFGREDLIPSMFTAILK
NFQENLPETDLSKLLYYFERHIELDADEHGPMAMQMITDLCEDDAQKWKEVEEISILALE
KRIGLWNAIEEEILMKAEMV
>EGALAKHO_02043 Acyl-CoA dehydrogenase
MKPDLFQAPDYFNLDDLLTDEHKLVRESARAWVKREVSPIIEEYAQKAEFPKQIIKGLGE
IGGFGPYIPVEYGGAGLDQISYGLIMQEIERGDSGVRSTSSVQSSLVMYPIWKYGNEEQR
MKYLPKLATGEFMGCFGLTEPDHGSDPGSMITNFKDMGDHYLLNGAKMWISNAPFADIAV
VWAKDETGRIHGLIVERGMEGFTTPETHNKWSLRASSTGELIFDNVKVPKENLLPNKSGL
GAPLGCLDSARYGIAWGAIGAAMDCYDTALRYAKERIQFGKPIGGTQLQQKKLAEMITEI
TKAQLLTWRLGVLRNEGKATTAQISMAKRNNVDMAIHIAREARQMLGGMGITGEYSIMRH
MMNLESVITYEGTHDIHLLITGMDVTGIPAFK
>EGALAKHO_02044 hypothetical protein
MRLIISFLLLFVLNIGFAQKKQISEQEYLTLQGKIRLHFNANVDSALVYARQMEKSDNNE
HLAFANGVMSVLYQAKGDKKESLKRYKTAFYYLEKMPESRNKIQMLSYVYNYGGIAEWRR
GDFSKALEYYQTGLKFSNQINDIKQIVKIKGNIALVNENVGNYQLTIKNLKYLTDFVDQN
EGVFTKVEFLNHKSNYNLGLGSAYEGFFMKKSTKRYLLDSAEYYYKKAINYSQNLTENKI
SAQLSLGNVYNWKHDFKNAEKTYYDVLFLAQQNNQTGLMCTANYNLGDIYYTTKKYDKAL
VFFKKSDSLASITGNKLEYLKSNYYQAKIYNILKQPDLAYKHSRIYLDNYENYEAKINEE
ALEVNYKQGVDDLAVEMVSIEKKYKSEVFLNRGLKVFYVLLFIGIVFLLIKNIRDKNKAH
KKMNALIEEFKANIEKKSNPEFEVVEKEELVFEHEEIQLKKENVNLSIDEAKENKIVEKL
LALESKLEYLNADFTLPYVAKKIKTNTTYLSYVVNKRFGKSFGEYSNELKINYVINEMIT
NHMYRKYSTQAIAESVGFKNAVSFAKSFRKRTGVSPAQFASNI
>EGALAKHO_02045 Photosystem I assembly protein Ycf3
MSFFVFNAAFPQQKNALIEDDYETLKEKIRLYYNDSNDRALMYAEQMAKSSNYEHLAFAN
GAMCCLLQKKGEVEKSKEKYKKAFVYISKIPESKAKKRVLADVYNYGGLAEWMRGNYGAS
LEEFQKGIKISSQLGDIKQIIKFKANIVLVNESVGNYQLSIKNSRQLLEFITKNERLFTD
AELLNRKSNLYHALGSAYESYYVDKGKMKILDSVAYFYKKAIQYSQNFSYTANSARLSLG
NVFNWRGDYKNAEKTYLEVVSLEKKSGVSDLSVVYYNLGDIYLTTKKYNKALSFYKKSDS
ISLLKNSHTLNYFKSNCYQARIYNILNMPELAHKHSKIYLDRLDEFESKLREERLKVNYK
QGEDNLTAEMLSIEKKYKEDLFLTRALYIFYALLFAGIAFLLLKNIKAKQAARRKMLDLI
TGEKNMEQMNQSAGKIAFTSSVKVKLKEG
>EGALAKHO_02046 Photosystem I assembly protein Ycf3
MYKVFYFSNEKFMKKVFCLLFCFVLATTFSQQKNTVVEDDYGILKDKIRQYWNISADRAL
VYANQMAKSTNYEHLAFANGAISCLLQVKGETEKSKKKYKTALCYLSKIPNSDDKKRLTA
DIYNYGGLAEWNRGNFGLALEKFQEGIKVSSQIGDVKQIMKFKANIGLVHEAVGNYQLAI
KNARECLDFINTNENQYTTTEIINKKSNLNHALGSIYESCFMENRNKWAFLDSAAYFYKK
AITYSESYLDNKTSAKLSLGNIFNLKGDYKNAEKTYSEIVVLSKQNNLEGLLCIGYYNLG
DINLTAKKYEKALLFYEKSDSISLLKNIQPYIYLKSNCYQARIYNILNMPELAHKHSKIF
LKRLDEYESKLREERLKVNYKQGEDNLAAEMHSIDKKYKEDIFKIRVLNVFYGILFIGIV
FCLIKIIRDKKKTHKKMIAFIAESKGL
>EGALAKHO_02047 hypothetical protein
MANMKLKFEDFEAEKLSKNQQKTVRGGDEVPVDPTKPGGGTIGTAGAGG
>EGALAKHO_02048 hypothetical protein
MLKLVQKFLQINRYSEIKNEFKDLFLSHPNYPSLFAITDSLDLLSIENAAIRVPKEQIVD
LPANFLAYFKEELILVEKAKNDVRITTTKKGAHRMAYEKFLLDWNGVIVAIEPNNVIARE
NLKVEFNWIKYSLPLILVVGLSFFYNTYSLFSLAFLTTSILGLIVSIFIIQEKLGFKNTI
ISKICNLSSNSSCNSVINANEGTENKLFNFSDLPLIFFSSSLIAILITPLDSAIFIGFLS
LLAIPIIVSSIWIQKFEIQKWCVMCLIISFLIFTQSAIWFASDFFTLSFEFSKIFPFLFS
LVVLVPMWLVAKPMIKNILKNDISLKELKKFKRNYSLLNFLSKKVPNTSGFDDLRGLNFG
NRNAAVKLSVIISPSCEHCNTTFQEAFDLVLKFPDRIFLKVLFNINPENTDNPYKAVVER
LLTINRSTPGKTVEAISDWHIKKMNLKKWLKKWHVESVSMMINQEINKQYEWCSKNNFNY
TPVKIVNEKLFPNEYELNELKYFLNDYVEEIEILEKIA
>EGALAKHO_02049 hypothetical protein
MLKNILNLEGSQELTASEQKMIIASNVKETSSRCDTWNNNEDCPSYEINYSS
>EGALAKHO_02050 hypothetical protein
MLKKILNLKDAQHISKNEQKTITGGIPECWIYAIEAGCVLIPAGGICPMDTLPGICDSSR
LCC
>EGALAKHO_02051 Lactococcin-G-processing and transport ATP-binding protein LagD
MKKFTHYKQADFKDCGPTCLKIVAKHYGKTINIQDLRDISETTREGSNLLFLSDAAEKIG
FRTLGVKLNLERLQEAPLPCILHWNKNHYVVLYKIKRDKYYISDPAFGLIEYNKEDFIKL
WIGNNADNLTKEGIALLMEAAPKFFQSDFDKEDNKGLGFRLLSQYVLRYKSFLTQLSIGL
VASSLLMLISPFLTQSIVDVGIQNQNLRFIYLILFAQLFLFAGKTGLELIRSWILLHLST
RINISLISDFFIKLMNLPISFFDVRMTSDIMQRINDHRRIEKILTTSSLNVLFSMINMVV
LGAVLAYFNLKIFLVFFIGSLLYFGWITLFLKRREILDYKRFAEVSQEQSKVMELINGMQ
EIKLHNAEKQKRWGWEYVQARLFRVSIKGLILEQTQTIGSSFINELKNIFIIFLSAKLVI
DGSITLGMMLAISSIVGSLNGPIAQLIEFVRELQDAKISLARLSEIHEKEDEIQQEIHQS
NEVPVDCDITLKNVSYRYLGSDIPVLDDLNLTIPANKVTAIVGVSGSGKTTLMKLLLKFY
EPEKGEINIGNAQLKNIAQKAWRSNIGAVMQEGFIFSDTIANNIAFGVDKIDKQRLVYAS
DVANIKEYISGLPLGYNTKIGAEGTGMSTGQKQRLLIARAVYKNPEILFFDEATSALDAN
NEKAIMQKLDVFFKNKTVIVIAHRLSTVMNADQIVVLDKGKIIEIGNHSALVEQKGNYFE
LVKNQLQLGN
>EGALAKHO_02052 Hemolysin secretion protein D, chromosomal
MAEDNTAFELRSEEVQDILTKVPHWMIRWGTVLIFAIIFMLFFVSWFIKYPDVVNTEIVI
TTNIPPEKIVSKSSGRIEAILVKNKTTVSKNTTLAIIENTANYKDVFLLKSIVDNYNINN
SQKAFPFSLLKNTQLGEIESAFAVFQKDYQAQELNENLQPFEVENRAQHSEKIQIKDRLD
ILQQQKVINESELQLQKNEIARFETLFNKGIISAQEMEAKKLGYLQAQKSYKSLLSSISQ
LKSSLIDNTKLSQNSQISGTKEEVNLGRNMAQSFYQLKKVIKDWELAYTLKSSVSGVVTF
LQVWTENQTINVGDNVFSIIPDAKNGFIGKVKAPALNSGKIKVGQAVNIRLANFPDREFG
VLKGKIQNISLIPDKDGNLLLDVALPNGLLTSYNKQIIFQQEMKGSAEIVTEDLRLIERI
LYQFKSIFEQV
>EGALAKHO_02053 hypothetical protein
MKKIFLIVFILFFQNSFSKSITETQKLAATCKVWGFLKFYHPNVTDGSKNWDEQLFQILP
KIEEAQTSEAFSIVIENWIDSLGEIKKQETLKPAVKKEYFDKNFDLSWFNNKELFSKSLS
KKLKFIEENRIHGQQFYYTSEPYIEVTNEIKYKDFKWTDKNLRLLALFRYWNQMEYFFPY
KYKMDQKWDTVLIEMMPRFSNPESEKDFALAMREISIKLNDTHASTQMKQMYDYFGDKFI
TADVVFIDNKAVVVALKNDSLAKIDDFRIGDVVTKVDGKTVGDLINENLKYAEGSNTPAI
LKNIYWVVFNGKTESIEIEFIRDNITSVKKVKRYSYSKLKIRNDNNEVKWKLLDETIGYV
DVEAIKADELPKVMEQFKNTAAIVFDARKYPKEPNIEEDIAQYLYPKEKAYAKFIDVDLT
YPGRYVWREDQKTGKTNPDYYKGKVIILENEKTQSHGEHLVMCLQAAPDATIIGSQTAGA
DGGTCRFEIIKGYSTIFTGFGIFYTNRKETQRIGIVPDIEVKPTISGIQQGKDEVLERAI
LFAKNGE
>EGALAKHO_02054 hypothetical protein
MGCFAYSQKLDCNKFKNGKFAAPAFPDEYAIRKDSIEEGYFDSKLQTVWSVKWLSDCKLE
KVCIKNLGAENVKIGDKSVAEIIYTDDDCVTYSIVYFNEENPNGIDFQRGVCLQKE
>EGALAKHO_02055 tRNA1(Val) (adenine(37)-N6)-methyltransferase
MFQFKQFSIQQDKTAMKVGTDGVLLGAWAPVNHNPFSILDIGAGTGIIALMLAQRTHAEQ
IDALEIDEDAYEQAVDNFENSPWGDRLFCFHAGLDEFIEEPEDEYDLIVSNPPFYAEDYK
TENEQRDLARFQDAMPFEELVEAADLLLSENGIFALIIPFREEERFIALAKESELYPIKI
TRVKGTPTSEIKRSLLAFSRNENPEVEIDELIIEIDRHVYTSEYIALTKDFYLKM
>EGALAKHO_02056 Ribosome maturation factor RimM
MRKEECFYLGKIAKKFSFKGEVLAYLDTDEPELYENLESVFVECNKHLVPFFIEKSSLHK
NDFLRIRFEDMNTEEDADAIMGNAIYLPLSMLPKLSGNKFYFHEVIGFEIEDQRLGVFGK
IVAVNDTTAQPLFEVLNGEVEMLIPMIDHFLVKIDRENKKVIMNLPEGLVEMYL
>EGALAKHO_02057 30S ribosomal protein S16
MSVKIRLQRHGKKQRPFYWVVAADARSKRDGKYLEKIGTYNPNTNPATIELNIDSAVKWL
HNGAQPTDTARAILSYKGALLKHHLDGGIRKGALTQEQADAKLADWLDAKAGKVDAKKEG
LTKAQADARAKSLKAEQEVNAKRLAAAAQAEADAIAAATPAVEEEEVAEVEAEAATEEAP
AAEENNETTEA
>EGALAKHO_02058 hypothetical protein
MLIFIVSSCTDDVKFNNPAFQTLKNNVFWRAAGYKANTVTNGNVVIEGDLGYEKVILKIP
SAAKKTYVLGIDDVSTASYSNTFPGELADFTTGTNKGSGQIVVTDYDAESKTISGTFKFT
ALNKNTADTENPKVIFTEGVFYKIPVSPTNQFVTY
>EGALAKHO_02059 hypothetical protein
MNIFVGSLPFSIEEADLRESFEAYGAVDSVKIITDKFTGRSKGFGFVEMPNDAEAQKAID
ELNGATVQGRAIVVNKSEPKPEGERRSFNNNSRGGDSRGGYGGGNSRGGNDRGGNRGGY
>EGALAKHO_02060 3-isopropylmalate dehydrogenase
MKFNIALLAGDGIGPEVINEAVKVSDAIAKKFNHEITWTPALTGACAIDAVGVPYPDETH
EVCMAADAVLFGAIGHPKYDNDPSAPVRPEQGLLLMRKKLGLFANVRPTFTFPSLIDNSP
LKRERIEGTDLVFLRELTGGIYFGEKGRRDNGETAFDNCVYTRAEVQRLAKKGFELAMTR
SKKLCCVDKANVLETSRLWRETVQAMEKDYPEVTVSYEFVDAVAMRLVQWPNSYDVLITE
NLFGDILTDEASVISGSMGLMPSASVGEHTSLYEPIHGSYPQATGLNIANPLATILSAAM
MFEDAFGLKDEAEAIRAVVNKSLEQGIVTEDLAPKGSKAYKTSEVGDWLVANL
>EGALAKHO_02061 2-isopropylmalate synthase
MDTTLRDGEQTSGVSFSAAEKLTIAQLLLEELNIDRIEIASARVSEGEFQAVKGITTWAE
ERGYINRIEVLSFVDGGVSIEWMKKAGAKVQNLLTKGSMNHLTHQLKKTPEQHFSEIAQI
IALAKENNIETNVYLEDWSNGMRNSQDYVFQFLDFLATQPVKRILLPDTLGVLIPSLTFE
FLSKIRSRYPQIHFDFHAHNDYDLSIANVMEAVKAGINGLHVTVNGMGERAGNAPLESTV
AVINDYLPEVSINIKETSLYSVSKLVETFTGYRIPANKPIVGDNVFTQTAGIHADGDNKN
NLYFNDLLPERFGRKRKYALGKTSGKANIEKNLQELGLKLNQEDLKLVTQRIIELGDKKE
TVTKEDLPYIISDVLDSHTYEDKITIESYILVHSKGMRPSTTLCLKIDGEVIEEHAQGDG
QFDAFMNALGKIYKSKKLTLPKLIDYAVRIPPGSSSDALCETIITWVNNEKEFKTRGLDS
DQTVAAIIATQKMLNVIT
>EGALAKHO_02062 Putative O-methyltransferase/MSMEI_4947
MNDNNIVLPKFYSEIKSSSEKIAFSMPSDLQTGSLLRTLIATKKDGHFLELGTGTGLSLA
WMIEGMSENSNLISIDNSAEYQNIAKKYFKESNISFVCEDAEQWILNYNGLKFDLIFADA
WPGKYVVLDETLNLLNSGGIYLIDDMLPQPNWPVNHDKNVEKLIQDLEKRTDIQLTKMCW
STGLILITKI
>EGALAKHO_02063 3-isopropylmalate dehydratase small subunit 1
MAYDKFNILTSSAVPLPIENVDTDQIIPARFLKATKREGFGDNLFRDWRYNGDDTPKADF
VLNDSTYSGKILVGGKNFGSGSSREHAAWAVYDYGFRAVVSSFFADIFKGNCLNIGVLPV
QVSPEFADTIFKAIEADPKTELEINLPNQTITLLATGQSESFAINGYKKNNMINGFDDID
YLQNIKEDIVAFADKLPY
>EGALAKHO_02064 3-isopropylmalate dehydratase large subunit
MSKTLFDKVWDSHVVRKIEDGPDVFFIDRHFIHEVTSPVAFLGLKARGVKVLYPERTFAT
ADHNTPTINQHLPVEDALSANQLKALEDNAAEYGISHWGLGHIKNGIVHVVGPENGITLP
GATIVCGDSHTSTHGAFGAIAFGIGTSEVEMVLSTQCIMQPKPKKMRINVNGELSKGVGP
KDVALYIIAQLTTSGGTGYFVEYAGDVFENMTMEGRMTVCNLSIEMGARGGMIAPDQKTF
DFLEGRLYAPKDEAWTKAVEYWKTLKTDADAVFDAELNINASDIEPMITYGTNPGMGIGI
SKHIPNANQVEGGEETYKKSLAYMGFQEDDVMIGKPIDYVFLGSCTNGRIEDFRAFAEIV
KGRKKADNVTAWLVPGSHVVEAQIKEEGILDILTEAGFVLRQPGCSACLAMNDDKVPAGK
YAVSTSNRNFEGRQGPGSRTLLASPIMAAAAAVTGKLTDPRELF
>EGALAKHO_02065 Xylose operon regulatory protein
MISLVDNTKLVINAELTNNAFLLDFYKISYKYSTNGKMGYGQGYYDFNEGGLMFTSPNQL
IFTDNEEGTEYHGFTLFFHPDFIRNYPLGKNIKKYGFFSYDTNEALHLSDTEKTTIIGLL
NSIDNELHNAIDEMSQDVIVSYLDVLLNYSNRFYKRQFITRKTISNDLLLKVENTLDNYL
NNAETLKKGLPTVDFLASQINVSSHYLSDMLRNLTGQNAQQHIHSKLIEKSKDFLISTNL
SVAEIAYQLGFEYPQSFSKLFKKKTNLTPLEFKNSLN
>EGALAKHO_02066 putative oxidoreductase
MKTIFITGASSGLGKATAKLFHENGWNVIATMRNPEKETELSGLQNVTLLPLDVTNYDQI
QSTVQKALELGDIDVVFNNAGYGLIGPLESFNDDQITKQLNTNLLGVIRVTNAFIPYFRE
RKSGLFISTTSIGGLISFPLGSVYHATKWGLEGWSESMAYELNPFGVNIKTVSPGGIKTE
FLHGSLDTGGRPEYEAMTNKMFENVDVMFEMASTAEQIADVVYEAATDGKTKLRYVAGED
AKALYQQRLEQGDEVFRAAFGKQFLGA
>EGALAKHO_02067 hypothetical protein
MDYEKRYVEYGGSPNLRFFLASGNKELNKKH
>EGALAKHO_02068 DNA polymerase III subunit alpha
MYLIFDTETTGLPKRWDAPITDSDNWPRCIQIAWQLHDEMGKLIEHQDYLVKPDGFNIPY
DAERIHGISTELAEADGITLAEVLEKFNIALSKTKFIVGQNLGFDVNIMGAEFHRMGVDS
PMSTMPVLDTCTEVTASLLQLPGGRGGKFKLPTLTELHSYLFNKPFAEAHNATADVEATT
RCFLELIRREVFTKEELDVPKDYFKEFQERNPQEFPLIGLKHINLKAASDKIREQIKALQ
VDDVQTTVSATDRADFKAAKYSHLHNHTQFSVLQSTIGIGNIVAATAKNGMPAVAMTDTG
NMMGAFHFVSAVMNHNKAASGKNKALVEAGEEPTETEIKPIVGCEFNVCENHLDKSKKDN
GNQVVLLAKNKAGYHNLAKMSSIAFTEGFYYVPRIDRNIIEKYKGDIMVLSGNLYGEIQS
KILNIGENQAEEALIWWKEQFGDDFYLEVMRHNQEDENRVNKTLIEFSKKHNVKLIATNN
TYYLNKEDANAHDILLCVKDGEKQATPIGRGRGYRYGLPNQEYYYKSEEEMKKLFSDLPE
AIINIQEIVDKVEGYSLYRDVLLPKFDIPEEFVVAEDEADGGVRGENKYLRHLTMEGAKR
RYGEITESIQERLDFELLTISNSGYPGYFLIVQDFIAEARNMDVSVGPGRGSAAGSAVAY
CLGITNIDPIKYDLLFERFLNPDRVSMPDIDIDFDDEGRGRVMEYVINKYGKNQVAQIIT
YGKMATKSAIRDTARVLDLPLFEADRIAKLIPAMMPSKWNLARFISENEDEVKKALRSDE
FDNVKELIAIANEDDLAGETIQQAKILEGSMRNTGIHACGVIITPSDITNFVPVTTAKDS
DLYVTQFDNSVAESAGLLKMDFLGLKTLTLIKDTVKLVKYRNGIDLDPDTFPIDDVETYA
LFQRGETVGIFQYESPGMQKYMKDLKPTVFGDLIAMNALYRPGPLEYIPSFVRRKNGEEE
IKYDLDACEEYLGETYGITVYQEQVMLLSQSLADFTKGEADVLRKAMGKKQKDVLDKMKP
KFVEQAAKKGHDAKVLEKIWKDWEAFASYAFNKSHSTCYAWIAYQTAYLKAHYPAEYMAA
VLSNNMNDIKQVSFFMEECKRMGLQVLGPDVNESYYKFTVNDSYAVRFGMGAIKGVGSGA
VATIVENRKDGRYKSIFDLAKRIDLRAANKKAIENLALAGGFDSFEGTTRAQYFHDDGDG
ITFYEKAMRYGSKFQENENSSQVSLFGEASEVQIAEPVVPPCEDWSTMEKLAKEKEVVGI
YISGHPLDDFRFEMKYFCNARLEALKSMNEYVGKNLNFAGIINNVQHRVAKNGKGWAVFN
LEGYDESYEFKIFGEEYLKFRHFLIQNNFAYLKVLIKDGWVNHDTGKKSDPRLTFVEVRQ
LQDILEVFAKKLILLLNIKDLQTDFIHTLSHLFNAYKGDNSVTFEIMELEKIKRLVAVET
NTDFEETEDAVFVDESENEDVDSPLEETKIQEVKEVEEIKVVTKLTMPSRRLKVRISTEL
LQELEKLQINFKLN
>EGALAKHO_02069 hypothetical protein
MKKNLFLLGLLVCSMATMAQTEKADKPESWYFKLGASYFNQTASTEFPTVGGQPANRDVY
SGTLANNKLISRESVTGSFGQGFRSGITAGYRFSTRLGVEMSANYYVSNNKTMAQTSDRL
ITASPSATTPVTYLSFTAEGEIKAFDLAPAIVMFLGEAHGFEPYTKVGVIVPIHGTLDIE
TNRNFSTFVGANKVANTDAYSKDVVKPNATIGFMAAIGTSYKLGKHIAAFAELEYRNFTV
HGKTKETTDYTENGVDKLNTSTSFRAASYSANHTNYHSKIDATSNNTLTNAAGFDSTKAT
DDLSSYVGISGLGLTLGLKYSL
>EGALAKHO_02070 1,5-anhydro-D-fructose reductase
MKIIKWGIIGCGNVTEVKSGPAFQKTPNSALVAVMRRDAKLAEDYAKRHNVPKWYSNAID
LINDPEVDAVYIATPPSSHKEYTILCAKAGKPVYVEKPMALTFEECNEMISVCKEHNVPL
FVAYYRRSLPRFLKIKQLIDQNKIGTVRHVNCVLYHPFEERYDDEINLPWTVLPHISGGG
IFVDLACHTLDFLDFVLGPIKSVRGHASSQLKAYPAEDSVSMSFLFENGIHGTGIWNFAS
FERYDNTEIVGDKGKISFSTFGNDPVHLQYLNGEKESFDIENPLHIQQPLIQTVVAELLG
NDGVNPSRGTSAARTTWVIDEVLKEFRNSK
>EGALAKHO_02071 Prolyl endopeptidase
MKKTFLIMAITTAGISFGQNKIQYPETKKGETVDVYFDTKVSDPYRWLEDDRSAETGAWV
QAENKVTYAYLDKIPFRDELKKRMEKLWNYEKISAPSTEGKYTYYSKNNGLQNQSVIYRK
GSDGKEEVFLDPNTFSKDGTTSLGGLDFSKDGSKAAYSISEGGSDWRKVIIIDAISKKVL
EDTLVDIKFSGISWHGNEGFYYSSYDKPKGSELSAKTDQHKLYFHKLGTLQKDDKLIFGA
DQKRRYVGGYVTEDDRYLVISAANSTYGNELYIKDLTVANSPIVTIVDNFNSDNSIIETE
GSKLFIETDLNAPNKRVITVDVSNPKPENWKDFIKETKDILSPSTGGGYFFANYTKDAVS
FVQQYDYNGKLVRDIKLPAVGTAGGFGGKKHEKTLYYSFTNYTTPGTIYSLEPKSGKSEI
YQKPVVDFKSEDYESKQVFYTSKDGTKIPMIITYKKGLKLNGKNPTILYGYGGFNISLTP
AFSIANAVWMENGGVYAVANLRGGGEYGKKWHDAGTKLQKQNVFDDFIAAGEYLIAQKYT
SSDFLAIRGGSNGGLLVGAVMTQRPDLMKVALPAVGVMDMLRYHTFTAGAGWAYDYGTAQ
DNKEMFEYLKGYSPVQNVKAGVKYPATMVTTGDHDDRVVPAHSFKFAAELQEKQTGDNPV
LIRIDVKAGHGAGKSVAASIQENVDVQAFTLYNMGFTALPKK
>EGALAKHO_02072 putative TonB-dependent receptor
MKKIILALILGFSSLLSAQNTVTGTVTDLQNQPLPGVSVYAPELHKGTTTDANGKYEFTN
LPNGSFRVAFTFVGFTTQNKTIAKLLKENTLDITLSESVFEMDEVVVSTPFNKLQSQNVM
KIEHESIKTLQQKGTSTLIEGLATIPGVSQISTGTSIGKPVIRGLSGNRVLVYSQGVRIE
NQQFGDEHGLGLNDAGIESVEVIKGPASLLYGSDALGGVLYFNPEKFADANTFKANFSQK
YFTNTEGSNSSIGLKTSTDNWKFLARGSFNTHSDYKIADGDRVTNSRYNETDFKTGIGYS
NSSFSSVLRYNYNKLDLGIPEDGIGEQSSSKNTMFPRQGIFNHLLSLNNVIFFENSKLDV
DLGYIANDRSEFEDSNDASLRMKLNTFNYNAKYHFAKMGKIETILGVQGMHQTNTNFGEE
YLIPDATTNDFGVFGTANYEWNNSVLQAGLRFDNRNITSEEHGIAGEEGYFQALDRSFDS
FNASLGYKTKLAEPLTLRLNVATGFRAPNLAELTSNGVHEGTNRYEIGNPDLKTEQNVQT
DLNLEYKNSHFEFFVNGFYNHVNNYIYTSPTGDVIDDNDVFAYVQDNAQLFGGEAGFHFH
PHPLDWLHFETSFETVTGKKDNKDYLPLIPANNWNNTIRTEFKIKDWLQEGFATLNVSST
FSQNNVSGFETASKGYTLVNLGFGGTVKLGKTAFDVNLNGNNLFDKEYIAHLSRLKTDGI
PNIGRNIVLGINFNL
>EGALAKHO_02073 hypothetical protein
MKKKQLILSVSFALTVLFSILFQSIHSYEHIVKQLSEKQCHHDYSDPSGEITHQHHNYDL
CYVCHFAFGSYILPEDFAFQFRTFHKEIPYFFTISENVFSFSGSAYLLRGPPAAIVS
>EGALAKHO_02074 hypothetical protein
MLKNVYLRTTLKPKYDMRFLLSCLFLVSFFNAFSQEEVKPEIKPVVKIDSLYREDQFYFT
ITYNMLVQGPPGLKQDKFSAGFSGGFLRDFPINKKRTFAIAPGLGISYQNYFQNLTVSTA
MDGSLLYGVNDYGEFVSNRFRQYSVDLPIEFRWRNSTFESTKFWRIYTGIKFSYVFAAKS
VLKDGETTYKIKNNPDLNDFQYGAYISAGYNTWNIYAYYGLNPLYKSTVKTINGDSVNMR
TLNLGLIFYIL
>EGALAKHO_02075 hypothetical protein
MLNTTKYSVLKKILPLFSYILHPIFISIYATLFYLFCKGDIFTNQEKYYVLFQILIITFL
VPVLFFLLLRSTGHVNSVMVPETSQRKIPLILQCFLYILLVKRSIVIARYPELHFFFLGA
LFSTILALICSLFKIKASLHVMAISGLTIFVIGLNIHLQMQNPYWGAFLILMTGVVASSR
LEMDAHTPKEVMIGLLLGVLPQLLFLYLWL
>EGALAKHO_02076 Alanine racemase 1
MSINLKNLISVLDAKWIGPDTDIFIDHISIDSRSLQNGSKTLFFALTGANNDAHLYIPEL
IEKGVQNFVVHHIPKNSEGKANFLIVKDTLKALQQFASYYRDLFDFPVIGLTGSNGKTIV
KEWLNFLLSPDYNIIRSPKSYNSQVGVPLSVIAINEKHNLGIFEAGISTVNEMSKLENII
KPTIGVLTNIGPAHDEGFENLKQKIKEKLLLFKKSKVIIYQKNELVDQCLKAFCGEYPIG
DRTLFSWSFKDSTADVFILEKESRNEKTTIQYQYQNEFFDLEIPFSDSASVENTISCLLV
LLYFNYDFETIQNRMKMLYPVEMRLEVKNGINNCSIIDDSYSSDFQSLKIALDFLESQQK
KNATKTVILSDIFQSGFSNEELYSKVAQLIADNKVNRVIGIGKTITSFAAKFPNIVTFEN
TAEFISKFESLNFNNETILIKGARSFQFEEIVSLLEEKTHETVLEINLDSISHNLNFFKA
KLNPEVKIMVMVKAFGYGNGGLEIAKLLEHHKVDYLGVAFADEGISLKNGGIKLPIMVLN
PESTSFPSIIQYQLEPEIYSIKGLNAFLKIAREKNLKDFPIHIKLDTGMHRLGFEENTLE
ELIETLKGNTTVKVKSVLSHLATSDEMKHYDFVISQINLFEKLSSKLISELNINPIRHIL
NTSGISNFPEAQYNMVRLGIGLYGVSNDPSEQKYLENVSTLKSIISQVRTIPAGDSVGYG
RRFMAEKTTKIATIPIGYADGISRLWGNQVGYVMIRNQKAFIVGSVCMDMLMVDVSAIDC
KEGDSVIIFGESPTVMEMAEALKTIPYEILTSISQRVKRVFFR
>EGALAKHO_02077 Large-conductance mechanosensitive channel
MGFFSEFKEFAMKGNVVDLAVGVIIGAAFGKIVSSFIENVITPLLLKPALDAAHLSTIEE
LTAFGGVKYGLFLSAVINFIIVAFVLFLIIKGINKVKKKDEVVAPAPAGPTQEELLTQIR
DLLKNKQ
>EGALAKHO_02078 Aspartate-semialdehyde dehydrogenase
MRIAVVGATGMVGEVMLKVLAERNFPVTELIPVASERSVGKEIEYKGTKYKVVGMQTAVD
MKADIAVFSAGGDTSLEWAPKFAAAGTTVIDNSSAWRMDPTKKLIVPEINADTLTREDKI
IANPNCSTIQMVLALAPLHKKYNIRRVIVSTYQSITGTGVKAVRQLENEYAGIQGEMAYK
YPIHRNAIPHCDSFEENGYTKEEMKLVRETQKILGDNTIRVTATAVRVPVVGGHSEAVNV
EFTNDFDVNEVREILHHTDGVVVQDNLDTFTYPMPVYAEGKNDVFVGRIRRDESQPNTLN
MWIVADNLRKGAATNTIQIAEYLIAAGLV
>EGALAKHO_02079 hypothetical protein
MPFPIDVKYIIETEGNLGVEFPYEFKQKMINQNGGELIIEDDDWQLYPFFDKSDKKRISR
TCNHIILETKQAKEWHSFPENAIAIATNGCGDYLILLPLENDAKKLSEKIYSWFHEKGEI
EEVAKNITELSAL
>EGALAKHO_02080 Rhodocoxin
MDVLIKIKDREGVIHELQAPTDMAMNIMELCKAYELPVEGTCGGMAMCASCQCYVLNDVA
LPEMGDEEEAMLSEAFYVKSNSRLGCQIPITTELEGLELELAPEY
>EGALAKHO_02081 hypothetical protein
MKNYYALFLLLFFASATYAQQVTQTLIVDKAWVNEAEEWSDFSYTGQIVFSTNANAEEGT
LRIGNYDFLYDFAEGKAKFANKATYSAAEFAHPRKVSSTTDKQGVVNSTYEGTLIFQSDK
DYYSVIAIVTILEKSGNTLGVKMHLKDNTRKEFAFSLKPTS
>EGALAKHO_02082 Fe/S biogenesis protein NfuA
MTTEELTSNVLLALDEIRPFLNSDGGDITLISIDDDKHVKVRLEGACISCSVNQMTLKAG
VETTIKKYAPQIETVVNIM
>EGALAKHO_02083 Iron-sulfur cluster carrier protein
MKLDRKEILKALETITIAGEGKNMVESGAVANVITFGDEVVVDLLLHTPAMHIKKRAEDD
IKKTIHELVSPEAKVKVNIKVEAKENPNEIKGKAIPGIKNIIAVASGKGGVGKSTVTANL
AVTLAKMGFAVGVLDADIYGPSMPIMFDVENEKPISITVDGKSKMKPVESFEIKILSIGF
FTAPSQAVIWRGPMAAKALNQMIFDADWGELDFMLIDLPPGTGDIHLSIMQSLPITGAVV
VSTPQAVALADAKKGVAMFMQDNINVPVLGIIENMAYFTPEELPDNKYYIFGQEGAKNLA
EDLNVPFLGEVPIVQSIREAGDYGRPAALQTASVIETIFEEITRNVVQETVNRNDSLPAT
EAIKITTMAGCSAVKKN
>EGALAKHO_02084 hypothetical protein
MIFNWFKIFIYHLKQSKLFSFLNILGLSIGIAGVIFAILYWNNENAYDQWNPEKENAYQV
LNKIGGTGDTWATNSIPFGETCKATIPEIESICFLNIWYDEAPVKFQDKKVMDKKISVSD
NSFFDVFPFPIVKGAKTNILKEKNSVALSDEAAKLLFKEEDPIGKSITYNSKVYIVKSVY
HLIRPSSIEPNYVFSDVQREGDKTSWGNFNYGLMVKIKKGADPAPVLKKMQNVNFVNRTL
KDAKASGQSVADYVKENGETTVIIDQLKMARLYGTKSSGGRNFPEGKGNLQLLYIMVGLS
ILILTLSLVNYINLATASAIKRAKEVGVRKIVGATKNQIIAQFIFETAIIVILAIIFALA
IVELSLPYYNTFLSKTLTMNGGEFYLQLIFIFGLVIVLAGIFPAIYISNFETLKVLKGNF
SRSKSGIWIRNSMLIFQFGIAAFFIIGALIVNSQVDYMMNKELGFTGDQIIRVPFNTPER
LKRTEDYLTMKQEIKKLSGVQEISTFAGSFGNSTGSSSGFTHNGVFVQPRNVEMDFGFLE
MMKIKIVQGRDLSPKFASDSISNWLINETLAKTLNLKNPINTIISSGWGDEKGNMKFKVV
GVVKDFHITGLQDKVPPMVFINLKTLKWNNFNNIYIKVSPNNLSETLAKLKSYWEKNVNP
DYPFDYEFVNKDFAKTYQEQVKQKNVFFILNLVVIIIAIFGLFALASFSMERRLKEIAIR
KTLGAETDILLKELSKQYIIFCLMGFLIGIVPAYILLQKWLENFAFRINVSVIPFTVALV
SLLVLTLMIVLAKAYQVTKIDILKYLKYE
>EGALAKHO_02085 putative ABC transporter ATP-binding protein YknY
MITIQNLTKVFRTEEVETSALSGINLEIKKGDFLTIMGPSGCGKSTLLNIIGLLDSATDG
SYKLLDQEMVGLKEKGRAAVRKENIGFIFQNFNLIDELSVYDNIELPLLYNNVKASDRKQ
KIEAIAEKLNISHRLKHYPQQLSGGQQQRVAVARALVNDPKIILADEPTGNLDSKNGNEV
MELLTDLHAKGATILMVTHSDYDASFSQKTIHMKDGVIFSERLNQRNVDVFMDAK
>EGALAKHO_02086 hypothetical protein
MDKVIPRKNRKFRYLTIAIGVFLVLAVIIFFSFNTKRSLNVKAEELSVQKIEKAFFEDFV
VFQAKVEPLNVMLVNVTEGGSVKEIFVENGAMVTQGQSLARLYNPNTELNYLTQETAIIE
QINNLNTGKLNIRNQELNLNKDLVLIEHDYNDAKRLYDMNARLYEKEVISKNDWNTFKES
LRFQEERKRTIQQSIQKEKQTNQVQISQINRSIQTMEKSLDILRNNKKNFLITAPETGRL
TSFEPVLGKTFQAGESIGKIDSKKGYKLAADVDEFYLEKVREGLKGQVEFKGKILEVLVT
KVIPEVKSGHFTVELAFTSKEEIVLQDGLSFGVKLILSEKNKTLVVPKGSFNQETAGKWI
FVVKGNKAERRNIKLGRENPSYYEILEGLKEDESVITSSYTDYKDVEELSISSQ
>EGALAKHO_02087 Transcriptional regulatory protein ZraR
MRKKLAQILIVDDQEEILFSAKMILKKHFETIFTTNNPKKIISLLSENEINVVLLDMNYR
IGFEDGREGIHWLKEIKTLSPQTIVILMTAFGKIETAVEGIKIGAFDYVLKPWHNEKLLE
TIDKAVAESRKNSKKPVVEKTEKRYFVGTSQKIKQAYSIAERVAKTDANVLILGENGTGK
YVFAEFIHQHSERKNQPFVHVDLGSLSDNLFESELFGYAKGAFTDAKIDTPGRFEMASNG
TIFLDEIGNIPLHLQAKLLHVLQTKTVTRLGESKPRPLNVRIISATNSDIKAEVKNKTFR
EDLLYRINTMEIQLPSLRERKDDIVPMANFILDQIAEKYNHGPEASGWQFEENAGPYLEK
YPWKGNVREMENKIERALILADNNTITVHDLDILDFEDIQQNDENPLSEMEKTAIEKALF
KHHGNISKTAEELGLSRAALYRRIEKYDLKNT
>EGALAKHO_02088 Sensor protein ZraS
MKNWKFYNALFVRVLFVMTLFFFCVFLIYKMFYYNAILIGLFAVIMLFEMYFFVKNQLLF
YDRTLLSMLQKDFTTNFPEENKKDNFESLYLLYETLKIQQQEQTSKELVYQSILNSIDTG
ALILEKENDEWNIFLMNDCFSNLFKVPKVSHWSYLKNYLPSLCNEIEKSDFAELKSAISI
KIEEQDLQTFMLQTSLTKTYNKEYFIILLDSIQRVIEKKEKEAWINLMKIISHELMNSLT
PIRALSQNLLQIVDQDKLEEDDFEDIKSSISTIINRSDHLQVFVENYRKLAMLPTPTKVM
TPINALFDDCLRIMNPILKAENIELINDINSSRSILIDKNQMEQVIINLITNSIYALKEK
SEKKMFLSSYTENNRFFITISDNGKGIDSEIRDKVFLPFFTTRKDGAGIGLTLSKNIIEA
HGGYLSYQTDEDKTSFVICLI
>EGALAKHO_02089 DNA base-flipping protein
MAEDNFFERVYAIARQIPYGKVTSYGAIAKALGTARSARMVGWAMNACHNMDDVPAHRVV
NRKGLLTGKHHFDGTNLMQQLLENEGVEVIDNQIIDFEKHFWTPDVSNI
>EGALAKHO_02090 hypothetical protein
MVLITPLLSGFIAAFIGIIPPGLINMTAAKVNLKEGRKNALWFVLGALVVIFFQVYVALL
FAHVIDNRPDVVTLLREVGFVIFSILTIYFLFIAKGPKTKKKSKIKKSSKKSRFFLGMLL
SGLNFFPIPYYVLVSVTLASYHLFVFESNIIFTFVMGSVLGSFAALYSYIGFFGKIEKKT
DYIMRNMNTIIGSITGLVAVVTLFNILNYYFG
>EGALAKHO_02091 tRNA (guanine-N(7)-)-methyltransferase
MGSKNKLKRFRENETFQNVFQPTREEVVGDLMPLKGKWNSDFFKNDNPLVLELGCGKGEY
SVGLAERYPDKNFIGIDIKGARFWRGAKTAVETGLHNVAFIRTQIELIDHIFNENEVDEI
WITFPDPQIKYKRTKHRMTNSEFLKLYKKILKKDGVVNLKTDSEFMHGYTLGLLHGEGHE
VLYANHNVYTNEGSPEEVTAFQTFYEKQYLEINKAITYIRFKIKD
>EGALAKHO_02092 Ammonia channel
MKIERRWIISFIIISLVCITGAFWPTVTKNNYVLSEFGTTDHIVPADVAWMLTSCCLVLI
MTPGLSFFYGGMVGKKNVISTMLQSFICLGVVTLLWVVVGFSLAFGDPVGFGSGKHFYSF
FGNPTTFAFMDYVNILPHKKLASTIPFMLFALFQMKFAIIAPAIITGSFAERVRFISYLI
FISLFTIFIYAPLCHAVWYPTGVLGSYFGVKDFAGGTVVHMSSGFAALAGVLVLGKRKNS
QHIPTNIPFVLLGTGMLWFGWFGFNAGSALAANGTAAMAFATTTTSSAAAMLTWVFFDRM
NGRKVSALGACIGAVVGLVAITPAAGFVSVPESMFFGFVTALVSNSVVNCRFSKRFDDTL
DVFACHGVGGIMGMILTAIFAHGEDASLLHGGWNVFGHHMMALVLVSIFTFFGAYFLFKV
TNFIIPLRVSEESEHIGLDLSQHDETLDPKTKAITEPHYG
>EGALAKHO_02093 hypothetical protein
MNLHHLYGEKIFFLPLTQITKPMKKTILLLLFVTVFANAQNAEKEKINKTLDAWHKAAAD
VKFEDYFNAMTEDAIFIGTDATENWVKPDFQAWAQPFFKSGKTWNFTSLERHIFFDKTGN
VAWFDELLNTQMKICRGSGVLVKVGKEWKIQQYVLSMTVPNDEVDAAIKIKAPIEDALIE
KLKKK
>EGALAKHO_02094 hypothetical protein
MNPKIFISSIVITSLLFVSCKKELEPQESTPTSELVKLGLVKDTAKVKSVVEAPQPQTNP
NTVLSETKGMNPAHGLPGHRCDIAVGAPLNSAPTQGQTATAQPTQTIQVNPNQKNMVTTT
TVAAPVKVAKGMNPSHGQPGHRCDIPVGAPLNSPVAKPVAATPAQSGSTSQTFTVTPPAG
TQNAVPALLSTEAPKVAEGMNPAHGQPGHRCDIAVGAPLPKT
>EGALAKHO_02095 hypothetical protein
MKIQINTDKNIEGHERLEAYFSGELEKGLTRFEEKITRVEVHFGDENGEKFSLNDKKCVI
EVRTAKLQPITVTEHSDTLEKAFSGALAKAKKTLTTTFEKQKTF
>EGALAKHO_02096 Very short patch repair protein
MDVHNPEQRSKNMRAIKSTATKAEITLAKALWNLGYRYRKNNKKVFGKPDFTFKKLKIAI
FVDSEFFHGKDWETRKKPQTNPEFWIKKIERNMQRDIEVNAYLESQNWKILRFWSNDIKK
KLDLCLVEIQNAIAERQNV
>EGALAKHO_02097 Type-2 restriction enzyme EcoRII
MENILDKAIESVQKSEISFCKFLSANDTKATKAHQSGYLISVTAWSLFLDKRPDDHIIKS
EAKIKWQDDFETSATFTYYKSKGELRLTGFGRNFPYREEDNVGDLFILARKDRYYFEAYV
LQSSEDIDEFFAAVNISSTQTNAIIPKQAEERAEEKLLKCFNHFLTSLKHDFPPTIELAT
SARNCYINSFNITQEIIQKNPDQQILNWLNTEFSLFKTIENDRYNNILKTHFSSVEELIT
TANTILNRRKSRAGKSLEHHLSEIFNNFEIKYSTQSITEDNKKPDFLFPDLDAYQNPHFD
NKKLITLASKTTCKDRWRQILNEADKIKIKHLFTLQQGISKNQLQEMYKYDVCLVVPKPY
LKSFPEEFRDKILTLDNFVKHVKDSQA
>EGALAKHO_02098 DNA-cytosine methyltransferase
MTQKKYSAIKEKLHIEVDKKTDNGLAQLTHYFQNHTNGVSQYFQNDAKEYLTDLHEKLNI
VEEPNFQYYLPIKWDVPFPPPKNPEFKFIDLFAGIGGIRLAYQNLGGKCVFTSEWDTYSK
KTYEANFGKVPFGDITQINETEIPDHDILLAGFPCQPFSIAGVSKKNALGRKHGFLDETQ
GTLFFDIARILKHKRPKTFMLENVKNLVSHDKGNTFKVIQNTLRELNYTIYFKVLDGKHF
VPQHRERIIIVGFDNEYFKGKENFKFPEMSDVKFALKDILLPEVDPKYTLSDKLWNYLQE
YAKKHKAKGNGFGFGLADLNGISRTMSARYYKDGAEILIPQEGKNPRRLVPRECARLQGF
PDNFVIPVSDNQAYKQFGNSVVSPLMQAVGKCLIKEITAINGKHSR
>EGALAKHO_02099 HTH-type transcriptional regulator SinR
MNIKEKFGFKVKELREQKGYSIEYLANISNVDRNYISDIEKGQRNVSIEIIEKIITALDT
DFGAFFNDNNFKK
>EGALAKHO_02100 hypothetical protein
MLSLMLRKFVPMTATLHRIKNFLQSAGFKKYAKRFGYFVLGLIALVLIAGAGLSIYFNQN
KTEIMAKINTKINDNINGDFHIGDFHYKFLTGLPNFTVALKDVELKDKQWKTHKHTLLKT
KEIEVRLNVWSLLQKEINIHKILINDAQIYLYKAENGYSNSDIFKPKKKKTPETQSDSET
TINQVDLNNVHFILDNRIGHKLFDFDVASLKSKVHYDGDDWKTDVFLDTQIGSLAFNTVH
GSFAKKKRLKGTFAVTYSAEREKIDVKTDGLKIGSDSFDIVAFFNLAKGSALFGINISTT
ILWQNASNLLSANISSKLNHFNLKKEIDVNCDIKGDFNAEGDPRIVVQAEVHNNELSIPD
GLLTDCDFKGIFTNNFKPKEGFSDANSAVILTRFSAKYRNVPLKIAQLSINNLEKPLATG
IVNSDFDLPVMNEENTEKWIHFTEGHATLNLKFQFDIVNLYITKPRFIGNVDIKNVSFHF
IPKNINAEKINVQLQFTQEALIINKIAYKHKNNTIFIDGKINNFLNLYYDAPEKMVVNWN
IYCPSIDVKQFLGVLATSQKRKVTAKKPSMSNQLRNAIEKCIVDINLKADKITYNKLTAT
NTKAVIQMIDSRLLIKNGSLQTCGGSINFSTTLSPNGKNYNFASNAQVNQVDITQFLKSF
NNFGIKSFTPNNIRGQLTSTTDMTGMIHNGELVPNSTHGSLNFNVTHGALINFEPIVKIG
KFAFPFRDVKNITFSDLSGNCKLRGELVDVNKLTISSSVLNLDAEGVYSFGRGTNMALTI
PLRNSKDDAKLATKAERDAVRDRGIVLHLLAVDDGGKMKIKWGKKDKGKNKKEK
>EGALAKHO_02101 Thioredoxin
MALAITDATFDEVVLKSDKPVMVDFWAAWCGPCRMVGPIIDQLSDEYAGKVVVGKVDVDA
NQEFAAKYGVRNIPTVLVFHNGEVVGKQVGVAPKQTYADSLDALL
>EGALAKHO_02102 Sensor histidine kinase RcsC
MKKLGFLLLLFITAAAFAQQEPNVARYKTENEKLKAWLTYTNKFLDAENYPQLIIAAQKG
IELSKNNLAYKSRFYFLKGNAYEFNNNQSKEAMLNYEIALQYAKKAKHLKNETSTLMRLS
YMYYALNETEKRKQLVAYMKQILDTTKSINTKSVLNGSLGEYYLDNAEYETFIGYQLKAI
NYKKLLKKSVANSETIGVSYSQIAAAYSKMKQFNKAIEYLNYAQPYIKTSPYICAFSCNY
YLQCFVPMKKLDSIQKYYKLIYTYPTVKDSLFLNLSFANRSLSEYYVNERQTNAAFYYAK
KAVLLGQKANDEDIIMEANTIMGRVLYEKGEYKKAIEILTLASKNAYTYDKESYVTINKK
LSQSYAALGLWKEAYKYNEIYSQASDEMMLESAKQNIANAEARFQNKAKGQEIKNLSAQN
TIKNIQISEAKKQRVFLISGLALVGIILLLLFKQSQNRKRTNQKLQLLNAELDEANKTKA
RFFGILNHDLRSPVSNLIHFLHLQKENPELIDEATALRMQTKVITGAENLLSSMEDILLW
SKGQMNNFKPQSHSFSVSGLFEETQKHFSSTENVELIFQDPENVILNTDENYLKTIIRNL
TGNAIKALDKTSNGKIIWKAWQENNQTFLSITDNGPGGTQEKFKALYDDSEVIGIKSGLG
LHLIRDLATAINAKIEVVSKPELGTTFTIVF
>EGALAKHO_02103 Transcriptional regulatory protein YpdB
MTKKYTCIIIDDDEIDRLTVVSFAKKFPVLDILGVFESADEALPFIDTQKIDILFLDIDM
PGLSGIEFRKKALEIPVCIFITAHPEHAVESFEIETLDFIVKPLKLDRFSQTVSRIEEFM
EVKLKASLFEASIGGDTIYIKEGHEQTKVKLHEILYLEALKDYTLIITNKKRHCVLSSIG
NLLKEDHFQSFIRIHRSFAVQKQFIQKVNSSEIILNNDIAIPVGRSYKENLNFIS
>EGALAKHO_02104 hypothetical protein
MKILKTILTLFSIVVFTASCSSDDGVDGTNGVDGQQGAPGATGTANVIYSAWLTAPTAVA
ETVDGTSGMSTTINAPQLSEDILAKGTILVYVSFGSGTFTLPYTSTAGGFVNTITAISTA
KKIKLFRFRHDGGGTVNIPTSLSWRYILIPGGVAAATAKTAKLDYAKMSYEEVCAHFNIQ
P
>EGALAKHO_02105 hypothetical protein
MKTLKTLFTILSLAVFTISCSSDDDKDSVKYAEENPLDAYMAGSGFSQKAVDVKNSGIYE
YGFSFKPTVTGKINALIVKIPDVNSALRITIWDAATKTVIKSETINVPTANVTVEKTIAS
IALTKDKEYFFTVNSDDWINRTKTDGSATTYPIVAGNITITGYAYISSTASETIFPTNAR
NTYYAGDISFKFQQTE
>EGALAKHO_02106 hypothetical protein
MKMKAIYVFLMLVYTSITLAQNQVEDLKKIIQQQELDWNKNDMKAFSDPFSEDAVLINFL
GMYWQGKEYITTQFSHLNECCIKPTSVKFDWIDSKSLSENAAVAHIKETLTAKEDYPVPG
GLVKKGNVSTKFITAVFEKKNAIWKIVSMQITQLNLPPR
>EGALAKHO_02107 hypothetical protein
MKIESEIEKVSSFQHLEMLANQVVEGFISGMHKSPFHGFSAEFAEHKVYNAGESTKHIDW
KLFAKTDRLYTKRYEEETNLRCHLIVDNSSSMHYPELKTNQPFYEKKIGFAVLASAVLMN
ILKKQRDAVGLSVFSDSYEYYAPEKGSDRHHRMLLNKLEQLLEQPKVKKSTDTITYLHQI
AEKMHRRSMIILFTDMFQSEDDEKLFNALQHLKHNKHKVVLFHVVDHETELKFDFDNTPR
KFIDVESGEEVSIFADNVKMEYEKRAEAYFKNLALTCAKNQIKYVPVNVGDNFEKILTTY
LVEKQNFG
>EGALAKHO_02110 hypothetical protein
MLKYKNIKSTNLKRNSKFQMNTDIIGIWNLKRLGFILEDFLKLKKPFR
>EGALAKHO_02111 hypothetical protein
MFKALRPEASGCDFNLVNFAVKSLQSNFGIWNFKILEFNFPYIYMSQERYYIQWNNRPSK
>EGALAKHO_02112 Transposon Tn10 TetD protein
MEQSTFKIDKYYLTKVDADKKSIYCHHDLMGELLVPTHKHDKAQMLYAEGDVVFVTTETK
SYFLPARHFIWIPAGLEHSIQPKSENVMMRNLYFPVEKDEDVFYKKEGIYPVNNLLLQMM
LFTNQWNGDLKKGSPNFTIAKAIKAILPQICTNNLPLELPQPKDKRLGKILRHVENNLGE
TILFSEVAHEFGYSERSLYRLFQKDLKMSFIQYYTIRRILKAIELLLDRKLSVKEVALEV
GYNSVPTFSNTFFKILGQRPSDYLNGEDVLKSR
>EGALAKHO_02113 hypothetical protein
MHHKIIYVIMFLNKTTNSTEDCFLKILLLFLIVFTFNSVQAQEIHSVSLSEALKLAKENN
KKILRSQLETTLSEQNIKERKELRLPDIELNGEYSRITNITEFKGSGFLNGKEVTKAIPE
IYQVNSTFTMPIYAGNKINNAIKIANQESEIAKIKTEKTENDIELEVVANYLAIYKMMEL
QKIFEENIKEEKSRLKEVQSLQKHGTLTKNEVIRAELQLSDRELNALTNSKNIKIALHDL
KTLIQFPENEEIAIDTTANLDEMQGLDPYDFYLSKASQNEEMRIASQELEIKKNELKLVK
GNYLPTVNFFGNYGFYYPNYKFFPPNPYLYTLGQVGIEAHFDISALYKNKTKMQQANTKI
EWQQMQTEIIKDEIQDKLYKEHTQYQEILEKFVVVDKALDLANENYRIVKLKYLNQLVLI
TEMVDADNALLQAKYNKVSTRLDAVLKHYELLHTAGIMPQS
>EGALAKHO_02114 Multidrug export protein EmrA
MVKIKNETSRNRTFHIIITSIACALVVSGVILGIWFYVFNSNHEETNDAQVEQYVTPIMS
RITGYVQEVRFDENQFVHKGDTLVVIDNREYKSKLNVALADVQSAQQSSVVAQKNVATTA
STTAIGESQLEASKSNLWKTKLEYERYKALVKEEAATSQQLEKVKADYESAQAHFQEMKE
RIHSSNLSTSVAEANVPTTQTNIASRQAVADNAALFLSYTIITAPYDGWVGKRTLQPGQL
VKEGQSLLSIVSKEKWITANFKETQLQYLTVGQEVKIEADAINDKEFKGIITSLSPASGA
RFSLLPPDNATGNFVKIEQRIPVRIQLKDNDKQTDFLRAGMNITVIAEHH
>EGALAKHO_02115 putative multidrug resistance protein EmrY
MEDKSIFKSWVPKWAIIIILFVCLLHSMILLGVYTSNVTYAASFLDIEPEDLQFAMCVTY
GTLLATILIESRFSSFFPAKNYLMAVYSVIGITIISSAYITNFYLFLLLRVAEGILMALP
VITIRQLLIEQFNSKNAIIIGFSFYYGSLLLSTPFIMNIAVWFLDHYDWKYMLYVSGGLQ
VLNVFLILVTFRGHRITKKIPLYQIDWLSYILVLTAILCGAYFFVYAEKKYWFQSSEMVL
MLIIALITGGLFIFKELLVKRPTFNFEVFKYANLRIGFLLFFLFYISRATLSLCHSAMFS
IWNWDPSRVAGVQYINGLGNVIGLILAAYFLMKSVSTKIIFIIGFSLIALFHFWFTFLFV
PDVALSDIIIPYILQGIGVGFLFVPLILFTTSSVPAKMAVSSGIVGVSGRFWGSTIGFCV
MQNAMVFLNKKHFLKLSQFVTGESPEAQQTIASTAQSFIAKGYSADNANTLALKKVFGTI
TKQATLLADMEIYTIVGYGLVVLIILIALNQHLRQTMTLVKSKIWIG
>EGALAKHO_02116 Fructose-1-phosphate phosphatase YqaB
MKQQCVIFDMDGVICHTNPHHAKAFEAFFDKYEIPHSAQEFEEHMYGKHNGYIMTHFFKR
PITGEELIKLEDEKEGMFREVYKDKVETIPHYLDFLSELRSRGFKTAVATSAPRANLDLI
ANVLKLDEKMDSMLSSEDVKQHKPNPEVYLKSAERIGVAPSDCVVFEDSFSGVTAGLNAG
MKVVGVLSTHTKEQLPPCDFYINDYSEVNVDKIIELLG
>EGALAKHO_02117 hypothetical protein
MFKKSTFALILLFLLSSCLVQRKVLEMNDWYAFTKTNTAQQQPSDIYEFKDGMIRMHGND
NSCLMTKKSYKNFELELEYRWNLEEQYKTTSTKNSGVMYNIPLDASDKIWPKGFQFQIKE
NTTGDFIFLDQVTAKVNGKSIEAGASVVSPKFLANENPYGEWNTVVVKSFNGKITQYLNG
KLVNECTDASSTEGKISLNYERSPIDFRNITIKEISK
>EGALAKHO_02118 hypothetical protein
MRNYLSDFFNNWLKPICFWIISFVLLVISEIIKNPIFSKICLVIFGAGILILLISIFHQL
SKRKWIKSIITLFLFCGTILVFIMYIVAMFWIGQNTPDTWADNLKIPKNININNPVNMES
GTGNNFIKPDNITNKTTTKTEFQLYNSFQPGLYEYDFWIGKIEKGTIYLKAFEITQNVAL
SEERLPKNSSIEIYNPTDTIKKFGTTDHFTIYEGDWGQPYAGRFEIWFKPDNGTEERKLF
SKNYKIEGWMR
>EGALAKHO_02120 N-formyl-4-amino-5-aminomethyl-2-methylpyrimidine deformylase
MENIKAYVQQHKDRFINELIELLKIPSVSADTAYSQDVIDTAEAVKESLSKAGCDFVETC
DTPGYPIIYGEKIIDPNLPTVLVYGHYDVQPPDPMELWTSPPFEPVIKKTEIHPDGAIFA
RGACDDKGQMYMHVKALEYMVQSNTLPCNVKFMIEGEEEVGSASLAWFVERNQEKLKNDV
ILISDTGMISNQQPSITTGLRGLSYVEVEVTGPNRDLHSGLYGGAVANPINILAKMIASL
HDEDNHITIPGFYDKVQELTAEERAEMAKAPFSLEKYKNALNIADVYGEKGYVTNERNSI
RPTLDVNGIWGGYQGEGAKTVIASKAFAKISMRLVPNQDWHEITELFTKHFTSIAPAGVT
VKVTPHHGGQGYVTPIDSIGYQAANKAYTETFGVPAIPVRSGGSIPIVALFEKELKSKTI
LMGFGLDSDAIHSPNEHFGIFNYLKGIETIPLFYKYFVELSK
>EGALAKHO_02121 hypothetical protein
MQKLFIVLFCGIMLSGCKSKPINQKIDHKKEGVWIDDYMQDNVRYKSFEYYKHDEPVKKW
KSYIGGKIYKTEKYKNGIGTVKYYYENGKVQSTGKTKMETNSKETHWFYFGDWKFYSDKG
KLTEIKKYSNGELISEQKIK
>EGALAKHO_02122 hypothetical protein
MKNLFIIILISLNIGFTQAQTYKDFVQKADSCYNLGDQKMSFAYYEKAFKIEKKSSTDLY
NGACCAALANNDTRAFQWLNLAIDNGYEGIAHLKIDKDLESLHDKKDWEKLITKFQKKLD
ILEANYDKPLQKELLAIYAEDQGIRSDFMKIYKEPNADKKKIDSIGKLMGKKDSINLIRV
MKILDEKGWVGKDVVGSQANQTLYLVIQHSDLKYQQKYLPMMRDAVKKGNATPGNLAYLE
DRVALREGKKQIYGSQIATNSITKKSFVSPLEDPDNVDKRRAEVGLGPITDYVKKMGIVW
DVEAYKKELPELEKISQQKKSKSK
>EGALAKHO_02123 hypothetical protein
MQLSNSEEQLMEHLWKLEKAFMKDLLEAYPEPKPATTTVATLLKRMIDKKFVAYNEFGNS
REYYPLVKKTAYFSKHVNGLISSFFNNSASQFASFFTTETDLSTSELEELKKIIDSEIKK
KKK
>EGALAKHO_02124 hypothetical protein
MITYLLKSGLLLVIFYAVYKLLLENEKMFRFNRIYLLGSILFSLIIPLQLFSIQSFFLTK
VKVIQLNEIMIVTNKAILDKVNYNEILADFLIISYAIIAGILVFRFVRNVYSFYNRIKKS
KVEIIEGQKMVLTKESILPHSFWNAVFVNYEDFKNGKIPSELIAHEKAHLEQKHTLDILF
VEVLQIVFWFNPVFVLYKKAIKLNHEFLADEAVNKQFGEVRNYQNLLLGFASQKHTISLA
SNINYLITKKRLLMMTKKESQTKIFLKIGSVTAVYLFLLFAFNTGALAQSGNNLINQNKD
KINYVSANVKEPQFPGGIEKFYMFIGQNFKIPQEFSKQKIDGKLALEFMVEKDGSLSEFK
VVKDLGYGSADEAIRVLKLSPKWIPASENGKPVRVMYSLPITIQAEK
>EGALAKHO_02125 hypothetical protein
MRSILIIGAGRSASSLIRYLLSKSESENLHLIVADLSLALAEKKTENHPNATPIALNIFD
TDERKAAIESASIVISMLPAHLHIEIAKDCLQYKKHLVTASYISDAMQALDEEAKKNNLI
FMNEIGLDPGIDHMSAMKVIDEIRSKGGNMLLFESFCGGLVAPESDNNLWNYKFTWAPRN
VVLAGQGGAAKFIQEGTYKYIPYGTLFRRTEFLEVESYGKFEAYSNRDSLKYRSIYGLDD
ILTLYRGTIRRVGFSKAWNMFVQLGMTDDSYIMEDSENMSYRQFTNSFLPYHPTDSVEIK
TRLILKIDQDDIMWDKLLELDLFNPDKKVNLPNATPAQILEKILSDSWTLAPDDKDMIVM
YHKFGYELYGEKSQIDSKMVCIGDDQTYTAMAKTVGLPVAMATLLILNGKITTPGVQLPI
KKEVYLPILKELEEYGVVFNEQTTPYFGYNPDLF
>EGALAKHO_02126 hypothetical protein
MKRRIILTGAFIGMLAIILGAFGAHLLKKYLSVEQLVTFETGVRYQMYHAFFLLFLSTRK
EFTPKALKTIYNLTVTGVILFSGSIYLLATKNLTLFDSKIIVFATPLGGFLLILAWLALF
VSIFKQKS
>EGALAKHO_02127 Phosphoenolpyruvate carboxykinase (ATP)
MDTNTLFSQSISLKELGIENAKVHYQLSADELHAITVQSGQGVENATGALAINTGEFTGR
SPQDRFIVKDTITEDKVWWGNVNIPFSPEAFEKLYNKVTKFLSNKEVFVRDSYVCADANY
RLNVRVVTETAWSNLFCYNMFLRPEESELANFTPDWTVICAPSFMADPAVDGTRQSNFAI
LDFTKKVALIGGTGYTGEMKKGIFSALNFILPVFENTLPMHCSANVGEAGDTAIFFGLSG
TGKTTLSADPARKLIGDDEHGWTAENTVFNFEGGCYAKVINLSEENEPDIFRAIKKGALL
ENVVFKAGTNEVDYDDVSITQNTRVSYPITHIDNIQPGSIGHNPKNIFFLTADSFGILPP
ISKLTPGQAAYHFISGYTAKVAGTEAGVTEPQPNFSACFGAPFMPLHPTRYAEMLTKKMK
DAGVKVWLINTGWTGGPYGTGSRMKLKYTRAMITAALNGELDNVEFKNHAVFGIAKPQSC
PNVPEEILNPRNTWEDKDLYDKKAIELAQKFKANFAKFEEFANEEILAGAPKTE
>EGALAKHO_02128 3-phytase
MKIRMKNNSIIAFLLLSVLFLSCKDDKLAPIAANAVKPTTVTEALPHDTDDPSIWIHPTD
SAKSIIFGTDKDTDGGLYAFDLNGKIVGKSEVLKRPNNVDIAYGLEINGKKVDVAVTTER
ESNKIRIFSLPDLKAIDNGGIPVFEGEELRDPMGIALYTRPRDHKIFAVIGRKSGPSGSY
LWQYELSGNAKFATAKVVRKFGAYSGKKEIEAIAVDNELGTILYCDEQFGIRKYKADPAL
NDNKEMALFGKTGFKADNEGIAIYKKTDSTGYILVSNQQANTFMVYPREGAKGNPDNYPL
LAEIPTSTIECDGADVTSINLGGKYKNGLFIAMSNGMTFHYYAWDLMQQRIDAAKK
>EGALAKHO_02129 Colicin I receptor
MKKIYLLVTFMLLAFSGYAQKAIISGKVLDIDDKLPLPGAMIQIVGENKYTVSDYNGRFE
LLNINEGTYQVQVKYIGYTAITHEIKVEAGKNNVLDFALKTSGTELNEVVVGDILKGQAK
ALNQQKNNKNIGNVISSDQVGRFPDANVGDALKRVPGITMQNDQGEARNIIIRGLAPSLN
SVTLNGDRIPSAEGDNRNVQMDLIPSDMISTIEVNKTLTSDMDADAIGGSVNLITRATPN
GERISATLAGGYLPIREHASYTAGLVYGNRFFDNKLGAVFSGSYNNVDYGSDNIENEWVK
DDFGNEYLQASEVRKYDVQRIRRSGSVALDYKFDENNTIFANAIYNWRDDRENRFRTTYD
DIEPIYNGEEITGFEGRVKRQTKGGVDSDRNKNRRLEDQRVQNYSIRGEHLINSKLDLDW
SANYAKAREYRPQERYIEYRQKGLEMMEDLSDPRFPLMTTVGESVDEFKFDSVTENTDET
SESEFGAKINIRFPFTVIPSQKGRLRTGLRLRLKEKERNNMFYSYEPINDGMELLSEIPT
SYYDGKNFNPGSKYVPGTFASANFLGSLDLNNPALFDKEASPSEYLAVNYNAKENIYAAY
VRWDQDFNDKLSMVLGFRLENTHIDYTGNRVLDEEELESQINNTNSYTNLLPSISFQYNA
TKDLVLRAAATTALARPNYYALAPYVNNIAADKEITAGNPDLDATYSYNYDFMAENYFKS
VGLISGGVFYKRLNDFIYNYSDNQYDSVKFATDFPNQINPIPAGENWSFVQSRNGDKVDV
YGFEVAFQRQLDFLPGKFLKGFGIYLNYTYTKSKAKGISDEDGNERNDISLPGTTPHMFN
GSLSWENKRFSARVSTNFTSDYLDELGSESYKDSYYDKQFFLDANASFKITKQLRVFAEA
NNLTNQPLRYYQGVEAHTKQAEYYQARYNLGLKFDL
>EGALAKHO_02130 hypothetical protein
MLKQFFILCSGADRDLLEGCSEGEQTKYVGIGATVFFTAVMAFLASAYALFTVFDSIYPA
LIFGFVWSLLIFNLDRFIVSTIKKRDRFIDEFLQATPRIALAIIIAIVISKPLEIKIFEK
EINTVLLKEKNEMELANKKQVGNYFKSDLDKNKAEIASLKADILKKEKEVNALYSTYITE
AEGTSGTKKLGKGPVYKEKREKHDATLREFETLKTTNEAKIAEKEKAGKQLQADLDKKVS
QTQPIIEGFDGLMARINALNKLPWMPSFFIMLLFLAIETSPIIAKLLAPKGEFDFKQEEA
ETAMKATLDQNKYQRELLKKTSAQMHDRVYADIAEDKSLYDLQRKNATELLELQSNSFVE
KQKATL
>EGALAKHO_02131 hypothetical protein
MKEQFKKFLNEEQDPKAIEKITSKLNDLLMKGEEVGYIAVQKKPAITVFPDSIVLTNKRI
IICKPKNLGLSMDFTDYTWDEIVGTFVKENILGSEFSFSTKTDIQASIDYIPKIQARKIF
TYAKEQLDILKNPVATATPVTETAQPVEEITDFEDEIEEVETEEVTNYAEIMPAVTPSPS
YETYEPIQPAQPSTGERKLSELSKEELFDKLQNYKKLLDNGLILQGEYDAYKKEILSYM
>EGALAKHO_02132 hypothetical protein
MNLETYYEYCLSKKGVSEHFPFDEDTLVFKVGGKMFALSSLSQWEKNEPSVNLKCDPERA
QELRAEYDEIKPGFHMSKVHWNTIALNGSLSTAFIKELIDHSYELVFKSLTKKIQNEIID
PR
>EGALAKHO_02133 hypothetical protein
MKTIIKLEELSLFILGIYLFSLLNYEWWWFLALILAPDFSMLGYLFGNKSGAFFYNIFHH
RGIAVLLYIIGCYFKIEILQLTGIILFSHSAMDRFFGYGLKYESGFKYTHLGEIGK
>EGALAKHO_02134 hypothetical protein
MNQITVSTDKNKLDVPFIQNFLKDIYWAAGRTIEEVQTTIDASVCFGIYLDDRQIGFARV
ITDYVVFGYVMDVFITEEHRGKGYSSILIENMMKEPILKNIQIWRLATTDAHFLYEKFGF
TALQHPEKMMEKKL
>EGALAKHO_02135 hypothetical protein
MKTATKQSTNQNNKYTLICIFLVTFFLNFSSLYSQNEKSQDTANFIYYPDKIMIRANLST
QSDNYLLNNKKGSNLDLETNNSYKLFLSIDYKFIGFSYGFYPKFFGGNKDEDLKGKSTFS
DYNFRFFLGRWLQTVNYSKTKGYYVANMSDFEPTWIEGKDPYLQFPDFKTLQLGMSTSYI
FNPKFSLKSITSFTEWQKKSAGSFVPSLIYSYNTIRSKSDDLDGKQKEFDLKLAVGYYYN
FIIHKNFYVAPNLSPSIGVKFMKDKSKDAGVQTIEKDTYFTKNLDGGLKLGYNSDRILFG
ASLNFSVSSYNEDKDNIISNDKIYGLLYFGYRFNAPGFIAKPVEKIDDKIKM
>EGALAKHO_02136 Kynurenine formamidase
MLALLNNKYQIDLSKPIDISIPLTNTDENPIAWYIEKPVIEPVVFGDWIGKVSEGKSSTN
FNNIFFNPHGHGTHTECLGHITTDFYSINQALKQFFFFAQLITVEPEKIGDDLVITKDQI
SASLNGTKTEAIIIRTLPNQAEKKSRKYSNTNPPYLSEDAAIFIRESEILHLLIDLPSVD
KEHDEGKLLAHKAFWNVKDTHQLNADARFEATITEMIFVPDEIQDGNYILNLQIASFEND
ASPSKPILYSIVNY
>EGALAKHO_02137 Oxygen-independent coproporphyrinogen-III oxidase-like protein YqeR
MSGIYIHIPFCKQACHYCDFHFSTSMKKKEEMVLALAKEIGMRKNEFELLDSAQSDNQIE
TIYFGGGTPSVLSNDEINFLIDEVYKNYKVSENPEITLEANPDDLSSERILELSKSPINR
LSIGIQSFYEEDLKLMNRAHNSAEAKKCLEGATKYFDNISLDLIYGIPGLTDEMWKQNIE
TALSFGVPHISSYALTVEPKTALRKLIDTGKIAEPQDEVASNHFMILVDILQKNGFIHYE
LSNFGKENYFSRNNSAYWLGKKYIGIGPSAHSYDGEKRGWNIANNSLYLKSIQENILPIE
TETLSKSDRYNEYIMTGLRTIWGVSLERIEKEFGLDYLDYLQKQSQKFLNDELLFIENNI
LKPTAKGKFLTDGIASDLFYLNLEE
>EGALAKHO_02138 Crossover junction endodeoxyribonuclease RuvC
MKLETKNSLTKERIILGIDPGTTIMGFGLIKVINKKMEFLQLNELQLSKYDNHYQKLKII
FERTIELIETHHPDEIAIEAPFFGKNVQSMLKLGRAQGVAMAAGLSRDIPITEYEPKKIK
MAITGNGNASKEQVAKMLQQLLGLKELPKNLDSTDGLAAAVCHFFNSGKIVAGKSYSGWD
AFVKQNEDKVRK
>EGALAKHO_02139 hypothetical protein
MISIPHKAKQFLVLLIKLLIVGGAFYFIYNQLANNDKLDWQKFIILFRKNQSVLGIGFIL
LLSVLNRYFEILKWQNLAKVIHEISLGEATTQVLAALTAGIFTPNGVGEYAGKALYYPKS
DAKNVVFLNLICNGIQMILTVIFGTIGLLFLGYWKWVLTIIAVSFILLLASFFLKSIKIK
GYSIEKLIQKINEIPKPIHRKNIILGILRYVVFSHQYYFLFLAFDVDLPYWTMISTIAVV
YFLASSLPTFQFLDFAVKGSVAVYFFGVLQVNEWIVVFVTTLMWFLNVVLPVVWGSYYVL
NFKTSQGIQNE
>EGALAKHO_02140 Undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
MMTIILTVILVIYISSIGLLIYGFLRIKKYQKKDLKPQTSFTIIVPFRNEEENLPNLLNS
FSNLNYPTDLFEVILVDDSSKEKFQVSSFRFQVSLIDNIRVSNSPKKDAITTAMQHVKTH
WVITTDADCIVPENWLLAFDNYIQENQVSMLAGAVSYECQNSFLHHFQQLDLTSLQGATI
GSFGLNKAFMCNGANFAYTKSLFEKLNGFDGNNKIASGDDVFLLQKAVEQFPKEVHYLKA
EEAIVVTKPTETWKILFYQRVRWAAKTSSYKSTFGKFLGLIVFFGNLSFVIGFIFLLFRI
WYYPIFVLFAFFKFGIDFVLLYITNQFLIKSRIKSLFLSSLLYPFFSSAVALYSLFGSYE
WKGRRFKV
>EGALAKHO_02141 hypothetical protein
MKQFPIFLVFIIFNSCQYFDKQVPSEKELLQKELKAINWKEVDEYPSVAECEKIADKKLR
QQCFFEVMGQLIEAKLDIDTLSILYPELDTIEVKVTVFPNATMKFEPQFPKDSVAYDTIK
IDSVLHARLVDFPKVNPAIKRGIPVKTQFILPVIIKAKDQK
>EGALAKHO_02142 hypothetical protein
MRKLLNLVFICFLISSIINNLHAQVKKLSIDDRLLQDSIYKSNKKKVLNFSMKEFDALFF
EYFNRRNDPNIILTKTEFYSYTVQIATFSDRLAHLYPDQKEIAATNKEKWLSESYEEYLQ
YKASQKK
>EGALAKHO_02143 hypothetical protein
MDLLLLLLGFICMIVGVFGSFLPILPGLSSCWVGLLLLYLTKAVENNYWVLGITLVLTIL
ITILDYVIPAKGTKKFGGSSYGIWGTNIGLAVGILAPIPFGVIIGPFVGAFIGELIYDSK
NHQRALKAATGSLLGFLASSFINFIFCIIFLGIFLHVTWEYRNILF
>EGALAKHO_02144 hypothetical protein
MTPNLQIELRRFISSNVVSKLNKFYFENDALLIKGIDVSIGTILMGLYNRAEESGFYKEL
TTLIAEDSTFYQEVDFTSGRILSVDDCYRIEGNALLKGIFTEKKGRISEMISNEVGIKSE
TAREILNFSALLVVSYLKNNAQLLDSLKLLLEEQKREILNSIQPGIKIILGFSCYEAVED
KNQSMGRSIFTLFGHNFFSF
>EGALAKHO_02145 23S rRNA pseudouridine(2604) synthase
MNNKEGNNKRGGSRPNSSRSNSSKPKPPMAKRAQGPKKAKPAVKAAEEEKAEKIKKQNQA
PKRQKAADEIRLNKYISNSGVCSRRDADIYIQSGNVKVNGVPVTEMGYLVKLNDVVNFDG
VTLTPEKKEYILLNKPKNFTTALDEGQEYRNVLELVRGSTTAKIAPIGRMDKNTTGLLLF
TNDTDMIRKFTLPSQKSSKIYQVSLDKNLKFEDLEKISKGLVLDGHRVFVEEVSYIDNEP
KSEVGLKLRSSNVKVVRAIFENFEYDVLRIDRVSFAGLTKKNLPRGNWRFLTEQEIINLK
NV
>EGALAKHO_02146 hypothetical protein
MLSRQHKLLVMKIVSLFSVVRGYNIPIIILAQYLSAIFILAPEKRALDILLDFNLFLIVF
ASAITIASGYIINNFYDSQKDLINRPNKSMLDRLVSQKTKLSVYFTLNFLAVLMAFIVSW
RAFLFFSAYIFFIWFYSHKVKKYPIVGNLMAAFMAVIPFFAILLYFYNKISFEEIEDHMS
HFMVISAHAVFLFLLLLIREMIKDLENLKGDLANDYRTIPILYNEAVSKQIITALTVLTV
IPVYVLINVYDVGYMDIYFYVCFVVMLFFLLYLWKSNSKEQYLLLHNVLKFLIVSGVFCI
VLINPSVLWHGKNLISRF
>EGALAKHO_02147 hypothetical protein
MKSILKIIKATFLGGILFLAPLILLLVLLEKGFSIIQKITKPIVNQFPDVKVLGLAIEEI
VAIFIIAFICFTAGLIAKTGGAQRLIRKLEDGILSFVPGYSFIKNMNESMLGFESNQDLK
VILVPTDAGIQFAFMVEEINENKFAVFIPDAPNPWSGSVVFVEKKDITEVDISQKEALAC
IRKLGYGSAALLKNKL
>EGALAKHO_02148 hypothetical protein
MKGPLFYSKILLFGEYGIIRDSKGLSIPYNFYNGALKRIEDPSAEAIASNASLKRFASYL
ETLQTEQPELVAFDLTALKNDVETGMYFDSSIPQGYGVGSSGALVAAIYDKYATHKITVL
ENLTREKLLQLKNIFSQMESFFHGKSSGLDPLNSYLSIPILINSKDNIEATGIPTQSFDG
KGAVFLLDSGIVGETAPMVNIFMENLKDKGFRAMLKNQFVKYTDACVENFLHGDMKSLFT
NTKKLSKVVLNNFKPMIPEQFHGIWQNGIDTNDYYLKLCGSGGGGYILGFTEDLERAKAS
LKDYKLEVVYQF
>EGALAKHO_02149 hypothetical protein
MFTAADFIPKKYTSTIENGNFEWSAPSNIALVKYWGKKDNQIPANPSVSFTLNNCKTITK
LGFEKRENQDSFSFDLLFEGKPKEDFKPKIQKFLERIEVYLPFLKDYHFTIDTQNTFPHS
SGIASSASGMAALAMNFMSLEKELNPEMTEDYFYQKASFLARLGSGSACRSVKGKVVIWG
NQSNIEGSSDLFGIEFPYAIHENFKNYQDTILLVDKGEKQVSSTVGHDLMHNHPYAEKRF
AQAHENLDQLISIFENGNLEEFIKVVESEALTLHAMMMTSMPYFILMKPNTLQIINSIWK
FRNETQIPVCFTLDAGANVHVLYPENVSAKVLQFIKDELVVFCQNGQYICDEIGEGSIAL
>EGALAKHO_02150 Tryptophan-rich protein TspO
MKLNKITRIAIAVIVCLAVGYSSSTFTKEGVETWYPTLLKPSFNPPNWIFMPVWTLLFIL
MGVAAGLVWDKIKEQNEEVKKALGFFLAQLILNAVWSYIFFGLKNPMLALIEIVLLWLMI
YETYLKFTKINKTAGYLLIPYMAWVSFAGILNASIWWLNR
>EGALAKHO_02151 hypothetical protein
MKVKLLTTISFFTYQLSVSQTEKLLHGKVVSQNLVLQDIEVINKTAKTSTTTNTLGEFSI
LVNVKDSLIFFSKDYFFSRLKITSQNIETNNLVVNMILKPEELDEVVITKIKFPHVGAAD
EGSTVIPSPSLQKYTGVYDGTIANGVNFIAVGTLISDLFKKEEKPKKKIPEIDFKKLIIT
TIPETFFTKDLKLTSEEKELFLQFCDADPKSKTLLEHPNILATMDFLTAKNEEFKKLKTE
LKN
>EGALAKHO_02152 hypothetical protein
MKVKLLTTISFFTYQLSISQTEKLLHGKVVSQNLILQDVEVINKTAKTSTTTNALGEFSI
LAKEQDSLLFFSKDYLFTRLKLTLKDLDKNYLIVEMNPKAEELDNVIVARSVFNKTELKQ
IANNREEINKIKIRKQFDDVTTKVTVYDGKIKNAINFNYPIFDKPKKKIEPLDDRFKKLI
IASFPPEFFLKNLNITSKEKELFINFCDADPKSKTLLEHPNVLATMDFLYAKNEEFKKLK
TKNIN
>EGALAKHO_02153 Phosphoglycolate phosphatase
MKYKGIIFDLDGTLVNSLEDISDAMNNVLTNLNYPTHTYNAYQYFIGSGLRNLVSKALPA
SNNSENEIEVCFENMIAEYREICTLKTKPYAGIVELLDDLVSRDIKLAVFSNKADELTKK
IALEIFPDYFNTAVGLSTEALKKPNPFEAIQISKNWNLQTEEIIFIGDSDIDMLTATNAN
MFPLGVSWGYRTEEELIASGAKLIINKPADLIEIL
>EGALAKHO_02154 Monomeric sarcosine oxidase
MSQNFDILIVGGGAAGFFTAINIAEKNPKLKIAILERGKEVLSKVRVSGGGRCNVTHACF
EPNELVKFYPRGEKELRGPFHQFCSGDTIEWFEKHGVELKIEDDGRMFPVSNSSQTIIDC
FLKATEKLGIKVLTGQSVQSIYKAENHWKIDTQNDKFIAEKLVLATGSNPKIWEMLQEKG
HAIVSPVPSLFTFNIKDPRIKELPGVAAQVTVNVKDTKLESTGPLLITHWGMSGPAILKL
SAWGARILFDKNYQFTIFVNWLNDVDTEDAEKILKDLKQEHAKKAVSKKSPFDFPNRLWE
SLVLASEIEAETKWADLSKIQLQNLASQLTKATFQVNGKSTFKEEFVTAGGIDLKEINFK
TMESKLHQNLYFAGEIVNIDAITGGFNFQNAWTSGFILANNI
>EGALAKHO_02155 Glycerophosphodiester phosphodiesterase
MLKIAHRGAKGYEPENTLQAFQKALDLNADGIELDVHLSVDGHIIVIHDETIDKMTNGQG
FVNTLSLPELKSFLIAEKHEIPTLNEVFDLVDKKCLINIELKSKDALQCVSTLIEKYVSE
KNWKYEHFIVSSFDWSALQHVHDLNQNIPIGVLTETDLNLALSFAETIKAKAIHPYYHLL
NEKNTREIQEKGFLVLPWTVNIEEDIQKIKNYKVNGIITDFPDKI
>EGALAKHO_02156 Periplasmic alpha-amylase
MKKYTFLFLPLVFLITSCSGSKSVSMNNENTSKTPFVWEGANVYFLLTDRFYNGNTANDI
NFNRTKTPAKLRGFEGGDIIGITKKIESGYFEKLGINAIWLTPIVEQIHDGVDEGTGLTY
GFHGYWAKDWTALDPNFGTKEDLAKLVQKAHEKGIRIILDGVINHTGPVTAEDPVWPSDW
VRTGVVCDYKSFENTTMCTLVDNLPDVRTESTQEVQLPPFLIEKWKKEGRYEKEVASLDE
FFKRTNYPRTPKYYIIKWLTDYIVEFGIDGYRADTVKHTNEDVWADFKKECDYAFETWKK
HHPLQVLDQNPFYTIAEVYGYGISGGQDYDFGDRKVNYFQNGFNSMINFEFKWNAGQNNY
EGLFSKYSNALNNELKGYSVLNYMSSHDDGQPFDANRAKTLEAGTKLLLSPGMSQVYYGD
ESGRSLVVEGTNGDATLRSNMNWDDILNNQETKKTLLHWQKLGQFRKNHPAIGAGIHQQI
SSEFYVFSRTFSKGTFEDKVVIGLDLPQGKKEIPVNSIFENGTKLKDTYSDQNVEVIDGK
VVIDSDFDVVLLEKI
>EGALAKHO_02157 Neopullulanase 2
MRIQINQSFYKILLLVLIFSASAKAQIQKVEPPFWYAGMKNPEVQIMFYGKNIAQYEALV
SNNVAIKNVEKTENPNYLFVTIDTQNIKASELVFSFKANNKVAFTQKYTLKERRANSADR
KSYDSSDLIYLIMPDRFANGNPKNDSNTSLTEKANRAEPAGRHGGDIEGIIKNLDYISSL
GATTIWNTPLCEDNDKQHSYHGYAQSDVYKIDPRYGTNEDYLRLSSELHKKNMKLVMDYV
TNHWGITHWMMKDMPTKTWFNQFENFTQTHHRREVITDIHASKIDQEVCVDGWFVPSMPD
LNLRNPLVAKYLTQNAIWWIEYANLDGFRVDTYNYSDKTAMANWAKAITNEYPNFNIVGE
IWMNNQANLSYWQKDSKIGAIENYNSNLPSVMDFTLQSQITSAFNEDEPSWDNGLIKFYN
NFAMDFLYPNTNSILVFAENHDTDRMNEKFKYDLPKYKLAMTLIATIRGIPQVYYGSEIG
MGGDKGKGDADIRRDFPGGWAGDKNNALTATGRTVEQAQYFDFTSKLFNWRKSNEAIHTG
KMTHYIPENNTYVYFRYNDTKTVMVVFNNNAKAQTVKTNRFKENIKNFKSGKDVITGKTF
DLTTEITLEPKSALVLELE
>EGALAKHO_02158 Glucan 1,4-alpha-glucosidase SusB
MKNLFFASLILFAFSSIAEAQQLKSPEGKFVMEFSLQNDGTPTYNLKYKNKEVVKTSKLG
LELKDDKKSLLNDFTVVDTKTATFDETWKPVWGEVDNIRNHYNELAVTLNQKGTDRQIVI
RFRLFDDGLGFRYEFPTQKNLTYFVIKEERTQFAMAGDHTAFWIPGDYDTQEYDYTKSKL
SEIRGLSQKAYTANVSQKNFSPTGVQTSLMLKTADGIYINLHEAALINYSCMHLNLDDKN
MIFESWLTPDAKGDKGYIQAPSHSPWRTIMVSDDARDILASKMTLNLNDPSKIDDTSWIK
PVKYVGVWWEMITGKSSWSYTNDFPTVQLGVSDFSKAKPSGTHGANNANVKKYIDFAAAN
GFDAVLVEGWNEGWEDWFGHSKDYVFDFLTPYPDFDVKGLHEYAKSKGIKIIMHHETSGS
VRNYERHMDKAYQFMKDNGYDAVKSGYVGDILPRGENHYDQWIVNHYQYAIEKAADYKIM
VNAHEAVRPTGICRTYPNLIGNEAARGTEYQAFGGSKPNHVTVLPFTRLIGGPMDYTPGI
FEMDISKMNPDNKSHVNSTICNQLALYVTMYSPLQMAADTPDNYNRFPDAFQFIKDVAVD
WSESKYIEAEPGDFITVARKAKGTNNWFVGNVNGDNSRTSNIDFSFLEKGKKYTATIYAD
AKDAHYKTNPQAYTIKKIAVTNKSKLSQLSAPGGGYAISIIENK
>EGALAKHO_02159 Maltose phosphorylase
MNQDYIKPDNWSIIEEGFDVERVKSSESLFSIGNGAMGQRANFEETYSGETFQGSYIAGI
YYPDKTKVGWWKNGYPKYFAKVLNAPNWIGIDVKINEENLDLKTCTEVKNFRRELNMKEG
WYNRSFEATLKNGTEIAVNIRRFLSLDLDEAGIIKYEITPLNKDAKIVYKPYIDAGVTNE
DANWEEKFWEPLEVKKGANEAFVTAQTFKTHFKVTTFMHNTIFANGENVNISPSTIDSTT
DKVQFTYGTIIAKGQTSSIQKIGGYTVSLNHENTLAAAEKTIKAAVNLGYDALLQNQIDA
WSKIWEMSDITIDGDVKAQQGIRFNIFQLNQTYLGKDSRLNIGPKGFTGEKYGGSTYWDT
EAYCIPFYMATKDQQVARNLLTYRFNQLDKAIENAKDNLGFKNGAALYPMVTMNGEECHN
EWEITHEEIHRNGAIAFAIYNYYRFTGDYSYIPEKGLEVLIGIARFWHQRASFSKEKNQY
VILGVTGPNEYENNINNNFYTNYIAKWCIDYAAEQIKKVSTEYPSDHKRILEKVSLSANE
IQEWKKVADDMYFPTSKELGIYLQQDGFLDKDLVPVKDLDRSQRPINQKWSWDRVLRSPY
IKQADVLQCFYFFEDHFSKEELERNFDFYESFTVHESSLSPCVHSIQAAHLDKMDMAYTF
YLRTSRLDLDDYNKEVEEGCHITSMAGTWMSIVEGFGGMRVKNDQLHFAPKIPKEWKGYS
FKINFRNQILKVAVNHNETTFTVDGDQDLTIMVNGNPVIASKFVQID
>EGALAKHO_02160 Beta-phosphoglucomutase
MKKAFIFDLDGVIVDTAKYHFLAWQKIAQSLNINFTHEDNELLKGVSRVRSLDIILGLGN
VQASQEDKDKWLIQKNEDYLSYLVDMDESEILPGVFTILKLLKDKNQGIALGSASKNARP
ILEKTGILSYFDVIVDGNDVTNAKPDPEVFLKAAQLLNIDPKNSIVFEDSVAGIQAANIG
EMVSVGIGEETILHEADYIFKDFTEINTAFIEKLIN
>EGALAKHO_02161 hypothetical protein
MEKRKLSFWEIWNMSFGFLGIQMGFALQNANASKILQIFGAEVHELSWFWIIAPLMGLIV
QPVIGHYSDKTWGKFGRRKPFFLAGAVLASVGLILMPQANIFISILPALWVGAGMLMIMD
ASFNIAMEPFRALVGDNLRTDQRTAGFSIQTSLIGFGAVIGSALPYVLTKWFHISNNAAP
GSIPLNLKLSFIIGAAVLIGSILVTLFTTKEYTPEELANFEDPQSEADIPSDEKAKLTDI
FTDFAKMPTTMRQLSWVQFFSWFGLFGMWVFTTPAIAHHIYGLPLNDTSSQQYQDAGDWV
GILFGVYNLVSAIIALFFLPLIAKKIGRKSTHAVSLIIGGIGLISIYFMPNEDWVVFPMI
LVGVAWASILAMPYAILAGSIAPKKMGVYMGIFNFFIVIPQIVNALIGGPIVKYLYNGDA
IYALITSGVSFLIAALLVYKVKDVDDTIQKS
>EGALAKHO_02162 HTH-type transcriptional regulator DegA
MKRKITLKQIAKELDVSISTVSKSLRNSLEIGEETRLKVQAFAKFYNYKPNNIALSLKNR
KTKSIGIIIPEIVHYFFSTVINGIEQVANENGYSVVICLSDDSFDKEVLNMEMLANGSID
GFIMSLSKETQYKGDFHHITEVINQGMPVVMFDRVTNDILCDKVIIDDKAAAYEAVQSLI
DNGRKKIALVTTVDYVSVGKLRTDGYEKALLDNGLPFNEDLIIKIEDVDTCEITISQLLH
DRAFDAVFAVNELFAVTIIKTASKMGLKVPEDLAVIAFTDGIISKYSTPSITTVSQSGEK
MGNKAAKMLIERLEAEHDDDEEENENYTTEVIETHLIKRESTD
>EGALAKHO_02163 TonB-dependent receptor SusC
MKTIYKKLLFLFLLLPFTVLAQSTLSGTVVDKATGQPIPGVNVNVQGSKGGTSTDFDGKF
QLPNLKNGDKVVVSFIGYVSSTVTFSGQKTVSVSLEEDTNQLKEVVVQVGYGTVKKKDAT
GAVTVLSGKDFNKGPVSSADQMIQGKVAGLQIINAGGSPGADPVVRIRSGSSLTANNDPL
YVIDGIPVANGGVEGGRNPLSTINQNDIESISVLKDASATAIYGSRASNGVIIITTKKGK
AGDIKVSYNGNFQVSEVTQQVDALSSGQFRDFVNANGSTAQKAAMGQANTNWQDEIYRTA
MGTDQNVSASGGADNIAYRASVGYTNLNGVLLRDNFERTTLGVSLTGDFFDKHLKVQVNN
NTSVIKSNYSNTGAVGSAVGFDPTQSVKNADGTYFQWMTNPTEFNQLAGKNPVAMINQQD
NLGTFNRSIGNIQLDYKMHFLPELKAVVNLGYDQMSGRGYGGTDADYLFGLKGSGYNNSY
VNIEKRNNKLMDLYLNYNKMIESISTQIDVTGGYTYQDFREEKNKSNYNFENDVNTVELF
TPTHINLQSFFGRANFTVADKYLATVSIRRDGTSRFTEEYRWSNFPAVSLAWKLNEESFL
KDVASINSLKLRGGWGITGQQNIGNAYPSIPLYLASNSAAQYQIGNTFYTTYRPQPYNTN
LKWEETTTINVGLDFALFNNRFTGTADVYQRTTDDLLLYTQNPAFFGFSNYDNYNVGSLK
NKGIELSGEVVAVQKDNLEWRIGGNITFQDSKITKLTTTQDNTPGLEAGDNISGGTGNKI
QNNQVGYAPNTFYVFEQAYNAAGKPIDGVFVDRNKDGVVNSDDMYRFHKPAADVFYGFYT
SLTYKSWDFSMNWRGSWGNYMYNNVDSGNGTYNNILIRQNDLSNGVENLLETGFKQGSNF
QLKSDYYIQDASFVKLDNVTVGYTFNQKIKGISTLKLTASAQNVLTITKYEGLNPEISNG
IDNNIYPRPITFMLGLNANF
>EGALAKHO_02164 Starch-binding protein SusD
MKKIQIKLLGISLFMMTMLVSSCTDDLNQSPDTGDSVSSDELFADPASYKGNLAKLYAGF
ATTGQQGPAGSPDISGIDEGTSQYIRGFWMMQELTTDEAVIAWNDGTIKDFHSQTWSSAD
TFIAATFARFSFQIVNCNEFLRQTTDAKLAGRGVTDAAVLADIKTYRAEARFLRALTYWH
LEDTFGAGSLVTEDSPTTFYYPDYASRADIYKFIDEELTAIEPLLKAPKTNELYRADQAA
AWMLHAKLYMNAKVYIGTDHYAEAVPLINKVISSGYAIHNNYNQLFLADNDKNGAQNEFI
LAVAFDGIHTQTYGGTTFLVHAPVGGSMVASEFGINGGWGGIRTTSAFVNKFDANTTDTR
GKFYTQGQSKEIADIGSFTDGYAIQKFKNVDVNGVQGSDKAGNFADTDFPIFRLADAYLM
YAECAVRGAGGNLGTATTYVNALRTRAKANTVSQGDLTLNFILDERGRELHWEGHRRTDL
IRFGKFTGGSYLWPWKGNVAGGTSTQSYRDIFPIPAGALGANQNLKQNPGY
>EGALAKHO_02165 hypothetical protein
MKNITKSLIALLALVAISCSVEDVQDRPVIEGIDTPVLTAPAAGAAYVLSPDDADVQAER
FTWKSANYGGDVEVTYTVEMDAKGNAFKTPQELGTVKSQNQVSVSVAKLNGAALALKAIP
FAAADFEVRVRSNVSTNVMFSNVTGIVVTPYTTETPRLWIPGEYQEASGYGAKWTPAAAP
QLMAEGYGKTAFDGYVYFAAASDFLLTPAANFDNKYTKGATAGTLLYNGSDNLKIDAPGY
YRIKADTDPAKLTYSATKTTWGIIGNGTPGGWDADTPMVYNPATKKWTVTVVLTTQAAPD
NGMKFRANGNWDLNYGDTGANGTLEEGGTNIGTTAGTYLITLDLSSPRNYTYTMVKQ
>EGALAKHO_02166 Malto-oligosyltrehalose trehalohydrolase
MKKTLLLFFFLLSAISFAQQQTATYSVSPASFEETASVTVTINGSSINEATWGVADHSLY
MWAWAFDTNDTTQKGTPNNGAWEASSDASKFTYNAGTDTYTKTITPTAYYNTTGIGKIGF
LIKAKDGTGDKKSQDILVEVGSFQVNLTSPIENSATILASGSNFNIAATNTNGVASYTLK
ANGTTIDTNASTSAYSYAANNVTSNQNYELVVVQGTVTISKKFSIIVNPNTVSEAMPAGL
VDGINYNTADATKATLVLDAPLKDFVYVAGSFNNWQPTGAYAMKKDPASDKFWLELTGLV
SGVNNTYQYWVVDGTPLANSPSLVKTADPYSTLVLSPYDDPTIPAASYPNMPVYPTGQNF
EVTVLKTGQTPYNWQVTNFTKPEKDKLVVYEVLVRDFDAKRSYQSLIDRIDYFKTLKINA
IELMPVMEFEGNESWGYNTSFHMALDKFYGTSDKLKELIDLCHQNGIAVILDVALNHAFG
RNPMVRMWMSDPDGDGFGSPTTENPYFNTVAKHSYSVGEDFNHQSLKTQYYVQRVVKQWI
EEYKIDGFRWDLTKGFTQACTASDESCTNAYQQDRVDVLKKYADYSWSLDPTHYTIFEHL
GSDSEEQQWANYKIAETPSKGIMMWGKMTDQYNQLSMGYATSNNISRMMSSSRGFTGNRL
MGYAESHDEERLMYKNVQYGNSAGSYNVKTLNTALSRMSAIGAVSLLIPGPKMIWHFGEL
GWDDSIFTCRDGVVNDASATLSGDCKLDTKPQPQWNENWLGDTNRNKIYYDWAKMINLKV
TEPVFSGTATMANTTTLTVNIKITNAALAATQLKDVLIITNFDVTAQNVATGFQYTGTWY
NLMDNTPLNVTDVNATINLAPGEYRIYGNKTANLAIPEFEKGNSVNLYPNPVLNYFTLNI
ATTKIQVYAMSGQLVKSFAPNSNTDFQFGVSELKTGLYIVKAIDENDKVQVMKFIKK
>EGALAKHO_02167 hypothetical protein
MNTIKRILGVLWVILSIAAAYFCVFEFGLPKFLSDKQDDLVFGIIILFILTPLIVLGLGT
FGYFSMIGEYDEKK
>EGALAKHO_02168 Proline/betaine transporter
MSKTSTKGIWKVISASSMGTMIEWYDFYIFGSLAVVISTKFFPSDNPTAAFLSTLATFAA
GFVVRPFGALFFGRLGDIIGRKYTFMATLLLMGGSTFLIGCIPSYETIGFMAPLLVLILR
LLQGLALGGEYGGAATYVAEHAPVGQKGYWTSWIQTTATVGLFISLMVILATKNILSPED
FDAWGWRVPFWVSIVMVGVSYLIRKNMDESPVFAKAKKEGTTSANPLKESFGNRYNLKFV
LLALFGATMGQGVVWYTGQFYAMSFMKTVMNVDSSQVDGLLGIALLIGTPFFIVFGWLSD
KVGRKYIMMLGMLLAILSYRSIYKEMYNTTNVSYKTEIVEKTTQNIEKTKNNDIVTTISK
TYTDGTSYIEKKTDFANKKESQSTISIKVNSKDEWVLIFWVFIQVLFVTMVYGPIAAFLV
EMFPTKIRYTSMSLPYHVGNGIFGGLLPAISTYFVTHAKASGKADFYLDGLWYPIIIASV
CFVIGMIYIDNKNKTNHL
>EGALAKHO_02169 hypothetical protein
MHYLYILYSDSSQKFYIGETNNIEERLLKHQNHSYENSFTKIANDWRIVLIFNCVNREEA
IYLEKFIKRMKSKTFNNKIITDPSILKDILSKRK
>EGALAKHO_02170 RNA polymerase sigma factor CarQ
MGSSIEPHDDLLIQQYIHGNNDALNILIKRHESRIYGFIYSKIPDREICNDIFQETFVKV
IKKLQSGSYHEQGKFIPWVTKISHNLTIDHFRRNKFRYSFLKSIEDTPYEYLLDETPSIE
NRIIKTQIKNDLKKILKELPAEQREILILKMYHNMSHKEIAELKNISINTSLGRVRYAII
NLRKIILKNKHDFN
>EGALAKHO_02171 Transposon Tn10 TetD protein
MKTIQQSFGADLDWIESFAKNFGGSVEGNFINTPENIDTGTRYFLNTGEEDVVLLYIDVT
YNTEIHIIQSHFKKDFIGIYFNLIRGKTFKTCNDFSYDIGTLGYDVSIIDSLLETDYYVS
PGTQSYGICIFIKKIKIEQFARKNKNFSANIDKIMDDSQNTFIKFDHMSPEIFNILNDLR
NQEVGGSLFDLNLIATGYQLISNYLDRMFDNDIIEKVNNDDLMRILGIQALLINNIDQPF
PSIKTISDKAHMSETKFKRLFKKVTGTTPNYFYMSNKLKKAKELLEDKKNTITDVCDELN
FSNYSYFICKFREYFGISPNAYIKKL
>EGALAKHO_02172 hypothetical protein
MKKFYKIYLPALFVLFSFFSSYGQDIAPPKEVGAAASSIEKIEAADRWVDHFSNQDLVEL
PVGIRNTVNNVQYSIGITKAIFSPEYTTLTVFCRVDIPQKGENGQPMQLFFGADNVKLSH
QGGIIGEAKLVLLGNVDIPFSANKWQLSLYGGFDMATGNVNSDLTYVKIDCDGFKEMRVS
GAVEFSRDLILPIDEKTHTVDEAKTTVSKTYYNGKTVPIPNRVRGEFSFTASSWNDILVN
VSLQPFVLKDKRNGKDFEGNFQFLVSNAVLDLSDIKNDPTVQFPDYYAKNALLVPSPEAW
KGVYIQTFDVGLPKEFQTTDTAASKARLYVGAQNLIIDKYGVSGTFYADNVFPLDRGITS
QEKSWAYSLDHIDVTIAANTFVKANLNGQILLPISKAPQEKKENKTTTTPGTVTKAPQTN
RAGLLYNGFISMEEQQLVVVTKDSIAFDIWKAKALLLPNSSVELKLVNGKFLPKANLNGT
VSFGTNKTATDDAEVEGKRTVDFKGLSFENLQLQTVSPIISVRNMGYKGTVAFGNFPVSI
GNINVAINGNDSRIDFDLGINLMDENSGAGATARIGILGKMYDDGYRQRSKYNGLDVSAI
HIECKFGGMTMKGGLILMENDPVYGNGFNADLEVDVVDVVNVKAKAIFGRTTFRYWYFDA
ALKLHVGPTPTPFMINGFGGGAYYKMRRNQDIAIADFSPSGLSYTPDEKINLGIKALVYF
FSGSEKICTGEAGFEVAFNSRGGINRLAIFGKAKVMAEIKGLKEISTLVEKVKSNLTAKK
SLLNMSAGELIGSFVSNYLPKANEAIPEAPSDEIGIKMISAIEFDFQNNSLHGTMDTYIN
TPKNFLTGTGEGGRAVWAVLHKDPKDWYMYIGTPQDRCGIKIGVGGMFLKTTSYFMAGTL
LPASPPPPPVVAQILGVDAKELDYMRDENALANGGGLAFGSNLDFDTGDLSFLLFYARFQ
AGMGFDIMLKDYQEARCSNTGEQVGINGWYANGQSYAYLQGELGIRVKLSFLKFKVPIIT
GGAAVILQAKLPNPVWMRGYVGGNMNILGGLIKGKFRFKLEIGEVCQFENASPLGGLKLI
TDVTPKQGSADVDVFAVPQAAFSMKVNEAFVIPEDTGDVTYKVILEKFKVFDGATEIPGK
FEWNSMKDKVNFVSTDILPPKKELKVQVEVSFQKMVNGIFQPVKVDGKVATEYEERLFAT
GGAPNYIPLNNIQYSYPVVDQKYFLEEEYPKGYIQLKRGQDYLFEDASWETSVKVNEDGT
SNAKATAFNYNTSSNEVFYDLPDIKQEKKYNFSIVSNLKQAPSRNTTASTKTSTIADEGN
DIQIKENQADALSKAEGSIDRLSYSFNTSKYKTFNSKMNSINTQSYNFGVLYSDVIYLTN
MISSQEAFDLAELQGVTYSDNKPIIMAQSKLNDEYYTTDIFPYLYKDYPLNGNYSITNRD
TDELGIIPAKSVPLNAYYMTSIENDVNQSWTKGNFPFKYNMPLLYKQDWVDLNNQVINAY
INGDTRVESIAKRFLNSNFLFMRYGNYEIVMKYNLPGDKQSNEFTYKYKNNNNFR
>EGALAKHO_02173 hypothetical protein
MKMNTKKCWIKFLVVLLFLIGKNSYSQDVDLETFYKPNFKVSGGVNANMIFYNSNQQNSR
EPFSYLLSGNLNISAFTFNIPISYSLTNQGNHLGYSAPFDFNRLCIMPKYKWVKAYIGNV
SMTFSPYTLSGFPFKGVGLELTPRSPFKISLMGGKLLKAVNEDDALGGVPVYERFGYGAK
IGFEKESYKIGWIGFYAKDNENSISLIGTDTGVTPKENWVNSFTFGTSLVKDLNFNVEYA
LSVLTDDIRAAGTSRRSYRDRLFSAKENTSYLNAVNVNFDYAIQKSKLGLTYERIDPNYN
TLGALYFNNDLENIALRFSRPFYKDNINVSASLGYQRDDLAQEKKQNTKRVVGSINMNYK
ITDQINFTGSYSNFSTYTNKKLDQFELINNPNVVAADTLDYRQLSQNANLNLTYAFGKKK
NQNMTLNYSIAGQANEQGGIIRKGQASTVQNYMVSHSVNFTGIKTALNSSLNYTNNQVGQ
FDNSSLGASVGVSKKLLKEKLNANFGLLYNNTKSDESSSSVFGINFNNSYTLLKKHNFKL
GMISMFRSATNKPANNDLMLNFNYGYSF
>EGALAKHO_02174 hypothetical protein
MKKTLLFLLLLVISSCYQETSIAVEGDFTTSYVNEDESVPVIVKIDSKVTGADTYEWTFE
GASPSSSNLKNPGEVLYDKQGTYTIKLRATNADGESKEISKTVVIKDGIDIQFTHEIIKS
NYSPVEVILTNTTIGEGFTFKWDFEGGIPATFTGKTPPNVIFTSPGEHKITLNVSNGFES
ETQIQTINVNTYLVSQFSYEPKFEDDDFQSPVTINFTNKSISATNYKWTFEGGNPATSAQ
ENPTVVFTSVGMHEVTLEALNDKTSQIFKSSITVQPDTNLRILTNIKLGINSAHNNNSIG
AMYSTTTRQVYKANEISDQNSGLIDIVFQGLNGNFSYNKFISPDQANSYGFITLKNAQST
VFVNSQNLCNCGLNFTESQFDTMINDTPIKSLNISYSAAGAQQFGFTYPRIILFKTQDGR
KGAIKIKDMVKNGTSSYILCDIKVQKQ
>EGALAKHO_02175 hypothetical protein
MKQNKIKMKKRILLVAVLQLFMVLGSCSSDSGNDSTPVQEEIKGEIKADYITDVSYVDDF
VIDGNNNVFVAGQISGQVSSYSLRKIDTEGKVTTLKSLDYINFNLSKLSISQEGEILLIA
RNSTENSDKIFRFENNFSELNPFYTMKPLSSPFASKIRLISICNNNDNTYFVYDSNNIQI
KRFIPDLNGDVFVAGSGKNEIKDGTGLNAGFGYVTKMISQNNVLYVIDNMSTGVSPTFVS
SNIRKLEYVNNEWKVSTLISTTNEAVYYSDIAFDSKNDLYVLVRGKGIYKLNLLDNSLVL
FKDGEFNVGKGNAHSSLDYKDIDMMKIKGNDMYLAIRSFVIKISDFQTKFAAAEK
>EGALAKHO_02176 hypothetical protein
MKKYFLTLLVLLYTVFISAQKIKIDKGEIKLDEKTIGYVEGKKPIFRIYNLDKSYSVTAK
LKSVPNEPSLTLPWIEVIDDATGKSNELDFKSRKFSAFNYDRSIIYELLDRNYFTTDGLN
KEEIEKFLDSEATGISEKRLGVQNVIDQANKIADTYQLSIDDAGTIYSIKAQNQDPLDKR
IGYIKVISPVTNGELQYEVVDLDNYRIATWFAKAGMYSNYDKFLNQELITFDKKVFKAAF
DNHGNPIGYRMSKDNTAMNIVRVLVGNGYTLGTQYSEKRK
>EGALAKHO_02177 hypothetical protein
MSKNSVLIIKKLREEIFSKEIISDYRVNEQDFTRKRKQPFGQVVLFMMNLLKKSMALEIN
NFLEHLNSKLDFQKVESFTLSAFVQKRKKIKPEVFNYLSSVILENYYVDSNQNIKRFKDF
RVLAVDGSKITLPLTDQLKMFYGESKNQTNTSIVQARSSVLYDVLNRLVLDSVLENIKTG
ERELALSHKSHWKEKDLIIYDRGYPSYDFKYEHIKAGIDYLIRVQKNHSKIVSSFILSEK
RTLIVDVFPQEKHTFEGKDYDKTTSIKVRLVRVDLPGGEIEILMTSLLDSQIYPSNIFKE
LYFLRWGIETFYDELKNKLKVEYFTGYSKMSIEQDFFCAVFISNLQSIIVNDLEEELKAK
NQNTKLDYKVNTNLSYGFLKNRILELLFKEAPLEEVFKELENLFLQNTIPIRLNRNNKRE
SGKYRTRVRPIVLKNQKDAL
>EGALAKHO_02178 hypothetical protein
MRDKLKDSEYFNLFVNEKNKSSIRLLSFIKNGEVVEGRLPIVLESKFKNHLYSLIAKYSA
GCVIDDLYSDYYEALDFMYQSWMELDNRAYINDKKFNHYFGDDYDLMLWMISLGFLLNVS
EEKFRKLVEIVDKYQVRDLIYETIICAKLKDRKPIEEESYKLIMDMPFVYEKLRQAIHED
NDDYGKERASALIEVFLRKDWYPRHKGFSFHDAHKSKHNAYYGYWSFETAAICIILNLDV
SKYENNKYFPKDIYKYPSSRERNVIKLRF
>EGALAKHO_02179 hypothetical protein
MKNLFKHIILFVAVSIIGLNTGYAQLYPVQLTPVFNTPYSVKLSDYATSMDTKMRLMIIP
SDISILQRQVRLKLSIKGNGLNIQSSDYIQGQQPLFINGGEFQTLTNTDLAALFRLENLQ
GISALQYANGLPEGMYDFCFEMYDFVTNQRISQKSCAMMYLQLNDPPLLNTPQKNEQIAA
TDFPNILFTWTPRNINATNVSYKFELKQLMDPTMDPQFAFQMSPVLYEETLFGTALMYNL
NMPILTPGMRYAWRVRAVSTTGLSENAIFKNDGYSEIYSFKYTASCAAPTFLLSEAQGPT
SVKVSWQGIPDHTRYQIQYKKQDVRNAQWFSTNSLNTQSLITNLEPGITYQCRIGSSCDP
ATDGVQSFTYSNISTFTTPTQTNGVPAYNCGIIPKINIQNQKVLDNLIQSETFTAGDFPV
TVLELQGHSPYSGRGYIIVPYLADTKIAVEFNNITINTDYQLISGVVETSYNPDWKNVTD
VEDFTGEGQGGQIEETVSFVIEKIVINANGDIVVNGKGGQQITIPGGKDTVITDGSGKVY
KVDSKGNGTNEGIAAAPGGKSTPENTDGVDKNGQATEFTAKGISIAFSPESKSKYAFDVL
PDNLDNIPVALQNLYKKVGKKPLPYKAVVNGDTDTLLANVTVTDANIKLDSIVFKSQSGA
KIDFKRSDKVFVLSVKGNQTYAEEQILATIKQGDKWKVIGAFMLVHISPKEVNVALVPTD
DVSAKRLDAVIATTQEIYNKVGIKINFKKEGVLNIDSEVSGNTIPTEKNTLTSTYSKEQQ
NINSLYQGADNSYVLFITDKESSNKQQQGYMRLNGQFGYVFKAGLPKTPAHELGHGIFKL
EHPFELYKTQESSTDLLMDYSQGTVLNHQDWKQINDPVFKLYAFQSQASGEQVDKDFVLK
EDGYFLTPSNKLIKLPKGTQIIFTCDQPQRYKNGALFSFKTPDGFYWHDTTKFTMNEKTF
DGYFKADKNGWIKSNGQLISYSDSNFKYNGAGKYAVYFINLLAINSDKSEYRVLKQEVQL
STQQISSLNNFTGEIQDLVFKGSDGLVDTITSTGCETKPEEERGDFVISIESKNKNAILK
VYKNAITGKYAVEAELKGEGHKNTRNQKAALERQMSALATQKINELGGLKEKVSQRIFET
TDDGGEFLVKEMNGEQWLATICDLGLNVWESAALPENYWNQDNEVFKDSNIHIPPTLSGV
SDGAIGLVSDYPQLVKLAYDVGTKEEVRTGIWKAVKNITPSSVYLLAENTVKDKISKYNF
SDKPYLGHHEIGKDGVAVVSMVLGGSFITKGNNALENGTKEVGEEISEKAAKKVDDILDN
YAKQQKEILEKIKKGELEVNSNYRKGNFGEMATDVDLSTRGFKPLHTDRVTNLDATMKQG
IDGVFEKNGQYFIVESKYSGTSKLKNTLGGPQMSDGWIKGNNRLLNSVGQETKDIIDVKG
YKRILSEIAPDGKIVYKELDVDGKIISTINMF
>EGALAKHO_02180 hypothetical protein
MKKIYLLVFLLISGVGFSQASYTIEFKNLTYKVSRNVKNNTSSHFNLILNYSDGTSTNLY
TSKIGDDSSENNYSINSFPTNKIPKSITYDLFVNFSSTANISEKFDINIYPCVTSNSYSK
VYDGMNVSFNYDIRPNLNVIQPELGVNNFLPVDEDVIISSNTGFIEDYYNWEYSVNSDPT
NPSGWVALPQYATKASFTTNAKAILGVAASSYHGRKIFFRQKACNTKSTPVEYSIRLSTP
KILSAMPENVSCYDLGSQDGKLKIQFDRPLYPNENLSIDLLFKGSNINREHLILNPDNSY
LIEDLSRGDYELRLIGNLGLGTLNTYSPTANNPIKFTIEAPKPLDFTLHGSDILCNGAQN
GEITITPTGGTRNGHANDFYSLDNGVTWIPFFNGSPYTLTGLSPGKYAIKIKDMNGCIAR
TQTLVNGNIELGEEKIIEATISQPTSPLRLNYTFKKDPTFYGAANGKLVASISGGTINDD
QSYWYEWKNSTGVVLPTAARYNSADKSYNITLENVPAGEYKLIAHDKNYDAATNKEGCSV
IESSQILIQPEKIKIILEETQPISCHTESLDPLGNTDKKSDGIITATVSGGIPFTGSVNN
GLPYKFVWSKYNTVTNLWDELSEYKTETAINLSQGNYSLNVEDSNGIVQGAYNTTDLVTA
IPTTKAITEPTKLELSFTSGNVSCNQGNNGWATVNVTGGAGSYKYAWYNVNGGIIDKNRI
SQLTAGTYTVEVTDKNGCFTTGNIEITEPQSPVAIEYEEIFTPSFSGATDGRIVAKITGG
TPNDNQSYGYEWKNSKGELQAATAELKNGIYTITINNLPANDYFLTIKDKNYNEAANQIV
NCSKLDSKVTLSEPDPLKVVFEIVRSISCNTSNEFGNDTDTTPKDGQRDESQDGILVAHV
TGGTALATSANNGLPYYFYWKKQQADGSWIPLPMIKDSIASSLSHGNYALNIKDRNGIVL
GTYVNNKLTQEVDVTQLMQEPPKLAVTITHGDVFCNGGNDGWATANVTGGTPPYDYKWSN
DFDTDKNTILKAGDYWVFVTDAKGCTTQADVTITEPTAPLVIKYTETLNPSFYKATNGKI
VVEVTGGTIFSDNSYWFEWKNSKGIVQNTTAANFSNGIYTISLNGLGEETYSLTVHDANY
NAAVNKTSCTVANSVVTLDDPDPLEVTFEVVRTISCNVGNEFGNETDMNPQDSQRDESQD
GILVAHVKGGIQLPADKNNGLPYFYTWKKQQKDGSWIIWNDKDETAENISDGIYALNVED
ANGIKLGTYVNNILVKEIDITQFMPEPAKLNLTFTKLNASCNSGDDGWAEAHVSGGTAPY
TYEWTNGETTSKIENITTNNYFVVVTDSKGCTVQGSIFVGDPKGILATETVKNPTCFQGN
DGSIQLNVTGGNLPYSYLWNTGATTKDLNNVAAGNYDVTISCPDCCVFKRKFTLKNPNPI
VVNLGKDRTLCNDQVLDLDVAIADAKAQYNWTSTNGFTSNQAKVSLTKAGTYHVKVTSAL
GCVGEDDIVIKTNKVEISSEFLLSSEAYLDEEVVLVNISEPFGESTNWVIPNGVKIIEQK
EKYITLKFDKIGTYTIGLEQTQGECFATYNKNITVEKRSTLPNAGTTTKSIIDFIVTPNP
SNGNFKAIVNLENNSAVNLRLFSTTGEFTTQKKDSGKKNYEVDFNTSLQSGMYILVLETE
QQTLVKKIIIY
>EGALAKHO_02181 hypothetical protein
MVSQIFYNNKVFGFSRYFHKKNKNNKDIRLMHKTLLIFLLLLSVSLGFSQTKQAKVMVNA
RAQKDQILIRWAIDSPAEWQKANKKGFIVTRTTVLRDGVIISKAEKTLLTTKPLVPQPLD
SWIDLVQKDNNAAIIAQSIYGESFEVTGAKEGELSKIVNMADELNQRYTFALYAADMNFE
AAVKAGWGFVDTTVKKNEVYAYQVSVFENPKVKESSYVIGLKDYSVLPAPTDFIAIPDDK
KVMLSWDYETFKRIYTSFMIEKSSDGVNYTPISNTPLVNLNDKEDHPSKTMYYVDTLSVN
DKNYQYRLYGITSFGEKGELTKPIIARGVAAVVTPARLMDYNIVNSNEVNLEWDYPVASE
EFIQGYEINLADNDKGPYKVVSKIIPPSQRKLNYKESLFPSNYFTISVVGKNNQRLTSQS
MLVQPVDSIPPAKPIGLEGVIDSLGTVRLKWKPNQEKDLRGYRILKANNPDEEFVDIYHK
SYVGTEYKDGVSLKMTNSKVYYRIAAEDMRFNISDPSDVLVLDKPDKIPPAAPIFKDYDN
KDGKVHLKWIRSYSEDVVGYSLRRREKGQEKWEEIKEINDTIQEFTDDRVQNKKIYQYAI
LAKDKSNLWSSLDHSTITVQVLDFTPIKVITFLQGLSDRETKKITLTWDYDKKKGKVTGL
SIYKNIKGTPPTLWRELNGDVFILDDKSLKINTEYEYHLIPNLESNSPAKEEVLTVVY
>EGALAKHO_02182 hypothetical protein
MKKLLCLFSAVLFALTSCSNNDDNSSDKASSILVKKISYPKNDGSVYTETIVYDGNKIVS
LTGDDYMIKYTYIGSFITKSEEFDEKGVLDYTNEYTYTNGKLTISVEKGANSSSSYKTKY
VYNADGTVSYEGFTVVSGVEQKNGNDGKYTYKDGNLIKDEESDEVTLYEYDNKNHPYKNA
LGFNLFLGDDAASSNNVIKETRTSGSGANVYTSVTTSVYKYDVNNFPLEKVESRLSGGST
STETTQYAY
>EGALAKHO_02183 hypothetical protein
MFKGFVFVAPPEQMSNFFAQDLERLLRIRKNVLINLKENILS
>EGALAKHO_02184 hypothetical protein
MNIETLTDGVPLNDAKKALIMIHGRGAGAHDILSISKHLNVDDFALVAPQAENRTWYPYS
FLVPINENEPSFSKSLEAIHQVVVAIQQNGIEKENIYFLGFSQGACLALEFTARNAAKYG
GVVAFTGGLIGDKVYENHYSGNFENTPIFIGTSDPDFHVPVERVNETEVLLKKMGANVTK
KIYENMGHTISQDEVDLVNELIFMKD
>EGALAKHO_02185 hypothetical protein
METIKLELDEKQHGAFNLYVDDKKLGEMTVSIKPDLLTVYHTGVEPEAEGKGYAKKLLDE
MTSYVRANNLMVLPLCPYVHAQFKKHPDEYQDIWKK
>EGALAKHO_02186 Putative ring-cleaving dioxygenase MhqO
MENKILGLHHITAIAGDAKRNFNFYSKILGLRFIKKTVNFDDPGTYHFYFGDETGSAGTI
LTFFPWGEGIQQGRKGAGMATEIGYSVPKGSIDFWQKRFEQYNVIYNKPAEKFGEKYLTF
LDPDGLKLELIESKTGDNRKAWETDEVKGDVATKGFHNITLTLNDIKPTAAILTEIFGYK
LIDQDVNRYRYATDTVENAAIVDLVELADEKRGLNANGTVHHVAFRVKNDEILMYFREKI
EAYGLSITPQIDRQYFHSLYFREPGGVLFEIATDNPGFTVDESLEELGQNLKLPAQYESQ
RSSIENHLVKIN
>EGALAKHO_02187 hypothetical protein
MDIVKFKITSKTIKVEVRNSNNYVFNFNTAQEIAKEDRDVLLKLYNALDILFKKETPSEV
KNYISPNQTNILDQISAVDNLEQE
>EGALAKHO_02188 Phytochrome-like protein cph1
MNNKEKSANKELILSSDQSSFLKKENDLKNTKSGISKKELASLNNKTKKNTTRFNGEAIF
ENIQKKNFKPELPTVNNQSAILNNKKQAAEIQDLKEQLKAKERQLSNHANAIDTSNASIE
FDLEGNILSANKNFLEIMGYNEGDLLGKHHRILVNPGYSESRAYQLFWDSLKKGIYQKDE
FIRVAKNGKLIWLSGSYNPIFDTLGKPCRILKIATDITLAKTQFLQLAVQAQEKEKRASE
LVSANKELAFQNEEKEKRAAELVIANKELKFQNQQKEQRAKELIIANKELAIQSKEKEKR
AAELVIANKELKFQNEQKEQRAKELIIANKELAVQSKEKEKRAAELVIANKELKFQNEQK
EQRAKELIIANKELAVQSKEKEKRAAELIIANKKLAAENILKEKRKVEKQKRAAELIVKN
RELAYQEKRSEELSLANDELKKAQQELEAFSYSVSHDLRAPIRAINGYTQIITEDHLDLI
DDDGKNMFQAIIKNSNKMGVLIDDLLAFSKLGRKQVSSNNINMKALVNGIINEIIIEKDE
NTPIFEIDELAPSNGDSSLIKQVWINLISNAIKYSKYKSETRIKITSASKDDKIIYSIKD
YGAGFDMAYYDKLFGVFQRLHSQEEFSGTGIGLAIVQKIVNRHYGTVWAESELDAGAKFY
FSLPNIKH
>EGALAKHO_02189 Response regulator rcp1
MNYDDIEILFAEDSMEDALLTIRALNKSGFTNKLLHVKDGAEALDFIYCRGIYSERNPKS
HPKLFLLDLKMPKMSGMQVLEKVKMDAELKSIPVVILTSSQEDPDIAKCYSLGANSYIVK
PVDSNNFFNAIKEMGMYWMILSQPAV
>EGALAKHO_02190 Phytochrome-like protein cph1
MIPYQMKENIKVLILEDNISDADLIVRYLKKSGMSFVSKTVESRKVFEESLDVFMPDIIL
SDYSLPSFDAVSAFKIIKERELNIPFIIVSGTIGEENAVMLIKEGVTDYVSKNNFSSLLQ
KITRALKEAEELIEKENLLKKLKTQTAALLIVNQELEFQNAEKEKRAIELLNANKELLAF
NFISSHDLQEPLRKIQIFISIIMEKEMETMTEGGKNNLKRIHVAATRMRQLIEDLMDFSR
VSAVDHQYEMNDLQDIIEDVKSELNDKIRQKKAVFKTNGLIPVNVIAFQFRQLIYNLISN
SLKFSIPEVPPQITMESTILKNKEFKLLNIADTQQKCDYWNFSFKDNGIGFEAQYNQNIF
VIFQRLHHIEDYSGTGIGLAIVKKIVENHNGIIIADGSLNKGVTFNIYIPIVENLDKNSA
DFKHKNRTPIAIKKKLHACETQ
>EGALAKHO_02191 Sodium, potassium, lithium and rubidium/H(+) antiporter
MLENFPFYLGLLIVILLLIMLASKIKVAYPVLLVLAGLVISFIPGVPVINIKPELIFFIF
LPPLLYEAAWTVSWKEMWRWRRIITSFAFVVVFLSALSVALVANYVIPGFSLALGFVLGG
IVSPPDAVSAGAILKFVKVPKAISSILEGESLLNDASSLIIFRFAMIAVATEQFIFYKAA
TSFSWMIFGGVAIGLLIGWLFMKAHKYLPTDANVDIVLSLLTPYIIYLAAEEVHCSGVLA
VVSGGLLLSNNRHRFLSSKSRLRGVNVWESVCFILNGFVFMLIGLDLPQITKGLEQVSLP
SAIGYGVLITFVLIVSRMLSSYGAVVVTLIARNFITVADTRNPGIKTPFILGWTGMRGVV
SLAAALSIPVYLNNGNGFPQRNLILFITFIVILLTLLIQGLTLPYFIRKIKLTDIYDPVP
RDEAYNNVRKELAEYATDYLKTNYSNEIEHNTSLQHLIQKWELHSNGIDDEAIGAELKVI
YLDLLNQQRYWLIEKNKKDKTLDESIIRRQMHYLDIEEEKLRYL
>EGALAKHO_02192 hypothetical protein
MKRSGTADLPLHYGHVPLWLAERMSKLGLAIVETIAMEFSTSEVISKLSNPFWFQSFGAV
MGMDWHSSGITTSVLGALKKSVNPHSKELGIYICGGKGKHSMLTPQELLFVGEKTGLNGN
DLANCSRLTAKVDNTAIQDGFQLYQHNFIVDNKGQWAVIQQGMNPNSKTARRYHWHSQDL
KSFINEPHTFIYGENQGTILNLTAEAATKSRQGILELSKEAPTKIMKEMQYLSMPAHHDV
RMEDVNMKRLGAMLWTTHENKPEDFQELLLLKGMGPRALQSLALVSEIIYGTPTRFEDPA
RFSFAHGGKDGHPFPVPVKIYDETIETLQRAINRAKIGNSDKIEAIRKLSEISRKAEESF
TPNSNFDALIQRERDESHKYGGRTVFGDAKPPKKKPSNPNNNQLELF
>EGALAKHO_02193 hypothetical protein
MSFQNTIKKAYSAFNERNIDNALSTMQSDVQWSKAWEGGYISGHDEIKQYWTRQWTEINP
KVEPVGFNERENGSLEVKVHQHVKDLQGNLMFDGLVKHIYTFQDGLIKTMDIELVENN
>EGALAKHO_02194 Methionine aminopeptidase 2
MSIKQESELIGMKKASEAVAYALKEMRKFAKPGMTTKELDEYGGKILNDLGAKSAPYLTY
GFPGWTCISVNNEFCHGIPSDMKILKEGDLINIDVSAELDGFWSDNGGSFVIGEDKNGHQ
KLVDASKDILQKAINNIKGGVKISEIGYLIESEAKKRGYKVIKNLGGHGIGRSLHEQPDE
LLNYKNRFDQRRFKKNSVVAIETFISTTSSQAVELKDGWTMVGNKGGFMAQHEHTIVVTE
GKPIILTEMNEIWN
>EGALAKHO_02195 hypothetical protein
MKPLKYLFIGLSLLAINFSNAQVNVNVNIGTPPAWGPAGYNDARYYYLPDLQTYYDVSTS
NYIYINNGKWTRARTLPSVYRNYDLYNEYKVVLTDYRGNSPYDNFNTHKVKYGKGYKGKP
QKNIGPKPGNGNNKEGKDNGNHGNGNGHGNGKGNGKH
>EGALAKHO_02196 hypothetical protein
MTQVIYDGTYEGWLTAVFEIYEFKFQEIVFAKKEASSDLFFAENHVVITELSKANRVLAG
LKQRLSPDGFAGIYKAFLSDLNKIEEIMFRFVQYVFSNEKNVEGDFGNPAVWDIRKTIRL
VRKEAHRMEAFVRFKLTKDQLYYAIIEPDCDVLPLIENHFKKRYADQRWLIYDAKRKYGI
YYDLENVAVIELQFNSKSNSAQYLTEICNEQEEFFQSLWRKYFSSVNIESRKNMKLHVQH
MPKRYWKHMIEKIPEIKK
>EGALAKHO_02197 hypothetical protein
MVNERVMEKLGILADAAKYDVSCSSALSKRENKDKGLGNAKGYGICHAFTEDGRCVSLLK
ILLTNHCIFDCAYCVSRKSNDVKRAAFTVQEVVDLTIGFYRRNYIEGLFLSSGIFDNADY
TMERLVKIAKKLRLEENFNGYIHLKAIPGASEELLKEAGIYADRLSVNVEMPTEQSLKLL
APDKNHKDVIKPMEYLKNEIVGYNEEKKRNYKAPLFAPAGQSTQMVIGATKESDLEILGM
ADYFYQQMNMKRVYYSGYVPISYDNRLPAIGTPVPIIREHRLYQADWLIRYYGFNVNEIV
GFNQPNLDLDIDPKLGWALRNLNQFPVDVNTADLELIKRIPGIGHLSATKIVSARKFKKL
FPEDLKKLGIAYSRAKFFLAFASPFQLQKDLTSIQIKDQILNLQKSKYKNDFSNQLSLF
>EGALAKHO_02198 hypothetical protein
MEHDKFIFCLEGVPDVDTYLETQVVRNLEEIAIDQGIASIYKTCDTIEGLEESLNVLLYE
DHNFKDYEIIYLVMPGEPNNICLHDYYYSLEEIAELFEGKMKGKVIHFANKKILDLNEEE
AQYFLDITGARAISGYGSTYNKIASSSTIDKAFFSLYQDNDDLTEVVEELYQKHYALCQL
LDFRLYY
>EGALAKHO_02199 HTH-type transcriptional activator Btr
MKKQATEKVKTYEPQGFRERFLGEENPIHLLFKLNSDHFFCLKIEEMMGLQFPVPPSKHS
CHTIIFITSGIHRIKIGFEEYNTYSNGIIVVPAGQIFSIEHLNNKHGGFVCQFHPNVLIG
KYGGGEMLHDFDFLKIGGNPKIPVSETDFPFILNLFSRLQYEYVENEKANLEIVHSYLMA
LFCEMNKNNIKTTKNNSAATVLSSKFRKLIYDHIKINHQVNYYASLLNVTPNHLNKSIKT
ATGKSATKWIDETIMLEAKYLLYQTTFSVNEIAMQVGHEDHSYFSRFFKKHEGLTPVQYR
KMIDKS
>EGALAKHO_02200 hypothetical protein
MIYVFKTTVDSKSKLEFASALLSELLPHALWNFDLEDCDNILRIESDTTISEIVLRNDIF
DCTELK
>EGALAKHO_02201 hypothetical protein
MITVIKILEKINKDIMMKTKYILKGLIATLLVAFAVSSCESYNEELLDGLGNTREFSPVE
FTAKVKNQTFVELNWTVNPEADHYTVEFSADDPEFKVIYKTLQVTASQLPLTVQLEGETT
YSIRVKAITTGLADSKWSVITATTLSEQLFFPVQPTDIEAKQVTLRWIPNSNVTQITAAP
GNITHVITAAEKTAGVAVVTGLTGETAYTATLLNGAKKRGVVTFTTGIDIGTGILVKPED
NLSTVITAAPSGSILVLMPGDYTVFTGEIVLNKSITIRGLRPADRPKLHVRFTLNAGTAN
FSLIDLDSEGTLTGDNNFVTISGASSNYGDVLISGCYVHDYLRALMYGNAATAKLNSFTV
DNTIVKNVNTNAQADFIDFRNTYVASIVVKNSTFDSCSIGRDFVRADAVVPTNGFSGTGL
TTNVLIDSCTLYNVSNTAAPKRILYVRFGANTSTVKNTLITSTTAIYTNQALTIMPTFSK
NYYYTAPSFMDATISNNKIDASGTTANPQFVDPATGNFKVQNQTLIDNKIGDPRWIK
>EGALAKHO_02202 hypothetical protein
MKHKIIIASLIITGFFTSCQEDYLDAPAQSTLDESVIFSTAGLAKGAVDGIKVPFAETNS
YRGRFLPFYGLNTDSEWYNSSQTAGDAADLCVYDAKAINSQMNTTNNAWAMMYSGVERAN
ICIRGLRAYGDPRPGTDLGYLLGEALTLRAIYYADLIKAWGDVPARFEPINSETIYLPKS
SRDVVYKQIIKDLEEAATLVPWPNETAATNSVERINKAFVKGFRARLALAASGYQQYPDG
IRRSNDPELSVAAMYRLALDESRSVIASGKAHLEPSFETFWKKYNQEVTTAGGESLWELP
FADGRGRMLFSFAVRHTTNDQFHANGANRGGTAGPLPFVFYDYDQQDTRRDVTCVPYKYG
TAVNNIAKQELGALNTWYFGKYRYEWMTRFVTSTNDDGVNKIYMRYAEVLLIAAEAANEL
EGPAAAAPYLKEIRRRAFPSAVQAVKVDAYVNALTSKEAMLNALVEENKFEFTGEMERKQ
ALIRWNLLKTNLDKAKQKMTNLAAHTGEYADVPATLYYKFKADNVSLDIYGLNRGETTNP
GVTYTAFPWTWTGAAADTKINSLYKPGVNPDNRQFWPIWQVFIDGSNGQLKNDYGY
>EGALAKHO_02203 TonB-dependent receptor SusC
MNFKDLFNKRTNCFAIVFLLCLFMSNRVSAQNVTLEGTVKDATGMSLPGVNVLEKGTKNG
TSTDFDGKYKLKLTNPKTAIVTYSFIGFKTKEVPVAGKTQIDVSLTEDSNSLNEVVVVGY
SSVKKSDLTGAVSVVSGNDLRKNPVANLAEALTGRVAGVQVTSSEGSPDSEIKIRIRGGG
SLTQDSAPLILVDGFPVNSMNDVPAADVESQTILKDASATAIYGSRGANGVILITTKRGK
DGAISVNYNMFYGMKTLAKQIDVLPTEDFVKWQYEYALLDAPTPGDVSSYTKYFGNWQDR
DLYNGVKGDNWQKQIYGRTGEVQSRDLGIRGGSDKINFNFNYAHYDEKAIMVGSDFKRNN
LSLALNSKASDKIDLALTMRYADTEINGGGLNEQKEVSSADARLRHAVGYSPIPLPGLTT
DNTDEAVSSYLVNPFVATADADRQQFRKVFNMLGSFSWKIIDNLQFKSDFGLDNFYYQDY
RFYGRSTYYVNNVPASENQGMPALTIGDRKDDRFRNANTLSYDFKKLLGEEHNLRVLVGE
EMIETHSNQVMTVIHGFPKFFDFEQTQKLTTQGKPNSVDNYYSPDDKLLSFFGSVNYDFK
DRYLFTATYRADGSSRFLDNNRWGYFPAAAVAWKLSEENFLKNSSWINLLKLRLSYGEAG
NNNIPVGQTVQNFESSTTTWINGVGSIWAASKTLANPDLKWETTVTQNLGLDYDFFKGRL
TGSFEVYKNVTKDLLILFPVAGTGYDNQYRNMGETQNKGFEATMNVVALERPNYGLNFSF
NIGVNENRINSLGVMSNFGMNTNWASTQIGNDYAVNVGSPIGLMYGYKSDGRYEVSDFDY
NGTTYTLKPGIANASTVVGTVQPGYMKLKDINGDGVVNNSDLTIIGNANPKATGGFAINA
NAYGFDFSAAFNYSIGNDIYNANKIEFTTSNQNGQYRNLSSEMADGKRWTNLNPETGTLV
TDPAALTALNANTTMWSPFMSRFVFSDWAVEDGSFLRLNTLTLGYTAPNSFTNAIHATKV
RAYLTATNVFVITNYSGPDPEVSTRRNTPLTPGVDYSAYPRSRQLVFGLNLSF
>EGALAKHO_02204 Inner membrane transport protein YdhP
MKKSLIALSLGGLTIGITEFVMMGLLPDIASDMKVSIPVAGYLISAYALGVVIGAPLLVI
IGRNFPPKKMLLILALMLTVFNALSIIAPTYNFLFASRFLSGLPHGAFFGVGAVVASRLA
DKGKEAQAISIMFAGLTLANLIGVPIGTYIGHHFIWRYTFILIAIVGMLTFLFISLWMPN
LEKSGDVNMKTQLLFFKKTEAWLIIGITAIGFGGLFAWISYIAPLLINVSRFSPEDVSYI
LILAGLGMVVGNFLGGKLADKFSPAPTVLALLFVMVIDLIMVYFFSSNQYISLFFTFLTG
AISFSVIAPINMLMIKTAKDAEMIASAALQGSFNIGNALGAFLGGLPLAAGYSYASPNLI
GVGMASIGMVITLILMQKHRTSLHLQSA
>EGALAKHO_02205 HTH-type transcriptional activator RhaS
MPKLNQFKTLAIDEFEDEKFHLPPHSHTYYEIIYIKKGSGVHHLNNNLLPYKTGDLFVIS
PEDEHYFDIKKSTRFFYIKFTDSYFNSKQNLTCDEFLIHTPESFMRNKALKETVLKLDDP
CKTILKNTIENIAAYNCHTDVSNSPIVFYQILSIFGLIKETMRGQNLVVKGNSIDNEQIT
SYIHQNIYNPKLVQIKVIASHFNIAETYFSAYFKRTFAISYRDYIHNLRTTLIEKRFHNN
QLPIKQIAHEFGFTDESHLSNYFKKRKNMKPTDYKKL
>EGALAKHO_02206 hypothetical protein
MKKSIATIVSVITLFTANIIQANIIKTETTSTEVVDSNQLQPVYDAYFTVKDALIKSDSK
LTSAKAKDLLIAISAVKMDKLKSDEHTAWMKVIKKLTADAKSISATTDLKKQRETFKSLS
KNTYDLIKVSKSAQVVYKQYCPMADADWLSKEKAVKNPYYGSSMLTCGNVVETIK
>EGALAKHO_02207 HTH-type transcriptional activator RhaR
MVCSRCKMVVKSEFEKLGLQTISVELGEVELKDNLSEDQKKELLTHLHALGFDLIDDKKS
KTIEKIKNLIIDLVHHKNNELKINLSDYLAQNLNQDYNTLSNLFSEVENTTIEKYFISQK
IEKVKELLIYNELSLSEIADILNYSNVAHLSNQFKKITGFTPTYFKQLKDKKRIQIENL
>EGALAKHO_02208 hypothetical protein
MTHTYQLTGMTCSSCEDKVKRALELVDNIATVEVSKENNTATVSMNKHIALADLQNALDP
KYKISAIEHNENIEQTRSWFETYKPILLIFFYISLITVLIQTTNHHFDYMQAMQHFMAGF
FLVFSFFKMLNLKGFAESYMMYDVLARKIPVWGYIYAFLEFGLGISYLLNFNPIFTNAVT
FIVMSISIIGVLQSVLNKKKIQCACLGAVFNLPMSTVTIIEDGLMIIMSLIMLTTML
>EGALAKHO_02209 Copper resistance protein A
MNYKKSSLTLLLLLFFTQIMLSQKVVRYDLYVRDTIVNFSGKEKRALTVNGQIPMPTLTF
TESDIAEIYVHNELNKEDTALHWHGLFLPNKEDGVPYLTQMPIKPGTTHKYSFPIIQNGT
YWYHSHSGLQEQIGLYGLFIINKKKDDTTFRKGIDDLPTIPVILSEWTDLKPENVQRMLH
NANDWFAIKKGTTQSYAEAIKKGHFSTKVTNEWKRMNAMDVSDVYYEKFLINGKNEDQLS
QFKAGDKVRLRIANGGASSYFWLTYGGGKITIVASDGNDVEPVEVDRLIIAVSETYDVVV
TIPEDKKSFAFLATAEDKTGSASLFLGDGIKQPVAHLPKLKYFEGMKMMNDMMKMNGEMN
DMGMNMSLNKMDMNSVMYPEISGEEQVSKTEDHSQHNMEGMNMANDTTEVAEITTLNYGM
LKSPTITTLPKDAPVKELRFELSGNMNRYVWSMDNKVISETDKILIKKGENVRIVLYNGS
MMRHPMHLHGHDFRILNEHGDYSPLKNVIDIMPMETDTIEFQANADGDWFFHCHILYHMM
AGMGRIFSYENSAPNPLIHHPEMAYKMLKMDDRMFHFMAENDFATNGNDGEAMFSNTRWS
IGTEWRLGYNDKHGYETETHIGRYIGKMQWLMPFIGFDWRYRKMGMDEQEQNLFGQTNTK
DNRSVFSAGLEYTLPMLVKAQVEVYTDGNVRVQFERKDIPLSRRLRMNLMWNTDKEYLAG
LKYIAGRNFGITTHYDSDMGIGFGINLNY
>EGALAKHO_02210 hypothetical protein
MKKVNFLFLFLTAFLLISCDPSQGILFTNKGESNVKVKVIINSKVKNDQLDEMKKGDSIV
FNLIPHNPDEKQGHIYFGRGRWDDENIIEISKSIKCIEIENDNYKIVYKSQQAINNLLKE
NYNGIIMKSLNIKIDDNFFK
>EGALAKHO_02211 hypothetical protein
MTKVITFITAAVFSIGVTAQETKPVQKEKAKKESCCKKTSTDKKDKKSCCVKK
>EGALAKHO_02212 hypothetical protein
MAVSVSKLNKFVLFKLPSAYFCGVRVKAIDKDKCIVSVKHRWINQNPFNSMYFAVQAMAA
ELTTGALVISQIQESGKKISMLVANNKGNFTKKATGRITFICNDGHLIADAIKRTIETGE
GQTFWMKSIGTNEEGVQVSEMDFEWSVRLK
>EGALAKHO_02213 hypothetical protein
METSTPLIMEKTSEKNTATFTHLSTLTQYFIPFGNYIFPILIWTNYKDKSEFVNYHGKQT
LNFQLSLLLYTLILALIAIPVFVTVFLQNLPMEAIFNDHDFVIRNFDFQGNIGLLTIGGT
AVVLFGLLKVVEFFLVIYASIKASNGEYYKYPLTIPFIK
>EGALAKHO_02214 hypothetical protein
MNIENTKAQMRKGVLEFCILSVLKEKDAYTSEILDTLKNAKLLVVEGTVYPLLTRLKNDG
LLNYRWEESTSGPPRKYYGLTEIGQTFLNELSGTWTELSDAVNLITNQNQ
>EGALAKHO_02215 hypothetical protein
MNKTVNINLGGMFFHIDEDAYLKLTRYFDAIKRSLNSSSGQDEIIKDIEMRVSELLTEKQ
KSEKHVVGLKDVDEVIAVMGQPEDYIIEDEEKPNQSFNEYGARKHKKLYRDKEKGMIGGV
ATGLGHYFGIDAVWIKIIFLVFVFAGFGTGILAYFVLWIVTPEAVTTSEKLEMTGEPVTI
SNIEKKVREEIESLSDKFKSADYDKMGNQVKSGAERISSSFGDFVITVFKIFAKFLGVIL
IMSGISVLIVLLIGVFTLGTNVFVDFPWQNFVDAGNFTDYPLWSFGLLMFFAIGIPFFFL
TLLGFKLLSPNLKSIGNITKYTLLAIWIIAVAIAISIGIKQATEISYDGKTVEKKAININ
AKDTLFVKFRYNDYFAKDLNNYHREFEFVQDSVNHQLIYSNDVRLHVLHTDEASPYLQIE
RSARGNSFTNAKKRAEKIDYKIQINGNHLVLDNYFLTDVKNKFRGQEVDVYLYLPEGQLF
KPDASIQEYDDSEDNFFNLHFSGNYNYKVEGSKIKCLNCPAGEDDHEDMDYDEDNTIDND
TVKEVSIKINGKEVLNGKKNNGKLTTDKNGVIIKIN
>EGALAKHO_02216 hypothetical protein
MIKIIIHITKFIIATVTALLFASCNFNDMKSIEGSGNVTTEKRIVQGDFKKVSVSNAIDV
VIEQSDKTEIIVEADDNLQKEIKTTVENGTLVIRCSFTSFHNVTKKKVIVKMPVIEELEA
SSASTITSNNVLQSTNIKLDASSAATMNVNIESDEITLDTDSAGSITIEGKALKVRSSAS
SAASIEAEKLLANDIEADADSGASINVHPIVSLKAHANSGGSINYEGSPKSIEKTSNSGG
SINQG
>EGALAKHO_02217 hypothetical protein
MIFLYLSKSNLALMKKNTALLLLLLVTTVTFAQKREKLKGSKVVTTSVKESGSFDVLEVD
DNIEVYLERGEKNEIKIEADDNLHEIIGMDLRDKVLRLYTSKESTIFKKLSVHVTYTNTL
NKVIVKNEAVVYAIQELQLDDITFNSVDYSKLFLNVNAKKFSLIADDKSKSEINLKADEA
SLQLSKNSAIKSLVSATKFKCDLYQKANAALEGIAQKATIRVDNNAIFTGTKLTLKDATV
TAEGYTTASIFAEITLSLAAGDKTEVTLFGSPAITLTRFSEEAKLIKKIK
>EGALAKHO_02218 Thioredoxin reductase
MSDTIEKIKCLIIGSGPAGYTAAIYAARANMNPVLYQGMQPGGQLTTTNEVENFPGYVDG
VTGPEMMIQLQDQAKRFGADIRDGWATKVDFSGDIHKVWINDSIELHCETVIISTGASAK
YLGLPSEQHYLNMGGGVSACAVCDGFFYRNQEVVIVGAGDSACEEAHYLSKLCKKVTMLV
RSEKFRASKIMEERVRKTENIEILMNHDTIEVLGDNSVVHAIKALNKTTGEVIEIPATGF
FVAIGHKPNTDIFKDFITLDETGYIINTPGTSKTNVDGVFVAGDAADHVYRQAITAAGTG
CMAALDAERYLASKE
>EGALAKHO_02219 hypothetical protein
MERQMIEMLLLWVTFLKIVVISSRLEIGKAAGSNPATPTKILSVYRGDFFILFLFDILYF
RIAKTD
>EGALAKHO_02221 Exo-beta-1,3-glucanase
MIKKLISLFTVFTVVLILCSFATFNSSSKKMQEDKIEGKIVYNKQKHSITLSWPSFGSSG
NYVITRGGSRLATDFVSMGSISKLTFTDKKPNADKYENYYKITRNAITIVLSLENQIFGD
NMYFYDRKYEKAETARNEINSQFSAIGLGGSNGEWTTKRQAYYFKANIKGQTYDSGGSGS
ASAAEANSIELGFYSHIGGLGKVPGDVKLGSIFTRPHLSGGANATCTFWRSIENVTVMRD
FAWTVSQSTSARRMLIESTSKYISDIGNTNFWGSGGFIADTHYTSSRPNWGGQQQWYTRN
TIFPSGSGVMGGSYNMVWQGCVNAPQADDTNSPVSTTPIIKEKPFLFIDKDGEYKVFVPA
WQKDRVGVSWSSTDMGNGQIQDLLTDWYVTKKGDTDVEINNALKAGKNIFFTPGHYALNA
PIQVNRKDAILLGAGIASVTLEPTEKNTWGCIYADDKDGIIIAGLLMDSFNSTTYQVRIG
NEGANADHSADPILLSDITCRVGGVQSKNIQIQAAMQINSNNVVGDHFWLWRADHGSQKG
GSLRWARDRCKNGLIVTGDDVTLYALFVEHFQEYEVLWLGERGRTYFFQNEPPYDAPNQA
SWSSQGGRVDGYAAFKVANTVKDHHTIGMGSYAVFTGTDGNVNKKNGFEIPNSPNVKFEK
MSITRFAGSGNIQNVVNGTGGSTATGVKRVPLYNDGTGIQPYDEEFDLPNRESYPAYIIM
EK
>EGALAKHO_02222 Sporulation initiation inhibitor protein Soj
MGKIIAIANQKGGVGKTTTSVNLAASLGVLEKKVLLIDADPQANATSGLGIDVESVEIGT
YQILEHSHTPKETIVKCSAPNVDVIPAHIDLVAIEIELVDKENREYMLKKALESVKDEYD
FIIIDCAPSLGLLTLNALTAADSVVIPIQCEYFALEGLGKLLNTIKSIQKIHNPDLDIEG
LLLTMYDSRLRLSNQVVEEVQKHFNDMVFDTVIQRNVKLSEAPSFGESIINYDATSKGAV
NYINLAQEIIKKNSK
>EGALAKHO_02223 putative chromosome-partitioning protein ParB
MTKAIKKQALGRGLSALLKDPENDITSVEDKNADKVVGNIIELEISAIEINPFQPRSNFN
EESLRELATSIKELGVIQPITVRKLEFNKYQLISGERRLRASTLVGLTHVPAYIRIANDN
ESLVMALVENIQRHDLDPIEIALSYQRLIDEIQLTQEQMSERVGKKRSTIANYLRLLKLD
PIIQTGIRDGFISMGHGRAIINIEDLDVQTDIYQKIVSQNLSVRETEALVKNYHEGVKPK
PEGETKAKAESSFLVKETQKNTFNDYFGAKVDIKVAGNGKGKITIPFNSQADFDRIIKLI
NG
>EGALAKHO_02224 hypothetical protein
MNKIVPISLLFFLIGTVSLFAQAKKDTVLVVKDTTKYQEIDPLTPAKAAFYSAILPGLGQ
AYNKKYWKIPLVYGAIGTSLYFYIDNNKKYHDYRDAYKRRLEGYNDDDYQFLDDDRLIAG
QKFYQRNRDLSALFVVGFYVLNIIDANVDAALIQFNVNERLSVRPEIYPADVTFKPNVGL
TFNYHF
>EGALAKHO_02225 4-hydroxy-tetrahydrodipicolinate reductase
MKIALLGYGKMGKVIERIALERGHEIVLKKDETNTFDGLSTADVAIDFSVPTAAVDNISN
CFHTNVPVVSGTTGWLEHFDEMVALCNEKQGGFISSSNFSLGVNIFFELNEYLAKIMSQF
DSYKVTMEEIHHTQKLDAPSGTAISLAKGVIENSNYANWTLDEAKNNEIHIEAKRIGDVP
GTHTVTYDSIVDSIELKHTAHNREGFALGAVIAAEWLAGKKGIYNMKDVLNLK
>EGALAKHO_02226 Signal peptidase I
MTLYLWFVFFLAVQVIHFLGTWKLYQAAGRKSWEAAVPVYNSIILMKIIGRPTWWTILLF
IPIINLIMFPVVWVETLRTFGKKSTLDTVLGIFTLGFYIYYVNYTQKLEYNANRSLTPEN
KTADTVSSLLFAIIVATLVHTYVVQPYTIPTSSLEKSLLIGDFLFVSKLNYGPRVPMTTV
ALPMVHDSIPLTKRKSYLSWPQLPYFRLPALEKIKRTDIVVFNWPVDTVHYFYEPKGRPG
VIKPIDKRSNYVKRCVGIPGDSLSIKDGYVYINGKKLILPERAKPQYSYKIALDEKTPID
LEALLKELNVNLVDVRGFRDQNKRDTLFIGALTETNAERMKSIPGITGVIKEIAKGNDDR
VFPHINKWNEDNYGPIYIPEAGKTVALTNESLPFYKEIITNYEHNTLQIDGSHFIINGKQ
TNTYTFKQNYYWMMGDNRHNSEDSRYWGYVPEDHIVGKPVFIWLSWDTNGKGINKVRWDR
VFTTVDGEGQPQSYFKYFLMVLASYFVGEYFWRKRKENKA
>EGALAKHO_02227 hypothetical protein
MNSLLLPTYFPSISHFAVMAQSENITFEMEDNFQKQTNRNRTYIYSPNGIQLLNIPVKHS
KTLHQKTKDVLIENEFDWQKQHFKSLEASYRSSPFFEFFEDDIRRVFEKKHTFLMDLNME
VLDIMIKCLRMKLEFSKTTEYFMDFENVSDFRYLANGKKDPNSFEKYPQVFDDKHGFINN
LSVLDLLFNEGKFAMDYLKSQNIL
>EGALAKHO_02228 Dipeptidyl aminopeptidase 4
MIKKHFLLLLFVCSSILAQKDIDINELKWLPNSHSFWINSGEKIVVYDVDKLNQGTTVLT
DNQLKDAGFNGEVEDLVWNQNRTKVLIYTNSKKVWRANTKGDYWFFDLATGKGKKLGANL
EESSLMFAKFSNDNENVAYVSKHNIYLENLVSGKITPLTTDGTDKVINGTFDWVYEEELA
ARDGFRWSPDGKSIAYWRVDASETKFHLMINNTDTLYPFVVPVEYPKAGEKPSSVKIGVI
DIASLITNWLNIPGEPDNNYLVRMEWVGADDVMVVQLNRHQNQASVYNCNAQSGKANLIY
QEKSGEWIDVFDISSGVYDGFPCQFVDNGKAFLWSSDADGWMHIYKISKDGKKKELITTG
KFDAYFKAYNDKTKSVYYISSPKDATQRYLYETDLNSRKTKRITPEVFNGTNEYEFSTDG
SYAKHTNSNINRNLNTRLVSLSDHQKILPKEDDVFTAPERQFSLEKFKVTTVDGIEMDGI
MAKPLDFDPTKKYPLFFYVYGEPMATVANDMPYFNGFIDLLIPKGYIGIAMDNRGTPSLK
GTKWRKSIYKNIGIINTRDQAMAAKEVLKWNFIDKDRVAVHGWSGGGAVTLNLMFQYPDI
YKTGVAISAVTDQHFYDNIYTERYMGLPTENEAAYIEASPVTYAKNLKGNLLYIHGTGDD
NVHYKNAEVLINELIKYDKLFNLMIYPNRSHAIYEGAGTRKHLIDTFLKFIEEKCPPGAK
>EGALAKHO_02229 hypothetical protein
MFFLNIVLTVLTFSVYILPFLAPKSFPLLSVLTLFMPAFFVLNALFFIYWAIQFKKRLIL
SGLVLLTGITFISKFYKFSAKEYVKDEKDFSVMSYNVRLFNVFKWLDRDDIPSNIKTFID
EKDPDILCIQEYSNSAHIDLKVYPHRYIFIDGNQIKTGQAIFSKFPILYQGNIIFPNSDN
NVIYADIKRGKDVIRVYNMHLQSIKISPDVAKISNDIDNVNQQKSQLIYTRISKGFRQQQ
EQAEMFKENIKQCKNPIIICGDMNNSPFSYVYRNIKGKLRDTFEEAGGGFGATYKFRYYP
ARIDYIFADSKMKVKQFESFSDFENSDHYPIMTRLSIE
>EGALAKHO_02230 hypothetical protein
MNILDDLKLQYKIGGIALRVIYWNIACFLISLVFFYQYSGGGFAYPDWLALSSDPNSFLF
RPWTLLTYAFFHSSFLHLLFNMMVLNFASQLFLTFFTQKQYLGLYILSAIFAGIVFVLSY
YFLGYSASIVGASAAIMAVLVAATTYQPLMNVRLLLIGNVKLWHITAVILILDLMQLRLE
NMGGHISHLAGALFGFIYIKLLQNGSDLSIVISRTLDFFTNLFKKSPSTPFKKVHKNYQK
PTEKVTSRIVTKDKTQQQIDEILDKISQSGYDCLTKEEKEFLFKAGK
>EGALAKHO_02231 Rhomboid protease AarA
MMKITPVVKQLLIINIIFFIGTMLVPAAQTYFMLFFPENPGFRVWQPITHMFMHGNVMHI
AFNMFALYSFGSTLEHFWGGKKFLFFYISCGLGAALINYAVNYYFYQDAFNTLIANGFNK
VQILQLLDDGKIDTRWQEILSVSEFKHFTEAYFGTVLGASGAIYGLLVAFAFMFPNAELG
IMFIPIPIKAKYFVPAYMLLYDGFFGILGNSFFGGADGVAHYAHIGGALFGFLIMWYWKK
NQFNSNRWN
>EGALAKHO_02232 DNA mismatch repair protein MutL
MSSIIQLLPDHVANQIAAGEVVQRPASVVKELLENAVDADATDIKLIIKDAGKSLVQVID
NGKGMSVTDARLCFERHATSKIRQAEDLFSLCTKGFRGEALASIAAIAHMEMKTKQDQEE
LGTHIVIEGSKFVSQEVAVLPKGTSFAVKNLFFNIPARRNFLKSDTVEFRHVMDEFQRVA
LAHPNIHFTFYHNGSEMYNLPAAGYRQRVVGIFSGKTNEKLVPVNEDTEIINVQGFVCKP
EFAKKNRGEQFFFVNDRFIKSGYLHHAVMAAYDGLLKDGSQPSYFLYLQVPPNTIDINIH
PTKTEIKFDDEQALYAILRASIKHSLGQFNVAPVLDFDRDANLDTPYHYKDLEAETPTIQ
VDGTFNPFTDDKTNQHYTKSGYSGSGSSSGSSFSSGSNSYSGYSKRVEPTASWESLYVGL
DTESIESSPFNFENEEVTSSLFNDDEVETASQKTYQIHKKYIVSPIKSGMVIVDQQRAHQ
RVLYEQFLLNMTVNQASSQQLLFPLNLFYSSDEMTLIEELKPSLETTGFVFEEAQTDHIV
ISGIPVNITESEVSLVIEQLLSDLQDGIPASSYSQNDTIAKSMAKSLAVKTGSYLTEKEQ
DNLVNGLFACKDPNISPFQKPTFITMRVEDIDKKFAI
>EGALAKHO_02233 6,7-dimethyl-8-ribityllumazine synthase
MATENKNLSEYDKNTIPNAKDFRFGIVVSEWNETITEGLYNGAFDALVDCDVPAQQIIRW
NVPGSFELIYGAKKMLQTQNVDAVIVIGCVIQGETKHFDFVCEGVTQGIKDLNVQTDIPV
IFCVLTDNNMQQSIDRSGGVHGNKGTEAAIAAIKMAYIRQQASMSHPFNQPLLTSGALQI
EETPIKIENE
>EGALAKHO_02234 hypothetical protein
MATYNKRGYKAPKEKEVKEVNEETQVIIDEKDSTTAGVFSKLDETASRTEDWVAKNQKII
IGLVAGIAIATIGYLAYQKFIEAPKQDEAANEMFVAQQNFDKATNGVASDSLYKLALNGS
EGKFGFVKIADEYSGTDAGNLANYYAGMAYLNTGKFDEAIKYLGDFKSEDLILSALAKGA
IGDAYSQKNQQKEALEYYVKAAESNKNDFTTPRFLLKAGKTALALGQKEDALKYLTDIKE
NFDTTPEAASVDVLIGLAQ
>EGALAKHO_02235 DNA replication and repair protein RecF
MHLNKISLFNYKNFSEVSFDFDLKINCFVGKNGIGKTNVLDAIYHLAYGKSYFNPLAVQN
IKHGEEFFVIDAEIIKNDRTEQIVCSLKKGQKKVLKRNGKAYDKFSDHIGFIPLVIISPA
DRDLIVEGSETRRKFMDSVISQLDSTYLHQLIQYQKVIVQRNALLKYFALNHTFDNDTLS
IYNEQLNSFGKSIFEKRKDFLEQFIPIFNIHHQAITGSEETVQLVYESHLYEKDLLTLLQ
ENINKDRALHYTSVGIHKDDLSFEIDSYPIKKFGSQGQQKSFLIALKLAQFEFLKKQSGV
KPLLLFDDIFDKLDETRVSKIIEMVNSETFGQLFISDTHPERTEAIVKSTHQSYKIFNL
>EGALAKHO_02236 Thioredoxin
MKFPKILLLIVSILLFSCNDQKAKPFESIAPKEFAEKIKTTDKPQILDVRTPEEFGSEHI
DNAVNVNWNSDDFTAKAESYDKSKPVFVYCLSGGRSKKAAAKLQELGFTNIYELDGGFLN
WNEEGLSGPSTEKVGMTMNDFNDLLNTDKKVLVDFYAEWCGPCKQMEPYLLKMQKEMADK
VVIVRIDVDKNKTLAETMKITSLPTILIYENKAVQKKIIGLTSEQNLKEQLQ
>EGALAKHO_02237 hypothetical protein
MLAKESLQFLDDLKKNNNRDWFQDNKKRYEIFKKDYHQLVSDFLDVMKPLDSSLELLEVK
NCTFRINRDIRFSKDKSPYKAHLGVWMSAGAKGANRSGYYVHIEKGASFIAGGFYSPEAE
DLKKVRKEIAFFNDDLEAILADKNFKKEFGNLDINETNSLKNPPRGYEKDHPAIAFLKLK
SFTATQKYDISEVTQKDFVAKMSKKLIALKPLNEFINRALETDEF
>EGALAKHO_02238 N-acetyl-alpha-D-glucosaminyl L-malate synthase
MKKRKILFLGESYRADAITWMKGLKEFGDFEICTWELQTPNTSKGNRFKRILEYAFSPIS
IRKTIRREKPDMIIAERTTSYGFLAAISGLHPIAIAQQGRTDLWPEGSVLLPLKKIIQKH
AFKKADLIHAWGPVMTISMKAIGVDMSKVLVIPKGIDLTLFTPYINNSNKIEAIVTRSLQ
PEYRHDSILLTFSILNQRGIDFSLTIVGDGTRLFYLKDLAKKLQIENKVIFTGRIPNTEL
PKLLQQSNIYISMPITEGVSASLFEAMACSCYPVVSDIAGNQSWIKHRENGQLITIDDVE
MLAEELIWSFENTESRNNAILENRKFVEKNTNYDINMKIVAGKYHELLNTKLKSSI
>EGALAKHO_02239 hypothetical protein
MEDLINESYEFQQVDKNPSHVKYDFVSIGKKKIPKRVAIRKYPQLGLDRYYNLGFGNILI
DENGEESISDMSRENNKNDKNKVLKTVFTCALDFLSTSPNSILTFFGNTHAKHRLYKMGL
NNNLASIERFFIIRGGIIRDLEIRENAETGKQPNSIINVDKIEYQIYDPSKSKLYNFITF
EIKDEFK
>EGALAKHO_02240 hypothetical protein
MENIIKDILNKSGKKTTVSYKDKENRTSFDETFGKQKMEIASKLIGENSVSLSKKLATK
>EGALAKHO_02241 UDP-N-acetylenolpyruvoylglucosamine reductase
MEIQSNFSLKNYNTFGIEAKAKEFVAVHSVAELKTILEENKNEKKFILGGGSNMLLTKDI
DALVIHIDLKGKKIIKEDDDFVWVESQAGETWHDFVLYTIENNFGGLENMSLIPGNVGTT
PVQNIGAYGTEIKDTFISCEAINIESLETKTFTNTECNFGYRESIFKNEVKDQYIITSVI
YKLTKRNHKINTSYGDITAELAKNNVVSPTLKDVSNAVIAIRQSKLPDPKELGNSGSFFK
NPILLKSDFEKIHQKFPEMKYYEVSETEVKVPAGWLIEQAGFKGKRFGDAGVHKNQALVL
VNYGNATGQEILAVSKEVQKTVFETFGIHIEAEVNVI
>EGALAKHO_02242 hypothetical protein
MEKLKIRIISMQFFGMIFLINGIFQLKIYAVAEKYACAIQYFQNQKSECWDRLFPNKEDF
SQFLSNILLWKFLGLIIGVVFISFLNWKNKISFINTILVSILIYTLLWSKFFKEGITTRL
FISFGNAFSNDFEIQYLIGGITFTVIGATILWLSVKKNLFKFNRN
>EGALAKHO_02243 hypothetical protein
MTENISIKTINPNDEKVLAIIEELSANLYLRFGSDGKNSFSDWEYNNSKYVFVVAIIDNE
IVGCGAIRPISENIGEVKRMYSKYPGKKIGQTVLAFLENKAKAIGYTDLILETRVKNQEA
TQFYKKQDYKVIPNYGKYIDRPQAICFGKSLK
>EGALAKHO_02244 Protease synthase and sporulation protein PAI 2
MYTPEIYKNEDPESIKAFLKENSFGILINQTNGKLCATHIPIEIEINADGKEILQGHISK
LNPQAAGFAENDQVLAVFTGPHSYISSSWYDHENVPTWNYIAVHVYGRIKIVDEAATIEQ
LKKLVDKYEANSENPVRVEDLSVKTMREARGIFGFEIEIDEIQATKKLSQNRDDHNYENI
ISELEKTENPQAIAVAKEMSKCRK
>EGALAKHO_02245 Poly-beta-1,6-N-acetyl-D-glucosamine synthase
MLITLFYFFIAIVFIQIFYYLGIFGKFAFSKPQEITQKKLPVSVIVCAKNEEENVKKFIP
LLAEQDYPDFEIVLIDDASSDETLEVFEEFEKQYSNIRLVKVQNNEAFWGNKKYALTLGI
KASKKDYLLFTDADCYPNSKDWITSMTSQFTMNKTIVLGYGGYEKIERSLLNKIIRFETV
LTAVQYFSWAKIGAPYMGVGRNLAYKKEEFFNVNGFIDHIQVRSGDDDLFINQAANKNNT
AISYNPESFTYSQPKESYKEWFTQKRRHVSTAEYYKFFDKMQLGLFYTSQLLFFLLVIIL
LAFQFQWIAVLAILATRYTVAWTVMGFSAGKLKEKDLKIWFPIVEMVLIFTQINIFITNL
FSKPVHWK
>EGALAKHO_02246 ECF RNA polymerase sigma factor SigW
MEINSKIEKAKKGDQIAFTFLLDFYWNEVYGFMLKRTENETTAEDITIETFSKAFDKIAT
YNSEFQFNTWLIAIAKNVYIDLLRKKKTNLFIEITDSEDQQAYNIADPTPSAEDALIKEQ
NLSRLLLCIKELKPHYQEVIQLRYFQEMSYQEIALKINEPLSNVKVKLLRAKKLLAEIIE
RNR
>EGALAKHO_02247 hypothetical protein
MSKSNIYETNWTDLVFENKNKEYGAYQLRQENAKTTITALFLGLLFFAGLGSVSMLINKL
STQDPTETGTIIPEPTVITEFHDQPIIPKTEDPIVPPQQSTATPPATSTQLVNPVVTTAD
KATPEVIAANTDNAPTVDNTSSGTGPVVNTLPSSGGNGNGTEIAPTITDPVNTAVLDKMP
EFPGGMAKFYSYVGNNFQRPELDVEKTLKVYVSFVIERDGSITDIKALNDPGYGLAKEAI
RVLKSIKSKWTPGILNGKTVRTAYNLPITIKTEVE
>EGALAKHO_02248 hypothetical protein
MGIFSALLGNAGSVSQEDLLKNYGQLLTDNESIEMGFKLIRDTFIFTNKRLILVDVQGIT
GSKTEYKSIAYKSITRFSVETAGTFDLDAELKIWVASELQPSIVKQFTKSVNVYEVQKVL
AHHVLG
>EGALAKHO_02249 Metalloprotease LoiP
MKKKFIVLGVLFATFGFTKINAQINFGDKAIGAVQKGVTGFTFSNADAAALSKAAVDKLD
TENEIAGPTDGYTIRLNRVFGKYNTGEGYTLNYKVYKLKEVNAFATADGSVRVYSGLMDI
MDDNELLAVIGHEIGHVANHDSQDAIKAAYKKEALLDAAASQSTTVASVTDSQLGKIGSA
IIDSKFSRKQEADADLFAYNFMKKNGYNVNAEESAFRILAKMSEGAQSSFIDQMMSSHPD
SKQRAEDAKKRAEKDGLYKAYVQQKIVNTVPAPAPVKKATTTKKTTTKKK
>EGALAKHO_02250 Lipoyl synthase
METVIENIPTGKPKWLKVKLPIGQKYTELRGLVDKYSLNTICTSGSCPNMGECWGEGTAT
FMILGNVCTRSCGFCGVKTGRPETVDWDEPEKVARSIKIMNIKHAVITSVDRDDLKDGGS
IIWIETVKAIRRMNPNTTLETLIPDFQGMERNLDRIVEANPEVVSHNVETVRRLTREVRI
QAKYDRSLEVLRYLKEKGINRTKSGIMLGLGETEEEVFQTMTDLRNANVDVVTIGQYLQP
SKKHLPVKEFITPDQFAKYEKFGLELGFRHVESGPLVRSSYKAQKHIL
>EGALAKHO_02251 Glyceraldehyde-3-phosphate dehydrogenase
MPLKTRIAINGFGRIGRNLFRLLINHPEIEVIAINDIADNKTMSHLIKYDSIHGVLPFKV
SHDEEGIIVDGKHFLFFHEKSIPNLDWKSHNIDFVIESTGKYKTHEELNAHIEVGAKKVI
LSAPSEVDTIKTVVLGVNEAILDGTENIVSNASCTTNNAAPMIKIIDELCGIEQAYITTI
HSYTTDQSLHDQPHKDLRRARGASQSIVPTTTGAAKALTKIFPKLHQKIGGCGIRVPVPD
GSLTDITFNVKRAVTIEEINNAFEEASKTILKGILDYTEDPIVSVDVIGNTHSCLFDAQL
TSVIDKMVKVVGWYDNEIGYSSRLIDLILLIRKT
>EGALAKHO_02252 Sensory/regulatory protein RpfC
MKYHLLILVCFLNSFLYSQTKKKNTDSITYYNKLANSNLDKKKYNQAVFYTKKSIDFCHT
NNKGENLANQTFKLGKIYYNQQKYDEALKNFHKSVSLFDKVKPTCTKVLALHYIGATNTA
KGNYDIANVYYQKAESLLKQLKLVDHAQILDYQKAMALKASKNLPLAAKTFQKIVKKPDN
SKILKTKTDSYYQLGLIETQLKRNDSALVYFDNALDYSVKNNNLFQKSKIILAISQYYKK
NRNFDLAYSYLDEHYQIENYILKLKNAKLDLNEYEKFKKNQSINNTLKRQSDEKIQLKTY
RYSKLVSILAIALISILSLLSLALYKNNIIRNQNNLLLREKNKELILAKNKAEKASKARS
EFLSTVSHELRTPLNAINGITHLLLEDNPKKNQLKYLESLKFSGNYLTTFINEILEINKI
DSTKVEIEHISFNLKELLFNIQSSLKELATANKNYFNLEIDEDIPDNLIGDPTKLSQIIL
NLINNALKFTQNGHVNVIAKLYAVEEENATVYFEIVDTGIGIPEDKLQTVFESFSQGSIE
VNRKYGGTGLGLTIVKKLIELLGGEIKLKSEVGKGSTFTFKLNFNINNEPLEIVQEAKPY
NDRQLKHKSILLIEDNKINQMITRKMLENKAICCEILDNGEEAVELLKVKRFDMVLMDVH
LPGINGTTATKLIREFDKNTPIIALTAISLDENRDMLLSFGMNDVITKPFVPDEFYSIIA
KFFD
>EGALAKHO_02253 Tetraacyldisaccharide 4'-kinase
MNVLRKILFPFAILYGFITSIRNFLFDKGILKSTSFDIPVIAVGNLSVGGTGKTPQIEYL
IRLLSDKYKIATLSRGYKRKSEGFVLADGTSNAEILGDEPFQFYQKFPNIQVAVDANRTN
GITQLLSQKNKPEIILLDDAYQHRKVKAGFYILLTSYGDLYEDDFILPTGNLRESRSGAN
RANIIVVTKCPKDLSDQKQEEIRLKLNLNCSQQIYFSFIDYDDTIYNKGEKVAVNDIKSE
AKILLAGIAKPKPFFDYLKNENDECLTYPDHHHFSDSDLDEIQNKANGKKIITTEKDYVR
LKDSKLVLQLYYLPIKSTFIKQHQNFEATILDYIKKTLEP
>EGALAKHO_02254 GTP cyclohydrolase 1 type 2 
MKIKDIIAVLEEMAPLAYAEDFDNVGLLVGDSETKSTGILVCHDALENVIDEAIAKKCNL
VVCFHPILFSGIKKITGKNYVERAILKAIKNDIAIYAVHTALDNHSAGVNKIFCDILGLE
NTKILIPKQNFIQKLVTYTVPENAQKVRQAMFDAGAGTIGNYDNCSFISNGTGTYKGNSK
SNPVVGKRHKLTETEEIKIEVTFEKHLQSRILKALFDNHIYEEVAYEIYELQNLHQNIGL
GMIGEFENAMNEKDFLLFVKDKMIANGIRHSAFIGKKIKKVAVLGGSGSFAIKNAIQAGA
DAFLTADLKYHQFYEAENKLLLADIGHFESERYTKNYIVDYLRKKILNFAIILSEENTNP
VKYL
>EGALAKHO_02255 Chromosome partition protein Smc
MANTKELSVEDKLRAIYDLQLIDSRIDEIRNVRGELPLEVEDLEDEVAGLSTRSEKLKSE
LEVIEDLIKAKKNAIDEHKEVIKKYTKQQESVRNNREFNSLTKEVEFQELEIQLAEKQIK
EMKASIEHKKEVISNLKEKLDAKSSHLKHKKSELDAIMSETQKEEIFLSEKSAEFSGQIE
ERLLAAYNRIRSSVRNGLAVVSIERGASAGSFFTIPPQTQVEIASRKKIITDEHSGRILV
DSALAEEEKEKMEQLFSKF
>EGALAKHO_02256 2-succinyl-6-hydroxy-2,4-cyclohexadiene-1-carboxylate synthase
MGIKKGIRFITLKSVGQYINFLSYVRPQKAVELSYALFSQPRIGRLQKDTLPKILKNTET
ETFHHNEHHFQTYIWKGNETKILLVHGWESNAARWKKTLPHLQKSGSTIIAIDAPAHGQS
SGKEFNVPLYAEFINKAVEKYQPEIIIGHSIGGAACVYHQYLFPNTSITKMVILGAPSEL
KTLIDNYISMLSLNTKMFSLLESKFMDRFNFKLEDFSGQKFASEFNVAGLIAHDTSDKIV
AFEEGKKIASNWKNSQFIETEGLGHGMHDDELYEKVLEFLFSEGSQGSESLIR
>EGALAKHO_02257 HTH-type transcriptional regulator KmtR
MEDQFIKTATLIGDATRASILWNLLDGRAFTATELAIAVETSAQNISMHLGKLLEANLIC
VEKQGRHKYYRFSNKEVAYAVEAMANLIPKTKVSTKQKSEEYPPVKYCRTCYDHLAGKIG
VALADSLLEQNIIIEKNDIFEISSEGEKWFSDFGINIEEAQKQKRIFLRPCLDWSERRNH
IAGSIGSLLLNKMISEDWIRKTKDSRAITITGKGEKELLRYFKIVV
>EGALAKHO_02258 Biotin biosynthesis cytochrome P450
MTSNLFFQSDIQDPYSLYKSMLDENPVYWDETNKIWAIYSYEYCAEILKSSKVEIPLVNP
NNEQELNESALEILSNLTRLSNGIQHKISKEIAMQLFSSIKSVDVGEIISFLIKNDLIEN
EIDWVKSVSKKLPVLVLLKSFGFKENDCEFISERIESFIKIMLPQKTEEQVKYINEISEK
LYSIVEKHLSSLSFYNSLLIKTSNQFNLSTEEIIPITVSNFIGLCIQSYDAGRGILSNSL
LQIIERKTFSNKIEIEKSVIETLRFDPPIHNTRRIAVEDFCIDESQIKKGDPILIVLASG
NRDSQKFENAMNFDIERINNNENLTFGIGGHMCLAKYFSIHLATETIWYLFQNYKSISLL
ENQIQYEPIINARLPQNIWISIQ
>EGALAKHO_02259 hypothetical protein
MIAVIFEVIPNEGKKEEYLNIAANLRPELDHIEGFISIERFQSFSDPEKVLSLSFWKDEE
SIKQWRNLEMHRHSQSKGRNEVFKDYHLRIAHVVRDYGMFDRKEAPQDSAGFHS
>EGALAKHO_02260 23S rRNA pseudouridine(2604) synthase
MEENLKRLNKFIGETGYCSRREADKLIEEGRVTINGVVPEMGTKVSPDDEVRIDGKLIVE
KHEKMVYLAFNKPVGIECTTNLEVRNNIVDYINYPKRIFPIGRLDKASEGLIFMTNDGDI
VNKILRARNNHEKEYTVTVNRPITDRFIERMGNGVPILDTVTRKCKVEQISKYTFKIILT
QGLNRQIRRMTEYLGYDVTALKRIRIINISLDVPVGRYRDLTDDEIKELNHLIEPSSKTE
EASLPKVENPKTAPTRRTEFISKHDPRFKKKGDY
>EGALAKHO_02261 Outer membrane protein assembly factor BamB
MVCFLTLVSFTGFAQRVADEVLKMNSKIEDLTQNAITGIIVVKEGNIVKGINPETKAEIW
SFDADKTVGNVTALETLSKVDTDNLFASKRILKPIDGTPYIEALVNYKTVLINSTDGHVV
YNSANYKYTVFNSQFLYDDNEYLVKGVEDGKVIASLIDLNTGDVKWKTVQGEAKSMFSSM
FTFKANQSNEAKVSSNMIYSLYYGKLSAIDRTNGDLKWVGDLEYTKVFPTQNNTNLVVIN
SKGLLSAKQYLNVLDSQTGKPIWEDAIKTKYIVYLEDWGTKILVAHNSGFNFYNLNDGSK
VWKKDARGDGLKKVIPIDGDYLYVAENEMMLIDKDGQKKWKSFIEISDNKEDAINYLGKV
DDKVLYLTATYGNLVDYKSGKKLWRGNLKFNESRPLLNVFDEENNQFLVYNDEKLYKFDS
RGADKPDAFAKVNVKKEKELNSIELFSWGVALSGPTEVMGVSKDGKVLYQKVYTQPGDGG
RAWGGALATAGSIGLGVSAFGNAVMGSEWTMTTIDPATGKETTAVVKQKGEAQLRRAANQ
AAGAAVLGDVSKRLGQRYQAMKQNRDYSYIFAKDEATSKKVLVKVKKEDGTELDKIIFEN
MRPIYEIDPGTQSIYYIYENELRIFNKKI
>EGALAKHO_02262 hypothetical protein
MKKHHIILVCSLIFTLLFYKEFPGGINLSIFGLVLTGFICYFFQDRFSDRTHLILVVTSV
LSCLAFAWYGDFASFLALAMSVLFLQFKTQDGKLKIIQIFPLVFLNGITSLGRVLMFKQW
LPEKKIHNNFAKKLVAFFVIPVIFLVLFFIVYSFGSSHFSSLFTDYTLDIDIVQLLLMSI
LGFYISFSFWNYWVPEVCYEKNELLDNEFSNIAEVKNQNTFSFLDLDFERKSGVITLILL
NLMLLVFIVTYNYEQFFEVVEKSKLSSDTHERVNSVIFSILMAVGVIMFYFKGGFNFDKQ
AVSLKRLAKLWIFLNGVLIVSTFIKNAEYVSFFGLTYKRLGVFAFLILAIIGLVYAFLKI
RRQKTNAYLVNQMVWYFYGTVLLCSFVNWGNLITNYNISVNKGVEPRFLSGLNFNDDLRR
EYFSTYDLDGKYAESIREEMISNYQDNTFLSKALYYDFLNNK
>EGALAKHO_02263 hypothetical protein
MGIIDKLNKDFESRVRLGIMSILMVNEWVDFTEMKTLLNITDGNLASHASALEKSEYIVV
KKEFVGKKPKTSYSVTERGRLAFKEHLSYLEKLMKS
>EGALAKHO_02264 hypothetical protein
MNQKHQEDLAHIRSMMERSSRFISLSGLSGVFAGLSALIGGLYVYQLFKINGVDYFGQGG
YDEGGYDEVVRTIPFKLVSELVVTGIVILVCAFVFGLAFTIRKSKKYNLPIWTSATRKML
FNLAIPLTVGGVFCLSLLYHQNYGLVAPATLLFYGLALINAEKYTFSDIKYLGYCQLFLG
CVSLFNIGYGLVFWIIGFGILHILYGLIMFKKYK
>EGALAKHO_02265 Cobalt/magnesium transport protein CorA
MKVFYTNNNGLLEIPKWTPNCWINIEDPSEAEKQYLLEELQIPEAFYNDIEDIDERPRIE
IEDGWTLIIMRVPIKSNDIKLPFQTIPLGVIFKGDICVTITFYKTEIIHDFMLYSRRKNI
QVNDNLDWVLRLLLSSSVWYLKYLKQVNQKIKLAEDNLEKSIKNEELQALLQIEKCLVFF
ITSLKANDVLFQRIKNLKAYKADYNLDLLEDVEIELSQAQDTANIYSNILTGMMDAYASV
ISNNMNNIMKQMTSISIILMIPTLIASLYGMNVPNGLEESKYGIWILLLVSVVLSAFGVF
LFKRRRWF
>EGALAKHO_02266 Bifunctional protein FolD protein
MQLLDGKKTAEDIKNEIAAEVQSIKAAGGKVPHLAAVIVGSNGASLTYVGSKVKSCQQIG
FDSTLVALPEDITEEALLAKIKELNEDDNLDGYIVQLPLPKHIDEQKILLAIDPDKDVDG
FHPTNFGRMALEMESFIPATPFGIMELLERYNVETAGKHTVVIGRSHIVGRPMSILMSRK
GNPGDSTVTLTHSRTKNLAEFTKNADIIITALGVPEFLKGDMVKDGVVIIDVGITRVEDP
SNAKGYVIKGDVDFDGVSKKASFITPVPGGVGPMTIAMLLKNTLLARKMRSAKNK
>EGALAKHO_02267 Signal recognition particle protein
MFDNLSDKLDKAFHILKGHGKITEVNVADTLKEVRRALLDADVNFKIAKDFTTKVKEKAI
GQDVLTTLQPGQLLVKLVKDELTELMGGDVAGINLSGTPSVILMSGLQGSGKTTFSGKLA
NFLKTKKNKKPLLVACDIYRPAAINQLHVVGDQIGVEVYSEPENKSPVEIAQNAIKHAKA
NGFNVVIVDTAGRLAVDKEMMDEIARVHKAIQPQETLFVVDAMTGQDAVNTAKAFNDILN
FDGVILTKLDGDTRGGAAISIKSVVNKPIKFVGTGEKMEAIDVFYPDRMAERILGMGDVV
SLVERAQEQFDEEEARKLQKKIAKNEFGFDDFLTQIQQVKKMGNMKDLVGMIPGASKAMK
DVEIEDDAFKHIEAIIHSMTPIERSKPAIIDVKRKARIAKGSGTKVEQVNQLMKQFDQMS
KMMKMMQGPGGKNLMKMMGGMKGMPGGMPR
>EGALAKHO_02268 Peptidoglycan O-acetyltransferase
MITIDSINNWFVQNFGEVTLEQAKSWFIYNPDEKLLFNTGLFLGLFLVFYFVYGFLRKTF
YLRLTYVILFSLFFYYKSSGIYFLLLLLSSVVDYGLSQIIYNTAKDSTKKVYLVISVILN
LGLLGYFKYMNFMIVTYNDMFSGHFELHNVFLPVGISFYTFQSMSYIIEIYREEIKPTKN
YIEYLFFVSFFPQLVAGPIVRAKDFLPQIYQKLNLTRQDVNNALFLIIGGLIKKTVISNY
ISINFVDRVFDTPMSYTSFENLMASYGYAIQIYCDFSGYSDMAIGIALLLGFKLPANFRT
PYKSVSITDFWRRWHISLSTWLKDFLYISIGGNREGSFAGFLFPSLFFFGLLLWGITNVN
TSFIPLGIAIGSIVVFCLSFLLSKKKNQTLVTNFNLFTTMLLGGLWHGAGAQFIVWGALH
GLALAVHKIFMELFPSKKEGPSWLWRFFSIVITFHFVVFCWIFFRARDFETALQVINNIG
QLTFEPENWKAIVLGYKNVFLLMLFGYVWHFLPEVVTDKMKWVFDNTPLLLKAVILGFVY
WIVYATAVAGSQPFIYFQF
>EGALAKHO_02269 hypothetical protein
MNKLIIFFCCLFLSANNKIQKTDPLPITKPMSSKIDTTTDDSFSEDKIYNAKVLESIFRK
LNENENHKSQKINIVHIGDSHIQGDLMTNEIRKNLQQRFGNAGRGLVFPYQLAKTNGSYN
ERFRSNRTWESYRNIHPHKNYPVGLSGIGLWRDNGGFAVELNVKDPSYKFNTIKIITPQN
QNMFDLATSSQTNIIQSTERKVITHKIKKGEVISTIADKYNVSVAEIKRDNRLKSDNIRA
GRTLKIQTNETKPKTIKSSAFVSLNVESDSFSHYYNSDKALDKIFLIPNKEASKFELNGI
VLEKDAPGLIYSSIGVNGAKYSDYNKYPLFFEQLKALHPDVLVLSLGTNESYDHMEASAY
IEQVRQFIKKVKEQNINVPIIISTPAPSLLKAKRTNTYIFDYARNIIQIAESDNIAVWDL
YDEFGGMHGINQLKIQGLIGPDYVHYSKKGYEKQGNLFTQAFLKAYDNFKLKN
>EGALAKHO_02270 hypothetical protein
MNTKSYFFQSFAIVALAFIAFIGFKQVLPNKIFSDSKIDSKNVLIDSMLLESVANDSLSL
ESDSIAEAEEQEAKQEIVFEDTEGIEFPSETFENYKGYQYLVSFYEKLYQLEKNPQSKVR
IAYYGDSMTDGDLIVQDVRTNYQERFGGNGVGFVSITSESAASRGSVKSVYSKNWKTQSY
LNVKRPTSPFGVNGHVFFANDKTNPTWVQYEAGTNKYATTLDNPVLFYGKSTKRGNVNFI
IGKDTLKKNLVPSNLVNSLKVTSGSIKAFKANFVHADSIPIYGFNFDNGSGVHVDNFSQR
GNSGLPISMFDADVMRAFNNNLKYDLVVLHYGTNVLNYGTKNYYWYEKGMKKAVNKIRES
FPGVSVLIISTADKSTKYDLEMKTDSAVVPLMKAQKRYALESESGFVNLYTLMGGDGSMV
KWVDETPARANKDYTHFNQRGAKAIGRLLYDQLNKGYEEYKILREKRDVATRQQRATRKT
NTDSVSVQKDSVNE
>EGALAKHO_02271 hypothetical protein
MKKNFVLILSFVLLAFTACNNDDDTVPANAVAFAATSLNLSAATTPIEIKFATPTAAAGT
LSISFVETAVTSGTDFSTTPAAAGKTIVVPFEKNASSVSFTFTKIKEAIEGEVKNVVFTI
NSATINAVISENKSIQVNFNETASLGTALAAEVGGPLQPNQVYVDLSSGKMTTAVRNSWD
LGFYSGTDFRVVLNSSVKMAAKQLATANIDEVQVADETMIISQGTGIASQIDDPTGDITK
TTIAAISATDADNKVYLLYLGNKPAATAPALGKEGAVGGDARGWKKIRVLRSGSDYKVQY
ADISSTTHEEIVISKNSAYNFTFLSLIDKKVVNVEPQKNQWDINFTTFTNIIPGATPTPY
FYPDFVTNNLNGNAKAYQVLTSAFTYEAFTLANVDNTKFTADQRNIGSNWRGTSVTGADG
IPVSQFVLRTDRFFVIKDPAGNVYKLKFTGGAKADLERGHPTFQYAILK
>EGALAKHO_02272 Colicin I receptor
MKIKITLFVLFVFCQISFAQQDTIASKEKLSEVVVTGQLGPQSIKKSVFNVRVISKEDIK
QLAANNLSDVLNQYLNITVQNSGSDGRSTVSMFGLDSQYFKILVDNIPLVSDTGMGTNVD
LTQVNLDDVERIEIIEGSMGVTHGANAVSGILNIITKKGGSHKWDISATVQEETVGNEYS
FTDKGRHIQSAKVGHNFNDNWFINVGGNHNNFEGFYDDKQGKDYSLNDGLRGYSWLPKEQ
WVGNAMLGYQKTNFKIFYKFDYYGENVDYYSQIAIPQDNYPFPETYFSRDKRYLTNRFYH
HLNSNGKLFSKLNYNVSISHQKQERDVELFDYQLETKEESNNNRFTYQSKEVLYSTGTLS
NFFNNKKVDFQLGYEITNENGFYSGAAGTFLDNVLQSVDVRKRLENYDIFTVAEISLSDK
LSIRPGLRYSIQTAFKDQYASSLGLRYLFKKGLEARASLGKSYRTPNFDELYTYFVDSNH
NVQGNPNLVPENSTSYEVSFKRLCNFKSGAQIANNVAVTFLDVDDRIDMVLTQITPSKYK
YININKYKMWNISTTEQFAYKNWNLKVGAALVGISQKLDLAELNITSDDKYLYSLQLNSS
VSYNIPKWNTLFALYYKYNGQQQQFAAGTDANGNAKFYLNEINPYSWMDASIRKTFFNNQ
FEITVGARNLFNITNVQISQGSDGSTGGTHGGGATDMMLGYGRSYFLKLTYNLNFN
>EGALAKHO_02273 hypothetical protein
MITKSLFFSAVTALTCTLGFSQDKKQQDIKSIKSMCGCYEVKFNFTETFSYPKDTLTYKP
SETKHESALEWVDLLEDTPNKIVMQHLLIVSDDMIIKHWRQDWLYENTDLYSFDKGTSWK
YKKLDKKAVKGQWTQKVYQVDDSPRYEGSSTWVHVDGQDYWANVADAPLPRREQTKRNDY
NVLKRRNIHEITSTGWNHEQDNDKLVRDDNGKDVLLAQEKGFDVYTKVPDIKCAAAQKWW
KENNALWKNVRDKWQTLFDRHQDLNLEAKVDRKALYSLLFDLKPDATKAETDAIINKFVK
>EGALAKHO_02274 hypothetical protein
MKKYIKSIILATVSVILSTGCQSELDHFNENPNSPISTTPTLLLSAMEVSTFSTHTAGLI
RTSNIFDQHLAGTSVGQLGDIQRYIVSEQDVNNEWNTLYGTTLISGHILNRDFAGSYPYY
NGIGQILTAINLGYATDLWGDVPYDEAFRADQGNKTPKYNTQQEIYQRLQTILDEAILNL
KKPTASNISVPDADDYIFNGDPKKWIQIAYVLKARYALRLTQVDANAAQKALDYITASGI
SSNSDDANTFFPGTSNGLNQWYAFENSRTNYLKTGAYFVNTLKNSSDPRLTFSIALNKPK
SPITPIYVGNIPEDLDTTSSSYIGSAYASPTSAIGIVTYAEAKFIEAEAKFRMGQDAKPA
LTAAITASVLKVTGNAPTAGFLTIATTTVDLSTIIQQKYLALFLTMEPYNDYRRTGFPAL
IPNHNSNTKAIPVRLPTPSDERQYNPNATVVSNVTNNVWWDKN
>EGALAKHO_02275 TonB-dependent receptor SusC
MKQKIKGFLMLLFALSTQLFFAQEKTISGTVSDNAGIPLPGVSVLVKGTKSGTQTDFDGK
YVIKASSNQVLVFSYIGMKTQEAIVSSSSINIKLKDDSVELEGVVVTAFGIKKDEKKLGY
AVSKVTSEEITRSGEQNVLQALAGKAAGVQVIGTGGTPGASSKIIIRGVNTITGTSDPLI
VVDGVPIDNSTSQTSAGDNPFNANLSGINNSNRALDINPDDIESVSVLKGPAAAALYGER
AGNGVIIYTTKKGKAGKGLGIDYSTSLAIDKVSQLPARQNKYVQGTSATAVAVNPNTPQS
WGPAAQAIGVPMYDNVGNFFQEGLTFTNNISFYGGDEKATYRASYGNVTQTGMIPETGLK
RNTLRVVGDLKLNDKWKTGGSLQYTHTTNTLAQNGSNVSGVMLSLLRSVGNYDLRNYKDA
EGNNTNYYASYDNPYFTVNENPATSDVNRVFGNMFLTYSPATWLSLTAKGGIDAYSDYRK
QIFAISSNGDNLAGMGEVALNNINSKEFYGDFIASGLLPLKSEWLKINYTAGLNLRSSQN
TDVFSRGKELAVRGVYNLSNATQLYASNTEVNIMSRALFGQLEFDIKNQLFITGSVRKEW
SSTYGTDANSAIFPAASASWVLSNTFDLPEWASFAKLTYGYGEVGIAPQPYYTISTYAQP
FMTDGFTDGLSFPYNGVNGMAVSGVLGNQNLRPERVLGHEVGLSSKFLENRLSLDVNLYY
KTSKDLLIKLPLPQSSGFGIVYQNAAELVNKGVEVELGYDIFKKNNPFQWNINLNWAKNE
NEVTDISGNLDAISIETAFGSIGYYAVKGQPLGSFYGTKWQRDANGQKIIGTDGLPIIQG
ETGNLGNSAPKWTGGLRNTFTYKRITLSGLLDFRHGGAVYNGTLARLHNFGVSEASADRE
RTYIIDGVKSDGTPNNIAISAKNYYQKYLGDGGGASEEAITDVNWIRLRDVTLSYDFNVK
KFTAIHSAQLSFTGRNLWLDTNYKGVDPETSLTGAGSRINGLDYFNNPGSKSFIMTLKVG
F
>EGALAKHO_02276 Arginine--tRNA ligase
MSLSQILTPSIQSAIQALFDVTIDKIEFQTTRKEFEGDITMVIFPLLKVIKSNPAELGNK
IGNYLVENVSEVARFNVVSGFLNIVIADSYYLNFFNEIKDNTKFGYVTPNAEDKAIMVEY
SSPNTNKPLHLGHVRNNLLGYSVAEIIKASGKKVYKTQIINDRGIHICKSMLAWEKFGNG
ETPQSSNLKGDKLVGKYYVEFDKAYKAEINQLIESGKTEEEAKKQAPIIVEAQDMLKKWE
AGDEKVIDLWKMMNQWVYDGFATTYTNLGVNFDRYYYESNTYLLGKDVVQVGLDKGVFEK
DPDGSVWIDLTDEGLDRKIVLRSDGTAVYMTQDIGTAIQRVKDMPDVGGMVYTVGNEQDY
HFKVLFLILKKLGFDWASSLYHLSYGMVDLPSGKMKSREGTVVDADDLMQDMTDTAQQIS
EDLGKLDSYSAEEKAKLYKTIGLGALKYYILKVDPKKRILFNPEESVDFAGNTGPFIQYT
YARIQSIIRKADFDFSVKTNTEELHEKEKELVKQIELFPEVIQNAAQNHSPALIANYTYD
LVKEYNSFYQSVHILGEVDLTKKIFRVQLSQKVAEVIKSAFTLLGIEVPERM
>EGALAKHO_02277 hypothetical protein
MKLKFFLFALLGVIATAQAQNTGTVSGKISEKSNNAPISYATVSIKDNGKVVSGVNTDDN
GDFTIKNLALKSYTIEIQYIGFRKYIGSVILSDSKKTATVNVSLEEEATQLKGVNIVAER
STMEQKIDRKVITVGKDLTTAGASASDIMSNIPSVNVDQDGKLSLRGNDNVRVLIDGRPS
NIDPAQLLKQIPSTSIKKIELITNPSAKYNPEGMSGIINIILHKNANTGFNGSYSGGITF
GKTAKYNQSLDLNYKTGKVNFFGNAGQNFGTYQNEGHIVRLDQPVDQKLDISNDNDNYLY
KIGMDYLINDNNTLSFYTNQNKSTGTGIVLTDINYNNGDPNILNIYQDSKYHGPSTTGTY
NLAYKHIFKKEGHTLDFEGNYSDTKEIQNSSFDTQTTKPNNTSSDILYNDFINDERKLST
LNIDYVNPLNDKTTLEAGAEARITRTNNDYTTGNPLVAVENQISYYTYDTDIYSAYVTFG
QKFKKFSYQLGTRFESYKVAANLNHGETKFDDDYITLYPSAYLTYNLNEKNVLQLSYSRR
VDRPSLEQTKPIREFSTPLVTSYGNPELRPQFTNSVEVNYTKTLEKGSVTAGVFVRSIND
QISRTLSPDPNDPSGYKQILSFTNYDHNSAYGFDVSLNYKLTKWWDIQPSIDFSSIKQEG
VVFEFDPATSTSSPLQRSVTTSAFNARMNSNFKPTKRLSFLLFGFYRGPVDEIQQHRNEM
YKIDIGSRYTLLDNKMNISVRFNDVFNTMKYSFDGIYPYPQTGQFSWESQTVYVGLTYNF
GGAKIKNLQRKQREDNTNKGGGGMF
>EGALAKHO_02278 Copper homeostasis protein CutC
MRKSQLEIACFNYESALIAQESGADRIELCENMQLGGTTPNYILAVRVREKLTIKMHVII
RPRGGDFIYTDEEFVEMKQDIKQFKKLGVDGFVFGILKENGNVNKRRNKELVNLAHPLSC
TFHRAFDVVKDVKKSLKDVIDCGFSTILTSGQGINVEEGIFDLEKIQKWAKDRIEIMPGG
GLRSSNINLLQDKLEPTFYHSSAITDNTETANPEEIKELRNFL
>EGALAKHO_02279 Quinone oxidoreductase 1
MKALTFSSFGNSDVLEYIEIPNPQLKNDEILVEMKAIGLNFADIYRRKGNYHLKGNPPFI
AGYEGAGIVVDANNHPEYKVGDRVAFADVPFANAELVAVNTNHVLPLPEAISFETAAAIL
LQGLTAHYLATDSHKMAKGETVLIHAVAGGVGQTLTQISKLLGANVIGLTSSSDKAKVAF
EQGADHVFLYNEDWKSEVFKIIPKGVDVAYDSIGSTLMESFEVTKECGQVVFFGMAGGDP
APVDPRMLMDGSKTLTGGDLWSYLSSKEERIKRANQLFNWIIEGKITLSTPTSFKLSEGK
RAHDYLESRKSTGKIILIP
>EGALAKHO_02280 Xaa-Pro aminopeptidase
MKRFLVFFTFLITIYQVQSQENLPTDYLSKEFHKGRREAFRNLMPANSVAVVFSYPERVF
SRDINYNFHQNPDMYYLTGYKEPDAVLLIFKEAQGTGETYNEVLFVRERNAAREVWTGRR
LGVEGAKSKLGFTTVYNGKDFKDFAIDFKKFSKIIYDKIPTDIESSRNDFDLAGLLQSFK
IKAGITTEDKASLESFADITNSLREIKTPEEMDLMRKTVKLSCVAHNEVMKAVGPDMSEN
EADGIHAYIHRKYGAEGEGYPPIVGVGANGCILHYGENNSSKMDNQLLLMDVGSEYHGYS
ADVTRTIPANGKFTEEQKAIYQLVYDAQEAVFKICKEGTPLVNLNETAKDVLAKGLIKLG
IITDPKDVRLYYPHGCSHFLGLDVHDKGNFKGPQSLLKENMILTVEPGIYIPANSKCDKK
WWNIGVRIEDDIAIKKNSYENLSADSPRKWEDVEKMAAQKSTFNEMKFPKI
>EGALAKHO_02281 Peptide methionine sulfoxide reductase MsrA 2
MKNTILICLFALSLNGFAQNKKSSNLETITLGGGCYWCVEAVYENLDGVKSVVSGFSGGN
VADPTYEEVCTGETGHAEVVQITYDKNVTDINEIFKVFFTVHDPTTLNRQGADVGTQYRS
VIFYKNDEQRKAAQSIIAELNKAKVYSSPIVTKVEPFKKFYKAEDYHQNYYANNKNQPYC
RMVIQPKIDKFEKVFKDKLKKK
>EGALAKHO_02282 Peptide methionine sulfoxide reductase MsrB
MKTRTQFFSLCFLIPLFILQACGQSTKKQNTKTVAMENKINKPGNPYYSNTDTTVLHVSN
AEWKKVLPDDVYAVMREADTERPFTGKYWNTDEKGTYYCASCGNKLFRSGAKFASSCGWP
SFFEQDNKKSVVYKEDNSLGMERTEALCGRCGGHLGHLFDDGPEPTGKRYCMNSIALDFI
PDNK
>EGALAKHO_02283 Isopentenyl-diphosphate Delta-isomerase
MIEENVILVNQNDEQIGLMPKLEAHEKALLHRAFSVFILNNKNEVMLQQRAHQKYHSPLL
WTNTCCSHQREGESNIEAGSRRLFEEMGFKTELKELFHFIYKAPFDNGLTEHELDHVMIG
YFNESPAINHDEVEDWKWMKIEDIKEDIEKQPEIYTVWFKIIFDEFYHYLEDHKI
>EGALAKHO_02284 6-carboxy-5,6,7,8-tetrahydropterin synthase
MKVTISRKAHFNAAHRLHRKDWTFEKNNAVFGKCNNPNFHGHNYGLTVSVTGKIDPETGF
VLDVKVLADIIHEEVEIPFDHKNLNLDVPEFQDLNPTAENIAVVIWNKIRKKIHADFDLE
IVLNETDRNFVTYKGE
>EGALAKHO_02285 Putative peroxiredoxin bcp
MSLKIGDIVPNFTAKDSHGEVFESRNVLGRKPLVIYFYPKDNTPGCTTEACSFRDQYEDF
KDLGAEVIGISSDSVKSHHKFAKKHELPFILLSDPDKRLRQVFGVRNNLFGLLPGRVTYI
IDRNGVVIYIFDSMNAAKHIEKALETIRELVL
>EGALAKHO_02286 Mannose-6-phosphate isomerase ManA
MKPNLYPLQFEPILKDRIWGGEKLKTILNKPIVSKITGESWELSTVEGDVSVVANGVLKG
KSLMDIIDETPNEILGTAVYKRFGKQFPLLFKYLDAREDLSIQVHPNDKLAKERHNSFGK
TEMWYVMQADADSRIIVGFKENSSKEEYLKHLHDNSLVSILDDVKAKTGDVFFLETGTVH
AIGAGLVVAEIQQTSDITYRLYDFDRVDAQGNKRELHVDLALDAINYNKVETQKKYDTKV
NTSNTVVDCPYFTTNFIPLENKLEVSKSGESFTVYMCIEGSFEIEFDGFKQTYIKGDTVL
VPAEINAFILNGKASILEIYIS
>EGALAKHO_02287 hypothetical protein
MANVKNLKKDINFVLGDIIEAIYLFEMSTTGNPTPETNALIDQAIAAFDTLITKVNAKNV
ENKKAHFKQINVELEETANQLIAKINEL
>EGALAKHO_02290 hypothetical protein
MEETSVFEKFELQLDQSAKDFLKETAKWAYFLSILGFVGIGLLVLIAVFAGTFLAAMGNM
VPGMGAMGGSFGLIMGIIYFLIAALYFFPVYYLFKFATNTKAAFRDNDSEALTNSFSYLK
SHYKFIGITTLVVLGFYVLMLVLGILGALLGR
>EGALAKHO_02291 hypothetical protein
MKKSIIAFVALALLASCSKKESADSLHLTGNIKGLKNGTLYIQRIVDTSLVALDSIKIDG
NSAFERDIKLESPEMLYLFLDRGVTNSLDNNILFFAEPGSINIDTNLDNFIYGAKITGSK
NQELYEEYKKINSRFNDENLSMVESKFKAIKKQDQKAIDSLDAKQQSNIKRKYLFATNFA
INHKDYEIAPYIALAEIYDINIKFLDTIQKSMTPKVAQSLYGKKLTKFVSDRKKEEQK
>EGALAKHO_02292 hypothetical protein
MKKTAFLLLSICATALIYVSCSSDNVANQTDTTAVGASVAIDATNEMDINTGLLVTNSSP
TAKSALNVAGVCATITVSGSSYPRVFTVDYGTTGCADNQLTRKGKLKITLSGPIITTGSK
LTIERIDYSINGIKVEGTIEYTNTTTVATVPQWSRKVTNGKFTDLQGRVYTNSGMHTVKQ
TAGVDTPYVLEDNVYEMTEGTHSVTTEKGTTLTLTVQETLVKKYSCAYVSKGKLKIEGGF
LKGVIDYGNNDCDSKFTYTHESGVSYNLSM
>EGALAKHO_02293 Chaperone protein HtpG
MTTGKINVSVENIFPLIKKFLYSDHEIFLRELVSNGTDATLKLKHLISIGEAKVEYGNPV
IEIKIDKEGKKIHIIDQGLGMTADEVEKYINQVAFSGAEEFLDKYKDSAKDSGIIGHFGL
GFYSAFMVAEKVEIITKSYKDEPAAHWTCDGSPEFTLEPADKTSRGTEIILHIAEDSLEF
LEDSKISGLLNKYNKFMPIPIKFGTKTETLPKPEDAPEDYINETVEVDNIINNPNPAWTK
QPTELSDEDYKNFYRELYPMQFEEPLFNIHLNVDYPFNLTGILYFPKLGSDMQIQKDKIQ
LYQNQVYVTDNVEGIVPEFLTMLKGVIDSPDIPLNVSRSGLQADGAVKKISNYITRKVAD
KLKALFNENRADFEAKWNDIKIVLEYGMLSEDKFYEKAGAFVLYPTVDNTYFTLEELKEK
LKENQTDKDGKLVVLYAGNKDAQHSYIETAKEKGYEVLLLDSPIISHLIQKIEGDNKDLT
FVRVDSDHIDNLIKKDENTISKLSDEEKETLKTSLEAYIPKAYSVQLEAMDSQAAPFIIT
QPEFMRRMKEMSQSGGGGMFGMGNMPEMYNLVVNTNSDLATNILNTEDKTHQEHLVKQAL
DLAKLSQNLLKGEDLTAFVKRSFEMIK
>EGALAKHO_02294 hypothetical protein
MKKIIFMCMIATMVFACKSASTPASTEATELSTKLDKKTQVALKGNWVLTNVSYPGSDYI
KVNSFDLADSKCFIGSTWNFISNNNKGSMTLNAPSCTAFTSPIVWSINNQGLLVLKIVNP
GTKSKNVKEGYLLKVAAVTDNSFELIDNINVGGQTKDVTYQFQRAN
>EGALAKHO_02295 putative lipoprotein YiaD
MKKITVLGLSSLLVLVSFFASCDSVKNANNTQKGAGIGVVAGGLIGGILGNNLGHGGNAA
LGAAIGAAVGGGTGALIGNKMDKQAREIDQALPGADVERVGEGIHLTLNENAVRFDTNKS
TLTTQAKANLDKLIPVFTEYGDTNIEIFGYTDNTGKPEYNLTLSGQRAASVQAYLVAKGL
KSSRFKTSGLGIADPIATNDTPEGRTQNRRVEFAITANDKMVNDAKTEAGK
>EGALAKHO_02296 Fe(3+) ions import ATP-binding protein FbpC 2
MLDIQNISFSYTDKPVIKDVSFTINKGENIAIIGESGCGKSTLLKLMYGLYDLAEGKIFY
NEKPILGPKYNLIPGMPYMKYLAQDFDLSPYETVAENVGKFLSNGFANMKKLRVQELLEM
VEMESFSNVKAKFLSGGQQQRVALVRVLALEPEVILLDEPFSQIDAFRKNALRRNLFRYL
KQKGITCIIATHDSTDALSFADEAIVMRNGEVIVKDNPTKIYEDPQTKYVASLFGEVNEI
PTHLLLDYEDETHKTLVYPHQLKMLSDSKLPVKIRRTYFRGNHFLIETVFKRQLIFFESE
IDLPLEQEIFLGLNYL
>EGALAKHO_02297 3-oxoacyl-[acyl-carrier-protein] synthase 3
MYHSKIAGLGYYVPSNVVTNDDLSKLIDTNDEWIQERTGIQERRHIIRGEDTTTSMGVKA
AKIAIERSGVAKEDIDFVVFATLSPDYYFPGPGVLVQRDLGLRTVGALDVRNQCSGFVYA
ISVADQYIKTGMYKNILVIGSEVHSTGLDMTTRGRGVSVIFGDGAGAAVLSREEDLTKGI
LSTHLHSEGQHAEELALQAPGMGARWVTDIIADNDPNDESYYPYMNGQFVFKNAVVRFAE
VINEGLEANGLQVSDIDMLIPHQANLRISQFIQNKFKLSDDQVHNNIQKYGNTTAASIPI
ALTEAWEQGKIKSGDTVVLAAFGSGFTWASAIIKW
>EGALAKHO_02298 Putative thiazole biosynthetic enzyme
MPRELLLQVTPEIAANELLLKDYLSKQIKVSPKEIQHISILKRSIDARQKAIKINLKVII
YLQGEPFQETKIELPLYKDVSSAQEVIVVGAGPAGLFAALQLIELGLKPIVIERGKDVRG
RRRDLKAINVDHLVNEDSNYCFGEGGAGTYSDGKLYTRSKKRGDVTRILELLVAFGASED
ILVEAHPHIGTNKLPKIIEDIRNKIIEFGGQVLFDTRVTDILVKNNEVEGIVTQSGDKIL
ANKLILATGHSARDIFELLDKKKIFIEAKPFALGVRAEHSQQLIDSIQYSCDYRGEHLPP
APYSIVKQVNGRGMYSFCMCPGGVIAPCATSPGEVVTNGWSPSKRDQVTANSGIVIELKL
EDFKPFEKFGALAGMEFQKSIEQKAWHLAGETQKVPAQRMIDFTQNKVSADIPKTSYVPG
TTSVEMGQVFPGFLSQILREGFKEFGKSMRGYLTNEAILHAPESRTSSPVRIPRDPLSYE
HLQIKGLYPCGEGAGYAGGIISAAIDGEKCALMIAEALK
>EGALAKHO_02299 hypothetical protein
MSRKIKLIWDFRGPASAKTAEHHEIHLKEYIAIEKLPLNITGFKIINDMHAIAFMVVTEE
NMIMVRDALKPHRGEVFEG
>EGALAKHO_02300 ATP-dependent DNA helicase RecQ
MNSNEIEIHKELKKYFGFSQFKGLQEQVITSILGKKNTFVIMPTGGGKSLCYQLPALIQD
GTAIVVSPLIALMKNQVDAIRSLSSENGIAHVLNSSLTKTEIAQVKKDITSGLTKLLYVA
PESLTKEEYVAFLQSVPISFVAIDEAHCISEWGHDFRPEYRNLKNIIKQLGQVPIIGLTA
TATPKVQEDILKNLDMSDANTFKASFNRPNLYYEVRTKTKNIESDIIRFIKQHKGKSGII
YCLSRKKVESIAEVLQVNGISAVPYHAGLDAKTRAKHQDMFLMEDVDVVVATIAFGMGID
KPDVRFVIHHDIPKSLESYYQETGRAGRDGGEGHCLAYYSYKDVEKLEKFMSGKPVAEQE
IGFALLQEVVAYAETSMSRRKFLLHYFGEEFDSETGEGADMDDNVRNPKNKVEAKDQVVK
LLEIVRDTKHIYKSKEIVFTLIGRINAVIKAHKTDVQSFFGSGSDHDEKYWMALLRQVLV
AGYLSKDIETYGVVKITKEGLNFIKNPVSFTMSEDHEYNESEDEAIVTASKSSGTADEVL
MGMLRELRKKVAKKLGVPPFVVFQDPSLEDMALKYPITLPELFNIHGVGEGKAKKYGGEF
VTLISRYVEDNDIIRPDDLVVKSTGVNSANKLYIIQNIDRKLSLKDIASAKGLTMDALIK
EMEQIVYAGTKLNIKYWVDDMLDDDQQEEIHDYFMESESDKIEDALKEFDGDYDIDELRL
MRIKFISEVAN
>EGALAKHO_02301 Arabinose 5-phosphate isomerase KdsD
MISKENILAIAKKTILSESEAIIKLIDFLDENFYEAVQRIYETKGRLIVTGIGKSAIIAQ
KMVATFNSTGTPSMFLHASEAIHGDLGMIQKEDIIICISKSGNSPEIKVLVPLLKRFGNI
LIAITGNITSSLAKGSDYVLNTTVEMEACPINLAPTNSTTAQLVIGDALAVCLMEMRDFK
PEDFAVYHPGGALGKKLLLRVKDMIEHSLKPMVTPETSIKKAIFEISEKRLGVTAVIEDN
KIIGIITDGDIRRMLNNVDTIADLTARDVMSKNPKLVSSETMAVDALNILEDFSITQLIV
ADNGEYKGVLHLHDILKEGIV
>EGALAKHO_02302 Sec-independent protein translocase protein TatCy
MAKKNLGEMSFLDHLEELRWLLVRSTTATMIMAFVTYFISDYLFDKIILGPTRPTFFTYV
WFCDLSHKLGFADSICITELNFIIQNTEMEGQVNIFVWMCLLAGFILSFPYILWEIWKFI
SPALYEKERKNAKVFIFTSSLLFFLGVLFGYFVVIPMSVNFVATFSVSDVVKNQFTLDSY
MGMVKTSILGSAIFFELPIAIYFLTKLGLVTPDFLRKYWKYAVVIILIIAAIVTPPDVVS
QTIVAIPMLLIYEVSILISRIVYRNKLKEKNV
>EGALAKHO_02303 Alkyl hydroperoxide reductase AhpD
MSELIQEFNDYRSKMNEKLLADNNKIVKRIFNLDTNAYAPGALDVKTKELLGLVASTVLR
CDDCVKYHLETSHKEGVTKEEMMEAMGIATLVGGTIVIPHLRRAYEFWEALEEEASN
>EGALAKHO_02304 Lipopolysaccharide export system ATP-binding protein LptB
MKLRADNLIKTYKGRSVVKGISVEVNQGEIVGLLGPNGAGKTTSFYMIVGLVKPNQGNIY
LDDLNITDYPMYKRAQQGIGYLAQEASVFRKLSIEDNILSVLQLTKLSKEEQIAKMESLI
EEFSLEHIRTNRGDLLSGGERRRTEIARALATDPKFILLDEPFAGVDPVAVEDIQRIVAQ
LKNKNIGILITDHNVQETLAITDKTYLMFEGGILKAGIPEELVEDEMVRRVYLGQNFELR
KKKLEF
>EGALAKHO_02305 hypothetical protein
MTPQKPTQQDYNNWHNDPNNWHLGMFYYNKEDKRMFVPKKLKWAGFTINFGNSKAILITI
AFLFFMYTLTQLK
>EGALAKHO_02306 Lysozyme M1
MARKTTRRTSYSRKSQPTRSVFSRVIRFIVFSFLAIVFLGTIYHYRAGLAYYLGFKSDKV
LDEDEVDKHLSDVRNIQVLENHKGKVVGIDVSEFQGKVDWEEVEVLEEKYPVQFVFIRAT
AGNDRVDGQFKKNWEGAKENKIMRGAYHYYRPNENSIEQADLFIKTVKLQKGDLPPVLDI
ERLPKNQPLDSLKKGLKRWLTKVEKHYQVRPIIYTGERYYSDFLKEEFSEYLFWIANYNF
YREKIEDDWLFWQFTEKASLPGIKHRVDVNIYNGDFEQLQFITVE
>EGALAKHO_02307 hypothetical protein
MNIKKHIPNLITLINLFCGCIAVVFISEANYEMAFYMVCLGIFFDFFDGFFARLFKVSSP
LGLQLDSLADMVTSGVAPGYVMYSLFTNSAHELGTNPAIPFLGFIVTLGSCYRLANFNID
TRQTDSFIGLPTPANALFILSLPLVLKFSDSLMMLEILTNQWVLLVITLFSAYILNAEIP
LFALKIKKFNLKDNVLQIVFLAISLVLLFLFQFGAIPLIIIFYVLLSVVNNMFLKK
>EGALAKHO_02308 hypothetical protein
MLLLFWSCTQQYAQTVRKYSNEFMNIGVDAAALGMSSAVVASTNDVNAVYWNPAGLTHLE
DHQISLMHANYFANIAQYDYIGYASPIDDRSAWGISMIRFGVDDIMDTTELIDSQGNIDY
NRIRLFSTADYGFTFSYARKLPVEGFQYGVNAKVIRRIIGQFANSWGFGFDIGLQFERND
WKFGLMLRDITTTYNVWNIDEEEYAKIANAIPGENNELPESTEITLPKAQLGVSKTFDFH
NDYSLMVATNLNMRFEQTNDIISSKVVSIDPAIGFEFGYTDLVFLRAGAGNFQNVMQLDN
TEKVNFQPNIGLGFKYKGIQIDYALTDLGNQSTALYSNIFSLKVDLGIFR
>EGALAKHO_02309 hypothetical protein
MKNVIFKKTLFSLLLLLSFVGFSQNLPLSKDAKISVLTCGLGNESYSFFGHTAIRVADPA
NNIDVVYNYGTFDFRTPNFVAKFAKGDLQYFATAHAFGDFMNDYTYEKRSVFEQELLISP
EMKQKLFDKLNKTIFSDDRFYTYKFIDKNCTSMVVDVINSSLNENVIVKKGDTDITYRSI
LFPYFNGHFYEQLGTSIIFGTKVDQLGTKIFLPFELKNSLEKTTFQNRPLADKTKTLLHF
EKETPTSWWNNIYTYLFILAFVVLAHNKIVDKIYLFILSLIGLFFVIMGFYSLHHELAMN
YNVLLFSPLLLILILLSILKNKRWTYRFAVLHVLFLIVYSLFIINKVHFLIVLPMIITSG
FVLVRVAIRNKKRIPIII
>EGALAKHO_02310 UDP-N-acetylgalactosamine-undecaprenyl-phosphate N-acetylgalactosaminephosphotransferase
MVSNRKMHFEISERKVLLRLFDIVFVLSALFLLNFLFEVQYFNLDPAHYFRPIMLIVYLT
IFGAIFEMYNLQVASNQFQILRSVVLTTTTAVLVYLFTPILSPELPKKRLVILVFYFTIL
GALLAWRYFYVFFLASHRFSQNVLLICEQNQVKELVLGLENVDPHYKILGFVSSDLVSQE
DSDFHYLKEIKRNDLELFVAKNNISEIVIASQKTDGITADLYQQLLHLLESGNIIREYTQ
VYESKTQRIPVQYIERDFYRFFPFSRSNNNKLYLFLIRLIEFSLSFLGLIFCVAFIPFIF
IGNLLANKGSLFYTQERVGKHGIVFKIYKFRTMVKNSDVNGPFASSNDIRVTPFGKFMRK
SRIDELPQFFNVIKGDMAVIGPRPERPYFVNEIAKMMPFYETRHVVKPGLTGWAQVNYSY
GESIEESLIKLQYDLYYIKHRSVFLDLSITLKTITTVLFYRGQ
>EGALAKHO_02311 hypothetical protein
MKIKLSYTYLLLIHAALALVVFIVPFLSKVYALLIPIIGFLIVIQNKNKNNEVLLVAAYL
VGIEVFLRMTGGNFNNEYVKVGVIFFMLVGMLYSNFSTAAFFYWFFLILLIPGVLITAMT
DHYNLDVKKILVFNLSGPICLAICAIYMYKRKVLFSDLQNIIVAMGLPIITTSVYLFLYN
PSVKDVVTGTGSNFETSGGFGPNQVATILGLGIFIFFTQLILFSKSKRDIVLNGFLLLFV
SYRGIVTFSRGGVITGVIMIVSFLVLMYLHSNAKSKAKLGIVIVLTFLMGLGIWTYSSLQ
TSGLIEKRYSNQDALGRTKKSTLSGREEIMDAEIKLFLDNPILGAGAGMGKELRKDSLGY
EIASHNEITRMLSEHGLFGICGLLILIITPFVLYINNRQHLYFLSFFVFWLLTINHAAMR
IAAPAFVYALALLSVHVKIPQKAEDSRD
>EGALAKHO_02312 Putative glycosyltransferase EpsF
MRIVQIIDSLEPGGAERMAVNYANALSKKIEFSGLTTTRDEGLLLNQIDEKVSYLFLNRR
KIIDFQSVLRLRKYIKENDVDIVHAHSSSFFIAILVKFTFPRIKIIWHDHYGISQDLKSR
RNLSLKFFSLFFSGSIAVNSALKKWARSYLYCSNSIYLPNFIEASTKTDESIVLKGIEGK
RIICVANLRFQKNHNLLIEAAVIIKKQFPDWTFHLLGKDFQDSHSKKLFQKVKDLKLEET
IFFYGAIHNTRSAMEQATIAVLPSLSEGLPLALLEYGLCKLAVVSTDVGEISQIIISDKE
GILIESNDVNQLASGIKKFITEKIYRTDVGLNLYNKVRLEYSEDVVVNEYLSWLKSFVIA
KI
>EGALAKHO_02313 Glycosyltransferase Gtf1
MKFAIITHVVHIQKEDKYYGYSPYTREMNIWLKYIDELVVIAPLASQKKITEIDAFYECA
NINFKKIPNFNFVGFSNVLNSIFRVPLIFWKVFWVMKEADHIHLRCPGNVGLLGCIAQIF
FPKKIKTAKYAGNWDPKSKQPWTYRLQKYILKNTFLTRNMQVLVYGDWKNQSKNIKSFFT
ATYSEDEKEFFQKKDLNPITEFIFVGSLVVGKNPMYAIKLVEKLSINGRKIILNIYGEGI
ERTILEEYIKNNQLERFVFLQGNQNQEKIKEAYQKSHFVILPSKSEGWPKAIAEGMFWGC
VPIATPVSCVPYMIDYGNRGVILEMDLNADVVKIEKNLINESDFFSKSKLAIDWSQNYTT
DIFEAEIKKLL
>EGALAKHO_02314 hypothetical protein
MKLELPRWTPHHNMIVYSLLFYSEKNNIDLSIVFNNKIQANSAILYIKGKVIFFDYSDDV
FFTDNPDQYDFYFKRSLPSLNFFDNVYPLNFQVNFSYKALSLLKKLPVREIINKKNRIEI
FRALDYCNSFTNLSHNAMDVRFFPKDVINNKGKIIFQTRLWNPENHIDFQEKERRRIQNE
FRIEGCRIIKKNFKNVSVGLFPDNLSLKIAPDILLDVKKTSKKGYFKSLYNSDICIADDG
LKDTPGWKIGEYLLFGKAIISTPITVTVENFSNHVNYEKLSTRNAYVELPEKIEYLLAQN
RYLEMGSNNLLWSEMYLHPKNYINRILAIIEKKDLEKIQ
>EGALAKHO_02315 tRNA U34 carboxymethyltransferase
MKTKETILETNIKQKEFYNSKKKNFATSIWSKIRNGVLNRIKKNIGVQEQSYILHKQWFG
DLSDKKVLDLGCFSGNYWSLHLAQNAREYLGIDLSDVAVEKLNERIKHLPNADAKAIDFL
SDEFTIGDFDLIYAYGVLHHFENTSVLIDRLNEKLVKGGEIISYDPLETSFPIKVLRMLY
RPFQSDAAWEWPFTKKTFYMFQDAFNIIERRGLLGKSKWIVMINMLPISSKRKNEIGNRW
HSQDWNESKVSDSALFNCMHVTMLMKKK
>EGALAKHO_02316 hypothetical protein
MRPKPLLKLLQSVQEQTLYPNEILIIDGSTNSDTEDILKGNLFHNLKYFIVGKENRGLTK
QRNFGIRNVNDSTEIVCFLDDDTVLESDYFENLLNTYNLLPEALGAGGYICNEVKWEKVT
RNYMPKLNEFYFDGWKRTDGSRFVLRKKLNLDSDCPPGFAPLFSHGRSVGFLPPSDKIYE
VEQLMGGVSSFRKSVFDTLSFSTYFEGYGLYEDADFTLRVAKIGKLYINTAAKLDHFHAS
SGRPNQYKYGKMVVRNGWYVWRVKNPDPAFKDCVKWNAITILLTLIRFSNALTSNAKQES
FTEAMGRTIGWWSLLFNKPKKEK
>EGALAKHO_02317 hypothetical protein
MIIVYHNNNRVVKAVTKDNVTLVYNKKAQIATVLSELALRYPEFKIVWCNQDYENYLDLA
VINDVFHHDKMMLSYNPNEIDFLGKKIGYIDESPFVKINKEVTYPTWLMSSVVGCTHAKV
LNAINQKIKTDENFDYYLSSMAKICMPLGLLCYSEPTLLRKNNLKNNLKHSNFTLFRFIK
QHYRKRWSFLLFLNLFLYERRVLLLPLLYSLISRSKKLNQISLDTIEVQSRNEVVEYGTI
DVIIPTIGRKQYLYDVLKDLSAQTHLPENVIIIEQNPKKDSVSELDFLKNESWPFNIKHT
FTHQAGACNARNLALSKVESEWVFLNDDDNRFDKNVLSSVLEHLKIFGLKSLSLAYLQLN
EIKRNLVVSQSSFFGSGNSFVHSSLLTKIKFNMQLEFGYGEDSDFGMQIRNQGIDVIYFP
NPEIVHLKAPFGGFRTKPILAWTNDVIQPKPSPTIMLYKQLHTSKEQISGYKTILFLKYY
KKQSIKNPIRYFLNFEKQWKQSLYWANQLKSK
>EGALAKHO_02318 Glycogen synthase
MKVAFLTPEYPHPQTGNSGGLGTSIKNLAIGLVAQGVSVRVLVYGQKKDGFFYDKGIFIQ
QIKNVKFKGISWFLTRKKLERIINKLYSNKEIDLLEAPDWTGITSFIKPDKCPIVIRLHG
SDTYFCYLDNRPIKWINKFHEKRAIKKADGLLSVSHFTADKTNSIFDLNKEFEIIPNLID
SELFKKDDLDKQTKQNILYFGSLIRKKGLLELPLIFNKVIEKHPGTKLILIGKDVPDIIS
GNSSTWKMMQNLFSEKALKNVEYLGSIPYNEIKQKIQESKICVFPSFAEAFPVSWLEAMA
LEKPIVASNIGWADEMIDDEENGFLVNPKNHALYAERIIKFLDNEDLCMQAGKAARKKVE
SCFDITVLAKRNIEFYKSVKLKF
>EGALAKHO_02319 hypothetical protein
MKRFLLYTAKIFVVLFLLAITLDGLYTAIFIHSKNRGKIETVFNSKAQNFDVIILGSSRA
NNHFVSQMFEDKGLKTFNYGMSGGHLFEASLMLKLMIERKYTIKNVILEADLNLSNDKES
DGVSAKFLPYIHNSEVIKKHFSKQENFYELYYIPFYRYIKFDGKIGFREVYKVVQKEKTN
ALDNLGYYPLVKHKNGNMKNNIVNLNPLLHNKYYEEIKGICKANKINLITVMTPMCENVV
GINYFEKVKKTYPEIHNYEDVVVENKYFSSCGHMTDAGAKLFTARILKDFFKK
>EGALAKHO_02320 Peptidoglycan O-acetyltransferase
MFFNSLAFAVFLPIVFFLYWFIFNKTKSTQNALLIVASYYFYSCWDWRFLFLLVFSTFLD
YYTGIQIEKGKSENSRKFWFWLSIIVNLGFLGIFKYYNFFAASFSELLTSAGFKASPILL
NVILPVGISFYTFHGLSYVIDIYFKRIKAEYNFVDYSLFVSYFPLLVAGPIERATHLLPE
IKIKREFDLEKAKEGVYQIIWGLVKKVVIADTCAMYANAIFDHYESMNSLSLILGAIYFA
FQIYGDFSGYSDIALGVSKLFGLDLLRNFNYPYFSRDIAEFWRRWHISLSSWFRDYLYIP
LGGSKGGMRMKVRNTFIIFVVSGFWHGANWTYIVWGFINAVYFLPLLLSSSNRNNIDAFK
LKFNVDSAKIVMSIVYTFSLTCIAWIFFRARTITDAILYIKRIFSNRDFGFQFLENERYN
YELLLMIGLFVLVEWNNRNKVEPLSGKRSLLKISLAIAAILALGTFSDYKEFIYFQF
>EGALAKHO_02321 Glycosyltransferase Gtf1
MNKKIAVICNYELLPNRVGGMDYFFWSFDQKCKENGIEVDWFFPNISDHGSYSALTIYNA
EELSVENCFLTYLKQNKPEYTHVITHFVELCTPFFFKISKFSSAKVIAVDHNPRPLEGFT
LKKKISKKIKGIVFSQYIDTFIAVSNYSKKDLLKDFGNHIKKKIKVIPNGLDLAKFKKKV
NFAPNNKFITACHLRKEKGIQDLINAVKEINENYNFEFLIDIYGDGNFKEDLNKLITEYS
LQHIFTFKGSVSDLNEIYFNYDYLIHPSHGETFCYTVLESLLSNLPVITTKDQGNVLGLV
KENRNGFLFEVSKIDQLKQILIKILNQNIILEDNSFFNDNLHAFSLTGMVDNYFDLL
>EGALAKHO_02322 hypothetical protein
MEENKIIGVVITDGVGFRNFIMSDFIVEAVSEFEKIIIYSGLPKSCYNDWRHLSVEVVEL
PIFTESKMTWFFRKWKELGHLQQHKQFYGMKSNLNSGYPKNNSIRSLLVKGLYFLTQYIN
TNSSILFAERLQFSSFSRNKITREYIEILKKDQPSHLFFTHQRPPYLAPFLYAAIKLKIP
SSTFIFSWDNLASKGRMLGTFDRFLVWSKLMKDELLYFYPNVKKENVQIVGTPQFEPYVL
DKYKSEKQNFFSKFQLDSNKKIICYSCADVSIGKNDPLVIKVIAEAIRNNEIQFPVQLLV
RTSPAEGDSRFKTIREEFPEIIWNVPKWILTRENHQESWSQRIPSQEDIMDLRALLENAD
LSINMCSTMSLDFMLFDKPVINTVFGNLKNGLYNDQRFLNYNHYKKVIDGNAVTIAKDKE
ELITQINQNLQKPAERAIYRKAMTDLQIGKDLRGTSKRIASVLKSFHE
>EGALAKHO_02323 CMP-N,N'-diacetyllegionaminic acid synthase
MKILALIPARGGSKGVPGKNIKLLNGKSLLAYTAEVALKSTYFNEVIISTEDEKIIEVAK
NLGIKVPFVRPMELAQDDTPTIDVIIHTLQWYENQNISFDAVCLLQVTTPFRTVEFLNKA
IEKFIEKDSDSLVSVQKVPHEYNPHWTFEVNSIGNLKIATGESEIIKRRQELPVAYHRDG
SIYITKTKVLLQNKSLYGKTTTFLESDSESHVNIDTIEDWVKAEAIIKNNK
>EGALAKHO_02324 UDP-N,N'-diacetylbacillosamine 2-epimerase (hydrolyzing)
MPKRKIAVVITARPSYSRVKTVLSAIQQHPDLELQLVVAASALLDRYGSAVNFIEKDGFT
IAAKVFNVLEGENLTAAAKTTGIGILELSTVFDNLKPDIVVTVADRFETMATAIAASYMN
IPLAHIQGGEVTGNIDEKVRHAITKLADYHFVASESAKDRVIKLGEDPKMVFNTGCPSID
LAEEITKSESLRFDPYKKYGGVGATPDLSQGYLVVMQHPVTTEYKDSRKHIEATLEAIYK
INKPTLWFWPNVDAGADGTSTGIRAFREQHQLPNVHFFKNMEGKDFLELLKHSECLVGNS
SVGIRECAFLGVPVINIGSRQNRRDRGGNSVDVDYSQEQIEAAIMASVKKGKATSSSIYG
NGKAGVQIADLLAELPLQFHKTIMY
>EGALAKHO_02325 N,N'-diacetyllegionaminic acid synthase
MLSKKTLPYIIAEIGQAHEGSLGILHSYIDAVAQTGVNAVKFQMHIAEAESSEHEPFRVK
FSLEDETRFDYWKRMGFSLEQWKGIKKHCDEVGLDFICSPFSNLAVDWLEEIGVKFYKIG
SGEVNNFLILEKIAQTGKFVILSSGMSSYAELDQTVAFLKERNVDFSILQCTTAYPTQPE
QYGLNVIQELKNRYNVPVGFSDHSAKIETCIAATAFGANILEFHVVFDRQMFGPDSKSSL
TISETTDLVISVRNIAIALSNSIDKNNNEVFSSLKQIFEKSLAVNKDLPKNHILSFDDLE
SKKPKGFGIDACRFNEIIGKTLNRDLKQWDFLNETDLL
>EGALAKHO_02326 hypothetical protein
MKASVLIVSKNRKEDLFKTLNILESLIDKSEVEVLVFLDGCTDKSENLKNEITWVKWFVS
DRSIGASAARHQIYPLADAEILIGLDDDAHPLNYNFVDHIEKLFKINPQVGILAFEEIKG
IFQSDEEALKHAETEKKEYLTSEFIGCGFAVRRSVYNLTNGFPVWIDIYGEESCLSIEVI
SKGYDILYTNQIKINHRVNKELRKLNKQNYFRFGKQLKNSTFYFLVYYPFPLINILKLYW
HNFKKYALTDWECFKIYFKTLFVVMINILKVLKYRKPIDKTVILKMRNLAQLKF
>EGALAKHO_02327 Putative glycosyltransferase EpsE
MKKLAVLMPTYNCAPYLQESIDSILNQTYTDFDLYIYDDCSIDNTCQIITSYSDKRIFYI
KNEKNIGIAKTLNLGLEKLLPNYEYIARMDADDWSFPERFEKQLDFLDKNKLTAICGTQG
FWIKNMREVPNSGWQYPVYNNYLKIYLLFGASFGHSSVIIRSSLFSLRNLKYNENIKTCE
DWDLWVRVSKYYEVHNLRDFLMKYRIVLTSNHRATENKMIHLKERSKIISNYWKTFDIDL
SPDQVYEYYYESEDRRTQSFIQKLNGLINSFNQLFGNHSLDLQKEDKKKFSYLLARKMAD
FRKRSKISLFNPIVWIIILSRVRFISIPRLINSQIIK
>EGALAKHO_02328 hypothetical protein
MKILVVAESINIEDSSGSKANVAFIHNLIKAGFEVLVYHYTLKDIKLKNVNTYAIPEIKI
SVNYFLSRLQRIISRNFKINFAPFLEKLFGFSFTFFNDTNSIIKALEKCKFEPDLIVTLS
KGASFRPHYAVLKLPELHNIWMAYVHDPYPFHFYPRPYTWVESNYKQKEIFFANVCDKAK
YSAFPSQLLLEWMGSFYPNFLKTGIVIPHQSSIYQIQNLNFPDYFDPSKFNLLHAGNLMK
ARSPEGLLKGLQLFFSRNKEAQEHTRLLLLGPSSDFSKILEEYKKGIPQLTIHNKNIPFD
EIYNIQKNVSVNVIIESKSEISPFLPAKFSHCVEANKTILSLAPFYSETKRLLGVNYDYW
SEADDENKIAAILEKLYNLWKQNSNNLLLNRNDLEQYLSADYLREIIVSLNKKTTVI
>EGALAKHO_02329 UDP-N-acetylglucosamine 2-epimerase
MKILLCFGTRPEAIKMAPIYHELKNNGFNVKVCVTAQHRQMLDQVLDFFEIVPEYDLDLM
QPNQSLNELSSKILSNINSVLILEKPDLILVHGDTTTSSMVALAGFHLGIKLGHIEAGLR
TYNKHAPFPEEINRQITSRLVDVHFTPTMQATQNLLMERITRDSIVETGNTVIDSLLWAI
NKIESANYENEEIERLKSIIPVDKKLILVTGHRRENFGEGMKNLCNALLKISERDDVTIL
YTVHLNPNVQNIVNELLSNKENIKLFEPVSYPSFVWLMRQSFLIVTDSGGIQEEAPSLGK
PVVVTRTVSERPEGITAGFSTLTGTNEVKIVNTIEGILNKFNGFGNVKNPYGNGDASKKI
VDYLSKMEVE
>EGALAKHO_02330 UDP-Glc:alpha-D-GlcNAc-diphosphoundecaprenol beta-1,3-glucosyltransferase WfgD
MNKLVSIIIATYNRAGYIEESLRSIQKQTYENFECIIVDDGGSDNTFEVIEPILKADSRF
FFQKRTDNYQKGLPGTRNCGLDLAKGDYVIFFDDDDIVHPQNLELCVLEMSRNDVSFCRY
LRGYFQEKFDYTFDYSKTYRHFFIDKNDVFNLLNQKLPFNSCVVLWKKECFDESRYTEHL
SHAEEWELYSRILSTGVTGISIDKTLYFARQHGNSMTGQYFRLDPKRSLSNVNAILLVLK
NLKEKKLLNNSIIRYFVAISYGYPEFDMFGQILQTLDFNKINNIKWRMYYFNLPLRFKIT
RLKKRFLTTN
>EGALAKHO_02331 Putative glycosyltransferase EpsE
MQNNPLISVILPVYNGEKYLSQSIDSCLNQTFKNIELIIVNDCSTDKTLNIANQYAKKDN
RIRIINNSVNKKLPASLNIGHNEAKGDFITWTSDDNFYELNALEILLNELLEHEADIVYS
NIFLIDNLGKRIREVKLLQFENLIFGNVIGSCFLYRKNVYQKNKGYNETLFLIEDYDFWL
RAIVHSKYLKLDQFLYNYRKHEDSLTSKIHTFNDKKNLFQKNIAKMYLDFSKSFLNQNYQ
VFSELQTKILTNQKINFYWIIENHVILKKFQKSILLNKNFQNKKPTGRVFLNQIIMLMTA
DSLHENRKQYCFFILKKYYKFLDKNSLKTLVKYSFLK
>EGALAKHO_02332 hypothetical protein
MPESKIKFLAYYLPQYHPIPENDNWWGKGFTEWTNVVKAKPLFRGHYQPILPADLGFYDL
RLPEIQEEQAKLAKKYGIDGFVYYQYWFGNNKMLLEKPAEAMLRNKNINTPFCFCWANET
WKGIWHGLDNPDILIKQTYEGEKGYEIYFDYLLPFFKDERYIKIDNKPMFHVYRFDDIPD
VDKFINIFKDLAIANGFDGIYFVATLGSDLILKNKHVYGKIGVDVFHKMRYKKGFLFENI
RYIGWLERKIKVKLGFTNELGKRLKPLIFDYKKAVSQLIVTFTHEKYIPCVFPNWDNSAR
SGKKSLIFVNSNPHSWKIHLEKTVNELRKNPRNPQMIIVKSWNEWAEGNHLEPDIKFGLQ
WLEAVKAVKDAK
>EGALAKHO_02333 Hyaluronan synthase
MNKKVSVIIPCYNQAQYLNEALESVLSQTFFDWECIIINDGSPDNTEDLALKWCNKDPRF
RYLKKENGGLCSARNAGIDISNGELILPLDADDKIGAKYLELAVKAFSEDDSLTVVYCKA
EKFGDENGLWDLPEFSLFNLSRNNLIFPSGMYRKTDWKIVGGYDSKMIYGWEDWEIWIAL
LKNGGRVKQLNEVGFYYRIKSVSMLKLVDKEKGDYLLNYLSVKHADFFVKYYGSFKTMEH
QLIALERKNEENLKSEKFVIDVFCKRFFGFTLFGKYKE
>EGALAKHO_02334 Chondroitin synthase
MLFSILVANYNNGHFFKDCYESILAQTFTNWEVIIVDDASTDNSVEVINQIIGEDNRFKL
FINKENKGCGFTKNRCAYLAQGEVLGFLDPDDALTSNALTIMYEAHCLHNETAIITSKYD
LVDLEMNFREVCKHGFSLPPNKSYLTYGKGAFTAFATFKKRFYSQTIGINIKMKRAVDQD
LYYKLEEQGEHLFIDQVLYRYRVHEGSISCNDNLYKAQYWHFYAINKAYSRRKKSNKEIN
NFTSEYMSIYRSNYYLSRFVKLKFSKRYKSKFYFLGKAFLADPTHKFELKFKSLILLLLY
RI
>EGALAKHO_02335 Putative glycosyltransferase EpsH
MTSQISIIIPTYNRAHLIVETLDSIIAQNHQNWECIIVDDGSTDDSENLIKKYQENDNRF
IFLMRPNSKPKGANTCRNIGLDTAKGDYIVFFDSDDLMTPDHLEIKVNGIQNYNCDYVIT
RTKFFNSDLNYMDDYYQFDKHEITPYNYVCQKNNWVTLDVLIKSDLAKSIRFNENLQSGQ
EYNYYSKLVHSSCNAKFIDKVVSLRRYHEKSIRTQLHTDNKLQESFFRANWHTYLDLRGV
AKEKTLKVLLIRCVKLVYENKAILISNKFLFCFEIFKLFKVKGTYFMMMYLSLKFFNKGD
VFKNKFLRT
>EGALAKHO_02336 Putative glycosyltransferase EpsE
MKDFLVSISCITYNHAPYIRECLDSFLMQKTSFAFEIIIHDDASTDGTKEIIEEYTSKYP
DIIFPLYQNENQYSKGVRGMMARFNFPRCKGKYIALCEGDDYWTDPLKLQKQVDFLEANN
EYSIVSGGYISKDIESNFEKMELLKNINQDLKGFDIDIKLFLKQWVTKTLTVVFKKDCID
FNRMRRFKYLRDVHIYYYLLKAGKGYYMSNVLGVYNKHAGGIFSRISEENKYVSYLNTYG
ELYKSNKSDLHIRNKYYSILDRVTKDELFPKKQSKYLLEMLLISLKMKDIKNYIKFKLR
>EGALAKHO_02337 Ubiquinone biosynthesis O-methyltransferase
MNEELIELYKKTSKHSNYQILPSSLKNIIDESIVPTISRYENERMDFLKKQLSFQNKKVL
DIGGNTGFFSFEAIEAGAEQATLIEGNSAHETFVKKAAQITNKNISTNNYYLDFKTNNIT
EPYDIVLLFNVIHHLGDDFGDKTIALDDAKVEMQNAINFFTDKTDLLVLQMGFCWKGDKN
LLLFENGTKKEMIEFVTNSIKDKWEVQAIGVAEEIAGKTTYNKLDDQNIERYDSLGEFRN
RPIFILKKKTKVFNRIEELEFLDHLVSDYKDDSPYSKIKKNIILDLIKSNVDLDVKSKKA
LQLGCSNGYETEQLSKIFNNLYVADGSQKFINKVKSLHRNVNFVHTLFEDIDVSFSNEKF
DFIFCHYILEHVFDSVLILQKLKSLLVPEGVIFIVVPNANALSRQLAQKIGLIENLTDLT
KNDLDHGHRRVYTHTTIIEDIKKADLKINKINGLVFKILADFQLNELLRSGFLKEEHILG
MQKMALIKENIQFSDSFFAVVKA
>EGALAKHO_02338 hypothetical protein
MKVLIFSGSNDRAIISFCRYAVQKGIPIHIVANGDSDYILDTIYKENVIGVRTKNELNIY
SVLEYCEFIRTNKNSNVLIIPSTEFLNRFLLQNRKILSEHNIQIGLCENEVYEKLSDKYL
FNELCISEGIKVPGEYKTPPKNYPFVVKPKKYFINSKVEKPVLIYNQDDFDNFAEDKNLS
EHYFQEYIGGKSFYLLYYIFKNGSYSVYSQENLMQQQNGGSMILCKSASIHKEIISKNFA
DLFIKHSFSGLVMVEVKFYNNKFYMIEANPRLWGPSQLILDASMNLFDCFAFENKLISTI
PESHYEENQWYFWSGGLIQNQQIEKNISYHNFDNDLFFKNYNAFLNNEVYLKKDSINIYL
KENVYERGTN
>EGALAKHO_02339 dTDP-4-amino-4,6-dideoxy-D-glucose transaminase
MINVTKTFLPPIEEYHKQLQRAWDNQWLTNRGELVLELEEKLKKHLEVSNIIITNNGTVP
LQIALKILGKGGEIITTPFSYVATTAAIVWENCTPVFVDIHPEYLTIDETKIEEAITDKT
TAILATHVFGNPCNVDVIEAIAKRHHLKVIYDAAHAFGVTYKGKSIFDFGDISTCSFHAT
KLFHTGEGGAMFTNDLELQRQLFYSHNFGHNGTLAFHGLGVNAKMSELQAAMGLAVLPYM
EKIINERKKVVDFYNENIDFTKVRSLNIRENTIWNYSYYPLIFESEVKLLEVQKVLNEQL
IFPRRYFYPSLNTIEYTNGTEMPISESVASRILCLPLYEGLNVESLKKIVNDIN
>EGALAKHO_02340 Teichoic acids export ATP-binding protein TagH
MGEVLIKVDGVSKKFAKDLKKSLLYGLSDVFSGIIGKKQDKSLRGDEFWAVKDISFEVRR
GECLGLIGHNGAGKSTLLKILNGLIAPDEGSVTMYGKVGALIELGAGFNPILTGRENIYN
NAAVIGFSKEEIETKFDAIVAFAEIEEFIDMPVQNYSSGMKVRLGFAIAAQMQPDVLIID
EVLAVGDLGFILKCFKQIDQLLPNTAVVFVSHSMPMVARVSNQIMLMEKGIVAFQGKEVS
KGINSYYNRFNSNVQNVMFDDGTVSLIKHFVNNNNNVTLQRGDDLIIELEMEFKKEIFNV
PLIYIEFRDKEQRPIAGVFNKKKTYEFINNKLIVEIKIPKVLFAQGIYTYDLSVNHFENK
SPILRINNVDVFQIESETEMWVPFHLEADWQITCRAND
>EGALAKHO_02341 Teichoic acid translocation permease protein TagG
MNLEKHIYTSSNSYSFLDVVKASLKGFRNSFYLANQLAKRDIKAQYRQSFLGVFWAIFPL
LVNSLVWIFLQSSGTIQVTATKVPYPAFVLIGTTLWGIIGECINLTTQSVNANSSIITKI
NFDKEALITLGLIKFFFNFLIKMGLIILFLIFFKIVPSIEILFFIPLLFLSIVFFVAIGT
LLMPISLLYNDISRLIPIALQFLMYATPVVYAIPHQGVMRGIMLLNPLTYIITDLRNLLT
GYSIENPVFWFSGVFITAILSTIALVVYRVSMPILTERMS
>EGALAKHO_02342 UDP-N-acetyl-alpha-D-glucosamine C6 dehydratase
MNTDKQTKVADLLHNSFSPRNLRAHINNLSYLPRWIIVALDVMILIFSFSFTYMLFEGTA
LGYIITSHHYYFVSSLIFVNVFFFWLFRTYSGIIRHSGYIDAIKLLFSQMSVLVFFLFFN
LVFELYTSHKAFLNTALFINMVLSFCGLFLYRVIVKQTFELYFSEKTSTKLIRTVIYGTD
ANAISVANALKFETPSRFKIVGFVDKNNQNASKRMLDLPILILRKKLPALMRSVAAEGVI
IADKSLSKEEQLIIVDQCLEFNYRVYTVPLISDWENQKEISQKVKNIQIEDLLERKPIVL
DSKSISKQLKDKTILITGAAGSIGSEIVRQVLGFNPKVVIILDHAETPLHNLCLETLGMN
SETKIVAVVADVRSKKALEKVFKSYSPHVVFHAAAYKHVPLMEENPAQAILTNIKGTKNL
ADLACKYHVKKFVMVSTDKAVNPSNVMGASKRIAEKYVQSLFLKNQRENNEGSTKFITTR
FGNVLGSNGSVVPLFTKQIAEGGPVTITHQDIIRYFMTIPEACQLVLEAGAMGNGGEIYI
FDMGKPVRIIDLAKKMIKLAGFIPDKEIKIKIVGLRPGEKLYEELLNDTSKTLPTYHNKI
MIAQEIQDEYENLHTEVDELIGIADFYDNDDIVAKMKKIVPEFKSMNSAFEVLDK
>EGALAKHO_02343 Glucose-1-phosphate thymidylyltransferase 1
MKGIILAGGSGTRLHPLTLAMSKQMMPVYDKPMIYYPLSTLMMAGINEILIISTPHDLPN
FKKLLGDGSSLGCKFSYAEQAIPNGLAQAFVIGEEFIGDDNVALILGDNIFFGSNMQELL
KSNTKPDGGVVFAYHVSDPERYGVVEFDENLKAISIEEKPEEPKSSYAVPGLYFYDNSVV
EIAKNIKPSARGEYEITDVNKVYLEREALKVGILSRGTAWLDTGTFNSLMQAGQFVQVLE
ERQGLKVGCIEEIAWRQGFINDAQLEELALPLVKSGYGAYLIEFLKQKRKGVKV
>EGALAKHO_02344 dTDP-4-dehydrorhamnose reductase
MEKILVTGANGQLGSELAVLSTQFPKYEWIFADRTKITLDNLELLKIQLNEIKPDIILNG
GAYTAVDKAETEKELAFAINHLAVELIAKYASEYNVKLIHVSTDYVFDGTSSIALDEEAA
TNPINVYGESKRLGEIACLKQNPDSIILRTSWVYSKFGNNFVKTMQRLMQERDSINVVND
QIGSPTYAADLAQAMINIIEFPNWVPGIYNYSNEGEISWHEFALTIKELGGYDCNVGGIP
SASYPTPAKRPKFSLLDKKKIKDIYNFDIPNYKESLKKMFTKI
>EGALAKHO_02345 dTDP-4-dehydrorhamnose 3,5-epimerase
MKIEETFIKDLVVVEPTVFGDERGYFFEAYSKTKFSDLGINIEFVQDNQSFSKKGTLRGL
HYQNPPFAQTKLVRVLEGEIIDIAVDLRKDSPTYGKSFSVLLTAENKKQLLVPQGFAHGF
SVISETASVMYKCDQFYNKASEGGIKFDDPSLNIDWGLNLEEAIVSEKDQILPFIENCNS
LF
>EGALAKHO_02346 Putative pyridoxal phosphate-dependent aminotransferase EpsN
MDNQRIYLSLSQQSGFEQEYVQKALVTNWITSGGPNVDDFENVIENYLDANSFVTALNSG
TSAIHLALILLGVKVNDEVICQSMTFSASANPILYQGAIPVFIDSEKETWNICPENLEIA
IKDRIKKGKKPKAIIAVHLYGNPYKVDEIHAIADRYQIPIIEDSAEALGSTFKGKKCGTF
GTFGILSFNGNKIITTSSGGALTTDSRELKEKAIFYATQSKDNAAHYQHSEIGYNYRMSN
ICAGIGLGQIKILNEAIAKRRENHEFYKDAFSDIENVELFEVLNEDYFSSYWLNTILIEP
NAQKNISSQGLRLMFEKQNIETRPVWKPMHLQPIFEKYPYYGNKVAEDLFNKGLCLPSGS
NLSVEDKNRIKEVIFNFFK
>EGALAKHO_02347 hypothetical protein
MIPKIIQGGNFSDHRGTISYVNDFSFKDIERFYIISNSVENPIRAWQGHKLDAKNFYCLN
GSFKIHFVKVDNWENPSEDLIIETVLVCESDSKIVHIPAGYANAIESLEKDSKLISFSTL
PLANVAADDVRYPSDYWKING
>EGALAKHO_02348 Undecaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase
MEYTILGILLMILMLLYFKVADRFNIIDKPNQRSSHTEITLRGGGIIFWFSALIYFLQHV
DNNYFFFTGITLVSLVSFWDDIQSLSNKIRISVHFSSITLIFYDLGLFDLVPIWAIVIAY
VFAIGLINAYNFMDGINGITGLYTLVVMGSLLYVNSNIQWFTDGTFIKYGMIASLVFLFF
NYRKKAKCFAGDVGSIAIAFWIIYLVLKLILQTSSLIWLMFLAVYGVDAVCTIIHRLYLK
QNIFEAHRLHLYQVLSNEYKIQHRLVAAYYALVQIIISVLVIVLYQKVNDVLLFLIVILP
LLFVYTLKFYLLNKHALKFNS
>EGALAKHO_02349 N-acetyl-alpha-D-glucosaminyl-diphospho-ditrans,octacis-undecaprenol 4-epimerase
MKNVIITGSSGFVGKNLSKYLSDHSFLVNAISLRNLEWQNNFKGTAVVHLAGKAHDIKNT
SDTSEYFKINTDLTKILFDAFLESEIADFIYFSSVKAVADQVPEVLFENILENPITPYGQ
SKLKAEEYILSKEIPSGKRVFIIRPCMIHGPGNKGNLNLLYNVVKKRIPYPLAAFQNERS
FLGIDNLNFLINEILKNKEISSGVYNFSDDEFLSTNELVEIISAVSNKKNLSFVIPKSII
LGLAKIGDLARLPLNSETIQKLTENYRVSNQKIKTAIGIEKMPNTAKQGIEKTIISFINK
>EGALAKHO_02350 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MKTIATVSIVLYNSDSNELEKVIKSIFNTNTEIRLYLIDNSPSDLLKVFQDFDQRIIYIH
NPSNPGFGAAHNIAIQKAITEEVNYHFVVNPDIYFKGDPISSMLDFMKKDSTLGMMMPQI
LNLDGTVQNLPKLLPSPLSIFLRKLKKPVKQYKKFINQYELRLVPEKLIYNAPVLSGCFT
LLNLNAIKKVGGYDDKFFMYFEDWDLSRRVHRHYKTIYFPLVSVYHGYESGANKNSKLFK
IFLNSAITYFNKWGWFFDSERKKINKEALQQFR
>EGALAKHO_02351 Putative acetyltransferase
MLKRYGILGSLGLLYSLIYTKVFFYNTRLIRMPFDIRNKRYIKMGDGLTTGFGCRFEAYP
QKNVDQKILQFGSNVEINDYVHIAAGEKIIIGDNVLIASKVFISDLNHGNYKGKDSDSPL
SIPKTRKLSTSPVIIKDNVWIGEGVCIMAGVTVGVGCVIGASSVVTKNIPDYCIAVGSPA
IVIKQFDFERNEWLLVNRS
>EGALAKHO_02352 hypothetical protein
MSLEKKIVISAINFFEGGPLSVLKDCLNFVNNCKYQNNCKFIVLVHKKELFDTKEYPNVD
FVEFPKSRKSYFFRLYYEYFYFKNFAISNKIDFWFSLHDITPSVGNIPQAVYCHNPSPFN
TINASDIYLQPTQFFFRLFYRYLYQINIKKNKYVIVQQLWMKNRFVGMFDLDKNKIIVAP
PQIPKISDEFIVSNSNSKNQDNIKLFFFPTFPRPFKNIEVICEAARLVLNENPNFKIIIT
IDGSENKYSKAVVTKYQDVKNISFVGLIKRDEVYSYYSQIDALIFPSKLETWGLPISEFK
QFEKPMLIADLPYAKETVGNYEQVNFFRPDDARQLSELILNHLNNKVKFDSNAKIDYEEP
FVQGWEELFTALLKD
>EGALAKHO_02353 Transmembrane protein EpsG
MGIYIGTLLLIFVLGVLDLMLKLSDLQRKYLMFLLYVVLVVQIGLRWETGTDWNPYLDNF
ETSDNYGVVLLNSLVGFEIGYGTAVFIVKKIFNNYSVFLFLHAVIFYWGIFRTAKKYSPY
FFISLMFFYATTLGVVGSNRQLLAIIICLWGLDFIFEKKVFKFFITIAVASLFHTTALIF
GVYYFLNRNFKTVTVFSILILSFIIGKTGLPLLLFSKFGGLIGEVASSKATFYSENNSSS
GENLGLSVFGLVKRIVFVMIFAYNYAFLNKKLIYYKLLYNGYVFGLVIYFLFASSLLILI
NRGSLYFNIMESLLISCQFLVFYKRLDKSYIYFILLLISIIFLFQSISAYSDLFDPYKGV
FYNVDFVREMY
>EGALAKHO_02354 hypothetical protein
MGKQRLVFLGFNSMLVHKRGVENVIHFQSQASPADLNYYIFWDAQTAVRRYENLICVGIK
KNMFWFVALNVVLLKLKRKKCKIFIHSHNPLMSIMSFFQTDLFTVHDGLYYLTTATKHKL
NVFFWLLEKLLYLRCSFVHFISEYAKKMSLYKSDKNYEIIANTSHFEVVNIDGFSDNNLR
RFDIDVTKVFTVRSIEERALINLIIEVAGKLKNSKIEFFIAGKGPLLDFYRERIEKLELK
NITLLGYVSDKDLLYYYNDCDIVLIPAAYGEGFGLPIIEGYFFDKPVIASNVCAIPEVII
SEDFLFENTCDSVLSKLNFAKEMTHIKYRKHYDDFFSNKVVLSQMLALYKKLL
>EGALAKHO_02355 hypothetical protein
MKIALFGSKDYDSLEYHLNDSFTFLGHTVAHIDIKDIVAIPYKYNYFASKLFKKYDELLF
RKVARKIIDSQPELVVCTYRFTHPICIKLIKEALPKVKIIHINPDQLTTLEYQQIFASSY
DAFFTKDLYMVDFMKNKMRLNTFYLPEAFNPRIHKMPNVNRFEHEQKINIDVVAFGTMYP
YRANMVGQLLKEGINVDLFGTPDKRFAKPEIDNRFRNEYITGARKAEVLYGSKIVFNNFH
YAEVESANVKFFEIGGIGGFQICDYKPVLKDYSAVPVEKFTFKTIGEAIDLIKFYLDKPE
LRHDLAKTQYDHFSLKHTYENRIGEIFEVL
>EGALAKHO_02356 hypothetical protein
MVDSTCFGNWHLHFNSQLIEILSNIASVVEYRGAQNIGNSKLNIKRRKLFVITGSGKLRI
ILRFLFTLMNDVWQVIIVPNDEIIVYCFDATVSVRAVNMINKIVKKKVIMFRHGSMEMLQ
TSPSGKGIFYRFENNLVKQFFLNKNLNISTDLHFFVLGDVILKNLSVFLSKDKVKHFHSI
DHPYNFDRNALIKERVQTSKLYIGTVGVFNEYKGGADLLELAQILKRKALDDIHISISGK
IEFDISLLQDAEIDLPSNGGKEMVSVEELKDRIDKLDYILYFYPVNTYRLTASGAIFDAI
NRKRPIIALRNDYFEYIFNKFGSIGYLVDSVSEMADIIYRISNGVEKRVDYDFEQIQDLL
SVDNLTKIFAEQLREIGFIKK
>EGALAKHO_02357 N-acetylglucosaminyl-diphospho-decaprenol L-rhamnosyltransferase
MDVSIIIVNYNTCDLTLQCLRSVYEKTTGVLFEVIVVDNASSDNSVEQIKLKYPQVQLIE
SKENLGFGRANNLGFEYSSGDYIFLLNSDTILINNAIEILWSFLTEKPDIAIVGGQLFEE
DGLTCSHSFSVLFPSLLMELDILFRGNITHRIENKRLKLIESDGFVPVAYITGADMMLRR
SDIQQHGFFDPSFFLYFEETELSYRYYRNGKVSVFLPKAKIIHLAGGSFSLAKARSKFYV
EGRKNYYRITHSVLYHKLADFIWYITYFSEVIRNARNRSKRKEWMGKVRLLFNGNFK
>EGALAKHO_02358 O-acetyltransferase WecH
MKQEIPYLNVARVLACLMVVSLHSLPKISVYGIDSYFFTLVLIFTRPCVPIFLMVTGVLL
FPVKNENISDFYRKRIFRIIFPLLVWGVIYSILPYQLGVEKFDQMISNIFLVVVTFPKEI
GGILWYLYVLIGLYLIVPFINPKVFDDRKMLHIYLSIWLIASLINSLKIYMPEILGIGPS
SAFDMLQYFSGYLGYLFLGFYINRYFLETKNLRWYKIKFYTTLAVIYFVSMIIIMQIMKY
SIYNEFKELYIAITTFLSFPVILMSACFFIAIKEMKINLNGWFYKIVNHLSPLTFGIYLS
HMLINRLFTDRLYTINTSPLMQASVMIITFFGAYILTLLLSKISFRKYIIG
>EGALAKHO_02359 hypothetical protein
MILNKASIAKKINKVYCAVARLRLKNHDFTIISNDCWGGGVYEDLRRKYTTPTVGLFFYA
PCYIDFLENFNQLIGLDLVFVNMSKYKEANDYRVQNNLHYPIAKLKEVEIHFLHYSSNEE
ACNNWNRRKSRINFNNLFFKFHDNNLCTPELIERFERLPLSEKNKVMFTAKKLINIKSAV
FLRKYKGKLFIGDVYSNPWAYRRDFDVVKWLNRGL
>EGALAKHO_02360 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MINISNLYLAIILLVIILFRRTIGLMLSFVLLRFFNQKAKRYIVNEQSKQKEDISSSANK
KTSRTFKSFVLNLLYGFNRYCDFECGRIPSHHIRDFMYRTIWLINLAPKAVIYWGAEIRA
GYNLTIGEGSIIGDNALLDARNSIIIGKNVNFSSRVCIYTEHHDHRDPYFGGNSDRSFRV
QIDDRAWIGPNVIILHSVHIGEGAVVAAGSVVTKDVPSFAIVAGIPAKIIGERNHDLRYE
FDGSYLPFY
>EGALAKHO_02361 Glycogen synthase
MINKGNLTLIFNHFEFGEEHLGKDVFLIPYHLGKQLGYDVTIVYPRTKTNDNIPKSLKGV
RLIPLNYRKDLPFLPFWKHLNFYIYLLRHVKSINLLMRFHLSTHTEFMTIFYKLLNRKGK
VYVKLDINADALEEMYGNQKNTLKRRIHGWIEAFFIRKSDCFSCETSIAFQRLKESAFAQ
LQFGNKLQLVPNGFDELLLQSLNIQERSFEEKENLIITVGRLGTTQKNTEMLLWALNKVK
LNDWKVCLIGTIDPRIEQIIEAFYKENPDKLESVKFVGAIFDKTELWEYYNRAKVFVLTS
DWESYALVLNEAKRFRNYIVSTEVGACKDLIEEEKYGVSLAINDVAGLADVLNDIITGKR
DIDVYKGYDMNELSWETQSKKLKL
>EGALAKHO_02362 putative lipid II flippase MurJ
MPEPNLKKTTFYLFILRFLRMSLSIMTLPLTAKYFGVSIERDAWILTTTFFSTVGLALWG
PIDETFRTKFVFLKEKEGEEAALSRTVSLVGFIVLITLTVSLIVLVLKQPIAHTLDSTGS
PEKLDIIVTLMLIMLPTLLINQLTSIGISVLNAYDIYYLPEFAGSISSVCNILFIFFLAP
IIGIYSLVISQYVAILLLFIAVIFYLKKQSFKLRPFWIIHWEDVKVFILFALPFFLPYFA
GQINQLAEKLIANSLGDGSVSSLDYARQFSMVLQGVISSVLTTVMVPMLAKSFAQKDVNQ
FAKIVKENFSTCFVIMCLTVPILIGSASPLSNFFFAHGKVSSNALSTIINLIRFYGLAFV
GVILYVMFGLILLASNKGKIYAFWGILAQLVVLFFNIIFVHQWGIYVFPISVGIGHLLTA
CILSYFVVVDDKWKLYLRIAKYIIILFIISLGLYLINLRPVSDIVIIQLFMNGVVLIVMF
IIFSKFLDVNIMLYGKKILSKIVK
>EGALAKHO_02363 hypothetical protein
MENRSVEDNGISLKELLEKGKEWYYYLLFQWKIILIAGIIGGVLGLTYAFIKKPIYTATL
SFALEDEKAGGGLGGALGLASSFGFDIGSSGGGIFTGSNLTELFKSRIMVEQTLLTPVII
NGKKVSLAEMYIQNNEWRKNWNKIAKLKNIQFLPDSNRKNFTRVQDSILGTIYQNLSTGS
LVVAQKDKKVSIISIDVTSSNELFSKFFCEALAKQVGTFYVQTKSKKARMNMAILDRQVD
SIRGELNAAITGVAVANDNTFNLNPALNVRRTPSARRQVDVQANTAILTELVKQAELAKV
TLRKETPLIQVIDRPILPLPKERFGKAKGILLGGIFVGFAMVLSLIIRKGIKDI
>EGALAKHO_02364 Polysialic acid transport protein KpsD
MKKITYVLTLFFILLMSLNVNAQDIMKSKDLSTIQVDYLSDDDLAKISAQLKSNNATIDQ
VEPMALSKGMSQGEFNKLKIKLIEFDKKNAKNSANDKNNKPKLNEKGSEFGRKQEQIKNE
KVKDSANALIFGSELFDNPTLNFEPDLKLATPMNYVLGPGDELQISVYGVQEYNANVPVS
VEGKVTIDYVGQIAVSGMSIEAATQKIKAAIARVYSTVRSGQSQVSVSLGQIRTIKVTIV
GGKQPGNYSISSLATVYNALHLAGGPGKNGSYRNIELIRNNKVYRNIDIYRFLVKGDQSD
NVSLKDNDVIRIPAYSQRVTVEGEVKRPGIFEMKKGETFSDLLNFASGFNEFAYTASVNV
LQKTGKEFKVHDINESEYNSYTPQSGDVFRITKILNRFENRIKIEGAVFRPDYYSYSEGM
RISDLITRAEGLKEDAYTKRARIIRLKTDLSTEIVNVDLSAALSGDLNADIELKREDIVT
VYSILDFREEYKVTIDGEVKNPGEYEYFENLTLNDLVVQVGGLTGSASKRVEIARMVKSD
VIDDADPKRIELIELEITADNNEQIKNFVLKPFDVINIRRMAVYEKPQMVIVSGAVGYPG
KYVLANKKETVYNVVMRAGGLTSIANLDGMKIKRPIKQEQIEQLESIDLNLSKNDTLKEK
LTKKLKEDLKYATIPVNWEKIVKDKNHYSNVTLFPGDEIEVAVYNEGVKVTGNVLLTSEI
PYRSGKGFRYYIDAVGGVDSKGWKKKAYIIYPNGKADVTKSFLFFRSYPNVEPDSQIVVP
EKPETKKMSTGEWVSIGSVLTSLALLIVTAFK
>EGALAKHO_02365 dTDP-glucose 4,6-dehydratase
MKKILITGGAGFIGSHVVRRFVNKYPEYQIFNLDALTYAGNLENIKDIENKTNYTFVKGD
IVDENFINELFSLHNFDGVLHLAAESHVDRSIEDPLAFVKTNVIGTMNLLNAAKNQWKGN
YEGKRFYHISTDEVYGSLGAEGLFTETTPYDPNSPYSASKASSDHFVRAYGETYGLPYVL
TNCSNNYGSYHFPEKLIPLFINNIINNKPLPVYGDGNYTRDWLFVEDHAIAIDLVFHQGK
NHETYNIGGFNEWKNIDLVKLLCQIMDEKLDRSKGTSQELITYVKDRPGHDLRYAIDASK
INKELGWKPSVTFEEGLEKTINWYLGNEDWLKNVTSGAYKDYYQKQYS
>EGALAKHO_02366 Alginate biosynthesis protein AlgA
MSTEKSITHVILTGGVGSRLWPLSRKSQPKQYLEIFEGKSLFEMTVDRNSHLASKVMVVG
NVDNHHLSGKVMDKTRTSYINIVEATPRNTAAAIAFAAFASDPDDILIVTPSDHIIDLMD
NYNNAINEAVSKASDGFIVTFGIIPTKPETGYGYIESKGDKVISFREKPNETTAKEFITK
GNFLWNSGMFCFKAGVLLDELKQFQPDVYEKSKAVWEASKEGFLDLNLSLEIPSISIDYA
VMERSKKIKVVPAAFSWSDLGSFESVYDYLISKNHPVDKNGNMVIGSGKHTTFLGLKNTI
FVYTDTANLILQKENSQDVKDIYSELEKINSDLLN
>EGALAKHO_02367 UDP-N-acetyl-D-glucosamine 6-dehydrogenase
MNENIKIAVIGLGYVGLPLARLFATKYAVVGFDINEVRVSSLKSGIDSTLEIEQKDLQEV
LLTNATSGIGLYCTSSLQDIADCNYFVITVPTPVDKNNRPDLTPLYRSSESVGKILKKGD
IVIYESTVYPGVTEEQCVPVLEKISGLQFNVDFFAGYSPERINPGDKEHTVEKILKVTSG
STPEIGLKVDALYKSVIIAGTYLASTIKIAEAAKVIENSQRDINIAFVNELAKIFNLMNI
DTQEVLAAAATKWNFLPFKPGLVGGHCIGVDPYYLAQRAQEFGYHPEIILAGRRLNDSMG
EYIASQVVKLMIKKGISVNGANLLMLGITFKENCPDVRNTKIVDVITALTEYGISVTIYD
PLANGKDVKKEYNLITINSVPTNRFDAIVLGVAHTEFLSLNFSELQKENSLLYDVKGVLG
ALADNRL
>EGALAKHO_02368 Transcription antitermination protein RfaH
MNWYVVYTKPKWEKKVAEKLAQAGIECYCPLITQIKQWSDRKKKVEVPLFNSYVFVQLPE
VDRNTVFKVPGVVRYLFWLGKPAIVRDEEINIIKTSLTSSNIADISVSSIQVGDRIKLDS
GAFSNQDAIVQEISKTHYILVLESLGCVLKIKYK
>EGALAKHO_02369 UDP-glucose 6-dehydrogenase
MKITKICCIGAGYVGGPTMAVIAQKCPHIQVTVVDLNEQRIKDWNDPNTDNIPIYEPGLA
EIVAEARGRNLFFSTEVEKAIDEAQVIFISVNTPTKTYGKGKGMAADLKYIELCARQIAK
VAKQNKIVVEKSTLPVRTAEAIKSILDNTGNGVQFQILSNPEFLAEGTAVTDLLNPDRIL
IGGDTTSEGEAAIDALVDVYANWVSKDKILTTNVWSSELSKLTANAFLAQRISSINAMSE
LCEKTGADVNEVAKAIGMDSRIGPKFLKASVGFGGSCFQKDILNLVYIAKSYGLNEVADY
WEQVIIMNDHQKRRFSNKIVQTLYNTVADKKITFLGWAFKKDTNDTRESAAIYVANDLIN
EQAQISVYDPKVSRNKMLSDLNYLETRTVEENSDALVIFDNAYEACKGAHAIAVLTEWDE
FTTYDWQKIYDTMHKPAFVFDGRNILNAKELESIGFIYKGIGS
>EGALAKHO_02370 UDP-N-acetylglucosamine 4-epimerase
MKTSTQNTILITGGAGFIGSNLCEYFLELGNKVICLDNFSTGYRHNLEGFINNPNFRLIE
GDIRNIDDCILAVQGVDYVLHEAALGSVPRSINDPITTNDVNVSGFLNMLVASRDAKVKR
FIYAASSSTYGDSQGLPKVEDVIGKPLSPYAITKYVNELYAEIFSRTYGLETIGLRYFNV
FGRKQDPNGAYAAVIPKFVMQLMNYESPVINGDGNYSRDFTYIENVIQMNELAMTSQNPE
AINTVYNTAFGDRNTLNDLVGYLKNYLAEFDSKIANVEIIYGSNRAGDIPHSLASIEKAK
IILGYKPKYSLQEGLKEAVSWYWNNLK
>EGALAKHO_02371 Tyrosine-protein kinase wzc
MLDIKDFSIFENHSNFDFKGFLLKILSYWKWFLISLIIAFTIAYQVNIRKEKIYGMQTMI
SIKEESNPFFTSNTSLVFNWGGISDQVNGISTILQSRSHNELVVGKLQYYIDYLTQGKYN
LVDSYGAVPFYVDIDKSKGQIANTLVSIKFLSPNEYEIRIPFENNSVSLITYSSNSYSNT
AVQPVEFVKRYKVGEQVSLPFLNWKLQINDNPGIYKGNEYFVKFNDFDGTVSRYKGISVD
SDDKGGSILTLGMQGTNKARMVEYLNSTVKMLIKIQLDGKNQFATNTIRFIDSTLVAMES
QLKQNGNELKSFRKDKNIYEIEGGGAKFSDKIMDFDVARDQVSRKITYYNSLKMYLNNSV
DYSRLPAPSVAGIDDPNIVANISKLIALSTQRSEMAYAVKSEKIFKDFDNQMQAVKSVLL
ENIASAKSSLLYDLSLVNAKIDEAENTVKRLPEEQQELLKIKRKYDLNDNIYTEFLQKRN
EAEIVKASNLSDIHFIDPAKDIGGALIGPKTSVNYVLALFLGLLIPLLVVFGIFFINNSI
QNADDISKLTQIPLIGIVGINKDNVSLAVFDKPKSALSESFRGIRSSLQFLYKKQQVNGS
KTLMITSSISGEGKTFCSINIATVFALSEKKTVIIGLDLRKPRLADEFNLKTQLGVVNYL
IKQNSLSEITNTTQIANLDVILSGPVPPNPSELILSEGMKELIDELKKKYDYIILDTPPV
GLVSDALELVQYADVTLYIVRQNYTKKDMITLLNTRVKRGELNNASIVLNGYENKAKYGS
GYGYGYGSYSNGYHEEEVELSLWKTILNKFNKK
>EGALAKHO_02372 hypothetical protein
MTKKSFYILLLISTLFTSCIPVKDLWYLQDKNKTAEKNTVSVVESKPYRLQVNDILTVNI
KAIDPKLVSIFNTTENNSGTTGKSEAALYFDGFTVDDHGNIRIPILGEINVIGYTLEEVR
VMIEKKLLEEYFKSEANIFVTVKLAGFRYTINGEVGSTGTKTLFQSHVNIMEAVANAGDI
NTVGNRKAVMIIRQTPTGVQMNEIDLTDANVMKSPYYYLQPNDYIYVKPLKQKTWGTGQT
GIQSIGTIITLLSLATTVYLIIKN
>EGALAKHO_02373 Recombination protein RecR
MEFSSKLIEKAVNEMSQLPGIGKRTALRLVLHLLKQPKEQTGFLSQALLNMREDIKFCEN
CHNISDTKVCEICANTNRNHQTICVVEDIRDVMAIENTGQYKGIYHVLGGKISPIEGVGP
SQLNISTLVDKVKSGKVIEIIFALSSTMEGDTTNFYIYKQIGETDIVISTIARGIAVGDE
LEYADEITLGRSILHRVPFEKTFKNN
>EGALAKHO_02374 hypothetical protein
MITFVKYSKIMKNKKTLVLGATTKPDRYAYRAINMLVQKGHTVLAIGQNTGEVAGVKIHT
KAVPVKNIDTVTLYLNPARQRDYYNYIIEAQPKRVVFNPGTENPELYQLLELNNIKSEVA
CTLVLLATNQY
>EGALAKHO_02375 hypothetical protein
MDLFIYLFAALFSVLNPIGTVPIFVGLTQHDSQKERSRISLWTAINVFIILIVSFFIGQY
VLSFFGISIDALRIAGGIVIVNSGFSLLSGKFNKKRGINKKIENEAQQRNDIALTPLAIP
MLAGPGSISLLIAFHQEHHGMEEIVISSLAILAIAVAIFAILKSAHYLARILGASGIVAI
SRIVGFIVISIGIQYIVSSIINIVKGNLM
>EGALAKHO_02376 hypothetical protein
MQQTTNSIVMIRPVAFRMNEQTAVNNYYQKVLDGLLPSTVNAKAQQEFDTFVEKLRAVGV
DVTVIDDTLETDTPDSVFPNNWVSFHENGDVALYPMFAENRRPERREDILDTLEEKGFEI
SNIMDYTSAEEDGFFLEGTGSLLLDRANAKAYCALSPRADEELFIEFCEDFDYAPVIFEA
FQTVDGERKLIYHTNVMMCLGETFAVICADCIDDKKERKMVLENLKGDKKEIILITEAQV
NNFAGNMLEVRGANDKKYIVMSASARQSLTPKQIAQLENHAEILSSSLDTIEACGGGSAR
CMMAEVFLPRN
>EGALAKHO_02377 Arginine deiminase
MLQLNIKNETSRLRAVVLGSAVHNGPTPSLDEAYDPKSLEHIKAGTYPLEKDMVAEMDAF
NAVFKKYDVTVYRPEMIENYNQIFARDIGFVIDDIFVKSNILPDRERELDAIQYVIDQMN
PLKVVRPPDEVHIEGGDVMLWNDHIFIGTYKGSDYKDYITARTNMHGVNYIKQLFPNKVV
KEFDLVKSKLEARDNALHLDCCFQPVGKDKGIIYKRGFREEADYLYLVNLFGKENLFHIE
RNEMYNMFSNVFSIDENVVVSEKNFTRLNNWLRANGFVVEEIPYAEIAKQEGLLRCSTLP
LIRD
>EGALAKHO_02378 Citrate synthase 1
MSKIATLEVDGQKIELPVITGSENESAIDINKLRDLTGIITIDPGYKNSGSCKSEITFLD
GELGILRYRGYSIEDLAEKANFLEVSYLLIFGELPTAQQLEQFENDIKKHTLVNEEMKNI
IDGFPKTAHPMGVLSALTSALTAFNPKAVNVDNEKEMYEAICKTMAKFLVIATWTYRKSM
GYPLNYYDNTKGYVENFMQLMFQLPTGPYKASPVIVDALDKLFILHADHEQNCSTSTVRM
VGSSHAGLFASISAGVSALWGPLHGGANQAVLEMLEEINKDGGDTDKFLAKAKDKNDPFR
LMGFGHRVYKNFDPRAKIIKKAAKEVLDTLGVNDPILEIAKKLEAAALEDDYFKSRNLYP
NVDFYSGIIYRALGIPTDMFTVMFAIGRLPGWIAQWKEMRENKEPIGRPRQIYTGHPLRD
FKSNK
>EGALAKHO_02379 Enolase
MSIIIKVHARQIFDSRGNPTIEVDVVTENGVLGRAAVPSGASTGEHEAVELRDGGKAFLG
KGVLNAVNNVNTVIAEELVGTSVFEQNTIDQLMIDLDGTPNKSKLGANAILGVSLAAAKA
AANELGLPLYRYVGGVSANTLPVPMMNIINGGSHSDAPIAFQEFMIFPVKATSFTHAMQM
GTEIFHSLKKVLHDRGLSTAVGDEGGFAPNLAGGTEDALDTIKLAVEKAGYSFGDEIMIA
LDCAASEFYVNGKYDYTKFEGETGKIRTSEEQADYLAELAAKYPIISIEDGMYEDDWNGW
KYLTEKIGNKVQLVGDDLFVTNVERLSTGIEKGIANSILVKVNQIGTLTETIAAVNMAKN
AGYTSVMSHRSGETEDNTIADLAVALNCGQIKTGSASRSDRMAKYNQLLRIEEELGSTAY
FPGLNAFKIK
>EGALAKHO_02380 Carbamoyl-phosphate synthase small chain
MKYTTRQSAILLLSDGTIFHGKSIGISGKTFGEVCFNTGMTGYQEIFTDPSYFGQILVAT
NAHIGNYGVNDLEIESDSVKIAGLVCKNFSFNYSREDASGSLEDYFTKQNLICISDVDTR
ALVSYIRDNGAMNAVICTDGTSVEDLKKELANVPNMEGLELASKVSTTEPYFFGDENASY
KISALDLGIKKNILRNLAKRDCYIKVFPYNSTYKDLAEFNPDGYFLSNGPGDPDPLFGAI
QVAKEIIADDKPLFGICLGHQVIALANGVKTYKMFGGHRGINHPVKNIITGKGEITSQNH
GFAVKREALEGHPELEITHVHLNDDTVAGMRMKNKNCFSVQYHPEASPGPHDSSYLFDQF
VENIKLGAAKTI
>EGALAKHO_02381 50S ribosomal protein L17
MRHGKKFNHLSRQTGHRKAMLANMACSLIEHKRINTTVAKAKALKQFVEPLITKSKEDTT
HNRRIVFAYLRSKYAVTDLFRDVAAKVGDRPGGYTRIIKVGNRLGDNADMAMIELVDFNE
LYNGGKKEVKKAKSRRGGKAKKAEETTEAPAAESETTTEASE
>EGALAKHO_02382 DNA-directed RNA polymerase subunit alpha
MIDSTDFEGKFEFRPLEPGYGLTVGNALRRVLLSALEGYAITSVRIEGVDHEFSTISGVV
EDVTEIILNLKQVRFKRQIEDIDNEAVTISVSGKDQLTAGDFQKFISGFQVLNPDLVICN
LDSKIKLNFDLTIEKGRGYVPAEENKKQNAAIGTIFTDSIFTPVKNVKYAIENFRVEQKT
DYEKLVFEIKTDGSINPKDALTEAAKVLIHHFMLFSDERITLEADEIAQTESYDEESLHM
RQLLKTKLVDMDLSVRALNCLKAAEVDTLGDLVSFNKNDLMKFRNFGKKSLTELDELVAV
KNLTFGMDLAKYKLDKE
>EGALAKHO_02383 30S ribosomal protein S4
MARYTGPKTRIARKFGEAIFGDDKSFEKRNYPPGQHGMAKKRGKKSEYAVQLMEKQKAKY
SYGILEKQFRNLFKKASATKGVTGEVLLQLCEARLDNVVFRMGIAPSRRGARQLVSHRHV
TVNGEVVNIASYHLKPGDKVAVREKSKSLEAIERSLSNSSHVYEWITWNNDLKEGTFVSV
PARLQIPENIKEQLIVELYNK
>EGALAKHO_02384 30S ribosomal protein S11
MAKATAKKRKVIVESTGEAHISATFNNIIISLTNKKGEVISWSSAGKMGFRGSKKNTPYA
AQMAAEDCSKVALEAGLKKVKVYVKGPGNGRESAIRSIHNGGIEVTEIIDVTPMPHNGCR
PPKRRRV
>EGALAKHO_02385 30S ribosomal protein S13
MARIAGVDIPKNKRGVIALTYIFGLGRSRAIEILEKAQVSQDKKVQDWNDDEIGAIRDAV
SFYKIEGELRSEVSLNIKRLMDIGCYRGIRHRSGLPLRGQRTKNNSRTRKGKRKTVANKK
KATK
>EGALAKHO_02386 Translation initiation factor IF-1
MAKQSAIEQDGSIIEALSNAMFRVELENGHIVIAHISGKMRMHYIKLLPGDKVKLEMSPY
DLSKARITYRY
>EGALAKHO_02387 Protein translocase subunit SecY
MKKFIESISNVWKIEELKNRILITLGLLLVYRFGAHVTLPGIDATQLTGLAGQTKNGLGS
ILDMFTGGAFSKASVFALGIMPYISASIVVQLMGIAIPYLQKLQNDGESGRKKINQITRW
LTIAITLVQGPTYIYNLYRTLPGSAFLLGFNSPEFLFSSVIILVTGTIFAMWLGEKITDK
GIGNGISLLIMVGILARLPQAFIQEFTTRVTNNNGGPMLLVIEIIVWLLVIISCVLLTMA
VRRIPVQYARRTTTGDYEQDLAGGNRQWIPLKLNASGVMPIIFAQAIMFIPAAVAGLSKS
DTSQSIVGAFSNMFGFWYNFVFATLIIVFTFFYTAITVPTNKMADDLKRSGGFIPGVRPG
AETSDFLDKVMSLITFPGSLFLALIAVFPAIVVSIMDVQQSWAMFFGGTSLIIMVGVAID
TIQQINSYLLNKHYDGLMKTGKNRKAVA
>EGALAKHO_02388 50S ribosomal protein L15
MNLSNLQPAEGSTHNQNKRLGRGEGSGKGGTAARGHKGAKSRSGYSKKIGFEGGQMPLQR
RVPKFGFTNINRKEYEGVNLDTLQLLVDNGVITDSVSMTDFVANRLATKNEIVKILGRGE
LKAKLKVTAHKFTATAKAAIEAAGGEAVTI
>EGALAKHO_02389 50S ribosomal protein L30
MAKLLVKQVRSKINCPLSQKRGLEALGLRKMGQVVEHDSNPAILGMINKVKHLVSVEETK
>EGALAKHO_02390 30S ribosomal protein S5
MSKYKNVELVKPSGLELKDRLVSVNRVTKVTKGGRAFGFSAIVVVGDENGVVGHGLGKSK
DVSEAIAKAVEDAKKNLVKIPLNGQSVPHEQKGKFGGARVFLIPASHGTGVIAGGAVRSV
LESVGIHDVLSKSQGSSNPHNVVKATFDALLQMRSAHTVAKQRGVSLEKVFKG
>EGALAKHO_02391 50S ribosomal protein L18
MSLTKSDRRQRIRFRIRKSISGTATNPRLSVFRSNKEIYAQIIDDVNGVTILAASSREKE
IGKGTNVEIAAAVGKLVAEKALKAGIDTITFDRGGYLYHGRIKSLAEGARAAGLKF
>EGALAKHO_02392 50S ribosomal protein L6
MSRIGKSPIVIAAGVTVEVKDGIVTVKGKKGQLTQEFSDITVKVEGDQVLLERSSDHKDQ
RAKHGLYRSLINNMIVGVSEGFTKELELVGVGYRASNQGQKLDLALGYSHNIVLEIAPEV
VLETISEKGKNPIVKLTSFDKQLLGQVAAKIRGFRKPEPYKGKGVKFVGEVLRRKAGKSA
>EGALAKHO_02393 30S ribosomal protein S8
MYTDPIADYLTRVRNAVAANHKVVEIPASNLKKEITKILFDQGYILSYKFEDNSVQGSIK
IALKYDKDTKEPVIKDIQRISKPGLRKYAGAAKLPRILNGLGIAIVSTSKGLMTGKQAKQ
LNVGGEVICYVY
>EGALAKHO_02394 Alternate 30S ribosomal protein S14
MAKESMKAREVKREKTVAKYAEKRKALKEAGDFEGLQKLPKNASPVRLHNRCKLTGRPRG
YIRQFGISRVTFREMANNGLIPGVKKASW
>EGALAKHO_02395 50S ribosomal protein L5
MAYTPRLKEEYKSRVISALKEEFGYTNVMQVPKLEKIVLSRGVGAAVSDKKLIDYAVDEL
TKITGQKAVSTISKKDVASFKLRKGMPIGAKVTLRGERMYEFLDRLVTSALPRVRDFSGI
KATGFDGRGNYNLGVLEQIIFPEIDIDKVNKISGMDITFVTTAKTDKEAKSLLAELGLPF
KKN
>EGALAKHO_02396 50S ribosomal protein L24
MIKLKIKSGDIVRVIAGDHKGAEGKVLRVYREKNKAIVEGVNMVSKHTKPSAKNPQGGIV
KKEASIQISNISLIDPKTKETTRVGIRVEGDKKVRFSKKSNQVL
>EGALAKHO_02397 50S ribosomal protein L14
MVQQESRLKVADNTGAKEVLTIRVLGGTKRRYASVGDKIVVSIKDATPNGNVKKGAVSTA
VVVRTKKEVRRADGSYIRFDDNACVLLNAAGEMRGTRVFGPVARELREKQFMKIVSLAPE
VL
>EGALAKHO_02398 30S ribosomal protein S17
MEEKRNLRKERIGVVTSNKMDKSIVIAEVRKVKHPLYGKFVLKTKKYVAHDETNDCNIGD
TVRISETRPLSKTKCWRLVEILERAK
>EGALAKHO_02399 50S ribosomal protein L29
MKQSEIKDLSAAELQEKLSQTKKIYADLKMAHAISPIENPLQIRSVRRTVARLATELTKR
ELQ
>EGALAKHO_02400 50S ribosomal protein L16
MLQPKRTKYRKVQKGKMKGNSQRGHELSNGMFGIKSVHEDGMFLTSRQIEAARIAATRFM
KREGQLWIKIFPDKPITKKPLEVRMGKGKGAVEYWAAVVKPGRIMFEVGGVPLSVAKEAL
RLAAQKLPVKTKFVVARDFEA
>EGALAKHO_02401 30S ribosomal protein S3
MGQKTNPIGNRLGIIRGWDSNWYGGNDYGDKLAEDHKIRKYIHARLSKASVSKVIIERTL
KLVTVTITTARPGIIIGKGGQEVDKLKEELKKVTDKEVQINIFEIKRPELDAYLVATSIA
RQIESRISYRRAIKMAIAASMRMNAEGIKVLISGRLNGAEMARSEGFKEGRIPLSTFRAD
IDYALAEAHTTYGRMGIKVWIMKGEVYGKRDLSPLAGMDKKQSGTGGGKGGDSPRGDRKP
FNKGGKPDARKRK
>EGALAKHO_02402 50S ribosomal protein L22
MGVRKRETADARKEANKSIAFAKLNNCPTSPRKMRLVADLVRGQKVERALNILRFSSKEA
SRKLEKLLLSAINNWEQKNSEGNLEEAGLFVKEIRVDGGMMLKRLRPAPQGRAHRIRKRS
NHVTIVLGAINNTQSNS
>EGALAKHO_02403 30S ribosomal protein S19
MARSLKKGPFVHYKLDKKVQENVESGKNSVVKTWSRASMITPDFVGQTIAVHNGRQFVPV
YVTENMVGHKLGEFSPTRSFRGHAGAKNKGKK
>EGALAKHO_02404 50S ribosomal protein L2
MSVRKLKPITPGQRFRVVNGYDAITTDKPERSLIAPIKNSGGRNSQGKMTMRYTGGGHKQ
RYRIIDFKRTKDGIPATVKSIEYDPNRTAFIALLAYADGEKTYVIAQNGLKVGQKLVSGP
ESQPEIGNTLPLSRIPLGTVISCIELRPGQGAVIARSAGTFAQLMARDGKYATIKMPSGE
TRLILLTCSATIGAVSNSDHQLVVSGKAGRTRWLGRRPRTRPVAMNPVDHPMGGGEGRSS
GGHPRSRNGIPAKGYRTRSKKNPSNKYIVERRKK
>EGALAKHO_02405 50S ribosomal protein L23
MSIIIRPIVTEKVTKESEVLNRFGFVVDKKANKVQIKKAVEAAYGVTIVSVNTMNVRPDR
TTKYTKSGLISGKTNAIKKAIVQVQEGETIDFYNNI
>EGALAKHO_02406 50S ribosomal protein L4
MEVKVLDFNGKDTGRKVQLSDSVFAIEPNNHAVYLDVKQYLANQRQGTHKAKERAEVTGS
TRKIKKQKGTGTARAGSIKNPLFKGGGTVFGPRPRSYSFKLNKSLKRLARKSAFSIKAKE
ANIIVLEDFNFEAPNTKNFINVLKALGLENKKSLFVLGESNKNVYLSSRNLKASNVVTSS
ELSTYAILNTNNLVLLEGSLELIEENLSK
>EGALAKHO_02407 50S ribosomal protein L3
MSGLIGKKIGMTSIFDENGKNIPCTVIEAGPCVVTQVRTKGVDGYEALQLGFDDKNEKHS
TKAAVGHFKKAGTVAKKKVVEFQDFATEQKLGDLIDVSIFAEGEFVDVQGVSKGKGFQGV
VKRHGFGGVGQATHGQHNRLRAPGSVGASSYPSRVFKGMRMAGRMGGDNVKVQNLRVLKV
VAEKNLLVIKGCVPGHKNSYVIIQK
>EGALAKHO_02408 30S ribosomal protein S10
MSQKIRIKLKSYDHMLVDKSAEKIVKTVKTTGAVVTGPIPLPTHKKLFTVLRSPHVNKKA
REQFEVMSYKRLIDIYSSSSKTIDALMKLELPSGVEVEIKV
>EGALAKHO_02409 Elongation factor G
MARDLKYTRNIGIAAHIDAGKTTTTERILFYTGKSHKIGEVHDGAATMDWMAQEQERGIT
ITSAATTCEWNFPTEQGKLLPNSLPYHFNIIDTPGHVDFTVEVNRSLRVLDGLVFLFSAV
DGVEPQSETNWRLADQYRVPRMGFVNKMDRQGSNFLAVCQQVRDMLKSNAVAITLPIGEE
NDFKGVVDLVKNQAIIWHDATQGATFDIVEIPADMVAEVKEYRDILIEAVADYDENLLDK
YMEDPDSITEEEINNALRAATMDMAIIPMIAGSSFKNKGVQFMLDAVCKYLPSPMDKEGI
EGIHPDDAELLEEDQTKILRRPDVKEPFAALAFKIATDPFVGRLAFFRAYSGRLDAGSYV
LNTRSGSKERISRIYQMHANKQNPIEYIEAGDIGAAVGFKDIKTGDTLCDEKHPIILESM
KFPAPVIGIAIEPKTKADVDKMGMALAKLAEEDPTFTVRTDEASGQTIISGMGELHLDIL
VDRMKREFKVEVNQGEPQVEYKEAFTRTATHRETYKKQSGGRGKFGDIVFTLEPADEVDG
KVPVGLQFINAVKGGNVPKEYIPSVEKGFREAMKTGPLAGYQVDSLKVTLTDGSFHPVDS
DALSFELAARMGYREVAKAAGAIILEPIMKMEVITPEENMGDIVGDINRRRGQVNDMGDR
NGAKTIKADVPLSEMFGYVTTLRTLSSGRATSTMEFSHYAETPSNISEAVIKKAKGNA
>EGALAKHO_02410 30S ribosomal protein S7
MRKRAAKKRPLLPDPRFNDQLVTRFVNNLMWDGKKSTAFKVFYDAIDIIESKKQDSEKSS
LEIWKDALTNVMPHVEVRSRRVGGATFQIPMQIRPDRKISMAMKWLILYSRRRNEKSMAQ
RLASECLAAAKEEGAAVKKRMDTHKMAEANKAFSHFRF
>EGALAKHO_02411 30S ribosomal protein S12
MPTIQQLVRTGRTQITKKSKSVALDSCPQRRGVCTRVYTTTPKKPNSAMRKVARVRLTNG
NEVNAYIPGEGHNLQEHSIVLVRGGRVKDLPGVRYHIVRGALDTSGVAGRTQRRSKYGAK
RPKEAKK
>EGALAKHO_02412 hypothetical protein
MKQLLLKHLSYILFTFLVSISSYAQNFHLIIKGKNETQNKIIDSLDYKTEHLNIKSLFDE
VKNTSEKLSQIGYLENKILKTNLINDSTYTSIIDLKTRTKFIHIYIGINNTFFNSEKAKG
DTIIIPYSEVKNYLNQKTSDAEKLGFALSKIKLENIRKKNSIIYADLNFKSEKKRTINSI
ILNYTNDNKYDFFPKGHLKQLNKKYLNKTFNQEIVKQLYNDINSFEFVNQTKYPEILFTN
DSTKIYTYIEKRKANTFDGYIGFSNDKDQKVNINGYLDIALLNILHAGEQFSLYWKSDGN
QQKTFNTKLEIPYLFKSPIGLKAQLNIFKQDSTFQNTKTTIDLGYYLNYNSKIYLGYQST
ESSDIQNTNNTTISDFKNSYITTSYDFKKTDNINNLTPKKANLNLTIGYGKRDTNYDPET
AGSSQQFYANLNGSYNFELNEKNFININSQNFYLKSKTYISNELFRFGGMNSIRGFLDNS
LQSNFNSLILTEYRYQFSKNIYVNTIADYGLYQDLTSTINPDKIKKLIGVGIGTVIQTTN
GLLKINLTNGGANLQEMQLYNTIINICYNVKF
>EGALAKHO_02413 TonB-dependent receptor SusC
MKLKFNGFLVLLLVLVAQLTFAQERAVSGTVSDNTGMPLPGVSVLIKGTKSGTQTDFDGK
YSIKASTSQVLVFSYIGMKTQEVAASSSVVNIKMAGDANELEAVVVTTALGVKREKKSLG
YATQEVKGGDLKAGTSSGNFLNELSGKVAGVNIVRNTNFGGSTSAVSRGIKAINQSNEML
IVIDGMPINNSNTSIDGTTNQQRGATGYDYGNNGMDINPDDIESVNVLKGAAASALYGYL
AGNGVLMITTKKGKAKKGLGITVSSEVVTGTIDKNTFVKYQDKYGAGYGGSFDHQDINGD
GVLDNVVFMGDDASAGDAFNPAVTAYQWDAFSVYPGNANYGKQTPWVAAKNDPTSFFKNS
LSLVNGISFEDANDKSNVVFNYTNTKQTGILPNSELDKNNFSLKLNHQFTDRLSLSAFAN
FANQATTGRNMTGYSDNMISGFRQWWQTNVDIKQLEQAYNASGGQNITWNRKSVTNGAPA
YWNNPYFERNKSYQNDSRNRFVGYANLTYKITDWLSATGKISTDTYAEIREERVAVGSVA
KTFGINLLDETSGYLRYNGNFSEQNYDLILNLKKNFGENFSLSGIVGGTVKRNEFNSITA
STQGGLIVPGLYALSNSVATSPYPYERDTKSGVNSYYASASLGYKDFLFVDATSRRDAFS
NLPADDNSLFSNSISGSWVFSNNFEASWLSFGKLRGGYSESPLGTPGLALVDTYSKIDAF
NGQQQYSVNGTKNNPNLQPIKTKTQEIGLEMQFLKKRVGFDLSLYKNVNNGEAVLVPYST
STGYTNRYINAATIENKGIEVQFNATPVKTNDFAWDITINWSKNDNMVTALAPGIENLLI
TTYPGSGTLNAVVGQPFGVIKGTDYTYYDPNFVPSYPGEVNKKGPRVVSATTGRYVINTS
TNNIVGNVNPDWIGGIRNKFSYKSLSFSFLIDTKQGGDVFSTDQWYGVGTGLGQQTAGNN
DLGNPIRNTVANGGGVIFEGVRPDGTPNTLRTAYFRPEAGAITNSYSGGATKGYVYDASF
VKLREVNITYTLPTSLVQKIHLVDAKISLIGSNLWIIDKNLPDADPESGLGSNAGSLGLS
LGSLPTTRNIGCNLTIKF
>EGALAKHO_02414 hypothetical protein
MKNRLLILIPLMALFVSSCTDDITGLNQDVKRPTTTQPNYLFTSAQHAMMDQVTSTSVNF
NVFRLFAQQWTEVQYPQESQYDLTGRTIPDRHWAVYYRDVLRDYKEAKDLLLQQKANFVG
SAADAKALDNKIAIIDILSAYAYGVLVDTFGDIPYTEALDIATYPLPKYDDAQTIYRDLL
AKLTTASHALDKSAGSFGDADLVYGGNTTKWAKFANTLRLRMAINMDDVDHTYASAQALA
ALTDGVILASTDNAYLEYASLQPNANPLYVDLVASGRDDFLPADTFVNKMNALTDPRRPQ
FFTEYPAGSGNYKGGVYGVLNTYGNFSHFTETIKQPEYPGVLLTYSEVEFLLAEAVERGI
AVGGTAAGHYNAAITASMQDWGVADAAITTYLAQPNVAYATATGTWQQKIGEQSWIGLYN
RGFEAWTSYRRLDFPVLKAPPVTFGDITEVPKRYSYPGIEQTLNATNLAAAVAKLGNNSP
VSKVFWDKK
>EGALAKHO_02415 Putative TrmH family tRNA/rRNA methyltransferase
MEKEHQIFGIRAIIEAIQAEKEVDKVFIQKEISGELMKDLMKVMKRANINFSYVPVEKLN
RLTPNNHQGAVATISPIGFIDLEHLVESTIESGSKPLFLILDQISDARNFGAIIRTAECT
GVNGIIVQKAGSAPVNGDTVKTSAGAVFNVPICKVEHIKDAIFYLQGSGIKTVAATEKTE
HNIYDLALNEPVAIIMGSEDRGINPSVLKIVDEKAKLPMFGTIGSLNVSVACGAFLYEAV
RQRS
>EGALAKHO_02416 hypothetical protein
MSSKSAQKISFIKTCCIITAFFVVGILNAQTKTYGQSWNELKFNRTINKKWSAELNLGSS
YSSTESSSNIFQSNIQRSLAGWAHYYLTPRWKLSTALAYFDNKDVPEIGQFKSPELRFSL
QGIYYFHKTGYTLSTRMRMELRHMKNSDDDYEDVLRYRQQIKYQQPINSKILREGVVYAV
ASDELFFKSGTKVTGESFFDRNRLNLGAGYLITNDFQVELTYANEYMPRNNENKIVNAAS
LIITFNNLFENIRKKIVRKKQTPTVDD
>EGALAKHO_02417 hypothetical protein
MKKISFFVVALLLLISLKMFAQCDIKNRLLADGTMVYYFDPAVFYTTKSKSLKINIVTDK
EHYFIALQPTPFPSKKEGKKIKNDLIVRLADQKSYKLSHYDTQYMRNDSIMQVLYLMDDK
DVEAFSKFEAIVAEINMKGTEFIRDYNFKLHKNAIIEQLNCFLKEEEEK
>EGALAKHO_02418 hypothetical protein
MNDNQFKFSNAVFGLPVFFVLFLWIVYWFQIRFDFDFYQNGIYPRDFSGLQGVLFSPFIH
ENLGHLYNNSIPLLVLLAALQYFYPKQTIAVILYGIIFSGLITWIIGRENYHIGASGLIY
VLVSFIFFKGIQTGYYRLVALSLSVILLYGGMIWYVFPDVDATISWEGHLAGFITGFVLT
LFYKTPEYKKAIVYDWQKPDFNPEEDPFMRHFDEDGNFVPVEKQEEEVEFISLYYTSDQL
VNYSVTKSESDDKR
>EGALAKHO_02419 Replication-associated recombination protein A
MEAPLAERIRPQKLEDYISQSHLVGPNGSLTQQISKGIIPSLIFWGPPGTGKTTLAQIIA
QESKRPFYILSAINSGVKDIRDVIDKAKQSGGLFTAKNPILFIDEIHRFSKSQQDSLLAA
VEKGWITLIGATTENPSFEVIPALLSRCQVYILNAFTKADLEALLHRAMKTDIELASKNI
ILKETEALLRLSGGDGRKLLNIFELVVNAAAEDEIIITNDRVFELVQQNTVLYDKSGEQH
YDIVSAFIKSIRGSDPNGAVYWLARMIEGGEDVKFIARRMLILSSEDIGNANPTAFIMAN
NTFQAVTTIGYPESRIILSQCAIYLATSPKSNASYMAIGNAQQLVKQTGDLPVPIHLRNA
PTKLMKELGYGDDYKYSHDYANNFAEQEFLPDAIKQTVLYNPGNNSRENSNREFLKNRWK
DKYGY
>EGALAKHO_02420 hypothetical protein
MRIKFLLAAFFCVVIGFAQSINDYKAVIVPLKYDFLKSENQYRMATISKSSLNKAGFQAF
YANEDIPAEFSDRCQLLYIDVKKDNAFLMTKLFVEFKDCYGKVVYTSEVGKSKEKDYETA
YRESLNMAFVSINALHYKYSGKTVSPAGAGNKIGTGAMNPAGVAVMTPVATAAVVTPTAT
VVTSVADTADPNLLYAQPTENGYQLIDKTPKVVIKLLKTSRPDSFIAIKDGIQGTLNAKD
NQWFFEYYQNDKLVSEKISVKF
>EGALAKHO_02421 Pyrimidine 5'-nucleotidase YjjG
MNTTITDVFFDLDHTLWDFDKNSEMAFDRIFRSKFPEIKIKDFIEKYAPINQACWKLYQN
DQITHVELRYNRLKFSFDALNVEISDENINEIANDYIEFLTDNNHLFDGAIEVLEYLKPK
YKLHIITNGFANVQEKKINNALLSGYFNTITNSELAGVKKPNSIIFDYAVNSASASKANS
IMIGDCLDADVNGALNAGLDAIFFNEKNIEVPENIKQINHLLELKKYL
>EGALAKHO_02422 hypothetical protein
METTHFPITNWSEDDRPREKLMLKGKSVLSDAELIAILIGSGSRNESAVDLSKRILASAD
NLNVLGKMSISQLMNFKGIGEAKAITIIAALELGRRRRAEDVVELIKITSSKLVFEIMQP
IIGELPHEEFWVLFLNNSNKVISKSQLSKGGIAGTIVDVRLVFKFALENGATGLILCHNH
PSGNLQPSDSDRQITKKIKLAGDSLDVKVLDHLIITETKYYSFVDEGIF
>EGALAKHO_02423 putative N-acetyltransferase YsnE
MNPIIKVVKTTNENPDFIDLIKTFDAFLWNRYPELKNDYWGNNLIEFNPNVFIIYLDEKA
VACGCFKKYNVSTVELKRMFVSPEARGLGLAQKVIKELENEAKSQGFEIMVLETLYKQIE
AISLYQKVGFEIVENYEPYVGMTNSVCMSKSII
>EGALAKHO_02424 hypothetical protein
MKSIYLLAISILLLSCNHKEKNILHAENNLEVVQTFGQQLSDAAISIIDPSIDYDPTYFS
IKYPNGDVPKNKGVCTDVIIRSYRKLGIDLQKEVHEDMIENFSKYPNLEKWGMTKTDTNI
DHRRVPNLEVFFERKGTKLTVTQNAKDYKTGEMVTWMINDKLPHIGIVTSKKSKDGQRNL
IVHNVGGGQVLEDCLFEYKIVGHYSYEKIR
>EGALAKHO_02425 UDP-N-acetylmuramate--L-alanyl-gamma-D-glutamyl-meso-2,6-diaminoheptandioate ligase
MKTHFIAIGGSAMHNLALALHNKGYQVTGSDDAIFEPSKSRLEKKGILPVELGWFPEKIT
ADIDAIILGMHAKADNPELLKAQELGLKIYSYPEFLYEQSKNKTRVVIGGSHGKTTITSM
ILHVMHYHNIEVDYMVGAQLEGFDTMVHLTEENDFMVLEGDEYLSSPIDRRPKFHLYQPN
IALISGIAWDHINVFPTYENYVEQFEIFIQKITNGGILVYNENDPEVKRVAEAATNPIRK
LSYHTPEYTVSDGVTLLKTPEGDMPIEVFGAHNLNNLAGAKWICQNMGVDEADFYEAIAS
FKGASKRLEKIAEGKGKVAYKDFAHSPSKVAATTKAVKEQYPNRTLVACLELHTYSSLNA
EFLKEYEGALEYADVAVVFYSPDAVKIKQLEEVTYEQIATSFNRKDLIIYTNPTEFKEYL
FNLNLENSALLLMSSGNYGGLNFDEVKGLIN
>EGALAKHO_02426 hypothetical protein
MKKLLFLFLFLPILSWSQSNFEKGEKLFHAKKYDEAQVVLEGVLKTKPADIKTLEYLGDI
AAHQKAWIKGAEYYKKLKELKPTEADYFYKYGGCLAMRAMEVNKLKALGMVGDMKEAFEK
AIILNPKHIPARWALIEIYLQLPGFLGGSESRALEYSNELMQISSVDGYLSRGRVDEYFK
RYASAEKNYLKANEIGKSKVTFQKLYNLYLNKLKDPIKAQQLKRKFEA
>EGALAKHO_02427 TonB-dependent receptor SusC
MKNILLVFLFFTTALFAQQNDKKWIKVASYENEGKIKSASKIVDQIYKKALNRKDEVQMI
KCFFYHSKYLQVVDENAKKKIINNLKTDIDRVSIPSKAILNLVYAKCLNNYANYDYDYAV
SAVDSAAAVVDEAAYMASDSIEVPSSEDFKINPPSEITHEEEVNAAFDKTLENEAILKAT
PLTNYQSIFEFLTIEKLKKENLYDYLLKENIEFFTQKIQRWEIQNSEITVYKSELLGSSD
AFLKLDLNFIKDENLRKVIALYQKLELSNPPLENQFNRIIFCSDFTIEPTEDLTKYLNEL
QQQTNDTILTQKILLKKAELLLTQASKELHPDYKIEAVKIYDNIIKINDKTNAAQSALQQ
RQNVISKSLDIRLQKYSYYKENTRAFIGYKNIDNLKISFYKIDQKTLKKYSASELIYNQD
SLTAVIINTHNKIISKEYQLQNKNDYFEYTTEVLLPQLETGSYLVYFESDSGLKDKKASA
FETLTVSNLSILASRGDNTENFQVLDRKTGKPLENVSINSSNYTLKTDSNGLATYVGSNN
HSYNDHIEFSLENDTISPNRNYIRYTQPYTAKENKTLNAKVEFYLDRAIYRPGQTVYYKG
IAFQKQENKTSIIANTSFKIIVKDANYQNFKEFEVTSNEFGSFSGEFVLPKNGVTGTFYI
FAGKPEDYAKGDIYIKNKPNESFWKAAILEFSETYFRVEEYKRPKFKVDFDPKKESFQVS
QSIKVNGTAKAFAGSNISDAKVTYTVNRFTSYFRNYYGQEQNETISTGETKTDASGKFVI
EFIAEPSKNAIKEQLPVFNYRITADVTDINGETHTSETIVKVGYHDLIINASIPDRIETK
NKNEITLTSSNLNGEFLAAKGEVKLYFVAPFRNKFKEQVWPEPEIETISASDFERLFPYE
IREIKSKKASETLLFSKKIDTEKDKKIALDFISNYKSGNYKIVFSAKDTFNNPIESVSTF
EIKQSKDKFNPGKLFTAEQINSDPKKDGFVEVKLSSVVPDLYITTNGNYDNQTYFENTYH
LQNNEVTIKVPLKNEFEKSVRLGFQSIFENEIFDEEIDVQLKTAESKFELIVESFRNKIE
PGSVEKWSFKLTNAKNEAEVLASMYDSSLDQFAKRDWNILNINKSRYNSSNLKSGLGFEK
INASLENLDEDLTISKFFKEEIKLNWFGFDFYNSRYGDSLGLTITEIKDKKVGSETIKGD
PDTVVTVDEPVGVGAASAVVQEDNQVYNTAAAPAYLAGRAAGIQIRGKASIGGQDPLYIV
DGEIVVDIKNINPADILSMDVLKDEKATALYGSKAANGVIIITTKKALEALTQIKARKNL
SETAFFLPNLRTDANGNVSFNFTSPEALTAWKLRLLAHNKDAVSGYLEKSVVTQKELMVL
PNFPRFFREKDTIVISAKISNVTDKAKSGIAILQFFDASTMQPIDAKMLNAKNVRNFNVG
AFGNTTATWTISIPEGLQGVQYKILAKSGNFSDGEENILPVLTNNMLVTESIPIWVRENS
TKEYTFKNLKNNTSSTLKNHQFTLEYTSNPTWIAIQSLPYLMEYEHECGEQTFARFYSNA
LASEIISSNPKIATVFEDWRKNGKLNSKLEENEELKSIILAETPWLNDAQSEDEKKKNLA
LLFDLEKMKTSQEATFDKLKQNQKSSGGFAWFNGGNESEYITRHILAGLGHLSKLNKTED
TNTKIDAIAKTGIPFLDNKFLQYYKAQTKNLKTTAKLIWINPYSDLHYLYTRSFYLDKYP
LSDTLKKATKLYLETAKKDWLNYSIYEKGLAALALNRFGESDSAKKIIENLKETSSNNED
WGMYWIANKSGWYWYQAPIETQALLIEAFAEVNRDTKSVDAMKVWLLKNKQTKNWPTTKS
TTEAIYALLMQGNDWLSVKDNTIIKIGDQKILTKKLSENEKEAETGYIKMNWKADEVKKE
MANISIQNKSKVPGFGGVYWQYFEDLDKIKTNSGAVLSVSKELYLKKNSLKGDELQRITS
KNPLKTGDLVTVRLIITSKEDTEYVHLKDMRASCFEPVNVLSEYQYKDGVGYYMSTKDAA
THFFFDRINKGTYVLEYDIRVNNSGEFSNGITTIESMYAPEFSSHTKGIRVKVQ
>EGALAKHO_02428 Dipeptidyl-peptidase 7
MKKIILFFTMCLMAFPARADEGMWFLMFIERLNHRDMEKMGLQLTAEEIYSINHHSLKDA
VVQFNGGCTAEIVSKDGLVLTNHHCGYNAIAELSTAEQNYLKDGFWAKEKSAEMKPKSLY
VRFFVRMDDVSKRILSKVNDTMTETERNKIIQQEIALIEKENNEGGKYTVSVRPFFQGNE
YYYFVYQDYTDVRLVGTPPESVGKFGGDTDNWEWPRQTGDFSMFRVYADKAGNPAAYSKE
NVPLQPKHYLPVSIKGVKENDFAMILGYPGRTNRWMPAGGIEQNVKFAYPAWVEGAKTGM
DQMKKYMDKDATVRLQYASKYASTANYWKNRQGMIDALTKAGTAEAKSAQEDKFYEWAAK
PANKEKYENVIPTINDYYKETNLKARHDNYLSQVLRTSSYATGPANLGNALIAYYNENDA
KKAEMLPKINTMIDNIYSEFYAPLEKDVLTAQLNLYASKAAEYGLAPQIAKMKTANNGDF
TADVAKATEISYFTSKEKVLAFMADPKPLAIVHDPLYIISNDLLTKYRAKTDDQAKADDG
FAIAYRKLVEGLRESKLNAIQYPDANSTLRLTYGKVRALPADPRNDAKINNYTTMESMVK
KYKAGDQEFDLPARLLELNKAKDFGQYADKAGYMPVNFLTDNDITGGNSGSPVLNGKGEL
IGIAFDGNIEAMAGDVIFDPKLQRTINVDIRYVLWIIDKYAGAKNIIDEMTIIK
>EGALAKHO_02429 GTPase Obg
MTEGNFVDYVKIYVSSGKGGKGSTHLHREKFIEKGGPDGGDGGRGGHVYLVGNKGLWTLF
HLKFARHIKAGHGGDGGGDRSTGADGDDKFIEVPLGTVVKDKETGETLFEITEDGEKRIL
SKGGKGGLGNWHFRSSTNQTPRYAQPGLPGVEMDVILELKVLADVGLVGFPNAGKSTLLS
VLTSAKPKIADYPFTTLKPNLGIVAYRDFQSFVIADIPGIIEGAAEGKGLGHYFLRHIER
NSTLLFLVPVDTPDIKGEYDILVNELTKYNPEMLDKERLLVISKCDMLDDELKAELKTEL
DVAFKDIPYMFISSVAQQGLTDLKDKLWKMLNE
>EGALAKHO_02430 Magnesium and cobalt efflux protein CorC
MSEIALISARKNRLETAAKKGNKSAKTALDLANSPNKFLSTVQIGITLIGILTGIYSGDK
ITMDVETFVTGFAVLKPYAHSVAVGIVVVVLTFFSLVLGELLPKRIGLNYPEAIAKMVAM
PMKVVSIITAPFIWLLTSSTDFLLKIFQIKPSADGKVTEEEIKAIIKEGTEVGEVQEIEQ
DIVERVFHIGDRKVNSLMTHRKSVDMLPLKDEKSKIKELVLQDLHTVYPVYSDNYDDIVG
IVTLKNIFANIESEHFDLSAIMTDPPYLMEQTTAYKALENFKKTGVHYALVSDEYGVFQG
IITLNDILEALVGDASDFYKDEFKLVEREDGSWLVDGHYSLHDFLTYFELDELTNDYEVN
TVSGMIMTELSHIPKEGEKLVWQKFVLEVIDMDGVKIDKVLVKALKE
>EGALAKHO_02431 Adenylate kinase
MINIVLFGKPGAGKGTQAEFLKEKYKLTHLSTGDIFRFNLKNDTDLGKRARVFMDNGELV
PCEVTTAMLIDEVNKHLDSNGFLFDGYPRTLDQAEALDKFLPTIGSSVTATIALEADDEI
LVARLLERGKTSGRVDDQDEEKIRVRYQEYNEKTAPLIGYYKAQNKFHAVNGIGTIEEIT
ERLTSVIDNL
>EGALAKHO_02432 Hypoxanthine phosphoribosyltransferase
MIQLHDKQFVPFISAKEIDFALTKIVAQVEDDFGDDTPIFIGVLNGAFMVVSDFLKKYKK
PCEVSFIKMASYEGTETTNVVKELIGINQDLSGRTVVIIEDIIDTGNTIEELKHLFKQQN
VKHFKIATLFFKPEAYKKDIKIDYIGIRIPDKFIVGYGLDYDGLGRNLTEVYKLAE
>EGALAKHO_02433 hypothetical protein
MKTAIQLLSISLLTIMTACNGQVKKEEKEALAKQPANVVKTAIGDITLPPPFATESKTNN
SKVIGWPEGKTPIAPEGFTVTKFADGFENPRWTYIAPNNDIFVVESGTRASKNQITVLRD
KDKDGKFETREVFIKDLNKPFGMLVLKDFFYIANTDGLYKYPYKNNPLKLETKGVKILEL
PAGGYNNHWTRNIISNPEGSKIYVSVGSGSNVAEHGIDKEVRRADILEINPDGTGEKIYA
SGLRNPVGMDWNPVNKELWTAVNERDELGDDLVPDYITSVKRDGFYGWPYSYFGNILDPR
MKGERKDLAAKAIVPDVSVGAHTASLGLAFYTKDKFPAKYKNGAFVGQHGSWNRANISGY
KVVFVPFANGKPSGKPEDFLTGFISDADKAQVYGRPVAVTVMNDGSLLVNDDSGNTIWKV
TANK
>EGALAKHO_02434 Colicin I receptor
MLLKKHCFLLLIIIFQNTFAQEGKSKSIDTVKTEKLEEVIISSFHINDSLQNAPASIGIL
SKKELTQNNATDITTVVNTIPGVFMQSSNFTTTRISIRGIGARTPYGTNKIRAFYGSIPL
TSGNSETVIDDIDLENLNQIEIIKGPLSSIYGAGLGGAILISPQLSKTKGQTAGISSTFG
SFGLLKNTLNYSLEEKNSSLNLSYHNLKSDGWRENSSYKREGVTLAGELFRRKNSKLTYF
TNYTYLKAFIPSSISKEVYDTNPQLGAPTWVASKGFKEYKSTLAGLAYDFKISDNLSNST
SVFINYKDSNEPRPFDILCQYTFATGARTQFSGNFEIWSRSLGIKNQFIFGMEYFTDNYN
GNTFENLYKQNNGQGSLQGNQLTESDQKRHFYNIFSQIRSVLSEKLELQFGLNYNETHFE
LTNFLPQKTATEKYSYDGIFSPQLSLLFKPNQQQTLYFSASRGFSLPATEETLTSNGTIN
PDIKPENGYNFELGGKFYFFNKNLYTEIAVYRMEIKDLLVAKRIGDDQYEGVNAGKTLHE
GIEITLKHNWQINRLFNLNSYVGTSIGKYEFQEFVDNGNDYSGNKLTGVPANKVNAGLIL
NTRFGIYLNADYQFVDEIPMNDSNTAFSDSYNIINLKTGYRFEILHNLNTNLAFGINNVT
NEKYASLILPNALPIGTSSPRYYYPGLPVNYYGNISLNYLF
>EGALAKHO_02435 hypothetical protein
MSSELQKKLDYVSAYRENRLKVAQEILENPRLFDELVSICFSPSDKNNHKACWILEFVSY
EELIWLQPHLDFFFSNLKNLKDESAIRPIAKVTQLLVKSHYKKEENGIVLSENNLQDCIE
ASFDWLINDIKVATKAYSIRTLYVLGNYYDWIHPELKIILDKDYGDHSAAYKAVAREVLK
KIK
>EGALAKHO_02436 N5-carboxyaminoimidazole ribonucleotide synthase
MNYFSSDFKLGILGGGQLGKMLLFDTRKFDIQTYVLDPSDEAPSKIACNKFFQGDLMDYE
TVYNFGKQVDVLTFEIELVNLEALTQLENEGLKVYPSPKTLKGIQNKGIQKQFYADSNIP
TASFLRFDSPEHLQKSVGNNEITIPFVWKCTEFGYDGNGVKVIRQISDMDDLPNVECIAE
TMVPFKNELAVIVCRNPSGEIKTYPVVEMEFHPEANQVEYVICPARIDEKVAEKARAIAL
NVSEKFNHVGLLAVEMFQTNDDEILVNEVAPRPHNSGHYSIEASYTSQFENHLRAILDLP
LGNTDSKVAGIMVNLVGAEGFSGDVVYENIETILGWNGVTPHIYGKKQTRPFRKMGHVTI
VNEDMAEARRIAEEVKNTIRVISGK
>EGALAKHO_02437 N5-carboxyaminoimidazole ribonucleotide mutase
MSKVAIIMGSISDMPVMQDAIDILKQFNIEVEVDIVSAHRTPEKLFDFSKNAHTRGISVI
IAGAGGAAHLPGMVASMSPLPVIGVPVKSSNSIDGWDSVLSILQMPGGVPVATVALNGAK
NAGILAAQIIGSHDKKVLDTIIAYKEELKAAVNKAAEGLK
>EGALAKHO_02438 hypothetical protein
MNYQVVIKNIDTVNEVEGYWSDEDLVVLLQKFNYPDGATAEKSSLPELLEMAISDYEPNE
AAQIVLEYKLGDELSAGQIEQISNNMLIDKVCEEYPEIHMQGRLFHVNQLLFKAYNGKFP
NAKASVVHFSMTPTDGETQKLTAENILKLLNNGLSDRNLIKRLFENQMSQNIPFPEAESI
IWELTTEDDVNYNLVTSENWINKDDVTASEFESILEEVEDEA
>EGALAKHO_02439 Oligopeptidase A
MSVLLSKFTTKYNTAPFSQIKIEDYVPAFQEGIVLAKAEIDAIVNNPEAPTFENTVVAMD
FSGDILDRLSSIFFNLNSAETSDEMQKIAQEVSPLLSEFGNDITLNAALFAKIKAVYEQK
EKLNLSPEQTTLLDKKYKSFSRNGANLPEDKKDQLREIDKELSKLSLQFGENVLAETNAF
ELHLTDEKDLAGLPEGTIEAARLLAKSQEKEGWIFTLDHPSYVPFLTYADNRELRKKMAI
AFGAKAFQNNEFDNQENVLKIAKLRFERANLLGYKTHAHFVLEERMAESPEKVFSFLNDL
LAKAKPAAQKEFAELTDFAKELDGIEQLEKWDGAYYSEKLKQQLFNLDDEKLKPYFQLEK
VLDGAFTVAQKLYGLTFTEVFDIDKYHEEVTTYEVRDTENNLVSIFYADFFPRKGKRNGA
WMTSFKHQSIKDGVNERPHISNVCNFTKPTETKPSLLTFNEVTTLFHEFGHGLHGMLANT
TYPSLSGTSVFWDFVELPSQIMENWCYEPEALALFANHYETGEIIPIEYVQKIKESASFQ
EGLATMRQLSFGLLDMAWHGQDPTNITDLKAFETEQFANTQLYPDVKENAMSTAFSHIFQ
GGYSSGYYSYKWAEVLDADAFEYFQEEGIFNKDVATKFKDNVLSKGGTEHPMILYKRFRG
QEPKPEALLKRAGLL
>EGALAKHO_02440 hypothetical protein
MKKYFKIALYLAFIGLVAVVSVNYYVKSSTKKNIHHSLKRFPKNDVGIIFGAGIRGDQPS
KYLKDRLDAGILLWKAKRINKILLSGDNGREEYDELTVMKNYCYTHGVDTTKIFIDYAGF
DTYSTMYRAKHIFNIKKATLISQEYHLNRAIYIGQKLGIKSVGYSANKGEYSGYNYVRFR
EYGSVFKSFLDVFRNREPHFLGNPIDINGVSNYSKEDKR
>EGALAKHO_02441 hypothetical protein
MENYFEFKGYNGSVEFSEEDKVFFGKIQGINDVVTFEGASIIELKEAFQESVLDYLEVLN
>EGALAKHO_02442 hypothetical protein
MKFKEAKNKFVQTWGALGSQWGINKTMAQIHALLMVSNEAVSMEDIMDELQISRGNASMN
LRALMDWGIVYKEYKAGERREFFTAEKDLDELAVKIARERSKREIKPALKILKEVSTIDA
NNSAEEKHFVDQTSKLYDFVLKADNMLDKMTEFNENWLGRLVLKIMK
>EGALAKHO_02443 hypothetical protein
MRTTAQLNTFAVGLPLLILLTYPIAKEGAFFYAMLSTLVTGFIQVLLGIKLIFEEPYNKF
IQFYIGGVIMFFLLCFIQIEIYYSENLRIILLGMPPLLATYLSILIYKKAHK
>EGALAKHO_02444 hypothetical protein
MNFLKAEWKNLALFNYEVDAEILEKYIPNGTEIDLWNNNCYVSLVGFMFKNTKVLGLKVP
FHIDFEEVNLRFYVKRFENGEWKRGVVFIKEIVPKKAITFIANTLYQENYETQKMRDEII
ENENTNTFIYQWKKDEDWNSIQLETEKKPTEIAIDSEAEFITEHYFGYTKIDLETTFEYE
VQHPRWEQFEVLNYNVAIDFRKTYGRDFEFLQNANPTSVFLAKGSDIKVKNKRKLETVFA
LEEAYH
>EGALAKHO_02445 hypothetical protein
MKTLENQTLLYDEDCPLCSLYTTGFVKSGMLDENGRKSYCQLSQEEQSFVDLKRAPNEIA
LVDNKTKTVTYGIDSLIKVIGFSFPLIEKIATIKPIHFILTKMYSFVSYNRKVIIPGNVK
TENKLQCTPDFNYKYRFIFIGFALTITTFVLFGFSNLIPNVPKTSILREFILAVGQIIFQ
SLFLLKMDKQTIINYAGNLMTISLMGSLILVPILILNQFVNLPQFLILGWFGTTIFIMFA
EHFRRVKVLKLPFYLCFTWVLYRIIALVFILNL
>EGALAKHO_02446 Epimerase family protein
MKKLIIAAGTGFLGQVLVHHFKNKFEEIIILTRGKSQTIDGIKYVNWNARTFSGWEKELE
NATVLINLAGKSVDCRYTKENKKEILLSRIESTKILNKAVLNCQNPPKHWLNSSTSTIYR
FSLDKPMDEIDGEIGNDFSINVALSWEKAFFKTETPNTLKTALRTSIVLGKNGGAFIPLK
TLAKIGFGGRQGKGNQFISWIHEEDFANAVDFIIEKEITGVINVVSPEPIPNVDFMMKLR
KAVGSPFGIPMSKFFLEIGSLFIRTETELVLKSRNVIPKRLLENGFKFKFGAINEAFQNL
LSK
>EGALAKHO_02447 hypothetical protein
MTTINLTTKIKASKQVVFDASRNIDIHQKSASKSNEKAIAGVTSGLINLNATVTWRGKHF
GFYLTHKSRITTMNLHDYFVDEMERGKFKSFKHEHFFEEENGFTIMKDKLKYETPCGIFG
ELFDILFLEKHLTKFLLERNKILKEVSEQVKF
>EGALAKHO_02448 hypothetical protein
MKFLKQILDFYLNSSIHVALSCYALVRVTFHVFHIQYDEAMALFVFFGTIVGYNFVKYDA
LVRVKKKPIGIQLKIIAVLSFISLVLVGYYFFHLKRITQIVSVGIFLITALYTLPFFPNR
KNARNWAGVKIYIVALCWVGATLVLPLINAEIPFTANFFIKCIQRFVLVFVLILVFEILD
LANDDPHLQTVPQTIGVKKTKILGFSLLVPFWVVGILSFDFHDLIINLIMVIMLMLFILF
ANPNRSKYYTSFWVESVPIFWWLMIEFL
>EGALAKHO_02449 Glycine dehydrogenase (decarboxylating)
MRTDAFALRHIGPRETDLPHMLKTIGVESIEQLVYETLPDDIRLKAPLNLDPAMTEYEFA
NHIQELGKKNKVFKSYIGLGYHPTIVPAPIQRNIFENPGWYTAYTPYQAEIAQGRLEAIL
NFQTTVIELSGMEIANASLLDEGTAAAEAMALLFDVRTRDQKKNNTNKFFVSEEILPQTL
SILQTRSTPVGIELVVGNHETFDFSNEFFGAILQYPGKYGQVNDYTAFVAKAKENEIKVA
FAADILSLATLTSPGEMGAAVVVGTTQRFGVPMGYGGPHAAFFATKDEYKRSMPGRIIGV
SIDVNGNRALRMALGTREQHIKREKATSNICTAQVLLAVMAGMYAVYHGPKGLQYIAGKV
HASAVTTAEALNKLGVYQTNTAYFDTILVKADAQKVKAVAEKNEVNFFYVDADTISISFN
ETTSIADINQIISIFAEALGKETFTVSELTTASQLPASLERTSSFLTHDVFNNHHSESQL
MRYIKKLERKDLSLNHSMISLGSCTMKLNAASEMLPLSMPNWNSIHPFAPVEQAEGYITM
LKKLEQQLNVITGFAGTTLQPNSGAQGEYAGLMAIRAYHLSRGDSHRNVCLIPSSAHGTN
PASAAMAGMKIIVTKTTPEGNIDVEDLREKAIEHKDDLSCLMVTYPSTHGVFESSIIEIT
KLIHDNGGLVYMDGANMNAQVGLTNPATIGADVCHLNLHKTFAIPHGGGGPGVGPICVNE
KLVPFLPTNPILKVGGEQAITAISSAPYGSALVCLISYGYITMMGAEGLKSATEHAILNA
NYMKARFEGHYPILYTGECGRAAHEMILDCRSFKENGIEVGDIAKRLMDYGFHAPTVSFP
VAGTLMIEPTESEDLAELDRFCDALISIRKEIEAATADDKNNVLKNAPHTLAMLTTDNWD
FPYTREKAAYPLEYIADNKFWPSVRRVDDAYGDRNLVCSCAPIEAYMEN
>EGALAKHO_02450 3-oxoacyl-[acyl-carrier-protein] synthase 3 protein 1
MKIKIIGIGSYIPNKEVSNTDFDKHVFLNEDGTPFGYPNEVVIKKFKGITGIENRRYAET
QHNASDLAFFAAEKAIENAGIDRETLDYIIFAHNFGDVKSGTHQTDILPSLATRVKNKLA
IKNPKCVAYDILFGCPGWIEGVLQANAFIKSGMAKRVLVIGAETLSRVVDDHDRDSMIYS
DGAGASILEGTEGESGLLSYESATFANEEANFLYFGKSYNPDLDLDIKYIKMYGRKIYEF
ALSQVPCAMKSCLDKSGIGIDEVKKILIHQANEKMDEAIIERFYKLYEKTAPKDIMPMSI
HDLGNSSVATVPTLYDLILKGKIEGHEINKGDVIIFASVGAGMNVNAFVYRH
>EGALAKHO_02451 hypothetical protein
MYEKTFPNKRFKLTLEFLQKHIKTSETILDLGVENPFSKIMKEAGYSVKNTTGEDLDLDQ
NVLKTDTQDVVTAFEIFEHLLNPFTILSEIKSDKLLISIPMRLWFSPAYRSKTDMWDRHY
HEFEDWQLDWLLEKTGWKIIDRQKWTNPVKKFGLRPFLRSFTNRYYIVYAEKA
>EGALAKHO_02452 Hyaluronan synthase
MKYYIVIPAHNEQDLIGLTLQSLVSQTVLPSKIVVVNDNSTDKTEEVVLGFAKDNPYISV
VNKTSDAIHMPGSKVIQAFQKGFETLDSEYDIIVKIDGDLIFPPNYFETIIKHFESDPKI
GMAGGFCYIEKNGDWILENLTDKDHIRGALKAYRKETYQQIGGLKPAMGWDTVDELLCKY
YDWKVVTDESLHVKHLKPTGANYNKTARYKQGEAFYTLGYGFWITAIASAKLAMMKKKPL
LFLDYIKGFWKAKKSKTPLLVTAEQAKFIRNYRFKKMKEKLI
>EGALAKHO_02453 putative phospholipid ABC transporter permease protein MlaE
MLIRYLSQIGRYFLMLKEIFNKQTKWSVMKKLIFKEIDDLIIDSLGIVCFISFFIGGVVA
IQTALNLTNPLIPKYLIGFATRQSVILEFAPTFISVIMAGKMGSYITSSIGTMRVTEQID
ALEVMGVNSLNYLVFPKIVALLMYPFVIGISMFLGIFGGWLACAYGGFSTSQDFIQGAQM
DFIPFHITYAFLKTLIFAMLLATIPSFHGYYMKGGALEVGRASTVSFVWTSVCIILFNYI
LTQLLLG
>EGALAKHO_02454 putative ribonucleotide transport ATP-binding protein mkl
MIEVKNIEKSFGDSRVLKGVSTVFETGKTNLIIGQSGSGKTVLLKTLLGIHTPDSGTIEF
DGRVYSDLNPDEKRELRTEIGMVFQGSALFDSMTVEENVAFPLRMFTNDNKTKIKERVDF
VLERVNLVDAHKKLPSEISGGMQKRVAIARAIVNNPKYLFCDEPNSGLDPNTSTLIDNLI
KEITEEYNITTVINTHDMNSVMEIGENIVFLKKGVKAWQGTKEEIFRTDNKDIVKFVYSS
NLFKKVREAYLKG
>EGALAKHO_02455 Protein SprT
MNETLARYIPEHAVKPVFELIVANQVHLKIVNERQTRHGDYRRGHTGKHEITVNASLNKY
RFLMTLIHEIAHLVAFEKFGRNIKPHGDEWKFTFQRLMVPFIRPEIFPGQLLPLLARHFK
NPSASSDTDTTLSLALKQYDAQNDKSYVFEIPYGSVFRIKNGKIFKKLAVRTKRFECIEI
SSGKTYLFNPNAEVELINISEKF
>EGALAKHO_02456 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MKNIIVTGTSRGIGYELALQFANAGHQVLAISRKIPQTLLAHQNVTCLSVDLSDESALQE
VDSFLSSTWKKVDAVVHNAGALLLKPFAETTQADFESIYKVNVFAVANLTRICLPYLQKG
SHVVTISSIGGVRGSLKFAGLAAYSSSKGAVITLTELLAEEYKEKGISFNVLALGSVQTE
MLNEAFPGYQAPISAEGMATYIYDFTLNGNKYFNGKVLEVSSTNP
>EGALAKHO_02457 Bacterial leucyl aminopeptidase
MKKLYFLLFLLALLSCKSNPSATTEKPSQSDSKPLEISYKVKESDVSDFLKYLSSDELEG
RETGTKGIEKAAVFLESFLKANNIKPYFSSYRDTLTNFKTPAFNIVGVIEGTDPELKKEF
VVLSAHYDHIGIEKKQQPDVINNGANDDASGVTVVAQMAKYFAETKSNKRSILFVFFAGE
EKGLLGSKSLVPKLQKLNFNLYTQLNIEMVGVPMKRDFLAYVTGFDKSNMAEKINEYTGK
NTIGFLPKEAEYKLFYRSDNYSFYEAFKKPCQSISTFDFENFDFYHHVSDEFKVMDIPHM
TSFIQELLPAVTQISSTPTEEITMK
>EGALAKHO_02458 Acyl-CoA dehydrogenase
MDFNLTEEHLMIQQAARDFAQNELLSGVIERDEKQIFPTEQVKKMGQLGFMGMMVDPKYG
GSGLDAISYVIAMEEISKVDASASVVMSVNNSLVCWGLQEFGTEEQKQKYLPGLASGEIH
GAFCLSEPEAGSDATSQKTTGIDMGDHYLVNGTKNWITNGNTASVYLVIVQTHPEKKHKG
INALIMTKDMPGFSVGPKEQKMGIRGSDTHSLMFSDVKVPKENRIGEDGFGFKFAMKTLA
GGRIGIASQALGIASGAYELALKYSKERKAFGTEICNHQAIAFKLADMAVNIEAARHLCM
KAAWDKDQGKNYDVSGAMAKLFASQVAMDTAVEAVQIHGGNGYVKEYHVERFMRDAKITQ
IYEGTSEIQKIVISRSVIAG
>EGALAKHO_02459 hypothetical protein
MKKILLALTFLLSLQFSTVSAQTQLEVNGVTVPRKIEFQNKTLQLNGAGGRSKMWLEVYV
QALYLSQLSQDPKFIIDSDTEMAIRIEITSSMVSSNKLTKAMNTGFEKSAGSNLEELRPR
IEQFKTMLSDAITEKDVFILAYNPLDQTINVIKNDVVKGKVPGFDFKKALFGIWLSDKPV
DETLKKHLLGI
>EGALAKHO_02460 hypothetical protein
MFSAFFFSLNKIAIKYIIRIILFYTFTQNKHITTK
>EGALAKHO_02461 NADP-specific glutamate dehydrogenase
MKDLLQQFENKEPEIVFNWKDSETEAEGWTVINSLRGGAAGGGTRMRKGLDMNEVLSLAK
TMEVKFSVSGPAIGGAKSGINFDPNDPRKKGVLQRWYKAVSPLLKSYYGTGGDLNVDEIH
EVIPMTEECGVWHPQEGVFNGHFKPTEADKINRIGQLRQGVIKVIENPKFSPDVTRKYTV
ADMITGYGVAEAVRHFYNTYGGDIKGKKAIVQGFGNVGSAAAFYLAEMGAKVIGIIDRDG
GLINEEGFSFEEIRTLFLNKDGNKLVADNMIPFEEINSKIWTIGAEIFTPCAASRLVQQT
QIDSLIANGLEVISCGANVPFADKEIFFGSIMEEVDHKVSLIPDFISNCGMARVFAYFME
KKVQMTDEAIFNDTSEIIKNAIVKAHALNPSKTNISATAFEIALKQLV
>EGALAKHO_02462 hypothetical protein
MSSTISSDKKKSLLLTTAIYAVILVLLFFIRFWPPYNPENNVALAEGGGGGGVTVNFGDS
DLGSGANYKSEVLNVKNQAKATPAKSTPDEAIITQENSADDANDVVIPVKEKPKKPTPVE
KPVTKPVPEKPKVSNSTNDALSSIMKGSNKGGDGDDKVAGNKGKANGSLGSNGYYGSGGS
GGGTGGGNGTGNGIGTGSGYGAGSGGGSGGGSGYSLNGRKALSKPKPNSDCSNETGTVVV
QITVDKNGNTINAVPGVKGTTIAAKCLREQAKMAAMNTKWDADSNAPTKQTGTITYNFSL
N
>EGALAKHO_02463 hypothetical protein
MSIKRKRRFHAEVATSSLSDIMFFLLLFFLIISTLANPNVIKMTLPKAKSNEKTNKQLIS
LSVTEDKKFYIDKEPVDFENLETSLMSKIGADKEQTVVVRIPFNLQVQDLVDVLQIGVKN
NLKFVIATSPK
>EGALAKHO_02464 hypothetical protein
MFSFIQQQTDTIANAASNVVIEKIAPNTEISVLGFILKGGFFLIPIAILLFYTIYIIFER
YLYISKASKIDSRLMQDVGDKLNAGNIELARTIVERSDTAAANILKEGVLVIGRPIAEIE
SNMDRAADIEIGEMERRLGHLGLIAGIAPTLGFIGTISGVIKIFYSISVTENISIGNISG
GLYEKMISSGSGLIVGIIAYSAYHLLNGKIDDFALKIQKQILEFVNIIQRA
>EGALAKHO_02465 Folylpolyglutamate synthase
MNYQETTNWMFNQLPMYQLQGASAYKEDLTNIKILAAHLDNPHDQLKCIHVAGTNGKGST
SHMLASVLQEAGYKVGLYTSPHLKDFRERIKINGEDISEDFVIEFVEKHKNFFEANDMSF
FEMSVGLAFDYFASEKTDIAIIEVGLGGRLDATNIITPLISVITNIDLDHTQFLGNTPAL
IAGEKAGIIKPNVPVVIGEYTPETQPVFLAKAEEDKAPIYFASDLISEVFPSDLIGDYQF
HNKKTVQQTISVLNAQNEFKVSDEDLKAGLLSVVKNTGLQGRWQQLGENPKIICDTAHNK
HGLAVVMNQIQKETFENLHIVLGVVNDKDLDSILPLFPEKAHYYFCRPDSSRGLSTEILQ
DVAKKYNLVGEKYDSVESAFLDAKKNATKDDFIYVGGSTFVVAELPLNSKN
>EGALAKHO_02466 hypothetical protein
MKTRSTLLELVLWMTLGCVIGNAQEKQEKAKPVFITVTTLHRSMDVKAKDWKASEQEYFD
KVTSKNDLIIGSEILTHYYTEDNTEIILVNVYKTWEDIEKANAVSDELIKKAWPDEKART
TFFEKYDKFYTPVHSDEIYQSITSIGEIPYKDTTKKPMIVYIRKSQMNMAGKGKNVKEFN
EKITFKDPFIKAYYPFRHLWGSNSTDFMEAFFYDSLADLEKSSEKIDELIKSTWPNDKDA
DAFFDELEKSFTGKHSDYIYRNIPSLSK
>EGALAKHO_02468 hypothetical protein
MENLKGEQFDNDNIISKNYEDLESEKEQKFVNLMIEIIVSLTLKELYEEGDQISKV
>EGALAKHO_02469 hypothetical protein
MENEEKKNRNIGGRPPKIDPAVYRYSISLTAEENARFLTLFETSGMHVMAHFITACVFQR
GIKTIKIDKATMDYYMRLTSFYSQFRAVGVNYNQVVKILYQKFSEKKASAYLYKLEKQTI
ELAVLSKKIIQLTEEFELKHLKK
>EGALAKHO_02470 hypothetical protein
MLYKETVTQEMWELLQRLMKDEKLKEHVLVGGTALALRLGHRLSVDIDLFTTKGFNSQMM
LKYLHNTYGANREESRFFPNTVLTHIDDIKVDIVTHNYPLLNSVETTEGVRMISNEDIGA
MKLHAIHQSGNRYKDFVDMYFMLEQEPLKFYLQAYQRKYDKDPYWASKGLNTYDKITTFE
GVNVLKEKDQNWKNIQKRLELAVKNPLYKFKSESQDLPINPNKKRGFRR
>EGALAKHO_02471 hypothetical protein
MEKLTKNIPNLHPKFFWDFRFDSIDWDGGYKMVIARIVERGGQDQIEEILRFYGREKVIK
AVREEISFLPNYAIEDALKFFPELKREDMYCYLNRKDKPYYWI
>EGALAKHO_02472 hypothetical protein
MEIDEIEKLETIKRLTFNCMNTLRPVDNKNRIHSAEIKVYDYYELASVIRNLMKLCIVAL
DRDGAEVPDTIENKSIDVGLILGIALQLFPVDEFELLNEIGILFPDDSKNEDNKITEH
>EGALAKHO_02473 hypothetical protein
MNRKDKSMYHNILTQKEQPNYRAVKKIVKLLVEFVQTDSIYFSKTEDRTNLGILTVLSKK
STYYYDEIREHLEKLIENHSEFSFCIFDRDLVKRNVKEGNLFFILNCKESDLVYSKDNFK
PVINIANIKLKRLLRKTRERFKERMTQCETIGRDLKHHNRCDNHLMALYVIHQQFRYMFI
NISWLVSGERRFENSIKGQQEYIIEFNNSLGKVFDKNKKEEWVILKKLDRACRAVQWGEE
IEPLDMEVVAAASEKLEWMKNAVNALFREHEEKTRLIFKDYGNR
>EGALAKHO_02474 hypothetical protein
MDYQLRIPEPYPMREHLEKAITELLAFVEAGTIYISNNKDDNVPIIITFILKKNCGQCGD
RLQEISKKITKSYPDFIFRFINAFRASHGFKAGLPYLIRNCTINELVYYEQDSKLFYPVN
FNPKKLIKKAKLSFNGDKQATLESFKASLTHIKNNQNFEAAIAMYMAFWSLYSCYSGFLI
GELGEDMEYPNFLEEYKRVTAFVPHLKNILDYDAPQDKEIIISLITANKSKTLNIPMEDV
SWAVLERAKQKFELLSTELDRRFKLYTKYCKQKKREFSNLSFLGKSIFTTKIKSNYIMDL
ALFEISNLIANFFKTRAVYCFGYTIIDGQEEKKENYSKKLPRYHFYLLVLNLEYKDNAVS
LLQSLIHEKFQGRYEVTILSHRANYLGKQSQNQKYFFDSIMRNGLLTYNNPLYPIYSKTF
DVARDLKFSQNYWQNRILAAEHFLILVQDSNEPEVPLIINSILQESVKQIAVGLLDLFLG
YHPNRHSIKHLFSLLLYLDIIELPFDLNNEKEKFLFQLLSANSNMIMHKDLKRESAQDSD
ILFDKCEKFFELAEEIGNKEIKRIESLNNDEPQRQEYVS
>EGALAKHO_02475 hypothetical protein
MNTTTKPKHIGRNISRIRELRGMKQEALAVAIGVSQQSVSNIEGSESIDEEKLLVIAEVL
GVSAEAIKNYSDEAVFNIIGNTVNNHDNASFFQYQPTFNPLDKLVEAYEENKKLYERLVQ
AEKEKVEFLEKLLNK
>EGALAKHO_02476 hypothetical protein
MNKTIHLKIKKIIDHKNEFKVIKLKGTLISKGFTEIIHATDENEDFYLNTFSTSPKDKKE
VEDFVIDYISSHDLTDTITILRS
>EGALAKHO_02477 hypothetical protein
MSFLAKLELDGETFNVLEFDVTLEQNTDSNGKPASNTKGGQVRLVIETTQTDLFSQWMVS
KTSVKDGKIIFYRRDAMSTMKNVTFKKAYCISLHESFRSVGSNPMTTGILITSNEIKIGN
TLFENNWKNS
>EGALAKHO_02478 hypothetical protein
MDEQQILKIVEKARRNTELSLKRGKFSHPEDVFNREIKEQFDFLNSSNSGVSKQNPVLYV
SKDVKIKEIQEKKENHSSKKIMTGSALVLAGQPLIKKRFVTRGASLGTSLASKYLSKVFP
QKMPVRILGTRVFGRAIGRAVPYVGWALVVVDVIELIIEEVESESHDSASHFNGFGGSFG
GGGAESYW
>EGALAKHO_02479 hypothetical protein
MDYTKFYLFIKREIGTQINDSSQNFDLSKDFNLYGDEAKNFISLFSKKFDVNIDGFRYDN
YFNPEIDVISLFFKNLFNKKAKQKLTINDLKKAITEGFLI
>EGALAKHO_02480 Actin cross-linking toxin VgrG1
MALQTITTIKIGETIIKNFCHLEITQNIHDHHTFLIEVRQDVLIDEMQSVMPLSQKLTSE
KIGIEIKAIPDLDDVMVVASPNDYQMQFYGIVTKVSMRKSRMRNIEETIIIQGYGSSIIL
DNGPHSNSFTEKSLGDIVEKVKSGYDIDMRINPFYTEELPYTVQYNESDFDFLNRQAMRY
GQWLYYNGCNMVFGVPGGSTEPKLVYGVNMHEFSYDVKLSPTLFKAIENDNIKGEYFTES
TARYRNEVDGFHQSFINKSNQVFDKETVIQLNQNAVGGMGKKASEEYAKNKMRSIMGDMI
QIEGSSEVPGIIIGNNVSIRGVDPQLENSYRVTQVKHTCDDGGGYENSFTAVNFNGAVFS
PMTNPDLIPRCESQTAIVIANNDPNGLGGLKIQMPWQEANGVTTPYVPMVHPHGGGEKGF
YVIPEVGERVFVDFQGGNAEMPVVFGSMYHRNAKSGYVTPNNDMKVMRTRSGIKIVYNDA
DGSLLIEDPSGNQYFMDGKGNTFVKVPKNMTFDIGEDLIFKVGNNMITEVGNDKTTTVTN
KIELEAKEYKQDINKNKTTTIGGDLNETTKTTTHKATGGNILIQSTGVSRLLGKIDAKVN
KG
>EGALAKHO_02481 hypothetical protein
MKNLKIHFYAISLLLTLTTSCQNIKQDKEMNEPKFEYEGNICSPLGYPVDVYEGGLESSS
GSTSLYLGTTHGEWGSNGGGMSHSEKAVPRGLNVTWLSYAEDTFYTIDCDIDHDKMLRLF
KEGYQDSMWFFNDGRYQTQTYDAIVVGFAPGGVVVIWLNGAGKQVEIGRYQGKKIIMREN
EIAGLDNHERLIFDPEYRKETMLNKQIVPLEVQEANKNKPIPYGLWDKYREKYLWRPTYI
VQHGGEMESVSFATYNAEQEELFDESFIKNEFLKRAIPKEIALTWHNKEGERFSGYIVFN
EDKIFNAYKEIYKDNEEVKAELEFRINIPNTFITITLKGNGKEAHINEQAKVRVFKIKKR
>EGALAKHO_02482 hypothetical protein
MGKSFVYNAGSSEDVIPVETIELPFGLFFDGTLNNLENTKLRKKYRDEKFMNNEKKDDYT
FDEAGEKARKDARHYEDGDYSNRYSLGFSAEKIKYLEASHRGFMDKMGVDNSFSNDFSNV
ARMSLCCTNDYKIYIEGMGTNDNAKDTDQGFQYGAGNTGIRAKVRKACEFLAKKIKKAID
NNANKDKIVTQVTVDVFGFSRGAASARNFVYEITEKPPFVLTKTGEFDKNKISKDIRNKL
NPAKHPISNSQNKEFGNDNGLPAMPKGGLQAIDLKPSNMEPIYGKGDSDGKPVDSSLIKD
GKMPIMGHLGYSLLNLGLDPELLKNLRVIVRFVGLYDTVSSYEEDGDGTLKEEDGGTLIK
GGEHLYKSKFKDDVTQLQLNKLDAAQKIVHFTAKDEHRENFDLTRVPLNGCAIEKNLPGV
HGDIGGAYENGEEIVEEIETNFHDNLYNFAEYLMKNYWYDKEQLLLIPGFYSNLKGTRMI
RKEYSYLPLHFMQDFFRELTEEKHMTRSVISDYPIDNDKVLEDTKKHLEKYVFGKGGREW
NFIDDEELKKLKDNKRVDDLIKDDKLNERNNESHHDNLNQNDYKPKTRLGLEKIPGLVTE
SKEKWDDLPEQTLLRILRNGYFHWSANRDWLGMDPAKNRIRDIH
>EGALAKHO_02483 hypothetical protein
MVPKTYFFEEFYLNPILEKRNPYRFETAITDFSKDEMGVLKSCIRDVNIAYLGKIEDLFF
FDVFTRKVTFASSHSIENERLLKEDMYAFDDILLGVNDKGEIVKVQNLEEIQNKWQQTKS
ELRKDYQGHEFEGFLSDVTEVLENDQDLVYYLNTYAMFGLYFHGLFGKYDTLKMPLERKK
ILLDFDDSEITEQIWTDTRVTGFVMSAKKSDDTNKKIITNNVAIQEYQGSLAYNSENELM
EGDLNIKSENKNLNYNILWVG
>EGALAKHO_02484 hypothetical protein
MGWLSRLRDFFREMDNPDYDKMFRDRMAKEQKEKEAIFDFRENIGLINRIVATDKVKYKR
SKEAEQKKETKEENKKEEKAEDGFKMVIDGAKLQCTLCTNPVGDLKVNFDTPTTQDKKTA
TVKEKDMKSLIFKGNCKKSPQSSSPCASVMQLGGWKNVGTSKIQEQFPLLLKSTIKCNYG
GVDIKITDCGQRSEPEDVSPANKGLKKKKILSAKWMCAEMQEDIQKAHVGQKVSILVKTR
NYDEGETVTIIVDDKNGYDAKEGEKEITFTGEVQADGFAELKEQIAIEDVAENPKHKTDK
QLEREEAEKTEIYITREGKDYTRAEWKAYQDKWHDDMMAAKKKGFWG
>EGALAKHO_02485 hypothetical protein
MAENTGRCLRIKSVDGNTSFQCETIGIFPELKFVNGYFYSEDGTFEGKENKPNNDGSNED
VYVCVGKTTQNDKHGNAMTTYNNIKKLDVTHEVLLAFASVIHAESKGSKEESYAIGNVTM
NFINAGGSKQIPTLDDAVMYDNRFAQGATQDNLSSFIGLSNKNSKFGIGAAINAIGYSQG
ISGFSDYSGGANGWDGIDLISTKWNNSHRNYTWSDGSKELLLTYKKNNNGGVDVSAFTYK
KEGYEISATKIIGNTIYTNITTGRGEKKQNSTRFHL
>EGALAKHO_02486 hypothetical protein
MTGMKTLKKVTLIVIILLIFINCRYKEEKNNTAQNKNELIFKNWLRDTVNILNNEHHLDY
GRKITISADSLSMDIIKTFDKKINSNNIHKIKYKELIYAMDLLTRSHDLPKDEFRLKLVI
SSYYSVSMVEQLKYEYDSEINLFDVIKKNKIEKYKFLKGNFIEKSIRNLPIKK
>EGALAKHO_02487 hypothetical protein
MTKDQIKDRILRRAAKAWGFSDTAMETSFDPLMSLMINALSDELEKISYALQDSNSSVVG
RILEIMFPESSIGAKPSQAILHASPVENNVKVSLLNQLTISKRIPNIYNPLEPIFKEIAF
SPTLEVKLAACDLKYIAYGRNLYEVSNVVDRKAITDYNTALPSGEVFLGIEMSSPDVLYI
EDLMLYIDIKEIDQKEMLQYYLKNMKCFYDDALVAAIAGYNVPMHNSNNVKLNKTSVHLS
EITKEVNEFYVDNFYTLHGKLKCKALKDYNQKLECFEQVTSMNENPIIWIKMVFPESLIP
QVIDKVTFQVNCFPAINKKRHKISKVIKNTLTYLRLNTEKDIYLDIENVTESLTNHYEIR
EFTDAALEDGTAVLRKTGTSKFDQRDATELIQQVLDLIKDESTSFSEIGKDFTATSFGEI
NRLLTSIYKQIGEAAYSKTSDPHLLIKPSGDTEGDLSFEVNYWSTSAEDGNDIKAGSLLE
PHDKLFDSNKTIMSMTTSVGGLSKQSDQDKIFFYRNALLTRGRIVTIADIKAFSFNHFKN
CISSVRVEKGTRKEISIKEGYSRTIDIYVKINKAEKEKLSASGWDYLCESYMKYLKSKSS
NTFPYRLYEE
>EGALAKHO_02488 hypothetical protein
MIEIIIGLITAFITILSNENIIINKKITSRIDSFYIRGELYIQQIATSTYKTASERVLIK
TIQYSIIFIAIITFLTSLILSFLLKTKNTNHESIVIEYNDFSVLLYVLLFLFALRFGTEN
NFKRFLLLLKKDLIGILNSKILWLVIMTLEFIAFFLFYIIKPIAGKNNYLSNRQILDIIV
ENNSFNNMIILVFPILLLFLSILIYVVGYFAVCLFSKLLSFLFYYILKKVFELFLFLNDE
KPLKTFLQFLLVLIIVITPIIDFVMKII
>EGALAKHO_02489 hypothetical protein
MFLEILIIITLNNLFLVKNINNEPPNKNEMDLSLGNEIVFLRR
>EGALAKHO_02490 hypothetical protein
MKLKISWEEFSKQIDNYITEGKEIKLTESNVNNIEELEKLKADIQNFNSRCFSFLKLSFD
NDNNEYNDYAMSFHNARPVRFNIGNQQKQFNQLKKETLEDLNEKLLTLPYFKKILSISDA
IIKPEIVEEQNRTNYTTEQTLELILEKLYDLYDNLHHSVSTILEGNGITLKRHGEDRELL
KTLENLGYVHVIHTRDASAQLTLSGKMYIEEKRKAYKENYDDIVADKEEINKRIDEIINQ
LSKLGFGQEIIFDELHELKEFYTTLNKKNWGQLVKGKLLDLAVSKLVENDTISYIYEALT
EHKLRLP
>EGALAKHO_02491 hypothetical protein
MSNLKGHIFDWLMELEEEKAANFLNECEIDQTYIDTLFSMDSDAESYMYEVTVNVPLKIY
RKIEDYTQEVSAIQSAITESGQASGIYVRKIDWSPYLKNEHKKQADKKGEEITQLLTQEY
VYKQIRLMNNSIESNPHLALGISKK
>EGALAKHO_02492 hypothetical protein
MVVLEIEANRNSYFFTQKTNIVHLRLSGDFDLLDEQKRVAFVIDEKAFHLTSSKDLYNLG
KEIKGKRESEIISTISKYIIEKEQFQLLSFVGIIELELIKSVFLIYEWLDLLFKSPYDQR
IEHLLYNQFIVDLTNIAEPQKDIYFIDKKYIDEYYNSSIKRLIELNLLAKIIVTSQGQRY
ESYYIPLTKPGIGKEKFKTLNDKNGEKTYDLWKRILFEREIRITNWLNKRY
>EGALAKHO_02493 hypothetical protein
MLYFNNEIFVLFLGGIFSVLLPSVLTVSKRELLRLNKKKELMAAENPERYGDLDAYLDET
TQYKRINFLNYLVEQAIQPLFIVCLFNLFTYNGKAEIFLIVVLIIIMILHELFAAEIYSG
KKIYRMFIVCLWIISYLIFSYKSSENITEKSTVIRTMHNNG
>EGALAKHO_02494 hypothetical protein
MEKKINIPKPCNQNWNSMLPNKDGKFCTSCNKTVVDFTKMENLEIQNYLIQNSSKESICG
HFKSNQIETKNNIKYYNLRNRISGIKIKPLKTFALFSLSLLFSLTSCMGKATIDGDPVVI
DNDTINDNEIIKKELDTLKQNDSIKSEVIEMKKRK
>EGALAKHO_02495 Bacterial leucyl aminopeptidase
MKKIIVSMFVLSQCFNVHGQSIDKIITNKEVTRIEKILSADDMQGRRTFTPGIDKASAFI
ESEFAAIGLQTFNAAANYRQEFSMTASSALSSKITIDGKEINNNKVVTFSYLPQVSLTEK
SDISIVKINKGDNIGEKFNEYYKSPKNLLVLVDSSFDKVLPNIQHIDRVNATPGNNTIMF
VFGTTEATTFSVELTNAISKKTLNNVVGVLPGKTKPNEYVIFSGHYDHLGVGSPEEGAPH
TATDSIYNGANDDAAGTTAVIMLAKYFKKQNNNERTIIFTTFVAEELGGYGAKYFSKQLA
PEKVIAMFNIEMIGTESKWGKNSAYITGYEKSNMGPILQANLTGTSFTFYADPYPDQQLF
YRSDNATLAKLGVPAHTISTSKMDSEKNYHTADDEFETLDIDNMTQIIKSIALSSSSIIS
GKDTPTRVDTTQLK
>EGALAKHO_02496 Penicillin-binding protein 4*
MNKQFFFIFIASILASTASGQEINDFFTTLNKNNLFNGSVLVSKSGEDVFSNFYGFSNIE
KKEKINEKSQFPIASVSKTFTATAILQLKQKGKLKLDDPVQKYLPDFPYPNVTIRHLLSN
TSGLGEYYHLFDNVIKEQPEKIISNEDIIPTLIQNKTPLSFSPGDKWEYNNLNFCLAALI
VEKISGITFREYLEKNIFKPAKMADSFLPENRKLKKPNQVELYTYSNLYSTNLVNITNLK
DPFLISEKSNFYGNGGIVSTAVDLQKYQKALFKYQLLDKKELEEALTPTKLNNGKIASYR
FEEKEIAYGLGWEMYTDESNGKIVFHDGSITGLTSILMHNIDKKQTVILLSNNAAPMFTL
SNAISQLINNKPYVIPVQNLSRVYGSLLESGSKEKANQLIEEYLKNPKRYNASERDFNSL
GYQFLRLQKNENALQTFASATLIFPKSSNIYDSYGEALLQCGKKEEAIKMYQKSVELNPD
NENGKKVLKGLL
>EGALAKHO_02497 hypothetical protein
MSNIIKNYYSVLEVIRFLNCELAFKIRIEGRRKIFDLDSNVLRFVAAQANHFIWRNYLYV
KLV
>EGALAKHO_02498 Outer membrane protein assembly factor BamB
MKNLLPLLFLFTVINIFGQTPTPQTPVENSNVISTVPAISDVLNNKAISPVKKVPLDEAL
ILIYDYDGTLFTFDLESETIAWTVKATDSHTEMCANGVTLVDGVLYVSFINGEIFAIDNQ
TGAIFWKSRIGNSTDQIVLKDQLPIVNDGKLFITSQNGNIYALNIKDGSLLWKYKLDSAN
NDIPVLFFDNKVFTQSGNFLYSFEANTGKLIYQKDFGETMHGKPVTDGENVFIANGKNIL
FALSPSKPDILWQFKFDENQQNVKERILCKDKKIYFAAQGPEVSSVYAVDSKTGTQLWKT
DFKGDIIEYIIEESDNIWGYTRKAKLFQLDITNGEIAAETKLTTQPISNFEFPVDESLFY
YSDAALIQFDLKTKDENEVYLRTSIKDNAYSAYVKIIRQ
>EGALAKHO_02499 Signal peptidase I
MNLSEWLVFILIMLIIHGLSTWKLYIKAGRKPIESFIPIYNLLILMKIINRPRWWVILLF
IPIINLIMIPVIWVETIRSFGKNSRFDTIIVLLTLGFYITYLNYNAEKLTYIENRDLTPQ
TKTSDTISSLLFAVIVATLVHTYIIQPFTIPSSSLEKTLLTGDFLFVSKINFGARTPMTT
VALPMVHDSIPLLGTKSYLFNDDVTKKETSLLNKFQLPYFRFPSIEKIERNEIVVFNQPA
DTLRDMDNFHPDRTYYKPIDKKTNLVKRCVGIPGDSLEIKDGDIYINGRLSKLPESAKPQ
FNFFVDTKGQAINQEILVNFYGAREGMKYPTGEFALTRNGEYFLTLTDKEAAAIATNPVV
KSVKKYLSPKGKDEGVFPHVSSLGWNIDNFGPIYIPKKGVTIKLDIKTLPFYKRIIQEYE
KNSLQVKDQQIIINGKVSTSYTFKQDYYWMMGDNRQNSLDARFWGYVPFDHVIGKPVFIW
FSWDKEAKGIKKVRWNRIFSVVNGNSEPKSYLIHFIILLVCYIVGKRIITRKA
>EGALAKHO_02500 hypothetical protein
MKDLRSTINMSKIYQLALIFLLCFASCQKDDDIQDIKYVTNAGTDALNIEEFKVQLNASE
LKSDEKGTWIIESGLIDDQVFIENKDNPKAIFHGLPGEKYKLIWKVTNSKSTALDTIAVS
FNTLKIEIENLSPSFYKTRLHLQVKNQIKGKWTVEGKYVNIWNQNFGGISMPDEESPNIK
FFGLENTPYKLTWTTKYGSKSFSKTFEFNSGVFQQDEALEDLALLGDWSRVKKDNDNNVI
SIHLGGDGYAWRFGAMDKYPALQSLTHLKKLTLYGDGFYTFPEVIANKYLDLEVLDFSGN
AISKLPENIGNLKKLDSLTIYNNQDNKLLPELPASFGNLTNLSYLNLSGMGLTTLPESFS
NLRKLEFLDLEGNFLDKLPTNFGNLVMLNTFRGPNIVQNVPASFSKLISLKFCFFFSSNT
NPSLPGDFGKLVNLETLTLYGKYKTLPKSFTSLKNLKQFQISGGSLLTSLPDDFGALTSL
ETLIINGVPSSLPASFSNLKNLKNLQLTGSLQNLPVKIGDLKKLEYLAVDGMQIKEIPES
FGGLTSLKFFNAASNQINVIPASFGNLPSILTVDLSYNKITEFPNSLSNLSNTLYDFTIR
GNNFTEDELKKLQKLLPKTRITPY
>EGALAKHO_02501 Beta-lactamase
MKTSLKFFSALLITSTFSFAQDFTRKIDSIIKDNYQKNPDVGISVGFIQNDKEYFTAYGN
LSKESQIKIDKNSLFEIASITKIVTSNLIAQAVLENKFKVDDYIDNLLPKGYVLHNNLKN
KIKISDLASHQSGLPDIDFGKLIELNPQQPVSSVTEKSLIDIINNCTELKDYGKYRYSTI
GYTLLGQILEKAYGKSYDAIIRSKIIDPLKMKNTLTTDFNVKNRTVGHNPDGGVQEFFNW
NVTAPAGLVKSNTSDMVTYLKAVLNDKTQIGKAAIITEKTFYKVENRELGLGVNIMTDEK
NTLYQKSGDSMGESSILCYDRAKNWGIIILLNQRNSKMRSDLLNKIYDNVLKDAQANKAN
L
>EGALAKHO_02502 hypothetical protein
MDKINLLVTISIIIIFIALFLSLFLLTVKTAHKLSNRLFAFFLVLTAIDISANLGDLLAI
LLNMRIFISSFFFLQLPTFYLYVLSVCYSDFKLKPKHLIHGVTFLIANLVLLPRFYAVDQ
ESKISFLSKIGSRPEVQFNHVLMHIQMLFYIVAAFMILRKARKIYLENYTGASIESLNWL
FQFTVALSAFYFIALVKNIFKFTEYPNISAGLKIGLVLFELFIIFWYLYKALNNPGLFRT
IDSKLKLVQDIISEEKNSAQFANEKEHNEELLKLQHYMMEEKPFLSSSLTIQDVSAAIEI
PVRDLSLLINHTLEQHFYDFVNTYRVESAMDILKDGSKSKLTILEILYDVGFNSKSSFNT
AFKKHTGYTPTSYRKML
>EGALAKHO_02503 hypothetical protein
MKKRLLLAFLLLTTLTFAQKTTFKIKYSEQLAVFVFLQNLSENYPENVFKTEFQKSKYNT
DYYKNIISKYDKLTIDYSYRFEEFPYGSKKGVQTEDLLKKNLIETKNIEEFKLRSNGIIP
NKILSDLAQCISEFTPIYNELIYNPNKEKFEKQLEEITKYSNEYQIENYFEMGLLFYNSS
WDNSIPFNIAFYPLPNSKGFTAQAFCNNFISAIQTDLKSYKVLFSVMLHETFHIIYDEES
WEVKTEIDTYFKESKSKYSNYAYQIMNEALATALGNGYVYEQLDGKIDTQDWYNKKYING
IAKQIYPLVTEYIDQNKSIDKNFIDNYIRIYETNFPNWINELDNIMTYRYVITEDEKDFT
TINQLFRYRSRTEYEDQITESSIENMQKTPLTKVIIISKNNAEKLKLVKSKFAALKNWRF
NANKEFAEKIFLEDKSQLIIVNQKNSTLETLFKSIK
>EGALAKHO_02504 hypothetical protein
MFTINLKINYMKKTLLVAVIFFSFFSVKAQNETNVDPYQKNNELKLNVVSPLSGALEASY
ERHLNKKSSLGISFLTVYDNTINKDLNYYVSPYYRRYFGKKYASGFFAEGFGMLTSIDGK
KIYSEDHSTFTENPNVTDGALGVGLGGKWLTKSGFVFEVNVGYGFLLFNADKTDHNIVNK
IGLNVGYRF
>EGALAKHO_02505 hypothetical protein
MEDSKKQSDNSGSDKTPKVTGIGGIFFFSDNPKDTKDWYAKNLGLDVNDWGSTFESRNIN
NPDEIEALQWSTFKKGDDYFAPSKKEFMINYRVQNLEGLLEKLKQNGVTILDEVAAFDYG
KFVHIMDADGNKIELWEPM
>EGALAKHO_02506 FAD-dependent urate hydroxylase
METKNKINLLQNKKIAIIGGGPGGLTLARLLQRKGLDVKVYERDENRNVRLQGATLDLHF
ESGLKALESAGLMDAFKDNYRPDNDRYRVVDKNGVLFVDDHDKESTGAFGDEAFRPEIDR
GPLRDILLDSLQPDTVVWDSHIVSLENKSDQWEIIFKNGQTATADLVIGADGANSKIRPF
VTPIKPVYSGVIYLVSNILEAEKNAPKLYEFVKGGKILAMDDSKTLFLSEKGDGSLDVYI
GFKASENWALESGVDLKNVKEVSEWFKEEYKGWDSLWMELFEQEQIELLPRPLYGMPLDQ
KWETQNNVTLLGDAAHLLPPNGEGVNSAMLDALILCENLTNGAFKDLQSAIADYEKQMFT
RFAQEGKETAEMMAFMYSPDGLKIMIAMFNELPN
>EGALAKHO_02507 HTH-type transcriptional activator Btr
MPKKPKNIPIIAKSENGQGIFISTMSVEDTELFEDVKHSHRDDYHLFSLQLKGTTSLEID
FQKYTIESSSIFYIHPNQVHRVVSFENVSFSSLAIANASLSPENLKLLEEITPVKPLLLS
EEKLSMVSEVVSLCLKFSERKEEKLYHSLLKDSCNVLVSLVASYYLEETHSADKLSRFET
ITQSFKAILEHNFSTLKKPTEYAQLLSISTPYLNECVKNTTGYSVTYHIQQRIILEAKRL
LYHSDNSVKEIAAELGYDDYPYFSRLFTKVAGISPMAFRNKNLE
>EGALAKHO_02508 Endonuclease V
MILAFDTYYYDGKAKTICLEFQQWNQSTDFKVHTEIIDNVAEYIPGEFYKRELPCILSLL
NKIDLKKVEVIIVDGFVYLDDEKKYGLGGHLYEKLNQKIPIIGVAKTNFASIEKDKRSLL
RGDSQKPLYVTGIGIELEDAFQKVESMAGEFRMPTLLKEMDRLTKEI
>EGALAKHO_02509 hypothetical protein
MEKKLSPQQIEAIKEAHLKEDKVAIENQVVKLIVAGFDEYTAEYLVNKVIKEYREELFKD
AEEKKENEKEKHIADCVVLFASVSGSIFGVTNPAWYLFVVIVCAIAGYLGYNEKPLAGMI
RSIIVAGLFPLTFNFFFGSRSEFRYIELLLPLGICLIVGYGFQYLIGKMFYPDED
>EGALAKHO_02510 hypothetical protein
MDLKLDFKIALKYSLFVLLYCILEKLHLHFTLEKDYYPSSGTFYFLFILFPYFFAAIILL
SFLEYIKYKKNYIDLIIISFTILFLFSVSNYIVNFSFYKLLYEDIPVPHEEGILGLMNRP
SVLMKPQFNFLYTEFVFPFQYLKDAIISRDIFLMIGVMQSRIFIILILLYHFNLFFLFKK
YEENKWYSLVPVLNKLILIRIAGKPVFWIVLVYVPFLSYFLMYSINKEIAEENGFDSKLA
LGMTILPSFFYGKISFNEEAIPVQL
>EGALAKHO_02511 Sensor protein ZraS
MFKTFQTYKLLFLRLILIVAMIEISIYFFKTELLFTGVFGLFIVFLLVREMYFYVRNFVL
LYDKTIASILQNDFTSDFSNHKFNKSYNDLFQLYDVLKNKQNEQVSKDIIYRSILNNIET
GIIILQKQDTDWDVFLMNDYFSKQFNVPKVSKWKYLKNQLPSLCEIIEEDDFQEIKTSVE
ISINEQNKQTFVLQASRTEIFEKDYFIVLLDSIQNVVEKKEKDAWVNLMKVISHELLNSI
TPIRSICQNLQDLVEQDSLSAEDLEDVKNSVETMLRRSDHLQKFVEGYRKLAMLPSPKKE
KIELQYLIDNGIQVMNPLFKENGIEVVNAITFKRWIEVDSQQIEQVLINLLTNCIHALKN
VSQKKISISAEAKENRTFIRITDNGTGIEKEIEDKIFLPFFTTRNEGAGIGLTLSKNIIE
AHGGYISYKSEVGNTVFEICLVEN
>EGALAKHO_02512 Alginate biosynthesis transcriptional regulatory protein AlgB
MKKTNASILIIDDQEDILFASKVFLKKYFEDIYTLNNPKNVVELLSKKTIDVVLLDMNYR
IGFEDGREGLYLLKEIKTLSPKTVVILMTAFGKVETAVEGLKNGAFDYILKPWENKKLLE
SVKQAVDKARKDQKKNKEVEIENNFFVGTSEIIKKAYSLADKVAKTDANVLILGENGTGK
FVLAHHIYSQSERKNNPFIAVDLGSLNSNIFESELFGYAKGAFTDAKLDTPGRFEMAQNG
TIFLDEIGNVPLHLQSKLLQVIQTKTVTRLGETKPRPLNVRIITATNLNLKLEVADKNFR
EDLYYRINTMEIVLPPLRERNEDKIPLAEYLLEKMIVKYGRDEITFDKKVLEQIEKHAWN
GNIREMENKIERAVILCENNKITVSDLDLETITAYEETPDDIQLSSVEKAAVEKALLKNN
NNVSKTAEELGLSRGALYRRLEKYNINIKTDGYN
>EGALAKHO_02513 putative ABC transporter ATP-binding protein YknY
MISITKLSKIFRTEEIETNALSEISLNINQGDFVSIMGPSGSGKSTLLNIIGLLDSASGG
SYQLLGQEMIGTKEKAKSKARKENIGFIFQNFNLIDELSVFDNIELPLIYNDVPSAERKK
KVNEIANKLGISHRLKHYPQQLSGGQQQRVAVARALINDPKIILADEPTGNLDSKNGNEV
MELLTDLHANGATILMVTHSDYDASFSQKTILMKDGIILSEKTNNRNVDVLVAASKN
>EGALAKHO_02514 Macrolide export ATP-binding/permease protein MacB
MLQNWINIFIYHIKNNKLFTALNILGLSIGIAGLIFSILYWNEEQSYNDWNPNKEVVFQS
ICQVSPTNFWTNNVSTFEEYFKTDFKELESYCYLDTWYSQKVIQHDNKKGIFKIIDAQKT
FFEMFPFPFIKGNAKTALRDATSIAISKQTALNLFGSVDVLGKTVTYYDKKLIVTGIYTI
PGKSSLAPEAVTNFIDERVPTEKDDWGNFNTGLLLKLKNPVDKEKVIAKMENLLYQNRTA
KYAKAEGLTIAQWEKKNGAENMKIFLEPLKDARLKSIVEGYAEGKGNYQFLMIMMGLSVL
ILILSLFNYINLATANAIKRAKEVGIRKIVGASKSNIVSQFIFETFVLTSFSILLSLVIV
ELSLPFYNNFLEKQLSINGASFFYELVIIFIVTVVLAGIFPAIYIANFETLKVLKGNFSR
SKSGIWLRNGMLILQFSIASFFIIGSYVVYEQVQFLNQRDLGFKGDQVLEINYRKPEINS
NDEKALKGLFTRYETLKQEISKIKGVSQVSTGSFSFGGGGGSASTFTYKDKNIQGQNMAV
DYDMLRMLKIKLSQGRYFDSRISSDTITNMLINESALKLMNEKNPIGKIVNWNDRKFKII
GVVKDFNLWGPKAEIPPMLFFHLKTIDWMNLNVNRIFVKVNPDEMDNTIADLEKFWKKNI
TSDFPFKYDFVDKAYARNYKEYVNQKNLFWLLNIIVILIALFGLFALASYSIQSRMKEIA
IRKTLGAETNTLLKELSKQYILFCVIGFLIALFPAYYLLRKWLEDFVFRIDISVVPFVIG
FIALFSLTLIVVLSRTYQATKVDVLKYLKYE
>EGALAKHO_02515 Macrolide export ATP-binding/permease protein MacB
MLKNWTNIFIYHIKNNKLFTALNVLGLSIGIAGLIFAILYWNEEHSYDQWNPEKDKVYSV
MSNLGGGNIWAVSSAIPAPLLKSTTSYLEDYCYFRTNYSKETIQYQGKTELVDKILTAQS
SFFSFFPFEFIRGNAKSAIHDRNSIAISEETASRLFKDENPMGKQVRYAERIFVVRGVYR
LTEKSSVMPAAITTVIEEDLEKNRESWGLNYGLMLKLKKQSDTTAVIKKLDQIFLEENYK
KQAKNEGLSLEAFIKRYGEPIKAELLPLTSVRLYQGNSSFAEGNANLTFLQILMALSILI
LLLSIANYINLATANAVKRAKEVGIRKVIGASKLQIVIQFVFETILITLFSVLLALVIVE
LSLPFYNALLNKNLILIGSQFYFQLVLVFILVVFVSGVIPAIYISNFEVLKVLKGNFSRS
KSGVWLRNGMLILQFAIATFFIIGSFIVYQQVNFMTEKDLGFKGAQVIDISFSTKKGKGQ
FERYKAIQQELQKITGVEAVSAGSFSIGGIENSWSGLHYKTNKEVITQGMGVDFGMLKLL
NIKVIKGRDLTEKISSDSISNVLLNETAAKTLLEKDPINKIVNWEDGNYKVVGIVKDFNY
FGLENKIGPMIFFHIKIVPWAQNSMHTIAVKISPDKMSQTIDAIGKFWKTKVDAEYPFEY
NFVDRNFARTYKKYQDQSQLFSLLNGIVILIAVFGLFALASFSMERRLKEIAIRKTLGAE
TNILLKELSKQYVLFCLVGFVIGIIPAYLLLRKWLENFAFRIDIPLLPFFIALVSLMFLT
LTIVLAKAYQITKIDVLKYLKYE
>EGALAKHO_02516 Macrolide export ATP-binding/permease protein MacB
MLKNWINIFIYHLKNNKFFSALNVLGLSIGISGLIFALLYWNDEQSYNAWNPEKDNVYQV
LVKLSDMPALSDCALFLKPALDQDPNVESVLYADSWYQKDKIIYKGKKEFVDKIINVEQN
FFSFFPFKIIKGDSISAIKDDSSIAISDITAKRIFGNENPIGKQIKCFDQLFSVRAVYHI
PGNSSIAPNVIVNRMKQYTTAGLTGPFLLKLLLKVKDPSKVDLTRQKLERIYNHDFIAKI
AKEAGFTVEVMTKKVGHFTVILEPLSKARLHSIIDGYPETRGNYQFLIIMMGLSLLILVL
SIVNYINLATANAVKRAKEVGVRKISGASKGDIVNQFLFETVLTTSFSILLALVIVELTL
PYYNNFLNKNIVLLASQFYIQLLLIFIITILAAGLFPAIYISNFETFKVLKGNFGRSKNG
IWLRNGMLIFQFAIAAFFIIGSNIVYQQIKYLQNKDLGFKGDQVISVSLNFPSVDYQGED
AAQNIYNKYNIIKQQLSKIKGVEQISTGLITFDGSDNSLSGVLYNDELFKQRVIPLDFGM
FEMLNIKIVKGRNFDRKLASDTINSVIINESALKLMNLKDPLGKELVIREQKVKIIGIVQ
DFSLLSPESKVPPIVFYNIKMFGMTQNINKVYAKLKRDDLGNTIANIEKLWSKVNTEYPF
KYDFVDKEYARTYESYVKQKNLFSLLNIVVILIALFGLFALASYSIQRRMKEIAIRKTLG
ADTNVLLKELSKQYILYCIIGFIIALFPVYYLLNKWLENFAFRIDISIFPFLLGFVILLI
LTLLIVLSRAYSATKTDILQYLKYE
>EGALAKHO_02517 hypothetical protein
MASINFEQLKERSLKIRAKYRELELTHHGSEWTVEEDALAFLTDAGLVGRHVMSQQGRWP
KGNTEEELKHKLGESIWWLTVLAERMNINIEEATEEFLTKSEKLF
>EGALAKHO_02518 HTH-type transcriptional activator Btr
MKNQPKIFQSISELHKAMGQPKPMHPLISVLDYGKAIFDPKDFEQGIILDFYKISFKTNF
SGKLRYGHGFYDFEEGGMSFVAPGQILKMQEEEADYSGMSLNIHPDFIRPYTLNENIKKF
GFFSYSAAEALYLSEKEKETILAVFANIQDELNQRIDNFSQDVIISQLELLLNYSNRFYN
RQFITRKAVNNDVLSKLENLLEDYFNTEKPLENGLPTVQFVADELQLSSRYLSDLLRSVS
GQNTQQFIHDKLIEKAKEYIAKGTLSISEIAYKLGFEHPQSFNKLFKKKTNISPVSFQEL
FNKN
>EGALAKHO_02519 hypothetical protein
MKNKAIELTTFKLNGFTTQQFIDANAEIDAFLKRQNGFCSRTIFELKKGVVYDMLVWDST
EDGTNAMHKLMTELSDSVVHDMIDQSTVSWNIAPIEHFVNLYDTIQKNEKSA
>EGALAKHO_02520 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MQKTIFITGASSGLGKSTAKLFQSKGWQVIATMRNPEKETELNQLENVILLPLDVSNSEQ
IKATIKNVTEKYAVDVVLNNAGYGLIGALESLEEEQIERQIETNLLGVIKVSKAFLPHFR
EKKSCTFINVTSTFGLMGFPTCSIYSATKFAVDGFSESLASELVQFGIQVKVVAPGGMQT
DFAVRSMEVGQHPAYEKLTAEVSKGYSPEKLESYTKAEDVAQIIYGAATDNKNQLRYVAG
NNANALYDERLKLGAETQVQNIKTMFTF
>EGALAKHO_02521 hypothetical protein
MTPNDKQNERVAQMTFASVYPHYVVKVEKKGRTVAELHQVIEWLTGYDEKKLQELIDEKI
TFKDFFEKAILNPNVSLITGVICGYRIEEIENQLMRQVRYLDKLVDELAKGKKMEKILRV
>EGALAKHO_02522 4-hydroxybenzoate transporter PcaK
MIAKLNEKKSYPWIVVGLLWFVALLNYLDRQMLSTMKSAMMEDIPELAKAENFGLLMAIF
LWIYALMSPVSGVIADRFNRKRIIIASLFIWSGVTMAMGYATTFNQIYILRGIMGFSEAF
YIPAALSLIADYHQEKTRSFAIAIHTTGIYLGQALGGFGATISKHFSWHFSFHSVGLLGV
LYSLVLIFFLQEKKTYFFDPTKKSSVTYEFRQMFKGLGILFGNISFWVLLFYFSAPSLPG
WAAKNWLPTLFTETLHLDMALAGPIATVTISMSSFFGVLIGGAISDKWVMKHLKGRIYTS
AIGLFLTIPALFLFGYCCDIEAIIFGAILFGLGFGIYDTNNMPILCQFVAPRYRATGYGI
MNFVGISAGAVITEFLGKAADNGGMRHVFVLLLFVVVSAIVLQLVSLHPKTIDMTEGNEI
>EGALAKHO_02523 Beta-galactosidase BoGH2A
MNKHQNILQKTTIILALLLLVACATKSKNARIVEDFNKDWNFKIGDYPTAIQSDFNSSDW
RALQLPHDWSIEGAFDKDSKTKQAQGFLPAGMGWYRKTFTIPQDWESKTVSVEFDGVFKN
SEVFINGHSLGIRPNGYISFSYELSKYLKFGGQNIIAVKVDNSAQPNSRWYTGSGIYRNV
RLVASDKLHVAEWGTFVTTPEISKEKASIHLEVEVKNASETEKEFRMVSSILNQNNVEVT
QAESTETISPNATLKKNQNFTLKNPILWDIENPYLYKIVTKIYEKSTLVDSYETPLGVRY
FNFDAEKGFSLNGKPMKILGVCLHHDNGALGAVENIHAVRRKLTILKEMGTNAIRMSHNP
HSLEMMQLCDEMGFIVQDEAFDVWKKKKVTNDYHKDWDAWHKKDLEDFIKRDRNHPSVMM
WSIGNEIREQFDSTGIAITRELAQIVKSLDTTRPVTSALTENVIEKNFIYQSGALDLLGF
NYKHEDYKDFPTRFKGQKIIASESVSALETRGHYDFPADGVKAWPTKYGASFDGNADWTV
SAFDQVKSYWGATHEENWKTIKKQDFMAGTFIWTGFDYIGEPDPYPYPARSSYFGIVDLA
GLPKDVYYMYQSEWTTKPVLHIFPHWNWTAGQEVDVWAYYNNADEVELFLNGKSLGKKAK
QNDDLHISWRVKFEPGTLKAISRKDGKVVLEKEIHTAGAASKIDLKVDKPTIKNDSYDLV
YVTVSIVDKDGNLLPNANDLINFEVSGGGKLVGVDNGYQANLDSFKANSCKLFNGKCIAI
IQSNGKKENIQLKASTGNGILISVLDVKVN
>EGALAKHO_02524 Beta-galactosidase BoGH2A
MTLYHLYGSKIMKKIVFFICIFLVFSSARSQKNSDSVKLRKEISLNSSWETILLNDPLKQ
EETFVSNPKIDANWERTDVPHNWDQYYGYRRMKHGNLHGTAWYHKTFSVDKKDKGKRLFL
YFEGVSSYATVWVNGKKVGAHKGGRTTFTLDITNAVSFDGQNNMMVKAEHPSFIADLPWV
CGGCSGEWGFSEGSQPMGIFRPVTLVVTDEVRIEPFGVHIWNDKSISKEKAILHTTTEIK
NYGKANRNLTIENILFDASGKKVAISKSDIKNISGETKEIAHTLPEILNPKLWSPASPYL
YELVTSVYENGKKIDELKTPYGIRWVSWPVSRDGKDNRFYINDEPLFINGTCEYEHLIGK
SHSFSDEEIHARIEQIKAAGFNAFREAHQPHNLLYQKELDENGILFWSQFSAHIWYDTPE
FKENFKTLLREWIKERRNSPSVVLWGLQNESTIPKEFAEECTKIIREMDPLSASQRIVTT
CNGGEGTDWNVVQNWSGTYGGDPLKYHLEMSTQLLNGEYGAWRTADLHTEGEFDQKGILS
ENRFSQLMEIKVREAESVKDKIAGQFNWLFASHENPGRSQNGEGFRDIDKVGPINYKGLF
TVWGEPLDAYYMYRANYVSNKTNPMVYIVSHSWPNRWDSAGIKNGINIYSNCDEVELFND
VDKSSLGKLKNPGLGQHFQWNNVNIQYNVLYAVGYVNGRAVAKDYVVLNTLPKAPNLNAL
YTDQADITKSKKGYNYIYRVNCGGSEFTDSTGNTWLTDTHKNGQTTWGSLSWTNKFEKLP
DFYASQRSTFDPISGTKDQALFQTFRYGADKLSYEFPAADGEYIVELYFTEPWYGTGGGL
DCKGWRLFDVAINDNVVLKDFDIWSEVGHDKALKKTFVVKSKGGKIRISFPNAKVGEAII
SAIAIATKDIHARPAAESPKNIQNLVLKTYDKSVNGVASWLDINSKQYSDSEVVFTKLPS
EIFGADYLQFSSQSKTSGSFIVKEDSDVYILIDNKVKTQFAWLSDYKKIEETAKNSIGVE
FSIFRKKVKKGEQVSFDNSEVVNSIIVVPTYDMGEKDDSRQTLVLEAENAKTTGTDIVKG
NFKKADYIEFTKKTNNSIEFEVKPGVAGIYLMRFKFMNRNETPLKVKFKMEDAYGILMRN
DTIEFFPSPEKWKVLNTTSGGYINAGTYKITLEGDDLKGLMLDSFEFQ
>EGALAKHO_02525 hypothetical protein
MKYFSLLFLCFYATFATAQNITIVSDPKSPRAQFGVEKLSEIASIKGFKVITSEKINKNS
KDKIIVIGEKGTDFWKQNSKNAKIDDSKLIKKEGFQIRTQKNIIYIEGTDASGTLYGAME
LADRIKSSGQLPSEINIDDSPEMVLRGACIGVQKTTYLPGRDVYEYPYTPETFPWFYDKK
LWIKYLDMLVENRMNSLYLWNGHPFASLVKLKEYPFAVEVSDEDFKKNEEVYKFLTVEAN
KRGIWVIQMFYNIIVSKPFAEHYNIKTQDRSRPITPLLSDYTRKSIAAFIEKYPNVGLMV
CLGEAINTVDDDVEWFTKTIIPGVQDGMKALGRTDEPPIILRSHDTDGPLVMEKSLPLYK
NLYTESKYTGESLTTYTPGGPWGETHKQLSALKSIHIENVHILANLEPFRYGSPDFIQKT
VKAMHSAHGANALHLYPQASYWDWPYSADKTKTGERLLEMDRDWIWYKAWARYAWDSKRD
RNEEIKYWDKDLAAKYGTDTEAANNIQKAYDESGEIAPKTLRRFGITEGNRQTLLLGMFE
SQLVNPAKWRVYPGFHESCGPVGELLLEYSKKEWNHEPHIGELPTQIIAEITEHGRLAVE
AIDKAEPSVTKDKDEFLRLKKDMHCYKAFADFFSEKVKAALLVLRYSYSNDISDLDKAQP
HLEKSIEYYELLVNLTKDHYWYANSMQTAQRRIPIGGDDGNNKTWAELLPHYERELVNFK
RNLDLLKSSKDGKIATKEGKPWQTADVTLLSESKGTYAVKNGTKVYGTPISELTKIAPEL
QNLKGIAFEETAQNEKGTQLKFKNTKPVKLVVGYFNSDQKRFLFPPSLETDAAGNAYGQA
EVILASAMNLKELPRVNIHTYTFQPGENELNLGKGRVLILGFIDANQTITPRDVGYIDAG
EKGAIDWLFY
>EGALAKHO_02526 hypothetical protein
MKLAHFKKNSIIAILAVLSCSFNSCATAQSSKNKQQYKVAVCDWMILKRQKLGAFGLASE
IKADGIELDMGGLGKRPTFDSKLGDPVERQKFLDKSKELGVGISSIAMSGFYAQSFAKRQ
TIEPMINDCVKAMKDMKVKVAYLPLGTESDLIKNPELRPIVIERLKWAGKQVGKIGGVIA
IETSLNATEEKKLLEEIGSKHIKSSFNFANAADNGRDIPSELKILGKKHLAQIHASNTDK
VWLENDTMINMPEIKKTLDEMKWSGWLIVERSRDVTQVHNVKVNYGANVAYLKKIFQN
>EGALAKHO_02527 hypothetical protein
MKIIKLTFVLFGLLLLGSCKSALEKKTWKEGILVDEFIYDKAPYPSCHAVTIVEATNGDL
VSSWFGGTHERHPDVCIYVSIKPKGSDKWGEGVKVADGVMKEGPRLPTWNPVLYQIPGGD
LMLFYKIGPKPSEWWGVIRTSSDGGKTWSEAKKMPDGFLGPIKNKPVLLSNGTLLCPSSI
EGDGWRLRMESTPDFGKTWVMGDTLPRGKQKINAIQPSILFHKDGSIQAIGRTRNRAIFS
TFSKDNGKTWSDVELIGLPNNNSGTDAVTLKNGKHLLVYNHVLPPGTEAKGPRTPLNVSI
SDDGINWKAALVLEDSKISQYSYPSIIQSSDGMVHIVYTWRREKLKYVKIDPSKLKALPI
KNGIWPGDENKTVTAVKAEEE
>EGALAKHO_02528 hypothetical protein
MKKFLLHLTIIISLLTLSAKAQNKISVTNLQCEMLNNPEGIDVLQPRLSWQINADVNDVK
QTAYQILVASTLEKLNANNADLWDSGKVESNEAVNIIYKGKKLENRQDVFWKVTIWTNKG
EIKSNENAHFSIGILTYADWKSTRWIGYEKLSKEDSVSQYARLSARYLRKEINLKKQVKN
AKVYIMGMGLYELYINGNKIGDQVLAPVPTDYTKNVKYNVFDVTSQLKEGKNMLGTILGN
GRFFAMRQDYKPYKIKSFGLPKMALQLFVEYTDGTQDIIRTDDTWKVTTDGPILSNNEYD
GEEYDARKEMKGWNTTTFDDKNWEKARYVQEPGGFYEGQMTPNMKIMGEVKPISIKATAK
GTYILDMGQNMVGWLQLRVKGKSGDQVTMKFAESLQADGSLYIANLRDAKTTDVYTLKGE
GEEIWEPRFIFHGFRFVEVSGFPTKPTVDNFVGKVVYDDIKTTGTFESSDAIMNQIFKNA
YWGIRGNYKGMPIDCPQRNERQPWLGDRTTGAYGESFLFDNQTLYAKWLDDIKNAQTQDG
GLPDVAPAFWRYYGDNVTWPGTYITVADMLYQQFADQEVIKKQYPYMKKWMLYMEENYLV
NDLMDKDKYGDWCVPPESLELIRSKDPARLTDGGLISSAFYYQLLGIMKKFAKIANSDTD
IAHYTDLSERINKAFNAKYLNTSTNTYANNTVTANVLPLAFGLVPENLKEKVFQNMVHEV
EVTKNGHISTGVIGTQFLMRTLTNFGRGDLAFKLASNKTYPSWGFMVENGATTIWELWNG
NTADPSMNSQNHVMLLGDLLIWYYENMAGIKSNPETPGFKQIIMKPDFDAGLTYVNASYE
SIHGLIKSNWKKSKNNLQWDITVPANTSALVYLPTTTSSNVILNGKKIIAETYRIDGNNL
MLTLPSGTYNVSVKR
>EGALAKHO_02529 Beta-L-arabinobiosidase
MLQNFKYKIIAFIILITTLSSCKSGAGHSKSTAAILKQENYKHYVDYFNTMEDENLKFAI
PNDSAWTWMEKNIPLFECPQQNFEEIYYFRWWSARKHIKKTPQGYAITEFLVDRSYADKY
NMISCALGHHINEFRWLHNPQYLEEDVHLWFRGNDGKPMKKLRTFSSWTADALYNRYLVN
KDDKFLLDMFPDLAAEYAAWEGDRKRKDGLFWQFDVKDGMEESLSGARKFRNARPTINSY
MFGNATALAKIARLKGDTKQETYFEEKADTLQKLVETKLWNTKSEFFETFTEKDTLAQVR
EAIGFIPWYFNLPQKDKGFEKAWEQIKDEKGFSAPFGLTTAERRSPRFRTHGSGTCEWDG
AIWPFASSQTLTALANVLNNYDQNFVGKPDYFKQMSLYVESQYFHGRPYLGEYLDETTGY
WLMGERERSRYYNHSTFNDLVITGLVGLRPRADEKIEVNPLIPQEKWDWFCLDNVLYHGN
IITILWDKTGEKYHKGKGFRILKNGKEIAVSEKLEKLVSE
>EGALAKHO_02530 hypothetical protein
MKLRNKITAICFGIFSFAATAQSNSDLKLWYDKPAAIWNEALPLGNGRLGAMVFGDPAVE
RLQLNEETIWAGSPNSNAHNKSIKALPIVRQLIFDGKFDEAQELATQDIMSQTNDGMPYQ
TFGSVYISFPGHQKYTNYYRDLDISNATAKVKYTVNGVEFTREILTAFSDQVIAVKLSAS
KPGQITCNVFMNSPIDKTVSASDGDQILLSGIGTNFENVKGKVKFQGRLTAKNKGGEVSS
SNGIISINQADEVTLYISIATNFKNYQDISEDEVARSKGYLAKAENKDFESIKKDHIAYY
QKFFNRVSFDLGTNELAKKPTNERIRDFSKQFDPQLASLYFQFGRYLLISSSQPGGQPAN
LQGIWNDMVTPPWDSKYTTNINAEMNYWPAQVTNLQEMHEPFVQMAKELSVTGAETAKKM
YNANGWVLHHNTDIWRVTAPVDQAASGMWPTGGAWVSQDLWERYLYTGDKKYLAEIYPIM
KGAADFFLDFMVIDPNTKYLVVVPSSSPENTHAGGTGKATIASGTTMDNQLVFDLFTHVI
EASKLVSPDAAYVKKLSEALGKMPPMKVGKHSQLQEWQTDWDNPKDNHRHVSHLYGLYPS
NQISPIKTPELFEAAKQSLIYRTDESTGWSMGWKVNLWARLLDGNHAYKLIQDQLHLVTA
DQRKGGGTYPNMLDAHQPFQIDGNFGCTAGFAEMLMQSQEDAIHLLPALPSVWKNGSIKG
LVTRGGFVIDMIWENNKVFMLKVYSKIGGNCRLLLENELTTEHLTYVSKDGRQASSPQLL
GTKAYDVYKSRSEKGINIKKAKGKNPNPLFYDVEVKKPIISKEAKLSKVELPKYYEYDVE
MKAGQTFTFYGN
>EGALAKHO_02531 hypothetical protein
MMKIKIYIAVLFFGVTFANAQITSDENFRKPVSETLKKIETIFHVTITDDRGLLKGKELD
YADWRIEPGNLAISLTNILAPFELMYFKQPDGTYIIRKYENHKVSVDKGRERLDYLVTLY
SNVSQWEARKKEIKACMITSFGLDKAPPMPKSKPTLTPKRIYKDYSVENIGLEILPGVYA
TGSIYKPYPLNKKAPVILTPDGHFGDGRYRKDEQYRCAIMAKMGAIVVSYDLFAWGESLL
QFPEETHRNSIASTVQVLTGIRLLDYLSTQKNVDMTRVGVTGGSGGGSHTMFLAALDDRI
TVSAPVVMVSSHFSGGCPCESGRGIHLCGNGTNNAEISAMMAPKPQLIVSDGKDWTLAVP
ELEFPFIQRTYELYGKKDLVENAHFPKEGHDFGVSKRMALYPFMAKYLGLDLNKVKNAKG
EIDESTCVIETYDKLYVFGNKAENLPKNALKDIDKLYEMFGEKNNKIYEVKK
>EGALAKHO_02532 hypothetical protein
MVQLKIYKVKLLKNILLLFCLLITFISNGQIAAEHLTCEMTENPLAVIQKQPRLSWQLVS
KESNASQIGYQILVASSEEKLKNDDGDIWNSGRINSTKNLQISYAGSPLKTETKYFWKVK
VWNQTGKLSKWSKTAFFRIAPDESDLNPIWIGAITKADSHLPEGRIFHSATYKKEKKDAI
INASDSLSRRSIMLRKSFNVAKEIKEAVVYISGLGHYELTFNGKKIGNSEFAPLWTDYDK
TVNYNTYELSAEELEKGENVIGVLLGNGMYNTLAERYTKFFVSFGPPTLFFKMKVVYKDG
SEEIIKSDQSWKYSKSPITYNSIFGGEDYNANLEQKGWNLKGFKDSNWKAVVVQEAPKGV
LRAQTAPPITIQKRYDIKEVKELKPNFYVFNMGQNLSGFPTIKVKGKKGQTVRVWVGEGL
NDDGTIGQGRSGKPYYYDYTLKGDGVEEWQPKFSYYGFQYVQIENINYEKTEDKNLPTLV
DLKSNFIYNSAGEAGTFESSNVIFNKAHELINNSIKSNFQSVFTDCPQREKLGWLEEIHL
NGPGLMFNYNLESYIPAIMQNISDGQRENGLIPTIVPEYVVFGGDFTDSPEWGVTGVILP
WMYYEYYGDASLLEKYYPVMKKYVDYLGTKATNHILSYGLGDWYDYGTHAAGYSKNSPIA
LSATSHYFYGASLVAKAAKLLNKTEDIQKYETLTADIKTAFNKEFFNSETKQYGTSSQFS
NAVPVYMDIVEPQYKAAVMQNLLADIKAKGDRLTTGDVGNRYLFQALAQNGENEMMYKMN
NHYDAPGYGFQIKFGLTTLTEQWDPRKGNSWNHFMMGQIEEWFYQSLAGIVPDNKKPGFK
HFFIQPEVVGDMTFVKAIYKSIYGNIGSAWEKKDGKLILKVEIPVNTSATIKLPVSKNTE
IKINGKVAKNLELGSGKYTIECKI
>EGALAKHO_02533 hypothetical protein
MILLQNIKTNIITTAAILLACASVNAQNDTIRYVGKTLSNVDYHHGQLSPAVGVHATQIM
RASREHPEKADGFGWTYNHQPMMAYWNNTFYLHYLSDPSGEHIPPGQTFMMTSKDGVTWT
KPQILFPIYHVPDGFKKEGVEGVAKNLDAVMHQRMGFYVSSDNRLLAVGYYGVALDKKDD
PNDGKGIGRVVREIYKDGNYGPVYFVRYNKNGNPLPTTFPFYTKSKDKKFIKACDEMMSK
PLLMQQWVEEADRDDALIPLKKQYKAFNYYHLPNGNVVGLWKFALTSISKDEGKTWQYTP
TRAPGFVNSNAKIWGQKTSDNRYATVYNPSEYRWPLAISTSDDGLNYKDLLLVHGEITPM
RYGGNYKSAGPQYVRGIPETDGTPPDGKLWVGYSVNKEDIWVASIPVPITSEVKDNVNDV
FNNLPNGEELKLWNTYDLSWASTKIEKKTDGVKWLTLRDQDFFDYSRAERVIPFAQKMEA
TFTVKPEQNNHGLLQIEFQNKQGLPAIRLEFDSDGELKAKNGARFGGLSKYEAGKEYTIT
VKLDVTSRSYTVKVNDGKETNKIFYAPVDGISRIMFRTGDQRYTPNADTEPDTPDFTDLP
DTGKLIPEAVFNIKSLVTKKL
>EGALAKHO_02534 hypothetical protein
MKLVFNFKSMKKIFIIIILFLSTISYSQKKKEIYLFTSFREPATEGLYLAYSEDGYHWKG
LEGSFLKPDIGASKIMRDPSITKGADGTYHLVWTTDWKGGNGFGYASSKDLIHWSKQEYI
PAMKSEPEVVNVWAPEIFYDDVKKEYIIIWASTIPFRFEKGQEEEKNNHRMYYVTTKDFK
TFSDAKLYYEPGFSVIDCVIVKKGKKEYVLVLKDNTRPMRNIKVAFGKSPLGPFGKSSEP
FTAHLSEGPTVVKVGKEWLIYYDNYGEKNYKASSTTDFVHFEDVSSKISLPEGHKHGTIT
TISGEVLKGLIEKK
>EGALAKHO_02535 Polygalacturonase
MKIKSIIIVLFFITGFNTAFANDGWLNILNEGGNNKGIKCTEAIQNAIEKASKNGGGTIF
FPAGEYLTGALKLKSNITIHLDSGALLKFSDNFDDYLPYVEMRYEGLVMKSFSPLFYAKD
AENITITGRGVIDGQGKAWWNEVYRIETAKGPIPETKYQKMWTEQNKGIVYEPYYKRTID
KHFFRPSFFQAYGCKNILIEGVTFQNSPFWTINPEFCDNVTVTGISIFNPHSPNTDGINP
SSCTNVHISNCHISVGDDCITIKSGRDADGRKYGKATENVTITNCTMLSGHGGVVIGSEM
SGGIKKVTISNCVFDGTDRGIRIKSARGRGGVVEDIRVDNIVMKNIKEEAIILDLFYDKD
NAAEPVTERTPTFRNIHISNVTGGNVNKAGVVRGISEMPIQNISFSNINMDGKEGFTIIT
ATDIEFHDVKVNASVGSSFKISDAKNLILDNVGSSTPIKGVPVIKIDNASNIMINNNFPF
NATDVFIEAGGKETKNIFLKNNVFNNVNTVLKKGKDLDKKAITE
>EGALAKHO_02536 hypothetical protein
MNLKIKYLYALGLSLVLAAQSGYSQSAGKGALPKIKVSKNQHYFVTENEKPFFWLGDTGW
LTFGKLDRAGVDKYFKDRKAKGFNVVQVMVLHNLNAVNVYGSAALINEDVSKPFITAGNN
FNSKKEYDYWDHVDYTLEVARKNGIYLAMVPVWGTNVAKGNKVSKEQAIEYATFLANRYK
NKTNVIWLNGGDTHGNEFKDIWNAIGSTLKTNNPEQLVTFHPFGRTDSSDDYHTATWLDF
NMFQSGHRRYDQDSIKTNFKEDNYKFVLRDFELKPTKPSLDGEPSYEGIPHGLHDTLQPK
WKASDVRRYGYWSVLSGAAGYTYGHNAVMQMFRKGDKPAYGNKELWTSAINAEGAGQMVY
IKKLMEEVPFLEGIPDVSLVVNQGEKYDYIPAIRGEKYALLYTYNGRIIEVKPGKISGDK
FEAIWYNPRNGKKTKIGTFDNKGTQNFQPAGKKEDGNDWVLILRSK
>EGALAKHO_02537 hypothetical protein
MNFTQLKNTISLQKDKIILSGFAMLFSINIGIAQNTFPDIVKTKEGKLSFTADAKGNQIP
DFSYAGYMASEKAIPNVENKIFVPKQEADATERIQAAIDYVSNLKLNKSGFRGAVLLDKG
TFKISGTLFIRKSGVVLRGSGNNENGTILLGTGLKREAIIRILGVDDKKLSETFEFNTTY
TPLGTIKIQLKNTSKLKPADEIIISKPLTDNWIKELKMDDFGAETGWVGWKKNDWDISWN
RVVAKINGNEVTLNAPLTMTLDDTFGTAKVTAFTWAGRIEQIGIENMLLKSTFDQSKPKD
EEHRWLGISIENTRNAWVKQVSFKHFAGGAVALLKSAQQITVEDCIATEPVSEIGGFRRH
TFYTEGQQTLFQRCYSEYGYHDFAVGGFGTTGPNAFIQCESHLPFNNSGAIGSWATGVLF
DIAYVDGHALSYNNREQNGRGAGWTAANSVIWETSASKIECYNPPTAQNWAFGTWGGIMA
GDGHWKDVNGHISPRSLFYAQLETRLNQLPVKPFIYDLGSEPSSSPEVAVAQELTKNSVE
RKENLLEWIAEVSKVNPIDINNSGLKNANDLKINSAQNNSSATKVVTQNGWLIYDGKVIA
GNRLSVPWWRGSLRDSDISKSLPDVTRFVPGRTGTGFTDNINDVSDYLSTNNMVALEHNY
GLWYERRMDDHERVRRFDADVWPPFYEQPFARSGQDFAWDQLSKYDLTKFNDWYWDRLSL
FADLAETKGQLLVNQQYFQHNIIEAGAHWASSPWRSANNINSTGFPEPPPYAGDKRIFMA
EQFYDVNNPARRKLHQGFIRKSLENFQDNSNVIQLTSAEYTGPLHFMQFWIDEVQKWKDE
TGKKGIIGLSATKDVQDAILNDAQRAKTVDAVDIRYWYYKEDGSAYAPQGGLNLAPRQHA
RKLKVGKETDDQVYRAVREYREKYPEKVILYSTDGSPRFGWPALMGGASLPNIPKIALPE
FYSALSQMKLVEGNTFSDNIWTLENKGNSYLFYIKNEKEVSIDLSAYKGDFEIYAINAAT
GTSTKKANIKGGKNVTIPASEIKEKVLFIIKK
>EGALAKHO_02538 hypothetical protein
MKKNFPKTNLKRTMMLMSFCSFFSAAYAQYPEIPKPLQDKTDAILADEEKRLAEIWTANY
STIQAEAKLGRPYLPWASYPKDFVHADIPAFPGAEGGGAFTPGGRGGKIFVVTSLEDSGK
GTFREACEAVGARTIVFNVSGIIRLKKRISMRAPYVTIAGQTAPGDGICIAGETLEIDTH
DVIIRHMRFRRGETDVTRRDDALGGNPIGNIIVDHCSVSWGLDENISLYRHQFAANDKSK
LEKLPACNITIQNTISSEGLDTYNHAFGSTIGGLNSTFMRNLWADNISRNASIGMYGDFN
FVNNVIFNWWNRSLDGGDYRSMFNIINNYFKPGPITPTDQPIRYRILKPESGYMKPKTYG
RAYVDGNYIVGSPEVTADNWNGGIQLEDQSEAETKEYLELIKQPKAFSMPNITIMKAEEA
YEFVLKNVGANLPKRDAVDERILKQVRTGKIEVKDGLENSIGKEFIKRRLPADSYKKGII
TNPNQVGGYPEYKGKAYKDSDNDGIPDAWEKKFGLNPNDASDANKDSNGDGYTNLEKYFN
GIDPTKKVDWTKFENNTDTLSKVLLQ
>EGALAKHO_02539 hypothetical protein
MSKSKLNISVLMLLLVFFNGIAQQHLDPEYIKVTNERASKIVAKLELANPAKEKAVTDII
AQQFRDLSEIQDGRDAEIKKIKEDTTLAKEKQNEKIDKLKSKADTAIEKLHKSYLKKLGT
QLSEDKIIAVKDGMTYGVVEITYAGYQDMLPALTKEQKEYIYTNLVEAREHAMDGGSSKE
KHAWFGKYKGRINNYLSKQGYDLNKESADWHKRVEEREKNKKKE
>EGALAKHO_02540 hypothetical protein
MKNFTLSASFLLFLGSFQCFAQYPKISPEVQAQSKVIMDEAEKRSDEAWEKALVVIEEEA
KHGKPYIPWASRPNDLPQAEIPSFPGAEGGGMYTFGGRGGNVYTVTSLEDSGPGTLREAC
EKGGARTIVFNVSGIIRIKSPLIIRAPYITIAGQTAPGDGICVAGESVWINTHDVIIRHM
RFRRGETFVGRRDDAIGGNPVGNIMIDHVSATWGLDENMSMYRHIYSPGPGYPDVKVGTV
NITIQNSLFGEALDTYNHAFGSTLGGENCAFIRNMWANNAGRNPSIGWNGIFNFANNVVF
NWYNRSTDGGDYTAIYNIMNNYYKPGPVTDLNEPISYRILKPEAGRSKLPYMVFGRAFVS
GNIVAGNDKVSKDNWDGGVQIENKKGELMTFDESKTYFDKMRSDKPYPMPWFHPFMKADE
AYEYVLKNVGATLPLRDKVDERIVRTVKTGVPEYAKGLEKKEFYQFEHRRLPMDSYKKGI
ITDISQVGGYPEYKGKPYVDTDKDGIPDKWEKKHGLNPNDPSDARLDSNNDGYTNIEDYI
NGIDPTKKVDWKDLSNNQETLVKPLQE
>EGALAKHO_02541 hypothetical protein
MKTKFNKYIALALVLVLGVSCSDNFLEDVKPIGQYDDSFYQSQARVQAYVDNQYFDFFAA
FKGPTASVVGVYTDANTKLTEELGGVQDYTNPSKILNTPDVAKDYFGAKIGTGIVNNAYT
RIRECNNLLEDIDVKGASLDKTFRDRAKGQMYYLRALQYFDLMRTYGGVPIVTSVMQPSV
DDESIKLPRAKVSEVVAQIVKDFDMAASLLPGDWDSSNYGRFTRGAALAQKSRVLLTYAS
PLFNKSWDSANDRWQAALDAGLAAENQLTQDGYGLYGASIKDWDNMFLIDNLKCREAITV
QLLSNANSDVNFNVNNNWEKTIRLPSQGGTGGVSAPKEMIDLFPMANGSRPTAANGYNDF
TFFVNRDPRFYRTFAFSGEKWAYKENTNAVLWSYRWVDAANKAYFNDLNTTSTSPAFVRK
MTNTTATNATNYQYSPTDIMEYRYAELLLNIAECYAALGQTTNTLAYLGKIRARVGIPSA
NNYGIGTLADKYAAIEAVLYERRVELAYEGKRFWDVQRWMLYDNAALPGTSGGTVSKLGL
APINGTQRTGNYLQFKSPATAADPLATLRASVIADPDAANFQAQLTTLAAFYNTNFIRTT
LVTPMDNVSGAAVKIKFNPNYYISGLNTTALTSNPWLVQTIGWSDNTGGAGTFNYQE
>EGALAKHO_02542 TonB-dependent receptor SusC
MTNQNKTFMKQTLIKRCSFLLFMLMSILASAQSSSDVTITGTITDDLGGLLPGVNVTEKS
SKNTVTTGFDGQYKIKVRAGATLVFSYIGMKKAEIPLAGRTKLDYKMQSDSNQLENIVVV
GYGTQKKKELTGAIATIKPDDLMALPVTNLSDALKGLVPGLSVSGGSGRPGDAATIQIRQ
TFGFSKDGNSTIPLIVIDDMVQVDPATGKATLDAFNRLDPSEIESITILKDASAAIYGSR
ASQGAVVVKTKRGKAGKAKFSYNSQFVVNDAVSHTKTMNAYEFGVFNNRFLTGQNPTIAP
ASLFSAAELEEMKGLDYDWLKEAWKPAIQQKHSFNISGGSEDITYFAGATYLTQDANLGY
QKYDKWNYRTGINAKIAKNLDFSASISGTTAFIDKSFTKASANISDGGYGTTSGGEQADY
GYLVHMPKFIPWQTTVDGKSYYMSPFPNTNKNFGSANANNTIAGWNYFANLDNGSHQTTD
DASFNVNASLNYKVEAIKGLSFKATFARTNNSTYSEQIQLPYDLARITNYQLQDNHLASA
AYPSTTVKNPEVGGMIDYAIETNVRNSRVYYNSNFSKSTQADFFANYNRTFGSHQISAMF
GAERSESEWQSTRLAYINTPKDYLGDWRTAGTVDTGNSTALKGNNATLSYFGTLNYNYQS
KYLVQFLIRSDASTKFAPENYWGTFPSLQLGWVASKEAWFEKHLPAVNFFKIRYSIGKTG
KDNLQPWKWYQFYDLTVNKGWGFGPNVGGAGGGVLTSGLTPKVNPNRDAKWDSTLKNNLG
FDLAFLQNRLQFTADFYYDVTKDMLTDMGSATGVPISIGGAFAEQNYAHVDAWGSEFSIN
WSDKIAGKVSYDIGVNFAYGDNKIVKYPDQGNLLPSNNTRREGYSEGFNPVWGFKTWKET
STGDGILRTDQDITNYWNYLSQNATAAGGTPSYLGITDPTKIQKGSLAYQDVAGVLNADG
TLTGPNGQILVGNDYAKLANSSRTYGFTTNLGMRYSNLSVRTQISTSWGGANFVDLVSQA
TSSASNMWAREPFWNDMYGTDNPNGKYPNLAQTNVLSPSDFWQISTFRCFVRNLTVAYDI
PKQALAQTKLQNISVGITGNNLWDFYNPYPDHYRNMYDNSSVGYPTLRSWSFNLNVSF
>EGALAKHO_02543 Non-reducing end beta-L-arabinofuranosidase
MSSFAQNKGLVANSNSPYSKLQSVSLEDVKWTNGFWKEQFDVETKSTLPYMWDLYHNDSI
SHAYKNFEIAAGESKGTFKGPSFHDGDFYKIFEGMAATYAVTKDKKLDAEMDQAIALFAK
VQRKDGYIHTPVLIDERWGTLGPEEVKKQLGFEKYNMGHLMTAACVHYRATGKTNFLDIA
KGVADYLYDFYKKASPELARNAICPSHYMGIVEMYRTTKNPKYLELANNLIDIRGTTNDG
TDDNQDRIPFRQQTTAMGHAVRANYLYAGVADLYAETGEKKLLDNLESIWDDVTYRKMYI
TGACGALYDGVSPDGTSYNPTDVQKIHQAYGRPFQLPNATAHTETCANIGNVLWNWRMLQ
ITADAKYADIVELALYNSVLSGMSLEGTKFCYNNPLNVSKDLPFKQRWSKQREGYIALSN
CCAPNVTRTIAEVNNYAYSISKEGLYVNLYGSNSLKTILPNGEKIEIEQQTNYPWDGKIT
LKIVKAPKEVQSFFLRIPGWSQHATISINNQKLNNAVVSGTYSKINQKWKKGDVIELNIP
MPVELMQANPLVEEIKNQVAVKRGPIVYCLESDQLPVNININEVILNANSTFTTNFIEIN
NRKLLTINATSFLNQDGSWDKKLYQPLSVNKSPAYNLKLIPYFAWGNQNHDAAEMTVWMS
H
>EGALAKHO_02544 hypothetical protein
MIKKLLSAAVLSMLLTTNGQAQSSGKTAEKQIVKVDFDFSGRRAEEVSDPHYNSWPITEQ
TEAEKSFNNVKFKLKGNFSSKWFKVGMNAPFYGRLTSDGLFTDKSLELTISGLKAGQHSL
LTFHNTFDKIEGKSYAPVKIFVNNKLVETVTSTNRATSAIEAATAYIEFNAQTGKNVVIR
FELDSKDANLIQQMVINGFEIDTPNLKKQSHTPKPENGDEHVVLGDKFIMNWEASKEAVA
HKLYFGTNKNAVTAATDKSPEFKGKQTDTKFAVADLYSLTTYYWRVDEVDAKGNTTLGTV
WSFKPAQLAFPGAEGYGRFAVGGRGGRVVEVTNLEDSGPGSFRAAVNDGEGPKTIVFNVS
GNIKLTDRLVVNNPYITIAGQTAPGEGITISRAPVGLTGNDGVIRFLKVRIGGGKTYDGM
GLTGANHSIIDHCSISWTIDESFSSRGAHNITLQRTLISEALNVAGHDKYEVGKMHGFAA
TIGGDVGSFHHNLLAHNYGRNWSIGGGLNGDGYYTGRLDIRNNVVYNWGQRTTDGGANEV
NFVNNYYKPGASTKYFFALNAQHEGVGKGTQRYYFDGNIMQGYFDEKNQEKGRTSTISHN
EIVKYETFVDKPFFESYVKTESAVGAYKNVLSDVGASEPFFDKHDNRVIDETLKGTFTYK
GSKSGLGGMIDSEKDLGDLGEYASEKRASDWDTDHDGLPNWWETAKGLNENSKAGDFADT
NLDADKDGFTQLDEYLDWMAQPHFFIISGEKKELSAADYFKGYEKTPVYTFSDLKNGKVV
LKGKDIEFTAIEKGFASVVITVKDADGDSMSRTINFFVK
>EGALAKHO_02545 hypothetical protein
MLLAKAQTPVLENYNPVWNTQSNNSAESMPLGGGDIGLNVWVEKGDLYFYFSRSGTFDEH
NTLLKLGRVKVTLTPNPFTDNEGFKQELVLKDGYISIAQNNTQIKLWVDVFKPVIHLDLE
SKATLKMTASYETWRHFNRPSKGKANNANSYKWAPQGEIFTFKDSVSVQNNGIQFYHRNR
EQTVFDVAVKQQKMESVKDQMLNPLANLTFGGFMTGSNLMSDGTYSGKYQDTDFKGYSLS
SIKPSKKQNLQIHLFTNQSSQQSSWENGLKNQISDYKINSKKAEKNTVNWWNNFWNRSFI
YTQKNNVAEKDSVYQIGKNYQLFRYMLGCNAYGKYPTKFNGGLFTVDPVFTNPDLNFTPD
FRNWGGGTMTAQNQRLVYFPMLKSGDFDMMKSQLDYYLSLQKNAELRSKVYWNHNGAAFT
EQLENFGLPNPAEYEWKRPADYDPGMEYNAWLEYEWDTVFEFCQMMLQQKEFAKEDIQKY
NSFIISCLRFFDEHYQYLAKQRGRKALDGNGKLILFPGSGAETYKMANNSNSTIAALQVI
TEKLLNLSSEQLSREELEYLKGFQTRIPPLNFGTIENHKVLVPAKSWERVNNSEVPQLYP
VYPWGIYGVGKPDLETALNTWNYDADAIKFRSHIGWKQDNIFAARLGLTEEAAKYNLLKM
SDSGRRFPAFWGPGFDWVPDYNWGGAGMIGMQEMLLQEANGKVYLFPAWPKDWNVHFKLH
ATQNTTIEAELQNGITKIIKVVPQEREKDIINLLGISIEQKKKLD
>EGALAKHO_02546 hypothetical protein
MKDFKHIFIALITLLASLQINAKIKLPALFSDNMMLQQKSNAPMWGWAEKNGNLTIKTSW
NSKIYKAKADAQGKWKVDLQTPVAGGPFTIEVTEGTEKIIVKNVLIGEVWLCSGQSNMEM
PLKGFQGQPVKNGNEIIVRSTNKNIRLITVPRATVLEPLTDFEGKWEVASPKSTSNFSAT
AWYFGSLLQNVLDVPVGLIHVSYGGSSMEAWMNQEMLKDFASAKIPTTKEELAKDPNRVP
TTLFNGMLSPVIGYGIKGCIWYQGESNYERAAEYKDLMKKMVSSWRALWKQGDFPFYYAQ
IAPFNYASFHPKDYLDKYNSAYLREAQLKATKEIPNSALAVLMDIGEENSIHPMDKEKGG
SRLAYQALARTYGIEGFEFESPKYKSMEIKDNSVTVSFDDVANGITSYEKEVTGFELAGE
DKIFYPAKTVVRRKSVVLTSDKVAKPVAVRYLFKDFAKAELFSAGGLPVSSFRTDEW
>EGALAKHO_02547 hypothetical protein
MFQKKQFFLFRIDFRLSAFRLSTVLLLLVGFVSAQELHKKETTEFQPTIESSKPWVYWYW
MKSAYSKAGITADLQAMKQAGIAGAYLMTIKGPANPPLIDPPVLQLTPEFWDMINWAFKE
ANRLGLKMAFHGADGFAVAGGPWITAEMSMQKIVWSTTEIGGGKTITSKLPVPEHYKDYY
KDIATFALPIKQYQTNSQLQLPKVTTSNNTDASFLADPKKDENFKFAEKGWIQYEFDQPF
TCKSIVIETKGRDFQAQRLIVEVSNDGINFKFHERLIAPRHGWQDMDYAHTHVITPVTAK
YFRFVYDPVGTEPGAEDLDFAKWKQNLKVSKITLSNQALIDNYEGKSGAVWRLSPETSSK
QIPNSESFKKSEIINITNLVDSDGNLNWKAPKGKWKIIRMGHTSTGHENATGGAGKGLEV
DKFNPELIRFQLDHWFGEMVRTIGPDLAAKTLEILHFDSWECGSQNWSSVFQAEFQKRRD
YNLVDYLPVMAGIPIESADVSEKILYDVRKTIAELVADNFYGTVAQIAKENNVKLSSENV
APVVTSDALLHFKFVDYPSGEFWLKSPTHDKPFDMMDAISGGHIYGKDIIQAESFTALRM
DWDEHPGNLKTTADRNYALGINRLFYHVFVHNPWTDRKPGMTLDDIGSFFQRDQTWWKPG
KAWFDYCQRVQLQLQKGKPVIDLAVFIGEDFPSRSFVPDRLVPFIPNVFGKERLESEKIR
LENDGQPTTKMPKEVTYSKNNTDLSQWINPLNGYQYDSFNADVLINNAKVENGKISFGGG
IEYGALLFPGSHKMAPNKMISLAAAEKILQLVKEGATIFVDEKPDLQPGMHSNEEHEKWQ
LVIDEIWTNNSNASTWKIGKGTIIKLPYLGNDFASIGIEQDIYFPKLNRADSETIAWTHR
KSNEEEIYFLSNQKGEKRSFEASFRLTGKKPQWYNPVTDKTSALSNWKMDNGRTIVAISL
AENESGFVIFKDNNEMISVRGTPSISKFETVQTLDENWELQFDSEYKGPKEVVKINKLFD
WSTSTNDQIKYYSGTVIYKKDFVWKGKTNEGFWLDLGTIANIAEVTVNGINCGTIWTFPY
KADISEALKKGKNTIEIKITNTWANRLIGDEKLPKEERLTWTTAPFRLQEGILLKAGLLG
PVKIVKKLNSVQL
>EGALAKHO_02548 Beta-galactosidase
MSIHIHQFFRFRFSIQSFLFTFCILLLTSNIHAQSVTGEPAGIPEVPKKYEFAPWEDPTV
TSINRQPSRATAYSYTNVEDALKGDRTKSRMKMLTGDWDFKYASNLKEASKDFYKARVAG
WDKIEVPSNWEMKGYDIPIYKSAVYPFRPINPPFIPKDYNGVGSYQRTFTVPENWKDMTV
TLHFGGVSSGFQVWLNGEFLGYGEDSCLPSEFDITPYLKEGENVVSVQVIRWTDGSYLED
QDHWRVSGIQREVFIMAEPKLRIQDFFYQTKLDKEYKDASFQLRPKVENLTGEKIKDYTF
QAQLYDANNVALFKEPLQKPVIDMINESYPRLDNVRFGMFKENIANPKKWSSEEPNLYTL
VMSIKDASGNITEAKSCKVGFRSIEFSKENGKMLINGKETYVYGINRHDQHPTKGKAVNR
EDIRQDITTIKKFNFNFIRTSHYPNDPYFYELCDQYGIMVMDEANQETHGIGGKLANDPK
WTNAYLERMTRMVERDKNHPSVIFWSLGNEGGKGPNHAAMAGWVHDFDITRPVHYEPAQG
NPRLEGYIDPLDPRYPKTIDHAYRFENPQDEPYVDMVSRFYPGVFTPKFLVDQKKDTRPI
IFVEYSHAMGNSVGNLKELWDEFRSLPRVIGGCIWEFKDQGLVKKDPATGQEFFAHGGDF
GEKYHDGNFNTKGIVDSNGKPKGSIFENKWIYQPATSTLKDNFQLEIKNRQAVKSLADYI
PVLKILENGNVIKTQILKPFNLEAGQSTVLDVKQYLPKLKKDAEYFLNIEFQLSKDELWA
SKGYAVAEDQFLLKKSDVVLDFKNEKDSKFKTTETDSDFKIKGKNFDINISKTNGALNSY
VFNGEEQVFAPLLPNFVRPLTDNDKRGWKSNKVLKPWYQAKPKLVNTKMAITTDVTIITS
DYEVIKDSAQVQVVYKINENGIIKVDYSLKATNKLPNIPKIGMQMGVQRKFDQISWYGKG
ELENYIDRSFGSFVGKYSLPINDFLEHYVKPQENANRTEVRWMAFTTPQKNKGLLVVDDA
KVLSMSAWPYTQENLSAAKHTFDLKDPGFLTVNIDLIQMGVGGNDSWTAVAQPLEKYQIK
SGDYQYSFYLAPFSAAKNGLEESLKRFKY
>EGALAKHO_02549 hypothetical protein
MKIKYLIIAITTLLISSCTTTKYKKREINETVMQEIYNEIKTPYKYGLVMVPTDNSYKMD
CPSVFRKDGKWFMTYLIYDGRGYETWLAESDDLLHWKHLGKVMSFSENEQHWDVNQKAGY
ISLQDPTWGGSYEWEKYDDKYWMSYFGGNTKGYEAGVLSIGMAYTKESPTKPHEFQRLEN
PVLTPKDKDTRWWDNSTMYKNSVIRDKDKVTGHNFIMYYNARGDSINPAKGAERIAMAVS
NDMEHWERYGNKPLINHHKGISGDAYIQRINDTWVMFYFGAFWTGWNQGAFNRFAVSNDL
VNWTDWKGDDLIKSSESYDNMFAHKSFVVKHDGVVYHFYCAVNKAEQRGIAIATSKDLGK
SEMNFVAPPEKKEKK
>EGALAKHO_02550 hypothetical protein
MFSKNTKYNFKLKIAFLALFLLCFQFSVQAQNPTWKPAPFEVVNKYKTFKTTQYAHVFSG
SKHNIVRLAPELQGLTGIELPLDQYKNATNTPLKLKFKENVQILIGVFQEKENPEYLQFN
NSAKAKLILENGVTITGLSPVNVYAISFPKGTQTINPGKGLFAILGVVKESQKLESRNAE
LPDGKLWNPTFIVEGFSDEKPLFEIIGGENKPVIDEGMSGTEEIQGGFEGGRVVKVGDTY
HMFPTERAGEKGVDYYYDRVKTRIGHWTSKDAIHWKRESTIYQASGTYAITEDDNPMNDR
RAAIWSYMPVFNEKANKWYGYYLAYTVSKTIEPNHSFGRIWRCESTVDGIEGIGGPYKDM
GIIMEPGLDSQPWEGRQGVASFFPYKVGDKYFGFYSGAYPFASWADYPKKSGKGWFVALA
ESKSLEGPWQRMNKGLEPIKSMHPQFVENPIVSQLPNGLYIAIFDGGPDGWGHHLPNMIG
YSLSKDGINWGKARYLPIETKVDKWWDIMRTPLCLIPEGNDVYTIVYNAIDLKRRFHPTG
MVKVKLNKDVMESRLKELK
>EGALAKHO_02551 hypothetical protein
MLNRFLTFKIFLVLSVLFSSFLFAQEKPKEATWIWYPGDFEVWLSNKMQVRRTEREAVFP
PLWQYYSPYALVTFQTEVDIPEPDEVKIYSEGSFQLLLDGVQVYGQPKSLKVPAGKHKIS
FKVYNQEVLPAIYIDGKYVKSDPSWKVTNEDKLWIDENGKAQQSGTPWVPVGSWNFYSPE
NKPSGFKLTTKPLSAKKTEKTGAGELVDFGKETFGYIKIHGLKGKGKVALYYGESREEAL
DTAKCETLDHLSFDGNQLETYTHNGSKAFRYVQVQADATVKYDSISMLYEYLPLDYRGAF
KSSDEQLNQIWDVSAYTMHLTTREFFIDGIKRDRWVWSGDAYQSYLMNYYLFFDSASVER
TLLALRGKEPVTAHINIIMDYSLYWFVGVYDYYLHTGDTKFIKTFYPRMKSLMEFCLERR
NANGFLEPLEGDWVFIDWANGLPKTGEVSFEQMLLARSLEAMAVSAKIAGESEDQKQYQK
LADDLKTKLFDVFWDKKENVMKHQRINGKIQDIVTRYANMFGIFFNYFNEEQKQSIKKKV
LLNDNILKITTPYMRFYELEALCAMGEQDYVLKEMKNYWGGMLKEGATSFWEEYNPTKKG
TEHLAMYGRPYGKSLCHAWGSSPIYLLGKYYLGVKPTAPGYTEYEIKPNLGGLQWMQGKV
PTPNGEVELYCSTKEIKVKAAEGEGKLIFESASKPKTNSGTITTLAKNKYQLIVKPNVEY
KVSYKAI
>EGALAKHO_02552 hypothetical protein
MKTHFDIEKIIEKGVITNELDYDRALVADRKLRLLAKENLHFKNLRSKLRDIIEKYEKSE
WSDVEKIDDNKVLESDKSERLAELERLFLENRKQVIRKKLKELELTQENLALILGHKSKT
HMSELMNGIKPFTLRDLIIINRVLKIEIAVLIPVFLSIEDQIRVKEAVVKLGKPKVKLTS
NDLVLS
>EGALAKHO_02553 hypothetical protein
MRIIGKKTILKIKKKNIGNKKLGAEIDKLIIDLENFNPDEKNINDIRNDADCVHNEGFYF
FNISIHRTLIMIEFDDDGEATIVWAGSHQEYESTFRNNKLTIEKWLRKNGYIK
>EGALAKHO_02554 Sodium/glucose cotransporter
MNSIYDKLTTLDFIIVAVYLVALLIIGYVVSVKQSKKNETLFLAGNSLKWYSIGFNMWGT
NVGPSSLLAFASIGYATGIVAGNFEWYAFVFLLLLAMVFAPRYIASKVSTMPEYMGKRYG
DSTQNILAWYALVKILVSWLSLGLFSGGILVRQILGIPMWQSVTVLVIFSGIFTFAGGLK
AIAKVNVFQMILLIVVSLTLSYLGLQKVGGISALIAKTPSNFWNLVQPASDAHYPWPAIL
LGYPVAAVAFFCTDQSMVQSVLGAKNLEHGQLGVNFIGWLKVLALPLFILPGILCYVLYP
ELGKNSDLAYMTMVTNLFPSGMNGLVICVMIAVLVGTIGSSLNALSTVFTNDIYVKKINP
TATINEQIKIGRITIAAGCLFAILIAVAIDNIKGQNLFNIFQAVLGFLAPSLSVVFLLSI
FWKRTTKKAVNATLSWGSAFSLFVGVLYLWIFPADKYPVWPHFLLISFYIFATLLIAAII
ISLADKNPEINFSDETDIPKTSKKVKLLFAFLGIVILSLYFIFNGN
>EGALAKHO_02555 Putative 4,5-dihydroxyphthalate dehydrogenase
MAINNYQKLNKPMLKIAILGLGEGRSTMSAALKSAKLELVKVCDRNEELCKQRAKEFDFH
SYTTNYDDLLNDSAIDIIAIYTPDHLHADHIKQALLHGKHVVCTKPFIDNLADAKELLAL
SEKTGKKVFIGQSSRFFEPAKRQRNDFEAGLIGDLITIEAHYHADHRWFLEKEWSLLQSF
KWLYGGLSHPVDFIRWYLPNIEEVMGYGMISSNGSVAGLKNEDTMHFIFKATDGRIARVS
GVYTSPTQPAQRDSGMSTILRATEGASQADYHELRYAITDKTGEEKVITWGDATLKHYFR
FEGQSHHAGEYQNYLEYFVDSIEQNFTAYPDMKEGIGTVALLQAMDKSLQTGMPVKIADV
LKEYEL
>EGALAKHO_02556 L-fucose mutarotase
MRLHTVNKLLVIFLIICSVFSATAAEIWVSTSGKDTNPGTKESPLATVSMAMRKARELRR
LKDSSIKDGIHIIVTDGTYYLNEPLFIRPEDSGTSESPTTIEADVNARPIISGGLEIKNW
KKGAIVNGVKKANVWVADAPQKAGEIINYRQLWVNGKKAVRAKSTAGNQMDRILSWDAKT
ETCWIPFKDKSIKYEPGMEMFIIQWWSTANLRIKNIEVQKDSARLSFEQPESRIQSEHPW
PAPWISKNNGNSAFFLNNGISMLNEPGEWFLDKKNAKIYYIPRAGEDLASAKITVPVLEN
LVEMKGTIDSPVHHFNFKGISFQYSNWLRPSQQGHVPLQAGMYLLDAYKLQVPGTPNQAN
LENQGWVGRPRAAVEMNYANNNQFESCRFEHLSSTGLDFNKGTNHNIIKGNLFKDIGGNA
MSIGVFSEEAFEAHLPLVIKDEREICSYELIADNLITNVANEDWGCLGIAAGFVKNLTIE
HNEISDVAYSGISMGWGWTHTKNVMENNKIIGNKIHHYAKHLHDVSGIYTLSSQPNSRIE
ENYIDKVYFSPYAHDPFLWLYLYTDEGSQGFTIKNNWIATEKILKNNNGPEGNVWENNNP
YVSTKIKEAAGIRSPYAALTKEVIVDEASSLQELPKSVAIEMIGSDFDIEKVKSTIKGFR
IVGESIYQWKNHLVIYGKMNQPERTKKKLALAYPSAEIKIYEKPIYDFQNFERCKDSKPA
SEWENIVLTANLVNDEKLQKEYVDYHMTQFEKWPEIAKGFCNADFQQLQVFKNGRQLMLV
ISIPKGENLDKLNPKTTENNPRVDDWNALMKKYQTGIEGAKPDETWIFLNKIETK
>EGALAKHO_02557 Dihydroanticapsin 7-dehydrogenase
MSNTTTHTNFKHVSYLWDESKAAALAGDEVALFIYRSNLLGADLRLTNYGGGNTSVKITD
KDPLTGESSEVMWIKGSGGDIGTLTKSGCAALYLERLRNLENVYRGIEFEDEMVELFNHC
IFDLASKAPSIDTPLHGFLPFKHIDHLHPDAAIAIAAAKDGAKITEELFDGEIGWVGWQR
PGFDLGLQLRSCLEEAEKKGKKLRGIMLGSHGLFTWGDTSYDSYINTLEVIEKCATYLED
NYGKKRPVFGGQKIQSLEVAERRLKAAKVAPILRGFCSSERQMIGHYTDDARVLEFINSN
DLEKFAPLGTSCPDHFLRTKISPFVLELDPNEDLSDVNAIKAKLQPAFEAYRAMYKDYYN
ACKKSNSPAMRDPNPVVILYPGVGMFTFAKDKTMARLASEYYVNAVNVMKGAEAVSEYTS
LPHQEAFDIEYWLLEEAKLQRMPKPKALSGRVALITGSAGGIGKAIAKKFAQEGACVVIN
DINEERLEEATKDFIRSFGKDAVSSTLLNVTDEKSTEKALDEACLAFGGVDIVVNNAGIS
ISKSIAEHTLEEWDRLYDILVKGQFIVSKAGIEVMRKQGFGGDIVNIVSKNAVVAGPNNP
GYGSAKAAQAHLTRLMAAELGADKIRVNTVNPDAVISDSNIWSGGWAEGRAKAYGITVEE
LPAYYAKRTLLNEIILPDDIANACFAFVGGLLGKSTGNALNVDGGVSMGFYR
>EGALAKHO_02558 hypothetical protein
MSKRIDAHQHFWKFDPVRDSWIDETMQKIQRDFLPEDLLPLLRENQFSGCVAVQASQSED
ETNFLVNLGAKNDFIKGVVGWVDLRGVTIEEQLNHFSSYKKIKGFRHVVQGEADDFMLRK
DFQNGIVALKQFNFTYDILIFHRQLPAAINLVNQFPDQPFVVDHIAKPDIKSGDIASWKK
GITEISKAENVLCKISGMVTEADWKNWKTDDLKPYLDVVFENFSADKLMYGSDWPVLNVA
SNYTEVVKTLEDYIAQLSSEDQNKIWHKNATSFYKL
>EGALAKHO_02559 Dihydroanticapsin 7-dehydrogenase
MDLRLKDKIVVVSGSAGKQGSIGETIINRLADEGAIPVLVDRNSRGFGYAEALQKKGIDA
LFVQTDVTDPVEIENAVKTIVAKYGKIDAVINNVGVNDGAGLDSTYEEFMNSLKLNVVSY
FLLVKYALPYLKESKGNILNIGSKVALTGQGGTSGYAAAKGGVLGLTREWAVDLIQYEIR
SNAIIIAESYTPAYEDWIKTVPDGEAVLKKINKSIPLKGRMTQTEEIADTALFIISDRSS
HTTGQFVFVDGGYVHLDRALINDVN
>EGALAKHO_02560 L-galactonate-5-dehydrogenase
MKFIVCEKPQEFILKEKAIPEPKEGEVLLKIKRIGICGTDIHAFGGTQPYFEYPRILGHE
LAAEYVKGNAKGFEPGDKVTFIPYFNCGKCVACRNGLTNCCVNIKVFGVHIDGGMAEYVT
IPEQYLLHGQGLDYDQLALVEPLAIAAHGVRRAAVKPTDTVLVMGAGPIGIGLIQFAKIA
GAKVIVMDINEYRLGFCKNELNADETINPLHDDVAQKLAEITNGDMANVVIDATGNQKVM
NSAFNYISHGGRFVLVGLQKGELSFSHPDFHKRESTLMSSRNATIEDFEYVMECLKNGKI
DPKKYITHRTNFSEMISDFGQLIDPKNNVIKALIEID
>EGALAKHO_02561 Ureidoglycolate lyase
MKLIRFGEIGKEKPGVLIGEKRYDVSSIVTDFNESFFEENGLEKLQKALDSNPTLPEVGA
NVRLGSPVARPSKIICIGLNYVDHCKETGAPIPTEPIIFFKSTTSLCGPDDDLIIPKNSE
KTDWEVELAFVVGKKASYVEEAEALDYVAGYALLNDYSERAFQLERGGQWAKGKGSDTFA
PLGPFLATKDEVKDVDNLSMWLTVNGKKFQDSNTLNLVFKIPFLVHYLSQFMTLLPGDII
STGTPPGVGLGIKPDPIYLKAGDVVELGIEGLGTSKQTAVAYSK
>EGALAKHO_02562 2-(R)-hydroxypropyl-CoM dehydrogenase
MFSLKNKKAVITGGGSGIGRAIATLFAKQGAEVHIIDLTIESAKDTLDEILKEGGTAFSH
ACNVANQEEVSATFEKIGNINILINNAGIAHVGKVDTTPEADFDRVMEVNVKGVYNCLFA
AIPQFRLSNGGVIINMASIAAWVGIPDRFAYSTAKGAVMAMTLSVAKDYIKENIRCNSIS
PARVHTPFVDGFISKNYAGKEEEMFEKLSQSQPIGRMGKPDEIAALALYLCSDEAGFITG
CDYPIDGGFIKLNN
>EGALAKHO_02563 hypothetical protein
MTILKGITWNHTRGLLPMVATAQRFTELNPGVEITWEKRSLQEFADASIEDLAKRFDLLV
IDHPWTGFGAHSKSILPLSDYLSSEYIKDQELNTVGRSYGSYVFNDKLWALPIDAATPVA
ASRLDILEKEGLKVPQTYDDLLALAKKGFVAFAGIPVDVLMSFYMFCCSLGEAPFQSIEK
VISPETGKKALQMFRELAQLIDPANFNRNPIQVYEAMVNSDDIAYCPFAYGYSNYSRTGY
SRKLLHFYDLVRLNDQPMISSLGGTGLAVSSFSKHIPEAIKYAEFTGSSQVQQNIFADNG
GQPGHLQAWKSDRINSVTHDYFKNTLPTLERAFLRPRYSGHMYFQDHAGEVVRNYLMNGG
DENLVLEEMNSLYAKSLNLVTT
>EGALAKHO_02564 Acetyl-CoA:oxalate CoA-transferase
MKPLEGLVVLEFCQFLAGPSAGLKLADLGARVIKIERPVKGEACRQLSIKDLFVDDSSLL
FHTINRNKESFAADLKNPEDLILIKKLIAKADIMTHNFRPGVMEKIGLDFSESLTINPKI
IYGTITGYGNIGPWAKKPGQDLLLQSLSGLSWLSGRKSQGPVPFGLAVADLMCGNHFVQG
ILAALLKRAKTGKGVLVEVSLLESVLDVQFEAITSFLNDGGQLPERGDVKGSAHAFLSAP
YGVYQTQDGFISLAMGDLLFIGNTLGVDLNKYADKQDWFTFRDEIRELLAKKLATQTSDY
WLELLQKEGIWSGKVLDYEELDSQPFVNELQLKQTVQNATGEKLVTTRSPIQLDGKILTS
TKAAPSVGEDNIKIHEQFLSE
>EGALAKHO_02565 Acetyl-CoA:oxalate CoA-transferase
MKPLEDYLIVDFSQFLSGPSASLRLADLGARVIKIEKPGTGDICRTLYTSDLIMNGESSV
FHTINRNKESFAIDFKQPEELEKLKKLLAKADVVMHNFRPGVMERVGLRYEDVKAINPNV
IYGSISGFGEHPDLKDLPGQDLLLQSLTALTWLSGNQEDGPVPMGLSIVDMLAGAHLAQG
ILAALYRKATHNIGASIQVSMLESAFDFQFETITTFFNDGGELPVRTKTNNAHAYLGAPY
GIYKTNNGFLALAMGSIPILASLLKCEALLQFPENKFHLRDEIKNILAEHLQTQNTDFWL
NILEPADIWCAGVLNYQELFAEEGFKVLDFTQKVQMLDGYSYETTRCPIKIDGEYLTSGK
GSPKLGQDNEKIIKEFIAV
>EGALAKHO_02566 putative ABC transporter-binding protein
MEKLRIAVRKFDPFESTLKKLWDLFCLKNNIQIEAEMIPLELHDLYEETITKEGLKKGKW
DIAHINTDWIFDAVNEKAVLDLTSLINQNRPKDYPEGWHQSLLNLQQINKGTYGLPFHDG
PECLIFRKDLFEDKTEQENFKKQFGYELQPPKTWEQFVQIAEFFNRPEENLYGCVFANYP
DGHNMVFDFCLQLWTRGGSLLNAKNQIDISQNVAIEALDFYRSILNNKNAVHPKSKSFGS
VEAGLAFANGEAAMAINWFGFASMCEVIPESKVKGKVDITELPSDPNHKTASLNVYWLYT
IGIGSKQKELAYDFLRFATSPKSDKLLTNEGGIGCRKSTWNDIEINEMIPFYHKLEMLHE
NALTLPQTPVWPKVAELIDQMVLKAIESDIPSEKLIAEIQNKIENITH
>EGALAKHO_02567 1,5-anhydro-D-fructose reductase
MNIPYKPLLPETDQPIIIIGASGIVKDAHLPAYEMAGFTVFGITNRTISKAHDLAKQFKI
AHVFENVADAVQHAPANAVYDITVLPDQYIEILEQLPDGAAVLIQKPMGNDLAQAREIVA
VCERKKLVAGINFQLRFASFVSATRHLIAEGIIGELYDLEVKVTVNTPWELFPLIKEHPR
LEILFHSVHYIDCIRSFLGNPESVMAKTAKHPLKKLSSSRSTIILDYGEDKHVVINTNHD
HHFGPKHEESYIKWEGTKGAIKAKMGLLMNYPDGLPDEFEYSVTNENGEYEWKKIELEGS
WFPEAFIGTMSNLMRFKEGSDSKLLASVQDVLDTMKVVEACYISNKSGGVSLEQL
>EGALAKHO_02568 Bifunctional protein PaaZ
MNLYNLYGENKKTMYFKSTFFEDYQIGDKRVTFGRTITETDFVVHAGHTGDFFPHHMDEE
WCKTQPFGQRIAHGTMVFSIGIGLTASEINPEAFSKGYDRMRFVKPVHIGDTIHSEITIS
EKGEAKKPDMGTVTEHVEIINQRGEVVLVCDHLLLVKKNL
>EGALAKHO_02569 L-fucose-proton symporter
MQITNQTGDQHEVATEKGTETKYLLPFILITSLFFLWGMAHGLDGILIPHLKKACQLNNR
QSTLIDTAIFFAYFIMAIPAGIIIKKIGYKNSIITGLLVFAAGAFLFVPAANTRTYELFL
LALFIIGCGLTILETSANPYAAILGPPESSSNRLNLAASFNGLAVTLAPLLGGVFILSGV
NHTSEQLAAMPDATRAAYFLQEASAVKLPYIILGSILVLVAILFYFMHLPSMKSQPTETE
IKPGFFSVLKFSHLSWAVVAQFFYVGAQVCVTSFFIRIAQKEAGLDEKTAAYYLTAYGFL
FMLGRFSGTFFLKFVKDYILLSIYCIISIFLCLIAIYGKGIYIIYALGGIGFFMSIMFPT
IFSLGLVGLKSNTETGSSWLVMSIVGGAILPYGMGTLIDMNHDDIQSGYIIPLVCFIIIL
SFGVFGHKVKTQVSA
>EGALAKHO_02570 Pectinesterase A
MKKTFPILLLLLAVNSTIFAQKDKKTTYDIIVAKDGSGNFTKVQDAFDAVSDNNFKRTTI
FVKAGIYKEKLKLISTKKNVTLIGESYKNTILTYDDYAEIAGGTSKSFSTLIEADDFYAE
NITFENTIDSNLPQYKKGGQAVALMVNGDRTIFHNCKISGFQDTFYLKANKRTYIKDCII
DGTTDFIFGSAIALFENCFIQSKRDSFITASNQDIGKNKYGFVFKDCVIMANPKKDATKV
SLGRPWGAGANVVFVNCFEESHIIPEGWSVWSKDPEHKAYNNWKTTFYAEYNCYGPGYIP
VNRIEWSHQLNETEAAEYTKEKIFAAKTTTANNLEIDWNPIIENEQCKTILPSKKAKNAD
SIFKKGF
>EGALAKHO_02571 Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase
MKNTIIGKKAIIGNNVHIGNFSTIDDDVVIGDNTWIGNNVSILNGTRIGKNCQIHSGAVL
GGIPQDLKYRGENTLLEIGNNTIIREFVTINKGTSSKGKTSVGNNNLFMSNAHIGHDCQI
GSNSIIGFSVGMAGEVVVGDWANISGLTAIHQFSIIGDHAMISGLSRVVKDIPPYITAAR
DPLSYVGLNIVGLKRRGFESEKINELKEIYKILFLERRNTTFALELIASLCKQTIERDRI
LTFVKESKRGIIKGFME
>EGALAKHO_02572 hypothetical protein
MTELIKVINSFQEMDLETENAIKKYFVEEKFKKDEFIIMESKICGKVYFIKSGAIRRFCH
EEGTEITKWIYTDNQFVTSLSSFFEQKPSFESFQACEETILYSLSYSDELILLEYPLFLK
FHIKQLRLYLSKINEFHHVFRQMNAQEKYTYLLESFPQIILKSKMKHIASLIGVSQETLS
RIRASIN
>EGALAKHO_02573 hypothetical protein
MKYVCNFEVKNREPDMNNLVVSLRAGLSAISFAIDVLGLKRSFGCRKRMPLPSLTRFIII
KKSGFQKKFQLLSRRFGTKFQSSVPHRFIFRRIKYSNCYLNTKNYAKFATKSFATLTRQQ
QTGSKKTFARFAVKFQRILRLKNTK
>EGALAKHO_02578 6-phosphogluconolactonase
MIQIYNTTEEINSKAADLFVATAQKAIAEKGKFTAVLTGGSSPAGIYKLLASEDYKTKID
WSKVFIFWGDERWVPLNDDLSNAKMSYATLLSHVPIPSENIFEMYKDGVTPEDFAVTYEQ
SIRKVLGDDGKFDLILLGMGDDGHTASLFPGQAVLEEQNKWVAAYYLEPQKMFRITLTAP
LINKAEKIIVVAFGANKAPALKEVTKGEYNPTIYPMQLIKPVSGELLFLVDKNASGTN
>EGALAKHO_02579 Glucose-6-phosphate 1-dehydrogenase
MSKFKNINPTIIVIFGGTGDLAKRKLFPAFQNLYLDGRMSEKFQIIALGRAEKSDEEFRN
YVLENLETFSRKKGLSDPKTQNFLSHITYHSLDIDKEESYQSLNEKINNIDEAFGERANR
LFYLSITPSFITTISANIKKIGLAANPKQDRIIIEKPFGYDKTSAIALNEMLSQTFKEEQ
IYRIDHYLGKETVQNILAFRFGNSMFEPLWSRNFIDFVQITVAEEVGVEERGGFYEGVGA
LKDMIQNHLLQILCMTAMEAPASLEADDIRNRKADVLKSIRRIKPEEVDHYVVRGQYDAG
AIKGKSVPGYRQDKGIAPDSITETYVAMKIYLDNWRWQGIPFYLRTGKRMEEKQSSIIIQ
FKPVPHSSFSYGKEGMTPNRLIINIQPAMDIKLQFMTKKPGLSLSLRPAEMIFDYFACST
MSPEAYETLIADALAGDPTLFMRWDQVEQAWDAIDTIQQVWKNTVPVNFPNYKAGSWGPE
EADELLARQGHKWIANTQTKEELLEDDTDI
>EGALAKHO_02580 6-phosphogluconate dehydrogenase, NADP(+)-dependent, decarboxylating
MSKFDFGIVGLGVMGRNLLLNIASHNFAAAGLDLDSEKVNSLQQEAGPDDTIEATTDVKH
FVELIQQPRAIMLLVPAGKPVDSAIASLLPHLDKGDIIIDGGNTFFTDTDRRFLELSEKG
IHFFGMGISGGEKGARFGPAMMPGGDQKAYERLRPIFEAIAAKVDGEPCVEYLGNGSAGN
YVKMVHNGIEYGIMQLISEVYDLMKRGYNLDEDTIQKTFEEWNQTHDLKSYLIEITGNIL
KQKDEDGSRLINKISDWAKSKGTGKWTSQNAMDLQVPIPTIDAAVFMRDMSKTKPERIEA
AKKLVWNAPTTDVNTSEAIAALKSALYLSIVVTYAQGLAQLHTASKEYNYGLNLETVAKI
WRGGCIIRANILEDFRKAYVAKTDLPNLLLDAGIASKLTQNQAGMRSVIQFAVQKGLPVA
GLMNSLAYFDAYRSENLPTNLIQAQRDYFGAHTYERIDTTGIFHTQWSE
>EGALAKHO_02581 hypothetical protein
MAKRLPKLPPLLQSKIYKTGQTRSANDDVIYQNRANRNGTVLIPFESVELFDISVFTSNR
FESGFIVVLSPEDYYTNPDTLISMKARKLKLGVNAILLYETRAQWNEFNPYKNKLAIAEK
RTSPIDGHFVARILSSTSKDEEKIILGFNTSSCKGAGIRVAEYASLLTIKSSHLQLEYLF
WLCYNSKEVALGAGMTENEIENRIEAISTACNNQKLSNTDRLYKTRIIDNAKNTICPLCL
KKLSGEAFLLNFFESAEKSDIDKEISPINLFYINQLKTGEFNHAPYNLAWGHQNCNMICK
ETGVIETIKWMKEVVVNTIIFNKDSSN
>EGALAKHO_02582 Multidrug resistance protein MdtG
MFSDLRKKYIENYSGFPKEIWILTLITFINRTGTMVIPFLSKYMRENLHFEYNQIGWVMV
CFGVGSFIGTWLSGVLSDKIGFYKVMIGSLFGSGLIFFALQYTTSFEGFCIAILFLTTIA
DMFRPAMLVSLNTYTRKENKTRALALVRAATSLGFLFGPPLGGLIIVLIGYKYLFYVDSA
TCILAVLVFVLLVKERKLPFKLKTHNIGVDKYAILKDKTFITHMFISLITGIMYFQVFTT
LTLYHKEQFNLSEVNSGLLLSFSGILTLLFELPIVNYVEKNKMNKLNVIMVGLSFMVLSY
ILLLLNDKWYGILYVMMFFMTLGVMLTFPFSNSFAMTRSHNNQEGRYMSVFTMSFSLAHI
LSAKTGMEIVAYASYRADFIFMSLIGVLAITLCYWLVKAVEKETIETKIKIVQSIFVDKS
KK
>EGALAKHO_02583 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MKKFIALKIIIVFIFLIPTSLISQELYAGIEVGSKGVKMSIINVQNIKKGKYEVVDFWTE
NVAIAKGISIDGKLAENDIDTAFDVVVKNYTKLLKEFKIEEKNIFIVVSSGVGMAQNVDV
LLHRLYVFTNINVGIITAETEAKLLLKGCIPPKEYSDSLILDIGGGNTKGGYVEQFNEDD
ILIFYPVTLDLGTVTFTEKISKKAKTNSIDEFKELLSTALPELREQTDRLYQQSPKISNK
DNVYMSGGAVWAFYTLYKGNSAIENFSPFEVKDVEAYNTMIKTDYAKFEALATQNKDVEK
VLKTYSQKYLIAANSLLLTLLEKMPDIKSKKIYFTKQGQMAWLLSYIADSARRAKNIR
>EGALAKHO_02584 hypothetical protein
MKKKLLLLVFFTFTILIKAQSTKGISGDTNWLNMWTNFNPKTTSYNDASIIITGTITSNM
TLKKENVYVLVGTVYVAPNVTLTIQPGTLLRCDTQTLTTLVITKGAKIIAEGTETDPIVF
TSNKNSGDRNAGDWGGIIILGDAPINKTGGIGTLDFELDPQKALYGGDNKDSDSGILKYV
RIEFSGKKTSHNKPINGLSLAGVGKKTKLEYIQVTSSEEDSFQFYGGYINTSHLVSLRSA
DDDFDFTQGVQCNISNSIAIRSPFLSDSYGSRCFEMETVDTRKGEVLDSKKEMTRVNATN
FTMMHTEDIGTEIEGLKHEAILIRENTFLTLTNSVISGFSHLIVFADAVSISDEYLDQII
LKDLLINDTKVIGITQNNNFNSIINNWYQEKQFGIEFIKLKNDQLFGSTSMRKKPDFRIK
D
>EGALAKHO_02585 hypothetical protein
MSDFLNQFGDDLQKNVPGFIAVSVAEIQSGMSYFSQSVVSDFDPELASAFNLEVVKAKMN
AISALGLKNQVVSDIMITLSSQIHIIDISDNNLYMIYLAVDSTKANLGMTKSILNKYKKE
IASKL
>EGALAKHO_02586 hypothetical protein
MILHGKLYQLSVIFAKYRFWQREIIIIKLVIEKEIYAVVLNYRTNLNK
>EGALAKHO_02587 Alkanal monooxygenase alpha chain
MKKIGFLSFGHWANHPSYQTRTAGDTLLQSIDLAVAAEEIGLDGAYFRVHHFATQLASPF
PLLSAIGAKTSKIEIGTGVIDMRYENPLYMVEDAGAADLISEGRLQLGISRGSPEQVIDG
WRSFGYEPLEGETDADMGRKKALEFLERLKGVGFAEPNPYPMFPNPPGLLRLEPHSEGLR
ERIWWGAASNATAVWAAENGMHLQSSTLKYDENGKPFHIQQAEQIRLYKEAWKKAGHDYE
PRVSVSRSIFALVNDQDKYYFGDQGRGSDSFGNIERDKRAIFGKSYAAEPDKLIAELAQD
EAIQEADTLLLTIPNTLGVEYNVHILSSILKYIAPELGWR
>EGALAKHO_02588 Phytochrome-like protein cph1
MELLENKDLFQTIINASSNGIAVLQPIYNDTGKIDDFLILLSNSYMLNLAGTTGSNDKRY
SNFFSNFKDADILKRIIEVTQSGESSNFEKCYEIDTAIQWLAFTAIKECELIVLTIEDIT
EKKQTAVVLESLLTAAEKQKRFYDSITNNTPDLVYVFDLSYRFTYANKALLTMWGKSEKD
AIGRGLRENGYEEWHALMHEREIDEVVSTKRTVRGTVSFPHAELGNRIYDYILAPVLNEQ
GEVEAIAGTTRDITEIKQAEEKLQKSETRFRNMIEQAPVAMLLSKGEDVIIESVNKPMLQ
FMNKENAAEALGKKMTEALPELIGQPALETVINVQKTGVPFKGDEQPVDLIINDKLERRY
FNFSYDCIEEMEESPSVLHMAIDVTEQVLARRKLEDSQSRLKSMIDQTPSPTLVLMGDDL
VIEQINKHMLEMIGRDQQVIGCPLIEVLPELKGQYVWTQVQNVYNKGIPYDQTEVLVSHA
RNGVVQDYYYNLAYRPLIENGQATGMIQVAIDVTEQVTSRKKLEESEGRFRALVNASSDV
VYRMNADWTVMRNLEGHGFLSDTGEPIFNWIDKYIHPHDKEKVLSSISESISNKSIIELE
HRVLNTDGTFGWSFSRAVPILDDHGNIIEWFGSASDITSQKELQQVIKDSEEKFRQLADL
VPQIIWTGRPDGFVDYYNKRWYEYTGFEENEFGDSSWIPILHPDDAPIVTKYWYQSVQKG
TPYQLEFRLKNAQTGEFRWFLSKAVPIRDKSGIITKWFGTCTDMHQQKTITDSLESLVQD
RTKELQRSNEDLQQFAHVASHDLKEPVRKIKTFTSRLEDHLQGQLDESATKFIDRIHVAT
DRMYNMIDGVLAYSKINADLEKPTMIDLNEVIKNIEIDLEIALQKSGGKIEYANLPTLQG
AQVLLYQLFYNLINNSIKFAKQAVPPKITLLSKIISENDSSFAVITLEDNGIGFEPQQAG
RIFETFTRLNSKDSYEGTGLGLSLCKKIVERHAGSIKATGSLTKGATFIINLPLLQKENE
I
>EGALAKHO_02589 Chemotaxis protein CheY
MADDDIDDTEMFCEALVDVSKDIICHCALNGNEVMEILSNLTEKPDLIFLDLNMPVMDGW
ECLKLLKKDKQCHDIPVIMISTSSHKNDIDTALSLGAIGYFVKPNNFNDLKFVLHSIASH
LGKGLQDAICDLHSSGVNHIYS
>EGALAKHO_02590 hypothetical protein
MKTILNSIIILITVLTSCNTFAQNDHFVQNGVIEFEKKSNMYALITKKIKGETSSYYQAA
FESYKKTNPQFKTTKSILSFSKNKSLYKWDETNQSANNSWIADDAMANLKNVIATDLDTQ
TSITQKNVYDDLYLVKDSLRKIDWKITDETREIAGYECRRANAIIIDSVYVVAYYTIQIP
FSGGPESFTGLPGTILGLAMPHENMTWFATKVTEIPVSDKDLAPPIKGKPTDNKGLNKIL
MDALKDWGKWAKKTLQAYSL
>EGALAKHO_02591 hypothetical protein
MRQTILLLCCFLFLSNTLQAQKSGTVKGYVTDTINNSTLTNASVSLLRAQDSILVKFTRA
KENGYFELNNVKAGKFILLVSYPKYADFVDQFSVDSTKLIKDYGKINLADKGRLLSEIII
KGNRAAMKIKGDTLEFDPKAFKIEPNAKVEDLIKQFPGIQIDKDGKITAQGETVTKVLVD
GEEFFGDDPTLVTKNLRADMVDKVQLYDKKSDQAAFTGIDDGQKTKTLNVKLKEDKKNGY
FGKVELGGGTDDFYKGQAMFNKFWDKKKLAAYGILGNTGQVGLGWGDKDKYGQSGYQVSD
DGGINFSNNGNDEFESWDGQFNGEGIPVAQTGGIHFDNKWNNDKESINLNYKIGDIKLSG
NRNDINQQNLSSSSIYNTSDKVFEKNMTKNKLDLAYEIKIDSTLTLKLNVDGLFKNSNSS
DAEMRKGTDEQGNQLNNLKQTNTNDVDDKIFNINTLLTKRLKKTGRTLSLNLSQSSTDSK
SDGYLNSRAEFFKTSVISPDSTKVVDQNKVNNISNTVFKSNLIYTEPLSKSLSLILNYGF
NISNGKADRKSFNQSSNGDYTVLDSVFSNNYELDQTINQLGAIFNYKKNKTVFSFGSKFS
GVNFKQYDVYTDSSFKQKFINYMPQLNYQYNFKQRESLRFSYNGNTDQPTLEQIQPIPNN
QNQLNTILGNPNLDPSFRNNFRGSYYSYKVLSNQYFSLNGSYNFTLNPIISNVVTNDSGE
SISQFVNLKNKATTSYFLNSNFGKTIKAIDMTAGIGLSANKNLNYNYINTKLNQTKNSTY
SFNLNLSKNKEKKYNFNTSFGPTYNVANASINENSDSNGWGFNGNFWTSIQLPLKLEIST
DGNYQYNGKTQVIQESFERFIWNASITKKFLKSDNLRVSITGRDLLNQNVGFNRSAFNGN
INQSTYTTIQRYFMFSVSWDFSKMGGGEIKQN
>EGALAKHO_02592 Phytochrome-like protein cph1
MQNNLIFLQDILQHTPLPTAVYCTDDLLISFANPAMRNLWNKGEQVIGEKFTDINAEFGK
DSISEEMLRVMKSGMPLQANDQKLNILKDGVWTPLFFNYNFTPLRNENGVVYGVIHTCTE
VTKLHEAKSQIVNSDEMLAMAIEACGMGTYEIDFKTNKIKTSDNFKKLWSIDSEITVEEL
VARLHPDDRHLREKAHKDALLNGLVCYEARIIQKNKSEKWMKVFGKIIKDEKGDPATILG
VVQDIHDQKEFEVELKKKIQESTMELRRSNDDLLHFANVVSHDLQEPVRKIKIFNHFLKN
EIAGQLPGRSVMHLNKIAHSANRMQCIIEGLLAYSTIDKSTQPVEKIFLNDLLKNIKTDL
ELIIKEKGAILIISDLPEIEGAAILIQQLFYNLIQNALKFTKANQPPKVIITSIIKYIDS
VEYIEISFKDNGIGLDPIYAEKIFTAFERLHSKNEYEGNGIGLALCKKIINRHNGTIIAK
GEKENGAEFIVTLPLKQATEKI
>EGALAKHO_02593 Response regulator rcp1
MITPKNSATTSNDLEEKEPLKIILAEDDKDDQELFMEALSATKVPSEVITVENGEQLVNT
LKDPDEQKPDIVFIDINMPVKGGKEALAEIKSDQELKEIPAVMLSTSNHPKDIEETFNKG
ANLYIQKPSSFTGFILILKKVFILHWTKALINPVKNIFFVSEKNISQKD
>EGALAKHO_02594 Glucose 1-dehydrogenase
MEEIKIRNNDLKGKTVVITGASSGVGRAAAEAFAHEGCNVIIVARGQEGINQVVEYCRGI
NVLAVGVSADMSVAEDVDKVVQQALALSGRIDIWVNNAGVMASGKFEEIPLEVHQQVIKT
NLFGYMHGAYNSIKIFKKQNEGILINNVSIGGFMPAPYSAVYSATKYGIRGMMECLQGEI
SNRKHIHICNLYPQLQNSTGNLHSAKYSGFDMKIPFIASDPRETAAKMVDLAKHPQKDMF
PDFTAATITTTYRLFPKMVINSASAALRIKMKLNKDKEGDPGNVLAISKEPLRVYGNPPS
KTTRNISLALFAGLGFGVAMILMGKDRNSFQ
>EGALAKHO_02595 putative transport protein HsrA
MNVNTGIQTTETIKKVLPIILATSIFMQMLDSTILNTSITAIAKDLHESPLEMQNAIISY
VLTLALFMPVSGFLSDKFGTRKVFIFALLLFSIGSLFCALSQSLNHLIFSRVIQGIGGSL
MTPVGKLALIRTFPKNELLKAMNFAIIPALIGPVLGPLVGGYMVDYLSWHWIFLINIPFG
IIGIILSLKYMPDYKSPIIDFDLKGFLIFAAASLLLSISLELFGNTVRVTPVLLILMSGF
LMLYWYYRHAVTDNNPLFPLNLFQVRTFRVGMIGNLATRLGYSSIPLLLPMMIQIAYRQS
AVTSGWIVAPMALTAIFGKSLVIIILNTFGYRKTLMVNTFIIGILICALAIPSIHTSIYW
YIPIIAVLGFFNSIQFTSMNSISIADLRVYHTSSGNSLVSVNQQLAIGFGIALGLLVLKF
FQGDVKLIHNEIHNAFRYTFLVVGSLTILSGFVFRRLHFKDGDNLKPSS
>EGALAKHO_02596 hypothetical protein
MNIDNRENYRQEDQNFQNKDKKETINHSITENAEPDYGDDLINDESENKEFDGDNLANEE
FDQENLDKDEIDNDEFASEDFNNGQMDNKELGNENFDNEGLENKEDRDRPFITG
>EGALAKHO_02597 hypothetical protein
MIGNDVIDILQSRKESNWRRKGFIEKIYIPDEQLLIANAADPEIMVWILWSMKEAAYKVY
NRQTKIREYIPQKLVCSLASQTHDSITGSVICSGKTFHTNTILSQDYIHTIAVSHFDDLS
KVIEIEKKTISKDQNGLPYLSNTLQNTIQDVSVSHHGRFEKVVTIDRYLNYN
>EGALAKHO_02598 Acyl carrier protein
MNKEELIAKLKLIIKPYTTNTEAYDNLTEDTDFINDLSINSANLVDIVLDIEEAFDVVID
NTDMERMLDVKTAVEIIETKLAQK
>EGALAKHO_02599 3-oxoacyl-[acyl-carrier-protein] synthase 1
MSKRVVITGLGVAAPNGVGIAAFSHAIKNGISGIRHDEQLQELQFSCQIAGKPQISEELK
AEYFTELELRGFNSTGILYGVIAGIEAWKNAGLPIQINDEPDWESGTIFGSGTSGIDKFR
ESIYKIDELQTRRLGSTVVAQTMNSGISAYLGGKLGLGNQVTTNSSACATGTEAIMMAYE
RIQAGQAKRILAGSTGDSGPYIWAGFDAIRVCSSKYNDNPEQGSRPMSASAAGFVPGSGA
GALVIEDLESALERGAPIYAEILGGNVNSGGQRGNGSMTAPNSTAVQRCITNAISNSGIS
ADQIDAINGHLTATTKDSLEIENWTKALNRKGNDFPLINSLKNMTGHCLSAAGSIESVAA
VLQLHEGFIFGNTNCEDIHSEISALIDPSKIPLKTINSNPNIIAKASFGFGDVNACIIFK
KFQK
>EGALAKHO_02600 3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ
MELTDILAKLPYSKPFLFVDELLHVDENSISGTYTYSKDLDFYKGHFKDNPVTPGVILTE
TMAQIGLVCLGIHLLSDTFTKDTVIAFTSADMQFLKPVYPNEKITVTSQKSFFRFGKLKC
DVIMKNEAGQEVCKGILAGMMTNKL
>EGALAKHO_02601 Alpha-pyrone synthesis polyketide synthase-like Pks11
MSVKIVTVAKQLPQYSRATVDILPMLDGWLHGQDDRFIKKVKKIFEGAAVDKRYSIMDPE
EVFTATSFEEKNDIYTREAIILGEQVLQKALEKAGWDPQTLDYIITVSCTGIMIPSLDAY
LINKMKLRQDIVRLPVTEMGCAAGISGIIYAKNFLKANPGKRAAVIAVESPTATFQLDDF
SMPNIVSAAIFGDGAACCLLSSHEEDYGPEIINEEMYHFYEAEHMMGFKLTNSGLQMVLD
IEVPDTIASHFGDIIHPFLQKNNLEIKDIDYMIFHPGGKKIITTVEALFSGLGKNIDDTK
EVLKEYGNMSSATVLYVLEQIMNRNPKQGEKGLMLSFGPGFSAQRVLLQW
>EGALAKHO_02602 Ubiquinone biosynthesis O-methyltransferase
MAVNTKFRTQEAEIMDDFSLQGEELREALDQIARINQLLGGNKVILQGIKEFLKQSHHTK
TISIADIGCGNGDMLRMLAKFGQKNKLSFQLTGIDANEFTINYAKKLSQEYSNIEYKCVD
IFSEDFKTMKYDIILCTLTLHHFTNEQILKIISIFSNNAETGVIINDLHRSKTAYRLFEL
ICVVFNLNNMSREDGLISILRGFRKKELVEFSKKLDLKNYTINWKWAFRYQWIIKKK
>EGALAKHO_02603 Menaquinone reductase
METNSDVVIIGGGLAGLTAAIHLSQKNLKVILIEKSTYPRHKVCGEYISNEILPYLRSLG
INVSELNPTKISKFEFSTSSGKTAKAQLPLGGFGISRYALDFFLYQKAISSINCTIIQEN
VTDVCFSNDIFSVATANQMVTAKILLGAFGKRSNVDQLLDRNFFHKKSPWLAVKAHYSGS
FDNDVVALHNFKGGYCGVSKVEHNIINICYLADYATFKQYKNIDDYQQNVLYKNIHLKSV
FENSSLLFDKPLTISQISFEKKQPVENHMLMIGDTAGLIHPLCGNGMAMAIHSAKIASEL
ILSFYTDKSISRDQLEKNYRKEWNKHFGKRIFMGRILARILTHKTITNMFVSLVASFPKI
LPEIIKQTHGKPIAIN
>EGALAKHO_02604 Toxin ParE1
MDQADNYFNMFYDCFDKIEQNPFLFPSADHIKKGYRYCVCGVDTIYYRLNGDKRIEIITI
IGRQAF
>EGALAKHO_02605 hypothetical protein
MPNNKKIHVFAGPNGSGKSTLQKELSKTYFSEIFINADEAINFLIKKARSQEEFYDFVRA
KIDKGEKSGFVKKQTKEEMLAEFKTDLGDV
>EGALAKHO_02606 hypothetical protein
MKPAKLFRTDSRQTKSLISAGINSAKNAIRQSKALDLPITYIKDDAIYVEDKFGIKQQGS
IVRKEQPKNIIKGMILRAK
>EGALAKHO_02607 hypothetical protein
MNSQNDNWKITPEKALKMLADEGMNVTLDQAAKILSFLRLMAEITVKKF
>EGALAKHO_02608 hypothetical protein
MENQIYIGTSGWSYKHWKGTFYPKELKVKDQFNYYLENFNTVEINNTFYKLPSEEIFFNW
KKNTPNNFTYVIKASRFITHMKKLRDPSQSIMKFMDRIILLEEKMGAVLFQLPPFMKPDL
NLLENFLIALPKQHRYVFEFRHTAWYTSELYLLLKKYNCAFCIYELAGHISPIEVTADFV
YVRLHGPDDKYQGSYSKEILHKWSLLCRDWLKTKDVFVYFDNDQKGYAPQNALELKKMVS
CTNFAK
>EGALAKHO_02609 hypothetical protein
MKTSENTNDKDGNTVFANGIPKQSELEQNHCLWSLKEEILCWGEESSYLSREDCIALEKQ
DQGKQQ
>EGALAKHO_02610 hypothetical protein
MDEKNKNLANDQMANERTYLSWIRTGVGIMVFGFVIVKFSLFVNQLPARFYQVPDLPKNG
YTPFIGISIVLTGAIIILLSYFRYKQTSKLLEQGRYLYSTMMLTVITVVIFAMSIIIIAY
LVTAAYPSV
>EGALAKHO_02611 hypothetical protein
MIHTDTEVRYISKEKGYGLVAVKFIPKGTITWVQDDLDRVFLRGSTSNLNPLIKDYLNTY
SFTNKNGDHVLCWDNGKYVNHSFNPSCFSTPYDFEIAVRDIYPGEELTDDYGYLNVEKPF
>EGALAKHO_02612 putative zinc-binding alcohol dehydrogenase
MKAAVIHGPGSVQYDTVDDPKLESNEDIILRVTSTAICGSDLHIYSGRPSTTETHGSWT
>EGALAKHO_02613 Alcohol dehydrogenase
MVLGHEFMGIVEETGAGVTHLKRGDRVVVPFPIACGNCFFCNHDVPGNCEHSNPEHYGPE
GGILTEKGGALFGYTDLYGGYDGGQAQYVRVPYANYGPRVVPENLTDEQVLFLTDIFPTG
YTGVDWGEVKGGETVAIFGSGPVGLMAAKSAWLRGAAQVIVVDTLEFRLDAAKATSGCIT
ILWDDGPKDVVEQIRALTQGRGADVCIDAVGFEPDRNIADRIKATINFEKGSTKVLEACM
SAVRRSGIVSVLGVYPVNYDNFPLGQFFDKGIILKGGQAPAHKHIDKLLQYVVQGKVQLD
DIISHRLPLSDISHAYDVFKKREDGCVKIVLDPW
>EGALAKHO_02614 hypothetical protein
MKTATKSTNSAKSASGNRSTGSVKAKTTAAEGLRELFVESLKDIYWAEKALTKALPKMAK
NSTSENLITTINEHLAVTQQQVTRIEKVFEIVGEKAVAKKCEAMDGLIKEGEGIMEETEA
GAVRDAGIIAASQKIEHYEIATYGTLAAFAETLGEQEAVELLRATLEEEKEADTLLTEAA
YNTINFDAADDQEA
>EGALAKHO_02615 hypothetical protein
MNASNEILKSTGNRYFPLPDRPWKYFQQWDNTLFLHWKCSVSALRQYVPPSLEIDTVEGN
AWVSLVVFSVKKLRMNGLPWLSYVSKFEEINLRTYVVKDGIRGIYMFSLETNKFLTVLMT
RIFIGLPYILSKIVRKQENVKSQNTKKKYALKVKYKAGSSIGKTPIDLWLTERHCLYEIK
NARMHRFDIHHTEWVLKYPILNLKNVEYRAGKLDLGALKPDLKHYGASIKVLLCGSTAV
>EGALAKHO_02616 hypothetical protein
MKAENNEFYGEEDRIFHHAENANIDPKSEENDRLFDEFQNEESRNNDAQYQEDKKHLSDN
PYDSENLDDESGSEFKDITEQDIENDLRNHDSSEEFESTDSEIDDPDSNEFDTDQFENNE
LDKSDFHNKEFDIGELSNDEIKNDELNRNEIDNDKFENEQLASNRSDDRDLEEDLKKA
>EGALAKHO_02617 Chemotaxis protein methyltransferase Cher2
MKFSPIKTPLKTEQNFPVIGIGASAGGLDAYKKLLRAIPKDSGMAYVIVQHLSPDHSSNL
TEILAQSTEIPVYEIINDINLAANNIYIIPENVIVIAQDGVLKLQPRSRNERKNSSIDIF
FESLAEVHKTFAVGVILSGTAFDGTIGFKKIKEFGGITIAQDPETAAFKGMPQSAIDADA
ADYILPPELIPAQLLQIHQTYITNHGYTEEEHLPTDEEQILGQILTLILSKTGNDFRNYK
QPTIRRRIARRMVAVQRETLLDYYNYLRNDKGEQDLLFNDFLIPVTYFFRDDKYFEKLSN
DVFPRLLKNTINNNLRIWVAGCATGEEAYSLAILFDEFLTQTNNKDIRVQIFASDLSEKC
IAKARTAMYSSQDVQHLTQERLRNYFIKRNGQYHITKTIRDMCIFAVHNFIKDPPFARID
MVSCRNVLIYFDHYLQNKVLSSFHYSLKEKGLLFLGKSESINNAQGLFDPLEKQEKIYVR
KFAVNRHVPEAFNPTNLRLRDKIEVFDKINLPETDFRKVTSDILFSKYTPSSVVINEHLD
IVHFHGDTGAFLLPSPGKPNFNILKMARDGLSFELRNAIIKVKKDGETVIRENISIKDQP
YLISFEIISLPRDEHHWMIIFSKRPLPEKVSNYSIENADTNRIADLEAELKQLREDIKRV
TEEQQTAFEELQTTNEELLSSSEELQALNEELETSTEELQSNNEELMCVNDELLDRQDQL
ISMRNYSESIIKTIREPLLIIDKDFRVISANPAFYKYFQTNETETETFSFFDIGNCQWDI
PEFKEQIIKMLSDEHILEDFKVETFCKGIGKKIMLVNARRILNSQPAGMILLALEDITNL
VHTNDLLVARNLELQTYNEQLQTFSTAASHDLQEPLRKVHMFCKRMIENEKDISEAGRHN
LERMLFAVTNMSQMITDLINYSMVNFLEKDFKKTDLNLILKKIVADLKETITAKNAIIQI
DAFPPLDTIPSQIQQLFTNIITNSLKYSKEGITPEIKIENTYPSKEELAGFSADPTINYI
KICVSDNGIGFHKLYENRIFDPFYRLHNNDKYNGSGLGLTLSKKIVANHNGFIKASSKEE
RGTTIFIYLPL
>EGALAKHO_02618 hypothetical protein
MFTFALVMIVGYASAQETPKSKSTTDTITKGKSQKSTHKSSATHKKSGTTKSDTIKSTKR
TRKSTTTDTINRGSSTVPKTDRPNGVNTPQ
>EGALAKHO_02619 hypothetical protein
MKALHFKILFFLFFLVVLTLSCSAHCDDEDYRREEQEKKLVPADSLKTGA
>EGALAKHO_02620 hypothetical protein
MKILKFVDTDKSGVYSEFPAAAKKSLKDMFTESLRSMKWSERELEYLLLKIKAVADNETM
YKTIQQYISLSCTKLNRIEQIFNVLNQTSNDKRNATIEGLIKEVEIATAKHLQGTVCDMT
ILMMLQFISQYKITHYSLLASIAKTIGSVQINTILYGIIEEEKIADDMIGEVINKITDI
>EGALAKHO_02621 hypothetical protein
MKTLFKTKMALLLVLSGLAFSCKKNDTATDTQYTDSTATETTVDTAGIPTDTAGVNSGTG
AAAGAGTEGTTGKGSGTTGGAGGAGSAGSAADTTATRGR
>EGALAKHO_02622 hypothetical protein
MKTFLRNNGLSIAFFTLFLAALGGQVIFGFKEHNKELLEQGGAALAFWDYLSSGHFLQST
FENWESEFLQMALFVVFTIFLQQKGSSESKDFDKEQKVDKEPSAVTKETPWPVKKGGFIL
TIYKHSLTIVLLVLFLFSFIVHFYGSLKDENDELSLKGLPLETAQKYMGDSRFWFESFQN
WQSEFLSVFAIIILSIYLRQLGSSQSKPVDAPNMETGE
>EGALAKHO_02623 CinA-like protein
MPSDIIIKCSEAIAEKGWNIAFAESASAGRLCSEFSLTPFSGEILRGGIVCYEVFVKEQI
LHVPHYLIKEFTAESMEVTQYLAQQTAQFFNSKITLALTGLTTSGGSETKEKPVGTIFLY
IITPLGTISHKEVFSGNPEEIVLRAADRAAALIEQKISK
>EGALAKHO_02624 hypothetical protein
MQLISPWTATVQDDLENGTVLWEKKFHDYSFQLYNTGDSIWTVSLWPNQGKMAFRAAFGM
NSCFEVTNLFEDGQKTVLNLVSKLGKYEIEVDFPEDNSPLLHYKTSFNAAFPMTIPFWPR
DILPLTEKGNVENTFGTIHAHQVGARSGILFASMTKPAAGSVFYFQDLGSMSPYCEATET
SVAETVGGEWPEIGFQLPLTKQKPLPADTDFIISDAYIVFSEQVIKDATAATQQFLNNLA
AVYKTLPHPKTEYHKWPELPKNAWAICTITKGAGPRLMEFRT
>EGALAKHO_02625 hypothetical protein
MVMDSWYLHHPLMNLTRLALKGVKIAEKMLLDSIQYAITVAHHFDYDWPVFYKMDTLEVI
KKETAPGRGGEKDVPGSYAHLMLLVFELTKDELYLREAKKAVKSLKGLGFDIFYQANNTA
FSAGALLDLYKITGRKSYLNLSYGCLAGLFKNMQIWDCQYGFGKNYPNYFSIFPLSDAPY
TAAYEEQEVYAKLREYLLKAADIEILPALRILIPEFIKYAVTRMSYYYPSKLPAEMLSEE
VKTGEIQPQLWIPVEDLYTGWEKSGQVGQEVYGGGIAFGMVPRQYHRVKDEDFLVFSDYP
ISGFRKVKNAVTFKTFGTEEFSSNLKIIYSKQISRGVKVTQNKKAIEPEFSGATVLHYSI
QGNSSVKIIW
>EGALAKHO_02626 hypothetical protein
MKAIILLATLKRDGQSNTETLVEFFTPYLDQQKIEYEVIKLVDYYIVPGTYTNMEIEDDW
PEIYQKITQAEILIFATPIWWNNHSSELQRCIERLDEVYDKILAEERSPLEGKIGGFLIT
GDSDGAEHVTGNIANFFCTIGLTIPAFTSLGIIWEGHGKNAKKTKDELLDYYTKTYAPDA
KAMAESLLKAVK
>EGALAKHO_02627 putative oxidoreductase
MKNLNEYFGSNISEKNIVITGGTTGIGKATAELLLSLGARVLIFGRNPDDFNAAFDELSV
KYPETELFGTPADVTNEDDIKKIFDIVDLNMGHIDILINNAALSSQGIIDSADWKYIIDT
NIKGYIDFAQQAVLRMKMQKSGHIINVGSMSAEVRNAESTIYVTTKAAINGFTASLRKEI
NPIGIKVTLVEPGAVMSDMQPGTKEEQREKIEKMEMLEAGDIAMSILFILSQPPRCDIVS
MQIRPHLQII
>EGALAKHO_02628 hypothetical protein
MILENEKSTEGTAAKAIEEQTSKIPSDIYLYASLAAMGTSLTLKCLGRRHSALFVGQWAA
PFLLLGIYNKLVKQSGHDAEDKGENH
>EGALAKHO_02629 Chemotaxis response regulator protein-glutamate methylesterase
MSQIKNLIIIGASAGGIRAVSTVVAGFPNNIDAAVLIVLHVSKNSNAHNIAEILQRNTPL
KCRVAVHGLTIEKSNIYIAPPDYHLMIDGPVMHLNQGPYENRYRPSIDVLFRSAAVHYAN
KVIGIIMTGMLDDGTSGMYAVKTCGGRCIIQNPLEAEFPDMPQSVLNKVQVDYIADLADI
PVIVEDLIKKPLPLKVEIPQELKLEAEITQRLMSNIDDLKKIADRSDFVCPDCGGGLWEI
KNDPLHRYRCHTGHVYSEKILQELQDHRIEESIWVSIRMLEEKQNMLRLALGRNTLKSNN
DNAASTSFNRRIEDTGEHIRRLKTLLKTT
>EGALAKHO_02630 putative oxidoreductase YghA
METTNTISRRSAITSMGAVLATAAFTPILANGIEPGEISASDIPEDPTTKYPRPPFKEQS
QPWPGLVSKMDPRPDHGEKSYKGTGRLKGRKALITGGDSGMGRAAAIAYAREGADVAINY
FPTEEEDAREVIQLIRAEGRKAIAIPGDLRDETFCKSLVDQAAKGLGGLDIVVNNAARQQ
THASILDISTEDFDWTMKTNIYAPFWIIKGALPYLKPGACIIGTSSVQAYAPTEDLYDYA
QTKAATTNYIKSLAKQLAPKGIRVNGVAPGPIWTPLQVSGGATMEKLKEFGSMTPMGRPG
QPVELASIYVQLAANDASYATGQIYGASGGEGNP
>EGALAKHO_02631 Glucose 1-dehydrogenase
MVLLVHLLFLAGCTTWKLGSSGQKKISGKTYVIIGASSGFGQGVAKELGRCRANVVLAAR
RTDLLEAIADTIRSEGGTAMVVTTDISKPEDVQRVADEALKKYPKIDVWINMAGIAAIGR
FWEIPPEDDARIIDVNLKGFLYGSKAALKQFIKQGQGVLINMGSVESEIPLAYQTSYAAS
KAGVRSISLSLSQELRLNGYKNIKIVTIEPWAADTPLWRHAANYSGVEPKMALMDEPCKI
VNAVLRKSLRPKKMVPVGWKAQGASFFANVLPRFSEWFSGNLSQKYQMEMGPAAVNTQGS
IYRPMPEGRGVDDGADKRMKQNRKERRDKNNKE
>EGALAKHO_02632 hypothetical protein
MNPSIQILIATFTATSAMTMFSYFVSAGFKELYKEPLLLKYLLMRLKITVSDRLKEILAW
LIHYSIGFIFVLGYYVLWEKGIITFTVVTGIYLGAVCGVIGIIGWIIMLKLARFQRKAHD
KGYYIQLFLAHIIFGVTAIITFLILNGEKMT
>EGALAKHO_02633 hypothetical protein
MRILKKGMIAGIALAGLALACKKNETAPADHNNSADSTETVIDSVGPNSDSTIVGAGTTG
ATGEGSTGSGSAGTTQKGTVNIKQDSAAAKEK
>EGALAKHO_02634 Sporulation initiation phosphotransferase F
MKYQNILQIDDDCDDCSFFLEAVEEVSTATYTAIHNPVQALQKLSNKEIRPDLIFLDINM
PIMNGLEVLQEIKKKETIKNIPVIIFSTFIPLEVKNRMNDLGIMGYFIKPNDFNALKKIL
CTLI
>EGALAKHO_02635 hypothetical protein
MRASNEDRVLKDSKAFTEAKLDPKATITEKVKVVIMKEKQKII
>EGALAKHO_02636 hypothetical protein
MKIPKEILNGFFIFLAIAVFFLLMEVLNLSHLFYLRLLNVLFIFYGVNRTLKMNIAQGKN
SFVPTAVSAMVTSFTGVMLSVLALLIYSYAKGGDPYVKSLSQAFMFGGEPSVPTYTLCLL
FEGSASCIIVTLLLLLYWNNKYKAD
>EGALAKHO_02637 hypothetical protein
MAIETYAFLKGQNSALEMIALQFPSLKKDVAKTSTVFIRAEQNVERFLKSQIGEEFTVLQ
KRIGALLQEQFKNPIEKEKYARDFLEKIRHRSRFSSDSMVTKGILSFAYEDVPHQEIIDG
HTIIFTTKGHPKAEKTILRVPIPKSWKAEEAEMPETVQQFTSYGGQGTEKILIVVYDLTQ
EDRNLTLSEKSIREMIPPEAKLLRSEPTIIDHNPGIITETEETLNFSNKKMKIRMLQFMF
IEKGKLYCLQGSIGPAEVDTNLEIPLKKYEPLFRIVASRANVEN
>EGALAKHO_02638 Small-conductance mechanosensitive channel
MLRLIEGKRFDATLLKFIMDVLIWSFRALLFVSIITKLGVETSAFVAIIGAAGLAIGLSL
QGSLANFAGGLLIILFKPLRVGDYIEAQGEAGTVAAIFIFSTKIITPNNQSVYMPNGALS
NGIIRNFSKEMLRRTDITISVNHNSDITLVKSLIFDIKADKRILENPRPIVLVKDLTAQA
VLLSVFAWTSNADFGFVVSDFYQSIKTAFTTNKINIPASRTDISIEQISKI
>EGALAKHO_02639 hypothetical protein
MESKTKKTAEVTAASAVDSGMGKLFTDQLKNILWSERALGKMLSKMVRSAGSPNLISILK
KYDNLGQERVKRLEEVSESIGIGGRGKKCGAMEILIRECGNILEHIKPGALRDAAMIASW
QKILHYKIPAYSTIIAYCELSRKDPISEILTFTLRQDKHTDAVLSDAAFNTINFDAAIDE
NKVLASHYNNRIDL
>EGALAKHO_02640 Phytochrome-like protein cph1
MYQNVTLLKDIVDNTPLPIAVYTGDQLKIELANTAMITTWGKGDQVLGKNYKEVLPEIEN
EPFFDQAITALRTGIPFHAKDKKVDLLIGGILKTHYFNYSFIPLKDEQGNIYGVMNTGAD
VTDLHLSKLKTQSAEERLRIAIESSGMGTYEIDMETKKIKTCGNFKAIWSIDWETSNQEL
TAKLHPDDLEVREKAHQQAEKTGKISYEARIINEDQSVKWTKINGKIIKDENGTPTTIIG
IIQDISDQRKFEEELKKQVASSTEELKRSNDDLLHFANVVSHDLREPLRKIKIFNTLLQN
EKDTDFNENCQKYLGKIDQSTSRMNNIIEGILSYSTIDKTQQPIESIDLSEVIENIKTDL
ELIIKEKGAILSACDLPEIEGAPILITQLFYNLLQNALKFSKADQPPRVIITCQTTALND
REAVKIIIKDNGIGLDSAFAERIFTAFERLNSKDKYEGNGLGLALCRKIAKRHGGTITAT
GEKDNGAEFTLTLPLKQTADTI
>EGALAKHO_02641 hypothetical protein
MAISNNENYGHSGRQSQTESQAINSETMENKDPAINQHQDQSAENVNHEYSDQDLNAAGS
SENEDDDNDTEDPYFQKNAEIAQDLDDDLEDKNTSGRDNSDNDYTDPDFDQDDASDVQND
NYDEENDENYSDSTIEEDEDIDPDIKEQDPLNQ
>EGALAKHO_02642 hypothetical protein
MPGKDPGPQIKDKDQYEALRDKGYSKEKSARISNSKGAEKRGGSSKDYSDRTREEIYSEA
KKADIKGRSTMTKKELIHALRNN
>EGALAKHO_02643 hypothetical protein
MKNKDNENFDGEERSFYSEGQRPGRNNSQEKEPLNIDKIQNNAENYNGGTSQDEKTAQKG
DVDNSLQNDFYHNPDKVASGNNPQRRTLDEYNANEYEPEQDNGLERAEPDNINSNEDADP
LNDNYDAYDNQPEDDDVRENNLRDAFNDDDLRDSDHPDFSNEDFDKED
>EGALAKHO_02644 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MINNAGQGEWGTFTTTDLDRETAIIELNIISTMSLTKYFLRDMVQNNSGKILMLASSVSK
APSPYMSVYAATKAFILSFSEALIKEIEGTEVTITILQPDATDTDFFHKAKAENSIAYRE
KKLTDPQRIALEAFRSLNEGKDIEVPGFQNKIQQALNTIMPDNMIVSSMEKQMKESHKKN
GRKQSSHTPSLRERKSINAYNNGHNGDY
>EGALAKHO_02645 putative oxidoreductase YciK
MIQKNVLITGATSGIGYELAKIFAQHGHNLVLVARNKENLKKTADEMKSFSNMKSHITVI
AIDLFERDSAKEIYEFVEDLGFQ
>EGALAKHO_02646 hypothetical protein
MKKLIIFISLSIVVIITIITYIAINFGFSKDNTIGLLGYFSIFSSAFLVFFSLYINLKYN
KRKSAMDFLHDRVKKELQPLYNELKGIIHKDFFLESSGKSFNEYLKHEQDNAKKSKAIEL
AEEMLAFYERMALGILKEVYDKDICFDHSAFNMLHFYDWTKTYLSTLQQNYYRRSFINFG
HLAENWRKRYEKQRKVIEKKDSLRDETVANKNI
>EGALAKHO_02647 hypothetical protein
MAGTKHKKKKLKTPEAQTADLLSKGRTEKFPVALRPMLPH
>EGALAKHO_02648 hypothetical protein
MENKNNTADNNQQEDTSQNANSAYSSSRSMQAGAGTGEAGKLNDYSDEQDQKETLESTGK
KTKPQTTGKSIAQATDPSKLSDI
>EGALAKHO_02649 hypothetical protein
MPWYNGDYPPSYKNQPKELREKAVEIANALLQDGAEEGIAIATGLKQARELLKNHKQENL
KTANHGKQE
>EGALAKHO_02650 hypothetical protein
MDNKSKTGKADDSRININESYQVQYWPEKLCVSRNQLKEAIKATGPHADDVATYLKQKS
>EGALAKHO_02651 hypothetical protein
MELLNYLRANVFKTYIVTGGIIEVVRAISADFYGISKDQVVVTSFKYSFDDATNSIKREP
ALDHLNDKEGKPAGIQLHIGQRPVFACGNEAGAGDIAMLKYSQGNKYSSFQLLVNHDDAV
REYSYQEKDNLSLDAAAKNNWHVISIKGDWKKVFADQ
>EGALAKHO_02652 hypothetical protein
MKPSFSRFEKDLKVHLENTFNASAKEDDIEKISQTEETVLEFTKNYLEKYGLTFKDVHQI
IESTLDEFAKSKIILR
>EGALAKHO_02653 hypothetical protein
MYLSEIKLAADINTSIVEIYLKTDLRFCGKKRYAFQTLHGPFPVANCSIRVKKYAEKLEI
R
>EGALAKHO_02654 putative chromate transport protein
MNSETPLKEIAKLFLKLGVIGFGGPAAHIAMMQEEVVEKRKWLTQQHFLDLMGATNLIPG
PNSTEMAIHIGHEKAGWKGLLTAGLCFILPAVFITGFFAWLYKQYGQLPEVQPFIYGIKP
AIIAIILGAVFPLAKKSLKTIQLGIIAGIVLVLSLLNCNEIILMFGAGIAALIIYYLKQN
TNKSINAFIPLTLFQVSNNNLFSAANLNLFLIFLKIGAILYGSGYVLFAFLEAELVSTGL
LSRTQLIDAIAVGQFTPGPVFSAVTFIGYQINGLSGAVVSTIAIFLPSFVFVALLNPLVS
KMRNSKVFSTFLDAVNVASIAIIISICLEMGKETITGWRTILIALLSIAIVFNYKKANSA
VIVLAGSLVGYFLTLIVF
>EGALAKHO_02655 putative membrane protein
MKFKIFRTDNSKTTILIRLMTGAVFLSEGIQKFLFSESLGSGRFAKIGLPTPEFLGNFVG
AFEIICGVLVLLGLFVRTASIPLIIIMLSAIATTKTEILIDKGFWKMLHESRTDWAMLLG
SIFLLIKGAG
>EGALAKHO_02656 Colicin I receptor
MNSTMQFSFFTTTFTRFFVILILSISFLNSANAQNATVRGFVTENETKLPVEFASVSVLK
KENAAIVKGELSKSNGEFSITDLNIGTYVLKIISIGYETTEVDFVISGKTEKIVLDVKLN
LSNKLLDEVVVKGEKSNIRNKIDKQTYKANQFESAKGGNAVDVLKNLPSVAVDGSGDISV
RGSSGFLVLINGKPVLTDAQTILSQLPANTIENIELVTAPSAKYEADGKAGIINITTKKG
AADGISLQTNALVGLPSTTTYNNLEDPLRFGGDFTFNYKKNKWDLTLTSNYTRNDANGKR
EGDVYTKDFTNNTITKFPSVGERSFDRYNYGARTSISYTADKSNILNFGFSASKKYQQRR
ADIVYNNSTEDLATGEVLDQLTYFNSNLQEKQGTFVLGSFDYTHIFKNNSKISGLAIYEY
ADLYGNTHNQNLDYPAKTALLQEVNNPYTNPINGFCFKLDYSTKIGEGRLESGYQIRNDK
QDGKFDYIVNPVTTPQEDEKFRALQNHQTKLMPYTASIPENILN
>EGALAKHO_02657 hypothetical protein
MKYIAGLRYEYSEREVVLSIDSDDHNQYLSKLFPSANLLYTFNDSWNAKAGYSKRIQRNN
NYELNPIPEREHSETLEQGDPDLLPQFIDLIELGINHTFKKGSFFSTFYYQNIKNPVQRV
NSVYSETILNRLFTNADKARLIGLEIGTTYKPVNWFSAYIGANVYNYKITSGSKIAELGT
TGSNSDFVYSLNMNSTFDLGKDWSLQANVNYVSSKPTAQGEDSSFLSPNTSVKKSFMNGK
MTIGLQWQNMNLGFMNSNQQRITTSGADFYTTTNYIYETDVFLLNFSYNLNKLNSKTKLP
SSELGEKEF
>EGALAKHO_02658 putative chromate transport protein
MTENPKYTLRELTLYFLKLGTIGFGGPVALVGYMHKDLVENRQWISEEQYKEGLALAQLA
PGPLAAQLGIYLGFVHYRFLGATLAGFAFVLPSFIMVVLLGMVYKVYGGLSWIQAVFYGV
GAAVIGIIALSSYKLTLKSIGQFNLESFKSKWLLWLFFTLAIIITYLTEQEQVLLFVAAG
LLYMIIKAPPVWWHPKAINSLAFFTIAFWNFEHATLTKIAVFFATAGTFVFGSGLAIVPF
LHSGVVIENQWLTEQQFLDAVAVAMITPGPVVITVGYIGYLVDGFLGALVAALATFLPCY
LFTIAMAPYFKKIAQNKPVKAFVDGITAAVVGALVGSVIVIAKRSIMDIPTVLIAVVTIF
ALLYIKKIQEPYIIVIAAVLGVIIKLIVL
>EGALAKHO_02659 hypothetical protein
MLLKNYILFTLLLASLTSFSQTVYPKFTGYFGILHPILTVSKDQTNVNFRDYYAVGFPTG
INIWKNEKIGFSFEIVPNIKDDQGTDKVTGILFHPGVLVALGNGYTFAGRLAFESGGRYG
ITPVLNKTIIKSKNCSYFAAVPLPLRFGNEHPASFTVGFQFGIAF
>EGALAKHO_02660 HTH-type transcriptional activator Btr
MKWITRERPKIDRIACPWLISRFVDKEAEFIYLPYAEVLLKAKELDAIPFDIPDVEFTHY
NEQCTFDYIIKKYKIDDPAVLIIAGIVRGADTDRHDLAKESAGLWAISAGLSHNITDDHK
LLETGMVLYDALYSWAAHLYKQNHLQNSPFENLLHQVYNKFLSDKKSKSKKTPLWVKDLK
NLIQDQIDTQFTFDLKQISNDLELNPSYVSREFSKYFEDLNFGDYVRKLRIEKAVTLIET
SSYTLTEIAYRTGFSDQSHFTRIFKLHTGKNPSSYRKKSAKK
>EGALAKHO_02661 hypothetical protein
MIQVINAPENVVAFRALDEVTKDDYQKVMAPAIEKLVERINEINFLFLIDTELENFTAAA
WIQDAMIGLKNLGKWNRAAIVTDSKKAITFTNGFSYFVPGEFKGFKKDSFDQAMHWVQGN
NENKPLDKWTK
>EGALAKHO_02662 hypothetical protein
MKTTKSTGTAATKTKSTGTQTKSRGTVKAKSSAAEGLRELFVDSLKDIYWAEKALTKALP
KMAKNATSEDLVNTINDHLTVTEEQVSRLEQVFDLIGEKALAKKCEAMEGLIKEGESIME
ETQQGPVRDAGIIGASQKIEHYEIATYGTLAAFAQTLGEDEALQLLQQTLEEEKQADTLL
TEVAYNNINFEASEDDQE
>EGALAKHO_02663 CinA-like protein
MPSEIVKKCSNTIAAQGWNIAFAESASAGRMAAEFSLTEKSGAVLRGGIVCYEVFVKEQI
LNVPHSIIEKCTPESADVTKILAQQTLKIFNSKIAVAITGLTTPGGSESKEKPVGTMFFH
IITPADIINHREVFKGTPEEIVLQAIDKTAQLIIDSINKL
>EGALAKHO_02664 hypothetical protein
MIHPDTEVRFISKEKGYGVVATKLIPKGTITWVQDDLDQIFTKDQVKNLSPFIKKHLDIY
SFTNKNGEMVLCWDNGKFVNHSFKPSCFSTPYDFEIAIRDIHPGEELTDDYGYLNVEKPF
KAIDENTERKTVYPDDILKFHKEWDELIKENTPKVLEVRQALRELIPEKTWIEFVNAVCN
PHLMKSILECHYQHDISVKSAS
>EGALAKHO_02665 Glycerol-3-phosphate cytidylyltransferase
MELTKTITGITFSAFDLLHAGHVKMLEEAKLHCHYLIVGLQTDPTIDRPEKNKPAQSVVE
RYIQLKACKFVDEIVPYATEQDLQDILQSFAIDVRIIGDEYKDSNFTGREYCDKMGIRLI
YNKRNHRFSSSGLRKEVYERECLKLV
>EGALAKHO_02666 hypothetical protein
MESFTTFFMGGYECADHINRSGERINLLKETQHDIRFYDDYEALASIGIKTVREGICWSL
VEKSPEIFDFSEVHNRMLAAEKFGIQQIWDLIHFGYPNGIYPTHPHFCKRFEKLCEAFTL
FYKEHSRQPLFVVPINEISFLSWHSGDVRGTVPFAVNSGWDIKFHLCKAAILGIKKIKSI
DPESHIILVEPLVRIHPSGPETVNQIIDLNENQFQAMDIIAGRMCPELGGSEDLLEILGF
NYYWNCQWEANGAPLDWPDKNEKRIPFSELLQQAYKRYQKPLFVSETGHFGSGRAEWLNE
IASECLLAQKSGVDLKGICIYPVTDRPDWDDVTKYCDCGIWDLDENKNRIPHQPYIDALV
KIQPRFKKSFFNQLLEFLK
>EGALAKHO_02667 UDP-galactopyranose mutase
MKQIDILVIGAGISGAVLAERYASIGKKVLIIEKRNHIAGNCYDYVDENSILVSKYGAHL
FHTNDEEVWKYVNQFSDWYPWEHKVIAKVDDKTVPIPVNITTVNKLFGIEISNEEQMKTW
LEEHRSPIAKPSNGEEAVLSRVGPFLYEKMFKHYTKKQWDKYPAELDASVLDRIPVRTSF
DDRYFSDIHQALPKGGYTQLFEKMLDHPNIEVLLETDYFDVKDQYENYEKLFYTGPVDRF
FEFKHNLLEKLEYRSINFVSETIEAEFFQENSVVNYPGTEVDFTRIIEYKHFGNQKSDKT
TVVKEFTVDEGEPYYPVPNPRNQEIYARYKKEADKLIDIYFVGRLANYKYFNMDQAFKNA
LDLFNALENKRTYKTAV
>EGALAKHO_02668 Putative teichuronic acid biosynthesis glycosyltransferase TuaH
MINNLKNAHKNTTPKKDIINSGTPQYYDMIVFCHLRWQFVYQRPQHIISRFASEMKILFI
EEPIPHNEDDNTSANLLVITEQLHVLQPYVKDIESIIDIIPEYVKNKTIPIGWFYSASFS
SLLEQINFETIIYDCMDELSLFKGAPVHLINQEKYLMAHTDIVFTGGKSLYESKKQLHSN
VYCFPSSVDEQHFAQALNGISVATDVAVLPKPIVGYYGVIDERIDLELLHKCAKKLPNVS
FAMIGPLAKIEDADLPKENNIHYLGMKSYNELPHYLKAFDIAMMPFALNDATKYISPTKT
LEYMAAGKPIISTKITDVVRDYSESVTLIENDGDFCSAIENFLTNKDRLAMETQYSKILK
KTSWNTTADKMESIIKEFAK
>EGALAKHO_02669 hypothetical protein
MKTLFKSTAALLVIVAGLAFSCKKNETAPADNYGNITDSTETTIDSVDTSIDTTTTNTGT
NGTAGATVAGSTGSGAAGTTQKGNTSLNDSARTVTPKR
>EGALAKHO_02670 putative manganese catalase
MFHHSKDLQFNARVSKPDPAFANILLEQFGGENGELAAAMQYFTQAFGAKQPHPDKYDML
MDIATEEFSHLEIVGATIQMLLKGVNGELKDAADSSEIMQVLDGNAAKETIIHAALTANP
QLPIITGGGPTLRNSQGIPWCASYIHSNGDLTVDLRSNLASESRAKLVYEHLMKFTDDPY
VKDTLSFLMTREVAHYKMFEAALDSIQPNFPPGVLQADPRFTQQYFNFSPEKSMQGPWNT
GEMPDMSKDWQYIQDPQSYVKQTQGMTDSEYINDADLDEMDTLNEQMSRLRSEEVKEAEP
EGTGVWSDYGTLR
>EGALAKHO_02671 Small-conductance mechanosensitive channel
MEFLNNYWQKTVHAPTAFWPHLLSAVVTLIIGLIIIKVFKKIMLRIIDVKRFDTTMIKFI
MDVLIWTFRTLLFVSIITKLGVETSAFVAVIGAAGLAIGLSLQGSLSNFAGGLLIILFKP
LRVGDYIEAQGEAVTVAAIFIFSTKIITPNNQSVYMPNGALSNGIIRNFSKEMLRRTDIT
LSVNHNSYITLVKSIIFDALKADKRILELPEPLILVKDITAEAVLFSVLACTTNADYGFV
VSDFYQAIKKTFTENQIKIPASKTEITLEHICTFNTGADKKMS
>EGALAKHO_02672 hypothetical protein
MKAIILLSTLKNTEQSNTETLVEFVGGHLVEKDINFEIIKLLDHQIRPGTCTQMETEDDW
PMIYEKILQAEILIFATPIWWNNHSSELQRCMERLIDVYDIIGEGGKSPLDGKLGGIIIT
GDADGVEHVTGNLANFFLSMGITMPPYTALGVLWDGHAKGSGKSKADLLQYYKEVYSHDA
IKMAEYLKNAK
>EGALAKHO_02673 6-phosphogluconolactonase
MNTADQQSLTKFNLLVGTYTNTCESEGIYIYEFDANSGALKLKNNSQKSINPSYLSVSAD
NKFIYAVNENETESTISSFAFNSASGSLTLLNKKDAIGASPCYLINDDQNIIVANYLGGS
ITVFKKMPNGSISQVKQVIQHEGKGINETRQDKAHVHMVYFSPDKKFLLCNDLGMDKVFI
YIYDPNAEEEILTLKETIDVKAGSGPRHSVFGKNGKFLYLIHELDEILTAFSYEENGQLN
FLSQTNITPENDEPANSSAAIKISPDGDFLYTTDRGKANLISTYKILQNGYLELVEQLST
EGENPRDFAIDPLGNYLLIANQDTNTITFFKRDKTTGKLTYTSKKIEICAPACLHFTAF
>EGALAKHO_02674 hypothetical protein
MKPIDTKTHGYIDYIMGILLVIIPYILNFNLSAIESKILYVLGVTAVLYSLLTRYELGLI
KMIPMKLHLMLDIVSGVLLAASPWLFGFANTVYIPHLILGLVEIVAAAMTNSKSKAEYLN
>EGALAKHO_02675 hypothetical protein
MTWLLCRLGRIYRLYEYDMRNTDAILASTSNRHYPLPKKKWKYFQQWHDTLFLHWEVPVY
FLREHIPREIELDTFNNMAWVSLVAFEVKNMRPRNLPSLPFISNFQEINIRTYVIKDEIP
GIYMFSIETDKLIEVLLTRFLIGLPYQKSKINRTSTKLAAKNRVSNQRLDITIGKSRPLT
EKTNLDFWLTERHALYDTCENEICRFDIHHKEWDLKNIKVSINDIVYEAGKFSLTILPDK
IQYAEELDVLLWGKEKV
>EGALAKHO_02676 putative oxidoreductase
MGNLSNYFGQNIDRRRIVITGGTTGIGKATAVLLASLGGHIFIFGRDKDDFDRAIDDIKA
QAEGEVYGVTADITRKEDIELIWNEIDNTLGGIDILINNAAVPADGIIDEEYENIKYILE
TNILGYIAFTKQAVSRMKIQQRGHIVTIGSMSAETHEETGTVYVATKSAIRGFSAALRKE
INELGIKVSHIEPGAVTSDMQPAPKDEQRENVKNMEMLEAEDIAMSILFCLSQPKRCDVV
AMQVRPHLQII
>EGALAKHO_02677 hypothetical protein
MQIIDTKTHGYIDYIFGLIVIALAYLLNFNTVNTPNIALYIVGTSAIVYSLFTNYELGVI
KLIPINIHLMLDSLSGIFLAVSPWLLGFSDKVFLPHLLFGLIEIGTTVITRFKPRYKVTA
SQKKLKRKTLQSN
>EGALAKHO_02678 hypothetical protein
MMITDETSPEDFVNARQGKYSHIKGWAIDANIKNDPTYPIKKRNNAEHDGYSWERPLQQD
ETVEILKSVERPNLSAVYGTSKPPSGLSGIIRRIAYKFSESSYGRWLPLILADRIDMIEG
VADDFSKGHIPNIPQEIGLKSEWKYNREEFLFKTAAGILITGTVLMLLFSSNKKQSQSKS
>EGALAKHO_02679 putative zinc-binding alcohol dehydrogenase
MLAMNYRGPHRVRLDRNKPIPEIIHPDDAIVRVLRSCICGSDLHLYHGLVPDTRIGSTFG
HEFIGEIVEIGSGVEKVKIGDRVMVPFNVSCGKCAFCRQELYGNCHESNPEATAVGGIFG
YSHTAGGYDGGQAEYVRVPYANVGPVVIPKWMDPDDAVLLTDVVPTGYQAAEMGGIQPGD
TVVVFGAGPIGIMAAKCSWLFGAGRVIIIDHIDYRLEFAEKYAQCEAFNFNSIGDPVVFL
KTMTDSLGADVCIDAVGCEAAGNLMNTLTGRRLLLQGGSTTALHWAINGVKKGGIVSIVG
VYGPIDSLIPIGNVVNKGITIRANQASVKRLLPRLIDHVQSGILNPKGLITHRIPLEEVS
EAYHIFSSKLDNCIKTVLIPPTAG
>EGALAKHO_02680 D-arabitol-phosphate dehydrogenase
MEDKMTAALKTAKGDFSISEVELPEMQKPDWILARVKVAGICGTDLRHWMHADPHLECKI
MGHELAGEIVSVGPEVTHVKPGDRVVIETVLGDDTCEWCNIQQYNLCPELYKVRMETISQ
AFAQYVSGPAKKFYKLPDHVSFEEAALLDTFSVGLHAIQLSGLKINDKVAIIGSGSIGLG
QLQLAKISGADVIIFDIVESSLDLAKELGADVVVNTDKEDGYQKLMEFTNNRGADITFEC
AGGSAMQMTLPRATEYTRIGGKVVIVGGFDSGKTETELDWHRIQMAEIKLIPSASYSYWG
IYPEMQICLDLLSKGQLNAKKMITHSFPIEKINEGFSTARDKKHSNALFVALTIT
>EGALAKHO_02681 hypothetical protein
MQNPVTPWTATVQADLVNGVLIYETEMSGYTLQIFNAGDSIWLKTSWPETGSIAFRLAFG
MNSDFEDAAVNENRDELIVTAPTRLGLYTIKLSFKADLSLVRYTTSFKASFPFLIPYWPR
DIVPLTQDGHIENTAGTIHAKQIGTRSGNLYFSMTKPKNGSVFYFQNLTAMSPYCEATQC
SVKDAVGGEWPEIGFEFPINEKKPIPAGIEYIISDAFVIFDEEIVEKADQVSINYLNNLA
AIYELIQKPEPVYQDWHAIAENVLSGLHLNKGCWTLTDDNTYLTAYAGDYNTPAELMVQL
AVLLPLHEYRDWSGKTHPLYEDVSGGLTDFYNETIKSIVRWHPSLIDHLDKSEPQKEDMV
MDSWYLHHPLLNLSRLALRGDKTARKLFLDSVDYAIRVAHKFEYKWPVFYKMTTLEIIQS
ETSPGKGGEKDVAGSYAHVMLMAYKLTNENRFLKEAVKAFKSLEELSFDIFYQANNTAFT
AGALVELYRETNDQKYLDLSYSCLAGIFKNVQLWECKYGYGGNFPNFFAVFPLNDAPYTA
AYEEFEVYTALHHYMEVTEGIDILPSLKILIPEFIKYAVSRMPFYYPTLLPAEMISDQVK
TGQIQKDLWAPLEDIHDGWEKSGEVGQEVYGSGLPFGVIPRQYFMLGDSKAMGFINYPAA
RFRFGKNNVTFHMNGNPNFKALLMLSGLSKTAISKIKVEIKSTGSYTEIINKENHFEFPG
DAMVRITW
>EGALAKHO_02682 hypothetical protein
MDKDDIKIDDWHRILFGEAPPEIIVEVAIRSIILYLALIFVVRLLGKRTNSILTITERAV
FITLGAIVAMPMHGPSHGIVIGIVVLLTVLVLQKSLTRSFFISEKWEKLMQGQAATLIAD
RIIDIGQLEKHFISRQQLFELLREKDIRHLGQVKRAYIEACGTMSLYKYKDPKPGLSIIP
EKDIDIIISKDESHSACSWCGNVVEENQFSECPNCGHNHWVKPSNEFLKDE
>EGALAKHO_02683 hypothetical protein
MNKDDIKLSDWARIFLGDVPPEFIIEVIIRMAFIYVILVVSLRLLGRRMESMLSRGEMVT
LVTLGASVGVAIHTPERGLLPSVMVILIIISLQALQAYITSRNSKAERLLLDQISTLVED
GRLIIKEMIKSRITRERLFAALRLKGIANLGNVQRVYFESKGVFSIITYIDHTERPGLCI
LPESDYAFREELKYDKNLKACRSCGNIIEKEKQKDQKCTVCKENDWEIAIKEN
>EGALAKHO_02684 hypothetical protein
MEKQENNFINKNKYKDTDQICNANLQDGILGDFNPDKKKGIHKKRPEYSQAFSRVNHKSA
KSLTELEQEYYDSLQSGNAN
>EGALAKHO_02685 General stress protein 39
MENASLKNPLTQYNQPPYEEKKQDTPGYETEMWKKPDHGEESYKGSGKLTGRKALITGGD
SGIGKAVAIAFAREGADVVISYADEHQDAQQTAGYIEQAGQKAVLIPGDISSEEHCKKLV
QQAIEQLGGIDIIVNNAAFQMSRNSLQEITTEEWLETFNTNIHPMFYICKAAENHLQPGS
TIINTTSVLAYKASPKLIPYSATKAAIQNFTASLAQLWGEKGIRVNCVAPGPIWTPLIPS
TMPVEQVKEFGADAPLKRAGQPAELAPAFVLLASQESSYMTGSTVQVTGGYPTI
>EGALAKHO_02686 Sensor histidine kinase TodS
MTYKNILQIDDDYDDCEFFEQALKAVSDAHYTAVTNPLDALRLLINKEIMPDLIFLDVNM
PLMSGPELLTEIKKRDMIKNIPVIILSTAPLISKNNEKVLGAKDFLVKPNTFSELKNMIR
NTLI
>EGALAKHO_02687 hypothetical protein
METPIKKRQSGGKAKIAANDGLQKLFTDQLKDILWSERALSKIISKMAKNIGSPNLIFIF
RDQASLNEIQIERLRKIFESIGIKARGKKCEAMEGFISECENILETTTQGPVRDAGIIAA
FQKILHYKMPAYTTLAAYSRTLHKEPVDEMLELTLAEDSKTDALLSDAAYSTINFDAAID
ENKVLASHYNNRINL
>EGALAKHO_02688 Multifunctional non-homologous end joining protein LigD
MAAIKRKKMNAQNTEAPTAELLSKGRSEKFPAGLKPMLATLTGEPFDDPAWTYEVKWDGY
RALGYIKKGKAELYSRNNKSFTEKYYPISARMGKWPIDVVMDGEIVVIGKNGKANFSALQ
NWRSEADGDLIYYVFDLLWYDGKNIMGLSLSQRQQLLKEILPRDDDHIRLSQVFTSSGLD
FFAAAKKMGLEGIMAKRSDSLYRPDSRSRDWLKIKANLRQEVVIGGFTKNEGSSKQFSSL
LLGVYENGVFQYVGKVGTGFSDKLQKQMIQEFIPLITDRIPFAAEPDINKPSRFRPNPPH
ATATWLKPSLVCEVSFAEITSDGVFRHPSFEGMRADKKASEVIREIPLETAKIFSESNEN
KDNDLTAPAKNSGRQTLLNPSEESQVKKIKGHALQFNHLSKIYWPEDGYTKRDMFNYYYQ
AAEYILPYLKDRPLSLNRFPGGIHGPGFYQKDVKGKAPEWAKTFPYTTSEGEDKEFLVGG
DEATLLYMASLGCIEMNPWFSRIQHPEHPDYCVIDLDPDKNTFDQVIQAAQEVKKILDAI
EVTGYVKTSGSTGIHIYIPLSAKYSYDQSQMFAKLIVSIVHGQLPEFTSMERQIKNRSGK
MYLDFLQNRPGATIACPYSLRPKTGATVSMPLHWEEVKKGLSMKDFTIENSIVRMRSEGD
IFKGSLKKGINMKKALAKAQSIFF
>EGALAKHO_02689 hypothetical protein
MENNDNIPDNNPQENTNQNANSAYSGSGSMQPGAGTGEAGKLNDYSDEQDQQETLASTDK
KTKPDTTGKSIAEATDPSKLSDL
>EGALAKHO_02690 hypothetical protein
MPWYNGDYPPSYKNQPLELREKAVEIANALLKDGVEEGIAIATGLKQARELLKNHKEENL
KTRNHGKQR
>EGALAKHO_02691 hypothetical protein
MDDKSKTGKGDDSRININESYEMQYWSEKLNVSRDQLKEAIKAAGTNAADVAKYLKQKS
>EGALAKHO_02692 Phytochrome-like protein cph1
MSDSDINKITNKFPVVAIGASDGGLDAYRDLLEAMKADSGMAYILMHLSADNRSNLSEML
SKYTALPVIEIVNEINLLPNHIYVIPEDNNLIAEDGVLKLYKRNRSDKVNKAIDIFFDSL
AQVNKSYAIGVILSGTAFDGTLGLKKIRQAGGTTIAQDPKTAYFTGRLQSAIAGDTVDFV
LAPQEIPSRLIEIRNSYITTHAFSEEEHISKKEQQVLDQIINLIFSRTGNDFGHYKQPTI
RRRIARRMVILQKLTLEDYYNALRNSKEEQDLLFNDFLIPVTYFFRDEHFFESLAGLVFP
NLIQNIQNNTLRVWVAGCSTGEEAYSLAICIHEYLFHNNLKGIRVQIFASDLSEKSIAKA
RTAIYSSQDVQQISETRLSIYFTKKDGQYYVQKVIRDMCIFAVHNVIKDPPFARIDLVCC
RNVLLYFDQSLQNKVLSSFHYSLKENGFLLLGQSETASNAQYLFDSIEKLEKVYVRKYSP
DLNVPEAFKSTQIAVNKTTNVTKNKGIAQTDFNKVLSEILFSKYTPATVIINKHLEIVHF
HGDTTPFLQPSAGKPDFNILKMARAEVSFELRNAISKIKKDKVPVIEENIPVRDQDYLSS
FEIMGVPNDEDHLVIVFQKKLPHDTENNIKTKKNSSDNRHTAELERELAQMGEDIKRVTE
EHHTALEEVQTTNEELLSSSEELQALNEELEASSEELQSNNEELMCVNSELLDRQDQLIS
ARNYAQSIVNTMREPLIVIDKNSMIKSANPAFYKYFQTTESQTEGHSFFEIGNCQWDIVE
FKDLILKMPAEKTPIVDYKVDIVCSGIGKKTMMVNANPIVDSKPEGMILLTLEDITDIVA
ANELLRSKNTKLQKNNEQLQIFSAAASHDLQEPLRKIQMFSRKILDKGKDLDGSSIYNLE
RILFAASNMSQLIDDLINYTRINFTDKEFKKTDLNVLLKRTLSNTKETIEEKNANISVSP
LPELTVIPHQIQQLFTNIITNSIKYTKENEIPKICIDSTVPSNEEIAEFAGNSDMNYVKI
CVSDNGIGFSKGYETKIFNPFYRLHSQNEYSGSGLGLTLVKKIIDNHHGFIKASSIINKG
TQMLIYLPLQNLKN
>EGALAKHO_02693 hypothetical protein
MRALNFLLLLGVILLISLFSCSHCDDEDNNSAQHENQNIIVDTLKLEPQYHEKSYTNSRL
Q
>EGALAKHO_02694 hypothetical protein
MNWKPMLDDHNFQEGKSAKQRQNSDSSLADHSFYKQH
>EGALAKHO_02695 scyllo-inositol 2-dehydrogenase (NADP(+))
MKKYKIGIIGYGGFGRFLHHWWSRLENIEVTAIADSGEHPHHVGSTTLYHDWKQLLEDPI
IDIVSIVTPPGMHAEMACAAMQAGKHVLLEKPVAITLEQAQAILATQKETGMIITVDHMI
RYNPIIQSFMKLGHDETFGRLRHVIVNNYAQDETLAPNHWFWNEGLSGGILVEHGVHFFD
IVNAISGQHYKEVYGTSHSRNKSQRDRVAAMVLYNNGLIASYYHAFSGPGYFEQTTISLV
YDLARIEIEGWMPMKGSVKTLVNKDIKDKLKSIPGWTINKVQSLGELKDVSRPEGWGSSD
ASSSAENQLTYFGETAYDLDEMISGIFEIHKTKGEVYGSCVQLILSDIIEKVENPSHELT
ITLDNAVEALKTAILASE
>EGALAKHO_02696 hypothetical protein
MKTSSLIGIKDLAETIALDYPDIITPLERILSEEDLDLYYDNYGEAFDGMTIYAHSQFFI
HINIFRGNKPGSPRSRFSIAHELGHYFIDNHRVGLKKGLLSPHPSKNNENTHFRIESEAD
YFASCLLMPEERFKKFVLRKKFDFSIIKALSELFHTSITATAIRFADLGNHPIMIVFGEN
GKIKWKHCSKDFPFQYLLYSSKIPEDSVMGEYFYKNRIPVRSEDVWPMDWFEYVNDRNSQ
RKFKEHCIPYKNLAFSIIWEIK
>EGALAKHO_02697 hypothetical protein
MQENNTPNITMENLDHHLGALGFLYPVNEAQLDMFNIVYADFDFKLKEVHIDVNSIINNQ
ITKKSVIQLNNYNPSEIDDLKMAARNGSENLSKNIIDKMYEKHRKKRDNED
>EGALAKHO_02698 hypothetical protein
METTLNDTIDFEKICSSELLDYISFKSEYPKEAELAFAEFCRRFEQDVLQKAEVYCSKFG
YNEIIALDVAHCAFARVWKYPTFDVKKLKSKTIDKGILLWLYPIMYTQILKFEHASTCAD
PNEEEALEIITNLDGLAEKLCDSDDIEDKKILRKKLQIMDGAFLGLTEKHKIIYLTYKAY
ERVGKNIPRAISKKLQETLELVPVTIRIYKRDANLHVENYLKESHARK
>EGALAKHO_02699 hypothetical protein
MKEKIEHVKFIIDRFDTYMESTQTKSNLYLALNTAILGGIITLAASSKPQDVTFFSVFVL
GSIAFLAVASITITLIAITPYLVSASEKSESVIFFQDVRNITFDEYVDKIKDMSDKNFLK
DLSCQAYSLAGGLQSKYKKLFYAGRLIIIEFILLLIYAITLVTNII
>EGALAKHO_02700 hypothetical protein
MEPFLEYQNIIEKALNRNEIHKSLNESITFSDQSRAVALGKYTMSDYISNRSQLSLSTDL
AAIAKSMGAIPRSNQVIGHHPDFMYLKGTSNTEKHYIISAFIDIKGSTNLFKKYDEETNM
IITNTIQLAAINVCQVFGGFVQRIQGDGLFVYFGGKNIDRNKATQHCLTALSLFSYFVKN
DLKRIFEQHGIERIYTKIGIDFGDDNKVLWGVAGTEQTSEIATYSLHTSLAAKMQAYAGS
NEIIVGQNVKDKAQFEDKFYSVVVEKRYIFSDPENGFFYTQYVFDWIKYLRSSPYIATSV
SGDITIKPQISNVPNIASLREVVGENRPYAKIKNR
>EGALAKHO_02701 hypothetical protein
MEKTDPMQRSKIDNDLEEVLEMFPKMDLIVENKFKVLSGEVDIFDSANIYVESFNIKVIV
PPGYPYQFPRLFEIGNKFEHVPERHISEDGSCCVCSLQEENLVSQRGISIKNFFLKYVLT
YLANQLYFDSQGKWANGDFDHGDLGIFQYYSELLKLGNITEVVEFLSVFNVTKLYRNDVC
FCGSGKKLKRCHEGVYQVFKGLSKKRREMDLFELRSLAKKK
>EGALAKHO_02702 hypothetical protein
MTNYWKQSGIPHKGWILNDVIDVRQDGESEDETDYETCMMCGNEKIRYVHLVEHPEVEDE
FRVGCVCAENMTNDYYNPGKREKELRNRANRLKNWHNRKWKLSQKGNFYLKIENHILVIF
KDKFTRKFKVMIDSTTGSKVFENLEKAKIAAFKGIEYFKKSGKW
>EGALAKHO_02703 hypothetical protein
MENIDKSKVIELLENTELIISKTVYGSKLLSDLRVEGLLLIKDLHLKEFVTFSNCHFDQV
IFNNVASKEQLEFKHCTFSQDFTIVFADLINFQLDNCQFEKGVIINNCKLYYLSLRKLES
QNGINFEAGQINYMEIKPVNEKTHFSLIGKFLLIKELHIISLSGISVFAKKAIINNIHLS
GYYNISSRLDFNGIINKSLEINELNNEGKIYFSNLNPLNVKDFKNPPLTDYINTYELSEK
ANLSELGWINKLRGKVTTLDLLTGQFPVFVFREFIEENYYTDFLEYDNKLSPVFRINDSA
AGILELKNIYFERYKVEINNSDLSAVKLINSKIPDITATDNYLSYYSIYNDLYTSANRQN
NTKDKVEYYRISQRYLYKHLKDGSTSKHRDTGSLIAIAVSNIYSSHGTDWLKACFVTLLI
SFLFFCLFAASLRQIYPDISLTGLYNFLTEIFPFFPQFLNPLHKIEMMETVGQIGPWSAL
FDFVSRIFIGIGIFEIVRAFRKHVR
>EGALAKHO_02704 hypothetical protein
MFEKGDILEAADRELTKVRHYILYYEGFSHDDFIGGMITHSDIHGNLKMQNEHFESFDHN
GSKYKVIYDETYLVNAKLIKPHVWGPFSKVGSLSESGITFFENSINYLPSETFEDYRRRT
MNIA
>EGALAKHO_02705 hypothetical protein
MSFKLLAIRPLIGCDDKILKNLKIDEIYKFYNDYQFEDGIAYSLIDNQPSLRVKIASEKR
KSAPENLYGNNINVSAIVGKNGSGKSALVELLIATIIKISLVVDRNFIKPDELYYDDFER
GINNFNKSIKTDLEKLKVEIYYEHSSNFGVANRSNKIVTYNSGSGKKIRCIQLDGENVII
KDQINRTVKYFRLIDLDQANPNKQKLSQELYYFLGDLFYSMVINYSHYGFNPNEIGEWIR
GVFHKNDGYQLPVVINPYRDNGNIDINSEKDLAKSRFLVNILQEKELRIIQKFKAISHIS
ISLDQSKFRWEESKMSDRRILNTEDDKRKILNVISQKFYIKNDLFLNQNNYFYNYALDYL
LIKLFKITNYPIYREYRKCFEEITVNINGEKINQFRIIPGELFENYVESLFVNFSHVTHK
FRQALFFLEYIYFDISDVRSDGSEKILEIGTLYDWINSSYLKGLKSAIESYNNEDEILFK
ESLMQRFNTGKFESQHSLPSFFKIEYFFEDKISNNNFSNLSSGEKQKIFSLHSVLYHLRN
LISISENNSIGLENNVRKLITYKNINIIFDEIELYAHPDFQRIFISDLLKSLKAINMNGK
YLNILFITHSPFILSDIPKQNVLFLEVDELSEKSTPGTYEGNNTFGANIHEMLTNGFFME
STKGEFSIFKINEFLDFYKVATNLKKDSNEYNKFKADFENKDKKYFKDLIFIIGEDFIRN
ILNNHLLELYNHFDISFEEELSMMELEERKKVLENELDELKKRIENEKN
>EGALAKHO_02706 hypothetical protein
MRRINYPYTNYIEKEKFKEDYYNLLKKKIDVVTFEAILKMIDSNLTLKALITSDFSELLS
ISKKIKKSKYEKNIKAFFIKNDKMLYDQCQIIISGFLMDKKMELNTCHYCNIDFINTVEQ
HYKFKSVKEFILEAPYHVLMLIKEINSTTAKRIIKYRKYYNWTINWTSLLNKSVYNSLFK
LFNKKNITDSNALDLSNIVIKKNHFTLDHVLPKNEYAFLSLSIFNLVPSCYSCNSKFKHQ
KELTINNDLEMLCPTSENFRLHDLMHFKMKFNINDVEFERKINEIKEVKDVEIILENTSS
IEGVDEFIDIFKLQSRYEFHKYISFEMIENRKSYSDSQIKEFSEIFLKKGIVKDADSIKK
NIFGKALFEETNSPFEKYRRDIAKQLGLIK
>EGALAKHO_02707 hypothetical protein
MGSFSQLTIADYPLFSVKNGYYQEVIDLIFLPEDFIKEKRKNSSRNKLVWGDVYEGDKKS
FVFNGYKQTAGICKQRLEILGMNIRKAKKEFPIAKKIAAEEFFYSFPISKISFKEYIEEI
SDIIVKKEVHYDQLYSNFRESLITGELSIFGQTTTSQLYSILSCVPEDSIVEYDLTDIIR
GGWIKENVAEEIDFEKILVLTEGKTDVEFISSSLQKLYPHLYPYYHFIDFDEYKVESNAS
ALVKLVIALAASNIKHPIIVLFDNDTTGIMEMKKLSSISMGSNFKILKFPDLPYAKKYPT
IGPTGLKSMNINTLACGIEMYLGIDTLTKDGKFIPVHWKAYNEKEKKYQGEISEKNYVQD
VFRNKLKSNTVSDFSAIDLILKMIFEAFHN
>EGALAKHO_02708 GTP pyrophosphokinase YjbM
MVDIQNEYEQIKNDYDDFLNEVKRTVEKLLKRHQIPIAFGINGRRKDLVSIQEKAQRFTI
KKTICELNDIVGLRIVLLFPEFKQNVIDLLCREFKLLNDPNKTQQLPDKFGYSSIHLILG
IKDEWLKSPDWEGHADKKIEVQIRTVSEHVWAETSHSLFYKREENIPNIITRDLYRLAAL
LEVVDEKLQNIKGQVEHHFKHIRECSYEEILKMDLNSETFRRVMMENSKDIYSFNDLQNK
ELSSRIEHDYNILNIDMLDNLITEKIDLNNIDSDEYIRKVIEILEEYKNGIDTLEKEKVK
>EGALAKHO_02709 hypothetical protein
MGKFVITRRANGEFQFNLKAGNGQTILTSEGYTTKTACSNGIESVKVNSQDENRFDRKET
SNGKPYFNLKASNGQIIGSSEIYESTSARDNGIASVQSNAPHAIIDDLTV
>EGALAKHO_02710 hypothetical protein
MNQNEDFMVNMDLKDFRKKIKSSDFETSYSKLMISSDLEENEINHLLKCAIIFVNFGDLD
IQKLGYKIIVNYSNQYNDYKPLYDFAINKGFIPISKLIESNYFDEGKKESFFSNYLSAFH
DNFKESNYYISNGQKKLIEFSKNNNKTDFVLVAPTSYGKSEIIVNKVLLNLNKITCIIVP
SKALLTQTKKRLLKDSGITGLNRIITHPEMYKGTEVNFVAVLTQERLLRLLQKNSNLKFD
LVLIDEAHNLFGDKEDDERAVLLAQVIIILKKRNSDTRLNFFSPFISNSDNLRIKQSDYS
LENQFTEEFIKTEKYFVCNTKNGNNELKIYEQFSDRFLLLRKYYSNEFDLLNEESAAKNI
IYLNRPKHIEEFSKLFSEQIQDSLVDSEEIVNTISDFLHPDYNLISCIKKGVVYHHGGMP
EIVRLYVESIFSEKKELKFVITSSTLLEGVNIPAEKIFLLSTKKGKRNLSTSQFKNLIGR
VNRFSEIFDKENGGLTLLEPNVYIVKGNYSDNRANIENFVRKNAKTEISIEDEVNNLFLK
DEQNLSQDQRQKLNNSLEYLENIEPNSTDLVNVDYVNSEIAQACYRNNIYDFGIKISERV
LIRNLFDYLESNVNLINNVNDLLEAFYLIFLKNIDIQNKNIERLTNIAARRFYSMILEWR
STGTSYKEMIGSFLSYWGGLDPSQQFIYIGEKWGELKRLETDFIPLYVDLSKKTRQEKVN
LAILKIKEEQDYVEFNLLKYIDIMADLELLEKNFYEKIKYGSSDLKIIMLLKNGFSIELA
KIVVKSEYSDFIVFDFDKDEIILNENILVKMEANLENKILIFEVKYHINQ
>EGALAKHO_02711 hypothetical protein
MIDGVNILKKTNYSLLYFNSFSDEMKNIIREQLRGIYHGFNEIDLAPEFYSYKNTLSSFL
DRYEGKTEETQKGMIGELLLHVLINHLDFGIKSLSILKNKEERSIKKGFDVVYFEINEKK
LWYTEIKSGRCEDGSKNSSQYNLELLNRAKTGILTMFSQKLNSRWESALIDVSLTIKEAD
GALNLKNILANDSPIMGNIEKKNAILVSVLYHPLSDLIEDSNVNKFCEDVLNEGSFLSIM
IISIQKTTFDKVAQFLRDESK
>EGALAKHO_02712 hypothetical protein
MDYKCQIKELSNCSEYEINMFHDLVVKGGKVKLKGLRERILNCKLLAFCYNNSNEIIAIS
SIKRPQKSYILKVIENARLDRFHTDLQFELGYSFTEVEYRRKGINGYLKKYLLDEIKTEN
CLVFSTTAITTSQIFLENNGFICYGKSYDGENDKDIKYYEKKCGKF
>EGALAKHO_02713 hypothetical protein
MIKELLSNIFSKIEIINEKENFKIYEIIFLCKEFKDFSINLNQVNYDLIDNYIKIFNYKW
DLYIEQLSYSISQDSFSPLEMDDDLETDYEIKFAIYKEGSKSLIVNSNIFETFLNTLTLS
NLLLLVNNKEYPHYFYDDSFGLVVSNEKIGINFDSQIPSFESNLIISKQCNFRNYSEYLF
NPYYFHFSDIAKKDFLLIKLFSRLSLIYCLIYLYDSSEIKDDMIILKISGNKTFEYSIKF
KDIDEKLLPNYFQIFEWVYSEHTKIEDKIGLARNIITSYLKESSIEIEDSVFTSILSSNQ
IYIKGNISKYFETKNKIIEQVEQTVNKVNQSVDTFFNSFQKSLFVFISFFLTVFIYKIIN
KAEVDKIFNKETSIIGLGFLLLSLFFMLFSRLILNLDKKRMKSRYDKVKDRYKDVLIKED
IEKILNNDEEYLSEIDYLNKRVYWYTFLWIITLILFLIMLFLASDYLELNLIVDNNSNAN
CCS
>EGALAKHO_02714 hypothetical protein
MDIRKLTLHKIDISKNTAEEIEIDISKETIVEYVDNLVNEILESPNKRMYRFKNGETQVK
SSLVKLVKQDVEVDRIILHNAERLLEKELQANEQLKSKKLGVKIQKGSLLHLHFVQDKMD
KILVCKVEHDEYLNELNFDKNNGLNTKKKVFKSFLMFLDSSTIYLNDKNNSKYWWDDFLE
LEQVNNDNDNTEKSVHKIMVIVDSYKKEYLLDGTLLRNAIIGHFKSNKNFNLTELLDNVV
ASYTPINQNFPLKKISERVNKLATDNSFDNQFVIMQEKVNKRIVNKIRLGSGLYLSIEDF
VKNLYEILKPFSDSQGNGITIISEEAYQFVNQMKK
>EGALAKHO_02715 hypothetical protein
MPERISTILNVTEEHLDEKGVFNSFIDIDSNLYIDPCLLEIIRISEFKNSYKKFQDHFSA
IIFLIEKIKAKDDMYWRAALRKLQFKEFRFTGLGYSVGGKKGNGIGKVLAEKMLNIAIEI
VEEGFKDPIIFELIGLIQMNISLDRISDMTTHIIKEDLINYTIRVSQELELETKRFSKIY
LPFNPHNNEPIIFIPKKILRDIPIALCWTDIDIVSSQTESLKSEVNNIIGKSWKEVKSNK
NYLRNILLNNSDAFKDLIKQYKNKPRVGYDFINDPLGEVIWANLSEKAVEENPIDFKTLN
LYPVTSENILEVVKVICSQYCHLIENCGWYEFLYDNNKLRNERFAQKLFYGIADIHCRVN
DLNLSREPNAGNGALDFKITQGYNSVVTVEIKYSTNSNLTKGYTIQLPTYNKAENSRNSI
YLVLKTKDSETGLKNLMVEHDKLVQKGEYAPEIIVIDARKKLSASKRKN
>EGALAKHO_02716 hypothetical protein
MIPKTIIEREISHLSTTLKPISAEMQHWAEKSIFLKWGVLSRGKFHCLECTHSWKPESQN
KSCEKYIKCTACQGRLKMQGCNQVHFREIEYSAVLNVCRGYQVVRIICSHKHMKKNFAPS
YFHKEVMQHWINPQGEVRTMSLSTNVFSGAYDAWQYYSALEIRPKDFQNSPKYRINPYKV
FPKIKVLPVLKRNGFKSGFYNIAPQILFTSLLKDSIAETLLKSSQTSLLSYYLQSHEQHI
EENWQAVKVCIKNRYVIKDYKIWEDYISILRWFKKDLNCAIFVCPENLNEVHDKLVAKKR
ELQRKKYLLKMRSEIEQAQLLYEKEKKQFFGLCFKEEDITITVLENVSQFMEEGDTLKHC
VFTNEYFKKKDSLIFSARINNQSIETIELSISKMEIAQCRGIKNNKSHHHKMILRLMQKN
FYQIQSRIK
>EGALAKHO_02717 hypothetical protein
MKASEQFKSVMEKYLNDTAQSDSVFAQNFTKASKNLESCINYIFGEVKKTGFCAFDNQEI
FDMALKYYTDDSIGTPAPVSCKVVVNQPVKADLFTSAPAVSENTIQKTEKLQTPKPAEQQ
TLTLFDL
>EGALAKHO_02718 hypothetical protein
MKALEKSMYKQYDVCTAFNKIILSDLGSYDGTKKEQLKSFLEDLQNGGCMSGMISEFIYH
VDCKKFYIENLDDLENIREEIEDSLGEPVKNTHRLPHYTFMCWLCFEEYCFDIYRNSFE
>EGALAKHO_02719 Single-stranded DNA-binding protein B
MEITGRIVKDASVFKLKENREVVNFTIAINDSYKPKDSTELKKITTYINCSYWVSSKSAK
WLKKGALVELFGRIGLNVYIGSDSEAHGALTFHTSHIKILAFAKDGEQTPQISKGAKASS
EKEPDDLPF
>EGALAKHO_02720 Exodeoxyribonuclease 7 large subunit
MIHDTISARFASQRFWVLADITNHSYKADKKIHYFELVEKAQNGNAITAKMMGKSWGGGA
VRIEEFEKNTGQTFTNNLHVLVQVSVDYHPLYGLSVSVLDIDSNFMLGILEQQRNATLDR
LVKENDYIQKVGDGYSTFNSRLKLPAVIQRVAVISSSSSAGNEDFRHTMQHNDFGYVFQI
DDYYTVVQGDNNAKLFLNKLIEIYNTGIPYDAVVINRGGGSQSDFLIFDNYNIGRAVAKF
PIPVITGIGHQKNVSITDLMAHTHTKTPTKAAEFIIAHNRSFEQNILSLQQNILIKSQQL
FHGHYKELNEIKNAVSRNVRELVQLHGEELTRTNQRIISSSRAILYGHQKRLILTAHQVV
QSPKLLFQQRKNDLVHIKNTIRNSTSEYLRREKLTLEHHQKSITMMSPQNILRKGYAIVK
VNQKIISNAKNIETGQEIEVILKEAKLKSTVKEKIQYDGRETDL
>EGALAKHO_02721 Exodeoxyribonuclease 7 small subunit
MEEKLTYEAALAELTAISKEIESETISVDELASKVKRASELIEFCQTKLKNTEEEVNKII
SRMENPEN
>EGALAKHO_02722 hypothetical protein
MMLFDDTEIFSSGRGGKRIFDVPDADLLLIDNFFNKEESDYYYNVLYHGTQWREYEMPMY
DKVVTAPRMISWYGQTNRPERKSDPNWPTELLQIRERIQKETQITFNAVLLNLYRDGSDG
VGWHSDKTSSSNKNMNIASVTFGETRLFRLRHKTLKHIPPIEIPLHHGTFLLMAGSTNTY
WEHQVPKTARDVLPRINLTFRQVKET
>EGALAKHO_02723 DNA polymerase III subunit alpha
MYLNCHSFHSLRYGTIPLEDLIAHAAACGVTAMALTDINTVTGIYDFIKGCDVAGIKPLV
GMEFRSEHELRYIGLAKNASGLAEMNRFLTHHNYEKTSLPLSAPGFLDVFVIYPLENAPV
SLTENEFIGIRPEQLPKLVLSDWKNRQEKMVILQPVTFRSKREYNLHKILRAIDLNLILS
RLSADDYCKDSEVMVAPERLLNCYEQYPHIIANTRKIIGQCHFEFDFTTPKNKKFYTNNK
RDDMTLLTSLAKQGLEWRYGKNNAEAKSRMFKELKVIDQLEFSGYFLITADIIRFSTSQG
FLHIGRGSGANSIIAYCLGITDICPLELDLYFERFLNLNRKSPPDFDIDWSWKERDVILE
YIFSRYGYDHVAFCGTNVEFKYRSIFREVGKVFGLPKEELDALAKNPMTLHATNKVVKQV
QEYGMLLEKYPNQRSMHSCGILISEEPITNYTPLEMPPKGFPIVLFDMHIAEDIGLEKFD
ILSQRGIGHIDDSVKLIEKNRGIRLNIRDTSISKNEASCNAFLGIGRTIGCFYIESPAMR
GLLRRLKCDNYKTLVAASSIIRPGVAQSGMMKEYIFRHNHPDKFEYFHPVFEQQLGETYG
IMVYQEDVIKIALHYGGLPAEDGDILRRAMSGKGRSKAALQKVKDNFFLSCTKQGHPIKL
SEEIYRQIESFAGYSFCKAHSASYAVESYQSLYLKVHYPVEFMVAVINNQGGFYRTEVYV
HEARMSGAVIHNPCVNKSEFETTLYGSDVYLGFMHLQSLESKTALHIQTERENNGEYKSL
EDFINRIPIGIEGIQILIFIGAFSFTGKTKNQLLVIARLILVNFKPENRNLMLIQQPVKE
YELPKLERSEFEDAFDEIELLSFPVSCSPFDLLQTKFRGDVMAKDLLKHHKKTVRMLAYL
ISRKHVPTKMGAMYFGTWIDAEGEMFDTAHFTDSLAKYPFQGGGCYLLLGNVEVDYHFPT
ITVSKMAKMPFIADPRYANSDDRQFKVHGQIREDVSMTDRQPYPQEHEINLPRLKMGN
>EGALAKHO_02724 DNA polymerase IV
MGRSIVHIDMNTFFVSCERLTNSELNGIPLIIGGGERGVVASCSYEARRFGVRSAMPIHL
AMKLCPQAKIMKGDMELYSRLSHDITEIIQEKAPVVEKASIDEFYLDITGMDKFHGSYKW
TNELAQTIIKETGLPLTFALSINKTVSKIGTGEGKQKQNLEIPEHLVQQFLNPLSVQKIP
MVGDKTFQLLSRIGIRKIQTLSEMPCEVLQQMIGKNGSELWKKANGIDHNPVEPYTERKS
ISTEHTFSQDTIDIPKLKRVILGMVEKLAFQLRSEEWLTSTVTVKIRYANFDTETKQCRV
QYTSADHILTKTVTDLFEKLYQRRMRLRLIGVRFSGLVRGTYQIDLFQDTEEMLALYQAM
DKMKSRYGFDAVMRCAGASFKPNNKNEILKRKSQ
>EGALAKHO_02725 hypothetical protein
MQTGENEQALRKILDMTRLMGIAVLLIHFYYYCFDSFRHWNLAPDFACRILENIYRTGLL
ESFHKSKLFALGLLVISLMGARGRKDEKLHFRTAFYYISLGLLLYFGSYLAVLIFLDPEV
CSVLYISLCSLGYLITLSGGTLLSRIIHIKLSSADIFNKENETFPQEERLIENEYSVNLP
ARYHLKNKVRSSWINIINPFRGILVPGTPGSGKSYFVIRHIITQHIAKGFSMFIYDFKFD
DLTVIAYNAWLKFRHLYAMEPKFYIINFDDLSRTHRCNPLDPAAMSDITDAAESARTILM
GLNREWIKKQGDFFVESPINFLTAVIWYLRKYNDGEFCTLPHVIEMIQTDYESLFTLLRT
EKEIEVLINPFVSAFQNEAVDQLEGQIASAKISLAKLSSPQLYYVLSGSDFTLDINNPSD
PKIVSMGNNPQKIQTYGAVLSLFVSRLIKQVNQKGKLKSSLVFDEFPTIYLNNIDSLIAT
ARSNKVSTCLGIQDFSQLRKDYGREQADVILNITGNIISGQVTGDTAKQLSERFGKIMQD
RESLSINSSDTSISRSKQLESAVPASKISTLSSGEFVGIVADDPDCRIELKAFHCDIIND
HQALKKEQDSYQDITAVRKIDNSMIQRNYMQVKQDISELVNSEMERLLNDPALVHLVIKK
HNS
>EGALAKHO_02726 hypothetical protein
MVAVINTGHSIRGILIYNENKVSQGAAVCIGEGNYPIDIEKMSESFKLGVFLKQLQLNEN
VKRSAVHISLNFDRSDKDLSKEKLMQIASSYMEKIGFGAQPYLVYQHHDAGHPHLHIAAI
NVRADGSRINMHNIGRNQSEKARRELEISFNLVRADSRKKQSPALINAIDAEKIKYGAID
SKRAINSVLNAVIQHYKYTTMGELNAVLNLYNVKAERGKENSKMFQNKGLIYQILDGNKK
TVGVPIKASSFYSKPTLSRLEINFTASKTSRMINMKRTRNAVDLLLLKYPSLTLSQLETR
LANQGITAVVRKNEQGLIYGMTYIDHNTKCVFNGSSLGPGYAAKGLLQRLGHSSYSEKHY
NTVPDGTAHKQGSFISAGEVQRIIDEVLYAGTPSDYVPRELKNKRKKRKRKGQSDNN
>EGALAKHO_02727 hypothetical protein
MEDKNSSRNRWLHIRLTKEEFDFIDKNFKASACRKRSDFVRRNLLRKPIVMRYRNESLDK
LLQELIQLRTQLNFMGNNFNQSVKKLHTLFEISDLRVWILSFDSDRNKYFSLVEEIKKNI
EDLAQKWLQS
>EGALAKHO_02728 hypothetical protein
MFTAIDAAKVFDTVLSIPGMNETVKMDLKISRKNVLLLSHLIQEGMKFREGSSVLLESIN
DHGRTELENLSEEFLQKAGLIELHEKLAGISASIKG
>EGALAKHO_02729 hypothetical protein
MTLSNHVKYYITETICLLFILLFIYASISKLMDFENFQVQVGQSPLISAFASWIAWFVLI
LELTIALLLCLPKFRIWGLLGAFSLMTFFTIYIFIVLNYSSFIPCSCGGILEKMSWKVHL
VFNFVFILLAALAVYWRTKIDHVKIFSHNLKPVRSMFILCLCSTGIMIFLFLYSEDIMHY
ENPFIRRYAKHPVTFLSKKNLTFNSFYIAGISQGRIYLGNYTSPLHIISVDEKLQDEQVH
QISFIPQKTPFKSITINVRGKYFYLKDGTVPAIFRGKISDWRVSSELKGLPYFTQAEPMD
SIAVVFRSNNGKNLAHVLGIYNSNDKTKVVYNDSLLQKQIDGVFDTDGVLTYSEMQRKIV
YLYLYRNEYIVADQIGRLTLRGNTIDTTTKAKIKVSYIKDSTQRKMSAPPYVVNAKAAVC
ENLLFVQSKIKGRYENDKLWNQASIIDVYDLSRNAYVLSFPVYNLKDEKMKSFRVTHTHL
YAVIGRDLVVYDFKDELRNKMENKGSE
>EGALAKHO_02730 hypothetical protein
MKTQFFKNAMPFAVAALGIIGAFTTTSMQSAEKEMVLVDAYNPSNCQDIVKQCDNQERTY
ICSFNGNQLYAKDNIGNCTETLWQEQP
>EGALAKHO_02731 Dipeptidyl-peptidase 5
MTAFIPLRIFKISFLPFFTLVPFFILPLVTCPLKGQVMQKKKLDQASYKLWSNFEIDKTA
PNEKWVSYGINYAYSFDTLFLRNVTDDRTYSFPSALKSLFTKNNLFLFMKGDTLTTINPE
NGKKDIITAADHYEYSYQNNLLLVFIRSEKNKGILRVKSPLDETLLEIPNVTKFSMSTSG
SRLLYNVAFNGKNSLFLTDLKKLSVSEKIISTNENYYDNFTWQRNDKAIAFCSNSKAGDP
VSLFLYTISNKKMYQLDPTRLDIFPRGASIAAPSRNKMLISDDLKKVFFSVKNKSEAPLN
QSDSKVEIWSTKDKWIYPQEQRNGNSSSTPKMVVWMPEQKLFRQITDNNLSSMMLSPDCS
YAVLSDPKAYEPQFEFEGPRDYYLLDLTTFEKHLLLRKQPVLMHDISISSTGKYISYFKD
KNWWIYCLKDKTHTNLTSKSRIPFLGKVIALSADSPYGNAGWTTSDEEILLYDEFDLWAF
KPDGTRNRRLTNGREAQIRFKLDLKPKTINRKYLYDGLLHQQYDIKKTLLIRGENQNGQT
GFYTWNSTEGIKTIIARDSYFSNLITGSKRDTYFCMEQKFDLPPRMIAVGNNSNEKCIFQ
SNPQHANFSWGRNELVSFQNSKNKNLKGVLYYPADYNPNKKYSMIVYIYEVQSGGLHRYW
NPTLENESGFNPSVFTAADYFVFLPDIVHEKENVGPSTLDCVLSGTKKIMETGHVDTKRI
AIMGHSFGGYETSYIINQTNIFAAAIASGAITDLTRRYLTIGINTARPEIWRFASGGWRM
GDKTPFSNQADFDRNSPLSFIENLQTPLLMWSGKEDTQVDPFQTTAYYMALRRLNKKNIM
LLYPKESHTLLNPVNQKDLTIRVLQWFDYYLKDEKTPYWINGHI
>EGALAKHO_02732 SusD-like protein
MIHSINSFFSMLAILLMFISCTDFVEVDLPKSQLTAQAVFDNYDTANAALTNIYSKMRDN
GILNGSTMGISNHLGNYADELTAYGLPSNAVFTFYDNTVPASSTVVLTYWNNSYNQIYTA
NAILKGVENSINFSEHRKKQLVGEALFIRALSHFYLLNLFGGIPYIKETDYEQNTKVSRM
AEEKVYQNIINDLNQAMELLPENYTSTDRIRPTKYVCHAFLARVYLYNKMYEQASNEASA
VLNKTELFIMENDLSKVFLNNSKETIWQLQTSVAGQNAAEGSFFIFQAGPPSTVALTPYL
LNSFSNADLRKANWIRTVTNTNGSWSHAYKYKEQNNTSVSKEYSIIFRSPEQYLIRAEAR
IRQGDLIGAKEDLNKVRSRAGLAGTAAVSPQEILNAILQERRWELFTEQGHRFFDLRRFG
QIDAVLSEVKPGWDATDKLLPLPENELNLNPNLLPQNPGY
>EGALAKHO_02733 TonB-dependent receptor SusC
MNYFSFYKDGRALYCLFFAGILLSFSSSSAKNSNRTFNTFLQQNHQVEGTVTDGTTPLPG
VTITVKNRSNNAVISDYSGQYKITASATDTLLISFIGFKTAVIPIAGKQTINVKLLFDST
TLQEVKVNAGYYSVKESERTGNISKITSKDIETQPVTNVLAVMQGRMAGVNITQTTGIAG
GGFDIKIRGQNSLRSAANAPLYIIDGVPYSSSPIGSGQTSSIFPTSTSPLNSINPDNIES
IEVLKDADATSIYGSRGANGVVLISTKKGKSGKTRFTITSSTGTGTVTRFLKLMNTEQYL
AMRKQAFVNDGKQYGSTDYDVNGTWDQNRYTDWQQELLGGTSKINDNQVTVSGGSKNTQF
LLSGTYHSESTVFPGHFGYNRGGVQVNINHRSEDNRFQMTFSGGYSSQKNNQPASDLTNA
TRFLAPNAPALYNLDGSLNWENQTWENPLRNLNAKYESKTKDFIANAMLSYEILEGLSIK
SNFGFTDLATLETRTAPSTIFNPAYNFTSQRSVLYQNQTSRTSWIIEPQLTWEKELGKGK
INLLAGTTFQNQTTAALYQSGSGFSSNSLIYNLAAAKVITIQLDDETQYKYQAIFGRLNY
NWQDRYILNLTARRDGSSRFGPGRQFANFGAAGFAWLFTNENFLKNSSWLSFGKLRGSYG
TTGNDQIGDYQFFDTYSTTGVNYDGVTGISPSRLYNADFGWEINKKLEIALETGFLRDRI
FTTAAWYQNRSSNQLVGIPLPGTTGFSSIQANLNAVVENRGLEFTLRTVNFQKANFQWTT
NFNLTFAKNKLLSFPGLEGSTYSQQYRIGEPLNILLLYKFKGVNPQTGIYDFEDVNSDGV
ISSPYDRQHTANLNPKYFGGIQNQLTYKGWNLDFLFQFTKQRNRIYPMGTPGMMSNQQTR
ITDSWQTTGNQTAYQMYTTGTDRNVVNANNNYLLSNTIITDASFIRLKNIALSYTVPLSL
KDTSCKVMLQAQNLLTFTKYQDGDPEFSTIGYLPPLKVVTAGVQLTF
>EGALAKHO_02734 hypothetical protein
MDKLNFLAERKLLGKRITQLRNLCVNENTGKKISQEELALRLGLAKNHIGLIERGKTNTT
VDVLYGISREFKTDIVELFNFKDLK
>EGALAKHO_02735 hypothetical protein
MKDLVAKINAEIETFKTESEAVAEKGVKAAGARARKSSLEIEKLLKEFRKISIEESKK
>EGALAKHO_02736 hypothetical protein
MKCNLPVLLILFLIKSLNAQNTPNRIPDSLIFKSYGYLDDKIYQYKNDSLKASPYLYAYL
RKARREKNHEELVNAYQNMLHQSPMILRLKYADSMVQTAVKSRSNELIGSAQLSKGIVYY
SQKNYVKAYDYYIKANESISKTENDYLIYKTKYHIAQIKFYLGFYDEAISLFNDCIEYFK
KNQPRPYLNSLHSLSVSYNKIGDYSKCSETNAFGIKECERLKIPEMEFFFKHSEGINQFF
LNNYHTSIQLLQEVMPHLNSMTEFANESIANFYIGKNYWKLQHPAKAVPYFKKVEKAFVE
KGYIRPDLREVFELMIKYYKKENNLKSQLHYIDQLLKADSILTDTNKYLMGKIHKEYDTK
EIILEKEKIQQQLVKEKYNDVILISVVVVLFSAVIYGTYNHFETKKRNKIKFDLLLEKNE
KSTLQKQATDKFEITDISQETVQQIIKHLDKFERDKKFLHKEATLATLTVRFNTNSKYLS
KVIYHRTGKRFADYINDLKIDYLVELLRNSSMHRNYSIGSLAEEAGFTSTPRFTNAFRSK
TGISFSYFLKELKKENS
>EGALAKHO_02737 hypothetical protein
MKNLLLTGLIVFLGSCSNDDFDNSDLRLVSSQAINKEKTADFKNGSALEENFKEVPAGDY
LLLVPAQLKEKIISVLKAQSGRNELKTFEKSSSALDTISSTGDPVSTLFIIVDESTLGSS
LKLDLKGYIVNLGNLRGQQYQIVDDFIIQYEISKRQDSTLLTDEKESLLSISSISEAVLF
SEKDRKDRDWETSTTSKITRP
>EGALAKHO_02738 hypothetical protein
MKKRALFYIFLFLFNLCSLYFIMKLFAADQLVQYVLYEDNIIESPRLTAYILYVCCLSNL
YFQFFTWMEYFFKDEI
>EGALAKHO_02739 Urease operon transcriptional activator
MIREILNTEIKSIENDGIDVVYITDYRAKNTVPVPFSVSNFSVLLIKSGKMNIRFHDETN
IVNRKDLLVIPFNSICTRLEATDDIQLYLVRTNFDFAFNNCYEKELSDAFSFLMLKSDRK
ISLQETDFKVLSLIYKLMYVLQNSNDKPEVITKLRRICFNLFIYELKFIHSKYKPDLNLD
FSRRESIVIQFLTLLSIHLRKQHHVQFYAGALFITPGHLNKMVKESTGKTAKAFIIEALV
NVSKNLLTDSRYSVANIADELEFSSAENFCVFFKRHTGMLPTEFRSNKK
>EGALAKHO_02740 hypothetical protein
MYPLEWFDSLIINSFDTDNSSVKVSEYELENLSKTIVSESKKIKIHIKDSFFELKSKRQI
RLLIRKYHSSLVFLIDRVVEIRMIEKFNSPEFFRIFDLIVSSLDDLLSFVEIRYSSFISL
DQRVSFSYFSIWKKETLEVLKNLIKKKENTEENDLELEYVVNLLAAPLHNSRNSKYTYRQ
ILYYREIIMELEKLNDQVTESEGFSNLDLMLIRMNFNSREYTERLVNRIGRYLEGFENLS
ERLEKLLYFCKKLSKINADLKLTFNPSQQNLISFLEYWFSSEIRFAEKKAAILIQEQIDA
SVGSEYVEKADSKLECILSGDQIGLILRATDEARIIKAKSMNYIFKSIVPYLSTPVKRNL
SYQSVRSKSYNAEERDKEIAIESLEKIIRKIKTY
>EGALAKHO_02741 hypothetical protein
MFTNISWGSYLTAAGITIIFWYLIILLKFHSSDLKKILSGEKKLQIPFLKKTSKNLQDIK
SISDSFPKSFDTLEDAENLSQRIKDAVKESAEKRLTKQQFQNYLRMLLDEYPYVKISSLR
ENINQQMVFESQKHPNLLLTLSEADSLWEGPIF
>EGALAKHO_02742 hypothetical protein
MKKCRWKLKSLFRRFRAMGSSLLMILVSNVIYSQDGVAGINEANQKVRSYFDAGTELMYA
VGAILGLIGAVKVYQKWNAGDPDTGKVAAAWFGSCVFLVVVATVIKSFFGV
>EGALAKHO_02743 hypothetical protein
MSNSVYSINKGINQSIEFKGLKAQYIWYLGGGVVGLMILFAALYIIGVPSLICIGFIGTA
GGFLVFKIYRMSNTYGEYGMMKALAKKQIPKWIKVYSREVFMKL
>EGALAKHO_02744 Type IV secretion system protein virB4
MEKRMEDLLPIMAVEHDCILSKQGDVTIVFKAELPEIFTLSDQEYEAFHQSWIKALKVLP
KFCVFHKQDWFLESAYKANFSSEDSSFLTRSSERFFNERPFLDHSCYIMLTKKPAGRRNA
TSLFSNLLRSSIVPEETLKPQLLQDFADTCGQFKRIMEDSGFIKLVRLQNESLRSESRRI
GLVEKYCFLSEREDSFVFKDIRFDEGLAVGDKHCQLFTLGDAADLPGLCGSRINFDRYST
DKTKFSVGFASTLGQLLSCNHIYNQYIFIDDSQKTIQKLESKRLRLQSLSAYSRENMIAR
DATNDFLNEAVSKQRLAVKAHFNVLAWSTDKEELKEIKNKVSSALAQMDAAAKQETVGAP
QIYWAGMAGNAADFPMNDTFDTFTEQAVCFLNMETGYKSSLSPCGIRLGDRLTGKPVHVD
ISDEPVKTGICTNRNKFILGPSGSGKSFFTNHMVRSYYEQGTHIVLVDVGHSYKGLCDMV
NGYYFTYDEKNPIRFNPFYISDGDSLDTEKKESIKTLLLALWKKDDETFNRSEYVALSNA
LQLYYEKLDINAEIFPCFNSFYDFLKEDFISILEGDKVKEKDFDVNNFLYVLRPYYRGGE
FDYLLNATENLNLLKERFIVFELDNIKDHPILFSVVTIIIMEVFINKMRKLKGIRKMILI
EEAWKALMKEGFADYIKYLFKTVRKFFGEAIVVTQEVEDIISSPVVKQAIINNSDCKILL
DQSKYQNKFDQIQELLGLTDKEKALVLSVNKANDPARKYKEVFISLGGMLSKVYRTEVSL
EEYLAFTTEESEKVKMNAYAQKFGGDIKKGIAAMAQDMRNGIK
>EGALAKHO_02745 hypothetical protein
MKKKLIVCLVCLLLVGTSARPAEKVTVLPILEIVKAVTKKVIKAIDLRIQRLQNKTIWLQ
NAQKQVENVLSKLKLDEISDWTQKQKDLYKGYYEELAKVKSIITYYQRIKEITRKQTRLV
QEYERAWNLFKQDTHFKDSEIQYMERVYTGILEESVKNIDQIFLILDSFATQMSDLKRLE
IINKAADQIDGNYDDLTMFNQQNILLSLQRAKTEADVNQVKQFYGIP
>EGALAKHO_02746 hypothetical protein
MKKIAVLLVALCVFNQSMSGQAKQRKELILQIAALQVYIDYAKKGYSAVSKGLNFIGDAR
KGELNLHGDYFTSLLKINPKVRNYYKTVEIIFMQFKIIKLCRKTLADLKTVDLFHGNELD
YIERSFEKLLQNCSQTLDQLLVITTDAELELKDDQRLERIDLLHKTMLEDYNFCLSFCSD
ARLLSISKSADKKDSKNVEELYGL
>EGALAKHO_02747 hypothetical protein
MKKILILTILITLLMIPVKSMGQSAEIQQLILNIEKLSQFKKILSDMKKGYELLSGGYKT
VKDMTEGNFSVHKTFLDALMQVSPAVRNYKRVGEIVEYQISIVKESRNGMNRFIKNGNFS
GQEINYFEKVYGNLLNESLRNLDELTMVITADKLRMSDDERLKAVDDIYEQMQDKLLFLR
NFNASSNVLALQRSKEKNDVYVSKSFQEFKE
>EGALAKHO_02748 hypothetical protein
MKYLLNKKAVCVMLIILLLPCRIIAQGLGDDMSSLHGVLDQLYDEMMPLCSNLIAVGQGI
AGFGTIWYIASRVWRHIASAEPIDFYPLFRPFVIGFCIMIFPSVLALINGVMKPTVTATA
AMVTGSNTAVAVLLKEKEKAIKESDPWKMYVGTAGTGDRDRWYKYTHDGADPSDESMLAG
IGNDVKFAMEKASYSFRNSVKEWLSEVLRVLFESAALCIDTLRTFQLVVLSILGPLVFGI
AVFDGFQHTLTVWLARYINIYLWLPVANIFGSIIGKIQELMLKLDLSQVQATGDTFFSRT
DMAYLIFMIIGIIGYFTVPSVANYIVHAGGGGGALGHKVTSMFGSSANTVVRTSSNAVGM
AADAMGDADRRMTSSMAATAGSSPYFTDKGNYMNDRLKGNSKQT
>EGALAKHO_02749 hypothetical protein
MFTKMKNIDTAFRYVRGFTMLVIAGCIIISCYAVYKSFQTVSLMQDKVYILANGKALEAY
ASERKDNIAVEARDHVKTFHKFFFTLDPDDKVIKTNITKALYLADDSAKRIYDDLKENNF
YSGIISGNISQTIQIDSVSIDIREYPYRFRCYAGQNIIRTTSILKRSLLTEGALRNVSRS
DNNPHGFLIERFNTIENKDLSAETRK
>EGALAKHO_02750 hypothetical protein
MKSFFTRQTEPFVYHKYYLLLQKRWAEKMKSVTDGLSKKKLIWGLLFFTVLTSGYLIYNL
YRTFYKQAEVSTASKIKTINLKN
>EGALAKHO_02751 hypothetical protein
MQEKTLSPKESKKRKMLLMLPLITFPFLTFLFYSLGGGRMESKMAGNDERKGFNFNLPLP
KFKEDSALDKMSYYDQAAVDSIKLREQIKKDPNYIDNKVSEDKADSFSTSDFESRMLPKN
RSAFSSQSFQDRNEQKVYEKLRALENIISQPAVPAYGQDMREFENYGTSRGESEEIKKLE
GLMSTMSTPQEPDPELQQLGGMLENILDIQHPQRVQERLKQTSESKKGKIYSVQKKEAEN
NISSLQLNVDLQTSSKTNEFYSLDEAQPAEEIQNSIEAVVHQTQTIVNGSVVKLRLTNDI
FLQGTIIPRNTFLYGMAALKGERLEVKITNIQYNNSIFPVDLAVYDIDGIDGIYIPGAIN
RDVAKASADRSIQTLGLAGISDSWGAQAAGMGIEAAKNLMSKKVKLIKVVVKAGYQVLLY
DEKQKNLNLKREKI
>EGALAKHO_02752 hypothetical protein
MKRANYLFLISLLLVCVSVNPQSNAGETVFYEDQYKNLQVGFSKTTSIIFPYTIKSIDKG
SAEVLVQKAKGVENILLVKAAKQHFFQTNLTVVTSDGKLYVFVLNYDDSCPDLNFKAENA
VAASRDVLFSLENENQKRIEQCASAAYSKKKKISGLKKSKYQIRLEVNGIFIQQDVLYLR
VVFENKSKINYDIDQFRFFIRDKRKSKRTASQEIELEPLYATSSSSVIPYKSEIIKVYAL
QKFTIPENKYLTIQMIEKNGGRHLEVDINNNLTDLVFPISELSSDTF
>EGALAKHO_02753 hypothetical protein
MIINLADTEMMLSFAEEMAYNGHRFAAFNTDEVTDTDTIEFFRNPLDAKEYCLVMTNDVN
YFQSLPIESVIDDLRAVLNSGADTSENEAIELTGFAKREIDRREILENNLNENAMNEKNL
EYLKDQLKYTGFGETFDAELRENIMKGDKDFKIMHTGIMNNGLPNKDTLTVELNFKRSEQ
TDMYFFNSYHVNLQKEENKPGLEQTFYINKDSASITMKEAYNLMEGRSVNKDLKNKEGES
YNCWLKIDFKQSDNGNFKLNQYHQNYGYDLEASLAKHSIKELNTPKYKEDLLNSLKKGNL
QSATFVVGGTESKMYVEANPQFKTVNVYDENLQRINHRESKEEKKAESQKESVSKDQKKN
LDSDEGDSGRKDNKVKKRRTPSL
>EGALAKHO_02754 hypothetical protein
MEKLKPLSDFFTAIENDYRISPMHIAIYAALLQFRSVKGFINPIFVFSSEIIVIAKVSSA
NTYHKCVQELHQYGYIKYRPSFKKNRGSEVYFLFSADADI
>EGALAKHO_02755 hypothetical protein
MNEIVTKEDLRQFGLLLVDKIQAIFKDKDSGRKETLEPEWIKSKSVRKLLDISAGSVQNL
RTSQKVRFKKVLGSYYYNKEDLQKLFDDDKN
>EGALAKHO_02756 hypothetical protein
MMIKTKRLKESYIMSYLSMYSNDPKLNVWHLSILTAILGLGYRQGQRGRIKVSRTKIMEL
SHVNTLPTYHKYFKQLQDLGYIKYTPSYHPGYKSEVKLCKKRLSQNI
>EGALAKHO_02757 Tyrosine recombinase XerC
MLESSFGLGFFLKRPKIESKEWIVYFRITVDGIRKESSTKRKWDNTRWDQRFERAVGSKE
DAKSLNFFLDSLTLKINEIKTEMMYSGKTITAEKIMDEVLGRTAPKIKVLEEFQKHNDEM
EALLGKGYAKGTLDRFTITKNHLTAFIKFKLKKHDIEFADLNLEFVKDFEFYLRTVRDCS
NNTTLKYIANFKKIVIRAIDKEIITKDPFKNFKGRKTKLVKKPLTAQELYELESHYFTTD
RLNVVRDVFVFQCYTGLAYIDAYQLKKTDIKKGIDGNLWIMSERQKTNSSFNVPLLPQAL
KIIEKYKDHPLCIQRGTVLPVSSNQKMNEYLKEVAVLCGFPFTLNTHMARRTFGSTVTLN
NNVPINVVKELLGHASVKQTEAYAITEQATIGREMSILNKKLNKTGSKMSKPDLAVLSRL
EKEIQTIKKKYNISS
>EGALAKHO_02759 hypothetical protein
MKKIFFLLTASVAIMSCSKVKDGEYLITGTAKGIANGKTIILQSQDPTTGATIPLDTVKV
ENEKFEIKGKVTEPAFHTLILQDANGPIPFILETGEITVAIDKDSIHKSKIAGTYNNEEY
VKFNDELTKTQKRLIDFQKNNTQKMQQAQQAQDTATVNGLMKQYMTIQTEVQADSKKKYV
AYAETHPKSLISVLIVKGMLGDPSTDIKKAEALYNSLDESLKNTTPGKEVKSKIGQAKMP
AVGATAPPIGSAK
>EGALAKHO_02760 Chaperone protein DnaJ
MKKIVEYRKLLNVDKTAELKDLKTIYRNAMKESHPDKFQGDDAGLKAAEEKSKAIIEAYH
FLVSINPETIKANLPEYTETISTCSITDYKFVEGRLIIDFSNGSVYEYISVPKATYVKMV
NADSPGRFAKRHILNSFTWRKKTNQE
>EGALAKHO_02761 hypothetical protein
MSKDSQEKMPQKGVYTGIIEKDENNNYFCGEYLLDYKIAHTNFNLGDWVTIKSVIENPSD
ISYDKYPKKSKNFDKANHKPENK
>EGALAKHO_02762 hypothetical protein
MQKNFRPHPNSFKNTFCVFHEVLPDAIEGLKKQFESKAGSAYYYSEAGMYRVSNHWGRLA
NSKWRLIAMEPETPSKTKIGFAAWSEFHPDNAEEKLYYIEADFDKNTVTYQHKNNPIYDK
KAILRTSFETTKRIKQIRNLQQLTSWAKHFDEDIDVLRERIITELIYTEKTLEEIKRQI
>EGALAKHO_02763 hypothetical protein
MGRNNERNIKKHNDKLHKAQNKVKQAEIARKEKLKEIIKKFNEDKAQE
>EGALAKHO_02764 hypothetical protein
MKFEDLKVSVQEIIDLIAAKQNREANNKLLEVNETLDEMLDHAEEDEELREISRYQVLLN
QLHVKINGEEAVDGE
>EGALAKHO_02765 hypothetical protein
MEKKQLMGNNKCFCDTGLLFNDCCGLYLENNQKAPTALALMRSRYSAYATHNADYLFGTT
HISERAYYSKSEILKWATSNKWQKLEILRFTENTVEFKAYFLDSNSQPQTHYEFSTFKLE
NGAWYYVDGKFE
>EGALAKHO_02766 hypothetical protein
MKNEFKKGFYFKSYEAPFQSPFEKLFGIFKELITHTSGDFDEAIDWLRELDKEYKLTDEN
YTIDDFIEDLKKKGYIKDEAKPDGTAGFGITAKTERAIRQQALDQIFGNLKRSGNGNHKT
KHAGNGDEHTGEFREFNFGDGLERIALTESLRNAQINNGVEGFMLTENDLVVEETQYKAQ
MSTVLMIDISHSMILYGEDRITPAKKVAMALAELITTRYPKDTLDILVFGNDAWTIPIKD
LPYLQVGPYHTNTVAGLQLAMDILRRKRNTNKQIFMITDGKPSCVRERDGSYYMNSNGLD
EYIVDKCYTQAQQARKLHIPITTFMIANDPYLQRFVNHFTEANQGKAFYTGLKGLGEMIF
EDYETNRKKRVR
>EGALAKHO_02767 hypothetical protein
MEIKNINTLGQLKASGYKSTSIKDELRNNLREKIKSGTPVFEGVHGFENTVIPELERAIL
SRHNINLLGLRGQAKTRLARKMIELLDEYIPFISGSEINDDPLNPISRFAKDLIDEKGDE
TPISWLHRSERFFEKLATPDVTVADLIGDVDPIKAANLKLSYADDRVIHFGMIPRANRSI
FVINELPDLQARIQVALFNILQEGDIQIRGFKLRMPLDMQFVFTANPEDYTNRGSIVTPL
KDRIGSQILTHYPESVAIARTITEQEAKLDETQSEIVYVPSLAKDILEQISFEARDSEYI
DNKSGVSARMSITAYENLISTAERRALKAGVDHTILRLSDFIGIIPAITGKVELVYEGEQ
EGAAAVAQNLIGSAIRTLFPDFFPKIEKLEKPGEKTPYSDLIEWFFAESGFELLDDASDA
EYKSILDEVTPLDTLLKKYQPQLDKKDQYFMKEFILWALVEYKKLSKDRFAQGHQFKDMY
GSYISKL
>EGALAKHO_02768 PKHD-type hydroxylase YbiX
MEEGFEDLIASYIENKVGISEHFLSRELADNLKQNLLDLNQRSLLSEAGIGNSEKLSYDG
AIRSDSIYWLDKKHNNVFENEFFAQIDAFILYLNESCYAGITGYEFHYSLYEKGDFYLKH
LDQFKNNPSRKYSMISYLNSNWLESDGGELMIHQENNNQKISPTQGKTVFFKSNELIHEV
LVTQNTRMSITGWLKSD
>EGALAKHO_02769 hypothetical protein
MLFLILSILCSVIVGVIFKITRKYNANPTQVVALNYVTALALCYFTFSPNLSEVDAKAPW
NIYFAIGILLPVVFLFLIASIKHMGIVKTDAAQRLSLFIPILAAWFIFKEEFNSYKVIGL
VIGFLALLFILRKQSENAENKWIYPAVVLIGFGIIDILFKQIALYTTLPYPTSLFVVFAI
SLIIAIGIVLYEMIAKKEKLTVKNILFGGLVGLFNFGNILFYLKAHKGFSENPSTVFAGM
NMGVIILGSLIGLLFFREKLSKINFIGIFLALIAIIFIVISQF
>EGALAKHO_02770 Glutamate dehydrogenase
MSTEIIKQNPFQSMIDRFNIAADILNLDESIRQKLQRPEKQIVVNFSIALDNGTVQNFEG
YRVIHNTALGPSKGGIRYDTAVNLDEVKALAAWMTWKSAVTGIPFGGAKGGIICDPRKHS
KAELEKITRGYTKALADIFGPDKDVPAPDMGTGPDEMGWLMDEFSLLHGKPIHAVVTGKH
LHSGGSLGRVEATGRGVSIITLLALQKLKLRPARSTAAIQGFGNVGLHSALFLYEKGLKI
VAVSDVSEAFYNPEGLNIPELILYYNLNNKNIKGYPNSVAIKHEDLLLLDVDVLIPAAKE
DVITQKNAADIKAKIIVEGANGPVSSDADKILHDNNVLVVPDILANAGGVTVSYFEWLQN
SLLESWRIHQINTRLEDILEKGFETVFRIALKHNVTPRIAAYIIALQKVADTQSVKEVAL
DAPKFKQN
>EGALAKHO_02771 hypothetical protein
MKNINFLAFAMPAFFLFLFLEYKLAQRKKRPEIFNYESSVSNISIGIAERLINLFISASF
YQLYYLIYDNYRLFDIPANIFVWFSLILATDFVWYWYHRLGHEVNFFWAAHIVHHHSEEF
NFTAAARITTFQAVIRTGFWCVLPFVGFHPTMVITMLIVHGAYSFFTHTQLIGSIKWLEY
VFVTPSVHGVHHASDEKYLDKNYGDMFTFWDRFFGTFQEEEEKPKYGLTHPLKSYSFLWQ
HFHYYFEIYELWKRSIGFKARWKAVFGSPAHMDQDIRPTLEKRFLQDKENPHQRLKFRNY
LYIQLGVCTLFLTVFTYYFEYLNGLDKIFVLFFILITLVNCGALLEQRKWIYYLEYARLF
MISTYFLYEENLTAFFFVPLAIMIFAEQLFSLSKRYQNVVLQLETSE
>EGALAKHO_02772 hypothetical protein
MQRIFILFFFIAGFSLTAKETNPVLEELDKVLLKKDIYLKQKYRKIEALKKDVSKFTVSQ
NNEQLYNSYMSLFEEYKSFKYDSAYYYLEEAKVKAIALKDPKYLAKSRIKEGFVLLSSGL
FKEAIDTLNVIDDQKLDQKNKFEYYSIKARAYYDLADYNKDQRFNIHYVQQGNHFLKKAL
ELIGTNTNEYWAAESLKRLKQQDWRGAEFAFSYWINNYKLPPDYYGIATSSLGYIYSERG
YTKKAIYYLALAAIADVKNATKETVALRNLANELFKMGYLDKANEYINIAMDDATFYNAR
HRKIEISSILPIIEKAQLNNVKEKNDKLERIIILLTILTVIIVLFLIIIFKQLKERNKAR
KIMASSYAQLQEMNISLSEANAIKEEYITYFIKATSAFINKIDHIQKSTLHKIITKKTDE
VIASLKRYNVKEERENLFHQFDEIFLKLFPTFVTDFNHLFPNDHKCIVKKGELLNTELRI
FALYRLGIQDSSQMAEFLELSVATIYTYKTRIKSKSDFKDTFEEKIMAIKTI
>EGALAKHO_02773 hypothetical protein
MRCKSIYWLAVIMCLFAIGCDSIDDGSYVDPITIYEKVNGDWGLTNLKMVDESAKANAIE
PHEENLSTYFNYEDFKIRFSVDEKNQPTSYEVMGNVPPLFAPKGYWALSSDFQQTNASAV
RIYLYSDAKKTQKTDELRLTSVPGSNDEMEFQLVHSSNGTPFVSYVFKLNAIN
>EGALAKHO_02774 hypothetical protein
MIPNYKLEQRMAIPYSDKKQILNTYEKVYIYNFICPFDGS
>EGALAKHO_02775 hypothetical protein
MKKFIYTILFALLMAPNFTQAQEAAGAVGAMSSFPVVYKYDEKVTWYFDMSGSTFAENED
LYIWIWSPSEPDAGNWENSSDFAKLKYEGNKVWSFTLTPTVYFSKTPDEIAASAGFWFRL
KNKNGSKQSDVANMTYTDFSSFYTANELIRAYPTKPTIDKGLSILFNANLIPGFAGATSV
HMHSGLNDWAILQEYQVWVPEVVEKTKLKDLGNGFYKMDLIPKTYFNAPDGFVMEKMNFL
FVKDEWAATTPDQVLFAGEYIPPPPPVFGFFPLQISQKDFLGMSRKNNEPGVNKLIYTIN
AGSKIISGEFAGGTAEIKGFVNLVSELNGIPGLTEIHVLVKDNKDKTISDTTIPLKTLDK
>EGALAKHO_02776 TonB-dependent receptor SusC
MNSKNKKIVLQHLWTTKTVVFMIFMLFLSAGMFAQEKKQVSGTVYDNTGTVLPGASVIEV
GTKNATTTDFDGKFTLSVAVGGAIEVSFIGTTTQKVQITSATKANIDVRLQNDGYQLAEV
QVVSVGYGTQKKSDLTGAISTLKADDLVKGTISSTEQVLQGKVAGLNVIRPSGDPAAGST
LRLRGGTSLTASNSPLIVVDGIAGVDINVVQPSDIKSVDVLKDASATAIYGSRGANGVII
ITTKSGTKGVSVTYSGLSSFGYVNDNLDLLSANQWRGYVRQTGNKDAIDYGGNTDWQKAI
EQTAISQSHTLSINSGKADSGFRMSLSYLNNEGVIKTTGLERLSGNVSGYQYLGDNKDVK
FDMGLFANIDKWHPLDYRIFERSYNLNPTIPVYDANGEFTSVGGTIYENPVEILTNRTVD
NERHRLLGYFKTEVKFLNDFTAVANISLEHNAVQGSTYKPSYAVMEGRTEDGYAQKTYAE
YTNAQGELYVNYNKTFGKHTVSALGGYSYLENIYEGFGAQRSGFVSDAFSYNNLGAGYNY
RLGDVYSYKGKSNLVSFYARANYSFDSKYLFTATVRRDGSSRFGENNKWGTFPSASAAWR
ISNEEFMSSTKDWLGNLKLRVGYGVTGNQDGIGEYKSLSILGVGNDSYYDPVTQTWSLAY
SPKQNPNPDLKWESTKQLNIGVDFTLFDRVTGSFEYYSKTTDDLLYTYEVPQPPYLVGTM
LANVGEMSNKGVELTLNADIIKGDKFSWNANLTLGHNVQKIEKLSNTTYETDVIYSGSLH
GLSGMSGQYSQIIAEGYPVGTFWGFKNAGLDADGKIQYYNAAGAVVAESALVDADKRDLG
NIQPDLTMGIGMNFTYGNFDLGVSGYGMFGQKALNATNMMLNDPNRLPAYNVPDDFLNSG
LTSSPKYSDYWIEDASFFRLQTLSVGYTLPLKSKSSKFRVYAMGENLFVITGYKGVDPEI
GLNAQDGADQTGLASPGIDKYNNYPRPTTISVGLNFTFNN
>EGALAKHO_02777 Starch-binding protein SusD
MKIKITAALLISMLFTISCTNLDEQLYDKVEDGDFGNTPKEIDALVGGAYSSLRGFADAI
SNNYPTCEYVFFLNETVSDEATIPTRGTNWYDGGQYQDAQKHTWKADNRMILSAWRYNYT
GIAKINSIIYQIDKSSLTDAAKAPIYAELKALRAYYYYNLLDLFGNVPIVTNFEDTALPS
NSTRKQVYDFVEKELLDAIPHLTANVVYSKFTKNVAYSLLARLYLNSEAFVGTARWQDCI
NMCQKVTGYTLAPDFFANFATENQKSPEIIFAIPYDSKAGTVGNYMSSMSCHYLHKLTLS
PIGDYPWSANGMCAQPGVYSAFADTDRRKKCMVAGDQINLANGQVIVMDNGEPLTYTEEV
TSVADAKENQGVRLGKYEMKAGEQWERDHDLVVIRYAEILMMQAECYVRLGSADLAKPFL
QQVTARAGEEMPATIDLHFIDQELLKEFTFEGRRRTDNIRFGTFFLPWWEKGATEKYRAI
FPIPSTVLTTNKNLKQNPGYPLN
>EGALAKHO_02778 hypothetical protein
MKRYITLLFFGIMNILVAAGCSSDDKGSDKPTEPETIQPVAIEKTNSTKIYVHYMPWFET
NESSADKKWGYHWTMANKNPNTIGANNRREIASYYYPLIGPYHSGDKNVIENHLLLMKYS
GIDGVLIDWYGTYDVNDYRMVKENTEQLITMLDKVGLEYAIVYEDRVTTNVVNAGKAISV
TSAAKTDLAYMEKNYFDDANYIKVNGKPLLLNFGPIVLQTPAEWTNVFGAVTTKPTFLTL
WDQSVEAGANASGEYSWVFKNSTYLTNWYTNTKPKLSVAIGSAYPGFKDFYAEGGGGAAI
GWTIEHNNGATLDETLALAKNANLNYLQLITWNDFGEGTMFEPTVEFGYTYIEKVKAFAG
VKNTEAVFPDISKMYNLRIEKKGDATAQQKLDQAFNYFVSMQPAKAKQLISEIK
>EGALAKHO_02779 Glucan 1,4-alpha-glucosidase SusB
MKNIKYRYCLILFASILIYACSASTKKTYKISSPGKITELVFELTASGQPQYSFTSNGKS
VIEPSLMGFEFQGIQKMTEGFEVVSFEEKTSDQTWEQPWGEFKKVRDHHNELLVHLKEAK
GEERLVDIIFRVFDDGVGFRYSFPQQPHLGKVKISNEVTQFTFKSDNDVWWIPVHRENSY
YESTYRKTPISKTDTINTPATFETKEKLYVAIHEANLTDFASMTLLKTSDKQYKSDLVPW
ADGVKVYAETPFQTPWRTIVVGKTPGDVATSTIMLNLNEPSKIEDLSWITPSKYIGIWWG
MHLEKFTWGQGPKHGATTKNTKEYIDFAAKNNFDGVLVEGWNEGWDGDWTADGSAFSFVK
AYPDFNLEEITKYAAIKNVRLIGHHETAGATKNYESQLEDAFKLYQKMGVNSVKTGYVNK
YLDKKEWHDSQYGARHYRKVIETAAKYHIMIDNHEPMKGTGIQRTYPNFMSQEGGRGQEY
NAWSVDGGNTPEHLTTLPFTRMLSGPFDYTPGNFNFDYKTPSGARVQTTLANQLALYVII
FSPLQMASDLPENYVGKPEFQFIKDVPCTWSYTKVLDSKIGEYTTIARKDWDEKNWYLGS
ITNKDARDLKVQLSFLDAGKEYEAEIYADGAGANYKTNPYPVTISKQKVNNKTVLDIKLA
AGGGTAIKFSPIQK
>EGALAKHO_02780 hypothetical protein
MKKLFSLLIISLFWFSANAQTTAEIATENALPAVQNNTDSPQNYDPEDLPWHNRRFKFTA
GVFFPSNNTQVEVGSNNGEFGNMIDFEKDLGFNKNSTSFDGSFEWRISKRSRVGSEFFYL
KRTSTKTLQRDIEFGDHTYPINAKVSAFMDNQIVRVYYSYAIIAKPKYEIGALIGAHVLL
GDIGLRFDGETAQAEYKDNFDFTAPLPDIGIWGEFVLGEKFGLYVNTNYFSIKVNDVDGR
IWSYNLSLLYNVYKNFSLTAGYTGLNIRVDVEKERLNGYLKWGYHGPTLTAAYTFGKHVS
VTKK
>EGALAKHO_02781 HTH-type transcriptional repressor NicR
MKDTNTNSEPFGKAFSAEIADSFLFQIHRIKKALFRRTNALMSEAGITLQLEQLPLIMIL
QHKDFSQRELSDKTMRDKSSILRSINALEKKSLLVVRKDKTDKRKNVVSLTEEGITLANV
IRSLMKKSEDEVLSVFTAKERIEALHTIRNYADRLERT
>EGALAKHO_02782 Multidrug export protein MepA
MNKKELLEGPILSSLLKLAVPIMIANLLQAAYQLVDAFWVGRLGGDAVAAVSVSTPVIFL
TIALGTGLAIAGSILIAQYFGAGQQEMVNHVAAQTLLMVITVSVVLSIVGYWLSPYFLKV
LNVTPQVYSDALGFMRVAFIGLVFSFSFMIFQSVMRGVGRVTLPVYIVLGTVILNFALDP
LFIFGWNFIPAMGVKGAALATLSTQSLAIVIGFFILFRGKHGIHLQLKDFKPDYKHIKKA
FKIGFPSSIEQSMRAIGMMAITFLIVHFGTTTVASYGAGSNLIQLILIPALGLSMAIATL
VGQNIGAGNIARAAQIGKLGGYLGFGLLSGLGIIAYAFAPYLIAFFVPNDPAVIEGGTQL
LRITCLSWGFLGLQLCLMGVFRAVGNTTLPMILTLVSQWVIQFPLAYILSHNTSLGKVGI
WWAFPISSVLTGLITLVIYAKGDWKKERLTGKTNKLINKVEKEIVKEGFESVK
>EGALAKHO_02783 hypothetical protein
MKIQTYYNHIRFYTPHHFVYYPILTIFLIASIYFAFTTDQALIWSFISVAFVFLFCLAFM
LRQHYALILQNRIVRLELRYRYLTLTGKRLEEFEYKLTDDQLFALRFAPDDEFLPLLEDA
IKNSLPGDSIKKAIVHWKGDYNRV
>EGALAKHO_02784 hypothetical protein
MIYMKLRLFFINTDITKKTQSKSSGLYIRNIGYVSLF
>EGALAKHO_02785 hypothetical protein
MKSFSFAPITSQDANILILGTMPGTKSLELNQYYGHNQNNFWKFMFHIFNEDFSNDYQIR
KELLQKNKIALWDVLQFCDRVGSLDSAIKNEIANDFETFLAEHPNIKTILFNGQKAAAFF
KKYVHLKKEYQLITLPSTSPANAGKSFNSKLEEWSAAISRRL
>EGALAKHO_02786 Regulatory protein SoxS
MKTVTINTEKIDAIFEQLHFNFGGKVTSDLDEFTLEINNSTARGSIIGASFNDNISYVQF
DMNFAVDVRIDITNVQSSPIYFAYCSQGSLSHSFGVLGEERRFKTFQTAITTSKVSQENV
LFFEKEKNTKFTLIIVGTQVADNELYAVDNSLSDKVKETFFENNNAEDFFYLGSYNLQIA
EKIEQLNAVTQTGIVRKLLKEGILRIILAMEIQQHTDDLNAFSKDANCLTLREMEEIKEL
SEFIKNSPEEPFTIKSLSKKSGLSPNKLQEGFKMIHNRTVNDYITHMRVLKAELLIRTSD
LNISEIVYCIGFTSRSYFSKIFKQKFNCSPKEYKFNLNPLAITA
>EGALAKHO_02787 Gamma-glutamylputrescine oxidoreductase
MKLRSTETFWPLKSAMRYSYPSIDQDLNTEILIIGGGITGALIAYKLITEGKKVILVDRR
DICNGSTAASTALLQYEIDVSLHELIKLRGLGCAVDSYKNGKQAIFDLRTIIETIKSDCQ
FEFKKSIYYCSFKKDIPFLKHEFKTRKQYGFNVNWLEKSDLKKIGLNAMAAIESNTAAVM
DPYRLANDLLHYCQQKGMQIFDRTNITSIQNQTKKLIAHTENRHLITANHIIHCSGYEST
ETLSEKVVDLKSTYVIASEALPEVPNSFKNAIFWDTAKPYFYFRITEDNRIIMGGGDEEF
KDPKRRDKLLPKKEQMLLRQFQKKFPDITFKIDYSWAGTFGETQDGLPYFGKPNPDKNEH
YVLGFGGNGITFSVLGMNSILDSINNTKNKDLEYYRFGR
>EGALAKHO_02788 hypothetical protein
MEKKKPKGASAFEKFATNVSKAAGSTTAFIGAFLIVVAWAVSGPIFNYSETWQLVINTGT
TIITFLMVFLIQKAQNKDSLAIQLKLNELVASSEFSSNSLVDIESMTEEEMIIVQKYYKR
LSELSKKDESITTSHSIGEAQDQHERKDKNRNQLKAVKKTTQPAKSKPPKAEKKPTKK
>EGALAKHO_02789 hypothetical protein
MKASYKNISLKILKITGIVIASILLLLFLIPLLFPGQVAAEVKKIANERLDTKMDFSKSR
LSFFTHFPSLTVSLDDLSMTGSAPFRNDTLLKAEQVAFGINLKRLIFDNEVKINKLYVSK
AMINIMVNQKGEANYNIYISDPKNIKKEDQPEEGTAIRLERIDLEDCHVKYNDRSAKILV
DANGFNYVGKGNLSEDIFDLSTDADIDKLDFYYDRTGYVRRKRVHADLITRINTHALSFI
LQKNELQINKLPLKFTGLFTILRDGYKINIKAASENTTVKDLLSVMPPEYLTWLDETEIS
GRSDLLFTFKGNYNVAKKQKPNLAFNLKIDKGAINYQNAPVPLTDFNMDLNALLPELDPE
KLIINLRALKFKVGEKDYFNAYLRSKGLSEMTVDASVKGALDLAVVDAAIGLNTIDLRGI
LKTDIKAKGLFSTSKKLFPKTIGGISLRQGWLKTESYPNPITDITFVANVLNKAGTFQDL
IVAVAPASFVFEGNPMYVNATLSDFGDLAYNAKIKGELNVGRIYQVFSKKGLDVTGYAKA
DLSLKGKQSYATNGQYDKLDNRGTLLLRNIKATSELFPKAFFIKQGNFRFQNEKMWFDKF
YASYGKSDFDINGYLLNTINYFLESHGTLNGSFNMKSKLINVDEFMSLKKGENTDRNLEV
EYAKEDHPKMSGVVIIPKNLNVALTANADKVEYKGLVLNKLSGKVGIAKGGFFLENSTFN
IIDCILGVDASYKDETPTSAHFAAHFTAKDFSVQRAYKEIPMFHDMVTAAEKAQGIISVD
YNVKGDLDGNMGPIYESLEGGGTINLRDVQVKGLKLFDGISSQTGQKGLNNPDLKGIEIK
STIDNNLIHIEPFTFSVASFRPTIKGTTSFDGLLDLRMRLGLPPFGIVGFPIVITGTHED
PKIKIFSKTGQKIYDAIYDEKNNKVIREEKVSKRKS
>EGALAKHO_02790 hypothetical protein
MEKQSGYTWKLGMFVTIGLLLFILAVYFIGKQKNLFGSTFNITSQFKTVSGLEVGNNVRF
SGINIGTVEEIRLINDSSVVVSMVIKDEVKKFIKTDARTSIGSDGLMGDKVLTISPGVKS
QKEIENGGQLASLKGIEMNDIMKSVKKSMDNVGVISEELATFSHNMNNGNGALARLVRDD
KMANSVSNTLSNLESGTKGFSENMEAAKSNFLFKGYFKKKEKQKEKAAEEAKEKKEEQAE
KAAKEKEEKEKEAKEKEEKAKEEKAKAEKQKEEDAKKAAEKAKS
>EGALAKHO_02791 putative ribonucleotide transport ATP-binding protein mkl
MITEKENIEAKSKEKSKTPIIEIKDLHKTFGKDNKILQGVNITVNKGEDLVILGRSGSGK
SVTIKCIVGLIEPDKGEIKVFDENVLNLSKRDLNEIRVRIGFLFQSGALYDSMSVRENLA
FTLRKHKSELTSEEVENEVIEALESVGLADAIDKMPSELSGGMQKRIGLARTLILKPEII
LYDEPTTGLDTITSREISELILDIKHKQKTTSIIITHDMACAKLTADRIMVLKDGVIHAE
GTYEELEKDEDEWVRSFFE
>EGALAKHO_02792 putative phospholipid ABC transporter permease protein MlaE
MILTLRNTFTEIGNATLFAKQFFKEVFVPPYEAKELLKQCYIIGYKSLPLVAITGFIMGL
VLTLQSRPTLVKFGAESWLPGMVALSLIREIAPVITALICAGKISSGIGAELGSMKVTEQ
IDAMEVSAINPYNYLVVTRILACTLMVPLLVFFADAIGILGGYIGVNIHGDVNLYRYMTQ
IFQSLEFLDLFPATIKTFFFGFFIGMIGCYKGFTAANGTESVGKAANSAVVTASLTIFII
DMVAVQITDLFF
>EGALAKHO_02793 D-inositol 3-phosphate glycosyltransferase
MKTITNKSKIVFLSTFPPTQCGIATYTQDTIKGITDVFGKSVSCEICELVNEPKAKPTQA
FTLNTKDKAEYAKVAEQINNDKSVKLVHIQHEFGLFGGNYGDYLLDFLNVIKKPLTYTFH
SVIQNPNNELKTFVKLLLSYSNSVFVMTNQSKEILMRDYDIADEIISLVPHGTHIVIYEA
PHQAKEKFGFQDRKVLSTFGLLGEGKNIETGLQALPKIIEKEPNVLYLIIGKTHPNLIKD
GVDAYRDKLEGIVEDLNLKDNVRFINQYLDTNELLDYLKATDVYLFTSKDPNQAVSGTFS
YAMSCACPMVASKIPHTLEVLTSDCGILVDIGDVDQFSEQTIKLLADDNLREEMGINAFT
KMRASSWENVAITHMNTYKTLMENTAEIKFSYPSIQLKHIKKLTTDLGIIQFSKISIPDL
ESGYTLDDNARALIAFCMHYKLTKDKDDLPYILIYLDFIERCQKPKGNFINYVDQENREH
IEQNAEVNLEDSNARGLWALGTVVSMSDILPESISKKASKVLLNSLKWAETIQSPRSIGF
ATKGLYLYHTAIPNLYVAAIINKLNAKLLSNYEIHASSDWKWFENYMTYGNGILPESMLF
AYLVTNKPIYKKVAMDSLDFLMSKMFINKNFKVISNNGWLHRGEEPKEYGEQPIDVAYTI
HTLNSFYDAFGTPEYKHKMKMAFNWFLGKNHLNQIMYNPVSGGGYDGLEKENVNLNQGAE
STVCYLTSRLIMENLKSSDTKVIPLMKSNPGVAINL
>EGALAKHO_02794 Beta-1,4-mannooligosaccharide phosphorylase
MELAATETLIATKHGVILEKTDRAFEELGVLNPAIYQDGNTVHMFYRAAKRGNFSTIGYC
RFEGPTTLVERHTEPIFVPEYIYEIHGVEDPRITKIDDTFYMTYVTYDGINACGALATSK
DLTKFKKKGIITPKFMLHDFTNFIRNHLQNPSVARILAVNTARNYPLTETMKEHLLVWDK
NVVLFPKKINGKFVGLHRLFPSIQIFSFEKKSELTPEYWKAYLKDLPDHIVMEPKYDHET
SHIGPGAPPIETKDGWLLIYHSAEKRDKGLVYHASAVLLDLENPQKVIGRLPKPIITPAE
YYERHGYVNYVVFPTGTAIFDDQLYIYYGAADDKIAVASLNLNDLLNELKQNPNENDNK
>EGALAKHO_02795 hypothetical protein
MKSKSGTIFLSGLIAGTLDMLAAIIVYAVVLQKTTAIKILQSIASGIFKKDAYSGDSQMA
LYGLLLHYFIALIFAWFYFTIYQYFTFLKKNTLLSGILYGIFVWITMNLVVLPTVFPVLP
EKHLDFPLILSILILIFCIGIPIAFITKKHYSFNR
>EGALAKHO_02796 hypothetical protein
MKTELQTNIVETFKNLNEIHSNFSETELNKVPFEGSWTAGQTTQHILKASSGYAALFLGK
TEKTNREPYLYIDDLKALFLNYDIKMESPDFLLPEIIDYDKKEQTLELLNREADLLTLSA
IHDLTLTCLDFQLPGFEKFTILEWISFTLIHTQRHTHQLNEIYKILNKV
>EGALAKHO_02797 hypothetical protein
MPYLILDGALKFIDFTKNVFNATVLHAPHLRDDGTALHAEINIHGSTIMFADTSSDWKPQ
TANLFVYVPNADESFKKALEEGATELMGLSDQEYGRTCGVTDPFGNVWWITSINEFTI
>EGALAKHO_02798 hypothetical protein
MIEVFKTNVQEVEQSILIVGKLLEHFPSSAINFDLEDCDKILRIHGASISHKKIIELLDS
YGYHCEVLS
>EGALAKHO_02799 hypothetical protein
MKKAKIIFWITTIIIFLFEGVMPALTSQTELAKEGIRHLGYPEYFGNALVVFKILGVLIL
VIPSIPKNAKEWAYAGFGFDFIFASISHFAVDGVTFQSFFPLIFLVILAISYIYYHKIER
YKNIAL
>EGALAKHO_02800 hypothetical protein
MTKHFILSFIIFLLILSCKKESNSETVKNSKLPEVHKVPPPLDYSKYILNPRKTDTLCLN
EIEQAKNDLKEYPGVYVQTICFGCDFKPYEEEIKEVLKKRKFKLGIQDIGCVRYEGQTQG
CYRAYVDLKMKEKYGDNYKSEIETEAQNILIKNISINDKIISIYDLEDKERPKVFLQNVF
IDVDSNITLKTDLPINKKSSHNLFVDIQFIIEKNGSISNLLADNWVNENGIDEKFKSELI
DFATKTLKKDYNKWQPGNYKGNKARVENNLRVSFD
>EGALAKHO_02801 hypothetical protein
MNHKIQTEKSAKSAESARGFLNKVTTKNVGRKIHKKIKKSATIRVFACESASSAFKKLRT
LAPSWQNNKKTLQNRSLTASSQINN
>EGALAKHO_02802 Cation efflux system protein CusC
MTTYKMKKYITKIVMVAILITTLISCSVSKDIETPKDALPENFRNASVSKDTTSIADLEW
KNFFTEKDIIKLIDEAVIRNNDLQIATKNIEIAQYRFTQSKWNNVPQINLGVNASTSNPS
DNSFTGKNLGQALGQNHINDFTAGATLSWEADIWGKIKNQKKGAYAEYLQSEEVKKALQT
TIVADVSKGYYNLLMLDAQLEIAKQTLKLNDSTTSIIKLKYDAGQVTSLAIQQSEAQKLN
SAQLIPLLEQNIAIQENALSVLTGSFPDSKERTIRLSNITVKDNAAVGIPSSLVSRRPDV
KSAELALKIANANVGITKADFYPALRITAQGGVNSFEASNWFTIPASLFGTVAGGLTQPL
FNNKRVKTEYNIAVVEREKAVINFRQSVLIAVSEVADALVAVEKLQQQEAFLQERVKTLQ
QAIKNANLLFKNGMAEYLEVLTAQATLLQSELELADIKRAQLSANTELYRALGGGWR
>EGALAKHO_02803 Efflux pump membrane transporter BepE
MFKIFIQRPVLATVISILLVILGVLGLTKLPLQQFPDIAPPSVLVTAVYPGANAETVLRS
VAPSLEESINGVENMTYMSSTASNDGTLAITVFFKLGTDADQAAVNVQNRVAQATSQLPA
EVVQQGVITAKQQNSFIMAIGMYTEDESKYDQTFVANYAQINIIPEIKRIPGVGSASIFG
GVKDYSMRVWLNPTQMSTYNVTPNEVMAAIQDKSLEAAPGKFGERSKEVFEYVIKYKGKL
TKPEDYQNIAIRSNADGSILRLKDVARVELGAYSYNSLTRLNGKKGVVIGVIQLAGSNSN
EIQIAINKLMVKASKDFPQGIKHNIFYSTKVSLDQSIEQVEHTLIEAFILVFIVVFIFLQ
DFRSTLIPAIAVPVAILGTFFFMQLFGFSINLLTLFALILAIGIVVDDAIVVVEAVHAKM
EHKHLSPKVATHEAMHEITGAIISITLVMAAVFLPVGFMEGSTGVFYRQFAFTMAIAIVI
SAVNALTLSPALAALFLKDNHAAHEGDAPYVKKGFKEKFFTGFNNSFESLTNRYVGGLKF
LIRNKWVSLGGLALITFATIVMVKTTPAGFIPTEDQGFIAIAVNTPSGTSLDGTQKVMTE
AENTLKKLDASRFVTAISGFNLLTNSTSPSSAVVFVLLKPNEERGDVKNIDEIMNQVRGQ
LGAISGGSFFVFSFPTVPGFSNVEALDLVLQDKTGGKLDKFSGISQNFIGEVMKRPEIAV
AFTSFKADYPQLQLDINDEKADQLGVKVKDILQTMQAYFGSAQASDFNRFGKYYRVVVQA
DIADRADPSAIDRVFVKNKNGEMVPINTLVKLSRIYGSETASRYNLFNSISINAIPKPGF
SSGDAIKAIEEVAAQQLPAGYSYEWSGQTREEISSGGQSATIFLLCLIFIYFLLAAQYES
YILPLAVILSIPAGIFGVFVAIGLTGIENNIYVQVALVMLIGLLAKNAILIVEFAVQKRK
SGQALVKASIDAAKLRLRPIIMTSLAFVVGLIPMMSAKGPSAQGNHSISIGAAGGMISGV
ILGLLIIPVLFIVFQHLQEKVTGKPVAVVHNEEEK
>EGALAKHO_02804 Multidrug export protein AcrE
MNTQNARLQKILTQMNVQQIKTNMKMKNVIITSFILALVLSSCADKAQAPAPAAPLLPVL
AIQNSDAVTDAEYPASIQGTVDVEIRPQVSGNLDRVLVDEGAYVNKGQTLFKINERPFRE
QLNNALASLHASEAALINAQLEVDKLTPLVQNKVVSDYQLKTAKASQKIAAANIEQARAM
VASARINLGYTNVTAPVSGYIGRLPKKQGSLVSATDVEPLTKLSDVHEVFVYFSLGETDF
IKFKTQYAGNTLGDKIKKLPPVTLILADNNAYAQSGKIDMVDGQFDKNTGAITLRATFPN
ANGTLRSGNTGKIRLGINHDDAILVPQSATIEMQDKVFVYTLNKGNKVNKMPITIIGKSG
TNYLIGEGVKSGDQIVLSGIDKLQEGQVIQPQKSTSEVAQIINKK
>EGALAKHO_02805 HTH-type transcriptional regulator BetI
MASKDRILRQKEETRNNILEAAYAIVKEEGWQGLSMRKIADKIEYTAPIIYEYFSNKEAI
LTELTGKGFIKLSKELQNARAKFDKPEDQLEAMWMAYWDFAFTDTEMYQVMFGVQMNCCS
QQCSAAEAPYKLFTAVIAEIMKNSNPGPEVIKQKYFTFFSVIHGLIAINIINKSEVMETI
NNQILKDAIGGIIKSIQ
>EGALAKHO_02806 hypothetical protein
MNSETIKIGILGIGGIGGFVGAPLAKKYKDSTTKIIFICRGETKNNIEKKGLVFESKGEK
ETIFPDLVSDNPREIGILDVLILTSKSYSIKEVLSAYKDCINADTIIITLQNVVNAEEII
RETLPQAGQIMEGCIYVASNVKKPGHVQHVGGPGKIFVGGKENKALINLLLAGGLDITYL
ENINETLWKKYLFVAPVAALTSAYKVSFGQLLEDHNLMHILENMMIEIQSLALKNNIILT
NDDIENAKDLLTKFPFESKSSLQLDFENNNKTEKQFLVDYVIENAIKHGIETPFYNDVND
KIKALYNVS
>EGALAKHO_02807 HTH-type transcriptional activator RhaR
MKDTFFIYKDFEIYSVEELTWKKEVHRHNFFELLYIEYGTGNHILNSIPHHYKEHDIYLL
TPKDYHSFKTLKPTKFHCLRFLPNFFSNKKEIEEIEKLFYYHNQTNGNLIFPDEDKAFCE
MLIVKILDEVARPKGQNEVIIKSLMTALIQIIRRNAILNENNLNLQTTEILKIDTILSYI
RSNIANPHLLKKKEMANHFNVSIHYIGEYFKKHLNITLRDYIVQTKLKVVTEKLSKSNLT
FSEISNDLGFIDSSHFNKFMMKSTGISPSEFKKSLSIS
>EGALAKHO_02808 Acetyltransferase
MVLEKSKSLVLGNLLQRLTENLRKEAQLFYKSQNIDFEPKWFPVIYVLSQKKAISVVELS
LEIGYSHPTTISLLKELEKKELIGSAKDPKDERKRLITLTEKASELIQQLQPLWAVMTQA
LVELTDTENNLYKAINEVNQNLKTKNLFDRMTTIKEMNLHNPLKEVENDIKVEKIEDPKL
ESIAFAIRRQVFVEEQNVSQERESMDDAEAIHYLATVNGLPAGAARYRIMEKGAKIERIA
VLNSYRGKKVGEAILKKIVEDLRNEDKIYLYAQVNASPFYIKNGFKQTNNYFLDAGIEHV
EMDLVK
>EGALAKHO_02809 Gluconolactonase
MNHLRLKIKSNLLFFIAFVFTNFISAQKSEDSNHNLAAKGAVLTKLSDQYSFTEGPAADK
KGNIYFTDQPNNRIMKWSINGELSVFMENAGRSNGLYFDHAGNLLACADEKNEIWKIDQN
KNTTVLVNNFEGKRLNGPNDLWVDPKGGIYFTDPFYKRDYWTHTSKEIEKECVYYLSPDK
SKIINADNELVKPNGIIGTSDGKTLYVADIGANKTYCYTINSDGSLDKKTLFTESGSDGM
TRDESGNIYLTGKGVTVFNPKGEKIAHIDVPEPWTANVCFGGKKFKTLFITASKSVYTLE
MNVRGMK
>EGALAKHO_02810 hypothetical protein
MKSKEFIREALRNGWVFVRQGKGSHEIYQKEGKQVVIPNHGSKEIGKGLEQKLRKEMGL
>EGALAKHO_02811 hypothetical protein
MKTIKIIIERNEDGFWGYAENEKAIVGGGNTVQECKQDVLDCIETLKELDEENKPGFLDK
DYMLVYKFDTASLLNYYKGIFTNSALERITGINQKQIQHYASGHRNPRLEQRLKIESALH
NLGKELLAVEL
>EGALAKHO_02812 Zinc-type alcohol dehydrogenase-like protein
MKAIGFKTSLTIDKEDSFIEFETPKPIPGAHDLLVKIEAVSVNPVDFKIRQNSAKETVLE
TPKIIGWDAVGIVEAVGDQVSLFKVGDEVYYAGDLTKQGSNAEYQIVDERIVGKKPKSLS
IEQAAAMPLTGLTAWEILFDRIRINPEKDKGKSILIIGGAGGVGSVAIQLAKKVAGLTVI
ATASRPESIEWCKQQGADFVVNHKNLIEEVRNAGFQHVDFILDFVDVNQYWNAFVELIKP
QGHIGSISDPVENVSLRQLKGKSASFHWELMFTRSMFQTEDMIEQHHILNELSNLLDNGT
IQSTLKATFNGLTVSNFKEAHQLLESGTTIGKIAIKF
>EGALAKHO_02813 hypothetical protein
MKLAATITITILALFAQQSAQAQETKKETTSTEPKYTIENCVNHFELDKATKTKVGYQYW
FGDKNFTQENTLKMSIVEPGKSTHAPHHHVEEEFFFILEGTAQFYLDGKTVTAGPNTSFY
CPSNMEHGISNAGTTDLKYLVIKKDLK
>EGALAKHO_02814 Gnt-II system L-idonate transporter
MSLLILIASILLLLILISGVKLNAFIALIIAAFFVGIAKEMPFPDLINSIQQGIGSTLGS
LILIIAFGVVLGNLLSDSGAAQRISSVMIRSFGVKHIKWAMVITGFSVGISMFYNAGFII
LIPMVFAVAKSTKQPMIYLGIAMASALSITHGFLPPHPGPTAIAVIFKANIGKTLLYGLL
VALPALFVAGIVFPEFIKKIEAFPPKGLFESKTFTEAEMPSFQISILTALVPVFLMATAT
FSELLLPEGNDLRALLLFIGNPTTSMLLAVLFAIYSLGIFRGRKMQDIMDKSGTAMSSAT
MIILIIAAGGAFKQVLIDSGMGTDISTFFEKSSLSPLLLGWLIATIIRIALGSATVAGLT
AAGIVQPLVIASGVSPELMVLSIGAGSLMCSHVNDTGFWMFKEYFGISVSDTFKTWTVME
TIIGVMGLIGVLVLNIWIK
>EGALAKHO_02815 Xylulose kinase
MESFYIGIDIGTTATKAICFDIQGNVIRQVSNAYPMYHPKPDWSVQNPQEILQTIIDCIA
EITKDIQPEFISFSSAMQSIIAIDKTGKPLTDAILWADNRANGIAEKLKNSEKGKHFYQK
TGIPIHPFSPMTKIAWFKEFDSDIFSQTYKFISIKEYVWHHLTNEYCTDTSMASGTGLLN
IHTLQWDPEILEFLNLKPEQLSTVCEVTHQSKGVADDFLYVMGGGDGALANLGTGAMNKG
CIALTIGTSGAVRLPIDKPYLDEQMRTQCYHLMNDQYLTLGAVNNGAIILQWVRETLLKT
DQSFEVLFEEAEKIQAGSEGLLFVPYLLGERAPIWDAAAQGSLLGMQITHTQAHLVRATL
EGILFGLFQITEILLPDPEKRKQTKVMASGGFGKSELWLQMVADIFQMEVETSQTIEGSA
WGAVIIGMKSIGKDITNENKTGKTFYPNTVHKSVYEAAFNKFKKVYPVLKDLL
>EGALAKHO_02816 hypothetical protein
MAAINPYIHFNGNAEEAFTFYKSVFGGEFANISRYRDISSEQYPIPENDQNSIMHIVLPI
GKTGVLMASDVMQAMGKVNETDNRYTVSIIAESKEEADKLFNGLSEGGKIEMPLFDGPSG
NYFGMFADKFAVQWMVNYNPKFSGEV
>EGALAKHO_02817 hypothetical protein
MKTDLLFDFTVDKPSKTVYITREFAAELPLVWDAFTKAELLDQWVAPKPFTARTKYMNFE
VGGRRFYAMVSPDGQERWSVQEFTSISPKTNFKMYNTFSDENENRVLPGSDWDYNFSEQN
GITKVNISIFNESLERLEKMIEMGFSEGFKMSIDNLDELLETLSKK
>EGALAKHO_02818 Transcriptional repressor SdpR
MRRDIFQAIADPTRRSILTLIALQAMTPNAIAENFNTTRQSVSKHLRILTECDLVKQEQR
GREIYYSLEIEKMKEIDKWIEQFREIWETKFNQLDELLVTLKNQKK
>EGALAKHO_02819 hypothetical protein
MKLKTTTKSFASFFNKKKGMSLLFIVFINIISHNLYAVEKDSLKGRWDITIDVDGKPAPA
WLEIRRSGRTTLVGQFMCVVGSARPISEIHLKDGKFNFAIPHQWEQGSNDLRVEGQIEGE
KISGILHTVDGKTQTWTGVRAPVLRRTAAPVWGKPIHLIKENSIKDWHAEGTSQWVVENG
ILRSPKSGVNLFTNQKFNDFKLHIEFRIPKGSNSGVYLRGRYEVQVTDGKGLEPALDQMG
AIYGLLVPNEMVAKEAGEWNTYDITLIGKMVTLVANGKTVISNQDIPGITGGAIDSNEAE
PGPIFLQGDHGPVEYRNIIITPAK
>EGALAKHO_02820 hypothetical protein
MIKINYKIQFVLFVFCLFFIGLGIFETANEGLKTGTALFWQISHFVPFVMGAIIFGNNLY
SKRVENFKN
>EGALAKHO_02821 hypothetical protein
MKKTIITFALTLFAVISVTSQIKFDLPQNIELKKESDYAKYESDIVSAAKWLEETDLNQE
TDKRKQVDGFIIKWVSGTPNVTIEMNSSLMKLYGDNHELLVMYMASYSGYSLENKTADKT
ASVKAGIISMINVYKKGISISKSKEMEKAIKALDQNKLDEYIEKNFG
>EGALAKHO_02822 hypothetical protein
MKKINQITLIAIVIIICVFGLSGKISGEKFDSKKWKTANLDLEDNWSLRWDMMNSLRNNN
NLIGLSKSEIITLLGNPDESLATKNTFRYYLGYSHTGINTGSLTLTFDNGIVSEIHVWQG
>EGALAKHO_02823 hypothetical protein
MGLLDFFKKKNNQQALDNTITLETLLEKATTEPAYRAEFYKRILSEDLVIITQNSEMPNG
SKILQENTKVKIVSYADGKIPVFTSTDRIFDQGVVTDEVAYMQMKGENLFELAKGATFLL
NPYSEYGKELLPEEVERILSGEILTDNSKTVTIQKKTEVQIGQPANYPTDIINSLKVLFS
NKPDLKAAYLGWIFDAESGEPPHYIFGLEANGDIESLTQEAGFTVKQFLDADEFVDFIKV
DKKSSLSDYFYSTEPFYKR
>EGALAKHO_02824 hypothetical protein
MKKLLFVLASIFVISCADNKKEAVKTDHQETELDNVKKENTVNELEKFREIFENKIVVLL
DKKGTNLKTNDVSFQTYIDEKNVEFIPVFTSSAKLSESTGGVVLGNQMELDGFLFLSQSG
SAKDLVVLRINPALSDDTYVNLHDLKKYFAKEIKQKTEELKINIE
>EGALAKHO_02825 hypothetical protein
MKSLFALIFIFINHCVTYSQNELVGKYYSIHNKFERWSIIELKNDGKFIYKYGLSGCQSE
INGTYLITKNKIKFKNDSEFINQSIKTDSLNPIYPDMSLTAWIISKDYIKPIEEINTGCI
KEKGKHRKHTK
>EGALAKHO_02826 Putative cysteine protease YraA
MKKNIAILATNGFEESELASPKAYLEEQGWNADIISLKSGTIKSWKDGNWSKEYNVDVVL
DQANEADYDALVLPGGVLNPDSLRREEAAVNFVRSFFESKKPVAAICHGPQILVDADVLE
GRKVTSFFSVKNDLINAGAQWEDSEVVVDNGLVTSRNPNDLPAFNKKMVEEIKEGKHERQ
TV
>EGALAKHO_02827 hypothetical protein
MHIIAQEDTTGIKIDTVYNNLLNRTPKGFAINEATKPKNSYFDSNINLNSIGGLEIIYGF
KEQIKLNAIEIKWLNEQIDQIALAFYLEGKPILIRKVGGYDGCPDKNIYTEKIKDNNVTI
LNFCFTCTDSRKLDDFISVFNNRTNLLLK
>EGALAKHO_02828 hypothetical protein
MKISNEVKENIYNYLVSSMAKPFWNENSNVSFLAYDFFSQVWDLQSLPVIDSRYSTAKEE
IEKNLDLKIWTFDYVLIERLNILKETPSFVRFIEAIISPNYNTNSNEQALHLFAINNELE
NDGLLLRAERESNTYKIYEITEDDIDGLELRKSKYNFYVAKYREKIPDEIQSLSEYFVLY
ESNWDDYNSKTTFSLSFWKGSELIENFGQVKIMTKGENITMNVIPRNFSIIPQKFCSLGQ
SESFYFSIFKLFPNDFSTILSALGDCAFFSDKLEAYENHPRFIDSLIRDDENERILRVIK
YKILNYDLSKLFNFTYEFKPPYSKNSVDIKFEFPAHREKKFGFYHNEIISNRIYAIIGKN
GTGKTQLLNSLPKNITSNVEKLFTPRIPGFSKLIHVSYSIFDTFKASSIPNKTQYVYCGL
KDDNGDLIDSRRLLLRFHNSWKKIKTRKRIGRWREILSQIIDVELLKQFILEDRNDFYNG
FRVDISKFHEVKDKLSSGQNILLFIITEIVANIRYDSLILYDEPETHLHPNAITQLVNTI
YQLVDEFESFCIIGTHSPLVIQELLSKNVYIIERNENYPSIRKIEIESFGENLSKLTDDV
FGNREVAKKYKNIIKNQISFGKSFEEIERLLISDDVPLSLNLKLYIASQLARNEKS
>EGALAKHO_02829 hypothetical protein
MKNLNPYTKNTFQFHKDVVKSTKSKKDDIAYKTRLLDLEVNIEILYSNFLDNHNVNNLIS
TLAHNYLGSEKDDLLSLYSYKRAIIQKLKNEVTTTETGRLISTCQNCTVNKINSFDHILP
KEEFSEFAVNPLNLFPSCSECNSYKGVYWQMGGVPYFLNLYLDILPNLQYLFVDVDLTAQ
VPKIKFYLDDINGIDPRLFSITKTHYSRLHLFDRFSDSIDDVITPLVNEVKAGIDEFLDY
PTIQRIVIRTQTQNQLKFGFNYWKAILALALINHPDFFDFVQNNG
>EGALAKHO_02830 hypothetical protein
MSNSPFTRYEDNNTVWLSQNSKQEFDFTDYGVTPTILNSEAEVGQAMLKELYSTAKSKEG
DINIALLGGRGAQELHRLLGALAKSTEQDELLARLNVFTQDALAPLSMDNGLSFVRDFER
ILGEAFFKKIKSFTPMRTDTKDLESALVEYLTKLEELGGLDIFFIGHGPEENQASHLAYI
KPFSGAQSHHIAGVIPISSSILEHHISKFKAGGSLINENDEKECRSAEYILTLGPAAILQ
AKKIVQSVVDADSAPAKIQTYANVLQTKLSSNKEEALEQLNKNPGLWIRLHSNAKSFVLP
GLGV
>EGALAKHO_02831 Toluene efflux pump periplasmic linker protein TtgG
MKTKILQSSALFFAALFFLNSCNSKKEEAPVAELEPKTETFLLEKEKLTTELRLPAELTG
FQQVDLYAKVSSFVKLLKVDIGTKVKKGQLLIVLEAPEISSQLAAAESRLKSMEAIYATS
KSTYNRLYETSKVEGTISKNDLEMASGKKNSDYAQYQAAVAGHKEVSIMRGYLEIRAPFD
GVVAARNVNLGTFVGPAGKGSDLPLLTIQQQDKLRLAVSVPELYTGYLHTGDEMTFNVKS
LPEPFTAKITRMSGALDLKLRSERVEMDVQNTKKDLLPGMVAEVLLPLNAKDSTFVIPKS
ALVSSAEGTFVIKVIDHKATRVNVKRGREIEDKIEIFGDLNRKDKLVKIASEETKEGDII
NE
>EGALAKHO_02832 Cobalt-zinc-cadmium resistance protein CzcA
MNLIRFALRKPISILVMVAGLFFFGIGAIKDIKVDILPKMNLPVIYIAHPFGGYTPDQME
AYFAKTYVNILPFANGVKSVETKNIQGLMIMKLTYYENTNMAQAAAELSSLSNRIQAAFP
PGTQPPFIIRFDASSLPIGQLVLSSKIRSNNELQDLANVYVRASFTSIPGLLSPAPFGGS
PRTIEVNVDPDLLRSHNMTPDQIVEAIRINNQTAPSGNVRMGNTNYITPTNNTIKEVKDF
ENIPLFKGSVQNLKLGDVATVKDGADITAGYALVNGKRSVYISIAKAGDASTWDVVQKLK
AELPKIQSTLPEDVKLSYEFDQSVYVINSVKSLITEGIIGAVLTGLMVLLFLGDRRAALI
VILTIPISIISGVLFLKLFGQTINLMSLSGLALAIGILVDESTVTIENIHQHLDMGKPKA
LAIWDACQEIALPKLLILLCILAVFAPAFTMVGIPGALFLPLALAIGFSMVISFLLSQTF
VPVMANWLMKGHEKHEHDPNITDDEAEFNQCGLTPESEKQLITQKKDYVERTDTDGNGKI
GAFERFRIRFMRTLDRLFPFKKTAALVYLVSATLLAVAFITFIGKDVFPKVNSSQFQLRM
RAPDGTRLERTEEKAVIILKELQKMVGKEHIGISSVYVGQHPSLFSINPIYLFMAGSHEA
VFQVSLKEYHVDMDDFKDEFRARIKKVLPDVKLSFEPIELTDKVLSQGSPTPIEVRIAGK
DKKRNELYANKIVEKLQKIAYFRDVQIGQPIHYPAMNIDIDRTRAAELGVDMNDISRSLV
ASTSSSRYTEKNTWVDERAGLSYNVQVQVPLNQMKSKTDIGEIPVLKNSLRPVLSDVAKI
TPGFVSGENDNLGAMPYITVTANINQTDLGTASKDVAATISSLGELPRGLFISPIGLSKV
LEETLSSLQVGLLVAIFVIFLMLAANFQSFKVSLVILTTVPAVVLGALLMLTITGSTLNL
QSYMGIIMSVGVSIANAVLLVTNAEQLRKINGNALESAREAAALRLRPIIMTSVAMIAGM
LPMAIGHGEGGDQVSPLGRAVIGGLLFSTFAVLLILPLIFAWAQEHTTTQSVSLDPEDEE
SIHYISSLNKPKV
>EGALAKHO_02833 hypothetical protein
MYFKKITLLFFLIFASIGYSQTLSLKEAVKTGLENYGSIRAKSNYTNASRETLKQSKRDY
LPNLNLSAQQDYGTINGQNGALYGLNGLAAASSGPALPNQNWNSAFGALYLVNMNWDFFT
FGKAKEKINLAKVDVQSKERDLQQEMFQQEIKISAAYLNLLASQRLLISQQKNLSRAEVF
KKTAVARVKNGLLAGVDSTLATAEVSKAKIALNLARNFVKEQNNKLVDLMGVAPQDFKTD
TLFVNQIPKAILTAEKTTDSLHPLLQYYKTRIDYSDQQTKLYKRFYYPTMSAFGVVQTRA
SGFDTNYVQDQTAFTRNYWDGVNPDRSNYLVGIGISWNLTTPVRMSRQVSAQKFVSQALK
EEYNQADRELKSQMSFAEDKIKITLENFAEAPIQVNAAQKAYLQKSTLYKNGLTDLTDLT
QTMFTLNRAEIDRDIVNNNVWQSYLLKVAASGNFDLFINEF
>EGALAKHO_02834 Sensor histidine kinase YpdA
MNKKFDNILDNKWWQEIAVVLFSFTIYTLKNDWMLFSSVASILMGIFFYFILYMHAQFNR
FFLLPILFKTQRPLTYIFLTLFGVFVFSVILYEITMLDMFSNCRLYQNSHQRSYIYQLAS
VLGTLVCILSPIIVFKFYRIHRKQTDETLLFNQMQLNSLKGQLNPHFLFNTFNTLYGISL
EFPERTPDLIMKVSQLMRYQLESNNKQCVSLEEELQFINSYVQLEKERVGYRCDITYDCK
IDNENAYKVSPMLLIAFIENAFKHGTCAIEKCFVRIIVTVENGLLHLHVVNSIPTKKADV
VSTKIGLKNTIERLNLIYGKDYKLNIQDDKNTYIVDLKLQLKKFV
>EGALAKHO_02835 Transcriptional regulatory protein YpdB
MKDPKKCIIVDDEPAAHYVLANYIKQNPQLELVFQGYNGIEAMDYLRENHVDLMFLDINM
PEISGMELLKIIPTHPKTILTTAYSEFALESYDYGVIDYLLKPIYFPRFLKAVDRFFSTE
NAKAKEEEAAVNSISVKVDGYFMDIELDQLLFAQSFGNYVKLHTIKRTYLASITTSELEK
CLPEKSFMRIHKSYIVALDKIDVTEKDFVIIKNEKLPIGITYKRELSDRLKK
>EGALAKHO_02836 hypothetical protein
MKNVLVAVLFLCSGFLLAQEGTNMKEKVTPPEKVLFTFQKEYSNKVPVWAMEYVGDDNDE
VRYEAKFKTDTNQEALAVYDNLGVLKAYELQIPLSQLPAKAQTYLKKNYAPNAIREIAVV
VDYQSKTTYEVGVEKAGKFYDVVFDKNGGFDVTIEKN
>EGALAKHO_02837 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MSVNTKIALVTGGSRGLGKNMAIAIAQKGIDVIITYNSKKEEADTVVKEIESLGQKAASL
QLNVADSGTFDAFFASVSEVLKNTFKTDKFDFLVNNAGIGIHNSFIGTTEAEFDQLTNIQ
FKGPFFLTQKALNVMNDGGGIVNISTGLARFSFPGYAAYASMKGAIETLTKYQAKELGER
KIRANVVAPGAIETDFGGGVVRDNEQLNKNLAAATALGRVGLPDDIGGVVAFLCTEEARW
VNAQRIEVSGGMML
>EGALAKHO_02838 Serine 3-dehydrogenase
MNLANNKILITGGASGIGLGLTERFIQENNTVIICGRRESVLNEVKAKFPSVITRVCDLS
DEKERIALYEWIAKNHPDLNVLINNAGIQKWVSVTDGDFYESMKTELSTNIEAPLHLTSL
FIQLESLKTVMNVTSGLAFSPFAKVPVYSATKAFFRSFTISLRHILKAKNIEVIEIIPPA
LNTDLGGVGLHDAHPSVADFIVSIFEQLKQGKNELTFGTSETRINASVPELKASFEALHG
IN
>EGALAKHO_02839 HTH-type transcriptional activator RhaS
MKSLDSFYQDITEGSTVEPNSLLPNDIKKEIGHFNVFDIKELYERLKDKPGMPYDRRAYY
KISLIRGKNRAEYADKIIDIEKQGLLFATPKIPYNYLPQDTNQSGQFCVFTSEFLSKNKS
GIDLDDLPIFASDGYPIFQLSDEEVNEVELIFNKIQKEINSDYIYKYDLIRNYVAELIHF
GQKLQPITALYSKHNSAARVSSLFAELLERQFPIESPHQRLELRTAKDFAERLSVHVNHL
NKVLKENTGKTTTELISTRLINEAKILLKQTDWNISEIAFSLGFEELAHFSNFFKKQTSF
TPLAFRS
>EGALAKHO_02840 RNA 2',3'-cyclic phosphodiesterase
MIKRYSIAIYPSQYVIDFIKQMKGELKIKIKWYNSCNSVAHITICEFEIEESQIEKIKQK
LYKICDSFTPFQVYLNGFGTYENSGAFFINPNKDSKEKLKPILKKIQETLKPLSLKKSDD
PHMSIARRLTSEKLQIASEIFTTIDLYFLCREIVLRELDPVKKQFFVIDTIPFGSNPQPE
LIQGSLF
>EGALAKHO_02841 hypothetical protein
MKTLFRILLLLGFFYNANAQQKVAFQKLRYDDDLTYLKDSTRNWYEKIKYIPLGQNSNYY
ATIGGEARLQYTYTVNDKWGDESDEGDGYLLSRYLLHADVHLEAFRTFVELQSSLANSKI
DPSPVDENELDFHQAFLDIDFIHNENERLTLRSGRQEMSYGSQRLIAVREGPNSRLAFDA
AKLFYKKNNWQTDAFFTHPVANKPGIFNDSFNENAQFWGSYTVIHKVPFIQNIDFYYLGL
WKKRAVFDDATGEENRQSIGTRIWKNKGNWKYDFEGLYQFGNLNQKSISAWTMSSFACYT
FTEVKFSPEIGLKTEIISGDKHSDDNHLETFNPLYPRGAYFGLVALIGPSNLIDIHPSIN
FTLTDNLGLGFDYDIFWRESISDGIYAPNMQLLYSGKDTTERFIGSQLITNLDYTANDFL
GFTLEAGWFNAGSFLKEVGTGKDYFYAALTAQFKF
>EGALAKHO_02842 N-substituted formamide deformylase
MKPKALLSALLLILSLPIFAQGKSATLIVHHAVIHTLDDKNTIVEAMAVADGKILKTGTN
NEILKLKNKKTTIIDAKGKVIIPGIFDSHMHIIRGGRFFNTELRWDGVRSLKRALAMLKE
QAQRTPKGQWVRVVGGWNAYQFEEKRLPTLEEINEATGDVPTFVLHLYGHAYLNKAGLQA
LKIDANTPNPNGGLVEKDASGNPTGLLVAEPNAFILYSTLSKLPELTPEEKINSTKQFMS
EMNRLGVTAIIDAGGGFQNFPDDYGVTNGLCKDSGLTIRMPYYLFAQKAGSELNDYTKWV
NTVEIGEGCDDHDENKVEYHAQGAGENLVMSAGDFENFDKPRPELSPAMEGQLKSVLSLL
IKNRWPFRIHATYNESITRFLNVIEEIDKETPLNGLLWFFDHGETVSVENLKRIKALNGG
LAIQHRMAYQGESFIKRYGKTAAANTVPLKKILEMGIKVGMGTDGTRVASYNPWVGLYWL
TTGKTLGGTKYMLDENIQDRTTALKLFTYGSAQLINLEKDRGMLKANNLADFVILSDDYF
NTSEDNILKIESKLTVVNGKVVYADNDFRTYANPIPKAIPDWSPVNYFGGYQKN
>EGALAKHO_02843 hypothetical protein
MKKLISTAVLLFVTFIGFAQKPSPALLNPTNHTLVLIDYESQMAFAVGSIPIDQLRNNTA
LVAGASKIFKVPTIVTTVAEKSFSGPVFPEIEEFYPQKTSNYIDRTSMNTWEDGPAYKSI
TEKGKKKIVFGGLWTSVCIVGPVLSAINDGYDVYVITDASADVSKEAHEMAVTRMVQAGA
HPVTSLQYLLELQRDWARQETYAAVTDLAKKHGGAYGIGIQYAHDMIKH
>EGALAKHO_02844 hypothetical protein
MKIFEFLILGKNEPILEILLRLVNAYEDWNAVGYSDENAAQEYFLNNKIDIVLLSSGIED
HVEKEFTSFCLKHQPDVEVIEHFGGGSGLLKSEIQHRLHLKGKI
>EGALAKHO_02845 hypothetical protein
MRNFEILITIARGFSHCKCNHYQVSIGLYGWKRGLCLKILIRKESVL
>EGALAKHO_02846 Acetylxylan esterase
MKNSKHFITGKSLFNLILFFGITTHITAQNQVIPLWKTIPQEIKAPDYQEKESIKDGKVQ
STSQVSIPTLSIFFTKEIKQNQTAVIILPGGGYSHLAIDKEGTKVAEWLNSLGIVAFVLK
YRLPSDLIMTNKTVGPLQDAQEAMRIVRLNASKWNIDPNKIGIMGFSAGGHLASTISTHY
DERVYETSSKISARPDFSLLIYPVVSMENDITHKGSQTSLLGNNPSQDQINSFSNEKMVT
AQTPPAFIIHATDDSVVLPENSINYYLALKKNGVTSELHLYESGGHGFGLGVKDTSKFWT
RDCEEWLKAHGL
>EGALAKHO_02847 Hexuronate transporter
MNQTNEISISKTNKTGRYRWSICALLFFATTINYLDRQVLSLTWNDFIAPEFHWTNNDYG
NITALFSIFYAVSLLFAGRFVDWLDTKKGFLWAIGIWSIGACLHAFCGIATAGIITGNWF
VGFEGAKEVIKTVNDTGMVINVSVSLFIFARFILAIGEAGNFPAAIKTTAEYFPKKDRAF
STSIFNAGATVGALAAPISIPFIAKSFGWEMSFIIIGALGFVWMGFWMFMYDKPERHPKV
SPEELAYIQQDDIADSKIVGYVADTSTKVSFADCFKYKQTWAFAFGKFMTDGVWWFFLFW
TPAYLSSVYGMDSTEAALPLFVLYMITLLSIIGGWLPTYFVEKKGMNPYEGRMRAMLIFA
FFPLLALVAQPLGYISYWVPVVIIGIAGAAHQSWSANIFTTVGDMFPKKAIATITGIGGL
AGGLGSTLINKGSGVLFDFTQRNWSLINGQSLLEKYPQFLNPDTEKIFLKEKGFSNLGDF
LKSLSESGDTVVNGINSGYMIIFSICAVCYLIGWVVMKTLVPKYRPITDL
>EGALAKHO_02848 Hexuronate transporter
MDQANAAIGKYRWTICGLVFFATTVNYLDRNVISYLRPFLAEAFHWTPEQEVIDYSNIEL
AFKIAYALGMLVAGGIIDKLGTKIGYAIATGLWSLAAIGHALATGTPGFLIARVFLGITE
AGNFPAAIKATAEWFPQKERALATGVFNSGSNIGAIIVPLSVPFIAENYGWQWAFILTGI
VGFIWLALWFVLYEVPEKQKRLSQAEFEYINSDKIVTTEVEDTEKVSWFKLLSFRQTWAF
AIGKLLTDPVWWFYLFWLPDFLMKQYKLTATGIIWPCALVYVIGSVGSIGGGWLPLKLIE
KNWPAYKARKTSMLIYAFAVLPVLFSQYLGSINMWWAILVIGLAVSAHQAWSANIFTTVS
DMFPKKTTASVTGIGGMFGALGGILLTLVVQKNMFVYYTKIGKIETGYFIMFCICGASYL
LAWLIMHILVPRMKKVEV
>EGALAKHO_02849 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase
MTKYSSRYASSPEAVKQYDTQQLRNEFLIDDLMQENEIVLTYSHYDRYIAGSAVPVKDLT
LETIDPLKAGYFLERREMGIINVGANGSVVVDGTSYELGFKDALYIGSGNKEVIFKSDDS
ANPAKFYINSAPAHTHYPTVKVSLEQANKLQLGTMETANHRTVNQMIIGSVVTTCQLQMG
MTELRPGSVWNTMPAHVHDRRMEVYFYLDIPENQAVCHFMGQPQETRHIWMNNHQAVISP
PWSIHSGSGTSNYTFIWGMAGENLDYGDMDVCKITDLR
>EGALAKHO_02850 Gluconate 5-dehydrogenase
MTNLFDIKGKVALITGSTHGLGMAMAKGLGEAGATIVVNGNSSQEKIDAAVKELKSEGIN
AVGYKFNVTDEQEVKTAVAKIESEVGPIAILINNAGIIKRIPLIEMEVADFKEVIDIDLV
SPFIVSKHVAKGMIERRQGKIINICSMMSELGRNTVGAYAAAKGGLKMLTKNMATEWAKY
NVQINGIGPGYFATEQTKPIRVDGHPFNDFIISRTPAAKWGDPSDLAGAAIFLSSKASDF
VNGHILYVDGGILATIGKPSNEE
>EGALAKHO_02851 Uronate isomerase
MSSNKTFINDNFLLENKYAEELYHNYSKNQPIIDYHNHLNPQFIAEDKIFDNITQVWING
DHYKWRAMRTLGINEQFVTGNGSDKDKFLQWGKTVPYTMRNPLYHWTHLELARYFDIYDL
LNEKSAEKIYIETSEKIKSEAYSTQNLLKKVNAELVCTTEDPIDTLEFHQKLTKNPIGTK
MSTAFRPDKAILISNDGYNAYLDTLGDVSGVAINTYADLRDALRKRIEFFNQNGCKLSDH
GLDQIYFEEFTEAEVASIFKKKRENRIITPEEALKFQSAILLFLTETYHEFGWVQQFHLG
ALRNNNARMHRILGPDTGWDSIGDYPQAQKLSSFLNALDSKDKLTKTIIYNLNPADNEVM
ATMIGNFNDGSVRGKVQFGSGWWFLDQKDGMTKQLNALSNMGLISCFVGMLTDSRSFLSF
PRHEYFRRILCNLLGDEIQRGELPADMEWIGKLVSDISYNNAKEYFKF
>EGALAKHO_02852 2-dehydro-3-deoxygluconokinase
MSKIVAFGEIMLRLSTERHLRFAQSTAFGATYGGGEFNVCVSLANYGLNAEFVTRLPENE
IGGSALREIRKMNVESKNIIFGGERLGIYFLETGAGTRGSNVVYDRAHSSMATIERGLVN
WEKVLEGATWFHWSGITPAISQSAAEACLEAIKVAHKMGITISCDLNYRSKLWQYGKTPS
EVMPEMLQYSNVILGDIDTAYFMLGIPKVNPNYQDEKSLPVLYTKLFDLIPNLKTVATTL
RYSVSASHQRIGGVLFNGKAIYHAAVKEVTPVVDRVGSGDAFMGGLIYGLSQYENDNQKA
LDFAVAACCLKHTIAGDYNLVTLKEVENMLGGDSAGLVSR
>EGALAKHO_02853 KHG/KDPG aldolase
MAKYSRIEVAQQMKDNGMVPLFFHSDIEVSKKVLKACYDGGSRLMEFTSRGDFAHEVFGA
LNKYALAELPGMMLGVGSITDAASASLYMSLGANFIVTPVFREDIAIACNRRKVLWSPGC
GTLTEIARAEELGCEIVKLFPADIYGPEFIKAIKGPCPWTNIMPTGGVYPTVESLSSWLN
AGATCVGLGSQLISKDILDKNDYDGLKNKVSQVLDIIKNIRK
>EGALAKHO_02854 Altronate oxidoreductase
MKQLNRKNTGLEKLQPIKVVQFGEGNFLRAFVDYAFHKLNKEVDFNAGIAMVQPLKDGMV
NMINDQDGLYTLFMNGIKKGEKIQDIELITNIVKAINPYTEFADYLALAKEEELQFIVSN
TTEAGIEFIESDTPDMQPPVSFPAKLTVLLYERFKHFKGDASKAVTIIPCELIDYNSETL
KKYILQYVDLWKLEDAFKTWVSDACTYHSTLVDRIVPGYPRAEIEEYNNKLDYQDNLIVA
AEPFFLWAIEGGDALKAKLPFDKTDLNVKIVDDIRPFKMIKVRILNGAHTAMVPFSLLYG
NKLVMETVNGDFTGKFVNSVISEISETLDMDKNEITAYSEEVMDRFKNPFIKHALADIAL
NSISKFKVRVLPSLLGYYNTNKKLPVNLTFSLASLIQFYKGTWNNEALPVKDSPEIVEAF
NNAWKLGSTDLVVAKVLSNTDFWGEDLTKVQGLSEALVLALNEIEKNGIEQGFANFSKQY
>EGALAKHO_02855 Altronate dehydratase
MQKKLIKVNPSDNVAVALVNLVAGEVINFEGQDITIESDVKMKHKIAMVPFNVGDRIIMY
GVLVGKASARIEKGGLLSTANVKHESDKVTGKTETIGWNSPNIDKWKDRTWQGYHREDGQ
VGTENVWLFFPLVFCENRNIEILKDIFEKELMKPKENDYQLLLRSLVKTETGGAGNEAAS
NDANLFNNIEVKFITHQGGCGGIRQDSHSLAKLLAGYVNNPNVAGATVLSLGCQNLQIQI
FKDALDAINPNSKKPVLIYDQQQIGTIETMLSSVVKDTFEAIKKANEIKREPAPLSKLRI
GLECGGSDGFSGISANPTLGVLSDHLVALGGTTILSEFPELCGVEQELVNRCVDDKDGKR
FLDLMQWYEKTVVDAGSGFDMNPSPGNIKDGLITDAMKSAGAAKKGGTSPIVGVYDYGEY
INEAGFTLLCTPGNDVECTTAMVGSGANMVLFTTGLGTPTGNPIAPVVKISSNTELAKKM
SDIIDIDTGGIITGEKSIDEMADEMLEFIIDVASGTIKTKAAILNQNDFIPWKRGVSL
>EGALAKHO_02856 HTH-type transcriptional regulator DegA
MSEKITIYDIAKKLNITAATVSRALNNNPKIKESTRELVIKTAASMNYKQNKLALALKSG
RSNNIGVIVPRIDSNFFASVIRGIEEELQPHGYQVIICQTHEDLKRESENLYTLIDAQVD
GILMSVTAVSTENDGAFHNVLEKNVPLIFFDRSKHIDGVSSVTINDFKGGYIATKHLIDE
GCRCIAHLSGDQKLEIFKNRFLGYKQALLDSGMTFKEEYVIPVKSSVDAGKEAVDLLLKL
QTPPDAIFSSSDFAALGAIQELKERNISIPKEFCVAGFSNEPFTKFMELSITSVDQSPLE
MGKMSARVFLEQVDKTDTIKIEKKVVLAPELHIRKSSSRTNF
>EGALAKHO_02857 Exo-poly-alpha-D-galacturonosidase
MITNKPLMLKSIALACVLTTMILSCGKQVSTVSETDPWKKMDLIINSIPETKFLNKDYNI
NDFGAVADGKTMNTVAFERAIKACSENGGGKVIVPNGKYLTGAIHLESNVNLHLEDKAEI
LFSINPKDYPIVHTSWEGTEVMNYSPLIYAKNKTNIAITGKGTLNGQANSSNWWVWSGGK
SYGWQKGIPSQNDPTNREVLVDMAEKGVPVSERVFGDGRYLRPSFVEFFECNTVLIKDVT
IINAPFWILHPLKSNNIIIDGVTVNSHGPNNDGCDPEYSQNIIIKNCTFNTGDDCIAIKA
GRDADGRRVAIPSKNIIIQKCKMIDGHGGVVIGSEISAGVNNVFVEDCVMDSPNLDRVIR
IKTNSKRGGIIEDVFVRNLEIGTVKECVLLATMYYNVYGSQTGNFIPVIRNINLENIKVK
NAGKYGVLAEGYKESPVENITLKNVTIEKADSIYKLKNVKNINFIDTYINGRKVEPIKN
>EGALAKHO_02858 Carboxylesterase NlhH
MKRLLFIILLISNAIFAQSNFSIDTSYTIKSTYNKLIKKYPFITIPQLQINNDIAEVKEV
IYQQNSDRELHFDAFFNKKQKKNPAVVMIHGGGWRSGNQSQMHDMAKEIASKGYSCFAIE
YKLSLEAKYPEGVIDIKNAIKYIKDNAKKFNVDPAKVAVLGCSSGGQMAALIGTTNDVSD
FEDKSFKSKSSSKVQAIIDIDGVLAFKHPESSEGDMASFWLGGNYDQKPENWKNASALNH
TNKGSPPILFINSSFDRFHAGRDDMITILNQYKIYNEVKTIPNSPHSFWFFEPWFTETVV
YTTQFLDKIFK
>EGALAKHO_02859 hypothetical protein
MKTKITITSLLLLGSMVVSAQKYDIKTAKTYAEISSKTDGKWEGRKYKGGTVFKNVDRLK
AAPEHTDHSFDIRYEGPGWESNRIAYRLYLDWRNAIDIFGKKTPEMILPRVGQDNFDSYH
KMSDWGADILQAGKAIGIGSIDRYLNNEKLHFREVDSTIATVVNKTTESGVKVNYYGWKT
ASDKIDFISELTIKPDQLYTQHTIKASKEIKGICTGIAKQKNTELLKKESKNKKWAYIAT
YGEQSLVPDKLGMAIFYQTGTIENSVETDLDYLLVFKPTTKATTFYLLGAWEQEINGIKS
KEEFVKYLDEKLEILNKKAKM
>EGALAKHO_02860 Unsaturated rhamnogalacturonyl hydrolase YteR
MLKTLFIKKNYTIWAFVLLLLVGNNTIAQTDINTISDDLKWSERTALSILNKYPQAWQLD
GNDKPKWDYKMGFVLSGFEKLYQKTNNQKYLNYIKEYVDEMIDSTGNIKKYDIKEYNIDY
LNPGKLLFNLYDKTKDARYLEITGQLRNQLETQPRTPSGGFWHKQIYPDQMWIDGLYMGE
PFYVQFTMKYEKGKSLEDIAKQFELAHNNIVDKMIGLPYQAWDESKQIGWANKQTGNSPT
IWGRGIGWYMMALVETLDYFPKSHPKYKVLVGYLNQIAKNVNQYKSPEGLWYQVADKPEL
FGNYVEPSASGMIIYAFAKGADKGYLPSSYKRQALKSFDSFVKEFVKVDKKGEVTILNVS
SNVGLGGRPFRDGTNDYYLMAKTKENGAIGIGAFLLSAIQLNK
>EGALAKHO_02861 Unsaturated rhamnogalacturonyl hydrolase YteR
MKNKRKQGYFVSALLVCVMAFTSCKVISQEPANKDIVISKNLKWSDKMALTLMKRHPESY
MIDDSKKPKWDYVHALVLHSFEELYKKNPDPRYNAYVRGYVDQFVESDGSIKTYEFDKYN
IDLVVPGRLLFDVYQTSKDEKYLKAMQLVRKQLSEQPRTASGGFWHKQIYPNQMWLDGLY
MGEPFYAQYTATFEGGKSFDDIAKQFELIHQHATDPKTGLLYHAWDESKQMPWANKQTGN
SPNFWSRALGWYVMALVDVLDYMPKDHPKQKELVKYLNSACEALAKYQDKSGLWYQVTDK
GGEKGNYLEASGSSMFAYAFAKGVNKGYLSAKYKKLANKAFDGLTKVLIKKVDEDGGITL
TNCCQVAGLGGTPYRDGTYEYYINERKKDNDPKATGPFILAALELNR
>EGALAKHO_02862 Xylan 1,3-beta-xylosidase
MKNIKVIFLLFSVFSIEQNFAQVWVPDNGDGTYTNPIIHADYSDPDAVRVGDDFYMTASS
FNCIPGLPILHSKDLVNWRIIGYALTKQIPTETFDKVQHGNGVWAPSITFHNNEFYIYYP
DPDFGIYMIKSKKAEGPWSEPILVKAGSGLIDPSPLWDDDGKVYLVHAYAGSRAKIKSLI
TVCTMNDDGTIANNDEVMVIDGHESEGTIEGPKFYKRNNYYYIFAPAGGVSTGWQTVLRS
KNVFGPYEKKKVLEQGKTSINGPHQGAWVQTQTGEDWFLHFQDKGAYGRIVHLQPMKWEN
DWPVMGQDFDKNGIGEPVTTFKKPNVGKIYPIETPAESDEFNNPKLGLQWQWQANAQVQW
GFPTSLGYLNLFCLPTIKESNKIFEAPNLLLQKFPAEEFTTTTKVTFNTRLSGESTGLLI
MGLDYSYLCLRNDNGKLYLNQKTGTFDKKISETETTPILISNNTIYLRVKIKKGGICSFY
YSLDDKKYQPIGNDFTSKEGKWIGTKVGLFALSEKVTNDSGNVAVDWFRITK
>EGALAKHO_02863 Pectinesterase A
MLLLSVLSFGLQAQTTYKNWPDIIRKNDAAWFGTTEAKAIAENVLLYQRNIGGWPKNIQM
QTVLSETERQKLVALKTDEHEVTTDNGATSQEMLFMSRMYAQVKDERYKESFLKGLNYLL
EAQYANGGWPQFYPLKKGYYTHITYNDNSMVNILIILKEISEETDYYSIKPSKEIVEKTK
KAFDKGIECILKTQYKQNGVLTAWCAQHDEVTLAPANARAFELASLSGFESAKIVLLLMS
IEKPSPEIITSVKSAQAWFQKTKITNLEEKRVLNDAGKIIDKKMIPKENADPIWARFMDL
ETNEPFFCDRDGIKKKSLDQIGSERRNGYSWYSDAPKEVLKKYPEWAMRNGVKVGAKDTP
AKKNDNVVLTVAQDGSGDFTKIQDAIYASPAFPYEKVTINIKNGVYNEKVRIPEWNTHLS
LIGESKENTIIAFDDNFKKINLGRNSTFYTYTVLVEGDDFSASNLTIKNTSGDHGQGIAL
SLVANRAKISNCAILGNQDTLYLSGNNTKQYFKDCYIEGTTDFIFGGATALFENCTINSI
KSSYITAASTPEGVSFGFVFKNCTLTANPEATAVYLGRPWRIYAKTVYLNCDMGKQIRLE
GWENWSKPDAEKNTFYAEYNCKGEGFQPAKRVLWSHQLTKKEAEKYTTENILKDSTSNWF
SK
>EGALAKHO_02864 Polygalacturonase
MNFRYLVFLLISCISFAQNKDFPSAKVDSIVSRMQVPVFPSYQINIVKLGANGDSITNNK
AAFDKAMALCKKNNGGTIIVPKGIYKVNGPIHFVSNVNLKIEKGAKIKFSDNPQDYLPMV
LTSWEGTMLYNYSPLIYAYECSNIAITGEGTIDGEGGKTWKSFKAKEEAGKNRSREMNHN
SVPVSDRKFGEGYFLRPQMIQFFNCKSILVENIRIENSPFWCLHLLKSQSITVRGVSYKS
LNYNNDGIDPEYAKDVLIEKVTFDNGDDNVAIKAGRDHEGRANAVTPSENIVIRNCNFKG
LHGVVIGSEMSAGVQNVYVENCKTVGYLKRGIYLKTNADRGGFIRNVFVRNIQLDEVEDC
LYITANYHGEGKGFQSEISNVHFSNITCNKASESGIVIQGFSDKKIKNISLNNIEIKSAK
NAISNENAENVLMTDVFIGKRASVPSAAK
>EGALAKHO_02865 Rhamnogalacturonan acetylesterase RhgT
MKHYIIILFLATTICFAQKTTIYCIGDSTMANKKDPDRNPEHGWAQVLQPFFNDNVVVEN
KAVNGRSTKSFINEKRWDSIYKRLKKGDYVFIEFGHNDEKIEDSTRYTNPHTSYRYNLIR
FVKETRAKGATPILLTSIARRNFNEKGVLVPTHGDYPLETRLVAQEYKVPFIDLEYYTEL
LEQSYGPEKSKQLHLHFKAGENPYYDKDKADDTHLSIIGATKIAQIVVNQIKALEDNNLE
KLKKTIK
>EGALAKHO_02866 hypothetical protein
MFKRKFKNEFDFSEDTFLIKNENDLENFDRSIFVVYDKFEMIEYLKLEKKGSNVLVCLFN
KQLYGSLTFMDEINNLILLDGSKTKPEIVKDLKLYLKRNIESTEQNTKSLFTNSMIFQTQ
FHNFYKALFFLM
>EGALAKHO_02867 hypothetical protein
MKKSNHVHHLKVIIFFIFLWLTPPVFSQKNEISSSDKIPNGYVFTYFKGNGEDGLHLAYS
EDGYKWNTLKNDTSFLIPEVGKDKLMRDPCVIKGGDGLYHMVWTVSWTDKGIGYATSKDL
IHWSKQEFIPVMAYEEKARNTWAPEITYDEKSKKYIVYWASTVEGKFLETKSEEEKGYNH
RIYYTTTKDFKKFSKTKLLYEPGFNVIDASIVKEDKKFVMYLKDETRNPIQKNIKIAVSK
RLKGKYKKASEAITGNYWAEGPTAIKIDNSWIVYFDKYTEKKYGAVKQTPTGWEDISEEI
SFPKGVRHGTVIKVSGEEITALKKEEEY
>EGALAKHO_02868 Unsaturated rhamnogalacturonyl hydrolase YteR
MKKLLLILAICTFQITNAQQPFDKKLVLKQMILANDYFMQKWPETGKTIITNKERPSNIW
TRGVYYEGLMALHEIFPKEAYYDYAYSWSEFHKWGFNSGNTTRNADNYCAAQTYIDLYNL
EPDSRKLKNTRANINMLLNTAQLDDWSWIDAIQMGMPVFAKMGVLEKDNRYFEKMYEMYM
YSRNKHGDNGLFNPKDGLWWRDADFDPPYKEPNEQDCYWSRGNGWVIAALAKVLTIIPEN
APHREQYVKDLKAMAAALAPIQRPDGFWNVSLHDPTNFGEKETSGTALFVYGITYGINSG
ILKKETYLPVVQKAWNAITTESLHTNGFLGFLQSTGKEPKDGQPLSYDKIPDFEDYGLGC
FLLAGSEIYKMK
>EGALAKHO_02869 hypothetical protein
MMRLNKPNCSLILLFFYCFINSFAQETISPWPKSTNINQPWARWWWMGSAVDKPNLKKSL
IDFHNAGIGGVEITPIYGVKGEENNFINYLSPKWLEMLDYTIHISDSLNMQVDMVLGTGW
PYGGSHVTLPHAATKLVIEKYQLKKNESIDRIIKVENTKEKQPAELLYVVAYGSDGSVID
LTNQLNKNLSKPKDKGIDGKSVSIPNSLEPNNLKWKAKKTDYTLYAVFSGKTGQQVKRSA
PGGSGFTLDHYSEEALNAYVVPFNNAFKGREGKIRAIFNDSYEVYGTDFTPNFFEEFEKL
RGYDLKKQMPILLSETDNEIGNRVKSDYRQTIGDLLLNKFDKPWTQWAHSKSFKTKLQAH
GSPGNLIDLYASADIPECETFGSMPFDIPGFRREKEDIREGDADPVMLKFSSSAAHISGK
NLVSSETFTWLREHFKTALSQCKPEAEDLMLNGVNHIFLHGSTYSPERAAWPGWKFYASV
NFNSNNSIWEDAPALFSYIANCQSMLQQGKSDNEILLYWPIFDNWGKFKKGSLFVEYKIH
SLSEWLYETSFYDTTKSLMKKGYGVDFISDNFIAEAKVVNGKVILPGGTFKSMIVPACKK
MPLATLHKLIELKKAGANIIFEGLPESVPGFNEYQKQEKELKTLLTSNSELVKPTTDIYK
ALESTQIYPETLVNTGLKFIRRNIDGEKIYYIVNHTPKTIDEFIPLQIGNKEVVIFDPLN
RNYGNAIVKKEANTTLVKIKIEPGQSYFLKTENTASQKKWNYYEPTAEAIPLRGNWKITF
DKGGPKLPESATISNLESWTKLSPDAEAFSGSATYTLHFDNPDNKTETWSLNLGDVRESA
KVWLNNEYISTAWSVPYKLNIGRLKSGKNTLKIQVTNLSANRIRDKELKGEEWKIFYEIN
MVDKDYKKFDATKWAPMPSGLLGPVTLTPLKQQN
>EGALAKHO_02870 hypothetical protein
MIPETEHIIVNIKEHSSIPKFIQVANSIAADIESGIIKTGQRLPSINELSDKNSMSRDTA
EKAYKVLRDRYLVFSVKGVGNFVSDINSDVKTDVFFLINKPSSYKMEVYNAFVDTIGLKG
RVNMFIYYCDEELFINSLKKNINNYNYFIIMPHFIGKGKSHVNYTPKVIKAIEAIPKEKL
VILDNSYSEISGNFTAIYQDYKKDIAQALEEGVEKVKKYKKFILVYPSKSLFPYPKAVLQ
GFVQFCKKHKMDFEVLDEIYPDQEFDSREAYITLEDSDLVNLIQEIRAKNLTMGVDVGVI
SYNETPLKALLGITVISTDFKVMGEQAAKLLLSGKKEIFKNPFHYIERNSL
>EGALAKHO_02871 TonB-dependent receptor SusC
MKNKFNLLLIMALFALLHTSGYAQNKTVTGTVTDQSKLSIPGVNVIVKGTDRGVSTDFDG
KYSISAAPGETLVFSFVGFIKKEQAVGVSSTYNVSLDAESSSLNEVVVIGYGTQKKKLTT
GAISGIKTENFTERPISRIDQGLIGQVAGVRVKQTTGLPGQPFSIEIRGSGSITAGNEPL
YVVDGFPIYTEGSNVNGGFSNGSPLDNMNPNDVASIEVLKDAAAASIYGSRASNGVVLIT
TKKGKKGKPQFTFNTYGGINKEANRVDMLSAQGWIDRAKTMIDGQWVASGITGASASQSN
AERIAAYNLKNPTAPLIPSNTRYYTYLYDDRWDIPGHPGLDYIDWQDKVFRTGEFSNYQL
SASGATDAVNYYVSANYQKNTGYIVGTDYTLFSARANVDIKLSESFKMGINIAPSYSVKN
DPGVEGKDNTLFKALTATPVFESAENAAGEKYTTRYAWGSSTTNMLNALARTGKNSMYRT
LISSYASYQFAKGWTLKSTVNFDNSDNTNESYTPNDVIASIRGAYNTYRRQNFVNENTFN
YDKSIGNHNINLLLGQSFSSYEITKASLSSGALYNSSTIETLPVGSLGSTTAEKSTLLSY
FARLQYNFKEKYIMSASIRRDGSSKFGSDRQWGVFPSLSLGWRIKQESFLQDVDWLSDLK
LRASTGINGSNNIGSYASYATLGTYNYSIGGAAAIGQGAASIPNPDLHWEESRSIDLGVD
FGFIKNRLSGTFEVYRKNNSELLLRVPVPGDTGFVSYLTNIGEVQNQGWEFELNSLNVKT
NNFEWRTSANLSHNENKVLALGPGQSKIEISNAYDGGIPFIKLEVGKPMYTIFGLKQNGV
VSQADIDTGGTTIGGNKLILGDPRYIDQNGDKKINSEDRVDLGNPTPKYTWGITNSFKYK
DIDLNVLVQGQNGGTVYGLTGRAIDRTGMGSVENSLDVDPAVRGNWRTSFGYQANSDWLY
KSDYVSVRSISLGYNLRQALKGIKRIDNARLYVTGENLFYWNKYRVGFNPEAVNTSGSSN
SDFSVPVDYGGAPLAKSIVIGLNINFN
>EGALAKHO_02872 SusD-like protein
MKKYIFLMASALLFVLTSCDDELNQLPLSQGTIESFYATPGDFVQARNATYSIAFHGAGT
YGYANRVLNLSETRSDNLYATTTASRDWEGINSFYTSISSNTYVKEAYTSNYNAIYKANQ
LLEKLAEKGDAIFTNPADKTAMAAEARFLRAFCYFDLIRWFGRVPLIDRTMTAQEASKIK
RTSVTEVYDLIISDLNSAIADLSPTYDAANFGRVTKYGAKSLLGLVYMTRSSPTYGIDGA
TLGLNEWDKAYKELNDIKTSGLYAVGADYATIFKTEGLANKENVLTIPYTQNISTPVGGN
FMVEVGYEPYFASVNLSAQGSLEAKPISKGFLNMFAAADKRKNSCIATSYTVASGTYKGS
YTEPVFIKYIDPTRYGNGREDWGVDFMVTRYTDVLMLMAECTLHGGGGTQADVDAIVNQV
RTRAGVPANAVNINLDQLFDERRKEFFSEGTRWFDLIRSGKAVTIMNAWRIAEDTGNKIR
TIDNNSLLYPIPIQEILAVPGLYDQNPGYD
>EGALAKHO_02873 TonB-dependent receptor SusC
MKNKLNVLLLIAMIALFHASGYAQNKVVKGTIKDATGLPVPGANVLVKGSQNGVSTDMDG
SYSISAAPGSVLVYTFIGFKKQEITVGNAAVYNVVLKEEDNSLEEVVVVGYGTKKKKDLT
GAIVSVGAEEIASRPVVNAVQAMQGKAAGVDVASTERPGTVGAVTIRGARSISASNAPLY
VVDGIPLNSRLVTDASTGKISVDPNSGGLDFLNPTDIETIDVLKDASATAIYGSRGANGV
IIVTTKKGKNGRFTLNYDTSIVMETIHENAPLMNAGQYIEFRRWARYYSNPSGFPKGDAP
TIENDRNIFTATADPAAWANIEKGWAGGTWDGSKVATTDWTKFVTRTGVTQQHTIGVSGG
TEKMKAYGSFGYLDNTGTLFGQSYKRYSGTASVDITPTKWFQMGVSLNTSYGINEYGQSN
VGRTAVTSADGIYAIARTNLPYAVPYDANGKRIDNPGGDSAIRTPVDEYKLSQDQRITMR
AFGSLYAQLDLGGISSKLDGLKYRINFGPDLTSFRDGVYLDGKSAIRSGTSYASLAKEQT
ISYTLDNLLFYNKTFGNHTVGGTLLISKTEYQNETSSMSANDVKNPENKWNALNPSNVTL
AGYSSGLTQTGLLSYMGRANYSYADKYLFTGSLRSDSASQLAPGNKEALFPSASAAWVIS
KEKFLENVSWIGQLKMRVGYGVTGNAAVPAYATQPPLTGIVYPNGSGVVNNTSLGNIDLG
WEQTTQFNYGIDFALFNNRITGALDYYTSHTTDLLLKRSVPTVIGVKDTYQNVGETEGNG
VELTLNTVNVTAKDFEWTSTFNGSYQQSKIVTLANGKFDDINNNLFIGDSQNVIYGFESA
GIWKPEDAAEMDKFNKAAGSNIFSFGNARPVDQNGDYKIDANNDRVIIGSKDPKYIVGLT
NTFTYKNVEFSFFIYGRMGYYYDTLGENEGARLSQRQINYYTDNNINAEYQKPIYSAGTA
DPYFPVLGYRDGAFLKMRNVSLAYHFDKDLVQKLGLSKLRLYCQATNPGMIFTKVKWTDL
DTQTTASNRGMTLGLNVEF
>EGALAKHO_02874 hypothetical protein
MKNYKKLYINLMLVAALTLTSSCNKDFLDEELTTAYSSDYYKTEAGIQALATGTYYQVFA
AEFQGEVPLAATESGTDEFHAGGDPSNWIWNSYSSGFKAFVTVSNANTVAANTNWDNLYI
GIGNANQLIESATNIVSTNDAIKKTALGEGYFLRAFNYLKLVSQYGAVPLKLKTSSTVEL
EFTRAAPQEVLGQVIEDLKQAYNLLGNAGAPAKITKDAAAHYLAKAYLARASEINDSWNG
TTKAADLQQVVTLSDEVISHHPLAANYDNLWNYTIADGANEKLPELILSAQFNASTLTTG
GNQQHLYFLSTYDQLPQMKRNLAGGRPFSRLAPTYFVYDAFDHVNDSRFWKSFQTKSIAN
NASGAVYKNGDLGIMYIVNTPADTRFAKTKNTDVIIYPKTGKTIPSAFVAYAADKVGLMA
DVRFPSLSKYLDGNRIDLSNIKGSRDIILARSAETYLMAAEAKVRLAKLGSASFADALPY
INTVRTRAAYKAGENRAAYVDGSAAWTTTGQAGIPISYIPENSYYESNNIAVATTATSLT
IASVNALPAEDMAVITKLGYGSDYDRMLCLILNERTRELCGEFHRWGDLSRTKTLVARAK
AYNIEATSNIQEYHNLRPIPQTFLDGVYASGKPLTADEKQAMQNPGY
>EGALAKHO_02875 hypothetical protein
MIYLRKFSLLFIFLSLQSTIFAQVKLPALVADNMVLQQNSKVNLWGWAAPNEKINIQLSW
QNNPIEITANSDGNWKTAVSTPQGSEKTYDITIQASNKIVLNNVLIGEVWICSGQSNMYF
PVGKEDGTWKTGVKNYEEELKSASYPNIRLFTVATNASPKPLDDVIGSWKECSPTNVNTF
SAVSYFFGRELYQKLNVPIGLISTSWGGTKAEAWTAQNILEENTDFLPILEQDAKNEKLY
QEKLETYYLNLKSERITNANDLSKIQLKKPKKEANKTSYVLYNAMLHPVINYTMKGVIWY
QGESNSEKAFLYRSLFPAMVKSWRDEWKQGDFPFYYVQIAPHKGQNPDIREAQLIASKTI
PNSGMVVTTDVGNATNIHPIDKQTVGYRLGLIARAKTYGENKLVYSGPIYNHLKIKKDKI
QLFFDDVDSGFKKPSEDLKEFEIAGNDQVFYPAEAKIDGKTVVVSSPKVKNPTAVRFAWK
AVPEPNLFNNENLPASPFRTDDWEVGVQKK
>EGALAKHO_02876 hypothetical protein
MPKQNLKYLFLNLTIVLFCLTMSAQNEIKKNKNHIADKPLYHDPIFDGAADPTIIWNDKE
KKWFMFYTNRRAKDSTAKGITWVHGTRIGVATSVDGAKWTYKDTCNINYRIKDVTHWAPD
VIKYKNKYHMYLTIVPGIFNDWYHPRSIVHLTSENLMDWKFESELKLASDRCIDASVFRL
PNGTWRMFYNNENEEKSIYYADSKDLYNWVDGGTKIIKDRGEGPKVFVWKGKNWMITDSW
RGLNVYSSEDFLNWNRQEKNILQTPGTGEDDKVIGGHPDVVVNGDKAYIFYFTHPGRTAE
NKGVDSFETKRSSIQVAELEYVNGEIVCNRDQPVQINLKH
>EGALAKHO_02877 hypothetical protein
MNRRKFIIGNSLAVMALCLPLPVMANDFVEGPKLSDFEKRLRPVGRALEFEDYYVWCNSP
IEGPDGKIHVFFSRWPKAKGMSGWISSSEIAHAVADKPEGPYEYVSTILAPRGEGFWDAT
TCHNPSIHFVDGKYALFFMGNSNGKMNTKRVGLATADSLYGPWERPDKPLLLPGKQGEWD
DLLTTNPSFVKHPNGEYWLYYKSLDTENYEHPKFSIKGNRKYGLAISKSLHGPYEKYKGN
PVVDFSKLGDNKQCEDAFVWYENKKFKMLARDMGVFGMDNGLYMDSDDGIHWSDPLISYQ
PLNKYIKQPEAPKHLNRYGRGERPQLLFQNGKATYLFMASQGGKYETASAFIFKIV
>EGALAKHO_02878 L-rhamnose mutarotase
MENKQKIRNAFKMQLKPGFEAEYKKRHDEIWPELESLLSETGIQDYSIFLDEETLTLFAV
QKISPDFDEKLLPNHPIVKKWWAYMGDIMETNPDNSPVAIPLKEVFHLD
>EGALAKHO_02879 hypothetical protein
MKTNLYLSIAITAMILTSCKAQQRTAGNKITLKNTSELVVPQKAITIKRSQLSVKETGTI
YPILIYKKDTIPAQLNDLDGDGKWDELFLVTDFAPNEKKTVELKWSAVDPKFPVKTSVRF
GKREAKNLPVKPATEEVLMANEVHKALGFQRYQTDGPTWENDKVGFRHYLDGRNSKDVFG
KKRPAITPEDVGINSKGAVEDNYHVMYDWGRDIFPVGNSVGLGGYALLINDKINRLGILG
TDTINNVEKTTFKIVSEGPVNSVLSYKYQNWEASGNKYQVQETTSIWPGMYGYKNTVKID
GIKGRETFLAAISNLNNKNPLKVVEAGDWVCLIQHDYLTYERTWILGTAILVPKKLYQGY
IEAPKTGQLTDSYLAKLAIENNKEISYYAIAGWELSADLNFKDSAYFSNYVTTLAKQLSA
KINVEVSKK
>EGALAKHO_02880 Unsaturated rhamnogalacturonyl hydrolase YteR
MNYKSIKIVVLFAFGICTAASAQKTDATAPLHLMQPDYPTPYVIPQKENIKVVLDRVYNF
LDKNSASKIVDANTKVAITDYKKSNQDIVFEPGAFRLTSYEWGVTYAGMLLASKATGEKY
FADYTNKRIQLIADVAANYDEKNIKDKDMLKTLHPEALDFAGALCAAFIKAKKDGLKANA
DPLINNYIDFISNKQFRLKDGTLARNRPQDNTLWLDDMFMSVPALAQMGSYTGDVKYFDD
AVKQVNQFSKRMFNEQKGIYMHGWVESMAVHPQFHWARANGWAVMTMVELLEVLPKNHPG
YPQVLAQLQKHIAGLVQYQDGTGFWHQLLDRNDTYLETSATAIYAYSIARAINRGYVDKM
TYAPAVLLAWNAVATKVNDKGQVEGTCVGTGMGFDPAFYYYRPVNVFAAHGYGPVLLAGA
EVILMLNDSQFQINDSSIQLKIEGKNNLHK
>EGALAKHO_02881 hypothetical protein
MKLKTSLNILFLSFTIITFGQIGTRFPSEKKIIKDPVTGVDLIFLTTKSAGDSKTYPTHP
QWTSDGEWLIFRSKRVNDEAMAVNEKSGIIVQVTEGGYTGTLCMAQKSMKLYFMRKAEGD
KMQIMEVNLEAVFKDSQSGKMKPVSAYERICGVTNSEMGASGDMALDADEERVYFRIGKE
EAARHLDSNIKIEKNFGPRNMGAGPGGIGSMNIKTGEFKHVISVPFQVGHIQSNIWNPGE
LVFCWETGGKSPQRTWTVMADGTGLRPLYPESDFEWVTHEAVISKDEVAMAIMGHRKIDI
QKETPVEVTASTEIRNPQNPGQESNWGNSGTREKPTGLAIVNLRTREMIIAGQTKSGSGL
WHVHGSSDGRWAVGDDFSRSLYLIDRKTNEMMMLTTGHKETAADHIHPTFNRDGTKIEIQ
SAMLSTDNKTMNICIVNVPKEWLKRK
>EGALAKHO_02882 hypothetical protein
MTVSVTGERPNWSDKRKSNYGSTGYYISENQIKIKK
>EGALAKHO_02883 Endo-polygalacturonase
MKKFFALAICVLGISQAAFSQKYANDKFPDGSEITPWFKDYTKLQLKDLGKKYTITDFGV
SKDSTKIQTVAIQKVIDKASANGGGVIVIPKGVYLSGALFFKPKTALYVSEGGVLKGSDD
IANYPIMPSRMEGQNLDYFPALVNAYGVDHFSISGKGTINGNGKKYWDAFWARRKENPKC
TNLEVSRPRLVFIWNSNNVQLQDVKLINSGFWTNHFYKCNNVKMLDLYIFSPHLKDKAPS
TDAIDIDICSNFLVKGCFLSVNDDAIALKGGKGPYADQDKNNGPNSNIIIEDCNFGFCHS
SLTNGSESIHNRNVIMRNCKIDGASRLLWLKMRPDTPQRYEYIRVEDIKGSAKTGLAVFA
WKQFFDLKGRPDIPLSYGDNVTLKNIELKCDTFYGVENDPNVRLSNFTFENLNIESTKTD
IDKSLIKGVTFKNVYVNKVLVD
>EGALAKHO_02884 hypothetical protein
MNKFLAFIFAISTLTSYSQDKNSVDFSIADANQTATIYIDKNTDPLIVWAVNDLADDIKE
ITGKRPEIIQTNTISKNGIYIGEASSSLFQSQKNRKELANQWEKFSIQKKNDNLLVIGSD
VRGTVYAIFEIAERLGISPWKWWADVHPIKTEKVALQLPRKGIISSPSVQYRGIFLNDED
WALQPWAAKTFEPETGDIGPKTYEKIFQLLLRLKANTIWPAMHPSTKGFFTLPGNKEMAQ
KYNIVIGSSHAEPMLRNNVDEWKPKINGDYNYFTNKVQVDKYWQDRLYEVKNSQNETIMT
LGMRGVHDSKMEGAKDLAGSIDMVEKIILNQREMLSNTFKKPLTSIPQAFVPYKEVLELY
DNGLKVPDDITLVWPDDNYGYIRRLSNEEEQKRTGGSGVYYHISYWGRPHDYLWLSTTQP
GLIWYEMNKAYENGAKKMWIVNVGDIKPAEYDTELFLDLAWKINSIKSDGLNQYSKDWAA
REFSPKISTEVSSIFEEYYRLAFLRKPEYMGWSQTEPTTAVKLSDFSTEEIWSRIKAYHV
LIEKVDKLSDLIPKERKDAWFQLVVYPVKGAAYMNFKFLYWNLASTTSDANQKRKYDSLS
AEAYQKIKDLTDFYNTKLSTGKWNQMMSMQPRNLPVFDSIKKTEFPEVPIKAKENKIVIE
ANQFVSKKDAKEYQWKAINGLGYSNNAVTLFPLKQQYFKTEKPFVLYEFEIENTGDYEIE
IHLLPTHSNNFDHEIGVQLDGKTTRFFKINTKDRDTTWKENVLRNSAIVNVSAFNLQKGK
HTIKVEVNQTGIVLDYITVNEH
>EGALAKHO_02885 Arylsulfatase
MKKRDTKTQLVIMLWFCFSISYSQDVSKKSIEKPNIILIIADDMGWNDVGYHGSVIKTPN
IDFLAKNGVELNRFYVNPTCSPTRASLLTGRPSSRMGIVAPIGDRDQTKLPDSIPTLPKL
LHQDSYQTALIGKWHLGLQLSSGPKAYGFDYSYGFLHGQLDQYTHLYKNGDKSWHRNGEF
IEEKGHTTDLITTEAIKWISEIRDPNKNFFLQVAYSAPHFPLQEEQKWKDPYMNSIKDAS
RRNYAAAVSHMDSSIGILLEKLKQQKLDKNTLVIFMSDNGAMENWDSKNEYNGVHPSNTT
LGDNKPLRDWKTSNYEGAVRVPCVMYWKDHLKSYKNSSYISVIDLLPSILFLAGDNNLPA
SVEGKNVWTAISENKTIPNSEIYIRGHLQECLISKPWKIIRTRHPKGTPADYELYNIEKD
PEEKNNVWSQNEAIAAQMKNALENQFGKDAKKVNNENIK
>EGALAKHO_02886 hypothetical protein
MKDLLVKINAEIDTFKAEAESLTEKGIKAAGARARKSTLELEKLLKEFRKVSIEESKK
>EGALAKHO_02887 hypothetical protein
MKAKVYLLLLLFSVISCNKQNPIEENLITASDEHWVYYNSNSTHFTYFKFNKDKLSHRFK
RNEKGQLYEYHDEGDVDKVPKKWSVSKDSVLTWGKFKYDVVSYSKTTIILTFPIAKEPFA
GYIFLVKQKDSEIKTGPGVFEQKRIKHPEK
>EGALAKHO_02888 putative rhamnogalacturonan acetylesterase YesY
MKSIKILSAFLLALLFFNFIPKQDNKPTVYMVGDSTVKNGKGDGTGGLWGWGDYIGQFLD
TTKVHVENHALGGTSSRTFQDKGLWIEVLNKLKKGDYVLIQFGHNDDGPLNDTIRARGTI
KGIGNETQEIDNLITKKHETVHSYGWYIQKVVQEAKSKGAIPIICSPIPRNDWKEGKVPR
NDKSYGLWAKQIAEKEKVTFINLNEKMALEMEKFGEAKVTGTYFYQKDHTHTSAKGAILS
ASIIINELKASKNSLKNYILPDPKIVLPAKKKVFLIGDSTMASNDGNPDAVGWGVAFPKY
CDTTRIEVINKARGGRSTRTFVNEGLWEEVKNQLQPGNFILIQFGHNDAGAVDKEKFRGS
LKGNGDETQEVTRPDGSKEIVNTFGWYMAKFIREAKEKGAIPIVLSQTPRNEWPNDKVER
RTDTYGNWSKIAADKEGAYYIDLNEIVAQKYEALGKENVKAFFPKDHTHTGLEGATLNAL
TAAESIKKLKDCNLKDYIEIPK
>EGALAKHO_02889 Beta-galactosidase
MQLKNTIQNLSILAFSLFLTQNSNAQQTDKIYLSGKDFEHPVQWDFYCTGGNNSQKWSKI
NVPSQWELEGFGEYTYGRWYKELEQKEPSKEEGLYKYEFEVPADYKDKDILIAFGGSMTD
TEVKVNGKLAGAIHQGGFYEFKYDISSLLKYGTKNTLEVHVWKQSTNKSVNAAERRADWW
LFGGIYRPVWLEVAPKTHIQNIAVNPKMDGSLTVDLKLKNIPKNATLEATLKGINGENFE
TFTFPVKAKSISATIAAQWKNIKPWNPETPNLYDLQLLLKQNETVIHEYDKRIGFRTLEF
KKQDGIYVNGTKILMKGINRHSFWPEGGRSTSKRISELDGKLIKDMNMNAVRGHYPPDEH
FLEVCDSLGLFVLDELAGWQNSYDTETGKKLATEMITRDVNHASVIIWDNGNEGGWNYDT
DKIFANLDPQKRIVIHPWADFNGWDTHHYPTYLTGMHRFNAGENVFFPTEFMHGTYDNGH
GAALEDFWNRYKESPLFAGGFMWAMLDEAVKRSDWTGDVKFDSKGSLAADGILGPHRERE
GSYYTVKEVWAPIQFQPKQVNEGFDGSFFIKNEYLFSNLNTCKMEFKVMKAEKNVLYSNG
VTTAISSGKIELPSIEPGETRKINFAVPNNFAEGDVLSITAYDQFNKEIYTWTWPIHKAL
FYANKLLAVQNTKTKASAVKTGNEITLKGSDITVILDATTGEISSIKNGTSTIPLTNGPR
PIGMKAKLKDIQVSQEGDKAVCIVNYTGGLASIKWIMEPDGRFKMELVALKNASGGEGFD
GAFFEDKISAFGITFSFPEKEVTGIKWFGRGPYHVWKNRIKGTTYGIWEKDYNNTITGES
FENLIYPEFKGYHANLLGANLKAGASSFKVFSENDNLFLRLFTPDLPKNGFPGSNPQPAF
PEGDISFMYEIPAMRDFKPLEQQGPQSQPTNIRIKSGDDGIKMNLWFDFRN
>EGALAKHO_02890 Rhamnogalacturonan acetylesterase RhgT
MVKVSTFLCVIFCLIMPASIFAMHNDNTLNETHLYDSIKNTKSISFHFGTSKNSKDISVN
KAVTYSTETGYGFDFNSSSKVKINTNSFSIEKPTYFSVQLPEGNYQVEVTMGNTEKASTI
TIKSESRRLMLNQLSIPKGQKVTKTFNINVRTPKIDNQLNVTLKDREKDILDWDDKLTLE
FLGEASIQNIKITAKDNLKVVYLAGDSTVTDQDVEPWASWGQFITNYFDDNVVVANYAYS
GSSLSSFKNGNRLKKILNQIKKGDYLFVEFGHNDEKIKGEGNGAWGSYSDLLTEFVEAAK
EKGAIPILVTPTQRRFFNESGTLKETHGDFPAAMRSVAQKNNVALIDVTKMTTELYEAWG
DEPSRKAFVQYPANTFPGQEKALDDNTHFNSFGANEISLCVLKGIRELDLPLKKQIKKET
PNYNPKKPNNISSWTLPMSDRFEIAKPDGN
>EGALAKHO_02891 hypothetical protein
MNLMKIKTQHFLFLIGTFFLCSMISFGQEKKPVRKIHYVPEGNSFVLKNGTRKFNRALYG
SNTGFRVETGDLPEFAMYMPGMGGNFKLGISNGKESKWITEASKIDTRYVLGIMQYTIED
AVLGSGKLFVDVVALKEKEGFLIKVYGKNISKNVNLIWAFGGATGKKFSRDGDIGADPES
VFYLQPDYCLNNKYTLKKQSFVLEYGSETNKQKTGNNKSLVGFFPESETHLANANQQKNP
LELFTSNAETLPVITGKINSITEKSNYWLLATEDLKVDVSQKGLAQLYDKSIQQTELLAN
RVKVVTPDPYINTLGSALSIASDGIWESPAYLHGAIAWRMYLNAWRGAYTADPLGWHDRA
KSHFESYSKSQVTSPESGPVVFDEEKNLARQKEEMGTAMFSSGYISRSPNKNTVAHHYDM
NLVFIDQMLRHFKWTGDTAFMKEMWPTIQRHLNWEKRNFDADGDGLYDAYATIWASDALQ
YSGGGVIHSSAYNYYANKTVAETAKKINEDPNPFYKEADKILKATNDQLWIPNKGIFAEY
KDALGNRLLHDTPGIWSIYHTIDSELSSPFESYQMLGYVENRIPHIPISAEGLDKKDLYM
ISTTNWQPYTWSINNVALAEQLHTALAFWQGGQSEEAYKMWESALIESMYLGASPGGFEQ
LMYQDAIRGELYRDFADPIGMASRTLVEGLYGIQPDALAGILRIKPGFPSKWNEASLEIP
DITFSFKRENKKDTYKIENRLASKMNLKLILNAPFDGIENIKVNGKEVSWKLIPESIGAP
KISIEMPFNPVYGVIVNWKGNVLEELKAETLYTSGQSINLIASKAKIISVRDPQWVLSEI
SKMDNALAAKVNGSGHKTFFIELKQGELSWWNPIDFNIKVEEKSNKETNWDVPLDKSAKI
ETVSISSFFNSKVTDIFNYEYLSPRPKTTTLQLPKQGIGNWCYPNVTVKIDDKGLREKAK
TSGQIATPNGIPFQTPSDENLKNIIFTSMWDNFPESIKIPLDGKASHAYFMLAGTTNPMQ
SRIVNGEIKVEYTDGTSEVLELKNPENWWPIEQDYFVDGLAFTTDAPKPPRVYFKSGEIS
RDFKDFKTIKGFSNYGIDGGAGTILEMPLNKNKTLKNLTLRTIANDVVMGLMSVTLIR
>EGALAKHO_02892 hypothetical protein
MKKYQLIITALFSLSLSAQKIDRKALVTRHNVQITAIDTLASLTVGNGAFAFTVDATGLQ
TFPKKYQNGIPLGTQSEWGWDSYKNTKGYKFSETLRDYKQYGRDISYTVQIKEPARKVEA
VNWFRQNPHLLQLGNLGFEITKKDGSLAKPEDIKAISQKLNLWTGEIESYFEIEGIPVTV
LTVSHQEKDAIGVKVKSDLLQQKRLKISLRIPFPTGDWGDMGTKWEGKDDYKSTLVEKSK
TEAVVTHVMDSISYNVNLNWKGNAQIKKTADHYFVIEASNTNTLEVSCLFAVADKKSATN
SSFAEIENSSIKGWEQFWKSGAAVDFSGSTDKRASELERRVILSQYLTKVQCTGKVPPQE
TGLTYNSWYGKPHLEMHWWHGVHFALWGRPELLEKSLPWYQKVFDKAKNIAKRQGFEGAR
WQKMTDPDGNESPSSVGSFLIWQQPHFITYAELMYRDKPTTTTLNLYSERVFATADFMAS
FANYDAKNDRYVLGPGVIPAQERFKAMETFNPTYELAYWNWALKTAISWKKKLNQKVPEK
WETVLAKLSPLPVADQVYLATESATDSYTNPEFKTDHPSVLGTFGMLPETSLLDKKIMKN
TFDLVWKTWSWDKTWGWDFPMTAMSAARLNMPDKAIDALFMNVTTNTYLKNGHNYQAERL
TLYLPGNGGLLTAVAMMCAGWDGTTEENPGFPKDGTWKVKSEGFKKMF
>EGALAKHO_02893 Rhamnogalacturonan endolyase YesW
MKNKILFLLLFFSYSIFAQRQMENLDRGIIAVKDKGQFFIGWRVLGTDSDDLSFNLYRKS
GSKKAIKLNDKPISGATNFVDSKANPKEENTWFVKTVLKGKETDAKGSFTIPAASPDKDY
LSIVLKPVEGYIPNDLSVGDLDGDGRYDLIVHMTGKSLDNSFKGITDPPIFQAYTLEGKF
LWQICLGKNIREGAHYTQFMVYDLDGDGISEFVCKTADGTTDSQNNVVGDASKDWVDRDP
NSPVLGKILKGPEYLSVFDGRTGKLITTVDYIAERGDLAGWGGHGGSGGNDTKGNRIDRF
TACIAYLDGIHPSVVMCRGYYGRTVLAAWDFKNGKLTSRWVFDSKDAENPYSGMGNHGLT
VADVDNDGKDEIIYGSMCVDDNGQGLYTTGFRHGDALHVTDLDLDIPGLEVFGIHEIENG
TTGPGVTFFSAANGKVLFTDSLDKDVGRGVADNIDPTRKGAQCWWSGSPDLHDMKGNVIG
KAPTSTNFLIYWDGDTSRELLNSNYIDKYNVGRLFTATGAASNNGTKSTPALSADILGDW
REELILRSEDNKELRIYSTTIPTEIRQYTLMHDPQYRLSIAWQNVGYNQPPHTSFYMGKD
MKPAPKPNIILMKVQSDKGAKVQRL
>EGALAKHO_02894 Mannosyl-D-glycerate transport/metabolism system repressor MngR
MIKLIKIDEDSRVPKYKQIVDSILQNIANGNLKINQKIPSINSFSEEFYMSRDTVEKAYN
ILKERKIISSIRGKGYYITRTKLESKVNILFLFNKLSAYKMKTYNSFIDTVGANAHTDLH
IYHCDETLFLNLLDKFEGAYDYYVITTHFKTDELKHLSFTDDVVKAIQRIPREKLVIMDN
IKLNMDGEIIKIYQDFENDIYNALKEGLSKIKKYKKLILIYPEKAVYPYPRRILHGFRKF
CVEYEINFEILDEVYDDMILKKGDLFITIEESDLVNLMKQIRDEEYELGKDIGVISYNDT
PLKELLGITVMSTDFNVMGETAGRMILNKEKGSVKVPFNFIDRNSI
>EGALAKHO_02895 L-rhamnose-proton symporter
MESLLGIIFHSIGGFSSGSFYMPFKKVKNWAWESYWIVGGFFSWLIVPPIAAYLTIPHFT
EVITAAAPTIKAFTFTMGLIWGIGGLTYGLGVRYLGMSLGNSIILGFCSAFGALVPSIYY
DIYPTEGKISFSHMLSNPGGQLVLLGVVVCLLGIAISGKAGILKEKDFATGHEDKDKDFS
LTKGLIIAVISGILSSFFNFGIEAGKPMAEAAVVAGCNPLFQNNVTYIVLMWGGLTTNFI
WCMYLNFKNKTFGDYTNTATPITKNVLFSALAGTMWFLQFFFYGMGESKLGNGASSWILH
MATIILTANFWGFYLKEWSGVSKKTFRTFLWGIGLIMLSIVLVGIGNSL
>EGALAKHO_02896 Dihydroanticapsin 7-dehydrogenase
MSNINTNLNFKHVSYLWDESKAAALAGDEVALFIYRSNLLGADLRLTNYGGGNTSVKITD
KDPLTGESSEVMWIKGSGGDIGTLTKSGCAALYLERLRNLENVYRGIEFEDEMVELFNHC
IFDLASKAPSIDTPLHGFLPFKHIDHLHPDAAIAIAAAKDGAKITEELFDGEIGWVGWQR
PGFDLGLQLRSCLEEAEKKGKKLRGIMLGSHGLFTWGDTSYDSYINTLEVIEKCATYLED
NYGKKRPVFGGQKIQSLEVAERRLKAAKVAPILRGFCSSERQMIGHYTDDARVLEFINSN
DLEKLAPLGTSCPDHFLRTKISPLVLELDPNEDLSDVNAIKAKLQPAFEAYRAMYKDYYN
ACKKSNSPAMRDPNPVVILYPGVGMFTFAKDKTMARLASEYYVNAVNVMKGAEAVSEYTS
LPHQEAFDIEYWLLEEAKLQRMPKPKALSGRVALITGSAGGIGKAIAKKFAQEGACVVIN
DINEERLEEATKDFIRSFGKDAVSSTLLNVTDEKSTEKALDEACLAFGGVDIVVNNAGIS
ISKSIAEHTLEEWDRLYDILVKGQFIVSKAGIEVMRKQGFGGDIVNIVSKNAVVAGPNNP
GYGSAKAAQAHLTRLMAAELGADKIRVNTVNPDAVISDSNIWSGGWAEGRAKAYGITVEE
LPAYYAKRTLLNEIILPDDIANACFAFVGGLLGKSTGNALNVDGGVSMGFYR
>EGALAKHO_02897 hypothetical protein
MLIGANKIESHNDELLKKHQNKFAFTASEIGETESIIQKLIDFQIAIPSWALGTGGTRFG
RFAGGGEPRSLEEKIEDVGLLHALNNASGAISLHIPWDIPTDYNAIKTLAAQHGLKFDAM
NSNTFQDQANAEHTYRYGSLQNVNKAVRKQAIAHNIEVIKHGIELGSDSLTVWLADGSNF
PGQLNFRKAYQNTLESLEEIYDALPSNWKLFLEYKCAEPNFYSTTVADWGQSYSYVQKLG
DKAKTLVDLGHHLPNANIEQIVSILLMDNKLGGFHFNDSKYGDDDLTAGALKPYQLFLIF
NELVEGMDARGMNHAKDLGWMIDASHNIKDPLEDLLQSVEAIMIAYAQALSVDRKALEIA
QEENDVVKAQEILQNAFRTDVRALVAEARLRSGAALNPVALYRGLDVRGNLIGERGLKTM
ATGL
>EGALAKHO_02898 L-Rhamnulokinase
MNVVAIFDIGKTNKKVFLFDENYRIVWEKSVNFDETVDEDSFPCEDIELLKNWIFECLSE
IKNLTKYVLKAINFSTYGASFVYIDEEGKSLTPLYNYLKDYPEELKQGFYNKYKGEEVFA
VKTASPVLGSLNSGMQIYRLKEERPELFDQVKYCLHLPQYLSFLLTGEAYSDITSIGCHT
NLWNFKKMKYHKWLTKEEIIEKIPPLHFGKDIIKKEDGIAVGVGLHDSSSAIIPYTINFT
EPFVLLSTGTWSISLNPFNNRPLTFEELKYDCLCYMQYTEKPVKAARLFSGNEHEIQAKR
LAEHFNVPFDTFKDIYFDKKIVSNLRALNFQIIYPKKYDFDILKECPFQKRDLNTFKSYD
IAYHQLMLDLVEQQVFSTNLVIHNSPVKKIFVDGGFSKNSIFMNLLAEAYPDVEVYAASM
AQASALGAALAIHQNWNPKPIQNDLIDLKFYKH
>EGALAKHO_02899 Lactate utilization protein A
MKVGLFIPCYVDQFYPKVAIATYELLQKLGCDVEFPMGQTCCGQPMANSGYQYLTKGCDA
NFIANFAGFDYIVCPSGSCVLHVKDHLHDEKNEELATEMRKKVFELTEFITDILKVDHID
GNFPHRVGMHVSCHGQRGLKLSQMTELNAPFFSKPEQLLHNIKGLDLVSLTRKDECCGFG
GTFCVTEEAVSVKMGQDRIKDHENHNVDFITGGDMSCLMHLEGILKRQKSNIKTIHIAEI
LNTLI
>EGALAKHO_02900 Polygalacturonase
MKKITLCFALLLSLVFLSFKKDKSGVTLQEVLVKAPFEMPTIKIPDFSKCEEFSIVDFGA
VKGDKEKTSEAINKAIAKANKVGGGTVVIPEGEWLTKKIHFKSNVNLHLNKGAVLLFSED
PNDYLPAVRSTWEGYECYNYSPLIYAYQCKNIAITGEGELKAKMDVWTKWFARPKAHMES
LKRLYYLASYKKPVEERQMVNDTANLRPHFIQFNRCENVLMDGVKITNSPFWTIHPFLSK
DVVIRNLYVYAHGHNNDGVDPEMSQNVLIENCVFDQGDDAIAIKSGCGIDAWNLNTPSKN
IVMRNCTVKNGHQLVAIGSELSGGIENVFIDNCTVVDGAKLNHLLFIKTNERRGGFVNNI
HMTNITSGKIDAGILGIETDVLYQWRDLVPTIERKLTPIKNVYLENVKATDVKFISRILG
QKELPVENIFLKNVHADVVQGSQNIHENVVNFENKN
>EGALAKHO_02901 Lactate utilization protein B
MSSEKIIEHSEAATRFNKDVERVNWHDETLWFVREKRDKSANQIQDWELLRETASQIKNN
VLANMHDYLSDFEANAQKNGIIVHWAADAKEHNEIVHSILQKHDVKQMVKSKSMLTEECH
LNDYLADKGIEVIDSDLGEYIVQLRKEPPSHIVLPAIHLKKEDVSETFHEHLGTEKGNFD
PQYLTESARRQLRDTFLTRKAALTGVNFAIAETGEFVVCTNEGNADMGAHLADVHIACMG
FEKLIPQRKHLGVFLRLLARSATGQPITTFSSHFKKPRDGKEIHVVIVDNGRSTQLGRPD
FRNSLKCIRCGACMNTCPVYRRSGGHSYHNAVAGPIGSILAPNLDMSKNADLPFASTLCG
SCTNVCPVKIDIHDQLYKWRQVLVKEGHTPTSKTIAMKTMATVLANPTVFNLAGKSGRFV
MKNIPALVNNKMNKWYDQREMPEVPEESFREWYKKNSRESKAKKDE
>EGALAKHO_02902 Lactate utilization protein C
MSSKAEILQKIKNSQPNGIADLPNLNVLGSDQFDVLEMYKTVLTNIGGNPIEVANYDEIL
AFLKSNYPLEKQIITTVPELSEIAVLDWKNDDPHSLKDVELTIIKAHFGVAENSALWVTD
DILGQRVVPFITQYLAIIVNKKDLIPTMHQAYDRIGDQEYGFGTFIAGPSKTADIEQSLV
LGAHGARGLVVFLMD
>EGALAKHO_02903 hypothetical protein
MENLNNYNSEDLKKCPYHSQQNNNNDERENANTGDWNDERDEAGTDPNRYDPEKFEEGGN
DNSGGAGSTGSAATNS
>EGALAKHO_02904 hypothetical protein
MKKYLFYVGIDVSKAKLDINILDSSTLKSEHFIIENNVRCILIFIKKLDRKIDKESTLFC
CENTGVYTNHLSGILVKLNLDLWIVPAIEIKKSKGISRGKNDKTDAKDISYYSYRNIDKL
KLFTFASIDIQKLKILYTEREKMLKALLLIQATKESKAFTDKIIFKEVSQINQTLVKSIK
NSIHKIESKIKEVIKANDQLTKQAQLIKSIPGLGEQTSVYLIIATKGFTAFKSWRQFACY
SGVVPFEHSSGSSVKGRTRVNHMADKKMKSLLQMCAMTTLRYDPQLKEYYNKKKLEGKNS
MLVLNNIRCKLISRVFAVINRETPYINTYKFAS
>EGALAKHO_02905 hypothetical protein
MNYNLLYAILFSITSFGFFKLHKWWLKERNENNESKPFTYAETFKHWLIIIGLAVAAIVN
FFIAIV
>EGALAKHO_02906 hypothetical protein
MKYHLLKTLFVFLFSLSMFGQKNIEPTPEDIILAKSLRAKYDKDDIAILESNENLSFELN
KNASKVQVKSSTKEVLMNINHRADIHKYEFYDSESKIESFTLRYRNQKEASFPVKDEFYK
DDDLFYNDARVMYMTVDFPVQGYTYNYALEKKYDDIKYFTALYFHDEYPVIKKTISVTIP
NWLDLELKEFNFEGNVITKTVTPDAAKNATTYTYVMNDVPAFAKEENAPGKSYLYPHLLL
IAKSFKNKETVSSLFNSSADLYKWYKSLTDSMKDDPNALKEKVNELTVNAKTDEEKIKNI
YYWVQDNIRYIAFEDGIAGFKPDEANNVFQKRYGDCKGMANLNKQMLKLAGFDARLTWIG
TKHIAYDYTTPSLAVDNHMICTLLYKGKKYFIDGTEKYNSLGENAERIQNKEVMIENGDQ
FIIEKVPTSTSEANKEIFRAKLSIDGEKLKGSCYKEFIGESRSQFLNIYQSFENNEKGET
LEKYLSKYDKNIEVSEIKTSDLKNRDQKLTVDYNVSVANKVSSFENEIYIDLEYMNEYKK
FELKDRKNDYEFRFKTNYESNVTLEIPNGYKVTKLPENLSIEEKNFSAKIALQQVGNTII
YKKTFNFKNAVIKAGDIAKWNAFNKNLNTVYNQQITIIKQ
>EGALAKHO_02907 hypothetical protein
MKLKLLFLFVLLYTAAFSQDKDEVREQFWGKSDIYKEVTATPDKWKNESAVVIYKFEYYN
YKNSGGKVVYTSAIRKRIKLQDQASIKEFSEFSFNDKFYSKHGYSYKKGSTFFAVKIIKP
DGKVIEIDVDKEAKKIDEEKKIAISSLEIGDILDYYYYSFEPFAANFMTFDPVENTLGDV
YPVMNKKISLIAENDFYLSLNTYNGAPKFKEIVGKKKYIKEYELEAKDIEKNDFPRWFYP
IAEMPCYKFQVYFGRNGGLANYRYAKVFLPEEDTYLRTSVNKDDVFKYYQEKYEAFGDLK
PVEKFLKDKKFDSEEEKIKAVYNFARHSFYTQYIEAAVIKEADIFYPYSLFGDAVYFSSE
YYFIGYFMQFLKENKINYDIILATGRENGTLEDLLISDNVKMLIRVNTPKPLYLEYFDPY
TEPGEFDYSLENAKGYILEIEKNKKIVKADFTNLPATTADDNVTTVVSKVSLNDDFSTLN
VKRDASYFGHFKADEQKEKLKFYNFLDEDYDKYGTERVLDKVSSDKKQIQYKKEFESLVN
KIKDKDKEAYKQSLANEFDFEIDNPQFKITNTGRFGDNAPFAYEEDFEIKNNLLKKAGNN
YIVEIGKILTGQLEIDKKEKERKNNIYMPFPRKFENEIVFEIPKGYAVSGIEKLNKNVEN
TTGKFTSNATLSDNKLIIKTVKQYNNYYEPNANWNKMIGFLDAAYQFTQEKILLKKI
>EGALAKHO_02908 Acetyltransferase YpeA
MDVNIKDISIRRATNVDLPKLAEFLQFLVAAERPFDPTLKEGEILYYNIEDFISDDKTEL
LVIDYKHQIIGCGYAQIRLAKPYQNHELFGYLGFMYVSPEFRGNGLNNLLLDDLKKWILS
QGINEVRLDVYHENEAAIRAYEKAGFKQILTTMRCDIS
>EGALAKHO_02909 hypothetical protein
MNYQIMDLKRIFLLTIIYFLCESCFQFNGEKLEINYRDKTIKVLSDDYIIESVLMKNNQT
KYYVLELQETLKGSNIINFENKPLGYKIVVDSLNYYCSVKPNVDSPGVWVTIIKKDFKNN
EDDFKEIQYFSFNELPCNSIIIDTIVASNPYR
>EGALAKHO_02910 hypothetical protein
MKINVTSNYFKIIIILSFVVIWYSMFKKDKDYNIYRCETKKLEIKGIIDKVGLRANYSQV
RIKGNNSFFSLNIEETKFKKGFTKYYTYNIGDSIIKKANSKEFTIKRGNNIAIYILDCDD
>EGALAKHO_02911 Fructokinase
MNKNKTLKAVAYGEVLWDVFPDKKKIGGAPLNVALRMKSLGCDVAMISCVGKDEDGEAII
NHIKQLGLNTEAIIQSQEFPTGLVNVKLNETGSATYEIKYPSAWDKIVLNDQAKNVVTNA
DVLIYGSLVCRDDVSRKSLEELLQAKVFKVFDVNLRKPHYSYDILKKLMLSADFIKFNDE
EILEIASALQSPFTALEENIHFIAEKTNTNAICVTRGKDGALLFWKGMLYENKGYPVKVA
DTVGAGDSFLASLITYLLTNKDPQLAIDFACAVGALVAEAPGANPEISISRIEDRINKR
>EGALAKHO_02912 Beta-galactosidase BoGH2A
MIFSCFSAFSQISFGDSEKINDNWKFNLQDTPEAQNEIFNDTKWQTVNVPHDWSVKGQLS
PTLASCTGYLPGGIAWYRKSITIPQSKSGEKVYFYFEGIYNRSEVFINGHSLGKRPNGYI
SFSYDATPYVKYGSENSISVRVDHSQSADSRWYSGSGIYRNVWLVYANPVHIAQWGVYAY
PEVTKGVGSLNIEVAVENGSKTKSKLTVINELLSKEGKSVGKTSSKIEVAANQNGKISTK
INVKNPQLWDLENPNLYQLKTTVLKDGKQIDQDITKTGFRSFTFDANNGFALNGKEMKMK
GVCLHHDAGVLGSAVPREVWESRLKTLKEIGVNAIRTSHNPQAPDFYELCDELGLLVLNE
AYDEWEFPKRKWLEGWNVGIPGFEGSFDIFADYAEKDLEDFVRRDRNHLSVFAWSIGNEV
DYPNDPYSHPVLDKGKDGFGQAAYGGFKKDAPDAMRLGVIAKRLVAAVKKYDKSRPTTAG
LAGVAMSNETEYPGALDIAGYNYTESKYQSDHEKYPNRVIYGSENGHDLAAWLAVKNNKH
IFGQFLWTGIDYLGESGKWPSRGFYSGLVDFAGFIKPRGYFRQSLWTDKPMIYIGTYPLQ
NEKDISKDAWSIWNYTEGQKIRVVCYTNAIKARLELNGKIVGEVKQYDEKTGIIYWDIPF
TSGKLETIGLDKNDNEISRYAITSSRQPAELTIADSTITILKEKGIAKIELQIKDQNGVP
VMLSDNEVTCTIAGPGALLGLEAGNNTDMTDYTDNIQRVYHGRLVTYIKATGLSSEPIKI
TFASQWLKPAEVMITVK
>EGALAKHO_02913 hypothetical protein
MGKFVITKRANGEFQFNLKAGNGQTILTSEGYSTKAAATNGIESVKTNSQDDSRYDKKES
SNGKPYFTLKAGNGQIIGSSEMYESTSARDNGIESVKTNAPDATTDDQTS
>EGALAKHO_02914 putative xanthine dehydrogenase subunit A
MKEINEILKAYSEAKKAGKKTALATVVKVEGSSYRQPGARMLVTEDGNLTGAISGGCLEG
DALRKALLSIHQEQNKLITYNTSNENDSEVGLQLGCNGIVHILFEYISDDVINNPIQLLQ
QLERERKTAIIETIFSLKRNAPQIGTVLFYRQDSDILHNNDIAINTIPDVKKVLESKTTI
IKKMQDDDQNEALIECIEPVIALVIAGAGNDVQPLVNMASLLGWETIIGDGRVTHATTKR
FPDARQTFVVKSEDFLDNIQIDDQTYFVLMTHDYKYDLAVLKLLLRRDCKYIGILGPKSK
LNRMLDDLNSEGITLIEEQLDRIYGPIGLDIGAETSEEIALSIIAEIKAVMSGKTGTSLK
YKTHKIHDSKVVI
>EGALAKHO_02915 Nicotine blue oxidoreductase
MTGIVILAAGNSSRLGQPKQLLGYKDSTLLKNTIAEAFLVPDVVIIVVTGANNQLIEEEL
DPSRIKICFNPDWETGMSSSIVKGLNALLHLYPDCENCIFAVCDQPYVSSLVFENLIQEH
SKTGKGIVASAYSGTFGTPVLFDKKYFTELAALQGQEGAKKIINRFLEDTASIPFEKGNI
DIDTEEDYNKLISEL
>EGALAKHO_02916 Cysteine desulfurase IscS
MPQLPNIYLDNNATTRIDDRVLNAMLPYFTDFYANAGSSHLAGLEIQEAIENAAWQTANL
IGAKEEEIIFTSGATESINLAIKGLANETKKHIVTVATEHKAVLETCRYMESIGFEVTYL
PVTSDGIIDINLLNDIITNKTLIVSIMITNNETGVIQDITKMAEISHAKNALFLCDATQA
IGKISVDVKKLGIDLLALSAHKFYGPKGVGALYISAKAKIKLTPLLNGGNQQRKLRSGTL
NVPGIIGLGKASEITVLEVDNDKKRITKLRDLLENSLLKIKGSFVNGNTQNRICNTTNIC
FPGVNSEKLILALQNISVSNGSSCSSVTSQPSHVLKALGLSDEHALSSIRFSLGRFTTAE
EIEETIERVITLTKELNDK
>EGALAKHO_02917 Putative xanthine dehydrogenase YagT iron-sulfur-binding subunit
MAAKRSTKDKLIEDESNASRRDFLKKSGLFTALALAPPSLVMASEKKWDEKIAEYLETVP
LSIEVNGVKQNLNVEPRTTLLDLLREQLHLTGTKKGCDHGQCGACTVHVNGTRILSCLTL
ASMQQNAQVTTIEGLSKGKKLHPMQEAFIKNDGFQCGYCTPGQIMSGIACIKEGHANSRE
EIREYMSGNICRCGAYHNIVDAITEVKEGGMLS
>EGALAKHO_02918 Putative xanthine dehydrogenase YagS FAD-binding subunit
MKNFQIIRALSSGSAVSSIAKEKEAMFIAGGTNLVDLMKKNVVAPDKLVDITALDLKKIE
FLTGKTSIGALAKNSQVAEDKAIIEKHPLLALALAAGASQQIRHMATVGGNMLQRTRCSY
FYNTDMPCNKRVPKSGCGAIGGSNRMHAIFGASDSCIAVHPSDMCVALAALDATVQVEGP
KGKREIKFTDFHRLPGNTPEKDNTLQNKELITSVEIPNNNFNKNVHYLKVRDRSSYAFAL
ISVAAALDIQNNTINDVRLAMGGVAHKPWRLTEAEEFLKGKTVSETIFRQAADLAMKGAR
GYGDNDFKLTLGPNAIVEALTIASSK
>EGALAKHO_02919 Putative xanthine dehydrogenase YagR molybdenum-binding subunit
MSKTSNINRVDGFAKVTGSATYSAEYKTDGVVYACLVGSTIAKGRIKTIDTKKAEWAPGV
LAVISHLNVDKPSGYEKAKDPHNFGQPLQVFKDDTVLYYDQPIAMVIADTFERMQYAAGL
IKAEYLKEEHITNLQKAKDKEKKVETDKGDDYHRGIQDNYKNAAVVLEEEYTIPTEVHNP
MELANIIAKWDGNKPTVYTKSQGVEGTRKSIGGVFGIPPEDVSVNSEYVGGAFGMGLHTW
PYEIAALIGSKKLNRPVKLVLHREQMFTNVGFRPYTIQKMGLGATKEGKLIGLTHEAVAM
TSSYEDFMEGTVNMSRFIYNCDNVSTRYRIVKLDTCTPIWMRGPGEATGSFALESAMDEL
AHKLDMDPIEFRKLNYAEKDLEQNKPWSSKYLLDCYEGGMERIGWKNRKNKPGSVKEGEW
LVGYGMGTGTFGCYRSPTSVKAKFLADGNLVLQCSVNDMGPGTATMMTAIGAEITGLPTE
NVIIEMGKSGLPKGPTQGGSATTSSVGSAVHDSCNLLVSKILGLASATSTFKGIPITDLS
FANGVISSTKDTSKTVSLASLISANKPEDFEVENTSKGNEEMKKYSIYSFSVHFVKVLVN
PNLGKIRLAHVVSCADIGTVINQKTSAGQMYGGAVGGIGMGLMEALEIDHRFGRPINNNF
ADYHVPVNADIEKQEVFFVNKKDPISNPMGTKGLGETALVGMAPAIANAVFNATGKRVRD
LPITLDKIIEPTTATA
>EGALAKHO_02920 hypothetical protein
MKRTSLLLFLLSFFSGYSQQKFKITYEQLKEYEGIYEYQNNTTLQIAASPKDTILYAIIN
ESKYALKPSEKDIFLNMSKEKVTFLRNNTSVITGYSSDGKTFNLINKKVNFPKEMWYPRL
NATKDFKYVYQQPKKDLDGLVTGSIDNTVLDKSLLNEMMQKIVDGTYRNVHSVLIIKDGK
LVFEEYFYEYNKTKLHEMRSATKSLVSALTGIAIDKGFIKSKSETVLSFFPEYTLKNLTE
DKRQITIENLLTNQSGLDCDVSNPKSEGNETTMNYSEDWVKFTLDLPMVDVPGGRGMYCS
GNPITLGKIVEKATKMTLPDFAKETLFKDIGIKNFKWNFKPDMSSAETFCQIYLTPRDMA
KFGLLYLNKGIWNDKQVISKEWVNESLTKHSVVQGVNYGYLWWIKYLNVNDTKFYGKAAQ
GNGGQKIYIWEDQNMVTVITGGNYNSQSPSDELIQKYILPAFSKK
>EGALAKHO_02921 hypothetical protein
MKKLCLLAVILFTAVTVQAQDVVKFAPLDASPVDISYFPSRSIKYKKTDIPLATIKVTYA
RPSAKGRVIFGDLIKFGEVWRVGANENTEIKFYKPATINGVAVPVGTYSLFAIPDKDKWT
IIINKELDMWGAYAYDESKDLVRVSVPVKPVSTPIEALSIAFTTQGSVTNLVIGWDKTTV
ELPITIK
>EGALAKHO_02922 Beta-glucuronidase
MKKLITTLLLTLSLFGQAQNQNLISNVPNRNTTSLNGVWNYIVDPYETGYYSFHHDEYDK
QAKAPNAAYYSNYHAVNKQELVEYDFDKSPKINIPGDWTSQVPELKYYEGNVWFKKSFDY
NLKAGKRLFVYLGAINYKADVYLNGKKLGTHIGGFTPFNYEVTSIIKAKDNYLVIKVDNT
RHKEDVPTINTDWWNYGGITRDVTLIEEEASFVEDYNIQLKKNNAALISGFVKISDPDAV
KNAVTITIPELKINYKGKVGADGILNFEIPAKKISLWSPENPKLYDVTVDYNGQKLKDNI
GFRTIETKEDQILLNGKPIFLRGISIHEENAKGGRANSEEDALRLLNWAKELGCNYVRLA
HYPHNENIIRTADKMGLMVWEEIPVYWTVEFTRDATYKNAEDQLTAAITRDKNRACIIIW
SMANETPISDARNSFIKKLVDHTKSLDNTRLISAALLTQSDSAGFGTINDAIGDYLDIIS
FNQYLGWYGGKLEDAEKIFWKTKYNKPVIVSEFGGDAKQGLHGEKNERWTEEYQEYLYIQ
NLKMIEKIPHLSGLSPWILVDFRSPRRLLPGIQDEYNRKGLISNDGNKKKAFYIMQDWYA
KKKKEQIQN
>EGALAKHO_02923 Beta-galactosidase
MKKQHNNYKPFSFIAFLIVCLLGINSNFAQSNSAMRTKTNINDNWLYLENHTADLSEAQK
ATNWNTINLPHSWNAEDATDLNPGYRRDASWYQKKLNIPSIDKDKKYFLYFEGSNVTTKV
YVNGKEAGGHIGGYIGFTIDITNLIKEGNNDVFVRVDNSYDIEIIPSQKSDFFIYGGITR
DVWLLSQYKNRIDNLKITTPEVTVKKASVQILASTINPENNKDLSLTVILKNPKGKKVAS
KTIPVSEKTSNITFENIKNPELWDTDNPNLYSITAILSEKNQIKDSVNEKVGFRWFEFKD
HGPFYLNGKRLLIRGTHRHEEQAGVGAAMSNEQHWADMKSIKNMGANFVRLAHYPQDPEV
YKACDELGILVWDELPWCRGGIGDELWQTNTKNMLTEIINQNYNHPSIIIWSLGNEMNWL
PDFPDGDNADKTNVFLTELNDLAHKLDPTRKTAIRKYYEGSKIVDVFSPSIWSGWYSGSY
KSYQKAIDVYKKEYKHFIHAEYGGDSHVGRHSENPITGENVIKAEGWEEAIVQTKVANIA
QIGDWSENYIVDLFDWHLHISENDPTFVGNVQWAFKDFATPLRPEDDIPYMNQKGLVDRN
GVPKDAYYVFKSYWSKEPFTYIESHTWTERQGPENTPRTLSVFSNCERVTLYHDGKSLGE
KLRNLSLYPANGLTWDVNFKKGDNILVAVGKNKEGKTVSDTLKVNYRFNKNDTATSLQLS
SQKLKNGNYLVTAIAIDNNNLRCLDYEESVYFQCLKGGKTMKNQGTPTGSESIKMANGKA
SIEVIPDGSGLPIEMTALNQSFKGEYLKIMLK
>EGALAKHO_02924 Unsaturated chondroitin disaccharide hydrolase
MNKVSFFLILGFALLASCKSGVNSQTKTARSTSENLLEKRYKMLLDYPVDSMSMPRSMSI
KTNLIKKVPSRDWTSGFFAGNLWQLYRLTGNEAYKNQAEKWTPFSKKESLNHNSHDVGFK
VYCSYGEALKVENKQEYKDVIIKGAETLCTRFNAKVGAIRSWDFSKEIWDYPVIIDNMMN
LELLFEASKLSGNKKYQEIAIQHANTTLKNQFRADNTCYHVIDYDPTTGAVRKKTTLQGY
NDDSVWARGQGWAVYGFTMSYRYTKDPAYLKQAEATAKFFINNKNLPEDGIPYWDFNDPA
IPNSARDVSAATVMASALYELYGYTKNKSYLAFADKIMASLNSDKYILGDAVQGPFILDH
STGNWPKHDEIDEPIIYADYYFIEALLRKKAL
>EGALAKHO_02925 Sensor histidine kinase TmoS
MKYKIAFLVLLFISGNTFSQNKYRLKNISTTDGLSQNSVIAIHQDKFGQMWFGTRDGLNK
YDGSRFTVFRNDVANKTSISNDILSIEEDDSGKLWIGTYNGLNCYDPVNNTFDRYLHDKK
DHGINSNTIWCIKKIGDEMWFGTSKGLSVYNRKTKQFASALHSGTDNTSIPSNNILSILK
TKKGQIWIGTTKGLCVLTSRKNGKFSFKNYPLNNIDVLNVSAIAEDRFNNLWVGTKNKGL
LKFNTATNSFVSFLSDEKYKEISSEIRALGIDKKGSVWIGAYDGIYILGEDKSIQKINNN
SSNNNGNNNNNNSGIEKVKSIFIDKKGSVWIGCYYKGVSMWDISNLNFSNYNQNSKKIPM
SFDVVSSIVADKNQNVYFGTEGGGITIYNKNTEATSYINNKIGQTNKNDIKSMCLAENNI
LWIGIFSKGLSAYNTVTKRSEDDRISPQLKDSLKDVGVYSIKTEGNGILWLGTFSKGLVR
YNTVSKAFQFIRNDNTKLNSLTNNYVRTVLVDKQKRLWVGTLSGLNLIGLKNFQPNKYVV
KHFFFDDVSLSGDDILTLFQDSQNKIWVGTKAKGLYYFDGKKFNRINLKIENTTITSIHS
ILEDNDKNLWISTNQGIIKYSTTRNTVINYDQKDGIINNEFNDNAALKLDGDKFYFGSPS
GATYFDAQKISINQYAPQVLITDLKIKNETTNPNDSLGILEKSIGYTKTVTLDYDKANFS
INFAIPNYIRSKKNKYSYRLTGLENNWTITKNTEAMYAIQNPGTYVFEVRGANNDGVWNK
VPTTLTIVVKPAPWRSIWAFLLYGIIIGSALYGLIWIMKSKARLKQKLELEYLETKRIEE
NNRAKLDFFTNISHEFRTPLTLILGPLQQILSNYNGTNEMYKKLLVIEGSANHLLSLINR
LMDFRKLENDQVKLESANGNIVKFTKEIFLSFIEYAKDGGYEYTFEPSEEEILVYFDRYK
LERVFYNLISNAFRYTPKGGSINIKINHDHENLFIAVEDSGAGIADEHIDKIFDLFFEVP
LHNNVQKNYNKGTGIGLSIVKNIVKLHKGNIEVTNKKTGGVVFKVTLPLGRAHLLDSEII
EDFKISDDIAQYATQLETAEFTEPEDIDDLVVNTEKQTILIVEDHKVLRTFMKNLLKKEY
NIIEAENGKIAFEKALQHVPNLIISDVIMPEMVGTELCSKIKENLKTSHIPVILLTSRSS
LVYKFEGLESGADDYISKPFNLMEFKLRVKNLLNSTERLKNKFSSEDNFVPSEITVSSLD
EELLKKAFKIVEENISNEQFDIPLFCSELGVSRTMLFLKIKAWTNYTPNEFIHEIRLKRA
AQLLEQNKLNVSEVSYKVGFNNPKYFSKCFQKKYGETPTQFADKFSKSITVI
>EGALAKHO_02926 hypothetical protein
MPSWQIANQNLTNQNNHKTMNRQTIIICCSLFVSSMNIMAQQTPKILTDSKTNYLPDFSY
TGYHFGESQIPESQGKIVNAADFGVKANDNLDDSKALLKAIKAANATEGNVILQLPAGRI
ILSAILYIERSNFILRGTGSGENGTEIYCPRPMMYLKDPESLAELREYLTTFDKRQKETE
NNIDLPFSQYAWSGGFIWTQVPKERVKSYLDKYEPTPNVLAKVSSGNMGEHVINVSDVKG
LKVGDIVELQLFNKDGENGEIIKDLYKGAKVKPGSHHWNFPKLPIVRQQVEITKISNSKI
TIKTPLTIAIKPSYQAQLVEWKHLNEVGIEHIRFTFPDIPRVAHHVEPGNNAIFLTRLFN
SWVKDVTITNADSGILGEEISNVSIQDIVTDGNHMAHYTVTLGGVHNVLVKNLKIYNKAV
HPLSFNTFATKNVYQNCEIFADPVLDQHSGANHQNLFDHITVHLAPDKNNSYALFGGGGA
EYWKPSHGPYSTFWNLNVQVEKPVDSAKPILLYGMKDGPFARIIGVTGNAKFEVKYEPDA
YIEFLNTSLDKVPSLYDYQLRKRLKN
>EGALAKHO_02927 Mannonate dehydratase
MEQTLRWFGPNDPVSLQDIKQTGATGIVTALHHIPNGQVWEIEEIIKRKVEIEHENGDPK
KGASGLTWSVVESIPVHEDIKKQTGKYLEYIENYKQSIRNLALCGIKCVCYNFMPVLDWS
RTDLSYEVEDGSKALRFDINAFAAFELFILKRPGAEKEYSAEQTEKATKYFEAMTDADKV
KLQQNILAGLPGAEEAYSVEDFLVTLSGYNHIDRQALKENLFFFLKEIIPVAESKGVLMA
IHPDDPPYPILGLPRVVSTEEDLMELMNAAPSKSNGFTMCTGSYGVRADNDLPGIVRRHG
DKMNFIHLRSTQRDAEGSFYEANHLEGDVDMYEVVKAIIEVEKRNNSQLPMRPDHGHQML
DDLKKKTNPGYSAIGRLRGLAELRGLEMGIKRTL
>EGALAKHO_02928 putative oxidoreductase UxuB
MNSIFNLEGKIALITGGAGVLGSNFANVLAKQGVIVGIVSQSIEKANKTVAAIESNGGKA
FAIQANVLKKEELEKAKDFIVEKYGRLDILINAAGGNMPGATIQPDQAIYNMKTDDLQQV
VDLNIIGTMLPSQVFAELFAKQREGNIINISSTSAQRPLTRVVGYSAAKAAIDNFTKWMS
VELASKYGEGIRVNAISPGFFIGEQNRALLLTPDGNLTPRGEKIIDHTPMGRFGKPEDID
GALLFLCSDMSKFVTGTIIVVDGGFAATSI
>EGALAKHO_02929 hypothetical protein
MIIDVLSNAAKYCGLHPNFKKAFDYLSQNDLLNLEDGAFEIAEGLKVIVISGEGTTKEES
IKGFECHDQNIDIQISLKGPETFAWKPREKCVNPNGEYSEERDVRFFHDKPDMFFELQEG
QFAILFPTDVHAAMIGEGTLKKIVIKVKI
>EGALAKHO_02930 hypothetical protein
MAQENVDKVNAIIEQYGYKRNILASNLALNKKFRFAVFLPKYENIEYWKSQIIGIEKAAV
EFGKFGVVLDYFFYDFNATSFKESVEKVLNFECDGLLFAPIFYEDSVRFLNEYEKKNIPV
VMIDSNISSDEEHAYVGQDAFQSGYLAGRLISFAVNNERQVLIFKITREIESTSVYLQRI
AGFYSFFKDHHELTNFKFSEVTIKDSGIDQLCLDMFSGINSVFVPNSRAYIVARFLEQNN
IKGVRIIGYDLLKENIEYLNKGIIDFLINQRPEEQGYMAVNHLYKKLVLQEKVEKTHYIP
LEIILKENYFPARK
>EGALAKHO_02931 hypothetical protein
MKKYLLLTTIMASSFAVHSQTKIITVTNSLAVDREFETVELTKKELRLANSVKLEELAVK
EKNSGLFLESQAVDNDGDGTMDVLLFQPKISASSKKEFEIVPSTNTSATKNINCYSRFVP
ERTDDYAWENNKVAFRTYGPVAQKMVEDKIAGGTLTSGIDAWLKKVEYPIINKWYEKTVS
GTGSYHKDTGEGLDNFQVGPSRGIGGIAVNANGKYYFSKNFISWKTITTGPIRTSFILTY
ADWDANGNKITESKLISLDYGSYLSRFEIHITGTKTIAAGLTLHDKKGTIGTNIKEGWLS
HWEPIDDSEIGMGLVAPKNTLLSFDNHVTEEKDLSNLYGNLKVKDNKAVYFAGFGWKKGS
PFQTKAEWEKYLSSFAEKVNNPLVVKVKK
>EGALAKHO_02932 RNA pyrophosphohydrolase
MKQSAGILLYKFIDCTVYFLLVHPGGPFWKNKDLESWSIPKGEFTDDEDPLDAAKREFQE
ETGFEVDGDFIALESVKLKSGKTVFAWAVEFDIDVTLVKSNEFEMEWPPKSGSIKSFPEI
DRAEWFQTAEALKKINPAQADFIIQIISKISTSL
>EGALAKHO_02933 6-phosphogluconate phosphatase
MEVKCIIFDCDGVLVDTEKIGNGILLEMASEHGFEMKIEDAYRDFNGRNLKECFQHIETA
IDKKLPDNFESEYRERSFEAFKTQVRPMEGVVDFIENLNIPYCVASSGPVEKIRLNLEVS
GLLEKFEGKIFSSYEIKSWKPDPGIFLFAAKEMGFEVEDCIVIEDSKAGVKAGVSGGFKV
YGFANGFNNADLAEEGAILFKTYEELEELLK
>EGALAKHO_02934 hypothetical protein
MRLTYCYRMIILLQGLFNRFFFTTENTKILYQKGYYKHRVHKAGIEKAL
>EGALAKHO_02935 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKLKNTAYKAYFILLLAIFLNATISAQNPKKLNGTQIAFLSDVHLQDLFGSFSDNDYKGI
LNPKTGQNTLIRTMASQLHSTRIFNENYFAFIAALEDIAKRKIKYVALPGDYTDDGQPIH
VRGLQQILDQYQKKYGIEFFITTGNHDPVGPFAQDSGKEDFLGKDGKTQPIYSKYGLYKP
NLSTEQPVIVTADIAKMGYLGITDGLKDFGFYPNKKYKFWATPFSTYNSQNYSFEKASQA
ALLSNRVYNVAPGFEVPDVSYVVEPIEGLWLMAIDGNVYIPKKNEGDPKDPKNYSEASTG
YNNVLSNKKHLIKWVEDISAEAKKQGKTLIAFSHFPMIDFNDDASAEIKELLGPNKWQLN
RVPVEEVAKTFADAGLKIHFGGHMHINDTGIRRTEKGNTLVNIQTPSLAAYIPAYKLLTI
KKDNVVDIQTITIDDVPRYNELFDLYKMEYKFLESQNAKDIWNIDILKTKNYHDFTDFHL
KELVRLRFLSDDWPSNFKDFFLKLSAQDLLVLASVQSDKDFDEVLQNKERFQKEWEEAKV
KSAQYLKVNKLKKEDFNWTGYDLLVDFYRFRSADELALADVGTAKAKQYKILSQLFFENH
AADTSKEKPLQNQMRLFLIIFNKFMHEVPADHFSVDLKNGKIKRK
>EGALAKHO_02936 hypothetical protein
MKQILFTLFLAGAINSSVQSQDNNLKINQIQVIGSHNSYRHAIETDLYNFIQAKDTSRSL
KGLQYTHIPLTEQLNKGLRNLEIDVQADPKGGKFAHPKGLDLAKSEEAYDPNGEMKKPGF
KVFHMIDIDFRTSCYTLQSCLAELKKWSDANPDHVPVFITLEPKDDDSYLGTKAEKFTPE
LFDALDKELRKGLGNKLITPDMVRGKYKTLEEAVLNNNWPTLKKAKGKFLFILDNNGAKR
DLYALNHPSLKGRAVFINAEPGKPEAATLFRNNSEDPQIADLVKKGYIIRTRADSDTKEA
RKNDYSHFEAAKKSGAQIITTDYYLPSTFFNSPYQIKYDDGTYVRVDPVNGVK
>EGALAKHO_02937 ECF RNA polymerase sigma factor SigL
MKNPEIFEQTYTEYWKKLNAFSYTMTQDKDLAQNIVQDVFIDLWERKDDLNINAIEPYLF
RAVKNQVFKHYQNNRFDKTILEDQFEDYVIDNFASIDPELMDLLYSLLDKLPEKRKEVLL
MYKFQDMSIEQIADELGISKQTVKNQISSALKQLREGLKDLAWLAPYIILHQKF
>EGALAKHO_02938 hypothetical protein
MFLCVKKLRQQGSANNMIKRIKHSLEHLIDKSSRNKTSIAEENLLNDFAFDQYQNSKWNE
TAMGNPDEVSQHIYEGIQLRIGKKKNFNPYLKYMAAASILFLVGLGFFFKPGFSVEKQLT
FKTLDTPKSIQLNDGSKIYLAANSIFQYPEKFEGEERKVSLLKGNAFFEVAKDKTHPFII
TSGEIKTKVVGTSFHIQLSKSKCEVIVVTGKVNVTSKGKSVDLVPNEEALFESQKLTKQL
ADKSFLVNWYNTDVTLNQTTLKQVITILQYKYGVSFQYDNAHVLAMPLTVFIKKDASLEN
VLEQINYITNLKFKVYGEIVKVN
>EGALAKHO_02939 TonB-dependent receptor SusC
MYFKLSYLNLKRIVFLVMALLAIQNGYSTTNFLEKSNVKNKIEKATLVSIFSKLSQQTDY
KFSYGQAIIADNTVYTVNYSNESVSLILSDLSKKANFNYNINGKLVLIQKTEAPKTVTRK
VLDRIKVKGKIVDENKVPIPGATIMETSSSNSTVTNFDGEFEITVGEGKTIEVSYMGYKT
KTVAAQSGFMTIQLEPNAAELAEVLVVGYGKQSKKDVTGAVTQLEAANFKQGISISPDQL
LQGKVAGVRVISTSGEPGAGVNVTIRGVGSIRSGSTPLFVVDGVPLSNDDVSPGASNVGF
GTSQAKNPLNFLNNSDIESITVLKDASAAAIYGARGSNGVVLVTTKKGSKGEGTLTFDSY
TGISTVANKLDVLDADQYRKAIKDPAFDHGGNTDWQDVIFRSAVTTNNSLAFSKQTETGN
YYASAAQMNQEGIIRNSGFKRMSGRINAAESFLDNKRLKVKMNLTASETKDDGVPTSDDG
GSNGQLIVHTLMANPTRSVFDANGKYTNFNMNAHYNPAYLLSIYDDQTRTLRVLANFEAS
LRIVNGLEYKVNIGFDRSAAERNTTIFPNLTDLNPKGKYVQNNLDSKNSLIEHYLTYNLL
SNKHKLEALGGFSYQKFERSGTSFSIDGITNQGVGVPPSINPGFAGTQSGVSGYAQENEL
QSYFGRVNYTFNEKYLLTASMRADGSTRFGDNNKYGYFPSAALGWNISKEKFLENATAVS
NLKLRLSWGQTGNQEVENKITQASYSLAGADGYYLYNDLNLVNGVSVNRTPNPDLKWEVV
TQYNAGLDFSFWNDKFYGTLDYFNKTTTDAILNVPSQALSPTTTIWTNIDGKIVNTGFEF
MLGSKLIDKKDFSWNIDMNGATLRNKIEDLPVSEILSGTISGPGQSGVNANIYKSGYAAG
SFYLLQHTGFDANGANVFKDQNGDGKIDNSDRVIIEGALPTFYYGFNSDMRYKNFTFSFS
IIGQTGGYLLNNTGLNALNINNLASDRNVATGYYESGANATNSPILSTLFLEKSDFIRLN
TARVGYNFDLKGMNWINGLTLYVTGQNLITITNYSGYDPLINSPKSNGGNQSIGIDYASY
PTSRTFSFGATLKL
>EGALAKHO_02940 Starch-binding protein SusD
MKTNTFFNIKLITLFSFIWLFASCTDLDEVVLDEVLGNNASNPAGALAAAYDRLGDGTFT
DHGAIFSLQEYTTDEAILPTRGSDWGDGGKWRDMHEFTWKSDNAVVGDNWNKLTNGITRS
LTAIQSVEESSIPQKKLFSAEAKALLAYYMYTTLDLYGQVPYRDPMNPNAPLQILKADTQ
IDKLITDVEALIPDLAPMGEQQTHHGRFTKEAAYGFLATMYLNRAVFKDRFNANSSFNFT
EPAVSGGGTDMDRVIYYTSLLINSGKYSLESDYFKNFARDNENGKELIFAISQKIDYIRN
GSNSFAYVSMERNQRTSAANRGTNAACITPEFYATWDGNHDDPRFEQHYQYADGTWFMND
GTDVSVPATDIVPKSTNLPWFHFNRGIQAGLQYGPILLPSGSLEMVGNRIKVSPLFMEKS
TTTRMNFTPSLTFKNPAQAVFAQNEINQGARVFKYEFDPEGGNGNSNVDIPLFRLGGIYT
MRAEAYFRKGSAGLAMDDLNKLRTSRKRESLYASAPGKALTSLDATQLYNEIGFELYWEL
YRRPQMIRFGKFDLPGTAKAASQPFRRVFPIPQSTIDVTKEFKQNQGYN
>EGALAKHO_02941 ComE operon protein 3
MAEVYKVVTTLYTHVYKSIGTDGKPKSKNNTLLMGSFVKVLPEENGNWQKIYAFSKESWV
DKTCIGLSPSLKCFYVDVGQGDGALIEVGNDENGLKIIIDGGPNDNLSHYLSKWQYKYYF
DKSKKVHLDYLFISHFDKDHYQGLIDIINDDHYTIGTIYHNGIAKFNNAKVNFPKLEYNT
ELGEKSKQGNEYFLETSFSTLAEFNALKIKGGMLDLQEKFLAAVNNATAQGRLTNFERLD
HTSVIPQKLINNKNFKIEVLGPVTSQINNKLAYKYFDDEAHTINGHSIVLKITYGNRSFL
YGGDLNIPAEEHLMEHYQNTNPFEVDVAKSCHHGASEFTTEFMNQVNPYATVISSGDNET
YSHPRADAIGCAGKYTKSKRPLVFSTELARSIDSTNRIKFGMINLRCDGENIIMAQMKEA
VSGASVWDLYEEIHFNPSI
>EGALAKHO_02942 hypothetical protein
MKSMKIKLLSMLGAVQETHISSQGYLVKKRTELYSP
>EGALAKHO_02943 hypothetical protein
MKKYHLLFAVFLFSLTMSAQSEGSFLLNLYGGYTFSDKVEFDSSYAKVEDGFEYGAGLEY
FFIDNQSIELKYNRLDTKMPLYTKVPLTGFPVGSQVNAGDDKGAINYILADYTYYFGSSA
SKAMPYLGAGAGIAILETPRSGSGTYFAWEIKAGVKVKTNSPLSLNFNAYLQSMSAAVGY
DYYWDYYWGPIAVNDYASTFQFGLGVALSYDFSK
>EGALAKHO_02944 hypothetical protein
MKKIFLLIVLAFTAGGYAQSSSSLADDVAVIQSIYGRSKADLVKQYMNLSEPQAAAFQTI
YDEYEIQRKALGQKKMQLIKDYADNYEKLDDVKAAELTETNLKNIADTDKLLSKTFSKVK
KAVGGRNAAKFVQLEQYLQVTIRGEIQDSIPFIDEIDKSKISK
>EGALAKHO_02945 hypothetical protein
MIHQIDTTDNMVAFRALAEVTKEDFLSVVVPAVEHLVKQTNEINFLLVLDTDIENFTAGA
WLQDALLGLKHLGKWNRAAIISDSEDIISFTNGFSYVVPGEFHGFKKENFNKALNWVEGN
INLA
>EGALAKHO_02946 hypothetical protein
MENLNFIDPLLHGITPNPASKLSVKNLVCAGISSIVIGAILKKTGHNKAAAVVGGLAVPL
LASACYKKLSKISKDKKAETESSGIEYNH
>EGALAKHO_02947 hypothetical protein
MDLSTQIIWLFVLAVPIACISWTVTHEEIFREPREWCVRHSKNDKTLLSRKAFYLFTCEY
CFSHYVTIACLFFTDYKLLLNDWRGYILAGFSLVFVANVYMSLLALLRQAIKKEKVEIEK
IEIETDNEKISK
>EGALAKHO_02948 hypothetical protein
MEKYNNENYGQTDPDFIDQDTLIDNDNYKKEEDPYEQQYNGEFIGDVNHETNDYNRNENI
PNEERIINEDGLITNDEENDTEYVPDDVDDHSNRDDEEEEHIEDDLDEIDDFDAEHFPET
HPRE
>EGALAKHO_02949 CinA-like protein
MASKKVIACCKALIEKKWTITFVESASAGKLNYEFSTVMDSGKILIGGMVCYHASMKEDL
LHIPPGTIEKYTAESAIVTKLMAQNFHLHVKSDICVGLTGLTTPGGSESPKKPVGTIFIH
IIFPEKEIATRILFNGSAEEIINQAIDTVADLILEEAKN
>EGALAKHO_02950 Small-conductance mechanosensitive channel
MENFIHDIINHLESYYYSLVDLTPKLLLATLTLLLSWFIASRIGLFADLRLKRRMDDPLL
ATFIARLIKYILLIIGLLFMFRIIGLTGVAQSILAGAGISAFIIGFALKDIGENFLAGIL
LAFKRPFSIGDIIESNGVKGEVLTLNLRDTEIKSDNKIIYIPNALLIKSTLINYNSGGFL
LQTFTVGLEYGSDYNRAISLVKEILKRNDKVSDKDHDDAAVITDVTAAVVQLNIRYWEDT
STKKNDSENRSKIIAEVLNALKENGFVLK
>EGALAKHO_02951 hypothetical protein
MKKFLYVLILSLVVVSGLVFANRANKNENPKKSISKPLSVAEKKAALKKWEATPDGIMYN
QWKVSPAGKKVHASVTKISKSVIDYTNMEAVVTSLSLPPGSRLGFGMMVRIDGEDFILVF
GSERVGTNILSFKYEFEELHQLKVNDKIIIRSHHISQAPKYSYPIIAGDYVEQNGKPIYK
RVPGKDGC
>EGALAKHO_02952 Transcriptional regulatory protein SrrA
MFNSRNLFSGKRKYVFGLLVLSLICVICAAFTTEESDDFNIARREVLLRRIGHEILLQSG
DSISRVLPVKKITENEYLIRFENDFTFQPESLMNTTSRFLDKAPFAGNYIVNVLNCNNSS
VAYGYAISKNKKDNIVACIGRKQPKACYIINIKFKPTGINRVKNGYLLGGLSFLGFLGFI
LLKPFKPKKSLSHNEPNDSITIGSALFDTVNKKLIADGNAIELTGTETRLLLIFALSPNE
IIEKSRIQKEIWEDEGVIVGRSLDMFISKLRKKLEFDPNIKIVVVRGKGYKLEISTQ
>EGALAKHO_02953 hypothetical protein
MNLPKVLTDLIKAQNEFDAVTYANLFSETAVVFDEGKTHNGKLEIERWIDHSNKNYQSVM
KPLEYTEIGTTGILTAECSGTFPGSPITLKFHFNIVNEQIQHLKVTD
>EGALAKHO_02954 3-oxoacyl-[acyl-carrier-protein] reductase FabG
MDYQNELSGKIALVTGGTKGAGRAIAERLLQAGATVIITARNAPEKENSKLHFIPSDLSK
AEGTQKVISEVLSAYGRLDILVNNLGSSTTPAGGFTALSDEDWESTLQANLLAPVRLDRG
FLPQMIDRKNGVIIHIASIQGILPLYDSTLPYAAAKAGLRNYSKSLSNEVSPKGVRVLTV
SPGWINTGASKAWLAEIARNANSTVEEAQQGVMAALGGIPNGRPAEPEEVAELVGFLVSP
RASYLGTEYVIDGGTVPTI
>EGALAKHO_02955 HTH-type transcriptional activator HxlR
MYERKTIPNLNCGLDLIGEVLYGKWKIRLLWFINEGFQRPSELQRKIPDASRRGLNIQLK
ELEDHELVSKVIYPVVPPKVEYSLTDFGKTLIPIIAAIGGWGDEHEERLRKLILKRLEN
>EGALAKHO_02956 hypothetical protein
MGTPEIITLIISSSVLSAILTGLVNFRIQNLNYKREYYKKLIERRIDSQEQILNLTNKLR
IQVKLDEGVLCNGICTAGENHFESFSILVTCSVNISFWLSSKLSDILLDFNIFLLNEITH
EIKGDNQNERDRSLIDLGLLHHEKLRDFRSKIEKQLMKDFANLADVKSFVKSKHKSNDKL
Y
>EGALAKHO_02957 hypothetical protein
MTKKKKKRKSESENFSLFYQIQYDRIDKLETKRENLCNYVITISSALFAFGLTKSNSIEI
DNKNIMLCFIILVNSFVIVFIDKTRLWINMHQNRANQASAKYSSEFNMIKDSVGKAESDK
DFFRRSRIYSYVHLSIILMSIILIIAENHLLCFCK
>EGALAKHO_02958 hypothetical protein
MYYYYYYNSSVQLNFRFLDDESNPLIKGEEISMIDFENLITCINELNKCAIENNSEIKKY
SKREDSLILKKISYNSPLELSVIVSLTASIIGVPYLIIKCIEKINNIIREKEIHKNNIEN
HKYNIEKQKLEIEKQKLEIEKLKIDKKEKSKNRVEITDEKMELVFSEITSSKRFNKVLKK
WKKLPFKNIKYEVQFEVVDNEENN
>EGALAKHO_02959 hypothetical protein
MKKTIITLIFITQFSFSQNFEKEKSKLVGYKSFEIKNLDSYKSSWSQINYLINGIINQNE
HYFEGKLRSKQYYIYDKFGNKIYEVQTFDSNIGTKNDTIQNNKLTYNSKGFLSQIDYHSG
NIEKYSDFTETGKPRLIESFIPKNDSLILWPSKKIIIYDGNGNIEKEMIYVFSYSQENNS
TKRDIQIETNHYKYDKFNNIIEIKRENEPNIKFPIIMAGGRPQYEIEKFRYVYNSDGLWT
KMFWIVDGKEKLIKKRKLIK
>EGALAKHO_02960 hypothetical protein
MEENNNALDGFLKILKEQEDKIVSTINQNLYDDICRTAEIVNKTENEAEVKEIKNKLLER
FKNVDLNQVTDLFIYNQMFFTTNEDPLPTPSILCINIGKLFKEENLHYTATKVYSNDEVE
GGSALSFLGYLTLHEHHKSYVLNFIKENFNGFSQNKKTELVFQLKNYLPDDNVAKEIVNN
SGITEYKLTFSTEEDSSSRPITFKFKNDETEKFNGVIKDNEDLKSTNTENIISNSVNEKL
DVKTPWWQFWKK
>EGALAKHO_02961 Internalin-J
MKKNNKQRLLFIAFLFICFSAIVVIYIYKTNRKYTAIPDANFEQALIDTGIDSGSIDGEV
ETANIARITDLNVSNKSIEDLTGIQDFIALIKLNCYSNRLKTLDLSKNRALKELYCYWNQ
LTILNVSNNKDLMRLQVYSNKLSSLDVSKNLALTHLSCHGNKLTSLDISRNTSLTEIYFG
DNLLTDIDVTKNKALTKMYFYNSQLKTLDVTQNKALIELNCQRNHLTTLDVTQNKGLTKL
VCGMNQLKVLDLTKNTSLTQLHCIRTLLKHLDLTKNTGLTKLDCSTNQLTLLDIKRNTAL
TELNCSNNPLKILDLTKNILLTSLKCSEDKLTSLDVRKNTGLTTLECSHNSLSTLNLINN
TNLANLACENNQLTELDITENIVLIKLNCSSNKLTTLNIQNGNNISIIDFDATQNPGLKC
IKADFKMPKSIMWYKDHNANYSTTACE
>EGALAKHO_02962 hypothetical protein
MKKIIPIFIFLIFTIHSFSQTKTGNELVAEGIAKTKIKPDLANFKITVTKQNTIEKTAIK
ELNQEIEKLQNVLFKLGFTEKNVKISEYKISKDDYENRKEFSAINTLSVDFVLDNKRIEG
FYQEIQNENLQDVDIEFETQISEDLEKSTRQKLVQNAIINAKNNAENIANALNVKLNNVK
QVSKYNLRDIAFSTVKVDEVRFLKPRVASEALNPKTSFDKFDVEDVELEETITIVYEITT
K
>EGALAKHO_02963 hypothetical protein
MEFKGEINLRILPIEISKLTILSKGASKDFVCHKYFYKDFKLSKHIDFINWKISCHSYNK
NSERTELRTFSFDENPEESKQLGFKKFDYENGKLINESYFINDGKEDILKYEGKFTYNEK
GIVREDYYYPNETYSILYEFKNKILTKVFPNDDGDFEYHYDENDFVKKTINFKTENYCEI
NEYEYQDGRLHKLIKYPNLKYEKNFFSNEIKLLQKPMFIHESKFSYNKDGLLIKEIKTDL
IDNYEVEVLHYEYEK
>EGALAKHO_02964 hypothetical protein
MINKEEILRQLDSEAESYVFPMLDNGYYYHGDQKLTIFRDEKRWAILLEILAYNNHLDGL
EGITTYVAVFGNCLTGWNDNDNFNYFANNSEIEAFLYDENNYPSYLNPLAKTFKVKGIEI
PIIFDLEHYKSKKIDFEYANKITPWEFMRGFIPEYSHLFWLTREEISKKIPIDLPTFMIL
DNWHHPDLVVGEMPSETETFRQLANVILNGDKNLYNTSEANNTHWSNWPEGGTL
>EGALAKHO_02965 hypothetical protein
MKLKQIIFTSIITIIVTIISGVAVNWYTKNNIENDSKDNLYYRIVDISEFKSDSTKLSII
SIEILNKNKEKYTNVELSVEFNKDSKIIDIISKNDVTNKTYNPVKRTKNNLVFNYPVFFP
NEKIKINIAVSDLNSITNIALISNESLGKKFIPELEKEKINLTTIYIQIIILSIILLVTI
FFLFKRLRILLGFFSNSLNNTAFLFLHSKQYDIAEKLLLNRIEKNGATSFELSNLATAEF
LVNRNLDKAKSLFKMSEYISHSNQSKFVIAFNEFIVYGDEKNYMLAKEKFELCRKLNSKD
LKKYLLFSVIIKDLAESDETIKEIINIA
>EGALAKHO_02966 hypothetical protein
MVTNKTICSGETYTWAANSTAYTTNQSALRIANDGCTADQVLNLTVTPKPAKIVTTVTIC
SGESYLWSVNGNTYTVANTYTITNNGCTADRELVLNVDTVAKPIVGTITQPTCASSLASV
ELSGLPSGTWTINPGNITGNTNTTVITGLVPGTTYNYSITNSLGCESLASANITILDYIC
AENDTPIAINGLIGGTTSSIFVNDKINGVSFLPADVTVSTTTIPAGLTFNLDGTITVAPN
TVVGTHLITYTICKSTNNSLCDSATIEIIISAPVIDAVKETTASINGNLGGTTASLVLND
TLNGNAVTIGTNPGEVILTGITVPAGLTLNTNGTVSVAAGTAAGTYNVEYRICEVNNPTN
CDSVISEVLVTGGSLVANTDIVGSAVGINQPTTLINVFANDTNNGLPVVATDMDLSIITA
DPTGFITLNPDGTAVLGANAPAGTYELVYQICEKLNPANCSSASIKVTVTAPTMTVTANS
YCSNNVPYVSYNVAADNFTPSNLLTVKWIDSANNVVATQSNLPLSGDLLWPGAIIDSNGN
GVDWPGWILTNGQWTEGADGFENTRTGVTIQFSLNPTVNFVVNYPPATPQCNARPTFTIK
ANNDNAGPIDTNKSINTALNIFDNDTLNGTAINPANAILSTVIANPSLILNGNGSVDIKS
GTPSGTYQLTYQICDISNTSSCSQAVVKVTVLNSENPPPVVDPRLVLVTKDDLGATVDGI
NGELEFINILDNDLFNGVAINPANVVISNTSNSPYFEFNSDGTVNVKPNTPGGNYVLTYQ
VCEKANTSNCSTSTLNVFVEVPAIAIVKTAVFNDENGNGFANAGETITYKFKVTNTGNVP
LTGITVSDPLAGITLSGQAINLGVNESDENNFTAQYKITQKDINFGSVSNQASVQGHSAK
GVIVDDKSDDVNNSGDNPTVISLDGCQLKVLNGFSPNGDGKNARFYIQGLECYPDNTVEI
YNRWGVLVFDIDHYNNEDRAFIGISAGRATIKQTHGLPVGTYFYILKYKDSASKQHELSG
YLYMNK
>EGALAKHO_02967 hypothetical protein
MFFSIMCSAQQDAQFTQYMYNTISVNPAYAGSRGVLSVFGLYRTQWIGLDGAPETSTFSI
NTPLNNSKLGLGVSLVNDKIGPTNENTLSADLSYSIPTSETFKLSFGIKATANVFNLDFN
KLSFEDQDDPQFQGLDNKFTPNVGAGVYWHSDRAYLGFSVPNFIETNRYDDNETAIFKDK
INYYFIAGYVFNLDHLEYIKFKPALLTKMVQGAPLQVDVSGNFMFNDKFTIGLAYRWSAS
VSAMAGFQVSDGLYIGYGYDHETTNLRRYNSGSHEIFLRFEFFNKYNKMISPRFF
>EGALAKHO_02968 Photosystem I P700 chlorophyll a apoprotein A2
MKIKNFTYTLLLVCFFFKINAQTISTKDADKKYEDYAYADAIKAYEHIVNKGTKDEKIVQ
RLGNSYYYIGELQEALKWYDELFRMNDQQESEYLYRYAQCLKSSGNYQKADEILEKFNQK
AGLEKRASLIRNEKNYLEEIKSNSGRFDIADAGINSPYSDYGSVVYHNKIVFTSARDTGG
VAKRYFKWTNESFSKLYKAELMPDGSVSKPELLQKKENVKFNESTPIFTKDGRTMYFTRN
NFIDGKRGQNEKQITLLKLYKAELINDQWENIKELPFNSDQYSTAHPTLSVDEKILYFAS
DMPGTLGLSDLYKVKINEDGTFGEPQNLGSSINTEGRETFPFISGDNELYFASDGRPGLG
GLDVFVSKIEEDGTFNDVENIGEPINSKQDDFGFTIDSKYRNGFFSSNRENGHGLDDIYR
FTETRRLVCEQDLMGTVIDSESNELLPNTSLTLFDEKYNLVQTIVSDEKGNYIFPSIKCG
KKYAIRVSKNDYGMKEIPVTIKKVNGKTTLQISIDKVFKPMVATKAIEVKKVSVSPVKIG
AIRVGTDLAKLLHIPMNFFDLGKATIKKSSEPQLQKIVDMLNQYPTIKLDIRSHTDSRQS
DANNMILSEKRAQSTKNWLIQKGIDANRLTAKGFGETKLVNRCADGVKCTEKEHEQNRRS
EFIITNL
>EGALAKHO_02969 Hypoxic response protein 1
MTVNQILNAKGKNVYSVLSTTTVYEALKVMGEKNIGAILVIDGTDLKGILSERDYARKIV
LKDKSSKETYVHEIMESNVFSVNLSNNIEDCMELMSTKRIRHLPVLEDEIVVGIISISDV
VKAIIEIQKDTINHLNSYISQ
>EGALAKHO_02970 NADP-dependent malic enzyme
MNKESKRREALLYHSEPTPGKIQVVPTKKYATQRDLSLAYSPGVAEPCLEIAANVDDVYK
YTAKGNLVAVISNGTAVLGLGNIGPEASKPVMEGKGLLFKIFSDIDVFDIEVNTENIEEF
IQTVKNIAPTFGGINLEDIKAPESFEIERRLVEELDIPVMHDDQHGTAIISSAALINALE
LAGKKAEDVKVVVSGAGSAAIACTDLYVLLGVKVENIKMFNSKGLLTKDNPSLSELQLKY
AVDGPKIELAEAVKGADVFIGLSSGDILSPEMLLTMKDNPIVFAMANPNPEIDYNLAVET
RKDVIMATGRSDFPNQVNNVLGFPYIFRGALDVRATKINEAMKMAAVKALAILAKEPVPE
QVNVAYGATKLGFGQDYIIPKPFDPRLITIVAPAVAKAAMESGVAKNPITDWAAYEDVLR
ERMGNDNKMVRLMTNRAKMDPKRIVFAEADQLNVLKAAQIVHEDGIGFPILLGNKEVILE
LKAELGFDAELEIIDPKTNEEEARRNRFAKSYWETRERRGVSLLDAQKFMRERNYFAAMM
VNEGEADALVTGHTRSYPSVVKPMLQLIEKAHNASLVATANMMLTSRGPMFLSDTAININ
PSAEDLVNIAIMTAKTAKMFGVEPVIAMVSYSNFGSSTSQSASKVREAVAYLHKNHPDLI
VDGEIQADFALNQEMLAEKFPFSKLAGKKVNTLIFPNLESANITYKLLKELYKVNSIGPI
MMGMGKPVHIFQLGASVEEMVNMAAIAVIDAQEKENKKNKLAK
>EGALAKHO_02971 Holliday junction ATP-dependent DNA helicase RuvA
MIAHLQGKLVEKNPTEVVIDCGGVGYHVNISLHTFSLIPNADFIKLYTHLQIKEDAHTLF
GFVEKSEREIFRMLLSVSGIGANIARTMLSSIEPRQIINAIASGDVGLIQSIKGIGNKTA
QRVILDLKEKVLKLYDLDEVSVVQNNTNRDEALSALEVLGFIRKTSEKVVEKIVKEDPEA
TVETIIKKALKSL
>EGALAKHO_02972 hypothetical protein
MRKICILLLFLLCGNFLRAQVNQSTQDTTKTQFSVGKVELKDPPSILSAYKYDPVSDRYI
YTNSVDGFSIDYPIILTPKEYEDLVLKESRRDYFRKKMDAIDGKKTGSEAAKKDLLPRYY
INSSLFESIFGSNTIDVKPTGSVEMDLGIRYTKQDNPSFSPRNRSSLTFDFDQRISMSLM
GKVGTRLEVNANYDTQSTFAFQNLFKLAYTPSEDDIIQKVEVGNVSMPLNSTLIRGAQSL
FGVKTQLQFGKTTVTGVFSEQKSQTKSIVAEGGGTVQNFDLYALDYDNDRHFFLSQYFRN
KYDASLKGYPFIDSRVQITRIEVWVTNKQNRVSTTSNNLRNVIALQDLGEGQITGIPDNE
VVVISSSAGFFNNAIDSPTDNNNNKYDPEKIGQAGSYLNSNIREIVTAKSGFNNTNVSEG
TDYSVLENARKLTANEFTFNPQLGYISLQQRLANDEILAVAFEYTVGGKIYQVGEFGSDG
VDATVVTGNNNSNQAIISQSLILKMLKSNLTNVQNPVWNLMMKNVYQIPQAYQIKQDDFR
LNILYTDPSPINYITPVPGSTFPANPTPENKVDQTPLLNVFNLDRLNYNNDPQTGGDGFF
DYLPGITVDVQNGRIIFTTKEPFGELLFQKLQNSGSGENYNDPNTYNANQQKYVFRNMYR
NTQSGALQDSDKNKFLLRGKYKSSGSNGIPIGAFNVPQGSVVVMAAGRRLVEGIDYSVDY
QLGRVQILDPSLQASNTPIEVSLENNSIFGQQTRRFMGFNVEHKISDNFVVGGTYLKMTE
RPFTQKSSYGQESVNNTIFGFNGNYATEVPFLTRLVNKLPNIDTDVPSNLSIRGEVAFLK
PDAPKASDFEGEATIYVDDFEGSQSTIDMRSAYAWSLASTPYLNSINDNTFNANSNNLEY
GYKRSKLAWYTIDPIFYSSKPSGISNDDLSLNTTRRIYSRELYPNTDIAQGQIQVINTLD
LTYFPSDRGPYNNNPAFSTDPVTSNFGGIMRSLNSTNFEQGNVEYIQFWVLDPYVGNAEA
QPNNTGKIYFNLGEISEDVLKDGRKQYENGLGPDQVMVNPQPIWGDVPASQSLIYAFDTN
ASNRQNQDVGLDGLPSSKEGSIYTNYAGEEDPAADNYTYYLNTDGGVLDRYKKYNGTENN
SAVSIDDPNRGSTTLPDVEDINRDNTMSTINAYYEYSIDVKPGMQVGQNYITDIREVTNI
ELPNGATTNARWIQFKIPVSQPQNTIGNITDFRSIRFMRMFMTGFSNQMTVRFGALDLVR
GEWRRYTGTLDANDTNPDDDGTEFDVAAVNIQENSTKCPVNYVIPPGVQREQLYNNNTII
NQNEQSLALRVGGTGLQFQDSRAVFKNVSVDMRQYKKLKMFLHAEQLPNENTLLDDEMVG
FIRFGNDFTQNYYQVEIPLKVTRTGGSCTISPDLVWLEDNNIDLAMELLTKMKIQAMSID
INSTKRDINGVYYPDDDLSLTGGDGDGRLRLGIKGNPNFGLVRNLMVGVKSKADHKDIKG
EVWFNELRMSDLDNKGGMAALLNVDTNMADFATVSAVGKKSTIGFGSLEQGANERDREDI
QQYNIVTNLNLGKLLPQRWGINLPFNYAIGEEVITPEYDPFNQDIKLDQLLKETADPDEK
DNIRTRAVDYTKRKSINFIGVRKDRAPEQKPHVYDVENFTFSQSYNQVERHDYEVEDYED
EQSNTAVNYAYTFQPKEVVPFKETKFMKKSDYWKMLSDFNFNYLPSNITFNTNILRQSNR
QQYRDVETEGIGLDPLYRRNFAFNYQYGFGYNLTKSLKINYNAASNNIVKNYLNEDNSPK
EDFNIWDSYWDIGTPNQHLQQLVLNYDIPINKIPLLSFVKATYSYTADYSWQRSSTALSQ
YVDPDGNMFDLGNTIQNANSNTLTTTLNMNMLYKYLGLTPGAKSAAKPKATAPPKPGEKI
VNTAKPVTNSSPFYDGMIGILTSVKNIQVNYTKNNGTVLPGYTPSVGFFGTSKPTLGFIF
GSQDDVRYEAAKNGWLTNYDNFNQNFTQVTNTLLKITANIDLLPDLKIDLAMDRAYSENS
SEQYRVADTLGTKLYKPLSPYTYGMFSISTVLIKTSFSTSNEIESAAFDEFRNNRLVIAN
RLAEEHYGGAAIPRYGDANNPIPAETDPNYAVYVANQGYPIGFTKSNQAVLLPSFLAAYS
GGNASSSSTDIFRSFPIPNWSIKYNGLMRYKYFKDKFRRFSLQHNYRASYTINQFRSNFD
YNEHPGGQDVNTNFYNQTIMSNVNLVEQFSPLIRMDFELKSSLRVLTEVKKDRALSMSFD
NNLLTEVKGLEYIVGLGYRFKDVIFSSRLADNPTGIIKSDINIKADFSYRNNQTLVRYLD
YDNNQLAAGQNIWSLKLTADYAFSKNLTAIFYYDHSFSKAVISTSFPLTNIRSGFTLRYN
FGN
>EGALAKHO_02973 Glycine cleavage system H protein
MSIPSNLKYTKDHEWVSIEGDVATVGITHFAQKELGDIVYVEVETLDQTLDKDEVFGTVE
AVKTVSDLFLPLTGEIIAFNDSLESAPETVNSDPYGAGWMIKIKIANTSEIDSLLSDEAY
KQLIGA
>EGALAKHO_02974 hypothetical protein
MPKQLLLIWAIICSGIITYFCLTNSSNIPAIDFPSIDKIVHFCFHFGFTVSWILFFKKEL
KGKEANDYKAYLISFIFSVFFGITIEILQGVITTTRTPDVTDVLSNTIGATAAVFSAIAF
RKQIDKIIGI
>EGALAKHO_02975 Deoxyribose-phosphate aldolase 1
MNIKQYLDSTYLKTASQAGLSEGENSDVVKEVIREAITEGFKLIMIRPKYVTLAKEMILK
ANSNLLVGTVVDFPEGKSSIEDKIKEANQAIEDGADDLDFVCNYEAFKNGEIALVKQEII
YGTQIGLAHNKTVKWIIEVAALTDKEIMQLSALIKNVVISNFKEEDYASVFVKSSTGFYK
TENDLPNGATISAIIMMLENASPLPVKAAGGVRSYEDAIEMIRLGVKRIGTSAAKEIANG
EENTTNQY
>EGALAKHO_02976 hypothetical protein
MKTEIYVNKIFLSFIFTLTTIIVFSQETNNSSVKPGFTTEQFPVFPNCEKLESKKLENCF
YKEVHDFVFQNFQVPENLKQTNYKGEVRVLFEVDATGVFKVIYVDAANDQLSEEAKRVFG
KFPQIKPSTYNGRPTYSKYTISIGIPLKSAEQIEAEALAAAEILKPVEKPMTELDSIVYK
KYNNPEFESHLNIPFSHSYYAQFDGAMNQVGSNNHTASKPYTYAEVSKYYNLKAVNESLQ
KKVSTWLGRKWWNENLVQIQGEDYWLSLNPIVDLQIGKASDLDASYTYVNTRALNFRGGL
GKQINFTTTVFESQGRFAGYFNDYAESLKPSGGNPAIIPGVGIAKRFKTDAYDFPLAEAN
ITYVPSKFFDLQLGYGRNFIGDGYRSLLESDGASPYPYFKINTTFWKIKYTNTYMWLKDV
RPDVTVEKTYATKFMANHYLSWNVSNRLNLGFFESVVWADTNNRGFDVNFVNPIIFYRTV
EFTSSSKSGNALLGFTGKYKWNNNVNLYGQFLLDEFSVGDMAAGEQSWKNKFGYQLGAKY
FNAFEIKDLLVQLEYNHVRPYVYSHSAVITNYGHNNQSVGHQWGGNFNELLIIGRYHKGR
YFGDAKFTIGTRGLDFDTAKDSYNYGGNIYKSYDVKRPYDTDVKVGQGNKTNVFIADIQG
GYVINPMTNLKLFGSFIYRNFDPTQETATTFKQSTTWFTIGLRTDVFNWYFDY
>EGALAKHO_02977 Protoheme IX farnesyltransferase 1
MNTTKNTFSFKSIFQDFKEITKAGLAISVLFSSIAGYLLGVNDEHPFKWSVLIILSIGGY
CMVGASNAFNQVIEKDIDSLMDRTKNRPVPSGRMSPKMALCVAGLLTILGISLLYSINAK
SAMFAAISIFLYTSIYTPLKTVTSLSVFVGAFPGAIPFMLGWVAATGEFGIEAGTLFLIQ
FFWQFPHFWAIGWFLYEDYEKAGIFMLPTGKKDKGTALQVILYTVWLIIASLLPVLGYTG
QLFISPIAAIIVFLLGLWMLFYAVRLYKLRTAKAARTLMLVSVSYISLLQIVYIVDKFLR
>EGALAKHO_02978 Cytochrome c oxidase subunit 3
MEMTMTTGEEQLRKSKSAKLILLFAMVSMTMMFAGLTSAFVVSKSRADWLKNFELPTAFY
YSTAVIIGCSVTFYLAKKAIQKDNRSATTALLLGTLALGILFVVLQFVGFGQIVESGYYF
TGEGSSITTTFLYVVTVTHLLHLAGGLISLLIIIYNHFKQKYNSTQTLGIELGAMYWHFL
DLLWVYLFLFLYFFK
>EGALAKHO_02979 putative cytochrome c oxidase subunit 3
MEATVTTANNEEKTWGGGNEPLGASYGKMMMWFFIVSDALTFSGFLAAYGFSRFKFIETW
PLADEVFTHFPFMHGVSAPMYYVALMTFILIFSSVTMVLAVDAGHQLKKTKVAIYMFLTI
IGGLIFVGSQAWEWKNFIKGEYGAVETAGGSLLQFVDKDGKRVALEAFAVKLPEQQEELT
RAKGKWFMESAETVPTYSVAEVQAGFKAHPELLIRTEKLTDKKKKTVLTRAESEARLGTA
KYVVEGANLTRNEYGSKLFADFFFFITGFHGFHVFSGVIINIIIFFNVLLGTYEKRRSYE
MVEKVGLYWHFVDLVWVFVFTVFYLV
>EGALAKHO_02980 hypothetical protein
MSHDHEYVSNTKRIWFVFGLLSVVTTFEVFLGIVKPGFLEFNHFVGLNLLNWIFYILTIF
KAYYIVWAFMHMEGEKSSLRWSVVSPVIFLVLYLLFILLTEGHYIYGVFKDSTIKWNF
>EGALAKHO_02981 hypothetical protein
MKKNIVLFVLFVLPIVAYLFFASGVNSFTKLPTITPKIADLGNWKSLKDEKVTLNNKITI
LGFSGSEILKNRGNFFNLNEKIYQRYNGFKDLQFVVVCPLGTEKDALKIEESLGAFTDVS
GWHFVFASPQEIKTFYDQLHLKGKLDKNLGTSNVYIVDKERNLRGRKGTTKDNKDEYKEG
YDTFHPSELSNEMLDDFKIILYEYRAALKKNHNATKEL
>EGALAKHO_02982 SCO1 protein 
MFKNKSYIGISFIILIFGIYAVPKIVDRIKNGEVVKGNRLDNVGLKTSKSDSKLLTIGPA
PKFELTNQDNAKISNQTYKGKVYVLEFFFTTCPSICPKMNLSMLEIEKTFFGNPNFGIVS
ITIDPLHDTPQVLKDHAKLLGAKSSNWNFLTGDKATIMDLSNKGFNLYAGENDKVNGGFE
HSGLFALIDKDGNIRCRKDEFGNPILYYDGLDKKGVRDIQEDIKILLEE
>EGALAKHO_02983 hypothetical protein
MEDHSLEKKYNKYIIAVSIVVPTLVAILFAIKLKDFGINVEPLSFLPPIYATINGICAIV
LVLAVIAVKNGKRKLHERLMTLAIALGLAFLAMYVAYHMTADSTKFGDLNHDGILDLAET
AKIGALRYVYFFILITHILLSITIIPLVLISYVRALAQRFDRHRKIAKITFPLWLYVAVT
GVVVYLMISPYYA
>EGALAKHO_02984 hypothetical protein
MENRGGVRKLMSTKYFYFLFSMFFSLAANAQCAMCRAALAGDSNVKKAEAVNDGIVYLMV
IPYLLVGIIGVLIYRMYQSKKKKAV
>EGALAKHO_02985 hypothetical protein
MMKFFSIFSLFTALTLLTGCSTSQKLETLKPEPDDASPLIYDANPSFINLPITVKLSDIE
YQTNSILNGLIYEDNNIEDDDIEMKIWKQAPIKIQNDPVNPDKKIKTILPLKATIKYRIG
TKKLGVELYDTREFNLNGVITLSSEVALTNWKLNTKTEFKSLDWSESPTMVVFGKNMPIT
YLINPAITIFKSKIEKKIDEAIEKSMDFKPNVLSALEKICTPFQMSDTYESWLRITPVEI
YSTNAKLKNDLFLLDMGMKCNMETIVGKQPESKFSASKIVLKPVAKIPNQISANIAAVST
YTDASKIMTKNFAGQEFGSGSKKITVKNVTIWHKDGKMVIALDVLGSINGTLYLNGFPQY
NPQTKEIYFDKLDYILDTKSKLMRTASWLGQGYILRKMEESCRYSIQSNLEEGKKNMAAY
LKNYSPMPGVFVNGKMEDIQFDKIQLTNQAIIAFIKINGTVNVSVDGLK
>EGALAKHO_02986 putative ABC transporter ATP-binding protein YknY
MIEIKDLHKSYKMGSSELHVLKGINFNIEEGELVAIMGSSGSGKSTLLNILGILDEADSG
SYILDNTPIKKLNETIASKYRNKFLGFVFQSFNLINYKTALDNVAMPLYYQGIKRKERYE
IAMRYLEKVGLGSHSHHLPNELSGGQKQRVAIARALASNPKVLLADEPTGALDTKTSYEV
MELIQGINDEGKTILIVTHEPDIAAMCKRNVVLKDGLIIDDKKVEQVRASSYV
>EGALAKHO_02987 Macrolide export ATP-binding/permease protein MacB
MFNIERWQEIFEAISKNRLRTFLTGISVASGIFILVILLGAGKGLQNGIEKQFERDAAGI
IEVWSGTTTKEYKGLNPGRQIQYRDGDYNQSVQKFDDKLDMRASTYNFWGGAFSYGKESG
SYQYRGVTPDYGGIENIVIVQGRYVNSSDLANNEKVACIGMKIKTDLFKDQDALGKEIII
NGINFKVVGIFTDPGGEREEARAYLPLTTVQRAFGGGDKISNLFFTMKKTDNYDEALAQS
EKFTQDLKDLLKSRNMVAPDDDSGIGVYNSVKDAKQFYDLNLYIRLFFWWVGICTIIAGV
VGVSNIMLIIVKERTKEIGIRKALGASPFSIISMILHESIFITTIAGFVGLLASLLLLEF
VGPMVQSEYFQNPEVDFSVALTTLALLVFAGAMAGFFPAYRAAKIKPIVALRDE
>EGALAKHO_02988 Macrolide export ATP-binding/permease protein MacB
MFKKDNWDEILQALTANVFRTILTAFGVFWGIFILVILLAAGKGLENGVKKGFDGIATNT
MFMWSQTTSKAYKGLPKTRRYDFRNSDVAALKAALPDLLYVSPRNQLGDFNGTNNVVRGT
KTSAFTVYGDYPELIKQQPMDIIKGRFINQQDILERRKIAVIGKGVISELYEKEEEAIGT
YIKVNGVNFMVVGVYHSKQQGGNAEQEQKNIFVPFTTFQQAFNYGDKVGWMALTAKDETS
ITALKPKILELIKSLHSINPADDRAVGNFDLYEQFNKVQSLFDILKIIAYFVGTLVLISG
VIGISNIMLIVVKERTKEIGIRRALGATPAAIRGQILSESIFLTIISGMFGIAVATGIIA
LLNMVLDSMPPGSNTMFANPSVDLRVVFVALLILVGSGLLAGFIPAQTAINVKPVDALRT
E
>EGALAKHO_02989 Macrolide export protein MacA
MKKGVTVTILIFIALVFFGALYYLYAKNQESPIVFKTEKAEVKTIVKTTIATGNIQPDEE
VLIKPNISGIIEEVYIKAGEKIKAGDMIAKIRVVANVSNVSSTQNQVQTAKIALDNQEKI
YKRQKTLFEKEVISANDFDAAQLAYTQAKQNYLAARQSLDIVKTGTTTSLGSYANTLIRS
TVNGMVLQVPVKVGNQVIESNNFNEGTTIASVADVGRMIFIGKIDESEVGKIKVQMPIEI
TVGAIENKKFDAVLTDIAPKGVVENGAIQFEIKASLQNRDATFIRAGLSANASIILEKAD
KVMAIKESLVQFDKKTQKPYVEVETAPQKFQRKDLVLGVSDGIYVQVKSGIKESDKIKIW
NQGLISEGEEKK
>EGALAKHO_02990 Outer membrane protein TolC
MVSLLCFHSKYMKINKYNSFVLAILLGFGISAQAQTKQWTLEECVRYALDNNITIKLSEL
DVKNADIDKKDAFGNYLPSANGNASHSWNIGLNQDVTTGLLRNQTTQYSSIGLNAGVDIY
KGLQIQNTYRRAKLAIVASQFQLLKMQEDISLNVANAFLQILSYKEELKVKKEQLSIDDK
RFKRSEEMVNAGTIPRGDLYDLKATLATDQQAIIIAENNLLISKLSLAQLLQLKEFADFD
VIDDTNAKDENNIMAQSPIDIYNKAKETRTELKLAQTNLEIAEKNVAIAKGAYQPTLSGF
YGFNTRASYSDKVIGVDANNNPILAGPDPVFQQFSDNKGHNFGFQLNVPIFNGFAVRNNV
ERNKVSLEKSKIDLEQKSLDLQRNVYTAFTNAKGALNTYESSTVTLEARQQAYNYAKEKY
DVGLMNSFDFTQAQTLLTNAQSDVIRTKYDYMFKIKILEFYFGIPIVPIITK
>EGALAKHO_02991 Macrolide export protein MacA
MSKKTVYFLIGGAVVIIAILIGLSKSGVIGNKDEGKEVEISKVVASTIVETVSATGKIQP
EIEVKLSSMVSGEIIALNVKEGQVVKKGDLLVKINPDLYTSGLDRSVANLSGTKASLSQS
EANFKEAKASYERNKTLYDKGVISKSDWDKSIATFEVAKATKQSSYYNVQSASASVTEAK
DNLGRTLIYAPADGTISVLNVELGERVLGTQQMAGTELLRVANLNNMEVEVDVNENDIVK
IKIGDEANVEVDAYLKKKFKGTVTSISNSASTTLTSDQVTNFKVKVRILKESYQDLLEGQ
PSSYSPFRPGMTATVDILTKTKANVLAVPISSVVVKSDTAAVKDFTVEDPNEKKVVPKND
KKFECVFVKVGDKAKIRIIKTGIQDDTNIEVMSGLKSGDVVITGPYTTVSKELNSGDKVK
LKKADPVKK
>EGALAKHO_02992 hypothetical protein
MAIALHGGLTGEMLFCIFGSYICTAIYVVYAHYRTYKTKFYSEEYVYFPTGKKVVMYLGF
LIVNLIFAYLLFWLFTFVLLYCIT
>EGALAKHO_02993 tRNA threonylcarbamoyladenosine biosynthesis protein TsaB
MSFILNIETATKNCSVAIAKNGETILCKEIAEEGYSHAEKLHVFIEEAIAEAGITVQDLD
AIAVSQGPGSYTGLRIGVSAAKGLCFALNIPLIAVDTLQTLASQAKVADGKIIPMLDARR
MEVYSEIFNANLEVEREILAEVITVDSFKDFTEKLYFVGDCADKCKSVLTKENFVFLEDI
KYPSASAMSKISFDKYQKSDTVDVAYFEPYYLKDFMMAPPSKKQ
>EGALAKHO_02994 Small-conductance mechanosensitive channel
MSPEQLSNYATKFIDVLVDYSPKLISAFVILFVGIYAIRLINRIIIKVMVQRNLDPTLTK
FLSDILIWALRILLFVTFISKLGIETSSFVAILGAMGLAVGLSLQGSLSNFAGGMLIIVF
KPFKVGDTIEAQGVIATVSEIQIFVTKMLTANNQTVFVPNGALSNGTIINYSMQGERRAD
LTFAVSYDSDIKKAKEVLLDVLNKNPKVLKKPAPEVFVKNLTTSAVEFSVRPWAKNANYG
AVFSETLENCKTALDEAGISVQPYTLQK
>EGALAKHO_02995 hypothetical protein
MGLSSFFKNLFGSAKESATGLASQAESTFEQAKEAATPYIEKAETFAEETIAKAKETSEP
ILESAVEYAHQAKDIVSEYVEKATDSISDVIDSVKEKTSNITDNTKTVASETVVDASETA
AIIEEKATDEIADKE
>EGALAKHO_02996 Fe/S biogenesis protein NfuA
MTKITIRETQNPTILKFEFEDFITQNQNFEFKNIDEAQESPLAQQLFYLPFVKTVYISGN
FIAIERYSIVEWEDVQDAVSEQISAFVDKGGVIIKIDENKAKKQPITVYGETTPNPAALK
FVVSRMLTRNPVEYKNIDQTASSPLAKELFKFPYVKEVFIDENYISVTKYDINDWDEITL
EVRTFIKQFIENGGTVLDESLIEVATKNDVTKDEAFDKLDVTSQQIINILEEYVKPAVAA
DGGNIAFDSYNENDKTVKVILQGACSGCPSSTFTLKSGIENMLKSMLNDEAIKVEALNA
>EGALAKHO_02997 hypothetical protein
MELRIRVLFIFLFTSFYSFSQEGIPVYSDYLSDNYYLIHPSMAGAANCAKIRLTARKQWF
GQDDAPELQTLSFNGRIGERSGAGIIIFNDKNGYHSQKGVKLTYAHHIMFSRDEIDLNQL
SFGISGGLIQNQLDETTFGTTFDPIVSGQIQKDSYFNVDVGASYNYLDFYAHATVQGLLE
TRRELYTDYESDNIRKYLLSVGYVFGKSENITWEPSVLFQLYDQTKEKSIDLNMKAYKNM
DFGSLWAALSYRRSFDGAQYVSGSDVSSQKLQYFTPIIGINYNNFMFAYTYSQVMGDVKF
DTGGYHQITLGINLFCKKERYDCNCPAIN
>EGALAKHO_02998 2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-acetyltransferase
MLIKSVNGKSPSIPEDCYVAENATIIGDVTFGESCSVWFNAVIRGDVHFIKIGNKVNIQD
GAIIHCTYQKHPTIIGNNVSIGHNAIVHGCTIHDNVLIGMGAIVMDNCVVESNAIVAAGA
VVTQNTIVTSGSIYAGVPAKKVKDIDQSDFAGEIERISNNYVMYSSWFKE
>EGALAKHO_02999 Transcriptional regulatory protein YehT
MKCVIIDDEPLAVELLEDFVRKVDSLELVSTFNNAIDAVSFINQTNVDLIFLDIQMPHFS
GIEFLNTIEKKPLIIFTTAYSDYAVEGFNLGAVDYLVKPIPFHRFLKSVVRAQQIFNPAA
SVQAISENTTAPELEQDFMFVRAEYENVKMNFADILFIEGLKDYVKIYTTDNKFTLTLIS
LIKLENLLSSKGFSRIHRSYIINIKHVKSIQKNKVLISDKRIPISESYKSTFFEKINL
>EGALAKHO_03000 Chlorocatechol 1,2-dioxygenase
MDRKKFIRNGILGIASLATASKLLESCSKNDNDDSGTNSSNEGSCTISPAETKGPFPIKT
PSQLVLENIKSDRIGIALLINLTIENKNNNCAPLEGVLVDVWHCDKDGNYSEYGGTSMQQ
TNYTTVHFLRGRQTSNAKGVVSFISIFPGWYQGRAPHVHVEVLTANGSSLLVTQIAFPEN
VSSVVYSSTNYAAHGQADTSNTKDNVFSDSLTDELATLTGNLTDGYTLSKTITVNA
>EGALAKHO_03001 Sensor histidine kinase YpdA
MNIDTIKNTSSNKILFHSIIWTFFILTSLIQFYESPFRINNDFYVQWITGIILFYLNYFY
LVPALLLEKKYWLYFAFVFALIILFMVIRINYFIPEFNHVRPPNMLPSKIMPEGPTDFVR
GERRIIMARRQPLFFKIGPSLFYILILTISAIIRTLTEFYNNQQNKLIAETHRTNTELIY
LRKQTNPHFLFNSLNSIYSLAHKKSDLVPDAIVTLSELMRYMLYETDNKTVALEKEINYI
QNYIELQKLRLNDIEDIVINVHGDTRNKFIEPLLLISFVENAFKYGTDYKGAAHVKIKIF
IHENSLDFWIENTIEDYRKDPDNSGIGLANIKNRLDLLYPDAHQLDITQDNQYYRVHLNL
KLDEIQTPIN
>EGALAKHO_03002 hypothetical protein
MNKTMTIINLKKQFFWYRIQKNLLCLLLTTLVIACTKRESLKIESFKTTSGWGYSIASKD
RVLIKQSIIPVINETKSFATEEDALKLGNLVVEKLNKDLSPTVTKNDLILLKIKL
>EGALAKHO_03003 N-acetylneuraminate epimerase
MNNLKKGILFAALFSSLIFIGCSNDDDDDDLIGNWVKKSAFDGPARSSATSFVIGDYAYV
ATGYTGDVYLKDLWAYNSNGDYWEQKADFTGVGRSSAASFTLNEKGYIGLGYDGTNKLKD
FYQYDPTSNSWTQKTDFAGTGRYAAVGFQVGGKAYFGTGYDGNYLKDFYQYNDQSNTWTL
VNGFSGNKRRNATVFVIGNKAYLGTGINNGVLQEDFWEFDPATDVWTRKRDIDKDTDDDD
SYNDDYAIIRSNASSFAMNGLGYVVGGESVRTIWEYNPSTDLWVERTPMEGATRTDAVGF
AINNRGFYMLGRIGSTYFDDAWEFKPLDEQNDDDN
>EGALAKHO_03004 hypothetical protein
MKIRLLICSLFTISFYSMKAQENLSVDMNLKTEPTDKINFNETNIGIKINKQINAKNNVT
NTLEYTHLKVNYELGSFTSFENLNQFNQLQDKFEFYQNVSKTTKLNLNIIPTANFQQNFG
ISDITILGSFEVHQQLSSNTDLSFGAARTAIFGSAKYMPVFSLNYKMNDKSNILIGFPDS
KISYSNNIRNKFNLINSFNGNFYNLDSKINLNKEATKVSLSQMTSAFEYERNIDSNWFLN
FKAGYNFNKKYTLINSNNHEVYDFNTGNGYILGIGIKYKQ
>EGALAKHO_03005 hypothetical protein
MHKFILMLFFAITILSCGTDTDAGEFVVGSDYLALNNKVVLIDTVTVDISTINFDSLVTS
SQNRILIGNYDDPIFGKVKANSYFQLASGTYTLNNGGSDTEAVNFVFDSISMILKYDNYH
YGDTTKVQTFDIHRLTQKVKPNVDDASFYNNSSLSYDEKSIGTISYRPRPIEKDSINIKM
DDAFGEAIFQKIKKREITDFDSFSEYLKGLVIVPSTSNSSSVIGFNVATSKVRLYYSKYQ
ADTEETPYVIDLTIQDATKQFNSISLDKTGTLLQNLPVSSSKLSSSLTNRQGFIQSGTGV
ACRVDFPNIKQLKYISDKGAIVDAQLILKPVNNSYSEQYPLADSLRIYVADNLNRMSGYL
TNSAGSTVYGLLNKKTDEFNENIGYIIPIGNFLQKEMWKQADSRSSLILTLPSISKTVNR
IVLGDQKHPDNKVQLKIYYISY
>EGALAKHO_03006 hypothetical protein
MSLTSFSQSISSSPYSLYGVGSLYDSNFGIIPSIGSSGIALPSSTFINNLNPSSLGFLPQ
NHFMFDIGGKAIATTYESSSRSENRNNFQFSHIAFAFPVTKNSGFSVALRPYSSSTFKIS
NLKLPIENSQEYYYLTAEGSGGLNNFDFSYGYKFGSKFSAGVSAALLFGNTTDDRSSLIL
NSITTIHKKTDYNGLRATIGAQYKIDSTLTIGSTFKMPAQIKASKIQTVQTIADEVVTTI
ESDVASDTDDYYMPLEIGVGISKRFKNNLNMTLDYERSLWNDTNQSELYGDFVNQDRFAL
GFTYKEKKNIRKYWDAVQYAVGANFDTGYLEIDGKRISDAAISIGLSLPIENTFSALNIS
YSYGQKGRISDNLIKENYHKISLNLSLDGIWFVKRKIE
>EGALAKHO_03007 Glutamate racemase
MTNNNPIGVFDSGIGGTSIWSAIHDLLPNEKTIYLADSKNAPYGQRTKEEIVALSKKNVD
FLLDMNCKLIVVACNTATTNAIRELRATYDIPFIGIEPAIKPAANNSKTQVIGILATKGT
LNSELFNKTAEMFQHTTIIEQVGHGLVQLIEDGNLNSPEMTQLLESYLQPMIDANIDYLV
LGCSHYPYLIPQIKKILPEHIQIIDSGEAVARQTQNVLREKVGFSDNQKSEPEFYVNSDP
AVLESILNYKYPVVKKDF
>EGALAKHO_03008 hypothetical protein
MKQIKTLLIAAILILGASNTMNAQAKVAHVDVSEIMSKMPAMLDAQNQLQKLSGTYDAEY
KKMVDEYQVKIKKYEAEAATVTEAVNGERSKEVQDMQKRIVDYRDNAQKELQQKDSDIVK
PIMEKVRASIQKVGKAKGYQYVLDGSTLILADGPNITADVKKDLGF
>EGALAKHO_03009 hypothetical protein
MRKQFLFIFLALTVANTSQAQTRTTRIGYIDMEYILENVSDYKEATAQLELKAQKWKQEI
EAKKLEINTLKESLKAEKALLTKELIDERETEIKFLEDEMLDYQQKQFGANGNLIHQKAA
LAKPIQDQVFTAVQDIAEAKNYDFIFDKSSDLTMLFSNKKFDISDQVIRVLNRTDKREQL
TKKQLKEQEVKESKENAIDENPEMADRQKALDEKRAAREKLIEDRRLEQEAKKKEYDDRR
KAILAEREAKKNGTVSEPAKTTEAAKTTESGKTDATAKPAAVNETTPPATDPAVNKAEER
QKLYEQRKKELEERRKKIIEEREAAKKAKEAETQKTNTTNN
>EGALAKHO_03010 Outer membrane protein assembly factor BamA
MEKPVNKLNNFLVLQKRIQIVLTLILLGSFSQIKAQERVPFDQGKKYILAKVSVVGKISF
NEQTVVTFSGLQKGQEITVPGEEISGAIKKLGKLGLFDEISFYVNKIENDSIYLDLDIVE
LPKLNEVKFVGIKKSKVEGLIKDNNLTKNKIVNENLITTTKNYIENKYKKEGYYNTKVTI
TNTPDSIAGNQVNMLVRVDKGDKVKISSIDFVGNKQLTDSQLRAAMKDTKQKNVLRVLKA
SKFIPEKYKTDLEKVIAAYKEKGYRDARIIYDSVTYNKEKNMLAIKINMEEGNKYYFGNI
KFLGNTVYSDQLLNRYLGIKKGEVYNGVLLEKRIADNTKPDAEDITNLYQNNGYLFSKIN
SVEVRTVNDTIDFEIRVTEGPIAYFNKIYVTGNDKTNDHVIYRELRTKPGEKYSKEQLVR
TIREIGQLGFFDPESIKPEFRNVDAGAGTVDIEYQVVEKGSSQVELQGGYGGGGFIGTLG
LSFNNFSARNMFKKDAYKPLPMGDGQKVALRLQGSTYFQTYSLSFSEPWFGGKKPVQFSS
SISYSKQFLNNYITRDVDKSKSFNIFTVQVGLAKRLTVPDDYFVLSQSVSYQHYDLNNYN
TGLFTFGNGASRNLAYTIGISRSNKGVNPIFPMYGSEFSVSAKVTPPYSLFNGIDYADLP
NQKEYKQQYTGTPTSDIYGRPLNTGDYIKNVVVNGNPGYESVGSDYASADTDQGKVDQKR
YNWLEYYKVKFKADWYTKVYGKLVLRTLTEFGFLGAYDQARGVVPFERFYLGGDGMANYS
MDGRETIQLRGYPNNSLTPVNAAGEQIGATIYNKFSMELRYPITLKASASIYALTFLEAG
SSYPTFKDYNPFDLSRSAGVGLRVFMPAFGLLGIDLGYGFDALPGSVTNKANGWETHFII
GQQF
>EGALAKHO_03011 Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)
MNLLDSIDQTNLPKHLAIIMDGNGRWAKQQGFLRAFGHENGTKSVKKTITTCAKLGIEYL
TLYAFSTENWNRPKLEVEALMKILINSLKKELGTLQENNIKLNAIGNLEKLPKSAQKELL
DVIDKTKNNTRLTLTLALSYGSREELVNAVRIISDKVKNNIISLDTIDDSIINEHLYTQN
LPDVDLLIRTSGEHRISNFLLWQIAYAELYFTNVLWPDFKDQDLYEAIISYQKRERRFGK
TSEQIK
>EGALAKHO_03012 hypothetical protein
MKKIFNLLLCFFPFITLNAQINEIGVFLGGSNFVGDVGSTTYIAPEKLAFGILYKWNKSP
RHSYRFSYTQSTVAGNDANSEETGRSNRGYRFENNVKELSAGLEFNFFDFNLHDYHPKIT
PYIYSGLSYFIYDGLYRYDTSPNVTQSVNSSSIAIPITLGIKSNVTPHFVLAAEVGARYT
FTDNIDGSNPNTDNPNILKFGNLNNNDWYVFSGITLTYTFGQKPCYCAE
>EGALAKHO_03013 NAD kinase
MKVAIYGQYYQNSTEPIIKDIFQFFKSNNVEMVIEETFLKMLYEKELIKKEYKTFSSSTS
LDSSFEMLISIGGDGTILRAATLVRNSGVPILGINAGRLGFLATVQKEKIDSFLQFVIDK
KYTTTERTLLSLTCEPQNDAIAEMNFAMNEVTVSRKDTTSMITVETYLNNEYLNSYWADG
LIISTPTGSTGYSLSCGGPILTPNVASLVITPIAPHNLTARPLVIPDDTEIKLRVSGRED
QYLISLDSRISSVKNESVLTIKKTDYKIKMVEIPGETFLKTLRNKLLWGEDKRN
>EGALAKHO_03014 hypothetical protein
MTEITNYITNDFRAIDSQETIASVQDFFADVNFSHFPVLENSVFIGSIASDDVETFDTDK
KAIDYKYTLERFFARKSMMWLDVLEVFAKNHTNTVPVIDENNLYIGYYEMEDIMKFFQET
PFLKEQGGIIIVQKGLLDYSMGQVTQIVESNNGKILGCFVSEADLENVQITLKIGIGPMN
EIIQTFRRYNYEIISEHQEDAYINSLKERSDYLDKYLNI
>EGALAKHO_03015 Pyridoxine 5'-phosphate synthase
MTKLSVNINKIATLRNARGGNVPDLLKVATDIQKFGGQGITIHPRPDERHIRYQDARDLK
SIVYTEYNIEGNPQHNFIDLVLECKPTQVTLVPDAIGAITSSAGWDTIKNQDYLTEVIQE
FQRKGIRTSIFVDPILEMVEGAKKTGTDRIELYTEAFAHEYALGNKSGIDPYVQAAELAN
KLDLGINAGHDLSLDNIQFFKQNIPGLLEVSIGHALIAEALYLGLDNVVNMYLNKLK
>EGALAKHO_03016 Esterase YbfF
MLYSKIEGEGKPFIIMHGFLGMSDNWKTLAGQYVEAGFQVHILDLRNHGRSFHSAEWSYE
AMVQDVFEYCQANQLNKIDILGHSMGGKVAMLFATTHSEIADKLIVADIGPKFYKQHHQD
ILAGLNAVDFSVKPSRNDVEAIVAQYVPDFGTRQFLLKNLYWKEPGQLAFRFNLEVFNNN
LDAIGRALADDLVFDKPTLFIRGGESGYILDSDFDSIRQHFPNTKFETIPNAGHWLHAEN
PKMFFEITTEFLKE
>EGALAKHO_03017 hypothetical protein
MKLLLRLLVTAALVLLIANFLPGVHVASFATAVIVAIVLGLLNLFIKPILVILTLPVTLI
TLGLFLLVINAIIILLCTNIVGGFAVDSFWTALFFSIILSILQSITYKILGDDK
>EGALAKHO_03018 Trigger factor
MDIKRVATDAVNETIVINVVHMDYKGQVAKRINEKMPLATVKGFRKGQVPKDLVEKQYGK
AIKQEEVKKVVDLALERFVQSERLNLLGTPLAKENENFDWDAEELTFEYEIGLVPNFEID
LEAKNNIVKYIVTADDKLIDGQVERIQKQFGKAIPQDKVEADSDLTGTFSNEEKGINNTT
TISVSTFNKKAGDKFIGKKVGDVVTVSTKGLFEDDHQLMDYLKVGHDDVHGLDIEVNFTI
EAINGAELAELNQELFDKLFGEGKVASLEDLKAKIKEDAEAQFAQQADQKLLLDVQDFLI
ENTKFDLPAEFLKKWLQTVGEKKLSAEEAEVEYARSEKGLRFQLIEGKAMAQSNIQITFE
DLKAFTTNAIRQQMAQFGQTNPTDEEVQGIVARVLSNQEEVKRLSEQVVAEKLLEVFKEK
ANPTTKEVTYEEFIAASYGE
>EGALAKHO_03019 ATP-dependent Clp protease proteolytic subunit
MNYGKEFKKFATKHQGVNAMYYDKIVAAMNPTNMTPYIIEERQLNVSQLDVFSRLMMDRI
IFLGTGIDDQIANIVQAQLLFLESADASKDIQIYLNSPGGSVYAGLGIYDTMQYIKPDVA
TICTGMAASMGAVLLCAGAAGKRSALPHSRVMIHQPSGGAQGVATDMEINLREMLKLKDE
LYHIISQHSGQTFDKVHKDSERDYWMKADEAKEYGMIDEVLRRS
>EGALAKHO_03020 ATP-dependent Clp protease ATP-binding subunit ClpX
MAKVVLECSFCGRKKPETNLLIAGINAHICDKCIEQAHGIVLEELKSSGSAKLVGDLILK
KPKEIRAFLDQYVIGQDQTKKVMSVAVYNHYKRLMQQQLDDEVEIEKSNIIMVGQTGTGK
TLVAKTIAKMLDVPLAIVDATVLTEAGYVGEDVESILTRLLQAADYDVTKAERGIVFIDE
IDKIARKSDNPSITRDVSGEGVQQALLKLLEGTVVNVPPKGGRKHPDQKFVEVNTQNILF
IAGGAFDGVERIISKRLNRQAVGYSTSKNVDNIDKDNLLQYIIPKDIKDFGLIPEIIGRL
PVLTHMDPLDKETLRAILTQPKNALVKQYQKLFLMDDVEFTITDEALDFIVDKALEYKLG
ARGLRSLCEAILTDAMYELPSSEDKVLVIDEDYAKHTLSKNLLKRMEIAS
>EGALAKHO_03021 hypothetical protein
MKKIIFGVISILLFSCNKSNDVQQTSVSKTKHKTDSILSEKPRSEIKTVDYSEYFKEAKQ
YCKSNNLNQDKFILIDLGLHSGLKRFFVYDFQQKKILKSYIVSHGCGDNQWGRTFSKENA
PISNEFDSHSSSIGKFVISDRGVSQWGIKVNYVLKGKEKTNSNAVKRAIVLHSWEAIPNE
EVYPEGTPEGWGCPAVSNESMIEIDEILKQNKNVLMWIIKSEGFSL
>EGALAKHO_03022 hypothetical protein
MNEAIEDSNGHILLWQIINIIGLIIIVYVLYLLIKFFRNKYKK
>EGALAKHO_03023 hypothetical protein
MKKVILICLSLFFLISCDSNDVVIDGFVYDASLDIRVANSNGDDLLDPNTSNAFDQRKIK
ILYLVKGKLIEEPNGSDSPLNFLIYKQDNYNIIRVFLNNTKEEQYPETYIQWSENNTDII
KIEYNRTRNSITKKTIWLNDKLTTEIVPYLKIIK
>EGALAKHO_03024 HTH-type transcriptional regulator CdhR
MSKKVALIVPHDYKLLSIAAILEVFETANKLHKGPEKPFEIMVFQSDEQIEQKHLFGYEV
NSIEVSDKNLDLILIPAFTTDNMSEMIAKNKKFIPWLQKQHQAGAELASFCTGAFLFAAS
GLLNEKLATTHVDACSAFTKAFPLVKLKQEETLTADGSLYTSGGSTSTFHLLILLVQKYC
GNEIAVQIAKIFSIDLNRYKQSYFSTFRPNHLHNDTLVAMLQQKIESNYNTIEKLEEITK
DIPTSSRNMTRRFKQVTGIPPIEYLQNIRVESSKKYLEQTQLSISEIIEKTGYNDPKAFR
KVFYKMVGMKPIEYREKFRVQ
>EGALAKHO_03025 hypothetical protein
MKTKIFLNLPVKDLNKSISFFKQLGFSFDSKFTNDKGTCLIIGENIFAMLLVEEFFKTFT
QKEICNTTTSTEMIAAISVESRSKVDEIISAVVKAGGKLHNEAKDYGWMYQRDFFDLDGH
HWEIFYMDESQIPTEV
>EGALAKHO_03026 hypothetical protein
MIKVQHTINAPIEKVWDLWTLPQHIMNWNTPFSDWHTPYAENDLKVGGKFKFTMAAKDGS
DGFDFEGVYTKIEKFSWIAYTLLDNRTANVSFESNGAEVKLTETFEPETKNSEEMQKQFC
SAVIQNFKEYVENNKQ
>EGALAKHO_03027 hypothetical protein
MITVQNTINASIEKVWNFWTLPEHITKWSFASPDWHTPFAENDLQEGGKFKSTMAAKDGS
MSFDFEGEYTLVKQNEAIEYVMADGRKVEISFKETPNGVEVIESFDPETQNPEEMQRGGW
QTILDNFKSYAEAN
>EGALAKHO_03028 hypothetical protein
MTKQIWLNLPVKEVAKSKAFFSEIGFSFNEEHDTPSSTCMVVGEGKFVVMLFEESLFASF
SQNELTDTKASSEILISIDAESKEEVDELAKKAAEAGGNVFAPPADSQGWMYGCAFADLD
GHRWNVLYMDFSKLS
>EGALAKHO_03029 hypothetical protein
MEPIETLEFKIRIKAPVEKVWSVLWDDETYKAWTGAFCEGSYAISDWNEGDKIHFMSPGG
EGMNSIIEKKIPNEYMAFKHLGEIKDFKELPIDDETKKWSGAMETYRLTLDDEFTDLVAQ
VDVVEKYIDYFKEAFPKGLETVKELSEK
>EGALAKHO_03030 hypothetical protein
MATSVNPYLLFNGNCEEAFLFYKSVFGGEFPYIGKFKDMPKDENGSCPEISEKDADRVMH
VSLPIGDTILMGSDSNEQSGDVAFGGNFSVSINVDSAAEGDRIFNGLSAGGSIYMPMNKT
FWGAYFGMFKDKFGVSWMVNFDENEPNK
>EGALAKHO_03031 Phosphoserine phosphatase
MAIEDKEIILLKVSGHDKIGVTAGLTAVLATYDANILDIGQADIHDTLSLGILFEIEAGS
SSAPVLKDLLFKAYELEIKVKFIPISIEDYETWVKSQSKQRYIINILGEKLAASQLAAVT
KIMSDQNLNIDSIIRLTGRTSVVDLEEYPRSCIQLSVTGEIVNKILMTASFMEISRTLNV
DISFQEDNIYRRNRRLVCFDMDSTLIQTEVIDELAELNGVGDQVRAITESAMNGEIDFNE
SFKQRMALLEGLSEDVLQKVAENLPITQGAHRLMKALKYYGYKTAILSGGFTYFGEYLQK
ELGIDYVHANQLEIKDGKLTGKYIGDIVDGLKKAEHLKAIAEKEGIHINQTIAVGDGAND
LPMLNLAGLGIAFHAKPKVKESASTSISSLGLDGVLYLLGYHDRYIDMM
>EGALAKHO_03032 hypothetical protein
MPVSIINSFASWVLKQRIHQIELFLKYPNEVQEELLHNLLTSSENTFIGRKYDFASINSY
QTFTERVPIATYEELQPLIERTRQGEQGVIWETPIKWFAKSSGTTNAKSKFIPVSSEALE
DCHYKGSKDLLCLYLNNNEDSELFLGKSLRLGGSSQIYENNNTFFGDLSAILIENMPIWA
EFSSTPSSKTSLMSEWEAKIAAIINETKTENVTSFAGVPSWMLVLMNKILEDTGKGNLLE
LWPNLEVYFHGGVSFSPYKDQYKNILPSKDFKYYEIYNASEGFFAIQDLNNSSDLLLMLD
YGIFYEFIPMDTFDTPNQKVIRLADVELNKNYAIVITTNSGLWRYLIGDTVRFTSLNPYR
IRVTGRTKHHINVFGEELMVENTDQAIAKACQVTQTEVIDYTVAPIFMQDKEKGAHEWMI
EFKKKPADVGLFQKVLDETLQTLNSDYEAKRYNNMTLNPLVINVARENLFYDWLKERDKL
GGQHKIPRLSNQRDYLEQLKEM
>EGALAKHO_03033 hypothetical protein
MRYQGVLTKMQTEIGNPIQYYLVFEDSFLSMNQLLNKEIEINCTGFQCLNCNKKKKIYRQ
GFCYDCFYSSPAVGDWIMRPELSTAHLGIADRDLAYEEKVQLQPHIVYLALSTEIKVGVT
RKTQVPTRWIDQGATRAIAIVEVPNRYLAGITEVALKNHYTDKTNWRKMLQDTEIAFDLI
AEKAKVESLLPLQVQEYFVTKSDDLYELNYPVANYPSKIASLNLDKTPTFQGKLVGIKGQ
YLIFEDGTVFNVRGSEGYFVDINV
>EGALAKHO_03034 hypothetical protein
MGNLKKVNVFRRSLMRNLTKNIGNSSISENGPIDKSKIKKVLICRPNKRLGNLLLITPLI
QEVTETFPNCKIDLFVKGTLAPIVFENYNNIDKIIPLPKKPFKELIKYLKVWTLIRKQNY
DIVINVDQNSSSGRLAVKFSNAKYKIFGDLPENVELPYEDYEHIAKYPVYNLRYTLSQVG
IAKNEEPVALIDLKLSEKEIANGKKILNDIIDQHKKTIAIFTFATGDKCYCVEWWEEFYG
ILKKEYPDYNIFEVLPVENVSQINFQAPTFYSKDVREIGSVLANVDVFVGADSGIMHLSS
ASKAPTVGLFSVSNLEKYEPYGNNSVGIDTTKNDYSEFIKAINRILHKEI
>EGALAKHO_03035 hypothetical protein
MLKKILKITAIVLVVIVAALFAIPYFFKDQIKAKISEAINESVDAKVSFADADLSLFKNF
PNATVGIEKLVIINKAPFEGDTLVSLGELNLKMSIKEIFKGKEEPLNIQGISSTNGLINI
IFNKDGVGNFDIALKDKKEDTKDDKSKPLSLKIQNYKIENFTFRYIDQGSKIKMVIDSLN
HEGTGDFTNSKLDLTTKSTAKVSLDMDKINYMKNVKLTLDAVLGIDLEKSKYTFKENKAL
INQLPLEFDGFIQMVEAGQIYDLKFKTPTSSFTNFLGLIPSAYAAGLDGVKTTGDFTVVG
FAKGQLTDTTVPKFNIAIASNNASFQYPNLPKSVQNIVIDTKIINETGILNDTYVNLDKL
SFRIDQDVFNAKANIKNITVNPYVNAALKGTINLANLSKAYPIKMDKPLAGILKADVTTE
FDMASVEKSQYENIKNAGTMSLSGFKYTDENNKSMNISTALVEFNPSKINLKQFNATTGK
SDIAINGVLENFYGFMFKKQELRGNFNMSSNQLAVDDFMTEGEPATEKTAAKPTEAMKIP
AFLNCTINAKATTVLYDNLKLKDVSGRLIVKDEKALLENFKTSIFGGTIGLTGSVSTKEK
VPTFDMNLGFNQVDISQTFTQLDMMKKIAPIAGIINGKLNSTIKLNGNLDANELTPDLKS
ISGDLLGQLLSTTINSKNSTLLNALGSNIKFIDMNKVNLNDIKAALTFENGKVNVKPFDI
KYQDIKVTVGGTHGFDQTMNYNLKFDVPAKYLGSEANAFIAKMSPADQSKLQNIPINAMI
TGNFSNPKISTDMKSAVSSLASQVANQQKEKLTQKGTAALTDLINKNTKAKDTTQAAKTE
KEQKTQEVTKKASDLINGLFKKKN
>EGALAKHO_03036 Esterase EstD
MKKIFLFISLMFLSIVNAQDKNVVTFKETPIILKINTDQLFGTLTTPDLIKKYPVALIIA
GSGPTDRNGNNPMMKNNSLKMLAEALAKNGIASLRYDKRGIGESKASAISEQSLVFENYT
EDVKSWINLLKQDKRFSQIVIIGHSEGSLIGMIAGAKANKFISIAGPGESADKLIKTQIA
SKSNKQIEDMTFPIIDSLKSGNRVKKVDPMLNSLFRPSIQPYLISWFKYNPEAEIKKLNI
PILIIQGNNDLQVTVKDAETLSKANKNAELLIVDKMNHIMKIVDGDKQTNLDSYNNESLP
LSEVMTTKIVSFIKK
>EGALAKHO_03037 Protease 4
MKFLGNVIATVIGIFVFIMLFFFGVILIGAIFGGDDKVSVKSDSVIELDLKKIQNDYAGK
YKDPWVTVFSDQEGVGLSDVINAIEAAKTDDNIKGISILNDESSLGLAQYKDLRNALESF
KKSGKFVWAYANTYSQKEYYLNSVANTIYLNPAGDLDFKGLSSEVMFFKDFQDKSGIHME
VIRHGKYKSAVEPFLENKMSDANREQVTALLNSIWATVSTDISKSRNIPLPKLNEIANGL
LARTPEMAKKEGLVDIVAYEDVYHNAIKKALKVTGDDDYNKISILDYTQNNVTTALTNTA
SDKIAIIYAQGEITGGEGDVNVIGEGAMRRSLQEARKDDDVKAIVLRIDSPGGSALTSDL
IWREIEVTKKVKPVVVSMGNYAASGGYYIACNANKIFAESNTITGSIGVFGILPNFSPLA
NKLGINTEQVKTHENSANYSPFVPIDEKFKAFTLEGVEHIYNTFVTHVAEGRKMTFAQVD
AIAQGRVWSGSEAIKIGLVDKIGGLKDAIAEAAKIAKIKSYSTQNYPEYEKTFGDLLANL
PFAQSKEAFIKEEIGEENYLLIEQVKRFQRQQGVQAMLPFGINIK
>EGALAKHO_03038 Deoxyguanosine kinase
MKSQHQIVLSIGSNQGNRLENIESCIALIHQEVGTVIQVSKLYETPAWGFESDAFYNCAL
LLHSASSAQKILNQVLKVEKQLGRIRSNQQGYQSRIIDVDLIVFDDEIIDSEKLQVPHLL
MQNRKFVLMPMQDLKLNWKHPVFQKSVSELIAVTTDDSICTFVQELKNPLEEIPLEKFNY
IAFEGNIGAGKTTLVNKIADDFNAKTVLERFADNPFLPKFYKDQNRYAFPLEMSFLADRY
QQLSDDLAQFDLFKDFVVADYHIFKSLIFAKITLAEDEYRLYRNLFDIIYKEMPKPDLYV
YLYQNTERLLQNIKKRGRNYEQNIEAEYLDKINNGYLDYIKSQTDLNVLIIDVSDRDFVK
KHEDYLFILNEIQRKIG
>EGALAKHO_03039 hypothetical protein
MKTKLSYNPFMVVVLLFFNTIFAARILPPQKIEKKKNGTEISSKIKTAASVIQATGNQVY
CPKSSIKIVTDVTISSTEANTINAIYIQISSGYINGEDFLTLSGTHPNLTSDWNQITGIL
TISNRTGSIASLPDFITAIKSVEFKNTSEIPSGIRNFSISLGQANYLPSSKHYYQFVSSP
GISWGDAKRVAAATNYYGLKGYLVTITTLDEAVFVGEQLGGTGWIGASDTRKEPEWRWET
GPEEGTQFWYGRESGSALTFAYWNDFKEPDNGGELALVGVEDYAYITPPGSGQKGKWNDA
SLYGSSDPLNVNYPRGYIVEYGGMPGDVYPQISASTSLTMLSIIETKSPEICGSGSSLLE
AKSSAGIINWYDSETGGLIANGPSYTTSILNATKTYYVAAEFNGCISKRIPIEVRVNTVP
EITSVSHPDPTCGSGIFFLEATSSQGEVNWYDTNTGGTMLGTGSLFITPSISKNKIYYAE
ANNNNCLSTSRTPIQIEIYPLPVVKDEEVVLCAPNSITLDAGITNVEYLWSTGEKSQKID
VSQLGTYFVDVTASTPGNCSNRKTIRVIERSAPEIQKIDVNNRTVTIDLTNPQDYFEYSI
DDHNYQDSNVFFDAPGGLQTAYVREKSGCKKTNKNFIVLVFPAFFTPNNDSFNDVWEVTG
MENYPQAQVTIFDRYGKLIAQLSSSRMSWDGTFNKTQLPASDYWYAFKIDSNQPVLRGHF
SLKR
>EGALAKHO_03040 hypothetical protein
MKTINFFKITILFFALCFNQSHANEKVKTFNIARATITNDTLKLNKKKNTKTTFAITPPV
LKATGDQLYCPLNTINVVTSISITHDPLETGTQAVYIQVSSGYSNGFDQLALSNPGLHPT
IATSWDSTAGKLKLSSATGTGDVSYSDFEAAIRDVVFSNSSAAASGTKTFSITVGQANYL
PSTGHYYLYVPSIGITWTAARDAASASNYYGLKGYLATLLSADEAKLSGEQASGTGWIGG
SDQETEGIWKWVTGPEAGTVMSYTFWNNGEPNNQGDEDYAHITQPGVGIRGSWNDLSNTG
DSNGNYQPKGYVVEYGGSPGELPLEIAASTKITIPVATALTPNPICDSGSFTITATATVG
ATISWYDQATGGVALATGNSFTTPVINTTTTYYVDAGCESNRKSVVAVLNKTPTTPVVTS
SNVSRCGPGSVNLQATTDVGLINWYTTSSGGTSIFTGNNFATPTISSNTVYYAEASNNGC
LNNNRTAVNISIYTPPVVTDQEIPLCQNQKVTLDAGIAGMNYLWSTGETTQTIEVTSGGT
YTVDVTSPSPESCTSRKTVKVDEHEIPQIDHIDVNGTKVVIYLKKEQDYFEYSVDGTNFQ
SSNVFYDVPGGLQTAYVKEKNGCGGTTKNFIVLVFPAFFTPNNDTYNDVWEVTGMENYPQ
AQVTIFDRYGKLIAQLTASKMSWDGTFNKTLLPASDYWYALKIDNTQPILRGHFSLKR
>EGALAKHO_03041 tRNA (guanosine(18)-2'-O)-methyltransferase
MRKLENSELDRKSIEDFKKSDKTPLILVLDDIRSLHNIGSVFRTSDAFLVEKIILCGITA
TPPNKEIHKTALGATETVAWEHHENVLEVIQNLKKENVLTLAIEQVESSIFLQDFKVTKN
QKYALVFGNEVYGVAQEAVALCDGCIEIPQLGTKHSLNIAVSAGIVVWDLFQKLNWPSAD
>EGALAKHO_03042 hypothetical protein
MLAVVGITASNAQTTKKAKVAKIEGAGMVFENETIDYGTIAHNADGNRQFVFVNNGTKPL
IITNTQGSCGCTVPTTPKEPIAPGAKGIIGVKYATDRVGAFTKTVTVTSNAEGQPTKVLT
IKGTVLPDPVKS
>EGALAKHO_03043 DNA mismatch repair protein MutS
MPLKYYKFAVINFHLKHYNLAAKEKVVKETPLMKQYNEIKRKYPDACLLFRVGDFYETFG
EDAIRASKILGITLTKRGAGSETETALAGFPHHSINTYLPKLVKAGLRVAICDQLEDPKM
TKTIVKRGVTELVTPGVSLNDEVLQSKSNNFLASVYFANKNIGISFLDVSTGEFLTAQGN
AEYIDKLLQNFNPSEVLVPKNNKGDFKAAFGEDFHSFYLEDWIYKEDYALEILTKHFETV
SLKGFGVEELKEGIIASGAILYYLSETQHNRVQHITAIQRIAEDAYVWMDRFTIRNLELY
HSYNPNAVTLLDVIDRTLSPMGGRLLKRWLALPLKDSNKIKGRHDVVSYLKSNPEVLHNI
QYQIKQISDLERLISKIAAGKVSPREIVYLKESLDAIIPIKTLALQSPQEAVKVIGDSLH
ACDLLREKIKVTLNQDAPVAIAKGNAIAKGISEELDELRAISTSGKEYLEGIEKRESERT
GISSLKISFNNVFGYYIEVRNTHKDKVPTEWIRKQTLVNAERYITEELKEYETKILGAEE
RIHKIETDLFEQLVAWIATYIKPVQMNANLVAQLDCLCSFTQLAVENKYVCPEIDETFEL
DIKNGRHPVIEKQLPVGTPYIANDVYLDRETQQLIMITGPNMSGKSAILRQTALIVLLAQ
MGSFVPADSVRMGIVDKIFTRVGASDNISMGESTFMVEMNETASILNNISDRSLVLLDEI
GRGTSTYDGISIAWAIAEFLHEHPGRAKTLFATHYHELNEMTESLPRIQNYNVAVKELKD
TVLFVRKLVKGGSAHSFGIHVAKMAGMPQTVILKAQKLLKKLEKNHSSDALNGIKSANDE
MQMSFFNLDDPLLEEIKEEILSLDINSITPVEALMKLNEIKRMIVKK
>EGALAKHO_03046 hypothetical protein
MGAFVISRRFNDEYKFVFTSRKGKVIFTSLSYELKFECEEDIEKFKVNIDQARFLKFKGS
GGKYFFKLMLGELHFATSRKYTTELLLQKGIKEIVTYASKSEILDFSSNDMIFEDEEVVE
DEME
>EGALAKHO_03047 hypothetical protein
MKKVFLSLAVVAVLTVVSCKKADAAAEPAVDSTAVAVDSAAAVVDSAAATVDSAAAKVDS
AAAKVEEVKK
>EGALAKHO_03048 3-deoxy-D-manno-octulosonic acid transferase
MLFLYNLVVSIAGFFLKIVALFSPKIKLFIDGRKNVFAILEEKIKPTDKTIWFHSASLGE
YEQGLPVIEKIKEKYPSHKIIITFFSPSGYEVRKNNTVADATIYLPLDTKSNAKKFLKLA
HPELVFFIKYEFWLNYLKELEKAKTPTYLISGIFRDNQMFFKWYGGFYRKALKAFTYFFV
QNEKSKEKIEAIGFKNVIVSGDTRFDRVAAILERDNTVDFIEQFKNNTPTIVIGSSWPKD
EALLVEYINQAPSTVKFIIAPHNIKQDQIINLKSQITKPTVLFSEKDNKDLSTYDVFIID
TVGLLTKIYSYGTIAYVGGGFGNPGIHNILEPATFGIPILIGPNYANFAEAVKLVKIGGC
IVISDATELKQTFDRLLLDEKYLKEKSQICKSYIQDNKGATESIMKIVL
>EGALAKHO_03049 UDP-2-acetamido-2-deoxy-3-oxo-D-glucuronate aminotransferase
MVDLKSQYEKIKSTVDASIQEVLDTNTYINGPLVHQFQKNLEDYLGAKHVIPCANGTDAL
QIAMMGLDLKPGDEVITADFTFAATVEVIALLQLTPVLVDVDVTNMNIDIEAIKKAITPK
TKAIVPVHLFGRAANMDAIMEIAAEHNLYVIEDNAQAIGADYISKSGAKSKVGVIGHVAA
TSFFPSKNLGCYGDGGAIFTNDDKLAHIIRGIVNHGMYERYHHDVVGVNSRLDSIQAGVL
NAKLPLLDEYNAARRLAASKYNAALSGNAHIITPEFDANENDHVFHQYVLRIVDADRNAL
MQHLLDKGIPCAIYYPIPLHSQKAYVDTRYKEEQFPVTNQLVKEVIALPMHTELDDEQIK
FITDSVLEFLNQ
>EGALAKHO_03050 hypothetical protein
MKKVGVLILMILIQVSGFAQKSNAKEETAVGNQVEILRKAMIDADGVKLKSLTSEKLNYV
HSNGVFQNQAEFIDGIVSGKSDFVTIEFQDQTITIQNDVAIVRHVLAAHTKDGGVDKDIK
IGIMLVWQKQKNNWILIARQAYKLTT
>EGALAKHO_03051 UDP-glucose 4-epimerase
MKVLVTGGLGFIGSHTVVELQNEGFEVVIIDNLSNSSEDVLKGITNITGKTPLFEKLDLR
EKASVQDFFKKHSDVTGVIHFAASKAVGESVENPLLYYENNISTLVYLLQELQQKPEASF
IFSSSCTVYGQAEKMPITEDAPVQEAMSPYGNTKQIGEEIITDTTKVTNINAILLRYFNP
VGAHSSNQIGELPLGVPQNLVPFITQTGVGLRKELSVFGDDYPTPDGTAVRDYIHVVDLA
KAHVIALQRLLNKKNLQKVETFNLGTGTGSSVLEVIHSFEKVSDKKLPYKIMPRREGDIT
EAYANTDKANNILGWKAELSLDEAMASAWKWEQKVRS
>EGALAKHO_03052 hypothetical protein
MTVFVYIRSEKTCLKINYMIQYRFRMVVFLFIMIFFESVWGQNNLVSRDSVLMNSEKFEI
QMNTKSFNELSTISFGDYFVENGSNKIRSESSKPNRWFFATKLTNKHTSGYSFLFKSKSN
EKATVEVSFVRTNFYKKQFEINVSFVIRSSSYNDTSVDQDEADESMLFVGETYNFDADIS
INDAKNDIWHLEIKKEKIGGNDKKSLVNGDRKIEILSINDNKDIPNNRFPAVGYEFYENG
NLLGSLQYDSDDSTGINKSTIWIDKSLSSQMKFILTASMTSIIEYRNFL
>EGALAKHO_03053 hypothetical protein
MESKKENEKNDKVQEPRVEYEIQKPEFKGIDRETFDFDAEFAKGLTPEEFKAEMSKRIKA
YPWKK
>EGALAKHO_03054 hypothetical protein
MEKIIFENDVLEYFDDLVFTLFKEEYFSYAESAQKYTDKVVAFIISGISTFPHKKTPRTI
QYLGSNYIFYKANTRTTWYVFFEKSNQNYLITGIINNYCSEVKEL
>EGALAKHO_03055 Malonyl CoA-acyl carrier protein transacylase
MKAYVFPGQGAQFTGMGKDLYESSALAKELFEKANGILGFRITDIMFEGTAEELKETKVT
QPAVFLHSVILAKTLGEDFKPEMVAGHSLGEFSALVANGTLSFEDGLKLVSQRALAMQKA
CEITPSTMAAVLGLADNIVEEVCASIDGIVVAANYNCPGQLVISGETTAVEKACEAMKAA
GAKRALILPVGGAFHSPMMEPAREELAAAIEATTFSTPICPVYQNVTASAVSDANEIKKN
LIIQLTAPVKWTQSVQQMIADGATLFTEVGPGKVLAGLINKIDKEAVTANA
>EGALAKHO_03056 hypothetical protein
MSNALTHILSNECPVCHKGKVFKDKNIFLTFGLPKMNEYCSHCNYKFQKEPGYFFGAMYV
NYGLTVAQGIATYCIAQLFFDQTFDLRIIPIIAVVITLLTSFNLRFSRLAWIYMFKDYTS
>EGALAKHO_03057 HTH-type transcriptional activator Btr
MKKYPIYSVQNFSCNDVHRDFYVNSFAEHLKSHSFVEEPHRHDSYLMVFFTNGSGLHEVD
FDQFEIKRGSLFVLQPGQMHHWSLSEDIEGFVIIFSQELYNLYFGQKKINEYNFYHSIHN
RPEMVFEENEMLKILPYFDLLIQENNQNNKLQLDKMLNLLDCIHIEISRKYSETYSHQTH
SYNIKINKFESLLEQYFRQEKLPSFYAEKLNITLKHLNRICNEILQKTATEVIMDRVILE
IKRMLIDKQLAVNEVAFAVGYEDYSYFSRFFKKQTGMSPTEFRNTVR
>EGALAKHO_03058 Protein YceI
MATTKWSIDPTHSEIGFKVKHMMFTNVSGKFGTYDATITTDGDNFENADIQFSGDIASID
TANADRDGHLRSGDFFDAENHPKLTFKGSSFKKVNDGEYELTGDLTIKGVSKTVKFSVEF
SGIMTDPWGNTKVGLNIEGKINRKDWGLNWNSALETGGVLVGEEVRLNIELQFAKQA
>EGALAKHO_03059 Quercetin 2,3-dioxygenase
MENIVLHKAETRGNANHGWLNAYHSFSFASWYNPDRIQFGALRVLNDDTIAGGMGFGTHP
HDNMEIITIPLEGDLAHKDSMGNTEIIKNGDIQVMSAGTGVQHSEFNPNADQQTKLLQIW
LFPNKRNVAPRYQQITLDVADRHNKLAQILSPNADDEGVWIHQDAWFNMGNFDAGIATEY
KIKKEGNGVYAFILKGNVTINGQELNTRDAVGISGTDILTIKANTDAEFLLMDIPMNY
>EGALAKHO_03060 hypothetical protein
MKYLFIIVTLLSISLNQKTNKLNGRYNYLIEDNNSYIQRDKITFKDSVFVFDSKYMPKGK
ISYGNVILLENFINTDLIISISKDQITKDTIPFYMHDKQSSAANYLDEVVGKGKLIRIK
>EGALAKHO_03061 HTH-type transcriptional regulator RamB
MDIEKDYIKLIFGLKLKQVRTQKNLSLFGLAKLTNLSKSYLNEIEKGKKYPKTDKILLLC
EHLDVSYDQMVSLKLDNNLAPIGEILKSGILKEIPLELFGIQEADLIDIIANAPAKVNAF
ISTIIEIAQHYNLSRESFFLAALRSYQEAHSNYFEDLEEKVIAFSKSFQINLDSKITIEE
LEAILKEEYDYTITEIAFTDQEALGDLRSIYVPKSKTLLLSTEIDDPQRAFILAKEIAYN
YLKISDRLLTFSWIKFDNFDQVLHNFYASYFAGALLLPRQLVVGKINDFLNNEKPNPEEF
VTLIESFEVSPESFYQRLTNLLPKDFHLKNLFFLRMSHRIGSDVYQIKKELHITNQQEPH
ANETNEHYCRRWVSVKTIDEAIRQNKPHFFDAQISSYVHSGNEYLVFSSATKDPFMQDTI
RSISVGILINPTMKKKFKFIEGKPLVKRIVGVTCETCDVKNCLERAAPPIALEQKKRHDN
TDTVVQQFINQYS
>EGALAKHO_03062 Malate synthase A
MKNQLEITETAMEFLAEKNFSYPSIWTEEAIVFISELHRKFEAQRKLLLLQRDQKQVALN
LGIMPSFPSETKTVRESNWTAGETPKDLLDRRVEITGPVDRKMIINALNSGAKTFMADFE
DSTSPTWQNLMEGQMNLIDAVNKTISYTDSVKNKSYQLNEKIATLIVRPRGLHLPEKHLL
IDGKEVSGSLVDFGLYVFHNHKKLLENNSGPYFYIPKLEHYLEARWWNTVIDFTENYLKL
KRGTIKVTVLIETITASFQLDEIIYELKEHIVGLNCGRWDYIFSYIKKFGKNPKFIVPDR
DQVNMTSPFMNAYSNLVIQRCHKRGIHAIGGMAAQIPIKNNEEANALAFAKVKTDKEREV
RNGHDGTWVAHPDLVSLAKAVFDAGMPTPNQIHIKREHRKITEEDLLEPPIGIITENGVR
KNINVGVLYLASWLNGQGAAALHNLMEDAATAEISRSQLWQWLQHKVTLDNDKKLDLAYY
HELALDEYQKIKSELGEENYEKRQFPLAEKVLERLVVNTDFVDFLTIPCYKYL
>EGALAKHO_03063 Isocitrate lyase
MKTTEDRIQELINDWITNPRWKGVERPYTATEVVTLQGSYQIEHSIAKMGAQKLWRKLKS
QDYVAGLGALTGNQAIQEVDAGLEAIYLSGWQVAADANLAGEMYPDQSLYPVNSVPMVVK
KINSALLRADQIQVVNEVEDKKDYLVPIVADAEAGFGGNLNAFELMKSMIEAGASGVHFE
DQLSSAKKCGHLGGKVLVPTQEAINKLIAARLAADVMGVPTLIVARTDADAANLLTSDAD
PRDAKFITGEKTNEGFFYVNSGIEQGIARGLSYAPYADLIWMETSNPDLVYAKKFADAMR
KEFPDKMLAYNCSPSFNWAAKLSVAEMETFREDLAAMGYKFQFITLAGFHALNTSMFELS
KAYKERGMAGYSELQEREFALQKNGFRAVKHQAFVGTSYFDAVQNTVMIGKSTITAMEHS
TEVEQF
>EGALAKHO_03064 hypothetical protein
MELILENIAKHVSLTPEEQTHFLSKLETNTYKTKTILLNAGEVCKHSYFVNSGILRSFNI
NDNIVEHVLSFACQGWWMSDMYSFFSQKPGQLFIEVLEDAEVVSLSKENQEQLYHDIPKL
ERFFRILIENSLVANQQRLMDNLSLPAEERFEKFTAKYGTLVHKVPQKQIASFIGVTPEF
FSKMKARLLKK
>EGALAKHO_03065 hypothetical protein
MKKALFVLFLLIGIATQAQDKKTTEKPQIVETACGECQFGMKGNGCDLAVRIDGKAYFVD
GTTIDEHGDAHAKDGFCNAIRKASVTGKVENNRFKATSFTLIKEK
>EGALAKHO_03066 Formate-dependent phosphoribosylglycinamide formyltransferase
MKILLLGSGELGKEFVIAAQRIGQTIIAVDSYENAPAMQVAHGFEVINMLDGEALDRIVA
KHKPDFIVPEIEAIRTERFYDYEKQGITVVPSAKAANFTMNRKAIRDLAAKELGLKTAKY
KYATSAGELQKAVQEVGIPCVVKPLMSSSGKGQSTIKTESDIEKAWQYAVAGSRGDVIEV
IVEAFVDFNSEITLLTITQNNNPTLFCAPIGHRQERGDYQESWQPALVSEKDLYEAQDMA
EKITEALGGAGLFGVEFFLTNEGVYFSELSPRPHDTGMVTLAGTQNFNEFELHLRAILSL
PIFEITLEKAGASAVILASEDSANPTFTGIEKVAALPKTDFRIFGKPTSRPYRRMGVVLS
HDSLATAIEEIVERAKTTSKLITVNS
>EGALAKHO_03067 hypothetical protein
MYQKKRIVLDSLTYMNTDGNDNPRVDGYSKDLDNYKTIILLSKARNEESEIDSLGITHIY
VWHRKGTDFAYPAKKHEKAIPFKQIFYKKAKVPFFWLLAVIITFITFKLITRNKLFKGFD
H
>EGALAKHO_03068 hypothetical protein
METKNSIQKYSIIAGLFVCAFFPLMIFSDSYFIFQCIQICNFGVFWNPLFWGILFPLFIV
FLFWNTSKKLTFSLNQITYFKACSQFSFGVSSNIIIALFTIYIIGLFANGISSVFNVQIP
YQILFSLLMILFLSFTLMILTFISSLIIVKLNQKNL
>EGALAKHO_03069 putative protease YdcP
MKKKIEILAPAKDLIGGMAAINSGADAVYIGAPQFGARSNANNSIEDVAALVQYAHLFNA
QVFVVMNTILYDNELETCRSMIWELYDIGVDALIIQDMAIMEMDLPPIVLHASTQANNRD
ADKIKFLKDAGIKRVVLARELNLHQIKTIYDEADVELEFFVTGALCVSFSGNCYMSVANG
ERSANRGSCAQNCRLPYNLIDGNGETLIKNSHLLSIKDLDISEQIPNLIEAGIVSFKIEG
RLKDVVYVKNNVSYLRQKLDSYLEGEGSDKYMKASSGTCTYTFDSSLNRTFNRGYTDYFV
NERHSSIGSWESPKSKGQYIGKLIRTVGNAYEIENGEFLNNGDGLCFINENNEADGIYVN
KAENGKIYPNVLKEIKDGTFIYRNNDAAFIKIVEREDSAVRKISTTLLLTENETGFELIA
TDEDGNVSIVNLEHSKEQTKTGESIEENIKTQLAKTGFTPYTANEINIMFSQNWFLPISK
INEMRRTVYDQLTEIRLANYKREEHQIVKTSHPYPETKLDFMYNVSNKTARKFYERHGVT
EIEKAFELQWDPGKSRVMTTKYCIKYELKKCPIHQKDIVGVKVKEPLVLKQGELEYKLKF
NCKPCEMEIWEKDAEFEIEEDHFH
>EGALAKHO_03070 hypothetical protein
MNHLHMKQLFFTIIIFSTIKFYSQSTLTSLNFGKKNDFHSTKLVSETIRNTTFYNSNNTI
EQTKEITSYNAQNNVLAELRYDGENNLKQRLIRMYDSTGTKCTMRKFENWHRYVGHTIEI
ASYGFDSNGYLISIIDKDQNGKIFRKTEIINNEKGDPIEMKGFIGDEIVGIEKSKYNYAE
NEVIIEYYNKNNNFISSQTSNIDSSKRDPDDIINEYGDVIKSNTYEMEFKYDKFGNWIKK
KYSIIKNGILIKKSETSRIIKYIN
>EGALAKHO_03071 hypothetical protein
MIHTEETTTEAVNTLEGLISILEDGKLGYTNAAEHVEDLIIKADFLEYARERALFIVELQ
DQINKLGKSTDTSGGGPLGALHRTWIDIKSSFTGGDTEAIINACITGEEAAVEKFKMALE
KNELDGSQIAIVSKQLNSIQSTLDKIKTKRSS
>EGALAKHO_03072 Aspartate aminotransferase
MNHILSDRINNLATSQTLAMAALARELKAQGKDIISLSLGEPDFNTPDFIKEAVKKAVDE
NYSTYSPVEGYLELREAISRKFKRDNGLEYKPTQIVVSTGAKQSLYNIAQVMLNDGDEVI
LPAPYWVSYFEIVKLSGGVPVEVPTSVETDFKITPEQLEAAITPKTKMMWFSSPCNPSGS
VYSREELTALAKVLEKHPNIYVVADEIYEHINFSGTFCSIGSIPGMLEKTITVNGVAKAF
AMTGYRIGYIGAPEFIAKACTKIQGQVTSGANSVAQRATITAVDADPSVLNHMVQAFHTR
RDLVVGLLKEIPGVKINVPEGAFYVFPDVSSFFGKTLRGTEIKDANDVSMYLLAEANVAT
VTGDAFGNPNCIRFSYATSDDILKEALRRIKEALTV
>EGALAKHO_03073 NADPH-dependent stearoyl-CoA 9-desaturase
MNNIAPTFAKQDNLKFFRTLNSRVNNYFKENNIQKTGNWKLHLKAVILFAVFLTPYFLIL
TLNMPFWAQLLLNILMGVGMAGIGMNVMHDGNHGSYSSKSWINKIMGGSIYILAGNVHNW
QVQHNVLHHTYTNIHGHDEDLDAGRIIRFTQNAEWHRFHKFQHYYSFFLYGLLTFNWALT
TDFKQMKNYLKRKLSYGAPQNPTKLWTVLVITKIIYVLIWIALPMILGVTWWKVVIGFFV
MHYTAGLILSIVFQLAHVVEETSNPVPNEEGEIENTWAIHQLYTTANFAPKNKIINWFTG
GLNHQIEHHIFPNISHIHYGKIAEIVKQTAIECNLPYHEFKTMRGAVIAHYKHLKDLGMK
PELA
>EGALAKHO_03074 Ribosomal RNA small subunit methyltransferase G
MDEILKYFPDLTDLQIEQFQKLDFLYHDWNEKINVISRKDIDALYTKHILHSLGIAKIMK
FEPGATVLDVGTGGGFPGIPLAILFPETRFYLIDVIAKKIKVVQGVVDALELKNVKAEQK
RAELVKGDFDFIVSRAVTNMPDFVSWIKDKIKKQHKHTLKNGILYLKGGDLTEELAAFPK
ATLYDLADIFEDEFFETKKVVHLPLKFTV
>EGALAKHO_03075 hypothetical protein
MKSLNTPEVILKSKSIGAPIDFKWNKKKIEQFLDPLELNKDLENALNHINHKATVGLSAA
LLEWIYCRFTGYSKSINDIQQRIEALWCSIANRENSQPLDFDIDLNVPASGSVNGPIWTA
LMNIRMVDVKYRKGSYFIQDEIIGLVLLARHITPKKKVFDKWFNNVIVELNYHYPCTYSY
TNLDESDEAIYDSSNEPLICREFFFDPEFEYSVEATENALHNFISNLNYKANPFLHLSQE
AS
>EGALAKHO_03076 Carbonic anhydrase 2
MKNTFGKIFTLLIIFSVNAFCQNNDSKKADKNDNGVSVSKMIPLKEKVLTAEEQKALTPD
KVIQSLNEGNKRYMKNDLTLRDHSALVRDASQGQYPKAVIISCLDSRVPVGDVFDKGIGD
LFVGRVAGNFVNEDLLGSIEYGCKVSGAKLVLVLGHESCGAIKSAIDDVKLGNITAMLSK
IKPAIAKSQDFKGEKKSKNPEFVEYVAKNNVLQTIETIRAQSPILKEMEDKGEIKIIGGY
YDLHSGEVIFL
>EGALAKHO_03077 Sensory transduction protein LytR
MKYKCIIVDDEPLARELIASHLTHFESFQLIDSFENALKAYTFLEANTVDLIFLDIEMPL
LKGNDFLKKLKNPPKVIFTTAYREYAIEGYELNVIDYLLKPITFDRFFVSIEKFKQMQSS
KKEISFVTENHVFVSSGSKNIKLIFDEILYIESLKDYITIHLESGKSHHIKQNISVFEKT
LNSNFVRVHRSFIIQTKKLTAYSKNEIEINAIEIPIGTSYKENWLNHLETIILK
>EGALAKHO_03078 Sensor histidine kinase YpdA
MNFIKKLDLKRIGLHFLYWFFFLFLYVTSKSENDSYYDFTFIYTLKISAQAAVAYVLIYW
IIPNTLNKKRYLLFIVLALGWLYFLYALLMTLKFYYLEPKFPAFFADWLGHKMTVPERLI
SGKLILREFSFITYPVIIFGFISFNRKQQRLLKLEEEKKSMELKVLKNQLNPHFLFNTLN
NLYTLTLKKDDKAPEVIAKLSEILDFVLYRCNEDYVSIEKEIALIENYIALEKLRYSENR
LDISFNKDIQENCKISPLIILTFIENAFKHGVINETEKAVIRLNLESNKQQIIFCIENTK
PKNKFSKISDLSKIGLLNVQKQLDLLYPKKHQLEIEETQTKYTVKLYLTL
>EGALAKHO_03079 hypothetical protein
MKTTIKNAICILILMNTINLFSQKRKQDIVYEKPSRFIESPLAVGKAQTYQVLDKNLNSS
FINVKPISGEKDGNNILICQLIKLMLLEKKPLKIITSLDDVKLKILLYPKDEVLLVILTD
LKGSHSDDYLQEIANLYNGENK
>EGALAKHO_03080 1-pyrroline-5-carboxylate dehydrogenase
MLKGFFHVPKAVNEPVKGYAPNSPEKAAVQAAYTTMWNSKIDVPLYIGSEEIKTGNTKTI
SAPHDHKHIVGTYHLAEKQHIEKAIANALESRKAWANMAWEQRAAIFLKAAELIAGPYRA
RINAATMIGQSKNIHQAEIDASCELIDFLRYNVEFMTQIYGDQPKSDSTTWNRLEYRPLE
GFVYAITPFNFTAIAANLPASAAMMGNVVVWKPSDSQVFSAKIIIDVFKEAGVPDGVINV
VFGDALMITDTVLASRDFAGIHFTGSTHVFKDIWAKIGANINNYKTYPRIVGETGGKDFI
IAHPSANVKQVATGITRGAFEFQGQKCSAASRAYIPQSLWPAVKEQLIADAKSMKMGSPE
DFGNFITAVIHEGSFDKLAGFIDQAKKDADAEIIIGGNYDKSVGYFIEPTVIVTTNPKYT
TMETELFGPVITIYVYEDAKWEDTLELVDTTSEYALTGAVFSQDRYAIEVATTKLQNAAG
NFYINDKPTGAVVGMQPFGGARASGTNDKAGSALNLLRWASPRTIKETFVTPEDYRYPFL
G
>EGALAKHO_03081 hypothetical protein
MKIPLLAFNDKGIYCQQADVYLDPWKPVKNAIITHGHADHSRWGNQNYITHHTNIPIIRH
RLGEINVTGKEWGETFVINNVKFSLHPAGHIIGSSQIRVEHKGEVWVFTGDYKTEDDGIS
VPYEVVKCDTFITECTFGLPAFNWTPQAEVITEINNWWAENKAEGKTSILFGYSLGKAQR
LLKYLDTDIGTIYTHGAIENMTNVLRPMVDFPPTTLVTRETKKEDLLGNIVLAPPSAHGS
IWIRKMTPFVTGSASGWMAFRGARRRRAIDKGFVLSDHCDWFSLLDSIKATGAERIICTH
GYTDIFSKYLRELGYDARTEKAQYEGETAEMEKEVETEKEIQE
>EGALAKHO_03082 DNA ligase B
MKNFAQLIKTLDSSNKTNVKVDALTTYFKNASQEDKVWTIAILSHRRPPRPVNTTLLRIW
ANELANIPLWLFEESYHIVGDLAETIALIIPTTKEHSDKSLTEYLQEIIALKKKSDSEKK
EYLHENWLALNYYERFVFTKLITGSLRIGVSQKLMTRALSKAEDVDEDALAYKLMGNWDP
NTITFQELILDEKSSDYLSKPYPFYLAYPIEGEVENLGNPEDWSVEHKWDGIRSQTIIRE
SEIYVWSRGEELVTDKYPEFHSFVGLIPNGTVIDAEILAFPEGEIGIFNDLQTRIGRKSI
SASLLEKVPVILKAYDILEWEGQDIRNLPYLERRLLLEQLYDSIKDKTKSFQLSKRVLLH
SWEDVAAERMRAREMKSEGLMIKRNDSTYQVGRKKGDWWKWKIEPLVIDAVLTYAMRGHG
RRSNLFTDYTFALWQTNEKEEKELVTFAKAYSGLTDAEFRKVDDFIKKNTLERFGPVRSV
TPKLVFEIGFEGIALSKRHKSGVATRFPRILRWRQDKKIEDANSIEDLKSMIS
>EGALAKHO_03083 DEAD-box ATP-dependent RNA helicase CshB
MNREELYTIAENWFQDQGWKSFPFQTQTWTAFLQGKNGLLNAPTGSGKTYALWFPIVLDY
IKTNPAFKTKHKPGLKAIWITPLRALSVEIKQAAERIITDLDLPLTVGIRSGDTSQSERT
KQSKKMPDLLITTPESLQLLLASKEFAKTFANCSAIVVDEWHELLGTKRGVQMELALSRL
KTVAPKMKIWGISATIGNLELAQQVLLGVNSEAYENSVLIKAHINKKIKIESILPEKMES
YPWRGHMGLHLIDEVAKIVRKSKTTLIFTNVRSACEMWFQALLEKYPEFAGDMAMHHGSI
SRETRLWVENAIRDEELKVVVCTSSLDLGVDFAPVETIIQVGGPKGVARFLQRAGRSGHQ
PGKESVIYFLATHAMELIEASALKKAVAKTVVEDRMPYLNSWDVLVQYLNTLAVSDGFFP
DEIFEEVRQTFCFQNITKENWNWVLNFITNGSQSLQAYDEFKKVEIEEDGRFKINSRLIA
MHHRMQIGTIVGDAALNVKYLSGGYIGSIEEWFASKLQPGDVFTFAGKRLELFRVKNMQV
LVRKADPKKASRVVSWMGGRMTLSAQMSELLREELYAANTENLSPELKALKPLFERQRKE
SIVPNDDEFLIETFKTREGFHAIFYPFEGRYVHEALASLISYRISLLSPITFSLAYNDYG
FELLSDQEIDMQAVFDNNLFTTEYVHHDLQKSLNSTEMARRKFRDIAVIAGLVFTGMPGK
PIKTRHLQSGSQLLFEVFRDHEPDNLLLQQAFIETFEHQLEEGRLIQAMERINSQNIVWK
QCNKPTPFSFPIITDRLREKLSSETLQERIKKMTASYMK
>EGALAKHO_03084 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MKITINNQNFVLHQSGAAFWEEEKTLFISDLHLGKIGHFRKHGMAIPEKAILENFAKLNT
VLELFDSETIIFLGDLFHSKINNEWNFFSEWTKTHSQKIILIEGNHDIISKQYYLDLNIE
VYSELIIHDFLLTHHPSETEKLFNFCGHIHPGIKLKGMGRQFLSLSCFFRKPNQMIFPSF
GEFTGNFYLIPEENDQIYAITKEEVIEIKR
>EGALAKHO_03085 Protein ApaG
MVSQITRGIKISVLTSFEGTYFKNYKIHFAFSYVVTIENHSKDSVQLTSRHWEIFDSLND
LEVVDGEGVIGKKPVLKPGENHTYSSGCLLSSPYGAMKGHFNMINFTTTKTFKVIVPTFR
MCAPFALN
>EGALAKHO_03086 hypothetical protein
MSKFLFQSLLLLFIFTSAKAQEVQTEVTPPYNIKTVSFIQNGSNVVPIFELGSVFELQFD
DLFGNEANYYFDVIHCDYNWVPTDIPKTDYVRGFDNQRITDYSNSFNTLQAFSHYRLSFP
NQFTTQLRISGNYMLRVLNEEREVVFSRKFILFEDHSTVGAVVKRSRNLNNIDYKQNLEF
TVLSNDIVFQTPLQNVKVLLLQNGDFNTSIKNIAPQYTIGNQMVYKYDKETQFWAGNEFL
YFENKDIRAASNNVAKVGSANDIYSSFLYTNQARANQIYTLYEDVDGNFVVKNINASNNE
IEADYAWVYFSLSAPAFQLNKDIYIVGMFNNYSLSPEYKMDYNEKKGIYEKAVMIKQGFT
NFEYRVADKKGIIDYENAIDGNFYQTENEYTILVYYKHSSDRYERVIGKGNANSINITN
>EGALAKHO_03087 hypothetical protein
MVTSQSFQFCFDISLEKTLNTYIPIAYIVDNTEEIKYLNKKASADVLESFGIFENLDSNT
KKVLAVCESLKPDFIFKKFSTKVKSAKTITDLQKDSKIDFAIRQHLQLNLNSFYNLVVKE
QFPLSINMGLEKDFFRSRVTIDPLHFEPQIQFDKHSDGITYTLSLKENKTSFLPMNSTVD
ILLDEPGWLIIDKKLGQLKDLNSKKLLPFLKKKSIEIPSKLVDNYFKNFIPEIAKKIDIQ
ATGFEIEHRNKIISSTIQPVYDFFKNCYYLNVYFDYNGYSFDSSKTKKTHSFVDFSLINA
PKIIQFKRSADEVLYTDKLLEIGLIKIKNELFGLNSEAEINDPYANIQFVIDHKEELESL
GFIIQNLKLESKEIITDSHTVFASKEETKEDWFDIKIIISVGVFTINFSEIIPNIKSKER
LFLLPDGNYFLIPLEWLSKYSSLAKLAQTENETLLLRKSNFTALDTIPEIKDDVIQKAEY
TASDLLKATLRPYQIEGAKWLLGHFNSNLGACLADDMGLGKTLQTLAVLVAVQEQLGFTT
KTSNFDLFANETTIEREPLKALIVLPSSLVFNWYNEASKFTPHFSKMQYVGNDRKLLANR
LASTDLIFTSYSIVHRDISILEKYNFRYLILDESQYIKNKNSKIFKAINKISTAHKIALS
GTPIENSLDDLWSQMQFINPDILGTYNFFAENFKIPIEKKQDENSLAELKNLVQPYILRR
TKEQVLKDLPELTEQIYYCDMDPEQEKLYEQEKSKARNFLLKTDGTSPDKISIINTLMKL
RQLSNHPKMVDQDSEIDSGKYIAVTNYLENLVKGKQKTIIFSSFVTNLNFYTDWCKDNKI
TFCEITGETSASKREQQVKQFQEKEEPLLFFISLKAGGVGLNITKASYVLFLDPWWNPFA
EKQGVGRAHRIGQLNKVNVIRFISKNTVEEKIIKLQENKKLLSDSLLEESYINDEIEVNL
EYILGS
>EGALAKHO_03088 Demethylrebeccamycin-D-glucose O-methyltransferase
MKKLFKLVLNTIPRPLLIRLSYVARPILALSLKGDKFTDPIDGKSFRSFLPYGYGKQRNN
VLSPSTLSLERHRLLWLYLNDQTDFFTAPKKVLHFAPEQAFYKLFRKQKNLDYTTTDLFS
PLADVKADICNLPFKDNEYDVILCNHVLEHIPDDTKAMQELFRVLKPGGMAVLQIPQDLS
RAVTFADDSITDQKERAKIFGQYDHVRIYGRDYFDKLRSIGFIVIEEDYTNKMTQEMVEK
YCLAKGEIIPLCFKPENQN
>EGALAKHO_03089 hypothetical protein
MLASLLKDKKFYQLFIYKDIKLDHGYRLDLLIENTIVIELKTVEAFTDVHFAQILTYLKL
GNYPLGLLINFDSKILKNNIKRFINTL
>EGALAKHO_03090 hypothetical protein
MFEENNESRNRLDAITYKIIGLAIEVHKQLGPGLLESAYQECLYYEIANAGFTVERQKVL
PIIYL
>EGALAKHO_03091 Methionine aminopeptidase 1
MRTENLKNMIIQKSREEIELMRESALIVSKTLGMIASEIKEGVTTLYLDKLAEEFIRDHG
AVPSFLGLYDFPNSLCMSPNAQVVHGIPNNTPLKSGDVISVDCGAFKNGYHGDHAYSFEI
GEVAPEVKKLLQVTKESLYVGIREFKAGNRVEDVGNAIQKYTESHGYGVVRELVGHGLGQ
KMHEEPEMPNYGKRGRGKLFVEGMVVAIEPMINMGTKNIKQLKDGWTILTADGKPSAHFE
HDVALIDGKPELLSTFQYIYKALGIESNEEDEFRKVPLVL
>EGALAKHO_03092 hypothetical protein
MYLIEVPPRIHEFSLYALRLNIKFMKLNLKNISLLLIREIRGKKIILKLYFCELKI
>EGALAKHO_03093 hypothetical protein
METSTDQDIVKVKALKKMKANALLLLGVAVLLFIIAIYFKIPMLQAFSEAAMVGGIADWF
AVVALFKHPLGIPIWHTAIIPTKKNEIGENLGNFVSEEFLNREKLEIKLEEFNFATKASD
WLSQEENANKIADAVAVNIIPGILRTIKDEDVKRFIQVQFTEKLEAINFGDWVALALEPL
QKGNVKDQLLTNLLEVMSAELSNNKDLIRKKVKASTPFLSFGLADKSISEGVFNGLQEFL
DEAKKPESEIRIKIDEYIADFLEKVKNSEEMRIKINNLILGFAGKKEVQDYINGIWDEIK
SSISNDLEKGDESSIKNSISSLIQGFGNGIKEDPVMIDKINNFIKNDLLSVLLNNKKVIG
DLISSTVKSWDGKEVSEKLELEIGKDLQYIRINGTLVGGLIGLVIYGVEWTYHYFVM
>EGALAKHO_03094 2,3-bisphosphoglycerate-independent phosphoglycerate mutase
MILDGWGKSPDPKVSAIDNANVPFINSLYKNYPSAQLRTDGLNVGLPEGQMGNSEVGHMN
LGAGRIVYQDLAKINLAVAHKTLAKEQVLIDAFTYAKENNKKVHFLGLVSDGGVHSHTSH
LRGLIDASQEYGLDQVYVHAFTDGRDVDPKSGAKYIHDLEEHIKDTPVKIASIIGRYYAM
DRDKRWERVKLAYDLVVNGTGTPSKNAVASVLDSYAHDVTDEFIAPIVMVDEQEKPLATI
VEGDVVIFFNFRTDRGRELTEALSQHDFHEQNMHKLNLYYVTLTNYDETYQNVKVVYNKD
NITETLGEVLEKAGKKQIRIAETEKYPHVTFFFSGGRETPFEGESRILRNSPKVATYDLQ
PEMSAYELTAALVPELNKGEVDFVCLNFANGDMVGHTGIMAAAIKACEAVDACVKEVIEA
ALANDYTTIVIADHGNCETMINPDGSPNTAHTTNPVPIILVDKNLKNIQNGVLGDIAPTI
LELMGVPQPNAMTCHSLL
>EGALAKHO_03095 hypothetical protein
MKKVVFLYFLLFVSFGYSQKKALQAQATSQSITIDGKLDETAWENVPIASDFIMFEPDNG
KPIPESQKTEIKVIYNNDAIYIGAIMYDNEPNKILKEISQRDNFGTADIFGVFINGFNDG
QQNFEFFVSAADVQGDCIMTDAIGEDYSWDAVWISKARITDKGWIVEIKIPYAALRFSAE
NKQTWGINFFREVKRDRRKYTWNLINTKIGTFTQQNGELTGIENIKPPTRLFFMPYASYY
LNAADGQKTYGTLKGGMDIKYGINDAFTLDAILVPDFGQTKYDDQILNLSPFEQQFNENR
AFFTEGTDLFNKGNIFYSRRIGGAPSIDPELNNNEEVIETVQNVNLINALKVSGRTKNGL
GIGILNAVTEKTFATVKDTISGDTRKIIVEPLTNYNVLVLDQRFRKNSSVTFINTNVTRN
GHYRDANVTGLAWDLNTKANTYNLSGNVKYSTINLDEDKTGVFSTIGFAETTGKYRYSIG
TDFVTKGYDPNDLGINFYTNYYNFYGNANYRILNPTKLFNSFRVNYNMYAEFNKESGKVQ
DNSINANVNLSTVKNNYYGGGITVYPLVSYDYYEPRADNRYVILPRRMEAWGSISTNYNH
KFALDLNPSISIADESGRMAYGFDVSPRYRFSDKLLMVYTFSYFRKNNNKGYIDSVDDDD
NESTPKTIVFANRNVITYSNTITGKYALNSAMTLNLALRQYWSYAENKDILELQQDGTLT
PYPQYTDNKNSSFYSWNADLSYSWWFAPGSQVSVLYRNSASNFERIIDKQFRDNVTALLN
NDALKHVFSVSVKYFIDYNAVKNKLRKRA
>EGALAKHO_03096 hypothetical protein
MIYKIYPLFVFLLLSFGKDSKSTLETKKEATRSIAKVEKLTVEAKIEGVYHALNSNNYQL
PELKTFSEALKGFYLLKEKGVVQKDILTLIDFSLSSNTKRLWVIDLATNTILFQSLVAHG
RNTGEEYASAFSNNNSSNKSSLGFYATGEIYQGKHGVSLRLDGLENGVNDNARERGVVMH
AADYVSESFIRNNKRLGRSQGCPAIPFELRDKIIETIKNKSCLYIYHPSRSFAMEERLIS
>EGALAKHO_03097 hypothetical protein
MRKLYFLIIICIFISCKKEEPKVIPVKKTTPPPSIILTDERKVSIDTTLIGVFKSKTLQE
FYNSSNNQTVWGNLKKRTYVLSQIKNCEKLGLNPENYKHATLEKYEKRISKLNDKELATY
DILLTYNFELYLNHLHKGKLDPKKLYTDWDLTEKKLDVNSVLIKAFNKNKLDSIVENIQP
KSETYRELLKALEIINTFPEDDIGMIAMDSLTKKIALNDNNPALINIKKRLLFWGDMSGK
DSLNSNYNQKTFEAVKRFQERHGLASDGVIGQGTISALNYSKEKRKQQIIANLERWRWYN
NDFAENYFIINIPNYSLNVVENQDTILSRNIVVGTSKRKTPIITSVLKTVVFNPTWTVPP
TILKEDVVPAMKRNRNYLKNKNITIYDTTGNEVDPNNWNENKPGNYKYVQSPGYNNSLGL
MKILFPNHHSVYLHDTNHRNYFGRNNRSLSSGCVRIENPLELAEHILNDSISTNWPKEKI
DSIIETKITTNIRITKKYALYQWYWTAWSKKNQLIFRADIYNLDSDLYAKLRN
>EGALAKHO_03098 hypothetical protein
MIQIKEIPSKETYIVRQPVLRKGKPIDSCIFEGDDLQTTHHFGIFDNKNLTGIISLFSKT
NPIFAEQNQAQIRGMAVLETHQKKGFGETLVKHFETYCNENKVDLIWFNARTAAVGFYKK
MEYQTLGGPFDIKNVGEHYLMYKKL
>EGALAKHO_03101 Peptidase E
MKSIIIASTSTLHEGSYLAYLLPTLKEHFKNCKSILFIPFARPGGISHNDYTEKVAEAFA
TINISVKGIHEFENPADAIKIAEGIFTGGGNTFLLVTQLYKHNIMQLLSETVKNGTPYLG
TSAGSNICGLSMQTTNDMPIIYPPSFQTLGLIPFNLNPHYLDPDLQSKHMGETRETRIKE
FHAFNSIPVLGLREGSWLEVKGEKISLKGSLTARLFKQNQNPTELETESDLSNLK
>EGALAKHO_03102 hypothetical protein
MGWSQNQDRSLINGKISSNTNDLEGVYVVNAQTEVMVITNAEGAFSIMAKPGDTLVFSSI
QFKENRILVTNENFTDLNFTVKLSMVMHQLQEVIVKRYDNINAIALGIVPSDQKTYTESE
RKLRTATALDATASVSGMAGGSISADPFLNFLSGRTKMLKKELAVEKKEFFMKLLENMFS
LDHFINRLKIPNEYVKGFEYYAVDNDKFTVILNSKNKTSIEFLLAELAVKYKEILAGENK
>EGALAKHO_03103 hypothetical protein
MKTNNTLLILFLLIAQISFGQTSGAKEILGQVFEQSSSVEGVNIINNNTQITAVTDENGM
FSIVVKEGDVLVFSSVNLEPLKHRITPEDLTSSTIQVKMTAKEIELKEVVVNGNAGLTAE
NLGIVPHGQKTYTPAERKLYTAKSTSVDKIINGISGRTAMLKKEVKVEKKEMLFRKLEYL
FDDNYYTERLRISLEDIKGFQLYCVEDSEFAVSLNSKNKTMSMFLITELARKYLKILENE
K
>EGALAKHO_03104 hypothetical protein
MKNSLRILVLCLLCQISFGQNSTRKPLHGQVTNTSLAIESGYVMNINANVRTFIGSGGLF
DIMAKPKDTLLFTGMAFQSRKIVLTEKDCSQILFTVSLDLVNNQLKEVLVHKDFQDKTLG
SGSQKIVDMQFEDDKQSTAKNTVMYSDQTIKYGTDFVRIFKDVKKLLRKNDEVEEEVISD
IAFTAYARDNFTPDFFHKTLNLKDDEIELFLMYCSNDPESKRYLKPDDKFQLIDFMINKN
KDFKNITVSKNEK
>EGALAKHO_03105 hypothetical protein
MKNKLIYPLIGVLFLSLSSFAFHKFYMGVYQVNYAAEKKMIQITSRIFIDDLNNGMEKKY
HKKTFIGTEKETPEDLELFKKYLSENFTIKVNGQSKPITFLSKEVEAGDVLVCYSRIKDV
DKFKTLEISNTILVDWNAEQQNITHISAYGTKKSVLFTESSRKEVLKY
>EGALAKHO_03106 hypothetical protein
MKKLSLLLIFPALLMAQEKNTTVAPKQQGKYDTNKFSQMYDLLATPNMFRTASGAPGPAY
YQQQADYKIDIELDDKNSKITGSEVITYSNNSPDSLEYLWIQLDQNQAKANTQAPLAESE
KINQVLPLDGFSSKYLKKDLERGFNIEQVKDAKGNPMSYTINETMMRINLATPLKAGEKI
SLAIKWWYNINNYRKEGGRSGYELFEKDGNKLYVIAQFYPRMAVYNDVEGWQNMQFWGSG
EFALPFGNFDVNITVPADHVIDATGELTNRAEVFTAEQVKRYEQAQKSFDKPVVIVTQAE
AEAAEKGFSEKKKTWKFSAKNVRDFGIASSRKFIYDAMAVKLGGKIVMAESVYPKEANPL
WGETSTMTVAHTLKSYSSHTFDYPYPKAVSVSAEDQGMEYPMICWNFGRPDENGVTSKEV
KNGMIGVVIHEVGHTFFPMIVNSDERQWTWMDEGLNSFLEYLAEQELDPNFPSRRGPAKN
IVPYMSGDQKFLEPIMSNSETIAQFGNNAYGKPATGLNILREVVMGKELFDYAFRTYANR
WKFKHPTPEDFFRTMEDASAVDLDWFFRGWFYSTDFVDIGIKDVKQYYVSDTPTADIKDV
KVRKGRFGFDKGPFVYLVSSDNAEVNASKKKALKVDDVKLLADYVNQSFTAEEKASLKSP
KYFYEVEFNKPGGMIMPILVEITYEDGSKQNFQYPAQIWRKNNDTAKKVYATEKAIKSIQ
IDPKLMTADIDVTNNSWPKVEEKSKFD
>EGALAKHO_03107 Sec-independent protein translocase protein TatA
MFGIGGGELVFILFIVLMLFGSDKVPEIARTMGKAMAQLKNATNDIKSEIQKGAEANGLD
SKALTDITGNINAQINDAKTNLLGDTTNLTGNLLGDTATEIDKVKEDIDTISGPVKRQM
>EGALAKHO_03108 hypothetical protein
MLEKIQELDTNLFVYLNGLGSETYDKLWLIITNQLYWTPFFLFLFYLIYKKVGIKQTLYI
LLFIAVLIAFTDQTCNLFKHTFQRLRPCNNPDLKSIIRIVQVRTSYSFFSGHAANTMAVA
IFLFLVLRSKFKYLGFLFLWPLIFAYSRIYLGLHYPGDILTGYFFGALFGSLLYLVYRKL
KPQYFPG
>EGALAKHO_03109 Putative O-methyltransferase
MHFISQDLEDYIEQHSENEPELLAKLNKETYQKILLPRMLSGHFQGRVLSMLSKLIRPVN
ILEIGTYTGYAALCLCEGMQENGQLHTIDIKEELIDFQRKYFDASPWGKQIFQHLGEAID
IIPTLDVKFDLVFIDADKENYLNYWEMIVPKMNKGGIILSDNVLWSGKILEPVHPNDVST
KVLLEYNLLLKNDPRVETVLLPIRDGLTVSRVL
>EGALAKHO_03110 hypothetical protein
MKKQILSLAVVALLAFAVQSCEKKEPKPGEDELTLGNKVDTLTTDIEQAKDSAVIKAENA
AAKAKAASENAVQDVKDATSKAAQDVKDATKKGAEKVENAAKVAKDGTVKTAKEVNEELK
K
>EGALAKHO_03111 hypothetical protein
MKRLFLNLILGLVIFFFLGSAKPTFLPDDSVLVITKIKIEITGNSTVGKYNCSNYFTKKD
TVYLNSTKKNVFNTEIKMSNFDCGNKIMTKDLQGTVKIKQFPNSTVCIREIRQIGKNYKC
NLNFLITNKTLQYKDFILYADDNKIQGSLNLKFSDIELEPPTKMAGLIKVKDEIVINFSL
YKN
>EGALAKHO_03112 hypothetical protein
MKRIYILFITLVSTVAVNAQVSFGHIQNQIPRSQKGINQFDVKKDTVTYKGLSVDMGAAF
ALQFQALNSFNDQKDLATAPGYRLNNLENNFNLPNANFTIGAQLYDGVRVNLDVYLASRH
HNETWVKGGYLQIDKLDFIKKDFLADFMQYATIKIGQMENNYGDAHFRRSDNGNAFMNPF
VGNNIMDAFITEMGAELYYNRSGFVSMIGVTNSKLNQSVAEIVPAPTTPLKPDSNTTISP
SIIAKLGWDKQINEDLRIRLTGSYYHTANSSGNLYASDRAGSRFYGVMSHADYNVINPAT
QAVISSVVNNFDPTANKDTGRFNPGYGNWATSYMVNPFIKYKGLEFFGTLEFTSGGDFKG
TDDTRKVNQYVGDLVYRFGEGERFYVGGKYNLVDGKLSNASAEAIQINRFEGAAGWFMTK
NVLAKLEYVNQNYKNFAQFNGATPNDLFGGSFKGIMFEAVISF
>EGALAKHO_03113 hypothetical protein
MKSRKIKLFAIAISFFGITSIASAQKNYALDSKSTFSVSGTSTLHDWEMKSGSGSGTANL
AITNSKLTEIESLSITLLAESIKSEKKSMDKVAYETLKTDKQKNIKYVLKSAEKVNETTW
ELTGNYTIAGVSKTLKTTVRTVITKDGVNMQGSNKITFADFGMKSPTALLGTIKTGQDLT
LKFNLNFNL
>EGALAKHO_03114 putative dual-specificity RNA methyltransferase RlmN
MQIEKKDIRALSKDQLRDFFVANNDKAFRGNQVYEWLWSKGAHSFEDMTNVAKTTRSMLE
DNFVINHIKVDTMQRSSDGTVKNAVRLHDGLVVESVLIPTNTRTTACVSSQVGCSLDCNF
CATSRLKRMRNLEPGEIYDQILAIDKESRLYHNHPLSNIVFMGMGEPLMNYNNVIKAIDM
VTSSEGLGMSPKRIMVSTSGIPKMIKKMADDDVKFKLAVSLHSAIDEIRARIMPFSKNFP
LADLRESLEYWYRKTKTKISYEYVVWKGINDDKASIDALVKFCKYVPCKVNLIEYNPIDD
GEFQQASEESIMAYIKALENIGVVVKVRRSRGKDIDAACGQLANKEG
>EGALAKHO_03115 hypothetical protein
MNSLTKSKSRKRIIMKTKILFIGTLVALSFFISCNSDEKTNDGSSAAITKDEIVTNSKID
ASIDDVTNIAEDQFSAQQNVTSKPSGPVKNFLPSCATITTVLTNNTWTRTVDFGVEGCTL
ENGNSVKGKMVISFSNDFSASTQTISYTFDGFYHNGKKLQGSKSIVRTVKTTDLLATAHP
VFTAAIDLTITFDDGGVYTRKGSLVKEMVEGYDTWFNWEDNAYLVTGSGTTTFPNGDTFS
AEITTPLQFKAICKKSFAVKGIVTVTKNSASAVIDYGDGSCDTLAKITKDGVTEEIDLKK
>EGALAKHO_03116 All-trans-nonaprenyl-diphosphate synthase (geranyl-diphosphate specific)
MELFEKKFHESMTSKVALLNRITYYIVNRKGKQMRPMFVFLTAKMVSDGIVNERTYRGAS
VIELIHTATLVHDDVVDDSNRRRGFFSINALWKNKIAVLVGDYLLSKGLLLSIDNGDFDL
LRIISVAVREMSEGELLQIEKARRLDITEDIYYEIIRKKTATLIAACCALGAKSVIEDDI
QVENMRKFGELIGMAFQIKDDLFDYSEEAIGKPTGIDIKEQKMTLPLIYVLNTCTPQEKK
WLINSIKNHNKDKKRVKEVIAFVKDNNGLAYAENKMVQFQHEALLLLENYPDSEFKAALI
LMVNYVIERKK
>EGALAKHO_03117 ECF RNA polymerase sigma factor SigE
MKIIHLHQEETELLKLAVENNRQAQQQIYSRFSSKMLSVCRQYIKDIQLAEDVMITAFMK
VFTNLNKFEHKGSFEGWIRKIMVNECISYLRVQKKVKFTEDEIYVEESFNAIDSQFSIDQ
IQFLIDALPDGYKMIFNLYAIEGYKHNEIAKMLGINEGTSKSQLSHARKMLQTQITILKK
QDNGTE
>EGALAKHO_03118 hypothetical protein
MEPNNFEKDFREKLNQRKIEPSNKAWDRLDAMLSVAEEKKQPKKKNKWLYIAASLVGFLL
VGTFFFNQKSEIETPNKKVVIEENVKKDSVEKPILNTIDAEKTAVATSENATVQNSNKEE
EKISNQKLNQLVKKEANQVAESSIIIKNNQEKQSINNQTSIVENPKKESVDQLLNSAEKT
VVAENSAKPKSKVRVNANDLLNQVDGELELSFREKVITKVNKNYQTVKVALANRNQQE
>EGALAKHO_03119 hypothetical protein
MKNFTIYLVILIFLFVSKVLGQETFESQAKKIANKIEKITKEEKATLKEEVEAVNVQLSE
GKITQEQADKRKKELAEARAVIIEEKVTLAQNELNDLVQQKVDGKIKEQDSTHTYTIRWH
KRDCDKDSIHGERRTTSQFVFAMGLNNMMVDGKLQDSNYSFIGSHFYEWGFTYNSRLMKN
DNLLHAKYGLSLMYNNIRPTDNRSFVVNGEQTNLEVNTINLDESRFRNVYIVLPVHLEFD
FTKPKVSNGKTYFRTHESFRFGIGGYAGINVKSKQILKYDQDDLDYKTTIKGDYNVNNFI
YGLSSYVGYKALSLYVKYDLNPLFQDNLVDEKNISLGLRFDIN
>EGALAKHO_03120 DNA primase
MENHKFQEGFVYFYKLSTLKIFYVLISQSTIDSVFETARVEEVIGDFVNLKRAGSNFKGL
SPFSDERSPSFMVSPAKGIWKDFSTGKGGNSVKFLMEHSQFTYPEAIRYLAKKYNIEIEE
TEQTDAEKAITDVRESMYLVSEFAKDYFHKTLLNSEEGKAIGLSYFKERGFTNETIKKFS
LGYSPETWDALTKEALGKGYKLEFLESTGLTIPREDRPFDRFKGRVMFPIESMSGRVLGF
GGRILTNDKKAAKYLNSPESDIYHKSKVLYGIFQAKQSIAKQNNCYLVEGYTDVIQFHQA
GIENVVASSGTALTPDQIRLVNRLTRNITVLFDGDAAGLRASIRGIDLILEEGMNVRVCA
FPDGEDPDSFARKNSHDDLVAYLEENSKDFIQFKASILMKEAKNDPIKKADLIRDMVNSI
SKIPDRIQREVYTQECARIMDISEQVLVSTLAQLIQKDLTDANKKQKQEQKPFQVYRNQN
PNTGFSGGDPDDPRTGPPDGYFEEPGYPQQQQAEKVDILYRLERKVIEILLLYGDKTEEF
EDVLLKNNEEGEIVMVSEKREYKVFQRIYLSLQEDEVELSNNLFKDIFTDLIGYYNQNEK
FNLEQYLMRLQPDFAQEVTDILMEDERLALHNWEGQNIFSKMKHETIAQYVTETIMSMRW
FLVDKIIEELKSSIQPDNSDNTELLSMVVDYSKLVNSFSKKLGRVMSRYH
>EGALAKHO_03121 Putative transcriptional regulator
MIKVCLADNHPVTHFGVKSYFKDHDQISIVANVGNFSMVRDILQTKEIDILILDLELEGL
SSIFEVKSILKNFPKTKIVIFSDLAEQMYAPNAIKAGVSGYVHKTEKLETLGLSIIKVHE
GKIIINETVRKNMALIAKQSKSERLYRKLSNREIEVLRYLSDGKKNNEISKILNLNEKTI
STYKLRLLTKLNVTNLVDLVNKAKTLEII
>EGALAKHO_03122 NH(3)-dependent NAD(+) synthetase
MAKKSTIQTEKVNSHIVDWLKNYANSAKVNGFVIGISGGVDSAVTSTLCAQTGLQVLCVE
MPIHQAASQVSRGREHIDQLKKRFPNVTSVETDLTAIFEAFKSSVPKTDDEAKVSLSLAN
TRARIRMTSLYYLAGIHGLLVAGTGNKVEDFGVGFYTKYGDGGVDLSPIADLMKSDVYAL
GEFLAIPNSILTAAPTDGLFGDNRTDEDQLGASYDELEWAMLAAESGKTQADFNGREKSV
FEIYKRLNTSNKHKMDAIPVCIIPKTLK
>EGALAKHO_03123 hypothetical protein
MKIYRFIVVLSLFFLSCDQKSKVEKEVEEIPVDIKVERFDKVFFETKPEDLAKVKRQYPF
FFPAGNDDSVWLQKMQEPIWREVYEEVQKKYSNFEPVRQEFNSLFQHVKYYFPKTKIPKV
ITVIGEMDYNAKAIYADSLVIVALELYLGKDHKFYEFPNYLKQNFEEKQIMPDVVSSFAY
RNIPAFPDRNLVSQMIFEGKQLYAKDLLLPEYTDADKIGYTPEQIKWCEENEAYMWRYFL
EKEMLYSDDPKLTTRFMTPAPFSKFYLEIDNDTPGRVGAWIGWQIVRSYMKNNNVTLPEL
LKTDSKEIFEKSKYKPKK
>EGALAKHO_03124 hypothetical protein
MSDTINSEIKFNIELDENRVPEKLTWSAQDGGVQAEEAKAIMLSIWDSKAKETMRIDLWT
KDMPVDEMKIFFHQTLVAMSDTFKRATDDEKMSDTMKDFCDYFAEKLELTK
>EGALAKHO_03125 hypothetical protein
MFTSGPRSGVDFTSGKWLLNELDCPSKSKDKLTEESLAFFKKNLGERVFFIHDVSGLLVT
RKIQLNPSKTKLKELKDGTGFDFFINISTTKNKSDFSSIELYQYDNETGKNEASVTLEIY
DLNSQEIIYSQNVVGIDQKTTTESVWQTEKSTKLLDNVNFYKTSNKLMFGALKKVFKDLE
KRSVK
>EGALAKHO_03126 putative GTP-binding protein EngB
MKITTAEFIVSNSEVAKCPAEFLPEYAFIGRSNVGKSSLINMLTNHKNLAKTSGRPGKTQ
LINHFKINNNWFLVDLPGYGYAKVSKKTKSVFQQFITDYFETREQLVCAFVLIDIRHEAQ
NIDIEFMSYMGESEIPFCIIFTKADKISKTKIDSHIAAYKKQMFANNWEEMPQYFVTSST
ESTGKEDLLSYIDEVNQEVFKNNSQF
>EGALAKHO_03127 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase
MDKHYKKEGKYSYYEAGEGTPIVILHGLMGGLSNFDAVAEYFPTKGYKVVIPDLPIYTQS
ILKTNVKSFAKYVKDFITFKGFDQVILLGNSLGGHIALYHTKLYPEKVAGLVITGSSGLY
ESAMGDSYPKRGDYEYIKKKAEDVFYDPAIATPELIDEVYATVNDRIKLIKTLTIAKSAI
RHNMAKDLPKMTVETCIIWGKNDAVTPPNVAEEFDKLLPNSTLYWIDKCGHAAMMEHPQE
FNKILEEWLVKKNL
>EGALAKHO_03128 Transcriptional regulator MraZ
MPAPLKKQLASSLQDGFVLKRSVFQPCLELYPMEEWNLMMQKINKLNRFVKKNNDFIRRF
TAGVKMVEIDALGRLLVPKDLVAFSGIAKDVVFSSAVNIVEIWDKDLYEKSISGEDMDFA
DLAEEVMGNINDDDNGIS
>EGALAKHO_03129 Ribosomal RNA small subunit methyltransferase H
MEYHNPVLLHPTVDGLNIKPDGIYVDVTFGGGGHSKEILKRLGPNGKLFAFDQDEDALAN
ALPDERFTLINENFRFIKRFLRFHGVKSVDGILADLGVSSHQFDVPERGFSTRFDAELDM
RMSQKNDLNAYRVVNEYEEQDLRRVFFDYGELKNAPVLARTIVEAREKYPIKTTDELKDV
LAKYLPERVKNKILAQIYQAIRIEVNQEMDVLKEFIEQSLEILNPGGRFSVISYHSLEDR
LVKRFIKNGMFEGEPERDFYGNFSVPFKTIGKLIVPDDAEIKINNRARSAKLRIAEKI
>EGALAKHO_03130 hypothetical protein
MKGGVFGILKARFLINDDALKNWRFIVFIILLAIIMIANTQRYEQKVFEIAKLNNEVKEL
RSEFVDRRSELMKLKMESTISDKMLEKQIFPSTVPPVKIEVKKEEEKSFFKRIWQ
>EGALAKHO_03131 Stage V sporulation protein D
MAVDDKHISYRIYLVAVFIFVMAIAIVVKLTNIQWVEGDYYRKLAKQRTVRNFVIPANKG
NIYSADGSLLATSIPNYEIRFDAKAPKTETFEKHVKALSDSLATVLDRPGGYYEQELRKA
RANKNRYYLIARNLSYTDYVKIKGFPLFNLGAFKGGIIVEQETVRKHPIGKIAERTIGYD
RIDPATGVEVGKGIEWAFKSYLNGKDGKILKQKIAKGQWKPIRDVNEVDPIDGYDVISTI
DVFIQDIAHHALLKQLEDYEADHGCVVVMETETGYVKAISNLGRQEDGSYTETTNYAVAE
SHEPGSTFKLVDLMAILEDKVADTSTVYDSHGGVIKYYGRSVRDSHTGGYGKVSLARGFE
LSSNTVMVQAVYENYKNNPSKFVDHIKNFGLNKTLGLHFQGEGRAIIPHPKDKNWSGVSL
PWMAFGYGVSVTPMQTLTLYNAVANNGVMVKPQFVSEIKEWNKTIKKFDTEVMNPSICSP
ETLKKVRAVLQNVVKKGTGSKLYSKDFSMAGKTGTAMVNYGKAGREGMYYASSFAGYFPA
DHPKYSCIVVVHKPNTANNNYYGADVAGPVFKRIAQKIFTDAPSTNKIKKLDSNVPKQDS
SYDKYYVVEANKKSNQVPDLKGMPGMDAIALLENLGLKVKVNGVGKVKKQSLQAGQNISK
NTTIVLELS
>EGALAKHO_03132 UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase
MKILKDILYKVAIESVTGSTEIDVHKIDFDSRKIEANDVFVAIRGSLSDGHDYIEKAIQL
GAIAVICDTLPSTIEKGITYIKVKDTNTALAFMAANFFGNPSEKLKLVGVTGTNGKTTIA
SLLFQLFEKAGFKVGLLSTVKIMVDDIEYKATHTTPDSITINYYLNEMIEAGVTHCFMEV
SSHGIHQKRTEALHFVGGIFTNLSHDHLDYHPTFAEYRDVKKSFFDSLPKTAFALSNIDD
KNGTVMLQNTVARKFTYALKSYADFKATILESQLSGLLLKVNDNEVWVKLIGTFNAYNVL
AIYGTAIELGMDSLEALRLLSDLESVSGRFQYIVSEGNITAIVDYAHTPDALDNVLKTIN
DIRTKNEQLITVVGCGGNRDKTKRPIMAKIASDLSDKAILTSDNPRNEDPEVILDEMEKG
VEAHNYKKLLRITDRKQAIKTACQLAQPNDIILIAGKGHETYQEINGVRHHFDDMETVKE
ILDQLKK
>EGALAKHO_03133 Phospho-N-acetylmuramoyl-pentapeptide-transferase
MLYYLFEYLDKTLDIPGTGVFQYITFRSALALMLSLLLSTIYGKRIINFLRNQQVGETVR
ELGLQGQNEKAGTPTMGGLIIIFATLVPVLLFARLHNIYIVLLIVTTLWMGTIGFIDDYI
KIFKKDKEGLKGIFKVIGQVGLGIIVGAVLYFNPAVTVRTDTGRTDILRTGTNTTVVLPA
PVEEKSTATTIPFVKNNEFDYAEILAWTGEGYEKWAWLIFIPVVIFIITAVSNGANLTDG
IDGLAAGTSAVSVLALGIFTFVSGNIIFSNYLNIMYIPNSGEMTVFISAFVGALIGFLWY
NSYPASVFMGDTGSLTIGGIIAVLAIAVRKELLIPLLCGIFLVENFSVVLQVSYFKFTKK
RYGEGRRIFLMSPLHHHYQKKGYHESKIVTRFWIVAIMLAILSIVTLKLR
>EGALAKHO_03134 UDP-N-acetylmuramoylalanine--D-glutamate ligase
MRLVVLGGGESGVGTAILGKKKGYDVFVSDFGKIKESYKEVLIINKIAWEEEQHTEDLIL
NADVVMKSPGIPEKSPIVKKLIEAGVKVISEIEFAKPFTEALTVGITGSNGKTTTTMLTY
HLLKSAGLNVGLGGNIGKSFAWQVAENKYDAYVLELSSFQLDGIIEYRPDIAIITNISPD
HLDRYEYKYQKYIDSKFRITMNQTESDYLIYDADDEASAEWLKNNTTKAKLIPFSLTKKF
DEGASINNNKMEIKINQEEFTMETEYIALEGKHNMKNAMAASSVAKLMQIRNATIRESLS
NFQGVEHRLEKVLKIQNVQYINDSKATNVNATFFALDSMNVPTVWIVGGVDKGNDYNELM
SLVREKVKAIICLGIDNRKIIEAFGNVVDIMVEVNNMSDAVKTAQRLTEKGDAVLLSPAC
ASFDLFENYEDRGKQFKQAVHNL
>EGALAKHO_03135 putative peptidoglycan glycosyltransferase FtsW
MKELVNKLKGDRVIWSFVALLALFSFMPVFSASSNLAYIGHGTGNTLGYLVKHLAHICIG
FLIIYWVHKVPYHYFRAISKIALPIVWFLLLYTLLKGTVIAGANASRWIQVPFIGITFQT
STLASIVLFIFVARYLSKTKEENEPFQVSLIQLWLPVFITLALILPANFSTTALIFAMVM
MLTFIGKYPLKYIGFIIGSGVAMLAFFLLVAKAFPDSRFFSRVSTWESRIANFTTDKPDE
DDYQIEKAKIAIASGRLGGLGPGKSVQKNFLPQSSSDFIYAIVVEEYGLVGGVSILILYL
LLLFRFVIASHKATTLFGKLVVVGLGFPMIFQAMINMAVAVELLPVTGQTLPLISSGGSS
IWMTCFSLGIIISVTKKDEEIAEEKEEKQRRKEALQRLIDKELAEEDLPADEVYEEEELM
YSIEDNSRNPMNAVLNK
>EGALAKHO_03136 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MTNYKFILSGGGTGGHIYPAIAIANELKLQFPDAEFLFVGAQDKMEMQKVPQAGYEIKGL
WIAGLQRKLTLQNLMFPLKLATSLLESRRIIRQFKPNVVIGTGGFASGPLLQAAGQAGIP
TVIQEQNSFPGITNKLLSKRANAICVAYENLERFFPKEKIVLTGNPVRQDLIDIVSKRDE
AITFYGLDPNKKTLLVLGGSLGARRVNQLIEKELHNMLSQDVQIIWQCGKLYFEDYKKHQ
QQHVRVVDFIERMDFVYAAADVIISRAGASSVSELCIVGKPVIFIPSPNVAEDHQTKNAQ
AILDAKGAILLRESELDSQFSIVFEALMKDDGKQKQLSANIKKLAMPNATKVIVDEIKKL
L
>EGALAKHO_03137 UDP-N-acetylmuramate--L-alanine ligase
MNLNQIQNVYFIGIGGIGMSALARYFKYIGKQVSGYDKTPSMLTNELIESGIDIHFEDNI
NLIPSDYFVENTLVIFTPAVPKSHSEWNYFIERNYEIKKRAEVLGIITKDTFSFAVAGTH
GKTTTSSILGHILYESGADVTAFVGGIVENYNSNLIGTGKTVTVVEADEFDRSFLHLHPN
IACITSMDADHLDIYGTSDAIEASFVEFASKVEDKSKLFITKELPLEGVQCAINEDAVYK
AFNVRIEDGSYVFDVQTPSEIMKDLHFGLPGKHNLMNGLMAIAMAKTFGTPTDSIAKAIA
SFNGIRRRFSYQIKSEKLVYIDDYAHHPTEINAVYQAVTELYPGRKVLAIFQPHLFSRTR
DFADGFAESLSQFDEVFLMDIYPARELPMEGITSDWLLGKMTSSNKKIVAKNDLLAEIKA
SNAPIIVTIGAGDIGEMVPSIKKMLNENI
>EGALAKHO_03138 hypothetical protein
MKIFNWTNIRLILIFGLVLFLYSFAQHRNGDRKLKKSMVVFVGENTLFVKPESVNKLLIE
NKRDASSIRKDEVDLNKIEKNLDTQDMIEKSDVFVSIDGVLKARVKQKTPIARVYDGDNS
FYIDYEGHKMPLSDNFTARVPLVSGAINEKNNDDLAALFRTIYDDAFLKKNIIAIQIMPN
GSLKMFNRNYDYFIDFGRTMNVDKKFNNYKAFFQKAVLDSSLYKYKKIDLRFTEQVVCTK
>EGALAKHO_03139 Cell division protein FtsA
MEKDNIAVGLDIGTTKIVAMIGKKNEYGKLEILGIGKSKSLGVARGVVNNITQTIQSIQQ
AILEAENNSGYKIKDVVVGIAGQHIRSIQHTDYISRTNPEEVIGEKDIQLLIDQVNKLAM
LPGEEIIHVLPQEFKIDGQSEIKEPIGMYGGRLESSFHVVVGQASSIRNVGRCIQSSGIE
LSGLTLEPLASADAVLSQEEKEAGVALIDIGGGTTDLAIFKDGIIRHTAVIPFGGNVITE
DIKEGCSIIEKQAELLKIKFGSAWPGENKDNEIVSIPGLRGREPKEISLKNLSKIIHARV
VEIIEQVFAEIKAYGHEDPRKKLIAGIVLTGGGAQLKHIKQLVEYITGMDTRIGYPNEHL
AGNSSEEISSPLFATAVGLVMNSIENSTQSAVRMELVNEQPKVVYRNVPPQQQQPVQQRY
EVEENYVERVETVEQSREVRNTVEAESTETKIRRSFFDRYVDKIKDFLDNAE
>EGALAKHO_03140 Cell division protein FtsZ
MSNSEFGSISFDLPKNQSNVIKVIGVGGGGSNAINHMFKQGIKGVDFIVCNTDSQALQNS
AVPNKIQLGMNLTEGLGAGANPDVGQQSAIESIADIEKMLDRGTKMVFITAGMGGGTGTG
AAPVIAQLAKEREILTVGIVTIPFQFEGKVRQEQALLGIEKLRKQVDSLIVINNNKLREV
YGNLGFKAGFSKADEVLATASRGIAEVITHHYTQNIDLRDAKTVLSNSGTAIMGSSVATG
ENRAKEAIVSALDSPLLNDNKITGAKNVLLLIVSGSNEITLDEIGEINDHIQAEAGYNAN
IIMGVGEDETLGEAIAVTIIATGFDVEQQNEIVNTEPKKIIHTLEDEQRSVHNLTNKTVT
SFDLNAETPTAKSEEKVVFELMEDEPFANTHNPVVPTPVAPVAVAPTINQEELVVMSEFI
KNLDVTFEIVSPITDIDFTISAPAAEFVQEVKPVQQRTFEREEQTTFSFDLPLFRSEPEV
KKEPVVEETKILFELSNETRNIKVNDPVQFVPVTEVAENGVIKYSLEEYMEVEDNLMASK
PVEKPVDVVPAELNITLKPKVDFAQEADYSTTSNVSPMELTIEETLRLRAEERRKKLKEF
NYKFHNNVSRIDELEKEPAYKRLGIDLSNNQSNTTNSRISVGTDSNNDLQLRSNNSFLHD
NVD
>EGALAKHO_03141 hypothetical protein
MSLQTLIMDEIKTAMRAKDTVALEALRAIKSEMLLAATASGSKEELTEDDEVKLLQRLVK
TRKESARIFTEQNRPDLAEPELAQVAVIEKFLPAQLSEEEVEAVIAKIIAETGASGIASM
GKVMGLASAKLGGTAEGKTISAIVKKLLV
>EGALAKHO_03143 hypothetical protein
MLEYLTKLEINKNLRINYSKEFLDKENTDFITMPLENFLQKYYSKLDAFDEEVWEKTLLN
LVKLAYDEKTFNKMVENFGYSSIEKHDFKKQFDFFDELKNDNRLDIDTQKFIGFMAGNHF
FDKYVFTINDWFNSYYWATPYLIGTDQKGTSYTINHILNSPYGLNYLKSILPRLNHWRR
>EGALAKHO_03144 hypothetical protein
MRLIGVISEYNDELSGKKFHDYKIRSDYQNKEMILNYLKKGTSIAVTMQVVKSLIKDDSS
IIGGVSYLTDGYWIWPNYLHFYVDKLSIELPSDFLNFISKNEQIKLISDGQKLEAINFLK
LLK
>EGALAKHO_03145 hypothetical protein
MKKLQFKVSINAPVTKIYDFMLGITNKSTYEQWTALFNPTSTYEGSWDKGSKILFVGVNE
KGEKGGMVSRIAINVPNQFVSIQHYGLLKDDKEITEGPDVEKWANGFENYTFEENNGTTT
VTVDLDTTEEFLDYMNEHYPKALEKLKEICEK
>EGALAKHO_03146 hypothetical protein
MENKKVVNFIFWICAIILGVTLFKQFDFETFKFEKPALAVIYFLCFAFSVFILVKNSKKG
SEK
>EGALAKHO_03147 TonB-dependent receptor SusC
MKNILLISLLFFGFFTQAQSPQLNVKGKDSSLVRLNQLKVAVKIVGNIAYTTTEMHFYNG
TNRQMEAELMFPLPEGVSVSRYAIDINGKMREAVPVNKNKGKQVFEAVEHRRVDPGLLEK
VEGNNFRTRIYPLMPGKERIVIIGYEQELSSFDATHLSYQMLSSYSGKLDAFELNVAVLG
ATAAPTIANDEGILALENQNQSYVTSVKKVNYQLKDKLVITIPIRAEIPSVVAQSVNDQH
YFYANTILDNPKILKKNPATIGLIWDVSLSCKNRNIKKELQLLAAYFNQLKNVSVTLYFA
GYNFDKKNTYTIQNGDWASLKSVLENVVYDGGTRFSKIKLPVHDEYLFFTDGLSSLSANV
LTTTKKPIYTISSLCSSDYAFLNYNAIKTGGNFINLNELKIDEAYDKLMYQSLKFLGIKE
NYLVTDLYPMAGTPVSGSFSVAGISLKSKNEVVLLFGYDEKPVLEKTIHIDATIPVSGEI
SIEKLWAQKKIANLEIQYKTNADEIETLGKRYGIVTQNTSLIVLESLHDYIQYDIIPPAE
LRAEFDNVMKQQMANAQAKKFSNWGNVASYYEQLKTWWDKNTKYTIPKPVPVTKNPKNVS
TISGNVRGVVLDESGLPLPGASVLVKGTRRGTTTDFDGKFGIDAVSGDKLQISFIGMDTK
EIRVGSGRNYSITMKDAHQELQEVVTVGYGTQVQRESVGAVEESDKKEKRDLPAASARML
RSESVSASSNNVQKALAGKVAGIAISSGSADALISENAIQNQNVVDSNLDVIVGYSSYNQ
TKVNTWNPDRIYLKALANAPAEKRYSVYLELRADQINNPNFYFDVANYFYDNGDKEKALL
VLSNIADLGLENHQLYKSLTYVLRQWSTYEDALFTASQVAKWREQEPQAHRDLALTLEDS
KQYQAAFDELIKALEVNYFGEMSGQYSGVEDIILMDLNRMIQEHSGIKTDKLDKKYLNKM
PVAIRIILNWNQMDTDIDLHIIEPTNEECYYGHRDTEIGARFSKDFTQGYGPEQYLLRNA
VKGKYIIKSNYFGERTLTENGPTTVMVEVYTSKNGVTERKLQTIQLGKIKENQNLAEVVI
D
>EGALAKHO_03148 Protein MtfA
MLLLYFLGALLAAVLVLIVVFRIIEPIYLMLFNKPLFLFWYPVLQRIDPADKTILRREFP
FYENLSAKKQSYFEHRIKRFINHYNFDGKDIEITQEMKLIIGGTYVMLTFGMRNYLIELF
ENIIIYPTSYYSILNKNYHKGEYNPRMKTVVFSWEDFLSGHKTKDNINLGLHEFTHILHF
HSKRSADPNAVIFFDEFTEIEKYFDDEFLTNKLKERAYFRDYAYTNKFEFLAVILEHFFE
TPEIFKKEFPELFQNVKAMINYRDFI
>EGALAKHO_03149 hypothetical protein
MKINITDEIKIESYDIFTYRRIRRAIGYLGISLPILLVALSFLSFFKTPLQPSISDYYYT
NLREIFTGTLAAVGLFMIRYKGHGNASIWKNDNLLTNIAGIMAIGVALFPMNPDDSFNKI
YTLIPYPEKWLGWLHYGFAALLFLIMALLAINVFTIGQENETRDPKSMLNENNIYRFCGY
SIIVFVILVPISETFKLFRYSTLILETLALFAFGIAWLIKGRALGDSGEIGKKLYQENNP
VDTEKVFEE
>EGALAKHO_03150 Thiol:disulfide interchange protein DsbD
MRRLFIFLFLFNVAFLSAQKSKFTEAKLIILNDSLTLQQYDSIVSKEFENGKIPILYFGA
TWCGPCKEFKKNITENQYLKTKLKDFTFIQADLSDLNTCEGNTKLGNILGCRNWHGSVPR
FSKVDKKGVEINYIMGSGWFMQKPLRIDEFIRMIMIPNTESYIFPNLK
>EGALAKHO_03151 hypothetical protein
MRTLDQWFAEYAVSHQNPKNKAIHYVCVPAIYFSIVGLLMSIPSGIIANTLKLNAPIIEN
WAVVVLLFVLIFYIRLSVAMAIKIAVFSAICLVVNYYIGQFVPLWIFSIGVFVIAWIGQF
YGHNIEGKKPSFLKDLQFLMIGPAWVVENLFSRK
>EGALAKHO_03152 hypothetical protein
MRLTTFLSEQGYDIIEGPVRNHKPLQLWLKKPFDEAQLYYDNIGHAFKSDIVLNEIENAA
LNVDYTKKDEYGFNIGITLLGEILKTLGLGTFEITSKIQSGKTVTISYGNSVTKEYTIGN
LEEYFYSADFLHPNPSLLKNINQNYLLLTTGIVFAQNLVVDIETNFTVNAAFVAGLNDVA
DGKLDFSTDGLNKLKMNSNVGISFPIAVKASRIDYDRSRFKKLIQVTDTNNIF
>EGALAKHO_03153 hypothetical protein
MSAVWYECKVKYRKTDDIGGQKVTTEPYLVDAISYTEAESRINEEMAAYVSEEFKITNIK
VANYAEIHPFENADRWFKSKVSLIAFDEESGKERKTNMYLLVQANDVKEAYDNTVSVMKG
TMGDYTIPAISESPIMDVFPYFSGEEGDLEQIERFNALKGSKPELVAVGDMGENVEDLVE
VDSE
>EGALAKHO_03154 hypothetical protein
MTREHYIPFNKEFLLEQQLTAFAQDPKKNDDFKKLFDIIEHYFHYEAFNLNRNLKQNYAL
FDPDLSNKERKSFIGKSDFSVFKETLLTVLALGNYTRIDQETLDVAFKESDLIGLNLSID
FNAFKDYEFYVRGQHTAKEKVKKYFFWKKEVEIEYYDRVLIYLHYNDTNFLKEKKVKLGK
MPIEPGSVVLKIFKRVPKNDLETIFPNAIPRMSLKDKLLLWVPGIFGGVSLLSAKVIPAL
VNMYKAYETGEAIDLLNSKTSLNQGLIALGILSLYCFRQYNNFVNKKIRYSKILSDSLYF
KNLGNNSGAFYSLLNSSEEEVLKETILAYTFLYKSKTPLTAEELDAQIEIWFETKFNTNL
DFNVKDALTKLKNIGLGIETNGKWEVIPLDKALVTIDALWDGVFEYN
>EGALAKHO_03155 hypothetical protein
MGSQIIELEKKYWQAMENHDYETVKNLTHFPCIIAGKTGLQSVDEATFKKMFESADGNKI
KVLNISNVETQLLAENTAVTAYQIALEMTDDKQNTQMKCVCTSTWIKENNNWVCALHTET
ELSQQ
>EGALAKHO_03156 hypothetical protein
MLLLIQSGFMMAQTKTVVTQNGEKVAISTGAKNGLTANNGYIQLGGALTQPSVLTTTSAY
TLAIQGLQAGAASDNVLVSDANGVLKFVPRSSFTGADNLGNHTATQNLDMTSKNILNINN
AYIKNEAQIMDRVTSNTNYFGIYKNSGLLGIWNNLHGNNALSIDEATNKTTLVSAQIAHG
TDGSTPALGSVAVAADANGNVKWVSPSTIGAGDNLGNHTATTDLAMSGKNINNAANVTAT
GTVAAANVIASAKATVQTAQITKGSDGASPAAGSIAVAADTNGNVKWVSASSIGAGDNLG
NHTATTDLAMSGKNINNAANITATGKTSTEMAQIIKGSDGVSPAIGSVAVAADTNGNVKW
VSASTLGAGDNLGNHTATKDLAMSGKNISNAANITATGKTTTNSAQIAKGTNGVAPQAGY
IATAADTSGNVVWIAATSAPGAIDGVYEFLGTSQINVPSGTTTKVPMNGSSFTLNKPGKV
LITYSLLPLPANAGQPVQGSIDLIIDNNKTISSYYSASDAPSGLGRLGNYSTAQKIASLA
AGTHTIGLNLKSWYNTTMTNVNPVTVGYNGSTASDSQAMIARITVIVFND
>EGALAKHO_03157 hypothetical protein
MKNIFFIIMMALLPILINSSYGQQRTKEDNKQKEMSQKNSDEEMFKYLNLSQEQVAKIQA
IRKNSKESWKVMKDVPQVQNALLFNMATTQESFDNVLSPAQKVRMRKFEMKQNYTEGLKQ
KVNLSPNQEDKIANVSEMAYDKQQAIINNTSLSEEDIKQQIGKLNNETSNEVTNLLTAEQ
KKQLETEKGK
>EGALAKHO_03158 hypothetical protein
MRKFTCLLLLIQSGLIMAQKTVVTPYGEKVTINTGANNGLTANGGNIQLGGPLTKASVLT
TTSTSTLAIQGLQTGTNSDNVVVTDANGVLKTVAGTSFGGNDNLGNHTAIKNLDMSSFNI
LNIKNAYIKNEAQILDRVTTNSNYFGIYKNNGLFGIWNNLKNANALTIDETTNKTTLTSA
QIVKGTDGLAPKTGDVAMAYDNNGNVVWRPLAEVSGTSSIQFYIQSTGKSTIGSTAWSNV
PGFTNVPYVAPQDGDLILQSVLYSALDKNPTAGTPAMTNTQMKITVNGTDTAYGMSTPIG
IAGAGKNPACTVLFTKFEVKKGTTYLISVQAQDVWNSNAGGSQGAYVGTFTYSTYSTPST
MMATLITK
>EGALAKHO_03159 hypothetical protein
MDKSKKTKPSYNQDVLKIIKARHGYSYDYIRKSIRGDRVGIICDMLKAEYQKLNSEAKKA
IENQVNKL
>EGALAKHO_03160 hypothetical protein
MAENTIKRIKQYIDFKGIKISAFEKEIGMSNGSFASQLKNNKTIGVDKLENILKKYSELN
PEWLLTGNGNMLKMDLLNEAPETYSKTDKEESEATLNYKELAESRKETIDSLKKIIVYLE
AQLAEKK
>EGALAKHO_03161 hypothetical protein
MWLEPFRLAYLTKKRMAIEHKVRLVEELFDKLELEIKAFQTETHLHCNAGCGKCCSTPNI
DASPLEFLPWAFHLFLNGQAEETLAVLGNLSTKNCFIYHPLSVLQYQKGSCREYRYRGLI
CRLFGYGATTDKFGKLRLATCTIIKEEQNQNFTAAELAINNGKSVPIFTDYYMQLAQIDL
RMGITLLPINEALKMAIEEVLHYYAYRPFPGGLENIA
>EGALAKHO_03162 hypothetical protein
MKKHFFLFIALCFIVTAHAQKKVFKCEDIHKAVQLIDEGKFDESITILKECEKIDPTEYA
YPYEIALAYTYKKEYQNAIDQLEKIKNYNSVQSDYYQLLGNAYDYAGNPEKAITTYSEGL
QKFPDAGRLYLEKGVIYESQENYLEAISSYQKGMEVEPMYSSNYYRSALLYLNSTDKLSG
LIYGEIFMNLERTTKRTLKMSELLYQTYQNGIQINGEGVKVDFCKTVINADINSKSDEIK
LPLCAVFDRNLILGVVLQKEINLNSLSQIRTSFITSYFKNDSKKYPNVLFEYQKTLLDND
YLDAYNHYLFQMGSKTEFDDWQAANKDQMDKFVAWYTTPANGLKMTKENIYLSN
>EGALAKHO_03163 hypothetical protein
MNGLKLFILLSAVFTFIVSIALGGRSLTFYFNNKEMFQDPQSYKKEFVVIDSTYTKTIGS
RNKQILTYGLSKKFDDYKTIFDLNTPDGSAVIENDIRIEPLADTLNNSNLNYYAWVNKQK
RKGFIGNKYEQSIQENWIFCDQILYIKTTIGMLLFSLIVFYWLKVYLIFKK
>EGALAKHO_03164 hypothetical protein
MENSTTTKTQNFFRILLGIFMITAAMGHFTFQRTDFQAQVPNWVPMDKDLVVILSGIVEL
AIGLVIIFLTRYKTLIGIGLAIFYVLVFPGNIAQYLNGTDALGMNTDQARLIRLFFQPVL
ILWALWCTGALRVLFRRR
>EGALAKHO_03165 Bicarbonate transporter BicA
MKKAFQLFDFTQKVNYKNEILAGLTVAMTMIPESLSFAILAGFPPLVGLYAAFIAGLVTA
IFGGRPGMISGGAGATVIVLIALMKSHGIEYVFAAVALGGVVQICIGLFKLGKFIRLVPQ
PVMFGFVNGLAVVIFMSQLEQFKTVINGQVSWLQGTPLYIMLGLVALTIGIVLLFPKITK
TVPASLVAIMMVFAIVLIFNIDTKTVQDIASVQGGFPPFHIPEIPLSFETFKVIFPYSVI
VAAVGLTEGLLTLNLVDEITGTRGNSNRECIAQGSSNILNGFFFGMGGCPMIAQTLVNLG
AGSRARLSGIIAALTILLIILFGAPVIGKLPMAALVGVMIMVAITTFEWASFKVINKMPK
HDIFVGILVAVVTILLHNLALAVLIGVIISALVFAWESAKRIRARNFIDENGIKHYEIYG
PLFFGSIAAFMEKFDIQNDPNHIIIDFKESRVSDMSAIEALNNLTKKYSQLNKVVELKHL
SEDCRTLLKNAEAVIEVNVIEDPTYKVVS
>EGALAKHO_03166 hypothetical protein
MRKFTTQLLSFTFLLLSIFSYSQSSKDTYVVLVSMDGFRWDYAKHFKLQNLNRIAKEGVH
AKSMKPSYPSKTFPNHYAIVTGLYPDHHGIINNVFYDAALNESFSLSTKAKNDSRFYGGN
PIWNVAEQQGVKAASFFWPGSDTDQKRPGIYKNYDDKIPYGNRIDTVIKWLELPEKQRPH
LITLYFDEPDHTGHNFGPLSPENEKMVHKMDSVMGQLSSKLDQLAIRKQINLIIVSDHGM
ADISNEKKVAVLDYLKPEWLGYKAVINPIMSLQAKPGFQDSIAKVLKKVPHIKFWRSSEV
PKRLHYGTNPRVHDFVIEAKKGYSLVSKESTHIKGGTHGYDNNEKDMHAIFYAKGPAFKV
NKEVKTFQNVSVYPLIAHILGLKIEEVDGKFSEVSKMLIN
>EGALAKHO_03167 60 kDa chaperonin
MAKDIKFDIEARDGLKRGVDALANAVKVTLGPKGRNVIIGKSFGGPTVTKDGVSVAKEIE
LKDPLENMGAQMVKEVASKTNDLAGDGTTTATVLAQAIVKEGLKNVAAGANPMDLKRGID
KAVEAIVADLAKQAKVVGSDSDKIKQIASISANNDEVIGELIATAFAKVGKEGVITVEEA
KGTDTFVDVVEGMQFDRGYLSPYFVTNPEKMEVELDSPYILLYDKKVSSLKELLPVLEPV
AQSGKPLLIIAEDVDGEALSTLVVNKLRGALKIAAVKAPGFGDRRKAMLEDIAILTGGTV
ISEERGYTLENTTIEMLGTAKRVSIDKDNTTIVSGAGEADIIKNRVNQIKGQMETTTSDY
DKEKLQERLAKLAGGVAVLYVGAASEVEMKEKKDRVDDALHATRAAVEEGIVAGGGVALL
RAKAALAGITADNADEATGIQIVSRAVESPLRTIVENAGLEGSVVVAKVGEGTGDFGYNA
KTDEYVDMLKAGIIDPKKVTRVALENAASVAGMILTTECALIDIKEESAGGMPMGGGMPG
MM
>EGALAKHO_03168 hypothetical protein
MRDFKKYDIWQLSHSFTLEIYKMTSTFPKEELYGLTSQIRRASSSIPTNISEGCGRNSDK
EFNQFLNIALGSANETEYLLILAKDLQYLNNEIAENQIEKINNIKSKIYKLKQVLVQQ
>EGALAKHO_03169 10 kDa chaperonin
MALNIKPLSDRVLIEPVAAETKTASGIFIPDTAKEKPQKGTVVAVGNGSKDHTMTVKVGD
TVLYGKYAGTELKLEGTDYLIMREDDILAII
>EGALAKHO_03170 hypothetical protein
MSTFSIFLVLITIVCFLLIVVIMVQNPKGGGLSSTISGTQMLGGVQKTTDFLDKSTWTLA
TILIALILLSSLSFTGSLSDTDSKLIEKTEAPATTPAAPVQQTPAPATPAAK
>EGALAKHO_03171 hypothetical protein
MNVTDYTYLMNKPDAITEKQAEALGNVLNEFPYFQSARALRLKGLYNQNSFKYNYALKVT
AAHTTDRSVLFDFITSESFTSIQGEYYDQKLKDLLNITVFDSEIVLAEEKKKLIEVRIDP
IEKSILDSIKEATGVAFEEPVKVEEKTIDTIIEQPILNSFAEETIVTFEEPAKIEEKTID
LVIEQPTVDSFTELPTITVEEPVKIEEKSIEQIIPTLDSFQEVISTNEEPIIVEENPIEI
VTEQVILDSFKEVTAVTFEESLKVEEKIVEEKIIEAIIEQPTLDSFEEVTTALEEHKEVE
EEPITLVIEEPTIDSFEAVTPTIEDTPIIETTPIAESTPIIKQPTPTFFDEIVEEEIPSV
RVEPIEESTYNALQEATAVVFEEAPVVEEPKATEELKETEVSETVKTAEENLELGKPLDF
SANEKHSFQEWLQLAKTEPIDRTKDTPEESESIQKVENTVENVTESETIDEEKKKKAEII
DKFIETNPKISPIRQTAIVPAVPLDNDKEENSYLMTETLARVYLEQKKYTKAIQAYEILI
LKYPEKISFFADRISDIKILQQNNNNN
>EGALAKHO_03172 hypothetical protein
MKKIYSLLAFFSLFLLSGCNVYNFTGTGTIDAKTFQVNFFQNNADLIEPGIDRQFTLALQ
DLIMNQTNLNLVSNSGDLTYEGEIIDYRITPMTATADADLKAAQNRLTIRVNVRFTNRKK
ETDDFEKAFEFYYDFAGTSLPTGSLLNTAITTIFERITQDVFNESLAKW
>EGALAKHO_03173 Transcriptional regulatory protein GlrR
MRNLKPETNKNLKQNYMETVQAIKQRFEIIGNDPKLNRAIEKAIQVAPTDISVMVTGESG
VGKENIPRIIHSLSHRKHGKYIAVNCGAIPEGTIDSELFGHEKGAFTGATSTREGYFEVA
DGGTIFLDEVGELPLTTQVRLLRVLENGEFIKVGSSQVQKTNVRIVAATNVNLFNAIEKG
KFREDLYYRLTTVEITLPPLRERNEDIHLLFRKFVADFAHKYKMPPLKLDDDAVQLLQKF
RWNGNIRQLRNVAEQISVLETNRDITLATLRSYLPTEGSNLPSVISDKKKDSDFSTERDI
LYKVLFDMKSDLNDLKKLTLELMKNGNSKVQDINPNLIQKIYGSQENDSEIDFEEEPRTA
VMTPAAREDNYRIQDDNNYLDAETIEEEEILRLEQKEIEMIKKSLEKNKGKRKAAADELG
ISERTLYRKIKQFDL
>EGALAKHO_03174 tRNA-2-methylthio-N(6)-dimethylallyladenosine synthase
MEKIIEESKQGESLVLENKPENTKKLFIESYGCAMNFSDSEVVASILSINGYNTTQTLEE
ADLVLVNTCSIRDKAEQTIRKRLEKYNAVKRINPKMKVGVLGCMAERLKSQFLEEEKIVD
LVVGPDAYKDLPNLLAEVEEGRDAINVILSKEETYGDISPVRLMSNGITALVSITRGCDN
MCTFCVVPFTRGRERSREPQSIMTEIQDLWDKGFKEITLLGQNVDSYLWYGGGLKKDFVN
ASEMQKATAVDFDQLLEMVAVGFPKMRIRFSTSNPQDMHESVLHVIAKYPNICKHIHLPV
QSGSNRILKEMNRLHTREEYMTLIDKIRTIIPNASISQDMITGFPTETEEDHKDTMSLME
YVKYNFGYMYSYSERPGTLAGRKMEDDVPEETKARRLQEIVDLQQKHAWFRSEEYVGEVV
EVLVEKVSKKSKEEFSGRNSQSITVVFPKENYKIGDFVNVKIESCTSGTLKGTAIGYSEM
N
>EGALAKHO_03175 DNA topoisomerase 1
MAKNLVIVESPAKAKTIEKFLGSDFQVESSYGHIADLPSKEIGVDVENGFKPKYEVSPDK
KALVSKLKTLSKNAEMVWLASDEDREGEAISWHLAEELKLDIKKTKRIVFHEITKSAILK
AIENPREIDYNLVNAQQARRVLDRLVGYELSPVLWRKIKGGLSAGRVQSVSVRLIVERER
EIQNFNAIASYSIVAEFVNEAGKAFKAKLPKNFNTKKEAEDFLKQNIGSKYKVADLETKP
TKKSPTAPFTTSTLQQEAARKLYLPVGITMQLAQRLYEAGLITYMRTDSVNLSKDAMDAA
EAEIIKSYGKEFSKPRTFANKSKGAQEAHEAIRPTDMSRHTVNIDRDQARLYDLIWKRTL
ASQMSDAQLERTNVKIEANNHSEIFTASGEVLLFEGFLKVYLEGHDDDEEEQEGMLPALK
VNEKLANNYITATERYSRPPARYTEASLVKKLEELGIGRPSTYAPTISTIINRNYVEKGT
LEGQERNYTQLTLQADKVGEKLLKENTGSDKGKLVPTDIGTIVTDFLVKNFGNILDYNFT
AKVEQDFDEIAEGNIDWATMMQEFYDKFHPNVKDVEANAERESGERILGKDADGRQVSVR
LGKFGPMAQIGEADDEDKKFASLMADQNIGNITLEEALNLFLLPKNLGEYKGEEVEVSNG
RYGPYVRHGSVFISLPRGEDPLAVTKERAQELIDEKALADAPIAVYKGEAVQKGVGRFGP
FIKWNGLFVNVSKKYNFDNLSQADVEELIEDKLQKNIDKVLHNWEDEGILVEKARWGRSV
ITKGKIKIELSKDVDATKLTLAEVQEMIAKKTPAKKTPAKKATTAKKAPAKKPAAKKK
>EGALAKHO_03176 Formimidoylglutamase
MEFDFLEPVNDGIVQFISSLSSQELGSKIVLHTQDQFPDITKVHIAIVGVLEDRRNINMV
NEVNLTAVRKKLYSMFPGNWDASIADLGDILAGDSVEDTYFALKKVTASLIKNKVIPIVL
GGSQDLTYALYRAYDDLEQMVNMVAVDNRFDFGKENETVSANSYLTKIIIDEPNNLFNYC
NIGYQTYYNSQEEIDLIEKLFFDAYRLGEISNKIALAEPVFRDADLVSIDLNSIKSSASG
NTVTFEPNGFNGKEICSLARYAGISDKVSSFGIFNHNSTVHESTMIAQIVWYFIEGYHYR
SKEYPFGSRTNYLKYIVPLEEEELIFYKSDKTDRWWIEIPFVSNGNNKLKRNTLLPCSYD
EYLCACNQELPERWWKAQRKNAL
>EGALAKHO_03177 Serine/threonine-protein kinase pkn1
MKKFIAFATMVTLVIGCGKSGDKGELVGVTGGKWHPEKPYGMTLVPGGSFIMGKSDADLA
NVEDAPTKTVTVRSFYMDETEITNSEYRQFVEWVKDSTMRVRLAILADETGQKSTGDAKG
KKAGSISDYAFNDSEPDKMTAYDKYMYDNYYSVGTKDDPYAGRKLNKKVKLIKDTKAYPD
EYYAEVMDSMYLPIEESYNGLRTIDVNKLKFRYSWMDIQAAAKAKVGKRKDFVKTEQVSV
YPDTTVWIKDFAYSYNEPMHNDYFWHKAYGDYPVVGVTWKQAKAFCAWRTLNKNSYIKSK
KKGRDLVNAFRLPTEAEWEYAARGGLESATYPWGGPYTKSDRGCFLANFKPSRGDYAADE
ALYTVEAKSYEVNGYGLYNMAGNVSEWTDSAYNPNAYEYVSTMNPNVIDGNNQRKVVRGG
SWKDVAYFLQVSTRDHEYADSARSYIGFRTVQDYMGTQVTGGKKKK
>EGALAKHO_03178 hypothetical protein
MALLSKKAMNFAYGMGAAVVIIGALFKITHFEIGPLTGTLMLSVGLVTEALIFALSAFEP
VDEELDWTLVYPELANGQARKKADKVETPTDAQGLLSQKLDAMLKEAKIDGELMSSLGNS
IKNFEGAAKAISPTVDSIAGQKKYAEEMSMAAAQMESLNSLYKVQLESASRNAQANSEIA
ENASKLKEQMQSMTANIASLNSVYGGMLSAMSNKG
>EGALAKHO_03179 hypothetical protein
MAGGKLTPRQKMINLMYLVFIAMLAMNMSKEVLSAFGLMNEKFESANTSSEQSNAGLLMS
LDQKAAEAKGEFAIAAVTAHKVETASKEFYAYIGSLKGDVLKGFESDKETGKLPYESMDK
GDNIDNWFTGEGYTAKGNEIISKIEAYKAAMKAALADKKYAAIVAEIDKKFDVSDVKNKE
GLKDKYLAYHFKGFPAVASLAKLSAWQNDVQKAESDVYSAALGKAAVAAASYSNYQAIVV
LDKNAYFQGEKVTGKVVLGRYDENTKPTSFQGPGQIVNGQAVISLTAGGVGEQDINGQFT
FLEDGKNIPLKFKGTYVVVPKPNSATISADKMNVVYRGVVNPISVSFAGVDANKIVASAP
GLASAGKPGKYNMSPGAGTEATISVTGTLPNGDKVVDKKTFRIKGIPGPTGTIRGEMGVV
KGPKSNLEIATIGAKLQDFDFEVGLDVVGFNLKIAGQPTVVVTGNRLNAQCKSVLSKAGR
GDQVTISEIKTKLVGAGSYLLPRTAPVIYEIQ
>EGALAKHO_03180 hypothetical protein
MMKVRNFLIAIVSIAGGFASNAQSNLLNAKTPDQIGLKTPAQLISDNDKPLAYGYVDDRD
VLMGKTTWEIIDLNEKINFPLYFPVDTANIGSDRRSLYDVLTKAIKSGKVTEVYTDSYFN
TKKSMKDIEGSLSRIDTTDAGRELINQYPDDYKTHVVKKKVVTGTGKKKVVTYVDETVGA
TRTVPSEYILKQDLTAQDVTQYKIKGYWYFDKRQSELKYRLLGICPVTPDVYTMNSDEKD
YIELFWVFFPNAREALHEAKAFNDNNSALPISFDQILNSRRFNAVIYKEENLYGDREIKE
YMKDNAQNQLLESERVKEKIRNFEQDMWNY
>EGALAKHO_03181 Glycine oxidase
MLDYIIVGSGLAGISFAEIALKNNKSILVIDDKSQISSRVAGGLYNPVILKRFSEVWKAE
EQLVLMEDFYNQIEAKLQTKVNFKLPILRKFFSIEEQNNWFAASDKPLLAPFLSTKLIFK
KYFGIDSPFDYGEVLHTGYVDTSLLLDRYQNYLIENKLLLQESFQHDILVINDDVIEYKN
IKAKHIIFAEGFGLHSNPFFKDLPLDGTKGELFIIKAAELDLDVIVNTSVFILPLGDHLY
KVGATYNWKDKTDNPTEEGRTELVERIQEIINCDFEIVSHFGGVRPTVRDRRPIIGTNDK
YSKLHLLNGLGTRGVMLGPAMAKDLFDYIENKKPLDPTIDIQRFYKKRK
>EGALAKHO_03182 hypothetical protein
MLKKGSKLNSILTGSCPKCQNESMYSDKNPLHLTKVLKMNENCSHCGLKYQIEPSFFYGA
MYVSYGLNVAVGIAAFIVSFIFFGASIEQSFLSIVITLIVLFPFVLRLSRNLYINMFVSY
DPNAGKK
>EGALAKHO_03183 putative ABC transporter ATP-binding protein YheS
MLNIHNLSVSFGGTYLFEEVTFRLGAGDRVGLVGKNGAGKSTMLKMLAGDFAPDSGVISQ
EKDIRMGFLRQDIDFEQGRTVLEEAYEAFTEIKIVEKKLEEINHQLVTRTDYESEEYSKI
IEDLSDYTHRFDLLGGYNYVGDTEKILLGLGFKREVFNNQTETFSGGWRMRIELAKLLLQ
SNDVLLLDEPTNHLDIESIIWLESFLRNYPGVVVIVSHDKMFLDNVTNRTIEISLGKAYD
FNKPYSQYLELRHEIREKQLATQKNQAKKIEETEKLIEKFRAKASKASMAQSLIKKLDKV
ERIEVDEDDNSVMNISFPVSKEPGRVVVEAEHVTKAYGDKVILKDIDLLVERGSKIAFVG
QNGQGKSTFIKAIVNEFEYQGNIKLGHNVQLGYFAQNQAEYLDGEITLLQTMEDAAMDTN
RSKVRDMLGSFLFRGDDVEKKVKVLSGGERNRLALCKLLLQPINVLLMDEPTNHLDIKSK
NVLKAALQKFGGTLLLVSHDRDFLQGMSNIVYEFKDQKIKEYLGDINYFLEQRNLENMRE
VEKKDVAKAAAPKETNKASYEDQKKGKSLQNKLSKVESQIKQLEKDIQHDDKMLASNYDK
HIEDASFFTAYNKKKADLDQLLSDWESVQEEIDNFNA
>EGALAKHO_03184 hypothetical protein
MKPILQLYRGYANEEELIVMGHVFKRTYNYDFQKKNFKNATSIINQFRIKTIKNFDVYLK
LGDQEIHSKTLDDGYFKFCIPLEKEFDFGWMEYEVSIKYKSEIITTVGSFIRPHTGNLGI
ISDIDDTFLISHTRNVFKKMYILLFKNVNDRKVFKDVVPHYQALSSAGRNNKEEENAFFY
ISSSEWNLYRFIVKFTKIHQLPRAVILLKDIKRGITDFFMSGRGNHNHKFDKIKHVLEFY
PNLKYVLLGDDSQHDPFLYEQICKIFPVTVKAVYIRQTGKFQKKSTKAILKNLENLEVSV
CYFKDSSQAIMHSKSIGIIK
>EGALAKHO_03185 Lipid kinase YegS
MKKNIIFVVNPISGDLDKSDLIEAVEEFATTNHFDLEVYETTGKSDQKNIQALYNQYNPE
RIVVAGGDGTIKMVAEAMEQHDVIIGILPAGSANGLSVDLNLPVTIEENLKIAFLNRYIE
MDMICINGKKSIHLSDIGINADLVKNYEESNLRGFWGYALQAYSTIKDLDEPFIATISAN
NQEVVHTARIIVIANSQRYGTGVTINPNGVMNDGRFELVILKSLDIFLLGKIITGNMPID
SDDIVIISTDKATIKTDYPVNFQIDGEYCGAQTDLEIHILHKQMKIAIP
>EGALAKHO_03186 hypothetical protein
MTTTYSFEIYNSALLLPLEWNSLASDNIFLTREYLTVLENSCPVNMICHFIGIFEEKRLV
GIAISQFLFAEKLESFGDRDQCLKTSVRNFAFKNFASHVLFVGNNMLTGQNAFAFDENIA
PSKAIKTLHKAINQLKKDLKAKGKKVHITSIKDFTESEIKPLQAEFKKNYTFSTQPNMIF
EINENWKTEQDYIDALSKKYRDQYKRARKKAEGIVKQKMSLSDILKYEDIIYDLYFHVAK
NAPFNTFFLARNHFSFFKEIMKDDFLLYGYFLDGKLIGFNTLIKNGAIMDTYFLGYDESI
QREKMLYLNMLYDMIAYSINQGFREIVFARTALEIKSSVGAKPLKMYGLITHSNSLINHN
IARFFNYLEPKTDWQERNPFK
>EGALAKHO_03187 hypothetical protein
MEINFIALLLAGIVTLVTGFIWYNPKVFGTIWMKENNLTQEELRTGNMLKIFGFTYIFSL
MITVVLMGLTIHQSGAVGMVGGPPMLANAKPSFAAFMADYGTAYRTFKHGALHGFMSGLF
FAFPIIGINALFERKSWKYIFVHAGYWILTLTLMGGIICAFA
>EGALAKHO_03188 hypothetical protein
MKSLTLFFIAFIFSLNIYADTVSDKEKDALIKFYYATNGANWKIKWDLSLSVSTWYGVQA
ENGKVIGLYLEDNNLVGELPAEFFDLINLVTIDLHKNNLQGKLPAEIGKLKQLEVLSLFN
NEIQGDLPGSIYQISTLKVLLLNSNKLSGTLSSEIINFHALQNLSLFDNSFEGEIPKGLE
KLHNLSEMNLSYNKFKGTVSKSLALLDPLNMTMFDEDGTPFLLEINTEKETTIVTQN
>EGALAKHO_03189 hypothetical protein
MVVQYQGEQHGKATTFTIRIIGNNLSKSSSNYQIDLLVGDKQLPTFTSEIHQSLSNCLKE
IYLFRKHNGITFNASSEKIKSLFVPYDQVLYNYNKYALFRA
>EGALAKHO_03190 hypothetical protein
MKSVTSIFLFLMFVCSNSYSQLSADKIFESFKQGERTNCSSIAFIKASLNVYGLDNLFVA
EKINDSLLKITLKNNASFNLKDDEINKAKLSAGFVFIKDNCESEQITDYAILTYAVMAKY
KQIIDKEATFDRALEDLEDGEVYTPTIYKYLGFEKGKQVQKLKRESGSEFCGVVAWSTAH
AVFVCGEFMDYYGNKKSIWIKYPGRFRIIKS
>EGALAKHO_03191 hypothetical protein
MKSKIILLSVLFFLTTGAISAQAKNAPRSIISTTALIRKYHDQKELSGMQKGELLELYIE
RIKVLVKTLPYIALVTKPGVTMADLGIPDDSEHKKVLDTQALGTTTFLDTTVEFQRKMMP
YSDKGNLIAAILFYESTLKSLHEFNDLNEM
>EGALAKHO_03192 hypothetical protein
MLKKNKSQILFFILLNLFFSINSFAQKNLYAGIEIGRRAIKVSVLDVNNIRKADYDILYF
ATERFSFADHITANGELTQEDIDKASITVFNQLNKIKTDFKLLEGNIFIVAAPVFSSARN
IDVLKNKIISLTKKNLDILNVNEEPKTLVKGAIPPVDYANAFLLDIGAQTTKGGYIDELE
DDKLEFIPLELDFGTMTLTDAVQKTVANQNQANDMSVYQEKSFDFNSVLRKKIKDLLDKN
PLLLKKDKIYLSGGAVWAFATLYYNENIKEHYVSLSMEDVLNYDAILKNNFIKFTTLSKT
NKEAARVLSTYDQKYLISANNILVSCLESIPNLETKKIYFVKDGQTIWLISHIADRSKKV
NTNF
>EGALAKHO_03193 hypothetical protein
MADVLQGMLDIANFAEQYTNSVVNSEVFVEITTYQS
>EGALAKHO_03194 Neutral endopeptidase
MKNSLLLFIAILAFTACSKHQEKKNIAITGIDSTLRPGNDFFKYVNGKWYDSIQIPASQA
GVGAYMFMNYPQRMRLQGILDSLSQSKSPTGSIAQKVGDFYASGMDTVTIDKRGYAPIKP
LLAKIEAISDLPSLMNFVVNEVKVGNTSIIGFGVSPDEKNSSMNIAQIYQTGISLPDRDY
YFKSDSSTVAIQEAYKKYLTTLFQQTGSNVNDAKKNANLVYDIDKQLAISHKTKVELRDV
HANYNKIAVTDLAKRHPNIDWTTFLNKLGAQTDFINVGQPAYYDALNKLLKTIPITNWKI
YLKANSLERYADDLSKPFVDASFEYTKVLSGQAVQKSRGEKMANVVDNYLGEGLGELYVK
KYFSEDAKKRMLVLVNNLQKAYATRIDKLDWMSQVTKQKAKEKLFAITKKIGYPDKWKDY
SNVHIARDTYFENMVSAATAAYQFQLAKLGKPVDKSEWYTTVPTVTAYNNPTANEIVFPA
GILQAPYFDNNADDALNYGGIGMVIGHEITHTFDDQGAQYDKDGNLKNWWTKEDYAQFKS
RIQQVINLYSTYTVLGDLHINGAMTVGENTADIAGIAVAYDAFKMTQQGKGNTKIDGYTP
DQRFFISIAKIWRVKMKDEFLRLWINNNPHSPPNWRVNGPLMNTTPFYEAFNVKPGDKMF
LPKKDRITIW
>EGALAKHO_03195 tRNA pseudouridine synthase C
MLEILYQDEYIIAINKPSGLLVHKSFYARDAKVYAIQELRNQIGQHVYPIHRLDRKTSGV
LLFALDKEVLKIMNDRFATREVEKKYLAILRGWSPEELTINYDLTNDDDITQNAITHFHR
LQNAEVDLEFNNRPTSRYCLVEAIPETGRMHQLRKHFKHIFHPILGSRPHGCNKQNKLWL
ENYDLKGMMLHAHQLIFNHPIKNEQLILNAKINEEFSRVGTILNLDLSSYK
>EGALAKHO_03196 hypothetical protein
MTFLKTLSTFLITLLIATTTFAQESKHKTKILLIGTIHFETPHLDTHELKTDDFLAPKRQ
QELEELTETLKRTNADKVMIEKPFKQQKQFDSLYNSYLENKYKLTVSEREQIGFRLAKKL
NLKQINCVDVLYLMKQDSLLAATAKEKNQLYLLNELGTTAKNFMAEIDGVVKRNSITGIL
KYLNTKELLQKNLSLYLKYMVKVGAGENYIGAEAVSEWYLRNLAIYSNVITQVNANDKYV
ILIFGQGHIPILKHLLQNNDDFEVVEVNSVLK
>EGALAKHO_03197 hypothetical protein
MNNKNHSFKEKAKEVFAEILIIVFAVSLSIWLHSWSEERHEHKDAQTFLIGLKEDLQNDI
SNLEETKKKLDKTQQQISFALHLTPKKIDSIKANHQQIQSGTNLINTIVNNGRYEGFKSS
GKINTIENQNVRNEILSYYQQTIPQIVHVEASYDKLTSKYVDLLLNGKEDEDINKTVLKQ
KTKIILSGINDFTKYNQKPYEDAIKQAREIIKEIDKEENK
>EGALAKHO_03198 hypothetical protein
MQEEITKHSKKIYKTVKNTEHKFGEKVKEIIVEICIIVFAVTISIWFHSMSEKSHQREEA
KEFLTDLNQDLNQDILLMETYSTRLKSFNKNLEKVNQYKSNYEEFKKLKINPLPPFINRE
TSTGDYDGFKSSGKIGYIENKKLKSAILKYYQQNMLRLANAEKFFGNLSVETSLRVTDKG
MESVIDDSNISRLNILGGMSTEILQVYDQQIKAANEIIKEIEKETK
>EGALAKHO_03199 hypothetical protein
MKRLLCISFLLFNSISFGQIGDPTPNFDIELAYEKPVTPGDKWDFSKKPYKKIINFENSK
CIDEFDFIGRHTKRSVFWNDFTIIDITKYNGDMVVERTKKRIYNLDRNGNKIGPDEIITT
KLNLNDRGKIIDGKTFKLTKDSIYKIIGYQYYDKKNRLLKSTDSTGQKYIANFYYSGKNL
IKNEEINQIDTKTKTITERTYKYDKDNQITFSESFRSIFKNNILTEKKSYRTVQQEFKNK
QVVRKVLKNNSETIERNYTYDQNKNLIAFIETKKNNEDGLITSQMKRTKKYENNLLVYSE
VQEGLGTPQSEFSFTYYFHSDKESLAKTETTYDKGNLQVEYLYNEYSHLIKTITTYSTKP
SRNEDVYEIEYY
>EGALAKHO_03200 hypothetical protein
MKMYMKLNTIKKNCTQHLLEQFWVMGLKENWFCVWDLANPNNGINLVPNPL
>EGALAKHO_03201 hypothetical protein
MFTRNANKTKMKSIVQHLREEKNLTQTELADKSGLSLRTIQRIEAGNIPKGFTLKALANA
FETQPEKLIPFKEIAKLDRAKLINFSSLVGLLIPFGGVVFPLILTYKTKDTKNKELGKNI
VSVQILIAVALAVSQIASPFIQKGLSLHFPLFIFPLLLIICLKLLVVIVNGISLNTKKDL
HKSLKINYL
>EGALAKHO_03202 hypothetical protein
MKVLKKIVLNILAVLILAVLGGYIYFDNKFTPEKNYLSVGSESGFVPLTWLGTEKNVLLL
PLHFSNDTITYYLQFDTGSPYTIFYSNPIKKIRQISVYKELAKTSFYIGKTKITSDKFKI
YDQGKSDNDSIKIIGTIGADILENRKTLINFKENYIALNLSKMPAQFQDKLFDFKFKKRK
IIFRGLLKNKKENFLFDSGTSAYELLTNKEVWADLKLPNSKINIEKSKSWDKVLTAYTAN
CNQKIEFYNREISLKNVTYVEGFSQAQYAMMKFSGMTGMLGNKIFLNNSLYIDCTKNKIG
IQ
>EGALAKHO_03203 hypothetical protein
MNRIIYVLALALLTSCSTLTKSVENESVFSVALDTLTLLDQSRNREIPIAIYKPQTKHPQ
LVLISHGYSQNEGRPYLGYSDLANFMASKGYFVVSIQHERPTDSLIPEKGIPQIVRRPFW
ERGADNILLVINELKKSNPEIDFKHITLIGHSIGGDMTALFPQKYPGIIYKIITFDNRRM
ALPRTTNPKVYSLRSSDQPADPDVLPTEAEKKKYGITIIKLPNTIHSDMCDNATDKQREE
IRDYVLMFLND
>EGALAKHO_03205 hypothetical protein
MASKMNDFSSIEYLKAEMRSKLLHQKTKNFD
>EGALAKHO_03206 hypothetical protein
MTKKTIILIGFIILKFVLQYILLSPEYDLQRDEYLHLDQAHHLAWGYLSVPPVTSWFSYI
IFLLGNSVFWIKFFPALFGVLTLIIVWKTIEILKGNLYASILAATCVLFSCLLRLNMLYQ
PNSLDVLCWTAFYYVVIQYITTEEKKWFYIGSIVFAFGFLNKYNILFLLIGLLPALLLSN
QRKILAEKKLYIALVLGLLLILPNLLWQYNNHFPIAHHMKELAETQLVNVDRVGFLKEQL
LFFIGSFLVILSALYALLFYKPFTKYKFFFATIIFTLVVFLYFKAKAYYAIGLYPIYIAF
GAVFLSEILKTSWRHYLKPVFILIPLLLFIPMYNLAFPNKSPEYIVSHPQKYEKLGMLRW
EDGKDHALPQDFADMLGWKELARKTDSVYTSIPNPKETLILCDNYGQAGAINYYTKKGIK
AVSFNADYVNWFDLNIEYKNIIRVIEYEEAENEFKETSQYFQSSAYVTQITNKYAREYKT
SIFTFIGAKGNINKILKQEIKNVNDYGK
>EGALAKHO_03207 Kynurenine 3-monooxygenase
MLLKDKKVAVIGAGPVGLTMAKLLQQKGINVNVYERDENAETRISGGTLDLHKDSGQQAL
KKAGLLENYYKIAIPMGIIMTDAQTKVLSSHPPQYDNPEINRNDLKRIMLDSLTNETVVW
NRKFTGLSTNNEKWLIHFENEKDEIADVVIGANGGMSVARKYVTDNEVEDTGTFIIQGDV
SQPEINCPEFYQLCNGSRLMTAYEGNLFVANPKNNGALSYGIIFKKPENFMDNNKRLNFQ
NNDSIIKFLSDRFYNWHECYQNLFKSTSFFVGLSTRKISLNKPWKNDRVLPITLIGDAAH
LMPPFAGQGVNIGLLDTLILSENLTNGKFDSINEAIKDYEQKMFAYATEAQFESNKNEME
MHHPEFSFQKIFSN
>EGALAKHO_03208 HTH-type transcriptional activator Btr
MRSSKTLHQEFEVPEALQNIIKCFWYNRNEFGTQESSFEVMPDGYAEIIFYFGSSLSISE
DEVLYPLSSPFMMGLLNHPAHFSTKNCLEIIGIRCFPWTIFDLLGLSSRKKGVQIFEHPI
SKLQSVLQEFINTGKIEEAISYTKQYFTDSHLFNTDNSLLSKAGFAIRNNNGKISVNQIA
EEACTTVRTLERNFKQSSGHTVKDVAGLTRFEQVRNYLWHHPDTNLAGLAHEHGYTDQSH
LTREFKRYSGTTPSAFARKGKKEKLALSNDFVAFVQS
>EGALAKHO_03209 Chaperone protein ClpB
MDEGKLHDRLGKEGDFSNAIILFTSNIGADHIVETFNKGQIPSSNSLMEIMGNYFRPEFL
GRLTEIVPFAPISKENALKIFEIHLKKEFTDLLKNINIDVEVPMEVKLYLAENGYNAKYG
ARPIKSIIRSHLRRPLAKKIISGEVKDGDKIIVAIENKELKWIKKEIVL
>EGALAKHO_03210 hypothetical protein
MVNRGSTELFEWMTNNFERKDGSVKFIKRDSNATLKELKFTEAYMVKYKENFDHNSENPL
TETFMISARKISMGGGEFDNAWV
>EGALAKHO_03211 hypothetical protein
MSFLSKLHIDGEEYNVLDFNINFRQDIDTASKPTGNPKGGIINMTLEATNNSLFLSWMLS
GDLTKDGKISFYRRDAMSKMKELKFVKAFCINYHEQFTSTTEIPMKITMELVTKELTFGD
AKFVNNWIELD
>EGALAKHO_03212 hypothetical protein
MKIKFILMILLFYSCSDNNFQGHVYDYDTEKPLKNVYVKINDNSTQTDNTGWFSIKIKSN
STIAIFLKREGYASKKIYRKPDSSGGYSQKKLKENAIYLYNKESDFFNKRIKK
>EGALAKHO_03213 hypothetical protein
MRQERIKDRVLKRAATAWGFSDVEIENSFDPVVAMMLNALSYELEKVAHELEDSKTRVVE
RVLEIMFPEVTSGAKPTRGIMHALPIENNLKVSLYNQMKVSKRIHNIYNPLVPIIKEIVL
SPTLEVKLSGCEVKYIAYERNLFKISNLFYKDTVHDYSTTLPSGEVILGIELKANLEEIE
DLMLYIDIKNTHQKEMFHYYLKQMKCFYDDIEIKVEEGYNVSINKLNVENIINRNYSQLS
EIMQEVNEFYFDNFYTLKGVLKHKEITEYSSEYAHLKEISKNNENKVIWIKMVFPESLVP
QIIDNISFTANCFPVVNKKYHSTGKTFGTFLSYVSLDTDNDIYLDVDSVVDSLNIHYEIK
EFKADVIEEGNAVLRTGGVSRFDSRSASELLQNVLDLLKDESSAFSGLGKDFMNSSLNQI
NQLLSSIHQQVKENSFSKNNDPYLMIKPRNDETVGKSFTISYWSTCAEEGNDVKAGTILE
SKDDLFFISQTLTLMTNTVGGINKQNNKDRILAYRNALLTRGRIVTFADIKAFGFDHFKN
SITDIKIEKGTRKEISVKAGFSRTVDICIKTNFTEKKYLSESEWNYLCDTFLRNLQTRSS
NIFPYRLFIED
>EGALAKHO_03216 GTPase Era
MSHKAGFVNIIGNPNVGKSTLMNAFVGERLSIITSKAQTTRHRILGIVNGEDFQLILSDT
PGIIKPAYEMQESMMNFVKSAFEDADILVYMVEIGEQDLKDEAFFNKIIHAKIPVLLLLN
KIDNSNQEQLEEQVAFWTAKVPNAEIFPISALQNFNVPEVFSRIISLLPESPAYYPKDQL
TDKPERFFVNETIREKILLNYSKEIPYAVEIVTEEFFEDEKIIRIRSIIMVERETQKGII
IGHKGAALKKVGTDARADLEKFFGKQIHIELVVKVNKNWRSNANMLKRFGYNQ
>EGALAKHO_03217 GTPase Der
MNNIVAIVGRPNVGKSTLFNRLIQRREAIVDSVSGVTRDRNYGKSEWNGKEFSVIDTGGY
VRGSDDVFEGEIRKQVELAIDEADVIIFVVDVEEGITPMDDVVARLLRKVTKPVLLAVNK
VDNAMREKDALEFYNLGLGEYFTFASISGSGTGDLLDALIESFPVKPEPVQEEVVLPRFA
VVGRPNAGKSSFINALIGKERFMVTDIAGTTRDAIDTKFDRFGFEFNLVDTAGIRRKAKV
KEDLEFYSVMRSVRAIEHADICILVIDATRGFEGQDQSIFWLAEKNRKGVVILVNKWDLV
EKDTMSTRDYEEKIKKELMPFTDVPILFVSALTKQRLLKALEATVQVFENRKQRIATSKF
NEYMLKVIEAYPPPATKGKYVKIKYCMQLPTLTPQFVFFANMPQYVKEPYKRYLENKIRE
NWDFAGVPIDIYIREK
>EGALAKHO_03218 hypothetical protein
MTRIYSFLLFFLFCFAANAQNDIIVKGTVVDINTQLPLELATVYFTTVKDSTIIEYATTD
KNGVFRINTKKYDKPLLLKINYVGYQPYIEEQKGLLESKDFGKLYVLENVNALDNVVVKS
AAPPITMKKDTLEFNAASYKVRPDSNVETLLKQLPGVDVDNDGKVTVNGREVTQFLVNGK
TFFDKDGALLLKNLPAEIIKKIQVSDFKSKKEELAKQESTSDYSSINLTIDEKKNKGYFG
KILGGYGSDDRYESSLLMNFFNNKRKISVLGSSNNINSTGFAQDEVFDNMGGGRNNSSKN
SGSTGSGKGITQSNLFGVNYTDDWSEKLAAMGSYNFSNTINKNESKANQLSFLPTGNIIT
ESDAKTRNENTGNKANFELEYKIDPTTRLVFAPKLNQSRSNSDSFSSTSSVDENGDALNE
STAKSYNESTNTSFANTINFNKVFKKKNRNLSFVFDNNNSKTDSDGFNQSETIFYQDSKP
DDLRNQNTKNNSTSDSYSADIEYTEPITDSLRIRFGSDFDWKNEVKDQKTFDFDAATQSY
SELNESLTTYTTSRQNSVSPKVGITLQKNKFTLNLDSKTSLVDFDNYSLYLGKETQLNKK
YALPFATAQFRYKFSRSKNLTLKYDYSSTLPAANYLMPVANLSNPLNSIIGNPNLDPIEK
NTVNFNFRNFDFRTRSGYSFMAKGDYYSNDIYATSVYDDSGKRTTSYINISGTYTVSVGG
NWSQSIKRDAHVLRYGLALNGSYSFDKGFTNAVMYNAKSTAISPKVYMTYEYGEVLTISP
SYSLSYNETKYENYNRDASSNVLHRINLQTTSYWPANLIFGNDFGYTYNSNISGDFKKDF
FLWNTSLSYGFFDKKVYAKVKVYDVLNQNQSATRTISATSIRDEENTVLKRYMMFSLAYK
IGNFSAKEKGQKRRGGGAERQGEE
>EGALAKHO_03219 hypothetical protein
MKILRIFFLLGFLSHIGIAQTKRNIDQQTLTWIRYYNIFPLTEKWALHSEFDNRSFLNPV
HENLFVIRVQGRYRANKLVDLGSGFAFFNVNTQDPHFDPDFSVPEYRAQQDITLINDIAK
ITFHNRFQLEERFMQKATKTELIDDFSFSFRFRYRLQSTFDLWKKEKRSIKGTISDEVLL
NFGKDNKRNTFDQNRLYAALRYHFNPNIGLEVGYLKSFQRRASGVDFYDRDIIRFTFYHR
IDRKMKK
>EGALAKHO_03220 hypothetical protein
MLFCDYKKNEASLRTCLVLYFKIQLISYNEYFNVTP
>EGALAKHO_03221 TonB-dependent receptor SusC
MKNLYKISLTSIFILLAFTTSYAQNIEGVVTTSENTPLEAVNVVIKGTTSSTTTDSNGKF
SINTKGKLPVTILVQYVGYKTTEIELDAIPATPLLVTLKEENELVEVVVSSRRRIEKVQD
VPIAISVITGKQAEQTGAFNVNRIKELVPSVQLYSSNPRNTGINIRSLGSPFGLTNDGID
PGVGFYVDGVYYARPAATTLDFIDVEQIEVLRGPQGSLFGKNTTSGAFNITTRKPSFTTG
ADFEVSYGNYAFLQAKASVTGALGKKVAGRISFSGTQRDGLIDNVVTGRPTNTLNNQGIR
GQLLWTPTVNTNIILAADITTQRPDGYAQVVAGVAPTQRAAYRQFDAIIKDLNYQLPSLN
AFDRKIDHDTPWRSGQDMGGISLNIDTKIGGGTLTSTTAWRFWNWDPSNDRDFTGLQVLA
KSQNPTRQTQITQEVRYAGQITSKISGVAGVFFIDQTSQTDGTEESGNAQWRFAQSTTSP
LWKTPGLFEGYGIKTDANIRASSAAVFGQLDWAITDRLHILPGLRYNFDKKDAHYARTTY
GGLQTTDPALLALKKLVYSDQAFDSSTDNTDFSGNLTLTYKASDKINAYATYAKSYKPVG
VNVAGLPTDAKGQPLLELAVIKPEKVNHYEVGVKTSPFRNSIFNLALFNTEIKDFQTNVQ
AAELGVNRGYLANADKVRVRGAELDASFVVSQHLTINGAATYTEGTYVKFTNAPLPLEET
GAPVAYKDVSGTDLPGASRWAGSLGGELSDNARFFGNAGKIFLAVDSYARSEFSSSPSAS
KYLVVPGYAIFNARLGFRASQGLSIHFWGRNLLNKDYYEQLLPAGGNSGQYAGVIGDQRT
YGVTLKYSL
>EGALAKHO_03222 Putative HTH-type transcriptional regulator
MLSHKAKYALKALLYLAEQDENHISRTIEIADGANIPKKFLEQILLDLKRGRFVSSKQGK
FGGYYLIKSKNEITLAEIHRLFDGAIALLPCASLNFYEPCADCKTESECSLRHGLLLIRD
KTLKAMEGITIASLVKK
>EGALAKHO_03223 hypothetical protein
MKNSNNKIPNSKGIFQFTFLLIAFFICNSIFAQFTIPEKPSLQTSVYDYANILSAGEKSQ
LEEKLIHYADSTTTQIVVITIESLKGEDVSQLATKWGQTWGIGGTAKDDNGVIILLAKNE
KKIAINPGYGVEDRLTAGLGGTIIRNIIIPEFKAGSFYNGLDKGTDAIIDVFKGKFKGER
KQTQGKGFPIFPFIVIVIIVLILLSRNKRGGGGNSGNNGGGPSLMDVILLSSLGRSGGGG
FGGFGGGSSGGGFGGGGGGFGGGFGGGGFSGGGSSGGW
>EGALAKHO_03224 hypothetical protein
MSQVEDFLSKEDEQAIVEAIRVAEKNTSGEIRVHIEQTTSKVPFDRALEVFYDLKMNETQ
QQNGVLFYFAVADKSFAICGDKGINDLVSSDFWDCTKDKMTEQFKAGNFKQGIVDGILNA
GEQLKKYFPWSENDTNELSNEISKG
>EGALAKHO_03225 hypothetical protein
MKRFLPWIIGAVLIIIIYSWVKGINNTAVTLNQTVEQSWGDVQTAYQRRNDLIGNLVNTV
KGAADFEKSTLTAVIEARAKATSVTVDPSNITPEQLAEFNKAQSGVSSSLSRLLVSVEQY
PTLKANENFLKLQDELASTENQILTARTRFNEAVAPYNNHIKTFPNSLFAGMFGFKEKAY
FNAVEGADKPVEVKF
>EGALAKHO_03226 HTH-type transcriptional repressor BluR
MHIELSKDKRYYSIGEVAKAFNVNASLIRFWDSEFDILKPKKNAKGNRMFTPEDITNLQL
IYHLVKERGFTLEGAKTHLKEGQKKTLDKFEIIRKLETIKTQLNEIKNEL
>EGALAKHO_03227 Murein DD-endopeptidase MepM
MAKVKYYYDSENLAYTKIKTRKRAKIGYALLFLLASALFGFLVFVLLINTPFFETPKDRL
QAREIENLKLQYAILNKKMDEIDDVTEALEDRDNNIYRVYFNKTEIPDSIRKAGFRDPKR
YKDLEGYNNSQLVLNTTKRIDKLSKELAIQSKSLDEILKLASVKGSLLLAIPAIQPVQNE
NLKRVASGFGYRIDPFTKVRKMHNGMDFTANTGSPVYATGDGVVARADNSASGFGNHVVI
RHGFGYESLYAHLSKYNCRPGQKVKRGDVIGYVGSTGRSEGPHCHYEVHKDGKVVNPLNF
YYGNISAVEYVAISQMANQENQSLD
>EGALAKHO_03228 Alanine--tRNA ligase
MKSQDVRKQFLDFFESKGHTIVPSAPIVLKDDPTLMFNNSGMAQFKEYFLGNGTPKSPRI
ADTQKCLRVSGKHNDLEEVGIDTYHHTMFEMLGNWSFGDYFKKEAINWAWELLTEVYKID
KDILYVTVFEGSEEENVPFDQEAYDIWKTLIAEDRILLGNKKDNFWEMGDQGPCGPCSEI
HVDIRSAEEKAVTPGKDLVNNDHPHVVEIWNNVFMEFNRKADGSLEKLPAQHVDTGMGFE
RLCMVLQNVQSNYDTDVFTPLIKEIESITGSKYTIKASNEAEEKVNIAIRVIADHVRAVA
FAIADGQLPSNTGAGYVIRRILRRAIRYGFTFLDTKEPFIYKLVEVLSTQMGGSFPEIRI
QKSLCANVIKEEENSFLRTLDQGLILLENIISNSTETTISGKKAFELFDTYGFPIDLTAL
ILSEKGLQLDEAGFESELQKQKERSRAASKVKAGDWQILIDDEDEEFIGYDHTEAKVKIT
RYRKVESAKDGEVFQIVFNMTPFYPEGGGQVGDKGYFEASNGDVIYIFDTKKENNVIIHF
AKDLPNNLTETFRAVVDKTIRKSSASNHSATHLMHQALRHILGTHVEQKGSLVNQKNLRF
DFSHFSKVTDEELQQVEDFVNARIQEQLPLIERRNVPFKQAVEEGAMALFGEKYGDNVRA
IKFGDSMELCGGIHVNNTADIWYFKIVSEGAVASGIRRIEAITADAVKEYFASQADKLKE
INGVLKNAQDPIKAVISLQDENAKLKKQLEALLKDKAKNMKDDLAKELQEINGIQFLAKQ
VDLNPEGAKDLAYELGNSSKNLFLVLATAEEGKPMLTCYISKELVAEKNLNAGQVVRELG
KYIQGGGGGQPFFATAGGKNVDGIAEALAHAVDFIK
>EGALAKHO_03229 Lipid A export ATP-binding/permease protein MsbA
MKLLYSYIIKHKMLLFFALIMASINICFSLSDSIITGKLMQDCGVGLHKYAGNPTGFIKS
LSFWLGLSLGAAMISRITKNFQDYFTNVVIQRTGAQMYTDGIKKSLDLPFAEFEDQRSGE
TLSKLTKVRSDSEKLITLSISLIFQTVIGFVFVIVYVARIDYRISLIFLITAPIIALVSS
YLGKKIKVVSKKIVNQTNALAGSTTESLRNIELVKSLGLTYQEEKRLNLNTFKILHLELE
KIRFIRSLSFIQGTTVHFLRTCVVFTLYYFLFGNKIIVGDLLTMVFFTFFIFGPLQELGN
FIIALNETKVSMENFKILLSAPKEFRPKNPKHVGAIQSLLFSNVSFQHKTAKFKAVENIN
FDIKQGETVAFVGPSGSGKTTLVKLLVGLYTPAEGQVLYNDIDSTEIDLLDLRKQLGFVT
QDAQLFSGTIRENLLFVKPNATDEEVYDALKRASCEKLLKRAEDGLNTTIGEGGIKVSGG
EKQRLSIARAILRNPNLLIFDEATSALDSITEEEINATIRNISDKNRITVLIAHRLSTVM
HADKIFVLEQGKIIEQGKHEELIVERGLYYAMWRQQIGERK
>EGALAKHO_03230 hypothetical protein
MQFRTQIPLSKSNNPIDYNSKVLSFGSCFAENMAEKFDYFKFQNETNPFGIIFNPVSIEK
VIERTVNEKEFTEKDVFFYNERWHSFEVHSDLSNSDRQELLETLNKAISETHNQLKEVTH
VIITYGTSWIYRNLESDEIVANCHKVPQKQFSKELLPVDVIQKSIQNTIDLIQTLNPNVN
FIFTISPVRHIKDGFAENQLSKSHLFTAVHEVLKTHNSKLITQNYFPSYEIMMDELRDYR
FYAEDMLHPNQVAIDYIWHKFSENYMTEESISLMQEISEIQKSLRHRSFNPQSEQHQEFL
AKLQQKIKALGEKYPNITF
>EGALAKHO_03231 hypothetical protein
MNTKTIHLLKKTLRILLWCVGSIIALLLLVIILIQVPSVQNFVKDKAITYLHDKIKTKVA
LDHISIKFPKDVVLEGFYFEDQKKDTLLAGKRLVVDVDLFKLVSSELEINSVSLENTTAN
ISRNKDGVFNFDYIIKAFESKEPEKPKDPDSKPFKISVVKVNLDNIKFNFKDDYSKNDVR
VKLTHFDTKFNEFDLDKMNFDIPNIALNGLKVVLNQDVVEKIAEVSVKTVDTISKRKDFS
LKLGKISLSQIDLLYDNKDSKLDSGIKLGNLDLSVNKIDMNNQFLDFDTFEVKNLKGNLR
LGAKDKQIQAPSLDTTAIKQSGWKVKLADVNLENIAFKFDDMQSKPVSKGIDYSHMDLDK
FNFKAEKLYYGNDTISGNIKALAINDKSGLQIQSLKTNFFYGPKNASLENLYLRTPQTLL
QNKIKVAYSSLDALKKDIANLNLDANLNQSKIGFKDILLFAPDLQKSNPFKSNPNAILYL
NTRLSGKVKDLNIPQFEMSGIGTTKVSLSGKINGLPDAQKAYYDLDIKKLSSTSKDIYGF
VPAGTIPKNIQLPSQLSLQGKFKGSVQNFKTNLALNSSFGNAKVDALFDQRVKRREKYDA
TVYLLDFDLGRLIKNDSIGKITLKAKVKGKGLDPKTAQANFDGLVQKAVFNKYTYRDLAL
KGNIENGSFAVKSGMKDPNLNFDLVASGNTKDKYPSVQLKLNLDIADLEKLHLHAGPMKL
RGNVDADIANSNPDFLNGKVFLSNIQVLQDKEPIVLDSIRVIAFSDESRNNIKISSQFLK
AEVDGKYKLTTLASAIKKSLSKYIDLKNPKVNGESDEQRLAFTLTVDNDPILFKLVPKLT
GLEPLKIEGKYNNVTDSLEIKGTIPRIVYAENTIADGKINIEAKENALEYQISVATIESG
SLKIPFTSLSGKVENNILDYALEVKDAKDKQQYFIAGNFKAEDSKNIFKIDAENFVLNYD
KWNIDPENVVEFGPKRLYINKFFLANSGNELKIQSQGTQDNAPLKVDFVNFKIETIMNMV
KKDKLLMQGLINGNAVAENVMKKPTFTSDIKIDDFAFKGEPVGDIAVKVDNKTNNLLNAN
VTLTGEDNDVNLTGTYAISDGNLDFNLDLNKLNIKSIQGFSMDNIKEGTGYLSGNFKITG
NASAPKVNGELNFNDTGFRVTKFDSYFKTKQEKITLQNDVITFDSFTFNDENDNELTING
TIKSVDYTNFDFGLTVVADDFRAIHSKEKDNDLFYGDLILDTKLNIKGTLENPVVSGNIK
IKDDTKFSVVLPQSDPSIADREGIVEFVDEDNVYLRQTAEMKAKLNQSELLGMDVSVAIS
IDKEAELTLVIDKGNGDYLNLKGEAELIGGIDPSGKTTLTGKYEFSDGAYEMNFNMIRRK
FNIQKGSYIIWNGEPTMANVNITAIYKVDAAPIDLLGNQLGNDSQTVKNTYKQKIPFQTL
LKMNGELMKPEITFDIVLPDGNYDVSSAIVETTQQKLEQLRQEPAELNKQVFALLLLNRF
IGENPFASEAGGTSAESLARQSVSKILSQQLNDLAGELITGVQLEFDLESTDDYTTGTRE
DRTDLNVGVSKKLLDDRLKVTVGSSFAVEGQERANEESTNIAGDVALDYQLTKDGRYMLR
AYRKNEYQVAVEGQVIETGVAFIITMSYNKFRELFHRSLAEKEMIREEKIRKEKKKLKDK
ENKDKEKDENQLEGNEQKT
>EGALAKHO_03232 Outer membrane protein assembly factor BamA
MSKKHSHIKAKYVRYFIALSLFFVFGCSNTKYLPEGELLYTGGSVTVKDSVIKKKERKEL
ENELEGLLRPKPNKGFLGLRPKLWIYNIAGEPKKQKGIRYWLRTKVGEPPVLFSKVDLDY
NASVLRNFTENRGYFKTRVSADSTAKNKRATAEYTVTPKQQYIIKSVTFPDDSLAMSRII
GRSSRRSLLKVGKPYDLDVIKAERERIDARLKEKGYYYFNPDYILAQVDSTKGDHEVKVR
LVIKADAPPKALTAYKINKIIVYPNFSISKDSLKYTKEDVVQYKDFTIIDTADTFKPRVF
DRAIYFKKGDLYNRKDHNLTLSRFVNLGTFSFVKNEFKLSDSLPKTLDSYYYLTLLPKKF
IRVEVLGKTNSASYTGTELNVNWNNRNLFRGAELLTVSFFGGADFQLSGTNNGKNIYKVG
TETSLTWPRFIVPFFHVEGSSEYIPRTKATVRYEYQNRTQLYSLNSFKASYGYMWKENVR
KEHQLNIMDITYVSPNNVTQEYLDDIEKDPSLGKVIEKQLIFGPTYTYTFTNTMQKRKKN
TFYFSGEADLAGNVTGLVTGANVKEGNQKSIFDVPFSQYAKFRGDFRHYLKLGKESQLAS
RIIVGAGIPYGNSNVLPTSKQFVVGGTNSIRAFRARSIGPGSYLNTETENNYLPDQSGDL
KLEFSTEYRAKLFSIVKGAAFIDAGNIWLMNKDPNKPGAEISKDFMKEIAVGAGVGLRFD
VSFFILRTDLAFPLRKPYLPDGERWVIKDIDFGSGPWRKENLILNIAIGYPF
>EGALAKHO_03233 hypothetical protein
MQNTLKRILVLASVVFLIILAFKFCQFKKDDDKDIEYNTNLIQQQILNVGKLVVTEGHFS
EVITYKNQQKYFLNMVSFEKKALVVVNANVTVAYDLHKMKYDIDEKNKTITILNIPKEEI
TINPDIKFYDIEQSQMNQFTGDDYNKINKSVKANLAKKIESSSLKTNAQNRLISELSKIL
ILTNSMGWKLQYDGKTIESDKDFNQDLNSKL
>EGALAKHO_03234 Phenylalanine-4-hydroxylase
MNPNIETNPLLERLPKHLKQFIKPQDYSDYTPINQAVWRYVMRKNVDYLSKVAHHSYLDG
LKKTGIEVDSIPSMYGMNRILTEIGWAAVAVDGFIPPNAFMEFQAYNVLVIASDIRQLEH
IEYTPAPDIIHEGAGHAPIIANPEYAEYLRRFGEIGCKAISSHKDYQMYEAIRLLSILKE
AEDTPQDKIDEAEKAVADLQNNMGELSEMAQIRNLHWWTVEYGLIGTVEDPKIYGAGLLS
SIGESAWCMTDNVKKIPYDISAANQNFDITQLQPQLYVTPTFSYLSLILEEFANKMALRT
GGLSGIQKLIHSNALGTIELSTGLQISGVFTNVLEDEGKPVYIQTTGKTALSYREKELVG
HGTLTHPHGFGSPIGKLKGFNLAIEDMSPKDLQAYSIVENETVKLEFEGNIIVEGEIITG
SRNLHGEIILISFRNCTVTHGETILFQPDWGNYDMAIGKKVVSAFSGPADVNSFDLINIV
PSSQTIKAKHTDERDDLEVLYQTVRSIRENKDSKSELKSVFEKLKNNHSNDWLLSVEIAE
LLKDSEEKQLLQEVLVYLDQLKEKRPEVAHLISGGLELIFDKEAV
>EGALAKHO_03235 hypothetical protein
MKKAFLSLLFFLFIIISSNAQDSKSNLYKGTIDGKIAVTFFIKTEENPCTADLQYTAMYR
YDKSGSWIQLDITQNTKNENQFALVEHGFTGLMILKKDETTFSGLWISSDSKKQLKVELK
ESKMTKKETESYEAKMEKVNYENNDC
>EGALAKHO_03236 Group 3 truncated hemoglobin ctb
METLKDISNIEDIQLMVDTFYDKVRKDDLLGPIFNDKLQDRWPMHLQKMYGFWQTILFDV
RAYSGTPFPPHKQLPVDKTHFDRWVFLFKSSIDKLFAGTITEEAKMRAANMAYMFNHKID
YFRNLENQ
>EGALAKHO_03237 L-threonine dehydratase biosynthetic IlvA
MAKNKTKNMNLFNEVLAAKKQLENVVAATPLTQNLNLSDEFKSTILLKREDLQIVRSYKI
RGAYNKISSLNETEKAVGIVCASAGNHAQGVAYSCHLLQIQGKIYMPKTTPKQKVKQVQL
FGKSFVEIVLTGDTFDDAYASATADAIKNHKIFIHPFDDEKVIAGQGTVGLEILESYKEP
IDYVFVPIGGGGLASGLSEVFKHLSPNTKIIGVEPKGAPSMKTSIEENKNTALATIDKFV
DGAAVKQVGDMTFEICKENLEDIILVPEGKVCTTILRLYNEEAMVVEPAGALTIAALDFY
KDKIKGKTVVCVVSGSNNDIERTAEIKERSLLYEGLMHYFMIQFPQRPGALKEFVNNILG
PDDDITYFQFHKKNNREVGSVVVGLELKNKKDIMNIKLNMTKNGFEFQYLNDNQDLFTQL
IG
>EGALAKHO_03238 hypothetical protein
MKVFKLIPILLLLVLASCDTVSAYSDYDKTVDFTPYKTYAFFKPGIDKVEISDLDKKRIL
HAIDDQMQAKGFTKSENPDILINIFTKAKEQVDVNQFYAGYGYGWGYGWGWGWNPYMYGG
TTVSRYTEGTLFIDLIDAKKKEMIWQGQGIGTLYKNIDKKDARITEFVTKILAQYPPVKK
>EGALAKHO_03239 Urocanate hydratase
MTFKEEIQQGIPSILPPKKQYDLAINHAPKRKEILSPEEKKLALKNALRYFEPQHHAELI
QEFSEELEKYGRIYMYRLRPDYRMYARPIDEYPGKSLQAKAIMHMIQNNLDYAVAQHPHE
LITYGGNGAVFQNWAQYLLTMQYLSEMTDEQTLTMYSGHPMGLFPSHSEAPRVVVTNGMV
IPNYSKPDDWEKMNALGVSQYGQMTAGSYMYIGPQGIVHGTTITVLNGFRKIKLNPEGNL
FVTSGLGGMSGAQPKAGNIAGCITVCAEVNPKITKIRHEQGWINEIVTSTEELVKRVNSA
KANKEVVSIAYLGNVVDVWECFDKENIKIDLGSDQTSLHNPWAGGYYPVGISFEEANEMM
ANNPELFKEKVQESLRRQAKAINKHTAKGTYFFDYGNAFLLEASRAGADVMAENNIDFKY
PSYVQDIMGPMCFDYGFGPFRWVCTSGKPEDLQKTDTIASQVLEELAKTSPDEIQQQMQD
NIKWIKGAQENKLVVGSQARILYADAEGRIKIAEAFNQAIAKGEIGTVVLGRDHHDVSGT
DSPYRETSNIYDGSRFTADMAIQNVIGDSFRGATWVSIHNGGGVGWGEVINGGFGMVLDG
SKEASKRLASMLFWDVNNGISRRSWARNDEAIFAIKRAMEVQPLLKVTLPNIVDETLF
>EGALAKHO_03240 hypothetical protein
MFLIVAKYLIPKGYRGMAVFPFVIVKYDFDKINGTFVNHEKIHLRQQLEMLILPFFLWYF
LEYLIRLIQYKNKDLAYRNISFEREAYANEDDHNYLKNRSFFQFLKYITLK
>EGALAKHO_03241 D-cysteine desulfhydrase
MNQQIHINFPNNISLTIKREDLIHPFVSGNKFRKLKYNLLQAKAENKETILTFGGAFSNH
IAAVAYAGKEQGFKTIGIIRGDELFDKIEENPTLKFAHENGMKFEFVSREDYRNKSESSF
LEKLKEQFGDFYLVPEGGTNELAVKGCEEILTAEDAVFNYVCCAVGTGGTISGLINSALP
NQKILGFPALKGDFLNDEIRIFAKKDNWNLISAYHFGGYGKINLELIEFINAFFDENKVP
LDPIYTGKMVFGVIDLINKNYFPADSKILLIHTGGLQGIDGMNIKLKQKKLPILKSND
>EGALAKHO_03242 Exo-glucosaminidase LytG
MIKKILLFFIVAVLASCSSSKPAIATTKKQAEVQRPRTVAAKKQTPVKPIGKNYPSTNNT
TEVIQSTSKTVVTSSSINDYVLQYKDIAMGNMQKYGIPASIILAQGILESGAGKGDLAVS
ANNHFGIKCHKDWLGESVRHDDDSAQECFRKYREASESYRDHALFLVGKNRYASLFTYEK
DDYKAWAKGLRACGYATDPNYPDKLISYIERYNLHQYDCQITGKTYVAINKSAPTRKSSY
DVASDPKINMSSNDPNLYEVQKGDTLYSISKKFNILVDDIKQKNNLSDNAISIGQRLKVK
>EGALAKHO_03243 hypothetical protein
MKKIIAIGIFIFFTVLTIRIFCGVYIHDEFAEKHFFIKHRPTWKWTFYSPLGMSDIKIEE
LSKEKQTEQKYFNEFVRDQGLSR
>EGALAKHO_03244 Glutamate-1-semialdehyde 2,1-aminomutase
MIYKRSSQLFAEAEKVIPGGVNSPVRAFKAVGGTPIFVKSAKGAYLYDEDGNKLIDYINS
WGPMVLGHAYQPVVDAVIEKAKLGTSFGMPTELETQIAALAVSMVPNIDKIRFVNSGTEA
CMSAIRLARGFTKRDKIIKFAGCYHGHSDSFLIQAGSGAVTFGSPNSPGVTEGTAKDTLL
AKYNDLENVKTLIEANKNEIAAIIIEPVAGNMGCIPPQKGFLQGLRDLCTANGILLIFDE
VMTGFRLARGGVQELYNINADIVTFGKVIGGGLPVGAFAARAEIMNYLAPLGPVYQAGTL
SGNPLAMAAGLAMLQSLDNDRAIFTRLEEKTAYLEAGIDKVLKANNVVFTINRVGSMISV
HFDENPVVDFQTAAKGDNETFKKFFHGLLNEGVYIAPSAYETWFITDALTYEDLDFTINA
IDKVSKTF
>EGALAKHO_03245 hypothetical protein
MKKLFIAALLFVGIVSFAQDINQKPAHHQKENLTPEQRNEKHLQKLTSELTLDKKQQEQV
KQLLAERSAKAEKFKASRKDNKTKPTDAEKEAFKKQMETEKAANDAKMKAILNTDQYTKW
TALKKDHRGKHDHKSPQERDQAHLQKLTTDLNLNADQQKQVAALLSDRSTKMEMLKKSRK
DGVEPTSAEKATMKKQMEEDHKATDAKMKSILNADQYKKWTAIQKEHKDKMKDHRKDKM
>EGALAKHO_03246 hypothetical protein
MKKLFIAALLFVGVASFAQDADQDQSQDQHREHRERMTPEQRNEKQLKKLTSDLTLDANQ
QAQVKQLLADRSAKAEKFREAREANKDSNVKPTAAEKEAFKKEMMAEKEANDAKMKAILN
ADQYTKWKAIQEENKDKAREKMKEYKKENNM
>EGALAKHO_03247 D-lactate dehydrogenase
MRIFKVSMNTNLEEFIMNLESSSNNNKIAFFSTQPYDKTFFNKYNEDFGFALDFFETQLN
PQTVILIESASIVCVFVNDIVNESVIKQLAEKNVKIIALRCAGFNNVDLEAAKKYNLKVC
RVPAYSPQAVAEHAMAMILTLNRKTHKAYNRVREQNFSLNGLLGFDLFGKTIGIIGTGNI
GKAFAKIALGFGCKVLAYDIVTNAEMEKDGVEFVSLETIFKSSDIISLHCPLNEQTKHII
NSKSIEEMKDSVMIINTSRGGLIETACVIEGLKEGKIGYLGIDVYEQEEKLFFRDLSADI
IQDDAIQRLMSFPNVLVTAHQAFFTNEALTQIALVTFNNIKALVTQKDIENKAALLV
>EGALAKHO_03248 hypothetical protein
MKTKILVAFIALAMFSCQNKEKPASKNIIKTIVQDTLSKTLGGTANLSDVTAKNDKVVEL
IRKQLLVLLKKDLPALTKDQRFFYYEAYDLNNDKKDEYFVGFSNPYFCGSGGCSGYILNN
DGSVINKFTVTDFPIFIGTTSSEDFKDLIFKSDNSLHSLKIKNGKYPSNPSVQEKWKGEI
PAASPVVLDIYSKKLEKYSF
>EGALAKHO_03249 Lysine--tRNA ligase
MALSEQEIIRREKLQNLRNLGINPYPANLFPVNHTSKQVKESFEEGKKVIVAGRLMSVRD
QGKACFAELQDSEGRLQLYVNRDVLCVGEDKTLYNTVFKKLTDLGDFIGIEGELFTTKVG
AQCIRVDGFTFLSKTLRPLPLPKTDEDGNVHDAFNDPELRYRMRYVDLTVNQHVKDTFVK
RTKLFTAMRGYFNDAGYLEVETPVLQPIPGGAAARPFTTHHNSLDIPLYMRIANELYLKR
LIVGGFEGVYEFSKNFRNEGMDRTHNPEFTAMEIYVAYKDYNWMMEFAEGLLEHCAIAVN
GTSEVTFGEHKINFKAPYARVTMTDSIKHFTGFDISGKSEAELFEAARGMGIDVDNTMGK
GKLIDEIFGAKCEGNYIQPTFITDYPKEMSPLCKEHRDNPELTERFELMVCGKEIANAYS
ELNDPIDQRERFEDQMRLSEKGDDEANGIIDEDFLRALEYGMPPTSGMGIGMDRLIMYLT
NNASIQEVLLFPQMRPEKKQAQIELSDEEKFILDLLKGNENKMDLQQLKITANLSGKKWD
ASMKNLSKHGLTKVAVEGEFKFVELVE
>EGALAKHO_03250 hypothetical protein
MKIIKVLLLLLLVSSCQITETIKINPDGSGSIEVFQLRDENSYMQLGRPLSSSEKFIDTL
FVFQDYITKYKETFVKFNKSDQELFQEHANVKMHVKLDPIQMENFNVISSDFKKIEELPN
VYESLSLANSLKENYPVSKEFFKIKYTFDGFTFKRNLVIVDQEAFDKNKKMLEERKKTYG
KHKLVQSYTLKYHFPGKIKSVSNEKAILSPDKKSLTLEFQLSDCLQNPEITNLEVVLEQS
N
>EGALAKHO_03251 hypothetical protein
MMKLYKLLSFSFLLATLTSCTFTENMYINDNGTGKYSVDLDGSALMEMAGDQLGNQMGAD
AKKNIDSTFTFKQLIAEKQDSISKLSPEAQKEIKKLENFVFNIKMNGEQKQFLMNISTDF
KSVSDLQDILQSMSTLQKLEGGNAPATPFAGLGDNKSKLSYTYDGKKFTRKAIIDKQKLA
EKPADSTADMSKMMFASSNYVIKYHFPKRVKKVSNPTALFSEDRKTITIQYPFTDYMENP
DKLNFDVEFEK
>EGALAKHO_03252 Octanoyltransferase
MNKKIQLQDLGSKDYKSTWEYQEELFKDIVDLKIKNRREELELETPNYLLFVEHPHVYTL
GKSGDLENLLLNEKQLEAKGATFYKINRGGDITYHGPGQIVGYPILDLENFFTDIHKYLR
FLEESIILTLEEYGLKCGRSEGETGVWLDVGTPFARKICALGVRASRWVTMHGFALNVNV
DLGYFDNIIPCGIRGKGVTSLQVELGVEKVDEDEVKAKIIKHLTQLFEAEFV
>EGALAKHO_03253 hypothetical protein
MRKIYFLCFLFILNNVFAQKKDKLNPIAVYEKVWQEHNSDVRLKLIKTIWLDDSTFEDPS
ASIKGSIALNNVINEFYKKFPDAVLTSASKVVKDNYVSWDWKIFDSKNKLIMAGRDFARL
NGKGQVSKIIGFWDQEVSPSETEILKNLENDNYKVVAKYYESLFKTRDFTAMATIIEEGA
IYNQAEGLPYGGTYVGFNEWTKMYAKSAEFFDLEIEKEPVYFSDASKNEVIIYFTIKCKA
KKSGKTLSMPISEHFDLKNGKITAIRPFYFDTKQFAEFLKSKK
>EGALAKHO_03254 Ribonuclease HII
MLEKNYSGFILETGTDEAGRGCLAGPVTAAAVILPADFENTILKDSKQLSEKDRFLLKPI
IEQYAVCYSVTHLFPDEIDEINILNASMKGMQECILKLKHKPDFIIVDGNRALNAKLGLK
NTFGRQFSLEEIEHLKSIPNQSIIKGDGKFLSIAAASILAKTYRDLYMEQIHEEFPMYNW
KQNKGYPTKEHREAIRKHGTTKYHRMSFRLLPEQLELDFFEL
>EGALAKHO_03255 hypothetical protein
MRILFFLYLLIVPTLLFSQEKTSSKNSLDMNTKYSSITDTVKKKKALIAKIDQYKIYTLE
HDTIYADTSLTLKSAYKQNYLRKDNFGLLPFSNIGQTYNTLQYSLTDFSPYPEIGFKGKH
FDYMEASDIRYYSVATPLTELFFNTTINKGQNLDSFITLNTSKNLNFSAAYRGLRSEGDY
INQLVSAGNFRFTTSYFTTNRRYILNAHFAFQDITNEENGGITRPQDFESEDPDFKNRQR
LQVYLTDAQSLLKGRRFFFDHAFRVNPNEGNNNLYVTHQFNYEYKYFEYKQPTVLSTVTP
VVGANIQVERFGESYVTNNINDQTRFEKLYNKVGLAYENSLLGKFNFFVDDYRSNYKYDR
IIVNIDGTAIPDNLFLQINNFGGQYEYQKNKWNGRFLYTRSITNQSLSDLDAKLRYNLNE
KIQFDFRYRNINKLPNNNYNLYQSSYVDYNWSHNFKNEKINQLSANVFTPWLNAEVQYSV
LKDHLYFEDVSEEKNAPLYTQIINPAQYGNVINYLSIKASKEFKFGPFGLDNTLLYQKVD
QSDLILNVPDFVTRNTFYYSSHFFKKALYMQTGVVFNYFTKYYGNDYNPVIGDFFVQDKK
KIGGYPLFDLFVNARIRQTRFYLKAEHINALFAKSDYYSAPNNPYRDFILRFGLVWNFFQ
>EGALAKHO_03256 Putative cystathionine beta-synthase
MDFSKNILETIGNTPLVKLNKIVAEIDALVLAKVETFNPGNSVKDRMAVKMIEDAEADGR
LQPGGTIIEGTSGNTGMGLALVAIIKGYKLICVISDKQSKEKMDILRAVGAKVVVCPTDV
EPTDPRSYYSVSKRLAEETPNSWYVNQYDNLSNSLAHYEQTGPEIWKQTDGKITHFVVGV
GTGGTISGVGKYLKEKNPNIKIWGIDTYGSVFKKYHETGIFDENEIYSYITEGIGEDILP
KNVDFSLIDGFTKVTDKDAAVYTRKIAMEEAIFVGNSAGACIKGLLQLKEHFKPEDVVVV
LFHDSGSRYVGKMFNDDWMRERGFLEENVTKAEDVIKDHIDKELIVVRTEELVSHAIERM
RKYKISQIPVVDINGFVGSVDETDLFRSYVADKNVAEKPIKEVMGKPFPIVKLGTTIEEV
SKLFTKENDAVLVDLGNGKHHIITKYDIIGSIK
>EGALAKHO_03257 DNA polymerase III PolC-type
MNFTAIDFETATGYHPCSVGIVTVQDGVIVDEFVSLIKPPNNLYNPFTIQVHGIYPRDTV
NAKSFSQVFPEIERRLKNRVVVAHNESFDRNVLMKSMALYGLQYEDLNIAARWECTVKIY
KAKGLKPTKLSDCCREMKIQLNHHEALSDARACAKLYLLR
>EGALAKHO_03258 hypothetical protein
MKEDFLHYLWKFRKFETLNLRTTQNDQIVIIKTGDYLELSGPDFFNAQIKIGTQKWAGNV
EIHLKSSDWYVHHHEKDPAYENVILHVVWEHDTEIFSKNNTEIPVLVLKDYVSAEVLNNY
NSLVSPKSWISCEKQIAQIDEFVFKNWQERLFFDRLERKSKFIYDLLEETNYDWESVLFS
LLAKNFGLNTNGNTFLQIAKAIPFSVVRKESFEIENLEALLFGTSGLLNSEKEDLYFNDL
KIRYFYLLHKYQLDRVYTDPLQFFKHRPDNFPTIRLSQLGSLYNKHQNLFSKVITLKSVK
DVYGLLNVTTSLYWENHYQFDKESPQKLKPLSRSFIDLLIVNTIIPLQFAYSNRIGEFNV
EDFIVFMNEVSPEKNAIIDKFESFGITAKNAFETQTLLELKNEFCNNKACLHCAIGVELL
KSN
>EGALAKHO_03259 hypothetical protein
MSAILKLKFFFEKYGFHVSSRLADKLGMRVTSVRLFFIYISFVTAGLGFGIYLTLAFWIR
LKDLIRAKRTSVFDL
>EGALAKHO_03260 putative amino acid permease YhdG
MSIWKTKPLSVLLGEASESEKGLKRTLSSRSLVALGVGAIIGAGLFSLTGIAAADHAGPA
VTISFILAAVGCAFAGLCYAEFASMIPVAGSAYTYSYATMGEFMAWIIGWDLVLEYALGA
ATVGVSWSRYLLELLAKYGIHLPPDLICSPWETLTLSNGTVIHGGIVNLPAIFIVSLLSL
LLIKGTKESASLNNVLVVIKVAVVIIFIVLGWKFIDPTNYTPYIPENTGVFGKFGWSGIA
AGAGTVFFAFIGFDAVSTAAQEAKNPQKGMPIGILGSLIICTILYVLFSHVMTGLVPYYK
FAGDAKPAATAFAVTGYDFLQTGLIVAILAGYTSVMLVMLMGQSRVFYTMSKDGLLPPFF
SEIHAKFRTPWKTNLFFLVFVSLFAGLVPVSDLGHMVSIGTLLAFVLVCIGVMVMRKKMP
DAPRAFRTPWVPFVPVAGIVICLALMYSLPNESWARLVIWMALGIVIYFAYGKKNSKLNN
PDK
>EGALAKHO_03261 hypothetical protein
MLNFKALALHFKFTSQQRTGIFLLFLIIIILQTIYFFTDFNLSEKSFPEKQEWLSLQSEI
DSLKLNKHNEKPKLYLFNPNFISDYKGYKLGMSAEEIDRLLAFRKENKFVNSAEEFQKVT
KISDSLLKIISPLFKFPDWIQKENNFKTEKKEFIKKPDLKKEKIVALDINEATQEDLVKI
YGVGEALSLRILKQKEVLGCFVSMEQMNEIWGLSPEVVTQLNAHFKVVLPANFKKIAIND
ASLKELSQFSYFRYSLAKQIITYRSMNGDFKNIEDLSKIKGFPVEKAKIISLYLEF
>EGALAKHO_03262 Acyl-CoA dehydrogenase
MNFDYNETQSMIAQSIKDFAEKNIRPNIMEWDEAQIFPIPLFKKLGEMGFMGVLVPEEYG
GSGLGYHEYITVVEEISKVDPSIGLSVAAHNSLCTNHILTFGNEEQKKKWLPKLATAEYI
GAWGLTEHNTGSDAGGMNTTAVKDGDFWVVNGAKNFITHAISGDIAVVIVRTGEKGDSKG
MTAFVFEKGMQGFTSGRKENKLGMRASETAELVFDNCRVPDANRLGEVGQGFVQAMKILD
GGRISIGALSLGIAKGAYEAALKYSKERYQFGQPISNFQGISFKLADMATEIEASELLLH
KAAFLKQQHKPVTTLGAMAKMYASEACVKIANEAVQIHGGYGYTKDFPVEKFYRDSKLCT
IGEGTTEIQKLVISRNLLKE
>EGALAKHO_03263 30S ribosomal protein S21
MLIIPIKDGENIDRALKRYKRKFDKTGTVRQLRARTAFIKPSVIKRAQIQKAAYIQNMRD
GLES
>EGALAKHO_03264 Tyrosine recombinase XerC
MKSNKDAFRDYLQLEKKYSIHTVNAYLNDIIFFETFNKENFQQESIEKVNYSQIRSWIIS
LVDQNISNVSVNRKMASLKAFYKFLLKTKQIEVSPMLKHKALKTPKIVQIPFSEKELSDL
MSQVGSPVGFEEIRDKLIVDMFYTTGMRRAELINLMINNVDSVSSVIKVLGKRNKERIIP
VLPIITDQLKMYLDERDLVENIADADYFFISKKGLKLSESFVYRLINSYFSRVSEKVKKS
PHVLRHTFATHLLNNGADLNSVKELLGHSSLASTQVYTHNSLAELKKVYGDAHPRNR
>EGALAKHO_03265 Ribosome hibernation promotion factor
MGMLILGIDNASEMFNHKINIMKVDVHAVNFTVDRKLVDFIQERMDKLEKYYDRVVSADV
FLKVERTSDKENKAVEIKINVPGDDFLVKKQCKTFEEAVELSAESLERLLVKRKEKIRAH
I
>EGALAKHO_03269 Elongation factor Tu
MAKENFNRSKPHLNIGTIGHVDHGKTTLTAAITKVLSDAGYCQAKSFDQIDNAPEEKERG
ITINTSHVEYETANRHYAHVDCPGHADYVKNMVTGAAQMDGAILVVAATDGPMPQTREHI
LLGRQVGIPRIVVFMNKVDMVDDAELLELVEMEIRDLLSFYEYDGDNGPVVQGSALGGLN
NDPAWVPKIIELMEAVDAWIEEPVRDVAKPFLMPVEDVFTITGRGTVATGRIETGIANTG
DPVEIIGMGADKLTSTITGVEMFRKILDRGEAGDNVGLLLRGIDKESIKRGMVIIKPGSV
KPHATFKAEVYILKKEEGGRHTPFHNNYRPQFYVRTTDVTGVITLPEGVEMVMPGDNLTI
NVSLLSPIAMSVGLRFAIREGGRTVGAGQVTEIVG
>EGALAKHO_03271 Protein translocase subunit SecE
MTKVTNYLSEAFEELKSNVTWPAWAEVQKLTIVVAVFSILFALATWGVDEFFAKALAGFF
NWLKG
>EGALAKHO_03272 Transcription termination/antitermination protein NusG
MADNNVKKWYVVRAVSGQENKVKAYIETEIARLGMGDYVSQVLVPTEKVVTVKEGKKMSK
DKVYFPGYVMIEANLIGEIPHIIKSITSVIGFLGEIKGGEPVPLRLSEVNRMLGKVDELA
VNTDTRAIPFNLGETVKVIDGPFNGFNGTVEKINEEKRKLEVMVKIFGRKTPLELSFMQV
EKV
>EGALAKHO_03273 50S ribosomal protein L11
MAKEISKVVKLQVKGGAANPSPPVGPALGAAGVNIMEFCKQFNARTQDKPGKICPVQITV
YKDKSFDFVVKTPPAAVQLLEAAKLKSGSGEPNRKKVASVTWDVIKAIAEDKMVDLNAFT
IESAMSMIAGTARSMGITVSGDAPF
>EGALAKHO_03274 50S ribosomal protein L1
MAKLTKKQKEAASKIEKNKLYSLKDAAALIKVIASAKFDESVDIAVRLGVDPRKANQMVR
GVVTLPHGTGKDVKVLALVTPDKEAEAKEAGADYVGLDDYLQKIKDGWTDVDVIITMPAV
MGKLGPLGRILGPRGLMPNPKTGTVTMDVAKAVAEVKAGKIDFKVDKTGIVHAGIGKVSF
GAEQIYDNAHEIIQTLIKLKPTAAKGTYIKGIHLTSTMSPAIALDPKAV
>EGALAKHO_03275 50S ribosomal protein L10
MTREEKSIAIEDLTAQLAGTNIIYVSDISGLNAETTSNLRRACFKAGIKLEVVKNTLLAK
AMEASANDYGDLPSVLTGNSAIFISDVANAPGKIIKDFRKKSAKPVLKGAYINSEIYIGD
DQLDALATIKSKEELLGELIGLLQSPAQRIISALQNKFAGSEEEAEA
>EGALAKHO_03276 50S ribosomal protein L7/L12
MADLKQFAEQLVNLTVKEVNELATILKDEYGIEPAAAAVVVAAGGGEGAAEEAQTEFTVV
LKEAGASKLAVVKLVKELTGLGLKEAKDVVDGAPSNVKEGVSKEEAEGLKKSLEEAGAVV
ELK
>EGALAKHO_03277 DNA-directed RNA polymerase subunit beta
MITNQTERLNFASTKNIPDYPDFLDVQVKSFKDFFQLETKSDERGNEGLYNTFMENFPIT
DTRNNFVLEFLDYFVDPPRYTIQECIERGLTYSVPLKARLKLYCTDPEHEDFETIVQDVY
LGTIPYMTPSGTFVINGAERVVVSQLHRSPGVFFGQSFHANGTKLYSARVIPFKGSWIEF
STDINSVMYAYIDRKKKLPVTTLFRAIGFERDKDILEIFDLAEEIKVSKTGIKKYIGRRL
AARVLNTWHEDFVDEDTGEVVSIERNEIILDRDTIIDKDNVEEIIDSNVKSILLHKEDNN
QADYAIIHNTLQKDPTNSEKEAVEHIYRQLRNAEPPDEETARGIIDKLFFSDQRYNLGEV
GRYRMNKKLGLDIPMEKQVLTKEDIITIVKYLIELINSKAEIDDIDHLSNRRVRTVGEQL
SQQFGVGLARMARTIRERMNVRDNEVFTPIDLINAKTLSSVINSFFGTNQLSQFMDQTNP
LAEITHKRRLSALGPGGLSRERAGFEVRDVHYTHYGRLCPIETPEGPNIGLISSLGVYAK
VNGMGFIETPYRKVTNGVVDLESTPIYLSAEEEEGKMIAQANIEMDASGKITASNVIARE
EGDFPVVEPSAVHYTDVAPNQIASISASLIPFLEHDDANRALMGSNMMRQAVPLIRPEAP
IVGTGLERQVASDSRVLINAEGDGTVEYVDANIITIKYDRTEDERMVSFDADEKTYNLIK
FRKTNQGTSINLKPIVRKGDRVVLGQVLSEGYATQNGELALGRNLKVAFMPWKGYNFEDA
IVISEKVVRDDIFTSIHVDDYSLEVRDTKLGNEELTNDIPNVSEEATKDLDENGMIRIGA
EVKPGDILIGKITPKGESDPTPEEKLLRAIFGDKAGDVKDASLKASPSLHGVVLDKKLFA
RAVKDKRKRTQDKDALGALEMEFETKFVELKDRLVEKLFLIVNGKTSQGVMNDLGEEVLP
KGKKYTQKMLYAVEDFAHLSKGQWVADDATNKMVNDLIHNYKIKLNDLQGSLRREKFTIT
VGDELPSGILKLAKIYIAKKRKLKVGDKMAGRHGNKGIVARIVRHEDMPFLEDGTPVDIV
LNPLGVPSRMNIGQIYETVLGWAGQNLGRKFATPIFDGASLDQINELTDEAGVPRFGHTH
LYDGGTGERFHQAATVGVIYMLKLGHMVDDKMHARSIGPYSLITQQPLGGKAQFGGQRFG
EMEVWALEAYGASSTLREILTVKSDDVIGRAKTYEAIVKGESMPEPGLPESFNVLMHELK
GLGLDIRLEE
>EGALAKHO_03278 DNA-directed RNA polymerase subunit beta'
MNNRNNNKDKNPVKRFNKISIGLASPESILKESRGEVLKPETINYRTHKPERDGLFCERI
FGPVKDFECACGKYKRIRYKGIICDRCGVEVTEKKVRRDRVGHINLVVPIAHIWYFRSLP
NKIGYILGLPSKKLDMIIYYERYVVIQAGIAKNADGESLQRLDFLTEEEYLNILDTLPQE
NQYLDDMDPNKFVAKMGAECIMDLLARIDLDALSYELRHSANNETSKQRKTEALKRLQVV
ESFRESNLNRENRPEWMIMKVVPVIPPELRPLVPLDGGRFATSDLNDLYRRVIIRNNRLK
RLMEIKAPEVILRNEKRMLQESVDSLFDNTRKASAVKTESNRPLKSLSDSLKGKQGRFRQ
NLLGKRVDYSARSVIVVGPELKLFECGLPKDMASELYKPFVIRKLIERGIVKTVKSAKKI
IDKKEPVVWDILENVIKGHPVLLNRAPTLHRLGIQAFQPKLIEGKAIQLHPLVCTAFNAD
FDGDQMAVHLPLGPEAILEAQLLMLASHNILNPANGAPITVPSQDMVLGLYYMTKERIST
PEHVILGQDLTFYSAEEVNIALNEGRLELNARVKIRAKDFNDAGELVFKIIQTTAGRVLF
NEVVPEAAGYINDVLTKKNLRDIIGHILSVTDVPTTAAFLDNMKDMGYKFAFRGGLSFSL
GDIRIPEQKTKLIADAREQVEGISVNYNMGLITNNERYNQVIDVWTSANAQLTELAMKNI
REDQQGFNSVYMMLDSGARGSKEQIRQLTGMRGLMAKPKKSTAGGGEIIENPILSNFKEG
LSILEYFISTHGARKGLADTALKTADAGYLTRRLHDVSQDVIVNIEDCGTLRGVEVSALK
KNEEIVESLGERILGRVALQDVINPLTNEVMVQSGHQITEAIMRTIEASPIEKVEVRSPL
TCEALKGICAKCYGRNLATGKMTQRGEAVGVIAAQSIGEPGTQLTLRTFHVGGVAGGISE
ESSIVTRFNGRLEIEDLKTVKGEDSEGNATDIVVSRSTELKLVDEKTGIVLNTHNIPYGS
SIFVKDGEVVTKGTVICKWDPYNGVIVSEFTGKIAYEDLEQGQSFMVEIDEQTGFQEKVI
SEARNKKLIPTLLVYGKEGELIRSYNLPVGAHLMVENGEKIKAGKVLVKIPRRSSKAGDI
TGGLPRITELLEARNPSNPAVVSEIDGVVSFGKIKRGNREIVIESKFGEIKKYLVKLSSQ
ILVQENDFVRAGVPLSDGAITPDDILRIQGPAAVQQYLVNEIQEVYRLQGVKINDKHFEV
VIRQMMRKVRVQDPGDTLFLEDQLIHTKDFIVQNDKLYGMKVVEDAGDSAVLKPGQIITP
RDLRDENSLLKRNDKNLVVARDVITATATPVLQGITRASLQTKSFISAASFQETTKVLNE
AAVAGKVDDLEGLKENVIVGHRIPAGTGMREYDNTIVGSKDDYNEMMANKEEYIY
>EGALAKHO_03279 hypothetical protein
MSNPKQQQEQINIELDETIAEGIYSNLAIINHSSSEFVLDFVSIMPGIPKAKVKSRIVLT
PQHAKRLLKAIGENIHRFEVAHGEIKDTEQAPIPLNFGPAGQA
>EGALAKHO_03280 Peptide chain release factor 3
MSFLKEIQRRRTFGIISHPDAGKTTLTEKLLLFGGAIQEAGAVKNNKIKKGATSDFMEIE
RQRGISVSTSVLAFNYKDKKINILDTPGHKDFAEDTFRTLTAVDSVIVVIDVAKGVEEQT
EKLVAVCRMRNIPMIVFINKLDREGKDAFDLMDEVEQKLGLTVTPLSFPIGMGYDFQGIY
NLWEQNINLFSGDSRKNIEETIAFSDVQNNPELDKIVGQKAAEKLREELELIDEVYPKFE
RQDYLDGKIQPVFFGSALNNFGVRELLDCFVTIAPSPRPKDSETRLVDPKEEKMTGFVFK
IHANMDPKHRDRLAFIKIVSGTFERNKPYYHVRQKKNLKFSSPNAFFAEKKEIVDISYPG
DIVGLHDTGNFKIGDTLTEGEIMSFKGIPSFSPEHFRYINNADPMKAKQLDKGVDQLMDE
GVAQLFTLEMNNRKVIGTVGALQYEVIQYRLEHEYGAKCTYENFPVHKACWVKPDDAKND
EFKEFKRIKQKFLAHDKYGQLVFLADSDFTIQMTQSKYPTVKLFFTSEFD
>EGALAKHO_03281 Alpha-amylase
MKNRNAKIYVISAISAFFCSCSPNETNEVDSRAESQQFEIINVTHHDGKPFSTGAKSSLT
GKYVDNPGGGVMMQAFYWDVPSGGNWWNTVSGKVTAWSNAGIGSIWLPPASKAQNGAFSM
GYDPTDYFDFGDYNQNGTTETRFGSKTELVSLITKAHTENMKVYADIVINHNSGGQSEAN
PFTGTNTWTNFNGIASGKFKRTYVNFYKNSYGNNDEGSFGGFPDLCHADPYVQDWLWKRT
DGVGKYYKNTMKFDGWRFDYVKGFAPWVIHDWNANVGGFSVGELWDSNVDILNNWANSAN
SSVFDFACYYKMNDAFDGNNLALLNDDMMWKRNPYKAVTFVANHDTDEISNKLLAYSYIL
THEGYPTIFYRDYEEWLDKTKLNNLIWIHNNKATGTTSILYSDNDEYVARRNGYNGNPGL
VVYINNSTVWQERWIQTNWANTQIKDFTGASTWYPTTQADKWVKIQCPPKGYSVWSINQ
>EGALAKHO_03282 hypothetical protein
MARISISQIQRCSRWLLPKNKAKPCFILFPEITLLEILAKTQNAKIQQTKKSF
>EGALAKHO_03283 Foldase protein PrsA 3
MLLKKLQLKTIDYKLVLTMCFLLFFNSIVSAQEIIPDVVAQKPVEVPSGQKLKVDGIIAT
VGDYIILDSDIDKGFLEITAQGGNVKDITRCQMLGKLLEDKLYAHQAIQDSIIVSDAEVR
SMMDERLNYMVKQVGDINKVVEYYKKSSVEEFKTYFADILKEQKLSADMQKKIVDAVEIT
PEEVRNFFKKIPKDELPTFGAEMEVAQIVVEPKVSKEDKQKVIDRLNAIRKDVLEGSSFA
TKAVLYSQDPGSASTGGYYKMTRRTPFVKEFKDVAFSLQEGEISEPFETTFGYHIIMIDK
IKGQEVELRHILIMPTVSEDALKEAKERIINIRKKIESKEISFADAARTESDEKETRANG
GILINPNTQDTRFELTKMDPTLYSQVSNLKDTEISQPLLSTDEKGKKTYKLITVTNRIDE
HVADYAKDYTKIKELALKEKQIEAIGKWFTAKIKDTYIKIIGEYRDCTFTNNWLKK
>EGALAKHO_03284 ATPase RavA
MSDVAAIHNLVQKRNELKSEIAKIIVGQDAVVDQILLCIFSGGHALLIGVPGLAKTLMIN
TLSQALGLDFKRIQFTPDLMPSDILGSEILDENRQFKFIKGPIFSNIILADEINRTPPKT
QAALLEAMQERSVTIAGQNYKLDLPYFVLATQNPIEQEGTYPLPEAQLDRFMFAIKLEYP
SFEEEVQVVKRTTSDIKTTINPLFTAQEIIDFQHLIRRIPVADNVIEYAVTLVSKTRPDN
KLSNDFVKNYLDWGAGPRASQNLILAAKAHAAFHGKFSPDIEDVKAVATGILRHRIIKNY
KADAEGITEDIIIQKLL
>EGALAKHO_03285 hypothetical protein
MNYLLKYQKAIGIFIVACLLILNYKIVLTGLDSNLFGIIFSIALFCIGGRKTTLNLNFPL
FVMIFMLEFISYRLHTKSVHFLALALFVCLIYYNITQKFSFIAFICILLFSSLFSTFFDY
LTTEIKQALCYYVYMTLKNFIPMNKIEGVNFYINNAKITVDTACMGLSMFKTGLLSGALL
LTLEEKKYQKYFNIIQIFLFCCLLIVLNIISNYFRIITLILFNCTEENVLHHTIGIICFI
FYQILPMLFLIRFFKPKKENIKIKKNLYPIFFIIIPAILVFTTSFEIKKEQHYNLLENLN
PKYQNEKGVWVNKEVFKISTSQKLIYIKTPNHNPLVCWTGAGYKIIESKEIKKGNEKIWF
VKMEKNQIQYSSYWWYECNKKKYTSLIEVLLIKLFDNKPVRLVNETSKV
>EGALAKHO_03286 hypothetical protein
MKNKLDILKQYTQKTGVPISLLVTGFSTTLLIVSLIGIKLKYSDLESLAIISLLIEFAYG
ITLSYLILKSKEEYIHLLPFVILNWFIGCFCLNTFIPVFQDLPVWVYLTTFTFCISNFFI
YKKSEEDFDSLLFFFLNGATFGMIIYFVFYLIPIMPISIVGILALGMGFYGLVPAIVVIV
HTVSILTYLQRNRLYFFSFSAGISTVFIGLLLFTIGLTIESRKIANSAMIKSFNNNDDLS
AYISVSQNLEPNFFNEILLKKDIVYMAADDFFNFRSFNSFGVKQFNQRKINNPFISIAYL
FCEDPGLSNDDKINILRSNFDKRLETEEQLWSGEDLFTKTIKEDVKIYSDSRLAYTEITM
NIAAAEDSRRNQEAIYSFQLPEGSVATSLSLWVNGIERKGVLTTKEKAKKAYKQIVGVEY
RDPSLMQWKEGNKVVVRVFPINNKTPRIFKCGFTTPLKAEDNEMSYQSLSIKGPNISNAQ
TISRIQIVGNTKIDTSKDFELKNGFYINQSKGLDDWQAKMPLNKISHNSFVWKNKIYEVK
DIQKTVIPFTPSEIILDLNTSWTTKQIESFVNLNKRNIYVFINGQKTAINKENFKAIQLD
FEDFHYSLLPLYKLAENSLIITKSGTFSANFEDLEDSNYLKKIKTETKQRNIKIINISAD
INPFWQTVKEQKYVDYFQTSLKNSLKMIEQHQFILFKTAKNTVNIEPSQISIQENLKDSI
SKSNGTNHIYRMYAFGKVLEEHVEIQGDTLANNQYVELAKDANIVTPISSLIVLETDKDY
KKNGIDKNVNTLGNASINNDGSVPEPHEWLLIIIGTATLYFYYRKNKKQTI
>EGALAKHO_03287 Aconitate hydratase B
MNIYKDYIQEIGERKTQGLHPKPIDGAELLSDIIAQIKDLNNEYREDSLNFFIYNVVPGT
TSAAGLKAKFLKEIILGQFDVKEITPAFAFELLSHMKGGPSIEVLLDLALGNNTAIAKEA
ANVLKTQVYLYEADTDRLKEAFKNDNAIAREILESYAKAEFFTSLPEVVEEIKVVTFIAG
EGDISTDLLSPGNQAHSRSDRELHGKCMITPQAQEEIQALQAKHPEASVMLIAEKGTMGV
GSSRMSGVNNVALWTGKKASPYVPFINIAPIVAGTNGISPIFLTTVDVTGGIGLDLKNWV
KKLDADGNVIRNENNEPILEEAYSVATGTVLTINTKSKKLYNGDQELIDISKAFTPQKME
FIKAGGSYAIVFGKKLQTFAAKVLDVEAPLVFAPSKEISIEGQGLTAVEKIFNKNAVGIA
PGKVLHAGSDVRVEVNIVGSQDTTGLMTAQELESMAATVISPIVDGAYQSGCHTASVWDK
KAQANIPKLMKFMNDFGLITARDPKGEYHAMTDVIHKVLNDITIDEWAIIIGGDSHTRMS
KGVAFGADSGTVALALATGEASMPIPESVKVTFIGEMKGYMDFRDVVHATQSQMLKKFGG
ENVFQGRIIEVHLGTLTADQAFTFTDWTAEMKAKASICISEDDTLIESLEIAKGRIQIMI
DKGMDNHKQVLQGLINKADKRISEIKSAEKPALQPDANAKYYAEVVVDLDQIIEPMIADP
DVNNVDVSKRYTHDTIRPLSFYGGDKKVDLGFIGSCMVHKGDMKILAQMLKNIENLHGKV
EFKAPLVVAPPTYNIVDELKAEGDWEVLQKYSGFEFDDNAPKGAARTEYEKMLYLERPGC
NLCMGNQEKAAKGDTVMATSTRLFQGRVVEDTEGKKGESLLSSTPVVVLSTILGRTPTLD
EYTAAVDGINLTRFAPSHKLLVM
>EGALAKHO_03288 Aconitate hydratase A
MAFDIEMIKKVYENMPGRVDKAREIVGRPLTLTEKILYNHLWDGNPTKAFGRGVDYVDFA
PDRVACQDATAQMALLQFMHAGKPKVAVPTTVHCDHLIQAKVDAATDLARAKTQSNEVFD
FLSSVSNKYGIGFWKPGAGIIHQVVLENYAFPGGMMIGTDSHTVNAGGLGMVAIGVGGAD
AVDVMSGMAWELKFPKLIGVKLTGKLSGWTAPKDVILKVAGILTVKGGTGAIVEYFGEGA
TSMSCTGKGTICNMGAEIGATTSTFGYDDSMSRYLRSTNRADVADAADKVASYLTGDAEV
YANPEQYFDQVIEINLSELEPHLNGPFTPDLATPISKMKEEAIKNNWPLQIQVGLIGSCT
NSSYEDISRAASLARQVSAKNLKTKSQFTITPGSEVVRYTIERDGFIDTFEKIGATVFAN
ACGPCIGMWDRAGAEKEERNTIVHSFNRNFSKRADGNPNTLAFVGSPELVTAMAIAGDLG
FNPLTDTLINEDGEEVMLEAPTGDELPPKGFDVKDPGFQVPAEDGSGVQVVVSPTSDRLQ
LLAPFDPWDGKNITGAKLLIKAFGKCTTDHISMAGPWLRFRGHLDNISNNMLIGAVNAFN
QKTNSVKNQLTGDYDAVPAVARAYKAAGVPSIVVGDHNYGEGSSREHAAMEPRFLGVKAV
LVKSFARIHETNLKKQGLLGLTFANEADYDKIQENDTINFTDLTEFAPGKPLTLEFLHSD
GTKSIILANHTYNAGQIGWFVAGSALNLIAAGKA
>EGALAKHO_03289 N-acetylneuraminate epimerase
MPLISIGQNIKGIVISQKSGLPIEDVNIFALTTNSSALTNIKGEFTLRLVNQINDKSVFQ
FSHVGYITIKMSLNDLKKTNFKISLSEEIENLNGLMITSNKKIKLKAKLDYSKLAPLKYG
IYSFGSLLENGKIYVTGGDATYKMDSWEKIKHEKIDFTLQDYLRELRFQSNSEIYRDKLL
IYDIKNDIWEKSELKFKKRAYHNLNYYDNKIYIIGGKSISENAIFQYLRDEIEILDSEKQ
SIAIDKTNPHQASGAASFTYNDNIIVIGGSTKISYKNNKKDFTNKVHLYNITSGYWYELA
SMPTAKETSGVLINNKIYLIGGNDGQPVSRIETFDLTTEKWESEGELFNGLEKPAITYHE
NIIYFFENDNMYLYDIKTKQLKEYIINLGLKECAMYYYNSKLYILGGRIEDYYSNSPSAN
VYSIAIDEFKITQLNRIKVLSSGVNLAKLTD
>EGALAKHO_03290 hypothetical protein
MFVKLTNLISTYFEKTTSTTSFYAPNFNWTKY
>EGALAKHO_03291 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MVFRLITILFFFSVGAFSQEKYIKHKISKGENLTVIAKKYGVKAKEISEANPNAPKILKL
NSILLIPNVNQASENKASEIVSNSTPGFHEVQSKETLWGISKKYNISVDDLKKANPSLET
EGLKIGQQITIPSSSVEVSAKPIDDLKIVTDVEVVVEVQPKETKYAIAKRYGITITELEK
QNPFIKGKLPVGYVLKIRTSKEKADAAQALTLQTNPVIKDTLDLKNQNVQIADNSEIKKD
SSTVIRISNHSDLINQLIVNATDNIGTRYRSGGTTKAGFDCSGLMIFTFSNFDIKLPRSS
IEQSRIGIKVNSDQAQKGDLIFFRTNGRRQINHVGMVVEVVDGEIKFVHSSTHGGVMISS
TKEPYYERTFSQVNRVLEKI
>EGALAKHO_03292 Regulator of RpoS
MPVKPIFLLIEDNLIDQLVIKQLLKKVLSVEEIYITNNGKEGIEWLLDNGKIYSSIIILL
DVQMPVMNGFEFLNAYANLDDEIKKGNQIYVLSSTLDSDEINKISESIYVTDFLGKPFPI
EEFKTKIYLNS
>EGALAKHO_03293 Aerobic respiration control sensor protein ArcB
MLKFQFLKKLRFANVFILLLIVFVSCALLICINFFTIKTLSANRAYVNGESHYSKGQKDA
SRHLITYLYTKDTNQWKLYLEELKVPQGDGIARITLLKAGDNKAARQGFLVGRNHEDDLD
DLIWLFDNFKEVPFLAKAIHEWEQGDKLIFQLFITGQQINAKIKKGIMTSADRENFLQTI
SVISDKLTVNERNFSNTLGEGTRKIKSLLIITNIFFILVIVCSVCLYYSIMVRRLIVSKK
EIEVKNENLMIVNHELDRFVYSASHDLRSPITSLKGLIEITQLEDDPRQIKKYLFLMHQS
LAKQDRFINDIIDYSKNKRKEIVMEPVSLQELFEEAISQLMHIENANKITFTKELLVDKI
QSDSLRLKIIISNLISNAIKYADSNKQEMFISIKTYFIDGFHKIEVADNGIGINDEYKDN
IFEMYFGTNKNKGSGLGLYIVKEAVENIKGNISVSSQSNIGSKFIVTIPYAYAC
>EGALAKHO_03294 hypothetical protein
MKEVFEKLVQLGMIALCLVFCQTCTNDYIKGGDNKIISNYQKIISDNTYTTAVYSPIYKE
STIKIAGIPIKTYEFDYSFKVDNQRYEGKKTFSKLPKSGLTKVFYLKENPSFNTLNPQSD
LKAEKDKNSATGNLYWGIFWGVLGIILLGGFIMNIREFINNRKLENQSLSADT
>EGALAKHO_03295 hypothetical protein
MIVWSGKGYLSVLILFISIFLCISVLPETYVTQCFVIPLYIAAIFSYIFGIKWNTTLRVF
IDKETGKEINVKSNHGLFWINMEYWGLLFPVLALVMLAQGLDKQGTEFYLNIFLVAIGIL
CLIFFSINLFKIKDSTNSSSQIQKAATDSQPKVSFVKEEIVTNKFEKEDHNQYLPK
>EGALAKHO_03296 hypothetical protein
MEITNVESPDVANHHYNYAANLLLNENKSAYETKAKLVEQGLSHEIAELIVENVEIQIQE
AKHEKARKDMVYGALWFCGGTILTLADIGFIFWGAILFGGIQFFKGLINSNS
>EGALAKHO_03297 hypothetical protein
MRKFITILIVAIGLISCSSDGDDKISNSDFIGKWNWTGTHGGLAYHLHATPASTGNSLQL
NLMKNYTFSIFKNGQEVVTGKYQLTMTKSIYSGEMEKYITCDMSNTPDTGYFVTNGIITI
YDQNKLAIDDNNYDGIGSGFGKME
>EGALAKHO_03298 hypothetical protein
MIFDILLLTIFFLFGIFLFYSAYKGWNKNYVPHKHSARIVKEAIGYNGTRFVVGLIGSIL
ILIPTLIFLNKVAGIEPPKKMTRSELVFLTPNNDNNQDKSIHFGDTTGDLNIITEHVKYA
PREIRDNYIKVSFKDNYLDELPQFIFKLQNLQEIDLTNNDIENLPIEQLKSLKKLRKIIL
TNNPVSPENLNQIKQLQYIQIVK
>EGALAKHO_03299 hypothetical protein
MHTQEKLISNIAQDKIDFNIGIKLLLEHDKYNFEEIFMTLKNYIINSIPNKTDYNSGAYQ
RALNTIPLKSTYTPIVILTTYPTKIAFNKLPLLPKSENKKTITALLWIFKITDTERRNTE
CKNGCGISGIKLNKN
>EGALAKHO_03300 hypothetical protein
MKKTLLLFFFIFLAIQKTHSQKIDATLLELNYLSDSNPKNLTKGKTKIYFTANDGTHGTE
LWVYDDISKKTTLVKDILPGDSSGLDSPNFLVINDILYFIAKDETRKIGLWKSDGTEAGT
HLIKYLNEYNTYSTYSLLNYNGKVIFFSKEEDDQSQSFWITDGTPEGTSLIKNFSNTYWQ
TIANIKIFKNSIIFSASDSTHGQEIWISDGTPIGTKILKDINVGSSSSNPSSFLILNDNL
FFSASTSENGNELWKTDGTENGTFLLKDIDPNPYRSGIQSENNFFTYNNSAYFYAKSNIN
SIELWKSDGTISGTVMVKVISTGSNVGYKLHGGVLNSGLVFSNFNYLTGTEIWKSDGTSN
GTNIIKTIPPAQNDWDDNANFVSFKDKLYFVGGGVNEGKELWITDGTTDGTTLIRDIYPG
EPGSGIIKLTATSKYLFFSANDGKKEYRTLWLSDGISNGKIINEDINLSQFSNTELSFVE
LNNKVFFQGGYNSDNGVELFKTDLSTDSTKIEKDINHIQAAFINAGDFTNFNGKMIYAGT
NGKSGIEPFITDGTVLGTKIIKNINTEDYVGSIYSSYDYRPFFTVAEKNVFFRASDGKNG
FELFKTDGTEENTGMIKDIAPGSGSSIDEFSLFMSNKNICYFKANDQVHGMELWRSDGTE
AGTYILKDINPGLGHGVTDSNIFYDHDYIMNEKLYAVLNGNLYFSAFDGNESSLWKTDGT
SNGTTKAIAIPSSGVYDTRPAIINETNNKIFFKTDSNNSNNGNNSLWSTDGTQEGTIFLG
LWNITGPVQFKKNIIHNNKLYFTVHNENGLALMVSDGTVAGTNILTKDHFTDLPSFGALK
SCGKYVYFTIADNNGFGIELELWKTDGTKEGTTLLEKIDNQNAVDYIHDCTCVQDNLFYL
KRSGSKIWYVNDETATPSYYDINITNGENFLEYEGISELISYGDNLLFIGHSYISGNELY
FTKIGKSLGAGNFNINPSYKSVTHLNLFPNPAASNSKLSISSDDNSTIETVDIYSILGTK
IQSLSPNGETPLSINLNFLSKGIYLVKINTAQYTETKKLIINK
>EGALAKHO_03301 Serine/threonine exchanger SteT
MQENEQDQEHFKRELGLLDGTMLVVGSMIGSGIFIVSADIARQVGSAGWLTLIWLISGLI
TIIAAVSYGELSAMFPKAGGQYVYLKEAYNKLIAFLYGWSFFAVIQTGTIAAVGVAFSKF
AAYLYEPLSDENILYELGSFKLNAAQLVSIFTIILLTYINSRGVKNGKILQTVLTIIKIL
SLLGLIVFGLTLAAKASIWDANWADAWTTRSYNAESGSWLPISGTALITGISAAMVGSLF
SSDAWNGVTFIAGEIKNPKRNVGFSLFLGTFIVTIIYVLTNLMYLAVIPLNEIATAKSDR
VAVVASQYIFGNIGTLIIAIMIMISTFACNNGLIMAGARVYYTMAKDGLFFKKAAVLNES
SVPEWALWAQCIWASALCLTGKYGDLLDFVIIIVLIFYILTIYGIFILRKKMPDAERPYK
AFGYPFLPMLYIIVATAICISLLLTKFSTCGWGVLIMLTGIPVYYLTKPKEN
>EGALAKHO_03302 hypothetical protein
MNEKIKILKTIHLAICAGVIITYIMLGGFSMETLKIPILDSSSIVFAVLPFLAIFVGNFL
FKSQLKQADQNLKIEEKLPVYQTASIIRWAILEGVAFVILFAKPDLVLFGLIAIAYLIFL
RPTEDTINADFQNV
>EGALAKHO_03303 hypothetical protein
MAYSNNDLSRFLDAQNKLYLTALSEIKKGKKETHWMWFIFPQIKGLGSSDTANLYAINDL
KEASEFLEHPILGKHLIEISELFLTFKRKSADGILGDLDARKLRSSMTLFSLAENTNPVF
QEILDAFFSGETDPLTLNIINSSIKSSAETEMV
>EGALAKHO_03304 hypothetical protein
MTLFNDTELFATGLAGKKVFDIPDSELILIDNFFTKEESDRFYERLLRKTKWREYEMEIY
DKIYTVPRMIAWYEDKDNPGADQNGPDWNYELLTIRGRIEKETQLDFNTVLLNLYRDGND
GVGWHSDKEHNTGKDPVIASVTFGETRMFRLRHKFNKDIPQVEIPLHHGSFLLMSGTTNS
FWQHQVPKTARDVLPRINLTFRQTHRSL
>EGALAKHO_03305 Exodeoxyribonuclease III
MKIATYNVNGVNGRLNVLLRWLEEAKPDIVCLQELKAPQDKFPIKAINDAGYNAIWHGQK
QWNGVAILARNMEIEEITRTLPGDKEDVQSRYVEALINGIVIACLYLPNGNPAPGPKLEY
KLKWFDRLAERAETLLSLKTPVILIGDFNVMPTELDVYKPEKWVKDALFLPEVRKAFKDI
VSQGWTDAIRTLYPDEKIYTFWDYFRNAYERDAGLRIDHFLLSPQLAKKLTSGDVDRHVR
GWEKTSDHAPVWIEIDKK
>EGALAKHO_03306 putative ATP-dependent helicase DinG 
MILQEQKQVLRYSKEMKKQEYAIVDIETTGGNASGSRITEIAIIIHDGENVIDRFETLVN
PEKEIPLSIFGLTGINNEMVANAPIFDDISEKVLEMLSDRIFVAHNVNFDYSFVRHQLEQ
AGFKWTARKLCTVRAARKIKPGLSSYSLGKLCYSLDIPLENQHRAGGDADATAILFSRLL
EWDGEGEIAKMIKMTSQDQRLPPNLPPEDFNNLPEKPGVYYFYNQMKKVIYVGKAINLKK
RVASHFSGHKINPQRQHFLRDIHGISFEVCANELMALLLECTEIKQLWPTYNRALKRFEA
KFGIYQYEARNGYKYLAVGKLTKFQTCIHEFNSLYNAIDLLRSLSEQFEIDQRFCKYSRP
EEGEFFQNNEIKSLPDVLLHNEQVDNAIDFLLRNRPTFAIIEKGRTADERSCIWVENGHF
YGMGYIPSDVAITDPSEVKNYVTQYKSNQYMVQLIFAYAEKYPGKVFFNKQFLK
>EGALAKHO_03307 DNA polymerase III subunit alpha
MYLNCHSYHSLRYGTIPLKELVDDAVLHGIKAMALTDINTVTGIYDFIRACQSKEIKPLV
GMEFRCNHQFRYIGLAKNAEGLGEMNRFLTDHNFSGEALPLIAPEFESVFVIYTLENAPK
TLRDNEFIGIRTDEVSKLFTSEHKNKISKMVVLQPVTFRNKKEFNLHKILRAIDTNIILS
KLTEADYSRTSEKMLPLESLLPFYEKYPEIIANTQKIIDSCDFQFDFSIKRNKKFFTGSR
ESDLEKLTELAEIGFEWRYEKENTIARKRVEKELKVIDQLEFSGYFLITWDIVRYSNSQG
FMHIGRGSGANSIIAYCLGITDICPIELDLYFERFLNLNRKSPPDFDIDWSWKERNTILE
YIFETYGREHVAFCGTNVEFKHRSIYREVGKVFGLPKEELDMLAKNPMSLHETNSIVNLV
QKYSMMMGKYPNQRSMHACGIIISEDPITNYTPLEMPPKGFPIVLFDMHIAEEIGFDKFD
ILSQRGIGHIDDSVKLIEKNRGIKLNIRDTSISKDEAVCNVHLAQGKTIGCFYIESPAMR
GLLRRLNCDNYKVLVAASSIIRPGVAQSGMMKEYIFRHNYPDQFEYFHEVFKEHLGETYG
IMVYQEDVIKIAQHYGGVPAADGDILRRAMSGKGRSLEALQKVKDNFFASCARKGHPEAL
SQEIYRQIESFAGFSFCKAHSASYAVESYQSLYLKINYPVEFMVAVINNQGGFYRTEVYV
HEARMSGGTILNPCVNKSEYQTTVYGNDIYLGFMHLQGLESKTANLIESDREKNGTFLSL
EDFINRIPIGIESIKILIFIDAFRFTGKTKNQLLVIASLLLNNFKPENRSLMLLQEPVKE
YKLPTLERSVFEDAFDEIELLSFPVSCTVFDLLQIKYRGDIMAKDLVTYHKKQVKMLAYL
ISRKQVPTKKGNMYFGTWIDHEGTYFDTAHFPDCLAEYPFQGGGCYLLLGNVEVDYHFPT
ITIIKMAKMPFIPDPRYMDAKDQFKTQRQIKEDVSPTHREPYPQGHEINLPRHRMKFQK
>EGALAKHO_03308 DNA polymerase IV
MARAIVHMDLDTFFVSCERLTNSELRDKPLIIGGGDRGVVASCSYEARRFGVRSAMPIHM
ALKLCPQAKVMKGDMELYSQLSHDVTQVIQEKAPIMEKASIDEFYLDITGMDKFHGSYKW
TNELAQSVIKETGLPISFSLSVNKTVSKIATGESKPRGNLEIPENVVQDFLNPLSIQKIP
MVGAVTFQLLSRIGVRKIQTLAEMPPEVLQQMIGKNGLDIWKKANGIDNTPVEPYTERKS
ISTEHTFSQDTIDIAKLKRVLIGMVEKLAFQLRSEQWLTSTITVKIRYANFDTETKQCKI
AYTSADHILTKNVMELFEKLYQRRMRLRLIGIRFSGLVRGTYQIDLFEDTEEMLSLYEAM
DKMKSRYGFDAVMRCAGAIFKPNNKDEILKRKK
>EGALAKHO_03309 HTH-type transcriptional regulator Xre
MSLFSDNIRALRVKHKISQEKLAENLKITRGRYVKYEDGTSEAPYDILKQIALYFHMSID
LILSVDIRKIDVENLIKLEGNRLILPIQVDRFGENFIEIVSQKAKAGYLNGYADPEYIES
LQQVSLPFLGPGKHRGFPVEGDSMPPHEDGSIIIGRYVERLGEVMDGKTYILITKNEGMV
YKRLNKNKKNALVLESDNRFYPNYEVKASDILEIWEYECNIGRSDRRHEQTESQSMKDLL
LEVKREVMEIKNNTSGTN
>EGALAKHO_03310 hypothetical protein
MFYKTISLVFLFGFFSATAQQNDSITKIDSTSNHLKFSYKQLIIPGVLIGYGVIGIGNDQ
LLSFNHQIKAEVTEDIDEKITIDDFSQYAPAASVYALNAFGVKGKNNMRDRSVIFVTSYA
IMATTVLGLKSIVHEERPDGSSNNSFPSGHTATAFAGAEFLWQEYKDKSIWYGIAGYAVA
TGTGLFRIYNNRHWLTDVAAGAGIGILSTKIAYWMNPYITKKLFKSSSENKSTSMIMPFY
NGQQYGLGFVKVF
>EGALAKHO_03311 Alginate biosynthesis sensor protein KinB
MRIKTKLNLGVGLLFLMIIILSLVSGYSVFLIKADTENILKANYNTLEYSRNMILSLDEI
KESPDNKIPIFKEYLEKQMQNVTEPGEKEATTKLENDFSLLEKNSSDETLKAQIRQDIFA
IMKLNLDAIKQKSDIAKHTAENANLWIAVVGSLCFLIAFNLLVNLPNNIANPIKELTQSI
REIANKNYSERVHFTSHSEYGDLAKSFNTMAQKLQEYNDSNLYKLFFEKKRLETLINNMN
DPIIGLDNDGIILFVNDEALKIIGMKLEDVVGKSASTLALSNDLIRSLIVKEENDSPKKQ
PLKIYAHGKESYFEKEILNITIIPTGEEKEINIGDVIILRNITLFKELDFAKTNFIATVS
HELKTPIASIKLSLQLLENAKTGDMNDDQKQLVESIKDDSQRLLKITGELLNLSQLETGN
IQLNIEKSNPQEIVNYAMEAVKVQADQKQIKLVINADENLEDVKADSEKTGWVLINYLSN
AIRYSSEKSTITIQLKKDNNQIVFQVIDTGKGIDARYKDKVFDKYFQVPGSQKSGTGLGL
AISKEFIEAQNGNVGVESNLGLGSTFWFALKV
>EGALAKHO_03312 Sensor protein KdpD
MEQKNNAQHFLDLIQKSRKGKFKVYIGMSAGVGKTFRMLQEAHSLLKNGIDVKIGYIETH
MRKETHELLAGLPVIPRRTIFYKGKQLEELDVQAIINLRPEVVIVDELAHTNVEGSKNEK
RWQDVLEILDAGINVISAVNIQHIESLNEDVKRITGIDVQERIPDNILRLADEVVNIDLT
SEDLIARLKEGKIYTPDKIQTALTNFFKSEQILQLRELALKEVASQVVRKVENEVPQLHA
LRHEKLLACISSNDKTAKIVIRKAARLASYYNGSWYVLYVETPKESSTKIALDKQRHLIN
NFKLAVQLGAEVIKLENKNIADAILIAVEEKQITTVCIGKPHLNLFKVILSTTIFRRLLN
RLSLSNVDLVILS
>EGALAKHO_03313 hypothetical protein
MKKIILTALISFGFSNLHAQEELKSPLTFSGYVETYYSYDFGKPDNHTRPGFFYNYNRSN
EVNLNLGMAKVNYTKDNIRGNFALMAGTYAQYNMSAEQDLLKNVYEANVGVKISQNHNLW
IDAGIMPAHIGFESAIGKDCQTLTRSILAENSPYYEAGVKIGYTSESGEWYLAGMYLNGW
QRIQKVDGNHTPAFGTQITYKPTDKVVLNWSTYVGNEQPDIDKKWRYFNNFYGQFKVTDK
TNITAGFDVGSQQSAKNSNKYDTWFSPVLILQYKPTDKIQLAARGEYYSDEKGVIIATET
PNGFKTYGFSANFDYLVTDNVMFRIEARNLLSKDEIFTKDNLPTDTNTFVTTSLAISF
>EGALAKHO_03314 Potassium-transporting ATPase KdpC subunit
MKNIFSLLKLTLLTLILFAVIYPLAIYGIAQTAPNQGKGETVSVNGKVVGYQKIGQKFDK
SNYFWGRPSAVDYNAAGSAGSNKGPSNADYLALVQKRIDTLLLVHPYLKKGEIPSDMVTA
SGSGLDPNISPQGALIQVKRVAKERKLAEDKVKALVESKINTAVVGPETVNVLELNMALD
ELR
>EGALAKHO_03315 Potassium-transporting ATPase ATP-binding subunit
MTTNKSASLFESKQVKEALAQSFVKLNPKLMIKNPVMFTVEIGTAIMFAVCVSILMGATD
QGSFTYNLIVFLILLATLLFANFAEAIAEARGKAQADSLRKTREETPARQILTNGEIRNI
SSSELKKGDIFVCESGDLIATDGEIIEGLATIDESAITGESAPVIREAGGDKSSVTGGTK
VLSDKIKVIVTSEPGESFLDKMIALVEGASRQKTPNEIALTILLAAFTLIFVIVCVTLKP
FADYANAPITIAAFIALFVCLIPTTIGGLLSAIGIAGMDRALRANVITKSGKAVETAGDI
DVLLLDKTGTITIGNRKATSFYPTKGVSEEDFIKSAVLSSLADDTPEGKSIVELAGAETA
NKLSIEGATLIKFTAETRTSGVILKDGTNIRKGAQDAAKNIAAQAGNSFPEDTAQKVIAI
STNGGTPLVVIKNNQVQGVIELQDIIKPGMKERFDRLRKMGVKTVMVTGDNPLTAKFIAE
AAGVDDFIAEAKPEDKMNYIKNEQNLGKLVAMMGDGTNDAPALAQANVGVAMNSGTQAAK
EAGNMVDLDNDPTKLIEIIEIGKQLLMTRGTLTTFSIANDVAKYFAIVPALFITAIPALQ
GLNIMHLHSPESAILSAVIFNAIIIPILIPLALRGVDYKPIGASAILKRNLLIYGLGGLI
IPFIGIKLIDLLVALFM
>EGALAKHO_03316 Potassium-transporting ATPase potassium-binding subunit
MNTELFGVISIFIISIVLAIPIGKYIAKVYLGDKTLFDPIFNPIEKFIFKISGINSTEEM
NWKQHLKALLSVNMIWFFLCFFVLLFQGSLFLNPDNNPSMTPDLAFNTAISFVVNCNLQH
YSGETGLSYLSQMVLMFLQFVSAGVGMAAAAMIFTAMKERTTDKLGNFYNYFIKSCTRIL
LPLSAIVAVALLFSGTPMTFEGKDTITTLQGDSVQVSRGPAAAFIAIKHIGTNGGGFFGA
NSAHPLENPTYFTNAVELWAQLIIPFAMIFALGFYLKKKKFAYVIFGVMTIGFLLLVIPT
VISELNGNPAIEKMGIAQATGAMEGKEVRFGPAISGFWSIATTVISTGSVNSMHDSSMPI
SGAMQLLAMMVNAFYGGCGVGILNFYIFIILAVFISGLMVGRTPEFLGKKIEAREVKIAA
FIAILHPLLILAGTAIASYFAAHDTAMGYWFSGNATGWLNNPGNHGFSEMLYEYTSSAAN
NGSGFEGLGDNNPFWNITTGIVLLLSRFIPIIGPLAIAGLLANKKYIPESAGTLKTDTTI
FGIMVFAVIAIIAALSFFPALALGPLAEYFTLK
>EGALAKHO_03317 hypothetical protein
MAKSTTANASKRKVIIIILDFRVQILDFVYAIKQLTN
>EGALAKHO_03318 hypothetical protein
MKNQVTSIYKQAERFAEITKKSIISGNIVRAKKCLALAERLFISGSIETKNAISNVYVFS
VSSFMEVRHCNISHLFPQTLKAEYIKQVNASGV
>EGALAKHO_03319 Transcriptional regulatory protein ZraR
MTHKILIIDDEEKLRNLLARIIKSEGFEVFEAKDLKSGFKKLEQTEIDVVLCDVKLPDGN
GVDFLQNIKSSFPLVEVVLLTAFGNIPDGVQAMKNGAFDYIVKGDDNDKIIPLLYKAVEK
VQLQKKVQQLEKRIGDKYSFNTIIGKSKGIEQVIDLAQKVAKTDSTVLLTGETGTGKEVF
AQAIHENSNRVGKSFVALNCSTFSKEILESELFGHKQGAFTGALKDKKGFIEEANGGTLF
LDEIGEMPIDLQAKLLRVLETSEYIPVGDTTPKKSNFRLIAATNRDLKTESDEHRFRSDL
YFRLNIFEIKLPSLRERVKDISVLAHYFVKQFSEKTNKKTLNIADDFLQKLENYSWPGNI
RELKNIIERSVILSNGDILTSDVLPYEMQHQPEKATKSMSAFSMQSIEKLHIQKVLNYTK
GNKAETARLLEIGIATLYRKLEEYGIQ
>EGALAKHO_03320 DNA-binding transcriptional activator HyfR
MKTVSNDATIPLKSVSTKRILIVEDQFIEAHDLQLILEKANYEVTGIARSVEQALEQIEN
EKPDLVFLDIMLKGSRNGIELAHILKEKHIGFIFISANSSKSILDQAKTTQPYGFIVKPF
RDQDVLTTLEIAFYRQEYSLESQLMQQIQLQNDINEIVNANLKWEEALLILAKKIQPFIS
FDYLEVGFSNTTHYDNLGIMRKNIDEYQIISPEKFSKIADIAVKELNETYKKSKIDLKPS
IYSEESLINNFQVAPIKSLIAHNFGIKSYLVFPVTIASIQRFYFTFYSRSFNVYSDENLK
LLSNLENNLIQFIAKTYSGNDLKLDEKFRKETIKKNLNSEKTTVGFEGIIGSSTQMMTVF
DYIRKVAPSDTSVLILGESGTGKEKIAQSIHALSPRKEKPLVIINCGAIPENLAESLLFG
HERGAFTGALDKRIGKFELADGGTIFLDEIGEMPLELQVKLLRVLQEREIERIGGKSPLK
IDVRIIAATNKNLEEEVAAGRFRMDLYYRLHVFPIMVPPLKKRKDDIPELANYFIKVYSE
KMGRKVPVLSDNALQQITNYNWPGNIRELEHVMQRTILLTDGNTIKEIELSATSKLHGEQ
ANDSFSIKTILENERDYILYILKKCNGKISGIGGAAEILDIHPSTLNSKIKKLEIKRELN
>EGALAKHO_03321 hypothetical protein
MYLSNTKTIVFITGAFVSHSCWEEWIVYFDDKGYKTVAPPWPHKNEVPEILRNEHPNSKI
ASLRLSTLIEYYTEIIEKLPEKPILIGHSYGGLLTQLLVQKELASAGICIHSVPPQGIFT
SKFSFYKAVWKPLGFFTSSRKTYLMTFKEWQFAFTNEMSFGEQKESYEKLVIPESKQVMR
DALSDTAKINFKKIHVPLLFLSGSNDNIIPSSLNYSNFKKYKNIHSITCYKEFKNNNHFV
LGQINWKEGAEFIANWLEKIS
>EGALAKHO_03322 hypothetical protein
MKIPQLRMKAFLFTIVLLINSSFFCFGSNSFKADSSKTKTISFKIKLKSAEKVTVTAAPL
KFNKHLAYSFTVDDGYRSAYLTAFPLFNGGKISPPMINEWKKDQGGDGTISKGLFYSDGL
GNKIPFKLGLAINGGAIGDLPVNRGHLSWLELKELYNAGWDILNHGFHHATKHGTNFLTE
VTENTVSIKQNLGFTMSHFVVPGGESDPGYHLEYEKDALANGSFSVASYAGAGPVIKVDN
KVNLDKMIYARTFVQSSKDTIGFKTMDRFLTTFDSVAKLSGPVWYNEFTHGAGNSNLWNL
SMRFPDFKYYMTTIANKYGVKGDDSIWMAPWQEVYEYIWLRDRIKIHFEQSNKEGIVTIE
LPEIPDNFRYHDISLAVETVSKFEIESNSTEVVISSDGKTKHKLINIHLK
>EGALAKHO_03323 Limonene 1,2-monooxygenase
MKDPISVSILELAIITQGSNPTETFQKTKDIAQLADQLGYKRFWLAEHHNMAHVASTATV
VLIGYIASQTQNIRVGSGGIMLPNHSPLIVAEQFGTLETLYPNRIDLGLGRAPGTDQPTA
EAIRKDFFEQAQRFPQNVTKLQDYFSEENATAKVRAFPAEGTNIPIWILGSSMESAALAA
AYGLPYAFAGHFAPRQMIQAFEFYRENFQPSTVLDKPKTMACVNIIAADTNEEAELLSTS
LYQMFLNLIRGDRKGLQPPVPSLDDIMGEEERFHVNQMTACTFTGNKEQLEIDLKKFINY
ARIDELMVTSPIYDHQAKLKSIQITKEVIDSLNSIHI
>EGALAKHO_03324 Lipoprotein-releasing system transmembrane protein LolE
MNLEYFIAKRLITAKDYKSSISAPIIKIAISAIAIGIIMMLVSVATGIGLQQKIRDKVSA
FNGQVIISNYDNNNSEVTLIPISKKQDFYPNFKSVPEVKHIQAIASKAGIIRTENAFEGI
IFKGVGADYDWNNIKEYLVEGRLPDFTKELNEEVIISRFLADRLNLKVGDKFNTFFIKEE
QGKMPNSRRFKITGIFNSGFQNFDATYIIGDIRHIQRINKWAPDQVGAFEVFVKDFTKIK
ETGVEVYEQTSSTLDTKTIIEKYSYIFDWLQLFDFNIIVILAVMILVATINMVVALLVLI
LERTQMIGILKALGANNWTVRKIFLYNAFYLIIRGLFWGNLIGISLLLIQQQFGVIHLNP
ENYYVNVAPVYINWGYIILLNLLTVTICFLVLLIPSYIITRISPVKAIRFD
>EGALAKHO_03325 hypothetical protein
MKQILNNLNKLAKDKHIENKKYFDKLKKKQPKNLDYVMQDLHDAEFKKTDCLQCANCCKT
TGPLFTLADIERISKSFRQKPQQFIDQYLRIDEDKDYVLKSVPCTFLYSENYCMIYDVRP
KACREFPHTDRKKFHQIADLTLKNVAICPAAYNIVEEMKKKLPL
>EGALAKHO_03326 Ubiquinone biosynthesis O-methyltransferase
MKDLFGKAMYDFQTNNSPENIITETSISEEDEMSVDYLFRSYNEMPKLEQKALQLATGKT
LDVGCGAGSHSLSLQDDRNLEVTSIDISEKAIATCKLRGVKNAKVQNILDFEGEKFDTII
LLMNGVGIFGKLDNCNKYLSKLKSLLNPGGQILLDSSDIIYMFDEDEDGGKWIPSNNDYY
GELVFNISYKGEKEEPFDWLYLDYNTLQNAAIANGLKCELILEGEHYDYLARLSI
>EGALAKHO_03327 Putative metal-dependent hydrolase YfiT
MDELDLEKLKFPIGKFEAPKAFTSEYISERIAEIESFPEKLRKETLHLSDEQLDTPYRPG
GWTVRQVIHHCAESHMNCFIRIKWALTENNPVIKAYDETLWSELPDNLKMPIQPTLSLLE
GLHYRLAFIMKNLSETDLEKSFIHPENNSEYRIKQIIGTYAWHGNHHLAHITTLKKYRNW
D
>EGALAKHO_03328 7-carboxy-7-deazaguanine synthase
MLSKEIQLEVNKGAMLPLMEEFYTIQGEGFHTGTAAYFIRIGGCDVGCHWCDVKESWNAE
LHPPTSVDLIVKNASSYADTVVITGGEPLTWDMSLLTQQLKNKNLKVHIETSGAYPLSGT
WDWICLSPKKNKLPTQTVYDNAHELKVIIYNKHDFIFAEEQAELVNDNAILFLQPEWSKK
EEMTPLIVDYVMNNPKWRVSLQTHKYLNIP
>EGALAKHO_03329 Lipopolysaccharide assembly protein B
MNKFKIFSLALVASASVAKAQDINQAKKAIDAEQFEKAKSLLKSIIKAKPSDGEANFVLG
NVYLNQAIVDSAKIYYLNGLEAADHKNLNYIGLGQLDLDAKNAASAQANFGLATKDMKRK
DVNEFIYIGRAYMNSTNPDYTNAVASLKKALLLEPQNATALLAIGDAYYGANNQNDAYKA
YRDAFTADPTLLRAKMQLGVLLKGAKSYDEAIKSFNEVIALDANYGPVYRELAETYYKWA
RNKPSTRQVNYQKAIQNYEKYLSLTDYSMNSRMRHADFLILVEDYKALEKEANKMIELDK
VNPRIYRYLGYSAYENGNYDIAIKSLEDYMKVPSNKVIAKDNLYLGFAKIKKGTDAAGVV
EPAAFDAGLAEIKKAVAVEPLAVEDLGDFGKDLFGKKQYNQAAAIYELSTTNTEQKNYLN
DNVYYGISLYYANANKEKTAIDAAGLAKADAAFDRVLVASPTYDEAYLYKGRINNLLEKD
DLIIKNYQEYITKTTAKGAEELAKPATVKKVVESYNSIGAAYANTDKAKAIEYFNKSLVL
DPTNAYAAQSVKALK
>EGALAKHO_03330 Phosphate-binding protein PstS
MLKYSRVFGLVIFVFLFAMCNQKSKNESEKETILKGSIDITVDETVKPIVDDQVAVFEGT
YYDAKIAVKPKSEAEVINDLLNQKAKVVITTRDLTKAELQGFEKSKIKPRVTPFAIDAIA
LISNKSNNDTLIALKSVIDFMQGKADPRIKGLVFDNPNSSTVRFMKELAKVKEIPATGVF
SFKTNDEVIKFVSENDGMIGVVGVNWLSQPSPAMAETIKKINILSVKGLNDSKYYNPSQN
DLAEVKYPLARDLYIINCQGYSGLGMGFASFIAGEIGQRIVLKSGLLPVKTPGRKLKIRS
QIINDKE
>EGALAKHO_03331 hypothetical protein
MLNNIQKKSLKERFLLVLGILFFLIYLVLGLMIMFWKKLPLDMEPKYRYAFGGLLIVYSA
IRFLRLINSNAE
>EGALAKHO_03332 hypothetical protein
MKLDIIKNQWLDIVFEGRNKIYGAYELRKSNSKTTVKALIIGSIIFSFAVAAPLIASFLP
DSGEDEVDNNVKIATVKLPPKKEEVKPNQPPPPPPPPKVDQVKFTKPVVAKAEEVTEDPP
KIEDLKDKKVGSETIKGDPDAVLTVDEPVGTGTAAVVEEDNQVYNTAGIEVKPDFPGGIE
KFYKFVGNNYKTPEEEGLKGKVYVTFVVEKDGSLTDIKVLRDIGYGTGAEAIRVLKKCPK
WTPGEQNGKKVRVLYSLPITIQSAE
>EGALAKHO_03333 hypothetical protein
MAELNTGDGGGGKGGKVRSKKQNSKVDLTAMVDLAFLLITFFMLTTSLSKPQSMDLSLPD
KDPDSTKTEDTKVDENLTMTVILGENNKLTYYMGLLSAPKIGPKDIAYGKDGIRRELLKR
KKLAAEYAASIGKPKNGIIVIIKPTKKSNYRNLVDILDEMAITGVKTYAIVPEFTPEENK
LVEKK
>EGALAKHO_03334 hypothetical protein
MAKIKMKKKSTSTDMTAMCDVAFLLLTFFILTATAKVPEALPVDMPASVAEFKLPDTDLA
IISIGKGADGKSKVFFDLKGREIRKKTLEGMGAKFGVTFSEDDKTKFALMDDFGVPVANL
KEIIAMKASDRVKANQPGIPIDSLDNQLKEWLLVSRRAAIDIDDKELQIAIKGDAKEQYS
QIKKIMDILQDQKINSFNLVTGMRGKDF
>EGALAKHO_03335 Biopolymer transport protein ExbB
MANVKVKKESTSNGGGMVTGIIIAACILVGVLIWKFVMGAPANFEGGNPETGHPINTLGM
VYKGGFIVPVLLGMFLMVVVFSIERFIVIGKAAGKANLDKFMQGVQASIKEGNIEAAIAS
CDKQQGSVANAIKSALIKYQDVKKEGFNSEEASEVIHKEIEEATSLEMPMLEKNMTIIST
LVSLGTLGGLLGTVSGMIKAFGALASAGTPDQAALATGISEALINTATGISTSVLAIISY
NFFTAKIDDLTYSIDEAGTTIVNTYRRFRGSLKQ
>EGALAKHO_03336 hypothetical protein
MNKKDNFIQDINTGYLSKGDSIILGGAMLDGEAIAEAHVKIPLKTLNRHGLIAGATGTGK
TKTIQVFSEQLSNAGIPVLMMDIKGDFSGIAKEGKEEGFITERHAKINVPYNVASFPVEL
MSLSKQDGVRLRATVSEFGPVLFSRILDLNDTQAGVVAVIFKYCDDNQMPLLDLKDIKKV
INYITEEGKDEIAASYGKISTATTGTILRKIIELEQQGADLFFGELSFEIDDLMRIDENG
KGYVNIIRLTDIQDKPKLFSTFMLSLLAEIYQKMPEKGDSEQPELVIFIDEAHLIFNEAS
KVLLEQIETIVKLIRSKGIGVYFVTQNPMDVPSGVLAQLGLKIQHALRAFTANDRQAIKK
TADNYPTSTYYKTEELLTSLGIGEALVTALNEKGVPTPLVATMMRAPESRMDILTADEIE
EINSKSKLVKKYNEEIDRESAYELLCKKIEEATQAAAEQEEQAPTKSTKSEPSTASVVGK
SVLKVVTSATFIRGVFGVLSKIFKK
>EGALAKHO_03337 Kynurenine 3-monooxygenase
MQTSLKIAVVGSGLVGSLLAIYLKKAGHTVHVYDRSPDIRKINFSGRSINLAMSNRGWRA
LDGVGVGDSVREIAIPMDKRAIHLVDKLNFQNYGQEGESIYSISRGTLNRKMIDLAEQAG
AEFLFDQKIWDVTLSDATLHIGETERGEWEEKKYDMVFGADGAFSRIRHRMQRQSMFNYS
QEFLNMGYKELNIPANANGTHKLDKNSFHIWPRGKYMLIALPNLDGSFTCTLFMPFEGES
SFESLTDRKMVEDFFEKNFPDSIEVIPKLAEDFFKNPTSTLVTMKCFPWTFEDKIALIGD
ACHAIVPFYGQGMNAGFEDITVLNEMIEKYGNDWKKIFSEYQISRKPNADAIAELSYRNF
MEMSTKTADEKFLLQKKIEKAFSDKHPDKWIPLYSRVTFSDRPYAEALAIGDFQNGIMEE
ILKLNNIENIWNTPEVENKILELLNK
>EGALAKHO_03338 Putative ribosomal N-acetyltransferase YdaF
MNSHLLQSNIILENERVLLLPFENERNIELKEIIFDDEIWKYMGMYVRTETDFENYIQNT
IKQKANGICYPFLIIDKATNKVAGSTRYGYLNHASQKCEIGWTWYGKAFQGTGLNKACKY
ELLNFGFEKIQFKRIQFSADLENKKSQRAIEKLGAVKEGIFRNNYVDSEGKSKDDVYYSV
ILEEWENTKKENFQEFI
>EGALAKHO_03339 Bifunctional (p)ppGpp synthase/hydrolase RelA
MELQTIYQKTIKFAAKKHADQNQVIPGTNLPYVVHLSNVAMEIIFASKETKEFDTAFAIQ
VALLHDILEDTETTFEEIVKEFNKEIAHAVLALTKNAKISKEERMTDSLTRIRKLPKEVW
AVKLADRITNLQVPPKNWSLEKIQEYQKQALQILESLKGGNIYLEKRLSERIQNYLQYCI
SQV
>EGALAKHO_03340 hypothetical protein
MNLYSEHYVSKTCERFVNKIWCLDNSIGESLIENKLVLPNGCFNLAIVSGNAIEVHTSKN
KYVMNEGFYFCSQMTNNVLVNIQPKTKVTIIQLQAWTLSFFPNYDLNNFIDSIIKIDSAE
LPFKANLSGNISTLLNTINTYFEELDSINSSKNTIEKICEIIKLKNEEISVSEIGTVLNV
SQRMLQIKFKSATGLTIKKYIQILKFRKSVDQMVNSGLDKLKLTDVALYNQYFDQSHFIK
QFKDVTKTTPKMFNSDSYFLSKKR
>EGALAKHO_03341 D-alanyl-D-alanine carboxypeptidase
MKINNSIFRLKIILVGILFFQIHFGFSQEGKNAELYKTIMSKDSLLFNVGFNTCDIKQFE
NLLANDFEFYHDKDSISDKNKFLQTLKKGLCANTGTYQSRRYLVPNSTEVYPLYKKGVLY
GAMQMGIHQFYEKSVGKNESLSDAKEHFGSTAKFTHVWLLENGIWKLKRSFSYDHQNTST
AGTKSTIFDNDEEIKKWLQQNNVPTLGIGIINNGKLQEIKVFGELKKGVAAPYNTIWNVA
SLTKPITTIVALKLVSQGKWNLDEPLDKYWIDPDIANDSNHKLLTTRIVLSHQTGFPNWR
FMNESKKLDFKFKPGTQYSYSGEGMEYLRRALEKKFHKTLDQLADELIFKPLKMNDTKFI
WNDISDVSRYAVNYDNKGNAYEPVKNKTANAADDLLTTIQDYGTFLCSVMNGDGLSKKVF
EEMNSHQVAQKKKDKYFGLGFEIYDLGNDNYALSHGGADQGVQTLFFLLPKTKQGLLIFT
NVDDGYKVYEKLLLNYLGENGQKLIDIETK
>EGALAKHO_03342 hypothetical protein
MNSKKIKIMEPMMNILVLFMLFLSREVKAQTNSEVLKMDALKTEIMKMDSLLFDVSFNQC
DAALFKKIIADNIEFYDDRSGLNTSKGNEIKSLLDKCGRSDKLTRKLNSCTIDKLGDFGA
VQIGEHTFYVDGKPTGTGKFVHIWERKDNEWKLKRIVSYEHRAIKK
>EGALAKHO_03343 Putative penicillin-binding protein PbpX
MKKSIKLLVLTFLFTLNATFSQDKAKQIDQLLSKYKEYGQFNGSALVSENGKVIFKKGYG
SANMEWNIPNQPDTKFRLGSISKQFTAFLIVKLAEDGKLKLDVPITTYLPDYPKANGDKI
TIHHLLTHTSGTPNYTSAPNFFKEKSRNPYTPEELVKTFSSLPLEFTPGEKFNYSNSGYF
LLGYIIEKVTGKTYEQYLQETILTPLKMTNTGYDHNEPILKNRAAGYEKQGKKIVNSAYL
DMSIPYAAGSLYSTVEDLYLWDQALYTTKLLSQKSMDLFFKPYISTGGDDFYGYGWFLEE
APNGDKAKLKIVEHGGGINGFNTIISRVPADKNLVVLLNNTGGTILSEMNEGIRAILYNQ
PFNEPKKSMALELLDVYSENGAIAGTELYKKLKKDPIYGIKEADINRVGYVLLQNGKKKE
AIEAFKINVENFPKSGNVYDSLGEAYLADGDKNLAIENYTKSIELDPKNESGKKALAEIL
KK
>EGALAKHO_03344 hypothetical protein
MKNLKKFAFLALLLCLFIPVISISQTNPPPPAMPSQQNKIIVDKIIEAAHYKTFVVDYCL
NKINEASAKEGWNEQKAMEITESINYKNFRDAIYNVFAFYDEVELETLLKAYEKDTAYQT
TNAMTTNKVLLNNLNIFANDIVKGKYISK
>EGALAKHO_03345 Acyl-homoserine lactone acylase QuiP
MVLVIIIVLLGIGLCAYIFHLKPKYEGELQLKNLQKETTVYFDDFGVPHIYADSEKDAMT
ALGYVHAQERLWQMELLRRIAPGRLSEIFGSVALKNDMFFSGIGIEEASAKAIAKLDKNS
ESYKLTLAYLDGINQYLEEGVTPIEFTLVGVKKEKFTIKDVYNIFGYMSFSFAMAQKTDP
LLTDLRAKYGAEYLKDLGIEGEFNTTKIRSSKEHLEEYSEISKSVASLLDKSPIPPFVGS
NSWVVGPHKTKSRKVIFANDPHIGFSQPATWYEAHIVTPKQELYGCYLAGTPFPLLAHNR
DYAYGLTMFENDDIDFYQETNKGDDANQYQTPTGFAAYESRKKTIKIKDTSDVVLTVKSS
RHGPIMNDLLANLKSKKPIAMSWIYTQQPIQILDAVYGLSHAKSKDDFRKAVQLVAAPGL
NVMYGDAKGNVAWWATGTLYKHNKGVNSFFILDGASGKDDITEYLDFTKNPSAENPKWGY
VYSANNQPEAVDGYLYPGYYLPEDRAKRISGLMDAKSDWDKEAISKMIFDNTSSVATGVV
QNLIVNLDVKTISAEEKEVLNVLKGWKGTTNLEDVAPTIYNKWIYLYLKNTFEDEMGKED
FTIFLGTHLGKQIIARQIVNENSVWWDNIKTKNVKETRTQIVSKSFHDAVSQLTTQLGNT
IVDWNWGKVHTVEHEHPLGKVAALRKLFNVGPFPAPGSNEVINNQFFGFNDEGKYYVKGG
PSTRRVIDFSDIENSWSIIPTGQSGNPFSEHYHDQAEMFNAGKFRKMKLNKEEIIKTSTK
LVLKPKK
>EGALAKHO_03346 hypothetical protein
MSIYKKIAIGVISIFVFVLLVNFGLNYWIKKQLPIIIEEKNKTAYHINYEKIEVSLWSRN
IYAQTLLVHPKNQLENTKIKTGIYSKIESITIKHFNIWDLAFHDVIQAESIIIDKPRVIL
YKKNDKLLNNSKSIRTEIIEPFRKVVAVSNIYLNDGSVDVVYLKNNKPIFSVKNILLKLE
GILITDATLKEQIPMQYDKYVLVCDSLYYKPNQFYRMDIGQISTENNFLKVKKFSMLPEY
NRKTFVQKLEKEKDIYTLKVDSVNVNKMEWGFKNDRFFFKANSVVMNHFDANIYRGKMPN
DDLSKKYLYNHLLRNIKFPLQIDTLQVLKSKLVYEEEMDFSKGPGKLNFDHFNLQATNLR
SGFGLKKTADVKIKVNCQFMKASPLHVDWSFNVLDLKDSFHIQGMISNFDVAAMGQFSKP
YMNASFTGVFNKYRFNFYGNDNISKGNASLDYDDLKVKLYKKKHPEKEAKLKSAIVNLLV
KDDSKEKAKTADVELERIQEKSFYNFLWRSIAESLKKILI
>EGALAKHO_03347 hypothetical protein
MKKTPLHTFHIPVMGLAYTIDSPIRVAQYGISSVISIADDELIEKMRNFYSLKFNFPYEE
ISQKFHDYRAERITSYLNLVDKIVKQKFESFKTELTESKTALENFMSMLPNTSDIKKGFQ
NLLEDGISFKENIQNYIESQLSVGEIDVNIMTKLDKDNFIKNEQLPLEFNDAHAALRGFA
NSNLESSVVLSAGMNPRLYSYFENFSDFYPNKNNQLKKRIILKVSDFRSAMIQGNFLAKK
GLWVSEYRIESGLNCGGHAFATDGLLLGTILEEFKQKKEQLIQSAHELMVKALQQRGASF
PDQPLNLKITVQGGVGTSEEHEFLLNSYNVDSVGWGTPFLLVPEATSVDQTTRDLLIKAK
DRDLYLSHISPLGVPFNTLRGTTNEILKQKRIQENKAGSSCPKKFLALSKEYDPHGICTA
SKKYQDLKLAELENIKETLSADAFEKSKIKITEKSCLCVGLANSSYLENDIKIKGQAQGV
VICPGPNMAYFDQEVSLKHMVEHIYGNKSVLRANNRPNLFVKELKMYVDYFKNEIETVSG
EITAIQLKKWNSFKSNLLEGIEYYHNLFESTFYFKNETEKIKYQIDFYKLELSSIKIPVP
EMVLKRKPDLEF
>EGALAKHO_03348 hypothetical protein
MKALYIVFAVLSIVSCQNQGKQDLNKAKQASIDSMKVEINKQKIIDSMKTEMAQIKQEKQ
VEAQKVVVVHQQDGTATTTTTTKKKGWSSTAKGAVIGAGVGAATGAIISKKKGEGAIIGG
LAGAGVGAGTGAIIDGSKKKE
>EGALAKHO_03349 Kynureninase
MTFQNTREFARELDSQDTLNHYQEQFIFPKVNDKRVIYFTGNSLGLQPKRTKAYVDEVMN
DWAELAVEGHFYAQKPWWDYQERFAEPLSKIVGALPSEVTVMNTLTVNLHLLMVSFYQPK
GKRYKIICEEKAFPSDQYMFQSQVHFHGYKPEDAIVEIKRRDGEHNIRLEDVLAKIEEVG
DELALVLIGGVNYYTGQVFDIKTITSAGQKAGAKVGWDLAHAAGNIKLELHDWNVDFAAW
CSYKYMNSGPGNASGCFVHEKHHNDPDLPRFAGWWGHNKERRFKMEPTFDPVHGAGGWQI
SNLPVLSLAPYLASVEMFAEVGMDALIAKRDHITSYLEFILHEIDKEVKGNFEVITPSNP
LERASQLSVFLHGEGRSLFDYLMKNGVITDWREPNVIRLAPVPLYCSYEDMYDFGQILKQ
GILGK
>EGALAKHO_03350 S-adenosylmethionine:tRNA ribosyltransferase-isomerase
MKLSHFQFNLPKELLAEFPAENRDESRLMVIDRAKQTIEHKMFKDVINYFDDGDVLILNN
TKVFPARLYGNKEKTGARIEVFLLRELNSEQRLWDVLVDPARKIRIGNKLYFGDDDSLVA
EVIDNTTSRGRTLRFLYDGSYEEFRNKLTELGETPIPKYINREVTAEDAERYQTIYAKEE
GAVAAPTAGLHFSKHLLKKLEIKGVNFAEVTLHVGLGTFNPVEVEDLSKHKMDSEELIIK
QEACDIVNEAKAKKKRICAVGTTSMRAIESSVSSQNTLNPYEGWTNKFIFPPHDFSIANC
MITNFHTPKSTLLMMISAFCGHDLMKKAYDEAIKEGYKFYSYGDAMLII
>EGALAKHO_03351 3-phosphoshikimate 1-carboxyvinyltransferase
MNLILQTTQHNLQGQIAVTGSKSETNRLLLLKALFPNITLANTSNSDDSEVMQKALIGND
EIVDIHHAGTAMRFLTAYFAVNEGRNVVMTGSSRMQERPIKILVEALAQLGVEISYEKEV
GYPPIKIKGKKVTASKVTLAADVSSQYISALLLVASKLENGLELTLEGEITSIPYIKMTL
ALLTDLDIQTSFEGNVIKVYPKESVVSKEMVVESDWSSASYFFSLVALADTASITLTSYK
ENSLQGDSELVSLYEKLGVKTTFQNNKMTLVKQEDFKYETVNFELNNTPDIAQTIVVTCL
GLGIGCHLTGLHTLKIKETDRLEALRIELTKLGANISVTNDSLTLIASENINHNVKIATY
NDHRMAMAFAPLALKVPIIIEDAGVVSKSYPDFWNDLKALNFEISEL
>EGALAKHO_03352 hypothetical protein
MDLKNAQLDVDTWIKEHGVRYFNELTNMAQLTEEVGEVARIIARRYGEQSEKESDKNKDL
GEELADVVFVVLCLANQTGIDLQAAFDKKMDLKSVRDKDRHKNNDKLK
>EGALAKHO_03353 hypothetical protein
MKFQKILIIIVFFCFSKITAQKYELGKVTVAQLQEKLHPKDSTAPAAIIFKKGKTFFTYN
RTNGFSANHVYEFKIKIYKKEGLAWADQKVKFYIGYEKLNEDRLEFSQAVTYNLENGSIV
KTKLDNQGSFKKKINKYWNEKTITLPNVKVGSIIEYKYILKTENIVKLPDFDFQYEIPVD
YFEYKTEIPEFYVYKTILVGKTPITSDAKISPGAQSFEDEYNRTSTLSYQQINSLYTGKD
ISALRLEPFVNNIENYKGSIQYELERIRYPDQPVKDFTMTWEGVASTIFKDENFGKELNQ
SDFLLEDLRKLLGDVASLKERLDIVFKFVQNKMNWNEENGYYTDKGVVKAYKEQTGNAAE
INFILINMLKLAGIEVNPVLVSTIENGIPVYPTRTGFNYVIAAAEIDGKQILLDATHKFT
SPNILPLNLLNWKGRLIKKDGTSKEIDLYPVLLSKEFSNTIAKLDALGKIEGKVRVQRTD
YDAYSFRIQNANKNQENYLEKYEEQLGDLKISDYAIENKKTNFSNPIIETFSFTSDNQSE
IIGGKIYINPLLFFTRTKNPFTQEKRQMGIYFGYPTQEKFNLNLDIPEGYVVESIPNPVR
IASEDKLIVYTFNISNVGNKIQISCVKEINSSIFAADEYTGLKELFQKMLASQNEKIVLK
KI
>EGALAKHO_03354 hypothetical protein
MKFTRLAVVTFFLIFTASKSNAQTYSLGNVTIAELEEKFHPKDSAAVAAILFSKGLSKIG
DNGATETSLQRRIKIYKKEGYQWANLQVAFAAGKLSTIRITDIYTYNLVDGKIVKSVVKP
EGEFIEKNNQDYWVKKIAFPEIKEGSIIEFQLKRYGGLHIQDWDFQENIPVNYSEFKTVI
PDAFVFKRIVKGFFTPKINSQIAKTYGSPAMETTYVLKDLPAMKEESYVNNINNYRSAIL
YEMETIAIPGQITKSFSSTWPTVVNTIYNFENFGTELNKTGYFEDDLELLLKEKVNPDQK
MIAILDYVKSNIKWNNNQGYVCEKGVRKAYKEKSGNCGDINLMLTAMLRESGLNANPVLI
STRSNGIAFFPTTDAFNYVIAAVETPNGKVLLDATDKFATINILPLRDLNWIGRLIRKDG
TSEEVDLMPATISNKNVSMSYDIDENGSISGKIRRQFSEYNALNFRNDLNEDKEDVYLEK
FENENKNIELSNYKRTNEKELLLPIIESFSFMGSNLSEVIGDKIYINPMLFFLNEKNPFK
QEKREYPIDFGFPFLDKYAITIKIPDSYTVESLPQSIGVVMEDNLGGFKFEIAFNEKRIQ
LSIVHQINDAVISIDKYEMLKEYYKKMIAKETEKIVLKRI
>EGALAKHO_03355 hypothetical protein
MKFTKLFSLITILFFFSKITAQEFKLGKVSIAELEQKVHPKDSSAAAAILYKKGKSKIEY
NDNDGFVLTTEVETRIKIYKKDGYDWANQSIRYYSVKNDSKETVYISDAVTYNLVNGKIE
KTKLKSDGEFDEQVNKYRSKKKITMPNVKEGSVLEYKYTIRTLNIGMMPDWKFQYSIPVN
FSEYVTYIPEYYTFNARQKGYVFPKVTAVKNPKAVLTTSKDRTLGRGLVSNTTFSTDKFE
YIETQTNYFLENLPAIKDESFVNNIDNYTASIEQELSMVKPFNQPLKMYSTDWNSVVKTI
YEYDDFGPELNKTGYFEDDLKAILATANTPEEKTMVILNYVKSRVTWDEYYSYSCDKGVK
KAYQEKTGNVAEINLMLTAMLRYAGLTANPVLLSTRSNGIPLFPNRTAFNYVIAAVETPN
GNVLLDATDKFSTPNILPLRTLNWNGRLIRKDGTSEEVDLMPKKVSNDNVFINYVIDPEG
KINGKVRRQCTDFNAMAMRDHFSSLKEDAYLEKLENENNKIEVSEYSRTNEKEILLPTIE
TFSFKGDNLTEIIGGKIYINPMLFFANTENSFKQEIREYPVDFGFPFSDKYNITIQIPEG
FAVETLPVPAGITMEDNLGAFKFNIAANGNSLQLSVSHQINEAIVSAEKYEMLKEYYKAM
VAKETEKIVLKRI
>EGALAKHO_03356 hypothetical protein
MKNPFFALFFLFFTFISSAQKSDYAVLSIADSLKNNADAVVRLDQMDIVISSQRSMNVKV
QRIVTVFNESGMSDVDAYQGYDKSTSIKNIEAIVYDAFGKEIKKIKRKDFKDQSAVSGST
LFSNNRVTFLEYTPVSYPFTIVYNSEIESSNTAFLPQWYFLGGYAVTIEKSVLNVTFPNN
LGFKKKEFQFSGYNIKKTLETDTQLSYVATNILAQKSEDLSPSHTDLFPKIMMGLENFHL
EGVDGTAKTWEAFGKWYSEKILAGTTDLSEETKTKIRALVGDEKDPIKKAKIIYDYVQKK
SRYVNIAIGIGGWKPMLAADVDRLGYGDCKALSNYTKALLQAVDVPSYNTILYGDRYKSN
IQSDFVSMQGNHMILAIPNGDNYTWLECTSQDDPFGYQGTFTDDRDVLVVKPEGGIIVRT
NIYADKGNSQKDKGIYTIDENGNFSGSISIVSEGTQYSSKSRIESLQPTEKETYYKKYWD
NINNLKLGKIAFTNDKENIRFIEDVQISAINYAPISANKMIFALDVFNQNTGSVKRIRNR
KNPFQIQRGYVDTDEIEINLPAGFMIEFLPSNFELKGKFGEYKTEIIKKENNKLTYKRSM
FLNKGKYSNKEYDEYRLFMEQISRNDNAKIILTKN
>EGALAKHO_03357 D-aminoacyl-tRNA deacylase
MRVVLQRVSQASVTVEGNKTADIQKGLLVLVGIEDADTQEDIDWLVGKIIKMRIFGDEND
VMNCSVQDVDGDIIVVSQFTLHASTKKGNRPSYIKASKPEFAIPMYENFVKALERDFGKK
VQTGIFGADMKVSLLNDGPVTIIIDSKNKE
>EGALAKHO_03358 hypothetical protein
MADNVIKTKSFNFALRIVKLFQFLNQEKKEFVLSKQLLRSGTSIGALVRESEQAESKKDF
IHKLAIAQKEANETDYWLELLFQSDYLNETQFKSIKSDIVEINKILASIIITTKQKLNTI
>EGALAKHO_03359 Small ribosomal subunit biogenesis GTPase RsgA
MTGLVYKSTGSWYTVKSEQGDFIECRMKGKFRMKGIKSTNPIAVGDIVDYELEETSDAVT
GTIFNIHERKNYIVRKSVNLSHQMHIIASNIDRVFLLITINNPPTTFNFIDRFLVTAEAY
NIETILVFNKIDTFDEPTLEDQLYMQYVYQQIGYKCLRVSSTEMKGVDELKEMMIGKVSM
FSGHSGVGKSTLVNAMEPSLHLKTKTISEASKQGQHTTTFAEMYDLSFDAKIIDTPGIKG
FGIVDMEKEEISGYFPEFFKLKDQCKFNNCLHKEEPHCAIKAALERDEIAWSRYNSYLKI
LEGDEENYRTDTYDEDRKISDETRNQK
>EGALAKHO_03360 Phospho-2-dehydro-3-deoxyheptonate aldolase
MENKKEMRKWLEDFNLNHPLVIAGPCSAETEDQVLKIAHELKDSKVSVFRAGIWKPRTRP
GGFEGVGEIGLKWLQKAKKETGLLMGTEVATAAHCKLALEHDIDVLWVGARTTANPFAVQ
EIADTLKGTDKIVLVKNPVNPDLALWLGGVERLHMAGIEKLGVIHRGFSTYEKTKYRNIP
EWQIAIELQNKFPDLPLIIDPSHITGDRKMIFEVTQEALDLNYDGMIIETHYDPDNAWSD
AAQQVTPDALKQIIKDLTIRKTDDTTDEYSSKMTKLRANIDVLDANLLELLGKRMKVADE
IGQVKKDANVAILQNNRWNEILGKMILEGEKKGLTEEFVLRMFKAIHQESIGHQEKIFNA
>EGALAKHO_03361 Prephenate dehydrogenase
MKVYVIGIGLIGGSMVLDIKDQHPDATIFGIDNNEKHLQEAIDLGVIDQAGSFEELGDAD
FVIVSVPVDVALIVLPKVLDLVGDKTIVFEVGSTKKPICDAVASHPKRRNFIATHPIAGT
EFSGPSAAIRGLFKGKTNIICEVEKTTFKLQEKALKFFSEIGMRIRYMDPTSHDKHIAYV
SHLSHISSFMLGKTVMNKEKDEQDIFDMAGSGFESTVRLAKSSPAMWTPIFKQNKEHVIE
TLEEYISNLSRFRDLLKEDNYNAIFEEMESTNKIKEILNGLTTTKK
>EGALAKHO_03362 LL-diaminopimelate aminotransferase
MITTAKRLDTVEEYYFSSKLREVRQLMSEGKSIINMGIGSPDLSPSKAVIEAVAAAIQDE
NGHGYQSYQGLPELRKGMADFYQNQFGVELNPNNEILPLMGSKEGIMHISLAFLNEGDHV
LIPNPGYPTYTSVTNLVGAVPVYYDLKEANAWEPDFEALEKLDLSKVKIMWLGYPHMPTG
ARGSLALFEKLVAFAKKHNILLVNDNPYSFVLNDNPMSLLQVEGAKEVALELNSLSKTFN
MAGWRVGMVLGNPEIIDAVLKVKSNMDSGMFYGIQKGAVAALNCDKSWFEDQNKIYRRRR
ELTEKLAEKLGCEVYKEGVGLFVWAKLPEGIESAEKFIDEILYEKHIFITPGTIFGSNGE
GYIRFSLCVKEEKVQEAIDRF
>EGALAKHO_03363 P-protein
MTTKIAIQGIKGSFHHQVVKEYFSENVEIDECLSFEELIDSLLSGKSDQAVMAIENSIAG
PIIPNYALIDKNNLHIIGEHYLSIHQNLMALKGQKIEDIKEVHSHPMAILQCMDFLKQYP
NIKLVEDKDTAETARRIQEKQLTGIAAIASKTASEMYDLEIIAPEIQTIKNNMTRFVIIK
KQNSFLPESEINRASIKFELDHKRGSLAAVLNVMSDCKLNLTKIQSLPKIETPWKYSFFV
DVTFEKYEDFAKAKTLLNIMAEYLKVLGEYKNTKPLSQS
>EGALAKHO_03364 hypothetical protein
MKNKKETMMTLDQFIEEHYGKVGTPKRDKLEKGYEKFKKQYLKKHNL
>EGALAKHO_03365 hypothetical protein
MNRRNFLTLTGTFTGGLLVLPDFLHAFGSQNNLITGEQCIVFVQLNGGNDGLNTFIPYDN
PLYYDLRTKIALNKDVVVGKNKGMAFHPSLKDFAQMQQNGDLTVIQNVGYPEPIRSHFRS
QEIWQTATDSDKYINEGWLGRYLDLQCNGHLATAGINLDSIDNLALKGMEPNFITVKDPN
RFKVKSDKDENITLSDNPQLDFVRKIANSVTEGSDEIQKALAKSKTEISYPKTGLSKNLE
WIARLIKGNLNSKVYYTSLGGFDTHDNQLAIHEKRLTDLNDALFTFYQDLKQAQLMQNVT
VVVFSEFGRRVRDNGNGTDHGTAAPMFIIGGNNKGTILGNNPNLSDLDNGDLKHEIDFRS
VYASLLKEKMNFDYSKIGIRNKPVSGLFV
>EGALAKHO_03366 hypothetical protein
MKKSNLWSLRLGFSGKEADKIEKLGLEKFLKHSYDSKFDKQLPAFLDDDPKTLLELKALR
ESIKTADTEFKKKILKKEIYSNVELKKWWIAKMRNDEFPLRENMVCFWHNHFVSTSQKVK
VNYWIYQHNMILREHAFGNFKELTKQIVKSNAMVKYLDNVDNKKGKYNENLSRELLELFT
IGIGNYSESDIKEGAKALAGLNYGDEGALYRKNIEDNSDKTYFSKTGNWKADDLVDIIFE
QKNIPYLITRKILKWFVYDNPSEELVTYYGDYFRKVKFEIQPLLTKIFTEEYKKENSGTK
IKNPLVYILQLLEELHIDDLDDAMIMFFLKQQGMDFYNQINVKGWDGGNSWLTSQIYLQR
NNTSDLLCSGRSITRRVLNTMNSENEKPKTEFEKVEVKIDFDSDGNNKTIITELSDRLLF
KVNDAMQKDMENLLKYDFDPKEPHANFAVARLFNYITKLPEYQLI
>EGALAKHO_03367 hypothetical protein
MKIIIEDYSRIAKKLREEYPKLSDFEILSLAIQIERNQILENGLVVSSSDKYPSGLEAIA
IALGFNGEQLDVTITDVLKDIANK
>EGALAKHO_03368 Ribonucleoside-diphosphate reductase 1 subunit alpha
MFVVKRDGHKEPVMFDKITERIKKLCYGLNELVDPVKVAMRVIEGLYDGVSTSELDNLAA
ETAASMTIAHPDYAQLAARVAISNLHSNTKKSFSETMKDMYHYVNPRNGQEAPLLSDEVF
NVIQENAAFLDSHIIYTRDFNYDYFGFKTLERSYLLKINGKIVERPQHMLMRVSVGIHLD
DLKSVIETYDLMSKKFFTHATPTLFNAGTPKPQMSSCFLLAMQDDSIDGIYDTLKQTAKI
SQSAGGIGLSIHNVRATGSYIRGTNGTSNGIVPMLRVFNDTARYVDQGGGKRKGSFAIYI
ETWHADIFEFLDLKKNTGKEEMRARDLFFAMWTSDLFMKRVQEDASWTLMCPNECPGLYD
VYGDEFEAMYLDYEFRGKGRKTIRARELWEKILESQIETGTPYMLYKDAANRKSNHKNLG
TIRSSNLCTEIMEYTSKDEIAVCNLASISLPMFIDNGKFDHQALYNVTKRVTRNLNKVID
RNYYPVKEAENSNMRHRPVGLGVQGLADAFIMLRLPFTSDEAKVLNQEIFETLYFAAVTA
SMEMAKEEGPYSTFEGSPMSKGEFQYNMWGMKDEELSGRWDWASLRKEVVEHGVRNSLLV
APMPTASTSQILGNNEAFEPYTSNIYTRRVLSGEFIVVNKHLLHDLVERGLWNETLKQEI
MRHNGSVQNIDVIPADLKELYKTVWEMSMKDIIDMSRQRGYFIDQSQSLNLFMQDANYSK
LTSMHFYAWQSGLKTGMYYLRTKSAVDAIKFTLNNDKKEETAPALVAETEEINIEDYKAM
LLKAQAAGPEDCEMCGS
>EGALAKHO_03369 Ribonucleoside-diphosphate reductase subunit beta
MSQVEPILQENKNRFVIFPIKHHDIWEWYKKMEASFWTAEEIDLHQDLTDWNNKLSDDER
YFIKHILAFFAASDGIVNENLAENFVNEVQYAEAKFFYGFQIMMENIHSETYSLLIDTYV
KDEAEKAELFNALEVFPAIKKKADWALKWIESDSFAERLIAFAAVEGIFFSGAFCSIYWL
KKRGLMPGLTFSNELISRDEGVHCDFAVHLHNHHLINKVPKDRIKEIIVDALDIEREFVT
ESLPVSLIGMNAILMTQYLEFVADRLLVELGCDRVYGSANPFDFMDMISLQGKTNFFEKR
VAEYQKSGVMNTDSDAQKISFDADF
>EGALAKHO_03370 hypothetical protein
MFQLGKTIISEDILEKEFVCNLSACKGACCVDGDAGAPLSEAETKILEEIYPKVKPFLRK
EGIAAIEAQGTWVKGTDGDLETPLIDEKDCAYVIFDGKTALCGIEQAYNQGIVDWKKPVS
CHLYPIRVKDFTEFAAVNYDKWDICDDACSLGKELEVPVYKFVKEALIRRFGADWYMELE
KVAEELKNSK
>EGALAKHO_03371 hypothetical protein
MLEIDFKEIITVGMVLFAVIDIVGSIPIIVNLRAKVGHIESEKASIVAGMIMIVFLFVGE
GLLNLIGIDVHSFAVAGSFVLFFLALEMILGIRIYRDEEPGSASIVPLAFPLIAGAGTMT
TLLSLRSQFHTINIIIAILLNIILVYIVLKSSKKIENLLGENGLGVVRKTFGVILLAIAV
KLFAANVKGLFV
>EGALAKHO_03372 hypothetical protein
MKIFTSILVLLALALIVFNITQLDFQNPFQGDSGVALIGIAAAFCAVLILLIFRISKRIE
EKMHDNR
>EGALAKHO_03373 Ferredoxin--NADP reductase
MFDVLIIGGGVSGMSCALVLGSAKNKAFVTDKKIGIFTHQKNSSLQEAIFYNAYGIIPGK
LGSELLVESTQDLAMTYPHITQIPNEKVVKVEGTYPEFTVTTNKNSYQTKNIVIGIGSAN
TFDIEGLMQYLEPHKKALPEKQRIQLKNDDHKVAEGIFVIGTLAGWRSQLAIAAGSGAAV
ATDILTLWNNGIQTHAHDSIR
>EGALAKHO_03374 hypothetical protein
MKNLKKISFLFVLMTFVISCKTMKDSSSNTITGKVDAIEAGKDGYTAKISTDSKEVYFAT
ISIVNVGGPQNYKQLKIGDVVSVKGEIWKAEEEKHIKVTEIVSVK
>EGALAKHO_03375 hypothetical protein
MKIEAIVNAEIELLTAIKNADVLILEKILHDDLLFNLPDGNTITKEFDLSSYRSGKMKID
ALEASDQIINLIGDTAVVSVIVSLKGVFDATPINGAFRYIRVWKQFDESLKVIAGSCIQL
Q
>EGALAKHO_03376 Carboxy-terminal processing protease CtpB
MKFNSKYLPIVIGATFALGTVLGSLMNAPVDEGLLAKNYSKTKLNKLIDFINNEYVDSIN
TDSIVNLTVDNILSKLDPHSVYIPPAEQAEVAESMKGDFVGIGINFYMYKDSVAIIKPIE
NGPSAKAGIKSGDRILFAGKTKLFGRKLPSDSLFSKLKGLQGSEIELTVFRKSEQKKLKF
KVKRDVIPIKSVDASLLLGNNIGYIKINRFAETTFNEFKTGLTRLKQSGIQSLVIDLRDN
GGGYMEEAIAIADEFLKDKQLIVFTKNKNGTTEKTYATKAGSFETGKVYVLINENSASAS
EILAGALQDNDRGIIVGRRSFGKGLVQREMDFNDGSAVRLTVARYYTPTGRSIQKPYKKG
NEEYFKESESRIKSGELYAKDSIKVADSLKFKTPKGKIVYGGGGIVPDIFVPMEAEHGNE
NVGYLLQTGVVGHFVFEELDKNRKAFAGLKFNEFLVEMKNSDVYFKKFKNYIFMTGLDLK
LDKTKGLVNRYITAEFARQLYGEIYYYDVILKEDAMIKAVQNPKK
>EGALAKHO_03377 tRNA-specific adenosine deaminase
MDLKKINKYDKAYLRIAKEWGALSYCKRKQVGAIIVKDRMIISDGYNGTPSGFENCCEDE
EGLTRWEVLHAEANAILKVAKSTQSCEGATLYITLSPCKECSKLIHQSGIKRVVYQNGYR
DDSGIQFLLKAGVEVEHIPVLEE
>EGALAKHO_03378 hypothetical protein
MSEFWIYFQIGLKHVLDIHAYDHVLFLIALTIPYLFKDWKRILLLVSLFTIGHTLALLLS
VFGIIAIKVNIVEFLIPITILITAIFHLFTAGKATKNEGVNLIFMVTLFFGIIHGLGFSN
YFKSILGGSPSSKLLPLGEFALGIEAAQLIVVFVVLILSYIVQTVFRFSKRDWALVMSAF
IIGVVIPMIIDSPIWNR
>EGALAKHO_03379 hypothetical protein
MPFSELFDNEFKQRNRGHFSAIVRVAYADGKINDEEKSFLDKLASRLEISEEEYTEILKD
PWQHSINPPYLYAQRLERLYDLARMVHVDHHLGDQQEVMLTRMGLALGFTPGNVNYIIRK
ALSLVDKKVDLDTFLFEMENMNK
>EGALAKHO_03380 hypothetical protein
MKKILILVVIAVALFGCSNEDSNSELRIRLSNGSKFNFQNITVNTSTGNVNFGNLSPGKN
TTYKIFEIAYSYAFIELQIDGKTYTLQPIDYVGETPLEKGNYTYEITANDSQEKYGKLSL
TLIKN
>EGALAKHO_03381 Fructose-1,6-bisphosphatase class 1
MEERNKTLGEFIIENQKAFQYSSGELSRIINSIRLAAKVVNYKVNKAGLVDIIGAVGEQN
IQGEDQQKLDVYANEVFIQTLINREIVCGIASEENDEFITVKGSDNSNNNKYVILMDPLD
GSSNIDVNVSLGTIFSVFRRITPIGTPVTSEDFLQPGINQVAAGYVIYGTSTMLVYTTGH
GVNGFTLNPAIGTFYLSHPNMQFPKDGHIYSVNEGNYVHFPQGVKNYIKYCQREEDDRPY
TSRYIGSLVSDFHRNMIKGGIYLYPTSSKAPKGKLRLLYECNPMAFIAEQAGGKATDGFG
RIMEIQPTELHERVPFFCGSYNMVEKAEEFMAEAL
>EGALAKHO_03382 hypothetical protein
MNIRKGNPEDMESVLGLIKELAIFEKEPDAVVVTVDDLVRDGFGEKPLFHVFIAEVENEI
VGIALYYYRYSTWKGKTIHLEDLIVKDKMRGTGLGSALYAEIMKQGKRDNVRRIEWNVLD
WNTPAVNFYKNSGARILEDWQVVQMDETGINSFLEKL
>EGALAKHO_03383 Lysine-sensitive aspartokinase 3
MRVFKFGGASVKDADGIKNVYDVLQKVGYEDVILVVSAMGKTTNALEVVIKNYFDKSAEL
NSSVQEIKKYHNQILLDLFEDEKHAVFAAVTEQFSELEYFLAHNKSPNYNFVYDQIVSFG
ELISTTILSHFMNFMGIKTQWLDVRNFIKTNANYRDAEVDWETTQQLISKNVPRKQLNIT
QGFLGADENNFTTTLGREGSDYTAGIFAYCLNAESVTIWKDVPGVMNADPRYFENASLLN
QISYREAIELAFYGATVIHPKTLQPLQKKEIPLYVKSFINPLLKGTCVSKGVDLEPQYPC
FIVKRNQLLISLSSIDFSFIMEENISEIFALFHEFKIKVNLIQNSAISFSVCVEDKFENF
NDLNAILSKKFKVDYNENVTLYTIRHFTEQAAQTVEDNKEVLLKQVSRETMQIVTKELN
>EGALAKHO_03384 hypothetical protein
MKFQVSVFFFIYCLLLYSTGTNAQISPVTSDKVANKNNELNEVVIKKQTQLVKYSSNGTI
EVNVSNTLLSTSSSVNELLSRVPNVTVAEGQISVLGKGEAIIYLNGILINYERFAAIPVS
QISKIEVISNPSSKYDAEGKSVINIITKKNIENGIMGTATQQVTVSEFAGTSTNTLLDFN
YTKGNFSFITNYGLQLGKGRELLYTTRTRPNPEEFMKSELTTDWKRQFNNFSNFGFGVQY
TFSEKNYISLAYSGNIEDLGGIVESRNSIENNSGNSFYATDIDKNDVLLNQFVNLNYNAI
TDKKGSSLFIGSQYSNYNGTIRDFIDENGLENDVITQKYLKNNVGNTINIVASQVDYSKK
IKEDTKLETGAKYSYATVKSATDFLIADADDMNFEFDDALSSDFKYQERIGAAYFNYGSS
IGNKFDFSVGARGEWTKYNLYTNANGSQKFEKSYGNLFPNVLLNMNLSEDWKAHFSYVSR
ITRPRYQALNPYVIYQDPFTTIEGNPNLLPEKNHAFEIGAMYKKFDFKIGYTYKIDPISG
AALRGDTANSYILRSLNLDKGHTFFTSLSRSFNVKWWNSTNTVSMNLTKSVDDFYEFELG
PVKPQIYLYSNNTFAIPNLFKLQLLAWYLGDRSYGLGSDNSRSTVTVGIERNFFKEALKL
NFTANDIFHDFMVSGDYNVGQTQIYYHRTYTTNYFRFMAVYSFGNSKKINYKKSEIEQTE
NNRAR
>EGALAKHO_03385 HTH-type transcriptional activator RhaR
MDTGKELLFFFSALGVFNGIILGVYFFFFTKKKYLTNYFLGALLFALSIRIGKSVFVYFD
SALPKMYLQFGLTACFFIGPCLYYFLKSAVEEINIMPRSWKLTLLFWAILIVTVGVVFPY
EAYPKLWRFYFIRIIYFQWFVYIAFSGFAIKDILVKIISRKHKATPAETWFGMLFLGNFL
LFLFYFLSIMGAPGATYISGAVVFSFILYLIISILLYRKKTDDLFLLNNQKYSGKKIDSA
EAAILSQKLENVMIEKELFKNANLTLQDLAKEVNISSHQLSQFLNNNLGKNFTSFINEFR
INEACEIIKASDKFTLEAVGYDVGFNSKSAFFAAFKKHTGKTPLNYQLQVL
>EGALAKHO_03386 hypothetical protein
MSQEEAADYLNISQSAYARMESGESNSWANHIFKICKIFAITPEELLKIEINQKELPSSN
GAIQMSEGVIEQYEERIKDLKKVIKDLKANKKYQP
>EGALAKHO_03387 hypothetical protein
MSFNNDSENQNKWQNDPENWIWGIFYYNPEDSRLFPPKRIKELGWTINFANPNSVFLVIV
IIAIAFIFS
>EGALAKHO_03388 hypothetical protein
MLKKLLFLTVFIWFSGLQAQETESSYQTKKVIATRDTIHLEKFSINSGFFQLLNTKNEPI
DSTFYKIDFQKGTLLLNEKFSSTSDTLIVNYLKYPDFLTKEYSLYNESQVVSNDVGTEKL
YQIENKNAKKVTPFDGLNTSGSITRGVTIGNNQNTVLNSNLDLQITGKISDKVSLRASLQ
DSNIPLQDGGYSQKLDQFDNIFMELFSDDWNIRAGDVFLENRKTQFLSFNKKVQGLSTSF
NFGSDENKTNVFASVAFVKGQYAKSTFTGQEGNQGPYKLKGQNGELYVLVISGSERVYVN
GVLLKRGENNDYVIDYNAGEIVFTSLFTITSEMRINVEYQYSERNYNRLVTYAGVTHENK
NWSFGGYLYSENDLKNQPLQQNLSPDQVQVLSQAGDDPTLMTASSAYVDKYADNKILYKK
IIFNSVEVYEYSSDPNEVLYNVKFSLVGNNLGNYIIQNSNTVERIFEYIAPVNGIPQGNY
EPIVQLIAPIKIQVATFLGKYNPNEKTAVDFEIAMSSNDKNLYSSIDDANNDGLALKTNI
KKRLFTRSWTLDGFANYQFVQEDFKSVERLYNIEFNRDWNLNTTLFGNQSLLVTGLNFNL
FAKKKTTNIGLFAYQFEKLDYTESYSGARHTTTAFFKLKKWTIENQGSFLNSDGTTSTSK
FIRNQARTKYHFGKNWIGASFQIEDNQEKDKVTNQFSALSQRFSEYGAFVGRGDSTKVFV
ELGFLQRRNDSLQNGLLQHVNNSQTYFLRSKLIQNKTTDLAVYASYRILDFTDATRKNEP
SLNSRILYTDRFFNQLMQLGTTYETSSGTIAQQEFTYIEVPTGQGVYTWNDYNGNGIQEL
EEFEIAQYSDQARFIRIFLPNQIYIKTNQNKFSQSVALNPLQWQNEKGFKKLLSYFYNQT
SFIMDRKVKSEGENLELNPFASSEENILGLNSSFRNSLFYNRGKQKHSVTYSYLVNKGKN
LLSVGSQTVKNNSHQLQYTHLYQKSWLFNFFTKTIKTDLVSEDFVEKNYDLTGYQLAPKI
SYLFSKNTSLDFFYEFQNKENQIGNLETLRQNRLGTSFSYAGDKKVTINGEFSLYENKFN
GNEFSSVGFQMLEGLQAGQNLVWKLLVQKNITQFLDVNLNYQGRKSETGATVHTGNVQLR
AYF
>EGALAKHO_03389 hypothetical protein
MKKLFLICFLVVLSNNFYAQETATTTKAKSEATAKKKKADADKAAADAKKESTKAKKSAD
DATAAASKAKKESASATKKTADKEAAKAKKSADDVTAAASKAKKESADATKKSADKEAAK
AKASSDKAKSSADKAKTSADKAKKDATAAKKSSTKTLKETNEKAPSVPDKVTGEYNGKKV
YTGPRGGKYYINKNGNKTYIQD
>EGALAKHO_03390 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MSIDYSANKTILVAPLNWGLGHATRCIPIIKALQENNFIPIIASDGVALALLRKEFPYIQ
TLELPSYHIEYAKNGKNFKWKLIKNLPKMITAILDEKKMVNSWIKKHGIDGIISDNRLGV
FSRKIPSVFMTHQLNVMTGNTTWFTSKCHQHIIKKYTECWVPDTNEATNLTGDLGHLKTN
NLNLKYIGPLSRMRQKETVKIYDLMVILSGPEPQRTYLDEKLQKEIVNFNGKVVFVQGIV
EKTQNKWQTGNVTYYNFMNSKQLEQTFNESEFVLCRSGYTTVMDLAKLGKKAFFIPTPGQ
YEQEYLAIKLQDENLVPYAMQDDFTIEDLSKVKSFKGLSQFKNDIDWDKLFSVFED
>EGALAKHO_03391 hypothetical protein
MKIKLLAILLLFTCVSNAQELSKEDVKKEVVRLLDSINKAKLPETKSGGGGEEHWYDKIS
LRGYAQIRYNGLFSTNDKITCDQCDRSWGTTSTAPDAKANNGLFIRRARLVFSGQVHPNV
FFYFQPDFASSPVTGIQNFVQIRDLYFDLSFDKKREYRVRVGQSKIPYGFENMQSSSQRL
TLDRADAINSSIANERDLGIIFYWAPAEIRERFAMLVKDGYKGSGDFGVFAFGVYNGQIA
NKIDANRDLNVVARVSYPFVIGSQIIEPGIQAYTGKWAFTDEISTGVIVNDQKYVKDQRI
GATFVLYPKPFGIQTEYNIGTGPRYNPATNTVDETDLNGGYILLNYKWDIKKQHIYPFAQ
FQYYDGGKKYEKDARSYVVRDYEFGIEWQPIKAFELTAEYVIADRTFEDSARPINRQEGN
LLRLQAQFNF
>EGALAKHO_03392 Alkaline phosphatase synthesis sensor protein PhoR
MKINFKKTYKFAVKSALYISLFATGFVLILMSLFYKGQLNHQIAFGIIFIISIYIFSFLV
LQYRVERFIYRRVKKIYDEVSLLESTTLINQPITTDMETLSREVKKFATDKKLEIEMLEI
REQYRREFLGNVSHELKTPLFTVQGYVSTLLDGAMDDKNIRKKYLKRAEKGVERLIYIVE
DLDMITKLESGDLDLNITDFDIVELIQNVFDLLEMKADKKKIKLAFESRNVKSVIIRGDQ
DRIQQVLENLIVNSIKYGKDGGLTEVGVVNLTKKKVLIRISDNGEGVEKQNIPRLFERFY
RVDKSGTRSEGGSGLGLAIVKHIIEAHKEKVYVESEFGIGSEFSFTLEKANKTIKAEVK
>EGALAKHO_03393 Alkaline phosphatase synthesis transcriptional regulatory protein PhoP
MKKTQTKILLVDDEPDILEIVGYNLAQEGYQIVTASNGKDAIAKAQKELPDLIIMDVMMA
EMDGMEACEHIRKIPELNNVIITFLTARSEDYSQVAGFDAGADDYITKPIKPKLLVSKVK
ALLRRLKEQEVVSDTLNVGGIEINREEYKIIKGNVEIALPRKEFELFYLLASKPGKVFKR
DEILDKVWGNEVVVGGRTIDVHIRKLREKIGEDLFKTIKGVGYKFEV
>EGALAKHO_03394 hypothetical protein
MKFNLKFLLFTLFICTISIAQNKGTISGLLTDKESNNQALPFANVLIKGTNISANTDIDG
KYSINVNPGTYTIIFSFVGYESVEKPVTVKANETVTVNQVLSSGGYTLKDVVVKSTANRE
KETALLLDQKNAVVIKQSIGAQEMSRKGVSDVEEGLTKITGISKVGSRGLFVRGLEDRYN
NLLINELAAPSNSPFSKIVPLDLFPTNIVGVIDVYKTFNPNIYGDFAGGTFNIQTSKATK
SVTKLNLGFGYTTGNSFKDFLLSSDADTAAGFFGFNGKDREIPSFLGPNASKTAFTNDQA
LSSVSGDKGFNASKNKSPLNSSLNLLHSEKFDLSNERSFAYLLSINYDNNYAIREGVDRT
LDIQTTGSKYVNNFVTTDYRFKTTTSALVGLNYNANRFKLAFNTLYIKTTLNSIKDQFGQ
SNGTAIQNTLIRTNQLDKSDYLNLQLLGEYNLTEDKSQTLKAGVSYADTKFEQPDRKFFT
GQKTGEDEINTSYGGNNFLRQYLTIDGNSFVSAMAEYNLKFGKDGKQNKLTVGYNGNVSQ
MESSYRFVSSRGGLFSSSINNINDHIISDLQANNGTSFEENSNSTWNVKLMETANAGYTN
LLLKFADKYELNAGVRVESTTKETKYRGLGSFDAPFRVSTYDNLYVLPSLNLKYLMNEKS
NLRFAASKTYTKPVIMESFPISYQNADGTSIQGNSILKNSDNYNVDLKYELFPTGKEMFA
VGVFGKYIDNPIERTFVSNATTGTVTTFLNSDSANLYGAEAEFLFGLERISENLKAFSFG
LNGTLMATKVNVSPTYTSVDEDGNPTINTSIETHKGSRDLQGASNWLVNSDLKYEFNLAK
DWTNTMSLVYGVFGKRIYAVGTNGQDHTYELPVSQLDFVWSSKISEHFDVKFTADNLLNP
ARRLEFGNDGTIKVAEESLLAQSYKKGVGFSVKLGYTF
>EGALAKHO_03395 hypothetical protein
MKTKLFALALATGLFLNSCSSSDDPTPVTPPATGEITGTITANKTFAYGNYTLKGIVKIN
SGVTVTFDAGSTITIDKATGDNALVVLKGGKLITNGTADKPVVFTEKSKLPGSWGGIIVY
GDAPAKVAGGGTTGTSEDGNKISYGGTNATDNSGSLVYTRVEYAGSKLADGEKENNGFTF
YSVGSGTVLDHLVSYKGADDGYEFFGGTASLTNAISYGNYDDAFDWQDGWQGQTNTNWYA
YQTGKGNYGMEIEASLNDNSFGPKVSNITLKREAGNVPEVGDNQVDAFQFKREGNGEYSN
IIIDGYGNFTTTTGTITTYKGSAVSILDAATNDHQVKTSKIKLINVKITNTTNILPIGAT
DAIVVAFPAGTFVQSAAATGASLTPGAWATVDGVNLIK
>EGALAKHO_03396 hypothetical protein
MAKNYFYITFLLAFFFTVSVSAQDSKQLPKPQEPTTIEGLSLYPNPVTNGKVYISSKNDL
EKEIIVFDVLGKKVIQTHLSSKELNVSDLVPGVYIIKIYEENASATRKLIIR
>EGALAKHO_03397 hypothetical protein
MITANDIFTISSQKQFEKIALKVFRFQHENNKVYRDFCDFLKVNPQQVKSLEQIPFLPIQ
FFKSHEVVSNSDFPQVTFTSSGTTGIITSRHLVTDVSLYEESYRNGFSQFYGNIEDYVVL
ALLPSYLERDGSSLIYMVEDLIKLSNQAESGFYLHNHDDLIKKLTALDESGQNVILIGVT
YALLDLIEKHQFDLQNTIIMETGGMKGKRKEMIREELHEQLCKGFGVSSIHSEYGMTELL
AQAYSLGEGIFECPSWMHILVRDPEDALTYVNDGKTGGINVIDLANINSCSFIATQDLGK
KYPNNSFEVLGRFDNSDIRGCNLMVL
>EGALAKHO_03398 Tyrosine--tRNA ligase 1
MKNLVEELKWRGLYHDSMPGTEEQLLKEVTTAYIGFDPTADSLHIGSMVQIILLVHLKNF
GHQPIALVGGATGMIGDPSGKSDERNLLNEETLAKNVAGIKSVLSRFLDFNSSDTNAPVM
VNNYDWMKEFSFIDFAREVGKRITVNYMMAKDSVKKRLSGEGEGMSFTEFTYQLIQGYDF
YHLYKNNGCLLQMGGSDQWGNITTGTELVRRMGGESAKAFALTTPLITKADGSKFGKSEG
GNVWLDADKTSVYKFYQFWVNATDVDAEKYIKIFTFLDKETIDALIEEHKTAPHLRVLQK
KLAEEITIFVHSKEELEKAIQASNILFGNSTAEDLKQLDEATFLEVFDGVPQAEIAKADL
ENGLDIVSVLNEKTGFFKSNGEARRALTANSISVNREKIKEDFVLTANDLINNQFVLLQS
GKKNYFVIRVV
>EGALAKHO_03399 GDP-6-deoxy-D-mannose reductase
MVLVTGGTGLVGAHLLLHLIENGENVRAIYRSQNNIQKTKSVFELYGKTDLFEKINWLEA
DILDVPSLEIAFIDIKYVYHCAAFISFDPKDEDILRKTNIEGTANMVNFSLAKGIKKFCY
VSSIAALGDLAPHETYITEETDWNPEKPHSDYAISKYGAEMEVWRAVQEGLDIIIINPGV
ILGPIATTKIFLEGSNELYRRVANGLSFYTLGSTGFITVNDVVRIAFELMKSDIKNERFT
LISDNIIFRDVLNTIAETLKVRKPHVHANPLLMNFLWIADGIFSTLFFQKRHMPKATAKA
SYSKSLYSNEKIKTAQGTVFLDVHQYIKDTSKL
>EGALAKHO_03400 hypothetical protein
MKNFVFIILVLFLSVSCKKELVKEPKRLIEKGKMIDIMYDLSLLEAIKYQNPLSLDSVNS
DPKNFILKKYKVDSIQFAQSNIYYAADYDMYKDMYDEIGKRLAVKQRAVDSIVKIEEKKA
AKVAAKKNKAKVNLKDSIKKPAKPINIDSIRRTRQLK
>EGALAKHO_03401 Allantoinase
MNRILIKNAKIVNEGSIFEGDVLIENDLIVEISDSISLKTSDCKVIDAEGSYLIPGAIDD
QVHFREPGLTHKGDIESESRAAVAGGITSFIEQPNTVPNAVTQEILEDKYVIASEKSFAN
YSFMMGATNDNLEEVLKTNPKNVAGIKIFLGSSTGNMLVDKEETLEKIFSSTPMLIAVHC
EDETTIQNNLAAFKEQYGEDIPVTAHHLIRSAEACYISSSKAVALAKKTGARLHIFHLST
AKEMELFTNKIPLEDKKITAEVCVHHLWFTDEDYKTKGNFIKWNPAVKTAEDRAELWKAL
NDGRIDVIATDHAPHTKEEKMQPYLKAPSGGPLVQHAVVAMFEAHHQGKITVEKIVEKMC
HNPAKIFKIEKRGFIKEGYYADLVIVNPSLPWSVKPENILYKCGWSPFENFTFKSRITHT
FVNGQMVYNNFKVKDIRVGKRLLFDR
>EGALAKHO_03402 Polyprenol monophosphomannose synthase
MKLPRKMNDCIVIIPTYNEIENIESIVRAVLSQHKPFHLLIIDDNSPDFTANKVIALQEE
YPGRLFLEKRAKKSGLGTAYVHGFKWALERNYDFIFEMDADFSHNPNDLEKLYDACHFGG
ASLAIGSRYVTGVNVVNWPLSRVLMSYFASVYVKFITGMKIHDATAGFVCYKREVLEKIN
LNKIKFVGYAFQIEMKYRTYCGKFEITEVPIIFTDRTKGVSKMSNAIIKEAILGVISLRL
KKLFNTL
>EGALAKHO_03403 hypothetical protein
MIEQLTPRILENKDWATLLFVLTFAVVAMTKSAYETRFSEFSKLIFSDKYAKIYRDNNHL
KSSFTIGLFFVQVISFAFFIQLTMHIFSQDPKTGTYSVLKTDWILFIQIATFLLYFILAK
YLIEKIVATSFNIDDFADLFNLQKVTYRTYIGVLILPINAVLFYYDNIPKIIPLAIIGVS
LCISLYSYFISIKTYQNAIFSKLFYFILYLCALEIAPYYFLYYWITKGSA
>EGALAKHO_03404 hypothetical protein
MKVKTILVSQPEPKVENSPYFELQQKHKIKIDFRPFIHVEGVSAKEIRLQKIDLNHYTAI
ILTSRNAVDHFFRVADEMRYKVPEGLKYFCQSEAVAFYLQKYVVYRKRKIYVGAKDFADL
SPLIKKYKDEKFLLPASDQLNADAPVTLNNLKVDWAQAIFYKTVMSDLSDLADVYYDVLA
FFSPTGIKSLFKNFPDFKQNNTRIAVFGSTTQKEALDHGLRIDILAPTPETPSMTMALEK
YISEANKGK
>EGALAKHO_03405 Regulatory protein AsnC
MKINSLIIEIDGIDKEILRDLMDDARKPILQIANKIGISGAAIHQRLKKLEQSGVISGSK
FTVNPKVLGYTTMAFIGVYLDKASRNSEAVKDLKKIPEVLECHYTTGNWSVLIKIICRDN
EHLMQLLNTKIQAIEGVSRTETFISLDQQIDRQIQL
>EGALAKHO_03406 hypothetical protein
MGSGYLIIAGAIMLFSWLVSSKLKSKFELYSKLQLRNGMSGAEIAEKMLADNGITDVRVI
STPGQLTDHYNPSDKTVNLSEAVYNHRNAAAAAVAAHECGHAVQHSIGYEWLTMRSKLVP
IVSVASNYVQWILLAGILMIRTFPQLLLIGIVIFAATTLFTIITLPVEYDASNRALAWLE
NKHMLTQEEQAGAKDALKWAARTYVVAAIGSIATLLYYISIYSGNRRN
>EGALAKHO_03407 hypothetical protein
MDNNNIDFKDLWKKQTVSQPNIEDLMARLKQFKKEGLKSLWKTNILLFATSVFILFVWYY
YQPQFISTKIGIVLAIAAMVMYVAVYNGLLNVYKNIDANQTNHEYLQKLIEIKKKQQFMQ
STILSWYFVLLMAGICLYMYEYAARMTVFYALITYGITLLWIGFNWFYLRPKQIKKQQEK
INQLIDKFEEVNEQLE
>EGALAKHO_03408 ECF RNA polymerase sigma-E factor
MEFEQIYKNYWDRIFRLCMGFVNDYDIAQDLAQETFIIVWQKLETFRNESNIGTWIFRIA
SNNCLRQIEKDKRFPKSDLPTHLSEEKQTSIEPQIQFLYKCIAELPETERIIISLELEDI
KQAEIATIVGLSEANVRVKIHRIKEKLTQKFKENGQQ
>EGALAKHO_03409 Sigma factor SigB regulation protein RsbQ
MKKYILIIALLFSALCLNVFAQTKQYPFEVSKTGKGKQAILFIPGFASSGAVWDETKAGF
EKDFTCYTLTMAGFAGVKPQPNPSFENWKNEIANFIKNNKIEKPILIGHSLGGGLALAIA
ADYPDLIGKIVVVDALPCLAALSDPSFKSKENNDCSPMVTQMTAMNETQFYDMQKQTMPR
LLADTSKLEMVVDWSVKSDRVTFAQMYCDFFNTDLREKIAAIKCPSLILLESYFINLKPA
IEGQYKNLKTANFQYANKGMHFIMYDDKEWYMQQLGNFLKS
>EGALAKHO_03410 Leucine--tRNA ligase
MKYNPNEIEEKWQKYWAENQTFAASNNSEKPKHYVLDMFPYPSGAGLHVGHPLGYIASDV
YSRFKRHQGFNVLHPMGYDSFGLPAEQYAIQTGQRPEDTTRVNIDGGVDKEGKQIAGYRK
QLDKIGFSFDWSREVRTSNPDYYKHTQWIFIQLFNSWYCRKEGKAFDIAELVKVFEEEGN
GLVEAVCDDNVAIFTAAEWNSYSDDQKEKILLQYRMTYLAETEVNWCPGLGTVLANDEIV
NGVSERGGYPVIRKKMTQWSMRISAYAERLLQGLNDIDWSESIKESQRNWIGKSVGALVT
FNVKNHDEVIEVFTTRPDTIFGVTFMTLAPEHDLVAKITTAEQKATVEAYIEKTAKRSER
ERMADVKTISGVFTGAYAEHPFTKEAIPVWIGDYVLAGYGTGAVMAVPCGDERDYAFANF
FKAHPEASGGMPEIKNIFANVDISEAAYGSKDNVEIANSDFLNGLNYKDATQAVITALEK
IGQGSGKTNYRLRDAVFSRQRYWGEPFPVYYVNGLPKMIDAQHLPIILPEVEKYLPTEDG
LPPLGNATIWAWDTKNNEVVNTDLVDNFEIFPLELNTMPGWAGSSWYWMRYMDAHNETEF
ASKEALAYWESVDLYIGGSEHATGHLLYSRFWNKFLKDKGFAPTEEPFKKLINQGMILGT
SAFVYRIEGTNSFVSKNKIGDHKVQPIHADVSMVNSSDELDVEKFKAWREDYADAAFITD
DNGKYIVGREVEKMSKSKYNVVTPDDICAEYGADTLRLYEMFLGPLEQAKPWNTAGISGV
FGFLKKLWRLYIDENNGLIVNNDEPTKDNLKSLHKTIKKVAEDIENFSFNTSVSQFMICV
NELSSQNCHSKAILEPLAILVSPYAPHIAEELWSQLGHKTSIATVEFPVFDAKHLVETNK
EYPVSFNGKMRFTIELPLDLTAAQIEEIIMKDERTLKQLDGKTPNKVIIVPGKIINLVG
>EGALAKHO_03411 Molybdenum-pterin-binding protein MopA
MADSKKYKVEVRVWIEETEGAFLGIGKIWLLENIRKTGSITNAAKEMKMAYRQAWQLVEE
MNQRAESPLVEKLLGGKGGGGAKLTEAGEKAITVFYEIEKRIKEFALRETQNLKF
>EGALAKHO_03412 Vitamin B12 transporter BtuB
MKQKLYLIFLFISLKSFSQTEKSKTVQDSIKKEELNEVVITASRRSENLMHSPISIEQLK
SAEAKKMGSATIYEALENVKGVQIITPSLGFKVINTRGFANSTNVRFAQLVDGIDNQAPH
LGAPIANALGANDLDIDKIEIIPGTAAALYGMNAINGLANIQTKNPFEYQGISVQQLTGV
NHVGNIDRFSPKVYSQFNLRFAKAFNEKFAFKTNISTTGGTDWVADDRTDLAPLANASTN
LFGADNPAYDEVNGYGNESANRKTLNLNGKNYVVARTGYRETDISDYEIKNYKADVGLYF
RPKQGHELAATYKTALINTIYQRSNRFRLDNYTLNQFAVDYHTPVFQVKAYATTENTGDS
YNIRSLAENMDRAFKSDDKWFADYSTAYKNAITGGATVADAHRMARTSSDQGRFIPGTKA
YENEKNELIDINNWDIGAALRVKSTLVHGEGLINWDKAFASFFEKIDAKLLSGFDYRNYI
IVPDGNYFINPVNTSENLTYQKYGGFTQLTKNLFQEKLTLGATLRIDKADYFDAKFTPQF
TAVYAPKETISFRTSYQTGYRFPSIFEGFSNVNSGGVKRVGGLRIMSDGIFENSFTKASI
DKFQAQVNTDVNTNGLTQAQAIEKNKNTIQKNPYTYLEPEFVKSFEFGFRGMALNRNLFI
DADFYYNSYKNFIAQVEASIPNTNDLSLIPTALYSKNTQNRYRLWTNSKSKIYNYGGSLG
LRYRIDQTFTALTNVTFTKLDRTDDKDGLEDGFNTPEFNVNGTLLANNIWRNLGASVTAR
YQNNFDYVSFLVSGTVPAYWSMDAQMNYNFNKGISAKLGATNLLNKPYTSILGGPSIGGL
YYLSLVWETKI
>EGALAKHO_03413 hypothetical protein
MKTQNYILVLLIAFFCTMCNSSKKEEKTTIEKAVTAEKESEHKKLSPADSLKLVNHEIEI
KGEVEFPLQLNVDSLRKMKVATISNFKIVGQNGDVKKDDKISKGVLLKDILEKAKIKQNG
HKDRNFYIVARASDNYKATFSWAEIFNNPTGENTYVVFEENGKPVKNGDMVLICKNDIKT
GPRHVYWLKRIEVYKVK
>EGALAKHO_03414 Cell division protein FtsX
MSSNFDKFQKRRLISSYFSVVLSVFLVLFLLGVLGLFIINSKKLANDFKEKIAMTVFFKN
EANDSVIKAFNTELKRSPFARSYAYVSKERAAKEHTDIIGEDFLTFLGENPLLNSYDIHL
KADYVERDSISKIESSLRQNTMIEDIVYDKQLVNLVNDNIKKVSMWILIISCFLAVIAVL
LINSSLRLSIHSNRFIIKTMQMVGATKSFIRKPFVMRSVKLGILGAGLAIVALIAVLLYV
DTNFPGLGILEDKALIGLVLLAVFGLGILITWVSTHFATQRFLNLRTDDLY
>EGALAKHO_03415 hypothetical protein
MKNISNKEELHPQKQEFLFEGINYKILLIGIGVIALGFILMSGGGSDNPNVFNEDVFSFR
RIRLAPTTVLLGFGITIYSIFKKSK
>EGALAKHO_03416 Undecaprenyl-diphosphatase
MNTLQAIVLAIIEGITEFLPVSSTGHMIIASSFFGIAHEDFTKLFTIVIQLGAILSVVVL
YFKRFFQTLDFYFKLLVAFIPAVVLGLLLSDFIDGLLENPVTVAISLLIGGIILLKVDEW
FNNPNTAETSQEITYLQAFKIGLFQCIAMIPGVSRSGASIVGGMSQKLSRTTAAEFSFFL
AVPTMLGATVKKCYDYYKAGFELSHDQINLLVIGNVVAFIVALLAIKTFIGFLTKNGFKV
FGYYRILAGIILLIIHFFIHPLTII
>EGALAKHO_03417 tRNA pseudouridine synthase B
MTTEEYLDGQVLLIDKPLKWSSFQAVNKLKYLLINKVGLPKKFKIGHAGTLDPLASGLLL
ICTGKFTKRISELQGQAKEYTGTFYIGATTPSYDLETEIDQTFPTDHIGEALIHETVKQF
LGEIDQKPPIFSAIKKDGVRLYEHARAGETVEIASRKTTIHEFEITRIALPEIDFRVVCS
KGTYIRSLAFDFGKAMNSGSHLTALRRTKIGDYDVKDAIDITLFEESLQ
>EGALAKHO_03418 hypothetical protein
MKYFLVAIITFFFFSLKLSAQERKFTYIQFDINLSITGNPDYGDAPEYEGDKQPWLLPDG
LGSKLGYGVHYKQWLTLGIHSGLDWKWNEKLVAVPVYLNFGLRPKIAEGTRITMEVGYGK
SFALGRGDLSGEYKKARLGLTVDDHTIFLEVADFGFPLHDYNSIGSVNFGFSLISF
>EGALAKHO_03419 hypothetical protein
MKSIVAKALFNSHSYAEYRKLIADLLLEGKSTGKDQSESLTHYTSLNETRMNRLEKTITI
SEETIVKLQNLDHHYIWLVISEGWCGDAAQILPIINKMAVASDKKVDLRIVLRDENDELM
SHYLTNGGRAIPKVIIICKEAGIVRADWGPRPKGATELMTNYKKDFGVIDEKIKTDLQLW
YLADKGISVQEELVEIMENIKYNRL
>EGALAKHO_03420 Uridylate kinase
MKYKRILLKLSGEALMGDLQYGIDPKRLAEYAEEIKQIHSKGVEIAIVIGGGNIFRGVAG
ASAGMDRVQGDYMGMLATVINGMALQGALEDKGMKTRLQTALKMESIAEPYIKRRADRHL
EKGRIVIFGAGTGNPYFTTDTAAVLRGIEINADVILKGTRVDGVYDCDPEKNASAVKFDF
ISFDDVLKKGLNVMDTTAFTLSQENKLPIVVFDMNKIGNLLKICEGENIGTVVNI
>EGALAKHO_03421 Ribosome-recycling factor
MSEEIDFILESTEESMNGSIAHLEKEFLNIRAGKASPAMLGSVFVDYYGSATPLSQVSKI
SVPDARTITLQPFEKNMLHVIEKAIMIANIGFNPMNNGDMIIISVPPLTEDRRRELAKQA
KSEAEDAKIGVRNVRKDANTDIKKLEKEGTSEDVCKSAEEEVQNLTNAYIKKIDELLAAK
EAEIMKV
>EGALAKHO_03422 hypothetical protein
MKLFCLLTLFFTLTIQAQFQINGIVTDSNKKPLPFATITTSDNNNTITDVDGKFDLKINA
KTSTFAVSYIGFQTKTIALADNKKFYSISLSQKTDALNEVVISNENPALTIIKKVIANKN
LNNPQKKLSSFEYKTYNKLIVTANPDSIDGRIDSSAAYKDFNKKTINIDSSDYKFKEIIS
KQHLFQTEKVSQYQFGNNKLKETILGTKMAGFKQPVYEIIAFNLQSISIYDSKYELFETK
HQSPIAENASSDYNYKLLDTVPIKGRNTYMIYFKNKKKRKSNGLEGVLYIDQENFAVAKA
VMRIKGVLDISGIHEFEYVPDEKIWFQSKTTFKIVKGKSNDDIKILGGTIQFDGDVKDNF
EPRKKAASDFTYLLSESNNFDIHYNTNSQIKNPSLYIEIKDDASKKPEEFWNTYRKESLD
LKSQRTYQLIDSLSLSKRIEKRLGLGRKIINGYLPIGPIDLDLKKIISFNNYEGFRLGIG
GVTNDRFSKNFRIEGYTAYGTKDGVFKYSLGSGVLLDKSTNTWLNGSYTDDVREIASTVF
AVDKRVFKIYDPRPINISTFYKYISWKANVQTKIIPKTEAVFELARTYVEPKFDYLFNLN
GQLYSSYIMTTAMASIVWAPFSDFMQTPTGRTESDKRFPRFTFQYTQSLPNVLENDFAFA
KIDFKTEYEKKYLNGQKTSLLLQGGYAMGDVPITHLYNTMPNNLTKETVIQRITFAGRNS
FETMYFNEFFSSQYIFFQVKHGFDRIKIMKKVRPSLVLVTRMAWGNMENPEQHVGPAYKT
LDKGFFESGIELNRIFKGFGLGGFYRYGPNQLLKFEDNIAVKISYVLDLGL
>EGALAKHO_03423 Na(+)/H(+)-K(+) antiporter GerN
MNNIKNSLFYVTVIGGFTALIYWVISKGASLEVGRGIVQKKTESNHWNDFLHSMIENLQH
PLAILLAQIVTIILVARLFGWIFRKIGQPSVIGEMIAGIVLGPSLVGMYFPEFSAALFPK
ESLGNLQFLSQIGLILFMFVIGMELDLKVLKNKAHESVVISHASIVIPFALGLTLAYFVY
GTFAPQGVAFSSFGLFMGIAMSITAFPVLARIVQERGMQKTKLGTIAITCAAADDITAWC
ILAVVIAIVKAGSLTSSLYVIGLAILYVIIMLKIVRPFLKRVGDLNSTRESLNKPVVAIF
FITLLFSAYASELIGIHALFGAFLAGAIMPENNKFRNIFIEKVEDVAIIVLLPLFFVFTG
LRTQIGLLNDPYLWKVTAVIIAVAVVGKFFGSAFAAKFVGQNWKDSLAIGALMNTRGLME
LVVLNIGYDLGVLSTEIFTMMVIMALVTTFMTGPALDFINFIFKDKVTAVPEEIGNKSKY
KILLSFATPEKGKKLLQIANSLVKKQGDNSIVTAMHLSLSTEIHSFDVKDHERKMLVPVI
EESQRLNQNMLSVFKVTNDIDTEIIDTANQGEYDLLLVGLGQSIFDGTLLGKILGFTTRI
VNPDRLIDKFTGKEGLFENSPFDERTRHIIAKSKMPVGIFIDKDLEEVNQIFMPIFSQED
AFLIDYAKKLINNNGSQITVLDASGEVKSTRDIQESIRSIEQIAPNHIMIMHDRTIKKEF
LETQNLMIISLDSWKKLIESQSTWLNNTPSVLILKP
>EGALAKHO_03424 Transcriptional regulatory protein NatR
MNTKLKCLLLDDELPGLMYLKMLCEQIPEVEIVKTFNNPEKLLAEIPNLDFDLLISDIEM
PGIDGLHLAEMLDNKLVIFCTAYKEYAADAFNIDAVDYITKPVKLERLQKAISKAFERFN
KPETAKKFIQLNTDRGKTLLYFDQIQLVKTALSDSRDKTVLLSDGSFLNLKNVKFDTLLK
ELPETDFCRINKKEILAVKAIKFFNHNEIVLHHLEENNKNTTLILSETYRSDFLKKVKI
>EGALAKHO_03425 hypothetical protein
MQENNTITFIFLAIILLLVVIICFMVYQLMQAKKSKDDAEESFYALERKVNDLQLETLES
KLNPHLFKNILNSIQSHAYQTYFALDKLANVLDYILYESKKKFVTAKEEIDFALNLIEIN
KIKISPLFELKIKTNINKEDKLYEQPLLAPLISIDLIENAFKHADLQSADAFISVVFEFK
DNAFSMTVSNKISDKKVLKKERSGLGKTTLEHRLKIIYKNNFKLDRFIENDIYIAHLKID
LLEYKTEMLASGR
>EGALAKHO_03426 hypothetical protein
MLNEILNYLNIEFSKAEISKIIEDKIMFHFKRSLSELDKFFEGERKSVSFFKRNEFSIED
LGNNPIKLKWINLDFIQNYGFNNSFRLLEFLSSTEIFLEYKKKFHQKYTDYELVLFVSEG
EFCCGTKKIVFSS
>EGALAKHO_03427 hypothetical protein
MKLVEKFISILNATRRFGSCSSGVEFGTIFNYLSNDNTKVTLVEDDFSSSLIIGFKEVFN
GDIIEYTINLKKIDNGLLMSSLKMNFRGDYIIKNK
>EGALAKHO_03428 Quaternary ammonium compound-resistance protein SugE
MNWILLIIAGLFEVGFASCLGKAKETTGIVSTYWMGGFFICLSISMILLYKATQVLPIGT
AYAVWTGIGAVGTVLVGIFVFKEPATFWRIFFLSTLIASIIGLKFVSSH
>EGALAKHO_03429 hypothetical protein
MKNAIHVGFWEKVARIILKNRITILVLVALLTIFLGYQWKNLAMTYTEANLLPKNHIANK
EYQKFLDKFGEEGNLVVIGFQDKKFFTPKNYAAWNELMTGLKNSKEVDLVVSLNDLKKLE
KDTVNQKFVLKPFIDQSKTVDPAYLKTVQHDLFNNLPFYEGLLFNKESGSVRSAIYINKA
LVNTAERKTFILENLVPKIDKFEKTTGIDLKVSGMPYIRTINAADMKGEIGLFIGAALFT
VSLIFFFFFRSFRATFISICILIVGVIWSFGTLGLFHYKITILTAIIPPLIIVIGITNCI
FLINKYQQEIKLHNNQAKALQRIISKIGVSTLMTNLTTAIGFATFMITGNDLLFEFGLVT
SINVISVYLLTLLIVPIVYSFMSLPKEKHLYHLTKTYISTLLDFVENVVKNKRKVIYTIY
GLLLVFSVIGVAQMKVSGSLIGEMPKSASFFKDILFYEKEFNGVMPLEIMIDTKHKKGVM
KASTIRKMDELQNTIEEMPELAKPVSIVNLVKYSKQAFYNGNPEYYQLPTSQEQTFILGY
AKNATKNSKENLMKAYVDSTGQYARITTFMKDIGTDEMAKVEKKLHSKIDEIFPKDRYEV
TVTGKALVFQKGTSYLVDNLIESLIFAILVIAILMLYLFRSFKMVFASVITNVLPLCITS
GLMGYFGIPLKPSTILVFSIAFGISVDNAIQFMAKYKHDLIQSNGKVKKSVFSALRETGI
STFYTSVVLILGFATFTLSSFSGTIALGGLISCTLAFAMFANLLVLPALVLTFEKKKAKK
EDLEGLEGNTNFTN
>EGALAKHO_03430 hypothetical protein
MKKSIITLAFLFLYNTNCHAEGQDIGLNELANIMNLVRSIVILISIVCYIIISRFILKLI
LTEKTIIVFGKKINNSTFLTTAIITFLSVLFFVMIFYFYFEE
>EGALAKHO_03431 Asparagine--tRNA ligase
MKHTKVKDLLNSTTTLQEVNAKGWVRTFRNNQFIALNDGSTINNIQCVVDFENTPEETLK
RITTGAAVSVIGTLVESKGAGQKYEIQVKTLEILGDSDAEKFPMQPKKHSLEFLRENAHL
RVRTNAFGAIMRVRSVLSFAVHNYFQQKGFVYVNTPIITGSDAEGAGEMFKVTALPFDNT
PRTEDGKVNYKEDFFGKETNLTVSGQLEGETFAMALGQIYTFGPTFRAENSNTSRHLAEF
WMIEPEVAFNDLDDNMDLAEDFIQYVIKYALDNCKDDLKFLEGRLLEEEKSKPQADRSEM
PLLEKLNFVLENNFKRVSYTEAIDILRDSTPNKKKKFNYIINEWGADLQSEHERFLVEKH
FKCPVILYDYPANIKAFYMRLNDNTEPGRETVRAMDILFPGIGEIVGGSEREERYDVLIE
KMKALEIDEEELSWYLDTRRFGSATHAGFGLGFERLVLFVTGMTNIRDVIPFPRTPGNAE
F
>EGALAKHO_03432 RNA polymerase sigma-54 factor
MKLIQLPTQAFEQRLLEEMNENPALEAGKEDEYEADEFANEDYDDYDDAESDRIEADDIN
IDEYLSDDDTPDYKTQVNNYSEDEERETPFASPISFHQDLINQLNTFILNDEEREIAEFL
VGSIDDMGYIRRSVADMVDDMAFTQGIYTDDVMVEKMLHVIHELEPSGVGARDLQECLLL
QLKHKTPTEYVDLAIDIIENQFDAFTKKHYDKLLQKYAVSNEQLKKAIHEIERLNPKPGG
SYTGNNKVTENVVPDFAIRIVDGELELTLNGRNAPSLHVSKDYQEMMQTYKDSRDKSSAQ
KDAVQFIKQKLDSAKWFIDAIRQRQETLFVTMNAIMHYQEEYFLDGDETKLKPMILKDIA
DMVGLDISTISRVANSKYVETPYGTKLIKEFFSEAMKNDQGEDVSTLEIKKILKNTIEEE
DKKKPLPDDQLAEILKEKGYPIARRTIAKYREQLDIPVARMRKKI
>EGALAKHO_03433 hypothetical protein
MQDKKTKRKQNILLFGVIGIAVALAVYFQFFLSETKGEVKTEITELVAKYNKNCPLKIQE
GIRLDSVSLPKVTDEKDVQYNLTLLNVEKESAEIDVIQTEIEKSLISTAKANIGLQVFRD
NDYTLVYSYKDKKNVFLFDVKILPDQYK
>EGALAKHO_03434 Thymidine kinase
MFLENTVNHKEQFGWIEVICGSMFSGKTEELIRRLKRAQFAKQKVEIFKPAIDTRYHDEM
VVSHDSNEIRSTPVPAAANIAILAQGCDVIGIDEAQFFDDEIVTVCNDLANQGIRVIVAG
LDMDFKGNPFGPMPALMATAEYVTKVHAVCTRTGNLANYSFRKTDNDKLVMLGETEEYEP
LSRAAYYNAMKKSQEK
>EGALAKHO_03435 hypothetical protein
MKKKLEADLISIAHRILKLKNKSDINQLYLETQKLYEKLAVLKFIDENFEGAKPTISHGE
ITSQIETIFEKEEVTPTEIKEEAPIVAEETVVEETPEPIIAEEIAAEIPEEITPEPAEEI
IEEPVVEKIEEPEAVIETEEVETVEETKTVESVKDPIIEKINEAVIEAKKTIEANRDLSF
KTSSDLNPIPDFKPAFELDKSEEKIEEKEEPKIQTTSKSNPLPLAFEDFGINYADAQFVK
VDSFEAVPSSSFPSLNEIQETTIETEVLETPAEPKAVSLNEKLAKGFHIDLNDRIAFTKN
LFGNSAEDYSRVLNQLLTFDTYAEAQEFIENMVKPDYNNWEGKDDYAERFLGIVEKKFS
>EGALAKHO_03436 Ribosomal RNA small subunit methyltransferase I
MSKLYIVPTPIGNLEDMTFRAIRILKEVDLILAEDTRTSGKLLKHFEIGTHMHSHHMHNE
HKTTENLIARLKAGETIALISDAGTPAISDPGFLLTRACVENKIEVECLPGATAFVPALV
NSGLPNDKFVFEGFLPDKKGRQTRFLALAEETRTMILYVSPHKLVKTLAEFIQYFGEDRQ
VCVSRELSKMHEENVRGTAREVLTHFEKTAPRGEIVVVVAGKTIIKEPKKSKFSKDEEE
>EGALAKHO_03437 hypothetical protein
MFFSCNEKKIDPEIKPDNKEFNDQELQKIGHFYQPEKMTTRPIKLEINSEEKNYEIDIYN
SDILKKDNENLKLHSDKIALLLKKHLIKNNVTYNDIIIRIYQKNNGKQSFQYTNQELVNI
ENRQHLDQSKKIKL
>EGALAKHO_03438 hypothetical protein
MSIQAFLEKVKQTPNEITFPETIAVIEENYNFTPTAFQNGTQHNTAGENSGSCKLFSFAK
LQNLSKEETLACFGAFYFEEVLKDPNGTNHQNIRNFINLGWDGIKFEGNALEAK
>EGALAKHO_03439 Single-stranded-DNA-specific exonuclease RecJ
MRWTLKPKPSEDKVKHLAQALNVEDFVATLLIQRGIETFEDAKNFFRPSLEHLHDPYLMK
DMDKAVARIESAIENQENILVFGDYDVDGTTAVSLVSSYLKSHYPNIATYIPDRYDEGYG
ISFKGIDFADDNGFSLIIALDCGIKSIDHIAYAKAKNIDFIICDHHRPGNTLPDAVAILD
PKREDCSYPYDELCGCGVGFKLIQALGQNRNETIENLVTYLDLVATAIAADIVPITGENR
VLAYFGLQVINSDPRPGIKALVHQVKKKVLDITDVVFIISPRINAAGRIKHGNHAVELLT
EFDFDQAQQFASEIEQYNADRKDLDKKITKEAFQQIIENQEEERFSTVVFQEDWHKGVIG
IVASRLIETYYRPTLVFTKSGDKYAASARSVKGFDVYNALDACAHHLEQFGGHMYAAGMT
LKAENYKPFKEAFEKQVEETILPEMRTPEIEIDAEINFSDITPKLIRILKQFEPFGPLNM
TPVFMTTEVKDTGYAKTLGSEDEHLRLFAKQFNSEGIAAIGFGLGKKLNITKNQNTFQLA
YTIAENEWNGNVSTQLMLKDIRTNER
>EGALAKHO_03440 Enterobactin exporter EntS
MKDKEKKNDPYQALRYREFNVFLLLRFCMVFAWAMQFIVIEWEVYSLTKNPLSLGIIGLM
EVIPAVGMALFAGHIVDQSEKKGLLVKCILGFSVISFGLFLVTWPKVVGDLSQTVILYSI
YTLVFLGGLVRAFLGPTTFSLQSLIIPKKVYPNASTWSSSVWQIGAVMGPALAGFSINWI
GVHWSMCMVFGFSILSLIALSQISKKPIVNPKIGESIKDSLTEGLTFVFKNQIVLGALSL
DMIAVLFGGAVALLPVFAQDILKVGSEGFGILRAAPAVGSFITMLVSAYVPLYKNAGKKL
LVAIFVFGLSIILFGISTYFWLSVFALFLSGLADGISVVIRQTILQLKTPDHMRGRVGAV
NSIFVGSSNELGAFESGATAKLMGTVTSVVFGGSITLLTVLGFGITSPTFRNLDLQKDMD
DHQNME
>EGALAKHO_03441 Arylesterase
MKKLVLAFFFTISLVASGQNLYIKTYGSKKEKVLIFIHGGPSGNSTLFESTTAQKLADLG
FYVIIYDRRGEGRSADPEAKITYAEAFDDLNLIYKKYNLKKATLLAHSFGGLVATLYTEK
YPQNVSNLIMVGALFSQQETYDHILNSVSKIAAAKKDTTQLSKIKAIEKLSKNSAEYRKA
CFDLASENNYFKMPNPTEASKKLYSDYEASDFFKTNIRNKNAPFLFYKNEKQNNIDTRPS
LKKIKTAGIPIYAIYGKEDGVFSSAQINSIKGIAGQNHFALLDNCSHYLFVDQQDQFLQN
IKKWLK
>EGALAKHO_03442 hypothetical protein
MREIEQLYHNNFGIAFYWKKENETITDKVQLVFKETGFYFTVQELNYFCDLIEDSMIENA
CCEACELKNSCHKFLLKTPCAQIDLAVSIKELKSIKDLVEGSLFRIELDEYVYGAGMN
>EGALAKHO_03443 Dissimilatory sulfite reductase
MKKLRILFAIAVLAVLLSNCTNKSDEYIDPRGTDYAGSESCIQCHQTQYDMALKSSHFKA
TAPASLENVLGDFDKGNHTFIYDKNTKLAIEKRNDSLYQVLYKNGKEVEAHPFDIVFGTK
HAQTSVYWRDGNTYELPISYYHSIKGWATSPGFPADKPYFDRMVVKDCYSCHASNASSRT
VQQNSAEKNVMSMDVEDIIDPKTIVYGIDCERCHGPAKQHAEFHLKNPNVKVANSITSFK
NLNRQQRLDACALCHGGNDGMKMKSRFDFKPGNNLSEFYRSTRSVTDTASFDVHGNQFRL
MAQSKCFINSEKMDCITCHNPHENASKNVASYSKICMSCHQNGIKHSDKTLKTMSGSLLA
NNCVECHMPKKSSGAIKFQLSDSKQLSNYILRTHKIGIYPAK
>EGALAKHO_03444 UDP-2,3-diacylglucosamine hydrolase
MKKIYFASDQHFGAPTPESSLPREKKFVAWLDEVKEDAEAIFLLGDLFDFWFEYKTVVPK
GFVRILGKLAEIRDSGIPIYFFVGNHDLWMNDYFETELNIPVYHDNKEFTFNGKTFLIGH
GDGKGPGDKGYKRMKKVFTNPFSKWLFRWLHPDVGVSLAQYLSVKNKLISGDEDVKFLGE
ENEWLVLYAKRKLETKHYNYFIFGHRHLPMIIPVGEESKYVNLGDWIGYFTYGVFDGETF
ELKKFEK
>EGALAKHO_03445 hypothetical protein
MSNIRITKQFNFETGHALYGYDGKCKNVHGHSYKLSVTVIGSPITDRSNVKYGMVIDFSD
LKKIVKEEIVDQFDHATVFNETTPHIELANELKNRGHHVILVDYQPTSENMVVDFSKRII
ARLPAGITLFSLKLQETESSFAEWYASDNQ
>EGALAKHO_03446 putative polyketide biosynthesis enoyl-CoA hydratase PksH
MSLENQNGSLYTSFQNAVATVQFGHPASNSFPRELLNRLTLEINDLSRNEAVSVIVLQSE
GSKAFCSGASFDELLQVENEEQGTEFFSGFAHLLNAMRNCSKLIVGRVQGKAVGGGVGII
ATCDYVLATTESAIKLSELAIGIGPFVIEPAVSRKIGKTAMTEMTLAATDWKSATWALEK
GLYASLHTAEELDGAVENFAQKLSSYNPEALFEMKKIIWEGTEQWESILIERAAITGKLV
LSDFAREALTQFKK
>EGALAKHO_03448 hypothetical protein
MPSFLNINLDGKIETNFFIKHIFFSFFWVLGILIFVFRIDILLTQKYIDSTTWLSFSIPS
IYFLLLVFFFFFIRWYYIIAFFFYPFLMFFWFIPKTILSVGKVYLLGTYLNWIFSKLSNI
KLFAFNVFFFVFSFIFLIIINENWTRWICIICLSYFYLIYLYKFLIKSFKQPTLFGADID
EVFEKLIGDKSAENSLVIKSYIIQKEDDKIDQYLLKEVRIKRMIMANYAIELLSKRLNGY
KGRQAYLTSWIFGAFMFLLSSIIFFWFINFQLFKIDPTNFQYTGIFPSFDFLYYTLKTIT
FGDIELIKPSSVLSRFTEICSFLTIGIFILVIVISIFLSMKQDRVNENVKLTTELMNSES
LTLVKYMKDEFGMEIKSAFNEIKNIDDSVKKIKEIIDKIF
>EGALAKHO_03449 hypothetical protein
MREFDLDDEFKMIFNDFTGLYDYYKNGELLSKSADKLFKYYSLNINNIDALLNNYFHLSN
PATFNDPFDCNVNLASDVDNEKLINMKTVKRNDIQNIGIVSFSETINNHLMWAHYTNNYN
GFAIEFKGTEVTVNLVEDRFEKFTLTKVFYPKEMKKIRSGYPFAMHYVLSTKMKHWEYEK
EWRIICQLKKDDNRVLYYYPDKVKAIYIGHKLIDESESAYRLLLEICEIRFPKTPIYVVY
PHPTDIKLFFERVLN
>EGALAKHO_03450 hypothetical protein
MYNSKDILFHINHYQNELDESYNLLKLLESGNLKGNNEPAQESIEDVKKHIKYLCFFTSC
FLDIASSLRGLVDSETDWERKFYLKNGFVVIYESLKTFGKHQNEIRNLISRDFNELEPRF
VNIILKLKKLKKEHKYDTLITKFRNKAGAHYDENFAEYFEHLKSIDKPISVKTVSDFSNF
LMSLIIFWSDITDIYCEKITERMSSGK
>EGALAKHO_03451 hypothetical protein
MDTEKIFDENGQGFIRAFYSDKVERVNPIKFYETAELKHSATLIKDILVLKNPLLTSFLD
SDYFERKAKEMIVGYCEKCLKTEIHQNFIELLNTTRKKDQIRLLKGMTLNPDELMSLIFK
SYYEFGYLYSKYHFKNLPNIFEGKKLPKIFRLDENDNIIKIGNTDLTDGELKHIIENRKV
IVSHFFERQDVWHCFFSTYKSMGGKENWKDGQPHFHYISSGFGISKEDFIESMRTGNYKS
TSIHIDLLEYGEQPKKQEE
>EGALAKHO_03452 hypothetical protein
MFFIFGYVLVFFGYLKQENYNQIATIVGGLASIIGLLGFVLPSLKTSDIKNIELETLKSL
AKTAEEIQKKEAELTTKQSDLTKLELQKQELEFLVRKASLNLFFKEQMERYYETLDKQIS
DNKEISRTIKEIKELEYKIVELEIEIEKSPNTENILKIIEEARKHRKTNIELNTPFDFLI
EPFIRILKNK
>EGALAKHO_03453 hypothetical protein
MAKTTSDLLMIAGTGASLIIDASSKTTSDLIMIVGSVGRKGGHITLTNCYKKTTSDLLMI
CNIYPSNVTLDFTETLNK
>EGALAKHO_03454 hypothetical protein
MKKNYSFTLIALLTSSLIQAQTEIYLPFENRELTIEKVMAGAVMLFVYLYQRLIHGIKKT
ANTYLCLTFSPHGQCFAGLFLLFGRYN
>EGALAKHO_03455 hypothetical protein
MGNRNAFFALFLLTTVLGFGQAKTKEFGFITDNDLYTSSKNDMYYTNGIEFFFRYLSKNE
NEKINKKITEFRVGQYIYNPRYINETAVDINDRPFTGYLFAEAGCSFFYNSESVLKTDFQ
LGYMGPNAFGRETQESFHHIIGYKKVYGWENQLHNALAVQAHVMYSKKLFPGKHNDFVDL
HFQSEANLGTIFDGISTGFLARIGFRKLLPVYDSNLHDASVSAQTQFDVREFYFYAMPSV
NYQFYDATIEGSMFSNTSPVIFELEPLRFNAEAGLKYRHNNFNISYSFLYRGRELRDPET
NTNSGYFYGSIRLGFLIK
>EGALAKHO_03456 Biosynthetic peptidoglycan transglycosylase
MAATKKPAPKKTTASKPKPAAKKKTNRTFGQKVKWFFIKLCLWFFGLSIGSVIFFKFVPV
PFTPLMVIRAIENKMAGKEVYFDHDWEPIEKISMNLQKAVIASEDGTFLYHNGFDFKALQ
KAYKSNERGRRIRGGSTISQQTAKNVFLWQGKSYLRKGLEAYFTVLIEIIWGKERIMEVY
LNSIEMGDGVYGAYAATEHWYRRDASSLTQMQAAGIAAILPNPRKFKATGSSSYINRRKE
RIVREMRAVGKINYNGK
>EGALAKHO_03457 hypothetical protein
MELSYWELRNWFTNVDYTIVGSGIVGLHAALRLRDRFPTAKILVLEKGMLPQGASTKNAG
FACFGSLSEIMEDLKTHTEEDVIALIEKRWQGLQLLRKRLGDAAIDFKPHGGYELFLKED
ERGFNECVARLPFINEILKPLFKADVFTKEVDRFGFENIQEYLIFNPFEAQIDTGNMMQE
LLKQAVAADILILNQQTVTGYADLGNHVEIALNDFSFKSKKILFATNGFANTLTKGAVQP
ARAQVLITEPIPNLDIRGTFHLDRGYYYFRNIGDRILLGGGRNLDFETENTTEFGQTKIV
QNKLEDLLKNVILPNQEFQIAHRWSGIMGVGNSKKPVVSQLSENVFCGVRLGGMGVAIGS
LIGTELADLI
>EGALAKHO_03458 Dipeptidyl-peptidase 5
MKKVLFTTLIMMSLNAIGQNVMSPELLWKLGRVTALGLSKDEKNVVFKVSTPSVEENKSS
SKFYILPVNGGTATEIKDTKAILADKNVSPDGKFLVYNEEVKLEKVLGKDFYPSLGKSDA
QIYDGLDYRHWDTWNEGKFNHVFYKENKEGAAGIDILKGENFDSPQKPFGGDEDYIWSPD
GKSILYVCKKKAGTQYAISTNTNIYEYNLETQKTINRTEDNLGYDTAPQFSPTGNLTWLQ
MKRDGYEADKNDIIVEFKGIKTNLTANWDGTVDNFIWSKDGKNVYFVAPVDGTKQLFVVN
FPGLTRIAIQVRQITKGDFDVNDLVGFAGDDIIVTRNDMNHAPEIYSFNLKKNTWKQLSN
VNTDTYKTLALSKTEKRYVTTTDGKKMLVWVILPPNFDATKKYPTLLFCQGGPQSALTQS
YSFRWNFSLMAAKGYVVVAPNRRGMPGHGVEWNEKISKDWGGQVMDDYLSAIDDVAKESY
VDKSRLGCVGASYGGYSVFYLAGIHNNRFKTFIAHDGVFNTVSMLGTTEEVFFNNWDFGG
AYWEKDNAVAQKAYTTFNPATMVEKWNKPILIFQGGKDFRVPIGQGQEAFQAAQLRGIKS
RFVYFPDENHWVLKPQNAQVWQGEFFKWLNETL
>EGALAKHO_03459 Autoinducer 2 sensor kinase/phosphatase LuxQ
MESKRSYTAIKVLFSYVALLALVVTVGWFLYSENVVYNKLEDKIAFEKTKILRVSKLFSN
VYKTESLARKTIQTNSESDFKSYLIETDSLRSRIDTLKQIVTTQYQKTLLDSVTYYLSEK
TKNIQQLKTIKNKADDEVSVNSAIDEITKMEFKLRKLELQDFNKNPNELGSYQRNVLQKY
VDYLNQNIPDDSTNTLSKKASDSILANSKKLLSNVKLKAEKKKESLNFEENKLLKNEIAI
SEQLRKVLRIIEREIIINSIKNNSLKEKSLKKVNEIVTASAIIGLVLTLFFSILIVSDYS
KSQVYKKQLEIANFKTKNLLKSREQLISTVSHDLKTPLSTIVGYSELLGNSDVNTKQSYF
IKNIKNSSEYITQLVQDLLDFSKIEAGKITIEKVPFSLPEIIDEVAKSIQTVYKQKNIEL
IINGDEKLHTKIVGDPFRLKQILSNIIGNAYKFTEEGFIRISAFLSENDQFFTITIEDSG
IGIEKGNQKLVFEEFAQANEGIEKKYGGTGLGLSICQKIISILGGTLALESTFGKGSTFE
IQLPLLFDTSTTLIPDIKKPTVRNTKKQIFIVIDDDINLLNLTTGVLRQENHQVLSFNNA
IKALEAIQKTNFDFIITDIQMPEMDGFMFLQKLKNTSDYKNQPVIALTGRTDLDASVYAN
AGFTTVVKKPYSPRILLETIHLILENDTLPAVEINDSEQKVALKSYSLETLKEFLGNDND
ALKEVLKSFIESTNENLAHLETAITEENVSEINAIAHRIAPMFNQIEAYEIGGILKVLDK
NDFEISDLKDIFKALKAKTESLFKALQKEII
>EGALAKHO_03460 Transcriptional regulatory protein ZraR
MSKILLIEDDISFCKLLEKFLIKKAYDVTVAFSAEEARLAMKKESFDLILTDLRLPDSDG
IGLMSEFKTSNPEIPVVLMTGYSDVNTAVKAIKNGAADYISKPFNPDEVLLVITNALKNS
EVENVPTKEIKAPKKKEINSSENEFVRGISVASKKLLDHIHLVSPTDMSVLIIGESGTGK
EIIAKSIHQQSTRKNNNFIAVDCGAIPKELAASEFFGHLKGSFTGAISDKMGYFEAANGG
TLFLDEIGNLSYENQIQLLRALQERKIKPVGSNKEINVDIRIITATNEDLREAVKNGDFR
EDLYHRINEFSILSPSLKDREEDLMVFADYFLEKANQQLNKEIIGFSPEVVAIFQNYNWP
GNLRELQNCVKRATLLSRGDYIESEVLPAEFFQVQKTNQQNSNETFSLSENEKETIIHAL
SRTQNNKSEAAKLLKITRKTLYNKLKQYNID
>EGALAKHO_03461 hypothetical protein
MKKLILSAAIILGSLSIYATTTEAEPVKIAVNVQDEYKEVATDAVPAVVKTALETAYPGA
KLVKAYSNEKKEYKLEISVGDQKATVYSDVNGNWLKI
>EGALAKHO_03462 hypothetical protein
MKKLILSAAILLGGLSMNAATSVVTNQIVSSVNIQDEYTEVAADAVPAAVKSTIEKSFVG
SKLEKAWKNAKEEYKLEISKEGKKYTFFTDASGNIIKK
>EGALAKHO_03463 hypothetical protein
MKKLILSAAILLGGLSMQAGVIDVKSTITQSVNIQDEYKEVDAVPAAIKTALDNAYPGVK
LDKAYVNDKKEYKIEVTVRGEKSIVYTDATGNILKK
>EGALAKHO_03464 hypothetical protein
MKNLFLSAAIVLGSLTSFASTSPVTNTIVKSISVQEEYTEIKVEEVPSAVTDALKKAYPD
AILSKAYKNATSQYKLEVTVGDKVGSLYANADGSWVKK
>EGALAKHO_03465 hypothetical protein
MKNLFLSAAIVLGGLTSFASTSPISNTIVKTISIQDEYTEIKVVELPTAVTDALKKAYPD
AVLTKAYKNAKSEYKLEVAVGDKVGSLYANADGSWIKK
>EGALAKHO_03466 hypothetical protein
MKNLFLSAAIVLGSLSSFASTVPMTNSIIKTISIQDEYTEIKLEEVPAPITEALKKSFPD
AVLSKAYKNAKSEYKLDVTVGEKVGSLYANADGTWIKK
>EGALAKHO_03467 Biotin carboxylase
MFKKILIANRGEIALRVIRTCKEMGIKTVAVYSTADAESLHVKFADEAVCIGPPPSNLSY
LKMSNIIAAAEITNADAIHPGYGFLSENAKFSKICQEHGIKFIGAAPEMIDKMGDKASAK
ATMKAAGVPCVPGSDGLLESFEQTQKLAKEFGYPVMLKATAGGGGKGMRAVWKEDELLKA
WESARQEAAAAFGNDGMYMEKLIEEPRHIEIQVVGDSYGKACHLSERDCSVQRRHQKLTE
ETPSPFMTDELRAAMGEAAVKAAEFIKYEGAGTVEFLVDKHRNFYFMEMNTRIQVEHPIT
EQVIDYDLIREQIMVAAGIPISGKNYLPQLHAIECRINAEDPYNDFRPSPGKITTLHMPG
GHGVRLDTHVYSGYSIPPNYDSMIAKLITTAQSREEAISKMRRALDEFVIEGVKTTIPFH
RQLMDDPRYIAGDYTTAFMDTFKMNPIE
>EGALAKHO_03468 Biotin carboxyl carrier protein of acetyl-CoA carboxylase
MDLKEIQNLIKFVANSGVAEVKLEMDDVKITIRTTLEGNVTETTYVQQLPAQQALPQAVA
PQAAPAVVNVTSEASIPAEDSKFITIKSPIIGTFYRKPSPDKPVFTEVGSVISKGDVLCV
IEAMKLFNEIESEVSGKIVKILVDDMSPVEFDQPLFLVDPS
>EGALAKHO_03469 3-oxoacyl-[acyl-carrier-protein] synthase 3
MNTITAAITAVGAYVPDFVLSNKVLETMVDTNDEWITTRTGIKERRILKDADKGTSFLAI
KAAQDLIAKANIDPLEIDMVIMATATADMPVASTGVYVATEIGATNAFAYDLQAACSSFL
YGMSTAAAYIQSGRYKKVLLIGADKMSSIVDYTDRSTCIIFGDGAGAVLFEPNYEGLGLQ
DEYLRSDGVGRDFLKISAGGSLIPTTAETVQNRQHNIIQDGKTVFKYAVTNMADASELIV
KRNNLTNEDVDWLVPHQANKRIIDATASRMNLEESKVCMNIEKYGNTTSATLPLVLNDFE
QKFKKGDNIILAAFGGGFTWGSIYLKWAYDTK
>EGALAKHO_03470 50S ribosomal protein L32
MAHPKRKISKTRRDKRRTHYKATVAQIATCPITGEAHLYHRAYWHEGKMYYRGQVVIDKS
VAVA
>EGALAKHO_03471 hypothetical protein
MSKSKEFLIPFMGLKLGKHHFEYQISNAFFENFDYDEFQSSDIKVSLVLDKKSNMLELEF
KHKGTVNVPCDLTGEDFDLPIKGKMKLIVRFGDEFNNDNEELLILPHGEHELDVAQYIYE
MIALSVPLKRVHPGVKDGSLQTEALKKLNELTVKEVKEEKKESKKEEDIDPRWDKLKQLL
TDK
>EGALAKHO_03472 4-hydroxythreonine-4-phosphate dehydrogenase 1
MNKKAENIIVGISVGDLNGIGSEVILKTFEDSRMLEMCTPVIFANAKILSFVKKSMTSTI
QFHGVDKLDQVLPGKVNVFNLWKEGVDINLGTNDEKIGEYAIKSFVAATKALKEGTIDVL
VTAPINKYNIQSEEFKFPGHTDYLDQELEGNALMMMVQDNLRVGLLTDHVPLNEVSSYLT
EELITRKIETVRKSLIQDFSIVKPKIAVLGLNPHAGDGGVIGKEDDLVLKPALKKIFEAG
TMVFGPFPADGFFGSGQYEKYDAIVATYHDQGLIPFKTLSFGKGVNYTAGLNRVRTSPDH
GTAYDIAGKDMADFNSFKEAVYLAIDIYRSRNQYEEISQKPLKIKEKQL
>EGALAKHO_03473 Riboflavin synthase
MFTGIIETLGRIHEIKKDQSNLHITVDSSITNELKIDQSVSHNGICLTVVAVKDSFYTVT
AIDETILKTNIGDWKEGDIVNLERGMKLGDRLDGHIVQGHVDQTGTCIKIEEANGSWNYT
FEYDKNLNNITIEKGSITVNGVSLTVVNSKTNEFSVSIIPYTFENTNFKNFKVGTKINLE
FDVVGKYISRLYSINK
>EGALAKHO_03474 hypothetical protein
MQVEFMKVTKTIFVAFCLALFSVNIAMAEEHALPEPDAAAARGATATSTTAKPPNPPGVP
IDNNLLILTMSALVLGTVVIYKNEIKKASV
>EGALAKHO_03476 hypothetical protein
MVNKIEHIGIAVKNMNDANVLFEKLLGVPSYKEEEVESEGVLTSFFQTGTNKIELLMATN
SESPIAKFLEKKGEGIHHIAFDVEDIYSEIERLKSEGFVLINEVPKKGADNKLVVFLHPK
NTNGVLVELCQEIK
>EGALAKHO_03477 hypothetical protein
MKRIFLNKLFLVSSVALFTVYGIIYACGGGDDWDFFGYNSNFTPETFTDKSYSPLFLSGD
VFYGIGFDTQHNSRFNEDLKSDWNTYLKAKADTATVSYFLIGDLTPRYSDESKAGKNKAE
ITDLHVFFKTKKANATSLKWAKKLNLKDDKIKSFIEFLYLAQKIETVSINEDYWSYDPVV
AKIFNDLKMIQSIENVYNTTSDAFLKNRYWFLTVKAYFYSSNKPKTVEFFNKTEKSVPKN
TLYYRALSYVAGVKYQQKKYSESNYLYAQVFDKCPEMRVVTAYSFHPQNETDWNKSLAMA
KDNKEKAALWAIHGYYKDETQAIEKIYELDPKSEHLNYLLTRLVNKQEQDINNSFEESAK
ENVPAKKLTVAETKELNKSKIDKKAFDLVSKITTASNTEKPYLWNIALGYLQTLKGDYAN
ADNNFDKAEKIMPKTELAKYQLRLLRFVNNMSKIDKLTNANEKTILADLNWLYQELPKTY
KGGEFRYQNASSWSRSYLATLYKASGNPVMTEIFGESRYSYWNDGNAFYDNDKNLLAIKA
FLTKADKTEIEKIGAGIYSLKLKDINNFQAVQATFKNKIPEAIAFIKETDSVQYYNFLGN
PFNGNIKDCHDCEHAAYQKKKYSQIEFLNTVKAMQDKLAQKEDVYTNSLLLGNAFYNITH
FGNGRTFYEISIVGYGSSPYSFRDSMKKMITNCDVSKMYYQKAFEAATTKEQKAKCIYLL
AKCERNDYYNKKYNNVTNWWSVEDDKINFIAWSGFKALKKDYSDTKYYQDVIAECGYFRT
YINQ
>EGALAKHO_03478 hypothetical protein
MIKKSLLIFFVFLLTACSKSDNPIIAFYYWKTVFKLSETEKEVLKDNNVEKLYIRYFDIG
LHPKSTEPIPVSPIHFKESSNKFNIVPVVFIQNKVLLKSNIDIDDLAEKTLYLVDQINIK
NKINCIEIQIDCDWTLGSKENYLKFIERFKKISHKKLSATIRLHQVKYFKKTKIPNVDSG
VLMYYNMGTIASDSLNSIYSHEVAEKYLKSLKKYPLHLAIALPIYSWAIHIRNQKVIGLR
SKLNVAELKKDENFEQMNARFFKVKKSNYKNGFFYEEGDVLKIEGISAEDLKTMGEELNE
NVANTPKEIIFYDLDEFNLKNYEKNIFEQVISCF
>EGALAKHO_03479 hypothetical protein
MLKNNFKYIPFLLVFLMMSCAKRGSITGGLKDTLAPVLKYSSPKNFSTDFKAKEIILTFD
EYVKLKNTNKQLIISPPMKHEPIILPTTASREITIKITDTLQPNTTYSMNFGQSIADNNE
GNALNQFKYVFSTGSYIDSLSIGGRIKDAYEKNVDNFVSVMLYEVNDKYKDSVVYKEFPR
YITNTLDSLRTFKLENLKAGKYLLVALKDKGNNNKFNPKDDKIGFIKHYITVPNDTLFEL
ELFKETLPLKALKPIQASGNRLFLPYDSKQDFTNSKPKIVLKNREEILESIVTRFPKKDS
LQVWYKPLKVDSLSMEVSNENYNKKFTFKIKDQKKDTLNITATQSGVINFRDRFTLESAT
PLVKFDKSKIKLTNKDSVAVDFTTEYDEFDQKMYLDFKKEPLEKYKFTFLPGAITDFYDK
TNDTLSYKLTTREYADYGNLILNLKNVKRFPIIVEITNKKGDVVLASQYSEGQTKLTFDL
VEPNAFTVRITYDDNKNKIYDSGNFLKKTYAEEVFYYQKEVDVRTNWDVDETIDMSIPYN
PELEKKEDAKKKKEAVKKSKAF
>EGALAKHO_03480 hypothetical protein
MDNELVKKENWFKRNWKWSVPTTILVIFIAGLFLSSNSPEDISDVIQAYNDSSIYEKAIE
KANSDERITQTLGIIQPIDKLAILEGNAVYSNDNNSVSLSVRIKGSKGNGKLDISADKIG
MAWKYKKIIVRNKKTKEEIIVVNEF
>EGALAKHO_03481 2-oxoglutaramate amidase
MKIALIQSDLYWEDPSENKKNFESKINHIDSEVNLIVLPEMFSTGFTMNASEVAETMQGE
TVLWMQRVATQRNCALTGSLIIVENDQFYNRMLFVFPSGEIQHYDKRHLFSLAGEDRTYT
SGKEKVIVEYLGWKICLQVCYDLRFPVFVRNIENYDLILYVANWPKVRTNAWDILLKARA
VENLSYVVGVNRIGLDAHNYEHIGHSQVVDYLGNYILEPQEIEGVFMVELDKNAMLETRK
KLDFLSDKDFFEIKI
>EGALAKHO_03482 Glycerol-3-phosphate regulon repressor
MNDNELVNYTKEERKNHIIKEINLHTRVSFETLSAKLGVSEDTVRRDINELETESLLIKV
KGGAMTKGYHYASSNQTYEIESKQVIAQKAVSLLHDGMVLLLDGGTTIREFIRLIPNDLN
LTIFTITVVTAVQLLDKPNIKVIMIGGSISSYSQMCVSGEVYHQLANIKADLLILGTNAL
DVDGGYSDSDWETVQVKKAMIQASKKTAIITITEKLNTVLKMKIAGLSEVDYIVTEVDPN
NKKLQAYNKAFPNLVLI
>EGALAKHO_03483 Fumarate reductase iron-sulfur subunit
MKLTLKIWRQKNAQDKGGIVDYPIDGIEPDMSFLEMLDVLNEQLINKGEEPVAFDHDCRE
GICGMCSLFINGEAHGPDRGVTTCQLHMRMFKDGDTIFIEPFRAKAFPVIKDLVVDRSSF
DRIQHAGGFISVNTSGNTIDANTIPINKDDADKSFDAAACIGCGACVATCKNSSAMLFVG
AKVSQFALLPQGQVEATDRVLNMVHQMDLEGFGNCTNTGACEVECPKGISLENIARMNRE
YLSASLKG
>EGALAKHO_03484 Fumarate reductase flavoprotein subunit
MALDSKIPNGPISDKWTNYKDHINLVNPANKRNLDIIIVGTGLAGGSAAATLAELGYNVK
AFCFQDSPRRAHSIAAQGGINAAKNYKGDGDSVYRLFYDTVKGGDYRAREANVHRLAEVS
ANIIDQCVAQGVPLAREYGGLLDNRSFGGTLVSRTFYAQGQTGQQLLLGAYSAMNRQIGR
GKVKMYNRHEMLDIVIVNGKARGIIARNLITGEIERHSAHAVVVGSGGYGNVFFLSTNAM
GSNATAAWKIHKKGAFFANPCYTQIHPTCIPVSGDHQSKLTLMSESLRNDGRIWVPAKLE
DAQAIREGKKKATDLSEAERDYFLERRYPAFGNLVPRDVASRAAKERCDAGFGVNKTGEA
VYLDFAAAIKRYGTEDAYVKGLDDKDTALVTKLGAAIVKSKYGNLFQMYYKIVDEDPYTT
PMMIYPAVHYTMGGTWVDYNLMTTIPGCFSIGESNFSDHGANRLGASALMQGLADGYFVL
PYTIGDYLAPDIKMGEISTDLPEFVAAEKEVKDQIDRFINNKGTHSVDYFHKKLGKIMWD
KVGMARNAKGLTEAIEEIAALREEFYKDVKVPGSANEFNQELEKATRVADFLELGELFAK
DALHRNESCGGHFREEYQTEEGEALRDDENFAYVAAWEYKGKPSDAVLHKEPLVYENIKL
VQRSYK
>EGALAKHO_03485 hypothetical protein
MAQSAQLNASILKKVAMALSGIFLITFLALHVTLNFISVISENVFNEASHFMGYNPLIQY
VMQPVLAFGVIFHFVMGFVLTAQNSAARPIAYAKYNGAANASWSSRNMIISGLVILAFLG
LHFYDFWFPEVSYKYIAGTAPDATRYYGELVHKFHDPIRTGLYCISFVLLGFHLWHGFAS
SLQSVGMHNKYSRFLSKVGYWFAVVVPALFVIIALFHHFNN
>EGALAKHO_03486 Hydroxymethylglutaryl-CoA synthase
MKTGIDAISFDVANIHLPIRTLAVARNIEPEKLEKGLGLIKMTLPDVHQDAVVFGANALT
KLILENEINLNEISRIYVGTESGIDSSKPISSYLINLMEQKFGEDSLAECDVVDFTFACI
GGVDALQNCIDFVKLNPTKKAIVVTTDFAKYDLNSTGEYTQGAGALAMLVTSNPRIIAFD
ENWATSTKGVFDFFKPYRTISKEAITKNESNDPWFDNLEAEIEIHKDQPVFDGQYSNQCY
MDRTRNAYFSFKKLKNTTETLYNTWNSIIMHLPYSFQGRRMLSEIYALDSADKIIAENIE
PADYQNKIKEVGKSDDYKKFVTEKLQPAELASSLIGNLYTGSIFMGLLSTLAHYYDTKQE
VAGTKFGFLAYGSGSKSKVFEGTIQPQWQSALAKVKLFENLKESIEIGFETYENLHKKQQ
KQSVRTPKSEWVLDRIEKEIPNLIGARYYKWID
>EGALAKHO_03487 hypothetical protein
MNKNLKYLIYLFLAFVVIASDGTLVSQSKSADYYQSSFVISRELDSEKSRSYGFNQFVSR
LKIAFTFPVNYLQFKQVRSFQIQIIQKLQKLLHQNINSFIRQAVFINETITSNNLYKSLY
SA
>EGALAKHO_03488 hypothetical protein
MNKIFTLLILFFVFNISAQTKIQFDKKFVQSEDKWVAFSADSTGAYPYGFIYIDAQAGLT
FDYEGTFKIDPTGKFIPKKREVVGQVKYRLQPNNNLVAFIPESKFAELNVEKVPDWLKSY
KTGEGSVQRLYQWGFMYNGWNECEKALEYLEKAQKIDSEYKGLRVELAFSYNCLKQYEKA
VDVLKIALQKEPLDAYTNKELIYAETKNGNLQDAENLCRKVFKECEEKTYNAENAYNVLQ
AYYIKKDIEKFNKWFAEANSYLLSDQKIKSLAEQMKVELKQ
>EGALAKHO_03489 hypothetical protein
MKTKLFCTLGLLFFVTSYLLFSKVLPDFQSPIDFAHWFNLIGACLLLSFNDVFPKNKLNS
VASVVTSLGVIAHIGLCTIDFIMSSYGTNDFAREELSQHINKVPSILYPFVIVGPSLLFI
GLSLHALNFIKTNTISFLMVFISSLAIGFSFFILKNGTYMLLSCMIFVLGLGFLLCKNDS
KKMK
>EGALAKHO_03490 hypothetical protein
MKELNPSIKHHLVVGLLMALWIFAFAFIIKPFDDGTLNFRSWFFISFGFSVLAFFCYSIL
AVLQKSIYNKISKWNLGLEIGSIVFFFIVYLFGIYAFYKSPILKGGYNFSEFLSIIFIKI
ALILTPVIILARRYLIKLIPVKDDILTFTGENKLDILKIQKADLVCISNAQNYVEIFYIE
NGKLHSKLIRSSLKKILEDFTFLIQIHRSHLINPSHFKSWRNSNTIILTQIELPVSKNYK
ESILTL
>EGALAKHO_03491 Aminoalkylphosphonate N-acetyltransferase
MYSNLQIRKIDSQDLNFVYKSICELENEELNFKVFAVIFTENIANPNNLYLIAENENEEL
GFISFHTQNLLHHCGRVGEIQEFFINEKHRGKGIGRQLIEKIMQYAEEHKLKSIEVTTNK
RRVENVLIYENLGFTLSHNKFTIYK
>EGALAKHO_03492 hypothetical protein
MENIINYISGDATNPIIDGNKVIVHICNDIGGWDKGFVLAISKRWKQPENEYRKWFNSKD
NFLLGEVQFVQVEDDIGVANIIGQHKINKDENGNAPIRYEAIKTGLKKVIQFVKENNAST
HMPRIGCGLAGGTWDKIEPLINESFLKNNIGTYIYDFNLK
>EGALAKHO_03493 hypothetical protein
MDILYFKRYFDESRIEKSENWGTCIYYFEANFNGEILRQIEIYENGKVLKYSHEFIEDEY
GFLADQEIDLLEFKEFSISKSEFEDQWKIL
>EGALAKHO_03494 hypothetical protein
MFENFLSSVCLRNLVISRNEKSPREARQRLDYSCGVTCGDFSFLEMTRLAKSQQLSNSES
QNLYLGVSLRAGLSAISFTPLRFIKGYRLNPSRSRFHKKIVVYVENEFFNCGNLYIGLSK
KNC
>EGALAKHO_03495 Xaa-Pro aminopeptidase
MKYHQINSALFVKNRKKFTAEMKPNSVAVFNSNDIYPISADSTLPFAQHRDIFYLSGVDQ
EESILLLFPDAPYENQKEMLFLKETNDHIAVWEGEKLSKERAYQVSGIRTVYWLQDFHKI
LNEMMTYADTMYINTNEHYRATVETETREARFIKWWKERYPAHNVAKSNPILQRIRSVKE
SEEIDLIQQACDITEKGFRRLLSFVKPNVTEYEIEAELAHEFIRNRSKGFAYTPIIASGN
NANVLHYIENNQQCKAGDLILLDVAAEYANYSSDMTRTIPVSGKFSERQKAVYNAVLRVK
NEATKMLTPGTLWKQYHIEVGKIMTSELLGLGLIDKADVQNENQDWPAYKKYFMHGTSHH
MGLDTHDYGLLHEPMKANMVFTVEPGIYIPAEGFGIRLEDNVVVQEKGATFNLMRNIPVE
VEEIESLMNS
>EGALAKHO_03496 Proline iminopeptidase
MKKIFLFSFLMFLGNAFAQTEGYSTNNDSSKTYYKIFGKGEPLLIINGGPGMNSNGFEGM
AKILAETQETIIYDQRGTGKSKLAELNSKTISMKIMAEDIEALRKHLKIKKWNILGHSFG
GMLASYYATVYPNSINKLVLSSSGGIDLTLLKTPNLIERNLSKVEKDSMDYWNDKIEKGD
TTHAARLGRGRAMAPAYVYDQKYVPIIAERLTQGNSTINGLLWDDMQKINFDCAAKLKSF
KNPVLIIQGKEDVISNQIGELAQKTIPNSKLILLENCRHYGWLDAKEKYFSEVNSFLKS
>EGALAKHO_03497 hypothetical protein
MQAHEIDYQIFGEEMQYVEIELDPQEIVIAEAGSFMMMENNIQMETIFGDGSQQTGSGLF
GKLLNAGKRVLTGESLFMTAFLNQGNTKNKVSFASPYPGKILPIDLTQFQGKFICQKSSF
LCAAKGVSVGIEFSQKLGRGLFGGEGFIMQKIEGDGMAFVHSGGTMAKKELAAGEVLKVD
TGCIIGFTKDVDYDIEFIGGIKNSIFGGEGLFYATLRGPGTVYIQSLPFSRLADRIIASA
PRAGGNSREEGSLLGGLGNLLDGDNRF
>EGALAKHO_03498 3-oxoadipate enol-lactonase 2
MKTLLYKKTKISYTDSGEGNAIVLLHGFLENKKMWQEYVNFFSEQYRVITIDLLGHGESD
CLGYVHSMEENANAVHEVLTEAKIERAIIVGHSMGGYVGLAFAELYPKNIQKLVLLNSTS
KEDSAEKKLNRTRAIKAVKQNYVSFVSLAIANLFSENNRTRLVDEIEKVKDQALKTPLQG
IIASLEGMKIRKDREALLHENRFPILLVLGKKDPVLNYEESLSQIEDTTAEVISFDDGHM
SHIENKEELKPILQEFFSK
>EGALAKHO_03499 hypothetical protein
MNGFFYFYKMINTSFLEKIATVVIQDFSSKLADTTIILPNKRAKVFLIEALKKETTKTIL
SPEIISIEDFVQDVAAIRSVDSIELLFEFYEVYLSVTEKQSQQSFELFANWAKTLLQDFN
EIDRYLLDPSHVLSYLKDIEDIKKWGIEVENKTKLLENYIDFWKLLPLYYNSLYEHLLNK
SIGYQGLIYREAVNNLNHFSNTISNRTFIFAGFNALNAAEEKIVQHLLALEQAEIYWDVD
QTFLNDPYHDAGLFVRRFKENWKHYKANPFEWIVDDFSQSKNIQVIGTPKTIGQAKLTGS
IIENIINENEISSLDKVAIVLGEENLLMPVLYALPSSVGALNITMGYSGKNNPSQILIAK
LFKMHTNALSRKSESYVLYYKDILDVLTHPLVEPYANAGNLVKVIKENNYTFITHNRLVE
LNSNPSNLFLLLFKKWENGAVAVLENISTLLLLIKENFSNDNEEEKIAKAFVYAIFKVIN
KLTNYYLQHKHIDNIDTLYAIYKQIIDVAEVSFEGEPLRGLQIMGVLESRVLDFETVIVT
SMNEGKFPAGKSQNSFIPYDVKKELGLPTFKEKDAIYTYHFYHLLQRAKNIYLIYNTEND
GLDAGERSRFITQLEVEKQPNHNLTFDIYNPVLPTTAYQPMVVPKSEAVMERLREIATAG
FSPSALTSYIRNPIDFYFQKILRIREVEEVEENIALNTLGTIIHETLKALYEPFVGKFIS
ESDISNCFKLLDDEVLKQFKLVYKEGEIKKGRNLLAFEVAKRNVSNFLKMELESIQNGDA
IQIIALEQTYGRELVHPNLPFPVLIKGNVDRIELRNGKIRIIDYKTGKVEKANVILKSWN
GLTQELKNDKIIQVLAYAFMFEEEAKDFPIEVGIISFKNLKSGFLPFGFKEEKELDITVT
KEILNSYLEEIVLLLNEIFDVTIPFEEKIL
>EGALAKHO_03500 Outer membrane porin F
MKHLNKLLVAVMMVMGLSSHAQDSNNPWAISFGVNAVDTRTGSGSGSGFFDQHFSQPFAV
KDNWNILPSLSYIGVSRYVGSGFSVGLQGSVNKIDKLVIFDPTNPAHDARGNYVTNPGDL
MYYGIDATIKYSFQELIKSKVIDPSLSVGGGYTFFGDESFGTVNPGAGLTFWFTDAIGLE
LATKYKWAVADGQGDKSVFQHTAGLVFKFGGKDTDGDGIYDKDDACPDVAGLKQFNGCPD
TDGDGIVDASDACPDVFGLAALNGCPDTDGDGIADKDDACPDVAGLAALKGCPDTDGDGI
ADKDDKCPTVAGPKENGGCPVLDADKDGVADKDDDCPTVYGPASNRGCPEVTTEALEDLK
VQARAVYFNSGKATFKTGDKETQARLDAIKQILINYPNAKFSIEGHTDSDGSDKLNQKLS
EDRAAAVMNALIERGINVDNLTSKGFGESQPVASNKTAAGKAQNRRTEIRHIGSKYEGKL
>EGALAKHO_03501 2-amino-3-ketobutyrate coenzyme A ligase
MYGKIKEHLQNELQTIEESGIFKKERIITSEQGAEITISTGEKVLNFCANNYLGLSSHPE
VVQAAKHTMDTHGFGMSSVRFICGTQDIHKTLEKKIADFYGTEDTILYAAAFDANGGVFE
PLLGENDAIISDSLNHASIIDGVRLCKAARYRYENSNMDDLEQQLIKANEAGARFKIIVT
DGVFSMDGLVAPLDKICDLADKYDAMVMVDECHAAGFIGATGKGTLEAKGVMGRVDIITG
TLGKALGGAMGGYTTAKKEIIELLRQRSRPYLFSNSLAPAIVGASIKVFELLEKDTSLRD
KLEWNTNYFKEGMKKAGFDIIDGDSAIVPVMLYDAKLSQTMANELLKEGIYVIGFFFPVV
PKDKARIRVQLSAAHTKEHLDKAIGAFEVVGQKLKVI
>EGALAKHO_03502 ATP-dependent helicase/nuclease subunit A
MQSPSFSIYDASAGSGKTYTLVKEYLKIILSSPKNDAYRNILAITFTNKAVHEMKSRIVG
SLSEFAKDEPSAKAMDLMEDLSRDTGLSVIKIKIKSQNIIKHLIHNYAAFDISTIDKFTH
KVIRAFAHDLNLPMTFEVTLDTENLLVEAVDAIIAQAGQDETLTKLLIDFTMEKTDDDKS
WDVSREILETGRLVLNENNRNEIVHFHDKSIEEFVAIKKKMSVLCADLEKGNAELASQSL
ASIDKNGIDLKSFSRGTFPNHLESIREGKFNPRNKTFHEFDDIAINKTASDRALIENIIP
ELLLTLGEIYKNFEKRDFYKAFLKNITPLSLLNTVSNELAKIQSEQNILSISEFNAIIHR
EIQNQPAPFIYERLGERYRHFFIDEFQDTSEMQWQNLIPLIDNALSGQDDFGNKGTLMIV
GDPKQSIYRWRGGKAEQFIELGKDSNPFNNPEKVIKHLDTNYRSYSEVIDFNNAFFKLIS
TEFSNDDYRDLYENHSHQNANSKKGGYVNISFLPIIDKNDFADEEEVVEKSDLYVLATLN
TIQKVLRDGFEYRDIVVLTRKRDQGISIANYLTEQNIPLLSSETLMIQNATEVRLIIHLL
KYLNNSINLEAKANFLHFLATTKELEMPIHDFIAAGMARKNENEFEKWLLTFDVSLSFED
VRKKSLYEAVEIIISKFVLSSEGNAYVQYFLDIVLERDIRNQAGIADFLSYWDKNGEKFS
IPSPEGNNAVRIMTIHKSKGLEFPVVIMPFAEEDYSRKPKDKLWLDTEDVDLGVPKALID
NSSAVEGFGESASAIFNLKKQEELLDNINVLYVALTRAEEQLYVISQTIKERKDGEFPGN
MASFFIKYLINKGIYEPEKLEYEFGSRAKLSPTGKALDLVKTIPIVSEVLNPKNIKIAQR
ESLMWGTHQQEAISYGNVVHEILAFVKDKSDVELAVTKAIENGLITFDQTEKVLKTLYEI
VSHPELSVCFDGKNNVLTEQTIVQKEGRILKPDRIVLTQNKEAYLLDYKTGAVNSKYGQQ
IQEYQDAIEDLGYKVLKKALVYIGTEIDVVNL
>EGALAKHO_03503 Lipoprotein signal peptidase
MSLRKAYLLIFLVLLVDQISKIYVKTNFVLGEEVHVFNWFKIHFIENEGMAWGTKIPGEY
GKLILTVFRIFAVFGIGYWLADAIKKHHSTYLIVAIALIFAGAAGNILDSVFYGVIFDDS
THNLATIFSPTPYGTWFHGLVVDMFYFPIWEGNLPTWMPIFGGKHFMFFNAIFNVADMAI
STGVGILLVFNKRAFPKTA
>EGALAKHO_03504 General stress protein 16O
MIDEITRYSDADLAEFKEIIQNKIQKAQADLDLIKSAYMNDLNNGTDDTSPTFKAFEEGS
ETMSKEANSQLAIRQEKFIRDLKNALFRVENKTYGICKVTGKLISKERLKIVPHATMSIE
AKNLQR
>EGALAKHO_03505 Isoleucine--tRNA ligase
MSTKFTEYKGLDLPTVASEVLDFWKKENIFEKSVTTREGAEPYVFFEGPPSANGLPGIHH
VMARAIKDIFCRYKTQKGFQVKRKAGWDTHGLPVELGTEKELGITKEDIGKTISIEEYNE
ACKKTVMRYTDVWNDLTEKMGYWVDMEDPYVTYKPKYMESVWWLLKQIYDKGLLYKGYTI
QPYSPKAGTGLSSHEVNQPGAYRDVTDTTIVAQFKTLPETLPSFLQGFGDIHILAWTTTP
WTLPSNTALTVGPKIDYVLVKTFNQYTFEPVNVVLAKNLVGKQFGKGFFASEDDADFDNV
KEGDKKLPYKILAEAKGTDLVEIRYEQLLPYVLPYQNAENAFRVIAGDFVTTEDGTGVVH
TAPTFGADDAKVAKEAKPEIPPMLVLDENGTAVPLVDLQGKFTSHLGDLAGKYVKNEYYD
AGQAPERSVDVEIAIRLKEENKAFKVEKYVHSYPHSWRTDEPLLYYPLDSWFIKVTDVKD
RMFDLNETINWKPKSTGEGRFGNWLKNANDWNLSRSRYWGIPLPIWRTEDKKEEVLIGSV
EELYNAIEKSIAAGFQKENPFKGFEIGNMSETNYDLIDLHKNVVDQITLVSASGQPMKRE
SDLIDVWFDSGAMPYAQWHYPFENKDKIDENKDFPANFIAEGVDQTRGWFYTLHAIGTLV
FDKVAYKNVVSNGLVLDKNGQKMSKRLGNATDPFETIAEYGPDATRWYMISNANPWDNLK
FDIEGIAEVRRKFFGTLYNTYSFFSLYANIDGFKYAEAEIPLNERPEIDQWIISELHSLI
KFVDECYEDYEPTKAARAISDFVQENLSNWYVRLCRRRFWKGEYAHDKIAAYQTLYTCLL
TISKLSAPIAPFFMDKLYRDLTSSTGSEQYSSVHLAEFPKFVENFVNKTLESKMQKAQTI
SSLVLSLRKKEMIKVRQPLQKVMIPVLDENQRAEIEAISELVKAEVNVKEIILLDDDSGI
LVKQIKPNFKALGPRFGKDMGLISKEIQAFSADQINQLDKQGALDIVIAGKNVTLSLEDV
EITSQDIEGWLVANSNGITVALDITISEELKNEGIARELVNRIQNIRKDSGFEVTDKIKV
QIKRNGLLEEAILKNEDYIKSETLTDDLVFVDALENGTEIEFDDIKTVILISK
>EGALAKHO_03506 hypothetical protein
MKRIITFLLLLAFTISAFSQSTDLDPHSFNLSYVTLPPKPVLDKGNRTFKITVNEYNAAQ
AKIAQDYIEENSGIDGFKKVSSNGYFEIVFNLENSISNLQEVRKNVVVVKDRNGKDRVET
TYTNVFKCKDYGNYSLVCASDPSFNKKYSLERTYIIEKDFSSQADTNSATLLSPGILRDH
YLANIISNIENRLNRDYGFIVEQTSDYLWILDSKKHPEHENSMKSLSTIKTVFNKMQYDE
DIAPLKVELEPVISYFQGLDKIYTEDEKKHRKMRYEAYYDLAVIYHYLDMPDESDIWCEK
LIANKYDESDGTGIKLKNEALRDLFAINQVKTRHMDVELRSNGVEDVIVDAVNLDPNYLL
KNDPKYGLVSLILTSNDTISGYAKWKDIDNLDKKLAVSIADENGSHNHLFKTYFADQVSK
LILKDNDFYETVSFKETGKNAKAKPAFKFVKPILNGKTVSLYQYLTGEIIIKKRIDEIGY
STNSVGWQMNTRTKFVELANACPVLASRAYKNEFNTSVGSLWKFVEALDVCK
>EGALAKHO_03507 DNA repair protein RecO
MKPETKKNKNLLVKTKAIVISALKFQEKSLIVKCFTLSSGLKSYFVRDAFSSRKTSQKIA
YFQPFSILEIEAIHKNKGTLENFKEIKTAVPFQTIHTDVVKSTIVMFLSEMLHYSIQEEE
KNESLFEFLETALTWLDHHDEISNFHLILLLEATKYLGFYPDVSDIDLPFFEMNEGVFTL
FHGVNALTEHETNLFKKLIDLKFDNTQKIFHVLERQILLKILIDYYSFHLDGFKRPKSVE
ILKEIFS
>EGALAKHO_03508 hypothetical protein
MKKRFLYVLFLFLIQFSFSQNKLSWEGYFSFNEIKDISESSTTVYSASENALFSKNAATN
AVKTTTTIDGLSGQTISAVYYSEAFKKTIVGYENGLMIVINETDGSMLKVVDIINKQLAP
NVKKINHFMEHNGLLYVSCDFGIVQFNLTTLQFGDTYFIGDNGAEISVKQTAFFNEFIYA
ATSSGIRRANSTNPNLNDFTQWSVVNSGDWSSVETLDTELIAINAAGYVHRFNSATFIGF
LQLPQPSVDMRATNHNLFITIPNEVYIYNNQMILNRKVINTQVLDNTLVFTCATTVGNSI
YIGTKENGLFSSTLSGAAAFENNTPTGPARNNIFSLDVTPNVLWTVYGDYDSFYNPYPLD
SYGVSKYNSSGWLNIPYSDVYDAKSMTKIIVNPSNEKQVYASSFFSGLLKIEGDVPGALY
NDKNSGLESITTEGPNYFDVRVNGTAFDKTGNLWVTNSRIKNGLKVLKTNGQWGSYAMTS
ILDNAEASSYANIVIDRNSVKWIATNRDGVVGFDETTNKFKKMTFGADVGNLPTADVRSI
AIDTKNQLWIGTTKGLRVLSNVSNFQTENQLKANPIIIMEDNLAQELLYEQFITSIAVDG
ANNKWIGTSDSGVFMVSPNGQETKYHFTITNSPLPGNAVNDIKINSATGEVFIATNKGMI
SFKGIATDANEDLNNVYVYPNPVRPTYTGTVKVAGLLDKANIKITDIEGNLVYETISEGG
TIEWDTTAFGRYKVASGVYMIFISAQDGGETKVKKVMIIR
>EGALAKHO_03509 NAD-specific glutamate dehydrogenase
MEQKINEFMALVESKNPNEPEFLQAVREFAETVIPFIAERKKYDGKNLLLRIAEPERSII
FRVPWVDDKGEIIVNRGFRIQMNSAIGPYKGGIRFHHSVNLSVLKFLAFEQVFKNSLTTL
PMGGGKGGSDFDPEGKSDGEIMRFCQSFMTELCRHIGPDLDVPAGDIGVGAREIGFLFGQ
YKRIRNEFTGVLTGKGLAYGGSLIRPEATGYGVVYFTDQMLRTIGHEIKGKRVAISGFGN
VAWGVALKINELGGKVVTISGPDGYIYDEEGISGEKIEHMVEMRATGDNRAEVYTQKYPN
AVFHKGKSPWEVKVDIAIPCATQNELNGEDAKKLIDNGVLCVTEAANMPSTLDAIKLFLD
NKVLFAPGKAANAGGVAASGLEMTQNSIRLNWTSEEVDLRLKDIMVGIHNQCKKYGAGED
GYVNYVKGANIAGFVKVADAMLAQGVV
>EGALAKHO_03510 hypothetical protein
MLKPIVLTLFAFIGISTASQAQGIAQEIGIVFGPVTFQSDYGERHDLETNVGNRGIGVGI
VHFINFSANNNHESFFSEHFKVRSELSFTHTNLKHFGRWVEKTPPTIGVLRLKAMNGKSS
ILSLGAQGEFSPIKIHDFENSVGSFSPYLSLGFLVSYYSTSVGSDLGPLGTIETTPAKYL
VPSDGHQYGYSSENGIVLSATAGLGVHYKLTTMSDLMLECRFQSFSSDWVDGLNPNKDVF
KENKANDWQVWLNVGYIHYLEF
>EGALAKHO_03511 Cystathionine beta-lyase
MKFNTKVIHGGQHHDPSTGAVMPPVYQTSTYIQTSPGQPLGDYEYSRASNPTRTALENAL
ASIENGTRGLAFSSGLAATDCILRGLKSGDEVIAMDDLYGGTYRMFSRIYKDSGIKFHFV
DMTDIAKLKALINENTKLVWVETPTNPLMKLADIEEVAKITKANNILFAVDNTFATPYLQ
KPLDLGADIVMHSATKYLGGHSDVIAGALIVKDEALGEQLHFQQFATGATLGPMDSFLVL
RGIKTLSLRVQRHCENGEKVVEFLTKHPKIKTVYYPGLPSHPFHEIAKKQMKAFGGMVSF
TFVSGKKEDSITFLERLKVFTLAESLGGVESLANHPALMTHASIPADKRAEVGITDDLVR
LSVGIEDAEDLIADLEQALA
>EGALAKHO_03512 hypothetical protein
MKQYTFLIFLFLIFISCNKELSFEKKTFEKKSSIPCKKDCPIITIEIPFAKNIPVVADSI
NKKIFSVVKEIVYFGEKPVKLNDYIALTNSFITSYEEMHKKFPDETFGWEGKIKGNVEFE
TDQIINIKIDHYTFTGGAHGYQGYRSLLFNPKTGKTIFSDQIFKNEKEFKALAEKTFREK
YKIPTKANINATGLMFENDKFQLPQNIFYTEEGLLLYYNSYEAASYADGPKELLFPYDEV
NKFLLYR
>EGALAKHO_03513 hypothetical protein
MINKRLLIKNLLAHNDESSFYDKKRQLNLHSREGKGKFLKHICALSNSNPTNNSYIVVGV
EDQDNEIVGDDFFDDSRIQNLVNAFLENPPKIQYENVPFPNLPKDKVIGLVTIKPKNKIS
YFKKGIHTILANSVFIRRGSNSVPVEGEIEKNYQNTETVIGIENSSRNSIQYTLDGVIDF
MNFRHKDMSPKYHVFKELFVICWAGVPKKSRDKTFLSRVDIELINEQIKLFYSAQDVVTI
VFDDDSFTITEYVPLGLNDKTSYYPLEEQTIRFFDNGYYKIDRKMLFQPPEFNRKMLYHI
YNSNMALLQKLQKGTALSEREMVDLENLPSTFMICYLNGFDEAKQKLIDAKLLLKPFSQV
YLSFKEALRILRKMKYDFQEGTK
>EGALAKHO_03514 Serine 3-dehydrogenase
MSLCVKITNTTRMKKTVLITGATSGIGKATAQIMAKNDYKVILCGRRKERLVELEKELSA
FTEVHSLSFDVRDKEAVFSNINSLPVEFSQIDVLINNAGNAHGLDPIQNGNIDDWDAMID
INVKGLLYVSKAIIPQMIERKAGHIINIGSIAGKEVYPNGNVYCASKHAVDAINNGMRMD
LNPYGIRVGAIHPGMVETEFSEVRFKGDADRASNVYKGLDALQAEDIADIIHFVVSRKYH
VNIADLIVYPTAQASATIVKKNI
>EGALAKHO_03515 Oxidoreductase YdhF
MSKTTLSPIISGTMNWGVWDKNLTTKEMENMIQICIENKITTFDHADIYGSYTTEADFGK
AFQASKISREKLQLITKCGIQMIAEERPENKIKHYEYSKEYIIWSVEESLKKLKTDFIDV
FLLHRPSPLMQADEIAEAVEKLKSEGKIIDFGLSNFTSSQTELIRSKTEVSFNQVQFSAT
HYEAMTDGSLDYMQTHGIRPLSWNPLGTVFREDTKKTRRLKKLLADLVQKYSFGSDTLLL
AWILKHPAGVIPIAGTVNIARIQSLMKAAELEMDKEDWFAIWTESMGDDVP
>EGALAKHO_03516 hypothetical protein
MEENTTTLDIRAINEKIERESAFIDLLTMEMNKVIVGQKHMVERLLIGLLGQGHILLEGV
PGLAKTLAINTLSQAVQGSFSRIQFTPDLLPADVVGTMIYNIKANEFSIKKGPIFANFVL
ADEINRAPAKVQSALLEAMQEKQVTIGDTTFKLDRPFLVLATQNPVEQEGTYQLPEAQVD
RFMLKTVIDYPKIDEERFVIRQNLKGSYEKVNPVVSVEQILRAQEAVREVYMDEKIEKYI
LDIIFATRYPEKYKLADLKPLISFGASPRGSINLANAAKCYAFIKRRGYVIPEDVRAVVH
DVLRHRVGITYEAEAENITSVDIINKIVNEIEVP
>EGALAKHO_03517 hypothetical protein
MDTKELLKKVRKIEIKTKRLSNHIFSGEYHSSFKGRGMTFSEVRQYQYGDDIRNIDWNVT
ARYNEAHVKVFEEERELTMVLMVDISGSEGFGSKSQFKKDIVTEIAATMAFSATQNNDKI
GLILFSDNVELYIPPKKGRSHVLRIIRELIEFEPKSHKTDISQALKFLSGTQKKKAIVFV
ISDFMSENYEQTLKIASKKHDITGVRVYDIREEKIPNLGIVSMLDAETGKIQLVDTGSKS
VRMNYEKHYHDRVNYFKDIFSKSGAGVVNTRVDENYVTKLLGYFKSR
>EGALAKHO_03518 hypothetical protein
MKLKFYIFLFLLTSAVFAQQKQIETSIDTTKNKIGAEFKLTLKTVVSSKSKVVFPKLKTI
GPLEVIQSYPIDTVKKNDTYELIKKYGLTQFDSGKYTIPSIKILIDKKPYLSDSIRVEVA
NVKVDTLQQKMYDIKDISSADSNNDWWIYVLILIVILGIGAFVYWYVKKHQKKKIEEEVY
KTPIEKATSLLNNLESKELVQKGEIKEYYSELTDIARNYIEEAIHIPAMESTTSELIQAI
RLASTKKKMTLTPETVENLERVLRQADLVKFAKSKPLDFEITDDRNKIQKVILTLDNAIP
TEVPAEEEDQLLNEAQRQKQIQLQLRKKRNKRITLAVATVVFLLTATTTFFIVTKGFAYV
KDNVIGHPSKELLEGEWVKSAYGNPAVLIETPKVLKRMDTQKVLPKEAMALIKEMQLFAY
GSMIDNFYVTVSTSKFKNPVELDLAKTLEGTLKIIEAQGGQNIIVKQEDFQTNAGIQGLK
GYGTMTVLNPVSKTSTKAYYEILLFKQDQGLQQIMILHQEGDTYANDITARILNSVELQK
ASN
>EGALAKHO_03519 hypothetical protein
MEKITFLNPEFFWLFLLIPIAIAWFFWKRNQQSPTLKMSSTQGFKNSESLLTKLKPCLYV
FRIIALSSLIIALARPRTVDISNQTKTTKGIDIVMAIDVSGSMLAKDLKPNRMEALKRVA
GEFVEERPNDRIGLVLYASEAYTKTPVTSDKAIILEAIKDIKYDTALQDGTGIGMGLATA
VNRLKDSKAKSRVIILLTDGVNNAGFIEPETAADIAKQYGIKVYTIGLGTNGMAPSPYAY
APNGGFLFKMQKVEIDETLMKSIARKTDGTYFRATSNDRLAQIYSAINKLETTEIQELKF
YDYDEKYRVFVLLAAFLLLLEVGLRNTVYRSFI
>EGALAKHO_03520 hypothetical protein
MKFQITNWKLEFKTSFLNKQKKLEFGIYPHNNWDWNFKKFMELDEKKYLYLLFLLPIVVC
IFLFNMYWKRKKQREFGDLEMVKRLSPERSVFKPVLKLSILLLALACLIIGLVNPKIGTK
METVKREGIDIVFAVDVSKSMLAEDVAPSRLEKSKQLVSQIINNLGSDRIGIVAYAGSAF
PVLPITTDYSVAKMFLQSMTPDMVSSQGTSLDDAIRLSSTYFDEKSKTSKLLILISDGED
HSEGAAAAAEEANKLGMKIITIGIGTEKGGTIPLKENGVVKSFQRDQNGEVVITKLNQEG
LKTIAKATKGGYVYGGSTKEVLDYIKNALNNIQKTEFEATQMADFQSQFQWFLGFAFLLL
FVDIFLLERKTNWIKELNLFNEKK
>EGALAKHO_03521 hypothetical protein
MKNLLLYILLTFSLAVSAQEKDKTLPDANEEYKQNKFVDAEANYRISQSKFPKKTAASYN
LGNTIYRQNQASEAKFAYGKAIKDAKTRPEKHKAFHNLGNVFMKEKDYTQAVEAYKQALR
NDPTDDETRYNYALAKQKLKENPPKNDKNKDKNKDKDKDKNKDKDKDKDKNKDKDKDKKD
DKGDKDKDKKDGKNDPKKDDKSDNKGEPKPQPGGISKERVQNLLDAVNNEEKKIQDKVNA
QKVKGNPKKTEKDW
>EGALAKHO_03522 hypothetical protein
MKRYLILLLFTFQGLMAQVQFEARVSKNSLGINERLRIDFIMNVDGDNFEQPSFDGFRIV
AGPSQQISQSWVNGRSSFQKIYSYILQPAQKGNLTIKQAAIEFNGQKYKTTPIKVAVTNA
VAEERDPNDPRPQSGAGSETLNLVAEISKTNPYLNEPITVVYKLYFNNINVTGFKELGKP
KYNDFWNQNIEIKQLAIEEGSYKGQRCYFVVLKKTILYPQKSGKLTIEPLSLDIGVQLPT
NRRDMFGQMILSEDNKVVSAGAKTINVRPLPEANKPEGFTGAVGKFNFTVTPSKTTLKNG
ESLDLVVSAAGSGNMKLFTLPKPVVPNALEMYDPVHDEKVTTSLSGMSGKISDKYAIIPQ
YKGKYVIKPMQFSYFDLSSGSYKTITSQEITVDVLDGPMQAEANATANAAKNVITKTEQF
KYIKPKTTLVSMTKNDFYGSNLYYGLLLAPFLILPIIVLVKKKKEAIDSDVTGNRIKMNN
KLAKKYLSEAKKQLNNKEPFYIALQKAMHNFLKAKLHIETSEMSKDNIRELLLSRNANPE
SVQNFINLTENCEFARYAPASSASIQQDYDKAVLIISELEKQIV
>EGALAKHO_03523 hypothetical protein
MKNIVYLFLLITQVFFAQSSFEKGNLLYQDNKFEQAAQEYENVLKENKEHSAELYFNLGN
CYYKLNKVAPSIYNYEKALVLKPHDEQTLNNLKFAKKLTIDEIKEVPKVGFAKLIQNFTG
IFDYNTWAKIAVGIAFLFLLSFIGYYFSQLTLSKRLYFIGMFVLLVGVLLSVAAAMSEKD
HYDNDRPAIVFSEVSEVRSEPQKAGSAIFLLHEGAKVYVTETLQNWKKIELTDGTEGWID
ASTIKEVK
>EGALAKHO_03524 5-formyltetrahydrofolate cyclo-ligase
MATNKKELRLHYKNLRAALSIDEIEEKSLAVANELLQLPIWDKTYYHVFLPIEEQKEVNT
EYILHLLSGKDKEIVISKSDFETRKMAHFLLTDNTKIKKNEYNIPEPVNGLPVPSETIEV
VFVPLLAFDVFGNRIGYGKGFYDKFLAECKPETIKIGLSFFEAVNQIDDVFESDVKLDYC
VTPEKVYKF
>EGALAKHO_03525 N-alpha-acetyl-L-2,4-diaminobutyric acid deacetylase
MIIFGEPVLPGENRTINVEIARLHTTTKLNIPVIVRRSKIDGPVVLFSAGIHGDEINGVE
IVRQLISKKINRPIRGTIICIPIINMYGFVNKSREFPDGRDLNRVFPGSKKGSLASRFAF
HIVAEILPVIDYAVDFHAGGASRFNAPQIRITENNPELRLLADVFNAPFTLYSKNIAGSF
RNTSEKANVKMLLFEGGKSLDINNVIANEGVMGVKRLLNYLNMLDPKQIVEDALHPSIYI
KYSVWLRAKCSGLLHDYNLIGKFVTKGTILAIITDPFGKFEQKVKAPHDGYIINANHSPI
VYEGDAIYHISKTLPDGDE
>EGALAKHO_03526 UvrABC system protein C
MLSFLRKIKQFFRTLFDHLQKQNRMQKPSLELQIQTLPDNPGVYQYYDKDDKILYVGKAK
NLKKRVSSYFNKIHDTRKTNVLVRKIVTIKHIVVPTETDALLLENNLIKTLQPRYNVLLR
DDKSYPWICIKKEPFSRIFLTRRMVKDGSEYFGPYTNFKMVYTILDLIKELYPLRTCNYD
LSESNIKSGKFKVCLEYHIGNCKGPCEGIEPLEDYQRQVDAIREILKGNFKESMKDFKRV
MNQYAQDLRFEEAQKIKEKIEILENYQSRSTIVNPKITNVDVFSIVSDESAAYVNFLQIS
HGSIIRSHTLEIKKKLDESDEELLELAIIELRERFHLLSKEVIVPFEVDLGEKIKTTVPQ
LGDKKQILDLSIRNAKFYRIEQLKQLQIVDPDRHVNRIMAQMQKDLRLPSEPRHIECFDN
SNIQGTNPVAACVVFKDGKPSKKDYRHFNVKTVEGPDDFASMTEIVYRRYKRLLDEKEPL
PQLIIIDGGKGQLSAALKSIDDLGLRGKIAIIGIAKRLEELFYPGDSIPLYLDKKSETLK
VIQQLRNEAHRFGITFHRDKRSKAALNSSVESIPGIGEKTMLTLIKHFKSVKRLKLATEK
EISDVIGVSKAKKIVDFYKTN
>EGALAKHO_03527 putative NTE family protein
MMAFLLFFGCPEKSFSQEIKKDSVKRPKIGLVLSGGGAKGFAHIGVLKVLEEAGIKIDYI
GGTSMGAVIGGLYASGYNASQIDSIFKQTNFDELINDYIPRSSKNFYGKKNDELYAIVLP
FSNFRVGIPEALSKGMYNYNLLSSLTRNVRHIRDFNKLPTPFLCMATNIETGEEVLLNKG
NLVQAMMASSAFPSLFTPVEIDGNLLVDGGVVNNYPIQEVRNLGADIIIGVDVQDDLLKR
KNLKNATRILVQITNLQSIDKMKSKIKDTDIYVKPDIRDFGVISFDRGEEIIRKGEEATF
AVYEKIKSLVTEDNIYKKPKLKISTDTIQIKKINSTKLDNFTKEYINGKLRFKPGSTITY
GDLKTGINNLNATQNFSTISYCLQPDGKQQDDLDLVLTENPTQTYLKLGLHYDGLYKSAI
LLNLTHKKTFLKNDITSLDIILGDNFRYDFNYYVENGFNISFGFRSRLNQFNRNVTSNLG
NFTAPNPDVNLINVDFLDVSNQAYFQTIFVQKFLMGGGFEYKYLKINSPTLSNEENVIDK
SSYFSVFGYLKYDSFDNKSFPHSGLYFSTDVQTYLGSSDYTNTFKPYSMAKAEVAVANTL
FRKATFKFEADAGLTFGNDSVPFFDYILGGYGYNKINNFNYFYGYDFLSISGNSFIKAGI
TFDYEIFKKNHLNLSANYANLGDDIFSGVDWVSMPKYSGYAFGYGLETIIGPIEIKQSWS
PELSKSFTWFSIGFMF
>EGALAKHO_03528 Homogentisate 1,2-dioxygenase
MPLYHKLGDFPQKRHTQFEKPNGGFYYEQLFGTEGFHGHSSLSYHVHRPTQVKEILNSYS
VEPKIAIGKNIKSLLFKGFELKPENDFLDSRKAMLVNKDCIIGLAAPKDSLRNYFYKNAD
ADEMIFIHKGKGKLRTMLGNIPFEYGDYLIIPRGIIYQIEFETEENRLFYVESYSPFYTP
KRYKNQSGQHLEHSPFCERDFILPNELETHDEKGDFLIKIKKEGMIHEVVYATHPFDVVG
WDGYNFPYGFSIHNFEPITGRVHQPPPVHQTFETATFVVCSFCPRLYDYHPKAIPAPYNH
SNIDSDEVLYYVDGDFMSRNNIEQGHITLHPKGIPHGPAPGAMERSIGHKETHELAVMVD
TFRPLMVTEEAMGLDDGQYYKSWTE
>EGALAKHO_03529 hypothetical protein
MTFNEKYKDNALLIKTFNFALNIIDYTSELQDQKKFVIANQLLKSGTSIGANSKESQNAE
SKADFIHKLKIAIKEADETEYWLFLCDAHKEYPSCKRLLNDLSETLKILNKIISTSKMK
>EGALAKHO_03530 4-hydroxyphenylpyruvate dioxygenase
MSKEVKSVEYGLEKIFEGAQDFLPLLGTDYVEFYVGNAKQSAHYYKTAFGYQSLAYAGLE
TGVKDKASYVLKQDKIRIVLTTPLTQDSPIHAHLQKHGDGVKVAALWVEDARSAYEETMK
RGARSFMEPTVESDEFGEVVRSGIYTYGETVHIFVERKNYNGVFLPGYKEWKSDYNPEPT
GLKYIDHMVGNVGWNEMNTWVKFYEEVMGFVNFLSFDDKQINTEYSALMSKVMSNGNGRI
KFPINEPAEGKKKSQIEEYLDFYGGPGIQHIAIATDDIIKTVSDLKSRGVEFLSAPPHTY
YQAIPERLGVHMDMMKEDLNEIEKLAIMVDADEDGYLLQIFTKPVQDRPTLFFEIIQRMG
AKGFGAGNFKALFESIEREQELRGTL
>EGALAKHO_03531 hypothetical protein
MKCKDCTMKKLVLIILILTSFSFDTQKEDAFGTGEYFKFRIHYGIVNAGYATLEIKDATI
NNKKVHHAIGKGYTTGMSKFFFKVEDLYESYFDKETGTPYRYIRKIDEGGYTKNQEGFFN
PAENRVLVKDYKRKSEKTIITTDNVQDIISSFYYLRNHPNIDKLKSGDAITIDMFFDEEI
TKFKLKYIGRQDITTKFGTVSTMVFKPLVQTGRVFKEKESVTLWITDDNNKVPVRIKADL
AVGSLKADLDEYKGLKYPFKAKK
>EGALAKHO_03532 Tryptophan 2,3-dioxygenase
MNLTDHSESILNEIDLKFQAINQKTDVQLEGLLWSKPITYWDYIQTDALLNLQIQRTTLP
DEMVFIMYHQVNELIFKMILWEIDQIADTENIQVDFFSERLSRITRYFDMLTNSFSIMEN
GMEVDQYMKFRNTLTPASGFQSAQYRLIEFASTDVINLTDRRYKANFDENTDLETSFEHL
YWQAAGKDYQTGEKSYLLNEFEKKYKDQFLKQMSSFKTKNIWQKFTQLPEKDQQNAALIN
AMRHYDKTVNITWVMQHLNTARKYILESGKGNGEATGGSDWQKYMHPKYQRRIFFPKLWT
EDELSNWGNETTT
>EGALAKHO_03533 Murein DD-endopeptidase MepM
MNCPIGEMKQPLNFLKKNKSLKKAFVIIIVLFSIFSCNKTDEKVETKITKPKTKKVEFGF
NYADFNVVNDTISKGDSFGSIIQNQNIGDKQVYDIVEQVKDSFNVRTIRYNKPYTLLRAK
NKTNKLQVFIYQPDALTYYVVDLRDSIAKAYKKIKPVTFKRKIIGGVLKSSLSETLGNAS
VETALANRITKVFSWSIDFFKLKKGDRYGLIFTERFINGKTYDGVEDLEAAFFEYKGKIV
YAFPFEKDTLSGKIEYYDDQGKTLKNFFLKTPIKFSRITSRFTMNRFHPVQHTWKAHKGT
DYAAPTGTPISTTAAGVVEATGYTAGNGNFVKVKHNGTYSTQYLHMSRILVRRGQRVTQG
QTIGLVGSTGLASGPHVCYRFWKNGVQVDALRLNLPTGESLTGNDKTRFLKQMEPLKREL
DSIGNL
>EGALAKHO_03534 hypothetical protein
MENKRIKDILDETFSELKLFYRDTNLSDDLISKYRIGQILKEKGFTDMTFLGGRLSENCR
YLIASSDARDLSKFNPDSAKNGHALLDDNSFFKVLDIYKIGNKTQIFLLNIPGNSLPLFK
NSTSNLEEEITEKARQKFLSKINSALTKELQTEDWKERTKSPIGMSDVGEFFFDDSTIKT
EETKRIEINKAEKKIEINKKPWWKIW
>EGALAKHO_03535 hypothetical protein
MILSCGPILQPLIGMFFSGIICIILFFYSIKKIKRTSFYENEFILLPRTKQFGHIIAFII
VNLCLLSILYFILALVIAGIAFYFV
>EGALAKHO_03536 Glucose-6-phosphate isomerase
MALNTTNPTGTEAWKNLQNHYNAIHETTIQELFQQDNTRVEKFNLQWNDFLVDYSKNNIS
QETISLLLELANAIGLKEAIAQYFGGEIINQTENRAVLHTALRAPESATIKVDGENVIPE
VYEVKNKIKNFTNEVISGERKGFTGKAFTDIVNIGIGGSDLGPVMAVEALQFYKNHLNLH
FVSNVDGDHVNEIIKKLNPETTLFLIVSKTFTTQETLSNSETIKEWFLKSASQEDIAKHF
VAVSTNIQKVTEFGINPDNVFPMWDWVGGRFSLWSAVGLSIALAVGFDNYNDLLNGANEM
DEHFKSAEFDENIPVILALLSVWYNNFFGAESEALIPYTQYLQKLAPYLQQATMESNGKS
VGRDGKPVNYQTGTIIWGEPGTNSQHAFFQLIHQGTKVIPTDFIGFVKPLYGNEDHHDKL
MSNFFAQTEALMNGKTPAQVQSEFDKQGLSAEKASYLLPFKVFTGNKPTNTILIQKLTPK
SLGSLIALYEHKIFVQGVIWNIFSFDQWGVELGKQLANSILDEINSKTVKSHDSSTSFLL
KHFLKNK
>EGALAKHO_03537 TonB-dependent receptor SusC
MKTMKNWLLTGLLFMIVSTAFSQGKITGTITDGVGSLPGANVAIKGSTTATSTDFDGKFT
LNATSSTGEIVISYLGYQNQTIKFSVSNGATTNLGNIVLVANSNELSEIVVKSSVVDIAK
DRKTPVAVSTIRATEIQEKLGSQEFPEILKSTPSVYASKAGGGYGDSRIAIRGFDQKNIA
VMINGVPINDMENSAVFWSNWAGISDVTSAMQVQRGLGASKLAISSVGGTINIVTKTSDM
KEGGSISSSFGNDNYLKAQASYSTGLMKNGLSASVLFSRTEGNGYVDGTKFEGYNYFIAL
GYKINDKHSLEFTFTGAPQWHDQRSTSPLLSDFLKYGSDGKTPNIKYNSDWGYKNGEEYN
LKTNYYHKPVMSLNWDYDINETTKLSTVAYASWGRGGGTTTNGGIKGNNAYSVNNSLRNA
DGLINFDLIQNWNSGKPTTLGTRTQTNGQYQNSSASGSATVTNTGITEIASVNSHNWYGA
VINLDKKLTENLTLDFGVEGRMYKGIHYQNLIDLFGATNYRDATNVNSVPNPAYFSTTYA
PRPSGNPFVSTDYQERINYWNDSEVNYYGAFTQLEYSKGNFTAFLQGAVSQQGYKRIDHF
KYLTSDPLSETDFKNIAGGDVKAGVNYNINEQHNVYFNTGYYSKQPFFNAVYPNNASIIN
DNLTNEKVKAAEIGYGFRSKIFNATLNAYYTKWDDRFTPGTDPDAASNPGGYYTFSGVNE
THKGIELEVNARLLEKLKLNGMISIGDYKYDGNATSNRFDASNNPFPGGVAQTLYLDGVK
VGNNAQTTMAIGAAYEILRGFNVDYNLNYSEKLYGNISPVNFLSATNKGALELPGFATSD
AGLSYKFLFGKDKANALNFRFNVNNLFDRTYINESFTNIFADDVKTPAAGGNPAITYAQA
GALYKGIATGNKVYFGYGRTWNFTLRYEF
>EGALAKHO_03538 hypothetical protein
MYYFLQKFHSGWAYLALFLLLIAVVNSILGLTSKKEFTAKDRKIALFALIGTHTQLLIGL
ILYFVSPLGKAAFGEMSNAELRLTSLEHPLINIIAIILITIGWSKHKKLINSEAKFKTFA
IFYGLGLLLILSRIPWNLWF
>EGALAKHO_03539 Endolytic peptidoglycan transglycosylase RlpA
MRIKKNILLSVFTITFLSCVTYVMSQQVRPTEPKIVQDTVKTDKTKNQALAVNDSVFTDK
NLKLKPYKKSAHASYYADRFNGKKTADGSRFNNSKYTAAHKKLPFGTKIKVTNEANGKFV
IVKVTDRGPFVKTRELDLSKRAFMDISGSKGYGALKVTIETIVE
>EGALAKHO_03540 hypothetical protein
MNSVFEVQKTIREILLKVLDHHSLEQLNKIPTGFGNNLIWNIAHCVSSQQVLIYKLSGLP
SMVSEEFINKYRKGTKPEGDVSQAEVDEIRTLLSTTLEQVQKDFSDGIFQTYQEYTTSMG
YTLKNINGALDFNNYHEGIHTGIIMSIRKFV
>EGALAKHO_03541 Regulatory protein Spx
MNKIYYLASCDTCRKIIKGLPANHNLEFHDIRQNPITEAELEEMHKLAGSYEALFSKKAQ
LYKSMDLKNKSLTEADFKKYILEHYTFLSRPVFIIDGKIYIGNSQPVTLQAMKALEK
>EGALAKHO_03542 hypothetical protein
MTGFGKASLQLPTKKITVEVKSLNSKGLDLNVRMPSLYREMELGLRTLISTKLERGKIDF
GIYIESTSEQTSTKVNVPVVKNYIAQLKQVYPDADETELMKMAVRMPDTLKTEREEIDEN
DWDQIQIIIEEALQNILTFRKDEGESLEKEFNLRIGNIRQYMDDALALDPERVQAIKDRL
QTAISELKVNVDENRFEQELIYYLEKLDITEEKVRLTNHLDYFLETIKGTEANGRKLGFI
TQEMGREINTMGSKSNHAQMQKLVVMMKDELEKIKEQVLNVL
>EGALAKHO_03543 Guanylate kinase
MNKGKLIVFSAPSGSGKTTIVRHLLGKEDLNLEFSISAASRDPRGEEEHGKDYYFISLEE
FKKHIKAEDFLEWEEVYRDNFYGTLKAEIERIWALGKNVIFDIDVAGGLRIKHKFPEQTL
AVFVKPPSVDELKRRLKQRSTETDDKINMRIAKASVELATAPQFDTIIKNYDLDTAKEEA
YQLVKDFVNK
>EGALAKHO_03544 putative nicotinate-nucleotide adenylyltransferase
MKVGLYFGTYNPIHVGHLIIANHMAEFADLDQVWMVVTPHNPLKKKATLLEDHQRLEMVY
LATEDYPKIKPSDIEFKLPQPNYTVNTLVHLQEKYPNNEFSLIMGEDNLKTLHKWKNYEV
ILDHYEIYVYPRISDEPENIELKSHPKVHVIDAPVVEISSTFIRNNIKKGKNIQPLLPPK
VWEYIDHNNFYKK
>EGALAKHO_03545 HTH-type transcriptional regulator YjiE
MVNLEWYRTFKAVYKNGNFSVAAKELFMSQPAVSQQISMLEAHVGYKLFNRKSKGVEATE
YAKLLNNLIIDALDRLENVESGFRAKAEDSKRLISIGVSKDLFNSFGSTLISKFDLIDFT
FAEDDVLFSLVDAKKLDFAVVTKKFDTFDTIYEIIGKIKLVVVGSTNLDTTDFRQKLKSD
NAVEIEQWLNDQKWYSHDARIPHVKLFWLHAFNKKRPAIMPNYIIPSESEMLEMLSRNTG
IAITWNCNSRKYIKENKLQLLWNSFHVPEEYVYLLSAKNNNLNSFFDTISKELKLFFGNR
M
>EGALAKHO_03546 General stress protein 18
MKKIALLAIIAFTASSLTATAQKSNKKGMKKVLFVVTSNDKLGNTGEKTGFWSEEFAAPY
YELLDQGVEITIASPLGGQPPIDPKSADPASATEDTKRFDADKTLQEKLKNTHKLSTINQ
KDYDAVFYPGGHGPLWDLVEDQNSIDLIESFYTHNKPVAFVCHAPAVLKNVKVNGEFLVK
GKKVTGFTNEEEEAVGLTKVVPFLLEDALSSNGGKFSKGPNWQPYAVEDGLLITGQNPAS
SKLVAGKLLQKLGK
>EGALAKHO_03547 Alcohol dehydrogenase YqhD
MLNFELYNPTNLIFGKGQIEKLSTLVPQGAKILLAYGGGSIFKNGVHEQVINNLKGFDIV
EFGGIEPNPHFETLMKAVDVIKAEKIDFILAVGGGSVIDGVKFISAAVNFQGNPIDILQK
RILIKENAVPFGTVLTLPATGSEMNSGSVVTIAATQEKLAFGGSALFPKFSICDPTVITS
LPKRQLQNGVVDAYTHVMEQYLTYPHEGFLQDRIAEGILQTLIEVGPKVVENPADYALAS
NFMWSCTMALNGLIQKGVPQDWATHMIGHELTALYGIDHARTLAIIGPSLYEVMFDTKKG
KLAQYGRRIFNLTGSDDEVAKEAINKTVEFFHTMGMDTKLSQYTDDYSETADFIVKRFDE
RNWKGLGENQLVTLDKVKSIVEMSY
>EGALAKHO_03548 Glycerol-3-phosphate dehydrogenase [NAD(P)+]
MSQNLKFAVIGGGSWATAIAKMLCVNLSEIAWYMRNEAAIEHIQKYKHNPNYLSSVEFDT
TKLKLTNNINEAIEYADYVIFAIPSAFLDAELKNMTVSLSDKIIFSAIKGIVPETSLIVG
EHFHIQYDIPYYNIGVITGPCHAEEVALERLSYLTIACGDPDKASIVAKSLSGNYIKAKI
SDDIIGTEYAAMLKNIYAIAAGIAHGLGYGDNFQSVMMSNGIREMKKFIRKVHKMKRNIN
DSAYLGDLLVTGYSVFSRNRMFGNMIGKGYTVKSAMMEMSMIAEGYYATKSAYKLNQGYG
AKTPIIDAVYAVLYEGKDAKTVFKKLTESLD
>EGALAKHO_03549 hypothetical protein
MKKDITIPEVENVFLAAVQEWSDDFMEKVWYAYLVNDSDFNLDSVMVVSKAFGTIDGEMK
KTSVLRHAFVEVPAVSVVKIEMIEKSLLVLNNEFMVTFFIGNTLYDKKFIFKSNLINENK
TEEVPILFVEGVMVK
>EGALAKHO_03550 Phenylalanine--tRNA ligase alpha subunit
MIDKIKQHIEEAKSFNDKNKESLEQFRIKYLGSKGLLKELFTEFKNIPNDQKKDFGQVIN
TLKAVAEEKVRVIQEELESKQEVKGMFGDLTRSAEPVIIGSRHPISIVKNQIIDIFANIG
FNVSEGPEIEDDWHNFTALNLPEYHPARDMQDTFFIQTNPDVLLRTHTSSVQVRYMENHK
PPIRTISPGRVFRNEAISSRSHCIFHQVEGLYIDKDVSFADLKQTLLYFTKEMFGKSKIR
LRPSYFPFTEPSAEIDIYWGLKTETDYRITKGTGWLEIGGCGMVDPNVLKNCDINPDEFN
GFAFGMGVERIAMLLYQIGDIRMFYENDVRFLEQFKANI
>EGALAKHO_03551 hypothetical protein
MSRDTQLKERWEKLVDILSNQFSQGEDLDLDAIIYLIGVQELGKVHREFKKDEKLNLMHI
AICRLLEPYGFYEFEYFDEDGWPHYRVKEELPPLKAGEQSVLMKEAIVNYFLEREVIE
>EGALAKHO_03552 hypothetical protein
MSFFDMIFGALLAFSLYKGFKNGLFVEVASFISLLLGIYIAIKFSSLMKEIIMKHVSWNP
NTIQVTAFILTFILVVIGVYFLAKILTGIADFAFLGLPNKLGGAFFRVLKTILIMSIFIA
LFEKINFNNTFAKKETLDKSIFYNPVKKVAAFVYPSIEKWYESFKEEHAKESEKKSTETS
EKE
>EGALAKHO_03553 hypothetical protein
MNSNLTKKTFFILLITFFCKNANAQSNHVLWYNQPAEFFEESLVLGNGKMGATVFGGANL
DKIYLNDATLWSGEPVNAKMNPEAYKNILAIREALKNENYKLADELNKKVQGKNSESFAP
LGTLEINNAEKGKAVNYRRELDLSNAISKVSYEMAGIKYTREYFVSAPDQIMVIKLTSDQ
KGALNFDINLKSLLKSNVEVRNNILIMTGTAPIHENPGYTVLPKYLEVKERGTKFTTLVQ
IKKIDGKITNSRESINLRDATEAIIYVSVATSFNGFDKNPATEGVDDIAIASQHLNKALA
TPFDKLKESHSTDYQKFYNRVNLDLGKTTAPDLPTDERLLRYSEGKEDKNLEILYFNFGR
YLLISSSRTMGVPANLQGIWNPHLNPPWSSNYTMNINVEENYWLAENTNLSEMHLPLLSF
IKNLSVTGKVTAKTFYGVNEGWASAHNSDIWAMTNPVGTFGNDDPSWACWPLSGAWLSTH
IWEHYVFTQDKNYLKNEGYPIMKGAAEFFLGWMVTDKNGKLITSPSTSPENKFIAPDGYI
GATMYGGTADLAMIRECFDKTIKASKTLNIDTAFRTKLETALSKFYPYQVGKKGNLQEWY
FDWNDEDPKHRHQSHLFGLFPGDHITPQKTPDLAAASRKTLEIKGDETTGWSKGWRINLW
ARLWDGNRAYKMYRELLRYVDPDGKKTEKSRRGGGTYPNLFDAHPPFQIDGNFGGAAAVA
EMLVQSDENEIRLLPALPDAWETGSVKGICARGGFEIEMSWENKSLKKVTIISKNGRETT
VISGDKKQDITLKKGEKLEINW
>EGALAKHO_03554 hypothetical protein
MKKNITFLFLLCCIIATANVKMPLLFADGMVLQRNKEIPVWGWAEANEKVEVHFNKQTKT
IVADKNGKWMIKLSAEKAGGPFELIITGKNKIIIKDVLVGEVWICSGQSNMEFQVSKAIN
AEKEIADSNYPMIRHFGVAQDLSGKPKDDLKAGKWEVSNKETVGNFTAVGYYFAKKLYAE
LKIPIGIINTSWGGTNVETWTSREAFQKSEDFKTMIADVPALNIDSISKLYARQMKERVE
KIQGTPVSTENENTFNEPTFNDTNWGELNTPGLWENQPLGDLDGIVWMRKTITLSAEDIK
NKATLYLSKIDDEDITYVNGIEVGKNMQWDFKRVYEVPANILKEGQNVIAVRIVDNSGGG
GIYGDAADLKLTLGNKTIPLDGKWKFKVIVVKTSLSPNSYPSLLYNAMVNPLVPYAIEGV
LWYQGEANVWRANQYKKAFPLMINDWRTKFNQGDVPFYFVQLSTFDEFKGNSKVGSRWAE
LREAQAETLKLKNTGMAVTTDIGNAKDIHPTNKQDVGLRLAAIALNNVYGKKQVYSGPTF
KSQEIKGNQIILTFDNIGSGLSASDNSQNVKGFEIAGADKVFHSAKAIIKDNKIIVSSEN
VQNPVAVHYGWADDDTEINLFNKEKFPASPFRTDNWEMITANEKYKVSK
>EGALAKHO_03555 Xyloglucan-specific endo-beta-1,4-glucanase BoGH5A
MNRLIKSYLLNTVLCLSWISVLACSSDKEATPDNPIPVAKTLTVDVNKIDFQSASSTAEV
IVTTNSAGWSVAAADASWLKFTPTAGVSGRTTITVTASENTSSVVRTAVITISSSEVASV
QVAISQAGKSGIYPSYNTTPITADATGMGSTAVQLAAKIKLGWNIGNTMEATGGETAWGN
PKVTKALIDLVKSKGFNAIRIPCSWNQYLENTATAKIKAEWLNRVKEVVQYCVDNDMYVL
VNIHWDGGWLENNITEAKKEENNAKQKAFWEQIATTLRGFDEHVLFASANEPAVEDAAQM
AVLTSYHQTFIDAVRSTGGKNANRVLVIQGPTTDIEKTNKLMLTLPTDKVPNKMMVEVHY
YSPWNFAGMTKDESWGKMFYYWGANYHSTIDTERNATWGEEADLEKNFKLMKTQFVDKGI
PVLLGEFGAIRRTTLTGDALTLHLASRAYYLKTVVKQAKANGLLPFYWDEGNTGDGGFGL
FKRADNTVSDTQALNALIEGLQ
>EGALAKHO_03556 Beta-glucosidase BoGH3A
MKNKMIYLPVFMAFALLTSCKKETQSENSGAVQTEEHQGKEISSEFDGEIEKLVSQMTLE
EKIGMLHGNSMFSTGAVERLGIPELKMADGPLGVREEISRDNWAPAGSTDDFATYYPAGG
ALAATWDAEMAYTFGNSLGQEMRARDKDMLLSPAINMVRTPLGGRTYEYMSEDPFLNKKI
AVPLVVGLQDNDVMACVKHFAANNQETNRDFVDVQIDERTLREIYLPAFEAAVKEGHAYG
IMGAYNKFRGEYLCENDYMLNKILRDEWGFKGIVVSDWAAVHSTAKSLKSGLDIEMGTPK
PFNEFFLADKLVAAAKAGEVSEAEIDIHVKRILRTLFQVKAMGPDSKNRAKGSISTEAHY
QDAYKIAAEAIVLLKNDKNALPLKLDGVKSIAVIGNNATKKNALGGFGAGVKTKREITPL
EGLKNRLPSSIKINYAEGYLERYDEKNKGKLGDITLNGPVTIDELDPAKVNEAVEAAKKS
DVAIIFAGSNRDYETEASDRRTLKLPFGQEELIKKVQAVNPRTIVVMIAGAPFDIDAVSK
NTSALIWSWFNGSEGGNALADVILGKVNPSGKLPWTMPKNIMDSPAHATNSFPGGKTVNY
AEGILIGYRWFDTKNIAPLYPFGYGLSYTTFAFENAKADKTSYDENETITVSVTVKNTGK
IDGKEVVQLYASKSDSKVSRASKELKGFKKVLVKSGNSETVTIQLPVKELAYYDVASKKW
VVEAGKYTLKVGNSSRDIKKDIAITIQ
>EGALAKHO_03557 Beta-xylosidase
MKRNLITLLIFISLININVFGQNSNALKSEERIIKIDYNKSAGKLNTMFKECIGAGRANE
GLRADWQQQLAMTKKECDFKYIRMHGLLSDDMGVYREDAKGNPEYNYQYIDVLYDFILSI
KMKPFVELGFMPEALASGKETIFWWKGNVTPPKDYKKWEDLIRNLTQHFTERYGAEEVKT
WYFEVWNEPNLSPGFWTGTQAEYFKLYEYAARGIKTVNPAYKVGGPATAGAGWVPETIDF
CAKNNVPLDFISTHTYGVKQGYLDEFGTSGTILNKEDSSISGDVIKSRNQISNSAKPKLE
LHYTEWSSSYTPADPVHDSYHSAAYILQKLKQVGNAANSMSYWVFTDVFEEPGPRFTPFH
GGFGLLNTQGIKKPSYFSYSLLNKLGETELQNKDSSSWATKNAKGDVQLLFWDFTNTHPG
DKVWNQTYYVQDLPSQPKGIVKIEVNGLQKGKYNLEIYKVGYKTNDAYADYLAMNKPNQL
TIDQVKKIKEHNNGAPIAIEKVVIDSKGTYSKDFKMNENDVVLFNFVKQ
>EGALAKHO_03558 Glucan 1,4-alpha-glucosidase SusB
MKNYLILPALILSVSIGYSQKNKNAYELASPNGQNKIKFELVKNAPKYAVSHGKTEVITP
SDMGFLLKGNENLSSDFEIKNVKNTSFDETWEQVWGEKKNIRNHYNQLSVQLQQKSGNKR
KLEIQFRAFDDGIAFRYVYPKQNVKDSIFIMDEKTTFNLKEDGKAWWIPANRENRDEYLF
KDAPVSTLDTVLTPLTIESKSGLALSFHEANLTDFASMTLVNTTGTQLKSDLVPWADGVK
VRVKDTFTSSWRTIQIGENPGDLITSYLILNLNDSNKLKNTSYFKPYKYFGIWWGMHIGK
YSFWESDIQGATTKHAKEYIDFTAKEGFHHLLIEGWNKGWTPAWYQNKMHMFSFTKSADN
FDIDKVVAYGKAKDVELMGYHETGSNLINYLKEVDEGFALYKKLGIHTVKIGHVGSKLNM
KENHFGQFGVNYFRYILEKAAQYDLAVLYHESIKDTGERRTFPNMVSREAARGQEYNAWS
EGNPPNHLTIIPFTRLLSGPMDFTPGIFDVEVKQGYPGKRVHGTAAQQLALYVTIYAPIQ
MMADLPENYEGKPALQFLKDVPTDWEDTKVLEGKIGEYITTARKDRNSADWYLGTITNEK
ARDVNVALSFLDPNATYEAQIYADAEGTDETHNPAEIAISKKTVKASDVLKLHLGGAGGT
AIRFKKL
>EGALAKHO_03559 Alpha-xylosidase
MKNSQLTTLFSICMFGLLLSPKASAQIQNADVLNAPIDISKDFQNYLNTFYFADELSNFD
PATGKGTIKYLRYNYKTRQAFNNMMMKPDVEKPNEFPTTEYDVSPELPFQIQFVSDRTIR
IKTTSGPQFHPEKESLMLINGVAPNHPELWKYSKIEGGHSYTSKHGRVEILTKPWHVKIY
DENGKLLTSTLHDSDFKNTYTPTLPFSYVRRNSDYSRSMGAAFSLEPDEKIFGCGESFTQ
FNKRGQKVVLWTDDANGIQNETMYKPVPFYMSSRGYGVFMHHSTPITVDFGKYFGSANEM
YIGDDEADLFFFIGEPKEILDQYTDLTGKAAMPPLWSFGFWMSRITYFTEKEGREVAKDL
RKYKIPTDVIHFDTGWFDVDWRNNYEFAKARFPDAQKMMSDLKDDGFHVCLWQLPYFTPK
NTLFPEIMEKNLAVRDRKGNLPYEDAVLDFSNPETVTWYQAKLKKLFDQGVSVFKVDFGE
AAPPDGIYHSGRTGFYEHNLYPLRYNKAVAEITQKEKGYTLIWARSTWAGSQRYPLHWGG
DAETSNGAMSAELRGGLSLGLSGFSFWSHDVGGFATKSPENLYRRWAPFGMFTSHVRSHG
EPPREPWLYSKDFLEGFRKADNMRYELMPYIYAQAKESSQKGLPMMRALFVEYPNDPGAW
LVDNEYLFGSSMLVAPLFEEVTERDVYLPEGTWIDYQTKKVYQSGWHKIKAGEVPIVVLV
KDGTALPHIALAQSTKDMDWSKLTLKVYASDATTSAKAKVFLPDGNAVQEITVTKNGSNF
EVAPNTLNGKTTFKTEWIK
>EGALAKHO_03560 Beta-galactosidase BoGH2A
MKSKSKYLSNCLTALMLIGITLLSSCSKKEEVFSNRKISFNSDWSFHLNDSIIDKDTIGS
STKWRTLNVPHDWSIEGKFDEKSPAGYGGGALNGGLGWYKKTFKVAAADSSKVTSVIFDG
VYRNSEVWVNGHYLGKRPNGYIGFQYEISPYLNYGDKNNEIIVKVDNSKQPNSRWYSGSG
IFRNVWIETTDKLHVGQWGTYVTTPKVTAGKASVNFETTIQNQNSASKKATIITTIFKED
TKVTAVTQNITIGANANSTIKQTAEVESPILWSVEKPELYTAVTEIAVDDQIVDQYKTNF
GIRDFKFDLDKGFLLNGKQVKIKGVCMHHDLGPLGSAINTRAIERQLEILKGMGVNGIRT
SHNPPAPELLDLCDKMGFIVMDEAFDMWKQSKTKYDYGNDWDKWHKKDLIDQLLRDRNHP
SIFMWSIGNEIPQQWDESGVVIAKELAAIVRQHDKTRPITAAMNPPVNMNLDGIDLQFDK
AKVDYNKIAASGTLDIIGYNYAHQTYEYHKKNFPNTPFIATETTSALETRGYYDANSDSI
KKWPVRWDLKFTDGNPGNTVSAYDQVQAPWGSTHEATWKVIKKHDYLSGMYIWTGFDYIG
EPTPYEWPSISSYFGIVDLAGFPKDVYYMYQSEWTDKTVLHLFPHWNWKAGQTVDVWAYY
NKADEVELFLNGKSVGIRSKKGDDLHVMWRVPFQAGTLKAISRKNGKTVLETEIKTAGNP
ENLKLTADRSNIKADGNDLSFVTVDILDAKGILAPKANNEINFSLKGEGKIVGVCSGDPV
SHESYKGSKHTALNGKCLVIVQSSNKSGRLELTAKANGLKPATIVITAE
>EGALAKHO_03561 hypothetical protein
MPVGNFKLKSNKMKNIKIVISSFLMLVAMLISSCSPESYSLDPVTDKSDIKFEITQDFAV
DPGGNTVILKNTTPGVVLTWDYVTGKSNKAIESVKYAFKGNYTIKISAITDAGIVQLDPV
TITVTKDNLNYVNDPLWTALSGGVGKKKSWVADNGKYGLAPGAMSYADPSGVVEWGNFTP
NWEPEGNANSSSDADMHWGRYMTFSLDGGPFMTISEKDGTVKENGTYFLDINAHTLTTTG
ATILRPDNYIANASNWNNNIKVLKLTDNQLRIAILRTNNEGTWWYIWNYVAKDYADSYVP
PVTVPVVDEGFNPKFAPGELLTMLTGGVGAGRVWNLDGKGNPVDWIGKGKGWTVDATSSY
NWGWNDDWAALAGNSWIRFDQWGGKLNYTRSQNGVVTTGLFTINSETNEINLGTDTLIQN
STSWMNPTTNVIKVVKAFNTSYLQKGIWLGTSYDAGKDEWFVFHYIIP
>EGALAKHO_03562 SusD-like protein
MKNTYLYIFCFSLLSLGSCSLETEPLTQLTDTNFYKTTDDAYTALVGCYDGLQVATGASG
LGVPVISEVMSDDCFGGTGNSDGFNYAAIDEFDITRSPSDIDMLNGNWIAYYKALYRCNV
FLSKMDQIDWKGNTALRNTYESETKFIRAYLYFEMVRLWGNIPLLTAPSSENIPQANPDE
VYKVIAQDLVFASENLPATAYNTTTSGRITKWAAKSLLGRVYLYYTGYYGKSDLVGVVTK
AQALGHLENVIANSGHGLVADFSTLWPAASVDKYAGESNKEIVFSIKYTYTSDYSGNTDG
NHWLVMFGMREFSSYPYGRGWGITVNSKLWNVYDAKDTRRVATVIGIDEEKIAFDKKNSQ
REYTGYYNKKYAPMVDKDGKDLPLTMGSQFWDISQFQDYVVLRYADVLLMAAELGSGNAQ
AYFDEVRKRAYKENFTALPVNADNILKERHLEFALEGVRYWDLLRQGIGTASSTIAETTT
LLSGGVAGTKTITAAKIQATKGLQQIPNTQITLSNGVLKQNAGW
>EGALAKHO_03563 TonB-dependent receptor SusC
MKTTLSSFCAALLFSLFMIQSGFAQAQSRSVSGNVTSAVDGMGIPGASIAVQGTKIGATT
DFDGNYKIEAKSGDVLVFTFIGFKSQKITLGTQQTINVTLQEETAELKEVVVIGYGSQKR
TLVTNAVTQVSGENLAKTNTTNALQALQGQAAGLQVTSTSGQPGEGLNVVIRGAGSTSGT
SPLYVVDGILTGDISYLNNSDIESISVLKDAASAAIYGSQASNGVILVTTKKGKRGAGGQ
ITFDQYYGIQSVARKVDLLNATEYGVMLNEAAVNSGKNPYFTNDQIAALGSGTNWMDHML
TDNAATKNFSFGASGGSDTSVYSTSLSYLGQEGVVGGKDLSNYERYNFRFNSEHKLYKDV
VTLGENLSFAYIDKNGIGVGNQYNNSLRSAFQATPLMPMYDADGNYYDTTKNSEPWLAGA
ANPYALMVYNNQNESNNQKLLGNVYLQIEPIKNLTLKTTLGLDYYAGEGHSYSPVYQLSI
YANSAFDKVNQNMNKGKTITWDNLLTYKFDAAENHHFETMLGTSSINYDGTSVSATNADV
IFNDLEHAWLNNTTNKDGAKMSMTGLKQETKRMSYFGRLNYNFKETYLLNATFRMDGSSI
FSKENQWGYFPSVSAGWIVSNEEFLKDSKVINFLKLRGSWGQVGNQNARAFQYLSTIKSN
NTNYIFGDTEGVLTPGAYPDRLSNLDLKWETSEQIDFGFDARFLNNALSVTFDYYNKKSK
DWLILAPILATAGADAPFINGGDVVNEGVELSLSYQNKIGDFSYNISANGAYNKNTVGKI
PNADGIIHGLSNELYDNAGEFYRAQNGFPLGYFWGYKTGGVFQNQEQINNYKSASGVVLQ
PNAAPGDLIYQNINGDDKIDASDKTEIGKPNPDFTFGFSLSANYKAFDFSLMANGVAGNQ
IVQSYRNQAGAYGNYTSAILDRWHGEGSSNTVPRVTEDNRNFTQFSDLYIQDGDFLRIST
VTLGFDFAKMKQSKPFFASQFRLYFSVLNLYTFTKYDGMDPEIGFGSSNDDQKFSSGVDV
GYYPRPRTFMMGLNVKL
>EGALAKHO_03564 hypothetical protein
MNRKVDEDAVIKSEQNAMNAITIDCVIFGFDEGILEVLLVQHGEGISKGKWGLPGGWIYK
KESTDNAAHRLLNELTGLDNIYLEQLKAFGDPDRFPLRRVITIGYYALVKREDYNVKAGF
TAADAKWYKIDAIPDLIYDHNEILSYSLKHLRNRVRQAPIGFNLLPEKFTLLQLMHLYEE
ILGVEMDKSNFRRKILHMKLLVALDEKQQDVSHRAAKLYKFDPQIYNKLTEKGFNFEF
>EGALAKHO_03565 hypothetical protein
MASLHPKEISKIDTILNSPTPAVDGISIDCVIFGFKKGSLEVLLVQHASGESEGNWGLLG
GWMKREESADDAAHRILYELTSVDNIYLEQLKAFTNPKRVLDRRIITIGYYTLVNQEDYD
VKASLAVKEARWCRINEMPNLIFDHNEILNFSLLQLQNRVRQAPIGFNLLPEKFTLLQLM
HLYEEILGIELEKSNFRRKILHMKLLVALDEKQQDVSHRAAKLYKFDPDIYKKLTEKGFN
FEF
>EGALAKHO_03566 Elongation factor 4
MKKIRNFCIIAHIDHGKSTLADRLLGATQTVTAREEKAQLLDNMDLERERGITIKSHAIQ
MEYTYKGEEYILNLIDTPGHVDFSYEVSRSIAACEGALLIVDAAQSIQAQTISNLYLALE
NDLEIIPVLNKVDLPSANPEEVSDDIIDLLGCKLEDIIHASGKTGFGVENILAAIIEKIP
PPKGNVDEPLQALIFDSHYNPFRGIEVIFRVVNGEIRKGQKIKFMATGNEYFADEVGTLK
LNQVPKNVISTGDVGYLISGIKEAKEVKVGDTLTDAKTPTTNMITGFEDVKPMVFAGIYP
VDTEDYEDLRSSMEKLQLNDASLVFTPESSAALGFGFRCGFLGMLHMEIIQERLEREFDM
TVITTVPNVSYLAYTKKDPETPFVVNNPSDLPEPSRLDRVEEPYIKATIITKSDFVGNVM
SLCIEKRGQITNQTYLTTERVELNFDMPLAEIVFDFYDRLKTVSKGYASFDYSPIGMRTS
KLVKLDVLLNAQTVDALSALIHEDNAYNIGKKMTEKLRELIPRQQFDIPIQAAIGAKIIA
RETIKALRKDVTAKCYGGDISRKRKLLEKQKKGKKRMRQVGNVEIPQEAFMAVLKLND
>EGALAKHO_03567 hypothetical protein
MIRNYTFDEAYKRFEPHDHKCTYCGEAEMENMNDCYFVPLFVEGDRTNIVVYRSVKYSKV
LIGIPRCRSCKDIHYDAKNKAITISIVSVIVLLGLLLYNFMNLNAFVFIFGIFAVIFGGI
YGSSKLAERYVANKGIYTLQDGAETNEVVQDLVIAGWSFTMPTA
>EGALAKHO_03568 hypothetical protein
MDNELSYSQQEELKNKMKNGGFNAETEINNLMSLGFDQEKAKEELLKIVKSYKEDLFFEA
KEAKENEEKGKIAAFAVIFSSLLIALLGGQNGIMILVSLVVACVAGFYGFPKNPIPAVVG
FAVGALLMPFACGYYLRGRDTFLNLELFIPMIMAFGPAFLIKYILSKLIPAND
>EGALAKHO_03569 hypothetical protein
MKTKFLIIATLFTFSFINAQQQEAEEEMHSAKGVRFQKGNMFLEGGISISTSDDANAYSI
NPKFGYLIADNFAVGGDLDFGGGKTDVNDGKTSFFGIGAFARYYFFEADSRRFKAFADAG
LGYSHARAEYNIVGDPVRYDNTTNGIKANITVGLNYFFSQKFAATFVLADILTYNNANPE
NGASSNSFELNINLFNNIFAQPKFGLLYKF
>EGALAKHO_03570 Bifunctional ligase/repressor BirA
MLDESPKRFDRIVAILIQLQSKKIVKAQELANRFEVSLRTIYRDIRTLEASGVPIYSEAG
VGYALMDGYRLPPVMFTREEVSSFIAAEKLMQKFTDPSLGNHYASAMFKLKSVLRSTDKD
WLSNIESKVVMQTAEPMFNDNSPNTLAVLFESIAEKKQILLSYKTVEKDETTQRNIEPVG
VFHDHNNWYFLGYCHLRKDYRQFRTDRIQGIVKTESDFTIEHDSLETYLTKTETIPTIKV
RILIEKKIARYLETERKYHGYISEKEVDGQIEMTFMCRDIESGFARWFLMFGDFAKILEP
ERLKIRALELLEINKKRLL
>EGALAKHO_03571 hypothetical protein
MKTLAAQVITSEDLLNHWQGHRALTRRIIEAFPEKDFFEFSIGGMRPFAKLVDEFLAMGA
PAMKGIVNKDTAPFAEESEGLIFKAQYLEKWDEATAEINKYWNQLRIEDFNETFNLFGQY
NFPVIQNIFYLIDNEIHHRGQGYVYLRALNIEPPFFWER
>EGALAKHO_03572 ATP-dependent 6-phosphofructokinase isozyme 2
MNSHYIITLTVNPALDKSTHFKGLVAEQKIRCSEPRFDAGGGGINVSKAISRLGGDSLAV
FTSGGPLGKMLEELVAKETIAFQAIPIQTWTRESFVAVDENTNSQYRFGFTGGEITADEE
KAVLNALSTSKSKFLVASGSLNEGLSTDFYQKVAEIAKASNSKLIVDTSGEALKKVLETG
AYLIKPNVGELAKLIGVERLEMEEVNEAAKKIISQGGAEIVVVSLGPQGAVLVTKDEYEY
VPAPNVAKKSTVGAGDSMVGGMVWALSQNKSLKEVIRWGVACGSAATMNEGTQLFKFEDA
NRLFEWLSK
>EGALAKHO_03573 hypothetical protein
MRAPLLLLLLFYSTISFSQGIIVDTTSVGIPQLIREELMQNACANESNFKFSSHQGIGKF
TSSNPNFPISSGIIIRNGMAKYSEGIYTGNNESSQLNTANDSDLQLISDENGQMVPITDV
SFIQFDFTPLSTNFSFDFLFASNEYGEFQCGFSDVFAFILTDLTTGVATNLAVVPGTSTP
VSVKNIRDQQYNSSCLSANANLFDHYNVTDPTESAINMRGETKVLTASSTVIPNRTYSIK
LAIGDYHDSGYDSAVFIKGGSFLTTMDLGPDKSICQGEKITLQSGLVGNYDYVWTLDGAV
IPGQTGSSLVLTAAGTYGVTATLSGCVIKDEVVISTLVTKSPQNLVACYNGNANYQYDLT
QNNLSALGLNPAEYYLLYFESLAAANSNGPAIPTNQLTSYTSIGNQTIYIKPVHFSNENS
LCNNLISFNLLVTNPINVVKPADLSFCDTRSGRVLIDLTAQEASILNGLNPSDYKISYYT
SQIEAGSATNRIQNPTEFITTLFQSPQTIWVRIEHVSSFVCYATVNFNITIYSLPSVDDI
PDVITCNSYTLPPIIAGNYYTGPGGTGTKLNAGDVITKGGVYYIYSGPTPANSCTNENFF
NLILIYELDFPEEACGQYIVPTVVAGGFFTEAGGGGNSIPSGTSFTTNQTIYYYAVINGV
VCRDEPVTFVVYPLPLVDKPSNVVTCDSYTLPPLTNGNYYTLSGGLGSRLNSGDLITSTQ
TVFVFANDGRCTNQNSFKIDIVNSSTFTPITECGSYTLPNISIGGYYDSPGGQGTNIPAG
TIITNSQTVYYYANTTTTPNCTINLKYEITIKPLPPVDKPANRLECQSYILPPLVNGNYF
TKTNGGGLPLKAGDVIDKTQTIYIYSVGTDCTNEHSFIVEIRPLPLVDSFTDVVTCSDFK
LPKLKNGKYYTATAGPHGLGTQIAEGTSISSSQTIYIYNEWPDFTNCRNETFFKINFNGI
DLGTFNNINVCDSYTLPPLKLGNYYSQPTGKGAIIPPGTILKTSQTIYVYAIVGNRLTCT
GEKSFTVTISATPIVANVPDVAICQSYTLPPLSVGNYYSGPNGTGTLYLAGQQINASQTM
YIYAPAATNASCASQDDFNITVYPLKDLVIKNGIICVDYQTGALLNAAQLTSGVNSTIYT
VDWFLNGNKISTGPNYAATEDGTYTVIFTKNTSNIGNDCGYNPATVTVVKSSPAVATVTV
SDAFEDTIDIIVNLSNGFGIYEYQLDGGNFQTTNVFSNVDSGEHVITIKDVKGNCDDQIL
MAKVLKYPKFFTPNADGYNDTWNIPDLAFQSDAFINIFDRYGKLLKRINPSGPGWDGNYN
GNPLPSTDYWFQVFYTLEGVNQVFKAHFSMKR
>EGALAKHO_03574 TPR repeat-containing protein YrrB
MKTFFLTVALCTLTICSSQTNADQKTTEINEKTNSVTKDASYYNELGISKEKLKRYQEAI
DNYTLAIQLNPKEDAYFINRGVSKAKLNKYQDAISDFNTAIGLNPDSGSAYNNIGLAKRE
LGSYQDAILNFDKAIGLNAKEASYFYNRANVKIDMNNVQAAILDYNIAIQLDSNDTFSYN
NRGLAKAKLKNYQGAIADYTKSIQIDPKDATAYVNRGNAKTDVKNYEGAILDFNKAITID
KNLADAYFNRGAAKLQAGKKNEGCSDFKKAGDLGIKDAYEILKKYCK
>EGALAKHO_03575 hypothetical protein
MGILALLFTLYLSYRFSISNKKTIFPFSIIALFFAGMLFEGFRISENLKNFIFTFIVTWF
FSLIPFVLNIQESNFNFDSPFLAFISFFIFLFTILIGVFNKDRVTAQLTEGITLVLSLSL
IYWIIDYGFINLDNWFVKSILVISLLFSAFSIINALTHFKLSKLTRLTLSIWSTVLMVSF
AIDNIYRVLSNRDIENTDLSLGVSIGLQYFLLGVSAIYIMQNFMLLVSLFPNKNGDYKDD
LKEIRKEHIDRYSNKQVNTMLSLFCILYSGTIYILNYKFQMLPRHTMIWFVFFSFPLITY
FTNRLNENQRLKSALKN
>EGALAKHO_03576 Thiamine-monophosphate kinase
MIEDKNPQRTSIAQLGEFGLIEHLTKNFDVTQESTLKSIGDDAAVLDFKDKKVVVSTDLL
IEGVHFDLAYMPLKHLGYKAVVVNVSDICAMNARPTQITVSVAVSNRFPLEALEELFEGI
THAAKEYKVDVIGGDTTSSQKGLIISITAIGEANEEEIVYRNGAQKTDLLVVTGDIGAAY
MGLQVLEREKQVFQVNPNSQPDLDMYSYLIERQLKPEARKDVRTLLHALEIKPTSMIDIS
DGLSSEIIHLCKQSKVGCNLYEDKLPLDPQFISTCEEFNIDSTTVAINGGEDYELLFTID
INDFDKIKGNPNFSIIGHMADESEGINLVTRANTQIPLKARGWDALSE
>EGALAKHO_03577 Transcriptional regulatory protein ComA
MTFNLTTPISSLISRNILIVDDHPFIIEGYKNAITRYNPKEYDFAISQAYDCRSAYDLIE
DEATPNFDVAFLDISMPAYEEKDIFSGEDLAKLIMKKMPHCKIILLTMYTELLKIKTIIR
TINPNGLVIKNDLTFDELLFAFDKVMKNEKYYSQSVVKMLNQSTHNSIEIDEFDKQILFH
LSKQTPVAHMPQYIPISLNAIEKRKVNLKELLKIKSGSDEELIKEAKSKGLF
>EGALAKHO_03578 Oxygen sensor histidine kinase NreB
MKKHSPILLFLFLVLFGCTGKKKENKDVSLKSSDDSLSIYFSLANNINLPFQYKQKYNQK
AFDLVMDQKDDSLKKVNLFKVANRYYNMNDWRSYQKVTKLVLLESIESKDSINIGKAYNY
LGDYYASQTISDSAFLNYFKAEKIYIGINDDFNLVKTFLSKANLQLNEGDFFESEITIFK
ALKILKEKKNVSNDLYDCYNLLGILYNEREEYDKALEYHNKALLTLEDKSIPSELQLKAT
SLNNIGFVYLRMNNFNKAKFYFQKGLEEKDLFNGKTFLYAMLLDNLAYAKFKSQNFTDLP
GQFYDALKIRDSLKFESGIILNKIHLSEYYAFKKDTFRAIQLSKQALLLSRNSNKPRNTL
EALKQIAVVDQKNAAIYSREYIRLNEKMVKTERNMGEKFSRIQYETNEIKDQNSNLQEKN
RALVYVFSICTLLGLFFYVYKTQQAKNRELIFKQQQQIANEDIYNLMISQQNAIELTRIK
EKKRVAQELHDGVLGRMFGVRISLDSLDKIDEAQAVSKRKKYLTELKHIEEDIREISHDL
NREKSDLINNFIAILNKLFENQQNTYDSKLITSFDPHIKWELVSNIVKINLYRIIQEALQ
NCNKYADADTITVEFKSEIDYLILSISDDGNGFNTKRTKNGIGLHNIQYRAKECKGTVTI
KSAKGEGTILIIKVPIDQKINLQKNDI
>EGALAKHO_03579 hypothetical protein
MIMKKATLTIGLFSLIMVATSFANPVVTNASSTKNMAMAIDPGLGGQAGRDGRKLDVQGT
TNKLNASNQLNSLSSSNQSARSTVKVD
>EGALAKHO_03580 Transcriptional regulatory protein YehT
MNLKKYSYIIIDDDVESILKTKTIAEGFSELTFMASATNYQSGLHLVLEFKPCFVFLEID
PEDASSNLSLAFINELYRYLLVIPKIIITTTKKGLAFDAIQYGVFDYLLKPLAHIDLLKT
VLKLEKAFVDTTFKENVNEVASVVVSEIQTPQAVERPLIICIKSYGDYRYLNAADIAYFQ
ADNNSTDIYLNSGEMITAFKTLKHFESILSHPFIRIHNSYIINQNYIARIHNGNSVCYIK
NSPKKIPFSKTYKSNVDIIIANFASGNYIEV
>EGALAKHO_03581 Glycine--tRNA ligase
MAKQEDIFKNVVSHAKEYGFIFPSSEVYDGLSAVYDYAQNGVELKKNIREYWWKSMVQMN
DNIVGLDAAILMHPTTWKASGHVDAFNDPLIDNKDSKKRYRADVLVEDFAEKINQKAQKE
IEKARARFGDAFNEEEFVTTNARVVEYLSKYKEILSRLAKGMTDNLPDVKALIEELEIAD
PETGSKNWTDVKQFNLMFGTKLGASADSAMDLYLRPETAQGIFVNFLNVQKSGRMKVPFG
IAQTGKAFRNEIVARQFIFRMREFEQMEMQFFVRPGEEMQWYHHWKETRLKWHLSLGLGK
ENYRFHDHEKLAHYANAAADIEFNFPFGFKELEGIHSRTDFDLKAHEQYSGRKLQYFDPE
LNENYVPYVVETSVGLDRMFLAVFATSLQEEVLEDGSTRTVLKLPAVLAPTKAAVLPLVK
KDGLPDIAKKIIDDLKWDFNVAYDEKDAVGRRYRRQDALGTPFCITVDHQTIEDETVTIR
HRDTMKQDRVKISELRAIIENEVSMKNWLMKM
>EGALAKHO_03582 hypothetical protein
MINYLISLFFPKVCAACHTLLMTNEAVICTHCRHEMPLTQYYLDTKNEAVKKFYGKIEIQ
HASAFLYFNKKGMIQELIHNLKYKGHEEIGFVLGNWYVEDLKELKLEIPFDVVIPVPLHK
RKFKERGYNQVTTFGKAIAEGLNIIFDETILYRKKYSKTQSKKNLLGRSENIENIFDVKF
AEENQNKHFLIVDDVLTTGATLEACSRALLKIPGAKISIVCMAMANS
>EGALAKHO_03583 hypothetical protein
MKKPLLFLFVIFCCVKIHAQNDDLWQRTSSNSTLNKNVNQSDSGRLYYKLNSDFLKSKLN
TATGRTSKNSTSEITIPNSNGVLEHFTVWESSNFDPELQAKYPEIRAYEGKGLDDKSAKI
HFSVSPIGVQTMVLRANKATEYIEENSDDKTQYVLFTSKTNTSERLLCKTTDIISDKNIS
GKTAKTTSNAKVFKTMRLALSCTAEYTTYFGGTKTGALAGMNASMTRVNGIFNRDLAVKL
VLIANNDAVIYTDAKTDPYSDAKPGAEDGKWNQEVQTTLTDVIGNANYDIGHLFGASGGG
GNAGCIGCVCTNPSTDEPLGKGSAYTSPSDGRPQGDSFDIDFVAHEMGHQLGANHTFSYD
PAERTNVNIEPGSGSTIMAYAGVLKDYNVQDASDDYFAYASILQIQNTLSGKSCPVSTTI
INNPPTILAGPDYTIPISTAFVLKGTGSDPEGDSVTYNWEEYDNSITTTGDNSIAYPTKP
DGPLFRSVIPNTSTVRYMPELNSVLQNKLTTTWESVSSIARSLHFTLTGRDNAADGTAQT
NSDAMVVNVASFAGPFAITSHVNDNVSWWQGLSETVTWSVNNTNTLEGSTAVNIKLSTDG
GVTFPIILAANTPNDGSETIVLPTNVPSSKNCRILIEPTGNIYYAINSKPFAVGFTSTTT
CNSYSFGSSFSIPTTTTFVTRTLAVPAATESVLDVNVSVNVTHARFSDLEIQIVNPQGTV
VRLFNKGCAATNSTLAMQFDDSGNTLDCNKTTDQIVLPVDMLSAFNGQNPEGTWTLRVRD
AVSGMFGTLNSASISICGQTYTLGTPDFENIDFVLYPNPNKGSFTIQFESKSNDGVIVFV
HDILGKKVYEKTFEATADFNQNIQLQDVSAGIYLVTVIDGNRRTVKKIVVN
>EGALAKHO_03584 Riboflavin biosynthesis protein RibF
MKLFHSINDFHSTKKTILTLGTFDGVHIGHKKILERITQNTENGKYESLVLTFFPHPRMV
LQEKSEIKLLNTISEKSKLLEQTGIENLVIHPFNESFSRLTAEEFVHSILVDQFHIQKII
IGHDHRFGRNRTANIDDLIAFGAEYGFEVEQISAQEIQDVSVSSTKIRKALTDGNMDLAN
NYLGYAYFLSGEVVKGKQLGRTIGFPTANIQIEEDYKLIPKNGVYVTKALIGEKEVFGMM
NIGFNPTVNGEKQTIEVHLFDFDADIYGEKIEVSLLHYLREEQKFGSVDLLKAQLNQDKI
DALAFISQL
>EGALAKHO_03585 hypothetical protein
MNLPKEITNGFLIFLGIGIYFLLMNLLGLADLFYLRTLNVFFIFYGVNRTMQMNLREGET
NFVSNAVSAMTTSVVGVCMSVFGLLVYSYARGGDAYVQTLSETFMFGGNPSVPTYCICLL
FEGVASSVIVTLMMMLYWNNKYAAD
>EGALAKHO_03586 Biotin synthase
MSITKHNWTKDEIIAIYNKPMMDLLYEAATIHRTKHDPNVVQVSTLLSIKTGGCPEDCGY
CPQAARYNTGVEGNDLMSVSQVKAQALRAKSSGSSRVCMGAAWRNVKDGEEFDQVLEMVR
TINKLDMEVCCTLGMITENQAQRLAEAGLYAYNHNLDTSEEYYKDVISTRGFEDRLQTIE
NVRKTNVTVCSGGIIGMGESIEDRAGMLVALSTLNPQPESVPINALVAVEGTPMEEEKPV
EIWEMIRMVATTRIVMPDTQVRLSAGRTNMSREGQAMCFFAGANSIFAGDKLLTTPNPDV
HEDMKMFEMLGLIPQKPFVKVSQPQTVEAADSQFAPLGEKPKWSRPGHTIERNLEASIKS
KN
>EGALAKHO_03587 hypothetical protein
MRYKQFFYLIEMNLKQIERVKKISKAEFISQYVKKQIPVVIEELTEDWPAYHKWKLSYIN
EIAGDITVPLYDDRPVNHEDGFNEAHTKMKMSDYINLLQSKPTNYRIFLYNLMKEVPVLK
NDFLWPDIGLKLVKQMPMLFFGGENSRVFMHFDIDYSNILHFHFHGEKQCMIFPPDQSKY
MYKVPHALISREDIDFDDPDYEKFPALKNAEGYITNLKHGEMLYMPEGYWHYMKYLTPGF
SMSLRAFPKNISNLSKAAYNVFIMRHFDIMMRKFKGQKWIDYKNEKAIQNTNENLAKSA
>EGALAKHO_03588 hypothetical protein
MKHSLPTKLFFFPPLLQFALKGFCSKHFCCIRIKFSLFLLFISTFLSAQTPNTLTSDTLQ
VPVKIDLKEVKGDGGESGAVNSALGADQLAKNSATHKVMAAFICPKYSISNVSVSAVCAE
AGNTTVVLSSTQAALPIGIYKVTYNLYNPVSKGLIAEMKVETAGSGQFLLSGLTTVGRRK
IIITNLTSGECSSIIKKASAEIVISGAAVSGTVSLSGSSHICSGSNSPLLTLNNYNGNIV
RWEYAQSVPYVWKTISNTANTYQPGILAVSTSFRAVLKSGSCSEQYSGETRIEVDSAPVA
PVPVKIIQPTCATPTGTIILNGLPGSGKLLQNDGTVIVSRAFSGNSITISGLPLGTYKFA
VENNCATNYSSDIVIQANTWNGANWSYGTQPSLDNLVDFQASYYLDKDINACSCTISNDA
FVTIQHERTLKIINGLHVVSGSLTFADGASLIQTNPDNNLNTGDIRYKRKSQPIRQADYV
YWSSPVKLQTLQKVSPLTATDKYFSYDGTKWLSVPNTTIMNTGKGFIIRGPETFLNTERR
PFATVFEGVPNNGDITGETVEAGKFYLIGNPYPSALNANDFISENNFLEGTLYFWTHNTP
VVLNEANEYSSDDYAVYNLTGGSGVGEPALLGGIPESENNMAPSGNIAAGQSFFVGATAP
GTVKFNNSMRRGGNTNSQFFKIDKNSNSEQAENSRIWFDMTNSGGAYKQLLIGYVAGATN
EYDLKYDGPSFNGNKFLDFYSLNSGKNLAIQGRTFPFTVSDTVALGYRTTIAGDFTISIN
HADGKLVNHSVYLEDKLTNSIHDLLASNYTFTTDIGTFDDRFVLRYTNKSLGIVNVDDME
QAVFVSVKDRIIKVTSIKENIKDVLIFDISGKLLYTKNKVNAIELQISNLQAVNQVLLVK
TTLENDYSSSTKIIF
>EGALAKHO_03589 hypothetical protein
MKNYLLNTSIFFQFWIASFLFSKGNEKRVLVTKLKLIVLLSFCSASLFAQPPHTYSSDNN
LFVPAGVTSMDVEAWGAGGGGGDASGATVDGRSGGGGGGGAYVKGQITVVPGTTLNIKVP
GISASGVNGGNATILGFESIFFAAGGKAGTANNSGGTPAGGKGGLNTASFGSIKTTSGVD
GGSGSTGLIGLLQGSGAGGKGGDAGGGAGGAGITSIVLGNTSGKPGSPPGGGGSGAMNSI
SLLGILGGPQVGGTGAAGQVNVNYTCPSYGISGVSASPVCSSSGNTTITLASSPASLPVG
VYTVTYNLTSPASNGLTITMNVLAAGSGSFDLLGFSTAGTRNISITKLTSGACSADISSN
NTASIVVSSPSVGGTVGGGTTICSGSTSGVLTLTVNTGAVLNWESSVNPFSVWTPIANTA
TTYTSGVLTQTTQFRAVVQNGGCSSIPSAATTVTVTPRPIPTFSAQPAATVCVNTDVTYT
TQNGQVNYIWTVPGIAGIDYTIISGGITATDSSVTLHWISEGNKTVTVSYSLNGCAAVIN
ASNTTSVTKTERGVVNGGLHICSGSASPLLTLHSYNGTIVRWEYAEAIPYVWQPINNTAN
TYQPGILTTSTSYRAVVKNGTCPEEFAIETRIDVDPKPSIPTLATIVQPNCVTPTGSIIL
NGLLATNWTITQDGTFPRLYSGLGNDFTISNLAPGTYSFTIQENSSCPSLPTVTVEIKAP
ITNIWNGAWSDGTPLNTESIEFAADYESDGNLEGCSCKVNAGKKVTINSGHTLSIENEVV
VESGANATLTFENNASLVQKNNVPNTGNIIYNRNSKPIRQADYVYWSSPVSGQTLAGVSP
LTKADKYYSYDGTKWVNVSKNDVMIVGKGYIIRGPETFSNADRGAFSASFTGIPNNGDIN
GEAVILNRFYLIGNPYPSALDADDFILGNNVLEGTLYFWTHNTPVVLGGAYEYASDDYAS
YNLSGGVRAAFAAESGDDDVDNNDDIPSGKIAAGQSFFAEVKTSGTIVFNNLMREGGTAN
SMFFKPGKNDKTTALQKHRVWLDMTNDRGAFKQTMIGYIEGATNGNDQRFDGTSFDGNKY
LDFYSINEGSNLVIQGRALPFADTDFVPLGYRTTISGEFTISIEQADGNLTNQAVYLEDK
KMGGIYDLRSGNYKFTTEAGTFADRFVLRYTNKSLGTNDIPDVQAGVIISVRDKVIRIQA
ANDVIKDVYIFDGSGKLLYSKKNIDQAELQISNLKSSNQVLLVKAILANDFIENAKIIF
>EGALAKHO_03590 hypothetical protein
MKKSLLILMVCVPFFLYSQTTTTFSFAGNQTFVAPAGVTSITVQAWGAGGAGGGTTDPGF
NATRGGAGGGGGAFASATFNITPGQTMQVVVGKGGAGSVGNGANGGFSRITEYAALISAA
GGLGGIRNNAGGTPLGGAGGTIAASVGTTRIAGSNGIDGATGLGISSGAGGNAANGGGAG
GAGNDDLFVSIDGVAGTAPGGGGGGSRSVAFGGNQLGGAGGDGKVIISYDCPNPPYSLTS
TTASAVNVCSGTSSEITLTGNLPIGLYAVSYEIQGVAQTPASMNVTTAGTGSFIASGFTA
VGTKFIKITGLSSGSSAIASENCNSAITTFNTASVIVNSSGTAPVATAVTAATCTQITAN
WQAVPGAVYYEFDLSTDSTFGSFVTGYSALNVGNVVSLTITDLTNTTYYYRVRAFNGTCS
SANSNTITHANPTTPLAPTTNTNGVATCSQITVNWTAVTGATTYFIDVSTITGANFNTGI
LPAYSNLNVGNVITKDITGLNASATYYYRVRASNNCGTGPNSTVRTIATLTLVNGTPAPP
NASAATNPTCSQFTANWASSIRTSSYSIEVSTSNTNMTAFNNNRLPAYTNLNVGNVTSFD
VVGLAASTNYYYRVKAINNCGTSGASGIISTGTTNGGTGTPPAPLATAGSGQNCSQITAN
WNASALATAYFIDVSTSVTAFNANILPAYNNLNVGNVLTKNITGLAVNTNYYYRVRAMNN
CGTSANSNVMTYNTISIPGTPTITATPTGASPLSICQTDGVKLTSSAASGNVWSTGETTQ
DIFVTSAGTFTVKVENGGGCSSNTSIPFTVNIDGLPTAVAGSLQTICSNQSTTVLGASAS
NGTINWTVSGGGTLNNYSIINPIYTPSLGGPGRTVVLTLTVTSNNSCTPQIATAKQTINI
QAAPTVLVSGSQEICSSGSATIGAGEATAADGTLLWTHDGTGSLTNATTLTPTYTAAPGD
AGKQVDLTLTVTASPICSTPYRVTGIYPVFVLANNTVTAASSSPILCINTLMTSITHTTT
IATGIGAPVNLPAGVSASWASNTITISGTPTQAGTFAYSIPLTGGCGPGINAIGTIVVNL
NEAGAASATPTVCNLTAMTAITHATTGATGIDTPTNLPPGVTAVWAADVITISGTPTSTG
TFNYNIPLTGGCGTANATGTITVNPLAVTPMLGTIIQPTCVNSTGSVELTGLLSGSALQI
IQDGPSPRTIPVTISGSTYEISNLAPGTYTFAIQEGVNCPSIPTVTVEIKAPITNIWRTS
GWSQISPPVFSESIEFADDYTSTGDLSGCSCKVDAGKVVTIKSGHTLSIDNAVIVDPAAG
TTLTFENKASLIQKNPDRNINSGNINYFRTTTPIRQADYVYWSSPVSGQKLSGVSALTKS
DKYYSYDGTKWVNASKNDVMIVGKGYIIRGPETFSNTARVAFSTSFMGVPNNGDINGETV
VLNRFYLIGNPYPSALDADDFILGNNVLEGTLYFWTHNTPVVLGGAYEYASDDYASYNLS
GGVGTAAALSGDDDVDNNDDIPSGKIGAGQSFFAEVTTSGTIVFNNLMREGGSDNSQFFK
PGKNAKTTALQKHRVWLNMTNDRGAFKQTMIGYIEGATNGNDKRFDGASFDGNQYLDFYS
INEGSNLVIQGRALPFTDTDFVPLGYRTTISGEFKISIQQADGNLTNQAVYLEDKKTGSI
YDLRSGNYKFTTVAGTFADRFVLRYTNKTLGTVDVKQVEQAILVSVKDKIIKVTSTKESV
NGISIFDVTGKLLYTKNKIGTTEFVISNLQSGNQVLLVKTTLENDHINTTKIIF
>EGALAKHO_03591 hypothetical protein
MVHAQQGKVDVTFNTIDDGSIGDGFDNAVRTLSLQADQNLIVGGDYLNLNGHSSPYLTRL
RPDGTVDEDFNIGSGFNGKIYATHIQPDGKIIVGGNFTAYNGVPVGRLLRLNTNGSLDQT
FNTLIGATTGIVYEITAQPNGNILIVGSFTRYNNVTVNRIARLLPNGSLDTSFMIGSGAP
VAINNVKVLSDGKILLSGNFTAFNGVQINRIVRLYDNGEVDITFNTGSGFDDDVNAIAVQ
PDGKIIAGGKFTSYNGITANRIIRLNENGTIDNSFVTGSGFSAGAVQAIKVDLLGNIMAA
GSFTGNYNGVSVNRICFLNQTGILKTEIDFGSGPASASVLALENDSEGSWYVGGTFSVFD
GLNQGRLAKITSDGEYDTGYLSAGIGFENSVYKILPLENGKTMVLGNFKKFNGTLASRIA
RLLEDGSLDVSFNTEKSGANNLIKTAANQLDGKIILGGNFTKYNDTDSNRIVRILADGSV
DPTFNFGTGFNSQIYALAIQPDSKIIVAGNFTKYNDGTAGRIVRLLPDGQRDNSFNTGLG
ADAVIEAVLIQPDGKIIVAGHFNTFNGNSFPRLVRLNDNGSIDTSFNIGNGFDKYVYTLA
IQSNQKIVAGGSFLIYNGVTQKRILRLNTDGSLDTTFNSGIGFSKGDVRSIIVQPDDRIL
VGGTFSGTYKNVVSLRLIRLQKSGDFDDSFDARLNNKLLAMTFTSDFKLMIGGDFNSVSG
SAKHRIARLKLCLDTTTWDGGSWSNGFPSGGKEVIFKEDYPSLTTANICSCSINEGKKVT
LVKENTLGIEFAYSGSGTLILENSAGVYQSDNDIVNTGIINLKRESSPIVKLDYTYWSSP
VANQKLVDVSPNTPSDKYFSYDYTVKNWKHENPSSPMIAGKGYIIQGPKTFSPTAASKYE
ATFKGIPNNGKVEVNIGDSESFSLIGNPYPSTLNADIFLKSNAAQIKGTLYFWTHNTPIT
KGQYASDDYAVYNLLGGVGTRGALASGVNETIPDEKIASGQAFFVSGKTSGTVEFNNMMR
MAEKNTTFFKPAKVQNDDAQVKVEKNRIWLNLKNSEGIFKQILLGYIEGASNAYDTDFDA
ESFNGNQFVDFYSIVENKELVIQGRALPFVESDSVLLGYSSTISGEFNLSIDHLDGLFSD
LDVFIEDKKLKIMHNLKDGPYLFQTQKGTYNDRFALKFSNVQLGTDDFEKDKKELLVSVR
DKSISVFSTKEFISEIDIFDVSGKLLFVKKKIDARELQISNLQSRNEILLVKTILKNGYQ
STKKILF
>EGALAKHO_03592 hypothetical protein
MTSTTSYRRYAKDGTCNTTATVSTGTWTVTVTPLPTVSPITGGSTSICSGANTPAFTSAT
SGGIWSIINGTPGSATISSTGVVTGGIAGTVTVVYTVTVSGCSNKATIALTINPNHAAPI
AGVPSRVTCTVGAFVSISNLPASGTLLQNDGTTITPITITGPTTIVTGLAPGTYKFAVDN
GCTITYSSDVIIKENTYNAGNWSEGTPTSTDLVNFESDYPINADVTYCSVRVSNGAKVTV
ASGKTLNVTNGVHVDSGTLTFEDSASLIQTTTSTTLNTGAINYKRKSVDIRLADYVYWSS
PVKNFKVGLVSPLTSAKFLYSNNGTNWVNEPKTKPMAQGKGYIVRGPDNITNDTRYPFEA
TFIGTPNNGDIHGEVVKKDLFYLVGNPYPSALDADEFLGRNHDILEGTLYFWTHNTPVVL
GGAYEYSSDDYATYNLSGGAGTGPAPSWDDAGGNNDNVPGPFIGAAQSFFTGIAADGQIE
FDNDMRELGSDNGQFFKPGKTDKKTALEKHRVWLNMTNAKGAFKQILVGYIQGASNGYER
FYDGTTLDGNKYVDFYSVAEGNNLVIQGRALPFTDADTVPLGYRSTLVGDFTIGIDHADG
KMNTQAIYLEDKKTGKILDLTAANYTFTTEKGTFNDRFVLRYTNKTLGTGDFENVENGLL
VSVKDKVIKVTSAKETIKEVTIFDVSGKLLFNKKKVSNTELQIANLQSANQVLLVKVTLE
NGFETTKKIIFN
>EGALAKHO_03593 hypothetical protein
MARVSVPTYNVPPDEALYHFKLSPVATKSFTFFASTEQIACAEAIGAEGIVLTITFTPVE
DALKQPEAFET
>EGALAKHO_03594 hypothetical protein
MRQIVCLEPIDIMVQTYFDFNRNLKKDFIFYSKSNLYIFSYLSYMLKTMLGSSAYNICIP
QIPFAYA
>EGALAKHO_03595 Epoxyqueuosine reductase
MTINSKETYSKFIKAEAKRLGFLSCGISKAGFLEQEAPRLEKWLKNNHNGQMAYMENHFD
KRLDPTLLVDDAKSVVSLLLNYYPAESQNQESFKISKYAYGQDYHFVIKEKLKELLDAIQ
ENIGDISGRAFVDSAPVLDKAWAAKSGLGWIGKNSNLLTQKVGSFYFIAELILDLDLEYD
YATTDHCGSCTACIDACPTQAIVAPYVVDGSKCISYYTIELKENIPYEMKGKFDEWMFGC
DTCQDVCPWNRFSKPHSEPLFNPNPELLSFSKKDWIEITEETFKKVFKDSPIKRTKFDGL
KRNITFLE
>EGALAKHO_03596 Pentalenene oxygenase
MSENRKYNYPNKLSIFRFFLDAEGVRKNPIPFHKKYFDKFGDSFSLKIGISKHLILSRDN
EIAQHILQKNQKNYYKSKFQSVYLSKYLGKGLLTVDGDFWLKQRRLIQPAFHKQKMNQLV
ENMNHTIISELDVLEEEKKVDLFPVMSQLAFNVVAKSLFELSISEEKLNRIKVIIEEVQN
FLIKEIRLPHKAWWFSATGQVKKHLELAEENNSIIRGIIEERISSNEEINDLLNMLLETR
YEDTGEGMSVKQLIDEIKVLFIAGHETTANALTFTLYLLGKNPEIQQKVFDEIIEIESQT
ENVVEQLQKMTYTNAVLNEAMRLYPPAWITDRQNVEDDNIGSFNLKKGTLIGVSFYELHR
NPKYWVEPNEFNPDRFLGEQKKKSMQYFYPFGAGPRMCIGAGFAIYEMCLTISHIVKKYT
IKSVNLDIKLNPLITLKPVGVEVIFSKR
>EGALAKHO_03597 hypothetical protein
MKHFVLFLLFAYFTSFGQTKHFSNLAYGKSSQQVLDLYIPNGNLKNLPVVILVHGGAWSM
GGLEYTAKHAEDICSQGFVVANVDYRYVSEKISGKDLLTDIEKAVTYVSDISEKYGYAKK
GYHIVGISAGAHLALLYGYSDKNVKSITALCAPSRLDSPAALEFIIKNGHLDIIEKLAGA
KLNINGDNTAFVAISPFNNISNVPTLLIHGDADPLVNFSQSQNLYNELKRKGVETKLIIR
EGKGHDVGMNSPDTEIQNIKDITEWIIKHNK
>EGALAKHO_03598 Holliday junction ATP-dependent DNA helicase RuvB
MNENLDPTTKGYNPEELDLEKRLRPLSFDDFAGQDQVLENLKVFVAAANQRGEALDHTLF
HGPPGLGKTTLANILANELEVGIKITSGPVLDKPGDLAGLLTNLDERDVLFIDEIHRLSP
IVEEYLYSAMEDFKIDIMIESGPNARTVQINLNPFTLIGATTRSGLLTAPMRARFGISSR
LQYYTTELLTTIVERSSSILKMPIALDAAIEIAGRSRGTPRIANALLRRVRDFAQIKGNG
TIDLEIARYALKALNVDAHGLDEMDNKILLTIINKFKGGPVGLSTLATAVSESSETIEEV
YEPFLIQEGFIMRTPRGREVTDKAYKHLGKLNTNIQGGLF
>EGALAKHO_03599 Alternative cytochrome c oxidase subunit 1
MSAEAHDHDHGHDHEHEHHHKDTFITKYIFSIDHKMIAKQYLITGIVMGVIGIAMSLLFR
MQLAWPEESFKIFNVLLGDKFAPDGVMANDIYLALVTIHGTIMVFFVLTAGLSGTFSNLL
IPLQIGARDMASGFMNMISYWLFFLSAVVMLSSLFVEAGPASAGWTIYPPLSALPQAIPG
SGTGMTLWLVSMAIFIASSLMGSLNYIVTVINLRTKGMSMTRLPLTIWTFFVTAIIGVIS
FPVLLSAALLLIFDRSFGTSFFLSDIYIAGEVLHYQGGSPVLFEHLFWFLGHPEVYIVIL
PAMGLVSEIMATNSRKPIFGYRAMIMSVLAIAFLSTIVWGHHMFISGMNPFLGSVFTFTT
LLIAIPSAVKAFNWITTLWKGNLQFNPAMLFSIGMVSTFITGGLTGIILGDSTLDINVHD
TYFVIAHFHLVMGISALYGMFAGIYHWFPKMYGRMLNKNLGYIHFWVTAVCAYGVFFPMH
FIGLAGLPRRYYTNTNFPLFDDLQNVNVLITTFALVGGAFQLVFLYNFFSSIFYGKKAVQ
NPWRSTTLEWTTPVEHIHGNWPGEIPHVYRWPYDYSNPNHDVDFVPQNVPMKEGEEVLHH
>EGALAKHO_03600 Alternative cytochrome c oxidase subunit 2
MTSLLVIIVLVLLAVALWQLTKIFDLTQVGSSSDDSQVASDNDNNVQGYVMFGFLAFIYI
FTIYGLLKWGHLVLHTPASEHGLLVDNLMNITWVLIFVVQFITQGLLYWFSFKNRGHKDK
KALFFADSNKLEAIWSIIPSVVLACLILYGLYAWNNIMFVDKDEDVIEIELYAQQFKWTA
RYAGQDNVLGKANVRLIEGVNTLGVDMSDPNAQDDIVVSELHIPKGKKIHFKMRSQDVLH
SAYMPHFRAQMNCVPGMVTEFAFIPTYTTSEYRELPFMVEKVANINKLRAEKSAELVAKG
GTALDPYTFDYLLLCNKICGASHYNMQMKVVVDTPEDYKKWLSEKTTLAQDIKAAAAAEK
PAEGVKPTTDSTAKDTVKAVIDTVKAVVAKVAMR
>EGALAKHO_03601 hypothetical protein
MYTFSSKLKTFSIILMALGILGIGYGFLTAPKNIEEVETLLAKEASEHGGGHGEAAAAHH
EVKAEATQHAETVEAVHSEETKAVIVEDAASKDSLAANEEITPEVKSEEAQETKAAVVHD
VKEDKHAEASAEHDPKAHAEHVLHQLQNKPWSALYVACIFFLLLSMGVLAFYAIQQVAQA
GWSPVLFRVMQGITAYLPVASVIFFIILILCGLHFNHIFVWLGEGVTDPKNPNYDEIIAG
KAGYLNFPFWIARAFVFLLGWNLYRHFSRKNCLAQDEANDDLNYKKNFKLSAGFLVFFIV
SESIMSWDWIMSFDPHWFSTLFGWYVFASFFVSGITAIALVTIYLKSKGYLEYVNTSHIH
DLAKFMFGISVFWTYLWFSQFMLIWYANIPEEVTYFVTRIQLYNLPFFGAVVMNFVFPLL
ILINTDFKRLNWVIVMAGTVILLGHYVDFFNMIMPGTVGDKWFIGVPEIASILFFLGLFI
FVVFTALTKAPLLAKRNPFIEESKHFHY
>EGALAKHO_03602 hypothetical protein
MKRIYKITLLVGITILVSSCHNNSAPNYQYFPNMYESVGYETYSEAKIFKGGKEGQLPVE
GTINRGFEPYEYENSTAGYELAKANLKSPLTEADRNSGKGKELFEIYCISCHGAAGNGKG
KLVEREKFLGVPSYKDRVITEGSIFHVETYGLNAMGSHANQLSAHERWLVADYVLKLKSQ
L
>EGALAKHO_03603 hypothetical protein
MSNKVIYAIYNDDDILMDAVKKTRAAHHHIEEVFTPFPVHGLDKAMGLAPTRLAICAFLY
GCVGISVATTMMSYIMIHDWPQDIGGKPSFSFIQNMPSFVPIMFEMTVFFAAHLMVITFY
MRSRLWPFKQAENPDVRTTDDHFLMEVAVNDNEAELVSFFEGTGAVEVKVIEKN
>EGALAKHO_03604 hypothetical protein
MSSHYEAPIRKPLVIGDKSYHDVTVDVAAPVEGPANKQWWIVFSIALIAFLWGLGCIIYT
VSTGIGTWGLNKTVGWAWDITNFVWWVGIGHAGTLISAVLLLFRQRWRMAINRSAEAMTI
FSVVQAGLFPIIHMGRPWLAYWVLPIPNQFGSLWVNFNSPLLWDVFAISTYLSVSLVFWW
TGLLPDFAMLRDRAVTPFTKRVYSILSFGWSGRAKDWQRFEEVSLVLAGLATPLVLSVHT
IVSMDFATSVIPGWHTTIFPPYFVAGAVFSGFAMVNTLLIVMRKVSNLEAYITLQHIELM
NIIIMITGSIVGVAYITELFVAWYSGVEYEQYAFLNRATGPYWWAYWSMMTCNVFSPQFM
WFKKLRTSIMFSFIISIVVNIGMWFERFVIIVTSLHRDYLPSSWTMFSPTFVDIGIFIGT
IGFFFVLFLLYSRTFPVIAQAEVKTILKGTGDNYIRERANKDSHHE
>EGALAKHO_03605 Menaquinone reductase, iron-sulfur cluster-binding subunit
MSSNKKYWKSVEELENSSIVEALRNNEFVEEIPTEEFLGNADALAQSGTSRRDFLKYVGF
STAAVTLAACEGPVHKSIPYVLQPEQIIPGVADYYATTVFDGFDFANLLVKTREGRPIKI
DNNTISGAKFSANARIHASILSLYDSMRLKEPKLEGKNSSWSAVDLKIKSSLADAKAKGG
QVVLLTNTLASPSTEKLIGEFIAKNPNAKHVVYDAVSSSDALDAFETVYGERALVDYDFS
KASLIVSVGADFLGDWQGGGYDAGYAKGRIPQNGKMSRHFQFESNMTLSGAAADKRVPMT
IADQKQALVQIYNIVAGASVAVTLDGNFKAEVVKAAQQLKAAGSKGVLVSGIEDKNAQLL
VLAINQVLASEAFNTAGTRQIRKGSNAIVSQLIKDMNAGSVHTLIMSGINPVYTLADSAS
FVSGLKKVKTSVAFSLKEDETASITTIAAPAPHYLESWGDIMITKGTYSLTQPTIRPIFN
TKQFQEVLLSLNGVPGNFYDYLKASSAGIIAGSSWNKVLHDGVFVIGSTALSAGSFDYTA
AASAVSKSRAAGDFELVLYTKTGMGDGQQANNPWLQEFPDPITRVSWDNYVTISNADAKK
LGLTNEIVANGGLNGSYATITTADGAKLENVPVIVQPGQAVGTVGLAVGYGRKAALKDEM
QVGLNAYALYKNFNSVQSVSIAKASGVHEFACVQGQKTLMGRGDIIKETTLEIFNTRDAE
FWNEKPMVSLDHQEVEATTVDLWESFDRTTGHHFNLSIDLNACTGCGACVIACHAENNVP
VVGKAEVRRSRDMHWLRIDRYYSSESTFEGDNERKENIAGLSSSLSTFNEMEKAGDNPQV
SFQPVMCQHCNHAPCETVCPVAATSHGREGQNHMAYNRCVGTRYCANNCPYKVRRFNWFL
YNKNTEFDYHMNDDLGRMVLNPDVNVRSRGVMEKCSMCIQMTQATKLKAKNEGRPVADGE
FQTACSNACSSGAMIFGDVNDTESKVAKLAADERSYHLLEHVGTKPNVVYHVKVRNT
>EGALAKHO_03606 Menaquinone reductase, multiheme cytochrome c subunit
MKKVGNHNSISRKLLLSLSLTLIFSLTSFAQDPAAAPAEPAAAAPAATSGGDPVKGKELF
NANCAACHKLDAKSTGPALRGVAAKHEMAWIYKWVHNSSEVIKSGDPVAVKLFEENNKSV
MTAFPQLAEADIDNIIAYTSEVKAEPAAGAPGSAAPPGTKVEEGGISNNIILGALALVMA
ILVIMLVMVNKVLTKVASKNGIEIPSREARTPIWKAFAKNQFLVLVTSIFLLLASGYFVY
AYLMQVGVDQNYEPIQPIHYSHKIHAGDNEINCKYCHSAARVSKNAGIPSLNVCMNCHKN
ISEVAESTATPEYSKAFYDAQIQKLYDAVGWDKTKQAYTGKTQPVKWVRIHNLPDFVYFN
HSQHVNVAGVECQTCHGPVQEFEIMKQYSKLTMGWCIDCHRKTDVKMEGNAYYDKIHAEL
SKKYGVEKLTAAQMGGLECGKCHY
>EGALAKHO_03607 hypothetical protein
MRILTPSKRVFLTFTMLTFAYNIHAQDQNLTVNQDPKFEQLLNDKRKINTSISTNDTYKI
QIFSGKSDEAKKTLSDFKRENSDIDGTIIFNTPNYKVIVGNFKTRIEAERNLAEIKKKYK
LVFLIKPSK
>EGALAKHO_03608 Fosmidomycin resistance protein
MTNVKTQPEVVQKTIYSILFIISFSHFINDLLQAVIPSVYPLFKEKFNLSFTQIGMITFT
YQLTASILQPFVGMYTDKKSKPYSLVVGMTFTLVGLFFVSIADSFSYLLIAVSLIGIGSS
VFHPESSRVAHLASGGKKGLAQSIFQLGGNAGSAVGPLLAALIVIPHGQSYIVWFCAVAL
IGIFALYRIAIWYTDHLELKRKNKAVSNEGIVHQLSKRRVWLSLIILLVLIFSKYFYMAS
ITSYYTFFLIDKFHLSIQQSQIYLFVFLGAVAAGTLMGGPIGDKFGRKYVIWISILGVAP
FTLMLPYVSLFWIGILSVVIGLILSSAFSAILVYATELLPGKVGLVAGLFFGFAFGMGGL
GSAILGKLADLTSIEYVFRICAFLPLIGVIAGFLPNIESKKV
>EGALAKHO_03609 HTH-type transcriptional regulator NimR
MNNDYQTYLVVEYGFQINPSLPVLGYTEKITDAICASHSHPRAQLLYATSGVMNVVVKNQ
IWVVNPLQGLWIPGGIEHQVSFQKNVKLYSVFIDPSFTNELPSNSFSFDISIFLKQLMFK
IISFENNENPTLSQKRIMDVFLDELALIKPSSTFLPTSNHVKLQNIISLLINDIASKYTI
DHYADLSFMSTRSLSRLFIKELGMNFSDWRIRLKLLEAIKRLGEKQSIKEIAFDLGYETT
SAFIFMFKKNLGKTPSNYILENKINESF
>EGALAKHO_03610 hypothetical protein
MKLVIYSILLCVCFSTFSFSQEAVEKKSPPAGNAIIGDYYGADVSKAAESKAISVEKLET
KLKDEKKVENVAVKGQVTDVCEKRGCWLTVKTEDGSPFFVKMKDYAFFVPTSLKGKNVVL
EGNAEKMVTSVDELKHYAKDAKKSQAEIDAITIPKGEVRFLAAGIKVVE
>EGALAKHO_03611 Translation initiation factor IF-2
MSEERVIRINKVLRELNISLERAVDYLKDKGIAIDANPNAKISDSEFNILQSQFAGDKGN
KEASKEVGEEKRKEKEALRVEREKEIEDKRRQDEERQKQQEIIKARAVVTGPVQVGKIDL
NPKKPAIVSAPVEEPAKAEEPKAVVTPAQPEKPVQKEVVQPEPVAPVVSEEKKVEKPIIT
EKKEVKVEAPKVVAQEPVVSTDPATAEETITTQYQKLSGTTLTGQTIDLSQFNKPKKKKE
DPKIVPNKPGAPGAGNNANKNKRKRIAPKPGTPGAPKPATGNAPGTPNPNKITPNTGGGG
FNANRSARPGFVKGNRPAIVAKVEPTEEEVKNQIRETLEKLQGKGGKSKAAKYRRDKRET
HRQKSDDEQRALDEGSKTIKVTEFVTVGEIAIMMDVPITKVIGTCMSLGIMVTMNQRLDA
ETLTIVADEFGYEVEFITVDIEEAIEVVEDKEEDLVVRAPIVTVMGHVDHGKTSLLDYIR
KENVIAGESGGITQHIGAYGVTLDNGQKIAFLDTPGHEAFTAMRARGAQVTDIAIIVVAA
DDDIMPQTKEAISHAQAAGVPIIFAINKIDKPNANVEKIKERLASMNLLVEDWGGKIQSH
DISAKVGTGVKELLEKVLLEAEILDLKSNPNKAAQGTVVEAFLDKGKGYVSTILVQHGTL
KVGDYMLAGKHHGKIKAMHDERGHIVKEAGPSTPVSVLGLDGAATAGDKFNVFEDEKEAK
QIASKRSQLMREQSVRTQRHITLDEIGRRIALGQFKELNVILKGDVDGSVEALSDSFSKL
STEEIQINIIHKGVGAITETDVMLASASDAIIIGFNVRPAGNARQLADKEEIDIRYYSII
YAAIDDLKDAMEGMLAPEMKEEILGTAEIREIFKISKVGSIAGCMVMDGKIMRTSKIRVI
RDGVVVHTGELVALKRFKDDVKEVSKGYDCGIQIKGYNDIEERDVIEAYHEVAIKKKLK
>EGALAKHO_03612 Transcription termination/antitermination protein NusA
MENLALIDSFSEFKDNKLIDRVTLMAILEDVFRNALKKKYGSDDNFDIIINPDKGDMEIW
RRRVIVADEDLDFENEEITLTEARLIEADFEIGEEVSEEVKLIDLGRRAILALRQNLISK
IHEHDNTNLYKQFKDIIGDIYTAEVHHVRPRVVILVDDEGNEIVLPKEKQIPSDFFRKGD
NVRGIIESVELKGNKPQIIMSRTSEKFLEKLFEQEIPEVFDGLITVKNVVRIPGEKAKVA
VDSYDDRIDPVGACVGMKGSRIHGIVRELGNENIDVINYTSNIQLFITRALSPAKVSSIK
IDEENKRAEVFLKLEEVSKAIGRGGHNIKLAGQLTGYELDVIREGDVAGATADEDDVELT
EFSDEIEDWVIEEFAKIGLDTAKSILKQEVEDLVRRTDLEEETILDVMKILKEEFDN
>EGALAKHO_03613 Ribosome maturation factor RimP
MRGLSVPSFYKIMTFKEKVNGLIAEALLEKPSIFLIDLSISDSFKISVGLDGDNGVALQD
CIDVSRAIENNLDREEQDFSLEVASVGVGSPLKMTRQYKKNIGRTLIVTTNTEKIEAELV
EANDVFIILSWKAREPKKVGKGKETVQKEQQIPYTEIKEAIVTVTF
>EGALAKHO_03614 TRAP-T-associated universal stress protein TeaD
MKRILVPTDFSEHAEDALKVAAQIAKKNDSEIIVLHMLELPHQMNDAILGGASIPETMLF
MKKANEMLDTISSRPYLDGIPLTEIVKMDKPIHGITQVSKDYDVDLIVMGSHGSSGVEEL
LIGSNTEKVVRNSEIPVLVIKKDISNFNVSNIVFASDFSAETKKPFEKLLNFTKFFESKI
HLVTICTPNSFKPTHVIEKAMRDFIIEFNITNYTTHIYNDTNIEKGIINFANSINADIIG
MCTHGRTGFAHFFNGSISEGLVNHAIRPVITLKI
>EGALAKHO_03617 hypothetical protein
MAQFNFNKWNTIIGWFAFAIALTTYTLTVEPTMSFWDCGEYIATAAKLEVGHPPGAPLFQ
MMGAFFAMFAIDNQHIAVMVNMMSVFSSAFTILFMFWSSSMILKKIVARFAEIDQNNSIV
ILGSSFVGALAYTFSDSFWFNAVEAEVYAMASLLIALLFWLGLRWEQDMDKPKGNKWLLI
ISLVVGLSFGVHFMALLTIPAIGFLYYFKHYEKVTIKNFIIANAVVIAILLFIFKLLLPL
TMAFFGKTEVFMVNSMGLPFNSGTIFVALLFIAFFYFGLKYTKQKGLIFYNTIILCVLFI
LIGFSTWIMLPVRANANTVINENKPSDATEVLAYYNREQYGVNPLFYGPQYTEVFSGLDE
KTPYLDKKPNYERDYKTGKYIITNNYKNADQNSDDNQKTILPRMWSTETGHIQNYISFTN
PPAFKINPNYPYEDDLAKYGIDASQLSEEEYNKATGQLRNEVEKTVSEFRKAYAQKQIDN
EGYVKFLNSYKDYLIIEKPSTADNFSFMFEYQFGYMYWRYLMWNFVGRQSDEQGKYDNLD
GNWISGIKALDSLHLGSQDNLPSDVLNNKGRNVYFFLPFILGLIGIMYHANKDLKSFYVL
LALFLFTGIALKIYLNERPFEPRERDYALVGSFYVFAIWIGFGVYSLYESIQKYIAPKIA
GPIIIAATFLAAPILMASQNWDDHDRSNKYTAVAMAKAYLNSCDKNAILFTIGDNDTFPL
WYAQEIEGIRTDVKIVNTSLFMTDWYIDQMKAKSYESDPLPISFNHDEYVGDKLDYVAYI
QKIDTRWNINDFISFIKNPKSTVGLQNGQTIHFYPTNKIRVPVDKNLIIKNKVVNPKYND
SIVPYMDIDIKGSAIYKNRLMMLDILANNNWKRPIYFSGGAFDDEDYLWLKDYLQLDGMV
YKLVPIRNVPSKDGGPMDMGQIDANKMYDIVMKWDWGNSDSDKIYHDPETRRNSITYRTN
LSRLSEQLIAEGKIDKAKNVINLAMTKLPVDKYGYYSLVEPFANGYYKVGETAKAHDLLN
KLVQKYKENLNYYATLTPVDQTDLAMDIITDIERYRSLLQVMEHNKDKAFYEKHKVTFNT
YVNVFERFGREKE
>EGALAKHO_03618 Peptidoglycan-N-acetylglucosamine deacetylase
MSFYWVKTNSFIKRVFSKYCWDIPNQEKKIYLTFDDGPTPEVTDWVLSELKKFDAKATFF
CIGKNINANSSLFERLIAEGHSIGNHTMNHINGWKSQTNDYIENVKNCASILSNEKRLNG
LLFRPPYGKIKKGQSKILRNLGYKIIMWDVLSADFDQSITPEKCLENVTKNVQSGSVIVF
HDSIKASHNLKFALPKTLHFLKENGYKFDIIH
>EGALAKHO_03619 Thioredoxin-like protein
MSKFGELINAQVPVLIDFYTDWNESSVSMHPVIKDVAAALGDKAKVIKIDVDKNQELAEA
LRIKGLPTLMIYKEGQMIWRQSGELDANTIIGIVQDQFNI
>EGALAKHO_03620 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MILRFVILCALFLFIEFYSYQAFRTLIKLRWVLISYQIISLLILIFIIYSFSQVDRSVGQ
TKQFMFTTGLMLLVYVPKIVMTLILFGEDIFRIGASIFNYFIYNTPRKEMMPDRRKFISQ
IALGLAAIPFLSLIYGIFEGKYNFKVIKQTVFFPDLPDAFDGFRITQISDVHSGSFDNPE
KINYAIDLINEQEADMILFTGDIVNTHAKEMHPWLETFNRIKDYKYGKFSVLGNHDYGEY
VTWPSEKQKDENFQEIKKLYGQIGFKLMLNEHTYIQKGEDKIALIGVENWGVNFKKAGDL
NKASQNVHQDDFKVLMSHDPSHWEAEIKNHPKNFHLTLAGHTHGMQFGIEIPGYFKWSLA
QYIYKQWAGLYENVGRYVYVNRGFGFHAYPGRVGIMPEITVIELKKGNNVA
>EGALAKHO_03621 hypothetical protein
MKKLVMLAVAILGTTAMVSAQTTPAQTAPAKEAKVSKKDKKADKKAKKAEAKPEAAKAQK
>EGALAKHO_03622 Alkaline phosphatase synthesis sensor protein PhoR
MKIKHQLAIFNALTRLLVILVLWLMLPILVENVVYRHINNGLVEKKEKFIDHLNKKEIND
FIENSDDSTETYSQFSTLHSEFLVLSKITGKPHQKKTTFSNDYRIIEGEENEYRILQYHF
TYENQGYQLEIGSSLSEVNDLTFIIRLFIIIVLVVILLVTFLADTVYIEYLLKPFYKIID
TKIRRVNEPEAFDHTPINAKSRDFRELDLVLNQMMDRIGELFKKEKQFISNVSHELLTPI
ALLKNKFENLLQNDSLDDNAIDKIAGALRTLDMLKKIINNLLLISRIENNQYEANEKINF
KEILNDLQEDLQDRIEDKEIQFSNQIEHDFIFTGNKTLIHILIYNLVTNAIKYNKPKGRI
VVEDGFNNSQYFISIKDSGIGMNAAQIEKVFNRFARISSDQDGQGLGLAIAESIAVFHRI
EIKVMSEINEGSCFTLLFPEVHLHN
>EGALAKHO_03623 putative transcriptional regulatory protein YedW
MNILIVEDNKELAVEVYDFLCNVGYICKIANNCSDALEEVGSNDYDAMLLDLGLPDGDGF
EVLKTIRKTKSKMAVIVLTARGELDDRINGLHLGADDYLTKPFALTELSARLFAVIRRIH
GFTLNNLEVHGFLLQLQDYKVSYGEIPINLTKKEFDIFQYLVLNKNRVITRLQLTEHIWG
DILEVNSDSNFIDVHVRNLRKKLDKHTTIDWFETVRNVGYRINE
>EGALAKHO_03624 hypothetical protein
MRNLLMLLVAVLGTSVMVHAFPPAVKVGPAKEVKELPAKEVKATKHPKNKADKKTKSAKT
EAPKAETTKVKK
>EGALAKHO_03625 DNA polymerase I
MSTQKRLFLLDAYALIFRGYYAFIKNPRINSKGMDTSAIMGFMNSLLDVIKREKPDHLAV
AFDKGGSHVRTEMFVEYKANRDATPEAIKIAVPYIQELLRAMHIPIIEIEGCEADDLIGT
IAKQAEKENYKVFMVTPDKDFAQLVSENIFMYKPARMGNGIEIWGVPEVLAKFEIERPDQ
VIDFLGMMGDAVDNIPGLPGVGEVTAKKFLKEFGTMENLLDNTHLLKGKMKENIEANKEK
GILSKKLATIICDCDVTFNEDDYELSRPDIEKTDAIFQELEFRRMAEQFDNLFKVGGGNE
LAASATPASDAKLYKKPQPKNEDQFDLFGGGATTDENSETERTSFYNTLENTPHSYQLIQ
GDLGTKLLLQNIQNQTSVCFDTETTGLDALHAELVGIAFSYEKGKGFYVPFPESQEEAQV
LIEKFRPFFENENIEKIGQNLKYDLKILSNYGITVKGKLFDTMIAHYLINPDMRHNMDIL
SETYLKYSPKSIETLIGKKGKNQITMRDVALEDIKEYAAEDADVTFQLKELFTTELDKTE
TKKLFDEIEIPLVTVLAAMETEGIRLDVDFLKQMSTEMEVEIKSLEQKIYETAGEKFNLA
SPKQLGDVLFDKMKIGGAKQKKTKTGQYATGEDVLMYLANDNPIIKEILDWRQMVKLQST
YILALPEQVDKKTLRVHTDYMQTVAATGRLSSNNPNLQNIPIRTERGRQIRKAFVARDEN
HTLISADYSQIELRIIAALSGEENMIAAFKNGEDIHKATASKVFDVPLEEVSREQRSNAK
TVNFGIIYGVSAFGLSNQTSLSRSESSALIEAYYKTYPRLRSYINEQIEFARENGYVQTI
LGRRRYLKDINSANAVVRSAAERNAVNAPIQGSAADVIKIAMINIHKKLTEENWKSKMLL
QVHDELVFDVHNDELEKIQPMIKHEMENAFMMSVPLDVELGMGADWLAAH
>EGALAKHO_03626 Catabolite control protein A
MKAKATLKQIAKELGVSVSTVSKALNDSPEISEQTKVKIKEYAKLKNYKPNVIGLNLKNR
KTKTIGVIIPNILNSFFAKVFSGIEKVADKKGYNVITCISNESLEKEIHTLEMLSNGTID
GFILSVSEEAQKLQDYSHFSAIINDGTPIVMFDRIADEVECDKVVVDDFDSALNSTQHLI
NLGCKNIALISSVDNLSVGKLRADGYLKALADNNIPVNEKIILRTDSEEDMKSKIDAIFD
NKIDAIFALDENDSVAALRVSLKKGYRVPEDISIIGFADGILASRRLSPSLTTVSQHGIE
IGEVAAKKLIERLEESEDETSDYETIVIKTKLKERESTRKA
>EGALAKHO_03627 hypothetical protein
MKNEVKIHEVDPSLNNRRSFLKLSGLTLVGAGLVLAGCSDNDNEDNMQDNTLPGIKNGVF
DLGSGDFGVLTYAYALEQLEADFYTKVVNASNFNSTFNDIERQVLTDLYHHEVVHRDFFK
AALTGALPDPSSQLLPSLAFNYGSMNFNSRTEVLATAKALEDTGVAAYNGAGKLIKSADY
LLLAGKIVSVEARHASAIRSLINPNSSDFAGDDVVNTSTGLDVASDPSKILPIAGGFITT
KFTAKYLP
>EGALAKHO_03628 hypothetical protein
MNILKFIETFTDDSLMNSTGSRRDSFNQFGNIGKNLAMAAIPFGLSAFANKALAKDITAT
PATPIGALQFALTLEYLENEFYAMALDSGVIPASENGGRDRKVFQQIAAHESDHVKFLIA
GLGGTASANFVPKPTFDFTVGGAFNPFGDYPTFLALAQAFEDTGVRAYKGQAANLITTPD
LLTAALQIHSVEARHASEVRRLRGLKGWISNAERGAGMPAATQAVYDGEGVTMQAGYNTA
SLFGAAAGSEAYDEPLTTQQVVDIANLFIV
>EGALAKHO_03629 50S ribosomal protein L13
MDALSYKTISASKATVTKEWIVVDAEGHNLGRLASKVAMILRGKYKPSYTPHVDCGDNVI
VINSEKINLTGTKMNDKIYMRHTGYPGGQRTLTAKVLQSKNPALLVEKAVKGMLPKNKLG
AELFRNLNVVVGAEHTHGAQKPRTVNLNDLK
>EGALAKHO_03630 30S ribosomal protein S9
MGVIHKIGRRKTAVARVYVSEGTGKITVNKKEFATYFPTATLQYKVLQPMSMTENVNNFD
VKVNVYGGGSTGQAEAVRMALARVMCEVNAENRAILKPEGLLTRDPRMVERKKFGQKKAR
KRFQFSKR
>EGALAKHO_03631 30S ribosomal protein S2
MANKIEVKDLLEAGVHFGHMTRKWDPNMAPYIYMERNGIHIINLYKTAAKIEEANEALKK
IAASGRKILFVATKKQAKDIVAEKAKAANMPYITERWPGGMLTNFVTIRKAVKKMSSIDK
MKKDGTFMTLSKKERLQVDRLRAKLEKNLGSIADMSRLPAALFVVDIKAEHIAIKEAQKL
NIPVFAMVDTNSDPREVDYVIPANDDASKSIDKILSLVTAAVIDGLSDRGSDKEAEVFTE
EAPATEAAAPAVEAAPAVEAAAPATEE
>EGALAKHO_03632 Elongation factor Ts
MATITAADVNKLRQTTGAGMMDCKKALVEADGDFDKAIQNLREKGQKVAANRSDRESSEG
AAVSFINADNTKGAIITLNCETDFVGKNEAFVTLAKELVERAINFSTKEEFLASDFNGIT
VAEKLIEQTGVIGEKIEIGGFEILEGAFVGSYVHVNKIAALTAISAAIPNADVLSKDVSM
QVASMGADTLSYKDFDPAFVESELAARIAVIEKDNEEAKRLGKTLKNVPKYISYSQLTEE
VLKQAEEDAKAELKAEGKPEQIWDKIIPGKVQRFISDNTTLDQEKALLDQNFIKDDSKKV
GDYVKGYNVEITGFKRVTLG
>EGALAKHO_03633 Dipeptidyl carboxypeptidase
METNAINFLIKKWTGPYGGVPAFNEYKVSDFKPAIEFAIQERLGQIDAIANNLEEVNFEN
TIVALELAGKTLNQVQTVFGIYRSNLSSPEFNDVDTEMSPRLAEVNNKMYQNKKLFSRIE
KLYKSDAKEKLNDEQQRLVWLYYTDFVREGAELSEFDKEEVAKINQKLAGLFTLFSQKLL
AEENDQFLELRSEDDLNGLPEAFKNAAIAEAKERKLNVLACIGNTRSSIEPFLTFSNRRD
LREKAFDIFVKRGDNTNENNTNETLVSILQLRARKAKILGFDNFAQWSFSNKMAKDPQKT
LDLMESVWKPAVEKVKNDVASMQEMVDKEGGNFKIQPWDYRYYAEKVRKAKYDLDQNELK
PYLQLENLREGMFWVAGELFDLGFKQVFDVPVYHPDVRVWEVNNKGIGNPIGLWYFDPYA
RQGKRSGAWMNSHRKQQKIEGNVLPIVSNNCNFIKGAADEPVLISWDDATTLFHEFGHAL
HGLCSNVTYPSLSGTAVARDYVEFPSQLLEHWLATPEVLNKFALHYKTNQPLPTILVERL
EKAANFNEGFATVETISSSFVDMKLHLTTETINPHKFENDVLQEINMPSEIVMRHRIPQF
AHIFSSDGYAAGYYSYLWADVINADAYEAFLEGKGPYDKEISKRLYDAVLSVGNTIDNEK
MYENFRGRVPESNALMRARNFPAV
>EGALAKHO_03634 hypothetical protein
MKKLLYISLLITSVLQAQNKSLFWEISGNGLTKKSYIYGTMHVNDKISFHLSDSFFTNLL
GSDIVANESNPETWGDLNDLMKSNDFNSYKKFYTEFYLFPTTKENIQTIFINDNGKYFRN
MLSGAEGDQADFQEDTVLDMFIFQTGKKYKKKIVGLEDAKESMLSILKIIDEDAKPKEEN
KLALVKILKNRNPQEVLKEYYREKDIIMLDSIYKLIFSKKAHDALIVNRNKVMTKSIDSI
AKTGSLFSAVGAAHLAGNDGIITLLRQKGYTVKPIIDTFTENGKNQKKTIEAYFPNPNFT
VSNTKDKMVQLPLYKTTIEENESMGSPDFTNGGAITIKRIPLNYFLKNNNITYNPKSLDS
LFFEKIPGDIIEKKYVEQANYTSYDIKNITKTGNAQHSKFYITPLEIISIAMTGPANYVR
QYENEVFENIKIKPFKNEWEKIKPLKGGFEAEIPSFNFVFGNSAEKGTNIDIQAYDNQEK
GFYFLREKTLNDTSFLENSEYEQKQIHYQFYLQQNQDSTATKYNKIDNSFVSSSKIGDRN
IKLKTIISGNKYYLLGSVNTCEENTNRFFNSFLLTPFDYKPKSKVLVDSTANYKIEIPEK
ENENLFLKLNKNKRETKNAFKVVNQFQAFNSETGRKIKLAYHKFPKYERTLSIDSVQRML
KKEFLNQYESDLEQNYFEGEDEENYETATSLLSPELFLKKGFSQSLWDEILADKKDNYEF
LSESTTFNKDQNSYIINALISKPNATQAVKYKVLYKDNTYYLLNTLVEKNYKNDDPFIEK
TFNSLDLVDNIKTYTTEDKVKLFIEDAKSEKDTIRYSALNTIDNLDITKNDFEAITNFIN
TFNFKESETDAITSLLEKIGKIEDERVIPYLENYYKKESTKTDVQISILKSISHQKSKAA
YKKINELLEYDLPISDLQYEIGSLFYTFERDPENSKELFPEIFQYYSIKEYNKPIISFCN
SLLEKKLISVKKLKAFKKIILTNTKLEYKRVASWNEKNKATQEAATAEDEVAFYSESSRS
LTDLINYTNLIYNYADDTAVKEVLKKIKNLDIPELNIELARLGITHNALNTTEIEGFIKD
PKTQFITINLLLNQNKKDLIHFTDEEIAKSAAINFQNLSKKDSITLLKKQIVEKDNHEIS
FYFYQIQRKNDETKAVKKQLYTIAFLNENKKINPLAYTTSPIKTISIEEDPEKTYALIIN
ETLNGDHMRASFEKEKEEEELSLGEEY
>EGALAKHO_03635 Inner membrane protein YhhQ
MFKTKKEIVFVILAGIFITNAVVAELIGGKLIQIGPFVMSIGILPWPVVFLTTDLINEYF
GEKGVKKLSFITACLIAYAFLILFMAIVIPAAKGISPVNDEQFQAVFGQSMWIIVGSIIA
FMVSQLIDVSIFWFFKNRTGDKKIWLRTTGSTVISQLFDSFIVLGIAFWLPGKIDFDTFL
SSALIGYTFKLSIAILLTPLIYAGHHLIKKYLEGDISHKD
>EGALAKHO_03636 hypothetical protein
MKKTNVILLFSICCFLYSCGSDDKKQPNDKVYPVSSLKPAPQKPLDPTPAKIAVAKDSDD
KSPLNKKKAFTVNKPIVTPEIPAAKITTAEKAPTPAPEKKEEDLMSFVNLRKIFSGTKIG
QTMSQKDLTQNFKIPEEAVKLVKSVTRTAHDELNVKWRSTWLVEKVSDAELEDGKMKVRF
QANKMFMSGKAIGIKYNRKVYNDLIIIGHSAYIPSVKGYHWQIGK
>EGALAKHO_03637 DNA-3-methyladenine glycosylase 1
MENEDLIRCGWCTSSDLYKKYHDEEWGVPVYDDPTLFEFLILETFQAGLSWITILNKREN
FRNAFDHFDYKKVAHYSEDKVEELMQNTGIIRNKLKIKAAVSNAQAFMKVQDEFGSFSDY
IWKYTNGKPIINNLETSKDAPATTPLSDEISKDLKKRGFKFVGSTVIYAHMQATGMVNDH
AEDCWKRAK
>EGALAKHO_03638 Sulfur carrier protein ThiS
MELKINQQIKKFNAESLSVQSLLDLEIPNKQNGIAVAINNTVVPRINWNQHLVQETDEIL
IISATQGG
>EGALAKHO_03639 Phosphomethylpyrimidine synthase
MTTEEQISRTPFPNSKKVYVNGEIHPIKVAMREVILSDTKLSNGGIEKNPPVTVYDTSGA
YTDPNIEIDIRKGLPRLRESWILDRNDVEILNEITSDYGQTRLKDESLNHLRFEYLHQPK
RAKKGANVTQLYYAKQGIITPEMEYIAIRENQRIELLNEQTKAMQCQHAGHSFGANTPKS
KITPEFVRSEVACGRAIIPNNINHPESEPMIVGRNFLVKINANIGNSAVTSSIEEEVEKA
VWACRWGADTIMDLSTGKNIHETREWIIRNSPVPIGTVPIYQALEKVKGIAEDLTWEVFR
DTLIEQAEQGVSYFTIHAGVLLRYIHLTADRVTGIVSRGGSIMAKWCLFHHKENFLYTHF
EEICEIMKQYDVAFSLGDGLRPGSIADANDAAQFAELETLGELTKIAWKHDVQVFIEGPG
HVPMHMIKENMDKQLEHCKEAPFYTLGPLTTDIAPGYDHITSAIGAAMIGWYGCAMLCYV
TPKEHLGLPNKKDVKDGVITYKISAHAADLAKGHPGAQYRDNALSKARFEFRWEDQFNLS
LDPDTAREFHDETLPADGAKVAHFCSMCGPKFCSMKISQEIRDVAAAEKGMQEKSEEFIE
QGKEIYI
>EGALAKHO_03640 Thiamine-phosphate synthase
MIVITNPSAISGEMSIIDSLLEEGLSLLHIRKPEFSAVEMAHFIDKIKVEFRSHLVLHSH
HELAEGFGINRIHLSEKDRKHSHDFPAKFSKTCRYSTSTHSIEDFNSLEKDFEYAFLSPV
FKSISKEDYFPEKDLFEELKSKTNFNTKVIALGGIDFENIKKTLKNGFDDVALLGSIWNS
ENPVKQFKLCQQIAHSYLA
>EGALAKHO_03641 Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase
MSANRPFVLSIAGFDPCGGAGVLADVKTFEQQLVTGFAVVTANTIQTEDGFYEIQWTNLS
FVIRSIETLFLSYKIKTVKIGIMPSLHYLNRILSTIKLLSPTTKIVWDPVLKSTTKFEFL
KVEEDTDLNKILSKIDLITPNYNEIEILFPGFVPNKLWLQNEIPTNILLKGGHNESQIGT
DRLFLKNQIIELAPSQKKCFEKHGSGCVLSAAIAANLALDQTLEEACKNAKTYIEKYLSS
TSTLIGYHYVQ
>EGALAKHO_03642 Thiamine-phosphate synthase
MYNKLQYISQGKTIEEQLYNIHHALDAGCDWIQMRFKNQTAKDTFALAEAVKFLCEEYLA
NFIVNDNLYLAQQIAADGVHLGLTDMNIAEARAILGNTKIIGGTANTFEDIENHVKNGCD
YIGLGPFRFTDTKEKLSPILGLSGYYTTLQKIKNSKIETPVYAIGGITLNDISPLMETGI
HGIAVSGMITKSDQKEKLIQQLNEKLYANVIV
>EGALAKHO_03643 Thiazole synthase
MQTSLFNIGDKSFKSRLFLGTGKFGSNIQMEEAILASESELVTVALKRIDLETDTDVILS
HLKHPNINLLPNTSGARNAKEAVFAAQLAREALETNWVKLEIHPDPKYLMPDPIETLRAT
EELAKLGFFVLPYIHADPVLCKHLESAGTTAVMPLGSPIGSNKGLKTIDFLEIIIEQSTV
PVIIDAGIGSPSDAAKAMEIGADAVLVNTAIAVAGNPKLMAEAFREAVIAGRKAFEAKIA
NQQNHANASSPLTSFLYE
>EGALAKHO_03644 hypothetical protein
MMSENEISYKIRGAIFKVYNNLGPGLLESIYESALYYQLKKDGLNVVKQMEIPVKYEEVI
LDISFRLDLLVEDKVIIELKSVDELKSIHFKQLNSYLKLTDKKLGLLVNFNCTNILDNIQ
RVANKI
>EGALAKHO_03645 2-iminoacetate synthase
MKTFKSVFDNYNWDSIQSKIYQTTSQDVERALKKTKRNLDDFLVLISPIAQNYLEQMAQQ
CHELTKKRFGKTIQMYAPLYLSNECQNICTYCGFSLDNKIKRKTLTDPEIKLEVEALKNV
GFDHVLLVTGEANYTVNINYFLNAIALIREQFSIISVEVQPLSTEDYERLHEAGVYSVLV
YQETYHQEVYKKYHTKGKKSNFDYRLETPDRIGTAGIHKIGLGVLLGLEDWRTDSFFNAL
HLDYLQKKYWQTKYSVSFPRLRPAEGIIEPNFIMDDKDLTQLICAYRLWNEDLEISISTR
ENEKFRNNIIPIGVTSMSAGSKTNPGGYVVDPQSLEQFEISDERSAEEIAQIITNSGYEP
VWKDWDRTFSQKSESRKS
>EGALAKHO_03646 putative adenylyltransferase/sulfurtransferase MoeZ
MSIIQEFLRYNRQTILHEIGDEGQEKLKKAKVLVIGAGGLGCPVLQYIATAGVGYIGIMD
FDTIEIHNLHRQILYTENEIGQEKALVAKEVVSKLNPLIEVEAINAKLTSENAATIIQQY
DVIVDGSDNFATRYLVNDTCVEFHKPLVYGSILKFEGQVAVFNHNGSKNLRDLFPEMPDP
KEVPNCNLNGVLGTLPGIIGTMMAHETLKLILELPTLKNELVLFNTLNWGFTKLNF
>EGALAKHO_03647 hypothetical protein
MSAMYVVKEIYIYPIKSLAGISCENAKAEEMGFENDRRWMLIDADNQMITQREHRIMSQF
YPQISDGKISITFKDQKHEFSIDENLENAIKVNVWDDKSEVVEVNQTTSKWFSEQLGFEC
KLVKIIKNGDRKHESSRLKETFNVSLADGYPYLLIGTESLDFLNDKLAEKITIKRFRPNI
VISTQKEHEEDDLDTFKIGEVQFKNVKPCGRCIMVNNDPANGRLKKEPLKTLSKYRNVNN
SVLFGTNIVSLNSGVISVGDAVVF
>EGALAKHO_03648 Leucyl/phenylalanyl-tRNA--protein transferase
MYYLFENIAFPPVSEADEEGILAIGGDLKPERLKLAYQSGIFPWFNEGEPILWWSPDPRM
VLFLDELIVSKSMRNVLNRNQFKVTFNQNFEDVISNCQKIKRDGQDGTWISNEMIEAYCK
LHAEGIAKSVEVWQGEVLVGGLYGIDLGDVFCGESMFSKISNASKVAFIALVNKLKKENY
KLLDCQVYNPHLESLGCREIDRDEFMSILKSK
>EGALAKHO_03649 hypothetical protein
MEVTGKVKVVNPEQQVSAAFKKRELVVTTDEQYPQHILIEFTQDKCDLLSSYKQGEAVKV
SINLRGREWVNPQGETRYFNSIQGWRIERLAPEGPAQTAPMPAAEAFAPATNLNEDEPDD
LPF
>EGALAKHO_03650 hypothetical protein
MISINPKEIPTAKLHGYLQSAVGPRPIAFASTMSEKGIPNLSPFSFFNVFSANPPILVFS
PARRVRDNTVKHTLINVEATREVVINVVNYDLVQQTSLASTEYAEGVNEFIKAGLTQIPS
DLVKPYRVKESPVQFECKVTQIIPLGTEGGAGNLVLCEVVKIHIHETVLDENGGIDQHKI
DLVSRLGNNWYSRSNQGLFEVPKPLTTLGVGVDAIPNFVKESPVFNGNDLGKLGNIEALP
TTEEVSIFVKENFSVKGVLSSDDQEKIHLEAKKYLNNDDVSSAWKVLLAKK
>EGALAKHO_03651 Sporulation kinase E
MSFSERRNTTRWIIISISFLIISLILWNTYIFFQVFKNEERLKMNLLANAQKALVNADEN
TDLDLPLEILNNNHSVPVMLTMYGDKIISSVNVPERIMEDEEKSLSYLNNLKRENDPIVI
EYAPGKFQKLYYGNSELINKLKYYPIALLLIIVLFGALIYNFYKSTKMATQNKLWAGMAK
ETAHQIGTPLSSLIGWVEILRTEEIDPSITLEIEKDIDRLQTITDRFSKIGSVPALELHD
IVSETLSSYEYLQSRFSKQVTFSYDAPKEPVLAMINPTLHSWTIENLVKNAIDAMKGKGT
LDLQIEQDAHHVKINVKDSGTGIAKKQFKTIFEPGFTTKKRGWGLGLSLTKRIVEEYHRG
KIKVLHSEIGKGTTFQISLNKKEQ
>EGALAKHO_03652 putative HIT-like protein
MSIFTKIVNGEIPSYKIAEDDNYLAFLDVNPNAKGHTLCIPKQEIDKIFDMDDELYLGLM
KFSKKVAIALEKTVPCKRVGMAVVGLEVPHAHVHLIPLNDMDEMRFQNKVSLSKEEFEAL
AQSIQSNL
>EGALAKHO_03653 Transcription elongation factor GreA
MSKVSYYTAEGLKKLKDELEHLKSVMRPKASQDIAEARDKGDLSENAEYDAAKEAQGLLE
MRIAKLEEVYSNARLIDESQLDVSKALVLSNVKIKNQGNGMEMKYTLVAESEADLKTGKI
SVTSPIGKGLLGKSVGEVAEITVPNGVLKFEILEISRD
>EGALAKHO_03654 hypothetical protein
MKKIWLLLVFVSILFSCSGSERSNNNPNIPNYSVNLSVDMNLPAYSNLKFVSNGVIVPNF
GAKGVIIFNAGGTYNAFDAACPNQAINSCTAMTIDGINAVCSCDKTSYSLFTGLGGKEYP
LKQYKVEVNGTLIHVYN
>EGALAKHO_03655 Vitamin B12 transporter BtuB
MKTFFKGTKPQRYKGSKVNQKSILFTLFSLLFTLLSIAQEKDSTKVNSLDEVLVSAVRVT
AKTPVTFSNLDKKDIKYRNLGQDIPILMNYMPSVVTTSDAGNGMGYTGIRVRGSDATRVN
VTINGIPYNDAESQGTFWVNMPDFASSVESLQLQRGVGTSTNGSGAFGASLNMLTDNYAS
KANGEISSSYGSFNSQKNTVKFSTGLLNDHFELAGRLSRIKSDGYIDRASSDLKSYFLQG
TYVGKTTLIKALVFGGTEKTYQSWNGIDAEKLNENRTYNSSGEYTDEAGITRYYDNETDN
YQQDHYQLHWSESFSDKWSSNLAVHYTKGKGYYENYKEDADMADYELLPVGAVNTTDLVR
QKWLDNDFYGTTFSVKYKDEKLDVIFGGGWNKYEGAHYGKVIWARYASQSELGDHYYDDF
STKTDGNIFAKANYQFTEKLSFYGDLQYRNVKYKANSAETGLVDDNFNFFNPKAGLNYEI
NQKNTLYFSYARANREPNRTDYEGGNVKPEKLNDFELGWRFNSEKFQLNSNFYYMAYKDQ
LILTGTLDDVGSPIRSNTDKSYRLGFEVDATIKLSEKFLLRPNFTLSSNKNVDLAVEGQN
YGTTKIAYSPEVIAGNIIVYSPIESLHISLLQKYVGEQYMNNIELPSAKLADYFVNDLNV
SYEIKPKSVFKSIMITGLVNNILDKKYVSNGYMYDVYPYYYPQAGINFLAGLTLKF
>EGALAKHO_03656 Peptidyl-tRNA hydrolase ArfB
MDIEKIISELSFKAVRSSGAGGQNVNKVSSKVVLTFDLTTSQALSEEEKTLLLTNIASRL
TTENILILNCDEDRSQLKNKDIVVKRFLEIIKKGLHVPKARKATKIPKSVIKKRIKDKKN
ISEIKQSRRKPNLD
>EGALAKHO_03657 Trifunctional NAD biosynthesis/regulator protein NadR
MEKNLKQQKTNIIKIALFGPESTGKTTLAKQLADYYETEWVPEFARDYLQEKWEENQHIC
VADDMMPIAYGQTALENEKLSTAKKYLFCDTNLMVTKVFSEMYYGFCDPLLNEAALKHEY
DLFFLTDIDVPWEKDDIRDTPNGRETVFSVFRQTLLDNKKPFITLSGNKKSRLAKAAAIV
ADLALAKERGFSTEDFIQMYDHGISFDSIAKQLEVFENGIVKSNLVSPATIDNGILSLSE
AEFEEKASFFDSQKGSLKIKKFVPASGAATRMFKFLRTFLNDFDIEQETINAYINRRKDK
ELPIFIVAMDKFPFFEALHEKLKILYPDFETLERDYKNYYFIKLLLSSDHFDFANKPKAV
LPFHKYKEHIANPIEEHLNECSHYASSNQVSNLHFTVTKAHQDLFENEVGILKGKVEKDS
GIQINIGYSYQDKSTDSITVDTKNNIVRDKNEALVFRPGGHGALIQNLNTLDSDIIFIKN
IDNVIQNHIDKITLYKKALAGVLIEVQQKVFGFLRAIEEQKIKEDDLEKITLFLSERLNI
KITNDFNKFTFENKISKVKELLDRPIRVCGMVKNEGEPGGGPFWVMNNKGVVSLQIVEAS
QVDGTNKKQHKILAEATHFNPVDLVCGIKNYKNNKFDLQQFVDQDAGFIVEKNFEGKAVK
SYELPGLWNGAMANWITVFVAVPLITFNPVKTVNDLLKAPHQPQ
>EGALAKHO_03658 Nicotinamide riboside transporter PnuC
MIDFFLDNYKNAPLWHIALEFLVFVFGILSVWFAKKENIWVYPTGLIATVISVYLLYIAG
YIGDMIINGYFSIMSIYGWYVWARGGTTEDNLPITRTNFNEKIIGIVLFIVTVFVVFGIY
KYFDYEIKNDNYVDMISSGIFFAGMWYMARKKIENWTLWIIGDIIVVPLYAYRGLGMLSL
QYLIFTILAISAYLEWRKILNNKKQIS
>EGALAKHO_03659 Geranylgeranylglyceryl phosphate synthase
MKQRIFNIHQQILEAKKNGQKLLAILLDPDKIVWENLDHLLEKIKQSPATHIFVGGSIVQ
ATILEDLLAELKQKTNLPVVIFPGDPSQISPQADAILFLALLSGRNPDYLIEYQVQAAPI
LKKTNLEVISTGYILIESGNETAVARVSKTKPLNRENFDLVLATAQAGEMLGNKLMYLEA
GSGAKNAVPLKMIQLIAQNIEIPIIVGGGIVDLHGIQNAYNAGADLVVIGTAFENDSHFF
EV
>EGALAKHO_03660 Nitrogen fixation regulation protein FixK
MIASGLLKKYGAVKKSFDKNEIIFEEGNLPTHYYQIVSGEVKMSNYNDDGREFIQGIFYK
EQSFGEPPLFLNQNYPANAIAVDDSEVLLLSKSNFLKLLEENPSISLKIIENLAQRLYYK
SVMAAEMSTQEPEHGVLKLIDHGIAYFNFKKDVNGYLINFTRQQIGDLTGLRVETVIRTI
KALEKKGLLKIINRKVYR
>EGALAKHO_03661 hypothetical protein
MTLYQTTFENFNKNYMGSAAMAVIGQSCLGGAAAMYILSHGTSIGQMIQLAIIVLACVFA
NTSILAQMKHKVVFNLIILSAILSVLLIFLNSFVL
>EGALAKHO_03662 Group 3 truncated hemoglobin ctb
MKKQIENRTDVEFLVHQFYTKIRADKEIGFYFNTIIKDWDAHLGKLTDFWETNLFAVKKY
KGNPHEVHNEVDAQFGGKITSNEFGIWLNHWFQTIDEHFEGENADTLKRRARKMSTFLYM
SMFEHRKKGSKI
>EGALAKHO_03663 hypothetical protein
MPLFKTIQCKETTKLLIWEITESFEELLSKVVLKEKTQLRLNGMKSQMHQRAFLSVRMLI
QEMGFTDKDLHYDEFGKPYFDCHNYISITHSYHFAAIIISHETVGIDMELQREKIGKIAD
KFVDTEFEYLNANVSEEYIKKLTVIWGAKEAIFKIRNEKGISFKDHIRVGDFSLDKKQTH
ASLHFDDLIKDFNVHYEEIKSNNFEGKFTLVYAFEK
>EGALAKHO_03664 Adenosylhomocysteinase
MSTTTTPYVAFKVKDISLAAWGRKEIELAEAEMPGLMALRAEYKDEQPLAGARIAGCLHM
TIQTAVLIETLIALGAEVTWSSCNIFSTQDQAAAAIAAAGIQVYAWKGLDEQSFDWCIEQ
TLFFGEDRKPLNMILDDGGDLTNMVIDRFPELVPGIKGLSEETTTGVHRLYERVKAGTLP
MPAININDSVTKSKFDNKYGCKESAVDAVRRATDLMLAGKRVIVCGYGDVGKGTAASFRG
AGSIVTVTEIDPICALQAAMDGYEVKKLNTVIANADIIITTTGNKDIVLGEHFEQMKDKT
VVCNIGHFDNEIDMAWLNKNHGASKIEIKPQVDKYTIAGKDIIILAEGRLVNLGCATGHP
SFVMSNSFTNQTLAQIELWKNSAAYNNDVYMLPKHLDEKVAALHLAKLGVELETLRDDQA
AYIGVPVEGPFKPEYYRY
>EGALAKHO_03665 putative NTE family protein
MKKTTYLIVFLFLISLPQIIFSQEKKPKVVLVLSGGGAKGIAHIPLLQKLDSLHIVPDLI
VGNSMGSIIGGLYAMGYSGDSIEKITKNIYWDKLLGGGQSLKTVSVEEKREFQRYLVGIG
VKDGKLNSVSSLLNDQNLREYLSELTFPVYNVKDFDSLPIPFRAMATDLAEGKEVILSRG
SLSYAMRASMSLPAIFKPMPYEKTVLVDGGVLNNFPTDIAKQMGADIIIGSDVGGGMVPM
DKLNNLATILVQTSMFPSNIKNPANRELCDILVDHLPYLRFSTADFAKSDEIYEDGKIAT
QQNLPALIALAEKLKNYPQRTHELPKIIDEFILDTIVYKRISPENIPLVRARVNLKTHTK
YTSKDLIAGINRAMGTNLFNQITYNYFIDDNNKLGIAIIGFEYDKNQLNTSLHYDTYRGV
GIIFNYTARNVLDKSSRLLVTADIAEQPKARINFQKNFGRNKDWWWSSELYGAFLKQEIF
IDGKATDNMLYNAFESNNEINKNLNSLKSYVGFGLNYHYTKLKPKYDTDYNPNTFNITNY
DFNSIELNMHYSYNDMDKVFFATNGTIMKANISRSFLTDVDVSFSDPIQADISGATNGYT
KFGFGYERRLLLKKKITGIVGFDSYFIFQDKLKSDQISFSKFGYASKYFIGGIIPTSGSN
RFSFAGLNEDELNITQFMRIKLASQINLLGKIYLSPHFDVATVGFGNFNDYVNEVFSPKG
NWDQNAAPSLVLSGGAAISYQSILGPIHFDTSWVNNIGKVRLFFSVGLSLNP
>EGALAKHO_03666 hypothetical protein
MKIQLFVITLLLPFFMNAQSNASMQASQMRMQMNNQNAAWASQRDTKTLQWSQNGRDKQQ
MQSTLTPAQIALFEKALAQEEVNQKKLEEKLQEQEADLKTKQEQLTNLEKDPENSNNPDS
QKNIKKLKKEITKAEEQLNKTKTETESHAKGIITLREEIESKKGESAKKTEEEKTEKEET
KEVKK
>EGALAKHO_03667 Multidrug transporter EmrE
MKNFLFLFIAIIFEIIATSALKKSSEFTKLIPSIITVTGYCGAFYCLSFAIRTIPVGFAY
AIWSGVGIVLITAIGAIFFKEIPDFPAIIGLSLIVIGVVVINVFSKTTAH
>EGALAKHO_03668 putative N-acetyltransferase YafP
MDFRKATILDLAEMQEMYIETIKWVCKNDYTPLQIDAWVSGLNNTERWLKLIHEQYVLLA
TIKDQIVGYGTLKNGNYIDFFCVHKDFQRQGIADKVFNELEHEAIKENSKTITADISITA
KPFFEKKGFVVKAKQKNMRLGVELVNYKMEKELE
>EGALAKHO_03669 Bifunctional transcriptional activator/DNA repair enzyme Ada
MNTQENINYNRIADAIDYIKTNFKTQPNLDEVAENVHLSPFHFQRLFTEWAGTSPKKFLQ
YISVEHAKKILKEDNQATLFDAAFDTGLSGTSRLHDLFINIEGMTPAEYKNGGKNLEINF
SFAESPFGNIIVASTQKGVCFMAFAESEEIGFEDLKHKFPNATFSRKLDLVQQNALFIFQ
NDWSKLSEIKLHLKGTDFQLKVWETLLKIPMGQLSTYGSIAHQIEKPNASRAVGTAIGNN
PVAFLIPCHRVIQSTGTFDGYMWGNTRKTAIIGWEGAQINL
>EGALAKHO_03670 hypothetical protein
MQNIQSKIASQNWESITESMHENGFAVIPNLLNNEQCEDLKFDYDNPNLYRKTVVMERYR
FGLGEYKYFNYPLPDLIQSIRSAIYPKLAPIANAWMKVLNINTFFPETHEELLNQCHKNN
QLKATVLILKYGKSGFNTLHQDLYGDVYFPIQIVLFLNEPDEDFTGGEFVLTQQTPRAQS
KAIVLKPKKGDILIFTTNFKPVKGTKGYYRVNMKHGVSEIHSGERHTLGIIFHDALS
>EGALAKHO_03671 hypothetical protein
MIQHSKISDSNLRNKIKNAEICFGGNLKLKIYGTLKCSSGKRMKRENRVFFLSEKEARQN
GFRPCGHCMKTEYKNWKNGLI
>EGALAKHO_03672 hypothetical protein
MDLFNPHTDETTNLLPKDGTVNYYGKLFSRENSNHYLDILLNTIEWKNDEAIIFGKLILT
KRKVAWYGDSGFEYTYSNTTKKALPWTKELLELKAIIEEKTGETFNSCLLNLYHCGDEGM
AWHSDAEKDLKKNGAIGSVSFGAERKFAFKHKETKEVVSLILEHGSLLVMKDETQTHWLH
RLPPTKTTSKPRVNLTFRTIVR
>EGALAKHO_03673 hypothetical protein
MVSIDIFRKLAMSFPDATEEPHFEKTSFRIKKKIFASFDEKNNRAVLKLNEIDQSVFCAS
SEIIFYPIPNKWGKQGWTIVELSEVRPEMFEDALIRSYENVISKKK
>EGALAKHO_03674 hypothetical protein
MLKDIIENNENYQPGLSIDCVIFGFHDNQLKVLLIKIPHRETWSLPGGFIPVDQDIDVAA
VTVLNERTGVDGVFLRQFATFGKVKRNDQHFDKNVLEYLQIEEEKGKWLMRRFVTIGYYA
LVDFLKTIPKPANKDEIIEWIDHKEVPELILDHKEILDKALDTLRIELNLMPVGYNLLPE
KFTMPELQKLYETILDKKLDRRNFLRKITNIGILTKLDEKKSNVAHKAPNLYTFDKDKYE
EVLKNGLNQGW
>EGALAKHO_03675 hypothetical protein
MNSNPLKNINQKIRTKIWTSFGFVSKTYLLEESIKYSKEQEKIFNQMIVETEAKDKKAKR
EAFDKALYASYKGIGAMDFINTVLK
>EGALAKHO_03676 Beta-glucosidase BoGH3B
MKKITTFTLLMVSLFAVAQQQTIDQKVNDLLKKMTIEEKIGQLNQYTGDNQATGPITINP
NKQSEIKQGLIGSMLNIIGTKYTRQYQELAMQSRLKIPLLFGQDVIHGYKTTFPIPLAEA
ASWDLAAIELAARVAATEAAASGIHWTFAPMVDIGRDPRWGRVMEGAGEDTYLGSKIAYA
RVKGFQGNKLGDLNSVMACVKHFAAYGAGVGGRDYNSVDMSERMLLETYLPPFKAALDAG
AATFMNSFNDLNGIPATANSHLQRDILKGKWNFQGFIVSDWGSIGEMVAHGYSKDLKEAA
YSAITAGSDMDMESNAYRYNLAELVKEGRVSIDLVDDAVRRILRKKFELGLFDDPYRYSD
EKRAEKALNNPENRKAALEVAEKSIVLLKNENQTLPLSKSVKTIAFIGPMVKEYKANMGF
WSVELPDVNYDKWVVSQWDGLQNKVGKNTKLLYAKGCEVDGDNKDGFAEAVATAQQADVV
ILSIGERRDMSGEAKSRSDLHLPGVQEDLVKAIQATGKPVVVLVNAGRPLIFNWTADNVP
AIVYTWWLGTEAGNAIANVLFGDYNPSGKLPMTFPREVGQVPIYYNHFSTGRPAKDEDSK
NYVSAYIDLKNSPKFPFGYGLSYTKFDYSGLKLSSTKIKSNETIKVSFQLSNVGKVAGEE
VVQLYLKDKFGSVVRPVLELRDFQKVKLNAGESKTIEFTIDKEKLSFYNNKLEWGAEPGD
FEVMIGASSADIKLKSDFELVQ
>EGALAKHO_03677 Glucuronoxylanase XynC
MKNSIKTLQILLLLPLIAVQIKCGSSKNTASNSGKAESWITTTDESSKLQKQNDLVFNSD
ANSNQTILVDASQKFQTIEGFGFSLTGGSAQAILKLDKAKKEALLQELFSRKEDAIGLSY
LRISIGASDLNESVFSYDDMPEGQTDLKLEKFNLGPDLKDVVPVLKEILAINPKIKIMGS
PWSPPVWMKDNGSTKGGSLQLKYYQVYAEYFVKYIQAMKAQGIVIDAITIQNEPLHPGNN
PSMFMPALAQAEFIKNNLGPAFAKANIKTKIVVYDHNCNKPEYPLTILNDPKALPFVAGS
AFHLYEGDISALSTVHDAHPNKALYFTEQYTGSKSSFESDLKWSVKNVVIGSMRNWSVNA
LSWGLANDEFYKPFTPGGCSTCKGALMIDQAQNIKREVGYYIIGHASKFVPEGSVRIGSN
ITGNLYNVAFKTPSGQIVLIVENDGAAAETFNIKYNQKQISTTLNTGAVATYVW
>EGALAKHO_03678 hypothetical protein
MKKINRIVFVVILLLAGGSFYSQNLKIMTYNIRLDIASDGENAWPNRKDYFTSQIQFYSP
DIFGVQEATPNQVTDIALALPNYNKFGLGREGEGKGEACTVYYKKDRFQVQHSNTFWLSE
TPDVISKGWDAAYNRVCTYGLFKDLKTKKSFWVFNLHLDHMGNEARVKGIQLVLSKIAAV
NTKKQPVFLMGDFNSEPNTPQIVEVKKVMNDTRDVSIEKPFGPSGTFNDFKHDKPVTLLI
DYIFVSKNSGLKIEKHAVLSDSKDLKYPSDHLPVLIEID
>EGALAKHO_03679 Beta-glucanase
MKINNHIKKLGFLAIVLSFVSQSCSGGNDSGDGTPVVAAPSNLSVQVDVIGKTAANPDGD
GSGKVHFTINASNAISYKVLIEGQVKELTSGDLTYEFTASGTKTYQIIVSAYNAAGQFIS
ATSSVNVFVTRKILWSDEFDVDGAPNTSKWGYNTGTGDGWGNNELEYYTTRPENVIISNG
TLKIKAIKEEYMGSHYTSTRMLTKGKFAFKYGRAEVRAKLPVGGGTWPAFWMLGDNIDTV
PWPACGEVDILESVGNNPNVNHSSLHSPGRSGNTPDTKTTTVPNSATEFHIYAAEWSAES
IKFYVDDNLFYTYANSSSTPFNEKFFLILNLAMGGNFGGTVDPNFTNATFEVDYVRVYN
>EGALAKHO_03680 Endoglucanase C307
MKKILIIGQLLLSIATFGQGFLHRDGQNIVDGNGKNIILRGLGLGGWMVQEGYMLQTQPF
ASPQYQIKQKIQEVAGEKGTKEFYAAYKANGITKRDVDSLAAWGFNSIRLPMHYNLYTPS
IQEEKNGEITWVEEGFTMTDNLLKWCAENKIYLILDLHAAPGGQGNDAAISDYDTTKPSL
WDSEANQKKMIALWKKLASRYRDNPWIGGYDIINEPNWNFTGTNKNGCDENSNGPLRDLL
VAVTKAIREVDNNHMVIIEGNCWGNNYNGVFPLWDENMALSFHKYWNYNDKASIQKMLDY
RTQYNVPIWLGESGENSNVWFKDALTLMETNNIGWAFWPMKKIENIAGVTSVTKIPEYNI
LLKYWKDGGEKPSEDFAKKTLMKMADNYKMQNVTVKPDVIDAMFRQVQTNDTKPYKKHII
PGKISATQYDLGTNGYAYSDKDFVNYRVATGNFDQWNKGNTMRNDGVDISLCKDSGSNGY
QVSFIEDGEWLQFTSQVKKQNTYKVAIRYSSESSEGKLHLETENGNKSETITLAPTGDNN
KWKTVILSGVKLNAGTNKIKVVFEKGGFNLNYLDFSEGKK
>EGALAKHO_03681 Glucuronoxylanase XynC
MKLNFKNTIKALFFAIAIFAQVKCSSSNDATDPVPPPVIPPVVPPVVVTNDVDFWLTKGD
QSVLLAKQTTTLGFGTVPNTYSNIEVSESQKYQTVDGFGYTLTGGSADVINQLTASKKSA
LLQELFGSGENSIGISYLRISIGASDLNATPFTYDDIPTGDTDLDLAKFSLDKDRAGVIA
LLKEILVINPKILILATPWSAPIWMKDVNSFKGGKLQTQYYDVYAKYFVKYIQQMKAEGI
TIDAITPQNEPLHDGNNPSMYMSAGEQANFIKNNLGPAFKTAGLKVKIIAYDHNCDNPNY
PKAILADVDANPFVDGSAFHLYAGDISALTNVYNSYPTKNVYFTEQWTSSEGSFSGDLKW
HVRNVIIGSMRNYSKNALEWNLANNGTFQPHTDGGCSMCKGALTVISSEAFQRNIAYYII
AHASKFVPMGSVRIGSNSSGDLQNVAFVTPSGSKVLIVENDGATPQTFNIKFNEKWVTTS
LDAGSVGTYTWK
>EGALAKHO_03682 Glucuronoxylanase XynC
MKTINRILIAPILVLQLSCSSSKVVDNGTVSASKSNEKIQVYTTAENTNLRLSLSNNLIS
NSTSQQTNSTVSIIIYTEKTDQTFLGIGGAITDASAEVFAKLSPKKQQEFLTAYYDKNKG
IGYSLARTNIHSCDFSSDTYTYISEGDKELKTFNIDHDRKYRIPLLKKAIETAGGKLTLF
VSPWSPPAFMKDNNDILHGGVLLPEFAQSWANYYAKFIKAYEKEGIPVWGLTIQNEPMAK
QRWESCIYTPEAERDFLKNFLGPTLEKERLGSKNIIIWDHNRGDQLETRANLVFSDPEVS
KYAWGIGFHWYETWRGGPPQFQSVGNVHKNFPNKNLLFTEGCVEKFDASKFQFWGNAERY
GLNMINDFNNGTVGWTDWNILLDQNGGPNHVGNFCFAPIHADTTKDELIFTPMYYYIGHL
SKFIRPNAKRINQTISDQTLLSTSFKNIDGKIATIVMNQSDQNVVYSLINNTLKTTITIP
PHAMQTIVY
>EGALAKHO_03683 hypothetical protein
MKKNSFKILCFLFSLTAFAQQPKTKKEFTTNGKKITVYTTAENSNLRITSTDNLTFSPSK
QPLEIETSVFVEPSKKFQTFMGIGGAITDASAEIFAKLSKEKQTEFLNAYYDKNKGIGYS
LLRTTIQSSDFSSESYSYIKEGDKDLKTFSIDHDRQYRIPLIKQAIQTAGGKLLTYVAPW
SPNAFMKSNKDVLKGGTLLPEYYQTWANFYAKFIKAYEKEGIPIWGTSTQNEPMAVQTWE
SCIYTAEAERDFIKNFLGPTLKKEKLGDVKIIAWDHNRDLMNYRANVIYSDPEASKYVWG
MGFHWYETWSGGSSMFENVAKVKEAYPDKGLLFTEGCVEKFDAKKFQFWGNGERYGISMI
NDFNNGTAGWTDWNILLDQNGGPNHVGNFCFSPIHADTTTGELIYTPSYYYIGHFSKFIH
LNAVRVSSAVSRSALLSTSFLNTDGTMATIVMNQTDKEVTYNLIIAAEKTVVKIPAHAIQ
TLVY
>EGALAKHO_03684 hypothetical protein
MNLNINLKKSVFLMFALGLGILTSCDDDAGSGNGLTATNVDAAFTITPVTGAVNTYLLAA
QTKGVIGSKWNTGDGAYLGKMNETITLPDAGTYTITHTAIGAGGATGSTSQQLVVAKTDP
LKGNLVQGGSFETAADQAKWTVLNLSANGSAFWSYANKSATIHSPGGWAQEGIYQAIDVI
KDKEYTIDMLVSCPSGSDETWFEVYAGTSAPASGVEYKDNKVMGLSTWDGCAKAAFSGKL
STVGCVKNDKTATVSNVVKFAQTGKIYLLIRSGGNTFTKDGITVTKIEFRGK
>EGALAKHO_03685 SusD-like protein
MKTIKFKYIFCGIAMAVIGSCSEDFITTSPKGKLDADTYYSNESQTYAALVGVYDPMRKN
TGGFENMVAMLNAGSDDFWAGGGSATDGAGIQNFSSHSLTSTLMPGSYWNDHYQGIYRAN
VLLAKLPAATMSDAVRARFTAEAKALRALYYFNLVRMFKNIPLILVPLTASDINTPEQAK
PEDVYAQIEKDLREAILVLPGTVPAATEAGRMTKGGAQALLGKVYLFDNKKAEAAAVLAE
VNGTPGGTNQYGNKLLAKFSDLWVTANKFNTESLIEVGHSSAGNSDWGFWGSGKDEGNSL
NVMVGPRSYTRTANSDAPDLPSGWSFSVPTQKLYDAMKDDPRLAATILDVKALKAAGKAD
YIAANQDTGYFLNKFLPRMSDVRTGGGAAELNYKQDSYIIRLADTYLMEAEALGSGARAQ
ALLDAVRARVGLASVPVTLAAIKNERRMELAGEGHRFFDLVRWGDAATALADRGFNAGTD
EIFPIPYVELTGTKLKQNPNYQ
>EGALAKHO_03686 TonB-dependent receptor SusC
MKLTKLLIFCISSLLFSVIAVAQDVTVNGMINDESGMPVPGATVLLKGTTKSTASDFDGK
FQIQVPSNGVLTVTFIGYATVSEAVNGRTKITFQLKPESQSLNEVVVVGYGTQKKAVVTG
AISSVKAADLEKVPNGRVEQALQGRAAGVSVAATSGQPGSSSKVRIRGITTFREGGNDPL
WVIDGVVIDAGAVGFINQSDIESIEVLKDAASAAIYGTRAATGVILVTTKKGKAGKISVN
YNGFAGVSTPAKKLDLLNAEQYGTLMNEKLAADGNPIRYANPAALGKGTDWQDAIFNNQA
FRYTHELSISGGGEKSTFYASFGIQDQQGIVATDISNYNKKNFRLNSTHKISDYFTFGQT
FGYTRQKSQGIGNTNSEFGGPLSSAINLDPTTPLVVTDPVLAGQAPYNNPLVIRDSHGNP
YGISPWVGQEMTNPLAYTQTRLGGYNWSDDFVGNAYLEANFASHFKFRTTIGGKIAYWGS
QGFTPSFFLSNNVNAARNNYTENNEKSFAWTLQNTLNYTNKFGDHNVNVLLGQEALAENI
GGVIGTTMYGLPITDYRDASFSFDVPQTDRVSWSSDKDVHKLASLFARVNYDFKEKYLFT
GIVRRDGSNRFGDNKKWGVFPSFSLGWVLSKEAFWKENEVVNTLKLRGGYGVVGNDNIDP
YKYLPVVVGGYNYTLGNSGNITTGYANSTLPNPDLGWEETSQATVGLDARLFNDFNLTLD
YFKKKTSGILRDVVIPGYVGVAESPSANIADMDNTGFEIELGYKKKLGDFNLGVNGNFAT
LKNEVTYINTNTDFMLGDASFQSMGPVTRTKVGHSFNEFYGMKTNGIFQNEAEVAAYKNS
AGGLIQPNAKPGDFRWVDTDGDGAIDENKDKQFLGTNIPKYTFGLTVNLDYKNFDFMAFA
QGSAGSKIFQGLRRLDILNANYQTEALGRWTGEGTSNDYPRLTNTDPNKNFSLMSDFYLE
SGDYVRLKIVQLGYTLPLKVSSNIGADKIRFYLNGENLITFTKYTGYDPEIGGQVYGVDK
GVYPQARTIMFGANIQF
>EGALAKHO_03687 hypothetical protein
MKLIKSYFIITFFTLFSTTFFGQVKSIGLPDVRNYKRNEYKGGTQNWNIGQDKNGNLYFA
NNSGLLQFDGSSWRKYPLPNLTSVRCLKIDDSGKIYVGGYNEFGYFQPNEKGRLKYTSLA
KRIDKNKIKIIDFIWKIHTFNNETIFQSFARAYIFKNDKLTILKAPTRFQFSFVVQNKLY
FQDEGKGILEYKNGKLYALPNTTSFNNTEIWAMYALDKNKTLIITLEKGLFIYENNTVKP
WNTEANDFVKKNNSLGGVTIKNNFIVLNSVLDGIAICDFNGKIIQHLNRKKGLQNNTVLT
SFIDNKNNLWLGLDNGIAFINEGSPFTYFGFSYDISTVYASVIHQGNLYVATNQGVFYHA
WNNSFKEDTFKLVEGTTAQSWNVQVIDNELICSNNRGALIIKGGKVINSIDSKGYFGFKS
IPTRPGFFIGSNYDGFAIFQKTPSGLVYKNQVIGFDKSSNSFELDKSYLWLKKDESIYRM
SLSNDLTRFSSIKKIDRLTPKYKNIGSIQKIDNQLYFQTNNHFYKYSEEQDLFYEDKNLS
NLFKNIPIINALSEDSQSNLWYAFNESLGVLMKRNNYYTNIVAPFSNLTGNLVSSYLSVN
TIDSKNIFIGLTDGLAHYDSELLNNFVTKPKAFIRSFSFPGDTIILGNNQNKIENIRIPY
SSNHVRFTFSSPTYENLENVEFSYQLEPFDDKWSNWSTIAIKEYTNLREGDYKMNVKVRN
SYGIQSEPSTLLFTVSPPWYRHFLALIFYFVLIIIGIYVISNRIKMKIRKNKYYETIEQR
RLYLEKESRIRQEQYDLEKEIEKLKNDKLQIKILAKDKELVNNSLQVVKKNKILNGIIHK
LKEIDVEALDDSTKFQVSKLNKSIVKEVNTDKSWKDLEKHIKNVHFEFLKRLKEKYPTIS
PRELDLSTYLLMNMSTKEIAEIMNISTGGVELARYRLRKKLGLNKKENLIGFLMSI
>EGALAKHO_03688 UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase
MNIQEIHNLFLQCKSLSIDTRKIEKGSMFFAIKGENFDANTFAKQALELGALFVVIDNES
YLIDERTILVQNSLETLQELAKFHRAYLKLPIIALTGSNGKTTTKELINVVLSKKYRTKA
TVGNLNNHIGVPLTLLSFNTETEIGIVEMGANHKKEIAFLCEIAQPDYGYITNFGKAHLE
GFGGVEGVIEGKSEMYQYLAKNNKLAFVNLEDPIQIEKSSGIKIFTFGVNNDKADVKIKN
ITANPFVVIDYENFNVESHLIGLYNSNNINAAVSIGRYFKVDNEAVKEAIENYIPENNRS
QLLKKGSNQIILDAYNANPSSMAVAIANFLQLDSHNKVMVLGDMFELGKESQQEHKIIVE
SLLKQNKSVCYLIGKAFYENKISNESIQFFESFEEFSNHLKTVHFENNTILIKGSRGMAL
ERTLEYIS
>EGALAKHO_03689 Hercynine oxygenase
MKVNKIVALQLMMSMVLMLGTASCSKKSSSTHASRATGWDVDSQNGTAARNAGKKQQAGP
GLVFVEGGTFTMGKVQDDVMHDWNNTPTQQHVQSFYMDETEVTNGMYLEYLEWLKKVFPP
TEENYKNIYEGASPDTLVWRNRLGYNETMTNNYLRHPAYANYPVVGVNWIQAVEFSKWRT
DRVNEAVLEKDGYLQKGAKTSDVTAENAFNTEAYLMSPSTARGGSEEIVLKKNPGGKRPK
AGKDGVVPEEKNVYAQRSSGVILPEYRLPTEAEWEYAAAADVGQREYNIYKGQKKYPWSG
DYTRSSKRKNKGDQLANFKQGNGDYGGIAGWSDDGADITNSVKSYAPNDFGLYDMAGNVA
EWVADVYRPIIDNEANDFNYFRGNLYAKNKIGKDGKIEIVSTANIKYDTLSNGKVVARNL
PGEIAQVPVDEQETYLRTNFSTSDNINYRDGDKQSSRYFDFGDSESGPKTDQAMYNSPKH
NITTDSLGKMIRKYDNSSKRTTLIDDKVRVYKGGSWRDRAYWLDPAQRRYFPQDMATDYI
GFRCAMSRVGSKSEKRKSPRN
>EGALAKHO_03690 hypothetical protein
MKQALILYLLLVPILAFSQLNGDFTIDWQPKKEMSFGDFKTIIPYFSGNSFRYDNSKKSI
TLLLNLNQSNYSNSSSVQISNIIYESVSNSDLGDLSIGNIPEKPNETLKIASSRDKKQFF
ISLSPIIRDGNSFKRIRSFSYNLNNSTSKNNNTFLTERSNVIQNSVLTSGDWYRFYVEKS
GIYKISKSFLQSLGFDPSKTDPKRIKIYGNGGRMLPLMNSTYYPDDLIENAIQIIGESDG
VFSNEDFILFYAEGTENWNDESQTNLNLFDNKSYYYITVTGGDGKRISNLNQPSANATLD
LNTFDDYQFHEIDQTNIAHLGRQWFGESFDINQEQEFTFSFPNLETSVPLKIEVNSASAA
YTPTSFAIAANGQNIGTINFNALVSSSDTKFYTGKLPSNTTFTGAESVKIKLTYNNNGVP
GSKGYLDYINLIAKRKLLGTGKQFKFQYDLAGSTAGIVNYTIGNASGISQIWDVTDLYNV
SKVENPNQATFSFKASLGEIRKYIAIDPADYFTPLKESQSKIANQNLKGTLLKNAQNIFQ
DVDYVIVAPKFLLSQAEKLASFHRTYSNLNTKVIALENIYQEFSSGKQDIAAIRNCIKYI
YENASSPEKRIKYVNLFGDASFDYKDRIPNNTNIVPIYHSVNSNTIGESSFASDDFYGLM
DPDEGNIISFFGGIDIAVGRMLVSDNAQAGEMVNKVLEYHDTKSYGNWRNNFVLVSDDSD
QSSDASLQSRQNSLADVIAAEKPFFNIDKIILDSYTQEASAGGSRYPKARTDLFNAFEKG
ALVFNYLGHGGEDGLASERIWEKSDGQNLNNQYKYPLFITITCEFSRFDDPTRPTAGEYT
FWNPKGGAISMLTTIRAIGQFNAENFNDNLSKNLLSYGSNQYTTIAEALRISKNENPSYS
SNVIFYIGDPALMLAIPKPRINLTKVNDIVISQPIPDLKSLAKIKISGEITDENNTLLSN
YNGELATAIFDKLITTSTLNNDGYSPAMSFKILGETIFRGNATVTNGQFEFSFVVPRDIR
IPVDYGKISFYSKKNQLLENQSGYSNVIKIGGINENAPQDNISPKVKLYMNDETFVSGGI
TNSSPFLLALLEDENGINTASGIGHDIVAILDGDVSNPYILNDYYQTKLDDYTNGNLRFP
LRDLTPGMHTISFTAWDVYNNPVTSEIQFIVVGDESLTLTHVLNYPNPFSTYTQFWFSHN
RPYEPLDVQVQVMTITGKVVWTKNQIITTEGFLSREITWDGKDDFGDRIGKGVYIYKLTV
KSNLTNKKAEKYEKLVIL
>EGALAKHO_03691 hypothetical protein
MKKISLLLICLLIISYAKAQDIDRPITTGVPFLLVAADARAAGLADQGVATSNDAFSQQW
NPAKYAFATDAKGLSISYTPYLTDLASDISLGQVTYYSKINEKSAFATSFRYFGFGGIEL
RYTGDPNEPVREVTPNEFALDGSYSLKLSEKFSMAVAGRYIRSNLKIASEEIDASAAGSF
AVDVAGFYQSEEIAYSDFNGRWRAGFNVQNLGPKISYDNDDLSANFLPANLRVGGGFDFI
LDDYNKVGVSVEFTKLLVPTPPGPGTPVDANGDGDFTDPGDISQEQANTNNYNNYNNIGW
VEGIFKSFTDAPDGFSEELKEITYSVAGEYLYQDSFALRAGYFHESPVKGARQFFSLGAG
FKYNIVKVDVSYLFSSSKVKNPLENTLRFSLTFNFGDKYDEY
>EGALAKHO_03692 Cytidine deaminase
MKEISITSSFIVYDNLKELSAEIQDLMDQAVEIRKKAYAPYSQFRVGAALLLDNGKIVLG
SNQENAAYPSGLCAERVAIFHAGSVYPEAKILKIAITAASDNNQTKAPIPPCGSCRQSIA
EYEIKQETPIEIYFMGEIGEVYQSASLKNLLPFMFDKKFL
>EGALAKHO_03693 Acetoin:2,6-dichlorophenolindophenol oxidoreductase subunit alpha
MHPDLSGANLWEETILRYRQQLITQTTLAKERIQMKEVTKEVYLKWYEDMLLWRKFEDKL
AALYIQQKVRGFLHLYNGQEAVLAGALHAMDLTKDKMITAYRNHVQPIGMGVDPRRVMAE
LLGKATGTSKGMGGSMHIFSKEHRFYGGHGIVGGQIPVGAGLAFADKYFETGGVTMTYFG
DGAARQGSLHEAFNMAMLWKLPVVFIVENNGYAMGTSVERTANHTDIWKLGLGYEMPCGP
VDGMNPVKVAEAMTEAIDRARRGDGPTFLEMKTYRYRGHSMSDAQLYRSKEEVEEYKKID
PITQVLDVIMDQKYATEEEIEAIDQRVKDLVEECVKFAEESPYPELQQLYDVVYAQEDYP
FTPHKL
>EGALAKHO_03694 Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex
MAIKVTMPRLSDTMTEGTVATWLKKVGDKISEGDILAEIETDKATMEFESFNEGTLLHIG
IQAGETAPVDSLLAIIGNEGEDISALLAGGDAPAAEAPKTEAAPAAEAKTETAAPAPEAS
GLATSLPKGVIVVTMPRLSDTMTEGTVATWLKKVGDAVAEGDILAEIETDKATMEFESFN
EGTLLYIGIQEGNTAPVDSLLAIIGPAGTDISGIAENYTAGGAAPAPEASGPATEEKAAP
AAEKATEATADTSSNGGRILASPLAKKIASDKGIQLTQVKGSGENGRIVKSDIENFTPSA
QAQPAATATSAAPKADAAPAAPKVFVPAGEVFTEEIKNSQMRKIIAKRLAESLFTAPHYN
LVIEVSMDDAMAARATINTVPDTKVSFNDMVIKACALALKKHPKINSQWKEDAIIINHHV
NIGVAVAVEDGLVVPVLKFTDAMSLSQIGASVRDLAGRAKNKKLGPQEMEGSTFTVSNLG
MFGITEFNSIINQPNSAILSVGAIVEKPVVKNGQIVVGNTMMLSLACDHRTIDGATGAQF
LQTLKQYIESPVTMLA
>EGALAKHO_03695 Aminopeptidase N
MKKLILVTLFLTAIACQKKDQTEKPAVVKDEHTFAKPELAVVKHLDLDIKVNFETQTISG
KASWTIDNVSKGNEIIFDENTLNITKVTLGDEEKETKFELGAAVEFHGKPLHVTIEPNTT
KVNIYYSTTKDAVALQWLNPQQTADKKSPFVFSQGESIWSRTWIPCQDSPGIRFTYNAKV
TVPKDLMAVMSASVNPQKKNDTGVYTFKQDKAIPSYLMAIAVGDIGFQAIDNRTGVYAEP
SLLKKAAWEFAELGKMVGAAEKLYGPYRWGRYDVLVLPPSFPYGGMENPNLTFLTPGVIA
GDRSLTSLLAHELGHSWSGNLVTNATWDDIWLNEGFTTYVEHRIGEEIFGKKEAEMQDVL
TRKDLDDNIAEYGATNPDTRLKVSLTNRNPDDGISQIPYVKGYNFLKVIEAAVGREKFDP
FIKNYFDAHAFQSITTEDFVKYLKENLIKDDKALADKIKLDDWIYKPGVPSNITAVSSED
FTTIDNIQKNWRTTGVKGLSEKIKSTTEKQHFIDYLPADITVEEMTAIDNEFSFTKNGNF
VIKRQWFIQAIRHQYKTAYPAIEQFMIATSRTGSLMSLYKELVKTPEGKTWAKQIFEKAK
SGYHATTVQAVGDLLK
>EGALAKHO_03696 hypothetical protein
MNQIKKLLIIGFVWPEPNSSAAGGRIMQLISIFKQNGFEITFASPAMDSDFMVNLSEFGV
EKKTIELNNSSFDDFVIELNPDVVLFDRFMIEEQFGWRVAENCPKAIRLLDTEDLHCLRT
ARQKAFKENRTFALNDLLSEEVAKREIASILRCDLSFIISEFEMKVLKEVFKIDSDLLYY
LPFLVYEMSDLDLLKLPLFEERKNFVFIGNFLHEPNWNTVQYLKESIWPLIKNQFPEAVL
EVYGAYPSQKVLQLHQPKNGFFIMGRAADANEVVKNARIVLAPIRFGAGLKGKLLEAMQC
GTPSVTTTIGSEAMYANLPWNGFITDDIETFAKKAVELYHDENLWKQAQKNGVAIVNECY
QLSKYSTALITKINSLLNDSESHRLQNFMGSLLQHHTLKSTKYMAKWIEAKNKN
>EGALAKHO_03697 hypothetical protein
MLGLKLATDPRWVNIVESNIEEILTDHAWCEQKAASNAISLVTYNSELEELVTEMLVIAR
EELEHLQMVHDLIKKRGLTLGRERKDHYVNELFKFMKKDGSRKDALCDRLLFSAMIEARS
CERFKVLSENIKDEELAKFYRDLMISEAGHYTTFLGFARKYADNVDVDKRWKEWIEYEGS
IITNYGKNETVHG
>EGALAKHO_03698 hypothetical protein
MTASKKKSILFKIAKYFGITFVVILGLLFLTPIIFADTIKEQIKKTANEKLSAELNYSDV
SVSFFHHFPSLTLTLSDLNLNGSAPYKNEKFITAKEISFGINVASLVFSKTVKIDQIYLS
DSFINVKVNPNGEANYNIYKSSKPSNPKDTTETALKLERIEILNSKIIYDDQSTKVHFDA
FGFNYKGKGNLDKAVFDLYSVAKIEKLNIVYEGEPYLMNKKIDADLITKVNVNSLSFFFQ
QNNLKINQLLVDFKGKFDFLKDGYNMDFVIKSTNSNLKDVFTAFPPKYITWLSKTEIKGN
TNLLFTLKGDYIASQNIAPDLNLDIKIDSGFVNYNKSAFPVSNLSLDVKTKVPSLNPDLL
IVDAKNLSLNINKDYLKSKFYVKGASTPDINGEFKAKIDLEKLTKALGIPDIELKGTLAG
DIKTNGKFDQKNRLFPVTSGIINLENGFIKTKYYPNPITNIIIKSKIENNKGTFDDLKVS
LKPAQFTFEGKPVFVEANLSNFDDLTYDVKAKGELDVNKIYKVFSQKGLDLDGFVKADLV
LKGKQSDAEKGNYSKLHNKGTLELRNIGITSEYLPKKFIIKEGIFKINQDKMFFNNFLAA
YGQSDFRMNGYLQNVFNYATTNTGVLRGSFTSTSRYVNVDEFMSNTTADASVTKNPAPQT
ETKPTETKGTGVIIIPTNLNLQFTANAQKVNFDKLNLQNAVGNLSMNKGKLTMQNTGFNL
IGCNVVMNANYQAITPQKANFDYSIKASDFDIKRAYNEIEVFRKMASAAEKAQGIVSLDY
QLKGRLNGNMEPVYPSLTGGGTLSVKDVKVRGLKMFNAVSKETSSEAMKNPDLSKVDIKT
TIKNNIMTVERFKFKFAGFRPRIEGTTSLDGKLNLKMRLGLPPLGIFGIPLTVTGTQDNP
KIKVGRKSQDLEETKDSE
>EGALAKHO_03699 Bifunctional transcriptional activator/DNA repair enzyme AdaA
MKHSKKGEFYGQTNKTILLDGITLTDTVYTHPKVDWHYHEHAYFTFILQGNVIEGNKKEV
YNCSPGSLLFHNWQEAHYNIKPEGFTRGFHLEIEKQWFDDLTLNSNNLQGSTTVHNPDIK
LLMYKIFRATKIDDIHSDLSTQTLLIEILSKLNGDAQSILHKNPKWVLMIDEILHDQFTE
NISLDYLSKIVNIHPIHLSRDFSKYFHCNLGEYIRKLKVEKALSLIALQNKSLTEIAYEC
GFSDQSHLTRSFREINGLNPYEHKKLLFKK
>EGALAKHO_03700 hypothetical protein
MIKRIFLASILFFTSLISAQNNDLVKTDGITTALHKNNIGKITFMNGNIPLDQYKESDFL
KSFELKRKSDLNIRVFMNNSATNYLHQLNPDLTAEKLLQTGNLQFSFYVDNQFIYKENIN
YGCNFGSGGNKNTSTTFRVPLTSSKGEDWWAMYMWDRFKLNGGEKALTEGTHKLKIEIRP
YLKSDISNDIKTGDLIATGEIQLIIKTPKLTAKQIEIQPILPNSDWEISTFPFDKKKIEK
LNTDIANYSLKEITSVVVVYDKKLLLEEYFNDANRNTLHDTRSAGKSFASTIMGIAIKDG
HIKNENQTLNKFYDLKGFKNYEAKKDSVKIKDLLTMSSAFNGSDQDSDSPGNEENMYPTE
NWVKFTLDLGMDKSKTNGGKWDYFTAGTILLGDILNKSVPDGLEKYADNKLFKPLNITNY
QWQYTPQKVANTAGSLQMNSLDYAKYAQLYKNKGAWNDKQIIPTEWVQKTLTHQMQIPER
ENQFYGYLFWNRTFTFKEKNYEAYYCAGNGGNEFIIFNNLPLIIIITSKAYNKPYGHPQA
DKIVLDYILPSIIKE
>EGALAKHO_03701 50S ribosomal protein L27
MAHKKGVGSSKNGRESESKRLGVKIFGGQAAIAGNIIVRQRGSKHNPGENVYISKDHTLH
ARVAGVVKFQKKKDNKSYVSILPFEA
>EGALAKHO_03702 50S ribosomal protein L21
MYAIVEIAGQQFKVSKDLKVYVNRLANEEGSSISFDKVLLLDDNGSVTLGAPAIEGASVE
AKVLQHLKGDKVIVFKKKRRKGYKKRNGHRQYLTQIVIEGITAAGGTKKAAAKKAVVAED
APATEVEAAPKAKKAAAPKAKKEATKE
>EGALAKHO_03703 putative zinc protease
MMLSAALMLGGVAHAQKVAFEEYNLDNGMHVILHNDPSAPVVITSVMYHVGSKDERPDRT
GFAHFFEHLLFEGTQNIKRGEWMKIVTANGGVNNANTSDDRTYYYEVFPSNSLELGLWME
SERLMHPIINKIGVDTQNEVVKEEKRMRYDNQPYGNILPVVKENMFKNHPYRWTTIGSMK
DLDAATLEEFQAFNKKFYTPNNAVLVVAGDFDKTKTKEWIQKYFGPIPKGEVIKKQTFTE
EPINKTIKATYEDPNIQIPMVVASYRTPSMKTRDARVLDLISSYLSDGKSSKLYKKIVDD
KKMALQIGAVGFSQEDYGMYILYGLPMGTYTMADILKEMDEEIVKIQTDLISEKDYEKLQ
NKFDNNFVNANATVEGIAENLASYYLLYGDVNLINTEIDLYHSITREEIREVAKKYLNPN
QRLVLEYIPSTKVQN
>EGALAKHO_03704 hypothetical protein
MKKIHTVLILLFLTGIMQAQDRPQPKPGNSPVVNIKKPQTFVLANGMKVLVVENHKLPRV
SFNLTLDNAPFTEGSKKGVDELTSSLIGNGTKKTTKEAFNEEIDFYGANINFTSQGAYAS
SLSKYSGRVLELLAEGALLPNFTQTEFDKEKAKLLEGLKADEKSVPAIANRVVDVLAFGR
NHPAGEYLSEETVKNVTLADVQTNYATYFVPENAYLVIIGDIKFKETKEAVEKLFGGWKK
QTAPKNTYPDPVNVSKLQIDFVDVPNAVQSEISLVNTVNLKMSDPDFFPAVIANQILGGD
FNSYLNMNLREKHAWTYGASSSIGSGKYVTKFKASSAVRNTVTDSAVVQFVEEIKRIRTQ
KVSEDVLKNVKAGYIGRFVMQVEKPQAVARYALNIETEKLPADFYEKYIQTINNVTPDDI
YRVANKYFLLDNMRIIIAGKGSDVIPGLEKLEIPIYYFDKYGNPVEKPVTKKEAPAGITA
KTVFENYLKAIGGEKAVSAVKTLYMNGTTTIPQAPGPLTFTSKLDSKGKMMVSLAMGTMN
LMKQVVNEKGAYIEQQGQRKNLEGNDLAEMKANAAPFEELQLQKRTDLKIDAIEPINGSD
AYAIKDGKTTYFYDVKSGLKVAESKVREQDGKSSTQITNFNDYKEVKGVKVPFNLIQNVG
FELDIKMTDIKINEGVSEADFL
>EGALAKHO_03705 hypothetical protein
MDAKQLKWAYLLVLSLIWGSSFILIKRGLVGLTAVQVGSFRIIFAALFLLIVGFKSLKKI
SRRQWKFVAITSLFGTFTPAYLFAIAETEVDSSIVAILNSLTPLNTLVLGILIFGIQFQK
RQVLGVFVGLIGCLLLVLSGASAHPGQNYYYVGLVVIATLCYAINVNLIKKYLSDLNSLS
ITTGNFAVLLLPALIILSTTDIPQRISFETAQHSILFVMILGVLGTGIANVLFFKLIQMS
SPVFATSVTYLIPIVAFFWGLLDNEMLTPIQFFGAFIILIGVYLSAKK
>EGALAKHO_03706 Mercuric transport protein periplasmic component
MKFTKIIATLAIACLVLVSCKKEEDKNLANIKAIETAPKEHKAIAAENVQTASFQIEGMT
CAMGCAKTIEKELTNLDGVEKATVDFDKKTATVVFDKTVQNQENLIKVVQATGDGKTYKV
SNIKS
>EGALAKHO_03707 hypothetical protein
MFKRIISITIILLTLTVVSCKDDVLPKPSSYLRLDYPEANYVTFENNCPFSFEMNEAAII
KGENNCGFTITYPKMKATIYLTYKPVNGNIEKLLKDAQKLTYEHVIKADDILEQPYLNPQ
KKVYGMFYQVDGNAATNSQFYVTDSTKHFITGSVYFYAKPNFDSVMPAASYIKNDMQRLM
ETVKWK
>EGALAKHO_03708 Magnesium and cobalt efflux protein CorC
MDPEPSLFFTTTLDINLIIGFVGIFILLFLSAIVSGAEVALFSLSQKDIDETLQDNLPKG
KIISNLLDKPKKLLATLLVANNFLNIGVVILFSFIGQNIFDDISSPVLKFILEVILVTFL
ILLFAEVLPKVYASRNNIKFAKWVAYPISFLDKLLSPISLPMRSVTLYLQHKLGKQKNSF
SINQLSQALELTDSEGTSKDEQKILEGIVSFGNTDTKQVMSPRIDIFGLEISESFEAIYP
KIVEKGFSRIPVYRDNIDQIEGVLFVKDLLPHIDKKEFDWTTLIREAFFVPENKKLDNLL
KDFQSLKSHLAIVVDEYGGTSGLVSLEDVIEEIVGDISDEFDDENLNFSQIDEKNFLFEG
KINLKDFYRIIDVDEDVFESHKGEAETLAGFILEILGNFPKKDQKIAFENCVFTIETVDK
KRIKQIKVTIE
>EGALAKHO_03709 Single-stranded DNA-binding protein
MNGTLNKVMLIGHLGDDVKMHYFDGGNCIGRFQLATNEVYINKTTNEKITSTEWHNLVVR
NKAAEICEKYLSKGDKIYVEGRIKSRQWQAEDGTTKYTTEIQVTEFTFLTTKKETGNHKP
HQDQESAKNTNFDASNESLPINDLPF
>EGALAKHO_03710 Adenine DNA glycosylase
MFSKYFTMDFHNILISWYLQNKRDLPWRNTTDPYLIWLSEIMLQQTRVAQGMPYFFNFTQ
EFPTVFDLANASEEQVLKLWQGLGYYSRARNLHKTAQYVANELNGVFPENYSALLKLKGV
GEYTAAAIASFSYNEAVPVVDGNVFRVLSRYFDIESDIGLPATKKEFTALAYELMPKDNP
AIFNQAIMEFGALQCVPKSPNCMICVFNESCAALQKKKVDALPVKSKKVKVTNRFFNYLV
LEDAVGDTLIQKRTAKGIWHNLYEFPLLETEEIVGFDIVSKAVQFDVFPSYTIIGIEECA
EATVIHKLSHQHLHIQFWKVKINEKIVNGVNTSDLKTFPFPIVIYNFIEKQEIIC
>EGALAKHO_03711 DNA-binding protein HU
MTKADIVAKISEKLGLEKGDVQATVETFMEEVKTSLETGDNVYLRGFGSFIVKTRAEKTG
RNISKNTTIKIPAHNIPAFKPAKVFVEGVKTNNEAK
>EGALAKHO_03712 hypothetical protein
MPSGKKRKRHKVATHKRKKRARANRHKKKK
>EGALAKHO_03713 Ribonuclease G
MNKELIIRSSSEAVDFALLKDGKLIELHKEEEKSNFQVGDIFIAKIRKPVAGLNAAFVNV
GFEKDAFLHYHDLGPNLASQLKFIKLVSAGKIKDFSLKTFQFEKEIDKDGIITDILSANQ
SVLVQVVKEPISTKGPRISAELSLAGRFIVLVPFSDRVSISQKIEDKKEKDRLKKLVLSI
KPKGFGVIVRTVAEGKNVAELEKDLQNLLGRWTAMCKKLPTAHHPSKVLGELNRASSILR
DVFNDTFSGIQIDDEELYHQTKEYLQEIAPSKQSIVKFYQSNDTPIFEKYNIERQIKTSF
GRTVSMSKGAYLIIEHTEALHVIDVNSGNRSNKATNQEDTAMEVNMIAAAEIARQLRLRD
MGGIIVVDFIDMSNPENRKVLFDFLREEMSDDKAKHKILPPSKFGLVQITRQRVRPEVNI
KTREEDPNNEHGEIEAPILIIDKIASDLDRILKIRKDVVLNVHPFVAAYLSKGFPSLRSK
WFFEHKKWVKIIPRDAYTYLEYHFYDKKGNVISE
>EGALAKHO_03714 Penicillin-binding protein 1C
MKNKLIAFSQRIINWIKKNKIKSAIVFILLLIYYFSIPRTLFQEPYSTVIESKEGELLGA
KIADDGQWRFPAQDSVPDKFKKCIVYFEDEYFYKHPGFNPVAMVNAIKQNKKAGKVVRGG
STLTQQVIRLSRKGKGRTYFEKIIEIILATRLELGYSKNEILEMYAAHAPFGGNVVGLEM
ASWRYFGVQSNQLSWAENATLAVLPNAPSLIYPGKNQIKLLNKRNRLLLKLHQEGIIDKQ
TYKLSIDEPLPQKPYDLPQIAPHLLQRVAKNEEGTRVKTTIDYALQNRVNQIAKYYYNQY
KQNEVNNLAILVIDVSNRNVMSYVGNAPTDKDHQKDVDIIDAPRSTGSILKPLLYAGMLD
DGELLPNTLVADVPTQIAGYTPQNFNLTFDGAVPAHRALSRSLNIPAVLMLQDFGVNKFY
EELQKFKLRDINKTPDHYGLSLILGGAESNLWDLCRTYAGLSSTVNYYTKNQAKYRTKEF
IELNYKNDFEPDFGSETNQKNIIGAGAIWLTYNAMEQVNRPEGDEAWKFYDSSLKIAWKT
GTSFGNRDAWAIGTNSKYVVGIWVGNATGEGRPTLTGVTSAAPILFDVFNLLPRQKWFET
PYKDLEEVEVCRLSGYLAKEDCPKIKQWVSKKGKSTAVCPYHKKVHLDKSERFQVNSSCE
SVDNIVTKSWFVLPPVMAWYYKSQHIEYLPLPPFKEDCQGTQTTTMDFIYPKTNSKIYLT
KNFNSEVQPVILKVAYSERDKELFWYVDDVYKATTKTFHELPITPTSGTHYITVVDAFGN
EIRRKIEIVRE
>EGALAKHO_03715 hypothetical protein
MKKDFFEEGQYYHIYNRGNNKENIFIEEKNYNYFLEKLKKYIIPIADIYAYCLLKNHFHI
VLRIKDRKDIPEKFKEKIHLPFSNLFNAYSKSINKAYNRTGSLFQEHLQRNRIENENYLK
QLIIYVHLNPIKHKFTEHFDNYLHSSYRSYLSVKQSSIDRQFILELFDDLENFKFCHDER
RIVYEGILNDVSLSDD
>EGALAKHO_03716 putative lipoprotein YfhM
MKAKGLVLVFCVFFIFQSCGRKSAADFNSDFSLFKEYIVSFTGGIVSSESDIRVVLAFDK
KEWKAGQVLDSDLFDISPSVDGKVVALSPNTIAFIPEKKLKPGTEYQVTLNLDKLITLPK
EKEKELSDFNFTVKTIKQDFTINTADIQSYSKEYQYLNCVLKTADNIDIETAKKLVEAKQ
KGNNLKIKFEKNAGSAKEFHFIIDSIQRYSEATNLEIIYDGSDFDIDQKGQIDLPITNIN
EFKIVKVEVPDGSNQSVLINFSEPLEKGQNFAGLVSIQNTNNLKFSTQGNLLKVYFNNEK
APVKKEVEVSVPVEETAVSLVDSAAVVVDSAAAVVDDAVEVVQNEEAEPEQILAGDLLIE
VFQGIESQYGKKMDSNYTEKISFDQIKPAVKFIKNGTILPSSNNLKLNFEAVNLSAVDVK
VYKIYKNNILQFLQYNELNGSQNLKKVAQPIAKTTLNLIESKLINPAKWNTFALDLSKII
TPEPGAIYRVEFVYKKKYSLYKCETSEADQNEEEEEEVDENDVNYSENSYDDYYYDDYEW
RESQDPCTSSYYYNAKIATNILATDLGVIAKRGENKSYVFAVNNIVTTEPVSNARVDLYT
YQQQKIATAATSSEGIASFQLNKFAYFAIVSLGNQSTYVKLDDGLSLSVSNFDVAGETLQ
KGLKGFIYGERGVWRPGDNLYLSFILNDASNKLPKSHPIKFRLNDPNGKTVYQTVQKTNE
LNHYAFTVPTSQDAPTGNWEAMVSVGGAKFYKSIKIETIKPNRLKIKNTFTRKTLSSSYP
NTDNLEVTWLHGAIAKNLNVEMQAKFSQQTTTFKGYEKFSFDDLVRQFSTEEINVFSGKL
NESGKASVNIQPKLQGQAPGMLRASFITKVYEEGGDFSTDVISTTYSPYKTYVGIKSPEP
NKYGMLETRTNNRFDIVTVDENGRPKSVRNLEVKVYKVEWRWWWDASSDNLSNYNSSNAT
TSYKTFVINTDSSGKGSVQFSLTDEEWGRYLIRVSDNADGHATALTVNIDWPIWSGKTRN
RDASTANMLVFSTDKKNYAVGEKAQISFPSSEGGRALISIENGSKVVQTIWAKTEKGETK
VEVPITSAMAPNVYFNITLLQPHASTKNDSPIRMYGIVPIEVVDKNTILAPTLSMPDVLK
PEQTFTVKVGEKTGKEMTYTIAVVDEGLLDLTRFKTPNAWDSFYVREALGVKTWDIYDDV
IGAYGGKINQIFSIGGDQDLGGGKAKKANRFKPVVLYYGPFKLEKGQTKSHQLKLPKYIG
SVRTMVVAGDANTSAYGSVEKATPVKSPLMVLASLPRKISPSEKVTIPVTVFATENNIKN
VSIQIKTSNGLKVMGSATQSLTFASPDEKMAYFNLVVGSGTGIAKVQVVATSGKEKSVYD
VEIDMTNPNPVTNTFTDVILPPNSTKTISWKTFGVSGSNKARLEVSSMPTMNLNGRLQYL
IQYPHGCVEQTTSSVFPQLYLNDVVDLDATRKGIIQKNITAGITRLGSFQLSNGGVAYWQ
GNTIADDWGTSYAGHFLIEAEKKGYVLPINFKSKWISYQQREAKQWRFEAKYGNDLAQAY
RLYTLALAGNADLSSMNRLRETKGISNESKLRLAAAYVLAGQKSAGLNLFLHSKIEDESS
NYNYYYYGSSERNRAMALETMLLLGQKQKAFVMATKLAKQMSNNQWMSTQTTAYCLYAMS
KFAVSNGPKGINIQFSKNGKGETINTQKTIADRSLVAQTGANSITLKNIKNNTVYVRVLN
TGILPIGQEKAIQSDVSAAIVFKNRKGSIINVSKISQGTEFIAEVTIRNQRNEHVENVAL
SQILPSGFEIVNTRFTDYGDATNNIADYIDIRDDRTNFYFGMKAGETKVFRILLNASYLG
NYYLPGLQCEAMYDNTFLARTKGFWVEVVK
>EGALAKHO_03717 hypothetical protein
MADQSNRYSTENEFIIKNKNVIIYLLGLVIFFILIGFTDYYVLPTSKTKDLITYSFVRTS
GGKNGSKPQTVSYHYYTQKGFRFSTAKDDVEENNIEIEYSLLFKFVTKVRSKDNDYTKLL
SSDLSINGIQFYLCIVLLFSIAISIKILVLKKGFSENTFYNIICFNSFMIFVCLYMTYMF
>EGALAKHO_03718 tRNA-specific adenosine deaminase
MINPFTDEYFMKKALQEAEMAFDKGEIPVGAVIVVANKVIASSHNLTELLNDVTAHAEMQ
SITAAANFLGGKYLKDCTLYVTLEPCQMCAGALYWSQISKIVFGARDEQRGFIVMGTKLH
PKTTVVSGIMANEAADLMKRFFIERRK
>EGALAKHO_03719 hypothetical protein
MERKYKLTIPEPCKENWDKMTPKDNGRFCMSCSKTVVDFTSMLPNEVQHFFIQNQNQNIC
GRFRKSQLDSITIQIPNHVLYTQIHYPKMFLLALFIAMGTTLFSCQDKNGNKQKIDKIEV
VQDDVPVEHISVGDPKITNLHDTIVPLPPPPPKVDQVKFVKEKAQKKSTKKLQSKTNNCC
DTIKHKTTVEDEVYNGGVAIETNAEFPGGIEQFYNFFEKEFKKPENINTANLKIKLSFVV
ERNGSTSFLQSDPVIEKTLETEINRVLSLCPKWQPATSNGKKTRIQYSLPIVLE
>EGALAKHO_03720 1-deoxy-D-xylulose-5-phosphate synthase
MKSNLLSNIVNPADLRLLKEEQLPEVAKELRQFIIDVVSVKEGHLGASLGVVELTIALHY
VFNTPEDLLVWDVGHQAYGHKILTERRENFHTNRQIGGISGFPKRSESMYDTFGVGHSST
SISAALGMAIASQLKGEINKQHIAVIGDASIASGMAFEGLNHAGVTDANLLVILNDNAIG
IDPSVGALKKYLTAVKEGKNPKKNNMIKSLNFDYSGPIDGHDLPTLIKELNRLKNIKGPK
FLHIVTTKGKGLQQAEENQVKYHAPGKFDALTGELLLKSEENLPPKYQDVFGLTILDLAK
KNEKIIGITPAMPSGSSLKFMMDEIPERAFDVGIAEQHAVTLAAGMATQGMIVYCNIYST
FLQRAYDQVIHDVALQNLPVIFCLDRAGLVGEDGATHHGVFDIAYLRAIPNMIIYAPINE
IALQNILYTAQLGLNHPIAIRYPRGRGVLPKWEVENFGHYEKIKIGEANCLKNGTKIAVL
STGSIGNNVIEALNECSNSNEIAHYDFPFIKPLDYNVLHSVFSNFSSIITIEEATINGGF
GSAVLEFAASNNYKNDIQILGIPDVFIEHGTVNQLQQLCKIDVKSLVNLFSNDSK
>EGALAKHO_03721 hypothetical protein
MKLLRSTFLLLLLLCTSNNFAQIIQTTLDPNQLPKLPTNWTKKNQLGFDISEIAFVNWSA
GGTSSVSGLFKGEFGRTYAKGNHKWVNELIVKYGLNKQDGTELRKTDDAFQLNSTYGFRK
DTISNWYYSAKFNFNTQFSNGYNYPNKDIAISKPFAPAYIFLGAGAENSNKKKNRTFYFS
PITLKTTLVLDQYLANQGSFGVKKAVYITDPNDPTAQILVEEGQKVKAEFGILFTGYMKS
EIYKNIFYENRLSLYTDYLNKFGNVDVDYDTRLDLVVNAYVKANIGVHLVYDDDIKTKKD
VIDPTTGAKTQVNDGPRAQLRQVLGVGLVYAFQ
>EGALAKHO_03722 Deoxyguanosinetriphosphate triphosphohydrolase
MNWEQLLSLKRQGDTSKRLRVEQDDTRLGFEVDYDRIIFSAAFRSLQDKTQVIPLSKTDF
VHTRLTHSLEVSVVGRSLGRLVGKKILEKYPHLKEIHGYHMNDFGAIVAAASLAHDIGNP
PFGHSGEKAIGEYFSIGKGLKYKDKLTAKQWQDLIDFEGNANGFSVLTASRPGIEGGLRI
SYATLGAFMKYPKESLPKKPTNNIADKKYGFFQTDKLFFEEVANDMGMIPNKSDGDLGFE
RHPLAYLVEAADDICYTIIDFEDGINLGLVSEDYALEYLIKLVKDNIGVAKYKLLETKED
RISYLRALAIGALISDAVDVFVENEEAILRGEFPYALTDKSKYKAQMNDIINLSVEKIYQ
SREVIEKEIVGYQIIQTLLDKFITAFNNKYDGTASNYDKLILKMLPEKHHLDKGNLYERL
LHICHYVSLLTDGNALELFEMINGRKQN
>EGALAKHO_03723 DNA-binding transcriptional activator DecR
MESLDKTDLLILKHLQENSNINTKDLASKLFLTVTPVYERIKRLERDGYITKYVALLDKN
KMNRGMTVFCNVRLKEHAKNVGSNFVKDIVALPEIIECYNIAGDYDFMLKILVKDMASYQ
DFVMNKLSTIENIGNTNSIFVMGEIKHSTALEF
>EGALAKHO_03724 5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase
MKTNNLGYPRIGSNRELKKASELYWAGKIPVEELIETGKDIRGRNWHLQKEAGVDLIPSN
DFSFYDQVLDLTLTVGAIPQRYQEFAKTHSAIDLYFAMARGAQKDGEDVVAMEMTKWFDT
NYHYIVPEFTKNQKFELFSEKIINEFKEANALKIATKPVLIGPISYLLLGKEKEEGFHRI
DLIDKLLPVYFEIFEKLQAENVEYIQLDEPFLALNLTDKERNTFTEVYNEINIRFPKIKI
ILANYFDCFGENLTTALALPVDTFHLDLVRCPSQLDDILESGQLASNVNLSLGVVDGRNI
WKNDFKKSLELIQKATDSLGENRILVAPSCSLIHSPCDLDLETNDATLTPEIKQWLAFAK
QKINEIVVLKQLSASNEIDVKNSIDYERNVIANDNRKTSKLIHNNEVKARVTGITASDDK
RKSTFATRRKSQIDALNLPLFPTTTIGSFPQTAEVRSWRAKFKKGELTTEQYNELIEKET
EATIRFQEETGIDVLVHGEFERNDMVEYFGEQLAGFTFTKNGWVQSYGSRCVKPPVIYGD
VSRPNPMTVKWSKYAQSLTPKWVKGMLTGPVTILQWSFVRNDQPRSETCTQIALAIRDEV
VDLEKAGIKIIQIDEPAIREGLPLRKEEWANYLDWAVKAFRISASVVQDDTQIHTHMCYS
EFNDIIQNIADMDADVITIECSRSQMELLDAFANFKYPNEIGPGVYDIHSPRVPSSAEMV
RLLEKASAVIPVDQLWVNPDCGLKTRHWDETKKALIEMVAAAQEMRAVVENGATV
>EGALAKHO_03725 hypothetical protein
MKKMLVVVALAIVSFANAQKKGSILVMGSIEYNSQNVSNSGSENKYNTFAFSPKVGYQFH
ENWTAGIEAGVGTSKQETGNNTEYKTNNFSLGGFLRYAKPLNQTFSAYADLGVGYQSRKV
TQDVGPVNTINEGDGFYIGITPAILVNVGKGFGLNFNVGGLGYNTLNYDGDNGNGDNVKN
FNFSFGQQFSVGISKNF
>EGALAKHO_03726 putative ABC transporter ATP-binding protein YxlF
MSIEVNNISKSYGTQKALNEISFSIQKGEIVGFLGPNGAGKSTLMKILTTYLLADEGSAL
VNSHDVMTDAKAVQRSIGYLPEHNPLYLDLYVREYLAFNADVYNVAKSRIEEVIQLTGLS
AESHKKIGQLSKGYRQRVGLANALLHNPDVLILDEPTTGLDPNQLMEIRNVIKNVGKDKT
VFLSTHIMQEVEAICDRVIIIDKGQIVADKKLDHLVSEDKEQVIEVEFDYQVEEQLLAKL
PNITSYKNTHDMTWELTFVADKDMRPAIFDFANENGLKTLQLNQKNKNLEDVFREITK
>EGALAKHO_03727 L-2,4-diaminobutyrate decarboxylase
MNTVLKNDLHNLSTILDRTKQQGIDFLNNLENVPTSTKNSIDPTRELNELGLGSLAALEE
FNERLAPLLVSSSGPRYWGFVTGGSTPASIVGDWLATVYDQNTQAIKAQGGVSALIEFET
INLLLQLFQLPDSFLGGFVTGATMSNFTCLGVARQWFGKQFGKDFAKNGISEKIDILTAT
PHSSSIKSLAMLGIGSNNYTTLKTIEGNREAIDINDLEKNIESLNGKPFVLISSAGTVNT
ADFDDFEAISKLKEKYNFWWHIDAAFGGFAAVSDKFKHLVDGWEGADSITIDCHKWLNVP
YESAFYLIKKDHTSLQIETFQNSNAPYLGNPLENFNYLNVLPENSRRLRALPVWFSLLAY
GKEGFCDIVENSAAMALHFGNELIEDGDFELLAPIRLNNVCFTLKGSHNQEKVSAFLTLL
NDKEKVFMTPTVYQNRKGIRASFVNWRTTEEDIKIVIEEMKETILDLEI
>EGALAKHO_03728 C4-dicarboxylate transport protein
MEVKKINFLKSYSSILLLLGGIILGSILGLFYGKDVLVIKPLGDIFLNLLFTAIIPLIFF
TIASSIANLERTEKLGKLFLVMIVVFLATILISAIVMILAVYLFPIHQNIIISKVPIENI
KSGTIGDQIAQLLTVNDFFELLSRKSMLALIIFSFLIGFASLHSGEKGSAFRSFLDSGNE
VMKQLLNMIMKLAPIGLGAYFAYQVGVFGPQLFGVYAKPLGVYYGACTFYFFVFFSLYAL
VAGGKRAFKVFWSNNITPALTAVGTCSSIATIPANLEAAEKMNIPKHVRNLVIPLGAPLH
KDGSSMSSILKITVLFAMFGKDFTEHSTILLALGITVIVSIVEGGIPNGGYIGEVLAIAV
YGLPMEQALPVAMILGTLVDPIATLLNVNGDLICSMMISRFSEKTKW
>EGALAKHO_03729 Demethylrebeccamycin-D-glucose O-methyltransferase
MEKEELQAIAAQLKHPKGEKGIEMANMMNETNINMTRHSIQNLNIKAGNSILELGHGNAG
HVEFIFEQAENLKYYGLEMSELMFQEARQINRNFVSQKQAFFSLYDGNVIPFQDSFFDKI
FTVNTIYFWKEPEKLLSEIYRVLKPNGVFCITFAEESFMKQLPFTKFEFELYSTEKVEQL
AQKTAFKILYKETLTEKVKTRTGELVDRDFTTIVLENNF
>EGALAKHO_03730 5,10-methylenetetrahydrofolate reductase
MKVTEHIENAKGNTLFSFELIPPQKGKSIQELYDNIDPLMEFKPPFIDVTTSREEYIYID
KGNGLLDKKLTRMRPGTLGICASIKHKYNVDTVPHLLCGGFTQEETEYMLVDCQYLGITN
VMALRGDAMKDEQSFVPKVGGNHFAIDLVKQINNLNCGKYLHEVMDIDNKADFCIGVAGY
PEKHLESPSLQSDLKRLKEKVDAGADYVVTQMFFDNAKYFEFVKKAREIGITIPIIPGIK
PIAVQRHLQILPQIFRIDLPEDLIDAVDKCKNNAEIKQVGIEWAIQQSLELKAAGVPVLH
YYSMGKSENIRQIASQIF
>EGALAKHO_03731 Methionine synthase
MAEKRRDLVLAGLEPLIITPESVFVNVGERTNVTGSRKFLRLIKEEKYDEALDIARQQVE
GGAQIIDINMDEGMLDGVQAMTKFLNLIASEPDISRVPIMIDSSKWEIIEAGLKVVQGKS
VVNSISLKEGEEAFIHHAKLIKRYGAAAIIMAFDEVGQADNFDRRVEICQRSYDILVNKV
GFPPQDIIFDLNIFPVATGMEEHRLNALDFFRGTKWVRDNLPHAHISGGVSNVSFSFRGN
DHVREAMHSVFLYHAIKNGMTMGIVNPEMLSIYDDIPKDLLEHVEDVILNRRDDATERLL
DFAENVKGEVKSDEKAIQEWRLGTVQERITHSLVKGVDAFIEEDVEEARLAATKPIEVIE
INLMTGMNVVGDLFGSGKMFLPQVVKSARVMKKAVAYLLPYIEASKQAGDKQGNGKILMA
TVKGDVHDIGKNIVSVVLACNNYEIVDLGVMVPPEKIIAAAIEHNVDIIGLSGLITPSLD
EMVYLAKELDKQGIKIPIMIGGATTSRAHTAVKIAPQYRETVIHVNDASRAVTVAGNLLD
HNRKIYASDIRAEYDSFRETFLNRSRDKNFLSIEDARKNKMQLDWSEYTPTKPKFIGKQT
VEVDLDVLVPYIDWTPFFQTWELHGKYPAILTDEVVGKEATSLFADAQAMLKVILAEKKL
QAKGIYGIFPANQVDDDDIELRDENGKVLEKFLTLRQQSQKTKGAPNIALSDFILPKESG
IEDYMGAFCVTTGFGVDEWAAEFEKDLDDYNSIMVKALADRFAEAFAEYLHEKVRKEFWG
YDREESLTNEELIKENYKGIRPAPGYPACPDHLEKPTIWKLLNVAEEIGVTLTESMAMWP
ASSVSGYYFGNPKSRYFGLGKIKEDQVVDYAKRRSVSTEYASKWLNPNIAD
>EGALAKHO_03732 hypothetical protein
MKWHNLKIAILSTIILSSLYFIHKNSNKYDEHRKTFKGETIGFTTRIKPGKGSLLRYYFY
DSNKKILSSVSNGNYELVNKFYKVKYDLNNPKKNYIVLEEELKPDSISLVKAGFTKTKYY
IYDAGVTCKYIEKSKWK
>EGALAKHO_03733 Methionine synthase
MAITIQEAIKKNILILDGAMGTMLQRYNFSEEDFRGERFKDFPHPLKGNNDLLSITQPQA
IRDVHAAYFDAGADIVETNTFSGTTIGMADYFLEDLVYELNYESAKIARAVADEFTAINP
EKPRFVAGSIGPTNRTASMSPDVNDPGYRAVTFDDLRIAYKQQVEALMDGGCDLLLVETI
FDTLNAKAALFAIEEVKDERNLDIPIMVSGTITDASGRTLSGQTVEAFLISVSHIPLLSV
GFNCALGADLLKPYLKTLSQHTQFNVSAHPNAGLPNAFGQYDETPEQTQALIKEYLDDNL
INIIGGCCGTTPDHIRLIAEVAKDYKPRVAPVLE
>EGALAKHO_03734 Ferredoxin--NADP reductase
MIKTDILIIGAGPTGLFAVFEAGLLKLKCHILDALPQAGGQLSELYPKKPIYDIPGFPEV
LAGDLIDNLQEQIKQFEPGYTLGERAETIEKQEDGSFIVTSNKGTKFHAPVIAIAGGLGS
FEPRKPLIEDIEFYEDKGVKYFIKNPEKFRDKRVVIAGGGDSALDWSIFLANIASEVTLI
HRRNEFRGALDSVEKVQELKTAGKIKLVTPAEVIGINGAEHVESIDIEENGAHRKIETDY
FIPLFGLTPKLGPIADWGLEIEKNAIKVNNALDYQTNIPGIFAIGDVNTYPGKLKLILCG
FHEATLMCQAAYQIINPGKKYVLKYTTVSGVDGFDGTRKEAPKAVVKAIV
>EGALAKHO_03735 Siroheme synthase
MEQNELYPIFLKLHNLNVLIVGGGNVGLEKLSFLLKSSPNANVEVVAPDFHLEIKVLAEN
HPSIKLTQSKFKKKMLKKRHMVIACTDDLEVNKKVYDLSRKRYLICNIADTPDLCDYYLG
GIVTKGNVKIAISTNGKSPTTAKRLREFFEEVIPEDINQMVENLNEYRKTLKGDFEEKVK
RMNEITNSLKNKE
>EGALAKHO_03736 Uroporphyrinogen-III C-methyltransferase
MHNTIKPKVILVGAGPGDPDLLTLKGAKALAEANVVLYDALANEEILAYAPKNAIRIFVG
KKIGNHAYTQDQINQLIVDNALTYGNVVRLKGGDPFIFGRGSEEIEFIESFGIETVVVPG
ISSVVAVPASLGISITKRGVSESFWAITGTTSDRKLSADVALAAQSSATVVILMGMHKLP
QIINLFQKEDKGDLPVAIIQNGTTSEEKVGVGTVNSILEIVKEKELSSPAIIVLGEVVRE
SNKLKGFYEEFLSKEIVR
>EGALAKHO_03737 Sulfite reductase [ferredoxin]
MESFRTEIENPIVQKEIIDLEKKIHLFRGGKIDDERFRSLRLARGIYGQRQEGVQMIRIK
LPYGKVTSEQLVRITKVSDEYSTGRLHITTRQDIQIHYVSLDRTPELWANLAKDDVTLRE
ACGNTVRNITGSELAGVDVNEPFDVSPYAHALFQYLLRNPICQEMGRKFKISFSSSDEDT
ALSYLHDLGFIPKIVDGQRGFKIMFGGGLGSQPAHAELLSEFVPANEIIPTAEGIIRIFD
RYGERAKRMKARMKFLIKEMGRDVFLDLVEKEKKAIAFETYEIDTTAFDGPIAEPLLEVP
QVTIEDTAAYEAWKNSNVIAQKQAGYYAIGIKVLLGDFYTDKARLLAALIKNYAANELRF
SLRQNIVIRHVKEENLPFFYQELAKLDFVHLGYNSTVDITACPGTDTCNLGIASSTGIAE
ELERVINAEYPQYLNNREIEIKISGCMNACGQHNMSAIGFQGMSINSGKLVAPALQVLLG
GGRLGNGEGRFADKVIKIPSRRGPDALRTILNDFDKNANGEKFLNYYDLKGEKYFYEILK
PFADITNLTEADFVDWGNADNYVKAVGVGECAGVVIDLVATLLLEAKDKLTFAQESFDEG
KWSDAIYHAYAGFVNGAKALLLSENEKTNNHAGIVDLFDNVFIVTGKIELATSFKELVYQ
INQNEPSEAFAKQYIQEGIAFFDTIEKYRAQELANA
>EGALAKHO_03738 Bifunctional enzyme CysN/CysC
MEVLKIATAGSVDDGKSTLIGRLLYDTKSLTTDKIEAIEKSSKQKGYDYLDFSLATDGLV
AEREQGITIDVAHIYFSTAKKSYIIADTPGHVEYTRNMVTGASTSQVSIILIDARKGVIE
QTYRHFFINNLLRVKEVIVAINKMDLVDYSEEVYNKIKADFQALNAKSTFKEQNVSYIPL
SAINGGNVVDQSKDMPWYTGQTVLEHLEGLHSSDVFEAGKARFPVQTVIRPKTEEYHDFR
GYAGKLYGNSIKVGDAVTVLPSLTESKVSKIHFFDKTFDEAVAGSSITIELENDINVTRG
DMIVKTSELPKIEKDITTTVCWMDSKKLVAGTKYIVQHNTNRVLAKVESIKNTISTDYSG
TKEASQLAINEIGEVTIKLSKPLYFDAYNENKSNGAFILIDTATNTTAGVGFIR
>EGALAKHO_03739 Sulfate adenylyltransferase subunit 2
MSSVLKTNALESEAIYIFREVISQFDKPVLLFSGGKDSITLVRLAQKAFFPAKIPFPLLH
VDTGHNFPETIAFRDKLVEELGLELIVRNVQDAIDEGKVVEETGKYSSRNSLQTTTLLDA
IEEFKFDACIGGARRDEEKARAKERIFSVRDDFGQWDEKNQRPELFDILNGKIENGQNVR
VFPISNWTELDVWSYIEKEHIEIPSIYFSHKRKVFLRDGLIWSHSPFVYQEEDEQIEERI
VRFRTVGDMSCTAAVESYAATIQEVVGEIRTSTISERGARIDDKRSEAAMEKRKQQGYF
>EGALAKHO_03740 Thioredoxin-dependent 5'-adenylylsulfate reductase
MSAPIIESLLDITKDFSLDETLVFLAKEFPGKVIFSTSFGQEDQVITDFIAKSNTDITIF
TLDTGRLFQETYDVFHKTLKKYKRPIEVYFPEATAVENLLKEKGPNSFYDSVENRKECCF
IRKVVPLRKALAGNSVWITGLRAEQSENRQDLNLFEYDGGFEIIKFNPLLKWSLEEVETY
LSENNVPQNALHKQGFVSIGCAPCTRAIFPGEDIRAGRWWWESSHKECGLHSAKKE
>EGALAKHO_03741 hypothetical protein
MEKELKLNSVEVKADTSLKEKLWVIVPVVLLVGLLTVLVYNHHAEFSWNGFVSGFNQEFL
VFFFIGVFAQLVDGTLGMGYGATSTSFLLAYGVPPVVSSTAVHVSEMFTTGASALSHHKF
GNINKKLVKHLLIPGVLGSITGAYLLSDVINGDIIKPFIAVYMIVLAIIIIRKALAKSIV
KKKTKKLGFLATFGGFMDSVGGGGWGPIVTSTLLGRGRNPRYTIGSVNAAEFAVSFASGI
TFMLFGGIHGWQVIFGLILGGVIAAPLGAYLINKIKRKPMMIAVGILIILLSLKTLSKLL
>EGALAKHO_03742 hypothetical protein
MDFQIGLVIAGLLVGFVVGLTGVGGGSLMTPILLYFGIPPTTAVGTDLLYAAFTKMGGVF
VHHKKGNINWKITGWLTLGSVPAALITLLILNSIKTDISTINAVIKYSLGWALLFTSVAI
LFKKKLLVLSQKHAGDKFHSESHTQNMLTIGIGVLLGATVTLTSIGAGALGTVTLFFLYP
LLPTPRLVGTEIAHAVPLTLVAGIGHASMGNLDLGLLGQLLMGSLPGIFIGSMLSGKVPD
LFLRNAIAVMLFLAGYKLVF
>EGALAKHO_03743 HTH-type transcriptional regulator CymR
MLSKKTKYGIKALTYLARRDNNEPVQIAEIAKSEHISIKFLESILLLLRNSGFLGAKKGK
GGGYYLIKDPKDISMAKVYRILEGPIALLPCASHNFYEKCDDCDDESTCAARRLMTEVRD
NTLKILESNSLADIAF
>EGALAKHO_03744 hypothetical protein
MNNSSYVLEKKVMASDGDRFINGILDLFFVFVTIFIFSFIVVIVGNTFNVDVFSIWEKII
IEDTYLVLFGFLLFNYLVLEWLFGRSFGKLITGTVVVNKNGLRPTFDSILIRTICRLIPF
DGLSFLGKSGRIWHDSLSKTYVVNRKALKEELKLFSDLNLIGINDLN
>EGALAKHO_03745 L-methionine gamma-lyase
MNEQEFGFETQAIRTHLEKTQFQEHSTPLYLSSSFVFEDAEDMRASFTEEKVRNIYSRFS
NPNTTEFVDKVCAMEGAEAGYAFATGMAAIYSTFAGLLESGDHIVSAGSVFGSTHALFMT
YFPKWKIETSYFDINQPETIESFIKPNTKILYAETPTNPGVDVIDLELLGQIAKKHNLIL
IIDNCFATPYIQQPIKYGAHIVIHSATKLIDGQGRVLGGVAVGDAELIRKIYLFSRNTGP
AMSPFNAWVLSKSLETLAVRVDKHCENALKVAEFLEAHPNVASVKYPFLKSHPKYEIAKK
QMLLGGNIIAIEIKGGLEAGRKFLDKIKLCSLSANIGDVKTIVTHPASTTHSKLSVEEKL
AVGITEGLVRVSVGLETVKDVIADLDQALS
>EGALAKHO_03746 hypothetical protein
MKVTLNRVNDAFHFKLKNERGHVVDVDSRAEFGGSDLGASPMELVLMGVAGCSAIDMISI
LKKQRQEITSFNAEVEGERVQVGEAKPFKEIDVVFYLEGDINPEKAKRAAELSFEKYCSV
AKTVEPTATIKYKVVLNNEIL
>EGALAKHO_03747 Bifunctional aspartokinase/homoserine dehydrogenase 1
MKILKFGGKSLSNGEGLNKVVSIISDKVNQGENIAVVVSARGDATDELEYILKIAAKNGN
YKILLENFKVYQISDYPEVDLSEEFNILDKLFEGVSLIGDYSNKIKDQILSKGELLSAKL
LTAILKEKGIPANFVDSRDLLKTDSKFGDAQPLEQLSKKNVINYFKEHNGSTVNIVTGFI
GSNNNNDTTTLGRNGSNYTASLIANYLNAEELQNFTHVDGIYTANPDLVADAKKIEFLSF
NEANELANFGATILHAKTIIPLLEKNIPLRILNTFNHENRGTLITSDSTKEGIKTLSVLE
NVSLVNLEGRGLLGKAGVDARIFKVMGDNNISVSIISQGSSERGIGLVVATEKATTAMVE
LEKEFENDFYSKDVNQITVTDNVSVISIIGQDLSTFHKPYTALIKNKIVPILFNNTVTGK
NVSLVVKKSELNKALNVIHGEIFGVSKKINIAIIGHGLVGGTLINQILESAAAIEKRKDV
KLNVFAIANSKKLLLNKNGVTSNWKTEIEKEGLAYTIQDIIAYANQHHLENLIAIDNTAS
ATFVENYIPLVEGSFDLISSNKVANTLSYGFYKELRKALAENQKNYLYETNVGAGLPLID
TIKLLHLSGENITKIKGVFSGTLSYLFNNFSAKDVPFSEILKEAIDNGYTEPDPREDLCG
NDVGRKLLILARELDLQNEFEEISIQNLIPEHLRDGNVSDFLTKLKEFDPIYEKIKADQK
PNHVLRYIGELSGDLQNDKGILEVKLVSVPSDTALGGLKGSDSFFEIYTESYGDRPIVIQ
GAGAGSAVTARGVFGDILRLSDKG
>EGALAKHO_03748 Homoserine O-acetyltransferase
MENIPNPISIQNFTTENGAVYRSLPLSFTVAGLPLHSAPIVLVNHALTGNAQVTGKNGWW
NDLIGEGKTIDTNRYTVLAFNVPGNGTDSFLIEKYQDFTTRDIARIFIKGLKSLAIDQVY
TIIGGSVGGGVAWEMLALEPNITQNLIPIATDWKSTDWMIANCFLQEQILNNSSKPIEDA
RIHAMLCYRSPESFKEKFQRTVNENLSIFNIESWLAHHGDKLQKRYQLASYKLMNQLLKT
IDITRNSADFETLMSKTNASIHIIGINSDLFFTARENKETYEELKKFKDNVFYSEIDSVH
GHDAFLIEYKQLDHLLADIFKAETIAK
>EGALAKHO_03749 hypothetical protein
MSTLNYLSKTFSTLKNRSKRNNPPPKNELIHPRFGITETDKKTDKKEPNSLLFLMYSKEN
ETLFI
>EGALAKHO_03750 Bifunctional aspartokinase/homoserine dehydrogenase 1
MSKLKINIILFGIGNIGSTLINQIIESQEFFLQSKNIDFHFPIITNSTVAFFEKEGVGYA
WETNFRELAVPFKVKDIVEFAKENEFENLIAVDATASDELIGHYNTLIENGFNIVAVNKK
ANTLPIDLYKKIRENLKKYDKEFLYETSVDTGFPVLQTLRDLYYSGEKITKIRGVFSDNL
SYVFNRFSAEEASFSSILKDASLLGLMRSTFKEDLSGNDTARKLLILTREIGKDFDLSDI
KINPLIKEEHLEKNGILDKEAIDRSFKIAKITQADNHVLRYVGEFDVERNLLEVKLVSEP
VSSAIGQLKGSDSIFEIYTQSYAKVPIVIQSASPCKQAISRGIITDILKVSEKIKNKEAV
WL
>EGALAKHO_03751 L-methionine gamma-lyase
MSTQKFATNALHAGHDVTKNAGTRAVPIYQTSSYVFNNADHAANLFGLAEAGFIYTRLNN
PTNDVLEQRLAALEGGIAAVVTASGASAIATTFLTLLKAGDHIVASNSLYGGTYNLLKVT
LPRLGITTTFVDPSKPENFTKAAKENTRAFFVESLGNPKLDVLDLKAISAEAKNFKVPFI
VDNTVATSYLLKPIEHGANIVIHSLTKYIAGNGTSLGGAIIDAGTFDWSNGKFPEFTEPS
AGYHGLVYHEALGNAAFIAKARIEGLRDFGSALSPFNAFQIIQGLETLPIRIKKHSENAL
ALAEWLEKQDEVVWVNYPGLKSNKYYDLAQKYLPEGQSGIITFGLKGGFDAAKKVVDETK
LFSLLANIGDTKSLIIHPASTTHQQLSDDEQLETGVSKDLVRLSVGIEDIEDLIEDLQTV
FASVTQSQYSINKN
>EGALAKHO_03752 hypothetical protein
MNTLDLNTIAFQYLLRTESQKNNNKSEEPTSETLKYNPEHYIKGQKSLLFHMYDVEEEDL
YI
>EGALAKHO_03753 Ferric enterobactin receptor
MKKNVVIVLGLLTFSGIYAQENKTVQDTLKNNELSEVTIVGSRSKNRVKTDVPVPVDVFN
ISEITKGSPQTSVTQILNYVAPSFTSNATSTADATDHVDPAQLRGLGPDQVLILVNGKRR
HTSALVNINGSPGRGSVGTDLNAIPSFAIERIEVLRDGAAAQYGSDAIAGVINIVLKKNA
NFLSGGIQYGSNLSSGSNNFEGGADGQTVQVDLNYGTSLGKPGSFLNVTGTAVTRQATSR
AGIRNNGIFNAYNAVENRAAQDGVAINSLFSNINTTPNSAQILTSLKQYAPQVSYFTPAQ
QTAISSANTITQMQTALNFDVTNNEIAYRGQERSDYNMSVGQSELASGQAYYNAKYPLTE
TTALYSFGGVSYRNGKSYAFNRLPNGSGTFTQVYENGFLPEIESDILDASAAVGVTTELF
GFDTDLSTNLGTNSFKYDVNNTINATLGVNSPFSFDAGKVSFLQSTTNLDFSKKYDFLEG
LNIAFGGEFRYENYQIKQGEEASYGLYDVNGALVSGILPSASPLIVTDFFGNKRGAGAQG
FSGFQPSDAKEKDRKSGAVYIDLELNATEKWLINGAARYENYSDFGSTVTFKLASLLKLN
ENINWRISGQTGFRAPSLQQKYFEASSTQFINGSPYQVGYFTNDSQAAKSIGVENLKPEK
SKSISTGFTFKIPEANITIATDAYFTRIDDRIVLTGQYSRPTDAQIAAATSPEQAEALTL
FQQAFDTKGVERASFWTNGINSETKGIDLVISQKYDVAQDFVIRNDFALSFNETKRVGDL
NVPQSIIDAGGDPYKYSFFPESSRIYLEEAIPKLKANLMTTFNIKKLDIYLRNSYFGKVT
DPGATDVNLDGSSSVYEHPEYSAKLVTDLSLGYQINEHLRATVGFNNIGDVYPDRNNPAT
PAFTNTTPTLSPAPSTDLTNANQFAYSRAVSQFGLNGRFGFARLSFKF
>EGALAKHO_03754 S-adenosylmethionine synthase
MAYLFTSESVSEGHPDKVADQISDALIDNFLAFDADSKVACETLVTTGQVILAGEVKSNT
YLDVQQIAREVIRKIGYTKSEYMFEANSCGILSAIHEQSADINQGVDRAKPEEQGAGDQG
MMFGYATNETENFMPLALDLSHKLLQELAILRRENKEITYLRPDAKSQVTLEYSDDNKPT
RIDAIVISTQHDDFDEEATMLAKIKKDIIEILIPRIIAKNPAHAHLFNDKINYHINPTGK
FVIGGPHGDTGLTGRKIIVDTYGGKGAHGGGAFSGKDPSKVDRSAAYATRHIAKNLVAAG
VADEILVQVSYAIGVAEPMGIFVETYGTSKVNLTNGEIAKKVEAIFDMRPYFIEQRLKLR
NPIYSETAAYGHMGRTPEVVTKTFSAPGGHVKTVTVELFTWEKLDFVDKVKSAFGL
>EGALAKHO_03755 hypothetical protein
MKNILLYVILVMTSLSFAQTVRFDGFIQDEQKNPLEMANIMAVNNGTKAMDSYGITNDKG
KFQLTLKPNTAYTVKVSYLGMKSKEISISTNTENIVQNIVMDGSGIELEGVEIVREMPVS
IKGDTIVYNADSFKSGTEKKLEDVLKKLPGVEVNADGEIEVEGKKVSKLMVEGKDFFDGD
TKLGVKNIPADAIDKIQVLRNYNEVGALKGLENDQDNVAMNIKLKEGKKNFWFGDVTAGI
GVAELDSRYIINPKLFYYSPKYSINLITNFNNIGELPLTAQDYFKFTGGFKNMMKKGGSN
FNISSNDIGISLLRNNRAKEIETKFGATNFAYSVTKAWNISGFGILSASKTDLETKSQTT
ILDSRDQQKRDELTHQKNNLGLFKLSSTYKPNDKFQFDYDILTKLSKQDEDTDLLRESVV
NDISSVETILTNKKQNPTSINQNLSLYYTQSNKNIFAFEMQHLYQDENPFYNANLRSQPF
DLSGYISGQQRNDLNQDRFVKTNKLDAKLDYYYMVTPKSNINITLGNTYSYQDFNSHIFQ
MLDNGNRNDLNDSQNNNQVNYNFNDTFLGFHYKILSGKFTLTPGVSLHSYSMTNTQLGTN
YSQNFTKVLPDFFALYQIKKSETLTYNFSLSNDFTDINQLAAGYVLSDYSSLFRGNRFLE
NATSQVHSLRYFKYNMFNFENIFANATYTKKVDAIKTKADFDGINQSSVPYNSNLADETF
SGMGSYGRSFLKNYKASAVASFNWSKFNNIQNNVLATTESFTQSYTVRASTNYKNFPNLE
VGYNALINQYSGSTYYTDKPFARLDYYFWNSFSFVSEYEFYHYYNSDKTVDNEYDFLSAS
LIYQKKDSKWEYKVSATNLLNTTYLNDDSFSQFSTRVSQYTVQPRYIIFSMKYNL
>EGALAKHO_03756 hypothetical protein
MKKIFIYMSLMLVFTQIRAQKDFQGMAVYESKTQAPKMDGMRANRDITPEMQKNMEERMK
KMLEKTFILNFDKSASIYKEEEKLETPGQQGGGMRIMMNSFMGGGGTFYKDVKSKSYTVD
KEFMGKEFLVIDSLPKLNWKMESETKQIGGYTCYKATAVKEASKTDFRNFRPKNDNDKKP
EDKKEDTKKTSGETKTNFADNFEIPKEIIITAWYSPEIPVNQGPENYWGLPGLILEVNDG
RTTILCSKIVLNAKDKVEIKAPTKGKVISQKDYDETVIKKMEEFREMNRGREGGPGGGPV
MIRR
>EGALAKHO_03757 hypothetical protein
MNKTVRKILILFIACSFSVVSAQNQKVKTSLISNFTVDIDDFLGYDSFGFSYHIKNNVFR
KTKEKEVFEYKSVSLGNITKVDILNPLKIVLFYEDFNTVVLLDNQLNKMTEINFSQNSTP
IVASAIGMSTQNQLWIFNTLNQQIGLFDYLKNEYKTVSTPLTEAIKYYRTDFNTFFWIDK
KNNWFSCDIFGKTTALGKIPDFDKIEILNDHQYIFSKANLLYFKDISSVNSDTVSEIEIL
QKSFDKFCYKDQILSIFTAKEITNYKIVTP
>EGALAKHO_03758 Deoxyadenosine/deoxycytidine kinase
MHIAIAGNIGAGKTTLTKLLAKHFKWEPHYEDVVDNPYLDDFYHQMERWSFNLQIYFLNS
RFRQVQQIRESGKKIIQDRTIYEDAYIFAPNLYSMGLMTSRDFENYTSLFELMESLVKAP
DLLIYLRSSIPNLVGQIHKRGREYENSISIDYLSRLNERYEAWVQTYTKGKLLIIDVDNI
NFVDNPEDLGNIINRIDAELNGLF
>EGALAKHO_03759 hypothetical protein
MFGSADFVGNNKVIFNICGNHYRLIVKINYNTQIVYILFVGTHNEYDNLKDIKTL
>EGALAKHO_03760 hypothetical protein
MEIRPIKTEQDYNLALERVNILFDAKPNTEEADELDILVTLIEKYEKIHYPIPEPDPIEA
IKFMMEQNGLTDADLGILLNSRSRVSELFKRKRALTIKQIRILTAELHIPASILIKEYAL
DL
>EGALAKHO_03761 K(+)-stimulated pyrophosphate-energized sodium pump
MNSFMIYLPIVMAILGLLFMGIKRTWVLKQDAGDGKMKEISDHIYEGALAFLKAEYRLLT
FFVIGASLILAGISFIVPTTHILIVVAFIFGAFFSALAGNMGMKIATKTNVRTTQAARTS
LPQALKVSFGGGTVMGLGVAGLAVLGLTGFFIVFFQIFMNGVWTSSEDMTKVLETLAGFS
LGAESIALFARVGGGIYTKAADVGADLVGKVEAGIPEDDPRNPATIADNVGDNVGDVAGM
GADLFGSYVATVLAAMVLGNYVIKDMGGSIQDAFGGIGPILLPMAIAGFGILFSIIGTML
VKISDDNAKEAQVQKALNIGNWVSIALTAIACFFLVQHMLPETMQMSFFGEGSKDISSMR
VFYATLVGLVVGGAISSVTEYYTGLGTKPVMAIVQKSSTGAGTNVIAGLATGMVSTFPTV
LLFAAAIWISYALAGFYGVALAASAMMATTAMQLAIDAFGPISDNAGGIAEMSELPKEVR
TRTDILDSVGNTTAATGKGFAIASAALTSLALFAAYVTFTGIDGINIFKAPVLAMLFVGG
MIPVVFSALAMNSVGKAAMDMVYEVRRQFKEIPGIMEGTGKPEYGKCVEISTKAALREMM
LPGILTIGFPIAIVLLGKLVYGDNNQLIAEMLGGYMAGVTVSGVLWAVFQNNAGGAWDNA
KKSFEAGVMINGEMTYKGSDAHKAAVTGDTVGDPFKDTSGPSMNILIKLTCLIGLVIAPI
LGEGHSSSTMAEKGSCCKMEMSASKCGDLSGMTKEECIKMCKEKGCTAEETAKCLAHYDA
NGKYTHQKTDCFDTTKYSKNRVEVNLSTTNGVTVGTVTKTENGKTTTEVYEGTEAEVKAK
IEAAK
>EGALAKHO_03762 Inorganic pyrophosphatase
MTADKLTTFDVLIEIPRGSRNKYEYDFEIKRMRFDRMLFSSMMYPADYGFIPETLALDGD
PLDVLVLINEPTFPGCVIEVKPIGVFHMADDKGPDEKIICVPVSDPIWNSLNDLSDINGH
LLKEIEHFFQVYKDLENKQVDVEGWGDVNEAFAIIAECTKRFNDIENKPEGLFSIK
>EGALAKHO_03763 DNA-3-methyladenine glycosylase
MQEAIDFLSTKNPIFQEIIDKYGLPPIPKRPQGFETLVLLILEQQVSVDSAKATFLKIKA
HTNCNPETMLVLPDEEFRSLGVSRQKTKYIKILAEAVLSKELDIESLASKSAEEVREELI
KLKGIGNWTIDIYLMFCLQEPDLIPLGDIAVINTIKELLDIHDKQEMEIHARQWSPYRSY
ATYLLWHYYLNKRNRKITY
>EGALAKHO_03764 TonB-dependent receptor SusC
MIKKIILLSLFFVFALANIATAQTKVSGIVLDKLNQPVPFANIVFKGSNTGIVSNEDGRF
YLESPKIYTALLVTSAGFSDKEIPLEKAVNYNFKIVLSEAEALNEVVIFTGKTSKKNNPA
LDILRKIWERKRKNGLYQFNQYQMQKYEKVEFDMNTIDSAFMKNKLFKGMEFVFDHVDTS
DVTGKTYLPIFINESVYDVYGDNKLKKVKENIKGSKTSGFNGNQQILSFVKDLYSDYNIY
DNHLTFFDKSFTSPLSKTGIDVYNYVLKDSAYIDKKWCYNIVFYPRRKNELTFKGDFWVN
DTTFAIKKINMGVTKSANINWVKDIYIEQEFDVENDSVFLLTRDYMMSDFALNKKEKSKG
VYGKRTTLYRDHKFNIQKPEKFYKEEVNYIDNAVYDRPEEFWDENRFEKLNKDELGIYKM
LDTLQTVKRFKQIYNLVSILGSGYVEFKNFDYGPIFSTFGYNEVEGLRVRVGGRTYFGPN
DPWRIQAYTAYGFDDNKFKYGASGKWMVDKKKRVIISGGNRRDIEQIGASLTTTNDILGR
SFASSALFTTGSNGKLTNINLSNISVEMEPKKNFVVQAGLSYRTLESASPTFSLDYYTTL
PSPSNPAGVVASAVTQSEANVQFEFMPNRKTIGFGVERDLVDSPFSHFFVNFSYGLKGVF
NSDFAYEKIQIYYKQPIIIGPLGRSNIILETGKTFGTIPLGLMSVIPGNQTYFTIENTFS
NLNFYEFITDQYTTLQWNHDFGGRLFARIPFMRKLNWREFVGVKGVYGTISDANRAINAS
DQPYNAPENVYWEYNAGIGNIFKVFRIDFSWRGSYLNAPDANKFAVKGSFGFYF
>EGALAKHO_03765 Pyruvate dehydrogenase E1 component subunit beta
MRTIQFREAICEAMSEEMRHDESIYLMGEEVAEYNGAYKASKGMLAEFGEKRVIDTPIAE
LGFTGIAVGSAMNGCRPIVEYMTFNFCLVGIDQIINNAAKMRQMTGGQFNVPIVFRGPTA
SAGQLGATHSQALENWFANTPGLKVVVPSTPYDAKGLLKSAIRDNDPVIFMESEQMYGDK
GEVPDGEYTIPLGVADVKREGTDVTIVSFGKIIKEAFIAADELAKEGISCEIIDLRTVRP
MDNEAILKSVKKTNRLVILEEAWPFASISSEITYIVQEQAFDFLDAPIQRITTADTPAPY
SPVLLKDWLPNAADVVKAVKKVMYK
>EGALAKHO_03766 Electron transfer flavoprotein subunit beta
MKILVCISHVPDTTSKINFSNGDSEFDTNGVQYVINPNDEFGLTRAIWFQEQQGATVTVV
NVGGPDTEPTLRKALAIGANEAIRVNANPTDGFFVAKQLAEVIKNGGYDLVIAGKESLDY
NGGMVPGMIAGILGSNFLNSCTNVTVDGNNVKAVREIDGGKETVSTTLPLIIGGQKGLVE
EKDLRIPNMRGIMTARTKALTILEPVDAPVNTKAVKFEKPAPKSAVKLVSPDNLDELINL
LHNEAKVI
>EGALAKHO_03767 Caffeyl-CoA reductase-Etf complex subunit CarE
MSILIYAESAEGKFKKVAFELASYAKKVAESLGTTVTALTVNISDVSELSKYGVDKVLKV
NSDKLAGFTAKAYADVIKQAAEKEGTKLVLLSSTTDSIYLSSLVAVALNAGFASNVVGLP
VSTSPFQVKRNAFSNKAFNITEISTDVKVLGLAKNSYGIFESAGSATEEDFNPSIGDNDF
GVKVESVEKVTGKVSIADADIVVSGGRGLKGPENWGLVEDLAAVLGAATACSKPVSDLGW
RPHSEHVGQTGKPVATNLYIAIGISGAIQHIAGINSSKVKVVINSDPEAPFFKVADYGIV
GDAFEIVPKLTEKLKAFKAQHS
>EGALAKHO_03768 hypothetical protein
MSLVKLSIKGISYSQTQNGAYALILNEVDGERKLPIVIGAFEAQSIAIALEKEIKPPRPL
THDLFKNFAERFDIVVKQVIIHKLVDGVFYSSLICERDKIEEIIDARTSDAIALALRFNA
PIFTYKNILDKAGIYLKSNTADTDSGAQEIDDVLSNPETFGHEEETNQSGEVYAKHSLQE
LNELLDQAVSQEDYEKAAKIRDEISKR
>EGALAKHO_03769 Thymidylate synthase 2
MKQYLDLVKHVLETGCQKGDRTGTGTKSVFGYQMRFDLSEGFPMVTTKKLHLKSIIYELL
WFLKGDTNIKYLQDNGVKIWDAWADSNGDLGPVYGHQWRNWNSEEIDQISELITELKTNP
NSRRMLVSAWNPSVLPDTKKSFEENVANNKAALPPCHAFFQFYVSSPDVEKGETKGKLSC
QLYQRSADIFLGVPFNIASYALLTMMIAQVCDLDAGEFIHTFGDAHIYNNHIEQLELQLS
REPKPLPKMILNPDIKNIFDFDYNDFTLLDYEPHAGIKGSVAV
>EGALAKHO_03770 hypothetical protein
MSLKKQFIKTKPVCKVTFSVEAKDANSAAVVGDFNNWNPEEGALSKLKNGTFKATYDLVK
DAIYEFKYVIDGLYVNDPEADSYKWNDFAGSENSVLVV
>EGALAKHO_03771 hypothetical protein
MEKEVHEQYEYARRRLRQKKILYFHFVLFLLGSLFLFIANRFFGFGANTDQNWCVWGITI
WFFIFILHFIKVYITDRFMNKKWEREQIDRLVALQQKRISQLESKINEDTDNKI
>EGALAKHO_03772 Dihydrofolate reductase
MIIMIAAIAENNALGKNNELVWHLPNDFKRFKSLTTNHHIIMGRKTFESFPKPLPNRVHV
VITRQKDYNPEGCIVVDSIEKAIAVCPENEDSYIIGGGEIYNLGMEYADILELTKVHHSF
DADTYFPEIDKTDWQLVESEENFRDEKHLYDYTYETYIRR
>EGALAKHO_03773 hypothetical protein
MLFENKSQKEPLITNTTKILKARKLKFPKTNLILRTYFALIKK
>EGALAKHO_03774 Demethylmenaquinone methyltransferase
MSEKITPYKDSSLGKKEQVAQMFDNISGNYDNLNRVISFGIDIKWRKKVLKIVSDTNPKI
ILDIATGTGDLAILMSQTKAEKIIGLDISAGMLEVGKKKVEDKNLSNIIDLVLGDSENIP
FEDNYFDAITVGFGVRNFENLEKGFSEILRVLKPGGVFVILETSVPDKTPYKQGYRFYSK
NILPIIGKLFSKDNSAYGYLSESAAVFPYGEALNNILRKIGFIDVVAMPQTFGVATIYSA
SKK
>EGALAKHO_03775 hypothetical protein
MKKTVILLLLVLSTKGYSQFAKSMFSKDPIINLENWQKQRLYFGYYLGFNSFDFKFDYKN
PGPDIQVKKTTGFNVGVVADLRLQEYINLRFEPGLYYTKRDLYYPNMALQKDYLREVNST
YIHFPLLLKFSALRTGNIRPYLVGGMSTTLNLSSNAKSQDDNFEGKFRVKQWTAAYELGF
GIDIFSEYFIFSPSIRGMFGITDELIRDNPTNGPSPWTDNIDSMKSRAILINFTFH
>EGALAKHO_03776 23S rRNA (uridine(2479)-2'-O)-methyltransferase
MVSKNQIKLITGLHQKKQRFANQLFFAEGVKVIQELLQSNFELEHLYTTLNDFETVQSSK
RTLINEQELKKISALATPNTCLAVFKIPAENKIIDSGLIIALDDIRDPGNLGTILRLCDW
FGIKQIICSKETVDIYNPKVVQATMGSIARVNVNYLDLKTFIAQTKLPVFGTFMDGDNIY
QSSLPQSGIIIMGNEANGISAEIEKTVTSRISIPRFGELQKTESLNVATATAIILSEFKR
NS
>EGALAKHO_03777 Outer membrane protein assembly factor BamA
MKKNSTKIIAFILIAIFICACNAVKRVPDGKKLLVKNNIIVNGKSTNDETASNQMYQKPN
GTLLGYKLRLNLYNLANLNPDSTYQAKFKNHPGLYERQAKILSAKQVDRLGQSFLYKGIH
EFLKNTGEPPVIIDTTKTKKTLLRLKFYYFNNGYFNVKTDYTIDSIAPKKARINYNILTG
PGYILDSIKTTILTPALDSLYKTNPEPSVLKSGNQYKTSDFEEEKNRITTYFRNHGAYFF
QPTYVTFDIDTIGKKNKADINLKISNNNIQERDSSRTEPFKLYKISDVNIYTDYSAVNSK
SKINDSTTYNNFNLYSYSKLKYKPRAITDAIFINKGSTYSDTRTTLSSRYLNNLKIFNYP
SIQYEVDKRDSTAQSLIANVYLTPRKKYSFGATLDLTHSNIQDFGIGASVSETIRNVFNR
AETLEISARVNVGSSKDMANPNDNFFNVSEYGIDTKLNFPRILMPFGTEKIIPKRMIPST
TIAAGFSKQRNIGLDKENFTGGLSYNWSPKRLNTVKLEVLNAQFVRNLNPDNYFNVYTSS
YDELNNIGKDHNTEESYFDDPIKKNLIIPTGTTGFTNDVLSDKTDLLPSDEEYQDVKSIE
ERRVRLTENDFILASSYTFTKTTKKDLADNIFYQFKAKIESAGTLLSAVSNIANLQKNVN
GNYEIFNLEYSEYIKTEFDYIKHWDFGKEKVLAVRSFFGIAIPFGNSDYIPFSRSYYSGG
SNDNRAWQPYSLGPGSTDALDDFNEANMKIALSAELRFKILGDVKGAVFADAGNIWNVLD
NVVDDKATFNNVNDLAEIALGTGFGLRYDLSFFVVRLDLGFKTYNPAHEKGDRWFKEYNF
GHSVLNFGINYPF
>EGALAKHO_03778 Fructose-bisphosphate aldolase class 2
MAHNIKPGVATGDQVQEIFNYAKEKGFALPAVNVTGSSTINGVLETAAKLNAPVIIQFSN
GGAQFNAGKGLSNAGEKAAIAGGIAGAKHIHALAEAYGATVILHTDHCAKKLLPWIDGLL
DASEKHFAETGKPLFSSHMIDLSEEPIEENIEICKEYLARMSKMGMTLEIELGITGGEED
GVDNSDVDSSKLYTQPEEVAYAYEELSKVSPKFTIAAAFGNVHGVYKPGNVKLTPKILKN
SQDFVQNKFNTGHNPVDFVFHGGSGSTLEEIREGISYGVIKMNIDTDLQFAYTEGIRDYM
VKNLDYLKSQIGNPEGADVPNKKYYDPRRWVRESEVTFNARLEQAFADLNNVNTL
>EGALAKHO_03779 Acetyl-coenzyme A carboxylase carboxyl transferase subunit beta
MAWFKRQEKGITTATEDKMDVPKGLWYKSPTGKIIDADELARNLFVSPEDDFHVRIGSAT
YFEILFDNNEFVELDKNMTSKDPLHFVDTKKYAERLKDVMEKTHLKDAVRTGVGKSKGRE
LVICCMDFAFIGGSMGAVVGEKIARGIDHAIKNKLPFVMISKSGGARMMEAAYSLMQLAK
TSVKLAQLAEAKLPYISLCTDPTTGGTTASYAMLGDINISEPGALIGFAGPRVVRDTTGK
DLPEGFQTAEFLLEHGFLDFITPRKELKDKINLYIDLIQNNTIR
>EGALAKHO_03780 hypothetical protein
MSFNLKPVDTVESISREDFKKNYLDKKKPLIIKGLTKDWPAREKWTTDYFKQIAGDIEVK
LVDNSKADPTKVINASIATMKFGEYLDLIKREPTQLRIFFFNLFKHRPELINDVKVPKEL
MGGFIESMPAMFFGGSSAFTFLHYDIDLPHLFHTHFGGRKHIILFDYKWKKRLYCVPNTT
YALEDYDVANPDFEKFPALKGVEGYEVFLEHGDTLFMPTGMWHWMRYVDGSFSLSLRAWD
QSITRKMESVWSLFMHGAVDSAIKIVFRERYAIWREKLAFKIAEKELKKGRPKGSAS
>EGALAKHO_03781 Macrolide export ATP-binding/permease protein MacB
MLLYLRLLKESLSFAINALRNNKLRTLLSLLGVTIGIFSIIAVLAAVDSLDRKISKDLSS
LDKNTIYLMKFCFGPSEIPQWKREQFPNVKYDEYIALKNSLNNTEQVGYQLFVNHESLKY
DSKTVADVNMVPSSYEMVDIDGLTFDKGRFYTESESNSGSPVIVLGYEIATGLFGPDDPI
GKSIRLYGQRFTVIGVMTKQGAGFFGDSNDTSVYFPANFLRRMYGDSDAMTPVIVLKPVK
GVDMDAYKAEVAQKLRAIRGMKAGEIDNFFVNVLSGFTDFIDGILGQMNVVGWIISGFSL
LVGGFGIANIMFVSVKERTNLIGIQKSLGAKNRFILFQFLFEAIILSVIGGIIGLLMVWG
IALVLTKVLDFEFVLSFGNIILGTTLAAIIGLISGILPAISAANLDPVEAIRTGM
>EGALAKHO_03782 Bifunctional purine biosynthesis protein PurH
MQSENHNYTMSTTKTIQSALISVFSKDGLEPIVRKLHEQNVTLYSTGGTEDFIKNLGIPV
VPVEDITSFPEILGGRVKTLHPKIFGGILNRQDNESDVQQMREFDIPQIDLVIVDLYPFE
KTVASGASEQDIIEKIDIGGISLIRAGAKNFKDTVIVASVNEYSLLLDLITEQNGATTLE
NRRLFATKAFHVSSHYDGAIFNYFNTDETIYKESIADGQVLRYGENPHQKGFFFGDFDAM
FKKVHGKELSYNNLLDVDAAVNLINEFKTDGPTFAILKHNNACGLASRKTISEAYLAALA
CDPTSAFGGVLIANTKIDLATAQEINKLFCEVVIAPSYDDDAIAVLQEKKNRIILVQNEV
ELPSRQVRTCLNGLLIQDRNNITDTKEHLKTVTTTEPTAQEIEDLIFASKICKNTKSNTI
VFAKDGTLISSGTGQTSRVDALMQAVDKAKAFGFDLTGASMASDAFFPFPDCVELAKKAG
ITAVIQPGGSIKDELSINYCNENNLAMVFTGTRHFKH
>EGALAKHO_03783 Rod shape-determining protein MreB
MGFFDFMTEDIAIDLGTANTLIIHNDKVVIDSPSIVARDRISGKIIAVGKEANMMQGKTH
ENIKTIRPLKDGVIADFDASEKMINMFIKSIPALKKRMFTPALRMVVCIPSGITEVEMRA
VKESCERVNGKEVYLIHEPMAAAIGIGIDIMQPKGNMIVDIGGGTTEIAVIALGGIVCDK
SVKIAGDVFTNDIVYYMRTQHNLFVGESTAEKIKIQIGAAIEDLDGPPEDMSVQGRDLLT
GKPKQVDVSYREIAKALDKSIQRIEDAVMETLSQTPPELAADIYNTGIYLAGGGSMLRGL
DKRISLKTDLPVYIAEDPLRAVVRGTGMALKNIAKFKSILIK
>EGALAKHO_03784 Cell shape-determining protein MreC
MQQIFNFIIRNSNRLLFLLLLGISLVLTIQSHSYHRSKVISSANFLSGGVYERINHVNEY
LNLRTENDELILENARLKSLLFNKKDTTKTPPADSIKGVKPADIIVSKVIHNSYNTHENY
ITLNSGAISGIKQDMGVINSLGIVGIIDNISPRYSTVASILNMKSHINAKIKKSNHFGTL
TWDGKSTGFVQLEDVPRLASIKKGDTIITGGQSEIFPEGINIGTVDKIYIKNKTSYYVIN
VKLFNDMTNLGHVYIIKSKDRDELINLEKKEKDE
>EGALAKHO_03785 hypothetical protein
MNSALLVNIFRFIMLLAIQIVIFNNMNFLGYISPFPYILYIILYPVNSNRSGLIISSFLL
GLTMDMFCNSGGIHATACVILAYYRPYIFKFSFGLSYEYQTIKLNESLTPERFSFILVSV
LLHHIILFTLEAFQFKFIWDILLRTLFSTIFTIIISIIIIYLIKPNKR
>EGALAKHO_03786 Peptidoglycan D,D-transpeptidase MrdA
MRKVLLPSLIIIAASLLLIRVFYLQIIDESFKLKSENNAIKKQYDYPERGYIYDRNGKLL
VANQASYDIMVIPRDIKEDLNVDEFCALLNITKEDYEKRIAKAKVYSPRLPSVFLSQLNK
SEFAAFQEKIRKFEGFYFQKRSLRDYEVDFGANIFGFITQVNEKLIAKNPYYNSGDLIGK
QGVEESYEEVLRGIKGVKYIQKDKYNREIGSYKDGKYDTIAVAGEDINLTIDAEIQKYGQ
ELMINKRGGIVAIEPKTGEILALVTAPSYDPGILVGRQKSKNYTLLYYDSIAKPLYDRGL
MAEYPPGSPFKIMTGLAGLQEQAVNEQTSFMCLGHLGFYVARGHYMGCHSSAGNFQLHNG
IYQSCNTYFANVFINSIDKNHNPNENLDIWSGHVKSFGLGQFLGYDLPTGRRGKIPDSKT
YKKMYPGWQWSARTIISNSIGQGEVLTTPIQLANMMAAVANQGYFYTPHIIKKIEGKKID
AKFTTKHETTIDKKYFPPVISGLFDVYNLGTARSLRVEGIDICGKTGTAENFAKIDGKRT
QLKDHSIFVAFAPKDNPKIAIAIMIENGGFGATIAGPIASLMIEKYLKKKITRTDLETRV
LNISLKSEYAKLGGISNAEAIESTPKDSILKAKIVTPKVVVPKSEVKKTTLDTTKKN
>EGALAKHO_03787 Peptidoglycan glycosyltransferase MrdB
MRNQSVKNNIDWVSVFIYIALVTLGWLNIYSSSLLSTEGTYQKQLIFIGCTIPLIFVVLF
VDGKFYEKYASIIFGVSLLSLAGLFIFGKTIAGQRCWYAIGSFTLQPSEFAKAATSLALA
KYLSDTQINLKDVNRQVQALAIVFLPVLLILPQPDPGSALIYSIFIIVLYREGLPSWYVW
TGFITILLFVLTLVLEPYVVILIALGVLLIIHFKGRVVDRNIILSGLILLGISAFVLSVD
YVFDHVFKQHHRDRFNILLGKSVDMKGIGYNTNQSEIAIGSGGWIGKGFLEGTQTKGGFV
PEQHTDYIFTTVGEEWGFVGSLVVISLFVGLFLRVIYLAERQKTKFSRVYGYCVAAILFT
HFFVNIAMVIGIFPTIGVPLPFFSYGGSGLWGFTILLFIFLKMDANKVNEW
>EGALAKHO_03788 putative membrane protein
MNNFDWTQLVNPEFYITLSIGGFQIGLYIVLFIVFAETGLFAGFFLPGDSLLFLSGIYSR
DLIQNVIYIPSDFINVFLLSTLVGIMGVFGNMTGYWFGAKSGYYLFKKEDTFWFKKKYLL
QSKDFFEKYGGKAIIYARFLPIFRTFAPIIAGIVSMDKKKFMFFNILSSFLWSFILIFSG
HYLYGVFLEHGIDLKEHIEVIVIGIIILSTFPVFLKLIKKRTSTSEKI
>EGALAKHO_03789 hypothetical protein
MKNLILIAMITFLGFSAQAQTKKNKNLKYSTEVNGNCEQCKKRIEKAAFSVPGVKTANWD
ISSHQLTVILNEEKSSPEDLNKAIAKVGHDTKEVKAAQTDYDNLHTCCKYERD
>EGALAKHO_03790 Vitamin B12 transporter BtuB
MLFGMILLSVSVFSQEDLQEVKVTKKQKGIKKSYTLTSNTTVITSKELLKAACCNLAESF
ETNPSIDVNFSDALTGTKQIKMLGLTSPYLMITEENIPSVRGASQAYGLSFTPGTWIESV
QITKGAGSVINGYESISGQINTELLKPLSDIPFFLNVYGSTDARFELNTHFNKKISDKWA
TSLFVHGNTRVAKNDMNNDGFLDNPLGKQINVLNRYQYYNPESGLVSFINFRYMNDKKQT
GEVDFDKDRDRGTTNHWGSEINTERFDVSTKIGYVFKDMPYQSIGFQNAFNSHNQNSYFG
LNLYDIKQNSFYSNLIFNSIINNTKHKFTTGLNFTYDQYKEFVNVTDYSRIDNSVGAFFE
YTYDNTDNFSLILGGRVDNHNRLGFFVTPRLHMRYNPWENGVIRFSAGRGKRSANIFAEN
QQLFASSRTFSILDNNGKIYGLNPEIAWNYGVSFSQKFKLFNKNAEAGFDFYRTDFQNQA
VVDLMQSPQDVLFYNLKGSSFANSFQVEFNYELIHNLNLRTAYKYYDIQTDYLRGTFQRP
LQAKHRFLGNLEYETPMNDNKQWKFDYTFNWSGEQQLPYTASNPVEEQFPEFSPSYAVMN
VQITRVFSPVFEVYIGGENIGNYKQEKAILGANDPFGPNFDASVAYAPIFGQMYYAGLRF
KIK
>EGALAKHO_03791 hypothetical protein
MNLKKCTGLFLAFLLLVSNIGFAFDVHYCGGEIASVSLNTSVAAAPEKSCCGSAEKKSSC
CKDKVVHIEKKSDNATFKIFFFQLAFPAVIQEYQPIAFLAVPNFKSNQITSYYSDANAPP
LFKLYKQYIFYS
>EGALAKHO_03792 hypothetical protein
MLNKLLQHKAKILITVIIVLCFGLIRAFENQLFYDPFLDYFESDFKNLPFPQVDSFKLFY
GLFLRYFLNSILSLILIYVLFRDREILKFSTFLYVFFMVILFVLFFVILSYFTDGNWLLF
YVRRFIIQPIFVLLFIPAFYYQMQNSKK
>EGALAKHO_03793 hypothetical protein
MKKYLIQFKPFLVFIGTFFFAYILLTALYKLYLTSYVANDVDGITNIVGSNVEQVMKWFN
SDIKVQKSLLYPYLEVYYNGLFTIRIVEGCNAMSVVILFVSFVIAFSGKIKTTLLFILIG
SILIYIINVIRIVILAVLLFHFPENEHILHGVLFPLIIYGLVFILWVFWVNKFSKYAK
>EGALAKHO_03794 Free methionine-R-sulfoxide reductase
MTFQELQPKISAIVANNNIVRDEKLLAICQLLNENVEYYNWVGFYFANHENKTLHLGPYV
GAETDHTVIPFGKGICGQVAESNANFVVPDVAAQDNYIACSFTVKSEIVVPLFVDGVNIG
QIDIDSHVIDPFTEADERFLEFVNQEVAKLY
>EGALAKHO_03795 hypothetical protein
MKPLLRVLFFLLISTKLFSQTAIPAGKIIYLDSSWVESTEDNYKYIRIVEEYYSEKKSYV
YKDYYKSKALKAIGTSLDKDIIKPDGQFITYYENGNKKSIVTFIDKKKNGKEFNWYENGN
LKSELEYFANKKGEVEYKINNYWNPKKEQTVTDGNGDYEDISEYGEERGKIKNGLPDDIW
TGKFSKSKTTFTESYENGKLISGVSKDSLKIEYPYTIVDQRPSPKKGIDSFYSYVAKSMY
IPMEARNKVVGKIYLTFIVDKDGTLVEPKILKGLGHGLDENAIRIIKDAKKWNPGIRRGI
PVRVLYSLPITITKKD
>EGALAKHO_03796 30S ribosomal protein S15
MYLTKEKKEEIFAQHGAATNTGSAEGQIALFTYRISHLTEHLKKNRHDYNTERSLVLLVG
KRRALLDYLKKKEINRYREIIKVLNIRK
>EGALAKHO_03797 Polyribonucleotide nucleotidyltransferase
MIPQLFVEKIDLGDGRSITIETGRLAKQADGSVVVRMGDTMILATAVSARSANPNVDFLP
LTVDYREKFAAAGRFPGGFFKREARPSDSEVLTMRLVDRVLRPLFPDDYHAETQVMIQLM
SHDETVMPDALAGLAASAALAVSDIPFYNLISEVRVARIDGKFVINPSREDLEKSDIDMM
IGASMDSVAMVEGEMKEISEAEMVEAIKFAHEAIKVQIQAQLRLQAAFGKKEIRTYEGEK
ENEEIYKKVKAAAYDKIYAIAKVGSAKHERTAAFAEVKEEVKALFTEEELAADGDLVSKY
FYKTNKEAVRNVVLELGVRLDGRKTTDIRPIWCEIDYLPRVHGSSLFTRGETQALATVTL
GTSREANQIDSPSEQGEEKFYLHYNFPPFSTGEAKPLRGTSRREVGHGNLAQRALKNMIP
VDCPYTIRIVSEVLESNGSSSMATVCAGTMALMDAGIQMVKPVSGIAMGLITDGEKFAVL
SDILGDEDHLGDMDFKVTGTADGITACQMDIKIDGLRYDIMEQALGQAREGRLHILGKLT
ETIAAPRADVKAHSPKIITRTIPGNFIGALIGPGGKVIQELQKATGTTIVINEVNEEGVI
EILGTDPAGIEAVLAKIKSITFKPQMGEAYEVKVIKMLDFGAVVEYTAAPGNEVLLHVSE
LAWERTENVTDVVNMGDVFEVKYLGVDPKTKKEKVSRKALLQRPPREEKKE
>EGALAKHO_03798 hypothetical protein
MKNYQKNSIFLVLFGLFLNFHPIYSQSNADISTYNWFDKTVNKKNLDIVNGAPHTNPYRT
VGDNNMYYIDDKYEIGTLVYENQKYYNVKLKYDIYRDILVLNPYEASENIGLNVIRNKVQ
SFSIKDKNFILIDRKENSLPEFTTGYYEENKIAPDFIFYIKHHKDQQKAINDAGLYYVYK
ENTSFFVELKNKVYKINDKSDIINLFPEQKKQINGFYLMNRELKKTDLNQFMTNLMKYIN
NSISIQTK
>EGALAKHO_03799 hypothetical protein
MKKILLALVLLFSFQLSFAQNTDEKLSITFKDDTLENALKAIESKTSYKFYFDPTWVSAN
RTLISGTYTDIKIDDLLDKILNKTDLNFIILKNKVILTLNSTIHDDLPANYFPDAPIATN
DQNKGNNGDNPVFYQQYDSVNSYSVTKKASIVFIGKENKDAIKKTYTVTGSIKNAETGKP
EANIYIVVRNKNINTSSDPDGNYSLQLPRGINIIEIKSLSHKPVVKTLMVYDDGTFDVNI
NEKSNQLDEVVINKKGKKQTETAVSGLVSIDIEGIKNVPLILGERDILKVATTFPGIKTT
GEGSAGFNVRGGKDDQNLILLDNAVLYNPQHFLGFFSAINPYTAKKADIYKGSIPADFGG
RLSSVFDITTKNGNQEKFAGEGAIGPITSNLTLSVPIEKNKSSIIFGGRATYSDWILKSL
DDENLKNSQAGFYDGILKYNNAINSNNNLEATLYYSHDRFSLSSDSIYKYSNRLASVKWD
HAFNKKSKAALIFTNSEYKFNIDYNSSDINSFDFGYKVNESQLQLKFNYLLNPKHTLSYG
IASKLYNISPGYQHPTKPDATLISTDIEKERGLESGIYLADSYKVSDKLLVDLGLRYSFY
ASLGEANVNVYQPGLPLSDETVIGTEHYGKNEVAKTYGGLEPRLAARYFFTEDFSIKAGF
DMTRQYIHLLSSNVTQSPTDTWKLSDANVAPQSAQQVSVGLFKNLKDDEYELSLEGYYKK
SKNILDYKVGAQLLLNENVETELLQGEGKAYGIEFLLKKTVGRLNGWIGYTYSRTFIKLD
SQFSSEIVNNGNFFPANFDKPHDLSAILNYKFTRRYSLSTNFLYQTGRPITYPIGTFHYG
NADYTLYSDRNAYRIPDYIRLDIGINIEGNHKIKKLAHSFWNISVYNVLGRNNPYSIYFV
TDQSGKVKGYKTSIFSIPVPSITYNFKF
>EGALAKHO_03800 hypothetical protein
MKNLKLKYVLFFLVLAIICNGCTEAYPLLTNTYEEALVVEATITNELKTQEIKLTKTAKF
EDEKYLPESEAEVFMTDDAGNQYDFKDDGDKYISKIEFQAVSERKYQLHINTKDGRSFES
SPEILTAINPMQDVKAAVETKDDARGVGIRVTSSDPDGTSKYYRYEYEESYKIVTPKWVT
TKAVLDEKGRIIFVENSPSTKVCYGSKKSTDLLLATTSNLSEDSVNFLVRFLSTQNYIIT
TRYSILVKQYIESLNAFTYYKTLKQITDSGALLSPTQPGILLGNIKSLNNANSKVVGYFD
VASVSSERIYFNYTDFFLGEAPPPYVTDCLEYCYAGYPFNPVPCTHLGSIAEDIENGFIN
FFLQSERSWWVNAPCGDCTTFASNIKPPFWVD
>EGALAKHO_03801 hypothetical protein
MRPLKIIFILLITCFLAQSCTEAYPLLTNTYEEAIVVEATLTNELKYQEIKINKTSKFED
KDTQKESNAHVFVTDDSGNQYDFQEDTEKYVSKVEFQAVSGRKYQLHITTADGRSFASSP
EILTAINPIESVKAAVEKDNNDQRGVSIRVNSFDAKNESKYYRYEYEETYKVVAPKWVPT
KVVSYSGNTFVYGPNATDIRICYGDKKSTDIILTQTNNLSEDRVDNFLLRFISDKDYIIT
TRYSILVTQYIESFGAYSYYKTLKEMSGSESILSPKQPGILLGNLRAVDNSNSKILGYFD
VASVSRERIYFNYDDFFLGEAAPPYYTNCDDFCYSISPFVPIPCTHESGGFDEDFNTHQI
TYYIDRFDVGYLFWVNAPCGDCTTFASNIKPPFWID
>EGALAKHO_03802 hypothetical protein
MSLKKILMTLFTPLIFQGCTETYPLLTNTYKEAIVVEATLTNELKKQEIKITKSAKFEDT
DYLPESGAEVFITDDSGNQYNFDEDSEKYVSTIEFQAIPERKYQLHIKTKDGKSFESAPE
TLTTVSPIESLKATVEIEDKVRGVAIKVQSFDPGNSSKYYRYDYDETYKVVAPKWTTAKL
TLNEDGILVPGVNGIETRTCYGNKKSAEILITDTNDQKDDRVNFLVRFISDQNYIITTRY
SILVKQYVESLNAYTYYKSLKKMSSSESILSPTQPGILLGNIKEISNSGEKILGYFDVAS
VSTERLYFNYDDLFRNEPRPPYPEDCVEFCYSDHPSPSECTHTLAINYIDDLERGKIIFF
IDDFKKKLLFWVNTACGDCTAIASNIKPAFWID
>EGALAKHO_03803 hypothetical protein
MSLNKIFYLLIICFSIQGCTETYPLLTNTYEEAIVVEATLTNELKTQEIKITKTSKFEDK
QIQTEKGALVVVKDNQNNEYVFAENDGVYKSKNQFQILPQREYKLEIKTTDGKIYESSSA
ILTTESPIQSVVPTLVTNKDNVTGIQINVNSNDPTKTSKYYRYEYEETYKIIAPRWNPYK
VITTGPESVQVILNSKDTRICYSTKKSTDIILFDTNKETEDRVNLPIRFIEEENYIIGHR
YSILVKQYVESFEAYNFHKTMRDIASSASILSPKQPGVIAGNIKCISDSNTKVIGYFDVS
SVSEQRIFFNYSDFFPGQPAPYFDPCNDIKFNFCFRGEGCNGEDMIFNIDENLMSYISNV
GLAYILTPVECGDCTSFSSNAIPPFWVE
>EGALAKHO_03804 hypothetical protein
MKYKIIHIILFALTAFLFHGCTEAYPLLTNTYEEAIVVEATLTNELKTQEIKITKTSRFE
DKQIQPEKGALVVVKDNQNNEYIFEESDGVYKSKNQFQILPEREYKLEIKTTDGKIYQSS
PEVLTTESPIQSIVPTLVTNKDNVTGIQINVNSNDPTKTSKYYRYEYEESYKIEAPRWNP
YKVITTGPESVQVILNSKDTRICYSTKKSTDIILFDTNDQTEDRVNLPIRFIAEDNYIIG
HRYSILVKQYVENLEAYTFHKTMRDIASSASILSPKQPGVIAGNIRCISDSNTKVIGYFD
VTSVSEQRIFFNYNDFFPGQPAPYFDPCDDIKFLFCFRGQNCNGDSMIFNIEENLMSYIA
NRGIDYTLTPVACGDCTSFSSNVVPPFWIE
>EGALAKHO_03805 hypothetical protein
MKYNKILNIALLTLTAFVLNGCTEVYPLVTNTYEEAIVVEATLTNELKTQQIKITKTARF
EDKGIQTETGASVVVKDNQNNQYIFEENSGVYVSQSAFQILPDRKYTLEIKTKDGKIYES
SPEVLPTVNPIQSVVPAIATNKDGETGIEITVNSYDPNRTSKYYRYEYEETYKIVAPRWS
SLKTVVTGPQSVKNIANDPNTRTCYSTKNSTDIILVNTNDQNEDRVTLPIRFIAEDNYII
GHRYTILVKQYVENLEAYTFHKIMRDVSSSASILSPKQPGVISGNIKCISDPNAKVIGFF
DVSSFSEQRIFFNYVDFFPTNPVPYFDPCFDIPFLFCFYDDGCNGESMIFDLEQNNITYI
RNVGIDYTMVTAVCGDCTSFSSNIIPPFWIN
>EGALAKHO_03806 hypothetical protein
MDKLKHLFVLLVLFSTQLIKAQQIIPVDESIFIHANATTFVTGETLLYKVYCIKSSDKTA
SNISKVAYVELVDDSKKSVFKTKIFLDNAVGQGDFFIPTTLKTGNYKLIGYTNWMLNKSV
SEFFQIGVNIINPYKTTEKTSTESNLSSNSLNSAINTNETISKENSQTNENVKFELNKKI
FTNRELVNLKIETSNEAFKDGNYSLSVRKLDNIPSKNQISSKEFASVLSNPILIDLQNPE
KKITLPELRGEIISGKIASKNNTDKIENINVGLSLPGKSFAFKVVSTDAQGNFIFNIADA
YYTSDIKVQIIDDNANNYTVTVDNAPEIDYSKLSYDSNSNLSYSIKETLLDRSVSSQIEN
AYYHKKVDNIVKSETLEPFYYPTAKEYVLDDYTRFKTLKETITEVATEIYHKQKEDKFYL
HVNDPSVFPQLPESALVLVDGLYLENQTELFTYSMKNVYKIEVFVGRYYLGPKSFNGLIS
FTTFDKDFKSTQSGSFIAKPTVLRPQPKKLYNRIEYKDVADNARIPDFRNQLFWNPEVKL
DNENNNTFYTSDTSGVFEIKLEGFAKNGSPVSLRETIEVKDTAAN
>EGALAKHO_03807 RNA polymerase sigma factor SigA
MRQLKITKQVTNRETASLDKYLQEIGKVDLITADEEVELAQRIKAGDQRALEKLTKANLR
FVVSVAKQYQNQGLTLPDLINEGNLGLIKAAQRFDETRGFKFISYAVWWIRQSILQALAE
QSRIVRLPLNKIGSINKINKMYALLEQSNERPPSAEEIAKELDMTVNDVKESMKNSGRHL
SMDAPLVEGEDSNLYDVLRSGESPNPDRELIHESLRTEIERSLETLTPREADVVRLYFGL
GDQHPMTLEEIGETFDLTRERVRQIKEKAIRRLKHTSRSKILKTYLG
>EGALAKHO_03808 Ribulose-phosphate 3-epimerase
MKNTLIAPSVLAADFANLQRDIEMINNSQADWFHIDIMDGVFVPNISFGMPVLEAISRHA
KKTIDVHLMIIDPDRYIKTFADLGANILTVHYEACTHLHRTLQAIKAEGMKAGVAINPHT
NIDLLEDVINDIDLVLIMSVNPGFGGQSFIENTYNKVEKLKALITRKNASTIIEIDGGVT
SKNAKQLAEAGADVLVAGSFVFKAENPTQTIAELKALTTF
>EGALAKHO_03809 Nuclease
MRNYIFLGLMILVSISCKKEIVESDIKNDLKETESNFVSGQSRTDSIYTFAYLPTSTTKQ
IVKHQYYTLSYNEKFEQAEWVAYELKKEYLKNNDFKRPYFIEDPKVTTGSADWRNYKKSG
YDKGHLCPAGDMEFSEDAYNDTFYTSNISPQKHDFNSGIWNRLEQKTRYWAEKYSDIYVV
TGGILKDSDKKIGTEKVAVPKYFYKIILAKSGKEHKAIAFLVPNEDSDKSFYDFVVPIET
LEKMTGIDFFPNLKNLKSSKSF
>EGALAKHO_03810 Tail-specific protease
MNAIIKFMKRNYKILIAVLCLSLTLFAFKINADKTEDPDPNRDKTLLELLAFVIEKGHYS
PAEINDEFSKGIFKDYIDALDPSKRFFLQSDIDEFKQYELQLDDQFLNKDLTFFNLTYTR
LMKRMEESKKRYKTILAQPFNYNVDETFNADYEHLPYAKNATEINERWRKQIKLSTLSSL
VTKQKLEEDKKKTDPAYKAKSTETLEKETRESSLKSLDDQFGLIKDLNKEDWFSVYVNSI
MTRFDPHTSYFAPEEKDRFDVNISGKLEGIGARLTKKNDFTQIDELISGGPAWKGKQLEA
GDLILKVAQGNEEPVDVVGMRLDDVVKKIKGHKGTEVKLTVKKVDGSIKVISIIRDVVEI
EETYAKSSIVERNGLKYGVIYLPKFYIDFENKDGRDAGKDIALEVERLKKEDINGIVLDV
RDDGGGSLSTVVDIAGLFIEEGPIVQVKSAGKKKEVLYDKDKKIEWDGPLVIMVNSFSAS
ASEILAAAIQDYKRGVIIGSKQTYGKGTVQNVLDLNQFVRNANYGDLGALKITGQKFYRI
NGGSTQLEGVHSDVVMPDRYAYLKMGERDIDNAMPWDKIDPADYNTWTSNEKFNQAIANS
RNRIAGNAQFKLIEDNAKWIDVKNKENTYSLNINSFKATQEQVENEGKKYKPIADYKNDL
VFKSLPYEELEMNNDATLKEKREAWHQALAKDVYVEEALNVLDDLQTKSYVKNAVTPKMK
KDKLVKS
>EGALAKHO_03811 5'-nucleotidase SurE
MKNEKPLILVTNDDGILAPGIRALISVMETIGEVIVVAPDKPQSAMGHAITINNTLFLDK
ISKENDPITEYSCSGTPVDCVKLAVNEILHRKPDLCVSGINHGSNSSINVIYSGTMSAAV
EAGIEGIQAIGFSLLDFDWNADFEPIKSFVKKITLETLANKLPAGVVLNVNFPKLKEKEI
KGIKICRQAKAYYAQKFDKRQTPYGKDYYWLTGKFTNEDKGEDTDEWALENGYISVVPVQ
FDLTAHHTMQQLNTWKLNE
>EGALAKHO_03812 hypothetical protein
MNKKDILIGFVIGIFTALLGSYLFITFFTTFDISSGIETIKHYGYLGKIITLGTLLDLAV
FLILLKRNKELMARGVVLAVIVLAISTLFI
>EGALAKHO_03813 Lipid-A-disaccharide synthase
MKYYIIAGEASGDLHGSNLMKALYEEDPQAEIRFWGGDLMQKAGGTLVKHYRELAFMGFV
EVIFNLKTILSNITFCKKDILEFKPDVIIFIDYPGFNMRIAKWAKELNYKTHYYISPQIW
AWKENRIKAIKQDVDKMFVILPFEKSFYEDKHHFPVDFVGHPLIDAIQNQPPFDEAVFRK
ENQLGDKPIIALLPGSRKQEITKMLSVMLSVVDDFKDYEFVIAGAPSQEYEFYKQFISNE
NIAFVSNKTYDLLRSSTAALVTSGTATLETALFKVPEVVCYKGSNISYQIAKRIITLKYI
SLVNLIMDQEVVTELIQADCNTKRIKEELQKLLEPHSREKLLKNYDILEQKLGGVGASKK
TAKLIVADLKKL
>EGALAKHO_03814 Murein DD-endopeptidase MepS/Murein LD-carboxypeptidase
MKKILIFLLLTVIFTSCKSTSNVVGTKETKRENKYIVNHLIENATDNIGVKYKAGGTTKS
GFDCSGLVFTSFESENIKLPRSSYEQSKIGKIINIDDAQKGDLIFFKTNKSKQINHVGLI
TEVKSDEIKFVHSSTSKGVIISSTKEPYYKNSFSQINRIIE
>EGALAKHO_03815 ComE operon protein 3
MKVLDFPLAKITFSFVFGILAAYYWLPPIIISVLYLFVGLLFVSTFYIFSKKNKRLTILF
GLSTYYTSFCIGMMALAINTDSFQNSNYIYYKDAFESPHYIEITLREKLKSNDFNDRYIA
VIDRIDNKYYSGRIIINVAKDSIKTSLIVGNTIRVKTILQHNSLAKNPNQFDYGKYLANK
QIYAQINVSKIDIAVNKKIKKDIWFYTSRLHSRIIQNLEKGKFNKTEMNVALALILGQQQ
EISSDIKQDYQYSGVTHVLSVSGLHVGFIMLFILFILKPIPNTKKGSFIKLVVIIISLSL
FAIISGLSPPVLRSVVMFSFLAIGNHLHRHSNTYHTLLVSIFLILLFEPYFLFDAGFQLS
YIALFSIHWLQPLLKNIWLPKNKIAKYLWEALTVSFAAQIGTFPICLYYFHQFPALFFVT
NILILPVLSFIMIVGIVVMLISVFTSCPIILIQVFQKSIYLLNQIIHYVASFESFVIKNI
SFNSCHLISFYFFLVTSIIWFKKPNYNKLIILLLTIILVQLSFIQTKKEIESTQEFIVYN
TKKGTIITERIGKDIKLFASNELSEKESKNNILQPYLVANYGVLKSVNKIKNVLFFNGKK
ILVIDSTGIYENRIQPDILILTQSPKINLQRVLNDLKPKNVIADATNSYSLQKYWTITCL
EKKIPFHATREKGFYKLN
>EGALAKHO_03816 Disulfide bond reductase DsbH
MTKKLLILLFFLGSFFSHAQNLVWRTNMTDAIAISNEQRKPMLILFTASGVPENLQNEIF
KTPDFAVWSRDNVVLVKLDLSDSNASDGDKEQNIKLKNAFGVEDLPEVCYALASIRKNKT
TFSALGKIAYKPGGAKAWIAESNALLHPSE
>EGALAKHO_03817 Disulfide bond reductase DsbH
MKKIFLIIFFLTGVFAVQSQELKWYTDVREAITESNKVHKPMLMFFTGSDWCGWCIRLQN
EVLTTSEFKKWAADNVVLVELDYPRRTPQTPEIKNQNNELQQAFGIQGFPTIYFTSAEAI
DGKVDFKGLGQTGYVAGGPIAWLAVANGIVNPKKS
>EGALAKHO_03818 Dipeptide and tripeptide permease A
MESNTITLEQIQNFKGKYPKQLWYLFLVEMWERFCFYGMRGVLAFFMVDQLGLLEGKANL
QYGAIQAFVYAFTFIGGIFADKVLGFKKSLLFGGIIMILGNLLIAASPHDFFYYGITLSI
IGTGFFKPNVSSMVGELYHESDGRRDAGYGLFYAGINIGGMLGGAIPIYLGKNYSWSLCF
LSSAVVMIIGVVTFLLTKKHLAPIGNSPLEDQTPKKRRMNEIAVYLGSIIVIPFIYIMVI
NSDYTDYFMYTIGVIAIGYFLFELIRIKDRKQQYKLLAAFIFIFGYFMFMAISEQSGGSL
SLFAKDNLSSKLLFFNIDPNVVNNSINSLYVIIFSPLVGILWIFLYKRKIEPNTVIKFGL
SFILLAAGFFIFYSARFFIDPKGLSSLNVFALGYLVYTLGELCIGPIGMSVITKLSPKRL
FGMMMGLWFLSSAFGQLAAGKLGSEMSNANTGATLMSKLIAYTDGYYQLALYSLVAGIVL
IVTTPLIKKLMQEVK
>EGALAKHO_03819 Di-/tripeptide transporter
MGETQVKTGHPKGLWVLFGTEMWERFNFYGMRALLTLFLVNSLMMKEEEASLIYGGFLGL
CYLTPMLGGFVADRFLGNRNCILLGGLLMATGQMLLFTSGSVFESNLGLAKTIMYCGLGV
IVFGNGFFKPNISSMVGSLYPKQEKTKLDTAFTIFYMGINIGAFLGQSICPLLGDVKDAG
GIRDIHAFRWGFMAASVAMLIGTVLFYFLKNKYVVSPEGRPLGGLPSKNVAADFEEGEAQ
KANFSNKALTIAGIAFIALGFFFHYGVGQNLIYTLIYSSGLALAGLIISDTSLTKIERDR
IIVIYIVSFFIIFFWAAFEQAGSSLTFIADNQTDRHFFGYLMPPSMVQIFNGLFVVVMAV
PFSILWDTLRAKDKEPISPVKLAAGLVIISISFFMIATQVSYIGTSGLLLVKWLILLYFL
NTCAELCLSPIGLSLVGKLSPKRFASLLYGVFFLSNASGYALGGTLGSILPATGDKFAKA
KELGIDLQAVLDNKITPTAEQLALLDQHQISAHNHFFAGFEIHNLYEFFMVFVVLTGIAA
LILFALTPFLKKMMHGVR
>EGALAKHO_03820 Prolyl tripeptidyl peptidase
MFIFFTKIGLFFIFKIIQMNTSKITVMLLFLVASVFGQQKITVENIYGGAFRAKGMDELQ
SLKNTDQYTVLNVDQASRSQQIDLYDFATLKKVSNLIDTKNHKELSDGIDSYTFDASEKK
ILIACNSKQIFRHSFTADYFLYDIATKSLTKLFDFQVQEPTFSPDGTKIAYAKENNLYVY
DVVSKKSTAVTTDGKKNAVINGITDWVYEEEFAFVRAFDWSKDSKKLAYIRFDESAVPEF
SMSIFKKDLYPTVETFKYPKAGEKNSVVSLHIYDAAANATKKVDLGNYNDFYIARLQWTN
DNNILSAQVLNRHQDNLDLLFVDGTTAAAKVVLNEKDKAYVDVTDNLTFLKDNSFIWTSE
KDGYNHIYVYDKTGKLKNQVTKGNWEVVSYYGFDEKTKTIFYQSTENGSINRDIYKIGLD
GKSKLRLTSKVGTSAATFSPNFQYFITTFSSNLVPTTYTLNEAKTGKEIQVIENNQALAD
KLKAYNLPAKEFFVLKTAKGNELNAWILKPKDFDPSKKYPVFMYQYSGPGSQQVNNDWNN
TDDYWFLSLTQQGYIVACVDGRGTGFKGADFKKVTQKELGKYEVEDQIDAAKVIGAYPYV
DASRIGIFGWSYGGFMASNCIFQGNDVFKMAIAVAPVTNWRFYDSVYTERYMQTPQENAS
GYDQNSPINHVDKLKGKFLLIHGSGDDNVHVQNSMQMMEALIQANKQFDSQIYPDKNHGI
YGGKTRIQLYNKMTNFIKENL
>EGALAKHO_03821 3-hydroxy-3-methylglutaryl-coenzyme A reductase
MNNAVAGFSKLSKKEKINWIAKEYFSNPEEAQTIIRNYWNSDEKLQQLHDEFIENTITNL
YIPLGVAPNFLINGKYKTIPMAIEESSVVAAASKSAKYWATRGGFKATVINTEKIGQVHF
TFNGDTEKLQSFFDEIKPKFFSDTQSITKNMQQRGGGILDIKLKDKRSLLENYFQLHATF
ETKDSMGANFINSCLEQFATTLKEEFQQSDLFSADENIKVVMSILSNYVPNCIVRAEVSC
PIEDLTEKHITNPQDFAERFVQAVQIAEVEPFRAVTHNKGIMNGVDAVILATGNDFRAVE
AGVHAYASRNGQYSSLSHAKIENGIFTFWLEIPLALGTVGGLTSLHPLVKLCLEMLEKPS
AQELMEIVAVAGLAQNFAALRSLTTTGIQEGHMKMHLNNIINQFEANDEERHLIKTHFKK
NVVSHSAVVEFIENLRK
>EGALAKHO_03822 hypothetical protein
MKTIFYSNGKLLITGEYLVLDGATAFALPTKFGQNLIVRKGQNQEIIWKSYNYDDQLWFE
DVISFSEIINNVEAKTETVKTTLITILHEAYLLNADFINKADGYEISTHLTFPKNWGLGT
SSTLLNNIAQWVKIDAFILLKNSFGGSGYDIACAQNNTPITYRLDQNLPIVEKVEFNPEF
TKNIFFVYLNKKQSSKIAINAYYNNKNENLTENILDNNKITKAILEAKTLNEFAYYVEKH
EIHLSNILELETIKEIAFPDFNGVVKSLGAWGGDFVMAISKENPKDYFTSKGYETILTYD
EMILQE
>EGALAKHO_03823 hypothetical protein
MFFMFNFFKRKPRVYSKIENHIYGIITELLKVSSTDINVDELGGKYYLSNEEQHFKVTIL
SNDYVIRLTNTRDSVAEKYDKIFVEDVLKAVKEEKHRRMELVYDSINNSIEKMAERLHNT
LIESNEQESQKVRRLETKDIKNKKVNY
>EGALAKHO_03824 Foldase protein PrsA
MAVLAKIRQRSALLIGVIALALFAFIIQDLIGKGTFSQSSKDVGSIDGKDISFEDFRVKV
SNVEKSGQGISSTEAANRVWDQEVSIALLSAQFDKLGLRVGEKHLLEVLKADPNIGKNPM
FLNAAGMFDVVKFKEYFKTNPEAAQYISAKEKDAELNAKFQIYNTLIKSGLYTTASEGKL
KYEMEANKVNFAYVGALYSSIKDSEVKISDDEIVDYMKKNEKKFKADETREIQYVLVEDK
ASKEDEAEIKAKITGLLNGSVVYNAKTGKNDTLPGFRNAKNIAEFVNANSDVPYDSTYVA
KNDLPAVDADKLFSLPAGSIYGPYVYGRYYAISKSLGFKAGVNAKASHILIGYEGSQTPN
QKEKRTKEEAKAKAEEILAQVQANPDSFMMLAFTSSDDPSAQQGGDLGYFGQNQMVKPFN
DFVFSNGIGKIGLVETPFGFHIIKITDKQDGIRLATIAQKIEPSEATSDKVFTLATKFEM
DAADKDFAATAKELGLKVAAPVTAKAMDEAFGPLGNQRNIVRWAFDKETSIGDVKRFELA
NIGHVIAQYKSENKSGLVSVTMARPYVEPILKNKKKAEMLKAKLTGSSLEAIAKSAGVAV
QQAANVTMDNPVLPGGVGQEPKVVGNAFALTANKVSAPIEGNTGVYVVKNISTVKAPAIA
SHAEYVAKVKAQSASDASRILPALKNNAKIEDNRLQFNY
>EGALAKHO_03825 Hemolysin C
MEISIIILCLILSAFFSGMEIAFISSNKIYLGIEKKQDNFASQILTKLTENPSKFIAAML
IGNNVALVVYGFFMGDLVLKCITRLGFHFSDITGLLIQTIISTFIVLITAEFLPKVFFQI
YANSLIKILAVPAYLFYRLFYYISTFFIWISDFVLRKFLKTEGDQVQLYFSKVELGNYIT
EQMNSVEDDEEVDSEIQIFQNALEFSGVKARDIMTPRTEIVDIDLFDSITDLKALFIETG
YSKIVVSQNSLDDIVGYVHSFDLFKKPKTIKSVLMTVEFVPETILIKDALNLLIKKRKNV
AVVLDEYGGTSGIITIEDIVEELFGEIEDEHDLDEELIEQELGEGKYLFSTRLDVEYLNE
TYKLMIPEEDSYGTLGGFIVNFTKEIPQKGEEIVIDHYHFVIEEATNKKIELVKMTIKE
>EGALAKHO_03826 hypothetical protein
MGLLKYTQYLYLLIAVAFVYDGITKLNDPAAGPWLSFGIAAVSVFMFFFRRKYAKKFDDH
YKKQ
>EGALAKHO_03827 Lipopolysaccharide export system protein LptC
MNLPKKYIINAVTVLAVTLFFGCESNFKEVQKINFSEFVPGSDVDTVNIKYTDSGRITGV
LKSRKMLDYSNLEFPFTEFPKGIDVTLYDKKQKRTFIVANYAVSYKQTGIIDLQGKVKIT
SETGQMLETEQLYFDQKNEWFYTERKFKLTDAKGVSNGQGIDFSKDFKVINSQRITGELE
ANE
>EGALAKHO_03828 hypothetical protein
MIKKIIISACLLISFVSFAQQGTASPYSFYGIGDARFKGTLENRSMAGVSVEQDSIHLNI
DNPSSYASLGQTTFTVGGSFGTSTLKNSNQSEKAQRATFDYLAVGIPMGKFGAAFGLVPL
SSVGYKILNDNTDVPGATNSQYEGKGGVNKVFLGLGYKIMPNWNIGADVQYNFGQITTTS
IEGITDVQNVTKETNQSELSGVNFNLGTMYQRKIYKKTSLFTSLNYTFASTLNSGNTRVI
SVSGDPDPYEYPSTQTNLKLPNKLTIGVGVGEARKWLVGTTLAFQGDGRYANYYNASDDV
RYEKYSKYAVGGYYIPNYTSFSSYFSRITYRAGLKYEKIGLVINNESINDVGMTLGAGFP
ITGSFSNVNLGLEFGKRGTTAAGLIQENYFNFSLSFSFNDRWFVKSKFN
>EGALAKHO_03829 Type III pantothenate kinase
MVLTVDVGNTRIKAAVFEGSTVLENFVFEKNELEKKIKIILEKFQNCSDLVVASVGNVEK
QSFLTFEAQLKIHFLTHEDDFPFINNYATPKTLGIDRMVLAAGATLQFPKQNRLVIDAGT
CITYDFIDENDHYLGGAISPGLRLRYESLHNFTAKLPLLALDAPESYIGNSTKESIHSGI
VNGFVYEIDGFIDEYRGNFSNFIIILTGGDAEFLAKRLKNTIFANSNFLLESLNQTFQYK
IDND
>EGALAKHO_03831 hypothetical protein
MGTAITNLTPANTGGAATSYSVSPALPSGLILNASTGVISGTPSQVTAQSTYSVTTTNSA
GNSVFPLVITVKTNVVSPSITYNSQNVFVVGTTIGNLIPLNTGGKVVNYTISPVLPNGLN
FSETSGIISGLPSEAKEETIYTITATNNGGSSAYEIKISISPALGLKDPTLSKIRIYPNP
VQDILNIDGKEGIKSVEVYNMLGQLVHSQQYNDFDTAGFLKLVDFSSLKTGIYLIVIFTD
SEKSSYKILKK
>EGALAKHO_03832 hypothetical protein
MKYIEHFYSLNPDWQYDFAKQMDICLIDDKIMIIPNTIGSGHVYFTQSLPGISVLVTDFT
IKTPLTLNKLVSQEEFYMFTFSSIGNRVENANQFSLIISNNQFEESFSPTLNKKVFELSV
FVEKNGMHNLISGLDNPQFVTNRISNINDCYTEYLDSDSLRLLQSVKNESIYNLSFEYFL
RGVSLKLLANFLSQN
>EGALAKHO_03833 hypothetical protein
MIQLNHYYSLKGDWQKQIAKKMGIILIRDKVAVLPNHFAQGISYFTPVTKGISIVLLDAV
FTKEVNITRLASDDDLYILQFDLSEKINTVTIKDNTNKNKEIETGFSVLHTSIENSFRPN
LKQRTFALRLLIDRQMLHDLLKIKGKKNIDKKILFYNHVNSNSKILINSLKQKHAFNIQF
DSYIRGITLKILANFIETYSHPNKEQVLKMDNDLINKTTQYMLENLNSKFPTIKFLSDMA
RMSDTKYKIIFKKIYHTTPNHFFNEQKLILANKLLKSGSFRCIIEISDLLNYSKTSYFAD
KYFKFFKRKLSEDFIKKDSHL
>EGALAKHO_03834 HTH-type transcriptional regulator CdhR
MKTITQHYGADLEWTQKLAEQLEGKVEGNFIKASESIHSGIRYFQDCGAGIVAQYVDVTY
NTDVKFIHKNLTDDFVGLHFCLSESEALVSFKKASKMVSSWSYNLLLIDSSLPFEFEIKK
GSKIFLFSIFIKKETIKIYAEKNNIFKKTISKIMNPQQNTIVKWERMSTKSYQALKELQK
LKKKDFLFDLNMSGAVHLLISDYLHKISEKDFIIQLVNQTDLSNILAIQHNLLENINDHF
PSINMLADKCNMSSTKFKILFKKISGETPNAFFIENKLFKAKELLEERQLTVSEISNLLN
FHNTSYFAYKFKEKFGIAPKTFSQQL
>EGALAKHO_03835 hypothetical protein
MFPAAIVVVSFVPFKTTLGKITPLSVAVISNIVEGLGFLFPIPTCALAVSPRLNAKTK
>EGALAKHO_03836 hypothetical protein
MKGEKGDQGAALTFADLTQADKDALKGAKGDQGDKLTFADLTQADKDALKGADGIGGSTV
AGANATITGAGTLADPFVVNAAKQVADAINDGELNLAPSQNAVSDALLLKAPLDAPVFTG
NAQAVTPAAGDSSTSIATTAFVKAAMPSLVAKEVVATDSQITFAIAETPVAGSVSFYVNG
VKIPIAAISFAGTSVTYNSASNLGYDLLAGDLVTITYIK
>EGALAKHO_03837 hypothetical protein
MKRIEKLVVVLTFGGCFSAMAQQTPVKTILATTGEKVSYAQTSSNVVADEAAMLALPARI
GDVAVQSSTNKTFILKLKDASALASWVEIKAPSSGGTVTSVTSELGTTGTDIDIAVTTGT
TTPLITLNIPTASAANRGALSAADWTIFNDKEPAIAPGTAGQYYTGEKNWATLDKAAVGL
GNVDNTSDLLKPISTAAQAALDDKAPINAPVLTGDAQAVTPAAGDSDTSIATTAFVADAI
TAGMTTGTTNTLTMAVNTLSSTVNGKLATADIVTGVSNTLTGTKLTTTVNGVEGAAVDLA
VALGTTVTEEFTAVDGQIDFTLTTAPTAGSKIKFYINGVRIENAITLAGSKVSYDNTKNL
AYELQAGDLIVIDYLK
>EGALAKHO_03838 hypothetical protein
MRHCIFLRKSVPDYNLINKKHEKNNMHAALDPWGLYDSAK
>EGALAKHO_03839 hypothetical protein
MLLLTLGGSMTAQNKKVVAQTGEKVTLSPVLTTTERDALATPYIGFLIFNTTTNCHEFYN
GLNGWYNYCWGGYTKGNDASTGGTAVVSGYNCSGAAAGTMTAGVAVTGVTQTITATVTTA
GTYNITAAANGVIFAGTGTFAGTGAQNIVLTATGAPVLDGVYNFIMSTTPGCGFNRTIGS
NISATSNGTAVITALDCAANSAGTMTAGTAVSGVTQSITATVATAGTYSISTTANGVTFA
GAGTFAGTGAQTVVLTATGTPTAVGSNAYVLNTTPNCNFIRNTVSAISATSNGTAVVSAY
DCSGAAAGTMEEGTAVSGVTQTITATVTTPGTYSISITANGVTFAGTGTFAATGAQPVVL
TATGTPTAPGSNSFVLNTTPNCGFNRTTNPMVGTITGAAGKIWMDRNLGASQVATSSTDY
LAYGSLYQWGRGSDGHQLINWTSASAGTPVNGTTGTLSSTDTPGNSLFIISNSGNYDWRN
PQNNTLWQGKDGINNPCPSGYRLPTDAEFNSEVTTAGITNSATAYAKLKLVVAGYRYYGN
GTLVSTGTNGYYWTSTVSGTPAYNRYFNSSGTDSYVNNRANGFSVRCLKD
>EGALAKHO_03840 hypothetical protein
MSKEKILHNLYQAYYTARKNKVNSKDKQLFEIEHEQRLHLLCESICDRTYVVSPCKAFVI
EKPVCREIFAPQFVDRVVHHLVAQYLLPVLEGTLIQDAYSCRTGKGTSYGVKRATYFMRS
VTGNYAKDAYVLKLDISGYFMNINHVFLYEKIKSMKLVEHSFASNYEKEILDFLIQKIIF
TSPVQNCVRTGDKSLWKFVPNNKSLFYSPDACGLPIGNLTSQLFANIYLNAFDHWIKNEL
GMNYYGRYVDDMIWMHEDKEKLKELTTLVSQKLKSIGLDLHPKKIYPPAGASVPPRWRER
PARERVVIKIAIG
>EGALAKHO_03841 hypothetical protein
MSRKYKFADTAGAYFISFATVYWIDVFTREEYFGNIVESLDYCRKNKGMEIYGYYIMPSH
IHLIFRSENKDPSGLIRDFKGFTSKKMLKSIEDNHNNPPLARASRS
>EGALAKHO_03842 hypothetical protein
MKKIICFLLLTLGFTMAAQNKKVVARTGEQVTVERVMTTTERDALQPVPYIGFLIFNTTT
DCHEFYNGAQGWYNYCWQGYVKNNDPSSNGTAVVSSYNCAGTDVGAMTVGKGVNGVTHTI
TADVATAGTYNIKATVNGVTFAGSGTFAATGSQDIVLTATGTPATASTSSFALNTTPSCS
FDRTVIGSYNATSGGTADIALVNCSANQAGNMTEGTAVSGVTQTIAVNVITPGSYVILTD
TKNGIYFSGSGTFATAGLQNVVLTASGTPTAAGSPVFTLSTTPNCTFNRTIDANISSSTG
GTAVVSGYSCSTGSTGTMVIGTAVSGVTQTITANVTKVGTYTITATANGVTFTGSGTFAT
TGSQNIVLTATGTPVAIGNNDFVLSTTPGCSFNRTTNSNISATSNGTAIVSSYDCSGGAL
TGTLTETTAVSGVTKTIIANVATTGTYSITTTANGVTFAGTGAFAGTGNQNITLTATGTP
AVAGSNNFVLNTTPNCSFSVITNTIIPTVLGAAGKTWMAMNLGATRVATSSTDYLAYGDL
YQWGRGADGHEKINWTSGTAGTPVNGYTNIVSSTDTAVNSLFIDSGSAGDWRSPKNDALW
QGYAGTNNPCPAGFRLPTDPELTAEFTNNNITNLATAYSSNLKLVAAGWRGTNYGAMQSI
GTYALLASSTTSGTLVKTISITPTGVIHSDWFRGNGHTVRCMKD
>EGALAKHO_03843 hypothetical protein
MKFTKLNCIVALLLTSLLFTAISCNSSDSEVVSLTLGQRIVAKRWQTTEVYEDGGTSNKI
EDYPGVVSVSTWTLAAGKTNSGIFEFRNVTDPEGTPRAQGTFEFVGDIRFLTFPNGNSTM
ATMKTLNTEINEYTQAVPQQIKGIAVVPQKMVVIRVVHKPYPLK
>EGALAKHO_03844 hypothetical protein
MTIAQVMMALVIAMAVIFVIALLIKIVKYILGK
>EGALAKHO_03845 hypothetical protein
MTIIIVTVGLIIGLGITIAIGLIMAIINKKPNANNSKNSSHNDIENDVKNYRELSANDAD
SQYGHNNS
>EGALAKHO_03846 hypothetical protein
MKIMMSILMIIVMMIVLTTIITIAMLVVKMISALFTLFTTAKEK
>EGALAKHO_03847 hypothetical protein
MYETFIKLLPSLPFKSVGLFMSGLLQKKELSKLNNLKSAYSTFDKFETDFEKNFLEHAQK
EACFFIETGIETNYISIPKFIEFKDRLGLRWNWRQIKEVLDHLDLRGEKIKINLSTLEKI
CTNAIVVLFFILVFSGIVWSSCADQYKTPLPKYLLSPLLFIIPALCGYFLVIVLAGSRLT
AMTMERRLNSLQKNLNES
>EGALAKHO_03848 Thiol-disulfide oxidoreductase ResA
MKRYFKILVKKIILFLLLLVGVAAIAQKQYTVKGNFPQAKNIELKLEGFEAFKDTLLSGA
KTDDQGNFVLTYPAAYKGAALLKIKEGGSVIVLLNQENFTINWGDFKDFNTLQFTNSPEN
ENFGKGIVIAQEAENILAGLKYLKPMYAKSPVELQWLDKEIVIKENAFTDFSKKLPASSY
AVYYLTIRKLIQDMPLTANRYIERMPDHEKQFAAINFSDPRLVHSGLLKELIDGFYLLME
SYGDQDKVAEHTKPATEALLKSLENNTKLKQEIAEYLFKLLEKRSLFIPAEQVAMYMLND
KSCSLTENKTALYEQYRKMKVGNKTVEINLNSNTKGISKLSDINAKYKLIVFGSSWCPRC
QEELPALKDKYKQWKDKYDLEIVFISLDTDQLKYQAFVKDFPFISSCDFKEWKTQSAIDY
CVFATPTMYLLDNQNTILLKPLSAGHLDSWLSSVVRVN
>EGALAKHO_03849 6-phosphogluconolactonase
MFKKKSFLGLMTLLSGLLFLSGCSNDNNSKSENEGGGVFTMSNSATGNELIQYKIDDDGS
LEFKAKIKTSGLGSGTGLGSQGAVIISADKKFIFAVNAGDNSVSSFKIVSDNDPVLFIGK
YNLVGKKPISITQRGNLVYVLNSEGATGASSIEGFTLNAATGILTAIPNSSTTFAVNVDP
AQVSFVYDNIIVVTERGANKLASYTLSANYVPTNRQEITSQATTPFGFAVGSKGKIYVTE
ASAMSSVSSYMVSSTGAISNISTLRNNQGGACWAVLNKAESIVYSTNFNSHTISSFNIGT
DGKLTATQIASDLGSGNGPLDAGITRSSNYFYVLAGTSGSILGYGLNGNLLTAIPGATIF
VPTTSVGLAVY
>EGALAKHO_03850 hypothetical protein
MKLNDSKIAYYVGVFGVIITLFWVGLFKFTLKEALAIKPLVENHFGMSWMYKIMNVQTVS
NVIGIVEIIVALGLVLSFFYKKAGIYAGQASAVIFATTLSFIATTPGIFGYVDGLPLIKN
FLIMDFFILKDIPFLGISLWVYAKSKML
>EGALAKHO_03851 hypothetical protein
MKKEHQKLFYFVFAMSLGFAASAQVGIGTKKPNSSSQLEIVSEDKGILIPRISLTSLVDL
TTISNGNIESLLIYNTNVTTELIAGYYFWSKDRWHHIATDDEKNSDKVKMIDNGNGTYSF
IDGDGKVTVINKSVGETLTSLVVDPRGTLSYKDEKGETTVIKVADLESLTSLALNTDKKN
LNFTDEKGVVTKIDMQAVVKNLETETKLTKNDDGTFTYINENGTSVTIEGFGLEVVNGVT
KKGQNLELGGSLNKPTQIISSATNTLAIEGLQQGGLTDNIVVVDSATGVLKSLPATSFNN
LRKIQIYIAKAGQNSYAAPFQIFDKDKVQVFRNGVQIDFNVTTDARSVTLDFSGYAEDNI
TSCFAGDEIKIFQWK
>EGALAKHO_03852 hypothetical protein
MKTRILKQGIGKVTIIVTLFLSALAANAQQKAANIVKQSAAKQGDVGTGLADGGAIRVVD
NKGTIKYLQVQNGITQVTSTAPSGGGIVTTWQLGGSLTDDTYIDVAGKIFSLDGIELVSS
GLTASIDATDKSIHGTGTGYTFLVRDEVTGAIKKLKLVDLVKGGQYSDKAIAGSDFVYSG
DSTVPADINKIWVYRNGVKMLGGVDYNVTGTLGVVIVTVNKSGGIDPEDYSLITGDRIEV
QWVR
>EGALAKHO_03853 hypothetical protein
MGFNIKILFVFFWTLVLACTASAQIRVVDNKGTIKEIDTTKWLLKNNNIYNKNSQNVIIG
ESLTYVPTARFTVSTTSTHPAFKLKYPFVGSLADSILTWNSKDSIVRKISVSKLNSGDWQ
TLGNAGTNSSSFIGTIDNQPLQFKVNNVNAGILTANNTYYGYNAFNLETVGINNTAVGSQ
SLSGNRMGNDNVAIGYYSLMNAEASNNLGIGTSTGLAISTGFNNTFVGAFSDATEKDLIN
ATAIGYKAKVGASNSMVLGGMGADAVNVGIGISKPIQKLDVNGNVQATSFMKVGGTTSQF
LKADGSTDNSTYITNTPVSSSVAGIINNVSLQELGGADKTIHGIRIGIGSGNSVSNTALG
ANVLKFNSTGANNTAVGYNALNINQTGSNNSALGQGVLSNNSSGSNNTAVGQNALNANEI
GGNNTAIGFGSLQKNISGSYNIAVGSNSLYSNNTASNNIAVGFGSMQFNTTGSFNVGIGS
LALSANSIGSRNVVTGYYAGNLNNEGSDNVAYGYKAFSFNNEGSGNVIIGSLAAAINNTI
NQLDSCVLIGKGVMPNDNGEFNEIVIGTNVKGNGSNTVTIGDVNITQTMLSGIVYSAGTA
LTSDKRLKTNIQPVENGLSKIMQMNPVIYSKKASLESTDYNMSEIGFVAQELQALFPMGV
VHEGKDKDKLLSVSYDSLIPILTKAIQEQQKIIETVKIKNDKQQKEIDELKKMMRQLLAK
T
>EGALAKHO_03854 hypothetical protein
MLTADINTDCSPYWQRKSTDRAISKLKTKIQTNVETEKLDLTGFKKVS
>EGALAKHO_03855 hypothetical protein
MKITKTSKLLLGTVILVSATSSAQTVNTGELSITPGTEVGILEEFDNSITGDFVNDGELY
LFDHYNNDGLVSFSKDKNFGTTFMVGKKGYQDISGSVPMEWNNAVFNNAVIQPAFRLSNE
IRISGKATFQTGIVDSDNNGGSMVFEQNATHDKTSDLSHVDGIVRKNGNTEFVFPIGDGG
FYRYARISSPQKMESAYSGHYFFKDSDFLYPHASKEEIIKLIDNSEYWTLERTAGTDTVF
LTLSWSSDTTNSEIYDLPYDEIHIVRWDEVQSKWIDLGGATNSSAKEVSMVVNPLESYGV
FTLARVSKVLGDLIIYNAVSANEDGSNDYFKIGGIENYKKNNVEIYNRWGVKVFETSGYD
NTTNVFRGFSEGRATVKKGEKLPVGTYFYIIHATDTASGKNSEKSGYLYLSY
>EGALAKHO_03856 hypothetical protein
MNIRIKKRNFILLLAIIASGFKASAQQESQFTQYMYNTISFNPAYAGSRDALSIMGIYRA
QWIGLQGAPKTANFSINGPVGDRVGIGFSFINDKIGPSDETNFNLDLSYNIIVNADARLF
FGIKASGNLLNIDYSKLSQSDGNDQMFNENVKNLFTPNVGAGVYYQTQNAYIGVSVPYFL
ETNHYKDNAVSTVREKMHAYLMGGYVFDINRDLQFKPAALIKAVSGAPLQVDLSANFLIN
DKLTLGAAYRLNSAVSALAGFQITNGLMAGYAYDFETSKLGNYNSGSHEIFLRFEIAKGN
LPILNPRFF
>EGALAKHO_03857 Outer membrane lipoprotein Omp16
MKKKNIYIAGLLLMSIVSFAQIKDAKLREGDKSFEEQAYFKSIEIYEKVANDGYKSVELF
EKLGDSYFFNGEYVKANIWYAKLFELSKDVDPVYFYRYSQTLKSVSDNVNSNLYLQQFAA
LNQMDSRSKYFAESKDYLSEIKDFSGRYTTKDAGINTQYSDFGTTILKDKIVFSSSRVTD
QNEKKDNWTSDNYYSLYTALLGKDNTLVDAQLFATEIKSKYHESDPVFTKDGKTMYFTRS
VPTKSKKKSKKSILLKIYKASLINDKWDDIIELGFNSDAYSCAHPALSPDDKILYFVSDM
PGGYGDSDIYRLPVNDEMNPSKIVNVGPNVNTSGKESFPWIDENNNLYFASDGHLGLGGL
DVFVTKMENFNYTSKVVNLGKPVNSQFDDFGFVKLKNSNSGFFTSNREDGIGKDDIYSFT
EKILNSKIQGSVIDDETGVAIAGAVVNVYDLDHNLIATMTSDDSGKFWVDVDKTHYIKVG
KSDYETKEIVLHLSNEDSDKEITVGLSKALKYLEGGKDLAKLLSVRDIQFDLNKFDIKSD
SEVELQKIIQVLNEFPEMKITVKSYTDSRQSTRYNMNLSNKRAKSTREYLIAHGIAGNRI
AAKGYGETNLLNKCADGVECTEDEHRVNRRSEFIIK
>EGALAKHO_03858 hypothetical protein
MKKKPFFCLTPELQLQLAEEIHGKLIQNKIIEIPQDLGKGQVLFIQAIPGMALLLWNCTL
DKPLKIQAYKDNTKRYIFHYDINHQPDFLTIQNKKAGIENLKDHGLTIFSNQKESFFKPP
IKKEIFGIRLYIDKKLMKKFLTDNENIIQKLKMAKKNAFYDNIDGNSYLLMLSVKEKSIY
EESFDAFIKGIVLQLLGNFIKKHTETPSSHNIKELEQEGLIASKNYLTSHLCEQFPSIAF
LSQLAGMSGTKFKILFKKKFNTTANDFFIQEKMNLAHQMLQSGDYNTLTEIIHELHYNKL
QQFTFRYLEIFKKKPSENFIKKNKKPPNIV
>EGALAKHO_03859 HTH-type transcriptional activator Btr
MKTIQHSYGADLDWIPSYIKGFGGSVNGNFIYTPEDISTGTRYFLETGEEDVVIFYIDAI
YHSEIHVIQSHSKKDFVGFYFNLTQGKTLKTCTDLSYDIGTLGYDVSIIDSLLETDYYIS
PGTKSYGICIFIKKIKIKSFASRNENFSSNINKIMDTNKNTFIKFDHMSPEIFAILNDLR
KLKVGGEIFNINLMATGYHLISNYLNQMFNDNIIEKVNKYDLLSIIEVQTLLLNNSQEPF
PTIKKLSDRANMSETKFKKLFKKITGTTANNYYMSTKLKKAKELLENKTNTITEVCEQLN
FSNYSYFIFKFREYFGISPNTFIKKL
>EGALAKHO_03860 hypothetical protein
MCRTIICSIIILMLSTSCSNDSYDFQGKNSISIPDVSYSYTESEQQVMNLINNYRVENGL
NALEIIDYVSIKSEEHNNYMIATNSVSHNGFVERSEDIIKALRVHKIAENIGYNYSSAQG
VFDAWLRSPEHKKNIVGDFTSFGISIRQSSDNKKYYTNIFVKE
>EGALAKHO_03861 hypothetical protein
MPKGAINKTKEKRKFFALQEKILPQWKKIALEVLSDEETILINNTTCNVFLN
>EGALAKHO_03862 hypothetical protein
MKIFLLSLFAIAFFSNTKNSDKIESNLDFDLERFNNEVSAIIPCINSNASYNNKVAFFID
MKIKSGKNRFFVYDLVNKKIIDQGLVANGSGSETGIRGDLKFSNIVNSNSTSLGRYAIGK
NYNGIFGKAYKLYGLDQTNSNAFVRNIVLHQYSAVPSEEQDYYIVNSHGCPMINEQFFKR
IEKIIDSSKTKIIMSIYY
>EGALAKHO_03863 hypothetical protein
MQNIESRDQLLIREYIRGNNSSMNMLIKKYES
>EGALAKHO_03864 hypothetical protein
MQDAKSFIQLTNFFISNNKKAYPGDFSASYNKINIGLKLQHIAKLKKHNEISLKKFEKIK
LRLIQRRHL
>EGALAKHO_03865 hypothetical protein
MILKIIVVFTELKAGGLSKNKIVSKTTSIGFI
>EGALAKHO_03866 hypothetical protein
MKLFIYKVSNWEYWPYQVLYIPIYFLWVYYSIKAKSIFFFNASNPRMKNGGFIMESKKQI
YDLLPKKYYPKTILIQKNMNLSKIVDLIVEKNIHFPLIAKPDIGLRGSGVKKIKTVSDLK
KYTKKADFDFLLQGLIPFQNEVGIFYVRHPHQKNGRITGIVSKEFLIITGDGKSTIEDLI
KQTPRFELQFNVLKEEYKNQLDQILKKDETLNLVPFGNHCRGAKFLDKSDLITPKLTAMI
NEIATQIPEFYFGRFDIMYNTIEELECGENFQIVELNGAASEPTHIYDPKHSVWFAWKEL
ARHITYMYEISVENHKMGIPYLEYKVGMREYKLHLVQNRKIINF
>EGALAKHO_03867 hypothetical protein
MCTVSFINNNGNIIITSNRDEKVIRPCAIAPVNYQLNGKNLLYPKDLKAGGTWFAIDEKG
TVLVLLNGGRTNHLSKIANGKSRGLIALDIISDKSPRNYWNHVHLEDIEPFTLVLYQNEE
LYELIWDGFIKFATRLNPINNHIWSSVTLYSEEIRKKRAGWFFDFLKNKKEISPLEILNF
HRNTERGNSENGLIINRGNVLKTLSITQAILEDNRGILRYFDLSKTQSHLSTFIRI
>EGALAKHO_03868 hypothetical protein
MLLKSICHSLDELTNLLVQLQDKDYTKTYEALSNATIGEHIRHILEMFYCLQINYDSGIV
NYDNRERNKQIQTEIKYAKQCILGIKLGFKNKNKIIYLEQIIDGIAIKIESNYHRELLYN
LEHCIHHQALIKVAILQCDNILINKNFGVARSTIEYRKQCAQ
>EGALAKHO_03869 hypothetical protein
MTKMKITWILKIIASIILLQTLFYKFTAAPESIYIFSTLKMEPYGRIGIGISELIVAVLI
LIPKTTLMGSLAGVAIMAGAIVSHLFVLGIQIQNDKGFLFTLAIITLFCCLGLVYLNKDK
ISTILKSK
>EGALAKHO_03870 hypothetical protein
MKKITLLLLTLVSMVSFAQNDANRVIHYNLQNKVALQGYDPVAYFTQKKAIKGKKELSIT
YKGIVYKFSSNKNKDSFSKAPSKYEPQYGGWCAYALGSSGEKVEINPQTFKIIDGKLYLF
YNAYFNNTLKSWNKDETNLKNKADNNWKKLFK
>EGALAKHO_03871 hypothetical protein
MKYIVNMIFLSMSFFATAQGKRTDLDKIVKKDFSVVEGHVIKVTATVVDFSYLNEDTVNS
LEVNEVAKIYFSSGRIQEFINNNELTSDIKNIQENTHKVIFKEIKKNTIAVLPVSFLNTE
THEFSDERSKYAQNDLYIEVTKYTNQYSLQDVRETNSLLSMAGIDSNSLDLVPIETLQGI
LGVDNIVVGRVSYTVNNRQDVITGSYSSIGTNKRKDRGYETGFSNTSIQDNAVYEYKVYL
DVYKNFQKTYSQTRVPLNIFGAGPDKWVDAMKYLIKRSPLYVKKN
>EGALAKHO_03872 hypothetical protein
MDKVLVNDKQGTFLKMFKRQFKNQFEFSENSLLNHTSPEDFNHFIFVVYNKEEMIEFLKL
DKNGNNVLVCIFNKQLFTSLSFLEEIKNLILLDNSKTRTEIVKELKLYFKNTPCYKSESE
MSKTNFVNSNIIQTQFHDFYKALFFLL
>EGALAKHO_03873 Outer membrane porin F
MKKIVMTLAFALGLIHANAQKENNVATVYNKWSVELDGGFNKPQRPFTSEKYYTDRINPF
TVDLGVRYMLNNKFGLKVDMGYNSFTGQNHSSTGFESKYYRVDLQAVANLGRIMNFETWT
KTFGLLGHTGFGVGELENKDLHVKDMVGNFIAGITGQIRLTDRFALTGDVSTILNAYQDR
TFDGVSDTNARGFSGLLFNGTIGLNVYLGKNTKHADWIVLSEDNNLNELESKVANLEDLI
KKVPEKQIIVEKPVYNNVLNDKDVVKQMINDKYYSVYFNFNQSTPIENSTAAIDVVLSYL
RKNPSASLDILGYADQVGSQEYNTKLSNARATNVKTIFEKAGIASSRLNVVPQGADTTIQ
KDSEEARRLARRVAFNVR
>EGALAKHO_03874 hypothetical protein
MKKCIIFSTIIILFFSCNKYDSPKNQTAIEKNITHPMAPKNSGPPRILFIGNSQTEYFVS
APILFKEFCNANNVSININQLITVGVSLQQVYETNKTEANLIFSNKDKDGNYYDYVVIQE
STNVALSEIENYKANVAMLVEKIHKNSPDVAVYIYQGISPVSYLDSDFIKYHNEMRKNAI
SVMRCIKNAGLLRVGDAVKDAYDGESGYKYLIANKDNLRYGKHTLHLINDGGFMQSILLY
VTIFDKKPIVPKKLLLIKGTRYYDGLRKQEVIKVVSNPNALQKIAFNNR
>EGALAKHO_03875 hypothetical protein
MKKVILVLSIIVGIFLFAGIYKFNFTNHDIYVKDSKGNLIPINKEKKLKKNSKLKELKTK
TGKILTVIETHPIGQSISSITITTEGFKVNRTIELNDIDPIEKIELHDLDNDGFDELFLF
TRSAGSGSEGNIYAYCSYKDEYLKTLKKEKIDDKEYSKGGLMEGFMGHNRFFFNKQMVVM
EFPIYRENDINNKPTGGTKKIYYKLNHHKFSIIKAD
>EGALAKHO_03876 hypothetical protein
MYAQEDITYLKNKSDLDTNYIKKLNDKFIVKVFLDNKVDSYSFFYKNNNENFTITPNIAS
KISVSLDYEIFSLTLSVPKKWSLYYVDPLKGQTKNISFSLGFFLKKWYQNFYFSDTKGYY
VVNTENLILEGNQKNGSYLQLPGFRIRKVEGTTSYIVNSNKFSYRSFLYDTEIQKKSSGS
FIPSLNYVYLYQSDGKIEEYYNFKGNIFSISGIAAYQYNWTISSKFYFSTGVSAGIGFRN
SNKISIETDGQAKYHYTSFSSTLGYNINVKYRNKSFFCGAKGNVSENNAKDSVESSFTNS
FFYGTVFLGYCFDPPRLISKKLSKIFF
>EGALAKHO_03877 hypothetical protein
MINNNFSIFFLFLVLSHSASAQESIFSAARTNNVEQLNKILVQTSQINITDERGSTALII
ACYNDNYEAALWLLQHNANPDVRDKMGNTALMGASFKKLDRIAQLLVDYNTDIDQRNFNG
ATALIFAATFGADNIVQILRRKGADKTLRDKFNKTALDYALIQENETTVRLLE
>EGALAKHO_03878 Catalase
MKFKNIMTVLLITMTAAAQQKQITTNTGAPVGDNQNSKTIGEDGQVLLEDIHLIEKLAAF
DRERIPERVVHARGTGAYGEFVSTGDFTKFTKASVFKKNKITPVFVRFSTVVHGNGSPET
LRDPRGFAVKFYTDQGNYDLVGNNLPVFFIRDAMKFPDMVHAFKPSPVNNKQDANRVFDF
FSNIPEGTHMLTRVYSDYGIPASYREMDGSGVHAYKWINDSDDVVYVKYTWKSLQGVRNL
TAEQATALQGKDFQHATVDLYDNIRKNNFPQWELYVQILKASDFGKMDINPLDPTKIWPT
DSIPLQLVGKMTLNKIPDNFFQEVEQSAFSPGTLVPGIEPSEDKLLQGRLFSYFDTQRYR
IGTNFQQLSVNMPKTVVATNNQDGVFATRKTNGDINYQPSATKAGFTDNADYKYSKSIFV
NTSTAQQKIKKSNDFKQAGEFYRSLSEQEKQNLILNLSGDLKSVTNRDVVRKMVGYFYMA
DNDYGKRLAKELSITREEVEKMFSPIQ
>EGALAKHO_03879 Hydrogen peroxide-inducible genes activator
MISYSIINLSMNIQQLEYIIAVDKYRHFLKASEACYVTQATLSGMIKKLEEELNVILFDR
SKHPVVPTDVGKKIVAQAKSALREINRIKEVVIEDSGEIKGVIKIGIIPSLAPYLLPLFI
ADFTNTNKDIKVIINEMTTEKIKQKLKEGIIDVAILALPLEDKELIEDTLFFEEFFHYGE
LNVNSDKKKKFILPKDINFNKLLLLEEGHCLRDQVLNICELRVKDSKDLRIEYQSGSIET
LKLMVDLNLGSTILPELSLLTLDQKQKEKLSSFSAPYPVREIGLVCYGNYVKKNLIKALK
KCILDNTSDKVLTKKDICVLPIK
>EGALAKHO_03880 Catalase-peroxidase
MENNSTDISKCPFHNGNEKQATEANSGTKNSDWWPSQLKVNVLRQHSFLSNPMGESFNYA
EAFKSLDLKLVKKDLHALMTDSKAWWPADFGHYGGLFIRMAWHSAGTYRVGDGRGGAGAG
QQRFAPLNSWPDNVSLDKARRLVWPIKQKYGRKISWADLMILTGNVALESMGFKTFGFAG
GRTDVWEPEQDIYWGSENVWLSGDERYKHGSEGVAKHAVVSSDDNADGHIHTRDLERPLA
AVQMGLIYVNPEGPDGNPDPMAAAKDIRDTFGRMAMNDEETVALIAGGHTFGKTHGAASS
DHVGVEPEAEDIEMQGLGWHNKFGSGKGADAITSGLEVTWTKTPTQWSNNFFENLFGFEW
ELSKSPAGAYQWVAKNAEAIIPDAFDATKKHLPTMLTTDLSLRLDPEYEKISRRFLENPD
QFADAFARAWFKLTHRDMGPRTLYLGTDVPSEELLWQDPIPAVDHKLIDQGDVTYLKSKV
LASGLTVSELVSTAWASASTFRGSDKRGGANGARIRLAPQKDWSANNPAQLQKVLGVFES
IQNEFNAAQSDNKRVSLADIIVLAGGAGIEKAAKNGSIDITVPFIPGRTDALQEKTDVES
FSFLEPIADGFRNYKKTKYSVPTEALLIDKAQLLTLTAPELSVLVGGMRALDANFDGSKK
GVFTNRPQILSNDFFINLLDMEVTWKAVTEDKEEYNGLDRTTGELKWTGTRADLVFGSNS
ELRAIAEVYASSDALGQFVTDFVAAWTKVMNLDRFDLI
>EGALAKHO_03881 hypothetical protein
MLPGPTKPNYLIYNTHIGSVCLLILSGLIVYNSVKYKIEFLSEKCREVCKTKSINTIKLD
VYGFLI
>EGALAKHO_03882 Melibiose operon regulatory protein
METLSNFQYKKLFLPNITEKILSNNADIQLYRLEEYLKGILMPVIPYRTTFNFVLFITNG
HIKQYLENKEYNVEKGGVIFIKQGTITATIELSDDAEGFFLAYENNIVSEQELPKHKTSI
FFMPPFLNLDSLTYGTIKQLLTIMEQELWLNELNLNEIIITMLHLILVKILSTDSDSHHK
SATRPMELSLQFRDILFKYHRDEKRVTFYADKLSVTENYLNKCVKNITQKSPKQWINEMD
INYSKALLQSSKDIAEIAYQLNFHTASHFTQLFKKITGITPKEYRLQFFR
>EGALAKHO_03883 Vitamin B12 transporter BtuB
MTRIQNTIAFFVLMISVASVAQKKESEMQTFLKDADNKFPIGNTLIEYNHGHIHTHSEQD
GSFKLHIQSFPDTLVISHEGYDQRKWVVNSNVDYENKVIFLQRKPIEISEIIINHNSFLS
DITKVDLNKFPANSAQDLLRKVPGLFIAQHAGGGKAEQIFLRGFDADHGTDVSVNVDGMP
VNIVSHAHGQGYSDLHFVIPETINNIDFGKGAYYADRGDFNTAGYVDFKTYGSLKNSMIK
LEAGSFNTKRILGMFNIINDPGNKKNFYIATEYNYTDGPFDVKQNFNRVNIFGKYNQWIT
DNNYFNIQFSTFNSSWNASGQNPERAVNEGIIDRWGSIDPTEGGSTSRSNVQMNFKHIIS
PSEHIEVMGWYSKYNFNLYSDFTFFLNDPIHGDEIQQKDGRNIYGGEFKHVKNFIFSNSS
LELISGIGFRNDDIQTLQLNHVYHRDVLLDKKIDVTGVETNFHAYSELIWKTGKWTIAPA
LRLDHFIFNMHNLLDQEQLPAGQSSEATKLSPKLNLSFASSDKVVWLLKTGMGFHSNDMR
VVIPQNGRNTLPYSIGADFGTRLHPLKSLIITPTVWHLFLQQEFVYVGDDAVVEPSCKSK
RYGFDLGIRYQPLEKLYLNVDIDYSHARLIEEPKGQDYIPLAPIITSTGSLNWDFLKGFS
VGLQYRYLSERPAVEDNSLKTKPYLVNDLILSYNHAKWGTNLQINNLFNVKWNEAQFATE
TQLKNEATPITDITYTPGNPFGIKMEIFYKF
>EGALAKHO_03884 hypothetical protein
MKNSKFAFLFLVVTGCYTAQAQINFPSQQKTDDGKSLYEMEFSPRLKLNGYLNLGGNDMN
SQSINLNSADPYNPIDQKNAGFNMYQTQLAWKTTYNGFSKGPLVAYVEAQWWGAPGAGGN
LQLRVAYVDYNHWHIGQDWTFFGNGVSSWYNTLDWEGPNSGTWARHLQVKYYTDFGADKS
WKLEAGVESSSEYLKIAGGVTPGQFSADPILAFTKKLHDQAGYLRLAVMGRTLRYEKDAN
TKAMTIGWGVNANYKTMLNEKSYFMAQAVAGSGIGGSYTLSGSLFGNGGAGNMYDAIYDQ
NGNFKTVPIYGGSAGVEYYFGEKKRLHSNLVVGYTTMTYNAIPISLVNSKVINDNSTADF
VNNNTNSNTRIALPSATINAMYDVTKNFLIGLEYNTGAKQIINTNTQTSTVNRIAVGMMV
GF
>EGALAKHO_03885 2-iminobutanoate/2-iminopropanoate deaminase
MASNKINSLLARNTENAPKSIGPYSQTVAFSHYNNLSAQLPIDPKSGKIVAGGIKEQTEQ
CFKNIKAILDSIDHVMNDVVRITVFVKNINDIDTVDQVYRIFFPTYVPTRTTVAVAALPM
YALVQIEALVSNGEGTIPNAPQAGNLIKLVNNTSNAPICTLSAQTVSFSHYNNLSAQLPI
DPKTGRLITGGVKEQTQQCLKNIKAILNSIDVPFDDIVKINIFLKNLSDIEAVDEVYATF
FPDSAIARAVAYVPARTIVAVSDLSMHALIQIEAVVSHGGGTPPQAIEDRHGIVINANNT
ENAPKNSLSTQTLAFSHYNHISAQFPIDPKTGKMITGSVKEQAEQCLKNIKAILESISHV
MEDVVKVNIFLKNITDSDLVDEVYTTFFPTGIPARRTIGVSALQKDALIQIDVVVSNAEG
TPLKA
>EGALAKHO_03886 Urea transporter
MNKIFTKIPFIDNVLKGMGQIMLQENRWTGLLFLIGIFIGSWQGGVAILLATSVGTFTAM
KLDYDKSEINAGLYGFSAALVGVALSFFFQTTILIWILIILGGALATIIQHFFISKKIPA
FTFPFIFIIWVCVFALHHFTNIPPSEMISTKPENVAYSEFITPINGFGEVIFQGGLLSGV
IFFIAIFISSPAAALYGLLGSLLGAYFSYMDGESIEGIHMGLFGFNAVLSAIVFSGFKKT
DGLWVLIAVLITVGIDDFLIDHKILTEVGGVLTFPFVAGTCITLLLQRFFITKKQN
>EGALAKHO_03887 hypothetical protein
MNTTIWALVLSAVSISFIHTASGPDHYLPFIVLSKSKQWSKSKTILLTIACGFGHVFSSL
ILGTIGVFMGWQLNKFSWFQEIRGNISGWALLIFGVIYLIYGVIQTIKNKPHKHFDVLGD
DVYVYEHNHGEVVMPQSRIKVTPFVLFMIFVMGPSEPLTPLLFYSGLNRSVTEIVALVVP
FALTTVATMLGMVLLGRYGYSTFFQTDKLERYMSVVSGAVVTVCGIGMVFLGW
>EGALAKHO_03888 Urease accessory protein UreH
MNSRLHIIAGYKQGSSYVKDLYVSPPFRVVSVGQRKTDNKLYQIVMSTSPGILCGDRYQL
DIDLEKGAALQLQSQSYQRLFNMKNDAVQQLTISMEDDTSFAYVPHPVVPHENSDFKSKA
EIRIGTNSQVIISEIITCGRKHYGELFKLRRFQNLTEIYHKNKLVVKDNVLIQPDLIPIN
GIGNLEEFTHQGTLIFYSTKENVDKNLLVDAIHSIIESQSEMEIGISAMEDNGFVIRTLG
HGGEVMYNFFLRIQEILWELE
>EGALAKHO_03889 Urease accessory protein UreG
MKNRKYIKVGVAGPVGSGKTALLERLSRHLYGTYDLGVITNDIYTKEDAEFMAKNSLLPH
ERIIGVETGGCPHTAIREDASMNLEAVDELAKRFENIELIFIESGGDNLSATFSPDLADV
TIFIIDVAEGEKIPRKGGPGITRSDLLVINKIDLAPYVGASLEVMENDARRMRKGAPFIF
SNLKTDVGVPEIIGWIKKYALLEDCEEPNLVR
>EGALAKHO_03890 Urease accessory protein UreF
MNNIKFLASLLHISDPTLPIGGYSHSNGLETFIQNKIVHSATTAQEFVENMLKYNLKYND
GAFVKLAYEATASNDLKALLDLDQECNALKCPREIRQASQKLGLRLIKIFKRHENFQLME
AYEEAVRNGDANSHYCIVFGMYCSLLKIPLQEALFGFYYTSTAGMITNAVKLVPLGQLDG
QDILFSLYPIMEKTAQETITLERDYVGLCNTSFDIRCMQHERLYSRLYMS
>EGALAKHO_03891 Urease accessory protein UreE
MTISETLGTISNSTINGRSIDYLDLEWFESTKRIQRKKTRQGEDIAIKFLREGQRLREGD
ILFENEKKIIVVNILETEAIVISPSSMLEMGTVCYEIGNKHIPLFIQEEKVLLPFEMPMF
RWLEVSGFKPEKKSVKLLNLLKSNVEPHGHGSLGSTIFTKILKMAAPKDE
>EGALAKHO_03892 Urease subunit alpha
MSLNVDRKQYANILGPTTGDRIRLGDTDIIIEIEKDFTHYGDEAVFGGGKTVRDGMGQNV
ERTRDQGVLDLCITGATIIDHWGIVKADIGIKDGKIIAIGKAGNPDTMDGVSPNMIIGAS
TEVHGGKGYIVTAGGIDTHIHYICPQQIETSLYSGITTMIGGGTGPNDGTNATTCTPGKF
NIQRMLESAEEFPMNLGFFGKGNCSAEAPLEEQVEAGALGLKIHEDWGATTGTIDAALKV
ADKYDVQVAIHTDTLNEGGFLEDTMKAINGRVIHTFHTEGAGGGHAPDIIKAAMYPNVLP
ASTNPTRPYTVNTIDEHLDMLMVCHHLSKNIPEDVAFADSRIRPETIAAEDILHDMGVFS
IMSSDSQAMGRPGEVITRTWQTASKMRDQRGQLEEDKNTQNDNFRTKRYVAKYTINPAIA
HGISNYVGSIEPGKIADLVIWKPALFGVKPEMIVKGGFVIAAKMGDPNASIPTPQPVIYR
NMFGAYGRAKFTTCATFVSQASIDNGSIADYKLDKMILPVKNCRNISKKDLIHNDKTPVI
EVNAENYHVTVDGVHVTCEPAETLPLTQLYYLF
>EGALAKHO_03893 Urease subunit alpha
MKPGEIFVKEGTIICNEGRETVKLKVTNTGDRPIQVGSHFHFFEVNKAMSFNREKAFGKR
LNIVASTAVRFEPGEEKEVILVAIGGNKKAMGFNNLVDGLVDSDTTKKESLAKANQLNFK
NS
>EGALAKHO_03894 Urease subunit gamma
MHLTPREIEKLMLHTAGELALKRKARGLKLNYPEAVALISHFLLEGARDGKRVADLMREG
AQILTKDDVMPGVADMIHDVQIEATFPDGTKLVTVHDPIR
>EGALAKHO_03895 hypothetical protein
MKTKKGSIERYAIYFFTIFCGVFFMLKSDSHLLLKNNSEKYSQKTNNQISASVFNLFDIQ
EGIAIDDDLNQPLFDINILFEKWSTYTLNLHFYSTQPVTIATHNYSYITLPRYILFHSIR
IPSC
>EGALAKHO_03896 Chaperone protein ClpB
MESRSGLSKAGQPIASFFFLGPTGTGKTELAKSLADFLFQDENAIIRFDMSEFKEEHSAA
LLYGAPPGYIGYAEGGLLVNKIRQKPYSIVLFDEIEKAHPSVFDVFLQIMDEGKLHDRLG
KEGDFSNAIILFTSNIGANHIVESFNKGQIPNSISLMEIMGNYFRPEFLGRLTEVVPFAP
ISKENALKIFEIHLKKEFMDLLKNINIEVEIPMEAKLYLAENGYNAKYGARPIKSIIRSH
LRRPLAKKIISGEVKDGDKMIVVIKNGEVKWIREELLIKSDI
>EGALAKHO_03897 hypothetical protein
MLASVEQQAKENSFSKNNDPYLMIKPKINGSKDESFKIAYWSTCAEDGNDIKAGTVLESK
GDLSFVSKQAVLVTNTVGGMNKQNNKDRILAYRNALLTRGRIVTIADIKAFGFNHFKSSI
THIKVEKGTRKEISIKAGFSRTVDIYLKINTIEKENLSTAEWEYLCDSFMKNLKNRSSNV
FPYRLFIED
>EGALAKHO_03898 hypothetical protein
MRHICSSIALLFLSAVSYGMENVKMPIENSNISAIEYNLKNSLKSSLSVDGIYDTKMILT
RLNGKVVSGTGFYITIDSGSNTIQGKSGCNNFSVNYKNLAKKNRIETASPRGTIMACDEE
KMGLEQEFMSSMNNKILKITRKKNTVIFKDLNSKTIMEFAVPTQNGIWSFIGKQNWKLIQ
LEGVGKDYGPVSIKFDITANKVSGNSGCNNFFGTYAADGDFVSFSKIGATRMVCSDDQVA
LTEQKILGYINQNLRFDVADQTLNFYLDDKLVMMFAK
>EGALAKHO_03899 hypothetical protein
MIMIKTKTIFIIKQSILATIMISVFISCKENSGKSKKEVVIEKPIKNEKLSVESDSIIFK
KSLSQQNIGFDISTTGQGSIQQLTIQPSGLEIDNRKITIEVLGNVTNAEIGDLNSDGFPE
ILIYTTSAGSGSYGDIIGYSVNNGKSISPIHFPPVDENKKISTGYQGHDEFAIVKNLLVQ
RFQVYNENDVNSKPTGNMREIHYKLKNGEATKEFVVEKVMEYPLK
>EGALAKHO_03900 hypothetical protein
MKSEYHTCPKCKASIKIKLSRWAGKTICPKCTEKLYVFYELIDYKNIKIDLHELLENDNN
IFDSSFLDYFESDL
>EGALAKHO_03901 hypothetical protein
MKTSISFKNIVVDIICLLFVLLFVYAATSKLFDFENFKIQLGQSPLLSAVVNWISITVPV
LEIIIAASLLLRHVRLLGLYACYLLMIMFTAYIYIILNYSAFVPCSCGGILEKMTWEEHL
IFNICFIILAIIGILFIPVKSNVNK
>EGALAKHO_03902 hypothetical protein
MRYKLKIILLLICTVLGVGIMILFFTLSEHMIHYKNKFIRRFPQHVAQEIHQADLSFNSY
YFAGSNNGKIYLGNYTAPLQIMELDFTLKRRKIHHIKLKQQRLEFRSPQIRILEQNFYVF
EGIVPYIFKGNTKTWTASLRINSGYYFSHLEPIDSVNMAIRYMKPGRGESLMGTLNLSDT
IKVKYAPLLLQKQFDGIFDTDGSFHFNRELNKIVYVYLYRNQYIVSGPDLTLDYRGNTID
TVSRAQIKLAKFKNSNMKTFSRPPLVVNKLSAVEGNLLYVNSSLPGLYEPEEIWKRASII
DVYDLTNNTYRSSFPVYNIGQKKLRAMYVTNNYLYALIDKKIVCYKLRGHLMQSKPVKK
>EGALAKHO_03903 hypothetical protein
MKRNFLKGIMMPAAVVVLGVGGAFTTTSMSSTKALANVQGYRYVSQADPCHAQQQCSTVF
NANICTSGGTQLYGKANPNVNVCDVPLYKIP
>EGALAKHO_03904 Dipeptidyl-peptidase 5
MRTIIYNSRIIWISFILFLMACPVIGQVKKTKQLTPEDYHLWSTLKAESISDQGTWVSYS
LMYESGLDTLFIKNTNNEKTVAFAKGRDGKFIGDTSWFGCITADNLFQIINLKTDKIQYT
ENVEAFSLSNNGKYIILYCNEAEGKTKIVIRNLDGNIIENIDNVTSYSLNPKGNMLGYCS
SESNKNTVGLLKFGKELTKTAVVENRERQYENIIWQAEGISIAFVSRLVSAKSFTADIVL
FYKIEDKQLFQYDTTIEKVWKKNMILDANYTSALGISDDGERVFFRIKKKPNQNKSRNNL
DVQVWNAADKELLASRDNYGSTQDNPRLVCWRPENNHFSEIENDEHSVAIFGGTQQFALV
YNPDTNKPTFKQEADRDYYLLDLKTGIKTVFLQQQSGTLGKIYFSPSGKYILYFKQRNWW
IYSIATGIHTNITINSAVSFYDDSNDEPEEPNPYGYIGFTANDKFVLLYDQFDIWQFKSN
GALAKRLTFGRENKQIFRLADTDKENIDHVVFKGKVIDNYSDLILKAQAIDNSKSGYFNL
DNKQHLQSIIYEPKLISSIFKAKISNSYMYVQEDYNEPPALIIKKGNAPVKADYKSNPQH
DYYRWGKSELIEYKNSKGAILKGVLFYPFDYDPGRQYPMIVNIYQKQTKALHTYVNPSLL
NGSVFNVTYYTSHDYFVLLPDIIYEIGSPGLSAADCVISATQSAIETASIDKAKIGLIGH
SFGAYESFFIITQTNLFAAAVAGSGISDLTSGYLSVNWGYKNMNSWRYEYQQFRMKKTLF
DNYEGYRRNSPIYFASNVNTPLLSYTGAEDTTVNPAQTMEFYLALRRLKKEHIMLLYPKE
NHTIQGRANQIDLTHKISEWFGYYLKGEKKPDWFDAH
>EGALAKHO_03905 hypothetical protein
MKNFNINSLHTGNSSTRIWNSTFWKFPLLLFVLMINSCDDFVEVDLPSSQLTANAVFEER
ATANAAMTDIYSKIRDAGLLTGSASGLSFLLGNYTDELKFYGDPQNGAVPFYNNSLIASN
VDVKGLWDSSYNQIYAANAVIEGVQASTSLATADKNQLKGEALFTRALLHFYLTNLFGAV
PYNTTTNYEQNRHAQKVSINTVYATAKIDLEQAVLLLPENYISQDRIRPNKYAAHALLAR
VNLYAGLWDEAANEASTVLNNTGVYIDEEDLDKIFLKESTGTIWQLAPGFSGGNTLESVT
FNFTSGPPPLSALTDDFISAFTDNDLRKTHWIKAVSDGSGIWYHPFKYKYSDTDSSREYS
IIFRLAEIYLIRAEARAHTGDLIGGKEDLNKIRSTAGLLDTEANSQTEILDAILRERQVE
LFTEFGHRFFDLKRFNKIQSVLKAVKTGWDTHDALFPIPEVELNLNGNLKPQNTGY
>EGALAKHO_03906 TonB-dependent receptor SusC
MNNFSFYKDGKAFYCLFFLGFFLTFSSLYAKNSFRHISKISQQYQIQGTITDGINPLPGV
TISIKNKLNNAVVSDYSGQYALLASPYDTLVVSFIGFKTALVPINNRKTVDIQLQFDTTT
LQEVKVNAGYYSVKESERTGSIAKITSKDIEKQPVSNVLATMQGRMAGVNIVQTTGVPGG
GFDIQIRGQNSLRLSGNNPLYIIDGVPYSSDPIGTGINSAVLPTQPSPLNSINPDQIESI
EVLKDADATAIYGSRGANGVVLVTTKKGKSGKTKFSAKLSTGTGTVTRFMDLMNTQQYLE
MRREAFANDGISPIPDYAYDVNGTWDQNRYTDWQKELLGGTALITDIQTSLSGGSEHTQF
LLSGNFNKQTTVFPGDFNYKKANLHLNVNHESENKKFRTSISVGYTMQNNNQPRMDLMRE
AVNMSPNAPTLYNPDGTLNWENNTFNNPLRNLEGKYKAETNDLIANAMLSYKLTDNLELK
SSFGYTALGNSETTANPSTRYNPAFGLGPEFSTLIVSGADRSSWIIEPQLNWNKDIGQGK
LDVLVGGTFQSQQSSQLVQYASGFPSNSLIYNLASASNIFTMESAQSQYKYQAFFGRVNY
NWKEKYIINLTGRRDGSSRFGPADQFATFGAVGAAWLFSRENIFKNSTILSFGKLRTSYG
LTGNDQIGDYQYMDTYASTGINYGGTIGLQPTRLFNPDFGWETNRKFEVALETGFLNDRI
FLTAAWYSNESSNQLTGIPLPGITGFPALQANLDATVQNRGTELTLRTINIQRKDFNWST
NFNLTIAKNKLLEFPNLESSTYANQYVIGESLNIQKVYHFTGVDKQTGVYTFEDVNSDGQ
LTATEDKKTIKDFSPEYYGGLQNTLKYKRWQLDFLFQFVKQINYNQSIYFGVPGSGSNQP
VAALEHWQKAGDSKPYPIYTDGNNSAAVDAYYKYFESDGAISDASYVRLKNISLSYELPL
KDLQCRVFFEGQNVLTFTKYKGADPEFKSSGYLPPLRVLSAGIQFSF
>EGALAKHO_03907 hypothetical protein
MLIAIVKKELDDYTKLKIAISLRRLLESNGSLPSMQSYNKIALAANIRKATVSDTFNAKS
IPNSLTLFLIIEAIGFSLTDFSKIYDTLRDIDINLFRKTISK
>EGALAKHO_03908 hypothetical protein
MKDLVAKINAEIETFKTESESLTEKGIKAAGARARKSSLELEKLFKEFRKVSIAESK
>EGALAKHO_03909 hypothetical protein
MNAKYLLVVSLCAVLFTNAQSFKIPDSLRNRNFDYLFDRIEDGNNSTEQRSLYLRSFLMK
AKMEEHWEELSNAYKNYVHYAPDRLKLIYADSMVIAAKKSNSNEIIGSAYLSKGIAYYSQ
KRLVEAMDIYLIADRYIKKTNDKYLIYKTKYRIGQIKLYLGYYNEAVSIFQQCISYFKDS
NDRAYLDSLHSLGICYSKIGNYGLCTSINETGIAEGIRIGNRDMEPYFIHSEGINQYMIH
NYAIGIEKIQSSLPDIRANRDFSNVMIGYFYIGKSYLGLDNKEKALAYFEKVDKSYMERD
YMRPDLREAYEFMISYYKDKNMIKEQLRYVEKLLEVDKKLHLTYTYLQGKIRKEYDTKEL
VDEQQKLKNSLNIRKYNDQISIAIIGGMFLFIVYGIVRHIKNKKESRKRYEELVQKIEDM
EKAKAYKADDSDFSISKGAEAAVLHSLQKFENSKKFLERDWDLTKLASYCNTNTKYLSLI
ILRHRGKKFNEYINGLKVDHIAQRIRSEKVLQKYSHEALAVEAGFSTTRRFVKAFIGCTG
ITPKYFIEEAKKENIQG
>EGALAKHO_03910 hypothetical protein
MKNLKVCLAILPLFTIACSDEYTGEMTKTAHVEQSAKKLVIGPGNSANPFDIAGSIHNEI
LETLDQTDFNSQSIEDIAILIDSISAIHPELVSISSDSALSSRLPEIIWIVNNNDVMNDV
LGASTLGVNAKISLISFVDSLLLATDDSYGDIHSMIVSYEASILNNSELTSNDKRIMLTT
TSVVRYSVYEDKRKDKDWETGISRIAATTVTGAENNLVLALKMALTVGLCQDNNLSQ
>EGALAKHO_03911 HTH-type transcriptional activator RhaR
MKIQTYNPWFRDLHVLYLSECTSVKACNALLKPGWFSMILIVSGSVDFIVGSTIVRLRAG
QLYAVPSGAKAGTVVSPIKFYLLSCTIAFAINNRIAKYGNGYIEVITTQSYVVLSLSKVE
LKHMIQLAELLKKKISNQNHTVFQHEMILLCLNLLLYEYSSLYYKKGENLSAVHNRKEKI
VIGFIELIQEHSKGHHDVKFYADSLFVSKGHLRKAVYWVTGMPAKYFIEMAVVSEAYLLL
ADSNLSITEISEQLNFSALSSFSGFFKKYTKVSPTQYRQNLKP
>EGALAKHO_03912 hypothetical protein
MKSLNSIVSEIRIKEDKISQGTSHFIDEAHQMTLYLKELLHTTREYILRHGFKNQEEEIE
FFRVIKPQILGKLIYYNKVFRIETVCPVKEGKVYQKFFMSQIQELKQEFKEHICVPHFYR
YYRSGRSDRDQEYFTRGKINYRDGLNSYVFEIDHQFSTYYDSKVARIMANELIYAYLITK
INPEEPSGTLLHNGESTKDIFWTDSKNALIELIYALYASGVISHGKIGIRKITLVFQILF
RIPLGDIHHSFHRMKDRAGSRTSFLDHLKLSLEQYMDKGL
>EGALAKHO_03913 hypothetical protein
MGKNKLLDKLLEKSSTTPLDEERVRNIEEESSLTLEDIKDRIQDREERKKYAKRTFSFLV
AFTFTVLGIVIAVGLDNWICFHLSDTVLITLITTSLASIVGIFAIVMRYLFKQSSNNT
>EGALAKHO_03914 hypothetical protein
MENVYAVANEFLELSRNSEKQLTNLQLAKLCYITHGLSLAILNKKAFTEPIQAWKFGPVI
PKLYHEFKDFGSNPIDRKATVVDSETLESKAPEVQDNNLKKVIALTWNIYKDVSGTALVS
ITHQGNTPWSLTYVPNENKEISDELTLKYYTKFIENLEHELA
>EGALAKHO_03915 hypothetical protein
MGRTWQKKLFSCFNFVLLNLKDWIMNVDRLEFMAWMERIMERFDIVMELVSTAKNKHTSI
DGEELLDNQDILQMLKISTRSLQRYRSSGRLPYYTISGKIYYKQSDIHQFVRESFTASVP
RTKANS
>EGALAKHO_03916 hypothetical protein
MSEQILDKPQSPEQLSEILLVMDKAKKKIQAVTGLDENGNLKTIDPTKKNQNQFMRVDKQ
GDFFSNFFSNFLSQLKNPTDFSFFKVPAPLAINMAKEMQKQVDNPTPEGEKLMAQHEVKA
EPNENNKQENKNSMETTQTTPETGEYRYKPEQIDWETMNNLGLSKEKLEKLNLLDPLLRG
YKTNELVPVSLNLGTAVTRMDARLSLQHNDEGQVVVAIHGIRKEPSLNYAFFGHEFTKED
KDNLLQTGNMGRVVNLTNPKTNETIPSIISVDRLTNELVALRTDFIKIPDEIKGVKLNQE
QKQTLQEGKPLHLEGMVSKKGTEFAATIQFNADKRFVEFLFDRTGGNKQTQHNPQNQSEE
APKIFRDKELDSEQYQKFKDGQTVYVSGLIDKKGKEYNGYITFNKETNKIDFSFQNPDKI
KEQAKPTEAHKTQTAVNSEGKTNEATKNIKEPLKSGQKNPDSEKQQEQQEAIESPGKSKG
RKM
>EGALAKHO_03917 DNA topoisomerase 3
MKVVIAEKPSVAREIAGLLGATEKKDGYLTGNGYCVTWAFGHLIGLGMPEDYGIYGFQKN
SLPILPNPFLLVLRKIKKDKAYIPDTGALKQLKIIKQIIDSCQSIIVATDAGREGELIFR
YIYEYLKCEKPFARLWISCLTEKAIREGFDNLKPGSDFEGLYKAAKGRSRADWLVGINAS
QALSIAAGNGIYSLGRVQTPTLALICKRYLENINFTAQRYWQLQFSHTKEFTGFTSLSKN
KWEDKKGAEDALKSIERNGNIAAVTLIETKNVTEQPPLLFDLTGLQKEANKKLNLSAEET
LNIAQSLYEKKFITYPRTGSKYIPEDMWAEIPNLIRGLQEKEIYKQALANVKWGYLNKRI
VNDLRVTDHVRYPRNILLE
>EGALAKHO_03918 Type-1 restriction enzyme EcoKI specificity protein
MRPSKIIDTDYLLYLINSEIVQSQFKDITKGTTRARVNLTQVRSIKIPLTGMSEQRAIVL
QIKSFFSRLDEAESILNKAHRQLKIYRQSISKNAFEGKLTERWRTETNPQPAKKILDAIE
IERQTKFEVDFLEWKEEIIKWDKNSQSKLRPSRPSKPVVPDKPSEEHIFKMWKIPSGWEW
TQLGFITFVTKLAGFEYTKYVKYTEKGDLQVIKAENVGAKGFKKTNYSQVIAASVSHLKR
SQLYGGELIIVFVGAGTGNVGTIPQNNIFFLGPNIGMARPYGNIDSKFLEYFYQSPRGKE
LLLVSAKAVAQPSLSMGNIRQTPFAIPSKDEQLNIVQLLEYQFTLVENLEKTIMTTFNNI
IAFRHTLLKKAFEGRIVNYTSTESVLDLMKILEKQRNEYQKVQKQLSRNKTKLTIKMEEK
KSLLELLKELKSPITVQELWENSSTEGDVERFYSELKEIADQIVEIKSETQSLLSFKNEN
>EGALAKHO_03919 DNA replication and repair protein RecF
MKINQVHIKGSFKNLENFHFDFGEKSMETVLLGANATGKSNFMEAIVIIFRDLDLERAPV
LHKQSNPFEYNIKYTCREKEIEVDFSATDGYTFFIDGEKLKSKTLFFKNKDKYLPSHVFV
YYSGLSERLKSLYADHKLLQFKKMMNSESKYDDFNEMPRIFLVEPIHASFALIAFYLFDE
REKETIDFLRTELDIVDFGSALFMLKQPNWSKSRKDLDRFWNADGLVRRFIEDLWNFSIA
PMFYKEIVRGSLNKRETLNRLFLFLKDKDAIRVFVDMKYKNKITLFNALCSLHYSELVED
QDVRIKVLKEHVPGELAMGELSEGEKQLITVLGLLKFTKDDEALILLDEPDTHLNPLWKW
KYLEFLENVVSKSAKTQIVFCTHDPLVIGGMEKEQVRVFKRDANYNTEVSEPDISPKGLG
VAGILTSPLFGLPTILDKKTQEKLNRKRYLQGRLMREKLNEVEYDEYQKLKAELEDYGFY
EEVEDKWFKEYLAEMSKLEAFGKTELTESEKQLLAGESTKAAERVLKLIQKMD
>EGALAKHO_03920 hypothetical protein
MRVINLSDLRAKFDSLEENHAGSFDEWVQRAEQCLNDIRPMTKKQRSQYWSKNNIWRELY
PALSELSGHKCWYSEAPESSGEWEIEHFRPKAESKSEDGAVILEDGYWWLSYSWTNFRFA
GSLVNKLRKDRFDVGSEVYGKGNFFPLDGDGLAQTGDEECDCERPLLIDPVKPRDVTLIS
FDQNGDPYPTYNEEDNPIYNKKATLSIKFYGLDHTPLRRGRSKIWSNCEIAVKKAHNYIK
NNINDPVRRDEKIDECFLLLHNYSKYTEPYSMIVRNFVKEKIKDDEYSWLKDVERVLV
>EGALAKHO_03921 putative type I restriction enzymeP M protein
MASTNILVAKIWSFCDTLRDDGLGYGDYLEQLTYLLFLKMADENKSLYQIPDGCDWQELK
ASVQIIETYETILKKLSNSGGMLSKIFAGALNKIHDSVKLKRLISLIDEEDWTSQEIDVK
GEIYESLLQKNAENSGAGQYFTPRSIINAMVDCIQPKPMETVADPSCGTGGFFLGVLNHL
KKNKLTKSQQDFLKFYTFKGWEIEKATARLCLMNLFLHGVGDLKETPEIEVTDSLKRPNG
AVLELEKVDIVLANPPFGISSSDVPTMDKKQAEKDGYFLRKDFWITTSNKQLSFLQHIVT
MLKEHGRAAVVLPDNVLFEGGAGETIRKKLLECTNLHTILRLPTGIFYAQGVKSNVLFFQ
KESELGTPATKDVWIYDYRTNIRHTPKKNPLKQEHLKDFIECFNAKNISQRIETWNQENE
TGRWRKYSYEEIIDRDKTNLDIFWLRDDNLIDLDNLPDPEVLIDDIIENIESALTNFRTI
RESLN
>EGALAKHO_03922 hypothetical protein
MEKQRKKILLATTLMLTGFSALAQGNGTAGINEATQMVTSYFDPATQLIYAIGAVVGLIG
GVKVYNKFSSGDPDTSKTAASWFGACIFLIVAATILRSFFL
>EGALAKHO_03923 Type IV secretion system protein virB4
MRNTAKVTTLENKFPLLAVENNCILSKEADITACFEVRLPELFTVASAEYEAIHSAWHKA
IKTLPDFTVIHKQDWYIRENYNPDLAKEDQSFLAKSYQCHFNERPFLNHYCYLFLTKTTK
ERMRAQSNFSSLCKGVLIPKEIRDKETIYRFMESVAQFERILNDSGFVSLVRLTEEDIIG
AEGKQGILEQYLTLSKEAGTPMQDIVLGGEEVRVGNKRLCLHTLADTDDLPATVSADTRY
EKLSTDRSDCRLSFAAPVGLLLNCNHIYNQYLFLDNSEDNLQKFEKSARNMHSLARYSRA
NQINKEWIERYLNEAHSFGLSSIRAHFNIMAWSDDPGELKQLKNDSGSALALMECKPRHN
TTDTATLYWAGMPGNAGDFPSEESFYTFIEPALCFFTEETNYHNSPSPFGIKMADRLTGK
PIHLDISDLPMKRGIITNRNKFILGPSGSGKSFFTNHMVRQYYEQGAHVLLVDTGNSYQG
LCELIKGKTKGEDGVYFTYAEDNPIAFNPFYTDDGVFDIEKRESIKTLILTLWKRDDEPP
TRSEEVALSNAVSGYIQRIQQDGAYPSFNNFYEYVQVDYRKILEEKQVREKDFDIANFLN
VLEPYYKGGEYDYLLNSDKQLDLLSKRFIVFEIDAIKDHKILFPIVTIIIMEVFINKMRR
LKGIRKLILIEEAWKAIAKEGMAEYLRYLFKTVRKFFGEAIVVTQEVDDIIQSPIVKESI
INNSDCKILLDQRKYMNKFNDIQAMLGLTDKEKAQVLSINMNNDPSRLYKEVWIGLGGTH
SAVYATEVSAEEYLAYTTEETEKLEVMQLAAELGGNVELAIKHIAMGRREEENQ
>EGALAKHO_03924 hypothetical protein
MKKIMYLVCAAILAAAPSAKAQFVVTDPANLASGILNSANEIVQTSSTVSNVIKNFKEVE
KVYKQGKEYYDKLQAVNNLVKDARKVQQTVLLVGDVSQMYVQNFGKMLNDPNFSPQELAA
IANGYSALLGESTELLKELKQIVSSTNLSLNDKERMDIIDRVYKEVKDYHSLVRYYTNKN
ISVSYLRAKKKNDAKRVFELYGTPNQKYW
>EGALAKHO_03925 hypothetical protein
MEWNNLHEVLRSLYDDMMPLAGDMAAVAKGLAGLGALFYMAFKVWEALSRAEPIDVFPLL
RPFALGLCIMFFPTIVLGTVNAVLSPLVTGTHAILDDQVLDLNKLQQQKDQLEYEAMVRN
PETAFMASDEEFDKKLDELGWSPSDVGTMAGMYMDRQEYKIEKAMKEWFRNLLEILFQAA
ALVIDTIRTFFLIVLSILGPIAFAISVWDGFQSTLTQWFTRYVSVYLWLPVSDLFSSMLA
RIQSLILERDIEMLSDPTFIPDTSNTVYVIFMIIGIVGYFTIPTVTGWIIQAGGAGNFTR
NINQTAMKSGNIAGAGAGSTVGNIGGRLMNK
>EGALAKHO_03926 hypothetical protein
MEFKTLRNIENSFRQIRLYAIVFAVLCTGVAGYAVWKSYSFAQQQREKIYVLDNGKSLML
ALAQDASINRPVEAREHVRRFHELFFTLAPDKNAIESNMKRAFNLADKSAFDYYKDLSEK
GYYNRIISGNVQQRIEIDSVSCNFENYPYAARTYAKQFIIRSSNVTKRNLVTSCFLVNSV
RSDNNPQGFNIEKFSVVENKDIEVIER
>EGALAKHO_03927 hypothetical protein
MKLLLDLGAFSKTLTDKGYDGDFHTESCCAGKLKDSITGFLQTWENGNDASLVANYLHLS
TYLEWNGEDKPKVECDMWVRYENGKFDLGDIEMHITRTDRYGQLLKQSKLTNLTASSVPS
IMQAIAQVSEKPNVEIAPRKRGFRM
>EGALAKHO_03928 hypothetical protein
MKKLRTNIEKWFDKMDKRWRSLPVRKQHQFMLYFFVGYLLLTAGVIFKMWYDIAKSDNRM
VIEHIDNPVSKSEISGSQSDTLSTILKEKIYERK
>EGALAKHO_03929 hypothetical protein
MKENKKRVSVLVEEADQSRASNLLDDKKSSKERLKKPVIFILMGMVILGCMYLIFKPSSD
KKGIENIGMNDTVPQASEIGMQADKQKAYEQEMLEQKDQEKRNALTTLSDYWNEDNSFSG
KQDTLADQEEQSMGYGNNPGRSGNPALNSYRNTQSALGSFYKDDNSETRELRKQLDELKE
KLADKDVPKSVTVDEQLALMEKSYQMAAKYLPTATNTGEPFSNKGSTASASTQKEYFVAF
APAAKSAVSALYREPSDSTFLGDWSANRNFYTAGSVQQIAQPKNSVKACIQQTQTIIGES
AIRLRLLEPAQTPNGTIPQGTLLTAIAKFQGGRLEMKVTSIELDGNIIPVDITIYDLDGQ
QGLYVPYSPEMNALTEMAGNMSQTSGTSLMLTQSAGQQVAADLSKGVVQGISGYFSKKVR
TPKVTLKAGLQVLLVSKK
>EGALAKHO_03930 hypothetical protein
MKNHIKTFWTIAIMIGSATASFAQDSVKTRLALGKIEPYEMEVTYDKTSHLIFPTAIRYV
DLGSEYLIASKAEDAENVLRVKASVKEFELETNFSVITDDGRFYSFNVLYNPFPEALSYD
LQTMQKSVDKEKGNDVLFEELGNTLPSLAGLLLETIYKKDKRIVKHIGAKSFGIEFILKG
IYIHNGKYYFHTQLTNRTNVPFGIDFISFKVVDKKLAKRTVVQERPMIPLRTYKSLDEIG
GTTTDKNVFLLDKFTITDDKVLLIEIFEKNGGRHQTLQVENSDLIKARLITDMNLKF
>EGALAKHO_03931 hypothetical protein
MKKYIYTAMLILVGIAMAQAQRMLPKQKGLEISTGTLTDENPGRNYYLNIGMTVNGKNGN
YRLWALEYSHQYSQYRDMRIPQETYTAEGGYSFFLLGDARKNITLNAVITGVVGYESINR
GEALLFDGAKIVSEDNFIYGGCARLSIETYLSDRFVLLLQGRIKVLWGTDLEQFRPSAGV
GLRFNF
>EGALAKHO_03932 hypothetical protein
MTAILNKFRIGLLPVLVAVLISSITFLSCNKEELEIQNDFPFEVKVMPVPKEIANGDKAE
IRITIQPTGNYTGIQYLIRYFQFDGKGTLQYSDETPYKPNDLYSLPAKQFRLYYTSHSVV
SQTFDVWISDNFGNEKKLRFEFNSSD
>EGALAKHO_03933 hypothetical protein
MKDVIARTNRFYIEMSRKVLSEKEYDVLHKLLIEKMTLREAAVIYGVTSESVRQIYERTY
KKVKSVTDLLGEIDNYKHKLKQLKSDCKFETRQIKKRKKTPETEFAPDCCLQKTLYESHF
PFSKRMYSMFEILDVHTIGQLCEIPLTDFHRYRGFGKQCKKELITFIEFENIEYLFEGFS
VWKTEPIE
>EGALAKHO_03934 hypothetical protein
MNTEKAKIHFTDNYLMNPTNPITVNLIGAGGTGSKVLTALMEMNHSLIELGHAGLSVRLW
DDDIITSANLGRQRFAECEVGLHKSIALINRANRFSGTNWKAETRKFKKKPLGGLPDNAQ
ATIYISCVDSVKARFNIADILNLQKNRRHHRDDPKYWFDFGNSQHTGQVILSTIGEIKQP
NSEKYKTVASLPFVTEEFGDLLKQSEEHDNTPSCSLAEALEKQELFINSTLAQMGCSLLW
SLFRYGMTENRGFFLNLKDFRTHPLKVA
>EGALAKHO_03935 hypothetical protein
MNITNDITTGFGTFYHPKSALVFYKSKGVDTDIYVEHFDMDKNGNPINAHPLTVREADAL
VKALQIEKKKDTAFLKSNGILPSNILHINPSTDKGGVLWHTKAQKRQLYFVNSLDIPSGT
AYVPSMIWYASKNSLTVFALSSDRRPTEKTSLYFAPFFNIYEDGKVCMGSVSIDIKNSAS
VEEFTSAWEDYFFNSYFSHLLGSNSPVKVNCVNLWKDLIQTGKPFPKEILKKNNKTIKNI
LR
>EGALAKHO_03936 hypothetical protein
MNHAQTYYIGNNKPTRTKRSKTVTQTTQRVRPLDAKTQRCKRDSERQTKISTNTNVANGF
LRTSFLPKLEETKTVLACQKTAKMENDFYCSLSRLAKHYDIVLMQTSHYDYPYNMALALW
DVEEKLKERVLNWQEIRLVQDRKKTYLISEEKYDTGTTLYYIPIEPLYQMLHDSKRKRNA
QLLISVCSYLYHIVNIPYFRQEESYLYWMYEMHEDWLEQDDVTDETEVYKREFYKAELIG
DCIEQKIFNPINLQVFEQRLNSFKKRDSFDNDCWRIACSAFSLYTEYPHATIFRNAPVRD
DPENEENENETIGMEKYISFISHTKGCLYESISESINNEFNEYGSMEEPTIYKCFDGNDI
IQSNLDFESRLFLLLDNICSLLYNYKTTRK
>EGALAKHO_03937 hypothetical protein
MLLATQLKRVFVLKDKGQDIMLTDPEPHWSVETVLNFYSNTYPILTTAKISAPAIKDDAV
EYRFESVMGTKG
>EGALAKHO_03938 hypothetical protein
MNTNFFNQIAQLGVAGDLHLTIAKGAENNLIVSIMLQNEQCGDNAKNIIPPLNLRGTAEE
LDNGFFEKITTPIQTASGLMVDMEGFMKQLEETKKQSAMEKDKADKQKQEQQSKDKKFKD
GMTKAEELEKEGKFREAWIKVPEIAEFPEKADEIRKRKTELSDKFSAPSLFGTEQDNNV
>EGALAKHO_03939 hypothetical protein
MNIGIITYREYEVKNIGLNWNFNLSELLNIMLNNKDFVRFEIFDPNNNLLLSTYYPNVEQ
KGIYIEVVKIKKETEITGITYDAFRTPSTIRRMKVRWNVNGRKFRTKKRALEYVYWENRR
VSLKIESFVDRR
>EGALAKHO_03940 hypothetical protein
MAHNINFNEQTGSYSFFSVKEKAWHGLGQIVEQYPTSEEAIKYAGLDYEVAKSPLYTRGS
GIIQTSNSIEIGSSELEVPNYYANIRTDNNAVLGVVGKDYHIVQNREAFNFFDEIVGGDQ
GILYETAGALGQGERIFITAKLPDYIRVGNGDDVTEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRCMSNVVRIKHTSGAKQRLDDAHKVMGLANTLSSQLEDIFNHWAKVKVTD
REVKKLIQLALCPNKETLDLIKKGAEHDVSTLFKNTVDDAFAYAMASDSQQMNTTKGTLF
GAYNAVTGYYQNVRSYKDNEAKLQSIVMGGTAQLKSQKAFELCTSFATDGAEILNLN
>EGALAKHO_03941 Single-stranded DNA-binding protein A
MNITGRLTADAQVRNVSNSKTVVNFSVAINDSYRNKAGERIEQTTYFDCAYWLSPKVAQI
LTKGTVVELTGKVSARAWTGSDGQAHAGLNFNTSQIKLHGGGKKSETVQAPTGNNNDKTG
DDLPF
>EGALAKHO_03942 hypothetical protein
MGEHDEKAAEKPLKIMVASTVLNSQDIVEQVCSTLSTYGYQVMNSHFKTIPTNPKISNLQ
NCLNAVEASDLVFGIITPRYGAVIAGDLSITHQEMRRAIELEKPRWFVSHRDIYVARELL
KQYMYLPGPAPQAANPDFLFKKTGVLDDIRLVHQYNDVIRNEIDPDKRTGHWVDEYYRLA
DILKVVETQFKDIDRVRAIVEAMKP
>EGALAKHO_03943 hypothetical protein
MREEDQLHSLLKEGESDQMEFKSSIDEMAIGKAICSFLNAKGGRILVGVDDLGQVRGISN
AIEHVERLKIFLLSEIVPEAPITISNEPIDDKQIILLKVYKGSKQPYIFDGNIYYREGKE
TKRATSNQISELIHGRQKSEIHWERSPAINVEFEDLDQKLIRSTIEESRRNHRGNFESDD
LLDFLSYYGLYENGYFSNACVVLFAKNPSKFIPQVRVRLTEYGDSKTNNSLLRDEVLEGN
LFDTQDRLERYISNLGVRSVFASNQWKRVDFKFPIKALQEGVINALMHRDYSNQSSSAVI
SIYPDKIIISNSGHLPGDLKVSELKKSHTSHPVNPDIAHIVFLRGLIDKLGRGTLKVIEE
CHKEGLKDPVWKDAGDGVTLTFNGPKALPYKRMARDDDFRDDLNDGIDEGLSDGVNKLLD
AAVNDGLIDGISDGIRRELVKIVSLLRDNEGLNANGIIDVMDKSKPTVERYLSIAKSAAI
VEFKGSRRTGGYYLTDTVKQVIK
>EGALAKHO_03944 hypothetical protein
MGYNLISGTSQRFYHTIESDLDAITTSPTREGIFKNLSQIGYDKFPEFILDILVKVEGHT
AVDVTDGQGDEKQDILTTNTKGERCITQCKHTGNYQSHYNGNDLDTLVVAAMRKDCQQGV
FVTNADLTPQGKKYINDEEYNRGIKSAEDFRDISYWNGFKIWEKIKNNKDILNKWFSDLG
QVHSLRSFKFDLTVQEFPYDDDRDEGESFNNIIAKLKSKKWVKEVEEGLVYRGNFSSRYE
VHFKKWFQFTGGLDINFIPPGNNLDFINKALYALTIEVKIKSDKNYSPSIIRQDIVNKIV
KEILPISQPGKTWWHITSSKIKSFIYIHDIQEPREIDLTSSLTFISTETGKVFPELKYCT
DLKGKFKTINVDEDIVMVHRNSGISVIPYFEQKIDPVQQYDNQIIQQRQLAEIASYNFFA
VKNIDSSYLMRIRRLLDHHWMALQMDDDTIIWAVDPDTDPEKIDLIHGRVETLGVSILQI
PAEETPKILKNIQKDLSPSTWMYTPDIDSISFPILLEKRIFWLSKEFSLAKEIDVEMAME
LLKYKYTYESRNGFDNMVTDQMATHSTEIKSLLLDILNIRGTKMLDLGFSKNTITLYMRF
REIGLESADVLAAKYIKEFQKVMDEIQLL
>EGALAKHO_03945 hypothetical protein
MAINWNNIRPLNNSLNDGFEELVCQLASREIIVGKDKFWRMGKPDAGKECYWVLKNGDLH
MWQAKFFTTSLSATQWTEIDKSVITAIDNHPKLKKYNIAIPIDMPDGKVKEKKSMLDKWK
SKTQEWIDYAKTKGIDLTFDFWGSSELITRLSKKENEGIKYFWFNQEEFLDTWFNYKNQE
STTALGARYTKDLNVKLPIAKLFDGIARDKNFKKQSDERYVEFIEKYREIRITTEQTIIK
ENLEILDAIINKVKEDYKQIDFEGQANLGFDNIIESLEAAYDPTEKVLRDFYAMRSEKEK
KPEPHVYTRPFATEVNVVGKFISAIGDYKDFLTGDTVFLANHPYLLLVGEAGIGKSHLFA
DVVKTRSEKQQKSLFLLGENFSNRDLPWTQILRNQLRINGIDELVFLSALNAQAESAQTR
TVIFIDAINEGEGVSIWPNRLRSFIDSVKSFPWLGLVLSLRSSYERLIAPDSQFDESVIL
KVQHEGFANYEYEATKRFFDFYGIIEPGTPILNPEFHNPLFLKLFCKSIQAKGLTQIPAG
VDGITSIIEFYLDSINAKLSTATELHYDESKKLVHKAVNAVLSQMVDADQEFLSYDNANT
TIDSIFSGNCYKPEPFLKKLLSEGVFNKDLRWSDDGKQFEVVYFAYQRFQDHLTVSMLLD
KHLDMENPKDSFEKGKLHELLKDDVACWKNQNLIEAFAIQLPERTGREIFELAEHAKSFY
QIADAFLNSLIWRKPESIGNAAKDFVNDVIAHDEELFHRFLGTVISASMKPEFYFNAESL
HNFLSGFTMADRDEAWTIYLQDKYGDNSSTNAVNRLIDWAWKDDVKSHVSDNVMLLACTT
LAWFLCSPNRYLRDATTKALICLLENRVHLIPRLLEKFKDVNDPYIFERLYAVAYGCVLR
SGKSQSLMELCNYIYENIFNKDMVIPNILLRDYARGVIEFALHEHLELNFEITKVRPPYK
SQRLPVKFPSNKEIDDKFEPDGEEGHYGKGQWGSTAILRSMTTEYGRKTGGYGDFGRYVF
QSALSNWKIDYDGLSNYAVERIFELGYDPKIFSEFDSRQGSGRDGDHNERMGKKYQWIVF
NELLARVSDQCKLLDESEWDEKGKTLPYDGPWYPNVRDIDPTMIIKETKAERYKKYTPNW
WFNTNFNSYDSPIKDWLIGTDNLPVPSDILEVADSDGKKWLWLDIDLSWTEPETLGEDKY
GSARKKLSYWISSYLVRRSDLVNIEKNFKGDFFRSDLPEIRTMTHVFSREYYWSAAFAFH
NKPYYSGEDWIEVYSRKNSKLIGEFHRTSEYFLWEEEYDCSKSDSIYYHKPVQKIKEGLE
MKFSKNEGEFVDGNGELVCFDPSVNNKSLTGLLVRKDKLIEWLEKEDLALLWNVKGEKQV
LGNWHWKKGEYLGQLQISGLYKLENHEINGKLGFLKAR
>EGALAKHO_03946 hypothetical protein
MISPNEIKTKAERKYFSFLQSVVQAIPFSRIVIPGDKTYSKTSISEFHNEILALASQSKE
KKGFGFTIEYQTVKTKTIGMQSLPTIIYFDSEKDFLKFLGKEKEVDIFVNNWQLIHSHFP
ELKDWIIKNPTKIIQNQGKWESILKVCNYFKNYPKPNLYMRELPVNVHTKFVESNQSIIT
ELLDIIIQNHINLNERDFEKRFNLKFREPLVRFKVLDKKISQTYFSNLDDIAIPVSQFVN
LRLPLKQVLIVENKTTLYTTLTLPKMDKTIAIFGQGNAVTNIQDAKWLNDITVLYWGDID
THGFEILSRLRKHFKHTKSVLMDKTTFEKFFENDSGKPATDTTTLNLTENENELYNLLKI
NNWRLEQEKIPFDYVNRHFCNW
>EGALAKHO_03947 hypothetical protein
MLSLFSTNSDKAGFRLQYMEVYNWGTFHDKIFRINPKGNNSLLTGANASGKSTFIDALLT
LLVPVKKDRFYNQSSGVEKKGDRTEETYVCGHYGNIQREGELSTTTQTLRGKDTYSVLLA
SFSNTDQKSVTLFQVRWFASDGKLNRAFGIAYVPLDIEKDFSHFDGKGNWKKRLDRTYNS
NSNKKKIEFFDGPTFYGERISDVFGMRSIKGLSLFNQVVGVKVLEDLDEFIRTNMLEEYK
EDNENAEEKFIKLKSSFTTLIDAKTNIEKAKEQIEQLKPINEIAIELAKIRNEIQTLNVS
KDMSVYWFAKKSVELFELELLKSNTQLDELNDELQVLKEREDLLKGEERSLSISIETDEV
GGKIKELEKDIKQLEKSRDLRKTKLDEYNIIAKRIELSSNPSIDVFKENREISKNKKNEY
QLKIDSETENQRKLKNEEESLVLQSDEIVATIQALQKNKNNISGKEAEIRENIIAYVGAT
KEEVPFIGELIKVREDEKEWELSIEKILHNFALRLIVPDKYYSKVNEYVNKTNLNGRIVY
QRYRGFTSLDSFTVKSISQNSLVNKIEFKEKNLYTPWLEDIIANQYNYSCVNDLSEFNRY
DERAITKEGLVKFGKGKHEKDDRPHISKRENYVLGWDNKEKISNLKKNLIEIQSSQVTNK
KDIATIYGLIKGLGNLKDDCFSIFSTYTKYDDIDWQTYANQIQEKEDAKKKLEATNDRVK
SLQEQLTKVRDALALLTDADIKNKNKEIFQLEEIVIKEIIRDLEINKKLLDSIGTKDTSE
FEILNLELSNIDFADIKVKQTEFQKNNASKLKELENSNESNERKVIKLISEFKNPPIEIT
DKYKDWRSDVSRLPDSNNIDLLGEYQTFYQKLIADDLPRFEKKFNEYLQDTILRKIGDFR
MFFENWSDSIKENIRLLNESLKGIDFKNSPITYIQLISQRRKNQLVDDFRDLLYKAIPNF
KEIEATIDGKKNHFYTNIEPLITKLENEKWRQEVMEVRSWYSYKAEEFYKETNQKFKTYE
NMGQLSGGEKAQLTYTILGSAIAYQFGLTKEGLQTNSFRFIAIDEAFKAQDEDKARYLIT
LCKQLHLQLLVVTPSDNIHIVEDAISFVHFVERKDEKYSWLYDMPIEQFKEERNNFLNK
>EGALAKHO_03948 hypothetical protein
MSSLERNIRPYSKAIVKLLKGSIERTSNVWEDIVHYQTEIQDYISQIGLELIVKKEEGFA
FVKQFEDSEGNTLGLVVRRQIGFETSIVLVVLRQSLEEFDSNPTQFQVFEKFITNSEIKE
EVELFLPEKFNRVKFLKELDSYINNIVKLGYLSEVSKKESETKYQIKRIIKEKVTLDILQ
EFKLKLQENVESI
>EGALAKHO_03949 hypothetical protein
MIESSKIANILNNSPSVDLLRMRNREVIITFLLNTFSNQQGAISSEKMHHQLADYLEAVQ
VEIDEDIEITFADTYEIKAKKYVQNWTNKGFLTNYQDETGEIYYELSSHSSKTLDWLSSL
KKEEYVGAESKFKNIFNQLKELVEFTNEDIDKRVQLLEDKKLEIEQQIQRIKIGEDVKVF
QDFEIVPRFNQLTKSAKELLSDFKEVEDNFKEITKDIYLKHAEGSLTKSHILEFTFDAID
ELKNSHQGKSFYAFYTFMLTPALQEEWGKLTKELYSTLKEKDIEITDYFLKGMKKHLYSS
GQKVSKANDKMAEKLSRIIRENEASKSENTKKIIQDIKKSLIELSKAKKRPDISFELEID
ADINIPFERKITFEQSQELVYKTKPKLADESISHSHHLNKLFSISVIDKEILRVRIREVL
KNKSQTTLAEIIENFGGIEKGLPELFGYIGIVKEFKHSIHPDKKQRIEFDIENQKSIQIP
EIILSK
>EGALAKHO_03950 hypothetical protein
MPLINPNDIHSAADTWSGFIYQGKIALYHVLTLILNEANVDDLELQLDSLEDFAIVRNDG
TNISPVSLHQVKATKSHLYSYYEEAFNKLEKRKHDFPCERDAFFHLAINNERTKVAIEAA
HPTLVIYEYDGDPFCRIEDLQNKVDRTAQACLLKFGLAAESGNADYVSMISEVLEEIITS
QIIAVHAANHIKNGLTISEGAYYFTIPLNNFIAQLTANVNTRLFDKNYYRRVLRNDLNLY
FQEYCMDIESEVDDVVKTKLASYLIYFNSLNDSEFEMFLQNIMPHKIVKFSKLQEYKDNT
LQIDEFKNALIFTLREIRDSDKDLINKLGWICPNNKRYFPSTINISNTAASKKRISEQII
GVALDKLIDTPYNSDYIITEGCQVDSLEDEAVNIFNVGNENYNNITKWRKISLINLEQAK
INLNGINN
>EGALAKHO_03951 hypothetical protein
MESIINSLFEEVGLEAQLTEFGKVYYFGDTNQFSFWLVIETTDLSSIIENQSKFFTVSKE
LLKNEWFDKNANLLILCKSSSESPLDKNQLIDIEENPFLFKKQILFYTENEKQKLLEAIT
ASNLTTKKFFEQKLLSNSIFEQHKTNLNNNAFESLLYRVAHKVPFLNIKVVQKDGLSALT
ENNNNEVAKNSQLKELDDLISEMILDKTFDDFSSISPEAVYEKILIVISKDEDSKN
>EGALAKHO_03952 DNA replication and repair protein RecF
MKIQKIKIQNFKVLREKELDFEASDLVVFDGPNGFGKTSLYDAIELLYTGKIRRYDVLRL
LLIDGRESYHEHPFYSEGATGDISIIIEFTKNDSTYILERFAKKEELTNSINFSTYKLYQ
KESFEANEKVLIENEEDFLSNILGPNYKENFQFLNYIEQEDSLYLLKSQDKNRKQYISHL
FNVLEFENKIANINLIKQKIERLCNGEEKKVVEDLKSVIKQTQDFLSRGFNDIEYVRLFP
DKEVIWDAKEFDFKSIDYLDLLGEDGIVTKLNNFLNQKESFNKYLYNENIDAVLRTDSVL
KDFCQFYSFIPQQENLIIIKDSFIKKQQYIEKLENFSTDDFQDEFFEFDFDDFDFLNDDL
KEEFFEEFEILKTDLLALNKLEGIYSKINESRQKLIEKIEDLREEEDLTSGSCFLCGYEW
GDINGLLDNISLQSDNLENVASESSKVFKEKFYLFKTSTVGQIMVAITEDITNNNVDKEF
INKLISFEPTHFNNIAKNFEKINFDYSEYLNNVIKVDIDLKFEKLNLDLKEKKHEIVIEE
IQPHFKEYFNDFFDNNFDDFDAFDQENVKTKIDYLKYIYSLQQNDFFTAKIQELAVKQVK
YDNAKLLSDKIKQLKNVYDSSLLKYQKKVIKDIEIIFHIYSGRIMQDFQGGLGLFIYSDK
NGIRFQTNPNKTFDAIFSMSSGQLSALIISFTLALHKKYSQNKIILIDDPVQTMDELNVV
GFIELLRNEFSKNQIIISTHEDMMSAFMRYKFKNYNLTQKRINLKSLEQSEI
>EGALAKHO_03953 hypothetical protein
MANYDFSTLNDRDLEELSRDILSTKLGLDFQSFKPGPDKGIDLRYATVNDENEIIVQVKH
LLGSGVVALKSILKTEELPKVIRLNPKRYIVVTSLPLSPQDKESIKNTFSPYILSTRDIL
GKNDLNNFLRNNPNIEEQHFKLWLSSSNIFKRILKNGVKARSEFHADKIKRQIKLFVPNK
AHSNAIKILNTNNFILITGAPGIGKSTLANMLTYQLLAKDFELIYVREITEAEDLIITGR
KQVFYFDDFLGSITLDLKSSRNADSAIVNFIDMIKNDSQKKLILTCRTTLLNQAKQTSEK
IKDSKIDIAKHEVHIKDYRNIDKAKILYNHIYISQLSVEQKHIFFKDMFYWQVIKHKNYN
PRVIEYFTDNDRIESDKPYATTVIDFLNNPSLIWEKPFTKQISLSARLLLTSLYSLGSRF
ILFENRLKEAFSARLEYEVKNNNFVKQGGDYEAVIKETVGMFINRIIKEKNTIEYSFFNP
SIEDFLYDYFTRNKDEYLTHLRSAISYEQFKGRITTTFIKDSKQILFSEKKLATQLLEIF
ISKAPHLSGYGDNDLNYIVILIRLFAWDSIGSMVQDRINSLNLQILGWTDRENLIEILSY
MAEHDLTNCIDQLDDLILILSKNMESHHQIESFSKLISKYNIYSNVIENFKSSNNEYYDQ
IKVNIEESWRKNIDQYIKQSYNLSSITTKEELMKVVTKRKEEANNIVRAINLSSSSAVDN
YEFNYEQQLDTNKSAMSSEKITIDNFQESHDPINEIIEVNRLFNSNDVDEWDDLPF
>EGALAKHO_03954 hypothetical protein
MNDINKIKQLLTSDFELDLFDAALASLNDKHNKLRYNNFAYSIRELSRHFLYNLAPELNI
QNCSWFKKETEDGKPSRTQRIKYAIQGGIDDKTLKKWGFNIEELKQTIREIKASIDSLNK
YTHINPEVFNLGDDEIEQKSRETFSSFESFVKMIESYRTELKSFLDGHIEEQMIMSVVTN
SFVNVDSLAPHYSLNHSDVTDYHISEINDHEIIVNVSGDLYVTLEYGSNRERREGDGLDL
DKDFPFETKIRYEIDESFPLSEYEVDDFDVDTSEWYGDDDDRL
>EGALAKHO_03955 hypothetical protein
MYSDDDDNNNTSQSQNSGDSGRQTPERDTSTYQERSENQAGIVKK
>EGALAKHO_03956 hypothetical protein
MQEENKQILNRIDKEKLLLVKGEAELLMDEITLSESTTISKSNNYFQILFAVSVSIIGFL
ISRSDSYDKYSLFNQVSLLFLIFFTASLFFLSRILYPKAEGLKGTIPSEVLQNDIFNKSD
CEVELFLSNRILSLQKCIAKRMINQENRIKDLKRAIGLILASLIAVSIYSFLYFIS
>EGALAKHO_03957 hypothetical protein
MNDFELKKIAIGEAFKRMKDAGMEVSYEDVVLIMEFLHNLTYLVIKKHYKLP
>EGALAKHO_03958 Serine recombinase PinR
MKSAILYIRVSTDEQADKGYSQRDQDERLRRYCNNHNIHVENVIFEDHSAKTFNRPEWIR
LLDGVKKRKARPDFVLFTKWDRFSRNAGDAYQMINMLNGLGVEPQAVEQPLDLSVPENKM
MLAIYLAAPEVENDRRALNTFYGMRRAKKEGRVLGMAPYGYINRTKEDGKKYIAIKEPEA
TNLQWAFNEIAKGVLAADQVRQTMVKRGKNISRSAFHVALRNVVYCGKVFIQKHKDEEAH
SVQGQHEPLVSEALFYRVQNIIDGNIRQVRPQTKIFSDDNLPLRGFLICPDCGRNLTGSA
SKGSKGGHYYYYHCIPKCGFRKSAVKANEIFQEDLKKYEFPIVIQGILRDIMMTNYKSFA
SVFENRRRAIALEIEKFNTKLSKARELLLAEKLDADDYKEIKEECKSNIENLEEELSAYV
SEQKNQNIMKNLDDALNALSSLSSLYNDGDTETKRYIIGSIYPEKLYFNGSEYRTPRLNV
IAECISLVNKALGDKKNRTNESFSHLSGLVARTGVELWQILNKWRDGFNYALPDWLIICF
QDLRDLKSFRFNRLEWC
>EGALAKHO_03959 hypothetical protein
MNEVGKFLKAYKKINRRLQFLENLMKVNDQSAYITRLTIPNKKEKCGSVYNKSDLASLFY
FLMDENILFFNLEDRKLNRGNFQNFMIENFTYCGDGGQQSEVISISKQFSECKGFTYREK
QISFLNNLVEIIQKRKERLMYW
>EGALAKHO_03960 hypothetical protein
MTKKERELSFLMRVKQLIEPIMIRLETIDSKISGQSKVTRPVYYRNEDLKKIFGLSNNTI
IKYRQTGILPFTKLGDIFLYDSAKIEKILHENNN
>EGALAKHO_03961 Tyrosine recombinase XerC
MLKVIFYQKSDKVDKNGESPIFVRLSYKTKRISISTGKSISKERWIFTNNLRNVLKLEKE
KVIKNSLDLLQLQTEKKFLELYRIDPDVSLELLKAELSGKRKIKTREITILEVMKKHNNF
FERKVDAGERSKASFQKYLRSCDLLRNFIKKQYGFDDIPATDVSNAFVFNLEEYLKYESS
FKGQVGIKNNSVVKYMKMFKTACNYCIRMDLIVKNPFDAYDGKLSVKDAIFLTQTELNRI
EEKPIFNERLQKVRDIFLFCCYTGYAPVDALNLTPANLFEDNDGNLWIMTTRAKTAIREN
VPVLPPALSIINKYKKKQMKLLPQISNQKMNAYLKEIADICEINKHLTWYVSRHTFATTV
TLGNGVRLEHVSAMMGHTNIKQTQHYAKVLDVNIMQDMEKLKLKYK
>EGALAKHO_03963 putative acyl-CoA thioester hydrolase
MGTLEERITKSETHIFKAVFPSTTNHYDTLFGGTALHLMDEVAFICATRFSRKKVVTIST
GQIDFKKAIPAGTLIELVAKVISVGRTSCKIHVDIFMEQMYSELRETVVSGTFSFVAVDE
NKKPMPILDNLEK
>EGALAKHO_03964 Riboflavin biosynthesis protein RibBA
MSTTKIQLNTIEEAIEDIRQGKVIIVVDDEDRENEGDFLAAAEKVTPEMINFMATHGRGL
ICTPLTESRCKELDLRAMVSNNTDHMETAFTVSVDLKGHGVTTGISAADRSKTVQALVDG
NTKPHDLARPGHIFPLIAKQGGVLRRTGHTEAAIDFARLAGFKSAGVICEILNEDGTMSR
LPELIKVAKKFNLKLVSIEDLVAYRMQHDSLIVKKEDFDIETRFGTFRLRAYEQTTNKQI
HIALTKGTWNLGEPILTRIHSSQVNNDLLGTLTNNAEQQLDGMFKVINENGKGAVVFINQ
DMQAVNLLSRITELKTLQADGTMKAPKVIIDSKDYGIGAQILHDIDISKIRLVSNTEQTK
RVGMIGYGLEITEYVNY
>EGALAKHO_03965 hypothetical protein
MPRIIPLVLPLSVLLASIMTFGNLAENYEFAAMKSSGISLQRAMRVLVAFIFVLSIVAFW
FANNVIPYAEYKFVNFRKNIAQAKPAMAIAEGQFNDVGTYNIKVNKKSGENGNILTGVTI
HEKANNVGENKTVIKAKNGKLISNEKSSILKLVLNDGYYYQDVTPKKYEDRAKLPFVKAS
FKKQIINIDLSELNKVDDNQEISSTNGMLNVNELRYTLDSLNKNLDNEILSFSENINQRV
GFKKQSPVTIKTDKKKKALPNDLLSLYDNKQKLDILKMATSNVTSNTYSIDATQKELKDK
QRDINKHLSALYEKFVIAFACFLMFFIGAPLGAIIRKGGLGLPIVFAVLIFITFHFINTF
GKRLSQEGGMSPFMGSWMSSFILLPLAILLTYRATNDNGLINFDAITTPISQLFQKISER
FTPAQKQ
>EGALAKHO_03966 Outer-membrane lipoprotein carrier protein
MAILLLLSFTSIQAQDKKAKDLLNQVTAKIKSYDNISIDFKYSLNNTKENINQDSKGNVI
MKGNQYVLNFMGVTKIFDGQKTYTINPEDEEVTISKVNEKDDNAITPSKMLTFFNSGYKY
NMDIVQNIKGRKIQYIKLAPTNTKDQRKEILLGIDVQTKHIYNLIETGKNGTKTTLTVNS
FKTNQPLSKNQFTFVASKYPKYYINKLD
>EGALAKHO_03967 DNA translocase SpoIIIE
MAKTTKKETVNKKNEPNTGNKRSWKITKQQKFVLGCLLVLFSIALLVAFISFYVNGQWQT
DQSAVSHLGDRSEEVQNWLGKFGAYLADLLVYRGFGLASFILVRLFFLTGLFLALEMSTK
RLKSIWFWDLFAIIIVSVLFGFFATSAPELGGTIGYELNLFSQDYIGKTGTLLALLFGLI
VYLIFKIKLSPEKIQSYFDSTKNEFKSELGALKTPQQPESAYNLEEFAIEEEDPELDNIH
LKTEDTQFEINKEALKPTISNSSEIDLNPVLKPVQMDIKPATVTAPVHTEEFVVEKPEEE
DIIEENLASRLVADFGLFDPTLDLSNYKFPTIDLLKEYSTGGITINQEELEENKNKIVDT
LRNYKIEIAQIKATVGPSVTLYEIVPEAGIRISKIKSLEDDIALSLSALGIRIIAPIPGK
GTIGIEVPNKNPTMVSMKSVIGSAKFQEAEMELPIALGKTISNETFVVDLAKMPHLLMAG
ATGQGKSVGLNAVLTSLLYKKHPAEVKFVLVDPKKVELTLFNKIERHYLAKLPDTEDAII
TDNAKVVNTLNSLCVEMDNRYSLLKDAMVRNIKEYNDKFKARKLNPEAGHRFLPYIILVV
DEFADLIMTAGKEVEIPIARLAQLARAIGIHLIIATQRPSVNVITGLIKANFPARIAFRV
TSKIDSRTILDTQGADQLIGRGDLLYTNGNDVVRVQCAFIDTPEVEKITDFIGSQKAYAT
AYLLPEFVGEETGINLDMDISERDTLFREAAEIIVNAQQGSASLLQRKLKLGYNRAGRLI
DQLEAAGIVGPFEGSKARSVNISDLSSLDQFFNNEQN
>EGALAKHO_03968 Undecaprenol kinase
MEFQKDNTFVTGRLKSMTYAFNGAVKLIRTEHSIMVQFSLGIIMTIAGFYFHISQTEWLC
QTLAIGLVLAVEGLNTAVEKIADFIHPDYSKRIGFIKDIAAGAVFFAAMTAIAIGLIIYL
PKFI
>EGALAKHO_03969 putative thiol peroxidase
MASITLGGNPIHTSGELPTVGSQLADFKLVQNDLSVASLSNFAGKKLVLNIFPSIDTGTC
ATSVRKFNESASNLENTTVLCISRDLPFAQKRFCGAEGLENVVNLSDFQAGDFGKTNGLE
IVDGPLAGLHSRAIIVVDADGKVLHTEQVAEIANEPNYEAALAAL
>EGALAKHO_03970 hypothetical protein
MKLPVIKQLTQFIEENDQDYIIETIEVLEAMTEIPSLKDEELDVIGELISNMYGALEVHK
MVVQGTDKKEALNAFMKRVLGSIDK
>EGALAKHO_03971 Thioredoxin
MLIDLNEDTLADLVAKNEKVVVQYSASWCGNCRIMKPKFKKLATENEAITFVLVDAENSP
ESRKLANVSNLPTFATFVNGQLVGETQTNKQEVLIDLVNAIA
>EGALAKHO_03972 putative peroxiredoxin
MSLVGKKFPSIAVDAISEMGDNLKINIFEEAVNNNKKVLLFWYPKDFTFVCPTELHAFQA
ALPEFEKRNTIVIGASCDTNEVHFAWLNTPKNNGGIEGVTYPILADTNRNLSNILGILDI
DSTEYSEETDSVIIEGSNVTYRATYLIDETGKIFHESVNDMPLGRNVNEYLRMVDAYTHI
QTKGEVCPANWEAGKEAMSADRLSTAEYLSAN
>EGALAKHO_03973 Beta-hexosaminidase
MKMTAEALRQKVGQFFFPAVFINDTEENIQETERLIKEHNIGGLTFFHSRASAATNYESK
KKVVFNDDSYEKIKALIVRYQKSASTPLLISIDAEWGLAMRIEKTPQYPYAITLGALPES
KSDLVYEVGKQIGLDLKAAGIHYNLSPLADINNNPNNPVIGYRSFGENKEKVAHFAVEYL
NGMSEVGVLGCLKHFPGHGNTNVDSHLGLPVLKETLEELLENELYPFIKGIENNVDSIMI
GHLAVPSLNNGKDTSATLSKAVIQTLLREKLGYDGLVISDALNMHSVSKLYETKGDLEWE
AFNAGNDVLCFAENVPEGIEAILKNASTERIEESFNRIMKAKEKVGILSENQFTSGELNF
KKASELNFEIAQDSITKIIDNSNTELAFEAQKKNQFAKLSLYKNVENTFFQTINSKLESP
EFAFENLEVSDISKIKKELNNFETILISLFVPKAKPMNNFEINDEVLALLSDLLQTKKCI
VYVFGNPYVLPIIPNLSKASGLIQVYQDFEEFQKNAGTQFLENKTCNGILPVNIDLQ
>EGALAKHO_03974 putative N-acetyltransferase YsnE
MITLKRTNSDDTDFKNLVVLLDQDLAIRDGEDHAFYNQFNKTDKIKHVIVFYENETAVGC
GAFREKESDTVEIKRMFVHPDFRKKGIASTVLKELEIWAKEIGYAYTILETGKNQPEAIN
LYQKQDYTIIPNYPPYETMDNSVCMKKTL
>EGALAKHO_03975 hypothetical protein
MKTKIYITTLAMMLLFSCGQTNEKNKKLLDKKQPAVKIFEQREKERLEKRAEIEKEEKKD
SIRLDKVLSEALKIATLEIHQKKFQKKYKVRPDNEYDVQVEININDYFTKNDPHLIIRRL
EPNNLYIDIYSKDGNKFKNVLSHKQWTLTYTNDTIRDINGDGLKDFVVNWYGATGCCLKG
FSNIYLLRKDKKEFSKGFEFINPTFSPQEKIIRGVQYGHPGETEIYKFKWNGEAIDTLEY
VYYDTNKEGKKTGKIIISKKRAYSENKKDIQKLNSIPAEYKKIEGFDWFTGKGYE
>EGALAKHO_03976 hypothetical protein
MEFNENLQVERNLKGAEFEKTGDFEKAIEVYEENVAESFKGNHPYDRLATIYKNQNDIEN
EIRVLEKAIIVFEEITLEDRLEGLPKLFRFKNRLEKAIETKKQLAKQKKAKLK
>EGALAKHO_03977 hypothetical protein
MKTDNKPWYWIPLLNFASGLPYAVIISVSVIMYKNLGISNEDIGVYTSLLYLPWVIKPLW
SPFIELKGTKRKWFLSMQLLISIAFLLVGFTIPASGFFIMTLAIFWVAAFASASNDIASD
GFYLLVLPKEQQSFFLGIRSTFYRLSLLAGNGLIVLFAGYLEHKYGDNTKAWSYTMIAVG
LLMTFITVYNFFFTPKNEINADENHKIVPHQNFATIFVSFFKKKQIGVVLAFILVFRLGE
SQLLKMLSPFLLDKKEIGGMGLDTEAVGIIYGTLGIFALTVGGILGGIAISKQGLTKWMF
PMFLVMHLPIIGFIGLAHFQPEELFHLHLNLYFFEINSPLNLYTCITVILEQFGYGFGFT
GFMMFLIHVAEGESKTAHYALATGFMALGMMLPGMLSGYIQQFLGYQNFFVWVLLATIPG
LILSRFLIFPKDFGKKSEEV
>EGALAKHO_03978 hypothetical protein
MHKNQPLLFSIIFLLFLGWTSNAQEKLLHPKNEFRGVWIATVVNIDWPKTAADGVAKEKA
DYIETLEAYKKLNYNAVIVQVRSVGDAFYPSELAPWSRFLTGKEGQAPNPYYDALAWMIE
EAHIRGFEFHAWLNPYRATFDLNKNLLSPTHDIFKHPEWMIEYAGKYYYDPALPEVQAHL
TKVVKEVVDKYDIDAIHFDDYFYPYTVPGKTFNDNASYKKYGSGLSLADWRRANVSNFVH
TISTTIKASKPWVQFGISPFGVWRNKSQDPKGSETQSTSNYDDLYADPVLWMDQKWIDYI
MPQLYWSMNNPRASYSKLVKWWSENSNDNTALYIGHASYKIRGDADKSWNYVNEIPTQID
YARSFKKVGGSAYFSSKWFMDKNFDITKLLEDNQYKYPALPSPVPNLKHVIIDTPVVNEY
QKDSTKYSFNIKSPLNTKVRYVVLYGAEHISKVDINDASKIIDKIMVNQFDGSISFSIPA
QKMSQYKACAVTFIDYFANESTPTFIDLNNTFKIVYPNQPNENR
>EGALAKHO_03979 Anhydro-N-acetylmuramic acid kinase
MNKNISALFEIAQKETRKIIGLMSGTSLDGLDIALCAISGAGENTAVKILEFETINYTED
IKTEIRKVFAQKTIDFQHLALLNEWIGLLHAGMVNDCLQKWNIPAHEVDLIASHGQTVLH
APKFLHQQEKFPNATLQIGDGDHIAVKTGIITLSDFRQKHVAGGGEGAPLAVYGDYLLFS
KKGENRIMLNMGGIANFTYLPASQNAEEVFVTDTGTANTLIDIFTKHFFPEKSYDKDAEI
AQTGTVNQTLLTELKSNAFFQKSFPKTIGQELFNKAFVDSALAKTKLENISAPDLLATLT
RLSAETIAEAILFVVKNTGTPIEDFTVYMSGGGASNPLLVKGLKELLSCKFQKSDDLGIS
GDAKEAVLFAVLANETVAGGDYNFGTKKGIPSVTMGKISFPD
>EGALAKHO_03980 hypothetical protein
MEVFYLVMLKWDLFGDKFRESWGFFWVGKTGITT
>EGALAKHO_03981 hypothetical protein
MDKNTIANNIDYLNNERLKVWERLIQLEEEINKKTSDFEKDAKQSSRKASEYRNKSSEAK
DVAVQNAEISASKVKDARVCLTNIKSIETKSESSFEKIEKFSSDVQSRSQKIESNLVLLE
ENFENNDEFVERLETLEGHFDKGQEIYSKIETLQKSIQSKKRDIDNLHRELFGYIENETN
EEGVEIETKVEGLKEQIQSTYEGLEEGFSNLEKDVTNIRRETLAKYNEFIAQKETSYQVK
ESKWNSDYNSVLNKINKLLPNALTTGLSYAYSEKKEREIEDSAKFAITFKTATLGLALVS
LIPFGLSVFFIFEKKTLLEVIEYSPRFVLAIIPLYIPVLWIAYSANKKVNLSKRLIEEYT
HKEVLSKTFEGLSHQINSIDDEEVSNDLKIKLLYNILSVSSENPGKLISDYNKSDHPLMD
ALEKSANLSDAVERLEKIPGFSKLARILDNKSKRILKEQADKVDSTLGEIVEETLETE
>EGALAKHO_03982 hypothetical protein
MSKITIKYQKPFERLIEKLQLLLKNEEGYLTYINDRGDFEVKTPIGLFKGSYVYSNQIIS
IRLEKKPFFISSKLIESEVKKYLLEN
>EGALAKHO_03983 hypothetical protein
MVLNLCSKILLFIKSNFKIFFSWLVLVIITLIFQSKIASFLAENTIIKHNNVKEQNFKWA
FIILVLIFLIRFLWFLVKNYRISQKHNYFIFFLSSIYFFLRNDENDSLYFSYLNRKPDLY
YSDIILLIAILSIVLLSRNIFLQNWKLYDNLIIWFDKLIKKDQLKNSSYLIEDTPLNKTD
INDNEKVIDEVVKAIVNIKPSHSFIIGINSIWGIGKTSFLKRLEFKLKTEDIKNESKPIP
ARAHNLYN
>EGALAKHO_03984 hypothetical protein
MIKKTIISIFLIFIILSCKKNNEKNIPNQIIRNDSVNYAKVKKNINSVDDVNVQTKQSFT
LDCGSSCAMTYNEVSKKNNPNSVEIKYKVTQYINERIEDEYFETYIFETDGNGYLLSIHL
DNNKENILNDDSSLIRHQLIEISSEIFDKKLSNQSNSKDCELVIGNKPFKLMIVPFNLKN
YVKNLPNEIQNSYLPTEKTKKYLVSIGYEGENYKCFFLKVDNKSAEVIISITRGDSEYFL
LIKSADNKFLSYKEIGIVGNEETKYFNIGKNYNIDL
>EGALAKHO_03985 hypothetical protein
MKEKFILALLLILVGCKDNNLPENRTRKTIVETASSEVKKLSCEEIIYKIVKSSNLKLEK
NIVFLTSIDRIDNDCIIIHVFFENNLSDDPKVKQIVESTIAWLSLNPNKLKLYNTTADPD
NPIELNFDKNIILNENDIFSSCQIVKKNKKIVSNTPIKYSKLPIDFDEYYEACVNPYDSI
SCNNNYPKYPFSEDDNIAEVFGKKYNPSSYMYLPKLNNYQPIILCNTDTDVESYQLIISN
GHTIISSLEIGLMDGESITQFTISKDYKINLYKRKNSSEKNVFFKSYSIDKNGIIIEIR
>EGALAKHO_03986 hypothetical protein
MSDFKIIGNPNPVVGVLEFYTVSDFFSEISPSQEFVYIPKSPENQVKWEVYVLEFGKWRK
TKENDKTGKQITYTFFEKSLTRKGIRLLARKGDKVARLDIKPLPAHPKIDHVELLDKNGS
KITVRLAYGQTVKARVFCLNMENRRVHVTLWEDDVKGAGHSKANEKNFIETRSAIVNFGK
ADIDFLLRPSFAKIATKGGPENDKIHEYYVTAEYDKEKTASKNVNVNAPETPVAPYKGKT
TQKLPTAIKAPSRQPKTELPKSGKPDAPAEAKGKINSVNITDTSGHAIKGRFREKQIKVW
INSSNLKEKEVRLKLFDDDYGKDDLLFQKEFTIQSNLHAIVVFLDTIPRSWGGNFLEEGN
EQELFAEVEVLQTHTFTKSAIVDVDATVFKQDPFEIFNKVFKVDMPEKKEEKKENCGEKY
CIKKGDKSELIREINIRLAGFGGNVPTDEFTDRTEKMIRQFQRDYMQVPETGKVCGNVLK
AIDEFQVKYSIHFEDLKCDCKKCTGFGDGSNKNIYKEALKEEVNHTYEYPGIHRNLIWAL
RAVMFYTTVKEKELGYSVKSISSGYRCRYNNLQHNRTSTNHMGKALDIHFNKNGKRTQKK
EDMEELRKKIYNKYLGAKWDWKIGQKNIFNLESSDKGAKTWVHYDVREFDKIYLLDHYFA
KTINDVNGKSILQLAKDNGFEKTCACLTTSNKIIIGATTDKNKKNNFTIEDAEKVLKIIY
LKYGLEMAKTVEMIYRWECDHFRSGQYKNCGAPGMEVSGNSSAPNYGWNGSIYETHPEYI
PIGLWSKFENKGKSGQGGNDQVTDIPKKYIMFPSVEAGMMYIANFITRHNNNVGRWHSLD
KNIQKNYLKDINTTIPRISNNLK
>EGALAKHO_03987 hypothetical protein
MSGKHVVVQGATVKCKFSEKPQTDILKVKSQSRHFANDKDASKKLIATTKETGQTLEKNT
FGNCKLQPTGSSYKPCQAVITQWNGAYEKVTLSNQGKILVEDSKATCPIGGPDCITVDKH
GQKAEVSKQNVRNANDMISNQINPLVNMAEFKESLEDHDAICK
>EGALAKHO_03988 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MSLLKDLEQLSASLEGTLLYDDLHKTLYSTDASVYRIKPKAVAVPKTIADISKLIRFAGE
HNISITPRTAGTSLAGQTVGDGIVVDVSKNFTKILNFDPIKKTVTVEPGVIRDELNLFLK
PHGVFFGPNTSTSNRCMIGGMVGNNSSGTTSIRYGVTRDKIVEIKAILSDGSEVVFKELT
SAEFVEKTKGDTLENKIYKSVYDELSVKATQDEIVKEFPKPEIHRRNTGYAVDILLNSDL
FGGTEPTINLGKLLCGSEGTLAFTYEITLKVDDLPPANNIMVVAHYHSIQESLESVVVAM
KHHLYTAEMIDDTILDCTKTNREHIKNRFFLVGEPKAIMMFEVASHDAQDAENQANALIA
DLEKNNFGYALVKIYGADIEKVNELRKAGLGLLGSIVGDDKAADSIEDTAVELSDLPAYI
AEFSAMMLRHGQGAIYYAHAGAGELHLRPVLNLKKTSDLKLFRTIATDVAILVKKYRGSL
SGEHGDGIVRGEFIPFMIGETNYELLKRIKLAFDPNSVLNIGKIVNALKMDENHRVVSGR
VEPDIKTFQDFSDSLGILRAAEKCNGSGDCRKLPSAGGAMCPSYRATKNEKETTRARANA
LREYLTYSEKENKFDQKELYEVFELCVSCKACASECPSNVDVATLKAEFLYQYQKANGFS
TRNKIFAHNAKLNKMGSLFPSITNFISNQSLVKKSMGIAPERQVPLLAKKTFRKWHENHK
PTVTDFQNGRLYLFVDEFTNYYDVNIGIDAFELLTKLGYQVLVIDHEESGRAYLSKGFLE
EAKKIANHNVNIFKDLVLGNAPLVGIEPSAILTFRDEYLRLADDKEEAEKLSRNAFTIEE
FFKKEIIDGKIKPESFSDEKKEIKIHGHCHQKSLSSVEATFAMLNLPTNNTVTIYNSGCC
GMAGSFGYEKEHYQVSMQMGEDTLFPKVRATAENVKIAAAGTSCRHQIYDGTSREAQHPV
SILRACLK
>EGALAKHO_03989 Glucose--fructose oxidoreductase
MEKITRRSFVNKFGVGVGASVIITTLPSFLSAPEGNKTPYTGKKLNVALCGLGVYAGLVA
EGLQVSEYCTLAGIVTGTPAKAEKWKAQYNIPEKNIYNYQNFDEIIQNKDIDLVYVILPN
GLHKEFVIRVAKAGKHVITEKPMAITVKDCEEMIKACDDNKVQLAIGYRLHYEPTHLEIK
RLGQEKVLGQVRFIEASLGYQIHDPRDTKSIINLNDRNEWRLNKKLSGGGPLMDLGIYCI
QASRYILGEEPIAVTAQFGTVHNKQIFSETEESISWQMEFPSGAISNCNTTVSYNVDRLY
ASADEGFFELSPALSYGPYEGKSSKGPLKFPVINQQQTQMDEIAKLLLENKKLPSHITGE
EGLKDIKVINAIYKAAETGKKVSL
>EGALAKHO_03990 putative amino acid permease YhdG
MALSGLFRKKTVQDILKQVAKNEADGHNALGKHLTTRDLTAFGIAAIVGAGIFSTIGKAS
ADGGPAVIFLFLFTALACSFAAFAYAEFASMVPVSGSAYTYSYVAFGEIIAWIIGWALIM
EYAVGNITVAISWSDYFTGLLQSGGINLPQWVQMDYLTASNGFRDAEALIRSGKAPENLS
AGLQAAHTAWTTAPTIGSFHFVADLPALFIIVLITALVYRGMKESRNASNAMVVVKLCIV
LLVIAVGVFYVDTANWHPFAPNGVSGVLKGVSAVFFAYIGFDAISTTAEECKNPQRDLPR
GMMWAIIICTILYIAIALVLTGMVRYNELNVGDPLAFVFDKLNLKWMSGIIAVSAVIAMA
SVLLVFQMGQPRIWMSMSRDGLLPKKFSTVHPKFKTPSFATIVTGFVVAVPALFLNLTMV
TDLCSIGTLFAFVLVCAGVLVLQNKPEIPRGKFKTPYVNSKYILPVLMIAGIYYAFAFNN
KATMAFINNEAQTNDATTIITSLDKEQSAKVFNYLESIDVKNKTAETSDLEHLLSQYQDD
DAKYAEVVKGLPINDSLKYESGFSLFKHKIPMWIFLFVLVGLAVWSFRQNLSLIPLLGLI
CCLYMMAELSVWNWIYFTVWLLIGLFIYFTYSRKNSKLNFPAEA
>EGALAKHO_03991 L-methionine gamma-lyase
MKNFNPADKIQDLQYFGEFGGVNPSISDSSTYTFLSAKTMFDTFEGNMEGCYLYSRHSSP
SNLYLDQALAAMEGTETANVSASGMGAITPTLLQLCGAGDHIVSSRTIYGGTYAFLKNFT
PRFGIETSFVDITKLDVVEASITPNTKVIYCETVSNPLLEVADIAGLAKIAKKHNLKLVV
DNTFSPLSVSPAKLGADIVIHSLTKYINGSSDTVGGVTCASKEFINSLKNVNSGASMLLG
PTMDSLRSASVMKNLRTLHIRIKQHSHNAHFLADQFEADGLKTVYPGLKSHPSHELYKTM
INPEYGFGGMMTIDVGTLEKANELMELMQSRNLGYLAVSLGFYKTLFSAPGTSTSSEIPL
EEQAEMGLTDGLIRFSIGLDNDIQRTYEMMKACMVELGIL
>EGALAKHO_03992 Leucine-responsive regulatory protein
MTLDATDKKLLVLLQTDSKKTTKELSLKLNLSITAVYERIKKLEREGIIKNYVALVDKSK
IEKGFVVFCHLKLIQHTKEFLTKFESEVIKLNEVLECHHVSGDYDYILKVLVKDMEAYRE
FLVTKLTTLQHIGSTQSTFMISEVKNSTVIF
>EGALAKHO_03993 hypothetical protein
METKELRRKLIKDFGKFIEDDSKLEILESVFDAINNDEKKSIVSDSHYDLVAEEREKYNS
GENQSSSWEEVEKRLNAKYGF
>EGALAKHO_03994 hypothetical protein
MLNMVFKIIILPLAEKEIDESIEFYESRSKGLGKQFLLYLKSYLKVLKTNPQLFEIKKQP
CFRELTLVKFPFVIIYEISGNEIIIHSVFHTSRNPQRKP
>EGALAKHO_03995 Dihydrolipoyl dehydrogenase
MSSFDVVIIGSGPGGYVSAIRCAQLGFKTAIVEKYNSLGGTCLNVGCIPSKALLSSSHHY
AEIAHFADHGIEVSGDVKINLEKMIARKQAVVDQTVGGINYLMDKNKITVFNGLGSFVDA
THIAVAKADGTSETIEAKYTVIATGSKPSSLPFIKIDKERIITSTEALALKEVPKHLVII
GGGVIGIELGQVYLRLGAQVSVVEFMDRIIPGMDGALSKELTKVLKKQGMKFYVSHKVKS
VERNGDAVVVQAENAKGETITLEGDYSLVSVGRRPYTDGLNADKAGVKISDRGQVEVNDH
LQTNVPNIYAIGDVVRGAMLAHKAEEEGTMVAEILAGQKPHIDYNLIPGVVYTWPEVAAV
GQTEEQVKASGTEYKVGSFPFKALGRARASGDLDGFVKIIADAKTDEVLGVHMIGARTAD
LIAEAVTAMEFKASAEDISRMSHAHPTFAEAVKEAALAATDNRAIHV
>EGALAKHO_03996 hypothetical protein
MKKYLFAALFLFITISRSQSVKSVDSLNLEICKSLVQNKNLDNEIRMNTMEKSHIFPYLS
RFNDTIIQKRLFAQIYYRLLKNCDEFRTLFPAEPFSNGYGEQSTEPMINISKEQCNHFDE
ISKYYYIDGNSKKVEVTLRDNLWIEKFEDNTYSKLYYRKKSNCQFELEFIESNNFSRGNL
SVKGEKYLYKIFNEENEIYSIYLKNKETYYTFKIIKQ
>EGALAKHO_03997 Outer membrane lipoprotein Blc
MKNKYIAPILIGAGIAFVLTSCKATIPKKAVAVTNFDKAKYLGKWFEIARLDYKWEKNLN
NVTAEYSLKDDGTIKVDNRGYNVKKDKWEESIGKAKFVKKDNVGMLKVSFSGPFYAGYNV
IAVDPDYKYALVAGESLKYMWILSREKTIPESVKADYLIKAQEIGYNVTDLVWVEHNKAN
>EGALAKHO_03998 hypothetical protein
MKIATIIVRVLIGLLLLFASISYFFHLMPEPETTGNFKAFNVGLMASTYLMPLAKSIELL
CGIAFVTGRYVTLANILILPITVNILFINYFLAPEGLPIAALLFLANLFLIYRYWDNYKS
VFTA
>EGALAKHO_03999 hypothetical protein
MKTIAQLGLTTLVIIALLFSCKKADSTATADVANYESTADSTAISSSAAVEKKDSKQKFI
RTADIKFKVKNVVKSTYAIENAVAKFGGFVTYTNLQSNIHDQIKTKISQDSTLETTKYSV
ENNITIRVPNTQLDTVIKSIARQIDFLDFRVIKADDVSLKLLANQLSQKRSTTNEKRVEK
AIDTKGKKINDIMEAENALASQKEANDNKTIEHLSMQDQVNFSTVTLQLYQNETIKQEIT
AGEKDSAYYKPNLGIQIIDSLKSGWYILQSILVFFINIWPFILLSLGGFFLYKRYLKK
>EGALAKHO_04000 Aminodeoxychorismate synthase component 1
MRVSIHKSISNPEQFKQQLLTWSQQFREVVFLDSNSHTQQYSSYDCILAVDAFTSLKTDF
QNAFDDLKQYQQTTKDWLFGYLTYDLKNDVEELKSANFDGLNFPDLFFFQPKKIFLLKGN
ELEIRYLLLCDDEVEEDFNEIVESQSRSVGTKVESSGALNIQQRISKEFYIEKVNKMLEH
IHIGDMYEANFCMEFYAENAVINPLEKFFKLNEISKAPFSVFFKNHKQYLISASPERYLK
KAGETIISQPIKGTSKRSSDPIEDEKSKQFLESDSKERAENVMITDLVRNDLSHTAQKGS
VEVVELCKIYSFLQVHQMISTITSKLDPQYAPVDVLKTTFPMGSMTGAPKISVMKIIENL
EETKRGLYSGAVGYFTPEGDFDFNVVIRSILYNQENQYVSFSVGSAITAQSDPEKEYEEC
LLKAKAMHEVLR
>EGALAKHO_04001 tRNA(Ile)-lysidine synthase
MFSKFQNHIISRFPFLEGKKLFLAVSGGLDSMVLLHLLQQLPFEIAVLHCNFQLRGLESF
GDQSFIENYCDQNNIPIFTTQFDTEAFAKDYKLSIQVAARELRYSWFYELLENEKFDYIL
TAHHADDNLETFIINLTRGTGLDGLTGIPEQNDKIIRPLLPFSRDEILKYAEENKIAWRE
DSSNASNKYLRNKIRHDLVPMLKEINPNFLNAFQKTQSYLQESQEMVEDASIMIYQQVAK
EVGEDIHFDLNQLQKLPNYKSYLYQWLNEFGFLAWNDIYDLVDGQSGKQVLSAEFRLLKN
RNTLILSPLSEEDQKDEYQINKEDQDVNFPLKLRLYNVDHITLDSNKAIFVDAEKIQFPL
VLRKWNDGDVFHPFGMNGKSKKVSKLFKDEKLSLIEKEKTWILCSDNQIVWVIGIRQDER
FKIENTTNKILKIELQ
>EGALAKHO_04002 Thiol:disulfide interchange protein DsbD
MNFTQSYQTITSKSIWNKTIVFLLFFIFAFAKGNAQILEPVKWTAKIEKKSGTNAVLIFD
ATIEKGWHMYSQFTPDGGPLPLEIVFKNQKENYNLVGKAKEGKTKTAFNDVFGVNETFFE
GKAHIEQEITITNPDLKTVDVDFDFQVCKEVCINSNKKFSIAIPASFKMEAVATVSEAKK
DETKVTGIAVDTLSTVTKEVKSEPAKAEVTASKDNDIPPPAPTRSLWSIFLIAFISGFAA
LLTPCVFPMIPMTVSFFTKQSKSRAKGIRNAVIYGLAIIAIYVILGLIVTKIFGADALNA
LSTNVWFNLIFFVLLIVFAVSFLGAFEIMLPNSWANKADQQADRGGIIGILFMALALAIV
SFSCTGPIVGTLLVEAASNGGIAPVIGMLGFSSAMALPFMLFAMFPGWLNSLPKSGGWLN
TVKVVLGFLELALAFKFLSNADLVLQLHLLEREVFLAIWIAIFGTLAFYLFGKITLPHDS
PMNHISVGRLSFGLIVLTFTIYLIPGLWGAPLKLISAFPPPQTYSESPLGFGGSGNGAAT
IGEIKGLPEGAELGPHGIMIFTDYEDGLAYAKSINKPIMLDFTGHACVNCRKMENNVWSD
ERVLPILKNEVVLISLFVDDQRPLPIKEQFVTAAGDKIETVGDKWTDFMISKYKTNTQPL
YVITDLEGKNLNNSKPTISYVDVEEYLIWLKTGISNFK
>EGALAKHO_04003 Ammonia channel
MRKIILSVILITILVLTFVSNFILSDNPIPAEAVKFDTGDTAWMIVATAFVLLMTPGLGF
FYGGMVGKKNVISTMLQSFMAMVIVTILWVVVAFGLAFGPTIGGIIGNPLPNLFFQGVGT
STAWSLAPTIPFMLFALFQAKFAIITPALITGAFAERVRFWAYLLFMVLFILIIYAPLAH
MTWHPDGVFFKMGVLDFAGGTVVHMSAGWAALAGAIFLGKRKIQKVNPARITYVLLGTGL
LWFGWFGFNAGSALGSNGLAVQALGTTTVAAAAAAMAWVFLDKILGHKLSALGACIGAVV
GLVAITPAAGFVSIPHGIFIGAFAAIVSNLVVSKFPKGKIDDALDVFACHGVGGMVGMLL
TGVFASKAINPVVGDNQGLIFGTPTLFINQLIALVIVSIFAFVGSYILFFVVNKITPLRV
TEEKEELGLDISQHGEYL
>EGALAKHO_04004 Glucose--fructose oxidoreductase
MKNNERINWGIIGLGNIANQFATDLLLIQEANLVAVASRDFVKANDFAKQYNCPNAYDSY
EALFADDQVDIVYIATPHDSHAELSIKALENGKHVLCEKPLSLSYKDAIRMTEASKKYNR
FFMEAFWTRFMPSVKEVLEKVNQGIIGDVNYVKADFAFYANEKEGGRLFDKKLGGGALYD
IGVYPLFLSYIILGIPKQIIAKSVCNENGIDLQTSMILHYEKAQAILNASIVSESDMKAV
IGGTHGHIQLNAPWYVADGYSIIKDNQEEIVSLANLGRGYAHEAIECHQCIRNNQIESEL
WSHQNSLDLSKMTEEIKIQINLPF
>EGALAKHO_04005 Competence protein ComM
MLVKVYGSAVFGVEATTITIEVHMDKGIGLHLVGLPDNAIKESSFRIAAALKNNGLNLPG
KKITINMAPADLRKEGSAYDLPLAMGILVGSDQIKAPEIEQYIIMGELSLDGSLQPIRGA
LPIAIKAKEEGYKGFFLPIQNVKEAAIVTGLDVYGVTNLQEVINFFNGKGDLKPTVIDTR
AEFYKTLDFPEFDFSDVRGQESIKRCMEIAAAGGHNIILIGPPGAGKTMLAKRVPSILPP
MTLREALETTKIHSVAGKLKEVGLMNQRPFRSPHHTISNVALVGGGSYPQPGEISMAHNG
VLFLDELPEFKRDVLEVMRQPLEDREVTISRAKFTVTYPSSFMLVASMNPSPSGFFNDPS
MPNTSSPHEMQRYLSKISGPLLDRIDIHIEVTPVPFEKLADDRKAESSVEIRKRVTAARE
IQTKRFEEVENIHYNAQMSSKLIREYCALDEQSKELLKTAMERLNLSARAYDRILKVART
IADLDAAPTVVSQHIAEAIQYRSLDRDGWLG
>EGALAKHO_04006 putative ABC transporter ATP-binding protein YbiT
MLILQNISYLHTNRDLLFDKITFTANQQEKIALIGNNGVGKSTLLKIIAGKLQASVGLLK
TNTKPYYVPQIFGQFNHFTIAQALQVEDKLNALKNILDGNVTEENLEILNDDWTIEDRCN
EALEYWQLTDLDLSQKLENLSGGQKTKVFLAGISIHQPELILLDEPSNHLDLEARKLLYD
FIQNTSGTLIIVSHDRKLLNLLNTVYELSKHGITVYGGNYDFYAQQKQIENNALQQDIHS
KEKALRKAKEKERETLERQQKLDARGKKKQEKAGVSRIMMNTLRNNAENSTSKAKSIHAE
KIGGISQELQGMRSGLPDIDKMKFGFDNTELHKGKILFTATDINYGYHEKLLWKQNLNFQ
ILSGERLVLKGSNGSGKTTLIKIITGNLLPEQGDIYKAEAKIVYIDQDYSLIENQLTVYE
QAQKFNVSGLQEHDIRMRLNRFLFSQNDLEKPCSALSGGEKMRLMLCCLTINNQAPDIII
LDEPTNNLDIQNIEILTAAVNEYQGTLIVVSHDEAFLEQINIERCVELS
>EGALAKHO_04007 hypothetical protein
MKNSTENKLDNPVWNSLSESHKEFAVQYGSIKFYDPNYGPFGGFIKVENTAIATKEYSDL
TDNFFVVGEKPEINSSLKIAKELVCLQMIINEKIQLPIDVEIVKLTLDYNEVLCDLVNLV
QPGYFKNKTILLGDYYGIFKDNQLIAITGERMKMNAFTEVSAIITHPDHTGKGYAKQLIT
YVVNAIFDQGKIPFLHVAETNFGAIALYEKLGFTTRRKMSFWNITK
>EGALAKHO_04008 hypothetical protein
MKKTFLFLIFLLITVHVFGQNPATYPKDTTLSLPEKTFETLWLTFEDHYAFFKLRNIDWK
KTYDQYRPTVNKNTTDDALFETFSKMLAPFEDNHINVIIPSKKQFKSTKPSNFAKEFPND
SLRTLFWSMVDQTLIKNGFEKPKYAGPKFHDKNLFTYTTSKKYGYLRFNRCFVSDDAESI
PDAAMASKILDSVFQNFKSSKVLIVDVRDNIGGNDEFSYEVAGRFAAKKAIGMYKKNRIG
GYEDFGEAETWYIEPKGNPKFLKPVILLTNDKTVSAGDVFAMIMKELPKVTIVGENSRGI
YSDMYGFELPNKWLVSLSHQRYYNADMVCYEGSGTPVDIVVKNTKEDLVNMADPVLIKAL
EIAVKK
>EGALAKHO_04009 Ferri-bacillibactin esterase BesA
MNKFHFLACLFFSVTFIFSQTSKIKSTDTSKPFVLGVIDEIQSKELNEKRILNIYLPEGY
NPNEATKYPVIYLLDGSADEDFIHISGLVQFNSFEWVNQVPKSIVVGIATVDRRRDFTFP
TSIEKDQKRFPTSGHSDQFIAFIEKELQPFIDKKYKTTESKTIIGQSLGGLLETEILLKK
PNLFNKYIIVSPSLWWNNGSLLNQDSIIFQQNFSHPTDIYIAVGKEGLTPTEIPRVMEVD
ANLLAEKIKASKSKNIKVHFDYFSEENHATILHPAVSNSFRVLYPKPQE
>EGALAKHO_04010 hypothetical protein
MKSNLLMNFTVDKENSTVNVKREFNASLDNVWSAWTEPEILDQWWAPAPWKARTKTMDFK
EGGRRLYAMVGPQGEEHWAIADFTSITPKTNFKYLDAFSDSEGNLNKDFPRSDWNVNFSE
QGDSTIVDIAIKHENLSDLEKIIEMGFKEGFTIAMEGLDEIFAARAK
>EGALAKHO_04011 Transcriptional repressor SdpR
MKRDIFQAIADPTRRAILVLVATNALTPNAIAEQFNTTRQAVSKHIKVLNECELLDEKKV
GREIYYQLKIDKMKEIDKWLVQFKEIWESRFSQLDQVLMNLKSKENEI
>EGALAKHO_04012 hypothetical protein
MKTKKIWANLGVEDLARTTKFYSELGFKPNGTNEELTSFCFGDDNFIIHFFIKERFKWAV
NDEAADLQQGNEIIFSLSAESVDEVHQRLLAVKNAGGRIFAEPQSFEKGYFFGFSDPDGH
KFNVLYWPKENA
>EGALAKHO_04013 hypothetical protein
MKHYFLRTIKQTLFFSAFILLSSCGLKSIPSEYTFVKTDFEKVDINNLGNGKILIYNGAD
ILHTIDNTSRLNIWINEKPLGQLRASEYVIIDLKNGKYNFKALHLDMVNMRSTDEVEITE
TTKVIKIKPNLNSNKLTVTNELPKNFEKFKYAENRK
>EGALAKHO_04014 hypothetical protein
MKFGEIAFYFIVALIVIGLAYKFLFSKTEQEKEFERKMKESLADEFIYDPETGAKLTLEE
AESGNWVAHDNLNRIKPKEELDQYYRGKEREIEELTNFLKSNGYEFTKLTNYQVDFLERT
KILSKYDDWSYACSYSFNEGKDYVFFPRVTYNNDRHKNGYSESQIMFWINNINVDGHIYL
REKTSFEAFTDMIRNDDLVELDHFETFVFKETTNMISLVKTLQLLDTEKDLEIEIVENSL
LIKSLKYVNQSDYLRIEKLIKSIKVTG
>EGALAKHO_04015 hypothetical protein
MKRENSIDIVRGIVMIIMALDHVRDLMHVDALTQSPTDLATTTPILFFTRWITHLCAPIF
VFLAGTSVYLSLKRKNNFTETKQHLIKRGFWLLLLEFTLVNFGLFFDIGFHTLLFEVIAA
IGFGFIIIGLLLKIPAKQLGILGLIIIFCHNLFPLIPFAEGSVLKTIVSPFFSPTVIPFF
AGKVFFIAYPPIPWLGIMLVGFASGQFFMKEQSKRKKLFLKISFSALSLFAIIRFITIYG
DPAIWSSQKNAVFTFLSFMNITKYPPSLLFCLVTLGILFLLLAFADQFHNRIKKVTTAYG
RVPLFYFVVHFYVIHIITLFMLLLQGFNWSQFEFATGTFGRPKNLESGLPLWAIYLVWMS
VVTILYKPCVWFGEYKAKNTYWWLRYI
>EGALAKHO_04016 hypothetical protein
MKPQIRILIYSILFFLYLSTTPALLTLGEKIKTDPFVTLGFGFALLNLIYSFFALKWTVL
LNIICSVAIASLSLFLALKFTNLHLFLNYDPYQVKTAILANAIISIIFWEIVYQVKIRKH
TKS
>EGALAKHO_04017 hypothetical protein
MKIKILIPLLLLCFISCKNSDKVERKNQPDIYDVEASDREMNEAIEKANQTLADFNSALL
NPKIEVKALKVKFQNETDVEHIWISDVTLKDGKYSGVLDNEPEYIKDHKIGDTINIDNKD
ISDWMYIEDGKLFGGYTIKVLRNRMSESEKKQFDAESGMQID
>EGALAKHO_04018 hypothetical protein
MKKYYFALILCFQISFSQNVDHLDTVLKQLGIKKSEINIELLAQKMLPYDKGKSVLAIPK
YIEKVEDEYSIFDAYIVVIDNSTGKIICKFIEPGAWTSDAVRLEEISIDTGLYLLNKSTR
AFGVRVSYYGSSRPNPFSETILSLFIVDKNSLKQVLKDYTISQSSGEWDTNCAGEFEDQT
SSIDIDKVQTNNFNNLIIKTKIVKTKNIPTKDDCVAKESTKQATSKLFFDGKQYK
>EGALAKHO_04019 hypothetical protein
MERTIFKSSVSFLPIAFGLIGASFFFAISYYLLSGFTKRESSNNGDLIAFCILVGVFVFF
GLLSLFLVFNMKTIVLTNKNLIIKRPLLFLKFVIPLENIKNISEEDYEINSASNSRKINV
YKGEKMTIEIQKGKKIVFTSFEISEYDDLVEYLKNIEFNTSNAMIKNDYSNTSKVYSWLL
FIFILTIILIYNIVNSR
>EGALAKHO_04020 hypothetical protein
MKITIPLSALFLLLSTTLFSQTIADLKLKPKEIPKSYFLSDGQICVTNQACNFYTDIATY
SNIIGVVKSKEIQSFKNKADSGSIMYIEFENRFKGDRFLQGLLWGKDGQPTDEHPEEYLA
KGKFLIIWSFHPDSPIKEKSEAKIDAILQ
>EGALAKHO_04021 Diaminopimelate decarboxylase
MQAKDLLQLADQFGSPLYVYDAEKIQSQYNRLTKAFSKVENLRVNYAMKALSNVAILQLL
KNMGSGLDTVSIQEVLLGLHAGYDPDKIFFTPNGVSLEEIEEVAAMGVQINIDNLSILEQ
FGTKYPQIPVCIRINPHVMAGGNANISVGHIDSKFGISVHQIPHILRIVENTKMSIVGIH
MHTGSDILDIEVFLYAAEILFDTAKHFKDLEFLDFGSGFKVPYKKDDIETDIEELGKKLS
KRFNAFCAEYGKDLTLIFEPGKFLVSEAGFFLAKVNVVKQTTSTVFAGVDSGFNHLIRPM
FYGSQHYIENISNPKGKERFYSVVGYICETDTFANNRKISEITEGDILAFRNAGAYCFSM
SSNYNSRYKPAEVLWKDGKGILIRQHETFEDLLKNQIPLPQEIAATV
>EGALAKHO_04022 Glutamate synthase [NADPH] small chain
MGKIGGFKEYNRADESNLAVAERVSNYNEFTIPLSEEKKKEQGSRCMDCGIPFCHSACPL
GNLIPDFNDMVHQEEWQGALEILQSTNNFPEFTGRLCPAPCEKSCVLGIIKEPVAIENIE
KNIIERGFDEGWIKPQPPKTRTGKTVAVIGSGPAGLAAAQQLNRAGHTVTVFERDNAIGG
LLRYGIPNFKLEKGIIDRRVLILEAEGITFKTNVNVGVNFSVEELNSFDSIVLCGGATER
RSLPTKGIESKGVVQAMDFLTQQTKVLYGESIPDQVKATGKDVIVIGGGDTGSDCVGTSN
RHGAKSVTNFEILPKPPVGRSESTPWPFWPLQLKTSSSHEEGCDRNWLINTKEFISNSNG
ELTGLKTVEVQWKMTPGQRPELIEREGSEKIWPCDLALLALGFTGPEKTLSEQLGLEVDM
RSNYKAKNYQTNVPHIFTAGDMRRGQSLIVWAISEGREAAREVDLFLMGSTNLPTKGNGD
LPSL
>EGALAKHO_04023 Ferredoxin-dependent glutamate synthase 1
MKVKEQGLYLPEFEHDNCGAGFICNLNGIKSNDIIHKALDILIKLEHRGAVSSDGRTGDG
AGILFDIPHNFFKKVCDFEIPETREYAVGMVFLPKSKNQVSFCINTFEATIKDQNLKILG
WRDVPVEVENLGQIAAEKEPTVKQVFVSKNGQDLTENEFNAKLFAARKIAEHAIRGSKTS
ESHMFYFSSLSTTTIIYKGLLMPEDISRYYVDLKDPDLVTRLALVHQRFSTNTFPSWELA
QPFRYMCHNGEINTLRGNVSRMRAREELMQSKVFGDDIKKLFPIILEGKSDSASMDMVVE
LLLMTGRSLPEAMMMVVPEAWEKHQTMSPEKRAFYEFNACIMEPWDGPASIPFTDGNVIG
ALLDRNGLRPSRYTLTKSGFVIMSSEIGVLDIDPEDVIQHGRLEPGKMFLVDMNEGRIIE
DEEVKKAIVTKRPYQEWLDANLLPLAKVPYTNNPTPVEKLDFQTRQRLFGYTIEDLKTII
NPMGGQGAEAISSMGNDTPLAVLSDQPQLLYNYFKQLFAQVTNPPLDGIREEIITDISLA
VGGDFNIFEIESKQCKKLKIQNPVISNEDLDKIRNIDHADFKSATISTLYKIEKGVNGLE
RALEKCVQATFKAVSEGCNVIILSDRGVSEELAPIPMLLACSYIHHSLNILQVRSKFGII
IESAEPREPHHFALLFGYGASAINPYMVNEIIHDQVAQGFITGVKADYAVVNYNKAIAKG
IVKIMNKIGISTLHSYRAAQIFEILGLNKTFTSKYFPYTPSRIEGIGLMEVEKEVKKRFQ
KAFPNSKVANLLPLEIGGIYRWRRGGEKHMFNPTTIAKLQQAVRLNSPESYKEYSNMVNE
QSSNLMTIRGMFEFNNLDPISIDEVEPWTEIVKKFKTGAMSYGSISREAHENLAIAMNRI
GGKSNSGEGGEDPKRFQKEINGDSRNSAIKQVASGRFGVSINYLTNAKEIQIKMAQGAKP
GEGGQLPGEKVVPWIAETRNSTPYVGLISPPPHHDIYSIEDLSQLIYDLKNANREARVNV
KLVSEVGVGTIAAGVAKAKADVILISGYDGGTGAAPLTSLQHTGIPWELGLAEAQQTLIL
NDLRSRVVLECDGQLKTGRDVAIAALLGAEEFGFATAPLVASGCIMMRACHLNTCPVGIA
TQDPELRKNFKGTPEHVINFMYFIAEELREIMAQLGFRTLKEMVGQSQKLNVNKAIKHYK
ANGLDLSSILYKPEKAKTEPIHNTIEQDHQLENVLDFDIIKEAIPSIYRKEKTRVTFKIK
NTDRSVGAILSNEISKIYGAQGLPEDTILVDFEGSAGQSFGAFATNGLSFKIHGNCNDYL
GKGLSGAKLIIKVPPTATFKPEENIIIGNVALYGAITGEAYINGMAGERFCVRNSGATAV
VEGIGDHGCEYMTGGTVVVLGKTGRNFAAGMSGGVAYVYDPNKKFDSTLCNMEMVAFDPI
EEEDITKLRRLIKNHSLYTSSPLAKRILADWENEQKHFVKVMPTDYKKALQRIAEEKKIE
ELIAG
>EGALAKHO_04024 Succinate--CoA ligase [ADP-forming] subunit beta
MLLLSHFYSEINSEPDKFYIMNIHEYQGKEILASYGVRIQRGIVANNAVEAVAAAKQLTA
ETGTGWHVIKAQIHAGGRGKGGGVKLAKNLQQVEEIAGQIIGMQLITPQTSAEGKKVNKV
LVAEDVYYPGESETSEFYVSVLLNRATGRNMIMYSTEGGMDIEEVAEHTPHLIFTEEVDP
TVGLQGFQARRIAFNLGLSGNAFKEMVKFIDSLYNAYIGSDASMFEINPVLKTSDNKIMA
VDAKVNIDDNALYRQPKYAEMRDIREENPIEVEAKEVGLNYVDLDGTVGCMVNGAGLAMA
TMDLIKYAGFEPANFLDVGGTADAKRVETAFRIILKDPNVKAILINIFGGIVRCDRVAQG
VVDAYKNMGDAIKVPIIVRLQGTNAEIAKELIDNSGMPILSAVQFQEAADQVKAALS
>EGALAKHO_04025 hypothetical protein
MTNNDILKKLRVALMLRDDQIVEILELVDFRITKSELGAFFRAEDHENYMECGDQVLRNF
LNGLVIHLRGTKENPKNPNDVLAKHKAEIPKKDSTKERPEFKASAKDAEKGRGDKAPSKT
GPAAKKSFKKKPATPKIQVVEKVVYKNGKNKK
>EGALAKHO_04026 8-amino-7-oxononanoate synthase
MNVNQFPDRIIEIDQEQYLYFGGTAYLGLSTNKAFQKLVVQNILKWGTTYGSSRNANVKV
TAYENGETFLAHYIKAEAVVTVSSGMLAGKLVVDELKKQTDTFFHFDDVHTAIQTNNSLP
VFVDGKINSRLLDDKREKITILTDGVPSFETNAIDLNVLREIPKHKEVSLLIDESHSLGI
LGQNGCGIYADINFPIKRKIMVSSLGKAFGLTGGVIASDASFIEEIKKSEIFGSAAGMNP
AFVQTLADASEIYPKQHQKLVENLHYIDQKLIKDDSIKFDKSYPLIYLKDKNSIEILKDN
KIIIASFKYKQNADNLNRIVVTANHLPEDLDKLITVLNNYKLKK
>EGALAKHO_04027 L-Ala-D/L-Glu epimerase
MELILREYNLKLKHTFTISRESIDFQPSLIVELKSDGFSGFGEATSNPYYKTTVPVMIQD
LEKIRNIIEASENETPEVFWAKIYPFLKHDMFALCALDLAYNDLYARKKGKKLYELWKYT
TERNPMTDYTIGIASIEKMVSKMQELPWPIYKIKLGTKEDIAIVKELRKHTDAIFRIDAN
CGWGVEETINNAVELKKLGVEFLEQPMKADNWEAHKEVFKHSVLPIIADESCIIEEDVAK
CHSHFHGVNVKLVKCGGLTPGKRMIEEAKKLGLKTMVGCMTESTVGISAIAHLLPQLDYV
DMDGALLLAEDIATGVIIKNGVISYSELNGTGVTLL
>EGALAKHO_04028 Endo-1,4-beta-xylanase/feruloyl esterase
MIRGLFFFIFLCMTTIGNAQQSTASKNVSTFIIDAPQLKSTKKIWIYLPEGYSASAKKRY
NVIYMHDAQNLFDAKTSFVGEWNVDEKLDSLKAPVIVVGIEHGNDKRIDELTPYKNEKYG
GGNADNYLDFIVKTLKPHIDKNYRTKTKAKNTTIMGSSLGGLVSYYAILKYPEVFGKAGV
FSPSFWFSKDIYTLTEQAPKNKTKIYFLCGDKESDDMVAEMKKMETLLDRNRCYCLHLTK
DKIVKGGEHNEKIWRDGFVDAILWLGY
>EGALAKHO_04029 DnaJ-like protein DjlA
MNTEAEKRSLLLEMIAFSTVDGQLHKREYDFLWLVAQELNIHFHDFKDLFHQENTKQIIK
SEFQRIQQFYRLALIMHCDGILHEKEAKAIQQIAIEMGLNPGAVKRVLDLMKKAPNAMID
PKLLLRVFQEQHN
>EGALAKHO_04030 UvrABC system protein B
MNFQVSSEYSPKGDQPQAIEKLAQGVRDGEKYQTLLGVTGSGKTFTVANVIEEVQRPTLV
LAHNKTLAAQLYSEFKQFFPNNAVEYFVSYYDYYQPEAFMPVTGVFIEKDLSINEELEKM
RLSTTSSLLSGRRDILVVASVSCLYGIGNPVEFKKNVIEIFRDQVISRTKLLHSLVQSLY
ARTEADFNPGTFRIKGDTVEVYPSYADDAFRIHFFGDEIEEIESFDAKTSHVIEKFKRLT
IYPANMFVTSPEVLQGAIWEIQQDLVKQVDYFKEIGKHLEAKRLEERTNFDLEMIRELGY
CSGIENYSRYLDGRQAGTRPFCLLDYFPNDFLMIVDESHVTVSQVHAMYGGDRSRKENLV
EYGFRLPAAMDNRPLKFEEFEALQNQVIYVSATPADYELQKSDGIYVEQIIRPTGLLDPV
IEVRPSLNQIDDLIEEIQIRCELDERVLVTTLTKRMAEELAKYLTKVNIRCRYIHSEVDT
LERIEIMQDLRKGIFDVLIGVNLLREGLDLPEVSLVAILDADKEGFLRNHKSLTQTIGRA
ARNLNGKAILYADKITGSMQKTIDETEYRRTKQINFNVENNITPQALNKKIDSAFTKNPL
VEYELGHTLSVAAEPETAYLSKPELEKMIREKRKSMEKAAKELDFLQAAKLRDDIKKLQE
QLA
>EGALAKHO_04031 Carboxylesterase YbfK
MSTPKIFFRTILFLFLASCASSKKAKFEDYVFKTKTEKQAYITSYDKALKLWEIPYTEEN
IKTSFGTAHIIMAGPKNGKDLVLLHGMDASSTMWYPNIKALAKNHRIYAIDFLMEPNKST
LTAKPLSRDEMVVWYNEIFNHYKLKKFDIVAASRGGWIATLLATQKENNIDKIVLLSPAQ
TFKFIDKVGKTSNALMLKLFPSEKKFTKTLTTFSTHPEKISPVYKRQFYLANKYAKSNSS
MLKMTPFSDDELKSISNPVLVLIGDHDVINSDESLERAQKYLIKSKTQKITDAGHFLSID
QSKIVNDAMVNFLD
>EGALAKHO_04032 hypothetical protein
MADYIGYLASVFIVGGFLLKDLRTIRFINLFGCICFVIYGIFLKDYRDVSQWLLPVIIPN
AILAVVQLYHLTVKDSKRL
>EGALAKHO_04033 Ribosomal RNA large subunit methyltransferase F
MKATDNSEKTNLHPRNLHRSRYDFKLLVTNCPELKKYVAINPHGIETIDFSIPDAVKALN
KALLQTYYDIQNWNIPKNYLCPPIPGRTDYIHYLADLLAESNNGIIPTGSSVLGLDIGTG
ANCIYPILGNAIYDWSFVGTDIDKKAIENCSMIIERNPKLIDAISLQLQIESRFIFKNII
TPEDRFTFTMCNPPFHASAEEANKSTSRKVSNLNPKEKKNFNPVLNFGGHNAELWCDGGE
IGFVTQMIYESAKYAMQCQWFTTLVSKRENLSIIYKTLNKVNAASIKTIDMAQGQKNSRI
VAWTFLSEAQQKSWKIQNVDFQQ
>EGALAKHO_04034 hypothetical protein
MKFFTILILALFMSCNSQEKKCNNDFNLKGLVQNVEETTKYSNYEMKSIYFLNENDYVLS
IEVYTNNNLFEKSELKYDKNNIIQEIIVVDSKGKEKTKSHFVKNKENRIEKTLITSSNGK
SIIFHHYNGSSEFPDSGKELDNKGNFIRSWKLEYKNDLVSVQYNCNLDGTIISHTNFIYN
DNNDLVEVFEKNKNEEITNSQYSEYQYDNKKNWIERKLYDADKNLISTSIRKIKYW
>EGALAKHO_04035 hypothetical protein
MKNILLLLFTIMMISCNKKTEKNDTVTLNQNDNVDFFRPADLGAFGSKTRLILYANFDEC
GEWGGHKESFEIFSKEDKQFYANYKRTKVDCNKIGELYGKPEFQQPYIIKEIKLADKQKK
AINIYLSQLIKSKIKEDFPGNAGQNFGVIKTDSTLVIDVYDSDKKNLENYNKLLKEFRLE
IVKYKYR
>EGALAKHO_04036 hypothetical protein
MVDKKDIEKLIIQNKKSNLINHFKDSQSYNTTKYSGEIRNNEILIWRSAYFIRGVYPIFH
LTFDQNNKLKEIKMEKNPFNIFLDRATIMVLIILIVTVFISTNLITTVFAILALTLIGFL
MRLLLSKSKIFETKILIEELKTTIDNLEGLNNSKQKKDQNLENEKVNEWSFSKIMSRILI
YPFCVILIWLSLTLMIPEGKIIEGIFAIILGLAYPISDLLIIINKKNYS
>EGALAKHO_04037 hypothetical protein
MRKYSLIIFILISLISCKSSKTYYETGELETKVRTVNKLKNGQWRNYYKSGKIYEIGKFK
NNKEIGLWKIYHENGILWQIGKFKEGKQDGQWLFFHDNGNKEGIGNLSSGKMIGKWVWYH
SNGKIYTERLYEDGKLIEIISCFDGSGNILEKGTLNSGNGSLNSYDLNGNLLDVQNFENG
IIIKK
>EGALAKHO_04038 hypothetical protein
MTLILTLISCSKQSKIYYEYDGLVVTRFTDYPKDYFLIGKHQNISDTLNSTFIKSSFRGF
SSSMDAYMVFRPDKKIDIIRLDASFEKFGADDSINLKEFENNIDFIKWEDNAKLNFKNIV
RLSYVLELEKKRNLKYKTEVLTSYEN
>EGALAKHO_04039 hypothetical protein
MKLKYYLFLSFLLITTSTIYSQNDRKIYEVIIFKWTKVENKDVMKVVKIDSLGNIFLSKQ
KTGKKVELKNFTKKINQFIVKEKLEKVPGDDNPPRMSLIPKDGKQTIEISIVFLDDFLKE
TKLANNTYYSWNKTGLEIDSEDYLIFKYLNKTDINTIKSLLK
>EGALAKHO_04040 hypothetical protein
MRKTIQIIISLYILVFASCQNKNSNVLDGKKFIGFEEDVYFDSPRNTFQTILTFEDDSVL
VVKNLISIIDKDTLNFKKKQSSYQYKGFVKKEKNNLEFVAYAYNCKGCSVFYSVDKKGKQ
KKSLDKKTYKGFVTKNGINLNGINFKSE
>EGALAKHO_04041 hypothetical protein
MGLISSKPVVVPRRYAAFYQMRIFDFLMRKNNCQDNISESEAEFEMHSAKTLFSYLSLKL
ENAVTYEDLFNLCYTLFCTLDILPENLKTLKLSKEVLAMTFAKLAREKTIINFNTNKSIE
FMFNDISDEKHWIEQIKVHMIADKWPNKESARILLE
>EGALAKHO_04042 hypothetical protein
MSTINMTNVSKDNCIEKICNLPLDFKVADKSSLTLLQESRFTDFYNVITRQDIKDYLSLH
KNVIENWETWSEDKQTWGYYLSIRPDKYFIGSLDKDGKENFSKSFATIDDACAEFILREV
SAILDIKMT
>EGALAKHO_04043 hypothetical protein
MQTISWIFLATALATNTKPTDISGISSVADGINHAVPTQKELQTSISWLTTQGLIIKQGK
NYELTSKGKLEYEKASKNTQTLMKIWKNIELNLNRYVDN
>EGALAKHO_04044 hypothetical protein
MKLLKGCLITLILFIVVCVIGWLFLENNVSGNLSSLNQNVEKNWENYVANLKERNAEFTQ
QKIKNDSLKYYSENSKKIIDSKDYLKELELIEYKLNKIAMSNSFKSNLNDKLNSNLDNYN
QAVREYNVYRIRFPNSIIARRMNFRKSYKYFDIRYGVENEKVMARKKEMEIWVKNGGEYP
Q
>EGALAKHO_04045 hypothetical protein
MKNKRLIITIIIFLILVNTSYYWKGKLDFLTFPAFFILFIVYVGLGIGLIRELYFAVKDN
FTDKKRILTIGLLIAILALTFLKPFGFINFEEFEGKNVLIAEREGVAGCMMTLKLKENNE
FTAKGVCFGMTEINGNYKFRNDTIYFENVELGRGEKEFYKYAVIKPLKFYSDNKHFELLS
YRSKNDTIGHRLKITLNELN
>EGALAKHO_04046 hypothetical protein
MHHPTQITPKYTENEVYKFVDNDDFMDAYVELLKNSIECLWYIVYLKYYEKNDTPKEILK
DDAVVGGNLIRLIKLNTSFLENVCNNKTEICLIVNRCLAETAINLKYLLIESEERVKRNY
IKYSLITEKELWEVIKSKISERPEDVWNIEKRMQKSIQNSFDDSDFDLEDINRSSKWKSI
KSRADAVAGEMFYSVYYGIGSHSVHGNWQDILTNNLDRFGENFKLHINWQKPRPQMMDLA
IFFNLDILNLFIQKELEVDEDTELLKKNYTTLLDYGRLLTEAHEKMLKKKNGL
>EGALAKHO_04047 hypothetical protein
MQNKQRHGCLTAWLIYLMISYSIVSLGLFYKIDTIARKFQYIKSENLLLIVASIEILNVL
FLFMLLKWFKLGFWGLLSTSTLLFIIQIMNSNNILTPIITAIVMLIIYGLLKLKKRNVSG
WDNLE
>EGALAKHO_04048 hypothetical protein
MKLKQIIFTSIITIIVTIISGVAVNWYTKNNIENDSKDNLYYRIVDISEFKSDSTKLSII
SIEILNKNKEKYTNVELSVEFNKDSKIIDIISKNDVTNKTYNPVKRTKNNLVFNYPVFFP
NEKIKINIAVSDLNSITNIALISNESLGKKFIPELEKEKINLTTIYIQIIILSIILLVTI
FFLFKRLRILLGFFSNSLNNTAFLFLHSKQYDIAEKLLLNRIEKNGATSFELSNLATAEF
LVNRNLDKAKSLFKMSEYISHSNQSKFVIAFNEFIVYGDEKNYMLAKEKFELCRKLNSKD
LKKYLLFSVIIKDLAESDETIKEIINIA
>EGALAKHO_04049 hypothetical protein
MEEMVIGIISGLITAFITIVLRAFWIRVLIPWYEELLFKDVKIEGIWNGYLIDDHFLDGH
NLNEPTFTICEQLVTLPNDDYEPSEVRVEISRTGYNIKGRIIATSGSEKGNTFNIRGNFK
NLILSGLYDGNDNEIIDRGSFSIMAIENGKLLKGFFSSYENKSNSIRPFYCILRKK
>EGALAKHO_04050 Non-homologous end joining protein Ku
MRSIWTGSISFGLINIPIKLFSAVQESSLDLDMLDAKDLSHIIFKRFNETTGKEVAYGNI
IKGYKIEDKYVILDDEDFQAADAVKTKTIDIQSFVAEKDIDSIYYEQPYFLEPDKGAMKA
YALLRDALSASGKVGVTSFVLRNKESLAILKPYKNVIVLNRIRFEQEVRDPSELKLPPVA
KSTSAKEMDMAEKLIDQLTEKFDISSFKDEYTAKLLDIIKKKAKGKAPKKPAELKVVHKQ
TDDLMEMLKASLETKKKKSS
>EGALAKHO_04051 Multifunctional non-homologous end joining protein LigD
MSLSKYNKKRDFKQTQEPKGKVEKSADKLIFVVQKHAASHLHYDFRLEMDGVLKSWAVPK
GPSMDPDVKRLAMMVEDHPYSYKDFEGTIPAGNYGAGNVIVWDNGTYTPSEKTTSPERTL
LANLKKGRLSFVLNGKKLKGEFSLVKLNGKQENAWLLIKKNDKYVNDTDILEKDKSVISR
RTLADLGEKETSADSEKENETKQPEKKAEKPAEFIKPMLATITDKAFDDEDWIFENKYDG
YRTLAVINPNDDVELYSRNQISFNVNFKPIAEELKKIDHAVVLDGEVVVEDEKGKASFQL
LQNYLKTGIGNLKYYVFDLLNLDGNLVTKLSTLDRKELLKILFNKYKFNNIFYADHSVGD
GIKQFEIATKNTEEGIVAKKADAIYLSDKRSHDWLKIKTANQDEAIIIGITEPKNSRKHF
GAILMAQYYGKRLQYIGKCGTGFTEQILEELYTKLQPYFISDSPLNEKTGLRDTIQWVKP
KLVCQIKFSEWTDDKRLRHPVYLGLRIDKKPNEVFLPTDTKNTTELKKEEKMDDTTHKNK
TENDYDLKVGKTVLHLTNQNKIYFPDDKITKGDIVQYYNEVADLMLPYLKNRPQSMNRFP
NGIAGTSFYQKEVDVEKSPSWLKTKKIFSESNDADVNYLICNNKETLLYMANLGCIEINP
WNSTIQHIENPDWLVIDIDPDNQDFTEVVKTALTVKEVMDELETECLCKTSGASGLHVYI
PLGAQYDYDSTKILAELIAKEVQSRLPDTTTLERSIKKRDRKIYIDFLQNRHGQTLAAPY
SVRPKPGATVSTPLEWSEVNDDLHPSQFTIKNVLSRFEKKGDLWKPVLEKGANVKKIIKK
IEDRDRG
>EGALAKHO_04052 Aldose sugar dehydrogenase YliI
MRHLNYIAILSSALLIACGCSNDKDPGTNPDPGTPVNPVENNPANTSYSPAFSGQTRIGG
LQTNTSYEAKVITSSLTSPWGVKSLPDGRLLITQKAGTMRIVTTTGEVSSPITGIPTVNP
AGQGGLLGLCLDPEFSSNRMIYWVFSESSSGGNQTSVAKGKLSADEKTIEGAVVIYRANP
ANPSDLHYGGRILFDQTGNLIVSTGERSVLQTRPLAQSVTAGLGKVIRITKNGQAAAGNP
TFTGAGALPELYSIGHRNPQGLAFNSVTNEIWLAEHGPRGGDEINRLKPGANYGWPTITY
GIEYSGEKVGAGIQKQDGLEQPVYYWDPVVSPSGMTFYTGNRVPEWQNNLFIGALSGMHI
VRLAIENNKVVGEERLLAGEGQRFRDITQGNDGALYAITDQGRLYKIDKK
>EGALAKHO_04053 hypothetical protein
MDFYLIFQIITVSIAATSTMTLFSYAVSASFREIYKEPLLLTYLMHNFRINLSNASKNTL
SWLIHYGIGGLFVTVYHYFWARNILQLSFLHALLLGVGSGFIGIISWMIFFKLSRYQPSI
DFKGFYIQLFVAHLIFALTATAVYAISLTVALLANTYFAPK
>EGALAKHO_04054 hypothetical protein
MENIFNPESMENLGETLEKKFSGLSSNTFLCAGAGSLFLAATLKLAGNGKAGSFFGKWAI
PLLAIGCYKKYSDNSASQINDNKAEEGIQTADSIAST
>EGALAKHO_04055 hypothetical protein
MRTINEENYGQSDPDFHFSEPSVTDPQLDENASYVEEYESNKTDTDYDPNEEIVNEEDSI
TNDQDNLDQEFLDALHEDEEEETYDDQNNLDKQATLDKGDPNADDDKDLDTDDLFENEDD
NDFADNDLNDLEGDHLNNPELDKEEQNIRNRDALKVD
>EGALAKHO_04056 hypothetical protein
MISLNHRSSNTAGPKISDKKTDSKGSTEKSSTKLNNEDKKPAFKKN
>EGALAKHO_04057 Chemotaxis protein methyltransferase
MKLTETKHLKKTGQDFPVVGIGASTGGLDALKNLIKAIPSNSGMPYVIIQHLSPDHPGNL
TEVLSQHTEIPVHEIINDINLAPDRIYIIPENNNLIAQDGVLKLHQRTRNERTTGSIDIF
FESLAEVYQSYAIGVILSGTGFDGTFGFKKIKEVGGATIVQDPETAEFKGMAQSALDAHT
VDYVLAPEHIPLQLVQIRKNYIATHAYSEEEHLPNNEEEILMQIINLVLVRTGNDFHHYK
QPTLRRRIARRMVISNKENLQDYYYHLRNDKSEQDLLFSDFLIPITYFFRDKDFFESLPK
IAFPQLLENAENKNLRIWVPGCSTGEEAYSLAIALHEYLTETKSAIKVQIFASDISEKYI
AKARTAIYSEQDLQKVSQTRLDHYFTKRDGHYHINKVIRDMCIFAVHNFIKDPPFARIDL
ISCRNVLLYLDSFLQDKVLNSFHYSLKDNGILFLGKSESITNGQKLFEPIEKDEKIYVRK
FIKENYASEILTSATITTEDKDDKKEIIDIETSRELLIKKLQNDLALANKDLKRITSELE
TANEHVKSNNTELLFINDELTNRQEQLTSMRNYSESIVNTIREPLLIIDRDFFIKSANPA
FYKYFETTEKETEGHSFFEIGGCQWDIPEFKELLFKMFSEKKSVLDFKVDTLCNGTGKKI
MIVNAHQIQNSQPAGLILLAIEDITDLETTNVALKKKNLELQKYNEQLEVVTTAASNNIQ
EPLRKIQMFCKRILDNEENLTESGLHNLERIRIASSNMNQLVTDLIDYSRINLNEKESKK
TDLNVLLKKIIADLKDYILEKNAIITVAALPQVNVIPHQMQKLFNNLIINALKYSKEDVI
PQIKIETEEPSKEDITEIGGNPALNYIKINVSDNGIGFSTEYKTKIFEPFYRLHSNDQYT
GSGLGLTLSKKIVSDHNGFLTATSQVNHGTTFSIYIPL
>EGALAKHO_04058 hypothetical protein
MKNLISTLMMLLCVGVVSAQETPKTTKKAKTSTDTILKSTSTTKSSTYKTDTVKTTHPTT
KKKSSTKPKTKMDTIKPVE
>EGALAKHO_04059 Response regulator rcp1
MKYKNILQIDDDFDDCEFFQQALEAVSSAAYMALHNPIEALQKLVDKEIKPDLIFLDINM
PLMSGIELLAEIKKRDNIKNIPVIIFSTAPVSSHLAKLLDAKDYLTKPSNFNDLKNILKD
IL
>EGALAKHO_04060 hypothetical protein
MKDLNLETMKEVLILRIVSISYSNHFDDDDYQRDLKT
>EGALAKHO_04061 hypothetical protein
MNSDFFEINNYFVDNRSSLRKNYHIYNDRRERVGTIKQKLNLKQKIMRMMPFRGLFPFSI
EIRNANGGLESSIAQNSLSFLSDIIVSDAQGKKIGTINKRNFFKPEFSVLNASNEVIAEI
RDAWHGPNFVVYDTTEKQIGSIDKKWNRRMRNFVKSNRSYNVNMSTNYSENEDKIAILSS
AIAINMLFFN
>EGALAKHO_04062 Nitrogen regulation protein NR(I)
MKQLYTPEVPNKRMTYNNILQIDDDSDDCELFMEALEAVSAATYTAIYDPVEALRKLTQK
EIIPDVIFLDLNMPIMSGMEFLTEIKKKEGLKEIPIIIFSTSQLDDIICEAKAHGAYDFI
SKPNDFNVLKKILSQYTLSAKCY
>EGALAKHO_04063 Phytochrome-like protein cph1
MKLSTQIFVAFTLVILLSIADSYTNYMLSKKVQLNSQFLARSEEIIRNSNKTHKSIIEMQ
SAFRGFLLTEDYTFLDSYFIGLKRVPLLIKEQQLRIGDKNSQRAILDSISTLHSSWVRYS
EELIKSRKDYPYSYKNLFDTSLKRHVGKKINDAIAEKFSRFDKSEYKVRKHHTEMLLTSL
KYAHTFSFIFLSLTVIVGLLSTVFIMYITNKRITSMVRLAENISKGNFTVVKDTRNDELT
ALAKSLNRMSGKLDKNIHELKNRNAELNKFAYAVSHDLKAPIRGIHNVVSWIEEDHEKEL
SPDIKRYLSIIPQKTRRMEALINGLLDYARLNLKAPSENIDTNALVNEIADSIVPRNFKL
EIGNLPNLYTERIKLEQVFANLISNAVKYTPQEDGLIQISCYTFGSVHEFSVKDNGIGIA
VEYHDKIFEIFQTLREQNEQESTGVGLAIVKKIIDDQQESIVVKSKLGEGAEFIFTWRNN
>EGALAKHO_04064 Response regulator rcp1
MKKPTILLVEDDELDVISVERSLKKLESEYVLYTAYNGIEALKFLRDPELKLIPDVILLD
INMPRMNGIEFLKVVREDKKLKDLKVFIMTTSSEEMDRTDAEKLGISGYIIKPLNYNDNT
KRSDSMDAFVQFHLRKILFDDGL
>EGALAKHO_04065 Sensory/regulatory protein RpfC
MKKINEIKTAESQEVILELPIVSAEKPSKVRGIKVDSEESILNDAEFLKILLKVKNGNFT
QRFPTDQNGIKRSICDTLNEIIDLNERMVFEFQKVGKSIGKQGKLTNRVALDGARGSWSS
CVDSVNTLISDLVHPTIEIAHVITSVAKGNLSQEMPLSIEGNPLQGEFLRIAKEVNGMVK
QLNLFSMEVTRVAREVGTEGKLGGQAKVRGVGGVWKDLTDSVNKMASNLTGQVRNIADVT
TAVAKGDLSKKITVDVKGEILELKNTINTMVDQLNSFSSEVTRVAREVGTEGKLGGQAQV
KGVGGTWKDLTDSVNQMASNLTGQVRNIADVTTAVAKGDLSKKITVDVKGEILELKDTIN
TMVDQLNSFSSEVTRVSREVGSEGKLGGQARVRGVGGVWKDLTDSVNQMASNLTGQVRNI
AEVTTAVAKGDLSKKITVNVAGEILELKNTINTMVDQLNSFGSEVTRVAREVGSEGKLGG
QAKVKGVGGTWKDLTDSVNQMASNLTGQVRNIAEVTTAVANGDLSKKITAVAEGEILELK
KTINTMVDQLNSFSSEVTRVALEVGTEGKLGGQAKVKGVGGTWKDLTDSVNQMASNLTGQ
VRNIAEVTTAVAKGDLSRQITVDTKGEILELKNTINTMVGQLNSFASEVTRVAREVGTEG
KLGGQAQVEGVGGTWKDLTDSVNQMASNLTGQVRNIAEVTTAVAKGDLSLQITVDVKGEI
LELKNTINTMVDQLRGFASEVTRVSREVGTEGKLGGQANVPGVAGTWKDLTDSVNQMAGN
LTAQVRNIADVAIAVANGDMSRKITVDVRGEILQLKETLNTMVDQLREFASEVTRVAREV
GTEGKLGGQANVPGVAGTWKDLTDSVNQMAGNLTTQVRNIAEVTIAVANGDMSKKITADV
RGEILQLKETVNTMVDQLRSFASEVTRVSREVGTEGKLGGQAFVPGVAGTWKDLTDSVNQ
MASNLTGQVRNIADVTKAVANGDLSKQITVDVKGEILDLKNTFNTMVEQLNSFSSEVTRV
AREVGTEGKLGGQSEVKGVAGTWKDLTDSVNLMASNLTSQVRGIAKVVTSVAKGNLKQKL
SIDAKGEVAQLTDTINEMIDTLATFSDQVTTVAREVGAEGKLGGQANVPGASGTWKNLTE
NVNQLAANLTTQVRAISEVASAVTQGDLTRTIGVEAKGEVEALKDTINQMISNLKATTLR
NQEQDWLKSNLAKFTQMLQGQKELNSVTKKILSELATVVTAQHGLFYILQEDENFEDSKL
NLIASYAYIKRKNSPTQYAMGEGLIGQVAIEKERIILSNVPKDYIRINSGLGSAKPQDVI
ILPVLFEGQLKAVIELASLDTFSQTHLDFLEGLTESIGIVLNTIESNSRTEELLVQSQSL
ASELKSQQEVLKNTNEELEEKAFLLANQKEEVELKNQEVEVARKALEEKADQLTLTSKYK
SEFLANMSHELRTPLNSLQILANELIANRDGNLSEKQIQFAKTINSCGDDLIQLINDILD
LSKIESGYISVDYNPISFDEISRFVESTFNPIAEAKHLRFRISMDDELPELIETDSQRLN
QILKNLLSNSFKFTEKGEVQLKIYKANNNWKTANLSLDKAEAVVAFEISDTGIGISKEKQ
NIIFEAFQQAEGSTSRKYGGTGLGLSISRGLSDLLGGSIELESDMNIGSKFTLFLPLQYV
DISEIIDIEVEEEAADVKGRIKSLPSEKFNRSDIDLFFVDEIGDDRTDIKPGDKVLLIAE
DNLTFAKIMLEQAHVNGIKAIVTTKGNDVIDFINQFHPHAITMDLNMPDTSGWKILDRLK
TDFNLRHIPVYIISGEDERNKGLKRGARNFFLKPVKNDSLSYLFNDIHDFKNKKIKNLLV
VDDNELELSRIINAIDGDDITISSAKTASEAVTLIQQKSFDCIILDLVLPDADGLDIITD
LENNIAGQETAIIIHSAGDVTKKQRLRLNRFAHSIITKSAGSMEELIDQTALFMHRVHKE
LPDEMKEIIESFYLKEDVLPGKKVLLVDDDVRNLFALTTALERYGLDVISAESGLEAIDI
LNQNKDINIVLMDIMMPEMDGYETMKRIRKDAKHKDLTIIAVTAKAMKGDRQRCIESGAS
DYMTKPVNVEQLSSLMRVWLK
>EGALAKHO_04066 Phytochrome-like protein cph1
MGDAIKILIVDDKKENLLSLQVILADRGYQFVEATSGKDALRILLKNQDFAIILMDVQMP
LMDGFETAEMIRQSDKLKHVPIIFLTANMNTNEYIFKGYQSGAVDYMIKPLSPEILQAKV
MVFTELFRKNQELRKKEEETHALNEIILKTNKELASQYAAIEKHADELKKKNMELDAFTY
ISSHDLQEPLRKIQTFSNLILSNEYANLSDDGKTKFDRILYACNRMRELINSLLTFSRAT
LVDRRYETVDLNTIIKDVKEALHENLNEKGASITTDFHDTVKIIPFQFVQLMENLIHNAI
KFAKAETPLEITIKSRLVPGFDLQIENLATDVNYCHISFGDNGIGFEPQHSEKIFGVFQK
LHGRDVYEGTGIGLAIVKKIVENHNGHINAVGEPMQGATFNIYIPY
>EGALAKHO_04067 hypothetical protein
MKNKILNGLLLGSVLVSMLACNTKKEEEKPVAVVDKEQVKTEIQAKEDEFAATYNSGKAK
EIGYYADDAVSYYQHKKPLVGKKAIAEFLMADLGTNSNKIAFKTNEVFVSNDGNQVVESG
SFTVTDSVSKTVINSGNYLSLFEKRDGKYVCVRDMSASDVEAR
>EGALAKHO_04068 hypothetical protein
MKKSLLSFLVVVICLFSSTVFSQTTEDAPELGLPGDNLDLYAVLDLFQKSKTIEAFEKSL
NEKETGINNLDLNLDKKVDFIKVVTKKDGNAYTFVLQVNVSKKETQDVAVILVNKDKNGK
VSLQMVGDEDLYGKNYVIEPKTKSDSVTANPAYQGSNPVTVNVPATTTVVVESAPIVQYV
YSPAYVPYYPPYYYGYYPPYFAAFTVLAVGIYRHNNWYHHGGYYGGHYHGGNNTVIINNR
NQINHYNNERNRSNTVNNNRTNGKYGNGNRANTSNRPTAGTADRGSNANRPSAGTSDRSS
KVNRPSAGTSDRSSSANRPSAGTSDRSSNVNRPSTSNRSSSSNFDSGRTRSSSGGSSFNH
GSSGGGFSGGSRGGGGFGGGGGGRRR
>EGALAKHO_04069 hypothetical protein
MKIFNLLLFLSLSFYGTLKPIPKEEILSAEELERFNNEISRSKEIIHSNSSYNTKIAFLV
DMRIKSGKNRFFVYDLVNDKILDEGLVAHGSGSETAIKGNLKFSNEPNSNATSIGRYVIG
KAYKGIFGKSYKLSGLDESNNNAFKRAVVLHSYSAVPEEEQEYYITRSHGCPMVSEAFFK
RLEKIIDSSKSNIILDIYY
>EGALAKHO_04070 hypothetical protein
MKIQKQYSFRFIILLFSCIIGIGTTGIAQEFNIKNDIFWNTKEGLPLNSQGGGIFKFADP
VSGTQKYYWHGVQYVEANRYRANPAITLTTSTFEAVTCYSSTDLANWTFEGNVLTKEKAN
PSGKSWVGRLGVCYVKELKKYAMFVQHDKEVLITLSDSPTGEFSWDHKINMEKIIGTSNT
GDQTVFTDEDTGKSYLIYCYGKGRDKIYVSEIGLKDGKVNLLDCTQVFKGESREGNCMFK
YQNKYYMFASNIYGWDASFAYYLVADDIRGPYLPTNEMLVTKGSEEDFAHISQTGFFFSV
KGSQKETIVYCGDRWANFAGNGLGYNQWCPISFDGKTPYFNSLSSWNINAQTGNWKVASD
NNYVKNGSFEADRRHIPSPVKPVQIQLTGWASDVIEGNKIGLDSINSPVLNHFNTEKERK
IVIGEKSLNISDKVNFKRKIFQVISSSSYVKVEDGLYTLTAKIKNSSGFNTLEMYALSNS
KTFKINIKNENQDWKIIEVKNIAVKAGKVEVGFIADGNANAFCLVDDVTLVKNKK
>EGALAKHO_04071 Oxygen regulatory protein NreC
MTKKILIVDDHLVVRNGVAMVLEKQIEDVAISNAENFFDAVALLKEVSFDLIILDINIPG
GKSTEMINDIRAIQPSVKILVFSAYEEEQYALKFISSGANGYLNKLCSEEKMMFAINSIF
ESSTYISSELLNKLVEKKVSKVKINPLEILSKRELQIAELLINGDGNLEISNKLDIHMST
VSTYKARVFEKLKINNLVELINLYKAIRD
>EGALAKHO_04072 Sensor histidine kinase RcsC
MSKMTLFSSYRFCLLLLLTAIKVTSQENYIATWYTADNNELPQSSVKAIVQDKYNFIWMT
TENGLVRYDGNTFLVYNSATTNLQQCRFTEILGNVQADSLFCYNEKKKELVLINKRKIQL
VTKNRLTYKIIRNGKRYFYHDGLPSYLTINPHEPYYIKLANGNIFFIDSEYVELCDAKTK
SIYKIAYKNDSVFNFFIINDNLYYLKNNGDYDSFSIGGKSPEKNNSPLLKTKYKLYWNIA
AKQVFLYSQNKIYLVKSNGQQLVTEPIVEFKNFEKSNIVSIFYDRKNKKLYLGSYTNGLC
IISFSDFKAVKKNPFKAAEVYYAALPFTDNTIVTAEGLIMNNKKVVDSIPFEKCIFFNDH
LSMDKDDSENFWIIALFDVQCYLRSSGYKKHINYHFSQVPRTLFKDNSNTIWISLASDEF
HKSRLYCIKNGVLTYVAALNETINFINQGDNNTLYFGSERGLLRYEEDSKKLFFIKSTKN
LNIRSIFIDSEKKIWLTTYEKGFFLFENNTLHSFPKDEDNYLNSSHSIVEDKKGFFWIPT
NKGLFQVSRKALLKYNKNKKGAIYYHQYNKMDGFLTNEFNGGCQPNSNYLKNNEIVFPSM
NGFVFFYPNKITPLTPPKELFIDKIIVDQKPLFPKDTIVLKNNFQRVSFFIDYPYYGNTE
NINIEAKLDKRSNSHWEKIRDEKSISFTTLPPGEYTLTLRSLCGFDGNYIHKKFTVIIPA
RFYQTTWFNILCYILAFALLIFIWFVRSYYIKLKNIKLKEVIEEKTKKLATAVKKLEKTK
RNLKQEIKQQETLVKSISHDIKSPLKFLTSSINHLSDNINIQQDPKIKKQIETIQMSTFQ
LYDYVENLIKYSTIFIEGRKLEDKSYSLYNLIEEKIQIFEKIAKEENTIIINKVPQDFLI
KTNNKALSIIIHNLLDNAIKNTQNGEIVLQSAINDKTLSLMIMDNGKGMSKELINYYLDF
YKNPIVKNYHLGLHMIIELLIIIKGNINISSTINEGTIIEILVEYT
>EGALAKHO_04073 hypothetical protein
MKIGIIGACNMTLDIAKRAANSGHEVLISQSRCIESLKPIVEKMGDKVKLVTKEKAFNAK
IIVLFIPRQELNGFFEGLPDMSDKIILHTNNPFFNIASLRSPIAEVQSSSEIITSLLPNA
HVVKIFHVLEPELVLSKCQSQSGNEIFYTGTNQKAKNKVKSFLKTLNLSACDLGELCVAG
KC
>EGALAKHO_04074 Catalase-peroxidase
MDNQSNDISKCPFHNGSMDNVAATGTKNRDWWPKQLKVNILRQNSSLSDPMGENFNYAEA
FKSLDLEAVKKDLHELMTDSQEWWPADFGHYGGLFIRMAWHSAGTYRVEDGRGGAGAGQQ
RFAPLNSWPDNVSLDKARRLLWPIKQKYGRKISWADLMILTGNIALESMGFKTFGFAGGR
ADVWEPDEAVYWGSETTWLGGDERYKDGSEGVPKDHGVVSSDDDADGHIHSRNLEKPLAA
VQMGLIYVNPEGPDGNPDPIAAAKDIRDTFGRMAMNDEETVALIAGGHTFGKTHGAASSD
HVAEEPEAADLALQGFGWKNSFGSGKGADAITSGLEVTWTTTPTQWSNNFFENLFGFEWE
LSKSPAGAHQWIAKNASPIIPDAFDSSKKHLPTMLTTDLSLRLDPEYEKISRRFLENPDQ
FADAFSRAWFKLTHRDMGPVTRYLGPDVPQEELLWQDPIPAVNHELINQNDIEQLKEKIL
NSGLSISQLVGTAWASASTFRGSDKRGGANGARIRLAPQKDWPVNNPSQLKLVIEKLESI
QADFNAAQGTAKRVSLADLIVLAGCAGVEKAAKDAGTSVSVPFSAGRMDAAAEQTDIDSV
GHLEPKADGFRNYRRTKSTVATEELLIDKAHLLTLTAPELTVLLGGLRVLDINTDGSKNG
VFTHRPGQLTNDFFINLLDMNTQWQSVSNDKQLYAGNDRTTGQPKWIGTRADLVFGSNSE
LRAVAEVYASNDAQEKFVKDFVATWNKVMNLDRFDLA
>EGALAKHO_04075 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MRVSVIRKNIIFTPDSKRVVARYFMNGDERTQQMVMRIIMLDEKQVTETLEQTLREFARR
HRNISAIFFRHCEKIRDLIEAMQIDYEAISLDRKMLIGSYCTMEYAIESAAIFNPSIIED
FDQSGLEAGEKRVILSFRATGEGHISSIVFRRGILDRDNNLLVMKIGHNIDKAEIMHKSF
FNKERFLMKLSEMHTQDKYIVQIMQDLPDEFEYAVLKNMVNTALSDPSNREERRTALNEI
LWLAKSFYDLEFKHDSDITERVIFPISDSESRGIEDARFVRFVDDDGTNRVMATYTAYNG
HTILPKLISTEDFYTFRVMPLHGVGAQNKNLALFPRKIKGKYAMLARIDGVNNYIMYSDR
VTQWNTPILLQEPRYTWEFTQIGNCGSPLWTEEGWLVITHGVGTMRRYCIGASLFDLDDP
SKEIGRLKEPLLSPLEDEREGYVPNVVYSCGAIIHNNSLILPYAVSDYSSTYAIVDMAEL
IDALKKSK
>EGALAKHO_04076 1,4-beta-mannosyl-N-acetylglucosamine phosphorylase
MSDIARRFPENPLLMPKDLQASSEELQIISLLNPGVFVFEGKTWLLVRVAESIAQKEGVI
FFPVVNALGKIEIIEIPLNDPDLIATDPRVIQYKGLDYLTTLSHLRLLCSDDGIHFYTPQ
GVNPLMGSGILEQFGIEDARVSYLEDTYYITYTAVSSNGVGVGLRTTKDWKNFEKKGMIF
PPHNKDCAIFEEKINGKLYALHRPSSPQIGGNYIWLAESPDGIHWGNHQFLVGTRLGLWD
SARVGAGAAPIKTDKGWLEIYHGANAEHQYCLGAFLMDLNDPSKIIARTLEPIMIPQENY
ELSGFFGYVVFTNGHVVDGDKITVYYGAADEFVCGAHFSIKEILAALEV
>EGALAKHO_04077 hypothetical protein
MIKLAKREEQIMQVFWDLNKAFIRDIIPLLPDPKPHYNSVATIVKILEEKGFLNHETAGN
MHCFFPVISREEYQQFALKDIVSQYFDNSYPRMLAFFAKEQKLTETELDEIVHLIKKEKI
>EGALAKHO_04078 hypothetical protein
MIPYILYSALILTACLVFYKLLLQKETFFHLNRFVLLSCMALAFILPLIPVPQQLSFRKI
VVEKPVLVAKTSITANATPALQEQPVQPTLVEQTSQVINIKSITLVLIYLYWFGVIIFAL
NFLMQAVLLFYRAYSKSVIKDGKFRIVEITDDKAPCSFANNIFINPEKYEWETYNQILLH
EKIHIEQKHTIDLLLAEMVLIFQWFNPFAWQWRKALETNLEFLTDNQMLQQDAVEKESYQ
FSLLKVAAPQFPLSLTTNYNQSLLKKRIIMMNSKKSNVHTTWKYFFLVPIMVLFACLFNQ
PAAQSQTLASKEKEVQQEGQSNIKSGMETEGNWFATIKGNTVNIQFKSDENNSNSTFELN
EFKDLPRDKQGTFTLTREAGTMTFIGKFEGDKGMGTYKFTANKDYSTAMHKEGIDLKDDE
DLMVFFMINIKQSYVQMLKKNGYTKLDKDQLIPLAALDVNEAYITSIKQVVPDIDLENLV
PFKSLNIDKAYIEEIRKSGYKDLSPGNIIALKSQGIDAKYIKDFHSSTNSKKKNKDADDE
EDKDDDVIAFKSLGIDQAFIDSYKKIGYNDLSNDDLMALKSLNVTPEYITSFKKAGYNDI
KAEDLFALKSLNVTPELILEYKNLGFNDLNLEDVVGAKAVGATPSFIKSMKGKGHDFKSL
DKYISLKSVLGN
>EGALAKHO_04079 hypothetical protein
MNIDEREKFGRDEPNFQDENRYDDEDLNRQFTDPLNDIDDDDDLDDIDEESRDEDDDFAD
VDDDDLEKDGDLDDDDDDDDLKDTDRPGDLYKDVDLSLQDEVNQDREEVDAVNHQRKF
>EGALAKHO_04080 hypothetical protein
MNTSNQKNSSTSSAKSSDKKSDSKGTASKSTSKSTDTDAKKGASSTKK
>EGALAKHO_04081 Glycerol-3-phosphate cytidylyltransferase
MKLTKTITGITFSAFDLLHAGHVRMLEEAKQHCDYLIVGLQTDPTVDRPEKNKPTQSVVE
RYIQLKGCKFVDEIIPYTTEQDLQDIIQAFPIDVRVIGEEYKDKNFTGREYCEKMDIKLI
YNKRNHRFSSSGLRKEVYERECLKLV
>EGALAKHO_04082 hypothetical protein
METATTSSKQASSSKTSKLKTNVSALERILMVTSGGYLLYKGLAKDDKNISQIGSGSAML
LRGLSGYCPVYDAVDHLKNDKASNVNIRVNSIINKPISEVYNFWRDFENLPKFMNHLESV
KPLNYTTSKWTAKGPAGIGKLTWKAEIVKDEKERLISWSSLPDSSIKNAGKVVFRPSGKG
TEIIVTISYHAPLGVAGETAAKLLNPYFEKLVKDDIMNFKTYLESV
>EGALAKHO_04083 hypothetical protein
MKNSDKPTPTKAATDKGSKNINIVSPSPDAASELKDFFIDCLKDIYWAENALVSALPKMA
SNATSPTLTSAILEHLSVTENQVARLEKVFELLGESAEGKKCEAMAGLLKEGDSILAETQ
PGAVRDAGIIAASQKIEHYEIASYGTLCAFAKTLGENDVAKLLTQTLAEEKEADCVLNDV
ALNSVNMVAAE
>EGALAKHO_04084 Catalase HPII
MKNLQDEKQRDLLQNKSDGTNKFLTTDQGVRINDDNNSLKAGERGPSLLEDFILREKITH
FDHERIPERIVHARGSGAHGFFEVTNPIPELTKAGFLKEAGLKTPVFVRFSTVAGFRGST
DLARDVRGFAVKFYTQEGIYDLVGNNVPVFFIQDASKFPDLIHAVKPEPHNEIPQAASAH
DTFWDFISLMPESMHMIMWAMSDRAIPRSYRMMEGFGVHTFRLINEANESTFVKFHWKPK
LGTHAVVWDEALKISGKNPDFHRQDLWEAIENGNFPEWELGVQIIPQEDEHKYEFDLLDP
TKIVPEELVPVKIIGRMVLNKNPDNFFAETEQVAFHPGHVVPGIDFTNDPLLQGRLFSYT
DTQLSRLGSPNFHEIPINRSVSPIHNNQRDGHMRQEINKGRVSYHPNSLGGGCPFQAKIA
DGGFSSFNERVDAHKVRERSESFADHFGQAKLFFNSQTPTEKSHIVKALRFELGKVETVA
IRVRMLGLLSQVDMQLAEKVAEGLGASVPSILETPINHGVSPENEMGNQEPRSIDSSVKS
SDALSMIKNPTNSPTIASRKVAIICADGVSAASVMNMKNTLLKEDAKGFIIAKNLGSVLT
DEGGAIPVDFSLLTTSSVLFDAVYIPHSEGLNDLGQNDDILEFLNDAYKHCKVIGADGQA
IGILSETPFASKLNNEDTGIILYSEPATETFALDFVNAMANHRIWEREENLYN
>EGALAKHO_04085 hypothetical protein
MKDFLRNNGLSICFLALFIAALIGQTIFGFQEHNKELIDEGSQAINLSAYLISGHFIQST
FENWESEFLQMALFVVFTIFLMQKGSSESKDLDKEEEVDREPSPTRKDAPWPVKKSGWIL
VLYKHSLTISLLFLFVISFILHFYGSLKDENEQLNLKGLPLESVSDYLRDSRFWFESFQN
WQSEFLSVFAIILFSVYLRQIGSSQSKPVDAPHMQTGE
>EGALAKHO_04086 hypothetical protein
MEKAIQLKVRKELNGQQQLNIIKLKGSLISKGYTEIIHILDQDDEFHINSFETPVETTNE
VQEYITAFINRENLTDTITLYK
>EGALAKHO_04087 hypothetical protein
MTIQDLIGKYSISGSNQDENQEITYKGILNLSLDKNNRIIAHWTINNTQEQKGYGFFKDN
ILVINFNYKGENNKTFKGVAVYRCITKDVLDGFWSEKHGNPLYLGSEYCLRLESKEQLN
>EGALAKHO_04088 hypothetical protein
MGEVFFRDWKSIGHVVLTTIIAFVILFFFVRISGKRTLAKLNAFDFVVTVALGSTLSYMM
LAIVPIIEGAIVLLLIIALQYIFAWTARSSKKVEKLINAVPTLIFYDGKFIEHAMAKEAV
TKGEIFSMIRNSGIDQMDEVKAVVMELNGVITVVRKSKGNGKSSLDDVVI
>EGALAKHO_04089 hypothetical protein
MTFQNYFYTPQESAGDMISYEEQLLLNYDNYLEGRFVKPNVSNHYNLELDELNEEKPGTF
QVNN
>EGALAKHO_04090 Non-reducing end alpha-L-arabinofuranosidase BoGH43A
MKQRQIFLSLSLLFLFSFNGINFEGTLGKEPIFSNVVYTGDDIIYKNNPLKPDEFYSPVL
QGCYPDPAITRKGDDYYMVCSSFAMFPGVPIFHSKDLVNWTDLGGILNNVSEFNPHDTGI
SQGVYAPGITYNPHNDTFYMIVTAFTGNMGNIIVKTKDPMKGWGSPIKLDFNGIDPCIFF
DDNGKGYIVHNDAPDKGKELYEGHRVIKVWEYDVVNDKVIPGTDKIIVDGGVDLSKKPIW
IEAPHLYKKDGHYYLMCAEGGTGDNHSEVIFISDSPKGPFKPASNNPILTQRYFPQDRPE
KVDWAGHADLVKGPDNKYYGVFLGVRPNDKNRVNTGRETFMLPVDWSGVFPVFENGLVPL
EPKIKMPKGVTENKTGKDGFFTNGNFTFTENFTSQKLDYRWIGLRGPREKFISITKIGLQ
IKPFEVNIKELKPTSTLFYRQQHNNFSFATTIDFKPTSEKDLAGIVCLQNERFNYVFGIT
KKGKDTYILLERTEKGVSKIIASMKIEIKKNIRLQVRATGDSYEFSYALNGIDFENLGGS
VSGDILSTNVAGGFTGALVGLYATASNDTQVK
>EGALAKHO_04091 Carbohydrate acetyl esterase/feruloyl esterase
MKSILRFFAFAVVFLIAQKGYSQDPNFHVYLSFGQSNMEGYAKIEEQDKVGVDDRFQVLQ
VVNCPDLNRTKGNWYAAIPPLCRCNTGLTPVDYFGRNMVANLPKNIKVGVINVAVGGCKI
ELFDKDKTAEYITTAPDWMKGILKEYNDNPYARLLEMAKIAQKKGVIKGILLHQGESNTG
DTLWTKKVKIVYDNLLKDLNLDPKKVPLLSGETVNEDQNGKCGSMNKIIATLPKTIPNSY
VISSKGCTAEPDFLHFNAAGYRELGRRYADKMLYLLGYKFAEGKAPLRVQAPVGFDELNS
NIPSGKIEAITYESKTVGSVRKVTVYTPPGFNKKKKYPVLYLLHGIGGDEKEWLNGGNPQ
VILDNLYAEGKIEPMIVVMPNGRAMKDDSATGNIMAPDKVQAFAVFEKDLLNDLIPFIEK
KYPVYKDREHRAIAGLSMGGGQSLNFGLGNLDKFAWVGAFSAAPNTKKPEELVPNPEEAK
KKLKLLWISCGDNDWLIENSRRTHEYLAKNNVPHIYYIEPGVHDFKVWKNGLYMYSQFLF
KPVDQSLFSSYTILGEPAQTNIRNAKYPQILPDNRVVFKVKAPEASKVQIDLGRKYDMAR
DSEGLWTVTTDVINKGFNYYSLLIDGVAVADPSSETFYGMGRMASGIEIPNKEGDFYALT
TVPHGDIRIKKYFSKATNSWREMYVYTPAGYDNSAEKYPVLYLLHGGGEDQTGWATQGKA
NLILDNLIAEKKAKPMVIAMLDGNMGNTGGVAGFNENALKAFENELKMGAIPFVESNFKV
ATDAKNRALAGLSMGGLQTLYAGVKNSDLFSSIGVFSSGWWANNTDLSGPQYEFMKNNAT
AINSNIKNFWISMGGKEDIAFENCKIMMSKFDQMGIKYQYSEYPGGHTWPVWRHDLFMFA
PLLFN
>EGALAKHO_04092 Non-reducing end beta-L-arabinofuranosidase
MKNLFIKYRIFYCLLGLLITSSATAQMQLFDLKEVRLKEGPFKNAQDVDLKYILEMNPDR
LLAPYLIASGIPVKAERYGNWESIGLDGHIAGHYLSALAMMYASTGNTEVKNRLDYMISE
LAVCQEKNGNGYVGGIPQGKVFWDRIHNGDIDGSNFGLNNTWVPLYNIHKLFAGLTDAYR
YTGNEKAKQVLIKLGDWFIELIRPLSDDQIQNILKTEHGGINESFADLYIITKDKKYLET
AEKVSHLAILNPLEKREDKLTGLHANTQIPKVIGFEKIGVLSGNKDWTNAAQFFWENVTQ
KRSVAFGGNSFAEHFNPTEDFSGMLKSNQGPETCNSYNMERLSKALFLDKNQVSYLDFYE
RTLYNHILSSQHPEKGGFVYFTPIRPNHYRVYSQPETSMWCCVGSGLENHSKYGELIYSH
SDNDVFVNLFIPSTLDWKEKDICIEQSTKFPYQNSTDLVLKLRKSNTFSMNIRRPEWAQD
FEISINGKIQKIEAKPSSYVTLNRKWKSGDKITVTFKTSTHLESLPDGSNWSAFVNGPIV
LAAKTSNKDLDGLFADDSRMGHVASGKYYPLDQAYEMIGGKANYIAKLKEEGDLHFRLDS
LELQPFFEIHDTRYQMYFQNYTKEQYQEKHDLFKQQEIEAMALETRTVDKISCGEQQSEV
DHRYKGEKSDSGYDDTKAWRSTRSYISYQLLNKNKSGKYLDISCTGDFKIDKITILINEK
SAQIISSANKTIRLNVEKIEIVNITIKSNDGSNSPKFHQFRILKE
>EGALAKHO_04093 Xylan 1,4-beta-xylosidase
MTQNIHHTIQKIMKFTYLFIINLVAVCSVSAQQYRFKDASLSSKERAEDLISRLTLEEKA
ALMCDQSDPIPRLGIKKFNWWSEALHGYANNDNVTVFPEPIGMAASFDDQFVYTVFNAVS
DEARAKYNQWIQNGNENKRFLSLSVWTPNVNIFRDPRWGRGQETYGEDPYLTSRMGISVV
KGLQGPADAKYRKLLACAKHFAVHSGPEWSRHELNLNNVDPRELYETYLPAFKALVQDAD
VRQVMCAYQRLNDEPCCSNTRLLQRILRDEWGYKYMVVSDCGAVTDFYTTHKVSSDATHA
ASKAVLAGTDVECVWEKYPFKNLPEAVEKDLIKEADINKSLLRVLIGRFDLGEMDDDAIV
PWAQIPASVLNSKEHQQLALEMAQKSMTLLQNKNNILPLNKTNKVAVIGPNADNEPMLWG
NYNGTPVKTITIKSGIESKVAANKIVYDKACDLVEDKVNETYFDQLSFEGKKGIKATYWN
NPNREGNSVATQQILNPIKMTTAGQHEFASGVKLEGFSAKYEGEFSAKANDTLVFKTGAT
GAFELIVDGKSIAKYTNWRTLPGKIAFPVEAGKKYKIEILYAQSNNWQANLEFDFGKEHD
IDFAGLIQKLKGIDTVIFVGGLSTLLEGEEMPVSYPGFKGGDRTNIELPAVQRKCLQELK
AAGKKVVFVNCSGSAIALTPETASCDAILQAWYPGESGGQAVADVLFGDYNPSGKLPVSF
YKNSDKLADFEDYSMKGRTYRYTTDVLFPFGFGLSYSKFQIGTAKLNKTKINSTENIQLN
FSIKNSSKREGTEIVQVYVRKVNDTNGPLKTLKAFKRIDLKAGSNQNVAINLPASSFEFY
DSKTRRMNVTSGEYEVYYGTSSDAKDLKMIKVAIQ
>EGALAKHO_04094 Retaining alpha-galactosidase
MSFKYVLCLCLFGFFKLNAQSIVKSPDGKLKVSLSVSNGMPLYSVSYNEKNFVENSPLGL
KTNVGDFTTRLVLKADVNQNKIDETYELPNIKQRNVHYEASEAVFSFSKENKPAMDVIFR
VSNNNVAFKYKIYPQKEVLSCVVQEEASGFKLPEGTTTFLCPQSKPMTGFARSSPSYETT
YTLDAPMGKNGIGEGYTFPCLFKVKNNGWVLISETGVDGNYCGSRLIGHEKELYTIGFPM
AGENNGNGTTAPGMSLIGETPWRTITIGETLAPIVVTTIPFDLVKPKYKASKEYQYTKGS
WSWIIKMDNNTTFPVQKQYIDFSAAMGYETILVDALWDTQIGKDKITELAEYGKTKNVGL
YLWYNSNGYWNDAPQGPRGKMDNSTIRRQEMAWMKSIGVKGIKVDFFGGDKQVTMKLYED
ILTDANDFGLMVIFHGCTLPRGWERMYPNYAASEAVLASENLHFGQASCDNEATNAATHT
FIRNTVGSMDFGGSALNEFYNSDNIPNKGSKRRTSDVFALATAVLFQSGVQHFALAPNNL
TDAPAWAIDFMKEVPTTWDEVRFLEGYPGKYVVFARRQGSKWYIAGINAQKETLKIKIKL
SMVSVGTTLKYYFDDEELNGKVKTLKLKNNTEVEIKIPNNGGVVLLN
>EGALAKHO_04095 Sensor histidine kinase TmoS
MSKENCFRVILFFLINNLFSQNTFENYQFRLVNKEASKSGIYTIAQDQYGIMWMGTNGAG
LYKFDGVNYVSYEQNSNVTNSINSNLIYATYVDVRNRLWVGTDEGLCLYNRDLNNFESID
IQKKVNKETVISVKSIIEDNNGNLFLGTFNGGLLKLNIKTREITSVKLDVHNPANFQINS
LVKDKNGVIYLGTNFGLKVVDQKKNEVKKVTATNDNQILSGNIVSMFLDSSQSLWIGNGY
KGLVKVNLNSKQAFSYPITTKRIMSILATDSKTILCATENDGLIVVNDQGVIQEKYLNSK
FNVRSLSSSSVWSLFLDKEHRIWLGYYNKGLGVFDKINSKVNIIESLPGNPQSLQTNCVT
GIAKDHEGQLWISMEGGGVDVYNLVTKKFKHITKSDGSLYSGLTNDNITKVFIDKKQNIW
LSSWNEGIFLLKKGSRTFINYNTKNTPNLASDNIMSITEDSRGVIWIGTFAKGLHYYTPS
DGQFHHCNSKPFYNVMNLDIRNVMVDSDDAVWVGSTTGLYKVTTKDFITFSVVSFRDKMS
EKLKNHKSTHTINTLYEAKNKEIWIGTDGAGLFSYNKKTDSLKWYINFRGLHEKSISSIV
ESNDGGIWLSGKKGITKLDLKNKTTFNYSIYDGLLGNDFNNNSVLKDEKGVLYFGSYEGL
NYFNPTNLVKSKKQLPIYFTDLKLFNKSVGPLEKNSPLVKVISQTKKIILRHDQSVFTID
FIAVNYSFPARNEFAYYLEGFEDSWNYVGNKRSATYTNLAPGNYIFKVKASEKNGVWSQK
PLELRIEILPPWWKTSFAYLFYTLLVLAAIYFGNQYYQNRFKQKQMIEFEKTKAVQIEKL
NNKKLQFFTNISHEFRTPLTLILNPLGDILRNYSSDLPDSVLKKLQTIQKSSDRLSRLIN
ELMDFNQLQFNKMTLQLQLIEVVSFTREIVSYFDEEALSRGIQLEFESNKTALKDWIDPK
MFEKIIFNVVSNAFKVTPDNGRIAVKIVIKNELVPFPLIDSGTSYPSFVVIVEDTGSGLD
KKDIKRIFDRFYQVNNLNKAYYGSTGIGLEVVRGFVELHKGIIEVESELGVGTTFKLLFP
VGKEFFNESEILLEDFKKEKKMSFTPIAEKEEIQSDNIEEKQDRIYTILIVEDNVELRNY
LKNELKKEYKVLVAENGQVGLELALQKLPDLILTDVIMPVMNGLELCKNIKADLKTSHIP
LMMLSAKALVKDRLEGIDSGADMYLSKPFDMDILRSSLVQLINSRQIMFNKFYNGITPKA
KEKTTTLDNDFIKTVLNYINENISETELSVEDLASKVFLSRSQLYRKIKTLTGVSVNEFI
RNVRLEKAKELIELGNDNITEISYKVGFSSPSYFTKCYKDKYGYLPTHNKK
>EGALAKHO_04096 hypothetical protein
MYRDNLAFTLFFLLFEIFKNYEYDVLLIFYFSNLKMSVLNFDCEKKELFNTQKLVSFHVL
NWFKVVNNGFMVIDI
>EGALAKHO_04097 TonB-dependent receptor SusC
MMLKLKFAIIALLMISYQNVMAQSKTIQGVVIDPSGFPLPGATIYVEGSKNSASTDFDGK
YALKGVNSTDRITFSYVGLITQTITVGTSSTINVTLVEAAQNLQEVVVAYGAQKRSKVTG
AISTVSSKDITAVPITNAESALQGRAAGVTVVNGAPGSSPTVTIRGLATMGNSAPLYVID
GVLTGNLSGLSPNDIESMSVLKDASTTALYGSKAFNGVIMVTTKKGKKGPGQLNFSTYAG
FQTITKRYDVLNTQQYLKYAKDLGSDLTARAAQFGNINTDWQDQIFQSGVMQDYNLSFSN
GTENSTSRYSAEYLKQDGAVISTGFERYSFRANNTQNIGKLTIGSNIGLSFSETNPERAS
GGRTLLEHAIKMAPYLPVYNADNVGGYQGPSTVDGQDAENPVRVANLGYQKINGLSIIGN
IYAELQIIKGLKFRSQVSLDYYTSEDHTFIPGYEDGSAHKQAYSSTAETNSKGQTIVFDN
SLTYKTTFANKHNLEVLGVITKIENKSENLIASSRYYISNDIDQLRLQDANLSSSNIEAN
NLGYIARINYDYDDKYLLAVSGRRDASSRFGSNNRYGNFYSVAVGWNIAKESFMTDSVFS
TLKLRASTGTTGNDRIDDYQYSSSLAANYTYPFNGAAGAGVTAGRAANPDLKWESKNDRN
IGLDFGLFDEKFTGSFEYFNNKSSDILFAVPLPASVGSAGGGTQIQNIADVKVHGFEVTL
GYNDRKGDFTWSAVANLGTSKNEVTALAPGVTSVLAGPAVRAGLENFSRLEVGQPLFYFY
GYETNGIYQNQAEVTSALGATQTTVQPGDIRFVDRNGDKVINSDDKTNIGNPYPDFTYGL
NLTAAYKKFDFNAFITGVSGNDVFNANKFDLEAMSRLFNASTDVLDRSIVQNGVVTNPSA
TLPRALGTGQNWSSASQRYVEDGSYTRLKNVTVGYTFSGDSFSTYFSHIRFYVSAQNLVT
ITNYSGLDPEVARVDANANSAGIDIGRYPQPKSVIFGLDVTF
>EGALAKHO_04098 SusD-like protein
MRKIKYIVVVLLGILTINSCNDSDLELTNPNQLSPETFFKSEAQVQSSVNAAYANLQTRG
LYARHIFFALDNMAQENKGNPQLEGNKKPFLDFSFDASSDIIQFYWETCFLGISKANFVL
DNEDKIQALPNSVLTQEKKNKFLGEAHFLRAYYYFLLVPRFGDLPLYTKQTIEGAPRSPK
ADIYKLIEADFDFASKNLLSKTVEDKGRATKEAAFAYLGKALLYQKKYDEALAAFTKVTG
FSLESNFYNNFMDETEHGPESIFEIEYDEKLGVADKWGSDTAGDGVAESTLRGQEYGNLG
WYNVYPSDDILDEYEANDKRFGDTFYVPGSKYNNGANTMTAANFSSSEGLRRAGWKKYQN
YYKRTDENLDSSINFKVMRYSDVLLMMAECESMRAGGVQATAIGYINQVRSRAGVTLLAT
TLTKDQVFTALIHERKVELAGEQVRFDDIIRWGIASTELAGTGFKAGRSELWPIPNRETS
SNPNIKPSNNNPGY
>EGALAKHO_04099 hypothetical protein
MKRIASLFLIVTLFYNVLGFYIMFAEQKEQVWVTAMEKTDNSNFEIIEVKITPYAYVVDS
GIEDANEDFTINNKTYHVFKKRIQNNVLKLYCLKNSHNEAFNKDLKKIVDSQLFDDNSNK
ENPSKKLMKSFIQDYIQSNTILLLSTSVKLFSTVTLNSYSPQKNLLSGYFTTNYPPPDMV
>EGALAKHO_04100 hypothetical protein
MKMYKFLFKVLFFSALSVNTFAQTNVNKNKITEPTGINNIAYKWGEMAAQATANDTDRFR
PRPTVTSRFLGLTFVAIFDAWSRYDEKAIPVYLTDIKRRPKKEQNLKNKEIAISYAAYGA
LCEYYYSDKELFASYMKKLGYDPTNTSLDPKTPEGIGNLAAKAVIAARRGDGSNQYAEEE
GSNGKPFFDYTKYAPVNTVDQLNDINHWQPKYFSDGKGGKFAPACLTPFWNRVKPVGLKS
GDQFRSVPPPLFGSEKLKNEVDEVIALQAKLTDEDKALVEFMRDGPKSVQQAGHWLRFAQ
DISRRDNHTLDQDVKMYFLNQITAMDCFIACWDTKMFYDSSRPNALVHYYYGDKTITAWG
GPGKGMITMQGQEWRPYSPDTFLCPPFPSYVSGHSTISGGCAEALKLWTGSDEFGQSAEL
VSGAMTDPDYVGKKVVLKFNTLTETANMAGISRVMGGYHIQSDNVEGLKLGRNVAHQEWK
FYNIHIGNKTPETIAEN
>EGALAKHO_04101 hypothetical protein
MKIKQLVSLFIVFILTQSCDYFSNPNDKMIKILEARNKMYKVKDNAFASKTEVAYYDSII
KSSDEGFFKLFNEINKGNALLKLGKEADAVATLESAINRKKKIDGKEDPQSLKFLAIAYM
RLGEKQNCVNYHNPESCIMPIQKNGIHTIRQGSQKAIEIYKKLLVIDPNDYESRWLINIA
YMTLGGYPSEVPKQWLIPNLNKDSGYSIKPFLDVAVNAGIKGRNMSGGVIVDDFNNDNYL
DIVTSDWSLDGVMHYYQNDKKGKYLDYSKASEIGRFKGGLSMIQADYDNDGDTDIFVLRG
AWMRKYGRQPNSLLRNNGDGTFTDVTIKSGLYSEFPTQAGTWNDFNNDGYLDLFIGNESS
DNESYPSELYLNNQDGTFTNVAKEAKCDIVAYIKGATSADYDNDGDIDLFLSGMNKRKTL
LKNTGLKNGIPQFVDVTDQAGLAGINVMTFPTWFWDYDNDGWQDIFVCGYQYSGSIAGEI
AMEALNIPNESSKMYLYHNNHDGTFSDVSKTAGLSKTVFAMGSNYGDIDNDGFLDMYLGT
GNPDYKSLAPNRLFRNMGNGKFADVTVSGRVGNLQKGHAVAINDLDNDGDSDIFIEVGGA
YLGDSFSNSLYMNPGQNSNRWIKLQLEGTDSNRSAIGTKVKVTFKENGISRSVYRVLNSG
GSFGASALRMEIGIGQARIIDQIEITWPKDQKKTVFKNIQPNQFIKIIEGENNFSKIDIK
RILFSTAGAHSPLCI
>EGALAKHO_04102 hypothetical protein
MKNIKIKAVYFSLLGLVLLTSCSKESDEKIFTTLDRSDTGIDFSNNLTENDSLNYFTYNY
IYLGGGVATGDINNDGLVDIFFTGNQVSNKLYLNKGKLKFEDITKKAGVGGDSRWYTGVT
MADVNGDGFLDIYCSVGGKFGPKNNELYINNGNGTFTEKAKEYGIDDIGNSVQGTFFDYD
KDGDLDLFVANYPPTKFNSATGDYVQMMLHVKDNESGHLYRNDGNHFANVTQEAGVKNYG
LSLSATIGDLNNDTWPDIYVSNDFNSPDFMYINNQDGTFKEVVKEAMAHNSFYGMGVDVS
DFNNDGNLDIFQVDMDAKDNRRKKANMSSMNPKLFWDVVDAGFNYQYMHNCMQLNTGVNE
NGIPHFGNVSRITGTSSTDWSWGPLFADFDNDGNKDLFVTNGTRREINNNDFFHSLEALN
LKPKDLLKKSQEIPSEKIDNFMFQNKGNLNFEQANKKWGIEFKGFSNGVAYVDLDNDGDL
DLVVNNIDDYASVFENSSSKINNYIKVNFKGNTKNTFGLGNRVYIKTKKGTQMQELTLTR
GFQSSVAPELHFGVGKDKTIDEVKVVWTDGKVQKLSNVKVNQTLSFKEQDAKEEVTVKTT
PKAHLFATETTVFPVFKHEENKYDDFKDQVLLPHKMSTFGPAIAVGDLNKDGLEDYFIGG
SATYSGKIFMQTKNGFVEKSSQALEDDKASEDTGALIFDADNDGDNDLYVVSGGYEFLVN
DPKLQDRLYLNDGKGNFTKAPKGVLPTMLTSGSKVYAIDYDKDGKQDLLVLGRQVPGQYP
SPATTYLLHNISSPTQPKFEVSKKSPKEFTNLGMATSAVITDFNNDKSADIIIVGEWMPI
RLFQNTTSGFKEVTKDMGLNDDTTGWWWSIQQGDFDHDGDMDYIVGNNGLNYKYKATPSE
TFDIYVKDFDNNKHKDIVLSYYNDGKQYPVRGRGCSSQQIPNIKKKFKDYESFSEATLVD
VYTEKSLKEALHYKVKSFASIYLENKNGKFIIHELPVEAQLTCINQIMVDDYDKDGKLDI
LVTGNMYNSEVETPRNDAGHGLFLKGDGKGKFKSISAVESGFFTPGDVKNMEKIQVKGKT
YLLVTKNNLFLQSVRIN
>EGALAKHO_04103 TonB-dependent receptor SusC
MLQEKYIKLLFCFFFLLSAQMKAQQQNLNGIVVDGKNDLPLNGVTIQSEMEEITTNESGE
FVIQNQKLPVTLTISFLGYKTQEIEVNSFDLVKVKLIKDSNQLDEVLISSGYLSQKKSEF
SGSVATVSAKQLQNRPSTSFDQLLGGQGTGIDVIQSTSVLNNTPVIRVRGLNTITSGLFP
LIVVDGVAVFTGSLGGFVGNNPLSGINPNDIASVDVLKDASAAAIYGSRAANGVMVISTK
KGKKGKTRFNYNTWFSRSTPYNLPKLLNAEDYTMIKNEALVNAGKAPGFFLSKNPDGSTV
DTNWYDVAYEPGISSNQNLNISGGNETTQYYFSVDYTNQNSFIKNNTFQNYMTRLNLSHE
VNRSIRVGINLSYSRAKNVGPNTGAVAGNTLSSSTYNTEYITNEPLGRMTYVLPPNVPVY
NPDGSYSIQNGISVGYGANIPSIIGTINAYNLAMVQELDLTTSISKSLLGNIYGEFDITK
KLSFRTSFGLNTIGLENKLVLNPIHGGGAAYNGVATNIATDLERTDWANTLTYRDSFNEN
NHFTFLLGYERIKTTLDSWGASQSNVTDPYYKNYQGSYANISPIGNDLSENALLSYFSNL
NYNYKNKYFLSLNYRIDGLSALPEGNKYGNFGGGSVSWNLLEESFLKDSKVRGFLDNLRL
RASYGIVGNSEIGNYPAIGTYNSSTYGGSPTLGYSQTANPNLKWETSSKLDLGLNFAMLN
NRISVEFDYFNNKIRDLILKTPQSLSAGIPNNYINENVGGMYNTGYEIGINALAVTNRNF
NWNISLNLSTLENKVTSLSSDVFVPSVFGVQNMTRVGYSVGSVFAVPTKGVNPDNGQMVF
INSEGKEVQYNHIGSPKWTYLDGTAAPAIDNYKDGVIQGPSLPKLFGGLNNTFSYKNFVL
NVNLTFAQGNKLYNGTRATNSDQRYFNNGEFIKNRWTTPGQVTDIQKLYYGDNVSAGFSF
SSTSKVEDGSYLKFKNVSLGYNVPMELSFLKNTFSSIYVYLQGNNFYTFTKYRGSDPEVS
INGNSINSGKDQNVPPNAQVYTLGLNIGF
>EGALAKHO_04104 hypothetical protein
MKKYILMSCFILMFATACSDDLLDTQPETSIPESIAFSTPEKILAQTNNLYKQLQNQSFY
GGRFIVFNEQRADQFGQNDGNAATGSAVWNQNVASTNDFVNNVWSVGYTAINASNILISK
MNETTVISKELAKNYIAEAKFVRAFCYFSLIQTYAKPYNQDKSSLGLPLRLMPITTSGNN
DLARSSVEMVYNQILKDLDEAEIDLPVSYTTPLLNTSRAKKVTAIALKTRVLLVQNNFDK
VITEAKKIVSATPPFQYTEGTLTQKLEPNYTSIFGGSYTGTEAVFSIPFANSTTETPSAQ
YALAYNYLTQPIIFLAAAGIVSDPVFSSASDARSSLIGTNAANQKVLKKFSVTTAPFRDY
VPVMRYAEILLNYAEAAANTNDLVQATALLKAVRNRSDPNYVFPANDIATKEALIATIQK
ERDIEFLGEGFRLMDLQRKVQTLPAKKGSIGTAPLVLPTSSNYIWPIPSGEISTNKLMVP
NP
>EGALAKHO_04105 Beta-glucosidase BoGH3A
MRLRFIAAALFSVFFQSSFSQTNPSTEKRIQQLIKKMTLKEKVGMLHGNSKFYTEEVKHL
GIPEWALSDGPHGVRAEMNRHNWQYAGLTDDASTSFPPGTAMAASWNLELAKQRGIVLGE
EARFRKKDVLLGPGINIIRSPLCGRNFEYLSEDPFLISQLSINYIKALQTQDVAACVKHF
VANNQEENRFVVDVTMSERALREIYLPGFKASVVDAGVLGVMGAYNKFRGSYCTENDYLG
RTLLRDEFKFKGVYMSDWDAVHSTEKAALAGLDLEMGTEKENYNDWYFADPLIKAVQEGR
LKESLVDEKVANILRVMIKTKVLDPKTRIKGAINTKEHQQAAYRSAVEAVILLKNEKQIL
PLNMSAIKSVAVIGDNATRTHCGGGFSSEIKALYEITPLQALTTKYGKSMQINFAQGYEK
QSHVVERSSDGQLNTDKVDWKLIEEAVAQAKKSDVAIVFAGLNHDFDSESFDRLHMRLPY
GQETLIQEVAKANPKTIVVIIAGSPLELAGIESRVPAVVWGWYGGMEAGNAVVDVLSGKE
FPSGKLPFTMPVTLSQSPAHALGAYPGHNLKVNYEEDILVGYRWFDTKGIAPQHPFGYGL
SYTSFDISNVTADKKVYSVNDEITVKFTIKNTGKTNGAEVVQLYAGQTKASVLRPKKELK
AFDKIFLKPGEEKTIDLKVKVKDLAFYDEKSAAWKVEPGEFVLYTATSAENIVNTLPITV
Q
>EGALAKHO_04106 Inner membrane symporter YicJ
MGVSRKKSASILMSNTSQKLSVLEKIGYGLGDFAANLIFQTLLTFLAFFYTDVYKIPAGT
ASVIIFTGGFVGAFFNIIMGVIADRTHTRWGKFRPWILWTALPFGIGAVLSFLTPNFGEN
DKIIYTLLTYFFLVIIYSANNLPYVALSGVLTGDMKERNSLSSYRFVAVMIAQFIIQSLL
LPLVLILGHGDKAVGFKNTMILFAVIGVICFLITFFTTKERIIPAKHQKSSIRQDFVDLT
KNGPWLVMVLVTILVFITLSLKGGMYVFYFKYYLDPVAQTVFLKDIGFTAFIHDLNNSLI
AMGLVDFQWPGDVPTSAFSLFNAGGILFMIFGILFSKSLADAFGKRNIYITFIFLSAISL
LLFNFYSRTAIAMVFLTQLAHGFIYGVTIPLLWAMIADVADYSEWKNNRRATATVFSAMI
FGLKIGISIGGALGAAFLSKYGYVAEEVNQVPAAVEGIKLCVSIYPGFIFIISAVLLCFY
VIDRNMEIGIEKDLKERRGN
>EGALAKHO_04107 hypothetical protein
MRILYLLLIVSCFFIGCNKKQNTEEYHKYTNDLINETSPYLLQHAHNPVDWKAWNQETLD
KAKAENKLIIISVGYSACHWCHVMEEESFENEAVAKLMNDNFISIKVDREERPDIDQIYM
NAVQLMTGKGGWPLNCIALPDGRPIFGGTYFTKEEWTKALTGISELYKKDPKKASEYADK
LVAGIQKSELISVNSNPVDFKNSALSEAVKLWQKQLDYKEGGLAGNTKFPMPNALRFLLR
YSVQNNDKATQTYVQTTLTKMANGGIYDPIGGGFCRYSVDSKWHVPHFEKMLYDNAQLVS
LYSDAYLANKKDLYKKTVIETLNFVEKELMASNGAFYSSLDADSKNKSNKLEEGAYYVWK
KQELQTLLKSDFSLFQEYFNINENGLWENGNYVLYTTQSDKDFAIKNKLTVTELDSKIKN
WKEILLAARNKRPRPHLDDKTLTSWNALMIKGYVDAYRAFKNPHYKEVALKNANFIVNNQ
LQKDGSLYHSYKEDKSSIVGFSEDYATVIDAFISVYQITLDEKWLNKAKQLTDYTMTHFW
DKKSNLFYFTSNASADLITRKMEIADNVIPGSNSILANNLFLLGHYYSNDAYSKTAQRML
NNVKEDALQAPTEYYNWLNLMLNYTDDYFEVAISGKNAVTKMSQLQSYYLPNILIAGATA
ASKLPILENRFADNETYIYVCVKKACKMPEKEVTVAVSKIKNGL
>EGALAKHO_04108 Arabinoxylan arabinofuranohydrolase
MKNHIKILFALLCCVSAIKTTAQNPIIKNIFTADPAPIVHKGTLYLYTGHDVATEQDTNY
KMADWHVFSTTNMATWKDHGAPLSPSTFSWATGDAYAAQCIERNGKFYWFVSTFHKKDDV
SGGGAAIGVAVSDSPTGPFKDAIGKALIINEMTTDMTYAWDDIDPTVFVDDDGQAYMFWG
NGSCKWVKLKKNMTEVDGPITTFKPKNYIEGPWVYKRKGIYYLVYASAGTKPEMIEYCTA
KKATGPWEYQGIIQENVPNSFTTHPGIIDYKGKSYFFYHNGSLPTGGSYRRSVCVDYMYY
NEDGTIQKIIQTTEGVSKIK
>EGALAKHO_04109 Non-reducing end alpha-L-arabinofuranosidase BoGH43B
MKKGIKFIFVFFVLFTQTFALAQAQNPILFADVPDLSIIRVGATYYMSSTTMHMSPGLPI
MKSTDLVNWKIINYAYNTLADMPESNLTEGKSTYGRGSWASSLRFHNGMYYVTTFAQTTG
ETYIFKTTAIEKGNWQRVSFKPAYHDHSLFFDDDGKAYLIYGSGKIKLVELNDDLTGIKQ
GVPEKVIIENASEPAGNNIMLGAEGSQLFKIKGKYYLFNICWPQGGMRTVIIHRADNING
PWEGKVGLQDLGVAQGGLIDTPDGRWFSYLFRDFGAVGRIPYLVPVKWEDGWPILGENGK
VPEKLDLPASKGLIPNLVASDEFNRKKSQEALPLVWQWNHNPDNTLWSLKERKGFLRLKT
GRIDTDFLLARNTLTQRTIGPTSSASVSLDISKMKEGDFAGLSALQKEYGLVGVKVEEGK
KEIVMVNTNKDKAIEVQRIPLDQNQVYFKIDCDFTNKKDEANFFYSLDGKVWNAIGETLK
MKYTLPHFMGYRFGLFNYATKSTGGYVDFDWFRIKY
>EGALAKHO_04110 Reducing end xylose-releasing exo-oligoxylanase
MIIDKSFTNEFLIRIHVLVLVFGLIVPVFAVGQIKKKAEKSESKPQYRNLFKEAGYTQTD
IDKKLAKAYYDVFEGPNKVYFEEGDSLGYVSDVKNKDARTEGMSYGMMVAVQLNKKEVFD
RIWRWSVKYMQHQEGPREAYFAWSVNPETKKQNSAGSASDGELYYITSLLFAANRWGNDT
GINYYKEARRILDAMWKKDGTDGIHNIINTEHKQISFVPERGGYNWTDPSYHVPAFYEIW
ALYAKDGHEQFYAACAEVSRQFLHKATHPVTGLNSDYTEFNGEPHPTPWMPPGFRYDSWR
VPMNIAMDYTWYGKDKKWQEEYAGKFQNFLRSKGLNTFEDQFNLDGTAPDFILQAGPVKK
LRHSIGLVGTSATASLVNPDKASMDFVRAVWNAKLEPYEDGYFDPYYDGLMYLFSLMHLS
GNYQIINPAVK
>EGALAKHO_04111 Endo-1,4-beta-xylanase/feruloyl esterase
MKQYKVVMLWVFILSGFIGFSQTNQAITEDFKPSTVNQPGQEYPQVNSQGYARFQILAPE
AKSVVVSLGLGGAKGGTVLAKGEDGFWRGTTAGAMDEGFHYYHVTVDGGVFNDPGVLNFY
GSTRWESGIEIPAHDQDFYALKDVLHGNVQQILFPSKSTKTSRRAFVYTPPGYYKDKSKQ
YPVLYLQHGWGEDETAWSNQGHVNLIMDNLIAEGKIKPFIIVMTYGMTNEIKYGGLASFK
IEPFQTVLVEELIPYVDSNFRTLANPANRAMGGLSMGGMETKSITLNKPEVFSHYALLSG
GTYKPEDIKDKSKVKLIFLSCGSKERPDGIKDAVSTLKNAGFNAVSYISENTGHEFQTWR
RSFKELAPLLFKD
>EGALAKHO_04112 hypothetical protein
MRKLNSRLLVVFNKVLFKKTLIFFCLFSLANKSFSQNLVLNEKEYFETPGLNVWVFNNEY
NGMFFDEKTAGIEFIHHGVRTVTGGAIRLQNTPEQWDLIPKMLSRKVDKTNNSIEVVLRY
EEFNFDSKIIVTAKGKGFTINVVLDKPVPKELEGRAGFNLEFIPTSYFESNYLVDGKAGT
FPRYPAGNTEIRPLSQKIPQFAGHTTFDDRGKKEFITTLPLESGKNLILAPENPERTVKI
QSEDQDVMLFDGRNLGQNGWFIARSILPSNKTGKVLTWYVEPNAIPNWKRQPVIGFSQVG
YMPSQKKVAVVELDKSDKALSTASIFKLGDDGKFTEKLKADVKVWGNYLRYNYAQIDFST
IKEKGLYYIQYGDQKTNTFQIEYDIYSKIWYPTMDVWFPVQMDHMEVNEAYRVWHGKPFL
DDCLQAPINHEHFDGYKQGPTTETKYKPLERIPGMSVGGWFDAGDFDIQTFSHVSVINSF
VESWEAFKVNRDETYIDQKTQFVDIHRPDGQPDLLQQIEHGVLNLVAQVENIGHPVRGIV
VPNLHQYHHLGDASTETDNLPYNPALKPYESNGVSSGTLDDRWAFTNRSSFLDFRTAGSL
AAASRALKGYNDALSAKCLTLAIKLTNEATEIDKKAKPDNSPMSRWGKGSDMIAILQLYL
STKDDQYKKSFEDKIWKLLDENLEFNISPALLAVPSMDANYKQKLRGYVLKYKEKTEKEN
AENPYNVPIAKRGWGGSSQVINWASTNYYIHKIYPDIMDKESVYQGLNYILGCHPYSNLS
FVNAVGNRSKKVAYGGNRADFTTIAGGVVPGLIFLKPDYLENKDDWPFFWGENECIIDGG
AWYVFLANAVNDLAKEKQ
>EGALAKHO_04113 Carbohydrate acetyl esterase/feruloyl esterase
MKQFLNITLLISCLCFVSGWSQETQIVEDFKPSSVNQADKQFPQVNSQRRVRASISAPGA
NKVQLDLGGVKYDMRKDENGVWTGESNPQDEGFHYYQLNIDGASVPDPGSLYFYGAGRSG
SGIEIPARDQEFFALKNVPHGLVSENIYFSKLTNSFRRCFIYTPPGYNENTKTRYPVLYL
QHGSFEDESGWSAQGRANLILDNLIASKQATPMIIVMDNGYAYKPQTNESKDKKERPESI
FEDVLITEVIPMIDTKFRTLANREHRAIAGLSMGANQTMRIMMNHLDTFSYYGGFSGTAN
YPSIDPIDASTFLEGKYKDGNAVNKKVNLFWLGLGTKEPSPFPKSIGVFKTMLDQQGIKY
VYYESPETAHEWLTWRRCLNQFASKLFK
>EGALAKHO_04114 Endoglucanase D
MKKSIGFVLVIIALILNIKMEAQNLKLHPKGYFSARGIEVTVFDDIYPDGHQTGVTMIQH
GERVMANGDLRLEISPGQWSPVPKEVEKKIDPATQTISQSLSYPDETKNHVGFNPIDYPD
LKLKYKVNVTPTEGNNFRITVDLENEVDAKWLGKIGFNIELFPGDLFGKSYICDGNFGIF
THSPYGPVASQIDGQNLGTPLCKGKKITIAPESDLSRVTIQSNLEDIALWDGRINHNNGW
FIVRAPISKNSGKRVVDIVVSPNIIPNWTYKSVIQVSQVGYYPTQSKVAILETDPNDTET
SEVILIKHDELGKKNIKTITPKKWGNFLRYNYYQLDFSEVKEEGMYTLSYRGNETSPFQI
SKKLYDRNVWQPILEYFLPVQMCHVRVNEKYRIWHNFCHLDDAQMAPINLNHFDGYVQGP
STLTKYKSNEVVPNLNQGGWHDAGDDDLRVESQIGTVWNLALMLEEFNIESYDATSIDTD
KKIVEIHQPDGKSDALQQMEHGLASVLGAYRSMGRLYRGIITNDLKQYVLLGDFGGVTDN
KWSTNPSAKDDDRWVFTEDNPERELYVAAGLAASYRVLKNSNPKLATECLETAKALYKTS
YSKSKKADSKIMILVELALATNEAIYTNEIVSMQEDVLKNFEKSGWKVGRVKHLIKDKSF
LDKLNTEAKKWSVKTKNNSLTDSPYGVPYTPNIWGAGWTLQEFGVQQYYFSKAWPEFANY
EVYSNALNFILGVHPGNNTASFASGIGSNSLLVAYGMNRADWSYIPGGVTSGTALIRPNL
PELKKWPFFWQQTEYVMGGGSTDFMFLVLAVQKHFGN
>EGALAKHO_04115 hypothetical protein
MAEIKIEKKKPIWPWIAVLLIIAGLIYYVYFTDHEVHNENSIEVENTTSTQ
>EGALAKHO_04116 hypothetical protein
MENKDKNLYRLDELSNYKIASNYPDVRGWKIVDAENHTIGKIDNLWVNKDMQRVVYLDVK
LDKGLLEDNRNEVRDVIANDNGREFIYREGDSHIIIPIGSVNINKDTKIVMANSIGYDTF
RSTSRYNRENNFDRDYERRVMKSYYSENDSNINYDSEDDSFYKRREFDNH
>EGALAKHO_04117 hypothetical protein
MKRIFITGFALLALFQSRAQNVPTDSTSYKSKKLKLEEVNLVSSYYSQDGNNSAVTGGIG
SEHLTDIANTIDVKLVKYGETGIKHTFDIEAGIDHYTSASSDMIDLSANSSASSSDNRFY
PSLTYFRENEEKGRTLGIGVSSSTEFDYQSFGGNISFSQKTKDKNGEFTAKFQTFIDQLK
LIEPVELRPPGQEGYDSANRNTFAGTLSYSQVINKDLQIMLVGDVISQNGYLSLPFHRVY
FADGSVHQEKMPDTRLKIPLGIRASYFVGDNIIIRAYYRYYTDDWSLKAHTADLEIPVKL
TQAFSLSPFYRYYTQTGTKYFKPYGEHTAADQYYTSNYDLSKFDSSFFGMGMKFTPLNGV
FGLKHCNTLELRYGHYTRTTNMASDIISINIKYK
>EGALAKHO_04118 hypothetical protein
MKKPKQKALVLFCSIAFTGILLTSCTSIKEYQKGKINDSEMVLSNRKIEKTELSFQSYRE
GASGANSGKSGGGCGCN
>EGALAKHO_04119 FAD:protein FMN transferase
MGNNFTITVVAENEKTGSENINLAIEEIRRIEKLLTTYKEDSQTNLMNENAGIKPVKVHL
EVFNLIERATGISRITQGAFDISYGSLDKSLWNFDKTMTSLPDAITAKKMIHLIDYRNII
LDKQNCTVFLKEKGMRIGFGGIGKGYAAEMAKQVLLKNNVHSGIINASGDLCAWGLQPNG
QKWTIGVANPDAPNAAFSYMEISNKAVATSGNYEKFVTIKGKKYSHTIDPKTGLPITGIK
SVTIIASNAEFADAMATPIAVMGIKAGLFLIDQIPDLYCIIIDDNNKIYTSKNINLK
>EGALAKHO_04120 Disulfide bond reductase DsbH
MKLITLFLLLTVIPINWEPDFNNAKKIAKEKHELILLNFSGSDWCGPCIVLRRDYLESQV
FTDMANSNLVLVNADFPRKKKNIGTPDQVKRNEDLAEIYNKEGSFPLTLLLDGDGKVIKT
WHGKPETTPEQWTAEIKAICDSRK
>EGALAKHO_04121 hypothetical protein
MEIEKHYINRSGWLRAAVLGANDGILSTTSLVIGVAAASISREPILLAAVAGLVAGALSM
AAGEYVSVSSQSDVESADLKREKYALDNMPEEELKELTDIYIQRGLNKELAREVAIQLTS
HDALETHARDELGINEITQANPLTAAFASATSFIIGGLLPLLVAIFAPIKEMLFFQYGFS
ILFLAFSGILAAKAGGSNTIKAVLRICIWGTFAMGTSALVGYIFGIQTA
>EGALAKHO_04122 hypothetical protein
MFKYKNIRRKIQFKNNQSYKNIIYLMIIKVDHLTALNLEPF
>EGALAKHO_04123 hypothetical protein
MNILTTTEFLTRLAIALFAGLIIGFERQWHHKETGLKTNMLVATGAAAFVLLSIKISETA
PNVDVTRITAQVVMGVGFLGAGVIFREGPNVHGLNSAATIWCSAAIGCIAASGYFIEAFM
CTFLVTFVNTVLEPIDRWLRNRK
>EGALAKHO_04124 tRNA modification GTPase MnmE
MINQDSIVALATPSGAGAIAIIRISGSEAITIGNSVFKSIKNKDLTKQKTHTLHLGHIID
DSKTLDEVLVSVFKGPNSYTGEDTIEISCHGSTYIQQQIIQLLLRKGCRMADAGEFTLRA
FLNGKLDLSQAEAVADLISSDNEASHQIAMQQMRGGFSNEIAKLREELLNFASLIELELD
FAEEDVEFADRTQFHELLNRIEFVLKRLIDSFAVGNVIKNGIPVAIVGEPNVGKSTLLNA
LLNEERAIVSDIAGTTRDTIEDELVIGGIGFRFIDTAGIRETKDVVESIGIKKTFEKIEQ
AQVVIFLFDGFRFQVSGSDYIVEIEKVKNKYPLKPILVVINKVDLLNANEIENINQKLET
LNLKLLKISAKENIGVDELKNQLLSFVNTGALRNNETIVTNTRHYDSLLKALDEIQKVKF
GLETNLSSDLIALDIREALYQFGLITGQVSNDELLGNIFANFCIGK
>EGALAKHO_04125 hypothetical protein
MKKILFPTDFSEAATNAFVHALEFAKIVNAELVLLHTFEIPVYDSQFFPENYASIYSSIE
LAKFEMFKDEIPKLRTIAIERNLEDIVIKHRLMDGDLVYNLKNAVEEDNIDFVIMGTSGV
SDWTKFFTGSNTNSVISEVKVPVLCIPVTAKFQKIKVIGFTTRYREKDKAELRKVIEIAR
KTNAKVKCLYVKTSNSDVSATTIKDWENEFRGDNVEFLVLPSDEVKETILDFILYKDVDI
LTTITHKRSFFESIFESSFTKKIAKEVSVPVLVMHET
>EGALAKHO_04126 DNA mismatch repair protein MutS
MNSYQNKVTHYSELLSKINKRYNSISLLRILSVFLCLFLLFYYIKTDETLYSVLAFLSFV
GFIFLMRIHSKLSFQKQLTTAILKINQNEISYLKREKIPFENGIELNDFHHPYAYDLDVF
GDYSLFQNLNRTATYIGKKTLANKLLIQLPNEVILENQEAIKELITKMDWRHDFLALATI
SNDSKASYDSILYWNSFKNNTLPKVLIVLSFALPALFFGVLTAYFITSKTILLSYLSYVF
IANLMVVGRSLKRIQSEIAKADNVDKIIKQYSLLVQKIESETFQSKKLKDLQQQLIYKNA
TASVHLKQLSELFSRMDTISNLVAATLFNGTFLFNLHVLKALLKWKENYSEEFEKWIAII
GEFEALNSLANLAYNNQDFVFPEINSEYKIGFKNLSHPLLNPATRVGNDTHFYPETFMIL
TGSNMSGKSTFLRSLGVNMVLGGIGSVVCASEANIHPLPVLVSMRLSDSLADSESYFFAE
IKRLKQIMDALEEKPAFVLLDEILRGTNSDDKRNGTIEVVKKIIAKNAIGAIATHDIEVC
LTTNEYPDILTNQCFEVEIKNNELHFDYKLRSGICKNKSATFLMQKMGVI
>EGALAKHO_04127 hypothetical protein
MKIEIWSDIMCPFCYIGKRQLETALKEFPGNDFEIEWKSFQLDPTIEPQSGKDVYTFLAE
RKGISVLQSIEMHKGVVERAKSVGLDYHFDKAIISNSLTAHRIIHLAKSKKLGDEMEEIF
FKAYFTDGKDLNDAQTLIELGIQAGLDSNEVKEVVQNENLYLSEVKGDIKEAQEIGVQGV
PFFVFNRKYAVSGAQPVEAFVNTIKEVQK
>EGALAKHO_04128 DNA polymerase III subunit beta
MKFIVSSSYLLKQLQVLGSVINSNNTLPILDNFLFELDNDALTVSASDLETTMSATLSID
SKSKGSVAVPAKLLLEILKTFPEQPLTFTVEDNNTVEISSNSGKYALAYAAGEEFPKSVN
LEDPSVTLVPADVLATAVSKTIFAAGNDDLRPVMSGVFFQFSPEGLTFVATDAHKLVKYA
RTDVKASQVADFIMPKKPLNILKSILGSSDAEVKIEYNDSNATFSFDNYILMCRLIDGKY
PNYEAVIPKENPNKLMIDRSLFLSSVKRVAIFSNKTTHQIRLKIAGAELNVSAEDIDYSN
KAEERLTCDYQGDDLQIGFNSRFLTEMLTNLQSDMIMLEMSLPNRAGILTPVDGLEEGET
VTMLVMPVMLNS
>EGALAKHO_04129 hypothetical protein
MKASTQQNIKILGITVFVLIVLNVLGTLFFHRFDLTKDKRYTLSETSLQIVKQVKNPLSI
KIYMQGDLPADFKRLQQETKQLLEEFQAYNNNIVFEFVNPMENEDESMEMVKSLYQKGLT
PINITVDDKGKQSQAMVFPWAIAVYDNKEVNIPLLKNIMGASTEQKVIGSIQHLEYSISD
AINKITKAKQKKVAFIKGNGEMNEVHVAKMLRQIKESYYIGPFTLDSVSKNPTGTLDALK
KYDLAIISKPTETFSDEEKQVLDQFIMNGGKTLWLIDQVSADMDSLYNQSGATLAYPRDL
NLNDMFFKYGFRINPDLIKDEYGSPIKLATGEQGSATQYQEFKWKYAPIVIPSSKHPIVK
NLGQIKFDFASPIDTLKNGIKKTVLLQSSQYSKKIGTPTEINLNIVTEQTTPQEYLNKGN
SPLAVLLEGDFHSAFENRVLPFKENAFQAKGKPNKMIVIADGDLARNQLDKNMMPVELGY
DQRTGNLYDNKDFMMNCINYLLDDTGLINIRSKDVELPLLDKEKVYENYTMTQFITIGLP
ILILLVFGLVFTYMRKRKYSK
>EGALAKHO_04130 hypothetical protein
MKSIILREIKSFFGSPIGYLVIAIFLISNGLFLWVFEGDYNILNTGYADLTPFFTLAPWI
LIFLIPAVTMRSFSDEKKQGTLELLLTKPLSIWEIVNGKFLGSLLLIILAIIPTFIYVKV
ISNLGLPEGNIDMGSTIGSYFGLLFLIASYSAIGIFTSTLSENQIVAFIIAVFLCFFFYF
GFQGLASLIPGESNIVSAFGMQDHFKSMSRGVIDTRDVIYFLSITVLFLSFTVYQLKSFK
A
>EGALAKHO_04131 hypothetical protein
MFVRIVKMSFHEEKIPDFLENFETVKDKIRNAEGNRFLELYQDKNDKCIFFTYSYWETEE
DLENYRQSELFNSVWDFTKKLFNAKPEAWSVDKVVSLV
>EGALAKHO_04132 5'-fluoro-5'-deoxy-adenosine synthase
MSIITLTTDYGLKDHFVGSLKGKILSEYSEVQIIDISHDIDPFNTAEASYVIGASYLSFP
KGTVHLIGVDIERNKENQHIAMQWNDHYFICADNGILSMLTQKIVPQKIVEINIHDRFPM
EFSDLDIFIQVACHIAKGGLLNVIGKEVPGIKQITELQAVVANDGNSLKGYVIYIDHFGN
IVTNISKQQFIEVAKGRPYEIVMKPKSIKTILPNYSAIATSDKYPIKTYEGEKLAIFNEA
GFLEIAIFRSNPSKVGSANSLLGLNYRDVITIQFL
>EGALAKHO_04133 PhoH-like protein
MNERIIELIDIAPKDFWGAQDSHLEIIKKYYPKLKIVARGTTLKAFGEKEVLDEFEKRFQ
RLMLHFTRYNNIDDNVIERVIMSDGQDEKKSYDHDKILVHGVGGKIIKAMTPNQQLLVDT
IKKNDMVFAVGPAGTGKTYTGVAMAVKALKDKEVKRIILTRPAVEAGENLGFLPGDMKEK
LDPYMQPLYDALRDMLPNEKLEDYILKGIIQIAPLAFMRGRTLDNAFVILDEAQNTTHSQ
MKMFLTRMGKNAKFMITGDPGQVDLPRRTISGLKEAILVLKDVDGIGIIYLDDKDIVRHR
LVKKVIDAYKQIENHD
>EGALAKHO_04134 hypothetical protein
MRNINDFEVTDRQTFVKFIELLREDFLQNSESWENKTLPDFLESLSSYAEDIQGYYNNTN
QNINADKPDWKTFSDIFKGARIYE
>EGALAKHO_04135 hypothetical protein
MKQLDDFYLKQEEPVKGVFLSLKEIILKQDSEITHVLKYGMPFFCYKGKMFCYLWIHKKH
KQPYIGIVEGKHFEEPFLLQETRSRMKIMLLNPGEDLPLEQIQKVFQKATNLYKSGIIKV
>EGALAKHO_04136 Pyridoxal phosphate phosphatase YigL
MTKLKNIKVVVSDLDGTLLNPQHKISDYTKSIFEELHNQNYLIVVATGRHHLDAMAIIET
LEVPVYLVSSNGARIHSPNKEELFSFNLDSEVVKNALNVEIDPEITVVLFKENVWQTNRI
NEKLNAFQSELKYKPELVDYKTLEDFGAIKIFFSCDDHEKLVKLKDDILANSSEHLHHAF
SLPTCLEFMDKAVDKAVAIERVLEKEGFTLEEAVSFGDGFNDVQMLSVSGKGLIMGNAPS
LLKETLPNLEVIKTNAEDGVAKYIASKILSKEFVNS
>EGALAKHO_04137 hypothetical protein
MDKFLLQVQKNCISGIILLLPLVVFFMILEKVWGFFQKYGDKFSQFLRLDKVFGPIASDV
MGGVFLLVLIYFSGYLMQFSFLKKFTEWIDNKLMVFLPGYEKNKKLAEEKLAKEMGKPIT
DLPILLKSGEYWQPAHLIEENADGNAVVFVPAAPSKDHGQIYIVSASDIKRLPETTLGSL
NESIKSMGKGILDFK
>EGALAKHO_04138 Prolyl tripeptidyl peptidase
MTKNIFILAFLFLSITGKSQNLKLEEIMKGESFIGNQPTNGRWSLDGKKVYFEWNPKNEL
GTSTYFWQKGMTKPEIVSPKEEAFSQMDFKTKHGSDVAYYLDKGSLYSYSIQAKTSKKLI
QQSTAISNLQLGAQTGILFFEQNDNIFKYNTKEGTILQITNFNKGIKKETKLEKETFLNT
QQKELFQFIKDKEAKKQWNLAKSKAVKSDFAKEYFYGKDQFFNLKPNPNGNFATFLLVEE
PEIKKETMEVFITADGYNQTPETKEKVSTANFVKTKFGIYSVAKDSVYYLNFSSLSHIQD
TPKYFELYDNLKSKPKEDKLIVAQAPVYNEDGSLAIVEIRSQDNKDRWLINLNLDKGTFE
EVEYQHDEAWIGGPGIPGYSFESGILGFLADQETIYFQSEATGYSHLYTYNVKSKKKTQL
TKGNWEVRDVTLSKDKKAFYLTTNTTHPGNRNFYKLAVSDGVLQPILTKDGAHEVVLSPD
EKSLLVRYSYKNIPWDFYLADNKKNTTIQQISSSMTEAFKQYQWRAPEVITFKAQDGTPV
NARIYTPKAEVANKAAVIFVHGAGYLQNAHNFWSNYYREYMFHNLLTDLGYTVLDIDYRG
SDGYGRDFRTGIYRFMGGKDLSDHLDGKKLLVEKYGIDANRVGIYGGSYGGFITLMGMLT
TPGEFASGAALRSVTDWAHYNHGYTGNILNFPETDPEAYKKSSPIYFADNLKGNLVMLHG
MVDDNVEYKDIVRLSQRFIELEKKNWTLASFPVESHGFKETYSWIDEYGRILNLFNATLL
KK
>EGALAKHO_04139 Phosphoribosylaminoimidazole-succinocarboxamide synthase
MSNTITTTNFNFPNQKSVYRGKVREVYNINDELLVMVATDRLSAFDVVLPKGIPYKGQIL
NQIATRFMELTEDIVPNWLIATPDPNVAVGHLCEPFKVEMVIRGYVSGHAAREYAAGKRE
ICGVTMAEGLKENDKFPEPIITPTTKADNGSHDEDISREDILAKGIVTEEDYIVLEKYTR
DLFQRGTEIAASRGLILVDTKYEFGKTKDGVIVLIDEIHTPDSSRYFYADGYQERQEKGE
EQKQLSKEFVRRWLIENGFQGQEGQQIPNMTDEYIESVSERYIELYENILGEKFVKADIA
NIDQRINKNVLSYLGGI
>EGALAKHO_04140 hypothetical protein
MGCKIMLILFVFFGIIVIVFIFFTVKTTIGLLEDQSNDKKAAQAEKVRFEKLPVIKAIVL
DGDSIITPFSKNKVNVCFMNFGLTNSYRKNLRWRNSTARNYVTTYSNFSTIYSRPQLNLL
INGKKYVLKSKKIILTDVVFDTLEKKKSGMWMEEFSTNPKYDELLFLNNYDFYKKYSKTT
KEEEDAYLGRVKIFCSFRDLSDYINCYYLTRLVKKDIPEKCNYAIEYSYHLREYVYNVGD
TISFKGKIVNNEIIPLQ
>EGALAKHO_04141 hypothetical protein
MLIIKRILIILILIVSIVLITAYFMPKEYAVEREITINKPVDSVFSYVRYLKNQNEFSVW
ANIDPKMKSTYKGTDGSVGAISAWESDVKDVGVGEQEITKISEGKRIDFALRFKEPMNDT
AVGFMSTEAISGNRTKVKWGINGVFPYPMNVMMPMMNMDKMIGKDLQKGLENLKVKMEE
>EGALAKHO_04142 hypothetical protein
MKKSVIILGVALVAFANVSMAANHTMVLKSQIEISNLYSTPLNVAVIKGDIDIVKKFIEY
GADVNEKSEDMSPLMVAARYNKIEILKVLLASGARPNDKNEQGYTALKYAQLSNATEAIA
ILKDLK
>EGALAKHO_04143 Inner membrane protein YjdF
MKYIYFLITLFSISLLASVINAKEAFTCFLEVIPAVIGFLILAITFKKFRFTNFTYTLIL
IHCIILFIGGHYTYAEVPFFDYIKEIFHQSRNNYDKVGHFAQGFVPAMIIRELFIRKEVI
KNKSFFNFIIVSICLAISATYEFIEWFVSLATGEGGDSFLGTQGYIWDTQSDMLYATIGA
ITALILFSKIQDKQIQRIDF
>EGALAKHO_04144 Cobalt-zinc-cadmium resistance protein CzcA
MNKFIRNIIAFSLKNKAFTFFWVGLLAVAGFISFKNMPIDAFPDVTNTQIIIITQWNGKS
AEEVERFVTSPIEISMNSVQKKTSVRSITMFGLSVIKIIFDDGVDDTFARQQVNNLLKNV
SLPDDVEPDVQPPYGPTGEIFRYIVKSNSRDSRELLTYQNWVIDKQLRSVPGVADLNVFG
GQTKTYEVGVDPIKLAKYNITPLQVYNAVNAGNLNVGGDIIEKNGQAFVVRGVGLLKSIP
DIENIIVDDAGGNPILVKNVASVYESSMPRVGQTGIGKNDDAVEGIVVMRKGENAQETLA
LIKDKIKDLNDNVLPKDIKIETFYDRDNLMNFTTETVMHNLFEGIILVTCVVFLFMADWR
TTFTVSIVIPLSLLFAFLCLKMMGMSANLLSLGAVDFGIIIDGAVVMVEGLFVVLDHRAH
QLGMTAYNKIAKGSLIKKTGTEMGKAIFFSKLIIITALLPIFSFQKVEGKMFSPLAYTLG
FALMGALLFTLTLVPVLSHILLNKNVKEKHNPFVNFWDRIVGKGFAWTFKHKIQTLIASV
AIVASIFFSATFLGTEFLPQLNEGALWVTAELPMSTSLPESVQTASMIRKDLESFPEVKN
VLSQTGRSNDGTDPNGFGFIQLQVDLKPKSEWTRKISMDELINEMDNKLKVHQGITYNYS
QPVIDNVAESVAGFKASNAVKIYGDDLDKLDELSNEVLAKIKDIPGIKDAGILRNVGQPE
ISVILDREKMAAYGVTLSDAQAVLELAFGGKTATQKYEDEKKFDVRVRFSKEYRKDEEDL
AELKVPTISGVKIPLKEICDIKTVTGPAFIYRDNTKRFIGVKFSVRDRDLGSTIAEAQKK
VAELKMPTGYTTGWTGEFENQVRASARLAQVVPISLIGIFVLLFILFGNIKDSLLVLANV
PFAIIGGIMALHITGMNFGISAGVGFIALLGICIQNGVILISEFHHNLKAKFTLEESIFM
GVKARTRAVVMTALMASIGLMPAAISTGIGSESQKPLAIVIIGGLITATILTLLVFPIIF
WVFNRKKNVPIE
>EGALAKHO_04145 Cobalt-zinc-cadmium resistance protein CzcB
MKHKIIIGIAIVSLSLTSCKKEVENPQTNTSFALSDSMLKSTTTAEAQTKPVTNELNFYG
KITADNNKMIDVYPLVGGNVIKVNVELGDYVRKGQVLATIRSTDIADFEKQSLDAKSDLL
VAKNNLKVAQELFDGKLNSESDVLQAKSEVAKAQSQVGKIQETYKIYNIKAGSIYEVTAP
ISGFIIQKSINQDMLLRNDRSENIFDIAEISEVWAMANINEMDINKVKLGIDADVTTLSY
PDKVFKGKVDKIFNVIDPETKAMQARIKLQNPGYLLKPDMNANIKLSFKEDDKSMIAIPS
NAIVFDKSKNFVMVFKDRHNIETRQVEVYRVVGNTTYISSGLKDNEKVITNNQLFIYRAL
NE
>EGALAKHO_04146 Cobalt-zinc-cadmium resistance protein CzcC
MKKLCALFLLVFLNQVVMAQKTVNLQDCESQFLKKNLFLLASQYNIDASKALTIQARIWD
NPTLSAELNAYNPERNQYFDIGKEGQKAFGIEQLIYLGGKKRNEVKLAQTNEQLAELQFN
DLLRTLKLQLRKSFYTVYYNTKSLETTDKQLAHIEVLINSYSIQAQKGNVPLKDVVRLQS
LYLNFKNERMEVVNDNIEEQANLKLLLNETDTVVPNVSDSEFNKYLKTIPFDLKSFESDA
IANRPDYLAKQKEIDANEINVKWQKSLSVPDVTLGANYDQRSGAFNKEANLTLGIPLPLW
NKNKGNIKYAQTILEQSKVDKQNFDLQLQTEITSAWNKWDESRKNYTVINPTVNADFDAV
YNGMLNNFQKRNVSLLEFTDFMESYNQASIQVNELKKKVVLSGEELNSTINKDLF
>EGALAKHO_04147 Sensor kinase CusS
MTLKNRISLLVSLLFTILFGLASTVIFVLYSNFRKEEFRDRLEIKALSNIKLLVNVKEVD
DQLLKIIDQNSINKLYDEKTLVFDSHYKLIYSSIDDAKITWSIDDLKYLKKHKTFFKQQG
NYEVYGVFYDTKDRDFYALISATDDYGKRKLLFLRYTLIVSYIFFTCICWVLTSFMVKKA
MSPLSIFHQKIKNINENNLDTRIESESTKNEIDLIANEFNFMMDRIEISYQKQKEFTAHA
SHELRTPLSRITSQIENTITDSGTSEKGKSFLKTILSDVNQLTELINSLLILSKIDNKNH
ENYEVQRMDEILFSSIENLNKSFPDFVILFEMEENDNLDTALEIKGNKNLLEIAIGNVLK
NACVYSDNKQAKVKISCEKDHLIISVTNTGKTLNEKEQKNLFQPFMRGANSKGTSGFGLG
LRIVNRILTLHKGIITYSVPDRNTNLFQLIFHL
>EGALAKHO_04148 Transcriptional activator protein CopR
MKILLLEDDFTLSKEISAFFTSKEFECIPYYDGSLLLKKYLPQGYDLIILDINVPGTNGI
DVCKGIREVDKKTPIIMLTAFSEIEDKLASFDSGADDYLVKPFHFEELYARISSLLRRKD
IPQQSENKIIIEDLEILEDDMKVFRLGEEIKLTPKEFKLILILAHAKGKVLSKQFIAEKL
WDYHIETNQNTIEVYINFLRKKIDKDHETKLIRTKIGYGYYLSAQE
>EGALAKHO_04149 Putative aminopeptidase YsdC
MSTESILKDTSIAFLESYLNNASPTGYESEGQKLWMNYLKPYVDTFITDTYGTAVGIINP
DAPFKVVIEGHADEISWYVNYITDDGLLYVIRNGGSDHQIAPSKRVNIHTKKGIVKGVFG
WPAIHTRLRDKEEIPKLSNIFIDLGCETKEQVLEMGVHVGCVITYPDEFMILNENKFVCR
AIDNRMGGFMIAEVARLLHENKKTLPFGLYIVNSVQEEIGLRGAEMIAQTIKPNVAIVTD
VCHDTTTPMIDKKVEGDLKMGKGPVIAYAPAVQNKLRDLIVDTAEENKIPFQRHATSRAT
GTDTDAFAYSNGGVASALISLPLRYMHTTVEMVHREDVENVIQLIYESLLKIENNETFSY
FK
>EGALAKHO_04150 hypothetical protein
MRFTYILLFFILISFSSQAQVTPKENQQMGYVLTERDSILGDTIELPEIIITKEKLDPEA
QKQFLILQNRVYKVYPYAKLAADRLTALNQGMARLKTNREKKKYFKIVEDYLNNEFEERL
KKLSRRQGQILVKLIHRQTGITTYELIRTLKSGFKAFVSNTTANLFDISLKKEYKPYEVN
EDYLIETILQRAFESGRLVNQKAATPVNYNDLMNHWEAKAKEPKDQ
>EGALAKHO_04151 Threonine--tRNA ligase
MIKITLPDGSIREFASGVTPMEVAKSISEGFARNVISASFNGTTIETETPLTTDGSLILY
TWNDAEGKKAFWHSTSHVMAQALEELYPGIKLTLGPAIANGFYYDVDFEDQKIVEADFKK
IEDRVLEISREKHEFKMRPVSKADALEMYKDNVYKTELISNLEDGTITFCDHATFTDLCR
GGHIPNTGIIKAFKIMSVAGAYWRGDEKNKQLTRVYGTSFPKQKDLTEYLELLEEAKRRD
HRKLGKELELFAFSQKVGQGLPLWLPKGAALRDRLEQFLKKAQKKAGYEQVVTPHIGQKE
LYVTSGHYAKYGADSFQPINTPAEGEEFLLKPMNCPHHCEIYNVRPWSYKDLPKRYAEFG
TVYRYEQSGELHGLTRVRGFTQDDAHIFCTPEQLDEEFKKVIDLVLYVFGSLGFENFTAQ
ISLRDQENREKYIGSDENWEKAENAIINAAADKGLNTVVEYGEAAFYGPKLDFMVKDALG
RQWQLGTIQVDYNLPERFELTYKGADNELHRPVMIHRAPFGSMERFIAILLEHTAGNFPL
WLMPEQAIILSLSEKYEIYAKKVLDLLENHEIRALIDNRSETIGKKIRDAEMQKIPFMLI
VGEEEEKNGTISIRRHGQEGKGNITVSIDEFVAIVDEEIKKTLKVFTV
>EGALAKHO_04152 Translation initiation factor IF-3
MDYKKFVYEQKKRDKVLKAKSTQVVVKEIRFGPQTDEHDYEFKRKNAEKFLKEGAKLKAF
VFFKGRSIIYKDQGQILLLRLATDLEEHGKVEAMPVLEGKRMIMFIAPKKKK
>EGALAKHO_04153 50S ribosomal protein L35
MPKMKTKSSAKKRFKVTGSGKIKRKHAFKSHILTKKSKKRKLALTHSALVHSTDMKSIKQ
QLRII
>EGALAKHO_04154 50S ribosomal protein L20
MPRSVNSVAKRARRKKIMKQAKGFFGRRKNVWTVAKNAVEKAMCYAYRDRKQNKRNFRAL
WIQRINAGARLEGMSYSQFMGKVKANGIELNRKVLADLAMNHPEAFKAILNKVK
>EGALAKHO_04155 Transcriptional activator protein Anr
MNEALFRHIEKFIKLEPSEIDTLESCLQLSKVKKKEHILQEGQVCNTMYFVIKGCIRQYI
INSKGTEQTLQFAIENWWITDLLSYHNHTPSNFYIQAVENSEIIAIEKPTLEALLIQIPK
LERYFRIVSQKSFGAMQMRIKFLFTMSAEERYHHFNNNFPEFVQRVPQYMIASYLDFSAE
FMSKIRAGKV
>EGALAKHO_04156 Alkyl hydroperoxide reductase AhpD
MTPRIVIPTVAPQAYQAMMNLEKYISTTSLTPVHKELIKIRASQINGCAYCINMHTADAR
KYGVSEQRIYLLSAWREADVYSEEEKAILALTEQVTLINNHVSEDVYQNAARLFDEKYLA
EIIMMIITINAWNRIGVTTGMRAV
>EGALAKHO_04157 Sensor protein VraS
MVVRTKIFYFWLMITKGTQITLYITVLFLILFSCQKKKDITKTAPKNTKAQVEKLIVIAD
KLYDNKNFDSAFYYYNKVKSICNPITDSENFVSTLNRMADIQQNKSDYSGSESTATEAIP
YLKYIKNPKHAWNTYVILGINYLNIYDYKLALYYYNKALALKTTEWRKAAAKNNIARIYI
LQKKYKEAIKIFEALLEGDGVKKFPEDYARALDNLGYCYLKSNNTKALPYLNKALQIRTR
IKDDSALSSSYLNLAEFYVKKNIPLAKRYMLLSYEKSTLMNHVNDRMSSLKLLINNSKDT
ELKKFTLLYININDSITEVRQKAKNQFAKVKYDSKKEKEENLKLKTHKAENELQLERQKN
RNIVSYILIALSLSLIVFLYFYLTSRGNREKIEATYKSETRIAKKLHDELANDIYHTMAF
AENKNLSIIENKEQLLINLDAIYLRTRDISKENSPIITSEKYTFYLKEMISGFNTSNINL
LLNDLESIPWNEIEKNKKITVYRILQELLVNMKKHSNATLVGINFKKTDKSVIINYTDNG
KGINVNNIIFKNGLHNVESRILSIKGEIDIDSEPNKGFKVFIKFPL
>EGALAKHO_04158 Photosystem I assembly protein Ycf3
MKKQYLIFNKKKLKHLIIILSLLLSGGLFIYFYQNKPTAKSKPDLTEEIKRLTDIADVYF
DTNKQDSALYVYTKIKILCDPKVNTTDYIYALSCIAEIQQDQSDYIASEASATEALPYLK
EIKNPRYSWIVYNLLGINYTHTFDNKNAILYFKKAIKLKTSTWRKSLAINNLVVVYMEQH
KYREAAILLNILASLKEISSYDAPNNNDHAYIIDNLGFCYYKLGDSKKALECYYEGLNIR
LQYKNNDGLSNSLQHLSLFFQKSNPKLAKEYAKKAYNNASAINNIGEMISSLAILIKTSD
GSDLKKYSLKYIQLTDNLHIAQKKTKNQFSNIKYTFNKDKAENLQLKSIRTENKIQLERQ
KNRIIISYLIIAFVLVLILFLYFYLTSKGKKEKNDAIFSSEIRISKKLHDELANDVYQTI
AFAETKNLEKDENKEKLLNSLDTIYFRTRNISKENSNICTDKNYPQAVKEMILGHKAPEI
NILINGFDNIRWNEIDKNKKIILYRVLQELFVNMKKHSEATLASISFNIKSKNLHVTYID
NGVGIRNSTLILKNGLQNVESRIKTINGTIIFGNNSQRGFKISFTFPL
>EGALAKHO_04159 hypothetical protein
MFKKVLVAEDLDSISIAVIQVLEDLKIPTIHHVKYCDDGLLKIKKGLNDNEPYDLLISDL
SFKSDHRKTELDGGEELIEAVNKVQPSLKKIVFSIEDKSYRIKSLFADLGINAYVSKGRN
SINELRKAVESTFRGEEKILSSDLSFSFNDKALIEIESYDISILKLLAQGYILEHISNEF
KSSSITPNGTSSIEKRINKLKIYFKANNNVHLIAIAKDFGLV
>EGALAKHO_04160 hypothetical protein
MKTMLLCIFLSVSFAFVSEKTGWLEVDWKIIFIPALLVLQIIIISTALKNRYKKH
>EGALAKHO_04161 hypothetical protein
MKKNILIILICIIITLHWYNSTTERMIPKVTIKEKIKTTQQKKNILKKKLNLK
>EGALAKHO_04162 Deoxyribonuclease
MKNILSFVLLFFSITSFSQTKILSWNLENFGKSKSTDELNFIANTILNYDIIAIQEVVAG
YGGAQAIGELNRILNEKGIKWDYTISDPTTSSSYKTERYAFIWKTNKAKLKGNAWLEKKY
NLEIDREPYFASFEIDKKTITLVNFHAITKKKQPETEIKYFKYLPFEYPALNLIFMGDFN
CPQSHSVFNPLKKMGYNSILQNQKTSLKQKPANNTCLASEFDNIFYKKDLLDYKNSGIIP
FYKAFNTLQEARKISDHIPVWFEFSLK
>EGALAKHO_04163 hypothetical protein
MYKSLVYIFILLLSLTAKASFILVPMDETTQQNHLKAYGITYWCLSKDYKASWLLNYRGG
SFLLPDAEEIRKECQIRGVSFEILSDSEEASILNEISSPSQNMESVILEKAPKIAVYTPK
GKQPWDDAVTLVLTYAEIPFTPIYDEEVLSDQLLLYDWLHLHHEDFTGQYGKFYAAYKNT
PWYIDQKKDAEALAAKLGYSKVSQEKGAVAKKIRDFVIGGGFMFAMCSATDSFDIALAAD
GVDICEAMFDGDASDSNYQAKLNYGNSFAFKDFTLERRPEQYEFSDIDMTLKRKIPVEKD
YFSLMEFSAKWDPIPSMLCQNHTQLVKGFMGQTTSFDSALIKSNILIMGSCELNGEARYI
HGEKGKGMFTFFGGHDPEDFQHQVGDPPTVLDLHPNSPGYRLILNNVLFPAAKKKKLKT
>EGALAKHO_04164 Oxygen regulatory protein NreC
MSSAIKIALVDDEVLFRKGIAFLLQREDNIEIIFEASNGEELIANLSNNEIQPDIIVMDL
KMPVLNGVEATKIIRKSFPDIKIIALTSYDTKSFIANMIQVGAVAYLIKNTTPKDLIHTI
NEVASKGFYYNDNVLKTIQETIVSSKNSKGNLETSFLSPREIEILQLICQQKTTLEIADH
LFLSPRTVEGHRNNLLLKTESRNIAGLVVYAIQNEIAFLTI
>EGALAKHO_04165 Oxygen sensor histidine kinase NreB
MNTHSIPEKELVALILYISLFFIIVAVALIIFFYFSRKKIIQKELEKKDLVLQYQKEQLH
AIIFTQEEERKRIAQDLHDDISSKLNIVSLNTHLLSAPNLTEAETKEITENIINLTGKAL
ENSRKIAHNLLPPVFEKFGLNAGVEELCEEFESSKAVKVHYKNNIDFDENDIDRQLHVFR
ILQELMNNSLRHGKATEICISFKNIEGIATCNYEDNGIGFDSNNDKNQKGLGMKNIDSRI
SFLNGTININSQINKGVAVVFTF
>EGALAKHO_04166 hypothetical protein
MKKTILCIAIAAVFIMSSCQRELSKGEINLKAVSEREAWLSADLDDDFAAAQKEVKTYLF
SSEDFSKLTSTPNVHHLRFVLGYDSGIISIDAVGVDSKGHEVSRIESKVLYASSNEDKLA
ELDEVTVDLTKKRSAVLNKHLLSPQIAFSGIEAWQSKLNKVQNLNDVTSYDGLRVQHYAL
ETDVISAIIDKAGVENVGLFLGLNSEGKLTTILAGLDKNDNIKKASPASNVIDAVYDFSE
PSPPAKADDENQ
>EGALAKHO_04167 hypothetical protein
MKKTILCIALATVFIMSSCQRELSKGEINLKAVSEREAWLSADLNDDFAAAQKQVKTYLF
SSQEFSKLTSTPNVHHLRFVLGYDSGIISIDAVGVNSKGQEVSRLESKVLYASSNEDKLA
DLNEVSVDLTKKRSAILNKHLLSPQIAFSGIEAWQSTLDKVQNLNDVTSYDGLRVQHYAL
ETEVISAIIDKAGVENVGLFLGLNREGKLTTILAGLDKNDNIKKASTASNVIDAVYDFTQ
PSPPSTGDDH
>EGALAKHO_04168 hypothetical protein
MIDFLIYSGYLILLLNLILYLISFFRKGKANGFFMVYLVFLFVMQFSMEIMYHLKINNLF
AVNIFFIGQMILLGLFYNSLFSIKSQKIFVKSSLLISLIILVFQFALDSSQFLKFNLFEI
TLTSLLSVVFAFIHIYNMLTESKKFYYVSFGVVFYLLASTVLFLIGNLSLGLSNDLKYLI
WTLNAFFVVVYQFFILYEWKVSFSKNTKLEI
>EGALAKHO_04169 hypothetical protein
MSEETFPGPIEIPLSTAQAWERRFEEDNTVEDPKNKVKAFLIPRESLEKVLELKTEAVWA
YIGINDQKEKTLLFVGAEKDPKTGKYLNVYGPPSSDQNKSGDAAEEVVYDGARPSPPL
>EGALAKHO_04170 Replicative DNA helicase
MENFKNINPVKVDKTTIINLEKGKLPPQVLDLEEAVLGAMMIDKKGVDDVIDILQPDAFY
KDAHKFIFEAIVQLFTETQPIDLLTVSAQLKKNGKLDLAGGDFYLIQLTQKIASSAHIEF
HSRIILQKFIQRSLIRISSEIIEASYDETTDVFDLLDQAESKLYEVTQGNIKRSSETAQS
LVLQAKKRIEEIAKQEGLSGVETGFTNLDKLTSGWQPSDLIIIAARPAMGKTAFVLSMAR
NMAIDFGHPVALFSLEMASVQLITRLISSETGLSSEKLRTGKLEPHEWEMLSTKVKNLEK
APLYIDDTPSLSIFDLRAKCRRLVSQHGIKIVIVDYLQLMTAGGNSKGGGNREQEISTIS
RNLKALAKELNVPVIALSQLSRAVETRGSSKRPLLSDLRESGAIEQDADIVSFLYRPEYY
KIDEWDDDEASPTAGQAEIMIAKHRNGGIENVRLKFLGHLGKFDNLDDFSGSYDDLPSKM
NHDDNPFITKNLPSANEAFGSNLNDDDDDSDVPF
>EGALAKHO_04171 Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha
MEYLDFELPIKELEEQLEKCVIIGKESDVDVTPTCKEINKKLEQTKKDIYKNLTAWQRVQ
LSRHPNRPYTLDYIRAICGDTFLELHGDRGFKDDKAMVGGLGKVNGQSFMIVGQQKGFNT
KTRQYRNFGMANPEGYRKALRLMKMAEKFGIPVLTLVDTPGAYPGLEAEERGQGEAIARN
IFEMVRLQVPIITIIVGEGASGGALGIGVGDKVYMLENTWYSVISPESCSSILWKSWEYK
ERAADALKLTSSDMKRQKLVDDVIPEPLGGAHYDRETTFKTVAEYITKGYNELKDLSTAD
LIAQRMDKYSNMGEYKE
>EGALAKHO_04172 hypothetical protein
MRNDNLKSYLNLHLIVFIWGFTAILGALITIDAENLVWFRMLLAGIFLAGFIVYKKQSFI
ISAKSFAKLIFVGLLIAMHWIFFFKAIHVSNVSITLSIFSLGAFFASLLEPLFYGRKILF
YEVFFGLIIIAGLALIMQVEVKYLNGMYYALASIILGVLFTLMNGKLISDHEPSVITFYE
FGAGVFFISIYFLVQGKFNADFFTMSLNNWILLLILASVCTAYAFTASVKVMQKLTPYTV
MLTTNLEPVYGIMLAYFILGGKEKMSTEFYIGALIIVITVILNGVFKHYKNKKEV
>EGALAKHO_04173 Lipopolysaccharide export system permease protein LptG
MLTIIDKYILKRYLATFSVMILLFIPIGIVIDVSEKVNKMLENKIPFTQIAFYYYNFTIY
FANSLFPIFLFLSVIWFTSKLANNTEIIAILSSGISFTRFLRPYIIGASIVSVFVLLMGF
YIVPAASEGFNNFRYTYLKGNGKELMHGENTNVYRQINDNDFIFVNSFQEESKTAFNFSL
EHFEKDKLKYKITASRIKWDPKKKTYILYDYTKRTIGELGDVIEKNPEKSIPFKFELEDL
TPVVYIAETLSLGKLYKFIEKERKRGSGNINTYLVVLYKKYSVPVSAFILTIIAVAVSSM
KRRGGMGTNLAIGIAIAFSFVFFDKIFGTLAEKSTFSPLLAVWFPNIVFGILAVYLLRNA
KR
>EGALAKHO_04174 Queuine tRNA-ribosyltransferase
MKFDLLQKDPQSKARAGSITTDHGVIETPIFMPVGTVASVKGVHQRELKDDINPDIILGN
TYHLYLRPQTEILEKAGGLHKFMNWDRNILTDSGGYQVYSLSNNRKIKEEGVKFKSHIDG
SYHFFTPENVMEIQRTIGADIIMAFDECTPYPCDYRYAQRSMHMTHRWLDRCINHLDKVP
YKYGYEQTFFPIVQGSTYKDLRRQSAEYIANSGQQGNAIGGLSVGEPAEEMYAMTEVVCE
ILPEDKPRYLMGVGTPINILENIALGIDMFDCVMPTRNARNGMLFTANGTINIKNKKWEA
DFSPIDEMGHTFVDTEYTKAYLRHLFAANEYLGKQIATIHNLGFYMWLVREARKHILAGD
FRPWKEMMVKNMDQRL
>EGALAKHO_04175 hypothetical protein
MINSEEKNPVDLDQIKEDQIERNLENLDYPATEDIYNQEDKLEDIDPEDISGERIVNQDN
HEWKQNSDKLGNDLDIPGSELDDEQEEIGSEDEENNFYSEGDTN
>EGALAKHO_04176 Transketolase 2
MKPNTQQLSDLTIQVRRDILRMVHAVNSGHPGGSLGCTEFLVTLYQNIMDRKEGFDMNGI
GEDIFFLSNGHISPVFYSVLARSGYFPISELATFRLLNSRLQGHPTTHEGLPGVRIASGS
LGQGLSVALGAAQAKKLNGDNHLIYTLHGDGELQEGQNWEAIMYASAKKVDNLIATIDVN
GKQIDGTTDEVLPMGSIRAKFEAFDWDVIEIAEGNSIDAILAGLTDAKSRTGKGKPVCIL
LHTEMGNGVDFMMHTHAWHGKAPNNDQLASALAQNYSADQIDY
>EGALAKHO_04177 1-deoxy-D-xylulose-5-phosphate synthase
MKKYTNTGSKDTRSGFGAGMTELGQKNENVVALCADLIGSLKFDDFKKNHPERFFQIGIA
EANMIGIAAGLTIGGKIPFTGTFANFSTGRVYDQIRQSVAYSDKNVKICASHAGLTLGED
GATHQILEDIGLMKMLPGMTVINTCDYNQTKAATLALADHHGPAYLRFGRPVVANFTPAD
EPFVIGKAILLNEGTDVTIVATGHLVWEALIAAEALEAKGISAEVINIHTIKPLDEEAIL
KSLAKTKCVVTAEEHNILGGLGESISRVLALNTPAPQEFVAVNDSFGESGTPEQLMEKYK
LNNQAIVEAVERVIKRK
>EGALAKHO_04178 hypothetical protein
MNKFKYYFILLLAGISLVSCNKGDDDPEVEPLRDYQEQFNTDNANIEEYLTTNYITVTQS
PGNSEDQDVVIDSITNPATQPSIMSYLNSTTFPKLLTKNVDLNGITYKMYYLVLREGVGT
SVANTDGVLAAYKGEYLTRIAKTDKAPTYLETTFFEEVKFPQTSVDLYGAIVGWSETFPE
LKIGTSTPQPDGTIKYENFGSAVLFIPSGLGYYTGNGSIPAYCPLIFNVKFYNYKRLDHD
FDGVLDYQEDINGDHYARDFQNTTLYPNAPSNPDDTDKDGIPDFLDTDDDGDGYTTYNEI
TKPSGATYSGLSLYYPYDPIPDNPNTPNDDESEIWGIPRRPTGALADPNKPESITNSRAF
VPADYTDNPRLRIHLDKTYPYQKN
>EGALAKHO_04179 Heat shock protein 15
MRIDKYLWCVRYYKTRNMVTEACKKNHITVNGQVAKPSKEVFPTDKITFRKDQITQIITV
LDIPESRVGAKLVDIYRKNETPAEAYAHLELLKLSKEHYRKSGTGRPTKKDRRDIDEYGN
EIFDEDEKE
>EGALAKHO_04180 Bifunctional protein pyrR
MSKNIILTNQEIEHKIKRIAYQIYETFVDEEEVVIAGIASNGSIFAQKIALALSNISTLK
VSICEVKVDKQNPQLPIQTSLTKEEYQNKGLVLVDDVLNSGTTLIYAVRHFLDVPLKKFK
TAVLVDRNHKKYPVKADFKGISLSTSLLEHVQVVFNDQEGDYAFLS
>EGALAKHO_04181 Shikimate kinase
MKKIILLGYMGCGKSTIAQNLSKIINIPFLDLDKCIEKRANLSINEIFEQHGEIYFRKLE
HEMFLELLQSSENNIIGLGGGTPCYANNHLLLQRDDVTSIYLKASIETLYNRLVYNKSKR
PLIANMDEEEMKEFIAKHLFDRSFYYNHAQHKVVVDNKTVEETVQDIEVLLA
>EGALAKHO_04185 hypothetical protein
MKIHKALLISFILLLSNWSYSQIISGTIIDSISKKPIELATISLSTSKYTVLSSKTGYFE
IDYRKDKDNLQVSNIGYNTKNIILSDKEDHYLVYLSPKTEELKEIIIVSNNKPKNYSSDK
FLKSKRDHEEDFGFQFDTENCVFIPNPYQKKGKIKSIDLELKKVKGYNENNKNKIDYLAA
FNIRFYSYDSHKNKPGREIHNKNIIIEPENKTYTLKIDLDSLQIPFPENGVCIGVEIINT
KYKNPKMTFAYIGPFLNFYENRQFSPATSWTRYRNYKNDFITSIDQDYKGKKYKTIIVDL
TVKLEE
>EGALAKHO_04186 Transcriptional repressor SdpR
MNLRRDVFQAIADPTRRAILLLVTSHSMTAGAIASNFDTARPTVSKHLKILTECELLQQT
QNGREVHYTINAERMREVAEFIEPFRQMWDDRFNKLEDIMKNYKPEN
>EGALAKHO_04187 hypothetical protein
MELKTKINAEDGKQELVITRDFDLPVSLLFKAYIEPGIVEQWMGTKVLKLENKKHGGYQF
ETSDAKGNVVVQMNGAIHEYIPNQKITRTFEMENSPFAVQLEFLEFEALTENTSKLTMQI
VYKSNALRDQMLQLPFKQGINMAHNRLQEIVSKLK
>EGALAKHO_04188 hypothetical protein
MTKRNKIIYWVTTLWLALGMTSTGIVQILQIKEEADMMAHLGYPLYFLVILGVWKLLGVI
AILIPKFPLLKEWAYAGFFFAMSGAIVSHFAKGDEAIAYFGPTLLLVLTVLSWYFRPSDR
KTISV
>EGALAKHO_04189 hypothetical protein
MNPKVDFYFNKAGKWQKELEQLRTIALDCQLTEELKWGTPCYMHQKSNIVLIHDFKEYCA
FLFFKGALLKDTEGILIQQSENVQAARQIRFTNLKEITAQKSILKTYIYEAIEIEKAGLK
VELKKTSEFPVSEEFQKKLDEDSKLKKAFEALTPGRQRAYLLNFSQPKQAKTRESRVEKA
IPDILQGKGLND
>EGALAKHO_04190 hypothetical protein
MSKNILSPEHQEEIISILKTRFEKNKTRHVDIEWNKVQEKLEANPAKLWSLLEMEKTDGE
PDVVGYDKTTNEYIFFDCVVESPKGRRSLCYDRKALDSRKEHKPKNCAIDMAEEIGIEIL
TEEQYRALQELGNFDTKTSSWIATTPEVRKLGGALFSDFRYGRTFVYHNGAESYYAARGF
RGCLKV
>EGALAKHO_04191 hypothetical protein
MKKLLLLSFVMISCSTWAQSATAYFDKAMKKAEAGNTKGAIADYTKAINMDPKFVEAYQN
RGVAKYNLNDLKGALADFNKTLELNDMNTDAYTGRANVNYKLMNFKETIADCTSSLELNP
KDYVAYNLRGLAYNKIGDKKNCCKDFSKAIELGSQSAKKNKATFCK
>EGALAKHO_04192 Inward rectifier potassium channel Kirbac3.1
MALLKKANNQIQTDKNSGFGTNANSYGGRFVNKNGTPNIEKKGMNILRRISWYHTMIDMP
NWKFMLILFSFYIAINFVFALLYYAIGIEHLDGIAPTQSALIQFGQAYFFSAQTFTTVGY
GHISPNGFLTSALSAAEALIGLLSFAIATGLFFGRFSKPTAFLKFSHNALISPYGEGKGL
MIRLVPFKNTNFTDAKAKVTLGMSVEENGERTNKFYALDLELDKINALSLSWTLVHPITE
NSPLYNFTEDDFKRIHGEILVFITTFDDMYSNTVAARTSYTFNEIIYGAKFVTMYNRSKD
NSKTILYLDKLNQYDTTNF
>EGALAKHO_04193 HTH-type transcriptional repressor CarH
MINNIKTVFSIKDLENLSGIKAHTIRIWEKRYNILEPMRTDTNIRLYNVHNLQKLLNITL
LHEYGYKISKIATYPEEKIPQLVREIISKKNSQNYAITSFKMAMMNFDQELFFTTFDWLI
SEKTFSEVFKDHFLPLLKELGLLWQSETISPANEHFISHLIKQKILIYTESLQILKPAKT
DRVFVLSLPLNEVHQIGLLYIQYEILLKGYKTIYLGESMPIENLQDLTRYFENITFVSFM
TVQPDRSVINQYVKSMGQKLLEKNNEIWLMGSMIEHIDNTVLPDRIKLFYSMDETLERI
>EGALAKHO_04194 Dehydrosqualene desaturase
MTKTIAIIGSGFSSLAASCYLSQQGNKVTIYEKNESIGGRARQFKKEGFTFDMGPSWYWM
PDVFEKFFSDFNKKPNDYYELIKLNPAYRVYFGINDFINIYDNLEAIKTTFESIEKGSGS
KLEAFINQAKSNYDIAIKDLVYRPGVSPLELITPQTALKLNQFFGNVSNDIRKKFKNERL
IQILEFPVLFLGAKPTKTPSFYNFMNYADFGLGTWHPKTGMFDVVRGIEKLAIELGVTIE
TNASIEKIIVENKTATGIIINGKTIKADIILSGADYQHTESLLDEVHRSYSEKYWGSRVF
APSSLLFFVGFNKKVENITHHALFFDVDFNQHAADIYDKPKWPEAPLFYANFPSKTDASA
APNGMESGFFLIPLAPGIKDTEELREEYFEKIITRFEELTQQKIKNNIIFKRSFCKNDFV
TDYNAYKGNAYGMANTLLQTAFLRPKLKSKKVRNLYFTGQLTVPGPGVPPALISGKLVAE
LIHQSLRS
>EGALAKHO_04195 15-cis-phytoene synthase
MKSLFDTVSIKCSKLVTQNYSTSFSLAVKMLSPSIRDGIYSIYGFVRFADEIVDSFHDYD
KENLINDFEKEHYKAMKMGISLNPILNSFQHTVKQYNIDDDLVQAFLKSMKLDLVKSTYN
TQTEYEDYIYGSADVVGLMCLKVFVKGNNPKYEQLKHEAMRLGSAFQKVNFLRDLKDDNL
VLNRNYFPGVDLKSFDENAKTAIIKEIEEDFKIAYQGIVKLPMEAKFGVYTAYIYYKKLL
QKLKNTPYYEIGNSRIRVSNYTKAGLLAQSFVTYKLKLV
>EGALAKHO_04196 hypothetical protein
MISFLIFLGVFLFMECVTWLTHKYVMHGLMWYFHADHHQPKYDHAFERNDIFFVIFAVPS
IILFYFGVQGGFNYLFFIACGVTLYGICYFLIHDVLIHQRFKWFKNTKNKYLIGLRKAHK
IHHKHLGKEEGECFGMLFVPFKYYKM
>EGALAKHO_04197 hypothetical protein
MKVYKIETVQHVNASVEECWDFFSSPKNLQTITLDNMSFEIQDFDGKRMYPGQIITYTLK
PLLGIKINWVTIITVSKENQYFIDEQRFGPYSLWHHKHFFEPTEDGTKMTDIVHYALPLG
YLGRIMNYLVVRSKLKTIFEYRHNKIEELFNSKVLLESQN
>EGALAKHO_04198 Deoxyribodipyrimidine photo-lyase
MRNKKFLSVTNKMTKQKITLFWFRRDLRLEDNTGLFHALQSDFPVIPLFIFDDDILENLP
KNDARVSFIYDSLQKINEKLSTTDSSILIKKGKTIEIWKSLLEKYDIQQVFFNKDYEPFA
IKRDLAISSLLKENKIETFSFKDHVIFEEKEITKADGLPYTVYTPYKNKWLEKYHLSGGV
SEYNSESLFDNFSKIQFNFPELSEIGFETSVIKVLPHNLTQIANYKETRDFPALDSTSYL
SPHLRFGTVSIRKLVNWANRKNQTFLSELIWREFFIQILFNFPNCVNHNFKSAYDGIQWR
NNEDDFKRWCSGTTGYPMVDAGMRQLNETGYMHNRVRMVVASFLCKHLLINWQWGEAYFA
EKLLDFELASNVGNWQWAAGTGCDAAPYFRVFNPEIQQKKFDEKGIYIRKWIPEFDLGYN
EPMVDHAFARDRAIATYKAGIIK
>EGALAKHO_04199 putative protein kinase UbiB
MKTIDYIPTSKIERAGKLVQTGAKIGVNYVKHYAEKMVNPDLTRDKLNENNAEDIYDGLK
SLKGSALKVAQMLSMDKNFLPQAYVEKFSLSQFSVPPLSAPLVLKTFKTNFGKTPYEIFD
EFNANSVNAASIGQVHLAKKNNKKLAVKIQYPGVANSISSDLALVKPIAIRMFNLQGKDS
DKYFKEVEDKLIEETNYLLELKQSQEVVEACSKIENILFPNYYPEFSSEKIITMDWMTGI
HLSEFTAKNTDQEVGDKLGQALWDFYMYQIHVLKKVHADPHPGNFLVNDQNQLIALDFGC
MKQIPEDFYVPYFELINKNVITDPALFNQKLFELEILRPDDNPSEIEYFTEMFHDLLSLF
TKPFKDDTFDFADESFFESIAKLGERFSNDTALKKMNGNRGSKHFIYMNRTFFGLYNLMF
DLKAKIVVTNYLKY
>EGALAKHO_04200 hypothetical protein
MATKKKIISKEDIVSMYMNEVLEKGQKPKSVYHFAKENDFTETEFYAFFGTLEGLEKEIF
RLFLVNTIDLLHKNSDYQEYDMKNKMLSFYFTFFEILTANRSYVLQSLKLDRNPLKNLVQ
LTSLRESFKEYVSEILTDDYRLEQEKFQKFQEKGIQESAWLQLMMTIKFWMDDESAAFEK
TDIFIEKSVNASFELMNVAPLNYLIDFGKFLFKEKIYSKQ
>EGALAKHO_04201 Epimerase family protein
MAKNVLLTGGTGFIGKHLTDVLIESGFTISILSRSNRKNTPAITYYKWNLKENFIENDAI
LNADYIIHLAGEGIVEKRWTKKRKKAILESRIKPIELIYSILKENNKTLDAFISASAVGI
YGAITSQEICTEKTPPVNDFLGTTCQKWEAAADEITLLGIRTVKIRTGIVLGKDEGFLKK
IMPSFKAGFGAILGSGKQYLPWIHVEDLCQIYLKAIVDTEMQGAYNATITDNTTNATLSR
ILAHLYGYAIWLPNIPEFLIKLGLGEMSIAVLEGQRISSEKIQKAGFEFQFDDIEATLST
SLS
>EGALAKHO_04202 hypothetical protein
MKRTTLLILLFSAFSLFAQEKFITNTATVNFEASVPLFEEIKAVNRSVAIVLEPKTSVFI
CTVVVKDFRFKLDLMQEHFNDNYMESNRYPKAVFKGKIAKFDLKDINETEKEYTIKGKLT
VRGKSKEIEVKAYLKKVNEGIQIHSDFPIAVSDFNIQIPNRIAEKISQTANTDLIGVIRN
EDAFLITLK
>EGALAKHO_04203 hypothetical protein
MVKFGYTILYVENVEESIVFYENVFGFSRKFIAPGNDYGELITGETTLSFASKNLAAQNL
KDGFVESNLDNKPFAIEIGFITDDVPELVQKATSFGAVLVKEPTAKPWGQVVAYVRDLDG
FLVEICTEVK
>EGALAKHO_04204 putative acyl-CoA thioester hydrolase
MTADFKSVSSSKISISELMLPSHTNFSGKIHGGYILQLLDQIAFASASKFSGNYCVTASV
DTVNFLKPIEVGELVTMKASVNYVGRSSMVVGIRVEAENIQTGAVKHCNSSYFTMVAKDK
EGKSVQVPGLILSNLEEVRRFRKAIKHNEAKKEFQEHEKIAKVNSIEDLASLDQYNVLLE
IS
>EGALAKHO_04205 hypothetical protein
MFDFLPFLLAFIVALFLGIYLGRMLFSAKFQSEKVSLEERLNANTNQLQLQKEQFESEKR
NFEKLLQLNNAEKESIRTEKDSLAIQLSKKEVDFENLWERHKEQKTEITELQEKFTKEFE
NLANKILEEKSAKFTEQNSVNMKNILLPLQDKIQGFEKKVEQTHKESIDYHAALRQQIVG
LSEMNAQMSKETLNLTKALKGDSKMQGNWGELVLERVLEKSGLEKGREYEVQQSFTNSEG
ARVFPDVVINLPDGKKMIVDSKVSLVAYEKWINEESEILKIDYLKEHVNSIRRHVEQLGN
KNYHDLYQIESPDFVLLFIPIEPAFAIALNEDSALYNKAFDRNIVIVTPSTLLATLRTID
SMWANQKQQENAFEIARQAGALYDKFEGFVGDLVRIGNKIKDTKNEYDSAMNKLVDGKGN
LISSVEKLKKMGAKAKKSLPENIIARASNTEDNQLLN
>EGALAKHO_04206 hypothetical protein
MKKLMLSLFIAFGFSACSLSNDDMNVDCGADTDVAFTGFPLLCNYSVKSYPTNPVALVLD
SNEKMETYFTKHDNSCPVASDPTIDFTKYYFVGLFAGAKPTNGYAIKITSVIQNNCELVI
NFYEKGPQAGETLTSSPTYPSDFILIPKTLKAIIFNKMTESPDNIVIGSYAAKCTGTDCQ
KFFQINDFNILKFQNVAINNYDFSQYKYTATGKRGDLTAFLKTVPTEILNLKGQTKTYGT
PDSADQGGIYLQLTQGAVVTKVFIDNNDTDDQNTEIKLFKKAIQDKITSLK
>EGALAKHO_04207 hypothetical protein
MKKSLLLFIAFGLITAAYPLESKSLAAASIINTWIWEKSIGGTSNPYVATPKTTGFNKKI
VFTPEGRVITYKDNVEIRNSAYQIEKGIGFFDHSEHELVTFEGKTYIVENIDNQSLTIVS
NDNDATRSIYKR
>EGALAKHO_04208 ECF RNA polymerase sigma factor SigW
MKDDLEKYIRQCMQNDRDGQLKIYQLFSSVMYGICLKYMKNEDDAKDVFQEAFVIVFQKI
NQYKFEGSFEGWLKRIFINKLIETLNKKKKESFFLDVFDPDTDFIEEEELETIPIEQEKL
LEYIRDLPDQYRTVFNLYVFEKMKHKEIAELLKISEGTSKSNLNRAKGILQKRILSLKKN
FKIA
>EGALAKHO_04209 hypothetical protein
MKKQSIEDIFSSMENFSSVPPPELWANIEEKLDQPKKKKRAILWWSAAACLLLGLLLPSV
LYFSSNTGIKTIDNNSRGNNSVVIDENKKEIKATKTLSTEENSSAEKSGIVENSPEENSK
NESHSFQKDNTKETAVAHADSKNKIDSDTPNAESNSEKRNTNQTVAEQTSVSEKGNQFNS
FSGKKNLNAEKKNTNQVVVEKTFSNGNQNQFNSFSKNQSLSPEKRNTNQAIANKAFVSKN
QNLINSSEKNQFSETEKRNADKVLAEKTFTAGKQNQFNSFSKNQTSNSIFENQLNTNSNG
IASSSSNSNLKNKQTTTDNRKEIAATTSKTEEILANNSSKSNSKFSNVLSKQDSVQLAEL
QNLEKGITPEVKKGKEKDTKNASKAEKWALEVFAGIANSENYKNDKTLGNVNDSKQSSTY
GVKTKYKINKKWAVGSGLKINELGQSVANISYIKTANNAFLTTGDYFMQNATAPKIASDA
GYVLVSSTTKNSFSSNNVQSGSLDQSLRYVEMPLEVSYAVFSKNKASISLNTGGFVGKLI
SNNVTIDGNSLGENVNANDYVYGSTLSSTVQYRVYKKTNVFVEPAVNYYVNPLNSQSFNQ
FQWGLNFGLNVSF
>EGALAKHO_04210 hypothetical protein
MIVKNHWTNHKSIPKDLLLAKELVYDCFDFDCSQPQQESESIDYSAYRFYLNEKFICYRE
AKITPTKTGQFVTLWKRSRLGTIEPFDSSDLIDFVFVSVRKDDLFGQFIFPKAILLEKGI
FSTATKEGKRATRVYPPWDEVNSKQAKKTQKWQLEYYFEITPEPNFDGFRELLDY
>EGALAKHO_04211 hypothetical protein
MKNIYYVRYSIAFLCFFCFSVNLFAQTAPVPQALPYTQNFDALTHISTTYPDGFKGWTAS
VLPGSTYNTSGTLVADRALLASSTAFTNSGNFHNYNGKIGFLNNGSLDLTIGFAFDGTNQ
KAIQVQYDAMTIRNPYGTGSGTSASDRINEMILQYRVGTTAAFTSLLQTAYVNNTVTQTT
AVTDPQNLQTIKVTLPAECDNQPIVQIRWISKQNSGGGSRPSFAIDNIDIRSDVAAPISV
SGYPKAENILSNSFDFSNKLDEIGKTYFVLLPEGSAAPSITQIKAGQDANGTPALQAGFL
DILNPTQVYLKSFTGLAISTTYSVFSISEDLNGNIQTNVSKVDATTTATVIPSLTTTVSS
LDLGFSEANFSSESVTYQIQAANLSAGVTVSASGNFTISKDNTVFGSSLTFTVSDFVSNA
AATVYVRFTPNATGSFSGQITHESTGATSKIVTLSGTGINPYLQGFNDPAVLTNSGWTQY
NVAGNLNVWTSTTVTRNVNSGTGAVLMNGYSDTGASKDWLISPRLRLDNFTQIPLLSFYS
RKFYAGTDLKLMVSVNYDGKSNPETATWTEIPGDFPTITGTYKQSQYINLGPYKTNHTYL
AWVYVTTAGGTNNAAEWSLDDVAITNEAGFVASNPILDFGDVAVNMQSASQSFIFKAEGY
NDITIKAPADYQLSLDNATFQSEVLVTSADALTGKTVYVRFVPSVKALTISGLLTVTGTG
LNKQIGSLTASSWPKADTFDIVSYNLEFFGTDVKGTDGVEFGPTDDALQIENVAKVMNKL
NADVYVVQEVSDDPSLDLLIQKININGKTFDKSVSTSWSYSFNAPDPNFPPQKLVVLYNT
QTTTVKSTRVMFKELYDKVRSNAVTLPNYPSTDSNDDSFFSSGRLPYLVKIETNIGGIKK
EINLIDLHARANSGSDISRYNMRKYDVELLKDSLDVEFPNANFMILGDFNDDVKASVIAG
NPSSYQKIVEDTSRYNALTLEISKAGAYSFLSSGGFLDHIVISNELTDQYIPNSIAVYDP
RNDISNYTNTTSDHGPIIARFELKKDVLSTVDFGTNKDYFVQAYPNPAIDILNVAVKTKE
DKTLKLRLYDISGQLIGSPIEIKGTQEKSDSVIQLSNLASGIYVYTVSENNKIIYSSKII
KK
>EGALAKHO_04212 Dihydroanticapsin 7-dehydrogenase
MALLENKVAFVSGGGSGIGRAVAEAYAREGAKVVLSDINVEHGEETVKAIKDSGGEAFFV
KGDSSIASDNKHMVEVTVSKYGKLDIACNNAGMGGPAKPTGEYEPEAWDKVIALNLSGVF
YACRYQLEQMEKNGGGSIVNIASIHGQVAAPNSPAYTASKHGVVGLTKNIAAEYALKNIR
CNAVGPGYIETALLKDHMNKDMMDAIAAKAPMNRLGTAEEIAELVVFLSSDKSSFTTGSY
IIADGGYTAV
>EGALAKHO_04213 hypothetical protein
MENNNLGSKKINGTQKNIDESKGKNIPHDKELHESQINQEVVTDKSGNKEVVDRARNENE
VINETSNEVNPTNPNANRGVSSEEEAQKTVENKDRNSDITPNRYPNSNPESHEDRGNMKL
DE
>EGALAKHO_04214 Ribosomal large subunit pseudouridine synthase E
MHQHFILFKPYGYLSQFIYELKRKKKLLGELYDFPEGTMAIGRLDEDSEGLLLLTTDGKV
SEQIRSKKVDKEYYVQVDGVITQEAIEELKKGVEIGFDGGKYKTKPCKAFIVTEIPDFGP
RAKKIRDERHGPTSWASITVNEGKFRQVRKMTAAVGFPTLRLVRVRIGNVYLQNLKAGDV
LEVSDFQLDNYFDYQSSNF
>EGALAKHO_04215 tRNA (cytidine(34)-2'-O)-methyltransferase
MLNVVLVEPEIPNNTGNIGRLCVGTESRLHLIHPFGFVINDKNLKRSGLDYWVHLDVTEY
QNIEEWIQQIPDQSRVFLMSSHAEKSYLETDFQDGDWLVFGKESVGLSKEVLTRFENHLT
IPMSKLIRSFNIANSVAFVVGEAKRQIGLKKV
>EGALAKHO_04216 Fe(3+) dicitrate transport ATP-binding protein FecE
MPQINRLKRFLNLPIKKSVKICAISGRKNLSNFEKMKTILNTSNLTIGYKSKKATVTIAE
NLNLSLNSGKLISLIGANGIGKSTLLRTITGIQQPLEGKVFLNDKNINSYNPLDLAQNLS
LVLTEKLPPSNLSVFELVALGRQPYTNWIGTLTSEDIEKVQQAMTLTQIEHLSQKKHFEI
SDGQLQKVLIARALAQDTPLIILDEPTTHLDLLHKVSLFKLLKKLTQETQKCILFSTHDI
DLAIQLSDEMIIMTPEFVVQDEPCNLISKGSFETLFKDEHIIFDAEKGKFVIT
>EGALAKHO_04217 Hemin transport system permease protein HmuU
MANKKRNTILFIVLGLGLLLMFFASLSLGSVNIPFKDVYASLTGGQASKSTWEYIIINYR
LPKSFTAVLVGMGLSISGLLMQTLFRNPLAGPYVLGLSSGASLGVAFVILGAGFLPSFLS
SFILSSYGIVIASTFGSTMVLLLVLVVSQRLRDTMAILIVGLMFGSFTTAIVSVLTYFST
AEQLQKFTFWSMGSLGNLSWTTLSILAICVGIGLLLSASSIKPLNALLLGENYAKSMGLN
FKKARFIIIFATSILAGSITAFAGPIAFIGLAVPHIAKLTFQTSNHTILFWSTLFFGAVI
MLFCDIVSQMPGFDVTLPINAITSLIGAPVVIWLLVRKRNFQ
>EGALAKHO_04218 hypothetical protein
MKHLLPKTFYVLSFFLLISCKKNETTEVANSPIAKNSIEYASGLSIVKQEGYSVVTVSNP
WPNANKNFKYILKEKDAKIPDSLQTYTTINVPLETVVVTSTTNIPYLEMLDVENKLVGFP
HTDYISSEKTRILIDKGSVKNVGQNEKLNIEQLIDLAPDLIVTFGVDNNNPMLDNLKKSG
LNVMIQADWMEQSPLGKAEWIKLYGALFGKEDKAKELFDKIVESYNQAKKLVADKPATTT
VLYGSMYEDVWYVAKGNSWVAQFMKDAQSNYLWADLKGTGSEGLSFEKVLDKAKTANVWI
ASGSFQSLAELEKANPHYSEFDAFKNKSIYTLESKFGATGGTIYYELSPSRPDLVLKDYI
KIFHPDLLPSYEFTFASKLN
>EGALAKHO_04219 hypothetical protein
MNTTKTKVCSSCETTFSCGDISVENKCWCNDYPPIFNLSEGGDCLCPVCFKEACVDKIDA
YVETMTPKKALQNKAISLPKTEKLIEDLDYYKENGNTVFTSWFHLKRGTCCGNECRHCPY
>EGALAKHO_04220 hypothetical protein
MKNNVIKDKSFDFAIRIVKLHQYLSTEKKEFTLSKQLLRSGTSIGAMVREAEHAESKNDF
IHKFSIAQKEANESVYWLELLKATDYLNEKEFENISNDAITILKLITSILKTTKSHLISK
EVSTSN
>EGALAKHO_04221 Bifunctional adenosylcobalamin biosynthesis protein CobP
MIYLITGGERSGKSSYAQNLALNLSDTPIYVATARKWDDDFQTRIDRHQQERDERWTNIE
KEKQLSEIDFSGKVALIDCVTLWLTNFFVDTKYDMTLSLEEAKKEFLAIANQENATLIIV
TNEIGMGVHAETHIGRKFTELQGWMNQFLASNADEVVLMVSGIPVKIKG
>EGALAKHO_04222 Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase
MSYLDDILKSRRDTRHFTSDEVPDEVIKKALQAGHWAPSVGLTDATRYYIIKSAEVKSSI
KDLFLDYNKKAESLTDNPEQKEHYKSLKLEAIEEAPIGLIIAYDRSVLNQFTIGTVGSNE
AVKFSSVCAAQNIWLSLTDQGYGMGWVSILNYHQFKKILDLPENIEPLGYFCVGKPATNY
NNQPMLQQLHWKQKSEAPICSEIKNVTESYISDLKLKSQIEIENKNDFNKELQEKIDGKT
KPLGALGTLETLAFQMATVFDNLNPKITNPNIVVFAADHGIANHGVSAYPQDVTRQMVGN
FLEGGAAINVFCKQNDIQLSIVDSGVNYDFPTNANLINAKIAKGTQSFLHAPAMSETELQ
LCFEKGKIIVDNIAKTGSNCIGFGEMGIGNTSTASVLMSLLTGFPIEECVGKGTGVEDQK
LLQKQEFLKSAIKNYSGQADLKEQLAYFGGFEIIQMASGMLTAFENEMLILVDGFICSVA
FLIATKINPAIIKNTIFCHCSAEQAHQKLLQYLNAKPILNLDLRLGEGTGCAIAFPILKS
AEAFLNEMASFESAGVSRK
>EGALAKHO_04223 Adenosylcobinamide-GDP ribazoletransferase
MKKELHIFFTCLMFYTRIPCPKNIDHNPDYLNKATRYFPFIGWIVGSISFLAFYIFSQFL
SIEIAVILAIIASILTTGAFHEDGFADVCDGFGGGWTKEKILMIMKDSAIGAYGAIGLVL
LFLLKFKLLSESISLFQMENPIGILQVFLLFISAHALSRLAAISITYTHEYSRDDATSKS
KPIAKKHTWKEILGSFIFGLFPLLALSYFHYNFLLAIIPVFITRYFLARYFQKWIDGYTG
DCLGATQQVCEVVYYLSFLSIWKFI
>EGALAKHO_04224 Putative phosphoserine phosphatase 2
MEIYLVRHTETACEKGICYGQSDVDLAQPFDSIFENIVSQLPSEAILFSSPLKRCVVLAK
YIQDNIKTISYQEDSRLMEMDFGDWEMKNWNDILPEQLNPWMEDFVNVPASNGESFVLLH
KRTEAFLSDLVSKKNNSPIIVVCHAGIIRSILCHHTSLPLKDAFQNKVDFGEVIKIEL
>EGALAKHO_04225 Vitamin B12 transporter BtuB
MLVVNYKTTARPGEWEGKQQDASQETCLYNKYRTLGKKSVEIMTLKKLFAFCLILLCQIM
SAQNDSITKLKTVVVSDSNLNKYSTSQSVLKLNDSVINKNEALLTDLLNFNSTIYFKEYG
RGMLSTVAFRGTTSSQTAVIWNGININSQMNGSTDFNTISGSDYNSVSVKAGGGSVIYGS
GAVGGTVHLNNDLSFYRRFENNLKLDYGSFNTIGINYKTNISNEKWSAQIGFSKNSSTND
YKYLNQYTWKGEQRWNQNGQYDIITMSANLGYKFDAKNSLKLYSQTSNTDRNTSLLTETE
TKSKYVNGFNRNLLEYDGDFGKFKTNFKTAYIFENYQYYADNSTNQYTFGKTESFIAKAD
LGYTLFKSTQINGILDYNRTKGFGSGFGDNTREISSAALLVKQDFSKDWKNEFGIRKEFT
DNYKSPVLFSLGSSYQFGKLYNLKLNLSRNFRIPTFNDLYWEEGGNPDLKPESSYQAEIG
NVFTYKNISLTQTFYYIKITDLLRWVPGSGGIWTPQNTDKVNTYGTETLLSWKKQYGKNY
FGANATYAYTVSKDIATDKQLFFVPFNKVTAAVSYSRSNISAYYQVLYNGFVYTQSDNDP
NEIVDAYMVSNIGIDYDFKFLSSFKLGFQVLNLWNENYESLENRPMPGKNFNMYLNLKF
>EGALAKHO_04226 hypothetical protein
MKLTRLFLVALSASLFVSCSNDDDNNDPKGVYDNGFFILNEGNSGGGSVSFASDDLTNFT
SDIYKTANPSDIAGVYLQNIFFDGDKAYIIAGGSNVINVVNRYTFKLIAKVETGLANPRY
GVVKDGKAYVTNANTYSYMNAATGNTDDYIAVIDLATNKVESKIELGSTANRILLENNKL
YITDFYNDKVLVVNPATKALETPVTIGTSGDSMEVKDGILYVLRAPYGDNRSEIVKVKLS
DKSVSKITFPVTLDRGGYLDIYKDKVYYTIAKSVYAISTTATAISTTPVFTAALPTAGSI
YGFAVENDKIYIADGGDFGSNSKAYIYNLSGSLQKELTVGVGPNGFYFNN
>EGALAKHO_04227 hypothetical protein
MKTILKSLLLLFLLAFALQSCEDQDDVAAPADLQVNDFVWKGLNQFYLWQPDVPNLADDR
FSSQESLNSFLKGYSKPEDLFQDLLNKPSSKFPKGQAIDRFSWIVDDYTVLEQELQGTSK
NNGVDFRLSYKPGSTTELVGFVRYIIPNSDASTKDIKRGDLFTGINGTQLTVSNYQGLLN
ADSYTLNMASYNGSVFQTNGKTIALVKTTLDENPIFINKVIVSGSHKIGYLMYNGFYANY
DAELNNAFATLKSQGITDFVLDLRYNGGGSIQTASRLASMITGQFATKIFAKEKWNPKVN
EYYESEDPESLNVRFPDKIDGTAINSLNLSKIYIITTDGTASASELVINGLVPYISVVQI
GETTVGKNVGSVTLYDSPSFGKTNRNPNHKYAMQPLVLKIVNAADFGEYTDGLPPTYEQF
EQASNMGVLGDPSEPLLNLTISKITGSTAKKIQQDRTQALRTFTDGKAMNGIRNQMYIEK
APEGLLKALK
>EGALAKHO_04228 ECF RNA polymerase sigma factor SigE
MNQVAFIELINPFKDKVFRLAKRLLTSTEEAEDATQEVMVKLWNKKENLDAYNNIEAVAM
TMTKNYCLDQLKSKRAGNLKIVHNNYTDREPQLDKKLEDSDSLEWVEKIINQLPEQLQIL
IQLRDVEQYEFDEIAKIVNMNETAIRVALSRARKKIRESMVNTHSYGIR
>EGALAKHO_04229 hypothetical protein
MELDKIENILEKYFQGETTIAEENQLKEYFSSPNVAQHLEQYKPMFGYFSQVKQQKTTQE
IPLQTKKRNVAWLSIAASVVVLLGIGTFYFASQKTTAPVVAQSELGTYDDPEEALAATQK
ALALLSNNVNVGIESVQYIKEYEQSKSKIFKQ
>EGALAKHO_04230 hypothetical protein
MKNFIITLVFAFVSTAFYAQGAFDKFDGQDDVTSVIVNKKMFDLMSKVKVDASDKEMQQY
ISLIKKLDYLKVFTTKNPKIEAEMKASADKYVKTAGLEELMRINDGGRNVKISVKSGATD
SQVRELLMYVDGAKGDETVLLSLTGNFDINEISVLTDKMQLPGGSDLKKASKGKK
>EGALAKHO_04231 hypothetical protein
MRLNVFTSALLVLLTLVSCNSEPSLQKYFVQNTDNKDFIALDISPTILNIEKSKLTVEQT
EALNSFDKMNILAFKANDKNQAQFETERTKVKAILKNPKYQKLMSFGSGRDGASISYVGT
DENIEEFVVFANKKESGFAIVRVLGKNMNPNSIMTLMSVLKESKIDMEQLKPLMELANKK
>EGALAKHO_04232 hypothetical protein
MAKKIGLLIAFCLSQLCIQCSSDDNKSIEEKVITEQETNEITLLRNYIAESLHIDIIKVI
YDADKSIFIIDRDILMPLEHAIGNFNRSNSIITNKKNQMGGVYMIKPEMAKSIKVYISPD
VPAVWKNSINQAIKNWNSINTSINLAIVDSPTSANTTIVMYEEPLGVIATAYMPYDGKPG
ESIKINSKYNNLIESKKVCTITHEFGHTFGLDHTNSDNRRIECTPILDDDSVMTTPVFEF
VKLSPYDIIAISQLYPVAAGTKKLYRYKKKQYYFYTTDPCEIIPGKDGYVLDGDSGYLYL
TQVDGTVPLYRSLNGPSIKDHKLSIAQTSTSDVIIGYLYSTQQPGTTALYSSIASYEYFP
SNKHYLYTTIFNKDEVIMSPMGYVPNKIIQNYNPNDIIF
>EGALAKHO_04233 Carbamoyl-phosphate synthase large chain
MPKDTSIKSVLIIGSGPIVIGQACEFDYAGSQSARSIREEGIEVILINSNPATIMTDPTM
ADHVYLKPLTTKSIIEILKEHPQIDAVLPTMGGQTALNLCLEADEKGIWQDFGVRLIGVD
VNAINITEDREQFKQLLAKINVPTAPAKTATSFLEGKEIAQEFGFPLVIRPSFTLGGTGA
AFVHSKEEFDEKLTYGLEMSPIHEVLIDKALLGWKEYELELLRDKNDNVVIICSIENMDP
MGIHTGDSITVAPAMTLSDTTFQKLRDYAILMMRSIGNFAGGCNVQFAVSPDDKEDIVAI
EINPRVSRSSALASKATGYPIAKIASKLALGYNLDELQNQITKSTSALFEPTLDYVIVKI
PRWNFDKFEGADRTLGLQMKSVGEVMGIGRSFQEALHKATQSLEIKRNGLGADGKGYTNY
EQIIEKLTFASWDRVFVIYDAIAMGIPLSRIHEITKIDMWFLKQYEELYTLEKEISNYKI
SNLPKELLLEAKQKGFADRQIAHMMNCLESEVHTLRMDQNINRVFKLVDTCAAEFKAQTP
YYYSTFEAEIEKANGERYVDNESIVSDKKKIIVLGSGPNRIGQGIEFDYSCVHGVLAAKE
CGYETIMINCNPETVSTDFDTADKLYFEPVFWEHIYDIIQHEKPEGVIVQLGGQTALKLA
EKLSKYGVKIIGTSFDALDLAEDRGRFSDLLRELHIPFPQFGIAETADEASALADTLDFP
LLIRPSYVLGGQGMKIVINKKELEEHVINLLKTIPGNKLLLDHYLAGAIEAEADAICDAD
GNVYIIGIMEHIEPCGVHSGDSNATLPPFNLGEFVMQQIKDHTYKIARALKTVGLINIQF
AIKDDTVYIIEANPRASRTVPFIAKAYGEPYVNYATKVMLGHNKVTDFDFNPQLKGYAIK
QPVFSFSKFQNVNKALGPEMKSTGESILFIDDLKDDQFYELYSRRKMYLSK
>EGALAKHO_04234 50S ribosomal protein L34
MSKRTFQPSKRKRRNKHGFMDRMASANGRKVLARRRAKGRHKLTVSSEPRHKK
>EGALAKHO_04235 hypothetical protein
MFNKNIKLILAGLLVVAGVWQFTESNIGNGIFLILLTAIPIFLYFKNEFILLAFLKLRKQ
DFEGAKNWLAYIKNPESALVRKQQGYFNYLHGIMLSQTNINQAEKHFKKAIELGLSMDMD
LAVAKLNLAGVAMSRRRKLEATNLLNEAKKLDKQGMLKEQITMMKEQMKKI
>EGALAKHO_04236 hypothetical protein
MKNIIIGIDISSKTLDICIKNETVSYFSIENKVPVIKRFFKSYSGEKVIIAMENTGRYNW
NLFEVLEKFDFKVYVISALHIKKSIGLVRGKNDKIDALRICNFIEKNHQESREWKPGSCS
IKKIKILLTERASRIKIKKQLIVQQHDYKLMKSIGLDKQLKDLNNKLLKDIDVQIKIIEN
DIENIIQNQESLNQQQKLIKSVPGVGQVLSWTLLSKTEGFTTITDPRKMACYSGVVPFDF
QSGTSLKRRPGVSMLADKNLKTILHMAAMSAIRSDNDLRTYYIRKVDEGKNKMSVLNAVR
NKIIHRVFAVIKNQIPYQKDLVLS
>EGALAKHO_04237 hypothetical protein
MSKIPVYFMPGLAASSSIFERIKLDEAVFEMCLLEWEIPNPKESLSDYALRITKNIKHEN
PVLIGVSFGGILVQEMAKHIQVRKIIIISSVRSNTEFPRRMKIGKTTKAYKLIPMKLILN
IENLAKYSFGEKINKRIKLYEKFLAMRDLNYLQWAVENVILWDRDQRDENVIHIHGDKDD
VFPIKYIKSCIIVKGGTHVMILNKYKWLNENLPSIILED
>EGALAKHO_04238 hypothetical protein
MEPIETIMEIKDNTFARQFETITPEGLISVEYSFQEKKIFLTKINTPEGFENQELINTLL
KSIMEIVIEKKFKLMPIHPKIALFIKKNPKYKELLPPGIRI
>EGALAKHO_04239 putative ABC transporter ATP-binding protein YbiT
MITVNDISVQFGGTTLFSDVSFAINENDKIALMGKNGAGKSTLLKIIAGQSKPSTGSIST
PKDAVVAYLPQHLLTKDGSTVMEEASKAFGEIFKMKAEIDEINEQLTVRTDYESDAYMKL
IERVSDLSEKFYAIEEVNYEAEVEKILVGLGFEREDFTRQTSEFSGGWRMRIELAKILLQ
KPDLILLDEPTNHMDIESIQWLEEFLLNQAKAVVVISHDRAFVDNITNRTIEVTMGRIYD
YKAKYSHYLELRKDRRIHQQKAYDEQQKMIADNRAFIDRFKGTFSKTDAVQSRVKMLEKL
VIVQVDEVDNSALKLKFPPAARSGQYPVVVKDLSKSYGDHVVFKDANIVIERGQKVAFVG
KNGEGKSTMIKAIMKEIGIDEGSVDIGHNSQIGYFAQNQASLLDENATIFETIDNIAVGD
VRTQIKNILGAFMFQGDDITKKVKVLSGGEKTRLAMIKLLLEPVNLLILDEPSNHLDMKT
KDIIKDALRDFDGTLILVSHDRDFLDGLATKVFEFGNKRVKEHFEDVAGFLAHKKMDSMR
EIEK
>EGALAKHO_04240 Bifunctional protein GlmU
MNYILFDGPVRNALLPFTFTRPVADILIGIMTIRQKWEARLGSTITTITEDYLSTKFPMV
EMEENVMINAAYLPNDALAEMVSDLKQNQAIFKGDDVIAFFTTENQEEVDFDSYEIIQYN
EDCLTVEHTWDIFSKNDAAIRADFVFLTEDRKSQPIPKSVNVIAPENIFIEEGAKLEFVT
LNASTGPIYIGRNTEIMEGTVIRGPFALCENAMVKMSAKVYGATTVGPGSRIGGEVKNSV
LFANSNKGHEGFLGDSVLGEWCNIGADSNNSNLKNNYEEVKLWSYETEGFAKTGLQFCGL
MMGDHSKCGINTMFNTGTVVGVSANIFGSGFPRNFVPSFSWGGAAGFTTYVTKKAFETAK
LVMGRRNIEFDETESAILEHIFEETKKWRKD
>EGALAKHO_04241 50S ribosomal protein L31 type B
MKKGIHPENYRLVAFKDMSNDEVFITKSTADTRETIEVDGVEYPVVKMEISRTSHPFYTG
KSKLIDTAGRIDKFKTKYAKHVKN
>EGALAKHO_04242 hypothetical protein
MISEVIKKNGITYGVIIGIASTLITATIYAVDLNLFVSWWFGLLGLAINLTISIILLSKT
KKDLNGIFSFKDAFTTYFIAAVIGILISTIFNIVLFNFIDPGAKDTLSEIMIKYTVGMLQ
KFGTPASTINETIAKMKITNPYSTIELIKGSVFAIVICAIFGLIFAAFFKSKSTQE
>EGALAKHO_04243 Dodecaprenyl-phosphate galacturonate synthase
MNLSILIPLLNEEESLKELYSWIIKVMQSNNYSYEIIFVDDGSTDDSWNIIESFSNENPN
VKGIRFMKNFGKSQALHAGFAKAKGDVIITMDADLQDSPDEIPGLFEMITKEKFDLVSGW
KKKRYDSVVAKNLPSKLFNWAARKTSGVELNDFNCGLKAYKNTVVKNIEVSGEMHRYIPV
LAKNAGFNKIGEKVVIHQARKYGETKFGMERFINGFLDLITIWFLSRFGKRPMHLFGAMG
SLMFIIGFLLAGYIGISKLYHMYNGMKYSLITSNPWFFIALTTMILGTQLFLAGFLGEII
LRTKNNESRYKVAREVNF
>EGALAKHO_04244 Phosphoglucomutase
MNIAPNILNAVNEWLTPTFDNETQAAVKELMTTSPKELEESFYKNLEFGTGGMRGVMGVG
NNRINKYTLGKNTQGLSDYLHEVFPNQPLKVVIAYDCRHNSNTLAKVVADVFSANGIQVY
LFSDLRPTPELSFALKYLGCQCGIVLTASHNPPEYNGYKVYWEDGGQIVPPQDAAIINVI
ENLGYDKIKFDANESLIKYIDTEIDKAFVKSSIENASFNTPAEAKDNLQIVFTSLHGTSI
KSIPDTLSQAGYKNVHIVPEQAVPDGDFPTVKSPNPEEPEALTMALALADKTNSDIVVGT
DPDCDRLGVAVRNNDGKMILLNGNQTMVLMTSFLLKQWKKAGKINGKQFVGSTIVSTPMI
MELATSYGVECKVGLTGFKWIAKMIKDFPELQFIGGGEESFGFMVGDAVRDKDAVAATLL
ICEVAAQAKAAGSSVYKELLQLYVENGFYKEYLVSLTKKGMEGLQEINQMMIDLRQNPLK
EINGQRVIMVEDYDSSIALNLLTGEESTMDIPKSNVLIYYTEDGSKICARPSGTEPKIKF
YISVNAELESVQDFDAAEKFLDQKIEKIIADMQLK
>EGALAKHO_04245 Lipid A export ATP-binding/permease protein MsbA
MSNFKKIVPFIYPYKKYAFLNIFFNVLYALFSTLSFVSLIPMIQVLFDQTKRNTIEPVYN
GIWEIKTYAENYLSYFITHTTDTYGVGTTLGIMVGGIISIFLLKNLCDYMAMFFINFLRN
GILRDMRNAMYKKTLELPLAFYSEKRKGDVISRISADVNEVQTSFLAILELIVKEPLTII
FTIATMFAISAKLTLFVFIFIPISGYLISLIGKQLKKQSTKAQQEQGHFLSTIEETIGGL
KVVKGYNSENYFNNVFQNSTERFFKLSNSIGNRQNLASPASEFMGITVIAILLWYGGQMV
LIDKTLAGASFIAYMGLAYNILTPAKAISKASYGVKRGNAAAERVLEILEQENTITSKDN
AVEKTTFDNNINVKNINFKYEDETVLKDFSLEIKKGQTVALVGQSGSGKSTIANLLTRFY
DVNDGTISIDGINIKDMNLQSLRSLMGLVTQDSILFNDTIKANIALGKLDATDDEIIEAL
KIANAFEFVKELPLGIYTNIGDSGNKLSGGQKQRLSIARAVLKNPPIMILDEATSALDTE
SEKFVQVALENMMQNRTSIVIAHRLSTIQKADVIVVMQKGKIVEQGTHDELIAHNGTYNK
LVTMQSFES
>EGALAKHO_04246 hypothetical protein
MYLNNPNIKLPDDPDTIVWKYLDLSKFLDLLLSKKLFMSRSDKFEDQYEGTFSEPTFEEI
KKLAIDNPDFLKYYKTQREQVAISSWHINEYESFAMWQIFTQNSEGLAIQSTIGRLQKAV
KPENNFDQYIGEVNYIDYRKEYIPFDDLFFPFLFKRKSFQYEREVRILTDTSKSTIKLND
GLKINVDIDQLIEKIYIHPKSENWYKKLVIELVERLGFGFEIEKSDLESDILI
>EGALAKHO_04247 hypothetical protein
MKNYLKYIALVIIGTVVSCKDDAQKPKVIYDASNKAKVVTKTDSTQIEVADLPIQMEGTN
YLIHPVGDLRVFEKGTKARYGSSSVNDVSFTISNLGEFEITGYLQNLKFQKVDSDSIRPL
SDKPVLILTATYLKTVADRTQNKIMVYTLTDSDTNKDGKIDTGDIKTLYLSDISGENFTK
VSSDLQELVDWSLIESKSRLYFRTIEDTNQNGQFDKNDVLHYNYIDLASKKWEVKNYKPI
>EGALAKHO_04248 hypothetical protein
MSHRQLIFVFLILCSCVSFAQNAHVKGIILDQENRPVSDVNIAALGNVAQSDSNGFFEIE
IPSNKKVSLIFTHISLKMMSLTVSLKPNEVFVFNPVMNNSEEQMGEVFVSSKNKKRVQGI
TTIDVATIKKIPGANAGIENILKTLPGVNSNNELSTQYAVRGGNYDENLVYVNEVEVYRP
FLIRSGQQEGLSFTNTDLVQNVDFSAGGFEAKFGDKLSSVLDITYRKPTQFGAAFEASLL
GASAAVDLVSKNKKWSAVTGIRYRNNSLLVNSQDTETNYTPTFADIQTNITYDISKKWQM
SFLGNISQNKYLYQPLTRQTKFGTIDQPMELNVYYEGQEKDQYDTYFGALKTTYKVSPDF
TLKLIGSLFHTTEQEHFDILAQYRLGNVTDEGEPEAIDFTRGIGSQLNHARNDLDALIAN
VEIKGFKEWKNDSQLEFGLKYTRESIRDRVVEWEVIDSAGFSINPPLVILPKNNEPYQPY
TGPLLPYQDVRATNFNTVNRIVGYAQWNQKTAIGSNQVWYHVGARFQSWNVSGAAVEGKN
QTVFSPRAQFAIKPDWDMDMVFRLAGGIYYQPPFYRELRDINGVVNPNVKAQESVHIVLS
NDYNFKMWDRPFKWVTEVYYKSLSDVNVYSIDNVRIRYVANNNATAYAQGLDFRLNGEFV
PGTESWVSFGYLKTEENYQNRGDIARPTDQRLKFAMLFQDYMPNIPSVKLYLNLVYNTGL
PGGAPAYSDPYLYQNRLNDYRRADIGFAKVFVDSSTKIAKANWLKGFKELSVGLEIFNLF
NNQNAITNTWVRDVYSKNQYAIPNYMTSRVFNVKLNARL
>EGALAKHO_04249 Murein DD-endopeptidase MepM
MRFSILTLLFCQIIFAQTQYPKDYFAPPLDIPMQLSGNFGELRPNHFHAGFDLKTNQREG
LNVYAVAEGYVSRIKISTFGNGKCIYITHPNGYTSVYGHLQTTIGAFQDYVQKTHYKEKA
FEIEMFPKPGELPVTKGQLIALSGNTGSSEGPHLHFEIRDSKSEFVINPIFFGFDKNIKD
TKKPTISSLYVYPMDNTTVNQSKQPLLLNVALQKDGTYLASKVKANGKIGFGINAVDFDD
VSGNKNGVFNVSTFVNGNQNYNYQFNTYSFDEMRYVNALIDYARYKKSGQRVQKLFMKTP
YALSIIKTDSLRGIVPVEPNLVSTYRIEVSDYFGNLNAITVPIEYDTATPVVKEEPVTSP
YFIKVNKDSNFEKDNMSVFFPAGTFYDDFNLNFDVKNNKIYIHDDVVPVHSNFTITIKDS
TYSEALRDKVFIGRSGSYNATTRKNDVFTAKSKTLGQFGLVLDTIAPVIKIAKPIEGKWV
SDVKIIQFTISDSSSGIKSYNGYLNGNWVLFEYDNKTRKITHKFDDTLLAEGANDLKIEV
IDNVGNSAIFETHFFRSQQK
>EGALAKHO_04250 hypothetical protein
MSVIAEIIDTLEYKVEKLFEKSKGLEKNNQELRLQLAKAAQIIQKQSEEMEALKKQYDTL
KIANSLLGSDNNKRETKLKINSLIREIDYCIAQLSD
>EGALAKHO_04251 hypothetical protein
MDGKLRIKISIADRVYPLTVEPVQEEGLRSASKKIDAMIKQFEESYAVRDKQDVLAMCAL
QFASQVEQKQIDNAIDGEETIERIKRLNSLLDQYLEN
>EGALAKHO_04252 Ribonuclease Y
MDIITIIISGIIGIAAGFGIAKIIEKSNISNLIKNAKKEAASILKDANLEAENIKKDKIL
QAKERFIELKSEHEQVILARDKKVAEVEKRVRDKESQISNELSKAKKVNDDFEAKTAEYN
NKIEVLDKKQAEVDKLHKSQLQQLEVISGLSAEEAKEQLVEGLKAEAKSKAMSHIQDTIE
EAKLTAQQEAKKIIINTIQRVGTEEAVENCVSVFNIESDDVKGRIIGREGRNIRALEAAT
GVEIIVDDTPEAIILSCFDPVRREIARLSLHKLVTDGRIHPARIEEVVAKTAKQIDDEII
EVGKRTVIDLGIHGLHPELIKVVGRMKYRSSYGQNLLQHSREVSKLCGIMAAELGLNVKL
AKRAGLLHDIGKVPDTESDLPHALLGMQWAEKYGEKEEVCNAIGAHHDEIEMKSLLSPII
QVCDAISGARPGARRQVLDSYIQRLKDLEEVAYGFTGVKNAYAIQAGRELRVIVESEKVS
DDNAANLSFEISQKIQTEMTYPGQVKVTVIRETRAVNIAK
>EGALAKHO_04253 Alkaline phosphatase synthesis sensor protein PhoR
MVFDLYGNDDCLEVNNFYKKLLAEMPDLLFQFVIDKDNNYTFPLVSKSADDIFEICATDF
TNDIKLIVYDRIFPGDRELFFQSLVKARKEVKPWEIEFRAVLPKKGLRWFKVSCKTEKSS
WDSVSFFGHVSDITELKDKEEKLRISEERFQFALDASTVGVWDWDMVTNSVFYSSLSLKI
LELESTDIFDDPERWDKIVHPDDLPKYYSDIQEHFDNKIPYYENYHRVMTSSGNYKWILD
RGKVIKRDENGKPLRVLGTHTDVSLQKEKELELIKTMKLYSDQNSRLLNFSHIVSHNLNT
QAGNIKSILDFIDADVDKQTVSEMLVHLRTVSNDLNDTISNLTQIVKTQSNINIAVVPLK
LCEYIEKTVSTIKGYDKQKNVKIINNVPNYLTINFNPAYLESVLLNFTTNAIKYAHPDRD
PIVVFDFAIEPEGQKSLKITDNGLGIDLAIHGDLLFGMYKTFHKHEEARGIGLYITRNQI
EAMKGSISVESKVGEGTSFKIIFSDL
>EGALAKHO_04254 Tyrosine recombinase XerD
MNWNRYIKDYQSYLRIERGMSKNTIENYGFDIERLCLFLEVNKIEVSPLKITDEIIQQFI
YHVSKELNPRSQARIISGLKSFFNYLIFEDYRNDNPLELIESPKTGRKLPDTLAVQEIDA
LIAAIDLSSNEGERNRAMLETLYGCGLRVSELVSLKISDLFFDEGFIKITGKGNKERFVP
IGKLTQKYIQIYQNEIRGNLTIKKGCEDTLFLNRRGNQLTRAMIFTIIKDLAVKIGLKKN
ISPHTLRHSFATHLLENGADLRSIQLMLGHESITTTEIYVHLDRSFLKEVMHSYHPRK
>EGALAKHO_04255 hypothetical protein
MKKIILTALAVMAFGITNAQKTQFGVKGGLNITTLTGDISANSLVGFQVGGFAEIKVIER
LAIQPELLFSTQGADLEYIGGSRNPDLKLNYINIPVLAKFYITKKFTVEGGPQLGFLVSA
KFDDNDVKDSYRSVDTGFNFGAGYNFTDNLSAGIRYTVGISNVEKSSNESVEDYLDYSVR
NNVFALSLAYKF
>EGALAKHO_04256 hypothetical protein
MKKILLAAVLFIATSASIQAQLLQLGVKAGVNFASQTGDAYLQGVAFDKDGITSFHAGLV
AEIKLLDKFSVQPELLYSTQGATYKNAVNEFKNELGYISIPVMAKFYLTDSFSLEVGPQA
SFLVSQRNDFDVEDAETFEFGLNAGVGFKITKNFFVQGRYGLGLTEASKNADVKNSTVQL
SAGFMF
>EGALAKHO_04257 3-dehydroquinate dehydratase
MKICIINGPNLNLLGKREPEVYGSQTFEDYFETLEHKFKNVELSYYQSNIEGELIGKIQE
VGFTFDGIILNAGAYTHTSIGLGDAMKAITTPVIEVHISNTYARESFRHQSYLSGNAKGV
ILGFGLKSYELAIQSFL
>EGALAKHO_04258 hypothetical protein
MRNYTLFAFLFFSLTNFAQIKGTITDEKGSPLPFVSVLEENTYTSTTSNEQGKYQLNVKE
VGKNKITFQYLGFKTQKIAVSSESKTITLDVKMLEESFTLNEVIIDPKNNPANAIIRSAI
ANKKENSAKTSRYTADFYSKGMFKVKDLPKKILGQKVDLGEDMSSNLDSTGTGILYLSET
ISKISFEKPNKLKEKIIASKISGNNKGYSYNTATLSTYDFYDNTLDFDIKLISPIADNAF
SYYKYKLEGSFYDDNKQQIYKIKVIPKRDKEPVFEGYIYIVDDSFAIYAIDLDIKGYRMK
NEFTEIMTLKQSFSYNSKNKIWSKNAQTLSFNAGIFGVKFSGKFNYVYSNYEFPDSFEKK
TFGNEIVAFEPNSNKKDDAFWNEIRPIPLTIEESTDYTKKDSLLTIRKSQKYIDSVDAKH
NKFKVWDILMGYDYKNTFKKYSFEYKGLLNLTSLSFNTVQGFNFDSGFSFRKWDEEKGKN
TSVSTTFNYGFSDERFRITGDFSHRFNTINYATIWGSGGTKTAQFNGAEPITKFVNSISS
LFFKDNYMKLYNLEFAQINYSQDVANGINLNAKVAYEQRKPLFNTTDYSFFKKDDVYSSN
NPLAPDDFTTPAFDQHHLFKTALTAKINFGNKYISRPDGRYNIKDEKYPTIFLAFEKAFA
ASEKKYEFERIGASVQYDLSLGNKGLLGMNFRAGKFFNAENISFIDYRHFNGNQTHIGTS
DRYLNVFNMMPYYANSTNDSYLEIHSEYNDTGFIMNKIPLLNLLKSTMNVGFHSLAIPDR
KPYSEFTVGLDNLGFGKFKLFRVDYVHSYQGGVQQNGVVFGLKILNVLN
>EGALAKHO_04259 Ferrous-iron efflux pump FieF
MTDEQKAVKATIFSIVGNTCLALIKGLAGFFGNSYALIADAIESTADIFSSFLVLFGIKY
SNKPPDENHPYGHGRAEPLITFLVVGFLITSATIIGYESISNIQTSHDLPKSWTLYILGA
IIIWKEYSFRLVMKRSKETNSSSLAADAWHHRSDAITSIAAFIGISIALIMGKGYESADD
WAALFAAFFILYNSYKIFRPALGEIMDENLNDDLVEEIRIKSLTVDGILGTEKCFIRKAG
MKYHVDLHAIVSAEISVKEGHDLSHKLQDTLKEKIPQLGNVLIHIEPDDYH
>EGALAKHO_04260 UDP-N-acetylglucosamine 1-carboxyvinyltransferase
MGVFKIEGGIPLKGEITPQGAKNEALQILCAVLLTGDKVTINNIPDIIDINKLITLLGNL
GVKIQRNGPGSITFQADEVNVGYLETEAFKKEGGALRGSIMIVGPLLARFGKGYIPKPGG
DKIGRRRLDTHFEGFINLGAKFRYNREDHFYGVESPEEGLKGTDMLLDEASVTGTANIVM
AAVLAKGQTTVYNAACEPYLQQLCKMLNSMGAKITGVGSNLLTIEGVESLGGCEHRILPD
MIEIGSWIGLAAMTKSEITIKNVSWENLGLIPNTFRKLGITIEKRGDDIYIPAHKDGYEV
KTDIDGSILTIADAPWPGFTPDLLSIVLVVATQAKGDVLIHQKMFESRLFFVDKLIDMGA
KIMLCDPHRAVVMGHNFESQLKATTMSSPDIRAGISLLIAALSAKGTSTIQNIEQIDRGY
ERIDERLRAIGAKIVRE
>EGALAKHO_04261 hypothetical protein
MVEKYKKEVANDVVFNLEYNSERQRLLIPEYGRHLQKLIDQATIIEDAETRNKAAKYIIQ
VMGSLNPHLRDVPDFQHKLWDQLFIMSDFKLNVESPYPIPSRDVLQLKPDVLQYPQNFPK
YRFYGNNIKYMIDVANKWEEGEMKNALVLVIANHMKKSYLSWNKDTVKDDVIFEHLFELS
GGKINLLQSTEELLNTTDLLRTNKRMSNKITPPGQPKIQSNKNNKGPGKPKPFQKNNNQK
>EGALAKHO_04262 hypothetical protein
MENDKEKNTAEFYERLKVELDNSNTWPAEYLYKFIMPSVGDNVERVEKAFDNMGAVIKTT
KSKTGKFTSVSIDVTMNSSNDVIAKYKEVSTIEGIVSL
>EGALAKHO_04263 hypothetical protein
MKKILLFFIALTFGNIEAQEIKTMTYFQNDTIKLDLDLYLPEKKSNEKIPLVIFAFGGGF
SGGERTSEKEFGMFMAKNGYAVASISYSLYMKGKDFGCKGTLTEKIKAIQIGVSDMWQAT
SFLIENANKYNLDTSKIFISGISAGAEIGFHASFWDYKLMNLYKSNLPENFKYAGFIGGS
GAIQDINLITKEKAMPMLLAHGNNDQTVPYAAGSHRSCPTNASGWLILFGSYAVYNHMID
LHKDIELITFCGGGHEFSGYLFHDGKQYVLDFVNDVLKGKKFESHLIVPSKKKGADSGKY
LFCE
>EGALAKHO_04264 hypothetical protein
MQKEIIVLIGGPGTGKSTLINELVARGYCCYPEISRQVTLEAQQRGIEQLFLEQPLLFSE
MLLEGRIKQFENALEEPENVVFIDRGIPDVVAYMDYIGDEYPTHFTKACEDFKYSKTFIL
PPWEEIYESDTERYENFEQALTIQKHLVETYKKYGYDLIEVPKDTVENRILYILDKI
>EGALAKHO_04265 ATP-dependent DNA helicase RecQ
MPEAQEILLKYWKHDSFRPLQKEIIDSVLDGQDTFALLPTGGGKSICFQVPAMMQEGICL
VVSPLIALMKDQVTNLQKRDIKSIALTGGIHTEEIIDLLDNCQHGNYKFLYLSPERLQSD
WILERIKDLPINLIAIDEAHCVSQWGHDFRPAYLKISELKKYFPKIPFLALTATATPRVI
EDIKTELGLKDPNFFQQSFERKNIAYMVFEIEDKLYRTEQILKKNPQPSIIYVRNRKSCL
NMSTQLQSLGFKATYYHGGLSAKEKDKNMQLWMSEQAQVIVATNAFGMGIDKDNVKTVIH
TQLPENLENYYQESGRAGRNGEKAFSVLLFNNADANHTEQQFLSVLPDKKFLKTMYVKLC
NYFQIAYGEGLDDSFSFKLNHFCNKYDFPTLKTYNALQFLNQQGIITMSQEFSEKITMQF
LIESKEVIRYMSLNPNDEEIILAILRTYPGVYEMKTPFNLSLIAKKSHHTEEQVSAVLEK
LKEKEIIEYKSKNNDATILFNEVREDDLTINRVSKYLEKQNQLKHEQLSSVLYYIKENKT
CKNRLVLDYFGEETTTNCGVCSYCITQKGKITEADSIADKILHLLKSAALTSRELQTQIK
LDANDIVSVLQELLENNHITILANNKYTLKS
>EGALAKHO_04266 Methionyl-tRNA formyltransferase
MEKLRIIFMGTPEFAVGILDTIIKNNYDVVGVITAADKPAGRGQKIKYSAVKEYALANNL
TLLQPTNLKDESFLAELKALNANLQIVVAFRMLPKVVWEMPSLGTFNLHASLLPNYRGAA
PINWAIINGETKTGVTTFFIDDKIDTGAMILNSEIAIEPEESAGQLHDRLMNLGSITVID
TLKVIENGNVTTTIQEDNEEIKTAYKLNKENCKIDWTKSGAEINNLIRGLSPYPASWCFL
KDKEEEQTIKIYEAKLISEDHSYEVGSLICGKKEIKVAVQNGFLQLLSLQLPGKKRMQVA
ELLNGITFSNTAKVY
>EGALAKHO_04267 DNA-binding protein HU-beta
MNKSELIDAIAADAGITKAAAKLALESFLGNVGATLKKGGRVSLVGFGSWSVSARAARDG
RNPQTGKTIQIAAKNVVKFKAGAELEGAVN
>EGALAKHO_04268 hypothetical protein
MISEKLKKGHLLIAEPSIIGDLSFNRSVILLADHNKEGSIGFIINKPLKYTINDLIPEID
ATFKIYNGGPVEQDNLYFIHNIPELIPNSVEISNGIYWGGDFESTKDLINDGSISKNNIR
FFLGYTGWDENQLESEMQGNSWIITDNSYKNKIIGKSTTHFWKEQIIELGGDYLIWSNAP
ENPYLN
>EGALAKHO_04269 D-alanine aminotransferase
MINFNGNIVAQDENILTQNRAFLYGDGVFETLKIINNKILFLEDHYFRLMASMRVVRMEI
PMNFTMEFFEEQVLKLVQENEISASARARITVFRNDGGLYLPKTNEVSYLIHATPLENTS
YTLNTDEYEVDLYKDFYVTKQLLSSIKTTNKMINVTGSIFAHENGLANCLLVNDTKNVVE
GLQGNLFMMTGKKLITPPISEGCLNGIMRKQILALAKKVEGIEVLEEIISPFDLQKADEL
FLTNVIIGIQPITKYRKKEFTSDLAHLLVQKLNESISEN
>EGALAKHO_04270 hypothetical protein
MDPKIRYEIEFPINSSPQLLYQYISTPSGLSEWFADNVNSRGEFFTFIWNDSQEKARLAS
KKTGEKVKFKWVDESSKDTEYFFELHILVDELTKDVSLMVVDFAEKEEVGEAKQLWENQI
SDLKHLIGSV
>EGALAKHO_04272 hypothetical protein
MSPPLAAVVLTVAVGVPPLQMVWPVASIAPDVNAGRTVTVAVFKVAILEEQVPPVPDVKL
VILITIDPAVPKLAVVKLPDVKTPALLTVIALVNPVDAPAS
>EGALAKHO_04273 Regulatory protein RecX
MNSIPTIKEALLKLEHFCAYQERCHAEVVSKLYSLKMTSNEIDSIVVQLIENNFLNETRF
ACSFARGKHRMKSWGKIRITNELKARQISSTNITLALKEISPEEYESTFENLSERCWNSI
QEKNILKKRKKFCDYLLRRGYESHFVYDKAKEMEQK
>EGALAKHO_04274 hypothetical protein
MIRKLLLSVLFLLLPLFGVSQTLTVGNYTVGTAPGNNFPTLAAAITRINTDGISGNVTLL
LNNDQTVTSQIVINQFSGSDTNTLTIKPNTNLIKITAIKPNSYTGLAAVFLFNGARNVII
DGSYSNGSTKNLEIINDDDISYNHRSVIWIASNSNTGSSNISIINTKLKFNYRTQQNNLL
ACIYSGNNTTGGNNTINVSESSASNNKISIKNNEFIYAKEGINVNGSATASKASTTWTIE
NNIMTGGTNAVDKLARGIYLSNCTDFIVSSNTISKVTRYSNSVYQETAGICVVGNSAGKI
DSNYISDVSDMDYYGNANAVTAGLFLNSTNTGLITLSNNIISNIYTGSSDGSESNFNNKG
HGIYVKNAGTTSIYYNTVVMNYTSSAAKSSCLYIEGGTAFNIINNIFYNSQPGTQYGIFA
NIAASKINNISNNAYFVTNGTQNFSNRLGSSTYTGSPGTTTTGFSGWKTALGNKDALSII
KLPTFKSTTDFRLENVTANDLLKAGIPISGITTDIENEARSTTTPYMGADELACTPSTMS
LSSATGTNVQTTCINSPITNITYATSGATQVTATGLPAGVTGSFASNIFTISGSPTTTTG
SPFNYTVNLTGCGTATATGTITVTPDKTLSLTSASGTNIQATCINTPITNITYGTNGATN
ATVTGLPAGMTWGFVSNVVTISGSPSTTVGSPFNYTVNLTGCGTATATGTITVTPDKTIS
LTSATGTNIQTTCINTPITDITYATNGATAATVTGLPTGMTWSFVSNVVKISGSPSTATG
SPFNYTVNLTGCGTATATGTITVTPDKTISLTSATGTNIQTTCINTPITDITYATNGATA
ATVTGLPAGMTWSFVSNIVKISGNPSTTIGSPFNYTVNLTGCGTATATGTITVNPTNTIS
LSSSTGTNGQNICKGSAITNITYTTTGATGADVTGLPTGVTGSWASNTVTISGTPSTTTG
GAFNYTVTLLNGCGTVTATGTITVAVPNRGQVHGGKHICLGEDSPLLYMGTYSGTIIKWQ
YSDDPAESNASWIDIPNTADTFQPSKLTALRTFRAVVKNGNCPAETAVQTRIDIDIQPTF
TTSPSATSCPNVDVTYTTQSGLRDYIWTVPGTAGIDYTITSGGITLSNNSVTLKWLTAGS
KTVTVTYTNACSSNPVASATTTVNEYTVSGPSLHSPICINTQMSPITHTLKGFNGVGTGS
FNLPSGLTVNYDSTTKLLTISGKPTSVGTFNYSISLTVSGCIVSGAATGTITVNALPATP
TATLTSSPTCANPTASISITGLSGSWTLYRNSVQVATGTATSYTDSGLAGGTSYSYQVSN
TSCTSEATAAITPITVPTTKYTASGWDNGDPSNDVTNLKNVIFEGDYIAENNINACTCTV
NAGNVIIKGGKTLNITNEVKVNGGTLTFSDDASLLQTNPTALNTGAINYQRKSVDIRLAD
YVYWSSPVKNFKLGLVSPLTSAKYLYSNDGTKWVNEPSSRIMASGKGYIVRGPDNITNGA
RTPFMATFTGTPNNGNIDGEIVKKDQFYLVGNPYPSSLDADAFIDGNRSILEGTLYFWTH
NTPVVLGGAYEYSSDDYATYNLSGGSGTRTAAPSGDDDDTGDNKNNESAPSGFIGAGQSF
FAGIAANGQIKFENGMRAGGNTNGQFFKPGTTAKTTALEKHRVWLNMTNAKGAFKQILVG
YIQGASNAYERFYDGTTLDGNKYVDFYSVNDGNNLVIQGRALPFADTDTVPLGYRSTLVG
DFTIGIDHADGKLNTQSIYLEDKTTGKILDLTAANYTFTTEKGTFNDRFVLRYTNKTLGT
GDFENIENGLLVSVKDKVIKVTSAKETIKEVTVFDISGRLLYNKKKVGSTELEISNLQSA
NQVLLVKVILENDYVATKKIIFN
>EGALAKHO_04275 hypothetical protein
MFPKKQVLTRSLILKNLGLLLLLVPFKMFSQKPVTRIHTDWKGYWTAAAKTSEGNRPDDA
NNLLAFTWEGKTYSTGVNDNILISKNVTYIPQRFRALKIQTLGLDSGMYILQGSMIDGDL
SKAILIPGLVGSSATGAELASRLTDGMNGLSLGTGVANIKKATISEFKIGTDNLNLTGIK
DGIPDLIVTQVADTGGDADIFKFVDKDGKTVGNELSIKFESVSAVGTYSLDLFKADGGSN
GFSPAATRDIRILGIETKDFGITESNSPLVDRFVVSFSGSSDCAFIAFNTNSLKIAELSL
VKKGILTSCGKEGGEIKYTFEITNTGEVPITNIKLTDPKVGMTISGGTIASLAVGEKATI
NGSYIITAADVAIGKVINSAKVTGIDPSLNVVEDLSGETNQDDRPTETILLAAPIVGTIT
NTSCSSATGSVFLSNLPNGAWTIDRTPSATPINGTGTSTTISNLPIGNYTFTVRTPAGCK
SPSSTIATITNQSTTTWNGSTWSHGIPDATKNVVIAGAISITSDLTACSCTINPGISITV
PSGRTLNISNALTVSPTSTLTFENKSSLLQTSNDPNINSGKINYERITLPIRKADYVYWS
SPVKGQTLAGVSNLTGSSFYYAYNGSNWVSTAKTSIMTVGKGYIIRGPETYSNTERKIYP
ATFNGIPNNGNLSGETVAANKFYLIGNPYPSALDAEAFILANKLILEGSLYFWTHNTPVV
LGGAYEYASDDYATYNLSGSVKTMTAAPSGVKDPENYNVQPSGKIGAGQSFFANTKAPGS
ITFNNSMRRGGSDNGQFFKPGNTAKATVLEKNRIWLNMTNAGGVFKQLLVGYIEGATNDY
EGSFDAETFDGNKYLDFYSVNNERKLVIQGRSLPFSEKDTVQLGYRSTLAGDFTISIDQT
DGSMNTQSIYLEDKTTGKIHDLSTANYTFTAEKGTFDDRFILRYTNKTLGTGDFENVENG
LLVSVKNKTIKVTSANENIKEVSIYDISGKQLYIKNKIGTSELQISNLKSGSQILVVKVI
LENDFMTTRKIIFQ
>EGALAKHO_04276 3-oxoacyl-[acyl-carrier-protein] synthase 2
MNTNKISITAFSSISPLGNSTDEVWKKYLDNQHCFSQQLLDQQQTSVAALSAESEQIVAE
IRESDSKYKFLDDSVLFALAASRKAVKQAGWNSDDIFGINIGSSRGATDLFEKHYKEYID
TGKAQTLASPTTTLGNISSWIAHDLQSVGPEISHSITCSTALHALLNGVAWLKSGMADKF
LVGGSEAPLTDFTIAQMRALKIYSRINQTEEAWPNLAFDFEKTQNTMILGEGAAVCCLEA
GEKENAIAYVTGVGYATEILEHNISISAEADCFQKSMKMALKDESLEDIDVIVMHAPGTI
KGDLTELRAIEKVFGSKLPLLTTNKWKIGHTFGASGILSLELALLMMQNDTFIGVPFGEN
QNQTKPIKKVLINAVGFGGNAVSILVEKR
>EGALAKHO_04277 Adenosylmethionine-8-amino-7-oxononanoate aminotransferase
MTLTEKDSQYLWHPYTQHKTSQMPIAISRGEGALLWDENNKEYIDAIASWWVNPFGHSNK
FIADAIYKQLTTLEHVLFGGFTHEPAIKVAEKLMEILPKNQQKIFFSDNGSTAVEVAIKV
ALQYFFNKGEKRTTIIAFENAFHGDTFAAMAASGISFYTQAFQGMFIDVVRIPVPVKGQE
EVSFEALKNVIQTHNCAGFIFEPLVQGAAGMVMYEPEALGKLIQICKENKVLTIADEVMT
GFGKTGKTFAMDYVSEDPDMICLSKALTGGTIPMAITTFTQDVFDAFYDDDINKALFHGH
TFTANPTGCAAALASIDLLQTDEMQANIERIHKSHLTFQKKIESHVKVITARTLGVIFAV
EIKSDAEESYYGSMRTKLYNFFIDKGVILRPVGNIVYILPPYIMTDEQLQKVYKTIEEAI
EMV
>EGALAKHO_04278 ATP-dependent dethiobiotin synthetase BioD 1
MKIFITGISTDVGKTVTSAIVVEALEADYWKPIQAGDLDNSDSHKVKSHVSNSKSQFFPN
SYALNTPASPHLAAEIDGITIDLKQIQEPKTENHLVIEGAGGIFVPLNEKDAIIDLIQPN
YKVIVVSRHYLGSINHTLLTIEAIQHRGFQVAGIIFSGSENKSTESLILNKTGIKCIGRI
DQEPYFDQNVIREYADLFRDNLLNL
>EGALAKHO_04279 hypothetical protein
MDFNDIQNAWNNEKTENVVLPNNLQKIQSANTPLDQIKKNLKKEFIYQIISIVLIGLVPL
ICPFPPKGVILFYLLFSLFTAVCIYYLVKFYLFYKRLGAITLKTKDSLYETYFDIRLHME
LYKTFGFALTPFLILYLIGLFYFKLSKIAGFFADEFTHYQLIGLFSIVVFTMLFMGIALE
WWVHKFYGKYAKEIKKVIEELRED
>EGALAKHO_04280 ECF RNA polymerase sigma-E factor
MYMDNADDQLDLFQEIVCQLWKSYDSFRNESQFSTWMYRVAVNTAIVFLKKEKRKLDKYE
ITSENIKEDEGDSDIKENQIDHFYKAVQKLEKIDKAIIFYQLEGFSHKEIGDNLGISEGN
ARVKLNRAKEKLKEIIKNQGYGF
>EGALAKHO_04281 hypothetical protein
MKNIFKSIIVLIAVVFSGTLYAQTQSPKLENSLLWEVSGNGLSKPSYLYGTIHMICSGDY
FLSEKTKKAFDASDKLVLEINLSDPKELTEMQQLAMGKEPLSKRLSPEQLSKLDAILKKS
TGMTVQQVDAFSLVTVMSLISMKTFGCNDLKFYEMDFIESAKKRSEEVIGLETVKLQFKT
IDDAYTDPEMIEMLEQSDVEETKQLVVDYKQENLNALYKNTTAENIMNTKAKKYMLDDRN
LNWVKILPEMMAKQSVFVAVGSAHLAGDLGIINLLRKAGYTVKPIMN
>EGALAKHO_04282 8-amino-7-oxononanoate synthase
MKLPENLIQKLETRKQNNALRQLPSFNNLVDFSSNDYIGFSRSEAIFKLAHHYLVENEII
QNGATGSRLISGNHSLYQIAETIIAEFQDAESALIFNSGYDVNVGFFSAVPQRNDVILYD
ELSHASIRDGITMSNAKSYKFNHNDLEDLESLIVKFQSSKTQSPINIYIVTETVFSMDGD
TPNLEELVSLSEKYNCYLVVDEAHTLGVFGEKGEGLTQYLNLHHRIFARIMTYGKGLGCH
GAVVLGSTDLKEYLVNFARSFIYTTGLSPHSVATILVAYQHLEIEKGNIEKLRQNIVFFN
QQKNLLGLKPMFVRSKSAIQSAIVPGNEKVKQLAQQLQDKGFDVKPILSPTVPEGQERLR
FCIHSYNSEEEINQVLELLRDFVF
>EGALAKHO_04283 hypothetical protein
MFELIYSGNVLYGLRFVLAILVLFVCAAGLTFVKKVYTNSVLKTVRFNFTLFRIPLGKDN
VFKDVKYISVYKNYSDRDYEIKMWLSDIKKETVSVHLDATSAFKLASSIADGLEVDLLDA
TEKGNFKWIEKENLK
>EGALAKHO_04284 ATP synthase epsilon chain
MILEIVSPEAKLFSGEVTSVTLPGVDGSFQILNHHAPIVSILEKGTIKIAAASFNFSKEV
ADKFTKVNDQTYTLEITSGTIEMKDNKIIVLVD
>EGALAKHO_04285 ATP synthase subunit beta
MSKVIGKVAQIIGPVVDVVFNGKDVELPKIYDSLEVTKKDGTLLVLEVQSHIGENTVRTI
SMDSTDGLSRGYEVVGTGNPIQMPIGPDVYGRLFNVIGDAIDGLGNLPKTGENGLSIHRQ
APKFEDLSTSSEVLFTGIKVIDLIEPYAKGGKIGLFGGAGVGKTVLIQELINNIAKGHGG
LSVFAGVGERTREGNDLLREMLESGIIKYGDDFMHSMENGGWDLSKVDMPGMRESKATFV
FGQMNEPPGARARVALSGLSIAEYFRDGAGTDQGKDVLFFVDNIFRFTQAGSEVSALLGR
MPSAVGYQPTLATEMGAMQERITSTNKGSITSVQAVYVPADDLTDPAPATTFAHLDATTV
LSRKIAELGIYPAVDPLDSTSRILTPQILGNEHYDCAQRVKEILQKYKQLQDIIAILGME
ELSEEDKLSVSRARRVQRFLSQPFHVAEQFTGIPGVLVDIKDTIKGFNMIIDGELDHLPE
AAFNLKGSIQDAIEAGEKMLAEA
>EGALAKHO_04286 hypothetical protein
MKKNIKWLLLVSLTFMACNNDESDAPAEVPVVPGSAVFTKYVALGDSFAAGYSDNALFKK
GQEGAYTNILAQQFVAAGGGAFATPFMNDNLGGLLLGGNVIAGTRLYFVGETQTPTNVPG
KPTTEVTAHLTGTFGNLGVPGAKSFHLLAAGYGNVAGVASGAANPYFARFASAPGTTVLA
DAVAQNPTFFSLFIGGNDVLAYATSGGTGKDQTGNMNPATYGGSDITDPTVFASVFNNLV
TGLTAKGAKGVVANLPYITALPYFTTVPYNPLTPKILGGGNEAVGKATIKALNAQLYGPL
KQALTVFNAGDRINLLSETATNLPLLIKDESLTNLSAQLTAAFTPTLGAQTAAFYGAVFG
QARQAKATDLVVLTTRADIGTAPTAANSGVGIAPPAPLDKFGITYPLQDKHVLTPTETAE
VKKATDAYNVTIEAVAKEKGLAFVDTKATLTQLASGGIKFGNFTMSSSFATGGAFSLDGV
HPSARGYGLIANIFIDAINAKYGSTLRHVDLALYPIQFPQVIQ
>EGALAKHO_04287 TonB-dependent receptor SusC
MRVYLLIMLFFCGASFAQNTITGSVTDSNKQSIPGANINVVGSSTGTSTDFDGSFKLNTT
AKPPFAIKVSAVGFETKTINVTSLNQKLDVVLKDEETKLDEIVVSASRTPERVIESPVTI
ERMGIQEIKNTTAATFYDGLENLKEVNFNTSSISFKSINTRGFATVANTRFMQLVDGMDN
SSPALNFVLGNLIGVSDIDVANVELLPGASSALYGANAFNGIMFMNSKSPFTNEGISVYY
KYGQTSQDAAGTNDYNDFGIRAAKAFTEYFALKANFTYMEATEWIAADKRSMTGGSEGHA
MNQNYDGLNIYGDEVTTFIPNVGQVSRTGYREQDLTDNKVKNVKADFSAHIKPFKDDTEV
ILQYKIGLGSTIYQGANRYALKDFVMQQGKIEVKGKNFFARFYGTTEDAGNSYDMRFAAW
NVNRAAKSDQEWFTNYATAYQYSGAVMGTNANESAAIARNFADYNVLPAAISFIPKPTGS
ARFEPGSAQFNSALKTVISNPDLTQGAKFIDHSKLYHSDVNYNFKDMVKWAEIQVGGSWR
KYIMDSEGTIFTDYDGPIEYKEYGAYAQLQKKFMDDRLKFTGSLRYDKSQNFDGNISPRV
SFVYSAGESKRHNFRLSYQTGFRNPTTQDQYIGLDLGPFALIGSAADNLDRFQETVNVSA
AGQTIAGQPATIGMSGQNAYHNAYTVASVQAFAASANPADLQVANIGLVKPEQVQAFEIG
YRTVVQNDLSIDINAYYNIYNDFMNTARVISPYYGTVGTDSSNPAVQQSYQALAFGDRRV
YQVYTNTTAEVSSLGFGVGLSKKVYKDFELGVNYNYAQFDFDQSEDPSFIAGFNTPKHRI
KASLGNAKVIKNLGFNVNVRWNTEYLWQSSFGDGMIPENTVLDAQVNYAFPKLKSVLKVG
ATNLFGKDYLQVIGAGAIGQMWFASWTINP
>EGALAKHO_04288 hypothetical protein
MSRFFLLSDFFSNPCIFIKSSFFILNFICMHTILDLNCLLVAVSLIKVNVKKLKY
>EGALAKHO_04289 Glutamine--fructose-6-phosphate aminotransferase [isomerizing]
MCGIVGYIGHREAYPIVIKGLKRLEYRGYDSAGVMLHDNSGIKLCKTKGKVSDLEDKAKD
GFTTNGTIGIGHTRWATHGVPNDVNSHPHLSNSGELVIIHNGIIENYAPLKEELIKRGYT
FKSDTDTEVLVNLIEEVQKNEGIKLGKAVQIALNQVVGAYAIAVFDKKNPDEIVAARLGS
PLAIGVGEGEYFIASDASPFIEYTANAIYLEDGEMANIRLHKPLKVRKIKDDSLVDPYIQ
ELQMNLEQIEKGGYDHFMLKEIYEQPSVIRDTYRGRLHANEGIVQMAGVEDNLEKFLNAK
RILIVACGTSWHAGLVAEYIFEEFTRIPVEVEYASEFRYRNPIINKDDIVIAISQSGETA
DTMAAIKLAKENGAFVFGVCNVVGSSISRESHAGAYTHAGPEIGVASTKAFTTQITVLTM
IALRLGKAKGTLSNSDFHAYLQELEIIPEKVAEALETNDRAKEIAAAFKDAPNCLYLGRG
YNFPVALEGALKLKEISYIHAEGYPAAEMKHGPIALIDEHMPVIVIAPKQGHYDKIVSNI
QEIKSRSGKIIAVVTKGDTQVRELADYVIEIPETSDALSPLITTIPLQLLSYYIAVMRGC
NVDQPRNLAKSVTVE
>EGALAKHO_04290 hypothetical protein
MYNTSFIKKILLVATVVLLYSCDKDFNAIGDDLIGDNHFGLESEKYDVLAYNQEVTPVQS
NALTINGLGIYDNPVFGTTNGNYATQVGLAEYSPVIGEEPEIESVVLSIPYFNHIKSTNT
DGSTVYELDSIFGSPEGKLKLSVYESGVQMRGSYFDNGSQLVQLYYTDQNAEFDNFKKGN
RLNDDSNVFQNDQFFFDATEKVDSTTDATTKKVTVTRVAPEMRLNLNKAYFQTKILNAAA
SKLSSTDVFQEYFRGLYFKTERSGSSPSNMALIDFAKGKITIKYKAKTEITTDAETVKED
KSLVINLGGGANVNLLTDTKKTEYANAINPASVNKTEGDQELYLRGGQGSAAVIDLSNFA
TKLAEIRDNKWMVNEANLVFYIDSDKMTGADEPKRVYLYDLTNNVPLIDYNDGTSGSLTP
EDVKGTKFIFDGMLKVDATTKRGKYYKVRITNHIRNLIKDATAVNVKLGLVVTEDIAVVA
SNKLKNRIQMSPDEYFSEVPRGSVMSPVGTILYGSKASVPDDKRLKLEVYYTKPN
>EGALAKHO_04291 Glycogen synthase
MKDKRILYVSSEVVPYLAENEVSLMSYDVPKMINDQGGQIRIFMPRYGNINERRHQLHEV
IRLSGMNLVVNDLDMPLIIKVASIPKERIQVYFIDNDEYFKRKATFADEEGVLYPDNDER
AIFFAKGVVETVKKLNWVPDIIHVHGWLAAMLPIYMKHYYKNEALFSETKIVTSVYGQSF
DENLDLEMINKVKFDGVPHESVADLETPNYENILKASILHSDAVIIASENVSPSLTKFIE
SSGKPFLPFAPKDAFAEAYTNFYKSMGL
>EGALAKHO_04292 Pantothenate synthetase
MFALNFNNTAMHIFYGKVALIAYLKTIKTANSTIGFVPTMGALHQGHLALMQRSLKENND
TVVSIFVNPTQFNNPEDLEKYPRTLEEDVKKMRGLSDKIILYAPSVDDIYEGKTISQDFD
FDGLENQMEGKFRPGHFNGVGTIVKRLFEIVTPTNAYFGEKDFQQLQIVKKMVEKNHLPV
NVVGCPIYREENQLAMSSRNERLTTEERKEAAIIYKTLTEAKEVFKTKSPEETVEFVKNS
FKENEKFELEYFVIADESTLLPIENKSIDKKYRAFIAVFVNSIRLIDTISLN
>EGALAKHO_04293 Aspartate 1-decarboxylase
MQIQVIKSKIHRVKVTGADLNYIGSITIDETLLEASNIIEGEKVSIVNINNGERFETYAI
KGEKNSGDITLNGPAARKVQKDDIIIIISYATLDFEEAKTFKPWIIFPNENDNSLT
>EGALAKHO_04294 hypothetical protein
MKKAYLLFILVSISSFAQKKFDNIKSEKLGDERRITIGLPASYEANPEKKYPVLYLLDGD
YLFDPFSGAISYGSYWGDLPEMIIIGVHQNKDEERYDDTTIDQNTGLPFEKGAEFFEFIG
GELLPYIEKKYRTAPFKIIAGHDVTASFINFYLYKEQPLFNAYICLSPELAPKMEVRVPE
KFAKVTEPFFYYLSAADGDIKKIKEPIEKLDSNIRIANNPLVNYKYDVFKNTTHYTEVLH
SIPSALYQIFEIYRPINSAEFNDKIAILQSGYADYLENRYNAMSKVLGVQIPVRMSDFKV
IENLILKRNAYDELGKMAEIGNVNYPKAMLGEYELGLMYEKMGDPKRASKKYQNASQMEP
IGDLNKDLMYEKIDEMNTLAKKTK
>EGALAKHO_04295 DNA repair protein RadA
MSKVKTSFFCQNCGTQYAKWQGQCNACKEWNTIAEEIIQKQEKVAWKSEPTSSTKAPRPL
KINEIDSAQEIRMDTTDGELNRVLGGGIVPGSLTLLGGEPGIGKSTLLLQISLKLPYKTL
YVSGEESQKQIKMRAERITPNSDNCYILTETKTQNIFKQIEAIQPEIVIIDSIQTLHTDY
IESTAGSISQIRETTAELIKFAKETNIPVILIGHITKDGNIAGPKILEHMVDTVLQFEGD
RNHVYRILRSLKNRFGSTAELGIYEMLGSGLREVSNPSEILISHKDEEMSGTAIATTMEG
MRPLMIEIQSLVSTAVYGTPQRSTTGYNAKRLNMILAVLEKRAGFRLGAKDVFLNVTGGI
SVDDPAIDLAVVAAILSSNEDIPVTKGFCFAGEVGLSGEIRPVNRVDQRIQEAEKLGFNT
IFVSKYNKIALKNTGIKIELVAKIEDVASILFG
>EGALAKHO_04296 Biosynthetic peptidoglycan transglycosylase
MNFPKQKIYKALLILALVLAVLFSGLYFFRDSLLKQAIAKVTHKMTVDYNSTFSVKSASF
DGLSTIKLTDVILVPKNADTLFHIHKIETSVSLSNLLIGDVQLGTLKINNGYVQFVKKGK
VRNFDAFLKRDKSESDTNEKRKYATFAYRIISQLLNLVPTDMNLENLNFRIDDNGKKASI
AISKLVLDNKQLETNLHVQSKDFDQRWNIKGFADPRNKKADIRFFNLDTGAIRVPYLDER
YNLKASFDSIRLNVENIEKDGSELHIDGYTSIANLKINHPKIASKDVVIKNARFDYRFLL
GDDFISIDSTSTMQLNKIKVKPYVSYNTEKDTVYTLKVTIPKMKAQDFIVSLPDGLFTHF
QGMEATGNFDYKLDFKFNKNKPNTLVFDSKMNKEDLRITKYGEANLNKLNGEFVYRAIIQ
NVLQRPILVGNANPNYTPLDQISPYLRKCVLTTEDPSFFQHRGFINEAFKQSILKNIRTK
KFSRGASTISMQLIKNVFLTREKTVSRKLEEILLVYILENNRIVSKERMLEVYFNIIEWG
PNVYGIGEASHFYFQKPPSALNVDECLYLATIIPKPRKFMYQFNEQGNLKDYAIKNQKFL
KNLMFRRGLLMPEDTIGQLPVYISGNARSLIKIKAPDSTAVPADSLSIGDEFDL
>EGALAKHO_04297 General stress protein 69
MKYTTLPNTDIKVSKICLGTMTFGQQNTEAEGHAQMDYALERGVNFFDTAEMYSVPASEA
TYGSTEKIVGTWFKKSGNREKVILASKIAGPNANFGYMREKLDFSPASIKYAVENSLKRL
QTDYIDLYQMHWPERKTNTFGQRAFKVQNDPWEDNFREVLETFDGLIKEGKIKHIGVSNE
NAWGMMRFLEESKYQNLPRIKTIQNPYNLLNRLFEVGSAEVSIHENVGLLGYSPLGFGTL
TGKFLTGEKHPNARINLFPQYTRYASEQCTQATKLYQEIAKKHGLTLTELAMGFVLQQPF
LTSAIIGATTLEQLKENIDTIDIVLSKEILNEIEKVQAIIPDPAP
>EGALAKHO_04298 putative lipoprotein YiaD
MIKKTSIGLLVVAMSMTSCVSKKIYNDLESKYSDLKKENRSIADENADLKTAKNQLELDR
DKLTKDLNSTKDDLAKQKADLAAAQNKFKVLQDSYNALEKNSNDALESNMAKNRELLAQL
EAKSKKLAEEQARLDKTASRLNELEAMIAAKEAAMKKLKETLSKALNGFEGKGLTVEQKN
GKVYVSMENKLLFNSGSWAVGVEGRKAVVELGKVLGDNPDLSVLIEGHTDDDPYAGSGPI
ANNWDLSTKRATAIVAILSENTKINKQKLTAAGRSEFSPLASNATPEGKAKNRRIEIILT
PRLDEIAEMLNSIN
>EGALAKHO_04299 Exodeoxyribonuclease
MKIISYNVNGIRAAITKGFIEWLQQANPDVICLQEIKATQEQIPVDDITAAGYPFQYYYP
ATKKGYSGVAILSKIKPNNVVFGTGIHHMDFEGRNLRADFDDCSVMSLYLPSGTNIERLD
HKFMFMDDFQNYINELKVTIPNLIICGDYNICHEAIDIHDPVRNKTVSGFLPQERAWLDG
FMKSGFIDSFRHFNKDAHHYSWWSYRAGARGNNKGWRIDYNLVSDSMEHRLKRAVILPDA
VHSDHCPVLVEIE
>EGALAKHO_04300 hypothetical protein
MGLVTAKEVAKAINVDKYGVFGTFSGWILMKVLKISTLNKIYDNNKHLEDVAFLNGILDE
MEIKFEIPEEDLKRLPKDGAYITISNHPLGGIDGILLLKLMLEREPNFKIIANFLLHRIV
PLKKYIMPVNPFENHKDAKSSVVGIKETLRHLSDGKPLGIFPAGEVSTYKDGKLVVDKPW
EEGALKLIRKAKVPVVPIYFHAKNSKLFYWLSKIDDTLRTAKLPSELLTQKDRVIKVRIG
KPISVNEQNEIESFEDYSEFLRKKTYMLANPFEKDSKLIDTASLKIPKAPKKIVTPASES
KMIAEVDALRNSDCRLLQSKNYEVFFATAKSVPNILHEIGRLREITFREVGEGTNESIDL
DKFDQYYHHMFLWDDETKKIAGAYRMGLGSEIYPKYGIEGFYLNDLFRFEPELHDMMHKS
IEMGRAFIIKDYQQKPMPLFLLWKGIIHTTLRYPEHKYLLGGVSISNQFSDFSKSLMIEF
MKSNYYDPYIAQYIHPKKAYKVKLKDADKDFIFDEAESDLNKFDKIIDELEPGNLRLPVL
IKKYIKQNARVVAFNVDPLFNNAIDGLMYIRIADIPESTMKPVIEEFQIELERKLSDKED
>EGALAKHO_04301 hypothetical protein
MENTKPELEIVRPENKKVTAGILAIIIGSLGVHKFYLGYTKEGIIQIVLTIVTCGIGGMM
GLIEGIIYLTKTDEEFYRTYQVGKKGWF
>EGALAKHO_04302 hypothetical protein
MENTKTEHWNRPQRSETENKKVVAGIFAILLGYLGIHKFYLGYTKEGIIQIILTFACGIG
ALIGIIEGILYLLKSDEEFYQTYQVGYKGWF
>EGALAKHO_04303 hypothetical protein
MIIFGSKTVGSTVKSGKFDCPNCRRQESYKLKNYKQYFHIFFIPLLKMRDLGDELSCFFC
NTTYLPGSVLAQNEYDTRNKLGNLSHEENTRLGLEPCDFGKRMGAYAIDFAITYAILLAV
IYAIPEGTAFLILIGFVYFMACDFLLKGSSLGKLALSIKTVDFEEGQQILAYNVILRNLI
KGICTFFPLIFLTSLMNQDKRTLHDLAARTMVVDK
>EGALAKHO_04304 Hydroxypyruvate reductase
MSIKILHIDSNNPILWQQLEKAGFENHADFKSSKEEIEAKIQDYNGIVIRSRFKIDKTFL
DKATNLQFIARVGAGLESIDCDYAETKSIHLIAAPEGNRNAVAEHSLGVILSLFNNLNQA
DAEIRAGHWNRESNRGHELDGKTVGIIGYGNMGKAFAKKLRGFDVDVLFHDILENIGDEN
AKQVSLAELQKRADVLSLHLPWTTETDKMVNADFIKAFAKPFWIINTSRGKNIVTADLVE
AMKSKKILGAGLDVLEYEKLSFETLFQDKNTPEAFQYLLEAKNVLLTPHIAGWTFESHER
LAQVIVDKIKAVYLK
>EGALAKHO_04305 Na(+)/H(+) antiporter NhaA
MVLTKTFKSFFENEKSGGLLLLFVTIISLYLANSSFQTEYIAFWEKDLGGHSITHWINDG
LMTIFFLLIGLELEREIYHGELSNIKNASLPIIAAFGGMLVPAGIFLALNFGTATQNGAG
IPMATDIAFAIGILSLLGNKVPPSLKVFLTALAVIDDLGAIIVIAVFYTTSISFLNLAIA
LGIWGFLFILNRMKVQNLIPYLVGGVFMWYFMLNSGVHATITGVILAFVIPFGDGGEKSS
SYKLQHFLHRPVAFLILPLFAVANTCIAIESDWHQGLNHPNTFGIVLGLVLGKPLGILFF
SFIGVSAGLCTLPKSLKWPHILGAGMLGGIGFTMSIFITILAFKDPETIIFSKIAILIAS
VLSGVFGFVYLKYILKQQPNSNEIDT
>EGALAKHO_04306 hypothetical protein
MKSIHKIIYPVFSILLISACTNKKAENVIDRDTPKTEISIEPNKNEESIEGIYKTSACDI
SIEITKTKNGYQYFLKTSLRKVKGTATFSKSDSGEKYLVLEGIKWDEYEGDISTQENDSI
TETETKELEIPVGIDASYAKDTLTIQNYGNSMNSYTKISECGLKYIQLIKK
>EGALAKHO_04307 hypothetical protein
MIARIWHGKTKLEDYEVYTEFLQKTAIPDYSKTSGFIKLSFLRNIKNNEGHFTLITYWEN
LEVIKNFAGEDFEKAKYYPEDDDFLLEFEENVEHFEVFA
>EGALAKHO_04308 Pyrroline-5-carboxylate reductase
MKVHIIGGGNLGVSIALGIAKFSKNNQVTVTRRNTASIQYLTEYGITVSNDNKHNIQEAD
VVILTIKPYQVDTVFAEILPIIKGKTIASAVSGLSLDMLQSKTKNEYPVVRIMPNIAAQF
GESATCISFPETDREEAMPIVDLFQDLGTAPIIDEKLMDAATVLGACGTAYALRYIRASM
QAGIEIGFDSQTALAIAAQTVKGAAKMLLEEKVHPEQLIDRVTTPQGCTIVGLNEMEHNG
FSSSLIKGIKTSLKQIKG
>EGALAKHO_04309 Magnesium transporter MgtE
MEFKVSKELIHQLEEHIVNKNDKELEVLLNDLHHADIAEILDELDFDEATYIFRVLDSDK
TAEILLELEDDLRENILSRLSPKEIAEELDELETNDAADIIGELSQEIKAEVISELNDVE
HAKDIVELLRYDENSAGGLMGKELVKVNENWNVLTCVKEMRIQAENVSRVHSIYVVDDEN
RLKGRLSLKDLLTTSTKTQIGDIYIRKLNFVNVDTEDVEVARIMQKYDLEAIPVVDELGR
LVGRITIDDIVDVIKDEADKDYQLAAGITQDVESNDSVLELTKARLPWLLIGMVIEIVAS
FVLKGNEATFQKYSTLIIFVPLLSATAGNIGVQASAIVVQGLANGTLKEFSRGYFSKEIT
VSMISGSIISLLLLGYHSIMYQQYLVGMAISISMIVVILFAATLGTLVPLFLHKNKIDPA
IATGPFITTTNDVFGIMLYFGVAKLILGF
>EGALAKHO_04310 Ribosomal RNA small subunit methyltransferase A
MEKVKAKKHLGQHFLKDESIAKAIADTLSLKGYDEVLEIGPGMGVLTKYLLDKPINTHVI
EIDTESVTYLGENYPKLKDQIISQDFLKYNINEVYKDKQFAIIGNFPYNISTQIVFRTLE
FRDQIPEFSGMFQKEVAERICEKKGSKAYGILSVLAQAFYITEYLFTVDENVFIPPPKVK
SGVMKMTRKEDYSLPCGEKLFFTVVKTAFQQRRKTLRNSLKTLNLTDDLRLDTIFDKRPE
QLSVEEFIELTQKIEADGVQS
>EGALAKHO_04311 hypothetical protein
MIIYNVTTNIHESVHDQWLKWMQEKHIPEILATNKFSSARIVKVLIEEEMGGITYSVQYV
TDNKETLERYYIEDEPGFHREALELFADKMLSFRTELEVISEH
>EGALAKHO_04312 hypothetical protein
MKNIFIYIVLLCSGFAFSQNEQLAQYYYDKGDFEKAKISYEELLNSAPSNTQYFLRTVDC
YQQLQQFALAEKMIQDRYNRYKQGVFLVELGYNFQLQKNDAKAKNYYDQAIEKIKTNPND
VYGIGNSFEKKVLLEYALKAYQTAMQVQPNYNFNFQIGMLYGQLGKTDQMIDLLLTESYN
NPQNANLIQTQLSRFMNGETDNTAFKDAMRKALILKTQKDQDVFWNHYLSWFYVQQKEFG
KAFIQEKAIYKREPESLLSIVNLSQFALNEDDTETAAEILNYILLNTKDLDLLVQTNYYL
MEIKIDKAQEKDYPIIDAELQQLLTTYEITPFTLSLQLIQAHFKAFNLKKPEEGIAIVKR
ALELNLNDYQEADAKMELGDILLLQEKFNQALIYYSQIQLDLKNDVVAHEASLKAAKTSY
FKTDFEWALKQFKELKSANTQLIANDALEYFLLINDNTVADSTQTALKQFAKGDFLIYQN
KKTEAIAQFQNILTTFKGQEIEAVTMLRLGKIYESQKDFTSALSQYQQIIDHHSDGIYVD
EALFFSAEIYNDELKDIEKAKPLYEKVIFNHQDSIYFVDARKKYRELRGDKNL
>EGALAKHO_04313 Prolipoprotein diacylglyceryl transferase
MSAILNWNVDPVIFMITDSFPLKYYGALFASGLLLGYYIVRNIYKKEQLPLDNLDSLLIY
VVVGTILGARLGHCIFYEPDYFFKHPIEILLPIQKIAGVYKFVGFQGLASHGGTIGVLIA
IILYCRKYKVNFLGLLDKMAIGVPVTAAFIRFGNFMNSEIYGKPTNGNWGVVFQRDDLIP
RHPTQLYEAFSYLLIFAILFWMYKSEKIRQANGLLFGTFLALLFLARFLIEFFKENQESF
ENNMLINMGQILSIPFILIGLTLVIWKSNVEIK
>EGALAKHO_04314 Serine--tRNA ligase
MLQIAFIRENQEKVIKALAKRNIDAKSVVEEVVQLDENRRATQVELDNTLAESNKLSKDI
GELMKAGEKSKAAILKEKTVSLKEKSKELGEKAEALATELTNKLYTLPNLPADIVPEGKT
PDDNLNVFEEGDIPVLHEGAQPHWELVKKYDIIDFELGVKITGAGFPVYKGKGARLQRAL
INYFLDKNTAAGYNEVQVPHLVNEASGYGTGQLPDKEGQMYHSTIDDLYLIPTAEVPVTN
LYRDVILNESELPVLNTAYTPCFRREAGSYGAHVRGLNRLHQFDKVEIVRIEHPDNSYAA
LDGMVEHVKDILKELKLPYRVLRLCGGDMGFTSALTYDFEVFSTAQDRWLEISSVSNFET
FQANRLKLRFKDKDGKNQLAHTLNGSSLALPRVLAGILENYQTPEGIVIPEVLRPYCGFD
IIN
>EGALAKHO_04315 hypothetical protein
MKIKSLLLALTLSIGLFTTSCSSDDNEGETLVPLEGKWDLSKTGIVVGGTEQLNDPVENQ
SGCSKDYIELKVDNTINVGDYGTACTLTVQSGIYSRSHNNITTVVNGVTKTQDIVNLTLK
ELKVKDAAGIITVYTR
>EGALAKHO_04316 hypothetical protein
MLFLLVEIGFSQNKINLFSEINYSSIPAVSLNDYKSVQERNTKFQNPNIALGIAISGGGS
RAQFFSMGVLLGLEEIQENNQQRNFLNEIDYFSTVSGGCYSAGYYLTILKNKLNHNNCTF
NEFYFSKADAFKDYVDKSATILSLLSNGRNERGDKISMTQRLDSEILQYDSTNPENPDKF
STQMLLSDFFVPKESKNTPSLPMMVANGTAYNNGERVPFMPHIIRGLNLNSSLAPNRASL
ALNRNEVNDGFNFPVTYAITASSAFPGVLPKVKFGVKNQQKILCIIDGGASDNMGYKTLV
ELLNNDSKVDNKNKRALFIDCLGQGKKEPYISDEKIKLISLFETASLYTVQTRYITFDRD
VENLMDRYKIPVSNYQVIGFTTLRDHLLKMEKDQQYEDLVTELKNSDDDYSTWLRFYANF
KKELIDQFGELSFTKDKDGEVILATLTRHKFNELTASEILILYEFASHVQTKLRIAPEER
EVLLLSGRLATFLKTNELKELLVERK
>EGALAKHO_04317 Xanthomonalisin
MKKIATILCFTAFLVLSFSCGKDDIEKGIDCIAESIYEKVIHTADASDPKKINFSVEYTG
DKTLKSVKWTFGDGTPSVDGISVSHTYSAAGTYSVKADITVQDGKQTCTSSPVKSVTVN
>EGALAKHO_04318 hypothetical protein
MFFLLIIHFWWWEFNLKLITEWYFIDYFFIICYILIYYLLCAILYPDDLVDYTGYEDYFY
SRKNWFFAILAISFIADMIDTAIKGGNYFLYNQNEYYVRIATHVVLCVIAIKIHNKTFHT
VLAILFIVYELSYILRLFNVE
>EGALAKHO_04319 hypothetical protein
MEELTHIKSIIGIILGLSLTHLIKGSVIFIQHPGRKKVYFVHSLWVFYVFLADYSFLVVG
V
>EGALAKHO_04320 hypothetical protein
MEEFGRIIVSETAMNSENLQDIIHSNISVINLMREEGVDDEFIHPDALMSYYLDYYWSQY
AEGNFAQFVYKSGWNKELNELIEEGLTLLGAEKHLELFQQQSKKVKLMSSVKLNKFVSGK
FEGVNPVRDSLNNDTFYELEENLVTLNANFLKNHPDFEVLLVDDMFATLEEYVGHEIKRA
>EGALAKHO_04321 hypothetical protein
MAKGPEKNTKNKALHTKLLNRKKAKLQEEKRERALRLKALVAKMNEKNNTDGAEGI
>EGALAKHO_04322 hypothetical protein
MIVFRIIIIFLFFTSQTLSAQNSDSHKELTNVVWKMVNNNDWFKSDSLIFTKSIPNEVYY
DGVKIILTEDGTIETSYLEPTVVDAGFHERKRTGNWALEDNVLTTTILIIGNRTKFKIQE
LNGEKLVLLIIR
>EGALAKHO_04323 hypothetical protein
MKQIIFIFSVLFALTSCDSDDSQTKEVSFSTILQDDSFYGNYDNPKANLVIRNQEDWTAL
LSTMNPYTDTNYFVPDAIIDFTKYQVIAVFDEVRNNGGYSIDITKITQTNSRIFVKVEQL
KKGGDNTVMTQPYHIVKIAKSDKEVVFQ
>EGALAKHO_04324 hypothetical protein
MKAIKVYFPILIMMLSINVFAQNENNMTMTSFVPKSKAYDIYYPKSFSLKENENIVTIAD
QTSRLNITISSYAAEKEVTDEKLINQLNGFAESYYKKAIPRDNWKSYNTKFDILVELKIS
VEKANWIWWGVVNKNRLVLISISKETPITPEDTKLLQFMISNMIINS
>EGALAKHO_04325 hypothetical protein
MIRYILFFLFLIGFYSYSQENKAIQKLDKEFQNCLDHTQNNMLNCTQVYYNKIDEQLNVT
YKKIRAKLTKPEQEKLKNQQLTWLKKRDQYFKKVKAETAKELDGENESQDYRMICAHKNA
LFVRDRIIELEKVYLKN
>EGALAKHO_04326 hypothetical protein
MIFPKNLTLFYVAGILSIIAGIIYAIILINGNSAEDGLMGIYILFGLIPILLLILIDRFL
VRRFGNQKVNKVQFSFLGFIILLWIIRAIVNL
>EGALAKHO_04327 hypothetical protein
MRKGVLLVTIVFIFFGCKKEEVNEFPFDSLIVHLPVYITTFQLNLQIVILYFFKEDFPNQ
LRISTL
>EGALAKHO_04328 hypothetical protein
MTPTFFATQEKFRAWLEKHYETETELIVGFYRVSTKKPCMTWSESVDQALCFGWIDGVRK
SIDSESYTIRFTPRKKSSIWSVINIKKVEVLTKAGLMKEAGIKAFELKSDERSKIYSHEN
EAYVLDPEYEKQFKANKTAWEYFNNQAPSYKKVIIHVIMSAKQEKTRISRFEKAIKFSEE
QKRML
>EGALAKHO_04329 putative isomerase YddE
MENRTTLQYYVLDVFSNKSYKGNPLSVVFTNGDLELETYQNISKEFGYSETSFVYYSTKK
KALKVRSFTPTGIEIDGAGHNLLGAVCGALLKRMPIFEEQNESERFVIMKNSAIPLTVSF
DAVTQYPVVQMHQKSAVIKQEIPTYRIAVALGLKIEDLDVNAFVPTIVKTEVAHTMVPIK
NSQVLNSIVPDNQLLIEISKEYKFEGFYCFTLADENQEHVVETRFFNPIIGIYEDPATGT
AAGPLIGFLTQKKFTKSEKEYKILQGVKLKQASMIEVMNREEDILVGGSSIITMKGELYI
>EGALAKHO_04330 hypothetical protein
MDRIIILIRLAVAIFLFYVLNYLLYSTFNQIPDFISAPINLILVIGALYYVYTSRKQFII
DNEDEEGMPVQLEKSSYFFIPIGAVIAFFLVYSSFRTSLYIDNGNSVPVEVKISSTTKTV
APNDFIVIDTHLGENEISINGKKKTINIQDNGRWVYNVDNLNSYIEGTVDYADPEVKSIK
SANDTTVTKLSVDKIIHKEFFKLESDFIFEAPETISVSKNAQTNTIRTQTVLYRLPKEIS
QVK
>EGALAKHO_04331 hypothetical protein
MSKTKLIINKNGSIKIEGDFEIMDSEGTVYGLQGRSALGLCRCGLSANKPFCDGGHRNNF
EHDSVAFDLPPMKTN
>EGALAKHO_04332 Methionine--tRNA ligase
MIQNPKRYTITAALPYTNGPIHIGHLAGVYVPADIYSRYLRLQGKDVAFICGSDEHGVAI
SMKAKKEGITPQEVIDKYDGIIRKSFADFGISFDNYSRTSAKIHHDTAQEFFRTLYDKGD
FIEETTEQLYDAKADQFLADRFVVGTCPKCGNDGAYGDQCENCGSTLNATDLINPKSTIT
GETPILKETKHWFLPLDRYTDFLTEWILVGHKNDWKPNVYGQVKSWVDGGLEPRAVTRDL
DWGIDVPVEGAEGKKLYVWFDAPIGYISSTKEWAAREGKDWEPYWKDEETKLVHFIGKDN
IVFHCIIFPAMLKAEGSYILPDNVPANEFLNLEGNKLSTSKNWAVWLHEYLEEFPEKQDV
LRYALTSNAPETKDNDFTWKDFQARNNNELVAIFGNFINRVVVLTNKYYEGVIPTPNEFS
EVDEQTLAELKAYPAVISSSVERYRFREALGELMNVARLGNKYLADEEPWKVMKDNPERV
KTQMYVALQIAAALSVLAEPFLPFTSAKLSKILNLSDLKEHFEGFSKFLKEKNRDAKDII
IDKVLGWNDIAENSDLIPAGHKIGEAELLFAKIEDEEIQKQIDKLEATKTANLAESKQPE
PQKELIQFEDFAKMDIRVGTILEAEKMPKANKLLVLKVDTGIDVRTIVSGIAESFSPEEI
IGKRVSVLANLAPRALRGVESQGMILMTTNAEGKLVFINPDADAPNGETVN
>EGALAKHO_04333 hypothetical protein
MKLTKPRLALICGILCISIFPILVKLKLAPGLISAFYRMFFAILLLLPYVIITKSFKLPK
TKFLLLAMLCGVLFSSDVAVWNIAIQDSSATQASLLTNLSPLWVGIGSFFFLKVRPATNF
WIGTIVSLLGMVTLVGFSFFMELNFNQAFLFAVLSGILYSIYLLVSKNVLSEVDVLSFMT
ISLLASSVYLGILCYSLDQPFTGFSNTGWFVLVLQAVICQLCAWLSISYATQHMRATRVS
LSLLSQAVITSILAWWFLEEQITLQMVFGGIILLLGIRITFYDKTISLKRLFSKN
>EGALAKHO_04334 hypothetical protein
MLHKSKIPNLKVIAFDADDTLFVNEPYFQETEHKFCALMEDYLSHQGISQELFKIEIANL
PLYGYGIKGYILSMIEAAMNISNNTIPMEVIEKIIQYGKELLEKPIELLDGIEETLQALH
GKYKLVVATKGDLKDQHSKLHRSGLGHYFHHIEVMSDKQEIDYEKLLGRLDIQANEFLMI
GNSLKSDVLPVLGIGGFAVHIPFHTTWEHEKINHKVEHENFSSFENISEVLANLL
>EGALAKHO_04335 Chloramphenicol acetyltransferase
MKTLLDLENWNRKDHFQHFSRMEEPFFGVTVEIDCTKAYQTAKSLNSSFFIYYLHKTLVA
VNTVENFKYRISEGKIYINERVDASATIGREDGTFGFSLIEYHPDFRIFEKIALEEIDRI
QNTTGLFTRSFDDDNLIHFSAIPWINFKSLSHARSFTYPDSCPKISFGKMITSESGKKTI
AMSVHVHHGLMDGLHLGQFIDTFQELITL
>EGALAKHO_04336 Outer membrane porin F
MKKIVMTLAFALSLIHAKAQTENNTTTSYNKWSVELDGGFNKPQRPFTSGNYYTSRINPY
TVDLGVRYMMNNKFGLKVDAGYNSFTGQNDSSIDFDSKYYRIDLQGVANLGRIMNFESWT
NTFGLLGHAGFGVGRLENKDLHVKDNVGNFIAGFTGQIRLSDRFALTGDVSTIVNAYQDH
TFDGRAATNSRGFSGLLFTGTAGLNIYLGKNTKHADWTVISENADVAALENKVANLEALV
NKIPEKQVVIEKPVTNTVVNDKDVVKEMINDKYYSVYFDFNKATPIENSTAAIDVVLAYL
RKNPSASLDVVGHADQVGSSEYNEKLANARANNVKTILEKAGISPSRLNVISEGADTSIE
KDSAEARRLARRVTFKVK
>EGALAKHO_04337 hypothetical protein
MKKLFLFFLLLSKSVLLSQTILNSLPLQIDKPLENGQILNIEDVKTHDVYAFITDNEKIN
ILKYNQSLFLINRYIDSIHYEKDRILIGHSISEDGNPTLYWASPNVQNIIIIKYFLETKT
SRALNFNFPQNIQHIAKFENNNNLFILAKEKNDSDLLLFTFKNGICEIKKFDFSKISIQN
EKGQNFSLATLLRYHPIQKMDSDNFNTLDKTSSLNKMYIEDGHIILTLDYDLKKTQVLDL
NIETAEIKEKNFAKPISQKPSKTSNSFYNLGKLFQINSNTEEFLFDIKDFDTEKSIKSVS
VTKNDTIRFKNSPIFLQTDNNKPQKLKTTAKFFKNLSGLRGAISVLQNDKNTYITFGGYA
EYLGTDVLYTKSDMLDDFANPGIQQFMLTKMVFFDSTMDANFDFVTKQNEPLAIDNIYYF
LSVTKNIVLENIIRLKGYYILSYYDTALKQFVLRKFTDGFIDQNIGNPIINKSQFSKPFL
FGPLNRR
>EGALAKHO_04338 putative bacterial non-heme ferritin
MLKKNIESALNKQIRIEAESSQTYLSMACWAEVHGLEGIAQFMYTQSDEERAHMLKLVKY
VNERGGHATITDLKAPKTSYSTFKEMFEALYSHEIFVSESINELVHITFEEKDYATHNFL
QWYVSEQIEEEATAKSILDKINLIGDDKGGLYLFDRDIQQLTVTSSIAINPK
>EGALAKHO_04339 hypothetical protein
MENQISIPKSSLDFLVQLKTNNNKPWFETNKPAYLNELNHIENFAGALLHELAKTDVLET
ASGKKSVYRIYRDIRFSKDKTPFKTFWGGSYTRATAARRGGYYFHLEKGNSFLAGGFWGP
NGTDLKRIRSEFAHDPESMKKILNSKSFINTFGALQGEQLKTAPKGFDVNHEAIDLLRYK
QFLLIKRFTDDEVLRPNFLEEALETFKNMRPFFDYMSEILTTDINGASVL
>EGALAKHO_04340 Single-stranded DNA-binding protein
MNAMKNRVQLIGNVGNDPEIKTLESGKKFAQLTIATNDYYKNEKGEKIEQTDWHRVTAWG
KVAEIIEKYVVKGKEVAIDGKLTHRSYDDKNGEKKYITEVVVNEILLLSK
>EGALAKHO_04341 (R)-stereoselective amidase
MQAKINKVELRNLELDDYKQLKNSMVESYPEMANSYWESADIKKLLSIFPEGQLVILVDG
IVVGSALSLIVDEKLVDKRHNYRQIIGDYTFSTHNPNGEILYGIDVFIHPHYRGLRLGRR
LYDARKELCEQLNLKAIVFAGRIPNYSQHAKKLTPKNYIDKVKHKELHDPVLSFQLSNDF
HVLRIIKNYLEGDEESKEFAVLLEWNNVYYDESPKLINLEKSVIRLGLIQWQMRQLNNVE
EFFEQSEFFIDVVSGYGADFALFPELFIAPLMADYNHLSEAEAIRELARYADPIRKRFQE
FAISYNINIITGSMPYLDNNNLYNVGFLCKRDGTSEMYTKIHVTPNEVQHWGMKGGSQFK
TFDTDCGKIGILICYDVEFPELSRIMANEGMNILFVPFLTDTQNAYTRVKHCSQARAIEN
ECYVAIAGCVGNLPKVNNMDIQYAQASVFTPSDFAFPSNGIKAEATPNTEMTLIVDVDLN
LLKQLHEHGSVRILKDRRHDLYEIKKLDS
>EGALAKHO_04342 hypothetical protein
MKTCLECSEKIVGREDKKFCSDSCRNAFNNKINKDSTNFMRNVNNKLRKNYRILAELNTE
GKSKATRDKMINKGFDFDFFTNILHTKTGNTYYFLYDQGYRSLDNDYFMLVKKEI
>EGALAKHO_04343 hypothetical protein
MKKNPTSILAVVCILAILGIIYATMMPQWISKEEEALAEFSTERALNQVEIIAQKPHYVG
STNHELVANYLKLELNRIGLETSVQEGFTLNDKGLLVKSKNILARIKGTNNSKALLLLSH
YDSAPHSFSKGASDDASGVATILEGIRAFMYSKQPQKNDIIILFSDAEELGLNGAALFVN
KHPWAKDVGLVINFEARGSSGPSYMLMETNKGNEALVREFSNAKTKYPVSNSLMYSIYKM
LPNDTDLTVFRQQGNIQGFNFAFIDGHYNYHTQQDDVQHLNKMTLAHQGTYLMPLLKYFS
NIDLNATNSTEDDVYFSVPFSFISYPFTWVFPMTIIALGLLIIFIFIGKAKRLISFREIF
KGFVPFLGALIIAGLVTFLGWKIVLQIYPQYSDLLNGFTYNGHAYIGAFVTLSIAICFAF
YHNFSETKTTMNHFVAPLLLWIVINMFLANSLTGAGFLIIPVYFGIFLFGIFVITQHYSL
GLNLIFTLPALAIVAPFIVMFPIGLGLKILFGSAILTVLLFGLLLPIFGAFIRKGAWTVF
FFLVSLGFFIYAGYHSGYEHGEAKSNSLLYVYNANTNSAVWTTYDVNLDEWTKTYLGEKN
QKAVGLNALPLTSKYNSGFTYSAIAPVVAIPKPTISFLKDSVVGNNRYMKIQITPNRKVN
RYDIFAHPKMTFFNFKANGVSTSDQKGNRLERDGMKILSYYVVGNEPLVMEFYINKSSLF
DMDLIESSFDLMTNPLFQIKPRADWMMPTPFVLNDAVLIQQKIKRYTAPVPTIEAAPIKD
SLAVVKDSLAPVVKPE
>EGALAKHO_04344 hypothetical protein
MATNISAIVLNAPIEKVWNALTQPELIKQWQYGSDLITDWKVGNEIRFRNEWEGQVFEQW
GTVLEVVLNEKIRYSLFFPRPELEDKPENYFIMSYVLKEENQKTKLEIIQEDNRPGAVQE
EHQGEENPILQGLKAITEA
>EGALAKHO_04345 Thiosulfate sulfurtransferase GlpE
MEAQIKHYENKLAFEMDPSDLFDALNNGEKVVVIDARKAFGFEAEHIPTAINIPHREMTV
ESTKHLDKAVLYVTYCDGIGCNASTRGALNMAKLGFKVKELIGGIEWWKFDGYSTEGING
IKSGLKIECAC
>EGALAKHO_04346 HTH-type transcriptional regulator MetR
MKKPFENFVSLYTNYLKMEIRHLRLIKAIVEEGSITKAIDKLHLTQSALSHQLKEAEYQL
GTAIFLRTNKKLVLTKAGEKIYELANEILDKLSQTQTQIKQMVFGEYGEIRISTECFSSY
HWLPSVMKQFHLLYPNVDLKIVTEATHIPLQKLLDNTIDIAIISDQINDNNIKYLELFQD
EVVMAVSENHAWANKKYVVAEDFVNEHLLIHSLPMETVTIHQFILAPAKVTPKKITALPL
TEASLEMVKADMGVMSMAKWALLPHLKNNPIKAIKIGKNGLKRKHFIAIRDNQEYPAYFD
HFITFLQTEINLQWNIQ
>EGALAKHO_04347 hypothetical protein
MEYTIRNCEITDLPKLVILCQKHTEFEKADYDPTGKEEGLKKALFSENPKLHCLVVATEN
DIVGYVSYNFTYSTWSAGDFIYMDCLFLEEEVRNYGIGEVLINKLKEIGKAKNCVNMQWR
TPQFNERAIKFYHRMGAKGKDKICFFLDL
>EGALAKHO_04348 hypothetical protein
MNQVSILGCGWLGLPLAKRLIQKGNSVNGSTTSESKLSILKDAGINPFLVALECESVSET
IIDFLAESEILIIDFPPKLRGNNAETSHSTRKVFVEKIENLIPFIAKSTIKKVLFVSSTS
VYGDQNDLITEETNPNPETESGKQLLLAEAILQENQNFETTILRFGGLIGEDRHPVKFLA
GKENLENPDAPINLIHQNDCINIIEEIIFQSKWNEIFNAVAPFHPSRSAYYTQKAKEQNL
ILPKFSSEKSNIKKIISSEKIETILKYKFKLDAY
>EGALAKHO_04349 Methylated-DNA--protein-cysteine methyltransferase
MEIVYINSPLGITKIIGDENGIAVISVSDVDSNEVSADIPKVLKEAVSQLEEYFEGKRTD
FDLKLNPQGTEFQQKVWKALLEIPYGKTISYMDQTKKLGDIKAIRAVASANGKNPLWIVV
PCHRVIGTNGSLTGYAGGLSRKKWLLEHENPSTQQSLF
>EGALAKHO_04350 hypothetical protein
MIEKINLNNILFLDIETVPEEENFNSLDAEMQSLWDHKTQYQRKDDFTAEEFYDRAGIWA
EFGKIVCISVGYFTIKGDIRNFRVTSFFGDEKKILKDFNNLLNNHFNQPYHLLCGHNAKE
FDIPFIARRMIINQIAIPDKLNLFGKKPWEIPHLDTLELWKFGDYKHFTSLKLLTKILGV
PSPKGDIDGSQVAHVFYVEKDIDRIVTYCEKDTIAVAQIFLRLRREDLLIDEEIIHV
>EGALAKHO_04351 hypothetical protein
MTYQEISHHRLVSQKLYQTSPISPQEIVKHLGAMQAQDYSMAKWAIGSRCDATESAIEEA
INSAQIIRTHILRPTWHFVSADDIYWMLDVSSPQVKRFTASAGKKYGYDAKKFDQTNSKI
EKLLSGNNHLTRDEIMQELGVKKTSSADFLSAAIMMNAELDGLVCNGRMKGKQITYALLE
ERVAKPQSKFTKEEGLAKLALKYFVSHGPASLLDFSWWSGFSPTICQKTINAIQLQLNSV
EINGQMYWFGTDISNENNFRESVHFLPAFDEILISYKTREASILLEHQSKAFTNNGIFKP
IILENSKVIGTWKRTMAKDHAKIETQFFNETENHKKAVIFEGIKAFENYLETKIVIE
>EGALAKHO_04352 Spore maturation protein B
MVLSRFWLTIFISSIIFVIFSLFTANTYTIDYVLNGKKDDPILISEKYAEQLPAFIKDSI
KKAPDQTMIINRDTLNADTTYVYKNKTVKIFSGVQKSDGLLPTCKTTLLDLILPLMAYLA
FFCGLMELLIISGVSGKLAKVLSPVFVKVFPTIPKNHPSISYMTLNFAANFLGLDSAATP
FGLKAMESLQEINPDKDRASDAQIMFMCLHASGLTLIATSIIGYRAAAGASNPADVMLPC
IITSFIGTIAAFLIVGIKQKINFKSASLVIGLMVLIAAIIGLLMYVNHLDLIGKNYFTTN
LSALILMFIVVATLIFSFIHEKKFTDANTTVFDSFVVGANNGVKTGVTIFPYVLGMLVAI
SLFRNSGLFEIISDGIAFVFSNMGVNKQITDALPVAMLRPFSSAGSRGFLIDSMNTFGAD
SLTGRLSSIFQCSAESTFYVIAVYFGSVNIKNTRYALGTMLLVDVICVITAIFVASWFF
>EGALAKHO_04353 hypothetical protein
MANTYHQVYIQAIFAVKNREALITNDCKSKILSVIGNLINETGCKTIVINGVEDHVHCLL
ALKPTISISELMRIVKGKSSRFINEHQLTKHKFEWQEGYGVFSYSKSHIDAVYKYIANQE
EHHKKQNFKDEYLSFLDKYNVKHDERYVFENLI
>EGALAKHO_04354 hypothetical protein
MFKRFFTKKKETETIAEIVPEDKIQSEEEIKPVENEPIEEPETKEFDSNKIDWLINDSIL
TFLPRDLYMHYSDINTKKDQYDPSWQNQGVFFWMDDEPFERKSLPEFFESYERKPFIFDQ
FPDYIELVSAKAIPWFGMPGEGDKYCLRYEENPINIEEALKLNIIKYVEIIELNFENLSV
LNDRDNHFFLINPEVKFENGLFFLNGEKISLAELYQKEKLQVITFK
>EGALAKHO_04355 Fumarate hydratase class I, anaerobic
MIDFIYQDPYPILKDDTQYRKITSDFVKVEKFGEREVLTVDPKGLELLAEEALRDVSFML
RTSHLQKLRKILDDPEATDNDRFVAYNLLQNASVAAEGQLPSCQDTGTAIVMAKKGESIF
TGVDDAEWLSRGIFNTYQKRNLRYSQIVPISMFEEKNSGSNLPAQIDIYAKNGNSYEFLF
MAKGGGSANKTYLYQQTKSLLNEKSMDAFVRAKIKDLGTSACPPYHLALVIGGTSAEANL
SAVKKASAGYYDNLPTTGNMAGQAFRDHEWEQKVQQICQESAIGAQFGGKYFTHDVRVIR
LPRHAASCPVGLGVSCSADRNIKGKITKDGIYVEQLEVNPKQFLPETAPHLEAPVEIDLN
MPMKDMLAKLSQYPIKTRLKLNGTVIVARDIAHAKIMEMLEAGQPMPEYFKNHPIYYAGP
AKTPEGMASGSFGPTTAGRMDVYVDEFQKHGGSMIMLAKGNRTKQVTDACNKYGGFYLGS
IGGPAAILAQDNILKVEVVDFEELGMEAVRKITVKDFPAFIITDDKGNDFFENL
>EGALAKHO_04356 Blue-light-activated histidine kinase
MKNTKEEIPHRNIVPILSWDFHYEYINELRAIFADLKKVDKISNRFKWNDENLEIKNRIL
DEVILVTDANLKIVFASNGIKKMTGYTESEIIGKTPKMFQGPKTSEIVLKEIRTAIELQM
PFEKTLDNYKKDGEIYKCKINSVPIFNLKGELSHFIAFESEDKSA
>EGALAKHO_04357 DNA polymerase IV
MSEAPTYRKIIHIDMDAFYASVEQMDNPALRGKPVAVGGSENRGVVSAASYEARKFGVRS
AISGVLAKKYCPEIIFVRPRFDRYKEISTKIHKIFHEYTDLVEPLSLDEAYLDVTQNKKG
NPSASLLAQEIRLRILNEVGLTASAGISVNKFVAKIASDINKPNGQKTVNPDEILSFLEE
LPIRKFYGVGKVTTEKMYQLGIFTGADLKTKSEEFLEKHFGKSGGFYYRVVRGIHNSEVK
SFRVTKSVAAEHTFDVNLSSEIFMLEQLERIATSLEKRLKKHNISGKTVTLKIKYSDFTQ
QTRSKTLPYFISDKSLILETVEELLYQEKMKDSVRLLGISLSNLNTEEKKAVVVQLKFAF
>EGALAKHO_04358 Serine/threonine-protein phosphatase 1
MRTFVIGDIHGGLLALEQVMKKAEVTAEDTLIFLGDYVDGWSQSAEVIEYLIDLKSKQNC
ICIRGNHDQLALDWLENRHEEFDEEMWYKHGGKATVEGYAKLSEERKKEHIVFLESLQDY
YHDDQNRLFVHAGFTNLNGVIWEYFPKLFYWDRTLWESALSLDPNLKPDDLYYPKRFTIY
KEIFIGHTPVTRIGKTVPVNKACVWNVDTGAAFKGPLTIMNVDTKEFWQSDPLNELYFNE
KGRN
>EGALAKHO_04359 hypothetical protein
MKKVFTFLFLVSFGLTQAQQAFKGKGDIKVNVGANLQDGGSGIQGSVDFGLGENFSFGFV
TTYLLGVDNFTGFYHNNPTPYTDEKPEFQDRFDAKARINANLSSVIGVEQLDIYPGLSIG
LHNFGGHVGGRYFFTEGFGVFTEIGFPIAKYSNDHDVFDHLNNQATFSLGASFNL
>EGALAKHO_04360 putative succinyl-CoA:3-ketoacid coenzyme A transferase subunit B
MLTKEDIAKRIAKEVKDRYFVNLGIGIPTLVANYVREDIAVEFQSENGVLGMGPFPFAGE
EDADIINAGKQTITTLPGASFFDSAFSFGMIRSQKVDLTILGAMEVSENGDIANWKIPGK
MVKGMGGAMDLVASAENIIVAMMHVNKAGESKILKKCTLPLTGVGCVKKVVTELAVLEVT
EKGFKLLERAPGVSVEHIIASTQAELIIEGEIPEMAI
>EGALAKHO_04361 Succinyl-CoA:3-ketoacid coenzyme A transferase subunit A
MITKKVNNVQEAIEGIESSMTIMFGGFGLCGIPENTIAALVNTTISDLTCISNNAGVDDF
GLGLLLQKKQIKKMISSYVGENAEFERQMLSGELEVELTPQGTLAERCRAAQAGIPAFFT
PAGYGTEVAEGKEVREFNGKMHIMEQAFKADFAIVKAWKGDEAGNLIFKGTARNFNACMA
GAGKITIAEVEELVPVGTLDPNQIHIPGIMIQRIFQGEKFEKRIEQRTVRQRN
>EGALAKHO_04362 Penicillin-binding protein 1A
MAAKKNNQSNSVKDINYYKKKFWRVFAYTLLGILAFFLFASWGLFGSMPSFEDLENPDSN
LATEIISSDGVVLGKYFKTNRSQLKYSDLPKNLVDALVATEDARFYEHSGIDGRGTLRAA
FSLGTNGGASTLTQQLAKQLFHRGGSSFLPFRIVQKIKEWIIAIRLERQYTKNEILAMYC
NVYDFGNYAVGVSSASQTYFSKEPKDLTIDESAILVGMFNNSSLYNPLRNPVGVKNRRDV
VLGQMVKAKMITESQKEKYKALPIALKFKLESHREGTATYFREYLRDYMKKWVAENKKPD
GSDYDIYKDGLKIYTTIDSRMQSYAEEAVTEHMKNLQQQFFIEQKNNKNAPFVNITQAET
EKLMMQAMKNSTRWAIMKDMDKSEDDIIASFKVKTQMRIFTWKGERDTIMTPLDSIRYYK
HFLQSGLMAMEPQTGNIKAWVGGINYKYFQYDHVGQGARQVGSTFKPFVYATAIEQLNMS
PCDSILDGPFMIHKGRHHVTEDWEPRNSDNKYRGMVTLKQGLANSINTVSAKLIDRTGPE
AVVELTQKLGVKTEIPVQPSIALGAVDITVEDMVAAYSTFANQGVYVKPQFLSRIENKSG
EVIYEPIPESHDVLNKDIAFAVIKLLEGVTETGSGARLRTEGGGSGDNRWTGYPYMFKNP
IAGKTGTTQNQSDGWFMGMVPNLVTGVWVGCEDRSARFKSLTYGQGATAALPVWAYFMKL
CYKDEALQISKSEFERPANLSIKVDCYSRPAVVKDTTATEQNTDEFEL
>EGALAKHO_04363 Gliding motility lipoprotein GldH
MRIKNSGILLLAAILLFSCDKKRVFDEYKSVGSAWHKDSVVTFDLPVLDSTKKYNLFVNL
RDNNNYPFNNLFLIVSLEMPNGFTKVDTLEYQMANPDGTLLGNGFTDIKESKLFYKEDVK
FRGNYKVHIKQAVRQSGKIPGVQELEGITDVGFRIEQKD
>EGALAKHO_04364 hypothetical protein
MACTSCSTSDGGAPKGCKNNGTCGTDSCNKLTVFDWLSNMSPSNGEAIFDCVEVRFKNGR
KEFFRNSEKLTLSIGDIVATVASPGHDIGIVTLTGELVKIQMKKKGVNHESNEVPKIYRK
ASQKDIDIWSVARDREEPMKVRARELAIQHKLEMKISDIEFQGDGSKATFYYTANDRVDF
RLLIKDFAKEFSTRVEMKQVGFRQEAARLGGIGSCGRELCCSTWLTDFRSVNTSAARYQQ
LSLNPQKLAGQCGKLKCCLNYELDTYMDALKDFPDYDTKLVTEKGDAICQKQDIFKGLMW
FAYTNNFANWHVLKIDQVKEIIAENKQKNKVSSLEDFAIEVVSEPEKDFNNAMGQESLTR
FDQPKKKKKPNRKRKPNAEGATVAAPAPNKPQQGNNNNNNNKPAGGNPNKSNKPHNKQNQ
SNKPNNSNENKPAEPRKPIIITKNENKK
>EGALAKHO_04365 RNA polymerase sigma factor CarQ
MGSSIEPHDDLLIQQYIHGNNDALNILIKRHESRIYGFIYSKIPDREICNDIFQETFVKV
IKKLQSGSYHERGKFIPWVTKISHNLTIDHFRRNKFKYSFLKSIEDTPYEYLLDETPSIE
NRIIKTQIKNDLKKILKELPAEQREILILKMYHNMSHKEIAELKNISINTSLGRVRYAII
NLRKIILKNKHDFN
>EGALAKHO_04366 Regulatory protein PchR
MKTIQQSFGADLDWIESFAKNFGGSVEGNFINTPENIDTGTRYFINTGEEDVVLLYIDVT
YNTEIHIIQSHLKKDFIGIYFNLIKGKTFKTCNDFSYDIGTLGYDVSIIDSLLETDYYVS
PGTQSYGICIFIKKIKIEQFARKNKNFSANIDKIMDDSQNTFIKFDHMSPEIFNILNDLR
NQEVGGSLFDLNLIATGYQLISNYLDRMFDNDIIEKVNNDDLMRILGIQALLINNIDQPF
PSIKTISDKAHMSETKFKRLFKKVTGTTPNYFYMSNKLKKAKELLEDKKNTITDVCDELN
FSNYSYFICKFREYFGISPNAYIKKL
>EGALAKHO_04367 hypothetical protein
MKLPLKTGNSKSIIYKLSTSSTNKNTFDSYKKAIKESHYLFPKQ
>EGALAKHO_04368 Exodeoxyribonuclease 7 large subunit
MHKTNFSVSSLMNIYSNTLTSSLDGKLVVLEGFYSDKKGKLYKDSFYDEIIDKDRKHTVT
IQLSEALKSKLSADKYFEFEGFINKGQTLENDSRLKVFFRVTKILKYEQEIQLIPKEEYD
IIRSRIDRDFPFIHDMLFDKLKQKKKPVIDIIIGINSTSTDDYKSELQDAENYDIRHHRC
NLSSQTEILDFLSKHNFRNTDLLIVLRGGGSGLELFNDIELCKRFIEIPVPFITGIGHDK
DKTLLQRVADKGFSTPTAVGIFLQSIVNRYKGFQRDMEDKNQELEHYLNQAEKEKKVFEI
QMMEQKKMVTKVWLLVACLMVIILFLIFLFLK
>EGALAKHO_04369 hypothetical protein
MAIQTKEQKSQGLSSEQLLQESPSSKINLLNEYGGFAFLENVIDGLSNLNPTRKARKNIF
LNDSQWEGERTNLTNKIDLWLDLLKDNSSVESMIEVANAKAKSADSTLNKNLKYALNVSR
ELETSYRSVALFYKNTESDKIKNVTILNADISQLKDLDNTLFFDYVSNELKQNFDRLDLR
KNYSILSVPGYLGSNAVLDKWSKIAHENKAVLLTDFQDLETPDDVIDIFFNANHTGGDVH
KSNTIMTCNYLLGRSKYDEVGEEDNLYVPPSTSLAGKIYKTLMSQVVAGKKFGGLNEVES
VRFDLKKSEISELEKMGLVPMVNEYSKIMAFSAKTLFNGDNLGLQTYSVVRVFDHITKVL
FDFLNRRAFENWTTRTEADLRSQIIKFLDGIKGPTNLIEKFTVMKIEQDKTQKDRILLDI
HITPYFPAKSFVIQLDGHKGDGPEEAVWHSDYKQV
>EGALAKHO_04370 hypothetical protein
MSMFNYGIGGNEVKVDASESILEIPSNRTLLIQKLTNEQPIAPEAIYDLQTVEAVFEKFK
PNVEFEFTTEEGSDLNESMTFKNLGDFGAKSIKENSPFLNKLNTEKEQAYKIVRQLSSNR
GLIKAIQDPAVKDAIIELLENAKSEINNNKQ
>EGALAKHO_04371 hypothetical protein
MKYLKYPVNFKSLLKGSQDSFCKIEESIAYNIMMIITTSFGEIPETPHYGTIIWDLEFNQ
HIKKRDWEDLVRKSLYESISEFEKRLILSEVTISLDEIDDKELSSSIRRKANIIVKGSIM
ESLIPFNFHTKLNISPISQ
>EGALAKHO_04372 hypothetical protein
MKDHKFIEIQSRIQKKCLEIWGIEDIKMADPLVMMLLEIFIHEFYYLHQEVIESDNKIIE
RIAQEIVPSQWNLPMPSHALASTAATNGVVILNNDTEFIVKQSMSANADYDISFTPFTNE
KIIEGEISFQMYDSFLIDSLKNVTHLPSEHRVADHRIWIGLDISKENLQKLDSLKFTFIT
ENSSLDSFLKYVTIKDTTGNVLDLENENFDEVQDNKHYTETIKSFYKNFIYKLKLNPEKL
IHESILDRFKIDKEYLKSGKKNSGLIWLEFVFPEIFSKEELDKIQIKINTFPIVNRKLNH
NVHNAEIEGRLFALKAEPNTHFLDVMKIFNQNNIEFINGIKQPNLAASNTFTLFYGGLEN
YDSRNAKFFLKKLVRALREDISAFSNINADYVDATMTKINEEINLIENKISNSYSEVNDD
EEIYALVHETEKSKILYSSYWTTNGQAANNLKRGTILKQTALSELAQDTTIFETNSMGGI
YRNNKAEKLINLRYGFLSKERLVTKQDIKSAVHYHLRNVAKHVSITDGVGISNQRKKGLF
RTVDIEIILQEKYAAQIENKHRIELFLKETLEKQSVMNIPFQITII
>EGALAKHO_04373 ATP-dependent Clp protease ATP-binding subunit ClpC
MNELDYSPSLLSAIKSAKSLAIQDGHSTYGVAHLAYALLFEPTGLVEVLKTLSKDIEYIK
EWFDVRKEVYTSSQNNDNIITADAEMEQVFSESNFNRIRLGSDYIDAFCVFIAIIKPGLI
YSDKQIEGLNLSDKELLKHFGMRNSQKSFNLEDNNDENHEVVDINYCDSLYKKNIIEQGS
SVIGRNKEVRLILENIERYENQGILLIGESGIGKTSIIKNLIYHLHETNANFFEETLVLS
LNSSKLVANCGSENEISKKLIEIFEKLTKNGKSVLFIDDIQVLLNSSSSKSGAVINIINT
QLTQGTINIIASIDSDSYRKSIEGTSINGKFETVFIEELNYSLLLECLEIYKNKLEKHYK
IGIENEVIQEAIHLSKRFYKEKKLPYGAIDLLDRTASSVIVSNANSLVEIVKIKEQIKEC
NSDDESKISLLKKEIYNRISCVVTSKINVVESAKSTKNEVVTYEDIEKLSADIETIAKEK
ISTITKAEILAVVANATGIPMGKISAGEKEKLLTIEDKLQERVKGQSHAIKTLSEAIIES
RSGLSNPKQPIGSFFFLGPTGTGKTELTKSLAELLFDDENAMIRFDMSEFKEEHSAALLY
GAPPGYVGYEEGGMLVNKIRQKPYSVVLFDEIEKAHASVYDVFLQIMDEGKVHDKLGREG
DFSNAIIIFTSNIGSAWIQEQIESGHLPTSNQLIDIMSAHFRPEFLGRLTEVVPFAPINI
EIAKAIFKLHLKRLQEQLISIKNISFDLSDSALEYLTAKGFSKKYGARPIAGTVRTYLKK
TISKLIISEAILENETIVLDIQGDEFIWEKK
>EGALAKHO_04374 hypothetical protein
MEQDIAVLKQQINFNLKGEVLFYELQNILKDKTEVFVRHKGLSKRNNSRDAIDISSMLYQ
EGSGITREALVLHLAKNSIYHNLPELLFHPLSISNSTMSNKEIVEAVKKNKEAENDALDF
FMPFDNELFSVNTNATIRSLHLFNDKIDLFLNIVDELLAIEFELSKIQKKNLFIYLCEAE
KLKENLPELEKVLETLLGNKVKLKYKKHVFTSSAFLKLNHGILGFNLGLCGAVESEIDDI
EVALYFEENIDYSILERKMTLTRKVLEYFIISNRKIDIVFFNNYHMGIRLNENYLGINTI
I
>EGALAKHO_04375 hypothetical protein
MNTLLPFFLKYLLAPLLVLIVILIMSQFSSIKIKTKPAIIFVLCFSLIAALPCFFAFFNN
EFIWLGLLLSVFYYTLLGIGLLYFSNTPLFKSIGIEDSAPAKVFIFLIIAIISSWIYYLV
FNYIAISSYAHISMANILWLFTPLFFKEAKNKYLQIPDPFYEYWKAGKERKDVEYWDNID
KFRLMQVSIDIKKKVNSDISSKFDVKIAQDVNLGNWFDKFIEDQNYRFPNDAIESSAENE
NSGWIFYTAKYFSVPLFVRNLSPYKTISESKLKNKQIIFAKRVAINKNENETEE
>EGALAKHO_04376 hypothetical protein
MKSKIYLPINWTDGVKLTKDHFVNNYFNFITIVSDYNKVQLNNFNYGCIQTANEKSLDIE
IKIEGGQLVAYLKKCELIARNGHIISFNQKDYGTKLPQVSINANDLDKNSFDHYYVVVSI
NPYHLIPVGIPDPEMIPLHHPHVLPEIKLHIISQKELNDNFLEGYFLIVKKIAFQNGTFI
EDQKYIAPVVKTKNNEILNQFISNVNNELYLLNDYSTKIYKKNSHSSANNKLVINTFSLC
TKIINYYAESNFYLKNIAPEESPIYMFDKIIILANHLLSALSLMDDKEKEILLQYYYEWV
DVKPSELLGVLFEAKNTVYDHNDITQTLDTLNQFMGVLKRLWQKLSELEYIGVRKENIVI
SEETKTLPPRSNTWSILD
>EGALAKHO_04377 hypothetical protein
MKPLNHTKISTKKRQFFGMFFITSAFIFGCLYITLITANKGVAELEQKHKYYNDIAVKQG
EINLLLDEILIEINDLRFKDRTLNERKNLQSLINEKRFAINNEIRKSKTDLTNSFVLYEE
FLVELQRVQTKIDVLKQAETNYDINKVQLEKCIEKHDQENKKIKP
>EGALAKHO_04378 hypothetical protein
MKKATDLDETYWKKQKFNLLFIISVCIIYIGVTKFLLKTPNFNNTDMLNRINDYENMQKI
KIDYANKSKVIFKTIDTIKYDINQVQRIDEVKRNISEYKQLYKDNEFHSSYNFCLIGGNV
LNIFLEINLEESTVRKNDTLIQTSLNECKANFKNEH
>EGALAKHO_04379 hypothetical protein
MNIKNKTVVIILLCITVILVIVALLFPFNKKLSNLDFSVLDQNDNHQYELGEKLSFKIND
SSLISGKKAVWYFGNGDSIVSRKNIQYTFKKAGEYLITLRINDKFDFSKQINIVNGRSLT
AKDSIPKIFCSDFGYVGEEIVFTGYSPSSNNWYWEFGETGTIDSYEKQAIYVFNKPGIYT
VKLETDKTRYPITKEIEIYQVYQPFKEPEVIDSSNIVLNDIKKRLQIIANLSAKDTRGYK
EQVNYIKNKYICNNLSDVVVVVNEEKYNDFLSYCQGLHYLDGNATIIQEVKLDTIKCFKQ
INITQKTKKTQ
>EGALAKHO_04380 hypothetical protein
MKTGIYIRYTFLMFLLTLNSVFSQVKNSTSIIKKTEKTINTYNNETQKENTKSELKLVFS
DRNENYIYEEPYSSKITAKINILSPLYVIDQDKNYYQVVVADKKMIGKPKGTLSVLRSKK
NHFSNTKEVQYLGWVKKENVIEYSRAMQNQENFKYVKYFVACNDLESLFSSDKNIKKNAL
LLKADPNLESLAQKKIMLNDFVYVYKINKTTKSAFVSNFDNLMTKDTVNLKYGWVPLQYL
NPIKDNLVLRLTPSDTLKFSSGKITFQANELYKNTVFVNENQSSWPISFDNLDKISLPVN
IWNHDKNKITNLKGDDISIKTIEKIGTQSKNINFFYVFENNNSTRQHLKKILSALQNLKL
TTSNELYANYNFTYSFIAKGGSKNYYLIKSQSFSKWFDLIEKSIKTPDEIPTENILPNNY
GNISEFLSSDVNFENNFFILAGLNSGINNTLPDSFSTLAKNNAKLLFILFENENTADNQD
FILQSKMYLNEASEANKKNIQNYYVDPKLITKNDELIYNGEYDNDYIYDAPLKSNFNGGI
LFPKLSGQLTPETINKAIDSILGKTIKTNNLLLKSLTQYKNEFSFLRSQPSQKINDLIQS
FPKKDSISTEIKKNYKSETFAINTKDTLKADLEKRLSLLLSQDEIKQLIENYRELIVKEY
TDVNIDEVEILSFKNKCKMLLKSFKKIGLINSENSLADLLYYQTKTAVNSCELHEIKIKE
IKMFKKKPKEFRHLFAVLNTKLEVLENMQRNNTFEVFDNESQTKYYYIPKALLL
>EGALAKHO_04381 hypothetical protein
MEIINKAAIVKPLHEIILELFYFESKDKPCELTIKEILWKLKDPGISQYQMEEVLNWMVH
HKKLNENLGLYTLDRFELIDLEEKFKTERLNKDKKNEPVFYANYSTINNIHNFIRPKPLG
ILVRYILPTLLLSYIIFIFFLINKLNNSFEINNKETESINELTLMKPKVGAITKKRILSD
KEVKLLFANQHQNILYLNKTIDSLEKQVNKINKIHTTANLALNKQINTLQPQVNIIFLHI
SVVLLGFVLLFFMKNTMD
>EGALAKHO_04382 hypothetical protein
MKFKHITCKENLHKNRLRVIKYVITSRFALYILMLICSYLIAFILFCINPLLDFNWFSFL
LTCGAWSVFYSDSQEIIDLNQFTLYNILGFLIIILSGIMIVITKSSYLNFVITGYPLFFI
CYFRLLLFLFYKDFIRSYKKPTILFARKFGKWTHENADPSYIPTKKEIIFSNLLFFGPFA
IALLVFYLVNLL
>EGALAKHO_04383 hypothetical protein
MAFKAILEFEGNDYQVLFSKVDMMRHTDGKGAVSSEIKGGRLNLRVKSTDNTTVIEQAVN
SQHKPVSGKVKFFKADSEQVMKELSFENAFIVFYSEVLDALAETPMTTEITFSAEKITLG
NATLDNNWAKI
>EGALAKHO_04384 hypothetical protein
MFRNFESGKEKERNPFDRNDFFEDDIWARRDRLWEMLENRKTNDPHDNFFSSGPKRIALE
GEVYYNKYDKTIYVGNKKGTWTKINGLKAVRTSFAESAFIINSVSTGVGTVLGNVKGGAK
EVAELRNFEAMSFHPQGSYEFNKLVTKIERNIVLKHFIKDKVSNTINDGKIYIEGTAESV
STLKNVANVAKWLGYSAGFLGVLLSAKEYEEKKISGEILALDIFMTWLSFTGPGAFIAGA
YFILIRTDTKDKYFDPKPENIYESAKIKIDNTRVDGHINKIILKQ
>EGALAKHO_04385 hypothetical protein
MRKIIEPVFIHFSKMYIYFYEDKRDYWRMFPSLILSFLFAINLEIISFYFIDIPRYYYLL
VGVFFVIYFFILFKNIKYEYVKNYKMPTKTRVIISLLIVFDLIVIFVCLNILRNGKFMW
>EGALAKHO_04386 Actin cross-linking toxin VgrG1
MKPPIIIFGIDGKKISHFTDIRLKQVINSHHKFEIRVPHAIVESPLAYTLENAQGWLGMV
VHIMLDEKNNFLGVVTHIDFDQEDGHSGNHIVVSGYSKTILLESGEKLYSWAESTLKDII
KEVIKSGAGQQLQNDINPEYTSKMEYQNQYLETDFQFIQRLAKQFNEWLYYDGEKLIFGK
PKSFDDPISLTYNSDISKLKISVQAVPNKFSGFTYNENADKRYTAKSKDTVAGLPKLGNE
AFASSKDVFATPAYTHGIVSTGDDLVLESFLKKKQESAAASTNYVSATTKNSKLKIGSIV
NIQSSVLENMSMITQEVGSFIITEITHYATHLGEYENNFRAIPSKILCLPEPDVSYPIAQ
TQQAVVESSTDPKNQGRIRVQMLWQQGTQMKTAWLRVMTPDAGSSEKVGTNRGMVLIPEP
GDHVMVHFRYGDPNRPFILGSVFHGKSGGGGGENNNKRSLATRGGTSLVLDEADNSCTAS
DPSGNVLRLNGDGTVRLYAPNKIDIESKEINIIAQEKVNINGINEVNIDSKKITVTGTDE
ITQKSDTKITDEAPSITIKGTNTILAEGKIVDIDGKTMTNVKGGTVNLN
>EGALAKHO_04387 hypothetical protein
MNNAHNPIAVRVENIQKIWNKTRADKPKAQLFSMVYSEEDYPLVNGFLALECSQYGKSKD
SFVAFFIDFTDKNNFYYTLIEQWLLSFEEDLKKNPNWNWEDFKTIQNEFKQLKSNNTQEL
KNFYIKILQSFKLFESIKDNLLVVGIIIKNNLSVKQLNESIKELLDQLPNDIGILLLETQ
NNSIHKELFESVGKLGQIIQIPNQKINDAYKEIATQGNPSDPQVRYRKCLFEIGEAAKDK
KQEKVKKLGNELIDISKSAGEISFWASSYLIYASFLFQFKDQKELIHQLLDKGIKMVAPI
YKDKQDYAGILMQLYTFKASHYSMTDQLQKAIEYFLKQVAVGKETQQEMQAINGYNYALM
AAIREDKYLYKEIIEEAFQYGYALSNEKLRVINFTFIANSYLESNPKIEDEDIQNISNRM
VSIFGENWKDNPRQVAKKMQEEYKFNNVN
>EGALAKHO_04388 putative deoxyribonuclease RhsB
MLLTDNHFTVVVGIDIHFVTLAPANPLGLHPYVGIVIDPADYIPFLGTNVHVNGCKRGNS
DTGGMLVTLQHIMLFSPWVMAPIIGHESMNFFASETVFSDSTRLSPKGYMLMTCNDIGIP
LSLSVTRPKKKIKLIPSLFAPTSFSLPIPTGKPVMVGGPYSPDWGGMVTGLLMSMGFSTL
LRKMRGLVKKFNHSGKCPEGLKKILCRFGFEPINLINGAVIYEGSDFDIASPIPLNWQRS
WYSDSQYVGWLGHGVHCNYDRAVELYPENDALGLRMEDGRLVAFPALLPNEEFYLRQEKT
TLKRTQDGYQSYDHNNKLLYDFTLFDGKKYQLTKIANHDGIAINFEFSGFHLSKIIDASG
RELKVSTKDGFIQKLELIAPERNELLVAYEYDESHNMTAIVDALGKPTQIKFEDHLMIEK
TDRNGQTFYWEYDTKNRCIHTWGDGGWQEGWIEYREGYNLVTNANGAVTTYYYEPSQLVT
QVKDPLGNSIFYDYTEFMELYREIDQEGRITGFNYDEMGNKISTTYPDNTEEMMLYDDEN
RPSIAIDPEGQKTIYLYDKEKAHQLKTIIAPDKTTTHFTYHKNGLLATVSKNSSMLQLIY
DTEHNLVEWQENGQKLKSWEYDHRGRVWAIYTPMQMADYFSYDALDRVQKIVEKDSNTIE
FTYNSYDEVIALRDNKNNIKFSYTPMGSLATREQNGVKVRFDYDKMEQLKGITNEDYESY
TFTRNKAGHIIKETAFDGIEKKYRRNLAGEVTRIDHENGKYTEYEQDALGRIIRANYHDG
TWETYTYNKNGLLTEATNQNVSIYFERDANGRIVQETQKQQLDSPENGISLTATYNALGQ
RTNISTSLGANINTHYNQKGQLERIEAQSNELKEQHQAWETTLKRDELGREIERFATGGL
HIKTSYNNNGKQKEQEVFANGKRTGSRYYNWDTNQQLRSAVNQMTNSMTYFDYDAFGNLA
KSYNNTIELYKTPDAVGNLYKTRDRSDRKYGKGGKLLKDEKYYYKYDELGNLIHKSPRDI
NKALVFETPTSWIDKLGRDRTEEKRLQEEHLQWQEGDTTYNWLANGMLKNITNPDGKVIS
FEYDALGRRTAKIANKEINRYFWDGNVLLHEWKYTLKERPKLIVVEDDLVYDKPEPIENL
ITWVYETDSFVPSAKIVGEEKFSIINDYIGRPIQSYNKFGEIVWETEYDIYGDLRELKGD
RSFIPFRQLGQYEDAETSLYYNRFRYYDHQTGLYLSQDPIGLMGGNPTLYGYVYDTNSEV
DPFGLDCIQKRIGDWGEKWAKEQLENTNKYKNVIAVQNGSNHGIDLVGIRKDGKFDFFEV
KTNTTGKVSPVSARQSNASTFIKDILGPEKAQKGGWGITPSEALKMVDPKNLGDTRIIDI
FIKNGKLDKVLTSQW
>EGALAKHO_04389 hypothetical protein
MVKNINIKSIKKVLLEEERFLNKDLKNEETIEFYNKAKIEIDNFKKNGTKIFQRKEIVFG
EEEVIEVNIEQSLLSFSTLEISKAIVLFDSNPSNDTFSRLCNAYFLDLLTFIGASESFET
SSVSYLESDIGLLYIFTMTNFPELLENVEPVILKGLEYRQKVRDSNIRLMPGSYGRDSIL
YLAYWIAKEYERSEIIANQLLSYCNSKIESCYIKNIENALSKNEIDVQNLISELAEYHIK
NSKTSDLTYSFHKNQWIFYPIEILGLLKIRERKGFSNNFLSHPLINIFTPFLSSNLKIES
DVLLLFNKFL
>EGALAKHO_04390 hypothetical protein
MKQNHTTCIRVSDAIICPNCKSQGVIKNGKTKNKKQQYFCKNCNKRFIDNYTYNAYQNNV
NQNIIIFTKEGLGIRSTARVLKISTTTLLKRIISIAKNIRKPMIHFGKTYEVDEMRRYIK
CQK
>EGALAKHO_04391 hypothetical protein
MGRQHRYFDHDFKKAAVVLSYQRKNITQLERELNITLGLLHKWRREYDKFQGDCFRGKGK
YKIKLQNTIPLEHAKTNIKSKLRFFDSAFKEKAVLISYQRSNISQLEREMLIPSGFLHGW
RNTFDKFGVGCFCGKGSIRLDPERQKIYELERKCFQAELHLEILKKSYPYQKKGPLAVFE
FVKENELNFPLYKMCMALKISESSYRLWKKQPVSETKKRIISLKAKISSIFLESSKRYGC
VKIAKDLTDGGTKISYTQVGLYMAQMGLRPKAKRKFKTTTNSKHNFYTSPNVLNQQFKVR
GASMVWVSDITYIQTSKRFLYLTIIMDLYDRKIIGWSLSSTMTAEKTSLKAWEMAIDNRN
ISEGLIFHSDRGVQYACKAFTSRIDSYKIITRSMSRKENSLDNAPAESFFRTFKRELIYH
SKLASKEETKEIVIDYIENWYNRIRIHSALNYQTIEEFNADTNL
>EGALAKHO_04392 hypothetical protein
MNQGNLQISKKIQRVYDRAFKEKAVLLSYERDNIEKVEEELGITKSLLNRWRQDFTKYGS
GSFPGCGNLRLSPEEKKIYLLEKRIEKAELNSFIILNASPYLSKGKLMIYLFIQDFEKKC
SAKYICKVLGITQRSYSRWKNHYVSERKKRKLEMLHVIADLFILRKKRYGYMRIAAELQK
RGYKISSSTTARYMRELGLFVSIKKP
>EGALAKHO_04393 putative dual-specificity RNA methyltransferase RlmN
MQRSSDGTVKNAVRLHDGLVVESVLIPTQTRTTACVSSQVGCSLYCNFCATSRLKRMRNL
EPGKIYDQILAIDKESRLYHNHPLSNIVFMGMGEPLMNYNNIIKAIDMVTSTEGLGMSPK
RIMVSTSGIPKMIKKMADDDVKFKLAVSLHSAIDEIRARIMPFSKNFPLADLRESLEYWY
RKTKSKISYEYVVWKGINDDKASIDAL
>EGALAKHO_04394 putative dual-specificity RNA methyltransferase RlmN
MQIEKKDIRALSKYQLRDFFVANNDQAFRGNQVYEWLWSKGAHSFDDMTNVAKTTRAMLE
NNFVINHIILRLIQCSAAATEQLKMPFVCTMV
>EGALAKHO_04395 hypothetical protein
MKSKKIKLFAIVISFLGITSFASAQKSYTLDSKSSFSVLGTSTLHDWEMKSSSGSGTANF
MIVNSKLTGIESLSVTLGAESIKSEKKSMDKVAYETLKTDKQKNIKYVLKSAEKVNETTW
ELTGTYTIAGASKILKTTVKTTITKDGINLQGSNKITFTDFGMKSPTALLGTIKTGQDLT
LKFNLNFNL
>EGALAKHO_04396 hypothetical protein
MKKIYILFIALASTFAVNAQVSFGHIQNQIPRNQKGINQFDVKKDTVIFKGLSVDMGAAF
ALQFQGLNSYNDQKGLPTAPAYRLNNLENNFNLPNANFTIGAQLYEGVRVNLDLYLASRH
HNETWVKGGYLQIDKLDFIKKDFLADFMKYTTIKIGQMENNYGDAHFRRSDNGNAFMNPF
VGNNIMDAFITEMGAELYYNRSGFVSMIGVTNSKLNQDVKEIVATPTTSTKPDNNTTISP
SILAKLGWDKQINPDLRIRLTGSYYHTANSSGNLYASDRAGSRFYGVMSHADYNVINPAT
GNVVTAVANNFDPTANKDTGRFNPAYGNWATSYMVNPFIKYKGLEFFGTLEFTSGGDFKG
TDDTRKVSQYVGDLVYRFGEGERFYLGGKYNLVDGKLANANTQAIQINRFEAAAGWFMTK
NVLAKMEYVDQNYKNFGQFNGTIPNDLYGGSFKGIMFEAVISF
>EGALAKHO_04397 hypothetical protein
MLYRFLILILGLAIFFFLGSVKPTFLTDDYVLVIHKIKIEITGTSTVGKYNCSNFFIKKD
TIFLNSIKKNIFNTEIKMSNFDCGNKIMTKDLQGTVKIKQFPNSTVCIKDIKQFGKNYKC
NLTFLITNKTLQYKDFILYTDANKIQGSLNLKFSDIELEPPTKMAGLIKVKDEIVINFSL
YKN
>EGALAKHO_04398 hypothetical protein
MKKVYIVFLGFVVGFSGYSQAIPVVEPMLKPTPLTPTPIKDWNFNFYGYVKTDFIYDTRK
MAGAREDLVDFYPLDEVLDKNGKDINAVHQSNYLSVNTRTGIKIGGPEIWGAKTLAVIET
DFYGNLEGSSIGMLRLRHAYANFDWGKTAVTVGQTWYPQYIVEVAPDVAAFNGGLMFNPF
GWATQFRIKQMLSNTLSFSFIAYKEREFTAPGPGAANAATINSPLPSLHGQFQYRNKNII
LGAGVEYKSLQPLTVSNNQKTSEKINTTSFLAYGKYINDKISIKAYGITGGNMYNFVTIG
GYTGRTIDNGIETYTPSKTSAVWMEISKVGKKIAPGLFIGYVKNNGGSFDETTFDPTKIT
YANYIRGLNGAATNSTRVVDNIWRVSGRVDFKRNKFRVTPELEFTTGTWGDLSKSTAAAT
TNLTDVANMRFLLSCVYYF
>EGALAKHO_04399 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MTTKHQAFYNELKNFIQESNLYTDPMKTLAYGTDASFYRMNPQIVVKTETEEDIQTVIRL
AKTHKVAITYRAAGTSLSGQSVTDSVLVIMGDKWKKGEVLNDGLQIRLKPGIVGAHANSL
LKKYLRKIGPDPASIGAAQIGGIAANNSSGMCCGIKENGYHTLNSMRVILMDGTVLDTSK
PENVAAFRISHAALLSELTSLSNRIKSDKDLEEKVRHKYRLKNTTGYGINSLLDFEDPIE
MLIHLFIGSEGTLGFISEIVFNTVHDYKDKASALILFDELDRCCHAVTALRDAGEVEAVE
LIDSRSIAAIQDKKNLPDFMYEAVKIGTTAILIEVRNSSPEGLDRRIKAVNKTLADFNAT
HHSGFSKVPEVYANYWQVRSGLFPAVGAVRPVGTTVLIEDVAFPIKYLAEGVRNLNELFA
KYKYNEALVFGHALEGNLHFVFTQDFSIESEVERYDAFMTEVNDLVVDVFGGSLKAEHGT
GRNVAPFVKKEWGDAAYAIMCDIKKIFDPENLLNPDVIISGNKKIHLENLKALPAADDIV
DKCIECGYCEPVCPSATLTLTPRQRITVWRRIQDLKRTGKNPEELASLEKEYQYMGIDTC
ATCSMCATKCPVGIDTGKLIKKLKGEPSNPKLLRMAENNFSTIMGVSGFGLSAINAIEKV
TGKTAIEKLSSALHDVISTPYLPAKGLPKGAGTLPKPATKSGKEVIYLVSCVNRMMGEGR
DGDTHLASHTLFLLEKAGYKVSYPPVQTKLCCGQPFSSQNDYDLANKMLSDINRSLLEAT
RNGEVPVYLDNSSCSVRIIDAQKQGLVDPRLKLYDALTFLHNFVAPELSIAKKFDKLALH
VPCSVTKMGVSKQLIALSELCTNELIVPEIACCGFAGVKGFSTPELNANSLRNLKDSLPD
DCNKAVSNSRLCQIGLSHHTGLDYQSVEALLCECVLEN
>EGALAKHO_04400 Lactate utilization protein C
MNSRELILQKVKQNQPQIISALPSLEKLGVQKADLLEEYKTVLKGIGGDAVEVKNYDEII
SYIKDNYDTNKRIITTIPELSGIASLDWFNDDPHTLENVELNIFNAHFGVAENSALWVTD
KMFGQRVAAFIPQYLAIVVNKRDIVHNMHEAYNKIGNQEYSFGSFIAGPSKTADIEQSLV
LGAHGARSLVVFMID
>EGALAKHO_04401 Lactate utilization protein B
MKNNLTHSEAASVFNKDESRVNWHDETLWFVREKRDKQAFMTDDWEQLREAASKIKDNVL
SDMYHYLEQFESNALKNGIIVHWAADAAEHNKIVHSIMQKNGINQIVKSKSMLTEECHLN
EYLAQQGVNVIDSDLGERIVQLRNEPPSHIVLPAIHLKKSDVSTTFNEHLGTEKGNNDPQ
YLTEAARMHLRDVFLTRKAALTGVNFAIAETGEFVVCTNEGNADMGVHLADVQISCMGME
KLIPERKHLGVFLRLLARSATGQPITTFSSHFKRPREDKEIHLVIVDNGRSNQLGREDFR
NSLKCIRCGACLNTCPVYRRSGGHSYHVSTPGPIGTVLAPNLDKKANADLPTACTLCMSC
TNVCPVKIDLDKQIYTWRQELTKEGYTSIVKTAVMKTAATVFASPSLYAATTKMATFTMK
NMPFLVNNSKNVWYKNREMMTPPEETFKEWYRKNKKQKP
>EGALAKHO_04402 Lactate utilization protein A
MKIGLFIPCYVDLFFPKVAIATLELLEKLGCDVEFPEKQTCCGQPMANSGYEHLQKGCDK
NFVNNFAKYDYIVCPSGSCALHVKEHLHDENNEALATKIRNSVYELTEFITDILKVESIE
GKFPHKVGFHNSCHGHRGLKLAQMSELNAPQFSKPMQLLSKIRGLEMVSLTRKDECCGFG
GTFSVFEEAISIKMGKDRIKDHASKGVEFITGGDMSCLMHLDGILKREKSPIRVIHIAEI
LNSYEK
>EGALAKHO_04403 L-lactate permease
MNQISLFLLAIIPIAVLMLLIIKFKVAGNIATFSTLIVTAILALTIWHKPVQYVTVGALQ
GALKGFWPICMVIIGAIFCYNIMLATKSMDVIKNMLAKVSSDKRVQVLLIAWGFGGFLEG
VAGFGTAVAIPTGILIILGFNPMKAILLALLANTVTVAFGAVGIPVITLADLTELNVQTL
SFYIVAQLTIFNFIIPYLLIVVTEGSFKAINGVFWLTTVCTTICTAVQLFIAMKVGAELV
SIIGTVAFIISVIVYCKLFKKDEADKTPTEGNLLVAASSYIIMVLLIIAFCPLFPAINKA
VAFGSAIPFNYGAGADGVEVIKELKVTWLNTPGVLIIIATLIGGLMQGSNFSAMFKIFGK
TLYQLRKTIMTVMSIVALAQVMDSSGMILDLSNGLIILTGGFYPFIAPIVGAVGTFVTGS
DTSSNILFGKLQLNVANKIGVNPEWLVSSNTTGAALGKMISPQSIAVATSATNQEGQESA
VMGTSLKYCLALLVVAGLLVGILSMTMFAS
>EGALAKHO_04404 hypothetical protein
MYWWNKIYDKKQRQLIDFQANYNTPATGKSLFNGNISQTLWKTANTDTSLKGYNYYYDAL
NRLINSFK
>EGALAKHO_04405 hypothetical protein
MKTKVITTEVVKKRYGESGIDISIEEAEQILAFANKLVNLVLTKHLPNYKEYMLNRWG
>EGALAKHO_04406 Extracellular exo-alpha-L-arabinofuranosidase
MKSNIITKIFIGGLLFSSIYGFAQKTTLEVDITKTVTKIQPTMFGLFFEDINFAADGGLY
AEMVKNRSFEFDKPLMGWEQPNTKRSSLNMLSGVATTFKENKTNTNFCRVLVNDDKGYAI
INEGFRGMGVKKDTKYNLSLKAANHGGAIKKIIIQFIDKDKKVIGETSIVPISEEWKNYS
AQFTATQTEAKAKLKITFEGTGTIDLDMISLFPEDTWKNRKNGLRKDIVQLLYDMKPGFL
RFPGGCIVEGRTLADRYQWKKSVGDVENRRTMMNRWNVEFSHKQTPDYFQSFGLGFYEYF
QLSEDIGATPLPILSCGMACQYNTGELAPIDELDPYVQDALDLIEFANGAETSSWGKLRS
DMGHPKPFNLKYIGVGNEQWGPDYIERYKVFEKAIKSKYPNIIIVSGSGPSPKGEFFDYG
MQELKKLNADLVDEHYYESPKWFRENANRYDKYDRKGPKIFAGEYAAQSVSGANPNNRNN
WECAFSEAAFMTGLERNAEVVNLSSYAPLMAHEEAWQWTPDMIWFNNLEAYGSANYYVQK
LFSINKGTDLLAITNAGEPLIGQNNLYASAVKDINTKEIIVKLVNTSTKSQEVIIDLKGG
KLVSKGSVITLTSPNLQDENTFADPKKISPTESDYKLKGQKAQINLPAYSVTVLKLKRQ
>EGALAKHO_04407 Exo-poly-alpha-D-galacturonosidase
MIKRSIIAIIVFCISLTASAQKVYDIKKYGAKGDGKTNDAVAIQKAIDACSLTGGQVLVP
APFTFLTGPFNVKSNVDLHIEGGAKILASPDEKLYTESAFRENKGEGTIWIGGKNIENFT
ISGNGKIDGNGISFMGAEEEDAYVLKPFNILDPRPHVLTIIGGKNIRIKDVHIGNSAYWT
VHLVGCNDVVISGITLLNSLKVRNSDGIDIDHSKNVRISDCYIESGDDCICLKNRREFEE
FGSCENIVVTNCTMTSSSCAIKIGSENMDVIKQVLFNNCIIKNSNRGVGIQNRDEGTVSD
VIFSNMIIEGKLKTDTWWGKAEPIYVTAYSRASGNHKDANWRFPKGATEGKVGAISNIYF
TNIQCFGENGVYVSGETKDKIKNIVFEGVNVSIDKTSNFPGGVYDRRPSKVDGFIKGSTS
GFYFDTAEDIKIQNCSVSWGKNKQDYFKYAVESKNVDVLKVNNLDGESAFSDKYEAVKK
>EGALAKHO_04408 Exo-poly-alpha-D-galacturonosidase
MMNNRTLRNSVILLFLFFLSCNAEMYANKRKDYLVTSFGAVADGKTLNTKAIQRAIDAAN
KNKGGRVVFLKGIFLTGSIVLKSNVELFFEDGTTLLGSANPDDYPKYNDARALIIAHAQK
NISITGKGIIDGQGRELALAVDSLHHTGVRIDPNYNYRRLRPSDGRGKLIFLSECDSIKV
TDVLLKNSSGWVFSFRKSKNIMIDYVNVNSRAYWNNDGIDLDGCDNVRITNCDINAADDG
ICLKSDSPGLYNNNYYIANCTIRSSSCAIKFGTGSYGSFKNIIIENIKVFDTFRSAIAIE
SVDGAEIENIKVSDITAVNTGNAILIRLGHRNGDKPGYIKNVSIKNVKAQIPFGRPDIDY
DMRGPEVDYFHNPFPASISGIPGHSIENITLENIEITYPGRASKGMALLPLWRLKDVSEN
EKGYPEFTMFGELPSWGFYVRHVNGIQMKNIKLILEKEDFRPAFVFDDVKELQMENIDVP
SDKINQIIFKDVFSSHLDVDALKRKNEPKQNTFELPQR
>EGALAKHO_04409 Sodium/glucose cotransporter
MNTLQTADYIVFLIYFVIVSAYGMYIYRSKKTAATSSNEYFLAEGSLTWWAIGASLIASN
ISAEHFIGMSGSGFAIGLAIASYEWMAAATLIVVAIFILPVYLKNKIFTMPQFLAKRYNG
TVSTIMAIIWLLIYVFVNLTSIIYLGALAISSIAPISFQFCVIGLSLFSIIVTLGGMKVI
GYTDMFQVIVLILGGLVTTYLSLTLLSEQFGFGKDILKGLSILGEKAPDHLHMILDKSNI
HYNELPGISVLVGGMLINNLAYWGCNQYIVQRALGADLKTARKGILFAAFLKLLVPIIAV
LPGIAMFVMHQNGMFQQEMVDTAGTLKPDHAYPTLMNLLPSGLKGIALAALTAAIVASLA
GKANSISTIFSLDIYKKYFNKNATEKKLVRIGRWCVVVSMFIAAIVAPALKSLDQAYQFI
QEYVGFFSPGVLAIFLLGMFWKKTTASAGLAGALLTVPIATVLKFLPMWTNGAFPDYPFL
DRMTIAFFTIVFIMVAISLAKPESEEQFDTQKIEVDTKLFNVSSEFVIGSFIICGILVAL
YTVFW
>EGALAKHO_04410 hypothetical protein
MNNNISGRLVSLDALRGFVMFWIMSGEHIIHALAKAAPIPVFIWMSSQLHHTDWNGITFY
DMIFPVFIFVAGVSMPYSFERKMSMAGVNTPMELPSKEKRKIYLSMLKRTCILLVLGFVV
NGLLRFDGFDQTRFASVLGRIGLAWFFAGLIYLNFDLKKQLFWFTGILFGYYLVLKLVPV
PNFGAGILTPEGSFSSYIDQQFLPGRLHSKIYDPEGLFSTIPAVATALLGIFLGTFLKKA
NDFSTNKKLLIMIASATILIGIGILWNYDFPINKRLWSSSFVCYVGGFSILFFTFFYLII
DVLGFKKWAFPLLLIGSNSILIYMASEGLINFRYTADFVFGGLINFSPVIWQPVFTTLSI
TFIQFLLLYFLYKRKWFLKV
>EGALAKHO_04411 Beta-galactosidase
MQKIKTKILLLCLFIICGKAVFGQEKINRNDWENPEVFQINREPARAEFLPYADEISAIN
DNYNSSPWYFSLNGKWKFLWSPTPDQRPKDFYKLDYSTINWNELSVPSNWELHGYGIPIY
TNITYPFERNPPFINHSDNPVGSYKKDFVLPENWKNRHVFLHFEAGTSAMYIWINGEKVG
YTENTKSPAEFDISKYLKPGKNNLAVEVYRWSDGSYLEDQDFWRLSGIDRNVYLYSTNDI
RISDFFAKPDLDSNYKNGSLSVDVSLKNLTSITVNNQKLEAKLVDASGRNIFSKVVGVNF
SANKNQIINLSENVSSPKLWSSEEPNLYTLLLSLKNEKGDIIETVSTQVGFRKVELKDGQ
LLVNGIRLMVHGVNIHEHNPVTGHFQDEATMMKDIKMMKQLNINSVRCSHYPNNILWVKL
CNKYGLYLVDEANIESHGMGVEGQTFMNPKTHPAYLPEWRESHLDRIYSLVERDKNQPSV
ILWSLGNECANGPVFYDAYKWIKNRDNTRLVQFEQAKENEDTDIICPMYPTIAHMKEYAE
RKEVSRPYIMCEYSHAMGNSNGNFQEYWDIIRGSKNMQGGFIWDWVDQGFEATDEAGRKY
WAYGGDLGSQNYTNDENFCHNGLVWPDRTPHPGAFEVKKVYQDILFQAVDVKNGVIQITN
DFGFTNLNNYNFKYEVLENGKIIKEGIIDVDLDPQSKKEFKIDLPKLVSKSGVEYLLNVF
AYTKTGSEIVPQNFEIAREQFVIESGNYFAKAEQTNSSSKIKEEKNEFVLNAGNVIVKIS
KTTGLIMYYSSKGEEYFKQYPEPNFWRAPTDNDFGNKMPIKLNVWRNAGKNYTLENIQTI
EENGKTYVVAKLKLNDVFSEYTIKYSLNNDGALEIQPSFKKGNIPIPEMPRFGMIFSLKN
DFENLDYYGKGPWENYPDRNESSLKGIYQSKVADQYVPYTRPQENGYKTDVRWFKLTSNF
GKGFEIKGLRSLCMSTLNNYPSDFDPGLSKKNMHLSDITPRKEVVVCVDLTQRGLGGDNS
WGEYPHEQYLLKQNEYSYGFVIKPIE
>EGALAKHO_04412 hypothetical protein
MKKPINTDNPLHNLDEWEDDLLIRYPDPSENSKEKEEFRNYIDSERVETVKEFYRMNHTY
QTYDFVCSKEEEFLQFNKKEMSIWEAVDFLNTLVDDSDPDIDLDQTQHLLQTSEAIRADG
HPDWFVLTGFIHDLGKILCLFGEPQWAVVGDTFPVGCSYSDKIVYPEFFKENPDFTDERF
NTKLGVYTQNCGLEKVKMSWGHDEYLYQIMKDHLPDPALYMIRYHSFYSQHKENAYAHLM
NEKDVEMFDWVRKFNPYDLYSKAPVKPDVKALLPYYKELVAKYLPEKLKF
>EGALAKHO_04413 Sensor histidine kinase TmoS
MKSNPFIVLFCLIAVYYSHSQNIKFAHYNDNNGLSHNSVRHIVQDKKGFLWFGTFSGLNR
FDGYQFKNYLSSGSGENKLYNDDITALELDEASNHLWIGTRKGLTLFKMDTHVFVTFLLQ
KNNPNSLPEEEIRSVLVDKFKRVWVGTKTRGVYMFFLKENRFEKIPIKGFDYVKEIFEDK
KGNIWVGSYEKGSVAKITLDPKGAIVKINNYSLSVPNSNVKNPYINFIYEDAKSDIFIGT
REGLYKLDKKTDQFINLYIENKEIRGSLGPYFLSVARAPDGKYWVGTLGGLLVCKQLEDI
KDGNYKWYYSVLSDDTSIVDNLISALYFDKSGVLWIGTEDGLDKYDPYENQFTLNKDISR
FIGNQAPRIRGFSKTYDGKVIVVTSHNGLFISGVKGFAPLHNNSKDIASIYSDDGKIFYC
GLWNGNVLVYNYTSNTSKEINVGFENLPVFAFCKIGEQYLMLGSFGQGAVILNTKTLAVE
SSKGKLFPGFEINAIEKDNKGNVWFATETGVARYNIASGKIEIYKSLSRNETSTPHEDNV
SDIIVEKKGKIWASTRFGLCLYDASKNKFRTITSLKELSGKWVTDLLSDDNGDLWLNINN
NSIAWVKGNLKDIKIYHVNSGNRLDVFSSGGFFNFNNSNIYLGGKNGIIYFSPQTMKRNK
WSPEPIITEFKVQNEEVFPEMEINGQIPLLKDLNYGKEVELNNKNRNFSIQFSTPSFANE
KLNKFQYMLEGFDKQWIIANSNSRTVQYTNLYPGKYVFKIKSGNSDGYWSKEVSYKIKIL
PPFWLTPMALVLFLSLLYGIFYFVKRDIKNRIRLKQELLTEKVNREHDIKLNNEKLRFFT
NISHELRTPLTLILGPAKQLLDENKVNATDYEKSRYNLIYQNASRLLNLVNQVLDFRKAQ
SGELKLKVSKTDILAYSKNIFDSFKEMAYNKKIKLNFISEEEAISGLIDNDKYDKILYNL
LSNALKFTNKSGNVDLTIGLKKEEEGVLIIAVSDNGIGIPLKSQEKIFKRFYQATNSKEN
NTGSGIGLSLVKSLVKLHKGFIKVESTPGKGSTFTVELPIDRIFYEEVEVFEYALKDDNH
SMLIPEKVVKKTIQNTELKQKILVVEDNTELRKYLVDYLSDYYKVYDAENGEEGLKICRQ
IKPILCVCDVMMPVMNGLDFCKELKNDEFISHIPVVLLTALAENVDKVKGYEIGADAYLN
KPFEPSLLKTVIENIIKSRLELKAKFSGEVESKVSLLTHSPVDEEFMEKITNLINDNLSE
VDLSTEFLCDKLSVSSSKLYRKIKELTDLAPNEFIRTIRLKKSAELLKTKKYNVSEVTNL
VGFNDPLYFSRCFKKQFGFPPSKLIN
>EGALAKHO_04414 3',5'-cyclic adenosine monophosphate phosphodiesterase CpdA
MFKISGLLLLLLSLCACRSMHEENKNPVQIAFIADVHLQDIFGKFEDNNYQGIKNPVTGE
YANIRTMSAQLHSTRIFNENYFAFLEALNDIAKRGIKQVVLPGDFSDDGQPIHIRGLRKI
LDQYSKKYGISFFVTTGNHDAVKPFTQEATKTDFLGKDGKEQIISSKTNLKANEYQLEPV
ITSDIKNWGYKETLNEMADFGFYPKKEFLYWETPFSSYTYDEYNFDKALSEAVLEKRTYT
LKNTNLSLPDASYLVEPIKGVWLLGIDANAYVPNEKLSGLLNNSNDFSGASIGYNNVLIY
KSHLINWVKKISAEAKQKGKILIAFSHYPMVDFNDDASPELKLLFGFDKMQLSRVPNEEV
AQIFADAGIQIHFGGHMHINDTGVRTTAKGNTLFNIQTPSLAAYMPAYKILTIKSNTDVE
VETVVVNSVPKFNSLFPFYDEEYTHLLNIKSPKIWNKEILKAKDYEEFTQWHLKELVRLR
FLPEDFPVDFLTPILKLSGKDLLQINKNTSEINVALSSHHLAFKDFESWTGFDMIFDFYR
LKNADELAIPEIGMNRLKQYQMVCEQLGKASDEKLVLWSKIMLKTMNGKPSNHFKINLKT
NQIDRINP
>EGALAKHO_04415 hypothetical protein
MKRRISRGEFIRLSSLTLAGALVSDVVFANDLILNNNNSNEDIQLMKNLILNNDAKVKSI
LNNAPLNPSIKLSNFRPVANIIMVMTASISNPKSEYYKSKVLVEKLNQSVDLMLKEQYSD
GTMDAGGNRQSPPDTAFILEYMCPAVAILNTAKQKDLEIVREKLKKFILNAGEAMITGGV
HTPNHRWVICAALANINSLYPDVRYVRRINEWLAESIYINEDGHYLERSGIYSAVIDKAL
ITMARLLNKPQLLDIVNKNLTTYFYYTEPNGDLVTVDSKRQDQFMALKVTKFYLPYRYMA
IRTKNPLFAYMVKTIENLPDFTTDILADSLGFFMENEELRKQIPINDKVVNDFEKFFAIS
NLARIKRGKTSITLFGGNDQPVQIISGRSSNPNFLMYRKGDVILKYMRLSTSFFRMGYFS
SEGIVKEGNKYILKETKEADYYQPLASEFRKADGDYKLSESQDGRFWNKMDFDSRAKSNV
KKQITVIEITENNGALSLDFKVDGPPNVEVTIEMCFKEGSGISGAVLDEKKNYFLKSGDG
AVSDAAETIHFGPGKCEHLNVENLDSEEYTYHQGSLRTTGEHVYITGFTPFRHKMKIS
>EGALAKHO_04416 hypothetical protein
MKNTILVILFCAICQIGISQNIPSIKNNTELNYVCKLHGQTRTLTLTTEMTDDKLVMNLD
TKGVKNSTIIISQEALKKGNALSYIQGEDLEVITLKPTETFFMISQSAYQDLVKNNKFIY
NNTTYVLDGNAAKNGVLLDGKSVETLHVIAQIDETEMWIIKNPEFPLICKMTKNPLGINF
TLVKVADK
>EGALAKHO_04417 hypothetical protein
MKIYTKVIAFLGISLFLTVKSNAQNQLHNYVDPMIGSEGVGRVFVGPSCPYGMVKPSPDC
TVNSNSGWLALPKEVTGFSQVHVSGTGGGPKYGNIQIMPFSASLDKLDQTCHRAEENVKL
GYYETVFKENQIKTEITTAEKASFYRITYPKNTSKDLKIDLGFFLGENPEPNAREAQQFV
GSQIEIVSDTEVRGYSRIRGGWNNGRAYTVYFSAVFDQPIAKYVTWKDGKFYANQPAQFD
SGKKTAALLSFGATGKQELNIKIGISFLSELKAKNNIEAEIPHWNFNTVLSSLENKWEQL
VSRIKLSPDTSEEYKKMFYTGLYHTMIMPVDRTGENPLWENDGPYYDDFYTLWDTFRTSS
PLITLIDSKRQVEIINAMLNIYKHEGYLPEGRSGNDNGRTQGGSNAETVLADAFVKKLKG
IDYELALKGMLKDAEVPPGGNEEREGRGGLLEYLRLGYVPYGIDRAGNRTMDYAYNDFNI
ATVAKGLNHTDIYDRYMKQSEYWKNLWRDDYENNGSKGFIMPKDASGKWLDNVVFGESKI
QKPTFKYTPTITESPWYVCHWCVFFYEGTSWEYSWSVPHDIPGLIAKTGGDLAFQKRLDT
FFDAKLYDVSNEPSFLAPTMYHWIGKPYLSSDRIRGIIKENFNTSHEGLPGNDDSGAMSS
WLAFHMMGLYPNAGQPYYLLNTPLIKETTLQLENGKSFKITANKISDKNKYIKTAFLNGK
SYDKAWISHEDILNGGELIFEMDSKPSAWGMTILPPKK
>EGALAKHO_04418 hypothetical protein
MELNKIYKIGRIGISFFLIFFVSCKTEKSAVVKKGQLVDMVYPQLDTENSRWFYFSSASR
PFGMVNLNPDTEINGDWGGGYKYTTDTVKGFSHVHEWQMSALSVMPVTISSDNKTTVFKD
FYSKFSHQTEKITPGYHSLILERYQITSELTSTKRVGFHRYTFPVNAQKAVLFNLNTILG
PCENTNGLLEKNNDYELSGSLVLSTNFRRPKPLTVFFKIKFNEPIASIDRDAKTGNCLII
FNKSGKKLLMKAGISYTSVENAANNIQEELSHWDFDKVVTESRTEWNNLLGRIKVEGGTA
TDQRRFYTDLWHALQGRKMISDANGAYPDNTGEKFRIGQLPLNADGEPKFNQYNSDSFWG
AQWTINTLWGLIYPEVMDEFVHSLMQYYKDGGMIPRGPSGGNDTYVMTGASTTPFIVTAI
QKEIVKDDLESIYLALKKNHMLNGIMGKAGYEHNTDSGGGLKYYLERGFVPYPLPDGEFG
SHQDGASQTLEYAYQDWTLAQLAKKLNHVDDYNYFLARSKKYQNIFDKTIGWMRPKNADG
KWLENYDPYKYENGFIESNGAQSTWFVPHDIDGLVTLMGGKERAVEKLNTQFESAKKQNF
TSGTSHDAELHPEFSRIPINFGNQPSIQTSNIFNLLGRPDLTQYWTRNVVKETFSGLAPN
TGYNGDEDQGLMGSLNVLLKIGLFQMNGGTDENPQYQIGSPIFNKVTIQLNPKYYKGKKI
VIEANNNSSENVYINTIKYNNTPVEKFSLSHSAITNGGKLILEMNNKPKY
>EGALAKHO_04419 Starch-binding protein SusD
MKNILKYIALPLLVAGGLLGSCDDLEVPITTQLTPDVFPQNSAQYIQSSGAVYAAFRGDF
AFSWWWSQSLTTDEAIMPARGGNWFDNRGYACQHYHDWTADNGVGPWDWAEKVIGTSNQT
IAILDKNMPKGSEKSTMISELKTMRAISYFMMMDSYGGVPLDTVFGEFNSKARSSRIEVF
NFIEKELKNAIPNLNPASGITTYGRPNKQTANAMLAKLYLNAEVYTGTQRYNDCIAATDA
VINSGLYVIEPRATYLQMFYPNNGPQMKEFIFAVPFDPSASTVGFNGQMYHSRYDVPRSE
RAKFGLPATPSAPRSTLASFYAYFNDANDIRNKQWLTGLQFLNDGVTPVRVTTTKKGYDQ
FYTGADGGASYTYQVNLTPDIVLRQNPALFDCGNDEIAWNMGYRNIKFYPDNTSTSRNQN
NDVPFLRYSDVILMKAEAILRGGNATLGHTSIALVNMVRSNRSTSPAWTAVTLDDLYKER
SREFAWEAWHRNDMIRFGKYEDQWGFKTNSDKTRRIFPIPTYAKALNPKLDQNPGY
>EGALAKHO_04420 TonB-dependent receptor SusC
MEKLKLLLLTFFLSLSINSWAQKTEVSGVILDDKSMPLPTANVLEKGTKNSASADFDGRF
KITVLSKNAVLLISYIGFADQSVTLDGSKTNYTIKLVSTTTNLEQVVVVGYGKGSRKNLT
TAVSSVKADDLNNGVISDVGQLLQGKVSGLNVSTSGDPTKASSVVLRGASTLNSSQGPFY
VVDGIPGVDISIIAPDDIVTIDVLKDAAATAIYGNRAANGVIMVTTKRGSKEKSQISYSN
YFGFEKVSNQLDMMNAAQLRDFVTKNKLSFTPENDKGANTDWQKAILRPGYTPSTTQNLS
LSGGGEHGNYFASVSYINKEGVLQGNEFSRVIAHLAIEQNAFDDNVKFGLNVTNSNSKYN
NVPQRNAVLQQSINHLPVSPVTNPDGTYFENFIQTGYFNPVAMMNHADDDTKTNNLVASL
TTEVKLPWGFTYNLNLSYQQLNSLHGEFYDSYYQQYNSGNFYNNPDPPLTRTLMNFGVNG
SALRNSYQTNNTIIESFLNWDKAFGDHKLKAVIGYSWQEDVLGDGFQATNTNFPVDNVSY
NNLALGNYSSVSGYRVDFGDSKAYQKKRLISYFGRLNYNYKDKYLLQGSIRKDGGSVFGT
NNQWGYFPSVGGAWRIDKENFMANQRIFTDLKLRASWGQTGNSSGFNAYTAQFISGSLGT
FYYNGQQVGAYGPNQAANPDLNWEKTATANIGLDFTVLKGKLSGSIEVYDKKTTDMIYNY
AVNPVLVPVGTIVANGGNMSNKGVEVTLNANVVKTKNFSYATSLNFSHNKNEITKLTNPY
FIGGDSIRRVQPDGGGQTGSTLQIFKEGKPLGQFFTLQYAGKNTAGVSQYVAKDGSLTTN
PQIGVDYHYAGSAQPKFMMGWNNNFTYKKFDLNIFFRGVFGNKIFNATRADLFRPSTAMS
NNILADAANESPNDLNAYKYSTRFIEDGSYIRLDNMTLGYDFGKVGRYIKKIRIYETVNN
LFVITKYSGIDPEVEQGGTAPGVDSSNFYPKTTTFLFGMNVVF
>EGALAKHO_04421 hypothetical protein
MKKDFSEIKNYNYLKSVISVFLMLFFLTPNLYSKNEKKTESSRAVIQRLIGNRVSEFELT
IVENNNQNESDWFEVETIVNRVKIKGTSNTAICYAAYNFLRDIGAGLISWEGNRIDLPKT
WPKYSKKQATPFKYREYLNACTFGYTTPWWDWERWEQEIDWMAFHGINLPTAMEGQEAVW
QELWKGYGLTDTQLQEHFAGPAFLPWQRMGNINSLEGPLPQEWINKKEDIQKKILQRMRA
LGMHPVVPAFSGYVPKAFAEKHPGSKISELKSWSGGGFESTYLLDSKDPLFIEIGKRFIE
LYTKLYGQSEFYLADSFNEITPPVSEEHKYEELSDYGKTIFETINEASPGATWVMQGWLF
GDNKEFWTKEATKAFLSKVPNDRLMIQDYANDRYKVWENQQAFYGKQWTYGYVHNYGGSN
PVYGDLNFYKNELTNLLVNSRKGNIVGYGAMPEGLNNNSIVYEFIYDLPWNQGKESVNDW
LKKYLNARYGKNISSSVFKAWKLLIESVYSTKYWETRWWNDKAGAYLFFKGPTLKITDFK
GNPGDKEKLKQAIDILKKEARNFNKKSLYYYDLIDVSRHYYSLTIDDLLVECVKAYQVKD
IKKGDELFKRIEKQSLDIDNMMSGQPLNDLHYWLKSAWDYGSSETESELYLKNAKTLITL
WGGEGHLNDYASKSWHGMYKEFYWPRWKMFLQSLRESEINNKPFDELSERESIKQWEIKW
CESKEMY
>EGALAKHO_04422 hypothetical protein
MIENKLNTIFKMITDVLSNVAEMERTSLLERQKECIIIAKAKGTYKGKQLNTIETLQRLL
SKYNQSHLE
>EGALAKHO_04423 hypothetical protein
MNRIILIGNGFDLAHGIKTSYCDFIDYYWYKTVHSIQEKSTNELFENSEIKINGVPQYCY
AEKSYEGLLEDLKQTGATVHFKNQFLEIINNKKQIQNWVDIENEYYELLKNSFKDLNCRY
NISDLNKDFNDIQKLLENHLKEVEEHFKKNFGTSPIDKTLQRDIGNKIYSNFKFKDFSEA
SINKRAEIEFQKLNQSINDLKIHDVTLNDLSPEKQSLISRLRNNDDALKEIKKLLTSDVA
SNYFDLKPQEILFLNFNYTFTDAYYYQPNDFVHHSNINKSLEISKIHIHGTTNESDGNNV
IFGFGDEIDEDYKSIEKLENKYLDNIKSIKYLETDNYKKLLEFLNLGDYQIYIFGHSCGN
SDRLLSTLFEHKHCASIKPFYHKKDEDNDNYSDIIRNITRNFSNKAILRDKVVNKKYCEP
LT
>EGALAKHO_04424 hypothetical protein
MQTKDYFIIGLGILGWIWAILQFILNRKYQKSDKALDKRFEVYSNFMNKVDEMSMSMRTD
PQMIYGIQTELMAELLSGDEERTNSALLKFNESLIEFTKTSLQPMMIVNQELNKLKLVAS
EKLLPLITEYKFLVDDFSNDYKIALNNLSLSNDINDTARILGSMGHEERAEKFKGLWEVI
EKLMRNEIDYYKK
>EGALAKHO_04425 hypothetical protein
MNSIDSKTTARDFRFNIFLNNLQNNHFDEIIEEALSKSIQDIEELKSKKVDLDEDFKIIV
EQIFLEQKVKALSEMKIVYAYKIFENSIKHLLENMLPEFISTQGYRWEYLTNFLKKHNVF
ISQISSYTEMNQLRIVNNVIKHSEISNTADVPEFIGQKNISYLHILNFHKRVEDLKIDFF
TDLRNKILLSLQDYESERIY
>EGALAKHO_04426 Serine recombinase PinR
MFQCVNKISYTMKSAILYIRVSTDEQADKGYSQRDQDERLRRYCNNHNIHVDNVIFEDHS
AKTFNRPEWIRLLDGVKKRKARPDFVLFTKWDRFSRNAGDAYQMINMLNGLGVEPQAVEQ
PLDLSVPENKMMLAIYLAAPEVENDRRALNTFYGMRRAKKEGRVLGMAPYGYINRTKEDG
KKYIAIKEPEGSNVQWAFNEIAKGVLAADQVRQAMVKRGKNISRSAFHVALRNVVYCGKV
FIQKHKDEEAHSVQGQHEPLISEALFYKVQGIIDGNIRQVRPQTKIFSDDNLPLRGFLIC
PDCGRNLTGSASKGSKGGYYYYYHCIPKCGFRKSAVKANEIFQDDLKKYEFPIVIQGILH
DIMMVNYKSFASVFENRRRAIALEIDKFNTKLSKARELLLAEKLDADDYREIKEECKRNI
ENLEEELSAYVSEQKNHNIKKNLDDALTTLSSLSSLYKDGDIETKRYIISSIYPEKLFFD
GSAYRTPRLNVIAECISLFNKALGDKKNRTNESFSHLSGLVARTGVEPVTSGL
>EGALAKHO_04428 Proline iminopeptidase
MRYILFLTIFLLTISCQKENKSQTLQDYFTYNQKNAVESAGVQMIPIKTPVGEFKVWTKR
FGNNPRIKILLLHGGPAMTHEYMECFETFFQREGFEFYEYDQLGSYYSDQPKDSSLWTTE
RFVEEVEQVRKAIGADNNNFYVLGNSWGGILAMEYALKYQKNLKGLLISNMVASAPEYGK
YADEVLAKQMKPEILAEIRALEAKKDFANPRYMELLIPNFYKEHLCRLKEWPDGLNRASK
HMNGEIYTMMQGPSEFGISGRLAKWDVKNRLKEIAIPTLMIGAKYDTMDPKAMEEQSKLV
QKGRFLYCPNGSHLAMWDDQQVFMKGVIKFIKDVDHNEF
>EGALAKHO_04429 hypothetical protein
MELKTKNSMNKIPFILLLLCLFTNCSKDSEGENSGTTYKYYYPTDQAVITSSQIGAGTGE
LDPKGIAVANNKLYVCNGDVLEIFDATTLKYIKTITNYTKGATTIALTKLSSVCIDNGRI
YVGSVDSRLFVFDETTNTGITTVGNGQWWNTFVHVFGVIVKDGLVFVKEKETSIKVFETS
QITESSDWNLKPIAKLNTLNGFDQVYSLDVVSGNLVVAGRDAKSYLYYNIANIKTNAANS
LVEPIKPTTAPFTDAKPIAISFSEDWAITTETVGSLNYLRLYPKEEFMNKNYTPRINAID
IMGANPFGSIVSTAQLNDRIFLSDNTNKKIRVIKLNSSTITEQK
>EGALAKHO_04430 hypothetical protein
MIKNLKKGLFSILLLANLFCFTSCEDEKEDGNYKPNYQASIDATNLPVGNKPMTMFEDAE
SSSKMYDNNDRWFRVNEPLQVIQKGKDSVQISLYSPVGLSDVKIYAKLPNYNKRFVIYTF
SKIPAFHRSFHKIPLTTGKNDYLSETGEPVTIDKIEGFSSGGIEFSVESSDPLFAKFKKI
KSSRLVKFSDSYHLNNPADDPNKFLPMNPVLAKEAITMILNFSYAISHPLYYDTFINFDR
YKKEQAATAGTAINGALNWHGNAEDVDGVYDYLTKVQIEQAYTTYIDKRQLNMAMVGGGS
AWGGGALASQWESGYVTGHWKGEMSVWSHEYSHHSGYSHSSNLANSGEGGGQQEMLTHFY
KYLIYLNDLPFTDPEILKTYTKTNYLTGTYKKPVFTIDQKNPFLLKYKGEGKWN
>EGALAKHO_04431 hypothetical protein
MIKERLTSLDVFRGFTILLMTIVNNPGSWESIYPPLEHAEWHGCTPTDLVFPFFVFIMGT
AIPFAMPTKHFDWAVFNKIMVRSLRIFCLGLFLSCFSRIHLFDLEGIPLLGIRLIIAFAV
AYALLGNFSLKVKTYLAVGIFVILIGLAYSGLEHFEETRIPGVLQRIGIVYFFTSILYLK
TNLKTQLIIAASILIGYWLLMAFVPVPGVGPANFEKETNLGAWLDNLLLNGHLWSVSKTW
DPEGILSTLPAIGTGIIGMFIGQLLNLQIPKIEIAKKTAIVGVALVIAGLLWNIIFPINK
SLWTSSYVLYTAGIATVCLTILYYIIDIANYKKWAKLFLIWGVNPMIVFFFSGVIPRVMS
SIKVQNPEVPSEEINVQSLIYNHWIVPYFENPLNSSLAYAIIYAIFWSLILWIFYKNKLV
FKV
>EGALAKHO_04432 Beta-hexosaminidase
MKDYIIKISLCASFLFLITNCAVKKNNAVTDSKKDIPLKDTVVYKGDKSEKKTFFKDSDK
ETAWADSIYSKMTLREKVGQLFMISAYSNRDSVHVNQVENLIEEYKVGSVIFFQGGPVRQ
AKLTNLYQSKAKVPLFIGIDAEWGLAMRLDSTYRYPWNMTLGAIQDLTLIEKVGRNMANE
NKRIGVHFNFAPVLDINTNPKNPIIGNRSFGEDKVNVANKATALMKGVQSQGVFSTGKHF
PGHGDTATDSHQALPLVNFSKERIDLVELYPYKKLFDEGLVSVMVGHLNIPSLEPIPNLP
SSASYNVVTNLLQKELGFEGLIFTDGLAMKGASNFKGPGDLEIAVILAGNDVLLCPENVP
VAVQKLEEAYTNNIITEERLAHSVKKILHYKYKAGLNHYKPIDMANIYNDINPSQNDALH
YKLYENAVTVLKNEKEILPIKELDQKIAYVKLGDDTNSTFISTLKKYTEITEVKDTNLDS
LNQELKKFDKVIISFHKVNKPWEKQEFTLTEMLWLKEIAKHNKVILDVFAKPYSLLSISD
FDDIEGLVVSYQNSDISQVVSAELLFGAIEAKGKLPVSINNFFKVNDGLTTEKLNRLAFT
TPENVDMNPKILSKIDVIAQKAIDGKMTPGMQILVARKGNIIFQKSYGYQTYDKVKQVSN
SDLYDVASISKMISTLPNVMQLYDKNKVALDTKLKDMVPFFTNTNKENIIFKDLLTHYAG
LQAWIPFYKATLDGDGKASKKYYRKIAENNFTTKVADSLYIRNDYHDTIMKIIAHTPLIA
KKEYKYSDFTFIILKEYLERKTHKKLEELSQENFYSTLGMNNTLYNPLLKFDKNNIAPTE
IDTYFRHQTIQGYVHDMAAAMEGGVAGHAGIFSNAMDVAKMMQLYLQKGNYGNKQYFSPQ
TFDAFNTCYYADKGVQRGLGFDKRIGKDGPTCACVSTSSFGHTGFTGDIAWVDPETELVY
VFLSNRTYPEVVNDENKLAKGKIREEIQQIIQDAIIK
>EGALAKHO_04433 Sodium/glucose cotransporter
MTPTTILILIIVYFGTLFYISHRVSRKDDGNAAFFTANKNSKWYLVAFGMIGTALSGVTF
ISVPGEVGAPSGEQFKYFQFVLGNAIGFIVITKLLLPLYYRMNLTSIYGYIEQRMGFYSY
KTAASIFLISRTISSAFRLYLVVIVLQRFVFDFFHIPFALTVLISLLLIFSYTYRGGLKT
IIITDTLQTFFLVTSVFLTIYFICDSMDLSAVGAFEEVKNSNYSKIFFFDDFLGSKFHFI
KQILGGMFVTIAMTGLDQDLMQKNLSCKNIGEAQKNMFTFTGIFVIINIFFLSVGALLYI
YANKNGIAIPTDLVTGKPRTDLLFPEIALNHLALIPAIVFLLGIIAATFATTDSALTALT
TSFCVDFLGMDKSENTRKNTVRTRHLVHISFSVLIFFVIIIFNTINDSSVVGMIFKVASY
TYGPLLGLYAFGLFQKSRNVNDKLVPLICLAAPFLTYLINENSKLLFSGYVFDNELIVLN
GLITYFGLYLTSSRSSEKISF
>EGALAKHO_04434 N-acetylmuramic acid 6-phosphate etherase
MKNKNPETEQESLYKDLDQMSVKELLTNINIEDKKVPHIIEEQIPKIEKLVKAIVKKMQL
GGRLFYIGAGTSGRIGILDASECPPTFGVSHDMIIGIIAGGDTAIRKAVENAEDDTEQAW
KDLAKFEISSLDFIIGIAASGNTPYVLGALKKAREHNVKTASISCISNGLIAQEADYPIE
VIVGPEFLTGSTRMKAGTAQKLTLNMISTSVMIKLGKVKGNKMVDMQLSNEKLVKRGIKM
IMEELGIEYDLAEALLQKHKSVRAVLLAENKNHEI
>EGALAKHO_04435 hypothetical protein
MIKFIAKSVLIVASFVFTSSYSSSLISVSKNGTSVINLSTIKTGADNYEKYLPLLKDKKV
GIVTNQTGILSNKIHLVDFLLEKKVAVQTIFAPEHGFRGTADAGEHVVDGKDQKTGLAII
SLYGDNKKPKPTQLAGIDIMIFDLQDVGARFYTYISSLHYVMEACAENGIPLIILDRPNP
NGRIVDGPLLEKEFTSFVGMHPIPLLHGMTIGEYGQMINGEKWLKDGVQCKLTVIPCSDY
KREMNYSILAKPSPNLPNDQSINLYASLCLFEGTNVSMGRGTEKQFQIYGSPFLTNTNFS
FTPKPNFGAKDPLYNGKECFGEDLTAYPKLNKLELKWLLKAYQNTSDKTKFFNAFFTKLA
GTKKLQQQIESGFSEEKIRESWKSDLESFKKMRIKYLIY
>EGALAKHO_04436 SusD-like protein
MKKLITNSRIKLSVALLTIASLTVSCTDFLDTPPEDVFTDDNFWTSENNVKTYSWLNYNT
FNGYGNNTGVTADFYFHASTGLIDDNLANNVFTNFPTAPNATNANWNEYYTLIRRCNLML
ARVPNVPMDQTKKNHYIGVAKFFRAHTYFRLAQQFGDVPYTDMYLAQGDANVYKPALKRA
EVIDNVIKDLEEAIPLLLNVDDSNVTVNKYTAYALLSRVCLSEGTYRKYNLAQNGNAYLQ
KAKDASLAVMNNNSYKLNTDWKALYNSVELLGNSEVILTKRYIKGVLGNSVQSYTNTSTV
QNGLTKFAAESYVTTNGLPIKQAGNAQYLGDNNIANTFANRDPRFAKAFSTADYAYSDKP
YNGLTSITGYVFQLYNNPATTGTEVTTGGQNQIDAPVFTLSEVYLNYAEACAELGTITNT
DLNLSINKVRTRAGIATLTTDGTNASAGGVQINDPQRSTALEQISGIVNPIIWEIRRERR
IEFMSWTTMRKEDLMRWKKGDYLDTNANPDVVLGAKIVALIGTNSKTKVNADGYVIPYAA
GVSRPFVSPKNYLTAIPTNDISLYAAEGVELKQNPGW
>EGALAKHO_04437 TonB-dependent receptor SusC
MKKLFLISLLVLFVQASFGQSKTITGTVKSKADGIPIPGVTVQIQGTTNGTTTDFDGNFS
ISIASGGSLSFSYMGFETQVVKIEGQQKVNVDLAPSTSKLDEVVVVGFSSQKKANLTGAV
AKVDVKKALGSIPITDITRGLQGTTPGLNVTFNSGNIGKSSSVNIRGAGTIVNGEVSGSP
LILVDGVPGDLSLLNAEDVESMSVLKDAASASIYGARAAFGVILITTKSGKNAKGKVRFA
YSSNVGFSNPISLVKFNDPTVELPAMIEAQARAGNANPESFGMNYKTLLPGIINWKEKYA
ATRNSNDKNMILGEDFDVIGGKEYFYRVWDPHEEMLKKDATQTLHNLSAQGSLGEKSSFI
VSLGLSNQEGVMKINNETNKRFNLNLGMTTQLASWLTGDFKVLGTFQEYDSPFNYYNNGV
DTAGNGYFGYYMRWGSYFPYGTYNGTYFRHAPGYMSNASQNESKSNDMRISGKLTAQITK
DFNLIGEYSVNNNFSSLKMNGGQVPLWDWWTSAADLTSGKPTLMESGNDFVAQAKSSYTR
NVANIYANYTKTLGENHNFKVLGGLNTEWYDFERTYARRNTLLDKSKPEFNLAIGDQFTS
PLTSNAILNPGLSQYAIAGFFARVNYDYKGKYLLEINGRYDGSSKFPTDEQWGFFPSASV
GYRISEESFMQGTKSWLNDLKIRGSIGSIGNQNIAANAFLPVMTNATTNPTPSWIGSGTT
IPPTVNQPSNVDPNLTWEKVTTQDVGIDIRIFDMLGLTFDYYQRDTKGMLAPGKTLPGSF
GQAAANTNSGNLRTTGWELALNFNKNINQNISVYADLTLSDNTTEVTEWNNTSKLISTTS
FYAGQKLGEIWGLETDRLIQSTDNIDATGLIVNGVDYKNVRTGTFKYGAGDVMYKDLNGD
GVISRGDGTATNPGDLKVIGNTTPRYQYGVRLGGVLYGFDIDAFFQGVGKREYWSTSDLV
LPFYNRTDAMYVNQNDYWTPQNTDAYFPNPYPGQAGNAFGTYAPGSNNFVSQSRYLLDMS
YLRLKSVTVGYSFPKSITDKIGLDKVRPYISGLNLATWKSSKLPVDPEINETEAVWGRTF
PYSKTISFGIQLAF
>EGALAKHO_04438 HTH-type transcriptional repressor GlcR
MLKAERHKYIMSKLVEEQKVVTTDLALALDLSEDTIRRDLNELDDKKLLEKVYGGAIQIT
EKSVDIFNIDISAEDEKKQIVTKALSLLHDGQVIIMSGGSTNLVFAKLIPSNLKATIYTY
SLPIAMQLSQHPNIDLIFIGGKMQKNAMVTIGMDVIQVLSKIKADICFIGASSINVKQGL
TEIGYEVSIVKKAMIESSDRVVSMFSSDKLNTKMPHVVCELMQLDTIVTNLDPEDAKLEE
YRKSGVFVL
>EGALAKHO_04439 Glucosamine-6-phosphate deaminase 1
MKTNTSLAYDIPGKFEETRFEKNHNVIFESSLEASKIIAHEIAELIRSKQANNKSCVLGL
ATGSSPIKVYEELVRMHKEEGLSFHNVISFNLDEYYPMTKENRQSYHYFMHQYLFNHIDI
KPENINIPDGTVALDELNQYCVDYEFKIKKSGGLDFQLLGIGRTGHVGFNEPGSHINSGT
RIITLDHITRVDASSDFNGIDNVPKRAITMGVSTILRSKRIVLMAWGQNKASIIKRTIQG
EISSEVPATFLQNHSNATFVLDKFSASELTRFETPWLVGGCSWTEELKRKAIVWLCRETK
QAILKLTDRDYNNNGMSDLLALEGSAYDLNINMFNVLQHTITGWPGGKPNTDDSHRPERA
HPAKKRVILFSPHPDDDVISMGGTFSKLIRQGHDVHVVYQTSGNIAVTDDEALKFAEVCN
DFIGKEIDGVDFSSVIKFLNNKTENQVDSLEVRKLKGLIRRRESYAATRYIGLKDENTHF
LDLPFYETGQVKKNPLGPEDVAIVKDIIAKIKPHQVFAAGDLADPHGTHEVCLNAIFAAM
KELKPEKYMDDCWLWLYRGAWHEWDIHEIDMAVPLSPSEVLLKRHAILYHQSQKDRVMFQ
GNDSREFWVRAEDRNKNTAILYDELGLAEYEAIEAFKRFDY
>EGALAKHO_04440 Anaerobic glycerol-3-phosphate dehydrogenase subunit C
MPDSHQLQQLSDSLEGTLFYDDLHKKLYATDASAYRIMPEAVAIPKTEEDIVKIIRFASE
NNISITPRTAGTSLAGQTVGNGIIVDVSKHFTKIVDFDVIKKTITVQPGVIRDELNLLLK
PHGLFFGPNTSTTNRCMIGGMVGNNSSGTTSIRYGVTRDKIVEIKAVLSDGSIAVFKDLS
SEEFIEKTKGNSLESKIYKTIYEELSKKENQEEITREFPKPEIHRRNTGYAIDVLLKSEL
FSGTENTINLGKLLCGSEGTLAFTTEITLKVDDLPPTNNIMVVAHFHTIHESLEAVVTAM
KHHLYTCEMMDDTILDCTKTNREQSKNRFFIVGEPKAVIMLEVGSYISMEDAERQADALI
KDLQDNNFGYALPKIYGADIDKVNEVRKAGLGLLGSIVGDDKAADSIEDTAVELSDLPNY
IADFAAMMERHGQSAIYYAHAGAGELHLRPKINLKTKEGLHQFRNISTEVAHLVKRYRGS
LSGEHGDGILRGEFLPFMIGDKNYELLKRIKKAFDPNTILNVGKIVNASKMDENLRFEAG
RIEPEIKTIQDFSDSMGILRAAEKCNGSGDCRKLPSAGGTLCPSYRATRNEKDTTRARAN
ALREYLTHSEKENKFDHEELYKVFELCVSCKACASECPSNVDVATLKAEFLYQYQKANGF
SIRNKIFAFNSKLNELGSITPSITNFVANLSFVKKSMGIAPERQVPLLAPMTFRKWYTKN
RKSAKNNSFKNGKVYLFCDEFTNYYDVSVGIDAYELLTSLGYEVIITDHEESGRAFISKG
FLQEAQEIANKNVAIFKDLISEKTPLIGIEPSAILTFRDEYLRLAGDKESAEKVSKNTFT
IEEFFKREITAGKIHSGQFSDEEKTIKIHGHCHQKSLSSVEASFAMLNLPKNSSVTIYNS
GCCGMAGSFGYEKEHYEISMQMGEDTLFPKIRATETTTAIAAAGTSCRHQIFDGTNRKAM
HPVTILRDCLK
>EGALAKHO_04441 Outer membrane protein assembly factor BamB
MKYLFSRILLVFIFASGFSQNAEKSGNIKFVQLTDLHVSVGNDNDFLLQNIVKEINDSDF
EFVVVTGDLTNRGADDELKQVHSILSKLKKPYYVVSGNHETNWSESAGLTYKKIFGEDKF
VFSKGDYVFIGFPCGPYMKMGDGFVKHEDVLWLDKTLKDSLKNNNKKVLNFAHYPLDNSV
SNYKEVLSVLEKYPTVATFCGHGHTLRKYDFSGLSGLMGTSITSLDGKTKSYNEVIISKD
SISIYQKELDKPGVFRFSVPSKPSKIEIPKDNLVMQSPFIKDIASIYSLPAFDKKNLYFT
NSIGEIKSINLKNKALNWKTETGNSIYFSPIIVKNNLVIGTIEGNLEGFDTQSGKQKWTI
PVGGVLVGSPIAENNRVYTASSTAFICADAVSGKVIWQNNLPTSYSQGIPLIQRDKIIYG
VWDSYVYCLDKNTGKLIWKWNNGNDKQILYSAGNVNMVSTKNRLYFVTPQRFLTILDIET
GKTLLRTQKWKIRESMGKSQDGKWFYGKTMDGELIRVPLNDTIELTEESFVNQSKVLDLK
WGYEHNPAGILEKNNKIYIGSRKGEVIIVDAAKFEIIKQINLGSSSINGFTVDDKGQVWA
SLIEGGIFLLE
>EGALAKHO_04442 hypothetical protein
MKSLKILILVLLFQTKLFSQESPKREMRAAWISTVDNIDWPSKPGLSDKQMKAEMITILD
NLRSNNLNTVIFQIRPTADAYYKSTKEPASHWITGTQGVAPGFDPLQMMIDEAGKRGMNV
HVWLNPYRVQKDTLKDVLTKTHLFFKKPELFLTYGKSRYFNPGYKETRDFVSSVVGEIVR
NYDIQAVHMDDYFYPYKIEGQEFPDEKAFAKEPRQFKDKDDWRRDNVDLIIKQIRDTIIA
NKPEVEFGISPFGVWRNIAKDSQGSNTRAGATNYDDLYANILKWQKENWIDYVTPQLYWH
IGFDRANFEVLAKWWAEHKYGANVYIGHGDYKISNTAKEPEWRSADQIVKQIEMIRSMPL
LDGSMHFTANTFLKKGDTLRKPLLQKPYKYIALTPEANRITRIKPQPPTNALISKKGSKT
ILEWKIGTNDKKFVIYRFPKGKITDFSNAENIYYVTTATKFEAEGSDFENYIFAVSALSQ
TQMESSPVQFSTK
>EGALAKHO_04443 hypothetical protein
MIRNSILLRNMKKISTKITFVFLIFLGMNGYSQKKSKQSFDVKRNEVYIDSMMTNALEKG
FFPGAQIIVGSKDAVFIEKNYGYHDYSKKQKVTADDVYDLASMSKVLGATLVTIRLVGED
KIKLTDKLGDLVPIYNDSAISDLTLFELLTHTSGLKASITFYQSLLSTPDGSPLLSKDKS
DNYPDLFDTMYVNKNIVYDANYLSFTPKENWIQIYKNMWLNPEFYKTVYEQIALANTNTR
GKYVYSDLNLILVKQMIEAKTDLKLDQLAKEIYTELGISKIGYNPLKWTSEEKVMPTEID
NFFRKDTIKGYVHDEAAAIFGGVSGNAGLFANAESISVICQMLLNNGKYKGKQILKAKVV
KEFSDSPLTKQGIYRGIGFDKRKPDEFFKANDFGHTGFTGTFFFMNPDNNRYIIILTNRV
NPTRTNRLMYKDDFSAKIWKQINN
>EGALAKHO_04444 N-acetylglucosamine-6-phosphate deacetylase
MKQAIINATVHTGDEIISNGSIIIENGIIISVQKEIPTDIETIDLQGKHIAAGFIDIQIN
GGERLYFSQTPTEDTIQDIYDASLKYGTTHVLPCLISSSNETILQGIEAVRNYRTKHDNG
VIGMHLEGPFLNPLKRGAHSIDQVRKPTNAELEEIIRYGKDVIKVITIAPECFTDEQLNM
LLESGIVISIGHSTITYKEAQVYFAKGIKLVTHLFNAMTQFGHREPGLVGASLENENVFT
PVILDGAHCDYAAARLAYKLKKDKFFLISDATFLGRKVTNFNWDNFDAHLQDGFYRNSEG
NLAGATISMLEAVQNAYNHLNVSVDEAIKMATSNVATAIGLENKYGKIKTGFPAGFVKFN
ADLSEIETLNSSF
>EGALAKHO_04445 Glucosamine-6-phosphate deaminase 1
MIKSIIDKATGFEKRFENINTVVFENSIDASKAVAKEIATLIKSKQENNESCILGLATGS
SPKGLYAELVRLHKEEGLSFKNVISFNLDEYYPMEPNSINSYVRFMKELLFDHVDILPEN
AHVPDGLLTKQQIADYCHDYEAKIEALGGIDLQILGIGGNGHIGFNESGSLQNSKTRLVA
LDHITRVAASKDFFGLSNTPRTAITLGVKKIMEAKQVILMAWGEGKANIVKKSVEDEVTN
RVPASFLQEHNNAVFVLDKEASSKLTRINKPWLVEKVIWTDKLIRKAVLGLALQLKKPIL
MLTDADYIEHGMSDLLADSGPAYDINIKIFNKLQNTITGWPGGKPNADDSNRPERAEPAK
KRVLIFSPHPDDDIISMGGTFMRLQEQGHEVHVAYQTSGNIAVADDEALRFARFVIDYNE
KFGIKSSEADNIYQKAATFLTNKKNSEIDIPEVRYIKGLIRKGEARATSHFVGLTDDQIH
FMELPFYETGTIEKKPLGKEDIQLTMDLIEKIKPHQIYAAGDLADPHGTHKVCLDAIFEA
VKALKPKSFMDDCWLWLYRGAWQEWGIDEVEMAVPMSPDQVLAKRHGIFKHQSQKDGVVF
QGTDAREFWQRAEDRNAETADLYQQLGLATYAAMEAFVRWHY
>EGALAKHO_04446 Gluconate 5-dehydrogenase
MSINLFDLTGKTALITGGVHGLGMAMAKGLGHAGAKIVVNDHSSQEAVNNAIAEYKSEGI
EAYGYLFDVTDESAVIAAINKIEAEVGPIDILINNAGIIKRTPIIEMEVADFEAVIKVDL
TGPFIVSKNVAKGMIQRGGGKIINMCSMMSELGRDSVSAYASAKGGLKMLTKNMATEWAK
FNIQTNGIGPGYFATSQTAPIRVNGHPFNEFIMGRTPAGRWGDPEDLQGAAIFLSSKASD
FVNGHIVYVDGGILATIGKPSNED
>EGALAKHO_04447 hypothetical protein
MKIFKILFLLALSLPFSTNAQTKATVTIENNSALDRKETIVAIKWATVLSSYSNIDTLNF
VVINANTKKQVPYQLEHHGNAAIQNLLVQIDIKAKSSLNLIAQKGKPETFTAKTYARYVP
ERLDDFAWENDKIAFRAYGKALEKTEGDAYGFDVWVKRTDKLVLNERYKRNDYHLDHGDG
LDYYHVGYTLGAGNMAPFVKDTIRYSGNYHQWKVLDNGPLRSTFQLTFDSWNAGGIKVTA
VKTISIDAGSQLNRIENVYSFDGNNPLEVVVGIIRREKPGVISLNEQQGIMGYWEPTFEK
DGTTAVGSILTTPVSTMWVNKEQILAKTTLKNNEPIVYYSGAAWDKAGKITNSKQWFDYL
NNFQQQINNPLIVNIK
>EGALAKHO_04448 Sensor histidine kinase TmoS
MKKTIALLALFYIALYGAKSHAQVQDRYFRNISVDKGLSQSSVFAIQQDTLGFIWIGTQD
GLNRYDSKGFKVYRPIKDVKNSLQSYYIRSLFTDHKGQLWVGGNKGISVYNYNTDSFKNY
TLPRSIGEWYIASITEDSNHKIWATSITGEVFVLSPESQNFTAIKFNASSHEIKEIAYIG
LWQKQIILGTNVGLFKLHPDTHQLVKIDLGTKKPYVNDVFIDGKNLWAVTEGNGVINYNA
ENGKTTSLLHSSASNSIADDNVRCVGKDTEGNIWFGTFRGLSIFNPKTNSFTNYYHQITQ
PYTISQNSVRCFFRDKQNGIWLGTYYGGLNYYHKNDIKFNLLSQNSAKPSLNDEVIGVIK
QDAKGNFWIGSNDKGVNFWNKSANTISYYSNSENNSNSLSSNNIKAIAFDDNGNVLIGTH
NGGLNLLNPNSGSVQRFRHDENNPNSIASDLVYSLLKDSKGRIWVGTRPGLDQYHPETKT
FTHIHLDKAGKRPTSDDITYLFEDSKKRIWIGTTNGVTLFYPDNFLFGNIGHGKLSDDIV
TCITEDQKHRIWVGTRGGLRLYDEAQESFISFKAKIDFLKESIYGIIPDEDGNLWISTNS
GLIKFNPDKRTVQTFDQSDGLQNKQFNDYAFCKAKDGMLLFGGIKGITYFYPSMVKQRPV
PLKLSFTGLEVLNKNVAVGDDTDILEEHIDQSNELEIDPEYKQFSILFNTFNYISSNRTY
YYYKLDGIDKDWQRTDELKVSYSNLPAGKYNFQIKAIGPNGETSAVRNLKISILAPWYKT
IWFSLLLLIIIGTAAYIGYRIIKERIKAIQQLKLERIDKERVSYINQVKMDFFTNVSHEL
RTPLTLILAPLEELLKMPFIDKTFKKKHELMFINAKRLYNLVDQLFEFRKTEMGTRQLKV
GKGDIVRFTQEIFESFKPLSEKNSIHYTYQAEEPQLLFYFDKDAMEKILFNLLSNAFKYT
KAGQTIHVELIKKNDTVQIKVADTGVGISEEDLSKVFDRFYQVNNREMNLGSGVGLAFTK
RLVELHHGEIIVESTMQKGSIFTVTIPMADQVYKNDQHVEESAYDLSIISDNELETDDAL
LPEENEVIERDQPIKLLIVDDNKEILDYLEDYFSKIYDVTVAFDGQMALDLLEIQPYDLI
ISDVMMPELDGLHFCKRVKQNINTSHIPFMLLTARTETSQQIKGLEMGADDYITKPFSTP
LLAAKITNLLRSRKRLKEYYSVGKEMVPENIAFNTLDEEFLKQAIQIVEDHLADSEFSVD
QFSREIGMSRSNLYLKLKAITGESAMDFIKRIRFKKAVELMQSKRYTIAQITYMCGFNSP
SYFSTAFKQHYGCMPSEYLAKLEETKE
>EGALAKHO_04449 Heparin and heparin-sulfate lyase
MIKKKIFALSLLIITLHTFGQQTSATLKLTAEKLHGRVREWPYPINGITVPTNAPALLWP
ATNGTNMVKSMETGSEVPEDPNIGNVRYKVMLATDKDFKNNLIASGLQSWAVYPLHQPLK
AGRWYWKYGFALKGTNQWSWSPVYDFVVDAKYANEKVSPPVADVIKRNEGPHPNLWNMNK
IGEEFYRNNLQNPEAQKLIQYAEKLMLDPLPVEKPRRVIDTIGKNPLEKKKIIEWMYHGF
GDMVGTPIRNLVIAYQLTKDKRFILDAKRRAINILNMDPNGLTTRDDFNSGAVLENLSWF
YDAGYDFLSPEEREKFKENITFRAKRIYNHLPNRFELHVSDNHVWQITLRNLAIGTVAVI
NEVPEAKEWLTYMYEVWSARFPVLGTTDGGWHEGNAYFVVNFRSNIYLSQLFGDFSGIDY
FKLPWMQNTPMYMLYSHPPTSASTAIGDMWENIPKINKGEAGYLEALSYRIDNPYLNWYV
AEIKKAFPQYFTGTDDFLLFRLLNNNPNRKLTSTSPEKLPKTRKFADIGLVAMHEDLANT
DKTLSSYLTSNPFGSSGHGHASQNAFTINYKGTVLFGGSGYYSNFSDKHNLLDYRTSRAY
NTILADSLGQKIGEEGYGWIPRAISGKHIQYALGDASNAYGDIKSEFWLDRFKQIDLEPN
KTNGFGESGVTLYRRHMLQLSGGYIVLYDELEAKKPVKWTTQFHTPYATIEVQKTENPNQ
QNFIVKTDLGNVTANVFANAPLKMVVHDKFAETAVNWNNVNDANGNIKDFKLQWHAGITS
EPKQKFRYLTIIQVKDGKTEIIKTISNHNGLSQFQIGDWEIKTQLDGEKPAGLQVSNKTI
KSLFSYGDLSINFQGKNYVPKVKGSSILLEMMDSKVDKQEAIDELPDVAKYDKN
>EGALAKHO_04450 Choline-sulfatase
MLFKKNILVICLLTLLNIPFLSTAQTNARPNIVIIMTDQQTADAMSIAGNKDLHTPAMDK
LAQNGVRFTRAYCAQPLCSPSRSALMSGKMPFETGFIGNSPEKDGQWPENLLMMGKIFQN
GGYKTGYVGKWHLPVPTTKKSQHGFEFIENTNFLDYNDAATPSFCARFIKENKNIPFLLV
ASFLNPHDICEWARDEDLKMDVLKNAPPPDQCPALPANWEIPANEPKIVRDQQKTVGLRT
YPSVNYTPEKWRQYRWAYNRLVEKVDAYIEMVMASLKKYGVEKNTIIIFTADHGDGYAGH
SWNQKQILYEEAAKIPFIISKLDGSIPARTDDMLVCNGIDLIPTICGFTGVKKPEALKGI
DLSKKIANPSQILRDTLVIETDFADNEDLLDISGRSVITKDFKYIVYNKGVIKEQLFDLS
KDPGEITNLAVDKAYKKKLISMRNYLKEWCKNNGDTFVSGL
>EGALAKHO_04451 L-fucose-proton symporter
MKRNNFLVCVILVIWFVISFVTNILGPLMPLIIETYKLSLTMAAFLPFSFFLAYGIMSIP
AGIMIEKIGEKKSMLIAFSLNLIGALSFAFHPTYTIALGSLFIIGIGMAMLQVIINPLMR
TAGGEENFAFYSVMAQMIFGLASFVSPFVFSYMIKSLNGEIPNRITGTLRNLVGNNAHWT
SLYWLFSLIFAVMVILLIIIKIPVVKLNDDEKAGTSKTYLSLLKQKEVWLFFLGIVAYVG
TEQSLANWMSEFLRAYHNVDPSTVGANTIALFWGLMTLGCLLGLVVLKLWDSKMVLKSAF
LLSVLILFTALFGNTQMALWAFPAAGFTISVMFSIIFSLALNSVTKNHGSFSGILCSGIF
GGALVPLIVGSLGDLIGLRYALMFLFLTLGYILFLSFKARPIVANKTIKLKDLFKTEKI
>EGALAKHO_04452 Glucokinase
MITTVNNTQIPQSYAIGIDVGGTSLKCGVVNEFGEVLFSYLVSLKEAKTEQEIILLIANV
IQQCTERLNESILGIGIGFPGVIEENVIIGGADNLPGFVQFPLGEVLSELTDLPIIIDND
ANLMGLGELTYGAAKYSSDVVFLTVGTGIGGAILIDHRPYGGFKNHGSELGHIVIEHGGL
ECSCGGQGCLEAYASITALLKFYKNESGNSSNEIDGKYLIEKYHAGEREAVKALNHHFDY
LASGIISFINIFSPQKVVIGGGISESGPFYISELIKRVEKRVIPITAKHTEIVTANLGNK
AGILGCAARVFQNFKPAEYETK
>EGALAKHO_04453 SusD-like protein
MKTKIFSIKAIVALGITCLLLPLSSCDDQLEVTPYSYFTSANFFSNADEANMATLGVYEI
MSSLETYGWYVPQVFDLDTDIGQVSGLSNDDWRTIPHYLALSQTPFFYTLWSKYYAGIDR
ANVVIEKIPQMDLYTNGTQSEKDRLKAYLGEAKFLRGFYASELVRLWGDVPFKTKSSQAG
DNLRGGLVNRQEIYTQIVKDMKEASELLPATLSLNERVNKWTAKSMLARIALFAGGYSLQ
PNKQMERPANYKDYYILAQQQINDVMAANVYKLNNNYAQVFKNQCKHTLESTENIFEVAF
FNPSGFKENGSWVGHWNAPTTANGVYASTGTRYLTVRPFYESFQDNDQRKDFAVARYTIN
AAGARVYGYVTSVRQDEQWAVGKWSREYQTGKTEERQYTYINYVVMRYSDLLLLRAEVEN
ELNGGPNAIALDAINQVRRRAYGLDNTGSGVALTITNAGTGYTANPTLTITGGGGDYANA
VITARNTNNSLKTIVINNVGQGYTSVPTVSITGGGGTNAVITASLIPKPTTSQIYVPTGL
SQNGFLNLIIDERAKELCFEGMRRSDLIRWNKLHAKIIETSARALAIRSNYFYPAGTNFI
PNQHELYPFPQNETDVNKSITRQNPGY
>EGALAKHO_04454 TonB-dependent receptor SusC
MKRTIFLFLLLTTCRVVYGQEAITVKGTVTDSQSMPIPGATVSEKGTQNSTVTTMDGIYQ
IKVKSNAILVFSYLGTKTAEEKVRDRSSINIKLQEETNDLNEVVVIGYGTKSKKDLTGAI
SSVKGDELAKVPVQNVAEALQGRIAGMQVSMPDGTPGSQPSITIRGGMSITQSNEPLYVI
DGVPQTGGLGFLDTMDIETMDVLKDASSTSIYGAQGANGVILVTTKKAKAGKLTLSYDSY
GGIKMVTSEIPVMNPYDYVKLMYETNLGTVRFDAFTNNYGNYNEFESLYANRAGKNWQKE
IFGKPVVNQYHKVSISGGENDTKFNMFYSKSDDEGIMQGSASTKDIVKLALNHTMGKNLT
LNAIINYSDQEITGLGTNEGGNARLSMLQTLLQYRPVIGKSGSDDALEDLIIDPLDNPAS
PVFQNPQITIDNQKRESTIQALNSSLQLQYNFTPKIIYRGLVSYTNSGTTNKYFNGAEGI
QAIRAGGPNGGITDLSSYRFNYNNTLSYNTVFNKVHKFDVTLGQEYIYNYAESHSVSASA
FPVVNMGWDKLELGTIPGIPTSYAEDDKMLSFFARSNYSFKDKYLLSASIRADGSSKFGS
QNRWGYFPSISGAWRVINEDFMKESTTFSDLKLRLSYGEAGNNRIANYAALGIYTTGSYP
LNNQSVIAAFQNNIPNPSLKWEATKSANIGLDIGFFKQRIALTTELYENRSKDLLFNTRL
PASSGFQKQFQNIGSTSSKGVEFTLNTVNITNPNFIWNTSFNIAFNKTKVLSLSEGENTM
LTNSYSSINDYILQVGQPVGIMYGYVNDGLYQVSDFDYNATANTYTLKSTVPSDNVVVQP
GYMKFKDISGPNGVPDGKITDLDRAPIGNANPKFSGGFNNTFTYKGLDLSVFLNFTVGND
IYNANTLNNSKLNQDVLNTLEIFADRWTTINAAGQRVTNPDELAALNVGKKNPSYLGSSG
GRLYSDVIEDGSFLRINNISLGYTLPKKWLNDTKISRMRFYFTAYNLYVFTSYSGYDPEV
SVINNSLTRGVDFSAYPRAKSFVTGVNISL
>EGALAKHO_04455 Heparin-sulfate lyase
MINLKTTSVFLFMLMTVCLTKAQEVKINKESFEAINLNYPGLEKTNNLYISGKYEDAAKA
LLDYYRNRKNIKHPDFNIGDETQFRGKDIGKANQEKADNALEHKFQPHKGYGFFDYGKDI
NWEYWPIKDNEVRWQLHRVAWWQSLGLAYRSTGDEKYAKEWIFEFNDWAVKNPLGKSEEN
DRYAWRPLEVSDRIQSLPGTFNLFVNSPNFTPSFLLGFLNLYNKQVDYITQHYTKDGNHL
LFEAQRVLGSGAIFPEFKLAESWRKSGIEILTREIKKQVYPDGVQFELSPVYHVASIDIF
LKAYNSAKLAGVEKEFPASYVKTVENMMEATVKISFPDYNTPMFGDSWIQEKSFRLKQFQ
SWSNVFPNNQVIKYFATDGKEGKIDFLSTALPDGGFYTFRNGWDDKSTVMILKAGPPGEF
HAQPDNGTFELFVKGRNFTPDTGCYIYSGDAEVTKMRDWYRQTRVHSTLTLDNQNMVITK
AEQNKWKTSKNLDLITYTNPSYKDLNHQRTILFIDEKYFVIIDKAIGSATGNLGVHFQLK
EDSKAVFDKTNNKVYTTYTDGNNLLIQSLNSDKIILKEEEGKVSYAYAKEIARPAFVFEK
PKSNSTTEQFITVLYPFEGNKAPKISIQPNADNDYEKGNISLNIIIDGKKSEIKTSLKN
>EGALAKHO_04456 hypothetical protein
MKKSLLALLCVFALLEAKAQNSSWVYDFGTAAAAPYTSTNYSSTYLPTPIIGAGNTGVRA
SSATEGPVELISSNFAGGTGAELKMTSGTTTPGAKFGLATFTATTVASFECKINVNSGTN
GRFLLYFGNGSNFNSASGLSLPQTFAALRLSPTSTAVSLDWLSSATSPNYTTAGLSQTTL
NKNQAYTLKFFMNNSNTTASYVTGSGTNTTTHNLLAGTFDIWIDNVKVLTNADPGTGLLP
QGTAINGMNLLNVGGGSSAPVIYIDDISYSNFLTATPPPPSPTVTGTILNVNYENGTTNS
GFTGIDVTHATAPDAAFIVPGYNSTYGIGHTVKMGNPAYESDGGQRSESSTVDAYQFFPG
EERRYEVSIKMKDWPAWTSTDPLYGVVLFQLKMSDGVGEPLRVIAQRNGIESKRDVRNAN
GDAITTSAPLVNDFRNYVNDWIHLRIDVKWTTNATGYIKIYTKLPGEQDYSLKDQSENIV
TFVSQSAGNIGYLKWGVYTRAGNPGESLEGNTTLTFTAHHDNIKVFELNNTSTPIALWNN
TITDNNPAYLPAPYSPVNDLLTANVLSNSTSPSSDFSRSTLTPAGGATLNGRYLLGGWAT
GSAGTPSLFDATQYYEFKIAPKPGHQLNLKNMTFNWRTAGATNPNTYVLRSSLDNFASNI
SAPVTVSDDAANTSNFGNSSVYDLANISTNSEITFRMYWYGATTAGALVGIDNFTFNGNV
LAVESNLQIQTKNDVAKNTDSAVSTYTVQSNEFDATATGNCDNITYSYLLSGATTASGTG
SLANKVFNKGVTTVIWTATDGCNGTSTSFIITVNDTEKPVFTLPAAITVSSDENQCGAAV
LLPQPMVTDNCAVATITNNAPALFPQGTTIVTWTATDVNGNTATTDQTVSVNDTASPFVN
SIPSAAFCYDESGNYTIPSATAKDNCSINTPTYEVTGATIRSGNGLDASGNFNVGQSNIK
WTVTDNAGNSNIATTTVTINNLFSANITDVYAVNPGGNTNTIYLGYGPSSLTLTTTPLGG
TAPYTYLWSNGKSTNAISVNPSTTGIHDYNVVITDALGCSISVTKQITVKDIRCASKKVT
VCHNDKSLCISTNAVSAHLAHGCYLGDCENTFTKSNMISKQIDDFAAIVAPNPSRTEFQI
TITGGDETQAILINVVDLLGRKINTVKSNYTSSIILGSNLSPGTYLAEIYNGTNTQTIKL
IKQ
>EGALAKHO_04457 Unsaturated glucuronyl hydrolase
MKKTFSLFLAISAITLSSFAKPNQGDPSYDWFKKTTEVIHFQLNKAAQTYKPGKNPRSVN
PNGTVRLAGLTDWTTGFFPGSLWYGYELTGDKKLAEDAKKFTLALDSIRNIKNTHDVGFM
LYCSYGNAYRITRDKTYLAVLSDGAANLYARFNPKIGVIRSWDFPWWHYPVIIDNMMNLE
YLYWGAKQFNKPEYTNAADTHALTTMKNHYRKDFSSYHVVDYDPATGKVLRKATHQGLTD
ESAWARGQAWGLYGYTVCYENSKNPKFLQQAENIAKFIMNNPRTPKDKIPVWDYDVHNAL
ETDELAPRDASAAAVIASALLDLSTQVKDGQKYVDYAEEILKSLSSDAYLAKTDENSYFL
LKHSVGAFLYNSEIDTPLDYADYYYLEALKRYADIKKIQL
>EGALAKHO_04458 putative N-acetyltransferase YsnE
MILSQRLLIRPYKKDDTENLSCNLNENYEQLLDYFANMLKNNSTPESLEKYLEQKSLDWQ
ENKGYACGIFLKDNNQIIGHISVRDIDWRVPKGEIAYFIFKQYNGFNYGAEALNAFKKWC
FIDKRFNRLFMKIAEDNIGSIKVAERSGFVYEGLLKKDYRKREQNLINMKIYGYTEDVEL
IRTDSQNSDFAKLIKDLDANLQSRNGQMQEYFNQFNKVDAIKHVIVAYVNNEAVGCGAIK
QFDNNTVEVKRMFVAEDCRGKGIAGSVLNELENWAKELNYTNTVLETSNVQVEAVSLYTK
KGYAITENYGQYAGIDTSICFKKEL
>EGALAKHO_04459 hypothetical protein
MSLGRYLRWKKNGISEKTIYKIIKKYFQYFSVLKNTIIERKLLKISPNKDLNYRKAYVFY
MKQLGLKRIDKRKFTITTFIYIQTNLGFVYLTIIMDLFDIKVIGCNLSCRLFAQKITILL
WKWL
>EGALAKHO_04460 hypothetical protein
MGGPGLGEIIIGIVAFMIYFLPSYIARNHKCFFGILTLNLIMGWTIICWIGDFVGFY
>EGALAKHO_04461 hypothetical protein
MVSLKNSTNEIIYNKLYEWEYQIKIEEFGIYNLRCYLLKRNIR
>EGALAKHO_04462 hypothetical protein
MLEFKLLIIVKKNYSLFLFDEIEKAYLSVFDRFLQIMNEEKLHYSLRKKERKKERKKERK
KERKEISHMPSFFSIQISELITS
>EGALAKHO_04463 hypothetical protein
MKIEKKTGGKKIKTNSKSLPRIKKEKLLSCYENTWDLFFLLLSNYYEIMNMKTDDNFTNE
QHTLIAYNILYGEITTGGFLELIKNGYGAYIFETQFSETLKKWGAIEMAVHIDKAKKIYF
ANKSNLEIITASNEIFDIYRHYPEFNALDNHFFKIMNSESEKIKVYIQKNLNDFAILV
>EGALAKHO_04464 hypothetical protein
MDACSFSLEFRLNRGEVRRLNKMYFKSLYRERFRILFECGLFYSICCDFFDFDNDLIAWI
VRNLTFVIIFFLFQHSCVNFVCKCIFQLINKFLIFDFFLAQYRFNFTNSFIYVHSPLGEF
AHKWAAIEKVILTKDFLFLCFKNEYIISIFHKNHGENITELMAFIEDNVIHIKYI
>EGALAKHO_04465 hypothetical protein
MDLFKQKYNMPVVVFRDNFGEDSSSVYDIENGTIFTILNNSTYVFKDKYGNVWSTVPDSH
HFKGVPYYPSIGTKYNRHNGITVCFVAKEEVEALAIDYFRNFIDLLFGLKIIVQEFLFYA
DETCKNDKSVFVFRKFKSKSHDVIDAFISYN
>EGALAKHO_04466 hypothetical protein
MIKSNFASIFNAGIFDFLVTDIFLKKYSSDYNYGRNYN
>EGALAKHO_04467 hypothetical protein
MILSFYRKKGFTRSYQGCNNSIFLILRKHISTTIIRITHIVIYKSGITSRSPNSRIARIG
SRSRTIYNITCMRSRICTKITKRRITRRACMHRSIDYFTFKSVLQIKCMTQFMCFNCHRK
SFKSVRHYNRSIYYLSMKAWKSSKTLNSSTSIVVIYFRN
>EGALAKHO_04469 26 kDa periplasmic immunogenic protein
MKKVVLFLTIMFMTMSYGQETKQIPQINVNGEGKVKVAPDQVSISATVETKGNNAKDVKK
QNDEKMDAVLKFIKKMNIPTADFRTKQVALNPQYDYEKKKTSYNAVQTVEILVKDLSKYD
ELMEGLVQQGINRLDKVSFESSKLAQYQSEARKIAMKDAKAKAEDYVSVLGQKVGKAFVI
SDNSQVYHPQPMYAMKSMAMDNAEGASNETLAIGEIEITANVSVSFILD
>EGALAKHO_04470 Rhomboid protease GluP
MNTVNTVLVGIIVANALISYKGFNDLAFFRKYEFHVGSIRSGEQIRMLSSGFLHVDMMHL
IFNMLTLWFFAPVVIEWLGTISFVLIYLGSLIFGSLLTMLFHKNDYSYRAVGASGAVTGI
LYSAILLQPDMMLGIFFVIPMPAYLFGILYLLYSIYGMKAKNDNIGHTAHFGGAIGGYLI
TLIKEPSLIVDHSLMVILLAIPILILFAMAKLGKL
>EGALAKHO_04471 Lipid A biosynthesis lauroyltransferase
MQFLAYILAYPFLWLISILPFRIFYWFSDFVYFLVYHVIGYRRKVVRENLALTLPHLSAH
ERKAIEKKFYQHMCDMFLEMIKTMSITPEEMEKRFTITNMDLFHEYERKGKSVVLVASHY
ASWEWLLTLNKRMLFNGVGVYKKIANPYFDKLVRKIRGKYDAELVETKKAIPLMAQNQRD
GILSLYGLASDQSPKLDRIFHSMKFMGIEVPVHTGAEMLAKKYDLSVIFIKVKKVGRGYY
EATIVPIADNPKEYGNFEVTEKYLREVEKQIYEAPEYYLWTHKRWKHRVQ
>EGALAKHO_04472 hypothetical protein
MFKKLLFTFLISVIYINTFAQSPKRGIAYGNNSTADLTALKTGISWWYNWGSLPENDINA
NYESLGVEYVPMAWGKVNDADVQAFIDKIKPGAKYLLAFNEPNFIDGARLTPQEAVNAWV
NIEKIAAAKNLEIVSASPAYNGPDNYGGYTDPVAWHNQFFLLCPNCKVDYIAFHTYDSSS
GSVIGVTGNLKRFNRPVWVTEFANRVIQTAAEKTTFMKEIITSFENDPDIYRYSWFTGRV
PADWTDMQEGQLLAPESGVLKPIGTEYINTSYTSKKMNVPGRITANKHYRRKGTGLQNTT
DSGTGQNVCFIEAGDWNEFMLNVADAGTYNLTFRVASPTIPGKFDILINDAVVKTDETFP
VTGGYQTYADKLVSGVALPKGEVYLKIKFKSNDMNFNFIDVTAANLGVNDPILEKDFFTV
YPNPVKTQATLHIKSDVTEPLSLKIIDIKGIVCYSSNNHFTNEDIKIGDKLSSGVYIVNA
TYGTVKKSIKIIKN
>EGALAKHO_04473 Phosphomannomutase/phosphoglucomutase
MTLIKSISGIRGTIGGKVGDNLTPVDAVKFASAYGTFLKNNTTKEKLTVVIGRDARISGP
MIHNLVVNTLIGLGINVIDLGLSTTPTVEVAVPLEKADGGIILTASHNPKQWNALKLLNE
KGEFLSGAEGAKILEIAEAEAFDFSDVDNLGEITVNDAYMDIHIDEVLNLPLVDVEAVKA
AKFKVVVDGVNSSGGIIIPRLLELMGVEVVKLYCEPNGHFPHNPEPLKEHLTDISELVVK
EKAHLGVVVDPDVDRLAFISEDGEMFGEEYTLVACADYVLSKTPGNTVSNMSSSRALRDV
TKAHNGSYEASAVGEVNVVELMKKNNAIIGGEGNGGIIYPESHYGRDSLVGVALFLTHLA
NKKMSVSALRASYPEYYMSKNKIELTPQIDVDAILVAMTEKYKNEDITTIDGVKIDFATE
WVHLRKSNTEPIIRIYTEAPSQEKADVLALRIIDEIKAIAGI
>EGALAKHO_04474 Acyl carrier protein phosphodiesterase
MIYYKTDLKKFLYIYKRERRILASQNLSNSKKMNFLAHIYLSGDNDLIKIGNFMADGIRG
KQFEHFPEDVQKGIILHRFIDTYTDSHDVFRQSTKRLHEKYHHYAGVVVDIIYDHFLAKN
WTKYSDEKLEDFINRFYNSLHTNYDILTEKTQGLMPYMIERNWLLSYRTVEGIHQILTQM
DRRSKNLSKMQFASEELKEFYTEFEQEFTTFFEEMQQQAKQKLLSL
>EGALAKHO_04475 Gamma-glutamyltranspeptidase
MKKITLLFSFISIFSFGQQNPTGLVTSKAMVVSAREEASKIGADIMKKGGNAFDAMVGTE
LALAVAFPFAGNIGGGGFMVYRKANGEVGSLDYREKAPLAASKDMFLDKDGNVIKGKSTE
TALAIGVPGTIAGVFAVHKKFGSMPMSEILKPVIALAERGVIVTQKQEKSMNSYRESIVK
INGPTTLLATNFKEKDTIKYPALAKTLKRISKNGRNEFYKGETAKILVDYLQKKGGIITL
EDLSKYEAKWRKPLQFTYKDLKITSMSPPSSGGICLAQILKMIAPYDLAKMGHNSPEAIQ
VIVEAERRAYADRSQFLGDPDFVKIPIKALLSDEYLKDRMATFNVDKASLSSEIKEGKVT
YNESTETTHYSIVDKFGNAIAATTTLNDGYGSKYYCDELGFFLNNEMDDFSAKPGSPNMF
GLVGNEANSIAPQKRMLSSMTPTIVEKDGKLFMVVGTPGGSTIITSVLQTILNVYEYKLS
MQEAVNAPRFHHQWLPDLITFEPSTFDNTTINKLKTKGYLINENPTPIIGKVDAILILPN
KTLEGGADFRGDDAAVGF
>EGALAKHO_04476 H(+)/Cl(-) exchange transporter ClcA
MLKKYFRKLESVIALAQSLMTPKQFIFLSSVLIGISCSLAVIVLKTFAHSVFSFATYING
ILKLSFINSILPIIGIVLTVFVVKRVLNGTIEKGTSQILYAVAKKASIIPRKQMYAQIVT
SSLTVGLGGSAGLESPIVVTGAAFGSNFAQNYKLPYKDRTLLIGCGVAAGIAAAFNAPIA
GVLFAIEVLLVDVSISAFTPIMISAATGALVSAIVLDETILLSFKKQEAFNYHNIPFYVI
LGILTGFIAVYYARNFQKVEHYFAHLKMGAYKKALIGSSLLALLIFVFPTLFGEGYESIK
TLSESDPGKILDNTLFGDFRNNQWVLLLFVGCTMMVKVFASGLTIGSGGNGGNFAPSLFL
GSYLGFFFSKFITMIGLSKLPISNFTMVGMAGILSGLFHAPLTAIFLIAEITGGYSLMIP
LMIVSSISFAISKRFEKYSLDVKGLAKKGHAFTSNKDSNILSTLDIDTIIQCDYLTVHPE
ENLTKLVDLISHSNQVVFAVVTHEKELVGVVHFNDIREIIFNSYRVKYTLIKDVMKTPPA
TISSFDSMEIVMSKFEKSKSAFLPVLRNEKYYGFISKSIALEAYRMKLRSMTIE
>EGALAKHO_04477 Adenosine monophosphate-protein transferase and cysteine protease IbpA
MWNIDLTYREEFQSTFERLYQKRLDLQNSRPLPNIALHKIRESLSLEWTYNSNSIEGNTM
TLRETQMVIQEGITIKGKSLREHFETHNHDKAIDYLYSIVDDNYKLRSIDILSLHGLVLR
SIEDDFAGRLRNGGVRISGVNFMPPNANKVSDYLDELIDFINTNPLGLNDIELATIYHHK
LVWIHPFFDGNGRTVRLSMNLLLMRCGFPPAIILKNDRKKYYEALNQANNGNYQKLTLLM
CQALERTINIYLSAMPGSTYDYQSIQNIVSEPEAHYGHEYISLLARTGKIDAYKEGRNWY
TTKEAIEEYMATRKRKC
>EGALAKHO_04478 UvrABC system protein A
MLEKDNTIEVLGARVHNLKNIDISIPREKLVVITGLSGSGKSSLAFDTIYAEGQRRYVET
FSAYARQFLGGLERPDVDKIDGLSPVIAIEQKTTSKSPRSTVGTITEIYDFLRLLYARGA
DAYSYNTGEKMVSYSDEQIKDLIIQDFNGKRINILAPVIKARKGHYAELFQQITKQGFLK
VRVNGEVQDLVSGMKLDRYKTHDIEIVVDRMLIEDTEDNQKRLSESINTAMHHGENVLMI
LDQDTNDVRYFSRNLMCPSTGISYQNPEPNLFSFNSPKGACPHCNGLGTVHEINIKKIIP
NPKLSIKSGGFAPLGEYKSSWIFKQLEVIGEKFGFKITDPIEKIPEEAMTMILHGGKDKF
VVNSKDLGVTRDYKIDFEGISHFIKNQFDETSSTTIKRWAKDFMDEVNCPVCDGSRLKKE
AQFFRVNGKNITELCDMDISDLTAWFQDLNSHLTDKQLLIASEVVKEIKDRLNFLMNVGL
NYLALSRSSKSLSGGEAQRIRLATQIGSQLVGVLYILDEPSIGLHQRDNEKLIHSLEQLR
DIGNSVIVVEHDKDMIERADYVIDIGPKAGKYGGEIISIGTPAETLKSDTITAQYLNGKM
KLEIPKERRKGNGKFLKLTGATGNNLKNVSIELPLGQLICVTGVSGSGKSTLINETLYPI
LNAYYFNGVKKPQPYKKIEGLEHIDKVIDIDQSPIGRTPRSNPATYTEVFTEIRNLFTMT
SESMIRGYKAGRFSFNVKGGRCETCEGSGVRTIEMNFLPDVYVECETCQGKRFNRETLEI
RYKGKSISDVLNMTVDEAVPFFENIPKIYRKVKTIQDVGLGYITLGQQSTTLSGGEAQRI
KLAGELSKKDTGNTFYILDEPTTGLHFEDIRVLMDVINKLVDKGNTILVIEHNMDVIKLA
DYIIDIGPEGGKGGGQLIAKGTPEEVAKNKKSYTAKFLKKELE
>EGALAKHO_04479 hypothetical protein
MNLKDKFSNVDQYFSPKIIDEVNDQYIKVAKIKGQKIPWHNHENEDELFYIVEGELLMEI
ENEPSFTMRKGELFVVKKGINHRVSSVAECLIMLIESKTTEHTGKVKSPITKSIEEQTY
>EGALAKHO_04480 Cytokinin riboside 5'-monophosphate phosphoribohydrolase
MRLEDFDNDEDKVIQDRLKQKTWNEIRTNDSWAIFKIMSEFVNGYESMGRIGPCVSIFGS
ARTKPEDKYYLLAEKIAYKISKAGYGVITGGGPGIMEAGNKGAHLGGGISVGLNIELPFE
QHFNPYIDHDKNLNFDYFFVRKVMFVKYSQGFVVMPGGFGTLDEMFEAITLIQTKKIGKF
PIILVGVEFWSGLIEWVKTVLVEKMQTVSPDDLNLFKIVDTEDEVVDVLDKFYKKYDLSP
NF
>EGALAKHO_04481 hypothetical protein
MYPLISKPSLKSFYKIIFFILVLFSSIKQYAQHQSKMEVAVNLELKTLNVKQDITFYNTS
NDSLTSIVLNDWNNAFSDKNTPLAKRFSDEFYRGFHVAKPEERGNTTILNLTDSDNLALE
WERTDKNPDFIVVKLNRKLNPGEKIDLHLTYISKIPSDKFTHYGFDQNGGMNLKNWFITP
ARFENHHFVKNNNFNLDDIANATSDYEVEIKIPTNYSVTTDLNSASKDVSNSSFSSYLFS
GTNRTDFNLFIEKQNSFRSYTTGDLEVLSDLKTKKLNEIQRAIVINRVASFANEFIGKYP
HQKITVSQADYDRNPFYGLNQLPSFISPFTDEFIFEITFLKTYLNNYLKTSLRLDPRRDN
WVYDGIQIYTMMKYMEENHLDQKMLGRLSDMKLFKSYNITNLTFNEQYSYYYMLMARKNL
DQPLGDPKNTLIKFNEQIASKYRAGLSLSYLDDYLNHNIVPESVQEFYNLNKKEQTNRFD
FEAILTKNSPKKINWFFETIIDSRQIIDYKFTNVSRTKDSVQFQIKNKTGIYAPLPIYGI
KKNEVVFKTWIEPKKNDSIYSFDRKNADKIVINYDNEVPEYNQRNNWKSLKQVVITNRPI
KFNFAKDLEDPYYNQILYIPTLTYNLYDGLTPGIRFNNKTILDKPFTFDINPAYSINAGT
ISGSSAFSYSQYYRNSTLYNVRYSLSQNYFHYAPDATYLKLNPMVQFRIREKNFRDNRKQ
LFLLREVIVNREASDYITDNSKPNYAIFNMRYSNTKTELINHFSYMNDIQFSGDFGKLSG
EVEYRRLFENNHKLNLRLYAGTFLYNTSNSDYFSFGLDRPTDYMFDYNFYGRSESTGFFS
QQFVMAEGGFKSKIEPAYANQWMTTLNASYAVWNWIEMYGDIGFMKSKNQSADFVYDTGV
RLNLVPDYFELYFPVYSNNGWEISQTKYNEKIRFVITLSPKTLVNLFTRKWF
>EGALAKHO_04482 2-oxoisovalerate dehydrogenase subunit beta
MITEKNNTTLTFEDFKTEVLKDYRIAVTSRECSLLGRKEVLTGKAKFGIFGDGKEVPQLA
MAKAFKNGDFRSGYYRDQTFMMAIGELTPKQFFAGLYGHTDLDFDPMSAGRQMGGHFVTH
SLNEDGSWKDLTKQKNSSADISPTAGQMPRLLGLAQASKIYRNVDGIKIKDKFSVDGNEV
AWGTIGNASTSEGLFFETINAAGVLQVPMVMSVWDDEYGISVHAKHQTTKENISEILKGY
QRDEDSKGYEIFRVKGWDYAELVSTYERAGAIAREEHIPVLIHVNELTQPQGHSTSGSHE
RYKNGERLAWERDFDCIRQMRLWMIAINIASPEELSEIDFELKKEVLEAKKEAWNSFINP
IIEDQKNLLSLLEQIAEASINHKERIRKYISELSAIKSPLKKEMLVIARKILRFVEVPNS
KVLLSHWITDYISKTQPRFSSHLHSDSDQNVYSVQKVLPQYAENAKPDSDGRMILRDNFD
ALFTKYPETLIFGEDVGNIGDVNQGLEGMQEKYGELRVADVGIREATIIGQGIGMALRGL
RPIAEIQYLDYLLYAIQIMSDDLATLQYRTVGKQKAPLIIRTRGHRLEGIWHSGSPMGMI
INAIRGIHVLVPRNMTQAAGFYNALLETDEPALVIECLNGYRLKEKTPLNFGEFKTPIGV
VETLKEGSDITLVSYGSTLRLVEQAATELLDLGIDCEVIDIQSLLPFDINKDIVKSIAKT
NRLLVIDEDVPGGASAFILQQILEEQDAYVHLDSKPQTLAAKAHRPAYGTDGDYFSKPSA
EDIFEKVYSMMHEVNPSKFPDLY
>EGALAKHO_04483 3-deoxy-manno-octulosonate cytidylyltransferase
MKIIAVIPARYASTRFPAKLMQDLGGKTVILRTYEASVATNLFDDVFVVTDSDLIFNEIV
SNGGKAIMSIKEHESGSDRIAEAIFSLDVDIVVNVQGDEPFTEAGPLEQVLSVFINDEDR
KIDLASLMREITDEEEINNPNNVKVVVDQSQFALYFSRSVIPYPRDKDVGVRYFQHIGIY
AFRKQALLDFYSLPMKSLEASEKLEQLRYLEFGKRIKMVETTHVGIGIDTAEDLEKARGI
LASK
>EGALAKHO_04484 4,5-DOPA dioxygenase extradiol
MTTLNDLHSISSTFSNTDKMPVLFLGHGSPMNAIEENQFVAGFRNLAKTLPQPNAILCIS
AHWFTNGTKVTSMQMPRTIHDFGGFPQALFDVQYPAKGSPELAVETKKILEPVNVDLDEH
WGLDHGAWSVIKHLYPEANVPVIQLSIDYTKSGQYHFELAQKLQSLRHKGVLIIGSGNIV
HNLRLVDFRNFDKDNYGFDWAIEARETINNYLLDENFQPLIDFEKISKAVQIAIPTPDHY
LPLLYTLGLKEKSEELSLFNDKLLAGSLSMTSVKIM
>EGALAKHO_04485 ATP-dependent RecD-like DNA helicase
MEFYKLNLTFKKPYFVVQFYPMNSALFYGILQRKFPFAPTQKQDIFFQKIAIFLTEPAND
TIFVLKGYAGTGKTTVISTIVNNLGEINKKYVLLAPTGRAAKVIANYSNTPAFTIHKKIY
FPKKSSGGGVAFTKQVNKHKNTIFIVDEASMISDSNSDSKLYDNGSLLDDLIQYVYSGTN
CKMILLGDTAQLPPVNLDISPALDVHTLNAHYDKEIEHIELDEVMRQEENSGILYNATEL
RELLKDSFITEFKFNVKKFKDIVRLTDGYDIQDAINTAYSNYSIEDTAFIVRSNKRANQY
NEQIRTRILFKESELSVGDFLMVVKNNYFWLKETDEAGFIANGDIIEVLEMFGIKELYGF
TFAKVKIRMVDYPDQKPFETVLLLDTIKSESPSLTYEESNRLYEEVMKDYEDESTKYKKF
QKVKENEYFNGLQVKFSYAITCHKSQGGQWNTVFIEQPYLPNGIDRDYIRWLYTAMTRAK
NKLYLIGFKDESFEE
>EGALAKHO_04486 hypothetical protein
MAFQNTNITSKLYKKLSIQVSLTGFSFCCFDTLNNTITSFNEIHFDPNKKATKIEESFSD
AFKKYPELKDTYDEIMVIHNNNLSTFVPTALFDENYLGSYLQYNTKVFETDFFTFDTISN
YEMNAVYIPYVNINNFLIDNVGSFDYKHVNSILVEKILDASRNNDDKKMIVNFNPEHFEI
IVVQNQKLLLFNSFEYNTPEDFIYYLLFTAEQSNLNPEIFPLELLGTIEKNDPFYAIAYK
YIRNVSFLDVSTLQEKNDFSTAQNQKHYILFQS
>EGALAKHO_04487 Ribosomal RNA small subunit methyltransferase D
MRIISGKYKGRRIFPPKNLPVRPTTDMSKEALFNVLNNHFSFDSLKVLDLFSGTGNISFE
FASRGSEPITSVDGDFGCVKFIKQVASEYDFNIAATKSDVYKFLENCKTSYDIIFADPPY
GLDQAAFEKIVLTVFERDLLHEDGMMIIEHSKYTKMDHLSNFSFQKNYGGSFFSFFELNS
TDDDEELPNDSLKKVTEEDEG
>EGALAKHO_04488 hypothetical protein
MNIYLPLKLFIILLLFCFSLLGNAQNKTPKDSISNNLNEVIITQNKKAFSNQNGNIKLDV
SNSIYNSIPNTVDLLSKIPTVQVSADKESISVVGKGTPLIYIDNQKVGMNDLNTLAVADI
KTIEIIQNPSAKYEAEGRVVILITRKFSKKDSFRTEISEVASFKKNYNNYLGFNSNFKKN
KLELKANFNYNRLNPWESHSIDYQIPIADIASKYDVKAETKRNQYVFGAGLFYKINEDDY
FSFSVNSKLQSDTFPINTMTNNKNKDVVNNVVTFTDNDSKKNFVNSFLNYQKKIKPIDTQ
VFAGLQYSNLDQRLFTEVNNNFNETQFELDQIRDQKFQINYFSGRIDVEKKLKNEMKFEI
GGLYSTANSKSDVAIFYTQNNQNELSYYDFKEENLSGYTQLSGKIKKADFSLGVRVENSN
IVGKFRTDAEPLLEINYTNFFPKAQFTFPIDSLKSISVNYARSISRPNYSLLSQGATYIN
PYFLYARNINLGPTFINEISTTFQYHDKSVKLSYSQATDPVYNSFSFDDQTNIMTFKDIN
FDRSSAFTADFTLPFTYKFWTTTNSLLFILEKIEDNTAVSLGSKPYSYYSSNNEFKLPKD
YQFVLNFWGLTKRYTGVFESNARFIVDMAVSKTFSKKWNCTLSCNNVFKNNIETEKFTIN
NINSKARYVVDNHEISISVKYSFGKVKETGFKEKNNDENQNRVN
>EGALAKHO_04489 Alkaline phosphatase synthesis sensor protein PhoR
MNLMKQRINLLIAFSVVALIVLSTVQCYLVKTTYDYKVAQFHTEIKNEIAQISNNYSDID
SVLVAKKEALYKLLSENYLKGKTNKIDVKKAILESEFSDALTQKIKRKFERDLPNLKIDF
AIVLNKYILYQNAKKADTIFSEKPFIQNKLYGNLASLNNAFLVRNYVGTTNGTFENQDYK
LLTEDSMYVSVIDWEMIILRRMTFILILSLLSIVTLITLFVIAIKALIKQKKVSDVKTDF
INNITHELKTPLATLGISTKILEQKNIRDNDENFNMIVNTISRQNNRLQNLIDQVMANSL
AENEIELQKEKIEAEDFLLSIVNDFKITFPKINLKTDFQTQKTILILDKFHLTTAFLNVL
ENAVKYGSKTITLKTSIIENQFSISIEDDGIGIEKNKQSLLFDKFYRVEQGNLHNTKGLG
LGLYYVDQIVKAHQGSVKVVSDLGKGTEFTILLKV
>EGALAKHO_04490 Sensory transduction protein regX3
MKRLLLAEDDFDFAAILKQYLELHQFEVIWAENGEIALDYFKNQAFDICIFDVMMPKMDG
FSLAEKIITINPEIPFIFLTARKLKEDKIIGLKLGADDYIIKPFEVDELILRLQNILKRI
EQKRSLEGNNIIEIGSYVFDNERLTLNNKNHVQQLTEMEASLIEYLYLNHNQLLKRDQIL
MSVWKKDDYFSGRSMDVFISRLRKYFNSDPKIKIESVRNIGLEFKIEKP
>EGALAKHO_04491 hypothetical protein
MKKNYLFVILFAFLINASYAQDDAITSVQKNQFKINMLLPGFVYEHGFDAKNTLYSEASL
GFGFSSNSNNSNFAVFPNINEQFRHYYNLEKRAAKGKRTAFNSGNFLALAAIYNFESIST
NDDYRESVPSFTVGATWGLQRTYKRKFNLEFSAGPGVNFDKYDTEFALIANFTLGWVIGN
>EGALAKHO_04492 hypothetical protein
MNLKRLFGGILTILGIVGLIYTAVIFADTSGGERDIKSLIIYGILGIVFFTSGISLVRTT
KDES
>EGALAKHO_04493 Putative 2-dehydropantoate 2-reductase
MIRIGILGLGGVGGYFGGLLAKAYYNSADIEVVFIARGATKEAIAENGLKIINDDSEIVA
YPKLVSNDPDEISVLDYLICATKTYDIEESLLSLQKCITSKTVILPLYNGVDAPERIKKI
FPENDILQGCVYIVSMIASPGTIRRLGFYEKLFFGSETTSIDKLEELQNILQKAKIESYL
VDNIEETVWEKFIFISGLASVTSYLNQNIGEILKKKKSMKVYVELLHEIEAVAKAKGLQL
PEDIVNQTIIKLAKSPKEATSSMHRDLLANRKTEATSLTQFVVNEGLKYGVATPLYEKIA
NALL
>EGALAKHO_04494 C4-dicarboxylate transport protein
MNITTPNTSPKIKKSTFHSIITNLTFWVLIAIIAGVLLGHVSPENGVKMEIVGKTFVDII
KLFIGPIIFLTIVLGISGMGNLKKVGRIGVKALLYFEVVSTISLAIGVGVAYFFQPGKID
KSGLALQDASKYTNHAADNFSWLQFFLSNFTLQVLLAAIVCGIALNFYQKREQTILVLER
FSKVVFTGLKYVMYLAPIGAFGGMAYTIGKFGLETLIPLGKLMLCVYLTMALFVFMILGT
ILKYYKINILSILKYIKEELLLVLGTSSSEAALPSIMVKLEKMGCSKSVVGLVIPTGYSF
NLDGTSIYLSMSVIFLAQLYDVHLSFVEILSVIGILMITSKGAAGVTGSGFIVLASTLTA
IHKIPVEGLAFLLGVDKFMSEARAITNIIGNTVATIIISKTEHDFTELNLEPVIEE
>EGALAKHO_04495 hypothetical protein
MTRMYHYATVSKALDQLHEKGFTCDFNRNADAIKKNPEKFEIVHVYRYEGESDPGDEAVV
YGIKSNSGKKGVYVAGFSADSDQETAKFLFDLSIKGR
>EGALAKHO_04496 SpoIVD-associated factor A
MSLQEKYKELTDLASTLGVTNLQVREQDNVLYIDGTAKSAADKEKIWDSYGTLDPDYRSA
DVVMNIEVAEGTTTEYTVKSGDSLSKIGKEYGVSWQDIFEANKDIIKNPDLIQPGWKLKI
PTS
>EGALAKHO_04497 hypothetical protein
MKIRSILLGMSFAFSLVACAPKDADIQKEINEKLNTSSVQVTVHEGVATIVGTCDDDAFK
KNIERSVKAVKGVKSVVNNCQIPAPNVEPAAAAVIINSDAELDKSVGEVVKAYNGVSATV
VGGVVTLSGEIKRSQLAPLIQSVQELKPKKVENKLTIK
>EGALAKHO_04498 Toxin ParE1
MAKYYLTNKAVEDLAEIWNYTFEEWSENQADKYYHLLLDSCQEIAENPNQAKKYQDVSAE
LLGYKSNQHILFYQITSNDEIEISRILHGRMDLKNKFN
>EGALAKHO_04499 Antitoxin ParD1
MGRNTSISLGNHFENFIDHTLSEGRFKNASEVVRAGLRLLEEEENRLILLKNAVQEGINS
GRAENFDPNRHLESLKAKKRTNG
>EGALAKHO_04500 Quercetin 2,3-dioxygenase
MKTPTPIITVNESEGQKLKIAGGNYRIIISGKQTNGEYAVIEMSVPPDAGPSPHSHADFT
ETFFVLEGEVSFKSELGSYVAKKGSFVNIPKGGIVHGFKNLGNEPAKLLCTVTPAGLDDL
FGEIAEYLETASSNTENETKEKLNFLFKKYGQQMFPPDYLD
>EGALAKHO_04501 hypothetical protein
MIHQLKPSILVETPLGTGQAIFLIDYGMHQNTCWVVALQENGVIKHFDCNDIILSTNYTY
GMNLRKNNFSEKKDASK
>EGALAKHO_04502 DNA polymerase III subunit tau
MEQFVVSARKYRPQTFKDVVGQKAITNTLLNAIDSNHLASALLFTGPRGVGKTTCARILA
RKINQPGYDDPNEDFAFNVFELDAASNNSVDDIRSLIDQVRIPPQTGQYKVYIIDEVHML
SSAAFNAFLKTLEEPPKHAIFILATTEKHKIIPTILSRCQIFDFKRITVKDAKEHLAEVA
TSQGINFEDDALHIIAQKADGAMRDALSIFDRVVSYCGTNLTRQAVTENLNVLDYETYIS
ITDLLLENKIPELLLAYNDILAKGFDGHHFIAGLASHFRDLLVSKTPATLSLLEVGEQAQ
QMYGVQAQKCSQDFLLKGIDIANDCDLKYKLSQNQRLLVELCLMQLASINFDGEKKKLSN
S
>EGALAKHO_04503 hypothetical protein
MEEKTKSYVKPSSVLPTEEFNETDMLLQWNKYAQRLGEKGHKIMESLLLINDPKLNGTVI
TLELPNEGSKLDFEGQVNGLLGHLKGHLHNHDITIEIIVNEAIETKRSFNDQDRYNRLLE
INPNIELLRSTFGLDLLG
>EGALAKHO_04504 FMN-dependent NADH-azoreductase
MKKILIINGHPNPASFNYGIADSYQIGAIASGAQVETITIAELQFNPNLQFGYQKRTELE
PDLVKAWGKIQNADHLVWIHPVWWGGLPAITKGFIDRLFLPGMAFQYRENSVWWDKLLKG
KTAHIITTLDQPGWYYRLFFGRPSINQLKKSTLEFCGVKPVKVSYIAIVKTANDFQREKW
LKKVYNFGLRNK
>EGALAKHO_04505 hypothetical protein
MKSVFQSIHVLPQMELDQLDYLITFRKLKKGEVLLKENQVCNEIYFIKKGILRSYFFNHQ
GDEITNCFAFENEFMASFSSFITQKAAEENIQALVDTELQIISRESLEKLYKLGIHWQEI
GRKLTEIEYVTLQKRMISFQKLSGSQRYEELYKNHQKYLQLIPLQYLASYLGVTPRHLSR
IRKAIL
>EGALAKHO_04506 hypothetical protein
MNKTRLEAFSDGVLAIIITIMILEIKVPHGEEFSDLKPLIPKFLSYILSFIYVGIYWNNH
HYLLHGLSKVNGKILWANLHLLFWLSLIPVATGWMGEHNFAKASMALYGIVLLLCSISYF
ILQRAIIVNEGENSLLAKVIGRDLKGHASSILYIVGIVTSFYNEWISGAAYFAVALLWLI
PDKRIERVFTK
>EGALAKHO_04507 Guanosine-5'-triphosphate,3'-diphosphate pyrophosphatase
MIKIRKYAAIDIGSNAMRLLISNVVEQEGKEPQFNKSSLVRVPIRLGQDAFTVGEISEEN
IDRMVDAMKAFNLLMKVHKVERYMAFATSAMREAYNAKEVVALIKKKADIKIEIIDGKKE
AAIIASTDLHHLLKTDETYLFVDVGGGSTEFTLFSDGKMINSRSFKAGTVRLLNDMVCDV
VWDEIEKWIKTNTADYDEVTLIGSGGNINKLFKMSGKQQEKPLSYIYINSQYAFLNSLTY
EQRIAELGLNSDRADVIIHATRIYLNAMKWSGARQIYVPKIGLSDGIVKAMYYGKI
>EGALAKHO_04508 Polyphosphate kinase
MYEQKYIDREKSWLAFNARVLQEAADNTVPLLDRLRFVGIFSNNLDEFFRVRYAAIRRLS
LSGISGEKYLGGVSAHQLVKDITEIVIQQQSESLRILGNIEAELEAENIFIINENQITQD
QERFLKDFFIQKLSPELVTIILNDLAEFPILKDTLGYLAVRLEMNQNDEVRYAIIEIPKT
INRFVVLPSHDDKHYVILIDDVIRYNLKNIFNIFDYKSVSAHMIKITRDAQLDIDSDLSK
SMLEKIATSVKDRRIGEPVRFIYDNLIEEDTLRFFLDKMKIVETDSIIPGGRYHNRRDYM
NFPNLGRYDLLYKPNEPLPIPGLSLGGSILEKINKKDYLLHAPYQSFSYLTKFLREAALD
PKVTSIKITLYRLAKNSQIISSLINAAKNGKKVTVQIELQARFDEATNISYAEQMQTEGI
ELIFGIKGLKVHSKICVIERVEDGKTRRYGFISTGNFNESTAKIYTDVTLFTCHQGILKD
ISKIFEFFDINYRVHRYKHLIVSPHYTRTKFVKLIDREILHALAGRKTHIKLKMNSLSDF
KMIDKLYEASNAGVKIQLQVRGICSLIPGIPGMSENIEAISIVDNYLEHSRVYIFGNAGL
TEVYISSADFMTRNLDGRVEVTCPIYDLEIKKELIDNFNIAWKGNVKVRYHSYKLDNKYK
PRNHHAPFRAQIETYKYYQNKIAVLEEVPQKIN
>EGALAKHO_04509 hypothetical protein
MKNLILIRHAKSSWEAPLKDFDRPLMKRGILDAHDVSANISNFLPKTYIIWSSTAARASE
TALIFAQNISYPIESIVYKDDLYTFDERQLEKVIKSCDNSFESVILFGHNEAITNFVNKF
GDVFIENVPTSGFVSLQFDSESWDNINKGKTHKTIFPKDLK
>EGALAKHO_04510 hypothetical protein
MRTKTTLEKAVKFVNNCKFIFSFKKNIFQKNIFTILFCLITTISFAQSASCKATFEVEKN
RNYSNAGDGGAYFTLVLTNEGNSDDIFNLSAININGNCSNNDGTSTSANVNLISSFSDNS
SVPITSVSLSSHQTATFSIHLTVPHGTAFNRWNCTQINATSSNCSNYAVNTVVHTIVNNP
SEN
>EGALAKHO_04511 hypothetical protein
MKNHFKTFWAFALLIGFVVSAAAQDSAKTPLILGSIEPYHMEVTYDKTSHLIFPTAIRYV
DLGSEYLIAEKAEDAENVLRVKASVRDFEPETNFSVITNDGRFYSFNVLYSSSPQALSYD
LQTMQKSVDKENGNDVLFEELGNNPPSLAGLLLETIYKNDKRIVKHIGAKSFGIQFTLKG
IYIHNGKYYFHTQLINGTNVPFQVDFMNFKVVDKKIAKRTVVQERPLIPLRSYKPLGEIG
GKSMEQNVFLLDQFTIDDDKVLLIEIFEKNGGRHQTLQVENSDLTKASLISNMHLKF
>EGALAKHO_04512 hypothetical protein
MKENEKKTVILLEEGGQNKASDLHEDNKSVMERFKKPLIFVLMGIVFLGSMYLVFKPSSD
KKGIKNMGLNDTVPQASEAAMQSDKQKAYEQEMLEEKEEQKHSALTTLDDYWNRESTTSE
SERVLPNEDDLGGENSSRPVKSDNPALNSYRNAQSTLGSFYQDGNTETQQLRRQLEELKD
KLAEKDIPKSVTVDDQLALMEKSYQMAAKYLPSDTKTRKAVPSDSVYHISAAKLPEAYFT
ALAPIRKNRVSSLYREPSDSVFPANWSDNRNRNFYTAGSVGKELQPKNSIKACVQETQII
AGESGVRLRLLEPAQMPNGIIPKGIILTANAKFEARRLQLKVTSIELGGNIIPVAITIYD
LDGQQGLYVPYSPEMNALTEMAGNMSQTSGTSLMLTQSAGQQAAADLSRGVVQGISGYFS
KKVRTPKVTLKAGHQVLLVSKN
>EGALAKHO_04513 hypothetical protein
MKFLLDLDAFAKILTDKGYDGYFHTESCCAGKLKDSISEFLQTWENGNDAPLVANYLHLS
TYLEWNGQDKPKVECNMWVRYENGKFDLEDTEMYIKRTDRYGQLLKQSKLTNLTASSFPT
IMEAIAQVSEKPNVEIAPRKRGFRM
>EGALAKHO_04514 hypothetical protein
MEFKTLRNIENSFRQIRLYAIVFATLCTGVAGYAVWKSYSFAQQQREKIYVLDNGKSLML
ALAQDASINRPVEAREHVRRFHELFFTLAPDKNAIESNMKRAFNLADKSAFDYYKDLSEK
GYYNRIISGNVQQRIEVDSVVGNFDAYPYVVRTYAKQIIIRSSNVTKRNLITSCYLVNSV
RSDNNPQGFNIEKFSVVENKDMEVIER
>EGALAKHO_04515 hypothetical protein
MEWNNLHEVLRSLYDDMMPLAGDMSAVAKGLAGLGALFYVAFKVWEVLSRAEPIDVFPLL
RPFALGLCIMFFPTIVLGTVNAVLSPLVTGTHAILDDQVLDLNKLQQQKDQLEYEAMVRN
PETAFMASDEEFDKKLDELGWSPSDVGTMAGMYMDRQEYKIEKAMKEWFRNLLEILFQAA
ALVIDTIRTFFLIVLSILGPIAFAISVWEGFQSTLTQWFTRYVSIYLWLPVSDLFSSMLA
RIQSLILERDIQKLADPTFIPDTSNTVYIIFLIIGIVGYFTIPTVAGWIINSTGAGNFSK
NVHQTAVKSGNIAGAGAGSTIGNIGGRLMNK
>EGALAKHO_04516 hypothetical protein
MKKIMYLVCAVILAAAPSAKAQFVVTDPANLASGILNSANEIVQTSSTVSNVIKNFKEVE
KVYKQGKEYYDKLQAVNNLVKDARKVQQTVLLVGDVSQMYVQNFGKMLNDPNFSPQELAA
IANGYSALLGESTELLKELKQIVSSTNLSLNDKERMDIIDRVYKEVKEYHSLVRYYTNKN
ISVSYLRAKKKNDAKRVFELYGTPNQKYW
>EGALAKHO_04517 Type IV secretion system protein virB4
MRNAAKATTLESKFPLLAVENNCILSKEADITACFEVRLPELFTVASAEYEAIHSAWHKA
IKTLPDFTVVHKQDWYIKESYAPDMGKDDHSFLAKSYERHFNERPFLNHYCYLFLTKTTK
ERMRAQSNFSSLCKGALIPKEIRDKEAIHRFMETVAQFERIVNDSGFISLKRLKEEDIIG
AEGKQGLLEQYMTLSREAGTPMQDIVLGGEEVRVGNKRLCLHTLSDTDDLPSSVSADTRY
EKLSTDRSDCRLSFAAPVGLLLNCNHIYNQYLFLDNSEENLQKFEKSARNMYSLARYSRA
NQINKEWIERYLNEAHSFGLSSIRAHFNIMAWSDDPGELKQLKNDSGSALALMECKPRHN
TTDTATLYWAGMPGNAGDFPSEESFYTFIEPALCFFTEETNYHNSPSPFGIKMADRLTGK
PIHLDISDLPMKRGIITNRNKFILGPSGSGKSFFTNHMVRQYYEQGAHVLLVDTGNSYQG
LCELIKGKTKGEDGVYFTYTEDNPIAFNPFYTDDGVFDIEKRESIKTLILTLWKRDDEPP
TRSEEVALSNGVSGYIQRIQQEDTYPSFNGFYDYVQDDYRKVLEEKQVREKDFDIANFLN
VLEPYYKGGEYDYLLNSDKQLDLLSKRFIVFEIDAIKDHKILFPIVTIIIMEVFINKMRR
LKGIRKLILIEEAWKAIAKEGMAEYLRYLFKTVRKFFGEAIVVTQEVDDIIQSPIVKESI
INNSDCKILLDQRKYMNKFDDIQAMLGLTDKEKAQVLSINMNNDPSRLYKEVWIGLGGTH
SAVYATEVSAEEYLAYTTEETEKLEVMQLAAELGGNVELAIKHIVMERREKENQ
>EGALAKHO_04518 hypothetical protein
MNYNINKGIGRTVEFKGLKAQYLFIFAGGLLGTLILVMVLYMAGVNSYICLFLGAGGASL
IVWQTFSLNKKYGEHGLMKIAANKRHPRYIICRKAIHRYLKFTSKANAL
>EGALAKHO_04519 hypothetical protein
MEKQRKKILQATVIMLTGFSAMAQGNGTAGINEATQMVTSYFDPATQLIYAIGAVVGLIG
GVKVYNKFSSGDPDTSKTAASWFGACIFLIVAATILRSFFL
>EGALAKHO_04520 Modification methylase DpnIIA
MIAQANTLQLTITKPVLKWAGGKSQLLNELNVRAPKSYNKYIEPFIGGGALFFNLKPNEA
IIADLNPELVNLYKSIASSPEEVLKFLETFKNDHDFFYELRALDVKTLDPFFAAARTIFL
NKTCFNGLYRVNKKGQFNVPFGRYSNPNIADSETIFNASAALKNTQIICGDYKTVLRDFA
DEGDFVFLDPPYLPISKFSDFQRYTKEQFYEEDHRELADEVHRLHEKGCHVILTNSNHPL
VHELYGDYTVEILQTKRYINSKSSNRVGEDIIVNVLPKGSKSLRVVPDLIPDQVDKYPST
RWMGSKSKLLPHIQNISNRFEYDTAMDLFSGSGIVGYLFKSLGKEVVSNDYMALSATYTK
AMIENNKVTLSNEKASALLIPSEKKVDSFVKDTFQGLYYTDEENELIDIIRNNIKTKLNN
QYEKAIAMSALIRACVKKRPRGIFTYVGDRYNDGRKDLQISLGDHFLKAVKEINNCVFDN
GKINTSRKGDAMTIRKHADLIYIDPPYFSPLSDNEYVRRYHFVEGLACYWKDLEIQEHTK
TKKFKNYPTPFSTQKGAYDAFDKLFKKFKDSILIVSYSSNSLPTMDEMVGLLSKYKKNVE
VQKVDYKYSFGTQKQNAKGNNVQEFLFIAH
>EGALAKHO_04521 hypothetical protein
MFNKNDIPQADNLEKVIETVEAVNDGFTTDKMIAQAIGYSERQGRYYRHATEVLGFVLNN
KNSASLTDTGVLFINSTKDQRVIFIRKSLYENPFFNNIINFTESKENGFSERELNTHISS
ITDNDTQATIARRTKTILSWLLEVAIIVEDEDIYKFNDLLEDAIQDDPEIFRFPATYDQE
VDIKEEWFSVYELRRKIGQFKVVMNPDFQRNLVWKGQQKSQFIESIILNIPLPPLYFRKE
LNGEYIVVDGLQRTSTIDDFLSNKFQLTGLAALPDLNGLNFADLESRLQARIEDRKLLVY
ILQPQVPMKVVYDIFNRINTGGTKLERQEIRNCIFIGKATTLLKSLASAPEFREAIDNGI
SPTRMKDREAVLRCLAFTIFNFDKDYKNSMDDFLERTMKKINTMDDGDIEILKTEFLKIM
SATKKMFGNNNFRLPTQFSRGRINIAVLESVYSFFSKNIHLKLDLDKDQLINNFNRLLQD
ENYRTSVKYSTGSTSQVVNRFYIANQILSTK
>EGALAKHO_04522 hypothetical protein
MLNKLTLQNFKLFKDRTEFPLSKINLLTGVNGRGKSSVLQPFLLLMQSPGHDRNTDNIQF
NGNCVNLGYFVDVKNIENTVKEPLIFLFNYSAELLTYDIEYTIVHSPDENLIGQIVLIKI
SGEFDKDKFSYEIVDRGSEFELFDTIANTSTKFSALFDLFIPSQYQTDITKAIYSTLPFL
KIHYISADRIGPKLFYTSQSQKKFDSTGSLGENTISTLFHCRNNQVETTFIDYIGVFYNV
IPAELETTVEGQINFWLDKIFNGAKYEIKEVVDTNLLTFFVSPDGSFNYHKPTNVGYGFS
YILPILVSGLISKPGEIMIIENPEAHLHPYAQSIIAKFLTLVALKGVQVIIESHSEHILN
GLRISVFEDVISSQDLSVLYFDRDTKEPFIKIEMNDDGGIRNWPKDFFDQSTKDLNYLLG
L
>EGALAKHO_04523 hypothetical protein
MSMQVFINEKSLQGQFNSDNVETGIKTLISTLATLEKVKSEITTYKSSIFFNEQAIAGIH
LNASLSNNGDLLRGFLNNLKSAEMWENSQVHDSETIYSWNGDYLTGTSVAEIAERRILDG
ELNCVLINFINSTYSQNLQITVEKDKAGTIDIESSHNEVTLISWLRNKNLIAKHDGYDES
QRIAPIDDQTVLGGPEFEKTTFKNKGRRAFRLIGTNQLWAVDASNSHLFGKPHIEVFSEI
DGKHLGTSIYDEINLDTSRKVNLRKININRHYPID
>EGALAKHO_04524 hypothetical protein
MPNVWNIGNTTVRNPKRIENALRVFASEGFSGNAKGSEQEAKLHEIFKEKSVLDYDGAAS
DFNGRKWRAAFYQLGFISYERYIINGELIDVQKLFKIIGDQNIKLPYQLTKAGFNLINSE
TIPEVDDVYTRQFACYELPNSLETNFPEGRMKPFILFLQVLNHLQNEGHAGLNKFETGVF
LQKFQNHTTTLSIEIVEQILAYRERCINKTPKELKEIKQEYLTNLAEITGINSQTIVRDY
SDTTFRYFSLSGLFSRIGDTIIIRSNKRNFVNELLYNEPQFLFQNDPILYFKHFYGNSFP
IPTDNLRFALSEINDLKQGIKNRLNPLLKEANLLSVDSNINEVQIIRYKLIQYNNWEREE
DFANEQQTNNSINDILAYLHTLNNFTVPNAPDIDDKPAYLEWAVWRSFLAINEIICPVHE
TRRFPVDQDFLPRNTAPGGGSDLIFEFETYVLVVEVTLTVSHRQMSAESEPVRRHAVQYK
LQYPDKDVYCLFIAPSVDNNVVETFRIGVWYNGDDEEFVNIIPMSLTDFIILFETLAIKR
FRNIDFKTFLDRSLIFRNVRAPQWKTSISKEVREWRKRIIS
>EGALAKHO_04525 hypothetical protein
METIIVICLLIIIVLLLQDKIVIKKKMVQKPTQKKNNPIFPDIMGQPKPMRSLYVPINTT
KSHTQETEINPDNLDIKYDENENVSIQIRKEELDKVFSNIPDFEEEEEEWKNYGISSAND
GFAQGVTFEELSSVGMLLQKEKLEPSQKETAVALVQKIQGTELFSLLENSMESASRQIAE
LLDGSLSSESISGSSILRKNDLEGFDIREFM
>EGALAKHO_04526 hypothetical protein
MKIKIKIHENRKEQFKRLFMVNRFPAGRTGKVVYLRPEYHERLLRIVQLSREGKITLYSY
IDNIMEHHFREFGEDILDYYNEHNKPIL
>EGALAKHO_04527 hypothetical protein
MEKDNKKKITPDIDEALMMDIMADGVKKEGLRPPVEEHKPLPESVQEKIIKERIKIKRGT
DIDYEDIFFKKTDTNARDGKTVYIQPDFHEKLSRIVQVIGGDKIAIYSYLNNVLEHHFQE
FGEQITKSFNEKYKPIL
>EGALAKHO_04528 hypothetical protein
MAHNINYNSETGRYSFFSVKEKAWHGLGQIVAQYPTSEEAIKHAGLDYEVAKKPAFIKGT
GLSIGNEGEIIEGQDIIIPNRFGTYRTDTNQPFDVVGKDYHIVQNREAFNFFDAIVGGGE
GILYETAGALGQGERIFITAKLPDYIRVGNGDDVTEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRSMSNVVRIKHTSGAKQRLEDAHKVMGLANTLSSQLEGIFNEWAKVKVTD
REVRKLIQLALCPNKETFDLLKKGAEDEVSTLFKNTVDDAFAYAMTSDTQQMDTTKGTLF
GAYNAVTGYYQNVRSYKDNEAKLQSIVMGGTAQLKSQKAFELCTGFALDGAEILKLN
>EGALAKHO_04529 Single-stranded DNA-binding protein
MNITGRVTADAQVRNVSNSKTVVNFSVAINDSYKNKAGERIEQTTYFDCTYWLSPNVAKI
LTKGTVVELTGKLSARAWTGSDGQPHAGLNFNTSQIKLHGGGKKSETEQATTETSNNKPE
NDLPF
>EGALAKHO_04530 hypothetical protein
MKTIEYFKLQAKNLHKDFKTQKPYFDSSLGDNLYEYSPKFFDVDALVTDFEIHENHFTLM
NAQHIIARLGGFEKWTVLLKANREVLELSKLLFDNMHKISIEEWDMYISGEEDEKGFLFD
DEFKLEIFKAVYADVDGHQSYGYDYRLAKREKPSIENQKNKLMEKKSTIKITTLPLAGKD
QKEFIETANRKFEDTLKSIEHAHPELVRELWNPEQYIEEVIKTDMLPIDRDYALSLVEAF
LIHKVIELATEADEESLNLN
>EGALAKHO_04531 hypothetical protein
MDKVIFIASLHRPFSQQLKTTKWVCDFIALSKNKIPSSQLNLEFYYYLINLLYKEYQKET
PTEFNGLPSDSAIYNIYEYLKSKSKKKFIEEIPGIIKSRNTSLERQIYSTYKAASYFVNL
AKDKFGLIDDTNKLTVNGKYLIEIRSNIYRLSTVEKEFFFIRILEADFHLFLTLCLFNKL
EKKYSLKGTIDEQLDFIDKFLKISHFRFTSASLSNYNIVRSYWTEIIGVLNSKGNIRKKY
IDIINNNEKFRELFSELSSLFVKFEKENFKSKISYHARKAIFVKSYKDFLKQNISDLGYI
NLYDIKEQMRISSTNFQNFLAEFYELEKNNLSIFFNNTVNSIDRRERFYIRNRPVIKIKI
K
>EGALAKHO_04532 hypothetical protein
MEIKTLWEKLSLPTDRMTTFKKDIAEGKVPELPFFIVGQDKLKATIKQRVEQIDQSRMIT
NLIIAEYGNGKTNLLKYLELFFKTHDDLGISVQYSRADVERTDLVIFLLKIIQDKYLHEL
IRIVKILRETPDIIPTLANKFDSNFREIEEFTNKLFTKELDDQAITEILYLGTGRLSNKR
YFDKLKIEQLRDFNRREILVLFLNILSQDKKFIIFAIDEIEKIREKSKIRFNHFLTSYRE
LVDLFNQINGHYLIVSFTDSIGSSEISNANNALYTRIRGDIAQIEPLKSKEDIQNLITYL
NELFGTNKDINDIYTALSKKDATNNRSAIQEISKLLYAQESTESLGKLLEDNQLTDLFAS
TSTKLENDEAFKNMHRKFFDPLEYYIESLGQNSDGLNKQERTFIDVDNEKVHYFIFNTYL
EDFENEKIKINYLINDNPGSSIIVYAPITLELTHSKLDIDEENFSIIDIEPKDLFVLLVM
YRDNFDLQPQIAELISNYSRQKL
>EGALAKHO_04533 hypothetical protein
MFDNKSNITHYTYRIQLEGIIKAICDISFDIGIQIQDIIEVREAANGFTIEDLFVEAFIK
DINVRPESLSDQKTEDGEIILGLTADQFFSRIADHYNTELFYLDEFLEGLKGSSILFINK
KDSSFIGSNDTAKDRLLPALKGAKILKTLISKLKSEKIQGSLQKIDMFENDFFYKSTIQC
SKLESQPLLTNIHATLINGDTVKAEIVDRFDFWINFELYHSLRGIDLSTVEEYSLVTDKE
NDVEIGLLVGDYLLPYPNIDLVKYITVDKKLEYFWLLLENTYSMKPAPELIKDAIINEFI
GFNKDVELNQLLSYLKNNFYITDKKLIKEKFEKFFNEVVIVENLDFLSEYQFLLSPEMSQ
ETTLGIYSTEKKGNSYNLLHWINHKTSSKLDHFRKTVPTEKAKKIIYTLKPAICYYFLLK
YFEDVIESILDENKYIFLANHKFFDKGAETEIDFFVNTGRKLYYIETKTKLTKFYIDAFL
KKASSMINKFAPMLAHGVEVEFILIGGYSDKTVTDYQYFIETSDKSEDGYNIERADLYGM
PYNFTIPIPDKQGKHITCIAEPQYENLQSLVLQLCQK
>EGALAKHO_04534 hypothetical protein
MSKIKLPVTRYYGSKRKLIERIWNEIENLELEFNSVLDIFGGTAIFSYYSKVKGKTVIYN
DIFTFNTLIGRKLIEQTSNELTYDHAVSLLERIPGRIYLNTIQENFEGIYFTNEENAQID
AFIQNANALENDNQRLSAYYLLFQSCIIKRPYNLFHRNNLSMRLNYNGGNFGNKKTWERP
FDELFSRFINELDEFTFDNGKINRAVNSSALNCNEIADLVYVDPPYFNSKGHHTTYHSKY
HFLEGLANYAEIGNNINPVKNNREIIISKSDEFEKPARFLNELEQLILNHANSIIVISYR
NNGVPSIEEIAAVLKRCKPGLQTHTIDLGMYGYALNKTNQINNEFLIIGTNNPIA
>EGALAKHO_04535 hypothetical protein
MEGSYSQAGFYYQNNVAALKIIECLFFDSGIREIRLENYEKGNHIDDIIIYRKDKIDYFQ
VKWSEDEDKSYTLYGLISSQEGSDPVKKQKKSIFKQLAEGYLGAKKNSKNFSITLYTNKK
ESSQKRPSEGVNHNLAEIRTNIFDPLKNSDIRYDSLANFEEYKITIEKIRLECGLDENSF
NEFIKSLEFKFNQESIEQVQNAIKFKLDNLGIELHLFEKILNAAVKWSISGESITKDSVL
KELGITDRFEDKLSHYFKVIDDEYYVPNQSLFLKLEKALTELAGGYIFIEGLPGIGKSTA
LTKFMEQSEDITLAYYCFIPDTKNDFGELRHQSYYFLKSLCVAIEKNFGEVDFPNMYSER
YEEKLISHIDELSKLKRKIIFIIDGLDHVHRDTTIGERSLLNYIKGNLPDNIYFILSSQY
DEVLSDSVKLQIEADERRHIKVPPFVQSEIKQYLDNKAIFVSDLLDKVERVSGGIPVYLH
YISELLGKVEQRNYESTLDELPTLVNGAINSYHEYLFQKIEENIFAKWVLAVLAYRKENT
SIDTIKEILRLAGENRSIIEIEDAINGYSHLLRQIDGRSYSIFHNSFREFIITKTADLKE
TFNKALASFYEQNLFADEAYRNYFSHLYEIGEYKKIISITTLEWIKSAWSNYRSLEEIKN
NLDFAIRAAISETSLNEFIRIAFLKDQLETLEWNLSGTEINFSRLFLNVGETANSLRLIW
DGDFVLTNKEYFCFYLGEYYKKNKALLPHNIISQGLSKPLTERYVKNTTIELKAEALILE
NIIELFEDIEDITWEQKDRHNRTYLKKEHSDKRNKQINLKIKSDIISYLSECKHYSKLFQ
LLQAYKKDLKLLPRIQIALVKLFLPSPAEKKSAVKIIREIDFANIPDKSYFRLISYCCDF
LTNEDIIELFPSRAISEPELFDEVVNKDGMTFSIRKEIISLYDDLKPIVIFQPELIEKLT
LKNSFLLSPAEEIYDSIFNLSEVWNLSRTSDIGEDEILDKLKMSIDSLYIKRVKEFSSRA
RGLFDMDTDSSFIADSMKSIFSKIFKLSVELLSKEKLEDLVSYWITWDKSGNGFPHYSTG
LAIAEEIYSNSSKKFPDLTYMVIKHAEESSRQEHDTGSLTSYLGEVAEAYGKCGYKEDFK
RIYNQLVEISFGVGHRKDYKASNIIEPMELLHASDPSNTLKRLSEVLHIQDKINDAGNGR
MRHIVLSNLIRFTAGSYPELAFKLLELEETNIGRDEALDIVLSPLINNSSNEDLEFHLAI
IKTLSRWRNGSTSEGHFIDLAKKLLSRAIHYNNNDVVERILKIVKFNTTVELEDEKELIK
FSEILKENGIDYHSYGLPDPLITTIDKTDDQINRRESTQKVKFKISKIELPFEEIIELFE
DNYEEFEKYVQTQFRVQTQNDRNQSLKTEYGSAKKIFENFHKITSLKNKDALKANQFKIR
RHYAILKNEIASSDSESLNLKDIKKYFDKLILFIDSIISENEFASFVNEKMDFVQWLDNM
LSNLIRQREFLSYFIFSDEELNALVDQCSIMSIENLIQFIERWTRRTSRSRALLKIANRL
IDINPNRAKEIALLASEFEFDSQLFQRNDDPEKLDFDIIEMILNVDEDFGKKFLLNSYYN
QKGKYRGDLTGSIDKLLNYQTYFKDESVKSYFAANLQFNRELAQGLPEKENNYTFIEEHF
EKLMFSEIVLKHLVWLFNYPAIKIRETAMQSVFDLIADKPEYLRIFIHFAIENGSENEIE
YAIVVLQAIALKNPEMLIQFKNELITVFHKEHFNILETALELFLILNEYDSSFLTADELK
ALKAVNTADFSIVADNESSSYMPKIKTFKYSLFQENLINEINENDTDKSILNALHSDLDT
KGLADYDAEKESDVHHKYNINTNYDAIEIQSSYYGEVKASLNKIFYLKIKKNKFDPGFVK
KAKNKFRVYDASKILFSTITRPNYITWIPEEISKQNFLLFNDFDSLIQKFIAREDDLVTL
VEYGSQRVDQHSEFHGTCYFEIKAFLKAQDYDLNNLKDFPFMEIENEYAYAMPIAESDLS
SFNKKQVRSLVQISYNNFRGENDLVNANLNPNTFADFGIKEKNLLEIFGKAEFSLVALRW
SNSNKSNTDRRRYKSKSEGFTFKIRKDLLSEYLKKNNLILCYNIELRRSADKFVPEDYMY
WRQLHRNVEVSLE
>EGALAKHO_04536 hypothetical protein
MNDFELKKIAVEEAFKRMKDAGMEVTYEDVILIMEFLHNLTYLVIKKHFKLP
>EGALAKHO_04537 hypothetical protein
MQYSGFGGLKFVLNPVQNPTDINNWRKTEHELFPLTEELHRLLKENTADEKLYRSYVDSM
RSSVLTAFYTPPLVIDAISASLKDIGVNIQKFLEPSAGIGSFIQSFADKNAVKVTAYEKD
LLTGKILKQLYPDSTIRINGFEEITEKEQNSYDIVASNIPFGDTSVFDLSYSRGKDPARL
QAARSLHNYFFLKGTDMLRDGGILAFITSQGVLNSPKNEIIRRVLMQNNNLVSAVRLPNN
LFTDYAGTEAGSDLIILQKNTNKQSLTQAEELFCQSSLTQYNTPRNALFHDNIRIVHTDS
VLGTDPYGQPTLIYTHRAGVEGIAKDLKQMLSEDFSLHLDIGLYRGKQNDKSITQTSATQ
TSFSEEPTILQPETQTLFPTKNNNAEKKDSQLSIFDLFEEMGEMVTVNAPVKTKKTPAGK
NTKVRGNQPDLFSGLIQQTYTPTVSSISNNQSTTPSDKEEAVGDLFSSINENGQGGMTSL
SNIIPEPEIYTQQMQSFHRNDCLVMDRGWVGYLKDVDSDRERAMFHPLRLIPLQKARTEA
YILLRDSYLDLYKKEAQLQTEHTEERVNLNRLYDVFVKRYGNLNCAENIKLIKTDSAGKE
IPYLERIVGSVVHKADIFKRPVSFSITTLATDNPDEALATSLNKYGNVDLDYMSQISNMT
IDALKEALQGRIFYNPLQKEYEISERWIAGNVVEKTHEVRTYLEKNPNDTDAKKSLVALE
ESRPRRIEFEELDFNLGERWIPTGIYARFASHIFDTDVRVHYSETSDDFNIKCDQKNVHI
WDKYAVKSQSRTYDGIALLKHALVNTTPDITKKIWIDDKEVKVRDMEAIQMANTKIDEIR
TAFTDWLHAQNDEFKNRLTNQYNDTFNCFLRPQYDGSHQQFPGLDRKALGIEDLYSSQKD
AVWMIKLNGGAICDHEVGAGKTLIMCVAAKEMKRLAMVHKPMIVGLKANVHEIAETYRTA
YPHAKILYPGKEDFTPAKRQRIFGDIKNNDWDCVLLTHDQFGMIPQSPEMQKEILQTELN
SVEDNLAALEAQGNEISRGMLKGVIIRKQNLEVKLKTLEHDIENRKDDTVDFKMMGIDHL
LIDESHRFKNLMFNTRHERVAGLGNMQGSQKAMNLLFAIRTIQERTGKDLGATFLSGTTI
SNSLTELYLLFKYLRPQALEKQGINCFDAWAAIYARKTTDYEFSVANNIVQKERFRYFIK
VPELAQFYSEITDYRTAKDIGIDRPEKNEVLYNIPPTPEQEVFIKKLMEFAKSGNATLLG
RAPLSQSEEKAKMLIATDYARKMSLDMRMVSGKYEDHPNNKASHCAANIAKYYRKYNAQK
GTQFVFSDLGTYKPGEWNVCSEIKRKLVEDHGIPAHEIRFIQEAKNDKQRKELISGMNEG
KIRVLFGSTDMLGTGVNAQKRAVVVHHLDTPWRPSDLAQRDGRAVRKGNEIAKFFADNKV
DVIIYAVEKSLDSYKFNLLYNKQLFIDQLKNNSLGKRTIDEGSMDEKSGMNFSEYVAILS
GNTDLLDKAKLEKQVAGLESEKQAFNRSKFSSKYKLEDIIATLEAAGSRLERMNLDWQNL
QKRLQKHSDGTIANLVKLNDISANADMKQIGIKLNEIADKARTGGQYEEIGNLYGFILLV
KTELSEKEGVDLKINRFLVQGEGNIKYTYNNGIIAKDAQTASMNFLNALEKLPGYIEQEQ
KKIAELEKDLPVLKELVNSTWTKENRLSELKTELAAVERKIQLSITSENKEQIIKEQEET
NKIDGAYEDPFMRLKMNRLS
>EGALAKHO_04538 hypothetical protein
MRDTILTFLQHKEFDKIVEVLRDNKTFNILLEDEIFKTVFFQNFTNELFSQEDLQISYPA
FLLNCHDSSNYVFKLNGIDEEKVLIFLFEKTQEVNYAKRLPNHAEAIEVVNKHNLKLKTE
SEQGLIRAQKQRDFQIVEQFANNTQNLTKSIFNSPQEKELYLACKQIFSSYLILPNVSLT
TIFNQHVIKDKFSRYFDFYLKSSVDIVIVDKETFIPILYFELDSKTFHDENSSARDKIKN
ELFRELGHDLIRVKKRTGKEGVNEYVSLLEIIKQEKNIT
>EGALAKHO_04539 hypothetical protein
MTKIEGKYDERNRFWTEQALNQFGYTSNFFFLISLGFFAFLFKYFKDPSFDIELVDRQKN
LLVLAVTFAGISLITSAITVLSRLHDLRLTRHTIWIRKKSYDKFNHEYPDDDLDLDHYGL
CKQLKNFFSTLWYRHYFIKDKDIKNEKTINKKFTELRLRNLLLARFSWRMMNSQFVALAI
SLIFYLLSSL
>EGALAKHO_04540 hypothetical protein
MQGEDDLRGLAKIMAFMRAVSILLVLMHLYWYCYGFFLGHGWTLKVINKILGNFQRTAGL
FSHTLYTKVFAIVLLALSCLGTKGVKNEKITWPRIYTALVLGLLLFFLNTPLLSLPLKTA
AFFYAFTLGLGYITLMMAGVWISRLLRNNLMDDVFNMENESFQQETRLMKNEYSINLPTK
FYYKGKWNKGWINVVNPFRATIVLGTPGSGKSYAIINNYIKQHIEKGFSMYIYDFKFDDL
STIAYNHLLKHADKYSVKPKFYVINFDDPRKSHRCNPLNPDFMTDISDAYEAAYTIMLNL
NRSWIQKQGDFFVESPIILLAAIIWFLKIYDNGRHCTFPHAIELLNKKYADVFTILTSYP
ELENYLSPFMDAWQGGAQDQLQGQIASAKIPLSRMISPSLYWVMTGDDFSLDINNPKEPK
ILCVGNNPDRQNIYSAALGLYNSRIVKLINKKGQLKSSVIIDELPTIYFRGLDNLIATAR
SNKVAVCLGFQDFSQLNRDYGDKESKVIQNTVGNIFSGQVVGETAKNLSERFGKVLQKRQ
SLSINRNDTSTSISTQLDSLIPASKISTLTQGNFVGAVSDNFDERIEQKIFHAEIVVDNK
KVAAESNDYQKIPLILSFTDKKGKDNMKQEIDANYRQIKMDIVQIIVTELERIKNDPNLQ
HLVQKDKPKGNV
>EGALAKHO_04541 hypothetical protein
MKAKYPDAYPGESEQQYWTRIEEEQQRPDSDLGLLSILINLALFILKIAVVFGMFIYAGY
ILSQKILGEDINKSRIWGFTALFTYLMFCIIYFLKGLIIALYSKNRKLWILPWVICVLLC
CVFPAFIVKLLVTDMFKTSQQKDILCLGFSWGAFVLSLFYIYSIYQFKTPTAPRILYWSY
ALGFRISR
>EGALAKHO_04542 hypothetical protein
MIAKIGRGSNLYGALSYNQFKVEKENGQIIFANRIIETSSGHYSVAQLAQSFEPYLLANR
NTEKPTLHISLNPDPKDNVNDEKFRQIAQDYMREMGYAEQPFVVFKHTDLDRTHIHIVSV
CVDEEGKKISDKFEKRRSMNVCRELENKYRLLSATEKDHKQNDKIFHPVDYQAGDVKSQI
ASVVRHLPNYYQYQTLGEYNALLSLFNITTEKIEGELQGKMQQGLLYIPLNEKGERAGHP
FKASLFGKNAGLPTLELHFAKCKETFKTHPAKHTLKSAIDIVLKSTIDESSFKKHLAELG
INAVIRRNDTGRIYGITFIDHNSKTVWNGSRLEKDLSANTFNDYWNNNIKLDINKSVELQ
SKLSRSHEPNFPAEETHYLFDFLNTTEKHGDGLIEGLGNLLPEAQGDDHEQQDFVNKMKK
KRKRKGRY
>EGALAKHO_04543 hypothetical protein
MNENNNNKRNKGGRTLKDDPSIHRHVFRLTSEENAKLLSLFEASGMTNKAKFIISQLFGR
EIKTVKIDKGTIDFYMRLTSFHSQFRSVGVNYNQVVKLLYSHFSEKKASAYLYKLEKQTA
EFAVLCQKIIQLTEELEAKYLIK
>EGALAKHO_04544 hypothetical protein
MTFKIYIGIDISKLTLDVFIKEVQAHKKFKNDLSGFNSLLKWVKIQSKESCESMLFCFEH
TGLYSLPFAQFLEENSIPFSMISALEIKRSLGITRGKNDIVDSRRIADFACRFYDRITLT
KLPAKEIANLQSLLSLRGRLSVALGGFTVSRNESLKFIGKNSTPELFSSYDKMIITLKSE
IKALEKAIIEIIRNNEELRRTYELITSIKGVGLIVACNLIAYTNNFTRFSNWRKFACYSG
IAPFEYQSGTSVRGKSQVNSLANKQMKKLLHLAAICAIHTDTELQEYYTRRQSEGKPKMA
IINIVRNKIVARVFAVVKRDTPFVDLRKYAA
>EGALAKHO_04545 hypothetical protein
MNENSNKKQNKGGRKPKDNPSTHRHVFRLTEEENAKLLSIFEASGMTNKAKFIISVLFER
EIKTVKIDKGTIDFYMRLTSFHSQFRSVGVNYNQVVKLLYSHFSEKKASAYLYKLEKQTA
EFAVLCQKIMQLTEELEAKYLRK
>EGALAKHO_04546 hypothetical protein
MIAKIGRGSNLYGALSYNQLKVEKENGQIIFANRIIETSSGHYSVAQLAQSFEPYLLVNR
NTEKPTLHISLNPDPKDNVNDEKFRQIAQDYMREMGYGEQPFVVFKHTDIDRTHIHIVSV
CVDEEGKKISDKFEKRRSMNVCRKLENKYKLVSATEKERKQNDKIFRQVDSRAGDVKSQI
ASVVRHLPNYYQYQTLGEYNALLSLFNITTEKVEGELQGQLRQGLLYIPLNEKGERAGHP
FKASLFGKNAGLPTLELYFTKCKETLKSHPVKHTLKSAIDIVLKSTSDELSFKKQLAELG
INVVLRRNDTGRIYGIIFIDHNSKTVWNGSQLGKDLSANTFNDYWNNNIKIEIKESVELQ
SKLSRSHKLNFPAEEPHHLFDFLNTTEKQGDGLMEGLGSLLPEAQGEDHEQQDFVNKMKK
KRKRQRGQK
>EGALAKHO_04547 hypothetical protein
MQGEDDLKGLTKIMAFMRAVSILLVLMHLYWFCYGYFINRGWTLDLINKILGNFQRTAGL
FSHTFYTKVFALVLLALSCLGSKGVKHQKITWTKIHIALAIGFVLFFLNTPLLNLSITTA
IVLYILTTGLGYIALMVAGVWMSRLLRNNIMDDVFNYENESFMQETTLMENEYSVNLPTK
FYYKGKWNNGWINIVNPFRATIVLGTPGSGKSYAIVNNYIKQQIEKGFSMYIYDFKFDDL
STIAYNHLMKYQDKYKVPPKFYVINFDDPRKSHRCNPLNPAFMTDISDAYEAAYTIMLNL
NRSWIQKQGDFFVESPIILLAAIIWFLKIYDNGKHCTFPHAIELLNKKYTDVFTILTSYP
ELENYLSPFMDAWQGGAQDQLQGQIASAKIPLSRMISPQLYWVMTGDDFSLDINNPKEPK
ILCVGNNPDRQNIYSAALGLYNSRIVKLINKKGQLKSSIIIDELPTIYFRGLDNLIATAR
SNKVAVCLGFQDFSQLNRDYGDKESKVIQNTVGNIFSGQVVGETAKNLSERFGKVLQKRQ
SLSINRNDTSTSISTQLDSLIPASKISTLTQGIFVGAVSDNFDERIEQKIFHAEIVVDNK
KVESETKDYQKIPDILSFTDNSENDNMKQEIEANYRQIKLDIVHIIESELQRIKNDPDLQ
HLVQKDNRKKDA
>EGALAKHO_04548 hypothetical protein
MKLNLVFIASFLLFCNHTFGQNNFSENPLDAVFETNDSKNFWEAFDKMDKAEQNPFIEYM
QKGSLGVKGFTENRIINADSLFAAVKKRNSDYKLSRYVLNGLPSKEKRVRAIYSALKYWY
PNSKFPPIYFVYGRFNSGGTSASDGIIIGTEMLKNLDGVTGLIAHELIHYQQKLEGKDML
LKWALLEGAADFIGELISGESINNFSYKYGEQHLDKLCQEFIKRLKNQDCQDWLYGTSKK
DDRPNDLGYWMGYKITEAYFNNQKDKQKAIAEILNIKDPMQFLKQSGFLDSYIEKYQKSK
KETFNDFFR
>EGALAKHO_04549 hypothetical protein
MFISIKNKTALYFLDKSHMRTLNLNELEEKISSYSSDINYSDRVYVQDKITQFFTFLNEQ
AISKRILERINEDFTLLKNELPPTSDNPGVIMNINHKVKNNVKLMIIDREHQGAFGFFII
QELFEKQRKSENHYLNTPASWYDGITGDYGKRLDCIKENFFKPFIDLLEWYIYESKTKSD
EDYFSKNEIETISSRLDEIQSNQQLYSEVLFNEIDDLKELILLLNKKNWGEILRGKLGDL
VVGGFINTENAKAIFNFIVENYPLLLK
>EGALAKHO_04550 hypothetical protein
MPYNLFLLPLTAGYFFLVTFVFFKYKYQRLSSERLLFSSIIAGIVIIAITFTIRGFLDFL
FPHCISFLYRNLYAFFPIREEPYLWTSVFCFTIITMSTLLANLLIIKKYGKSFIVAKAID
EEGDEVEQLFKTSAVTGELMQITLQNNKVYIGFTDILSEPKKTNYLKITPVLSGYRNSET
KELQITTEYFEVLEIFTSECPKFDIYDIDISIKQDEIISASIYDQKVYDLFNPDLKVKKK
KKKKSKKK
>EGALAKHO_04551 hypothetical protein
MAKIKDYIEYKGQDSGVRTTFSGKLYVDKKVFFQREDVKRVLKEVMDSKVLKAHIATNKK
>EGALAKHO_04552 hypothetical protein
MQYSGFGGLKFVLNPVQNPTDINNWRKTEHELFPLTEELHRLLKENTADEKLYRSYVDSM
RSSVLTAFYTPPLVIDAISTSLKDSGVNIQKFLEPSAGIGSFIQSFADKNAAQVTAYEKD
LLTGKILKQLYPDSIIRINGFEEIPEREQNSYDIVASNIPFGDTSVFDLSYSRGKDPARL
QAARSLHNYFFLKGTDMLRDGGILAFITSQGVLNSPKNETIRRALMQDNNLVSAIRLPNN
LFTDYAGTEAGSDLIILQKRTNKQSLIQAEELFCQSSLTRNNTPGNALFHDNTRIVHTDS
VPGTDPYGQPTLLYTHRAGVEGIAKDLKQMLSEDFSLHLDIGLYRREKNDKPITQTPVTQ
TFLSIEPVRTQPETQTLFAAKNNNAEKKDRQLSIFDLFEEMGETVTVKAPVKTKKTPAGK
NTKVRGNQPDLFSGLIQQTYTPSISSISNNQSTTPIDKEEAVGDLFSSINENGQGGMTSL
SNIITEPEIYTQKMQSFHRTDCLVMDRGWVGYLKDVDSDKERAMFHPLQLPLLQKARAEA
YIALRDSYLDLYKKESQLQTEHTEERENLNRLYDVFVKRYGNLNGTENIKLIKTDSAGKE
IPYLERIVGSVVHKADIFKRPVSFSITTFATDNPDEALAASLNKYGNVDLDYMSQISNIT
SDALKEALQGRIFYNPLQKEYEISERWIAGNVVEKAFEVSSYLDGNPNDTDAKESLLALE
ESRPRRIEFEELDFNLGERWIPTGIYARFASHIFDTDVRVHYSETSDDFNIKCDQKNVHI
WDKYSVKSQSRTYDGIALLKHALVNTTPDITKKIWIDDKEVKVRDMEAIQMANTKIDEIR
TAFTDWLHAQNDEFKNRLTNQYNDTFNCFLRPQYDGSHQEFPGLDRKALGIEDLYSSQKD
AVWMIKLNGGAICDHEVGAGKTLIMCIAAQEMKRLAMVHKPMIVGLKANVHEIAETYRTA
YPHAKILYPGKEDFTPQKRQRIFGDIKNNDWDCVILTHDQFGMIPQSPEMQKEILQTELN
SVEDNLAALEAQGNEISRGMLKGVIIRKQNLEVKLKTLEHDIENRKDDTVDFKMMGIDHL
LIDESHRFKNLMFNTRHDRVAGLGNMQGSQKAMNLLFAIRTIQERKGKDLGATFLSGTTI
SNSLTELYLLFKYLRPQALEKQGINCFDAWAAIYARKTTDYEFSVANNIVQKERFRYFIK
VPELAQFYAEITDYRTAKNIGIDRPEKNEVLYNIPPTPEQEVFIKKLMEFAKSGNATLLG
RAPLSQSEEKAKMLIATDYARKMSLDMRMVSGKYEDHPDNKASHCAANIAKYYRKYNAQK
GTQFVFSDLGTYKPGEWNVCSEIKRKLVEDHGIFAHEIRFIQEAKNDRQRKELISGMNEG
RIRVLFGSTDMLGTGVNAQKRAIVVHHLDTPWRPSDLAQRDGRAVRKGNEIAKFFADNKV
DVIIYAVEKSLDSYKFNLLYNKQLFIDQLKNNSLGKRTIDEGSMDEKSGMNFSEYVAILS
GNTDLLEKAKLEKQVAGLESEKQAFNRSKFSSKYKLEDITATLEAAGSRLERMNLDWQNL
QKRLQKLSDGNILNPVQLGGLSPNADMKQIGIKLNEIADKARTGGQYEEIGDLYGFTLLV
KTEISEKEGVDLKVNRFLVQGEGNIKYTYNNGILAKDPQTAAGNFLNALEKLPGYIDQEH
KKIAELQKGLPVLQELVNSTWTKENKLSELKTELAAIDRKIQLSIIPENNGQKADEQKET
IKIDEVQVEERTPVRIKVT
>EGALAKHO_04553 hypothetical protein
MNYNINKGIGRTVEFKGLKAQYLFIFAGGLLGTLILVMILYMAGVNSYICLFLGAGGASL
IVWQTFSLNKKYGEHGLMKIAANKRHPRYIICRKAIHRYLKFTSKANAL
>EGALAKHO_04554 hypothetical protein
MEKQRKKILLATVIMLTGLSALAQGNGTAGINEATQMVTSYFDPATQLIYAIGAVVGLIG
GVKVYNKFSSGDPDTSKTAASWFGACIFLIVAATILRSFFL
>EGALAKHO_04555 hypothetical protein
MGGNAGIRGYLIQTIICVLDALEKDNLWTSVTLEPLDESEKVDIRWKYSNHTEKLCQVKS
SQNIIRHSAAKKWCEELETHSPDASNYELIVIGNVDVKLSEAKDIGKVKVGEIKPLNTQV
LIDQASTKIDKYYEDKNKPKISSQVRELIVKALTLEFGTSSIIGKEISRANFDTKLLEWI
SAVENQLDTNPFASLAPPFENQNIPINHRIVKKILELIGWHQFGENHTVERFNEKTEENE
IHSVNFIGDFESKLKEESGDLVMISSLHSLKYPDSSKTEIAQYINDADIIYSDLEEKKKI
PLKRYESTDVYSLLFWLSTDNSEVSTDFIHYTKGNYKRNLLNENITYLLIDNNKANFLIS
SITTAKNYRADVPVKFAYPITEANQSPKHIGERGLKLPPQFINSSVIPITKESKSKISFL
LFCSDPYSPEALKKLIWLTISLTSGYGNEYLLYFPDYNEAEDKNEALEIIRSFNEELLDE
KVKIQKYHSIDAEALDSLSSTKVITPKNETYEEDNQPSLVNSQHLNEAFVNILPYGDIIK
PFLKTDAITANDIKYFLAKKGIFTKNAEIKKLTELMCTLLFSPKELEDFKSYIDVKGKVV
NSSPTFFNIKQDETLESVFRKIKINTDNLTDGLDVKIINSDNIIFEASPAKDEYKLTLIT
ETKDPTSSLLVNTKPGKAEVVIKKNGNQLVVVTENTISRADKYIVNRIVKLVEEEFKRID
FIEEEKIKVMFKNFSSNTERVNFLLSFSNISSSMMFHEADIQSIKFKFDENTEIPELYRD
KVDKDLVINFEGKGLQTLTELSEQNAKGSIFLEEMKVLYKFNFLNIKNGLYKVTFNFSNA
LKNKPEFDGVFKSAPYLIKTNSVKSLSSIENLEKELGKEIENLKLEKLKLFNIIK
>EGALAKHO_04556 hypothetical protein
MIDFTGVKLQNIATHFVGNKLRDEGIRISSGEVNLSEGDTKKYLLNYFLSSFTDNEKYNF
SNPTELALNGVYTLIGRVFSNTDSFYENSVELSKHLYESSTHPKVNGGEFTICLFENIYL
DGIETNAIGLFKTEIKDVFLKFDSIKDNYIIKYDHGVNVGKLDKGCIIFNQQSEDGFKVC
IVDSNKSNDTHYWKDDFLSIRPSADEYHFTKNFLSITKDFVTKQLSEEFEVSKADKIDLL
NRSVEYFKSHDRFEKENFVEEVFDDPEMIKSFKNFDEQYRENKNVDISDNFEISSQAVKK
QSRVFKSVLKLDKNFHVYIHGNKNLIEKGVENDGRKYYKIYFEEEN
>EGALAKHO_04557 hypothetical protein
MASIKHPIFEAHVLEGLCRTIGDTATGLSGTEIGQILLNVNIADTDPQNTKWKRLYRAFA
DWQNKHKCSNHILRFIQDALQPVRYIGREEIFHNRRLEINKRLSFIGTELTEAGKYIQVE
KVTTIAEAEQRANRLKHKLEIRNVHATIFEYCKAELLVENYFHSVFEATKSVADRLRQMT
GLYADGNALVETAFSTNNPLIQINHLRNDTDRSEHIGLCNLIKGVFGLIRNATAHEPKIK
FEITEEEALDILNTISYIQKRLDKAI
>EGALAKHO_04558 hypothetical protein
METVIVICLLIVIVLLLQDKIVVKKISEQQPKQEKVNPNLPDIMGQPKRVRSLSVPNNAN
ECQIKETEINPDNLYIEYDKNENVSIQIPREELDDVFSNMPDFEEEEEEWNRYGISGGDN
GFAQGVTFEELSCVGMLLQKEKLESSQKETAVALVQKIQGTELFSLLENSIESASRKIAE
LLDGSLSSETDSSSSIMSKNDLENFDIGEFI
>EGALAKHO_04559 hypothetical protein
MRNFFKKNKQYKRTEQYRARFLVNRFPSGHNGKVVYIRPEYHERLLRIVQLTAEEKPTLY
SYIDNILEHHFREFKDDITNYFNERFKPIL
>EGALAKHO_04560 hypothetical protein
MEKNNKTIGTKKIGKTYSSKFLKRNTLKGRGDKSIYVRPEYHEKLTRIVKVIGAGEIPLY
AYLDNILQNHFEMYSEEIIEDYNKNNKPILP
>EGALAKHO_04561 hypothetical protein
MEKDNKKKITPDIDEALMMDIMADGVKKEGLTPPVEKHKPLPESVHEKIIKERIKIKRVT
DTDYEAIFFKKTDTNARDGKTVYIQPDFHEKLSRIVQVIGGDKIAIYAYLNNVLEHHFQE
FGEQITKSFNEKYKPIL
>EGALAKHO_04562 hypothetical protein
MNVDRMEFMAWMERIMERFDIVMELVSKAKNGHTSIDGEELLDNQDILQMLKISPRSLQR
YRSSGKLPYYTISGKIYYKQSDIHQFIRESFTASVPRTKASS
>EGALAKHO_04563 hypothetical protein
MSEQILDKPQSPEQLSEILLVMDKAKKKIQAVKGIDENGNLQTVDPTKKNQNQFMRIDKQ
GDIFSNFFSNFFSQLKNPTNFSFFKVPAPLAINMAKEMQKQVDNPTPEGKQIMKQHEVKA
EPNENNNKQENKNNMETTQTTPETNEYRYKPEQIDWETMNNLGLSKEKLEKLNLLDPLLR
GYKTNELVPVSLNLGTAVTRMDARLSLQQGDEGQVVVAIHGIRKEPNLNYAFFGHEFSKE
DKDNLLQTGNMGRVVNLTNPKTNETLPSIISVDRLTNELVALRTDFIKIPEEIKGVKLNE
EQKQTLMEGKPLYIEGMISKKGAAFDATVQYNADKRFVEFLFDRGNNNKQTQGNEQNQSQ
EVPKIFRDKELDNEQYQKFKDGQTVYVSGLLDKKGKEYNGYITFNKETHKIDFSFQNPNK
IKEQAKPTEAHKTQTAVNSEGKTNEATKNIKEPLKSGQKNPDSEKQHEQQEGIETPAKSK
GRKM
>EGALAKHO_04564 DNA topoisomerase 3
MKVVIAEKPSVAREIAGVLGATEKKDGYLTGNGYFVTWAFGHLIGLGMPEDYGIYGFQKN
SLPILPNPFVLILRKIKKDKAYIPDTGALKQLKIIKQIIDSSESIIVATDAGREGELIFR
YIYEYLKCEKPFARLWISSLTEKAIRQGFDNLKPGSDFEGLYKAAKGRSRADWLVGINAS
QALSIAAGNGIYSLGRVQTPTLALICKRYLENKNFTAQRYWQLQFSHTKEFTGFTSLSKN
KWEDKKGAEEALKSIERNGNIATVTSIETKNVTEQPPLLFDLTGLQKEANKKLNLSAEET
LNIAQSLYEKKFITYPRTGSKYIPEDMWAEIPNLIRGLQEKEIYKQALANVKWGYLNKRI
VNDLRVTDHHGLLITDKIPSALPAKENAVYNMIALRLLEAISQPCTREITDITLQVLHHD
FEIKGCRIVESGWRLIKGSFFDDNTEPLQELPQMKIGDQLKIKEALVLEKKTKPPVLYTE
AGLLSAMETAGKEIENREERKALQGIGIGTPATRAAIIETLLDRNYIQRELKSLIPTAKG
LQVYELVKDKKIADVAMTAEWEVALQKIENNKADAETFQKEMEEYAVEITNELLQTSIAK
ENLPELTCPKCKKQQLVIRDKIVKCPDAVCNWLQFRNVCGVQLGIADIESLVNTGKTSFI
KGMKSKAGKKFDAYIVLNDKTESSFEFEKNKTSKK
>EGALAKHO_04565 hypothetical protein
MDTPQKDLSYFRLRLQELLNASFPEKMHDIKFIDQRSNWAANAYEGAFRLGNPISQCDHI
AQYILFEGLHFSKFDTVFQVVCNEFDTRMADQELRPFALKMLPVCEPVFAHYKLTDDFSS
TTEFDLLYTELTGTIAIWIEENGLQ
>EGALAKHO_04566 hypothetical protein
MDLPEMTKLAITNIWTPMRPPELITEAQLDCSLQDCSTLILDGKPTGNLKWRLKPVFLMT
AYF
>EGALAKHO_04567 hypothetical protein
MKSDKILHFKIAIILVLKELRRQKNNVTQSEFNADFSERYGFIHNMGRSETKANFTMETL
FLYCDYFGISTVNFFQEVENVSKERILEYIDEKNKRKKNSH
>EGALAKHO_04568 hypothetical protein
MKKEKILVWDNHGAFLRMFKRRLKSGFIVENYVLNKDDPKDYKYQILVAYNKEELINFFK
LDKKGANIIVCLFNKDVPGSLSFLKEIKNLILISPSKGRVEIIKEIKLYLKKTSDATSEI
SKTSFLNSSILQTKFHNSYKALFFFS
>EGALAKHO_04569 hypothetical protein
MSGKLLVLRSNLTNNNMKDLVARINAEIETFKKESDSLTEKGVKAAGPRARKSSLELEKL
FKEFRKVSIAETK
>EGALAKHO_04570 hypothetical protein
MNNAQTYYIGNHPTSRTKTAKAVAPTTQRVCQLDAKTQRCKRGSERQKKISTCTNVTDGF
LKTSFLPKLQETKTAQACEKTVKMQKDFYKSLCKLAEHYGIIPMQSNQFEYPYNMALAIW
DIEEKLQHTVLNWQEIRLVQDRKKTYFISEERYNTGTTLYYIPIEPLYQMLHDPKYKKNA
QLLISVCSYLYHIVDIPYFRQEDTYLYWMYEMHKEWVEQDDETNENEAYKLEFEKVDLIG
DCIEQKIFNRINLSVFEQRINSFKCRDSFDLDCFKMANNALALYTEHPNESIFRNASKKE
DPESEEYETIGMEKYISFISHTKGWLYKSISDSINNEFNEYGAMEEPAIYKCFDRNEVTN
NSLDFENRLFTLLDDMCNLLYNYKTTRK
>EGALAKHO_04571 hypothetical protein
MNTTNEITANFGTLYHPKSALVFYETKEADAEIYVEHFDMDKNGSPVNAHPLTVREANKL
ARALQTEKEKDKAFLKSNGILKANILHINPNKDKGAVLWYTKMQKRQLYFVNGLDIPSAI
ASVPPMIWYATKNSLSLYALASERRPTEKTPLYYAPFFNIYEDGRVCMGTVNINIKNSAS
VEEFAIAWEDYFFNSYFSHLLGSNSPIKGNCINLWKDLVQTGKPFPKEVLKKNNKTLKNL
LS
>EGALAKHO_04572 hypothetical protein
MNTEKTKMHFTDDYLINPTNPITVNVIGAGGTGSKVLTALMEMNHSLVELGHSGLSVRLW
DNDVITSANLGRQRFAACEVGLNKSVALINRANRFMGTNWKAETQKFEKDCLGRLPQNAL
ATIYITCVDNVQARFGVAEMLKELTNRRNYRDTPKYWLDFGNSQHTGQVILSTIGEIKQP
DSEKYQTVASLPFVTEEFGELLLQSEGKDDTPSCSVAESLEKQELFINSALAQMGCSLFW
GLFRYGMTENRGFFLNLKNFSSHPLKVA
>EGALAKHO_04573 hypothetical protein
MKDVIARTNRFYIEMSRKVLSEKEYDVLQKLLIEKMTLGEAAVIYGVTAESIRQIYVRTY
KKVQSVTELLGEIDDYKHKLKQLKQDFKYETRQIKRRNNKIEIEIETETQKDIHKKLYAS
HFPFSKRMYSMFEVLDIHTIGQLCEIPLTEFYRYRGFKEKCKKELVAFIEFENIEYLFED
FSLWKTQPIE
>EGALAKHO_04574 hypothetical protein
MILFLNKLTSGVLPVVLAVLLFSITLVSCSKDELEIQNDFPFEVKVMPVPQAIANGNTVE
IRITIQPTGNYRKVQYFIRYFQFDGKGILRYYNEAPYQLNDSYRLPTEQFRLYYTSNSTV
SQSFDVWISDNFGNEQKLSFDFNSSD
>EGALAKHO_04576 hypothetical protein
MAHNINFNSETGRYSFFSVKEKAWHGLGQIVQQYPTSEEAIKHAGLDYEVAKKPAFIKGA
GLSIGNDGEIIEGQDIIIPNRFGTYRTDTNQPLDVVGKDYHIVQNREAFNFFDAIVGGGE
GILYETAGALGQGERIFITAKLPDYIRVGNGDDVTEKYIFLTTSHDGSGSITAAFTPIRI
VCQNTLNASLRSMSNVVRIKHTSGAKQRLEDAHKVMGLANTLSSQLEGIFNEWAKVKVTD
REVRKLIQLALCPNKETFDLLKKGAEDEVSTLFRNTVDDAFAYAMTSDTQQMDTTKGTLF
GAYNAVTGYYQNVRSYKDDEAKLQSIVMGGTAQLKSQKAFELCTSFATGGAEILNLN
>EGALAKHO_04577 hypothetical protein
MNIGIITYRECEVKNIGLNWNFNLSELLQIMLNNKDFVRFEIFDPNNNLLLSTHYPDVEQ
KGVYVEVVKIKKETEITGITYDAFRTPSTIRRIKVRWNVNGRKFRTKKRALEYVYWENRR
VSLKIEAFVDRR
>EGALAKHO_04578 hypothetical protein
MKYLISEELKAKAIKKNRVFMALNYGVGIIVAIVALSTKFNSLPIKSLLFFSGLIIIVPF
AWLYFDRNFKNKMNSEYEIVDGKLIITENGKQKITELKSIKKVTKIPNGHRIVSNNGTFY
ILDGIENKEDLMTKLKG
>EGALAKHO_04579 hypothetical protein
MKTSVSFKNAIVNAICLLFTLLFIYAATSKLFDFESFTVQLGQSPLLSAFADWISITVPI
LEIIIAVSLLIKPVRLPALYACYLLMVMFTAYIYIILNYSVFVPCSCGGILEKMTWEQHL
IFNIGFIILAIIGILFIPAKKNINNQQN
>EGALAKHO_04580 hypothetical protein
MKTSVSFKNAIVNAICLLFTLLFIYAATSKLFDFESFTIQLGQSPLLSAFADWISITVPI
LEIIIAVSLLIKPLRLPALYACYLLMTMFTAYIYIILNYSAFVPCSCGGIIAKMTWEEHM
IFNICFIILAITGILFIPIKTNVINNKFGNHEM
>EGALAKHO_04581 hypothetical protein
MTEIEKYIIDKVKDMRNKHGFSQLELSQKLDMNDSFVSHVESTSKRAKYNINHLNQIAKV
FNCSPREFIPEKAI
>EGALAKHO_04582 hypothetical protein
MKKEKILVWDNHGAFLRMFKRRLKSGFIVENYVLNKDHPKDYKYQILVAYNKEELINFFK
LDKKGANIIVCLFNKDVPGSLSFLKEIKNLILIPPSKVRVEIIKEIKLYLKKTSDATSEI
SKTSFLNSSILQTKFHDSYKALFFLA
>EGALAKHO_04583 DNA topoisomerase 1
METAGKEIENREERKALQGIGIGTPATRAGIIETLLDRNYIQRELKSLVPTAKGLQVYEL
VKDKKIADVVMTAEWEVALQKIENNQADVETFQKAMETYAVEITNELLQTSIAQENLPEL
TCPKCKKQQLIIRDKIVKCPNAVCNWLQFRNVCGVQLAIADIESLVSKGKTSVIKGMKSK
AGKKFDAYIVLNDKTESSFEFEKNKPSKK
>EGALAKHO_04584 hypothetical protein
MDTPQKDLSYFRLRLQELLNASFPEKMHDAKFIDQRSNWAANAYEGAFRLGNPISQCDDI
AQYILFEGLHFSKFDTVFQVICNEFDTRMADQELRPFALKMLPVCEPVFAHYKLTDDFSS
TTEFDLLYTELTGTIAIWIEENGLQ
